Citrus Sinensis ID: 040845

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------800-------810-------820----
Protein Sequence
MPSIINNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIPRGGSFGNFSAESFKGNELLCGSPNLQVPPCKASIHRTSRKNALILGIVLPFSTIFMTAIILFIIKYQKREKGPPNDPNMPPVATWRRFSYLELFQATDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLRNVGGRCIRQSNLN
Secondary Structure (PSIPRED)
cccccccccEEcccccccccccccccccccccccccccHHHHHccccccEEcccccccccccHHHHccccccccccccccccccccHHHHcccccccEEEccccEEEEcccHHHHHHcccccccccccEEEEcccccccccccccEEEcccccccccccccccccccccccccccEEcccccccccccccHHHcccccccEEEccccEEEEcccccccccccccEEEcccccccccccccccccccccEEEccccccEEcccHHHHcccccccEEcccccccccccccccccccccEEEcccccccccHHHHHccccccccccccccccccccHHHHccccccccccccccccccccHHHHccccccEEccccccccccccHHHHccccccccccccccccccccHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccHHHHHHHHcccccccEEEcccccEEEEEEcccccEEEEEEEEcccccccccHHHHHHHHccccccccccEEEEEccccccEEEEccccccccccccccccccccHHHHHHHHHHHHHHHHHHccccccccEEccccccccccccccEEEEccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHcccccccccccccccHHHHHHHHccccccccccccccccccHHHHcHHHHHHHHHHHHHHcccccccccccHHHHHHHHHHHHHHHHHHHccccccccccc
Secondary Structure Prediction (SSPRO)
ccccccccccccccHHHccccccEEEEcccccccccccHHHcccccccEEEEccccccccccHHHcccccccEEEcccccccccccHHHHHccHcccEEEcccccccccccHHHcccccccEEEcccccccccccHHHcccccccEEEEcccccccccccccccHHHccccccEEEEcccccccccccHHHHHHHHHHHcEEEcccccccccccHHHccccccEEEEEccccccccccHHHccccccEEEEcccccccccccHHHccccccEEEEEccccccccccHHHcccccccEEEccccEEccccHHHHHcccccEEEEEEccEEccccHHHHHcccccEEEEEEccEEccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHHHHcccccEEEccccccEEEccccccHHHccHHHcccccEEEccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccHHHHHHHHHcccHccEEEccccEEEEEEEcccccEEEEEEccccccccccHHHHHHHHHHHccHHHHHHHHEEEccccccEEEEEccccccHHHHHccccccccHHHHHHHHHHHHHHHHHHHccccccEEcccccHHHEEEcccccEEEccccccHEEccccccccccEEccccccccccHcEEEEEcccccHHHHHHHHHHHHcccccccccccccccHHHHHHHHHHcccEEEEcHHHcccccccccccHHHHHHHHHHHHHHccccccccccHHHHHHHHHHHccccccccccccccccccc
Coil and Loop (DISEMBL)
mpsiinnfltsttpkeidnisnlKVLYLYNNRLQGEIIHEIghlhnlgfldlsqnkllgtipaaIFNVSTLKAFAVTnnslsgclssitdvglpnLEVLYLWgnnfsgtiphfIFNASKLSKLALEMnsfsgfipstfgnlrnlewltlydnnltsstldlsflsslsnckslthislsnnpldgilprtyvgNLSHSLKNFYMYncnvsggipeeitnltdlttivlggnklngsipitlgklqklqdVDLEynqlegsipdsicLSVELYELElggnklsgsipacfsnmTFLKVLSLgsneltsiplnfwslkdildlnlssncfsgplplEIRNLKALIEIDfsmnnfsgiipmeigslknLENLFLEYNrlegsipdsfgdLISLKSLNlsynnlsgtipvslEKLSYLKDLNLSFNKlkgeiprggsfgnfsaesfkgnellcgspnlqvppckasihrtSRKNALILGIVLPFSTIFMTAIILFIIKYQkrekgppndpnmppvatwrRFSYLELFQATdkfsennligrggfgsVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEymphgslekylhssnyslDIFQRLNIMIDVASALEYlhfgysapvihcdlkpsnvllddnmvaHLSDFgiaklltgedqsmtQTQTLATIgymapeygregqvstngdvYSFGIMLMETftrkkptdelfngeMTLKHWVndclpistmevvdanllsqediHFVAKEQCVSFVFNLALectvespeqRINAKEIVAKLLKIRDSLLRNvggrcirqsnln
Flexible Loop (DISEMBL)
mpsiinnfltsttpkeidnISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHislsnnpldgILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIPRGGSFGNFSAESFKGNELLCGSPNLQVPPCKASIHRTSRKNALILGIVLPFSTIFMTAIILFIIKYqkrekgppndpNMPPVATWRRFSYLELFQATdkfsennligrggFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALEctvespeqriNAKEIVAKLLKIRDsllrnvggrcirqsnln
Low Complexity Region (SEG)
MPSIINNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYdnnltsstldlsflsslsnCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLIslkslnlsynnlsGTIPVSLEKLSYLKDLNLSFNKLKGEIPRGGSFGNFSAESFKGNELLCGSPNLQVPPCKASIHRTSRKNALILGIVLPFSTIFMTAIILFIIKYQKREKGPPNDPNMPPVATWRRFSYLELFQATDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLRNVGGRCIRQSNLN
Disordered region (IsUnstruct)
*****NNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIPRGGSFGNFSAESFKGNELLCGSPNLQVPPCKASIHRTSRKNALILGIVLPFSTIFMTAIILFIIKYQ**************VATWRRFSYLELFQATDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLRNVGGRCI******
Disordered Region (DISOPRED)
MPSIINNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIPRGGSFGNFSAESFKGNELLCGSPN********************LGIVLPFSTIFMTAIILFIIK*********************RFSYLELFQATDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED**MTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDS****************
Disordered Region (DISEMBL)
MPSIINNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIPRGGSFGNFSAESFKGNELLCGSPNLQVPPCKASIHRTSRKNALILGIVLPFSTIFMTAIILFIIKYQKREKGPPNDPNMPPVATWRRFSYLELFQATDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLRNVGGRCIRQSNLN
Disordered Region (DISPRO)
MPSIINNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIPRGGSFGNFSAESFKGNELLCGSPNLQVPPCKASIHRTSRKNALILGIVLPFSTIFMTAIILFIIKYQKRE********MPPVATWRRFSYLELFQATDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIR******************
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MPSIINNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIPRGGSFGNFSAESFKGNELLCGSPNLQVPPCKASIHRTSRKNALILGIVLPFSTIFMTAIILFIIKYQKREKGPPNDPNMPPVATWRRFSYLELFQATDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLRNVGGRCIRQSNLN
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	824	2.2.26 [Sep-21-2011]
C0LGP4	1010	Probable LRR receptor-lik	yes	no	0.973	0.794	0.388	1e-148
Q9SD62	1025	Putative receptor-like pr	no	no	0.975	0.784	0.397	1e-136
C0LGT6	1031	LRR receptor-like serine/	no	no	0.955	0.763	0.373	1e-135
Q9ZUI0	980	Putative leucine-rich rep	no	no	0.964	0.811	0.353	1e-126
Q9FL28	1173	LRR receptor-like serine/	no	no	0.966	0.678	0.337	1e-116
Q9FIZ3	1252	LRR receptor-like serine/	no	no	0.964	0.634	0.322	1e-112
C0LGQ5	1249	LRR receptor-like serine/	no	no	0.958	0.632	0.319	1e-105
Q9LYN8	1192	Leucine-rich repeat recep	no	no	0.949	0.656	0.319	1e-102
Q9LHP4	1141	Receptor-like protein kin	no	no	0.951	0.687	0.323	1e-102
Q9LVP0	1102	Probable leucine-rich rep	no	no	0.953	0.713	0.320	1e-101

>sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1

 Score =  526 bits (1354), Expect = e-148,   Method: Compositional matrix adjust.
 Identities = 324/835 (38%), Positives = 473/835 (56%), Gaps = 33/835 (3%)

Query: 7    NFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIF 66
            N +    P  + N++ L+ L L +N L+GEI  ++  L  +  L L  N   G  P A++
Sbjct: 172  NNMRGKLPTSLGNLTLLEQLALSHNNLEGEIPSDVAQLTQIWSLQLVANNFSGVFPPALY 231

Query: 67   NVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALE 126
            N+S+LK   +  N  SG L     + LPNL    + GN F+G+IP  + N S L +L + 
Sbjct: 232  NLSSLKLLGIGYNHFSGRLRPDLGILLPNLLSFNMGGNYFTGSIPTTLSNISTLERLGMN 291

Query: 127  MNSFSGFIPSTFGNLRNLEWLTLYDNNLTS-STLDLSFLSSLSNCKSLTHISLSNNPLDG 185
             N+ +G IP TFGN+ NL+ L L+ N+L S S+ DL FL+SL+NC  L  + +  N L G
Sbjct: 292  ENNLTGSIP-TFGNVPNLKLLFLHTNSLGSDSSRDLEFLTSLTNCTQLETLGIGRNRLGG 350

Query: 186  ILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQ 245
             LP + + NLS  L    +    +SG IP +I NL +L  ++L  N L+G +P +LGKL 
Sbjct: 351  DLPIS-IANLSAKLVTLDLGGTLISGSIPYDIGNLINLQKLILDQNMLSGPLPTSLGKLL 409

Query: 246  KLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNEL 305
             L+ + L  N+L G IP  I     L  L+L  N   G +P    N + L  L +G N+L
Sbjct: 410  NLRYLSLFSNRLSGGIPAFIGNMTMLETLDLSNNGFEGIVPTSLGNCSHLLELWIGDNKL 469

Query: 306  T-SIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLK 364
              +IPL    ++ +L L++S N   G LP +I  L+ L  +    N  SG +P  +G+  
Sbjct: 470  NGTIPLEIMKIQQLLRLDMSGNSLIGSLPQDIGALQNLGTLSLGDNKLSGKLPQTLGNCL 529

Query: 365  NLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKL 424
             +E+LFLE N   G IPD  G L+ +K ++LS N+LSG+IP      S L+ LNLSFN L
Sbjct: 530  TMESLFLEGNLFYGDIPDLKG-LVGVKEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNL 588

Query: 425  KGEIPRGGSFGNFSAESFKGNELLCGS-PNLQVPPCKASI-----HRTSRKNALILGIVL 478
            +G++P  G F N +  S  GN  LCG     Q+ PC +         +SR   +++G+ +
Sbjct: 589  EGKVPVKGIFENATTVSIVGNNDLCGGIMGFQLKPCLSQAPSVVKKHSSRLKKVVIGVSV 648

Query: 479  PFSTI---FMTAIILFIIKYQKREKGPPNDPNMPPVATWRRFSYLELFQATDKFSENNLI 535
              + +   FM ++ L  ++ +K+ K   N           + SY +L  AT+ FS +N++
Sbjct: 649  GITLLLLLFMASVTLIWLRKRKKNKETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNMV 708

Query: 536  GRGGFGSVYKARI-RDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSN 594
            G G FG+VYKA +  +   VAVKV N+Q   A KSF  EC  +K IRHRNLVK++++CS+
Sbjct: 709  GSGSFGTVYKALLLTEKKVVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSS 768

Query: 595  -----EEFKALVLEYMPHGSLEKYLHSS--------NYSLDIFQRLNIMIDVASALEYLH 641
                  EF+AL+ E+MP+GSL+ +LH          + +L + +RLNI IDVAS L+YLH
Sbjct: 769  IDFQGNEFRALIYEFMPNGSLDMWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLH 828

Query: 642  FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ-----SMTQTQTLATIGYM 696
                 P+ HCDLKPSNVLLDD++ AH+SDFG+A+LL   D+      ++      TIGY 
Sbjct: 829  VHCHEPIAHCDLKPSNVLLDDDLTAHVSDFGLARLLLKFDEESFFNQLSSAGVRGTIGYA 888

Query: 697  APEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVD 756
            APEYG  GQ S NGDVYSFGI+L+E FT K+PT+ELF G  TL  +    LP   +++VD
Sbjct: 889  APEYGVGGQPSINGDVYSFGILLLEMFTGKRPTNELFGGNFTLNSYTKSALPERILDIVD 948

Query: 757  ANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLR 811
             ++L           +C++ VF + L C  ESP  R+    +V +L+ IR+   +
Sbjct: 949  ESILHIGLRVGFPVVECLTMVFEVGLRCCEESPMNRLATSIVVKELISIRERFFK 1003

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1

 Score =  487 bits (1254), Expect = e-136,   Method: Compositional matrix adjust.
 Identities = 333/838 (39%), Positives = 478/838 (57%), Gaps = 34/838 (4%)

Query: 7    NFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIF 66
            N LT   P  + N+++L++L    N+++GEI  +I  L  + F  ++ NK  G  P  I+
Sbjct: 187  NNLTGKFPASLGNLTSLQMLDFIYNQIEGEIPGDIARLKQMIFFRIALNKFNGVFPPPIY 246

Query: 67   NVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALE 126
            N+S+L   ++T NS SG L       LPNL++LY+  N+F+GTIP  + N S L +L + 
Sbjct: 247  NLSSLIFLSITGNSFSGTLRPDFGSLLPNLQILYMGINSFTGTIPETLSNISSLRQLDIP 306

Query: 127  MNSFSGFIPSTFGNLRNLEWLTLYDNNLTS-STLDLSFLSSLSNCKSLTHISLSNNPLDG 185
             N  +G IP +FG L+NL  L L +N+L + S+ DL FL +L+NC  L ++++  N L G
Sbjct: 307  SNHLTGKIPLSFGRLQNLLLLGLNNNSLGNYSSGDLDFLGALTNCSQLQYLNVGFNKLGG 366

Query: 186  ILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQ 245
             LP  ++ NLS  L    +    +SG IP  I NL  L T+ LG N L G +P +LG+L 
Sbjct: 367  QLP-VFIANLSTQLTELSLGGNLISGSIPHGIGNLVSLQTLDLGENLLTGKLPPSLGELS 425

Query: 246  KLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNEL 305
            +L+ V L  N L G IP S+     L  L L  N   GSIP+   + ++L  L+LG+N+L
Sbjct: 426  ELRKVLLYSNGLSGEIPSSLGNISGLTYLYLLNNSFEGSIPSSLGSCSYLLDLNLGTNKL 485

Query: 306  T-SIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLK 364
              SIP     L  ++ LN+S N   GPL  +I  LK L+ +D S N  SG IP  + +  
Sbjct: 486  NGSIPHELMELPSLVVLNVSFNLLVGPLRQDIGKLKFLLALDVSYNKLSGQIPQTLANCL 545

Query: 365  NLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKL 424
            +LE L L+ N   G IPD  G L  L+ L+LS NNLSGTIP  +   S L++LNLS N  
Sbjct: 546  SLEFLLLQGNSFVGPIPDIRG-LTGLRFLDLSKNNLSGTIPEYMANFSKLQNLNLSLNNF 604

Query: 425  KGEIPRGGSFGNFSAESFKGNELLCGS-PNLQVPPCKASI---HRTSRKNALILGIVLPF 480
             G +P  G F N SA S  GN  LCG  P+LQ+ PC   +   H + RK   I    +  
Sbjct: 605  DGAVPTEGVFRNTSAMSVFGNINLCGGIPSLQLQPCSVELPRRHSSVRKIITICVSAVMA 664

Query: 481  STIFMTAIILFIIKYQKREKGP-----PNDPNMPPVAT-WRRFSYLELFQATDKFSENNL 534
            + + +   ++++  Y+ R K        ND +  PV + + + SY EL++ T  FS +NL
Sbjct: 665  ALLLLCLCVVYLCWYKLRVKSVRANNNENDRSFSPVKSFYEKISYDELYKTTGGFSSSNL 724

Query: 535  IGRGGFGSVYKARI-RDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCS 593
            IG G FG+V+K  +      VA+KV NL    A KSF  EC  +  IRHRNLVK+++ CS
Sbjct: 725  IGSGNFGAVFKGFLGSKNKAVAIKVLNLCKRGAAKSFIAECEALGGIRHRNLVKLVTICS 784

Query: 594  NE-----EFKALVLEYMPHGSLEKYLH--------SSNYSLDIFQRLNIMIDVASALEYL 640
            +      +F+ALV E+MP+G+L+ +LH        + + +L +F RLNI IDVASAL YL
Sbjct: 785  SSDFEGNDFRALVYEFMPNGNLDMWLHPDEIEETGNPSRTLGLFARLNIAIDVASALVYL 844

Query: 641  HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQ-----TLATIGY 695
            H     P+ HCD+KPSN+LLD ++ AH+SDFG+A+LL   D+     Q        TIGY
Sbjct: 845  HTYCHNPIAHCDIKPSNILLDKDLTAHVSDFGLAQLLLKFDRDTFHIQFSSAGVRGTIGY 904

Query: 696  MAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCL-PISTMEV 754
             APEYG  G  S  GDVYSFGI+L+E FT K+PT++LF   +TL  +    L     +++
Sbjct: 905  AAPEYGMGGHPSIMGDVYSFGIVLLEIFTGKRPTNKLFVDGLTLHSFTKSALQKRQALDI 964

Query: 755  VDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLRN 812
             D  +L           +C++ VF + + C+ ESP  RI+  E ++KL+ IR+S  R+
Sbjct: 965  TDETILRGAYAQHFNMVECLTLVFRVGVSCSEESPVNRISMAEAISKLVSIRESFFRD 1022

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1

 Score =  481 bits (1239), Expect = e-135,   Method: Compositional matrix adjust.
 Identities = 311/832 (37%), Positives = 451/832 (54%), Gaps = 45/832 (5%)

Query: 7   NFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIF 66
           N LT   P  + N+++L+ L    N+++GEI  E+  L  + F  ++ N   G  P A++
Sbjct: 179 NNLTGNFPASLGNLTSLQKLDFAYNQMRGEIPDEVARLTQMVFFQIALNSFSGGFPPALY 238

Query: 67  NVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALE 126
           N+S+L++ ++ +NS SG L +     LPNL  L L  N F+G IP  + N S L +  + 
Sbjct: 239 NISSLESLSLADNSFSGNLRADFGYLLPNLRRLLLGTNQFTGAIPKTLANISSLERFDIS 298

Query: 127 MNSFSGFIPSTFGNLRNLEWLTL-YDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDG 185
            N  SG IP +FG LRNL WL +  ++   +S+  L F+ +++NC  L ++ +  N L G
Sbjct: 299 SNYLSGSIPLSFGKLRNLWWLGIRNNSLGNNSSSGLEFIGAVANCTQLEYLDVGYNRLGG 358

Query: 186 ILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQ 245
            LP + + NLS +L + ++    +SG IP +I NL  L  + L  N L+G +P++ GKL 
Sbjct: 359 ELPAS-IANLSTTLTSLFLGQNLISGTIPHDIGNLVSLQELSLETNMLSGELPVSFGKLL 417

Query: 246 KLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNEL 305
            LQ VDL  N + G IP        L +L L  N   G IP       +L  L + +N L
Sbjct: 418 NLQVVDLYSNAISGEIPSYFGNMTRLQKLHLNSNSFHGRIPQSLGRCRYLLDLWMDTNRL 477

Query: 306 T-SIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLK 364
             +IP     +  +  ++LS+N  +G  P E+  L+ L+ +  S N  SG +P  IG   
Sbjct: 478 NGTIPQEILQIPSLAYIDLSNNFLTGHFPEEVGKLELLVGLGASYNKLSGKMPQAIGGCL 537

Query: 365 NLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKL 424
           ++E LF++ N  +G+IPD    L+SLK+++ S NNLSG IP  L  L  L++LNLS NK 
Sbjct: 538 SMEFLFMQGNSFDGAIPD-ISRLVSLKNVDFSNNNLSGRIPRYLASLPSLRNLNLSMNKF 596

Query: 425 KGEIPRGGSFGNFSAESFKGNELLCGS-PNLQVPPCKASIHRTSRK-----NALILGIVL 478
           +G +P  G F N +A S  GN  +CG    +Q+ PC        RK       ++ GI +
Sbjct: 597 EGRVPTTGVFRNATAVSVFGNTNICGGVREMQLKPCIVQASPRKRKPLSVRKKVVSGICI 656

Query: 479 PFSTIFMTAIILFIIKYQKREKGPPNDPNMPPVAT-----WRRFSYLELFQATDKFSENN 533
             +++ +  I+  +  + KR+K        P  +T       + SY EL  AT +FS  N
Sbjct: 657 GIASLLLIIIVASLCWFMKRKKKNNASDGNPSDSTTLGMFHEKVSYEELHSATSRFSSTN 716

Query: 534 LIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSC 592
           LIG G FG+V+K  +  +   VAVKV NL    A KSF  EC   K IRHRNLVK+I+ C
Sbjct: 717 LIGSGNFGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAECETFKGIRHRNLVKLITVC 776

Query: 593 SN-----EEFKALVLEYMPHGSLEKYLH--------SSNYSLDIFQRLNIMIDVASALEY 639
           S+      +F+ALV E+MP GSL+ +L           + SL   ++LNI IDVASALEY
Sbjct: 777 SSLDSEGNDFRALVYEFMPKGSLDMWLQLEDLERVNDHSRSLTPAEKLNIAIDVASALEY 836

Query: 640 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ-----SMTQTQTLATIG 694
           LH     PV HCD+KPSN+LLDD++ AH+SDFG+A+LL   D+       +      TIG
Sbjct: 837 LHVHCHDPVAHCDIKPSNILLDDDLTAHVSDFGLAQLLYKYDRESFLNQFSSAGVRGTIG 896

Query: 695 YMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEV 754
           Y APEYG  GQ S  GDVYSFGI+L+E F+ KKPTDE F G+  L  +    L   T   
Sbjct: 897 YAAPEYGMGGQPSIQGDVYSFGILLLEMFSGKKPTDESFAGDYNLHSYTKSILSGCTSSG 956

Query: 755 VDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIR 806
                         A ++ +  V  + ++C+ E P  R+   E V +L+ IR
Sbjct: 957 GSN-----------AIDEGLRLVLQVGIKCSEEYPRDRMRTDEAVRELISIR 997

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1

 Score =  451 bits (1161), Expect = e-126,   Method: Compositional matrix adjust.
 Identities = 307/869 (35%), Positives = 460/869 (52%), Gaps = 74/869 (8%)

Query: 7   NFLTSTTPKEIDNI-SNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAI 65
           NF     P EI ++   LK L L  N L G I  E+G L+ L +LDL  N+L G+IP  +
Sbjct: 100 NFFVGKIPPEIGSLHETLKQLSLSENLLHGNIPQELGLLNRLVYLDLGSNRLNGSIPVQL 159

Query: 66  F---NVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSK 122
           F   + S+L+   ++NNSL+G +       L  L  L LW N  +GT+P  + N++ L  
Sbjct: 160 FCNGSSSSLQYIDLSNNSLTGEIPLNYHCHLKELRFLLLWSNKLTGTVPSSLSNSTNLKW 219

Query: 123 LALEMNSFSGFIPS-TFGNLRNLEWLTLYDNNLTSSTLDLS---FLSSLSNCKSLTHISL 178
           + LE N  SG +PS     +  L++L L  N+  S   + +   F +SL+N   L  + L
Sbjct: 220 MDLESNMLSGELPSQVISKMPQLQFLYLSYNHFVSHNNNTNLEPFFASLANSSDLQELEL 279

Query: 179 SNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEIT-------------------- 218
           + N L G +  + V +LS +L   ++    + G IP EI+                    
Sbjct: 280 AGNSLGGEITSS-VRHLSVNLVQIHLDQNRIHGSIPPEISNLLNLTLLNLSSNLLSGPIP 338

Query: 219 ----NLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYEL 274
                L+ L  + L  N L G IP+ LG + +L  +D+  N L GSIPDS     +L  L
Sbjct: 339 RELCKLSKLERVYLSNNHLTGEIPMELGDIPRLGLLDVSRNNLSGSIPDSFGNLSQLRRL 398

Query: 275 ELGGNKLSGSIPACFSNMTFLKVLSLGSNELT-SIPLNFWS-LKDI-LDLNLSSNCFSGP 331
            L GN LSG++P        L++L L  N LT +IP+   S L+++ L LNLSSN  SGP
Sbjct: 399 LLYGNHLSGTVPQSLGKCINLEILDLSHNNLTGTIPVEVVSNLRNLKLYLNLSSNHLSGP 458

Query: 332 LPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLK 391
           +PLE+  +  ++ +D S N  SG IP ++GS   LE+L L  N    ++P S G L  LK
Sbjct: 459 IPLELSKMDMVLSVDLSSNELSGKIPPQLGSCIALEHLNLSRNGFSSTLPSSLGQLPYLK 518

Query: 392 SLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIPRGGSFGNFSAESFKGNELLCGS 451
            L++S+N L+G IP S ++ S LK LN SFN L G +   GSF   + ESF G+ LLCGS
Sbjct: 519 ELDVSFNRLTGAIPPSFQQSSTLKHLNFSFNLLSGNVSDKGSFSKLTIESFLGDSLLCGS 578

Query: 452 PNLQVPPCKASIHRTSRKNALILGIVLPFSTIFMTAIILF------IIKYQK-----REK 500
                   K   + +     L+  I  P   +F   ++        +  Y K      EK
Sbjct: 579 IKGMQACKKKHKYPSVLLPVLLSLIATPVLCVFGYPLVQRSRFGKNLTVYAKEEVEDEEK 638

Query: 501 GPPNDPNMPPVATWRRFSYLELFQATDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFN 560
              NDP  P      R SY +L  AT  F+ ++LIG G FG VYK  +R+  +VAVKV +
Sbjct: 639 QNQNDPKYP------RISYQQLIAATGGFNASSLIGSGRFGHVYKGVLRNNTKVAVKVLD 692

Query: 561 LQCGRAFK-SFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNY 619
            +    F  SF  EC ++K  RHRNL+++I++CS   F ALVL  MP+GSLE++L+   Y
Sbjct: 693 PKTALEFSGSFKRECQILKRTRHRNLIRIITTCSKPGFNALVLPLMPNGSLERHLYPGEY 752

Query: 620 S---LDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 676
           S   LD+ Q +NI  DVA  + YLH      V+HCDLKPSN+LLDD M A ++DFGI++L
Sbjct: 753 SSKNLDLIQLVNICSDVAEGIAYLHHYSPVKVVHCDLKPSNILLDDEMTALVTDFGISRL 812

Query: 677 LTGEDQSMTQTQTLA----------TIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRK 726
           + G +++++   +++          ++GY+APEYG   + ST+GDVYSFG++L+E  + +
Sbjct: 813 VQGVEETVSTDDSVSFGSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVSGR 872

Query: 727 KPTDELFNGEMTLKHWVNDCLPISTMEVVDANLL------SQEDIHFVAKEQCVSFVFNL 780
           +PTD L N   +L  ++    P S   +++  L         E    + +E  +  +  L
Sbjct: 873 RPTDVLVNEGSSLHEFMKSHYPDSLEGIIEQALSRWKPQGKPEKCEKLWREVILEMI-EL 931

Query: 781 ALECTVESPEQRINAKEIVAKLLKIRDSL 809
            L CT  +P  R +  ++  ++ ++++ L
Sbjct: 932 GLVCTQYNPSTRPDMLDVAHEMGRLKEYL 960

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1

 Score =  421 bits (1082), Expect = e-116,   Method: Compositional matrix adjust.
 Identities = 310/918 (33%), Positives = 462/918 (50%), Gaps = 122/918 (13%)

Query: 4    IINNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPA 63
            +  N L    P EI N S+L  L LY+N+L G+I  E+G+L  L  L + +NKL  +IP+
Sbjct: 247  LTENLLEGDIPAEIGNCSSLVQLELYDNQLTGKIPAELGNLVQLQALRIYKNKLTSSIPS 306

Query: 64   AIFNVSTLKAFAVTNNSLSGCLSSITDVG-LPNLEVLYLWGNNFSGTIPHFIFNASKLSK 122
            ++F ++ L    ++ N L G +S   ++G L +LEVL L  NNF+G  P  I N   L+ 
Sbjct: 307  SLFRLTQLTHLGLSENHLVGPISE--EIGFLESLEVLTLHSNNFTGEFPQSITNLRNLTV 364

Query: 123  LALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTS-------------------------- 156
            L +  N+ SG +P+  G L NL  L+ +DN LT                           
Sbjct: 365  LTVGFNNISGELPADLGLLTNLRNLSAHDNLLTGPIPSSISNCTGLKLLDLSHNQMTGEI 424

Query: 157  ----STLDLSFLS------------SLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLK 200
                  ++L+F+S             + NC +L  +S+++N L G L +  +G L   L+
Sbjct: 425  PRGFGRMNLTFISIGRNHFTGEIPDDIFNCSNLETLSVADNNLTGTL-KPLIGKL-QKLR 482

Query: 201  NFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGS 260
               +   +++G IP EI NL DL  + L  N   G IP  +  L  LQ + +  N LEG 
Sbjct: 483  ILQVSYNSLTGPIPREIGNLKDLNILYLHSNGFTGRIPREMSNLTLLQGLRMYSNDLEGP 542

Query: 261  IPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELT-SIPLNFWSLK--- 316
            IP+ +     L  L+L  NK SG IPA FS +  L  LSL  N+   SIP +  SL    
Sbjct: 543  IPEEMFDMKLLSVLDLSNNKFSGQIPALFSKLESLTYLSLQGNKFNGSIPASLKSLSLLN 602

Query: 317  --DILD---------------------LNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFS 353
              DI D                     LN S+N  +G +P E+  L+ + EID S N FS
Sbjct: 603  TFDISDNLLTGTIPGELLASLKNMQLYLNFSNNLLTGTIPKELGKLEMVQEIDLSNNLFS 662

Query: 354  GIIPMEIGSLKNLENLFLEYNRLEGSIPD-------------------------SFGDLI 388
            G IP  + + KN+  L    N L G IPD                         SFG++ 
Sbjct: 663  GSIPRSLQACKNVFTLDFSQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMT 722

Query: 389  SLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIPRGGSFGNFSAESFKGNELL 448
             L SL+LS NNL+G IP SL  LS LK L L+ N LKG +P  G F N +A    GN  L
Sbjct: 723  HLVSLDLSSNNLTGEIPESLANLSTLKHLKLASNNLKGHVPESGVFKNINASDLMGNTDL 782

Query: 449  CGSPNLQVPPC---KASIHRTSRKNA--LILG---IVLPFSTIFMTAIILFIIKYQKREK 500
            CGS    + PC   + S H + R     +ILG    +L    + +        + +    
Sbjct: 783  CGSKK-PLKPCTIKQKSSHFSKRTRVILIILGSAAALLLVLLLVLILTCCKKKEKKIENS 841

Query: 501  GPPNDPNMPPVATWRRFSYLELFQATDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFN 560
               + P++      +RF   EL QATD F+  N+IG     +VYK ++ DG  +AVKV N
Sbjct: 842  SESSLPDLDSALKLKRFEPKELEQATDSFNSANIIGSSSLSTVYKGQLEDGTVIAVKVLN 901

Query: 561  LQ--CGRAFKSFDVECAMMKSIRHRNLVKVIS-SCSNEEFKALVLEYMPHGSLEKYLHSS 617
            L+     + K F  E   +  ++HRNLVK++  +  + + KALVL +M +G+LE  +H S
Sbjct: 902  LKEFSAESDKWFYTEAKTLSQLKHRNLVKILGFAWESGKTKALVLPFMENGNLEDTIHGS 961

Query: 618  NYSL-DIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 676
               +  + +++++ + +AS ++YLH GY  P++HCDLKP+N+LLD + VAH+SDFG A++
Sbjct: 962  AAPIGSLLEKIDLCVHIASGIDYLHSGYGFPIVHCDLKPANILLDSDRVAHVSDFGTARI 1021

Query: 677  LTGEDQSMTQTQTLA---TIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPT--DE 731
            L   +   T   T A   TIGY+APE+    +V+T  DV+SFGI++ME  T+++PT  ++
Sbjct: 1022 LGFREDGSTTASTSAFEGTIGYLAPEFAYMRKVTTKADVFSFGIIMMELMTKQRPTSLND 1081

Query: 732  LFNGEMTLKHWVNDCL---PISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVES 788
              + +MTL+  V   +       + V+D  L   + I  + +E+ +     L L CT   
Sbjct: 1082 EDSQDMTLRQLVEKSIGNGRKGMVRVLDMEL--GDSIVSLKQEEAIEDFLKLCLFCTSSR 1139

Query: 789  PEQRINAKEIVAKLLKIR 806
            PE R +  EI+  L+K+R
Sbjct: 1140 PEDRPDMNEILTHLMKLR 1157

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2

 Score =  405 bits (1042), Expect = e-112,   Method: Compositional matrix adjust.
 Identities = 298/924 (32%), Positives = 451/924 (48%), Gaps = 129/924 (13%)

Query: 4    IINNFLTSTTPKEI-DNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIP 62
            +  N L+ + PK I  N ++LK L+L   +L GEI  EI +  +L  LDLS N L G IP
Sbjct: 319  LAKNRLSGSLPKTICSNNTSLKQLFLSETQLSGEIPAEISNCQSLKLLDLSNNTLTGQIP 378

Query: 63   AAIFNVSTLKAFAVTNNSLSGCLSSI----------------------TDVG-LPNLEVL 99
             ++F +  L    + NNSL G LSS                        ++G L  LE++
Sbjct: 379  DSLFQLVELTNLYLNNNSLEGTLSSSISNLTNLQEFTLYHNNLEGKVPKEIGFLGKLEIM 438

Query: 100  YLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTL 159
            YL+ N FSG +P  I N ++L ++    N  SG IPS+ G L++L  L L +N L  +  
Sbjct: 439  YLYENRFSGEMPVEIGNCTRLQEIDWYGNRLSGEIPSSIGRLKDLTRLHLRENELVGN-- 496

Query: 160  DLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITN 219
                 +SL NC  +T I L++N L G +P ++ G L+ +L+ F +YN ++ G +P+ + N
Sbjct: 497  ---IPASLGNCHQMTVIDLADNQLSGSIPSSF-GFLT-ALELFMIYNNSLQGNLPDSLIN 551

Query: 220  LTDLTTIVLGGNKLNGSI------------------------------------------ 237
            L +LT I    NK NGSI                                          
Sbjct: 552  LKNLTRINFSSNKFNGSISPLCGSSSYLSFDVTENGFEGDIPLELGKSTNLDRLRLGKNQ 611

Query: 238  -----PITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNM 292
                 P T GK+ +L  +D+  N L G IP  + L  +L  ++L  N LSG IP     +
Sbjct: 612  FTGRIPRTFGKISELSLLDISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKL 671

Query: 293  TFLKVLSLGSNELT-SIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNN 351
              L  L L SN+   S+P   +SL +IL L L  N  +G +P EI NL+AL  ++   N 
Sbjct: 672  PLLGELKLSSNKFVGSLPTEIFSLTNILTLFLDGNSLNGSIPQEIGNLQALNALNLEENQ 731

Query: 352  FSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKS-LNLSYNNLSGTIPVSLEK 410
             SG +P  IG L  L  L L  N L G IP   G L  L+S L+LSYNN +G IP ++  
Sbjct: 732  LSGPLPSTIGKLSKLFELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTIST 791

Query: 411  LSYLKDLNLSFNKLKGEIPR----------------------GGSFGNFSAESFKGNELL 448
            L  L+ L+LS N+L GE+P                          F  + A++F GN  L
Sbjct: 792  LPKLESLDLSHNQLVGEVPGQIGDMKSLGYLNLSYNNLEGKLKKQFSRWQADAFVGNAGL 851

Query: 449  CGSPNLQVPPCKASIHRT-SRKNALILGIVLPFSTIFMTAIILFIIKYQ-----KREKG- 501
            CGSP        +   R+ S K  +I+  +   + I +  +++ +   Q     K+ +G 
Sbjct: 852  CGSPLSHCNRAGSKNQRSLSPKTVVIISAISSLAAIALMVLVIILFFKQNHDLFKKVRGG 911

Query: 502  ---------PPNDPNMPPVATWRRFSYLELFQATDKFSENNLIGRGGFGSVYKARIRDGM 552
                         P            + ++ +AT   +E  +IG GG G VYKA +++G 
Sbjct: 912  NSAFSSNSSSSQAPLFSNGGAKSDIKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKNGE 971

Query: 553  EVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVKVISSCSNEE--FKALVLEYMPHGS 609
             +AVK    +    + KSF+ E   + +IRHR+LVK++  CS++      L+ EYM +GS
Sbjct: 972  TIAVKKILWKDDLMSNKSFNREVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYMANGS 1031

Query: 610  LEKYLHSSNYS-----LDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM 664
            +  +LH++  +     L    RL I + +A  +EYLH+    P++H D+K SNVLLD N+
Sbjct: 1032 VWDWLHANENTKKKEVLGWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNI 1091

Query: 665  VAHLSDFGIAKLLTGEDQSMTQTQTL--ATIGYMAPEYGREGQVSTNGDVYSFGIMLMET 722
             AHL DFG+AK+LTG   + T++ T+   + GY+APEY    + +   DVYS GI+LME 
Sbjct: 1092 EAHLGDFGLAKILTGNYDTNTESNTMFAGSYGYIAPEYAYSLKATEKSDVYSMGIVLMEI 1151

Query: 723  FTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSF-VFNLA 781
             T K PT+ +F+ E  +  WV   L           L+  E    +  E+  ++ V  +A
Sbjct: 1152 VTGKMPTEAMFDEETDMVRWVETVLDTPPGSEAREKLIDSELKSLLPCEEEAAYQVLEIA 1211

Query: 782  LECTVESPEQRINAKEIVAKLLKI 805
            L+CT   P++R ++++    LL +
Sbjct: 1212 LQCTKSYPQERPSSRQASEYLLNV 1235

Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1

 Score =  384 bits (987), Expect = e-105,   Method: Compositional matrix adjust.
 Identities = 298/933 (31%), Positives = 443/933 (47%), Gaps = 143/933 (15%)

Query: 4    IINNFLTSTTPKEI-DNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIP 62
            + NN L+ + PK I  N +NL+ L L   +L GEI  E+    +L  LDLS N L G+IP
Sbjct: 318  LANNHLSGSLPKSICSNNTNLEQLVLSGTQLSGEIPVELSKCQSLKQLDLSNNSLAGSIP 377

Query: 63   AAIFNVSTLKAFAVTNNSLSGCLS-SITDV----------------------GLPNLEVL 99
             A+F +  L    + NN+L G LS SI+++                       L  LEVL
Sbjct: 378  EALFELVELTDLYLHNNTLEGTLSPSISNLTNLQWLVLYHNNLEGKLPKEISALRKLEVL 437

Query: 100  YLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTL 159
            +L+ N FSG IP  I N + L  + +  N F G IP + G L+ L  L L  N L     
Sbjct: 438  FLYENRFSGEIPQEIGNCTSLKMIDMFGNHFEGEIPPSIGRLKELNLLHLRQNELVGG-- 495

Query: 160  DLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITN 219
                 +SL NC  L  + L++N L G +P ++       L+   +YN ++ G +P+ + +
Sbjct: 496  ---LPASLGNCHQLNILDLADNQLSGSIPSSF--GFLKGLEQLMLYNNSLQGNLPDSLIS 550

Query: 220  LTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGN 279
            L +LT I L  N+LNG+I    G    L   D+  N  E  IP  +  S  L  L LG N
Sbjct: 551  LRNLTRINLSHNRLNGTIHPLCGSSSYL-SFDVTNNGFEDEIPLELGNSQNLDRLRLGKN 609

Query: 280  KLSGSIPACFSNMTFLKVLSLGSNELT-SIPLNFWSLKDILDLNLSSNCFSGPLPLEIRN 338
            +L+G IP     +  L +L + SN LT +IPL     K +  ++L++N  SGP+P  +  
Sbjct: 610  QLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFLSGPIPPWLGK 669

Query: 339  LKALIEIDFSMNNF------------------------SGIIPMEIGSLKNLENLFLEYN 374
            L  L E+  S N F                        +G IP EIG+L  L  L L+ N
Sbjct: 670  LSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLNGSIPQEIGNLGALNVLNLDKN 729

Query: 375  RLEGSIPDSFGDLISL-------------------------KSLNLSYNNLSGTIPVSLE 409
            +  GS+P + G L  L                          +L+LSYNN +G IP ++ 
Sbjct: 730  QFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTIG 789

Query: 410  KLSYLKDLNLSFNKLKGEIPR------------------GG----SFGNFSAESFKGNEL 447
             LS L+ L+LS N+L GE+P                   GG     F  + A+SF GN  
Sbjct: 790  TLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKLKKQFSRWPADSFLGNTG 849

Query: 448  LCGSPNLQVPPCKASIHRT--SRKNALILGIVLPFSTIFMTAIILFIIKYQKRE------ 499
            LCGSP  +    +++  +   S ++ +I+  +   + I +  +++ +   Q+ +      
Sbjct: 850  LCGSPLSRCNRVRSNNKQQGLSARSVVIISAISALTAIGLMILVIALFFKQRHDFFKKVG 909

Query: 500  ------------KGPPNDPNMPPVATWRRFSYLELFQATDKFSENNLIGRGGFGSVYKAR 547
                            + P     A+     + ++ +AT   SE  +IG GG G VYKA 
Sbjct: 910  HGSTAYTSSSSSSQATHKPLFRNGASKSDIRWEDIMEATHNLSEEFMIGSGGSGKVYKAE 969

Query: 548  IRDGMEVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVKVISSCS--NEEFKALVLEY 604
            + +G  VAVK    +    + KSF  E   +  IRHR+LVK++  CS  +E    L+ EY
Sbjct: 970  LENGETVAVKKILWKDDLMSNKSFSREVKTLGRIRHRHLVKLMGYCSSKSEGLNLLIYEY 1029

Query: 605  MPHGSLEKYLH-------SSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSN 657
            M +GS+  +LH            LD   RL I + +A  +EYLH     P++H D+K SN
Sbjct: 1030 MKNGSIWDWLHEDKPVLEKKKKLLDWEARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSN 1089

Query: 658  VLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTL--ATIGYMAPEYGREGQVSTNGDVYSF 715
            VLLD NM AHL DFG+AK+LT    + T + T    + GY+APEY    + +   DVYS 
Sbjct: 1090 VLLDSNMEAHLGDFGLAKVLTENCDTNTDSNTWFACSYGYIAPEYAYSLKATEKSDVYSM 1149

Query: 716  GIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTM---EVVDANLLSQEDIHFVAKEQ 772
            GI+LME  T K PTD +F  EM +  WV   L ++     +++D  L  +  + F     
Sbjct: 1150 GIVLMEIVTGKMPTDSVFGAEMDMVRWVETHLEVAGSARDKLIDPKL--KPLLPFEEDAA 1207

Query: 773  CVSFVFNLALECTVESPEQRINAKEIVAKLLKI 805
            C   V  +AL+CT  SP++R ++++    LL +
Sbjct: 1208 CQ--VLEIALQCTKTSPQERPSSRQACDSLLHV 1238

Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1

 Score =  372 bits (956), Expect = e-102,   Method: Compositional matrix adjust.
 Identities = 280/877 (31%), Positives = 433/877 (49%), Gaps = 95/877 (10%)

Query: 4    IINNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPA 63
            + NN  +   P EI++   LK L L +N L G I  E+    +L  +DLS N L GTI  
Sbjct: 336  LANNRFSGEIPHEIEDCPMLKHLSLASNLLSGSIPRELCGSGSLEAIDLSGNLLSGTIEE 395

Query: 64   AIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKL 123
                 S+L    +TNN ++G +    D+    L  L L  NNF+G IP  ++ ++ L + 
Sbjct: 396  VFDGCSSLGELLLTNNQINGSIPE--DLWKLPLMALDLDSNNFTGEIPKSLWKSTNLMEF 453

Query: 124  ALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPL 183
                N   G++P+  GN  +L+ L L DN LT           +    SL+ ++L+ N  
Sbjct: 454  TASYNRLEGYLPAEIGNAASLKRLVLSDNQLTGE-----IPREIGKLTSLSVLNLNANMF 508

Query: 184  DGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIP----- 238
             G +P   +G+ + SL    + + N+ G IP++IT L  L  +VL  N L+GSIP     
Sbjct: 509  QGKIP-VELGDCT-SLTTLDLGSNNLQGQIPDKITALAQLQCLVLSYNNLSGSIPSKPSA 566

Query: 239  ----ITLGKLQKLQD---VDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSN 291
                I +  L  LQ     DL YN+L G IP+ +   + L E+ L  N LSG IPA  S 
Sbjct: 567  YFHQIEMPDLSFLQHHGIFDLSYNRLSGPIPEELGECLVLVEISLSNNHLSGEIPASLSR 626

Query: 292  MTFLKVLSLGSNELTS-------------------------IPLNFWSLKDILDLNLSSN 326
            +T L +L L  N LT                          IP +F  L  ++ LNL+ N
Sbjct: 627  LTNLTILDLSGNALTGSIPKEMGNSLKLQGLNLANNQLNGHIPESFGLLGSLVKLNLTKN 686

Query: 327  CFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGD 386
               GP+P  + NLK L  +D S NN SG +  E+ +++ L  L++E N+  G IP   G+
Sbjct: 687  KLDGPVPASLGNLKELTHMDLSFNNLSGELSSELSTMEKLVGLYIEQNKFTGEIPSELGN 746

Query: 387  LISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIPRGGSFGNFSAESFKGNE 446
            L  L+ L++S N LSG IP  +  L  L+ LNL+ N L+GE+P  G   + S     GN+
Sbjct: 747  LTQLEYLDVSENLLSGEIPTKICGLPNLEFLNLAKNNLRGEVPSDGVCQDPSKALLSGNK 806

Query: 447  LLCGSPNLQVPPCKASIHRTSRKNAL-ILGIVLPFSTI---FMTAIILFIIKYQKREKGP 502
             LCG    +V      I  T  ++A  I G++L F+ I   F+ ++  + +  + +++  
Sbjct: 807  ELCG----RVVGSDCKIEGTKLRSAWGIAGLMLGFTIIVFVFVFSLRRWAMTKRVKQRDD 862

Query: 503  PN-----------DPNMPPVATWRRFSYL-----------------ELFQATDKFSENNL 534
            P            D N+  ++  R    L                 ++ +ATD FS+ N+
Sbjct: 863  PERMEESRLKGFVDQNLYFLSGSRSREPLSINIAMFEQPLLKVRLGDIVEATDHFSKKNI 922

Query: 535  IGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSN 594
            IG GGFG+VYKA +     VAVK  +    +  + F  E   +  ++H NLV ++  CS 
Sbjct: 923  IGDGGFGTVYKACLPGEKTVAVKKLSEAKTQGNREFMAEMETLGKVKHPNLVSLLGYCSF 982

Query: 595  EEFKALVLEYMPHGSLEKYLHSSNYSLDIF---QRLNIMIDVASALEYLHFGYSAPVIHC 651
             E K LV EYM +GSL+ +L +    L++    +RL I +  A  L +LH G+   +IH 
Sbjct: 983  SEEKLLVYEYMVNGSLDHWLRNQTGMLEVLDWSKRLKIAVGAARGLAFLHHGFIPHIIHR 1042

Query: 652  DLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGD 711
            D+K SN+LLD +    ++DFG+A+L++   +S   T    T GY+ PEYG+  + +T GD
Sbjct: 1043 DIKASNILLDGDFEPKVADFGLARLISA-CESHVSTVIAGTFGYIPPEYGQSARATTKGD 1101

Query: 712  VYSFGIMLMETFTRKKPTDELFN---GEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFV 768
            VYSFG++L+E  T K+PT   F    G   +   +        ++V+D  L+S      V
Sbjct: 1102 VYSFGVILLELVTGKEPTGPDFKESEGGNLVGWAIQKINQGKAVDVIDPLLVS------V 1155

Query: 769  AKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKI 805
            A +     +  +A+ C  E+P +R N  +++  L +I
Sbjct: 1156 ALKNSQLRLLQIAMLCLAETPAKRPNMLDVLKALKEI 1192

Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LHP4|RCH2_ARATH Receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=RCH2 PE=1 SV=1

 Score =  372 bits (955), Expect = e-102,   Method: Compositional matrix adjust.
 Identities = 269/832 (32%), Positives = 410/832 (49%), Gaps = 48/832 (5%)

Query: 3    SIINNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIP 62
            SI    ++   P ++ N S L  L+LY N L G I  EIG L  L  L L QN L+G IP
Sbjct: 256  SIYTTMISGEIPSDLGNCSELVDLFLYENSLSGSIPREIGQLTKLEQLFLWQNSLVGGIP 315

Query: 63   AAIFNVSTLKAFAVTNNSLSGCLSSITDVG-LPNLEVLYLWGNNFSGTIPHFIFNASKLS 121
              I N S LK   ++ N LSG + S   +G L  LE   +  N FSG+IP  I N S L 
Sbjct: 316  EEIGNCSNLKMIDLSLNLLSGSIPS--SIGRLSFLEEFMISDNKFSGSIPTTISNCSSLV 373

Query: 122  KLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNN 181
            +L L+ N  SG IPS  G L  L     + N L  S         L++C  L  + LS N
Sbjct: 374  QLQLDKNQISGLIPSELGTLTKLTLFFAWSNQLEGS-----IPPGLADCTDLQALDLSRN 428

Query: 182  PLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITL 241
             L G +P      +  +L    + + ++SG IP+EI N + L  + LG N++ G IP  +
Sbjct: 429  SLTGTIPSGLF--MLRNLTKLLLISNSLSGFIPQEIGNCSSLVRLRLGFNRITGEIPSGI 486

Query: 242  GKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLG 301
            G L+K+  +D   N+L G +PD I    EL  ++L  N L GS+P   S+++ L+VL + 
Sbjct: 487  GSLKKINFLDFSSNRLHGKVPDEIGSCSELQMIDLSNNSLEGSLPNPVSSLSGLQVLDVS 546

Query: 302  SNELTS-IPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEI 360
            +N+ +  IP +   L  +  L LS N FSG +P  +     L  +D   N  SG IP E+
Sbjct: 547  ANQFSGKIPASLGRLVSLNKLILSKNLFSGSIPTSLGMCSGLQLLDLGSNELSGEIPSEL 606

Query: 361  GSLKNLE-NLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNL 419
            G ++NLE  L L  NRL G IP     L  L  L+LS+N L G +   L  +  L  LN+
Sbjct: 607  GDIENLEIALNLSSNRLTGKIPSKIASLNKLSILDLSHNMLEGDL-APLANIENLVSLNI 665

Query: 420  SFNKLKGEIPRGGSFGNFSAESFKGNELLCGSPNLQVPPCKASIHR-----------TSR 468
            S+N   G +P    F   S +  +GN+ LC S       C  +  +            +R
Sbjct: 666  SYNSFSGYLPDNKLFRQLSPQDLEGNKKLCSSTQ---DSCFLTYRKGNGLGDDGDASRTR 722

Query: 469  KNALILGIVLPFSTIFMTAIILFIIKYQKREKGPPNDPNMPPVATWRRFSYLELFQATDK 528
            K  L L +++  + + M    + +I+  +R      D  +     W+   + +L  + D+
Sbjct: 723  KLRLTLALLITLTVVLMILGAVAVIR-ARRNIDNERDSELGETYKWQFTPFQKLNFSVDQ 781

Query: 529  ----FSENNLIGRGGFGSVYKARIRDGMEVAVKVF---------NLQCGRAFKSFDVECA 575
                  E N+IG+G  G VY+A + +G  +AVK           + +      SF  E  
Sbjct: 782  IIRCLVEPNVIGKGCSGVVYRADVDNGEVIAVKKLWPAMVNGGHDEKTKNVRDSFSAEVK 841

Query: 576  MMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSN-YSLDIFQRLNIMIDVA 634
             + +IRH+N+V+ +  C N   + L+ +YMP+GSL   LH     SLD   R  I++  A
Sbjct: 842  TLGTIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRGSSLDWDLRYRILLGAA 901

Query: 635  SALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIG 694
              L YLH     P++H D+K +N+L+  +   +++DFG+AKL+   D          + G
Sbjct: 902  QGLAYLHHDCLPPIVHRDIKANNILIGLDFEPYIADFGLAKLVDEGDIGRCSNTVAGSYG 961

Query: 695  YMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEV 754
            Y+APEYG   +++   DVYS+G++++E  T K+P D      + L  WV       ++EV
Sbjct: 962  YIAPEYGYSMKITEKSDVYSYGVVVLEVLTGKQPIDPTVPEGIHLVDWVRQNR--GSLEV 1019

Query: 755  VDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIR 806
            +D+ L S+ +    A+   +  V   AL C   SP++R   K++ A L +I+
Sbjct: 1020 LDSTLRSRTE----AEADEMMQVLGTALLCVNSSPDERPTMKDVAAMLKEIK 1067

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1

 Score =  370 bits (951), Expect = e-101,   Method: Compositional matrix adjust.
 Identities = 288/898 (32%), Positives = 444/898 (49%), Gaps = 112/898 (12%)

Query: 7    NFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIF 66
            N ++ + P EI    +L +L L  N+L GE+  EIG L  L  + L +N+  G IP  I 
Sbjct: 203  NMISGSLPSEIGGCESLVMLGLAQNQLSGELPKEIGMLKKLSQVILWENEFSGFIPREIS 262

Query: 67   NVSTLKAFAVTNNSLSGCLSSITDVG-LPNLEVLYLWGNNFSGTIPHFIFNASKLSKLAL 125
            N ++L+  A+  N L G +    ++G L +LE LYL+ N  +GTIP  I N S   ++  
Sbjct: 263  NCTSLETLALYKNQLVGPIPK--ELGDLQSLEFLYLYRNGLNGTIPREIGNLSYAIEIDF 320

Query: 126  EMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDG 185
              N+ +G IP   GN+  LE L L++N LT +         LS  K+L+ + LS N L G
Sbjct: 321  SENALTGEIPLELGNIEGLELLYLFENQLTGT-----IPVELSTLKNLSKLDLSINALTG 375

Query: 186  ILP------------RTYVGNLSHSLK---NFY-------MYNCNVSGGIPEEITNLTDL 223
             +P            + +  +LS ++     +Y       M + ++SG IP  +   +++
Sbjct: 376  PIPLGFQYLRGLFMLQLFQNSLSGTIPPKLGWYSDLWVLDMSDNHLSGRIPSYLCLHSNM 435

Query: 224  TTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSG 283
              + LG N L+G+IP  +   + L  + L  N L G  P ++C  V +  +ELG N+  G
Sbjct: 436  IILNLGTNNLSGNIPTGITTCKTLVQLRLARNNLVGRFPSNLCKQVNVTAIELGQNRFRG 495

Query: 284  SIPACFSNMTFLKVLSLGSNELTS-IPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKAL 342
            SIP    N + L+ L L  N  T  +P     L  +  LN+SSN  +G +P EI N K L
Sbjct: 496  SIPREVGNCSALQRLQLADNGFTGELPREIGMLSQLGTLNISSNKLTGEVPSEIFNCKML 555

Query: 343  IEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSG 402
              +D   NNFSG +P E+GSL  LE L L  N L G+IP + G+L  L  L +  N  +G
Sbjct: 556  QRLDMCCNNFSGTLPSEVGSLYQLELLKLSNNNLSGTIPVALGNLSRLTELQMGGNLFNG 615

Query: 403  TIPVSLEKLSYLK-DLNLSFNKLKGEIPR----------------------GGSFGNFSA 439
            +IP  L  L+ L+  LNLS+NKL GEIP                         SF N S+
Sbjct: 616  SIPRELGSLTGLQIALNLSYNKLTGEIPPELSNLVMLEFLLLNNNNLSGEIPSSFANLSS 675

Query: 440  -----------------------ESFKGNELLCGSPNLQV------PPCKASIHRTSRKN 470
                                    SF GNE LCG P  Q        P +++      ++
Sbjct: 676  LLGYNFSYNSLTGPIPLLRNISMSSFIGNEGLCGPPLNQCIQTQPFAPSQSTGKPGGMRS 735

Query: 471  ALILGI---VLPFSTIFMTAIILFIIKYQKR------EKGPPNDPNM----PPVATWRRF 517
            + I+ I   V+   ++ + A+I+++++   R      + G P++ ++    PP      F
Sbjct: 736  SKIIAITAAVIGGVSLMLIALIVYLMRRPVRTVASSAQDGQPSEMSLDIYFPPK---EGF 792

Query: 518  SYLELFQATDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVF--NLQCGR---AFKSFDV 572
            ++ +L  ATD F E+ ++GRG  G+VYKA +  G  +AVK    N + G       SF  
Sbjct: 793  TFQDLVAATDNFDESFVVGRGACGTVYKAVLPAGYTLAVKKLASNHEGGNNNNVDNSFRA 852

Query: 573  ECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMID 632
            E   + +IRHRN+VK+   C+++    L+ EYMP GSL + LH  + +LD  +R  I + 
Sbjct: 853  EILTLGNIRHRNIVKLHGFCNHQGSNLLLYEYMPKGSLGEILHDPSCNLDWSKRFKIALG 912

Query: 633  VASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLAT 692
             A  L YLH      + H D+K +N+LLDD   AH+ DFG+AK++     S + +    +
Sbjct: 913  AAQGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID-MPHSKSMSAIAGS 971

Query: 693  IGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTM 752
             GY+APEY    +V+   D+YS+G++L+E  T K P   +  G   + +WV   +    +
Sbjct: 972  YGYIAPEYAYTMKVTEKSDIYSYGVVLLELLTGKAPVQPIDQGG-DVVNWVRSYIRRDAL 1030

Query: 753  E--VVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDS 808
               V+DA  L+ ED   V+    +  V  +AL CT  SP  R + +++V  L++   S
Sbjct: 1031 SSGVLDAR-LTLEDERIVSH---MLTVLKIALLCTSVSPVARPSMRQVVLMLIESERS 1084

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	824
224116832	1061	predicted protein [Populus trichocarpa]	0.964	0.749	0.535	0.0
255572272	1089	serine-threonine protein kinase, plant-t	0.976	0.739	0.522	0.0
255585401	843	serine-threonine protein kinase, plant-t	0.968	0.946	0.537	0.0
224139658	1019	predicted protein [Populus trichocarpa]	0.981	0.793	0.509	0.0
359483683	1228	PREDICTED: LRR receptor-like serine/thre	0.970	0.651	0.527	0.0
359485453	1202	PREDICTED: probable LRR receptor-like se	0.966	0.662	0.524	0.0
359483675	1250	PREDICTED: LRR receptor-like serine/thre	0.953	0.628	0.525	0.0
359485451	1454	PREDICTED: LRR receptor-like serine/thre	0.972	0.550	0.517	0.0
359483198	1087	PREDICTED: probable LRR receptor-like se	0.968	0.734	0.527	0.0
359483677	1229	PREDICTED: LRR receptor-like serine/thre	0.969	0.650	0.519	0.0

>gi|224116832|ref|XP_002317405.1| predicted protein [Populus trichocarpa] gi|222860470|gb|EEE98017.1| predicted protein [Populus trichocarpa]

 Score =  801 bits (2070), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 432/807 (53%), Positives = 556/807 (68%), Gaps = 12/807 (1%)

Query: 7    NFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIF 66
            N L    P+EI N + L  +++ NN L G I +E+G+LH L  LDL  N + G+IP+  F
Sbjct: 245  NGLNGNIPREIGNCTYLMEIHVENNNLTGVIPNEMGNLHTLQELDLGFNNITGSIPSTFF 304

Query: 67   NVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALE 126
            N S L+   +  N LSG L S T +GLPNLE LYL  N  SG IP  I NASKL  L L 
Sbjct: 305  NFSILRRVNMAYNYLSGHLPSNTGLGLPNLEELYLEKNELSGPIPDSIGNASKLIVLDLS 364

Query: 127  MNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLS--NCKSLTHISLSNNPLD 184
             NSFSG IP   GNLRNL+ L L +N LTS +L        S  NC+SL ++  + NPL 
Sbjct: 365  YNSFSGRIPDLLGNLRNLQKLNLAENILTSKSLRSELSFLSSLSNCRSLAYLRFNGNPLR 424

Query: 185  GILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKL 244
            G LP + +GNLS SL+  Y ++C + G IP  I NL++L  ++L  N+L G+IP  +G+L
Sbjct: 425  GRLPVS-IGNLSASLEELYAFDCRIIGNIPRGIGNLSNLIGLILQQNELTGAIPSEIGRL 483

Query: 245  QKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNE 304
            + LQD  L  N+L+G IP+ IC    L  L L  N  SGS+PAC SN+T L+ L LGSN 
Sbjct: 484  KHLQDFSLASNKLQGHIPNEICHLERLSYLYLLENGFSGSLPACLSNITSLRELYLGSNR 543

Query: 305  LTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLK 364
             TSIP  FWSLKD+L +NLS N  +G LPLEI NLK +  IDFS N  SG IP  I  L+
Sbjct: 544  FTSIPTTFWSLKDLLQINLSFNSLTGTLPLEIGNLKVVTVIDFSSNQLSGDIPTSIADLQ 603

Query: 365  NLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKL 424
            NL +  L  NR++G IP SFGDL+SL+ L+LS N+LSG IP SLEKL +LK  N+SFN+L
Sbjct: 604  NLAHFSLSDNRMQGPIPSSFGDLVSLEFLDLSRNSLSGAIPKSLEKLVHLKTFNVSFNRL 663

Query: 425  KGEIPRGGSFGNFSAESFKGNELLCGSPNLQVPPCKA-SIHRTS-RKNALILGIVLPFST 482
            +GEI  GG F NFS  SF  NE LCG   +QVPPCK+ S HR S R    ++  ++P   
Sbjct: 664  QGEILDGGPFANFSFRSFMDNEALCGPIRMQVPPCKSISTHRQSKRPREFVIRYIVPAIA 723

Query: 483  IFMTAIILFIIKYQ---KREKGPPNDPNMPPVATWRRFSYLELFQATDKFSENNLIGRGG 539
              +  + L +I ++   KR+     DP +PP ATWR+ SY EL++AT+ F+E NL+G G 
Sbjct: 724  FIILVLALAVIIFRRSHKRKLSTQEDP-LPP-ATWRKISYHELYRATEGFNETNLLGTGS 781

Query: 540  FGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKA 599
             GSVYK  + DG+ +AVKVF+LQ       FD EC +++ +RHRNLVK+ISSC N +FKA
Sbjct: 782  CGSVYKGTLSDGLCIAVKVFHLQLEGELMRFDSECEVLRMLRHRNLVKIISSCCNLDFKA 841

Query: 600  LVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVL 659
            L+LE++PHGSLEK+L+S NY LDI QRLNIMIDVASALEYLH G + PV+HCDLKPSNVL
Sbjct: 842  LILEFIPHGSLEKWLYSHNYYLDILQRLNIMIDVASALEYLHHGCTRPVVHCDLKPSNVL 901

Query: 660  LDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIML 719
            ++++MVAH+SDFGI++LL GE  ++TQT TLATIGYMAPEYG EG VS  GDVYS+GI L
Sbjct: 902  INEDMVAHVSDFGISRLL-GEGDAVTQTLTLATIGYMAPEYGLEGIVSVKGDVYSYGIFL 960

Query: 720  METFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFN 779
            METFTRKKPTD++F GEM+LK+WV   LP +  EV+DANLL +E+ HFVAK+ C++ + N
Sbjct: 961  METFTRKKPTDDMFGGEMSLKNWVKQSLPKAITEVIDANLLIEEE-HFVAKKDCITSILN 1019

Query: 780  LALECTVESPEQRINAKEIVAKLLKIR 806
            LALEC+ + P +RI  ++++  L KI+
Sbjct: 1020 LALECSADLPGERICMRDVLPALEKIK 1046

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255572272|ref|XP_002527075.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223533580|gb|EEF35319.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  789 bits (2037), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 425/814 (52%), Positives = 558/814 (68%), Gaps = 9/814 (1%)

Query: 7    NFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIF 66
            N  T + P+ I N++ LK L L  N L G I  EIG+L NL  + LS N L G+IP A+F
Sbjct: 274  NKFTGSIPRTIGNLTKLKWLSLGRNNLTGRIPLEIGNLQNLQIVHLSFNNLNGSIPHALF 333

Query: 67   NVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALE 126
            N+ST+K  A+T+N+L G L +   + LPNL  LYL  N  SG IP +I NASKL+ L L 
Sbjct: 334  NISTMKWIAMTSNNLLGNLPTSLGLHLPNLIWLYLGINKLSGPIPSYISNASKLTILELP 393

Query: 127  MNSFSGFIPSTFGNLRNLEWLTLYDNNLTS--STLDLSFLSSLSNCKSLTHISLSNNPLD 184
             NSF+GFIP + G+LRNL+ L L  N L+S  ++ +L+  SSL NC++L ++ LS NPLD
Sbjct: 394  SNSFTGFIPDSLGDLRNLQTLKLGANLLSSKKTSQELTIFSSLKNCQNLKYLWLSYNPLD 453

Query: 185  GILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKL 244
            G LP + VGNLS+SL++F   +  + G + E I NL+ LT + LG N L G IP T+G L
Sbjct: 454  GYLPHS-VGNLSNSLESFLASDGLIKGSVHESIGNLSSLTRLNLGNNDLTGRIPTTIGTL 512

Query: 245  QKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNE 304
            + LQ + L  N L+GSIP  +C    LY LEL GNKLSGSIP CFSN+T L+ L L SN 
Sbjct: 513  KHLQGLYLHGNDLDGSIPSELCDLRTLYNLELTGNKLSGSIPTCFSNLTSLRNLFLASNR 572

Query: 305  LTS-IPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSL 363
              S I    W+LKDIL +NL+SN  +G LP EI NL+A+  I+ S N  SG IP+ IG L
Sbjct: 573  FVSTISSTLWTLKDILQVNLASNYLTGSLPSEIENLRAVYMINISKNQLSGEIPISIGGL 632

Query: 364  KNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNK 423
            ++L  L+L  N+L+G IP S GD+ SL+ L+LS NNLSG IP SL+ L YLK  N+SFN 
Sbjct: 633  QDLAQLYLSGNKLQGPIPQSVGDIKSLEFLDLSSNNLSGMIPKSLDNLLYLKYFNVSFNY 692

Query: 424  LKGEIPRGGSFGNFSAESFKGNELLCGSPNLQVPPCKASIHRTSRK--NALILGIVLP-- 479
            L+GEIP GGSF NFSA+SF GNE LCGS  LQV PCK    R +    + ++L  VLP  
Sbjct: 693  LQGEIPEGGSFSNFSAQSFIGNEALCGSARLQVSPCKDDNSRATETPGSKIVLRYVLPAI 752

Query: 480  FSTIFMTAIILFIIKYQKREKGPPNDPNMPPVATWRRFSYLELFQATDKFSENNLIGRGG 539
               +F+ A ++ + +Y +R+     + +   + T RR SY EL  AT+ F E+N +G G 
Sbjct: 753  VFAVFVLAFVIMLKRYCERKAKFSIEDDFLALTTIRRISYHELQLATNGFQESNFLGMGS 812

Query: 540  FGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKA 599
            FGSVYK  + DG  +A KVFNLQ  RAFKSFD EC +++++RHRNLVK+I+SCS   FKA
Sbjct: 813  FGSVYKGTLSDGTVIAAKVFNLQLERAFKSFDTECEVLRNLRHRNLVKIITSCSGPNFKA 872

Query: 600  LVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVL 659
            LVLE+MP+ SLEK+L+S +Y L+  QRLNIM+DVAS LEYLH GY+ P+ HCD+KPSNVL
Sbjct: 873  LVLEFMPNWSLEKWLYSDDYFLNNLQRLNIMLDVASVLEYLHHGYTIPMAHCDIKPSNVL 932

Query: 660  LDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIML 719
            L+++MVA L+DFGI+KLL GE+ S+ QT TLATIGYMAPEYG EG VS  GDVYS+G++L
Sbjct: 933  LNEDMVAFLADFGISKLL-GEEGSVMQTMTLATIGYMAPEYGSEGIVSVRGDVYSYGVLL 991

Query: 720  METFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFN 779
            METFT+KKPTD++F  +++LK WV   L     +V+DANLL  E+ H  AK+ C+  +  
Sbjct: 992  METFTQKKPTDKMFTEQLSLKSWVEQSLSCEVTQVIDANLLGIEEDHLAAKKDCIVSILK 1051

Query: 780  LALECTVESPEQRINAKEIVAKLLKIRDSLLRNV 813
            LAL+C+ + P  RI+ K +V  L KI+   LR++
Sbjct: 1052 LALQCSADLPHDRIDMKHVVTTLQKIKTKFLRDI 1085

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255585401|ref|XP_002533396.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223526770|gb|EEF28996.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  783 bits (2022), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 436/811 (53%), Positives = 556/811 (68%), Gaps = 13/811 (1%)

Query: 4   IINNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPA 63
           I  N    T PK + N ++++ L L  N L G I  EIG L NL  L L  N L G+IP+
Sbjct: 34  IRGNDFNGTIPKSLFNCTSMRHLSLGGNSLTGPIPTEIGKLSNLVHLLLRYNFLTGSIPS 93

Query: 64  AIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKL 123
            + N+S +K  ++  N LSG L S    GLPNLE LY+  N F GT+P  I NASKL+ L
Sbjct: 94  TLLNISAIKTISINVNQLSGHLPSTLGYGLPNLEELYITRNQFIGTLPPSISNASKLTIL 153

Query: 124 ALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPL 183
               NS SG IP T  NL+NL+ L L DN+ T    +L FL+SL+ CK L  + L  NPL
Sbjct: 154 ESSSNSLSGPIPDTLCNLKNLKRLNLADNSFTD---ELGFLASLARCKELRRLVLIGNPL 210

Query: 184 DGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGK 243
           +  LP T +GNLS S++ F + +CN+ G IP EI  L++L T+ L  N+L GSIP+T+G 
Sbjct: 211 NSTLP-TSIGNLS-SIEYFNVQSCNIKGNIPSEIGVLSNLITLHLQNNELVGSIPVTIGG 268

Query: 244 LQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSN 303
           LQKLQ + L  N L GSIP  IC    L EL L  N L G +PACF ++  L++L L SN
Sbjct: 269 LQKLQRLYLHGNLLYGSIPTDICHLSNLGELFLSNNSLFGPLPACFGDLISLRILHLHSN 328

Query: 304 ELTS-IPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGS 362
             TS IP + WSLKD+L+LNLSSN  SG +PL I NLK L ++DFS N+ SGIIP  IGS
Sbjct: 329 NFTSGIPFSLWSLKDVLELNLSSNSLSGHIPLSIGNLKVLTQVDFSYNSLSGIIPNAIGS 388

Query: 363 LKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFN 422
           L+NL +L L +NR EG IP+ FG+LISL+SL+LS NNLSG IP SLE+L YLK LN+SFN
Sbjct: 389 LRNLMSLSLTHNRFEGPIPEPFGELISLESLDLSSNNLSGKIPKSLEQLKYLKYLNVSFN 448

Query: 423 KLKGEIPRGGSFGNFSAESFKGNELLCGSPNLQVPPCKASIHRTSRKNALILGIVLPFST 482
            L GE+P  G+F NFSA SF GN  LCGS  L + PCK + H  S+ +  +L I +  ++
Sbjct: 449 NLDGEVPNKGAFANFSASSFLGNLALCGSRLLPLMPCKNNTHGGSKTSTKLLLIYVLPAS 508

Query: 483 IFMTAIILFIIKYQKREKGPPNDPNMPPVATWRRFSYLELFQATDKFSENNLIGRGGFGS 542
           I   A IL  ++ QK +    N  ++  V TWRR S+ EL QATD F  +NL+G GG+GS
Sbjct: 509 ILTIAFILVFLRCQKVKLELENVMDIITVGTWRRISFQELEQATDGFCASNLLGAGGYGS 568

Query: 543 VYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVL 602
           VYK R+ DG  VA+KVFNL    AFK FD EC +M SIRHRNLVK+IS CSN++FKA+VL
Sbjct: 569 VYKGRLEDGTNVAIKVFNLGVEGAFKIFDTECEVMSSIRHRNLVKIISCCSNQDFKAIVL 628

Query: 603 EYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD 662
           EYMP+GSLEK+L+S NY L+I QRL +MIDVASALEYLH G+SAP++HCDLKPSNVLLD 
Sbjct: 629 EYMPNGSLEKWLYSHNYCLNIQQRLEVMIDVASALEYLHHGFSAPIVHCDLKPSNVLLDQ 688

Query: 663 NMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMET 722
           +MV H++DFG+AKLL GE   +TQT+TLATIGYMAPEYG +G VS +GDVYSFGI+LMET
Sbjct: 689 DMVGHVADFGMAKLL-GEGDLITQTKTLATIGYMAPEYGSKGIVSISGDVYSFGILLMET 747

Query: 723 FTRKKPTDELFNGE--MTLKHWVNDCLPISTM-EVVDANLLSQEDIHFVAKEQCVSFVFN 779
           FTR KPTD++F GE  ++LK ++ D L  + + E+ DAN L  E    ++ + CVS +  
Sbjct: 748 FTRMKPTDDMF-GERVLSLKQYIEDALLHNAVSEIADANFLIDEK--NLSTKDCVSSILG 804

Query: 780 LALECTVESPEQRINAKEIVAKLLKIRDSLL 810
           LAL+C+VE P  RI+  +++A L  I+  LL
Sbjct: 805 LALDCSVELPHGRIDMSQVLAALRSIKAQLL 835

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224139658|ref|XP_002323215.1| predicted protein [Populus trichocarpa] gi|222867845|gb|EEF04976.1| predicted protein [Populus trichocarpa]

 Score =  777 bits (2006), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 416/816 (50%), Positives = 551/816 (67%), Gaps = 7/816 (0%)

Query: 6    NNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAI 65
            +N L+   P ++     L++L+L  N   G I  E+G L  L  L+L  N L G +P +I
Sbjct: 204  SNQLSGQIPSDLFKCRELQLLWLPYNNFTGVIPEELGFLPMLEVLNLGVNMLSGDLPRSI 263

Query: 66   FNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLAL 125
            FN+++L+   +  N+LSG +     + LPNLE L L  N  +G++P F+ N S+L  L L
Sbjct: 264  FNMTSLRTMQICCNNLSGSIPQENSIDLPNLEELQLNLNGITGSMPRFLGNMSRLEILDL 323

Query: 126  EMNSFSGFIPSTFGNLRNLEWLTLYDNNLTS--STLDLSFLSSLSNCKSLTHISLSNNPL 183
              N  +G +   FGNLR L+ L+L  N+ T+  S+  L+F++SL+N + L  + + +NPL
Sbjct: 324  SYNKMTGNVLQEFGNLRALQVLSLQSNSFTNHPSSQTLNFITSLTNSRQLKELHIGDNPL 383

Query: 184  DGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGK 243
            DG+LP + VGNLS  L  FY+Y   + G IP EI NL++L  + L  N L G IP T+G 
Sbjct: 384  DGMLPNS-VGNLSSFLTKFYVYASKLKGNIPGEIGNLSNLIVLSLEENSLMGPIPTTVGG 442

Query: 244  LQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSN 303
            L+K+Q + L  N L GSIP  ICL+  L ++ L  N LSG IP+C  N+T L+ L L  N
Sbjct: 443  LRKIQVLYLHKNNLNGSIPSDICLARRLVDITLNNNVLSGEIPSCIGNLTSLRNLYLHFN 502

Query: 304  ELTS-IPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGS 362
             L+S IP+  WSLKD+L LNL SN   G LP ++  ++A I I  S N  SG IP  IGS
Sbjct: 503  ILSSTIPMALWSLKDLLILNLHSNFLYGSLPSQVGEMEAAIGIRLSSNQLSGNIPSTIGS 562

Query: 363  LKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFN 422
            L+NL    L  N  +GSIP++FG L+SL+ L+LS NNLSG IP SLE L YL+  ++SFN
Sbjct: 563  LQNLIRFSLSKNSFQGSIPEAFGGLVSLELLDLSQNNLSGEIPKSLEALRYLEFFSVSFN 622

Query: 423  KLKGEIPRGGSFGNFSAESFKGNELLCGSPNLQVPPCKASIHRTSRKNALILGIVLP--F 480
             L+GEIPRGG F NF+A SF  N+ LCG   LQVPPC     + S+  + +L   LP   
Sbjct: 623  GLQGEIPRGGPFANFTARSFIMNKGLCGPSRLQVPPCSIESRKDSKTKSRLLRFSLPTVA 682

Query: 481  STIFMTAIILFIIKYQKREKGPPNDPNMPPVATWRRFSYLELFQATDKFSENNLIGRGGF 540
            S + + A I  ++  ++R +  P    +P  A  RR SYLEL  AT++F E+NL+G G F
Sbjct: 683  SILLVVAFIFLVMGCRRRYRKDPIPEALPVTAIQRRISYLELLHATNEFHESNLLGIGSF 742

Query: 541  GSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKAL 600
            GSVY+ R+RDG+ VAVK+FNLQ  RAF+SFD EC +M++IRHRNLVK+I SCSN +FKAL
Sbjct: 743  GSVYQGRLRDGLNVAVKIFNLQLQRAFRSFDTECEIMRNIRHRNLVKIICSCSNLDFKAL 802

Query: 601  VLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL 660
            VLEYMP GSLEK+L+S NY LDI QR+NIMIDVASALEYLH GY +PV+HCDLKPSNVLL
Sbjct: 803  VLEYMPKGSLEKWLYSHNYCLDIIQRVNIMIDVASALEYLHHGYPSPVVHCDLKPSNVLL 862

Query: 661  DDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLM 720
            D++MVAH+ DFGIAKLL GE++S  QT+TLATIGYMAPEYG +G VST  DVYSFGIMLM
Sbjct: 863  DEDMVAHVCDFGIAKLL-GENESFAQTRTLATIGYMAPEYGLDGLVSTKIDVYSFGIMLM 921

Query: 721  ETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNL 780
            E  TRK+PTDE+F GEM+LK  V + LP S +++VD+N+L++ D + V KE CV+ +  L
Sbjct: 922  EMLTRKRPTDEMFEGEMSLKRLVKESLPDSVIDIVDSNMLNRGDGYSVKKEHCVTSIMEL 981

Query: 781  ALECTVESPEQRINAKEIVAKLLKIRDSLLRNVGGR 816
            AL+C  ESP +R+   EI+A+L  I+   LR+   R
Sbjct: 982  ALQCVNESPGERMAMVEILARLKNIKAEFLRDSERR 1017

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483683|ref|XP_003633001.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO1-like [Vitis vinifera]

 Score =  769 bits (1985), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 429/813 (52%), Positives = 557/813 (68%), Gaps = 13/813 (1%)

Query: 5    INNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAA 64
            IN F T + P++I N+S L+ +YL  N L G I    G+L  L FL L  N L GTIP  
Sbjct: 421  INKF-TGSIPRDIGNLSKLEKIYLSTNSLIGSIPTSFGNLKALKFLQLGSNNLTGTIPED 479

Query: 65   IFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLA 124
            IFN+S L+  A+  N LSG L S     LP+LE L++ GN FSGTIP  I N SKL +L 
Sbjct: 480  IFNISKLQTLALAQNHLSGGLPSSIGTWLPDLEGLFIGGNEFSGTIPVSISNMSKLIRLH 539

Query: 125  LEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTL--DLSFLSSLSNCKSLTHISLSNNP 182
            +  N F+G +P    NLR LE L L  N LT   L  ++ FL+SL+NCK L  + +  NP
Sbjct: 540  ISDNYFTGNVPKDLSNLRKLEVLNLAGNQLTDEHLTSEVGFLTSLTNCKFLRTLWIDYNP 599

Query: 183  LDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLG 242
            L G LP + +GNLS +L++F    C+  G IP  I NLT+L  + LG N L GSIP TLG
Sbjct: 600  LKGTLPNS-LGNLSVALESFTASACHFRGTIPTGIGNLTNLIWLDLGANDLTGSIPTTLG 658

Query: 243  KLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGS 302
             LQKLQ + +  N+++GSIP+ +C    L  L L  NKLSGSIP+CF ++  L+ LSL S
Sbjct: 659  HLQKLQRLYIAGNRIQGSIPNDLCHLKNLGYLHLSSNKLSGSIPSCFGDLPALRELSLDS 718

Query: 303  NELT-SIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIG 361
            N L  +IP++FWSL+D++ L+LSSN  +G LP E+ N+K++  +D S N  SG IP  +G
Sbjct: 719  NVLAFNIPMSFWSLRDLMVLSLSSNFLTGNLPPEVGNMKSITTLDLSKNLISGYIPRRMG 778

Query: 362  SLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSF 421
             L+NL NL L  N+L+GSIP  FGDL+SL+S++LS NNL GTIP SLE L YLK LN+SF
Sbjct: 779  ELQNLVNLCLSQNKLQGSIPVEFGDLLSLESMDLSQNNLFGTIPKSLEALIYLKHLNVSF 838

Query: 422  NKLKGEIPRGGSFGNFSAESFKGNELLCGSPNLQVPPC-KASIHRTSRKNALILG-IVLP 479
            NKL+GEIP GG F NF+AESF  NE LCG+P+ QV  C K +  ++ +  + IL  I+LP
Sbjct: 839  NKLQGEIPNGGPFVNFTAESFIFNEALCGAPHFQVIACDKNNRTQSWKTKSFILKYILLP 898

Query: 480  F-STIFMTA-IILFIIKYQKREKGPPNDPNMPPVATWRRFSYLELFQATDKFSENNLIGR 537
              S + + A I+L+I +    E   P D  +P      + S  +L  AT+ F E+NLIG+
Sbjct: 899  VGSAVTLVAFIVLWIRRRDNTEIPAPIDSWLP--GAHEKISQQQLLYATNGFGEDNLIGK 956

Query: 538  GGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEF 597
            G  G VYK  + +G+ VA+KVFNL+   A +SFD EC +M+ I HRNL+++I+ CSN +F
Sbjct: 957  GSLGMVYKGVLSNGLTVAIKVFNLEFQGALRSFDSECEVMQGICHRNLIRIITCCSNLDF 1016

Query: 598  KALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSN 657
            KALVLEYMP GSL+K+L+S NY LD+FQRLNIMIDVASALEYLH   S+ V+HCDLKPSN
Sbjct: 1017 KALVLEYMPKGSLDKWLYSHNYFLDLFQRLNIMIDVASALEYLHHDCSSLVVHCDLKPSN 1076

Query: 658  VLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGI 717
            VLLD+NMVAH++DFGIA+LLT E +SM QT+TL TIGYMAPEYG +G VST GDVYS+GI
Sbjct: 1077 VLLDNNMVAHVADFGIARLLT-ETESMQQTKTLGTIGYMAPEYGSDGIVSTKGDVYSYGI 1135

Query: 718  MLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFV 777
            +LME F RKKP DE+F G++TLK WV + L  S +EVVDANLL ++D     K   +S +
Sbjct: 1136 LLMEVFARKKPMDEMFTGDVTLKTWV-ESLSSSVIEVVDANLLRRDDEDLATKLSYLSSL 1194

Query: 778  FNLALECTVESPEQRINAKEIVAKLLKIRDSLL 810
              LAL CT +SPE+RIN K++V +L KI+  LL
Sbjct: 1195 MALALACTADSPEERINMKDVVVELKKIKIKLL 1227

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359485453|ref|XP_003633276.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera]

 Score =  764 bits (1974), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 426/812 (52%), Positives = 552/812 (67%), Gaps = 16/812 (1%)

Query: 6    NNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAI 65
            NNF T + P+EI N+S L+ +Y   +   G I  E+G+L NL FL L+ N L G +P AI
Sbjct: 393  NNF-TGSIPREIGNLSKLEQIYFRRSSFTGNIPKELGNLVNLQFLSLNVNNLTGIVPEAI 451

Query: 66   FNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLAL 125
            FN+S L+  ++  N LSG L S     LPNLE L + GN FSG IP  I N S L  L +
Sbjct: 452  FNISKLQVLSLAGNHLSGSLPSSIGSWLPNLEQLLIGGNEFSGIIPMSISNMSNLISLDI 511

Query: 126  EMNSFSGFIPSTFGNLRNLEWLTLYDNNLTS--STLDLSFLSSLSNCKSLTHISLSNNPL 183
              N F G +P   GNLR L+ L L  N LT+  S  +L+FL+SL+NC  L  +S+S+NPL
Sbjct: 512  SDNFFIGNVPKDLGNLRQLQLLGLSHNQLTNEHSASELAFLTSLTNCIFLRTLSISDNPL 571

Query: 184  DGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGK 243
             G++P + +GNLS SL+  Y  +C + G IP  I+NLT+L  + L  N L G IP   G+
Sbjct: 572  KGMIPNS-LGNLSISLEIIYASDCQLRGTIPTGISNLTNLIGLRLDDNDLTGLIPTPFGR 630

Query: 244  LQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSN 303
            LQKLQ + +  N++ GSIP  +C    L  L+L  NKLSG+IP+C  N+T L+ + L SN
Sbjct: 631  LQKLQMLSISQNRIHGSIPSGLCHLTNLAFLDLSSNKLSGTIPSCSGNLTGLRNVYLHSN 690

Query: 304  ELTS-IPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGS 362
             L S IP +  +L+ +L LNLSSN  +  LPL++ N+K+L+ +D S N FSG IP  I  
Sbjct: 691  GLASEIPSSLCNLRGLLVLNLSSNFLNSQLPLQVGNMKSLVALDLSKNQFSGNIPSTISL 750

Query: 363  LKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFN 422
            L+NL  L+L +N+L+G IP +FGDL+SL+SL+LS NNLSGTIP SLE L YL+ LN+SFN
Sbjct: 751  LQNLLQLYLSHNKLQGHIPPNFGDLVSLESLDLSGNNLSGTIPKSLEHLKYLEYLNVSFN 810

Query: 423  KLKGEIPRGGSFGNFSAESFKGNELLCGSPNLQVPPCKASIHRTSRKN--ALILGIVLPF 480
            KL+GEIP GG F NF+AESF  N  LCG+P  QV  C+    + SRKN  +L+L  ++P 
Sbjct: 811  KLQGEIPNGGPFANFTAESFISNLALCGAPRFQVMACE----KDSRKNTKSLLLKCIVPL 866

Query: 481  STIFMTAIILFIIKYQKREKGPPNDP---NMPPVATWRRFSYLELFQATDKFSENNLIGR 537
            S    T I++ +    KR +     P   ++      R   + EL  AT+ F E+NLIG+
Sbjct: 867  SVSLSTIILVVLFVQWKRRQTKSETPIQVDLSLPRMHRMIPHQELLYATNYFGEDNLIGK 926

Query: 538  GGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEF 597
            G  G VYK  + DG+ VAVKVFNL+   AFKSF+VEC +M++IRHRNL K+ISSCSN +F
Sbjct: 927  GSLGMVYKGVLSDGLIVAVKVFNLELQGAFKSFEVECEVMRNIRHRNLAKIISSCSNLDF 986

Query: 598  KALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSN 657
            KALVLEYMP+GSLEK+L+S NY LD  QRL IMIDVAS LEYLH  YS PV+HCDLKPSN
Sbjct: 987  KALVLEYMPNGSLEKWLYSHNYYLDFVQRLKIMIDVASGLEYLHHYYSNPVVHCDLKPSN 1046

Query: 658  VLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGI 717
            VLLDD+MVAH+SDFGIAKLL G  + M +T+TL T+GYMAPEYG EG VST GD+YS+GI
Sbjct: 1047 VLLDDDMVAHISDFGIAKLLMG-SEFMKRTKTLGTVGYMAPEYGSEGIVSTKGDIYSYGI 1105

Query: 718  MLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFV 777
            +LMETF RKKPTDE+F  E+TLK WV      + MEV+DANLL++ED  F  K  C S +
Sbjct: 1106 LLMETFVRKKPTDEMFVEELTLKSWVESSTN-NIMEVIDANLLTEEDESFALKRACFSSI 1164

Query: 778  FNLALECTVESPEQRINAKEIVAKLLKIRDSL 809
              LAL+CTVE PE+RIN K++V +L K+ + +
Sbjct: 1165 MTLALDCTVEPPEKRINTKDVVVRLKKLLNQI 1196

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483675|ref|XP_003632999.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO1-like [Vitis vinifera]

 Score =  764 bits (1973), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 424/807 (52%), Positives = 553/807 (68%), Gaps = 21/807 (2%)

Query: 5    INNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAA 64
            IN F T + P++I N+S LK +YL  N L G I    G+L  L FL L  N L+GTIP  
Sbjct: 421  INKF-TRSIPRDIGNLSKLKKIYLSTNSLIGSIPTSFGNLKALKFLQLGSNNLIGTIPED 479

Query: 65   IFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLA 124
            IFN+S L+  A+  N LSG L S     LP+LE L++ GN FSGTIP  I N SKL +L 
Sbjct: 480  IFNISKLQTLALAQNHLSGGLPSSISTWLPDLEGLFIGGNEFSGTIPVSISNMSKLIRLH 539

Query: 125  LEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTL--DLSFLSSLSNCKSLTHISLSNNP 182
            +  N F G +P    NLR LE L L  N LT   L  ++ FL+SL+NCK L  + +  NP
Sbjct: 540  ISDNYFIGNVPKDLSNLRKLEVLNLAGNQLTDEHLTSEVGFLTSLTNCKFLRTLWIDYNP 599

Query: 183  LDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLG 242
            L G LP + +GNLS +L++F    C+  G IP  I NLT+L  + LG N L GSIP TLG
Sbjct: 600  LKGTLPNS-LGNLSVALESFTASACHFRGTIPTGIGNLTNLIWLDLGANDLTGSIPTTLG 658

Query: 243  KLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGS 302
            +LQKLQ + +  N+++GSIP+ +     L  L L  NKLSGSIP+CF ++  L+ LSL S
Sbjct: 659  QLQKLQRLYIAGNRIQGSIPNDLFHLKNLGYLHLSSNKLSGSIPSCFGDLPALRELSLDS 718

Query: 303  NELT-SIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIG 361
            N L  +IP++FWSL+D+L L+LSSN  +G LP E+ N+K++  +D S N  SG IP  +G
Sbjct: 719  NVLAFNIPMSFWSLRDLLVLSLSSNFLTGNLPPEVGNMKSITTLDLSKNLISGYIPRRMG 778

Query: 362  SLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSF 421
             L+NL NL L  N+L+GSIP  FGDL+SL+S++LS NNLSGTIP SLE L YLK LN+SF
Sbjct: 779  ELQNLVNLCLSQNKLQGSIPVEFGDLLSLESMDLSQNNLSGTIPKSLEALIYLKHLNVSF 838

Query: 422  NKLKGEIPRGGSFGNFSAESFKGNELLCGSPNLQVPPCKASIHRTSRKN-ALILG-IVLP 479
            NKL+GEIP GG F NF+AESF  NE LCG+P+ QV  C  + H  S K  + IL  I+LP
Sbjct: 839  NKLQGEIPDGGPFVNFTAESFIFNEALCGAPHFQVIACDKNNHTQSWKTKSFILKYILLP 898

Query: 480  FSTIFMTAIILFIIKYQKREKGPPNDPNMP-PVATW-----RRFSYLELFQATDKFSENN 533
              +I    ++ FI+ + +R+    ++  +P P+ +W      + S  +L  AT+ F E+N
Sbjct: 899  VGSI--VTLVAFIVLWIRRQ----DNTEIPAPIDSWLPGAHEKISQQQLLYATNDFGEDN 952

Query: 534  LIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCS 593
            LIG+G  G VYK  + +G+ VA+KVFNL+   A +SFD EC +M+ I HRNL+++I+ CS
Sbjct: 953  LIGKGSLGMVYKGVLSNGLTVAIKVFNLEFQGALRSFDSECEVMQGICHRNLIRIITCCS 1012

Query: 594  NEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 653
            N +FKALVLEYMP GSL+K+L+S NY LD+FQRLNIMIDVA ALEYLH   S+ V+HCDL
Sbjct: 1013 NLDFKALVLEYMPKGSLDKWLYSHNYFLDLFQRLNIMIDVALALEYLHHDCSSLVVHCDL 1072

Query: 654  KPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVY 713
            KPSNVLLD+NMVAH++DFGIA+LLT E +SM QT+TL TIGYMAPEYG +G VST GDVY
Sbjct: 1073 KPSNVLLDNNMVAHVADFGIARLLT-ETESMQQTKTLGTIGYMAPEYGSDGIVSTKGDVY 1131

Query: 714  SFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQC 773
            S+GI+LME F RKKP DE+F G++TLK WV + L  S +EVVDANLL +++     K   
Sbjct: 1132 SYGILLMEVFARKKPMDEMFTGDVTLKTWV-ESLSSSVIEVVDANLLRRDNEDLATKLSY 1190

Query: 774  VSFVFNLALECTVESPEQRINAKEIVA 800
            +S +  LAL CT +SPE+RIN K++V 
Sbjct: 1191 LSSLMALALACTADSPEERINMKDVVV 1217

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359485451|ref|XP_002276944.2| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Vitis vinifera]

 Score =  763 bits (1969), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 423/817 (51%), Positives = 556/817 (68%), Gaps = 16/817 (1%)

Query: 3    SIINNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIP 62
            S+  N  T   P    N++ L+ L L +N +QG I +E+G+L NL  L LS+N L G IP
Sbjct: 644  SLWGNRFTGNIPPSFGNLTALQDLELGDNNIQGNIPNELGNLINLQNLKLSENNLTGIIP 703

Query: 63   AAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSK 122
             AIFN+S L++ ++  N  SG L S     LP+LE L +  N FSG IP  I N S+L++
Sbjct: 704  EAIFNISKLQSLSLAQNHFSGSLPSSLGTQLPDLEGLAIGRNEFSGIIPMSISNMSELTE 763

Query: 123  LALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTS--STLDLSFLSSLSNCKSLTHISLSN 180
            L +  N F+G +P   GNLR LE+L L  N LT   S  ++ FL+SL+NC  L  + + +
Sbjct: 764  LDIWDNFFTGDVPKDLGNLRRLEFLNLGSNQLTDEHSASEVGFLTSLTNCNFLRTLWIED 823

Query: 181  NPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPIT 240
            NPL GILP + +GNLS SL++F    C   G IP  I NLT L ++ LG N L G IP T
Sbjct: 824  NPLKGILPNS-LGNLSISLESFDASACQFRGTIPTGIGNLTSLISLELGDNDLTGLIPTT 882

Query: 241  LGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSL 300
            LG+L+KLQ++ +  N+L GSIP+ +C    L  L L  N+L+GSIP+C   +  L+ L L
Sbjct: 883  LGQLKKLQELGIAGNRLRGSIPNDLCRLKNLGYLFLSSNQLTGSIPSCLGYLPPLRELYL 942

Query: 301  GSNELTS-IPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPME 359
             SN L S IP + W+L+ +L LNLSSN  +G LP E+ N+K++  +D S N  SG IP  
Sbjct: 943  HSNALASNIPPSLWTLRGLLVLNLSSNFLTGHLPPEVGNIKSIRTLDLSKNQVSGHIPRT 1002

Query: 360  IGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNL 419
            +G L+NLE+L L  NRL+G IP  FGDL+SLK L+LS NNLSG IP SL+ L+YLK LN+
Sbjct: 1003 LGELQNLEDLSLSQNRLQGPIPLEFGDLLSLKFLDLSQNNLSGVIPKSLKALTYLKYLNV 1062

Query: 420  SFNKLKGEIPRGGSFGNFSAESFKGNELLCGSPNLQVPPC-KASIHRTSRKNALILGIVL 478
            SFNKL+GEIP GG F NF+AESF  NE LCG+P+ QV  C K++  R+ R    IL  +L
Sbjct: 1063 SFNKLQGEIPDGGPFMNFTAESFIFNEALCGAPHFQVIACDKSTRSRSWRTKLFILKYIL 1122

Query: 479  PFSTIFMTAIILFIIKYQKREKGPPNDPNMPPVATW-----RRFSYLELFQATDKFSENN 533
            P   I +  +++F++ + +R K   N     P+ +W      + S+ +L  AT+ F E+N
Sbjct: 1123 P-PVISIITLVVFLVLWIRRRK---NLEVPTPIDSWLPGSHEKISHQQLLYATNYFGEDN 1178

Query: 534  LIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCS 593
            LIG+G    VYK  + +G+ VAVKVFNL+   AF+SFD EC +M+SIRHRNLVK+I+ CS
Sbjct: 1179 LIGKGSLSMVYKGVLSNGLTVAVKVFNLEFQGAFRSFDSECEVMQSIRHRNLVKIITCCS 1238

Query: 594  NEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 653
            N +FKALVLEYMP GSL+K+L+S NY LD+ QRLNIMIDVASALEYLH    + V+HCDL
Sbjct: 1239 NLDFKALVLEYMPKGSLDKWLYSHNYFLDLIQRLNIMIDVASALEYLHHDCPSLVVHCDL 1298

Query: 654  KPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVY 713
            KP+N+LLDD+MVAH+ DFGIA+LLT E +SM QT+TL TIGYMAPEYG +G VST GDV+
Sbjct: 1299 KPNNILLDDDMVAHVGDFGIARLLT-ETESMQQTKTLGTIGYMAPEYGSDGIVSTKGDVF 1357

Query: 714  SFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQC 773
            S+GIMLME F RKKP DE+FNG++TLK WV + L  S +EVVDANLL +ED  F  K  C
Sbjct: 1358 SYGIMLMEVFARKKPMDEMFNGDLTLKSWV-ESLADSMIEVVDANLLRREDEDFATKLSC 1416

Query: 774  VSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLL 810
            +S +  LAL CT +SPE+RI+ K++V  L KI+  LL
Sbjct: 1417 LSSIMALALACTTDSPEERIDMKDVVVGLKKIKIELL 1453

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483198|ref|XP_002271405.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera]

 Score =  761 bits (1964), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 426/807 (52%), Positives = 545/807 (67%), Gaps = 9/807 (1%)

Query: 7    NFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIF 66
            N  T   P+ ID+++ L +L L  N L GE+  EIG L  L  L++  N L G IP  IF
Sbjct: 278  NKFTGGIPRSIDSLTKLTMLSLAANSLSGEVPCEIGSLCTLNVLNIEDNSLTGHIPFQIF 337

Query: 67   NVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALE 126
            N+S++ + ++T N+LSG L       LPNLE L L  N  SG IP  I NASKL  L   
Sbjct: 338  NISSMVSGSLTRNNLSGNLPPNFGSYLPNLENLILEINWLSGIIPSSIGNASKLRSLDFG 397

Query: 127  MNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTL--DLSFLSSLSNCKSLTHISLSNNPLD 184
             N  +G IP   G+LR LE L L  NNL   +   +LSFL+SL+NCK L  + LS NPL 
Sbjct: 398  YNMLTGSIPHALGSLRFLERLNLGVNNLKGESYIQELSFLTSLTNCKRLRILYLSFNPLI 457

Query: 185  GILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKL 244
            GILP + +GNLS SL+ F    C + G IP EI NL++L  + L  N L G+IP ++G+L
Sbjct: 458  GILPIS-IGNLSTSLQRFEANTCKLKGNIPTEIGNLSNLYLLSLNNNDLTGTIPPSIGQL 516

Query: 245  QKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNE 304
            QKLQ + L  N+L+GSIP+ IC    L EL L  N+LSGSIPAC   +TFL+ L LGSN+
Sbjct: 517  QKLQGLYLPSNKLQGSIPNDICQLRNLGELFLTNNQLSGSIPACLGELTFLRHLYLGSNK 576

Query: 305  LTS-IPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSL 363
            L S IP   WSL  IL L++SSN   G LP ++ NLK L++ID S N  SG IP  IG L
Sbjct: 577  LNSTIPSTLWSLIHILSLDMSSNFLVGYLPSDMGNLKVLVKIDLSRNQLSGEIPSNIGGL 636

Query: 364  KNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNK 423
            ++L +L L +NR EG I  SF +L SL+ ++LS N L G IP SLE L YLK L++SFN 
Sbjct: 637  QDLTSLSLAHNRFEGPILHSFSNLKSLEFMDLSDNALFGEIPKSLEGLVYLKYLDVSFNG 696

Query: 424  LKGEIPRGGSFGNFSAESFKGNELLCGSPNLQVPPCKASIHRTSRKNALILGIVLP--FS 481
            L GEIP  G F NFSAESF  N+ LCGSP L++PPC+     ++  + L+L  +LP   S
Sbjct: 697  LYGEIPPEGPFANFSAESFMMNKALCGSPRLKLPPCRTGTRWSTTISWLLLKYILPAILS 756

Query: 482  TIFMTAIILFIIKYQKREKGPPNDPNMPPVATWRRFSYLELFQATDKFSENNLIGRGGFG 541
            T+   A+I    + +KR    P        ATWRR SY E+FQAT+ FS  NL+GRG  G
Sbjct: 757  TLLFLALIFVWTRCRKRNAVLPTQSESLLTATWRRISYQEIFQATNGFSAGNLLGRGSLG 816

Query: 542  SVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNE--EFKA 599
            SVY+  + DG   A+KVFNLQ   AFKSFD EC +M  IRHRNL+K++SSCSN   +FKA
Sbjct: 817  SVYRGTLSDGKNAAIKVFNLQEEAAFKSFDAECEVMHHIRHRNLIKIVSSCSNSYIDFKA 876

Query: 600  LVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVL 659
            LVLEY+P+GSLE++L+S NY LDI QRLNIMIDVA A+EYLH G S PV+HCDLKPSN+L
Sbjct: 877  LVLEYVPNGSLERWLYSHNYCLDILQRLNIMIDVALAMEYLHHGCSTPVVHCDLKPSNIL 936

Query: 660  LDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIML 719
            LD++   H+ DFGIAKLL  E++S+ +TQTLATIGYMAP+Y   G V+T+GDVYS+GI+L
Sbjct: 937  LDEDFGGHVGDFGIAKLLR-EEESIRETQTLATIGYMAPKYVSNGIVTTSGDVYSYGIVL 995

Query: 720  METFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFN 779
            METFTR++PTDE+F+ EM++K+WV D L  S  EVVDANLL  ED  F+AK+QC+S +  
Sbjct: 996  METFTRRRPTDEIFSEEMSMKNWVWDWLCGSITEVVDANLLRGEDEQFMAKKQCISLILG 1055

Query: 780  LALECTVESPEQRINAKEIVAKLLKIR 806
            LA++C  +SPE+RI  K++V  L KI+
Sbjct: 1056 LAMDCVADSPEERIKMKDVVTTLKKIK 1082

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483677|ref|XP_003633000.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Vitis vinifera]

 Score =  759 bits (1961), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 421/811 (51%), Positives = 550/811 (67%), Gaps = 12/811 (1%)

Query: 7    NFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIF 66
            N    + PKEI N+S L+ +YL  N L G I    G+L  L FL+L  N L GT+P AIF
Sbjct: 423  NKFRGSIPKEIGNLSKLEKIYLGTNSLIGSIPTSFGNLKALKFLNLGINNLTGTVPEAIF 482

Query: 67   NVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALE 126
            N+S L++ A+  N LSG L S     L +LE L++ GN FSG IP  I N SKL+ L L 
Sbjct: 483  NISKLQSLAMVKNHLSGSLPSSIGTWLSDLEGLFIAGNEFSGIIPMSISNMSKLTVLGLS 542

Query: 127  MNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTL--DLSFLSSLSNCKSLTHISLSNNPLD 184
             NSF+G +P   GNL  L+ L L  N LT   +  ++ FL+SL+NCK L ++ + NNP  
Sbjct: 543  ANSFTGNVPKDLGNLTKLKVLDLAGNQLTDEHVASEVGFLTSLTNCKFLKNLWIGNNPFK 602

Query: 185  GILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKL 244
            G LP + +GNL  +L++F    C   G IP  I NLT+L  + LG N L GSIP TLG+L
Sbjct: 603  GTLPNS-LGNLPIALESFIASACQFRGTIPTRIGNLTNLIWLDLGANDLTGSIPTTLGRL 661

Query: 245  QKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNE 304
            +KLQ + +  N+L GSIP+ +C    L  L L  NKLSGSIP+CF ++  L+ L L SN 
Sbjct: 662  KKLQKLHIVGNRLRGSIPNDLCHLKNLGYLHLSSNKLSGSIPSCFGDLPALQELFLDSNV 721

Query: 305  LT-SIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSL 363
            L  +IP + WSL+D+L LNLSSN  +G LP E+ N+K++  +D S N  SG IP ++G  
Sbjct: 722  LAFNIPTSLWSLRDLLVLNLSSNFLTGNLPPEVGNMKSITTLDLSKNLVSGHIPRKMGEQ 781

Query: 364  KNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNK 423
            +NL  L L  N+L+G IP  FGDL+SL+SL+LS NNLSGTIP SLE L YLK LN+S NK
Sbjct: 782  QNLAKLSLSQNKLQGPIPIEFGDLVSLESLDLSQNNLSGTIPKSLEALIYLKYLNVSLNK 841

Query: 424  LKGEIPRGGSFGNFSAESFKGNELLCGSPNLQVPPC-KASIHRTSRKNALILG-IVLPFS 481
            L+GEIP GG F NF+AESF  NE LCG+P+ QV  C K +  ++ +  + IL  I+LP  
Sbjct: 842  LQGEIPNGGPFINFTAESFMFNEALCGAPHFQVMACDKNNRTQSWKTKSFILKYILLPVG 901

Query: 482  TI--FMTAIILFIIKYQKREKGPPNDPNMPPVATWRRFSYLELFQATDKFSENNLIGRGG 539
            +I   +  I+L+I +    E   P D  +P   T  + S+ +L  AT+ F E+NLIG+G 
Sbjct: 902  SIVTLVVFIVLWIRRRDNMEIPTPIDSWLP--GTHEKISHQQLLYATNDFGEDNLIGKGS 959

Query: 540  FGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKA 599
             G VYK  + +G+ VA+KVFNL+   A +SFD EC +M+ IRHRNLV++I+ CSN +FKA
Sbjct: 960  QGMVYKGVLSNGLTVAIKVFNLEFQGALRSFDSECEVMQGIRHRNLVRIITCCSNLDFKA 1019

Query: 600  LVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVL 659
            LVLEYMP+GSLEK+L+S NY LD+ QRLNIMIDVASALEYLH   S+ V+HCDLKP+NVL
Sbjct: 1020 LVLEYMPNGSLEKWLYSHNYFLDLIQRLNIMIDVASALEYLHHDCSSLVVHCDLKPNNVL 1079

Query: 660  LDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIML 719
            LDD+MVAH++DFGI KLLT + +SM QT+TL TIGYMAPE+G +G VST  DVYS+GI+L
Sbjct: 1080 LDDDMVAHVADFGITKLLT-KTESMQQTKTLGTIGYMAPEHGSDGIVSTKSDVYSYGILL 1138

Query: 720  METFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFN 779
            ME F+RKKP DE+F G++TLK WV + L  S ++VVDANLL +ED     K  C+S +  
Sbjct: 1139 MEVFSRKKPMDEMFTGDLTLKTWV-ESLSNSVIQVVDANLLRREDEDLATKLSCLSSIMA 1197

Query: 780  LALECTVESPEQRINAKEIVAKLLKIRDSLL 810
            LAL CT +SPE+R+N K+ V +L K R  LL
Sbjct: 1198 LALACTTDSPEERLNMKDAVVELKKSRMKLL 1228

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	824
TAIR|locus:2079157	1011	AT3G47580 [Arabidopsis thalian	0.734	0.598	0.324	4.3e-128
UNIPROTKB|Q40640	1025	Xa21 "Receptor kinase-like pro	0.907	0.729	0.382	2.9e-126
TAIR|locus:2079142	1010	AT3G47570 [Arabidopsis thalian	0.739	0.602	0.347	8.6e-88
TAIR|locus:2170483	1173	FLS2 "FLAGELLIN-SENSITIVE 2" [	0.952	0.669	0.340	2.9e-112
TAIR|locus:2149922	1031	EFR "EF-TU receptor" [Arabidop	0.711	0.568	0.343	1.3e-82
TAIR|locus:2156349	1252	GSO2 "GASSHO 2" [Arabidopsis t	0.703	0.463	0.298	4.2e-105
TAIR|locus:2075661	1025	AT3G47110 [Arabidopsis thalian	0.737	0.593	0.369	5.7e-91
TAIR|locus:2047525	980	AT2G24130 [Arabidopsis thalian	0.940	0.790	0.328	1.4e-96
TAIR|locus:2046525	1124	AT2G33170 [Arabidopsis thalian	0.663	0.486	0.303	1.4e-96
TAIR|locus:2167948	966	ERL1 "ERECTA-like 1" [Arabidop	0.947	0.808	0.321	1.2e-95

TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)]

 Score = 800 (286.7 bits), Expect = 4.3e-128, Sum P(2) = 4.3e-128
 Identities = 204/628 (32%), Positives = 319/628 (50%)

Query:     7 NFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIF 66
             N L    P+ + N+++LK L   +N ++GE+  E+  L  +  L LS NK  G  P AI+
Sbjct:   172 NNLKGKLPRSLGNLTSLKSLGFTDNNIEGEVPDELARLSQMVGLGLSMNKFFGVFPPAIY 231

Query:    67 NVSTLKAFAVTNNSLSGCLSSITDVG--LPNLEVLYLWGNNFSGTIPHFIFNASKLSKLA 124
             N+S L+   +  +  SG L    D G  LPN+  L L  N+  G IP  + N S L K  
Sbjct:   232 NLSALEDLFLFGSGFSGSLKP--DFGNLLPNIRELNLGENDLVGAIPTTLSNISTLQKFG 289

Query:   125 LEMNSFSGFIPSTFGNLRNLEWLTLYXX-XXXXXXXXXXXXXXXXXCKSLTHISLSNNPL 183
             +  N  +G I   FG + +L++L L                     C  L  +S+    L
Sbjct:   290 INKNMMTGGIYPNFGKVPSLQYLDLSENPLGSYTFGDLEFIDSLTNCTHLQLLSVGYTRL 349

Query:   184 DGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGK 243
              G LP T + N+S  L +  +   +  G IP++I NL  L  + LG N L G +P +LGK
Sbjct:   350 GGALP-TSIANMSTELISLNLIGNHFFGSIPQDIGNLIGLQRLQLGKNMLTGPLPTSLGK 408

Query:   244 LQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSN 303
             L +L  + L  N++ G IP  I    +L  L L  N   G +P      + +  L +G N
Sbjct:   409 LLRLGLLSLYSNRMSGEIPSFIGNLTQLEILYLSNNSFEGIVPPSLGKCSHMLDLRIGYN 468

Query:   304 ELT-SIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGS 362
             +L  +IP     +  +++L++  N  SG LP +I +L+ L+++    N FSG +P  +G+
Sbjct:   469 KLNGTIPKEIMQIPTLVNLSMEGNSLSGSLPNDIGSLQNLVKLSLENNKFSGHLPQTLGN 528

Query:   363 LKNLENLFLEYNRLEGSIPDSFGDLIXXXXXXXXXXXXXGTIPVSLEKLSYLKDLNLSFN 422
                +E LFL+ N  +G+IP+  G L+             G+IP      S L+ LNLS N
Sbjct:   529 CLAMEQLFLQGNSFDGAIPNIRG-LMGVRRVDLSNNDLSGSIPEYFANFSKLEYLNLSIN 587

Query:   423 KLKGEIPRGGSFGNFSAESFKGNELLCGS-PNLQVPPCKASIHRTSRKNALILGIVLPFS 481
                G++P  G+F N +     GN+ LCG   +L++ PC A       K++  L  V    
Sbjct:   588 NFTGKVPSKGNFQNSTIVFVFGNKNLCGGIKDLKLKPCLAQEPPVETKHSSHLKKVAILV 647

Query:   482 TIFMTAIILFIIK------YQKREKGPPNDPNMPPVAT--WRRFSYLELFQATDKFSENN 533
             +I +  ++L +I       ++KR K    +  +P        + SY +L  AT+ FS +N
Sbjct:   648 SIGIALLLLLVIASMVLCWFRKRRKNQQTNNLVPSKLEIFHEKISYGDLRNATNGFSSSN 707

Query:   534 LIGRGGFGSVYKARI-RDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSC 592
             ++G G FG+V+KA +  +   VAVKV N+Q   A KSF  EC  +K  RHRNLVK++++C
Sbjct:   708 MVGSGSFGTVFKALLPTESKIVAVKVLNMQRRGAMKSFMAECESLKDTRHRNLVKLLTAC 767

Query:   593 SN-----EEFKALVLEYMPHGSLEKYLH 615
             ++      EF+AL+ EY+P+GS++ +LH
Sbjct:   768 ASTDFQGNEFRALIYEYLPNGSVDMWLH 795

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)]

 Score = 1240 (441.6 bits), Expect = 2.9e-126, P = 2.9e-126
 Identities = 299/781 (38%), Positives = 437/781 (55%)

Query:     4 IINNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPA 63
             +  N L+   P  + N+++L+   L  NRL G I   +G L +L  ++L QN L G IP 
Sbjct:   183 LYKNGLSGEIPSALGNLTSLQEFDLSFNRLSGAIPSSLGQLSSLLTMNLGQNNLSGMIPN 242

Query:    64 AIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKL 123
             +I+N+S+L+AF+V  N L G + +     L  LEV+ +  N F G IP  + NAS L+ +
Sbjct:   243 SIWNLSSLRAFSVRENKLGGMIPTNAFKTLHLLEVIDMGTNRFHGKIPASVANASHLTVI 302

Query:   124 ALEMNSFSGFIPSTFGNLRNLEWLTLYXXXXXXXXXXX-XXXXXXXXCKSLTHISLSNNP 182
              +  N FSG I S FG LRNL  L L+                    C  L  ++L  N 
Sbjct:   303 QIYGNLFSGIITSGFGRLRNLTELYLWRNLFQTREQDDWGFISDLTNCSKLQTLNLGENN 362

Query:   183 LDGILPRTYVGNLSHSLKNFYMYNCN-VSGGIPEEITNLTDLTTIVLGGNKLNGSIPITL 241
             L G+LP ++  NLS SL +F     N ++G IP++I NL  L  + L  N   GS+P +L
Sbjct:   363 LGGVLPNSF-SNLSTSL-SFLALELNKITGSIPKDIGNLIGLQHLYLCNNNFRGSLPSSL 420

Query:   242 GKLQKLQDVDLEY-NQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSL 300
             G+L+ L  + L Y N L GSIP +I    EL  L LG NK SG IP   SN+T L  L L
Sbjct:   421 GRLKNL-GILLAYENNLSGSIPLAIGNLTELNILLLGTNKFSGWIPYTLSNLTNLLSLGL 479

Query:   301 GSNELTS-IPLNFWSLKDI-LDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPM 358
              +N L+  IP   ++++ + + +N+S N   G +P EI +LK L+E     N  SG IP 
Sbjct:   480 STNNLSGPIPSELFNIQTLSIMINVSKNNLEGSIPQEIGHLKNLVEFHAESNRLSGKIPN 539

Query:   359 EIGSLKNLENLFLEYNRLEGSIPDSFGDLIXXXXXXXXXXXXXGTIPVSLEKLSYLKDLN 418
              +G  + L  L+L+ N L GSIP + G L              G IP SL  ++ L  LN
Sbjct:   540 TLGDCQLLRYLYLQNNLLSGSIPSALGQLKGLETLDLSSNNLSGQIPTSLADITMLHSLN 599

Query:   419 LSFNKLKGEIPRGGSFGNFSAESFKGNELLCGS-PNLQVPPCKASIHRTSRKNALILGIV 477
             LSFN   GE+P  G+F   S  S +GN  LCG  P+L +P C   +        L + + 
Sbjct:   600 LSFNSFVGEVPTIGAFAAASGISIQGNAKLCGGIPDLHLPRCCPLLENRKHFPVLPISVS 659

Query:   478 LPFSTIFMTAIILFIIKYQKREKGPPNDPNMP--PVATWRRFSYLELFQATDKFSENNLI 535
             L  +   ++++ L I  +++ +KG P+  +M   P+      SY +L +ATD F+  NL+
Sbjct:   660 LAAALAILSSLYLLITWHKRTKKGAPSRTSMKGHPLV-----SYSQLVKATDGFAPTNLL 714

Query:   536 GRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSN- 594
             G G FGSVYK ++     VAVKV  L+  +A KSF  EC  ++++RHRNLVK+++ CS+ 
Sbjct:   715 GSGSFGSVYKGKLNIQDHVAVKVLKLENPKALKSFTAECEALRNMRHRNLVKIVTICSSI 774

Query:   595 ----EEFKALVLEYMPHGSLEKYLH------SSNYSLDIFQRLNIMIDVASALEYLHFGY 644
                  +FKA+V ++MP+GSLE ++H      +    L++ +R+ I++DVA AL+YLH   
Sbjct:   775 DNRGNDFKAIVYDFMPNGSLEDWIHPETNDQADQRHLNLHRRVTILLDVACALDYLHRHG 834

Query:   645 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT-----LATIGYMAPE 699
               PV+HCD+K SNVLLD +MVAH+ DFG+A++L  +  S+ Q  T     + TIGY APE
Sbjct:   835 PEPVVHCDIKSSNVLLDSDMVAHVGDFGLARILV-DGTSLIQQSTSSMGFIGTIGYAAPE 893

Query:   700 YGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANL 759
             YG     ST+GD+YS+GI+++E  T K+PTD  F  ++ L+ +V   L     +VVD  L
Sbjct:   894 YGVGLIASTHGDIYSYGILVLEIVTGKRPTDSTFRPDLGLRQYVELGLHGRVTDVVDTKL 953

Query:   760 L 760
             +
Sbjct:   954 I 954

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)]

 Score = 877 (313.8 bits), Expect = 8.6e-88, P = 8.6e-88
 Identities = 219/631 (34%), Positives = 332/631 (52%)

Query:     3 SIINNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIP 62
             ++  N +    P  + N++ L+ L L +N L+GEI  ++  L  +  L L  N   G  P
Sbjct:   168 NLYGNNMRGKLPTSLGNLTLLEQLALSHNNLEGEIPSDVAQLTQIWSLQLVANNFSGVFP 227

Query:    63 AAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSK 122
              A++N+S+LK   +  N  SG L     + LPNL    + GN F+G+IP  + N S L +
Sbjct:   228 PALYNLSSLKLLGIGYNHFSGRLRPDLGILLPNLLSFNMGGNYFTGSIPTTLSNISTLER 287

Query:   123 LALEMNSFSGFIPSTFGNLRNLEWLTLYXXXXXXXXXXXXXXXXXXX-CKSLTHISLSNN 181
             L +  N+ +G IP TFGN+ NL+ L L+                    C  L  + +  N
Sbjct:   288 LGMNENNLTGSIP-TFGNVPNLKLLFLHTNSLGSDSSRDLEFLTSLTNCTQLETLGIGRN 346

Query:   182 PLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITL 241
              L G LP + + NLS  L    +    +SG IP +I NL +L  ++L  N L+G +P +L
Sbjct:   347 RLGGDLPIS-IANLSAKLVTLDLGGTLISGSIPYDIGNLINLQKLILDQNMLSGPLPTSL 405

Query:   242 GKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLG 301
             GKL  L+ + L  N+L G IP  I     L  L+L  N   G +P    N + L  L +G
Sbjct:   406 GKLLNLRYLSLFSNRLSGGIPAFIGNMTMLETLDLSNNGFEGIVPTSLGNCSHLLELWIG 465

Query:   302 SNELT-SIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEI 360
              N+L  +IPL    ++ +L L++S N   G LP +I  L+ L  +    N  SG +P  +
Sbjct:   466 DNKLNGTIPLEIMKIQQLLRLDMSGNSLIGSLPQDIGALQNLGTLSLGDNKLSGKLPQTL 525

Query:   361 GSLKNLENLFLEYNRLEGSIPDSFGDLIXXXXXXXXXXXXXGTIPVSLEKLSYLKDLNLS 420
             G+   +E+LFLE N   G IPD  G L+             G+IP      S L+ LNLS
Sbjct:   526 GNCLTMESLFLEGNLFYGDIPDLKG-LVGVKEVDLSNNDLSGSIPEYFASFSKLEYLNLS 584

Query:   421 FNKLKGEIPRGGSFGNFSAESFKGNELLCGS-PNLQVPPCKA---SIHR--TSRKNALIL 474
             FN L+G++P  G F N +  S  GN  LCG     Q+ PC +   S+ +  +SR   +++
Sbjct:   585 FNNLEGKVPVKGIFENATTVSIVGNNDLCGGIMGFQLKPCLSQAPSVVKKHSSRLKKVVI 644

Query:   475 GIVLPFSTI---FMTAIILFIIKYQKREKGPPNDPNMPPVATWR-RFSYLELFQATDKFS 530
             G+ +  + +   FM ++ L  ++ +K+ K   N+P    +     + SY +L  AT+ FS
Sbjct:   645 GVSVGITLLLLLFMASVTLIWLRKRKKNK-ETNNPTPSTLEVLHEKISYGDLRNATNGFS 703

Query:   531 ENNLIGRGGFGSVYKARI-RDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVI 589
              +N++G G FG+VYKA +  +   VAVKV N+Q   A KSF  EC  +K IRHRNLVK++
Sbjct:   704 SSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLL 763

Query:   590 SSCSN-----EEFKALVLEYMPHGSLEKYLH 615
             ++CS+      EF+AL+ E+MP+GSL+ +LH
Sbjct:   764 TACSSIDFQGNEFRALIYEFMPNGSLDMWLH 794

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1108 (395.1 bits), Expect = 2.9e-112, P = 2.9e-112
 Identities = 282/828 (34%), Positives = 441/828 (53%)

Query:     6 NNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAI 65
             NNF T   P+ I N+ NL VL +  N + GE+  ++G L NL  L    N L G IP++I
Sbjct:   346 NNF-TGEFPQSITNLRNLTVLTVGFNNISGELPADLGLLTNLRNLSAHDNLLTGPIPSSI 404

Query:    66 FNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLAL 125
              N + LK   +++N ++G +      G  NL  + +  N+F+G IP  IFN S L  L++
Sbjct:   405 SNCTGLKLLDLSHNQMTGEIPR--GFGRMNLTFISIGRNHFTGEIPDDIFNCSNLETLSV 462

Query:   126 EMNSFSGFIPSTFGNLRNLEWLTLYXXXXXXXXXXXXXXXXXXXCKSLTHISLSNNPLDG 185
               N+ +G +    G L+ L  L +                     K L  + L +N   G
Sbjct:   463 ADNNLTGTLKPLIGKLQKLRILQV-----SYNSLTGPIPREIGNLKDLNILYLHSNGFTG 517

Query:   186 ILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQ 245
              +PR  + NL+  L+   MY+ ++ G IPEE+ ++  L+ + L  NK +G IP    KL+
Sbjct:   518 RIPRE-MSNLT-LLQGLRMYSNDLEGPIPEEMFDMKLLSVLDLSNNKFSGQIPALFSKLE 575

Query:   246 KLQDVDLEYNQLEGSIPDSI-CLSVELYELELGGNKLSGSIP----ACFSNMTFLKVLSL 300
              L  + L+ N+  GSIP S+  LS+ L   ++  N L+G+IP    A   NM     L+ 
Sbjct:   576 SLTYLSLQGNKFNGSIPASLKSLSL-LNTFDISDNLLTGTIPGELLASLKNMQLY--LNF 632

Query:   301 GSNELT-SIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPME 359
              +N LT +IP     L+ + +++LS+N FSG +P  ++  K +  +DFS NN SG IP E
Sbjct:   633 SNNLLTGTIPKELGKLEMVQEIDLSNNLFSGSIPRSLQACKNVFTLDFSQNNLSGHIPDE 692

Query:   360 I-GSLKNLENLFLEYNRLEGSIPDSFGDLIXXXXXXXXXXXXXGTIPVSLEKLSYLKDLN 418
             +   +  + +L L  N   G IP SFG++              G IP SL  LS LK L 
Sbjct:   693 VFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSNNLTGEIPESLANLSTLKHLK 752

Query:   419 LSFNKLKGEIPRGGSFGNFSAESFKGNELLCGSPNLQVPPC--KASIHRTSRKNALILGI 476
             L+ N LKG +P  G F N +A    GN  LCGS    + PC  K      S++  +IL I
Sbjct:   753 LASNNLKGHVPESGVFKNINASDLMGNTDLCGSKK-PLKPCTIKQKSSHFSKRTRVILII 811

Query:   477 VLPFSTIFMTAIILFIIKY-QKREKGPPND-----PNMPPVATWRRFSYLELFQATDKFS 530
             +   + + +  +++ I+   +K+EK   N      P++      +RF   EL QATD F+
Sbjct:   812 LGSAAALLLVLLLVLILTCCKKKEKKIENSSESSLPDLDSALKLKRFEPKELEQATDSFN 871

Query:   531 ENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQ--CGRAFKSFDVECAMMKSIRHRNLVKV 588
               N+IG     +VYK ++ DG  +AVKV NL+     + K F  E   +  ++HRNLVK+
Sbjct:   872 SANIIGSSSLSTVYKGQLEDGTVIAVKVLNLKEFSAESDKWFYTEAKTLSQLKHRNLVKI 931

Query:   589 IS-SCSNEEFKALVLEYMPHGSLEKYLHSSNYSL-DIFQRLNIMIDVASALEYLHFGYSA 646
             +  +  + + KALVL +M +G+LE  +H S   +  + +++++ + +AS ++YLH GY  
Sbjct:   932 LGFAWESGKTKALVLPFMENGNLEDTIHGSAAPIGSLLEKIDLCVHIASGIDYLHSGYGF 991

Query:   647 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA---TIGYMAPEYGRE 703
             P++HCDLKP+N+LLD + VAH+SDFG A++L   +   T   T A   TIGY+APE+   
Sbjct:   992 PIVHCDLKPANILLDSDRVAHVSDFGTARILGFREDGSTTASTSAFEGTIGYLAPEFAYM 1051

Query:   704 GQVSTNGDVYSFGIMLMETFTRKKPT--DELFNGEMTLKHWVNDCLPIST---MEVVDAN 758
              +V+T  DV+SFGI++ME  T+++PT  ++  + +MTL+  V   +       + V+D  
Sbjct:  1052 RKVTTKADVFSFGIIMMELMTKQRPTSLNDEDSQDMTLRQLVEKSIGNGRKGMVRVLDME 1111

Query:   759 LLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIR 806
             L   + I  + +E+ +     L L CT   PE R +  EI+  L+K+R
Sbjct:  1112 L--GDSIVSLKQEEAIEDFLKLCLFCTSSRPEDRPDMNEILTHLMKLR 1157

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0016020 "membrane" evidence=ISS;IDA

GO:0016045 "detection of bacterium" evidence=IMP

GO:0005886 "plasma membrane" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0042742 "defense response to bacterium" evidence=RCA;IMP

GO:0052544 "defense response by callose deposition in cell wall" evidence=IMP

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0016310 "phosphorylation" evidence=RCA

GO:0005768 "endosome" evidence=IDA

GO:0006898 "receptor-mediated endocytosis" evidence=IDA

TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)]

 Score = 828 (296.5 bits), Expect = 1.3e-82, P = 1.3e-82
 Identities = 207/602 (34%), Positives = 306/602 (50%)

Query:     7 NFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIF 66
             N LT   P  + N+++L+ L    N+++GEI  E+  L  + F  ++ N   G  P A++
Sbjct:   179 NNLTGNFPASLGNLTSLQKLDFAYNQMRGEIPDEVARLTQMVFFQIALNSFSGGFPPALY 238

Query:    67 NVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALE 126
             N+S+L++ ++ +NS SG L +     LPNL  L L  N F+G IP  + N S L +  + 
Sbjct:   239 NISSLESLSLADNSFSGNLRADFGYLLPNLRRLLLGTNQFTGAIPKTLANISSLERFDIS 298

Query:   127 MNSFSGFIPSTFGNLRNLEWLTLYXXXXXXXXXXXXXXXXXXX-CKSLTHISLSNNPLDG 185
              N  SG IP +FG LRNL WL +                     C  L ++ +  N L G
Sbjct:   299 SNYLSGSIPLSFGKLRNLWWLGIRNNSLGNNSSSGLEFIGAVANCTQLEYLDVGYNRLGG 358

Query:   186 ILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQ 245
              LP + + NLS +L + ++    +SG IP +I NL  L  + L  N L+G +P++ GKL 
Sbjct:   359 ELPAS-IANLSTTLTSLFLGQNLISGTIPHDIGNLVSLQELSLETNMLSGELPVSFGKLL 417

Query:   246 KLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNEL 305
              LQ VDL  N + G IP        L +L L  N   G IP       +L  L + +N L
Sbjct:   418 NLQVVDLYSNAISGEIPSYFGNMTRLQKLHLNSNSFHGRIPQSLGRCRYLLDLWMDTNRL 477

Query:   306 T-SIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLK 364
               +IP     +  +  ++LS+N  +G  P E+  L+ L+ +  S N  SG +P  IG   
Sbjct:   478 NGTIPQEILQIPSLAYIDLSNNFLTGHFPEEVGKLELLVGLGASYNKLSGKMPQAIGGCL 537

Query:   365 NLENLFLEYNRLEGSIPDSFGDLIXXXXXXXXXXXXXGTIPVSLEKLSYLKDLNLSFNKL 424
             ++E LF++ N  +G+IPD    L+             G IP  L  L  L++LNLS NK 
Sbjct:   538 SMEFLFMQGNSFDGAIPD-ISRLVSLKNVDFSNNNLSGRIPRYLASLPSLRNLNLSMNKF 596

Query:   425 KGEIPRGGSFGNFSAESFKGNELLCGSPN-LQVPPC--KASIHRT---SRKNALILGIVL 478
             +G +P  G F N +A S  GN  +CG    +Q+ PC  +AS  +    S +  ++ GI +
Sbjct:   597 EGRVPTTGVFRNATAVSVFGNTNICGGVREMQLKPCIVQASPRKRKPLSVRKKVVSGICI 656

Query:   479 PFSTIFMTAIILFIIKYQKREK-GPPNDPNMPPVATWRRF----SYLELFQATDKFSENN 533
               +++ +  I+  +  + KR+K    +D N     T   F    SY EL  AT +FS  N
Sbjct:   657 GIASLLLIIIVASLCWFMKRKKKNNASDGNPSDSTTLGMFHEKVSYEELHSATSRFSSTN 716

Query:   534 LIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSC 592
             LIG G FG+V+K  +  +   VAVKV NL    A KSF  EC   K IRHRNLVK+I+ C
Sbjct:   717 LIGSGNFGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAECETFKGIRHRNLVKLITVC 776

Query:   593 SN 594
             S+
Sbjct:   777 SS 778

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010204 "defense response signaling pathway, resistance gene-independent" evidence=IMP

GO:0016045 "detection of bacterium" evidence=RCA;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0002764 "immune response-regulating signaling pathway" evidence=IMP

GO:0009626 "plant-type hypersensitive response" evidence=IMP

GO:0019199 "transmembrane receptor protein kinase activity" evidence=TAS

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0050776 "regulation of immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2156349 GSO2 "GASSHO 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 615 (221.5 bits), Expect = 4.2e-105, Sum P(2) = 4.2e-105
 Identities = 183/614 (29%), Positives = 291/614 (47%)

Query:     3 SIINNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIP 62
             ++ +N L    PKEI  +  L+++YLY NR  GE+  EIG+   L  +D   N+L G IP
Sbjct:   415 TLYHNNLEGKVPKEIGFLGKLEIMYLYENRFSGEMPVEIGNCTRLQEIDWYGNRLSGEIP 474

Query:    63 AAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSK 122
             ++I  +  L    +  N L G + +        + V+ L  N  SG+IP      + L  
Sbjct:   475 SSIGRLKDLTRLHLRENELVGNIPASLG-NCHQMTVIDLADNQLSGSIPSSFGFLTALEL 533

Query:   123 LALEMNSFSGFIPSTFGNLRNLEWLTLYXXXXXXXXXXXXXXXXXXXCKSLTHIS--LSN 180
               +  NS  G +P +  NL+NL  +                      C S +++S  ++ 
Sbjct:   534 FMIYNNSLQGNLPDSLINLKNLTRINF--------SSNKFNGSISPLCGSSSYLSFDVTE 585

Query:   181 NPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPIT 240
             N  +G +P   +G  S +L    +     +G IP     +++L+ + +  N L+G IP+ 
Sbjct:   586 NGFEGDIPLE-LGK-STNLDRLRLGKNQFTGRIPRTFGKISELSLLDISRNSLSGIIPVE 643

Query:   241 LGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSL 300
             LG  +KL  +DL  N L G IP  +     L EL+L  NK  GS+P    ++T +  L L
Sbjct:   644 LGLCKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLSSNKFVGSLPTEIFSLTNILTLFL 703

Query:   301 GSNELT-SIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPME 359
               N L  SIP    +L+ +  LNL  N  SGPLP  I  L  L E+  S N  +G IP+E
Sbjct:   704 DGNSLNGSIPQEIGNLQALNALNLEENQLSGPLPSTIGKLSKLFELRLSRNALTGEIPVE 763

Query:   360 IGSLKNLEN-LFLEYNRLEGSIPDSFGDLIXXXXXXXXXXXXXGTIPVSLEKLSYLKDLN 418
             IG L++L++ L L YN   G IP +   L              G +P  +  +  L  LN
Sbjct:   764 IGQLQDLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQLVGEVPGQIGDMKSLGYLN 823

Query:   419 LSFNKLKGEIPRGGSFGNFSAESFKGNELLCGSPNLQVPPCKASIHRT-SRKNALILGIV 477
             LS+N L+G++ +   F  + A++F GN  LCGSP        +   R+ S K  +I+  +
Sbjct:   824 LSYNNLEGKLKK--QFSRWQADAFVGNAGLCGSPLSHCNRAGSKNQRSLSPKTVVIISAI 881

Query:   478 LPFSTI-FMTAIILFIIKYQ----KREKG------PPNDPNMPPV----ATWRRFSYLEL 522
                + I  M  +I+   K      K+ +G        +  +  P+           + ++
Sbjct:   882 SSLAAIALMVLVIILFFKQNHDLFKKVRGGNSAFSSNSSSSQAPLFSNGGAKSDIKWDDI 941

Query:   523 FQATDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCG-RAFKSFDVECAMMKSIR 581
              +AT   +E  +IG GG G VYKA +++G  +AVK    +    + KSF+ E   + +IR
Sbjct:   942 MEATHYLNEEFMIGSGGSGKVYKAELKNGETIAVKKILWKDDLMSNKSFNREVKTLGTIR 1001

Query:   582 HRNLVKVISSCSNE 595
             HR+LVK++  CS++
Sbjct:  1002 HRHLVKLMGYCSSK 1015

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009553 "embryo sac development" evidence=IMP

GO:0008544 "epidermis development" evidence=IGI

GO:0009790 "embryo development" evidence=IGI

TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)]

 Score = 907 (324.3 bits), Expect = 5.7e-91, P = 5.7e-91
 Identities = 234/634 (36%), Positives = 336/634 (52%)

Query:     3 SIINNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIP 62
             S+  N LT   P  + N+++L++L    N+++GEI  +I  L  + F  ++ NK  G  P
Sbjct:   183 SLGRNNLTGKFPASLGNLTSLQMLDFIYNQIEGEIPGDIARLKQMIFFRIALNKFNGVFP 242

Query:    63 AAIFNVSTLKAFAVTNNSLSGCLSSITDVG--LPNLEVLYLWGNNFSGTIPHFIFNASKL 120
               I+N+S+L   ++T NS SG L    D G  LPNL++LY+  N+F+GTIP  + N S L
Sbjct:   243 PPIYNLSSLIFLSITGNSFSGTLRP--DFGSLLPNLQILYMGINSFTGTIPETLSNISSL 300

Query:   121 SKLALEMNSFSGFIPSTFGNLRNLEWLTLYXXXXXXXXXXXXXXXXXXX-CKSLTHISLS 179
              +L +  N  +G IP +FG L+NL  L L                     C  L ++++ 
Sbjct:   301 RQLDIPSNHLTGKIPLSFGRLQNLLLLGLNNNSLGNYSSGDLDFLGALTNCSQLQYLNVG 360

Query:   180 NNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPI 239
              N L G LP  ++ NLS  L    +    +SG IP  I NL  L T+ LG N L G +P 
Sbjct:   361 FNKLGGQLP-VFIANLSTQLTELSLGGNLISGSIPHGIGNLVSLQTLDLGENLLTGKLPP 419

Query:   240 TLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLS 299
             +LG+L +L+ V L  N L G IP S+     L  L L  N   GSIP+   + ++L  L+
Sbjct:   420 SLGELSELRKVLLYSNGLSGEIPSSLGNISGLTYLYLLNNSFEGSIPSSLGSCSYLLDLN 479

Query:   300 LGSNELT-SIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPM 358
             LG+N+L  SIP     L  ++ LN+S N   GPL  +I  LK L+ +D S N  SG IP 
Sbjct:   480 LGTNKLNGSIPHELMELPSLVVLNVSFNLLVGPLRQDIGKLKFLLALDVSYNKLSGQIPQ 539

Query:   359 EIGSLKNLENLFLEYNRLEGSIPDSFGDLIXXXXXXXXXXXXXGTIPVSLEKLSYLKDLN 418
              + +  +LE L L+ N   G IPD  G L              GTIP  +   S L++LN
Sbjct:   540 TLANCLSLEFLLLQGNSFVGPIPDIRG-LTGLRFLDLSKNNLSGTIPEYMANFSKLQNLN 598

Query:   419 LSFNKLKGEIPRGGSFGNFSAESFKGNELLCGS-PNLQVPPCKASI---HRTSRKNALIL 474
             LS N   G +P  G F N SA S  GN  LCG  P+LQ+ PC   +   H + RK   I 
Sbjct:   599 LSLNNFDGAVPTEGVFRNTSAMSVFGNINLCGGIPSLQLQPCSVELPRRHSSVRKIITIC 658

Query:   475 GIVLPFSTIFMTAIILFIIKYQKREKGP-----PNDPNMPPVAT-WRRFSYLELFQATDK 528
                +  + + +   ++++  Y+ R K        ND +  PV + + + SY EL++ T  
Sbjct:   659 VSAVMAALLLLCLCVVYLCWYKLRVKSVRANNNENDRSFSPVKSFYEKISYDELYKTTGG 718

Query:   529 FSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGR-AFKSFDVECAMMKSIRHRNLV 586
             FS +NLIG G FG+V+K  +      VA+KV NL C R A KSF  EC  +  IRHRNLV
Sbjct:   719 FSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNL-CKRGAAKSFIAECEALGGIRHRNLV 777

Query:   587 KVISSCSNEEF-----KALVLEYMPHGSLEKYLH 615
             K+++ CS+ +F     +ALV E+MP+G+L+ +LH
Sbjct:   778 KLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLH 811

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)]

 Score = 960 (343.0 bits), Expect = 1.4e-96, P = 1.4e-96
 Identities = 277/842 (32%), Positives = 441/842 (52%)

Query:     6 NNFLTSTTPKEI---DNISNLKVLYLYNNRLQGEI-IHEIGHLHNLGFLDLSQNKLLGTI 61
             +N L  + P ++    + S+L+ + L NN L GEI ++   HL  L FL L  NKL GT+
Sbjct:   148 SNRLNGSIPVQLFCNGSSSSLQYIDLSNNSLTGEIPLNYHCHLKELRFLLLWSNKLTGTV 207

Query:    62 PAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNF------SGTIPHF-- 113
             P+++ N + LK   + +N LSG L S     +P L+ LYL  N+F      +   P F  
Sbjct:   208 PSSLSNSTNLKWMDLESNMLSGELPSQVISKMPQLQFLYLSYNHFVSHNNNTNLEPFFAS 267

Query:   114 IFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYXXXXXXXXXXXXXXXXXXXCKSL 173
             + N+S L +L L  NS  G I S+   +R+L  + L                      +L
Sbjct:   268 LANSSDLQELELAGNSLGGEITSS---VRHLS-VNLVQIHLDQNRIHGSIPPEISNLLNL 323

Query:   174 THISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKL 233
             T ++LS+N L G +PR     LS  L+  Y+ N +++G IP E+ ++  L  + +  N L
Sbjct:   324 TLLNLSSNLLSGPIPRELC-KLS-KLERVYLSNNHLTGEIPMELGDIPRLGLLDVSRNNL 381

Query:   234 NGSIPITLGKLQKLQDVDLEYNQLEGSIPDSI--CLSVELYELELGGNKLSGSIPA-CFS 290
             +GSIP + G L +L+ + L  N L G++P S+  C+++E+  L+L  N L+G+IP    S
Sbjct:   382 SGSIPDSFGNLSQLRRLLLYGNHLSGTVPQSLGKCINLEI--LDLSHNNLTGTIPVEVVS 439

Query:   291 NMTFLKV-LSLGSNELTS-IPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFS 348
             N+  LK+ L+L SN L+  IPL    +  +L ++LSSN  SG +P ++ +  AL  ++ S
Sbjct:   440 NLRNLKLYLNLSSNHLSGPIPLELSKMDMVLSVDLSSNELSGKIPPQLGSCIALEHLNLS 499

Query:   349 MNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLIXXXXXXXXXXXXXGTIPVSL 408
              N FS  +P  +G L  L+ L + +NRL G+IP SF                 G +    
Sbjct:   500 RNGFSSTLPSSLGQLPYLKELDVSFNRLTGAIPPSFQQSSTLKHLNFSFNLLSGNVS--- 556

Query:   409 EKLSYLKDLNLSFNKLKGEIPRGGSFGNFSAESFKGNELLCGSPNLQVPPCKASIHRTSR 468
             +K S+ K   L+     G+    GS     A   K        P++ +P   + I   + 
Sbjct:   557 DKGSFSK---LTIESFLGDSLLCGSIKGMQACKKKHKY-----PSVLLPVLLSLI---AT 605

Query:   469 KNALILGIVLPFSTIFMTAIILFIIK-YQKREKGPPNDPNMPPVATWRRFSYLELFQATD 527
                 + G  L   + F   + ++  +  +  EK   NDP  P      R SY +L  AT 
Sbjct:   606 PVLCVFGYPLVQRSRFGKNLTVYAKEEVEDEEKQNQNDPKYP------RISYQQLIAATG 659

Query:   528 KFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFK-SFDVECAMMKSIRHRNLV 586
              F+ ++LIG G FG VYK  +R+  +VAVKV + +    F  SF  EC ++K  RHRNL+
Sbjct:   660 GFNASSLIGSGRFGHVYKGVLRNNTKVAVKVLDPKTALEFSGSFKRECQILKRTRHRNLI 719

Query:   587 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYS---LDIFQRLNIMIDVASALEYLHFG 643
             ++I++CS   F ALVL  MP+GSLE++L+   YS   LD+ Q +NI  DVA  + YLH  
Sbjct:   720 RIITTCSKPGFNALVLPLMPNGSLERHLYPGEYSSKNLDLIQLVNICSDVAEGIAYLHHY 779

Query:   644 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA----------TI 693
                 V+HCDLKPSN+LLDD M A ++DFGI++L+ G +++++   +++          ++
Sbjct:   780 SPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQGVEETVSTDDSVSFGSTDGLLCGSV 839

Query:   694 GYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTME 753
             GY+APEYG   + ST+GDVYSFG++L+E  + ++PTD L N   +L  ++    P S   
Sbjct:   840 GYIAPEYGMGKRASTHGDVYSFGVLLLEIVSGRRPTDVLVNEGSSLHEFMKSHYPDSLEG 899

Query:   754 VVDANLL------SQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRD 807
             +++  L         E    + +E  +  +  L L CT  +P  R +  ++  ++ ++++
Sbjct:   900 IIEQALSRWKPQGKPEKCEKLWREVILEMI-ELGLVCTQYNPSTRPDMLDVAHEMGRLKE 958

Query:   808 SL 809
              L
Sbjct:   959 YL 960

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2046525 AT2G33170 [Arabidopsis thaliana (taxid:3702)]

 Score = 596 (214.9 bits), Expect = 1.4e-96, Sum P(2) = 1.4e-96
 Identities = 174/573 (30%), Positives = 265/573 (46%)

Query:     3 SIINNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIP 62
             ++  N L    P EI N+ +LK LYLY N+L G I  E+G L  +  +D S+N L G IP
Sbjct:   283 ALYGNSLVGPIPSEIGNMKSLKKLYLYQNQLNGTIPKELGKLSKVMEIDFSENLLSGEIP 342

Query:    63 AAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSK 122
               +  +S L+   +  N L+G + +     L NL  L L  N+ +G IP    N + + +
Sbjct:   343 VELSKISELRLLYLFQNKLTGIIPNELSK-LRNLAKLDLSINSLTGPIPPGFQNLTSMRQ 401

Query:   123 LALEMNSFSGFIPSTFGNLRNLEWLTLYXXXXXXXXXXXXXXXXXXXCKSLTHISLSNNP 182
             L L  NS SG IP   G    L W+  +                     +L  ++L +N 
Sbjct:   402 LQLFHNSLSGVIPQGLGLYSPL-WVVDFSENQLSGKIPPFICQQS----NLILLNLGSNR 456

Query:   183 LDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLG 242
             + G +P   +     SL    +    ++G  P E+  L +L+ I L  N+ +G +P  +G
Sbjct:   457 IFGNIPPGVLR--CKSLLQLRVVGNRLTGQFPTELCKLVNLSAIELDQNRFSGPLPPEIG 514

Query:   243 KLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGS 302
               QKLQ + L  NQ   ++P+ I     L    +  N L+G IP+  +N   L+ L L  
Sbjct:   515 TCQKLQRLHLAANQFSSNLPNEISKLSNLVTFNVSSNSLTGPIPSEIANCKMLQRLDLSR 574

Query:   303 NE-LTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIG 361
             N  + S+P    SL  +  L LS N FSG +P  I NL  L E+    N FSG IP ++G
Sbjct:   575 NSFIGSLPPELGSLHQLEILRLSENRFSGNIPFTIGNLTHLTELQMGGNLFSGSIPPQLG 634

Query:   362 SLKNLE-NLFLEYNRLEGSIPDSFGDLIXXXXXXXXXXXXXGTIPVSLEKLSYLKDLNLS 420
              L +L+  + L YN   G IP   G+L              G IP + E LS L   N S
Sbjct:   635 LLSSLQIAMNLSYNDFSGEIPPEIGNLHLLMYLSLNNNHLSGEIPTTFENLSSLLGCNFS 694

Query:   421 FNKLKGEIPRGGSFGNFSAESFKGNELLCGSPNLQVPPCKASI-HRTSRKNA-------- 471
             +N L G++P    F N +  SF GN+ LCG       P  +S  H +S K          
Sbjct:   695 YNNLTGQLPHTQIFQNMTLTSFLGNKGLCGGHLRSCDPSHSSWPHISSLKAGSARRGRII 754

Query:   472 LILGIVLPFSTIFMTAIILFIIKYQKREKGP---PNDPNMPPVATW----RRFSYLELFQ 524
             +I+  V+   ++ + AI++  ++       P     +P       +     RF+  ++ +
Sbjct:   755 IIVSSVIGGISLLLIAIVVHFLRNPVEPTAPYVHDKEPFFQESDIYFVPKERFTVKDILE 814

Query:   525 ATDKFSENNLIGRGGFGSVYKARIRDGMEVAVK 557
             AT  F ++ ++GRG  G+VYKA +  G  +AVK
Sbjct:   815 ATKGFHDSYIVGRGACGTVYKAVMPSGKTIAVK 847

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006486 "protein glycosylation" evidence=RCA

TAIR|locus:2167948 ERL1 "ERECTA-like 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 951 (339.8 bits), Expect = 1.2e-95, P = 1.2e-95
 Identities = 262/815 (32%), Positives = 404/815 (49%)

Query:     7 NFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIF 66
             N L    P  I  +  L+ L L NN+L G +   +  + NL  LDL+ N L G I   ++
Sbjct:   129 NLLYGDIPFSISKLKQLETLNLKNNQLTGPVPATLTQIPNLKRLDLAGNHLTGEISRLLY 188

Query:    67 NVSTLKAFAVTNNSLSGCLSSITDV-GLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLAL 125
                 L+   +  N L+G LSS  D+  L  L    + GNN +GTIP  I N +    L +
Sbjct:   189 WNEVLQYLGLRGNMLTGTLSS--DMCQLTGLWYFDVRGNNLTGTIPESIGNCTSFQILDI 246

Query:   126 EMNSFSGFIPSTFGNLRNLEWLTLYXXXXXXXXXXXXXXXXXXXCKSLTHISLSNNPLDG 185
               N  +G IP   G L+ +  L+L                     ++L  + LS+N L G
Sbjct:   247 SYNQITGEIPYNIGFLQ-VATLSLQGNRLTGRIPEVIGLM-----QALAVLDLSDNELVG 300

Query:   186 ILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQ 245
              +P   +GNLS + K  Y++   ++G IP E+ N++ L+ + L  NKL G+IP  LGKL+
Sbjct:   301 PIP-PILGNLSFTGK-LYLHGNMLTGPIPSELGNMSRLSYLQLNDNKLVGTIPPELGKLE 358

Query:   246 KLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNEL 305
             +L +++L  N+L G IP +I     L +  + GN LSGSIP  F N+  L  L+L SN  
Sbjct:   359 QLFELNLANNRLVGPIPSNISSCAALNQFNVHGNLLSGSIPLAFRNLGSLTYLNLSSNNF 418

Query:   306 TS-IPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLK 364
                IP+    + ++  L+LS N FSG +PL + +L+ L+ ++ S N+ SG +P E G+L+
Sbjct:   419 KGKIPVELGHIINLDKLDLSGNNFSGSIPLTLGDLEHLLILNLSRNHLSGQLPAEFGNLR 478

Query:   365 NLENLFLEYNRLEGSIPDSFGDLIXXXXXXXXXXXXXGTIPVSLEKLSYLKDLNLSFNKL 424
             +++ + + +N L G IP   G L              G IP  L     L +LN+SFN L
Sbjct:   479 SIQMIDVSFNLLSGVIPTELGQLQNLNSLILNNNKLHGKIPDQLTNCFTLVNLNVSFNNL 538

Query:   425 KGEIPRGGSFGNFSAESFKGNELLCGS--PNLQVPPCKASIHRTSRKNALILGIVLPFST 482
              G +P   +F  F+  SF GN  LCG+   ++  P  K+ +        ++LG++     
Sbjct:   539 SGIVPPMKNFSRFAPASFVGNPYLCGNWVGSICGPLPKSRVFSRGALICIVLGVITLLCM 598

Query:   483 IFMTAIILFIIKYQKREKGPPNDPN-MPPVATWRR----FSYLELFQATDKFSENNLIGR 537
             IF+   +   ++ +K  +G       +  +          ++ ++ + T+  +E  +IG 
Sbjct:   599 IFLA--VYKSMQQKKILQGSSKQAEGLTKLVILHMDMAIHTFDDIMRVTENLNEKFIIGY 656

Query:   538 GGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEF 597
             G   +VYK  ++    +A+K    Q     + F+ E   + SIRHRN+V +     +   
Sbjct:   657 GASSTVYKCALKSSRPIAIKRLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPTG 716

Query:   598 KALVLEYMPHGSLEKYLHSS--NYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKP 655
               L  +YM +GSL   LH S     LD   RL I +  A  L YLH   +  +IH D+K 
Sbjct:   717 NLLFYDYMENGSLWDLLHGSLKKVKLDWETRLKIAVGAAQGLAYLHHDCTPRIIHRDIKS 776

Query:   656 SNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSF 715
             SN+LLD+N  AHLSDFGIAK +    ++   T  L TIGY+ PEY R  +++   D+YSF
Sbjct:   777 SNILLDENFEAHLSDFGIAKSIPAS-KTHASTYVLGTIGYIDPEYARTSRINEKSDIYSF 835

Query:   716 GIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANL-LSQEDIHFVAKEQCV 774
             GI+L+E  T KK  D   N    +    +D    + ME VD  + ++  D+  + K    
Sbjct:   836 GIVLLELLTGKKAVDNEANLHQLILSKADDN---TVMEAVDPEVTVTCMDLGHIRK---- 888

Query:   775 SFVFNLALECTVESPEQRINAKEIVAKLLKIRDSL 809
                F LAL CT  +P +R    E+   LL +  SL
Sbjct:   889 --TFQLALLCTKRNPLERPTMLEVSRVLLSLVPSL 921

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010103 "stomatal complex morphogenesis" evidence=IGI;RCA

GO:0009553 "embryo sac development" evidence=IGI

GO:0048481 "ovule development" evidence=IGI;RCA

GO:0016020 "membrane" evidence=IDA

GO:0001708 "cell fate specification" evidence=RCA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0009827 "plant-type cell wall modification" evidence=RCA

GO:0009860 "pollen tube growth" evidence=RCA

GO:0009886 "post-embryonic morphogenesis" evidence=RCA

GO:0009909 "regulation of flower development" evidence=RCA

GO:0009965 "leaf morphogenesis" evidence=RCA

GO:0048441 "petal development" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

GO:0048507 "meristem development" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	824
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-98
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-52
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	3e-49
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	6e-49
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-47
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	4e-47
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	5e-47
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	9e-46
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-43
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	7e-39
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-34
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-33
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	7e-33
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	4e-32
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	9e-31
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	4e-30
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	6e-30
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-29
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-29
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-28
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-28
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-27
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-27
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	3e-27
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	4e-26
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-25
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-25
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-25
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-25
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	4e-25
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	6e-25
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-24
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-24
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-24
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-24
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-24
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-23
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-23
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-23
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	6e-23
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	6e-23
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	8e-23
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-22
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-22
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	3e-22
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	3e-22
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	6e-22
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	6e-22
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	6e-22
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	8e-22
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	8e-22
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-21
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-21
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-21
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	3e-21
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	3e-21
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	3e-21
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	4e-21
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	5e-21
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	7e-21
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	7e-21
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	9e-21
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-20
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	4e-20
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	4e-20
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	5e-20
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	5e-20
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	6e-20
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	6e-20
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	7e-20
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	8e-20
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-19
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-19
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-19
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	1e-19
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-19
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	4e-19
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	5e-19
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	5e-19
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	7e-19
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	7e-19
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	7e-19
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	8e-19
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	9e-19
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	9e-19
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-18
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-18
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-18
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-18
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-18
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-18
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-18
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-18
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	4e-18
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	6e-18
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	6e-18
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	8e-18
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	8e-18
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	9e-18
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-17
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-17
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-17
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-17
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-17
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	6e-17
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	6e-17
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	8e-17
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	9e-17
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-16
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-16
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-16
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	4e-16
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	5e-16
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	5e-16
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	5e-16
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	5e-16
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	5e-16
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	6e-16
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	6e-16
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	7e-16
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	8e-16
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	8e-16
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-15
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-15
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-15
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-15
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-15
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-15
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	3e-15
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	4e-15
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	4e-15
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	4e-15
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	4e-15
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	5e-15
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	6e-15
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	7e-15
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	7e-15
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	8e-15
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	9e-15
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-14
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-14
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-14
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-14
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-14
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-14
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-14
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-14
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-14
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-14
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	3e-14
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	3e-14
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	3e-14
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	4e-14
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	4e-14
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	4e-14
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	4e-14
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	5e-14
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	6e-14
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	6e-14
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	7e-14
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	8e-14
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	9e-14
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-13
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-13
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-13
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-13
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-13
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-13
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-13
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-13
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	3e-13
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-13
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	3e-13
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	4e-13
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	4e-13
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	4e-13
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	4e-13
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	9e-13
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-12
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-12
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-12
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-12
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-12
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-12
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-12
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-12
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-12
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-12
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	4e-12
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	4e-12
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	4e-12
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	4e-12
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	4e-12
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	5e-12
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	6e-12
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	8e-12
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	8e-12
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	9e-12
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-11
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-11
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-11
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-11
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-11
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-11
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	3e-11
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	3e-11
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	4e-11
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	7e-11
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	7e-11
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	8e-11
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	9e-11
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	9e-11
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-10
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-10
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-10
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	4e-10
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	4e-10
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	4e-10
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	6e-10
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	7e-10
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-09
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-09
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-09
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-09
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-09
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-09
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-09
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-09
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-09
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-09
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-09
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	3e-09
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	3e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-09
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	4e-09
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	4e-09
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	6e-09
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	7e-09
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	8e-09
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	9e-09
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-08
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	2e-08
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-08
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-08
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	2e-08
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	3e-08
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	3e-08
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	3e-08
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	3e-08
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	3e-08
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	3e-08
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	4e-08
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	4e-08
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	5e-08
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	5e-08
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	6e-08
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	6e-08
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	7e-08
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	7e-08
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	7e-08
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	9e-08
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	9e-08
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-07
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	1e-07
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-07
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-07
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-07
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-07
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-07
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	3e-07
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	3e-07
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	3e-07
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	3e-07
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	3e-07
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-07
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	3e-07
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	3e-07
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	4e-07
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	4e-07
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	5e-07
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	5e-07
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	5e-07
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	7e-07
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-06
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-06
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-06
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	2e-06
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-06
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-06
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-06
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	2e-06
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	3e-06
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	4e-06
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	4e-06
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	4e-06
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	4e-06
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	6e-06
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	6e-06
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	6e-06
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	7e-06
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	7e-06
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	1e-05
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-05
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-05
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-05
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	3e-05
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	3e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	4e-05
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	4e-05
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	5e-05
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	5e-05
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	5e-05
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	7e-05
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	8e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	8e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	1e-04
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-04
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-04
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-04
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-04
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	3e-04
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	6e-04
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	0.001
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	0.001
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	0.002
pfam12799	43	pfam12799, LRR_4, Leucine Rich repeats (2 copies)	0.004

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  327 bits (840), Expect = 2e-98
 Identities = 248/816 (30%), Positives = 395/816 (48%), Gaps = 61/816 (7%)

Query: 7   NFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIF 66
           N L    P  + N+++L+ L L +N+L G+I  E+G + +L ++ L  N L G IP  I 
Sbjct: 174 NVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIG 233

Query: 67  NVSTLKAFAVTNNSLSGCL-SSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLAL 125
            +++L    +  N+L+G + SS+ +  L NL+ L+L+ N  SG IP  IF+  KL  L L
Sbjct: 234 GLTSLNHLDLVYNNLTGPIPSSLGN--LKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDL 291

Query: 126 EMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDG 185
             NS SG IP     L+NLE L L+ NN T          +L++   L  + L +N   G
Sbjct: 292 SDNSLSGEIPELVIQLQNLEILHLFSNNFTGK-----IPVALTSLPRLQVLQLWSNKFSG 346

Query: 186 ILPRTYVGNLS--HSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGK 243
            +P+    NL   ++L    +   N++G IPE + +  +L  ++L  N L G IP +LG 
Sbjct: 347 EIPK----NLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGA 402

Query: 244 LQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSN 303
            + L+ V L+ N   G +P        +Y L++  N L G I +   +M  L++LSL  N
Sbjct: 403 CRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARN 462

Query: 304 ELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSL 363
           +      + +  K + +L+LS N FSG +P ++ +L  L+++  S N  SG IP E+ S 
Sbjct: 463 KFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSC 522

Query: 364 KNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNK 423
           K L +L L +N+L G IP SF ++  L  L+LS N LSG IP +L  +  L  +N+S N 
Sbjct: 523 KKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNH 582

Query: 424 LKGEIPRGGSFGNFSAESFKGNELLCGSPNLQ-VPPCKASIHRTSRKNALILGIVLPFST 482
           L G +P  G+F   +A +  GN  LCG      +PPCK    R  +  +    I      
Sbjct: 583 LHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCK----RVRKTPSWWFYITCTLGA 638

Query: 483 IFMTAIILFIIKYQKREKGPPNDPNMPPVATWRRFSYLELFQATDKFS------------ 530
             + A++ F   + +               TW     L+ F +  K S            
Sbjct: 639 FLVLALVAFGFVFIRGRNNLELKRVENEDGTWE----LQFFDS--KVSKSITINDILSSL 692

Query: 531 -ENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSF-DVECAMMKSIRHRNLVK 587
            E N+I RG  G+ YK + I++GM+  VK  N        S    E A M  ++H N+VK
Sbjct: 693 KEENVISRGKKGASYKGKSIKNGMQFVVKEIN-----DVNSIPSSEIADMGKLQHPNIVK 747

Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAP 647
           +I  C +E+   L+ EY+   +L + L + ++     +R  I I +A AL +LH   S  
Sbjct: 748 LIGLCRSEKGAYLIHEYIEGKNLSEVLRNLSWE----RRRKIAIGIAKALRFLHCRCSPA 803

Query: 648 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVS 707
           V+  +L P  +++D     HL    +  LL       T T+   +  Y+APE      ++
Sbjct: 804 VVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC------TDTKCFISSAYVAPETRETKDIT 856

Query: 708 TNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEV-VDANLLSQEDIH 766
              D+Y FG++L+E  T K P D  F    ++  W   C     +++ +D ++     ++
Sbjct: 857 EKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVN 916

Query: 767 FVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL 802
              + + V  V NLAL CT   P  R  A +++  L
Sbjct: 917 ---QNEIVE-VMNLALHCTATDPTARPCANDVLKTL 948

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  196 bits (501), Expect = 3e-52
 Identities = 152/412 (36%), Positives = 203/412 (49%), Gaps = 36/412 (8%)

Query: 19  NISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVS-TLKAFAVT 77
           N S +  + L    + G+I   I  L  +  ++LS N+L G IP  IF  S +L+   ++
Sbjct: 67  NSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLS 126

Query: 78  NNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPST 137
           NN+ +G   SI    +PNLE L L  N  SG IP+ I + S L  L L  N   G IP++
Sbjct: 127 NNNFTG---SIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNS 183

Query: 138 FGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSH 197
             NL +LE+LTL  N L                              G +PR  +G +  
Sbjct: 184 LTNLTSLEFLTLASNQLV-----------------------------GQIPRE-LGQMK- 212

Query: 198 SLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQL 257
           SLK  Y+   N+SG IP EI  LT L  + L  N L G IP +LG L+ LQ + L  N+L
Sbjct: 213 SLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKL 272

Query: 258 EGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELT-SIPLNFWSLK 316
            G IP SI    +L  L+L  N LSG IP     +  L++L L SN  T  IP+   SL 
Sbjct: 273 SGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLP 332

Query: 317 DILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRL 376
            +  L L SN FSG +P  +     L  +D S NN +G IP  + S  NL  L L  N L
Sbjct: 333 RLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSL 392

Query: 377 EGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEI 428
           EG IP S G   SL+ + L  N+ SG +P    KL  +  L++S N L+G I
Sbjct: 393 EGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRI 444

Length = 968

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  173 bits (442), Expect = 3e-49
 Identities = 76/270 (28%), Positives = 118/270 (43%), Gaps = 26/270 (9%)

Query: 533 NLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAF-KSFDVECAMMKSIRHRNLVKVIS 590
             +G G FG VY AR  + G  VA+KV   +  +   +    E  ++K ++H N+V++  
Sbjct: 5   EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64

Query: 591 SCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIH 650
              +E+   LV+EY   G L   L      L   +    +  + SALEYLH   S  ++H
Sbjct: 65  VFEDEDKLYLVMEYCEGGDLFDLLKK-RGRLSEDEARFYLRQILSALEYLH---SKGIVH 120

Query: 651 CDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNG 710
            DLKP N+LLD++    L+DFG+A+ L   ++  T   T     YMAPE           
Sbjct: 121 RDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPE---YMAPEVLLGKGYGKAV 177

Query: 711 DVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAK 770
           D++S G++L E  T K P    F G+  L                    +S E    +  
Sbjct: 178 DIWSLGVILYELLTGKPP----FPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLI-- 231

Query: 771 EQCVSFVFNLALECTVESPEQRINAKEIVA 800
            +    V +         PE+R+ A+E + 
Sbjct: 232 RKL--LVKD---------PEKRLTAEEALQ 250

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  173 bits (440), Expect = 6e-49
 Identities = 82/278 (29%), Positives = 132/278 (47%), Gaps = 31/278 (11%)

Query: 532 NNLIGRGGFGSVYKARIRD-----GMEVAVKVFNLQCGR-AFKSFDVECAMMKSIRHRNL 585
              +G G FG VYK +++       +EVAVK           + F  E  +M+ + H N+
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63

Query: 586 VKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYS 645
           VK++  C+ EE   +V+EYM  G L  YL  +   L +   L+  + +A  +EYL    S
Sbjct: 64  VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE---S 120

Query: 646 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQ 705
              IH DL   N L+ +N+V  +SDFG+++ L  +D    +      I +MAPE  +EG+
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLY-DDDYYRKRGGKLPIRWMAPESLKEGK 179

Query: 706 VSTNGDVYSFGIMLMETFTR-KKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQED 764
            ++  DV+SFG++L E FT  ++P        M+ +  +          + +   L Q  
Sbjct: 180 FTSKSDVWSFGVLLWEIFTLGEQP-----YPGMSNEEVLEY--------LKNGYRLPQP- 225

Query: 765 IHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL 802
                   C   +++L L+C  E PE R    E+V  L
Sbjct: 226 ------PNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  167 bits (426), Expect = 2e-47
 Identities = 70/191 (36%), Positives = 103/191 (53%), Gaps = 9/191 (4%)

Query: 535 IGRGGFGSVYKARIR-DGMEVAVKVFNLQ-CGRAFKSFDVECAMMKSIRHRNLVKVISSC 592
           +G GGFG+VY AR +  G +VA+K+   +      +    E  ++K + H N+VK+    
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 593 SNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
            +E    LV+EY   GSL+  L  +   L   + L I++ +   LEYLH   S  +IH D
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRD 117

Query: 653 LKPSNVLLD-DNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR-EGQVSTNG 710
           LKP N+LLD DN    L+DFG++KLLT +   +       T  YMAPE    +G  S   
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV--GTPAYMAPEVLLGKGYYSEKS 175

Query: 711 DVYSFGIMLME 721
           D++S G++L E
Sbjct: 176 DIWSLGVILYE 186

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  168 bits (427), Expect = 4e-47
 Identities = 78/281 (27%), Positives = 125/281 (44%), Gaps = 42/281 (14%)

Query: 535 IGRGGFGSVYKARIRD-----GMEVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVKV 588
           +G G FG VYK  ++        +VAVK           + F  E ++MK + H N+V++
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66

Query: 589 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPV 648
           +  C+  E   +V EYMP G L  +L      L +   L + + +A  +EYL    S   
Sbjct: 67  LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE---SKNF 123

Query: 649 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVST 708
           +H DL   N L+ +N+V  +SDFG+++ +  +D    +      I +MAPE  ++G+ ++
Sbjct: 124 VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTS 183

Query: 709 NGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFV 768
             DV+SFG++L E FT          GE           P   M         +E +  +
Sbjct: 184 KSDVWSFGVLLWEIFTL---------GEQ----------PYPGMSN-------EEVLELL 217

Query: 769 AK-------EQCVSFVFNLALECTVESPEQRINAKEIVAKL 802
                    E C   ++ L L+C    PE R    E+V  L
Sbjct: 218 EDGYRLPRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  167 bits (426), Expect = 5e-47
 Identities = 83/271 (30%), Positives = 126/271 (46%), Gaps = 28/271 (10%)

Query: 535 IGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDV----ECAMMKSIRHRNLVKVI 589
           +G G FG+VYKA+    G  VAVK+   +        D     E  +++ + H N+V++I
Sbjct: 7   LGSGSFGTVYKAKHKGTGKIVAVKILKKR--SEKSKKDQTARREIRILRRLSHPNIVRLI 64

Query: 590 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVI 649
            +  +++   LV+EY   G L  YL      L   +   I + +   LEYLH   S  +I
Sbjct: 65  DAFEDKDHLYLVMEYCEGGDLFDYLSRGG-PLSEDEAKKIALQILRGLEYLH---SNGII 120

Query: 650 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQ-VST 708
           H DLKP N+LLD+N V  ++DFG+AK L     S+T T    T  YMAPE    G     
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLT-TFV-GTPWYMAPEVLLGGNGYGP 178

Query: 709 NGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFV 768
             DV+S G++L E  T K P    F+GE            +  ++++   L    +    
Sbjct: 179 KVDVWSLGVILYELLTGKPP----FSGE----------NILDQLQLIRRILGPPLEFDEP 224

Query: 769 AKEQCVSFVFNLALECTVESPEQRINAKEIV 799
                     +L  +C  + P +R  A+EI+
Sbjct: 225 KWSSGSEEAKDLIKKCLNKDPSKRPTAEEIL 255

Length = 260

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  164 bits (417), Expect = 9e-46
 Identities = 82/279 (29%), Positives = 129/279 (46%), Gaps = 32/279 (11%)

Query: 532 NNLIGRGGFGSVYKARIRDG-----MEVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNL 585
              +G G FG VYK  ++       +EVAVK        +  + F  E  +M+ + H N+
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63

Query: 586 VKVISSCSNEEFKALVLEYMPHGSLEKYLHSS-NYSLDIFQRLNIMIDVASALEYLHFGY 644
           VK++  C+ EE   +V+EYMP G L  YL  +    L +   L+  + +A  +EYL    
Sbjct: 64  VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE--- 120

Query: 645 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG 704
           S   IH DL   N L+ +N+V  +SDFG+++ L  +D           I +MAPE  +EG
Sbjct: 121 SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY-DDDYYKVKGGKLPIRWMAPESLKEG 179

Query: 705 QVSTNGDVYSFGIMLMETFTR-KKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQE 763
           + ++  DV+SFG++L E FT  ++P        M+    +          +     L + 
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEEP-----YPGMSNAEVLEY--------LKKGYRLPKP 226

Query: 764 DIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL 802
                    C   ++ L L+C  E PE R    E+V  L
Sbjct: 227 -------PNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  158 bits (402), Expect = 1e-43
 Identities = 85/284 (29%), Positives = 131/284 (46%), Gaps = 37/284 (13%)

Query: 533 NLIGRGGFGSVYKARIRDG----MEVAVKVFNLQCGRAFKS-FDVECAMMKSIRHRNLVK 587
             +G G FG VYK +++       EVAVK          +  F  E  +MK + H N+V+
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLHSS--------NYSLDIFQRLNIMIDVASALEY 639
           ++  C+ EE   LVLEYM  G L  YL  S          +L +   L+  I +A  +EY
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 640 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPE 699
           L    S   +H DL   N L+ +++V  +SDFG+++ +  +D    +T     I +MAPE
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177

Query: 700 YGREGQVSTNGDVYSFGIMLMETFTR-KKPTDELFNGEMTLKHWVNDCLPISTMEVVDAN 758
             ++G  ++  DV+SFG++L E FT    P   L N E+ L++            +    
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV-LEY------------LRKGY 224

Query: 759 LLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL 802
            L +        E C   ++ L L C    PE R    E+V +L
Sbjct: 225 RLPK-------PEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  145 bits (367), Expect = 7e-39
 Identities = 83/290 (28%), Positives = 123/290 (42%), Gaps = 47/290 (16%)

Query: 528 KFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRA--FKSFDVECAMMKSIRHRN 584
           +++   L+GRG FGSVY A  +D G  +AVK   L        ++ + E  ++ S++H N
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60

Query: 585 LVKVISSCSNEEFKAL--VLEYMPHGSLEKYLHSSNYSLDIFQRLNI------MIDVASA 636
           +V+   S  +EE   L   LEY+  GSL   L         F +L           +   
Sbjct: 61  IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKK-------FGKLPEPVIRKYTRQILEG 113

Query: 637 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYM 696
           L YLH   S  ++H D+K +N+L+D + V  L+DFG AK L   +          T  +M
Sbjct: 114 LAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWM 170

Query: 697 APEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKH--WVNDCLPISTMEV 754
           APE  R  +     D++S G  ++E  T K P  EL N    L       +   I     
Sbjct: 171 APEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPE--- 227

Query: 755 VDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLK 804
                LS+E   F+ K             C    P++R  A E    LL+
Sbjct: 228 ----HLSEEAKDFLRK-------------CLRRDPKKRPTADE----LLQ 256

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  132 bits (334), Expect = 2e-34
 Identities = 86/294 (29%), Positives = 128/294 (43%), Gaps = 50/294 (17%)

Query: 535 IGRGGFGSVYKARIR------DGMEVAVKVFNLQCGR-AFKSFDVECAMMKSIRHRNLVK 587
           +G G FG V+           D   VAVK         A K F+ E  ++ + +H N+VK
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLHSSN-------------YSLDIFQRLNIMIDVA 634
               C+  +   +V EYM HG L K+L S                 L + Q L I + +A
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 635 SALEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA 691
           S + YL   HF      +H DL   N L+  ++V  + DFG+++ +   D       T+ 
Sbjct: 133 SGMVYLASQHF------VHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTML 186

Query: 692 TIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTR-KKPTDELFNGEMTLKHWVNDCLPIS 750
            I +M PE     + +T  DV+SFG++L E FT  K+P   L N E+             
Sbjct: 187 PIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV------------- 233

Query: 751 TMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLK 804
            +E +    L Q          C S V+++ L C    P+QRIN K+I  +L K
Sbjct: 234 -IECITQGRLLQR------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  137 bits (347), Expect = 3e-33
 Identities = 109/274 (39%), Positives = 145/274 (52%), Gaps = 8/274 (2%)

Query: 159 LDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEIT 218
           L LSF SS+++   L ++S  N+  D  L +    N S  + +  +   N+SG I   I 
Sbjct: 33  LLLSFKSSIND--PLKYLSNWNSSADVCLWQGITCNNSSRVVSIDLSGKNISGKISSAIF 90

Query: 219 NLTDLTTIVLGGNKLNGSIPITLGKL-QKLQDVDLEYNQLEGSIPD-SICLSVELYELEL 276
            L  + TI L  N+L+G IP  +      L+ ++L  N   GSIP  SI     L  L+L
Sbjct: 91  RLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPN---LETLDL 147

Query: 277 GGNKLSGSIPACFSNMTFLKVLSLGSNELTS-IPLNFWSLKDILDLNLSSNCFSGPLPLE 335
             N LSG IP    + + LKVL LG N L   IP +  +L  +  L L+SN   G +P E
Sbjct: 148 SNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRE 207

Query: 336 IRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNL 395
           +  +K+L  I    NN SG IP EIG L +L +L L YN L G IP S G+L +L+ L L
Sbjct: 208 LGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFL 267

Query: 396 SYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIP 429
             N LSG IP S+  L  L  L+LS N L GEIP
Sbjct: 268 YQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIP 301

Length = 968

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  127 bits (321), Expect = 7e-33
 Identities = 67/195 (34%), Positives = 99/195 (50%), Gaps = 7/195 (3%)

Query: 535 IGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCS 593
           IG+GGFG VYKAR  R G EVA+KV  L+     +    E  ++K  +H N+VK   S  
Sbjct: 8   IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67

Query: 594 NEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 653
            ++   +V+E+   GSL+  L S+N +L   Q   +  ++   LEYLH   S  +IH D+
Sbjct: 68  KKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDI 124

Query: 654 KPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVY 713
           K +N+LL  +    L DFG++  L+      T    + T  +MAPE           D++
Sbjct: 125 KAANILLTSDGEVKLIDFGLSAQLSDTKARNT---MVGTPYWMAPEVINGKPYDYKADIW 181

Query: 714 SFGIMLMETFTRKKP 728
           S GI  +E    K P
Sbjct: 182 SLGITAIELAEGKPP 196

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  125 bits (315), Expect = 4e-32
 Identities = 70/193 (36%), Positives = 103/193 (53%), Gaps = 13/193 (6%)

Query: 534 LIGRGGFGSVYKARIRDGMEVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLVKVISSC 592
            IG+G FG V     R G +VAVK   L+    A ++F  E ++M ++RH NLV+++   
Sbjct: 13  TIGKGEFGDVMLGDYR-GQKVAVK--CLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVV 69

Query: 593 SNEEFKALVLEYMPHGSLEKYLHSSNYSLDIF-QRLNIMIDVASALEYLHFGYSAPVIHC 651
                  +V EYM  GSL  YL S   ++    Q+L   +DV   +EYL        +H 
Sbjct: 70  LQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHR 126

Query: 652 DLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGD 711
           DL   NVL+ +++VA +SDFG+AK     + S  Q      + + APE  RE + ST  D
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEALREKKFSTKSD 181

Query: 712 VYSFGIMLMETFT 724
           V+SFGI+L E ++
Sbjct: 182 VWSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  121 bits (305), Expect = 9e-31
 Identities = 80/270 (29%), Positives = 126/270 (46%), Gaps = 23/270 (8%)

Query: 534 LIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFK-SFDVECAMMKSIRHRNLVKVISSC 592
            IG+G FG VYK  ++   EVAVK          K  F  E  ++K   H N+VK+I  C
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 593 SNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
             ++   +V+E +P GSL  +L      L + + L + +D A+ +EYL    S   IH D
Sbjct: 62  VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRD 118

Query: 653 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDV 712
           L   N L+ +N V  +SDFG+++   G   +++       I + APE    G+ ++  DV
Sbjct: 119 LAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDV 178

Query: 713 YSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQ 772
           +S+GI+L ETF+          G+       N      T E +++           A + 
Sbjct: 179 WSYGILLWETFSL---------GDTPYPGMSNQ----QTRERIESGY------RMPAPQL 219

Query: 773 CVSFVFNLALECTVESPEQRINAKEIVAKL 802
           C   ++ L L+C    PE R +  EI  +L
Sbjct: 220 CPEEIYRLMLQCWAYDPENRPSFSEIYNEL 249

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  119 bits (301), Expect = 4e-30
 Identities = 78/261 (29%), Positives = 125/261 (47%), Gaps = 29/261 (11%)

Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGR-AFKSFDVECAMMKSIRHRNLVKVISSCS 593
           +G G FG V+        +VAVK   L+ G  + ++F  E  +MK +RH  LV++ + CS
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKT--LKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS 71

Query: 594 NEEFKALVLEYMPHGSLEKYLHSSNYS-LDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
            EE   +V EYM  GSL  +L S     L + Q +++   +A  + YL    S   IH D
Sbjct: 72  EEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRD 128

Query: 653 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDV 712
           L   N+L+ +N+V  ++DFG+A+L+  +D+   +      I + APE    G+ +   DV
Sbjct: 129 LAARNILVGENLVCKIADFGLARLIE-DDEYTAREGAKFPIKWTAPEAANYGRFTIKSDV 187

Query: 713 YSFGIMLMETFTRKK-PTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKE 771
           +SFGI+L E  T  + P   + N E               +E V+               
Sbjct: 188 WSFGILLTEIVTYGRVPYPGMTNRE--------------VLEQVERGY------RMPRPP 227

Query: 772 QCVSFVFNLALECTVESPEQR 792
            C   +++L L+C  + PE+R
Sbjct: 228 NCPEELYDLMLQCWDKDPEER 248

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  119 bits (301), Expect = 6e-30
 Identities = 75/286 (26%), Positives = 127/286 (44%), Gaps = 23/286 (8%)

Query: 533 NLIGRGGFGSVYKAR---IRD--GMEVAVKVFNLQCGRAFKS-FDVECAMMKSIRHRNLV 586
             +G G FG V   R   + D  G +VAVK  N       +S F+ E  +++++ H N+V
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 587 KVISSCSNEEFKA--LVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGY 644
           K    C     ++  L++EY+P GSL  YL      +++ + L     +   ++YL    
Sbjct: 70  KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG--- 126

Query: 645 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMT-QTQTLATIGYMAPEYGRE 703
           S   IH DL   N+L++   +  +SDFG+AK+L  +      +    + I + APE  R 
Sbjct: 127 SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRT 186

Query: 704 GQVSTNGDVYSFGIMLMETFTRKKPTDE---LFNGEMTLKHWVNDCLPISTMEVVDANLL 760
            + S+  DV+SFG+ L E FT   P+      F   + +            M V     L
Sbjct: 187 SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQ--------MIVTRLLEL 238

Query: 761 SQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIR 806
            +E         C   V++L   C    P+ R +  +++  + ++R
Sbjct: 239 LKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  117 bits (297), Expect = 1e-29
 Identities = 64/219 (29%), Positives = 100/219 (45%), Gaps = 23/219 (10%)

Query: 528 KFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCG------RAFKSFDVECAMMKSI 580
           K+     IG+G FG VY  R   DG    +K  +L          A      E  ++K +
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALN----EVKILKKL 56

Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIF---QRLNIMIDVASAL 637
            H N++K   S   +    +V+EY   G L + +         F   Q L+  + +  AL
Sbjct: 57  NHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLAL 116

Query: 638 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMA 697
           +YLH   S  ++H D+KP N+ L  N +  L DFGI+K+L+     + +T  + T  Y++
Sbjct: 117 KYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLS-STVDLAKTV-VGTPYYLS 171

Query: 698 PEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGE 736
           PE  +    +   D++S G +L E  T K P    F GE
Sbjct: 172 PELCQNKPYNYKSDIWSLGCVLYELCTLKHP----FEGE 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  117 bits (295), Expect = 2e-29
 Identities = 71/276 (25%), Positives = 123/276 (44%), Gaps = 27/276 (9%)

Query: 529 FSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKV 588
           F+    +G G FG V++   ++ + VA+K+         + F  E   +K +RH++L+ +
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67

Query: 589 ISSCSNEEFKALVLEYMPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAP 647
            + CS  E   ++ E M  GSL  +L S     L +   +++   VA  + YL       
Sbjct: 68  FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQN 124

Query: 648 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVS 707
            IH DL   N+L+ +++V  ++DFG+A+L+  ++     +       + APE    G  S
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLARLI--KEDVYLSSDKKIPYKWTAPEAASHGTFS 182

Query: 708 TNGDVYSFGIMLMETFTRKK-PTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIH 766
           T  DV+SFGI+L E FT  + P   + N E                + + A         
Sbjct: 183 TKSDVWSFGILLYEMFTYGQVPYPGMNNHE--------------VYDQITAGY------R 222

Query: 767 FVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL 802
                +C   ++ + LEC    PE R + K +  +L
Sbjct: 223 MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREEL 258

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  117 bits (294), Expect = 2e-28
 Identities = 87/296 (29%), Positives = 127/296 (42%), Gaps = 33/296 (11%)

Query: 534 LIGRGGFGSVYKARIRDGMEVAVKVFNLQ---CGRAFKSFDVECAMMKSIRH-RNLVKVI 589
            +G G FG VY AR  D   VA+KV   +     +  + F  E  ++ S+ H  N+VK+ 
Sbjct: 7   KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64

Query: 590 SSCSNEEFKALVLEYMPHGSLEKYLHS--SNYSLDIFQRLNIMIDVASALEYLHFGYSAP 647
               +E    LV+EY+  GSLE  L        L   + L I+  + SALEYLH   S  
Sbjct: 65  DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKG 121

Query: 648 VIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTGEDQSMTQTQTLA----TIGYMAPEY-- 700
           +IH D+KP N+LLD D  V  L DFG+AKLL     + +     +    T GYMAPE   
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181

Query: 701 -GREGQVSTNGDVYSFGIMLMETFTRKKP---TDELFNGEMTLKHWVNDCLPISTMEVVD 756
                  S++ D++S GI L E  T   P            TLK  +    P     +  
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSP 241

Query: 757 ANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLRN 812
           +N            E       +L  +   + P+ R+++   ++  L     L  +
Sbjct: 242 SN-----------PELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKES 286

Length = 384

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  114 bits (287), Expect = 3e-28
 Identities = 72/289 (24%), Positives = 116/289 (40%), Gaps = 71/289 (24%)

Query: 535 IGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIR----------HR 583
           +G+G  G VYK R    G   A+K  +          D +    K +             
Sbjct: 9   LGQGSSGVVYKVRHKPTGKIYALKKIH---------VDGDEEFRKQLLRELKTLRSCESP 59

Query: 584 NLVKVISSCSNEEFK----ALVLEYMPHGSLEKYLHSSNYSLDIFQRLN---------IM 630
            +VK    C    +K    ++VLEYM  GSL           D+ +++          I 
Sbjct: 60  YVVK----CYGAFYKEGEISIVLEYMDGGSLA----------DLLKKVGKIPEPVLAYIA 105

Query: 631 IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT- 689
             +   L+YLH      +IH D+KPSN+L++      ++DFGI+K+L   + ++ Q  T 
Sbjct: 106 RQILKGLDYLH--TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVL---ENTLDQCNTF 160

Query: 690 LATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKP-TDELFNGEMTLKHWVNDCLP 748
           + T+ YM+PE  +    S   D++S G+ L+E    K P           L   + D  P
Sbjct: 161 VGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPP 220

Query: 749 ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKE 797
            S    + A   S E   F++              C  + P++R +A E
Sbjct: 221 PS----LPAEEFSPEFRDFISA-------------CLQKDPKKRPSAAE 252

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  112 bits (282), Expect = 1e-27
 Identities = 81/290 (27%), Positives = 124/290 (42%), Gaps = 53/290 (18%)

Query: 528 KFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFNLQ--CGRAFKSFDVECAMMKSIRHRN 584
            +   +LIGRG FG VYK   +  G  VA+K  +L+     A KS   E  ++K+++H N
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 585 LVKVISSCSNEEFKALVLEYMPHGSLEKYLH---------SSNYSLDIFQRLNIMIDVAS 635
           +VK I S    +   ++LEY  +GSL + +           + Y   ++Q       V  
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVY---VYQ-------VLQ 110

Query: 636 ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGY 695
            L YLH      VIH D+K +N+L   + V  L+DFG+A  L    +       + T  +
Sbjct: 111 GLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK--DDASVVGTPYW 165

Query: 696 MAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWV-NDCLPISTMEV 754
           MAPE       ST  D++S G  ++E  T   P  +L N    L   V +D  P+     
Sbjct: 166 MAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDL-NPMAALFRIVQDDHPPLPEG-- 222

Query: 755 VDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLK 804
                            +   F+    ++C  + P  R  AK+    LLK
Sbjct: 223 --------------ISPELKDFL----MQCFQKDPNLRPTAKQ----LLK 250

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score =  112 bits (281), Expect = 2e-27
 Identities = 83/289 (28%), Positives = 131/289 (45%), Gaps = 51/289 (17%)

Query: 535 IGRGGFGSVYKAR------IRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKV 588
           +G G FG V+ A        +D M VAVK        A K F  E  ++ +++H ++VK 
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 589 ISSCSNEEFKALVLEYMPHGSLEKYLHS---------------SNYSLDIFQRLNIMIDV 633
              C + +   +V EYM HG L K+L +               +   L + Q L+I   +
Sbjct: 73  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132

Query: 634 ASALEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTL 690
           AS + YL   HF      +H DL   N L+  N++  + DFG+++ +   D       T+
Sbjct: 133 ASGMVYLASQHF------VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 186

Query: 691 ATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTR-KKPTDELFNGEMTLKHWVNDCLPI 749
             I +M PE     + +T  DV+SFG++L E FT  K+P  +L N E      V +C   
Sbjct: 187 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE------VIEC--- 237

Query: 750 STMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEI 798
               +    +L +  +       C   V+++ L C    P+QR+N KEI
Sbjct: 238 ----ITQGRVLERPRV-------CPKEVYDIMLGCWQREPQQRLNIKEI 275

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  111 bits (281), Expect = 3e-27
 Identities = 77/274 (28%), Positives = 118/274 (43%), Gaps = 25/274 (9%)

Query: 526 TDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRN 584
            + +     IG G  G VYKA     G EVA+K   L+     +    E  +MK  +H N
Sbjct: 18  RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNK-ELIINEILIMKDCKHPN 76

Query: 585 LVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGY 644
           +V    S    +   +V+EYM  GSL   +  +   ++  Q   +  +V   LEYLH   
Sbjct: 77  IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH--- 133

Query: 645 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG 704
           S  VIH D+K  N+LL  +    L+DFG A  LT +++S   +  + T  +MAPE  +  
Sbjct: 134 SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLT-KEKSKRNSV-VGTPYWMAPEVIKRK 191

Query: 705 QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQED 764
                 D++S GIM +E    + P          L       +P     + +    S E 
Sbjct: 192 DYGPKVDIWSLGIMCIEMAEGEPPYLR-EPPLRALFLITTKGIP----PLKNPEKWSPEF 246

Query: 765 IHFVAKEQCVSFVFNLALECTVESPEQRINAKEI 798
             F+ K             C V+ PE+R +A+E+
Sbjct: 247 KDFLNK-------------CLVKDPEKRPSAEEL 267

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  107 bits (270), Expect = 4e-26
 Identities = 69/207 (33%), Positives = 97/207 (46%), Gaps = 28/207 (13%)

Query: 535 IGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDVECAM-----MKSIRHRNLVKV 588
           +G+G FG V   R +D G   A+KV   +  +  K  +VE  +     +  I H  +VK+
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKK--KIIKRKEVEHTLTERNILSRINHPFIVKL 58

Query: 589 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLN------IMIDVASALEYLHF 642
             +   EE   LVLEY P G L  +L           R +         ++  ALEYLH 
Sbjct: 59  HYAFQTEEKLYLVLEYAPGGELFSHLSK-------EGRFSEERARFYAAEIVLALEYLH- 110

Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAPEYG 701
             S  +I+ DLKP N+LLD +    L+DFG+AK L+ E     +T T   T  Y+APE  
Sbjct: 111 --SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS---RTNTFCGTPEYLAPEVL 165

Query: 702 REGQVSTNGDVYSFGIMLMETFTRKKP 728
                    D +S G++L E  T K P
Sbjct: 166 LGKGYGKAVDWWSLGVLLYEMLTGKPP 192

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  107 bits (269), Expect = 1e-25
 Identities = 65/226 (28%), Positives = 102/226 (45%), Gaps = 33/226 (14%)

Query: 534 LIGRGGFGSVYKAR-IRDGMEVAVKVFN---LQCGRAFKSFDVE-CAMMKSIRHRNLVKV 588
           +IG G F +V  A+      E A+K+ +   L   +  K   +E   + +   H  ++K+
Sbjct: 8   IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67

Query: 589 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPV 648
             +  +EE    VLEY P+G L +Y+     SLD         ++  ALEYLH   S  +
Sbjct: 68  YYTFQDEENLYFVLEYAPNGELLQYIRK-YGSLDEKCTRFYAAEILLALEYLH---SKGI 123

Query: 649 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIG-------------- 694
           IH DLKP N+LLD +M   ++DFG AK+L   + S    +  AT                
Sbjct: 124 IHRDLKPENILLDKDMHIKITDFGTAKVL-DPNSSPESNKGDATNIDSQIEKNRRRFASF 182

Query: 695 -----YMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNG 735
                Y++PE   E     + D+++ G ++ +  T K P    F G
Sbjct: 183 VGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP----FRG 224

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  106 bits (267), Expect = 1e-25
 Identities = 65/192 (33%), Positives = 100/192 (52%), Gaps = 8/192 (4%)

Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGRA-FKSFDVECAMMKSIRHRNLVKVISSCS 593
           +G G FG V++    +   VAVK   L+ G    K F  E  +MK +RH  L+++ + C+
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVK--TLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT 71

Query: 594 NEEFKALVLEYMPHGSLEKYLHSSNYS-LDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
            EE   +V E M +GSL +YL       L + Q +++   VAS + YL    +   IH D
Sbjct: 72  LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRD 128

Query: 653 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDV 712
           L   NVL+ +N +  ++DFG+A+++  ED    +      I + APE     + S   DV
Sbjct: 129 LAARNVLVGENNICKVADFGLARVI-KEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDV 187

Query: 713 YSFGIMLMETFT 724
           +SFGI+L E  T
Sbjct: 188 WSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  105 bits (264), Expect = 2e-25
 Identities = 78/272 (28%), Positives = 136/272 (50%), Gaps = 34/272 (12%)

Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSN 594
           IG G FG+V +     G +VAVK  N++C    ++F  E A+M  + H+NLV+++    +
Sbjct: 14  IGEGEFGAVLQGEYT-GQKVAVK--NIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH 70

Query: 595 EEFKALVLEYMPHGSLEKYLHSSNYSL-DIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 653
                +V+E M  G+L  +L +   +L  + Q L   +DVA  +EYL    S  ++H DL
Sbjct: 71  NGLY-IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDL 126

Query: 654 KPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVY 713
              N+L+ ++ VA +SDFG+A++      SM    +   + + APE  +  + S+  DV+
Sbjct: 127 AARNILVSEDGVAKVSDFGLARV-----GSMGVDNSKLPVKWTAPEALKHKKFSSKSDVW 181

Query: 714 SFGIMLMETFTR-KKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQ 772
           S+G++L E F+  + P       +M+LK  V +C+              ++       E 
Sbjct: 182 SYGVLLWEVFSYGRAPYP-----KMSLKE-VKECV--------------EKGYRMEPPEG 221

Query: 773 CVSFVFNLALECTVESPEQRINAKEIVAKLLK 804
           C + V+ L   C    P++R +  ++  KL K
Sbjct: 222 CPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score =  105 bits (264), Expect = 2e-25
 Identities = 64/194 (32%), Positives = 99/194 (51%), Gaps = 9/194 (4%)

Query: 534 LIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFK-SFDVECAMMKSIRHRNLVKVISSC 592
           L+G+G FG V+K  ++D   VAVK       +  K  F  E  ++K   H N+VK+I  C
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 593 SNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
           +  +   +V+E +P G    +L      L   Q +   +D A+ + YL    S   IH D
Sbjct: 62  TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRD 118

Query: 653 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLAT--IGYMAPEYGREGQVSTNG 710
           L   N L+ +N V  +SDFG+++    ED  +  +  L    I + APE    G+ S+  
Sbjct: 119 LAARNCLVGENNVLKISDFGMSR---QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175

Query: 711 DVYSFGIMLMETFT 724
           DV+S+GI+L ETF+
Sbjct: 176 DVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  105 bits (263), Expect = 4e-25
 Identities = 71/268 (26%), Positives = 119/268 (44%), Gaps = 26/268 (9%)

Query: 533 NLIGRGGFGSVYKARI-RDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISS 591
           + +G G +G VY+    +  + VAVK    +     + F  E A+MK I+H NLV+++  
Sbjct: 12  HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70

Query: 592 CSNEEFKALVLEYMPHGSLEKYLHSSNYS-LDIFQRLNIMIDVASALEYLHFGYSAPVIH 650
           C+ E    ++ E+M +G+L  YL   N   ++    L +   ++SA+EYL        IH
Sbjct: 71  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 127

Query: 651 CDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNG 710
            DL   N L+ +N +  ++DFG+++L+TG D           I + APE     + S   
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKS 186

Query: 711 DVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAK 770
           DV++FG++L E  T                       P   +++     L ++       
Sbjct: 187 DVWAFGVLLWEIATY-------------------GMSPYPGIDLSQVYELLEKGYRMERP 227

Query: 771 EQCVSFVFNLALECTVESPEQRINAKEI 798
           E C   V+ L   C   +P  R +  EI
Sbjct: 228 EGCPPKVYELMRACWQWNPSDRPSFAEI 255

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score =  104 bits (260), Expect = 6e-25
 Identities = 71/192 (36%), Positives = 102/192 (53%), Gaps = 13/192 (6%)

Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSN 594
           IG+G FG V     R G +VAVK   ++     ++F  E ++M  +RH NLV+++     
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70

Query: 595 EEFKA-LVLEYMPHGSLEKYLHSSNYS-LDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
           E+    +V EYM  GSL  YL S   S L     L   +DV  A+EYL    +   +H D
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRD 127

Query: 653 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDV 712
           L   NVL+ ++ VA +SDFG+ K     + S TQ      + + APE  RE + ST  DV
Sbjct: 128 LAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSDV 182

Query: 713 YSFGIMLMETFT 724
           +SFGI+L E ++
Sbjct: 183 WSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score =  104 bits (260), Expect = 1e-24
 Identities = 76/294 (25%), Positives = 123/294 (41%), Gaps = 50/294 (17%)

Query: 535 IGRGGFGSVYKARI------RDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKV 588
           +G G FG V+ A        +D M VAVK        A + F  E  ++  ++H+++V+ 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 589 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIF--------------QRLNIMIDVA 634
              C+      +V EYM HG L ++L S      I               Q L I   +A
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 635 SALEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA 691
           S + YL   HF      +H DL   N L+   +V  + DFG+++ +   D      +T+ 
Sbjct: 133 SGMVYLASLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 186

Query: 692 TIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTR-KKPTDELFNGEMTLKHWVNDCLPIS 750
            I +M PE     + +T  D++SFG++L E FT  K+P  +L N E        +C+   
Sbjct: 187 PIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAI------ECI--- 237

Query: 751 TMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLK 804
                       +         C   V+ +   C    P+QR+  K+I ++L  
Sbjct: 238 -----------TQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  104 bits (260), Expect = 1e-24
 Identities = 57/203 (28%), Positives = 97/203 (47%), Gaps = 11/203 (5%)

Query: 535 IGRGGFGSVYKAR-IRDG----MEVAVKVFNLQCGR-AFKSFDVECAMMKSIRHRNLVKV 588
           +G G FG+VYK   I +G    + VA+KV   +    A K    E  +M S+ H ++V++
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 589 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPV 648
           +  C + +   L+ + MP G L  Y+ +   ++     LN  + +A  + YL       +
Sbjct: 75  LGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE---EKRL 130

Query: 649 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVST 708
           +H DL   NVL+       ++DFG+AKLL  +++          I +MA E       + 
Sbjct: 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTH 190

Query: 709 NGDVYSFGIMLMETFT-RKKPTD 730
             DV+S+G+ + E  T   KP +
Sbjct: 191 KSDVWSYGVTVWELMTFGAKPYE 213

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  104 bits (261), Expect = 2e-24
 Identities = 69/218 (31%), Positives = 104/218 (47%), Gaps = 35/218 (16%)

Query: 535 IGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDV----ECAMMKSIRHRNLVK-- 587
           IG G +G VYKAR  + G  VA+K   ++  +  + F +    E  +++ +RH N+V+  
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMENEK--EGFPITAIREIKLLQKLRHPNIVRLK 64

Query: 588 --VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYS 645
             V S      +  +V EYM H  L   L S        Q    M  +   L+YLH   S
Sbjct: 65  EIVTSKGKGSIY--MVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH---S 118

Query: 646 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPE------ 699
             ++H D+K SN+L++++ V  L+DFG+A+  T    S   T  + T+ Y  PE      
Sbjct: 119 NGILHRDIKGSNILINNDGVLKLADFGLARPYTKR-NSADYTNRVITLWYRPPELLLGAT 177

Query: 700 -YGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGE 736
            YG E  V    D++S G +L E F   KP   +F G 
Sbjct: 178 RYGPE--V----DMWSVGCILAELFL-GKP---IFQGS 205

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  102 bits (257), Expect = 2e-24
 Identities = 71/258 (27%), Positives = 118/258 (45%), Gaps = 24/258 (9%)

Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSN 594
           +G G FG V+  + R  ++VA+K+   +   +   F  E  +M  + H NLV++   C+ 
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIR-EGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70

Query: 595 EEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLK 654
           +    +V EYM +G L  YL      L     L++  DV  A+EYL    S   IH DL 
Sbjct: 71  QRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLA 127

Query: 655 PSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYS 714
             N L+ ++ V  +SDFG+A+ +  +DQ  +   T   + +  PE     + S+  DV+S
Sbjct: 128 ARNCLVGEDNVVKVSDFGLARYVL-DDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWS 186

Query: 715 FGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCV 774
           FG+++ E F+          G+M  + + N        EVV++             +   
Sbjct: 187 FGVLMWEVFS---------EGKMPYERFSN-------SEVVES---VSAGYRLYRPKLAP 227

Query: 775 SFVFNLALECTVESPEQR 792
           + V+ +   C  E PE R
Sbjct: 228 TEVYTIMYSCWHEKPEDR 245

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  102 bits (256), Expect = 2e-24
 Identities = 62/204 (30%), Positives = 100/204 (49%), Gaps = 6/204 (2%)

Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSN 594
           IG G FG V+     +  +VA+K    +   + + F  E  +M  + H  LV++   C+ 
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIR-EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70

Query: 595 EEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLK 654
                LV E+M HG L  YL +          L + +DV   + YL    S+ VIH DL 
Sbjct: 71  RSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLA 127

Query: 655 PSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYS 714
             N L+ +N V  +SDFG+ + +  +DQ  + T T   + + +PE     + S+  DV+S
Sbjct: 128 ARNCLVGENQVVKVSDFGMTRFVL-DDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWS 186

Query: 715 FGIMLMETFTR-KKPTDELFNGEM 737
           FG+++ E F+  K P +   N E+
Sbjct: 187 FGVLMWEVFSEGKTPYENRSNSEV 210

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  100 bits (252), Expect = 1e-23
 Identities = 65/205 (31%), Positives = 102/205 (49%), Gaps = 13/205 (6%)

Query: 529 FSENNLIGRGGFGSVYKARIRDGMEV-AVKVFNLQ-C--GRAFKSFDVECAMMKSIRHRN 584
           F    +IG+G FG V   + RD  ++ A+K  N Q C    + ++   E  +++ + H  
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61

Query: 585 LVKVISSCSNEEFKALVLEYMPHGSLEKYL-HSSNYSLDIFQRLNIMIDVASALEYLHFG 643
           LV +  S  +EE   LV++ +  G L  +L     +S +  +    + ++  ALEYLH  
Sbjct: 62  LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKF--WICEIVLALEYLH-- 117

Query: 644 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE 703
            S  +IH D+KP N+LLD+    H++DF IA  +T +  +   T T  T GYMAPE    
Sbjct: 118 -SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TSTSGTPGYMAPEVLCR 173

Query: 704 GQVSTNGDVYSFGIMLMETFTRKKP 728
              S   D +S G+   E    K+P
Sbjct: 174 QGYSVAVDWWSLGVTAYECLRGKRP 198

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 99.7 bits (248), Expect = 2e-23
 Identities = 76/271 (28%), Positives = 118/271 (43%), Gaps = 42/271 (15%)

Query: 535 IGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKS-FDVECAMMKSIRHRNLVKVISSC 592
           IGRG FG V+  R+R D   VAVK          K+ F  E  ++K   H N+V++I  C
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 593 SNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
           + ++   +V+E +  G    +L +    L + + + ++ + A+ +EYL    S   IH D
Sbjct: 63  TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRD 119

Query: 653 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATI--GYMAPEYGREGQVSTNG 710
           L   N L+ +  V  +SDFG+++    ED     T  +  I   + APE    G+ S+  
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSR--EEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSES 177

Query: 711 DVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAK 770
           DV+SFGI+L E F                          S   V  ANL +Q+    + +
Sbjct: 178 DVWSFGILLWEAF--------------------------SLGAVPYANLSNQQTREAIEQ 211

Query: 771 -------EQCVSFVFNLALECTVESPEQRIN 794
                  E C   V+ L   C    P QR +
Sbjct: 212 GVRLPCPELCPDAVYRLMERCWEYDPGQRPS 242

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  100 bits (250), Expect = 3e-23
 Identities = 80/305 (26%), Positives = 141/305 (46%), Gaps = 48/305 (15%)

Query: 521 ELFQATDKFSENNLIGRGGFGSVYKARI--RDGME----VAVKVFNLQC-GRAFKSFDVE 573
           E+  +  +F E   +G G FG VYK  +   +       VA+K        +  + F  E
Sbjct: 1   EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQE 58

Query: 574 CAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYL--HSSN------------- 618
             +M  ++H N+V ++  C+ E+   ++ EY+ HG L ++L  +S +             
Sbjct: 59  AELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVK 118

Query: 619 YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 678
            SLD    L+I I +A+ +EYL    S   +H DL   N L+ + +   +SDFG+++ + 
Sbjct: 119 SSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIY 175

Query: 679 GEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRK-KPTDELFNGEM 737
             D    Q+++L  + +M PE    G+ +T  D++SFG++L E F+   +P    + G  
Sbjct: 176 SADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP----YYG-- 229

Query: 738 TLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKE 797
                       S  EV++   + +        E C + V+ L +EC  E P +R   K+
Sbjct: 230 -----------FSNQEVIE---MIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKD 275

Query: 798 IVAKL 802
           I  +L
Sbjct: 276 IHTRL 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 99.0 bits (247), Expect = 6e-23
 Identities = 73/278 (26%), Positives = 114/278 (41%), Gaps = 31/278 (11%)

Query: 535 IGRGGFGSVYKAR-IRDGMEVAVKVFNL-QCGRAFKSFDVECAMMKSIRHRNLVKVISSC 592
           IG G    VY A  + +  +VA+K  +L +C  +      E   M    H N+VK  +S 
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68

Query: 593 SNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNI---MIDVASALEYLHFGYSAPVI 649
              +   LV+ Y+  GSL   + SS Y         I   + +V   LEYLH   S   I
Sbjct: 69  VVGDELWLVMPYLSGGSLLDIMKSS-YPRGGLDEAIIATVLKEVLKGLEYLH---SNGQI 124

Query: 650 HCDLKPSNVLLDDNMVAHLSDFGIAKLL--TGEDQSMTQTQTLATIGYMAPEYGREGQVS 707
           H D+K  N+LL ++    ++DFG++  L   G+     +   + T  +MAPE   +    
Sbjct: 125 HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGY 184

Query: 708 TNG-DVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIH 766
               D++SFGI  +E  T   P  +    ++ +    ND  P S     D    S+    
Sbjct: 185 DFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQND--PPSLETGADYKKYSKSFRK 242

Query: 767 FVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLK 804
            ++              C  + P +R  A     +LLK
Sbjct: 243 MISL-------------CLQKDPSKRPTA----EELLK 263

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 98.9 bits (247), Expect = 6e-23
 Identities = 59/196 (30%), Positives = 88/196 (44%), Gaps = 8/196 (4%)

Query: 535 IGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRA-FKSFDVECAMMKSIRHRNLVKVISSC 592
           +G G  G V K   R  G  +AVK   L+   A  K    E  ++       +V    + 
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68

Query: 593 SNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
            N    ++ +EYM  GSL+K L      +       I + V   L YLH  +   +IH D
Sbjct: 69  YNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIHRD 126

Query: 653 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDV 712
           +KPSN+L++      L DFG++  L     S+ +T    T  YMAPE  +    S   D+
Sbjct: 127 VKPSNILVNSRGQIKLCDFGVSGQLV---NSLAKTFV-GTSSYMAPERIQGNDYSVKSDI 182

Query: 713 YSFGIMLMETFTRKKP 728
           +S G+ L+E  T + P
Sbjct: 183 WSLGLSLIELATGRFP 198

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 98.6 bits (246), Expect = 8e-23
 Identities = 71/211 (33%), Positives = 104/211 (49%), Gaps = 14/211 (6%)

Query: 533 NLIGRGGFGSVYKA-RIRDGMEVAVKVFNLQCGR--AFKSFDVECAMMKSIRHRNLVKVI 589
           N IG G FG VY A  +  G  +AVK   +Q       K    E  +++ ++H NLVK  
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 590 SSCSNEEFKALVLEYMPHGSLEKYL-HSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPV 648
               + E   + +EY   G+LE+ L H       + +   + +     L YLH   S  +
Sbjct: 66  GVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQL--LEGLAYLH---SHGI 120

Query: 649 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM-TQTQTLA-TIGYMAPEYGREGQV 706
           +H D+KP+N+ LD N V  L DFG A  L     +M  + Q+LA T  YMAPE    G+ 
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKG 180

Query: 707 STNG---DVYSFGIMLMETFTRKKPTDELFN 734
             +G   D++S G +++E  T K+P  EL N
Sbjct: 181 KGHGRAADIWSLGCVVLEMATGKRPWSELDN 211

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 98.1 bits (245), Expect = 1e-22
 Identities = 63/205 (30%), Positives = 97/205 (47%), Gaps = 21/205 (10%)

Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNL 585
           + +     IG G +G VYKAR I  G  VA+KV  L+ G  F+    E +M+K  RH N+
Sbjct: 3   EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62

Query: 586 VKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYS 645
           V    S    +   +V+EY   GSL+     +   L   Q   +  +    L YLH    
Sbjct: 63  VAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH---E 119

Query: 646 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIG---YMAPEYGR 702
              IH D+K +N+LL ++    L+DFG++  LT    ++ + ++   IG   +MAPE   
Sbjct: 120 TGKIHRDIKGANILLTEDGDVKLADFGVSAQLT---ATIAKRKSF--IGTPYWMAPEV-- 172

Query: 703 EGQVSTNG------DVYSFGIMLME 721
              V   G      D+++ GI  +E
Sbjct: 173 -AAVERKGGYDGKCDIWALGITAIE 196

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 98.2 bits (244), Expect = 2e-22
 Identities = 81/307 (26%), Positives = 140/307 (45%), Gaps = 52/307 (16%)

Query: 521 ELFQATDKFSENNLIGRGGFGSVYKARIR-DGME----VAVKVF-NLQCGRAFKSFDVEC 574
           EL  +  +F E   +G   FG +YK  +   GM+    VA+K   ++   + +  F  E 
Sbjct: 1   ELPLSAVRFMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEA 58

Query: 575 AMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYL-----HSS-----------N 618
           ++M  + H N+V ++   + E+   ++ EY+  G L ++L     HS             
Sbjct: 59  SLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVK 118

Query: 619 YSLDIFQRLNIMIDVASALEYL--HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 676
            SLD    L+I I +A+ +EYL  HF      +H DL   N+L+ + +   +SD G+++ 
Sbjct: 119 SSLDHGDFLHIAIQIAAGMEYLSSHF-----FVHKDLAARNILIGEQLHVKISDLGLSRE 173

Query: 677 LTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRK-KPTDELFNG 735
           +   D    Q ++L  I +M PE    G+ S++ D++SFG++L E F+   +P     N 
Sbjct: 174 IYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ 233

Query: 736 EMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINA 795
           E+              +E+V    L          E C   +++L  EC  E P +R   
Sbjct: 234 EV--------------IEMVRKRQL------LPCSEDCPPRMYSLMTECWQEGPSRRPRF 273

Query: 796 KEIVAKL 802
           K+I  +L
Sbjct: 274 KDIHTRL 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 96.5 bits (240), Expect = 3e-22
 Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 5/207 (2%)

Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSN 594
           +G G FG V   + R   +VA+K+   +   +   F  E  +M  + H  LV++   C+ 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70

Query: 595 EEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLK 654
           +    +V EYM +G L  YL          Q L +  DV   + YL    S   IH DL 
Sbjct: 71  QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLA 127

Query: 655 PSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYS 714
             N L+DD     +SDFG+++ +  +D+  +   +   + +  PE     + S+  DV++
Sbjct: 128 ARNCLVDDQGCVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWA 186

Query: 715 FGIMLMETFTRKKPTDELFNGEMTLKH 741
           FG+++ E ++  K   E FN   T++ 
Sbjct: 187 FGVLMWEVYSLGKMPYERFNNSETVEK 213

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 97.5 bits (243), Expect = 3e-22
 Identities = 78/309 (25%), Positives = 127/309 (41%), Gaps = 59/309 (19%)

Query: 527 DKFSENNLIGRGGFGSVYKARIRD------GMEVAVKVFNLQCG-RAFKSFDVECAMMKS 579
           D+ +    +G G FG V KA             VAVK+       +       E  MMK 
Sbjct: 12  DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM 71

Query: 580 I-RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHS-------SNYSLDIFQRLNIMI 631
           I +H+N++ ++  C+ E    +V+EY  HG+L  +L +       ++          +  
Sbjct: 72  IGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQ 131

Query: 632 --------DVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS 683
                    VA  +E+L    S   IH DL   NVL+ ++ V  ++DFG+A+ +   D  
Sbjct: 132 KDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYY 188

Query: 684 MTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKK------PTDELFNGEM 737
              T     + +MAPE   +   +   DV+SFG++L E FT         P +ELF    
Sbjct: 189 RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF---- 244

Query: 738 TLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQ-CVSFVFNLALECTVESPEQRINAK 796
                                LL +   + + K Q C   +++L  +C  E P QR   K
Sbjct: 245 --------------------KLLKEG--YRMEKPQNCTQELYHLMRDCWHEVPSQRPTFK 282

Query: 797 EIVAKLLKI 805
           ++V  L ++
Sbjct: 283 QLVEDLDRM 291

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 96.1 bits (239), Expect = 6e-22
 Identities = 65/214 (30%), Positives = 102/214 (47%), Gaps = 28/214 (13%)

Query: 533 NLIGRGGFGSVYKARIRDGM-----EVAVKVFNLQCG---RAFKSFDVECAMMKSIRHRN 584
           N +G G FG VY+    D +      + V V  L+ G   +  K F  E  +M +  H N
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 585 LVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYS------LDIFQRLNIMIDVASALE 638
           +VK++  C   E + +++E M  G L  YL  +         L + + L+I +DVA    
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 639 YL---HFGYSAPVIHCDLKPSNVLL-----DDNMVAHLSDFGIAKLLTGEDQSMTQTQTL 690
           YL   HF      IH DL   N L+     D + V  + DFG+A+ +   D    + + L
Sbjct: 121 YLEQMHF------IHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGL 174

Query: 691 ATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 724
             + +MAPE   +G+ +T  DV+SFG+++ E  T
Sbjct: 175 LPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 96.2 bits (240), Expect = 6e-22
 Identities = 58/204 (28%), Positives = 90/204 (44%), Gaps = 12/204 (5%)

Query: 535 IGRGGFGSVYKA-RIRDGMEVAVKVFNL-QCGRAFKSFDV-ECAMMKSIRHRNLVKVISS 591
           IG+G FG+V K  R  DG  +  K  +        K   V E  +++ ++H N+V+    
Sbjct: 8   IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDR 67

Query: 592 CSNEEFKAL--VLEYMPHGSLEKYLHSS---NYSLDIFQRLNIMIDVASALEYLHFGYSA 646
             +   + L  V+EY   G L + +         ++      I+  +  AL   H     
Sbjct: 68  IIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDP 127

Query: 647 P--VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG 704
              V+H DLKP+N+ LD N    L DFG+AK+L G D S  +T  + T  YM+PE     
Sbjct: 128 GNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL-GHDSSFAKT-YVGTPYYMSPEQLNHM 185

Query: 705 QVSTNGDVYSFGIMLMETFTRKKP 728
                 D++S G ++ E      P
Sbjct: 186 SYDEKSDIWSLGCLIYELCALSPP 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 96.7 bits (240), Expect = 6e-22
 Identities = 79/283 (27%), Positives = 124/283 (43%), Gaps = 42/283 (14%)

Query: 535 IGRGGFGSVYKARI------RDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKV 588
           +G G FG V+ A        +D + VAVK        A K F  E  ++ +++H ++VK 
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 589 ISSCSNEEFKALVLEYMPHGSLEKYLHSSN------------YSLDIFQRLNIMIDVASA 636
              C   +   +V EYM HG L K+L +                L   Q L+I   +A+ 
Sbjct: 73  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132

Query: 637 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYM 696
           + YL    S   +H DL   N L+ +N++  + DFG+++ +   D       T+  I +M
Sbjct: 133 MVYLA---SQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189

Query: 697 APEYGREGQVSTNGDVYSFGIMLMETFTR-KKPTDELFNGEMTLKHWVNDCLPISTMEVV 755
            PE     + +T  DV+S G++L E FT  K+P  +L N E      V +C       + 
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE------VIEC-------IT 236

Query: 756 DANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEI 798
              +L +          C   V++L L C    P  R+N KEI
Sbjct: 237 QGRVLQR-------PRTCPKEVYDLMLGCWQREPHMRLNIKEI 272

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 97.2 bits (243), Expect = 8e-22
 Identities = 67/225 (29%), Positives = 101/225 (44%), Gaps = 41/225 (18%)

Query: 533 NLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKS-FDV-----ECAMMKSIRHRNL 585
             IG G +G V  A   R G +VA+K    +    F    D      E  +++ +RH N+
Sbjct: 6   KPIGSGAYGVVCSAVDKRTGRKVAIK----KISNVFDDLIDAKRILREIKLLRHLRHENI 61

Query: 586 VK---VISSCSNEEFKAL--VLEYMPHGSLEKYLHSSNY-SLDIFQRLNIMIDVASALEY 639
           +    ++   S E+F  +  V E M    L K + S    + D  Q    +  +   L+Y
Sbjct: 62  IGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQY--FLYQILRGLKY 118

Query: 640 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQ-TQTLATIGYMAP 698
           LH   SA VIH DLKPSN+L++ N    + DFG+A+ +  ++      T+ + T  Y AP
Sbjct: 119 LH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAP 175

Query: 699 E-------YGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGE 736
           E       Y      +   D++S G +  E  TR KP   LF G 
Sbjct: 176 ELLLSSSRY------TKAIDIWSVGCIFAELLTR-KP---LFPGR 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 95.5 bits (237), Expect = 8e-22
 Identities = 76/261 (29%), Positives = 125/261 (47%), Gaps = 30/261 (11%)

Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGR-AFKSFDVECAMMKSIRHRNLVKVISSCS 593
           +G+G FG V+         VA+K   L+ G  + ++F  E  +MK +RH  LV++ +  S
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 71

Query: 594 NEEFKALVLEYMPHGSLEKYLHSSNYS-LDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
            EE   +V EYM  GSL  +L       L + Q +++   +AS + Y+        +H D
Sbjct: 72  -EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 127

Query: 653 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGQVSTNGD 711
           L+ +N+L+ +N+V  ++DFG+A+L+  ED   T  Q     I + APE    G+ +   D
Sbjct: 128 LRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185

Query: 712 VYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKE 771
           V+SFGI+L E  T+         G +     VN        EV+D     +         
Sbjct: 186 VWSFGILLTELTTK---------GRVPYPGMVN-------REVLDQ---VERGYRMPCPP 226

Query: 772 QCVSFVFNLALECTVESPEQR 792
           +C   + +L  +C  + PE+R
Sbjct: 227 ECPESLHDLMCQCWRKEPEER 247

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 95.7 bits (238), Expect = 1e-21
 Identities = 66/203 (32%), Positives = 97/203 (47%), Gaps = 14/203 (6%)

Query: 535 IGRGGFGSV----YKARIRD-GMEVAVKVFNLQCGRAFKS-FDVECAMMKSIRHRNLVKV 588
           +G G FG V    Y       G  VAVK    +CG+   S +  E  ++K++ H N+VK 
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 589 ISSCSNEEFKA--LVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSA 646
              CS +  K   L++EY+P GSL  YL     +L   Q L     +   + YLH   S 
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLA--QLLLFAQQICEGMAYLH---SQ 126

Query: 647 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-TGEDQSMTQTQTLATIGYMAPEYGREGQ 705
             IH DL   NVLLD++ +  + DFG+AK +  G +    +    + + + A E  +E +
Sbjct: 127 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENK 186

Query: 706 VSTNGDVYSFGIMLMETFTRKKP 728
            S   DV+SFG+ L E  T    
Sbjct: 187 FSYASDVWSFGVTLYELLTHCDS 209

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 94.8 bits (236), Expect = 1e-21
 Identities = 62/214 (28%), Positives = 95/214 (44%), Gaps = 27/214 (12%)

Query: 534 LIGRGGFGSVYKA-RIRDGMEVAVKVFNLQCGRAFKSFDV--ECAMMKSIRHRNLVKVIS 590
            +G+G +GSVYK  R+ D    A+K  +L      +  D   E  ++ S+ H N++    
Sbjct: 7   KLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNII---- 62

Query: 591 SCSNEEF-----KALVLEYMPHGSLEKYLHSSNYSLDIFQR---LNIMIDVASALEYLHF 642
               E F       +V+EY P G L K +        +        I I +   L+ LH 
Sbjct: 63  -SYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH- 120

Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
                ++H DLK +N+LL  N +  + D GI+K+L    ++M +TQ   T  YMAPE  +
Sbjct: 121 --EQKILHRDLKSANILLVANDLVKIGDLGISKVLK---KNMAKTQI-GTPHYMAPEVWK 174

Query: 703 EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGE 736
               S   D++S G +L E  T   P    F   
Sbjct: 175 GRPYSYKSDIWSLGCLLYEMATFAPP----FEAR 204

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 94.5 bits (235), Expect = 2e-21
 Identities = 76/292 (26%), Positives = 127/292 (43%), Gaps = 45/292 (15%)

Query: 534 LIGRGGFGSVYKARIR--DG--MEVAVKVFNLQ--CGRAFKSFDVECAMMKSIRHRNLVK 587
           ++G G FGSV + ++   DG  ++VAVK   L        + F  E A MK   H N++K
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65

Query: 588 VISSC----SNEEFKA--LVLEYMPHGSLEKYLHSSN-----YSLDIFQRLNIMIDVASA 636
           +I  C    S ++     ++L +M HG L  +L  S        L +   L  M+D+A  
Sbjct: 66  LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125

Query: 637 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYM 696
           +EYL    +   IH DL   N +L ++M   ++DFG++K +   D           + ++
Sbjct: 126 MEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182

Query: 697 APEYGREGQVSTNGDVYSFGIMLMETFTR-KKPTDELFNGEM--TLKHWVNDCLPISTME 753
           A E   +   ++  DV++FG+ + E  TR + P   + N E+   L+H            
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRH------------ 230

Query: 754 VVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKI 805
               N L Q        E C+  +++L   C    P+ R    ++   L  I
Sbjct: 231 ---GNRLKQ-------PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 94.4 bits (235), Expect = 3e-21
 Identities = 84/303 (27%), Positives = 131/303 (43%), Gaps = 44/303 (14%)

Query: 529 FSENNLI-----GRGGFGSVYKAR---IRD--GMEVAVKVFNLQCGRAFKSFDVECAMMK 578
           F E +L      G+G FGSV   R   ++D  G  VAVK          + F+ E  ++K
Sbjct: 1   FEERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILK 60

Query: 579 SIRHRNLVK---VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVAS 635
           S++H N+VK   V  S      + LV+EY+P+GSL  YL      LD  + L     +  
Sbjct: 61  SLQHDNIVKYKGVCYSAGRRNLR-LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICK 119

Query: 636 ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-TGEDQSMTQTQTLATIG 694
            +EYL    S   +H DL   N+L++      + DFG+ K+L   ++    +    + I 
Sbjct: 120 GMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIF 176

Query: 695 YMAPEYGREGQVSTNGDVYSFGIMLMETFT----RKKPTDELF-------NGEMTLKHWV 743
           + APE   E + S   DV+SFG++L E FT       P  E          G+M + H +
Sbjct: 177 WYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI 236

Query: 744 NDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLL 803
                           L + +    A   C + ++ +  EC    P QR +  E+  ++ 
Sbjct: 237 E---------------LLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVE 281

Query: 804 KIR 806
            IR
Sbjct: 282 AIR 284

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 94.5 bits (236), Expect = 3e-21
 Identities = 55/175 (31%), Positives = 83/175 (47%), Gaps = 23/175 (13%)

Query: 535 IGRGGFGSVYKAR-IRDGMEVAVKVFNL---------QCGRAFKSFDVECAMMKSIRHRN 584
           +G G +G VYKAR  + G  VA+K   L            R       E +++K ++H N
Sbjct: 7   LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR-------EISLLKELKHPN 59

Query: 585 LVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGY 644
           +VK++     E    LV EY     L+KYL      L      +IM  +   L Y H   
Sbjct: 60  IVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH--- 115

Query: 645 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPE 699
           S  ++H DLKP N+L++ + V  L+DFG+A+      ++   T  + T+ Y APE
Sbjct: 116 SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY--THEVVTLWYRAPE 168

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 93.9 bits (233), Expect = 3e-21
 Identities = 71/284 (25%), Positives = 137/284 (48%), Gaps = 32/284 (11%)

Query: 530 SENNLIGRGGFGSVYKARIR--DGMEVAVKVFNLQCGRAFKS---FDVECAMMKSIRHRN 584
           ++  +IG G FG V++  ++     EVAV +  L+ G   K    F  E ++M    H N
Sbjct: 8   TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHN 67

Query: 585 LVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGY 644
           ++++    +  +   ++ EYM +G+L+KYL   +     +Q + ++  +A+ ++YL    
Sbjct: 68  IIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS--- 124

Query: 645 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIG--YMAPEYGR 702
               +H DL   N+L++ N+   +SDFG++++L  +D   T T +   I   + APE   
Sbjct: 125 DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLE-DDPEGTYTTSGGKIPIRWTAPEAIA 183

Query: 703 EGQVSTNGDVYSFGIMLMETFTR-KKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLS 761
             + ++  DV+SFGI++ E  +  ++P  ++ N E+              M+ ++     
Sbjct: 184 YRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEV--------------MKAIN----- 224

Query: 762 QEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKI 805
            +     A   C S V+ L L+C  +   +R    +IV  L K+
Sbjct: 225 -DGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 94.0 bits (234), Expect = 4e-21
 Identities = 72/283 (25%), Positives = 120/283 (42%), Gaps = 33/283 (11%)

Query: 532 NNLIGRGGFGSVYKA----RIRDGMEVAVKVFNLQCGRAFKS-FDVECAMMKSIRHRNLV 586
              IG G FG VY+        + + VAVK        + +  F  E  +M+   H ++V
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70

Query: 587 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSA 646
           K+I   + E    +V+E  P G L  YL  + YSLD+   +     +++AL YL    S 
Sbjct: 71  KLIGVIT-ENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SK 126

Query: 647 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM-TQTQTLATIGYMAPEYGREGQ 705
             +H D+   NVL+       L DFG+++ L  ED+S    ++    I +MAPE     +
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSRYL--EDESYYKASKGKLPIKWMAPESINFRR 184

Query: 706 VSTNGDVYSFGIMLMETFTR-KKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQED 764
            ++  DV+ FG+ + E      KP   + N ++  +    + LP+               
Sbjct: 185 FTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMP-------------- 230

Query: 765 IHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRD 807
                   C   +++L  +C    P +R    E+ A+L  I  
Sbjct: 231 ------PNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 93.4 bits (232), Expect = 5e-21
 Identities = 69/217 (31%), Positives = 107/217 (49%), Gaps = 22/217 (10%)

Query: 529 FSENN---LIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRN 584
           + EN    ++G+G +G VY AR +   + +A+K    +  R  +    E A+   ++HRN
Sbjct: 7   YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66

Query: 585 LVKVISSCSNEEFKALVLEYMPHGSLEKYLHS------SNYSLDIFQRLNIMIDVASALE 638
           +V+ + S S   F  + +E +P GSL   L S       N    IF    I+      L+
Sbjct: 67  IVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL----EGLK 122

Query: 639 YLHFGYSAPVIHCDLKPSNVLLDD-NMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMA 697
           YLH      ++H D+K  NVL++  + V  +SDFG +K L G +   T+T T  T+ YMA
Sbjct: 123 YLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN-PCTETFT-GTLQYMA 177

Query: 698 PEYGREGQ--VSTNGDVYSFGIMLMETFTRKKPTDEL 732
           PE   +G        D++S G  ++E  T K P  EL
Sbjct: 178 PEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIEL 214

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 92.9 bits (231), Expect = 7e-21
 Identities = 68/219 (31%), Positives = 103/219 (47%), Gaps = 38/219 (17%)

Query: 534 LIGRGGFGSVYKARIRD-GMEVAVKVFNL----QCGR-AFKSFDVECAMMKSIRHRNLVK 587
           L+G G FGSVY+    D G   AVK  +L    Q G+ A K  + E A++  ++H N+V+
Sbjct: 7   LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66

Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLHS---------SNYSLDIFQRLNIMIDVASALE 638
            + +   E+   + LE +P GSL K L             Y+  I             LE
Sbjct: 67  YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQIL----------LGLE 116

Query: 639 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIG---Y 695
           YLH       +H D+K +N+L+D N V  L+DFG+AK      Q +  +   +  G   +
Sbjct: 117 YLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAK------QVVEFSFAKSFKGSPYW 167

Query: 696 MAPEY-GREGQVSTNGDVYSFGIMLMETFTRKKPTDELF 733
           MAPE   ++G      D++S G  ++E  T K P  +L 
Sbjct: 168 MAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE 206

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 92.7 bits (231), Expect = 7e-21
 Identities = 77/275 (28%), Positives = 121/275 (44%), Gaps = 36/275 (13%)

Query: 529 FSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVK 587
           F     +G G +GSVYKA  ++ G  VA+KV  +      +    E +++K      +VK
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYIVK 62

Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAP 647
              S        +V+EY   GS+   +  +N +L   +   I+      LEYLH   S  
Sbjct: 63  YYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNK 119

Query: 648 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIG---YMAPEYGREG 704
            IH D+K  N+LL++   A L+DFG++  LT    +M +  T+  IG   +MAPE  +E 
Sbjct: 120 KIHRDIKAGNILLNEEGQAKLADFGVSGQLTD---TMAKRNTV--IGTPFWMAPEVIQEI 174

Query: 705 QVSTNGDVYSFGIMLMETFTRKKPTDEL--FNGEMTLKHWVNDCLPISTMEVVDANLLSQ 762
             +   D++S GI  +E    K P  ++        + +      P  T+   D    S 
Sbjct: 175 GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK-----PPPTLS--DPEKWSP 227

Query: 763 EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKE 797
           E   FV K             C V+ PE+R +A +
Sbjct: 228 EFNDFVKK-------------CLVKDPEERPSAIQ 249

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 93.4 bits (232), Expect = 9e-21
 Identities = 75/296 (25%), Positives = 127/296 (42%), Gaps = 58/296 (19%)

Query: 535 IGRGGFGSVYKARI------RDGMEVAVKVFNLQCGRAFKS-FDVECAMMKSIRHRNLVK 587
           IG+G FG V++AR            VAVK+   +     ++ F  E A+M    H N+VK
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYL--------HSSNYS-------------LDIFQR 626
           ++  C+  +   L+ EYM +G L ++L         S ++S             L   ++
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 627 LNIMIDVASALEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS 683
           L I   VA+ + YL    F      +H DL   N L+ +NMV  ++DFG+++ +   D  
Sbjct: 133 LCIAKQVAAGMAYLSERKF------VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 186

Query: 684 MTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRK-KPTDELFNGEMTLKHW 742
                    I +M PE     + +T  DV+++G++L E F+   +P   + + E  + + 
Sbjct: 187 KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH-EEVIYY- 244

Query: 743 VNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEI 798
                      V D N+LS         + C   ++NL   C  + P  R +   I
Sbjct: 245 -----------VRDGNVLS-------CPDNCPLELYNLMRLCWSKLPSDRPSFASI 282

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 92.0 bits (228), Expect = 1e-20
 Identities = 65/196 (33%), Positives = 103/196 (52%), Gaps = 11/196 (5%)

Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGR-AFKSFDVECAMMKSIRHRNLVKVISSCS 593
           +G G FG V+        +VAVK   L+ G  + +SF  E  +MK +RH  LV++ +  S
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVK--TLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS 71

Query: 594 NEEFKALVLEYMPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
            E    +V EYM  GSL  +L      +L +   +++   VA+ + Y+        IH D
Sbjct: 72  EEPI-YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRD 127

Query: 653 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGQVSTNGD 711
           L+ +N+L+ D +V  ++DFG+A+L+  ED   T  Q     I + APE    G+ +   D
Sbjct: 128 LRSANILVGDGLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185

Query: 712 VYSFGIMLMETFTRKK 727
           V+SFGI+L E  T+ +
Sbjct: 186 VWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 91.6 bits (227), Expect = 4e-20
 Identities = 62/209 (29%), Positives = 107/209 (51%), Gaps = 26/209 (12%)

Query: 533 NLIGRGGFGSVYKARIR-DG--MEVAVKVFNLQCGRA-FKSFDVECAMMKSI-RHRNLVK 587
           ++IG G FG V KARI+ DG  M+ A+K       +   + F  E  ++  +  H N++ 
Sbjct: 13  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72

Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYL---------------HSSNYSLDIFQRLNIMID 632
           ++ +C +  +  L +EY PHG+L  +L               +S+  +L   Q L+   D
Sbjct: 73  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132

Query: 633 VASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLAT 692
           VA  ++YL        IH DL   N+L+ +N VA ++DFG+++   G++  + +T     
Sbjct: 133 VARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 186

Query: 693 IGYMAPEYGREGQVSTNGDVYSFGIMLME 721
           + +MA E       +TN DV+S+G++L E
Sbjct: 187 VRWMAIESLNYSVYTTNSDVWSYGVLLWE 215

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 90.9 bits (226), Expect = 4e-20
 Identities = 57/201 (28%), Positives = 91/201 (45%), Gaps = 20/201 (9%)

Query: 535 IGRGGFGSVYKAR-IRDGMEVAVKVFNLQ------CGRAFKSFDVECAMMKSIRHRNLVK 587
           IG G +G VYKAR    G  VA+K   L+         A +    E  ++K + H N++K
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALR----EIKLLKELNHPNIIK 62

Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAP 647
           ++    ++    LV E+M    L K +      L      + +  +   L + H   S  
Sbjct: 63  LLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHG 118

Query: 648 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPE--YGREGQ 705
           ++H DLKP N+L++   V  L+DFG+A+           T  + T  Y APE   G +  
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGS--PVRPYTHYVVTRWYRAPELLLG-DKG 175

Query: 706 VSTNGDVYSFGIMLMETFTRK 726
            ST  D++S G +  E  +R+
Sbjct: 176 YSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 90.5 bits (224), Expect = 5e-20
 Identities = 67/207 (32%), Positives = 109/207 (52%), Gaps = 12/207 (5%)

Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAF-KSFDVECAMMKSIRHRNLVKVISSCS 593
           +G+G FG V+        +VA+K   L+ G    ++F  E  +MK +RH  LV + +  S
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIK--TLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS 71

Query: 594 NEEFKALVLEYMPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
            EE   +V E+M  GSL  +L   +   L + Q +++   +A  + Y+        IH D
Sbjct: 72  -EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRD 127

Query: 653 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGQVSTNGD 711
           L+ +N+L+ DN+V  ++DFG+A+L+  ED   T  Q     I + APE    G+ +   D
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185

Query: 712 VYSFGIMLMETFTRKK-PTDELFNGEM 737
           V+SFGI+L E  T+ + P   + N E+
Sbjct: 186 VWSFGILLTELVTKGRVPYPGMVNREV 212

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 90.1 bits (223), Expect = 5e-20
 Identities = 70/261 (26%), Positives = 119/261 (45%), Gaps = 29/261 (11%)

Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGR-AFKSFDVECAMMKSIRHRNLVKVISSCS 593
           +G G FG V+     +  +VAVK   L+ G  + ++F  E  +MK+++H  LV++ +  +
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVK--TLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71

Query: 594 NEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRL-NIMIDVASALEYLHFGYSAPVIHCD 652
            EE   ++ EYM  GSL  +L S      +  +L +    +A  + Y+        IH D
Sbjct: 72  KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRD 128

Query: 653 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGQVSTNGD 711
           L+ +NVL+ ++++  ++DFG+A+++  ED   T  +     I + APE    G  +   D
Sbjct: 129 LRAANVLVSESLMCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 186

Query: 712 VYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKE 771
           V+SFGI+L E  T  K                   +P   M   D     Q        E
Sbjct: 187 VWSFGILLYEIVTYGK-------------------IPYPGMSNSDVMSALQRGYRMPRME 227

Query: 772 QCVSFVFNLALECTVESPEQR 792
            C   ++++   C  E  E+R
Sbjct: 228 NCPDELYDIMKTCWKEKAEER 248

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 90.0 bits (224), Expect = 6e-20
 Identities = 61/212 (28%), Positives = 94/212 (44%), Gaps = 18/212 (8%)

Query: 535 IGRGGFGSVYKAR-IRDGMEVAVKVFN---LQCGRAFKSFDVECAMMKSIRHRNLVKVIS 590
           I +G +G V+ A+    G   A+KV     +           E  ++   +   +VK+  
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 591 SCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIH 650
           S   ++   LV+EY+P G L   L +    LD       + ++  ALEYLH   S  +IH
Sbjct: 61  SFQGKKNLYLVMEYLPGGDLASLLENVGS-LDEDVARIYIAEIVLALEYLH---SNGIIH 116

Query: 651 CDLKPSNVLLDDNMVAHLSDFGIAKL------LTGEDQSMTQTQTLATIGYMAPEYGREG 704
            DLKP N+L+D N    L+DFG++K+      +   D      + + T  Y+APE     
Sbjct: 117 RDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQ 176

Query: 705 QVSTNGDVYSFGIMLMETFTRKKPTDELFNGE 736
             S   D +S G +L E      P    F+GE
Sbjct: 177 GHSKTVDWWSLGCILYEFLVGIPP----FHGE 204

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 89.7 bits (223), Expect = 6e-20
 Identities = 70/216 (32%), Positives = 100/216 (46%), Gaps = 22/216 (10%)

Query: 535 IGRGGFGSVYKA--RIRDGMEVAVKVFNLQCGRAF---KSFDVECAMMKSIRHRNLVKVI 589
           +G G FGSV K    ++ G EV V V  L+        K F  E ++M  + H  +V++I
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 590 SSCSNEEFKALVLEYMPHGSLEKYL--HSSNYSLDIFQRLNIMIDVASALEYL---HFGY 644
             C  E    LV+E  P G L KYL         D+     +   VA  + YL   HF  
Sbjct: 63  GVCKGEPL-MLVMELAPLGPLLKYLKKRREIPVSDL---KELAHQVAMGMAYLESKHF-- 116

Query: 645 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-TGEDQSMTQTQTLATIGYMAPEYGRE 703
               +H DL   NVLL +   A +SDFG+++ L  G D     T     + + APE    
Sbjct: 117 ----VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY 172

Query: 704 GQVSTNGDVYSFGIMLMETFTR-KKPTDELFNGEMT 738
           G+ S+  DV+S+G+ L E F+   KP  E+   E+ 
Sbjct: 173 GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVI 208

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 90.2 bits (224), Expect = 7e-20
 Identities = 64/211 (30%), Positives = 99/211 (46%), Gaps = 25/211 (11%)

Query: 533 NLIGRGGFGSVYKA--RIRDG----MEVAVKVFNLQCGRAFKS-FDVECAMMKSIRHRNL 585
             +G G FG VY+   R RDG    ++VAVK     C    +S F +E  +M    H+N+
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 586 VKVISSCSNEEFKALVLEYMPHGSLEKYLHSSN------YSLDIFQRLNIMIDVASALEY 639
           V++I        + ++LE M  G L+ +L  +        SL +   L    DVA   +Y
Sbjct: 72  VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131

Query: 640 L---HFGYSAPVIHCDLKPSNVLLDD---NMVAHLSDFGIAKLLTGEDQSMTQTQTLATI 693
           L   HF      IH D+   N LL       VA ++DFG+A+ +          + +  I
Sbjct: 132 LEENHF------IHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPI 185

Query: 694 GYMAPEYGREGQVSTNGDVYSFGIMLMETFT 724
            +M PE   +G  ++  DV+SFG++L E F+
Sbjct: 186 KWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 90.2 bits (224), Expect = 8e-20
 Identities = 63/206 (30%), Positives = 101/206 (49%), Gaps = 23/206 (11%)

Query: 534 LIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDV-----ECAMMKSIRH---RN 584
           LIGRG +G+VY+ + +  G  VA+K+ NL         DV     E A++  +R     N
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDT----PDDDVSDIQREVALLSQLRQSQPPN 63

Query: 585 LVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGY 644
           + K   S        +++EY   GS+   + +   + + +  + I+ +V  AL+Y+H   
Sbjct: 64  ITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIA-EKYISV-IIREVLVALKYIH--- 118

Query: 645 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGY-MAPEYGRE 703
              VIH D+K +N+L+ +     L DFG+A LL    Q+ ++  T     Y MAPE   E
Sbjct: 119 KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLN---QNSSKRSTFVGTPYWMAPEVITE 175

Query: 704 GQV-STNGDVYSFGIMLMETFTRKKP 728
           G+   T  D++S GI + E  T   P
Sbjct: 176 GKYYDTKADIWSLGITIYEMATGNPP 201

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 89.3 bits (222), Expect = 1e-19
 Identities = 71/286 (24%), Positives = 122/286 (42%), Gaps = 40/286 (13%)

Query: 535 IGRGGFGSVYK---ARIRDG---MEVAVK-VFNLQCGRAFKSFDVECAMMKSIRHRNLVK 587
           +G+G FG VY+     +  G     VA+K V      R    F  E ++MK     ++V+
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYL--------HSSNYSLDIFQR-LNIMIDVASALE 638
           ++   S  +   +V+E M  G L+ YL        ++        Q+ + +  ++A  + 
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133

Query: 639 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 698
           YL    +   +H DL   N ++ +++   + DFG+ + +   D      + L  + +MAP
Sbjct: 134 YLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190

Query: 699 EYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDA 757
           E  ++G  +T  DV+SFG++L E  T  ++P   L N E  LK             V+D 
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN-EEVLKF------------VIDG 237

Query: 758 NLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLL 803
             L          E C   +  L   C   +P+ R    EIV+ L 
Sbjct: 238 GHLDL-------PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 90.1 bits (223), Expect = 1e-19
 Identities = 60/209 (28%), Positives = 103/209 (49%), Gaps = 26/209 (12%)

Query: 533 NLIGRGGFGSVYKARIR-DG--MEVAVKVFN-LQCGRAFKSFDVECAMM-KSIRHRNLVK 587
           ++IG G FG V +A I+ DG  M  A+K+          + F  E  ++ K   H N++ 
Sbjct: 8   DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67

Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYL---------------HSSNYSLDIFQRLNIMID 632
           ++ +C N  +  + +EY P+G+L  +L               H +  +L   Q L    D
Sbjct: 68  LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127

Query: 633 VASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLAT 692
           VA+ ++YL        IH DL   NVL+ +N+ + ++DFG+++   GE+  + +T     
Sbjct: 128 VATGMQYLS---EKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMGRLP 181

Query: 693 IGYMAPEYGREGQVSTNGDVYSFGIMLME 721
           + +MA E       +T  DV+SFG++L E
Sbjct: 182 VRWMAIESLNYSVYTTKSDVWSFGVLLWE 210

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 89.2 bits (221), Expect = 1e-19
 Identities = 62/214 (28%), Positives = 107/214 (50%), Gaps = 20/214 (9%)

Query: 529 FSENNLIGRGGFGSVYKARIR----DGMEVAVKVF--NLQCGRAFKSFDVECAMMKSIRH 582
           F+   ++G+G FGSV +A+++       +VAVK+   ++      + F  E A MK   H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 583 RNLVKVISSCSNEEFKA------LVLEYMPHGSLEKYLHSSN-----YSLDIFQRLNIMI 631
            N++K+I        K       ++L +M HG L  +L  S      ++L +   +  MI
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120

Query: 632 DVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA 691
           D+AS +EYL    S   IH DL   N +L++NM   ++DFG++K +   D       +  
Sbjct: 121 DIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177

Query: 692 TIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTR 725
            + ++A E   +   +T+ DV++FG+ + E  TR
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTR 211

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 88.9 bits (221), Expect = 1e-19
 Identities = 67/277 (24%), Positives = 126/277 (45%), Gaps = 29/277 (10%)

Query: 532 NNLIGRGGFGSVYKARI----RDGMEVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLV 586
             +IG G FG V + R+    +  ++VA+K        +    F  E ++M    H N++
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68

Query: 587 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL-HFGYS 645
           ++    +      ++ EYM +GSL+K+L  ++    + Q + ++  +AS ++YL    Y 
Sbjct: 69  RLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNY- 127

Query: 646 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQ 705
              +H DL   N+L++ N+V  +SDFG+++ L   + + T       I + APE     +
Sbjct: 128 ---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRK 184

Query: 706 VSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDI 765
            ++  DV+SFGI++ E  +          GE       N        +V+ A    ++  
Sbjct: 185 FTSASDVWSFGIVMWEVMSY---------GERPYWDMSNQ-------DVIKA---VEDGY 225

Query: 766 HFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL 802
                  C S ++ L L+C  +   +R    +IV+ L
Sbjct: 226 RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTL 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 88.8 bits (220), Expect = 2e-19
 Identities = 69/268 (25%), Positives = 121/268 (45%), Gaps = 24/268 (8%)

Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSN 594
           +G G FG V+  + R  ++VA+K  N +   + + F  E  +M  + H  LV++   C+ 
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70

Query: 595 EEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLK 654
           ++   +V E+M +G L  YL      L     L++  DV   +EYL        IH DL 
Sbjct: 71  QKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLA 127

Query: 655 PSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYS 714
             N L+    V  +SDFG+ + +  +D+  + +     + +  PE     + S+  DV+S
Sbjct: 128 ARNCLVSSTGVVKVSDFGMTRYVL-DDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWS 186

Query: 715 FGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCV 774
           FG+++ E FT          G+M  +   N        EVV+   +S+    +  K   +
Sbjct: 187 FGVLMWEVFTE---------GKMPFEKKSN-------YEVVEM--ISRGFRLYRPKLASM 228

Query: 775 SFVFNLALECTVESPEQRINAKEIVAKL 802
           + V+ +   C  E PE R    E++  +
Sbjct: 229 T-VYEVMYSCWHEKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 87.4 bits (217), Expect = 4e-19
 Identities = 67/278 (24%), Positives = 105/278 (37%), Gaps = 29/278 (10%)

Query: 534 LIGRGGFGSV----YKARIRDGMEVAVKVF-NLQCGRAFKSFDVECAMMKSIRHRNLVKV 588
            +G G FG V    +       + VAVK   + +       F  E A+M S+ H NL+++
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 589 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRL-NIMIDVASALEYLHFGYSAP 647
                      +V E  P GSL   L        +   L +  + +A+ + YL    S  
Sbjct: 62  YGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKR 117

Query: 648 VIHCDLKPSNVLLDDNMVAHLSDFGIAK-LLTGEDQSMTQTQTLATIGYMAPEYGREGQV 706
            IH DL   N+LL  +    + DFG+ + L   ED  + +        + APE  R    
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTF 177

Query: 707 STNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIH 766
           S   DV+ FG+ L E FT          GE               ++ +D      E + 
Sbjct: 178 SHASDVWMFGVTLWEMFTY---------GEEPWAG----LSGSQILKKIDKEG---ERLE 221

Query: 767 FVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLK 804
               E C   ++N+ L+C   +P  R     +   L +
Sbjct: 222 --RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLPE 257

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 87.6 bits (217), Expect = 5e-19
 Identities = 63/210 (30%), Positives = 101/210 (48%), Gaps = 20/210 (9%)

Query: 534 LIGRGGFGSVYKA-RIRDGMEVAVKVFNL------QCGRAFKSFDV---ECAMMKSIRHR 583
           LIG G FGSVY       G  +AVK   L         R     D    E A++K ++H 
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 584 NLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNY-SLDIFQRLNIMIDVASALEYLHF 642
           N+V+ + S  + +   + LEY+P GS+   L  +NY + +     N +  +   L YLH 
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSVAALL--NNYGAFEETLVRNFVRQILKGLNYLH- 123

Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT----LATIGYMAP 698
             +  +IH D+K +N+L+D+     +SDFGI+K L     S            ++ +MAP
Sbjct: 124 --NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181

Query: 699 EYGREGQVSTNGDVYSFGIMLMETFTRKKP 728
           E  ++   +   D++S G +++E  T K P
Sbjct: 182 EVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 88.1 bits (218), Expect = 5e-19
 Identities = 56/197 (28%), Positives = 98/197 (49%), Gaps = 10/197 (5%)

Query: 534 LIGRGGFGSVYKA-RIRDG----MEVAVKVFNLQCGR-AFKSFDVECAMMKSIRHRNLVK 587
           L+G G FG+V+K   I +G    + VA+K    + GR  F+        M S+ H  +V+
Sbjct: 14  LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73

Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAP 647
           ++  C     + LV +  P GSL  ++     SLD  + LN  + +A  + YL       
Sbjct: 74  LLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE---EHR 129

Query: 648 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVS 707
           ++H +L   N+LL  + +  ++DFG+A LL  +D+    ++    I +MA E    G+ +
Sbjct: 130 MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYT 189

Query: 708 TNGDVYSFGIMLMETFT 724
              DV+S+G+ + E  +
Sbjct: 190 HQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 86.9 bits (215), Expect = 7e-19
 Identities = 71/279 (25%), Positives = 134/279 (48%), Gaps = 30/279 (10%)

Query: 534 LIGRGGFGSVYKARIR--DGMEVAVKVFNLQCG---RAFKSFDVECAMMKSIRHRNLVKV 588
           +IG G FG V   R++     E+ V +  L+ G   +  + F  E ++M    H N++ +
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 589 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLH-FGYSAP 647
               +  +   +V EYM +GSL+ +L   +    + Q + ++  +AS ++YL   GY   
Sbjct: 71  EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGY--- 127

Query: 648 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE-DQSMTQTQTLATIGYMAPEYGREGQV 706
            +H DL   N+L++ N+V  +SDFG++++L  + + + T       I + APE     + 
Sbjct: 128 -VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 186

Query: 707 STNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIH 766
           ++  DV+S+GI++ E  +          GE    +W      +S  +V+ A    +E   
Sbjct: 187 TSASDVWSYGIVMWEVMSY---------GER--PYW-----EMSNQDVIKA---IEEGYR 227

Query: 767 FVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKI 805
             A   C + +  L L+C  +   +R   ++IV+ L K+
Sbjct: 228 LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 87.1 bits (216), Expect = 7e-19
 Identities = 56/204 (27%), Positives = 95/204 (46%), Gaps = 11/204 (5%)

Query: 535 IGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCS 593
           +G G FG VYKA+ ++ G+  A K+  ++     + F VE  ++   +H N+V +  +  
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 594 NEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 653
            E    +++E+   G+L+  +      L   Q   +   +  AL +LH   S  VIH DL
Sbjct: 73  YENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDL 129

Query: 654 KPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY-----GREGQVST 708
           K  N+LL  +    L+DFG++       Q   +   + T  +MAPE       ++     
Sbjct: 130 KAGNILLTLDGDVKLADFGVSAKNKSTLQK--RDTFIGTPYWMAPEVVACETFKDNPYDY 187

Query: 709 NGDVYSFGIMLMETFTRKKPTDEL 732
             D++S GI L+E    + P  EL
Sbjct: 188 KADIWSLGITLIELAQMEPPHHEL 211

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 87.2 bits (216), Expect = 7e-19
 Identities = 66/280 (23%), Positives = 132/280 (47%), Gaps = 30/280 (10%)

Query: 534 LIGRGGFGSVYKARIR--DGMEVAVKVFNLQCG---RAFKSFDVECAMMKSIRHRNLVKV 588
           +IG G FG V + R++     E+ V +  L+ G   +  + F  E ++M    H N++ +
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 589 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPV 648
               +      ++ E+M +G+L+ +L  ++    + Q + ++  +A+ ++YL        
Sbjct: 71  EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS---EMNY 127

Query: 649 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA---TIGYMAPEYGREGQ 705
           +H DL   N+L++ N+V  +SDFG+++ L  +    T T +L     I + APE     +
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRK 187

Query: 706 VSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDI 765
            ++  DV+S+GI++ E  +          GE    +W      +S  +V++A    ++D 
Sbjct: 188 FTSASDVWSYGIVMWEVMSY---------GER--PYW-----DMSNQDVINA---IEQDY 228

Query: 766 HFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKI 805
                  C + +  L L+C  +    R    +IV+ L K+
Sbjct: 229 RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 87.1 bits (216), Expect = 8e-19
 Identities = 69/291 (23%), Positives = 123/291 (42%), Gaps = 43/291 (14%)

Query: 530 SENNLIGRGGFGSVYKARIRDGME------VAVKVFNL----QCGRAFKSFDVECAMMKS 579
            E   +GRG FG V+ A+ +   E      V VK             F+    E  M + 
Sbjct: 8   QEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRR---ELDMFRK 64

Query: 580 IRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYS--------LDIFQRLNIMI 631
           + H+N+V+++  C   E   ++LEY   G L+++L ++           L   Q++ +  
Sbjct: 65  LSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCT 124

Query: 632 DVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA 691
            +A  +++L    +A  +H DL   N L+       +S   ++K      +       L 
Sbjct: 125 QIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKD-VYNSEYYKLRNALI 180

Query: 692 TIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPIST 751
            + ++APE  +E   ST  DV+SFG+++ E FT+         GE+      ++      
Sbjct: 181 PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQ---------GELPFYGLSDE------ 225

Query: 752 MEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL 802
            EV+  N L    +     E C S ++ L   C   +P+ R +  E+V+ L
Sbjct: 226 -EVL--NRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 87.4 bits (217), Expect = 9e-19
 Identities = 66/263 (25%), Positives = 114/263 (43%), Gaps = 39/263 (14%)

Query: 554 VAVKVFNLQCG---RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSL 610
           VAVKV  L+      A + F  E  ++  +   N+ +++  C+ +    +++EYM +G L
Sbjct: 49  VAVKV--LRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL 106

Query: 611 EKYLH--------SSNYSLDIFQR--LNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL 660
            ++L          +  S  +     L +   +AS + YL    S   +H DL   N L+
Sbjct: 107 NQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLV 163

Query: 661 DDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLM 720
             N    ++DFG+++ L   D    Q +    I +MA E    G+ +T  DV++FG+ L 
Sbjct: 164 GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLW 223

Query: 721 ETFT--RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQED---IHFVAKEQCVS 775
           E  T  R++P + L +        V        +E  +A    ++D   I+      C  
Sbjct: 224 EILTLCREQPYEHLTD------QQV--------IE--NAGHFFRDDGRQIYLPRPPNCPK 267

Query: 776 FVFNLALECTVESPEQRINAKEI 798
            ++ L LEC     E R   +EI
Sbjct: 268 DIYELMLECWRRDEEDRPTFREI 290

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 87.4 bits (216), Expect = 9e-19
 Identities = 62/204 (30%), Positives = 103/204 (50%), Gaps = 11/204 (5%)

Query: 534 LIGRGGFGSVYKA-RIRDG----MEVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVK 587
           ++G G FG+VYK   + +G    + VA+K+ N   G +A   F  E  +M S+ H +LV+
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73

Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAP 647
           ++  C +   + LV + MPHG L  Y+H    ++     LN  + +A  + YL       
Sbjct: 74  LLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERR 129

Query: 648 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVS 707
           ++H DL   NVL+       ++DFG+A+LL G+++          I +MA E     + +
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFT 189

Query: 708 TNGDVYSFGIMLMETFT-RKKPTD 730
              DV+S+G+ + E  T   KP D
Sbjct: 190 HQSDVWSYGVTIWELMTFGGKPYD 213

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 86.4 bits (214), Expect = 1e-18
 Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 13/218 (5%)

Query: 529 FSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFNLQ-CGRAFKSFDV-ECAMMKSIRHRNL 585
           F   N IG+G FG V+K  R  D    A+K  +L    R  +   + E  ++  +    +
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61

Query: 586 VKVISSCSNEEFKALVLEYMPHGSLEKYLHS---SNYSLDIFQRLNIMIDVASALEYLHF 642
           ++   S  ++    +V+EY  +G L K L          D   R  I I +   L +LH 
Sbjct: 62  IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG--LAHLH- 118

Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
             S  ++H D+K  N+ LD      + D G+AKLL+  D +      + T  Y++PE   
Sbjct: 119 --SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS--DNTNFANTIVGTPYYLSPELCE 174

Query: 703 EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLK 740
           +   +   DV++ G++L E  T K P D    G + LK
Sbjct: 175 DKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILK 212

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 86.6 bits (215), Expect = 1e-18
 Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 29/212 (13%)

Query: 527 DKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDV------ECAMMKS 579
           +K+    ++G G +G V K R +  G  VA+K F      +    DV      E  +++ 
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFK----ESEDDEDVKKTALREVKVLRQ 56

Query: 580 IRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEY 639
           +RH N+V +  +   +    LV EY+    LE  L +S   L      + +  +  A+ Y
Sbjct: 57  LRHENIVNLKEAFRRKGRLYLVFEYVERTLLE-LLEASPGGLPPDAVRSYIWQLLQAIAY 115

Query: 640 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPE 699
            H   S  +IH D+KP N+L+ ++ V  L DFG A+ L     S   T  +AT  Y APE
Sbjct: 116 CH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS-PLTDYVATRWYRAPE 171

Query: 700 -------YGREGQVSTNGDVYSFGIMLMETFT 724
                  YG+        DV++ G ++ E   
Sbjct: 172 LLVGDTNYGKP------VDVWAIGCIMAELLD 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 86.4 bits (214), Expect = 1e-18
 Identities = 62/221 (28%), Positives = 102/221 (46%), Gaps = 41/221 (18%)

Query: 534 LIGRGGFGSVYKARIRD-GMEVAVKVFNL-----QCGRAFKSFDVECAMMKSIRHRNLVK 587
           L+G+G FG VY     D G E+AVK         +  +   + + E  ++K+++H  +V+
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68

Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLH---------SSNYSLDIFQRLNIMIDVASALE 638
                 ++E  ++ +EYMP GS++  L          +  Y+  I +           +E
Sbjct: 69  YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILE----------GVE 118

Query: 639 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTL-ATIGYMA 697
           YLH   S  ++H D+K +N+L D      L DFG +K L     S T  +++  T  +M+
Sbjct: 119 YLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMS 175

Query: 698 PE------YGREGQVSTNGDVYSFGIMLMETFTRKKPTDEL 732
           PE      YGR+       DV+S G  ++E  T K P  E 
Sbjct: 176 PEVISGEGYGRK------ADVWSVGCTVVEMLTEKPPWAEF 210

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 86.1 bits (213), Expect = 1e-18
 Identities = 66/261 (25%), Positives = 121/261 (46%), Gaps = 30/261 (11%)

Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGR-AFKSFDVECAMMKSIRHRNLVKVISSCS 593
           +G G FG V+        +VA+K  +L+ G  + ++F  E  +MK ++H  LV++ +  +
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIK--SLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT 71

Query: 594 NEEFKALVLEYMPHGSLEKYLHSSNYS-LDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
            E    ++ EYM +GSL  +L +     L I + +++   +A  + ++        IH D
Sbjct: 72  QEPI-YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRD 127

Query: 653 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDV 712
           L+ +N+L+ + +   ++DFG+A+L+  +++   +      I + APE    G  +   DV
Sbjct: 128 LRAANILVSETLCCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 186

Query: 713 YSFGIMLMETFTRKK-PTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKE 771
           +SFGI+L E  T  + P   + N E                  V  NL  +        +
Sbjct: 187 WSFGILLTEIVTYGRIPYPGMTNPE------------------VIQNL--ERGYRMPRPD 226

Query: 772 QCVSFVFNLALECTVESPEQR 792
            C   ++ L   C  E PE+R
Sbjct: 227 NCPEELYELMRLCWKEKPEER 247

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 87.0 bits (215), Expect = 1e-18
 Identities = 69/238 (28%), Positives = 111/238 (46%), Gaps = 34/238 (14%)

Query: 527 DKFSENNLIGRGGFGSVY--------KARIRDGMEVAVKVFNLQCG-RAFKSFDVECAMM 577
           DK +    +G G FG V         K + ++ + VAVK+       +       E  MM
Sbjct: 15  DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 74

Query: 578 KSI-RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSS-----NYSLDI-------- 623
           K I +H+N++ ++ +C+ +    +++EY   G+L +YL +       YS DI        
Sbjct: 75  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQM 134

Query: 624 -FQRL-NIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 681
            F+ L +    VA  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D
Sbjct: 135 TFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNID 191

Query: 682 QSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKK------PTDELF 733
                T     + +MAPE   +   +   DV+SFG+++ E FT         P +ELF
Sbjct: 192 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 249

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 89.9 bits (223), Expect = 2e-18
 Identities = 50/148 (33%), Positives = 84/148 (56%), Gaps = 9/148 (6%)

Query: 354 GIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSY 413
           G IP +I  L++L+++ L  N + G+IP S G + SL+ L+LSYN+ +G+IP SL +L+ 
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491

Query: 414 LKDLNLSFNKLKGEIPR--GGSFGNFSAESFKGNELLCGSPNLQVPPCKASIHRTSRKNA 471
           L+ LNL+ N L G +P   GG   + ++ +F  N  LCG P L    C   +   ++   
Sbjct: 492 LRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGL--RACGPHLSVGAK--- 546

Query: 472 LILGIVLPFSTIFMTAIILFIIKYQKRE 499
             +GI    S  F+  +I  +  +++R+
Sbjct: 547 --IGIAFGVSVAFLFLVICAMCWWKRRQ 572

Length = 623

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 86.5 bits (214), Expect = 2e-18
 Identities = 62/202 (30%), Positives = 97/202 (48%), Gaps = 8/202 (3%)

Query: 528 KFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLV 586
           K++    IG+G  G+VY A  +  G EVA+K  NLQ     +    E  +M+  +H N+V
Sbjct: 20  KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIV 79

Query: 587 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSA 646
             + S    +   +V+EY+  GSL   +  +   +D  Q   +  +   ALE+LH   S 
Sbjct: 80  NYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SN 134

Query: 647 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQV 706
            VIH D+K  N+LL  +    L+DFG    +T E     ++  + T  +MAPE       
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAY 192

Query: 707 STNGDVYSFGIMLMETFTRKKP 728
               D++S GIM +E    + P
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 84.8 bits (210), Expect = 3e-18
 Identities = 73/281 (25%), Positives = 124/281 (44%), Gaps = 30/281 (10%)

Query: 533 NLIGRGGFGSVYKARIRDG----MEVAVKVFN-LQCGRAFKSFDVECAMMKSIRHRNLVK 587
            +IG+G FG VY   + D     +  AVK  N +      + F  E  +MK   H N++ 
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 588 VISSCSNEEFKALV-LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSA 646
           ++  C   E   LV L YM HG L  ++ S  ++  +   +   + VA  +EYL    S 
Sbjct: 61  LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA---SK 117

Query: 647 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLAT--IGYMAPEYGREG 704
             +H DL   N +LD++    ++DFG+A+ +  ++       T A   + +MA E  +  
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQ 177

Query: 705 QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQED 764
           + +T  DV+SFG++L E  TR  P                   P   ++  D  +   + 
Sbjct: 178 KFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVDSFDITVYLLQG 218

Query: 765 IHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKI 805
              +  E C   ++ + L C    PE R    E+V+++ +I
Sbjct: 219 RRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 85.3 bits (212), Expect = 4e-18
 Identities = 57/203 (28%), Positives = 95/203 (46%), Gaps = 17/203 (8%)

Query: 533 NLIGRGGFGSVYKAR-IRDGMEVAVK------VFNLQCGRAFKSFDVECAMMKSIRHRNL 585
             +G G +  VYKAR    G  VA+K          + G  F +   E  +++ ++H N+
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALR-EIKLLQELKHPNI 64

Query: 586 VKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYS 645
           + ++    ++    LV E+M    LEK +   +  L      + M+     LEYLH  + 
Sbjct: 65  IGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW- 122

Query: 646 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPE--YGRE 703
             ++H DLKP+N+L+  + V  L+DFG+A+     ++ MT  Q + T  Y APE  +G  
Sbjct: 123 --ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMT-HQ-VVTRWYRAPELLFGAR 178

Query: 704 GQVSTNGDVYSFGIMLMETFTRK 726
                  D++S G +  E   R 
Sbjct: 179 -HYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 84.2 bits (208), Expect = 6e-18
 Identities = 55/211 (26%), Positives = 101/211 (47%), Gaps = 16/211 (7%)

Query: 529 FSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCG------RAFKSFDVECAMMKSIRH 582
           +++  ++G+G +G+VY      G  +AVK   L         + ++    E  ++KS++H
Sbjct: 2   WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61

Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDI-FQRLNIMIDVASALEYLH 641
            N+V+ + +C ++   ++ +E++P GS+   L+      +  F +    I     + YLH
Sbjct: 62  VNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQI--LDGVAYLH 119

Query: 642 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIG----YMA 697
              +  V+H D+K +NV+L  N +  L DFG A+ L       T +  L ++     +MA
Sbjct: 120 ---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176

Query: 698 PEYGREGQVSTNGDVYSFGIMLMETFTRKKP 728
           PE   E       D++S G  + E  T K P
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEMATGKPP 207

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 84.7 bits (209), Expect = 6e-18
 Identities = 73/304 (24%), Positives = 136/304 (44%), Gaps = 46/304 (15%)

Query: 521 ELFQATDKFSENNLIGRGGFGSVYKARI------RDGMEVAVKVFNLQCGRAFKSFDVEC 574
           E+  +T +F E   +G   FG VYK  +           VA+K    +     +      
Sbjct: 1   EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58

Query: 575 AMMKS-IRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYL-----HSSNYSLDIFQR-- 626
           AMM+S ++H N+V ++   + E+  +++  Y  H  L ++L     HS   S D  +   
Sbjct: 59  AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118

Query: 627 --------LNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 678
                   ++I+  +A+ +E+L    S  V+H DL   NVL+ D +   +SD G+ + + 
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLNVKISDLGLFREVY 175

Query: 679 GEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMT 738
             D       +L  I +M+PE    G+ S + D++S+G++L E F+              
Sbjct: 176 AADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS-------------- 221

Query: 739 LKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEI 798
             + +      S  +V++  ++    +     + C ++V+ L LEC  E P +R   K+I
Sbjct: 222 --YGLQPYCGYSNQDVIE--MIRNRQV-LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDI 276

Query: 799 VAKL 802
            ++L
Sbjct: 277 HSRL 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 84.1 bits (208), Expect = 8e-18
 Identities = 60/216 (27%), Positives = 98/216 (45%), Gaps = 36/216 (16%)

Query: 534 LIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDV------ECAMMKSIRHRNLV 586
            +G G F S Y+AR ++ G  +AVK        + +  +V      E  +M  + H +++
Sbjct: 7   QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66

Query: 587 KVISSCSNEEFKALVLEYMPHGSLEKYLH---------SSNYSLDIFQRLNIMIDVASAL 637
           +++ +   +    L +E+M  GS+   L            NY+  + +           L
Sbjct: 67  RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLR----------GL 116

Query: 638 EYLHFGYSAPVIHCDLKPSNVLLDDN-MVAHLSDFGIAKLL----TGEDQSMTQTQTLAT 692
            YLH      +IH D+K +N+L+D       ++DFG A  L    TG  +   Q Q L T
Sbjct: 117 SYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGE--FQGQLLGT 171

Query: 693 IGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKP 728
           I +MAPE  R  Q   + DV+S G +++E  T K P
Sbjct: 172 IAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 84.0 bits (208), Expect = 8e-18
 Identities = 55/201 (27%), Positives = 92/201 (45%), Gaps = 12/201 (5%)

Query: 535 IGRGGFGSVYKARIR-DGMEVA---VKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVIS 590
           IG+G F  VYKA    DG  VA   V++F +   +A +    E  ++K + H N++K ++
Sbjct: 10  IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69

Query: 591 SCSNEEFKALVLEYMPHGSLE---KYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAP 647
           S        +VLE    G L    K+       +         + + SALE++H   S  
Sbjct: 70  SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKR 126

Query: 648 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVS 707
           ++H D+KP+NV +    V  L D G+ +  +   ++      + T  YM+PE   E   +
Sbjct: 127 IMHRDIKPANVFITATGVVKLGDLGLGRFFS--SKTTAAHSLVGTPYYMSPERIHENGYN 184

Query: 708 TNGDVYSFGIMLMETFTRKKP 728
              D++S G +L E    + P
Sbjct: 185 FKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 84.3 bits (209), Expect = 9e-18
 Identities = 62/215 (28%), Positives = 99/215 (46%), Gaps = 31/215 (14%)

Query: 535 IGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDV----ECAMMKSIRHRNLVKVI 589
           IG G  G V+KA+ R+ G  VA+K   L   R           E   +++ +H  +VK++
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVAL--RRLEGGIPNQALREIKALQACQHPYVVKLL 65

Query: 590 ------SSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFG 643
                 S         LV+EYMP   L + L      L   Q  + M  +   + Y+H  
Sbjct: 66  DVFPHGSGFV------LVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH-- 116

Query: 644 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPE--YG 701
            +  ++H DLKP+N+L+  + V  ++DFG+A+L + E+     +  +AT  Y APE  YG
Sbjct: 117 -ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEE-PRLYSHQVATRWYRAPELLYG 174

Query: 702 REGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGE 736
              +     D+++ G +  E      P   LF GE
Sbjct: 175 AR-KYDPGVDLWAVGCIFAELL-NGSP---LFPGE 204

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 84.0 bits (208), Expect = 1e-17
 Identities = 68/226 (30%), Positives = 106/226 (46%), Gaps = 38/226 (16%)

Query: 527 DKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVF-NLQCGRAFKSFDV-ECAMMKSIRHR 583
           +K+    L+G G +G V K + ++ G  VA+K F   +  +  K   + E  M+K +RH 
Sbjct: 1   EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60

Query: 584 NLVKVISSCSNEEFKALVLEYMPH---GSLEKYLHSSNYSLD---IFQRLNIMIDVASAL 637
           NLV +I     ++   LV E++ H     LEKY +  + S     +FQ L         +
Sbjct: 61  NLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILR-------GI 113

Query: 638 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMA 697
           E+ H   S  +IH D+KP N+L+  + V  L DFG A+ L    +    T  +AT  Y A
Sbjct: 114 EFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY--TDYVATRWYRA 168

Query: 698 PE-------YGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGE 736
           PE       YGR        D+++ G ++ E  T     + LF G+
Sbjct: 169 PELLVGDTKYGRA------VDIWAVGCLVTEMLT----GEPLFPGD 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 83.4 bits (207), Expect = 1e-17
 Identities = 61/214 (28%), Positives = 95/214 (44%), Gaps = 21/214 (9%)

Query: 527 DKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFD------VECAMMKS 579
           + F+    IG+G FG VYKA  +     VA+KV +L+     ++ D       E   +  
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLE-----EAEDEIEDIQQEIQFLSQ 55

Query: 580 IRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEY 639
            R   + K   S        +++EY   GS    L      LD      I+ +V   LEY
Sbjct: 56  CRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP--GKLDETYIAFILREVLLGLEY 113

Query: 640 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAP 698
           LH       IH D+K +N+LL +     L+DFG++  LT    +M++  T   T  +MAP
Sbjct: 114 LH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLT---STMSKRNTFVGTPFWMAP 167

Query: 699 EYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEL 732
           E  ++       D++S GI  +E    + P  +L
Sbjct: 168 EVIKQSGYDEKADIWSLGITAIELAKGEPPLSDL 201

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 83.2 bits (205), Expect = 2e-17
 Identities = 63/209 (30%), Positives = 107/209 (51%), Gaps = 26/209 (12%)

Query: 533 NLIGRGGFGSVYKARIR-DG--MEVAVKVFNLQCGRA-FKSFDVECAMM-KSIRHRNLVK 587
           ++IG G FG V KARI+ DG  M+ A+K       +   + F  E  ++ K   H N++ 
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYL---------------HSSNYSLDIFQRLNIMID 632
           ++ +C +  +  L +EY PHG+L  +L               +S+  +L   Q L+   D
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 633 VASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLAT 692
           VA  ++YL        IH DL   N+L+ +N VA ++DFG+++   G++  + +T     
Sbjct: 121 VARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 174

Query: 693 IGYMAPEYGREGQVSTNGDVYSFGIMLME 721
           + +MA E       +TN DV+S+G++L E
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWE 203

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 83.2 bits (205), Expect = 2e-17
 Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 19/207 (9%)

Query: 535 IGRGGFGSVYKARIRDG---MEVAVKVFNLQ-CGRA-FKSFDVECAMMKSIRHRNLVKVI 589
           +G G FGSV + ++      ++VAVK   +  C R+  + F  E   MK   H N++++I
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 590 SSC----SNEEFKA--LVLEYMPHGSLEKYLHSSNYS-----LDIFQRLNIMIDVASALE 638
             C     +E + +  ++L +M HG L  +L  S        L     +  M D+AS +E
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 639 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 698
           YL    S   IH DL   N +L++NM   ++DFG++K +   D           + ++A 
Sbjct: 127 YLS---SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183

Query: 699 EYGREGQVSTNGDVYSFGIMLMETFTR 725
           E   +   +T  DV+SFG+ + E  TR
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATR 210

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 82.4 bits (203), Expect = 3e-17
 Identities = 62/203 (30%), Positives = 99/203 (48%), Gaps = 12/203 (5%)

Query: 535 IGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCS 593
           IG G +G VYKAR +  G   A+KV  L+ G  F     E  MMK  +H N+V    S  
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76

Query: 594 NEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 653
             +   + +E+   GSL+   H +   L   Q   +  +    L YLH   S   +H D+
Sbjct: 77  RRDKLWICMEFCGGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLH---SKGKMHRDI 132

Query: 654 KPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT-LATIGYMAPEYG---REGQVSTN 709
           K +N+LL DN    L+DFG++  +T    ++ + ++ + T  +MAPE     R+G  +  
Sbjct: 133 KGANILLTDNGHVKLADFGVSAQITA---TIAKRKSFIGTPYWMAPEVAAVERKGGYNQL 189

Query: 710 GDVYSFGIMLMETFTRKKPTDEL 732
            D+++ GI  +E    + P  +L
Sbjct: 190 CDIWAVGITAIELAELQPPMFDL 212

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 81.6 bits (201), Expect = 6e-17
 Identities = 64/206 (31%), Positives = 99/206 (48%), Gaps = 18/206 (8%)

Query: 535 IGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCS 593
           +G G +G VYKAR +  G   AVK+  L+ G  F     E  M+K  +H N+V    S  
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76

Query: 594 NEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 653
           + E   + +EY   GSL+   H +   L   Q   +  +    L YLH   S   +H D+
Sbjct: 77  SREKLWICMEYCGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLAYLH---SKGKMHRDI 132

Query: 654 KPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT-LATIGYMAPEYGREGQVSTNG-- 710
           K +N+LL DN    L+DFG+A  +T    ++ + ++ + T  +MAPE      V  NG  
Sbjct: 133 KGANILLTDNGDVKLADFGVAAKITA---TIAKRKSFIGTPYWMAPEV---AAVEKNGGY 186

Query: 711 ----DVYSFGIMLMETFTRKKPTDEL 732
               D+++ GI  +E    + P  +L
Sbjct: 187 NQLCDIWAVGITAIELAELQPPMFDL 212

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 81.7 bits (202), Expect = 6e-17
 Identities = 62/202 (30%), Positives = 89/202 (44%), Gaps = 14/202 (6%)

Query: 527 DKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAF-KSFDVECAMMKSIRHRN 584
           +K  E + +G G  GSV K R+++ GM  A+K           K    E  + KS +   
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 585 LVKVISSCSNEEFK--ALVLEYMPHGSLE---KYLHSSNYSLDIFQRLNIMIDVASALEY 639
           +VK   +  +E      + +EY   GSL+   K +      +       I   V   L Y
Sbjct: 61  IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120

Query: 640 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPE 699
           LH   S  +IH D+KPSN+LL       L DFG++  L     + T T    T  YMAPE
Sbjct: 121 LH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGEL-VNSLAGTFT---GTSFYMAPE 173

Query: 700 YGREGQVSTNGDVYSFGIMLME 721
             +    S   DV+S G+ L+E
Sbjct: 174 RIQGKPYSITSDVWSLGLTLLE 195

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 84.9 bits (210), Expect = 8e-17
 Identities = 59/143 (41%), Positives = 80/143 (55%), Gaps = 4/143 (2%)

Query: 290 SNMTFLKVLSL-GSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNL-KALIEIDF 347
           +N + +  + L G N    I    + L  I  +NLS+N  SGP+P +I     +L  ++ 
Sbjct: 66  NNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNL 125

Query: 348 SMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVS 407
           S NNF+G IP   GS+ NLE L L  N L G IP+  G   SLK L+L  N L G IP S
Sbjct: 126 SNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNS 183

Query: 408 LEKLSYLKDLNLSFNKLKGEIPR 430
           L  L+ L+ L L+ N+L G+IPR
Sbjct: 184 LTNLTSLEFLTLASNQLVGQIPR 206

Length = 968

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 80.7 bits (199), Expect = 9e-17
 Identities = 56/208 (26%), Positives = 108/208 (51%), Gaps = 11/208 (5%)

Query: 528 KFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQ--CGRAFKSFDVECAMMKSIRHRN 584
           K+ +  ++GRG FG V+  R + D   V +K   ++        +   EC ++K + H N
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60

Query: 585 LVKVISSCSNEEFKALVLEYMPHGSLEKYLHSS-NYSLDIFQRLNIMIDVASALEYLHFG 643
           +++   +   ++   +V+EY P G+L +Y+    N  LD    L+  + +  AL ++H  
Sbjct: 61  IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH-- 118

Query: 644 YSAPVIHCDLKPSNVLLDDN-MVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
            +  ++H DLK  N+LLD + MV  + DFGI+K+L+ + ++ T    + T  Y++PE   
Sbjct: 119 -TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT---VVGTPCYISPELCE 174

Query: 703 EGQVSTNGDVYSFGIMLMETFTRKKPTD 730
               +   D+++ G +L E  + K+  +
Sbjct: 175 GKPYNQKSDIWALGCVLYELASLKRAFE 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 81.1 bits (200), Expect = 1e-16
 Identities = 66/285 (23%), Positives = 118/285 (41%), Gaps = 37/285 (12%)

Query: 535 IGRGGFGSVYKARI-----RDGMEVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLVKV 588
           +G G FG V   R        G +VAVK    +  G        E  +++++ H N+VK 
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 589 ISSCSNEEFKA--LVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSA 646
              C+ +      L++E++P GSL++YL  +   +++ Q+L   + +   ++YL    S 
Sbjct: 72  KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SR 128

Query: 647 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTL-ATIGYMAPEYGREGQ 705
             +H DL   NVL++      + DFG+ K +  + +  T    L + + + APE   + +
Sbjct: 129 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSK 188

Query: 706 VSTNGDVYSFGIMLMETFT----RKKPTDELF------NGEMTLKHWVNDCLPISTMEVV 755
                DV+SFG+ L E  T       P           +G+MT+   V            
Sbjct: 189 FYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR----------- 237

Query: 756 DANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVA 800
               + +E         C   V+ L  +C    P +R   + ++ 
Sbjct: 238 ----VLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 80.5 bits (198), Expect = 1e-16
 Identities = 72/294 (24%), Positives = 131/294 (44%), Gaps = 38/294 (12%)

Query: 525 ATDKFSENNLIGRGGFGSVY----KARIRDGME--VAVKVFNLQCG-RAFKSFDVECAMM 577
           A +K + +  +G+G FG VY    K  ++D  E  VA+K  N     R    F  E ++M
Sbjct: 4   AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 63

Query: 578 KSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHS-----SNYSLDIFQRLNIMI- 631
           K     ++V+++   S  +   +++E M  G L+ YL S      N  +     L  MI 
Sbjct: 64  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQ 123

Query: 632 ---DVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQ 688
              ++A  + YL+   +   +H DL   N ++ ++    + DFG+ + +   D      +
Sbjct: 124 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 180

Query: 689 TLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLP 748
            L  + +M+PE  ++G  +T  DV+SFG++L E  T  +   +  + E  L+        
Sbjct: 181 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRF------- 233

Query: 749 ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL 802
                V++  LL + D        C   +F L   C   +P+ R +  EI++ +
Sbjct: 234 -----VMEGGLLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSI 275

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 79.5 bits (196), Expect = 3e-16
 Identities = 68/225 (30%), Positives = 107/225 (47%), Gaps = 33/225 (14%)

Query: 523 FQATDKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQC-GRAFKSFDV-ECAMMKS 579
           FQ  +K      IG G +G VYKAR +  G  VA+K   L        S  + E +++K 
Sbjct: 2   FQKVEK------IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 55

Query: 580 IRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYS-LDIFQRLNIMIDVASALE 638
           + H N+VK++     E    LV E++ H  L+K++ +S  S + +    + +  +   L 
Sbjct: 56  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLA 114

Query: 639 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 698
           + H   S  V+H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y AP
Sbjct: 115 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAP 169

Query: 699 E-------YGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGE 736
           E       Y      ST  D++S G +  E  TR+     LF G+
Sbjct: 170 EILLGCKYY------STAVDIWSLGCIFAEMVTRRA----LFPGD 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 80.1 bits (198), Expect = 4e-16
 Identities = 73/316 (23%), Positives = 133/316 (42%), Gaps = 65/316 (20%)

Query: 523 FQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFNLQCGRAFKSFDV--------- 572
           F    ++     IG G +G V  A   R G +VA+K       +   +FDV         
Sbjct: 1   FDVGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIK-------KIPHAFDVPTLAKRTLR 53

Query: 573 ECAMMKSIRHRNLVKV--ISSCSNEEFKA--LVLEYMPHGSLEKYLHSSN-YSLDIFQRL 627
           E  +++  +H N++ +  I      +FK   +V++ M    L   +HS    + +  +  
Sbjct: 54  ELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRYF 112

Query: 628 NIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG--EDQSMT 685
             +  +   L+Y+H   SA VIH DLKPSN+L++++    + DFG+A+ L+    +    
Sbjct: 113 --LYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYF 167

Query: 686 QTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVN 744
            T+ +AT  Y APE      + +T  D++S G +  E   R+    +LF G    K++V+
Sbjct: 168 MTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRR----QLFPG----KNYVH 219

Query: 745 DCLPISTM------EVVDA-------NLLSQ---------EDIHFVAKEQCVSFVFNLAL 782
               I ++      EV++          +             I   A  + +  +  +  
Sbjct: 220 QLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQML- 278

Query: 783 ECTVESPEQRINAKEI 798
                 PE+RI  ++ 
Sbjct: 279 ---QFDPEERITVEQA 291

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 78.5 bits (193), Expect = 5e-16
 Identities = 74/261 (28%), Positives = 122/261 (46%), Gaps = 30/261 (11%)

Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSN 594
           +G G FG V+ A      +VAVK        + ++F  E  +MK+++H  LVK+ +  + 
Sbjct: 14  LGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 72

Query: 595 EEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASAL-EYLHFGYSAPVIHCDL 653
           E    ++ E+M  GSL  +L S   S    Q L  +ID ++ + E + F      IH DL
Sbjct: 73  EPI-YIITEFMAKGSLLDFLKSDEGSK---QPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 128

Query: 654 KPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGQVSTNGDV 712
           + +N+L+  ++V  ++DFG+A+++  ED   T  +     I + APE    G  +   DV
Sbjct: 129 RAANILVSASLVCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 186

Query: 713 YSFGIMLMETFTR-KKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKE 771
           +SFGI+LME  T  + P   + N E+           I  +E                 E
Sbjct: 187 WSFGILLMEIVTYGRIPYPGMSNPEV-----------IRALE---------RGYRMPRPE 226

Query: 772 QCVSFVFNLALECTVESPEQR 792
            C   ++N+ + C    PE+R
Sbjct: 227 NCPEELYNIMMRCWKNRPEER 247

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 79.2 bits (195), Expect = 5e-16
 Identities = 61/204 (29%), Positives = 97/204 (47%), Gaps = 19/204 (9%)

Query: 535 IGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDV--ECAMMKSIR---HRNLVKV 588
           IG G +G+VYKAR    G  VA+K   +Q            E A++K +    H N+V++
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 589 ISSC----SNEEFK-ALVLEYMPHGSLEKYLHSSNY-SLDIFQRLNIMIDVASALEYLHF 642
           +  C    ++ E K  LV E++    L  YL       L      ++M      L++LH 
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA 126

Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
                ++H DLKP N+L+       L+DFG+A++ + +   M  T  + T+ Y APE   
Sbjct: 127 NC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQ---MALTPVVVTLWYRAPEVLL 180

Query: 703 EGQVSTNGDVYSFGIMLMETFTRK 726
           +   +T  D++S G +  E F RK
Sbjct: 181 QSTYATPVDMWSVGCIFAEMFRRK 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 79.0 bits (195), Expect = 5e-16
 Identities = 59/191 (30%), Positives = 83/191 (43%), Gaps = 39/191 (20%)

Query: 527 DKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFD---------VECAM 576
           +K+ + + IG G +G V+K R R+ G  VA+K F        +S D          E  M
Sbjct: 1   EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKF-------VESEDDPVIKKIALREIRM 53

Query: 577 MKSIRHRNLVKVISSCSNEEFKA-----LVLEYMPH---GSLEKYLHSSNYSLDIFQRLN 628
           +K ++H NLV +I     E F+      LV EY  H     LEK        +       
Sbjct: 54  LKQLKHPNLVNLI-----EVFRRKRKLHLVFEYCDHTVLNELEKNPRG----VPEHLIKK 104

Query: 629 IMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQ 688
           I+     A+ + H       IH D+KP N+L+       L DFG A++LTG       T 
Sbjct: 105 IIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY--TD 159

Query: 689 TLATIGYMAPE 699
            +AT  Y APE
Sbjct: 160 YVATRWYRAPE 170

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 79.4 bits (196), Expect = 5e-16
 Identities = 73/233 (31%), Positives = 104/233 (44%), Gaps = 35/233 (15%)

Query: 527 DKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDV----ECAMMKSIR 581
           DKF     IG G +G VYKAR +D G  VA+K   L   +  + F +    E  +++ + 
Sbjct: 7   DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--EGFPITAIREIKILRQLN 64

Query: 582 HRNLVK----VISSCSNEEFKA------LVLEYMPH---GSLEKYLHSSNYSLDIFQRLN 628
           HRN+V     V       +FK       LV EYM H   G LE  L   +         +
Sbjct: 65  HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSED----HIKS 120

Query: 629 IMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQ 688
            M  +   L Y H       +H D+K SN+LL++     L+DFG+A+L   E+     T 
Sbjct: 121 FMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP-YTN 176

Query: 689 TLATIGYMAPE--YGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTL 739
            + T+ Y  PE   G E +     DV+S G +L E FT+K     +F     L
Sbjct: 177 KVITLWYRPPELLLGEE-RYGPAIDVWSCGCILGELFTKKP----IFQANQEL 224

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 78.8 bits (195), Expect = 5e-16
 Identities = 65/222 (29%), Positives = 107/222 (48%), Gaps = 27/222 (12%)

Query: 529 FSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAF--KSFDVECAMMKSIR---H 582
           + E   IG G +G+VYKAR +  G  VA+K   +         S   E A++K +    H
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60

Query: 583 RNLVKVISSC----SNEEFK-ALVLEYMPHGSLEKYLHSSNYS---LDIFQRLNIMIDVA 634
            N+V+++  C    ++ E K  LV E++    L  YL  S      L      ++M  + 
Sbjct: 61  PNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYL--SKCPKPGLPPETIKDLMRQLL 117

Query: 635 SALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIG 694
             +++LH   S  ++H DLKP N+L+  +    ++DFG+A++ + E   M  T  + T+ 
Sbjct: 118 RGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE---MALTSVVVTLW 171

Query: 695 YMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGE 736
           Y APE   +   +T  D++S G +  E F R+     LF G 
Sbjct: 172 YRAPEVLLQSSYATPVDMWSVGCIFAELFRRRP----LFRGT 209

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 79.7 bits (196), Expect = 6e-16
 Identities = 66/230 (28%), Positives = 107/230 (46%), Gaps = 34/230 (14%)

Query: 535 IGRGGFGSVY--------KARIRDGMEVAVKVF-NLQCGRAFKSFDVECAMMKSI-RHRN 584
           +G G FG V         K +    + VAVK+  +    +       E  MMK I +H+N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 585 LVKVISSCSNEEFKALVLEYMPHGSLEKYLHSS-----NYSLD---------IFQRL-NI 629
           ++ ++ +C+ +    +++EY   G+L +YL +      +YS D          F+ L + 
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
              VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ +   D     T  
Sbjct: 140 AYQVARGMEYLA---SQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196

Query: 690 LATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKK------PTDELF 733
              + +MAPE   +   +   DV+SFG++L E FT         P +ELF
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 246

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 78.5 bits (193), Expect = 6e-16
 Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 12/207 (5%)

Query: 529 FSENNLIGRGGFGSVYKAR-IRDGMEVAVK---VFNLQCGRAFKSFDVECAMMKSIRHRN 584
           F     IGRG F  VY+A  + DG+ VA+K   +F+L   +A      E  ++K + H N
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63

Query: 585 LVKVISSCSNEEFKALVLEYMPHGSLEKYL-HSSNYSLDIFQRL--NIMIDVASALEYLH 641
           ++K  +S   +    +VLE    G L + + H       I ++      + + SALE++H
Sbjct: 64  VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123

Query: 642 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYG 701
              S  V+H D+KP+NV +    V  L D G+ +  +   ++      + T  YM+PE  
Sbjct: 124 ---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS--SKTTAAHSLVGTPYYMSPERI 178

Query: 702 REGQVSTNGDVYSFGIMLMETFTRKKP 728
            E   +   D++S G +L E    + P
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 79.1 bits (195), Expect = 7e-16
 Identities = 57/211 (27%), Positives = 96/211 (45%), Gaps = 17/211 (8%)

Query: 528 KFSENNL-----IGRGGFGSVYKA------RIRDGMEVAVKVFNLQCGRAFK-SFDVECA 575
           +F  NNL     +G G FG V +A      +    M+VAVK+       + + +   E  
Sbjct: 31  EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELK 90

Query: 576 MMKSI-RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYS-LDIFQRLNIMIDV 633
           +M  +  H N+V ++ +C+      ++ EY  +G L  +L     S L +   L+    V
Sbjct: 91  IMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQV 150

Query: 634 ASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATI 693
           A  + +L    S   IH DL   NVLL    +  + DFG+A+ +  +   + +      +
Sbjct: 151 AKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPV 207

Query: 694 GYMAPEYGREGQVSTNGDVYSFGIMLMETFT 724
            +MAPE       +   DV+S+GI+L E F+
Sbjct: 208 KWMAPESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 78.5 bits (193), Expect = 8e-16
 Identities = 74/284 (26%), Positives = 123/284 (43%), Gaps = 38/284 (13%)

Query: 535 IGRGGFGSVYKARIRDGME------VAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVK 587
           +G+G FG VY+   RD ++      VAVK  N     R    F  E ++MK     ++V+
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLHS-----SNYSLDIFQRLNIMI----DVASALE 638
           ++   S  +   +V+E M HG L+ YL S      N        L  MI    ++A  + 
Sbjct: 74  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133

Query: 639 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 698
           YL+   +   +H DL   N ++  +    + DFG+ + +   D      + L  + +MAP
Sbjct: 134 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190

Query: 699 EYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDAN 758
           E  ++G  +T+ D++SFG++L E  +  +   +  + E  LK             V+D  
Sbjct: 191 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF------------VMDGG 238

Query: 759 LLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL 802
            L Q        + C   V +L   C   +P+ R    EIV  L
Sbjct: 239 YLDQ-------PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 275

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 78.7 bits (194), Expect = 8e-16
 Identities = 73/229 (31%), Positives = 99/229 (43%), Gaps = 27/229 (11%)

Query: 518 SYLELFQATD---KFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNL---QCGRAFKSF 570
              ELF   D    F++   IG G FG+VY AR +R    VA+K  +    Q    ++  
Sbjct: 3   EIAELFSKDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDI 62

Query: 571 DVECAMMKSIRHRNLVKVISSCSNEEFKA-LVLEYMPHGSLEKYLHSSNYSLDIFQRLNI 629
             E   ++ +RH N ++    C   E  A LV+EY   GS    L      L   +   I
Sbjct: 63  IKEVRFLQQLRHPNTIE-YKGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAI 120

Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
                  L YLH   S   IH D+K  N+LL +     L+DFG A L       ++   +
Sbjct: 121 CHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASL-------VSPANS 170

Query: 690 -LATIGYMAPEY---GREGQVSTNGDVYSFGIMLMETFTRKKPTDELFN 734
            + T  +MAPE      EGQ     DV+S GI  +E   RK P   LFN
Sbjct: 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP---LFN 216

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 78.0 bits (193), Expect = 1e-15
 Identities = 64/204 (31%), Positives = 96/204 (47%), Gaps = 39/204 (19%)

Query: 535 IGRGGFGSVYKARIRDGMEV-AVKVFNLQCGRAFKSFD---VECAMMKSIRHRNLVKVIS 590
           +G G FG V   R +   +  A+K+ +       K  +    E  +++SIRH  LV +  
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68

Query: 591 SCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMI------DVASALEYLHFGY 644
           S  ++    LV+EY+P G L  +L  S        R    +       V  ALEYLH   
Sbjct: 69  SFQDDSNLYLVMEYVPGGELFSHLRKSG-------RFPEPVARFYAAQVVLALEYLH--- 118

Query: 645 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTL-ATIGYMAPE---- 699
           S  +++ DLKP N+LLD +    ++DFG AK + G      +T TL  T  Y+APE    
Sbjct: 119 SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG------RTYTLCGTPEYLAPEIILS 172

Query: 700 --YGREGQVSTNGDVYSFGIMLME 721
             YG+   V    D ++ GI++ E
Sbjct: 173 KGYGK--AV----DWWALGILIYE 190

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 77.2 bits (190), Expect = 2e-15
 Identities = 55/201 (27%), Positives = 88/201 (43%), Gaps = 15/201 (7%)

Query: 535 IGRGGFGSVYKARIRD-GMEVAVKVFN---LQCGRAFKSFDVECAMMKSIRHRNLVKVIS 590
           +G+GGFG V   +++  G   A K  +   L+  +  +    E  +++ +  R +V +  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 591 SCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMI---DVASALEYLHFGYSAP 647
           +   ++   LV+  M  G L KY H  N     F     +     +   LE+LH      
Sbjct: 61  AFETKDDLCLVMTLMNGGDL-KY-HIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRR 115

Query: 648 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVS 707
           +++ DLKP NVLLDD+    +SD G+A  L G            T GYMAPE  +     
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGRAGTPGYMAPEVLQGEVYD 172

Query: 708 TNGDVYSFGIMLMETFTRKKP 728
            + D ++ G  L E    + P
Sbjct: 173 FSVDWFALGCTLYEMIAGRSP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 76.9 bits (189), Expect = 2e-15
 Identities = 59/206 (28%), Positives = 102/206 (49%), Gaps = 14/206 (6%)

Query: 535 IGRGGFGSV----YKARIRDGMEVAVKVFNLQCGRAFK-SFDVECAMMKSIRHRNLVKVI 589
           +G G FG V    YK R +  ++VA+KV   +  ++ +     E  +M  + +  +V++I
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQ-IDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 590 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVI 649
             C  E    LV+E    G L K+L      + +   + +M  V+  ++YL        +
Sbjct: 62  GVCEAEAL-MLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFV 117

Query: 650 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLAT--IGYMAPEYGREGQVS 707
           H DL   NVLL +   A +SDFG++K L G D S  + ++     + + APE     + S
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKAL-GADDSYYKARSAGKWPLKWYAPECINFRKFS 176

Query: 708 TNGDVYSFGIMLMETFTR-KKPTDEL 732
           +  DV+S+GI + E F+  +KP  ++
Sbjct: 177 SRSDVWSYGITMWEAFSYGQKPYKKM 202

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 77.7 bits (191), Expect = 2e-15
 Identities = 72/296 (24%), Positives = 130/296 (43%), Gaps = 33/296 (11%)

Query: 520 LELFQATDKFSENNLIGRGGFGSVYKAR-IRDG----MEVAVKVFNLQCG-RAFKSFDVE 573
           L + + T+ F +  ++G G FG+VYK   I +G    + VA+K        +A K    E
Sbjct: 1   LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 59

Query: 574 CAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDV 633
             +M S+ + ++ +++  C     + L+ + MP G L  Y+     ++     LN  + +
Sbjct: 60  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 118

Query: 634 ASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATI 693
           A  + YL       ++H DL   NVL+       ++DFG+AKLL  +++          I
Sbjct: 119 AKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPI 175

Query: 694 GYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTM 752
            +MA E       +   DV+S+G+ + E  T   KP D +   E++           S +
Sbjct: 176 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-----------SIL 224

Query: 753 EVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKI-RD 807
           E      L Q  I       C   V+ + ++C +   + R   +E++ +  K+ RD
Sbjct: 225 E--KGERLPQPPI-------CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 77.7 bits (191), Expect = 2e-15
 Identities = 78/303 (25%), Positives = 128/303 (42%), Gaps = 61/303 (20%)

Query: 535 IGRGGFGSVYKARIRDGME---------VAVKVF-NLQCGRAFKSFDVECAMMKSI-RHR 583
           +G G FG V +A    G++         VAVK+  +    +       E  +MK I +H+
Sbjct: 20  LGEGCFGQVVRAEAY-GIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHK 78

Query: 584 NLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSS-----NYSLDI---------FQRL-N 628
           N++ ++  C+ E    +++EY   G+L ++L +      +Y+ DI         F+ L +
Sbjct: 79  NIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVS 138

Query: 629 IMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQ 688
               VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ +   D     + 
Sbjct: 139 CAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSN 195

Query: 689 TLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKK------PTDELFNGEMTLKHW 742
               + +MAPE   +   +   DV+SFGI++ E FT         P +ELF         
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK-------- 247

Query: 743 VNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL 802
                            L +E         C   ++ L  EC    P QR   K++V  L
Sbjct: 248 -----------------LLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEAL 290

Query: 803 LKI 805
            K+
Sbjct: 291 DKV 293

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 76.8 bits (189), Expect = 3e-15
 Identities = 62/212 (29%), Positives = 104/212 (49%), Gaps = 25/212 (11%)

Query: 534 LIGRGGFGSVYKA-RIRDGMEVAVKVFNL---QCGR-------AFKSFDVECAMMKSIRH 582
           LIG+G +G VY A  +  G  +AVK   L     GR         K+   E   +K + H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHS-SNYSLDIFQRLNIMIDVASALEYLH 641
            N+V+ +   + EE+ ++ LEY+P GS+   L +   +   + +       V   L YLH
Sbjct: 68  LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFF--TEQVLEGLAYLH 125

Query: 642 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL---LTGEDQSMTQTQTLATIGYMAP 698
              S  ++H DLK  N+L+D + +  +SDFGI+K    +   DQ+M+      ++ +MAP
Sbjct: 126 ---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQ---GSVFWMAP 179

Query: 699 EYGREGQVSTNG--DVYSFGIMLMETFTRKKP 728
           E         +   D++S G +++E F  ++P
Sbjct: 180 EVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 76.6 bits (189), Expect = 3e-15
 Identities = 69/231 (29%), Positives = 97/231 (41%), Gaps = 47/231 (20%)

Query: 529 FSENNL-----IGRGGFGSVYKARIRD-GMEVAVKVFNLQC-GRAFKSF--DVECAMMKS 579
           F+  +L     IGRG FG+V K   +  G  +AVK        +  K    D++  +M+S
Sbjct: 1   FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLD-VVMRS 59

Query: 580 IRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRL-----------N 628
                +VK   +   E    + +E M            + SLD F +             
Sbjct: 60  SDCPYIVKFYGALFREGDCWICMELM------------DISLDKFYKYVYEVLKSVIPEE 107

Query: 629 IMIDVA----SALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM 684
           I+  +A     AL YL       +IH D+KPSN+LLD N    L DFGI+  L     S+
Sbjct: 108 ILGKIAVATVKALNYLK--EELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV---DSI 162

Query: 685 TQTQTLATIGYMAPE----YGREGQVSTNGDVYSFGIMLMETFTRKKPTDE 731
            +T+      YMAPE      R+G      DV+S GI L E  T K P  +
Sbjct: 163 AKTRDAGCRPYMAPERIDPSARDG-YDVRSDVWSLGITLYEVATGKFPYPK 212

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 76.3 bits (188), Expect = 4e-15
 Identities = 55/189 (29%), Positives = 94/189 (49%), Gaps = 10/189 (5%)

Query: 535 IGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCS 593
           IG G  G V  A     G +VAVK  +L+  +  +    E  +M+  +H N+V++ SS  
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86

Query: 594 NEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 653
             +   +V+E++  G+L   +  +  + +  Q   + + V  AL +LH   +  VIH D+
Sbjct: 87  VGDELWVVMEFLEGGALTDIVTHTRMNEE--QIATVCLAVLKALSFLH---AQGVIHRDI 141

Query: 654 KPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGY-MAPEYGREGQVSTNGDV 712
           K  ++LL  +    LSDFG    ++ E   + + ++L    Y MAPE        T  D+
Sbjct: 142 KSDSILLTSDGRVKLSDFGFCAQVSKE---VPRRKSLVGTPYWMAPEVISRLPYGTEVDI 198

Query: 713 YSFGIMLME 721
           +S GIM++E
Sbjct: 199 WSLGIMVIE 207

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 76.0 bits (187), Expect = 4e-15
 Identities = 66/248 (26%), Positives = 117/248 (47%), Gaps = 31/248 (12%)

Query: 535 IGRGGFGSVYKARIRD---------GMEVAVKVFNL-QCGRAFKSFDVECAMMKSIRHRN 584
           +G+G F ++YK  +R          G EV+V +  L    R   +F    ++M  + H++
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 585 LVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGY 644
           LVK+   C  +E   +V EY+  G L+ +LH    ++ +  +L++   +ASAL YL    
Sbjct: 63  LVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE--- 118

Query: 645 SAPVIHCDLKPSNVLL---DDNM----VAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMA 697
              ++H ++   N+L+     N        LSD GI   +      +++ + +  I ++A
Sbjct: 119 DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITV------LSREERVERIPWIA 172

Query: 698 PEYGREGQVSTN--GDVYSFGIMLMETFTR-KKPTDELFNGEMTLKHWVNDCLPISTMEV 754
           PE  R GQ S     D +SFG  L+E  +  ++P   L + E    +     LP+     
Sbjct: 173 PECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPMPDCAE 232

Query: 755 VDANLLSQ 762
           + ANL++Q
Sbjct: 233 L-ANLINQ 239

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 77.6 bits (191), Expect = 4e-15
 Identities = 65/233 (27%), Positives = 109/233 (46%), Gaps = 58/233 (24%)

Query: 525 ATDKFSE---NNLIGRGGFGSVYKARIR-DGMEVAVKVF--------NLQCGRAFKSFDV 572
           A    SE    N IG G  G+VYK   R  G   A+KV           Q  R       
Sbjct: 69  AAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICR------- 121

Query: 573 ECAMMKSIRHRNLVKVISSC-----SNEEFKALVLEYMPHGSLE-KYLHSSNYSLDIFQR 626
           E  +++ + H N+VK    C      N E + L LE+M  GSLE  ++    +  D+ ++
Sbjct: 122 EIEILRDVNHPNVVK----CHDMFDHNGEIQVL-LEFMDGGSLEGTHIADEQFLADVARQ 176

Query: 627 LNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQ 686
                 + S + YLH      ++H D+KPSN+L++      ++DFG++++L    Q+M  
Sbjct: 177 ------ILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILA---QTMDP 224

Query: 687 -TQTLATIGYMAPEYGREGQVSTN----------GDVYSFGIMLMETFTRKKP 728
              ++ TI YM+PE     +++T+          GD++S G+ ++E +  + P
Sbjct: 225 CNSSVGTIAYMSPE-----RINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272

Length = 353

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 75.7 bits (187), Expect = 4e-15
 Identities = 64/246 (26%), Positives = 98/246 (39%), Gaps = 44/246 (17%)

Query: 535 IGRGGFGSVYKAR-IRDGMEVAVK------VFNLQCGRAFKSFDVECAMMKSIRHRNLVK 587
           +G GGFG V   +        A+K      +          S   E  +++   H  +VK
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFS---EKEILEECNHPFIVK 57

Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAP 647
           +  +  ++++  +++EY   G L   L       D +     +  V  A EYLH   +  
Sbjct: 58  LYRTFKDKKYIYMLMEYCLGGELWTILRDRG-LFDEYTARFYIACVVLAFEYLH---NRG 113

Query: 648 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTL-ATIGYMAPEYGREGQV 706
           +I+ DLKP N+LLD N    L DFG AK L    +S  +T T   T  Y+APE      +
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKL----KSGQKTWTFCGTPEYVAPE-----II 164

Query: 707 STNG-----DVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLS 761
              G     D +S GI+L E  T + P    F  +        D  P+     +   L  
Sbjct: 165 LNKGYDFSVDYWSLGILLYELLTGRPP----FGED--------DEDPMEIYNDI---LKG 209

Query: 762 QEDIHF 767
              + F
Sbjct: 210 NGKLEF 215

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 77.1 bits (190), Expect = 5e-15
 Identities = 62/218 (28%), Positives = 101/218 (46%), Gaps = 23/218 (10%)

Query: 535 IGRGGFGSVYKARIRDGME-VAVKVFN---LQCGRAFKSFDVECAMMKSIRHRNLVKVIS 590
           +G+GG+G V+ A+ +D  E VA+K      L      +    E  ++ + +   LVK++ 
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68

Query: 591 SCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLH-FGYSAPVI 649
           +  ++E+  L +EY+P G     L++    L        M ++  A++ LH  GY    I
Sbjct: 69  AFQDDEYLYLAMEYVPGGDFRTLLNNLG-VLSEDHARFYMAEMFEAVDALHELGY----I 123

Query: 650 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTN 709
           H DLKP N L+D +    L+DFG++K +     S+     + +  YMAPE  R       
Sbjct: 124 HRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSV-----VGSPDYMAPEVLRGKGYDFT 178

Query: 710 GDVYSFGIMLMETFTRKKP-----TDELFNGEMTLKHW 742
            D +S G ML E      P      +E +     LK+W
Sbjct: 179 VDYWSLGCMLYEFLCGFPPFSGSTPNETWE---NLKYW 213

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 75.8 bits (186), Expect = 6e-15
 Identities = 68/307 (22%), Positives = 125/307 (40%), Gaps = 64/307 (20%)

Query: 535 IGRGGFGSVYKA-----RIRDGME-VAVKVFNLQCGRA-FKSFDVECAMMKSIRHRNLVK 587
           +G G FG V KA     + R G   VAVK+       +  +    E  ++K + H +++K
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYL-----------------------HSSNYSLDIF 624
           +  +CS +    L++EY  +GSL  +L                       +    +L + 
Sbjct: 68  LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127

Query: 625 QRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM 684
             ++    ++  ++YL       ++H DL   NVL+ +     +SDFG+++ +  ED  +
Sbjct: 128 DLISFAWQISRGMQYLA---EMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184

Query: 685 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKK------PTDELFNGEMT 738
            +++    + +MA E   +   +T  DV+SFG++L E  T           + LFN    
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFN---- 240

Query: 739 LKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEI 798
                                L +        E C   ++NL L C  + P++R    +I
Sbjct: 241 ---------------------LLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADI 279

Query: 799 VAKLLKI 805
             +L K+
Sbjct: 280 SKELEKM 286

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 78.7 bits (194), Expect = 7e-15
 Identities = 54/186 (29%), Positives = 85/186 (45%), Gaps = 16/186 (8%)

Query: 551 GMEVAVKVFNLQCG---RAFKSFDVECAMMKSIRHRNLVKVISSCSNEE-FKALVLEYMP 606
           G EVA+K+              F  E A+   + H N+V ++ S          V EY+P
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62

Query: 607 HGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL---DDN 663
             +L + L +   +L   +   +M+ V  AL   H   +  ++H DLKP N+++      
Sbjct: 63  GRTLREVLAADG-ALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQTGVR 118

Query: 664 MVAHLSDFGIAKLLTGEDQSMTQTQTLAT--IG---YMAPEYGREGQVSTNGDVYSFGIM 718
             A + DFGI  LL G   +   T T  T  +G   Y APE  R   V+ N D+Y++G++
Sbjct: 119 PHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLI 178

Query: 719 LMETFT 724
            +E  T
Sbjct: 179 FLECLT 184

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 75.9 bits (186), Expect = 7e-15
 Identities = 73/264 (27%), Positives = 116/264 (43%), Gaps = 28/264 (10%)

Query: 528 KFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLV 586
           K++    IG+G  G+VY A  +  G EVA++  NLQ     +    E  +M+  ++ N+V
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80

Query: 587 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSA 646
             + S    +   +V+EY+  GSL   +  +   +D  Q   +  +   ALE+LH   S 
Sbjct: 81  NYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SN 135

Query: 647 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQV 706
            VIH D+K  N+LL  +    L+DFG    +T E     ++  + T  +MAPE       
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAY 193

Query: 707 STNGDVYSFGIMLMETFTRKKP-----------------TDELFNGE---MTLKHWVNDC 746
               D++S GIM +E    + P                 T EL N E      + ++N C
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253

Query: 747 LPISTMEVVDANLLSQEDIHFVAK 770
           L +   +   A  L Q     +AK
Sbjct: 254 LDMDVEKRGSAKELLQHQFLKIAK 277

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 76.2 bits (188), Expect = 8e-15
 Identities = 64/222 (28%), Positives = 104/222 (46%), Gaps = 33/222 (14%)

Query: 523 FQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKV---FNLQ--CGRAFKSFDVECAM 576
           F    ++   + IG G +G V  A  +  G++VA+K    F  Q  C R  +    E  +
Sbjct: 1   FDVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR----EIKI 56

Query: 577 MKSIRHRNLVK---VISSCSNEEFKA--LVLEYMPHGSLEKYLHSSNYSLD-----IFQR 626
           ++  +H N++    +I   S E F    +V E M    L K + + + S D     ++Q 
Sbjct: 57  LRRFKHENIIGILDIIRPPSFESFNDVYIVQELME-TDLYKLIKTQHLSNDHIQYFLYQI 115

Query: 627 LNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT-GEDQSMT 685
           L         L+Y+H   SA V+H DLKPSN+LL+ N    + DFG+A++     D +  
Sbjct: 116 LR-------GLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGF 165

Query: 686 QTQTLATIGYMAPEYG-REGQVSTNGDVYSFGIMLMETFTRK 726
            T+ +AT  Y APE        +   D++S G +L E  + +
Sbjct: 166 LTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 75.6 bits (186), Expect = 9e-15
 Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 23/211 (10%)

Query: 527 DKFSENNLIGRGGFGSVYKARIRDGME-VAVKVFNLQ---CGRAFKSFDVECAMMKSIRH 582
           D       +G G FG V+  R R      A+KV  +      +  +    E  ++K + H
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60

Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSS---NYSLDIFQRLNIMIDVASALEY 639
             ++++  +  ++ F  +++EY+P G L  YL +S   + S  +F    I+     ALEY
Sbjct: 61  PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIV----CALEY 116

Query: 640 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTL-ATIGYMAP 698
           LH   S  +++ DLKP N+LLD      L+DFG AK L        +T TL  T  Y+AP
Sbjct: 117 LH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKL------RDRTWTLCGTPEYLAP 167

Query: 699 E-YGREGQVSTNGDVYSFGIMLMETFTRKKP 728
           E    +G  +   D ++ GI++ E      P
Sbjct: 168 EVIQSKGH-NKAVDWWALGILIYEMLVGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 75.1 bits (184), Expect = 1e-14
 Identities = 66/204 (32%), Positives = 101/204 (49%), Gaps = 12/204 (5%)

Query: 528 KFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLV 586
           K++    IG+G  G+V+ A  +  G EVA+K  NLQ     +    E  +MK +++ N+V
Sbjct: 20  KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIV 79

Query: 587 KVISS--CSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGY 644
             + S    +E F  +V+EY+  GSL   +  +   +D  Q   +  +   ALE+LH   
Sbjct: 80  NFLDSFLVGDELF--VVMEYLAGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLH--- 132

Query: 645 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG 704
           +  VIH D+K  NVLL  +    L+DFG    +T E QS   T  + T  +MAPE     
Sbjct: 133 ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE-QSKRSTM-VGTPYWMAPEVVTRK 190

Query: 705 QVSTNGDVYSFGIMLMETFTRKKP 728
                 D++S GIM +E    + P
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 75.5 bits (186), Expect = 1e-14
 Identities = 55/221 (24%), Positives = 101/221 (45%), Gaps = 34/221 (15%)

Query: 527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDV----ECAMMKSIR 581
            K+ +   IG+G FG V+KAR +     VA+K   +      + F +    E  +++ ++
Sbjct: 12  SKYEKLAKIGQGTFGEVFKARHKKTKQIVALK--KVLMENEKEGFPITALREIKILQLLK 69

Query: 582 HRNLVKVISSCSNE-----EFKA---LVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDV 633
           H N+V +I  C  +      +K    LV E+  H  L   L + N    + +   +M  +
Sbjct: 70  HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKML 128

Query: 634 ASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK--LLTGEDQSMTQTQTLA 691
            + L Y+H      ++H D+K +N+L+  + +  L+DFG+A+   L+   +    T  + 
Sbjct: 129 LNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV 185

Query: 692 TIGYMAPE-------YGREGQVSTNGDVYSFGIMLMETFTR 725
           T+ Y  PE       YG         D++  G ++ E +TR
Sbjct: 186 TLWYRPPELLLGERDYG------PPIDMWGAGCIMAEMWTR 220

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 75.0 bits (184), Expect = 1e-14
 Identities = 64/241 (26%), Positives = 103/241 (42%), Gaps = 36/241 (14%)

Query: 525 ATDKFSENNLIGRGGFGSVYKARIRDGME---------VAVKVFNLQCG-RAFKSFDVEC 574
             D+      +G G FG V  A    G++         VAVK+       +       E 
Sbjct: 16  PRDRLVLGKPLGEGCFGQVVMAEAI-GLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEM 74

Query: 575 AMMKSI-RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYL---------------HSSN 618
            MMK I +H+N++ ++ +C+ +    +++EY   G+L +YL                   
Sbjct: 75  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPE 134

Query: 619 YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 678
             L     ++    VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ + 
Sbjct: 135 EQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 191

Query: 679 GEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKK------PTDEL 732
             D     T     + +MAPE   +   +   DV+SFG++L E FT         P +EL
Sbjct: 192 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 251

Query: 733 F 733
           F
Sbjct: 252 F 252

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 74.7 bits (183), Expect = 1e-14
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 15/214 (7%)

Query: 521 ELFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFNLQCGR-AFKSFDVECAMMK 578
           ELF   +K      IG+G FG V+K    R    VA+K+ +L+      +    E  ++ 
Sbjct: 4   ELFTKLEK------IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLS 57

Query: 579 SIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALE 638
                 + K   S   +    +++EY+  GS    L      LD  Q   I+ ++   L+
Sbjct: 58  QCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG--PLDETQIATILREILKGLD 115

Query: 639 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 698
           YLH   S   IH D+K +NVLL ++    L+DFG+A  LT  D  + +   + T  +MAP
Sbjct: 116 YLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAP 170

Query: 699 EYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEL 732
           E  ++    +  D++S GI  +E    + P  EL
Sbjct: 171 EVIKQSAYDSKADIWSLGITAIELAKGEPPHSEL 204

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 74.2 bits (182), Expect = 2e-14
 Identities = 57/207 (27%), Positives = 88/207 (42%), Gaps = 22/207 (10%)

Query: 535 IGRGGFGSVYKARIRDGMEVA-VKVFNLQCGRAFK---SFDVECAMMKSIRHRNLVKVIS 590
           IG G FG V       GM  A V V  L+          F  E    + + H N+++ + 
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 591 SCSNEEFKALVLEYMPHGSLEKYLHSSNYSL------DIFQRLNIMIDVASALEYLHFGY 644
            C       LVLE+ P G L+ YL S+   +      D+ QR+    +VAS L +LH   
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRM--ACEVASGLLWLH--- 117

Query: 645 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG 704
            A  IH DL   N  L  ++   + D+G+A     ED  +T+      + ++APE     
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177

Query: 705 Q-------VSTNGDVYSFGIMLMETFT 724
                    +   +++S G+ + E FT
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWELFT 204

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 73.6 bits (181), Expect = 2e-14
 Identities = 59/239 (24%), Positives = 109/239 (45%), Gaps = 16/239 (6%)

Query: 535 IGRGGFGS--VYKARIRDGMEVAVKVFNLQCGRAFKSFDV--ECAMMKSIRHRNLVKVIS 590
           +G+G FG   +Y+ R  D   V  K  NL      +  D   E  ++  ++H N++   +
Sbjct: 8   LGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66

Query: 591 SCSNEEFKALVLEYMPHGSL-EKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVI 649
              ++    + +EY   G+L +K +       +    L  +  + SA+ Y+H    A ++
Sbjct: 67  HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGIL 123

Query: 650 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTN 709
           H D+K  N+ L    +  L DFGI+K+L G + SM +T  + T  YM+PE  +  + +  
Sbjct: 124 HRDIKTLNIFLTKAGLIKLGDFGISKIL-GSEYSMAET-VVGTPYYMSPELCQGVKYNFK 181

Query: 710 GDVYSFGIMLMETFTRKKPTD-----ELFNGEMTLKHWVNDCLPISTMEVVDANLLSQE 763
            D+++ G +L E  T K+  D      L    +   +     +  S +  +  +LL Q+
Sbjct: 182 SDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQD 240

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 73.9 bits (181), Expect = 2e-14
 Identities = 66/222 (29%), Positives = 99/222 (44%), Gaps = 43/222 (19%)

Query: 534 LIGRGGFGSVYKARIRD-GMEVAVKV--FNLQCGRAFK---SFDVECAMMKSIRHRNLVK 587
           L+GRG FG VY     D G E+AVK   F+       K   + + E  ++K++RH  +V+
Sbjct: 9   LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68

Query: 588 VISSCSNEEFKALVL--EYMPHGSLEKYLH---------SSNYSLDIFQRLNIMIDVASA 636
                 + E K L +  EYMP GS++  L          +  Y+  I Q           
Sbjct: 69  YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQ----------G 118

Query: 637 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGY- 695
           + YLH   S  ++H D+K +N+L D      L DFG +K +     S T  +++    Y 
Sbjct: 119 VSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYW 175

Query: 696 MAPE------YGREGQVSTNGDVYSFGIMLMETFTRKKPTDE 731
           M+PE      YGR+       DV+S    ++E  T K P  E
Sbjct: 176 MSPEVISGEGYGRK------ADVWSVACTVVEMLTEKPPWAE 211

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 74.3 bits (183), Expect = 2e-14
 Identities = 62/208 (29%), Positives = 98/208 (47%), Gaps = 20/208 (9%)

Query: 529 FSENNLIGRGGFGSVYKARIRDGMEVA----VKVFNLQCGRAFKSFDVECAMMKSIRHRN 584
           F + N IG G +G VY+AR     E+     V++ N + G    S   E  ++ ++RH N
Sbjct: 9   FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLNLRHPN 67

Query: 585 LVK----VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
           +V+    V+    +  F  LV+EY     L   L +        Q   +M+ +   L+YL
Sbjct: 68  IVELKEVVVGKHLDSIF--LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYL 124

Query: 641 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPE- 699
           H  +   +IH DLK SN+LL D     ++DFG+A+      + M  T  + T+ Y APE 
Sbjct: 125 HENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM--TPKVVTLWYRAPEL 179

Query: 700 -YGREGQVSTNGDVYSFGIMLMETFTRK 726
             G     +T  D+++ G +L E    K
Sbjct: 180 LLGCTTY-TTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 74.4 bits (182), Expect = 2e-14
 Identities = 64/202 (31%), Positives = 98/202 (48%), Gaps = 8/202 (3%)

Query: 528 KFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLV 586
           K++    IG+G  G+VY A  I  G EVA+K  NLQ     +    E  +M+  ++ N+V
Sbjct: 20  KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIV 79

Query: 587 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSA 646
             + S    +   +V+EY+  GSL   +  +   +D  Q   +  +   AL++LH   S 
Sbjct: 80  NYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLH---SN 134

Query: 647 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQV 706
            VIH D+K  N+LL  +    L+DFG    +T E QS   T  + T  +MAPE       
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-QSKRSTM-VGTPYWMAPEVVTRKAY 192

Query: 707 STNGDVYSFGIMLMETFTRKKP 728
               D++S GIM +E    + P
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 76.1 bits (187), Expect = 2e-14
 Identities = 66/221 (29%), Positives = 99/221 (44%), Gaps = 29/221 (13%)

Query: 534 LIGRGGFGSV-YKARIRDGMEVAVKVFNLQ------CGRAFKSFDVECAM---MKSIR-- 581
           ++G G  G+V    R+ DG   AVKV +++        RA    +V C +     SI   
Sbjct: 39  VLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRA--QAEVCCLLNCDFFSIVKC 96

Query: 582 HRNLVKVISSCSNEE---FKALVLEYMPHGSLEKYLHSSNYSLDIFQRLN---IMIDVAS 635
           H +  K      N E     ALVL+Y   G L + + S   +   F+      + I V  
Sbjct: 97  HEDFAK--KDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLL 154

Query: 636 ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGY 695
           A+ ++H   S  +IH D+K +N+LL  N +  L DFG +K+               T  Y
Sbjct: 155 AVHHVH---SKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYY 211

Query: 696 MAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGE 736
           +APE  R    S   D++S G++L E  T K+P    F+GE
Sbjct: 212 VAPEIWRRKPYSKKADMFSLGVLLYELLTLKRP----FDGE 248

Length = 496

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 73.9 bits (181), Expect = 3e-14
 Identities = 58/214 (27%), Positives = 99/214 (46%), Gaps = 15/214 (7%)

Query: 521 ELFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFNLQCGR-AFKSFDVECAMMK 578
           ELF   ++      IG+G FG V+K    R    VA+K+ +L+      +    E  ++ 
Sbjct: 4   ELFTKLER------IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLS 57

Query: 579 SIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALE 638
                 + K   S        +++EY+  GS    L +  +  D FQ   ++ ++   L+
Sbjct: 58  QCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPF--DEFQIATMLKEILKGLD 115

Query: 639 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 698
           YLH   S   IH D+K +NVLL +     L+DFG+A  LT  D  + +   + T  +MAP
Sbjct: 116 YLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAP 170

Query: 699 EYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEL 732
           E  ++    +  D++S GI  +E    + P  ++
Sbjct: 171 EVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM 204

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 73.9 bits (181), Expect = 3e-14
 Identities = 56/208 (26%), Positives = 96/208 (46%), Gaps = 19/208 (9%)

Query: 535 IGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCS 593
           +G G FG VYKA+ ++ G   A KV   +     + + VE  ++ +  H  +VK++ +  
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 594 NEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 653
            +    +++E+ P G+++  +   +  L       I +     LE L + +S  +IH DL
Sbjct: 80  WDGKLWIMIEFCPGGAVDAIMLELDRGL---TEPQIQVICRQMLEALQYLHSMKIIHRDL 136

Query: 654 KPSNVLLDDNMVAHLSDFGIA----KLLTGEDQSMTQTQTLATIGYMAPEY-----GREG 704
           K  NVLL  +    L+DFG++    K L   D        + T  +MAPE       ++ 
Sbjct: 137 KAGNVLLTLDGDIKLADFGVSAKNVKTLQRRD------SFIGTPYWMAPEVVMCETMKDT 190

Query: 705 QVSTNGDVYSFGIMLMETFTRKKPTDEL 732
                 D++S GI L+E    + P  EL
Sbjct: 191 PYDYKADIWSLGITLIEMAQIEPPHHEL 218

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 74.2 bits (182), Expect = 3e-14
 Identities = 51/183 (27%), Positives = 95/183 (51%), Gaps = 15/183 (8%)

Query: 554 VAVKVFNLQCGR-AFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEK 612
           VAVK+      + A   F  E  +M  +++ N+++++  C +++   ++ EYM +G L +
Sbjct: 47  VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQ 106

Query: 613 YL----------HSSNY-SLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD 661
           +L          H++N  S+ I   L + + +AS ++YL    S   +H DL   N L+ 
Sbjct: 107 FLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCLVG 163

Query: 662 DNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLME 721
           ++    ++DFG+++ L   D    Q + +  I +MA E    G+ +T  DV++FG+ L E
Sbjct: 164 NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWE 223

Query: 722 TFT 724
            FT
Sbjct: 224 MFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 74.3 bits (183), Expect = 4e-14
 Identities = 78/287 (27%), Positives = 127/287 (44%), Gaps = 68/287 (23%)

Query: 523 FQATDKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKS-FDV-----ECA 575
           F+   K+     IGRG +G V  A+  +   +VA+K    +   AF +  D      E  
Sbjct: 1   FEVDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIK----KIANAFDNRIDAKRTLREIK 56

Query: 576 MMKSIRHRNLVK---VISSCSNEEFKA--LVLEYMPHGSLEKYLHS---SNYSLD----- 622
           +++ + H N++    ++     E F    +V E M     +  LH    S+ +L      
Sbjct: 57  LLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELM-----DTDLHQIIRSSQTLSDDHCQ 111

Query: 623 --IFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE 680
             ++Q L         L+Y+H   SA V+H DLKPSN+LL+ N    + DFG+A+  + +
Sbjct: 112 YFLYQLLR-------GLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK 161

Query: 681 DQSMTQTQTLATIGYMAPE-------YGREGQVSTNGDVYSFGIMLMETFTRKKPTDELF 733
              M  T+ + T  Y APE       Y       T  DV+S G +  E   RK     LF
Sbjct: 162 GDFM--TEYVVTRWYRAPELLLNCSEYT------TAIDVWSVGCIFAELLGRKP----LF 209

Query: 734 NGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNL 780
            G    K +V+    I   E++ +   S+ED+ F+  E+   ++ +L
Sbjct: 210 PG----KDYVHQLKLI--TELLGSP--SEEDLGFIRNEKARRYIRSL 248

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 73.6 bits (180), Expect = 4e-14
 Identities = 63/210 (30%), Positives = 101/210 (48%), Gaps = 25/210 (11%)

Query: 523 FQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC--GRAFKSFDVECAMMKS 579
           F   D + +   +G G + +VYK + + +G  VA+KV  LQ   G  F +   E +++K 
Sbjct: 1   FGKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKG 59

Query: 580 IRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKY-------LHSSNYSLDIFQRLNIMID 632
           ++H N+V +      +E   LV EY+ H  L +Y       LH  N  L +FQ L     
Sbjct: 60  LKHANIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLLR---- 114

Query: 633 VASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLAT 692
               L Y+H  Y   ++H DLKP N+L+ D     L+DFG+A+       S T +  + T
Sbjct: 115 ---GLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTYSNEVVT 166

Query: 693 IGYMAPE-YGREGQVSTNGDVYSFGIMLME 721
           + Y  P+      + ST  D++  G + +E
Sbjct: 167 LWYRPPDVLLGSTEYSTCLDMWGVGCIFVE 196

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 73.3 bits (181), Expect = 4e-14
 Identities = 65/215 (30%), Positives = 100/215 (46%), Gaps = 34/215 (15%)

Query: 535 IGRGGFGSVYKARIRDGME-VAVKVFNLQCGRAFKSFDVECAMM---KSIR----HRNLV 586
           +G G FGSVY AR ++  E VA+K       + F S++ EC  +   KS+R    H N+V
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMK----KKFYSWE-ECMNLREVKSLRKLNEHPNIV 61

Query: 587 K---VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLH-F 642
           K   V     N+E    V EYM     +                +I+  +   L ++H  
Sbjct: 62  KLKEVFRE--NDELY-FVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH 118

Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM-TQTQTLATIGYMAPE-Y 700
           G+     H DLKP N+L+    V  ++DFG+A+    E +S    T  ++T  Y APE  
Sbjct: 119 GF----FHRDLKPENLLVSGPEVVKIADFGLAR----EIRSRPPYTDYVSTRWYRAPEIL 170

Query: 701 GREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNG 735
            R    S+  D+++ G ++ E +T  +P   LF G
Sbjct: 171 LRSTSYSSPVDIWALGCIMAELYTL-RP---LFPG 201

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 73.7 bits (181), Expect = 4e-14
 Identities = 64/194 (32%), Positives = 92/194 (47%), Gaps = 15/194 (7%)

Query: 535 IGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAM------MKSIRHRNLVK 587
           IG+G FG V  A+ + DG   AVKV  LQ     K  + +  M      +K+++H  LV 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKV--LQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAP 647
           +  S    +    VL+Y+  G L  +L       +   R     ++ASAL YLH   S  
Sbjct: 61  LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIASALGYLH---SLN 116

Query: 648 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVS 707
           +I+ DLKP N+LLD      L+DFG+ K   G + S T +    T  Y+APE  R+    
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEYLAPEVLRKQPYD 174

Query: 708 TNGDVYSFGIMLME 721
              D +  G +L E
Sbjct: 175 RTVDWWCLGAVLYE 188

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 72.7 bits (179), Expect = 5e-14
 Identities = 66/212 (31%), Positives = 100/212 (47%), Gaps = 21/212 (9%)

Query: 535 IGRGGFGSVYKAR-IRDGMEVAVKVFNL-QCGRAFKSFDV-ECAMMKSIRHRNLVKVISS 591
           IG G +G VYKAR    G  VA+K   L        S  + E +++K + H N+V+++  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66

Query: 592 CSNEEFKALVLEYMPHGSLEKYL-HSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIH 650
             +E    LV E++    L+KY+  S    LD     + +  +   + Y H   S  V+H
Sbjct: 67  VHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLH 122

Query: 651 CDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY---GREGQVS 707
            DLKP N+L+D      L+DFG+A+      +  T T  + T+ Y APE     R  Q S
Sbjct: 123 RDLKPQNLLIDREGALKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGSR--QYS 178

Query: 708 TNGDVYSFGIMLMETFTRK------KPTDELF 733
           T  D++S G +  E   R+         D+LF
Sbjct: 179 TPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLF 210

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 72.8 bits (178), Expect = 6e-14
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 12/201 (5%)

Query: 535 IGRGGFGSVYKAR-IRDGMEVAVK---VFNLQCGRAFKSFDVECAMMKSIRHRNLVKVIS 590
           IGRG F  VY+A  + D   VA+K   +F +   +A +    E  ++K + H N++K + 
Sbjct: 10  IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69

Query: 591 SCSNEEFKALVLEYMPHGSLEKYL-HSSNYSLDIFQRL--NIMIDVASALEYLHFGYSAP 647
           S   +    +VLE    G L + + +       I +R      + + SA+E++H   S  
Sbjct: 70  SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRR 126

Query: 648 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVS 707
           V+H D+KP+NV +    V  L D G+ +  + +  +      + T  YM+PE   E   +
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--TTAAHSLVGTPYYMSPERIHENGYN 184

Query: 708 TNGDVYSFGIMLMETFTRKKP 728
              D++S G +L E    + P
Sbjct: 185 FKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 72.4 bits (177), Expect = 6e-14
 Identities = 63/234 (26%), Positives = 99/234 (42%), Gaps = 40/234 (17%)

Query: 513 TWRRFSYLELFQATDKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNL-----QCGRA 566
            WRR                 L+G+G FG VY     D G E+A K         +  + 
Sbjct: 3   NWRR---------------GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKE 47

Query: 567 FKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALV--LEYMPHGSLEKYLHSSNYSLDIF 624
             + + E  ++K+++H  +V+      +   K L   +EYMP GS++  L +     +  
Sbjct: 48  VSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESV 107

Query: 625 QRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM 684
            R      +   + YLH   S  ++H D+K +N+L D      L DFG +K L     S 
Sbjct: 108 TR-KYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSG 163

Query: 685 TQTQTLATIGY-MAPE------YGREGQVSTNGDVYSFGIMLMETFTRKKPTDE 731
           T  +++    Y M+PE      YGR+       DV+S G  ++E  T K P  E
Sbjct: 164 TGIRSVTGTPYWMSPEVISGEGYGRK------ADVWSLGCTVVEMLTEKPPWAE 211

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 73.1 bits (180), Expect = 7e-14
 Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 29/215 (13%)

Query: 535 IGRGGFGSVYKAR-IRDGMEVAVK---VFNLQCGRAFKSFDVECAMMKSIRHRNLVK--- 587
           +G G FG VYKAR I+ G  VA+K   + N + G    +   E  ++K ++H N+V    
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILKKLKHPNVVPLID 74

Query: 588 -VISSCSNEEFKA----LVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
             +      + K     +V  YM H  L   L + +  L   Q    M+ +   + YLH 
Sbjct: 75  MAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLH- 132

Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQ---------TQTLATI 693
                ++H D+K +N+L+D+  +  ++DFG+A+   G   +            T  + T 
Sbjct: 133 --ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTR 190

Query: 694 GYMAPEY--GREGQVSTNGDVYSFGIMLMETFTRK 726
            Y  PE   G E + +T  D++  G +  E FTR+
Sbjct: 191 WYRPPELLLG-ERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 72.5 bits (178), Expect = 8e-14
 Identities = 68/220 (30%), Positives = 109/220 (49%), Gaps = 20/220 (9%)

Query: 527 DKFSENNLIGRGGFGSVYKARIRDGME-VAVKVFNL-QCGRAFKSFDV-ECAMMKSIRHR 583
           D++ +   IG G +G VYKAR R   E +A+K   L Q      S  + E +++K ++H 
Sbjct: 2   DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61

Query: 584 NLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSS-NYSLDIFQRLNIMIDVASALEYLHF 642
           N+V++     +E+   LV EY+    L+K++ SS +++ +       +  +   + Y H 
Sbjct: 62  NIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH- 119

Query: 643 GYSAPVIHCDLKPSNVLLDDNMVA-HLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPE-- 699
             S  V+H DLKP N+L+D    A  L+DFG+A+      +  T T  + T+ Y APE  
Sbjct: 120 --SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR--TFTHEVVTLWYRAPEIL 175

Query: 700 YGREGQVSTNGDVYSFGIMLMETFTRK------KPTDELF 733
            G     ST  D++S G +  E   +K         DELF
Sbjct: 176 LGSR-HYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELF 214

Length = 294

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 71.9 bits (176), Expect = 9e-14
 Identities = 54/204 (26%), Positives = 89/204 (43%), Gaps = 18/204 (8%)

Query: 535 IGRGGFGSVYKARIRDGM---EVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVKVIS 590
           IG G FG V    +  G    +V VK   +    +    F  E    +S++H NL++ + 
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 591 SCSNEEFKALVLEYMPHGSLEKYLHS----SNYSLDIFQRLNIMIDVASALEYLHFGYSA 646
            C+      LV+E+ P G L+ YL S       + D      +  ++A  L +LH     
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KN 119

Query: 647 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE--G 704
             IH DL   N LL  ++   + D+G++     ED  +T  Q    + ++APE   E  G
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHG 179

Query: 705 QV-----STNGDVYSFGIMLMETF 723
            +     +   +V+S G+ + E F
Sbjct: 180 NLLVVDQTKESNVWSLGVTIWELF 203

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 72.4 bits (177), Expect = 1e-13
 Identities = 71/224 (31%), Positives = 101/224 (45%), Gaps = 23/224 (10%)

Query: 521 ELFQATDK---FSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNL---QCGRAFKSFDVE 573
           ELF   D    FS+   IG G FG+VY AR +R+   VA+K  +    Q    ++    E
Sbjct: 6   ELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKE 65

Query: 574 CAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDV 633
              ++ +RH N ++       E    LV+EY   GS    L      L   Q + I    
Sbjct: 66  VRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPL---QEVEIAAVT 121

Query: 634 ASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATI 693
             AL+ L + +S  +IH D+K  N+LL +  +  L DFG A ++   +        + T 
Sbjct: 122 HGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN------XFVGTP 175

Query: 694 GYMAPEY---GREGQVSTNGDVYSFGIMLMETFTRKKPTDELFN 734
            +MAPE      EGQ     DV+S GI  +E   RK P   LFN
Sbjct: 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP---LFN 216

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 72.4 bits (177), Expect = 1e-13
 Identities = 65/214 (30%), Positives = 107/214 (50%), Gaps = 24/214 (11%)

Query: 535 IGRGGFGSVYKAR-IRDGME-VAVKVFNLQCGRAFKSFDV--ECAMMK---SIRHRNLVK 587
           IG G +G V+KAR +++G   VA+K   +Q G          E A+++   +  H N+V+
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 588 VISSCS----NEEFK-ALVLEYMPHGSLEKYLHSS-NYSLDIFQRLNIMIDVASALEYLH 641
           +   C+    + E K  LV E++    L  YL       +      ++M  +   L++LH
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127

Query: 642 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYG 701
              S  V+H DLKP N+L+  +    L+DFG+A++ + +   M  T  + T+ Y APE  
Sbjct: 128 ---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVL 181

Query: 702 REGQVSTNGDVYSFGIMLMETFTRKKPTDELFNG 735
            +   +T  D++S G +  E F R+KP   LF G
Sbjct: 182 LQSSYATPVDLWSVGCIFAEMF-RRKP---LFRG 211

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 72.5 bits (178), Expect = 1e-13
 Identities = 60/235 (25%), Positives = 96/235 (40%), Gaps = 41/235 (17%)

Query: 532 NNLIGRGGFGSVYKAR-IRDGMEVAVKVFNL---------------QCGRAFKSFDVECA 575
              +G G +G V KA     G  VA+K   +                CG  F +   E  
Sbjct: 14  GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLR-ELK 72

Query: 576 MMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVAS 635
           +M  I+H N++ ++      +F  LV++ M    L+K +      L   Q   I++ + +
Sbjct: 73  IMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVV-DRKIRLTESQVKCILLQILN 130

Query: 636 ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK-------LLTGEDQSMTQ-- 686
            L  LH  Y    +H DL P+N+ ++   +  ++DFG+A+         T       Q  
Sbjct: 131 GLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRR 187

Query: 687 ---TQTLATIGYMAPE--YGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGE 736
              T  + T+ Y APE   G E +     D++S G +  E  T K     LF GE
Sbjct: 188 EEMTSKVVTLWYRAPELLMGAE-KYHFAVDMWSVGCIFAELLTGKP----LFPGE 237

Length = 335

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 74.1 bits (182), Expect = 2e-13
 Identities = 36/82 (43%), Positives = 49/82 (59%)

Query: 206 NCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSI 265
           N  + G IP +I+ L  L +I L GN + G+IP +LG +  L+ +DL YN   GSIP+S+
Sbjct: 427 NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESL 486

Query: 266 CLSVELYELELGGNKLSGSIPA 287
                L  L L GN LSG +PA
Sbjct: 487 GQLTSLRILNLNGNSLSGRVPA 508

Length = 623

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 71.1 bits (174), Expect = 2e-13
 Identities = 49/197 (24%), Positives = 92/197 (46%), Gaps = 17/197 (8%)

Query: 534 LIGRGGFGSVYKARI----RDGMEVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVKV 588
           ++G G FG + +  +    +  + VA+      C  +  + F  E   +    H N+V++
Sbjct: 12  ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71

Query: 589 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL-HFGYSAP 647
               +      +V EYM +G+L+ +L      L   Q + ++  +AS ++YL   GY   
Sbjct: 72  EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGY--- 128

Query: 648 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTL---ATIGYMAPEYGREG 704
            +H  L    VL++ ++V  +S F   +    ED+S     T+   + + + APE  +  
Sbjct: 129 -VHKGLAAHKVLVNSDLVCKISGFRRLQ----EDKSEAIYTTMSGKSPVLWAAPEAIQYH 183

Query: 705 QVSTNGDVYSFGIMLME 721
             S+  DV+SFGI++ E
Sbjct: 184 HFSSASDVWSFGIVMWE 200

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 70.8 bits (173), Expect = 2e-13
 Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 16/202 (7%)

Query: 535 IGRGGFGSVYKARIR-DGMEVAVKVFNLQCG--RAFKSFDVECAMMKSIRHRNLVKVISS 591
           IG G FG +Y A+ + D     +K  +L     +  ++   E  ++  ++H N+V   +S
Sbjct: 8   IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67

Query: 592 CSNEEFKALVLEYMPHGSLEKYL---HSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPV 648
                   +V+EY   G L K +       +S D  Q L+  + ++  L+++H      +
Sbjct: 68  FQENGRLFIVMEYCDGGDLMKRINRQRGVLFSED--QILSWFVQISLGLKHIH---DRKI 122

Query: 649 IHCDLKPSNVLLDDN-MVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGQV 706
           +H D+K  N+ L  N MVA L DFGIA+ L   + SM    T   T  Y++PE  +    
Sbjct: 123 LHRDIKSQNIFLSKNGMVAKLGDFGIARQL---NDSMELAYTCVGTPYYLSPEICQNRPY 179

Query: 707 STNGDVYSFGIMLMETFTRKKP 728
           +   D++S G +L E  T K P
Sbjct: 180 NNKTDIWSLGCVLYELCTLKHP 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 71.8 bits (177), Expect = 2e-13
 Identities = 76/233 (32%), Positives = 111/233 (47%), Gaps = 56/233 (24%)

Query: 535 IGRGGFGSVYKAR-IRDGMEVAVK-VF----NLQ-CGRAFKSFDVECAMMKSIR-HRNLV 586
           +G+G +G V+KA   R    VA+K +F    N     R F+    E   ++ +  H N+V
Sbjct: 15  LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFR----EIMFLQELGDHPNIV 70

Query: 587 KVISSCSNEEFKA-------LVLEYMPHGSLEKYLHS---SNYSLDIFQRLNIMIDVASA 636
           K+++       KA       LV EYM     E  LH+   +N   D+ +R  IM  +  A
Sbjct: 71  KLLNV-----IKAENDKDIYLVFEYM-----ETDLHAVIRANILEDVHKRY-IMYQLLKA 119

Query: 637 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT---GEDQSMTQTQTLATI 693
           L+Y+H   S  VIH DLKPSN+LL+ +    L+DFG+A+ L+      ++   T  +AT 
Sbjct: 120 LKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATR 176

Query: 694 GYMAPE-------YGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTL 739
            Y APE       Y      +   D++S G +L E     KP   LF G  TL
Sbjct: 177 WYRAPEILLGSTRY------TKGVDMWSVGCILGEML-LGKP---LFPGTSTL 219

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 70.9 bits (174), Expect = 2e-13
 Identities = 47/144 (32%), Positives = 77/144 (53%), Gaps = 7/144 (4%)

Query: 535 IGRGGFGSVYKARIRDGME-VAVKVFNLQ-CGRAFKSFDV-ECAMMKSIRHRNLVKVISS 591
           IG G +G+V+KA+ R+  E VA+K   L        S  + E  ++K ++H+N+V++   
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67

Query: 592 CSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHC 651
             +++   LV EY     L+KY  S N  +D     + M  +   L + H   S  V+H 
Sbjct: 68  LHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHR 123

Query: 652 DLKPSNVLLDDNMVAHLSDFGIAK 675
           DLKP N+L++ N    L+DFG+A+
Sbjct: 124 DLKPQNLLINKNGELKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 70.9 bits (174), Expect = 3e-13
 Identities = 66/213 (30%), Positives = 100/213 (46%), Gaps = 26/213 (12%)

Query: 535 IGRGGFGSVYKAR-IRDGMEVAVKVFNLQC-GRAFKSFDV-ECAMMKSIRHRNLVKVISS 591
           IG G +G VYK R  + G  VA+K   L+       S  + E +++K ++H N+V +   
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67

Query: 592 CSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLH-------FGY 644
              E    L+ E++    L+KYL S              +D      YL+       F +
Sbjct: 68  LMQESRLYLIFEFLSM-DLKKYLDSL--------PKGQYMDAELVKSYLYQILQGILFCH 118

Query: 645 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG 704
           S  V+H DLKP N+L+D+  V  L+DFG+A+      +    T  + T+ Y APE     
Sbjct: 119 SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR--VYTHEVVTLWYRAPEVLLGS 176

Query: 705 Q-VSTNGDVYSFGIMLMETFTRKKPTDELFNGE 736
              ST  D++S G +  E  T KKP   LF+G+
Sbjct: 177 PRYSTPVDIWSIGTIFAEMAT-KKP---LFHGD 205

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 71.6 bits (176), Expect = 3e-13
 Identities = 67/230 (29%), Positives = 100/230 (43%), Gaps = 45/230 (19%)

Query: 527 DKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDV------ECAMMKS 579
           D++   + +G G +G V  A     G +VA+K  +    R F+S         E  ++K 
Sbjct: 15  DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLS----RPFQSAIHAKRTYRELRLLKH 70

Query: 580 IRHRNLVKVIS-------SCSNEEFKA--LVLEYMPHGSLEKYLHSSNYSLDIFQRLNIM 630
           + H N   VI        + S E+F+   LV   M    L   +     S D  Q L   
Sbjct: 71  MDHEN---VIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQ 126

Query: 631 IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTL 690
           I     L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+     D  M  T  +
Sbjct: 127 I--LRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHT---DDEM--TGYV 176

Query: 691 ATIGYMAPE----YGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGE 736
           AT  Y APE    +    Q     D++S G ++ E  T K     LF G 
Sbjct: 177 ATRWYRAPEIMLNWMHYNQTV---DIWSVGCIMAELLTGKT----LFPGS 219

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 70.8 bits (173), Expect = 3e-13
 Identities = 59/196 (30%), Positives = 98/196 (50%), Gaps = 10/196 (5%)

Query: 535 IGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCS 593
           IG G  G V  AR +  G +VAVK+ +L+  +  +    E  +M+  +H+N+V++  S  
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88

Query: 594 NEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 653
             E   +++E++  G+L   +  S   L+  Q   +   V  AL YLH   S  VIH D+
Sbjct: 89  VGEELWVLMEFLQGGALTDIV--SQTRLNEEQIATVCESVLQALCYLH---SQGVIHRDI 143

Query: 654 KPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGY-MAPEYGREGQVSTNGDV 712
           K  ++LL  +    LSDFG    ++   + + + ++L    Y MAPE        T  D+
Sbjct: 144 KSDSILLTLDGRVKLSDFGFCAQIS---KDVPKRKSLVGTPYWMAPEVISRTPYGTEVDI 200

Query: 713 YSFGIMLMETFTRKKP 728
           +S GIM++E    + P
Sbjct: 201 WSLGIMVIEMVDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 70.7 bits (174), Expect = 4e-13
 Identities = 63/219 (28%), Positives = 111/219 (50%), Gaps = 22/219 (10%)

Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDV----ECAMMKSIR 581
           D++ + N I  G +G VY+AR  + G  VA+K   L+  +  + F +    E  ++  ++
Sbjct: 5   DEYEKLNRIEEGTYGVVYRARDKKTGEIVALK--KLKMEKEKEGFPITSLREINILLKLQ 62

Query: 582 HRNLVKV--ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEY 639
           H N+V V  +   SN +   +V+EY+ H  L+  + +        +   +M+ + S + +
Sbjct: 63  HPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAH 121

Query: 640 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPE 699
           LH  +   ++H DLK SN+LL++  +  + DFG+A+      +    TQ + T+ Y APE
Sbjct: 122 LHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY--TQLVVTLWYRAPE 176

Query: 700 --YGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGE 736
              G   + ST  D++S G +  E    KKP   LF G+
Sbjct: 177 LLLG-AKEYSTAIDMWSVGCIFAE-LLTKKP---LFPGK 210

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 70.5 bits (173), Expect = 4e-13
 Identities = 41/106 (38%), Positives = 54/106 (50%), Gaps = 9/106 (8%)

Query: 629 IMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQ 688
           I + +  ALEYLH   S  VIH D+KPSNVL++ N    L DFGI+  L     S+ +T 
Sbjct: 108 IAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLV---DSVAKTI 162

Query: 689 TLATIGYMAPEY----GREGQVSTNGDVYSFGIMLMETFTRKKPTD 730
                 YMAPE       +       DV+S GI ++E  T + P D
Sbjct: 163 DAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD 208

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 71.5 bits (175), Expect = 4e-13
 Identities = 90/304 (29%), Positives = 141/304 (46%), Gaps = 20/304 (6%)

Query: 138 FGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSH 197
             +          + N   S L+   ++ L+   S   + L  + L  +L    +     
Sbjct: 21  LSSNTYHTTPQSINLNFPDSNLESVAVNRLALNLSSNTLLLLPSSLSRLLSLDLLSP--- 77

Query: 198 SLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQL 257
                   +   S    E + NL  L ++ L  N+L  +I   L +L  L  +DL+ N +
Sbjct: 78  --------SGISSLDGSENLLNLLPLPSLDLNLNRLRSNIS-ELLELTNLTSLDLDNNNI 128

Query: 258 EGSIPDSICLSV-ELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLK 316
              IP  I L    L EL+L  NK+  S+P+   N+  LK L L  N+L+ +P    +L 
Sbjct: 129 T-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLSDLPKLLSNLS 186

Query: 317 DILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRL 376
           ++ +L+LS N  S  LP EI  L AL E+D S NN    +   + +LKNL  L L  N+L
Sbjct: 187 NLNNLDLSGNKIS-DLPPEIELLSALEELDLS-NNSIIELLSSLSNLKNLSGLELSNNKL 244

Query: 377 EGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIPRGGSFGN 436
           E  +P+S G+L +L++L+LS N +S     SL  L+ L++L+LS N L   +P       
Sbjct: 245 E-DLPESIGNLSNLETLDLSNNQIS--SISSLGSLTNLRELDLSGNSLSNALPLIALLLL 301

Query: 437 FSAE 440
               
Sbjct: 302 LLEL 305

Length = 394

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 70.9 bits (173), Expect = 4e-13
 Identities = 70/224 (31%), Positives = 100/224 (44%), Gaps = 23/224 (10%)

Query: 521 ELFQATDK---FSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNL---QCGRAFKSFDVE 573
           ELF   D    F++   IG G FG+VY AR +R    VA+K  +    Q    ++    E
Sbjct: 16  ELFFKEDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKE 75

Query: 574 CAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDV 633
              ++ I+H N ++       E    LV+EY   GS    L      L   Q + I    
Sbjct: 76  VKFLQRIKHPNSIEYKGCYLREHTAWLVMEYC-LGSASDLLEVHKKPL---QEVEIAAIT 131

Query: 634 ASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATI 693
             AL+ L + +S  +IH D+K  N+LL +     L+DFG A + +  +        + T 
Sbjct: 132 HGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPAN------SFVGTP 185

Query: 694 GYMAPEY---GREGQVSTNGDVYSFGIMLMETFTRKKPTDELFN 734
            +MAPE      EGQ     DV+S GI  +E   RK P   LFN
Sbjct: 186 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP---LFN 226

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 69.7 bits (171), Expect = 9e-13
 Identities = 60/214 (28%), Positives = 95/214 (44%), Gaps = 22/214 (10%)

Query: 534 LIGRGGFGSVYKARIRDGMEV-AVKVFNLQCGRAFKSFDVECAMM-KSI-----RHRNLV 586
           ++G+G FG V  A ++   E+ AVKV  L+     +  DVEC M  K +     +H  L 
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKV--LKKDVILQDDDVECTMTEKRVLALAGKHPFLT 59

Query: 587 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSA 646
           ++ S    ++    V+EY+  G L  ++  S    D  +      ++   L++LH     
Sbjct: 60  QLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLH---ER 115

Query: 647 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTL-ATIGYMAPEYGREGQ 705
            +I+ DLK  NVLLD      ++DFG+ K       +   T T   T  Y+APE      
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT---TSTFCGTPDYIAPEILSYQP 172

Query: 706 VSTNGDVYSFGIMLMETFTRKKP-----TDELFN 734
                D ++ G++L E    + P      DELF 
Sbjct: 173 YGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQ 206

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 68.8 bits (169), Expect = 1e-12
 Identities = 76/308 (24%), Positives = 116/308 (37%), Gaps = 72/308 (23%)

Query: 525 ATDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSI-RH 582
            T  F    +IG G +G VYKAR  + G  VA+K+ ++      +    E  +++    H
Sbjct: 4   PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII-EDEEEEIKEEYNILRKYSNH 62

Query: 583 RNLVK-----VISSCSNEEFKA-LVLEYMPHGS---LEKYLHSSNYSLDIFQRLNIMIDV 633
            N+       +  +    + +  LV+E    GS   L K L      L       I+ + 
Sbjct: 63  PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRET 122

Query: 634 ASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATI 693
              L YLH      VIH D+K  N+LL  N    L DFG++  L   D ++ +  T   I
Sbjct: 123 LRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL---DSTLGRRNT--FI 174

Query: 694 G---YMAPE-----YGREGQVSTNGDVYSFGIMLMET------FTRKKPTDELF----NG 735
           G   +MAPE        +       DV+S GI  +E            P   LF    N 
Sbjct: 175 GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNP 234

Query: 736 EMTLKH---WVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQR 792
             TLK    W                  S++   F++             EC +++ EQR
Sbjct: 235 PPTLKSPENW------------------SKKFNDFIS-------------ECLIKNYEQR 263

Query: 793 INAKEIVA 800
              +E++ 
Sbjct: 264 PFMEELLE 271

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 58/215 (26%), Positives = 101/215 (46%), Gaps = 27/215 (12%)

Query: 534 LIGRGGFGSVYKARIRD-GMEVAVKVFNL-----QCGRAFKSFDVECAMMKSIRHRNLVK 587
           L+G+G FG VY     D G E+AVK         +  +   + + E  ++K++ H  +V+
Sbjct: 9   LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68

Query: 588 VISSCSN--EEFKALVLEYMPHGSLEKYLHS-SNYSLDIFQRLNIMIDVASALEYLHFGY 644
                 +  E   ++ +E+MP GS++  L S    + ++ ++    I     LE + + +
Sbjct: 69  YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQI-----LEGVSYLH 123

Query: 645 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGY-MAPE---- 699
           S  ++H D+K +N+L D      L DFG +K L     S T  +++    Y M+PE    
Sbjct: 124 SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG 183

Query: 700 --YGREGQVSTNGDVYSFGIMLMETFTRKKPTDEL 732
             YGR+       D++S G  ++E  T K P  E 
Sbjct: 184 EGYGRK------ADIWSVGCTVVEMLTEKPPWAEF 212

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 69.2 bits (169), Expect = 2e-12
 Identities = 66/195 (33%), Positives = 91/195 (46%), Gaps = 15/195 (7%)

Query: 534 LIGRGGFGSVYKA-RIRDGMEVAVKVFNLQCGRAFKSFDVECAM------MKSIRHRNLV 586
           +IG+G FG V  A R  DG   AVKV  LQ     K  +    M      +K+++H  LV
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKV--LQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59

Query: 587 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSA 646
            +  S    E    VL+Y+  G L  +L      L+   R     +VASA+ YLH   S 
Sbjct: 60  GLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVASAIGYLH---SL 115

Query: 647 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQV 706
            +I+ DLKP N+LLD      L+DFG+ K   G +   T +    T  Y+APE  R+   
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVLRKEPY 173

Query: 707 STNGDVYSFGIMLME 721
               D +  G +L E
Sbjct: 174 DRTVDWWCLGAVLYE 188

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 68.8 bits (168), Expect = 2e-12
 Identities = 57/229 (24%), Positives = 103/229 (44%), Gaps = 35/229 (15%)

Query: 535 IGRGGFGSVYKARIRDGME------------------VAVKVFNLQCGR-AFKSFDVECA 575
           +G G FG V+     +GME                  VAVK+      + A   F  E  
Sbjct: 13  LGEGQFGEVHLCEA-EGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71

Query: 576 MMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYL---------HSSNYSLDIFQR 626
           +M  ++  N++++++ C   +   ++ EYM +G L ++L           ++     +  
Sbjct: 72  IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131

Query: 627 LNIM-IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMT 685
           L  M   +AS ++YL    S   +H DL   N L+  N    ++DFG+++ L   D    
Sbjct: 132 LIFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188

Query: 686 QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT--RKKPTDEL 732
           Q + +  I +M+ E    G+ +T  DV++FG+ L E  T  +++P  +L
Sbjct: 189 QGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL 237

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 69.1 bits (169), Expect = 2e-12
 Identities = 67/232 (28%), Positives = 105/232 (45%), Gaps = 41/232 (17%)

Query: 534 LIGRGGFGSVYKARIRDG--------MEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNL 585
           ++G+GG+G V++ R   G        M+V  K   ++  +       E  ++++++H  +
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62

Query: 586 VKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVAS--------AL 637
           V +I +        L+LEY+  G L  +L        IF     M D A         AL
Sbjct: 63  VDLIYAFQTGGKLYLILEYLSGGELFMHLEREG----IF-----MEDTACFYLSEISLAL 113

Query: 638 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMA 697
           E+LH      +I+ DLKP N+LLD      L+DFG+ K    E  ++T T    TI YMA
Sbjct: 114 EHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-TVTHT-FCGTIEYMA 168

Query: 698 PE-YGREGQVSTNGDVYSFGIMLMETFT---------RKKPTDELFNGEMTL 739
           PE   R G      D +S G ++ +  T         RKK  D++  G++ L
Sbjct: 169 PEILMRSGH-GKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNL 219

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 68.1 bits (166), Expect = 2e-12
 Identities = 57/204 (27%), Positives = 95/204 (46%), Gaps = 11/204 (5%)

Query: 535 IGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCS 593
           +G G FG VYKA+ ++ G+  A KV + +     + + VE  ++ S  H N+VK++ +  
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 594 NEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 653
            E    +++E+   G+++  +      L   Q   +      AL YLH      +IH DL
Sbjct: 73  YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDL 129

Query: 654 KPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY-----GREGQVST 708
           K  N+L   +    L+DFG++   T   Q   +   + T  +MAPE       ++     
Sbjct: 130 KAGNILFTLDGDIKLADFGVSAKNTRTIQR--RDSFIGTPYWMAPEVVMCETSKDRPYDY 187

Query: 709 NGDVYSFGIMLMETFTRKKPTDEL 732
             DV+S GI L+E    + P  EL
Sbjct: 188 KADVWSLGITLIEMAQIEPPHHEL 211

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 68.9 bits (168), Expect = 2e-12
 Identities = 64/193 (33%), Positives = 91/193 (47%), Gaps = 11/193 (5%)

Query: 534 LIGRGGFGSVYKA-RIRDGMEVAVKVFNLQC---GRAFKSFDVE-CAMMKSIRHRNLVKV 588
           +IG+G FG V  A R  DG   AVKV   +     +  K    E   ++K+++H  LV +
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 589 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPV 648
             S    E    VL+++  G L  +L       +   R     ++ASAL YLH   S  +
Sbjct: 62  HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLH---SINI 117

Query: 649 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVST 708
           ++ DLKP N+LLD      L+DFG+ K   G  QS T T    T  Y+APE  R+     
Sbjct: 118 VYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEYLAPEVIRKQPYDN 175

Query: 709 NGDVYSFGIMLME 721
             D +  G +L E
Sbjct: 176 TVDWWCLGAVLYE 188

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 68.3 bits (167), Expect = 2e-12
 Identities = 58/200 (29%), Positives = 93/200 (46%), Gaps = 11/200 (5%)

Query: 535 IGRGGFGSVYKA-RIRDGMEVAVKVFNLQCGRAF-KSFDVECAMMKSIRHRNLVKVISSC 592
           +G G  GSV K   I  G  +A KV ++    +  K    E  +M   R   +V    + 
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72

Query: 593 SNEEFKALVLEYMPHGSLEK-YLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHC 651
            NE    + +E+M  GSL++ Y       ++I  +  I + V   L YL+      ++H 
Sbjct: 73  LNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGK--IAVAVVEGLTYLY--NVHRIMHR 128

Query: 652 DLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGD 711
           D+KPSN+L++      L DFG++  L     S+  T  + T  YM+PE  + G+ +   D
Sbjct: 129 DIKPSNILVNSRGQIKLCDFGVSGELI---NSIADT-FVGTSTYMSPERIQGGKYTVKSD 184

Query: 712 VYSFGIMLMETFTRKKPTDE 731
           V+S GI ++E    K P   
Sbjct: 185 VWSLGISIIELALGKFPFAF 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 67.9 bits (166), Expect = 2e-12
 Identities = 56/211 (26%), Positives = 101/211 (47%), Gaps = 21/211 (9%)

Query: 534 LIGRGGFGSVYKARIRDGME--VAVK---VFNLQCGRAFKSFD-------VECAMMK-SI 580
            +G G FG VYK R ++  +  +A+K   V N   G+  +  D        E  ++K  +
Sbjct: 7   HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66

Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIF--QRL-NIMIDVASAL 637
           RH N+V+   +    +   +V++ +    L ++ +S       F  +R+ NI + +  AL
Sbjct: 67  RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126

Query: 638 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMA 697
            YLH      ++H DL P+N++L ++    ++DFG+AK     +  +  T  + TI Y  
Sbjct: 127 RYLH--KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK-QKQPESKL--TSVVGTILYSC 181

Query: 698 PEYGREGQVSTNGDVYSFGIMLMETFTRKKP 728
           PE  +        DV++FG +L +  T + P
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 67.5 bits (165), Expect = 2e-12
 Identities = 52/215 (24%), Positives = 92/215 (42%), Gaps = 19/215 (8%)

Query: 535 IGRGGFGSVYKARIR-DGMEVAVKVF---NLQCGRAFKSFDVECAMMKSIRHR-NLVKVI 589
           I +G FGSVY A+ R  G   A+KV    ++       +   E A+M        + K+ 
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63

Query: 590 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVI 649
            S  ++++  LV+EY+  G     + +     + + +   + +V   +E LH      +I
Sbjct: 64  YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAK-QYIAEVVLGVEDLH---QRGII 119

Query: 650 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTN 709
           H D+KP N+L+D      L+DFG+++        +   + + T  Y+APE          
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSRN------GLENKKFVGTPDYLAPETILGVGDDKM 173

Query: 710 GDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVN 744
            D +S G ++ E      P    F+ E     + N
Sbjct: 174 SDWWSLGCVIFEFLFGYPP----FHAETPDAVFDN 204

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 66.9 bits (163), Expect = 4e-12
 Identities = 62/212 (29%), Positives = 105/212 (49%), Gaps = 14/212 (6%)

Query: 535 IGRGGFGSVYKA--RIRDGME-VAVKVF-NLQCGRAFK-SFDVECAMMKSIRHRNLVKVI 589
           +G G FG+V K   +++   + VAVK+  N     A K     E  +M+ + +  +V++I
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 590 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVI 649
             C  E +  LV+E    G L K+L   N  +       ++  V+  ++YL        +
Sbjct: 63  GICEAESW-MLVMELAELGPLNKFL-QKNKHVTEKNITELVHQVSMGMKYLE---ETNFV 117

Query: 650 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLAT--IGYMAPEYGREGQVS 707
           H DL   NVLL     A +SDFG++K L G D++  + +T     + + APE     + S
Sbjct: 118 HRDLAARNVLLVTQHYAKISDFGLSKAL-GADENYYKAKTHGKWPVKWYAPECMNYYKFS 176

Query: 708 TNGDVYSFGIMLMETFTR-KKPTDELFNGEMT 738
           +  DV+SFG+++ E F+  +KP   +   E+T
Sbjct: 177 SKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVT 208

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 67.4 bits (164), Expect = 4e-12
 Identities = 53/205 (25%), Positives = 99/205 (48%), Gaps = 11/205 (5%)

Query: 529 FSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDV---ECAMMKSIRHRN 584
           F +  ++G+GGFG V   ++R  G   A K    +  +  K   +   E  +++ +  R 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 585 LVKVISSCSNEEFKALVLEYMPHGSLEKYL-HSSNYSLDIFQRLNIMIDVASALEYLHFG 643
           +V +  +   ++   LVL  M  G L+ ++ H      +  + +    ++   LE LH  
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH-- 119

Query: 644 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE 703
               +++ DLKP N+LLDD+    +SD G+A +   E Q++     + T+GYMAPE  + 
Sbjct: 120 -QERIVYRDLKPENILLDDHGHIRISDLGLA-VHVPEGQTI--KGRVGTVGYMAPEVVKN 175

Query: 704 GQVSTNGDVYSFGIMLMETFTRKKP 728
            + + + D ++ G +L E    + P
Sbjct: 176 ERYTFSPDWWALGCLLYEMIAGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 67.2 bits (164), Expect = 4e-12
 Identities = 56/203 (27%), Positives = 98/203 (48%), Gaps = 16/203 (7%)

Query: 535 IGRGGFGSVYKARIR-DGMEVAVKVFN---LQCGRAFKSFDVECAMMKSIRHRNLVKVIS 590
           +G+GGFG V   ++R  G   A K  N   L+  + ++   VE  ++  +  R +V +  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 591 SCSNEEFKALVLEYMPHGSLEKYLHS---SNYSLDIFQRLNIMIDVASALEYLHFGYSAP 647
           +   +    LV+  M  G L  ++++    N      +       + S LE+LH      
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRR 117

Query: 648 VIHCDLKPSNVLLDDNMVAHLSDFGIA-KLLTGEDQSMTQTQTLA-TIGYMAPEYGREGQ 705
           +I+ DLKP NVLLD++    +SD G+A +L  G+    ++T+  A T G+MAPE  +  +
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ----SKTKGYAGTPGFMAPELLQGEE 173

Query: 706 VSTNGDVYSFGIMLMETFTRKKP 728
              + D ++ G+ L E    + P
Sbjct: 174 YDFSVDYFALGVTLYEMIAARGP 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 67.5 bits (165), Expect = 4e-12
 Identities = 58/195 (29%), Positives = 96/195 (49%), Gaps = 11/195 (5%)

Query: 535 IGRGGFGSVYKARIRDGME-VAVKVFNLQCGRAFKSFDV-ECAMMKSIRHRNLVKVISSC 592
           +G G + +VYK R R   E VA+K  +L       S  + E ++MK ++H N+V++    
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67

Query: 593 SNEEFKALVLEYMPHGSLEKYL--HSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIH 650
             E    LV EYM    L+KY+  H    +LD     +    +   + + H      V+H
Sbjct: 68  HTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLH 123

Query: 651 CDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQV-STN 709
            DLKP N+L++      L+DFG+A+   G   + T +  + T+ Y AP+     +  ST+
Sbjct: 124 RDLKPQNLLINKRGELKLADFGLARAF-GIPVN-TFSNEVVTLWYRAPDVLLGSRTYSTS 181

Query: 710 GDVYSFGIMLMETFT 724
            D++S G ++ E  T
Sbjct: 182 IDIWSVGCIMAEMIT 196

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 67.4 bits (164), Expect = 4e-12
 Identities = 56/206 (27%), Positives = 93/206 (45%), Gaps = 9/206 (4%)

Query: 529 FSENNLIGRGGFGSVYKARIRDGMEV-AVKVFNLQCGR-AFKSFDVECAMMKSIRHRNLV 586
           F++   IG+G FG VYK       EV A+K+ +L+      +    E  ++       + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 587 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSA 646
           +   S        +++EY+  GS    L      L+      I+ ++   L+YLH   S 
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGSALDLLKPG--PLEETYIATILREILKGLDYLH---SE 120

Query: 647 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQV 706
             IH D+K +NVLL +     L+DFG+A  LT  D  + +   + T  +MAPE  ++   
Sbjct: 121 RKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVIKQSAY 178

Query: 707 STNGDVYSFGIMLMETFTRKKPTDEL 732
               D++S GI  +E    + P  +L
Sbjct: 179 DFKADIWSLGITAIELAKGEPPNSDL 204

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 66.8 bits (163), Expect = 5e-12
 Identities = 67/261 (25%), Positives = 113/261 (43%), Gaps = 53/261 (20%)

Query: 535 IGRGGFGSVYKA-RIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCS 593
           +G G  G+VYKA  +     +AVKV  L         D+   + K I     ++++  C 
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPL---------DITVELQKQIMSE--LEILYKCD 57

Query: 594 N------------EEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLH 641
           +            E   ++  E+M  GSL+ Y     + L       I + V   L YL 
Sbjct: 58  SPYIIGFYGAFFVENRISICTEFMDGGSLDVYRKIPEHVLG-----RIAVAVVKGLTYL- 111

Query: 642 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYG 701
             +S  ++H D+KPSN+L++      L DFG++  L     S+ +T  + T  YMAPE  
Sbjct: 112 --WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV---NSIAKTY-VGTNAYMAPERI 165

Query: 702 REGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTME-------- 753
              Q   + DV+S GI  ME    + P  ++   + +L       +P+  ++        
Sbjct: 166 SGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL-------MPLQLLQCIVDEDPP 218

Query: 754 VVDANLLSQEDIHFVAKEQCV 774
           V+     S++ +HF+   QC+
Sbjct: 219 VLPVGQFSEKFVHFIT--QCM 237

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 66.2 bits (161), Expect = 6e-12
 Identities = 56/197 (28%), Positives = 91/197 (46%), Gaps = 10/197 (5%)

Query: 535 IGRGGFGSVYKARIR-DGMEVAVKVFNLQ--CGRAFKSFDVECAMMKSIRHRNLVKVISS 591
           +G+G +G V   R R DG +  +K  NL+    R  K+ + E  ++  ++H N+V    S
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67

Query: 592 CSNEE-FKALVLEYMPHGSLEKYLHSSNYSLDI-FQRLNIMIDVASALEYLHFGYSAPVI 649
              E+    +V+ +   G L   L      L    Q +   + +A AL+YLH      ++
Sbjct: 68  WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHIL 124

Query: 650 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTN 709
           H DLK  NV L    +  + D GIA++L  E+Q    +  + T  YM+PE       +  
Sbjct: 125 HRDLKTQNVFLTRTNIIKVGDLGIARVL--ENQCDMASTLIGTPYYMSPELFSNKPYNYK 182

Query: 710 GDVYSFGIMLMETFTRK 726
            DV++ G  + E  T K
Sbjct: 183 SDVWALGCCVYEMATLK 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 66.6 bits (163), Expect = 8e-12
 Identities = 37/104 (35%), Positives = 52/104 (50%), Gaps = 9/104 (8%)

Query: 629 IMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQ 688
           + + +  AL YL   +   VIH D+KPSN+LLD +    L DFGI+  L     S  +T+
Sbjct: 119 MTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLV---DSKAKTR 173

Query: 689 TLATIGYMAPEY----GREGQVSTNGDVYSFGIMLMETFTRKKP 728
           +     YMAPE         +     DV+S GI L+E  T + P
Sbjct: 174 SAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 66.5 bits (162), Expect = 8e-12
 Identities = 57/200 (28%), Positives = 94/200 (47%), Gaps = 25/200 (12%)

Query: 535 IGRGGFGSVYKARIR-DGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISS 591
           +G G + +VYK   R +G  VA+KV +++   G  F +   E +++K ++H N+V +   
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIR-EASLLKGLKHANIVLLHDI 71

Query: 592 CSNEEFKALVLEYMPHGSLEKY-------LHSSNYSLDIFQRLNIMIDVASALEYLHFGY 644
              +E    V EYM H  L +Y       LH  N  L +FQ L         L Y+H  +
Sbjct: 72  IHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQLLR-------GLAYIHGQH 123

Query: 645 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPE-YGRE 703
              ++H DLKP N+L+       L+DFG+A+       S T +  + T+ Y  P+     
Sbjct: 124 ---ILHRDLKPQNLLISYLGELKLADFGLAR--AKSIPSQTYSSEVVTLWYRPPDVLLGA 178

Query: 704 GQVSTNGDVYSFGIMLMETF 723
              S+  D++  G + +E  
Sbjct: 179 TDYSSALDIWGAGCIFIEML 198

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 66.5 bits (163), Expect = 9e-12
 Identities = 54/200 (27%), Positives = 89/200 (44%), Gaps = 43/200 (21%)

Query: 528 KFSENNLIGRGGFGSVYKARI---RDGMEVAVKVFNLQCGRAFKSFDV--------ECAM 576
           K+     IGRG +G VYKA+    +DG E A+K F     +  K            E A+
Sbjct: 1   KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKF-----KGDKEQYTGISQSACREIAL 55

Query: 577 MKSIRHRNLVKVISSCSNEEFKA--LVLEYMPHGSLE--KYLHSSNYSLDIFQRL--NIM 630
           ++ ++H N+V ++        K+  L+ +Y  H   +  K+ H     + I   +  +++
Sbjct: 56  LRELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKF-HRQAKRVSIPPSMVKSLL 114

Query: 631 IDVASALEYLHFGYSAPVIHCDLKPSNVLL----DDNMVAHLSDFGIA-------KLLTG 679
             + + + YLH   S  V+H DLKP+N+L+     +  V  + D G+A       K L  
Sbjct: 115 WQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLAD 171

Query: 680 EDQSMTQTQTLATIGYMAPE 699
            D        + TI Y APE
Sbjct: 172 LD------PVVVTIWYRAPE 185

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 66.2 bits (161), Expect = 1e-11
 Identities = 72/267 (26%), Positives = 120/267 (44%), Gaps = 28/267 (10%)

Query: 535 IGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCS 593
           IG G  G V  A  +  G +VAVK  +L+  +  +    E  +M+   H N+V + +S  
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89

Query: 594 NEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 653
             +   +V+E++  G+L   +  +  + +  Q   + + V  AL YLH   +  VIH D+
Sbjct: 90  VGDELWVVMEFLEGGALTDIVTHTRMNEE--QIATVCLSVLRALSYLH---NQGVIHRDI 144

Query: 654 KPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVY 713
           K  ++LL  +    LSDFG    ++ E     +   + T  +MAPE        T  D++
Sbjct: 145 KSDSILLTSDGRIKLSDFGFCAQVSKEVPK--RKSLVGTPYWMAPEVISRLPYGTEVDIW 202

Query: 714 SFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ-EDIHFVAKEQ 772
           S GIM++E    + P    FN             P+  M  +  NL  + +D H V+   
Sbjct: 203 SLGIMVIEMIDGEPP---YFNEP-----------PLQAMRRIRDNLPPRVKDSHKVS--S 246

Query: 773 CVSFVFNLALECTVESPEQRINAKEIV 799
            +    +L L   V  P QR  A+E++
Sbjct: 247 VLRGFLDLML---VREPSQRATAQELL 270

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 66.7 bits (163), Expect = 1e-11
 Identities = 64/213 (30%), Positives = 98/213 (46%), Gaps = 39/213 (18%)

Query: 535 IGRGGFGSVYKAR-IRDGMEVAVK----VF-NL-QCGRAFKSFDVECAMMKSIRHRNLVK 587
           IG G FG V+     RDG  VA+K    VF NL  C R F+    E  M+   +H N++ 
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFR----ELKMLCFFKHDNVLS 63

Query: 588 VIS-------SCSNEEFKALVLEYMPHGSLEKY------LHSSNYSLDIFQRLNIMIDVA 634
            +            E +   V+  +    L K       L S +  + ++Q L       
Sbjct: 64  ALDILQPPHIDPFEEIY---VVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILR------ 114

Query: 635 SALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIG 694
             L+YLH   SA ++H D+KP N+L++ N V  + DFG+A+ +   D+S   TQ + T  
Sbjct: 115 -GLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLAR-VEEPDESKHMTQEVVTQY 169

Query: 695 YMAPEYGREGQVSTNG-DVYSFGIMLMETFTRK 726
           Y APE     +  T+  D++S G +  E   R+
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 66.0 bits (161), Expect = 1e-11
 Identities = 60/212 (28%), Positives = 97/212 (45%), Gaps = 20/212 (9%)

Query: 534 LIGRGGFGSVYKARIRDGMEV-AVKVFNLQCGRAFKSFDVECAMMK------SIRHRNLV 586
           ++G+G FG V  A ++   EV A+KV  L+     +  DV+C M +      + +H  L 
Sbjct: 2   VLGKGSFGKVMLAELKGTDEVYAIKV--LKKDVILQDDDVDCTMTEKRILALAAKHPFLT 59

Query: 587 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSA 646
            +      ++    V+EY+  G L   +  S    D  +      +V  AL +LH     
Sbjct: 60  ALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFLH---RH 115

Query: 647 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQV 706
            VI+ DLK  N+LLD      L+DFG+ K   G    +T T    T  Y+APE  +E + 
Sbjct: 116 GVIYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFCGTPDYIAPEILQELEY 173

Query: 707 STNGDVYSFGIMLMETFTRKKP-----TDELF 733
             + D ++ G+++ E    + P      D+LF
Sbjct: 174 GPSVDWWALGVLMYEMMAGQPPFEADNEDDLF 205

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 66.6 bits (163), Expect = 1e-11
 Identities = 62/226 (27%), Positives = 92/226 (40%), Gaps = 49/226 (21%)

Query: 534 LIGRGGFGSVYKARIRDGMEV-AVKVFN-----LQCGRAFKSFDVECAMMKSIRHRNLVK 587
           +IGRG FG V+  R +D  +V A+KV        +   A      E  ++       +VK
Sbjct: 8   VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAH--VRAERDILADADSPWIVK 65

Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQ----RLNIMIDVASALEYLH-F 642
           +  S  +EE   LV+EYMP G L   L       D+F     R  I  ++  AL+ +H  
Sbjct: 66  LYYSFQDEEHLYLVMEYMPGGDLMNLL--IRK--DVFPEETARFYIA-ELVLALDSVHKL 120

Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK------------LLTGEDQSMTQTQ-- 688
           G+    IH D+KP N+L+D +    L+DFG+ K              +            
Sbjct: 121 GF----IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVR 176

Query: 689 -------------TLATIGYMAPEYGREGQVSTNGDVYSFGIMLME 721
                        T+ T  Y+APE  R        D +S G++L E
Sbjct: 177 RRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYE 222

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 65.0 bits (158), Expect = 2e-11
 Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 11/204 (5%)

Query: 534 LIGRGGFGSVYKA-RIRDG----MEVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVK 587
           ++G G FG+VYK   I DG    + VA+KV       +A K    E  +M  +    + +
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73

Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAP 647
           ++  C     + LV + MP+G L  Y+  +   +     LN  + +A  + YL       
Sbjct: 74  LLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVR 129

Query: 648 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVS 707
           ++H DL   NVL+       ++DFG+A+LL  ++           I +MA E     + +
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFT 189

Query: 708 TNGDVYSFGIMLMETFT-RKKPTD 730
              DV+S+G+ + E  T   KP D
Sbjct: 190 HQSDVWSYGVTVWELMTFGAKPYD 213

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 65.0 bits (158), Expect = 2e-11
 Identities = 53/201 (26%), Positives = 94/201 (46%), Gaps = 15/201 (7%)

Query: 535 IGRGGFGSVYKARIRD-GMEVAVKVFNLQ-----CGRAFKSFDVECAMMKSIRHRNLVKV 588
           +G+GGFG V   ++++ G   A K  + +      G   K   +E  +++ +    +V +
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGE--KMALLEKEILEKVNSPFIVNL 58

Query: 589 ISSCSNEEFKALVLEYMPHGSLEKYL-HSSNYSLDIFQRLNIMIDVASALEYLHFGYSAP 647
             +  ++    LV+  M  G L+ ++ +     L++ + ++    +   + +LH   S  
Sbjct: 59  AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMD 115

Query: 648 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVS 707
           +++ D+KP NVLLDD     LSD G+A  L       T TQ   T GYMAPE  +E   S
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLAVELKD---GKTITQRAGTNGYMAPEILKEEPYS 172

Query: 708 TNGDVYSFGIMLMETFTRKKP 728
              D ++ G  + E    + P
Sbjct: 173 YPVDWFAMGCSIYEMVAGRTP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 65.0 bits (158), Expect = 3e-11
 Identities = 72/291 (24%), Positives = 129/291 (44%), Gaps = 31/291 (10%)

Query: 529 FSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDV---ECAMMKSIRHRN 584
           F +  ++G+GGFG V   ++R  G   A K    +  +  K   +   E  +++ +  + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 585 LVKVISSCSNEEFKALVLEYMPHGSLEKYLHS-SNYSLDIFQRLNIMIDVASALEYLHFG 643
           +V +  +   ++   LVL  M  G L+ ++++  N   +  + L    ++   LE LH  
Sbjct: 62  VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH-- 119

Query: 644 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIA-KLLTGEDQSMTQTQTLATIGYMAPEYGR 702
                ++ DLKP N+LLDD     +SD G+A K+  GE    +    + T+GYMAPE   
Sbjct: 120 -RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE----SIRGRVGTVGYMAPEVLN 174

Query: 703 EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ 762
             + + + D +  G ++ E    + P    F G    K  V         E VD  +L  
Sbjct: 175 NQRYTLSPDYWGLGCLIYEMIEGQSP----FRGR---KEKVK-------REEVDRRVLET 220

Query: 763 EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLRNV 813
           E+++     +    +  + L    + P+QR+  +E  A  +K R    RN+
Sbjct: 221 EEVYSAKFSEEAKSICKMLL---TKDPKQRLGCQEEGAGEVK-RHPFFRNM 267

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 65.2 bits (159), Expect = 3e-11
 Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 22/213 (10%)

Query: 534 LIGRGGFGSVYKARIRDGMEV-AVKVFNLQCGRAFKSFDVECAMMK------SIRHRNLV 586
           ++G+G FG V  A ++   E  A+K   L+     +  DVEC M++      +  H  L 
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKA--LKKDVVLEDDDVECTMVERRVLALAWEHPFLT 59

Query: 587 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSA 646
            +  +   +E    V+EY+  G L  ++ SS    D  +      ++   L++LH     
Sbjct: 60  HLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSG-RFDEARARFYAAEIICGLQFLH---KK 115

Query: 647 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKL-LTGEDQSMTQTQTLATIGYMAPEYGREGQ 705
            +I+ DLK  NVLLD +    ++DFG+ K  + GE ++ T      T  Y+APE  +  +
Sbjct: 116 GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST---FCGTPDYIAPEILKGQK 172

Query: 706 VSTNGDVYSFGIMLMETFTRKKP-----TDELF 733
            + + D +SFG++L E    + P      DELF
Sbjct: 173 YNESVDWWSFGVLLYEMLIGQSPFHGEDEDELF 205

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 64.9 bits (158), Expect = 4e-11
 Identities = 64/227 (28%), Positives = 101/227 (44%), Gaps = 24/227 (10%)

Query: 534 LIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMK------SIRHRNLV 586
           ++G+G FG V  AR++  G   AVKV  L+     +  DVEC M +      +  H  L 
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKV--LKKDVILQDDDVECTMTEKRILSLARNHPFLT 59

Query: 587 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSA 646
           ++       +    V+E++  G L  ++  S    D  +      ++ SAL +LH     
Sbjct: 60  QLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSR-RFDEARARFYAAEITSALMFLH---DK 115

Query: 647 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQV 706
            +I+ DLK  NVLLD      L+DFG+ K   G     T +    T  Y+APE  +E   
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAPEILQEMLY 173

Query: 707 STNGDVYSFGIMLMETFTRKKP-----TDELF----NGEMTLKHWVN 744
             + D ++ G++L E      P      D+LF    N E+    W++
Sbjct: 174 GPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLS 220

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 63.8 bits (155), Expect = 7e-11
 Identities = 59/237 (24%), Positives = 110/237 (46%), Gaps = 43/237 (18%)

Query: 535 IGRGGFGSVYKARI---------------RDG--MEVAVKVFNLQCGR-AFKSFDVECAM 576
           +G G FG V+   +               R G  + VAVK+      + A   F  E  +
Sbjct: 13  LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72

Query: 577 MKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQR---------- 626
           +  ++  N+++++  C +E+   ++ EYM +G L ++L SS++  D  +           
Sbjct: 73  LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFL-SSHHLDDKEENGNDAVPPAHC 131

Query: 627 ---------LNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 677
                    L++ + +AS ++YL    S   +H DL   N L+ +N+   ++DFG+++ L
Sbjct: 132 LPAISYSSLLHVALQIASGMKYLS---SLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188

Query: 678 TGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT--RKKPTDEL 732
              D    Q + +  I +MA E    G+ +T  DV++FG+ L E     +++P  EL
Sbjct: 189 YAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGEL 245

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 64.1 bits (156), Expect = 7e-11
 Identities = 73/269 (27%), Positives = 117/269 (43%), Gaps = 55/269 (20%)

Query: 523 FQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDV--------- 572
           F+ T+++ +   +G G FG V  AR +  G  VA+K       +  K F           
Sbjct: 6   FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIK-------KIMKPFSTPVLAKRTYR 58

Query: 573 ECAMMKSIRHRNLVKVISSC----SNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLN 628
           E  ++K +RH N+   IS      S  E    V E +    L + L S        Q   
Sbjct: 59  ELKLLKHLRHENI---ISLSDIFISPLEDIYFVTELLG-TDLHRLLTSRPLEKQFIQYF- 113

Query: 629 IMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQ 688
            +  +   L+Y+H   SA V+H DLKPSN+L+++N    + DFG+A++   +D  M  T 
Sbjct: 114 -LYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARI---QDPQM--TG 164

Query: 689 TLATIGYMAPE-------YGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKH 741
            ++T  Y APE       Y  E       D++S G +  E    K     LF G+  +  
Sbjct: 165 YVSTRYYRAPEIMLTWQKYDVE------VDIWSAGCIFAEMLEGKP----LFPGKDHVNQ 214

Query: 742 W--VNDCLPISTMEVVDANLLSQEDIHFV 768
           +  + D L     +V++  + S+  + FV
Sbjct: 215 FSIITDLLGTPPDDVIN-TICSENTLRFV 242

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 63.4 bits (154), Expect = 8e-11
 Identities = 64/234 (27%), Positives = 109/234 (46%), Gaps = 50/234 (21%)

Query: 534 LIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMK-----SIRHRNLVKV 588
           +IGRGGFG VY  R  D      K++ ++C       D +   MK     ++  R ++ +
Sbjct: 1   IIGRGGFGEVYGCRKAD----TGKMYAMKC------LDKKRIKMKQGETLALNERIMLSL 50

Query: 589 ISS-------CSNEEFK-----ALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMI---DV 633
           +S+       C +  F      + +L+ M  G L  + H S +   +F    +     ++
Sbjct: 51  VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL--HYHLSQHG--VFSEAEMRFYAAEI 106

Query: 634 ASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQ-TLAT 692
              LE++H  +   V++ DLKP+N+LLD++    +SD G+A      D S  +   ++ T
Sbjct: 107 ILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC-----DFSKKKPHASVGT 158

Query: 693 IGYMAPEYGREG-QVSTNGDVYSFGIMLME------TFTRKKPTDELFNGEMTL 739
            GYMAPE  ++G    ++ D +S G ML +       F + K  D+     MTL
Sbjct: 159 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 212

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 63.5 bits (154), Expect = 9e-11
 Identities = 69/267 (25%), Positives = 121/267 (45%), Gaps = 28/267 (10%)

Query: 535 IGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCS 593
           IG G  G V  A ++  G  VAVK  +L+  +  +    E  +M+  +H N+V++ +S  
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87

Query: 594 NEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 653
             +   +V+E++  G+L   +  +  + +  Q   + + V  AL  LH   +  VIH D+
Sbjct: 88  VGDELWVVMEFLEGGALTDIVTHTRMNEE--QIAAVCLAVLKALSVLH---AQGVIHRDI 142

Query: 654 KPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVY 713
           K  ++LL  +    LSDFG    ++ E     +   + T  +MAPE           D++
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKSLVGTPYWMAPELISRLPYGPEVDIW 200

Query: 714 SFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ-EDIHFVAKEQ 772
           S GIM++E    + P    FN             P+  M+++  NL  + +++H V+   
Sbjct: 201 SLGIMVIEMVDGEPP---YFNEP-----------PLKAMKMIRDNLPPKLKNLHKVSP-S 245

Query: 773 CVSFVFNLALECTVESPEQRINAKEIV 799
              F+  L     V  P QR  A E++
Sbjct: 246 LKGFLDRL----LVRDPAQRATAAELL 268

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 63.5 bits (154), Expect = 9e-11
 Identities = 72/245 (29%), Positives = 101/245 (41%), Gaps = 34/245 (13%)

Query: 500 KGPPNDPNMPPVATWRRFSYLELFQATDK---FSENNLIGRGGFGSVYKARIRDGME-VA 555
           KG   DP +            +LF   D    F   + IG G FG+VY A      E VA
Sbjct: 2   KGVVKDPEIA-----------DLFYKDDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVA 50

Query: 556 VKVFNL---QCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEK 612
           VK  +    Q    ++    E   ++ ++H N ++       E    LV+EY   GS   
Sbjct: 51  VKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYC-LGSASD 109

Query: 613 YLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFG 672
            L      L   Q + I      AL+ L + +S  +IH D+K  N+LL +     L+DFG
Sbjct: 110 LLEVHKKPL---QEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFG 166

Query: 673 IAKLLTGEDQSMTQTQTLATIGYMAPEY---GREGQVSTNGDVYSFGIMLMETFTRKKPT 729
            A   +  +        + T  +MAPE      EGQ     DV+S GI  +E   RK P 
Sbjct: 167 SASKSSPAN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP- 219

Query: 730 DELFN 734
             LFN
Sbjct: 220 --LFN 222

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 62.7 bits (152), Expect = 1e-10
 Identities = 54/208 (25%), Positives = 95/208 (45%), Gaps = 26/208 (12%)

Query: 534 LIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISS-- 591
           +IGRGGFG VY  R  D      K++ ++C    K   ++     ++  R ++ ++S+  
Sbjct: 1   IIGRGGFGEVYGCRKAD----TGKMYAMKCLDK-KRIKMKQGETLALNERIMLSLVSTGD 55

Query: 592 -----CSNEEFKA-----LVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLH 641
                C    F        +L+ M  G L  +L       +   R     ++   LE++H
Sbjct: 56  CPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF-YATEIILGLEHMH 114

Query: 642 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYG 701
             +   V++ DLKP+N+LLD++    +SD G+A   + +        ++ T GYMAPE  
Sbjct: 115 NRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH----ASVGTHGYMAPEVL 167

Query: 702 REGQV-STNGDVYSFGIMLMETFTRKKP 728
           ++G    ++ D +S G ML +      P
Sbjct: 168 QKGTAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 63.1 bits (153), Expect = 2e-10
 Identities = 57/214 (26%), Positives = 103/214 (48%), Gaps = 22/214 (10%)

Query: 534 LIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMK------SIRHRNLV 586
           ++G+G FG V+ A ++      A+K   L+        DVEC M++      +  H  L 
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 59

Query: 587 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSA 646
            +  +   +E    V+EY+  G L  ++ S  +  D+ +      ++   L++LH   S 
Sbjct: 60  HLYCTFQTKENLFFVMEYLNGGDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLH---SK 115

Query: 647 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKL-LTGEDQSMTQTQTLATIGYMAPEYGREGQ 705
            +++ DLK  N+LLD +    ++DFG+ K  + G+ ++ T      T  Y+APE     +
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT---FCGTPDYIAPEILLGQK 172

Query: 706 VSTNGDVYSFGIMLMETFTRKKP-----TDELFN 734
            +T+ D +SFG++L E    + P      +ELF 
Sbjct: 173 YNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQ 206

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 62.5 bits (152), Expect = 2e-10
 Identities = 54/205 (26%), Positives = 95/205 (46%), Gaps = 16/205 (7%)

Query: 535 IGRGGFGSVYKARIRDG--------MEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRN-L 585
           +G G +G V+  R   G        M+V  K   +Q  +  +    E  +++++R    L
Sbjct: 8   LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67

Query: 586 VKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYS 645
           V +  +   +    L+L+Y+  G L  +L+   +  +   R+ I  ++  AL++LH    
Sbjct: 68  VTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIA-EIVLALDHLH---Q 123

Query: 646 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQ 705
             +I+ D+K  N+LLD      L+DFG++K    E++    +    TI YMAPE  R G 
Sbjct: 124 LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS-FCGTIEYMAPEVIRGGS 182

Query: 706 VSTNG--DVYSFGIMLMETFTRKKP 728
              +   D +S G++  E  T   P
Sbjct: 183 GGHDKAVDWWSLGVLTFELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 62.0 bits (151), Expect = 4e-10
 Identities = 62/217 (28%), Positives = 98/217 (45%), Gaps = 42/217 (19%)

Query: 535 IGRGGFGSVYKAR---IRDGMEVAVK----VFN--LQCGRAFKSFDVECAMMKSIR-HRN 584
           +G+G +G V  AR     +   VA+K    VF+  +   RA +    E  +++  R H+N
Sbjct: 8   LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALR----ELKLLRHFRGHKN 63

Query: 585 LVK------VISSCSNEEFKALVLEYMPHGSLEKYLHSS------NYSLDIFQRLNIMID 632
           +        V     NE +  L  E M    L + + S       ++   I+Q L     
Sbjct: 64  ITCLYDMDIVFPGNFNELY--LYEELM-EADLHQIIRSGQPLTDAHFQSFIYQIL----- 115

Query: 633 VASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG--EDQSMTQTQTL 690
               L+Y+H   SA V+H DLKP N+L++ +    + DFG+A+  +    + +   T+ +
Sbjct: 116 --CGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV 170

Query: 691 ATIGYMAPEYGREGQVSTNG-DVYSFGIMLMETFTRK 726
           AT  Y APE     Q  T   DV+S G +L E   RK
Sbjct: 171 ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 61.9 bits (150), Expect = 4e-10
 Identities = 58/213 (27%), Positives = 104/213 (48%), Gaps = 22/213 (10%)

Query: 534 LIGRGGFGSVYKARIRDGME-VAVKVFNLQCGRAFKSFDVECAMMK----SIRHRN--LV 586
           ++G+G FG V  A ++   E  AVK   L+        DVEC M++    ++   N  L 
Sbjct: 2   VLGKGSFGKVLLAELKGKGEYFAVKA--LKKDVVLIDDDVECTMVEKRVLALAWENPFLT 59

Query: 587 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSA 646
            +  +   +E    V+E++  G L  ++       D+++      ++   L++LH   S 
Sbjct: 60  HLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFLH---SK 115

Query: 647 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKL-LTGEDQSMTQTQTLATIGYMAPEYGREGQ 705
            +I+ DLK  NV+LD +    ++DFG+ K  + G++++ T      T  Y+APE  +  +
Sbjct: 116 GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST---FCGTPDYIAPEILQGLK 172

Query: 706 VSTNGDVYSFGIMLMETFTRKKP-----TDELF 733
            + + D +SFG++L E    + P      DELF
Sbjct: 173 YTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELF 205

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 61.3 bits (149), Expect = 4e-10
 Identities = 50/221 (22%), Positives = 97/221 (43%), Gaps = 25/221 (11%)

Query: 522 LFQATDKFSENNLIGRGGFGSVYKARIRDGM-----EVAVKVFN-----LQCGRAFKSFD 571
           +  + D+ + ++L+  G FG ++   + D       EV VK        +Q     +   
Sbjct: 1   IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQ--- 57

Query: 572 VECAMMKSIRHRNLVKVISSCSNEEFKALVLE-YMPHGSLEKYLHSSNY-------SLDI 623
            E  ++  + H+N++ ++  C  +     VL  YM  G+L+ +L            +L  
Sbjct: 58  -ESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALST 116

Query: 624 FQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS 683
            Q +++ I +A  + YLH      VIH D+   N ++D+ +   ++D  +++ L   D  
Sbjct: 117 QQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYH 173

Query: 684 MTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 724
                    + +MA E     + S+  DV+SFG++L E  T
Sbjct: 174 CLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 61.0 bits (148), Expect = 6e-10
 Identities = 41/120 (34%), Positives = 62/120 (51%), Gaps = 19/120 (15%)

Query: 622 DIFQRLN--IMI----------DVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLS 669
           D+F RL+  +M           ++A AL++LH   S  +I+ DLKP N+LLD+     L+
Sbjct: 84  DLFTRLSKEVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLT 140

Query: 670 DFGIAKLLTGEDQSMTQTQTLATIGYMAPE-YGREGQVSTNGDVYSFGIMLMETFTRKKP 728
           DFG++K     D          T+ YMAPE   R G  + + D +SFG+++ E  T   P
Sbjct: 141 DFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGSLP 197

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 61.0 bits (148), Expect = 7e-10
 Identities = 57/219 (26%), Positives = 99/219 (45%), Gaps = 27/219 (12%)

Query: 509 PPVATWRRFSYLELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAF 567
           P  ++W+  S  E+            +G G FG V  A+ +  G   A+K    +     
Sbjct: 10  PDTSSWK-LSDFEM---------GETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKM 59

Query: 568 KSFD---VECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSS-NYSLDI 623
           K       E +++  + H  +V ++ S  +E     +LE++  G L  +L  +  +  D+
Sbjct: 60  KQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDV 119

Query: 624 FQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS 683
            +  +   ++  A EYLH   S  +I+ DLKP N+LLD+     ++DFG AK +      
Sbjct: 120 AKFYHA--ELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP----- 169

Query: 684 MTQTQTL-ATIGYMAPEYGREGQVSTNGDVYSFGIMLME 721
             +T TL  T  Y+APE  +        D ++ G++L E
Sbjct: 170 -DRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYE 207

Length = 329

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 60.8 bits (147), Expect = 1e-09
 Identities = 57/222 (25%), Positives = 105/222 (47%), Gaps = 39/222 (17%)

Query: 522 LFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFNLQCGRAFKSF------DVEC 574
           +++  +++   + +G G +GSV  A   + G+ VAVK    +  R F+S         E 
Sbjct: 12  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 67

Query: 575 AMMKSIRHRNLVKVIS----SCSNEEFKALVL-EYMPHGSLEKYLHSSNYSLDIFQRLNI 629
            ++K ++H N++ ++     + S EEF  + L  ++    L   +     + D  Q L  
Sbjct: 68  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL-- 125

Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
           +  +   L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+     D  MT    
Sbjct: 126 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT---- 175

Query: 690 LATIGYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 724
               GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 176 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 213

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 60.0 bits (145), Expect = 1e-09
 Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 18/207 (8%)

Query: 534 LIGRGGFGSVYKARIRDG--------MEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNL 585
           ++G G +G V+  R   G        M+V  K   +Q  +  +    E  +++ IR    
Sbjct: 7   VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 66

Query: 586 VKVISSCSNEEFKA-LVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMI-DVASALEYLHFG 643
           +  +      + K  L+L+Y+  G L  + H S       Q + I   ++  ALE+LH  
Sbjct: 67  LVTLHYAFQTDTKLHLILDYINGGEL--FTHLSQRERFKEQEVQIYSGEIVLALEHLH-- 122

Query: 644 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE 703
               +I+ D+K  N+LLD N    L+DFG++K    ED+         TI YMAP+  R 
Sbjct: 123 -KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH-EDEVERAYSFCGTIEYMAPDIVRG 180

Query: 704 GQVSTNG--DVYSFGIMLMETFTRKKP 728
           G    +   D +S G+++ E  T   P
Sbjct: 181 GDGGHDKAVDWWSMGVLMYELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 60.8 bits (147), Expect = 1e-09
 Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 20/206 (9%)

Query: 534 LIGRGGFGSVYKARIRDGMEV-AVKVFNL-----QCGRAFKSFDVECAMMKSIRHRNLVK 587
           +IGRG FG V   R +   +V A+K+ +      +   AF  F  E  +M       +V+
Sbjct: 50  VIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAF--FWEERDIMAFANSPWVVQ 107

Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAP 647
           +  +  ++++  +V+EYMP G L   +  SNY +          +V  AL+ +H   S  
Sbjct: 108 LFCAFQDDKYLYMVMEYMPGGDLVNLM--SNYDVPEKWAKFYTAEVVLALDAIH---SMG 162

Query: 648 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT-LATIGYMAPEY----GR 702
           +IH D+KP N+LLD +    L+DFG    +  ++  M +  T + T  Y++PE     G 
Sbjct: 163 LIHRDVKPDNMLLDKHGHLKLADFGTC--MKMDETGMVRCDTAVGTPDYISPEVLKSQGG 220

Query: 703 EGQVSTNGDVYSFGIMLMETFTRKKP 728
           +G      D +S G+ L E      P
Sbjct: 221 DGYYGRECDWWSVGVFLFEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 59.6 bits (144), Expect = 1e-09
 Identities = 60/233 (25%), Positives = 104/233 (44%), Gaps = 36/233 (15%)

Query: 527 DKFSENNLIGRGGFGSVYKARIRDGME-VAVKVF-NLQCGRAFKSFDV-ECAMMKSIRHR 583
           +KF    ++G G +G V K R ++  E VA+K F + +     K   + E  M+++++  
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60

Query: 584 NLVKVISSCSNEEFKALVLEY-----------MPHGSLEKYLHSSNYSLDIFQRLNIMID 632
           N+V++  +        LV EY           MP+G   + + S  Y L           
Sbjct: 61  NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQL----------- 109

Query: 633 VASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLAT 692
               ++ +H+ +   ++H D+KP N+L+  N V  L DFG A+ L+ E  +   T+ +AT
Sbjct: 110 ----IKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLS-EGSNANYTEYVAT 164

Query: 693 IGYMAPEYGREGQVSTNGDVYSFGIMLME------TFTRKKPTDELFNGEMTL 739
             Y +PE           D++S G +L E       F  +   D+LF  +  L
Sbjct: 165 RWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVL 217

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 60.0 bits (145), Expect = 1e-09
 Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 21/208 (10%)

Query: 534 LIGRGGFGSVYKARIRDG--------MEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNL 585
           ++G G +G V+  R   G        M+V  K   +Q  +  +    E  +++ +R    
Sbjct: 7   VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPF 66

Query: 586 VKVISSCSNEEFKA-LVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMI---DVASALEYLH 641
           +  +      E K  L+L+Y+  G +  +L    Y  D F    +     ++  ALE+LH
Sbjct: 67  LVTLHYAFQTEAKLHLILDYVSGGEMFTHL----YQRDNFSEDEVRFYSGEIILALEHLH 122

Query: 642 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYG 701
                 +++ D+K  N+LLD      L+DFG++K    E++  T +    TI YMAPE  
Sbjct: 123 ---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS-FCGTIEYMAPEII 178

Query: 702 R-EGQVSTNGDVYSFGIMLMETFTRKKP 728
           R +G      D +S GI++ E  T   P
Sbjct: 179 RGKGGHGKAVDWWSLGILIFELLTGASP 206

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 61.0 bits (148), Expect = 2e-09
 Identities = 28/74 (37%), Positives = 42/74 (56%)

Query: 233 LNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNM 292
           L G IP  + KL+ LQ ++L  N + G+IP S+     L  L+L  N  +GSIP     +
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489

Query: 293 TFLKVLSLGSNELT 306
           T L++L+L  N L+
Sbjct: 490 TSLRILNLNGNSLS 503

Length = 623

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 60.2 bits (146), Expect = 2e-09
 Identities = 64/239 (26%), Positives = 106/239 (44%), Gaps = 38/239 (15%)

Query: 535 IGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVI---- 589
           +G G  G V+ A   D    VAVK   L   ++ K    E  +++ + H N+VKV     
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72

Query: 590 --SSCSNEEFKAL--------VLEYMP---HGSLEKYLHSSNYS-LDIFQRLNIMIDVAS 635
              S   E+  +L        V EYM       LE+   S  ++ L ++Q L        
Sbjct: 73  PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLR------- 125

Query: 636 ALEYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTGE-DQSMTQTQTLATI 693
            L+Y+H   SA V+H DLKP+NV ++ +++V  + DFG+A+++          ++ L T 
Sbjct: 126 GLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTK 182

Query: 694 GYMAPEYGREGQVSTNG-DVYSFGIMLMETFTRKKPTDELFNG--EMTLKHWVNDCLPI 749
            Y +P         T   D+++ G +  E  T K     LF G  E+     + + +P+
Sbjct: 183 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKP----LFAGAHELEQMQLILESVPV 237

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 59.5 bits (144), Expect = 2e-09
 Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 17/208 (8%)

Query: 529 FSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAM-----MKSIRH 582
           F    ++G+GGFG V   ++R  G   A K   L+  R  K      A+     ++ +  
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACK--KLEKKRIKKRKGEAMALNEKQILEKVNS 59

Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHS-SNYSLDIFQRLNIMIDVASALEYLH 641
           R +V +  +   ++   LVL  M  G L+ ++++  N   D  + +    ++   LE LH
Sbjct: 60  RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH 119

Query: 642 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIA-KLLTGEDQSMTQTQTLATIGYMAPEY 700
                 +++ DLKP N+LLDD     +SD G+A ++  GE    T    + T+GYMAPE 
Sbjct: 120 ---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE----TIRGRVGTVGYMAPEV 172

Query: 701 GREGQVSTNGDVYSFGIMLMETFTRKKP 728
            +  + + + D +  G ++ E    K P
Sbjct: 173 VKNERYTFSPDWWGLGCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 59.3 bits (144), Expect = 2e-09
 Identities = 51/169 (30%), Positives = 80/169 (47%), Gaps = 28/169 (16%)

Query: 517 FSYLELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC--GRAFKSFDVE 573
           F  LE ++  DK      +G G + +VYK R +  G  VA+K   L+   G  F +   E
Sbjct: 1   FGKLETYKKLDK------LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-E 53

Query: 574 CAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKY-------LHSSNYSLDIFQR 626
            +++K ++H N+V +      ++   LV EY+    L++Y       L   N  L +FQ 
Sbjct: 54  ASLLKDLKHANIVTLHDIIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFLFQL 112

Query: 627 LNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 675
           L         L Y H      V+H DLKP N+L+ +     L+DFG+A+
Sbjct: 113 LR-------GLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 59.1 bits (143), Expect = 2e-09
 Identities = 61/236 (25%), Positives = 101/236 (42%), Gaps = 39/236 (16%)

Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNL 585
           D + +   IG G +G VYKAR    G  VA+K       +     D E     ++R  +L
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALK-------KTRLEMDEEGIPPTALREISL 53

Query: 586 VKVISSC------------SNEEFKA---LVLEYMPHGSLEKYLHS----SNYSLDIFQR 626
           ++++S                +  K    LV EY+    L+K++ S        L     
Sbjct: 54  LQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTI 112

Query: 627 LNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDN-MVAHLSDFGIAKLLTGEDQSMT 685
            + M  +   + + H      V+H DLKP N+L+D    +  ++D G+ +  +   +S  
Sbjct: 113 KSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSY- 168

Query: 686 QTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLK 740
            T  + T+ Y APE        ST  D++S G +  E  +RK+P   LF G+  L+
Sbjct: 169 -THEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAE-MSRKQP---LFPGDSELQ 219

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 59.6 bits (144), Expect = 2e-09
 Identities = 60/195 (30%), Positives = 91/195 (46%), Gaps = 15/195 (7%)

Query: 534 LIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAM------MKSIRHRNLV 586
           +IG+G FG V  AR + +    AVKV  LQ     K  + +  M      +K+++H  LV
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKV--LQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 59

Query: 587 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSA 646
            +  S    +    VL+Y+  G L  +L      L+   R     ++ASAL YLH   S 
Sbjct: 60  GLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLH---SL 115

Query: 647 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQV 706
            +++ DLKP N+LLD      L+DFG+ K     + + T +    T  Y+APE   +   
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAPEVLHKQPY 173

Query: 707 STNGDVYSFGIMLME 721
               D +  G +L E
Sbjct: 174 DRTVDWWCLGAVLYE 188

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 59.2 bits (143), Expect = 2e-09
 Identities = 56/212 (26%), Positives = 101/212 (47%), Gaps = 17/212 (8%)

Query: 517 FSYLELFQATDKFSENNLIGRGGFGSVYKAR--IRDGMEVAVKVFNLQCGRAFKSFDV-E 573
           F  LE +   DK      +G G + +VYK R  + D + VA+K   L+         + E
Sbjct: 2   FGKLETYIKLDK------LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIRE 54

Query: 574 CAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDV 633
            +++K ++H N+V +      E+   LV EY+    L++YL     S+++    N+ + +
Sbjct: 55  VSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMH---NVKLFL 110

Query: 634 ASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATI 693
              L  L++ +   V+H DLKP N+L+++     L+DFG+A+       + T +  + T+
Sbjct: 111 FQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLAR--AKSIPTKTYSNEVVTL 168

Query: 694 GYMAPE-YGREGQVSTNGDVYSFGIMLMETFT 724
            Y  P+        ST  D++  G +  E  T
Sbjct: 169 WYRPPDILLGSTDYSTQIDMWGVGCIFYEMST 200

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 59.4 bits (144), Expect = 3e-09
 Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 34/213 (15%)

Query: 527 DKFSENNLIGRGGFGSVYKARIRDGMEV-AVKVFNL-----QCGRAFKSFDVECAMMKSI 580
           + F    +IGRG FG V   R +   +V A+K+ +      +   AF  F  E  +M   
Sbjct: 43  EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAF--FWEERDIMAHA 100

Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSL-DIFQRLNIMIDVASALEY 639
               +V++  +  ++++  +V+EYMP G L   +  SNY + + + R     +V  AL+ 
Sbjct: 101 NSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLM--SNYDIPEKWARFYTA-EVVLALDA 157

Query: 640 LH-FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 698
           +H  G+    IH D+KP N+LLD +    L+DFG    +         T  + T  Y++P
Sbjct: 158 IHSMGF----IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDT-AVGTPDYISP 212

Query: 699 E----------YGREGQVSTNGDVYSFGIMLME 721
           E          YGRE       D +S G+ L E
Sbjct: 213 EVLKSQGGDGYYGRE------CDWWSVGVFLYE 239

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 58.9 bits (142), Expect = 3e-09
 Identities = 55/208 (26%), Positives = 96/208 (46%), Gaps = 17/208 (8%)

Query: 529 FSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAM-----MKSIRH 582
           F    ++G+GGFG V   ++R  G   A K   L+  R  K      A+     ++ +  
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACK--KLEKKRIKKRKGEAMALNEKRILEKVNS 59

Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHS-SNYSLDIFQRLNIMIDVASALEYLH 641
           R +V +  +   ++   LVL  M  G L+ ++++  N   D  + +    ++   LE L 
Sbjct: 60  RFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ 119

Query: 642 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIA-KLLTGEDQSMTQTQTLATIGYMAPEY 700
                 +++ DLKP N+LLDD     +SD G+A ++  GE    T    + T+GYMAPE 
Sbjct: 120 ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE----TVRGRVGTVGYMAPEV 172

Query: 701 GREGQVSTNGDVYSFGIMLMETFTRKKP 728
               + + + D +  G ++ E    + P
Sbjct: 173 INNEKYTFSPDWWGLGCLIYEMIQGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 59.8 bits (145), Expect = 4e-09
 Identities = 29/90 (32%), Positives = 49/90 (54%), Gaps = 2/90 (2%)

Query: 176 ISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNG 235
           + L N  L G +P   +  L H L++  +   ++ G IP  + ++T L  + L  N  NG
Sbjct: 423 LGLDNQGLRGFIPND-ISKLRH-LQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNG 480

Query: 236 SIPITLGKLQKLQDVDLEYNQLEGSIPDSI 265
           SIP +LG+L  L+ ++L  N L G +P ++
Sbjct: 481 SIPESLGQLTSLRILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 58.9 bits (142), Expect = 4e-09
 Identities = 53/200 (26%), Positives = 89/200 (44%), Gaps = 12/200 (6%)

Query: 534 LIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFD---VECAMMKSIRHRNLVKVI 589
           L+G+G FG V   R +  G   A+K+   +   A         E  ++K+ RH  L  + 
Sbjct: 2   LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61

Query: 590 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIM-IDVASALEYLHFGYSAPV 648
            S   ++    V+EY+  G L  + H S   +    R      ++ SAL+YLH   S  +
Sbjct: 62  YSFQTKDRLCFVMEYVNGGEL--FFHLSRERVFSEDRTRFYGAEIVSALDYLH---SGKI 116

Query: 649 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVST 708
           ++ DLK  N++LD +    ++DFG+ K   G   + T      T  Y+APE   +     
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGTPEYLAPEVLEDNDYGR 174

Query: 709 NGDVYSFGIMLMETFTRKKP 728
             D +  G+++ E    + P
Sbjct: 175 AVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 60.2 bits (146), Expect = 4e-09
 Identities = 63/228 (27%), Positives = 94/228 (41%), Gaps = 39/228 (17%)

Query: 534 LIGRGGFGSVYKAR-IRDGMEVAVKVFN---LQCGRAFKSFDVECAMMKSIRHRNLVKVI 589
           LIG+GG G VY A        VA+K       +     K F  E  +   + H  +V V 
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68

Query: 590 SSCSNEEFKALVLEYMPH--GSLEKYLHSSNYSLDIFQR-----------LNIMIDVASA 636
           S CS+ +    V   MP+  G   K L  S +  +   +           L+I   + + 
Sbjct: 69  SICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICAT 125

Query: 637 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ-------------- 682
           +EY+H   S  V+H DLKP N+LL       + D+G A     E++              
Sbjct: 126 IEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICY 182

Query: 683 -SMTQT-QTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKP 728
            SMT   + + T  YMAPE       S + D+Y+ G++L +  T   P
Sbjct: 183 SSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230

Length = 932

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 58.9 bits (142), Expect = 6e-09
 Identities = 63/202 (31%), Positives = 99/202 (49%), Gaps = 23/202 (11%)

Query: 533 NLIGRGGFGSVYKARIRDGME-VAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISS 591
           N+IG G FG VY+A   D  E VA+K   LQ    +K  + E  +MK++ H N++ +   
Sbjct: 72  NIIGNGSFGVVYEAICIDTSEKVAIKKV-LQ-DPQYK--NRELLIMKNLNHINIIFLKDY 127

Query: 592 CSNEEFKA--------LVLEYMPHG--SLEKYLHSSNYSLDIFQRLNIMIDVASALEYLH 641
              E FK         +V+E++P       K+   +N++L +F        +  AL Y+H
Sbjct: 128 YYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH 187

Query: 642 FGYSAPVIHCDLKPSNVLLDDNM-VAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
              S  + H DLKP N+L+D N     L DFG AK L    +S++    + +  Y APE 
Sbjct: 188 ---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSY---ICSRFYRAPEL 241

Query: 701 GR-EGQVSTNGDVYSFGIMLME 721
                  +T+ D++S G ++ E
Sbjct: 242 MLGATNYTTHIDLWSLGCIIAE 263

Length = 440

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 58.0 bits (140), Expect = 7e-09
 Identities = 64/235 (27%), Positives = 114/235 (48%), Gaps = 46/235 (19%)

Query: 522 LFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFN------LQCGRAFKSFDVEC 574
           +++  ++++    +G G +GSV  A   R G +VA+K  +      +   RA++    E 
Sbjct: 10  VWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR----EL 65

Query: 575 AMMKSIRHRNLVKVI----SSCSNEEFKA--LVLEYMPHGSLEKYLHSSNYSLDIFQRLN 628
            ++K ++H N++ ++    S+ S +EF+   LV+ YM    L+K +     S D  Q L 
Sbjct: 66  TLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYM-QTDLQK-IMGHPLSEDKVQYL- 122

Query: 629 IMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQ 688
            +  +   L+Y+H   SA +IH DLKP N+ ++++    + DFG+A+     D  MT   
Sbjct: 123 -VYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR---HADAEMT--- 172

Query: 689 TLATIGYMAPEYGREGQVSTNG-------DVYSFGIMLMETFTRKKPTDELFNGE 736
                GY+   + R  +V  N        D++S G ++ E  T K     LF G+
Sbjct: 173 -----GYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKT----LFKGK 218

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 58.1 bits (140), Expect = 8e-09
 Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 18/205 (8%)

Query: 534 LIGRGGFGSVYKARIRDGMEV-AVKVFNL-----QCGRAFKSFDVECAMMKSIRHRNLVK 587
           +IGRG FG V   R +   +V A+K+ +      +   AF  F  E  +M       +V+
Sbjct: 50  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF--FWEERDIMAFANSPWVVQ 107

Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAP 647
           +  +  ++ +  +V+EYMP G L   +  SNY +          +V  AL+ +H   S  
Sbjct: 108 LFYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARFYTAEVVLALDAIH---SMG 162

Query: 648 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY----GRE 703
            IH D+KP N+LLD +    L+DFG    +  E      T  + T  Y++PE     G +
Sbjct: 163 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISPEVLKSQGGD 221

Query: 704 GQVSTNGDVYSFGIMLMETFTRKKP 728
           G      D +S G+ L E      P
Sbjct: 222 GYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 57.8 bits (139), Expect = 9e-09
 Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 43/213 (20%)

Query: 535 IGRGGFGSV---YKARIRDGMEVAVKVFNLQCGRAFKSF------DVECAMMKSIRHRNL 585
           +G G +GSV   Y  R+R   +VAVK    +  R F+S         E  ++K ++H N+
Sbjct: 23  VGSGAYGSVCSAYDTRLRQ--KVAVK----KLSRPFQSLIHARRTYRELRLLKHMKHENV 76

Query: 586 VKVIS----SCSNEEFKALVLEYMPHGS-LEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
           + ++     + S E F  + L     G+ L   +     S +  Q L  +  +   L+Y+
Sbjct: 77  IGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFL--IYQLLRGLKYI 134

Query: 641 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
           H   SA +IH DLKPSNV ++++    + DFG+A+     D  MT        GY+A  +
Sbjct: 135 H---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR---QADDEMT--------GYVATRW 180

Query: 701 GREGQVSTNG-------DVYSFGIMLMETFTRK 726
            R  ++  N        D++S G ++ E    K
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 57.3 bits (138), Expect = 1e-08
 Identities = 57/212 (26%), Positives = 98/212 (46%), Gaps = 27/212 (12%)

Query: 523 FQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVF------NLQCGRAFKSFDVECA 575
           F    ++ +   IG G  G V  A     G+ VAVK             RA++    E  
Sbjct: 17  FTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYR----ELV 72

Query: 576 MMKSIRHRNLVKVIS----SCSNEEFKA--LVLEYMPHGSLEKYLHSSNYSLDIFQRLNI 629
           ++K + H+N++ +++      S EEF+   LV+E M   +L + +H     LD  +   +
Sbjct: 73  LLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIH---MELDHERMSYL 128

Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
           +  +   +++LH   SA +IH DLKPSN+++  +    + DFG+A+       +   T  
Sbjct: 129 LYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC---TNFMMTPY 182

Query: 690 LATIGYMAPEYGREGQVSTNGDVYSFGIMLME 721
           + T  Y APE         N D++S G ++ E
Sbjct: 183 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 57.3 bits (138), Expect = 2e-08
 Identities = 84/305 (27%), Positives = 130/305 (42%), Gaps = 17/305 (5%)

Query: 116 NASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTH 175
           N   ++   L +N  S  +     +L  L  L L   +  SS   L    +L N   L  
Sbjct: 41  NLESVAVNRLALNLSSNTLLLLPSSLSRLLSLDLLSPSGISS---LDGSENLLNLLPLPS 97

Query: 176 ISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTD-LTTIVLGGNKLN 234
           + L+ N L   +    +  L++        N      IP  I  L   L  + L  NK+ 
Sbjct: 98  LDLNLNRLRSNISE--LLELTNLTSLDLDNNNITD--IPPLIGLLKSNLKELDLSDNKI- 152

Query: 235 GSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTF 294
            S+P  L  L  L+++DL +N L   +P  +     L  L+L GNK+S  +P     ++ 
Sbjct: 153 ESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSA 210

Query: 295 LKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSG 354
           L+ L L +N +  +  +  +LK++  L LS+N     LP  I NL  L  +D S N  S 
Sbjct: 211 LEELDLSNNSIIELLSSLSNLKNLSGLELSNN-KLEDLPESIGNLSNLETLDLSNNQIS- 268

Query: 355 IIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYL 414
                +GSL NL  L L  N L  ++P     L+ L+ L    N L     + L+  S L
Sbjct: 269 -SISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLL---NLLLTLKALELKLNSIL 324

Query: 415 KDLNL 419
            + N+
Sbjct: 325 LNNNI 329

Length = 394

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 56.0 bits (135), Expect = 2e-08
 Identities = 50/206 (24%), Positives = 97/206 (47%), Gaps = 15/206 (7%)

Query: 528 KFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNL--QCGRAFKSFDVECAMMKSIRHRN 584
           K+ +   IG G FG     + + DG +  +K  N+     +  +    E A++ +++H N
Sbjct: 1   KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60

Query: 585 LVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIM---IDVASALEYLH 641
           +V+   S        +V++Y   G L K +++    L  F    I+   + +  AL+++H
Sbjct: 61  IVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVL--FPEDQILDWFVQICLALKHVH 118

Query: 642 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT-LATIGYMAPEY 700
                 ++H D+K  N+ L  +    L DFGIA++L   + ++   +T + T  Y++PE 
Sbjct: 119 ---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVL---NSTVELARTCIGTPYYLSPEI 172

Query: 701 GREGQVSTNGDVYSFGIMLMETFTRK 726
                 +   D+++ G +L E  T K
Sbjct: 173 CENRPYNNKSDIWALGCVLYEMCTLK 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 56.2 bits (135), Expect = 2e-08
 Identities = 57/205 (27%), Positives = 93/205 (45%), Gaps = 26/205 (12%)

Query: 534 LIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSI-RHRNLVKVI-- 589
           ++G G +G VYK R ++ G   A+KV ++      +   +E  M+K    HRN+      
Sbjct: 23  VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIKLEINMLKKYSHHRNIATYYGA 81

Query: 590 ----SSCSNEEFKALVLEYMPHGS---LEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
               S   +++   LV+E+   GS   L K    +    D      I  ++   L +LH 
Sbjct: 82  FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGLAHLH- 138

Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT-LATIGYMAPEY- 700
             +  VIH D+K  NVLL +N    L DFG++  L   D+++ +  T + T  +MAPE  
Sbjct: 139 --AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFIGTPYWMAPEVI 193

Query: 701 ----GREGQVSTNGDVYSFGIMLME 721
                 +       D++S GI  +E
Sbjct: 194 ACDENPDATYDYRSDIWSLGITAIE 218

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 55.6 bits (134), Expect = 2e-08
 Identities = 55/207 (26%), Positives = 92/207 (44%), Gaps = 26/207 (12%)

Query: 535 IGRGGFGSVYKARIRD--------GMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLV 586
           +G+G F  ++K   R+          EV +KV +       +SF    +MM  + H++LV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 587 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSA 646
                C   +   +V EY+  GSL+ YL  +   ++I  +L +   +A AL +L      
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE---DK 119

Query: 647 PVIHCDLKPSNVLL---DDNMVAH-----LSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 698
            + H ++   NVLL   +D    +     LSD GI+  +  ++        L  I ++ P
Sbjct: 120 GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKE------ILLERIPWVPP 173

Query: 699 EYGREGQ-VSTNGDVYSFGIMLMETFT 724
           E     Q +S   D +SFG  L E F+
Sbjct: 174 ECIENPQNLSLAADKWSFGTTLWEIFS 200

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 55.8 bits (134), Expect = 3e-08
 Identities = 54/211 (25%), Positives = 96/211 (45%), Gaps = 15/211 (7%)

Query: 517 FSYLELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDV-EC 574
           F  LE +   DK      +G G + +V+K R +     VA+K   L+         + E 
Sbjct: 1   FGKLETYVKLDK------LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREV 54

Query: 575 AMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVA 634
           +++K+++H N+V +      E    LV EY+    L++YL +    + +      M  + 
Sbjct: 55  SLLKNLKHANIVTLHDIIHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQLL 113

Query: 635 SALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIG 694
             L Y H      ++H DLKP N+L+++     L+DFG+A+       + T +  + T+ 
Sbjct: 114 RGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLAR--AKSVPTKTYSNEVVTLW 168

Query: 695 YMAPE-YGREGQVSTNGDVYSFGIMLMETFT 724
           Y  P+      + ST  D++  G +L E  T
Sbjct: 169 YRPPDVLLGSTEYSTPIDMWGVGCILYEMAT 199

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 56.4 bits (136), Expect = 3e-08
 Identities = 31/92 (33%), Positives = 50/92 (54%), Gaps = 3/92 (3%)

Query: 633 VASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLAT 692
           VA  +E+L    S   IH DL   N+LL +N V  + DFG+A+ +  +   + +      
Sbjct: 182 VARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238

Query: 693 IGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 724
           + +MAPE   +   +T  DV+SFG++L E F+
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 55.3 bits (133), Expect = 3e-08
 Identities = 48/195 (24%), Positives = 90/195 (46%), Gaps = 13/195 (6%)

Query: 535 IGRGGFGSVY-----KARIRDGMEV--AVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVK 587
           +G+G FG+VY     KA   + ++V   + V  L      ++ + E  ++  + H  +VK
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQA-NQEAQLLSKLDHPAIVK 66

Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAP 647
             +S    +   ++ EY     L+  L    ++        +       L  +H+ +   
Sbjct: 67  FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR 126

Query: 648 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE-DQSMTQTQTLATIGYMAPEYGREGQV 706
           ++H DLK  N+ L +N++  + DFG+++LL G  D + T T    T  YM+PE  +    
Sbjct: 127 ILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLATTFT---GTPYYMSPEALKHQGY 182

Query: 707 STNGDVYSFGIMLME 721
            +  D++S G +L E
Sbjct: 183 DSKSDIWSLGCILYE 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 56.4 bits (136), Expect = 3e-08
 Identities = 38/153 (24%), Positives = 72/153 (47%), Gaps = 11/153 (7%)

Query: 572 VECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYS--LDIFQRLNI 629
           +E  +++++ H +++++  +  +     +VL   PH S + Y + +  S  L I Q L I
Sbjct: 106 IEAMLLQNVNHPSVIRMKDTLVSGAITCMVL---PHYSSDLYTYLTKRSRPLPIDQALII 162

Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
              +   L YLH   +  +IH D+K  N+ ++D     + D G A+        +    T
Sbjct: 163 EKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGT 219

Query: 690 LATIGYMAPEYGREGQVSTNGDVYSFGIMLMET 722
           + T    APE     + ++  D++S GI+L E 
Sbjct: 220 VET---NAPEVLARDKYNSKADIWSAGIVLFEM 249

Length = 357

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 55.5 bits (133), Expect = 3e-08
 Identities = 56/203 (27%), Positives = 92/203 (45%), Gaps = 22/203 (10%)

Query: 534 LIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSI-RHRNLVKVISS 591
           L+G G +G VYK R ++ G   A+KV ++  G   +    E  M+K    HRN+     +
Sbjct: 13  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGA 71

Query: 592 CSNEEFKA------LVLEYMPHGSLEKYL-HSSNYSLDIFQRLNIMIDVASALEYLHFGY 644
              +          LV+E+   GS+   + ++   +L       I  ++   L +LH   
Sbjct: 72  FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH--- 128

Query: 645 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT-LATIGYMAPEY--- 700
              VIH D+K  NVLL +N    L DFG++  L   D+++ +  T + T  +MAPE    
Sbjct: 129 QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFIGTPYWMAPEVIAC 185

Query: 701 --GREGQVSTNGDVYSFGIMLME 721
               +       D++S GI  +E
Sbjct: 186 DENPDATYDFKSDLWSLGITAIE 208

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 56.2 bits (135), Expect = 3e-08
 Identities = 32/104 (30%), Positives = 53/104 (50%), Gaps = 3/104 (2%)

Query: 621 LDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE 680
           L     L+    VA  +E+L    S   +H DL   NVLL    +  + DFG+A+ +  +
Sbjct: 234 LTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHD 290

Query: 681 DQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 724
              +++  T   + +MAPE   +   +T  DV+S+GI+L E F+
Sbjct: 291 SNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 55.8 bits (134), Expect = 4e-08
 Identities = 52/200 (26%), Positives = 87/200 (43%), Gaps = 12/200 (6%)

Query: 534 LIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFD---VECAMMKSIRHRNLVKVI 589
           L+G+G FG V   R +  G   A+K+   +   A         E  ++++ RH  L  + 
Sbjct: 2   LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61

Query: 590 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIM-IDVASALEYLHFGYSAPV 648
            +    +    V+EY   G L  + H S   +   +R      ++ SALEYLH   S  V
Sbjct: 62  YAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYLH---SRDV 116

Query: 649 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVST 708
           ++ D+K  N++LD +    ++DFG+ K   G     T      T  Y+APE   +     
Sbjct: 117 VYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDYGR 174

Query: 709 NGDVYSFGIMLMETFTRKKP 728
             D +  G+++ E    + P
Sbjct: 175 AVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 55.4 bits (133), Expect = 4e-08
 Identities = 52/205 (25%), Positives = 99/205 (48%), Gaps = 11/205 (5%)

Query: 527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDV-ECAMMKSIRHRN 584
           D F   + +G G  G V K + +  G+ +A K+ +L+   A ++  + E  ++       
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 585 LVKVISSCSNEEFKALVLEYMPHGSLEKYL-HSSNYSLDIFQRLNIMIDVASALEYLHFG 643
           +V    +  ++   ++ +E+M  GSL++ L  +     +I  +++I   V   L YL   
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA--VLRGLAYLREK 122

Query: 644 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE 703
           +   ++H D+KPSN+L++      L DFG++  L     SM  +  + T  YM+PE  + 
Sbjct: 123 HQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSPERLQG 176

Query: 704 GQVSTNGDVYSFGIMLMETFTRKKP 728
              S   D++S G+ L+E    + P
Sbjct: 177 THYSVQSDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 55.5 bits (133), Expect = 5e-08
 Identities = 53/208 (25%), Positives = 99/208 (47%), Gaps = 19/208 (9%)

Query: 535 IGRGGFGSVYKARIRDG---MEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLV---KV 588
           +GRG +G VYKA+ +DG    E A+K   ++      S   E A+++ ++H N++   KV
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALK--QIEGTGISMSACREIALLRELKHPNVIALQKV 66

Query: 589 ISSCSNEEFKALVLEYMPHG--SLEKYLHSSNYSLDIFQRLNIMID--VASALEYLHFGY 644
             S S+ +   L+ +Y  H    + K+  +S  +    Q    M+   +   L+ +H+ +
Sbjct: 67  FLSHSDRKV-WLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125

Query: 645 SAPVIHCDLKPSNVLL----DDNMVAHLSDFGIAKLLTGEDQSMTQTQ-TLATIGYMAPE 699
           +  V+H DLKP+N+L+     +     ++D G A+L     + +      + T  Y APE
Sbjct: 126 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185

Query: 700 YGREGQVSTNG-DVYSFGIMLMETFTRK 726
                +  T   D+++ G +  E  T +
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 55.4 bits (133), Expect = 5e-08
 Identities = 30/92 (32%), Positives = 49/92 (53%), Gaps = 3/92 (3%)

Query: 633 VASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLAT 692
           VA  +E+L    S   IH DL   N+LL +N V  + DFG+A+ +  +   + +      
Sbjct: 188 VAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244

Query: 693 IGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 724
           + +MAPE   +   +   DV+SFG++L E F+
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 55.0 bits (132), Expect = 6e-08
 Identities = 31/92 (33%), Positives = 50/92 (54%), Gaps = 3/92 (3%)

Query: 633 VASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLAT 692
           VA  +E+L    S   IH DL   N+LL +N V  + DFG+A+ +  +   + +      
Sbjct: 183 VARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239

Query: 693 IGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 724
           + +MAPE   +   +T  DV+SFG++L E F+
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 55.0 bits (132), Expect = 6e-08
 Identities = 62/231 (26%), Positives = 106/231 (45%), Gaps = 39/231 (16%)

Query: 522 LFQATDKFSENNLIGRGGFGSV-YKARIRDGMEVAVKVF------NLQCGRAFKSFDVEC 574
           +++  D++ +   +G G +G+V      R G +VA+K         L   RA++    E 
Sbjct: 10  IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR----EL 65

Query: 575 AMMKSIRHRN---LVKVISSCSN-EEFKA--LVLEYMPHGSLEKYLHSSNYSLDIFQRLN 628
            ++K ++H N   L+ V +   + + F    LV+ +M    L K +     S D  Q L 
Sbjct: 66  RLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFL- 123

Query: 629 IMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQ 688
            +  +   L+Y+H   +A +IH DLKP N+ ++++    + DFG+A+     D  M  T 
Sbjct: 124 -VYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR---QTDSEM--TG 174

Query: 689 TLATIGYMAPE----YGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNG 735
            + T  Y APE    +    Q     D++S G ++ E  T K     LF G
Sbjct: 175 YVVTRWYRAPEVILNWMHYTQTV---DIWSVGCIMAEMLTGKP----LFKG 218

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 55.1 bits (133), Expect = 7e-08
 Identities = 47/164 (28%), Positives = 84/164 (51%), Gaps = 22/164 (13%)

Query: 565 RAFKSFDVECAMMKSIRHRNLVKVIS----SCSNEEFKA--LVLEYMPHGSLEKYLHSSN 618
           RA++       +MK + H+N++ +++      S EEF+   LV+E M   +L + +    
Sbjct: 61  RAYREL----VLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQ--- 112

Query: 619 YSLDIFQRLNIMI-DVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 677
             LD  +R++ ++  +   +++LH   SA +IH DLKPSN+++  +    + DFG+A+  
Sbjct: 113 MDLD-HERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-T 167

Query: 678 TGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLME 721
            G    M  T  + T  Y APE         N D++S G ++ E
Sbjct: 168 AGTSFMM--TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 209

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 55.0 bits (132), Expect = 7e-08
 Identities = 58/213 (27%), Positives = 92/213 (43%), Gaps = 25/213 (11%)

Query: 528 KFSENNLI---GRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDV-----ECAMMKS 579
           K+ + N I   G G FG V  A  ++     V +   +  +  K   V     E  ++  
Sbjct: 28  KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNY 87

Query: 580 IRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLH-SSNYSLDI--FQRLNIMIDVASA 636
           I H   V +  S  +E +  LVLE++  G    +L  +  +  D+  F    I++     
Sbjct: 88  INHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVL----I 143

Query: 637 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTL-ATIGY 695
            EYL    S  +++ DLKP N+LLD +    ++DFG AK++       T+T TL  T  Y
Sbjct: 144 FEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD------TRTYTLCGTPEY 194

Query: 696 MAPEYGREGQVSTNGDVYSFGIMLMETFTRKKP 728
           +APE           D ++ GI + E      P
Sbjct: 195 IAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227

Length = 340

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 54.5 bits (131), Expect = 7e-08
 Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 22/200 (11%)

Query: 535 IGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRA-FKSFDVECAMMKSIRHRNLVKVISSC 592
           +G+G +GSVYK   R  G+ +A+K   L+   + F    +E  ++       +V    + 
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68

Query: 593 SNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRL--NIMIDVASALEYLHFGYSAPVIH 650
             E    + +EYM  GSL+K       +  I + +   I   V   L++L   ++  +IH
Sbjct: 69  FIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIH 126

Query: 651 CDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIG---YMAPEYGREGQVS 707
            D+KP+NVL++ N    L DFG++  L     S+ +T     IG   YMAPE  + G  +
Sbjct: 127 RDVKPTNVLVNGNGQVKLCDFGVSGNLV---ASLAKTN----IGCQSYMAPERIKSGGPN 179

Query: 708 TNG------DVYSFGIMLME 721
            N       DV+S G+ ++E
Sbjct: 180 QNPTYTVQSDVWSLGLSILE 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 55.0 bits (132), Expect = 9e-08
 Identities = 34/107 (31%), Positives = 56/107 (52%), Gaps = 9/107 (8%)

Query: 633 VASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLAT 692
           VA+ +E+L    S   +H DL   NVL+ +  +  + DFG+A+ +  +   +++  T   
Sbjct: 248 VANGMEFLA---SKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304

Query: 693 IGYMAPEYGREGQVSTNGDVYSFGIMLMETFT------RKKPTDELF 733
           + +MAPE       +T  DV+SFGI+L E FT       + P +E F
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF 351

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 49.1 bits (118), Expect = 9e-08
 Identities = 25/60 (41%), Positives = 34/60 (56%)

Query: 365 NLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKL 424
           NL++L L  NRL      +F  L +LK L+LS NNL+   P +   L  L+ L+LS N L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 54.8 bits (132), Expect = 1e-07
 Identities = 30/85 (35%), Positives = 43/85 (50%), Gaps = 1/85 (1%)

Query: 250 VDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELT-SI 308
           + L+   L G IP+ I     L  + L GN + G+IP    ++T L+VL L  N    SI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 309 PLNFWSLKDILDLNLSSNCFSGPLP 333
           P +   L  +  LNL+ N  SG +P
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVP 507

Length = 623

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 53.7 bits (129), Expect = 1e-07
 Identities = 59/228 (25%), Positives = 97/228 (42%), Gaps = 23/228 (10%)

Query: 535 IGRGGFGSVYKARIRDGMEVA-VKVFNLQCGRAFK---SFDVECAMMKSIRHRNLVKVIS 590
           IG G FG V  + I     VA V V  L+   + K    F  +    + ++H N+++ + 
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62

Query: 591 SCSNEEFKALVLEYMPHGSLEKYL-----HSSNYSLDIFQRLNIMIDVASALEYLHFGYS 645
            C       LV EY   G L+ YL     H  N  L + QR+    ++A+ + ++H    
Sbjct: 63  QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRM--ACEIAAGVTHMH---K 117

Query: 646 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY--GRE 703
              +H DL   N  L  ++   + D+GI      ED   T+      + ++APE      
Sbjct: 118 HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFH 177

Query: 704 GQVSTN-----GDVYSFGIMLMETF-TRKKPTDELFNGEMTLKHWVND 745
           G + T       +V++ G+ L E F    +P   L + E+ L H + D
Sbjct: 178 GGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREV-LNHVIKD 224

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 53.8 bits (129), Expect = 1e-07
 Identities = 50/209 (23%), Positives = 98/209 (46%), Gaps = 17/209 (8%)

Query: 517 FSYLELFQATDKFSENNLIGRGGFGSVYKAR--IRDGMEVAVKVFNLQCGRAFKSFDV-E 573
           F  +E +   +K      +G G + +V+K R  + + + VA+K   L+         + E
Sbjct: 2   FGKMETYIKLEK------LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIRE 54

Query: 574 CAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDV 633
            +++K ++H N+V +      ++   LV EY+    L++Y+       +I    N+ I +
Sbjct: 55  VSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCG---NIMSMHNVKIFL 110

Query: 634 ASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATI 693
              L  L + +   V+H DLKP N+L+++     L+DFG+A+       + T +  + T+
Sbjct: 111 YQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLAR--AKSVPTKTYSNEVVTL 168

Query: 694 GYMAPEYGR-EGQVSTNGDVYSFGIMLME 721
            Y  P+      + ST  D++  G +  E
Sbjct: 169 WYRPPDVLLGSSEYSTQIDMWGVGCIFFE 197

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 53.9 bits (129), Expect = 2e-07
 Identities = 51/187 (27%), Positives = 85/187 (45%), Gaps = 30/187 (16%)

Query: 565 RAFKSFDVECAMMKSIRHRNLVKVISSCSN----EEFKA--LVLEYMPHG---SLEKYLH 615
           RA++    E  +MK + H+N++ +++  +     EEF+   LV+E M       ++  L 
Sbjct: 62  RAYR----ELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELD 117

Query: 616 SSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 675
               S  ++Q L         +++LH   SA +IH DLKPSN+++  +    + DFG+A+
Sbjct: 118 HERMSYLLYQML-------CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167

Query: 676 LLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNG 735
                  S   T  + T  Y APE         N D++S G ++ E    K     LF G
Sbjct: 168 T---AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPG 220

Query: 736 EMTLKHW 742
              +  W
Sbjct: 221 RDYIDQW 227

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 53.2 bits (128), Expect = 2e-07
 Identities = 63/232 (27%), Positives = 101/232 (43%), Gaps = 52/232 (22%)

Query: 534 LIGRGGFGSVYKARIRDGMEV-AVKVFNLQCGRAFKSFDVECAMMK------SIRHRNLV 586
           ++G+G FG V  A  +   E+ A+K+  L+     +  DVEC M++        +   L 
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKI--LKKDVIIQDDDVECTMVEKRVLALPGKPPFLT 64

Query: 587 KVISSCSNEEFKALVLEYMPHGSLE---------KYLHSSNYSLDIFQRLNIMIDVASAL 637
           ++ S     +    V+EY+  G L          K  H+  Y+ +I          A  L
Sbjct: 65  QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEI----------AIGL 114

Query: 638 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTL-ATIGYM 696
            +LH   S  +I+ DLK  NV+LD      ++DFG+ K      ++   T+T   T  Y+
Sbjct: 115 FFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT---TRTFCGTPDYI 168

Query: 697 APE------YGREGQVSTNGDVYSFGIMLMETFTRKKP-----TDELFNGEM 737
           APE      YG+      + D ++FG++L E    + P      DELF   M
Sbjct: 169 APEIIAYQPYGK------SVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM 214

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 53.1 bits (128), Expect = 2e-07
 Identities = 59/218 (27%), Positives = 95/218 (43%), Gaps = 31/218 (14%)

Query: 535 IGRGGFGSVYKARIRDGMEV-AVKVFNLQCGRAFKSFDVECAMMK--------SIRHRNL 585
           +GRG FG V  A  +   E+ A+K   L+ G      +VE  M +        S RH  L
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKA--LKKGDIIARDEVESLMCEKRIFETANSERHPFL 64

Query: 586 VKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVAS---ALEYLHF 642
           V + +    E+    V+EY   G L  ++H+     D+F     +   A     L+YLH 
Sbjct: 65  VNLFACFQTEDHVCFVMEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLH- 118

Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTL-ATIGYMAPEYG 701
                +++ DLK  N+LLD      ++DFG+ K   G      +T T   T  ++APE  
Sbjct: 119 --ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD---RTSTFCGTPEFLAPEVL 173

Query: 702 REGQVSTNGDVYSFGIMLMETFTRKKP-----TDELFN 734
            E   +   D +  G+++ E    + P      +E+F+
Sbjct: 174 TETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFD 211

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 53.1 bits (127), Expect = 2e-07
 Identities = 52/206 (25%), Positives = 100/206 (48%), Gaps = 13/206 (6%)

Query: 527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDV-ECAMMKSIRHRN 584
           D F + + +G G  G V+K   +  G+ +A K+ +L+   A ++  + E  ++       
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 585 LVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRL--NIMIDVASALEYLHF 642
           +V    +  ++   ++ +E+M  GSL++ L  +     I +++   + I V   L YL  
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLRE 121

Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
            +   ++H D+KPSN+L++      L DFG++  L     SM  +  + T  YM+PE  +
Sbjct: 122 KHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSPERLQ 175

Query: 703 EGQVSTNGDVYSFGIMLMETFTRKKP 728
               S   D++S G+ L+E    + P
Sbjct: 176 GTHYSVQSDIWSMGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 54.1 bits (130), Expect = 3e-07
 Identities = 24/54 (44%), Positives = 34/54 (62%)

Query: 376 LEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIP 429
           L G IP+    L  L+S+NLS N++ G IP SL  ++ L+ L+LS+N   G IP
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIP 483

Length = 623

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 53.4 bits (128), Expect = 3e-07
 Identities = 30/105 (28%), Positives = 50/105 (47%), Gaps = 3/105 (2%)

Query: 620 SLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG 679
           +LD    L+    VA  + +L    S   IH DL   N+LL    +  + DFG+A+ +  
Sbjct: 210 ALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRN 266

Query: 680 EDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 724
           +   + +      + +MAPE       +   DV+S+GI+L E F+
Sbjct: 267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 53.3 bits (128), Expect = 3e-07
 Identities = 33/104 (31%), Positives = 53/104 (50%), Gaps = 3/104 (2%)

Query: 621 LDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE 680
           LD+   L     VA  +++L    S   IH D+   NVLL D  VA + DFG+A+ +  +
Sbjct: 209 LDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMND 265

Query: 681 DQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 724
              + +      + +MAPE   +   +   DV+S+GI+L E F+
Sbjct: 266 SNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 53.1 bits (127), Expect = 3e-07
 Identities = 58/218 (26%), Positives = 96/218 (44%), Gaps = 24/218 (11%)

Query: 534 LIGRGGFGSVYKARIRDGMEV-AVKVFNLQCGRAFKSFDVECAMMK------SIRHRNLV 586
           ++G+G FG V  A  +   E+ A+K+  L+     +  DVEC M++      S +   L 
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKI--LKKDVVIQDDDVECTMVEKRVLALSGKPPFLT 64

Query: 587 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSA 646
           ++ S     +    V+EY+  G L   +      +  F+  + +   A     L F +S 
Sbjct: 65  QLHSCFQTMDRLYFVMEYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSK 120

Query: 647 PVIHCDLKPSNVLLDDNMVAHLSDFGIAK--LLTGEDQSMTQTQTLATIGYMAPEYGREG 704
            +I+ DLK  NV+LD      ++DFG+ K  +  G    +T      T  Y+APE     
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG----VTTKTFCGTPDYIAPEIIAYQ 176

Query: 705 QVSTNGDVYSFGIMLMETFTRKKP-----TDELFNGEM 737
               + D ++FG++L E    + P      DELF   M
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 214

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 52.9 bits (127), Expect = 3e-07
 Identities = 55/215 (25%), Positives = 91/215 (42%), Gaps = 14/215 (6%)

Query: 527 DKFSENNLIGRGGFGSVYKARIRDGMEV-AVKVFN---LQCGRAFKSFDVECAMMKSIRH 582
             F   +L+GRG FG V   R +   ++ A+KV     L        F+ E  ++     
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60

Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
             + ++  +  +++   LV+EY P G L   L  + Y  D F        +A  +  +H 
Sbjct: 61  PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLL--NRYE-DQFDEDMAQFYLAELVLAIHS 117

Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY-- 700
            +    +H D+KP NVL+D      L+DFG A  LT  ++ +     + T  Y+APE   
Sbjct: 118 VHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLT-ANKMVNSKLPVGTPDYIAPEVLT 176

Query: 701 ----GREGQVSTNGDVYSFGIMLMETFTRKKPTDE 731
                 +G      D +S G++  E    + P  E
Sbjct: 177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE 211

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 52.8 bits (127), Expect = 3e-07
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 35/210 (16%)

Query: 527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNL 585
           D F +   +G G  G V K   R  G+ +A K+ +L+         ++ A+   I  R L
Sbjct: 1   DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLE---------IKPAIRNQII-REL 50

Query: 586 VKVISSC-------------SNEEFKALVLEYMPHGSLEKYLHSSN-YSLDIFQRLNIMI 631
            KV+  C             S+ E  ++ +E+M  GSL++ L  +     +I  +  I I
Sbjct: 51  -KVLHECNSPYIVGFYGAFYSDGEI-SICMEHMDGGSLDQVLKKAGRIPENILGK--ISI 106

Query: 632 DVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA 691
            V   L YL   +   ++H D+KPSN+L++      L DFG++  L     SM  +  + 
Sbjct: 107 AVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANS-FVG 160

Query: 692 TIGYMAPEYGREGQVSTNGDVYSFGIMLME 721
           T  YM+PE  +    +   D++S G+ L+E
Sbjct: 161 TRSYMSPERLQGTHYTVQSDIWSLGLSLVE 190

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 53.7 bits (129), Expect = 3e-07
 Identities = 53/184 (28%), Positives = 87/184 (47%), Gaps = 23/184 (12%)

Query: 535 IGRGGFGSVYKARIRDGMEV-AVKVFNLQCGRAFKSFDVECAMMKSIR-HRN-------- 584
           I RG FG VY  R ++  ++ AVKV         K+  +   M+  ++  R+        
Sbjct: 12  ISRGAFGKVYLGRKKNNSKLYAVKVVK-------KADMINKNMVHQVQAERDALALSKSP 64

Query: 585 -LVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFG 643
            +V +  S  +     LV+EY+  G ++  LH   Y  D    +  + +VA AL+YLH  
Sbjct: 65  FIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGY-FDEEMAVKYISEVALALDYLH-- 121

Query: 644 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE 703
               +IH DLKP N+L+ +     L+DFG++K+    + +M    T  ++     +Y R 
Sbjct: 122 -RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMMDILTTPSMAKPKNDYSRT 180

Query: 704 -GQV 706
            GQV
Sbjct: 181 PGQV 184

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 52.9 bits (127), Expect = 3e-07
 Identities = 64/254 (25%), Positives = 106/254 (41%), Gaps = 56/254 (22%)

Query: 534 LIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFD---------VECAMMKSIRHR 583
           +IG+G +G V  A     G +VA+K  N         F+          E  +++ +RH 
Sbjct: 7   VIGKGSYGVVCSAIDTHTGEKVAIKKIN-------DVFEHVSDATRILREIKLLRLLRHP 59

Query: 584 NLVKVIS---SCSNEEFKAL--VLEYMPHGSLEKYLHS----------SNYSLDIFQRLN 628
           ++V++       S  EFK +  V E M     E  LH            ++   ++Q L 
Sbjct: 60  DIVEIKHIMLPPSRREFKDIYVVFELM-----ESDLHQVIKANDDLTPEHHQFFLYQLLR 114

Query: 629 IMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMT-QT 687
                  AL+Y+H   +A V H DLKP N+L + +    + DFG+A++   +  +    T
Sbjct: 115 -------ALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 164

Query: 688 QTLATIGYMAPEYGRE--GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHW--V 743
             +AT  Y APE       + +   D++S G +  E  T K     LF G+  +     +
Sbjct: 165 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP----LFPGKNVVHQLDLI 220

Query: 744 NDCLPISTMEVVDA 757
            D L   + E +  
Sbjct: 221 TDLLGTPSPETISR 234

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 52.1 bits (125), Expect = 4e-07
 Identities = 58/270 (21%), Positives = 107/270 (39%), Gaps = 37/270 (13%)

Query: 542 SVYKARIRDGMEVAVKVF---NLQCGRAFKSFDVECAMMKSIRHRNLVKV----ISSCSN 594
           S+YK  I +  EV ++ F   +          + E   ++ I   N++K+    I    +
Sbjct: 35  SIYKG-IFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93

Query: 595 EEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLK 654
               +L+LEY   G L + L      L    +L++ ID    L  L+   + P  + +L 
Sbjct: 94  LPRLSLILEYCTRGYLREVL-DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLT 150

Query: 655 PSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE--GQVSTNGDV 712
             + L+ +N    +   G+ K+L     S    + +  + Y + +   +   + +   D+
Sbjct: 151 SVSFLVTENYKLKIICHGLEKIL-----SSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDI 205

Query: 713 YSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQ 772
           YS G++L E FT K P + L                 +T E+ D  L+  ++        
Sbjct: 206 YSLGVVLWEIFTGKIPFENL-----------------TTKEIYD--LIINKNNSLKLPLD 246

Query: 773 CVSFVFNLALECTVESPEQRINAKEIVAKL 802
           C   +  +   CT     +R N KEI+  L
Sbjct: 247 CPLEIKCIVEACTSHDSIKRPNIKEILYNL 276

Length = 283

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 52.2 bits (125), Expect = 4e-07
 Identities = 61/205 (29%), Positives = 93/205 (45%), Gaps = 34/205 (16%)

Query: 535 IGRGGFGSVYKARIRDGMEV-AVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCS 593
           IG+G FG VY+ R +D   + A+KV + +   A K       +  +I  RN++ V +   
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKE------VAHTIGERNIL-VRTLLD 53

Query: 594 NEEFKA-------------LVLEYMPHGSLEKYL-HSSNYSLDIFQRLNIMI-DVASALE 638
              F               LV +YM  G L  +L     +S D   R    I ++  ALE
Sbjct: 54  ESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSED---RAKFYIAELVLALE 110

Query: 639 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL-LTGEDQSMTQTQTLATIGYMA 697
           +LH      +++ DLKP N+LLD      L DFG++K  LT    + T      T  Y+A
Sbjct: 111 HLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT---FCGTTEYLA 164

Query: 698 PEYGREGQVSTNG-DVYSFGIMLME 721
           PE   + +  T   D +S G+++ E
Sbjct: 165 PEVLLDEKGYTKHVDFWSLGVLVFE 189

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 52.4 bits (125), Expect = 5e-07
 Identities = 50/187 (26%), Positives = 84/187 (44%), Gaps = 30/187 (16%)

Query: 565 RAFKSFDVECAMMKSIRHRNLVKVIS----SCSNEEFKAL--VLEYMPHG---SLEKYLH 615
           RA++    E  +MK + H+N++ +++      S EEF+ +  V+E M       ++  L 
Sbjct: 69  RAYR----ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELD 124

Query: 616 SSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 675
               S  ++Q L         +++LH   SA +IH DLKPSN+++  +    + DFG+A+
Sbjct: 125 HERMSYLLYQML-------CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174

Query: 676 LLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNG 735
                  S   T  + T  Y APE         N D++S G ++ E          LF G
Sbjct: 175 T---AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV----LFPG 227

Query: 736 EMTLKHW 742
              +  W
Sbjct: 228 TDHIDQW 234

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 51.9 bits (125), Expect = 5e-07
 Identities = 45/174 (25%), Positives = 81/174 (46%), Gaps = 21/174 (12%)

Query: 535 IGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDV-----ECAMMKSIR-HRNLVK 587
           IG G F  V KA+  + G   A+K       + FKS +      E   ++ +  H N+++
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMK----KHFKSLEQVNNLREIQALRRLSPHPNILR 62

Query: 588 VISSCSNEEFK--ALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYS 645
           +I    + +    ALV E M   +L + +      L   +  + M  +  +L+++H    
Sbjct: 63  LIEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---R 118

Query: 646 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPE 699
             + H D+KP N+L+ D+++  L+DFG  +   G       T+ ++T  Y APE
Sbjct: 119 NGIFHRDIKPENILIKDDIL-KLADFGSCR---GIYSKPPYTEYISTRWYRAPE 168

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 52.0 bits (125), Expect = 5e-07
 Identities = 38/147 (25%), Positives = 61/147 (41%), Gaps = 15/147 (10%)

Query: 534 LIGR----GGFGSVYKARIRDGMEVAVKVFNL--QCGRAFKSFDVECAMMKSIRHRNLVK 587
           LIG+         + K +      VAVK  NL        K    E    + ++H N++ 
Sbjct: 5   LIGKCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP 63

Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRL---NIMIDVASALEYLHFGY 644
            ++S   +    +V   M +GS E  L    +  +    L    I+ DV +AL+Y+H   
Sbjct: 64  YVTSFIVDSELYVVSPLMAYGSCEDLL--KTHFPEGLPELAIAFILKDVLNALDYIH--- 118

Query: 645 SAPVIHCDLKPSNVLLDDNMVAHLSDF 671
           S   IH  +K S++LL  +    LS  
Sbjct: 119 SKGFIHRSVKASHILLSGDGKVVLSGL 145

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 52.3 bits (125), Expect = 7e-07
 Identities = 51/202 (25%), Positives = 87/202 (43%), Gaps = 12/202 (5%)

Query: 534 LIGRGGFGSVYKA-RIRDGMEVAVKVF---NLQCGRAFKSFDVECAMMKSIRHRNLVKVI 589
           L+GR    + + A R  D  E  V  F   N +   A+   ++ C  + +  H  +VK  
Sbjct: 74  LVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHC--LAACDHFGIVKHF 131

Query: 590 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMI---DVASALEYLHFGYSA 646
               +++   L++EY   G L K +         FQ   + +    +  AL+ +H   S 
Sbjct: 132 DDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SR 188

Query: 647 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQV 706
            ++H DLK +N+ L    +  L DFG +K  +        +    T  Y+APE     + 
Sbjct: 189 KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRY 248

Query: 707 STNGDVYSFGIMLMETFTRKKP 728
           S   D++S G++L E  T  +P
Sbjct: 249 SKKADMWSLGVILYELLTLHRP 270

Length = 478

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 51.7 bits (124), Expect = 1e-06
 Identities = 25/78 (32%), Positives = 43/78 (55%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAI 65
           N  L    P +I  + +L+ + L  N ++G I   +G + +L  LDLS N   G+IP ++
Sbjct: 427 NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESL 486

Query: 66  FNVSTLKAFAVTNNSLSG 83
             +++L+   +  NSLSG
Sbjct: 487 GQLTSLRILNLNGNSLSG 504

Length = 623

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 51.1 bits (122), Expect = 1e-06
 Identities = 59/205 (28%), Positives = 90/205 (43%), Gaps = 24/205 (11%)

Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDV----------ECAMMKSIRHRN 584
           IG+G FG V + R RD      +++ L+  R  K+  V          E  ++  +    
Sbjct: 1   IGKGSFGKVMQVRKRD----TQRIYALKTIR--KAHIVSRSEVTHTLAERTVLAQVNCPF 54

Query: 585 LVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGY 644
           +V +  S  + E   LVL ++  G L  +L       D+ +      ++  ALE LH   
Sbjct: 55  IVPLKFSFQSPEKLYLVLAFINGGELFHHLQREG-RFDLSRARFYTAELLCALENLH--- 110

Query: 645 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTL-ATIGYMAPEYGRE 703
              VI+ DLKP N+LLD      L DFG+ KL   +D    +T T   T  Y+APE    
Sbjct: 111 KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD---KTNTFCGTPEYLAPELLLG 167

Query: 704 GQVSTNGDVYSFGIMLMETFTRKKP 728
              +   D ++ G++L E  T   P
Sbjct: 168 HGYTKAVDWWTLGVLLYEMLTGLPP 192

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 50.7 bits (122), Expect = 1e-06
 Identities = 56/234 (23%), Positives = 96/234 (41%), Gaps = 63/234 (26%)

Query: 534 LIGRGGFGSVYKARIRDGMEV-AVKVFNLQC-------GRAFKSFDVECAMMKSIRHRNL 585
           L+G+G  G V+  R++   ++ A+KV + +         R       E  ++ ++ H  L
Sbjct: 8   LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVL----TEQEILATLDHPFL 63

Query: 586 VKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMI------DVASALEY 639
             + +S   E +  LV++Y P G L + L            L+  +      +V  ALEY
Sbjct: 64  PTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGK-----CLSEEVARFYAAEVLLALEY 118

Query: 640 LH-FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQ------------ 686
           LH  G     ++ DLKP N+LL ++    LSDF ++K    E   +++            
Sbjct: 119 LHLLGI----VYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVN 174

Query: 687 ---TQTLATIG------------YMAPE----YGREGQVSTNGDVYSFGIMLME 721
              ++T +               Y+APE     G    V    D ++ GI+L E
Sbjct: 175 SIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV----DWWTLGILLYE 224

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 50.4 bits (120), Expect = 2e-06
 Identities = 75/313 (23%), Positives = 132/313 (42%), Gaps = 30/313 (9%)

Query: 1   MPSIINNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGT 60
              ++ + L+     ++ + S +  L         +    + +L  L  LDL+ N+L   
Sbjct: 58  TLLLLPSSLSRLLSLDLLSPSGISSL---------DGSENLLNLLPLPSLDLNLNRLRSN 108

Query: 61  IPAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKL 120
           I   +  ++ L +  + NN+++  +  +  +   NL+ L L  N    ++P  + N   L
Sbjct: 109 ISE-LLELTNLTSLDLDNNNITD-IPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNL 165

Query: 121 SKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSN 180
             L L  N  S  +P    NL NL  L L  N ++    ++  LS+L        + LSN
Sbjct: 166 KNLDLSFNDLSD-LPKLLSNLSNLNNLDLSGNKISDLPPEIELLSALEE------LDLSN 218

Query: 181 NPLDGILPRTYVGNLSHSLKNFYMY-NCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPI 239
           N +  +L      +LS+      +  + N    +PE I NL++L T+ L  N++  S   
Sbjct: 219 NSIIELLS-----SLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQI--SSIS 271

Query: 240 TLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLS 299
           +LG L  L+++DL  N L  ++P    L + L  L    N L           + L   +
Sbjct: 272 SLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLL---NLLLTLKALELKLNSILLNNN 328

Query: 300 LGSNELTSIPLNF 312
           + SN  TS P   
Sbjct: 329 ILSNGETSSPEAL 341

Length = 394

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 50.8 bits (121), Expect = 2e-06
 Identities = 52/202 (25%), Positives = 86/202 (42%), Gaps = 11/202 (5%)

Query: 534 LIGRGGFGSVYKARIRDGMEV-AVKVFNLQCGRAFKSFD----VECAMMKSIRHRNLVKV 588
           +IGRG +  V   R++    + A+KV   +     +  D     +    ++  H  LV +
Sbjct: 2   VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61

Query: 589 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPV 648
            S    E     V+EY+  G L  ++       +   R     +++ AL YLH      +
Sbjct: 62  HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLH---ERGI 117

Query: 649 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVST 708
           I+ DLK  NVLLD      L+D+G+ K   G     T +    T  Y+APE  R      
Sbjct: 118 IYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGEDYGF 175

Query: 709 NGDVYSFGIMLMETFTRKKPTD 730
           + D ++ G+++ E    + P D
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 50.8 bits (121), Expect = 2e-06
 Identities = 50/202 (24%), Positives = 88/202 (43%), Gaps = 11/202 (5%)

Query: 534 LIGRGGFGSVYKARIRDGMEV-AVKVFNLQCGRAFKSFD---VECAMMKSIRHRNLVKVI 589
           +IGRG +  V   R++   ++ A+KV   +     +  D    E  + +       +  +
Sbjct: 2   VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61

Query: 590 SSCSNEEFKA-LVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPV 648
            SC     +  LV+EY+  G L  ++       +   R     ++  AL +LH      +
Sbjct: 62  HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARF-YAAEICIALNFLH---ERGI 117

Query: 649 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVST 708
           I+ DLK  NVLLD +    L+D+G+ K   G     T +    T  Y+APE  R  +   
Sbjct: 118 IYRDLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGTPNYIAPEILRGEEYGF 175

Query: 709 NGDVYSFGIMLMETFTRKKPTD 730
           + D ++ G+++ E    + P D
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 50.4 bits (120), Expect = 2e-06
 Identities = 50/206 (24%), Positives = 95/206 (46%), Gaps = 15/206 (7%)

Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFK-SFDVECAMMKSIRHRNLV---KVIS 590
           +GRG +G VYKA+ +DG +          G     S   E A+++ ++H N++   KV  
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68

Query: 591 SCSNEEFKALVLEYMPHG--SLEKYLHSSNYSLDIFQRLNIMID--VASALEYLHFGYSA 646
           S ++ +   L+ +Y  H    + K+  +S  +    Q    M+   +   L+ +H+ ++ 
Sbjct: 69  SHADRKV-WLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 127

Query: 647 PVIHCDLKPSNVLL----DDNMVAHLSDFGIAKLLTGEDQSMTQTQ-TLATIGYMAPEYG 701
            V+H DLKP+N+L+     +     ++D G A+L     + +      + T  Y APE  
Sbjct: 128 WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELL 187

Query: 702 REGQVSTNG-DVYSFGIMLMETFTRK 726
              +  T   D+++ G +  E  T +
Sbjct: 188 LGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 49.6 bits (118), Expect = 2e-06
 Identities = 42/174 (24%), Positives = 79/174 (45%), Gaps = 26/174 (14%)

Query: 575 AMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVA 634
           +MM+ + H+++V +   C  +    +V E++  G L+ ++H  +  L    +  +   +A
Sbjct: 56  SMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLA 115

Query: 635 SALEYLHFGYSAPVIHCDLKPSNVLL-------DDNMVAHLSDFGIAKLLTGEDQSMTQT 687
           SAL YL       ++H ++   N+LL       +      LSD GI   +      +++ 
Sbjct: 116 SALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITV------LSRQ 166

Query: 688 QTLATIGYMAPEYGREGQV-STNGDVYSFGIMLMETFTRKKPTDELFNGEMTLK 740
           + +  I ++APE   + +  S   D +SFG  L E           +NGE+ LK
Sbjct: 167 ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI---------CYNGEIPLK 211

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 49.2 bits (117), Expect = 3e-06
 Identities = 41/158 (25%), Positives = 67/158 (42%), Gaps = 8/158 (5%)

Query: 573 ECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQR-LNIMI 631
           E  ++  ++H N+V    S   +    +V+EY   G L + +      L      L   +
Sbjct: 48  EAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFV 107

Query: 632 DVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT-L 690
            +   ++++H      V+H D+K  N+ L  N    L DFG A+LLT          T +
Sbjct: 108 QMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLT---SPGAYACTYV 161

Query: 691 ATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKP 728
            T  Y+ PE       +   D++S G +L E  T K P
Sbjct: 162 GTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 49.6 bits (118), Expect = 4e-06
 Identities = 57/221 (25%), Positives = 91/221 (41%), Gaps = 33/221 (14%)

Query: 527 DKFSENNLIGRGGFGSVYKARIRDGMEV-AVKVFNLQCGRAFKSFDVECAMMKSIRHRNL 585
           D F    +IGRG FG V   +++    + A+K+ N       K  +  C      R    
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKW--EMLKRAETAC-----FREERN 53

Query: 586 VKVISSCS----------NEEFKALVLEYMPHGSLEKYLHSSNYSL-DIFQRLNI--MID 632
           V V   C           +E +  LV++Y   G L   L      L +   R  I  M+ 
Sbjct: 54  VLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVL 113

Query: 633 VASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLAT 692
              ++  LH+      +H D+KP NVLLD N    L+DFG + L   +D ++  +  + T
Sbjct: 114 AIHSIHQLHY------VHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGT 166

Query: 693 IGYMAPEYGRE-----GQVSTNGDVYSFGIMLMETFTRKKP 728
             Y++PE  +      G+     D +S G+ + E    + P
Sbjct: 167 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 49.2 bits (117), Expect = 4e-06
 Identities = 60/215 (27%), Positives = 96/215 (44%), Gaps = 29/215 (13%)

Query: 526 TDKFSENNLIGRGGFGSVYK-ARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSI-RHR 583
           TD +     IG+G +G VYK    +DG   AVK+ +       +  + E  +++S+  H 
Sbjct: 21  TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILD-PISDVDEEIEAEYNILQSLPNHP 79

Query: 584 NLVKVI------SSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLN------IMI 631
           N+VK              +   LVLE    GS+ + +      L   QRL+      I+ 
Sbjct: 80  NVVKFYGMFYKADKLVGGQL-WLVLELCNGGSVTELVKGL---LICGQRLDEAMISYILY 135

Query: 632 DVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA 691
                L++LH   +  +IH D+K +N+LL       L DFG++  LT     + +  ++ 
Sbjct: 136 GALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT--STRLRRNTSVG 190

Query: 692 TIGYMAPEY-GREGQVSTN----GDVYSFGIMLME 721
           T  +MAPE    E Q   +     DV+S GI  +E
Sbjct: 191 TPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIE 225

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 49.2 bits (117), Expect = 4e-06
 Identities = 54/225 (24%), Positives = 99/225 (44%), Gaps = 41/225 (18%)

Query: 534 LIGRGGFGSVYKARIRDGM----EVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVI 589
           LIG GGFG VY+ +         +   K+ NL+     ++  +E  +  +I   + + + 
Sbjct: 19  LIGCGGFGCVYETQCASDHCINNQAVAKIENLEN----ETIVMETLVYNNIYDIDKIALW 74

Query: 590 SSCSNEEFKALVLEYMPHGS------------LEKYLHSSNYSLDIFQRL---------N 628
            +  N +   +   Y   GS            LEK + ++    +IF+R+         N
Sbjct: 75  KNIHNIDHLGIPK-YYGCGSFKRCRMYYRFILLEKLVENTK---EIFKRIKCKNKKLIKN 130

Query: 629 IMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK--LLTGEDQSMTQ 686
           IM D+ + LEY+H      + H D+KP N+++D N   ++ D+GIA   ++ G+    ++
Sbjct: 131 IMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSK 187

Query: 687 TQT---LATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKP 728
            Q      T+ Y   +      V+  GD+ S G  +++    K P
Sbjct: 188 EQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLP 232

Length = 294

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 49.3 bits (117), Expect = 4e-06
 Identities = 51/200 (25%), Positives = 85/200 (42%), Gaps = 11/200 (5%)

Query: 534 LIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFD---VECAMMKSIRHRNLVKVI 589
           L+G+G FG V   + +  G   A+K+   +   A         E  ++++ RH  L  + 
Sbjct: 2   LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61

Query: 590 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIM-IDVASALEYLHFGYSAPV 648
            S    +    V+EY   G L  + H S   +    R      ++ SAL+YLH      V
Sbjct: 62  YSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALDYLH--SEKNV 117

Query: 649 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVST 708
           ++ DLK  N++LD +    ++DFG+ K   G     T      T  Y+APE   +     
Sbjct: 118 VYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDNDYGR 175

Query: 709 NGDVYSFGIMLMETFTRKKP 728
             D +  G+++ E    + P
Sbjct: 176 AVDWWGLGVVMYEMMCGRLP 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 49.4 bits (118), Expect = 6e-06
 Identities = 31/88 (35%), Positives = 54/88 (61%), Gaps = 5/88 (5%)

Query: 26  LYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLSGCL 85
           L L N  L+G I ++I  L +L  ++LS N + G IP ++ ++++L+   ++ NS +G  
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNG-- 480

Query: 86  SSITD-VG-LPNLEVLYLWGNNFSGTIP 111
            SI + +G L +L +L L GN+ SG +P
Sbjct: 481 -SIPESLGQLTSLRILNLNGNSLSGRVP 507

Length = 623

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 48.4 bits (115), Expect = 6e-06
 Identities = 45/174 (25%), Positives = 80/174 (45%), Gaps = 26/174 (14%)

Query: 575 AMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVA 634
           ++M  + H +L  V   C       +V E++ HG L+  L      + +  ++ +   +A
Sbjct: 68  SLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLA 127

Query: 635 SALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH-------LSDFGIAKLLTGEDQSMTQT 687
           SAL YL       ++H ++   N+LL    +A        LSD G++   T    ++++ 
Sbjct: 128 SALSYLE---DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS--FT----ALSRE 178

Query: 688 QTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLK 740
           + +  I ++APE    G  +ST  D +SFG  L+E           F+GE+ LK
Sbjct: 179 ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI---------CFDGEVPLK 223

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 49.1 bits (117), Expect = 6e-06
 Identities = 44/163 (26%), Positives = 69/163 (42%), Gaps = 9/163 (5%)

Query: 568 KSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPH--GSLEKYLHSSNYSLDIFQ 625
           K+   E  ++K+I HR ++ +I +      K+ V   MP     L  Y+  S   L + Q
Sbjct: 131 KTPGREIDILKTISHRAIINLIHAYRW---KSTVCMVMPKYKCDLFTYVDRSG-PLPLEQ 186

Query: 626 RLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMT 685
            + I   +  AL YLH      +IH D+K  N+ LD+   A L DFG A  L     +  
Sbjct: 187 AITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQ 243

Query: 686 QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKP 728
                 T+   +PE           D++S G++L E   +   
Sbjct: 244 CYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286

Length = 392

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 48.5 bits (115), Expect = 7e-06
 Identities = 57/224 (25%), Positives = 102/224 (45%), Gaps = 36/224 (16%)

Query: 534 LIGRGGFGSVYKARIRDGMEV-AVKVFNLQCGRAFKSFDVECAMMK----SIRHRN--LV 586
           ++G+G FG V  A  +   E+ A+K+  L+     +  DVEC M++    +++ +   L 
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKI--LKKDVVIQDDDVECTMVEKRVLALQDKPPFLT 64

Query: 587 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSA 646
           ++ S     +    V+EY+  G L  ++          Q +    +++  L +LH     
Sbjct: 65  QLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFLH---RR 120

Query: 647 PVIHCDLKPSNVLLDDNMVAHLSDFGIAK--LLTGEDQSMTQTQTLATIGYMAPE----- 699
            +I+ DLK  NV+LD      ++DFG+ K  ++ G    +T      T  Y+APE     
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG----VTTRTFCGTPDYIAPEIIAYQ 176

Query: 700 -YGREGQVSTNGDVYSFGIMLMETFTRKKP-----TDELFNGEM 737
            YG+      + D +++G++L E    + P      DELF   M
Sbjct: 177 PYGK------SVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIM 214

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 46.2 bits (110), Expect = 7e-06
 Identities = 32/146 (21%), Positives = 67/146 (45%), Gaps = 15/146 (10%)

Query: 534 LIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLV--KVISS 591
           L+  G    VY    +D  +  +K+   +   A +  +V  A+++ +  + L   KV++S
Sbjct: 5   LLKGGLTNRVYLLGTKDE-DYVLKINPSREKGADREREV--AILQLLARKGLPVPKVLAS 61

Query: 592 CSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPV-IH 650
             ++ +  L++E++   +L++        +   ++ +I   +A  L  LH      V  H
Sbjct: 62  GESDGWSYLLMEWIEGETLDE--------VSEEEKEDIAEQLAELLAKLH-QLPLLVLCH 112

Query: 651 CDLKPSNVLLDDNMVAHLSDFGIAKL 676
            DL P N+L+DD  +  + D+  A  
Sbjct: 113 GDLHPGNILVDDGKILGIIDWEYAGY 138

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 42.9 bits (102), Expect = 1e-05
 Identities = 18/60 (30%), Positives = 23/60 (38%)

Query: 95  NLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNL 154
           NL+ L L  N  +            L  L L  N+ +   P  F  L +L  L L  NNL
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 47.3 bits (112), Expect = 1e-05
 Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 15/210 (7%)

Query: 535 IGRGGFGSVYKA-RIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIR-HRNLVKVISSC 592
           IG+G +G V+K    ++G + AVK+ +       +  + E  ++K++  H N+VK     
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILD-PIHDIDEEIEAEYNILKALSDHPNVVKFYGMY 84

Query: 593 SNEEFKA-----LVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAP 647
             ++ K      LVLE    GS+   +       +  +   I   +  AL  L   +   
Sbjct: 85  YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK 144

Query: 648 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY-GREGQV 706
            IH D+K +N+LL       L DFG++  LT     + +  ++ T  +MAPE    E Q+
Sbjct: 145 TIHRDVKGNNILLTTEGGVKLVDFGVSAQLT--STRLRRNTSVGTPFWMAPEVIACEQQL 202

Query: 707 STN----GDVYSFGIMLMETFTRKKPTDEL 732
            +      DV+S GI  +E      P  +L
Sbjct: 203 DSTYDARCDVWSLGITAIELGDGDPPLADL 232

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 47.7 bits (114), Expect = 2e-05
 Identities = 53/180 (29%), Positives = 77/180 (42%), Gaps = 41/180 (22%)

Query: 527 DKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDVECAMMKSIR-HRN 584
           D F    +IGRG FG V   + +D G   A+K          KS  +E   +  +R  R+
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLR-------KSEMLEKEQVAHVRAERD 53

Query: 585 L---------VKVISSCSNEEFKALVLEYMPHGS----LEKYLHSSNYSLDIF---QRLN 628
           +         VK+  S  +E +  L++EY+P G     L K         D F   +   
Sbjct: 54  ILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKK--------DTFTEEETRF 105

Query: 629 IMIDVASALEYLH-FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQT 687
            + +   A++ +H  GY    IH D+KP N+LLD      LSDFG   L TG  +S    
Sbjct: 106 YIAETILAIDSIHKLGY----IHRDIKPDNLLLDAKGHIKLSDFG---LCTGLKKSHRTE 158

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 46.8 bits (112), Expect = 2e-05
 Identities = 42/166 (25%), Positives = 71/166 (42%), Gaps = 13/166 (7%)

Query: 576 MMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVAS 635
           +MK   + N +K+  S +  +   L+++Y+  G L   L      L   +   I+  +  
Sbjct: 64  LMKD--NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVE 120

Query: 636 ALEYLHFGYSAPVIHCDLKPSNVLLDDNMV-AHLSDFGIAKLLTGEDQSMTQTQTLATIG 694
           AL  LH      +IH D+K  NVL D      +L D+G+ K+            TL    
Sbjct: 121 ALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKI---IGTPSCYDGTLD--- 171

Query: 695 YMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLK 740
           Y +PE  +      + D ++ G++  E  T K P  E  + E+ L+
Sbjct: 172 YFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLE 217

Length = 267

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 46.4 bits (110), Expect = 3e-05
 Identities = 52/220 (23%), Positives = 89/220 (40%), Gaps = 47/220 (21%)

Query: 534 LIGRGGFGSVYKARIRDGMEV-AVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSC 592
           +IGRG +  V    ++    + A+KV      +   + D +   +++ +H     V  + 
Sbjct: 2   VIGRGSYAKVLLVELKKTRRIYAMKVIK----KELVNDDEDIDWVQTEKH-----VFETA 52

Query: 593 SNEEFKA-------------LVLEYMPHGSLEKYL---------HSSNYSLDIFQRLNIM 630
           SN  F                V+E++  G L  ++         H+  YS +I       
Sbjct: 53  SNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEI------- 105

Query: 631 IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTL 690
              + AL +LH      +I+ DLK  NVLLD      L+D+G+ K   G     T +   
Sbjct: 106 ---SLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTSTFC 157

Query: 691 ATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTD 730
            T  Y+APE  R      + D ++ G+++ E    + P D
Sbjct: 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 46.6 bits (110), Expect = 3e-05
 Identities = 54/208 (25%), Positives = 99/208 (47%), Gaps = 21/208 (10%)

Query: 534 LIGRGGFGSVYKARIRDGMEV-AVKVFNL--QCGRAFKS-FDVECAMMKSIRHRNLVKVI 589
           +IGRG FG V   ++++  +V A+K+ N      RA  + F  E  ++ +  ++ +  + 
Sbjct: 8   VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLH 67

Query: 590 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYSL--DIFQ-RLNIMIDVASALEYLHFGYSA 646
            +  +E    LV++Y   G L   L      L  D+ +  L  M+    ++  LH+    
Sbjct: 68  YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHY---- 123

Query: 647 PVIHCDLKPSNVLLDDNMVAHLSDFG-IAKLLTGEDQSMTQTQTLATIGYMAPEYGR--- 702
             +H D+KP N+L+D N    L+DFG   KL+  ED ++  +  + T  Y++PE  +   
Sbjct: 124 --VHRDIKPDNILMDMNGHIRLADFGSCLKLM--EDGTVQSSVAVGTPDYISPEILQAME 179

Query: 703 --EGQVSTNGDVYSFGIMLMETFTRKKP 728
             +G+     D +S G+ + E    + P
Sbjct: 180 DGKGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 41.8 bits (99), Expect = 4e-05
 Identities = 24/59 (40%), Positives = 31/59 (52%)

Query: 342 LIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNL 400
           L  +D S N  + I       L NL+ L L  N L    P++F  L SL+SL+LS NNL
Sbjct: 2   LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 46.3 bits (110), Expect = 4e-05
 Identities = 56/219 (25%), Positives = 90/219 (41%), Gaps = 29/219 (13%)

Query: 527 DKFSENNLIGRGGFGSVYKARIRDGMEV-AVKVFNLQCGRAFKSFDVECAMMKSIRHRNL 585
           D F    +IGRG FG V   ++++  +V A+K+ N       K  +  C      R    
Sbjct: 1   DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKW--EMLKRAETAC-----FREERD 53

Query: 586 VKVISSC----------SNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVAS 635
           V V               +E    LV++Y   G L   L      L        + ++  
Sbjct: 54  VLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVL 113

Query: 636 ALEYLH-FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIG 694
           A++ +H  GY    +H D+KP NVLLD N    L+DFG + L    D ++     + T  
Sbjct: 114 AIDSVHQLGY----VHRDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTVQSNVAVGTPD 168

Query: 695 YMAPEYGR-----EGQVSTNGDVYSFGIMLMETFTRKKP 728
           Y++PE  +     +G+     D +S G+ + E    + P
Sbjct: 169 YISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 46.7 bits (111), Expect = 5e-05
 Identities = 37/139 (26%), Positives = 54/139 (38%), Gaps = 33/139 (23%)

Query: 106 FSGTIPHFIFNASK--LSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSF 163
           +SG    F     K  +  L L+     GFIP+    LR+L+ + L  N++  +      
Sbjct: 404 WSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGN-----I 458

Query: 164 LSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDL 223
             SL +  SL  + LS N                            +G IPE +  LT L
Sbjct: 459 PPSLGSITSLEVLDLSYNSF--------------------------NGSIPESLGQLTSL 492

Query: 224 TTIVLGGNKLNGSIPITLG 242
             + L GN L+G +P  LG
Sbjct: 493 RILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 46.0 bits (109), Expect = 5e-05
 Identities = 52/182 (28%), Positives = 79/182 (43%), Gaps = 22/182 (12%)

Query: 534 LIGRGGFGSVYKARIRDGMEV-AVKVFNLQCGRAFKSFD---VECAMMKSIRHRNLVKVI 589
           L+G+G FG V   R +   +  A+K+   +   A         E  ++++ RH  L  + 
Sbjct: 2   LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61

Query: 590 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIM-IDVASALEYLHFGYSAPV 648
            S    +    V+EY   G L  + H S   +    R      ++ SAL YLH   S  V
Sbjct: 62  YSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALGYLH---SCDV 116

Query: 649 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTL--ATIGYMAPE------Y 700
           ++ DLK  N++LD +    ++DFG+ K    E  S   T      T  Y+APE      Y
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCK----EGISDGATMKTFCGTPEYLAPEVLEDNDY 172

Query: 701 GR 702
           GR
Sbjct: 173 GR 174

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 45.8 bits (109), Expect = 5e-05
 Identities = 50/211 (23%), Positives = 82/211 (38%), Gaps = 25/211 (11%)

Query: 142 RNLEWLTLYDNNLTSSTLDL-SFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNL-SHSL 199
            +L+ L L  N        L S L  L+    L  + LS+N L           L S SL
Sbjct: 51  PSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSL 110

Query: 200 KNFYMYNCNVSGGI-PEEITNLTD----LTTIVLGGNKLNGSIPITLGKL----QKLQDV 250
           +   + N  +           L D    L  +VLG N+L G+    L K     + L+++
Sbjct: 111 QELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKEL 170

Query: 251 DLEYNQLEGSIPDSICL----SVELYELELGGNKL----SGSIPACFSNMTFLKVLSLGS 302
           +L  N +  +   ++      +  L  L+L  N L    + ++    +++  L+VL+LG 
Sbjct: 171 NLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGD 230

Query: 303 NELTSIPL------NFWSLKDILDLNLSSNC 327
           N LT                 +L L+LS N 
Sbjct: 231 NNLTDAGAAALASALLSPNISLLTLSLSCND 261

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 46.0 bits (109), Expect = 7e-05
 Identities = 24/63 (38%), Positives = 36/63 (57%)

Query: 93  LPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDN 152
           L +L+ + L GN+  G IP  + + + L  L L  NSF+G IP + G L +L  L L  N
Sbjct: 441 LRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGN 500

Query: 153 NLT 155
           +L+
Sbjct: 501 SLS 503

Length = 623

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 46.0 bits (109), Expect = 8e-05
 Identities = 25/76 (32%), Positives = 40/76 (52%), Gaps = 1/76 (1%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAI 65
            N +    P  + +I++L+VL L  N   G I   +G L +L  L+L+ N L G +PAA+
Sbjct: 451 GNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAAL 510

Query: 66  FNVSTLKA-FAVTNNS 80
                 +A F  T+N+
Sbjct: 511 GGRLLHRASFNFTDNA 526

Length = 623

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 40.6 bits (96), Expect = 8e-05
 Identities = 22/57 (38%), Positives = 28/57 (49%), Gaps = 1/57 (1%)

Query: 271 LYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLN-FWSLKDILDLNLSSN 326
           L  L+L  N+L+      F  +  LKVL L  N LTSI    F  L  +  L+LS N
Sbjct: 2   LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGN 58

Length = 60

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 40.2 bits (95), Expect = 1e-04
 Identities = 22/65 (33%), Positives = 28/65 (43%), Gaps = 5/65 (7%)

Query: 119 KLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISL 178
            L  L L  N  +      F  L NL+ L L  NNLTS + +     + S   SL  + L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPE-----AFSGLPSLRSLDL 55

Query: 179 SNNPL 183
           S N L
Sbjct: 56  SGNNL 60

Length = 60

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 45.2 bits (107), Expect = 2e-04
 Identities = 30/87 (34%), Positives = 43/87 (49%), Gaps = 12/87 (13%)

Query: 350 NNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLE 409
           NN S ++ +++ S KN+           G I  +   L  ++++NLS N LSG IP  + 
Sbjct: 66  NNSSRVVSIDL-SGKNIS----------GKISSAIFRLPYIQTINLSNNQLSGPIPDDIF 114

Query: 410 KLSY-LKDLNLSFNKLKGEIPRGGSFG 435
             S  L+ LNLS N   G IPRG    
Sbjct: 115 TTSSSLRYLNLSNNNFTGSIPRGSIPN 141

Length = 968

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 44.7 bits (105), Expect = 2e-04
 Identities = 53/226 (23%), Positives = 95/226 (42%), Gaps = 36/226 (15%)

Query: 535 IGRGGFGSVYKARIRDGMEV----AVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVIS 590
           IG G FG V+  + +   E     A+    L+  R      +E  +M+ ++H+N+V+ I 
Sbjct: 21  IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-EREKSQLVIEVNVMRELKHKNIVRYID 79

Query: 591 SCSNEEFKAL--VLEYMPHGSLEKYLHSSNYSLDIFQR---LNIMIDVASALEYLHFGYS 645
              N+  + L  ++E+   G L + +          +    ++I   +  AL Y H    
Sbjct: 80  RFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKD 139

Query: 646 AP----VIHCDLKPSNVLLDDNM-----------------VAHLSDFGIAKLLTGEDQSM 684
            P    V+H DLKP N+ L   +                 +A + DFG++K +  E  SM
Sbjct: 140 GPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIE--SM 197

Query: 685 TQTQTLATIGYMAPEYGREGQVSTN--GDVYSFGIMLMETFTRKKP 728
             +  + T  Y +PE       S +   D+++ G ++ E  + K P
Sbjct: 198 AHS-CVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242

Length = 1021

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 44.2 bits (104), Expect = 2e-04
 Identities = 43/159 (27%), Positives = 71/159 (44%), Gaps = 24/159 (15%)

Query: 527 DKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRN- 584
           D F    +IGRG FG V   + +D G   A+K+         K+  +E   +  IR    
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILR-------KADMLEKEQVAHIRAERD 53

Query: 585 ---------LVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVAS 635
                    +VK+  S  ++    L++E++P G +   L   + +L        + +   
Sbjct: 54  ILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKD-TLSEEATQFYIAETVL 112

Query: 636 ALEYLH-FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGI 673
           A++ +H  G+    IH D+KP N+LLD      LSDFG+
Sbjct: 113 AIDAIHQLGF----IHRDIKPDNLLLDAKGHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 44.0 bits (104), Expect = 2e-04
 Identities = 34/105 (32%), Positives = 49/105 (46%), Gaps = 28/105 (26%)

Query: 636 ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK---------LLTGEDQSMTQ 686
           ALEYLH   +  ++H DLKP N+L+       L+DFG++K         L  G  +  T+
Sbjct: 113 ALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169

Query: 687 ----TQTLATIGYMAPE------YGREGQVSTNGDVYSFGIMLME 721
                Q   T  Y+APE      YG+        D ++ GI+L E
Sbjct: 170 EFLDKQVCGTPEYIAPEVILRQGYGKP------VDWWAMGIILYE 208

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 44.3 bits (104), Expect = 3e-04
 Identities = 55/271 (20%), Positives = 96/271 (35%), Gaps = 73/271 (26%)

Query: 499 EKGPPNDPNMPPVATWR---RFSYLELFQATDKFSENNLIGRGGFGSVYKARIRDGMEVA 555
           ++ PP+     P+A  +      +L  F+  D          G FG ++   +R   E A
Sbjct: 123 DEAPPDAAGPVPLAQAKLKHDDEFLAHFRVIDDLPA------GAFGKIFICALRASTEEA 176

Query: 556 VKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEK--- 612
                +      K    +C  + + R +   +      NE    L L  + H ++ K   
Sbjct: 177 EARRGVNSTNQGKP---KCERLIAKRVKAGSRAAIQLENE---ILALGRLNHENILKIEE 230

Query: 613 --------YLHSSNYSLDIF-----------------QRLNIMIDVASALEYLHFGYSAP 647
                   Y+ +  Y  D++                 Q   IM  +  A+EY+H      
Sbjct: 231 ILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKK 287

Query: 648 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVS 707
           +IH D+K  N+ L+ +    L DFG A     E +              A +YG  G V+
Sbjct: 288 LIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKERE--------------AFDYGWVGTVA 333

Query: 708 TNG-------------DVYSFGIMLMETFTR 725
           TN              D++S G++L++  + 
Sbjct: 334 TNSPEILAGDGYCEITDIWSCGLILLDMLSH 364

Length = 501

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 42.7 bits (100), Expect = 6e-04
 Identities = 44/158 (27%), Positives = 72/158 (45%), Gaps = 22/158 (13%)

Query: 527 DKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNL-------QCG--RAFKSFDVECAM 576
           + F    +IGRG FG V   + +D G   A+K+          Q G  RA +   VE   
Sbjct: 1   EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60

Query: 577 MKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASA 636
           +       +VK+  S  ++    L++E++P G +   L   +   +   +  I  +   A
Sbjct: 61  LW------VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIA-ETVLA 113

Query: 637 LEYLH-FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGI 673
           ++ +H  G+    IH D+KP N+LLD      LSDFG+
Sbjct: 114 IDSIHQLGF----IHRDIKPDNLLLDSKGHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 42.1 bits (99), Expect = 0.001
 Identities = 49/192 (25%), Positives = 80/192 (41%), Gaps = 24/192 (12%)

Query: 527 DKFSENNLIGRGGFGSV-YKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNL 585
           + F    +IG+G FG V    +   G   A+K   L     FK  D + A +K+   R++
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMK--TLLKSEMFKK-D-QLAHVKA--ERDV 54

Query: 586 ---------VKVISSCSNEEFKALVLEYMPHGSLEKYL-HSSNYSLDIFQRLNIMIDVAS 635
                    V +  S  + ++  L++E++P G L   L     +S D+  R   M +   
Sbjct: 55  LAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDV-TRF-YMAECVL 112

Query: 636 ALEYLH-FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIG 694
           A+E +H  G+    IH D+KP N+L+D      LSDFG++     +  S    + L    
Sbjct: 113 AIEAVHKLGF----IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKS 168

Query: 695 YMAPEYGREGQV 706
                  R    
Sbjct: 169 NKNRIDNRNSVA 180

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 41.3 bits (97), Expect = 0.001
 Identities = 32/100 (32%), Positives = 52/100 (52%), Gaps = 17/100 (17%)

Query: 585 LVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQ----RLNIMIDVASALEYL 640
           +VK+  S  +++    V++Y+P G +   L      L IF+    R  I  ++  A+E +
Sbjct: 63  VVKLYYSFQDKDNLYFVMDYIPGGDMMSLL----IRLGIFEEDLARFYIA-ELTCAIESV 117

Query: 641 H-FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG 679
           H  G+    IH D+KP N+L+D +    L+DFG   L TG
Sbjct: 118 HKMGF----IHRDIKPDNILIDRDGHIKLTDFG---LCTG 150

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 41.1 bits (96), Expect = 0.002
 Identities = 38/153 (24%), Positives = 69/153 (45%), Gaps = 8/153 (5%)

Query: 573 ECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLH-SSNYSLDIFQRLNIMI 631
           E  ++++I H +++++  + +  +F  L+L   P    + Y + ++  ++ I   L I  
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLIL---PRYKTDLYCYLAAKRNIAICDILAIER 189

Query: 632 DVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA 691
            V  A++YLH      +IH D+K  N+ ++      L DFG A      + +        
Sbjct: 190 SVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWA-G 245

Query: 692 TIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 724
           TI   APE           D++S GI+L E  T
Sbjct: 246 TIATNAPELLARDPYGPAVDIWSAGIVLFEMAT 278

Length = 391

>gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies)

 Score = 35.2 bits (82), Expect = 0.004
 Identities = 15/44 (34%), Positives = 21/44 (47%), Gaps = 7/44 (15%)

Query: 143 NLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGI 186
           NLE L L +N +T        L  LSN  +L  + LS N +  +
Sbjct: 2   NLETLDLSNNQITD-------LPPLSNLPNLETLDLSGNKITDL 38

Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	824
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.98
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.98
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.98
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.98
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.98
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.98
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.98
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.97
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.97
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.97
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.97
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	99.97
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.96
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.96
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.96
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.96
KOG1152	772	consensus Signal transduction serine/threonine kin	99.96
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.96
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.95
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.95
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.95
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.94
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.94
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.94
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.93
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.92
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.92
PLN00181	793	protein SPA1-RELATED; Provisional	99.92
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.91
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.91
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.91
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.9
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.9
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.9
PRK09188	365	serine/threonine protein kinase; Provisional	99.89
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.89
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.87
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.87
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.86
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.85
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.84
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.83
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.82
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.82
PRK12274	218	serine/threonine protein kinase; Provisional	99.8
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.8
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.8
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.8
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.8
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.78
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.78
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.77
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.76
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.76
PRK10345	210	hypothetical protein; Provisional	99.76
smart00090	237	RIO RIO-like kinase.	99.72
PRK14879	211	serine/threonine protein kinase; Provisional	99.7
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.7
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.7
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.69
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.68
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.64
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.6
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.57
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.57
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.55
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.55
PLN03150	623	hypothetical protein; Provisional	99.5
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.5
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.44
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.44
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.43
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.35
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.33
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.33
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.31
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.31
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.3
KOG1243	690	consensus Protein kinase [General function predict	99.3
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.29
PLN03150	623	hypothetical protein; Provisional	99.29
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.27
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.25
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.24
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.24
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.23
COG4248	637	Uncharacterized protein with protein kinase and he	99.22
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.22
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.21
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.2
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.19
KOG3087	229	consensus Serine/threonine protein kinase [General	99.16
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.11
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.1
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	99.05
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	99.0
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.97
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.92
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.89
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.87
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.87
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.87
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.83
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.77
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.76
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.71
KOG2982	418	consensus Uncharacterized conserved protein [Funct	98.66
PRK09902	216	hypothetical protein; Provisional	98.65
KOG2982	418	consensus Uncharacterized conserved protein [Funct	98.63
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.6
KOG2120	419	consensus SCF ubiquitin ligase, Skp2 component [Po	98.57

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.2e-94  Score=887.45  Aligned_cols=777  Identities=30%  Similarity=0.454  Sum_probs=566.7

Q ss_pred             CcccccccccCCcccccCCCCCcEEEccCCcccccccccccCCCCCCEEeCCCCcCCcccChhhhCcCCCceeeccCCcc
Q 040845            2 PSIINNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSL   81 (824)
Q Consensus         2 ~~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l   81 (824)
                      |+|++|.+++.+|..++.+++|++|+|++|.+.+.+|..|+++++|++|+|++|.+.+.+|..+.++++|++|+|++|++
T Consensus       145 L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l  224 (968)
T PLN00113        145 LDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNL  224 (968)
T ss_pred             EECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCcc
Confidence            57788888888888888888888888888888888888888888888888888888888888888888888888888888


Q ss_pred             ccccCccccCCCCCccEEEccCCeeeeecCccccCCCCCceEeccCccccccCCccccCCCCCCEEEccCCcCCCCcCcc
Q 040845           82 SGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDL  161 (824)
Q Consensus        82 ~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~  161 (824)
                      ++..+... ..+++|++|+|++|++++.+|..+.++++|++|+|++|++.+..|..+.++++|++|++++|.+.....  
T Consensus       225 ~~~~p~~l-~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p--  301 (968)
T PLN00113        225 SGEIPYEI-GGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIP--  301 (968)
T ss_pred             CCcCChhH-hcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCC--
Confidence            75433322 257788888888888877778788888888888888888877777777777888888888777764322  


Q ss_pred             cccccCCCCCCCcEEECcCCCCCccCCccccccccccccEEEeecCcceecCCccCCCCCCCCEEEecCCcc--------
Q 040845          162 SFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKL--------  233 (824)
Q Consensus       162 ~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l--------  233 (824)
                         ..+.++++|++|++++|.+.+..+..+..  .++|+.|++++|.+.+.+|..++.+++|+.|++++|++        
T Consensus       302 ---~~~~~l~~L~~L~l~~n~~~~~~~~~~~~--l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~  376 (968)
T PLN00113        302 ---ELVIQLQNLEILHLFSNNFTGKIPVALTS--LPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGL  376 (968)
T ss_pred             ---hhHcCCCCCcEEECCCCccCCcCChhHhc--CCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhH
Confidence               23455566666666666655554443322  23455555555555555555555555555555555544        


Q ss_pred             ----------------CCccchhhcCCCCCCEEEcccccCcccCCccccccCCccEEEccCccccccCCccccCCCCCcE
Q 040845          234 ----------------NGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKV  297 (824)
Q Consensus       234 ----------------~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~  297 (824)
                                      .+..|..+..+++|+.|++++|++++..|..+..+++|+.|++++|.+.+..+..+..+++|+.
T Consensus       377 ~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  456 (968)
T PLN00113        377 CSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQM  456 (968)
T ss_pred             hCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcE
Confidence                            4445555555555556666666655555555566666666666666666555555556666666


Q ss_pred             EEcCCCCCCCCCCcccccccccccccccccccCcCCccccccccchhhhcccccccccCCCccCCCCCCCeEEccCcccc
Q 040845          298 LSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLE  377 (824)
Q Consensus       298 L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  377 (824)
                      |++++|++..........++|+.|++++|++.+..|..+.++++|+.|+|++|++.+.+|..+..+++|+.|+|++|.++
T Consensus       457 L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  536 (968)
T PLN00113        457 LSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLS  536 (968)
T ss_pred             EECcCceeeeecCcccccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCccc
Confidence            66666666533333345577888899999998888999999999999999999999999999999999999999999999


Q ss_pred             ccCCccccccccccEEEccCcccCCCCcccccCCcccceeeccCCcccCCCCCCCCccccccccccCCccccCCCC-CCC
Q 040845          378 GSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIPRGGSFGNFSAESFKGNELLCGSPN-LQV  456 (824)
Q Consensus       378 ~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~~-~~~  456 (824)
                      +.+|..|..+++|+.|+|++|++++.+|..+..+++|+.|++++|+++|.+|..+.+..+...++.||+.+|+.+. ...
T Consensus       537 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~  616 (968)
T PLN00113        537 GQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGL  616 (968)
T ss_pred             ccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCC
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999998653 334


Q ss_pred             CCCCCcccccccccceEeeehhhHHHHHHHHHHHHHHHHhcccC-CCCCCCC---CCCc-----cccccccHHHHHHhhc
Q 040845          457 PPCKASIHRTSRKNALILGIVLPFSTIFMTAIILFIIKYQKREK-GPPNDPN---MPPV-----ATWRRFSYLELFQATD  527 (824)
Q Consensus       457 ~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rkr~~-~~~~~~~---~~~~-----~~~~~~~~~~~~~~~~  527 (824)
                      ++|.....  ...+++++++++++. ++++++++.+++++++++ ..+....   ....     .....+++   .....
T Consensus       617 ~~c~~~~~--~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~  690 (968)
T PLN00113        617 PPCKRVRK--TPSWWFYITCTLGAF-LVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITI---NDILS  690 (968)
T ss_pred             CCCccccc--cceeeeehhHHHHHH-HHHHHHHHHHHHHHhhhcccccccccccccccccccccccchhhhH---HHHHh
Confidence            56754311  111222222222222 222222222222222211 1111000   0000     00011222   33345


Q ss_pred             cCCCCceeeeccceEEEEEEE-CCCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEeccC
Q 040845          528 KFSENNLIGRGGFGSVYKARI-RDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMP  606 (824)
Q Consensus       528 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  606 (824)
                      .|...+.||+|+||.||+|+. .++..||||.+.....    ....|++.+++++|||||+++++|.+++..++||||++
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~  766 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIE  766 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCC
Confidence            678889999999999999986 4689999998863321    22456889999999999999999999999999999999


Q ss_pred             CCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcccc
Q 040845          607 HGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQ  686 (824)
Q Consensus       607 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  686 (824)
                      +|+|.++++    .++|.++.+++.|+|+|++|||+.++.+|+|||+||+||+++.++..++. ||.+.....      .
T Consensus       767 ~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~------~  835 (968)
T PLN00113        767 GKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT------D  835 (968)
T ss_pred             CCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc------C
Confidence            999999996    37899999999999999999997667899999999999999999888876 665543211      1


Q ss_pred             ccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCc-chhhccccccCchhh
Q 040845          687 TQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPIS-TMEVVDANLLSQEDI  765 (824)
Q Consensus       687 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  765 (824)
                      ....+++.|+|||++.+..++.++|||||||++|||+||+.||+...........|++...... .....|+......  
T Consensus       836 ~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  913 (968)
T PLN00113        836 TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDV--  913 (968)
T ss_pred             CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCC--
Confidence            2235789999999999999999999999999999999999999766555666777776544332 2233444332211  


Q ss_pred             hhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhcc
Q 040845          766 HFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLR  811 (824)
Q Consensus       766 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~  811 (824)
                        ..+..+..++.+++.+||+.||++||||+|++++|+++.++...
T Consensus       914 --~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~~  957 (968)
T PLN00113        914 --SVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSSS  957 (968)
T ss_pred             --CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccccc
Confidence              11224456789999999999999999999999999998765443

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=3.7e-51  Score=502.59  Aligned_cols=440  Identities=37%  Similarity=0.583  Sum_probs=371.8

Q ss_pred             CcccccccccCCcccccCCCCCcEEEccCCcccccccccccCCCCCCEEeCCCCcCCcccChhhhCcCCCceeeccCCcc
Q 040845            2 PSIINNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSL   81 (824)
Q Consensus         2 ~~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l   81 (824)
                      |+|++|++++.+|.  +.+++|++|+|++|.+.+.+|..|+++++|++|+|++|.+.+.+|..+.++++|++|+|++|++
T Consensus       123 L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l  200 (968)
T PLN00113        123 LNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQL  200 (968)
T ss_pred             EECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCC
Confidence            67899999998886  6789999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCccccCCCCCccEEEccCCeeeeecCccccCCCCCceEeccCccccccCCccccCCCCCCEEEccCCcCCCCcCcc
Q 040845           82 SGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDL  161 (824)
Q Consensus        82 ~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~  161 (824)
                      .+..+... ..+++|++|+|++|++++.+|..+..+++|++|+|++|.+++..|..|+++++|++|++++|.++...   
T Consensus       201 ~~~~p~~l-~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~---  276 (968)
T PLN00113        201 VGQIPREL-GQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPI---  276 (968)
T ss_pred             cCcCChHH-cCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccC---
Confidence            86544322 35899999999999999999999999999999999999999999999999999999999999987542   


Q ss_pred             cccccCCCCCCCcEEECcCCCCCccCCccccccccccccEEEeecCcceecCCccCCCCCCCCEEEecCCccCCccchhh
Q 040845          162 SFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITL  241 (824)
Q Consensus       162 ~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~  241 (824)
                        +..+.++++|++|++++|.+.+..|..+..  ..+|+.|++++|.+.+..|..+..+++|+.|++++|.+.+..|..+
T Consensus       277 --p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~--l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l  352 (968)
T PLN00113        277 --PPSIFSLQKLISLDLSDNSLSGEIPELVIQ--LQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNL  352 (968)
T ss_pred             --chhHhhccCcCEEECcCCeeccCCChhHcC--CCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHH
Confidence              245788999999999999999887776643  4689999999999999999999999999999999999999999999


Q ss_pred             cCCCCCCEEEcccccCcccCCccccccCCccEEEccCccccccCCccccCCCCCcEEEcCCCCCC-CCCCc---------
Q 040845          242 GKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELT-SIPLN---------  311 (824)
Q Consensus       242 ~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~---------  311 (824)
                      ..+++|+.|++++|++++..|..++.+.+|+.|++++|++.+..|..++.+++|+.|++++|.++ .+|..         
T Consensus       353 ~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~  432 (968)
T PLN00113        353 GKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYF  432 (968)
T ss_pred             hCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCE
Confidence            99999999999999998877777776666666666666665555555555555555555555554 23333         


Q ss_pred             ---------------ccccccccccccccccccCcCCccccccccchhhhcccccccccCCCccCCCCCCCeEEccCccc
Q 040845          312 ---------------FWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRL  376 (824)
Q Consensus       312 ---------------~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  376 (824)
                                     ++.+++|+.|++++|.+.+.+|..+ ..++|+.|++++|++++..|..|..+++|+.|+|++|.+
T Consensus       433 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l  511 (968)
T PLN00113        433 LDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKL  511 (968)
T ss_pred             EECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcc
Confidence                           4445555556666666555555444 346778888888888888888899999999999999999


Q ss_pred             cccCCccccccccccEEEccCcccCCCCcccccCCcccceeeccCCcccCCCCCC-CCccccccccccCCccccCCC
Q 040845          377 EGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIPRG-GSFGNFSAESFKGNELLCGSP  452 (824)
Q Consensus       377 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~~~~~~~~~~~n~~~c~~~  452 (824)
                      ++.+|..+..+++|+.|+|++|.+++.+|..+..+++|+.|+|++|++++.+|.. ..+..+..+.+.+|+..+..|
T Consensus       512 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p  588 (968)
T PLN00113        512 SGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLP  588 (968)
T ss_pred             eeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCC
Confidence            9999999999999999999999999999999999999999999999999988863 446677888889998776554

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-49  Score=420.88  Aligned_cols=290  Identities=42%  Similarity=0.679  Sum_probs=246.6

Q ss_pred             ccccccHHHHHHhhccCCCCceeeeccceEEEEEEECCCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeee
Q 040845          513 TWRRFSYLELFQATDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSC  592 (824)
Q Consensus       513 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  592 (824)
                      ....|++.++..+|++|...++||+|+||.||+|..++|+.||||++.........+|..|++++.+++|||+|+++|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            56789999999999999999999999999999999998999999988655433145599999999999999999999999


Q ss_pred             ecCC-eeEEEEeccCCCCHHHHhhhCCC-CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEee
Q 040845          593 SNEE-FKALVLEYMPHGSLEKYLHSSNY-SLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSD  670 (824)
Q Consensus       593 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D  670 (824)
                      .+.+ +.++|||||++|+|.++++.... .++|.+|.+||.++|+||+|||+.+..+|+||||||+|||+|+++++||+|
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD  220 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD  220 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence            9988 59999999999999999998776 899999999999999999999988888999999999999999999999999


Q ss_pred             cccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccc-cCcchhhhhhhhhCCC
Q 040845          671 FGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELF-NGEMTLKHWVNDCLPI  749 (824)
Q Consensus       671 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~  749 (824)
                      ||+|+.......... +...||.+|+|||+...+..+.|+|||||||+++|++||+.|.+... .++..+..|+......
T Consensus       221 FGLa~~~~~~~~~~~-~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~  299 (361)
T KOG1187|consen  221 FGLAKLGPEGDTSVS-TTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE  299 (361)
T ss_pred             ccCcccCCcccccee-eecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC
Confidence            999965432111111 11179999999999999999999999999999999999999888644 4455688998766655


Q ss_pred             -cchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 040845          750 -STMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRD  807 (824)
Q Consensus       750 -~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~  807 (824)
                       ...+++|+.+......    ...+...+..++.+|++.+|.+||+|.||++.|+.+..
T Consensus       300 ~~~~eiiD~~l~~~~~~----~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~  354 (361)
T KOG1187|consen  300 GKLREIVDPRLKEGEYP----DEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS  354 (361)
T ss_pred             cchhheeCCCccCCCCC----hHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence             4778889887631111    01345668999999999999999999999999966543

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-48  Score=404.27  Aligned_cols=256  Identities=32%  Similarity=0.506  Sum_probs=222.6

Q ss_pred             cCCCCceeeeccceEEEEEEECCCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEeccCC
Q 040845          528 KFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPH  607 (824)
Q Consensus       528 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  607 (824)
                      .+...+.||+|.||+||.|.|+...+||+|.++.. ....++|.+|+++|++|+|++||+++|+|..++..+||||||+.
T Consensus       207 ~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~  285 (468)
T KOG0197|consen  207 ELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPK  285 (468)
T ss_pred             HHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEeccc
Confidence            34556889999999999999997779999999754 44567889999999999999999999999999999999999999


Q ss_pred             CCHHHHhhh-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcccc
Q 040845          608 GSLEKYLHS-SNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQ  686 (824)
Q Consensus       608 g~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  686 (824)
                      |+|.++++. .+..+...+.+.++.|||+|++||+   ++++|||||.++|||++++..+||+|||+|+.. .++.....
T Consensus       286 GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~-~d~~Y~~~  361 (468)
T KOG0197|consen  286 GSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLI-GDDEYTAS  361 (468)
T ss_pred             CcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEccccccccc-CCCceeec
Confidence            999999987 4567889999999999999999999   999999999999999999999999999999943 34444455


Q ss_pred             ccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhh
Q 040845          687 TQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDI  765 (824)
Q Consensus       687 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  765 (824)
                      ....-+..|+|||.+..+.++.|||||||||+|||++| |+.||......     +.+               ..-..+.
T Consensus       362 ~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~-----ev~---------------~~le~Gy  421 (468)
T KOG0197|consen  362 EGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE-----EVL---------------ELLERGY  421 (468)
T ss_pred             CCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH-----HHH---------------HHHhccC
Confidence            55667899999999999999999999999999999999 77776653221     111               1234567


Q ss_pred             hhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 040845          766 HFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDS  808 (824)
Q Consensus       766 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~  808 (824)
                      +++.|+.||..++++|..||+.+|++|||++.+...++++..+
T Consensus       422 Rlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~  464 (468)
T KOG0197|consen  422 RLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS  464 (468)
T ss_pred             cCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence            8888999999999999999999999999999999998887653

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-46  Score=396.40  Aligned_cols=258  Identities=32%  Similarity=0.509  Sum_probs=214.8

Q ss_pred             CCCCceeeeccceEEEEEEECCCcE-EEEEEeeccccc--hhhhHHHHHHHHhcCCCCcceeEEeeeecCC-eeEEEEec
Q 040845          529 FSENNLIGRGGFGSVYKARIRDGME-VAVKVFNLQCGR--AFKSFDVECAMMKSIRHRNLVKVISSCSNEE-FKALVLEY  604 (824)
Q Consensus       529 ~~~~~~lg~G~~g~V~~~~~~~~~~-vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~  604 (824)
                      ....+.+|+|+||+||+|.|+ |+. ||||.+......  ..++|.+|+.+|.+++|||||+++|+|.++. ..++||||
T Consensus        43 l~~~~~iG~G~~g~V~~~~~~-g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy  121 (362)
T KOG0192|consen   43 LPIEEVLGSGSFGTVYKGKWR-GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY  121 (362)
T ss_pred             hhhhhhcccCCceeEEEEEeC-CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence            344556999999999999998 555 999999765322  2568999999999999999999999999887 78999999


Q ss_pred             cCCCCHHHHhhhC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCC-eEecCCCCCCeeeCCCC-cEEEeecccccccCCCC
Q 040845          605 MPHGSLEKYLHSS-NYSLDIFQRLNIMIDVASALEYLHFGYSAP-VIHCDLKPSNVLLDDNM-VAHLSDFGIAKLLTGED  681 (824)
Q Consensus       605 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~-ivH~Dlk~~Nill~~~~-~~kl~Dfg~a~~~~~~~  681 (824)
                      +++|+|.++++.. ...+++..++.++.|||+|+.|||   +.+ ||||||||+|||++.++ ++||+|||+++......
T Consensus       122 ~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~  198 (362)
T KOG0192|consen  122 MPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK  198 (362)
T ss_pred             CCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence            9999999999883 568999999999999999999999   888 99999999999999997 99999999998754322


Q ss_pred             CccccccccccccccCccCcC--CCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccc
Q 040845          682 QSMTQTQTLATIGYMAPEYGR--EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANL  759 (824)
Q Consensus       682 ~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  759 (824)
                        ...+...||+.|||||++.  ...|+.|+||||||+++|||+||+.||...... ......+.               
T Consensus       199 --~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~-~~~~~v~~---------------  260 (362)
T KOG0192|consen  199 --TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV-QVASAVVV---------------  260 (362)
T ss_pred             --ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHh---------------
Confidence              3334467999999999999  568999999999999999999999999875441 11111111               


Q ss_pred             cCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhcc
Q 040845          760 LSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLR  811 (824)
Q Consensus       760 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~  811 (824)
                         ...+...+..|+..+..+|.+||..||++||++.|++..|+.+......
T Consensus       261 ---~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~  309 (362)
T KOG0192|consen  261 ---GGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS  309 (362)
T ss_pred             ---cCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence               1112222334788899999999999999999999999999999775543

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-46  Score=371.39  Aligned_cols=252  Identities=24%  Similarity=0.334  Sum_probs=209.9

Q ss_pred             cCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc-chhhhHHHHHHHHhcCCCCcceeEEeeeecCC-eeEEEEec
Q 040845          528 KFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVKVISSCSNEE-FKALVLEY  604 (824)
Q Consensus       528 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~  604 (824)
                      +.+..+.||+|..|+||+++++ +++-+|+|++....+ ...+++.+|++++++.+||+||.++|+|..+. ...++|||
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY  159 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY  159 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence            4455689999999999999876 588999999965533 44678899999999999999999999999988 59999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 040845          605 MPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM  684 (824)
Q Consensus       605 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  684 (824)
                      |++|+|++++...+ .+++....+++.+|++||.|||+  +++||||||||+|||+...|++||||||.+..+.+.    
T Consensus       160 MDgGSLd~~~k~~g-~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----  232 (364)
T KOG0581|consen  160 MDGGSLDDILKRVG-RIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----  232 (364)
T ss_pred             cCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh----
Confidence            99999999998765 78999999999999999999994  499999999999999999999999999999877543    


Q ss_pred             ccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchh
Q 040845          685 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQED  764 (824)
Q Consensus       685 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  764 (824)
                      .....+||..|||||.+.+..|+.++||||||+.++|+.+|+.||....++...            ..+.++..+...+ 
T Consensus       233 ~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~------------~~~Ll~~Iv~~pp-  299 (364)
T KOG0581|consen  233 IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLD------------IFELLCAIVDEPP-  299 (364)
T ss_pred             hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCC------------HHHHHHHHhcCCC-
Confidence            334567999999999999999999999999999999999999998764111111            1112222111111 


Q ss_pred             hhhhhHH-HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          765 IHFVAKE-QCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       765 ~~~~~~~-~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      .+  .|. .|++++..++..|+++||.+||+++|+++|
T Consensus       300 P~--lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  300 PR--LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             CC--CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            11  122 478899999999999999999999999886

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.3e-45  Score=384.20  Aligned_cols=248  Identities=25%  Similarity=0.368  Sum_probs=212.8

Q ss_pred             ccCCCCceeeeccceEEEEEEE-CCCcEEEEEEeecc---ccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEE
Q 040845          527 DKFSENNLIGRGGFGSVYKARI-RDGMEVAVKVFNLQ---CGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVL  602 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  602 (824)
                      .+|...++||+|||+.+|.++. .+|..||+|++.+.   .....+.+.+|+++.+.|+|||||+++++|++.+..|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5699999999999999999987 77999999999763   3456778899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 040845          603 EYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ  682 (824)
Q Consensus       603 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  682 (824)
                      |+|+.++|.+++++ ++.+++.+++.+++||+.|+.|||   +.+|+|||||..|++++++.++||+|||+|+.+..++.
T Consensus        98 ELC~~~sL~el~Kr-rk~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E  173 (592)
T KOG0575|consen   98 ELCHRGSLMELLKR-RKPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE  173 (592)
T ss_pred             EecCCccHHHHHHh-cCCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeecCccc
Confidence            99999999999984 458999999999999999999999   99999999999999999999999999999998864432


Q ss_pred             ccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCc
Q 040845          683 SMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ  762 (824)
Q Consensus       683 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  762 (824)
                        .....+||+.|.|||++....++..+||||+||++|-|++|++||+...-.+ .+..+...                 
T Consensus       174 --rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke-ty~~Ik~~-----------------  233 (592)
T KOG0575|consen  174 --RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE-TYNKIKLN-----------------  233 (592)
T ss_pred             --ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHH-HHHHHHhc-----------------
Confidence              2234579999999999999999999999999999999999999998731111 11111111                 


Q ss_pred             hhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          763 EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       763 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                         +...|...+.++.+||.++++.||.+|||+.+|+.+
T Consensus       234 ---~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  234 ---EYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH  269 (592)
T ss_pred             ---CcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence               111223456678999999999999999999999876

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4e-45  Score=366.13  Aligned_cols=201  Identities=31%  Similarity=0.516  Sum_probs=181.7

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecc--ccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQ--CGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVL  602 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  602 (824)
                      ..+|...+.||+|+||+||+|+++ ++..||||.+...  ..+..+....|+++|+.++|||||++++++..++..|+||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            467888899999999999999875 4899999998765  4456677889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCC------CcEEEeecccccc
Q 040845          603 EYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDN------MVAHLSDFGIAKL  676 (824)
Q Consensus       603 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~------~~~kl~Dfg~a~~  676 (824)
                      |||+||+|.+|+++.+ .+++..+..++.|+|.|+++||   +++||||||||.|||++..      -.+||+|||+|+.
T Consensus        89 EyC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~  164 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF  164 (429)
T ss_pred             EeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence            9999999999999887 7999999999999999999999   9999999999999999764      4689999999998


Q ss_pred             cCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccc
Q 040845          677 LTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELF  733 (824)
Q Consensus       677 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~  733 (824)
                      +...   ......+|++-|||||+++..+|+.|+|+||+|+++||+++|++||+...
T Consensus       165 L~~~---~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t  218 (429)
T KOG0595|consen  165 LQPG---SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET  218 (429)
T ss_pred             CCch---hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence            8632   23345679999999999999999999999999999999999999998643

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.7e-45  Score=366.38  Aligned_cols=253  Identities=24%  Similarity=0.347  Sum_probs=208.1

Q ss_pred             hccCCCCceeeeccceEEEEEEE-CCCcEEEEEEeeccccc-------hhhhHHHHHHHHhcCCCCcceeEEeeeecCCe
Q 040845          526 TDKFSENNLIGRGGFGSVYKARI-RDGMEVAVKVFNLQCGR-------AFKSFDVECAMMKSIRHRNLVKVISSCSNEEF  597 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  597 (824)
                      .+.|.+.+.||+|+||.|-+|.. ++|+.||||+++.....       ....+.+|+++|++|+|||||+++++|..++.
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds  250 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS  250 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence            46688899999999999999964 56999999999754211       12335789999999999999999999999999


Q ss_pred             eEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCC---CcEEEeecccc
Q 040845          598 KALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDN---MVAHLSDFGIA  674 (824)
Q Consensus       598 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~---~~~kl~Dfg~a  674 (824)
                      .|+||||++||+|.+++-..+ .+.+....-+++|++.|+.|||   ++||+||||||+|||+..+   ..+||+|||+|
T Consensus       251 ~YmVlE~v~GGeLfd~vv~nk-~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDFGlA  326 (475)
T KOG0615|consen  251 SYMVLEYVEGGELFDKVVANK-YLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDFGLA  326 (475)
T ss_pred             eEEEEEEecCccHHHHHHhcc-ccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEecccchh
Confidence            999999999999999998766 5777788899999999999999   9999999999999999755   78999999999


Q ss_pred             cccCCCCCccccccccccccccCccCcCCCC---CCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcc
Q 040845          675 KLLTGEDQSMTQTQTLATIGYMAPEYGREGQ---VSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPIST  751 (824)
Q Consensus       675 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  751 (824)
                      +...   ........+||+.|.|||++.++.   +..++|+||+||++|-+++|.+||.+......-..++.+..+.   
T Consensus       327 K~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~---  400 (475)
T KOG0615|consen  327 KVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYA---  400 (475)
T ss_pred             hccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCccc---
Confidence            9764   223344567999999999998664   3447899999999999999999998855443233333222221   


Q ss_pred             hhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          752 MEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       752 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                                   .....+...+++..++|.+|+..||++|||+.|+++|
T Consensus       401 -------------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h  437 (475)
T KOG0615|consen  401 -------------FGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH  437 (475)
T ss_pred             -------------ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence                         2223345667889999999999999999999999876

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.3e-44  Score=395.75  Aligned_cols=259  Identities=32%  Similarity=0.530  Sum_probs=224.5

Q ss_pred             ccCCCCceeeeccceEEEEEEEC------CCcEEEEEEeeccccc-hhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeE
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR------DGMEVAVKVFNLQCGR-AFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKA  599 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  599 (824)
                      .+....+.||+|+||+||+|+..      +...||||.++..... ...+|++|++++..++|||||+++|+|.+++..+
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~  565 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC  565 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence            34455678999999999999754      3467999999877665 7889999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHhhhCC---------CC----CCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcE
Q 040845          600 LVLEYMPHGSLEKYLHSSN---------YS----LDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVA  666 (824)
Q Consensus       600 lv~e~~~~g~L~~~l~~~~---------~~----~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~  666 (824)
                      +|+|||..|||.+|+....         ..    ++..+.+.||.|||.|++||-   ++.+|||||.++|+|+.++..|
T Consensus       566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l~V  642 (774)
T KOG1026|consen  566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENLVV  642 (774)
T ss_pred             EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccceEE
Confidence            9999999999999997432         22    788999999999999999999   9999999999999999999999


Q ss_pred             EEeecccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhh
Q 040845          667 HLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVND  745 (824)
Q Consensus       667 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~  745 (824)
                      ||+|||+++.....+++.......-+.+|||||.+..++||.+||||||||++||+++ |+.||++....+. +..    
T Consensus       643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV-Ie~----  717 (774)
T KOG1026|consen  643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV-IEC----  717 (774)
T ss_pred             EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH-HHH----
Confidence            9999999999888887776666778999999999999999999999999999999999 8899887543321 111    


Q ss_pred             hCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 040845          746 CLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDS  808 (824)
Q Consensus       746 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~  808 (824)
                                    .... .-+..|++||.++++||..||+..|.+||+++||-..|++.-+.
T Consensus       718 --------------i~~g-~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~  765 (774)
T KOG1026|consen  718 --------------IRAG-QLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA  765 (774)
T ss_pred             --------------HHcC-CcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence                          0111 12566789999999999999999999999999999999987553

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.4e-44  Score=346.72  Aligned_cols=266  Identities=24%  Similarity=0.331  Sum_probs=207.7

Q ss_pred             ccCCCCceeeeccceEEEEEEECC-CcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEe
Q 040845          527 DKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLE  603 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  603 (824)
                      ++|+...++|+|+||+||+++.++ |+.||||.+....  ....+-..+|+.+|++++|+|+|.++.+|......++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            578889999999999999999775 9999999985332  2334567889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 040845          604 YMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS  683 (824)
Q Consensus       604 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  683 (824)
                      |++. ++.+-+.+.....+...+.++++|++.|+.|+|   +++++||||||+|||++.+|.+|+||||+|+.+..+.  
T Consensus        82 ~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg--  155 (396)
T KOG0593|consen   82 YCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG--  155 (396)
T ss_pred             ecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcCCc--
Confidence            9987 666666777778999999999999999999999   9999999999999999999999999999999886433  


Q ss_pred             cccccccccccccCccCcCC-CCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhh---hCCCcchhhcc---
Q 040845          684 MTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVND---CLPISTMEVVD---  756 (824)
Q Consensus       684 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~---  756 (824)
                      ...+.++.|.||+|||.+.+ ..|+..+||||+||++.||++|.+-|.+..+-+. +..+...   ..|. -..++.   
T Consensus       156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQ-Ly~I~ktLG~L~pr-hq~iF~~N~  233 (396)
T KOG0593|consen  156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQ-LYLIRKTLGNLIPR-HQSIFSSNP  233 (396)
T ss_pred             chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHH-HHHHHHHHcccCHH-HHHHhccCC
Confidence            34566789999999998887 6799999999999999999999998765322111 1111111   1110 001110   


Q ss_pred             -------ccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          757 -------ANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       757 -------~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                             +.....+..+. .-+..+..+.++++.|++.||++|++-+|++.|
T Consensus       234 ~F~Gv~lP~~~~~epLe~-k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H  284 (396)
T KOG0593|consen  234 FFHGVRLPEPEHPEPLER-KYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH  284 (396)
T ss_pred             ceeeeecCCCCCccchhh-hcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence                   00000111111 112445578999999999999999999998864

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-45  Score=350.10  Aligned_cols=256  Identities=25%  Similarity=0.369  Sum_probs=204.7

Q ss_pred             ccCCCCceeeeccceEEEEEE-ECCCcEEEEEEeecc--ccchhhhHHHHHHHHhcCCCCcceeEEe-eeecCC-eeEEE
Q 040845          527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQ--CGRAFKSFDVECAMMKSIRHRNLVKVIS-SCSNEE-FKALV  601 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~-~~~lv  601 (824)
                      .+|++.+.||+|+||+||++. ..+|..||.|.+.-.  .....++...|+.+|++|+|||||++++ .+.++. ..++|
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            457888999999999999996 567999999987633  2445677888999999999999999999 454444 48999


Q ss_pred             EeccCCCCHHHHhhhC---CCCCCHHHHHHHHHHHHHHHHHhhcCCCCC--eEecCCCCCCeeeCCCCcEEEeecccccc
Q 040845          602 LEYMPHGSLEKYLHSS---NYSLDIFQRLNIMIDVASALEYLHFGYSAP--VIHCDLKPSNVLLDDNMVAHLSDFGIAKL  676 (824)
Q Consensus       602 ~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~  676 (824)
                      |||+++|+|...++..   +..+++..+|+++.|+++||.++|..+ .+  |+||||||.||+++.+|.+|++|||+++.
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~  177 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF  177 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhH
Confidence            9999999999998753   367899999999999999999999432 44  88999999999999999999999999998


Q ss_pred             cCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhcc
Q 040845          677 LTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVD  756 (824)
Q Consensus       677 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  756 (824)
                      +...  .......+|||.||+||.+.+..|+.++||||+||++|||+.-++||++.  .-..+..-+.   .        
T Consensus       178 l~s~--~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~--n~~~L~~KI~---q--------  242 (375)
T KOG0591|consen  178 LSSK--TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD--NLLSLCKKIE---Q--------  242 (375)
T ss_pred             hcch--hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc--cHHHHHHHHH---c--------
Confidence            7532  33445678999999999999999999999999999999999999999873  1111111000   0        


Q ss_pred             ccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 040845          757 ANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLK  804 (824)
Q Consensus       757 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~  804 (824)
                            ........+.++..+..|+..|+.+||+.||+.-.++..+..
T Consensus       243 ------gd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  243 ------GDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             ------CCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence                  011111224678889999999999999999985444444433

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-43  Score=352.31  Aligned_cols=242  Identities=29%  Similarity=0.368  Sum_probs=202.9

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALV  601 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  601 (824)
                      .++|++.++||+|+||+||.++.+ +++.+|+|++++..   ....+....|..+|.+++||+||.++..|++.+..|+|
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            568999999999999999999755 48999999997652   34567788899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 040845          602 LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED  681 (824)
Q Consensus       602 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  681 (824)
                      +||+.||.|..++++.+ .+++..+.-++.+|+.||.|||   +++|||||+||+|||+|.+|+++|+|||+|+..... 
T Consensus       104 ld~~~GGeLf~hL~~eg-~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~-  178 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQREG-RFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD-  178 (357)
T ss_pred             EeccCCccHHHHHHhcC-CcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhcccC-
Confidence            99999999999998777 7889999999999999999999   999999999999999999999999999999854322 


Q ss_pred             CccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccC
Q 040845          682 QSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLS  761 (824)
Q Consensus       682 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  761 (824)
                       .......+||+.|||||++.+..|+.++|.||+|+++|||++|.+||....     ...++.......        .  
T Consensus       179 -~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~-----~~~~~~~I~~~k--------~--  242 (357)
T KOG0598|consen  179 -GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED-----VKKMYDKILKGK--------L--  242 (357)
T ss_pred             -CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc-----HHHHHHHHhcCc--------C--
Confidence             122233689999999999999999999999999999999999999998732     222222222111        0  


Q ss_pred             chhhhhhhHHHHHHHHHHHHHHccccCCCCCC
Q 040845          762 QEDIHFVAKEQCVSFVFNLALECTVESPEQRI  793 (824)
Q Consensus       762 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp  793 (824)
                           ...+.-.+.+..+++.++++.||++|.
T Consensus       243 -----~~~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  243 -----PLPPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             -----CCCCccCCHHHHHHHHHHhccCHHHhc
Confidence                 001112356688999999999999996

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-43  Score=362.53  Aligned_cols=269  Identities=26%  Similarity=0.339  Sum_probs=212.3

Q ss_pred             hccCCCCceeeeccceEEEEEE-ECCCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeecC--CeeEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSNE--EFKAL  600 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  600 (824)
                      .+.|+..++||+|+||.||+|+ ..+|+.||+|.++.+.  .+......+||.+|++|.||||+++.+...+.  ...|+
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl  195 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL  195 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence            3457777899999999999997 4579999999987664  44456677899999999999999999998776  68999


Q ss_pred             EEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 040845          601 VLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE  680 (824)
Q Consensus       601 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  680 (824)
                      |+|||++ +|..++...+-.+++.++..++.|+++||+|||   +++|+|||||.+|||+|.+|.+||+|||+|+++...
T Consensus       196 VFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~  271 (560)
T KOG0600|consen  196 VFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS  271 (560)
T ss_pred             EEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence            9999987 999999988888999999999999999999999   999999999999999999999999999999987644


Q ss_pred             CCccccccccccccccCccCcCCC-CCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcch-------
Q 040845          681 DQSMTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTM-------  752 (824)
Q Consensus       681 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-------  752 (824)
                      . ....+..+.|.||+|||.+.+. .|+.++|+||.|||+.||++|++.|.+..+-+ .+..+.+-+......       
T Consensus       272 ~-~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEve-Ql~kIfklcGSP~e~~W~~~kL  349 (560)
T KOG0600|consen  272 G-SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVE-QLHKIFKLCGSPTEDYWPVSKL  349 (560)
T ss_pred             C-CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHH-HHHHHHHHhCCCChhccccccC
Confidence            3 3346778899999999988765 69999999999999999999999887643221 122222221111100       


Q ss_pred             ---hhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          753 ---EVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       753 ---~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                         ..+.+...-....+. .-...+....+|+..+|..||++|.||.++++.
T Consensus       350 P~~~~~kp~~~y~r~l~E-~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s  400 (560)
T KOG0600|consen  350 PHATIFKPQQPYKRRLRE-TFKDFPASALDLLEKLLSLDPDKRGTASSALQS  400 (560)
T ss_pred             CcccccCCCCcccchHHH-HhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence               000000000000111 123567788999999999999999999998763

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-44  Score=383.62  Aligned_cols=271  Identities=24%  Similarity=0.457  Sum_probs=233.4

Q ss_pred             CCCCceeeeccceEEEEEEECC----CcEEEEEEeecccc-chhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEe
Q 040845          529 FSENNLIGRGGFGSVYKARIRD----GMEVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLE  603 (824)
Q Consensus       529 ~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  603 (824)
                      ..+.++||.|.||+||+|+.+-    ...||||.++.... +...+|..|+.||.++.||||+++-|+.......+||+|
T Consensus       631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE  710 (996)
T KOG0196|consen  631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE  710 (996)
T ss_pred             eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence            3567899999999999998763    35799999986643 456789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC-C
Q 040845          604 YMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED-Q  682 (824)
Q Consensus       604 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~-~  682 (824)
                      ||++|+|+.|++.....+++.+.+.++++||.|+.||-   ++++|||||.++|||++.+..+|++|||+++.+.++. .
T Consensus       711 yMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~  787 (996)
T KOG0196|consen  711 YMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA  787 (996)
T ss_pred             hhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheeeccceEEEeccccceeecccCCCc
Confidence            99999999999998888999999999999999999999   9999999999999999999999999999999875443 3


Q ss_pred             ccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhccccccC
Q 040845          683 SMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLS  761 (824)
Q Consensus       683 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  761 (824)
                      .++..+...+.+|.|||.+...+++.++||||||+++||.++ |.+||.++...+.                 +.   ..
T Consensus       788 ~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdV-----------------Ik---aI  847 (996)
T KOG0196|consen  788 AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV-----------------IK---AI  847 (996)
T ss_pred             cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHH-----------------HH---HH
Confidence            344445567889999999999999999999999999999988 9999887543221                 11   22


Q ss_pred             chhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH--hhccccCCceeeccC
Q 040845          762 QEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRD--SLLRNVGGRCIRQSN  822 (824)
Q Consensus       762 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~--~~~~~~~~~~~~~~~  822 (824)
                      +++++++.|.+||..+++||..||++|-.+||++.|++.+|.++..  ...+.+++-..|+++
T Consensus       848 e~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk~~~~~~~r~s~  910 (996)
T KOG0196|consen  848 EQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLKTIAPESPRPSQ  910 (996)
T ss_pred             HhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhcccCCCCCCCcc
Confidence            4567888899999999999999999999999999999999999864  445556665555543

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=7.9e-43  Score=329.30  Aligned_cols=264  Identities=23%  Similarity=0.360  Sum_probs=209.3

Q ss_pred             ccCCCCceeeeccceEEEEEE-ECCCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEe
Q 040845          527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLE  603 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  603 (824)
                      .+|...+++|+|.||.||+|+ .++|+.||||.++...  +.......+|++.|+.++|+||+.++++|...+...+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            468888999999999999997 4569999999997653  2234567889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 040845          604 YMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS  683 (824)
Q Consensus       604 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  683 (824)
                      ||+. +|+..++.....++..++..++.++++|++|||   .+.|+|||+||.|+|++++|.+||+|||+|+.+......
T Consensus        82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~  157 (318)
T KOG0659|consen   82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI  157 (318)
T ss_pred             eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence            9965 999999988889999999999999999999999   999999999999999999999999999999988655443


Q ss_pred             cccccccccccccCccCcCCC-CCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhh---hhhhCCCcch-------
Q 040845          684 MTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHW---VNDCLPISTM-------  752 (824)
Q Consensus       684 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~---~~~~~~~~~~-------  752 (824)
                      .  +..+.|.||+|||.+.+. .|+..+||||.||++.||+-|.+-|.+    +.++.+.   .+........       
T Consensus       158 ~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG----~sDidQL~~If~~LGTP~~~~WP~~~~  231 (318)
T KOG0659|consen  158 Q--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPG----DSDIDQLSKIFRALGTPTPDQWPEMTS  231 (318)
T ss_pred             c--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCC----CchHHHHHHHHHHcCCCCcccCccccc
Confidence            3  334789999999988765 589999999999999999988875543    3333222   1111100000       


Q ss_pred             --hhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          753 --EVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       753 --~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                        +...-........+. .-..++..+.+++.+|+..||.+|+|++|++++
T Consensus       232 lpdY~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  232 LPDYVKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             cccHHHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence              111111111111111 112467778999999999999999999999886

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-43  Score=368.23  Aligned_cols=268  Identities=27%  Similarity=0.421  Sum_probs=219.7

Q ss_pred             HHHHHhhccCCCCceeeeccceEEEEEEECCCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCe
Q 040845          520 LELFQATDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEF  597 (824)
Q Consensus       520 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  597 (824)
                      .+++...+++.+...||+|.||+||+|+|-  ..||||++....  .+..+.|+.|+..+++-||.||+-+.|+|..+..
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~  462 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL  462 (678)
T ss_pred             cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence            455555677788899999999999999986  579999997664  3457889999999999999999999999999888


Q ss_pred             eEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccccc
Q 040845          598 KALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  677 (824)
Q Consensus       598 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~  677 (824)
                       .||+.+|+|.+|+.+++-.+.+++..+.+.||.|||+|+.|||   .++|||||+|..||++.+++.|||+|||++...
T Consensus       463 -AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk  538 (678)
T KOG0193|consen  463 -AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVK  538 (678)
T ss_pred             -eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecccceeee
Confidence             8999999999999999988888999999999999999999999   999999999999999999999999999999865


Q ss_pred             CCCCCccccccccccccccCccCcCCC---CCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhh
Q 040845          678 TGEDQSMTQTQTLATIGYMAPEYGREG---QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEV  754 (824)
Q Consensus       678 ~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  754 (824)
                      .............|..-|||||+++..   .|++++||||||+|+|||+||..||......  .            ...+
T Consensus       539 ~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d--q------------Iifm  604 (678)
T KOG0193|consen  539 TRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD--Q------------IIFM  604 (678)
T ss_pred             eeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh--h------------eEEE
Confidence            433222333344577889999998754   5899999999999999999999998742111  1            1111


Q ss_pred             ccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhh
Q 040845          755 VDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSL  809 (824)
Q Consensus       755 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~  809 (824)
                      +-......  .......+|+.++.+|+..||+.++++||.+.+++..|+.+..+.
T Consensus       605 VGrG~l~p--d~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~  657 (678)
T KOG0193|consen  605 VGRGYLMP--DLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL  657 (678)
T ss_pred             ecccccCc--cchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence            11110100  011123478899999999999999999999999999999887654

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-44  Score=361.88  Aligned_cols=265  Identities=23%  Similarity=0.314  Sum_probs=209.0

Q ss_pred             hhccCCCCceeeeccceEEEEEEE-CCCcEEEEEEeeccccchhh-hHHHHHHHHhcCC-CCcceeEEeeeecCC-eeEE
Q 040845          525 ATDKFSENNLIGRGGFGSVYKARI-RDGMEVAVKVFNLQCGRAFK-SFDVECAMMKSIR-HRNLVKVISSCSNEE-FKAL  600 (824)
Q Consensus       525 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~-~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~l  600 (824)
                      ..++|.+.+.||.|+||.||+|+- .+|..||||.++..-..+.+ .-.+|+..|+++. ||||+++.+++.+.+ ..++
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f   87 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF   87 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence            457889999999999999999974 46999999998755333222 2357999999998 999999999998877 9999


Q ss_pred             EEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 040845          601 VLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE  680 (824)
Q Consensus       601 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  680 (824)
                      |||||+ .+|.++++..+..+++..+..|+.||++||+|+|   ++|+.|||+||+|||+.....+||+|||+|+.+...
T Consensus        88 VfE~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk  163 (538)
T KOG0661|consen   88 VFEFMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREVRSK  163 (538)
T ss_pred             eHHhhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEecccccccccccC
Confidence            999995 4999999988889999999999999999999999   999999999999999999999999999999976533


Q ss_pred             CCccccccccccccccCccCc-CCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhh--hhCCCcchhhccc
Q 040845          681 DQSMTQTQTLATIGYMAPEYG-REGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVN--DCLPISTMEVVDA  757 (824)
Q Consensus       681 ~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~  757 (824)
                         ...+.++.|.||+|||++ +.+.|+.+.||||+|||++|+.+-++-|.+.-+    +.+..+  ........+....
T Consensus       164 ---pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE----~Dqi~KIc~VLGtP~~~~~~e  236 (538)
T KOG0661|consen  164 ---PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASE----IDQIYKICEVLGTPDKDSWPE  236 (538)
T ss_pred             ---CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcH----HHHHHHHHHHhCCCccccchh
Confidence               345678899999999965 577899999999999999999999987765322    222111  1111110000000


Q ss_pred             --cc----------cCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          758 --NL----------LSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       758 --~~----------~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                        .+          ..........+ +++.++.++|.+|+++||.+||||+|++++
T Consensus       237 g~~La~~mnf~~P~~~~~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  237 GYNLASAMNFRFPQVKPSPLKDLLP-NASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HHHHHHHhccCCCcCCCCChHHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence              00          00011111122 488899999999999999999999999886

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-43  Score=361.62  Aligned_cols=254  Identities=26%  Similarity=0.425  Sum_probs=212.6

Q ss_pred             HHhhccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcC-CCCcceeEEeeeecCCe
Q 040845          523 FQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSI-RHRNLVKVISSCSNEEF  597 (824)
Q Consensus       523 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  597 (824)
                      .....+|.+++.||+|+|++|++|+.+ +++.||||++.+..   ....+.+..|-.+|..| .||.|++++..|+++..
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            344578999999999999999999754 59999999986542   22345567788899999 89999999999999999


Q ss_pred             eEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccccc
Q 040845          598 KALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  677 (824)
Q Consensus       598 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~  677 (824)
                      .|+|+||+++|+|.++|++.+ .+++.-.+.++.+|+.|++|||   +.|||||||||+|||+|++++++|+|||.|+.+
T Consensus       149 LYFvLe~A~nGdll~~i~K~G-sfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~l  224 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKYG-SFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKIL  224 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHhC-cchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccccC
Confidence            999999999999999999887 7899999999999999999999   999999999999999999999999999999988


Q ss_pred             CCCCCc---------cc--cccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhh
Q 040845          678 TGEDQS---------MT--QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDC  746 (824)
Q Consensus       678 ~~~~~~---------~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~  746 (824)
                      .+....         ..  ....+||..|.+||++.++..+.++|+|+|||++|+|+.|.+||.+.-+ -..+..+..  
T Consensus       225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne-yliFqkI~~--  301 (604)
T KOG0592|consen  225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE-YLIFQKIQA--  301 (604)
T ss_pred             ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH-HHHHHHHHH--
Confidence            643221         11  1457899999999999999999999999999999999999999976211 111111111  


Q ss_pred             CCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          747 LPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       747 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                                        .....++.+++.+.+|+++.+..||.+|+|++|+.+|
T Consensus       302 ------------------l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  302 ------------------LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             ------------------hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence                              1122344567789999999999999999999998876

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-42  Score=353.92  Aligned_cols=261  Identities=30%  Similarity=0.435  Sum_probs=209.9

Q ss_pred             hccCCCCceeeeccceEEEEEEECC-CcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCC--eeEEEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEE--FKALVL  602 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~  602 (824)
                      ..+|...+.||+|+||+||.+...+ |+..|||.+........+.+.+|+.+|++++|||||+++|......  .+++.|
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m   95 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM   95 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence            3457788999999999999998654 8999999987664334677899999999999999999999854444  688999


Q ss_pred             eccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC-CCcEEEeecccccccCC-C
Q 040845          603 EYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD-NMVAHLSDFGIAKLLTG-E  680 (824)
Q Consensus       603 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~Dfg~a~~~~~-~  680 (824)
                      ||+++|+|.+++.+.+..+++..+..+.+||++||+|||   +++||||||||+|||++. ++.+||+|||+++.... .
T Consensus        96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~  172 (313)
T KOG0198|consen   96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG  172 (313)
T ss_pred             eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence            999999999999987767999999999999999999999   999999999999999999 79999999999987653 1


Q ss_pred             CCccccccccccccccCccCcCCCC-CCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccc
Q 040845          681 DQSMTQTQTLATIGYMAPEYGREGQ-VSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANL  759 (824)
Q Consensus       681 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  759 (824)
                      ..........||+.|||||++..+. ...++||||+||++.||+||++||......    ..++-.....          
T Consensus       173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~----~~~~~~ig~~----------  238 (313)
T KOG0198|consen  173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEE----AEALLLIGRE----------  238 (313)
T ss_pred             ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcch----HHHHHHHhcc----------
Confidence            1222334577999999999998643 345999999999999999999999874111    1111000000          


Q ss_pred             cCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 040845          760 LSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRD  807 (824)
Q Consensus       760 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~  807 (824)
                        .  .....+...+.++.+++.+|++.||++||||.+++++-....+
T Consensus       239 --~--~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~  282 (313)
T KOG0198|consen  239 --D--SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN  282 (313)
T ss_pred             --C--CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence              0  0012233467789999999999999999999999998766543

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-43  Score=365.13  Aligned_cols=396  Identities=22%  Similarity=0.226  Sum_probs=328.3

Q ss_pred             CcEEEccCCcccccccccccCCC--CCCEEeCCCCcCCcccChhhhCcCCCceeeccCCccccccCccccCCCCCccEEE
Q 040845           23 LKVLYLYNNRLQGEIIHEIGHLH--NLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLY  100 (824)
Q Consensus        23 L~~L~L~~n~l~~~~~~~~~~l~--~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~  100 (824)
                      -+.|+++++.+....-..+.++-  .-+.||+|+|+|+.+.+..|.++++|+.+++.+|.++.+|.....  ..+|+.|+
T Consensus        54 ~~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt~IP~f~~~--sghl~~L~  131 (873)
T KOG4194|consen   54 TRLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELTRIPRFGHE--SGHLEKLD  131 (873)
T ss_pred             ceeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhhhccccccc--ccceeEEe
Confidence            35678888888743223333332  344588999988888888888888999999988888888776543  55788899


Q ss_pred             ccCCeeeeecCccccCCCCCceEeccCccccccCCccccCCCCCCEEEccCCcCCCCcCcccccccCCCCCCCcEEECcC
Q 040845          101 LWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSN  180 (824)
Q Consensus       101 L~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~~L~~L~Ls~  180 (824)
                      |.+|.|+.+-.+.+..++.|+.|||+.|.|+.+.-.+|..-.++++|+|++|+|+.+..+     +|..+.+|..|.|++
T Consensus       132 L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~-----~F~~lnsL~tlkLsr  206 (873)
T KOG4194|consen  132 LRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETG-----HFDSLNSLLTLKLSR  206 (873)
T ss_pred             eeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccc-----cccccchheeeeccc
Confidence            999988888788888888899999999988877777788778888999999988887654     477788888888999


Q ss_pred             CCCCccCCccccccccccccEEEeecCcceecCCccCCCCCCCCEEEecCCccCCccchhhcCCCCCCEEEcccccCccc
Q 040845          181 NPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGS  260 (824)
Q Consensus       181 n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~  260 (824)
                      |+|+.+++..|..  .+.|+.|+|..|+|.-.-.-.|..|++|+.|.|..|+|.....++|..+.++++|+|+.|+++..
T Consensus       207 NrittLp~r~Fk~--L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~v  284 (873)
T KOG4194|consen  207 NRITTLPQRSFKR--LPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAV  284 (873)
T ss_pred             CcccccCHHHhhh--cchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhh
Confidence            9888877766633  34688888888888766567788999999999999999888888999999999999999999988


Q ss_pred             CCccccccCCccEEEccCccccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccccccccccccccccccCcCCcccccc
Q 040845          261 IPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLN-FWSLKDILDLNLSSNCFSGPLPLEIRNL  339 (824)
Q Consensus       261 ~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~-~~~l~~L~~L~l~~N~l~~~~~~~~~~l  339 (824)
                      ..+++..+++|+.|+++.|.|..+.++..+-.++|++|+|++|+|+.+++. |..+..|+.|+|++|.+.......|..+
T Consensus       285 n~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~l  364 (873)
T KOG4194|consen  285 NEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGL  364 (873)
T ss_pred             hcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHh
Confidence            888889999999999999999988888888889999999999999999776 6678999999999999988778889999


Q ss_pred             ccchhhhcccccccccCCC---ccCCCCCCCeEEccCccccccCCccccccccccEEEccCcccCCCCcccccCCcccce
Q 040845          340 KALIEIDFSMNNFSGIIPM---EIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKD  416 (824)
Q Consensus       340 ~~L~~L~l~~N~l~~~~~~---~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  416 (824)
                      ++|+.|||++|.|+..+.+   .|.+|++|+.|+|.+|+|..+...+|.++++|+.|||.+|.|..+-|++|..+ .|+.
T Consensus       365 ssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~  443 (873)
T KOG4194|consen  365 SSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKE  443 (873)
T ss_pred             hhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhh
Confidence            9999999999999876554   47789999999999999997666889999999999999999988889999988 8888


Q ss_pred             eeccCCcccCCC
Q 040845          417 LNLSFNKLKGEI  428 (824)
Q Consensus       417 L~l~~N~l~~~~  428 (824)
                      |-+..-.+-|.+
T Consensus       444 Lv~nSssflCDC  455 (873)
T KOG4194|consen  444 LVMNSSSFLCDC  455 (873)
T ss_pred             hhhcccceEEec
Confidence            888776655543

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-42  Score=392.96  Aligned_cols=263  Identities=29%  Similarity=0.489  Sum_probs=224.9

Q ss_pred             ccCCCCceeeeccceEEEEEEECC--Cc----EEEEEEeeccc-cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeE
Q 040845          527 DKFSENNLIGRGGFGSVYKARIRD--GM----EVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKA  599 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~~--~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  599 (824)
                      ...+..+.||+|+||.||+|...+  |.    .||||.++... .+...+|.+|+.+|+.++|||||+++|+|-+....+
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~  771 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL  771 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence            445567889999999999998654  43    48999887654 455788999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHhhhC------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccc
Q 040845          600 LVLEYMPHGSLEKYLHSS------NYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGI  673 (824)
Q Consensus       600 lv~e~~~~g~L~~~l~~~------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~  673 (824)
                      +++|||++|+|..|+++.      ...++..+.+.++.|||+|+.||+   ++++|||||.++|+|+++...+||+|||+
T Consensus       772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFGl  848 (1025)
T KOG1095|consen  772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFGL  848 (1025)
T ss_pred             EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccch
Confidence            999999999999999987      467899999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcch
Q 040845          674 AKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTM  752 (824)
Q Consensus       674 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  752 (824)
                      |+.+.+.+++.......-+..|||||.+.++.++.|+|||||||++||++| |..||......+ .+..|          
T Consensus       849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~-v~~~~----------  917 (1025)
T KOG1095|consen  849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE-VLLDV----------  917 (1025)
T ss_pred             hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH-HHHHH----------
Confidence            997776666655555567789999999999999999999999999999999 777776532211 11111          


Q ss_pred             hhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhccc
Q 040845          753 EVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLRN  812 (824)
Q Consensus       753 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~~  812 (824)
                               ..+.++.+|..|+..++++|..||+.+|++||++..+++.+.++.+....+
T Consensus       918 ---------~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~  968 (1025)
T KOG1095|consen  918 ---------LEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGT  968 (1025)
T ss_pred             ---------HhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccC
Confidence                     112277788899999999999999999999999999999999998755443

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-43  Score=367.10  Aligned_cols=365  Identities=25%  Similarity=0.283  Sum_probs=276.8

Q ss_pred             cEEEccCCcccccccccccCCCCCCEEeCCCCcCCcccChhhhCcCCCceeeccCCccccccCccccCCCCCccEEEccC
Q 040845           24 KVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWG  103 (824)
Q Consensus        24 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~  103 (824)
                      +.|++++|++....+..|-++++|+.++|.+|.++ .+|.......+|+.|+|.+|.|+.+..... ..++.|+.||||.
T Consensus        81 ~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L-~~l~alrslDLSr  158 (873)
T KOG4194|consen   81 QTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEEL-SALPALRSLDLSR  158 (873)
T ss_pred             eeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHH-HhHhhhhhhhhhh
Confidence            34666666666555555666666666666666666 556555555556666666666655444332 1356666666666


Q ss_pred             CeeeeecCccccCCCCCceEeccCccccccCCccccCCCCCCEEEccCCcCCCCcCcccccccCCCCCCCcEEECcCCCC
Q 040845          104 NNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPL  183 (824)
Q Consensus       104 n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l  183 (824)
                      |.|+.+.-..|..-.++++|+|++|+|+....+.|.++.+|..|.|++|+|+.+|.     .+|+++++|+.|+|..|+|
T Consensus       159 N~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~-----r~Fk~L~~L~~LdLnrN~i  233 (873)
T KOG4194|consen  159 NLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQ-----RSFKRLPKLESLDLNRNRI  233 (873)
T ss_pred             chhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCH-----HHhhhcchhhhhhccccce
Confidence            66664444455555566666666666666666666666666666666666666654     2356666666666666666


Q ss_pred             CccCCccccccccccccEEEeecCcceecCCccCCCCCCCCEEEecCCccCCccchhhcCCCCCCEEEcccccCcccCCc
Q 040845          184 DGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPD  263 (824)
Q Consensus       184 ~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~  263 (824)
                      .-+...+|.+  ..+|+.|.|..|.|...-...|..|.++++|+|..|++...-.+++.+++.|+.|+||+|.|..+.++
T Consensus       234 rive~ltFqg--L~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d  311 (873)
T KOG4194|consen  234 RIVEGLTFQG--LPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHID  311 (873)
T ss_pred             eeehhhhhcC--chhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecc
Confidence            6555555544  34666666666666666666778889999999999999888888999999999999999999999999


Q ss_pred             cccccCCccEEEccCccccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccccccccccccccccccCcCC---cccccc
Q 040845          264 SICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLN-FWSLKDILDLNLSSNCFSGPLP---LEIRNL  339 (824)
Q Consensus       264 ~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~-~~~l~~L~~L~l~~N~l~~~~~---~~~~~l  339 (824)
                      .....++|+.|+|+.|+|+...++.|..+..|++|+|++|.++.+.+. |.++++|+.|||++|.+++.+.   ..|.++
T Consensus       312 ~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl  391 (873)
T KOG4194|consen  312 SWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGL  391 (873)
T ss_pred             hhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccc
Confidence            999999999999999999988899999999999999999999999766 7789999999999999986554   458889


Q ss_pred             ccchhhhcccccccccCCCccCCCCCCCeEEccCccccccCCccccccccccEEEccCc
Q 040845          340 KALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYN  398 (824)
Q Consensus       340 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  398 (824)
                      ++|+.|+|.+|+|..+...+|.+++.|++|||.+|.|..+.|++|..+ .|++|.+..-
T Consensus       392 ~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSs  449 (873)
T KOG4194|consen  392 PSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNSS  449 (873)
T ss_pred             hhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhccc
Confidence            999999999999998888899999999999999999998899999999 9999887653

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-41  Score=355.03  Aligned_cols=250  Identities=27%  Similarity=0.381  Sum_probs=214.4

Q ss_pred             ccCCCCceeeeccceEEEEEE-ECCCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEecc
Q 040845          527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYM  605 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  605 (824)
                      ..|..-..||+|+.|.||.|+ ..+++.||||++........+-+..|+.+|+..+|+|||.+++.|...+..+.|||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            457777899999999999996 4568999999998887777888999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccc
Q 040845          606 PHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMT  685 (824)
Q Consensus       606 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  685 (824)
                      +||+|.+.+....  +++.++..|++++++||+|||   .++|+|||||.+|||++.+|.+||+|||+|..+.....  .
T Consensus       353 ~ggsLTDvVt~~~--~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--K  425 (550)
T KOG0578|consen  353 EGGSLTDVVTKTR--MTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--K  425 (550)
T ss_pred             CCCchhhhhhccc--ccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeeccccccC--c
Confidence            9999999998764  899999999999999999999   99999999999999999999999999999987754332  4


Q ss_pred             cccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhh
Q 040845          686 QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDI  765 (824)
Q Consensus       686 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  765 (824)
                      ....+||+.|||||+.....|+.++||||||++++||+-|.+||-.    +..+......              ......
T Consensus       426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln----E~PlrAlyLI--------------a~ng~P  487 (550)
T KOG0578|consen  426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN----ENPLRALYLI--------------ATNGTP  487 (550)
T ss_pred             cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC----CChHHHHHHH--------------hhcCCC
Confidence            5567899999999999999999999999999999999999999864    1111111100              011112


Q ss_pred             hhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          766 HFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       766 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      ++..++..+..+.+++.+||..||++|++|.|+++|
T Consensus       488 ~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  488 KLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             CcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence            333445667889999999999999999999999986

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-42  Score=354.80  Aligned_cols=241  Identities=24%  Similarity=0.406  Sum_probs=209.3

Q ss_pred             CceeeeccceEEEEEEECCCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEeccCCCCHH
Q 040845          532 NNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLE  611 (824)
Q Consensus       532 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  611 (824)
                      .+-||.|+.|.||+|+.+ ++.||||+++       +.-+.+|+-|++|+||||+.+.|+|.....++||||||..|-|.
T Consensus       129 LeWlGSGaQGAVF~Grl~-netVAVKKV~-------elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~  200 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRLH-NETVAVKKVR-------ELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY  200 (904)
T ss_pred             hhhhccCcccceeeeecc-CceehhHHHh-------hhhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence            456999999999999997 8999999764       22245889999999999999999999999999999999999999


Q ss_pred             HHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccccccccc
Q 040845          612 KYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA  691 (824)
Q Consensus       612 ~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  691 (824)
                      ++++..+ .+.....+.|..+||.|+.|||   .++|||||+|.-|||++.+..|||+|||-++...+.   .+.-...|
T Consensus       201 ~VLka~~-~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSFaG  273 (904)
T KOG4721|consen  201 EVLKAGR-PITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSFAG  273 (904)
T ss_pred             HHHhccC-ccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhhhhh
Confidence            9998776 7888889999999999999999   999999999999999999999999999999876433   23345679


Q ss_pred             cccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhhhhhhHH
Q 040845          692 TIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKE  771 (824)
Q Consensus       692 ~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  771 (824)
                      |+.|||||+++....++|+||||||||||||+||..||.+....-                   -..........++.|.
T Consensus       274 TVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA-------------------IIwGVGsNsL~LpvPs  334 (904)
T KOG4721|consen  274 TVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA-------------------IIWGVGSNSLHLPVPS  334 (904)
T ss_pred             hHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe-------------------eEEeccCCcccccCcc
Confidence            999999999999999999999999999999999999987632110                   0011234446677888


Q ss_pred             HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 040845          772 QCVSFVFNLALECTVESPEQRINAKEIVAKLLKIR  806 (824)
Q Consensus       772 ~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~  806 (824)
                      .|+..+.-|++.||+..|..||+|.+++.||+-+.
T Consensus       335 tcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~  369 (904)
T KOG4721|consen  335 TCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIAS  369 (904)
T ss_pred             cCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence            99999999999999999999999999999998543

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-40  Score=335.67  Aligned_cols=262  Identities=25%  Similarity=0.337  Sum_probs=214.6

Q ss_pred             hccCCCCceeeeccceEEEEEEE-CCCcEEEEEEeeccc-cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEe
Q 040845          526 TDKFSENNLIGRGGFGSVYKARI-RDGMEVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLE  603 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  603 (824)
                      .+.|+....||.|..++||+|+. ..++.||||++..+. ....+.+++|+..|+.++||||++++..|..+...++||+
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            46799999999999999999974 568999999998774 3446889999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 040845          604 YMPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ  682 (824)
Q Consensus       604 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  682 (824)
                      ||.+|++.+.+...- ..+++..+..|.++++.||.|||   .+|.||||||+.|||++.+|.|||+|||.+..+...+.
T Consensus       105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~  181 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD  181 (516)
T ss_pred             hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence            999999999997543 57899999999999999999999   99999999999999999999999999998776654432


Q ss_pred             c-ccc-ccccccccccCccCcCC--CCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhcccc
Q 040845          683 S-MTQ-TQTLATIGYMAPEYGRE--GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDAN  758 (824)
Q Consensus       683 ~-~~~-~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  758 (824)
                      . ... ...+||+.|||||+++.  ..|+.|+||||||+...|+.+|..||....+.++-+...-. ..|.....     
T Consensus       182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn-~pp~~~t~-----  255 (516)
T KOG0582|consen  182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQN-DPPTLLTS-----  255 (516)
T ss_pred             eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC-CCCCcccc-----
Confidence            2 122 45679999999999653  36899999999999999999999999886655443333211 11111110     


Q ss_pred             ccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          759 LLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       759 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                           .....+...++..+.+++..|+..||++||||++++++
T Consensus       256 -----~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh  293 (516)
T KOG0582|consen  256 -----GLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH  293 (516)
T ss_pred             -----cCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence                 11112223455689999999999999999999999875

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.4e-41  Score=355.39  Aligned_cols=250  Identities=26%  Similarity=0.369  Sum_probs=212.5

Q ss_pred             hccCCCCceeeeccceEEEEEEE-CCCcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARI-RDGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALV  601 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  601 (824)
                      ..-|+.++-||.|+.|.|..|++ .+|+.+|||++.+..   ......+.+|+-+|+-+.|||++++++++++..++|+|
T Consensus        11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv   90 (786)
T KOG0588|consen   11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV   90 (786)
T ss_pred             ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence            35678899999999999999974 579999999986542   22356788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 040845          602 LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED  681 (824)
Q Consensus       602 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  681 (824)
                      .||+++|.|.+++-+.+ ++++.++.++++||+.|+.|+|   ..+|+|||+||+|+|+|..+++||+|||+|..-.++.
T Consensus        91 lEyv~gGELFdylv~kG-~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk  166 (786)
T KOG0588|consen   91 LEYVPGGELFDYLVRKG-PLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK  166 (786)
T ss_pred             EEecCCchhHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeecccCCc
Confidence            99999999999998877 7889999999999999999999   9999999999999999999999999999998643222


Q ss_pred             CccccccccccccccCccCcCCCCC-CccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhcccccc
Q 040845          682 QSMTQTQTLATIGYMAPEYGREGQV-STNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLL  760 (824)
Q Consensus       682 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  760 (824)
                         -....+|++.|.|||++++..| +.++||||.|||+|.++||+.||++     ..+....                .
T Consensus       167 ---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD-----dNir~LL----------------l  222 (786)
T KOG0588|consen  167 ---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD-----DNIRVLL----------------L  222 (786)
T ss_pred             ---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC-----ccHHHHH----------------H
Confidence               2234579999999999999988 7899999999999999999999985     1222111                1


Q ss_pred             CchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 040845          761 SQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLL  803 (824)
Q Consensus       761 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~  803 (824)
                      .-+...+..|.+.+.++.+|+.+|+.+||++|.|++||++|-.
T Consensus       223 KV~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~  265 (786)
T KOG0588|consen  223 KVQRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPF  265 (786)
T ss_pred             HHHcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCch
Confidence            1112233445677888999999999999999999999999854

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1e-40  Score=345.51  Aligned_cols=264  Identities=25%  Similarity=0.434  Sum_probs=222.7

Q ss_pred             hccCCCCceeeeccceEEEEEEECCCcEEEEEEeeccccc-hhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEec
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGR-AFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      .....+.++||+|.||+|..+....+..||||.++..... ...+|.+|+++|.+++||||++++|+|..++..++|+||
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY  616 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY  616 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence            3456677899999999999999887899999999877543 458899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCC-CCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 040845          605 MPHGSLEKYLHSSNYS-LDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS  683 (824)
Q Consensus       605 ~~~g~L~~~l~~~~~~-~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  683 (824)
                      |++|+|.+|+.++..+ .+....++|+.|||+|++||.   +.++||||+.++|+|++.++++||+|||+++.+...+++
T Consensus       617 mEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy  693 (807)
T KOG1094|consen  617 MENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY  693 (807)
T ss_pred             HhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccCCce
Confidence            9999999999887533 356677889999999999999   999999999999999999999999999999988888888


Q ss_pred             cccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh--CCCCCcccccCcchhhhhhhhhCCCcchhhccccccC
Q 040845          684 MTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT--RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLS  761 (824)
Q Consensus       684 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  761 (824)
                      ......+-+.+|||||.+..++++.++|||+||+.+||+++  ...||.......  ..+-.....+.+           
T Consensus       694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~--vven~~~~~~~~-----------  760 (807)
T KOG1094|consen  694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ--VVENAGEFFRDQ-----------  760 (807)
T ss_pred             eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH--HHHhhhhhcCCC-----------
Confidence            77777888999999999999999999999999999999866  677887643321  111111111111           


Q ss_pred             chhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 040845          762 QEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKI  805 (824)
Q Consensus       762 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~  805 (824)
                      ....-+.+|.-|+..++++|.+||..|-++||+++++...|++.
T Consensus       761 ~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  761 GRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             CcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            11122345668999999999999999999999999999998763

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=2.4e-40  Score=357.78  Aligned_cols=260  Identities=25%  Similarity=0.422  Sum_probs=206.1

Q ss_pred             hccCCCCceeeeccceEEEEEEE------CCCcEEEEEEeecccc-chhhhHHHHHHHHhcC-CCCcceeEEeeeecC-C
Q 040845          526 TDKFSENNLIGRGGFGSVYKARI------RDGMEVAVKVFNLQCG-RAFKSFDVECAMMKSI-RHRNLVKVISSCSNE-E  596 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~  596 (824)
                      .++|++.+.||+|+||.||+|.+      .+++.||||+++.... ...+.+.+|+.+++.+ +||||+++++++... .
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            46799999999999999999974      2356899999864322 3345688899999999 899999999988764 4


Q ss_pred             eeEEEEeccCCCCHHHHhhhCC----------------------------------------------------------
Q 040845          597 FKALVLEYMPHGSLEKYLHSSN----------------------------------------------------------  618 (824)
Q Consensus       597 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  618 (824)
                      ..++||||+++|+|.+++....                                                          
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            5789999999999999987532                                                          


Q ss_pred             ---CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccccccccccccc
Q 040845          619 ---YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGY  695 (824)
Q Consensus       619 ---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y  695 (824)
                         ..+++.++..++.|+++|++|||   +.+|+||||||+||+++.++.+||+|||+++...............++..|
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence               23778889999999999999999   999999999999999999999999999999866433332223334567889


Q ss_pred             cCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhhhhhhHHHHH
Q 040845          696 MAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCV  774 (824)
Q Consensus       696 ~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  774 (824)
                      +|||++.+..++.++|||||||++|||++ |..||......+. ......           +..       ....+..++
T Consensus       243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~-~~~~~~-----------~~~-------~~~~~~~~~  303 (338)
T cd05102         243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-FCQRLK-----------DGT-------RMRAPENAT  303 (338)
T ss_pred             cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH-HHHHHh-----------cCC-------CCCCCCCCC
Confidence            99999998899999999999999999997 9999875322111 111000           000       001122456


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 040845          775 SFVFNLALECTVESPEQRINAKEIVAKLLKIRD  807 (824)
Q Consensus       775 ~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~  807 (824)
                      ..+.+++.+||..||++|||+.|+++.|+++.+
T Consensus       304 ~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         304 PEIYRIMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            678999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.4e-40  Score=323.56  Aligned_cols=269  Identities=23%  Similarity=0.280  Sum_probs=206.5

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccc--hhhhHHHHHHHHhcCCCCcceeEEeeeec--CCeeEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGR--AFKSFDVECAMMKSIRHRNLVKVISSCSN--EEFKAL  600 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l  600 (824)
                      .++|+..+.|++|+||.||+|+++ +++.||+|+++.....  ..-...+||.++.+.+|||||.+-.+...  -+..|+
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~  154 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI  154 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence            356788899999999999999865 5889999999766422  22345789999999999999999988754  467999


Q ss_pred             EEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 040845          601 VLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE  680 (824)
Q Consensus       601 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  680 (824)
                      |||||++ +|..+++.-..++...++..++.|+++|++|||   ...|+|||+|++|+|+...|.+||+|||+|+.+...
T Consensus       155 VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp  230 (419)
T KOG0663|consen  155 VMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP  230 (419)
T ss_pred             eHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence            9999987 999999988889999999999999999999999   899999999999999999999999999999987533


Q ss_pred             CCccccccccccccccCccCcCCC-CCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhC-CCc-------c
Q 040845          681 DQSMTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCL-PIS-------T  751 (824)
Q Consensus       681 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~-------~  751 (824)
                        ....+..+.|.||+|||.+.+. .|+.+.|+||+|||+.|++++++-|.+..+-+. +..+++... |..       .
T Consensus       231 --~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQ-l~~If~llGtPte~iwpg~~~  307 (419)
T KOG0663|consen  231 --LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQ-LDKIFKLLGTPSEAIWPGYSE  307 (419)
T ss_pred             --cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHH-HHHHHHHhCCCccccCCCccc
Confidence              3456677899999999988765 589999999999999999999988766322211 111111110 110       0


Q ss_pred             hhhccccccCchh---hhhhhHH-HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          752 MEVVDANLLSQED---IHFVAKE-QCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       752 ~~~~~~~~~~~~~---~~~~~~~-~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      ...+...-.....   .+...+. ..+..-++|+..++.+||.+|.||.|.+++
T Consensus       308 lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h  361 (419)
T KOG0663|consen  308 LPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH  361 (419)
T ss_pred             cchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence            0101000001111   1111111 134678899999999999999999999876

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-41  Score=357.29  Aligned_cols=260  Identities=28%  Similarity=0.421  Sum_probs=214.8

Q ss_pred             hccCCCCceeeeccceEEEEEEECC--C---cEEEEEEeecc---ccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCe
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIRD--G---MEVAVKVFNLQ---CGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEF  597 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~~--~---~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  597 (824)
                      .++....++||+|+||.||+|+++.  +   ..||||..+..   .......+.+|+++|+.++|||||+++|++..+..
T Consensus       156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P  235 (474)
T KOG0194|consen  156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP  235 (474)
T ss_pred             ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence            3445566899999999999998653  2   23899998752   24567789999999999999999999999999999


Q ss_pred             eEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccccc
Q 040845          598 KALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  677 (824)
Q Consensus       598 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~  677 (824)
                      .++|||+|.||+|.+++......++..++..++.++|+||+|||   +++++||||.++|+|++.++.+||+|||+++.-
T Consensus       236 l~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~  312 (474)
T KOG0194|consen  236 LMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGLSRAG  312 (474)
T ss_pred             cEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCccccccCC
Confidence            99999999999999999988877999999999999999999999   999999999999999999999999999998753


Q ss_pred             CCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhh-hhhCCCcchhhc
Q 040845          678 TGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWV-NDCLPISTMEVV  755 (824)
Q Consensus       678 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~  755 (824)
                      .  ..........-+..|+|||.+..+.|+.++|||||||++||+++ |..||.+....  ....++ ...         
T Consensus       313 ~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--~v~~kI~~~~---------  379 (474)
T KOG0194|consen  313 S--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--EVKAKIVKNG---------  379 (474)
T ss_pred             c--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH--HHHHHHHhcC---------
Confidence            2  12222223357889999999999999999999999999999999 78888764322  222222 211         


Q ss_pred             cccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhc
Q 040845          756 DANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLL  810 (824)
Q Consensus       756 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~  810 (824)
                               .+...+...+..+..++.+||..+|++||+|.++.+.++.+.....
T Consensus       380 ---------~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~  425 (474)
T KOG0194|consen  380 ---------YRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE  425 (474)
T ss_pred             ---------ccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence                     1222233457788999999999999999999999999999976544

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-40  Score=351.54  Aligned_cols=254  Identities=24%  Similarity=0.347  Sum_probs=207.5

Q ss_pred             hhccCCCCceeeeccceEEEEEEE-CCCcEEEEEEeecc----cc-chhhhHHHHHHHHhcCC-CCcceeEEeeeecCCe
Q 040845          525 ATDKFSENNLIGRGGFGSVYKARI-RDGMEVAVKVFNLQ----CG-RAFKSFDVECAMMKSIR-HRNLVKVISSCSNEEF  597 (824)
Q Consensus       525 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~  597 (824)
                      ...+|.+.+.||+|+||+|+.|.. .+++.||+|++...    .. ...+.+.+|+.++++++ ||||++++.++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            457899999999999999999964 46899999977553    11 23456778999999999 9999999999999999


Q ss_pred             eEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCC-CcEEEeecccccc
Q 040845          598 KALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDN-MVAHLSDFGIAKL  676 (824)
Q Consensus       598 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~Dfg~a~~  676 (824)
                      .++||||+.+|+|.+++.. ...+.+.++..+++|+++|++|||   +++|+||||||+||+++.+ +++||+|||++..
T Consensus        95 ~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~  170 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLSAI  170 (370)
T ss_pred             EEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence            9999999999999999998 447889999999999999999999   9999999999999999999 9999999999987


Q ss_pred             cCCCCCccccccccccccccCccCcCCCC-C-CccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhh
Q 040845          677 LTGEDQSMTQTQTLATIGYMAPEYGREGQ-V-STNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEV  754 (824)
Q Consensus       677 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~-~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  754 (824)
                      ..  ..........||+.|+|||++.+.. | +.++||||+||++|-|++|+.||++...... ...+..          
T Consensus       171 ~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l-~~ki~~----------  237 (370)
T KOG0583|consen  171 SP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNL-YRKIRK----------  237 (370)
T ss_pred             cC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHH-HHHHhc----------
Confidence            63  1222334567999999999999877 7 5889999999999999999999987211111 111111          


Q ss_pred             ccccccCchhhhhhhHHHH-HHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 040845          755 VDANLLSQEDIHFVAKEQC-VSFVFNLALECTVESPEQRINAKEIVAKLLKIR  806 (824)
Q Consensus       755 ~~~~~~~~~~~~~~~~~~~-~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~  806 (824)
                                .....|..+ +.++..++.+|+..||.+|+|+.|++ .-.-++
T Consensus       238 ----------~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~  279 (370)
T KOG0583|consen  238 ----------GEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQ  279 (370)
T ss_pred             ----------CCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh-hChhhc
Confidence                      011112223 56789999999999999999999999 333333

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=7.8e-41  Score=345.24  Aligned_cols=247  Identities=28%  Similarity=0.430  Sum_probs=209.8

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc--chhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEe
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG--RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLE  603 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  603 (824)
                      ++|.+.+.||+|.||.||+|+.+ +.+.||+|.+.+..+  +..+.+.+|+++++.++||||+.++++|+...+.++|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            57888899999999999999755 588999999875533  345678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 040845          604 YMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS  683 (824)
Q Consensus       604 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  683 (824)
                      |+.| +|..++...+ .++++.+..++.+++.||.|||   +.+|.|||+||.||+++..|.+|+||||+|+.+..  ..
T Consensus        82 ~a~g-~L~~il~~d~-~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~t  154 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDG-KLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST--NT  154 (808)
T ss_pred             hhhh-hHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhccc--Cc
Confidence            9976 9999998766 7999999999999999999999   99999999999999999999999999999997643  34


Q ss_pred             cccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCch
Q 040845          684 MTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQE  763 (824)
Q Consensus       684 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  763 (824)
                      ...+...||+-|||||...++.|+..+|+||+||++||+++|++||...     .+.+.++.+..+...           
T Consensus       155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-----si~~Lv~~I~~d~v~-----------  218 (808)
T KOG0597|consen  155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-----SITQLVKSILKDPVK-----------  218 (808)
T ss_pred             eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-----HHHHHHHHHhcCCCC-----------
Confidence            4556678999999999999999999999999999999999999999762     122222222211110           


Q ss_pred             hhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          764 DIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       764 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                           .|...+..+.++++..+..||.+|.|..+++.|
T Consensus       219 -----~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H  251 (808)
T KOG0597|consen  219 -----PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH  251 (808)
T ss_pred             -----CcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence                 112456678999999999999999999998865

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.9e-40  Score=343.41  Aligned_cols=254  Identities=26%  Similarity=0.355  Sum_probs=206.3

Q ss_pred             hhccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEE
Q 040845          525 ATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKAL  600 (824)
Q Consensus       525 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  600 (824)
                      ..++|+.++.||+|+||.||.|+-+ +|..+|+|++++..   ....+.++.|-.+|....+|.||+++..|++.+..|+
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            3578999999999999999999755 59999999997652   4456778889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 040845          601 VLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE  680 (824)
Q Consensus       601 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  680 (824)
                      ||||++||++..+|.+.+ .+++..+..++.+++.|+..+|   +.|+|||||||+|+|+|..|++||+|||++.-+...
T Consensus       219 iMEylPGGD~mTLL~~~~-~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~  294 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMRKD-TLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK  294 (550)
T ss_pred             EEEecCCccHHHHHHhcC-cCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccchhhhh
Confidence            999999999999998877 7899999999999999999999   999999999999999999999999999998543210


Q ss_pred             ----------------------CCcc----cc-------------------ccccccccccCccCcCCCCCCccchHHHH
Q 040845          681 ----------------------DQSM----TQ-------------------TQTLATIGYMAPEYGREGQVSTNGDVYSF  715 (824)
Q Consensus       681 ----------------------~~~~----~~-------------------~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl  715 (824)
                                            +...    ..                   -..+|||.|+|||++.+..|+..+|.||+
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL  374 (550)
T KOG0605|consen  295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL  374 (550)
T ss_pred             hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence                                  0000    00                   13469999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCC-
Q 040845          716 GIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRIN-  794 (824)
Q Consensus       716 G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt-  794 (824)
                      |||+|||+.|.+||......+ ....+++..                .....+....++.++.+||.+|+. ||++|.. 
T Consensus       375 G~ImyEmLvGyPPF~s~tp~~-T~rkI~nwr----------------~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~  436 (550)
T KOG0605|consen  375 GCIMYEMLVGYPPFCSETPQE-TYRKIVNWR----------------ETLKFPEEVDLSDEAKDLITRLLC-DPENRLGS  436 (550)
T ss_pred             HHHHHHHHhCCCCCCCCCHHH-HHHHHHHHh----------------hhccCCCcCcccHHHHHHHHHHhc-CHHHhcCc
Confidence            999999999999998743322 122111110                011111222345778999999999 9999995 


Q ss_pred             --HHHHHH
Q 040845          795 --AKEIVA  800 (824)
Q Consensus       795 --~~evl~  800 (824)
                        ++||.+
T Consensus       437 ~G~~EIK~  444 (550)
T KOG0605|consen  437 KGAEEIKK  444 (550)
T ss_pred             ccHHHHhc
Confidence              555554

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-40  Score=316.18  Aligned_cols=238  Identities=26%  Similarity=0.335  Sum_probs=202.1

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALV  601 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  601 (824)
                      .++|+..+.||.|+||.|..++.+ +|..+|+|++++..   -+..+....|..+++.+.||+++++.+.+.+....|+|
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv  122 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV  122 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence            356888899999999999999866 48999999997653   23345667799999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 040845          602 LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED  681 (824)
Q Consensus       602 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  681 (824)
                      |||++||.|..++++.+ ++++..+..+|.||+.|++|||   +.+|++||+||+|||+|.+|.+||+|||+|+.+.+. 
T Consensus       123 meyv~GGElFS~Lrk~~-rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-  197 (355)
T KOG0616|consen  123 MEYVPGGELFSYLRKSG-RFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-  197 (355)
T ss_pred             EeccCCccHHHHHHhcC-CCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEecCc-
Confidence            99999999999999877 7899999999999999999999   999999999999999999999999999999987533 


Q ss_pred             CccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccC
Q 040845          682 QSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLS  761 (824)
Q Consensus       682 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  761 (824)
                          ....+||+.|+|||++....|..++|.|||||++|||+.|.+||...-. ......++..                
T Consensus       198 ----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-~~iY~KI~~~----------------  256 (355)
T KOG0616|consen  198 ----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-IQIYEKILEG----------------  256 (355)
T ss_pred             ----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-HHHHHHHHhC----------------
Confidence                2235699999999999999999999999999999999999999987322 1111111111                


Q ss_pred             chhhhhhhHHHHHHHHHHHHHHccccCCCCCC
Q 040845          762 QEDIHFVAKEQCVSFVFNLALECTVESPEQRI  793 (824)
Q Consensus       762 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp  793 (824)
                          +...|...+.++.+|+.+.+++|-.+|.
T Consensus       257 ----~v~fP~~fs~~~kdLl~~LL~vD~t~R~  284 (355)
T KOG0616|consen  257 ----KVKFPSYFSSDAKDLLKKLLQVDLTKRF  284 (355)
T ss_pred             ----cccCCcccCHHHHHHHHHHHhhhhHhhh
Confidence                1122345567789999999999999993

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-40  Score=310.16  Aligned_cols=249  Identities=25%  Similarity=0.334  Sum_probs=212.0

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALV  601 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  601 (824)
                      .++|++++.||+|.||.||.|+.+ ++-.||+|++.+..   .+...++.+|+++.+.|+||||.+++++|.++...|++
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            467899999999999999999865 57889999986542   34456789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 040845          602 LEYMPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE  680 (824)
Q Consensus       602 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  680 (824)
                      +||..+|.+...++..+ ..+++.....+..|+|.|+.|+|   .++|+||||||+|+|++..+.+|++|||.+..-.  
T Consensus       101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--  175 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP--  175 (281)
T ss_pred             EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence            99999999999998544 46888999999999999999999   9999999999999999999999999999997532  


Q ss_pred             CCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhcccccc
Q 040845          681 DQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLL  760 (824)
Q Consensus       681 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  760 (824)
                        .......+||..|.|||...+..++..+|+|++|++.||++.|.+||+... .+..+..+...               
T Consensus       176 --~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etYkrI~k~---------------  237 (281)
T KOG0580|consen  176 --SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETYKRIRKV---------------  237 (281)
T ss_pred             --CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHHHHHHHc---------------
Confidence              233445679999999999999999999999999999999999999998754 22222222211               


Q ss_pred             CchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 040845          761 SQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL  802 (824)
Q Consensus       761 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L  802 (824)
                           +...|...+..+.++|.+|+..+|.+|.+..|++++=
T Consensus       238 -----~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hp  274 (281)
T KOG0580|consen  238 -----DLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHP  274 (281)
T ss_pred             -----cccCCcccChhHHHHHHHHhccCccccccHHHHhhhH
Confidence                 1122344567789999999999999999999999874

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2.3e-39  Score=339.96  Aligned_cols=246  Identities=22%  Similarity=0.309  Sum_probs=200.7

Q ss_pred             CceeeeccceEEEEEEECCCcEEEEEEeeccccch---hhhHHHHHHHHhcCCCCcceeEEeeeec----CCeeEEEEec
Q 040845          532 NNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRA---FKSFDVECAMMKSIRHRNLVKVISSCSN----EEFKALVLEY  604 (824)
Q Consensus       532 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~  604 (824)
                      ...||+|++|.||+|.+. |+.||||+++......   .+.+.+|+.++++++||||+++++++.+    ....++||||
T Consensus        25 ~~~i~~g~~~~v~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         25 SVLIKENDQNSIYKGIFN-NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             CeEEeeCCceEEEEEEEC-CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            368999999999999984 8999999987543222   4678899999999999999999999866    3467899999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 040845          605 MPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYS-APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS  683 (824)
Q Consensus       605 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  683 (824)
                      +++|+|.+++.... .+++.....++.|++.|++|||   + .+++||||||+||++++++.+||+|||++.......  
T Consensus       104 ~~~g~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH---~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--  177 (283)
T PHA02988        104 CTRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLY---KYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--  177 (283)
T ss_pred             CCCCcHHHHHhhCC-CCChhHHHHHHHHHHHHHHHHH---hcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence            99999999998754 7889999999999999999999   6 488999999999999999999999999998654322  


Q ss_pred             cccccccccccccCccCcCC--CCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccC
Q 040845          684 MTQTQTLATIGYMAPEYGRE--GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLS  761 (824)
Q Consensus       684 ~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  761 (824)
                         ....++..|+|||++.+  ..++.++|||||||++|||++|+.||......+. ........               
T Consensus       178 ---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~-~~~i~~~~---------------  238 (283)
T PHA02988        178 ---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEI-YDLIINKN---------------  238 (283)
T ss_pred             ---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHhcC---------------
Confidence               12357889999999876  6789999999999999999999999976321110 11110000               


Q ss_pred             chhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 040845          762 QEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIR  806 (824)
Q Consensus       762 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~  806 (824)
                         .+...+..++..+.+++.+||+.||++|||++|+++.|+.++
T Consensus       239 ---~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        239 ---NSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             ---CCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence               001112246778999999999999999999999999999875

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-40  Score=327.64  Aligned_cols=273  Identities=26%  Similarity=0.338  Sum_probs=209.8

Q ss_pred             HHHHhhccCCCCceeeeccceEEEEEEEC-CCcEEEEEEee--ccccchhhhHHHHHHHHhcCCCCcceeEEeeeec---
Q 040845          521 ELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFN--LQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSN---  594 (824)
Q Consensus       521 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---  594 (824)
                      +.+.....|...+.||+|+||.|+.|..+ +|+.||||.+.  .......++..+|+++++.++|+||+.+.+++..   
T Consensus        16 ~~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~   95 (359)
T KOG0660|consen   16 ELFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSR   95 (359)
T ss_pred             eEEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccc
Confidence            34555677777899999999999999764 68999999986  3334456778899999999999999999999854   


Q ss_pred             --CCeeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecc
Q 040845          595 --EEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFG  672 (824)
Q Consensus       595 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  672 (824)
                        -...|+|+|+| +.+|...++... .++...+..+++|+++|+.|+|   +.+|+|||+||.|++++.+..+||+|||
T Consensus        96 ~~f~DvYiV~elM-etDL~~iik~~~-~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFG  170 (359)
T KOG0660|consen   96 DKFNDVYLVFELM-ETDLHQIIKSQQ-DLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFG  170 (359)
T ss_pred             cccceeEEehhHH-hhHHHHHHHcCc-cccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEecccc
Confidence              46789999999 559999998765 6899999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCccccccccccccccCccCcC-CCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcc
Q 040845          673 IAKLLTGEDQSMTQTQTLATIGYMAPEYGR-EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPIST  751 (824)
Q Consensus       673 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  751 (824)
                      +|+...........+.++.|.||+|||++. ...|+.+.||||.|||++||++|++-|.+...  ...-..+....+...
T Consensus       171 LAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~--v~Ql~lI~~~lGtP~  248 (359)
T KOG0660|consen  171 LARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDY--VHQLQLILELLGTPS  248 (359)
T ss_pred             ceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCch--HHHHHHHHHhcCCCC
Confidence            999876543344557888999999999765 45799999999999999999999997765211  110111111111110


Q ss_pred             ---hhhcc-----cccc-----CchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          752 ---MEVVD-----ANLL-----SQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       752 ---~~~~~-----~~~~-----~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                         ...+.     +.+.     ......... ++..+.+.+|+.+|+..||.+|+|++|+++|
T Consensus       249 ~e~l~~i~s~~ar~yi~slp~~p~~~f~~~f-p~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  249 EEDLQKIRSEKARPYIKSLPQIPKQPFSSIF-PNANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             HHHHHHhccHHHHHHHHhCCCCCCCCHHHHc-CCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence               01111     0000     000001111 2567789999999999999999999999886

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-39  Score=329.09  Aligned_cols=285  Identities=26%  Similarity=0.386  Sum_probs=218.4

Q ss_pred             ccHHHHHHhhccCCCCceeeeccceEEEEEEECCCcEEEEEEeeccccchhhhHHHHHHHHhcC--CCCcceeEEeeeec
Q 040845          517 FSYLELFQATDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSI--RHRNLVKVISSCSN  594 (824)
Q Consensus       517 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~  594 (824)
                      .++.-......+..+.+.||+|.||+||+|+|+ |+.||||+|..   .+.+++.+|.++++.+  +|+||..++++-..
T Consensus       201 lplLVQRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~  276 (513)
T KOG2052|consen  201 LPLLVQRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNK  276 (513)
T ss_pred             chhHhHHhhhheeEEEEEecCccccceeecccc-CCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhcccc
Confidence            344445566678888999999999999999998 99999999974   3345667777777754  99999999988543


Q ss_pred             C----CeeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhh-----cCCCCCeEecCCCCCCeeeCCCCc
Q 040845          595 E----EFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLH-----FGYSAPVIHCDLKPSNVLLDDNMV  665 (824)
Q Consensus       595 ~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH-----~~~~~~ivH~Dlk~~Nill~~~~~  665 (824)
                      +    ...++|++|.+.|+|.||+.+.  .++....++++..+|.||++||     ++.++.|.|||||+.|||+.+++.
T Consensus       277 ~~gs~TQLwLvTdYHe~GSL~DyL~r~--tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~  354 (513)
T KOG2052|consen  277 DNGSWTQLWLVTDYHEHGSLYDYLNRN--TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT  354 (513)
T ss_pred             CCCceEEEEEeeecccCCcHHHHHhhc--cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCc
Confidence            3    3678999999999999999874  6999999999999999999999     456889999999999999999999


Q ss_pred             EEEeecccccccCCCCCc--cccccccccccccCccCcCCCC----C--CccchHHHHHHHHHHHHhCCCCCcccccCcc
Q 040845          666 AHLSDFGIAKLLTGEDQS--MTQTQTLATIGYMAPEYGREGQ----V--STNGDVYSFGIMLMETFTRKKPTDELFNGEM  737 (824)
Q Consensus       666 ~kl~Dfg~a~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~----~--~~~~DvwslG~~l~el~tg~~p~~~~~~~~~  737 (824)
                      +.|+|+|+|..+......  ......+||.+|||||++.+.-    +  -..+||||||.|+||+..+..--+-..+...
T Consensus       355 C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~  434 (513)
T KOG2052|consen  355 CCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQL  434 (513)
T ss_pred             EEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcC
Confidence            999999999887644222  3345678999999999886431    2  2458999999999999764321111111111


Q ss_pred             hhhhhhhhhCCCc-chhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 040845          738 TLKHWVNDCLPIS-TMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRD  807 (824)
Q Consensus       738 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~  807 (824)
                      .+.+|+......+ ..+++............+....+...+.++|+.||..+|..|.||-.+.+.|.++.+
T Consensus       435 Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  435 PYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             CcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence            2222332222222 234555544554444555556788889999999999999999999999999999865

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-39  Score=327.52  Aligned_cols=279  Identities=26%  Similarity=0.335  Sum_probs=213.4

Q ss_pred             ccCCCCceeeeccceEEEEEEECCCcEEEEEEeeccccchhhhHHHHHHHHhc--CCCCcceeEEeeeecCC----eeEE
Q 040845          527 DKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKS--IRHRNLVKVISSCSNEE----FKAL  600 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~~l  600 (824)
                      ...+..++||+|.||.||+|++. ++.||||++..   +..+.+..|-+|++.  ++|+||++++++-....    .+++
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL  285 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL  285 (534)
T ss_pred             CchhhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence            34556678999999999999987 69999999974   445677777777665  48999999999875544    7889


Q ss_pred             EEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcC------CCCCeEecCCCCCCeeeCCCCcEEEeecccc
Q 040845          601 VLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFG------YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIA  674 (824)
Q Consensus       601 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~------~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a  674 (824)
                      |+||.+.|+|.+|+..+  ..+|.+.-+++..+++||+|||++      .+++|+|||||++|||+.+|+++.|+|||+|
T Consensus       286 Vt~fh~kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA  363 (534)
T KOG3653|consen  286 VTEFHPKGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA  363 (534)
T ss_pred             EeeeccCCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence            99999999999999876  589999999999999999999954      3678999999999999999999999999999


Q ss_pred             cccCCCCCccccccccccccccCccCcCCCCC------CccchHHHHHHHHHHHHhCCCCCcc--cccCcchhhhhhhhh
Q 040845          675 KLLTGEDQSMTQTQTLATIGYMAPEYGREGQV------STNGDVYSFGIMLMETFTRKKPTDE--LFNGEMTLKHWVNDC  746 (824)
Q Consensus       675 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~------~~~~DvwslG~~l~el~tg~~p~~~--~~~~~~~~~~~~~~~  746 (824)
                      ..+............+||.+|||||++.+...      -.+.||||+|.|+|||+++...++.  ..+-...+..-+...
T Consensus       364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~h  443 (534)
T KOG3653|consen  364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNH  443 (534)
T ss_pred             EEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCC
Confidence            99876655555556889999999999876532      1368999999999999998765532  111222222222222


Q ss_pred             CCCcc-hhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhcc
Q 040845          747 LPIST-MEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLR  811 (824)
Q Consensus       747 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~  811 (824)
                      ..... .+.+-.+..+..-...+........+.+.+..||..||+.|.||.=|-+++.++......
T Consensus       444 Pt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~  509 (534)
T KOG3653|consen  444 PTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED  509 (534)
T ss_pred             CCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence            21111 122222222222233444446677899999999999999999999999999988765543

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-40  Score=340.58  Aligned_cols=257  Identities=27%  Similarity=0.450  Sum_probs=221.9

Q ss_pred             hccCCCCceeeeccceEEEEEEECC---C--cEEEEEEeeccc-cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIRD---G--MEVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKA  599 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~~---~--~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  599 (824)
                      .+.....++||+|.||.||+|.+-+   |  -.||||.-+.++ ....+.|..|+.+|+.++||||++++|+|.+. ..+
T Consensus       388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~W  466 (974)
T KOG4257|consen  388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMW  466 (974)
T ss_pred             hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-cee
Confidence            3444556789999999999997543   3  358999887754 34578899999999999999999999999765 467


Q ss_pred             EEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCC
Q 040845          600 LVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG  679 (824)
Q Consensus       600 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  679 (824)
                      +|||.++.|.|.+|++.....++......++.||..|++|||   +.++|||||.++|||+.....+|++|||+++.+.+
T Consensus       467 ivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed  543 (974)
T KOG4257|consen  467 IVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLED  543 (974)
T ss_pred             EEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhccc
Confidence            999999999999999998889999999999999999999999   99999999999999999999999999999998865


Q ss_pred             CCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhcccc
Q 040845          680 EDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDAN  758 (824)
Q Consensus       680 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  758 (824)
                      ...+. .+...-+..|||||.+.-.+++.++|||-|||++||+++ |..||.+....+.                    .
T Consensus       544 ~~yYk-aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV--------------------I  602 (974)
T KOG4257|consen  544 DAYYK-ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV--------------------I  602 (974)
T ss_pred             cchhh-ccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce--------------------E
Confidence            55443 334557889999999999999999999999999999987 8899987543321                    1


Q ss_pred             ccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 040845          759 LLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRD  807 (824)
Q Consensus       759 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~  807 (824)
                      ..-+.+.+++.|++|++.++.||.+||.++|.+||++.|+...|.++++
T Consensus       603 ~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  603 GHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             EEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence            2234556788889999999999999999999999999999999999876

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.1e-40  Score=324.91  Aligned_cols=249  Identities=23%  Similarity=0.336  Sum_probs=209.7

Q ss_pred             hccCCCCceeeeccceEEEEEE-ECCCcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALV  601 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  601 (824)
                      ..+|++.+.||+|.||.|-+|. ...|+.||||.+++..   .+..-.+++|++||+.|+||||+.++.+|++.+...+|
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            3568888999999999999997 4679999999987653   33445688999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 040845          602 LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED  681 (824)
Q Consensus       602 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  681 (824)
                      |||..+|.|.+|+.+.+ .+++.++..+++||++|+.|+|   +.+++|||+|.+|||+|.++++||+|||++-.+....
T Consensus       132 MEYaS~GeLYDYiSer~-~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k  207 (668)
T KOG0611|consen  132 MEYASGGELYDYISERG-SLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK  207 (668)
T ss_pred             EEecCCccHHHHHHHhc-cccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhhcccc
Confidence            99999999999999877 8999999999999999999999   9999999999999999999999999999998775333


Q ss_pred             CccccccccccccccCccCcCCCCC-CccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhcccccc
Q 040845          682 QSMTQTQTLATIGYMAPEYGREGQV-STNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLL  760 (824)
Q Consensus       682 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  760 (824)
                         .....+|++-|.+||++.+..| ++.+|-||+||++|-++.|..||++..     ....++..-...          
T Consensus       208 ---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D-----hk~lvrQIs~Ga----------  269 (668)
T KOG0611|consen  208 ---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD-----HKRLVRQISRGA----------  269 (668)
T ss_pred             ---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch-----HHHHHHHhhccc----------
Confidence               3345679999999999999888 788999999999999999999998732     222222111110          


Q ss_pred             CchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 040845          761 SQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLL  803 (824)
Q Consensus       761 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~  803 (824)
                          ++.   +.-+....-||++|+.++|++|.|+.+|..|-+
T Consensus       270 ----YrE---P~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW  305 (668)
T KOG0611|consen  270 ----YRE---PETPSDASGLIRWMLMVNPERRATIEDIASHWW  305 (668)
T ss_pred             ----ccC---CCCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence                110   111445677999999999999999999988764

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=5.3e-39  Score=320.31  Aligned_cols=273  Identities=25%  Similarity=0.307  Sum_probs=207.2

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc--chhhhHHHHHHHHhcCCCCc-ceeEEeeeecCC-----
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG--RAFKSFDVECAMMKSIRHRN-LVKVISSCSNEE-----  596 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~-----  596 (824)
                      ...|+..++||+|+||+||+|+.+ +|+.||+|+++....  .......+|+.+++.++|+| |+++++++....     
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            445666788999999999999754 689999999987644  24566789999999999999 999999998877     


Q ss_pred             -eeEEEEeccCCCCHHHHhhhCC---CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecc
Q 040845          597 -FKALVLEYMPHGSLEKYLHSSN---YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFG  672 (824)
Q Consensus       597 -~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  672 (824)
                       ..++|+||++. +|.+++....   ...+...+..++.|+++|++|||   +++|+||||||.||+++++|.+||+|||
T Consensus        90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccc
Confidence             88999999955 9999998766   46788889999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCccccccccccccccCccCcCCC-CCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhC-CCc
Q 040845          673 IAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCL-PIS  750 (824)
Q Consensus       673 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~  750 (824)
                      +|+.+.-+  ....++.++|.+|+|||++.+. .|+..+||||+||+++||+++++-|.+..+-+ .+..+.+..- |..
T Consensus       166 lAra~~ip--~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~-ql~~If~~lGtP~e  242 (323)
T KOG0594|consen  166 LARAFSIP--MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEID-QLFRIFRLLGTPNE  242 (323)
T ss_pred             hHHHhcCC--cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHH-HHHHHHHHcCCCCc
Confidence            99965422  2335677899999999998877 68999999999999999999998776533211 1111111111 100


Q ss_pred             --c-----hhhccccccCchhhhhhhH--HHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHHH
Q 040845          751 --T-----MEVVDANLLSQEDIHFVAK--EQCVSFVFNLALECTVESPEQRINAKEIVAK--LLKI  805 (824)
Q Consensus       751 --~-----~~~~~~~~~~~~~~~~~~~--~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~--L~~~  805 (824)
                        .     ....+.........+....  ........+++.+|++++|.+|.||+.+++|  +..+
T Consensus       243 ~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~  308 (323)
T KOG0594|consen  243 KDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL  308 (323)
T ss_pred             cCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence              0     0001100000000000000  1112468899999999999999999999987  5544

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-40  Score=333.54  Aligned_cols=249  Identities=28%  Similarity=0.404  Sum_probs=209.6

Q ss_pred             ccCCCCceeeeccceEEEEEEE-CCCcEEEEEEeecccc-chhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEec
Q 040845          527 DKFSENNLIGRGGFGSVYKARI-RDGMEVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      ..|...+.||+|.||.||+|.. ++++.||+|++..+.. ...+++++|+.++..++++||.++|+.+..+...+++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            4567778999999999999975 4689999999987753 4578899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 040845          605 MPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM  684 (824)
Q Consensus       605 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  684 (824)
                      +.||++.+.+.... .+++.++..+++++..|+.|||   ..+.+|||||+.||++..+|.+|++|||.+..+.....  
T Consensus        93 ~~gGsv~~lL~~~~-~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~--  166 (467)
T KOG0201|consen   93 CGGGSVLDLLKSGN-ILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK--  166 (467)
T ss_pred             hcCcchhhhhccCC-CCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeechhh--
Confidence            99999999998765 4478888889999999999999   99999999999999999999999999999987753322  


Q ss_pred             ccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchh
Q 040845          685 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQED  764 (824)
Q Consensus       685 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  764 (824)
                      .....+||+.|||||++....|+.|+||||+|++.+||.+|.+|+....+...              ...+..    ...
T Consensus       167 rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv--------------lflIpk----~~P  228 (467)
T KOG0201|consen  167 RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV--------------LFLIPK----SAP  228 (467)
T ss_pred             ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE--------------EEeccC----CCC
Confidence            22557899999999999988999999999999999999999999987544211              100000    000


Q ss_pred             hhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          765 IHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       765 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      ..+.  ..++..+.+++..|+..||+.||+|.+++++
T Consensus       229 P~L~--~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  229 PRLD--GDFSPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             Cccc--cccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence            1111  1567779999999999999999999999876

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=6.9e-39  Score=349.85  Aligned_cols=257  Identities=24%  Similarity=0.389  Sum_probs=205.0

Q ss_pred             hccCCCCceeeeccceEEEEEEE------CCCcEEEEEEeeccc-cchhhhHHHHHHHHhcC-CCCcceeEEeeeecCCe
Q 040845          526 TDKFSENNLIGRGGFGSVYKARI------RDGMEVAVKVFNLQC-GRAFKSFDVECAMMKSI-RHRNLVKVISSCSNEEF  597 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  597 (824)
                      .++|++.+.||+|+||.||+|++      .++..||||+++... ....+.+.+|+.+++.+ +||||+++++++.+...
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            45788999999999999999974      235689999986442 23446788899999999 89999999999999999


Q ss_pred             eEEEEeccCCCCHHHHhhhCC-----------------------------------------------------------
Q 040845          598 KALVLEYMPHGSLEKYLHSSN-----------------------------------------------------------  618 (824)
Q Consensus       598 ~~lv~e~~~~g~L~~~l~~~~-----------------------------------------------------------  618 (824)
                      .++||||+++|+|.+++....                                                           
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            999999999999999986432                                                           


Q ss_pred             ---------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 040845          619 ---------------YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS  683 (824)
Q Consensus       619 ---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  683 (824)
                                     ..+++.++..++.||++|++|||   +.+|+||||||+||+++.++.+||+|||++.........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                           14678889999999999999999   999999999999999999999999999999876433322


Q ss_pred             cccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhccccccCc
Q 040845          684 MTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ  762 (824)
Q Consensus       684 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  762 (824)
                      .......++..|+|||.+.+..++.++|||||||++|||++ |..||...... .....++.....              
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~-~~~~~~~~~~~~--------------  335 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD-SKFYKMIKEGYR--------------  335 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch-HHHHHHHHhCcc--------------
Confidence            22223345678999999999999999999999999999998 88888653221 112222111100              


Q ss_pred             hhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 040845          763 EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLK  804 (824)
Q Consensus       763 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~  804 (824)
                          ...+...+.++.+++.+||+.||++|||+.|+++.|++
T Consensus       336 ----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         336 ----MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             ----CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence                00112235678999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=9.9e-39  Score=339.87  Aligned_cols=261  Identities=24%  Similarity=0.427  Sum_probs=203.2

Q ss_pred             ccCCCCceeeeccceEEEEEEECC-----------------CcEEEEEEeecccc-chhhhHHHHHHHHhcCCCCcceeE
Q 040845          527 DKFSENNLIGRGGFGSVYKARIRD-----------------GMEVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVKV  588 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l  588 (824)
                      ++|.+.+.||+|+||.||+|.+++                 +..||+|++..... .....+.+|++++++++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            578889999999999999997542                 33699999875432 234578899999999999999999


Q ss_pred             EeeeecCCeeEEEEeccCCCCHHHHhhhCC------------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 040845          589 ISSCSNEEFKALVLEYMPHGSLEKYLHSSN------------------YSLDIFQRLNIMIDVASALEYLHFGYSAPVIH  650 (824)
Q Consensus       589 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH  650 (824)
                      ++++.+.+..++||||+++|+|.+++....                  ..+++.++..++.|++.|++|||   +.+|+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCccc
Confidence            999999999999999999999999986432                  24677889999999999999999   999999


Q ss_pred             cCCCCCCeeeCCCCcEEEeecccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh--CCCC
Q 040845          651 CDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT--RKKP  728 (824)
Q Consensus       651 ~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t--g~~p  728 (824)
                      |||||+||+++.++.+||+|||++................++..|+|||++..+.++.++||||||+++|||++  +..|
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            99999999999999999999999986644333222233446788999999988889999999999999999987  4566


Q ss_pred             CcccccCcchhhhhhhhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 040845          729 TDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLL  803 (824)
Q Consensus       729 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~  803 (824)
                      |......  .....+.........           ......+..++..+.+++.+||..||++|||+.|+.+.|+
T Consensus       242 ~~~~~~~--~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         242 YGELTDE--QVIENAGEFFRDQGR-----------QVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCcCCHH--HHHHHHHHHhhhccc-----------cccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            6653211  111111111000000           0001112346678999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-39  Score=304.84  Aligned_cols=260  Identities=22%  Similarity=0.300  Sum_probs=211.5

Q ss_pred             hccCCCCceeeeccceEEEEEE-ECCCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecC-----CeeE
Q 040845          526 TDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNE-----EFKA  599 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~  599 (824)
                      .++|.+.+.+|+|||+-||.++ ..+++.||+|++.-...+..+...+|++..++++|||+++++++...+     +..|
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y   99 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY   99 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence            4689999999999999999997 567899999998777667788899999999999999999999987433     4589


Q ss_pred             EEEeccCCCCHHHHhhhCC---CCCCHHHHHHHHHHHHHHHHHhhcCCCCC--eEecCCCCCCeeeCCCCcEEEeecccc
Q 040845          600 LVLEYMPHGSLEKYLHSSN---YSLDIFQRLNIMIDVASALEYLHFGYSAP--VIHCDLKPSNVLLDDNMVAHLSDFGIA  674 (824)
Q Consensus       600 lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlk~~Nill~~~~~~kl~Dfg~a  674 (824)
                      ++++|+..|+|.+.+.+..   ..+++.+++.|+.+|++||++||   +..  ++||||||.||++.+++.+++.|||.+
T Consensus       100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH---~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~  176 (302)
T KOG2345|consen  100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALH---EKEPPYAHRDIKPANILLSDSGLPVLMDLGSA  176 (302)
T ss_pred             EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHh---ccCCcccccCCCcceeEecCCCceEEEeccCc
Confidence            9999999999999987543   57899999999999999999999   555  999999999999999999999999998


Q ss_pred             cccCCCCCc-------cccccccccccccCccCcC---CCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhh
Q 040845          675 KLLTGEDQS-------MTQTQTLATIGYMAPEYGR---EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVN  744 (824)
Q Consensus       675 ~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~  744 (824)
                      +...-.-..       ........|..|+|||.+.   +...++++|||||||++|+|+.|..||+..++.+..+.--+ 
T Consensus       177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv-  255 (302)
T KOG2345|consen  177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAV-  255 (302)
T ss_pred             cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEee-
Confidence            765321111       1223445789999999875   44678999999999999999999999987655333222111 


Q ss_pred             hhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 040845          745 DCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKI  805 (824)
Q Consensus       745 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~  805 (824)
                                ..      .....+....+++.+.++++.|++.||.+||++.+++.+++++
T Consensus       256 ----------~n------~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  256 ----------QN------AQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             ----------ec------cccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence                      11      1112222223678899999999999999999999999998775

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-41  Score=311.72  Aligned_cols=254  Identities=23%  Similarity=0.351  Sum_probs=207.0

Q ss_pred             hccCCCCceeeeccceEEEEEE-ECCCcEEEEEEeecc--ccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQ--CGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVL  602 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  602 (824)
                      .++|++.+.||+|+|+.||++. ..+|+.+|+|.+...  .....+.+.+|+.|-+.|+||||+++.+...++...|+|+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            4678888899999999999995 456999999987533  3456788999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC---CCCcEEEeecccccccCC
Q 040845          603 EYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLTG  679 (824)
Q Consensus       603 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~---~~~~~kl~Dfg~a~~~~~  679 (824)
                      |+|+|++|..-+-.. ..+++..+-..++||++++.|+|   ..+|||||+||+|+++.   ..-.+|++|||+|..+. 
T Consensus        90 e~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-  164 (355)
T KOG0033|consen   90 DLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-  164 (355)
T ss_pred             ecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEEeC-
Confidence            999999987554332 35788888899999999999999   99999999999999995   34578999999999876 


Q ss_pred             CCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccc
Q 040845          680 EDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANL  759 (824)
Q Consensus       680 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  759 (824)
                        ......+.+||++|||||+++..+|+..+|||+.||++|-++.|++||++.... .-+.++....+            
T Consensus       165 --~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~-rlye~I~~g~y------------  229 (355)
T KOG0033|consen  165 --DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-RLYEQIKAGAY------------  229 (355)
T ss_pred             --CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH-HHHHHHhcccc------------
Confidence              223445678999999999999999999999999999999999999999873211 11222222111            


Q ss_pred             cCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 040845          760 LSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLL  803 (824)
Q Consensus       760 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~  803 (824)
                          ..........+++..+|+++|+..||.+|.|+.|+++|=+
T Consensus       230 ----d~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpW  269 (355)
T KOG0033|consen  230 ----DYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPW  269 (355)
T ss_pred             ----CCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCch
Confidence                1111223355677899999999999999999999987643

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-40  Score=339.29  Aligned_cols=256  Identities=28%  Similarity=0.447  Sum_probs=219.9

Q ss_pred             hccCCCCceeeeccceEEEEEEECC-CcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEec
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      ..+..+.++||-|.||.||.|.|+. .-.||||.++.+ ....++|..|+.+|+.++|||+|+++|+|..+..+|||+||
T Consensus       266 RtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEf  344 (1157)
T KOG4278|consen  266 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEF  344 (1157)
T ss_pred             chheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEec
Confidence            3455667899999999999999986 567999998744 56688999999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 040845          605 MPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS  683 (824)
Q Consensus       605 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  683 (824)
                      |..|+|.+|+++.. ..++.--.+.++.||++|++||.   .+.+||||+.++|.|+.++..+|++|||+++.+.... +
T Consensus       345 M~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT-Y  420 (1157)
T KOG4278|consen  345 MCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT-Y  420 (1157)
T ss_pred             ccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhhcCCc-e
Confidence            99999999998766 34566667889999999999999   9999999999999999999999999999999987543 3


Q ss_pred             cccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhccccccCc
Q 040845          684 MTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ  762 (824)
Q Consensus       684 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  762 (824)
                      ....+...++.|.|||-+....++.|+|||+|||++||+.| |..||.+.     ++.+.+               .+-+
T Consensus       421 TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi-----dlSqVY---------------~LLE  480 (1157)
T KOG4278|consen  421 TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI-----DLSQVY---------------GLLE  480 (1157)
T ss_pred             ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc-----cHHHHH---------------HHHh
Confidence            34455567889999999999999999999999999999999 77777652     111111               1223


Q ss_pred             hhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 040845          763 EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIR  806 (824)
Q Consensus       763 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~  806 (824)
                      .++++..|+.|++.+++||+.||+.+|.+||+++|+-+.++.+.
T Consensus       481 kgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf  524 (1157)
T KOG4278|consen  481 KGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF  524 (1157)
T ss_pred             ccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence            45667788899999999999999999999999999999999875

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-39  Score=342.75  Aligned_cols=242  Identities=24%  Similarity=0.314  Sum_probs=202.5

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcC-CCCcceeEEeeeecCCeeEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSI-RHRNLVKVISSCSNEEFKAL  600 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  600 (824)
                      .++|...++||+|.||+|+.|..+ +++.+|||++++..   +.+.+..+.|..++... +||++++++++|+..++.|+
T Consensus       367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f  446 (694)
T KOG0694|consen  367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF  446 (694)
T ss_pred             ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence            467899999999999999999876 48899999998763   55677888899988877 59999999999999999999


Q ss_pred             EEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 040845          601 VLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE  680 (824)
Q Consensus       601 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  680 (824)
                      ||||+.||++..+.+  ...+++..+.-+++.|+.||.|||   +++|||||||.+|||+|.+|++||+|||+++.-.  
T Consensus       447 vmey~~Ggdm~~~~~--~~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m--  519 (694)
T KOG0694|consen  447 VMEYVAGGDLMHHIH--TDVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM--  519 (694)
T ss_pred             EEEecCCCcEEEEEe--cccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccccccccC--
Confidence            999999999544433  246899999999999999999999   9999999999999999999999999999998543  


Q ss_pred             CCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhcccccc
Q 040845          681 DQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLL  760 (824)
Q Consensus       681 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  760 (824)
                      ......+...||+.|||||++.+..|+.++|.|||||++|||+.|..||.+..+.                 +++|..+.
T Consensus       520 ~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe-----------------e~FdsI~~  582 (694)
T KOG0694|consen  520 GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE-----------------EVFDSIVN  582 (694)
T ss_pred             CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH-----------------HHHHHHhc
Confidence            2223445678999999999999999999999999999999999999999862221                 22222222


Q ss_pred             CchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCH
Q 040845          761 SQEDIHFVAKEQCVSFVFNLALECTVESPEQRINA  795 (824)
Q Consensus       761 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~  795 (824)
                      ...    ..|..++.+..+||+++++.+|++|..+
T Consensus       583 d~~----~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  583 DEV----RYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             CCC----CCCCcccHHHHHHHHHHhccCcccccCC
Confidence            211    1233567788999999999999999965

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=8.2e-39  Score=348.83  Aligned_cols=259  Identities=24%  Similarity=0.405  Sum_probs=205.4

Q ss_pred             hccCCCCceeeeccceEEEEEEEC------CCcEEEEEEeeccc-cchhhhHHHHHHHHhcC-CCCcceeEEeeeecCCe
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR------DGMEVAVKVFNLQC-GRAFKSFDVECAMMKSI-RHRNLVKVISSCSNEEF  597 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  597 (824)
                      .++|++.+.||+|+||.||+|++.      ++..||||+++... ....+.+.+|+++++.+ +|+||+++++++.....
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~  116 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP  116 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence            357889999999999999999742      24579999986543 23346688899999999 89999999999999999


Q ss_pred             eEEEEeccCCCCHHHHhhhCC-----------------------------------------------------------
Q 040845          598 KALVLEYMPHGSLEKYLHSSN-----------------------------------------------------------  618 (824)
Q Consensus       598 ~~lv~e~~~~g~L~~~l~~~~-----------------------------------------------------------  618 (824)
                      .++||||+++|+|.+++....                                                           
T Consensus       117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (374)
T cd05106         117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD  196 (374)
T ss_pred             eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence            999999999999999985421                                                           


Q ss_pred             ----------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcccccc
Q 040845          619 ----------YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQ  688 (824)
Q Consensus       619 ----------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  688 (824)
                                ..+++.++++++.|++.|++|||   +.+|+||||||+||++++++.+||+|||+++.............
T Consensus       197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~  273 (374)
T cd05106         197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN  273 (374)
T ss_pred             ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence                      24678889999999999999999   99999999999999999999999999999986543322222222


Q ss_pred             ccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhhhh
Q 040845          689 TLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHF  767 (824)
Q Consensus       689 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  767 (824)
                      ..++..|+|||++.+..++.++|||||||++|||++ |+.||....... ..........                  ..
T Consensus       274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~~~~~~~~~~------------------~~  334 (374)
T cd05106         274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KFYKMVKRGY------------------QM  334 (374)
T ss_pred             CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-HHHHHHHccc------------------Cc
Confidence            335678999999988899999999999999999997 999987643221 1111111000                  00


Q ss_pred             hhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 040845          768 VAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIR  806 (824)
Q Consensus       768 ~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~  806 (824)
                      ..+...+.++.+++.+||+.||++|||+.|+++.|+++.
T Consensus       335 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         335 SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            011123567899999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=2.6e-38  Score=333.89  Aligned_cols=269  Identities=20%  Similarity=0.239  Sum_probs=203.7

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEe
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLE  603 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  603 (824)
                      ++|++.+.||+|+||.||+|+++ +++.||+|+++...  ....+.+.+|+++++.++||||+++++++..++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            46889999999999999999876 58899999987542  2334667889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 040845          604 YMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS  683 (824)
Q Consensus       604 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  683 (824)
                      |++++.+..+.. ....+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||++........ 
T Consensus        81 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-  155 (287)
T cd07848          81 YVEKNMLELLEE-MPNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN-  155 (287)
T ss_pred             cCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc-
Confidence            998876665543 3447899999999999999999999   99999999999999999999999999999987643221 


Q ss_pred             cccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhC--CCcch---------
Q 040845          684 MTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCL--PISTM---------  752 (824)
Q Consensus       684 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~--~~~~~---------  752 (824)
                      .......++..|+|||++.+..++.++||||+||++|||++|+.||......+. .........  +....         
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07848         156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQ-LFTIQKVLGPLPAEQMKLFYSNPRF  234 (287)
T ss_pred             ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhhCCCCHHHHHhhhccchh
Confidence            122334689999999999888899999999999999999999999975322111 111100000  00000         


Q ss_pred             -hhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          753 -EVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       753 -~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                       ....+...............++..+.+++.+||+.||++|||++|+++|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h  284 (287)
T cd07848         235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH  284 (287)
T ss_pred             cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence             0000000000001111112356789999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2.9e-38  Score=333.27  Aligned_cols=267  Identities=22%  Similarity=0.288  Sum_probs=203.3

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc-cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEe
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLE  603 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  603 (824)
                      .++|++.+.||+|+||+||+|+.+ +++.||+|+++... ......+.+|+.++++++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE   83 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence            357899999999999999999865 58999999986543 2234567789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 040845          604 YMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS  683 (824)
Q Consensus       604 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  683 (824)
                      |+++ +|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++.......  
T Consensus        84 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~--  157 (288)
T cd07871          84 YLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT--  157 (288)
T ss_pred             CCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC--
Confidence            9974 999998776656889999999999999999999   9999999999999999999999999999997543222  


Q ss_pred             cccccccccccccCccCcCC-CCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhC-CCc-----------
Q 040845          684 MTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCL-PIS-----------  750 (824)
Q Consensus       684 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~-----------  750 (824)
                      .......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||......+ .......... +..           
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07871         158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKE-ELHLIFRLLGTPTEETWPGITSNEE  236 (288)
T ss_pred             ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChHHhhccccchh
Confidence            12233467899999998865 468999999999999999999999997532211 1111111100 000           


Q ss_pred             chhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          751 TMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       751 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      ......+......  ........+.++.+++.+|++.||.+|||++|+++|
T Consensus       237 ~~~~~~~~~~~~~--~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h  285 (288)
T cd07871         237 FRSYLFPQYRAQP--LINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH  285 (288)
T ss_pred             hhccccCccCCCc--hHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            0000000000000  001112345678999999999999999999999864

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.4e-38  Score=331.82  Aligned_cols=255  Identities=22%  Similarity=0.390  Sum_probs=206.3

Q ss_pred             ccCCCCceeeeccceEEEEEEEC----CCcEEEEEEeecccc-chhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEE
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR----DGMEVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALV  601 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  601 (824)
                      .+|++.+.||+|+||.||+|.++    .+..||+|.++.... .....+.+|+.+++.++||||+++++++...+..++|
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            56888999999999999999753    357899999876532 3345788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 040845          602 LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED  681 (824)
Q Consensus       602 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  681 (824)
                      |||+++|+|.+++......+++.+++.++.|++.|++|||   +.+++||||||+||+++.++.++++|||.+.......
T Consensus        85 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~  161 (266)
T cd05064          85 TEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA  161 (266)
T ss_pred             EEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence            9999999999999876557899999999999999999999   9999999999999999999999999999876532211


Q ss_pred             CccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhcccccc
Q 040845          682 QSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLL  760 (824)
Q Consensus       682 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  760 (824)
                      . .......++..|+|||.+.+..++.++|||||||++||+++ |..||......  .....+...              
T Consensus       162 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--~~~~~~~~~--------------  224 (266)
T cd05064         162 I-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--DVIKAVEDG--------------  224 (266)
T ss_pred             h-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHHHHCC--------------
Confidence            1 11112335678999999998999999999999999999875 99998753211  111111000              


Q ss_pred             CchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 040845          761 SQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKI  805 (824)
Q Consensus       761 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~  805 (824)
                          .....+..++..+.+++.+||+.+|++||++.|+.+.|.++
T Consensus       225 ----~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         225 ----FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             ----CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence                01112335677899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-39  Score=339.22  Aligned_cols=246  Identities=25%  Similarity=0.331  Sum_probs=202.5

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEE
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVL  602 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  602 (824)
                      ++|++.+.||+|+||.||+|..+ +++.||+|++....   ....+.+.+|+++++.++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            46888999999999999999865 58999999986532   223456788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 040845          603 EYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ  682 (824)
Q Consensus       603 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  682 (824)
                      ||+++|+|.+++...+ .+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||++....... 
T Consensus        81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~-  155 (291)
T cd05612          81 EYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT-  155 (291)
T ss_pred             eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc-
Confidence            9999999999998765 6889999999999999999999   9999999999999999999999999999998653221 


Q ss_pred             ccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCc
Q 040845          683 SMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ  762 (824)
Q Consensus       683 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  762 (824)
                          ....|++.|+|||++.+..++.++||||+||++|||++|+.||......     .........        .    
T Consensus       156 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~-----~~~~~i~~~--------~----  214 (291)
T cd05612         156 ----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF-----GIYEKILAG--------K----  214 (291)
T ss_pred             ----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHhC--------C----
Confidence                2245899999999999888999999999999999999999998753211     111100000        0    


Q ss_pred             hhhhhhhHHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHH
Q 040845          763 EDIHFVAKEQCVSFVFNLALECTVESPEQRIN-----AKEIVAKL  802 (824)
Q Consensus       763 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt-----~~evl~~L  802 (824)
                          ...+..++..+.+++.+||+.||.+||+     ++|++++-
T Consensus       215 ----~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~  255 (291)
T cd05612         215 ----LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHR  255 (291)
T ss_pred             ----cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCc
Confidence                0011123556889999999999999995     88888773

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=5.6e-39  Score=332.92  Aligned_cols=249  Identities=35%  Similarity=0.581  Sum_probs=196.9

Q ss_pred             CCceeeeccceEEEEEEEC-----CCcEEEEEEeecccc-chhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEec
Q 040845          531 ENNLIGRGGFGSVYKARIR-----DGMEVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       531 ~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      ..+.||.|.||.||+|.+.     .+..|+||.++.... ...+.+.+|++.+++++||||++++|++...+..++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            3578999999999999876     267899999965433 3467899999999999999999999999988889999999


Q ss_pred             cCCCCHHHHhhhC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 040845          605 MPHGSLEKYLHSS-NYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS  683 (824)
Q Consensus       605 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  683 (824)
                      +++|+|.+++... ...+++.++..++.|+++|++|||   +.+++|+||+++||++++++.+||+|||++.........
T Consensus        83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred             cccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccccc
Confidence            9999999999987 567999999999999999999999   899999999999999999999999999999876333333


Q ss_pred             cccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhccccccCc
Q 040845          684 MTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ  762 (824)
Q Consensus       684 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  762 (824)
                      ...........|+|||.+....++.++||||||+++||+++ |+.||......  .....+.                  
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~--~~~~~~~------------------  219 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE--EIIEKLK------------------  219 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH--HHHHHHH------------------
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccc--ccccccc------------------
Confidence            33334457789999999988889999999999999999999 67887653111  1111110                  


Q ss_pred             hhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 040845          763 EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL  802 (824)
Q Consensus       763 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L  802 (824)
                      ...+...+..++..+.+++.+||..||++|||++++++.|
T Consensus       220 ~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  220 QGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             TTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            0011122334677799999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=4.7e-38  Score=334.35  Aligned_cols=270  Identities=22%  Similarity=0.305  Sum_probs=203.5

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc-chhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEe
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLE  603 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  603 (824)
                      .++|++.+.||+|+||.||+|+.+ +++.||||+++.... .....+.+|+.+++.++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            478999999999999999999875 589999999865432 223456789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 040845          604 YMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS  683 (824)
Q Consensus       604 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  683 (824)
                      |++ ++|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++.......  
T Consensus        84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--  157 (303)
T cd07869          84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS--  157 (303)
T ss_pred             CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC--
Confidence            995 6888888776667889999999999999999999   9999999999999999999999999999987543221  


Q ss_pred             cccccccccccccCccCcCC-CCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCc--------chhh
Q 040845          684 MTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPIS--------TMEV  754 (824)
Q Consensus       684 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--------~~~~  754 (824)
                      .......+++.|+|||++.+ ..++.++||||+||++|||++|+.||.+.......+...........        ....
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (303)
T cd07869         158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH  237 (303)
T ss_pred             ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccc
Confidence            12234568899999998765 45789999999999999999999999764322222211111100000        0000


Q ss_pred             cccccc---Cchh-hhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          755 VDANLL---SQED-IHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       755 ~~~~~~---~~~~-~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      .++...   .... .........+..+.+++.+|++.||++|||+.|+++|
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h  288 (303)
T cd07869         238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH  288 (303)
T ss_pred             cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence            000000   0000 0001111234568899999999999999999999864

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.9e-39  Score=320.93  Aligned_cols=263  Identities=25%  Similarity=0.353  Sum_probs=199.7

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCC-----eeE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEE-----FKA  599 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  599 (824)
                      .-.|...+++|.|+||.||+|... +++.||||+.-.+    .+--.+|.++|+.++|||||++..+|....     ...
T Consensus        23 ~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d----~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln   98 (364)
T KOG0658|consen   23 EISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQD----KRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN   98 (364)
T ss_pred             EEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCC----CCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence            345777899999999999999865 4799999987433    222346999999999999999999885422     345


Q ss_pred             EEEeccCCCCHHHHhhhC---CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCC-CcEEEeeccccc
Q 040845          600 LVLEYMPHGSLEKYLHSS---NYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDN-MVAHLSDFGIAK  675 (824)
Q Consensus       600 lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~Dfg~a~  675 (824)
                      +|||||+. +|.++++..   +..++...+.-+.+|+.+|++|||   +.+|+||||||.|+|+|.+ |.+||||||.|+
T Consensus        99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK  174 (364)
T KOG0658|consen   99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAK  174 (364)
T ss_pred             HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcce
Confidence            89999966 999998753   356788888999999999999999   9999999999999999965 999999999999


Q ss_pred             ccCCCCCccccccccccccccCccCcCCC-CCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCc--ch
Q 040845          676 LLTGEDQSMTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPIS--TM  752 (824)
Q Consensus       676 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~  752 (824)
                      .+..+...   ..+..|..|+|||.+.+. .|+.+.||||.|||+.||+-|++-|.+. .+...+..+++......  ..
T Consensus       175 ~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~-s~~dQL~eIik~lG~Pt~e~I  250 (364)
T KOG0658|consen  175 VLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGD-SSVDQLVEIIKVLGTPTREDI  250 (364)
T ss_pred             eeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCC-CHHHHHHHHHHHhCCCCHHHH
Confidence            88655443   446689999999988765 6899999999999999999999987662 22223333333222111  11


Q ss_pred             hhcccc--------ccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          753 EVVDAN--------LLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       753 ~~~~~~--------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      ..+.+.        .......+ ......+++..+++.++++++|.+|.++.|++.+
T Consensus       251 ~~mn~~y~~~~~p~ik~~~~~~-~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h  306 (364)
T KOG0658|consen  251 KSMNPNYTEFKFPQIKAHPWHK-VFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH  306 (364)
T ss_pred             hhcCcccccccCccccccccee-ecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence            111111        11111001 1223567789999999999999999999999865

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=2.2e-38  Score=338.98  Aligned_cols=261  Identities=24%  Similarity=0.399  Sum_probs=209.6

Q ss_pred             ccCCCCceeeeccceEEEEEEECC-Cc----EEEEEEeeccc-cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEE
Q 040845          527 DKFSENNLIGRGGFGSVYKARIRD-GM----EVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKAL  600 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~~-~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  600 (824)
                      .+|+..+.||+|+||.||+|++.. +.    .||+|+++... ....+.+..|+.+++.++||||+++++++... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            468899999999999999998642 33    48999986443 23456788899999999999999999998765 4679


Q ss_pred             EEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 040845          601 VLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE  680 (824)
Q Consensus       601 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  680 (824)
                      |+||+++|+|.+++......+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.+...
T Consensus        86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~  162 (316)
T cd05108          86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD  162 (316)
T ss_pred             eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEccccccccccCC
Confidence            99999999999999877667889999999999999999999   999999999999999999999999999999876543


Q ss_pred             CCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhccccc
Q 040845          681 DQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANL  759 (824)
Q Consensus       681 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  759 (824)
                      ..........++..|+|||.+....++.++|||||||++||+++ |+.||++....  ....+....             
T Consensus       163 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~--~~~~~~~~~-------------  227 (316)
T cd05108         163 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILEKG-------------  227 (316)
T ss_pred             CcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHhCC-------------
Confidence            33222233345678999999998899999999999999999998 99998653211  111111100             


Q ss_pred             cCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhcc
Q 040845          760 LSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLR  811 (824)
Q Consensus       760 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~  811 (824)
                           .....+..++..+.+++.+||..+|++||++.+++..+.++.+...+
T Consensus       228 -----~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~~  274 (316)
T cd05108         228 -----ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQR  274 (316)
T ss_pred             -----CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCch
Confidence                 01111223556789999999999999999999999999988765544

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.2e-38  Score=341.61  Aligned_cols=242  Identities=24%  Similarity=0.297  Sum_probs=197.7

Q ss_pred             ceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEeccCCC
Q 040845          533 NLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHG  608 (824)
Q Consensus       533 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  608 (824)
                      +.||+|+||.||+|+.+ +|+.||+|+++...   ......+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999864 58999999987542   233456778999999999999999999999999999999999999


Q ss_pred             CHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcccccc
Q 040845          609 SLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQ  688 (824)
Q Consensus       609 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  688 (824)
                      +|.+++...+ .+++.++..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++......  .....
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~~  154 (323)
T cd05571          81 ELFFHLSRER-VFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKT  154 (323)
T ss_pred             cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Ccccc
Confidence            9999997655 6899999999999999999999   9999999999999999999999999999987532221  12234


Q ss_pred             ccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhhhhh
Q 040845          689 TLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFV  768 (824)
Q Consensus       689 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  768 (824)
                      ..||+.|+|||++.+..++.++||||+||++|||++|+.||......  .....+.   ..                ...
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~--~~~~~~~---~~----------------~~~  213 (323)
T cd05571         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLFELIL---ME----------------EIR  213 (323)
T ss_pred             eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH--HHHHHHH---cC----------------CCC
Confidence            56899999999999989999999999999999999999999652111  1111100   00                000


Q ss_pred             hHHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 040845          769 AKEQCVSFVFNLALECTVESPEQRI-----NAKEIVAK  801 (824)
Q Consensus       769 ~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~evl~~  801 (824)
                      .+...+..+.+++.+||..||++||     ++.|++++
T Consensus       214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  251 (323)
T cd05571         214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH  251 (323)
T ss_pred             CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence            1123456789999999999999999     89998865

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=9.5e-39  Score=343.12  Aligned_cols=246  Identities=22%  Similarity=0.277  Sum_probs=202.2

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALV  601 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  601 (824)
                      .++|++.+.||+|+||.||+|+++ +++.||+|++....   ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence            357889999999999999999875 58999999987542   23345688899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 040845          602 LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED  681 (824)
Q Consensus       602 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  681 (824)
                      |||+++|+|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++.......
T Consensus        97 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  172 (329)
T PTZ00263         97 LEFVVGGELFTHLRKAG-RFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT  172 (329)
T ss_pred             EcCCCCChHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc
Confidence            99999999999998655 6788899999999999999999   9999999999999999999999999999998653322


Q ss_pred             CccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccC
Q 040845          682 QSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLS  761 (824)
Q Consensus       682 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  761 (824)
                           ....||+.|+|||++.+..++.++|||||||++|||++|+.||......    ..+ ......            
T Consensus       173 -----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~----~~~-~~i~~~------------  230 (329)
T PTZ00263        173 -----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF----RIY-EKILAG------------  230 (329)
T ss_pred             -----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH----HHH-HHHhcC------------
Confidence                 1245899999999999988999999999999999999999998652111    100 100000            


Q ss_pred             chhhhhhhHHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 040845          762 QEDIHFVAKEQCVSFVFNLALECTVESPEQRIN-----AKEIVAK  801 (824)
Q Consensus       762 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt-----~~evl~~  801 (824)
                          ....+..++..+.+++.+||+.||++||+     ++|+++|
T Consensus       231 ----~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        231 ----RLKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             ----CcCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence                00011123456889999999999999997     6888866

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=3.3e-38  Score=344.90  Aligned_cols=259  Identities=24%  Similarity=0.417  Sum_probs=207.3

Q ss_pred             hccCCCCceeeeccceEEEEEEECC------CcEEEEEEeecccc-chhhhHHHHHHHHhcCC-CCcceeEEeeeecCCe
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIRD------GMEVAVKVFNLQCG-RAFKSFDVECAMMKSIR-HRNLVKVISSCSNEEF  597 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~  597 (824)
                      .++|.+.++||+|+||.||+|++..      +..||||+++.... ...+.+..|+++++++. ||||+++++++.+...
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~  115 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP  115 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence            4678899999999999999998531      34799999865432 33467889999999996 9999999999999999


Q ss_pred             eEEEEeccCCCCHHHHhhhCC-----------------------------------------------------------
Q 040845          598 KALVLEYMPHGSLEKYLHSSN-----------------------------------------------------------  618 (824)
Q Consensus       598 ~~lv~e~~~~g~L~~~l~~~~-----------------------------------------------------------  618 (824)
                      .++||||+++|+|.++++...                                                           
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (400)
T cd05105         116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK  195 (400)
T ss_pred             eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence            999999999999999886421                                                           


Q ss_pred             ------------------------------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC
Q 040845          619 ------------------------------------YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD  662 (824)
Q Consensus       619 ------------------------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~  662 (824)
                                                          ..+++.++..++.|+++|++|||   +.+|+||||||+||++++
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill~~  272 (400)
T cd05105         196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEEeC
Confidence                                                23677888999999999999999   999999999999999999


Q ss_pred             CCcEEEeecccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhh
Q 040845          663 NMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKH  741 (824)
Q Consensus       663 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~  741 (824)
                      ++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.||........ ...
T Consensus       273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~-~~~  351 (400)
T cd05105         273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST-FYN  351 (400)
T ss_pred             CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH-HHH
Confidence            99999999999987643333222333456788999999988889999999999999999997 8899875322111 111


Q ss_pred             hhhhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 040845          742 WVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIR  806 (824)
Q Consensus       742 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~  806 (824)
                      .+...                  .....+..++..+.+++.+||+.||++|||+.++.+.|+++.
T Consensus       352 ~~~~~------------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         352 KIKSG------------------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             HHhcC------------------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence            11100                  011112345677999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-39  Score=325.00  Aligned_cols=260  Identities=27%  Similarity=0.362  Sum_probs=203.0

Q ss_pred             HHhhccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc--------------chhhhHHHHHHHHhcCCCCccee
Q 040845          523 FQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG--------------RAFKSFDVECAMMKSIRHRNLVK  587 (824)
Q Consensus       523 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~  587 (824)
                      ....++|++.+.||+|.||.|-+|+.. +++.||||++.+...              ...+..++|+.+|++++|||||+
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~  172 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK  172 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence            445688999999999999999999854 589999999864311              12357889999999999999999


Q ss_pred             EEeeeec--CCeeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCc
Q 040845          588 VISSCSN--EEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMV  665 (824)
Q Consensus       588 l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~  665 (824)
                      ++.+..+  .+..|+|+|||..|.+...- .....++..++++++.+++.||+|||   .++||||||||+|+|++++|+
T Consensus       173 LiEvLDDP~s~~~YlVley~s~G~v~w~p-~d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~~g~  248 (576)
T KOG0585|consen  173 LIEVLDDPESDKLYLVLEYCSKGEVKWCP-PDKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSSDGT  248 (576)
T ss_pred             EEEeecCcccCceEEEEEeccCCccccCC-CCcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcCCCc
Confidence            9999876  46889999999988764332 22223889999999999999999999   999999999999999999999


Q ss_pred             EEEeecccccccCCCC---CccccccccccccccCccCcCCCC----CCccchHHHHHHHHHHHHhCCCCCcccccCcch
Q 040845          666 AHLSDFGIAKLLTGED---QSMTQTQTLATIGYMAPEYGREGQ----VSTNGDVYSFGIMLMETFTRKKPTDELFNGEMT  738 (824)
Q Consensus       666 ~kl~Dfg~a~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~  738 (824)
                      +||+|||.+..+....   ........+||+.|+|||...++.    .+.+.||||+||++|.++.|+.||-+.+.-+. 
T Consensus       249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l-  327 (576)
T KOG0585|consen  249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELEL-  327 (576)
T ss_pred             EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHH-
Confidence            9999999998663221   112223467999999999887643    36788999999999999999999876322111 


Q ss_pred             hhhhhhhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 040845          739 LKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKI  805 (824)
Q Consensus       739 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~  805 (824)
                      ..+++.            ..      ..++..++....+.+|+++|+.+||++|.+..+|..|..-.
T Consensus       328 ~~KIvn------------~p------L~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt  376 (576)
T KOG0585|consen  328 FDKIVN------------DP------LEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVT  376 (576)
T ss_pred             HHHHhc------------Cc------ccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceec
Confidence            111111            11      11111223466789999999999999999999999887654

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=3.1e-38  Score=332.44  Aligned_cols=250  Identities=21%  Similarity=0.290  Sum_probs=201.0

Q ss_pred             CCCCceeeeccceEEEEEEE-CCCcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEec
Q 040845          529 FSENNLIGRGGFGSVYKARI-RDGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       529 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      |+..+.||+|+||.||+|.. .+|+.||+|.+....   ......+.+|+.+++.++|++|+++++++.+.+..++||||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            67788999999999999986 468999999986542   12234577899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 040845          605 MPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS  683 (824)
Q Consensus       605 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  683 (824)
                      +++|+|.+++.... ..+++..+..++.|++.|++|||   +.+|+||||||+||++++++.++|+|||++.......  
T Consensus        82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~--  156 (285)
T cd05631          82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE--  156 (285)
T ss_pred             cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC--
Confidence            99999998876433 46889999999999999999999   9999999999999999999999999999998653222  


Q ss_pred             cccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCch
Q 040845          684 MTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQE  763 (824)
Q Consensus       684 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  763 (824)
                       ......||..|+|||++.+..++.++||||+||++|||++|+.||........ ...+.... .            .  
T Consensus       157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~-~~~~~~~~-~------------~--  219 (285)
T cd05631         157 -TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK-REEVDRRV-K------------E--  219 (285)
T ss_pred             -eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh-HHHHHHHh-h------------c--
Confidence             12344689999999999999999999999999999999999999976322110 01111000 0            0  


Q ss_pred             hhhhhhHHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 040845          764 DIHFVAKEQCVSFVFNLALECTVESPEQRIN-----AKEIVAK  801 (824)
Q Consensus       764 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt-----~~evl~~  801 (824)
                       .....+..++..+.+|+.+||+.||++||+     ++|++++
T Consensus       220 -~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  261 (285)
T cd05631         220 -DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH  261 (285)
T ss_pred             -ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence             000011234567899999999999999997     8888875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.1e-37  Score=335.46  Aligned_cols=265  Identities=21%  Similarity=0.295  Sum_probs=206.2

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc-chhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEe
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLE  603 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  603 (824)
                      .++|++.+.||+|+||.||+|+.. +|..||+|.+..... ...+.+.+|+++++.++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            368999999999999999999865 588999999876532 335678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-CeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 040845          604 YMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSA-PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ  682 (824)
Q Consensus       604 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  682 (824)
                      |+++++|.+++.... .+++..+..++.|++.|++|||   +. +|+||||||+||+++.++.+||+|||++....... 
T Consensus        84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  158 (331)
T cd06649          84 HMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLR---EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-  158 (331)
T ss_pred             cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHh---hcCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc-
Confidence            999999999997655 6889999999999999999999   64 69999999999999999999999999987653221 


Q ss_pred             ccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCC-------------
Q 040845          683 SMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPI-------------  749 (824)
Q Consensus       683 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-------------  749 (824)
                         .....|+..|+|||++.+..++.++|||||||++|||++|+.||......+  +..........             
T Consensus       159 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  233 (331)
T cd06649         159 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE--LEAIFGRPVVDGEEGEPHSISPRP  233 (331)
T ss_pred             ---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHhcccccccccCCccccCccc
Confidence               223468999999999998899999999999999999999999996532111  11111000000             


Q ss_pred             -cch-----------------hhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 040845          750 -STM-----------------EVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL  802 (824)
Q Consensus       750 -~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L  802 (824)
                       ...                 +..+.. ..... .......++.++.+++.+||+.||++|||+.|++++-
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~  302 (331)
T cd06649         234 RPPGRPVSGHGMDSRPAMAIFELLDYI-VNEPP-PKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT  302 (331)
T ss_pred             ccccccccccccccccchhHHHHHHHH-HhCCC-cCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence             000                 000000 00000 0000113567899999999999999999999999875

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=8e-38  Score=326.27  Aligned_cols=257  Identities=26%  Similarity=0.463  Sum_probs=209.5

Q ss_pred             hccCCCCceeeeccceEEEEEEECC----CcEEEEEEeeccc-cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIRD----GMEVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKAL  600 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  600 (824)
                      .++|++.+.||+|+||+||+|.++.    ...||||.++... ......+..|+.+++.++||||+++++++.+.+..++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            3578899999999999999998753    4579999886543 2334678889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 040845          601 VLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE  680 (824)
Q Consensus       601 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  680 (824)
                      ||||+++++|.+++......+++.++..++.|++.|++|||   +.+|+||||||+||++++++.++++|||++......
T Consensus        83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  159 (266)
T cd05033          83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS  159 (266)
T ss_pred             EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence            99999999999999876667899999999999999999999   999999999999999999999999999999877532


Q ss_pred             CCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhccccc
Q 040845          681 DQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANL  759 (824)
Q Consensus       681 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  759 (824)
                      ..........++..|+|||.+.+..++.++||||||+++||+++ |..||......  .....+....            
T Consensus       160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~~~~~------------  225 (266)
T cd05033         160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ--DVIKAVEDGY------------  225 (266)
T ss_pred             ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH--HHHHHHHcCC------------
Confidence            22222223345678999999998899999999999999999998 99998653211  1111111100            


Q ss_pred             cCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 040845          760 LSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKI  805 (824)
Q Consensus       760 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~  805 (824)
                            ....+..++..+.+++.+||+.+|++||++.|++++|+++
T Consensus       226 ------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         226 ------RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             ------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                  0011224566789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=5.7e-38  Score=325.36  Aligned_cols=251  Identities=25%  Similarity=0.408  Sum_probs=203.9

Q ss_pred             ccCCCCceeeeccceEEEEEEECCCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEeccC
Q 040845          527 DKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMP  606 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  606 (824)
                      ++|++.+.||+|+||.||+|+++++..+|+|.+... ....+.+..|++++++++||||+++++++.+....++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            468888999999999999999988889999987633 2334678889999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcccc
Q 040845          607 HGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQ  686 (824)
Q Consensus       607 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  686 (824)
                      +|+|.++++.....+++..+..++.|++.|++|||   +.+++||||||+||++++++.+|++|||.+......... ..
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-~~  158 (256)
T cd05114          83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-SS  158 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCcee-cc
Confidence            99999999765556899999999999999999999   999999999999999999999999999998865432221 12


Q ss_pred             ccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhh
Q 040845          687 TQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDI  765 (824)
Q Consensus       687 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  765 (824)
                      ....++..|+|||.+.+..++.++||||||+++|||++ |+.||......  .....+.....                 
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~--~~~~~i~~~~~-----------------  219 (256)
T cd05114         159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY--EVVEMISRGFR-----------------  219 (256)
T ss_pred             CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHCCCC-----------------
Confidence            23345678999999988889999999999999999999 88888653211  11111111000                 


Q ss_pred             hhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 040845          766 HFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL  802 (824)
Q Consensus       766 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L  802 (824)
                       ...+...+..+.+++.+||+.+|++||+++|+++.|
T Consensus       220 -~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         220 -LYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             -CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence             000112245689999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=5.7e-38  Score=330.65  Aligned_cols=255  Identities=29%  Similarity=0.524  Sum_probs=207.8

Q ss_pred             ccCCCCceeeeccceEEEEEEECC------CcEEEEEEeecccc-chhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeE
Q 040845          527 DKFSENNLIGRGGFGSVYKARIRD------GMEVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKA  599 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  599 (824)
                      ++|++.+.||+|+||.||+|....      ...||+|.+..... .....+.+|+.+++.++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            468889999999999999998643      25799998864432 33456889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHhhhCC---------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC
Q 040845          600 LVLEYMPHGSLEKYLHSSN---------------YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM  664 (824)
Q Consensus       600 lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~  664 (824)
                      ++|||+++++|.+++....               ..+++.++..++.|++.|++|||   +.+++||||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCCC
Confidence            9999999999999997542               35788899999999999999999   99999999999999999999


Q ss_pred             cEEEeecccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhh
Q 040845          665 VAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWV  743 (824)
Q Consensus       665 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~  743 (824)
                      .++|+|||++................+++.|+|||.+.++.++.++|||||||++|||++ |..||......+  ....+
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~--~~~~i  239 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE--VIEMI  239 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHH
Confidence            999999999986543333333334456889999999988899999999999999999998 999987632211  11111


Q ss_pred             hhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 040845          744 NDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLK  804 (824)
Q Consensus       744 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~  804 (824)
                      ...            .      ....+..++.++.+++.+||+.||.+||+++|++++|++
T Consensus       240 ~~~------------~------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         240 RSR------------Q------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             HcC------------C------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            110            0      011234567889999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-38  Score=339.04  Aligned_cols=253  Identities=23%  Similarity=0.324  Sum_probs=204.8

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEE
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVL  602 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  602 (824)
                      ++|++.+.||+|+||.||+|++. +++.||||+++...   ......+..|+++++.++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            36889999999999999999876 48999999997542   233456788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 040845          603 EYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ  682 (824)
Q Consensus       603 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  682 (824)
                      ||+++|+|.+++.... .+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||++.....   
T Consensus        81 e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---  153 (333)
T cd05600          81 EYVPGGDFRTLLNNLG-VLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---  153 (333)
T ss_pred             eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence            9999999999997655 6889999999999999999999   99999999999999999999999999999976532   


Q ss_pred             ccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCc
Q 040845          683 SMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ  762 (824)
Q Consensus       683 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  762 (824)
                        ......||+.|+|||++.+..++.++||||+||++|||++|+.||......+ ........ .     ..........
T Consensus       154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~-~-----~~~~~~~~~~  224 (333)
T cd05600         154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE-TWENLKYW-K-----ETLQRPVYDD  224 (333)
T ss_pred             --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH-HHHHHHhc-c-----ccccCCCCCc
Confidence              2233568999999999998899999999999999999999999997532211 11110000 0     0000000000


Q ss_pred             hhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          763 EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       763 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                            ....++.++.+++.+||..+|++||+++|++++
T Consensus       225 ------~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         225 ------PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             ------cccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence                  002346678999999999999999999999987

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.8e-39  Score=333.55  Aligned_cols=251  Identities=25%  Similarity=0.340  Sum_probs=213.1

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCe-eEEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEF-KALV  601 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv  601 (824)
                      .++|...+.+|+|+||.++.++++ +++.||+|.+....  ....+....|+.++++++|||||.+.+.|.+++. .+||
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv   82 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV   82 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence            467899999999999999999765 47899999987653  3345577889999999999999999999999888 9999


Q ss_pred             EeccCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 040845          602 LEYMPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE  680 (824)
Q Consensus       602 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  680 (824)
                      |+|++||++.+.+.+.+ ..++++++..|+.|++.|+.|||   +.+|+|||||+.||+++.++.|||+|||+|+.+...
T Consensus        83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            99999999999998766 67899999999999999999999   999999999999999999999999999999987644


Q ss_pred             CCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhcccccc
Q 040845          681 DQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLL  760 (824)
Q Consensus       681 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  760 (824)
                      .  ......+||+.||+||.+.+..|..|+||||+||++|||++-+++|....-... ..+..+..              
T Consensus       160 ~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~L-i~ki~~~~--------------  222 (426)
T KOG0589|consen  160 D--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSEL-ILKINRGL--------------  222 (426)
T ss_pred             h--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHH-HHHHhhcc--------------
Confidence            3  234557899999999999999999999999999999999999999976321111 11111110              


Q ss_pred             CchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          761 SQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       761 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                           -.+.+..++.++..++..|+..+|+.||++.+++.+
T Consensus       223 -----~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  223 -----YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             -----CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence                 112334567889999999999999999999999987

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1e-37  Score=329.34  Aligned_cols=259  Identities=30%  Similarity=0.491  Sum_probs=209.6

Q ss_pred             ccCCCCceeeeccceEEEEEEEC------CCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEE
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR------DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKAL  600 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  600 (824)
                      .+|.+.+.||+|+||.||++...      ++..||+|.+........+.+..|++++++++||||+++++++......++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            56888999999999999999742      245689998875554556778999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhhCC------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEE
Q 040845          601 VLEYMPHGSLEKYLHSSN------------YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHL  668 (824)
Q Consensus       601 v~e~~~~g~L~~~l~~~~------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl  668 (824)
                      ||||+++++|.+++....            ..+++.++..++.|++.|++|||   +.+++||||||+||++++++.+++
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEEe
Confidence            999999999999997433            24899999999999999999999   999999999999999999999999


Q ss_pred             eecccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhC
Q 040845          669 SDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCL  747 (824)
Q Consensus       669 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~  747 (824)
                      +|||++................++..|+|||.+.+..++.++|||||||++|||++ |..||......+ ..........
T Consensus       162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~-~~~~i~~~~~  240 (288)
T cd05093         162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-VIECITQGRV  240 (288)
T ss_pred             ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHcCCc
Confidence            99999986543332222233446778999999998889999999999999999999 888886532211 1111111000


Q ss_pred             CCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 040845          748 PISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDS  808 (824)
Q Consensus       748 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~  808 (824)
                                  .       ..+..++.++.+++.+||+.||.+|||++|+.+.|+++..+
T Consensus       241 ------------~-------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         241 ------------L-------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             ------------C-------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence                        0       00113456789999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=5e-38  Score=336.57  Aligned_cols=242  Identities=23%  Similarity=0.300  Sum_probs=197.3

Q ss_pred             ceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEeccCCC
Q 040845          533 NLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHG  608 (824)
Q Consensus       533 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  608 (824)
                      +.||+|+||.||+|+.+ +|+.||+|+++...   ......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46999999999999864 58999999987542   233456678999999999999999999999999999999999999


Q ss_pred             CHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcccccc
Q 040845          609 SLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQ  688 (824)
Q Consensus       609 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  688 (824)
                      +|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++.......  .....
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~~  154 (323)
T cd05595          81 ELFFHLSRER-VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKT  154 (323)
T ss_pred             cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Ccccc
Confidence            9999887655 6899999999999999999999   9999999999999999999999999999987532221  12233


Q ss_pred             ccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhhhhh
Q 040845          689 TLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFV  768 (824)
Q Consensus       689 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  768 (824)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||....... .........                    ..
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~-~~~~~~~~~--------------------~~  213 (323)
T cd05595         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-LFELILMEE--------------------IR  213 (323)
T ss_pred             ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH-HHHHHhcCC--------------------CC
Confidence            568999999999998899999999999999999999999986532111 111110000                    00


Q ss_pred             hHHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 040845          769 AKEQCVSFVFNLALECTVESPEQRI-----NAKEIVAK  801 (824)
Q Consensus       769 ~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~evl~~  801 (824)
                      .+..++..+.+++.+||+.||++||     ++.+++++
T Consensus       214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h  251 (323)
T cd05595         214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  251 (323)
T ss_pred             CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence            1123456789999999999999998     89998875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1e-38  Score=301.51  Aligned_cols=255  Identities=26%  Similarity=0.379  Sum_probs=209.4

Q ss_pred             HHhhccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc--------chhhhHHHHHHHHhcC-CCCcceeEEeee
Q 040845          523 FQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG--------RAFKSFDVECAMMKSI-RHRNLVKVISSC  592 (824)
Q Consensus       523 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~niv~l~~~~  592 (824)
                      ...-.+|+..+.+|.|..++|.++.++ +|..+|+|++.....        +..++-.+|+.+++++ .||+|+++.+++
T Consensus        13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y   92 (411)
T KOG0599|consen   13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY   92 (411)
T ss_pred             hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence            344567888899999999999999654 688999999865432        1234556799999999 699999999999


Q ss_pred             ecCCeeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecc
Q 040845          593 SNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFG  672 (824)
Q Consensus       593 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  672 (824)
                      +.+...++|+|.|+.|.|.|++...- .+++.+..++++|+.+|++|||   ...|||||+||+|||+|++.++||+|||
T Consensus        93 es~sF~FlVFdl~prGELFDyLts~V-tlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isDFG  168 (411)
T KOG0599|consen   93 ESDAFVFLVFDLMPRGELFDYLTSKV-TLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISDFG  168 (411)
T ss_pred             cCcchhhhhhhhcccchHHHHhhhhe-eecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEeccc
Confidence            99999999999999999999998765 7899999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCccccccccccccccCccCcC------CCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhh
Q 040845          673 IAKLLTGEDQSMTQTQTLATIGYMAPEYGR------EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDC  746 (824)
Q Consensus       673 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~  746 (824)
                      +|+.+.++.   .....+||++|.|||.+.      ...|+..+|+||.||++|-++.|.+||+...  .+-+...+.  
T Consensus       169 Fa~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk--QmlMLR~Im--  241 (411)
T KOG0599|consen  169 FACQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK--QMLMLRMIM--  241 (411)
T ss_pred             eeeccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH--HHHHHHHHH--
Confidence            999875443   345678999999999774      3458889999999999999999999997622  111111111  


Q ss_pred             CCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          747 LPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       747 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                                   .+....+.+.+.+.+....+|+.+|+++||++|.|++|+++|
T Consensus       242 -------------eGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH  283 (411)
T KOG0599|consen  242 -------------EGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH  283 (411)
T ss_pred             -------------hcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence                         111112223445677889999999999999999999999986

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=2.9e-38  Score=339.79  Aligned_cols=246  Identities=22%  Similarity=0.268  Sum_probs=201.5

Q ss_pred             hccCCCCceeeeccceEEEEEEECC--CcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIRD--GMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKAL  600 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  600 (824)
                      .++|++.+.||+|+||.||+|.++.  +..||+|++....   ....+.+.+|+.+++.++||||+++++++.+....++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            3578899999999999999998643  3689999986532   2334567889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 040845          601 VLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE  680 (824)
Q Consensus       601 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  680 (824)
                      ||||+++|+|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++......
T Consensus       109 v~Ey~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~  184 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR  184 (340)
T ss_pred             EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence            999999999999998665 6889999999999999999999   999999999999999999999999999999865321


Q ss_pred             CCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhcccccc
Q 040845          681 DQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLL  760 (824)
Q Consensus       681 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  760 (824)
                           .....||+.|+|||++.+..++.++||||+||++|||++|+.||...... .........            .. 
T Consensus       185 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-~~~~~i~~~------------~~-  245 (340)
T PTZ00426        185 -----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL-LIYQKILEG------------II-  245 (340)
T ss_pred             -----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH-HHHHHHhcC------------CC-
Confidence                 12346899999999998888999999999999999999999999753211 001111000            00 


Q ss_pred             CchhhhhhhHHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 040845          761 SQEDIHFVAKEQCVSFVFNLALECTVESPEQRI-----NAKEIVAK  801 (824)
Q Consensus       761 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~evl~~  801 (824)
                             ..+...+..+.+++.+|++.||++|+     +++|++++
T Consensus       246 -------~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        246 -------YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             -------CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence                   01122345678999999999999995     89998876

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.4e-37  Score=326.61  Aligned_cols=261  Identities=24%  Similarity=0.392  Sum_probs=207.2

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCc----EEEEEEeecccc-chhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEE
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGM----EVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKAL  600 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  600 (824)
                      ++|++.+.||+|+||+||+|.+. +++    .||+|.+..... .....+..|+.++++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            56888899999999999999864 344    477777653322 234567778889999999999999998864 45678


Q ss_pred             EEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 040845          601 VLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE  680 (824)
Q Consensus       601 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  680 (824)
                      ++||+++|+|.+++......+++..+..++.|++.|++|||   +.+++||||||+||++++++.+||+|||.++.....
T Consensus        86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~  162 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD  162 (279)
T ss_pred             EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence            99999999999999876667899999999999999999999   999999999999999999999999999999876443


Q ss_pred             CCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhccccc
Q 040845          681 DQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANL  759 (824)
Q Consensus       681 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  759 (824)
                      ..........++..|+|||.+.++.++.++||||||+++||+++ |..||.+....  ...+++.....           
T Consensus       163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--~~~~~~~~~~~-----------  229 (279)
T cd05111         163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH--EVPDLLEKGER-----------  229 (279)
T ss_pred             CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHCCCc-----------
Confidence            33333334557788999999988899999999999999999998 99998653221  11222111000           


Q ss_pred             cCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhcc
Q 040845          760 LSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLR  811 (824)
Q Consensus       760 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~  811 (824)
                             ...+..|+..+.+++.+||..||++|||+.|+++.|..+.+..++
T Consensus       230 -------~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~~~  274 (279)
T cd05111         230 -------LAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDPPR  274 (279)
T ss_pred             -------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCCcc
Confidence                   001122455678899999999999999999999999988765444

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.2e-37  Score=335.01  Aligned_cols=260  Identities=27%  Similarity=0.446  Sum_probs=205.6

Q ss_pred             hccCCCCceeeeccceEEEEEEEC------CCcEEEEEEeecccc-chhhhHHHHHHHHhcC-CCCcceeEEeeeec-CC
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR------DGMEVAVKVFNLQCG-RAFKSFDVECAMMKSI-RHRNLVKVISSCSN-EE  596 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~~  596 (824)
                      .++|++.+.||+|+||.||+|...      +++.||+|+++.... ...+.+..|+.+++++ +|+||++++++|.. +.
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            357899999999999999999642      247899999864322 2345677899999999 89999999998865 45


Q ss_pred             eeEEEEeccCCCCHHHHhhhCC----------------------------------------------------------
Q 040845          597 FKALVLEYMPHGSLEKYLHSSN----------------------------------------------------------  618 (824)
Q Consensus       597 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  618 (824)
                      ..+++|||+++++|.+++....                                                          
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            7789999999999999986421                                                          


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcccccccccccccc
Q 040845          619 --YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYM  696 (824)
Q Consensus       619 --~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~  696 (824)
                        ..+++..+..++.|++.|++|||   +.+|+||||||+||++++++.++|+|||++..+.............++..|+
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence              25789999999999999999999   9999999999999999999999999999998764433333333345677899


Q ss_pred             CccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhhhhhhHHHHHH
Q 040845          697 APEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVS  775 (824)
Q Consensus       697 aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  775 (824)
                      |||++.+..++.++||||+||++|||++ |..||......+ ..........                  ....+..++.
T Consensus       243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~------------------~~~~~~~~~~  303 (337)
T cd05054         243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-EFCRRLKEGT------------------RMRAPEYATP  303 (337)
T ss_pred             CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-HHHHHHhccC------------------CCCCCccCCH
Confidence            9999999999999999999999999998 999986532211 1111111000                  0001123456


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 040845          776 FVFNLALECTVESPEQRINAKEIVAKLLKIRD  807 (824)
Q Consensus       776 ~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~  807 (824)
                      ++.+++.+||+.+|++||++.|++++|+++.+
T Consensus       304 ~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         304 EIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            78999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=5.3e-38  Score=326.71  Aligned_cols=256  Identities=28%  Similarity=0.490  Sum_probs=211.6

Q ss_pred             hhccCCCCceeeeccceEEEEEEECCCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEec
Q 040845          525 ATDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       525 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      ...+|++.+.||+|+||.||+|.+.++..||+|++..........+..|+.+++.++|+||+++++++.+....++||||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   83 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL   83 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence            35678899999999999999999888999999998766554567889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 040845          605 MPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS  683 (824)
Q Consensus       605 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  683 (824)
                      +++++|.+++.... ..+++.++..++.|++.|++|||   +.+++|+||+|+||++++++.+||+|||.+.........
T Consensus        84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~  160 (261)
T cd05148          84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL  160 (261)
T ss_pred             cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence            99999999997643 46899999999999999999999   999999999999999999999999999999866432211


Q ss_pred             cccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhccccccCc
Q 040845          684 MTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ  762 (824)
Q Consensus       684 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  762 (824)
                        .....++..|+|||......++.++||||||+++|+|++ |+.||......+  ....+...                
T Consensus       161 --~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~--~~~~~~~~----------------  220 (261)
T cd05148         161 --SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE--VYDQITAG----------------  220 (261)
T ss_pred             --ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH--HHHHHHhC----------------
Confidence              123346778999999988889999999999999999998 888886532111  11111100                


Q ss_pred             hhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 040845          763 EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKI  805 (824)
Q Consensus       763 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~  805 (824)
                        .+...+..++..+.+++.+||+.||++|||++++++.|+.+
T Consensus       221 --~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         221 --YRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             --CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence              01111234567789999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=8.4e-38  Score=335.40  Aligned_cols=242  Identities=24%  Similarity=0.309  Sum_probs=197.7

Q ss_pred             ceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEeccCCC
Q 040845          533 NLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHG  608 (824)
Q Consensus       533 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  608 (824)
                      +.||+|+||.||+|+.. +|+.||+|++....   ......+.+|+.+++.++||||+++++++..++..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999865 58999999987542   233456788999999999999999999999999999999999999


Q ss_pred             CHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcccccc
Q 040845          609 SLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQ  688 (824)
Q Consensus       609 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  688 (824)
                      +|.+++.... .+++.++..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++.......  .....
T Consensus        81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~  154 (328)
T cd05593          81 ELFFHLSRER-VFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATMKT  154 (328)
T ss_pred             CHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc--ccccc
Confidence            9999987654 6899999999999999999999   9999999999999999999999999999987532211  12233


Q ss_pred             ccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhhhhh
Q 040845          689 TLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFV  768 (824)
Q Consensus       689 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  768 (824)
                      ..||+.|+|||.+.+..++.++||||+||++|||++|+.||......     .........                ...
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~-----~~~~~~~~~----------------~~~  213 (328)
T cd05593         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KLFELILME----------------DIK  213 (328)
T ss_pred             ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH-----HHHHHhccC----------------Ccc
Confidence            56899999999999889999999999999999999999999652111     111110000                000


Q ss_pred             hHHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 040845          769 AKEQCVSFVFNLALECTVESPEQRI-----NAKEIVAK  801 (824)
Q Consensus       769 ~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~evl~~  801 (824)
                      .+..++..+.+++.+||..||++||     ++.|++++
T Consensus       214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         214 FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            1123456788999999999999997     89999876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=8.9e-38  Score=328.65  Aligned_cols=255  Identities=32%  Similarity=0.508  Sum_probs=206.6

Q ss_pred             hccCCCCceeeeccceEEEEEEECC------CcEEEEEEeeccccc-hhhhHHHHHHHHhcCCCCcceeEEeeeecCCee
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIRD------GMEVAVKVFNLQCGR-AFKSFDVECAMMKSIRHRNLVKVISSCSNEEFK  598 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  598 (824)
                      .++|.+.+.||+|+||.||+|++.+      ++.||||.++..... ..+.+.+|+++++.++|+||+++++++......
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            3568888999999999999998643      478999998755433 457889999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhhCC-------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCc
Q 040845          599 ALVLEYMPHGSLEKYLHSSN-------------YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMV  665 (824)
Q Consensus       599 ~lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~  665 (824)
                      ++||||+++++|.+++...+             ..+++.++..++.|++.|++|||   +.+++||||||+||+++.++.
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~  160 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCe
Confidence            99999999999999997542             34788899999999999999999   999999999999999999999


Q ss_pred             EEEeecccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhh
Q 040845          666 AHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVN  744 (824)
Q Consensus       666 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~  744 (824)
                      +||+|||.+................++..|+|||++.++.++.++||||+||++|||++ |..||......  .....+.
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~--~~~~~~~  238 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE--EVIECIT  238 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHH
Confidence            99999999976543332222233446788999999999999999999999999999999 99998653221  1111111


Q ss_pred             hhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 040845          745 DCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLL  803 (824)
Q Consensus       745 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~  803 (824)
                      ..            ..      ...+..++..+.+++.+||..||++||++.|+++.|+
T Consensus       239 ~~------------~~------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         239 QG------------RL------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             cC------------Cc------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence            00            00      0011234667899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-38  Score=335.04  Aligned_cols=240  Identities=25%  Similarity=0.290  Sum_probs=195.1

Q ss_pred             eeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEeccCCCCH
Q 040845          535 IGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSL  610 (824)
Q Consensus       535 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  610 (824)
                      ||+|+||.||+|+.. +++.||+|+++...   ......+..|+.++++++||||+++++++.+++..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999865 48899999987532   23345677899999999999999999999999999999999999999


Q ss_pred             HHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcccccccc
Q 040845          611 EKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTL  690 (824)
Q Consensus       611 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  690 (824)
                      .+++.... .+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||++.......  .......
T Consensus        81 ~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~  154 (312)
T cd05585          81 FHHLQREG-RFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTFC  154 (312)
T ss_pred             HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccccc
Confidence            99997654 6899999999999999999999   9999999999999999999999999999987543222  1223456


Q ss_pred             ccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhhhhhhH
Q 040845          691 ATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAK  770 (824)
Q Consensus       691 ~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  770 (824)
                      ||+.|+|||.+.+..++.++||||+||++|||++|+.||.....     ...........                ...+
T Consensus       155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~-----~~~~~~~~~~~----------------~~~~  213 (312)
T cd05585         155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV-----NEMYRKILQEP----------------LRFP  213 (312)
T ss_pred             CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH-----HHHHHHHHcCC----------------CCCC
Confidence            89999999999998999999999999999999999999975211     11111111100                0111


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCC---HHHHHHH
Q 040845          771 EQCVSFVFNLALECTVESPEQRIN---AKEIVAK  801 (824)
Q Consensus       771 ~~~~~~l~~l~~~cl~~dP~~Rpt---~~evl~~  801 (824)
                      ..++..+.+++.+||..||++||+   +.|++++
T Consensus       214 ~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h  247 (312)
T cd05585         214 DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH  247 (312)
T ss_pred             CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence            234567889999999999999985   6776654

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-38  Score=338.22  Aligned_cols=260  Identities=27%  Similarity=0.437  Sum_probs=224.5

Q ss_pred             CCCceeeeccceEEEEEEE-CCC----cEEEEEEeecc-ccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEe
Q 040845          530 SENNLIGRGGFGSVYKARI-RDG----MEVAVKVFNLQ-CGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLE  603 (824)
Q Consensus       530 ~~~~~lg~G~~g~V~~~~~-~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  603 (824)
                      ...++||+|+||+||+|.| ..|    -+||+|++... ..+...++.+|+..|.+++|||+++++|+|.... ..||++
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq  777 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ  777 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence            4467999999999999986 333    46899988654 3445678999999999999999999999998776 779999


Q ss_pred             ccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 040845          604 YMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS  683 (824)
Q Consensus       604 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  683 (824)
                      |++.|+|.++++.++..+.....+.|..|||+|+.|||   .+++|||||.++|||+.+-..+||.|||+|+.....+..
T Consensus       778 ~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e  854 (1177)
T KOG1025|consen  778 LMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE  854 (1177)
T ss_pred             hcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence            99999999999999888999999999999999999999   999999999999999999999999999999998877766


Q ss_pred             cccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhccccccCc
Q 040845          684 MTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ  762 (824)
Q Consensus       684 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  762 (824)
                      +......-++.|||-|.+....|+.++|||||||.+||++| |..|+++....+.  .               |   .-+
T Consensus       855 y~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI--~---------------d---lle  914 (1177)
T KOG1025|consen  855 YSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI--P---------------D---LLE  914 (1177)
T ss_pred             ccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh--h---------------H---HHh
Confidence            66666667889999999999999999999999999999999 9999887433221  1               1   112


Q ss_pred             hhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhcccc
Q 040845          763 EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLRNV  813 (824)
Q Consensus       763 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~~~  813 (824)
                      .+.++.+|+.|+.+++.+|.+||..|+..||+|+++..++.++.....|..
T Consensus       915 ~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpqryl  965 (1177)
T KOG1025|consen  915 KGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQRYL  965 (1177)
T ss_pred             ccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcceEe
Confidence            334578889999999999999999999999999999999999876655543

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.4e-37  Score=323.51  Aligned_cols=255  Identities=25%  Similarity=0.422  Sum_probs=208.0

Q ss_pred             hccCCCCceeeeccceEEEEEEECCCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEecc
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYM  605 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  605 (824)
                      .++|++.+.||+|+||.||+|...++..||+|.+... ....+.+.+|+.+++.++|+||+++++++.+....++||||+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM   83 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence            4678899999999999999999888889999987643 234567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 040845          606 PHGSLEKYLHSS-NYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM  684 (824)
Q Consensus       606 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  684 (824)
                      ++++|.+++... ...+++.++..++.|++.|++|||   +.+++||||||+||+++.++.++|+|||.+........ .
T Consensus        84 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~  159 (261)
T cd05072          84 AKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-T  159 (261)
T ss_pred             CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCCce-e
Confidence            999999999754 356888999999999999999999   99999999999999999999999999999987543221 1


Q ss_pred             ccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhccccccCch
Q 040845          685 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQE  763 (824)
Q Consensus       685 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  763 (824)
                      ......++..|+|||+...+.++.++|||||||++|||+| |+.||......  .....+....+               
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~~~~~---------------  222 (261)
T cd05072         160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS--DVMSALQRGYR---------------  222 (261)
T ss_pred             ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH--HHHHHHHcCCC---------------
Confidence            1223345678999999988889999999999999999998 89998653211  11111111000               


Q ss_pred             hhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 040845          764 DIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKI  805 (824)
Q Consensus       764 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~  805 (824)
                         ......++.++.+++.+||..+|++||+++++.+.|+++
T Consensus       223 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         223 ---MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             ---CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence               001123456789999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.6e-37  Score=336.11  Aligned_cols=267  Identities=22%  Similarity=0.325  Sum_probs=198.4

Q ss_pred             cCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeecC-----CeeE
Q 040845          528 KFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSNE-----EFKA  599 (824)
Q Consensus       528 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~  599 (824)
                      +|++.+.||+|+||.||+|+.. +|+.||||++....  ......+.+|+++++.++||||+++++++...     ...+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            5788899999999999999865 58999999986432  22345678899999999999999999987543     3579


Q ss_pred             EEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCC
Q 040845          600 LVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG  679 (824)
Q Consensus       600 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  679 (824)
                      +||||++ ++|.+++.... .+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus        81 lv~e~~~-~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~  155 (338)
T cd07859          81 VVFELME-SDLHQVIKAND-DLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFN  155 (338)
T ss_pred             EEEecCC-CCHHHHHHhcc-cCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence            9999995 68999987655 6899999999999999999999   99999999999999999999999999999986532


Q ss_pred             CCC-ccccccccccccccCccCcCC--CCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhcc
Q 040845          680 EDQ-SMTQTQTLATIGYMAPEYGRE--GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVD  756 (824)
Q Consensus       680 ~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  756 (824)
                      ... ........+|..|+|||++.+  ..++.++|||||||++|||++|+.||.....  ......+.........+...
T Consensus       156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~  233 (338)
T cd07859         156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV--VHQLDLITDLLGTPSPETIS  233 (338)
T ss_pred             ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCCh--HHHHHHHHHHhCCCCHHHHH
Confidence            221 122234568999999998865  5789999999999999999999999865321  11111111111000000000


Q ss_pred             c-----------cccCchhhhh-hhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          757 A-----------NLLSQEDIHF-VAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       757 ~-----------~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      .           .......... .....++..+.+++.+||..||++|||++|++++
T Consensus       234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            0           0000000000 0001345678899999999999999999999976

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.3e-37  Score=322.55  Aligned_cols=252  Identities=25%  Similarity=0.414  Sum_probs=204.4

Q ss_pred             ccCCCCceeeeccceEEEEEEECCCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEeccC
Q 040845          527 DKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMP  606 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  606 (824)
                      ++|.+.+.||+|+||.||.|+++++..||+|.+... ....+.+.+|+.++++++||||+++++++.+....++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            467888999999999999999887778999988643 2334678899999999999999999999998888999999999


Q ss_pred             CCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcccc
Q 040845          607 HGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQ  686 (824)
Q Consensus       607 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  686 (824)
                      +|+|.+++......+++.+++.++.|++.|++|||   +.+++|+||||+||+++.++.+||+|||.+........ ...
T Consensus        83 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~~  158 (256)
T cd05113          83 NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-TSS  158 (256)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCce-eec
Confidence            99999999875557899999999999999999999   99999999999999999999999999999886543221 122


Q ss_pred             ccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhh
Q 040845          687 TQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDI  765 (824)
Q Consensus       687 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  765 (824)
                      ....++..|+|||...+..++.++||||||+++|||++ |..||......+  ....+.....                 
T Consensus       159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--~~~~~~~~~~-----------------  219 (256)
T cd05113         159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE--TVEKVSQGLR-----------------  219 (256)
T ss_pred             CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--HHHHHhcCCC-----------------
Confidence            22345678999999988889999999999999999999 888986532111  1111100000                 


Q ss_pred             hhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 040845          766 HFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLL  803 (824)
Q Consensus       766 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~  803 (824)
                       ...+...+..+.+++.+||+.+|++||++.++++.++
T Consensus       220 -~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         220 -LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             -CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence             0001123567899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-38  Score=344.06  Aligned_cols=257  Identities=24%  Similarity=0.340  Sum_probs=209.1

Q ss_pred             ccCCCCceeeeccceEEEEEEECCC-cEEEEEEeeccccchhhhHHHHHHHHhcCC-CCcceeEEee-eec------CCe
Q 040845          527 DKFSENNLIGRGGFGSVYKARIRDG-MEVAVKVFNLQCGRAFKSFDVECAMMKSIR-HRNLVKVISS-CSN------EEF  597 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~-~~~------~~~  597 (824)
                      .++++.+.|.+|||+.||.|+...+ ..||+|++-.......+.+.+|+++|+.|+ |+|||.+++. ...      ...
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E  116 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE  116 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence            4567889999999999999987665 999999987777778889999999999996 9999999993 211      246


Q ss_pred             eEEEEeccCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccc
Q 040845          598 KALVLEYMPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  676 (824)
Q Consensus       598 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~  676 (824)
                      +++.||||.+|.|-|++.... ..+++.++++|+.|+++|+++|| .++.+|||||||-+|||++.+|..||||||.|+.
T Consensus       117 vllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH-~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt  195 (738)
T KOG1989|consen  117 VLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMH-YLKPPIIHRDLKIENVLLSADGNYKLCDFGSATT  195 (738)
T ss_pred             EEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHh-cCCCccchhhhhhhheEEcCCCCEEeCccccccc
Confidence            779999999999999997432 46999999999999999999999 4467799999999999999999999999999876


Q ss_pred             cCCCCCccc-------cccccccccccCccCc---CCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhh
Q 040845          677 LTGEDQSMT-------QTQTLATIGYMAPEYG---REGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDC  746 (824)
Q Consensus       677 ~~~~~~~~~-------~~~~~~~~~y~aPE~~---~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~  746 (824)
                      .........       .-....|+.|+|||.+   .+...++|+|||++||+||-|+....||++...-  .+.      
T Consensus       196 ~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l--aIl------  267 (738)
T KOG1989|consen  196 KILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL--AIL------  267 (738)
T ss_pred             ccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce--eEE------
Confidence            533321111       1123479999999965   5667899999999999999999999999873211  111      


Q ss_pred             CCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 040845          747 LPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRD  807 (824)
Q Consensus       747 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~  807 (824)
                               +      ..+.++....++..+.+||+.||++||++||++-||+.++.++..
T Consensus       268 ---------n------g~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~  313 (738)
T KOG1989|consen  268 ---------N------GNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN  313 (738)
T ss_pred             ---------e------ccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence                     1      111222224678889999999999999999999999999999875

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2.7e-37  Score=326.57  Aligned_cols=260  Identities=31%  Similarity=0.480  Sum_probs=209.8

Q ss_pred             ccCCCCceeeeccceEEEEEEEC------CCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEE
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR------DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKAL  600 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  600 (824)
                      .+|.+.+.||+|+||.||+|++.      ++..||+|.+........+.+.+|++++++++|+||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            45778899999999999999743      345689998865544455678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhhCC---------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCc
Q 040845          601 VLEYMPHGSLEKYLHSSN---------------YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMV  665 (824)
Q Consensus       601 v~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~  665 (824)
                      ||||+++++|.+++....               ..+++..++.++.|++.|++|||   +++|+||||||+||+++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCc
Confidence            999999999999997532               24789999999999999999999   999999999999999999999


Q ss_pred             EEEeecccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhh
Q 040845          666 AHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVN  744 (824)
Q Consensus       666 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~  744 (824)
                      ++|+|||++................++..|+|||.+.+..++.++||||||+++|||+| |+.||......+  ......
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~~~~~  239 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE--VIECIT  239 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHh
Confidence            99999999976543332222334456788999999998899999999999999999999 999986532211  111100


Q ss_pred             hhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhh
Q 040845          745 DCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSL  809 (824)
Q Consensus       745 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~  809 (824)
                         ...         ..      ..+..++..+.+++.+||..+|++|||+.++++.|+++....
T Consensus       240 ---~~~---------~~------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~  286 (291)
T cd05094         240 ---QGR---------VL------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKAT  286 (291)
T ss_pred             ---CCC---------CC------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhc
Confidence               000         00      011234567899999999999999999999999999996643

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.2e-37  Score=312.33  Aligned_cols=253  Identities=26%  Similarity=0.362  Sum_probs=206.5

Q ss_pred             ccCCCCceeeeccceEEEEEEECC-CcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEE
Q 040845          527 DKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVL  602 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  602 (824)
                      +.|+..+.||.|.-|+||.++.++ +..+|+|++.+..   .....+.+.|.+||+.++||+++++|+.++.++..++||
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            456677899999999999999775 5899999997653   334566778999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 040845          603 EYMPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED  681 (824)
Q Consensus       603 e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  681 (824)
                      |||+||+|....++.. ..+++..+..++.+|+-||+|||   ..|||+||+||+|||+.++|++-|+||.++.......
T Consensus       157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~P  233 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP  233 (459)
T ss_pred             ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence            9999999999988654 67899999999999999999999   9999999999999999999999999999875432100


Q ss_pred             C--------------------------------c----------------------cccccccccccccCccCcCCCCCC
Q 040845          682 Q--------------------------------S----------------------MTQTQTLATIGYMAPEYGREGQVS  707 (824)
Q Consensus       682 ~--------------------------------~----------------------~~~~~~~~~~~y~aPE~~~~~~~~  707 (824)
                      .                                .                      ......+||-.|.|||++.+...+
T Consensus       234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg  313 (459)
T KOG0610|consen  234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG  313 (459)
T ss_pred             eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence            0                                0                      011234688899999999999999


Q ss_pred             ccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHcccc
Q 040845          708 TNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVE  787 (824)
Q Consensus       708 ~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~  787 (824)
                      .++|.|+|||++|||+.|..||.+.-.. ..+...+...                  ..++.....+..+.+||++.+.+
T Consensus       314 sAVDWWtfGIflYEmLyG~TPFKG~~~~-~Tl~NIv~~~------------------l~Fp~~~~vs~~akDLIr~LLvK  374 (459)
T KOG0610|consen  314 SAVDWWTFGIFLYEMLYGTTPFKGSNNK-ETLRNIVGQP------------------LKFPEEPEVSSAAKDLIRKLLVK  374 (459)
T ss_pred             chhhHHHHHHHHHHHHhCCCCcCCCCch-hhHHHHhcCC------------------CcCCCCCcchhHHHHHHHHHhcc
Confidence            9999999999999999999999874322 2233222211                  11122224567899999999999


Q ss_pred             CCCCCCC----HHHHHHH
Q 040845          788 SPEQRIN----AKEIVAK  801 (824)
Q Consensus       788 dP~~Rpt----~~evl~~  801 (824)
                      ||.+|..    |+||.+|
T Consensus       375 dP~kRlg~~rGA~eIK~H  392 (459)
T KOG0610|consen  375 DPSKRLGSKRGAAEIKRH  392 (459)
T ss_pred             ChhhhhccccchHHhhcC
Confidence            9999998    8887765

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=4.3e-42  Score=341.10  Aligned_cols=424  Identities=28%  Similarity=0.396  Sum_probs=320.0

Q ss_pred             CcccccccccCCcccccCCCCCcEEEccCCcccccccccccCCCCCCEEeCCCCcCCcccChhhhCcCCCceeeccCCcc
Q 040845            2 PSIINNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSL   81 (824)
Q Consensus         2 ~~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l   81 (824)
                      +.|++|.++...++ +.++..|.+|++.+|++. ..|.+++.+..++.|++|+|+++ .+|+.+..+.+|+.|+++.|.+
T Consensus        50 lils~N~l~~l~~d-l~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~  126 (565)
T KOG0472|consen   50 LILSHNDLEVLRED-LKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNEL  126 (565)
T ss_pred             hhhccCchhhccHh-hhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhccccce
Confidence            45677888777665 788888889999999988 67778888999999999999998 8888888899999999999998


Q ss_pred             ccccCccccCCCCCccEEEccCCeeeeecCccccCCCCCceEeccCccccccCCccccCCCCCCEEEccCCcCCCCcCcc
Q 040845           82 SGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDL  161 (824)
Q Consensus        82 ~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~  161 (824)
                      ..+++.+..  +..|+.|+..+|+++ ..|+.++.+.+|..|++.+|+++...|+.+. ++.|++||+.+|-++.+|.+ 
T Consensus       127 ~el~~~i~~--~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~tlP~~-  201 (565)
T KOG0472|consen  127 KELPDSIGR--LLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLETLPPE-  201 (565)
T ss_pred             eecCchHHH--Hhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhhcCChh-
Confidence            888888764  778888888999988 6778888888899999999998865555444 88999999999988888754 


Q ss_pred             cccccCCCCCCCcEEECcCCCCCccCCccccccccccccEEEeecCcceecCCccCCCCCCCCEEEecCCccCCccchhh
Q 040845          162 SFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITL  241 (824)
Q Consensus       162 ~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~  241 (824)
                           ++.+.+|..|+|.+|+|...+  .|.+  ...|++|++..|+|.....+...+++++.+|||.+|+++ ..|+.+
T Consensus       202 -----lg~l~~L~~LyL~~Nki~~lP--ef~g--cs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~  271 (565)
T KOG0472|consen  202 -----LGGLESLELLYLRRNKIRFLP--EFPG--CSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEI  271 (565)
T ss_pred             -----hcchhhhHHHHhhhcccccCC--CCCc--cHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHH
Confidence                 678888999999999988765  4544  346888899888888444444558889999999999988 678888


Q ss_pred             cCCCCCCEEEcccccCcccCCccccccCCccEEEccCccccccC------------------------------------
Q 040845          242 GKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSI------------------------------------  285 (824)
Q Consensus       242 ~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~------------------------------------  285 (824)
                      +-+.+|+.||+|+|.|+ ..|..++++ +|+.|-+.+|.+..+-                                    
T Consensus       272 clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t  349 (565)
T KOG0472|consen  272 CLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMT  349 (565)
T ss_pred             HHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCC
Confidence            88888999999999998 677778888 8888888888653110                                    


Q ss_pred             --Ccc---ccCCCCCcEEEcCCCCCCCCCCccccccc---ccccccccccccCcCCccccccccch-hhhcccccccccC
Q 040845          286 --PAC---FSNMTFLKVLSLGSNELTSIPLNFWSLKD---ILDLNLSSNCFSGPLPLEIRNLKALI-EIDFSMNNFSGII  356 (824)
Q Consensus       286 --~~~---~~~l~~L~~L~L~~N~l~~lp~~~~~l~~---L~~L~l~~N~l~~~~~~~~~~l~~L~-~L~l~~N~l~~~~  356 (824)
                        +..   ...+.+.+.|+++.-+++.+|...|....   ++..+++.|++. .+|..+..++.+. .+.+++|.++ .+
T Consensus       350 ~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~is-fv  427 (565)
T KOG0472|consen  350 LPSESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKIS-FV  427 (565)
T ss_pred             CCCCcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccc-cc
Confidence              000   11123456677777777777776555444   666777777776 5666665555544 3344444443 56


Q ss_pred             CCccCCCCCCCeEEccCccccccCCccccccccccEEEccCcccC-----------------------CCCcccccCCcc
Q 040845          357 PMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLS-----------------------GTIPVSLEKLSY  413 (824)
Q Consensus       357 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-----------------------~~~p~~~~~l~~  413 (824)
                      |..++.+++|..|+|++|-+. .+|..++.+..|+.||+|+|++.                       ...|..+.+|.+
T Consensus       428 ~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~n  506 (565)
T KOG0472|consen  428 PLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFRMLPECLYELQTLETLLASNNQIGSVDPSGLKNMRN  506 (565)
T ss_pred             hHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccccchHHHhhHHHHHHHHhccccccccChHHhhhhhh
Confidence            666666666666666666665 46666666666666666666653                       233344788889


Q ss_pred             cceeeccCCcccCCCCCCCCccccccccccCCccc
Q 040845          414 LKDLNLSFNKLKGEIPRGGSFGNFSAESFKGNELL  448 (824)
Q Consensus       414 L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~  448 (824)
                      |.+|||.+|.+...+|..+.+.++..+.+.|||+.
T Consensus       507 L~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNpfr  541 (565)
T KOG0472|consen  507 LTTLDLQNNDLQQIPPILGNMTNLRHLELDGNPFR  541 (565)
T ss_pred             cceeccCCCchhhCChhhccccceeEEEecCCccC
Confidence            99999999999988888899999999999999875

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=2.1e-37  Score=320.38  Aligned_cols=248  Identities=28%  Similarity=0.451  Sum_probs=198.7

Q ss_pred             ceeeeccceEEEEEEEC-CCcEEEEEEeeccc-cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEeccCCCCH
Q 040845          533 NLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSL  610 (824)
Q Consensus       533 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  610 (824)
                      +.||+|+||.||+|+.. +++.||+|.+.... .+....+.+|+++++.++||||+++++++......++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            36899999999999864 68999999875432 23456788999999999999999999999999999999999999999


Q ss_pred             HHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcccccccc
Q 040845          611 EKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTL  690 (824)
Q Consensus       611 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  690 (824)
                      .+++......+++.+++.++.|+++|++|||   +.+++||||||+||+++.++.+|++|||++................
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  157 (252)
T cd05084          81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ  157 (252)
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence            9999776656899999999999999999999   9999999999999999999999999999987653221111111222


Q ss_pred             ccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhhhhhh
Q 040845          691 ATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVA  769 (824)
Q Consensus       691 ~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  769 (824)
                      .+..|+|||.+.++.++.++||||+|+++|||++ |..||.......  ....+....                  ....
T Consensus       158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~--~~~~~~~~~------------------~~~~  217 (252)
T cd05084         158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ--TREAIEQGV------------------RLPC  217 (252)
T ss_pred             CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH--HHHHHHcCC------------------CCCC
Confidence            3567999999998889999999999999999998 888876432111  111110000                  0011


Q ss_pred             HHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 040845          770 KEQCVSFVFNLALECTVESPEQRINAKEIVAKLL  803 (824)
Q Consensus       770 ~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~  803 (824)
                      +..++..+.+++.+||..+|++|||+.|+.+.|+
T Consensus       218 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            2234667899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=6e-37  Score=329.56  Aligned_cols=264  Identities=21%  Similarity=0.314  Sum_probs=203.6

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc-chhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEe
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLE  603 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  603 (824)
                      .++|++.+.||+|+||.||+|.++ ++..||+|.+..... ...+.+.+|+++++.++|+||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            468999999999999999999876 588999998875432 334678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 040845          604 YMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYS-APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ  682 (824)
Q Consensus       604 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  682 (824)
                      |+++|+|.+++.... .+++..+..++.|++.|++|||   + .+|+||||||+||+++.++.+||+|||++....... 
T Consensus        84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-  158 (333)
T cd06650          84 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-  158 (333)
T ss_pred             cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc-
Confidence            999999999997655 6888999999999999999999   6 479999999999999999999999999987653221 


Q ss_pred             ccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcch----------
Q 040845          683 SMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTM----------  752 (824)
Q Consensus       683 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~----------  752 (824)
                         .....++..|+|||.+.+..++.++|||||||++|||++|+.||......+  ..............          
T Consensus       159 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  233 (333)
T cd06650         159 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKE--LELMFGCPVEGDPAESETSPRPRP  233 (333)
T ss_pred             ---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhH--HHHHhcCcccCCccccccCcccCC
Confidence               123458899999999998889999999999999999999999987532211  11110000000000          


Q ss_pred             -------------------hhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          753 -------------------EVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       753 -------------------~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                                         ...+... ....... .....+.++.+++.+||+.||++|||+.|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h  299 (333)
T cd06650         234 PGRPLSSYGPDSRPPMAIFELLDYIV-NEPPPKL-PSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH  299 (333)
T ss_pred             ccchhhhhcccccccccHHHHHHHHh-cCCCccC-CCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence                               0000000 0000000 001235678999999999999999999999875

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.3e-37  Score=336.13  Aligned_cols=264  Identities=19%  Similarity=0.194  Sum_probs=200.0

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEec
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      ..+|++.+.||+|+||.||+|... +++.||+|...      ...+.+|++++++++||||+++++++......++|+|+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            357999999999999999999864 58999999643      23467899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 040845          605 MPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM  684 (824)
Q Consensus       605 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  684 (824)
                      +. ++|.+++.... .+++.+++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+|........ .
T Consensus       165 ~~-~~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~-~  238 (391)
T PHA03212        165 YK-TDLYCYLAAKR-NIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA-N  238 (391)
T ss_pred             CC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc-c
Confidence            95 68988887654 6889999999999999999999   99999999999999999999999999999975432211 1


Q ss_pred             ccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccC------cchhhhhhhhhCCC------cch
Q 040845          685 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNG------EMTLKHWVNDCLPI------STM  752 (824)
Q Consensus       685 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~------~~~~~~~~~~~~~~------~~~  752 (824)
                      ......||+.|+|||++.+..++.++||||+||++|||++|+.||......      ...+...+......      ...
T Consensus       239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~  318 (391)
T PHA03212        239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ  318 (391)
T ss_pred             ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence            223456999999999999889999999999999999999999886542211      11111111111100      000


Q ss_pred             hhccc-------cccCchh--hhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          753 EVVDA-------NLLSQED--IHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       753 ~~~~~-------~~~~~~~--~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      ...+.       .......  .........+.++.+++.+||+.||++||||+|++++
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h  376 (391)
T PHA03212        319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF  376 (391)
T ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            00000       0000000  0011112356679999999999999999999999874

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.1e-37  Score=348.36  Aligned_cols=251  Identities=21%  Similarity=0.260  Sum_probs=203.2

Q ss_pred             cCCCCceeeeccceEEEEEEEC-C-CcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEecc
Q 040845          528 KFSENNLIGRGGFGSVYKARIR-D-GMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYM  605 (824)
Q Consensus       528 ~~~~~~~lg~G~~g~V~~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  605 (824)
                      .|.+.+.||+|+||.||+|... + ++.||+|.+..........+..|+.+++.++||||+++++++..++..++||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            4888999999999999999744 3 6788999775554444566788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhC---CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 040845          606 PHGSLEKYLHSS---NYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ  682 (824)
Q Consensus       606 ~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  682 (824)
                      ++|+|.+++...   ...+++.++..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++..+.....
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            999999988642   246889999999999999999999   99999999999999999999999999999987644332


Q ss_pred             ccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCc
Q 040845          683 SMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ  762 (824)
Q Consensus       683 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  762 (824)
                      ........||+.|+|||++.+..++.++||||+||++|||++|+.||......     ........            ..
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~-----~~~~~~~~------------~~  287 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR-----EIMQQVLY------------GK  287 (478)
T ss_pred             cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHh------------CC
Confidence            22233456899999999999889999999999999999999999998652211     11110000            00


Q ss_pred             hhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          763 EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       763 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      .   ...+..++..+.+++.+||..||++||++.+++.+
T Consensus       288 ~---~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~  323 (478)
T PTZ00267        288 Y---DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT  323 (478)
T ss_pred             C---CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence            0   00112345678999999999999999999999754

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=2.5e-37  Score=321.85  Aligned_cols=254  Identities=27%  Similarity=0.428  Sum_probs=205.6

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEecc
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYM  605 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  605 (824)
                      .+|++.+.||+|+||.||+|.++ +++.||+|.+... ......+.+|++++++++|+||+++++++..+...++||||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            45788899999999999999865 4889999998643 334567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 040845          606 PHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM  684 (824)
Q Consensus       606 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  684 (824)
                      ++++|.+++.... ..+++..+..++.|+++|++|||   +.+++||||||+||++++++.+||+|||.+......... 
T Consensus        85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~-  160 (263)
T cd05052          85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-  160 (263)
T ss_pred             CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCccccccccceee-
Confidence            9999999997543 46899999999999999999999   999999999999999999999999999999876432211 


Q ss_pred             ccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhccccccCch
Q 040845          685 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQE  763 (824)
Q Consensus       685 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  763 (824)
                      ......++..|+|||.+.+..++.++|||||||++|||++ |..||.....     ..........              
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-----~~~~~~~~~~--------------  221 (263)
T cd05052         161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----SQVYELLEKG--------------  221 (263)
T ss_pred             ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHHHHCC--------------
Confidence            1112234668999999988899999999999999999998 8888765211     1111110000              


Q ss_pred             hhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 040845          764 DIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKI  805 (824)
Q Consensus       764 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~  805 (824)
                       .....+..++..+.+++.+||..+|++|||+.|+++.|+.+
T Consensus       222 -~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         222 -YRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             -CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence             00011224567799999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4e-37  Score=320.03  Aligned_cols=254  Identities=29%  Similarity=0.459  Sum_probs=206.7

Q ss_pred             hccCCCCceeeeccceEEEEEEECCCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEecc
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYM  605 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  605 (824)
                      .++|++.+.||+|++|.||+|.+.+++.||+|.++... ...+.+.+|+.++++++|+||+++++++......++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            45788999999999999999998778899999986542 33567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 040845          606 PHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM  684 (824)
Q Consensus       606 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  684 (824)
                      ++++|.+++.... ..+++.++..++.|++.|++|||   +.+++||||||+||++++++.++|+|||++........ .
T Consensus        84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~  159 (261)
T cd05068          84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY-E  159 (261)
T ss_pred             cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc-c
Confidence            9999999997543 56899999999999999999999   99999999999999999999999999999987642211 1


Q ss_pred             ccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhccccccCch
Q 040845          685 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQE  763 (824)
Q Consensus       685 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  763 (824)
                      .......+..|+|||+..+..++.++||||||+++|||++ |+.||.+..... .... +....+               
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-~~~~-~~~~~~---------------  222 (261)
T cd05068         160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE-VLQQ-VDQGYR---------------  222 (261)
T ss_pred             ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH-HHHH-HHcCCC---------------
Confidence            1122223467999999988889999999999999999999 888886532111 1111 110000               


Q ss_pred             hhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 040845          764 DIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLK  804 (824)
Q Consensus       764 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~  804 (824)
                         ...+..++..+.+++.+||+.+|++||++.++++.|++
T Consensus       223 ---~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         223 ---MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             ---CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence               01112345678999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-37  Score=319.95  Aligned_cols=251  Identities=28%  Similarity=0.447  Sum_probs=203.5

Q ss_pred             ccCCCCceeeeccceEEEEEEECCCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEeccC
Q 040845          527 DKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMP  606 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  606 (824)
                      .+|++.+.||+|+||.||+|.++++..+|+|.+... ......+.+|+++++.++|+||+++++++......++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccC-CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            357888999999999999999887788999988643 2234567889999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcccc
Q 040845          607 HGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQ  686 (824)
Q Consensus       607 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  686 (824)
                      +++|.+++......+++..+..++.|++.|++|||   +.+++||||||+||++++++.+||+|||.++....... ...
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~-~~~  158 (256)
T cd05059          83 NGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-TSS  158 (256)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceecccccc-ccc
Confidence            99999999876557899999999999999999999   99999999999999999999999999999876532211 111


Q ss_pred             ccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhh
Q 040845          687 TQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDI  765 (824)
Q Consensus       687 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  765 (824)
                      ....++..|+|||...+..++.++||||||+++||+++ |+.||......+  ....+...                  .
T Consensus       159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~~~~~------------------~  218 (256)
T cd05059         159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE--VVESVSAG------------------Y  218 (256)
T ss_pred             CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH--HHHHHHcC------------------C
Confidence            22234567999999998899999999999999999999 788886532211  11111000                  0


Q ss_pred             hhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 040845          766 HFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL  802 (824)
Q Consensus       766 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L  802 (824)
                      ....+..++.++.+++.+||+.+|++|||+.|+++.|
T Consensus       219 ~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         219 RLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            0011123567799999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=4.5e-37  Score=320.85  Aligned_cols=254  Identities=28%  Similarity=0.385  Sum_probs=203.5

Q ss_pred             ccCCCCceeeeccceEEEEEEE-CCCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEecc
Q 040845          527 DKFSENNLIGRGGFGSVYKARI-RDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYM  605 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  605 (824)
                      .+|++.+.||+|+||.||+|+. .+++.||+|++..........+.+|+.++++++||||+++++++..++..++||||+
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~   88 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC   88 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence            5799999999999999999986 458899999987655455667888999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccc
Q 040845          606 PHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMT  685 (824)
Q Consensus       606 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  685 (824)
                      ++++|.+++.... .+++..+..++.|++.|++|||   +.+|+|||++|+||+++.++.++|+|||++..+.....  .
T Consensus        89 ~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~--~  162 (267)
T cd06646          89 GGGSLQDIYHVTG-PLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA--K  162 (267)
T ss_pred             CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeeccccc--c
Confidence            9999999987654 6889999999999999999999   99999999999999999999999999999986532211  1


Q ss_pred             cccccccccccCccCcC---CCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCc
Q 040845          686 QTQTLATIGYMAPEYGR---EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ  762 (824)
Q Consensus       686 ~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  762 (824)
                      .....++..|+|||.+.   ...++.++||||+||++|||++|+.||......+. ...+......             .
T Consensus       163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~-~~~~~~~~~~-------------~  228 (267)
T cd06646         163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFLMSKSNFQ-------------P  228 (267)
T ss_pred             cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh-heeeecCCCC-------------C
Confidence            22345788999999874   34578899999999999999999999864321111 0000000000             0


Q ss_pred             hhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 040845          763 EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL  802 (824)
Q Consensus       763 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L  802 (824)
                        ........++..+.+++.+||..+|++|||++++++++
T Consensus       229 --~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         229 --PKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             --CCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence              00001123456789999999999999999999998864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.9e-37  Score=336.43  Aligned_cols=254  Identities=24%  Similarity=0.301  Sum_probs=197.5

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEE
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVL  602 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  602 (824)
                      ++|++.+.||+|+||+||+|+.. +++.||||+++...   ......+..|+.++..++|+||+++++.+.+....++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            47889999999999999999765 58999999987542   223456788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 040845          603 EYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ  682 (824)
Q Consensus       603 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  682 (824)
                      ||+++|+|.+++...+ .+++.++..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.+.....
T Consensus        81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~  156 (363)
T cd05628          81 EFLPGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR  156 (363)
T ss_pred             cCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence            9999999999998755 7899999999999999999999   99999999999999999999999999999876532110


Q ss_pred             c---------------------------------cccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCC
Q 040845          683 S---------------------------------MTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPT  729 (824)
Q Consensus       683 ~---------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~  729 (824)
                      .                                 .......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf  236 (363)
T cd05628         157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF  236 (363)
T ss_pred             ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence            0                                 0012346999999999999889999999999999999999999999


Q ss_pred             cccccCcchhhhhhhhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccc--cCCCCCCCHHHHHHH
Q 040845          730 DELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTV--ESPEQRINAKEIVAK  801 (824)
Q Consensus       730 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~--~dP~~Rpt~~evl~~  801 (824)
                      ......+ ........  .. .             ...+.....+..+.+++.+++.  .++..||+++|++++
T Consensus       237 ~~~~~~~-~~~~i~~~--~~-~-------------~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         237 CSETPQE-TYKKVMNW--KE-T-------------LIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             CCCCHHH-HHHHHHcC--cC-c-------------ccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            7532111 11111100  00 0             0000001234556777777554  233456899999987

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-37  Score=340.25  Aligned_cols=253  Identities=24%  Similarity=0.347  Sum_probs=201.3

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEE
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVL  602 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  602 (824)
                      ++|++.+.||+|+||+||+|+.. +|+.||||++....   ......+.+|+.+++.++||||+++++++.++...++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            46889999999999999999865 58999999997542   233456788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 040845          603 EYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ  682 (824)
Q Consensus       603 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  682 (824)
                      ||+++|+|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.++|+|||++..+.....
T Consensus        81 E~~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  156 (364)
T cd05599          81 EYLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR  156 (364)
T ss_pred             CCCCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence            9999999999997655 6899999999999999999999   99999999999999999999999999999876432111


Q ss_pred             cc------------------------------------ccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCC
Q 040845          683 SM------------------------------------TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRK  726 (824)
Q Consensus       683 ~~------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~  726 (824)
                      ..                                    ......||+.|+|||++....++.++||||+||++|||++|.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~  236 (364)
T cd05599         157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY  236 (364)
T ss_pred             ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence            00                                    001235899999999999889999999999999999999999


Q ss_pred             CCCcccccCcchhhhhhhhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCC---HHHHHHH
Q 040845          727 KPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRIN---AKEIVAK  801 (824)
Q Consensus       727 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt---~~evl~~  801 (824)
                      .||......+ .......    ..            ..........++..+.+++.+|+. +|.+|++   +.|++++
T Consensus       237 ~Pf~~~~~~~-~~~~i~~----~~------------~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h  296 (364)
T cd05599         237 PPFCSDNPQE-TYRKIIN----WK------------ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH  296 (364)
T ss_pred             CCCCCCCHHH-HHHHHHc----CC------------CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence            9997532111 0111000    00            000000011235568899999996 9999998   9998875

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=2.2e-37  Score=324.95  Aligned_cols=256  Identities=25%  Similarity=0.448  Sum_probs=203.2

Q ss_pred             hhccCCCCceeeeccceEEEEEEEC------CCcEEEEEEeeccc-cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCe
Q 040845          525 ATDKFSENNLIGRGGFGSVYKARIR------DGMEVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEF  597 (824)
Q Consensus       525 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  597 (824)
                      ..++|++.+.||+|+||.||+|.+.      ++..||||++.... ......+.+|+.+++.++|+||+++++++.+...
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4578999999999999999999753      24679999875432 2234567889999999999999999999999999


Q ss_pred             eEEEEeccCCCCHHHHhhhCC---------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEE
Q 040845          598 KALVLEYMPHGSLEKYLHSSN---------YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHL  668 (824)
Q Consensus       598 ~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl  668 (824)
                      .++||||+++++|.+++....         ...++..+..++.|++.|++|||   +.+++|+||||+||++++++.+++
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEEE
Confidence            999999999999999987532         23577889999999999999999   899999999999999999999999


Q ss_pred             eecccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhC
Q 040845          669 SDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCL  747 (824)
Q Consensus       669 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~  747 (824)
                      +|||++................++..|+|||++.++.++.++|||||||++|||++ |..||.+....  .....+..  
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~--~~~~~~~~--  236 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE--QVLRFVME--  236 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHc--
Confidence            99999876543332222223345788999999998889999999999999999999 67887653211  11111100  


Q ss_pred             CCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 040845          748 PISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLL  803 (824)
Q Consensus       748 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~  803 (824)
                               ....       ..+..++..+.+++.+||+.||++|||+.|+++.|+
T Consensus       237 ---------~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         237 ---------GGLL-------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             ---------CCcC-------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence                     0000       011234567899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.9e-37  Score=332.38  Aligned_cols=242  Identities=24%  Similarity=0.341  Sum_probs=195.6

Q ss_pred             ceeeeccceEEEEEEE----CCCcEEEEEEeeccc----cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEec
Q 040845          533 NLIGRGGFGSVYKARI----RDGMEVAVKVFNLQC----GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       533 ~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      +.||+|+||.||+|+.    .+++.||||+++...    ......+..|+.+++.++||||+++++++..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            6799999999999975    357899999987532    12334567899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 040845          605 MPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM  684 (824)
Q Consensus       605 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  684 (824)
                      +++++|.+++.... .+.+..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++........  
T Consensus        82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  155 (323)
T cd05584          82 LSGGELFMHLEREG-IFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT--  155 (323)
T ss_pred             CCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC--
Confidence            99999999997655 6788888999999999999999   99999999999999999999999999999875432221  


Q ss_pred             ccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchh
Q 040845          685 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQED  764 (824)
Q Consensus       685 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  764 (824)
                      ......|++.|+|||++.+..++.++||||+||++|||++|+.||......     ........        .       
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~-----~~~~~~~~--------~-------  215 (323)
T cd05584         156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK-----KTIDKILK--------G-------  215 (323)
T ss_pred             cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH-----HHHHHHHc--------C-------
Confidence            122346899999999998888999999999999999999999998753211     11111000        0       


Q ss_pred             hhhhhHHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 040845          765 IHFVAKEQCVSFVFNLALECTVESPEQRI-----NAKEIVAK  801 (824)
Q Consensus       765 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~evl~~  801 (824)
                       ....+..++..+.+++.+||+.||++||     ++.+++++
T Consensus       216 -~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h  256 (323)
T cd05584         216 -KLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH  256 (323)
T ss_pred             -CCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence             0011123456688999999999999999     88888775

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=3.2e-37  Score=324.81  Aligned_cols=255  Identities=27%  Similarity=0.460  Sum_probs=204.2

Q ss_pred             ccCCCCceeeeccceEEEEEEE-----CCCcEEEEEEeeccc-cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEE
Q 040845          527 DKFSENNLIGRGGFGSVYKARI-----RDGMEVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKAL  600 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  600 (824)
                      ++|++.+.||+|+||.||+|.+     .++..||+|.+.... ......+.+|++++++++||||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            4678889999999999999974     246789999986433 2334678889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhhCC----------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC
Q 040845          601 VLEYMPHGSLEKYLHSSN----------------YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM  664 (824)
Q Consensus       601 v~e~~~~g~L~~~l~~~~----------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~  664 (824)
                      ||||+++++|.+++....                ..+++.++..++.|++.|++|||   +.+++||||||+||++++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCCC
Confidence            999999999999985321                24788889999999999999999   99999999999999999999


Q ss_pred             cEEEeecccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhh
Q 040845          665 VAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWV  743 (824)
Q Consensus       665 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~  743 (824)
                      .+|++|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.....  ......+
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--~~~~~~~  239 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--QEVIEMV  239 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHH
Confidence            999999999987644332222333446778999999988889999999999999999999 8888865211  1111111


Q ss_pred             hhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 040845          744 NDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLK  804 (824)
Q Consensus       744 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~  804 (824)
                      ....                  ....+..++..+.+++.+||+.||++||++.++.++|++
T Consensus       240 ~~~~------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         240 RKRQ------------------LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HcCC------------------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            1100                  001122456678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=8.1e-37  Score=318.95  Aligned_cols=258  Identities=24%  Similarity=0.346  Sum_probs=207.2

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEE
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVL  602 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  602 (824)
                      ++|++.+.||+|+||.||+|+.. +++.||||.+....   ......+..|+++++.++||||+++++++.+.+..++|+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            57899999999999999999864 68999999875432   233456788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhh---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCC
Q 040845          603 EYMPHGSLEKYLHS---SNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG  679 (824)
Q Consensus       603 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  679 (824)
                      ||+++++|.+++..   ....+++..+..++.|++.|++|||   +.+++|+||||+||+++.++.++++|||.+..+..
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            99999999988853   2245788999999999999999999   99999999999999999999999999999886543


Q ss_pred             CCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccc
Q 040845          680 EDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANL  759 (824)
Q Consensus       680 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  759 (824)
                      ...  ......++..|+|||.+.+..++.++|+||+|+++|||++|+.||...........+.+....        .   
T Consensus       159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~--------~---  225 (267)
T cd08228         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCD--------Y---  225 (267)
T ss_pred             hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCC--------C---
Confidence            221  122345788999999998888999999999999999999999998653221111111111000        0   


Q ss_pred             cCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 040845          760 LSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIR  806 (824)
Q Consensus       760 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~  806 (824)
                            .......++..+.+++.+||..+|++||++.++++.++.++
T Consensus       226 ------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         226 ------PPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             ------CCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence                  00011234567899999999999999999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.7e-37  Score=338.81  Aligned_cols=253  Identities=22%  Similarity=0.276  Sum_probs=198.5

Q ss_pred             cCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEe
Q 040845          528 KFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLE  603 (824)
Q Consensus       528 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  603 (824)
                      .|+..+.||+|+||+||+|+.. +++.||||++....   ....+.+..|+.+++.++|+||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5788899999999999999764 58899999997542   2334568889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 040845          604 YMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS  683 (824)
Q Consensus       604 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  683 (824)
                      |+++|+|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++..+......
T Consensus        82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~  157 (381)
T cd05626          82 YIPGGDMMSLLIRME-VFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS  157 (381)
T ss_pred             cCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence            999999999997765 6888899999999999999999   999999999999999999999999999998643211000


Q ss_pred             ---------------------------------------------cccccccccccccCccCcCCCCCCccchHHHHHHH
Q 040845          684 ---------------------------------------------MTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIM  718 (824)
Q Consensus       684 ---------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~  718 (824)
                                                                   .......||+.|+|||++.+..++.++||||+||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i  237 (381)
T cd05626         158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI  237 (381)
T ss_pred             ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence                                                         00123469999999999988889999999999999


Q ss_pred             HHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHH--ccccCCCCCCCHH
Q 040845          719 LMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALE--CTVESPEQRINAK  796 (824)
Q Consensus       719 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--cl~~dP~~Rpt~~  796 (824)
                      +|||++|+.||......+.. ......  ..              .........++.++.+++.+  |+..+|..||++.
T Consensus       238 l~elltG~~Pf~~~~~~~~~-~~i~~~--~~--------------~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~  300 (381)
T cd05626         238 LFEMLVGQPPFLAPTPTETQ-LKVINW--EN--------------TLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGAD  300 (381)
T ss_pred             HHHHHhCCCCCcCCCHHHHH-HHHHcc--cc--------------ccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHH
Confidence            99999999999763221111 110000  00              00000111245667888888  5556666799999


Q ss_pred             HHHHH
Q 040845          797 EIVAK  801 (824)
Q Consensus       797 evl~~  801 (824)
                      |+++|
T Consensus       301 ~~l~h  305 (381)
T cd05626         301 DIKAH  305 (381)
T ss_pred             HHhcC
Confidence            99986

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=7.9e-38  Score=336.82  Aligned_cols=253  Identities=23%  Similarity=0.332  Sum_probs=203.3

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEE
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVL  602 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  602 (824)
                      ++|++.+.||+|+||+||+|+.. +|+.||+|+++...   ....+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            36889999999999999999865 58999999997542   234456788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 040845          603 EYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ  682 (824)
Q Consensus       603 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  682 (824)
                      ||+++|+|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++..+.....
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  157 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM  157 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence            999999999999887567899999999999999999999   99999999999999999999999999999987643322


Q ss_pred             ccccccccccccccCccCcC------CCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhcc
Q 040845          683 SMTQTQTLATIGYMAPEYGR------EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVD  756 (824)
Q Consensus       683 ~~~~~~~~~~~~y~aPE~~~------~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  756 (824)
                      . ......||+.|+|||++.      ...++.++|||||||++|||++|+.||......     ..........      
T Consensus       158 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-----~~~~~i~~~~------  225 (330)
T cd05601         158 V-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA-----KTYNNIMNFQ------  225 (330)
T ss_pred             e-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH-----HHHHHHHcCC------
Confidence            2 223346899999999886      456789999999999999999999998653211     1111100000      


Q ss_pred             ccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          757 ANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       757 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                            .....+.....+..+.+++.+|++ +|++|||+++++++
T Consensus       226 ------~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         226 ------RFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             ------CccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence                  000000111345668899999998 99999999999875

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-38  Score=309.99  Aligned_cols=267  Identities=24%  Similarity=0.333  Sum_probs=227.3

Q ss_pred             HhhccCCCCceeeeccceEEEEEEECC------CcEEEEEEeecccc-chhhhHHHHHHHHhcCCCCcceeEEeeeec-C
Q 040845          524 QATDKFSENNLIGRGGFGSVYKARIRD------GMEVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVKVISSCSN-E  595 (824)
Q Consensus       524 ~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~  595 (824)
                      ....+++...++-+|.||.||+|.|.+      .+.|-||.++.... .....+..|..++..+.|||+.++.+++.+ .
T Consensus       281 v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~  360 (563)
T KOG1024|consen  281 VQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDY  360 (563)
T ss_pred             hhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeecc
Confidence            334567778889999999999997653      34567777654433 345677889999999999999999999855 5


Q ss_pred             CeeEEEEeccCCCCHHHHhhhCC-------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEE
Q 040845          596 EFKALVLEYMPHGSLEKYLHSSN-------YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHL  668 (824)
Q Consensus       596 ~~~~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl  668 (824)
                      +.++.++.++.-|+|..|+.-.+       ..++..+.+.++.|++.|++|||   .++|||.||.++|.++|+..++||
T Consensus       361 ~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~LqVkl  437 (563)
T KOG1024|consen  361 ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQLQVKL  437 (563)
T ss_pred             CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhheeEEe
Confidence            67889999999999999998322       45777888999999999999999   999999999999999999999999


Q ss_pred             eecccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhC
Q 040845          669 SDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCL  747 (824)
Q Consensus       669 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~  747 (824)
                      +|-.+++.+.+.+++.-......+..||+||.+....|+.++|||||||++|||+| |+.|+.+..+.++  ..+     
T Consensus       438 tDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm--~~y-----  510 (563)
T KOG1024|consen  438 TDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM--EHY-----  510 (563)
T ss_pred             ccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH--HHH-----
Confidence            99999999999999888888889999999999999999999999999999999999 8889876433221  222     


Q ss_pred             CCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhcccc
Q 040845          748 PISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLRNV  813 (824)
Q Consensus       748 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~~~  813 (824)
                                   -..+.++.+|-+||++++.+|..||+.+|++||+++|++.-|.++..++.+++
T Consensus       511 -------------lkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~qlt~YV  563 (563)
T KOG1024|consen  511 -------------LKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQLTRYV  563 (563)
T ss_pred             -------------HhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHHhhcC
Confidence                         22356777888999999999999999999999999999999999998887753

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=9.5e-37  Score=322.50  Aligned_cols=267  Identities=27%  Similarity=0.366  Sum_probs=197.2

Q ss_pred             ccCCCCceeeeccceEEEEEEEC--CCcEEEEEEeecccc--chhhhHHHHHHHHhcC---CCCcceeEEeeee-----c
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR--DGMEVAVKVFNLQCG--RAFKSFDVECAMMKSI---RHRNLVKVISSCS-----N  594 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~-----~  594 (824)
                      .+|++.+.||+|+||.||+|+..  +++.||+|+++....  .....+.+|+.+++.+   +||||+++++++.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            36889999999999999999863  368899999865432  2234556677777766   6999999999885     3


Q ss_pred             CCeeEEEEeccCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccc
Q 040845          595 EEFKALVLEYMPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGI  673 (824)
Q Consensus       595 ~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~  673 (824)
                      ....++||||++ ++|.+++.... ..+++.++..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGL  156 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence            456889999996 69999987543 45889999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhC-CCc--
Q 040845          674 AKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCL-PIS--  750 (824)
Q Consensus       674 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~--  750 (824)
                      +......   .......+++.|+|||.+.+..++.++||||+||++|||++|++||......+ .+........ +..  
T Consensus       157 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~-~~~~i~~~~~~~~~~~  232 (290)
T cd07862         157 ARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVIGLPGEED  232 (290)
T ss_pred             eEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHHhCCCChhh
Confidence            9865422   12234568999999999988889999999999999999999999997632211 1111111110 000  


Q ss_pred             c-hhh-ccccccC-chhh-hhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          751 T-MEV-VDANLLS-QEDI-HFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       751 ~-~~~-~~~~~~~-~~~~-~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      . .+. ....... .... .......++..+.+++.+|++.||++|||+.|++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h  287 (290)
T cd07862         233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  287 (290)
T ss_pred             chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence            0 000 0000000 0000 000112356778899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=5.8e-37  Score=334.84  Aligned_cols=259  Identities=25%  Similarity=0.413  Sum_probs=205.6

Q ss_pred             hccCCCCceeeeccceEEEEEEEC------CCcEEEEEEeeccc-cchhhhHHHHHHHHhcCC-CCcceeEEeeeecCCe
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR------DGMEVAVKVFNLQC-GRAFKSFDVECAMMKSIR-HRNLVKVISSCSNEEF  597 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~  597 (824)
                      .++|.+.+.||+|+||.||+|++.      .+..||||+++... ....+.+..|+.++.++. ||||+++++++.....
T Consensus        36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~  115 (401)
T cd05107          36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP  115 (401)
T ss_pred             HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence            456888899999999999999864      24689999997543 223456888999999997 9999999999999999


Q ss_pred             eEEEEeccCCCCHHHHhhhCC-----------------------------------------------------------
Q 040845          598 KALVLEYMPHGSLEKYLHSSN-----------------------------------------------------------  618 (824)
Q Consensus       598 ~~lv~e~~~~g~L~~~l~~~~-----------------------------------------------------------  618 (824)
                      .++||||+++|+|.+++++.+                                                           
T Consensus       116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (401)
T cd05107         116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM  195 (401)
T ss_pred             cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence            999999999999999996532                                                           


Q ss_pred             --------------------------------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee
Q 040845          619 --------------------------------------YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL  660 (824)
Q Consensus       619 --------------------------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill  660 (824)
                                                            ..+++..++.++.|++.|++|||   +.+++||||||+||++
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~NiLl  272 (401)
T cd05107         196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNVLI  272 (401)
T ss_pred             hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcceEEE
Confidence                                                  13567788899999999999999   9999999999999999


Q ss_pred             CCCCcEEEeecccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchh
Q 040845          661 DDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTL  739 (824)
Q Consensus       661 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~  739 (824)
                      ++++.+|++|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.||......+. .
T Consensus       273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~-~  351 (401)
T cd05107         273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ-F  351 (401)
T ss_pred             eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH-H
Confidence            9999999999999986543222222223456788999999988889999999999999999998 8888865322111 0


Q ss_pred             hhhhhhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 040845          740 KHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIR  806 (824)
Q Consensus       740 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~  806 (824)
                      ...+.            ..      .+...+..++.++.+++.+||..+|++||+++|+++.|+++.
T Consensus       352 ~~~~~------------~~------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         352 YNAIK------------RG------YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             HHHHH------------cC------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            10000            00      001112235677999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=5.9e-37  Score=323.03  Aligned_cols=270  Identities=27%  Similarity=0.426  Sum_probs=206.0

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-----CCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeec--CCeeE
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-----DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSN--EEFKA  599 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~  599 (824)
                      ..|++.+.||+|+||.||+|..+     +++.||+|.+........+.+.+|++++++++||||+++++++..  ....+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            46888899999999999999753     478999999876555556778899999999999999999998743  45678


Q ss_pred             EEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCC
Q 040845          600 LVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG  679 (824)
Q Consensus       600 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  679 (824)
                      +||||+++++|.+++...+..+++..+..++.|++.|++|||   +.+++||||||+||++++++.+||+|||++.....
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~  160 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ  160 (284)
T ss_pred             EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence            999999999999999876657899999999999999999999   99999999999999999999999999999987643


Q ss_pred             CCCccc-cccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCc--chhhcc
Q 040845          680 EDQSMT-QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPIS--TMEVVD  756 (824)
Q Consensus       680 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  756 (824)
                      ...... .....++..|+|||...+..++.++|||||||++|||++|..|+......   ............  .....+
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05081         161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE---FMRMMGNDKQGQMIVYHLIE  237 (284)
T ss_pred             CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh---hhhhcccccccccchHHHHH
Confidence            322211 11222445699999998888999999999999999999988775432110   000000000000  000000


Q ss_pred             ccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 040845          757 ANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKI  805 (824)
Q Consensus       757 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~  805 (824)
                      .  . ........+..++..+.+++.+||..+|++||||+|+++.|+++
T Consensus       238 ~--~-~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         238 L--L-KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             H--H-hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            0  0 00011112335667899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-37  Score=338.88  Aligned_cols=253  Identities=27%  Similarity=0.378  Sum_probs=205.2

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEE
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVL  602 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  602 (824)
                      ++|++.+.||+|+||+||+|+.. +|+.||||+++...   ......+..|+++++.++|+||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            46889999999999999999865 68999999987542   234567888999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC-
Q 040845          603 EYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED-  681 (824)
Q Consensus       603 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~-  681 (824)
                      ||+++++|.+++... ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++....... 
T Consensus        81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  156 (350)
T cd05573          81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD  156 (350)
T ss_pred             cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence            999999999999876 37899999999999999999999   9999999999999999999999999999998664332 


Q ss_pred             --------------------------CccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccC
Q 040845          682 --------------------------QSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNG  735 (824)
Q Consensus       682 --------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~  735 (824)
                                                .........||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~  236 (350)
T cd05573         157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ  236 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence                                      001223456899999999999999999999999999999999999999763211


Q ss_pred             cchhhhhhhhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCC-HHHHHHH
Q 040845          736 EMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRIN-AKEIVAK  801 (824)
Q Consensus       736 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt-~~evl~~  801 (824)
                      + .......    ..      ..      ...+....++..+.+++.+|+. ||++||+ ++|++++
T Consensus       237 ~-~~~~i~~----~~------~~------~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         237 E-TYNKIIN----WK------ES------LRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             H-HHHHHhc----cC------Cc------ccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            1 0011000    00      00      0000011146678899999997 9999999 9999986

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=5.8e-37  Score=322.11  Aligned_cols=260  Identities=24%  Similarity=0.392  Sum_probs=206.9

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCc----EEEEEEeecccc-chhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGM----EVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKA  599 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  599 (824)
                      .++|+..+.||+|+||+||+|++. +|+    .||+|++..... ...+.+..|+.+++.++|+||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence            357888899999999999999854 344    489999865432 3356678899999999999999999998764 467


Q ss_pred             EEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCC
Q 040845          600 LVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG  679 (824)
Q Consensus       600 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  679 (824)
                      +++||+++|+|.+++......+++.+++.++.|+++|++|||   +.+|+||||||+||++++++.+||+|||+++....
T Consensus        85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~  161 (279)
T cd05109          85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI  161 (279)
T ss_pred             EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence            999999999999999876657899999999999999999999   99999999999999999999999999999987643


Q ss_pred             CCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhcccc
Q 040845          680 EDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDAN  758 (824)
Q Consensus       680 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  758 (824)
                      ...........++..|+|||...+..++.++|||||||++||+++ |..||.....  .....++.....          
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~~~~~~~----------  229 (279)
T cd05109         162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA--REIPDLLEKGER----------  229 (279)
T ss_pred             ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHCCCc----------
Confidence            332222222345678999999988889999999999999999998 8888865322  112222221100          


Q ss_pred             ccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhh
Q 040845          759 LLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSL  809 (824)
Q Consensus       759 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~  809 (824)
                              ...+..++..+.+++.+||..||++||++.|+++.++++....
T Consensus       230 --------~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05109         230 --------LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP  272 (279)
T ss_pred             --------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence                    0011234567899999999999999999999999998775544

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=3.5e-37  Score=334.64  Aligned_cols=248  Identities=24%  Similarity=0.359  Sum_probs=194.4

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc-chhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEec
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      ++|+..+.||+|+||.||+|++. +++.||||++..... ...+.+.+|+++++.++|+||+++++++.+.+..++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            45667789999999999999865 589999999865432 3346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 040845          605 MPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM  684 (824)
Q Consensus       605 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  684 (824)
                      +++|+|.+..     ..++..+..++.||+.||+|||   +.+|+||||||+||++++++.+||+|||++..+.....  
T Consensus       154 ~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--  223 (353)
T PLN00034        154 MDGGSLEGTH-----IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD--  223 (353)
T ss_pred             CCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc--
Confidence            9999986532     3567778899999999999999   99999999999999999999999999999986542211  


Q ss_pred             ccccccccccccCccCcCC-----CCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccc
Q 040845          685 TQTQTLATIGYMAPEYGRE-----GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANL  759 (824)
Q Consensus       685 ~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  759 (824)
                      ......||..|+|||.+..     ...+.++|||||||++|||++|+.||......+  .........            
T Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~--~~~~~~~~~------------  289 (353)
T PLN00034        224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD--WASLMCAIC------------  289 (353)
T ss_pred             cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc--HHHHHHHHh------------
Confidence            1233468999999998743     234578999999999999999999997322111  111000000            


Q ss_pred             cCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          760 LSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       760 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      ..   .....+..++.++.+++.+||+.||++|||+.|++++
T Consensus       290 ~~---~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        290 MS---QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             cc---CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00   0001122456678999999999999999999999986

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.2e-37  Score=334.22  Aligned_cols=242  Identities=24%  Similarity=0.288  Sum_probs=196.4

Q ss_pred             ceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEeccCCC
Q 040845          533 NLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHG  608 (824)
Q Consensus       533 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  608 (824)
                      +.||+|+||.||+|+.. +|+.||+|++....   ......+..|+++++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999864 58999999997542   233456678999999999999999999999999999999999999


Q ss_pred             CHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccccc
Q 040845          609 SLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYS-APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQT  687 (824)
Q Consensus       609 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  687 (824)
                      +|.+++.... .+++.++..++.|++.||+|||   + .+|+||||||+||+++.++.+||+|||++........  ...
T Consensus        81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~  154 (325)
T cd05594          81 ELFFHLSRER-VFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMK  154 (325)
T ss_pred             cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--ccc
Confidence            9999987655 6899999999999999999999   7 7999999999999999999999999999875432211  122


Q ss_pred             cccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhhhh
Q 040845          688 QTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHF  767 (824)
Q Consensus       688 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  767 (824)
                      ...||+.|+|||++.+..++.++||||+||++|||++|+.||......     ..........                .
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~-----~~~~~i~~~~----------------~  213 (325)
T cd05594         155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KLFELILMEE----------------I  213 (325)
T ss_pred             cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH-----HHHHHHhcCC----------------C
Confidence            346899999999999889999999999999999999999999653211     1111000000                0


Q ss_pred             hhHHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 040845          768 VAKEQCVSFVFNLALECTVESPEQRI-----NAKEIVAK  801 (824)
Q Consensus       768 ~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~evl~~  801 (824)
                      ..+...+..+.+++.+||+.||++|+     ++.+++++
T Consensus       214 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         214 RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            01123456788999999999999997     89999876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=8.6e-37  Score=321.55  Aligned_cols=268  Identities=26%  Similarity=0.427  Sum_probs=205.1

Q ss_pred             cC-CCCceeeeccceEEEEEEE-----CCCcEEEEEEeecccc-chhhhHHHHHHHHhcCCCCcceeEEeeeec--CCee
Q 040845          528 KF-SENNLIGRGGFGSVYKARI-----RDGMEVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVKVISSCSN--EEFK  598 (824)
Q Consensus       528 ~~-~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~  598 (824)
                      +| +..+.||+|+||+||.+.+     .+++.||+|+++.... ...+.+.+|++++++++||||+++++++..  ....
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (283)
T cd05080           4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL   83 (283)
T ss_pred             hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence            44 7889999999999988653     3578899999875432 345678889999999999999999998765  3467


Q ss_pred             EEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccC
Q 040845          599 ALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT  678 (824)
Q Consensus       599 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~  678 (824)
                      ++||||+++++|.+++...  .+++.++..++.|++.|++|||   +.+|+||||||+||++++++.++|+|||++....
T Consensus        84 ~lv~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  158 (283)
T cd05080          84 QLIMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  158 (283)
T ss_pred             EEEecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeecccccccC
Confidence            8999999999999999764  4899999999999999999999   9999999999999999999999999999998664


Q ss_pred             CCCCcc-ccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCC-Ccchhhcc
Q 040845          679 GEDQSM-TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLP-ISTMEVVD  756 (824)
Q Consensus       679 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  756 (824)
                      ...... ......++..|+|||...+..++.++||||||+++|||+||+.||............+...... ....+..+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T cd05080         159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE  238 (283)
T ss_pred             CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence            322211 1122335667999999988889999999999999999999999986532211111111000000 00011111


Q ss_pred             ccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 040845          757 ANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIR  806 (824)
Q Consensus       757 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~  806 (824)
                      ..      .....+..++..+.+++.+||+.+|++|||++++++.|+++.
T Consensus       239 ~~------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         239 RG------MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             cC------CCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            11      111123356778999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=3.2e-37  Score=330.86  Aligned_cols=245  Identities=24%  Similarity=0.333  Sum_probs=195.0

Q ss_pred             CCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHH---hcCCCCcceeEEeeeecCCeeEEE
Q 040845          529 FSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMM---KSIRHRNLVKVISSCSNEEFKALV  601 (824)
Q Consensus       529 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv  601 (824)
                      |++.+.||+|+||.||+|.+. +++.||||+++...   ....+.+..|+.++   +.++||||+++++++...+..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            667889999999999999865 58999999997542   22344566666554   567899999999999999999999


Q ss_pred             EeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 040845          602 LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED  681 (824)
Q Consensus       602 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  681 (824)
                      |||+++++|..++...  .+++..+..++.|++.|++|||   +.+|+||||||+||++++++.+||+|||++.......
T Consensus        81 ~E~~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05589          81 MEYAAGGDLMMHIHTD--VFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG  155 (324)
T ss_pred             EcCCCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence            9999999999888653  5899999999999999999999   9999999999999999999999999999987532221


Q ss_pred             CccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccC
Q 040845          682 QSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLS  761 (824)
Q Consensus       682 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  761 (824)
                        .......|++.|+|||.+.+..++.++|||||||++|||++|+.||......+ ........                
T Consensus       156 --~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~-~~~~i~~~----------------  216 (324)
T cd05589         156 --DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE-VFDSIVND----------------  216 (324)
T ss_pred             --CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhC----------------
Confidence              12234568999999999998899999999999999999999999987532111 01111000                


Q ss_pred             chhhhhhhHHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 040845          762 QEDIHFVAKEQCVSFVFNLALECTVESPEQRI-----NAKEIVAK  801 (824)
Q Consensus       762 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~evl~~  801 (824)
                          ....+..++..+.+++.+||+.||++||     ++.+++++
T Consensus       217 ----~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~  257 (324)
T cd05589         217 ----EVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ  257 (324)
T ss_pred             ----CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence                0001123456788999999999999999     57777665

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=4.8e-37  Score=322.74  Aligned_cols=255  Identities=29%  Similarity=0.470  Sum_probs=205.0

Q ss_pred             ccCCCCceeeeccceEEEEEEEC------CCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEE
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR------DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKAL  600 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  600 (824)
                      .+|...+.||+|+||.||+|...      ++..||+|.+........+.+.+|+++++.++|+||+++++++.+....++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            46777899999999999999642      356899998875555556789999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhhCC--------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcE
Q 040845          601 VLEYMPHGSLEKYLHSSN--------------YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVA  666 (824)
Q Consensus       601 v~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~  666 (824)
                      ||||+++++|.+++....              ..+++..+..++.|++.|++|||   +.+++||||||+||++++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCCE
Confidence            999999999999997643              24788999999999999999999   9999999999999999999999


Q ss_pred             EEeecccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhh
Q 040845          667 HLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVND  745 (824)
Q Consensus       667 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~  745 (824)
                      ||+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |..||......+  .......
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~~~~~  239 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE--AIECITQ  239 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH--HHHHHHc
Confidence            9999999976543322222223345778999999988899999999999999999998 888886532211  1110000


Q ss_pred             hCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 040845          746 CLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLK  804 (824)
Q Consensus       746 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~  804 (824)
                      .                  .....+..++..+.+++.+||+.||++||+++|+.+.|++
T Consensus       240 ~------------------~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         240 G------------------RELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             C------------------ccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence            0                  0001112456678999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=2.5e-37  Score=327.43  Aligned_cols=259  Identities=29%  Similarity=0.470  Sum_probs=207.0

Q ss_pred             hhccCCCCceeeeccceEEEEEEECC------CcEEEEEEeeccc-cchhhhHHHHHHHHhcC-CCCcceeEEeeeecCC
Q 040845          525 ATDKFSENNLIGRGGFGSVYKARIRD------GMEVAVKVFNLQC-GRAFKSFDVECAMMKSI-RHRNLVKVISSCSNEE  596 (824)
Q Consensus       525 ~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  596 (824)
                      ..++|++.+.||+|+||.||+|.+..      ...||+|.+.... ......+.+|+++++++ +|+||+++++++..+.
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   89 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG   89 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence            34678889999999999999998642      3679999886542 23345688899999999 8999999999999999


Q ss_pred             eeEEEEeccCCCCHHHHhhhC---------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC
Q 040845          597 FKALVLEYMPHGSLEKYLHSS---------------NYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD  661 (824)
Q Consensus       597 ~~~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~  661 (824)
                      ..+++|||+++|+|.+++...               ...+++..+..++.|++.|++|||   +.+|+||||||+||+++
T Consensus        90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil~~  166 (293)
T cd05053          90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLVT  166 (293)
T ss_pred             CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEEEc
Confidence            999999999999999998642               246889999999999999999999   99999999999999999


Q ss_pred             CCCcEEEeecccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhh
Q 040845          662 DNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLK  740 (824)
Q Consensus       662 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~  740 (824)
                      .++.+|++|||.++.+.............++..|+|||...+..++.++|||||||++||+++ |..||......+  ..
T Consensus       167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~  244 (293)
T cd05053         167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE--LF  244 (293)
T ss_pred             CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH--HH
Confidence            999999999999987654332222222335678999999988889999999999999999998 888876532111  11


Q ss_pred             hhhhhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 040845          741 HWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIR  806 (824)
Q Consensus       741 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~  806 (824)
                      .....            .      .....+..++..+.+++.+||..||++|||+.|+++.|+++.
T Consensus       245 ~~~~~------------~------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         245 KLLKE------------G------YRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             HHHHc------------C------CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence            11000            0      000112234667899999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=5.1e-37  Score=322.81  Aligned_cols=260  Identities=23%  Similarity=0.387  Sum_probs=209.8

Q ss_pred             hccCCCCceeeeccceEEEEEEECC-----CcEEEEEEeeccc-cchhhhHHHHHHHHhcCCCCcceeEEeeeec-CCee
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIRD-----GMEVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLVKVISSCSN-EEFK  598 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~  598 (824)
                      .++|++.+.||+|+||.||+|.+.+     +..||+|.+.... ....+.+.+|+.++++++|+||+++++++.. ....
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            4678899999999999999998765     6889999886442 2335668889999999999999999998765 5778


Q ss_pred             EEEEeccCCCCHHHHhhhCC-------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeec
Q 040845          599 ALVLEYMPHGSLEKYLHSSN-------YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDF  671 (824)
Q Consensus       599 ~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df  671 (824)
                      ++++||+++++|.+++....       ..+++.++..++.|++.|++|||   +.+++||||||+||++++++.+|++||
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECCC
Confidence            89999999999999987542       35889999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCc
Q 040845          672 GIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPIS  750 (824)
Q Consensus       672 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  750 (824)
                      |+++.+.............++..|+|||.+.+..++.++||||||+++||+++ |+.||.....  .....++....   
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~---  236 (280)
T cd05043         162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--FEMAAYLKDGY---  236 (280)
T ss_pred             CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--HHHHHHHHcCC---
Confidence            99986644333222233346778999999988889999999999999999999 9999865321  12222222111   


Q ss_pred             chhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 040845          751 TMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDS  808 (824)
Q Consensus       751 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~  808 (824)
                                     ....+..++..+.+++.+||..||++|||+.|+++.|+++...
T Consensus       237 ---------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~  279 (280)
T cd05043         237 ---------------RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ  279 (280)
T ss_pred             ---------------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence                           0011123456789999999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-38  Score=331.11  Aligned_cols=251  Identities=24%  Similarity=0.396  Sum_probs=211.1

Q ss_pred             CCCceeeeccceEEEEEEECC--C--cEEEEEEeeccccc-hhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEec
Q 040845          530 SENNLIGRGGFGSVYKARIRD--G--MEVAVKVFNLQCGR-AFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       530 ~~~~~lg~G~~g~V~~~~~~~--~--~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      ...++||+|+||.|++|.|..  |  -.||||.++..... ...+|.+|+.+|-+|+|+|++++||+.-+ ....+|||.
T Consensus       113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL  191 (1039)
T KOG0199|consen  113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL  191 (1039)
T ss_pred             HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence            445789999999999999864  3  36899999765433 67889999999999999999999999987 566799999


Q ss_pred             cCCCCHHHHhhh-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 040845          605 MPHGSLEKYLHS-SNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS  683 (824)
Q Consensus       605 ~~~g~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  683 (824)
                      ++.|+|.+.++. ....+-....-.++.|||.|+.||.   .+++||||+.++|+++.....+||+|||+++-+..++..
T Consensus       192 aplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~  268 (1039)
T KOG0199|consen  192 APLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM  268 (1039)
T ss_pred             cccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence            999999999987 4456778888899999999999999   999999999999999999999999999999988766555


Q ss_pred             ccc-ccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhccccccC
Q 040845          684 MTQ-TQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLS  761 (824)
Q Consensus       684 ~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  761 (824)
                      +.. .....+..|+|||.+....++.++|||+|||.+|||+| |..||-+...              ....+.+|     
T Consensus       269 Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g--------------~qIL~~iD-----  329 (1039)
T KOG0199|consen  269 YVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG--------------IQILKNID-----  329 (1039)
T ss_pred             eEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH--------------HHHHHhcc-----
Confidence            443 34557889999999999999999999999999999999 6778765211              11122223     


Q ss_pred             chhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 040845          762 QEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLK  804 (824)
Q Consensus       762 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~  804 (824)
                       ...++..+..|++.++++|++||+.+|++||||..+.+.+-.
T Consensus       330 -~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l  371 (1039)
T KOG0199|consen  330 -AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL  371 (1039)
T ss_pred             -ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence             334666778999999999999999999999999999855543

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=6.7e-37  Score=325.81  Aligned_cols=260  Identities=26%  Similarity=0.431  Sum_probs=208.1

Q ss_pred             hccCCCCceeeeccceEEEEEEEC--------CCcEEEEEEeeccc-cchhhhHHHHHHHHhcC-CCCcceeEEeeeecC
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR--------DGMEVAVKVFNLQC-GRAFKSFDVECAMMKSI-RHRNLVKVISSCSNE  595 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  595 (824)
                      .++|.+.+.||+|+||.||+|++.        ++..||+|...... ....+.+.+|+.+++.+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            467888999999999999999742        24579999886442 23456788999999999 899999999999999


Q ss_pred             CeeEEEEeccCCCCHHHHhhhCC---------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee
Q 040845          596 EFKALVLEYMPHGSLEKYLHSSN---------------YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL  660 (824)
Q Consensus       596 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill  660 (824)
                      ...++||||+++|+|.+++....               ..+++.++..++.|+++|++|||   +.+++||||||+||++
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nili  170 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVLV  170 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceEEE
Confidence            99999999999999999997532               24778889999999999999999   9999999999999999


Q ss_pred             CCCCcEEEeecccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchh
Q 040845          661 DDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTL  739 (824)
Q Consensus       661 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~  739 (824)
                      ++++.+||+|||.++...............++..|+|||.+.+..++.++||||||+++||+++ |..||....     .
T Consensus       171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-----~  245 (304)
T cd05101         171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-----V  245 (304)
T ss_pred             cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC-----H
Confidence            9999999999999987643333222233346678999999988889999999999999999998 777775421     1


Q ss_pred             hhhhhhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 040845          740 KHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDS  808 (824)
Q Consensus       740 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~  808 (824)
                      ..+.......               .....+..++..+.+++.+||..+|++|||+.|+++.|+++...
T Consensus       246 ~~~~~~~~~~---------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~  299 (304)
T cd05101         246 EELFKLLKEG---------------HRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL  299 (304)
T ss_pred             HHHHHHHHcC---------------CcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence            1111111000               00111234567899999999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.7e-37  Score=347.19  Aligned_cols=256  Identities=23%  Similarity=0.319  Sum_probs=204.9

Q ss_pred             HHhhccCCCCceeeeccceEEEEEEE-CCCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeecCC---
Q 040845          523 FQATDKFSENNLIGRGGFGSVYKARI-RDGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEE---  596 (824)
Q Consensus       523 ~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---  596 (824)
                      ....++|.+.+.||+|+||+||+|+. .+|+.||||++....  ......+.+|+..+..++|+|++++++.+...+   
T Consensus        28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~  107 (496)
T PTZ00283         28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN  107 (496)
T ss_pred             cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence            34457999999999999999999975 468999999986542  233456788999999999999999988764332   


Q ss_pred             -----eeEEEEeccCCCCHHHHhhhCC---CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEE
Q 040845          597 -----FKALVLEYMPHGSLEKYLHSSN---YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHL  668 (824)
Q Consensus       597 -----~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl  668 (824)
                           ..++||||+++|+|.+++....   ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||
T Consensus       108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~vkL  184 (496)
T PTZ00283        108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVKL  184 (496)
T ss_pred             cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCEEE
Confidence                 3679999999999999986532   46889999999999999999999   999999999999999999999999


Q ss_pred             eecccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCC
Q 040845          669 SDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLP  748 (824)
Q Consensus       669 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  748 (824)
                      +|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||....     ...++.....
T Consensus       185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~-----~~~~~~~~~~  259 (496)
T PTZ00283        185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN-----MEEVMHKTLA  259 (496)
T ss_pred             EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHhc
Confidence            99999987643322222334568999999999999899999999999999999999999986521     1111111110


Q ss_pred             CcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          749 ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       749 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      ..               ....+..++..+.+++.+||+.||++||++.+++++
T Consensus       260 ~~---------------~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        260 GR---------------YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             CC---------------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            00               001123456779999999999999999999999875

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-37  Score=338.81  Aligned_cols=253  Identities=23%  Similarity=0.303  Sum_probs=198.6

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEE
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVL  602 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  602 (824)
                      ++|++.+.||+|+||+||+|+.. +++.||||++....   ....+.+.+|+++++.++||||+++++++.+....|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            46888999999999999999764 68999999986532   233456788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 040845          603 EYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ  682 (824)
Q Consensus       603 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  682 (824)
                      ||+++|+|.+++...+ .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.+.....
T Consensus        81 E~~~gg~L~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~  156 (377)
T cd05629          81 EFLPGGDLMTMLIKYD-TFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD  156 (377)
T ss_pred             eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence            9999999999997654 6888999999999999999999   99999999999999999999999999999964321100


Q ss_pred             c---------------------------------------------cccccccccccccCccCcCCCCCCccchHHHHHH
Q 040845          683 S---------------------------------------------MTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGI  717 (824)
Q Consensus       683 ~---------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~  717 (824)
                      .                                             .......||+.|+|||++.+..++.++||||+||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv  236 (377)
T cd05629         157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA  236 (377)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence            0                                             0001246899999999998889999999999999


Q ss_pred             HHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCC---CC
Q 040845          718 MLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQR---IN  794 (824)
Q Consensus       718 ~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R---pt  794 (824)
                      ++|||++|..||......+ ........  .. .             ...+....++..+.+++.+|+. +|.+|   ++
T Consensus       237 il~elltG~~Pf~~~~~~~-~~~~i~~~--~~-~-------------~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~  298 (377)
T cd05629         237 IMFECLIGWPPFCSENSHE-TYRKIINW--RE-T-------------LYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGG  298 (377)
T ss_pred             hhhhhhcCCCCCCCCCHHH-HHHHHHcc--CC-c-------------cCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCC
Confidence            9999999999996532111 11111100  00 0             0000011235568899999997 67665   59


Q ss_pred             HHHHHHH
Q 040845          795 AKEIVAK  801 (824)
Q Consensus       795 ~~evl~~  801 (824)
                      +.|++++
T Consensus       299 ~~~~l~h  305 (377)
T cd05629         299 AHEIKSH  305 (377)
T ss_pred             HHHHhcC
Confidence            9999887

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=4.1e-37  Score=331.55  Aligned_cols=252  Identities=23%  Similarity=0.286  Sum_probs=199.5

Q ss_pred             cCCCCceeeeccceEEEEEEE----CCCcEEEEEEeeccc----cchhhhHHHHHHHHhcC-CCCcceeEEeeeecCCee
Q 040845          528 KFSENNLIGRGGFGSVYKARI----RDGMEVAVKVFNLQC----GRAFKSFDVECAMMKSI-RHRNLVKVISSCSNEEFK  598 (824)
Q Consensus       528 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  598 (824)
                      +|++.+.||+|+||.||+|+.    .+++.||+|++....    ....+.+..|+.+++.+ +|++|+++++++..++..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            478889999999999999975    257899999986432    22345677899999999 589999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccC
Q 040845          599 ALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT  678 (824)
Q Consensus       599 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~  678 (824)
                      ++||||+++|+|.+++.... .+++.++..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++..+.
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~  156 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRD-NFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence            99999999999999997654 6889999999999999999999   9999999999999999999999999999998654


Q ss_pred             CCCCccccccccccccccCccCcCCC-CCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccc
Q 040845          679 GEDQSMTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDA  757 (824)
Q Consensus       679 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  757 (824)
                      ..... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||........ ...+.......      + 
T Consensus       157 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~~~~~~~~~------~-  227 (332)
T cd05614         157 SEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT-QSEVSRRILKC------D-  227 (332)
T ss_pred             ccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC-HHHHHHHHhcC------C-
Confidence            32221 12234689999999998765 478999999999999999999999964322111 11111110000      0 


Q ss_pred             cccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 040845          758 NLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRI-----NAKEIVAK  801 (824)
Q Consensus       758 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~evl~~  801 (824)
                               ...+...+..+.+++.+||+.||++||     +++|++++
T Consensus       228 ---------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         228 ---------PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             ---------CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence                     001123456688999999999999999     77888775

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=4e-37  Score=330.16  Aligned_cols=247  Identities=21%  Similarity=0.264  Sum_probs=197.4

Q ss_pred             cCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCC-cceeEEeeeecCCeeEEEE
Q 040845          528 KFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHR-NLVKVISSCSNEEFKALVL  602 (824)
Q Consensus       528 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~  602 (824)
                      +|++.+.||+|+||.||+|+.+ +++.||||++....   ....+.+..|+.++..++|+ +|+++++++.+.+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4788899999999999999865 47899999987542   23456677899999999764 6888999999999999999


Q ss_pred             eccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 040845          603 EYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ  682 (824)
Q Consensus       603 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  682 (824)
                      ||+++|+|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++........
T Consensus        81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~  156 (324)
T cd05587          81 EYVNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK  156 (324)
T ss_pred             cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC
Confidence            9999999999997655 6889999999999999999999   99999999999999999999999999999875322111


Q ss_pred             ccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCc
Q 040845          683 SMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ  762 (824)
Q Consensus       683 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  762 (824)
                        ......||+.|+|||++.+..++.++||||+||++|||+||+.||......+  ....+.   ...            
T Consensus       157 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~--~~~~i~---~~~------------  217 (324)
T cd05587         157 --TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE--LFQSIM---EHN------------  217 (324)
T ss_pred             --ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH--HHHHHH---cCC------------
Confidence              2233468999999999999899999999999999999999999997532111  111110   000            


Q ss_pred             hhhhhhhHHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 040845          763 EDIHFVAKEQCVSFVFNLALECTVESPEQRINA-----KEIVAK  801 (824)
Q Consensus       763 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~-----~evl~~  801 (824)
                          ...+...+..+.+++.+||..||.+|+++     +++.++
T Consensus       218 ----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  257 (324)
T cd05587         218 ----VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH  257 (324)
T ss_pred             ----CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence                00111235568899999999999999976     566654

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=5.8e-37  Score=326.62  Aligned_cols=260  Identities=27%  Similarity=0.420  Sum_probs=206.6

Q ss_pred             hccCCCCceeeeccceEEEEEEEC--------CCcEEEEEEeeccc-cchhhhHHHHHHHHhcC-CCCcceeEEeeeecC
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR--------DGMEVAVKVFNLQC-GRAFKSFDVECAMMKSI-RHRNLVKVISSCSNE  595 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  595 (824)
                      .++|.+.+.||+|+||.||+|++.        ++..||+|.++... ......+..|+++++.+ +|+||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            357899999999999999999753        23579999987542 23445678899999999 799999999999999


Q ss_pred             CeeEEEEeccCCCCHHHHhhhCC---------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee
Q 040845          596 EFKALVLEYMPHGSLEKYLHSSN---------------YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL  660 (824)
Q Consensus       596 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill  660 (824)
                      +..++||||+++|+|.+++....               ..+++.++..++.|++.|++|||   +.+++||||||+||++
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEE
Confidence            99999999999999999997542               24788999999999999999999   9999999999999999


Q ss_pred             CCCCcEEEeecccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchh
Q 040845          661 DDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTL  739 (824)
Q Consensus       661 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~  739 (824)
                      +.++.+||+|||.+................++..|+|||.+.+..++.++||||+||++|||++ |..||.....     
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~-----  248 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-----  248 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH-----
Confidence            9999999999999876543222111222234568999999988889999999999999999998 7888754211     


Q ss_pred             hhhhhhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 040845          740 KHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDS  808 (824)
Q Consensus       740 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~  808 (824)
                      .........         .      .....+..++.++.+++.+||..+|++|||+.|+++.|+++...
T Consensus       249 ~~~~~~~~~---------~------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~  302 (307)
T cd05098         249 EELFKLLKE---------G------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL  302 (307)
T ss_pred             HHHHHHHHc---------C------CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence            111111000         0      00111224566789999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=3e-37  Score=330.09  Aligned_cols=242  Identities=24%  Similarity=0.309  Sum_probs=194.2

Q ss_pred             ceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcC-CCCcceeEEeeeecCCeeEEEEeccCC
Q 040845          533 NLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSI-RHRNLVKVISSCSNEEFKALVLEYMPH  607 (824)
Q Consensus       533 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  607 (824)
                      +.||+|+||.||+|+.+ +++.||||++....   ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999865 58899999987542   23445667788888876 699999999999999999999999999


Q ss_pred             CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccccc
Q 040845          608 GSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQT  687 (824)
Q Consensus       608 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  687 (824)
                      |+|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++.......  ....
T Consensus        81 g~L~~~i~~~~-~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~~~  154 (320)
T cd05590          81 GDLMFHIQKSR-RFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTTS  154 (320)
T ss_pred             chHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cccc
Confidence            99999987665 6899999999999999999999   9999999999999999999999999999987542221  1223


Q ss_pred             cccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhhhh
Q 040845          688 QTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHF  767 (824)
Q Consensus       688 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  767 (824)
                      ...||+.|+|||.+.+..++.++||||+||++|||++|+.||......     ..........                .
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-----~~~~~i~~~~----------------~  213 (320)
T cd05590         155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED-----DLFEAILNDE----------------V  213 (320)
T ss_pred             ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH-----HHHHHHhcCC----------------C
Confidence            346899999999999888999999999999999999999999753211     1111111000                0


Q ss_pred             hhHHHHHHHHHHHHHHccccCCCCCCCH------HHHHHH
Q 040845          768 VAKEQCVSFVFNLALECTVESPEQRINA------KEIVAK  801 (824)
Q Consensus       768 ~~~~~~~~~l~~l~~~cl~~dP~~Rpt~------~evl~~  801 (824)
                      ..+..++..+.+++.+|++.||++||++      ++++++
T Consensus       214 ~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h  253 (320)
T cd05590         214 VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH  253 (320)
T ss_pred             CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence            0011235568899999999999999998      555554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=4.1e-37  Score=322.81  Aligned_cols=255  Identities=28%  Similarity=0.446  Sum_probs=202.9

Q ss_pred             hccCCCCceeeeccceEEEEEEECC------CcEEEEEEeecccc-chhhhHHHHHHHHhcCCCCcceeEEeeeecCCee
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIRD------GMEVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFK  598 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  598 (824)
                      .++|.+.+.||+|+||.||+|.+.+      +..||+|.+..... .....+..|+.+++.++|+||+++++++.+.+..
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            4678999999999999999998753      56799998764432 2345688899999999999999999999998899


Q ss_pred             EEEEeccCCCCHHHHhhhCC------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC---cEEEe
Q 040845          599 ALVLEYMPHGSLEKYLHSSN------YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM---VAHLS  669 (824)
Q Consensus       599 ~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~---~~kl~  669 (824)
                      ++||||+++++|.+++...+      ..+++.++..++.||+.|++|||   +.+++||||||+||+++.++   .+|++
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEec
Confidence            99999999999999997654      25889999999999999999999   99999999999999998654   69999


Q ss_pred             ecccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCC
Q 040845          670 DFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLP  748 (824)
Q Consensus       670 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  748 (824)
                      |||+++................+..|+|||++.+..++.++|||||||++|||++ |..||......+  ....+.... 
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~--~~~~~~~~~-  238 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE--VMEFVTGGG-  238 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHHcCC-
Confidence            9999987633222222222234568999999988899999999999999999997 888886532211  111111000 


Q ss_pred             CcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 040845          749 ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLL  803 (824)
Q Consensus       749 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~  803 (824)
                                       ....+..++..+.+++.+||+.+|++||++.+++++|.
T Consensus       239 -----------------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         239 -----------------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             -----------------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence                             00112234667899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=4.4e-37  Score=328.19  Aligned_cols=241  Identities=22%  Similarity=0.297  Sum_probs=191.2

Q ss_pred             ceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcC-CCCcceeEEeeeecCCeeEEEEeccCC
Q 040845          533 NLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSI-RHRNLVKVISSCSNEEFKALVLEYMPH  607 (824)
Q Consensus       533 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  607 (824)
                      +.||+|+||.||+|+.. +++.||+|+++...   ....+.+..|..++... +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999865 47899999987542   22334455666676654 899999999999999999999999999


Q ss_pred             CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccccc
Q 040845          608 GSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQT  687 (824)
Q Consensus       608 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  687 (824)
                      |+|.+++.... .+++.++..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||++.......  ....
T Consensus        81 g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~  154 (316)
T cd05592          81 GDLMFHIQSSG-RFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKAS  154 (316)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cccc
Confidence            99999997655 6889999999999999999999   9999999999999999999999999999997543222  2223


Q ss_pred             cccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhhhh
Q 040845          688 QTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHF  767 (824)
Q Consensus       688 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  767 (824)
                      ...||+.|+|||.+.+..++.++||||+||++|||++|+.||......     .........                ..
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~-----~~~~~i~~~----------------~~  213 (316)
T cd05592         155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED-----ELFDSILND----------------RP  213 (316)
T ss_pred             cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHcC----------------CC
Confidence            456899999999999888999999999999999999999999753211     111110000                00


Q ss_pred             hhHHHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 040845          768 VAKEQCVSFVFNLALECTVESPEQRINAK-EIVA  800 (824)
Q Consensus       768 ~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~-evl~  800 (824)
                      ..+..++..+.+++.+||..||++||++. ++.+
T Consensus       214 ~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05592         214 HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ  247 (316)
T ss_pred             CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence            01122455688999999999999999875 5544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.2e-36  Score=324.49  Aligned_cols=269  Identities=20%  Similarity=0.289  Sum_probs=202.3

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc-chhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEe
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLE  603 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  603 (824)
                      .++|.+.+.||+|+||.||+|+.+ +++.||+|.++.... .....+.+|++++++++||||+++++++..++..++|||
T Consensus         5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   84 (309)
T cd07872           5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE   84 (309)
T ss_pred             CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence            367889999999999999999865 578899999875432 233467789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 040845          604 YMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS  683 (824)
Q Consensus       604 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  683 (824)
                      |+++ +|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++........ 
T Consensus        85 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-  159 (309)
T cd07872          85 YLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-  159 (309)
T ss_pred             CCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc-
Confidence            9975 898888776666889999999999999999999   99999999999999999999999999999875432221 


Q ss_pred             cccccccccccccCccCcCC-CCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCC-Cc-ch-------h
Q 040845          684 MTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLP-IS-TM-------E  753 (824)
Q Consensus       684 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~-~~-------~  753 (824)
                       ......++..|+|||.+.+ ..++.++||||+||++|||+||+.||......+ ........... .. ..       +
T Consensus       160 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07872         160 -TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED-ELHLIFRLLGTPTEETWPGISSNDE  237 (309)
T ss_pred             -ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHHHHhhhcchhh
Confidence             1223457889999998765 457999999999999999999999997532211 11111110000 00 00       0


Q ss_pred             hccccccCc-hhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          754 VVDANLLSQ-EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       754 ~~~~~~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      ..+...... ..........++.++.+++.+|++.||++|||+.|++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  286 (309)
T cd07872         238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH  286 (309)
T ss_pred             hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence            000000000 000001112356678999999999999999999999874

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=5e-37  Score=324.01  Aligned_cols=262  Identities=26%  Similarity=0.420  Sum_probs=205.6

Q ss_pred             hhccCCCCceeeeccceEEEEEEECC------CcEEEEEEeecccc-chhhhHHHHHHHHhcCCCCcceeEEeeeecCCe
Q 040845          525 ATDKFSENNLIGRGGFGSVYKARIRD------GMEVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEF  597 (824)
Q Consensus       525 ~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  597 (824)
                      ..++|++.+.||+|+||.||+|..++      +..||+|.+..... .....+.+|+.+++.++|+||+++++++.+...
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            46789999999999999999997542      45899998764322 233457789999999999999999999999999


Q ss_pred             eEEEEeccCCCCHHHHhhhCC---------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEE
Q 040845          598 KALVLEYMPHGSLEKYLHSSN---------YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHL  668 (824)
Q Consensus       598 ~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl  668 (824)
                      .++||||+++|+|.+++....         ...++..+..++.|++.|++|||   +++|+||||||+||++++++.+++
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEEE
Confidence            999999999999999997532         23466788899999999999999   999999999999999999999999


Q ss_pred             eecccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhC
Q 040845          669 SDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCL  747 (824)
Q Consensus       669 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~  747 (824)
                      +|||+++...............++..|+|||.+.++.++.++|||||||++|||++ |..||......     ++.....
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~-----~~~~~~~  235 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE-----QVLKFVM  235 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHH
Confidence            99999986543332222222345678999999988889999999999999999999 77887652211     1111100


Q ss_pred             CCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhh
Q 040845          748 PISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSL  809 (824)
Q Consensus       748 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~  809 (824)
                              +...       ...+..++..+.+++.+||+.||++|||+.|+++.+++....+
T Consensus       236 --------~~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~  282 (288)
T cd05061         236 --------DGGY-------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPS  282 (288)
T ss_pred             --------cCCC-------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCC
Confidence                    0000       0011234567999999999999999999999999998865433

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1e-36  Score=329.36  Aligned_cols=260  Identities=25%  Similarity=0.417  Sum_probs=202.9

Q ss_pred             hccCCCCceeeeccceEEEEEEE------CCCcEEEEEEeecccc-chhhhHHHHHHHHhcC-CCCcceeEEeeeecC-C
Q 040845          526 TDKFSENNLIGRGGFGSVYKARI------RDGMEVAVKVFNLQCG-RAFKSFDVECAMMKSI-RHRNLVKVISSCSNE-E  596 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~  596 (824)
                      .++|++.+.||+|+||.||+|.+      .+++.||||+++.... .....+.+|+.++.++ +|+||+++++++... .
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            35799999999999999999974      2468899999875432 2345678899999999 689999999988654 4


Q ss_pred             eeEEEEeccCCCCHHHHhhhCC----------------------------------------------------------
Q 040845          597 FKALVLEYMPHGSLEKYLHSSN----------------------------------------------------------  618 (824)
Q Consensus       597 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  618 (824)
                      ..++||||+++|+|.+++....                                                          
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            6789999999999999986421                                                          


Q ss_pred             --------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcccccccc
Q 040845          619 --------YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTL  690 (824)
Q Consensus       619 --------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  690 (824)
                              ..+++.++..++.|+++|++|||   +.+|+||||||+||++++++.+||+|||++................
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                    13577888999999999999999   9999999999999999999999999999998654332222222334


Q ss_pred             ccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhhhhhh
Q 040845          691 ATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVA  769 (824)
Q Consensus       691 ~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  769 (824)
                      ++..|+|||.+.+..++.++||||||+++|||++ |..||....... .....+....                  ....
T Consensus       243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~~~~~~~~------------------~~~~  303 (343)
T cd05103         243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EFCRRLKEGT------------------RMRA  303 (343)
T ss_pred             CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-HHHHHHhccC------------------CCCC
Confidence            5678999999988889999999999999999997 888886532211 1111000000                  0001


Q ss_pred             HHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 040845          770 KEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRD  807 (824)
Q Consensus       770 ~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~  807 (824)
                      +..+++.+.+++.+||+.||++|||+.|++++|+.+.+
T Consensus       304 ~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         304 PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            11234568999999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=7.6e-37  Score=323.08  Aligned_cols=257  Identities=25%  Similarity=0.420  Sum_probs=205.5

Q ss_pred             cCCCCceeeeccceEEEEEEEC------CCcEEEEEEeecccc-chhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEE
Q 040845          528 KFSENNLIGRGGFGSVYKARIR------DGMEVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKAL  600 (824)
Q Consensus       528 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  600 (824)
                      +|++.+.||+|+||.||+|...      ....||+|.+..... .....+..|+.+++.++||||+++++.+...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4778899999999999999753      235789998865432 334678889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhhCC-----------------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCC
Q 040845          601 VLEYMPHGSLEKYLHSSN-----------------------YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSN  657 (824)
Q Consensus       601 v~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~N  657 (824)
                      |+||+.+++|.+++....                       ..+++.+++.++.|++.|++|||   +.+++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhhe
Confidence            999999999999986421                       24788999999999999999999   9999999999999


Q ss_pred             eeeCCCCcEEEeecccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCc
Q 040845          658 VLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGE  736 (824)
Q Consensus       658 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~  736 (824)
                      |++++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||...... 
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-  236 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE-  236 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence            9999999999999999986543332222233345778999999888889999999999999999999 98888653211 


Q ss_pred             chhhhhhhhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 040845          737 MTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRD  807 (824)
Q Consensus       737 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~  807 (824)
                       ....+.....                  ....+..++.++.+++.+||+.+|++||+++|+++.|+++..
T Consensus       237 -~~~~~~~~~~------------------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         237 -RLFNLLKTGY------------------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             -HHHHHHhCCC------------------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence             1111111100                  011122345678999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=3.1e-37  Score=330.50  Aligned_cols=242  Identities=22%  Similarity=0.291  Sum_probs=195.3

Q ss_pred             ceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcC-CCCcceeEEeeeecCCeeEEEEeccCC
Q 040845          533 NLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSI-RHRNLVKVISSCSNEEFKALVLEYMPH  607 (824)
Q Consensus       533 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  607 (824)
                      +.||+|+||.||+|+.+ +++.||||+++...   ....+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999875 47899999987542   23345567788888866 799999999999999999999999999


Q ss_pred             CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccccc
Q 040845          608 GSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQT  687 (824)
Q Consensus       608 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  687 (824)
                      |+|.+++...+ .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++........  ...
T Consensus        81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~  154 (321)
T cd05591          81 GDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TTT  154 (321)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc--ccc
Confidence            99999987655 6889999999999999999999   99999999999999999999999999999875432221  223


Q ss_pred             cccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhhhh
Q 040845          688 QTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHF  767 (824)
Q Consensus       688 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  767 (824)
                      ...||+.|+|||++.+..++.++||||+||++|||++|+.||......+ .......    ..                .
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~-~~~~i~~----~~----------------~  213 (321)
T cd05591         155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD-LFESILH----DD----------------V  213 (321)
T ss_pred             ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH-HHHHHHc----CC----------------C
Confidence            3568999999999998899999999999999999999999997532111 1111100    00                0


Q ss_pred             hhHHHHHHHHHHHHHHccccCCCCCC-------CHHHHHHH
Q 040845          768 VAKEQCVSFVFNLALECTVESPEQRI-------NAKEIVAK  801 (824)
Q Consensus       768 ~~~~~~~~~l~~l~~~cl~~dP~~Rp-------t~~evl~~  801 (824)
                      ..+..++.++.+++.+||+.||++||       ++++++++
T Consensus       214 ~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         214 LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            01112355688999999999999999       88888866

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.2e-36  Score=322.93  Aligned_cols=258  Identities=24%  Similarity=0.383  Sum_probs=206.0

Q ss_pred             hccCCCCceeeeccceEEEEEEEC------CCcEEEEEEeeccc-cchhhhHHHHHHHHhcC-CCCcceeEEeeeecCCe
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR------DGMEVAVKVFNLQC-GRAFKSFDVECAMMKSI-RHRNLVKVISSCSNEEF  597 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  597 (824)
                      .++|.+.+.||+|+||.||+|.+.      ++..||||+++... ....+.+.+|+++++++ +|+||+++++++...+.
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  113 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP  113 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence            357889999999999999999742      24579999886542 23346788999999999 79999999999999999


Q ss_pred             eEEEEeccCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccc
Q 040845          598 KALVLEYMPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  676 (824)
Q Consensus       598 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~  676 (824)
                      .++||||+.+|+|.+++.... ..+++.++..++.|++.|++|||   +.+|+|+||||+||+++.++.++++|||++..
T Consensus       114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~  190 (302)
T cd05055         114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLARD  190 (302)
T ss_pred             eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCccccc
Confidence            999999999999999997644 34899999999999999999999   99999999999999999999999999999986


Q ss_pred             cCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhc
Q 040845          677 LTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVV  755 (824)
Q Consensus       677 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  755 (824)
                      ..............++..|+|||.+.+..++.++||||+||++|||++ |..||......+ ..........+       
T Consensus       191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~-~~~~~~~~~~~-------  262 (302)
T cd05055         191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS-KFYKLIKEGYR-------  262 (302)
T ss_pred             ccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH-HHHHHHHcCCc-------
Confidence            643322222222345778999999998899999999999999999998 899986533221 11111110000       


Q ss_pred             cccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 040845          756 DANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKI  805 (824)
Q Consensus       756 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~  805 (824)
                                 ...+...+..+.+++.+||..+|++|||+.|+++.|+++
T Consensus       263 -----------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         263 -----------MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             -----------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence                       001112345689999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-36  Score=318.21  Aligned_cols=254  Identities=26%  Similarity=0.455  Sum_probs=201.8

Q ss_pred             CCCCceeeeccceEEEEEEECC----CcEEEEEEeecccc--chhhhHHHHHHHHhcCCCCcceeEEeeeecCCe-----
Q 040845          529 FSENNLIGRGGFGSVYKARIRD----GMEVAVKVFNLQCG--RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEF-----  597 (824)
Q Consensus       529 ~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  597 (824)
                      |.+.+.||+|+||.||+|....    +..||+|.++....  ...+.+..|++.++.++|+||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5678899999999999998642    36799999875422  234578889999999999999999998865543     


Q ss_pred             -eEEEEeccCCCCHHHHhhhCC-----CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeec
Q 040845          598 -KALVLEYMPHGSLEKYLHSSN-----YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDF  671 (824)
Q Consensus       598 -~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df  671 (824)
                       .++|+||+++|+|.+++....     ..+++..+..++.|++.|++|||   +.+++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCc
Confidence             789999999999999985432     46889999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCc
Q 040845          672 GIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPIS  750 (824)
Q Consensus       672 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  750 (824)
                      |+++................+..|+|||.+.+..++.++|||||||++|||++ |..||......  ....+.....   
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~--~~~~~~~~~~---  232 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH--EIYDYLRHGN---  232 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCC---
Confidence            99987654433222223345678999999988889999999999999999999 88888653211  1111111000   


Q ss_pred             chhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 040845          751 TMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKI  805 (824)
Q Consensus       751 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~  805 (824)
                                     ....+..++..+.+++.+||+.||.+|||+.|++++|+++
T Consensus       233 ---------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         233 ---------------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             ---------------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                           0011234567799999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1e-36  Score=325.70  Aligned_cols=267  Identities=26%  Similarity=0.420  Sum_probs=211.0

Q ss_pred             hccCCCCceeeeccceEEEEEEEC--------CCcEEEEEEeeccc-cchhhhHHHHHHHHhcC-CCCcceeEEeeeecC
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR--------DGMEVAVKVFNLQC-GRAFKSFDVECAMMKSI-RHRNLVKVISSCSNE  595 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  595 (824)
                      .++|.+.+.||+|+||.||+|+..        .+..||+|.++... ......+..|+.+++++ +||||+++++++...
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            357888999999999999999752        24579999886442 23456688899999999 699999999999998


Q ss_pred             CeeEEEEeccCCCCHHHHhhhCC---------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee
Q 040845          596 EFKALVLEYMPHGSLEKYLHSSN---------------YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL  660 (824)
Q Consensus       596 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill  660 (824)
                      ...++||||+++|+|.+++....               ..+++.++..++.|++.|++|||   +.+++||||||+||++
T Consensus        91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill  167 (314)
T cd05099          91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLV  167 (314)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEEE
Confidence            99999999999999999996532               34788999999999999999999   9999999999999999


Q ss_pred             CCCCcEEEeecccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchh
Q 040845          661 DDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTL  739 (824)
Q Consensus       661 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~  739 (824)
                      +.++.+||+|||.++...............++..|+|||.+.++.++.++||||||+++|||++ |..||......  ..
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~--~~  245 (314)
T cd05099         168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE--EL  245 (314)
T ss_pred             cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH--HH
Confidence            9999999999999986643222221222234567999999988889999999999999999999 88887652211  11


Q ss_pred             hhhhhhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhccccCC
Q 040845          740 KHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLRNVGG  815 (824)
Q Consensus       740 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~~~~~  815 (824)
                      .......                  .....+..++.++.+++.+||+.+|++|||+.|+++.|+++......++..
T Consensus       246 ~~~~~~~------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~~~~~  303 (314)
T cd05099         246 FKLLREG------------------HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSEEYLD  303 (314)
T ss_pred             HHHHHcC------------------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhcCCcee
Confidence            1111100                  000112345667889999999999999999999999999998776666553

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=4.5e-37  Score=329.88  Aligned_cols=248  Identities=22%  Similarity=0.294  Sum_probs=195.5

Q ss_pred             ceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcC-CCCcceeEEeeeecCCeeEEEEeccCC
Q 040845          533 NLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSI-RHRNLVKVISSCSNEEFKALVLEYMPH  607 (824)
Q Consensus       533 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  607 (824)
                      +.||+|+||.||+|+.+ +++.||+|+++...   ......+..|+.++.++ +||||+++++++......++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            47999999999999865 57899999987542   23345577888888777 799999999999999999999999999


Q ss_pred             CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccccc
Q 040845          608 GSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQT  687 (824)
Q Consensus       608 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  687 (824)
                      |+|.+++.... .+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~~~  154 (329)
T cd05618          81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTS  154 (329)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Cccc
Confidence            99999887654 6899999999999999999999   9999999999999999999999999999987532211  1223


Q ss_pred             cccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCc---chhhhhhhhhCCCcchhhccccccCchh
Q 040845          688 QTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGE---MTLKHWVNDCLPISTMEVVDANLLSQED  764 (824)
Q Consensus       688 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~  764 (824)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||.......   .....+......       ..       
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~-------~~-------  220 (329)
T cd05618         155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL-------EK-------  220 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHh-------cC-------
Confidence            3568999999999999999999999999999999999999996422111   111111111000       00       


Q ss_pred             hhhhhHHHHHHHHHHHHHHccccCCCCCCC------HHHHHHH
Q 040845          765 IHFVAKEQCVSFVFNLALECTVESPEQRIN------AKEIVAK  801 (824)
Q Consensus       765 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt------~~evl~~  801 (824)
                       ....+..++..+.+++.+||+.||++||+      +.|++++
T Consensus       221 -~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05618         221 -QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  262 (329)
T ss_pred             -CCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence             00112234567889999999999999998      4677655

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.1e-36  Score=322.94  Aligned_cols=260  Identities=25%  Similarity=0.437  Sum_probs=205.8

Q ss_pred             ccCCCCceeeeccceEEEEEEECC-C--cEEEEEEeeccc-cchhhhHHHHHHHHhcC-CCCcceeEEeeeecCCeeEEE
Q 040845          527 DKFSENNLIGRGGFGSVYKARIRD-G--MEVAVKVFNLQC-GRAFKSFDVECAMMKSI-RHRNLVKVISSCSNEEFKALV  601 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~~-~--~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  601 (824)
                      ++|++.+.||+|+||.||+|..++ +  ..+|+|.++... ....+.+..|++++.++ +||||+++++++.+....++|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            578899999999999999998654 3  347888876432 23456788899999999 799999999999999999999


Q ss_pred             EeccCCCCHHHHhhhCC---------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcE
Q 040845          602 LEYMPHGSLEKYLHSSN---------------YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVA  666 (824)
Q Consensus       602 ~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~  666 (824)
                      +||+++++|.+++....               ..+++..+..++.|++.|++|||   +.+|+||||||+||++++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeE
Confidence            99999999999997532               24788899999999999999999   9999999999999999999999


Q ss_pred             EEeecccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhh
Q 040845          667 HLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVND  745 (824)
Q Consensus       667 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~  745 (824)
                      ||+|||++.....   .........+..|+|||......++.++|||||||++|||++ |..||......+     ....
T Consensus       159 kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~-----~~~~  230 (297)
T cd05089         159 KIADFGLSRGEEV---YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE-----LYEK  230 (297)
T ss_pred             EECCcCCCccccc---eeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-----HHHH
Confidence            9999999864321   111111223567999999988889999999999999999998 999986532111     1111


Q ss_pred             hCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhccc
Q 040845          746 CLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLRN  812 (824)
Q Consensus       746 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~~  812 (824)
                      ...         .      .....+..++..+.+++.+||..+|.+|||+.++++.|+++.+.....
T Consensus       231 ~~~---------~------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~~  282 (297)
T cd05089         231 LPQ---------G------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAY  282 (297)
T ss_pred             Hhc---------C------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhccc
Confidence            000         0      000112235677899999999999999999999999999998766443

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-37  Score=327.79  Aligned_cols=244  Identities=29%  Similarity=0.444  Sum_probs=204.5

Q ss_pred             eeeeccceEEEEEEECC-CcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEeccCCCCHHH
Q 040845          534 LIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEK  612 (824)
Q Consensus       534 ~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  612 (824)
                      +||+|.||+||.|++.+ ...+|||-+.....+..+-+.+|+.+-+.++|.|||+++|.+.+.++.-+.||-++||+|.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            79999999999998664 66789999877767777888999999999999999999999999999999999999999999


Q ss_pred             HhhhCCCCC--CHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC-CCCcEEEeecccccccCCCCCccccccc
Q 040845          613 YLHSSNYSL--DIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTGEDQSMTQTQT  689 (824)
Q Consensus       613 ~l~~~~~~~--~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  689 (824)
                      .++..=.++  .+.++-.+.+||++||.|||   +..|||||||.+|||+. -.|.+||+|||-++.+.+-.  ......
T Consensus       662 LLrskWGPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin--P~TETF  736 (1226)
T KOG4279|consen  662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN--PCTETF  736 (1226)
T ss_pred             HHHhccCCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhccCC--cccccc
Confidence            997654445  67788889999999999999   99999999999999995 68999999999999875332  223345


Q ss_pred             cccccccCccCcCCC--CCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhhhh
Q 040845          690 LATIGYMAPEYGREG--QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHF  767 (824)
Q Consensus       690 ~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  767 (824)
                      .||..|||||++..+  .|+.++|||||||.+.||.||++||.+...+.-.               ++..   +....+.
T Consensus       737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA---------------MFkV---GmyKvHP  798 (1226)
T KOG4279|consen  737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA---------------MFKV---GMYKVHP  798 (1226)
T ss_pred             ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh---------------hhhh---cceecCC
Confidence            699999999999765  4899999999999999999999999874332211               1111   1111234


Q ss_pred             hhHHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040845          768 VAKEQCVSFVFNLALECTVESPEQRINAKEIVA  800 (824)
Q Consensus       768 ~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~  800 (824)
                      +.|+..+.++..++.+|+.+||.+||+|+++++
T Consensus       799 ~iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  799 PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             CCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            456778889999999999999999999999875

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=5.4e-37  Score=334.25  Aligned_cols=253  Identities=22%  Similarity=0.288  Sum_probs=201.3

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALV  601 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  601 (824)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|+.+++.++||||+++++++.++...++|
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv  121 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV  121 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence            467999999999999999999865 58899999986432   22334577899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 040845          602 LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED  681 (824)
Q Consensus       602 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  681 (824)
                      |||+++|+|.+++...  .++...+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++.......
T Consensus       122 ~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~  196 (370)
T cd05596         122 MEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG  196 (370)
T ss_pred             EcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC
Confidence            9999999999998764  4778888899999999999999   9999999999999999999999999999998654322


Q ss_pred             CccccccccccccccCccCcCCC----CCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccc
Q 040845          682 QSMTQTQTLATIGYMAPEYGREG----QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDA  757 (824)
Q Consensus       682 ~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  757 (824)
                      . .......||+.|+|||++.+.    .++.++||||+||++|||++|+.||...... ..........           
T Consensus       197 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-~~~~~i~~~~-----------  263 (370)
T cd05596         197 M-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-GTYSKIMDHK-----------  263 (370)
T ss_pred             c-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH-HHHHHHHcCC-----------
Confidence            1 122345689999999987643    4789999999999999999999998752211 1111111000           


Q ss_pred             cccCchhhhhhhHHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 040845          758 NLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQ--RINAKEIVAK  801 (824)
Q Consensus       758 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rpt~~evl~~  801 (824)
                           .....+....++..+.+++.+|++.+|.+  |+++.|++++
T Consensus       264 -----~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         264 -----NSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             -----CcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence                 00001111134667899999999999998  9999999877

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=5.6e-37  Score=329.40  Aligned_cols=248  Identities=21%  Similarity=0.284  Sum_probs=196.5

Q ss_pred             ceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcC-CCCcceeEEeeeecCCeeEEEEeccCC
Q 040845          533 NLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSI-RHRNLVKVISSCSNEEFKALVLEYMPH  607 (824)
Q Consensus       533 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  607 (824)
                      ++||+|+||.||+|+.+ +++.||+|+++...   ....+.+..|..+++.+ +||||+++++++.+....++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999865 58899999997542   23345677899999988 799999999999999999999999999


Q ss_pred             CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccccc
Q 040845          608 GSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQT  687 (824)
Q Consensus       608 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  687 (824)
                      |+|.+++...+ .+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 g~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~~~  154 (329)
T cd05588          81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DTTS  154 (329)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccCC--Cccc
Confidence            99999987654 7899999999999999999999   9999999999999999999999999999987432111  1223


Q ss_pred             cccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCc---chhhhhhhhhCCCcchhhccccccCchh
Q 040845          688 QTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGE---MTLKHWVNDCLPISTMEVVDANLLSQED  764 (824)
Q Consensus       688 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~  764 (824)
                      ...||+.|+|||++.+..++.++||||+||++|||++|+.||+.....+   .....+......       ..       
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~-------~~-------  220 (329)
T cd05588         155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVIL-------EK-------  220 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHH-------cC-------
Confidence            3568999999999999899999999999999999999999996422111   111111111000       00       


Q ss_pred             hhhhhHHHHHHHHHHHHHHccccCCCCCCC------HHHHHHH
Q 040845          765 IHFVAKEQCVSFVFNLALECTVESPEQRIN------AKEIVAK  801 (824)
Q Consensus       765 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt------~~evl~~  801 (824)
                       ....+..++..+.+++.+|++.||++||+      ++|++++
T Consensus       221 -~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05588         221 -QIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH  262 (329)
T ss_pred             -CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence             00112234567899999999999999997      6777755

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=5.2e-37  Score=327.67  Aligned_cols=241  Identities=22%  Similarity=0.293  Sum_probs=191.9

Q ss_pred             ceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcC-CCCcceeEEeeeecCCeeEEEEeccCC
Q 040845          533 NLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSI-RHRNLVKVISSCSNEEFKALVLEYMPH  607 (824)
Q Consensus       533 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  607 (824)
                      +.||+|+||.||+|+.+ +|+.||+|+++...   ....+....|..++... +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999876 58899999987542   23345566777777754 899999999999999999999999999


Q ss_pred             CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccccc
Q 040845          608 GSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQT  687 (824)
Q Consensus       608 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  687 (824)
                      |+|.+++.... .+++.++..++.|++.|++|||   +.+|+||||||+||+++.++.++|+|||++.......  ....
T Consensus        81 g~L~~~i~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~  154 (316)
T cd05620          81 GDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NRAS  154 (316)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Ccee
Confidence            99999987654 6889999999999999999999   9999999999999999999999999999987432111  1223


Q ss_pred             cccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhhhh
Q 040845          688 QTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHF  767 (824)
Q Consensus       688 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  767 (824)
                      ...||+.|+|||++.+..++.++||||+||++|||++|+.||......  .....+....         +          
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~--~~~~~~~~~~---------~----------  213 (316)
T cd05620         155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED--ELFESIRVDT---------P----------  213 (316)
T ss_pred             ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--HHHHHHHhCC---------C----------
Confidence            456899999999999989999999999999999999999999653211  1111110000         0          


Q ss_pred             hhHHHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 040845          768 VAKEQCVSFVFNLALECTVESPEQRINAK-EIVA  800 (824)
Q Consensus       768 ~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~-evl~  800 (824)
                      ..+..++.++.+++.+||..||++||++. ++.+
T Consensus       214 ~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~  247 (316)
T cd05620         214 HYPRWITKESKDILEKLFERDPTRRLGVVGNIRG  247 (316)
T ss_pred             CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence            00112355688999999999999999985 5553

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-36  Score=323.90  Aligned_cols=252  Identities=25%  Similarity=0.330  Sum_probs=211.8

Q ss_pred             hhccCCCCceeeeccceEEEEEEECC-CcEEEEEEeecccc---chhhhHHHHHHHHhcCC-CCcceeEEeeeecCCeeE
Q 040845          525 ATDKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCG---RAFKSFDVECAMMKSIR-HRNLVKVISSCSNEEFKA  599 (824)
Q Consensus       525 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~  599 (824)
                      ....|++.+.||+|.||.||+++.+. |+.+|+|++.+...   ...+.+.+|+++|+++. |||||.++++|++....+
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            34678889999999999999998765 99999999976543   24568999999999998 999999999999999999


Q ss_pred             EEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC----CCcEEEeeccccc
Q 040845          600 LVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD----NMVAHLSDFGIAK  675 (824)
Q Consensus       600 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~----~~~~kl~Dfg~a~  675 (824)
                      +|||+++||.|.+.+...  .+++..+..++.|++.+++|||   +.+|+|||+||+|+|+..    ++.+|++|||+|.
T Consensus       113 lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~  187 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK  187 (382)
T ss_pred             EEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence            999999999999999776  3899999999999999999999   999999999999999963    3579999999999


Q ss_pred             ccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhc
Q 040845          676 LLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVV  755 (824)
Q Consensus       676 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  755 (824)
                      ....   .......+||+.|+|||++....|+..+||||+||++|.|++|.+||.+....+... ......+        
T Consensus       188 ~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-~i~~~~~--------  255 (382)
T KOG0032|consen  188 FIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-AILRGDF--------  255 (382)
T ss_pred             EccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-HHHcCCC--------
Confidence            8754   334456789999999999999999999999999999999999999998743322211 1111111        


Q ss_pred             cccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          756 DANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       756 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                              ..........+..+.++++.|+..||.+|+|+.++++|
T Consensus       256 --------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  256 --------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             --------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence                    11112233557789999999999999999999999997

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.2e-36  Score=316.34  Aligned_cols=253  Identities=28%  Similarity=0.458  Sum_probs=204.0

Q ss_pred             hccCCCCceeeeccceEEEEEEECCCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEecc
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYM  605 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  605 (824)
                      .++|++.+.||+|+||.||+|..+++..||+|.+.... ...+++.+|+.++++++|++++++++++.+ ...+++|||+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~   82 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYM   82 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCC-CCHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEec
Confidence            35788999999999999999998888899999987543 234678899999999999999999998854 5678999999


Q ss_pred             CCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 040845          606 PHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM  684 (824)
Q Consensus       606 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  684 (824)
                      ++++|.+++.... ..+++.++..++.|++.|++|||   +.+++||||||+||++++++.++|+|||.+..+...... 
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~-  158 (260)
T cd05070          83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT-  158 (260)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc-
Confidence            9999999997643 45899999999999999999999   999999999999999999999999999999865432221 


Q ss_pred             ccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhccccccCch
Q 040845          685 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQE  763 (824)
Q Consensus       685 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  763 (824)
                      ......++..|+|||...+..++.++||||||+++|||++ |..||......  ..........                
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~~~~~----------------  220 (260)
T cd05070         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR--EVLEQVERGY----------------  220 (260)
T ss_pred             cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHHcCC----------------
Confidence            1122335678999999988889999999999999999999 88888653211  1111111000                


Q ss_pred             hhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 040845          764 DIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLK  804 (824)
Q Consensus       764 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~  804 (824)
                        ....+..++..+.+++.+||..+|++|||++++.+.|++
T Consensus       221 --~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         221 --RMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             --CCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence              001122345679999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=7.3e-37  Score=326.33  Aligned_cols=241  Identities=23%  Similarity=0.332  Sum_probs=191.9

Q ss_pred             ceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcC-CCCcceeEEeeeecCCeeEEEEeccCC
Q 040845          533 NLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSI-RHRNLVKVISSCSNEEFKALVLEYMPH  607 (824)
Q Consensus       533 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  607 (824)
                      +.||+|+||+||+|+.. +++.||||+++...   ....+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999875 47899999987542   23344566677787764 899999999999999999999999999


Q ss_pred             CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccccc
Q 040845          608 GSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQT  687 (824)
Q Consensus       608 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  687 (824)
                      |+|.+++.... .+++.++..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||++.......  ....
T Consensus        81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~  154 (316)
T cd05619          81 GDLMFHIQSCH-KFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AKTC  154 (316)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Ccee
Confidence            99999997654 6889999999999999999999   9999999999999999999999999999987532211  1223


Q ss_pred             cccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhhhh
Q 040845          688 QTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHF  767 (824)
Q Consensus       688 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  767 (824)
                      ...||..|+|||++.+..++.++||||+||++|||++|+.||......  .....+...         .+          
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~--~~~~~i~~~---------~~----------  213 (316)
T cd05619         155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE--ELFQSIRMD---------NP----------  213 (316)
T ss_pred             eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhC---------CC----------
Confidence            356899999999999888999999999999999999999999753211  111111100         00          


Q ss_pred             hhHHHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 040845          768 VAKEQCVSFVFNLALECTVESPEQRINAK-EIVA  800 (824)
Q Consensus       768 ~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~-evl~  800 (824)
                      ..+..++..+.+++.+||..||++||++. ++.+
T Consensus       214 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         214 CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence            00112345688999999999999999997 5544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.9e-36  Score=314.86  Aligned_cols=254  Identities=27%  Similarity=0.454  Sum_probs=203.9

Q ss_pred             hccCCCCceeeeccceEEEEEEECCCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEecc
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYM  605 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  605 (824)
                      .++|++.+.||+|+||.||+|++.++..||+|.++.. ....+.+.+|++++++++|+||+++++++.+ ...++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~-~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~   82 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   82 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccC-ccCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence            3568999999999999999999877778999998743 2334678899999999999999999998754 5578999999


Q ss_pred             CCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 040845          606 PHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM  684 (824)
Q Consensus       606 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  684 (824)
                      ++|+|.+++.... ..+++..+..++.|++.|++|+|   +.+++||||||+||++++++.++|+|||.+..+...... 
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~-  158 (262)
T cd05071          83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-  158 (262)
T ss_pred             CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeeccccccc-
Confidence            9999999997643 45789999999999999999999   999999999999999999999999999999766433221 


Q ss_pred             ccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhccccccCch
Q 040845          685 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQE  763 (824)
Q Consensus       685 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  763 (824)
                      ......++..|+|||...+..++.++||||||+++||++| |..||......+. ....             ...     
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~-~~~~-------------~~~-----  219 (262)
T cd05071         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-LDQV-------------ERG-----  219 (262)
T ss_pred             cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH-HHHH-------------hcC-----
Confidence            1223346778999999988889999999999999999999 7778765322111 0000             000     


Q ss_pred             hhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 040845          764 DIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKI  805 (824)
Q Consensus       764 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~  805 (824)
                       .....+..++..+.+++.+||+.+|++||+++++.+.|++.
T Consensus       220 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         220 -YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             -CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence             00011123566789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=6.1e-37  Score=322.77  Aligned_cols=255  Identities=25%  Similarity=0.421  Sum_probs=203.2

Q ss_pred             ccCCCCceeeeccceEEEEEEECC------CcEEEEEEeeccccc-hhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeE
Q 040845          527 DKFSENNLIGRGGFGSVYKARIRD------GMEVAVKVFNLQCGR-AFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKA  599 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  599 (824)
                      .+|.+.+.||+|+||.||+|++.+      +..||+|+++..... ..+.+.+|+.+++.++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~   84 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS   84 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence            346777899999999999998632      478999998754332 3466888999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHhhhC---------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC
Q 040845          600 LVLEYMPHGSLEKYLHSS---------------NYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM  664 (824)
Q Consensus       600 lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~  664 (824)
                      +++||+++++|.+++...               ...+++..+..++.|++.|++|+|   +++|+||||||+||++++++
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~  161 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKL  161 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCC
Confidence            999999999999998532               124788889999999999999999   99999999999999999999


Q ss_pred             cEEEeecccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhh
Q 040845          665 VAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWV  743 (824)
Q Consensus       665 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~  743 (824)
                      .+||+|||+++...............+++.|+|||.+.++.++.++||||+||++|||++ |..||.+...     ..+.
T Consensus       162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-----~~~~  236 (283)
T cd05091         162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-----QDVI  236 (283)
T ss_pred             ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH-----HHHH
Confidence            999999999886543332222233446788999999988889999999999999999998 7778765221     1111


Q ss_pred             hhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 040845          744 NDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLK  804 (824)
Q Consensus       744 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~  804 (824)
                      .......               ....+..++..+.+++.+||+.+|++||+++++++.|+.
T Consensus       237 ~~i~~~~---------------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         237 EMIRNRQ---------------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HHHHcCC---------------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            1111000               001123567779999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.3e-36  Score=318.38  Aligned_cols=254  Identities=26%  Similarity=0.436  Sum_probs=198.3

Q ss_pred             CCCCceeeeccceEEEEEEECC-Cc--EEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeecC------Ce
Q 040845          529 FSENNLIGRGGFGSVYKARIRD-GM--EVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSNE------EF  597 (824)
Q Consensus       529 ~~~~~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~  597 (824)
                      |.+.+.||+|+||.||+|++.+ +.  .||+|.++...  ....+.+..|+++++.++|+||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3567899999999999998764 32  68999876542  33456788899999999999999999987432      25


Q ss_pred             eEEEEeccCCCCHHHHhhhC-----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecc
Q 040845          598 KALVLEYMPHGSLEKYLHSS-----NYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFG  672 (824)
Q Consensus       598 ~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  672 (824)
                      .+++|||+++|+|.+++...     ...+++..+..++.|++.|++|||   +++|+||||||+||++++++.+||+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCC
Confidence            68999999999999987432     235789999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcc
Q 040845          673 IAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPIST  751 (824)
Q Consensus       673 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  751 (824)
                      ++................+++.|+|||...+..++.++||||||+++|||++ |+.||......  .....+....    
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~~~~~----  231 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS--EIYDYLRQGN----  231 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHcCC----
Confidence            9987643332222223346778999999998889999999999999999999 78888652211  1111111000    


Q ss_pred             hhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 040845          752 MEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKI  805 (824)
Q Consensus       752 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~  805 (824)
                                    ....+..++..+.+++.+||+.||++|||+.|+++.|+++
T Consensus       232 --------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         232 --------------RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             --------------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                          0001123456789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=9e-37  Score=318.88  Aligned_cols=256  Identities=23%  Similarity=0.445  Sum_probs=205.6

Q ss_pred             ccCCCCceeeeccceEEEEEEECC-C---cEEEEEEeeccc-cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEE
Q 040845          527 DKFSENNLIGRGGFGSVYKARIRD-G---MEVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALV  601 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  601 (824)
                      ..|++.+.||+|+||.||+|.++. +   ..||||++.... ......+..|+.+++.++||||+++++++.++...++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            457788999999999999998653 3   369999986542 33456788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 040845          602 LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED  681 (824)
Q Consensus       602 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  681 (824)
                      |||+++++|.+++......+++.+++.++.|++.|++|||   +.+++|+||||+||+++.++.+|++|||.+.......
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~  160 (269)
T cd05065          84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  160 (269)
T ss_pred             EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence            9999999999999876667899999999999999999999   9999999999999999999999999999987654332


Q ss_pred             Ccccccc---ccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhccc
Q 040845          682 QSMTQTQ---TLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDA  757 (824)
Q Consensus       682 ~~~~~~~---~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  757 (824)
                      .......   ...+..|+|||.+.+..++.++||||+||++||+++ |..||......  ....++....          
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~--~~~~~i~~~~----------  228 (269)
T cd05065         161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--DVINAIEQDY----------  228 (269)
T ss_pred             cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH--HHHHHHHcCC----------
Confidence            2211111   112457999999998899999999999999999987 99998653211  1122211100          


Q ss_pred             cccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 040845          758 NLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKI  805 (824)
Q Consensus       758 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~  805 (824)
                              ....+..++..+.+++.+||..+|++||++.++++.|+++
T Consensus       229 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         229 --------RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             --------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                    1111234567789999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.3e-36  Score=315.09  Aligned_cols=247  Identities=25%  Similarity=0.441  Sum_probs=197.7

Q ss_pred             eeeccceEEEEEEEC---CCcEEEEEEeecccc-chhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEeccCCCCH
Q 040845          535 IGRGGFGSVYKARIR---DGMEVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSL  610 (824)
Q Consensus       535 lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  610 (824)
                      ||+|+||.||+|.+.   ++..||+|++..... ...+.+.+|+.++++++|+||+++++++.. ...++||||+++++|
T Consensus         3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~L   81 (257)
T cd05115           3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGPL   81 (257)
T ss_pred             cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCCH
Confidence            899999999999764   356799999865532 234668899999999999999999998864 567899999999999


Q ss_pred             HHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc-ccccc
Q 040845          611 EKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM-TQTQT  689 (824)
Q Consensus       611 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~  689 (824)
                      .+++......+++.++..++.|++.|++|||   +.+++||||||+||+++.++.+|++|||++.......... .....
T Consensus        82 ~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  158 (257)
T cd05115          82 NKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG  158 (257)
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence            9999866667899999999999999999999   9999999999999999999999999999998654332221 11222


Q ss_pred             cccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhhhhh
Q 040845          690 LATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFV  768 (824)
Q Consensus       690 ~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  768 (824)
                      .++..|+|||.+....++.++|||||||++||+++ |..||......+  ....+....                  ...
T Consensus       159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~~~------------------~~~  218 (257)
T cd05115         159 KWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE--VMSFIEQGK------------------RLD  218 (257)
T ss_pred             CCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH--HHHHHHCCC------------------CCC
Confidence            34678999999888889999999999999999996 999987632211  111111100                  011


Q ss_pred             hHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 040845          769 AKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKI  805 (824)
Q Consensus       769 ~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~  805 (824)
                      .+..++.++.+++.+||..+|++||++.+|.+.|+.+
T Consensus       219 ~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         219 CPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            1234567899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=5.8e-37  Score=336.69  Aligned_cols=252  Identities=22%  Similarity=0.290  Sum_probs=196.8

Q ss_pred             cCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEe
Q 040845          528 KFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLE  603 (824)
Q Consensus       528 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  603 (824)
                      .|+..+.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|+.+++.++|+||+++++++.+++..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5788999999999999999864 58899999987542   2334568889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC-
Q 040845          604 YMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ-  682 (824)
Q Consensus       604 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~-  682 (824)
                      |+++|+|.+++.+.+ .+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||+|..+..... 
T Consensus        82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~  157 (382)
T cd05625          82 YIPGGDMMSLLIRMG-IFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  157 (382)
T ss_pred             CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence            999999999997654 6788899999999999999999   99999999999999999999999999999754321000 


Q ss_pred             --------------------------------------------ccccccccccccccCccCcCCCCCCccchHHHHHHH
Q 040845          683 --------------------------------------------SMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIM  718 (824)
Q Consensus       683 --------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~  718 (824)
                                                                  ........||+.|+|||++.+..++.++||||+||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi  237 (382)
T cd05625         158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI  237 (382)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence                                                        000112468999999999998899999999999999


Q ss_pred             HHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCC---H
Q 040845          719 LMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRIN---A  795 (824)
Q Consensus       719 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt---~  795 (824)
                      +|||++|+.||......+. .......  .              .....+.....++++.+++.+|+ .+|++|++   +
T Consensus       238 l~elltG~~Pf~~~~~~~~-~~~i~~~--~--------------~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~  299 (382)
T cd05625         238 LYEMLVGQPPFLAQTPLET-QMKVINW--Q--------------TSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGA  299 (382)
T ss_pred             HHHHHhCCCCCCCCCHHHH-HHHHHcc--C--------------CCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCH
Confidence            9999999999975322111 1111000  0              00000011123456778888876 59999997   8


Q ss_pred             HHHHHH
Q 040845          796 KEIVAK  801 (824)
Q Consensus       796 ~evl~~  801 (824)
                      .|+++|
T Consensus       300 ~ei~~h  305 (382)
T cd05625         300 DEIKAH  305 (382)
T ss_pred             HHHhcC
Confidence            888765

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-36  Score=315.20  Aligned_cols=252  Identities=25%  Similarity=0.358  Sum_probs=202.9

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc-----chhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEE
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG-----RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKAL  600 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  600 (824)
                      ++|+..+.||+|++|.||+|... +++.||+|.+.....     .....+.+|++++++++||||+++++++.+++..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            57889999999999999999864 589999999864321     123567889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 040845          601 VLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE  680 (824)
Q Consensus       601 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  680 (824)
                      |+||+++++|.+++.... .+++..+..++.|++.|++|||   +.+++||||+|+||++++++.++|+|||++......
T Consensus        82 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~  157 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYG-ALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI  157 (263)
T ss_pred             EEEECCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence            999999999999997655 6788899999999999999999   999999999999999999999999999998765332


Q ss_pred             CCccc-cccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccc
Q 040845          681 DQSMT-QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANL  759 (824)
Q Consensus       681 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  759 (824)
                      ..... .....++..|+|||.+.+..++.++||||+|+++||+++|+.||....... .......   . .         
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~---~-~---------  223 (263)
T cd06625         158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA-AIFKIAT---Q-P---------  223 (263)
T ss_pred             ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH-HHHHHhc---c-C---------
Confidence            21111 123457789999999998889999999999999999999999986531111 0000000   0 0         


Q ss_pred             cCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          760 LSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       760 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                           .....+..++..+.+++.+||..+|.+|||+.|++++
T Consensus       224 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         224 -----TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             -----CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence                 0011122345678999999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=3.3e-37  Score=338.06  Aligned_cols=252  Identities=22%  Similarity=0.280  Sum_probs=198.6

Q ss_pred             cCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEe
Q 040845          528 KFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLE  603 (824)
Q Consensus       528 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  603 (824)
                      +|++.+.||+|+||.||+|+.. +++.||||++....   ......+.+|+++++.++|+||+++++.+.+++..++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            6889999999999999999865 58999999986432   2234567889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC-
Q 040845          604 YMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ-  682 (824)
Q Consensus       604 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~-  682 (824)
                      |+++|+|.+++...+ .+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+|..+..... 
T Consensus        82 ~~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~  157 (376)
T cd05598          82 YIPGGDMMSLLIRLG-IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  157 (376)
T ss_pred             CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence            999999999997765 6788889999999999999999   99999999999999999999999999999853311000 


Q ss_pred             ----------------------------------------ccccccccccccccCccCcCCCCCCccchHHHHHHHHHHH
Q 040845          683 ----------------------------------------SMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMET  722 (824)
Q Consensus       683 ----------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el  722 (824)
                                                              ........||+.|+|||++.+..++.++||||+||++|||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel  237 (376)
T cd05598         158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM  237 (376)
T ss_pred             cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence                                                    0001134689999999999988999999999999999999


Q ss_pred             HhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCC---CHHHHH
Q 040845          723 FTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRI---NAKEIV  799 (824)
Q Consensus       723 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp---t~~evl  799 (824)
                      ++|+.||......+.. ...    ....            ..........++..+.+++.+|+ .+|++|+   ++.|++
T Consensus       238 l~G~~Pf~~~~~~~~~-~~i----~~~~------------~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell  299 (376)
T cd05598         238 LVGQPPFLADTPAETQ-LKV----INWE------------TTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIK  299 (376)
T ss_pred             hhCCCCCCCCCHHHHH-HHH----hccC------------ccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHh
Confidence            9999999763221110 000    0000            00000011123556778888876 4999999   899998


Q ss_pred             HH
Q 040845          800 AK  801 (824)
Q Consensus       800 ~~  801 (824)
                      ++
T Consensus       300 ~h  301 (376)
T cd05598         300 AH  301 (376)
T ss_pred             CC
Confidence            87

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=6.5e-37  Score=327.39  Aligned_cols=242  Identities=22%  Similarity=0.280  Sum_probs=195.6

Q ss_pred             ceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcC-CCCcceeEEeeeecCCeeEEEEeccCC
Q 040845          533 NLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSI-RHRNLVKVISSCSNEEFKALVLEYMPH  607 (824)
Q Consensus       533 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  607 (824)
                      +.||+|+||+||+|+.+ +++.||||+++...   ......+..|.++++.+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999875 47899999997542   23345667788898888 699999999999999999999999999


Q ss_pred             CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccccc
Q 040845          608 GSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQT  687 (824)
Q Consensus       608 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  687 (824)
                      |+|.+++.... .+++.++..++.|++.||+|||   +.+|+||||||+||++++++.+||+|||++........  ...
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~  154 (318)
T cd05570          81 GDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--TTS  154 (318)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--ccc
Confidence            99999987665 6899999999999999999999   99999999999999999999999999999875322211  122


Q ss_pred             cccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhhhh
Q 040845          688 QTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHF  767 (824)
Q Consensus       688 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  767 (824)
                      ...|++.|+|||++.+..++.++||||+||++|||++|+.||......     ..........                .
T Consensus       155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~-----~~~~~i~~~~----------------~  213 (318)
T cd05570         155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED-----ELFQSILEDE----------------V  213 (318)
T ss_pred             ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH-----HHHHHHHcCC----------------C
Confidence            345899999999999999999999999999999999999999753211     1111100000                0


Q ss_pred             hhHHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 040845          768 VAKEQCVSFVFNLALECTVESPEQRINA-----KEIVAK  801 (824)
Q Consensus       768 ~~~~~~~~~l~~l~~~cl~~dP~~Rpt~-----~evl~~  801 (824)
                      ..+..++..+.+++.+||..||.+||++     .+++++
T Consensus       214 ~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         214 RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence            0112345678999999999999999999     887765

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-39  Score=306.70  Aligned_cols=249  Identities=26%  Similarity=0.380  Sum_probs=214.0

Q ss_pred             CCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEeccCC
Q 040845          529 FSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPH  607 (824)
Q Consensus       529 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  607 (824)
                      |++..+||+|+||.||+|.++ +|+.||||.+..+  ...+.+..|+.+|++.+.+++|+++|.+......++|||||..
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA  112 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA  112 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence            566789999999999999765 5999999988654  4567888999999999999999999999999999999999999


Q ss_pred             CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccccc
Q 040845          608 GSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQT  687 (824)
Q Consensus       608 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  687 (824)
                      |+..+.++..++.+++.++..+++..+.||+|||   ..+-+|||||+.|||+..+|.+|++|||.|..+.+  ......
T Consensus       113 GSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD--TMAKRN  187 (502)
T KOG0574|consen  113 GSISDIMRARRKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD--TMAKRN  187 (502)
T ss_pred             CcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhh--hHHhhC
Confidence            9999999988889999999999999999999999   88999999999999999999999999999987643  223345


Q ss_pred             cccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhhhh
Q 040845          688 QTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHF  767 (824)
Q Consensus       688 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  767 (824)
                      .++||+.|||||++..-.|..++||||+|+...||..|++||.+..+..-              ..++    -..+...+
T Consensus       188 TVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA--------------IFMI----PT~PPPTF  249 (502)
T KOG0574|consen  188 TVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA--------------IFMI----PTKPPPTF  249 (502)
T ss_pred             ccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce--------------eEec----cCCCCCCC
Confidence            57899999999999999999999999999999999999999987543210              0000    01122334


Q ss_pred             hhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 040845          768 VAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL  802 (824)
Q Consensus       768 ~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L  802 (824)
                      ..|+..+.++-+++++|+...|++|-||.++++|-
T Consensus       250 ~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~  284 (502)
T KOG0574|consen  250 KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHT  284 (502)
T ss_pred             CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhh
Confidence            45677889999999999999999999999998863

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.6e-36  Score=318.59  Aligned_cols=245  Identities=24%  Similarity=0.317  Sum_probs=195.2

Q ss_pred             eeeccceEEEEEEEC-CCcEEEEEEeecccc---chhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEeccCCCCH
Q 040845          535 IGRGGFGSVYKARIR-DGMEVAVKVFNLQCG---RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSL  610 (824)
Q Consensus       535 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  610 (824)
                      ||+|+||+||+|... +++.||+|.+.....   ...+.+..|+.+++.++|+||+++.+++..+...++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999865 588999999864321   2335667899999999999999999999999999999999999999


Q ss_pred             HHHhhh---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccccc
Q 040845          611 EKYLHS---SNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQT  687 (824)
Q Consensus       611 ~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  687 (824)
                      .+++..   ....+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.++|+|||++..+.....  ...
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence            988753   2246899999999999999999999   99999999999999999999999999999976543222  122


Q ss_pred             cccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhhhh
Q 040845          688 QTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHF  767 (824)
Q Consensus       688 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  767 (824)
                      ...|++.|+|||.+.+..++.++|||||||++|||++|+.||....... ...........        .        ..
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~--------~--------~~  218 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKELKQRILN--------D--------SV  218 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch-hHHHHHHhhcc--------c--------CC
Confidence            3468999999999999999999999999999999999999987532111 01111110000        0        00


Q ss_pred             hhHHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 040845          768 VAKEQCVSFVFNLALECTVESPEQRI-----NAKEIVAK  801 (824)
Q Consensus       768 ~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~evl~~  801 (824)
                      ..+..++..+.+++.+||+.||++||     ++++++++
T Consensus       219 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         219 TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence            11223566789999999999999999     77777765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=2.1e-36  Score=314.39  Aligned_cols=253  Identities=25%  Similarity=0.440  Sum_probs=205.1

Q ss_pred             hccCCCCceeeeccceEEEEEEECCCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEecc
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYM  605 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  605 (824)
                      .++|++.++||+|+||.||+|..++++.||+|.+.... ...+.+.+|+.++++++|+||+++++++. .+..++||||+
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM   82 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence            46788999999999999999998889999999986443 34567889999999999999999999874 45689999999


Q ss_pred             CCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 040845          606 PHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM  684 (824)
Q Consensus       606 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  684 (824)
                      ++++|.+++.... ..+++.++..++.|++.|++|||   +.+++||||||+||++++++.++++|||.+........ .
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~  158 (260)
T cd05067          83 ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY-T  158 (260)
T ss_pred             CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc-c
Confidence            9999999986533 56889999999999999999999   99999999999999999999999999999976542221 1


Q ss_pred             ccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhccccccCch
Q 040845          685 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQE  763 (824)
Q Consensus       685 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  763 (824)
                      ......++..|+|||++....++.++||||||+++||+++ |+.||......+  .........                
T Consensus       159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~~~----------------  220 (260)
T cd05067         159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE--VIQNLERGY----------------  220 (260)
T ss_pred             cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH--HHHHHHcCC----------------
Confidence            2223345678999999988889999999999999999999 999987532211  111110000                


Q ss_pred             hhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 040845          764 DIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLK  804 (824)
Q Consensus       764 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~  804 (824)
                        ....+..++.++.+++.+||+.+|++|||++++++.|+.
T Consensus       221 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         221 --RMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             --CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence              001112345679999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=6.9e-37  Score=332.87  Aligned_cols=254  Identities=22%  Similarity=0.288  Sum_probs=199.9

Q ss_pred             hhccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEE
Q 040845          525 ATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKAL  600 (824)
Q Consensus       525 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  600 (824)
                      ..++|++.+.||+|+||.||+|+.+ +++.||+|++....   ....+.+.+|+.+++.++||||+++++++.++...++
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l  120 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM  120 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence            3578999999999999999999875 48899999986432   2234557789999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 040845          601 VLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE  680 (824)
Q Consensus       601 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  680 (824)
                      ||||+++|+|.+++...  .+++..+..++.|++.||+|||   +.+|+||||||+||++++++.+||+|||+|......
T Consensus       121 v~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~  195 (370)
T cd05621         121 VMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET  195 (370)
T ss_pred             EEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccceecccC
Confidence            99999999999999754  4788899999999999999999   999999999999999999999999999999876422


Q ss_pred             CCccccccccccccccCccCcCCC----CCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhcc
Q 040845          681 DQSMTQTQTLATIGYMAPEYGREG----QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVD  756 (824)
Q Consensus       681 ~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  756 (824)
                      .. .......||+.|+|||++.+.    .++.++||||+||++|||++|+.||...... .....+.....         
T Consensus       196 ~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~-~~~~~i~~~~~---------  264 (370)
T cd05621         196 GM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV-GTYSKIMDHKN---------  264 (370)
T ss_pred             Cc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCc---------
Confidence            21 122345699999999988653    3788999999999999999999999753211 11111111000         


Q ss_pred             ccccCchhhhhhhHHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 040845          757 ANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQ--RINAKEIVAK  801 (824)
Q Consensus       757 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rpt~~evl~~  801 (824)
                             ....+.....+..+.+++.+|+..+|.+  |+++.|++++
T Consensus       265 -------~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         265 -------SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             -------ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence                   0000111123556788999999866544  8999999987

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.6e-36  Score=319.40  Aligned_cols=251  Identities=24%  Similarity=0.346  Sum_probs=201.6

Q ss_pred             CCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEeccCC
Q 040845          529 FSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPH  607 (824)
Q Consensus       529 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  607 (824)
                      |++.+.||+|+||.||+|... ++..+|+|.+........+.+..|+++++.++|||++++++++..+...++|+||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            567788999999999999875 4788999998655445567788899999999999999999999999999999999999


Q ss_pred             CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccccc
Q 040845          608 GSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQT  687 (824)
Q Consensus       608 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  687 (824)
                      ++|.+++......+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+|++|||++.......  ....
T Consensus        87 ~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~~~  161 (282)
T cd06643          87 GAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRRD  161 (282)
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEccccccccccccc--cccc
Confidence            9999988765567899999999999999999999   9999999999999999999999999999987643221  1223


Q ss_pred             cccccccccCccCcC-----CCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCc
Q 040845          688 QTLATIGYMAPEYGR-----EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ  762 (824)
Q Consensus       688 ~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  762 (824)
                      ...++..|+|||++.     ...++.++||||+||++|||++|+.||......+ ..........+              
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~~~~~~~~~~~--------------  226 (282)
T cd06643         162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR-VLLKIAKSEPP--------------  226 (282)
T ss_pred             cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH-HHHHHhhcCCC--------------
Confidence            345889999999874     3457889999999999999999999987532111 11111110000              


Q ss_pred             hhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 040845          763 EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL  802 (824)
Q Consensus       763 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L  802 (824)
                         ....+..++..+.+++.+||+.||++||++.+++++-
T Consensus       227 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  263 (282)
T cd06643         227 ---TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP  263 (282)
T ss_pred             ---CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence               0011223456789999999999999999999987653

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=2.1e-36  Score=313.68  Aligned_cols=247  Identities=24%  Similarity=0.398  Sum_probs=197.7

Q ss_pred             eeeeccceEEEEEEEC---CCcEEEEEEeecccc--chhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEeccCCC
Q 040845          534 LIGRGGFGSVYKARIR---DGMEVAVKVFNLQCG--RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHG  608 (824)
Q Consensus       534 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  608 (824)
                      .||+|+||.||+|.++   ++..||+|+++....  ...+.+..|+.+++.++|+||+++++++.. +..++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence            5899999999999753   478899999864432  235678889999999999999999998864 4678999999999


Q ss_pred             CHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc-ccc
Q 040845          609 SLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM-TQT  687 (824)
Q Consensus       609 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~  687 (824)
                      +|.+++.... .+++..+..++.|++.|++|||   +++|+||||||.||++++++.+||+|||++.......... ...
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05116          81 PLNKFLQKNK-HVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT  156 (257)
T ss_pred             cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence            9999997654 6889999999999999999999   9999999999999999999999999999998764332211 112


Q ss_pred             cccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhhh
Q 040845          688 QTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIH  766 (824)
Q Consensus       688 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  766 (824)
                      ...++..|+|||.+....++.++|||||||++|||++ |..||......  .....+....                  .
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~i~~~~------------------~  216 (257)
T cd05116         157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN--EVTQMIESGE------------------R  216 (257)
T ss_pred             CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHCCC------------------C
Confidence            2234678999999988889999999999999999998 99998753221  1111111100                  0


Q ss_pred             hhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 040845          767 FVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKI  805 (824)
Q Consensus       767 ~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~  805 (824)
                      ...+..++..+.+++.+||+.||++||++++|++.|+++
T Consensus       217 ~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         217 MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence            111224567789999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.7e-36  Score=316.43  Aligned_cols=256  Identities=25%  Similarity=0.459  Sum_probs=206.3

Q ss_pred             ccCCCCceeeeccceEEEEEEEC----CCcEEEEEEeeccc-cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEE
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR----DGMEVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALV  601 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  601 (824)
                      .+|++.+.||+|+||.||+|++.    .+..||+|.++... ....+.+..|+.++++++||||+++++++..++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            57888999999999999999864    23479999886543 23356788899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 040845          602 LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED  681 (824)
Q Consensus       602 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  681 (824)
                      |||+++++|.+++......+++.++..++.|++.|++|||   +.+++||||||+||+++.++.++++|||++..+....
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd05066          84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  160 (267)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence            9999999999999876667899999999999999999999   9999999999999999999999999999998764332


Q ss_pred             Ccc-ccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhccccc
Q 040845          682 QSM-TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANL  759 (824)
Q Consensus       682 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  759 (824)
                      ... ......++..|+|||.+.+..++.++|+||||+++||+++ |..||......  .....+....            
T Consensus       161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~--~~~~~~~~~~------------  226 (267)
T cd05066         161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ--DVIKAIEEGY------------  226 (267)
T ss_pred             ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH--HHHHHHhCCC------------
Confidence            211 1122234568999999998889999999999999999887 99998653221  1111111100            


Q ss_pred             cCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 040845          760 LSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKI  805 (824)
Q Consensus       760 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~  805 (824)
                            +...+..++..+.+++.+||+.+|++||++.++++.|+++
T Consensus       227 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         227 ------RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             ------cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence                  0011123466789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=2.6e-36  Score=346.16  Aligned_cols=260  Identities=24%  Similarity=0.333  Sum_probs=205.1

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc---chhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEE
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG---RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVL  602 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  602 (824)
                      ++|++.+.||+|+||.||+|... +|+.||||++.....   ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            57899999999999999999865 489999999865422   23457889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhhCC----------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecc
Q 040845          603 EYMPHGSLEKYLHSSN----------YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFG  672 (824)
Q Consensus       603 e~~~~g~L~~~l~~~~----------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  672 (824)
                      ||+++|+|.+++....          ...++..++.++.|+++||+|||   +.+|+||||||+||+++.++.++|+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecC
Confidence            9999999999986421          23566788999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCC----------------ccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCc
Q 040845          673 IAKLLTGEDQ----------------SMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGE  736 (824)
Q Consensus       673 ~a~~~~~~~~----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~  736 (824)
                      ++........                ........||+.|+|||.+.+..++.++||||+||++|||+||+.||.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            9986521110                001122468999999999999999999999999999999999999986522111


Q ss_pred             chhhhhhhhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHHHH
Q 040845          737 MTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRI-NAKEIVAKLLKIRD  807 (824)
Q Consensus       737 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-t~~evl~~L~~~~~  807 (824)
                      ......    .       .++.       .......++..+.+++.+|+..||++|| +++++.+.|+...+
T Consensus       239 i~~~~~----i-------~~P~-------~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq  292 (932)
T PRK13184        239 ISYRDV----I-------LSPI-------EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ  292 (932)
T ss_pred             hhhhhh----c-------cChh-------hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            110000    0       0000       0001124566788999999999999996 67777888887755

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-36  Score=322.24  Aligned_cols=261  Identities=25%  Similarity=0.414  Sum_probs=201.5

Q ss_pred             ccCCCCceeeeccceEEEEEEECC---------------CcEEEEEEeeccc-cchhhhHHHHHHHHhcCCCCcceeEEe
Q 040845          527 DKFSENNLIGRGGFGSVYKARIRD---------------GMEVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLVKVIS  590 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~~---------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~  590 (824)
                      ++|++.+.||+|+||.||+|....               ...||+|.++... ....+.+.+|++++++++|+|++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            578999999999999999987532               2358999986542 233457889999999999999999999


Q ss_pred             eeecCCeeEEEEeccCCCCHHHHhhhCC-----------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCee
Q 040845          591 SCSNEEFKALVLEYMPHGSLEKYLHSSN-----------YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVL  659 (824)
Q Consensus       591 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nil  659 (824)
                      ++......++||||+++++|.+++....           ..+++..+..++.|++.|++|||   +.+++||||||+||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhEE
Confidence            9999999999999999999999986532           23678899999999999999999   999999999999999


Q ss_pred             eCCCCcEEEeecccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh--CCCCCcccccCcc
Q 040845          660 LDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT--RKKPTDELFNGEM  737 (824)
Q Consensus       660 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t--g~~p~~~~~~~~~  737 (824)
                      +++++.+|++|||++................++..|+|||...++.++.++|||||||++|||++  |..||......+ 
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~-  240 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ-  240 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH-
Confidence            99999999999999986543332222233345778999999988889999999999999999998  556765432111 


Q ss_pred             hhhhhhhhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 040845          738 TLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLL  803 (824)
Q Consensus       738 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~  803 (824)
                      ........ ....     .....      ...+..++..+.+++.+||..||++||++.+|++.|+
T Consensus       241 ~~~~~~~~-~~~~-----~~~~~------~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         241 VIENTGEF-FRNQ-----GRQIY------LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             HHHHHHHh-hhhc-----ccccc------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            11111000 0000     00000      0011234567999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.8e-36  Score=336.63  Aligned_cols=264  Identities=25%  Similarity=0.340  Sum_probs=195.3

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecC--------C
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNE--------E  596 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------~  596 (824)
                      ..+|++.+.||+|+||.||+|... +++.||||++...    .....+|+.+++.++||||+++++++...        .
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~----~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD----PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC----cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            467999999999999999999864 5899999987532    23345799999999999999999876321        2


Q ss_pred             eeEEEEeccCCCCHHHHhhh---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC-cEEEeecc
Q 040845          597 FKALVLEYMPHGSLEKYLHS---SNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM-VAHLSDFG  672 (824)
Q Consensus       597 ~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~Dfg  672 (824)
                      ..++||||+++ ++.+++..   ....+++..+..++.|++.||+|||   +.+|+||||||+||+++.++ .+||+|||
T Consensus       141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DFG  216 (440)
T PTZ00036        141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFG  216 (440)
T ss_pred             EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence            46799999964 78777653   3357889999999999999999999   99999999999999998654 79999999


Q ss_pred             cccccCCCCCccccccccccccccCccCcCCC-CCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCc-
Q 040845          673 IAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPIS-  750 (824)
Q Consensus       673 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-  750 (824)
                      +|+.+.....   .....+|+.|+|||++.+. .++.++||||+||++|||++|.+||.+.... ..+...+....... 
T Consensus       217 la~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~-~~~~~i~~~~~~p~~  292 (440)
T PTZ00036        217 SAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV-DQLVRIIQVLGTPTE  292 (440)
T ss_pred             cchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCH
Confidence            9987643222   2234689999999987654 6899999999999999999999999763221 11111111111000 


Q ss_pred             -chhhcccc-------ccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          751 -TMEVVDAN-------LLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       751 -~~~~~~~~-------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                       ......+.       ...........+...+.++.+++.+||++||++|||+.|++++
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence             00000000       0011111222233456789999999999999999999999876

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=5.3e-36  Score=312.79  Aligned_cols=258  Identities=24%  Similarity=0.342  Sum_probs=208.7

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEE
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVL  602 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  602 (824)
                      ++|++.+.||+|+||.||+|... +|+.||+|.++...   ....+.+.+|++++++++|+|++++++++.+.+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57899999999999999999876 79999999886432   223567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhhC---CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCC
Q 040845          603 EYMPHGSLEKYLHSS---NYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG  679 (824)
Q Consensus       603 e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  679 (824)
                      ||+++++|.+++...   ...+++.++..++.+++.|++|||   +.+++||||+|+||+++.++.++++|||.+.....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            999999999998642   245789999999999999999999   99999999999999999999999999999876533


Q ss_pred             CCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccc
Q 040845          680 EDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANL  759 (824)
Q Consensus       680 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  759 (824)
                      ...  ......++..|+|||.+.+..++.++|||||||++|+|++|+.||....   .....+......         ..
T Consensus       159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~---------~~  224 (267)
T cd08224         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK---MNLYSLCKKIEK---------CD  224 (267)
T ss_pred             CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC---ccHHHHHhhhhc---------CC
Confidence            221  1223457889999999988889999999999999999999999986422   111111111000         00


Q ss_pred             cCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 040845          760 LSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIR  806 (824)
Q Consensus       760 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~  806 (824)
                      ..     ......++..+.+++.+||..+|++|||+.++++.+++++
T Consensus       225 ~~-----~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         225 YP-----PLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             CC-----CCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence            00     0011245667899999999999999999999999998874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=8.8e-37  Score=327.31  Aligned_cols=247  Identities=21%  Similarity=0.280  Sum_probs=196.8

Q ss_pred             cCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcC-CCCcceeEEeeeecCCeeEEEE
Q 040845          528 KFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSI-RHRNLVKVISSCSNEEFKALVL  602 (824)
Q Consensus       528 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  602 (824)
                      +|++.+.||+|+||.||+|+.. +++.||||++....   ....+.+..|..++..+ +|++|+++++++.+.+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4788899999999999999866 47899999987542   22334566688888777 5899999999999999999999


Q ss_pred             eccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 040845          603 EYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ  682 (824)
Q Consensus       603 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  682 (824)
                      ||+++|+|.+++.... .+++.++..++.|++.||+|||   +.+|+||||||+||++++++.+||+|||++....... 
T Consensus        81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~-  155 (323)
T cd05616          81 EYVNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG-  155 (323)
T ss_pred             cCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC-
Confidence            9999999999987655 6889999999999999999999   9999999999999999999999999999987542211 


Q ss_pred             ccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCc
Q 040845          683 SMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ  762 (824)
Q Consensus       683 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  762 (824)
                       .......||+.|+|||++.+..++.++|||||||++|||+||+.||......  .....+..           ..    
T Consensus       156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~--~~~~~i~~-----------~~----  217 (323)
T cd05616         156 -VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--ELFQSIME-----------HN----  217 (323)
T ss_pred             -CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH--HHHHHHHh-----------CC----
Confidence             1223456899999999999999999999999999999999999999753211  11111110           00    


Q ss_pred             hhhhhhhHHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 040845          763 EDIHFVAKEQCVSFVFNLALECTVESPEQRINA-----KEIVAK  801 (824)
Q Consensus       763 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~-----~evl~~  801 (824)
                          ...+...+.++.+++.+|++.||++|+++     .++.++
T Consensus       218 ----~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05616         218 ----VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  257 (323)
T ss_pred             ----CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence                00112345668899999999999999984     566543

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-36  Score=317.15  Aligned_cols=261  Identities=25%  Similarity=0.403  Sum_probs=209.7

Q ss_pred             ccCCCCceeeeccceEEEEEEECC-Cc----EEEEEEeecccc-chhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEE
Q 040845          527 DKFSENNLIGRGGFGSVYKARIRD-GM----EVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKAL  600 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~~-~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  600 (824)
                      .+|++.+.||+|+||.||+|.+++ |+    .||+|....... .....+.+|+.++++++|+||+++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            568888999999999999998643 33    589998765533 334678889999999999999999999987 78889


Q ss_pred             EEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 040845          601 VLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE  680 (824)
Q Consensus       601 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  680 (824)
                      ||||+++|+|.+++......+++..+..++.|++.|++|||   +.+++||||||+||++++++.+||+|||.++.....
T Consensus        86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~  162 (279)
T cd05057          86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD  162 (279)
T ss_pred             EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence            99999999999999876667899999999999999999999   899999999999999999999999999999876533


Q ss_pred             CCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhccccc
Q 040845          681 DQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANL  759 (824)
Q Consensus       681 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  759 (824)
                      ..........++..|+|||.+....++.++|+||||+++||+++ |+.||......  ...+.+....            
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~------------  228 (279)
T cd05057         163 EKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV--EIPDLLEKGE------------  228 (279)
T ss_pred             ccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH--HHHHHHhCCC------------
Confidence            33222222334678999999988889999999999999999999 99998763211  1111111100            


Q ss_pred             cCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhcc
Q 040845          760 LSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLR  811 (824)
Q Consensus       760 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~  811 (824)
                            ....+..++..+.+++.+||..+|.+||++.++++.|+++.+...|
T Consensus       229 ------~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~~  274 (279)
T cd05057         229 ------RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDPQR  274 (279)
T ss_pred             ------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCCcc
Confidence                  0111223455688999999999999999999999999998665544

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2.5e-36  Score=313.09  Aligned_cols=250  Identities=27%  Similarity=0.396  Sum_probs=207.1

Q ss_pred             ccCCCCceeeeccceEEEEEEECC-CcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEecc
Q 040845          527 DKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYM  605 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  605 (824)
                      ++|+..+.||+|+||.||+|.+.+ ++.||+|.+.....  .+.+.+|++++++++|+||+++++++.++...++++||+
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~   80 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC   80 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence            578899999999999999998765 78999999875432  678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccc
Q 040845          606 PHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMT  685 (824)
Q Consensus       606 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  685 (824)
                      ++++|.+++......+++..+..++.|++.|++|||   +.+++|+||+|+||++++++.++|+|||++........  .
T Consensus        81 ~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--~  155 (256)
T cd06612          81 GAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--K  155 (256)
T ss_pred             CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc--c
Confidence            999999999876668899999999999999999999   99999999999999999999999999999987643221  2


Q ss_pred             cccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhh
Q 040845          686 QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDI  765 (824)
Q Consensus       686 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  765 (824)
                      .....++..|+|||++.+..++.++||||||+++|||++|+.||......+....  +..                ....
T Consensus       156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~--~~~----------------~~~~  217 (256)
T cd06612         156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM--IPN----------------KPPP  217 (256)
T ss_pred             cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh--hcc----------------CCCC
Confidence            2234478899999999888899999999999999999999999875322211000  000                0000


Q ss_pred             hhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          766 HFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       766 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      ....+..++..+.+++.+||+.||++|||+.|++++
T Consensus       218 ~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~  253 (256)
T cd06612         218 TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH  253 (256)
T ss_pred             CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence            111223455678999999999999999999999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2.8e-36  Score=315.39  Aligned_cols=257  Identities=26%  Similarity=0.421  Sum_probs=206.8

Q ss_pred             ccCCCCceeeeccceEEEEEEECC----CcEEEEEEeeccc-cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEE
Q 040845          527 DKFSENNLIGRGGFGSVYKARIRD----GMEVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALV  601 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  601 (824)
                      ++|.+.+.||+|+||.||+|.+.+    ...||||...... ....+.+.+|+.+++.++||||+++++++.+ ...++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            457888999999999999998643    2468999886554 3345678899999999999999999999875 456799


Q ss_pred             EeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 040845          602 LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED  681 (824)
Q Consensus       602 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  681 (824)
                      |||+++|+|.+++......+++..+..++.|++.|++|||   +.+++||||||+||+++.++.++++|||++.......
T Consensus        85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  161 (270)
T cd05056          85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES  161 (270)
T ss_pred             EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence            9999999999999876657899999999999999999999   9999999999999999999999999999998664332


Q ss_pred             CccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhcccccc
Q 040845          682 QSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLL  760 (824)
Q Consensus       682 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  760 (824)
                      . .......++..|+|||.+....++.++||||||+++||+++ |..||......+.  ..+....              
T Consensus       162 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~--~~~~~~~--------------  224 (270)
T cd05056         162 Y-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV--IGRIENG--------------  224 (270)
T ss_pred             c-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH--HHHHHcC--------------
Confidence            2 12223335568999999888889999999999999999986 9999865432211  1111000              


Q ss_pred             CchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 040845          761 SQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDS  808 (824)
Q Consensus       761 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~  808 (824)
                          .....+..++..+.+++.+||..+|++|||+.++++.|+++.+.
T Consensus       225 ----~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~  268 (270)
T cd05056         225 ----ERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE  268 (270)
T ss_pred             ----CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence                00111234567899999999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2.7e-36  Score=315.14  Aligned_cols=257  Identities=25%  Similarity=0.480  Sum_probs=205.9

Q ss_pred             hccCCCCceeeeccceEEEEEEECC-C---cEEEEEEeeccc-cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIRD-G---MEVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKAL  600 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  600 (824)
                      .++|+..+.||+|+||.||+|+.+. +   ..||+|.++... ....+.+..|+++++.++|+|++++++++.+.+..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            3567888999999999999998652 3   379999886542 2335678889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 040845          601 VLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE  680 (824)
Q Consensus       601 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  680 (824)
                      ||||+++++|.+++......+++.++..++.|++.|++|||   +.+++||||||+||++++++.+|++|||++......
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  160 (268)
T cd05063          84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD  160 (268)
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence            99999999999999876567899999999999999999999   999999999999999999999999999999866432


Q ss_pred             CCccc-cccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhcccc
Q 040845          681 DQSMT-QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDAN  758 (824)
Q Consensus       681 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  758 (824)
                      ..... ......+..|+|||++....++.++|||||||++||+++ |+.||......  .....+...            
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~--~~~~~i~~~------------  226 (268)
T cd05063         161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH--EVMKAINDG------------  226 (268)
T ss_pred             cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH--HHHHHHhcC------------
Confidence            22111 112223567999999988889999999999999999998 99998653211  111111100            


Q ss_pred             ccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 040845          759 LLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKI  805 (824)
Q Consensus       759 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~  805 (824)
                            .....+..++.++.+++.+||+.+|++||+++++++.|+++
T Consensus       227 ------~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         227 ------FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             ------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                  00111123566789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=2.2e-36  Score=312.27  Aligned_cols=247  Identities=29%  Similarity=0.459  Sum_probs=199.5

Q ss_pred             ceeeeccceEEEEEEECCCcEEEEEEeecccc-chhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEeccCCCCHH
Q 040845          533 NLIGRGGFGSVYKARIRDGMEVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLE  611 (824)
Q Consensus       533 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  611 (824)
                      ++||+|+||.||+|..++++.||+|.+..... .....+.+|+++++.++||||+++++++......++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            36899999999999988899999998865432 23456888999999999999999999999999999999999999999


Q ss_pred             HHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccccccccc
Q 040845          612 KYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA  691 (824)
Q Consensus       612 ~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  691 (824)
                      +++......+++..+..++.|++.|+.|+|   +.+++||||+|+||+++.++.+|++|||++........ .......+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~  156 (250)
T cd05085          81 SFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGLKQI  156 (250)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceecccccc-ccCCCCCC
Confidence            999776657899999999999999999999   99999999999999999999999999999875432211 11112234


Q ss_pred             cccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhhhhhhH
Q 040845          692 TIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAK  770 (824)
Q Consensus       692 ~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  770 (824)
                      +..|+|||+..++.++.++||||||+++||+++ |..||.......  ....+....                  +...+
T Consensus       157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~--~~~~~~~~~------------------~~~~~  216 (250)
T cd05085         157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ--AREQVEKGY------------------RMSCP  216 (250)
T ss_pred             cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH--HHHHHHcCC------------------CCCCC
Confidence            677999999988889999999999999999998 888986532111  111110000                  00111


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 040845          771 EQCVSFVFNLALECTVESPEQRINAKEIVAKLL  803 (824)
Q Consensus       771 ~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~  803 (824)
                      ..++..+.+++.+||+.+|++||++.|+++.|.
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         217 QKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            234567899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-36  Score=319.45  Aligned_cols=251  Identities=23%  Similarity=0.329  Sum_probs=201.0

Q ss_pred             cCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEe
Q 040845          528 KFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLE  603 (824)
Q Consensus       528 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  603 (824)
                      .|++.+.||+|+||+||+|... +++.||+|++....   ......+.+|+.+++.++||||+++++++..++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            3778899999999999999864 58999999986432   1223456789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 040845          604 YMPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ  682 (824)
Q Consensus       604 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  682 (824)
                      |+++|+|.+++.... ..+++..+..++.|++.|++|||   +.+++||||||+||++++++.++|+|||++....... 
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  156 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-  156 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-
Confidence            999999999886543 46899999999999999999999   9999999999999999999999999999997653222 


Q ss_pred             ccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCc
Q 040845          683 SMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ  762 (824)
Q Consensus       683 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  762 (824)
                        ......|+..|+|||++.+..++.++||||+||++|||++|+.||...... .....+......         .    
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~-~~~~~~~~~~~~---------~----  220 (285)
T cd05605         157 --TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK-VKREEVERRVKE---------D----  220 (285)
T ss_pred             --ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh-hHHHHHHHHhhh---------c----
Confidence              112346899999999998888999999999999999999999999753211 111111110000         0    


Q ss_pred             hhhhhhhHHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 040845          763 EDIHFVAKEQCVSFVFNLALECTVESPEQRI-----NAKEIVAK  801 (824)
Q Consensus       763 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~evl~~  801 (824)
                         ....+..++..+.+++.+||..||++||     ++.+++++
T Consensus       221 ---~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         221 ---QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             ---ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence               0001123466789999999999999999     88898776

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-36  Score=312.04  Aligned_cols=248  Identities=31%  Similarity=0.506  Sum_probs=201.3

Q ss_pred             ceeeeccceEEEEEEECCCcEEEEEEeeccccc-hhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEeccCCCCHH
Q 040845          533 NLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGR-AFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLE  611 (824)
Q Consensus       533 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  611 (824)
                      ++||+|+||.||+|...+++.||+|.+...... ..+.+..|++++++++|+||+++++++.+....++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            468999999999998777999999988755433 4567889999999999999999999999999999999999999999


Q ss_pred             HHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccccccccc
Q 040845          612 KYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA  691 (824)
Q Consensus       612 ~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  691 (824)
                      +++......+++..+..++.+++.|++|||   +.+++||||+|+||+++.++.++|+|||.+.................
T Consensus        81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (251)
T cd05041          81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI  157 (251)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence            999776557889999999999999999999   99999999999999999999999999999976542221111122234


Q ss_pred             cccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhhhhhhH
Q 040845          692 TIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAK  770 (824)
Q Consensus       692 ~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  770 (824)
                      +..|+|||.+.++.++.++|+||+|+++|||+| |..||......  .....+....                  ....+
T Consensus       158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~--~~~~~~~~~~------------------~~~~~  217 (251)
T cd05041         158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ--QTRERIESGY------------------RMPAP  217 (251)
T ss_pred             eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH--HHHHHHhcCC------------------CCCCC
Confidence            667999999988889999999999999999999 78887653221  1111111000                  01112


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 040845          771 EQCVSFVFNLALECTVESPEQRINAKEIVAKLL  803 (824)
Q Consensus       771 ~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~  803 (824)
                      ..++..+.+++.+||..+|.+|||+.|+++.|+
T Consensus       218 ~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            234667999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=2.9e-36  Score=319.24  Aligned_cols=250  Identities=28%  Similarity=0.359  Sum_probs=204.2

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEecc
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYM  605 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  605 (824)
                      .+|++.+.||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++|+|++++++.+......++||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            57888899999999999999864 58999999987665555677889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccc
Q 040845          606 PHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMT  685 (824)
Q Consensus       606 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  685 (824)
                      ++++|.+++...  .+++.++..++.|++.|++|||   +.+|+||||||+||+++.++.++|+|||.+........  .
T Consensus       100 ~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~--~  172 (296)
T cd06654         100 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--K  172 (296)
T ss_pred             CCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc--c
Confidence            999999998654  4788999999999999999999   99999999999999999999999999999876533221  1


Q ss_pred             cccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhh
Q 040845          686 QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDI  765 (824)
Q Consensus       686 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  765 (824)
                      .....+++.|+|||.+.+..++.++|||||||++|||++|+.||......+. ...+.....+                 
T Consensus       173 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~-~~~~~~~~~~-----------------  234 (296)
T cd06654         173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIATNGTP-----------------  234 (296)
T ss_pred             cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh-HHHHhcCCCC-----------------
Confidence            2234588899999999888899999999999999999999999865322111 1111000000                 


Q ss_pred             hhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          766 HFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       766 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      ....+...+..+.+++.+||..+|++|||+.|++++
T Consensus       235 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         235 ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             CCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence            000112345568899999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=3.5e-36  Score=318.37  Aligned_cols=252  Identities=24%  Similarity=0.326  Sum_probs=203.4

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEecc
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYM  605 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  605 (824)
                      +.|++.+.||+|+||.||+|+.. ++..||+|++........+.+.+|+.+++.++|+||+++++++..+...++||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            56889999999999999999875 48999999987665556677889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccc
Q 040845          606 PHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMT  685 (824)
Q Consensus       606 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  685 (824)
                      ++++|..++......+++..+..++.|++.|++|||   +.+++||||||+||+++.++.++|+|||.+......  ...
T Consensus        92 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--~~~  166 (292)
T cd06644          92 PGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--LQR  166 (292)
T ss_pred             CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceecccc--ccc
Confidence            999999988766667899999999999999999999   999999999999999999999999999998754221  112


Q ss_pred             cccccccccccCccCcC-----CCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhcccccc
Q 040845          686 QTQTLATIGYMAPEYGR-----EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLL  760 (824)
Q Consensus       686 ~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  760 (824)
                      .....++..|+|||++.     ...++.++|||||||++|||++|+.||...... .....+.....             
T Consensus       167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~~~-------------  232 (292)
T cd06644         167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-RVLLKIAKSEP-------------  232 (292)
T ss_pred             cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH-HHHHHHhcCCC-------------
Confidence            23345788999999874     345688999999999999999999998653211 11111110000             


Q ss_pred             CchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          761 SQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       761 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                          .....+..++..+.+++.+||..+|++||++.|++++
T Consensus       233 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  269 (292)
T cd06644         233 ----PTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH  269 (292)
T ss_pred             ----ccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence                0001122345568899999999999999999999874

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.9e-36  Score=318.98  Aligned_cols=269  Identities=23%  Similarity=0.415  Sum_probs=205.0

Q ss_pred             cCCCCceeeeccceEEEEEEE-----CCCcEEEEEEeeccc-cchhhhHHHHHHHHhcCCCCcceeEEeeeecC--CeeE
Q 040845          528 KFSENNLIGRGGFGSVYKARI-----RDGMEVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLVKVISSCSNE--EFKA  599 (824)
Q Consensus       528 ~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  599 (824)
                      -|++.+.||+|+||.||.|++     .++..||+|.++... ....+.+.+|+++++.++|||++++++++...  ...+
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK   84 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence            467889999999999999974     247889999986543 33456788999999999999999999998775  5788


Q ss_pred             EEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCC
Q 040845          600 LVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG  679 (824)
Q Consensus       600 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  679 (824)
                      +||||+++++|.+++......+++.++..++.|++.|++|||   +.+++||||||+||+++.++.++|+|||++..+..
T Consensus        85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05079          85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET  161 (284)
T ss_pred             EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence            999999999999999766556899999999999999999999   99999999999999999999999999999987643


Q ss_pred             CCCcc-ccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCC-cchhhccc
Q 040845          680 EDQSM-TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPI-STMEVVDA  757 (824)
Q Consensus       680 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  757 (824)
                      ..... ......++..|+|||.+.+..++.++||||||+++||++|++.|+........   ......... ........
T Consensus       162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~  238 (284)
T cd05079         162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFL---KMIGPTHGQMTVTRLVRV  238 (284)
T ss_pred             CccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhh---hhcccccccccHHHHHHH
Confidence            32221 11234467789999999888899999999999999999998876543211000   000000000 00000000


Q ss_pred             cccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 040845          758 NLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKI  805 (824)
Q Consensus       758 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~  805 (824)
                       .  ........+..++..+.+++.+||+.+|++|||+.++++.++++
T Consensus       239 -~--~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         239 -L--EEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             -H--HcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence             0  00001112234677899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=3.8e-36  Score=315.14  Aligned_cols=247  Identities=23%  Similarity=0.332  Sum_probs=194.7

Q ss_pred             eeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEeccCCCCH
Q 040845          535 IGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSL  610 (824)
Q Consensus       535 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  610 (824)
                      ||+|+||.||+++.+ +|+.||+|.+....   ......+..|++++++++||||+++++++.++...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999865 58999999986432   12234456799999999999999999999999999999999999999


Q ss_pred             HHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccccccc
Q 040845          611 EKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT  689 (824)
Q Consensus       611 ~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  689 (824)
                      .+++.... ..+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.++|+|||++.......   .....
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~~  154 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQR  154 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeecc
Confidence            98886543 46889999999999999999999   9999999999999999999999999999988654322   12234


Q ss_pred             cccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhhhhhh
Q 040845          690 LATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVA  769 (824)
Q Consensus       690 ~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  769 (824)
                      .++..|+|||++.+..++.++||||+||++|||++|+.||...... ..............        . .     . .
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~-~~~~~~~~~~~~~~--------~-~-----~-~  218 (277)
T cd05607         155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK-VAKEELKRRTLEDE--------V-K-----F-E  218 (277)
T ss_pred             CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch-hhHHHHHHHhhccc--------c-c-----c-c
Confidence            5889999999998888999999999999999999999998653211 11111111111000        0 0     0 0


Q ss_pred             HHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 040845          770 KEQCVSFVFNLALECTVESPEQRINAKEIVAKLL  803 (824)
Q Consensus       770 ~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~  803 (824)
                      ...++.++.+++.+||+.||++||+++|+++...
T Consensus       219 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~  252 (277)
T cd05607         219 HQNFTEESKDICRLFLAKKPEDRLGSREKNDDPR  252 (277)
T ss_pred             cccCCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence            1134567899999999999999999977764443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=2.3e-36  Score=320.72  Aligned_cols=262  Identities=26%  Similarity=0.409  Sum_probs=205.6

Q ss_pred             hccCCCCceeeeccceEEEEEEECC-----------------CcEEEEEEeecccc-chhhhHHHHHHHHhcCCCCccee
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIRD-----------------GMEVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVK  587 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~  587 (824)
                      ..+|++.+.||+|+||.||+|+..+                 +..||+|.+..... ...+.+.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            4578999999999999999997642                 24689999875432 34567889999999999999999


Q ss_pred             EEeeeecCCeeEEEEeccCCCCHHHHhhhCC----------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCC
Q 040845          588 VISSCSNEEFKALVLEYMPHGSLEKYLHSSN----------YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSN  657 (824)
Q Consensus       588 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~N  657 (824)
                      +++++..+...++||||+++++|.+++....          ..+++..++.++.|++.|++|||   +.+++||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhc
Confidence            9999999999999999999999999987644          25889999999999999999999   9999999999999


Q ss_pred             eeeCCCCcEEEeecccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh--CCCCCcccccC
Q 040845          658 VLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT--RKKPTDELFNG  735 (824)
Q Consensus       658 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t--g~~p~~~~~~~  735 (824)
                      |+++.++.++++|||++................++..|+|||.+.++.++.++|||||||++|||++  |..||......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ  240 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence            9999999999999999986544333333334456788999999988889999999999999999998  66777543211


Q ss_pred             cchhhhhhhhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 040845          736 EMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLL  803 (824)
Q Consensus       736 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~  803 (824)
                      +  ............     .      .......+..++.++.+++.+||+.||++|||+.|+++.|+
T Consensus       241 ~--~~~~~~~~~~~~-----~------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         241 Q--VIENAGHFFRDD-----G------RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             H--HHHHHHhccccc-----c------ccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            1  111111100000     0      00000112234567999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-36  Score=312.00  Aligned_cols=254  Identities=26%  Similarity=0.384  Sum_probs=207.2

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEecc
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYM  605 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  605 (824)
                      ++|++.+.||+|+||.||+|... +++.+|+|++........+.+.+|++++++++||||+++++++.+....+++|||+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~   82 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC   82 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence            57889999999999999999865 57899999997665556678899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccc
Q 040845          606 PHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMT  685 (824)
Q Consensus       606 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  685 (824)
                      ++++|.+++......+++.++..++.|++.|++|||   +.+++|+||+|+||++++++.++|+|||.+.......  ..
T Consensus        83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~  157 (262)
T cd06613          83 GGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--AK  157 (262)
T ss_pred             CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhhh--hc
Confidence            999999999876557899999999999999999999   9999999999999999999999999999987654321  12


Q ss_pred             cccccccccccCccCcCCC---CCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCc
Q 040845          686 QTQTLATIGYMAPEYGREG---QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ  762 (824)
Q Consensus       686 ~~~~~~~~~y~aPE~~~~~---~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  762 (824)
                      .....++..|+|||.+...   .++.++||||||+++|||++|+.||......... ........        .      
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~-~~~~~~~~--------~------  222 (262)
T cd06613         158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL-FLISKSNF--------P------  222 (262)
T ss_pred             cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhccC--------C------
Confidence            2334578899999998776   7899999999999999999999998753221111 10000000        0      


Q ss_pred             hhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          763 EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       763 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                       ......+...+..+.+++.+||..+|++|||+++++.+
T Consensus       223 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  260 (262)
T cd06613         223 -PPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH  260 (262)
T ss_pred             -CccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence             00011123456678999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=3e-36  Score=314.61  Aligned_cols=258  Identities=24%  Similarity=0.341  Sum_probs=207.4

Q ss_pred             ccCCCCceeeeccceEEEEEEE-CCCcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEE
Q 040845          527 DKFSENNLIGRGGFGSVYKARI-RDGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVL  602 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  602 (824)
                      ++|++.+.||+|+||.||+|.. .+++.||||.+....   ......+.+|+.+++.++|+||+++++++.+++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4688889999999999999985 468999999876432   223457888999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhh---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCC
Q 040845          603 EYMPHGSLEKYLHS---SNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG  679 (824)
Q Consensus       603 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  679 (824)
                      ||+++++|.+++..   ....+++..++.++.|++.|++|||   +.+++|+||+|+||+++.++.++++|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            99999999999864   2346889999999999999999999   99999999999999999999999999999876543


Q ss_pred             CCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccc
Q 040845          680 EDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANL  759 (824)
Q Consensus       680 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  759 (824)
                      ...  ......++..|+|||.+.+..++.++|+||||+++|||++|..||...........+.+..        ...   
T Consensus       159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--------~~~---  225 (267)
T cd08229         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ--------CDY---  225 (267)
T ss_pred             CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhc--------CCC---
Confidence            221  1223458889999999988889999999999999999999999986422111111111000        000   


Q ss_pred             cCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 040845          760 LSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIR  806 (824)
Q Consensus       760 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~  806 (824)
                            ....+..++..+.+++.+||..||++|||+.+|++.++++.
T Consensus       226 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         226 ------PPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             ------CCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence                  00011235667999999999999999999999999998864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-36  Score=318.51  Aligned_cols=255  Identities=27%  Similarity=0.433  Sum_probs=204.8

Q ss_pred             hccCCCCceeeeccceEEEEEEECC------CcEEEEEEeeccc-cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCee
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIRD------GMEVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFK  598 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  598 (824)
                      .++|.+.+.||+|+||.||+|.+++      +..||+|.+.... ......+.+|+.+++.++|+||+++++++......
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            4678899999999999999998642      4689999976442 23345678899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhhCC---------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEe
Q 040845          599 ALVLEYMPHGSLEKYLHSSN---------YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLS  669 (824)
Q Consensus       599 ~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  669 (824)
                      ++||||+++|+|.+++....         ..+++..+..++.|++.|++|||   +.+++||||||+||+++.++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEEC
Confidence            99999999999999986532         24678899999999999999999   9999999999999999999999999


Q ss_pred             ecccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCC
Q 040845          670 DFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLP  748 (824)
Q Consensus       670 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  748 (824)
                      |||+++...............++..|+|||.+.++.++.++|||||||++||+++ |..||......  ....+....  
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--~~~~~~~~~--  237 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE--EVLKFVIDG--  237 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH--HHHHHHhcC--
Confidence            9999986644333222233456788999999988889999999999999999998 88888642211  111111100  


Q ss_pred             CcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 040845          749 ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLL  803 (824)
Q Consensus       749 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~  803 (824)
                                      .....+..++..+.+++.+||+.+|++|||+.|+++.|+
T Consensus       238 ----------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         238 ----------------GHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             ----------------CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence                            000112234667899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=4e-36  Score=313.83  Aligned_cols=256  Identities=28%  Similarity=0.411  Sum_probs=202.5

Q ss_pred             HHhhccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEE
Q 040845          523 FQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALV  601 (824)
Q Consensus       523 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  601 (824)
                      +.+++.+.....||+|+||.||+|++. ++..||+|.+........+.+.+|+.+++.++|+||+++++++..++..++|
T Consensus         4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   83 (268)
T cd06624           4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF   83 (268)
T ss_pred             ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence            345566666789999999999999855 5788999998766555667889999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhhCCCCC--CHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC-CCcEEEeecccccccC
Q 040845          602 LEYMPHGSLEKYLHSSNYSL--DIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD-NMVAHLSDFGIAKLLT  678 (824)
Q Consensus       602 ~e~~~~g~L~~~l~~~~~~~--~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~Dfg~a~~~~  678 (824)
                      +||+++++|.+++......+  ++..+..++.|++.|++|||   +.+|+||||||+||+++. ++.++|+|||.+....
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~  160 (268)
T cd06624          84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA  160 (268)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence            99999999999998654344  78888999999999999999   999999999999999976 6799999999987653


Q ss_pred             CCCCccccccccccccccCccCcCCCC--CCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhcc
Q 040845          679 GEDQSMTQTQTLATIGYMAPEYGREGQ--VSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVD  756 (824)
Q Consensus       679 ~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  756 (824)
                      ....  ......++..|+|||++....  ++.++||||+|+++|+|++|+.||........  ..+.....         
T Consensus       161 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~--~~~~~~~~---------  227 (268)
T cd06624         161 GINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA--AMFKVGMF---------  227 (268)
T ss_pred             cCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh--hHhhhhhh---------
Confidence            2221  122335788999999886543  78899999999999999999999865321111  11100000         


Q ss_pred             ccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          757 ANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       757 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                          .   .....+..++..+.+++.+||..+|++|||+.|++++
T Consensus       228 ----~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         228 ----K---IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             ----c---cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence                0   0001122345678999999999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=4.7e-36  Score=311.71  Aligned_cols=252  Identities=27%  Similarity=0.443  Sum_probs=202.9

Q ss_pred             ccCCCCceeeeccceEEEEEEECCCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEeccC
Q 040845          527 DKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMP  606 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  606 (824)
                      ++|++.+.||+|++|.||+|.+..+..||+|.+... ....+.+.+|+.++++++|+|++++++++.. +..++||||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPG-TMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccC-CccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCC
Confidence            568888999999999999999887778999987643 2334678899999999999999999998754 56789999999


Q ss_pred             CCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccc
Q 040845          607 HGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMT  685 (824)
Q Consensus       607 ~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  685 (824)
                      +++|.+++.... ..+++..+..++.|++.|++|||   +.+++|+||||+||++++++.++|+|||.+......... .
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~-~  159 (260)
T cd05069          84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT-A  159 (260)
T ss_pred             CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCccc-c
Confidence            999999997643 45789999999999999999999   999999999999999999999999999999765432211 1


Q ss_pred             cccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchh
Q 040845          686 QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQED  764 (824)
Q Consensus       686 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  764 (824)
                      .....++..|+|||...+..++.++||||||+++|||++ |..||......+  ...+......                
T Consensus       160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~~~~~----------------  221 (260)
T cd05069         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE--VLEQVERGYR----------------  221 (260)
T ss_pred             cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCC----------------
Confidence            222346678999999988889999999999999999999 888886532211  1111111000                


Q ss_pred             hhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 040845          765 IHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLK  804 (824)
Q Consensus       765 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~  804 (824)
                        ...+...+..+.+++.+||..||++||+++++++.|++
T Consensus       222 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         222 --MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             --CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence              00112345678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.5e-36  Score=313.04  Aligned_cols=254  Identities=29%  Similarity=0.488  Sum_probs=206.9

Q ss_pred             hccCCCCceeeeccceEEEEEEECCCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEecc
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYM  605 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  605 (824)
                      .++|.+.+.||+|+||.||+|..++++.||||.+... ....+++.+|+.++++++|+||+++++++......++||||+
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   83 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM   83 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCC-ccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence            4688999999999999999999887889999998743 234567889999999999999999999999988999999999


Q ss_pred             CCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 040845          606 PHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM  684 (824)
Q Consensus       606 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  684 (824)
                      ++++|.+++.... ..+++.++..++.|++.|++|||   +.+++|+||||+||++++++.++++|||.+....... ..
T Consensus        84 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~-~~  159 (261)
T cd05034          84 SKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE-YT  159 (261)
T ss_pred             CCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccchh-hh
Confidence            9999999997644 46899999999999999999999   9999999999999999999999999999988654321 11


Q ss_pred             ccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhccccccCch
Q 040845          685 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQE  763 (824)
Q Consensus       685 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  763 (824)
                      .......+..|+|||.+.+..++.++||||+|+++||+++ |+.||..... ......+... .                
T Consensus       160 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-~~~~~~~~~~-~----------------  221 (261)
T cd05034         160 AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN-REVLEQVERG-Y----------------  221 (261)
T ss_pred             hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHcC-C----------------
Confidence            1122234678999999998889999999999999999999 8988865321 1111111100 0                


Q ss_pred             hhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 040845          764 DIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLK  804 (824)
Q Consensus       764 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~  804 (824)
                        ....+..++..+.+++.+||+.+|++||+++++.+.|+.
T Consensus       222 --~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         222 --RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             --CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence              001112335678999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.4e-36  Score=332.38  Aligned_cols=266  Identities=19%  Similarity=0.207  Sum_probs=200.1

Q ss_pred             hccCCCCceeeeccceEEEEEEECC-CcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEec
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      ...|.+.+.||+|+||.||+|.+.. ++.||||...      ...+.+|++++++++|+||+++++++...+..++|||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            4578999999999999999998754 7899999632      23467899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 040845          605 MPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM  684 (824)
Q Consensus       605 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  684 (824)
                      +. ++|.+++......+++.++..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.........
T Consensus       242 ~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~  317 (461)
T PHA03211        242 YR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP  317 (461)
T ss_pred             cC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence            94 6999988766557999999999999999999999   9999999999999999999999999999998764333222


Q ss_pred             ccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccC------cchhhhhhhhhCC-C-cch----
Q 040845          685 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNG------EMTLKHWVNDCLP-I-STM----  752 (824)
Q Consensus       685 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~------~~~~~~~~~~~~~-~-~~~----  752 (824)
                      ......||..|+|||++.+..++.++|||||||++|||++|..|+......      ...+...+..... . ...    
T Consensus       318 ~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~  397 (461)
T PHA03211        318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAG  397 (461)
T ss_pred             cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcc
Confidence            233456899999999999989999999999999999999988765432111      0111111111100 0 000    


Q ss_pred             -hhcccc------ccCc--hhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          753 -EVVDAN------LLSQ--EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       753 -~~~~~~------~~~~--~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                       ......      ....  ..............+.+|+.+||+.||.+|||+.|++++
T Consensus       398 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        398 SRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             hHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence             000000      0000  000000001233468899999999999999999999986

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.3e-36  Score=311.36  Aligned_cols=249  Identities=31%  Similarity=0.494  Sum_probs=205.3

Q ss_pred             hccCCCCceeeeccceEEEEEEECCCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEecc
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYM  605 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  605 (824)
                      .++|++.+.||+|+||.||+|... |+.||+|.+..... ..+.+..|+.++++++|+||+++++++.+....++||||+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            357888999999999999999876 89999999875533 4567888999999999999999999999899999999999


Q ss_pred             CCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 040845          606 PHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM  684 (824)
Q Consensus       606 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  684 (824)
                      ++++|.+++.... ..+++..+..++.|++.|++|||   +.+++|+||||+||+++.++.++|+|||.+........  
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~--  157 (256)
T cd05039          83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD--  157 (256)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence            9999999997654 36899999999999999999999   99999999999999999999999999999986532111  


Q ss_pred             ccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhccccccCch
Q 040845          685 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQE  763 (824)
Q Consensus       685 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  763 (824)
                         ....+..|+|||.+..+.++.++||||||+++||+++ |..||......  .....+....                
T Consensus       158 ---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~~~----------------  216 (256)
T cd05039         158 ---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPHVEKGY----------------  216 (256)
T ss_pred             ---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHhcCC----------------
Confidence               2235678999999988889999999999999999997 99888653211  1111111000                


Q ss_pred             hhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 040845          764 DIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLK  804 (824)
Q Consensus       764 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~  804 (824)
                        ....+..++..+.+++.+||..+|++|||+.|+++.|+.
T Consensus       217 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         217 --RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             --CCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence              000112346778999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=4.3e-36  Score=311.38  Aligned_cols=249  Identities=24%  Similarity=0.348  Sum_probs=204.0

Q ss_pred             cCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecc--ccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEec
Q 040845          528 KFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQ--CGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       528 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      +|++.+.||+|++|.||+|+.+ +++.||+|.+...  .....+.+..|+++++.++|||++++++++.+.+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4777899999999999999865 5899999998643  234456788899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 040845          605 MPHGSLEKYLHSS-NYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS  683 (824)
Q Consensus       605 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  683 (824)
                      +++++|.+++... ...+++..++.++.|++.|++|||   +.+++|+||+|+||++++++.++++|||++........ 
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~-  156 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN-  156 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc-
Confidence            9999999999875 357889999999999999999999   99999999999999999999999999999886643322 


Q ss_pred             cccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCch
Q 040845          684 MTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQE  763 (824)
Q Consensus       684 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  763 (824)
                       ......+++.|+|||+..+..++.++|+||||+++|||++|+.||......  .....+..   .         ..   
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~---~---------~~---  218 (256)
T cd08529         157 -FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG--ALILKIIR---G---------VF---  218 (256)
T ss_pred             -hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHc---C---------CC---
Confidence             122345788999999999888999999999999999999999998753211  11111000   0         00   


Q ss_pred             hhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          764 DIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       764 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                         ...+..++..+.+++.+||+.+|++||++.+++++
T Consensus       219 ---~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         219 ---PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             ---CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence               00111345678999999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=2.1e-36  Score=321.50  Aligned_cols=257  Identities=27%  Similarity=0.468  Sum_probs=201.9

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCc--EEEEEEeeccc-cchhhhHHHHHHHHhcC-CCCcceeEEeeeecCCeeEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGM--EVAVKVFNLQC-GRAFKSFDVECAMMKSI-RHRNLVKVISSCSNEEFKAL  600 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  600 (824)
                      .++|++.+.||+|+||.||+|.++ ++.  .+|+|.++... ......+.+|++++.++ +|+||+++++++..+...++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            357888999999999999999865 354  45777765332 23445788899999999 89999999999999999999


Q ss_pred             EEeccCCCCHHHHhhhCC---------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCc
Q 040845          601 VLEYMPHGSLEKYLHSSN---------------YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMV  665 (824)
Q Consensus       601 v~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~  665 (824)
                      ||||+++++|.++++..+               ..+++.+++.++.|++.|++|||   +.+++||||||+||++++++.
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~  162 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYV  162 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCc
Confidence            999999999999997543               25788999999999999999999   999999999999999999999


Q ss_pred             EEEeecccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhh
Q 040845          666 AHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVN  744 (824)
Q Consensus       666 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~  744 (824)
                      +||+|||++.....   ........++..|+|||.+.+..++.++|||||||++|||+| |..||......     ....
T Consensus       163 ~kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-----~~~~  234 (303)
T cd05088         163 AKIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-----ELYE  234 (303)
T ss_pred             EEeCccccCcccch---hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH-----HHHH
Confidence            99999999863211   111112234667999999988889999999999999999998 99998653211     1111


Q ss_pred             hhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 040845          745 DCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDS  808 (824)
Q Consensus       745 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~  808 (824)
                      .... .              .....+..++..+.+++.+||+.+|++||++.++++.++++.+.
T Consensus       235 ~~~~-~--------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~  283 (303)
T cd05088         235 KLPQ-G--------------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  283 (303)
T ss_pred             HHhc-C--------------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            1000 0              00001122456789999999999999999999999999887643

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.3e-37  Score=329.12  Aligned_cols=238  Identities=25%  Similarity=0.336  Sum_probs=192.3

Q ss_pred             ceeeeccceEEEEEEE----CCCcEEEEEEeecccc--chhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEeccC
Q 040845          533 NLIGRGGFGSVYKARI----RDGMEVAVKVFNLQCG--RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMP  606 (824)
Q Consensus       533 ~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  606 (824)
                      +.||+|+||.||+++.    .+|+.||+|++.....  .....+..|++++++++||||+++++++.++...++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999874    3588999999975432  233456779999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcccc
Q 040845          607 HGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQ  686 (824)
Q Consensus       607 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  686 (824)
                      +|+|.+++.... .+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||++........  ..
T Consensus        82 ~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--~~  155 (318)
T cd05582          82 GGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--KA  155 (318)
T ss_pred             CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--ce
Confidence            999999997654 6899999999999999999999   99999999999999999999999999999876532211  22


Q ss_pred             ccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhhh
Q 040845          687 TQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIH  766 (824)
Q Consensus       687 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  766 (824)
                      ....|++.|+|||.+.+..++.++|||||||++|||++|+.||......+ ........            .        
T Consensus       156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~-~~~~i~~~------------~--------  214 (318)
T cd05582         156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE-TMTMILKA------------K--------  214 (318)
T ss_pred             ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH-HHHHHHcC------------C--------
Confidence            23568999999999988889999999999999999999999987532111 01100000            0        


Q ss_pred             hhhHHHHHHHHHHHHHHccccCCCCCCCHHH
Q 040845          767 FVAKEQCVSFVFNLALECTVESPEQRINAKE  797 (824)
Q Consensus       767 ~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~e  797 (824)
                      ...+..++..+.+++.+||+.||++||++.+
T Consensus       215 ~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         215 LGMPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            0011234566889999999999999999544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=3.4e-36  Score=312.08  Aligned_cols=248  Identities=31%  Similarity=0.458  Sum_probs=200.6

Q ss_pred             ccCCCCceeeeccceEEEEEEECCCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeee-ecCCeeEEEEecc
Q 040845          527 DKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSC-SNEEFKALVLEYM  605 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e~~  605 (824)
                      .+|++.+.||+|+||.||+|... |+.||+|.++..  ...+.+..|+.++++++|+|++++++++ .++...++||||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            57888999999999999999876 888999988643  3346788999999999999999999976 4556789999999


Q ss_pred             CCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 040845          606 PHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM  684 (824)
Q Consensus       606 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  684 (824)
                      ++++|.+++.... ..+++..+..++.|++.|++|||   +.+++||||||+||++++++.+|++|||++.......   
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---  156 (256)
T cd05082          83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---  156 (256)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence            9999999997654 34789999999999999999999   9999999999999999999999999999987543221   


Q ss_pred             ccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhccccccCch
Q 040845          685 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQE  763 (824)
Q Consensus       685 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  763 (824)
                        ....++..|+|||+..+..++.++|||||||++|||++ |+.||...     .............             
T Consensus       157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~-----~~~~~~~~~~~~~-------------  216 (256)
T cd05082         157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-----PLKDVVPRVEKGY-------------  216 (256)
T ss_pred             --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC-----CHHHHHHHHhcCC-------------
Confidence              12234668999999988889999999999999999998 88887642     1111111110000             


Q ss_pred             hhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 040845          764 DIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKI  805 (824)
Q Consensus       764 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~  805 (824)
                        ....+..++..+.+++.+||+.+|++|||+.++++.|+++
T Consensus       217 --~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         217 --KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             --CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence              0001123567789999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=3.5e-36  Score=314.11  Aligned_cols=253  Identities=26%  Similarity=0.377  Sum_probs=202.2

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEecc
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYM  605 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  605 (824)
                      ++|++.+.||+|+||.||+|+.. +++.||+|+++.........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            46778889999999999999764 58999999987665555567888999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccc
Q 040845          606 PHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMT  685 (824)
Q Consensus       606 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  685 (824)
                      ++++|.+++...+ .+++.++..++.|++.|++|||   +.+++|+||||+||+++.++.++|+|||.+......  ...
T Consensus        89 ~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~--~~~  162 (267)
T cd06645          89 GGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT--IAK  162 (267)
T ss_pred             CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc--ccc
Confidence            9999999987655 6899999999999999999999   899999999999999999999999999998765322  112


Q ss_pred             cccccccccccCccCcC---CCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCc
Q 040845          686 QTQTLATIGYMAPEYGR---EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ  762 (824)
Q Consensus       686 ~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  762 (824)
                      .....|+..|+|||.+.   ...++.++||||+||++|||++|+.||.......... ........       .+.    
T Consensus       163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~-~~~~~~~~-------~~~----  230 (267)
T cd06645         163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-LMTKSNFQ-------PPK----  230 (267)
T ss_pred             cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHH-hhhccCCC-------CCc----
Confidence            23446889999999874   4558899999999999999999999986532211110 00000000       000    


Q ss_pred             hhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          763 EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       763 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                          ......++..+.+++.+||+.+|++||++++++++
T Consensus       231 ----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         231 ----LKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             ----ccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence                00011234568899999999999999999998864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=2.8e-36  Score=319.65  Aligned_cols=262  Identities=24%  Similarity=0.419  Sum_probs=202.5

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-----------------CCcEEEEEEeeccc-cchhhhHHHHHHHHhcCCCCcceeE
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-----------------DGMEVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLVKV  588 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l  588 (824)
                      ++|++.+.||+|+||.||+|.+.                 ++..||+|++.... ......+.+|+++++.++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            56899999999999999998643                 23468999987543 2345678899999999999999999


Q ss_pred             EeeeecCCeeEEEEeccCCCCHHHHhhhCC----------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCe
Q 040845          589 ISSCSNEEFKALVLEYMPHGSLEKYLHSSN----------YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNV  658 (824)
Q Consensus       589 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Ni  658 (824)
                      ++++...+..++||||+++++|.+++....          ..+++.++..++.|++.|++|||   +.+++||||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChheE
Confidence            999999999999999999999999987543          23677889999999999999999   99999999999999


Q ss_pred             eeCCCCcEEEeecccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh--CCCCCcccccCc
Q 040845          659 LLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT--RKKPTDELFNGE  736 (824)
Q Consensus       659 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t--g~~p~~~~~~~~  736 (824)
                      +++.++.++++|||++..+.............++..|+|||....+.++.++|||||||++|||++  |..||......+
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ  241 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence            999999999999999986543322222222345678999998888889999999999999999998  667776432211


Q ss_pred             chhhhhhhhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 040845          737 MTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLK  804 (824)
Q Consensus       737 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~  804 (824)
                           ++....     ........   ......+..++..+.+++.+||+.||++||++.|+++.|++
T Consensus       242 -----~~~~~~-----~~~~~~~~---~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         242 -----VIENTG-----EFFRDQGR---QVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             -----HHHHHH-----HHHhhccc---cccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence                 111000     00000000   00011122456789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=3.3e-36  Score=313.34  Aligned_cols=248  Identities=33%  Similarity=0.562  Sum_probs=204.9

Q ss_pred             ceeeeccceEEEEEEECC----CcEEEEEEeeccccch-hhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEeccCC
Q 040845          533 NLIGRGGFGSVYKARIRD----GMEVAVKVFNLQCGRA-FKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPH  607 (824)
Q Consensus       533 ~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  607 (824)
                      +.||+|+||.||+|....    +..||+|.+....... .+.+.+|+++++.++|+|++++++++......++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            469999999999998653    7889999987654333 67888999999999999999999999999999999999999


Q ss_pred             CCHHHHhhhC--------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCC
Q 040845          608 GSLEKYLHSS--------NYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG  679 (824)
Q Consensus       608 g~L~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  679 (824)
                      ++|.+++...        ...+++.++..++.|++.|++|||   +.+++|+||+|+||++++++.++|+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999999876        357899999999999999999999   99999999999999999999999999999987654


Q ss_pred             CCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhcccc
Q 040845          680 EDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDAN  758 (824)
Q Consensus       680 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  758 (824)
                      ...........++..|+|||.+....++.++||||+|+++|||++ |..||.....  .........             
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~~~~-------------  222 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN--EEVLEYLRK-------------  222 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHHc-------------
Confidence            433233344557889999999988889999999999999999999 5888876411  111111110             


Q ss_pred             ccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 040845          759 LLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLL  803 (824)
Q Consensus       759 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~  803 (824)
                           ......+..++.++.+++.+||..+|++|||+.|++++|+
T Consensus       223 -----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         223 -----GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             -----CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                 0011122345678999999999999999999999999873

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.8e-36  Score=312.42  Aligned_cols=239  Identities=22%  Similarity=0.360  Sum_probs=189.7

Q ss_pred             ceeeeccceEEEEEEECC-------------CcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeE
Q 040845          533 NLIGRGGFGSVYKARIRD-------------GMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKA  599 (824)
Q Consensus       533 ~~lg~G~~g~V~~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  599 (824)
                      +.||+|+||.||+|++.+             ...||+|++..........+.+|+.+++.++||||+++++++..+...+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            368999999999998542             2358999876654555567888999999999999999999999998999


Q ss_pred             EEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCc-------EEEeecc
Q 040845          600 LVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMV-------AHLSDFG  672 (824)
Q Consensus       600 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~-------~kl~Dfg  672 (824)
                      +||||+++|+|..++......+++..++.++.|+++|++|||   +.+|+||||||+||+++.++.       ++++|||
T Consensus        81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence            999999999999998876667899999999999999999999   999999999999999987664       8999999


Q ss_pred             cccccCCCCCccccccccccccccCccCcC-CCCCCccchHHHHHHHHHHHH-hCCCCCcccccCcchhhhhhhhhCCCc
Q 040845          673 IAKLLTGEDQSMTQTQTLATIGYMAPEYGR-EGQVSTNGDVYSFGIMLMETF-TRKKPTDELFNGEMTLKHWVNDCLPIS  750 (824)
Q Consensus       673 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~~l~el~-tg~~p~~~~~~~~~~~~~~~~~~~~~~  750 (824)
                      .+......      ....++..|+|||.+. +..++.++|||||||++|||+ +|..||......+  ........    
T Consensus       158 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--~~~~~~~~----  225 (262)
T cd05077         158 IPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE--KERFYEGQ----  225 (262)
T ss_pred             CCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH--HHHHHhcC----
Confidence            98754321      2345778899999886 456899999999999999998 5777765421111  00000000    


Q ss_pred             chhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 040845          751 TMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL  802 (824)
Q Consensus       751 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L  802 (824)
                              ..        ........+.+++.+||+.||++||++.++++++
T Consensus       226 --------~~--------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         226 --------CM--------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             --------cc--------CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence                    00        0001235688999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-36  Score=318.04  Aligned_cols=253  Identities=25%  Similarity=0.362  Sum_probs=205.8

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEec
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      .++|++.+.||+|+||.||+|.+. ++..||+|++........+.+..|++++++++|+||+++++++..+...++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            356888899999999999999875 5899999998766555567788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 040845          605 MPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM  684 (824)
Q Consensus       605 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  684 (824)
                      +++++|.+++...+..+++..+..++.|++.|++|||   +.+|+|+||+|+||+++.++.++|+|||.+.......  .
T Consensus        84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--~  158 (280)
T cd06611          84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL--Q  158 (280)
T ss_pred             cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhcccc--c
Confidence            9999999999876667899999999999999999999   9999999999999999999999999999887543221  1


Q ss_pred             ccccccccccccCccCcC-----CCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccc
Q 040845          685 TQTQTLATIGYMAPEYGR-----EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANL  759 (824)
Q Consensus       685 ~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  759 (824)
                      ......++..|+|||.+.     ...++.++||||+|+++|||++|+.||...... .....+.....            
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~------------  225 (280)
T cd06611         159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM-RVLLKILKSEP------------  225 (280)
T ss_pred             ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH-HHHHHHhcCCC------------
Confidence            223345888999999874     345678999999999999999999998763211 11111111000            


Q ss_pred             cCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          760 LSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       760 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                           .....+..++..+.+++.+||+.+|++||++.+++++
T Consensus       226 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         226 -----PTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             -----CCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence                 0011122345678999999999999999999999876

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=2.6e-36  Score=320.90  Aligned_cols=261  Identities=27%  Similarity=0.459  Sum_probs=207.0

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCc----EEEEEEeecccc-chhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEE
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGM----EVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKAL  600 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  600 (824)
                      ++|+..+.||+|+||.||+|.+. +|.    .||+|.+..... .....+.+|+.+++.++||||+++++++..+ ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            56788899999999999999864 344    578888764432 2234678899999999999999999998754 4679


Q ss_pred             EEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 040845          601 VLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE  680 (824)
Q Consensus       601 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  680 (824)
                      ++||+++|+|.+++......+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||+++.+...
T Consensus        86 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~  162 (303)
T cd05110          86 VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD  162 (303)
T ss_pred             eehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEccccccccccCc
Confidence            99999999999999876667899999999999999999999   999999999999999999999999999999876533


Q ss_pred             CCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhccccc
Q 040845          681 DQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANL  759 (824)
Q Consensus       681 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  759 (824)
                      ..........++..|+|||.+.+..++.++|||||||++||+++ |+.||.....  .....++.....           
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~--~~~~~~~~~~~~-----------  229 (303)
T cd05110         163 EKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT--REIPDLLEKGER-----------  229 (303)
T ss_pred             ccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHCCCC-----------
Confidence            33222233446778999999988889999999999999999998 8899865321  112222211100           


Q ss_pred             cCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhcc
Q 040845          760 LSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLR  811 (824)
Q Consensus       760 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~  811 (824)
                             ...+..++..+.+++.+||..+|++||++.++++.++++.+...+
T Consensus       230 -------~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~~  274 (303)
T cd05110         230 -------LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQR  274 (303)
T ss_pred             -------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchhh
Confidence                   001122455688999999999999999999999999998655443

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=3.9e-36  Score=328.87  Aligned_cols=266  Identities=25%  Similarity=0.323  Sum_probs=199.1

Q ss_pred             cCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeecCC-----eeE
Q 040845          528 KFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEE-----FKA  599 (824)
Q Consensus       528 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  599 (824)
                      +|++.+.||+|+||.||+|... +|+.||||++....  ....+.+.+|+++++.++|+||+++++++..+.     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4788899999999999999864 68999999885432  223456788999999999999999999998766     789


Q ss_pred             EEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCC
Q 040845          600 LVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG  679 (824)
Q Consensus       600 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  679 (824)
                      +||||+. ++|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus        81 lv~e~~~-~~l~~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~  155 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSPQ-PLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP  155 (372)
T ss_pred             EEeeccc-cCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence            9999996 58888876544 6899999999999999999999   99999999999999999999999999999986532


Q ss_pred             CCCccccccccccccccCccCcCCC-CCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhh----
Q 040845          680 EDQSMTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEV----  754 (824)
Q Consensus       680 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----  754 (824)
                      .. ........++..|+|||.+.+. .++.++||||+||++|||++|+.||......+ ...... ........+.    
T Consensus       156 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~-~~~g~~~~~~~~~~  232 (372)
T cd07853         156 DE-SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ-QLDLIT-DLLGTPSLEAMRSA  232 (372)
T ss_pred             Cc-cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH-HHHHHH-HHcCCCCHHHHHHh
Confidence            22 1222344678999999988764 47899999999999999999999997532211 111111 0000000000    


Q ss_pred             -------ccccccCchhh--hhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          755 -------VDANLLSQEDI--HFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       755 -------~~~~~~~~~~~--~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                             +..........  ........+.++.+++.+||+.||++|||+.|++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence                   00000000000  000111235678999999999999999999999886

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.1e-36  Score=332.64  Aligned_cols=266  Identities=21%  Similarity=0.197  Sum_probs=202.3

Q ss_pred             hccCCCCceeeeccceEEEEEEEC---CCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR---DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVL  602 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  602 (824)
                      ..+|.+.+.||+|+||.||+|...   .+..||+|.+...     ....+|+++++.++||||+++++++......++||
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            457999999999999999999753   3578999987532     33567999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 040845          603 EYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ  682 (824)
Q Consensus       603 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  682 (824)
                      |++. ++|.+++... ..+++.+++.++.|++.||+|||   +.+|+||||||+||+++.++.++|+|||++........
T Consensus       166 e~~~-~~l~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~  240 (392)
T PHA03207        166 PKYK-CDLFTYVDRS-GPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD  240 (392)
T ss_pred             hhcC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence            9995 6898888544 47899999999999999999999   99999999999999999999999999999987654433


Q ss_pred             ccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCc--chhhhhhhhhCCCc------ch--
Q 040845          683 SMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGE--MTLKHWVNDCLPIS------TM--  752 (824)
Q Consensus       683 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~------~~--  752 (824)
                      ........||+.|+|||++.+..++.++||||+||++|||++|+.||.+.....  ..+...+.......      ..  
T Consensus       241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~  320 (392)
T PHA03207        241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTN  320 (392)
T ss_pred             cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchh
Confidence            333344569999999999998899999999999999999999999987643221  11111111110000      00  


Q ss_pred             --hhccccccC-c---hhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          753 --EVVDANLLS-Q---EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       753 --~~~~~~~~~-~---~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                        ......... .   ...........+.++.+++.+||..||++|||+.|++.+
T Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        321 LCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             HHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence              000000000 0   000001112345678899999999999999999999887

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=3.1e-36  Score=318.14  Aligned_cols=256  Identities=27%  Similarity=0.436  Sum_probs=204.4

Q ss_pred             hccCCCCceeeeccceEEEEEEEC------CCcEEEEEEeecccc-chhhhHHHHHHHHhcCCCCcceeEEeeeecCCee
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR------DGMEVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFK  598 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  598 (824)
                      .++|++.+.||+|+||.||+|..+      ++..||+|++..... .....+.+|+.+++.++||||+++++++.++...
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            467889999999999999999864      467899999865432 3346688899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhhCC---------------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCC
Q 040845          599 ALVLEYMPHGSLEKYLHSSN---------------------YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSN  657 (824)
Q Consensus       599 ~lv~e~~~~g~L~~~l~~~~---------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~N  657 (824)
                      ++||||+++|+|.+++....                     ..+++.+++.++.|++.|++|||   +.+++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHhh
Confidence            99999999999999996432                     24678889999999999999999   9999999999999


Q ss_pred             eeeCCCCcEEEeecccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCc
Q 040845          658 VLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGE  736 (824)
Q Consensus       658 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~  736 (824)
                      |++++++.++++|||.+..+..............+..|+|||.+.+..++.++|||||||++|||++ |..||.+.... 
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~-  239 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE-  239 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence            9999999999999999876543322222223345678999999988899999999999999999998 77887543211 


Q ss_pred             chhhhhhhhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 040845          737 MTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLK  804 (824)
Q Consensus       737 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~  804 (824)
                          .+.......        ...       ..+..++..+.+++.+||+.||++|||+.|+++.|++
T Consensus       240 ----~~~~~~~~~--------~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         240 ----EVIYYVRDG--------NVL-------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             ----HHHHHHhcC--------CCC-------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence                111111000        000       0112346679999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=5.5e-36  Score=318.29  Aligned_cols=268  Identities=23%  Similarity=0.306  Sum_probs=202.8

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc-cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEe
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLE  603 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  603 (824)
                      .++|++.+.||+|+||.||+|+.+ +++.||+|.++... ......+.+|+.+++.++||||+++++++..+...++|||
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e   84 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   84 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence            357889999999999999999865 58899999986543 2334567789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 040845          604 YMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS  683 (824)
Q Consensus       604 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  683 (824)
                      |++ ++|.+++......+++..+..++.|+++|++|||   +.+|+|+||||+||++++++.++|+|||++........ 
T Consensus        85 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-  159 (301)
T cd07873          85 YLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-  159 (301)
T ss_pred             ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-
Confidence            996 5999998876667889999999999999999999   99999999999999999999999999999875432221 


Q ss_pred             cccccccccccccCccCcCCC-CCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcc----hhhcccc
Q 040845          684 MTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPIST----MEVVDAN  758 (824)
Q Consensus       684 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~  758 (824)
                       ......++..|+|||.+.+. .++.++||||+||++|||++|+.||......+  ....+........    .......
T Consensus       160 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  236 (301)
T cd07873         160 -TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE--QLHFIFRILGTPTEETWPGILSNE  236 (301)
T ss_pred             -cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHcCCCChhhchhhhccc
Confidence             12234578899999987654 57889999999999999999999987532211  1111111111000    0000000


Q ss_pred             ccC---chh----hhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          759 LLS---QED----IHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       759 ~~~---~~~----~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      ...   .+.    ........++..+.+++.+|++.||.+|||++|++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h  286 (301)
T cd07873         237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH  286 (301)
T ss_pred             cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            000   000    0001112456678999999999999999999999874

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.4e-36  Score=325.84  Aligned_cols=237  Identities=29%  Similarity=0.333  Sum_probs=188.5

Q ss_pred             ceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHH-HHhcCCCCcceeEEeeeecCCeeEEEEeccCC
Q 040845          533 NLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECA-MMKSIRHRNLVKVISSCSNEEFKALVLEYMPH  607 (824)
Q Consensus       533 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  607 (824)
                      +.||+|+||+||+|+.. +|+.||+|++....   ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999875 58999999987542   122233444444 56889999999999999999999999999999


Q ss_pred             CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccccc
Q 040845          608 GSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQT  687 (824)
Q Consensus       608 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  687 (824)
                      |+|.+++.... .+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||++.......  ....
T Consensus        81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~  154 (323)
T cd05575          81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KTTS  154 (323)
T ss_pred             CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Cccc
Confidence            99999997654 6889999999999999999999   9999999999999999999999999999987532221  1223


Q ss_pred             cccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhhhh
Q 040845          688 QTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHF  767 (824)
Q Consensus       688 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  767 (824)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||.....     .........        ...        
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-----~~~~~~i~~--------~~~--------  213 (323)
T cd05575         155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT-----AEMYDNILN--------KPL--------  213 (323)
T ss_pred             cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH-----HHHHHHHHc--------CCC--------
Confidence            44689999999999998999999999999999999999999875311     111111110        000        


Q ss_pred             hhHHHHHHHHHHHHHHccccCCCCCCCHH
Q 040845          768 VAKEQCVSFVFNLALECTVESPEQRINAK  796 (824)
Q Consensus       768 ~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~  796 (824)
                      ..+...+..+.+++.+|++.||++||++.
T Consensus       214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         214 RLKPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            00112356688999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2.1e-36  Score=329.44  Aligned_cols=258  Identities=23%  Similarity=0.287  Sum_probs=201.6

Q ss_pred             HHHhhccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCe
Q 040845          522 LFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEF  597 (824)
Q Consensus       522 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  597 (824)
                      +....++|++.+.||+|+||.||+|+.+ +++.||+|++....   ....+.+.+|+.+++.++||||+++++++.++..
T Consensus        38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~  117 (371)
T cd05622          38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY  117 (371)
T ss_pred             cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence            3444588999999999999999999876 58899999986432   2234557789999999999999999999999999


Q ss_pred             eEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccccc
Q 040845          598 KALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  677 (824)
Q Consensus       598 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~  677 (824)
                      .++||||+++|+|.+++...  .++...+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++...
T Consensus       118 ~~lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~  192 (371)
T cd05622         118 LYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM  192 (371)
T ss_pred             EEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCceeEc
Confidence            99999999999999998754  4788888999999999999999   999999999999999999999999999999876


Q ss_pred             CCCCCccccccccccccccCccCcCCC----CCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchh
Q 040845          678 TGEDQSMTQTQTLATIGYMAPEYGREG----QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTME  753 (824)
Q Consensus       678 ~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  753 (824)
                      ..... .......||+.|+|||++...    .++.++||||+||++|||++|+.||...... .....+...   .    
T Consensus       193 ~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-~~~~~i~~~---~----  263 (371)
T cd05622         193 NKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-GTYSKIMNH---K----  263 (371)
T ss_pred             CcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH-HHHHHHHcC---C----
Confidence            43221 122345699999999988643    3789999999999999999999999752111 011111100   0    


Q ss_pred             hccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHH
Q 040845          754 VVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQ--RINAKEIVAKL  802 (824)
Q Consensus       754 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rpt~~evl~~L  802 (824)
                               .....+....++..+.+++.+|+..++.+  |+++.|++++.
T Consensus       264 ---------~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         264 ---------NSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             ---------CcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence                     00011111234667889999999844443  78999999875

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=5.7e-36  Score=326.09  Aligned_cols=267  Identities=22%  Similarity=0.266  Sum_probs=198.3

Q ss_pred             HhhccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeecCC----
Q 040845          524 QATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEE----  596 (824)
Q Consensus       524 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  596 (824)
                      ...++|++.+.||+|+||.||+|... +|..||||++....  ......+.+|+.+++.++||||+++++++....    
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   97 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE   97 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence            34578999999999999999999864 58999999986432  233456778999999999999999999986443    


Q ss_pred             --eeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccc
Q 040845          597 --FKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIA  674 (824)
Q Consensus       597 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a  674 (824)
                        ..++||||+++ ++.+.+..   .+++.++..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++
T Consensus        98 ~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a  170 (359)
T cd07876          98 FQDVYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA  170 (359)
T ss_pred             cceeEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCCCc
Confidence              57899999965 67666643   4788889999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhh
Q 040845          675 KLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEV  754 (824)
Q Consensus       675 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  754 (824)
                      ......   .......+|+.|+|||.+.+..++.++||||+||++|||++|+.||......+ ......... .....+.
T Consensus       171 ~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~-~~~~~~~~~-~~~~~~~  245 (359)
T cd07876         171 RTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHID-QWNKVIEQL-GTPSAEF  245 (359)
T ss_pred             cccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhc-CCCcHHH
Confidence            754322   12233568999999999999899999999999999999999999997532110 010000000 0000000


Q ss_pred             c-----------c--ccccCch----------hhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 040845          755 V-----------D--ANLLSQE----------DIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL  802 (824)
Q Consensus       755 ~-----------~--~~~~~~~----------~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L  802 (824)
                      .           .  +......          ..........+..+.+++.+||..||++|||+.|++++-
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp  316 (359)
T cd07876         246 MNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP  316 (359)
T ss_pred             HHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence            0           0  0000000          000000112356689999999999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4.4e-36  Score=316.55  Aligned_cols=271  Identities=25%  Similarity=0.408  Sum_probs=209.4

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-----CCcEEEEEEeeccccc-hhhhHHHHHHHHhcCCCCcceeEEeeeec--CCee
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-----DGMEVAVKVFNLQCGR-AFKSFDVECAMMKSIRHRNLVKVISSCSN--EEFK  598 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~  598 (824)
                      +.|+..+.||+|+||.||+|++.     ++..||||++...... ..+.+..|+++++.++|+||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            45777899999999999999854     3688999998765443 46788999999999999999999999877  5678


Q ss_pred             EEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccC
Q 040845          599 ALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT  678 (824)
Q Consensus       599 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~  678 (824)
                      ++||||+++++|.+++......+++..+..++.|++.|++|||   +.+++|+||||+||+++.++.++++|||.+....
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLP  160 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence            9999999999999999876667899999999999999999999   9999999999999999999999999999998765


Q ss_pred             CCCCccc-cccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccc
Q 040845          679 GEDQSMT-QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDA  757 (824)
Q Consensus       679 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  757 (824)
                      ....... .....++..|+|||...+..++.++||||||+++|||++|+.|+.........   ++..............
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~  237 (284)
T cd05038         161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR---MIGIAQGQMIVTRLLE  237 (284)
T ss_pred             cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc---ccccccccccHHHHHH
Confidence            3322211 12233566799999998888999999999999999999999998653222111   0000000000000000


Q ss_pred             cccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 040845          758 NLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKI  805 (824)
Q Consensus       758 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~  805 (824)
                      ...  ...+...+..++.++.+++.+||+.+|++||||.|+++.|+++
T Consensus       238 ~~~--~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         238 LLK--EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHH--cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            000  0011112234567899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=4.3e-36  Score=312.53  Aligned_cols=252  Identities=27%  Similarity=0.478  Sum_probs=195.3

Q ss_pred             ceeeeccceEEEEEEECC----CcEEEEEEeeccc-cchhhhHHHHHHHHhcCCCCcceeEEeeee-cCCeeEEEEeccC
Q 040845          533 NLIGRGGFGSVYKARIRD----GMEVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLVKVISSCS-NEEFKALVLEYMP  606 (824)
Q Consensus       533 ~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~~  606 (824)
                      +.||+|+||.||+|.+.+    +..||+|.+.... ....+.+.+|+.+++.++||||+++++++. .+...++||||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            468999999999997532    4579999875332 234567888999999999999999999875 4556889999999


Q ss_pred             CCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc--c
Q 040845          607 HGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS--M  684 (824)
Q Consensus       607 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~  684 (824)
                      +|+|.+++.......++..+..++.|++.|++|||   +.+++||||||+||++++++.+||+|||+++........  .
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~  157 (262)
T cd05058          81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH  157 (262)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence            99999999876556788888999999999999999   999999999999999999999999999999765432211  1


Q ss_pred             ccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCC-CCcccccCcchhhhhhhhhCCCcchhhccccccCch
Q 040845          685 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKK-PTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQE  763 (824)
Q Consensus       685 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  763 (824)
                      ......++..|+|||...+..++.++|||||||++|||++|+. ||....  .......+...                 
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~--~~~~~~~~~~~-----------------  218 (262)
T cd05058         158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD--SFDITVYLLQG-----------------  218 (262)
T ss_pred             ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHHhcC-----------------
Confidence            1123346778999999988889999999999999999999654 444321  11111111000                 


Q ss_pred             hhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 040845          764 DIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRD  807 (824)
Q Consensus       764 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~  807 (824)
                       .....+..++..+.+++.+||..+|++||++.|+++.|+++..
T Consensus       219 -~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         219 -RRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             -CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence             0001112345678999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=4.5e-36  Score=323.64  Aligned_cols=260  Identities=26%  Similarity=0.419  Sum_probs=206.5

Q ss_pred             ccCCCCceeeeccceEEEEEEECC--------CcEEEEEEeeccc-cchhhhHHHHHHHHhcC-CCCcceeEEeeeecCC
Q 040845          527 DKFSENNLIGRGGFGSVYKARIRD--------GMEVAVKVFNLQC-GRAFKSFDVECAMMKSI-RHRNLVKVISSCSNEE  596 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  596 (824)
                      .+|.+.+.||+|+||.||+|++..        +..||+|.++... ....+.+.+|+++++++ +||||+++++++..+.
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            468899999999999999997421        2368999886432 23456788999999999 7999999999999999


Q ss_pred             eeEEEEeccCCCCHHHHhhhCC---------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC
Q 040845          597 FKALVLEYMPHGSLEKYLHSSN---------------YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD  661 (824)
Q Consensus       597 ~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~  661 (824)
                      ..+++|||+++|+|.+++....               ..+++.++..++.|++.|++|||   +.+++||||||+||+++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nill~  168 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLVT  168 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEc
Confidence            9999999999999999987532               24788899999999999999999   99999999999999999


Q ss_pred             CCCcEEEeecccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhh
Q 040845          662 DNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLK  740 (824)
Q Consensus       662 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~  740 (824)
                      .++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||....     ..
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-----~~  243 (334)
T cd05100         169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP-----VE  243 (334)
T ss_pred             CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC-----HH
Confidence            999999999999986643322222222334568999999998899999999999999999998 788876532     11


Q ss_pred             hhhhhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhh
Q 040845          741 HWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSL  809 (824)
Q Consensus       741 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~  809 (824)
                      .+.......               .....+..++..+.+++.+||+.+|++||++.|+++.|+++....
T Consensus       244 ~~~~~~~~~---------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~  297 (334)
T cd05100         244 ELFKLLKEG---------------HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT  297 (334)
T ss_pred             HHHHHHHcC---------------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence            111111000               000112234567899999999999999999999999999997544

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=2.5e-36  Score=323.43  Aligned_cols=241  Identities=21%  Similarity=0.272  Sum_probs=193.2

Q ss_pred             cCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcCC-CCcceeEEeeeecCCeeEEEE
Q 040845          528 KFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIR-HRNLVKVISSCSNEEFKALVL  602 (824)
Q Consensus       528 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  602 (824)
                      +|+..+.||+|+||.||+|+.. +|+.||+|++....   ....+.+..|..++..+. |++|+++++++.+.+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            3677899999999999999865 58999999987542   233456777888888885 577888999999999999999


Q ss_pred             eccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 040845          603 EYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ  682 (824)
Q Consensus       603 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  682 (824)
                      ||+++|+|.+++.... .+++.++..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||++....... 
T Consensus        81 Ey~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~-  155 (323)
T cd05615          81 EYVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG-  155 (323)
T ss_pred             cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC-
Confidence            9999999999987655 6899999999999999999999   9999999999999999999999999999987542221 


Q ss_pred             ccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCc
Q 040845          683 SMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ  762 (824)
Q Consensus       683 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  762 (824)
                       .......||+.|+|||++.+..++.++||||+||++|||++|+.||......  .....+   ...        .    
T Consensus       156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--~~~~~i---~~~--------~----  217 (323)
T cd05615         156 -VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED--ELFQSI---MEH--------N----  217 (323)
T ss_pred             -ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH--HHHHHH---HhC--------C----
Confidence             1223345899999999999888999999999999999999999999763211  111110   000        0    


Q ss_pred             hhhhhhhHHHHHHHHHHHHHHccccCCCCCCCH
Q 040845          763 EDIHFVAKEQCVSFVFNLALECTVESPEQRINA  795 (824)
Q Consensus       763 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~  795 (824)
                          ...+..++..+.+++.+||+.+|.+|+++
T Consensus       218 ----~~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         218 ----VSYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             ----CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence                00112345568899999999999999974

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=4.5e-39  Score=334.91  Aligned_cols=372  Identities=27%  Similarity=0.391  Sum_probs=229.6

Q ss_pred             CCCCcEEEccCCccc-ccccccccCCCCCCEEeCCCCcCCcccChhhhCcCCCceeeccCCccccccCccccCCCCCccE
Q 040845           20 ISNLKVLYLYNNRLQ-GEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEV   98 (824)
Q Consensus        20 l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~   98 (824)
                      ++-.+-.|+++|.++ +..|.+...+++++.|-|...++. .+|+.++.+.+|++|.+++|++..+-.....  ||.|+.
T Consensus         6 LpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~~vhGELs~--Lp~LRs   82 (1255)
T KOG0444|consen    6 LPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLISVHGELSD--LPRLRS   82 (1255)
T ss_pred             cceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhHhhhhhhcc--chhhHH
Confidence            334455555666555 345555555566666666555555 5555566666666666666655554444432  555555


Q ss_pred             EEccCCeeee-ecCccccCCCCCceEeccCccccccCCccccCCCCCCEEEccCCcCCCCcCcccccccCCCCCCCcEEE
Q 040845           99 LYLWGNNFSG-TIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHIS  177 (824)
Q Consensus        99 L~L~~n~i~~-~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~~L~~L~  177 (824)
                      +.+..|++.. -+|..+..+..|+.|+|++|+++ ..|..+..-+++-+|+||+|+|.++|...     +.+++.|-.||
T Consensus        83 v~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~l-----finLtDLLfLD  156 (1255)
T KOG0444|consen   83 VIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSL-----FINLTDLLFLD  156 (1255)
T ss_pred             HhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchH-----HHhhHhHhhhc
Confidence            5565555542 24555555666666666666665 44555555555666666666665555432     44555555555


Q ss_pred             CcCCCCCccCCccccccccccccEEEeecCcceecCCccCCCCCCCCEEEecCCccCCccchhhcCCCCCCEEEcccccC
Q 040845          178 LSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQL  257 (824)
Q Consensus       178 Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l  257 (824)
                      ||+|++...                           |..+..+..|++|.|++|.+...--..+..+++|+.|.+++.+-
T Consensus       157 LS~NrLe~L---------------------------PPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqR  209 (1255)
T KOG0444|consen  157 LSNNRLEML---------------------------PPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQR  209 (1255)
T ss_pred             cccchhhhc---------------------------CHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccc
Confidence            555555432                           33344455666666666665433233344555666666666553


Q ss_pred             c-ccCCccccccCCccEEEccCccccccCCccccCCCCCcEEEcCCCCCCCCCCcccccccccccccccccccCcCCccc
Q 040845          258 E-GSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEI  336 (824)
Q Consensus       258 ~-~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~  336 (824)
                      + .-+|.++..+.+|..++++.|.+. ..|+++.++++|+.|+||+|+|+++........+|++|+||+|+++ .+|.++
T Consensus       210 Tl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt-~LP~av  287 (1255)
T KOG0444|consen  210 TLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLT-VLPDAV  287 (1255)
T ss_pred             hhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccchhc-cchHHH
Confidence            3 235566666666666666666666 6677777777777777777777777666666667777777777777 677777


Q ss_pred             cccccchhhhccccccc-ccCCCccCCCCCCCeEEccCccccccCCccccccccccEEEccCcccCCCCcccccCCcccc
Q 040845          337 RNLKALIEIDFSMNNFS-GIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLK  415 (824)
Q Consensus       337 ~~l~~L~~L~l~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~  415 (824)
                      .+++.|+.|.+.+|+++ .-+|..++.+.+|+.+..++|++. ..|+.+..|..|+.|.|+.|++- .+|+.+.-++.|+
T Consensus       288 cKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~  365 (1255)
T KOG0444|consen  288 CKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLK  365 (1255)
T ss_pred             hhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcc
Confidence            77777777777777764 235667777777777777777776 67777777777777777777776 7777777777777


Q ss_pred             eeeccCCcccCCCCCC
Q 040845          416 DLNLSFNKLKGEIPRG  431 (824)
Q Consensus       416 ~L~l~~N~l~~~~p~~  431 (824)
                      .||+..|+=--.+|..
T Consensus       366 vLDlreNpnLVMPPKP  381 (1255)
T KOG0444|consen  366 VLDLRENPNLVMPPKP  381 (1255)
T ss_pred             eeeccCCcCccCCCCc
Confidence            7777777655555553

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.5e-36  Score=330.72  Aligned_cols=253  Identities=24%  Similarity=0.331  Sum_probs=198.5

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEE
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVL  602 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  602 (824)
                      ++|+..+.||+|+||.||+|+.+ +++.||+|+++...   ......+..|+.++..++|++|+++++.+.+.+..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46888999999999999999865 58999999987532   234566788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 040845          603 EYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ  682 (824)
Q Consensus       603 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  682 (824)
                      ||+++|+|.+++...+ .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.++|+|||++..+.....
T Consensus        81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~  156 (360)
T cd05627          81 EFLPGGDMMTLLMKKD-TLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR  156 (360)
T ss_pred             eCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence            9999999999997655 6889999999999999999999   99999999999999999999999999999875432110


Q ss_pred             c---------------------------------cccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCC
Q 040845          683 S---------------------------------MTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPT  729 (824)
Q Consensus       683 ~---------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~  729 (824)
                      .                                 .......||+.|+|||++.+..++.++||||+||++|||++|+.||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf  236 (360)
T cd05627         157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF  236 (360)
T ss_pred             cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence            0                                 0011346899999999999999999999999999999999999999


Q ss_pred             cccccCcchhhhhhhhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCC---HHHHHHH
Q 040845          730 DELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRIN---AKEIVAK  801 (824)
Q Consensus       730 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt---~~evl~~  801 (824)
                      ......+ ......    ...      ..      ...+.....+..+.+++.+|+. ||++|++   +.|+++|
T Consensus       237 ~~~~~~~-~~~~i~----~~~------~~------~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h  293 (360)
T cd05627         237 CSETPQE-TYRKVM----NWK------ET------LVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH  293 (360)
T ss_pred             CCCCHHH-HHHHHH----cCC------Cc------eecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence            7532211 111100    000      00      0000011234567888888764 9999985   6777766

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=3.9e-36  Score=311.90  Aligned_cols=248  Identities=26%  Similarity=0.395  Sum_probs=200.6

Q ss_pred             ceeeeccceEEEEEEECC--C--cEEEEEEeecccc-chhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEeccCC
Q 040845          533 NLIGRGGFGSVYKARIRD--G--MEVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPH  607 (824)
Q Consensus       533 ~~lg~G~~g~V~~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  607 (824)
                      +.||+|++|.||+|.+.+  +  ..||||.+..... ...+.+..|+.++++++||||+++++++.+ ...++||||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999998753  3  3699999876654 556788899999999999999999999988 889999999999


Q ss_pred             CCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc-c
Q 040845          608 GSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM-T  685 (824)
Q Consensus       608 g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~  685 (824)
                      ++|.+++.... ..+++..++.++.|++.|++|||   +.+++|+||+|+||+++.++.+||+|||++..+....... .
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  156 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM  156 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence            99999997755 56899999999999999999999   9999999999999999999999999999998765433221 1


Q ss_pred             cccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchh
Q 040845          686 QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQED  764 (824)
Q Consensus       686 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  764 (824)
                      .....++..|+|||.+.+..++.++|||||||++|||++ |+.||......+  ....+....                 
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~~~~-----------------  217 (257)
T cd05040         157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ--ILKKIDKEG-----------------  217 (257)
T ss_pred             ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHhcC-----------------
Confidence            223456788999999988889999999999999999999 999986532111  111111000                 


Q ss_pred             hhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 040845          765 IHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLL  803 (824)
Q Consensus       765 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~  803 (824)
                      .....+..++..+.+++.+||+.+|++||+++|+++.|.
T Consensus       218 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         218 ERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            000111234567899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2.6e-36  Score=323.89  Aligned_cols=248  Identities=22%  Similarity=0.310  Sum_probs=195.4

Q ss_pred             ceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcC-CCCcceeEEeeeecCCeeEEEEeccCC
Q 040845          533 NLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSI-RHRNLVKVISSCSNEEFKALVLEYMPH  607 (824)
Q Consensus       533 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  607 (824)
                      +.||+|+||.||+|+.. +++.||+|+++...   ....+.+..|+.++.++ +||+|+++++++.+....++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            47999999999999865 57899999997542   23345677899999888 699999999999999999999999999


Q ss_pred             CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccccc
Q 040845          608 GSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQT  687 (824)
Q Consensus       608 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  687 (824)
                      |+|.+++...+ .+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||++.......  ....
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~  154 (327)
T cd05617          81 GDLMFHMQRQR-KLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DTTS  154 (327)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Ccee
Confidence            99999887654 6899999999999999999999   9999999999999999999999999999987532211  1223


Q ss_pred             cccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccC-cchhhhhhhhhCCCcchhhccccccCchhhh
Q 040845          688 QTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNG-EMTLKHWVNDCLPISTMEVVDANLLSQEDIH  766 (824)
Q Consensus       688 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  766 (824)
                      ...||+.|+|||++.+..++.++||||+||++|||++|+.||...... ......+......       ..        .
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-------~~--------~  219 (327)
T cd05617         155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVIL-------EK--------P  219 (327)
T ss_pred             cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHH-------hC--------C
Confidence            356899999999999999999999999999999999999999653221 1111111111000       00        0


Q ss_pred             hhhHHHHHHHHHHHHHHccccCCCCCCCH------HHHHHH
Q 040845          767 FVAKEQCVSFVFNLALECTVESPEQRINA------KEIVAK  801 (824)
Q Consensus       767 ~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~------~evl~~  801 (824)
                      ...+...+..+.+++.+||+.||++|+++      .+++++
T Consensus       220 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  260 (327)
T cd05617         220 IRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH  260 (327)
T ss_pred             CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence            00112345668899999999999999985      466554

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=7.5e-36  Score=311.87  Aligned_cols=252  Identities=26%  Similarity=0.400  Sum_probs=191.4

Q ss_pred             ceeeeccceEEEEEEECC---CcEEEEEEeecccc-chhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEeccCCC
Q 040845          533 NLIGRGGFGSVYKARIRD---GMEVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHG  608 (824)
Q Consensus       533 ~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  608 (824)
                      +.||+|+||.||+|.+.+   +..+|+|.++.... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            368999999999998653   45799998865432 23356888999999999999999999999999999999999999


Q ss_pred             CHHHHhhhCC----CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 040845          609 SLEKYLHSSN----YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM  684 (824)
Q Consensus       609 ~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  684 (824)
                      +|.+++....    ...++..+..++.|++.|++|||   +.+++|+||||+||+++.++.+|++|||.+..........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            9999997532    24567788899999999999999   9999999999999999999999999999997543332222


Q ss_pred             ccccccccccccCccCcCCC-------CCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhcc
Q 040845          685 TQTQTLATIGYMAPEYGREG-------QVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVD  756 (824)
Q Consensus       685 ~~~~~~~~~~y~aPE~~~~~-------~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  756 (824)
                      ......++..|+|||++...       .++.++||||||+++|||++ |+.||......+. ....+..    ......+
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~-~~~~~~~----~~~~~~~  232 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV-LTYTVRE----QQLKLPK  232 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH-HHHHhhc----ccCCCCC
Confidence            22334567889999987532       35789999999999999996 9999865332211 1110000    0000011


Q ss_pred             ccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 040845          757 ANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLL  803 (824)
Q Consensus       757 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~  803 (824)
                      +..          ...++..+.+++..|| .+|++|||++|+++.|.
T Consensus       233 ~~~----------~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         233 PRL----------KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             Ccc----------CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            100          1123455788999999 68999999999998764

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=6.3e-36  Score=310.09  Aligned_cols=251  Identities=27%  Similarity=0.444  Sum_probs=203.3

Q ss_pred             ccCCCCceeeeccceEEEEEEECCCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEeccC
Q 040845          527 DKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMP  606 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  606 (824)
                      .+|++.+.||+|+||.||+|.+.+++.+|+|.+... ......+.+|++++++++||+++++++++......++||||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            467888999999999999998877889999988643 2234578899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcccc
Q 040845          607 HGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQ  686 (824)
Q Consensus       607 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  686 (824)
                      +++|.+++......+++..+..++.|++.|++|||   +.+++|+||||+||+++.++.++|+|||.+........ ...
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~~  158 (256)
T cd05112          83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-TSS  158 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCcc-ccc
Confidence            99999999876556889999999999999999999   99999999999999999999999999999876532211 112


Q ss_pred             ccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhh
Q 040845          687 TQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDI  765 (824)
Q Consensus       687 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  765 (824)
                      ....++.+|+|||...++.++.++||||+|+++|||++ |..||......  ..........                  
T Consensus       159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~------------------  218 (256)
T cd05112         159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS--EVVETINAGF------------------  218 (256)
T ss_pred             CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH--HHHHHHhCCC------------------
Confidence            22335678999999988889999999999999999998 88988652211  1111110000                  


Q ss_pred             hhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 040845          766 HFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL  802 (824)
Q Consensus       766 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L  802 (824)
                      +...+...+..+.+++.+||+.+|++|||+.|++++|
T Consensus       219 ~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         219 RLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             CCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence            0000112346689999999999999999999999887

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=3.4e-36  Score=315.14  Aligned_cols=252  Identities=23%  Similarity=0.315  Sum_probs=199.2

Q ss_pred             hhccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcC-CCCcceeEEeeeecC------C
Q 040845          525 ATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSI-RHRNLVKVISSCSNE------E  596 (824)
Q Consensus       525 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~------~  596 (824)
                      +.+.|++.+.||+|+||.||+|... +++.||+|++.... .....+..|+.+++++ +|+||+++++++...      .
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD   82 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence            4567888899999999999999865 58899999986543 3345778899999998 699999999998642      4


Q ss_pred             eeEEEEeccCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccc
Q 040845          597 FKALVLEYMPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK  675 (824)
Q Consensus       597 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~  675 (824)
                      ..++||||+++++|.+++.... ..+++..+..++.|++.|++|||   +.+|+|+|+||+||++++++.++|+|||++.
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~  159 (272)
T cd06637          83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSA  159 (272)
T ss_pred             EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCCCce
Confidence            6789999999999999988643 46889999999999999999999   8999999999999999999999999999998


Q ss_pred             ccCCCCCccccccccccccccCccCcC-----CCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCc
Q 040845          676 LLTGEDQSMTQTQTLATIGYMAPEYGR-----EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPIS  750 (824)
Q Consensus       676 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  750 (824)
                      ......  .......|+..|+|||++.     ...++.++||||+||++|||++|+.||.......    .+... ... 
T Consensus       160 ~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~----~~~~~-~~~-  231 (272)
T cd06637         160 QLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR----ALFLI-PRN-  231 (272)
T ss_pred             eccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH----HHHHH-hcC-
Confidence            653221  1223356888999999875     3457889999999999999999999986532111    11000 000 


Q ss_pred             chhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          751 TMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       751 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                          ..         .......++..+.+++.+||..+|++|||+.|++++
T Consensus       232 ----~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  269 (272)
T cd06637         232 ----PA---------PRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH  269 (272)
T ss_pred             ----CC---------CCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence                00         000111345678999999999999999999999864

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=2e-36  Score=322.96  Aligned_cols=194  Identities=26%  Similarity=0.405  Sum_probs=170.4

Q ss_pred             cCCCCceeeeccceEEEEEE-ECCCcEEEEEEeeccccchhhhHHHHHHHHhcCC-C-----CcceeEEeeeecCCeeEE
Q 040845          528 KFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIR-H-----RNLVKVISSCSNEEFKAL  600 (824)
Q Consensus       528 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~~l  600 (824)
                      +|++.++||+|+||.|.+|. .++++.||||+++.. .....+...|+.+|..++ |     -|+|+++++|....+.|+
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            78999999999999999996 456999999999865 344566778999999997 4     379999999999999999


Q ss_pred             EEeccCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC--CCcEEEeeccccccc
Q 040845          601 VLEYMPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD--NMVAHLSDFGIAKLL  677 (824)
Q Consensus       601 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~--~~~~kl~Dfg~a~~~  677 (824)
                      |+|.++ -+|.++++... ..++...++.|+.||+.||.+||   +.+|||+||||+|||+.+  ...+||+|||.|+..
T Consensus       266 VfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~  341 (586)
T KOG0667|consen  266 VFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE  341 (586)
T ss_pred             eehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence            999995 49999998766 57899999999999999999999   999999999999999964  448999999999875


Q ss_pred             CCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcc
Q 040845          678 TGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDE  731 (824)
Q Consensus       678 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~  731 (824)
                      ...-.     .++.+..|+|||++.+.+|+.+.||||||||++||++|.+-|.+
T Consensus       342 ~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG  390 (586)
T KOG0667|consen  342 SQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG  390 (586)
T ss_pred             CCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence            32221     45688899999999999999999999999999999999876654

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.4e-35  Score=315.90  Aligned_cols=265  Identities=22%  Similarity=0.303  Sum_probs=204.5

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc-chhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEec
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      ++|++.+.||+|+||.||+|.+. ++..||+|.+..... .....+.+|++++++++||||+++++++.+++..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            36889999999999999999865 588899998865432 2345688899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 040845          605 MPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYS-APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS  683 (824)
Q Consensus       605 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  683 (824)
                      +++++|.+++.... .+++..+..++.|+++|++|||   + .+++|+||||+||+++.++.++|+|||++.......  
T Consensus        81 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--  154 (308)
T cd06615          81 MDGGSLDQVLKKAG-RIPENILGKISIAVLRGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--  154 (308)
T ss_pred             cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc--
Confidence            99999999998664 6889999999999999999999   6 589999999999999999999999999987543221  


Q ss_pred             cccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcch-----------
Q 040845          684 MTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTM-----------  752 (824)
Q Consensus       684 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-----------  752 (824)
                        .....++..|+|||.+.+..++.++|+||||+++|||++|+.||....  ......+..........           
T Consensus       155 --~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (308)
T cd06615         155 --ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD--AKELEAMFGRPVSEGEAKESHRPVSGHP  230 (308)
T ss_pred             --cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc--hhhHHHhhcCccccccccCCcccccCCC
Confidence              123468899999999888889999999999999999999999986432  11112111111000000           


Q ss_pred             ----------hhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 040845          753 ----------EVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLL  803 (824)
Q Consensus       753 ----------~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~  803 (824)
                                +..+.. ....... .....++.++.+++.+||..+|++|||+.|++++-.
T Consensus       231 ~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~  289 (308)
T cd06615         231 PDSPRPMAIFELLDYI-VNEPPPK-LPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF  289 (308)
T ss_pred             CCccchhhHHHHHHHH-hcCCCcc-CcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence                      000000 0000000 001125667999999999999999999999998843

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=8e-36  Score=311.03  Aligned_cols=252  Identities=23%  Similarity=0.362  Sum_probs=202.3

Q ss_pred             cCCCCceeeeccceEEEEEEECCCcEEEEEEeecccc------chhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEE
Q 040845          528 KFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCG------RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALV  601 (824)
Q Consensus       528 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  601 (824)
                      +|.+.+.||+|+||+||+|...+++.+|||.+.....      .....+.+|+++++.++|+||+++++++.+....++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            4788899999999999999888899999998864321      2235688899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 040845          602 LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED  681 (824)
Q Consensus       602 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  681 (824)
                      |||+++++|.+++.+.. .+++..+..++.|++.|++|||   +.+++|+||+|+||++++++.++|+|||.+.......
T Consensus        81 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  156 (265)
T cd06631          81 MEFVPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG  156 (265)
T ss_pred             EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence            99999999999997654 6788999999999999999999   8999999999999999999999999999987653211


Q ss_pred             C----ccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccc
Q 040845          682 Q----SMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDA  757 (824)
Q Consensus       682 ~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  757 (824)
                      .    ........++..|+|||++.+..++.++||||+|+++||+++|+.||....... ..........   .      
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-~~~~~~~~~~---~------  226 (265)
T cd06631         157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA-AMFYIGAHRG---L------  226 (265)
T ss_pred             ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH-HHHHhhhccC---C------
Confidence            1    111223458889999999998889999999999999999999999996532111 0000000000   0      


Q ss_pred             cccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          758 NLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       758 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                              ....+..++..+.+++.+||..+|++||++.|++++
T Consensus       227 --------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  262 (265)
T cd06631         227 --------MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH  262 (265)
T ss_pred             --------CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence                    000112346678999999999999999999998763

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.1e-37  Score=315.33  Aligned_cols=253  Identities=22%  Similarity=0.326  Sum_probs=202.5

Q ss_pred             ccCCCCceeeeccceEEEEEEECCCcEEEEEEeecc--ccchhhhHHHHHHHHhcCC-CCcceeEEeeeecCCeeEEEEe
Q 040845          527 DKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQ--CGRAFKSFDVECAMMKSIR-HRNLVKVISSCSNEEFKALVLE  603 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  603 (824)
                      ..|++.+.||.||.+.||++...+.+.||+|.+...  +......|..|+..|.+|+ |.+||++++|-..++..|+|||
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE  440 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME  440 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence            568999999999999999999888888888876433  3455678999999999995 8999999999999999999999


Q ss_pred             ccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 040845          604 YMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS  683 (824)
Q Consensus       604 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  683 (824)
                      |= ..+|..++...........+..+..|++.|+.+.|   +.||||.|+||.|+++- .|.+||+|||+|..+......
T Consensus       441 ~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTs  515 (677)
T KOG0596|consen  441 CG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTS  515 (677)
T ss_pred             cc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEE-eeeEEeeeechhcccCccccc
Confidence            87 45999999877644443478899999999999999   99999999999999985 478999999999988877777


Q ss_pred             cccccccccccccCccCcCCC-----------CCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcch
Q 040845          684 MTQTQTLATIGYMAPEYGREG-----------QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTM  752 (824)
Q Consensus       684 ~~~~~~~~~~~y~aPE~~~~~-----------~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  752 (824)
                      ......+||+.|||||.+...           ..+.++||||+|||+|+|+.|+.||......      |.+      ..
T Consensus       516 I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~------~aK------l~  583 (677)
T KOG0596|consen  516 IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ------IAK------LH  583 (677)
T ss_pred             eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH------HHH------HH
Confidence            777788999999999987532           2568899999999999999999999763211      111      01


Q ss_pred             hhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          753 EVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       753 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      .+.++...-... ..  +  -..++.++|+.|++.||.+|||..|++++
T Consensus       584 aI~~P~~~Iefp-~~--~--~~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  584 AITDPNHEIEFP-DI--P--ENDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             hhcCCCcccccc-CC--C--CchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence            112221100000 00  0  12238999999999999999999999875

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=6.8e-36  Score=316.24  Aligned_cols=250  Identities=28%  Similarity=0.356  Sum_probs=204.8

Q ss_pred             ccCCCCceeeeccceEEEEEEE-CCCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEecc
Q 040845          527 DKFSENNLIGRGGFGSVYKARI-RDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYM  605 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  605 (824)
                      .+|++.+.||.|++|.||+|.. .+++.||+|.+........+.+.+|+.+++.++|+|++++++++...+..++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            4688899999999999999975 468999999987665555677889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccc
Q 040845          606 PHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMT  685 (824)
Q Consensus       606 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  685 (824)
                      ++++|.+++...  .+++.++..++.|++.|++|||   +.+++||||||+||+++.++.++|+|||++........  .
T Consensus        99 ~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~--~  171 (296)
T cd06655          99 AGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--K  171 (296)
T ss_pred             CCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc--c
Confidence            999999998754  5789999999999999999999   99999999999999999999999999999876543222  1


Q ss_pred             cccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhh
Q 040845          686 QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDI  765 (824)
Q Consensus       686 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  765 (824)
                      .....++..|+|||.+.+..++.++|||||||++|++++|+.||........ ...+... ..                .
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~-~~~~~~~-~~----------------~  233 (296)
T cd06655         172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LYLIATN-GT----------------P  233 (296)
T ss_pred             CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhc-CC----------------c
Confidence            2234578899999999888899999999999999999999999866322111 1100000 00                0


Q ss_pred             hhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          766 HFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       766 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      ....+..++..+.+++.+||..||++||++.+++++
T Consensus       234 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~  269 (296)
T cd06655         234 ELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH  269 (296)
T ss_pred             ccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence            011122345678899999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-35  Score=319.95  Aligned_cols=255  Identities=21%  Similarity=0.260  Sum_probs=198.9

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEE
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVL  602 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  602 (824)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|+.+++.++|+||+++++++.++...++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            47889999999999999999865 58999999987431   223456788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 040845          603 EYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ  682 (824)
Q Consensus       603 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  682 (824)
                      ||+++|+|.+++......+++..+..++.|++.|++|||   +++|+||||||+||+++.++.+||+|||++........
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  157 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT  157 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence            999999999999876667899999999999999999999   99999999999999999999999999999876543222


Q ss_pred             ccccccccccccccCccCcCC-----CCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccc
Q 040845          683 SMTQTQTLATIGYMAPEYGRE-----GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDA  757 (824)
Q Consensus       683 ~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  757 (824)
                       .......||+.|+|||++..     ..++.++||||+||++|||++|+.||......     ............     
T Consensus       158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~-----~~~~~i~~~~~~-----  226 (331)
T cd05597         158 -VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-----ETYGKIMNHKEH-----  226 (331)
T ss_pred             -ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH-----HHHHHHHcCCCc-----
Confidence             12223458999999998863     45788999999999999999999998652211     111111000000     


Q ss_pred             cccCchhhhhhhHHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 040845          758 NLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQ--RINAKEIVAK  801 (824)
Q Consensus       758 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rpt~~evl~~  801 (824)
                        ....    .....++..+.+++.+|+..++.+  |+++.+++++
T Consensus       227 --~~~~----~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         227 --FQFP----PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             --ccCC----CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence              0000    001124567888999987654443  8899999988

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=5.1e-36  Score=310.58  Aligned_cols=249  Identities=21%  Similarity=0.283  Sum_probs=202.0

Q ss_pred             cCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc-cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEecc
Q 040845          528 KFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYM  605 (824)
Q Consensus       528 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  605 (824)
                      +|++.+.||+|+||.||+++.. ++..||+|.++... ....+.+..|+.+++.++|+||+++++++.++...++||||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4788899999999999999865 58999999986432 334567888999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 040845          606 PHGSLEKYLHSS-NYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM  684 (824)
Q Consensus       606 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  684 (824)
                      ++++|.+++... ...+++..+..++.|++.|++|||   +.+|+|+||||+||++++++.++++|||.+........  
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--  155 (255)
T cd08219          81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA--  155 (255)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc--
Confidence            999999988653 345789999999999999999999   99999999999999999999999999999976543221  


Q ss_pred             ccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchh
Q 040845          685 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQED  764 (824)
Q Consensus       685 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  764 (824)
                      ......++..|+|||.+.+..++.++|+||||+++|+|++|..||......     ...........             
T Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-----~~~~~~~~~~~-------------  217 (255)
T cd08219         156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK-----NLILKVCQGSY-------------  217 (255)
T ss_pred             ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH-----HHHHHHhcCCC-------------
Confidence            122345888999999998888999999999999999999999998752111     11100000000             


Q ss_pred             hhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          765 IHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       765 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                        ...+..++..+.+++.+||..||++|||+.|++..
T Consensus       218 --~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         218 --KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             --CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence              00112345568899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2.6e-36  Score=313.84  Aligned_cols=253  Identities=30%  Similarity=0.455  Sum_probs=200.0

Q ss_pred             CCCCceeeeccceEEEEEEECC-CcEEEEEEeeccccchh--hhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEecc
Q 040845          529 FSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAF--KSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYM  605 (824)
Q Consensus       529 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  605 (824)
                      |++.+.||+|+||+||+|+... ++.||+|++........  ....+|+.++++++||||+++++++.+....++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            5678999999999999998764 67899999976643222  23345999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccc
Q 040845          606 PHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMT  685 (824)
Q Consensus       606 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  685 (824)
                      ++++|.+++.... .+++.++..++.|+++||+|||   +.+++|+||||+||++++++.++|+|||.+...  ......
T Consensus        81 ~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~--~~~~~~  154 (260)
T PF00069_consen   81 PGGSLQDYLQKNK-PLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKL--SENNEN  154 (260)
T ss_dssp             TTEBHHHHHHHHS-SBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEES--TSTTSE
T ss_pred             ccccccccccccc-cccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc--cccccc
Confidence            9999999998433 6899999999999999999999   899999999999999999999999999999764  122223


Q ss_pred             cccccccccccCccCcC-CCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchh
Q 040845          686 QTQTLATIGYMAPEYGR-EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQED  764 (824)
Q Consensus       686 ~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  764 (824)
                      .....++..|+|||++. +..++.++||||+|+++|+|++|..||.....  .........            .......
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~--~~~~~~~~~------------~~~~~~~  220 (260)
T PF00069_consen  155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS--DDQLEIIEK------------ILKRPLP  220 (260)
T ss_dssp             BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH--HHHHHHHHH------------HHHTHHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccc--hhhhhhhhh------------ccccccc
Confidence            34556899999999998 78899999999999999999999999886410  000000000            0000000


Q ss_pred             hhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          765 IHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       765 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      ............+.+++.+||+.||++||++.|++++
T Consensus       221 ~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~  257 (260)
T PF00069_consen  221 SSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH  257 (260)
T ss_dssp             HHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred             ccccccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0000111123679999999999999999999999864

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.7e-36  Score=309.19  Aligned_cols=249  Identities=29%  Similarity=0.437  Sum_probs=199.1

Q ss_pred             ceeeeccceEEEEEEECC----CcEEEEEEeecccc-chhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEeccCC
Q 040845          533 NLIGRGGFGSVYKARIRD----GMEVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPH  607 (824)
Q Consensus       533 ~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  607 (824)
                      +.||+|+||.||+|.+..    +..||+|.+..... ...+.+..|+++++.+.|+||+++++++.. ...++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCC
Confidence            469999999999997542    26899999875533 245678889999999999999999998764 467899999999


Q ss_pred             CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccc-c
Q 040845          608 GSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMT-Q  686 (824)
Q Consensus       608 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~-~  686 (824)
                      |+|.+++.... .+++..+..++.|++.|++|||   ..+++|+||||+||+++.++.+||+|||.+........... .
T Consensus        80 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~  155 (257)
T cd05060          80 GPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT  155 (257)
T ss_pred             CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence            99999998765 7899999999999999999999   99999999999999999999999999999986643332211 1


Q ss_pred             ccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhh
Q 040845          687 TQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDI  765 (824)
Q Consensus       687 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  765 (824)
                      ....++..|+|||...+..++.++||||||+++||+++ |..||.....  .....++....                  
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--~~~~~~~~~~~------------------  215 (257)
T cd05060         156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--AEVIAMLESGE------------------  215 (257)
T ss_pred             cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHHcCC------------------
Confidence            12224567999999988889999999999999999998 9999865321  12222221110                  


Q ss_pred             hhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 040845          766 HFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIR  806 (824)
Q Consensus       766 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~  806 (824)
                      ....+..++..+.+++.+||..+|++||++.++++.|+++.
T Consensus       216 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         216 RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence            01112235667899999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=4.1e-40  Score=327.04  Aligned_cols=422  Identities=25%  Similarity=0.371  Sum_probs=291.3

Q ss_pred             cccccccccCCcccccCCCCCcEEEccCCcccccccccccCCCCCCEEeCCCCcCCcccChhhhCcCCCceeeccCCccc
Q 040845            3 SIINNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLS   82 (824)
Q Consensus         3 ~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~   82 (824)
                      .+++|+++..+ ++++++..++.|+.++|++. .+|..++.+.+|..|+.++|.+. ++|+.++.+-.|..|+..+|+++
T Consensus        74 ~~~~n~l~~lp-~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~  150 (565)
T KOG0472|consen   74 NVHDNKLSQLP-AAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDATNNQIS  150 (565)
T ss_pred             EeccchhhhCC-HHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhhccccccc
Confidence            34555554432 33555555555555555555 44555555555555555555554 44444555555555555555544


Q ss_pred             cccCcccc---------------------CCCCCccEEEccCCeeeeecCccccCCCCCceEeccCccccccCCccccCC
Q 040845           83 GCLSSITD---------------------VGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNL  141 (824)
Q Consensus        83 ~~~~~~~~---------------------~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l  141 (824)
                      ..|..+.+                     ..++.|++||+..|-++ .+|..++.+.+|..|||..|+|. ..| .|.++
T Consensus       151 slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gc  227 (565)
T KOG0472|consen  151 SLPEDMVNLSKLSKLDLEGNKLKALPENHIAMKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGC  227 (565)
T ss_pred             cCchHHHHHHHHHHhhccccchhhCCHHHHHHHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCcc
Confidence            44444332                     01556666666666665 56666677777777777777776 444 66777


Q ss_pred             CCCCEEEccCCcCCCCcCcccccccCCCCCCCcEEECcCCCCCccCCccccccccccccEEEeecCcceecCCccCCCCC
Q 040845          142 RNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLT  221 (824)
Q Consensus       142 ~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~  221 (824)
                      +.|++|+++.|+|..++.+     .++++.+|..|||.+|++...+....   +..+|..||+++|.|+ .+|.+++++ 
T Consensus       228 s~L~Elh~g~N~i~~lpae-----~~~~L~~l~vLDLRdNklke~Pde~c---lLrsL~rLDlSNN~is-~Lp~sLgnl-  297 (565)
T KOG0472|consen  228 SLLKELHVGENQIEMLPAE-----HLKHLNSLLVLDLRDNKLKEVPDEIC---LLRSLERLDLSNNDIS-SLPYSLGNL-  297 (565)
T ss_pred             HHHHHHHhcccHHHhhHHH-----HhcccccceeeeccccccccCchHHH---HhhhhhhhcccCCccc-cCCcccccc-
Confidence            7777777777777666543     36678888888888888887765542   4567888888888887 567778888 


Q ss_pred             CCCEEEecCCccCCc--------------------------------------cchhh---cCCCCCCEEEcccccCccc
Q 040845          222 DLTTIVLGGNKLNGS--------------------------------------IPITL---GKLQKLQDVDLEYNQLEGS  260 (824)
Q Consensus       222 ~L~~L~L~~n~l~~~--------------------------------------~~~~~---~~l~~L~~L~L~~n~l~~~  260 (824)
                      +|+.|-+.||.+.++                                      .+..|   ..+.+.+.|+++.-+++ .
T Consensus       298 hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt-~  376 (565)
T KOG0472|consen  298 HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLT-L  376 (565)
T ss_pred             eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccc-c
Confidence            888888888877431                                      00111   12345677777777777 4


Q ss_pred             CCccccccCC---ccEEEccCccccccCCccccCCCCC-cEEEcCCCCCCCCCCcccccccccccccccccccCcCCccc
Q 040845          261 IPDSICLSVE---LYELELGGNKLSGSIPACFSNMTFL-KVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEI  336 (824)
Q Consensus       261 ~~~~~~~~~~---L~~L~l~~n~l~~~~~~~~~~l~~L-~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~  336 (824)
                      +|+.......   ++..+++.|++. ..|..+..+..+ +.+.+++|.+.-+|..+..+++|..|+|++|.+. .+|..+
T Consensus       377 VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~  454 (565)
T KOG0472|consen  377 VPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLN-DLPEEM  454 (565)
T ss_pred             CCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccccchHHHHhhhcceeeecccchhh-hcchhh
Confidence            5554443333   888999999998 667767666654 4577888888888888899999999999999998 689999


Q ss_pred             cccccchhhhcccccccccCCCccCCCCCCCeEEccCccccccCCccccccccccEEEccCcccCCCCcccccCCcccce
Q 040845          337 RNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKD  416 (824)
Q Consensus       337 ~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  416 (824)
                      +.+..|+.|+++.|++. ..|..+..+..|+.+-.++|++....|..+..|.+|..|||.+|.|. .+|..+++|++|++
T Consensus       455 ~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~h  532 (565)
T KOG0472|consen  455 GSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRH  532 (565)
T ss_pred             hhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeE
Confidence            99999999999999998 67888777788888888889998666666999999999999999998 99999999999999


Q ss_pred             eeccCCcccCCCCCCCC-ccccccccccCCc
Q 040845          417 LNLSFNKLKGEIPRGGS-FGNFSAESFKGNE  446 (824)
Q Consensus       417 L~l~~N~l~~~~p~~~~-~~~~~~~~~~~n~  446 (824)
                      |++.||+|. .++...- .+....+++.+++
T Consensus       533 LeL~gNpfr-~Pr~~iLmkgT~aiL~ylrdr  562 (565)
T KOG0472|consen  533 LELDGNPFR-QPRHQILMKGTAAILSYLRDR  562 (565)
T ss_pred             EEecCCccC-CCHHHHhccChHHHHHHhccc
Confidence            999999998 3333222 2233344455543

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2e-36  Score=324.94  Aligned_cols=240  Identities=27%  Similarity=0.315  Sum_probs=188.9

Q ss_pred             ceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHH-HHHHhcCCCCcceeEEeeeecCCeeEEEEeccCC
Q 040845          533 NLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVE-CAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPH  607 (824)
Q Consensus       533 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E-~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  607 (824)
                      +.||+|+||+||+|+.. +++.||+|++....   ......+..| ..+++.++|+||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999875 47889999987532   1222233334 4457888999999999999999999999999999


Q ss_pred             CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccccc
Q 040845          608 GSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQT  687 (824)
Q Consensus       608 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  687 (824)
                      |+|.+++.... .+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||++.......  ....
T Consensus        81 ~~L~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~~~  154 (325)
T cd05602          81 GELFYHLQRER-CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GTTS  154 (325)
T ss_pred             CcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CCcc
Confidence            99999997654 6778888899999999999999   9999999999999999999999999999987543221  1223


Q ss_pred             cccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhhhh
Q 040845          688 QTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHF  767 (824)
Q Consensus       688 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  767 (824)
                      ...||+.|+|||++.+..++.++||||+||++|||++|+.||......+     .......        ...        
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----~~~~i~~--------~~~--------  213 (325)
T cd05602         155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE-----MYDNILN--------KPL--------  213 (325)
T ss_pred             cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH-----HHHHHHh--------CCc--------
Confidence            4568999999999999899999999999999999999999997532111     1111000        000        


Q ss_pred             hhHHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 040845          768 VAKEQCVSFVFNLALECTVESPEQRINAKEIV  799 (824)
Q Consensus       768 ~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl  799 (824)
                      ..+...+..+.+++.+|++.||.+||++.+.+
T Consensus       214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         214 QLKPNITNSARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence            01123456788999999999999999887543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=6.1e-36  Score=325.51  Aligned_cols=267  Identities=22%  Similarity=0.262  Sum_probs=198.0

Q ss_pred             HhhccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeecC-----
Q 040845          524 QATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSNE-----  595 (824)
Q Consensus       524 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----  595 (824)
                      ...++|++.+.||+|+||.||+|... .++.||||++....  ......+.+|+.+++.++||||+++++++...     
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            45678999999999999999999754 58899999986542  23345677899999999999999999988543     


Q ss_pred             -CeeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccc
Q 040845          596 -EFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIA  674 (824)
Q Consensus       596 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a  674 (824)
                       ...++||||+++ ++.+.+..   .+++.++..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||++
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg~~  166 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA  166 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCccc
Confidence             357899999965 67776653   4788899999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhC-CC----
Q 040845          675 KLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCL-PI----  749 (824)
Q Consensus       675 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~----  749 (824)
                      +.....   .......+|..|+|||++.+..++.++||||+||++|||++|+.||.+....+. ....+.... +.    
T Consensus       167 ~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~  242 (355)
T cd07874         167 RTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ-WNKVIEQLGTPCPEFM  242 (355)
T ss_pred             ccCCCc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHH
Confidence            764322   122345689999999999988899999999999999999999999975321110 000000000 00    


Q ss_pred             -----cchhhcc----------ccccCch--hhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          750 -----STMEVVD----------ANLLSQE--DIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       750 -----~~~~~~~----------~~~~~~~--~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                           ......+          +......  ......+......+.+++.+|++.||++|||+.|++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                 0000000          0000000  00000111234568999999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=8.9e-36  Score=311.10  Aligned_cols=250  Identities=26%  Similarity=0.400  Sum_probs=201.3

Q ss_pred             cCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccc---------hhhhHHHHHHHHhcCCCCcceeEEeeeecCCe
Q 040845          528 KFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGR---------AFKSFDVECAMMKSIRHRNLVKVISSCSNEEF  597 (824)
Q Consensus       528 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  597 (824)
                      +|.+...||+|++|.||+|... +++.||+|.+......         ..+.+.+|+.++++++||||+++++++.+.+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            4778899999999999999864 5889999988644221         23567889999999999999999999999999


Q ss_pred             eEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccccc
Q 040845          598 KALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  677 (824)
Q Consensus       598 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~  677 (824)
                      .++||||+++++|.+++.... .+++..+..++.|++.|++|||   +.+++||||+|+||++++++.++|+|||.+...
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~  156 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYG-AFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKL  156 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhcc-CccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence            999999999999999997754 6788899999999999999999   999999999999999999999999999999876


Q ss_pred             CCCCCcc----ccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchh
Q 040845          678 TGEDQSM----TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTME  753 (824)
Q Consensus       678 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  753 (824)
                      .......    ......++..|+|||.+.+..++.++||||+|+++|+|++|+.||....... ..... ..        
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~-~~--------  226 (267)
T cd06628         157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ-AIFKI-GE--------  226 (267)
T ss_pred             ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH-HHHHH-hc--------
Confidence            5322111    1122347889999999988889999999999999999999999987532111 00000 00        


Q ss_pred             hccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          754 VVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       754 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      .          .....+..++..+.+++.+||+.||.+||++.|++++
T Consensus       227 ~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  264 (267)
T cd06628         227 N----------ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH  264 (267)
T ss_pred             c----------CCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence            0          0001112346678999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=5.4e-36  Score=313.35  Aligned_cols=238  Identities=24%  Similarity=0.357  Sum_probs=188.6

Q ss_pred             eeeeccceEEEEEEECC-------------------------CcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeE
Q 040845          534 LIGRGGFGSVYKARIRD-------------------------GMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKV  588 (824)
Q Consensus       534 ~lg~G~~g~V~~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  588 (824)
                      +||+|+||.||+|.+..                         ...||+|++..........+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999997421                         13588998865544445678889999999999999999


Q ss_pred             EeeeecCCeeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC----
Q 040845          589 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM----  664 (824)
Q Consensus       589 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~----  664 (824)
                      ++++.+....++||||+++|+|..++......+++..+..++.|+++|++|||   +.+|+||||||+||++++.+    
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~~~~~  158 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEG  158 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEeccCcccC
Confidence            99999999999999999999999999776557899999999999999999999   99999999999999997643    


Q ss_pred             ---cEEEeecccccccCCCCCccccccccccccccCccCcCC-CCCCccchHHHHHHHHHHHH-hCCCCCcccccCcchh
Q 040845          665 ---VAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETF-TRKKPTDELFNGEMTL  739 (824)
Q Consensus       665 ---~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~-tg~~p~~~~~~~~~~~  739 (824)
                         .+|++|||.+......      ....++..|+|||.+.+ ..++.++||||||+++||++ +|+.||......+  .
T Consensus       159 ~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~  230 (274)
T cd05076         159 TSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE--K  230 (274)
T ss_pred             ccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH--H
Confidence               4899999987643221      12346788999998865 56899999999999999995 6888886532211  1


Q ss_pred             hhhhhhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 040845          740 KHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL  802 (824)
Q Consensus       740 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L  802 (824)
                      ..+.....            .        .+......+.+++.+||+.+|++|||+.++++.|
T Consensus       231 ~~~~~~~~------------~--------~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L  273 (274)
T cd05076         231 ERFYEKKH------------R--------LPEPSCKELATLISQCLTYEPTQRPSFRTILRDL  273 (274)
T ss_pred             HHHHHhcc------------C--------CCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence            11111000            0        0011234588999999999999999999999887

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1e-35  Score=315.20  Aligned_cols=251  Identities=27%  Similarity=0.339  Sum_probs=204.9

Q ss_pred             hccCCCCceeeeccceEEEEEEE-CCCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEec
Q 040845          526 TDKFSENNLIGRGGFGSVYKARI-RDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      ..+|++.+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++..++..++||||
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   97 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   97 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence            36789999999999999999986 46899999998765555567788899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 040845          605 MPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM  684 (824)
Q Consensus       605 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  684 (824)
                      +++++|.+++...  .+++.++..++.|++.|++|||   +.+++||||||+||+++.++.++|+|||.+........  
T Consensus        98 ~~~~~L~~~~~~~--~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~--  170 (297)
T cd06656          98 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--  170 (297)
T ss_pred             cCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc--
Confidence            9999999998654  4788899999999999999999   99999999999999999999999999999876543221  


Q ss_pred             ccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchh
Q 040845          685 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQED  764 (824)
Q Consensus       685 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  764 (824)
                      ......+++.|+|||...+..++.++|+|||||++|++++|+.||............+..                .  .
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~----------------~--~  232 (297)
T cd06656         171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN----------------G--T  232 (297)
T ss_pred             CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccC----------------C--C
Confidence            122345788999999998888999999999999999999999999653211110000000                0  0


Q ss_pred             hhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          765 IHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       765 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      .....+...+..+.+++.+||..+|++||++.+++++
T Consensus       233 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (297)
T cd06656         233 PELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH  269 (297)
T ss_pred             CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0000122345668899999999999999999999884

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1e-35  Score=312.44  Aligned_cols=249  Identities=24%  Similarity=0.324  Sum_probs=198.6

Q ss_pred             ccCCCCceeeeccceEEEEEEE-CCCcEEEEEEeeccc-cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEec
Q 040845          527 DKFSENNLIGRGGFGSVYKARI-RDGMEVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      ++|++.++||+|+||.||+|.. .+++.||+|++.... ....+.+..|++++++++||||+++++++..++..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            3678889999999999999975 468999999986542 23345688899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 040845          605 MPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM  684 (824)
Q Consensus       605 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  684 (824)
                      +++++|..+.     .+++..+..++.|++.|++|||   +.+|+|+||||+||+++.++.++|+|||++......    
T Consensus        81 ~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~----  148 (279)
T cd06619          81 MDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----  148 (279)
T ss_pred             CCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc----
Confidence            9999997653     4678889999999999999999   999999999999999999999999999999765322    


Q ss_pred             ccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchh--hhhhhhhCCCcchhhccccccCc
Q 040845          685 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTL--KHWVNDCLPISTMEVVDANLLSQ  762 (824)
Q Consensus       685 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  762 (824)
                      ......++..|+|||.+.+..++.++||||||+++|||++|+.||..........  ..+.......     ..+.    
T Consensus       149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----~~~~----  219 (279)
T cd06619         149 IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE-----DPPV----  219 (279)
T ss_pred             cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhcc-----CCCC----
Confidence            1223468899999999998889999999999999999999999997643221110  0111000000     0000    


Q ss_pred             hhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          763 EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       763 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                           ......+.++.+++.+||..+|++||+++|++++
T Consensus       220 -----~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         220 -----LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             -----CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence                 0011234568899999999999999999999886

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-37  Score=320.15  Aligned_cols=245  Identities=30%  Similarity=0.431  Sum_probs=203.8

Q ss_pred             CCCCceeeeccceEEEEEEE-CCCcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEec
Q 040845          529 FSENNLIGRGGFGSVYKARI-RDGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       529 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      |.-.+-||.|+||.||.|++ .+...||||.+....   .+.+.++..|+.+|++++|||++.+.|+|-.+.+.++||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY  107 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY  107 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence            55567899999999999985 457899999986443   34577899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 040845          605 MPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM  684 (824)
Q Consensus       605 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  684 (824)
                      | -|+-.|.+.-..+++.+-++..|..+.++||+|||   +.+.||||||+.|||+++.|.||++|||.|....+.    
T Consensus       108 C-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA----  179 (948)
T KOG0577|consen  108 C-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA----  179 (948)
T ss_pred             H-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcCch----
Confidence            9 56888888888888999999999999999999999   999999999999999999999999999999876432    


Q ss_pred             ccccccccccccCccCcC---CCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccC
Q 040845          685 TQTQTLATIGYMAPEYGR---EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLS  761 (824)
Q Consensus       685 ~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  761 (824)
                        ...+||+.|||||++.   .|.|+-++||||+|+...|+...++|.-.+ .....+.+++....|         .+  
T Consensus       180 --nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM-NAMSALYHIAQNesP---------tL--  245 (948)
T KOG0577|consen  180 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNESP---------TL--  245 (948)
T ss_pred             --hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc-hHHHHHHHHHhcCCC---------CC--
Confidence              3467999999999774   678999999999999999999999996542 111122222221111         11  


Q ss_pred             chhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 040845          762 QEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL  802 (824)
Q Consensus       762 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L  802 (824)
                             +....+..+.+++..|++.-|.+|||.+++++|-
T Consensus       246 -------qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~  279 (948)
T KOG0577|consen  246 -------QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHR  279 (948)
T ss_pred             -------CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcc
Confidence                   1234577899999999999999999999998763

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.3e-35  Score=312.48  Aligned_cols=250  Identities=22%  Similarity=0.334  Sum_probs=200.0

Q ss_pred             CCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc---chhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEec
Q 040845          529 FSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG---RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       529 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      |+..+.||+|+||.||+|.+. +++.||||.+.....   .....+..|+.++++++|++++.+++.+.+.+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            667789999999999999865 589999998865421   2234567899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 040845          605 MPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS  683 (824)
Q Consensus       605 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  683 (824)
                      +++++|.+++.... ..+++.++..++.|++.|++|||   +.+|+||||||+||++++++.++|+|||++........ 
T Consensus        82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-  157 (285)
T cd05630          82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-  157 (285)
T ss_pred             cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc-
Confidence            99999999986543 46889999999999999999999   99999999999999999999999999999876432221 


Q ss_pred             cccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCch
Q 040845          684 MTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQE  763 (824)
Q Consensus       684 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  763 (824)
                        .....|+..|+|||++.+..++.++||||+||++|||++|+.||....... ....+ ..        ..+. .    
T Consensus       158 --~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~-~~~~~-~~--------~~~~-~----  220 (285)
T cd05630         158 --IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-KREEV-ER--------LVKE-V----  220 (285)
T ss_pred             --ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc-hHHHH-Hh--------hhhh-h----
Confidence              123468999999999998899999999999999999999999997632211 00000 00        0000 0    


Q ss_pred             hhhhhhHHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 040845          764 DIHFVAKEQCVSFVFNLALECTVESPEQRIN-----AKEIVAK  801 (824)
Q Consensus       764 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt-----~~evl~~  801 (824)
                        ....+..++..+.+++.+||+.||++|||     +.|++++
T Consensus       221 --~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h  261 (285)
T cd05630         221 --QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH  261 (285)
T ss_pred             --hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence              00011234567899999999999999999     8898875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2e-36  Score=324.90  Aligned_cols=239  Identities=29%  Similarity=0.343  Sum_probs=188.9

Q ss_pred             ceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHH-HHhcCCCCcceeEEeeeecCCeeEEEEeccCC
Q 040845          533 NLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECA-MMKSIRHRNLVKVISSCSNEEFKALVLEYMPH  607 (824)
Q Consensus       533 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  607 (824)
                      +.||+|+||.||+|+.. +|+.||+|++....   ......+..|.. +++.++||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999864 58999999987542   122334445544 57789999999999999999999999999999


Q ss_pred             CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccccc
Q 040845          608 GSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQT  687 (824)
Q Consensus       608 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  687 (824)
                      |+|.+++.... .+++.++..++.||+.|++|||   +.+|+||||||+||+++.++.+||+|||++.......  ....
T Consensus        81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~  154 (325)
T cd05604          81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DTTT  154 (325)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--CCcc
Confidence            99999887654 7899999999999999999999   9999999999999999999999999999987532211  1223


Q ss_pred             cccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhhhh
Q 040845          688 QTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHF  767 (824)
Q Consensus       688 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  767 (824)
                      ...||+.|+|||++.+..++.++||||+||++|||++|+.||......     ........        ...        
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-----~~~~~~~~--------~~~--------  213 (325)
T cd05604         155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA-----EMYDNILH--------KPL--------  213 (325)
T ss_pred             cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH-----HHHHHHHc--------CCc--------
Confidence            456899999999999999999999999999999999999998653211     11111000        000        


Q ss_pred             hhHHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 040845          768 VAKEQCVSFVFNLALECTVESPEQRINAKEI  798 (824)
Q Consensus       768 ~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~ev  798 (824)
                      ..+...+..+.+++.+|+..+|++||++.+.
T Consensus       214 ~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~  244 (325)
T cd05604         214 VLRPGASLTAWSILEELLEKDRQRRLGAKED  244 (325)
T ss_pred             cCCCCCCHHHHHHHHHHhccCHHhcCCCCCC
Confidence            0011235567899999999999999988643

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-36  Score=307.80  Aligned_cols=248  Identities=25%  Similarity=0.359  Sum_probs=208.6

Q ss_pred             ccCCCCceeeeccceEEEEEEE-CCCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEe
Q 040845          527 DKFSENNLIGRGGFGSVYKARI-RDGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLE  603 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  603 (824)
                      .=|+..+.||+|.|+.|-.|++ =+|.+||||++.+..  .-....+.+|+..|+-++|||||++|.+.......|+|.|
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            4578888999999999999974 479999999997653  2345678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee-CCCCcEEEeecccccccCCCCC
Q 040845          604 YMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL-DDNMVAHLSDFGIAKLLTGEDQ  682 (824)
Q Consensus       604 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill-~~~~~~kl~Dfg~a~~~~~~~~  682 (824)
                      .-++|+|.+|+..+...+.+.-+.+++.||+.|+.|+|   +..+||||+||+||.+ .+-|-+|++|||++-.+.+...
T Consensus        98 LGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k  174 (864)
T KOG4717|consen   98 LGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK  174 (864)
T ss_pred             ecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCCCcch
Confidence            99999999999988889999999999999999999999   9999999999999876 5789999999999987765443


Q ss_pred             ccccccccccccccCccCcCCCCCC-ccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccC
Q 040845          683 SMTQTQTLATIGYMAPEYGREGQVS-TNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLS  761 (824)
Q Consensus       683 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  761 (824)
                         .+..+|+..|-|||++.+..|+ +++||||+|||+|-+++|++||...-+.+. +-            .++|=    
T Consensus       175 ---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET-LT------------mImDC----  234 (864)
T KOG4717|consen  175 ---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET-LT------------MIMDC----  234 (864)
T ss_pred             ---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh-hh------------hhhcc----
Confidence               3445799999999999999885 678999999999999999999986332221 11            11111    


Q ss_pred             chhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          762 QEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       762 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                          ....|...+.++.+||..|+..||.+|.+.+||+.+
T Consensus       235 ----KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~  270 (864)
T KOG4717|consen  235 ----KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST  270 (864)
T ss_pred             ----cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence                112334567788999999999999999999998764

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.9e-35  Score=312.36  Aligned_cols=266  Identities=27%  Similarity=0.328  Sum_probs=195.9

Q ss_pred             cCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc--chhhhHHHHHHHHhcC---CCCcceeEEeeeec-----CC
Q 040845          528 KFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG--RAFKSFDVECAMMKSI---RHRNLVKVISSCSN-----EE  596 (824)
Q Consensus       528 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~~  596 (824)
                      +|++.+.||+|+||+||+|+.+ +++.||+|.++....  .....+.+|+++++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4888899999999999999865 589999999865422  2233456677777766   69999999998754     34


Q ss_pred             eeEEEEeccCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccc
Q 040845          597 FKALVLEYMPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK  675 (824)
Q Consensus       597 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~  675 (824)
                      ..++||||++ ++|.+++.... ..+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||++.
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLAR  156 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCccc
Confidence            5789999997 48988887643 45899999999999999999999   9999999999999999999999999999998


Q ss_pred             ccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhC-CCc--ch
Q 040845          676 LLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCL-PIS--TM  752 (824)
Q Consensus       676 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~--~~  752 (824)
                      ......   ......++..|+|||++.+..++.++||||+||++|||++|++||...... ........... +..  ..
T Consensus       157 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~  232 (288)
T cd07863         157 IYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA-DQLGKIFDLIGLPPEDDWP  232 (288)
T ss_pred             cccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH-HHHHHHHHHhCCCChhhCc
Confidence            654221   123345789999999998888999999999999999999999998653221 11111111100 000  00


Q ss_pred             hhcc--ccccCchhh--hhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          753 EVVD--ANLLSQEDI--HFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       753 ~~~~--~~~~~~~~~--~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      ....  .........  .......++..+.+++.+|++.||++|||+.|++.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h  285 (288)
T cd07863         233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH  285 (288)
T ss_pred             ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            0000  000000000  001112456678999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=9.6e-36  Score=311.15  Aligned_cols=248  Identities=28%  Similarity=0.473  Sum_probs=195.3

Q ss_pred             ceeeeccceEEEEEEECC-Cc--EEEEEEeeccc-cchhhhHHHHHHHHhcC-CCCcceeEEeeeecCCeeEEEEeccCC
Q 040845          533 NLIGRGGFGSVYKARIRD-GM--EVAVKVFNLQC-GRAFKSFDVECAMMKSI-RHRNLVKVISSCSNEEFKALVLEYMPH  607 (824)
Q Consensus       533 ~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  607 (824)
                      +.||+|+||.||+|+.++ +.  .+|+|.++... ....+.+..|++++.++ +||||+++++++......++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            368999999999998754 43  46888876432 33456788899999999 799999999999999999999999999


Q ss_pred             CCHHHHhhhCC---------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecc
Q 040845          608 GSLEKYLHSSN---------------YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFG  672 (824)
Q Consensus       608 g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  672 (824)
                      |+|.+++....               ..+++.++..++.|++.|++|||   +.+++||||||+||++++++.+|++|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCC
Confidence            99999987532               24788999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcc
Q 040845          673 IAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPIST  751 (824)
Q Consensus       673 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  751 (824)
                      ++....   ..........+..|+|||+.....++.++|||||||++|||++ |..||......     .......... 
T Consensus       158 l~~~~~---~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-----~~~~~~~~~~-  228 (270)
T cd05047         158 LSRGQE---VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-----ELYEKLPQGY-  228 (270)
T ss_pred             Cccccc---hhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH-----HHHHHHhCCC-
Confidence            986321   1111112234667999999988889999999999999999997 99998653211     1111110000 


Q ss_pred             hhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 040845          752 MEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIR  806 (824)
Q Consensus       752 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~  806 (824)
                                    ....+..++..+.+++.+||..+|.+|||+.|+++.|+++.
T Consensus       229 --------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         229 --------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             --------------CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence                          00011234567899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.2e-35  Score=316.16  Aligned_cols=194  Identities=23%  Similarity=0.347  Sum_probs=160.4

Q ss_pred             CceeeeccceEEEEEEEC---CCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeec--CCeeEEEEeccC
Q 040845          532 NNLIGRGGFGSVYKARIR---DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSN--EEFKALVLEYMP  606 (824)
Q Consensus       532 ~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~  606 (824)
                      .++||+|+||+||+|+.+   +++.||+|.+...  .....+.+|++++++++||||+++++++..  +...++||||++
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            468999999999999865   4678999988643  233457789999999999999999998854  467889999995


Q ss_pred             CCCHHHHhhhCC--------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee----CCCCcEEEeecccc
Q 040845          607 HGSLEKYLHSSN--------YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL----DDNMVAHLSDFGIA  674 (824)
Q Consensus       607 ~g~L~~~l~~~~--------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill----~~~~~~kl~Dfg~a  674 (824)
                       ++|.+++....        ..+++..+..++.|++.|++|||   +.+|+||||||+||++    +.++.+||+|||+|
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence             58888875321        25788999999999999999999   9999999999999999    46689999999999


Q ss_pred             cccCCCCCc-cccccccccccccCccCcCCC-CCCccchHHHHHHHHHHHHhCCCCCcc
Q 040845          675 KLLTGEDQS-MTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDE  731 (824)
Q Consensus       675 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~p~~~  731 (824)
                      ..+...... .......+|+.|+|||++.+. .++.++||||+||++|||++|++||..
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~  218 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence            876433221 222345689999999988764 589999999999999999999999965

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.2e-36  Score=324.26  Aligned_cols=263  Identities=19%  Similarity=0.213  Sum_probs=196.6

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEec
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      ..+|++.+.||+|+||.||+|+.. +++.||+|+...      .....|+.++++++|+||+++++++......++||||
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  138 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH  138 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc------cccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence            457999999999999999999875 478899997432      2235699999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 040845          605 MPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM  684 (824)
Q Consensus       605 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  684 (824)
                      + .++|.+++......+++.++..++.||+.||+|||   +++|+||||||+||+++.++.+||+|||++.......   
T Consensus       139 ~-~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~---  211 (357)
T PHA03209        139 Y-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP---  211 (357)
T ss_pred             c-CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccccccCc---
Confidence            9 46899998776667999999999999999999999   9999999999999999999999999999987532211   


Q ss_pred             ccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCc---------chhhhhhhhhC--CCcc--
Q 040845          685 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGE---------MTLKHWVNDCL--PIST--  751 (824)
Q Consensus       685 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~---------~~~~~~~~~~~--~~~~--  751 (824)
                      ......||..|+|||++.+..++.++|||||||++|||+++..|+.......         ..+...+....  +...  
T Consensus       212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  291 (357)
T PHA03209        212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPR  291 (357)
T ss_pred             ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCC
Confidence            1223458999999999999899999999999999999999665543221111         01111111100  0000  


Q ss_pred             -------hhhccccccC-c--hhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          752 -------MEVVDANLLS-Q--EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       752 -------~~~~~~~~~~-~--~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                             ....+..... .  ..........++..+.+++.+||+.||++||||.|+++|
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h  351 (357)
T PHA03209        292 DPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY  351 (357)
T ss_pred             CCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence                   0000000000 0  000011112345567789999999999999999999875

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.1e-35  Score=308.84  Aligned_cols=253  Identities=25%  Similarity=0.440  Sum_probs=204.7

Q ss_pred             hccCCCCceeeeccceEEEEEEECCCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEecc
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYM  605 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  605 (824)
                      .++|++.+.||+|+||.||+|.+.++..||+|.+... ....+.+.+|++++++++|+||+++++++.+ ...+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM   82 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence            4678999999999999999999877888999987643 2345678889999999999999999999887 7789999999


Q ss_pred             CCCCHHHHhhhC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 040845          606 PHGSLEKYLHSS-NYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM  684 (824)
Q Consensus       606 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  684 (824)
                      ++++|.+++... ....++.++..++.|++.|++|||   +.+++|+||+|+||+++.++.+|++|||.+........ .
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~  158 (260)
T cd05073          83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-T  158 (260)
T ss_pred             CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc-c
Confidence            999999999763 346788899999999999999999   89999999999999999999999999999976543221 1


Q ss_pred             ccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhccccccCch
Q 040845          685 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQE  763 (824)
Q Consensus       685 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  763 (824)
                      ......++..|+|||++..+.++.++|+|||||++|++++ |+.||......  ....+......               
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~~~~~---------------  221 (260)
T cd05073         159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVIRALERGYR---------------  221 (260)
T ss_pred             cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHhCCCC---------------
Confidence            2223345678999999988889999999999999999999 88888653211  11111111100               


Q ss_pred             hhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 040845          764 DIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLK  804 (824)
Q Consensus       764 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~  804 (824)
                         ...+...+.++.+++.+||+.+|++||++.++.+.|+.
T Consensus       222 ---~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         222 ---MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             ---CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence               00112345678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=3.4e-36  Score=322.67  Aligned_cols=237  Identities=27%  Similarity=0.320  Sum_probs=187.2

Q ss_pred             ceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHH-HHHhcCCCCcceeEEeeeecCCeeEEEEeccCC
Q 040845          533 NLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVEC-AMMKSIRHRNLVKVISSCSNEEFKALVLEYMPH  607 (824)
Q Consensus       533 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  607 (824)
                      +.||+|+||.||+|+.. +++.||+|++....   ......+..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999875 58899999986532   12233344444 468889999999999999999999999999999


Q ss_pred             CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccccc
Q 040845          608 GSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQT  687 (824)
Q Consensus       608 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  687 (824)
                      |+|.+++.... .+++.++..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||++.......  ....
T Consensus        81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~  154 (321)
T cd05603          81 GELFFHLQRER-CFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ETTS  154 (321)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Cccc
Confidence            99998887654 6788899999999999999999   9999999999999999999999999999987532221  1223


Q ss_pred             cccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhhhh
Q 040845          688 QTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHF  767 (824)
Q Consensus       688 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  767 (824)
                      ...||+.|+|||.+.+..++.++||||+||++|||++|+.||.....     ..........        .        .
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~i~~~--------~--------~  213 (321)
T cd05603         155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV-----SQMYDNILHK--------P--------L  213 (321)
T ss_pred             cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH-----HHHHHHHhcC--------C--------C
Confidence            45689999999999988899999999999999999999999965311     1111111100        0        0


Q ss_pred             hhHHHHHHHHHHHHHHccccCCCCCCCHH
Q 040845          768 VAKEQCVSFVFNLALECTVESPEQRINAK  796 (824)
Q Consensus       768 ~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~  796 (824)
                      ..+...+..+.+++.+|++.||.+||++.
T Consensus       214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         214 QLPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            01122355688999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.4e-35  Score=312.34  Aligned_cols=250  Identities=22%  Similarity=0.309  Sum_probs=198.8

Q ss_pred             CCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEec
Q 040845          529 FSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       529 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      |+..+.||+|+||+||+|.+. +++.||+|.+....   ......+.+|+++++.++|++|+++.+++..++..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            666789999999999999865 58899999986542   12234567899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 040845          605 MPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS  683 (824)
Q Consensus       605 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  683 (824)
                      +++++|.+++.... ..+++..+..++.|++.|+.|||   +.+|+||||||+||++++++.++|+|||++.......  
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~--  156 (285)
T cd05632          82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE--  156 (285)
T ss_pred             ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence            99999998886543 46899999999999999999999   9999999999999999999999999999987643221  


Q ss_pred             cccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCch
Q 040845          684 MTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQE  763 (824)
Q Consensus       684 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  763 (824)
                       ......|+..|+|||.+.+..++.++|+||+||++|||++|+.||....... ....+.......              
T Consensus       157 -~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~-~~~~~~~~~~~~--------------  220 (285)
T cd05632         157 -SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV-KREEVDRRVLET--------------  220 (285)
T ss_pred             -cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhhhcc--------------
Confidence             1223468999999999988889999999999999999999999997532211 111111100000              


Q ss_pred             hhhhhhHHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 040845          764 DIHFVAKEQCVSFVFNLALECTVESPEQRIN-----AKEIVAK  801 (824)
Q Consensus       764 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt-----~~evl~~  801 (824)
                        ....+..++..+.+++.+||+.||++||+     +.+++++
T Consensus       221 --~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         221 --EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             --ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence              00011234566889999999999999999     6666664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1e-35  Score=313.66  Aligned_cols=268  Identities=26%  Similarity=0.306  Sum_probs=200.6

Q ss_pred             cCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEec
Q 040845          528 KFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       528 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      +|++.+.||+|+||.||+|+.. +|+.||+|+++...  ......+.+|++++++++|+||+++++++.+....++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4788899999999999999875 58999999986542  22235677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 040845          605 MPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM  684 (824)
Q Consensus       605 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  684 (824)
                      ++ ++|.+++......+++..+..++.||++|++|||   +.+++||||||+||+++.++.++|+|||++........  
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~--  154 (284)
T cd07839          81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR--  154 (284)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC--
Confidence            96 5888888765557899999999999999999999   99999999999999999999999999999986532221  


Q ss_pred             ccccccccccccCccCcCCCC-CCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcc------hhhccc
Q 040845          685 TQTQTLATIGYMAPEYGREGQ-VSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPIST------MEVVDA  757 (824)
Q Consensus       685 ~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~  757 (824)
                      ......++..|+|||.+.+.. ++.++||||+||++|||+||+.|+.........+............      ....+.
T Consensus       155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07839         155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY  234 (284)
T ss_pred             CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence            123345788999999887654 6899999999999999999999865422221111111110000000      000000


Q ss_pred             ccc---CchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          758 NLL---SQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       758 ~~~---~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      ...   ............++.++.+++.+||+.||++|||++|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h  281 (284)
T cd07839         235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH  281 (284)
T ss_pred             cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence            000   00000001112356778999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1e-35  Score=314.06  Aligned_cols=261  Identities=23%  Similarity=0.303  Sum_probs=202.9

Q ss_pred             cHHHHHHhhccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcC-CCCcceeEEeeee--
Q 040845          518 SYLELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSI-RHRNLVKVISSCS--  593 (824)
Q Consensus       518 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~--  593 (824)
                      .++.+..+.++|++.+.||+|+||.||+|... +++.||+|++... ......+..|+.+++++ +|+||+++++++.  
T Consensus         9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   87 (286)
T cd06638           9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKK   87 (286)
T ss_pred             EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence            34555667889999999999999999999865 4889999987643 23345678899999999 6999999999873  


Q ss_pred             ---cCCeeEEEEeccCCCCHHHHhhh---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEE
Q 040845          594 ---NEEFKALVLEYMPHGSLEKYLHS---SNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH  667 (824)
Q Consensus       594 ---~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  667 (824)
                         .+...++||||+++++|.+++..   ....+++..+..++.|+++|+.|||   +.+++||||||+||++++++.++
T Consensus        88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~k  164 (286)
T cd06638          88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVK  164 (286)
T ss_pred             ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCCEE
Confidence               34578999999999999998753   2246788899999999999999999   99999999999999999999999


Q ss_pred             EeecccccccCCCCCccccccccccccccCccCcCC-----CCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhh
Q 040845          668 LSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE-----GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHW  742 (824)
Q Consensus       668 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~  742 (824)
                      ++|||++........  ......|+..|+|||++..     ..++.++||||+||++|||++|+.||........ ...+
T Consensus       165 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~-~~~~  241 (286)
T cd06638         165 LVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA-LFKI  241 (286)
T ss_pred             EccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH-Hhhc
Confidence            999999886543221  2233458899999998753     4578899999999999999999999865321110 0000


Q ss_pred             hhhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 040845          743 VNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL  802 (824)
Q Consensus       743 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L  802 (824)
                      ...                 .......+..++..+.+++.+||+.||++|||+.|++++.
T Consensus       242 ~~~-----------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         242 PRN-----------------PPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             ccc-----------------CCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence            000                 0000011122345688999999999999999999999864

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.8e-35  Score=332.73  Aligned_cols=268  Identities=22%  Similarity=0.290  Sum_probs=194.4

Q ss_pred             HHHhhccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcCCCC------cceeEEeeeec
Q 040845          522 LFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHR------NLVKVISSCSN  594 (824)
Q Consensus       522 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~l~~~~~~  594 (824)
                      +....++|++.+.||+|+||+||+|... +++.||||+++... .....+..|+++++.++|.      +++.+++++..
T Consensus       124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~  202 (467)
T PTZ00284        124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN  202 (467)
T ss_pred             cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence            3445688999999999999999999864 57899999986432 2334556688888777654      58889888876


Q ss_pred             C-CeeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEecCCCCCCeeeCCCC--------
Q 040845          595 E-EFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYS-APVIHCDLKPSNVLLDDNM--------  664 (824)
Q Consensus       595 ~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dlk~~Nill~~~~--------  664 (824)
                      + .+.++|||++ +++|.+++...+ .+++..+..++.||+.||+|||   + .+|+||||||+|||++.++        
T Consensus       203 ~~~~~~iv~~~~-g~~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl~~~~~~~~~~~~  277 (467)
T PTZ00284        203 ETGHMCIVMPKY-GPCLLDWIMKHG-PFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENILMETSDTVVDPVTN  277 (467)
T ss_pred             CCceEEEEEecc-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEecCCcccccccc
Confidence            4 5788999998 778999887654 6899999999999999999999   7 5999999999999998765        


Q ss_pred             --------cEEEeecccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCc
Q 040845          665 --------VAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGE  736 (824)
Q Consensus       665 --------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~  736 (824)
                              .+||+|||.+....     .......||+.|+|||++.+..++.++|||||||++|||++|+.||+.....+
T Consensus       278 ~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~  352 (467)
T PTZ00284        278 RALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLE  352 (467)
T ss_pred             cccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence                    49999999876422     12234568999999999999999999999999999999999999997532211


Q ss_pred             chhh-----------hhhhhhCCCcchhhcccccc-----Cchh------hhhhhHHHHHHHHHHHHHHccccCCCCCCC
Q 040845          737 MTLK-----------HWVNDCLPISTMEVVDANLL-----SQED------IHFVAKEQCVSFVFNLALECTVESPEQRIN  794 (824)
Q Consensus       737 ~~~~-----------~~~~~~~~~~~~~~~~~~~~-----~~~~------~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt  794 (824)
                       .+.           .|..........+.++....     ....      ............+.+|+.+||+.||++|||
T Consensus       353 -~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t  431 (467)
T PTZ00284        353 -HLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN  431 (467)
T ss_pred             -HHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC
Confidence             000           01100000000000000000     0000      000000112456889999999999999999


Q ss_pred             HHHHHHH
Q 040845          795 AKEIVAK  801 (824)
Q Consensus       795 ~~evl~~  801 (824)
                      ++|+++|
T Consensus       432 a~e~L~H  438 (467)
T PTZ00284        432 ARQMTTH  438 (467)
T ss_pred             HHHHhcC
Confidence            9999975

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=9.9e-36  Score=311.10  Aligned_cols=248  Identities=30%  Similarity=0.491  Sum_probs=198.1

Q ss_pred             ceeeeccceEEEEEEECC-------CcEEEEEEeeccc-cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEec
Q 040845          533 NLIGRGGFGSVYKARIRD-------GMEVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       533 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      +.||+|+||.||+|++.+       +..||+|.+.... ......+.+|+++++.++||||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            368999999999998653       2579999875432 23456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCC------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC-----cEEEeeccc
Q 040845          605 MPHGSLEKYLHSSN------YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM-----VAHLSDFGI  673 (824)
Q Consensus       605 ~~~g~L~~~l~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~-----~~kl~Dfg~  673 (824)
                      +++++|.+++....      ..+++.++..++.|++.|++|||   +.+++|+||||+||+++.++     .++++|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            99999999997532      34788999999999999999999   89999999999999999877     899999999


Q ss_pred             ccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcch
Q 040845          674 AKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTM  752 (824)
Q Consensus       674 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  752 (824)
                      +................++..|+|||++.++.++.++|||||||++|||++ |+.||.....  .....++...      
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~--~~~~~~~~~~------  229 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN--QEVLQHVTAG------  229 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH--HHHHHHHhcC------
Confidence            986643332222223345778999999999999999999999999999998 9999864221  1111111100      


Q ss_pred             hhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 040845          753 EVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLL  803 (824)
Q Consensus       753 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~  803 (824)
                                  .....+..++..+.+++.+||..+|++||++.++++.|+
T Consensus       230 ------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         230 ------------GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             ------------CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence                        011112345677899999999999999999999999886

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=4.1e-35  Score=307.61  Aligned_cols=248  Identities=25%  Similarity=0.378  Sum_probs=203.7

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc-cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEec
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      ..|+..+.||+|+||.||+|.+. +++.||+|++.... ......+..|+.+++.++|+||+++++++.++...++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            35677789999999999999875 58899999987543 34456788899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 040845          605 MPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM  684 (824)
Q Consensus       605 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  684 (824)
                      +++++|.+++...  .+++.++..++.|++.|++|||   +.+++|+||+|+||+++.++.++++|||++........  
T Consensus        84 ~~~~~L~~~i~~~--~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--  156 (277)
T cd06640          84 LGGGSALDLLRAG--PFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--  156 (277)
T ss_pred             CCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc--
Confidence            9999999998753  5788899999999999999999   99999999999999999999999999999976543221  


Q ss_pred             ccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchh
Q 040845          685 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQED  764 (824)
Q Consensus       685 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  764 (824)
                      ......++..|+|||++.+..++.++|+|||||++|||++|..||.........  .            .....      
T Consensus       157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~--~------------~~~~~------  216 (277)
T cd06640         157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL--F------------LIPKN------  216 (277)
T ss_pred             ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh--h------------hhhcC------
Confidence            122345788999999998888999999999999999999999998753221110  0            00000      


Q ss_pred             hhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          765 IHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       765 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      .....+..++..+.+++.+||..+|++||++.+++++
T Consensus       217 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         217 NPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             CCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            0011123456778999999999999999999999887

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.1e-35  Score=320.03  Aligned_cols=255  Identities=18%  Similarity=0.244  Sum_probs=199.4

Q ss_pred             ccCCCCceeeeccceEEEEEEECC-CcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEE
Q 040845          527 DKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVL  602 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  602 (824)
                      ++|++.+.||+|+||+||+++.+. ++.||+|++....   ......+.+|+.++..++|++|+++++++.++...++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            468899999999999999998764 7889999986431   223345788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 040845          603 EYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ  682 (824)
Q Consensus       603 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  682 (824)
                      ||+++|+|.+++.+....+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||++........
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~  157 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT  157 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence            999999999999876557899999999999999999999   99999999999999999999999999999876532221


Q ss_pred             ccccccccccccccCccCcC-----CCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccc
Q 040845          683 SMTQTQTLATIGYMAPEYGR-----EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDA  757 (824)
Q Consensus       683 ~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  757 (824)
                       .......||+.|+|||++.     ...++.++|||||||++|||++|+.||.....     .............     
T Consensus       158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~-----~~~~~~i~~~~~~-----  226 (332)
T cd05623         158 -VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL-----VETYGKIMNHKER-----  226 (332)
T ss_pred             -ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH-----HHHHHHHhCCCcc-----
Confidence             2223356899999999875     34678999999999999999999999975211     1111111000000     


Q ss_pred             cccCchhhhhhhHHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 040845          758 NLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQ--RINAKEIVAK  801 (824)
Q Consensus       758 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rpt~~evl~~  801 (824)
                        ..    .......++..+.+++.+|+..++.+  |+++.|++++
T Consensus       227 --~~----~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         227 --FQ----FPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             --cc----CCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence              00    00011234667889999988665544  7899999988

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-35  Score=309.85  Aligned_cols=249  Identities=27%  Similarity=0.376  Sum_probs=203.4

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc-cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEec
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      ++|++.+.||.|++|.||+|+.. +++.||+|++.... ......+.+|+++++.++|+||+++++++.++...++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            36888899999999999999865 58999999987553 33456788899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 040845          605 MPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM  684 (824)
Q Consensus       605 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  684 (824)
                      +++++|.+++...  .+++..+..++.|++.|++|||   +.+++|+||+|+||++++++.++++|||.++......  .
T Consensus        81 ~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~  153 (274)
T cd06609          81 CGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--S  153 (274)
T ss_pred             eCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeecccc--c
Confidence            9999999999765  6889999999999999999999   9999999999999999999999999999998764332  1


Q ss_pred             ccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchh
Q 040845          685 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQED  764 (824)
Q Consensus       685 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  764 (824)
                      ......++..|+|||.+.+..++.++||||||+++|||+||+.||........  ...+....+        +..     
T Consensus       154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~--~~~~~~~~~--------~~~-----  218 (274)
T cd06609         154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV--LFLIPKNNP--------PSL-----  218 (274)
T ss_pred             ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH--HHHhhhcCC--------CCC-----
Confidence            22334578899999999988899999999999999999999999865321110  000000000        000     


Q ss_pred             hhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          765 IHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       765 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                          ....++..+.+++.+||..+|++|||+++++++
T Consensus       219 ----~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~  251 (274)
T cd06609         219 ----EGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH  251 (274)
T ss_pred             ----cccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence                000145678899999999999999999999874

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.8e-35  Score=322.80  Aligned_cols=267  Identities=21%  Similarity=0.229  Sum_probs=198.2

Q ss_pred             HhhccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeecC-----
Q 040845          524 QATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSNE-----  595 (824)
Q Consensus       524 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----  595 (824)
                      ...++|++.+.||+|+||.||+|... .++.||||++....  ......+.+|+.+++.++||||+++++++...     
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~  100 (364)
T cd07875          21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE  100 (364)
T ss_pred             chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence            34678999999999999999999864 58899999986532  23345677899999999999999999987543     


Q ss_pred             -CeeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccc
Q 040845          596 -EFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIA  674 (824)
Q Consensus       596 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a  674 (824)
                       ...++||||+++ ++.+++..   .+++.++..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++
T Consensus       101 ~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a  173 (364)
T cd07875         101 FQDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA  173 (364)
T ss_pred             cCeEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence             357999999965 77777753   4788899999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCC-Cc-ch
Q 040845          675 KLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLP-IS-TM  752 (824)
Q Consensus       675 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~-~~  752 (824)
                      +.....   .......+|..|+|||++.+..++.++||||+||++|||++|+.||......+ .....+..... .. ..
T Consensus       174 ~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~  249 (364)
T cd07875         174 RTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID-QWNKVIEQLGTPCPEFM  249 (364)
T ss_pred             cccCCC---CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHHH
Confidence            764321   12234568999999999999899999999999999999999999997532111 11111110000 00 00


Q ss_pred             hhcccc----------c--------cCc--hhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          753 EVVDAN----------L--------LSQ--EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       753 ~~~~~~----------~--------~~~--~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      ....+.          .        ...  ..............+.+++.+|++.||.+|||+.|++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            000000          0        000  000000011124568899999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=3.3e-35  Score=310.00  Aligned_cols=267  Identities=25%  Similarity=0.299  Sum_probs=199.4

Q ss_pred             cCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEec
Q 040845          528 KFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       528 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      +|++.+.||+|++|.||+|+.+ ++..||+|.++...  ......+.+|+.+++.++||||+++++++.++...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4788899999999999999865 58999999986542  22345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 040845          605 MPHGSLEKYLHSSN--YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ  682 (824)
Q Consensus       605 ~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  682 (824)
                      ++ ++|.+++....  ..+++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||++....... 
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  155 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-  155 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence            97 68988886533  46899999999999999999999   9999999999999999999999999999987543221 


Q ss_pred             ccccccccccccccCccCcCCC-CCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCc--------chh
Q 040845          683 SMTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPIS--------TME  753 (824)
Q Consensus       683 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--------~~~  753 (824)
                       .......++..|+|||.+.+. .++.++||||+||++|||+||+.||........ ............        ...
T Consensus       156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  233 (285)
T cd07861         156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ-LFRIFRILGTPTEDVWPGVTSLP  233 (285)
T ss_pred             -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHHhCCCChhhhhcchhhH
Confidence             122334578899999987654 478999999999999999999999875322111 000000000000        000


Q ss_pred             hccccccCch-hhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          754 VVDANLLSQE-DIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       754 ~~~~~~~~~~-~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      .......... .........++.++.+++.+||..||++|||+.+++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~  282 (285)
T cd07861         234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH  282 (285)
T ss_pred             HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            0000000000 00000112356778999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.3e-35  Score=317.14  Aligned_cols=267  Identities=20%  Similarity=0.290  Sum_probs=196.7

Q ss_pred             CCceeeec--cceEEEEEEEC-CCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEecc
Q 040845          531 ENNLIGRG--GFGSVYKARIR-DGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYM  605 (824)
Q Consensus       531 ~~~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  605 (824)
                      +.++||+|  +||+||+++.+ +|+.||+|+++...  ....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            45789999  68899999764 68999999987542  233456778999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 040845          606 PHGSLEKYLHSS-NYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM  684 (824)
Q Consensus       606 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  684 (824)
                      ++|+|.+++... ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.++++||+.+..........
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~  158 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL  158 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence            999999999654 245899999999999999999999   9999999999999999999999999998765432211110


Q ss_pred             -----ccccccccccccCccCcCC--CCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcc------
Q 040845          685 -----TQTQTLATIGYMAPEYGRE--GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPIST------  751 (824)
Q Consensus       685 -----~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~------  751 (824)
                           ......++..|+|||++.+  ..++.++|||||||++|||++|+.||............ .....+...      
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~  237 (327)
T cd08227         159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK-LNGTVPCLLDTTTIP  237 (327)
T ss_pred             cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHH-hcCCccccccccchh
Confidence                 1112346778999999875  35889999999999999999999999753322111111 110000000      


Q ss_pred             hhh---------ccc-----ccc------CchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          752 MEV---------VDA-----NLL------SQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       752 ~~~---------~~~-----~~~------~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      .+.         .+.     ...      ............+++.+.+++.+||+.||++|||++|++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~  307 (327)
T cd08227         238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  307 (327)
T ss_pred             hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence            000         000     000      00000001122356789999999999999999999999875

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=4.8e-35  Score=308.92  Aligned_cols=267  Identities=25%  Similarity=0.335  Sum_probs=202.0

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc--chhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEe
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG--RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLE  603 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  603 (824)
                      ++|+..+.||+|+||.||+|+.+ +|+.||+|++.....  ...+.+.+|+.+++.++|+|++++++++......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46888999999999999999876 589999999864422  233567889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 040845          604 YMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS  683 (824)
Q Consensus       604 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  683 (824)
                      |++++.+..+..... .+++..+..++.|++.|++|||   +.+++||||||+||+++.++.++|+|||++........ 
T Consensus        81 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-  155 (286)
T cd07847          81 YCDHTVLNELEKNPR-GVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-  155 (286)
T ss_pred             ccCccHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCCCcc-
Confidence            999988888775543 6899999999999999999999   89999999999999999999999999999987643321 


Q ss_pred             cccccccccccccCccCcCC-CCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCC--cchhhcc----
Q 040845          684 MTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPI--STMEVVD----  756 (824)
Q Consensus       684 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~----  756 (824)
                       ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.+....+. ...+.......  ......+    
T Consensus       156 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07847         156 -DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ-LYLIRKTLGDLIPRHQQIFSTNQF  233 (286)
T ss_pred             -cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCChHHhhhcccccc
Confidence             1223457889999998765 4578999999999999999999999975432211 11111100000  0000000    


Q ss_pred             ------ccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          757 ------ANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       757 ------~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                            +......... ......+..+.+++.+||..+|++||++.|++++
T Consensus       234 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~  283 (286)
T cd07847         234 FKGLSIPEPETREPLE-SKFPNISSPALSFLKGCLQMDPTERLSCEELLEH  283 (286)
T ss_pred             cccccCCCcccccCHH-HHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence                  0000000000 0011346778999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=3.6e-35  Score=306.20  Aligned_cols=251  Identities=23%  Similarity=0.338  Sum_probs=196.7

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc-----cchhhhHHHHHHHHhcCCCCcceeEEeeeec--CCee
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC-----GRAFKSFDVECAMMKSIRHRNLVKVISSCSN--EEFK  598 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~  598 (824)
                      .+|+..+.||+|+||.||+|... +++.||+|++....     .+..+.+.+|+.++++++||||+++++++.+  ....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            46889999999999999999864 58999999886432     1234568889999999999999999998865  4677


Q ss_pred             EEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccC
Q 040845          599 ALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT  678 (824)
Q Consensus       599 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~  678 (824)
                      ++++||+++++|.+++.... .+++..+..++.|++.|++|||   +.+|+||||+|+||+++.++.++|+|||++....
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~  157 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ  157 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence            89999999999999997655 5788999999999999999999   9999999999999999999999999999987653


Q ss_pred             CCCCc-cccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccc
Q 040845          679 GEDQS-MTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDA  757 (824)
Q Consensus       679 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  757 (824)
                      ..... .......++..|+|||.+.+..++.++||||+||++||+++|+.||......    ...... ....       
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~----~~~~~~-~~~~-------  225 (266)
T cd06651         158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM----AAIFKI-ATQP-------  225 (266)
T ss_pred             cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH----HHHHHH-hcCC-------
Confidence            22111 1112345788999999998888999999999999999999999998753211    111000 0000       


Q ss_pred             cccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          758 NLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       758 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                             .....+..+...+.+++ +||..+|++||+++|++++
T Consensus       226 -------~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h  261 (266)
T cd06651         226 -------TNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH  261 (266)
T ss_pred             -------CCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence                   00011123345567777 6888999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=2.1e-35  Score=309.75  Aligned_cols=254  Identities=25%  Similarity=0.434  Sum_probs=203.4

Q ss_pred             ccCCCCceeeeccceEEEEEEEC------CCcEEEEEEeeccccc-hhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeE
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR------DGMEVAVKVFNLQCGR-AFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKA  599 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  599 (824)
                      ++|+..+.||+|+||.||+|+.+      +...||+|.+...... ..+.+..|++++++++|+||+++++++.+....+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            57888999999999999999864      2467999988654333 4567899999999999999999999999989999


Q ss_pred             EEEeccCCCCHHHHhhhCC--------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeec
Q 040845          600 LVLEYMPHGSLEKYLHSSN--------YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDF  671 (824)
Q Consensus       600 lv~e~~~~g~L~~~l~~~~--------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df  671 (824)
                      +||||+++|+|.+++....        ..+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.++++||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEccc
Confidence            9999999999999997544        15899999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCc
Q 040845          672 GIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPIS  750 (824)
Q Consensus       672 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  750 (824)
                      |++....... ........++..|+|||.+.+..++.++||||||+++|++++ |..||......  ........   ..
T Consensus       162 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~--~~~~~~~~---~~  235 (275)
T cd05046         162 SLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE--EVLNRLQA---GK  235 (275)
T ss_pred             ccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH--HHHHHHHc---CC
Confidence            9987543222 122233456778999999988888999999999999999999 77787543221  11111110   00


Q ss_pred             chhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 040845          751 TMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLL  803 (824)
Q Consensus       751 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~  803 (824)
                                    .....+..++..+.+++.+||+.+|++|||+.|+++.|.
T Consensus       236 --------------~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         236 --------------LELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             --------------cCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence                          000011235667999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.1e-35  Score=319.73  Aligned_cols=267  Identities=23%  Similarity=0.286  Sum_probs=198.6

Q ss_pred             HHHhhccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc--chhhhHHHHHHHHhcCCCCcceeEEeeeecC---
Q 040845          522 LFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG--RAFKSFDVECAMMKSIRHRNLVKVISSCSNE---  595 (824)
Q Consensus       522 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---  595 (824)
                      .....++|++.+.||+|+||.||+|... +++.||||.+.....  ...+.+.+|+.+++.++||||+++++++...   
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07878          10 VWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI   89 (343)
T ss_pred             HhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence            4456789999999999999999999754 588999999864321  2345577899999999999999999987533   


Q ss_pred             ---CeeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecc
Q 040845          596 ---EFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFG  672 (824)
Q Consensus       596 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  672 (824)
                         ...++++|++ +++|.+++...  .+++..+..++.|++.||+|||   +.+|+||||||+||++++++.+||+|||
T Consensus        90 ~~~~~~~~~~~~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg  163 (343)
T cd07878          90 ENFNEVYLVTNLM-GADLNNIVKCQ--KLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFG  163 (343)
T ss_pred             cccCcEEEEeecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCCc
Confidence               4568999998 77998887643  5889999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCccccccccccccccCccCcCC-CCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcc
Q 040845          673 IAKLLTGEDQSMTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPIST  751 (824)
Q Consensus       673 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  751 (824)
                      ++......     .....+|..|+|||++.+ ..++.++||||+||++|||++|+.||...... .....+...... ..
T Consensus       164 ~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~-~~  236 (343)
T cd07878         164 LARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI-DQLKRIMEVVGT-PS  236 (343)
T ss_pred             cceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHhCC-CC
Confidence            99865322     223468999999999876 46899999999999999999999998652211 111111111000 00


Q ss_pred             hhhccc-----------cccCchhhhh-hhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          752 MEVVDA-----------NLLSQEDIHF-VAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       752 ~~~~~~-----------~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      .+....           .......... .......+.+.+++.+|+..||++|||+.|++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         237 PEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             HHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            000000           0000000000 0001234567899999999999999999999976

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4.8e-36  Score=311.19  Aligned_cols=239  Identities=27%  Similarity=0.376  Sum_probs=189.8

Q ss_pred             ceeeeccceEEEEEEECC--------CcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEec
Q 040845          533 NLIGRGGFGSVYKARIRD--------GMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       533 ~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      +.||+|+||.||+|..+.        ...||+|.+........+.+.+|+.+++.++||||+++++++..+...++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            368999999999997642        234888887655445567788899999999999999999999998999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCc--------EEEeecccccc
Q 040845          605 MPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMV--------AHLSDFGIAKL  676 (824)
Q Consensus       605 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~--------~kl~Dfg~a~~  676 (824)
                      +++|+|.+++...+..+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.        ++++|||.+..
T Consensus        81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~  157 (258)
T cd05078          81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT  157 (258)
T ss_pred             CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence            9999999999876667899999999999999999999   999999999999999987765        69999998875


Q ss_pred             cCCCCCccccccccccccccCccCcCCC-CCCccchHHHHHHHHHHHHhCC-CCCcccccCcchhhhhhhhhCCCcchhh
Q 040845          677 LTGEDQSMTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRK-KPTDELFNGEMTLKHWVNDCLPISTMEV  754 (824)
Q Consensus       677 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~  754 (824)
                      ....      ....++..|+|||.+.+. .++.++||||||+++|||++|. .|+..... .. .......         
T Consensus       158 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~-~~-~~~~~~~---------  220 (258)
T cd05078         158 VLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS-QK-KLQFYED---------  220 (258)
T ss_pred             cCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH-HH-HHHHHHc---------
Confidence            4321      223477889999998764 5799999999999999999995 44433111 10 0000000         


Q ss_pred             ccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 040845          755 VDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL  802 (824)
Q Consensus       755 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L  802 (824)
                         .        ...+.....++.+++.+||+.||++|||++++++.|
T Consensus       221 ---~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l  257 (258)
T cd05078         221 ---R--------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL  257 (258)
T ss_pred             ---c--------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence               0        001112235688999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=6.1e-35  Score=308.77  Aligned_cols=271  Identities=22%  Similarity=0.284  Sum_probs=200.4

Q ss_pred             hhccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc-chhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEE
Q 040845          525 ATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVL  602 (824)
Q Consensus       525 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  602 (824)
                      ++++|.+.+.||+|+||.||+|... +++.||+|++..... .....+.+|+.+++.++|+||+++++++..++..++||
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            4578999999999999999999764 589999999865432 22346678999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 040845          603 EYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ  682 (824)
Q Consensus       603 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  682 (824)
                      ||+. +++.+++......+.+.++..++.|++.||+|||   +.+|+|+||||+||+++.++.++|+|||+++.......
T Consensus        83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  158 (291)
T cd07870          83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ  158 (291)
T ss_pred             eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence            9995 6888777655556788889999999999999999   89999999999999999999999999999875432221


Q ss_pred             ccccccccccccccCccCcCCC-CCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhh-CCCc----------
Q 040845          683 SMTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDC-LPIS----------  750 (824)
Q Consensus       683 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~----------  750 (824)
                        ......++..|+|||.+.+. .++.++||||+||++|||++|+.||+........+...+... .+..          
T Consensus       159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (291)
T cd07870         159 --TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLP  236 (291)
T ss_pred             --CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcc
Confidence              12234578899999988754 478899999999999999999999975432211111111000 0000          


Q ss_pred             -chhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          751 -TMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       751 -~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                       .......................+..+.+++.+|+..||++|||+.|++.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h  288 (291)
T cd07870         237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH  288 (291)
T ss_pred             cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence             000000000000000000111224578899999999999999999998764

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=5.2e-35  Score=305.56  Aligned_cols=250  Identities=25%  Similarity=0.366  Sum_probs=188.4

Q ss_pred             eeeeccceEEEEEEECC---CcEEEEEEeecccc-chhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEeccCCCC
Q 040845          534 LIGRGGFGSVYKARIRD---GMEVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGS  609 (824)
Q Consensus       534 ~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  609 (824)
                      .||+|+||.||+|...+   ...+|+|.+..... .....+.+|+..++.++|+||+++++++......++||||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            58999999999997543   35788887754332 234567889999999999999999999999999999999999999


Q ss_pred             HHHHhhhCC----CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccc
Q 040845          610 LEKYLHSSN----YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMT  685 (824)
Q Consensus       610 L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  685 (824)
                      |.+++....    ...++..+..++.|++.|++|||   +.+|+||||||+||++++++.+||+|||++...........
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            999997654    23467788899999999999999   99999999999999999999999999999875433322222


Q ss_pred             cccccccccccCccCcC-------CCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhccc
Q 040845          686 QTQTLATIGYMAPEYGR-------EGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDA  757 (824)
Q Consensus       686 ~~~~~~~~~y~aPE~~~-------~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  757 (824)
                      .....++..|+|||+..       ...++.++||||+||++|||++ |..||......+ ..........    .....+
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~~~~~~~~----~~~~~~  233 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-VLKQVVREQD----IKLPKP  233 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH-HHHHHhhccC----ccCCCC
Confidence            23344677899999864       2356889999999999999999 677776532211 1111111100    000011


Q ss_pred             cccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 040845          758 NLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL  802 (824)
Q Consensus       758 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L  802 (824)
                      .          .+..++..+.+++..|| .||++|||++||++.|
T Consensus       234 ~----------~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l  267 (269)
T cd05042         234 Q----------LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL  267 (269)
T ss_pred             c----------ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence            0          11234566788999999 5999999999999886

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-37  Score=318.94  Aligned_cols=250  Identities=24%  Similarity=0.341  Sum_probs=210.5

Q ss_pred             CCCCceeeeccceEEEEEEECC-CcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEeccCC
Q 040845          529 FSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPH  607 (824)
Q Consensus       529 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  607 (824)
                      |++..-||.|+||.||+|..++ +--.|-|++.....+..+++.-|++||....||+||++++.|..+...+++.|||.|
T Consensus        34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G  113 (1187)
T KOG0579|consen   34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG  113 (1187)
T ss_pred             HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence            4556789999999999998764 445678888877788899999999999999999999999999999999999999999


Q ss_pred             CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccccc
Q 040845          608 GSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQT  687 (824)
Q Consensus       608 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  687 (824)
                      |..+..+-.-+..+++.++.-+++|++.||.|||   +.+|||||+|+.|||++-+|.++++|||.+....  .......
T Consensus       114 GAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~--~t~qkRD  188 (1187)
T KOG0579|consen  114 GAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK--STRQKRD  188 (1187)
T ss_pred             chHhHHHHHhccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccch--hHHhhhc
Confidence            9999998887889999999999999999999999   9999999999999999999999999999886432  2223455


Q ss_pred             cccccccccCccCcC-----CCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCc
Q 040845          688 QTLATIGYMAPEYGR-----EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ  762 (824)
Q Consensus       688 ~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  762 (824)
                      ..+||+.|||||+.+     ..+|++++||||||+.+.||..+.+|....-.. ..+..+                 ...
T Consensus       189 sFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM-RVllKi-----------------aKS  250 (1187)
T KOG0579|consen  189 SFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM-RVLLKI-----------------AKS  250 (1187)
T ss_pred             cccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH-HHHHHH-----------------hhc
Confidence            678999999999753     668999999999999999999999986653221 111111                 122


Q ss_pred             hhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          763 EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       763 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      .+..+.+|...+..+.+++.+|+..||..||+++++++|
T Consensus       251 ePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H  289 (1187)
T KOG0579|consen  251 EPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH  289 (1187)
T ss_pred             CCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence            223344556678889999999999999999999999876

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.4e-35  Score=318.86  Aligned_cols=255  Identities=20%  Similarity=0.259  Sum_probs=199.2

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEE
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVL  602 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  602 (824)
                      ++|++.+.||+|+||+||+|+.+ +++.||+|++....   ......+.+|..++..++|++|+++++++.+++..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47889999999999999999865 57899999986431   223455778999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 040845          603 EYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ  682 (824)
Q Consensus       603 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  682 (824)
                      ||+++|+|.+++......+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||++........
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  157 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT  157 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence            999999999999875557899999999999999999999   99999999999999999999999999999976543222


Q ss_pred             ccccccccccccccCccCcCC-----CCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccc
Q 040845          683 SMTQTQTLATIGYMAPEYGRE-----GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDA  757 (824)
Q Consensus       683 ~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  757 (824)
                       .......||+.|+|||++.+     +.++.++||||+||++|||++|+.||......+ ...........   .. .. 
T Consensus       158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~-~~~~i~~~~~~---~~-~p-  230 (331)
T cd05624         158 -VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE-TYGKIMNHEER---FQ-FP-  230 (331)
T ss_pred             -eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH-HHHHHHcCCCc---cc-CC-
Confidence             12223468999999998865     467899999999999999999999996522111 11111000000   00 00 


Q ss_pred             cccCchhhhhhhHHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 040845          758 NLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQ--RINAKEIVAK  801 (824)
Q Consensus       758 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rpt~~evl~~  801 (824)
                                .....++..+.+++.+|+..++.+  |+++++++++
T Consensus       231 ----------~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         231 ----------SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             ----------CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence                      000124567889999999876654  5688888876

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=6.1e-35  Score=303.33  Aligned_cols=237  Identities=26%  Similarity=0.441  Sum_probs=189.2

Q ss_pred             ceeeeccceEEEEEEECCCc-----------EEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEE
Q 040845          533 NLIGRGGFGSVYKARIRDGM-----------EVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALV  601 (824)
Q Consensus       533 ~~lg~G~~g~V~~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  601 (824)
                      +.||+|+||.||+|.+.+..           .|++|.+...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            46899999999999876432           5788877544332 6788899999999999999999999987 778999


Q ss_pred             EeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC-------cEEEeecccc
Q 040845          602 LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM-------VAHLSDFGIA  674 (824)
Q Consensus       602 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~-------~~kl~Dfg~a  674 (824)
                      |||+++|+|.+++......+++..+..++.|++.|++|||   +.+|+||||||+||+++.++       .+|++|||++
T Consensus        79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a  155 (259)
T cd05037          79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP  155 (259)
T ss_pred             EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence            9999999999999876657899999999999999999999   99999999999999999887       7999999999


Q ss_pred             cccCCCCCccccccccccccccCccCcCCC--CCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcc
Q 040845          675 KLLTGEDQSMTQTQTLATIGYMAPEYGREG--QVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPIST  751 (824)
Q Consensus       675 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  751 (824)
                      .....      .....++..|+|||++...  .++.++||||||+++||+++ |..||......  ....+....     
T Consensus       156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~--~~~~~~~~~-----  222 (259)
T cd05037         156 ITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS--EKERFYQDQ-----  222 (259)
T ss_pred             ccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch--hHHHHHhcC-----
Confidence            86532      1223466789999998776  78999999999999999999 46666553211  111111100     


Q ss_pred             hhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 040845          752 MEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL  802 (824)
Q Consensus       752 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L  802 (824)
                            .....         .....+.+++.+||..+|++|||+.|+++.|
T Consensus       223 ------~~~~~---------~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l  258 (259)
T cd05037         223 ------HRLPM---------PDCAELANLINQCWTYDPTKRPSFRAILRDL  258 (259)
T ss_pred             ------CCCCC---------CCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence                  00000         0015688999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=5.2e-35  Score=308.66  Aligned_cols=267  Identities=24%  Similarity=0.309  Sum_probs=204.0

Q ss_pred             cCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEec
Q 040845          528 KFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       528 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      +|++.+.||+|+||.||+|++. +|+.||+|++....  ....+.+.+|+.++++++||||+++++++..+...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            5788899999999999999865 58999999987553  23356788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 040845          605 MPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM  684 (824)
Q Consensus       605 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  684 (824)
                      + +++|.+++......+++.++..++.|+++|++|||   +.+++|+||||+||+++.++.++++|||.+........ .
T Consensus        81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~  155 (286)
T cd07832          81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-R  155 (286)
T ss_pred             c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-C
Confidence            9 99999999876667999999999999999999999   99999999999999999999999999999987643322 1


Q ss_pred             ccccccccccccCccCcCCC-CCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcch-------hh--
Q 040845          685 TQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTM-------EV--  754 (824)
Q Consensus       685 ~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-------~~--  754 (824)
                      ......++..|+|||.+.+. .++.++||||+|+++|||++|.+||...... ... .+..........       +.  
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07832         156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI-EQL-AIVFRTLGTPNEETWPGLTSLPD  233 (286)
T ss_pred             ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH-HHH-HHHHHHcCCCChHHHhhccCcch
Confidence            22344688999999988654 4689999999999999999998777542211 111 111111100000       00  


Q ss_pred             ccccccC-chhhhh-hhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          755 VDANLLS-QEDIHF-VAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       755 ~~~~~~~-~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      ....... ...... ....+.+..+.+++.+|+..+|++|||+++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            0000000 000000 0112345789999999999999999999999875

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=2.3e-35  Score=305.40  Aligned_cols=246  Identities=29%  Similarity=0.492  Sum_probs=198.8

Q ss_pred             ccCCCCceeeeccceEEEEEEECCCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEeccC
Q 040845          527 DKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMP  606 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  606 (824)
                      .+|++.+.||+|+||.||+|.. +++.||+|.++..  ...+.+.+|+.++++++|||++++++++..+ ..++||||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence            5688899999999999999975 4888999998643  2346788999999999999999999998765 4689999999


Q ss_pred             CCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccc
Q 040845          607 HGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMT  685 (824)
Q Consensus       607 ~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  685 (824)
                      +++|.+++.... ..+++..+..++.|++.|++|||   +.+++||||||+||+++.++.+||+|||.+......     
T Consensus        82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-----  153 (254)
T cd05083          82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-----  153 (254)
T ss_pred             CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceecccc-----
Confidence            999999997544 45789999999999999999999   999999999999999999999999999998754321     


Q ss_pred             cccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchh
Q 040845          686 QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQED  764 (824)
Q Consensus       686 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  764 (824)
                      ......+..|+|||.+.++.++.++|+||+|+++|||++ |+.||......+  ....+....                 
T Consensus       154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~~~-----------------  214 (254)
T cd05083         154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE--VKECVEKGY-----------------  214 (254)
T ss_pred             CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH--HHHHHhCCC-----------------
Confidence            112234568999999988889999999999999999998 888886532111  111111000                 


Q ss_pred             hhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 040845          765 IHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLK  804 (824)
Q Consensus       765 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~  804 (824)
                       ....+..++..+.+++.+||+.+|++||+++++++.|++
T Consensus       215 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         215 -RMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             -CCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence             001112346778999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.7e-35  Score=310.72  Aligned_cols=247  Identities=25%  Similarity=0.367  Sum_probs=200.6

Q ss_pred             cCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc-cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEecc
Q 040845          528 KFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYM  605 (824)
Q Consensus       528 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  605 (824)
                      .|+..+.||+|+||.||+|.+. +++.||+|.+.... ....+.+..|++++++++||||+++++++......++||||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            3556678999999999999864 57899999986443 334567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccc
Q 040845          606 PHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMT  685 (824)
Q Consensus       606 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  685 (824)
                      ++++|.+++...  .+++..+..++.|+++|++|||   +.+++|+||+|+||++++++.++++|||++..+....  ..
T Consensus        85 ~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~~  157 (277)
T cd06642          85 GGGSALDLLKPG--PLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IK  157 (277)
T ss_pred             CCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcc--hh
Confidence            999999998653  5789999999999999999999   9999999999999999999999999999997654322  12


Q ss_pred             cccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhh
Q 040845          686 QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDI  765 (824)
Q Consensus       686 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  765 (824)
                      .....++..|+|||.+.+..++.++|||||||++|||++|+.||........  ..+.....        .+        
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~~~~~--------~~--------  219 (277)
T cd06642         158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV--LFLIPKNS--------PP--------  219 (277)
T ss_pred             hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH--HhhhhcCC--------CC--------
Confidence            2234578899999999988899999999999999999999999865322111  11100000        00        


Q ss_pred             hhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          766 HFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       766 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                        ..+..++..+.+++.+||..+|++||++.|++++
T Consensus       220 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         220 --TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             --CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence              0112345678999999999999999999999985

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.6e-35  Score=304.84  Aligned_cols=248  Identities=27%  Similarity=0.363  Sum_probs=201.6

Q ss_pred             cCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc-----cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEE
Q 040845          528 KFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC-----GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALV  601 (824)
Q Consensus       528 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  601 (824)
                      +|+..+.||+|++|.||+|... +++.||+|.+....     .+..+.+..|+++++.++|+||+++++++.++...++|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4777899999999999999876 68999999986543     22456788899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 040845          602 LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED  681 (824)
Q Consensus       602 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  681 (824)
                      +||+++++|.+++.... .+++..+..++.|++.|++|||   +.+++|+||+|+||+++.++.+||+|||.+.......
T Consensus        81 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~  156 (258)
T cd06632          81 LELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS  156 (258)
T ss_pred             EEecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence            99999999999997664 6889999999999999999999   9999999999999999999999999999987653322


Q ss_pred             CccccccccccccccCccCcCCCC-CCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhcccccc
Q 040845          682 QSMTQTQTLATIGYMAPEYGREGQ-VSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLL  760 (824)
Q Consensus       682 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  760 (824)
                         ......++..|+|||.+.... ++.++|+||||+++|++++|+.||........ ...+... ..            
T Consensus       157 ---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~-~~------------  219 (258)
T cd06632         157 ---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA-VFKIGRS-KE------------  219 (258)
T ss_pred             ---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHH-HHHHHhc-cc------------
Confidence               123345788999999887766 89999999999999999999999876331110 0000000 00            


Q ss_pred             CchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          761 SQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       761 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                           ....+..++..+.+++.+||..+|++||++.+++++
T Consensus       220 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         220 -----LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             -----CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence                 000112345678899999999999999999999864

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=3.8e-36  Score=289.33  Aligned_cols=273  Identities=21%  Similarity=0.277  Sum_probs=202.4

Q ss_pred             hccCCCCceeeeccceEEEEEEECC-----CcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeec-CCe
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIRD-----GMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSN-EEF  597 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  597 (824)
                      ...|+..+.||+|.||.||+|.-++     ...+|+|.++.+.  +......-+|+.+++.++|||++.+..++-. +..
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~  102 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK  102 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence            4679999999999999999995332     2379999987553  2345667889999999999999999999876 889


Q ss_pred             eEEEEeccCCCCHHHHhhhCC----CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCC----CcEEEe
Q 040845          598 KALVLEYMPHGSLEKYLHSSN----YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDN----MVAHLS  669 (824)
Q Consensus       598 ~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~----~~~kl~  669 (824)
                      .++++||.+. +|.+.++-++    ..++...+..+++||+.|+.|||   +.=|+|||+||.||++..+    |.|||+
T Consensus       103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VKIa  178 (438)
T KOG0666|consen  103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVKIA  178 (438)
T ss_pred             EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeEee
Confidence            9999999988 8988886543    56888999999999999999999   6779999999999999876    999999


Q ss_pred             ecccccccCCCCCc-cccccccccccccCccCcCCC-CCCccchHHHHHHHHHHHHhCCCCCcccccCc-----c---hh
Q 040845          670 DFGIAKLLTGEDQS-MTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDELFNGE-----M---TL  739 (824)
Q Consensus       670 Dfg~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~-----~---~~  739 (824)
                      |||+|+.+.+.-.. .....++.|.||+|||.+.+. .||.+.||||.|||+.||+|-.+-|......-     .   .+
T Consensus       179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl  258 (438)
T KOG0666|consen  179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL  258 (438)
T ss_pred             cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence            99999998755333 355677899999999988776 58999999999999999999998775432110     0   01


Q ss_pred             hhhhhhhCCCcchhhccccccCch-------------hhhhhh----HHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 040845          740 KHWVNDCLPISTMEVVDANLLSQE-------------DIHFVA----KEQCVSFVFNLALECTVESPEQRINAKEIVAKL  802 (824)
Q Consensus       740 ~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~----~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L  802 (824)
                      ..+.....-....+..+.+...+.             ...+..    ...-++..++|+.+++++||.+|.|+.+++++-
T Consensus       259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~  338 (438)
T KOG0666|consen  259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP  338 (438)
T ss_pred             HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence            111110000000011111101000             000000    001233478999999999999999999998864

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=3.9e-35  Score=304.54  Aligned_cols=250  Identities=32%  Similarity=0.576  Sum_probs=201.7

Q ss_pred             CCCCceeeeccceEEEEEEECC-----CcEEEEEEeeccccc-hhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEE
Q 040845          529 FSENNLIGRGGFGSVYKARIRD-----GMEVAVKVFNLQCGR-AFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVL  602 (824)
Q Consensus       529 ~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  602 (824)
                      +++.+.||+|+||.||+|++.+     +..||+|++...... ..+.+..|+.+++.++|+||+++++++.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            3567899999999999998764     388999998655433 5678889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhhCCCC-CCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 040845          603 EYMPHGSLEKYLHSSNYS-LDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED  681 (824)
Q Consensus       603 e~~~~g~L~~~l~~~~~~-~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  681 (824)
                      ||+++++|.+++...... +++.++..++.|++.|++|||   +.+++|+||+|+||++++++.++++|||.+.......
T Consensus        81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  157 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD  157 (258)
T ss_pred             eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence            999999999999765533 899999999999999999999   9999999999999999999999999999998765432


Q ss_pred             CccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhcccccc
Q 040845          682 QSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLL  760 (824)
Q Consensus       682 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  760 (824)
                      .... ....++..|+|||.+.+..++.++||||+|+++|||++ |..||.....  ......+....             
T Consensus       158 ~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~--~~~~~~~~~~~-------------  221 (258)
T smart00219      158 YYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN--EEVLEYLKKGY-------------  221 (258)
T ss_pred             cccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHhcCC-------------
Confidence            2221 12336789999999988889999999999999999998 7777765211  11111111000             


Q ss_pred             CchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 040845          761 SQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL  802 (824)
Q Consensus       761 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L  802 (824)
                           ....+..++..+.+++.+||..||++|||+.|+++.|
T Consensus       222 -----~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      222 -----RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             -----CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                 0011122566799999999999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=2.9e-35  Score=309.79  Aligned_cols=259  Identities=23%  Similarity=0.329  Sum_probs=202.7

Q ss_pred             cHHHHHHhhccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcC-CCCcceeEEeeeec-
Q 040845          518 SYLELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSI-RHRNLVKVISSCSN-  594 (824)
Q Consensus       518 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-  594 (824)
                      +..++....+.|++.+.||+|+||.||+|... +++.||+|++.... .....+..|+.+++++ +|+||+++++++.. 
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   85 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK   85 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence            44555566788999999999999999999864 58899999986542 3345678899999998 69999999999843 


Q ss_pred             -----CCeeEEEEeccCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEE
Q 040845          595 -----EEFKALVLEYMPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHL  668 (824)
Q Consensus       595 -----~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl  668 (824)
                           ....+++|||+++|+|.+++.... ..+++..+..++.|++.|++|||   +.+++|+|++|+||++++++.++|
T Consensus        86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~~l  162 (282)
T cd06636          86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKL  162 (282)
T ss_pred             cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEE
Confidence                 467899999999999999987643 45788889999999999999999   999999999999999999999999


Q ss_pred             eecccccccCCCCCccccccccccccccCccCcC-----CCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhh
Q 040845          669 SDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR-----EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWV  743 (824)
Q Consensus       669 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~  743 (824)
                      +|||++........  ......++..|+|||.+.     ...++.++||||+||++|||++|+.||.......... . +
T Consensus       163 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~-~-~  238 (282)
T cd06636         163 VDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF-L-I  238 (282)
T ss_pred             eeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh-h-H
Confidence            99999875532211  123345888999999875     3467889999999999999999999986532111100 0 0


Q ss_pred             hhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          744 NDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       744 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                                  ...     .........++..+.+++.+||..||++|||+.|++++
T Consensus       239 ------------~~~-----~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~  279 (282)
T cd06636         239 ------------PRN-----PPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH  279 (282)
T ss_pred             ------------hhC-----CCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence                        000     00000112356679999999999999999999999764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=7.6e-35  Score=304.07  Aligned_cols=257  Identities=26%  Similarity=0.344  Sum_probs=206.4

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc-cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEec
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      ++|++.+.||.|+||+||+|... ++..||+|++.... ......+.+|+++++.++|+|++++++.+..+...++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            46889999999999999999865 58899999986442 23557788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 040845          605 MPHGSLEKYLHSSN--YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ  682 (824)
Q Consensus       605 ~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  682 (824)
                      +++++|.+++....  ..+++..+..++.|++.|++|||   +.+++||||+|+||++++++.++|+|||++..+.....
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            99999999997642  36889999999999999999999   99999999999999999999999999999987654433


Q ss_pred             cc--ccccccccccccCccCcCCC-CCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccc
Q 040845          683 SM--TQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANL  759 (824)
Q Consensus       683 ~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  759 (824)
                      ..  ......++..|+|||.+... .++.++|+|||||++|||++|+.||......+ ....+.....+         . 
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-~~~~~~~~~~~---------~-  226 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-VLMLTLQNDPP---------S-  226 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh-hHHHHhcCCCC---------C-
Confidence            21  22334588899999988776 78999999999999999999999997642221 11111111000         0 


Q ss_pred             cCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          760 LSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       760 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      ...    ......++..+.+++.+||..||++||++.|++++
T Consensus       227 ~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         227 LET----GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             cCC----ccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            000    00012456778999999999999999999999875

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=2.8e-38  Score=329.00  Aligned_cols=376  Identities=26%  Similarity=0.380  Sum_probs=321.7

Q ss_pred             Ccccccccc-cCCcccccCCCCCcEEEccCCcccccccccccCCCCCCEEeCCCCcCCcccChhhhCcCCCceeeccCCc
Q 040845            2 PSIINNFLT-STTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNS   80 (824)
Q Consensus         2 ~~l~~n~i~-~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~   80 (824)
                      ++++.|.++ ...|.....++.+++|-|...++. .+|..++.+.+|++|.+++|++. .+-+.+..++.|+.+.+..|+
T Consensus        12 vDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R~N~   89 (1255)
T KOG0444|consen   12 VDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIVRDNN   89 (1255)
T ss_pred             ccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhhhccc
Confidence            467889998 589999999999999999999999 89999999999999999999998 667889999999999999998


Q ss_pred             cc--cccCccccCCCCCccEEEccCCeeeeecCccccCCCCCceEeccCccccccCCccccCCCCCCEEEccCCcCCCCc
Q 040845           81 LS--GCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSST  158 (824)
Q Consensus        81 l~--~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~  158 (824)
                      ++  |+|..++.  +..|..||||+|+++ ..|..+..-+++-.|+|++|+|..+....|.+|+.|-.||||+|++..+|
T Consensus        90 LKnsGiP~diF~--l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe~LP  166 (1255)
T KOG0444|consen   90 LKNSGIPTDIFR--LKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLEMLP  166 (1255)
T ss_pred             cccCCCCchhcc--cccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhhhcC
Confidence            86  67777764  999999999999999 77899999999999999999999777777889999999999999999987


Q ss_pred             CcccccccCCCCCCCcEEECcCCCCCccCCccccccccccccEEEeecCcceecCCccCCCCCCCCEEEecCCccC-Ccc
Q 040845          159 LDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLN-GSI  237 (824)
Q Consensus       159 ~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~-~~~  237 (824)
                      +.      ...+.+|++|+|++|++.-.           .|               ..+-.+++|++|.+++.+-+ ..+
T Consensus       167 PQ------~RRL~~LqtL~Ls~NPL~hf-----------QL---------------rQLPsmtsL~vLhms~TqRTl~N~  214 (1255)
T KOG0444|consen  167 PQ------IRRLSMLQTLKLSNNPLNHF-----------QL---------------RQLPSMTSLSVLHMSNTQRTLDNI  214 (1255)
T ss_pred             HH------HHHHhhhhhhhcCCChhhHH-----------HH---------------hcCccchhhhhhhcccccchhhcC
Confidence            54      67788999999999997522           01               12234677777788775433 346


Q ss_pred             chhhcCCCCCCEEEcccccCcccCCccccccCCccEEEccCccccccCCccccCCCCCcEEEcCCCCCCCCCCccccccc
Q 040845          238 PITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKD  317 (824)
Q Consensus       238 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~  317 (824)
                      |.++..+.+|..+|||.|.+. .+|+.+..+++|+.|+|++|+|+ ...-..+.+.+|++|+||.|+++.+|..++.++.
T Consensus       215 Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt~LP~avcKL~k  292 (1255)
T KOG0444|consen  215 PTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLTVLPDAVCKLTK  292 (1255)
T ss_pred             CCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhccchHHHhhhHH
Confidence            778888888888888888888 78888888888999999999988 4555677788999999999999999999999999


Q ss_pred             ccccccccccccC-cCCccccccccchhhhcccccccccCCCccCCCCCCCeEEccCccccccCCccccccccccEEEcc
Q 040845          318 ILDLNLSSNCFSG-PLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLS  396 (824)
Q Consensus       318 L~~L~l~~N~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  396 (824)
                      |+.|++.+|+++- -+|..++++.+|+.+..++|.+. ..|..++.|..|+.|.|++|++- .+|+++.-++.|+.|||.
T Consensus       293 L~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlr  370 (1255)
T KOG0444|consen  293 LTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLR  370 (1255)
T ss_pred             HHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeecc
Confidence            9999999999863 48999999999999999999998 78999999999999999999998 799999999999999999


Q ss_pred             CcccCCCCcccccCCcccceee
Q 040845          397 YNNLSGTIPVSLEKLSYLKDLN  418 (824)
Q Consensus       397 ~N~l~~~~p~~~~~l~~L~~L~  418 (824)
                      +|+-.-..|+--..-++|+.-+
T Consensus       371 eNpnLVMPPKP~da~~~lefYN  392 (1255)
T KOG0444|consen  371 ENPNLVMPPKPNDARKKLEFYN  392 (1255)
T ss_pred             CCcCccCCCCcchhhhcceeee
Confidence            9986623333322223444433

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=9.6e-35  Score=303.18  Aligned_cols=251  Identities=23%  Similarity=0.391  Sum_probs=186.6

Q ss_pred             eeeeccceEEEEEEECCC---cEEEEEEeeccc-cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEeccCCCC
Q 040845          534 LIGRGGFGSVYKARIRDG---MEVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGS  609 (824)
Q Consensus       534 ~lg~G~~g~V~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  609 (824)
                      .||+|+||.||+|...++   ..+++|.+.... ....+.+.+|+.+++.++||||+++++.+.+....++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            589999999999975443   345667665432 2345678899999999999999999999999999999999999999


Q ss_pred             HHHHhhhCC---CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcccc
Q 040845          610 LEKYLHSSN---YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQ  686 (824)
Q Consensus       610 L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  686 (824)
                      |.+++....   ...++..+..++.|+++|++|||   +.+++||||||+||+++.++.++|+|||++............
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            999997643   34566778899999999999999   999999999999999999999999999998643222221222


Q ss_pred             ccccccccccCccCcCC-------CCCCccchHHHHHHHHHHHHhC-CCCCcccccCcchhhhhhhhhCCCcchhhcccc
Q 040845          687 TQTLATIGYMAPEYGRE-------GQVSTNGDVYSFGIMLMETFTR-KKPTDELFNGEMTLKHWVNDCLPISTMEVVDAN  758 (824)
Q Consensus       687 ~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslG~~l~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  758 (824)
                      ....++..|+|||++..       ..++.++|||||||++|||+++ ..||...... .........    ......++.
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-~~~~~~~~~----~~~~~~~~~  233 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR-EVLNHVIKD----QQVKLFKPQ  233 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHhh----cccccCCCc
Confidence            34457889999998743       2457899999999999999975 5576542211 111111111    001111111


Q ss_pred             ccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 040845          759 LLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLL  803 (824)
Q Consensus       759 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~  803 (824)
                      .          +..+...+.+++..|| .+|++||+++|+++.|.
T Consensus       234 ~----------~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         234 L----------ELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             c----------CCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            1          1123456788999999 67999999999998773

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=4.1e-35  Score=305.76  Aligned_cols=254  Identities=24%  Similarity=0.315  Sum_probs=205.0

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc-chhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEec
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      ++|+..+.||+|+||.||+|..+ +++.||+|.+..... ...+.+.+|++++++++||||+++++++..+...++|+||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            35778889999999999999876 589999999876532 3456788899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 040845          605 MPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYS-APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS  683 (824)
Q Consensus       605 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  683 (824)
                      +++++|.+++......++...+..++.|++.|++|||   + .+++|+||+|+||++++++.++|+|||.+........ 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-  156 (265)
T cd06605          81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA-  156 (265)
T ss_pred             cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-
Confidence            9999999999876557889999999999999999999   8 9999999999999999999999999999876532211 


Q ss_pred             cccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCch
Q 040845          684 MTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQE  763 (824)
Q Consensus       684 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  763 (824)
                         ....++..|+|||...+..++.++||||+|+++|++++|+.||.....................             
T Consensus       157 ---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------------  220 (265)
T cd06605         157 ---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP-------------  220 (265)
T ss_pred             ---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCC-------------
Confidence               1155788999999998889999999999999999999999998764322111111111111000             


Q ss_pred             hhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          764 DIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       764 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      .... ....++..+.+++.+||..||++|||+.|++++
T Consensus       221 ~~~~-~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         221 PPRL-PSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             CCCC-ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence            0000 011156678999999999999999999999865

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=7.6e-35  Score=302.01  Aligned_cols=250  Identities=23%  Similarity=0.320  Sum_probs=203.8

Q ss_pred             cCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEec
Q 040845          528 KFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       528 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      +|+..+.||+|+||.||.++.. +++.||+|.+....  ......+.+|++++++++|+||+++++++.+....+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            4788899999999999999754 58899999886542  33456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 040845          605 MPHGSLEKYLHSS-NYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS  683 (824)
Q Consensus       605 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  683 (824)
                      +++++|.+++... ...+++.++..++.|++.|++|||   +.+++|+||+|+||++++++.+||+|||.+........ 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-  156 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-  156 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence            9999999999765 356899999999999999999999   89999999999999999999999999999986643321 


Q ss_pred             cccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCch
Q 040845          684 MTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQE  763 (824)
Q Consensus       684 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  763 (824)
                       ......++..|+|||...+..++.++||||+|+++|||++|+.||......     .........        .. .  
T Consensus       157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-----~~~~~~~~~--------~~-~--  219 (256)
T cd08221         157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL-----NLVVKIVQG--------NY-T--  219 (256)
T ss_pred             -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH-----HHHHHHHcC--------CC-C--
Confidence             223345889999999998888899999999999999999999998652211     111110000        00 0  


Q ss_pred             hhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 040845          764 DIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL  802 (824)
Q Consensus       764 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L  802 (824)
                          ..+..++..+.+++.+||..+|++||++.|++++.
T Consensus       220 ----~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         220 ----PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             ----CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence                00123456788999999999999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=6.7e-35  Score=304.02  Aligned_cols=251  Identities=23%  Similarity=0.312  Sum_probs=197.7

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc-----cchhhhHHHHHHHHhcCCCCcceeEEeeeecC--Cee
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC-----GRAFKSFDVECAMMKSIRHRNLVKVISSCSNE--EFK  598 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  598 (824)
                      .+|++.+.||+|+||.||.|... +++.||||.+....     ....+.+.+|+.++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            57889999999999999999865 48999999875432     12345778899999999999999999998663  567


Q ss_pred             EEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccC
Q 040845          599 ALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT  678 (824)
Q Consensus       599 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~  678 (824)
                      ++||||+++++|.+++.... .+++..+..++.|++.|++|||   +.+++|+||+|+||+++.++.++|+|||.+....
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~  157 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYG-ALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ  157 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence            89999999999999987654 5788889999999999999999   9999999999999999999999999999988654


Q ss_pred             CCCCc-cccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccc
Q 040845          679 GEDQS-MTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDA  757 (824)
Q Consensus       679 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  757 (824)
                      ..... .......++..|+|||.+.+..++.++|||||||++|||++|+.||......    .........         
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----~~~~~~~~~---------  224 (265)
T cd06652         158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM----AAIFKIATQ---------  224 (265)
T ss_pred             cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH----HHHHHHhcC---------
Confidence            22111 1122345788999999998888999999999999999999999998653111    111000000         


Q ss_pred             cccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          758 NLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       758 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                            ......+...+..+.+++.+|+. +|++||+++|++++
T Consensus       225 ------~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~  261 (265)
T cd06652         225 ------PTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH  261 (265)
T ss_pred             ------CCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence                  00011123345668889999995 99999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=4.3e-35  Score=309.97  Aligned_cols=260  Identities=25%  Similarity=0.313  Sum_probs=202.7

Q ss_pred             cHHHHHHhhccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcC-CCCcceeEEeeeecC
Q 040845          518 SYLELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSI-RHRNLVKVISSCSNE  595 (824)
Q Consensus       518 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  595 (824)
                      ...++..+.++|++.+.||+|+||.||+|... +++.||+|++... ....+.+.+|+.+++++ +|||++++++++...
T Consensus        13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~   91 (291)
T cd06639          13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI-SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA   91 (291)
T ss_pred             hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc-ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence            34455566889999999999999999999864 5889999998643 23345677899999999 899999999998653


Q ss_pred             -----CeeEEEEeccCCCCHHHHhhh---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEE
Q 040845          596 -----EFKALVLEYMPHGSLEKYLHS---SNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH  667 (824)
Q Consensus       596 -----~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  667 (824)
                           ...++||||+++++|.++++.   ....+++..++.++.|++.|++|||   +.+++||||||+||++++++.+|
T Consensus        92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~~k  168 (291)
T cd06639          92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVK  168 (291)
T ss_pred             cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEE
Confidence                 358999999999999998863   2346889999999999999999999   99999999999999999999999


Q ss_pred             EeecccccccCCCCCccccccccccccccCccCcCCC-----CCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhh
Q 040845          668 LSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-----QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHW  742 (824)
Q Consensus       668 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~  742 (824)
                      |+|||.+........  ......++..|+|||.+...     .++.++|||||||++|||++|+.||......+ ....+
T Consensus       169 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~-~~~~~  245 (291)
T cd06639         169 LVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK-TLFKI  245 (291)
T ss_pred             Eeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH-HHHHH
Confidence            999999886543221  12234578899999987543     36889999999999999999999986532211 11111


Q ss_pred             hhhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          743 VNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       743 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      .....                 .....++.....+.+++.+||+.+|++||++.|++++
T Consensus       246 ~~~~~-----------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         246 PRNPP-----------------PTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             hcCCC-----------------CCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            11000                 0001112334568999999999999999999999875

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.3e-35  Score=341.60  Aligned_cols=255  Identities=20%  Similarity=0.306  Sum_probs=197.1

Q ss_pred             HhhccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeec--CCee
Q 040845          524 QATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSN--EEFK  598 (824)
Q Consensus       524 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~  598 (824)
                      ...++|.+.+.||+|+||+||+|+.. ++..||+|.+....  ......+..|+.+++.++||||++++++|.+  ....
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l   89 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL   89 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence            34578999999999999999999865 47789999886542  2345678889999999999999999998854  4578


Q ss_pred             EEEEeccCCCCHHHHhhhC---CCCCCHHHHHHHHHHHHHHHHHhhcCC----CCCeEecCCCCCCeeeCC---------
Q 040845          599 ALVLEYMPHGSLEKYLHSS---NYSLDIFQRLNIMIDVASALEYLHFGY----SAPVIHCDLKPSNVLLDD---------  662 (824)
Q Consensus       599 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~----~~~ivH~Dlk~~Nill~~---------  662 (824)
                      ++||||+++|+|.+++...   ...+++..++.|+.||+.||+|||...    ..+||||||||+|||++.         
T Consensus        90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~  169 (1021)
T PTZ00266         90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT  169 (1021)
T ss_pred             EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence            9999999999999998753   246899999999999999999999311    145999999999999964         


Q ss_pred             --------CCcEEEeecccccccCCCCCccccccccccccccCccCcCC--CCCCccchHHHHHHHHHHHHhCCCCCccc
Q 040845          663 --------NMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE--GQVSTNGDVYSFGIMLMETFTRKKPTDEL  732 (824)
Q Consensus       663 --------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~tg~~p~~~~  732 (824)
                              .+.+||+|||++..+....   ......||+.|+|||++.+  ..++.++|||||||++|||+||+.||...
T Consensus       170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~  246 (1021)
T PTZ00266        170 AQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA  246 (1021)
T ss_pred             ccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence                    3358999999998653222   1233468999999998854  45889999999999999999999998642


Q ss_pred             ccCcchhhhhhhhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          733 FNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       733 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      ..    ...++.......       . .        ....++..+.+||..||..+|++||++.|++.+
T Consensus       247 ~~----~~qli~~lk~~p-------~-l--------pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h  295 (1021)
T PTZ00266        247 NN----FSQLISELKRGP-------D-L--------PIKGKSKELNILIKNLLNLSAKERPSALQCLGY  295 (1021)
T ss_pred             Cc----HHHHHHHHhcCC-------C-C--------CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence            11    111111110000       0 0        001235668999999999999999999999864

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.3e-35  Score=310.10  Aligned_cols=252  Identities=23%  Similarity=0.365  Sum_probs=200.2

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc-cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEec
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      ++|++.+.||+|+||.||+|.++ ++..||+|.+.... ......+.+|++++++++|+||+++++++..+...++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            46888999999999999999876 68999999886542 23346788899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 040845          605 MPHGSLEKYLHSSN--YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ  682 (824)
Q Consensus       605 ~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  682 (824)
                      +++++|.+++....  ..+++..+..++.|++.|+.|||+  +.+|+|+||||+||+++.++.++|+|||.+..+.... 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  157 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL-  157 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence            99999999987642  368999999999999999999992  2599999999999999999999999999987653221 


Q ss_pred             ccccccccccccccCccCcCCC------CCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhcc
Q 040845          683 SMTQTQTLATIGYMAPEYGREG------QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVD  756 (824)
Q Consensus       683 ~~~~~~~~~~~~y~aPE~~~~~------~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  756 (824)
                         .....++..|+|||.+.+.      .++.++|+||+||++|||++|+.||....... .... ...        ..+
T Consensus       158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~-~~~--------~~~  224 (286)
T cd06622         158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN-IFAQ-LSA--------IVD  224 (286)
T ss_pred             ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh-HHHH-HHH--------Hhh
Confidence               1223478899999987544      35889999999999999999999986521111 0000 000        000


Q ss_pred             ccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          757 ANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       757 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      ..       ....+..++..+.+++.+||..+|++||++++++++
T Consensus       225 ~~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         225 GD-------PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             cC-------CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence            00       001122356778999999999999999999999985

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=3e-35  Score=310.44  Aligned_cols=268  Identities=26%  Similarity=0.360  Sum_probs=202.0

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc--chhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEe
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG--RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLE  603 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  603 (824)
                      ++|++.+.||+|+||.||+|.++ +++.||+|++.....  ...+.+.+|+++++.++||||+++++++..+...++|||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            46888999999999999999876 489999998754322  234567889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 040845          604 YMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS  683 (824)
Q Consensus       604 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  683 (824)
                      |++++++.++..... .+++.++..++.|++.|++|||   +.+++|+|++|+||++++++.++++|||++........ 
T Consensus        81 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-  155 (286)
T cd07846          81 FVDHTVLDDLEKYPN-GLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-  155 (286)
T ss_pred             cCCccHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc-
Confidence            999988888776543 5899999999999999999999   89999999999999999999999999999986543321 


Q ss_pred             cccccccccccccCccCcCC-CCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhh--hCCCcchhhcc----
Q 040845          684 MTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVND--CLPISTMEVVD----  756 (824)
Q Consensus       684 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~----  756 (824)
                       ......++..|+|||+..+ ..++.++||||||+++|||++|++||......+ ........  ..........+    
T Consensus       156 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07846         156 -VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDID-QLYHIIKCLGNLIPRHQEIFQKNPL  233 (286)
T ss_pred             -ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHH-HHHHHHHHhCCCchhhHHHhccchH
Confidence             2233457889999998865 457889999999999999999999886422111 00000000  00000000000    


Q ss_pred             --cccc---CchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          757 --ANLL---SQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       757 --~~~~---~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                        ....   ............++..+.+++.+||..+|++||++.+++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence              0000   00000111122457789999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=6.8e-35  Score=305.31  Aligned_cols=255  Identities=25%  Similarity=0.390  Sum_probs=199.8

Q ss_pred             cCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc----------chhhhHHHHHHHHhcCCCCcceeEEeeeecCC
Q 040845          528 KFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG----------RAFKSFDVECAMMKSIRHRNLVKVISSCSNEE  596 (824)
Q Consensus       528 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  596 (824)
                      +|...+.||+|+||.||+|... +|+.||+|.++....          ...+.+..|+.+++.++|+|++++++++....
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            4778899999999999999754 589999998764211          12346778999999999999999999999999


Q ss_pred             eeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccc
Q 040845          597 FKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  676 (824)
Q Consensus       597 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~  676 (824)
                      ..++||||+++++|.+++.... .+++..+..++.|++.|+.|||   +.+++||||+|+||+++.++.++++|||.+..
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~  157 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYG-RFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKK  157 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeecccccc
Confidence            9999999999999999998764 6889999999999999999999   89999999999999999999999999999976


Q ss_pred             cCCCCCccccccccccccccCccCcCCCC--CCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhh
Q 040845          677 LTGEDQSMTQTQTLATIGYMAPEYGREGQ--VSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEV  754 (824)
Q Consensus       677 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  754 (824)
                      ..............++..|+|||.+....  ++.++|+||+|+++||+++|..||.....    ...+...... .....
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~----~~~~~~~~~~-~~~~~  232 (272)
T cd06629         158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA----IAAMFKLGNK-RSAPP  232 (272)
T ss_pred             ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch----HHHHHHhhcc-ccCCc
Confidence            53222222223345788999999887654  78999999999999999999999854211    1111110000 00000


Q ss_pred             ccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          755 VDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       755 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      +..          .....++..+.+++.+||..+|++|||+.|++++
T Consensus       233 ~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         233 IPP----------DVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             CCc----------cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            000          0111346678999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=9.1e-35  Score=307.54  Aligned_cols=270  Identities=23%  Similarity=0.332  Sum_probs=200.0

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc-chhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEe
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLE  603 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  603 (824)
                      .++|++.+.||+|++|.||+|..+ +++.||||.+..... .....+.+|+++++.++|+||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE   83 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence            367899999999999999999865 589999999865432 223456789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 040845          604 YMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS  683 (824)
Q Consensus       604 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  683 (824)
                      |+++ +|.+++......+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||++........ 
T Consensus        84 ~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-  158 (291)
T cd07844          84 YLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK-  158 (291)
T ss_pred             cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc-
Confidence            9974 999998876667899999999999999999999   99999999999999999999999999999875422111 


Q ss_pred             cccccccccccccCccCcCC-CCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCC-c-c-hhhcc---
Q 040845          684 MTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPI-S-T-MEVVD---  756 (824)
Q Consensus       684 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~-~-~~~~~---  756 (824)
                       ......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||.................... . . .....   
T Consensus       159 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (291)
T cd07844         159 -TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE  237 (291)
T ss_pred             -cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence             1222346788999998865 4578999999999999999999999965432111111111100000 0 0 00000   


Q ss_pred             ---c--cccCchhh-hhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          757 ---A--NLLSQEDI-HFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       757 ---~--~~~~~~~~-~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                         .  ........ ...........+.+++.+|++.+|++|||+.|++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~  288 (291)
T cd07844         238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH  288 (291)
T ss_pred             cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence               0  00000000 000000112567899999999999999999998764

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=4.8e-35  Score=303.49  Aligned_cols=249  Identities=23%  Similarity=0.336  Sum_probs=202.6

Q ss_pred             cCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEec
Q 040845          528 KFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       528 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      +|++.+.||+|+||.||.++.. +|+.||+|.+....  ....+++.+|+.++++++|+||+++++++.+....++||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            5788999999999999999754 58999999986542  23445788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 040845          605 MPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS  683 (824)
Q Consensus       605 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  683 (824)
                      +++++|.+++.... ..+++.++..++.|++.|++|||   +.+++|+||+|+||+++.++.++++|||.+........ 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~-  156 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE-  156 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence            99999999987643 35789999999999999999999   89999999999999999999999999999986543221 


Q ss_pred             cccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCch
Q 040845          684 MTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQE  763 (824)
Q Consensus       684 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  763 (824)
                       ......++..|+|||+..+..++.++|+|||||++|++++|+.||.....     ...+.......             
T Consensus       157 -~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-----~~~~~~~~~~~-------------  217 (256)
T cd08218         157 -LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM-----KNLVLKIIRGS-------------  217 (256)
T ss_pred             -hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH-----HHHHHHHhcCC-------------
Confidence             12234578899999999888899999999999999999999999864211     11111100000             


Q ss_pred             hhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          764 DIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       764 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                        ....+..++..+.+++.+||+.+|++||++.|++++
T Consensus       218 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         218 --YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             --CCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence              000122346678999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.8e-35  Score=310.17  Aligned_cols=257  Identities=22%  Similarity=0.301  Sum_probs=205.3

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc-cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEec
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      ++|++.+.||+|+||+||+|.+. +|+.||+|++.... ....+.+.+|+++++.++||||+++++++......++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            56788899999999999999865 58899999886543 23456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 040845          605 MPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM  684 (824)
Q Consensus       605 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  684 (824)
                      +++++|.+++...+ .+++..+..++.+++.|+.|||+  ..+++||||+|+||++++++.++|+|||++.......   
T Consensus        85 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~---  158 (284)
T cd06620          85 MDCGSLDRIYKKGG-PIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI---  158 (284)
T ss_pred             CCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc---
Confidence            99999999987654 68899999999999999999992  2689999999999999999999999999986542211   


Q ss_pred             ccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcc------hhhhhhhhhCCCcchhhcccc
Q 040845          685 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEM------TLKHWVNDCLPISTMEVVDAN  758 (824)
Q Consensus       685 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~  758 (824)
                       .....++..|+|||.+.++.++.++|||||||++||+++|+.||......+.      ....+........        
T Consensus       159 -~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------  229 (284)
T cd06620         159 -ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP--------  229 (284)
T ss_pred             -cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc--------
Confidence             1234688999999999888899999999999999999999999976432211      0111111111000        


Q ss_pred             ccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 040845          759 LLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLK  804 (824)
Q Consensus       759 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~  804 (824)
                           ... .....++..+.+++.+||+.||++|||+.|++++..-
T Consensus       230 -----~~~-~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~  269 (284)
T cd06620         230 -----PPR-LPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPF  269 (284)
T ss_pred             -----CCC-CCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence                 000 0111256678999999999999999999999987543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=9.6e-35  Score=301.46  Aligned_cols=249  Identities=24%  Similarity=0.360  Sum_probs=200.0

Q ss_pred             cCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeec-CCeeEEEEe
Q 040845          528 KFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSN-EEFKALVLE  603 (824)
Q Consensus       528 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e  603 (824)
                      .|++.+.||+|++|.||+|..+ +++.||+|.+....  ....+.+.+|++++++++|+|++++++.+.. +...++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4788999999999999999865 47899999986542  2345668889999999999999999998764 446789999


Q ss_pred             ccCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 040845          604 YMPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ  682 (824)
Q Consensus       604 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  682 (824)
                      |+++++|.+++.... ..+++.++..++.|++.|++|||   +.+++||||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~  157 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD  157 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence            999999999997643 45899999999999999999999   99999999999999999999999999999986632221


Q ss_pred             ccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCc
Q 040845          683 SMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ  762 (824)
Q Consensus       683 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  762 (824)
                        ......+++.|+|||+..+..++.++||||+|+++||+++|+.||.....     ..+........         .. 
T Consensus       158 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~-----~~~~~~~~~~~---------~~-  220 (257)
T cd08223         158 --MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM-----NSLVYRIIEGK---------LP-  220 (257)
T ss_pred             --ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-----HHHHHHHHhcC---------CC-
Confidence              22234578899999999998999999999999999999999999864221     11111110000         00 


Q ss_pred             hhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          763 EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       763 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                           ..+...+..+.+++.+||+.+|++|||+.+++++
T Consensus       221 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         221 -----PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             -----CCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence                 0112345678999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-35  Score=335.06  Aligned_cols=260  Identities=28%  Similarity=0.456  Sum_probs=215.3

Q ss_pred             hccCCCCceeeeccceEEEEEEEC----C----CcEEEEEEeecccc-chhhhHHHHHHHHhcC-CCCcceeEEeeeecC
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR----D----GMEVAVKVFNLQCG-RAFKSFDVECAMMKSI-RHRNLVKVISSCSNE  595 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~----~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  595 (824)
                      .++..+.+.+|+|+||.|++|...    .    ...||||.++.... ...+.+..|+++|+.+ +|+||+.++|+|...
T Consensus       295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~  374 (609)
T KOG0200|consen  295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQD  374 (609)
T ss_pred             hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence            344566679999999999999743    1    45799999875533 4567899999999999 599999999999999


Q ss_pred             CeeEEEEeccCCCCHHHHhhhCC---------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee
Q 040845          596 EFKALVLEYMPHGSLEKYLHSSN---------------YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL  660 (824)
Q Consensus       596 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill  660 (824)
                      ...++|+||++.|+|.++++..+               ..++..+.+.++.|||.|++||+   +.++||||+.++|||+
T Consensus       375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRNVLi  451 (609)
T KOG0200|consen  375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAARNVLI  451 (609)
T ss_pred             CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhhhEEe
Confidence            99999999999999999998776               34888999999999999999999   9999999999999999


Q ss_pred             CCCCcEEEeecccccccCCCCCcccc-ccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcch
Q 040845          661 DDNMVAHLSDFGIAKLLTGEDQSMTQ-TQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMT  738 (824)
Q Consensus       661 ~~~~~~kl~Dfg~a~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~  738 (824)
                      .++..+||+|||+|+.....+..... +...-+..|||||.+....|+.++|||||||++||++| |..||.+.... ..
T Consensus       452 ~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~-~~  530 (609)
T KOG0200|consen  452 TKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT-EE  530 (609)
T ss_pred             cCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH-HH
Confidence            99999999999999976554444322 22125677999999999999999999999999999999 77787652211 11


Q ss_pred             hhhhhhhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 040845          739 LKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRD  807 (824)
Q Consensus       739 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~  807 (824)
                      +..++                  ..+.+...|..|+.+++++|+.||+.+|++||++.|+++.+.....
T Consensus       531 l~~~l------------------~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~  581 (609)
T KOG0200|consen  531 LLEFL------------------KEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ  581 (609)
T ss_pred             HHHHH------------------hcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence            11121                  2344566778899999999999999999999999999999999543

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=8.5e-35  Score=304.02  Aligned_cols=251  Identities=23%  Similarity=0.372  Sum_probs=199.3

Q ss_pred             cCCCCceeeeccceEEEEEEECC--CcEEEEEEeeccc----------cchhhhHHHHHHHHhc-CCCCcceeEEeeeec
Q 040845          528 KFSENNLIGRGGFGSVYKARIRD--GMEVAVKVFNLQC----------GRAFKSFDVECAMMKS-IRHRNLVKVISSCSN  594 (824)
Q Consensus       528 ~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~  594 (824)
                      .|++.+.||+|+||.||+|.++.  ++.+|+|.+....          .....++..|+.++.+ ++||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47788999999999999998764  6889999875331          1223456678887765 799999999999999


Q ss_pred             CCeeEEEEeccCCCCHHHHhhh---CCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEecCCCCCCeeeCCCCcEEEee
Q 040845          595 EEFKALVLEYMPHGSLEKYLHS---SNYSLDIFQRLNIMIDVASALEYLHFGYS-APVIHCDLKPSNVLLDDNMVAHLSD  670 (824)
Q Consensus       595 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dlk~~Nill~~~~~~kl~D  670 (824)
                      ++..++||||+++++|.+++..   ....+++..++.++.|++.|++|||   + .+++|+||+|+||+++.++.++|+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLH---KEKRIVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhc---cCCceeecCCCHHHEEECCCCcEEEec
Confidence            9999999999999999998753   3356889999999999999999999   5 6899999999999999999999999


Q ss_pred             cccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCc
Q 040845          671 FGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPIS  750 (824)
Q Consensus       671 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  750 (824)
                      ||.+.......   ......++..|+|||...++.++.++||||||+++|||++|+.||....... ........     
T Consensus       158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~-~~~~~~~~-----  228 (269)
T cd08528         158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS-LATKIVEA-----  228 (269)
T ss_pred             ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH-HHHHHhhc-----
Confidence            99998654332   2234568889999999998889999999999999999999999986521110 00110000     


Q ss_pred             chhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 040845          751 TMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLL  803 (824)
Q Consensus       751 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~  803 (824)
                             ....      .....++..+.+++.+||+.||++||++.|+.++++
T Consensus       229 -------~~~~------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         229 -------VYEP------LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             -------cCCc------CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence                   0000      001123567899999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=5.3e-35  Score=306.29  Aligned_cols=254  Identities=28%  Similarity=0.470  Sum_probs=198.8

Q ss_pred             CCCCceeeeccceEEEEEEEC----CCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeecCC------
Q 040845          529 FSENNLIGRGGFGSVYKARIR----DGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEE------  596 (824)
Q Consensus       529 ~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  596 (824)
                      |.+.+.||+|+||.||+|.+.    ++..||||++....  ....+.+.+|+++++.++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            567789999999999999753    36889999986542  234567888999999999999999999875432      


Q ss_pred             eeEEEEeccCCCCHHHHhhhCC-----CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeec
Q 040845          597 FKALVLEYMPHGSLEKYLHSSN-----YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDF  671 (824)
Q Consensus       597 ~~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df  671 (824)
                      ..++++||+.+|+|.+++....     ..+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+|++||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcc
Confidence            3478999999999998875322     35788999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCc
Q 040845          672 GIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPIS  750 (824)
Q Consensus       672 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  750 (824)
                      |.++...............++..|++||......++.++|||||||++|||++ |+.||.....  .....++.....  
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--~~~~~~~~~~~~--  233 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--SEIYNYLIKGNR--  233 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--HHHHHHHHcCCc--
Confidence            99986643332222223345678999999988889999999999999999999 7888765322  111111111000  


Q ss_pred             chhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 040845          751 TMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKI  805 (824)
Q Consensus       751 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~  805 (824)
                                      ...+..++..+.+++.+||+.+|++||++.|+++.|+++
T Consensus       234 ----------------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         234 ----------------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             ----------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                            000123456789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.8e-34  Score=309.40  Aligned_cols=194  Identities=24%  Similarity=0.363  Sum_probs=159.5

Q ss_pred             CceeeeccceEEEEEEECC---CcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeee--cCCeeEEEEeccC
Q 040845          532 NNLIGRGGFGSVYKARIRD---GMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCS--NEEFKALVLEYMP  606 (824)
Q Consensus       532 ~~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~lv~e~~~  606 (824)
                      ...||+|+||+||+|+.++   +..||+|.+...  .....+.+|+++++.++||||+++++++.  .+...++||||++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT--GISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCC--CCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            3589999999999998653   578999988643  23346788999999999999999999884  3567889999996


Q ss_pred             CCCHHHHhhhC--------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee----CCCCcEEEeecccc
Q 040845          607 HGSLEKYLHSS--------NYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL----DDNMVAHLSDFGIA  674 (824)
Q Consensus       607 ~g~L~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill----~~~~~~kl~Dfg~a  674 (824)
                      + +|.+++...        ...+++..+..++.|++.||+|||   +.+|+||||||+||++    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            4 787776432        135788899999999999999999   9999999999999999    56789999999999


Q ss_pred             cccCCCCCc-cccccccccccccCccCcCCC-CCCccchHHHHHHHHHHHHhCCCCCcc
Q 040845          675 KLLTGEDQS-MTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDE  731 (824)
Q Consensus       675 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~p~~~  731 (824)
                      +........ .......+|+.|+|||.+.+. .++.++||||+||++|||+||++||..
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~  218 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence            876433221 122345689999999988764 579999999999999999999999865

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=8e-35  Score=307.68  Aligned_cols=250  Identities=28%  Similarity=0.343  Sum_probs=204.2

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEecc
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYM  605 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  605 (824)
                      .+|.+.+.||+|+||.||+|... +++.||+|.+........+.+..|+.+++.++||||+++++++...+..++|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            67888999999999999999754 58899999987554555677889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccc
Q 040845          606 PHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMT  685 (824)
Q Consensus       606 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  685 (824)
                      ++++|.+++.+.  .+++.++..++.|++.|++|||   +.+++|+|++|+||+++.++.++|+|||++........  .
T Consensus        99 ~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--~  171 (293)
T cd06647          99 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--K  171 (293)
T ss_pred             CCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc--c
Confidence            999999998754  4788899999999999999999   99999999999999999999999999999876543322  2


Q ss_pred             cccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhh
Q 040845          686 QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDI  765 (824)
Q Consensus       686 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  765 (824)
                      .....+++.|+|||.+....++.++||||||+++||+++|+.||......+.....+ .                 ....
T Consensus       172 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~-~-----------------~~~~  233 (293)
T cd06647         172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-T-----------------NGTP  233 (293)
T ss_pred             cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehh-c-----------------CCCC
Confidence            223458889999999988889999999999999999999999997532211100000 0                 0000


Q ss_pred             hhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          766 HFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       766 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      ....+...+..+.+++.+||..+|++||++.+++.+
T Consensus       234 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         234 ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            011122345568899999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.1e-35  Score=304.90  Aligned_cols=253  Identities=25%  Similarity=0.334  Sum_probs=200.9

Q ss_pred             hhccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcC-CCCcceeEEeeeecCC------
Q 040845          525 ATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSI-RHRNLVKVISSCSNEE------  596 (824)
Q Consensus       525 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~------  596 (824)
                      .+++|++.+.||+|++|.||+|..+ +++.||+|++.... ...+.+.+|+.+++++ +|+||+++++++....      
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            4678999999999999999999875 57899999987543 3456788999999999 6999999999986544      


Q ss_pred             eeEEEEeccCCCCHHHHhhhC---CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccc
Q 040845          597 FKALVLEYMPHGSLEKYLHSS---NYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGI  673 (824)
Q Consensus       597 ~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~  673 (824)
                      ..++||||+++++|.+++...   ...+++..+..++.|++.|++|||   +.+++|+||+|+||++++++.++++|||.
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~~  159 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGV  159 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCcc
Confidence            589999999999999998653   257889999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCCccccccccccccccCccCcCC-----CCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCC
Q 040845          674 AKLLTGEDQSMTQTQTLATIGYMAPEYGRE-----GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLP  748 (824)
Q Consensus       674 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  748 (824)
                      +.......  .......++..|+|||.+..     ..++.++||||+|+++|+|++|+.||....... .........  
T Consensus       160 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~--  234 (275)
T cd06608         160 SAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR-ALFKIPRNP--  234 (275)
T ss_pred             ceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH-HHHHhhccC--
Confidence            87653221  12233458889999998753     346789999999999999999999986532111 111111100  


Q ss_pred             CcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          749 ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       749 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                                     ......+..++..+.+++.+||..||++|||+.|++++
T Consensus       235 ---------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~  272 (275)
T cd06608         235 ---------------PPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH  272 (275)
T ss_pred             ---------------CCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence                           00111122356678999999999999999999999864

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.7e-34  Score=300.87  Aligned_cols=253  Identities=30%  Similarity=0.407  Sum_probs=203.3

Q ss_pred             cCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccc--hhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEec
Q 040845          528 KFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGR--AFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       528 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      +|+..+.||+|+||.||+|... +++.||+|.++.....  ..+.+..|++++++++|+||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            5788899999999999999864 6899999998765432  567889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 040845          605 MPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM  684 (824)
Q Consensus       605 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  684 (824)
                      +++++|.+++.... .+++..+..++.|++.|++|||   +.+++|+||+|+||++++++.+||+|||.+..........
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~  156 (264)
T cd06626          81 CSGGTLEELLEHGR-ILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM  156 (264)
T ss_pred             CCCCcHHHHHhhcC-CCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence            99999999998754 5788899999999999999999   9999999999999999999999999999998765433221


Q ss_pred             c--cccccccccccCccCcCCCC---CCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccc
Q 040845          685 T--QTQTLATIGYMAPEYGREGQ---VSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANL  759 (824)
Q Consensus       685 ~--~~~~~~~~~y~aPE~~~~~~---~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  759 (824)
                      .  .....++..|+|||++.+..   ++.++||||||+++||+++|+.||...... ......... ..           
T Consensus       157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-~~~~~~~~~-~~-----------  223 (264)
T cd06626         157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-FQIMFHVGA-GH-----------  223 (264)
T ss_pred             cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-HHHHHHHhc-CC-----------
Confidence            1  12345788999999988766   889999999999999999999999653211 111111110 00           


Q ss_pred             cCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          760 LSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       760 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                          ....+....++..+.+++.+||+.+|++|||+.|++.+
T Consensus       224 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~  261 (264)
T cd06626         224 ----KPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQH  261 (264)
T ss_pred             ----CCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                00000111235668899999999999999999998753

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=2.8e-35  Score=310.85  Aligned_cols=248  Identities=26%  Similarity=0.346  Sum_probs=199.4

Q ss_pred             CCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEeccCC
Q 040845          529 FSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPH  607 (824)
Q Consensus       529 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  607 (824)
                      |.....||+|+||.||+|... ++..||||.+........+.+.+|+.+++.++|+||+++++.+...+..++||||+++
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~  103 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG  103 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence            344467999999999999864 5889999998765555567788999999999999999999999999999999999999


Q ss_pred             CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccccc
Q 040845          608 GSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQT  687 (824)
Q Consensus       608 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  687 (824)
                      ++|.+++...  .+++.++..++.|++.|++|||   +.+|+||||||+||++++++.++|+|||++........  ...
T Consensus       104 ~~L~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~  176 (292)
T cd06658         104 GALTDIVTHT--RMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KRK  176 (292)
T ss_pred             CcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--cCc
Confidence            9999998653  5788999999999999999999   99999999999999999999999999999876532221  122


Q ss_pred             cccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhhhh
Q 040845          688 QTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHF  767 (824)
Q Consensus       688 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  767 (824)
                      ...++..|+|||...+..++.++||||||+++|||++|+.||....... .... +....        ....        
T Consensus       177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~~~~-~~~~~--------~~~~--------  238 (292)
T cd06658         177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ-AMRR-IRDNL--------PPRV--------  238 (292)
T ss_pred             eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHH-HHhcC--------CCcc--------
Confidence            3458899999999988889999999999999999999999986521110 0110 00000        0000        


Q ss_pred             hhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          768 VAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       768 ~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      ......+..+.+++.+||..||++|||++|++++
T Consensus       239 ~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         239 KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             ccccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            0011235568899999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.5e-34  Score=307.04  Aligned_cols=266  Identities=23%  Similarity=0.306  Sum_probs=200.7

Q ss_pred             cCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccc-----hhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEE
Q 040845          528 KFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGR-----AFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALV  601 (824)
Q Consensus       528 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  601 (824)
                      +|++.+.||+|+||.||+|... +++.||||.+......     ....+..|++++++++|+||+++++++.+....++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4778899999999999999865 5899999998755322     234567899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 040845          602 LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED  681 (824)
Q Consensus       602 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  681 (824)
                      |||+ +++|.+++......+++.++..++.|+++||+|||   +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  156 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN  156 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence            9999 88999999765546899999999999999999999   9999999999999999999999999999998764332


Q ss_pred             CccccccccccccccCccCcCC-CCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcch--------
Q 040845          682 QSMTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTM--------  752 (824)
Q Consensus       682 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--------  752 (824)
                      .  ......++..|+|||.+.+ ..++.++|||||||++|||++|.+||...... ................        
T Consensus       157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  233 (298)
T cd07841         157 R--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI-DQLGKIFEALGTPTEENWPGVTSL  233 (298)
T ss_pred             c--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH-HHHHHHHHHcCCCchhhhhhcccc
Confidence            2  1223346788999998754 45789999999999999999998777542211 1111111110000000        


Q ss_pred             -hhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          753 -EVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       753 -~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                       ............ ........+..+.+++.+||+.||++|||++|++++
T Consensus       234 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         234 PDYVEFKPFPPTP-LKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             cccccccccCCcc-hhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence             000000000000 001112346778999999999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=6.9e-35  Score=308.04  Aligned_cols=245  Identities=26%  Similarity=0.307  Sum_probs=201.3

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEE
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVL  602 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  602 (824)
                      ++|++.+.||+|+||.||+|.+. +++.||+|++....   ....+.+.+|++++++++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            36888999999999999999865 58999999986532   233466888999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 040845          603 EYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ  682 (824)
Q Consensus       603 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  682 (824)
                      ||+++++|.+++.... .+++..+..++.|++.|++|||   +.+++|+||+|+||+++.++.+||+|||++......  
T Consensus        81 e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--  154 (290)
T cd05580          81 EYVPGGELFSHLRKSG-RFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--  154 (290)
T ss_pred             ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence            9999999999997764 7899999999999999999999   999999999999999999999999999999865433  


Q ss_pred             ccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCc
Q 040845          683 SMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ  762 (824)
Q Consensus       683 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  762 (824)
                         .....+++.|+|||.+.+...+.++||||+|+++|+|++|+.||...... .........                 
T Consensus       155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~-----------------  213 (290)
T cd05580         155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI-QIYEKILEG-----------------  213 (290)
T ss_pred             ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhcC-----------------
Confidence               22345888999999998888899999999999999999999998653211 001110000                 


Q ss_pred             hhhhhhhHHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 040845          763 EDIHFVAKEQCVSFVFNLALECTVESPEQRI-----NAKEIVAK  801 (824)
Q Consensus       763 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~evl~~  801 (824)
                         ....+...+..+.+++.+||..||.+|+     +++|++++
T Consensus       214 ---~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~  254 (290)
T cd05580         214 ---KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH  254 (290)
T ss_pred             ---CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence               0001112356688999999999999999     77887755

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.1e-34  Score=308.74  Aligned_cols=256  Identities=22%  Similarity=0.272  Sum_probs=199.3

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEE
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVL  602 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  602 (824)
                      ++|++.+.||+|+||.||+|..+ +++.||+|.+....   ....+.+.+|+++++.++||||+++++.+..++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            36888999999999999999865 47899999987543   223456778999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 040845          603 EYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ  682 (824)
Q Consensus       603 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  682 (824)
                      ||+++++|.+++...+ .+++..+..++.|++.|++|||   +.+++||||||+||+++.++.++++|||.++.......
T Consensus        81 e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~  156 (305)
T cd05609          81 EYVEGGDCATLLKNIG-ALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT  156 (305)
T ss_pred             ecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence            9999999999997655 6889999999999999999999   99999999999999999999999999998863211000


Q ss_pred             -------------ccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCC
Q 040845          683 -------------SMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPI  749 (824)
Q Consensus       683 -------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  749 (824)
                                   ........++..|+|||.+....++.++|+||||+++||+++|..||.+.... ...........+ 
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~-~~~~~~~~~~~~-  234 (305)
T cd05609         157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE-ELFGQVISDDIE-  234 (305)
T ss_pred             ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcccC-
Confidence                         00111234688899999998888999999999999999999999998652211 111111110000 


Q ss_pred             cchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 040845          750 STMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLK  804 (824)
Q Consensus       750 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~  804 (824)
                            .+          .....++..+.+++.+||+.||++||++.++.+.++.
T Consensus       235 ------~~----------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         235 ------WP----------EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             ------CC----------CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence                  00          0011345678999999999999999986555444443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.1e-34  Score=303.10  Aligned_cols=254  Identities=25%  Similarity=0.383  Sum_probs=201.8

Q ss_pred             cCCCCceeeeccceEEEEEEE-CCCcEEEEEEeecccc------chhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEE
Q 040845          528 KFSENNLIGRGGFGSVYKARI-RDGMEVAVKVFNLQCG------RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKAL  600 (824)
Q Consensus       528 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  600 (824)
                      +|+..+.||+|++|.||+|.. .+++.||+|++.....      ...+.+..|++++++++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            478889999999999999985 4689999999864321      134678889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC-cEEEeecccccccCC
Q 040845          601 VLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM-VAHLSDFGIAKLLTG  679 (824)
Q Consensus       601 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~Dfg~a~~~~~  679 (824)
                      ||||+++++|.+++.+.. .+++..+..++.|++.|++|||   +.+++|+||+|+||+++.++ .++|+|||.+.....
T Consensus        81 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~  156 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA  156 (268)
T ss_pred             EEeccCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence            999999999999997655 6889999999999999999999   99999999999999998776 699999999987643


Q ss_pred             CCCc--cccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccc
Q 040845          680 EDQS--MTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDA  757 (824)
Q Consensus       680 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  757 (824)
                      ....  .......++..|+|||.+.+..++.++||||+|+++|++++|+.||....... ....+......         
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~---------  226 (268)
T cd06630         157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN-HLALIFKIASA---------  226 (268)
T ss_pred             ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc-hHHHHHHHhcc---------
Confidence            3211  11123457889999999988889999999999999999999999986422111 01111000000         


Q ss_pred             cccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          758 NLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       758 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                            ......+...+..+.+++.+||..+|++||++.|++++
T Consensus       227 ------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~  264 (268)
T cd06630         227 ------TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH  264 (268)
T ss_pred             ------CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence                  00011122356678899999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-34  Score=305.80  Aligned_cols=269  Identities=24%  Similarity=0.333  Sum_probs=202.8

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEe
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLE  603 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  603 (824)
                      ++|++.+.||+|+||.||+|.++ +++.||+|.++...  ....+.+.+|++++++++|+||+++++++..++..++|||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36888999999999999999876 48899999886432  2335678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 040845          604 YMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS  683 (824)
Q Consensus       604 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  683 (824)
                      |++++.+..+... ...+++.++..++.|++.|++|||   +.+++|+|++|+||++++++.+||+|||.+........ 
T Consensus        81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-  155 (288)
T cd07833          81 YVERTLLELLEAS-PGGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-  155 (288)
T ss_pred             cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-
Confidence            9988666655544 346899999999999999999999   99999999999999999999999999999987654332 


Q ss_pred             cccccccccccccCccCcCCC-CCCccchHHHHHHHHHHHHhCCCCCcccccCcchh--hhhhhhhCCCcchhhc--ccc
Q 040845          684 MTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTL--KHWVNDCLPISTMEVV--DAN  758 (824)
Q Consensus       684 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~--~~~  758 (824)
                      .......++..|+|||++.+. .++.++||||||+++|+|++|+.||......+...  ..+... .+.......  +..
T Consensus       156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  234 (288)
T cd07833         156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGP-LPPSHQELFSSNPR  234 (288)
T ss_pred             ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC-CCHHHhhhcccCcc
Confidence            122335678899999999888 78999999999999999999999987532211000  000000 000000000  000


Q ss_pred             c--------cCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          759 L--------LSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       759 ~--------~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      .        ..........+..++.++.+++++||..+|++|||+++++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence            0        000000111122347789999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.2e-34  Score=300.51  Aligned_cols=248  Identities=25%  Similarity=0.395  Sum_probs=200.7

Q ss_pred             cCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEec
Q 040845          528 KFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       528 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      +|+..+.||+|+||.||+|... +++.||+|.+....  ....+.+..|++++++++|||++++++.+..+...++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            5788899999999999999864 58899999986542  23456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCC-CcEEEeecccccccCCCCC
Q 040845          605 MPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDN-MVAHLSDFGIAKLLTGEDQ  682 (824)
Q Consensus       605 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~Dfg~a~~~~~~~~  682 (824)
                      +++++|.+++.... ..+++..+..++.|++.|++|||   +.+++|+||+|+||+++++ +.+|++|||.+........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK  157 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence            99999999997643 45899999999999999999999   9999999999999999854 4689999999986643221


Q ss_pred             ccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCc
Q 040845          683 SMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ  762 (824)
Q Consensus       683 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  762 (824)
                         .....++..|+|||.+.+..++.++||||||+++|+|++|+.||.......  ....+....               
T Consensus       158 ---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~--~~~~~~~~~---------------  217 (256)
T cd08220         158 ---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA--LVLKIMSGT---------------  217 (256)
T ss_pred             ---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH--HHHHHHhcC---------------
Confidence               122457889999999988889999999999999999999999986532111  111110000               


Q ss_pred             hhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          763 EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       763 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                         ....+..++..+.+++.+||..+|++|||+.|++++
T Consensus       218 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         218 ---FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             ---CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence               000112345678999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-35  Score=319.53  Aligned_cols=241  Identities=23%  Similarity=0.257  Sum_probs=186.5

Q ss_pred             eeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcC---CCCcceeEEeeeecCCeeEEEEeccCC
Q 040845          535 IGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSI---RHRNLVKVISSCSNEEFKALVLEYMPH  607 (824)
Q Consensus       535 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~  607 (824)
                      ||+|+||+||+|+.. +++.||||++....   .........|..++...   +||||+++++++.+....++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999865 58999999986432   12223344566666655   699999999999999999999999999


Q ss_pred             CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccccc
Q 040845          608 GSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQT  687 (824)
Q Consensus       608 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  687 (824)
                      |+|.+++.... .+++..+..++.||++|++|||   +.+|+||||||+||+++.++.++|+|||++........  ...
T Consensus        81 g~L~~~l~~~~-~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--~~~  154 (330)
T cd05586          81 GELFWHLQKEG-RFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--TTN  154 (330)
T ss_pred             ChHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--Ccc
Confidence            99999987654 6899999999999999999999   99999999999999999999999999999875322211  123


Q ss_pred             cccccccccCccCcCCC-CCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhhh
Q 040845          688 QTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIH  766 (824)
Q Consensus       688 ~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  766 (824)
                      ...||..|+|||.+.+. .++.++||||+||++|||++|+.||......     ..........         ...    
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~-----~~~~~i~~~~---------~~~----  216 (330)
T cd05586         155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ-----QMYRNIAFGK---------VRF----  216 (330)
T ss_pred             CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH-----HHHHHHHcCC---------CCC----
Confidence            34689999999988754 4799999999999999999999998652211     1111100000         000    


Q ss_pred             hhhHHHHHHHHHHHHHHccccCCCCCC----CHHHHHHH
Q 040845          767 FVAKEQCVSFVFNLALECTVESPEQRI----NAKEIVAK  801 (824)
Q Consensus       767 ~~~~~~~~~~l~~l~~~cl~~dP~~Rp----t~~evl~~  801 (824)
                        .....+..+.+++.+||+.||.+||    ++.|++++
T Consensus       217 --~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h  253 (330)
T cd05586         217 --PKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH  253 (330)
T ss_pred             --CCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence              0012355678999999999999998    56666654

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-36  Score=343.02  Aligned_cols=257  Identities=28%  Similarity=0.390  Sum_probs=209.1

Q ss_pred             HHHhhccCCCCceeeeccceEEEEEE-ECCCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCee
Q 040845          522 LFQATDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFK  598 (824)
Q Consensus       522 ~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  598 (824)
                      +...+-+|+....||.|.||.||-|. ..+|.-.|+|-++...  ......+.+|..++..++|||+|+++|+-...+..
T Consensus      1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred             hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence            44556778889999999999999997 4569999999876553  34456788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccC
Q 040845          599 ALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT  678 (824)
Q Consensus       599 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~  678 (824)
                      +|.||||++|+|.+.+...+ ..++.-...+..|++.|++|||   +.|||||||||+||+++.+|.+|++|||.|..+.
T Consensus      1310 ~IFMEyC~~GsLa~ll~~gr-i~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHGR-IEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred             HHHHHHhccCcHHHHHHhcc-hhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEec
Confidence            99999999999999998765 4566666778899999999999   9999999999999999999999999999999887


Q ss_pred             CCCCcc--ccccccccccccCccCcCCC---CCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchh
Q 040845          679 GEDQSM--TQTQTLATIGYMAPEYGREG---QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTME  753 (824)
Q Consensus       679 ~~~~~~--~~~~~~~~~~y~aPE~~~~~---~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  753 (824)
                      +.....  .-....||+.|||||++.+.   ....++||||+|||+.||+||++||...... -.+-  ++         
T Consensus      1386 ~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-~aIM--y~--------- 1453 (1509)
T KOG4645|consen 1386 NNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE-WAIM--YH--------- 1453 (1509)
T ss_pred             CchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-hHHH--hH---------
Confidence            654332  22456799999999998754   3577899999999999999999999863221 1110  00         


Q ss_pred             hccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          754 VVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       754 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                       +.      .+.....|+..+.+-.+++..|+..||++|+++.|++++
T Consensus      1454 -V~------~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1454 -VA------AGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             -Hh------ccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence             00      111222344467788999999999999999999988775

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=6.5e-35  Score=308.88  Aligned_cols=248  Identities=25%  Similarity=0.335  Sum_probs=199.5

Q ss_pred             CCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEeccCC
Q 040845          529 FSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPH  607 (824)
Q Consensus       529 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  607 (824)
                      |+....||+|+||.||+|... +++.||+|++........+.+.+|+.+++.++|||++++++++..++..++|+||+++
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~  102 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG  102 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence            334457999999999999864 5899999998765445556788899999999999999999999999999999999999


Q ss_pred             CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccccc
Q 040845          608 GSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQT  687 (824)
Q Consensus       608 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  687 (824)
                      ++|.+++...  .+++..+..++.|++.|++|||   +.+++||||+|+||+++.++.++|+|||++.......  ....
T Consensus       103 ~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~  175 (297)
T cd06659         103 GALTDIVSQT--RLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKRK  175 (297)
T ss_pred             CCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc--cccc
Confidence            9999987653  5789999999999999999999   9999999999999999999999999999987553221  1223


Q ss_pred             cccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhhhh
Q 040845          688 QTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHF  767 (824)
Q Consensus       688 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  767 (824)
                      ...++..|+|||++.+..++.++|||||||++|||++|+.||......  .............                .
T Consensus       176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~~~~~----------------~  237 (297)
T cd06659         176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV--QAMKRLRDSPPPK----------------L  237 (297)
T ss_pred             ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHhccCCCC----------------c
Confidence            356889999999998888999999999999999999999998642111  1111111000000                0


Q ss_pred             hhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          768 VAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       768 ~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      ......+..+.+++.+||+.+|++||++.|++++
T Consensus       238 ~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         238 KNAHKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            0011234568899999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=2.7e-34  Score=306.05  Aligned_cols=247  Identities=27%  Similarity=0.363  Sum_probs=198.1

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc---chhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEE
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG---RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVL  602 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  602 (824)
                      ..|+..+.||+|+||.||+|+.. +++.||+|.+.....   ...+.+.+|+++++.++||||+++++++.+++..++||
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            45888899999999999999865 589999999864322   23356788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 040845          603 EYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ  682 (824)
Q Consensus       603 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  682 (824)
                      ||++ |++.+++......+++..+..++.|++.|+.|||   +.+|+||||+|+||++++++.++|+|||++......  
T Consensus        95 e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~--  168 (307)
T cd06607          95 EYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--  168 (307)
T ss_pred             HhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecCCC--
Confidence            9996 5888887765567899999999999999999999   999999999999999999999999999998754322  


Q ss_pred             ccccccccccccccCccCcC---CCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccc
Q 040845          683 SMTQTQTLATIGYMAPEYGR---EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANL  759 (824)
Q Consensus       683 ~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  759 (824)
                          ....++..|+|||.+.   .+.++.++||||||+++|||++|+.||.......  .........+        +  
T Consensus       169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~--~~~~~~~~~~--------~--  232 (307)
T cd06607         169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--ALYHIAQNDS--------P--  232 (307)
T ss_pred             ----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH--HHHHHhcCCC--------C--
Confidence                1235788999999874   4568899999999999999999999986532111  0000000000        0  


Q ss_pred             cCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 040845          760 LSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL  802 (824)
Q Consensus       760 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L  802 (824)
                             ...+..++..+.+++.+||..+|++||++.+++.+-
T Consensus       233 -------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  268 (307)
T cd06607         233 -------TLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR  268 (307)
T ss_pred             -------CCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence                   001123566789999999999999999999998853

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.8e-34  Score=304.36  Aligned_cols=253  Identities=29%  Similarity=0.369  Sum_probs=206.5

Q ss_pred             hhccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEe
Q 040845          525 ATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLE  603 (824)
Q Consensus       525 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  603 (824)
                      ..+.|+..+.||+|++|.||+|.++ +++.||+|++..... ..+.+..|+++++.++|+|++++++++......++|+|
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   95 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME   95 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence            4567888899999999999999876 589999999876543 45678889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 040845          604 YMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS  683 (824)
Q Consensus       604 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  683 (824)
                      |+++++|.+++......+++..+..++.|++.|++|||   +.+++|+|++|+||+++.++.++|+|||.+........ 
T Consensus        96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-  171 (286)
T cd06614          96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-  171 (286)
T ss_pred             ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-
Confidence            99999999999876557899999999999999999999   99999999999999999999999999999876543221 


Q ss_pred             cccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCch
Q 040845          684 MTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQE  763 (824)
Q Consensus       684 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  763 (824)
                       ......++..|+|||.+.+..++.++|||||||++|+|++|+.||...... .....+.....                
T Consensus       172 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~-~~~~~~~~~~~----------------  233 (286)
T cd06614         172 -KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL-RALFLITTKGI----------------  233 (286)
T ss_pred             -hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcCC----------------
Confidence             112334778999999998888999999999999999999999998652111 11111100000                


Q ss_pred             hhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          764 DIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       764 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                       .....+..++..+.+++.+||+.+|.+||++.+++++
T Consensus       234 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         234 -PPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             -CCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence             0011122356678999999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-36  Score=300.77  Aligned_cols=254  Identities=24%  Similarity=0.336  Sum_probs=205.6

Q ss_pred             cHHHHHHhh-ccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeee
Q 040845          518 SYLELFQAT-DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSC  592 (824)
Q Consensus       518 ~~~~~~~~~-~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~  592 (824)
                      .+.|....+ +.|..-++||+||||.||-++.+ +|+.||.|.+.+..   .........|-.|+++++.++||.+-.+|
T Consensus       175 K~lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAf  254 (591)
T KOG0986|consen  175 KWLELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAF  254 (591)
T ss_pred             HHHHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeee
Confidence            334433333 55778899999999999999755 59999999875432   23345567899999999999999999999


Q ss_pred             ecCCeeEEEEeccCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeec
Q 040845          593 SNEEFKALVLEYMPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDF  671 (824)
Q Consensus       593 ~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df  671 (824)
                      +..+..++|+..|.||+|.=+|...+ ..+++.+++.++.+|+.||++||   ..+||+||+||+|||+|+.|+++|+|.
T Consensus       255 eTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDL  331 (591)
T KOG0986|consen  255 ETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDL  331 (591)
T ss_pred             cCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeecc
Confidence            99999999999999999988876654 57899999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcc
Q 040845          672 GIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPIST  751 (824)
Q Consensus       672 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  751 (824)
                      |+|..+.....   ..+.+||.+|||||++.++.|+...|.||+||++|||+.|+.||....+..    .          
T Consensus       332 GLAvei~~g~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv----k----------  394 (591)
T KOG0986|consen  332 GLAVEIPEGKP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV----K----------  394 (591)
T ss_pred             ceEEecCCCCc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh----h----------
Confidence            99998764432   344589999999999999999999999999999999999999997632211    0          


Q ss_pred             hhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCC
Q 040845          752 MEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRIN  794 (824)
Q Consensus       752 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt  794 (824)
                      .+.+|......+   ...++.+++++.++.+..++.||++|..
T Consensus       395 ~eEvdrr~~~~~---~ey~~kFS~eakslc~~LL~Kdp~~RLG  434 (591)
T KOG0986|consen  395 REEVDRRTLEDP---EEYSDKFSEEAKSLCEGLLTKDPEKRLG  434 (591)
T ss_pred             HHHHHHHHhcch---hhcccccCHHHHHHHHHHHccCHHHhcc
Confidence            012222221111   1122457788999999999999999983

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.2e-34  Score=300.26  Aligned_cols=257  Identities=26%  Similarity=0.316  Sum_probs=200.5

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc-chhhhHHHHHHHHhcCCCCcceeEEeeeec--CCeeEEEE
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVKVISSCSN--EEFKALVL  602 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~  602 (824)
                      ++|+..+.||.|++|.||+|... +++.||+|.+..... .....+.+|++++++++||||+++++++.+  ....++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            36788899999999999999875 589999999875432 345678899999999999999999999855  34789999


Q ss_pred             eccCCCCHHHHhhh---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCC
Q 040845          603 EYMPHGSLEKYLHS---SNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG  679 (824)
Q Consensus       603 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  679 (824)
                      ||+++++|.+++..   ....++...+..++.|+++|++|||   +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            99999999988753   2346788899999999999999999   99999999999999999999999999999875432


Q ss_pred             CCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCccccc---CcchhhhhhhhhCCCcchhhcc
Q 040845          680 EDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFN---GEMTLKHWVNDCLPISTMEVVD  756 (824)
Q Consensus       680 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  756 (824)
                      ...    ....++..|+|||.+.+..++.++||||+|+++|||++|+.||+....   .......+.......   ...+
T Consensus       158 ~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~  230 (287)
T cd06621         158 SLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNP---ELKD  230 (287)
T ss_pred             ccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCch---hhcc
Confidence            211    223467889999999888999999999999999999999999976422   111122222111000   0000


Q ss_pred             ccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 040845          757 ANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL  802 (824)
Q Consensus       757 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L  802 (824)
                           ..    ......+..+.+++.+||..+|++|||+.|++++=
T Consensus       231 -----~~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~  267 (287)
T cd06621         231 -----EP----GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHP  267 (287)
T ss_pred             -----CC----CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCc
Confidence                 00    00012356789999999999999999999998853

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-34  Score=302.77  Aligned_cols=248  Identities=27%  Similarity=0.418  Sum_probs=199.8

Q ss_pred             cCCCCceeeeccceEEEEEEE-CCCcEEEEEEeeccc-cchhhhHHHHHHHHhcCC---CCcceeEEeeeecCCeeEEEE
Q 040845          528 KFSENNLIGRGGFGSVYKARI-RDGMEVAVKVFNLQC-GRAFKSFDVECAMMKSIR---HRNLVKVISSCSNEEFKALVL  602 (824)
Q Consensus       528 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~  602 (824)
                      .|+..+.||+|+||.||+|.+ .+++.||+|.++... ....+.+.+|+.+++.++   |||++++++++.+....++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            477788999999999999986 468999999986542 334567888999999997   999999999999999999999


Q ss_pred             eccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 040845          603 EYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ  682 (824)
Q Consensus       603 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  682 (824)
                      ||+++++|.+++...  .+++..+..++.|++.|++|||   +.+++|+||+|+||++++++.++++|||.+..+.....
T Consensus        82 e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06917          82 EYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS  156 (277)
T ss_pred             ecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence            999999999998654  6889999999999999999999   99999999999999999999999999999987654332


Q ss_pred             ccccccccccccccCccCcCCC-CCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccC
Q 040845          683 SMTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLS  761 (824)
Q Consensus       683 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  761 (824)
                        ......|+..|+|||.+.++ .++.++|+|||||++|+|++|+.||......     .+.......     ..+..  
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-----~~~~~~~~~-----~~~~~--  222 (277)
T cd06917         157 --KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF-----RAMMLIPKS-----KPPRL--  222 (277)
T ss_pred             --ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh-----hhhhccccC-----CCCCC--
Confidence              22334688899999988654 4689999999999999999999998753211     111000000     00000  


Q ss_pred             chhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          762 QEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       762 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                             ....++.++.+++.+||+.||++||++.|++++
T Consensus       223 -------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~  255 (277)
T cd06917         223 -------EDNGYSKLLREFVAACLDEEPKERLSAEELLKS  255 (277)
T ss_pred             -------CcccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence                   001145678999999999999999999999875

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=4.1e-34  Score=297.99  Aligned_cols=251  Identities=25%  Similarity=0.346  Sum_probs=206.4

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc-chhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEec
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      ++|++.+.||+|++|.||+|+.+ +++.||||++..... .....+..|+.++.+++|+|++++++++..+...++||||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            36888999999999999999876 489999999876543 3457788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 040845          605 MPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYS-APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS  683 (824)
Q Consensus       605 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  683 (824)
                      +++++|.+++.... .+++..++.++.|+++|++|||   + .+++|+||+|+||+++.++.++|+|||.+.........
T Consensus        81 ~~~~~L~~~l~~~~-~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~  156 (264)
T cd06623          81 MDGGSLADLLKKVG-KIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ  156 (264)
T ss_pred             cCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence            99999999998654 7899999999999999999999   8 99999999999999999999999999999866432222


Q ss_pred             cccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCccccc-CcchhhhhhhhhCCCcchhhccccccCc
Q 040845          684 MTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFN-GEMTLKHWVNDCLPISTMEVVDANLLSQ  762 (824)
Q Consensus       684 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  762 (824)
                        .....++..|+|||.+.+..++.++|+||||+++|||++|+.||..... .......++....           .   
T Consensus       157 --~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-----------~---  220 (264)
T cd06623         157 --CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGP-----------P---  220 (264)
T ss_pred             --ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCC-----------C---
Confidence              1234578899999999988899999999999999999999999876432 1111111111000           0   


Q ss_pred             hhhhhhhHHH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          763 EDIHFVAKEQ-CVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       763 ~~~~~~~~~~-~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                          ...+.. ++..+.+++.+||..+|++||++.|++++
T Consensus       221 ----~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         221 ----PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             ----CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                001112 56679999999999999999999999885

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=2.1e-34  Score=303.30  Aligned_cols=249  Identities=25%  Similarity=0.304  Sum_probs=199.9

Q ss_pred             cCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEeccC
Q 040845          528 KFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMP  606 (824)
Q Consensus       528 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  606 (824)
                      .|...+.||+|++|.||+|... +++.||+|++........+.+.+|+.+++.++|+||+++++++...+..++|+||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            3455579999999999999864 689999999865544445668889999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcccc
Q 040845          607 HGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQ  686 (824)
Q Consensus       607 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  686 (824)
                      +++|.+++..  ..+++.++..++.|++.|++|||   +.+++||||+|+||+++.++.++++|||.+........  ..
T Consensus       100 ~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~~  172 (285)
T cd06648         100 GGALTDIVTH--TRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--RR  172 (285)
T ss_pred             CCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc--cc
Confidence            9999999877  35889999999999999999999   99999999999999999999999999998875432211  12


Q ss_pred             ccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhhh
Q 040845          687 TQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIH  766 (824)
Q Consensus       687 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  766 (824)
                      ....++..|+|||...+..++.++|||||||++|||++|+.||.....    . ..........      +.       .
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~----~-~~~~~~~~~~------~~-------~  234 (285)
T cd06648         173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP----L-QAMKRIRDNL------PP-------K  234 (285)
T ss_pred             ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH----H-HHHHHHHhcC------CC-------C
Confidence            234588999999999888899999999999999999999999865211    1 1111000000      00       0


Q ss_pred             hhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          767 FVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       767 ~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      ...+..++..+.+++.+||+.+|++|||+.+++++
T Consensus       235 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  269 (285)
T cd06648         235 LKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH  269 (285)
T ss_pred             CcccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence            00011245678999999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=2.9e-34  Score=302.41  Aligned_cols=250  Identities=28%  Similarity=0.363  Sum_probs=193.1

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc-chhhhHHHHHHH-HhcCCCCcceeEEeeeecCCeeEEEEe
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG-RAFKSFDVECAM-MKSIRHRNLVKVISSCSNEEFKALVLE  603 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e  603 (824)
                      ++|++.+.||+|+||.||+|+++ +|+.||+|+++.... .....+..|+.. ++..+||||+++++++..+...++|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            46888999999999999999875 589999999875422 223344455554 667789999999999999999999999


Q ss_pred             ccCCCCHHHHhhh---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-CeEecCCCCCCeeeCCCCcEEEeecccccccCC
Q 040845          604 YMPHGSLEKYLHS---SNYSLDIFQRLNIMIDVASALEYLHFGYSA-PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG  679 (824)
Q Consensus       604 ~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  679 (824)
                      |++ |+|.+++..   ....+++..++.++.|++.|++|||   +. +++||||||+||+++.++.+||+|||.+.....
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            996 688888754   2246899999999999999999999   76 999999999999999999999999999876532


Q ss_pred             CCCccccccccccccccCccCcCC----CCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhc
Q 040845          680 EDQSMTQTQTLATIGYMAPEYGRE----GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVV  755 (824)
Q Consensus       680 ~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  755 (824)
                      .   .......++..|+|||.+.+    ..++.++|+||+||++|||++|+.||..................        
T Consensus       157 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------  225 (283)
T cd06617         157 S---VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPS--------  225 (283)
T ss_pred             c---cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCC--------
Confidence            2   11223457889999998764    44688999999999999999999998653221111111111000        


Q ss_pred             cccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          756 DANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       756 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                       +.         .....++..+.+++.+||..+|++||++.+++++
T Consensus       226 -~~---------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  261 (283)
T cd06617         226 -PQ---------LPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH  261 (283)
T ss_pred             -CC---------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             00         0011245678999999999999999999999874

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=3.2e-34  Score=296.51  Aligned_cols=250  Identities=30%  Similarity=0.428  Sum_probs=205.3

Q ss_pred             cCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEeccC
Q 040845          528 KFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMP  606 (824)
Q Consensus       528 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  606 (824)
                      +|+..+.||+|++|.||+|... ++..|++|++........+.+.+|+++++.++|++++++++++..+...++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            4778899999999999999875 689999999876654456788999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcccc
Q 040845          607 HGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQ  686 (824)
Q Consensus       607 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  686 (824)
                      +++|.+++......+++..+..++.|++.|++|||   ..+++||||+|+||++++++.++|+|||.+........   .
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~  154 (253)
T cd05122          81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---R  154 (253)
T ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---c
Confidence            99999999876557899999999999999999999   89999999999999999999999999999987643322   2


Q ss_pred             ccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhhh
Q 040845          687 TQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIH  766 (824)
Q Consensus       687 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  766 (824)
                      ....++..|+|||.+.+..++.++||||||+++|+|++|+.||........ ... ...   ...             ..
T Consensus       155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~-~~~---~~~-------------~~  216 (253)
T cd05122         155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA-LFK-IAT---NGP-------------PG  216 (253)
T ss_pred             cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH-HHH-HHh---cCC-------------CC
Confidence            334578899999999888899999999999999999999999875321100 000 000   000             00


Q ss_pred             hhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          767 FVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       767 ~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      ...+..++..+.+++.+||+.||++|||+.|++++
T Consensus       217 ~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         217 LRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             cCcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            00111135668999999999999999999999864

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2.4e-34  Score=304.61  Aligned_cols=268  Identities=22%  Similarity=0.271  Sum_probs=200.4

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc--chhhhHHHHHHHHhcCCCCcceeEEeeeecC--CeeEEE
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG--RAFKSFDVECAMMKSIRHRNLVKVISSCSNE--EFKALV  601 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv  601 (824)
                      ++|++.+.||+|+||.||+|+++ +++.||+|.++....  .....+.+|+.++++++||||+++++++...  ...++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            57888999999999999999876 588999999875432  2233567899999999999999999998777  899999


Q ss_pred             EeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 040845          602 LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED  681 (824)
Q Consensus       602 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  681 (824)
                      |||++ ++|.+++......+++.++..++.|++.||+|||   +.+++|+||||+||+++.++.++|+|||.+.......
T Consensus        85 ~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  160 (293)
T cd07843          85 MEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL  160 (293)
T ss_pred             ehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence            99996 5999998876657899999999999999999999   9999999999999999999999999999998764332


Q ss_pred             CccccccccccccccCccCcCCC-CCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcc--------h
Q 040845          682 QSMTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPIST--------M  752 (824)
Q Consensus       682 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--------~  752 (824)
                      .  ......++..|+|||.+.+. .++.++|+||+|+++|||++|+.||...... ...............        .
T Consensus       161 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
T cd07843         161 K--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI-DQLNKIFKLLGTPTEKIWPGFSEL  237 (293)
T ss_pred             c--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCchHHHHHhhcc
Confidence            1  22334578899999988654 4689999999999999999999998753221 111111110000000        0


Q ss_pred             hhcc-ccc--cCchhhhhhhHHH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          753 EVVD-ANL--LSQEDIHFVAKEQ-CVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       753 ~~~~-~~~--~~~~~~~~~~~~~-~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      .... ...  ..........+.. .+..+.+++.+||+.+|++|||+.|++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence            0000 000  0000000001111 36678999999999999999999999864

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=3.7e-34  Score=305.46  Aligned_cols=268  Identities=25%  Similarity=0.295  Sum_probs=199.7

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc--chhhhHHHHHHHHhcCCCCcceeEEeeeecC--CeeEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG--RAFKSFDVECAMMKSIRHRNLVKVISSCSNE--EFKAL  600 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  600 (824)
                      .++|++.+.||+|+||.||+|..+ +|+.||+|+++....  .....+.+|+.++++++|+||+++++++.+.  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            467999999999999999999865 589999999865432  2233456799999999999999999998654  56899


Q ss_pred             EEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 040845          601 VLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE  680 (824)
Q Consensus       601 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  680 (824)
                      ||||++ ++|.+++......+++.++..++.|++.|++|||   +.+++||||||+||++++++.+||+|||.+......
T Consensus        86 v~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~  161 (309)
T cd07845          86 VMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP  161 (309)
T ss_pred             EEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence            999996 4899998876567899999999999999999999   999999999999999999999999999999876433


Q ss_pred             CCccccccccccccccCccCcCC-CCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhh----c
Q 040845          681 DQSMTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEV----V  755 (824)
Q Consensus       681 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----~  755 (824)
                      ..  ......++..|+|||.+.+ ..++.++||||+||++|||++|+.||......+ ...... ..........    .
T Consensus       162 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~  237 (309)
T cd07845         162 AK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE-QLDLII-QLLGTPNESIWPGFS  237 (309)
T ss_pred             cC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHH-HhcCCCChhhchhhh
Confidence            21  2223346788999998865 457899999999999999999999987532111 111111 1111000000    0


Q ss_pred             ccc---c--cCchhhhh--hhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          756 DAN---L--LSQEDIHF--VAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       756 ~~~---~--~~~~~~~~--~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      +..   .  ........  ......+..+.+++.+|+..||++|||+.|++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            000   0  00000000  0011236678899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-34  Score=308.41  Aligned_cols=253  Identities=26%  Similarity=0.374  Sum_probs=202.1

Q ss_pred             ccCCCCceeeeccceEEEEEEECC-CcEEEEEEeecccc---chhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEE
Q 040845          527 DKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCG---RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVL  602 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  602 (824)
                      ++|+..+.||+|+||.||+|...+ ++.||+|.+.....   ...+.+..|+++++.++|+||+++++.+.+....++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            368888999999999999998754 89999999875432   24456888999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 040845          603 EYMPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED  681 (824)
Q Consensus       603 e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  681 (824)
                      ||+++++|.+++.... ..+++..+..++.|++.|++|||   +.+++|+||||+||+++.++.++|+|||++.......
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  157 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP  157 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence            9999999999987542 56899999999999999999999   9999999999999999999999999999987543221


Q ss_pred             Ccc---------------------------ccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCccccc
Q 040845          682 QSM---------------------------TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFN  734 (824)
Q Consensus       682 ~~~---------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~  734 (824)
                      ...                           ......|+..|+|||++.+..++.++||||||+++|+|++|+.||.....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~  237 (316)
T cd05574         158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR  237 (316)
T ss_pred             cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence            110                           11123578899999999888899999999999999999999999865322


Q ss_pred             CcchhhhhhhhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCC----HHHHHHH
Q 040845          735 GEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRIN----AKEIVAK  801 (824)
Q Consensus       735 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt----~~evl~~  801 (824)
                      .. ......            +...      ........+..+.+++.+||..||++|||    ++|++++
T Consensus       238 ~~-~~~~~~------------~~~~------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~  289 (316)
T cd05574         238 DE-TFSNIL------------KKEV------TFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH  289 (316)
T ss_pred             HH-HHHHHh------------cCCc------cCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence            11 111110            0000      00001114567999999999999999999    7777774

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=2.7e-34  Score=302.77  Aligned_cols=265  Identities=26%  Similarity=0.332  Sum_probs=198.6

Q ss_pred             cCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEec
Q 040845          528 KFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       528 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      +|+..+.||.|++|.||+|+.. +|+.||||.+....  ......+..|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4788899999999999999865 58999999886543  22335688899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 040845          605 MPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS  683 (824)
Q Consensus       605 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  683 (824)
                      +. ++|.+++.... ..+++..+..++.|++.|++|||   +.+++|+||+|+||++++++.+|++|||++........ 
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~-  155 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-  155 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence            95 68998886543 46899999999999999999999   99999999999999999999999999999876532211 


Q ss_pred             cccccccccccccCccCcCCCC-CCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCC-cch-----hh--
Q 040845          684 MTQTQTLATIGYMAPEYGREGQ-VSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPI-STM-----EV--  754 (824)
Q Consensus       684 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~-----~~--  754 (824)
                       ......++..|+|||...+.. ++.++||||||+++|||+||+.||......+ ...+........ ...     ..  
T Consensus       156 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07860         156 -TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIFRTLGTPDEVVWPGVTSLPD  233 (284)
T ss_pred             -ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCCChhhhhhhhHHHH
Confidence             122334688999999876644 5889999999999999999999986532111 111111111000 000     00  


Q ss_pred             ---ccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          755 ---VDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       755 ---~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                         ..+... ..... ......+..+.+++.+||+.||++|||++|++++
T Consensus       234 ~~~~~~~~~-~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  281 (284)
T cd07860         234 YKPSFPKWA-RQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH  281 (284)
T ss_pred             HHhhccccc-ccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence               000000 00000 0012345678899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=4e-34  Score=300.10  Aligned_cols=247  Identities=26%  Similarity=0.376  Sum_probs=200.6

Q ss_pred             cCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc-cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEecc
Q 040845          528 KFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYM  605 (824)
Q Consensus       528 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  605 (824)
                      -|+..+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++.++...++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            4667889999999999999864 58899999876432 233467888999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccc
Q 040845          606 PHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMT  685 (824)
Q Consensus       606 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  685 (824)
                      ++++|.+++...  .+++..+..++.|++.|++|||   +.+++|+||+|+||+++.++.++++|||++........  .
T Consensus        85 ~~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~--~  157 (277)
T cd06641          85 GGGSALDLLEPG--PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--K  157 (277)
T ss_pred             CCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccchh--h
Confidence            999999998754  5789999999999999999999   99999999999999999999999999999876543221  1


Q ss_pred             cccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhh
Q 040845          686 QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDI  765 (824)
Q Consensus       686 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  765 (824)
                      .....++..|+|||.+.+..++.++|+|||||++|+|++|..||......  .....+..   ...              
T Consensus       158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~---~~~--------------  218 (277)
T cd06641         158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM--KVLFLIPK---NNP--------------  218 (277)
T ss_pred             hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH--HHHHHHhc---CCC--------------
Confidence            22345788999999998888899999999999999999999998653211  11111000   000              


Q ss_pred             hhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          766 HFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       766 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                       ...+..++..+.+++.+||..+|++||++.+++++
T Consensus       219 -~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         219 -PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             -CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence             00112345678899999999999999999999996

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-35  Score=287.59  Aligned_cols=241  Identities=22%  Similarity=0.269  Sum_probs=199.6

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc---chhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG---RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALV  601 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  601 (824)
                      .++|+..++||+|.||.|..++.+ +|+.||+|+++++.-   .....-..|-.+++.-+||++..+-..|+..+..++|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            477889999999999999999865 589999999987642   3344456688999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 040845          602 LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED  681 (824)
Q Consensus       602 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  681 (824)
                      |||+.||.|.-++.+.+ .+++.....+..+|+.||.|||   +++||.||+|.+|.++|.+|++||+|||+++.-  -.
T Consensus       247 MeyanGGeLf~HLsrer-~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~--I~  320 (516)
T KOG0690|consen  247 MEYANGGELFFHLSRER-VFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEE--IK  320 (516)
T ss_pred             EEEccCceEeeehhhhh-cccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhc--cc
Confidence            99999999998887765 6788888889999999999999   999999999999999999999999999999742  22


Q ss_pred             CccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccC
Q 040845          682 QSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLS  761 (824)
Q Consensus       682 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  761 (824)
                      ........+||+.|.|||++....|+.++|.|.+||++|||++|+.||+......  +-            +.+-     
T Consensus       321 ~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k--LF------------eLIl-----  381 (516)
T KOG0690|consen  321 YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK--LF------------ELIL-----  381 (516)
T ss_pred             ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH--HH------------HHHH-----
Confidence            2234455789999999999999999999999999999999999999998732211  00            0000     


Q ss_pred             chhhhhhhHHHHHHHHHHHHHHccccCCCCCC
Q 040845          762 QEDIHFVAKEQCVSFVFNLALECTVESPEQRI  793 (824)
Q Consensus       762 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp  793 (824)
                      .  .+...|...++++..|+...+..||.+|.
T Consensus       382 ~--ed~kFPr~ls~eAktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  382 M--EDLKFPRTLSPEAKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             h--hhccCCccCCHHHHHHHHHHhhcChHhhc
Confidence            0  01112334566788999999999999998

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=3.4e-35  Score=329.59  Aligned_cols=253  Identities=26%  Similarity=0.418  Sum_probs=191.6

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc-cchhhhHHHHHHHHhcCCCCcceeEEeeee----------
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLVKVISSCS----------  593 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----------  593 (824)
                      ..+|+..++||+||||.||+++.+ ||+.||||++.... ......+.+|+..+++|+|||||+++..+.          
T Consensus       478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e  557 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE  557 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence            356778899999999999999866 79999999987653 345667889999999999999999984210          


Q ss_pred             --------------------------------------------------------------------------------
Q 040845          594 --------------------------------------------------------------------------------  593 (824)
Q Consensus       594 --------------------------------------------------------------------------------  593 (824)
                                                                                                      
T Consensus       558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e  637 (1351)
T KOG1035|consen  558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE  637 (1351)
T ss_pred             ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence                                                                                            


Q ss_pred             ----------------------cC-------CeeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 040845          594 ----------------------NE-------EFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGY  644 (824)
Q Consensus       594 ----------------------~~-------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~  644 (824)
                                            +.       ...||-||||+..++.+++++....-.....++++++|++||+|+|   
T Consensus       638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH---  714 (1351)
T KOG1035|consen  638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH---  714 (1351)
T ss_pred             CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH---
Confidence                                  00       1357899999998888888776543357789999999999999999   


Q ss_pred             CCCeEecCCCCCCeeeCCCCcEEEeecccccccC----C------------CCCccccccccccccccCccCcCCC---C
Q 040845          645 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT----G------------EDQSMTQTQTLATIGYMAPEYGREG---Q  705 (824)
Q Consensus       645 ~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~----~------------~~~~~~~~~~~~~~~y~aPE~~~~~---~  705 (824)
                      ++|||||||||.||++|+++.|||+|||+|+...    .            .......+..+||.-|+|||++.+.   .
T Consensus       715 ~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~  794 (1351)
T KOG1035|consen  715 DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNK  794 (1351)
T ss_pred             hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccc
Confidence            9999999999999999999999999999998732    0            1112245677899999999988755   4


Q ss_pred             CCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHcc
Q 040845          706 VSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECT  785 (824)
Q Consensus       706 ~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  785 (824)
                      |+.|+|+||+|+|++||+.   ||....+.-..+........|.. .+..++               ..+.-..+|++|+
T Consensus       795 Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~-~~f~~~---------------~~~~e~slI~~Ll  855 (1351)
T KOG1035|consen  795 YNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEP-ADFFDP---------------EHPEEASLIRWLL  855 (1351)
T ss_pred             ccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCC-cccccc---------------cchHHHHHHHHHh
Confidence            9999999999999999984   45442222111111111111211 011111               1223457999999


Q ss_pred             ccCCCCCCCHHHHHH
Q 040845          786 VESPEQRINAKEIVA  800 (824)
Q Consensus       786 ~~dP~~Rpt~~evl~  800 (824)
                      +.||.+||||.|+++
T Consensus       856 ~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  856 SHDPSKRPTATELLN  870 (1351)
T ss_pred             cCCCccCCCHHHHhh
Confidence            999999999999875

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=6.2e-34  Score=295.68  Aligned_cols=252  Identities=28%  Similarity=0.388  Sum_probs=206.4

Q ss_pred             cCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc--chhhhHHHHHHHHhcCCCCcceeEEeeeecC--CeeEEEE
Q 040845          528 KFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG--RAFKSFDVECAMMKSIRHRNLVKVISSCSNE--EFKALVL  602 (824)
Q Consensus       528 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  602 (824)
                      +|...+.||+|++|.||+|... +++.|++|++.....  ...+.+.+|++++++++|+||+++++.+.+.  ...++|+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4777899999999999999876 689999999876542  4467788999999999999999999999888  8999999


Q ss_pred             eccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 040845          603 EYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ  682 (824)
Q Consensus       603 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  682 (824)
                      ||+++++|.+++.... .+++.++..++.|++.|++|||   +.+++|+|++|+||+++.++.++|+|||.+........
T Consensus        81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  156 (260)
T cd06606          81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET  156 (260)
T ss_pred             EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence            9999999999998766 7899999999999999999999   89999999999999999999999999999987654432


Q ss_pred             ccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCc
Q 040845          683 SMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ  762 (824)
Q Consensus       683 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  762 (824)
                      ........++..|+|||...+..++.++||||||+++|++++|..||......   .......         ..      
T Consensus       157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~---------~~------  218 (260)
T cd06606         157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP---MAALYKI---------GS------  218 (260)
T ss_pred             cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch---HHHHHhc---------cc------
Confidence            11223455888999999998888999999999999999999999998764311   0000000         00      


Q ss_pred             hhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          763 EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       763 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      .......+...+..+.+++.+|+..+|++||++.|++++
T Consensus       219 ~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~  257 (260)
T cd06606         219 SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH  257 (260)
T ss_pred             cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence            000011122336679999999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=6.5e-34  Score=299.61  Aligned_cols=261  Identities=21%  Similarity=0.259  Sum_probs=195.6

Q ss_pred             CCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc-cchhhhHHHHHHHHhcCC-CCcceeEEeeeecC--CeeEEEEe
Q 040845          529 FSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC-GRAFKSFDVECAMMKSIR-HRNLVKVISSCSNE--EFKALVLE  603 (824)
Q Consensus       529 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e  603 (824)
                      |++.+.||+|+||.||+|+.. +++.||+|+++... .........|+.+++++. |+|++++++++.+.  +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            567789999999999999864 58999999986542 222233456888898885 99999999999887  88999999


Q ss_pred             ccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 040845          604 YMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS  683 (824)
Q Consensus       604 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  683 (824)
                      |++ +++.+++......+++.++..++.|++.|++|||   +.+++||||+|+||+++. +.+||+|||.+.........
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~  155 (282)
T cd07831          81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY  155 (282)
T ss_pred             cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccccccCCCc
Confidence            996 5888888765557899999999999999999999   999999999999999999 99999999999865432221


Q ss_pred             cccccccccccccCccCcC-CCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcch----------
Q 040845          684 MTQTQTLATIGYMAPEYGR-EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTM----------  752 (824)
Q Consensus       684 ~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~----------  752 (824)
                         ....++..|+|||... ++.++.++||||+||++|||++|..||.....  .....+..........          
T Consensus       156 ---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
T cd07831         156 ---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE--LDQIAKIHDVLGTPDAEVLKKFRKSR  230 (282)
T ss_pred             ---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH--HHHHHHHHHHcCCCCHHHHHhhcccc
Confidence               2245788999999764 45578999999999999999999999965321  1111111111111100          


Q ss_pred             --hhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          753 --EVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       753 --~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                        ....+...... . ......++..+.+++.+||..+|++||+++|++++
T Consensus       231 ~~~~~~~~~~~~~-~-~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         231 HMNYNFPSKKGTG-L-RKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             cccccCccccccc-H-HHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence              00000000000 0 01112457889999999999999999999999875

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-34  Score=305.65  Aligned_cols=270  Identities=23%  Similarity=0.301  Sum_probs=199.6

Q ss_pred             cCCCCceeeeccceEEEEEEEC---CCcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeeeecC--CeeE
Q 040845          528 KFSENNLIGRGGFGSVYKARIR---DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSCSNE--EFKA  599 (824)
Q Consensus       528 ~~~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  599 (824)
                      +|++.+.||+|+||.||+|..+   +++.||+|.+....   ....+.+.+|+.+++.++||||+++++++.+.  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4778899999999999999865   37899999987632   33446678899999999999999999999887  8899


Q ss_pred             EEEeccCCCCHHHHhhhCC----CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC----CCcEEEeec
Q 040845          600 LVLEYMPHGSLEKYLHSSN----YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD----NMVAHLSDF  671 (824)
Q Consensus       600 lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~----~~~~kl~Df  671 (824)
                      +||||+++ ++.+++....    ..+++..++.++.|++.|++|||   +.+|+||||||+||+++.    ++.+|++||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999965 7777765332    36788999999999999999999   999999999999999999    999999999


Q ss_pred             ccccccCCCCC-ccccccccccccccCccCcCCC-CCCccchHHHHHHHHHHHHhCCCCCcccccCc--------chhhh
Q 040845          672 GIAKLLTGEDQ-SMTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDELFNGE--------MTLKH  741 (824)
Q Consensus       672 g~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~--------~~~~~  741 (824)
                      |++........ ........++..|+|||.+.+. .++.++|||||||++|||++|+.||.......        ..+..
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            99987643322 1223345678899999987654 57899999999999999999999997643322        01111


Q ss_pred             hhhhhCCC------------cchh---hccccccCchhhhhhhHH--HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          742 WVNDCLPI------------STME---VVDANLLSQEDIHFVAKE--QCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       742 ~~~~~~~~------------~~~~---~~~~~~~~~~~~~~~~~~--~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      ++......            ....   ..................  .....+.+++.+|++.||++|||+.|++++
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~  313 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH  313 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            11100000            0000   000000000000011111  345678999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-35  Score=281.32  Aligned_cols=256  Identities=21%  Similarity=0.253  Sum_probs=201.3

Q ss_pred             HHhhccCCCC-ceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcC-CCCcceeEEeeeec----C
Q 040845          523 FQATDKFSEN-NLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSI-RHRNLVKVISSCSN----E  595 (824)
Q Consensus       523 ~~~~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~  595 (824)
                      ...+++|.+. ++||-|-.|.|..+..+ +|+.+|+|++..     ....++|++.--.. .|||||+++++|.+    .
T Consensus        57 ~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r  131 (400)
T KOG0604|consen   57 YSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGR  131 (400)
T ss_pred             ccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence            4567778765 57999999999999754 689999998742     24456777765544 69999999999754    4


Q ss_pred             CeeEEEEeccCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC---CCCcEEEeec
Q 040845          596 EFKALVLEYMPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD---DNMVAHLSDF  671 (824)
Q Consensus       596 ~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~---~~~~~kl~Df  671 (824)
                      ....+|||.|+||.|...++..+ ..+++.++..|++||+.|+.|||   +..|.||||||+|+|..   .+..+|++||
T Consensus       132 kcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDf  208 (400)
T KOG0604|consen  132 KCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDF  208 (400)
T ss_pred             eeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEeccc
Confidence            57789999999999999998766 57999999999999999999999   99999999999999996   4568999999


Q ss_pred             ccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcc
Q 040845          672 GIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPIST  751 (824)
Q Consensus       672 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  751 (824)
                      |+|+.-..   ........-|+.|.|||++...+|+...|+||+||++|-|++|.+||+.....  .+..-.+..+....
T Consensus       209 GFAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~--aispgMk~rI~~gq  283 (400)
T KOG0604|consen  209 GFAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL--AISPGMKRRIRTGQ  283 (400)
T ss_pred             ccccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc--cCChhHHhHhhccC
Confidence            99985432   22334456899999999999999999999999999999999999999875431  11111111111111


Q ss_pred             hhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 040845          752 MEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL  802 (824)
Q Consensus       752 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L  802 (824)
                      .+           .....+...++...++|+.+++.+|++|.|+.|++++=
T Consensus       284 y~-----------FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hp  323 (400)
T KOG0604|consen  284 YE-----------FPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHP  323 (400)
T ss_pred             cc-----------CCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCc
Confidence            11           11123346788899999999999999999999998763

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=5.1e-34  Score=297.41  Aligned_cols=252  Identities=22%  Similarity=0.327  Sum_probs=201.8

Q ss_pred             cCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeec--CCeeEEEE
Q 040845          528 KFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSN--EEFKALVL  602 (824)
Q Consensus       528 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~  602 (824)
                      +|++.+.||.|+||.||+|... +++.||+|.+....  ....+.+..|+++++.++|+||+++++++..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            4788899999999999999754 58899999986432  2334567889999999999999999998753  45678999


Q ss_pred             eccCCCCHHHHhhhC---CCCCCHHHHHHHHHHHHHHHHHhhcCC--CCCeEecCCCCCCeeeCCCCcEEEeeccccccc
Q 040845          603 EYMPHGSLEKYLHSS---NYSLDIFQRLNIMIDVASALEYLHFGY--SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  677 (824)
Q Consensus       603 e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~--~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~  677 (824)
                      ||+++++|.+++...   ...+++..++.++.|++.|++|||..+  +.+++|+||+|+||++++++.+|++|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999998754   357899999999999999999999443  678999999999999999999999999999876


Q ss_pred             CCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccc
Q 040845          678 TGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDA  757 (824)
Q Consensus       678 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  757 (824)
                      .....  ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||.....  ......+....          
T Consensus       161 ~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~----------  226 (265)
T cd08217         161 GHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ--LQLASKIKEGK----------  226 (265)
T ss_pred             cCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH--HHHHHHHhcCC----------
Confidence            43322  12234588999999999988899999999999999999999999876321  11111111100          


Q ss_pred             cccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          758 NLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       758 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                        .      ...+...+..+.+++.+||..+|++||++.|++++
T Consensus       227 --~------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         227 --F------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             --C------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence              0      01122345678999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-34  Score=300.54  Aligned_cols=266  Identities=27%  Similarity=0.333  Sum_probs=198.9

Q ss_pred             CCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEecc
Q 040845          529 FSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYM  605 (824)
Q Consensus       529 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  605 (824)
                      |++.+.||.|++|.||+|... +|+.||+|++....  ....+.+..|+++++.++|+|++++++++.++...++||||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            667889999999999999865 69999999987543  223356788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 040845          606 PHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM  684 (824)
Q Consensus       606 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  684 (824)
                      + ++|.+++.... ..+++..+..++.|+++|++|||   +.+++||||+|+||+++.++.++|+|||.+........  
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--  154 (283)
T cd07835          81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR--  154 (283)
T ss_pred             C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc--
Confidence            5 68999987654 46899999999999999999999   89999999999999999999999999999975532211  


Q ss_pred             ccccccccccccCccCcCCC-CCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhC-CCcch-----hh--c
Q 040845          685 TQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCL-PISTM-----EV--V  755 (824)
Q Consensus       685 ~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~-----~~--~  755 (824)
                      ......++..|+|||++.+. .++.++||||+|+++|||++|+.||....... ....+.+... +....     ..  .
T Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd07835         155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID-QLFRIFRTLGTPDEDVWPGVTSLPDY  233 (283)
T ss_pred             ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChHHhhhhhhchhh
Confidence            12233568899999987654 46899999999999999999999986532111 1111111100 00000     00  0


Q ss_pred             cccccCc-hhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          756 DANLLSQ-EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       756 ~~~~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      ....... ...........+..+.+++.+||+.||++|||++|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            0000000 000001122345678999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1e-34  Score=301.29  Aligned_cols=248  Identities=27%  Similarity=0.333  Sum_probs=202.5

Q ss_pred             cCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEe
Q 040845          528 KFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLE  603 (824)
Q Consensus       528 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  603 (824)
                      +|++.+.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|++++++++||||+++++++.++...++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4788899999999999999876 58999999987542   2345678889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 040845          604 YMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS  683 (824)
Q Consensus       604 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  683 (824)
                      |+++++|.+++... ..+++.++..++.|+++|++|||   +.+++|+||+|+||++++++.++|+|||.+.......  
T Consensus        81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--  154 (258)
T cd05578          81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--  154 (258)
T ss_pred             CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--
Confidence            99999999999766 47899999999999999999999   9999999999999999999999999999988654332  


Q ss_pred             cccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCch
Q 040845          684 MTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQE  763 (824)
Q Consensus       684 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  763 (824)
                       ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||......  ....+......               
T Consensus       155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~---------------  216 (258)
T cd05578         155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT--IRDQIRAKQET---------------  216 (258)
T ss_pred             -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc--HHHHHHHHhcc---------------
Confidence             123345788999999998888999999999999999999999998763221  11111111000               


Q ss_pred             hhhhhhHHHHHHHHHHHHHHccccCCCCCCCH--HHHHH
Q 040845          764 DIHFVAKEQCVSFVFNLALECTVESPEQRINA--KEIVA  800 (824)
Q Consensus       764 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~--~evl~  800 (824)
                       .....+...+..+.+++.+||..||.+||++  +|+++
T Consensus       217 -~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~  254 (258)
T cd05578         217 -ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN  254 (258)
T ss_pred             -ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence             0011122345778999999999999999999  66553

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-34  Score=310.03  Aligned_cols=274  Identities=26%  Similarity=0.368  Sum_probs=207.0

Q ss_pred             cCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc-cchhhhHHHHHHHHhcCCCCcceeEEeeeecC------CeeE
Q 040845          528 KFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLVKVISSCSNE------EFKA  599 (824)
Q Consensus       528 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~  599 (824)
                      .|...+.||+||||.||+|+.+ +|+.||||.++... ....+...+|+++|++++|+|||+++++-++.      ....
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            3556678999999999999954 69999999997654 34456778899999999999999999986543      3667


Q ss_pred             EEEeccCCCCHHHHhhhCC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC--CCC--cEEEeeccc
Q 040845          600 LVLEYMPHGSLEKYLHSSN--YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD--DNM--VAHLSDFGI  673 (824)
Q Consensus       600 lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~--~~~--~~kl~Dfg~  673 (824)
                      +|||||.+|+|+..+.+..  .++++.+.+.++.+++.|+.|||   +.+||||||||.||++-  ++|  --||+|||+
T Consensus        94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            9999999999999998655  78999999999999999999999   99999999999999983  334  359999999


Q ss_pred             ccccCCCCCccccccccccccccCccCcCC-CCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhh-hhhhhh-CCCc
Q 040845          674 AKLLTGEDQSMTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLK-HWVNDC-LPIS  750 (824)
Q Consensus       674 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~-~~~~~~-~~~~  750 (824)
                      |+.+.++.   .....+||..|.+||.... +.|+..+|.|||||++||++||..||........... .|.... .+..
T Consensus       171 Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~  247 (732)
T KOG4250|consen  171 ARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSG  247 (732)
T ss_pred             cccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCc
Confidence            99875444   4566789999999999984 8899999999999999999999999987544322111 111111 1111


Q ss_pred             chhhccccccC--chhhhhhhHH----HHHHHHHHHHHHccccCCCCCC--CHHHHHHHHHHHHH
Q 040845          751 TMEVVDANLLS--QEDIHFVAKE----QCVSFVFNLALECTVESPEQRI--NAKEIVAKLLKIRD  807 (824)
Q Consensus       751 ~~~~~~~~~~~--~~~~~~~~~~----~~~~~l~~l~~~cl~~dP~~Rp--t~~evl~~L~~~~~  807 (824)
                      ..-..+....+  .....++++.    .....+-.++..++..+|++|.  .+.+....+.++.+
T Consensus       248 v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~  312 (732)
T KOG4250|consen  248 VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN  312 (732)
T ss_pred             eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence            11111111110  0011111111    2334466788889999999999  88888888887765

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=8.6e-34  Score=303.15  Aligned_cols=270  Identities=22%  Similarity=0.311  Sum_probs=197.3

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc--chhhhHHHHHHHHhcCCCCcceeEEeeeecCC------
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG--RAFKSFDVECAMMKSIRHRNLVKVISSCSNEE------  596 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  596 (824)
                      .++|++.+.||+|+||.||+|... +++.||||.+.....  .....+.+|++++++++||||+++++++....      
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            467999999999999999999865 589999998865422  22335567999999999999999999986654      


Q ss_pred             --eeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccc
Q 040845          597 --FKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIA  674 (824)
Q Consensus       597 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a  674 (824)
                        ..++||||++ +++.+++......+++.++..++.|++.|++|||   +.+++|+||||+||+++.++.+||+|||.+
T Consensus        91 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~  166 (310)
T cd07865          91 KGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLA  166 (310)
T ss_pred             CceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence              4599999996 5888888766557899999999999999999999   899999999999999999999999999999


Q ss_pred             cccCCCCCc--cccccccccccccCccCcCCC-CCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhh---CC
Q 040845          675 KLLTGEDQS--MTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDC---LP  748 (824)
Q Consensus       675 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~---~~  748 (824)
                      .........  .......++..|+|||.+.+. .++.++||||||+++|||++|+.||......  .....+...   .+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~--~~~~~~~~~~~~~~  244 (310)
T cd07865         167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ--HQLTLISQLCGSIT  244 (310)
T ss_pred             ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCC
Confidence            866433221  112234578899999987654 4688999999999999999999998653211  111111110   00


Q ss_pred             Ccc------hhhccccccCchh----hhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          749 IST------MEVVDANLLSQED----IHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       749 ~~~------~~~~~~~~~~~~~----~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      ...      .+..+........    .....+......+.+++.+||..||++|||++|++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h  307 (310)
T cd07865         245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH  307 (310)
T ss_pred             hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence            000      0000000000000    0000011124567899999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-34  Score=256.65  Aligned_cols=267  Identities=25%  Similarity=0.306  Sum_probs=201.0

Q ss_pred             cCCCCceeeeccceEEEEEEE-CCCcEEEEEEeecccc--chhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEec
Q 040845          528 KFSENNLIGRGGFGSVYKARI-RDGMEVAVKVFNLQCG--RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       528 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      +|+..++||+|.||+||+|+. .+++.||+|.++....  .......+|+.+++.++|.|||+++++...++...+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            566678999999999999984 4588999999876643  3456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 040845          605 MPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM  684 (824)
Q Consensus       605 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  684 (824)
                      |+ .+|..+.......++.+.+..++.|+++|+.++|   ++.+.|||+||.|.++..+|++|++|||+|+-+.-+-.  
T Consensus        83 cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgipvr--  156 (292)
T KOG0662|consen   83 CD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR--  156 (292)
T ss_pred             hh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCceE--
Confidence            95 4999999887778999999999999999999999   99999999999999999999999999999987643222  


Q ss_pred             ccccccccccccCccCcCCCC-CCccchHHHHHHHHHHHHhCCCC-CcccccCcchhhhhhhhhC-CCc-----chhhcc
Q 040845          685 TQTQTLATIGYMAPEYGREGQ-VSTNGDVYSFGIMLMETFTRKKP-TDELFNGEMTLKHWVNDCL-PIS-----TMEVVD  756 (824)
Q Consensus       685 ~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~tg~~p-~~~~~~~~~~~~~~~~~~~-~~~-----~~~~~~  756 (824)
                      -.+..+.|.+|++|+++.+.. |+...|+||-||++.|+.....| |.+... +..+..+.+... +..     .....|
T Consensus       157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dv-ddqlkrif~~lg~p~ed~wps~t~lpd  235 (292)
T KOG0662|consen  157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-DDQLKRIFRLLGTPTEDQWPSMTKLPD  235 (292)
T ss_pred             eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcH-HHHHHHHHHHhCCCccccCCccccCCC
Confidence            234456899999999988765 78899999999999999885555 333211 112222211111 100     111111


Q ss_pred             ccccCchh--hhhh-hHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          757 ANLLSQED--IHFV-AKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       757 ~~~~~~~~--~~~~-~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      -.......  .... .-+.....=++++++.+.-+|.+|.+|++++++
T Consensus       236 yk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh  283 (292)
T KOG0662|consen  236 YKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH  283 (292)
T ss_pred             CcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence            11111100  0000 001223345689999999999999999998765

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-35  Score=277.35  Aligned_cols=252  Identities=23%  Similarity=0.292  Sum_probs=198.1

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc-chhhhHHHHHHHHhcC-CCCcceeEEeeeecCCeeEEEEe
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG-RAFKSFDVECAMMKSI-RHRNLVKVISSCSNEEFKALVLE  603 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  603 (824)
                      ++.+....||.|+.|.||+++.+ +|...|||.+..... +..+++...+.++..- .+|.||+.+|+|..+...++.||
T Consensus        92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe  171 (391)
T KOG0983|consen   92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME  171 (391)
T ss_pred             HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence            33455678999999999999876 489999999876532 3345566666665544 48999999999999999999999


Q ss_pred             ccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 040845          604 YMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS  683 (824)
Q Consensus       604 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  683 (824)
                      .|. ..++.++.+...++++..+-++...++.||.||.+  +++|+|||+||+|||+|+.|++|+||||++.++.+... 
T Consensus       172 lMs-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA-  247 (391)
T KOG0983|consen  172 LMS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA-  247 (391)
T ss_pred             HHH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeecccc-
Confidence            994 47788888777788888888999999999999986  88999999999999999999999999999988754433 


Q ss_pred             cccccccccccccCccCcCC---CCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhcccccc
Q 040845          684 MTQTQTLATIGYMAPEYGRE---GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLL  760 (824)
Q Consensus       684 ~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  760 (824)
                        .+...|-+.|||||.+..   ..|+.++||||||+.++|+.||+.||..-...-..+....+.               
T Consensus       248 --htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~---------------  310 (391)
T KOG0983|consen  248 --HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNE---------------  310 (391)
T ss_pred             --cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhc---------------
Confidence              344568889999998753   468999999999999999999999997622211111221111               


Q ss_pred             CchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          761 SQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       761 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                        ....+.....+++.+.+++..|++.|+.+||...++++|
T Consensus       311 --ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  311 --EPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             --CCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence              111222223367789999999999999999999998875

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.3e-35  Score=308.64  Aligned_cols=244  Identities=26%  Similarity=0.426  Sum_probs=193.9

Q ss_pred             CceeeeccceEEEEEEEC-CCcEEEEEEeecc----ccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCe--eEEEEec
Q 040845          532 NNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQ----CGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEF--KALVLEY  604 (824)
Q Consensus       532 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lv~e~  604 (824)
                      ..+||+|+|-+||+|.+. +|..||=-.++..    ..+..+++..|+.+|+.|+|+||++++.+|.+...  ..+|+|.
T Consensus        45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL  124 (632)
T KOG0584|consen   45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL  124 (632)
T ss_pred             hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence            457999999999999754 4777763222211    23445889999999999999999999999977654  7799999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC-CCCcEEEeecccccccCCCCCc
Q 040845          605 MPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTGEDQS  683 (824)
Q Consensus       605 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~-~~~~~kl~Dfg~a~~~~~~~~~  683 (824)
                      +..|+|..|..+.+ ..+...+..|++||+.||.|||+. .++|+|||||-+||+++ ..|.|||+|.|+|+.....   
T Consensus       125 ~TSGtLr~Y~kk~~-~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s---  199 (632)
T KOG0584|consen  125 FTSGTLREYRKKHR-RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS---  199 (632)
T ss_pred             ccCCcHHHHHHHhc-cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc---
Confidence            99999999999887 788999999999999999999954 78999999999999997 5699999999999976432   


Q ss_pred             cccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCch
Q 040845          684 MTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQE  763 (824)
Q Consensus       684 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  763 (824)
                       .....+|||.|||||... ..|++.+||||||++++||+|+..||.+=...-.-+.+......|.....+-        
T Consensus       200 -~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~--------  269 (632)
T KOG0584|consen  200 -HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVK--------  269 (632)
T ss_pred             -ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccC--------
Confidence             233478999999999886 7899999999999999999999999875222111112222222222222222        


Q ss_pred             hhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          764 DIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       764 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                                .+++.++|.+|+.. .++|||+.|++++
T Consensus       270 ----------dPevr~fIekCl~~-~~~R~sa~eLL~d  296 (632)
T KOG0584|consen  270 ----------DPEVREFIEKCLAT-KSERLSAKELLKD  296 (632)
T ss_pred             ----------CHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence                      24578999999999 8999999999864

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.3e-33  Score=294.01  Aligned_cols=250  Identities=21%  Similarity=0.257  Sum_probs=196.4

Q ss_pred             HHHHHhhccCCCCcee--eeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcC-CCCcceeEEeeeecC
Q 040845          520 LELFQATDKFSENNLI--GRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSI-RHRNLVKVISSCSNE  595 (824)
Q Consensus       520 ~~~~~~~~~~~~~~~l--g~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  595 (824)
                      .+.....++|++.+.+  |+|+||.||++..+ ++..+|+|.+........     |+.....+ +|+||+++++++..+
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~   81 (267)
T PHA03390          7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTL   81 (267)
T ss_pred             HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecC
Confidence            3444555777877776  99999999999854 588999999864322111     22222222 699999999999999


Q ss_pred             CeeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC-cEEEeecccc
Q 040845          596 EFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM-VAHLSDFGIA  674 (824)
Q Consensus       596 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~Dfg~a  674 (824)
                      +..++||||+++++|.+++.... .+++.++..++.|+++|++|||   +.+++||||||+||+++.++ .++++|||.+
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~  157 (267)
T PHA03390         82 KGHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLC  157 (267)
T ss_pred             CeeEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence            99999999999999999998765 7899999999999999999999   99999999999999999988 9999999998


Q ss_pred             cccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhh
Q 040845          675 KLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEV  754 (824)
Q Consensus       675 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  754 (824)
                      ......      ....++..|+|||++.+..++.++||||+|+++|||++|+.||......+.....+.....       
T Consensus       158 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------  224 (267)
T PHA03390        158 KIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQ-------  224 (267)
T ss_pred             eecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhc-------
Confidence            765322      1234788999999999888999999999999999999999999854433333333322110       


Q ss_pred             ccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCC-HHHHHHH
Q 040845          755 VDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRIN-AKEIVAK  801 (824)
Q Consensus       755 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt-~~evl~~  801 (824)
                                .....+..++..+.+++.+||+.+|++||+ ++|++++
T Consensus       225 ----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h  262 (267)
T PHA03390        225 ----------KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH  262 (267)
T ss_pred             ----------ccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence                      000111235667899999999999999996 5888754

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.4e-33  Score=297.46  Aligned_cols=267  Identities=25%  Similarity=0.331  Sum_probs=200.7

Q ss_pred             cCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc-chhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEecc
Q 040845          528 KFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYM  605 (824)
Q Consensus       528 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  605 (824)
                      +|+..+.||+|++|.||+|+.. +|+.||||+++.... ...+.+.+|+++++.++|+||+++++++.+.+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            4788899999999999999875 589999999875532 23456778999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhCC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 040845          606 PHGSLEKYLHSSN--YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS  683 (824)
Q Consensus       606 ~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  683 (824)
                      ++ +|.+++....  ..+++..+..++.|++.|++|||   +.+++||||+|+||++++++.++++|||++........ 
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-  155 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-  155 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence            75 8988886544  46899999999999999999999   89999999999999999999999999999976532211 


Q ss_pred             cccccccccccccCccCcCCC-CCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhC-CCc-ch-hhcc---
Q 040845          684 MTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCL-PIS-TM-EVVD---  756 (824)
Q Consensus       684 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~-~~-~~~~---  756 (824)
                       ......++..|+|||.+.+. .++.++||||+||++||+++|+.||......+ .......... +.. .. ...+   
T Consensus       156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07836         156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED-QLLKIFRIMGTPTESTWPGISQLPE  233 (284)
T ss_pred             -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCChhhHHHHhcCch
Confidence             12234568899999987654 56889999999999999999999987532211 1111111000 000 00 0000   


Q ss_pred             --ccccCch-hhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          757 --ANLLSQE-DIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       757 --~~~~~~~-~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                        ....... .......+.++..+.+++.+|++.||++||++.|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  281 (284)
T cd07836         234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH  281 (284)
T ss_pred             hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence              0000000 00011112456778999999999999999999999864

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=9.5e-34  Score=300.44  Aligned_cols=266  Identities=24%  Similarity=0.301  Sum_probs=196.7

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc--chhhhHHHHHHHHhcCC-CCcceeEEeeeecCCe-----
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG--RAFKSFDVECAMMKSIR-HRNLVKVISSCSNEEF-----  597 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~-----  597 (824)
                      ++|++.+.||+|+||.||+|.+. +++.||+|.++....  .....+.+|+.++++++ |+||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46888999999999999999865 589999998765432  23456788999999995 6999999999877665     


Q ss_pred             eEEEEeccCCCCHHHHhhhCC----CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC-CCcEEEeecc
Q 040845          598 KALVLEYMPHGSLEKYLHSSN----YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD-NMVAHLSDFG  672 (824)
Q Consensus       598 ~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~Dfg  672 (824)
                      .++||||+++ +|.+++....    ..+++..++.++.||+.||+|||   +.+|+||||+|+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeecc
Confidence            8999999975 8988886532    35799999999999999999999   999999999999999998 8999999999


Q ss_pred             cccccCCCCCccccccccccccccCccCcCC-CCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcc
Q 040845          673 IAKLLTGEDQSMTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPIST  751 (824)
Q Consensus       673 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  751 (824)
                      .+..+.....  ......+++.|+|||++.+ ..++.++||||||+++|||++|..||........ ........ ....
T Consensus       157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~-~~~~~~~~-~~~~  232 (295)
T cd07837         157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ-LLHIFKLL-GTPT  232 (295)
T ss_pred             cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHHHHh-CCCC
Confidence            9876532211  1223356888999998765 4578999999999999999999999865322111 11111100 0000


Q ss_pred             hhhc-------c---ccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          752 MEVV-------D---ANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       752 ~~~~-------~---~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      ....       +   .......... ...+..+..+.+++.+||..||++||++.|++.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~  291 (295)
T cd07837         233 EQVWPGVSKLRDWHEFPQWKPQDLS-RAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH  291 (295)
T ss_pred             hhhCcchhhccchhhcCcccchhHH-HhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            0000       0   0000000000 0112456779999999999999999999999864

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=8.7e-34  Score=299.49  Aligned_cols=267  Identities=25%  Similarity=0.326  Sum_probs=201.1

Q ss_pred             CCCCceeeeccceEEEEEEECC-CcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeecC--CeeEEEEe
Q 040845          529 FSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSNE--EFKALVLE  603 (824)
Q Consensus       529 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e  603 (824)
                      |++.+.||+|+||.||+|+..+ ++.||+|++....  ......+.+|+++++.++|+|++++++++.+.  +..++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            5678899999999999998764 8999999997653  33345678899999999999999999999887  89999999


Q ss_pred             ccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 040845          604 YMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS  683 (824)
Q Consensus       604 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  683 (824)
                      |+++ +|.+++......+++.++..++.|++.|++|||   +.+++|+||+|+||++++++.++|+|||.+........ 
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-  155 (287)
T cd07840          81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-  155 (287)
T ss_pred             cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-
Confidence            9975 899998776557899999999999999999999   89999999999999999999999999999987644321 


Q ss_pred             cccccccccccccCccCcCC-CCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCc---chhhcc---
Q 040845          684 MTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPIS---TMEVVD---  756 (824)
Q Consensus       684 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~---  756 (824)
                      .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ..............   .....+   
T Consensus       156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07840         156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL-EQLEKIFELCGSPTDENWPGVSKLPW  234 (287)
T ss_pred             ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCchhhccccccchh
Confidence            12233456788999997764 45789999999999999999999998753221 11111111000000   000000   


Q ss_pred             -----ccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          757 -----ANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       757 -----~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                           ................++..+.+++.+||..+|++||++.+++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence                 000000000011111236789999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.2e-33  Score=302.46  Aligned_cols=247  Identities=28%  Similarity=0.395  Sum_probs=198.3

Q ss_pred             CCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEec
Q 040845          529 FSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       529 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      |+..+.||+|+||.||+|+.. ++..||+|.+....   .+....+..|+++++.++|+|++++++++.++...++||||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  106 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY  106 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence            667789999999999999864 58899999986432   22345688899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 040845          605 MPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM  684 (824)
Q Consensus       605 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  684 (824)
                      +. |++.+.+......+++.++..++.|++.|+.|||   +.+|+||||+|+||+++.++.++|+|||++......    
T Consensus       107 ~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~----  178 (317)
T cd06635         107 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA----  178 (317)
T ss_pred             CC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCCc----
Confidence            96 5888887665667899999999999999999999   999999999999999999999999999988754321    


Q ss_pred             ccccccccccccCccCcC---CCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccC
Q 040845          685 TQTQTLATIGYMAPEYGR---EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLS  761 (824)
Q Consensus       685 ~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  761 (824)
                        ....++..|+|||++.   .+.++.++|||||||++|||++|+.||..... ......+.....+             
T Consensus       179 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-~~~~~~~~~~~~~-------------  242 (317)
T cd06635         179 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-MSALYHIAQNESP-------------  242 (317)
T ss_pred             --ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH-HHHHHHHHhccCC-------------
Confidence              2235788999999873   45689999999999999999999999865311 1111111111000             


Q ss_pred             chhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 040845          762 QEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLK  804 (824)
Q Consensus       762 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~  804 (824)
                           ......++..+.+++.+||+.+|.+||++.+++++...
T Consensus       243 -----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~  280 (317)
T cd06635         243 -----TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV  280 (317)
T ss_pred             -----CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence                 00112345668999999999999999999999987654

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-34  Score=279.04  Aligned_cols=269  Identities=21%  Similarity=0.315  Sum_probs=210.1

Q ss_pred             cHHHHHHhhccCCCCceeeeccceEEEEEE-ECCCcEEEEEEeeccccchhhhHHHHHHHHhcC-CCCcceeEEeeeecC
Q 040845          518 SYLELFQATDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSI-RHRNLVKVISSCSNE  595 (824)
Q Consensus       518 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  595 (824)
                      .|++..+.++     ++||+|+|+.|--+. ..+|.+||||++.+.......++.+|++++..- .|+||++++++|+++
T Consensus        74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd  148 (463)
T KOG0607|consen   74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD  148 (463)
T ss_pred             hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence            3677777665     689999999999885 778999999999888777888999999999988 499999999999999


Q ss_pred             CeeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCC---CcEEEeecc
Q 040845          596 EFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDN---MVAHLSDFG  672 (824)
Q Consensus       596 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~---~~~kl~Dfg  672 (824)
                      +.+|+|||-|.||+|..+++... .+++.++.++.++|+.||.+||   .+||.|||+||+|||-...   ..+||+||.
T Consensus       149 ~~FYLVfEKm~GGplLshI~~~~-~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCDfD  224 (463)
T KOG0607|consen  149 TRFYLVFEKMRGGPLLSHIQKRK-HFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICDFD  224 (463)
T ss_pred             ceEEEEEecccCchHHHHHHHhh-hccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeeccc
Confidence            99999999999999999998776 6899999999999999999999   9999999999999998644   358999999


Q ss_pred             cccccCCCC-----CccccccccccccccCccCcC-----CCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhh
Q 040845          673 IAKLLTGED-----QSMTQTQTLATIGYMAPEYGR-----EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHW  742 (824)
Q Consensus       673 ~a~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~  742 (824)
                      ++.-..-..     ........+|+..|||||+..     ...|+.++|.||+|||+|-|++|.+||.+.-..+   .-|
T Consensus       225 LgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~d---CGW  301 (463)
T KOG0607|consen  225 LGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGAD---CGW  301 (463)
T ss_pred             cccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCc---CCc
Confidence            876443211     122233456888999999642     3358899999999999999999999998754321   223


Q ss_pred             hhhhCCCc----chhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          743 VNDCLPIS----TMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       743 ~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      .+...-..    ..+.+......-+   ...+...+.+..+++...+..|+.+|.++.+++.+
T Consensus       302 drGe~Cr~CQ~~LFesIQEGkYeFP---dkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh  361 (463)
T KOG0607|consen  302 DRGEVCRVCQNKLFESIQEGKYEFP---DKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH  361 (463)
T ss_pred             cCCCccHHHHHHHHHHHhccCCcCC---hhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence            22211111    1111111111111   11234678889999999999999999999999873

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=8.9e-34  Score=297.44  Aligned_cols=242  Identities=22%  Similarity=0.295  Sum_probs=187.7

Q ss_pred             eeeeccceEEEEEEEC-CCcEEEEEEeecccc---chhhhHHHHHHHHh---cCCCCcceeEEeeeecCCeeEEEEeccC
Q 040845          534 LIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG---RAFKSFDVECAMMK---SIRHRNLVKVISSCSNEEFKALVLEYMP  606 (824)
Q Consensus       534 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~---~l~h~niv~l~~~~~~~~~~~lv~e~~~  606 (824)
                      +||+|+||.||+|... +++.||+|.+.....   .....+.+|..+++   ..+|++|+.+++++..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999864 589999998864321   11223344444333   3479999999999999999999999999


Q ss_pred             CCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcccc
Q 040845          607 HGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQ  686 (824)
Q Consensus       607 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  686 (824)
                      +++|.+++.... .+++..+..++.|++.|++|||   +.+|+||||||+||++++++.++++|||++.......    .
T Consensus        81 ~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~----~  152 (279)
T cd05633          81 GGDLHYHLSQHG-VFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----P  152 (279)
T ss_pred             CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC----c
Confidence            999999987655 6899999999999999999999   9999999999999999999999999999987543221    1


Q ss_pred             ccccccccccCccCcCC-CCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhh
Q 040845          687 TQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDI  765 (824)
Q Consensus       687 ~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  765 (824)
                      ....++..|+|||.... ..++.++||||+||++|||++|..||.........   .......            .   .
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~---~~~~~~~------------~---~  214 (279)
T cd05633         153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---EIDRMTL------------T---V  214 (279)
T ss_pred             cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH---HHHHHhh------------c---C
Confidence            23458999999998864 45789999999999999999999999753322111   0100000            0   0


Q ss_pred             hhhhHHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 040845          766 HFVAKEQCVSFVFNLALECTVESPEQRI-----NAKEIVAK  801 (824)
Q Consensus       766 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~evl~~  801 (824)
                      ....+..++..+.+++.+||..||++||     +++|++++
T Consensus       215 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         215 NVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             CcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            0011233566789999999999999999     69999886

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.3e-33  Score=303.57  Aligned_cols=267  Identities=22%  Similarity=0.331  Sum_probs=196.2

Q ss_pred             ceeeec--cceEEEEEEEC-CCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEeccCC
Q 040845          533 NLIGRG--GFGSVYKARIR-DGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPH  607 (824)
Q Consensus       533 ~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  607 (824)
                      ..||+|  +||+||+|++. +|+.||+|++....  ....+.+.+|+.+++.++||||+++++++...+..++|+||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            356666  99999999864 69999999986542  22346788899999999999999999999999999999999999


Q ss_pred             CCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc--
Q 040845          608 GSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM--  684 (824)
Q Consensus       608 g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~--  684 (824)
                      +++.+++.... ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.++++||+.+..........  
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (328)
T cd08226          84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV  160 (328)
T ss_pred             CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence            99999987643 35888999999999999999999   9999999999999999999999999998654432211110  


Q ss_pred             ---ccccccccccccCccCcCCC--CCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhC--------CCcc
Q 040845          685 ---TQTQTLATIGYMAPEYGREG--QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCL--------PIST  751 (824)
Q Consensus       685 ---~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~--------~~~~  751 (824)
                         ......++..|+|||++.+.  .++.++||||+||++|||++|+.||..................        +...
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (328)
T cd08226         161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE  240 (328)
T ss_pred             cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence               01112345679999998764  4789999999999999999999999764332211111000000        0000


Q ss_pred             hhh-----------cccc-------ccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 040845          752 MEV-----------VDAN-------LLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL  802 (824)
Q Consensus       752 ~~~-----------~~~~-------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L  802 (824)
                      ...           .+..       .......+...+..++..+.+++.+||..||++|||+.|++++-
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~  309 (328)
T cd08226         241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHA  309 (328)
T ss_pred             hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCH
Confidence            000           0000       00001112223345778899999999999999999999998653

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=6.8e-34  Score=306.92  Aligned_cols=273  Identities=22%  Similarity=0.284  Sum_probs=200.5

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc-cchhhhHHHHHHHHhcCCCCcceeEEeeeecC-----Cee
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLVKVISSCSNE-----EFK  598 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~  598 (824)
                      .++|++.+.||+|+||.||+|... +|+.||+|++.... ......+.+|+.++++++|+||+++++++...     ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            468999999999999999999864 58999999986432 23456678899999999999999999987543     357


Q ss_pred             EEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccC
Q 040845          599 ALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT  678 (824)
Q Consensus       599 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~  678 (824)
                      ++|+||++ +++.+++...  .+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||++....
T Consensus        84 ~lv~e~~~-~~l~~~~~~~--~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~  157 (336)
T cd07849          84 YIVQELME-TDLYKLIKTQ--HLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD  157 (336)
T ss_pred             EEEehhcc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence            99999996 4888887543  5889999999999999999999   9999999999999999999999999999998654


Q ss_pred             CCCCc-cccccccccccccCccCcCC-CCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhh--
Q 040845          679 GEDQS-MTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEV--  754 (824)
Q Consensus       679 ~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--  754 (824)
                      ..... .......++..|+|||.+.+ ..++.++||||+||++|||++|+.||......  ...............+.  
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~  235 (336)
T cd07849         158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL--HQLNLILGVLGTPSQEDLN  235 (336)
T ss_pred             ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHcCCCCHHHHH
Confidence            32211 12233467899999998654 46899999999999999999999998652211  11111111111100000  


Q ss_pred             --ccccc-------cCchhhhh-hhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHHHH
Q 040845          755 --VDANL-------LSQEDIHF-VAKEQCVSFVFNLALECTVESPEQRINAKEIVAK--LLKIR  806 (824)
Q Consensus       755 --~~~~~-------~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~--L~~~~  806 (824)
                        .+...       ........ ......+..+.+++.+||+.+|++|||+.|++++  ++...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~  299 (336)
T cd07849         236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH  299 (336)
T ss_pred             HhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence              00000       00000000 0112346678999999999999999999999998  55443

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=4.5e-34  Score=296.41  Aligned_cols=249  Identities=23%  Similarity=0.333  Sum_probs=200.4

Q ss_pred             cCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEec
Q 040845          528 KFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       528 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      +|++.+.||+|+||.||+|..+ +|..||+|.+....  ....+.+.+|+++++.++|+||+++++.+.+....++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4778899999999999999875 48899999986542  23345778899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC-cEEEeecccccccCCCCC
Q 040845          605 MPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM-VAHLSDFGIAKLLTGEDQ  682 (824)
Q Consensus       605 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~Dfg~a~~~~~~~~  682 (824)
                      +++++|.+++.+.. ..+++..+..++.|+++|++|||   +.+++|+||+|+||++++++ .++++|||.+........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME  157 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence            99999999987643 35789999999999999999999   99999999999999999876 469999999986643221


Q ss_pred             ccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCc
Q 040845          683 SMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ  762 (824)
Q Consensus       683 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  762 (824)
                        ......|+..|+|||+..+..++.++|+||||+++||+++|+.||.....     ..++.........          
T Consensus       158 --~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~----------  220 (257)
T cd08225         158 --LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL-----HQLVLKICQGYFA----------  220 (257)
T ss_pred             --cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-----HHHHHHHhcccCC----------
Confidence              12234588899999999888899999999999999999999999865221     1111111110000          


Q ss_pred             hhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          763 EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       763 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                           ......+..+.+++.+||..+|++|||+.|++++
T Consensus       221 -----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         221 -----PISPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             -----CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence                 0011234568999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.1e-33  Score=298.92  Aligned_cols=258  Identities=20%  Similarity=0.272  Sum_probs=186.4

Q ss_pred             ccCCCCceeeeccceEEEEEEECC----CcEEEEEEeeccccchh-----------hhHHHHHHHHhcCCCCcceeEEee
Q 040845          527 DKFSENNLIGRGGFGSVYKARIRD----GMEVAVKVFNLQCGRAF-----------KSFDVECAMMKSIRHRNLVKVISS  591 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~l~~~  591 (824)
                      .+|.+.+.||+|+||.||+|.+.+    +..+|+|+.........           .....+...+..+.|+++++++++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            679999999999999999998654    34667776433221110           111223345566789999999997


Q ss_pred             eecCC----eeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEE
Q 040845          592 CSNEE----FKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH  667 (824)
Q Consensus       592 ~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  667 (824)
                      +....    ..++++|++. .++.+.+.... ..++..+..++.|++.|++|||   +.+|+||||||+||+++.++.++
T Consensus        92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~~~~  166 (294)
T PHA02882         92 GSFKRCRMYYRFILLEKLV-ENTKEIFKRIK-CKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGY  166 (294)
T ss_pred             eeEecCCceEEEEEEehhc-cCHHHHHHhhc-cCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCcEE
Confidence            65443    4468888874 46776665433 4578888999999999999999   99999999999999999999999


Q ss_pred             EeecccccccCCCCCc-----cccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhh
Q 040845          668 LSDFGIAKLLTGEDQS-----MTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHW  742 (824)
Q Consensus       668 l~Dfg~a~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~  742 (824)
                      |+|||+|+.+......     .......||+.|+|||++.+..++.++||||+||++|||++|+.||........ ....
T Consensus       167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~-~~~~  245 (294)
T PHA02882        167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN-LIHA  245 (294)
T ss_pred             EEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH-HHHH
Confidence            9999999876432211     111234589999999999999999999999999999999999999976422111 1110


Q ss_pred             hhhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 040845          743 VNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL  802 (824)
Q Consensus       743 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L  802 (824)
                      ...       +.......     .......++..+.+++..||+.+|++||+++++++.+
T Consensus       246 ~~~-------~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        246 AKC-------DFIKRLHE-----GKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             hHH-------HHHHHhhh-----hhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            000       00000000     0001124567799999999999999999999999875

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.3e-33  Score=300.47  Aligned_cols=271  Identities=26%  Similarity=0.308  Sum_probs=201.6

Q ss_pred             HhhccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc--chhhhHHHHHHHHhcCCCCcceeEEeeeecCC----
Q 040845          524 QATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG--RAFKSFDVECAMMKSIRHRNLVKVISSCSNEE----  596 (824)
Q Consensus       524 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  596 (824)
                      ...++|++.+.||+|+||.||+|..+ +|+.||+|.++....  .....+.+|++++++++||||+++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            45678999999999999999999876 489999999875432  23356778999999999999999999987654    


Q ss_pred             ------eeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEee
Q 040845          597 ------FKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSD  670 (824)
Q Consensus       597 ------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D  670 (824)
                            ..++|+||+++ ++.+.+......+++..+..++.|++.|++|||   +.+|+|+||||+||++++++.+||+|
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl~d  159 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLAD  159 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEeCc
Confidence                  78999999975 787877765557899999999999999999999   99999999999999999999999999


Q ss_pred             cccccccCCCCCccccccccccccccCccCcCC-CCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCC
Q 040845          671 FGIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPI  749 (824)
Q Consensus       671 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  749 (824)
                      ||.+........ .......++..|+|||.+.+ ..++.++||||+||++|||++|++||..... ...+..........
T Consensus       160 fg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~-~~~~~~~~~~~~~~  237 (302)
T cd07864         160 FGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE-LAQLELISRLCGSP  237 (302)
T ss_pred             ccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCC
Confidence            999987643332 12223346778999998764 3578999999999999999999999875321 11111111110000


Q ss_pred             ---cchhhc--------cccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          750 ---STMEVV--------DANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       750 ---~~~~~~--------~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                         ...++.        +....... ........++..+.+++.+||+.||++||++.+++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         238 CPAVWPDVIKLPYFNTMKPKKQYRR-RLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             Chhhccccccccccccccccccccc-chhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence               000000        00000000 0001111346779999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=2e-33  Score=296.05  Aligned_cols=266  Identities=24%  Similarity=0.278  Sum_probs=202.8

Q ss_pred             CCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccc--hhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEecc
Q 040845          529 FSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGR--AFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYM  605 (824)
Q Consensus       529 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  605 (824)
                      |++.+.||+|++|.||+|... +++.+|+|.+......  ....+..|++++++++|+||+++++++......++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            567789999999999999865 5899999998654322  3567888999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccc
Q 040845          606 PHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMT  685 (824)
Q Consensus       606 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  685 (824)
                      ++ ++.+++......+++.++..++.|++.|++|||   +.+|+|+||+|+||+++.++.++|+|||.+.......  ..
T Consensus        81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~  154 (283)
T cd05118          81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RP  154 (283)
T ss_pred             CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--cc
Confidence            65 898888776567899999999999999999999   9999999999999999999999999999998764432  12


Q ss_pred             cccccccccccCccCcCCC-CCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCC---Ccchhhcc---cc
Q 040845          686 QTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLP---ISTMEVVD---AN  758 (824)
Q Consensus       686 ~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~---~~  758 (824)
                      .....++..|+|||.+.+. .++.++|+||+|+++|+|+||+.||......+ ...........   .......+   ..
T Consensus       155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd05118         155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID-QLFKIFRTLGTPDPEVWPKFTSLARNY  233 (283)
T ss_pred             ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHcCCCchHhcccchhhhhhh
Confidence            2334578899999988776 78999999999999999999999986532111 01110000000   00000000   00


Q ss_pred             ---ccC-chhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          759 ---LLS-QEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       759 ---~~~-~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                         ... .........+.++..+.+++.+||..||.+||++.+++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence               000 0000011233567889999999999999999999999864

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.6e-34  Score=321.44  Aligned_cols=272  Identities=18%  Similarity=0.191  Sum_probs=191.6

Q ss_pred             hhccCCCCceeeeccceEEEEEEECC--CcEEEEEEe--------------ec---cccchhhhHHHHHHHHhcCCCCcc
Q 040845          525 ATDKFSENNLIGRGGFGSVYKARIRD--GMEVAVKVF--------------NL---QCGRAFKSFDVECAMMKSIRHRNL  585 (824)
Q Consensus       525 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~--------------~~---~~~~~~~~~~~E~~~l~~l~h~ni  585 (824)
                      ..++|++.+.||+|+||+||+|.++.  +..+++|.+              ..   ........+.+|+.++++++||||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            35789999999999999999987542  222222211              00   112234567889999999999999


Q ss_pred             eeEEeeeecCCeeEEEEeccCCCCHHHHhhhCC----CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC
Q 040845          586 VKVISSCSNEEFKALVLEYMPHGSLEKYLHSSN----YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD  661 (824)
Q Consensus       586 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~  661 (824)
                      +++++++...+..|+|+|++. +++.+++....    ......++..++.|++.||+|||   +.+|+||||||+|||++
T Consensus       226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl~  301 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLN  301 (501)
T ss_pred             CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEC
Confidence            999999999999999999994 57877775432    12345667889999999999999   99999999999999999


Q ss_pred             CCCcEEEeecccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccC--cchh
Q 040845          662 DNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNG--EMTL  739 (824)
Q Consensus       662 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~--~~~~  739 (824)
                      .++.+||+|||++..+..... .......||..|+|||++.+..++.++|||||||++|||++|+.++.....+  ...+
T Consensus       302 ~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~  380 (501)
T PHA03210        302 CDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL  380 (501)
T ss_pred             CCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence            999999999999987643222 1223356899999999999989999999999999999999988654321111  1111


Q ss_pred             hhhhhhh------CCCcc---hhhccccccC---chhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          740 KHWVNDC------LPIST---MEVVDANLLS---QEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       740 ~~~~~~~------~~~~~---~~~~~~~~~~---~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      .+.+...      .+...   .+.++.....   ............+..+.+++.+|++.||.+|||+.|++++
T Consensus       381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            1111110      11100   0111100000   0001111112345567889999999999999999999875

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-33  Score=293.67  Aligned_cols=251  Identities=22%  Similarity=0.316  Sum_probs=198.9

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc-----cchhhhHHHHHHHHhcCCCCcceeEEeeeecC--Cee
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC-----GRAFKSFDVECAMMKSIRHRNLVKVISSCSNE--EFK  598 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  598 (824)
                      .+|++.+.||+|+||.||+|+.. ++..||+|.+....     ......+.+|++++++++|+||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            57889999999999999999864 58999999875321     23346788899999999999999999998654  467


Q ss_pred             EEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccC
Q 040845          599 ALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT  678 (824)
Q Consensus       599 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~  678 (824)
                      ++|+||+++++|.+++.... .+++..+..++.|++.|++|||   +.+++|+||||+||+++.++.++|+|||.+....
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  157 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ  157 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence            89999999999999987654 5788999999999999999999   9999999999999999999999999999998653


Q ss_pred             CCCC-ccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccc
Q 040845          679 GEDQ-SMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDA  757 (824)
Q Consensus       679 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  757 (824)
                      .... ........++..|+|||.+.+..++.++|+|||||++||+++|+.||........ ..+..    .         
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~----~---------  223 (264)
T cd06653         158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA-IFKIA----T---------  223 (264)
T ss_pred             cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH-HHHHH----c---------
Confidence            2111 1112234588899999999888899999999999999999999999875321110 11100    0         


Q ss_pred             cccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          758 NLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       758 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                           .......+...+..+.+++.+||+ +|.+||++.+++.|
T Consensus       224 -----~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~  261 (264)
T cd06653         224 -----QPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH  261 (264)
T ss_pred             -----CCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence                 000011223456678999999999 57999999998765

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.5e-33  Score=301.70  Aligned_cols=267  Identities=21%  Similarity=0.267  Sum_probs=195.9

Q ss_pred             CCceeeeccceEEEEEEECCCcEEEEEEeecc--ccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEeccCCC
Q 040845          531 ENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQ--CGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHG  608 (824)
Q Consensus       531 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  608 (824)
                      +.+.+|.|+++.||++.. +++.||||++...  .....+.+..|+++++.++|+||+++++++.+.+..+++|||+++|
T Consensus         6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~   84 (314)
T cd08216           6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG   84 (314)
T ss_pred             hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence            334445555555555544 5899999998754  2345577899999999999999999999999999999999999999


Q ss_pred             CHHHHhhhC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc----
Q 040845          609 SLEKYLHSS-NYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS----  683 (824)
Q Consensus       609 ~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~----  683 (824)
                      +|.+++... ...+++..+..++.|+++|++|||   +.+|+||||||+||+++.++.+|++|||.+.........    
T Consensus        85 ~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~  161 (314)
T cd08216          85 SCEDLLKTHFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV  161 (314)
T ss_pred             CHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence            999999764 346888999999999999999999   999999999999999999999999999988765432221    


Q ss_pred             -cccccccccccccCccCcCCC--CCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCC----cch----
Q 040845          684 -MTQTQTLATIGYMAPEYGREG--QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPI----STM----  752 (824)
Q Consensus       684 -~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----~~~----  752 (824)
                       .......++..|+|||++...  .++.++|||||||++|||++|+.||............ .....+.    ...    
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  240 (314)
T cd08216         162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEK-VRGTVPCLLDKSTYPLYE  240 (314)
T ss_pred             ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HhccCccccccCchhhhc
Confidence             111233467789999988653  5789999999999999999999999764322211111 1110000    000    


Q ss_pred             -hhcc-----ccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 040845          753 -EVVD-----ANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL  802 (824)
Q Consensus       753 -~~~~-----~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L  802 (824)
                       ....     ....................+.+++.+||..||++|||++|++++-
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p  296 (314)
T cd08216         241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHS  296 (314)
T ss_pred             CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCc
Confidence             0000     0000011111222334567899999999999999999999998864

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=6e-34  Score=307.06  Aligned_cols=270  Identities=23%  Similarity=0.298  Sum_probs=200.9

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeec----CCee
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSN----EEFK  598 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~  598 (824)
                      .++|++.+.||+|+||.||+|..+ +|+.||+|++....  ......+..|+.++++++||||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            478999999999999999999865 58999999986542  2334567789999999999999999998753    3567


Q ss_pred             EEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccC
Q 040845          599 ALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT  678 (824)
Q Consensus       599 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~  678 (824)
                      ++||||++ ++|.+++.... .+++..+..++.|++.|++|||   +.+|+||||||+||++++++.+||+|||++....
T Consensus        84 ~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~  158 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSDQ-PLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLS  158 (334)
T ss_pred             EEEEehhh-hhHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence            99999995 68999987654 5899999999999999999999   9999999999999999999999999999997654


Q ss_pred             CCCCc--cccccccccccccCccCcCC-CCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhc
Q 040845          679 GEDQS--MTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVV  755 (824)
Q Consensus       679 ~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  755 (824)
                      .....  .......++..|+|||.+.+ ..++.++||||+||++|||++|+.||.......  ....+.........+..
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~--~~~~~~~~~g~~~~~~~  236 (334)
T cd07855         159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH--QLKLILSVLGSPSEEVL  236 (334)
T ss_pred             ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHH--HHHHHHHHhCCChhHhh
Confidence            32221  11223468889999998765 458999999999999999999999996532111  11111111110000000


Q ss_pred             cc-----------cccCchhhh-hhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 040845          756 DA-----------NLLSQEDIH-FVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL  802 (824)
Q Consensus       756 ~~-----------~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L  802 (824)
                      +.           ......... .......+..+.+++.+||+.+|++|||+.+++.+-
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~  295 (334)
T cd07855         237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP  295 (334)
T ss_pred             hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence            00           000000000 001123467799999999999999999999998863

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-33  Score=292.44  Aligned_cols=248  Identities=29%  Similarity=0.411  Sum_probs=203.7

Q ss_pred             cCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc--chhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEec
Q 040845          528 KFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG--RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       528 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      +|++.+.||+|++|.||+|+.. +++.||+|.+.....  ...+.+.+|++++++++|+|++++++++.+....++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4788899999999999999865 578999999876543  3557789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 040845          605 MPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM  684 (824)
Q Consensus       605 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  684 (824)
                      +++++|.+++.... .+++..+..++.|++.|++|||   +.+++||||+|+||+++.++.++|+|||.+......... 
T Consensus        81 ~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-  155 (254)
T cd06627          81 AENGSLRQIIKKFG-PFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-  155 (254)
T ss_pred             CCCCcHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-
Confidence            99999999997764 7899999999999999999999   999999999999999999999999999999876543321 


Q ss_pred             ccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchh
Q 040845          685 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQED  764 (824)
Q Consensus       685 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  764 (824)
                       .....++..|+|||...+..++.++||||+|+++|+|++|+.||.....    ..........                
T Consensus       156 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~----~~~~~~~~~~----------------  214 (254)
T cd06627         156 -DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP----MAALFRIVQD----------------  214 (254)
T ss_pred             -ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH----HHHHHHHhcc----------------
Confidence             2334578899999998887889999999999999999999999865321    1111110000                


Q ss_pred             hhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          765 IHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       765 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      .....+..++..+.+++.+||..+|++|||+.|++.+
T Consensus       215 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  251 (254)
T cd06627         215 DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH  251 (254)
T ss_pred             CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence            0001112345678899999999999999999999853

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.6e-33  Score=295.59  Aligned_cols=244  Identities=23%  Similarity=0.313  Sum_probs=193.0

Q ss_pred             eeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEeccCCCCH
Q 040845          535 IGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSL  610 (824)
Q Consensus       535 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  610 (824)
                      ||+|+||+||+|..+ +|+.||+|.+....   ......+..|+++++.++||||+++++++...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999754 58999999986432   22344567899999999999999999999999999999999999999


Q ss_pred             HHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccccccc
Q 040845          611 EKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT  689 (824)
Q Consensus       611 ~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  689 (824)
                      .+++.... ..+++.++..++.|++.|+.|||   +.+++||||+|+||++++++.++|+|||.+......   ......
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~~~  154 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIKGR  154 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC---Cccccc
Confidence            99987644 36899999999999999999999   999999999999999999999999999998765321   112234


Q ss_pred             cccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhhhhhh
Q 040845          690 LATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVA  769 (824)
Q Consensus       690 ~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  769 (824)
                      .++..|+|||...+..++.++||||+|+++|+|++|+.||....... ..........             .   .....
T Consensus       155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~-------------~---~~~~~  217 (277)
T cd05577         155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV-EKEELKRRTL-------------E---MAVEY  217 (277)
T ss_pred             cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccc-cHHHHHhccc-------------c---ccccC
Confidence            57889999999988889999999999999999999999986532211 0111100000             0   00011


Q ss_pred             HHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 040845          770 KEQCVSFVFNLALECTVESPEQRI-----NAKEIVAK  801 (824)
Q Consensus       770 ~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~evl~~  801 (824)
                      +..++..+.+++.+||+.||++||     ++.+++++
T Consensus       218 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h  254 (277)
T cd05577         218 PDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH  254 (277)
T ss_pred             CccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence            123466789999999999999999     66666653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.5e-33  Score=293.36  Aligned_cols=242  Identities=26%  Similarity=0.341  Sum_probs=195.5

Q ss_pred             eeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEeccCCCCH
Q 040845          535 IGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSL  610 (824)
Q Consensus       535 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  610 (824)
                      ||.|++|.||+|+.. +++.||+|++....   ....+.+..|+.+++.++||||+++++++.++...++|+||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999875 48999999986542   23446788999999999999999999999999999999999999999


Q ss_pred             HHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcccccccc
Q 040845          611 EKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTL  690 (824)
Q Consensus       611 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  690 (824)
                      .+++.... .+++..+..++.|++.|++|||   +.+++|+||+|+||+++.++.++|+|||.+.......   ......
T Consensus        81 ~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~  153 (262)
T cd05572          81 WTILRDRG-LFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFC  153 (262)
T ss_pred             HHHHhhcC-CCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccccc
Confidence            99997654 5889999999999999999999   9999999999999999999999999999998764332   122345


Q ss_pred             ccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhhhhhhH
Q 040845          691 ATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAK  770 (824)
Q Consensus       691 ~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  770 (824)
                      ++..|+|||.+.+..++.++|+||+|+++|||++|..||.......   ........        +      .......+
T Consensus       154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~--------~------~~~~~~~~  216 (262)
T cd05572         154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP---MEIYNDIL--------K------GNGKLEFP  216 (262)
T ss_pred             CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH---HHHHHHHh--------c------cCCCCCCC
Confidence            7889999999888889999999999999999999999997643211   11111100        0      00011112


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 040845          771 EQCVSFVFNLALECTVESPEQRIN-----AKEIVA  800 (824)
Q Consensus       771 ~~~~~~l~~l~~~cl~~dP~~Rpt-----~~evl~  800 (824)
                      ..++..+.+++.+||..+|++||+     ++|+++
T Consensus       217 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         217 NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            223567899999999999999999     666665

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.8e-33  Score=298.25  Aligned_cols=253  Identities=25%  Similarity=0.308  Sum_probs=196.7

Q ss_pred             hccCCCCceeeeccceEEEEEEECC-CcEEEEEEeecccc-chhhhHHHHHHHHhcC-CCCcceeEEeeeecCCeeEEEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCG-RAFKSFDVECAMMKSI-RHRNLVKVISSCSNEEFKALVL  602 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  602 (824)
                      .++|++.+.||+|+||.||+|.+++ ++.||||.++.... .....+..|+.++.+. .|+||+++++++.++...++||
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   93 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM   93 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence            3678889999999999999999865 89999999875422 2334556677766666 4999999999999999999999


Q ss_pred             eccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 040845          603 EYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYS-APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED  681 (824)
Q Consensus       603 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  681 (824)
                      ||++ +++.++.......+++..+..++.|++.|++|||   + .+|+||||+|+||++++++.+||+|||++..+....
T Consensus        94 e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~  169 (296)
T cd06618          94 ELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLK---EKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK  169 (296)
T ss_pred             eccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence            9995 5788887665557899999999999999999999   6 599999999999999999999999999987654322


Q ss_pred             CccccccccccccccCccCcCCCC----CCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccc
Q 040845          682 QSMTQTQTLATIGYMAPEYGREGQ----VSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDA  757 (824)
Q Consensus       682 ~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  757 (824)
                      .   .....++..|+|||.+.+..    ++.++||||||+++|||++|+.||.........+..+.....+.        
T Consensus       170 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--------  238 (296)
T cd06618         170 A---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPS--------  238 (296)
T ss_pred             c---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCC--------
Confidence            1   12234778899999887553    78899999999999999999999865222111111111110000        


Q ss_pred             cccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 040845          758 NLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL  802 (824)
Q Consensus       758 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L  802 (824)
                               ......++.++.+++.+||..||++||++.+++++-
T Consensus       239 ---------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~  274 (296)
T cd06618         239 ---------LPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP  274 (296)
T ss_pred             ---------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence                     000012456789999999999999999999998774

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.3e-33  Score=306.92  Aligned_cols=265  Identities=22%  Similarity=0.239  Sum_probs=198.2

Q ss_pred             HhhccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeecC-----
Q 040845          524 QATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSNE-----  595 (824)
Q Consensus       524 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----  595 (824)
                      ...++|+..+.||+|+||.||+|+.. +++.||+|.+....  ......+.+|+.++++++|+||+++++++...     
T Consensus        13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   92 (353)
T cd07850          13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE   92 (353)
T ss_pred             hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence            34678999999999999999999864 68999999986432  23345677899999999999999999988543     


Q ss_pred             -CeeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccc
Q 040845          596 -EFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIA  674 (824)
Q Consensus       596 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a  674 (824)
                       ...++||||++ ++|.+.+...   ++..++..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||++
T Consensus        93 ~~~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~  165 (353)
T cd07850          93 FQDVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA  165 (353)
T ss_pred             cCcEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCccc
Confidence             35799999995 5888887643   788899999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCC--Ccch
Q 040845          675 KLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLP--ISTM  752 (824)
Q Consensus       675 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~--~~~~  752 (824)
                      .......   ......++..|+|||.+.+..++.++||||+||++|+|++|+.||...... ............  ....
T Consensus       166 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~  241 (353)
T cd07850         166 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHI-DQWNKIIEQLGTPSDEFM  241 (353)
T ss_pred             eeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHhcCCCCHHHH
Confidence            8653221   122345788999999999889999999999999999999999998643110 001111000000  0000


Q ss_pred             h-----------------------hccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          753 E-----------------------VVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       753 ~-----------------------~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      +                       .........  .....+...+..+.+++.+||+.||++|||+.|++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPP--DSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             HHhhhhhhHHhhcCCCCCCcchhhhCcccccCc--ccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            0                       000000000  0000011345678999999999999999999999976

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.3e-33  Score=305.06  Aligned_cols=269  Identities=26%  Similarity=0.325  Sum_probs=200.0

Q ss_pred             hhccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecc--ccchhhhHHHHHHHHhcC-CCCcceeEEeeeecC--Cee
Q 040845          525 ATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQ--CGRAFKSFDVECAMMKSI-RHRNLVKVISSCSNE--EFK  598 (824)
Q Consensus       525 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~~  598 (824)
                      ..++|++.+.||+|+||.||+|... +++.||+|++...  .......+.+|+.+++++ +|+||+++++++...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            4567889999999999999999865 5889999987532  123345577899999999 999999999998643  468


Q ss_pred             EEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccC
Q 040845          599 ALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT  678 (824)
Q Consensus       599 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~  678 (824)
                      ++||||++ ++|.+++...  .+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||.+....
T Consensus        85 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~  158 (337)
T cd07852          85 YLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLS  158 (337)
T ss_pred             EEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence            99999996 5999988764  6788899999999999999999   9999999999999999999999999999998765


Q ss_pred             CCCCc---cccccccccccccCccCcCC-CCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCc----
Q 040845          679 GEDQS---MTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPIS----  750 (824)
Q Consensus       679 ~~~~~---~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~----  750 (824)
                      .....   .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+. ............    
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~  237 (337)
T cd07852         159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ-LEKIIEVIGPPSAEDI  237 (337)
T ss_pred             cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHH
Confidence            43322   22234568899999998754 4578999999999999999999999865322111 111111000000    


Q ss_pred             -------chhhccccccCc-hhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          751 -------TMEVVDANLLSQ-EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       751 -------~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                             .....+...... ..... ....++.++.+++.+||+.||++|||+.+++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         238 ESIKSPFAATMLDSLPSRPRKPLDE-LLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHhhhHHHhhhhcccccccchhh-hccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence                   000000000000 00000 111256789999999999999999999999986

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=8.7e-34  Score=299.52  Aligned_cols=253  Identities=26%  Similarity=0.310  Sum_probs=193.3

Q ss_pred             cCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc-cchhhhHHHHHHHHhcCC-CCcceeEEeeeecCCeeEEEEec
Q 040845          528 KFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC-GRAFKSFDVECAMMKSIR-HRNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       528 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      +|+..+.||+|+||.||++... +++.||+|.+.... ......+..|+.++.++. |+||+++++++..+...+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            4556678999999999999865 58999999986543 234556788999999996 99999999999999999999999


Q ss_pred             cCCCCHHHHh---hh-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 040845          605 MPHGSLEKYL---HS-SNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE  680 (824)
Q Consensus       605 ~~~g~L~~~l---~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  680 (824)
                      ++. ++.++.   .. ....+++..+..++.|++.|++|||+  +.+++||||||+||+++.++.++|+|||++......
T Consensus        85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  161 (288)
T cd06616          85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS  161 (288)
T ss_pred             ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence            854 655543   22 22468999999999999999999992  359999999999999999999999999999765432


Q ss_pred             CCccccccccccccccCccCcCCC---CCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccc
Q 040845          681 DQSMTQTQTLATIGYMAPEYGREG---QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDA  757 (824)
Q Consensus       681 ~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  757 (824)
                      ..   .....++..|+|||.+.+.   .++.++||||+||++|||++|+.||.....   .... ........     .+
T Consensus       162 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~-~~~~~~~~-----~~  229 (288)
T cd06616         162 IA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS---VFDQ-LTQVVKGD-----PP  229 (288)
T ss_pred             Cc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch---HHHH-HhhhcCCC-----CC
Confidence            21   1223578899999998766   689999999999999999999999865321   0010 11000000     00


Q ss_pred             cccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          758 NLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       758 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      ..      ....+..++..+.+++.+||+.+|++|||+.|++++
T Consensus       230 ~~------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         230 IL------SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             cC------CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00      000112356779999999999999999999999886

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=2.3e-33  Score=297.27  Aligned_cols=267  Identities=25%  Similarity=0.311  Sum_probs=196.6

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc--chhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEe
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG--RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLE  603 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  603 (824)
                      ++|++.+.||+|++|+||+|..+ +|+.||+|.+.....  ...+.+..|++++++++|+||+++++++.+....++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            57889999999999999999875 589999998864422  234567889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC-CCcEEEeecccccccCCCC
Q 040845          604 YMPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD-NMVAHLSDFGIAKLLTGED  681 (824)
Q Consensus       604 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~Dfg~a~~~~~~~  681 (824)
                      |++ +++.+++.... ...++..+..++.|++.|++|||   +.+++|+||+|+||+++. ++.+||+|||++.......
T Consensus        82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~  157 (294)
T PLN00009         82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV  157 (294)
T ss_pred             ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence            996 58888775433 34678888999999999999999   999999999999999985 5679999999997543221


Q ss_pred             CccccccccccccccCccCcCCC-CCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhc-----
Q 040845          682 QSMTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVV-----  755 (824)
Q Consensus       682 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  755 (824)
                        .......++..|+|||.+.+. .++.++||||+|+++|+|+||+.||......+.... ... ..........     
T Consensus       158 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~  233 (294)
T PLN00009        158 --RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFK-IFR-ILGTPNEETWPGVTS  233 (294)
T ss_pred             --cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHH-HhCCCChhhcccccc
Confidence              112234578899999987654 578999999999999999999999865322111111 000 0000000000     


Q ss_pred             --ccc--ccC-chhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          756 --DAN--LLS-QEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       756 --~~~--~~~-~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                        +..  ... ............+..+.+++.+|++.+|++||++.+++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~  284 (294)
T PLN00009        234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH  284 (294)
T ss_pred             chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              000  000 0000000112345678999999999999999999999874

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1e-33  Score=305.55  Aligned_cols=276  Identities=24%  Similarity=0.282  Sum_probs=204.5

Q ss_pred             hhccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecc--ccchhhhHHHHHHHHhcCCCCcceeEEeeeecC-----C
Q 040845          525 ATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQ--CGRAFKSFDVECAMMKSIRHRNLVKVISSCSNE-----E  596 (824)
Q Consensus       525 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~  596 (824)
                      ..++|.+.+.||+|+||+||+|+.. +++.||||.+...  .......+.+|+.+++.++|+||+++++++...     .
T Consensus         3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~   82 (337)
T cd07858           3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN   82 (337)
T ss_pred             cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence            3467999999999999999999854 5899999998643  223345677899999999999999999987543     3


Q ss_pred             eeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccc
Q 040845          597 FKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  676 (824)
Q Consensus       597 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~  676 (824)
                      ..++|+||++ ++|.+++.... .+++..+..++.|++.|+.|||   +.+++||||||+||+++.++.+||+|||++..
T Consensus        83 ~~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~  157 (337)
T cd07858          83 DVYIVYELMD-TDLHQIIRSSQ-TLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLART  157 (337)
T ss_pred             cEEEEEeCCC-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence            5799999995 68999887654 6899999999999999999999   99999999999999999999999999999986


Q ss_pred             cCCCCCccccccccccccccCccCcCC-CCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCC--cch-
Q 040845          677 LTGEDQSMTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPI--STM-  752 (824)
Q Consensus       677 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~-  752 (824)
                      .....  .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||..... ..............  ... 
T Consensus       158 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~  234 (337)
T cd07858         158 TSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY-VHQLKLITELLGSPSEEDLG  234 (337)
T ss_pred             cCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHHHHHhCCCChHHhh
Confidence            54322  12233457889999998764 4689999999999999999999999865311 11111111100000  000 


Q ss_pred             hhccccc--------cCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHHHHHh
Q 040845          753 EVVDANL--------LSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK--LLKIRDS  808 (824)
Q Consensus       753 ~~~~~~~--------~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~--L~~~~~~  808 (824)
                      ...+...        .............++..+.+++.+||+.+|++|||++|++++  ++.+.+.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~  300 (337)
T cd07858         235 FIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP  300 (337)
T ss_pred             hcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCc
Confidence            0000000        000000011123467789999999999999999999999998  7665443

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=3e-33  Score=290.31  Aligned_cols=249  Identities=27%  Similarity=0.378  Sum_probs=204.4

Q ss_pred             cCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc--chhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEec
Q 040845          528 KFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG--RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       528 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      +|++.+.||+|+||.||+|.+. ++..||+|++.....  .....+.+|+++++.++|+|++++++.+...+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4788899999999999999865 589999999875532  4556788899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCC---CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 040845          605 MPHGSLEKYLHSSN---YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED  681 (824)
Q Consensus       605 ~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  681 (824)
                      +++++|.+++....   ..+++.++..++.+++.|++|||   +.+++|+||+|+||++++++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            99999999998752   57899999999999999999999   8999999999999999999999999999998654332


Q ss_pred             CccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccC
Q 040845          682 QSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLS  761 (824)
Q Consensus       682 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  761 (824)
                        .......+++.|+|||...+..++.++|+||+|+++|+|++|+.||......     ..........        .. 
T Consensus       158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-----~~~~~~~~~~--------~~-  221 (258)
T cd08215         158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL-----ELALKILKGQ--------YP-  221 (258)
T ss_pred             --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH-----HHHHHHhcCC--------CC-
Confidence              1222345788999999998888999999999999999999999998653211     1111110000        00 


Q ss_pred             chhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          762 QEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       762 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                            ..+..++..+.+++.+||..+|++|||+.|++++
T Consensus       222 ------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         222 ------PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             ------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                  0011345678999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=2.5e-33  Score=295.87  Aligned_cols=245  Identities=26%  Similarity=0.332  Sum_probs=197.2

Q ss_pred             CceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEeccCCCCH
Q 040845          532 NNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSL  610 (824)
Q Consensus       532 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  610 (824)
                      ...||+|+||.||+|..+ +++.||||++..........+..|+.+++.++|+|++++++++...+..++||||+++++|
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            357999999999999864 6899999998654444566788899999999999999999999999999999999999999


Q ss_pred             HHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcccccccc
Q 040845          611 EKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTL  690 (824)
Q Consensus       611 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  690 (824)
                      .+++...  .+++..+..++.|++.|++|||   +.+++||||+|+||++++++.++++|||.+........  ......
T Consensus       105 ~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~~  177 (292)
T cd06657         105 TDIVTHT--RMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLV  177 (292)
T ss_pred             HHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceecccccc--cccccc
Confidence            9987543  4788999999999999999999   89999999999999999999999999999876533221  123345


Q ss_pred             ccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhhhhhhH
Q 040845          691 ATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAK  770 (824)
Q Consensus       691 ~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  770 (824)
                      ++..|+|||.+.+..++.++|+||+|+++|||++|..||.....  ...........+..        .        ...
T Consensus       178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~--~~~~~~~~~~~~~~--------~--------~~~  239 (292)
T cd06657         178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMKMIRDNLPPK--------L--------KNL  239 (292)
T ss_pred             cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhhCCcc--------c--------CCc
Confidence            78899999999888889999999999999999999999865211  11111111111100        0        001


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          771 EQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       771 ~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      ..++..+.+++.+||..+|.+||++.|++++
T Consensus       240 ~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~  270 (292)
T cd06657         240 HKVSPSLKGFLDRLLVRDPAQRATAAELLKH  270 (292)
T ss_pred             ccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence            1234567899999999999999999999885

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=8.5e-34  Score=295.75  Aligned_cols=245  Identities=28%  Similarity=0.362  Sum_probs=195.4

Q ss_pred             eeeccceEEEEEEECC-CcEEEEEEeecccc---chhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEeccCCCCH
Q 040845          535 IGRGGFGSVYKARIRD-GMEVAVKVFNLQCG---RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSL  610 (824)
Q Consensus       535 lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  610 (824)
                      ||+|+||.||+|...+ |+.||+|++.....   ...+.+.+|++++++++|+||+++++.+......++||||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            6899999999998764 89999999865432   3456788899999999999999999999999999999999999999


Q ss_pred             HHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC------cc
Q 040845          611 EKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ------SM  684 (824)
Q Consensus       611 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~------~~  684 (824)
                      .+++...+ .+++..+..++.|+++||+|||   +.+++|+||+|+||++++++.++|+|||++........      ..
T Consensus        81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  156 (265)
T cd05579          81 ASLLENVG-SLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK  156 (265)
T ss_pred             HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence            99998765 7899999999999999999999   99999999999999999999999999999875432211      11


Q ss_pred             ccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchh
Q 040845          685 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQED  764 (824)
Q Consensus       685 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  764 (824)
                      ......++..|+|||......++.++||||||+++||+++|..||......     ..........              
T Consensus       157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-----~~~~~~~~~~--------------  217 (265)
T cd05579         157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE-----EIFQNILNGK--------------  217 (265)
T ss_pred             cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHhcCC--------------
Confidence            223345788999999998888999999999999999999999998653211     1111000000              


Q ss_pred             hhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 040845          765 IHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL  802 (824)
Q Consensus       765 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L  802 (824)
                      .........+..+.+++.+||+.+|++|||+.++.+.|
T Consensus       218 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l  255 (265)
T cd05579         218 IEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK  255 (265)
T ss_pred             cCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence            00000001256789999999999999999995555444

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.9e-33  Score=291.46  Aligned_cols=247  Identities=26%  Similarity=0.345  Sum_probs=202.0

Q ss_pred             cCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEec
Q 040845          528 KFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       528 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      +|++.+.||+|+||.||+++.. +++.+|+|.+....  ......+.+|+++++.++|+||+++++++.+....++||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4778899999999999999754 58899999987542  23345677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhC---CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 040845          605 MPHGSLEKYLHSS---NYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED  681 (824)
Q Consensus       605 ~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  681 (824)
                      +++++|.+++...   ...+++..++.++.|++.|++|||   +.+++|+||+|.||++++++.+|++|||++...... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            9999999998662   246889999999999999999999   999999999999999999999999999999876433 


Q ss_pred             CccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccC
Q 040845          682 QSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLS  761 (824)
Q Consensus       682 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  761 (824)
                         ......++..|+|||...+..++.++|+||+|+++||+++|+.||......  .....+..            ... 
T Consensus       157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~--~~~~~~~~------------~~~-  218 (256)
T cd08530         157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ--DLRYKVQR------------GKY-  218 (256)
T ss_pred             ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHhc------------CCC-
Confidence               122345788999999998888999999999999999999999998753211  11111100            000 


Q ss_pred             chhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          762 QEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       762 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                           ...+..++.++.+++.+|+..+|++||++.|++++
T Consensus       219 -----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         219 -----PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             -----CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence                 00112456678999999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.6e-34  Score=299.34  Aligned_cols=251  Identities=26%  Similarity=0.337  Sum_probs=207.3

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccc--hhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGR--AFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVL  602 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  602 (824)
                      ...|.+.+.||+|.|+.|..|++. ++..||||.+++..-.  ....+.+|+++|+.++|||||+++.+...+...|+||
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~  134 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM  134 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence            467889999999999999999754 5999999998765432  3355889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 040845          603 EYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ  682 (824)
Q Consensus       603 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  682 (824)
                      ||+.+|.+.+++...+ ...+.++..++.|+.+|++|||   ++.|||||||++||+++.+..+||+|||++..+.... 
T Consensus       135 eya~~ge~~~yl~~~g-r~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~-  209 (596)
T KOG0586|consen  135 EYASGGELFDYLVKHG-RMKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGL-  209 (596)
T ss_pred             EeccCchhHHHHHhcc-cchhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeecccc-
Confidence            9999999999999887 3445888999999999999999   9999999999999999999999999999999885332 


Q ss_pred             ccccccccccccccCccCcCCCCC-CccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccC
Q 040845          683 SMTQTQTLATIGYMAPEYGREGQV-STNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLS  761 (824)
Q Consensus       683 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  761 (824)
                        ......|++.|.|||++.+..| ++++|+||+|+++|-++.|..||++..-.+..                 ++.+..
T Consensus       210 --~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr-----------------~rvl~g  270 (596)
T KOG0586|consen  210 --MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR-----------------PRVLRG  270 (596)
T ss_pred             --cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc-----------------chheee
Confidence              2334569999999999998876 78999999999999999999999873221110                 011111


Q ss_pred             chhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 040845          762 QEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLK  804 (824)
Q Consensus       762 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~  804 (824)
                      .    .-.+.....++.+++++++..+|.+|++.+++.++-..
T Consensus       271 k----~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~  309 (596)
T KOG0586|consen  271 K----YRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWR  309 (596)
T ss_pred             e----ecccceeechhHHHHHHhhccCccccCCHHHhhhhccc
Confidence            1    11112234557889999999999999999999887554

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2.9e-33  Score=298.04  Aligned_cols=249  Identities=27%  Similarity=0.385  Sum_probs=197.9

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecc---ccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEE
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQ---CGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVL  602 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  602 (824)
                      +.|+..+.||+|+||.||+|+.. ++..||+|.+...   ......++.+|+++++.++|+|++++++++......++||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            34666788999999999999865 4788999988643   1233456778999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 040845          603 EYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ  682 (824)
Q Consensus       603 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  682 (824)
                      ||+. |++.+++......+++.++..++.|++.|++|||   +.+++||||+|+||+++.++.++++|||++......  
T Consensus        95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--  168 (308)
T cd06634          95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--  168 (308)
T ss_pred             EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecCc--
Confidence            9996 6888887665557899999999999999999999   999999999999999999999999999998765322  


Q ss_pred             ccccccccccccccCccCcC---CCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccc
Q 040845          683 SMTQTQTLATIGYMAPEYGR---EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANL  759 (824)
Q Consensus       683 ~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  759 (824)
                          ....++..|+|||.+.   .+.++.++|||||||++|||++|+.||...... .....+.....+           
T Consensus       169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~~~~-----------  232 (308)
T cd06634         169 ----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQNESP-----------  232 (308)
T ss_pred             ----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH-HHHHHHhhcCCC-----------
Confidence                2235788999999874   356788999999999999999999998652111 111111111000           


Q ss_pred             cCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 040845          760 LSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLK  804 (824)
Q Consensus       760 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~  804 (824)
                             ......++..+.+++.+||..+|++||++.+++++-.-
T Consensus       233 -------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~  270 (308)
T cd06634         233 -------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV  270 (308)
T ss_pred             -------CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccc
Confidence                   00112345668899999999999999999999987553

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-33  Score=291.01  Aligned_cols=241  Identities=24%  Similarity=0.309  Sum_probs=186.6

Q ss_pred             ceeeeccceEEEEEEEC-CCcEEEEEEeecccc---chhhhHHHHHHH-HhcCCCCcceeEEeeeecCCeeEEEEeccCC
Q 040845          533 NLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG---RAFKSFDVECAM-MKSIRHRNLVKVISSCSNEEFKALVLEYMPH  607 (824)
Q Consensus       533 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  607 (824)
                      +.||+|+||.||+|... +|+.||||++.....   .....+..|..+ ....+|+|++++++++...+..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            56899999999999864 589999999864321   112234445444 4455899999999999999999999999999


Q ss_pred             CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccccc
Q 040845          608 GSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQT  687 (824)
Q Consensus       608 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  687 (824)
                      ++|.+++.... .+++..+..++.|++.||.|||   +.+++||||+|+||++++++.++|+|||++.....      ..
T Consensus        82 ~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~  151 (260)
T cd05611          82 GDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NK  151 (260)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccc------cc
Confidence            99999997654 6889999999999999999999   89999999999999999999999999999875432      12


Q ss_pred             cccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhhhh
Q 040845          688 QTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHF  767 (824)
Q Consensus       688 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  767 (824)
                      ...++..|+|||.+.+..++.++||||+|+++|||++|..||....... ..........             .   ...
T Consensus       152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~-------------~---~~~  214 (260)
T cd05611         152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA-VFDNILSRRI-------------N---WPE  214 (260)
T ss_pred             cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhccc-------------C---CCC
Confidence            3357889999999988888999999999999999999999986532111 0011000000             0   000


Q ss_pred             hhHHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040845          768 VAKEQCVSFVFNLALECTVESPEQRINAKEIVA  800 (824)
Q Consensus       768 ~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~  800 (824)
                      .....++..+.+++.+||+.+|++||++.++.+
T Consensus       215 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~  247 (260)
T cd05611         215 EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQE  247 (260)
T ss_pred             cccccCCHHHHHHHHHHccCCHHHccCCCcHHH
Confidence            011235677899999999999999997754433

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=4.4e-33  Score=298.85  Aligned_cols=267  Identities=25%  Similarity=0.307  Sum_probs=199.1

Q ss_pred             HHhhccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeec-CCee
Q 040845          523 FQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSN-EEFK  598 (824)
Q Consensus       523 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~  598 (824)
                      ...+++|++.+.||+|+||.||+|... +++.||||.+....  ....+.+..|+++++.++||||+++++++.. ....
T Consensus         6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   85 (328)
T cd07856           6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI   85 (328)
T ss_pred             eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence            456789999999999999999999755 68999999875432  2334677889999999999999999999865 5678


Q ss_pred             EEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccC
Q 040845          599 ALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT  678 (824)
Q Consensus       599 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~  678 (824)
                      ++|+||+ +++|.+++...  .+++..+..++.|+++|++|||   +.+|+||||+|+||++++++.++|+|||.+....
T Consensus        86 ~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~  159 (328)
T cd07856          86 YFVTELL-GTDLHRLLTSR--PLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQD  159 (328)
T ss_pred             EEEeehh-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCccccccccC
Confidence            8999999 56898888643  4778888899999999999999   9999999999999999999999999999987542


Q ss_pred             CCCCccccccccccccccCccCcCC-CCCCccchHHHHHHHHHHHHhCCCCCcccccCcchh-----------hhhhhhh
Q 040845          679 GEDQSMTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTL-----------KHWVNDC  746 (824)
Q Consensus       679 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~-----------~~~~~~~  746 (824)
                      ..     .....++..|+|||.+.+ ..++.++||||+|+++|||++|+.||...... ...           .+|....
T Consensus       160 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~~~  233 (328)
T cd07856         160 PQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHV-NQFSIITDLLGTPPDDVINTI  233 (328)
T ss_pred             CC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHHHhc
Confidence            21     122356788999998765 56899999999999999999999998653211 011           1111111


Q ss_pred             CCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          747 LPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       747 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      ......+...................++..+.+++.+||+.+|++|||+.+++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            1000001100000000000000011346789999999999999999999999876

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=5.1e-33  Score=291.66  Aligned_cols=242  Identities=23%  Similarity=0.306  Sum_probs=187.4

Q ss_pred             eeeeccceEEEEEEEC-CCcEEEEEEeecccc---chhhhHHHHH---HHHhcCCCCcceeEEeeeecCCeeEEEEeccC
Q 040845          534 LIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG---RAFKSFDVEC---AMMKSIRHRNLVKVISSCSNEEFKALVLEYMP  606 (824)
Q Consensus       534 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~---~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  606 (824)
                      .||+|+||.||+|... +++.||+|.+.....   .....+..|.   ..++...||+|+++++++...+..++||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999764 589999999865321   1112233333   34455679999999999999999999999999


Q ss_pred             CCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcccc
Q 040845          607 HGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQ  686 (824)
Q Consensus       607 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  686 (824)
                      +++|.+++.... .+++.++..++.|++.|++|||   +.+|+||||||+||+++.++.++|+|||++..+....    .
T Consensus        81 g~~L~~~l~~~~-~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~----~  152 (278)
T cd05606          81 GGDLHYHLSQHG-VFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----P  152 (278)
T ss_pred             CCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC----C
Confidence            999999987654 6899999999999999999999   9999999999999999999999999999987653221    1


Q ss_pred             ccccccccccCccCcCCC-CCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhh
Q 040845          687 TQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDI  765 (824)
Q Consensus       687 ~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  765 (824)
                      ....|+..|+|||.+.++ .++.++||||+||++|||++|+.||...............  ..                .
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~----------------~  214 (278)
T cd05606         153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--LT----------------M  214 (278)
T ss_pred             cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHh--hc----------------c
Confidence            223588999999998754 5899999999999999999999999764221110000000  00                0


Q ss_pred             hhhhHHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 040845          766 HFVAKEQCVSFVFNLALECTVESPEQRI-----NAKEIVAK  801 (824)
Q Consensus       766 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~evl~~  801 (824)
                      ....+..++..+.+++.+|+..+|++||     ++.|++++
T Consensus       215 ~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~  255 (278)
T cd05606         215 AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH  255 (278)
T ss_pred             CCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence            0011123456789999999999999999     99999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.7e-33  Score=300.84  Aligned_cols=269  Identities=22%  Similarity=0.298  Sum_probs=197.4

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeecC------C
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSNE------E  596 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~  596 (824)
                      .++|...+.||+|+||.||+|... +|+.||||++....  ......+.+|+.+++.++|+||+++++++...      .
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            478999999999999999999864 58999999986432  22345678899999999999999999998654      3


Q ss_pred             eeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccc
Q 040845          597 FKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  676 (824)
Q Consensus       597 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~  676 (824)
                      ..++|+||+.. ++.++..   ..+++..+..++.|++.|++|||   +.+++||||||+||+++.++.++++|||++..
T Consensus        94 ~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~  166 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIMG---HPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARH  166 (342)
T ss_pred             eEEEEeccccc-CHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence            46899999964 7776653   25788999999999999999999   99999999999999999999999999999875


Q ss_pred             cCCCCCccccccccccccccCccCcCC-CCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhh-CC-Ccchh
Q 040845          677 LTGEDQSMTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDC-LP-ISTME  753 (824)
Q Consensus       677 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~-~~-~~~~~  753 (824)
                      ....     .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||....... ......... .+ ....+
T Consensus       167 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~  240 (342)
T cd07879         167 ADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVTGVPGPEFVQ  240 (342)
T ss_pred             CCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHHHH
Confidence            4221     123457889999998876 458899999999999999999999997532111 111111100 00 00000


Q ss_pred             hccccc--------cCchhhh-hhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHHHHH
Q 040845          754 VVDANL--------LSQEDIH-FVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK--LLKIRD  807 (824)
Q Consensus       754 ~~~~~~--------~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~--L~~~~~  807 (824)
                      ..+...        ......+ .......+..+.+++.+||+.||++||+++|++.+  ++.+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         241 KLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             HhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence            000000        0000000 00011345678899999999999999999999976  666543

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2e-35  Score=276.10  Aligned_cols=272  Identities=21%  Similarity=0.330  Sum_probs=199.8

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecc--ccchhhhHHHHHHHHhcCCCCcceeEEeeeec--------C
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQ--CGRAFKSFDVECAMMKSIRHRNLVKVISSCSN--------E  595 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~  595 (824)
                      ..|+...+||+|.||+||+|+.+ +|+.||+|.+-.+  .........+|+.++..++|+|++.++..|..        .
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            45666789999999999999865 4788999875432  22334567889999999999999999988743        3


Q ss_pred             CeeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccc
Q 040845          596 EFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK  675 (824)
Q Consensus       596 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~  675 (824)
                      ...|+||++|++ +|...+......++..++.+++.++..||.|+|   ...|+|||+||+|+|++.+|.+||+|||+|+
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGlar  172 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGLAR  172 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeecccccc
Confidence            457999999987 899999887678999999999999999999999   9999999999999999999999999999997


Q ss_pred             ccCCCC--CccccccccccccccCccCcCCC-CCCccchHHHHHHHHHHHHhCCCCCcccccCcc-hh-hhhhhh----h
Q 040845          676 LLTGED--QSMTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEM-TL-KHWVND----C  746 (824)
Q Consensus       676 ~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~-~~-~~~~~~----~  746 (824)
                      .+...+  .....+..+.|.+|++||.+.+. .|+.+.|||+-||++.||+||.+-+.+..+... .+ ......    .
T Consensus       173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev  252 (376)
T KOG0669|consen  173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV  252 (376)
T ss_pred             ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence            664332  22345667789999999987654 689999999999999999999987765322111 00 011111    1


Q ss_pred             CCCc----chhhccccccCchhhh----hhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 040845          747 LPIS----TMEVVDANLLSQEDIH----FVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL  802 (824)
Q Consensus       747 ~~~~----~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L  802 (824)
                      +|.-    ....+..........+    ...+..-.++..+|+.+++..||.+|+++.+++.+-
T Consensus       253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~  316 (376)
T KOG0669|consen  253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD  316 (376)
T ss_pred             CCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence            1110    1111100000000000    001111234678999999999999999999887653

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1e-32  Score=291.29  Aligned_cols=265  Identities=25%  Similarity=0.319  Sum_probs=197.1

Q ss_pred             CCCCceeeeccceEEEEEEECC-CcEEEEEEeecccc--chhhhHHHHHHHHhcC---CCCcceeEEeeeecCCe-----
Q 040845          529 FSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCG--RAFKSFDVECAMMKSI---RHRNLVKVISSCSNEEF-----  597 (824)
Q Consensus       529 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~-----  597 (824)
                      |++.+.||+|+||.||+|+++. ++.||+|+++....  .....+..|+.+++++   +|+|++++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            5678899999999999999764 89999999874422  2234566787777666   59999999999987766     


Q ss_pred             eEEEEeccCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccc
Q 040845          598 KALVLEYMPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  676 (824)
Q Consensus       598 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~  676 (824)
                      .+++|||+. ++|.+++.... ..+++..++.++.|++.|++|||   +.+++|+||+|+||++++++.++|+|||.+..
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~  156 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARI  156 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCccee
Confidence            899999996 48999887644 36899999999999999999999   99999999999999999999999999999977


Q ss_pred             cCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhc-
Q 040845          677 LTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVV-  755 (824)
Q Consensus       677 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-  755 (824)
                      +.....   .....++..|+|||.+.+..++.++|+|||||++|||++|++||..... ......+............. 
T Consensus       157 ~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07838         157 YSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE-ADQLDKIFDVIGLPSEEEWPR  232 (287)
T ss_pred             ccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh-HHHHHHHHHHcCCCChHhcCC
Confidence            643221   1233478889999999988899999999999999999999998875322 11222222211100000000 


Q ss_pred             c----ccccCchhhh--hhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          756 D----ANLLSQEDIH--FVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       756 ~----~~~~~~~~~~--~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      .    ..........  .......+..+.+++.+||+.||++||++.|++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence            0    0000000000  01112345678899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.2e-33  Score=301.31  Aligned_cols=273  Identities=25%  Similarity=0.297  Sum_probs=206.5

Q ss_pred             cCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeecCC-----eeE
Q 040845          528 KFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEE-----FKA  599 (824)
Q Consensus       528 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  599 (824)
                      +|++.+.||+|++|.||+|+.. +++.||||++....  ....+.+.+|+.+++.++|+||+++++++....     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            5788899999999999999875 48999999986543  334567888999999999999999999987765     789


Q ss_pred             EEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCC
Q 040845          600 LVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG  679 (824)
Q Consensus       600 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  679 (824)
                      +||||++ ++|.+++.... .+++..+..++.|++.|++|||   +.+|+||||||.||+++.++.++|+|||.+.....
T Consensus        81 lv~e~~~-~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~  155 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP  155 (330)
T ss_pred             EEecchh-hhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence            9999997 58999987655 7899999999999999999999   99999999999999999999999999999987654


Q ss_pred             CCCc-cccccccccccccCccCcCCC-CCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCc-------
Q 040845          680 EDQS-MTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPIS-------  750 (824)
Q Consensus       680 ~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-------  750 (824)
                      .... .......++..|+|||.+.+. .++.++|+||+|+++|+|++|+.||......+. ... +.......       
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~-~~~-i~~~~~~~~~~~~~~  233 (330)
T cd07834         156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ-LNL-IVEVLGTPSEEDLKF  233 (330)
T ss_pred             cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH-HHH-HHHhcCCCChhHhhh
Confidence            3211 122334578899999999887 789999999999999999999999976422110 011 11100000       


Q ss_pred             -----chhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHHHHH
Q 040845          751 -----TMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK--LLKIRD  807 (824)
Q Consensus       751 -----~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~--L~~~~~  807 (824)
                           ..+.+..................+..+.+++.+||+.+|++|||+.+++++  ++.+.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~  297 (330)
T cd07834         234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD  297 (330)
T ss_pred             ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence                 000000000000000000112356778999999999999999999999986  555543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=8.5e-33  Score=295.05  Aligned_cols=244  Identities=27%  Similarity=0.360  Sum_probs=194.1

Q ss_pred             CCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc---chhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEec
Q 040845          529 FSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG---RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       529 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      |...+.||+|+||+||+|+.. +++.||+|.+.....   .....+..|+++++.++|||++++++++.+....++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            556678999999999999864 588999999864422   2345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 040845          605 MPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM  684 (824)
Q Consensus       605 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  684 (824)
                      +. |++.+++......+++.++..++.|++.|++|||   +.+++|+||+|+||+++.++.+||+|||.+.....     
T Consensus       103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-----  173 (313)
T cd06633         103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-----  173 (313)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccCC-----
Confidence            95 5888888766667899999999999999999999   99999999999999999999999999998864321     


Q ss_pred             ccccccccccccCccCcC---CCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccC
Q 040845          685 TQTQTLATIGYMAPEYGR---EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLS  761 (824)
Q Consensus       685 ~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  761 (824)
                       .....++..|+|||.+.   .+.++.++|||||||++|||++|..||....... ..........+         .   
T Consensus       174 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~-~~~~~~~~~~~---------~---  239 (313)
T cd06633         174 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNDSP---------T---  239 (313)
T ss_pred             -CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhcCCC---------C---
Confidence             12345788999999874   4568889999999999999999999986532111 01110000000         0   


Q ss_pred             chhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          762 QEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       762 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                            .....++..+.+++.+||+.+|++||++.+++.+
T Consensus       240 ------~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         240 ------LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             ------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                  0011234568899999999999999999999975

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.3e-33  Score=296.93  Aligned_cols=250  Identities=28%  Similarity=0.440  Sum_probs=202.6

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcCC-CCcceeEEeeeecCCeeEEE
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIR-HRNLVKVISSCSNEEFKALV  601 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv  601 (824)
                      ++|.+.+.||+|+||.||+|+.. ++..||+|++....   ....+.+..|++++++++ |+||+++++++..++..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            46888999999999999999865 68999999986531   233466788999999998 99999999999999999999


Q ss_pred             EeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 040845          602 LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED  681 (824)
Q Consensus       602 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  681 (824)
                      |||+++++|.+++...+ .+++..+..++.|++.|++|||   +.+++|+||+|+||+++.++.++++|||++.......
T Consensus        81 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~  156 (280)
T cd05581          81 LEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS  156 (280)
T ss_pred             EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence            99999999999998765 6899999999999999999999   9999999999999999999999999999988664332


Q ss_pred             Cc------------------cccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhh
Q 040845          682 QS------------------MTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWV  743 (824)
Q Consensus       682 ~~------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~  743 (824)
                      ..                  .......++..|+|||......++.++||||+|++++++++|+.||...... .......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~  235 (280)
T cd05581         157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY-LTFQKIL  235 (280)
T ss_pred             ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH-HHHHHHH
Confidence            11                  1222345788999999988888999999999999999999999998753211 0011100


Q ss_pred             hhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCH----HHHHHH
Q 040845          744 NDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINA----KEIVAK  801 (824)
Q Consensus       744 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~----~evl~~  801 (824)
                      .            .        ....+...+..+.+++.+||+.+|++||++    +|++++
T Consensus       236 ~------------~--------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~  277 (280)
T cd05581         236 K------------L--------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH  277 (280)
T ss_pred             h------------c--------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence            0            0        000111235568899999999999999999    777654

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=9.7e-33  Score=298.02  Aligned_cols=270  Identities=21%  Similarity=0.235  Sum_probs=197.7

Q ss_pred             hccCC-CCceeeeccceEEEEEEEC-CCcEEEEEEeeccccch--------------hhhHHHHHHHHhcCCCCcceeEE
Q 040845          526 TDKFS-ENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRA--------------FKSFDVECAMMKSIRHRNLVKVI  589 (824)
Q Consensus       526 ~~~~~-~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~  589 (824)
                      .++|. +.+.||+|+||+||+|..+ +++.||||.++......              ...+.+|+++++.++|+||++++
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   86 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV   86 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence            35665 4577999999999999865 58999999986542211              12467899999999999999999


Q ss_pred             eeeecCCeeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEe
Q 040845          590 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLS  669 (824)
Q Consensus       590 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  669 (824)
                      +++..++..++||||++ |+|.+++.... .+++..+..++.|++.|++|||   +.+++|+||+|+||+++.++.++++
T Consensus        87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl~  161 (335)
T PTZ00024         87 DVYVEGDFINLVMDIMA-SDLKKVVDRKI-RLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIA  161 (335)
T ss_pred             EEEecCCcEEEEEeccc-cCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEEEC
Confidence            99999999999999996 69999987544 6889999999999999999999   9999999999999999999999999


Q ss_pred             ecccccccCCCCC------------ccccccccccccccCccCcCCC-CCCccchHHHHHHHHHHHHhCCCCCcccccCc
Q 040845          670 DFGIAKLLTGEDQ------------SMTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDELFNGE  736 (824)
Q Consensus       670 Dfg~a~~~~~~~~------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~  736 (824)
                      |||.+........            ........++..|+|||.+.+. .++.++||||+||++|||++|+.||......+
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~  241 (335)
T PTZ00024        162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID  241 (335)
T ss_pred             CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            9999976541110            1111223467889999988764 46899999999999999999999987532211


Q ss_pred             chhhhhhhhhCCCc---chhhc-----cccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          737 MTLKHWVNDCLPIS---TMEVV-----DANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       737 ~~~~~~~~~~~~~~---~~~~~-----~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                       .+...........   .....     .+........-......++..+.+++.+||+.+|++|||++|++.+
T Consensus       242 -~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~  313 (335)
T PTZ00024        242 -QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH  313 (335)
T ss_pred             -HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence             1111111000000   00000     0000000000001112346678999999999999999999999874

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=6.4e-33  Score=296.53  Aligned_cols=271  Identities=23%  Similarity=0.290  Sum_probs=197.2

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc--chhhhHHHHHHHHhcCCCCcceeEEeeeecC-------
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG--RAFKSFDVECAMMKSIRHRNLVKVISSCSNE-------  595 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------  595 (824)
                      .++|++.+.||+|+||.||+|.++ +++.||||++.....  .....+.+|++++++++|+||+++++++.+.       
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            478999999999999999999865 589999999865432  2234677899999999999999999987543       


Q ss_pred             -CeeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccc
Q 040845          596 -EFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIA  674 (824)
Q Consensus       596 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a  674 (824)
                       ...++|+||+++ ++.+.+......+++.++..++.|+++|++|||   +.+++|+||||+||++++++.++|+|||++
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~  162 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLA  162 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence             346899999964 788877765567999999999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCCCcc---------ccccccccccccCccCcCCC-CCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhh
Q 040845          675 KLLTGEDQSM---------TQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVN  744 (824)
Q Consensus       675 ~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~  744 (824)
                      ..........         ..+...++..|+|||.+.+. .++.++|||||||++|||++|++||....... ....+..
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~-~~~~~~~  241 (311)
T cd07866         163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID-QLHLIFK  241 (311)
T ss_pred             hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH
Confidence            8654322211         11234568889999987654 57899999999999999999999986532211 1111111


Q ss_pred             hhCC--Ccch-------hhcc-ccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          745 DCLP--ISTM-------EVVD-ANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       745 ~~~~--~~~~-------~~~~-~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      ....  ....       ...+ .........-..........+.+++.+|+..||++|||+.|++.+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~  308 (311)
T cd07866         242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH  308 (311)
T ss_pred             HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence            0000  0000       0000 000000000000111234668899999999999999999998864

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-34  Score=321.04  Aligned_cols=258  Identities=25%  Similarity=0.330  Sum_probs=207.8

Q ss_pred             HHHHhhccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecc---ccchhhhHHHHHHHHhcCCCCcceeEEeeeecCC
Q 040845          521 ELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQ---CGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEE  596 (824)
Q Consensus       521 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  596 (824)
                      ++.-..++|++.++||+|+||.|..++++ +++.||+|++.+-   ......-|.+|-.+|..-..+=|++++.+|+++.
T Consensus        69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~  148 (1317)
T KOG0612|consen   69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER  148 (1317)
T ss_pred             HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence            34444688999999999999999999875 4889999998652   2344567889999999989999999999999999


Q ss_pred             eeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccc
Q 040845          597 FKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  676 (824)
Q Consensus       597 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~  676 (824)
                      +.|+|||||+||+|-.++.... .+++.-+..++..|+.||.-+|   +.|+|||||||+|||+|..|++||+|||.|..
T Consensus       149 ~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGsClk  224 (1317)
T KOG0612|consen  149 YLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGSCLK  224 (1317)
T ss_pred             ceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchhHHh
Confidence            9999999999999999999888 7899999999999999999999   99999999999999999999999999999987


Q ss_pred             cCCCCCccccccccccccccCccCcC----C-CCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcc
Q 040845          677 LTGEDQSMTQTQTLATIGYMAPEYGR----E-GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPIST  751 (824)
Q Consensus       677 ~~~~~~~~~~~~~~~~~~y~aPE~~~----~-~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  751 (824)
                      +.. +........+|||-|.+||++.    + +.|+..+|.||+||++|||+.|..||+..     .+..-+..+.... 
T Consensus       225 m~~-dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad-----slveTY~KIm~hk-  297 (1317)
T KOG0612|consen  225 MDA-DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD-----SLVETYGKIMNHK-  297 (1317)
T ss_pred             cCC-CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH-----HHHHHHHHHhchh-
Confidence            753 3344556678999999999875    3 57999999999999999999999999862     1221111111110 


Q ss_pred             hhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCC---HHHHHHH
Q 040845          752 MEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRIN---AKEIVAK  801 (824)
Q Consensus       752 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt---~~evl~~  801 (824)
                                 ....++.....+.++.+||.+.+. +|+.|..   ++++..|
T Consensus       298 -----------~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H  338 (1317)
T KOG0612|consen  298 -----------ESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH  338 (1317)
T ss_pred             -----------hhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence                       001111112356678888887765 5777776   8888765

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7e-33  Score=299.46  Aligned_cols=268  Identities=22%  Similarity=0.294  Sum_probs=198.6

Q ss_pred             HHHhhccCCCCceeeeccceEEEEEEE-CCCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeecCC--
Q 040845          522 LFQATDKFSENNLIGRGGFGSVYKARI-RDGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEE--  596 (824)
Q Consensus       522 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--  596 (824)
                      ++...++|++.+.||+|+||.||+|.. .+++.||||++....  ....+.+..|++++++++||||+++++++..+.  
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07880          10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL   89 (343)
T ss_pred             hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence            344578899999999999999999975 468999999985432  223456778999999999999999999986543  


Q ss_pred             ----eeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecc
Q 040845          597 ----FKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFG  672 (824)
Q Consensus       597 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  672 (824)
                          ..++||||+ +++|.+++...  .+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.++++|||
T Consensus        90 ~~~~~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~dfg  163 (343)
T cd07880          90 DRFHDFYLVMPFM-GTDLGKLMKHE--KLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFG  163 (343)
T ss_pred             cccceEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecc
Confidence                458999999 77999888643  5889999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCccccccccccccccCccCcCC-CCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCC--
Q 040845          673 IAKLLTGEDQSMTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPI--  749 (824)
Q Consensus       673 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--  749 (824)
                      ++......     .....++..|+|||.+.+ ..++.++|+||+|+++|++++|+.||....... ............  
T Consensus       164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~  237 (343)
T cd07880         164 LARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD-QLMEIMKVTGTPSK  237 (343)
T ss_pred             cccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCH
Confidence            98764321     123357889999998865 457899999999999999999999987532111 111111100000  


Q ss_pred             cchhhcccc--------ccCc-hhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          750 STMEVVDAN--------LLSQ-EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       750 ~~~~~~~~~--------~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      ...+.+...        +... ...-......++..+.+++.+|+..||++|||+.+++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~  298 (343)
T cd07880         238 EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH  298 (343)
T ss_pred             HHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            000000000        0000 000001112456678999999999999999999999853

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=9.9e-33  Score=290.76  Aligned_cols=263  Identities=22%  Similarity=0.289  Sum_probs=196.2

Q ss_pred             CCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccc-hhhhHHHHHHHHhcCC-CCcceeEEeeeecCCeeEEEEecc
Q 040845          529 FSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGR-AFKSFDVECAMMKSIR-HRNLVKVISSCSNEEFKALVLEYM  605 (824)
Q Consensus       529 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~  605 (824)
                      |++.+.||+|++|+||+|+.. +++.||||++...... ......+|+..+++++ |+|++++++++.+++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            567889999999999999876 4789999998654322 2233456899999998 999999999999999999999999


Q ss_pred             CCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 040845          606 PHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM  684 (824)
Q Consensus       606 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  684 (824)
                       +|+|.+++.... ..+++..+..++.|++.|++|||   +.+++|+||+|+||++++++.++|+|||.+........  
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~--  154 (283)
T cd07830          81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP--  154 (283)
T ss_pred             -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--
Confidence             789999887654 56899999999999999999999   99999999999999999999999999999986543222  


Q ss_pred             ccccccccccccCccCcC-CCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcc----------hh
Q 040845          685 TQTQTLATIGYMAPEYGR-EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPIST----------ME  753 (824)
Q Consensus       685 ~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~----------~~  753 (824)
                       .....++..|+|||.+. ...++.++|+||||+++|||++|+.||......+. . ...........          ..
T Consensus       155 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd07830         155 -YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQ-L-YKICSVLGTPTKQDWPEGYKLAS  231 (283)
T ss_pred             -cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHH-H-HHHHHhcCCCChhhhhhHhhhhc
Confidence             22345788999999875 44578999999999999999999999865322111 0 00000000000          00


Q ss_pred             hccccccCc--hhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          754 VVDANLLSQ--EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       754 ~~~~~~~~~--~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      ..+......  ....... ...+..+.+++.+||+.+|++|||++|++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         232 KLGFRFPQFAPTSLHQLI-PNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             cccccccccccccHHHHc-ccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            000000000  0000001 1225678999999999999999999999864

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.1e-32  Score=291.46  Aligned_cols=252  Identities=23%  Similarity=0.312  Sum_probs=197.2

Q ss_pred             cCCCCceeeeccceEEEEEEE----CCCcEEEEEEeeccc----cchhhhHHHHHHHHhcC-CCCcceeEEeeeecCCee
Q 040845          528 KFSENNLIGRGGFGSVYKARI----RDGMEVAVKVFNLQC----GRAFKSFDVECAMMKSI-RHRNLVKVISSCSNEEFK  598 (824)
Q Consensus       528 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  598 (824)
                      +|++.+.||+|+||.||.|+.    .+|..||+|+++...    ....+.+..|+.+++.+ +|+||+++++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            477889999999999999976    368999999987532    12345678899999999 599999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccC
Q 040845          599 ALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT  678 (824)
Q Consensus       599 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~  678 (824)
                      ++||||+++++|.+++.... .+++..+..++.|++.|++|||   +.+++||||+|+||+++.++.+||+|||++....
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  156 (290)
T cd05613          81 HLILDYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH  156 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence            99999999999999997654 6888999999999999999999   9999999999999999999999999999997654


Q ss_pred             CCCCccccccccccccccCccCcCCC--CCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhcc
Q 040845          679 GEDQSMTQTQTLATIGYMAPEYGREG--QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVD  756 (824)
Q Consensus       679 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  756 (824)
                      .... .......++..|+|||.+...  .++.++||||||+++|+|++|+.||..... ......+.......       
T Consensus       157 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-~~~~~~~~~~~~~~-------  227 (290)
T cd05613         157 EDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE-KNSQAEISRRILKS-------  227 (290)
T ss_pred             cccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc-cccHHHHHHHhhcc-------
Confidence            3221 112234578899999988653  467899999999999999999999864211 11111111111000       


Q ss_pred             ccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 040845          757 ANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRI-----NAKEIVAK  801 (824)
Q Consensus       757 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~evl~~  801 (824)
                           .    ...+..++..+.+++.+||..||++||     ++.+++++
T Consensus       228 -----~----~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~  268 (290)
T cd05613         228 -----E----PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH  268 (290)
T ss_pred             -----C----CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence                 0    001123456788999999999999997     67777665

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=100.00  E-value=3e-36  Score=329.18  Aligned_cols=424  Identities=27%  Similarity=0.348  Sum_probs=267.4

Q ss_pred             cccccccccCCcccccCCCCCcEEEccCCcccccccccccCCCCCCEEeCCCCcCCcccChhhhCcCCCceeeccCCccc
Q 040845            3 SIINNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLS   82 (824)
Q Consensus         3 ~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~   82 (824)
                      ++..|.+-..+-+...+--+|+.|+|++|++. ..|..+..+.+|+.|+++.|.|. ..|.+...+.+|++|+|.+|++.
T Consensus        27 n~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~  104 (1081)
T KOG0618|consen   27 NLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQ  104 (1081)
T ss_pred             hccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccchhh
Confidence            44455444433333334444677777777666 55666666667777777777766 55666666667777777777666


Q ss_pred             cccCccccCCCCCccEEEccCCeeeeecCccccCCCC-------------------CceEeccCccccccCCccccCCCC
Q 040845           83 GCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASK-------------------LSKLALEMNSFSGFIPSTFGNLRN  143 (824)
Q Consensus        83 ~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~-------------------L~~L~L~~N~i~~~~~~~~~~l~~  143 (824)
                      .+|..+..  +.+|+.|++++|++. ..|..+..++.                   ++.++|..|.+.+.++..+..+..
T Consensus       105 ~lP~~~~~--lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg~~~ik~~~l~~n~l~~~~~~~i~~l~~  181 (1081)
T KOG0618|consen  105 SLPASISE--LKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQRLGQTSIKKLDLRLNVLGGSFLIDIYNLTH  181 (1081)
T ss_pred             cCchhHHh--hhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhhhccccchhhhhhhhhcccchhcchhhhhe
Confidence            66655543  666667777776665 44444433333                   334444444444444444444444


Q ss_pred             CCEEEccCCcCCCCcCcccccccCCCCCCCcEEECcCCCCCccCC----------------ccccccccccccEEEeecC
Q 040845          144 LEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILP----------------RTYVGNLSHSLKNFYMYNC  207 (824)
Q Consensus       144 L~~L~L~~n~i~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~----------------~~~~~~l~~~L~~L~l~~n  207 (824)
                        .|+|.+|.+..+        .+.++.+|+.|....|++..+..                ..+..-.|.+|+.++++.|
T Consensus       182 --~ldLr~N~~~~~--------dls~~~~l~~l~c~rn~ls~l~~~g~~l~~L~a~~n~l~~~~~~p~p~nl~~~dis~n  251 (1081)
T KOG0618|consen  182 --QLDLRYNEMEVL--------DLSNLANLEVLHCERNQLSELEISGPSLTALYADHNPLTTLDVHPVPLNLQYLDISHN  251 (1081)
T ss_pred             --eeecccchhhhh--------hhhhccchhhhhhhhcccceEEecCcchheeeeccCcceeeccccccccceeeecchh
Confidence              477777766522        13444444444444444432211                1111223556666666666


Q ss_pred             cceecCCccCCCCCCCCEEEecCCccCCccchhhcCCCCCCEEEcccccCcccCCccccccCCccEEEccCccccccCCc
Q 040845          208 NVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPA  287 (824)
Q Consensus       208 ~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~  287 (824)
                      ++++ +|++++.+.+|+.+...+|.+. ..|..+...++|+.|.+.+|++. -+|......++|++|+|..|+|...++.
T Consensus       252 ~l~~-lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~  328 (1081)
T KOG0618|consen  252 NLSN-LPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDN  328 (1081)
T ss_pred             hhhc-chHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhccccccchH
Confidence            6663 3366666666666666666664 55666666666666666666666 3455555566666666666666644333


Q ss_pred             cccCCCC-CcEEEcCCCCCCCCCCc-ccccccccccccccccccCcCCccccccccchhhhcccccccccCCCccCCCCC
Q 040845          288 CFSNMTF-LKVLSLGSNELTSIPLN-FWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKN  365 (824)
Q Consensus       288 ~~~~l~~-L~~L~L~~N~l~~lp~~-~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~  365 (824)
                      .|..+.. |+.|+.+.|++...|.. -...+.|+.|++.+|.++...-..+.++++|+.|+|++|++...+...+.++..
T Consensus       329 ~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~  408 (1081)
T KOG0618|consen  329 FLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEE  408 (1081)
T ss_pred             HHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHH
Confidence            3333332 55555555666555532 123567788888888888777777888888888888888888666666788888


Q ss_pred             CCeEEccCccccccCCccccccccccEEEccCcccCCCCcccccCCcccceeeccCCcccCC-CCCCCCccccccccccC
Q 040845          366 LENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGE-IPRGGSFGNFSAESFKG  444 (824)
Q Consensus       366 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~-~p~~~~~~~~~~~~~~~  444 (824)
                      |++|+||+|+|+ .+|..+..++.|++|...+|+|. ..| .+..++.|+.+|++.|+|+-. +|.....+++..+.+.|
T Consensus       409 LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSG  485 (1081)
T KOG0618|consen  409 LEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSG  485 (1081)
T ss_pred             hHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccC
Confidence            888888888888 67888888888888888888887 788 788888888899888888853 34444446778888888


Q ss_pred             Ccc
Q 040845          445 NEL  447 (824)
Q Consensus       445 n~~  447 (824)
                      |++
T Consensus       486 N~~  488 (1081)
T KOG0618|consen  486 NTR  488 (1081)
T ss_pred             Ccc
Confidence            876

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=5.5e-33  Score=293.35  Aligned_cols=255  Identities=22%  Similarity=0.275  Sum_probs=199.3

Q ss_pred             cCCCCceeeeccceEEEEEEEC----CCcEEEEEEeeccc----cchhhhHHHHHHHHhcC-CCCcceeEEeeeecCCee
Q 040845          528 KFSENNLIGRGGFGSVYKARIR----DGMEVAVKVFNLQC----GRAFKSFDVECAMMKSI-RHRNLVKVISSCSNEEFK  598 (824)
Q Consensus       528 ~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  598 (824)
                      +|++.+.||+|+||.||+|+..    +++.||||+++...    ....+.+..|+++++++ +|+||+++++.+......
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4778899999999999999743    47889999986432    22345678899999999 599999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccC
Q 040845          599 ALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT  678 (824)
Q Consensus       599 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~  678 (824)
                      ++||||+++++|.+++.... .+++..+..++.|+++|++|||   +.+++||||+|+||+++.++.++++|||++..+.
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  156 (288)
T cd05583          81 HLILDYVNGGELFTHLYQRE-HFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcC-CcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence            99999999999999987654 6889999999999999999999   9999999999999999999999999999987654


Q ss_pred             CCCCccccccccccccccCccCcCCCC--CCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhcc
Q 040845          679 GEDQSMTQTQTLATIGYMAPEYGREGQ--VSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVD  756 (824)
Q Consensus       679 ~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  756 (824)
                      ..... ......++..|+|||...+..  .+.++||||+|+++|||++|..||..... ......+.......       
T Consensus       157 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~-~~~~~~~~~~~~~~-------  227 (288)
T cd05583         157 AEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGE-QNSQSEISRRILKS-------  227 (288)
T ss_pred             ccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcc-cchHHHHHHHHHcc-------
Confidence            33221 122345788999999887654  78899999999999999999999853211 10111111110000       


Q ss_pred             ccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 040845          757 ANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLK  804 (824)
Q Consensus       757 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~  804 (824)
                               ....+..++..+.+++.+||+.||++|||+.++.+.|+.
T Consensus       228 ---------~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         228 ---------KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             ---------CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence                     001122345678999999999999999998888776654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1e-32  Score=298.35  Aligned_cols=273  Identities=22%  Similarity=0.279  Sum_probs=201.3

Q ss_pred             ccHHHHHHhhccCCCCceeeeccceEEEEEEE-CCCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeee
Q 040845          517 FSYLELFQATDKFSENNLIGRGGFGSVYKARI-RDGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCS  593 (824)
Q Consensus       517 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  593 (824)
                      ....++..++++|++.+.||+|+||.||+|.. .+++.||+|++....  ....+.+.+|+.++++++|+||+++++++.
T Consensus         7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~   86 (345)
T cd07877           7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT   86 (345)
T ss_pred             hHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence            34456777889999999999999999999975 468999999986432  223456778999999999999999999875


Q ss_pred             cC------CeeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEE
Q 040845          594 NE------EFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH  667 (824)
Q Consensus       594 ~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  667 (824)
                      ..      ...+++++++ +++|.+++...  .+++..+..++.|+++|++|||   +.+|+||||||+||++++++.+|
T Consensus        87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~k  160 (345)
T cd07877          87 PARSLEEFNDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELK  160 (345)
T ss_pred             ecccccccccEEEEehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCEE
Confidence            43      3467888887 77998888653  5889999999999999999999   99999999999999999999999


Q ss_pred             EeecccccccCCCCCccccccccccccccCccCcCC-CCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhh
Q 040845          668 LSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDC  746 (824)
Q Consensus       668 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~  746 (824)
                      |+|||++......     .....++..|+|||...+ ..++.++||||+||++|||++|+.||...... ..........
T Consensus       161 l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~  234 (345)
T cd07877         161 ILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLV  234 (345)
T ss_pred             Eeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHh
Confidence            9999998754221     123457889999998765 46788999999999999999999998642211 1111111110


Q ss_pred             C--CCcchhhccccc--------cCchhhhh-hhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          747 L--PISTMEVVDANL--------LSQEDIHF-VAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       747 ~--~~~~~~~~~~~~--------~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      .  +......+....        ........ .....++..+.+++.+|++.||++||++.+++.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         235 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             CCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence            0  000000000000        00000000 0001245678999999999999999999999877

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-32  Score=289.33  Aligned_cols=264  Identities=28%  Similarity=0.341  Sum_probs=200.0

Q ss_pred             CCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEecc
Q 040845          529 FSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYM  605 (824)
Q Consensus       529 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  605 (824)
                      |+..+.||+|++|.||+|+.. +++.||+|++....  ....+.+..|+.+++.++|+|++++++++.+....++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            566788999999999999865 48999999987653  333466788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccc
Q 040845          606 PHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMT  685 (824)
Q Consensus       606 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  685 (824)
                      + ++|.+++......+++..+..++.|++.|++|||   +.+|+||||+|+||++++++.++|+|||.+........  .
T Consensus        81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~  154 (282)
T cd07829          81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--T  154 (282)
T ss_pred             C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--c
Confidence            7 5999999876457899999999999999999999   89999999999999999999999999999986543222  2


Q ss_pred             cccccccccccCccCcCCC-CCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCc----chhhc-----
Q 040845          686 QTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPIS----TMEVV-----  755 (824)
Q Consensus       686 ~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~-----  755 (824)
                      .....++..|+|||.+.+. .++.++||||+|+++||+++|+.||......+ ...... ......    .....     
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~~  232 (282)
T cd07829         155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEID-QLFKIF-QILGTPTEESWPGVTKLPDY  232 (282)
T ss_pred             cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHH-HHHHHH-HHhCCCcHHHHHhhcccccc
Confidence            2234467789999988766 78999999999999999999999986532111 000000 000000    00000     


Q ss_pred             cccccC--chhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          756 DANLLS--QEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       756 ~~~~~~--~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      +.....  ...... .-...+..+.+++.+||..||++||++.+++.+
T Consensus       233 ~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  279 (282)
T cd07829         233 KPTFPKFPPKDLEK-VLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH  279 (282)
T ss_pred             cccccccCccchHH-hcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence            000000  000000 011235679999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=7.5e-33  Score=299.25  Aligned_cols=267  Identities=22%  Similarity=0.300  Sum_probs=196.0

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecC---------
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNE---------  595 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---------  595 (824)
                      ..+|.+.+.||+|+||.||+|... +|+.||+|.+........+.+.+|++++++++||||+++++++...         
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            367899999999999999999864 5899999998766555567788999999999999999999776543         


Q ss_pred             -----CeeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC-CCCcEEEe
Q 040845          596 -----EFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLS  669 (824)
Q Consensus       596 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~-~~~~~kl~  669 (824)
                           ...++||||++ ++|.+++...  .+++..+..++.|++.|++|||   +.+|+||||||+||+++ +++.++++
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~kl~  157 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLEQG--PLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIG  157 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceEEEC
Confidence                 35789999996 5898888643  5789999999999999999999   99999999999999997 45678999


Q ss_pred             ecccccccCCCCCc-cccccccccccccCccCcCC-CCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhC
Q 040845          670 DFGIAKLLTGEDQS-MTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCL  747 (824)
Q Consensus       670 Dfg~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  747 (824)
                      |||.+......... .......++..|+|||.+.. ..++.++|||||||++|||++|+.||......+. ....... .
T Consensus       158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~-~~~~~~~-~  235 (342)
T cd07854         158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ-MQLILES-V  235 (342)
T ss_pred             CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHh-c
Confidence            99999765322111 11122357889999997654 4678899999999999999999999975322111 1111110 0


Q ss_pred             CCcch----hh---ccc-----cccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          748 PISTM----EV---VDA-----NLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       748 ~~~~~----~~---~~~-----~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      +....    ..   ...     ......... ......+.++.+++.+||+.||++|||+.|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  300 (342)
T cd07854         236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLR-DLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH  300 (342)
T ss_pred             CCCChHHhhhhhhhhhhhhhhcccccCCCHH-HHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence            00000    00   000     000000000 0011345678899999999999999999999865

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.7e-33  Score=300.99  Aligned_cols=266  Identities=24%  Similarity=0.323  Sum_probs=198.7

Q ss_pred             HHhhccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCe--
Q 040845          523 FQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEF--  597 (824)
Q Consensus       523 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--  597 (824)
                      ....++|++.+.||+|++|.||+|+.. +++.||||++....  ....+.+.+|+.+++.++|+|++++++++...+.  
T Consensus        11 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07851          11 WEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLE   90 (343)
T ss_pred             ecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccc
Confidence            345678999999999999999999875 58899999886432  2234567789999999999999999998766554  


Q ss_pred             ----eEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccc
Q 040845          598 ----KALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGI  673 (824)
Q Consensus       598 ----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~  673 (824)
                          .++|+||+ +++|.+++...  .+++.++..++.|++.|++|||   +.+|+||||+|+||++++++.++|+|||+
T Consensus        91 ~~~~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg~  164 (343)
T cd07851          91 DFQDVYLVTHLM-GADLNNIVKCQ--KLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGL  164 (343)
T ss_pred             ccccEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEccccc
Confidence                89999999 66999998753  5899999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCCccccccccccccccCccCcCC-CCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcch
Q 040845          674 AKLLTGEDQSMTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTM  752 (824)
Q Consensus       674 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  752 (824)
                      +......     .....++..|+|||...+ ..++.++||||+|+++||+++|+.||......+ ....+... .+....
T Consensus       165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~-~~~~i~~~-~~~~~~  237 (343)
T cd07851         165 ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID-QLKRIMNL-VGTPDE  237 (343)
T ss_pred             ccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHh-cCCCCH
Confidence            9865322     223457888999998765 367899999999999999999999986532111 11111110 000000


Q ss_pred             hhcccc-----------ccCchhhhh-hhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          753 EVVDAN-----------LLSQEDIHF-VAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       753 ~~~~~~-----------~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      ......           .......+. .....++..+.+++.+||..||++|||+.|++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         238 ELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             HHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence            000000           000000000 0111346789999999999999999999999875

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1e-32  Score=286.71  Aligned_cols=248  Identities=21%  Similarity=0.293  Sum_probs=194.4

Q ss_pred             cCCCCceeeeccceEEEEEEECC-CcEEEEEEeeccc-----cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEE
Q 040845          528 KFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQC-----GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALV  601 (824)
Q Consensus       528 ~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  601 (824)
                      +|.+.+.||+|+||.||+|++.. +..+++|+.+...     ......+..|+.+++.++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            57888999999999999998653 4556666654321     12234566799999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhh---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccC
Q 040845          602 LEYMPHGSLEKYLHS---SNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT  678 (824)
Q Consensus       602 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~  678 (824)
                      |||+++++|.+++..   ....+++.+++.++.|++.|++|||   +.+++|+|++|+||+++. +.++++|||.+....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeecC
Confidence            999999999998864   2356899999999999999999999   999999999999999975 569999999987764


Q ss_pred             CCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhcccc
Q 040845          679 GEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDAN  758 (824)
Q Consensus       679 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  758 (824)
                      ....  ......++..|+|||...+..++.++|+||||+++|+|++|..||.....     ..........         
T Consensus       157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-----~~~~~~~~~~---------  220 (260)
T cd08222         157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF-----LSVVLRIVEG---------  220 (260)
T ss_pred             CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-----HHHHHHHHcC---------
Confidence            3322  12234578899999998888889999999999999999999999864211     1111100000         


Q ss_pred             ccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          759 LLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       759 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                            .....+..++.++.+++.+||..+|++||++.|++++
T Consensus       221 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         221 ------PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             ------CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence                  0000122456678999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=3e-32  Score=293.58  Aligned_cols=268  Identities=22%  Similarity=0.245  Sum_probs=193.6

Q ss_pred             cCCCCceeeeccceEEEEEEEC-C--CcEEEEEEeeccc--cchhhhHHHHHHHHhcC-CCCcceeEEeeeec----CCe
Q 040845          528 KFSENNLIGRGGFGSVYKARIR-D--GMEVAVKVFNLQC--GRAFKSFDVECAMMKSI-RHRNLVKVISSCSN----EEF  597 (824)
Q Consensus       528 ~~~~~~~lg~G~~g~V~~~~~~-~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~  597 (824)
                      +|++.+.||+|+||.||+|+.. +  +..||+|.+....  ....+.+.+|+++++++ .||||+++++++..    ...
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4778899999999999999865 3  6789999886432  22345677899999999 59999999987532    346


Q ss_pred             eEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccccc
Q 040845          598 KALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  677 (824)
Q Consensus       598 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~  677 (824)
                      .++++||++ ++|.+++.... .+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||.+...
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~  155 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSGQ-PLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGF  155 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence            789999985 68999986544 6899999999999999999999   999999999999999999999999999999866


Q ss_pred             CCCCCc--cccccccccccccCccCcCC-CCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhC-C-Cc-c
Q 040845          678 TGEDQS--MTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCL-P-IS-T  751 (824)
Q Consensus       678 ~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-~-~~-~  751 (824)
                      ......  .......|+..|+|||...+ ..++.++|+||+||++|++++|+.||...... ......+.... + .. .
T Consensus       156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~  234 (332)
T cd07857         156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV-DQLNQILQVLGTPDEETL  234 (332)
T ss_pred             ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH-HHHHHHHHHhCCCCHHHH
Confidence            432221  11223468899999998765 46899999999999999999999998652210 01111111000 0 00 0


Q ss_pred             hhhcccc-------ccCchhhhh-hhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          752 MEVVDAN-------LLSQEDIHF-VAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       752 ~~~~~~~-------~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      ....++.       ....+.... .....++..+.+++.+|++.||++|||+.|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~  292 (332)
T cd07857         235 SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH  292 (332)
T ss_pred             HhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            0000000       000000000 0011235678999999999999999999999765

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-32  Score=281.97  Aligned_cols=236  Identities=29%  Similarity=0.333  Sum_probs=192.5

Q ss_pred             eeeccceEEEEEEEC-CCcEEEEEEeecccc---chhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEeccCCCCH
Q 040845          535 IGRGGFGSVYKARIR-DGMEVAVKVFNLQCG---RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSL  610 (824)
Q Consensus       535 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  610 (824)
                      ||+|+||.||++... +++.||+|++.....   .....+..|+++++.++|+||+++++.+..+...++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999875 489999999865432   2345788899999999999999999999999999999999999999


Q ss_pred             HHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcccccccc
Q 040845          611 EKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTL  690 (824)
Q Consensus       611 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  690 (824)
                      .+++.... .+++..+..++.|+++|+.|+|   +.+++|+||+|+||+++.++.++++|||.+.......  .......
T Consensus        81 ~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~  154 (250)
T cd05123          81 FSHLSKEG-RFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFC  154 (250)
T ss_pred             HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCc
Confidence            99998765 6899999999999999999999   9999999999999999999999999999998654322  1223445


Q ss_pred             ccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhhhhhhH
Q 040845          691 ATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAK  770 (824)
Q Consensus       691 ~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  770 (824)
                      ++..|+|||...+...+.++|+||||+++||+++|..||.....  .   ........                .....+
T Consensus       155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--~---~~~~~~~~----------------~~~~~~  213 (250)
T cd05123         155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--K---EIYEKILK----------------DPLRFP  213 (250)
T ss_pred             CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--H---HHHHHHhc----------------CCCCCC
Confidence            78899999999888889999999999999999999999865322  1   11111000                001111


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHH
Q 040845          771 EQCVSFVFNLALECTVESPEQRINAKE  797 (824)
Q Consensus       771 ~~~~~~l~~l~~~cl~~dP~~Rpt~~e  797 (824)
                      ...+..+.+++.+||..||++||++.+
T Consensus       214 ~~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         214 EFLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence            223566889999999999999999943

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.98  E-value=2.5e-33  Score=286.93  Aligned_cols=245  Identities=23%  Similarity=0.365  Sum_probs=197.5

Q ss_pred             CceeeeccceEEEEEEE-CCCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEeccCCC
Q 040845          532 NNLIGRGGFGSVYKARI-RDGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHG  608 (824)
Q Consensus       532 ~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  608 (824)
                      .+.||.|.||+||-|++ ++|+.||||++.+..  .+..+.++.|+.||+.+.||.||.+-..|+..+..+.|||-+ +|
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence            47899999999999975 469999999986542  334577899999999999999999999999999999999999 55


Q ss_pred             CHHHHhh-hCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCC---CcEEEeecccccccCCCCCcc
Q 040845          609 SLEKYLH-SSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDN---MVAHLSDFGIAKLLTGEDQSM  684 (824)
Q Consensus       609 ~L~~~l~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~---~~~kl~Dfg~a~~~~~~~~~~  684 (824)
                      ++.+.+- .....+++.....+..||+.||.|||   .++|+|+|+||+|||+.+.   -++||||||+|+.+..   ..
T Consensus       648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE---ks  721 (888)
T KOG4236|consen  648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE---KS  721 (888)
T ss_pred             hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecch---hh
Confidence            6666654 33457888788888999999999999   9999999999999999643   3799999999998743   23


Q ss_pred             ccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchh
Q 040845          685 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQED  764 (824)
Q Consensus       685 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  764 (824)
                      .....+||+.|.|||+++...|...-|+||+||++|--++|..||.+..    ++.+-++.   ..++            
T Consensus       722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE----dIndQIQN---AaFM------------  782 (888)
T KOG4236|consen  722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE----DINDQIQN---AAFM------------  782 (888)
T ss_pred             hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc----chhHHhhc---cccc------------
Confidence            4456789999999999999999999999999999999999999987522    22211110   0011            


Q ss_pred             hhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 040845          765 IHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL  802 (824)
Q Consensus       765 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L  802 (824)
                      +....+.+.+..+.++|...+++.-.+|.+....+.+-
T Consensus       783 yPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~  820 (888)
T KOG4236|consen  783 YPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHP  820 (888)
T ss_pred             cCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccch
Confidence            11112335567789999999999999999998877653

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.98  E-value=5.8e-32  Score=314.41  Aligned_cols=146  Identities=30%  Similarity=0.438  Sum_probs=131.7

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALV  601 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  601 (824)
                      .++|.+.+.||+|+||.||+|.+. +++.||||+++...   ......+..|+.+++.++|+||+++++++......++|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            367899999999999999999876 58999999986532   22346788899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccc
Q 040845          602 LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK  675 (824)
Q Consensus       602 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~  675 (824)
                      |||+++++|.+++...+ .+++..++.++.||+.||+|||   ..+|+||||||+|||++.++.+||+|||+++
T Consensus        83 mEy~~g~~L~~li~~~~-~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHIYG-YFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999999997655 6788999999999999999999   8999999999999999999999999999886

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=2.2e-33  Score=281.70  Aligned_cols=258  Identities=27%  Similarity=0.434  Sum_probs=202.6

Q ss_pred             hccCCCCceeeeccceEEEEEE-ECCCcEEEEEEeeccc--c-----chhhhHHHHHHHHhcCCCCcceeEEeeee-cCC
Q 040845          526 TDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQC--G-----RAFKSFDVECAMMKSIRHRNLVKVISSCS-NEE  596 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~  596 (824)
                      .++|-+..+||+|||+.||+|. ....+.||||+-....  .     ...+...+|..|-+.|.||.||++++++. +.+
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd  541 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD  541 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence            4568888999999999999996 4558999999754331  1     12245667999999999999999999996 456


Q ss_pred             eeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC---CCCcEEEeeccc
Q 040845          597 FKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFGI  673 (824)
Q Consensus       597 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~---~~~~~kl~Dfg~  673 (824)
                      .++-|.|||+|.+|+=|+..++ .+++.++..|+.||+.||.||.+. +.+|||-|+||.|||+.   ..|.+||+|||+
T Consensus       542 sFCTVLEYceGNDLDFYLKQhk-lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGL  619 (775)
T KOG1151|consen  542 SFCTVLEYCEGNDLDFYLKQHK-LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGL  619 (775)
T ss_pred             cceeeeeecCCCchhHHHHhhh-hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecch
Confidence            7789999999999999998776 789999999999999999999843 78999999999999994   468999999999


Q ss_pred             ccccCCCCCcc-----ccccccccccccCccCcCCC----CCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhh
Q 040845          674 AKLLTGEDQSM-----TQTQTLATIGYMAPEYGREG----QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVN  744 (824)
Q Consensus       674 a~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~----~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~  744 (824)
                      ++.+.+.....     -.+...||.||++||.+.-+    ..+.++||||+||++|+++.|+.||....... ++.+   
T Consensus       620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ-dILq---  695 (775)
T KOG1151|consen  620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ-DILQ---  695 (775)
T ss_pred             hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH-HHHh---
Confidence            99987654432     22345799999999976533    57889999999999999999999997632111 1111   


Q ss_pred             hhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040845          745 DCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVA  800 (824)
Q Consensus       745 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~  800 (824)
                                 ...++......++.++.++.++.++|++|+++--++|....++..
T Consensus       696 -----------eNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  696 -----------ENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             -----------hhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence                       011122223344455567788999999999999999998887654

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.98  E-value=5.1e-33  Score=276.53  Aligned_cols=264  Identities=22%  Similarity=0.280  Sum_probs=199.7

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcCC-C-C----cceeEEeeeecCCee
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIR-H-R----NLVKVISSCSNEEFK  598 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-~----niv~l~~~~~~~~~~  598 (824)
                      ..+|.+...+|+|+||.|..+-+. .+..||||+++.. ....++..-|+++++++. + |    -+|.+.++|...++.
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi  166 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI  166 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence            688999999999999999999644 4789999998754 455677788999999993 2 3    277888889999999


Q ss_pred             EEEEeccCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC---------------
Q 040845          599 ALVLEYMPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD---------------  662 (824)
Q Consensus       599 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~---------------  662 (824)
                      ++|+|.+ |.++.+++.... .+++...+..|++|+++++++||   +.+++|-|+||+||++.+               
T Consensus       167 Civfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~  242 (415)
T KOG0671|consen  167 CIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPKKKVCF  242 (415)
T ss_pred             EEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEeccCCccce
Confidence            9999999 669999998755 67889999999999999999999   999999999999999932               


Q ss_pred             -----CCcEEEeecccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcc
Q 040845          663 -----NMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEM  737 (824)
Q Consensus       663 -----~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~  737 (824)
                           +..++++|||.|+.-...     .+..+.|..|+|||++.+-.++.++||||+|||++|+.||..-|..-...+ 
T Consensus       243 ~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E-  316 (415)
T KOG0671|consen  243 IRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE-  316 (415)
T ss_pred             eccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH-
Confidence                 346899999999864322     244568999999999999999999999999999999999999887643211 


Q ss_pred             hhhhhhhhhCCCcchhhcccc---------ccC----------------chhh--hhhhHHHHHHHHHHHHHHccccCCC
Q 040845          738 TLKHWVNDCLPISTMEVVDAN---------LLS----------------QEDI--HFVAKEQCVSFVFNLALECTVESPE  790 (824)
Q Consensus       738 ~~~~~~~~~~~~~~~~~~~~~---------~~~----------------~~~~--~~~~~~~~~~~l~~l~~~cl~~dP~  790 (824)
                      .+ .........-...++...         -+.                ....  -..........+.+|+++|+..||.
T Consensus       317 HL-aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~  395 (415)
T KOG0671|consen  317 HL-AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA  395 (415)
T ss_pred             HH-HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence            11 011111110011111110         000                0000  0011123455699999999999999


Q ss_pred             CCCCHHHHHHH
Q 040845          791 QRINAKEIVAK  801 (824)
Q Consensus       791 ~Rpt~~evl~~  801 (824)
                      +|+|+.|++.|
T Consensus       396 ~RiTl~EAL~H  406 (415)
T KOG0671|consen  396 RRITLREALSH  406 (415)
T ss_pred             ccccHHHHhcC
Confidence            99999999875

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.98  E-value=1.8e-32  Score=291.05  Aligned_cols=243  Identities=24%  Similarity=0.285  Sum_probs=196.2

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcC-CCCcceeEEeeeecCCeeEEEEe
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSI-RHRNLVKVISSCSNEEFKALVLE  603 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  603 (824)
                      ++.|+....+|.|+|+.|-++... +++..+||++...    ..+..+|+.++... +||||+++.+.+.+..+.|+|||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e  396 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME  396 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence            567888888999999999999754 5889999998654    23345566666555 79999999999999999999999


Q ss_pred             ccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee-CCCCcEEEeecccccccCCCCC
Q 040845          604 YMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL-DDNMVAHLSDFGIAKLLTGEDQ  682 (824)
Q Consensus       604 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill-~~~~~~kl~Dfg~a~~~~~~~~  682 (824)
                      .+.++-+.+.+..... .. .++..|+.+|+.|+.|||   .+||||||+||+|||+ ++.++++|+|||.++...+.  
T Consensus       397 ~l~g~ell~ri~~~~~-~~-~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--  469 (612)
T KOG0603|consen  397 LLDGGELLRRIRSKPE-FC-SEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--  469 (612)
T ss_pred             hccccHHHHHHHhcch-hH-HHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence            9999988877765542 22 678889999999999999   9999999999999999 59999999999999876433  


Q ss_pred             ccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCc
Q 040845          683 SMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ  762 (824)
Q Consensus       683 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  762 (824)
                         ....+-|..|.|||++....|++++|+||+|++||+|++|+.||.....+ ..+..   . +..             
T Consensus       470 ---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-~ei~~---~-i~~-------------  528 (612)
T KOG0603|consen  470 ---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-IEIHT---R-IQM-------------  528 (612)
T ss_pred             ---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-HHHHH---h-hcC-------------
Confidence               22345688999999999999999999999999999999999999874443 11111   0 000             


Q ss_pred             hhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 040845          763 EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLK  804 (824)
Q Consensus       763 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~  804 (824)
                          .......+..+.+|+.+|++.||.+||+|.++..+=..
T Consensus       529 ----~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  529 ----PKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             ----CccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence                00014567789999999999999999999999877544

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=8.2e-33  Score=275.42  Aligned_cols=242  Identities=22%  Similarity=0.283  Sum_probs=194.4

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcC-CCCcceeEEeeeecCCeeEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSI-RHRNLVKVISSCSNEEFKAL  600 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  600 (824)
                      ..+|....+||+|+||.|..|..+ +.+.||||++++..   +...+--..|-.+|.-. +-|.+++++.+|+.-+..|+
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF  427 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF  427 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence            457888999999999999999765 36779999987653   23334445566777665 57899999999999999999


Q ss_pred             EEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 040845          601 VLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE  680 (824)
Q Consensus       601 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  680 (824)
                      ||||+.||+|--.++..+ .+.+..++.+|.+||-||-+||   +++|++||+|.+||++|.+|++||+|||+++.--  
T Consensus       428 VMEyvnGGDLMyhiQQ~G-kFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni--  501 (683)
T KOG0696|consen  428 VMEYVNGGDLMYHIQQVG-KFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI--  501 (683)
T ss_pred             EEEEecCchhhhHHHHhc-ccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeecccccccc--
Confidence            999999999988888776 6778889999999999999999   9999999999999999999999999999997421  


Q ss_pred             CCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhcccccc
Q 040845          681 DQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLL  760 (824)
Q Consensus       681 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  760 (824)
                      -...+.....||+.|+|||++....|+.++|.|||||++|||+.|++||++..+.+  +-+-           +.+... 
T Consensus       502 ~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e--lF~a-----------I~ehnv-  567 (683)
T KOG0696|consen  502 FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE--LFQA-----------IMEHNV-  567 (683)
T ss_pred             cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH--HHHH-----------HHHccC-
Confidence            12223345679999999999999999999999999999999999999998733221  1111           111111 


Q ss_pred             CchhhhhhhHHHHHHHHHHHHHHccccCCCCCCC
Q 040845          761 SQEDIHFVAKEQCVSFVFNLALECTVESPEQRIN  794 (824)
Q Consensus       761 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt  794 (824)
                             ..|...+.++.++.+..+...|.+|..
T Consensus       568 -------syPKslSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  568 -------SYPKSLSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             -------cCcccccHHHHHHHHHHhhcCCccccC
Confidence                   112344667888999999999999973

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.98  E-value=8.9e-32  Score=275.06  Aligned_cols=220  Identities=20%  Similarity=0.154  Sum_probs=176.7

Q ss_pred             ccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEeccCCCCHHHHhhh
Q 040845          538 GGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHS  616 (824)
Q Consensus       538 G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~  616 (824)
                      |.+|.||+|... +++.||+|++....     .+..|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            899999999864 58999999986542     233455555566799999999999999999999999999999999876


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcccccccccccccc
Q 040845          617 SNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYM  696 (824)
Q Consensus       617 ~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~  696 (824)
                      .. .+++..+..++.|+++|++|||   +.+|+||||||+||+++.++.++++|||.+......     .....++..|+
T Consensus        79 ~~-~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y~  149 (237)
T cd05576          79 FL-NIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMYC  149 (237)
T ss_pred             hc-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCcccc
Confidence            54 6899999999999999999999   999999999999999999999999999987654322     12234567899


Q ss_pred             CccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhhhhhhHHHHHHH
Q 040845          697 APEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSF  776 (824)
Q Consensus       697 aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  776 (824)
                      |||...+..++.++||||+|+++|||++|+.|+........               ..          .....+..++..
T Consensus       150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~---------------~~----------~~~~~~~~~~~~  204 (237)
T cd05576         150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN---------------TH----------TTLNIPEWVSEE  204 (237)
T ss_pred             CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc---------------cc----------cccCCcccCCHH
Confidence            99999888899999999999999999999988653211000               00          000011234567


Q ss_pred             HHHHHHHccccCCCCCCCHH
Q 040845          777 VFNLALECTVESPEQRINAK  796 (824)
Q Consensus       777 l~~l~~~cl~~dP~~Rpt~~  796 (824)
                      +.+++.+|++.||++||++.
T Consensus       205 ~~~li~~~l~~dp~~R~~~~  224 (237)
T cd05576         205 ARSLLQQLLQFNPTERLGAG  224 (237)
T ss_pred             HHHHHHHHccCCHHHhcCCC
Confidence            89999999999999999973

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.97  E-value=2.2e-33  Score=264.87  Aligned_cols=251  Identities=27%  Similarity=0.284  Sum_probs=190.2

Q ss_pred             CCceeeeccceEEEEEEEC-CCcEEEEEEeecccc-chhhhHHHHHHH-HhcCCCCcceeEEeeeecCCeeEEEEeccCC
Q 040845          531 ENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG-RAFKSFDVECAM-MKSIRHRNLVKVISSCSNEEFKALVLEYMPH  607 (824)
Q Consensus       531 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  607 (824)
                      -...||.|+||+|++-.++ .|+..|||+++.... .+..++..|.+. ++.-++||||+++|++..++..++.||.|+ 
T Consensus        68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-  146 (361)
T KOG1006|consen   68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-  146 (361)
T ss_pred             HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-
Confidence            3467999999999999765 599999999976643 445566677664 555579999999999999999999999995 


Q ss_pred             CCHHHHhhh----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 040845          608 GSLEKYLHS----SNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS  683 (824)
Q Consensus       608 g~L~~~l~~----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  683 (824)
                      -+++.+-..    ....+++.-.-.|....+.||.||.+  ..+|+|||+||+|||++..|.+|+||||++..+.   .+
T Consensus       147 ~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv---~S  221 (361)
T KOG1006|consen  147 ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLV---DS  221 (361)
T ss_pred             hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHH---HH
Confidence            477655332    12457777788888999999999986  6799999999999999999999999999987653   22


Q ss_pred             cccccccccccccCccCcCC--CCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccC
Q 040845          684 MTQTQTLATIGYMAPEYGRE--GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLS  761 (824)
Q Consensus       684 ~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  761 (824)
                      ...+..+|-..|||||-+..  ..|+.++||||+|+.+||+.||..|+..+..--..+.+.+....|          .+.
T Consensus       222 iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp----------~l~  291 (361)
T KOG1006|consen  222 IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPP----------ILL  291 (361)
T ss_pred             HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCC----------eec
Confidence            33455567888999998753  348999999999999999999999987643321122222222111          111


Q ss_pred             chhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          762 QEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       762 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      ...    ....++..+.+++.-|+.+|-..||...++.++
T Consensus       292 ~~~----~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  292 FDK----ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             Ccc----cccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            100    001345678999999999999999999998754

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=5.2e-31  Score=298.37  Aligned_cols=260  Identities=21%  Similarity=0.250  Sum_probs=170.5

Q ss_pred             hhccCCCCceeeeccceEEEEEEEC-C----CcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEee------ee
Q 040845          525 ATDKFSENNLIGRGGFGSVYKARIR-D----GMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISS------CS  593 (824)
Q Consensus       525 ~~~~~~~~~~lg~G~~g~V~~~~~~-~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~~  593 (824)
                      ..++|++.+.||+|+||.||+|++. +    +..||||++.....  .+....|  .+....+.++..++..      ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            4678999999999999999999865 4    68999998753221  1111111  1112222222222221      24


Q ss_pred             cCCeeEEEEeccCCCCHHHHhhhCCCCC-------------------CHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCC
Q 040845          594 NEEFKALVLEYMPHGSLEKYLHSSNYSL-------------------DIFQRLNIMIDVASALEYLHFGYSAPVIHCDLK  654 (824)
Q Consensus       594 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~-------------------~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk  654 (824)
                      .+...++||||+++++|.+++.......                   ....+..++.|++.||+|||   +.+|+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCC
Confidence            5667899999999999999987543211                   12345679999999999999   9999999999


Q ss_pred             CCCeeeCC-CCcEEEeecccccccCCCCCccccccccccccccCccCcCCC----------------------CCCccch
Q 040845          655 PSNVLLDD-NMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG----------------------QVSTNGD  711 (824)
Q Consensus       655 ~~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------~~~~~~D  711 (824)
                      |+|||++. ++.+||+|||+|+.+..... .......+++.|+|||.+...                      .++.++|
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            99999985 68999999999986543222 222345688999999955322                      2345679


Q ss_pred             HHHHHHHHHHHHhCCCCCcccc--------cCcchhhhhhhhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHH
Q 040845          712 VYSFGIMLMETFTRKKPTDELF--------NGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALE  783 (824)
Q Consensus       712 vwslG~~l~el~tg~~p~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  783 (824)
                      |||+||++|||+++..|++...        ..+.....|.....+         .....................+|+.+
T Consensus       362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~d~~~~~~~dLi~~  432 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEP---------RASPDLRRGFEVLDLDGGAGWELLKS  432 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhcc---------ccchhhhhhhhhccccchHHHHHHHH
Confidence            9999999999999877654311        001112222111111         00000000000000112345689999


Q ss_pred             ccccCCCCCCCHHHHHHH
Q 040845          784 CTVESPEQRINAKEIVAK  801 (824)
Q Consensus       784 cl~~dP~~Rpt~~evl~~  801 (824)
                      |++.||++|||+.|+++|
T Consensus       433 mL~~dP~kR~ta~e~L~H  450 (566)
T PLN03225        433 MMRFKGRQRISAKAALAH  450 (566)
T ss_pred             HccCCcccCCCHHHHhCC
Confidence            999999999999999986

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=2.4e-31  Score=289.80  Aligned_cols=256  Identities=24%  Similarity=0.346  Sum_probs=210.2

Q ss_pred             HHHhhccCCCCceeeeccceEEEEEEE-CCCcEEEEEEeeccccchhhhHHHHHHHHhcC-CCCcceeEEeeee-----c
Q 040845          522 LFQATDKFSENNLIGRGGFGSVYKARI-RDGMEVAVKVFNLQCGRAFKSFDVECAMMKSI-RHRNLVKVISSCS-----N  594 (824)
Q Consensus       522 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~-----~  594 (824)
                      +...++.|++...||.|.+|.||+++. ++|+.+|+|+..... ...++++.|.++++.. .|||++.++|++.     .
T Consensus        14 lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~   92 (953)
T KOG0587|consen   14 LPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGN   92 (953)
T ss_pred             CCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCC
Confidence            334467789999999999999999975 468999999887653 3456778899999988 5999999999984     4


Q ss_pred             CCeeEEEEeccCCCCHHHHhhhC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccc
Q 040845          595 EEFKALVLEYMPHGSLEKYLHSS-NYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGI  673 (824)
Q Consensus       595 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~  673 (824)
                      ++..++|||||.+|+..|+++.. +..+.|..+..|++.++.|+.+||   ...++|||||-.|||++.++.||++|||.
T Consensus        93 ~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKLvDFGv  169 (953)
T KOG0587|consen   93 GDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKLVDFGV  169 (953)
T ss_pred             CCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEEeeeee
Confidence            67899999999999999998753 367889999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCCccccccccccccccCccCcC-----CCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCC
Q 040845          674 AKLLTGEDQSMTQTQTLATIGYMAPEYGR-----EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLP  748 (824)
Q Consensus       674 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  748 (824)
                      +..++.  ........+||+.|||||++.     ...|+.++|+||+|++..||..|.+|+.++.+...-+.        
T Consensus       170 SaQlds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~--------  239 (953)
T KOG0587|consen  170 SAQLDS--TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFL--------  239 (953)
T ss_pred             eeeeec--ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhcc--------
Confidence            987642  222334567999999999875     34578899999999999999999999877543211000        


Q ss_pred             CcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          749 ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       749 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                                ....+...+..+.....++-++|..|+..|-++||++.++++|
T Consensus       240 ----------IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  240 ----------IPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             ----------CCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence                      1223344555566778899999999999999999999998764

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=4.5e-32  Score=294.05  Aligned_cols=245  Identities=26%  Similarity=0.410  Sum_probs=192.8

Q ss_pred             CCCCceeeeccceE-EEEEEECCCcEEEEEEeeccccchhhhHHHHHHHHhcC-CCCcceeEEeeeecCCeeEEEEeccC
Q 040845          529 FSENNLIGRGGFGS-VYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSI-RHRNLVKVISSCSNEEFKALVLEYMP  606 (824)
Q Consensus       529 ~~~~~~lg~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  606 (824)
                      |...+++|.|+.|+ ||+|... |+.||||++-.   +...-+.+|+..++.- +|||||++++.-.++.+.|+..|.|.
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~  586 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA  586 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeC-CceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence            33446789999985 7999987 89999998753   3345667899999887 69999999999999999999999994


Q ss_pred             CCCHHHHhhhCCCC---CCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC-----CCcEEEeecccccccC
Q 040845          607 HGSLEKYLHSSNYS---LDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD-----NMVAHLSDFGIAKLLT  678 (824)
Q Consensus       607 ~g~L~~~l~~~~~~---~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~-----~~~~kl~Dfg~a~~~~  678 (824)
                       .+|.+++......   ......+.+..|++.|+++||   +.+|||||+||.|||++.     ...++|+|||+++.+.
T Consensus       587 -~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  587 -CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             -hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence             5999999874211   111445788999999999999   999999999999999975     2578999999999987


Q ss_pred             CCCCcc-ccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhC-CCCCcccccCcchhhhhhhhhCCCcchhhcc
Q 040845          679 GEDQSM-TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTR-KKPTDELFNGEMTLKHWVNDCLPISTMEVVD  756 (824)
Q Consensus       679 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  756 (824)
                      ...... ......||-+|+|||.+....-+.++||||+||++|+.++| .+||++....+..+..-..           +
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~-----------~  731 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNY-----------T  731 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCcc-----------c
Confidence            655443 34567799999999999998888999999999999999996 8999875544332221100           0


Q ss_pred             ccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          757 ANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       757 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      -.       .+....+|  ++.+||.+|++++|..||+|.+|+.|
T Consensus       732 L~-------~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H  767 (903)
T KOG1027|consen  732 LV-------HLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLNH  767 (903)
T ss_pred             ee-------eeccCchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence            00       00011122  68899999999999999999999865

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=1.7e-30  Score=285.92  Aligned_cols=257  Identities=19%  Similarity=0.252  Sum_probs=182.2

Q ss_pred             hccCCCCceeeeccceEEEEEEE-----------------CCCcEEEEEEeeccccchh--------------hhHHHHH
Q 040845          526 TDKFSENNLIGRGGFGSVYKARI-----------------RDGMEVAVKVFNLQCGRAF--------------KSFDVEC  574 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~-----------------~~~~~vavK~~~~~~~~~~--------------~~~~~E~  574 (824)
                      .++|++.++||+|+||+||+|..                 .+++.||||.+........              +....|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            67899999999999999999964                 2357899999865432222              2234477


Q ss_pred             HHHhcCCCCcc-----eeEEeeeec--------CCeeEEEEeccCCCCHHHHhhhCC-----------------------
Q 040845          575 AMMKSIRHRNL-----VKVISSCSN--------EEFKALVLEYMPHGSLEKYLHSSN-----------------------  618 (824)
Q Consensus       575 ~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~-----------------------  618 (824)
                      .++.+++|.++     ++++++|..        ....++||||+++++|.++++...                       
T Consensus       224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~  303 (507)
T PLN03224        224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ  303 (507)
T ss_pred             HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence            77788876654     667777643        356789999999999999987421                       


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccccccccccccccCc
Q 040845          619 YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP  698 (824)
Q Consensus       619 ~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aP  698 (824)
                      ...++..+..++.|+++|++|+|   +.+|+||||||+||+++.++.+||+|||++........ .......+++.|+||
T Consensus       304 ~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        304 DKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSPP  379 (507)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeCh
Confidence            12456788899999999999999   99999999999999999999999999999976532211 111223357899999


Q ss_pred             cCcCCCC--------------------C--CccchHHHHHHHHHHHHhCCC-CCcccccC-------cchhhhhhhhhCC
Q 040845          699 EYGREGQ--------------------V--STNGDVYSFGIMLMETFTRKK-PTDELFNG-------EMTLKHWVNDCLP  748 (824)
Q Consensus       699 E~~~~~~--------------------~--~~~~DvwslG~~l~el~tg~~-p~~~~~~~-------~~~~~~~~~~~~~  748 (824)
                      |.+....                    +  ..+.||||+||++|||++|.. |+......       +.....|....  
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~--  457 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYK--  457 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhc--
Confidence            9875322                    1  234799999999999999885 66432111       11111221100  


Q ss_pred             CcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCC---CCCCCHHHHHHH
Q 040845          749 ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESP---EQRINAKEIVAK  801 (824)
Q Consensus       749 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP---~~Rpt~~evl~~  801 (824)
                                   ...........++....+++.+|+..+|   .+|+|++|+++|
T Consensus       458 -------------~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H  500 (507)
T PLN03224        458 -------------GQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH  500 (507)
T ss_pred             -------------ccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence                         0001111122346678899999999866   689999999876

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.97  E-value=3.4e-30  Score=264.57  Aligned_cols=238  Identities=31%  Similarity=0.383  Sum_probs=193.4

Q ss_pred             cceEEEEEEECC-CcEEEEEEeeccccch-hhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEeccCCCCHHHHhhh
Q 040845          539 GFGSVYKARIRD-GMEVAVKVFNLQCGRA-FKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHS  616 (824)
Q Consensus       539 ~~g~V~~~~~~~-~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~  616 (824)
                      +||.||+|.+.. |+.||+|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            589999998764 8999999987654443 67899999999999999999999999999999999999999999999976


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcccccccccccccc
Q 040845          617 SNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYM  696 (824)
Q Consensus       617 ~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~  696 (824)
                      .. .+++..+..++.+++.+++|||   +.+++|+||+|+||++++++.++++|||.+.......   ......++..|+
T Consensus        81 ~~-~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~  153 (244)
T smart00220       81 RG-RLSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYM  153 (244)
T ss_pred             cc-CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCC
Confidence            55 3889999999999999999999   8999999999999999999999999999998764332   223445788999


Q ss_pred             CccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhhhhhhHHHHHHH
Q 040845          697 APEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSF  776 (824)
Q Consensus       697 aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  776 (824)
                      |||......++.++||||+|+++|++++|..||......+ ...++......            ...    .....++..
T Consensus       154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~-~~~~~~~~~~~------------~~~----~~~~~~~~~  216 (244)
T smart00220      154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL-ELFKKIGKPKP------------PFP----PPEWKISPE  216 (244)
T ss_pred             CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHhccCC------------CCc----cccccCCHH
Confidence            9999988888999999999999999999999986531111 11111110000            000    000014567


Q ss_pred             HHHHHHHccccCCCCCCCHHHHHH
Q 040845          777 VFNLALECTVESPEQRINAKEIVA  800 (824)
Q Consensus       777 l~~l~~~cl~~dP~~Rpt~~evl~  800 (824)
                      +.+++.+||..+|++||++.++++
T Consensus       217 ~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      217 AKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHHHHccCCchhccCHHHHhh
Confidence            899999999999999999999987

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=7e-31  Score=255.00  Aligned_cols=247  Identities=23%  Similarity=0.302  Sum_probs=199.7

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcC-CCCcceeEEeeeecCCeeEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSI-RHRNLVKVISSCSNEEFKAL  600 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  600 (824)
                      ..+|+..++||+|+|+.|..++++ +.+.||+|+++++.   ++...-.+.|-.+..+. +||++|-++.+|+.+...++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            467899999999999999999865 57889999987653   34455567787887777 69999999999999999999


Q ss_pred             EEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 040845          601 VLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE  680 (824)
Q Consensus       601 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  680 (824)
                      |.||++||+|-=++++.+ +++++.+..+..+|.-||.|||   ++||+.||+|..||++|..|++|++|+|+++.--. 
T Consensus       329 vieyv~ggdlmfhmqrqr-klpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~l~-  403 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG-  403 (593)
T ss_pred             EEEEecCcceeeehhhhh-cCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcCCC-
Confidence            999999999977777665 7899999999999999999999   99999999999999999999999999999974322 


Q ss_pred             CCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCccc--ccCcchhhhhhhhhCCCcchhhcccc
Q 040845          681 DQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEL--FNGEMTLKHWVNDCLPISTMEVVDAN  758 (824)
Q Consensus       681 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  758 (824)
                       .....+...||+.|.|||++++..|+..+|.|++||+++||+.|+.||+-.  ...++...+|.-..+-+       ..
T Consensus       404 -~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvile-------kq  475 (593)
T KOG0695|consen  404 -PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILE-------KQ  475 (593)
T ss_pred             -CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhh-------hc
Confidence             222344578999999999999999999999999999999999999999853  23344444443222111       00


Q ss_pred             ccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCC
Q 040845          759 LLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRI  793 (824)
Q Consensus       759 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp  793 (824)
                            .+  .|...+.....+++.-+++||.+|.
T Consensus       476 ------ir--iprslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  476 ------IR--IPRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             ------cc--ccceeehhhHHHHHHhhcCCcHHhc
Confidence                  01  1223344566788999999999986

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=1.9e-31  Score=246.15  Aligned_cols=264  Identities=19%  Similarity=0.307  Sum_probs=199.5

Q ss_pred             hhccCCCCceeeeccceEEEEEE-ECCCcEEEEEEeeccccchhhhHHHHHHHHhcCC-CCcceeEEeeeecC--CeeEE
Q 040845          525 ATDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIR-HRNLVKVISSCSNE--EFKAL  600 (824)
Q Consensus       525 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~l  600 (824)
                      ..++|++.+.+|+|.|++||.|. ..+.++++||++++.   ..+.+.+|+.+++.++ ||||++++++..++  ..+.+
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL  112 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL  112 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence            45789999999999999999996 566899999999753   4567889999999997 99999999998764  57789


Q ss_pred             EEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC-CCcEEEeecccccccCC
Q 040845          601 VLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD-NMVAHLSDFGIAKLLTG  679 (824)
Q Consensus       601 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~Dfg~a~~~~~  679 (824)
                      |+||+++.+....-.    .++..++..++.+++.||.|+|   ++||+|||+||.|+++|. .-.++++|+|+|.++.+
T Consensus       113 iFE~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp  185 (338)
T KOG0668|consen  113 IFEYVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  185 (338)
T ss_pred             HhhhhccccHHHHhh----hhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence            999999877766543    5677788999999999999999   999999999999999984 56799999999998865


Q ss_pred             CCCccccccccccccccCccCcCCC-CCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhcc--
Q 040845          680 EDQSMTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVD--  756 (824)
Q Consensus       680 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  756 (824)
                      ....   ...+.+..|--||.+..- .|+..-|+|||||++..|+..+.||-........+..+++...-......+.  
T Consensus       186 ~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY  262 (338)
T KOG0668|consen  186 GKEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKY  262 (338)
T ss_pred             Ccee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHH
Confidence            5433   223456678899988654 5789999999999999999999998654443333333332222111111111  


Q ss_pred             -----ccccC---chh----hhhh---hHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          757 -----ANLLS---QED----IHFV---AKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       757 -----~~~~~---~~~----~~~~---~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                           +....   ...    .++.   ...-..+++.+++.+.+.+|-.+|+||+|+.+|
T Consensus       263 ~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H  322 (338)
T KOG0668|consen  263 QIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH  322 (338)
T ss_pred             ccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence                 11000   000    0000   011245778999999999999999999999875

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=9.8e-32  Score=274.63  Aligned_cols=251  Identities=22%  Similarity=0.301  Sum_probs=204.1

Q ss_pred             ccCCCCceeeeccceEEEEEEECCCc-EEEEEEeecc---ccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEE
Q 040845          527 DKFSENNLIGRGGFGSVYKARIRDGM-EVAVKVFNLQ---CGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVL  602 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~~~~-~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  602 (824)
                      .+++....||-||||.|-.++.+... .+|+|.+++.   .+...+.+..|-.+|...+.|.||++|..|.+.+..|+.|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            45566778999999999999876433 4888877543   3455677888999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 040845          603 EYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ  682 (824)
Q Consensus       603 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  682 (824)
                      |-|-||.+...++..+ .++..+...++..+.+|++|||   .++||+||+||+|.++|.+|-+||.|||+|+.+.....
T Consensus       500 EaClGGElWTiLrdRg-~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K  575 (732)
T KOG0614|consen  500 EACLGGELWTILRDRG-SFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK  575 (732)
T ss_pred             HhhcCchhhhhhhhcC-CcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhccCCc
Confidence            9999999999998776 7888899999999999999999   99999999999999999999999999999998754433


Q ss_pred             ccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCc
Q 040845          683 SMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ  762 (824)
Q Consensus       683 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  762 (824)
                      +   ...+||+.|.|||++.....+.++|.||+|+++||+++|.+||.+..+.. .+..+.+                ..
T Consensus       576 T---wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmk-tYn~ILk----------------Gi  635 (732)
T KOG0614|consen  576 T---WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMK-TYNLILK----------------GI  635 (732)
T ss_pred             e---eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHH-HHHHHHh----------------hh
Confidence            2   33679999999999999999999999999999999999999998732211 1111111                00


Q ss_pred             hhhhhhhHHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHH
Q 040845          763 EDIHFVAKEQCVSFVFNLALECTVESPEQRIN-----AKEIVAKLL  803 (824)
Q Consensus       763 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt-----~~evl~~L~  803 (824)
                      .  ....|...+....++|++....+|.+|..     +.|+.+|-+
T Consensus       636 d--~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~W  679 (732)
T KOG0614|consen  636 D--KIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRW  679 (732)
T ss_pred             h--hhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhh
Confidence            0  11122344566788999999999999985     677766643

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.5e-32  Score=257.12  Aligned_cols=267  Identities=22%  Similarity=0.314  Sum_probs=196.2

Q ss_pred             CCCceeeeccceEEEEEEE-CCCcEEEEEEeecccc--chhhhHHHHHHHHhcCCCCcceeEEeeeecCC-----eeEEE
Q 040845          530 SENNLIGRGGFGSVYKARI-RDGMEVAVKVFNLQCG--RAFKSFDVECAMMKSIRHRNLVKVISSCSNEE-----FKALV  601 (824)
Q Consensus       530 ~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lv  601 (824)
                      +..+.||-|+||.||.+++ ++|+.||.|++...-.  ...+.+.+|++++..++|.|+...+++.+-..     ..|.+
T Consensus        56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~  135 (449)
T KOG0664|consen   56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL  135 (449)
T ss_pred             CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence            4457899999999999975 4699999998754322  34567889999999999999999998875543     45688


Q ss_pred             EeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 040845          602 LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED  681 (824)
Q Consensus       602 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  681 (824)
                      +|.| ..+|...+-... .++...+.-+.+||++|+.|||   +.+|.||||||.|.++..+..+||||||+|+.... +
T Consensus       136 TELm-QSDLHKIIVSPQ-~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~-d  209 (449)
T KOG0664|consen  136 TELM-QSDLHKIIVSPQ-ALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ-R  209 (449)
T ss_pred             HHHH-HhhhhheeccCC-CCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccch-h
Confidence            8988 458888876544 7888889999999999999999   99999999999999999999999999999987543 3


Q ss_pred             CccccccccccccccCccCcCCC-CCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhcccccc
Q 040845          682 QSMTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLL  760 (824)
Q Consensus       682 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  760 (824)
                      .....+..+.|..|+|||++++. .|+.++||||.||++.|++..+.-|....  .....+.+.+.......+.+.....
T Consensus       210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~--PiqQL~lItdLLGTPs~EaMr~ACE  287 (449)
T KOG0664|consen  210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAG--PIEQLQMIIDLLGTPSQEAMKYACE  287 (449)
T ss_pred             hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccC--hHHHHHHHHHHhCCCcHHHHHHHhh
Confidence            33445666789999999999876 58999999999999999998887665421  1111112222222111111111110


Q ss_pred             Cchh---------------hhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 040845          761 SQED---------------IHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLK  804 (824)
Q Consensus       761 ~~~~---------------~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~  804 (824)
                      +...               +....+..-..+...+...++..||.+|.+..+++.+...
T Consensus       288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~  346 (449)
T KOG0664|consen  288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYL  346 (449)
T ss_pred             hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence            0000               0111112233456778889999999999999999887654

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=99.97  E-value=1.6e-32  Score=300.07  Aligned_cols=428  Identities=26%  Similarity=0.314  Sum_probs=314.0

Q ss_pred             cccccccccCCcccccCCCCCcEEEccCCcccccccccccCCCCCCEEeCCCCcCCcccChhhhCcCCCceeeccCCccc
Q 040845            3 SIINNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLS   82 (824)
Q Consensus         3 ~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~   82 (824)
                      ++.+-+++-+ |..+-.-..++.|+++.|-+.......+.+.-.|+.||||+|+++ ..|..+..+.+|+.|+++.|-|.
T Consensus         4 d~s~~~l~~i-p~~i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~   81 (1081)
T KOG0618|consen    4 DASDEQLELI-PEQILNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR   81 (1081)
T ss_pred             ccccccCccc-chhhccHHHHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh
Confidence            4445555444 444444445999999999888443334445555999999999998 88999999999999999999999


Q ss_pred             cccCccccCCCCCccEEEccCCeeeeecCccccCCCCCceEeccCccccccCCccccCCCCCCEEEccCC-cCCCCcCc-
Q 040845           83 GCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDN-NLTSSTLD-  160 (824)
Q Consensus        83 ~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n-~i~~~~~~-  160 (824)
                      .++....  .+.+|++|.|.+|.+. ..|..+..+.+|+.|++++|.+. .+|..+..++.++.+..++| +++.++.. 
T Consensus        82 ~vp~s~~--~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg~~~  157 (1081)
T KOG0618|consen   82 SVPSSCS--NMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQRLGQTS  157 (1081)
T ss_pred             hCchhhh--hhhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhhhcccc
Confidence            9997665  4899999999999998 88999999999999999999999 67878888888888888887 22222110 


Q ss_pred             ------------ccccccCCCCCCCcEEECcCCCCCccCCcccc----------------ccccccccEEEeecCcceec
Q 040845          161 ------------LSFLSSLSNCKSLTHISLSNNPLDGILPRTYV----------------GNLSHSLKNFYMYNCNVSGG  212 (824)
Q Consensus       161 ------------~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~----------------~~l~~~L~~L~l~~n~l~~~  212 (824)
                                  ..++..+..++.  .|+|.+|.+. +......                ...-++++.|+.+.|.++..
T Consensus       158 ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~-~~dls~~~~l~~l~c~rn~ls~l~~~g~~l~~L~a~~n~l~~~  234 (1081)
T KOG0618|consen  158 IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME-VLDLSNLANLEVLHCERNQLSELEISGPSLTALYADHNPLTTL  234 (1081)
T ss_pred             chhhhhhhhhcccchhcchhhhhe--eeecccchhh-hhhhhhccchhhhhhhhcccceEEecCcchheeeeccCcceee
Confidence                        012223333444  4888888886 2111111                11113555555555555522


Q ss_pred             CCccCCCCCCCCEEEecCCccCCccchhhcCCCCCCEEEcccccCcccCCccccccCCccEEEccCccccccCCccccCC
Q 040845          213 IPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNM  292 (824)
Q Consensus       213 ~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l  292 (824)
                      .+.  ..-.+|+.+++++|+++ ..|+++..+.+|+.|+..+|++. .+|..+....+|+.|.+..|.++ -+|...+.+
T Consensus       235 ~~~--p~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~  309 (1081)
T KOG0618|consen  235 DVH--PVPLNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGL  309 (1081)
T ss_pred             ccc--cccccceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCccccc
Confidence            211  11256777777777777 44577777777777777777775 66677777777777777777777 455566677


Q ss_pred             CCCcEEEcCCCCCCCCCCcccc-c-ccccccccccccccCcCCccccccccchhhhcccccccccCCCccCCCCCCCeEE
Q 040845          293 TFLKVLSLGSNELTSIPLNFWS-L-KDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLF  370 (824)
Q Consensus       293 ~~L~~L~L~~N~l~~lp~~~~~-l-~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~  370 (824)
                      +.|++|+|..|+|.++|..+.. + ..|..|+.+.|++....-..=..+..|+.|++.+|.+++..-..+.+.++|+.|+
T Consensus       310 ~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLh  389 (1081)
T KOG0618|consen  310 KSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLH  389 (1081)
T ss_pred             ceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeee
Confidence            7888888888888888776543 2 2367777777777643322223467899999999999987667788999999999


Q ss_pred             ccCccccccCCccccccccccEEEccCcccCCCCcccccCCcccceeeccCCcccCCCCCCCCccccccccccCCc
Q 040845          371 LEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIPRGGSFGNFSAESFKGNE  446 (824)
Q Consensus       371 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~  446 (824)
                      |++|+|.......+.+++.|+.|+||+|+|+ .+|..+..+..|++|...+|++.+-+ ....++++..+.+.-|.
T Consensus       390 LsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~~fP-e~~~l~qL~~lDlS~N~  463 (1081)
T KOG0618|consen  390 LSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLLSFP-ELAQLPQLKVLDLSCNN  463 (1081)
T ss_pred             ecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCceeech-hhhhcCcceEEecccch
Confidence            9999998544566789999999999999998 99999999999999999999998654 66777777777766664

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=6.9e-30  Score=267.14  Aligned_cols=205  Identities=22%  Similarity=0.331  Sum_probs=174.6

Q ss_pred             CCCCceeeeccceEEEEEE-ECCCcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEec
Q 040845          529 FSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       529 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      |...+.||-|+||+|..++ .++...||+|.+++.+   ......++.|..||.....+=||+++..|++++.+|+||||
T Consensus       631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY  710 (1034)
T KOG0608|consen  631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY  710 (1034)
T ss_pred             eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence            6667889999999999996 5557789999887553   33456678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC--
Q 040845          605 MPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ--  682 (824)
Q Consensus       605 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~--  682 (824)
                      ++||++-.++-+.+ -+.+.-+..++.+++.|+++.|   +.|+|||||||+|||+|.+|++||+|||+++-+.-...  
T Consensus       711 IPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdsk  786 (1034)
T KOG0608|consen  711 IPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK  786 (1034)
T ss_pred             cCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccccceeccccc
Confidence            99999999987766 5777788889999999999999   99999999999999999999999999999975431100  


Q ss_pred             ------c--------------------------------cccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh
Q 040845          683 ------S--------------------------------MTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT  724 (824)
Q Consensus       683 ------~--------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t  724 (824)
                            +                                ...-..+||+.|+|||++....|+..+|.||.|||||||+.
T Consensus       787 YYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~  866 (1034)
T KOG0608|consen  787 YYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLV  866 (1034)
T ss_pred             cccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhh
Confidence                  0                                00012369999999999999999999999999999999999


Q ss_pred             CCCCCcccccCcc
Q 040845          725 RKKPTDELFNGEM  737 (824)
Q Consensus       725 g~~p~~~~~~~~~  737 (824)
                      |++||.....++.
T Consensus       867 g~~pf~~~tp~~t  879 (1034)
T KOG0608|consen  867 GQPPFLADTPGET  879 (1034)
T ss_pred             CCCCccCCCCCcc
Confidence            9999987655544

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.96  E-value=1.3e-29  Score=230.84  Aligned_cols=212  Identities=28%  Similarity=0.356  Sum_probs=168.0

Q ss_pred             ccCCCCceeeeccceEEEEEEE-CCCcEEEEEEeeccc-cchhhhHHHHHHH-HhcCCCCcceeEEeeeecCCeeEEEEe
Q 040845          527 DKFSENNLIGRGGFGSVYKARI-RDGMEVAVKVFNLQC-GRAFKSFDVECAM-MKSIRHRNLVKVISSCSNEEFKALVLE  603 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e  603 (824)
                      +.......||+|++|.|-+-++ .+|+..|+|.++... .+..+....|+.+ ++...+|.+|.++|....+...++.||
T Consensus        46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME  125 (282)
T KOG0984|consen   46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME  125 (282)
T ss_pred             hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence            4445566799999999988864 469999999986543 2334455567665 445579999999999999999999999


Q ss_pred             ccCCCCHHHHhh---hCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 040845          604 YMPHGSLEKYLH---SSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE  680 (824)
Q Consensus       604 ~~~~g~L~~~l~---~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  680 (824)
                      .|+. +|+.+-.   ..+...++.-.-+|+..+.+|+.|||+  +..++|||+||+|||++.+|++|+||||++..+.+.
T Consensus       126 ~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS  202 (282)
T KOG0984|consen  126 LMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDS  202 (282)
T ss_pred             Hhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhh
Confidence            9954 7776643   234578888889999999999999996  679999999999999999999999999999876433


Q ss_pred             CCccccccccccccccCccCcCC----CCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhh
Q 040845          681 DQSMTQTQTLATIGYMAPEYGRE----GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVN  744 (824)
Q Consensus       681 ~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~  744 (824)
                      -   ..+...|-..|||||.+..    ..|+.++||||+|+.+.||.+++.||+.++..-..+.+.+.
T Consensus       203 i---Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe  267 (282)
T KOG0984|consen  203 I---AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE  267 (282)
T ss_pred             h---HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence            2   2233346678999998753    36899999999999999999999999886655444444443

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.96  E-value=1.5e-29  Score=245.99  Aligned_cols=263  Identities=23%  Similarity=0.292  Sum_probs=198.5

Q ss_pred             HhhccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecc--ccchhhhHHHHHHHHhcCCCCcceeEEeeeecC-----
Q 040845          524 QATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQ--CGRAFKSFDVECAMMKSIRHRNLVKVISSCSNE-----  595 (824)
Q Consensus       524 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----  595 (824)
                      ....+|...+.+|.|.- .|..|.+. .+++||+|....+  .....++..+|...+..+.|+||++++.++.-.     
T Consensus        14 tv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~   92 (369)
T KOG0665|consen   14 TVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEE   92 (369)
T ss_pred             eeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHH
Confidence            34567888889999998 66666432 4899999987443  234456778899999999999999999998543     


Q ss_pred             -CeeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccc
Q 040845          596 -EFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIA  674 (824)
Q Consensus       596 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a  674 (824)
                       ...|+|||+| ..+|..++..   .++-.++..+..|++.|+.|||   +.+|+|||+||+||++..++.+||.|||+|
T Consensus        93 ~~e~y~v~e~m-~~nl~~vi~~---elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~a  165 (369)
T KOG0665|consen   93 FQEVYLVMELM-DANLCQVILM---ELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLA  165 (369)
T ss_pred             HHhHHHHHHhh-hhHHHHHHHH---hcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhh
Confidence             4678999999 4599998873   5678889999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCc----
Q 040845          675 KLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPIS----  750 (824)
Q Consensus       675 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~----  750 (824)
                      +...   .....+..+.|..|+|||++.+..+.+.+||||.||++.||++|+.-|.    ++..+.+|.+..-...    
T Consensus       166 r~e~---~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~----g~d~idQ~~ki~~~lgtpd~  238 (369)
T KOG0665|consen  166 RTED---TDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFP----GKDHIDQWNKIIEQLGTPDP  238 (369)
T ss_pred             cccC---cccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEec----CchHHHHHHHHHHHhcCCCH
Confidence            8532   2356678889999999999998889999999999999999999998654    4455555543221110    


Q ss_pred             -chhhcccc----ccCchh-h---------------hhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          751 -TMEVVDAN----LLSQED-I---------------HFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       751 -~~~~~~~~----~~~~~~-~---------------~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                       ..+-..+.    ....+. +               ......--...+.+++.+|+..||++|.+++++++|
T Consensus       239 ~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  239 SFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             HHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence             00000000    000000 0               000001123458899999999999999999999876

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.3e-28  Score=249.80  Aligned_cols=130  Identities=28%  Similarity=0.410  Sum_probs=112.7

Q ss_pred             ccCCCCceeeeccceEEEEEE-ECCCcEEEEEEeeccccchhhhHHHHHHHHhcCC-----C---CcceeEEeeee----
Q 040845          527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIR-----H---RNLVKVISSCS----  593 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~----  593 (824)
                      .+|-+.++||.|.|++||.|- ..+.+.||+|+.+.. ....+....||++|++++     |   ..||++++.|.    
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            678899999999999999995 456889999998754 445677788999999995     3   36999999984    


Q ss_pred             cCCeeEEEEeccCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee
Q 040845          594 NEEFKALVLEYMPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL  660 (824)
Q Consensus       594 ~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill  660 (824)
                      ...+.++|+|++ |.+|..+|.... ..++...+.+|++||+.||.|||.  ..+|||-||||+|||+
T Consensus       157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl  221 (590)
T KOG1290|consen  157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLL  221 (590)
T ss_pred             CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeee
Confidence            457999999999 669999998765 679999999999999999999997  6699999999999998

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.96  E-value=4.3e-29  Score=259.43  Aligned_cols=198  Identities=22%  Similarity=0.362  Sum_probs=171.2

Q ss_pred             hccCCCCceeeeccceEEEEEEECC-CcEEEEEEeeccc--------cchhhhHHHHHHHHhcCC---CCcceeEEeeee
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQC--------GRAFKSFDVECAMMKSIR---HRNLVKVISSCS  593 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~  593 (824)
                      ..+|...+.+|+|+||.|+.|.++. ...|+||.+.++.        +...-.+-.|++||..++   |+||++++++|+
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE  639 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE  639 (772)
T ss_pred             cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence            4568889999999999999998764 6779999887552        112234556999999997   999999999999


Q ss_pred             cCCeeEEEEecc-CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecc
Q 040845          594 NEEFKALVLEYM-PHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFG  672 (824)
Q Consensus       594 ~~~~~~lv~e~~-~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  672 (824)
                      +++.+|++||-. ++-+|.+++..+. .+++.++.-|++||+.|+++||   +.+|||||||-+||.++.+|-+||+|||
T Consensus       640 ddd~yyl~te~hg~gIDLFd~IE~kp-~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~klidfg  715 (772)
T KOG1152|consen  640 DDDYYYLETEVHGEGIDLFDFIEFKP-RMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLIDFG  715 (772)
T ss_pred             cCCeeEEEecCCCCCcchhhhhhccC-ccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEeecc
Confidence            999999999986 4558999998766 7899999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCccccccccccccccCccCcCCCCC-CccchHHHHHHHHHHHHhCCCCCcc
Q 040845          673 IAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQV-STNGDVYSFGIMLMETFTRKKPTDE  731 (824)
Q Consensus       673 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~tg~~p~~~  731 (824)
                      .|.......    ....+||..|.|||++.+..| +..-|||++|+++|-++...-||+.
T Consensus       716 saa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  716 SAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             chhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            987654332    344679999999999999887 6678999999999999999999864

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.96  E-value=3e-29  Score=257.17  Aligned_cols=268  Identities=22%  Similarity=0.289  Sum_probs=202.9

Q ss_pred             HhhccCCCCceeeeccceEEEEEEECC-CcEEEEEEeeccccchhhhHHHHHHHHhcCC------CCcceeEEeeeecCC
Q 040845          524 QATDKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDVECAMMKSIR------HRNLVKVISSCSNEE  596 (824)
Q Consensus       524 ~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~~~~~~  596 (824)
                      ....+|.+....|+|-|++|.+|.... |..||||++.... .-.+.=..|+++|++|.      .-|.++++..|....
T Consensus       429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn  507 (752)
T KOG0670|consen  429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN  507 (752)
T ss_pred             hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc
Confidence            345789999999999999999998654 8899999998653 22344567999999995      347899999999999


Q ss_pred             eeEEEEeccCCCCHHHHhhhCC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCC-CcEEEeeccc
Q 040845          597 FKALVLEYMPHGSLEKYLHSSN--YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDN-MVAHLSDFGI  673 (824)
Q Consensus       597 ~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~Dfg~  673 (824)
                      ++|+|||-+ .-+|.+++...+  ..+....+..++.|+.-||..|.   ..+|+|.||||.|||+.+. ..+||||||.
T Consensus       508 HLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iLKLCDfGS  583 (752)
T KOG0670|consen  508 HLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNILKLCDFGS  583 (752)
T ss_pred             eeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcceeeeccCcc
Confidence            999999998 459999998776  56788899999999999999999   9999999999999999864 5679999999


Q ss_pred             ccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcch---------------
Q 040845          674 AKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMT---------------  738 (824)
Q Consensus       674 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~---------------  738 (824)
                      |.....+.    .+.+..+..|.|||++.+-.|+...|+||+||.+||+.||+.-|.+.....+-               
T Consensus       584 A~~~~ene----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Kml  659 (752)
T KOG0670|consen  584 ASFASENE----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKML  659 (752)
T ss_pred             cccccccc----ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHh
Confidence            98764333    34455678899999999999999999999999999999999887664322210               


Q ss_pred             -hhhhhhhhCCCcc------------------hhhccc------cccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCC
Q 040845          739 -LKHWVNDCLPIST------------------MEVVDA------NLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRI  793 (824)
Q Consensus       739 -~~~~~~~~~~~~~------------------~~~~~~------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp  793 (824)
                       -.++....+....                  +..+.+      .+...+... .........+.+|+.+|+..||++|.
T Consensus       660 RKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~-deq~~~~~~~rdLLdkml~LdP~KRi  738 (752)
T KOG0670|consen  660 RKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLP-DEQPKIVQQLRDLLDKMLILDPEKRI  738 (752)
T ss_pred             hhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCC-chhHHHHHHHHHHHHHHhccChhhcC
Confidence             0111111111110                  000000      000000000 01124566799999999999999999


Q ss_pred             CHHHHHHH
Q 040845          794 NAKEIVAK  801 (824)
Q Consensus       794 t~~evl~~  801 (824)
                      |..|+++|
T Consensus       739 t~nqAL~H  746 (752)
T KOG0670|consen  739 TVNQALKH  746 (752)
T ss_pred             CHHHHhcC
Confidence            99999875

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.95  E-value=1.8e-27  Score=238.52  Aligned_cols=211  Identities=36%  Similarity=0.569  Sum_probs=184.3

Q ss_pred             eeeccceEEEEEEECC-CcEEEEEEeeccccc-hhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEeccCCCCHHH
Q 040845          535 IGRGGFGSVYKARIRD-GMEVAVKVFNLQCGR-AFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEK  612 (824)
Q Consensus       535 lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  612 (824)
                      ||+|++|.||++...+ ++.+++|++...... ..+.+.+|++.++.++|++++++++++......++++||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999998764 899999998755332 35678999999999999999999999999999999999999899999


Q ss_pred             HhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC-CCcEEEeecccccccCCCCCccccccccc
Q 040845          613 YLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD-NMVAHLSDFGIAKLLTGEDQSMTQTQTLA  691 (824)
Q Consensus       613 ~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  691 (824)
                      ++......+++..+..++.++++++++||   +.+++|+||+|.||+++. ++.++|+|||.+........  ......+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~  155 (215)
T cd00180          81 LLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVG  155 (215)
T ss_pred             HHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccC
Confidence            99876446889999999999999999999   899999999999999999 89999999999986643321  1233457


Q ss_pred             cccccCccCcCCC-CCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhhhhhhH
Q 040845          692 TIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAK  770 (824)
Q Consensus       692 ~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  770 (824)
                      ...|++||..... .++.++|+|++|++++++                                                
T Consensus       156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------  187 (215)
T cd00180         156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------  187 (215)
T ss_pred             CCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------
Confidence            7889999998877 789999999999999999                                                


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 040845          771 EQCVSFVFNLALECTVESPEQRINAKEIVAKL  802 (824)
Q Consensus       771 ~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L  802 (824)
                          ..+.+++.+|+..+|++||++.++++++
T Consensus       188 ----~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 ----PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             ----HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                2467899999999999999999998753

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.95  E-value=2.5e-29  Score=265.60  Aligned_cols=253  Identities=27%  Similarity=0.427  Sum_probs=208.4

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEec
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      .++|+....+|.|.||.||+|+.. +++..|||+++.+.......+++|+-+++.-+|+|||.++|.+-..+..+++|||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy   93 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY   93 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence            467889999999999999999854 5899999999999888889999999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 040845          605 MPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM  684 (824)
Q Consensus       605 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  684 (824)
                      +.+|+|++.-+-.+ .+++-++..+.++..+|++|||   +.+=+|||||..||++++.|.+|++|||.+..+..  .-.
T Consensus        94 cgggslQdiy~~Tg-plselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqita--ti~  167 (829)
T KOG0576|consen   94 CGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA--TIA  167 (829)
T ss_pred             cCCCcccceeeecc-cchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhh--hhh
Confidence            99999998877655 7888899999999999999999   99999999999999999999999999999876532  223


Q ss_pred             ccccccccccccCccCc---CCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccC
Q 040845          685 TQTQTLATIGYMAPEYG---REGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLS  761 (824)
Q Consensus       685 ~~~~~~~~~~y~aPE~~---~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  761 (824)
                      .....+||+.|||||+.   +.+.|...+|||+.|+...|+-.-++|-....+              .+...........
T Consensus       168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp--------------mr~l~LmTkS~~q  233 (829)
T KOG0576|consen  168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP--------------MRALFLMTKSGFQ  233 (829)
T ss_pred             hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch--------------HHHHHHhhccCCC
Confidence            44567899999999965   466799999999999999999888877433221              1111111111111


Q ss_pred             chhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040845          762 QEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVA  800 (824)
Q Consensus       762 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~  800 (824)
                      .  ..+..+....+.+.++++.|+..+|.+||+++.++.
T Consensus       234 p--p~lkDk~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  234 P--PTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             C--CcccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            1  122223345677999999999999999999988765

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.95  E-value=7.1e-28  Score=243.60  Aligned_cols=271  Identities=23%  Similarity=0.319  Sum_probs=200.8

Q ss_pred             HHHhhccCCCCceeeeccceEEEEEEEC----CCcEEEEEEeeccccchhhhHHHHHHHHhcC-CCCcceeEEeeeecCC
Q 040845          522 LFQATDKFSENNLIGRGGFGSVYKARIR----DGMEVAVKVFNLQCGRAFKSFDVECAMMKSI-RHRNLVKVISSCSNEE  596 (824)
Q Consensus       522 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  596 (824)
                      +....+.|...++||+|.|++||+|...    .++.||+|.+...  .....+..|+++|..+ .+.||+++.+++...+
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            3445677999999999999999999743    3678999988654  4456789999999999 5899999999999999


Q ss_pred             eeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC-CCCcEEEeeccccc
Q 040845          597 FKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAK  675 (824)
Q Consensus       597 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~-~~~~~kl~Dfg~a~  675 (824)
                      ...+|+||+++....++..    .++..++..+++.+..||+++|   ..|||||||||.|++.+ ..+.-.|+|||+|.
T Consensus       109 ~v~ivlp~~~H~~f~~l~~----~l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~  181 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLYR----SLSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ  181 (418)
T ss_pred             eeEEEecccCccCHHHHHh----cCCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechhHH
Confidence            9999999999999888876    4567889999999999999999   99999999999999997 45778999999997


Q ss_pred             ccCCCC------------------C------------------------ccccccccccccccCccCcCC-CCCCccchH
Q 040845          676 LLTGED------------------Q------------------------SMTQTQTLATIGYMAPEYGRE-GQVSTNGDV  712 (824)
Q Consensus       676 ~~~~~~------------------~------------------------~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv  712 (824)
                      ......                  .                        ........||+||+|||++.. +..+.++||
T Consensus       182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi  261 (418)
T KOG1167|consen  182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI  261 (418)
T ss_pred             HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence            321100                  0                        001123469999999998765 456899999


Q ss_pred             HHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcch---------------------------hhcc-ccccCchh
Q 040845          713 YSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTM---------------------------EVVD-ANLLSQED  764 (824)
Q Consensus       713 wslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~-~~~~~~~~  764 (824)
                      ||.||++.-+++++.||.....+-..+.+.+....+....                           +-++ ........
T Consensus       262 ws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q  341 (418)
T KOG1167|consen  262 WSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQ  341 (418)
T ss_pred             eeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccc
Confidence            9999999999999999865443333222222111110000                           0000 00000000


Q ss_pred             --hhhhhH-HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          765 --IHFVAK-EQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       765 --~~~~~~-~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                        ...... +..+..+++++.+|+..||.+|.||+|+++|
T Consensus       342 ~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH  381 (418)
T KOG1167|consen  342 PNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH  381 (418)
T ss_pred             cceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence              011111 2334479999999999999999999999875

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.94  E-value=2.4e-26  Score=233.00  Aligned_cols=199  Identities=31%  Similarity=0.452  Sum_probs=173.5

Q ss_pred             CCCCceeeeccceEEEEEEECC-CcEEEEEEeeccccc-hhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEeccC
Q 040845          529 FSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGR-AFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMP  606 (824)
Q Consensus       529 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  606 (824)
                      |...+.||+|++|.||+|...+ ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            5667899999999999998765 899999998765444 56788899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcccc
Q 040845          607 HGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQ  686 (824)
Q Consensus       607 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  686 (824)
                      +++|.+++......+++..+..++.+++.++++||   +.+++|+|++|.||+++.++.++|+|||.+......... ..
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-~~  156 (225)
T smart00221       81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-LL  156 (225)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-cc
Confidence            99999999876533789999999999999999999   899999999999999999999999999999876543211 22


Q ss_pred             ccccccccccCccCc-CCCCCCccchHHHHHHHHHHHHhCCCCCcc
Q 040845          687 TQTLATIGYMAPEYG-REGQVSTNGDVYSFGIMLMETFTRKKPTDE  731 (824)
Q Consensus       687 ~~~~~~~~y~aPE~~-~~~~~~~~~DvwslG~~l~el~tg~~p~~~  731 (824)
                      ....++..|++||.. ....++.++|+|+||++++||++|+.||+.
T Consensus       157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            334577889999988 666778899999999999999999999966

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.94  E-value=2.5e-27  Score=224.59  Aligned_cols=269  Identities=19%  Similarity=0.266  Sum_probs=193.7

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcC-CCCcceeEEee-eecCCeeEEEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSI-RHRNLVKVISS-CSNEEFKALVL  602 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~-~~~~~~~~lv~  602 (824)
                      .+.|.+.+.+|+|.||.+-.+.++ +.+.+|+|.+..+. ....+|.+|...--.| .|.||+.-+++ |+..+.+++++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q  101 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ  101 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence            467888999999999999999876 47889999886553 3457788888766566 48999988865 67778888999


Q ss_pred             eccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC--CCCcEEEeecccccccCCC
Q 040845          603 EYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD--DNMVAHLSDFGIAKLLTGE  680 (824)
Q Consensus       603 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~--~~~~~kl~Dfg~a~~~~~~  680 (824)
                      ||++.|+|.+-+...+  +.+.....++.|+++|+.|+|   ++.+||||||.+|||+-  +...+|+||||..+.....
T Consensus       102 E~aP~gdL~snv~~~G--igE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t  176 (378)
T KOG1345|consen  102 EFAPRGDLRSNVEAAG--IGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT  176 (378)
T ss_pred             ccCccchhhhhcCccc--ccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeecccccccCce
Confidence            9999999999987654  677788899999999999999   99999999999999983  4458999999998753211


Q ss_pred             CCccccccccccccccCccCcC---CC--CCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhc
Q 040845          681 DQSMTQTQTLATIGYMAPEYGR---EG--QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVV  755 (824)
Q Consensus       681 ~~~~~~~~~~~~~~y~aPE~~~---~~--~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  755 (824)
                         .  .....+..|.|||...   .+  ...+.+|+|.||+++|.++||+.||......+..+..|..-...... .  
T Consensus       177 ---V--~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~-~--  248 (378)
T KOG1345|consen  177 ---V--KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNP-A--  248 (378)
T ss_pred             ---e--hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCc-c--
Confidence               1  1112455799999653   22  34678999999999999999999998654444444444332111100 0  


Q ss_pred             cccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH-HHhhccccCCcee
Q 040845          756 DANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKI-RDSLLRNVGGRCI  818 (824)
Q Consensus       756 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~-~~~~~~~~~~~~~  818 (824)
                      -+...          ...++.+.++.++-+..+|++|=...++.+..... .++......+.+.
T Consensus       249 ~P~~F----------~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~i~t~k~~ee  302 (378)
T KOG1345|consen  249 LPKKF----------NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKLIKTVKRPEE  302 (378)
T ss_pred             Cchhh----------cccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhhhccccChhh
Confidence            00000          12456688899999999999995444444443332 2444444444433

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.94  E-value=6.2e-29  Score=247.55  Aligned_cols=391  Identities=23%  Similarity=0.235  Sum_probs=255.3

Q ss_pred             CCcEEEccCCcccccccccccCCCCCCEEeCCCCcCCcccChhhhCcCCCceeeccC-CccccccCccccCCCCCccEEE
Q 040845           22 NLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTN-NSLSGCLSSITDVGLPNLEVLY  100 (824)
Q Consensus        22 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~~l~~L~~L~  100 (824)
                      .-.+++|..|.|+.+.+.+|+.+++|+.||||+|.|+.+-|++|.++.+|.+|-+-+ |+|+.++...+ .+|.+|+.|.
T Consensus        68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F-~gL~slqrLl  146 (498)
T KOG4237|consen   68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAF-GGLSSLQRLL  146 (498)
T ss_pred             cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHh-hhHHHHHHHh
Confidence            345677777777766667777777777777777777777777777777766665554 67776666544 3677777777


Q ss_pred             ccCCeeeeecCccccCCCCCceEeccCccccccCCccccCCCCCCEEEccCCcCCCC-cCcc------cccccCCCCCCC
Q 040845          101 LWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSS-TLDL------SFLSSLSNCKSL  173 (824)
Q Consensus       101 L~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~-~~~~------~~~~~l~~l~~L  173 (824)
                      +.-|++.-+..+.|..+++|..|.+-+|.+..+--.+|..+..++.+.+..|.+... ....      ..+..++.....
T Consensus       147 lNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~  226 (498)
T KOG4237|consen  147 LNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCV  226 (498)
T ss_pred             cChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceec
Confidence            777777766666777777777777777777744444777777777777777762211 0000      001223444555


Q ss_pred             cEEECcCCCCCccCCccccccccccccEEEeecCcceecCC-ccCCCCCCCCEEEecCCccCCccchhhcCCCCCCEEEc
Q 040845          174 THISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIP-EEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDL  252 (824)
Q Consensus       174 ~~L~Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  252 (824)
                      .-..+.++++..+.+..|... ..++..=....+...+..| ..|..+++|+.|+|++|+|+.+.+.+|.++..+++|.|
T Consensus       227 ~p~rl~~~Ri~q~~a~kf~c~-~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L  305 (498)
T KOG4237|consen  227 SPYRLYYKRINQEDARKFLCS-LESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYL  305 (498)
T ss_pred             chHHHHHHHhcccchhhhhhh-HHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhc
Confidence            556666777776666666442 1122111222333333333 35788899999999999998888889999999999999


Q ss_pred             ccccCcccCCccccccCCccEEEccCccccccCCccccCCCCCcEEEcCCCCCC---C---------------CCCcccc
Q 040845          253 EYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELT---S---------------IPLNFWS  314 (824)
Q Consensus       253 ~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~---~---------------lp~~~~~  314 (824)
                      ..|+|.......|..+..|+.|+|++|+|+...|.+|..+.+|.+|+|-.|.+.   .               .|. =..
T Consensus       306 ~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~Wlr~~~~~~~~~-Cq~  384 (498)
T KOG4237|consen  306 TRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEWLRKKSVVGNPR-CQS  384 (498)
T ss_pred             CcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHHHHhhCCCCCCCC-CCC
Confidence            999988777778888888999999999998888888988888999988887543   0               010 011


Q ss_pred             cccccccccccccccC---cCCccc---------cccccchh-hhcccccccccCCCccCCCCCCCeEEccCccccccCC
Q 040845          315 LKDILDLNLSSNCFSG---PLPLEI---------RNLKALIE-IDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIP  381 (824)
Q Consensus       315 l~~L~~L~l~~N~l~~---~~~~~~---------~~l~~L~~-L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  381 (824)
                      ...++.+.++++.+..   ..|++.         ..++-+.+ ...|+..++ .+|..+.  ..-.+|++.+|.++ .+|
T Consensus       385 p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk-~lp~~iP--~d~telyl~gn~~~-~vp  460 (498)
T KOG4237|consen  385 PGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLK-LLPRGIP--VDVTELYLDGNAIT-SVP  460 (498)
T ss_pred             CchhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccchh-hcCCCCC--chhHHHhcccchhc-ccC
Confidence            2345556666554432   122221         22333433 334444444 4454333  34577888899888 566


Q ss_pred             ccccccccccEEEccCcccCCCCcccccCCcccceeeccCC
Q 040845          382 DSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFN  422 (824)
Q Consensus       382 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N  422 (824)
                      ..  .+.+| .+|+++|+++..--..|.++.+|.+|-+++|
T Consensus       461 ~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn  498 (498)
T KOG4237|consen  461 DE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN  498 (498)
T ss_pred             HH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence            65  56677 8899999988555667888888888888876

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.93  E-value=5.9e-27  Score=221.75  Aligned_cols=249  Identities=23%  Similarity=0.372  Sum_probs=197.0

Q ss_pred             CCCceeeeccceEEEEEEECCCcEEEEEEeecc--ccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEeccCC
Q 040845          530 SENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQ--CGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPH  607 (824)
Q Consensus       530 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  607 (824)
                      ....+|.+...|+.|+|+|+ |..+++|++...  .....++|.+|.-.++-+.||||..++|+|..+....++..||+.
T Consensus       193 nl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~  271 (448)
T KOG0195|consen  193 NLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF  271 (448)
T ss_pred             hhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence            34457889999999999998 777888877544  234457899999999999999999999999999999999999999


Q ss_pred             CCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcccc
Q 040845          608 GSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQ  686 (824)
Q Consensus       608 g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  686 (824)
                      |+|..++++.. .-.+..++++++.++|+|++|||+ .+.-|.---+.+..|++|++.+++|+-=. +      ......
T Consensus       272 gslynvlhe~t~vvvd~sqav~faldiargmaflhs-lep~ipr~~lns~hvmidedltarismad-~------kfsfqe  343 (448)
T KOG0195|consen  272 GSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHS-LEPMIPRFYLNSKHVMIDEDLTARISMAD-T------KFSFQE  343 (448)
T ss_pred             hHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhh-cchhhhhhhcccceEEecchhhhheeccc-c------eeeeec
Confidence            99999999765 456778999999999999999994 24445556789999999999988876211 1      111122


Q ss_pred             ccccccccccCccCcCCCC---CCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCch
Q 040845          687 TQTLATIGYMAPEYGREGQ---VSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQE  763 (824)
Q Consensus       687 ~~~~~~~~y~aPE~~~~~~---~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  763 (824)
                      .+..-.+.||+||.+....   .-.++|+|||++++||+.|...||.+..+.+..+.                   ...+
T Consensus       344 ~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmk-------------------iale  404 (448)
T KOG0195|consen  344 VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMK-------------------IALE  404 (448)
T ss_pred             cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhh-------------------hhhc
Confidence            2334568899999987654   34678999999999999999999988655433222                   1223


Q ss_pred             hhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 040845          764 DIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIR  806 (824)
Q Consensus       764 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~  806 (824)
                      +.+...|+..+..+.++|.-|++.||.+||.+..++-.|+++.
T Consensus       405 glrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  405 GLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             cccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            3444556667788999999999999999999999999998874

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.92  E-value=5.2e-25  Score=213.90  Aligned_cols=170  Identities=22%  Similarity=0.218  Sum_probs=131.3

Q ss_pred             CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccccc
Q 040845          608 GSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQT  687 (824)
Q Consensus       608 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  687 (824)
                      |+|.+++...+..+++.+++.++.|++.||+|||   +.+      ||+||+++.++.+|+  ||.+.......      
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------   63 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ------   63 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeecccc------
Confidence            6899999876667999999999999999999999   666      999999999999999  99988653321      


Q ss_pred             cccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhhhh
Q 040845          688 QTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHF  767 (824)
Q Consensus       688 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  767 (824)
                       ..||+.|+|||++.+..++.++|||||||++|||+||+.||............+.....+...             ...
T Consensus        64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-------------~~~  129 (176)
T smart00750       64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDP-------------RDR  129 (176)
T ss_pred             -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCc-------------ccc
Confidence             257899999999999999999999999999999999999986543322222222221111100             000


Q ss_pred             hhHHHHHH--HHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 040845          768 VAKEQCVS--FVFNLALECTVESPEQRINAKEIVAKLLKIRDS  808 (824)
Q Consensus       768 ~~~~~~~~--~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~  808 (824)
                      ..+.....  .+.+++.+||..+|++||++.|+++++......
T Consensus       130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~  172 (176)
T smart00750      130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE  172 (176)
T ss_pred             ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence            01112223  689999999999999999999999999887543

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PLN03210 Resistant to P

Probab=99.92  E-value=3.6e-24  Score=263.41  Aligned_cols=305  Identities=21%  Similarity=0.245  Sum_probs=145.9

Q ss_pred             CCceeeccCCccccccCccccCCCCCccEEEccCCeeeeecCccccCCCCCceEeccCccccccCCccccCCCCCCEEEc
Q 040845           70 TLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTL  149 (824)
Q Consensus        70 ~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L  149 (824)
                      +|+.|++.++.++.+|..+.   +.+|++|++++|++. .++..+..+++|+.|+|++|.....+| .++.+++|+.|+|
T Consensus       590 ~Lr~L~~~~~~l~~lP~~f~---~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L  664 (1153)
T PLN03210        590 KLRLLRWDKYPLRCMPSNFR---PENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKL  664 (1153)
T ss_pred             ccEEEEecCCCCCCCCCcCC---ccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEe
Confidence            34445554444444444321   344455555555444 334444444555555554443222333 2444455555555


Q ss_pred             cCCc-CCCCcCcccccccCCCCCCCcEEECcCCCCCccCCccccccccccccEEEeecCcceecCCccCCCCCCCCEEEe
Q 040845          150 YDNN-LTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVL  228 (824)
Q Consensus       150 ~~n~-i~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L  228 (824)
                      ++|. +..++      ..+.++++|+.|++++|......|...   -..+|+.|++++|...+.+|..   .++|+.|+|
T Consensus       665 ~~c~~L~~lp------~si~~L~~L~~L~L~~c~~L~~Lp~~i---~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L  732 (1153)
T PLN03210        665 SDCSSLVELP------SSIQYLNKLEDLDMSRCENLEILPTGI---NLKSLYRLNLSGCSRLKSFPDI---STNISWLDL  732 (1153)
T ss_pred             cCCCCccccc------hhhhccCCCCEEeCCCCCCcCccCCcC---CCCCCCEEeCCCCCCccccccc---cCCcCeeec
Confidence            4432 22221      234444555555555433211111111   1234444444444333333322   245556666


Q ss_pred             cCCccCCccchhhcCCCCCCEEEcccccCc-------ccCCccccccCCccEEEccCccccccCCccccCCCCCcEEEcC
Q 040845          229 GGNKLNGSIPITLGKLQKLQDVDLEYNQLE-------GSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLG  301 (824)
Q Consensus       229 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-------~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~  301 (824)
                      ++|.+. .+|..+ .+++|++|++.++...       ...+..+...++|+.|++++|.....+|..++++++|+.|+++
T Consensus       733 ~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls  810 (1153)
T PLN03210        733 DETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIE  810 (1153)
T ss_pred             CCCccc-cccccc-cccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECC
Confidence            666655 334333 3555666655543221       1111122234566667777666555666666777777777776


Q ss_pred             CC-CCCCCCCcccccccccccccccccccCcCCccccccccchhhhcccccccccCCCccCCCCCCCeEEccC-cccccc
Q 040845          302 SN-ELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEY-NRLEGS  379 (824)
Q Consensus       302 ~N-~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~  379 (824)
                      +| .++.+|... .+++|+.|++++|......|..   ..+|+.|+|++|.++ .+|..+..+++|+.|+|++ |+++ .
T Consensus       811 ~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~  884 (1153)
T PLN03210        811 NCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-R  884 (1153)
T ss_pred             CCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-c
Confidence            65 456666544 4566666666665433233322   234555566666655 3455555566666666655 3444 3


Q ss_pred             CCccccccccccEEEccCcc
Q 040845          380 IPDSFGDLISLKSLNLSYNN  399 (824)
Q Consensus       380 ~~~~~~~l~~L~~L~L~~N~  399 (824)
                      +|..+..+++|+.|++++|.
T Consensus       885 l~~~~~~L~~L~~L~l~~C~  904 (1153)
T PLN03210        885 VSLNISKLKHLETVDFSDCG  904 (1153)
T ss_pred             cCcccccccCCCeeecCCCc
Confidence            45455555566666665553

syringae 6; Provisional

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.92  E-value=1.7e-25  Score=267.43  Aligned_cols=197  Identities=18%  Similarity=0.267  Sum_probs=140.8

Q ss_pred             cCCC-CcceeEEeee-------ecCCeeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 040845          579 SIRH-RNLVKVISSC-------SNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIH  650 (824)
Q Consensus       579 ~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH  650 (824)
                      .++| +||++++++|       .....++.++||+ +++|.+++......+++.+++.++.||++||+|||   +++|+|
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~gIvH  103 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAH---SQGIVV  103 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHH---hCCeee
Confidence            4566 6888888877       2334667889988 56999999865567999999999999999999999   999999


Q ss_pred             cCCCCCCeeeCCCC-------------------cEEEeecccccccCCCCC--------------ccccccccccccccC
Q 040845          651 CDLKPSNVLLDDNM-------------------VAHLSDFGIAKLLTGEDQ--------------SMTQTQTLATIGYMA  697 (824)
Q Consensus       651 ~Dlk~~Nill~~~~-------------------~~kl~Dfg~a~~~~~~~~--------------~~~~~~~~~~~~y~a  697 (824)
                      |||||+|||++..+                   .+|++|||+++.......              ........||++|||
T Consensus       104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A  183 (793)
T PLN00181        104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS  183 (793)
T ss_pred             ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence            99999999996544                   455566665543211000              000112357889999


Q ss_pred             ccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhhhhhhHHHHHHHH
Q 040845          698 PEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFV  777 (824)
Q Consensus       698 PE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  777 (824)
                      ||++.+..++.++|||||||++|||++|..|+.....   ....+.....+        +.           ........
T Consensus       184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~---~~~~~~~~~~~--------~~-----------~~~~~~~~  241 (793)
T PLN00181        184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR---TMSSLRHRVLP--------PQ-----------ILLNWPKE  241 (793)
T ss_pred             hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH---HHHHHHHhhcC--------hh-----------hhhcCHHH
Confidence            9999999999999999999999999998887653111   11111110000        00           00112335


Q ss_pred             HHHHHHccccCCCCCCCHHHHHHH
Q 040845          778 FNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       778 ~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      .+++.+||+.+|.+||++.|++++
T Consensus       242 ~~~~~~~L~~~P~~Rps~~eil~h  265 (793)
T PLN00181        242 ASFCLWLLHPEPSCRPSMSELLQS  265 (793)
T ss_pred             HHHHHHhCCCChhhCcChHHHhhc
Confidence            678899999999999999999875

>PLN03210 Resistant to P

Probab=99.91  E-value=1e-23  Score=259.36  Aligned_cols=339  Identities=21%  Similarity=0.212  Sum_probs=234.2

Q ss_pred             ccChhhhCcCCCceeeccCCccc-------cccCccccCCCCCccEEEccCCeeeeecCccccCCCCCceEeccCccccc
Q 040845           60 TIPAAIFNVSTLKAFAVTNNSLS-------GCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSG  132 (824)
Q Consensus        60 ~~~~~~~~l~~L~~L~L~~n~l~-------~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~  132 (824)
                      ..+.+|.++.+|+.|.+..+...       .++.... .-.++|+.|++.+|.++ .+|..+ .+.+|+.|+|.+|++. 
T Consensus       549 i~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~-~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-  624 (1153)
T PLN03210        549 IHENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFD-YLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-  624 (1153)
T ss_pred             ecHHHHhcCccccEEEEecccccccccceeecCcchh-hcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-
Confidence            34566777888888877655321       1222221 11357999999999997 667766 5799999999999998 


Q ss_pred             cCCccccCCCCCCEEEccCCc-CCCCcCcccccccCCCCCCCcEEECcCCCCCccCCccccccccccccEEEeecCccee
Q 040845          133 FIPSTFGNLRNLEWLTLYDNN-LTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSG  211 (824)
Q Consensus       133 ~~~~~~~~l~~L~~L~L~~n~-i~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~  211 (824)
                      .++..+..+++|+.|+|+++. +..++       .++.+++|++|+|++|......|..+. . ..+|+.|++++|...+
T Consensus       625 ~L~~~~~~l~~Lk~L~Ls~~~~l~~ip-------~ls~l~~Le~L~L~~c~~L~~lp~si~-~-L~~L~~L~L~~c~~L~  695 (1153)
T PLN03210        625 KLWDGVHSLTGLRNIDLRGSKNLKEIP-------DLSMATNLETLKLSDCSSLVELPSSIQ-Y-LNKLEDLDMSRCENLE  695 (1153)
T ss_pred             ccccccccCCCCCEEECCCCCCcCcCC-------ccccCCcccEEEecCCCCccccchhhh-c-cCCCCEEeCCCCCCcC
Confidence            567888999999999999875 44443       377889999999999875444444432 2 3578888888876666


Q ss_pred             cCCccCCCCCCCCEEEecCCccCCccchhhcCCCCCCEEEcccccCcccCCccccccCCccEEEccCcccc-------cc
Q 040845          212 GIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLS-------GS  284 (824)
Q Consensus       212 ~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~-------~~  284 (824)
                      .+|..+ ++++|+.|++++|......|..   .++|++|++++|.+. .+|..+ .+++|+.|.+.++...       ..
T Consensus       696 ~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l  769 (1153)
T PLN03210        696 ILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPL  769 (1153)
T ss_pred             ccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhhcccccccc
Confidence            666655 6788888888887655445532   357788888888876 455544 4677777777764422       11


Q ss_pred             CCccccCCCCCcEEEcCCCC-CCCCCCcccccccccccccccccccCcCCccccccccchhhhcccccccccCCCccCCC
Q 040845          285 IPACFSNMTFLKVLSLGSNE-LTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSL  363 (824)
Q Consensus       285 ~~~~~~~l~~L~~L~L~~N~-l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l  363 (824)
                      .+..+...++|+.|+|++|. +..+|..+..+++|+.|++++|...+.+|..+ ++++|+.|+|++|.....+|..   .
T Consensus       770 ~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~  845 (1153)
T PLN03210        770 TPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---S  845 (1153)
T ss_pred             chhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---c
Confidence            12222334677888888774 55677777778888888887765444566555 6777888888877654444432   3


Q ss_pred             CCCCeEEccCccccccCCccccccccccEEEccCc-ccCCCCcccccCCcccceeeccCCc
Q 040845          364 KNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYN-NLSGTIPVSLEKLSYLKDLNLSFNK  423 (824)
Q Consensus       364 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~l~~N~  423 (824)
                      .+|+.|+|++|.++ .+|.++..+++|+.|+|++| .++ .+|..+..+++|+.++++++.
T Consensus       846 ~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C~  904 (1153)
T PLN03210        846 TNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDCG  904 (1153)
T ss_pred             cccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCCc
Confidence            56778888888887 56777777888888888774 444 677777777777777777763

syringae 6; Provisional

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.91  E-value=3e-24  Score=244.30  Aligned_cols=224  Identities=25%  Similarity=0.392  Sum_probs=135.6

Q ss_pred             CCccEEEccCCeeeeecCccccCCCCCceEeccCccccccCCccccCCCCCCEEEccCCcCCCCcCcccccccCCCCCCC
Q 040845           94 PNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSL  173 (824)
Q Consensus        94 ~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~~L  173 (824)
                      ++|++|+|++|+|+ .+|..   .++|+.|+|++|.++. +|..   .++|+.|++++|+++.++.         ..++|
T Consensus       242 ~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls~N~L~~-Lp~l---p~~L~~L~Ls~N~Lt~LP~---------~p~~L  304 (788)
T PRK15387        242 PELRTLEVSGNQLT-SLPVL---PPGLLELSIFSNPLTH-LPAL---PSGLCKLWIFGNQLTSLPV---------LPPGL  304 (788)
T ss_pred             CCCcEEEecCCccC-cccCc---ccccceeeccCCchhh-hhhc---hhhcCEEECcCCccccccc---------ccccc
Confidence            34444444444444 22221   2344455555554442 2221   1344455555555544431         12445


Q ss_pred             cEEECcCCCCCccCCccccccccccccEEEeecCcceecCCccCCCCCCCCEEEecCCccCCccchhhcCCCCCCEEEcc
Q 040845          174 THISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLE  253 (824)
Q Consensus       174 ~~L~Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  253 (824)
                      ++|+|++|++.+++.      ++.+|+.|++.+|++++ +|..   ..+|+.|+|++|+|+. +|..   .++|+.|+++
T Consensus       305 ~~LdLS~N~L~~Lp~------lp~~L~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls  370 (788)
T PRK15387        305 QELSVSDNQLASLPA------LPSELCKLWAYNNQLTS-LPTL---PSGLQELSVSDNQLAS-LPTL---PSELYKLWAY  370 (788)
T ss_pred             ceeECCCCccccCCC------CcccccccccccCcccc-cccc---ccccceEecCCCccCC-CCCC---Ccccceehhh
Confidence            555555555554321      23345555555555543 2321   1467777777777774 3432   2467777888


Q ss_pred             cccCcccCCccccccCCccEEEccCccccccCCccccCCCCCcEEEcCCCCCCCCCCcccccccccccccccccccCcCC
Q 040845          254 YNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLP  333 (824)
Q Consensus       254 ~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~  333 (824)
                      +|+|+. +|..   ..+|+.|++++|++++ +|..   .++|+.|++++|+|+.+|..   ..+|+.|++++|+++ .+|
T Consensus       371 ~N~L~~-LP~l---~~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~LssIP~l---~~~L~~L~Ls~NqLt-~LP  438 (788)
T PRK15387        371 NNRLTS-LPAL---PSGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLTSLPML---PSGLLSLSVYRNQLT-RLP  438 (788)
T ss_pred             cccccc-Cccc---ccccceEEecCCcccC-CCCc---ccCCCEEEccCCcCCCCCcc---hhhhhhhhhccCccc-ccC
Confidence            888773 4543   3468888888888874 4432   35788999999999988854   356788999999998 678


Q ss_pred             ccccccccchhhhcccccccccCCCcc
Q 040845          334 LEIRNLKALIEIDFSMNNFSGIIPMEI  360 (824)
Q Consensus       334 ~~~~~l~~L~~L~l~~N~l~~~~~~~~  360 (824)
                      ..+.++++|+.|+|++|++++..+..+
T Consensus       439 ~sl~~L~~L~~LdLs~N~Ls~~~~~~L  465 (788)
T PRK15387        439 ESLIHLSSETTVNLEGNPLSERTLQAL  465 (788)
T ss_pred             hHHhhccCCCeEECCCCCCCchHHHHH
Confidence            889999999999999999997766555

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.91  E-value=3.8e-24  Score=243.47  Aligned_cols=267  Identities=22%  Similarity=0.326  Sum_probs=207.6

Q ss_pred             CCCceeeccCCccccccCccccCCCCCccEEEccCCeeeeecCccccCCCCCceEeccCccccccCCccccCCCCCCEEE
Q 040845           69 STLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLT  148 (824)
Q Consensus        69 ~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~  148 (824)
                      ..-..|+|++|.|+.+|..+.    ++|+.|++++|+++ .+|..   +++|++|+|++|+|+. +|..   .++|+.|+
T Consensus       201 ~~~~~LdLs~~~LtsLP~~l~----~~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~  268 (788)
T PRK15387        201 NGNAVLNVGESGLTTLPDCLP----AHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLTS-LPVL---PPGLLELS  268 (788)
T ss_pred             CCCcEEEcCCCCCCcCCcchh----cCCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccCc-ccCc---ccccceee
Confidence            345567777777776665443    47888888888887 45542   5889999999999995 4532   46899999


Q ss_pred             ccCCcCCCCcCcccccccCCCCCCCcEEECcCCCCCccCCccccccccccccEEEeecCcceecCCccCCCCCCCCEEEe
Q 040845          149 LYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVL  228 (824)
Q Consensus       149 L~~n~i~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L  228 (824)
                      +++|.++.++.         ..++|+.|++++|++..++.      .+++|+.|++++|++++. |..   ..+|+.|++
T Consensus       269 Ls~N~L~~Lp~---------lp~~L~~L~Ls~N~Lt~LP~------~p~~L~~LdLS~N~L~~L-p~l---p~~L~~L~L  329 (788)
T PRK15387        269 IFSNPLTHLPA---------LPSGLCKLWIFGNQLTSLPV------LPPGLQELSVSDNQLASL-PAL---PSELCKLWA  329 (788)
T ss_pred             ccCCchhhhhh---------chhhcCEEECcCCccccccc------cccccceeECCCCccccC-CCC---ccccccccc
Confidence            99999987653         12678899999999987643      256899999999999863 432   246888999


Q ss_pred             cCCccCCccchhhcCCCCCCEEEcccccCcccCCccccccCCccEEEccCccccccCCccccCCCCCcEEEcCCCCCCCC
Q 040845          229 GGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSI  308 (824)
Q Consensus       229 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l  308 (824)
                      ++|++++ +|..   ..+|++|+|++|+|+. +|..   ..+|+.|++++|+|.. +|..   ..+|+.|++++|+|+.+
T Consensus       330 s~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt~L  397 (788)
T PRK15387        330 YNNQLTS-LPTL---PSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTSL  397 (788)
T ss_pred             ccCcccc-cccc---ccccceEecCCCccCC-CCCC---Ccccceehhhcccccc-Cccc---ccccceEEecCCcccCC
Confidence            9999984 4532   2589999999999994 5543   3578899999999985 4543   35799999999999999


Q ss_pred             CCcccccccccccccccccccCcCCccccccccchhhhcccccccccCCCccCCCCCCCeEEccCccccccCCccccc
Q 040845          309 PLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGD  386 (824)
Q Consensus       309 p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  386 (824)
                      |..   .++|+.|++++|+++. +|..   ..+|+.|++++|+|+ .+|..+..+++|+.|+|++|+|++..+..+..
T Consensus       398 P~l---~s~L~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~~  467 (788)
T PRK15387        398 PVL---PSELKELMVSGNRLTS-LPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALRE  467 (788)
T ss_pred             CCc---ccCCCEEEccCCcCCC-CCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHHHH
Confidence            864   3679999999999985 5643   357889999999998 67888999999999999999999877766533

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.90  E-value=2.4e-23  Score=194.40  Aligned_cols=264  Identities=19%  Similarity=0.206  Sum_probs=202.2

Q ss_pred             hhccCCCCceeeeccceEEEEEE-ECCCcEEEEEEeeccccchhhhHHHHHHHHhcCCC-CcceeEEeeeecCCeeEEEE
Q 040845          525 ATDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRH-RNLVKVISSCSNEEFKALVL  602 (824)
Q Consensus       525 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~  602 (824)
                      ...+|.+.+.||.|+||.+|.|. ..+|..||||+-+...  ....+..|..+++.+++ ..|..+..+..+...-.+||
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM   90 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM   90 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence            45789999999999999999996 6679999999876443  23567789999999975 67888888889999999999


Q ss_pred             eccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC---CCCcEEEeecccccccCC
Q 040845          603 EYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLTG  679 (824)
Q Consensus       603 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~---~~~~~kl~Dfg~a~~~~~  679 (824)
                      |.+ |.+|++...-....++..+++-.+-|++.-++|+|   .++++||||||+|+|+.   ....+.++|||+|+.+.+
T Consensus        91 dLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d  166 (341)
T KOG1163|consen   91 DLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD  166 (341)
T ss_pred             ecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence            999 77999999877778999999999999999999999   99999999999999996   345789999999998865


Q ss_pred             CCCc-----cccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhh
Q 040845          680 EDQS-----MTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEV  754 (824)
Q Consensus       680 ~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  754 (824)
                      ....     .......||.+|.+-..+.+...+.+.|+-|+|.++.+.-.|..||.+...... ..++-          .
T Consensus       167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk-~QKyE----------k  235 (341)
T KOG1163|consen  167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATK-KQKYE----------K  235 (341)
T ss_pred             ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhH-HHHHH----------H
Confidence            4322     223455799999999988888889999999999999999999999988543211 11110          0


Q ss_pred             ccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 040845          755 VDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRD  807 (824)
Q Consensus       755 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~  807 (824)
                      +.....+.....+  =..+|.++...+.-|=..--++-|...-+.+.++-+..
T Consensus       236 I~EkK~s~~ie~L--C~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr  286 (341)
T KOG1163|consen  236 ISEKKMSTPIEVL--CKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFR  286 (341)
T ss_pred             HHHhhcCCCHHHH--hCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHh
Confidence            0000011000000  01346667777777777777777777666666655443

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.90  E-value=1.6e-22  Score=215.31  Aligned_cols=261  Identities=22%  Similarity=0.271  Sum_probs=199.8

Q ss_pred             cCCCCceeeeccceEEEEEEECCC--cEEEEEEeeccccchhhhHHHHHHHHhcCCC----CcceeEEeee-ecCCeeEE
Q 040845          528 KFSENNLIGRGGFGSVYKARIRDG--MEVAVKVFNLQCGRAFKSFDVECAMMKSIRH----RNLVKVISSC-SNEEFKAL  600 (824)
Q Consensus       528 ~~~~~~~lg~G~~g~V~~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~l  600 (824)
                      +|.+.+.||+|+||.||.|...+.  ..+|+|............+..|+.++..+..    +++..+++.. ..+...++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            799999999999999999986643  5799998765533333377889999999973    6899999998 57888999


Q ss_pred             EEeccCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCC-----CcEEEeecccc
Q 040845          601 VLEYMPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDN-----MVAHLSDFGIA  674 (824)
Q Consensus       601 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~-----~~~kl~Dfg~a  674 (824)
                      ||+.+ |.+|.++..... ..++..++..++.|++.+|.++|   +.|++||||||.|+++...     -.+.+.|||+|
T Consensus        99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            99999 779999886555 68999999999999999999999   9999999999999999754     46999999999


Q ss_pred             c--ccCCCCCc----cc--cccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhh
Q 040845          675 K--LLTGEDQS----MT--QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDC  746 (824)
Q Consensus       675 ~--~~~~~~~~----~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~  746 (824)
                      +  .+......    ..  .....||..|+++..+.+...+.+.|+||+++++.|+..|..||........ ........
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-~~~~~~~~  253 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-KSKFEKDP  253 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-HHHHHHHh
Confidence            9  33222211    11  1235599999999999999999999999999999999999999966432211 11111000


Q ss_pred             CCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 040845          747 LPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDS  808 (824)
Q Consensus       747 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~  808 (824)
                      ..    .....           .....+..+.+++..+-..+..++|....+.+.+++....
T Consensus       254 ~~----~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~  300 (322)
T KOG1164|consen  254 RK----LLTDR-----------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS  300 (322)
T ss_pred             hh----hcccc-----------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence            00    00000           1112345567777777778999999999999998877554

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.90  E-value=5.1e-26  Score=226.86  Aligned_cols=309  Identities=22%  Similarity=0.240  Sum_probs=222.9

Q ss_pred             eeccCCccccccCccccCCCCCccEEEccCCeeeeecCccccCCCCCceEeccCccccccCCccccCCCCCCEEEccC-C
Q 040845           74 FAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYD-N  152 (824)
Q Consensus        74 L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~-n  152 (824)
                      .+.++-.++.+|..+.    +.-..++|..|+|+.+.++.|+.+++|++|+|++|+|+.+.|++|.++.+|..|-+.+ |
T Consensus        51 VdCr~~GL~eVP~~LP----~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~N  126 (498)
T KOG4237|consen   51 VDCRGKGLTEVPANLP----PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNN  126 (498)
T ss_pred             EEccCCCcccCcccCC----CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCC
Confidence            4455556666666543    4778889999999988888899999999999999999988899999998888877766 8


Q ss_pred             cCCCCcCcccccccCCCCCCCcEEECcCCCCCccCCccccccccccccEEEeecCcceecCCccCCCCCCCCEEEecCCc
Q 040845          153 NLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNK  232 (824)
Q Consensus       153 ~i~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~  232 (824)
                      +|+.++.+     .|.++.+|+.|.+.-|++..+..                          ..|..+++|..|.+.+|.
T Consensus       127 kI~~l~k~-----~F~gL~slqrLllNan~i~Cir~--------------------------~al~dL~~l~lLslyDn~  175 (498)
T KOG4237|consen  127 KITDLPKG-----AFGGLSSLQRLLLNANHINCIRQ--------------------------DALRDLPSLSLLSLYDNK  175 (498)
T ss_pred             chhhhhhh-----HhhhHHHHHHHhcChhhhcchhH--------------------------HHHHHhhhcchhcccchh
Confidence            88888754     47777888888777777764433                          445667888888888888


Q ss_pred             cCCccchhhcCCCCCCEEEcccccCcccCCccccccCCccEEEccCccccccCCccccCCCCCcEEEcCCCCCCCCCCcc
Q 040845          233 LNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNF  312 (824)
Q Consensus       233 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~  312 (824)
                      +..+...+|..+..++.+.+..|.+-     ..|+++.+.. ++..|      +..++...-.....+.++++..++..-
T Consensus       176 ~q~i~~~tf~~l~~i~tlhlA~np~i-----cdCnL~wla~-~~a~~------~ietsgarc~~p~rl~~~Ri~q~~a~k  243 (498)
T KOG4237|consen  176 IQSICKGTFQGLAAIKTLHLAQNPFI-----CDCNLPWLAD-DLAMN------PIETSGARCVSPYRLYYKRINQEDARK  243 (498)
T ss_pred             hhhhccccccchhccchHhhhcCccc-----cccccchhhh-HHhhc------hhhcccceecchHHHHHHHhcccchhh
Confidence            88555558888888888888888743     1233333322 12222      223455555555666666666665442


Q ss_pred             cc--cccccccccccc-cccCcCCccccccccchhhhcccccccccCCCccCCCCCCCeEEccCccccccCCcccccccc
Q 040845          313 WS--LKDILDLNLSSN-CFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLIS  389 (824)
Q Consensus       313 ~~--l~~L~~L~l~~N-~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  389 (824)
                      +.  +..+..=-.+.+ ....-....|.++++|+.|+|++|+|+.+.+.+|.++..+++|+|..|+|.......|.++..
T Consensus       244 f~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~  323 (498)
T KOG4237|consen  244 FLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSG  323 (498)
T ss_pred             hhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhcccc
Confidence            21  222222122222 233223346888888889999999988888888888888999999999888766778888888


Q ss_pred             ccEEEccCcccCCCCcccccCCcccceeeccCCcccCCCC
Q 040845          390 LKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIP  429 (824)
Q Consensus       390 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p  429 (824)
                      |+.|+|.+|+|+...|.+|..+.+|.+|+|-.|+|.|.+-
T Consensus       324 L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~  363 (498)
T KOG4237|consen  324 LKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCR  363 (498)
T ss_pred             ceeeeecCCeeEEEecccccccceeeeeehccCcccCccc
Confidence            9999999999988888888888888999988888887543

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=6e-23  Score=216.74  Aligned_cols=167  Identities=21%  Similarity=0.195  Sum_probs=130.3

Q ss_pred             HhhccCCCCceeeeccceEEEEEEEC--CCcEEEEEEeeccc-----cchhhhHHHHHHHHhcCCCCcceeEEeeeecCC
Q 040845          524 QATDKFSENNLIGRGGFGSVYKARIR--DGMEVAVKVFNLQC-----GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEE  596 (824)
Q Consensus       524 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  596 (824)
                      ...++|.+.+.||+|+||+||+|.++  +++.||||+.....     ....+.+.+|+++++.++|+|+++.+..+   .
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---~   91 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---G   91 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---C
Confidence            34578999999999999999999865  47788999865331     12345689999999999999998533322   4


Q ss_pred             eeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCC-CCCCeeeCCCCcEEEeeccccc
Q 040845          597 FKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL-KPSNVLLDDNMVAHLSDFGIAK  675 (824)
Q Consensus       597 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dl-k~~Nill~~~~~~kl~Dfg~a~  675 (824)
                      ..++||||+++++|... ..    ..   ...++.++++|++|||   +.+|+|||| ||+||+++.++.+||+|||+|+
T Consensus        92 ~~~LVmE~~~G~~L~~~-~~----~~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~  160 (365)
T PRK09188         92 KDGLVRGWTEGVPLHLA-RP----HG---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDFQLAS  160 (365)
T ss_pred             CcEEEEEccCCCCHHHh-Cc----cc---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEECccce
Confidence            57999999999999632 11    11   1467899999999999   999999999 9999999999999999999999


Q ss_pred             ccCCCCCccc------cccccccccccCccCcCCC
Q 040845          676 LLTGEDQSMT------QTQTLATIGYMAPEYGREG  704 (824)
Q Consensus       676 ~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~  704 (824)
                      .+........      -+...+++.|+|||++...
T Consensus       161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             ecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            7754432211      1345678899999988644

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.89  E-value=3.8e-22  Score=195.05  Aligned_cols=264  Identities=17%  Similarity=0.191  Sum_probs=205.9

Q ss_pred             ccCCCCceeeeccceEEEEEE-ECCCcEEEEEEeeccccchhhhHHHHHHHHhcCC-CCcceeEEeeeecCCeeEEEEec
Q 040845          527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIR-HRNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      -.|.++++||+|.||+++.|+ +-++++||||.-...  ....++..|...++.|. .++|..++-+..+..+-.+|+|.
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL  105 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL  105 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence            368999999999999999997 556999999975433  34567788999999884 68999999998888888999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCC-----CcEEEeecccccccCC
Q 040845          605 MPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDN-----MVAHLSDFGIAKLLTG  679 (824)
Q Consensus       605 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~-----~~~kl~Dfg~a~~~~~  679 (824)
                      + |-+|+|+..-++..++..++..+|.|++.-++|+|   ++..|.|||||+|+|+...     ..+.++|||+|+.+.+
T Consensus       106 L-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD  181 (449)
T KOG1165|consen  106 L-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD  181 (449)
T ss_pred             h-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence            9 77999999988889999999999999999999999   9999999999999999643     4689999999999876


Q ss_pred             CCCc-----cccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhh
Q 040845          680 EDQS-----MTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEV  754 (824)
Q Consensus       680 ~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  754 (824)
                      ....     .......||.+||+-..+.+...+.+.|+-|+|-++++.+.|..||.+..... .-..|-+         +
T Consensus       182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~t-nK~kYeK---------I  251 (449)
T KOG1165|consen  182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADT-NKEKYEK---------I  251 (449)
T ss_pred             ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcc-hHHHHHH---------h
Confidence            5432     22344569999999999999999999999999999999999999998854332 1111111         1


Q ss_pred             ccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhh
Q 040845          755 VDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSL  809 (824)
Q Consensus       755 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~  809 (824)
                      -+.+-. .....  --+++|.++..-+.-.=..+-++-|..+-+..-+.++.+..
T Consensus       252 Ge~Kr~-T~i~~--Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~  303 (449)
T KOG1165|consen  252 GETKRS-TPIEV--LCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRL  303 (449)
T ss_pred             cccccc-CCHHH--HHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhc
Confidence            111100 00000  11245666777777777778888888877766666655443

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.87  E-value=1.3e-22  Score=228.63  Aligned_cols=261  Identities=20%  Similarity=0.247  Sum_probs=192.4

Q ss_pred             CCceeeeccceEEEEEEEC-CCcEEEEEEeec----c-ccc-hhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEe
Q 040845          531 ENNLIGRGGFGSVYKARIR-DGMEVAVKVFNL----Q-CGR-AFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLE  603 (824)
Q Consensus       531 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~----~-~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  603 (824)
                      ...++|.|++|.|+.+... ....++.|.++.    . ... ....+..|+.+-..+.|+|++..+..+.+....+-+||
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE  401 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME  401 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence            4678999999988877543 344455554331    1 111 11225668888889999999888888777666666699


Q ss_pred             ccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 040845          604 YMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS  683 (824)
Q Consensus       604 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  683 (824)
                      |+++ +|..++.... .+...++-.++.|+..|+.|+|   +.||.|||+|++|++++.+|.+||+|||.+..+.-+...
T Consensus       402 ~~~~-Dlf~~~~~~~-~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~  476 (601)
T KOG0590|consen  402 YCPY-DLFSLVMSNG-KLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK  476 (601)
T ss_pred             cccH-HHHHHHhccc-ccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeeccCcch
Confidence            9999 9999988763 5788889999999999999999   999999999999999999999999999999877544433


Q ss_pred             --cccccccccccccCccCcCCCCCCc-cchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhcccccc
Q 040845          684 --MTQTQTLATIGYMAPEYGREGQVST-NGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLL  760 (824)
Q Consensus       684 --~~~~~~~~~~~y~aPE~~~~~~~~~-~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  760 (824)
                        ....+..|+-.|+|||++.+..|.. ..||||.|++++.|.+|+.||......+.....            .......
T Consensus       477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~------------~~~~~~~  544 (601)
T KOG0590|consen  477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT------------NNYSDQR  544 (601)
T ss_pred             hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh------------hcccccc
Confidence              4556778999999999999999865 579999999999999999999764333221100            0000000


Q ss_pred             CchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhccccC
Q 040845          761 SQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLRNVG  814 (824)
Q Consensus       761 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~~~~  814 (824)
                      .............+.....+|.+|+++||.+|.|+++|++      +.|.+++.
T Consensus       545 ~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~------d~W~~~i~  592 (601)
T KOG0590|consen  545 NIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN------DEWIRSIE  592 (601)
T ss_pred             ccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh------ChHhhhcc
Confidence            0011111122345667888999999999999999999865      45555543

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.87  E-value=4.3e-22  Score=228.58  Aligned_cols=121  Identities=24%  Similarity=0.331  Sum_probs=66.1

Q ss_pred             CCCcEEEccCCcccccccccccCCCCCCEEeCCCCcCCcccChhhhCcCCCceeeccCCccccccCccccCCCCCccEEE
Q 040845           21 SNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLY  100 (824)
Q Consensus        21 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~  100 (824)
                      .+...|+|+++.++ .+|..+.  ++|+.|+|++|+|+ .+|..+.  ++|++|++++|+++.+|..+    .++|+.|+
T Consensus       178 ~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~LtsLP~~l----~~~L~~L~  247 (754)
T PRK15370        178 NNKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLTSIPATL----PDTIQEME  247 (754)
T ss_pred             cCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccccCChhh----hccccEEE
Confidence            34566777777766 4555443  35667777777776 4555443  46666666666666554432    23566666


Q ss_pred             ccCCeeeeecCccccCCCCCceEeccCccccccCCccccCCCCCCEEEccCCcCCCC
Q 040845          101 LWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSS  157 (824)
Q Consensus       101 L~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~  157 (824)
                      |++|+++ .+|..+.  ++|+.|+|++|+++ .+|..+.  ++|+.|++++|+++.+
T Consensus       248 Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~L  298 (754)
T PRK15370        248 LSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRTL  298 (754)
T ss_pred             CcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCccccC
Confidence            6666665 3444332  34555555555555 2343332  3455555555555443

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.86  E-value=8.7e-22  Score=226.08  Aligned_cols=246  Identities=26%  Similarity=0.431  Sum_probs=124.0

Q ss_pred             CccEEEccCCeeeeecCccccCCCCCceEeccCccccccCCccccCCCCCCEEEccCCcCCCCcCcccccccCCCCCCCc
Q 040845           95 NLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLT  174 (824)
Q Consensus        95 ~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~~L~  174 (824)
                      +...|+++++.++ .+|..+  .++|+.|+|++|+|+. +|..+.  ++|++|++++|++++++..      +  .++|+
T Consensus       179 ~~~~L~L~~~~Lt-sLP~~I--p~~L~~L~Ls~N~Lts-LP~~l~--~nL~~L~Ls~N~LtsLP~~------l--~~~L~  244 (754)
T PRK15370        179 NKTELRLKILGLT-TIPACI--PEQITTLILDNNELKS-LPENLQ--GNIKTLYANSNQLTSIPAT------L--PDTIQ  244 (754)
T ss_pred             CceEEEeCCCCcC-cCCccc--ccCCcEEEecCCCCCc-CChhhc--cCCCEEECCCCccccCChh------h--hcccc
Confidence            4555556555555 334333  2355666666666653 333332  3566666666666554421      1  13456


Q ss_pred             EEECcCCCCCccCCccccccccccccEEEeecCcceecCCccCCCCCCCCEEEecCCccCCccchhhcCCCCCCEEEccc
Q 040845          175 HISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEY  254 (824)
Q Consensus       175 ~L~Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~  254 (824)
                      .|+|++|.+..++..     ++.+|+.|++++|+++ .+|..+.  ++|+.|+|++|+++. +|..+.  ++|+.|++++
T Consensus       245 ~L~Ls~N~L~~LP~~-----l~s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~  313 (754)
T PRK15370        245 EMELSINRITELPER-----LPSALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQS  313 (754)
T ss_pred             EEECcCCccCcCChh-----HhCCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcC
Confidence            666666665543221     1234555555555554 2333332  356666666666653 333322  3566666666


Q ss_pred             ccCcccCCccccccCCccEEEccCccccccCCccccCCCCCcEEEcCCCCCCCCCCcccccccccccccccccccCcCCc
Q 040845          255 NQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPL  334 (824)
Q Consensus       255 n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~  334 (824)
                      |+++. +|..+  .++|+.|++++|.++. +|..+.  ++|+.|++++|+|+.+|..+.  ++|+.|++++|.++. +|.
T Consensus       314 N~Lt~-LP~~l--~~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~~LP~~lp--~~L~~LdLs~N~Lt~-LP~  384 (754)
T PRK15370        314 NSLTA-LPETL--PPGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQITVLPETLP--PTITTLDVSRNALTN-LPE  384 (754)
T ss_pred             Ccccc-CCccc--cccceeccccCCcccc-CChhhc--CcccEEECCCCCCCcCChhhc--CCcCEEECCCCcCCC-CCH
Confidence            66652 33322  2456666666666653 333332  456666666666666665432  456666666666652 333


Q ss_pred             cccccccchhhhcccccccccCCCcc----CCCCCCCeEEccCcccc
Q 040845          335 EIRNLKALIEIDFSMNNFSGIIPMEI----GSLKNLENLFLEYNRLE  377 (824)
Q Consensus       335 ~~~~l~~L~~L~l~~N~l~~~~~~~~----~~l~~L~~L~L~~N~l~  377 (824)
                      .+.  ..|+.|++++|++. .+|..+    ..++++..|++.+|.++
T Consensus       385 ~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls  428 (754)
T PRK15370        385 NLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS  428 (754)
T ss_pred             hHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence            332  24566666666665 233322    22344555555555554

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.85  E-value=4.7e-20  Score=199.60  Aligned_cols=258  Identities=32%  Similarity=0.419  Sum_probs=198.9

Q ss_pred             CCCCceeeeccceEEEEEEECCCcEEEEEEeeccccc---hhhhHHHHHHHHhcCCCC-cceeEEeeeecCCeeEEEEec
Q 040845          529 FSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGR---AFKSFDVECAMMKSIRHR-NLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       529 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~  604 (824)
                      |...+.||.|+||.||++...  ..+|+|.+......   ....+.+|+.+++.+.|+ +++++.+.+......+++++|
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            667789999999999999876  88999998665432   367789999999999988 799999999777778999999


Q ss_pred             cCCCCHHHHhhhCC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC-cEEEeecccccccCCCC
Q 040845          605 MPHGSLEKYLHSSN--YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM-VAHLSDFGIAKLLTGED  681 (824)
Q Consensus       605 ~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~Dfg~a~~~~~~~  681 (824)
                      +.++++.+++....  ...+......++.|++.+++|+|   ..+++|||+||+||+++..+ .++++|||.+.......
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            99999997776554  26888999999999999999999   99999999999999999988 79999999998654433


Q ss_pred             Ccc----ccccccccccccCccCcCC---CCCCccchHHHHHHHHHHHHhCCCCCcccccC--cchhhhhhhhhCCCcch
Q 040845          682 QSM----TQTQTLATIGYMAPEYGRE---GQVSTNGDVYSFGIMLMETFTRKKPTDELFNG--EMTLKHWVNDCLPISTM  752 (824)
Q Consensus       682 ~~~----~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~  752 (824)
                      ...    ......++..|+|||...+   ..++...|+||+|++++++++|..||......  .......+......   
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~---  233 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP---  233 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc---
Confidence            221    2355679999999999887   57889999999999999999999996553321  11111111111100   


Q ss_pred             hhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          753 EVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       753 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                           ..........  +......+.+++..|+..+|..|.++.+....
T Consensus       234 -----~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         234 -----SLASPLSPSN--PELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             -----ccccccCccc--cchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence                 0000000000  02223567889999999999999999988776

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.84  E-value=3.2e-21  Score=188.59  Aligned_cols=171  Identities=13%  Similarity=0.145  Sum_probs=133.5

Q ss_pred             hhccCCCCceeeeccceEEEEEEECCCcEEEEEEeeccccchhh---h------HHHHHHHHhcCCCCcceeEEeeeecC
Q 040845          525 ATDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFK---S------FDVECAMMKSIRHRNLVKVISSCSNE  595 (824)
Q Consensus       525 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~---~------~~~E~~~l~~l~h~niv~l~~~~~~~  595 (824)
                      ...+|...+++|.|+||.||.+.. ++..+|||+++........   .      +.+|+..+.+++|++|..+.+++...
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            358899999999999999999766 5778999999755332222   2      67899999999999999999886533


Q ss_pred             --------CeeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEE
Q 040845          596 --------EFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH  667 (824)
Q Consensus       596 --------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  667 (824)
                              ...++||||++|.+|.++..     .+.    ....+++.++..+|   ..+++|||++|+||+++++| ++
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~g-i~  174 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKNG-LR  174 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCCC-EE
Confidence                    35789999999999988732     222    24669999999999   99999999999999999988 99


Q ss_pred             EeecccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHH
Q 040845          668 LSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETF  723 (824)
Q Consensus       668 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~  723 (824)
                      ++|||...........              ..+.....+..++|+||||+.+....
T Consensus       175 liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        175 IIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence            9999988654211110              01334445678999999999887654

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.83  E-value=1.7e-20  Score=182.51  Aligned_cols=139  Identities=17%  Similarity=0.173  Sum_probs=108.8

Q ss_pred             CceeeeccceEEEEEEECCCcEEEEEEeeccccc--h-------h-----------------hhHHHHHHHHhcCCCCcc
Q 040845          532 NNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGR--A-------F-----------------KSFDVECAMMKSIRHRNL  585 (824)
Q Consensus       532 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~E~~~l~~l~h~ni  585 (824)
                      ...||+|+||.||+|...+|+.||||+++.....  .       .                 .....|++.+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4689999999999999878999999998754211  0       0                 122349999999988776


Q ss_pred             eeEEeeeecCCeeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHh-hcCCCCCeEecCCCCCCeeeCCCC
Q 040845          586 VKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL-HFGYSAPVIHCDLKPSNVLLDDNM  664 (824)
Q Consensus       586 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L-H~~~~~~ivH~Dlk~~Nill~~~~  664 (824)
                      .....+...  ..++||||++++++....... ..++..++..++.|++.+++|+ |   +.+|+||||||+||+++ ++
T Consensus        82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~-~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli~-~~  154 (190)
T cd05147          82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLKD-APLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLYH-DG  154 (190)
T ss_pred             CCCcEEEec--CCEEEEEEeCCCCCcchhhhc-CCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEE-CC
Confidence            443333222  237999999987776553322 3688899999999999999999 7   88999999999999998 47


Q ss_pred             cEEEeeccccccc
Q 040845          665 VAHLSDFGIAKLL  677 (824)
Q Consensus       665 ~~kl~Dfg~a~~~  677 (824)
                      .++++|||+|...
T Consensus       155 ~v~LiDFG~a~~~  167 (190)
T cd05147         155 KLYIIDVSQSVEH  167 (190)
T ss_pred             cEEEEEccccccC
Confidence            8999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.82  E-value=2.4e-20  Score=186.53  Aligned_cols=199  Identities=19%  Similarity=0.242  Sum_probs=144.8

Q ss_pred             CCCcceeEEeeee---------------------------cCCeeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHH
Q 040845          581 RHRNLVKVISSCS---------------------------NEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDV  633 (824)
Q Consensus       581 ~h~niv~l~~~~~---------------------------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i  633 (824)
                      +|||||++.++|.                           +....|+||..++. +|++++....  .+...+.-++.|+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~--~s~r~~~~~laQl  350 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH--RSYRTGRVILAQL  350 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC--CchHHHHHHHHHH
Confidence            4999999998763                           23477899999855 9999997654  5566677799999


Q ss_pred             HHHHHHhhcCCCCCeEecCCCCCCeeeC--CCC--cEEEeecccccccCCCC----CccccccccccccccCccCcCCCC
Q 040845          634 ASALEYLHFGYSAPVIHCDLKPSNVLLD--DNM--VAHLSDFGIAKLLTGED----QSMTQTQTLATIGYMAPEYGREGQ  705 (824)
Q Consensus       634 ~~~l~~LH~~~~~~ivH~Dlk~~Nill~--~~~--~~kl~Dfg~a~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~  705 (824)
                      ++|+.|||   ++||.|||+|++|||+.  +|+  .+.++|||++---...+    .........|....||||+.....
T Consensus       351 LEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P  427 (598)
T KOG4158|consen  351 LEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP  427 (598)
T ss_pred             HHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence            99999999   99999999999999983  333  57899999875322111    111122334777899999875321


Q ss_pred             ------CCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhhhhhhHHHHHHHHHH
Q 040845          706 ------VSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFN  779 (824)
Q Consensus       706 ------~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  779 (824)
                            ...|+|.|+.|.+.||+++..-||+...+...+...|-.                   ..-...++.|++.+.+
T Consensus       428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe-------------------~qLPalp~~vpp~~rq  488 (598)
T KOG4158|consen  428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQE-------------------SQLPALPSRVPPVARQ  488 (598)
T ss_pred             CCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhh-------------------hhCCCCcccCChHHHH
Confidence                  246899999999999999999999873222222222111                   1112234567888999


Q ss_pred             HHHHccccCCCCCCCHHHHHHHHHH
Q 040845          780 LALECTVESPEQRINAKEIVAKLLK  804 (824)
Q Consensus       780 l~~~cl~~dP~~Rpt~~evl~~L~~  804 (824)
                      ++...++.||.+|+++.-+...+.-
T Consensus       489 lV~~lL~r~pskRvsp~iAANvl~L  513 (598)
T KOG4158|consen  489 LVFDLLKRDPSKRVSPNIAANVLNL  513 (598)
T ss_pred             HHHHHhcCCccccCCccHHHhHHHH
Confidence            9999999999999998776666543

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.82  E-value=1.7e-19  Score=176.52  Aligned_cols=139  Identities=23%  Similarity=0.258  Sum_probs=111.1

Q ss_pred             CceeeeccceEEEEEEECCCcEEEEEEeeccccch--------------------------hhhHHHHHHHHhcCCCCcc
Q 040845          532 NNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRA--------------------------FKSFDVECAMMKSIRHRNL  585 (824)
Q Consensus       532 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~E~~~l~~l~h~ni  585 (824)
                      .+.||+|++|.||+|+..+|+.||||+++......                          ......|++.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            46899999999999987789999999987542110                          1123578999999999987


Q ss_pred             eeEEeeeecCCeeEEEEeccCCCCHHHH-hhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEecCCCCCCeeeCCC
Q 040845          586 VKVISSCSNEEFKALVLEYMPHGSLEKY-LHSSNYSLDIFQRLNIMIDVASALEYLHFGYS-APVIHCDLKPSNVLLDDN  663 (824)
Q Consensus       586 v~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dlk~~Nill~~~  663 (824)
                      .....+....  .++||||++++++... +..  ..++..++..++.|++.++.++|   . .+|+||||||+||+++ +
T Consensus        82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NIll~-~  153 (190)
T cd05145          82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNILYH-D  153 (190)
T ss_pred             CCceEEEecC--CEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhEEEE-C
Confidence            5544443332  4799999988755433 332  25678889999999999999999   7 9999999999999998 8


Q ss_pred             CcEEEeecccccccC
Q 040845          664 MVAHLSDFGIAKLLT  678 (824)
Q Consensus       664 ~~~kl~Dfg~a~~~~  678 (824)
                      +.++|+|||+|....
T Consensus       154 ~~~~liDFG~a~~~~  168 (190)
T cd05145         154 GKPYIIDVSQAVELD  168 (190)
T ss_pred             CCEEEEEcccceecC
Confidence            999999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.80  E-value=4.6e-19  Score=169.18  Aligned_cols=187  Identities=15%  Similarity=0.105  Sum_probs=139.0

Q ss_pred             CCCceeeeccceEEEEEEECCCcEEEEEEeeccccc----hhhhHHHHHHHHhcCC-CCcceeEEeeeecCCeeEEEEec
Q 040845          530 SENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGR----AFKSFDVECAMMKSIR-HRNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       530 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      .+...|++|+||+||.+.. .+.+++.+.+.....-    ....+.+|+++|+++. |+++++++++    ...+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            3567899999999998866 5888888877543221    1225789999999995 5889999886    346899999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCC-CCCCeeeCCCCcEEEeecccccccCCCCCc
Q 040845          605 MPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL-KPSNVLLDDNMVAHLSDFGIAKLLTGEDQS  683 (824)
Q Consensus       605 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dl-k~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  683 (824)
                      ++|.+|.+....        ....++.|++++++++|   ..||+|||| ||.||+++.++.++|+|||+|.........
T Consensus        80 I~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~  148 (218)
T PRK12274         80 LAGAAMYQRPPR--------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW  148 (218)
T ss_pred             ecCccHHhhhhh--------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence            999998754321        12357889999999999   999999999 799999999999999999999865433211


Q ss_pred             ----cc-------cccccccccccCccCcCCC-CC-CccchHHHHHHHHHHHHhCCCCCccc
Q 040845          684 ----MT-------QTQTLATIGYMAPEYGREG-QV-STNGDVYSFGIMLMETFTRKKPTDEL  732 (824)
Q Consensus       684 ----~~-------~~~~~~~~~y~aPE~~~~~-~~-~~~~DvwslG~~l~el~tg~~p~~~~  732 (824)
                          ..       ......++.|++|+-..-- .. -.+.+.++-|+-+|.++|++.|..+.
T Consensus       149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence                00       0112256677777633211 22 25678999999999999999987653

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.80  E-value=2.1e-20  Score=208.92  Aligned_cols=249  Identities=22%  Similarity=0.246  Sum_probs=180.3

Q ss_pred             cCCCCceeeeccceEEEEEEECCCcEEEEEEeecccc-chhhhHH---HHHHHHhcCCCCcceeEEeeeecCCeeEEEEe
Q 040845          528 KFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCG-RAFKSFD---VECAMMKSIRHRNLVKVISSCSNEEFKALVLE  603 (824)
Q Consensus       528 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~---~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  603 (824)
                      +|...+.+|.+.|=+|.+|+++.|. |+||++-+..+ -..+.+.   +|++ ...++|||.+++..+-..++..|+|-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            6778889999999999999988777 99999866542 2233333   3444 556689999999988888888899999


Q ss_pred             ccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccC-CCC-
Q 040845          604 YMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT-GED-  681 (824)
Q Consensus       604 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~-~~~-  681 (824)
                      |+.+ +|.|.+.... .+...+...|+.|++.|+..+|   ..+|+|||||.+|||++.=.-+.|+||..-+... +.+ 
T Consensus       102 yvkh-nLyDRlSTRP-FL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN  176 (1431)
T KOG1240|consen  102 YVKH-NLYDRLSTRP-FLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN  176 (1431)
T ss_pred             HHhh-hhhhhhccch-HHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence            9965 9999997665 5777788889999999999999   9999999999999999999999999997543221 111 


Q ss_pred             ---CccccccccccccccCccCcCCC-----------CCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhh
Q 040845          682 ---QSMTQTQTLATIGYMAPEYGREG-----------QVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDC  746 (824)
Q Consensus       682 ---~~~~~~~~~~~~~y~aPE~~~~~-----------~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~  746 (824)
                         ..........-..|.|||-+...           ..+++-||||+||+++|+++ |++||.-.     .+..|....
T Consensus       177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-----QL~aYr~~~  251 (1431)
T KOG1240|consen  177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-----QLLAYRSGN  251 (1431)
T ss_pred             cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-----HHHhHhccC
Confidence               11111222233469999965431           15678899999999999988 67777531     111111110


Q ss_pred             CCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 040845          747 LPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLL  803 (824)
Q Consensus       747 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~  803 (824)
                       ..      ++        +.....-....+++++..|++.||++|.+|++.++.-+
T Consensus       252 -~~------~~--------e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yr  293 (1431)
T KOG1240|consen  252 -AD------DP--------EQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQKYR  293 (1431)
T ss_pred             -cc------CH--------HHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence             00      00        00000011224788999999999999999999998844

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.80  E-value=1.6e-19  Score=193.66  Aligned_cols=216  Identities=29%  Similarity=0.433  Sum_probs=165.3

Q ss_pred             HhcCCCCcceeEEeeeecCCeeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe-EecCCCC
Q 040845          577 MKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPV-IHCDLKP  655 (824)
Q Consensus       577 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i-vH~Dlk~  655 (824)
                      |+.+.|.|+.+++|.+.++...+.|.+|+..|+|.|.+......+++.....+.++++.|++|+|   ..+| +|+.+++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh---~s~i~~hg~l~s   77 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLH---NSPIGYHGALKS   77 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHh---cCcceeeeeecc
Confidence            46789999999999999999999999999999999999988889999999999999999999999   4444 9999999


Q ss_pred             CCeeeCCCCcEEEeecccccccCCCCCccccccccccccccCccCcCCC-------CCCccchHHHHHHHHHHHHhCCCC
Q 040845          656 SNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-------QVSTNGDVYSFGIMLMETFTRKKP  728 (824)
Q Consensus       656 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~DvwslG~~l~el~tg~~p  728 (824)
                      .|.++|....+|++|||+.................-..-|.|||.+...       ..+.+.||||||++++|+++.+.|
T Consensus        78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~  157 (484)
T KOG1023|consen   78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP  157 (484)
T ss_pred             ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence            9999999999999999998876431111111222244569999988764       146779999999999999999999


Q ss_pred             CcccccCcch--hhhhhhhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 040845          729 TDELFNGEMT--LKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIR  806 (824)
Q Consensus       729 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~  806 (824)
                      |+........  +..++....    .....+.+..        ....++.+..++.+||..+|++||+++++-..++.+.
T Consensus       158 ~~~~~~~~~~~eii~~~~~~~----~~~~rP~i~~--------~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~  225 (484)
T KOG1023|consen  158 FDLRNLVEDPDEIILRVKKGG----SNPFRPSIEL--------LNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN  225 (484)
T ss_pred             cccccccCChHHHHHHHHhcC----CCCcCcchhh--------hhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence            9875443332  222222200    0111111110        0133446889999999999999999999999888765


Q ss_pred             H
Q 040845          807 D  807 (824)
Q Consensus       807 ~  807 (824)
                      .
T Consensus       226 ~  226 (484)
T KOG1023|consen  226 K  226 (484)
T ss_pred             c
Confidence            3

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.80  E-value=4e-19  Score=179.27  Aligned_cols=231  Identities=21%  Similarity=0.324  Sum_probs=147.0

Q ss_pred             cCCCCceeeeccceEEEEEEECC-CcEEEEEEeeccc---cchhhhHHHHHHHHhcCCC----------CcceeEEeeee
Q 040845          528 KFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRH----------RNLVKVISSCS  593 (824)
Q Consensus       528 ~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h----------~niv~l~~~~~  593 (824)
                      .+...+.||.|+++.||.+++.. ++++|||++....   ....+++++|.-....+.+          -.++-.++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            34567899999999999998764 8999999986554   2345566666655544332          12222222211


Q ss_pred             ---------c---CC-----eeEEEEeccCCCCHHHHhhh---CCC---CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 040845          594 ---------N---EE-----FKALVLEYMPHGSLEKYLHS---SNY---SLDIFQRLNIMIDVASALEYLHFGYSAPVIH  650 (824)
Q Consensus       594 ---------~---~~-----~~~lv~e~~~~g~L~~~l~~---~~~---~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH  650 (824)
                               .   ..     ..+++|+-+ .++|.+++..   ...   ......+..+..|+++.+++||   ..|++|
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVH  168 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVH  168 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEE
T ss_pred             EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEe
Confidence                     1   11     235788888 5588887542   221   2334455667799999999999   999999


Q ss_pred             cCCCCCCeeeCCCCcEEEeecccccccCCCCCccccccccccccccCccCcCC--------CCCCccchHHHHHHHHHHH
Q 040845          651 CDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE--------GQVSTNGDVYSFGIMLMET  722 (824)
Q Consensus       651 ~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~~l~el  722 (824)
                      +||+|+|++++.+|.++|+||+......   .... . ...+..|.|||....        -.++.+.|.|++|+++|.|
T Consensus       169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g---~~~~-~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l  243 (288)
T PF14531_consen  169 GDIKPENFLLDQDGGVFLGDFSSLVRAG---TRYR-C-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL  243 (288)
T ss_dssp             ST-SGGGEEE-TTS-EEE--GGGEEETT---EEEE-G-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred             cccceeeEEEcCCCCEEEcChHHHeecC---ceee-c-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence            9999999999999999999999876532   1111 1 345678999996533        2478899999999999999


Q ss_pred             HhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCC
Q 040845          723 FTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQR  792 (824)
Q Consensus       723 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R  792 (824)
                      ++|+.||+........  .|                ...    ..  . +.++.+..||..+++.+|++|
T Consensus       244 WC~~lPf~~~~~~~~~--~~----------------~f~----~C--~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  244 WCGRLPFGLSSPEADP--EW----------------DFS----RC--R-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHSS-STCCCGGGSTS--GG----------------GGT----TS--S----HHHHHHHHHHT-SSGGGS
T ss_pred             HHccCCCCCCCccccc--cc----------------cch----hc--C-CcCHHHHHHHHHHccCCcccC
Confidence            9999999863222110  00                000    01  1 457779999999999999988

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.80  E-value=1.3e-21  Score=173.30  Aligned_cols=176  Identities=26%  Similarity=0.407  Sum_probs=118.9

Q ss_pred             cCCccEEEccCccccccCCccccCCCCCcEEEcCCCCCCCCCCcccccccccccccccccccCcCCccccccccchhhhc
Q 040845          268 SVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDF  347 (824)
Q Consensus       268 ~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l  347 (824)
                      +..++.|.|++|+++ .+|..++.+.+|+.|++++|+|+++|..+.+++.|+.|+++-|++. ..|..|+.++.|+.|||
T Consensus        32 ~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldl  109 (264)
T KOG0617|consen   32 MSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIEELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDL  109 (264)
T ss_pred             hhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhhhcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhc
Confidence            344555555555555 4444566666666666667777667666666777777777777666 66777777777777777


Q ss_pred             cccccc-ccCCCccCCCCCCCeEEccCccccccCCccccccccccEEEccCcccCCCCcccccCCcccceeeccCCcccC
Q 040845          348 SMNNFS-GIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKG  426 (824)
Q Consensus       348 ~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~  426 (824)
                      ++|++. ...|..|..+..|+-|+|+.|.+. .+|..++.+++|+.|.+..|.+- ++|..++.+..|++|.+.+|+++-
T Consensus       110 tynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~v  187 (264)
T KOG0617|consen  110 TYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLTV  187 (264)
T ss_pred             cccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceeee
Confidence            777764 246677777777777777777776 67777777777777777777776 777777777777777777777777


Q ss_pred             CCCCCCCcccc---ccccccCCcc
Q 040845          427 EIPRGGSFGNF---SAESFKGNEL  447 (824)
Q Consensus       427 ~~p~~~~~~~~---~~~~~~~n~~  447 (824)
                      .+|..+++.-.   .......|||
T Consensus       188 lppel~~l~l~~~k~v~r~E~NPw  211 (264)
T KOG0617|consen  188 LPPELANLDLVGNKQVMRMEENPW  211 (264)
T ss_pred             cChhhhhhhhhhhHHHHhhhhCCC
Confidence            77765543322   2234555655

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.78  E-value=7.2e-21  Score=168.62  Aligned_cols=181  Identities=28%  Similarity=0.465  Sum_probs=145.7

Q ss_pred             CCCCCCEEEcccccCcccCCccccccCCccEEEccCccccccCCccccCCCCCcEEEcCCCCCCCCCCcccccccccccc
Q 040845          243 KLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLN  322 (824)
Q Consensus       243 ~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~  322 (824)
                      .+.+.+.|.||+|+++ .+|..+..+.+|+.|++++|+|. ..|..++.++.|+.|+++-|++..+|.+|++++.|+.||
T Consensus        31 ~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~~lprgfgs~p~levld  108 (264)
T KOG0617|consen   31 NMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLNILPRGFGSFPALEVLD  108 (264)
T ss_pred             chhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhhcCccccCCCchhhhhh
Confidence            4555666667777776 55666777777777777777777 566678888888888888888888888888888888888


Q ss_pred             cccccccC-cCCccccccccchhhhcccccccccCCCccCCCCCCCeEEccCccccccCCccccccccccEEEccCcccC
Q 040845          323 LSSNCFSG-PLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLS  401 (824)
Q Consensus       323 l~~N~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  401 (824)
                      |++|++.. .+|..|-.++.|+.|+|++|.+. .+|..++.+++|+.|.+..|.+- .+|..++.+..|+.|++.+|+++
T Consensus       109 ltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~  186 (264)
T KOG0617|consen  109 LTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLT  186 (264)
T ss_pred             ccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceee
Confidence            88888854 57888889999999999999998 78889999999999999999998 68999999999999999999998


Q ss_pred             CCCcccccCCcc---cceeeccCCcccCCC
Q 040845          402 GTIPVSLEKLSY---LKDLNLSFNKLKGEI  428 (824)
Q Consensus       402 ~~~p~~~~~l~~---L~~L~l~~N~l~~~~  428 (824)
                       .+|..++++.-   =+...+..|+|-..|
T Consensus       187 -vlppel~~l~l~~~k~v~r~E~NPwv~pI  215 (264)
T KOG0617|consen  187 -VLPPELANLDLVGNKQVMRMEENPWVNPI  215 (264)
T ss_pred             -ecChhhhhhhhhhhHHHHhhhhCCCCChH
Confidence             88888776533   245667777775444

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.78  E-value=3.7e-20  Score=197.67  Aligned_cols=224  Identities=25%  Similarity=0.299  Sum_probs=180.3

Q ss_pred             eeeccceEEEEEE----ECCCcEEEEEEeecccc--chhhhHHHHHHHHhcCC-CCcceeEEeeeecCCeeEEEEeccCC
Q 040845          535 IGRGGFGSVYKAR----IRDGMEVAVKVFNLQCG--RAFKSFDVECAMMKSIR-HRNLVKVISSCSNEEFKALVLEYMPH  607 (824)
Q Consensus       535 lg~G~~g~V~~~~----~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~  607 (824)
                      +|+|+||.|+.++    .+.|.-+|+|+.++...  ........|..++...+ ||.++++...++.+...+++.+|..+
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg   81 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG   81 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence            6899999999764    23477899998765532  12224556888899886 99999999999999999999999999


Q ss_pred             CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccccc
Q 040845          608 GSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQT  687 (824)
Q Consensus       608 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  687 (824)
                      |.+...+.... .++......+...++-+++++|   +.+|+|||+|++||+++.+|++++.|||+++..-.....    
T Consensus        82 g~lft~l~~~~-~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~----  153 (612)
T KOG0603|consen   82 GDLFTRLSKEV-MFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA----  153 (612)
T ss_pred             chhhhccccCC-chHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc----
Confidence            99988887665 5677778888999999999999   999999999999999999999999999999865432221    


Q ss_pred             cccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhhhh
Q 040845          688 QTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHF  767 (824)
Q Consensus       688 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  767 (824)
                        .||..|||||++.  ....++|.||||++++||+||..||..     .....+..                    ...
T Consensus       154 --cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-----~~~~~Il~--------------------~~~  204 (612)
T KOG0603|consen  154 --CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-----DTMKRILK--------------------AEL  204 (612)
T ss_pred             --ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-----HHHHHHhh--------------------hcc
Confidence              6899999999988  567899999999999999999999876     11111111                    122


Q ss_pred             hhHHHHHHHHHHHHHHccccCCCCCCCH
Q 040845          768 VAKEQCVSFVFNLALECTVESPEQRINA  795 (824)
Q Consensus       768 ~~~~~~~~~l~~l~~~cl~~dP~~Rpt~  795 (824)
                      ..|......+.+++..++..+|..|.-.
T Consensus       205 ~~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  205 EMPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             CCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            2344556778889999999999999865

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.77  E-value=2.6e-20  Score=199.70  Aligned_cols=81  Identities=21%  Similarity=0.232  Sum_probs=48.1

Q ss_pred             Ccccccccc-cCCcccccCCCCCcEEEccCCccccc----ccccccCCCCCCEEeCCCCcCCc------ccChhhhCcCC
Q 040845            2 PSIINNFLT-STTPKEIDNISNLKVLYLYNNRLQGE----IIHEIGHLHNLGFLDLSQNKLLG------TIPAAIFNVST   70 (824)
Q Consensus         2 ~~l~~n~i~-~~~p~~~~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~Ls~n~l~~------~~~~~~~~l~~   70 (824)
                      |+|..+.++ ...+..|..+.+|++|+|++|.++..    ++..+...++|++|+++++.+.+      .++.++..+++
T Consensus         3 l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~   82 (319)
T cd00116           3 LSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCG   82 (319)
T ss_pred             cccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCc
Confidence            456666666 45556666677777777777776432    34445566667777777776652      12334445555


Q ss_pred             CceeeccCCccc
Q 040845           71 LKAFAVTNNSLS   82 (824)
Q Consensus        71 L~~L~L~~n~l~   82 (824)
                      |+.|++++|.+.
T Consensus        83 L~~L~l~~~~~~   94 (319)
T cd00116          83 LQELDLSDNALG   94 (319)
T ss_pred             eeEEEccCCCCC
Confidence            666666555554

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.76  E-value=8.3e-21  Score=203.57  Aligned_cols=285  Identities=23%  Similarity=0.250  Sum_probs=146.5

Q ss_pred             EEEccCCeee-eecCccccCCCCCceEeccCcccccc----CCccccCCCCCCEEEccCCcCCCCcCcc-cccccCCCCC
Q 040845           98 VLYLWGNNFS-GTIPHFIFNASKLSKLALEMNSFSGF----IPSTFGNLRNLEWLTLYDNNLTSSTLDL-SFLSSLSNCK  171 (824)
Q Consensus        98 ~L~L~~n~i~-~~~~~~l~~l~~L~~L~L~~N~i~~~----~~~~~~~l~~L~~L~L~~n~i~~~~~~~-~~~~~l~~l~  171 (824)
                      .|+|.++.++ ......+..+.+|+.|+++++.++..    ++..+...++|++|+++++.+...+... .....+.+++
T Consensus         2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~   81 (319)
T cd00116           2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC   81 (319)
T ss_pred             ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence            4566666665 33444555566677777777776432    3334455566666666666654211110 0122344555


Q ss_pred             CCcEEECcCCCCCccCCccccccccccccEEEeecCcceecCCccCCCCCCCCEEEecCCccCCc----cchhhcCC-CC
Q 040845          172 SLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGS----IPITLGKL-QK  246 (824)
Q Consensus       172 ~L~~L~Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~----~~~~~~~l-~~  246 (824)
                      +|++|++++|.+....+..+.                      ..... ++|++|++++|++.+.    +...+..+ ++
T Consensus        82 ~L~~L~l~~~~~~~~~~~~~~----------------------~l~~~-~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~  138 (319)
T cd00116          82 GLQELDLSDNALGPDGCGVLE----------------------SLLRS-SSLQELKLNNNGLGDRGLRLLAKGLKDLPPA  138 (319)
T ss_pred             ceeEEEccCCCCChhHHHHHH----------------------HHhcc-CcccEEEeeCCccchHHHHHHHHHHHhCCCC
Confidence            666666666655432221110                      01112 4467777777666521    22234444 66


Q ss_pred             CCEEEcccccCccc----CCccccccCCccEEEccCcccccc----CCccccCCCCCcEEEcCCCCCCCCCCcccccccc
Q 040845          247 LQDVDLEYNQLEGS----IPDSICLSVELYELELGGNKLSGS----IPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDI  318 (824)
Q Consensus       247 L~~L~L~~n~l~~~----~~~~~~~~~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L  318 (824)
                      |+.|++++|.+++.    .+..+..+.+|++|++++|.+++.    ++..+..+++|++|++++|.++....        
T Consensus       139 L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~--------  210 (319)
T cd00116         139 LEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGA--------  210 (319)
T ss_pred             ceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHH--------
Confidence            66666666666522    122333444555555555555421    11222333445555555554432110        


Q ss_pred             cccccccccccCcCCccccccccchhhhcccccccccCCCccC-----CCCCCCeEEccCccccc----cCCcccccccc
Q 040845          319 LDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIG-----SLKNLENLFLEYNRLEG----SIPDSFGDLIS  389 (824)
Q Consensus       319 ~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~-----~l~~L~~L~L~~N~l~~----~~~~~~~~l~~  389 (824)
                                 ..++..+..+++|+.|++++|.+++.....+.     ..+.|+.|++++|.+++    .+...+..+++
T Consensus       211 -----------~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~  279 (319)
T cd00116         211 -----------SALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKES  279 (319)
T ss_pred             -----------HHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCC
Confidence                       01222344555666666666666542222221     23678888888887762    23344555677


Q ss_pred             ccEEEccCcccCCC----CcccccCC-cccceeeccCCcc
Q 040845          390 LKSLNLSYNNLSGT----IPVSLEKL-SYLKDLNLSFNKL  424 (824)
Q Consensus       390 L~~L~L~~N~l~~~----~p~~~~~l-~~L~~L~l~~N~l  424 (824)
                      |+.+++++|.++..    +...+... +.|++|++.+|+|
T Consensus       280 L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (319)
T cd00116         280 LLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF  319 (319)
T ss_pred             ccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence            88888888888743    44444444 5677777777754

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.76  E-value=5.7e-18  Score=194.22  Aligned_cols=196  Identities=23%  Similarity=0.283  Sum_probs=160.3

Q ss_pred             hhccCCCCceeeeccceEEEEEEECCCcEEEEEEeeccccchhhhHHHHHHHHhcCC---CCcceeEEeeeecCCeeEEE
Q 040845          525 ATDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIR---HRNLVKVISSCSNEEFKALV  601 (824)
Q Consensus       525 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv  601 (824)
                      --+.|.+.+.||+|+||+||+|...+|+.||+|+-+.....   +|.--.+++.+|+   -+-|..+..++.-.+.-++|
T Consensus       696 ~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv  772 (974)
T KOG1166|consen  696 GGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLV  772 (974)
T ss_pred             cceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcceee
Confidence            34678899999999999999999888999999997655332   2233345566666   23445555555566777899


Q ss_pred             EeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC-------CCCcEEEeecccc
Q 040845          602 LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD-------DNMVAHLSDFGIA  674 (824)
Q Consensus       602 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~-------~~~~~kl~Dfg~a  674 (824)
                      +||.+.|+|.+++... ...++.-+..+..|++..+++||   ..+||||||||+|+++.       +...++|+|||.+
T Consensus       773 ~ey~~~Gtlld~~N~~-~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~s  848 (974)
T KOG1166|consen  773 SEYSPYGTLLDLINTN-KVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRS  848 (974)
T ss_pred             eeccccccHHHhhccC-CCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEEEecccc
Confidence            9999999999999844 47899999999999999999999   99999999999999994       2446899999999


Q ss_pred             cccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCC
Q 040845          675 KLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKK  727 (824)
Q Consensus       675 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~  727 (824)
                      ..+.--..........+|-.+-.+|...+..+++++|.|.++.+++-|+.|+.
T Consensus       849 iDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  849 IDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             eeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            87654333344556678889999999999999999999999999999999975

>PRK10345 hypothetical protein; Provisional

Probab=99.76  E-value=7.7e-18  Score=164.95  Aligned_cols=137  Identities=14%  Similarity=0.255  Sum_probs=107.0

Q ss_pred             CCCCceeeeccceEEEEEEECCCcEEEEEEeeccccchhhhHHHHHHHHhcC-----CCCcceeEEeeeecCC---eeE-
Q 040845          529 FSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSI-----RHRNLVKVISSCSNEE---FKA-  599 (824)
Q Consensus       529 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~~~-  599 (824)
                      +.-.++||+|+||.||.  +.+....+||++........+.+.+|+.+++.+     .||||++++|++.++.   ..+ 
T Consensus         4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~   81 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD   81 (210)
T ss_pred             cCCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence            34467899999999996  433333479988765444567789999999999     5799999999998764   333 


Q ss_pred             EEEec--cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHH-HHhhcCCCCCeEecCCCCCCeeeCC----CCcEEEeecc
Q 040845          600 LVLEY--MPHGSLEKYLHSSNYSLDIFQRLNIMIDVASAL-EYLHFGYSAPVIHCDLKPSNVLLDD----NMVAHLSDFG  672 (824)
Q Consensus       600 lv~e~--~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l-~~LH~~~~~~ivH~Dlk~~Nill~~----~~~~kl~Dfg  672 (824)
                      +|+||  +.+|+|.+++.+..  +++.  ..++.+++.++ +|||   +.+|+||||||+||+++.    ++.++|+||+
T Consensus        82 ~I~e~~G~~~~tL~~~l~~~~--~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~  154 (210)
T PRK10345         82 VIADFDGKPSITLTEFAEQCR--YEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVCDNI  154 (210)
T ss_pred             EEecCCCCcchhHHHHHHccc--ccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence            78999  55789999997643  4444  35678888777 9999   999999999999999974    3489999944


Q ss_pred             cc
Q 040845          673 IA  674 (824)
Q Consensus       673 ~a  674 (824)
                      -+
T Consensus       155 G~  156 (210)
T PRK10345        155 GE  156 (210)
T ss_pred             CC
Confidence            33

>smart00090 RIO RIO-like kinase

Probab=99.72  E-value=3.7e-17  Score=164.63  Aligned_cols=143  Identities=18%  Similarity=0.153  Sum_probs=111.7

Q ss_pred             hccCCCCceeeeccceEEEEEE--ECCCcEEEEEEeeccccc------------------------hhhhHHHHHHHHhc
Q 040845          526 TDKFSENNLIGRGGFGSVYKAR--IRDGMEVAVKVFNLQCGR------------------------AFKSFDVECAMMKS  579 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~  579 (824)
                      -.-|.+.+.||+|++|.||+|.  ..+|+.||||+++.....                        ....+..|+..+++
T Consensus        27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~  106 (237)
T smart00090       27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR  106 (237)
T ss_pred             CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence            3457888999999999999998  567999999998754210                        11235679999999


Q ss_pred             CCCCc--ceeEEeeeecCCeeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC-eEecCCCCC
Q 040845          580 IRHRN--LVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAP-VIHCDLKPS  656 (824)
Q Consensus       580 l~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~-ivH~Dlk~~  656 (824)
                      +.+..  +.+++++    ...++||||++++++........ ..+..++..++.|++.++++||   +.+ |+||||||+
T Consensus       107 L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dikp~  178 (237)
T smart00090      107 LYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV-EPEEEEEFELYDDILEEMRKLY---KEGELVHGDLSEY  178 (237)
T ss_pred             HHhcCCCCCeeeEe----cCceEEEEEecCCcccccccccC-CcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCChh
Confidence            97533  3444443    23479999999988876543222 4566677899999999999999   999 999999999


Q ss_pred             CeeeCCCCcEEEeeccccccc
Q 040845          657 NVLLDDNMVAHLSDFGIAKLL  677 (824)
Q Consensus       657 Nill~~~~~~kl~Dfg~a~~~  677 (824)
                      ||+++ ++.++++|||.|...
T Consensus       179 NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      179 NILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             hEEEE-CCCEEEEEChhhhcc
Confidence            99999 889999999998754

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.70  E-value=8.6e-17  Score=161.07  Aligned_cols=134  Identities=25%  Similarity=0.348  Sum_probs=113.9

Q ss_pred             ceeeeccceEEEEEEECCCcEEEEEEeeccccc--------hhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEec
Q 040845          533 NLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGR--------AFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       533 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      +.||+|++|.||+|.+ +|..|++|+.......        ....+.+|+.++..++|+++.....++......++||||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999988 5788999986543211        124577899999999999988877777777788999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccc
Q 040845          605 MPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  676 (824)
Q Consensus       605 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~  676 (824)
                      ++|++|.+++....    . ++..++.+++.+++++|   +.+++|||++|.||+++ ++.++++|||.+..
T Consensus        81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999986533    2 78899999999999999   99999999999999999 78999999998863

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.70  E-value=4.4e-18  Score=178.44  Aligned_cols=174  Identities=27%  Similarity=0.432  Sum_probs=131.0

Q ss_pred             CeeEEEEeccCCCCHHHHhhhCC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccc
Q 040845          596 EFKALVLEYMPHGSLEKYLHSSN--YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGI  673 (824)
Q Consensus       596 ~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~  673 (824)
                      .+.|+.|++++..+|.+|+.+.+  ...++.....++.|++.|++|      ++.+|+|+||.||++..+..+||.|||+
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl  402 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGL  402 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhh
Confidence            36789999999999999996443  567888899999999999999      6789999999999999999999999999


Q ss_pred             ccccCCCC----CccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCC
Q 040845          674 AKLLTGED----QSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLP  748 (824)
Q Consensus       674 a~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  748 (824)
                      ........    .....+..+||.+||+||.+.+..|+.++||||+|++++|+++ =..+++.    .....+.-...+|
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er----~~t~~d~r~g~ip  478 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER----IATLTDIRDGIIP  478 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH----HHhhhhhhcCCCC
Confidence            98765444    2344566789999999999999999999999999999999987 2222221    1111111111111


Q ss_pred             CcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 040845          749 ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEI  798 (824)
Q Consensus       749 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~ev  798 (824)
                      ..                ..  .+ .+.-+.++.+++...|++||++.++
T Consensus       479 ~~----------------~~--~d-~p~e~~ll~~lls~~p~~RP~~~~~  509 (516)
T KOG1033|consen  479 PE----------------FL--QD-YPEEYTLLQQLLSPSPEERPSAIEV  509 (516)
T ss_pred             hH----------------Hh--hc-CcHHHHHHHHhcCCCcccCchHHHH
Confidence            00                00  01 1223578999999999999955543

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.70  E-value=1e-16  Score=158.39  Aligned_cols=140  Identities=24%  Similarity=0.191  Sum_probs=111.0

Q ss_pred             hhccCCCCceeeeccceEEEEEEECCCcEEEEEEeeccccc----------------------hhhhHHHHHHHHhcCCC
Q 040845          525 ATDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGR----------------------AFKSFDVECAMMKSIRH  582 (824)
Q Consensus       525 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~~l~h  582 (824)
                      ....|.+.+.||+|+||.||+|..++|+.||||+++.....                      .......|+.++..+.|
T Consensus        13 ~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~   92 (198)
T cd05144          13 RGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYE   92 (198)
T ss_pred             cCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHH
Confidence            33447888999999999999999888999999987643210                      11235678999999987


Q ss_pred             Cc--ceeEEeeeecCCeeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee
Q 040845          583 RN--LVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL  660 (824)
Q Consensus       583 ~n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill  660 (824)
                      ++  +...++.    ...++||||+++++|.+....       .....++.+++.++.++|   +.+++||||+|+||++
T Consensus        93 ~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p~Nill  158 (198)
T cd05144          93 EGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAY---KHGIIHGDLSEFNILV  158 (198)
T ss_pred             cCCCCCceeec----CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHH---HCCCCcCCCCcccEEE
Confidence            74  4444442    345899999999998765431       235678899999999999   8999999999999999


Q ss_pred             CCCCcEEEeecccccccC
Q 040845          661 DDNMVAHLSDFGIAKLLT  678 (824)
Q Consensus       661 ~~~~~~kl~Dfg~a~~~~  678 (824)
                      ++++.++|+|||.+....
T Consensus       159 ~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         159 DDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             cCCCcEEEEECCccccCC
Confidence            999999999999997654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.69  E-value=2.3e-16  Score=179.68  Aligned_cols=144  Identities=21%  Similarity=0.299  Sum_probs=115.7

Q ss_pred             HHHHHHhhccCCCCceeeeccceEEEEEEECCCcEEEEEEeecc--cc------chhhhHHHHHHHHhcCCCCcceeEEe
Q 040845          519 YLELFQATDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQ--CG------RAFKSFDVECAMMKSIRHRNLVKVIS  590 (824)
Q Consensus       519 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~------~~~~~~~~E~~~l~~l~h~niv~l~~  590 (824)
                      +.........|...+.||+|+||+||+|.+. +..+++|+....  ..      ...+.+.+|+++++.++|++++....
T Consensus       325 ~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~  403 (535)
T PRK09605        325 WIKEEEVKRRKIPDHLIGKGAEADIKKGEYL-GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVI  403 (535)
T ss_pred             eccccccccccCccceeccCCcEEEEEEeec-CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEE
Confidence            3333344455677899999999999999876 444555543211  11      12356788999999999999998888


Q ss_pred             eeecCCeeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEee
Q 040845          591 SCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSD  670 (824)
Q Consensus       591 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D  670 (824)
                      ++.++...++||||+++++|.+++.         ....++.+++++++|||   +.+++|||+||+||++ +++.++++|
T Consensus       404 ~~~~~~~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liD  470 (535)
T PRK09605        404 YDVDPEEKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLID  470 (535)
T ss_pred             EEEeCCCCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEe
Confidence            8777777889999999999999875         35678999999999999   9999999999999999 678999999


Q ss_pred             cccccc
Q 040845          671 FGIAKL  676 (824)
Q Consensus       671 fg~a~~  676 (824)
                      ||+++.
T Consensus       471 FGla~~  476 (535)
T PRK09605        471 FGLGKY  476 (535)
T ss_pred             Cccccc
Confidence            999874

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.68  E-value=1.3e-16  Score=158.16  Aligned_cols=130  Identities=21%  Similarity=0.336  Sum_probs=107.0

Q ss_pred             eeeeccceEEEEEEECCCcEEEEEEeecccc--------chhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEecc
Q 040845          534 LIGRGGFGSVYKARIRDGMEVAVKVFNLQCG--------RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYM  605 (824)
Q Consensus       534 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  605 (824)
                      .||+|+||.||+|.+. |..|++|+......        ...+.+.+|+++++.++|+++.....++......++||||+
T Consensus         1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            4899999999999864 78999998643211        11255678999999999887665555555666778999999


Q ss_pred             CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccc
Q 040845          606 PHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  676 (824)
Q Consensus       606 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~  676 (824)
                      +|++|.+++.....        .++.+++.+++++|   +.+++|+|++|.||+++ ++.++++|||.+..
T Consensus        80 ~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGND--------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcHH--------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            99999998754321        78999999999999   99999999999999999 88999999998875

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.64  E-value=1.7e-16  Score=178.07  Aligned_cols=212  Identities=25%  Similarity=0.316  Sum_probs=144.8

Q ss_pred             hccCCCCceeeeccceEEEEEEECC-CcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEec
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      ..+|+.++.|..|+||.||.++++. .+.+|+|+=+ +.     .+.+-  ++.....|++|                  
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~kiNk-q~-----lilRn--ilt~a~npfvv------------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK-QN-----LILRN--ILTFAGNPFVV------------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhcccc-cc-----hhhhc--cccccCCccee------------------
Confidence            3678889999999999999998774 6778885422 11     11110  33333344433                  


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC--
Q 040845          605 MPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ--  682 (824)
Q Consensus       605 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~--  682 (824)
                         |+-...+...+ .++.        +++.+++|+|   ..+|+|||+||+|.+++.-|++|++|||+++.--..-.  
T Consensus       136 ---gDc~tllk~~g-~lPv--------dmvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn  200 (1205)
T KOG0606|consen  136 ---GDCATLLKNIG-PLPV--------DMVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN  200 (1205)
T ss_pred             ---chhhhhcccCC-CCcc--------hhhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence               33334444333 2332        2278899999   99999999999999999999999999998764211000  


Q ss_pred             ----------c-cccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcc
Q 040845          683 ----------S-MTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPIST  751 (824)
Q Consensus       683 ----------~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  751 (824)
                                . ......+||+.|.|||++....|+..+|.|++|+++||.+.|+.||.+... +.-+.+.+...+..  
T Consensus       201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtp-eelfg~visd~i~w--  277 (1205)
T KOG0606|consen  201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP-EELFGQVISDDIEW--  277 (1205)
T ss_pred             hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCH-HHHHhhhhhhhccc--
Confidence                      0 111345799999999999999999999999999999999999999987422 22233332221110  


Q ss_pred             hhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHH
Q 040845          752 MEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAK  796 (824)
Q Consensus       752 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~  796 (824)
                               .+.      .+..+.++.+++.+.++++|..|--..
T Consensus       278 ---------pE~------dea~p~Ea~dli~~LL~qnp~~Rlgt~  307 (1205)
T KOG0606|consen  278 ---------PEE------DEALPPEAQDLIEQLLRQNPLCRLGTG  307 (1205)
T ss_pred             ---------ccc------CcCCCHHHHHHHHHHHHhChHhhcccc
Confidence                     000      112356788999999999999998443

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.60  E-value=5.4e-15  Score=144.90  Aligned_cols=136  Identities=24%  Similarity=0.241  Sum_probs=98.1

Q ss_pred             CceeeeccceEEEEEEECCCcEEEEEEeeccccch--hhh----------------------HHHHHHHHhcCCCCc--c
Q 040845          532 NNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRA--FKS----------------------FDVECAMMKSIRHRN--L  585 (824)
Q Consensus       532 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--~~~----------------------~~~E~~~l~~l~h~n--i  585 (824)
                      .+.||+|+||+||+|...+|+.||||+++......  ...                      ...|...+..+.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            46899999999999998889999999987542111  011                      134555666664432  4


Q ss_pred             eeEEeeeecCCeeEEEEeccCCCCHHH-HhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEecCCCCCCeeeCCC
Q 040845          586 VKVISSCSNEEFKALVLEYMPHGSLEK-YLHSSNYSLDIFQRLNIMIDVASALEYLHFGYS-APVIHCDLKPSNVLLDDN  663 (824)
Q Consensus       586 v~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dlk~~Nill~~~  663 (824)
                      .+.+++    ...++||||++++++.. .+....  .. .+...++.+++.++.++|   . .+|+|+|+||+||+++ +
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nili~-~  150 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLY---REAGLVHGDLSEYNILVD-D  150 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEEEE-C
Confidence            444443    23589999999854321 111111  11 567889999999999999   7 9999999999999999 8


Q ss_pred             CcEEEeecccccccC
Q 040845          664 MVAHLSDFGIAKLLT  678 (824)
Q Consensus       664 ~~~kl~Dfg~a~~~~  678 (824)
                      +.++++|||.+....
T Consensus       151 ~~~~liDfg~a~~~~  165 (187)
T cd05119         151 GKVYIIDVPQAVEID  165 (187)
T ss_pred             CcEEEEECccccccc
Confidence            999999999997654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.57  E-value=1.8e-16  Score=179.15  Aligned_cols=257  Identities=24%  Similarity=0.295  Sum_probs=197.5

Q ss_pred             hccCCCCceeeeccceEEEEEEECC--CcEEEEEEeeccc--cchhhhHHHHHHHHhcCC-CCcceeEEeeeecCCeeEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIRD--GMEVAVKVFNLQC--GRAFKSFDVECAMMKSIR-HRNLVKVISSCSNEEFKAL  600 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l  600 (824)
                      ...|...+.||+|+|+.|-.+....  ...+|+|.+....  ....+....|..+-+.+. |+|++.+++...+.+..++
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            3567778889999999998886533  4456666654432  333455566888888886 9999999999999999999


Q ss_pred             EEeccCCCCHHHHh-hhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC-cEEEeecccccccC
Q 040845          601 VLEYMPHGSLEKYL-HSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM-VAHLSDFGIAKLLT  678 (824)
Q Consensus       601 v~e~~~~g~L~~~l-~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~Dfg~a~~~~  678 (824)
                      +.+|.+++++.+.+ +......+......++.|+..++.|+|.  ..++.|+|+||+|.+++..+ ..+++|||+|..+.
T Consensus        99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~  176 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR  176 (601)
T ss_pred             ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence            99999999999888 4443356666778899999999999996  67899999999999999999 99999999999887


Q ss_pred             C-CCCccccccccc-cccccCccCcCCC-CCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhc
Q 040845          679 G-EDQSMTQTQTLA-TIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVV  755 (824)
Q Consensus       679 ~-~~~~~~~~~~~~-~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  755 (824)
                      . .+.........| ++.|+|||...+. ......|+||.|+++.-+++|..||+...........|.......      
T Consensus       177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~------  250 (601)
T KOG0590|consen  177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRF------  250 (601)
T ss_pred             ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeeccccccc------
Confidence            6 454445555667 9999999998875 457889999999999999999999987655544444443221000      


Q ss_pred             cccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040845          756 DANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVA  800 (824)
Q Consensus       756 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~  800 (824)
                                .............++..+++..+|..|.+.+++..
T Consensus       251 ----------~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  251 ----------TQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             ----------ccCccccCChhhhhcccccccCCchhccccccccc
Confidence                      00011122344677888999999999999888754

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.57  E-value=1.9e-14  Score=135.80  Aligned_cols=135  Identities=21%  Similarity=0.262  Sum_probs=113.2

Q ss_pred             CCceeeeccceEEEEEEECCCcEEEEEEeeccccchhhhHHHHHHHHhcCCC--CcceeEEeeeecCCeeEEEEeccCCC
Q 040845          531 ENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRH--RNLVKVISSCSNEEFKALVLEYMPHG  608 (824)
Q Consensus       531 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g  608 (824)
                      +.+.||+|.++.||+++.. +..+++|.......  ...+..|+.+++.++|  ..+++++++....+..+++|||++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~-~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK-DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEec-CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            3578999999999999986 47899999865432  4678899999999976  58999999888888899999999887


Q ss_pred             CHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccc
Q 040845          609 SLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  676 (824)
Q Consensus       609 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~  676 (824)
                      .+..+        +......++.+++++++++|.....+++|+|++|+||++++.+.++++|||.+..
T Consensus        79 ~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          79 TLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            76544        4556778899999999999932225799999999999999999999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.55  E-value=3.5e-16  Score=164.04  Aligned_cols=195  Identities=28%  Similarity=0.413  Sum_probs=168.3

Q ss_pred             CCCCCCEEEecCCccCCccchhhcCCCCCCEEEcccccCcccCCccccccCCccEEEccCccccccCCccccCCCCCcEE
Q 040845          219 NLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVL  298 (824)
Q Consensus       219 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L  298 (824)
                      .++.-...||+.|++. .+|..+..+..|+.+.|.+|.+. .+|..++.+..|++|+|+.|+++ ..|..+..++ |+.|
T Consensus        73 ~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvl  148 (722)
T KOG0532|consen   73 DLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVL  148 (722)
T ss_pred             cccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeE
Confidence            4556677899999998 78888999999999999999998 88999999999999999999999 6777777877 9999


Q ss_pred             EcCCCCCCCCCCcccccccccccccccccccCcCCccccccccchhhhcccccccccCCCccCCCCCCCeEEccCccccc
Q 040845          299 SLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEG  378 (824)
Q Consensus       299 ~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  378 (824)
                      .+++|+++.+|..+..+..|..||.+.|.+. .+|..++++.+|+.|.+..|++. .+|.+++.|+ |..||+|.|+++ 
T Consensus       149 i~sNNkl~~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~Lp-Li~lDfScNkis-  224 (722)
T KOG0532|consen  149 IVSNNKLTSLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSLP-LIRLDFSCNKIS-  224 (722)
T ss_pred             EEecCccccCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCCc-eeeeecccCcee-
Confidence            9999999999999999999999999999998 68889999999999999999998 4677777665 889999999998 


Q ss_pred             cCCccccccccccEEEccCcccCCCCcccccCCcc---cceeeccCC
Q 040845          379 SIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSY---LKDLNLSFN  422 (824)
Q Consensus       379 ~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~---L~~L~l~~N  422 (824)
                      .+|-.|..|..|++|.|.+|+|+ ..|..+.-.-.   .++|+..-+
T Consensus       225 ~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~  270 (722)
T KOG0532|consen  225 YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQAC  270 (722)
T ss_pred             ecchhhhhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecchhc
Confidence            79999999999999999999998 77776644333   355555555

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.55  E-value=4.2e-14  Score=142.78  Aligned_cols=136  Identities=19%  Similarity=0.258  Sum_probs=106.5

Q ss_pred             Cceee-eccceEEEEEEECCCcEEEEEEeeccc-------------cchhhhHHHHHHHHhcCCCCcc--eeEEeeeecC
Q 040845          532 NNLIG-RGGFGSVYKARIRDGMEVAVKVFNLQC-------------GRAFKSFDVECAMMKSIRHRNL--VKVISSCSNE  595 (824)
Q Consensus       532 ~~~lg-~G~~g~V~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~  595 (824)
                      ...|| .||.|+||.+... +..+|||.+....             ......+.+|++++..++|+++  +..+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            35788 8999999999876 7889999885321             1123457789999999998875  6677764332


Q ss_pred             -C---eeEEEEeccCC-CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEee
Q 040845          596 -E---FKALVLEYMPH-GSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSD  670 (824)
Q Consensus       596 -~---~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D  670 (824)
                       .   ..++||||+++ .+|.+++...  .++..    .+.+++.++++||   +.||+||||||.|||++.++.++++|
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~LID  185 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEA--PLSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWLID  185 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcC--CCCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEEEE
Confidence             2   23599999997 6999888653  34433    3678999999999   99999999999999999999999999


Q ss_pred             ccccccc
Q 040845          671 FGIAKLL  677 (824)
Q Consensus       671 fg~a~~~  677 (824)
                      ||.+...
T Consensus       186 fg~~~~~  192 (239)
T PRK01723        186 FDRGELR  192 (239)
T ss_pred             CCCcccC
Confidence            9988753

>PLN03150 hypothetical protein; Provisional

Probab=99.50  E-value=3.2e-14  Score=163.68  Aligned_cols=118  Identities=35%  Similarity=0.606  Sum_probs=103.9

Q ss_pred             cchhhhcccccccccCCCccCCCCCCCeEEccCccccccCCccccccccccEEEccCcccCCCCcccccCCcccceeecc
Q 040845          341 ALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLS  420 (824)
Q Consensus       341 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~  420 (824)
                      .++.|+|++|.+++.+|..++.+++|+.|+|++|.+++.+|..++.+++|+.|+|++|+++|.+|..+..+++|+.|+|+
T Consensus       419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls  498 (623)
T PLN03150        419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN  498 (623)
T ss_pred             EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence            47889999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCcccCCCCCCC--CccccccccccCCccccCCCCCCCCCCC
Q 040845          421 FNKLKGEIPRGG--SFGNFSAESFKGNELLCGSPNLQVPPCK  460 (824)
Q Consensus       421 ~N~l~~~~p~~~--~~~~~~~~~~~~n~~~c~~~~~~~~~c~  460 (824)
                      +|+++|.+|..-  .......+.+.+|+.+|+.|.  ..+|.
T Consensus       499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~--l~~C~  538 (623)
T PLN03150        499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG--LRACG  538 (623)
T ss_pred             CCcccccCChHHhhccccCceEEecCCccccCCCC--CCCCc
Confidence            999999999742  123345677899999999874  34664

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.50  E-value=8.4e-16  Score=161.21  Aligned_cols=195  Identities=31%  Similarity=0.449  Sum_probs=170.4

Q ss_pred             EEecCCccCCccchhh-cCCCCCCEEEcccccCcccCCccccccCCccEEEccCccccccCCccccCCCCCcEEEcCCCC
Q 040845          226 IVLGGNKLNGSIPITL-GKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNE  304 (824)
Q Consensus       226 L~L~~n~l~~~~~~~~-~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~  304 (824)
                      |.|++-++....-.++ ..+.--...||+.|++. .+|..++.+..|+.+.|+.|.+. .+|.++.++..|..|+|+.|+
T Consensus        55 l~Ls~rrlk~fpr~a~~~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~Nq  132 (722)
T KOG0532|consen   55 LLLSGRRLKEFPRGAASYDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQ  132 (722)
T ss_pred             cccccchhhcCCCccccccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccch
Confidence            4455555542211222 34566678999999999 89999999999999999999999 789999999999999999999


Q ss_pred             CCCCCCcccccccccccccccccccCcCCccccccccchhhhcccccccccCCCccCCCCCCCeEEccCccccccCCccc
Q 040845          305 LTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSF  384 (824)
Q Consensus       305 l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~  384 (824)
                      +..+|..++.++ |+.|.+++|+++ .+|..++.+..|..||.+.|.+. .+|..++++.+|+.|++..|++. .+|+.+
T Consensus       133 lS~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El  208 (722)
T KOG0532|consen  133 LSHLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEEL  208 (722)
T ss_pred             hhcCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHH
Confidence            999999988765 899999999999 78999999999999999999998 67889999999999999999999 578788


Q ss_pred             cccccccEEEccCcccCCCCcccccCCcccceeeccCCcccCCC
Q 040845          385 GDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEI  428 (824)
Q Consensus       385 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~  428 (824)
                      ..| .|..||+|.|+++ .+|..|.+|..|++|-|.+|+|+..+
T Consensus       209 ~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLqSPP  250 (722)
T KOG0532|consen  209 CSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQSPP  250 (722)
T ss_pred             hCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCCCCh
Confidence            865 6899999999998 99999999999999999999999543

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.44  E-value=1.8e-13  Score=150.98  Aligned_cols=261  Identities=30%  Similarity=0.379  Sum_probs=128.5

Q ss_pred             EEEccCCeeeeecCccccCCCCCceEeccCccccccCCccccCCC-CCCEEEccCCcCCCCcCcccccccCCCCCCCcEE
Q 040845           98 VLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLR-NLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHI  176 (824)
Q Consensus        98 ~L~L~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~-~L~~L~L~~n~i~~~~~~~~~~~~l~~l~~L~~L  176 (824)
                      .|+++.|.+. .....+..++.++.|++.+|.++ .++.....+. +|++|++++|.+..++      ..+..+++|+.|
T Consensus        97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~~l~------~~~~~l~~L~~L  168 (394)
T COG4886          97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIESLP------SPLRNLPNLKNL  168 (394)
T ss_pred             eeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchhhhh------hhhhcccccccc
Confidence            3455555543 11222333455555555555555 2333444442 5666666666655542      124555666666


Q ss_pred             ECcCCCCCccCCccccccccccccEEEeecCcceecCCccCCCCCCCCEEEecCCccCCccchhhcCCCCCCEEEccccc
Q 040845          177 SLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQ  256 (824)
Q Consensus       177 ~Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~  256 (824)
                      ++++|++..+++.                           .+.+++|+.|++++|++. .+|........|++|.+++|.
T Consensus       169 ~l~~N~l~~l~~~---------------------------~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~  220 (394)
T COG4886         169 DLSFNDLSDLPKL---------------------------LSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNS  220 (394)
T ss_pred             ccCCchhhhhhhh---------------------------hhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCc
Confidence            6666665543221                           112344444444444444 233332333345555555553


Q ss_pred             CcccCCccccccCCccEEEccCccccccCCccccCCCCCcEEEcCCCCCCCCCCcccccccccccccccccccCcCCccc
Q 040845          257 LEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEI  336 (824)
Q Consensus       257 l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~  336 (824)
                      +. ..+..+..+.++..+.+.+|++. ..+..++.+++++.|++++|.++.++. +..+.+++.|++++|.+....+...
T Consensus       221 ~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~~i~~-~~~~~~l~~L~~s~n~~~~~~~~~~  297 (394)
T COG4886         221 II-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQISSISS-LGSLTNLRELDLSGNSLSNALPLIA  297 (394)
T ss_pred             ce-ecchhhhhcccccccccCCceee-eccchhccccccceecccccccccccc-ccccCccCEEeccCccccccchhhh
Confidence            22 23344444455555555555554 224455566666666666666666665 5566666666666666665444443


Q ss_pred             cccccchhhhcccccccccCCCccCCCCCCCeEEccCccccccCCccccccccccEEEccCcccC
Q 040845          337 RNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLS  401 (824)
Q Consensus       337 ~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  401 (824)
                      ....... +... +.+. ..+..+.....+....+..+... ..+..+.....+..++...+...
T Consensus       298 ~~~~~~~-~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  358 (394)
T COG4886         298 LLLLLLE-LLLN-LLLT-LKALELKLNSILLNNNILSNGET-SSPEALSILESLNNLWTLDNALD  358 (394)
T ss_pred             ccchhHH-hhhh-hhhh-ccccccccccccccccccccccc-ccchhhcccccccCceecccccc
Confidence            3222222 1111 2222 22233333444445555555555 45556666666666666666655

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.44  E-value=2e-13  Score=150.58  Aligned_cols=262  Identities=29%  Similarity=0.351  Sum_probs=172.0

Q ss_pred             ceEeccCccccccCCccccCCCCCCEEEccCCcCCCCcCcccccccCCCCC-CCcEEECcCCCCCccCCccccccccccc
Q 040845          121 SKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCK-SLTHISLSNNPLDGILPRTYVGNLSHSL  199 (824)
Q Consensus       121 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~-~L~~L~Ls~n~l~~~~~~~~~~~l~~~L  199 (824)
                      ..|++..|.+. .....+..++.++.|++.+|.++.++..      ...++ +|+.|++++|.+..+             
T Consensus        96 ~~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~~i~~~------~~~~~~nL~~L~l~~N~i~~l-------------  155 (394)
T COG4886          96 PSLDLNLNRLR-SNISELLELTNLTSLDLDNNNITDIPPL------IGLLKSNLKELDLSDNKIESL-------------  155 (394)
T ss_pred             ceeeccccccc-cCchhhhcccceeEEecCCcccccCccc------cccchhhcccccccccchhhh-------------
Confidence            35777777774 2334556667888888888888877642      23342 777777777777633             


Q ss_pred             cEEEeecCcceecCCccCCCCCCCCEEEecCCccCCccchhhcCCCCCCEEEcccccCcccCCccccccCCccEEEccCc
Q 040845          200 KNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGN  279 (824)
Q Consensus       200 ~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n  279 (824)
                                    |..+..+++|+.|++++|++. .+|.....+++|+.|++++|+++ .+|........|++|.+++|
T Consensus       156 --------------~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N  219 (394)
T COG4886         156 --------------PSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNN  219 (394)
T ss_pred             --------------hhhhhccccccccccCCchhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCC
Confidence                          244567788888888888887 44545557788888888888887 55555555666888888888


Q ss_pred             cccccCCccccCCCCCcEEEcCCCCCCCCCCcccccccccccccccccccCcCCccccccccchhhhcccccccccCCCc
Q 040845          280 KLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPME  359 (824)
Q Consensus       280 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~  359 (824)
                      .+. ..+..+.+++++..+.+.+|++..++..+..+++++.|++++|.++....  ++.+.+++.|++++|.+...++..
T Consensus       220 ~~~-~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~  296 (394)
T COG4886         220 SII-ELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPLI  296 (394)
T ss_pred             cce-ecchhhhhcccccccccCCceeeeccchhccccccceecccccccccccc--ccccCccCEEeccCccccccchhh
Confidence            644 45666777888888888888888877777778888888888888874333  778888888888888888665554


Q ss_pred             cCCCCCCCeEEccCccccccCCccccccccccEEEccCcccCCCCcccccCCcccceeeccCCccc
Q 040845          360 IGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLK  425 (824)
Q Consensus       360 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~  425 (824)
                      ..... +..+... +.+. ..+........+....+..+... ..+..+.....+..++...+...
T Consensus       297 ~~~~~-~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  358 (394)
T COG4886         297 ALLLL-LLELLLN-LLLT-LKALELKLNSILLNNNILSNGET-SSPEALSILESLNNLWTLDNALD  358 (394)
T ss_pred             hccch-hHHhhhh-hhhh-ccccccccccccccccccccccc-ccchhhcccccccCceecccccc
Confidence            43322 2222222 3333 22223333344455555556655 55556655555666665555444

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.43  E-value=4.1e-13  Score=147.58  Aligned_cols=141  Identities=23%  Similarity=0.277  Sum_probs=101.4

Q ss_pred             CceeeeccceEEEEEEECCCcEEEEEEeeccccchh----------------------------------------hhHH
Q 040845          532 NNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAF----------------------------------------KSFD  571 (824)
Q Consensus       532 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~~  571 (824)
                      .+.||.|++|.||+|+.++|+.||||+.++......                                        -++.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            368999999999999999999999999864321100                                        0244


Q ss_pred             HHHHHHhcCC----CCcceeEEeeee-cCCeeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHH-HHHHhhcCCC
Q 040845          572 VECAMMKSIR----HRNLVKVISSCS-NEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVAS-ALEYLHFGYS  645 (824)
Q Consensus       572 ~E~~~l~~l~----h~niv~l~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~-~l~~LH~~~~  645 (824)
                      .|+..+.+++    |.+-+.+-.++. .....++||||++|++|.++........+   +..++..++. .+..+|   .
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~---~  275 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVL---R  275 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHH---h
Confidence            4665555552    333333333332 23456899999999999888654322222   3456666666 467889   8


Q ss_pred             CCeEecCCCCCCeeeCCCCcEEEeecccccccC
Q 040845          646 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT  678 (824)
Q Consensus       646 ~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~  678 (824)
                      .|++|+|++|.||++++++.++++|||++..+.
T Consensus       276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             CCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            999999999999999999999999999998764

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.35  E-value=1.1e-12  Score=141.19  Aligned_cols=249  Identities=23%  Similarity=0.263  Sum_probs=183.4

Q ss_pred             cCCCCceeee--ccceEEEEEEE---CCCcEEEEEEeecccc--chhhhHHHHHHHHhcC-CCCcceeEEeeeecCCeeE
Q 040845          528 KFSENNLIGR--GGFGSVYKARI---RDGMEVAVKVFNLQCG--RAFKSFDVECAMMKSI-RHRNLVKVISSCSNEEFKA  599 (824)
Q Consensus       528 ~~~~~~~lg~--G~~g~V~~~~~---~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  599 (824)
                      .|.+...+|.  |.+|.||.+..   .++..+|+|.-+....  ....+-.+|+.....+ .|++.++.+..+...+..+
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf  194 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF  194 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence            4556788999  99999999976   3588899997443322  2333344567666677 4999999999999999999


Q ss_pred             EEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHH----HHHHhhcCCCCCeEecCCCCCCeeeCCC-CcEEEeecccc
Q 040845          600 LVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVAS----ALEYLHFGYSAPVIHCDLKPSNVLLDDN-MVAHLSDFGIA  674 (824)
Q Consensus       600 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~----~l~~LH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~Dfg~a  674 (824)
                      +-+|++ +.++.++.+.....++....+....+..+    |+.++|   ...++|-|+||.||+...+ ..++++|||+.
T Consensus       195 iqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~df~~v  270 (524)
T KOG0601|consen  195 IQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTDFGLV  270 (524)
T ss_pred             eeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecCCccee
Confidence            999999 47999998877766788888888888888    999999   9999999999999999999 89999999999


Q ss_pred             cccCCCCCcccc---ccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcc
Q 040845          675 KLLTGEDQSMTQ---TQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPIST  751 (824)
Q Consensus       675 ~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  751 (824)
                      ..+.+.......   ....+...|++||... +.++.++|+|++|.++.+..++..+....     ....|.+.....-.
T Consensus       271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g-----~~~~W~~~r~~~ip  344 (524)
T KOG0601|consen  271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVG-----KNSSWSQLRQGYIP  344 (524)
T ss_pred             EEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCC-----CCCCccccccccCc
Confidence            887655422111   1224777899999875 46789999999999999999987754321     01112111100000


Q ss_pred             hhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          752 MEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       752 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      .+..+               .-..++...+..|+..+|-.|++++.+.++
T Consensus       345 ~e~~~---------------~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l  379 (524)
T KOG0601|consen  345 LEFCE---------------GGSSSLRSVTSQMLDEDPRLRLTAQILTAL  379 (524)
T ss_pred             hhhhc---------------CcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence            00010               113345558889999999999999887653

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.33  E-value=1.9e-13  Score=139.71  Aligned_cols=165  Identities=25%  Similarity=0.252  Sum_probs=117.9

Q ss_pred             cCCCCCcEEEccCCccccccc-ccccCCCCCCEEeCCCCcCCcc--cChhhhCcCCCceeeccCCccccccCccccCCCC
Q 040845           18 DNISNLKVLYLYNNRLQGEII-HEIGHLHNLGFLDLSQNKLLGT--IPAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLP   94 (824)
Q Consensus        18 ~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~Ls~n~l~~~--~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~   94 (824)
                      .++.+|++..|.++.+..... .....|++++.||||.|-+..-  +..-...+++|+.|+|+.|++...........++
T Consensus       118 sn~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~  197 (505)
T KOG3207|consen  118 SNLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLS  197 (505)
T ss_pred             hhHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhh
Confidence            567888999999998873222 3567889999999999988732  3345567889999999999887665555545678


Q ss_pred             CccEEEccCCeeeee-cCccccCCCCCceEeccCccccccCCccccCCCCCCEEEccCCcCCCCcCcccccccCCCCCCC
Q 040845           95 NLEVLYLWGNNFSGT-IPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSL  173 (824)
Q Consensus        95 ~L~~L~L~~n~i~~~-~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~~L  173 (824)
                      +|+.|.|+.|.++.. +-..+..+++|+.|+|..|..-.+.......+..|++|||++|++-+.+.    ......++.|
T Consensus       198 ~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~----~~~~~~l~~L  273 (505)
T KOG3207|consen  198 HLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQ----GYKVGTLPGL  273 (505)
T ss_pred             hhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCccccccc----ccccccccch
Confidence            888888888888622 23345567888888888885332444455567788888888888766542    2346777888


Q ss_pred             cEEECcCCCCCcc
Q 040845          174 THISLSNNPLDGI  186 (824)
Q Consensus       174 ~~L~Ls~n~l~~~  186 (824)
                      +.|+++.+.|.++
T Consensus       274 ~~Lnls~tgi~si  286 (505)
T KOG3207|consen  274 NQLNLSSTGIASI  286 (505)
T ss_pred             hhhhccccCcchh
Confidence            8888887777654

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.33  E-value=2.3e-12  Score=126.94  Aligned_cols=204  Identities=20%  Similarity=0.307  Sum_probs=140.0

Q ss_pred             HHhcCCCCcceeEEeeeecCC-----eeEEEEeccCCCCHHHHhhhCC---CCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 040845          576 MMKSIRHRNLVKVISSCSNEE-----FKALVLEYMPHGSLEKYLHSSN---YSLDIFQRLNIMIDVASALEYLHFGYSAP  647 (824)
Q Consensus       576 ~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~  647 (824)
                      -+-.+-|.|+|+++.|+.+.+     ...++.|||+.|++..++++..   ..+....-.+|+.||..||.||| .++..
T Consensus       120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLh-s~~Pp  198 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLH-SCDPP  198 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhh-ccCCc
Confidence            344556999999999986543     4678999999999999997643   45667777889999999999999 56899


Q ss_pred             eEecCCCCCCeeeCCCCcEEEeecccccccCCC--CCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhC
Q 040845          648 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE--DQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTR  725 (824)
Q Consensus       648 ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg  725 (824)
                      |+|+++.-+-|++..+|-+|+.--.-.......  ..........+-++|.|||+-.....+.++|||+||....||..+
T Consensus       199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail  278 (458)
T KOG1266|consen  199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL  278 (458)
T ss_pred             cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence            999999999999999998888532211111000  001111223467899999998888888999999999999999887


Q ss_pred             CCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 040845          726 KKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLL  803 (824)
Q Consensus       726 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~  803 (824)
                      ..-..........-.             .+.........          ..=+.++.+|+...|..||+|.+.+.|.-
T Consensus       279 Eiq~tnseS~~~~ee-------------~ia~~i~~len----------~lqr~~i~kcl~~eP~~rp~ar~llfHpl  333 (458)
T KOG1266|consen  279 EIQSTNSESKVEVEE-------------NIANVIIGLEN----------GLQRGSITKCLEGEPNGRPDARLLLFHPL  333 (458)
T ss_pred             eeccCCCcceeehhh-------------hhhhheeeccC----------ccccCcCcccccCCCCCCcchhhhhcCce
Confidence            753211111000000             00000010000          00134678899999999999999876643

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.31  E-value=1.1e-13  Score=137.84  Aligned_cols=248  Identities=21%  Similarity=0.256  Sum_probs=125.9

Q ss_pred             ccCCCCCcEEEccCCcccccc----cccccCCCCCCEEeCCCC---cCCcccChhhhCcCCCceeeccCCccccccCccc
Q 040845           17 IDNISNLKVLYLYNNRLQGEI----IHEIGHLHNLGFLDLSQN---KLLGTIPAAIFNVSTLKAFAVTNNSLSGCLSSIT   89 (824)
Q Consensus        17 ~~~l~~L~~L~L~~n~l~~~~----~~~~~~l~~L~~L~Ls~n---~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~   89 (824)
                      +..+..++.|+||+|.+..+-    ...+.+.++|+..++|+=   ++...+|+++..+.                ..  
T Consensus        26 ~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~----------------~a--   87 (382)
T KOG1909|consen   26 LEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLS----------------KA--   87 (382)
T ss_pred             hcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHH----------------HH--
Confidence            445566677777777766442    233455666666666653   22233443322110                00  


Q ss_pred             cCCCCCccEEEccCCeeeeecC----ccccCCCCCceEeccCccccccCCc-------------cccCCCCCCEEEccCC
Q 040845           90 DVGLPNLEVLYLWGNNFSGTIP----HFIFNASKLSKLALEMNSFSGFIPS-------------TFGNLRNLEWLTLYDN  152 (824)
Q Consensus        90 ~~~l~~L~~L~L~~n~i~~~~~----~~l~~l~~L~~L~L~~N~i~~~~~~-------------~~~~l~~L~~L~L~~n  152 (824)
                      ..+.|+|++|+||.|.+....+    ..+.+++.|++|+|.+|.+.-..-.             ....-+.|+++..++|
T Consensus        88 L~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rN  167 (382)
T KOG1909|consen   88 LLGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRN  167 (382)
T ss_pred             HhcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeecc
Confidence            0123455555555555542222    2345566677777777766522111             1223456777777777


Q ss_pred             cCCCCcCcccccccCCCCCCCcEEECcCCCCCccCCccccccccccccEEEeecCcceecCCccCCCCCCCCEEEecCCc
Q 040845          153 NLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNK  232 (824)
Q Consensus       153 ~i~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~  232 (824)
                      ++.+.+... +...|...+.|+.+.++.|.|......                      .+...|..+++|+.|||++|-
T Consensus       168 rlen~ga~~-~A~~~~~~~~leevr~~qN~I~~eG~~----------------------al~eal~~~~~LevLdl~DNt  224 (382)
T KOG1909|consen  168 RLENGGATA-LAEAFQSHPTLEEVRLSQNGIRPEGVT----------------------ALAEALEHCPHLEVLDLRDNT  224 (382)
T ss_pred             ccccccHHH-HHHHHHhccccceEEEecccccCchhH----------------------HHHHHHHhCCcceeeecccch
Confidence            766554332 334455556666666666665422110                      223455667777777777776


Q ss_pred             cCCc----cchhhcCCCCCCEEEcccccCcccCCcccc-----ccCCccEEEccCcccccc----CCccccCCCCCcEEE
Q 040845          233 LNGS----IPITLGKLQKLQDVDLEYNQLEGSIPDSIC-----LSVELYELELGGNKLSGS----IPACFSNMTFLKVLS  299 (824)
Q Consensus       233 l~~~----~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~-----~~~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~  299 (824)
                      ++..    +..+++.+++|++|++++|.+......+|.     ..++|+.|.+.+|.|+..    +..++...+.|..|+
T Consensus       225 ft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLn  304 (382)
T KOG1909|consen  225 FTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLN  304 (382)
T ss_pred             hhhHHHHHHHHHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhc
Confidence            6532    334455666677777777666644333322     234455555555544411    222333344455555


Q ss_pred             cCCCCC
Q 040845          300 LGSNEL  305 (824)
Q Consensus       300 L~~N~l  305 (824)
                      |++|++
T Consensus       305 LngN~l  310 (382)
T KOG1909|consen  305 LNGNRL  310 (382)
T ss_pred             CCcccc
Confidence            555544

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.31  E-value=9.8e-13  Score=123.66  Aligned_cols=124  Identities=29%  Similarity=0.406  Sum_probs=26.9

Q ss_pred             CCcccccccccCCcccccCCCCCcEEEccCCccccccccccc-CCCCCCEEeCCCCcCCcccChhhhCcCCCceeeccCC
Q 040845            1 MPSIINNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIG-HLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNN   79 (824)
Q Consensus         1 ~~~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n   79 (824)
                      |+.|..+.|..+..  +.+...+++|+|++|.|+. + ..++ .+.+|+.||||+|.|+..  +.+..+++|++|++++|
T Consensus         1 ~~~lt~~~i~~~~~--~~n~~~~~~L~L~~n~I~~-I-e~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N   74 (175)
T PF14580_consen    1 MVRLTANMIEQIAQ--YNNPVKLRELNLRGNQIST-I-ENLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNN   74 (175)
T ss_dssp             ---------------------------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS
T ss_pred             Cccccccccccccc--ccccccccccccccccccc-c-cchhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCC
Confidence            55566666665543  4555567777777777773 2 2354 466777777777777733  23555666666666666


Q ss_pred             ccccccCccccCCCCCccEEEccCCeeeeec-CccccCCCCCceEeccCcccc
Q 040845           80 SLSGCLSSITDVGLPNLEVLYLWGNNFSGTI-PHFIFNASKLSKLALEMNSFS  131 (824)
Q Consensus        80 ~l~~~~~~~~~~~l~~L~~L~L~~n~i~~~~-~~~l~~l~~L~~L~L~~N~i~  131 (824)
                      +|+.+..... ..+|+|++|+|++|+|...- -..+..+++|+.|+|.+|.+.
T Consensus        75 ~I~~i~~~l~-~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~  126 (175)
T PF14580_consen   75 RISSISEGLD-KNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC  126 (175)
T ss_dssp             ---S-CHHHH-HH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred             CCCccccchH-HhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence            6665432211 12555666666666554211 122334444444444444444

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.30  E-value=2.7e-13  Score=131.47  Aligned_cols=209  Identities=21%  Similarity=0.175  Sum_probs=146.3

Q ss_pred             CCccCCCCCCCCEEEecCCccCCccchhhcCCCCCCEEEcccccCcccCCccccccCCccEEEccCcc-ccccCCccccC
Q 040845          213 IPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNK-LSGSIPACFSN  291 (824)
Q Consensus       213 ~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~-l~~~~~~~~~~  291 (824)
                      +|-.+.-+.+|+.+.++++.-..+. +.-..-+.|+++...+.-++. . +.+.....+..+.-+.-. ..|..-.....
T Consensus       206 l~f~l~~f~~l~~~~~s~~~~~~i~-~~~~~kptl~t~~v~~s~~~~-~-~~l~pe~~~~D~~~~E~~t~~G~~~~~~dT  282 (490)
T KOG1259|consen  206 LSFNLNAFRNLKTLKFSALSTENIV-DIELLKPTLQTICVHNTTIQD-V-PSLLPETILADPSGSEPSTSNGSALVSADT  282 (490)
T ss_pred             cccchHHhhhhheeeeeccchhhee-ceeecCchhheeeeecccccc-c-ccccchhhhcCccCCCCCccCCceEEecch
Confidence            3444555667777777776544222 222233667777776665542 1 112222222222221111 11222334455


Q ss_pred             CCCCcEEEcCCCCCCCCCCcccccccccccccccccccCcCCccccccccchhhhcccccccccCCCccCCCCCCCeEEc
Q 040845          292 MTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFL  371 (824)
Q Consensus       292 l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L  371 (824)
                      +..|+++||++|.|+.+..+..-+|.++.|++|+|.+...  ..+..+++|+.||||+|.++. ..+.-..+.+.++|.|
T Consensus       283 Wq~LtelDLS~N~I~~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls~-~~Gwh~KLGNIKtL~L  359 (490)
T KOG1259|consen  283 WQELTELDLSGNLITQIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLAE-CVGWHLKLGNIKTLKL  359 (490)
T ss_pred             HhhhhhccccccchhhhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhHh-hhhhHhhhcCEeeeeh
Confidence            6789999999999999999988899999999999999843  348889999999999999984 4455567889999999


Q ss_pred             cCccccccCCccccccccccEEEccCcccCCCC-cccccCCcccceeeccCCcccCCCC
Q 040845          372 EYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTI-PVSLEKLSYLKDLNLSFNKLKGEIP  429 (824)
Q Consensus       372 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~~~~p  429 (824)
                      ++|.|.. + ..++.+-+|..||+++|+|.... -..++++|-|+.+.|.+|++.+.+.
T Consensus       360 a~N~iE~-L-SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vd  416 (490)
T KOG1259|consen  360 AQNKIET-L-SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVD  416 (490)
T ss_pred             hhhhHhh-h-hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccch
Confidence            9999984 3 35788889999999999997321 3568899999999999999997654

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.30  E-value=6.1e-11  Score=128.81  Aligned_cols=167  Identities=18%  Similarity=0.233  Sum_probs=130.5

Q ss_pred             ECCCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEeccCCCCHHHHhhhCCCCCCHHHHH
Q 040845          548 IRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRL  627 (824)
Q Consensus       548 ~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~  627 (824)
                      -.++.+|.|..++.......+...+-++-|+.+|||+|+++++.+..+++.|+|+|.+.  .|..++.+.+    ...+-
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~----~~~v~  107 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG----KEEVC  107 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH----HHHHH
Confidence            34688899988876655445667788999999999999999999999999999999983  6787877543    55566


Q ss_pred             HHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccccccccccccccCccCcCCCCCC
Q 040845          628 NIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVS  707 (824)
Q Consensus       628 ~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  707 (824)
                      .-++||+.||.+||+  +.+++|++|.-..|++++.|+.||++|.++....+...  .......--.|..|+.+....  
T Consensus       108 ~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~--  181 (690)
T KOG1243|consen  108 LGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE--  181 (690)
T ss_pred             HHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc--
Confidence            678999999999985  78999999999999999999999999998875533221  111112223466776543322  


Q ss_pred             ccchHHHHHHHHHHHHhCC
Q 040845          708 TNGDVYSFGIMLMETFTRK  726 (824)
Q Consensus       708 ~~~DvwslG~~l~el~tg~  726 (824)
                      -..|.|.||++++|++.|.
T Consensus       182 ~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  182 WSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             cchhhhhHHHHHHHHhCcc
Confidence            3569999999999999993

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.29  E-value=1e-11  Score=119.64  Aligned_cols=126  Identities=22%  Similarity=0.243  Sum_probs=96.0

Q ss_pred             ceeeeccceEEEEEEECCCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcce-eEEeeeecCCeeEEEEeccCCCCHH
Q 040845          533 NLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLV-KVISSCSNEEFKALVLEYMPHGSLE  611 (824)
Q Consensus       533 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~g~L~  611 (824)
                      +.++.|.++.||+++.. +..|++|+...... ....+..|+.+++.+.+.+++ +++.+..  ...++||||+++.++.
T Consensus         4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~   79 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELL   79 (170)
T ss_pred             eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCccc
Confidence            56889999999999876 78899998754322 234568899999998655544 4554432  3457999999998775


Q ss_pred             HHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC-----eEecCCCCCCeeeCCCCcEEEeeccccc
Q 040845          612 KYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAP-----VIHCDLKPSNVLLDDNMVAHLSDFGIAK  675 (824)
Q Consensus       612 ~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~-----ivH~Dlk~~Nill~~~~~~kl~Dfg~a~  675 (824)
                      +.    .     ......+.+++++++.||   ..+     ++|+|++|.||+++ ++.++++|||.+.
T Consensus        80 ~~----~-----~~~~~~~~~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          80 TE----D-----FSDPENLEKIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             cc----c-----ccCHHHHHHHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            43    0     112345789999999999   666     59999999999999 6789999999876

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PLN03150 hypothetical protein; Provisional

Probab=99.29  E-value=4.7e-12  Score=145.86  Aligned_cols=114  Identities=39%  Similarity=0.533  Sum_probs=105.7

Q ss_pred             cccccccccccccCcCCccccccccchhhhcccccccccCCCccCCCCCCCeEEccCccccccCCccccccccccEEEcc
Q 040845          317 DILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLS  396 (824)
Q Consensus       317 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  396 (824)
                      .++.|+|++|.+.+.+|..+..+++|+.|+|++|.+++.+|..++.+++|+.|+|++|++++.+|..++.+++|+.|+|+
T Consensus       419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls  498 (623)
T PLN03150        419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN  498 (623)
T ss_pred             EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence            47889999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CcccCCCCcccccCC-cccceeeccCCcccCCCCC
Q 040845          397 YNNLSGTIPVSLEKL-SYLKDLNLSFNKLKGEIPR  430 (824)
Q Consensus       397 ~N~l~~~~p~~~~~l-~~L~~L~l~~N~l~~~~p~  430 (824)
                      +|+++|.+|..+..+ .++..+++.+|+..|..|.
T Consensus       499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~  533 (623)
T PLN03150        499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG  533 (623)
T ss_pred             CCcccccCChHHhhccccCceEEecCCccccCCCC
Confidence            999999999998764 4678899999987776553

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.27  E-value=1e-11  Score=137.79  Aligned_cols=147  Identities=20%  Similarity=0.200  Sum_probs=95.9

Q ss_pred             hccCCCCceeeeccceEEEEEEECC-CcEEEEEEeeccccc----------------------------------hhh--
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGR----------------------------------AFK--  568 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~----------------------------------~~~--  568 (824)
                      -..|+. +.||.|++|.||+|+.++ |+.||||+.++...+                                  ..+  
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            345776 789999999999999887 999999998754210                                  001  


Q ss_pred             ----hHHHHHHHHhcCC----CCcceeEEeeeec-CCeeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHH-HHH
Q 040845          569 ----SFDVECAMMKSIR----HRNLVKVISSCSN-EEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVAS-ALE  638 (824)
Q Consensus       569 ----~~~~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~-~l~  638 (824)
                          ++.+|+..+.+++    +...+.+-.++.+ ....++||||++|+++.++-.-.....+...   ++...+. -+.
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~---la~~~v~~~~~  274 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKL---LAERGVEVFFT  274 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHH---HHHHHHHHHHH
Confidence                2334544444442    4444444444433 4566799999999999875321111222221   2222222 122


Q ss_pred             HhhcCCCCCeEecCCCCCCeeeCCCC----cEEEeecccccccCC
Q 040845          639 YLHFGYSAPVIHCDLKPSNVLLDDNM----VAHLSDFGIAKLLTG  679 (824)
Q Consensus       639 ~LH~~~~~~ivH~Dlk~~Nill~~~~----~~kl~Dfg~a~~~~~  679 (824)
                      .+.   ..|++|+|+||.||+++.++    .++++|||++..+..
T Consensus       275 Qif---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        275 QVF---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHH---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            334   67999999999999999888    999999999987754

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.25  E-value=8e-13  Score=145.84  Aligned_cols=64  Identities=30%  Similarity=0.393  Sum_probs=34.4

Q ss_pred             CCCCCceEeccCccccccCCccccCCCCCCEEEccCCcCCCCcCcccccccCCCCCCCcEEECcCCCCCcc
Q 040845          116 NASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGI  186 (824)
Q Consensus       116 ~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~  186 (824)
                      .+..++.+.+..|.|.. +-..+..+.+|+.|++.+|.|..+..      .+..+++|++|++++|.|+.+
T Consensus        70 ~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i~~------~l~~~~~L~~L~ls~N~I~~i  133 (414)
T KOG0531|consen   70 SLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKIEN------LLSSLVNLQVLDLSFNKITKL  133 (414)
T ss_pred             HhHhHHhhccchhhhhh-hhcccccccceeeeeccccchhhccc------chhhhhcchheeccccccccc
Confidence            34455555555555553 22335555666666666666655421      144556666666666666544

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.24  E-value=1.1e-12  Score=144.69  Aligned_cols=245  Identities=27%  Similarity=0.301  Sum_probs=140.1

Q ss_pred             CCCccEEEccCCeeeeecCccccCCCCCceEeccCccccccCCccccCCCCCCEEEccCCcCCCCcCcccccccCCCCCC
Q 040845           93 LPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKS  172 (824)
Q Consensus        93 l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~~  172 (824)
                      +..++.++++.|.|.. +-..+..+++|+.|++.+|+|..+ ...+..+++|++|+|++|.|+.+.       .+..++.
T Consensus        71 l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ls~N~I~~i~-------~l~~l~~  141 (414)
T KOG0531|consen   71 LTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKI-ENLLSSLVNLQVLDLSFNKITKLE-------GLSTLTL  141 (414)
T ss_pred             hHhHHhhccchhhhhh-hhcccccccceeeeeccccchhhc-ccchhhhhcchheecccccccccc-------chhhccc
Confidence            5566666677777763 334466677788888888887744 223677888888888888887763       4666777


Q ss_pred             CcEEECcCCCCCccCCccccccccccccEEEeecCcceecCCccCCCCCCCCEEEecCCccCCccc-hhhcCCCCCCEEE
Q 040845          173 LTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIP-ITLGKLQKLQDVD  251 (824)
Q Consensus       173 L~~L~Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~  251 (824)
                      |+.|++++|.|..+                            ..+..+..|+.+++++|.+..+.+ . ...+.+++.++
T Consensus       142 L~~L~l~~N~i~~~----------------------------~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~  192 (414)
T KOG0531|consen  142 LKELNLSGNLISDI----------------------------SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELD  192 (414)
T ss_pred             hhhheeccCcchhc----------------------------cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHh
Confidence            88888888877644                            223335666777777777664333 1 35566666666


Q ss_pred             cccccCcccCCccccccCCccEEEccCccccccCCccccCCC--CCcEEEcCCCCCCCCCCccccccccccccccccccc
Q 040845          252 LEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMT--FLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFS  329 (824)
Q Consensus       252 L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~--~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~  329 (824)
                      +..|.+.  ....+..+..+..+++..|+++..-+  +..+.  .|+.+++++|++..++                    
T Consensus       193 l~~n~i~--~i~~~~~~~~l~~~~l~~n~i~~~~~--l~~~~~~~L~~l~l~~n~i~~~~--------------------  248 (414)
T KOG0531|consen  193 LGGNSIR--EIEGLDLLKKLVLLSLLDNKISKLEG--LNELVMLHLRELYLSGNRISRSP--------------------  248 (414)
T ss_pred             ccCCchh--cccchHHHHHHHHhhcccccceeccC--cccchhHHHHHHhcccCcccccc--------------------
Confidence            6666665  22233333444444555555542211  11111  1444444444444433                    


Q ss_pred             CcCCccccccccchhhhcccccccccCCCccCCCCCCCeEEccCcccccc---CCcc-ccccccccEEEccCcccCCCCc
Q 040845          330 GPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGS---IPDS-FGDLISLKSLNLSYNNLSGTIP  405 (824)
Q Consensus       330 ~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~---~~~~-~~~l~~L~~L~L~~N~l~~~~p  405 (824)
                          ..+..+..+..|++.+|++...  ..+...+.+..+.++.|.+...   .... ....+.++.+.+.+|.+....+
T Consensus       249 ----~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (414)
T KOG0531|consen  249 ----EGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKISS  322 (414)
T ss_pred             ----ccccccccccccchhhcccccc--ccccccchHHHhccCcchhcchhhhhccccccccccccccccccCccccccc
Confidence                3444555556666666665533  2344445566666666665421   1111 3445677777777777765444

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.24  E-value=1.6e-12  Score=132.87  Aligned_cols=207  Identities=26%  Similarity=0.272  Sum_probs=128.5

Q ss_pred             CCCCCCCEEEecCCccCCccc-hhhcCCCCCCEEEcccccCccc--CCccccccCCccEEEccCccccccCCcc-ccCCC
Q 040845          218 TNLTDLTTIVLGGNKLNGSIP-ITLGKLQKLQDVDLEYNQLEGS--IPDSICLSVELYELELGGNKLSGSIPAC-FSNMT  293 (824)
Q Consensus       218 ~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~--~~~~~~~~~~L~~L~l~~n~l~~~~~~~-~~~l~  293 (824)
                      .++.+|+++.|.++....... .....+++++.||||+|-+...  +......+++|+.|+|+.|++....... -..++
T Consensus       118 sn~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~  197 (505)
T KOG3207|consen  118 SNLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLS  197 (505)
T ss_pred             hhHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhh
Confidence            356777888888777763221 3556778888888888877632  2234456788888888888876322221 12456


Q ss_pred             CCcEEEcCCCCCCC--CCCcccccccccccccccccccCcCCccccccccchhhhcccccccccCC-CccCCCCCCCeEE
Q 040845          294 FLKVLSLGSNELTS--IPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIP-MEIGSLKNLENLF  370 (824)
Q Consensus       294 ~L~~L~L~~N~l~~--lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~  370 (824)
                      .|+.|.|+.|.|+.  +..-...+|+|+.|+|..|............+..|++|||++|++..... ...+.++.|+.|+
T Consensus       198 ~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Ln  277 (505)
T KOG3207|consen  198 HLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLN  277 (505)
T ss_pred             hhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhh
Confidence            78888888888872  22224456788888888885333444455566778888888888764321 3456777888888


Q ss_pred             ccCccccccC-Ccc-----ccccccccEEEccCcccCCCCc--ccccCCcccceeeccCCccc
Q 040845          371 LEYNRLEGSI-PDS-----FGDLISLKSLNLSYNNLSGTIP--VSLEKLSYLKDLNLSFNKLK  425 (824)
Q Consensus       371 L~~N~l~~~~-~~~-----~~~l~~L~~L~L~~N~l~~~~p--~~~~~l~~L~~L~l~~N~l~  425 (824)
                      ++.|.++..- |+.     -..+++|+.|+++.|++. ..+  ..+..+++|+.|....|.++
T Consensus       278 ls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~-~w~sl~~l~~l~nlk~l~~~~n~ln  339 (505)
T KOG3207|consen  278 LSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIR-DWRSLNHLRTLENLKHLRITLNYLN  339 (505)
T ss_pred             ccccCcchhcCCCccchhhhcccccceeeecccCccc-cccccchhhccchhhhhhccccccc
Confidence            8888777432 222     244567777777777775 222  22334445555555555544

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.23  E-value=1.3e-12  Score=126.70  Aligned_cols=81  Identities=25%  Similarity=0.305  Sum_probs=42.7

Q ss_pred             CccEEEccCCeeeeecCccccCCCCCceEeccCccccccCCccccCCCCCCEEEccCCcCCCCcCcccccccCCCCCCCc
Q 040845           95 NLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLT  174 (824)
Q Consensus        95 ~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~~L~  174 (824)
                      .|++||||+|.|+ .+.+...-.++++.|++++|.|..+  +.+..|++|+.||||+|.++.+..   +   -.++-+.+
T Consensus       285 ~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls~~~G---w---h~KLGNIK  355 (490)
T KOG1259|consen  285 ELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLAECVG---W---HLKLGNIK  355 (490)
T ss_pred             hhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhHhhhh---h---HhhhcCEe
Confidence            4556666666655 4455555555666666666666532  235556666666666665554321   0   12334555


Q ss_pred             EEECcCCCCC
Q 040845          175 HISLSNNPLD  184 (824)
Q Consensus       175 ~L~Ls~n~l~  184 (824)
                      +|.|+.|.|.
T Consensus       356 tL~La~N~iE  365 (490)
T KOG1259|consen  356 TLKLAQNKIE  365 (490)
T ss_pred             eeehhhhhHh
Confidence            5555555554

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.22  E-value=4.5e-10  Score=114.84  Aligned_cols=268  Identities=15%  Similarity=0.113  Sum_probs=169.4

Q ss_pred             CCceeeeccceEEEEEEECCCcEEEEEEeeccccchhhhHHHHHHHHhcC-CCCcceeEEee------e-ecCCeeEEEE
Q 040845          531 ENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSI-RHRNLVKVISS------C-SNEEFKALVL  602 (824)
Q Consensus       531 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~------~-~~~~~~~lv~  602 (824)
                      ..+.||+|+.+.+|-.-.- +.. +-|++........   .+.++.|... .||-+-.-+.+      . .......+.|
T Consensus        15 ~gr~LgqGgea~ly~l~e~-~d~-VAKIYh~Pppa~~---aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm   89 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEV-RDQ-VAKIYHAPPPAAQ---AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM   89 (637)
T ss_pred             CCccccCCccceeeecchh-hch-hheeecCCCchHH---HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence            4578999999999965321 223 3466654322211   2233344444 56643321221      1 1223367888


Q ss_pred             eccCCC-CHHHHhhh-----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccc
Q 040845          603 EYMPHG-SLEKYLHS-----SNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  676 (824)
Q Consensus       603 e~~~~g-~L~~~l~~-----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~  676 (824)
                      +.+.+. ....+...     +-....|...+++++.+|.+.+.||   ..|.+-+|+.++|+|+++++.+.+.|-..-..
T Consensus        90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi  166 (637)
T COG4248          90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQI  166 (637)
T ss_pred             ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcccceee
Confidence            888664 23333221     1135789999999999999999999   99999999999999999999999998653332


Q ss_pred             cCCCCCccccccccccccccCccCcC-----CCCCCccchHHHHHHHHHHHHhC-CCCCcccccCcc---hhh-hhhhhh
Q 040845          677 LTGEDQSMTQTQTLATIGYMAPEYGR-----EGQVSTNGDVYSFGIMLMETFTR-KKPTDELFNGEM---TLK-HWVNDC  746 (824)
Q Consensus       677 ~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~~l~el~tg-~~p~~~~~~~~~---~~~-~~~~~~  746 (824)
                      .   .........+|...|.+||.-.     +-.-+...|.|.+||++++++.| ++||.+......   ... ++....
T Consensus       167 ~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~  243 (637)
T COG4248         167 N---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGR  243 (637)
T ss_pred             c---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcce
Confidence            2   2223344567889999999644     33456788999999999999886 899987542211   111 111110


Q ss_pred             CCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccC--CCCCCCHHHHHHHHHHHHHhhcccc
Q 040845          747 LPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVES--PEQRINAKEIVAKLLKIRDSLLRNV  813 (824)
Q Consensus       747 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~d--P~~Rpt~~evl~~L~~~~~~~~~~~  813 (824)
                      +-    ..-+...-..+....+.....++.+..+..+|+...  +.-|||++-++..|.++.+++..+.
T Consensus       244 f~----ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C~  308 (637)
T COG4248         244 FA----YASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKCT  308 (637)
T ss_pred             ee----echhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhhh
Confidence            00    000000001111122233355677888999999874  5679999999999999999888754

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.22  E-value=3.3e-12  Score=120.10  Aligned_cols=142  Identities=23%  Similarity=0.244  Sum_probs=43.7

Q ss_pred             ccCCcccccccccccCCCCCCEEeCCCCcCCcccChhhh-CcCCCceeeccCCccccccCccccCCCCCccEEEccCCee
Q 040845           28 LYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIF-NVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNF  106 (824)
Q Consensus        28 L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~-~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~i  106 (824)
                      |..+.|+ .++ .+.+..++++|+|++|+|+.+  +.+. .+.+|+.|+|++|.|+.+..-   ..+++|+.|++++|+|
T Consensus         4 lt~~~i~-~~~-~~~n~~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~l~~l---~~L~~L~~L~L~~N~I   76 (175)
T PF14580_consen    4 LTANMIE-QIA-QYNNPVKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITKLEGL---PGLPRLKTLDLSNNRI   76 (175)
T ss_dssp             ------------------------------------S--TT-TT--EEE-TTS--S--TT-------TT--EEE--SS--
T ss_pred             ccccccc-ccc-ccccccccccccccccccccc--cchhhhhcCCCEEECCCCCCccccCc---cChhhhhhcccCCCCC
Confidence            4445555 333 344555788888888888743  2344 467788888888887765432   2467777777777777


Q ss_pred             eeecCccc-cCCCCCceEeccCccccccC-CccccCCCCCCEEEccCCcCCCCcCcccccccCCCCCCCcEEECc
Q 040845          107 SGTIPHFI-FNASKLSKLALEMNSFSGFI-PSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLS  179 (824)
Q Consensus       107 ~~~~~~~l-~~l~~L~~L~L~~N~i~~~~-~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~~L~~L~Ls  179 (824)
                      +. +.+.+ ..+++|++|+|++|+|.... -..++.+++|++|+|.+|.++..+.-  ....+..+|+|+.||-.
T Consensus        77 ~~-i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~Y--R~~vi~~lP~Lk~LD~~  148 (175)
T PF14580_consen   77 SS-ISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNY--RLFVIYKLPSLKVLDGQ  148 (175)
T ss_dssp             -S--CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTH--HHHHHHH-TT-SEETTE
T ss_pred             Cc-cccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhH--HHHHHHHcChhheeCCE
Confidence            74 33333 35677777777777776432 24556677777777777777643210  11234566777776643

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.21  E-value=1.1e-10  Score=107.32  Aligned_cols=131  Identities=22%  Similarity=0.321  Sum_probs=103.2

Q ss_pred             ceeeeccceEEEEEEECCCcEEEEEEeecccc---c-----hhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEec
Q 040845          533 NLIGRGGFGSVYKARIRDGMEVAVKVFNLQCG---R-----AFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       533 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      ..+++|+-+.+|.+.+. |.++++|.-.+...   +     ..+.-..|+.++.+++--.|...+=+..+++...++|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            46889999999999886 55677775322211   1     123456799999999766776666667777888899999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccc
Q 040845          605 MPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  676 (824)
Q Consensus       605 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~  676 (824)
                      ++|..|.+++...        ...++..+-.-+.-||   ..+|+|+|+.++||.+..++ +.++|||++..
T Consensus        81 I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA--------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc--------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9999999898765        2456778888889999   99999999999999997765 99999999973

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.20  E-value=2.4e-10  Score=109.78  Aligned_cols=136  Identities=21%  Similarity=0.211  Sum_probs=98.9

Q ss_pred             CceeeeccceEEEEEEECC-------CcEEEEEEeeccc------------c----------chhhhHH----HHHHHHh
Q 040845          532 NNLIGRGGFGSVYKARIRD-------GMEVAVKVFNLQC------------G----------RAFKSFD----VECAMMK  578 (824)
Q Consensus       532 ~~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~------------~----------~~~~~~~----~E~~~l~  578 (824)
                      ...||.|--+.||.|...+       +..+|||+.+...            +          .....+.    +|+..|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3579999999999997542       4799999875321            0          0112233    7999999


Q ss_pred             cCCC--CcceeEEeeeecCCeeEEEEeccCCCCHH-HHhhhCCCCCCHHHHHHHHHHHHHHHHHh-hcCCCCCeEecCCC
Q 040845          579 SIRH--RNLVKVISSCSNEEFKALVLEYMPHGSLE-KYLHSSNYSLDIFQRLNIMIDVASALEYL-HFGYSAPVIHCDLK  654 (824)
Q Consensus       579 ~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~L~-~~l~~~~~~~~~~~~~~i~~~i~~~l~~L-H~~~~~~ivH~Dlk  654 (824)
                      ++..  -++..++++    ...++||||++++.+. ..+...  .++..+...+..+++.++..+ |   ..++||||++
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~--~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGDLs  152 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA--KLNDEEMKNAYYQVLSMMKQLYK---ECNLVHADLS  152 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc--ccCHHHHHHHHHHHHHHHHHHHH---hCCeecCCCC
Confidence            9853  456666654    3457999999764332 122221  344556677889999999999 8   8999999999


Q ss_pred             CCCeeeCCCCcEEEeeccccccc
Q 040845          655 PSNVLLDDNMVAHLSDFGIAKLL  677 (824)
Q Consensus       655 ~~Nill~~~~~~kl~Dfg~a~~~  677 (824)
                      +.||+++ ++.+.++|||.|...
T Consensus       153 ~~NIL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         153 EYNMLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             HHHEEEE-CCcEEEEECCCceeC
Confidence            9999997 468999999988754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.19  E-value=3.8e-13  Score=133.94  Aligned_cols=89  Identities=21%  Similarity=0.207  Sum_probs=51.8

Q ss_pred             cccccccccccccccccCc----CCccccccccchhhhcccccccccCCCcc-----CCCCCCCeEEccCccccc----c
Q 040845          313 WSLKDILDLNLSSNCFSGP----LPLEIRNLKALIEIDFSMNNFSGIIPMEI-----GSLKNLENLFLEYNRLEG----S  379 (824)
Q Consensus       313 ~~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~~~~~-----~~l~~L~~L~L~~N~l~~----~  379 (824)
                      ..+++|+.|||.+|-++..    +...++.+++|+.|++++|.+...-..+|     ...|+|+.|.|.+|.|+.    .
T Consensus       210 ~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~  289 (382)
T KOG1909|consen  210 EHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALA  289 (382)
T ss_pred             HhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHH
Confidence            3344444444444444321    23345555666666666666654322222     235778888888888773    2


Q ss_pred             CCccccccccccEEEccCcccC
Q 040845          380 IPDSFGDLISLKSLNLSYNNLS  401 (824)
Q Consensus       380 ~~~~~~~l~~L~~L~L~~N~l~  401 (824)
                      +...+...+.|.+|+|++|++.
T Consensus       290 la~~~~ek~dL~kLnLngN~l~  311 (382)
T KOG1909|consen  290 LAACMAEKPDLEKLNLNGNRLG  311 (382)
T ss_pred             HHHHHhcchhhHHhcCCccccc
Confidence            2334555778888888888883

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.16  E-value=3.3e-10  Score=103.47  Aligned_cols=142  Identities=18%  Similarity=0.206  Sum_probs=108.2

Q ss_pred             CCceeeeccceEEEEEEECCCcEEEEEEeeccc--------cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEE
Q 040845          531 ENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQC--------GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVL  602 (824)
Q Consensus       531 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  602 (824)
                      ...++-||+-+.|+++.++ |+...||.-....        .-...+..+|+..+.+++--.|....-++.+...-.++|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            4578999999999999997 8888887532211        112345677999999987666666666676777778999


Q ss_pred             eccCC-CCHHHHhhhCCCCCCHHHH-HHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC---cEEEeecccccc
Q 040845          603 EYMPH-GSLEKYLHSSNYSLDIFQR-LNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM---VAHLSDFGIAKL  676 (824)
Q Consensus       603 e~~~~-g~L~~~l~~~~~~~~~~~~-~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~---~~kl~Dfg~a~~  676 (824)
                      ||+++ .++.+++..........+. ..++..|-+.+.-||   ..+|+|+|+..+||++..++   .+.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            99976 4788888765433333333 688999999999999   99999999999999996544   458999999863

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.11  E-value=6e-10  Score=112.48  Aligned_cols=141  Identities=18%  Similarity=0.195  Sum_probs=110.7

Q ss_pred             ceeeeccceEEEEEEECCCcEEEEEEeecccc-chhhhHHHHHHHHhcCCCC--cceeEEeeeecC---CeeEEEEeccC
Q 040845          533 NLIGRGGFGSVYKARIRDGMEVAVKVFNLQCG-RAFKSFDVECAMMKSIRHR--NLVKVISSCSNE---EFKALVLEYMP  606 (824)
Q Consensus       533 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~---~~~~lv~e~~~  606 (824)
                      +.||.|.++.||+++..+|+.+++|....... .....+..|+++++.+++.  .+.+++.+....   +..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            56899999999999887678999998754322 1356788999999999764  457777777654   26689999999


Q ss_pred             CCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcC-------------------------------------------
Q 040845          607 HGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFG-------------------------------------------  643 (824)
Q Consensus       607 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-------------------------------------------  643 (824)
                      |.++.+.+..  ..++..+...++.++++++++||..                                           
T Consensus        84 G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (223)
T cd05154          84 GRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL  161 (223)
T ss_pred             CEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence            9888776532  2467777888889999999999831                                           


Q ss_pred             ----------CCCCeEecCCCCCCeeeCC--CCcEEEeeccccc
Q 040845          644 ----------YSAPVIHCDLKPSNVLLDD--NMVAHLSDFGIAK  675 (824)
Q Consensus       644 ----------~~~~ivH~Dlk~~Nill~~--~~~~kl~Dfg~a~  675 (824)
                                ....++|+|+++.||+++.  ++.+.++||+.+.
T Consensus       162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~  205 (223)
T cd05154         162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT  205 (223)
T ss_pred             HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence                      1256799999999999998  6678999999876

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.10  E-value=4.8e-11  Score=128.67  Aligned_cols=248  Identities=21%  Similarity=0.139  Sum_probs=176.4

Q ss_pred             hccCCCCceeeeccceEEEEEEEC--CCcEEEEEEeeccccchhhh--HHHHHHHHhcC-CCCcceeEEeeeecCCeeEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR--DGMEVAVKVFNLQCGRAFKS--FDVECAMMKSI-RHRNLVKVISSCSNEEFKAL  600 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  600 (824)
                      ..+|..+..||.|.|+.|+....+  ++..|++|...........+  -..|+.+...+ .|.++++....+......|+
T Consensus       264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i  343 (524)
T KOG0601|consen  264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI  343 (524)
T ss_pred             cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence            456888899999999999998643  57889999765443222222  23466666666 58999999888888888889


Q ss_pred             EEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCC-CcEEEeecccccccCC
Q 040845          601 VLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDN-MVAHLSDFGIAKLLTG  679 (824)
Q Consensus       601 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~Dfg~a~~~~~  679 (824)
                      --||++++++....... ..++...++++..|++.++.++|   ++.++|+|++|+||++..+ +..++.|||.++.+.-
T Consensus       344 p~e~~~~~s~~l~~~~~-~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~  419 (524)
T KOG0601|consen  344 PLEFCEGGSSSLRSVTS-QMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF  419 (524)
T ss_pred             chhhhcCcchhhhhHHH-HhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhccccccccccce
Confidence            99999999887666322 35777889999999999999999   9999999999999999876 8889999999874321


Q ss_pred             CCCcccccccccccccc--CccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccc
Q 040845          680 EDQSMTQTQTLATIGYM--APEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDA  757 (824)
Q Consensus       680 ~~~~~~~~~~~~~~~y~--aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  757 (824)
                      .     .....+.-+++  +|+......+..++|++|||.-+.|.+++..--..       ..+|...          ..
T Consensus       420 ~-----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~-------~~~~~~i----------~~  477 (524)
T KOG0601|consen  420 S-----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES-------GVQSLTI----------RS  477 (524)
T ss_pred             e-----cccccccccccccchhhccccccccccccccccccccccccCcccCcc-------cccceee----------ec
Confidence            1     11112333444  45555566788999999999999999998753211       0111100          00


Q ss_pred             cccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 040845          758 NLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIR  806 (824)
Q Consensus       758 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~  806 (824)
                             ............+..+.+.+...++..||.+.+...+.+-.+
T Consensus       478 -------~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~  519 (524)
T KOG0601|consen  478 -------GDTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR  519 (524)
T ss_pred             -------ccccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence                   000111122245667888899999999999998877665443

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=99.05  E-value=7.1e-11  Score=138.75  Aligned_cols=131  Identities=27%  Similarity=0.280  Sum_probs=93.5

Q ss_pred             cCCCCCcEEEccCCcccccccccccCCCCCCEEeCCCCc--CCcccChhhhCcCCCceeeccCC-ccccccCccccCCCC
Q 040845           18 DNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNK--LLGTIPAAIFNVSTLKAFAVTNN-SLSGCLSSITDVGLP   94 (824)
Q Consensus        18 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~--l~~~~~~~~~~l~~L~~L~L~~n-~l~~~~~~~~~~~l~   94 (824)
                      .+....++..+-+|.+. .++.... .++|++|-+..|.  +....++.|..++.|+.|||++| .+..+|..+..  |-
T Consensus       520 ~~~~~~rr~s~~~~~~~-~~~~~~~-~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~--Li  595 (889)
T KOG4658|consen  520 KSWNSVRRMSLMNNKIE-HIAGSSE-NPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGE--LV  595 (889)
T ss_pred             cchhheeEEEEeccchh-hccCCCC-CCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhh--hh
Confidence            44456677777777776 4454443 3468888888875  44344444666888888888866 45666666653  77


Q ss_pred             CccEEEccCCeeeeecCccccCCCCCceEeccCccccccCCccccCCCCCCEEEccCCc
Q 040845           95 NLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNN  153 (824)
Q Consensus        95 ~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~  153 (824)
                      +|++|+|+++.++ .+|..+.++.+|.+|++..+.-...+|..+..|++|++|.+..-.
T Consensus       596 ~LryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~  653 (889)
T KOG4658|consen  596 HLRYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSA  653 (889)
T ss_pred             hhhcccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccc
Confidence            8888888888887 778888888888888888886655667777778888888886654

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=99.00  E-value=3.3e-10  Score=133.21  Aligned_cols=144  Identities=24%  Similarity=0.275  Sum_probs=86.1

Q ss_pred             cccccccccCCcccccCCCCCcEEEccCCc--ccccccccccCCCCCCEEeCCCCcCCcccChhhhCcCCCceeeccCCc
Q 040845            3 SIINNFLTSTTPKEIDNISNLKVLYLYNNR--LQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNS   80 (824)
Q Consensus         3 ~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~--l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~   80 (824)
                      ++.+|.+..+.-+  .+.++|+.|-+.+|.  +.......|..++.|++||||+|.-.+.+|..++++-+|+.|+|++..
T Consensus       529 s~~~~~~~~~~~~--~~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~  606 (889)
T KOG4658|consen  529 SLMNNKIEHIAGS--SENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTG  606 (889)
T ss_pred             EEeccchhhccCC--CCCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCC
Confidence            3445555444333  222357777777775  443333446667777777777766555777777777777777777777


Q ss_pred             cccccCccccCCCCCccEEEccCCeeeeecCccccCCCCCceEeccCcc--ccccCCccccCCCCCCEEEcc
Q 040845           81 LSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNS--FSGFIPSTFGNLRNLEWLTLY  150 (824)
Q Consensus        81 l~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~L~~N~--i~~~~~~~~~~l~~L~~L~L~  150 (824)
                      ++.+|..+..  |..|.+|++..+.-...+|.....+++|++|.+-.-.  .+...-..+.+|.+|+.|...
T Consensus       607 I~~LP~~l~~--Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~  676 (889)
T KOG4658|consen  607 ISHLPSGLGN--LKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSIT  676 (889)
T ss_pred             ccccchHHHH--HHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheee
Confidence            7777666553  6677777777766554556666667777777765543  222222334445555555543

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.97  E-value=1.5e-10  Score=130.97  Aligned_cols=251  Identities=24%  Similarity=0.282  Sum_probs=173.2

Q ss_pred             HhhccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecc---ccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeE
Q 040845          524 QATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQ---CGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKA  599 (824)
Q Consensus       524 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  599 (824)
                      ...+.+.+.+-+-+|.++.++.++-. .|.-.++|+....   .....+....+-.+.-..++|.+++....+......+
T Consensus       801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~  880 (1205)
T KOG0606|consen  801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP  880 (1205)
T ss_pred             CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence            34566777788889999999988633 2444444443221   1223344444444444455677776666655667788


Q ss_pred             EEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCC
Q 040845          600 LVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG  679 (824)
Q Consensus       600 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  679 (824)
                      +|++|+.+++|...++..+ ..+..........+.++.+|||   ...+.|+|++|.|.+...++..+++|||.......
T Consensus       881 L~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~  956 (1205)
T KOG0606|consen  881 LVGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL  956 (1205)
T ss_pred             hhhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCcccccccccc
Confidence            9999999999999998776 4455556667788889999999   78899999999999999999999999984322110


Q ss_pred             ------C---------------CC--------ccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCc
Q 040845          680 ------E---------------DQ--------SMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTD  730 (824)
Q Consensus       680 ------~---------------~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~  730 (824)
                            .               ..        ........+|+.|.+||...+......+|.|++|++++|.++|.+||.
T Consensus       957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen  957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred             ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence                  0               00        011223468999999999999999999999999999999999999998


Q ss_pred             ccccCcchhhhhhhhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHH
Q 040845          731 ELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAK  796 (824)
Q Consensus       731 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~  796 (824)
                      ....... .........+.                 ...+...+....+++...+..+|.+|..|.
T Consensus      1037 a~tpq~~-f~ni~~~~~~~-----------------p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1037 AETPQQI-FENILNRDIPW-----------------PEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             Ccchhhh-hhccccCCCCC-----------------CCCccccChhhhhhhhhhhccCchhccCcc
Confidence            7433221 11111111110                 011123345577888899999999998776

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.92  E-value=2.2e-11  Score=131.62  Aligned_cols=184  Identities=28%  Similarity=0.251  Sum_probs=122.0

Q ss_pred             chhhcCCCCCCEEEcccccCcccCCccccccCCccEEEccCcc--ccccCCccccC------CCCCcEEEcCCCCCCCCC
Q 040845          238 PITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNK--LSGSIPACFSN------MTFLKVLSLGSNELTSIP  309 (824)
Q Consensus       238 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~--l~~~~~~~~~~------l~~L~~L~L~~N~l~~lp  309 (824)
                      |..+..+.+|+.|.|.++.|.. ..+...--..|+.|...+.-  +..++..+.+.      +-.|.+.+.++|.|+.+.
T Consensus       102 pi~ifpF~sLr~LElrg~~L~~-~~GL~~lr~qLe~LIC~~Sl~Al~~v~ascggd~~ns~~Wn~L~~a~fsyN~L~~mD  180 (1096)
T KOG1859|consen  102 PISIFPFRSLRVLELRGCDLST-AKGLQELRHQLEKLICHNSLDALRHVFASCGGDISNSPVWNKLATASFSYNRLVLMD  180 (1096)
T ss_pred             CceeccccceeeEEecCcchhh-hhhhHHHHHhhhhhhhhccHHHHHHHHHHhccccccchhhhhHhhhhcchhhHHhHH
Confidence            4455566677777777776652 11111111234444433211  11111111111      235788889999999888


Q ss_pred             CcccccccccccccccccccCcCCccccccccchhhhcccccccccCCCccCCCCCCCeEEccCccccccCCcccccccc
Q 040845          310 LNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLIS  389 (824)
Q Consensus       310 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  389 (824)
                      ..+.-++.|+.|||++|+++...  .+..++.|++|||+.|.+..+.--.-.++. |+.|++++|.++. +- .+.++.+
T Consensus       181 ~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lrnN~l~t-L~-gie~Lks  255 (1096)
T KOG1859|consen  181 ESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLRNNALTT-LR-GIENLKS  255 (1096)
T ss_pred             HHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhhh-heeeeecccHHHh-hh-hHHhhhh
Confidence            88888899999999999998533  788889999999999999854333334454 9999999999884 32 4778889


Q ss_pred             ccEEEccCcccCCCC-cccccCCcccceeeccCCcccCC
Q 040845          390 LKSLNLSYNNLSGTI-PVSLEKLSYLKDLNLSFNKLKGE  427 (824)
Q Consensus       390 L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~~~  427 (824)
                      |+.||+++|-|.+-- -..+..+..|+.|+|.||++.|.
T Consensus       256 L~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~  294 (1096)
T KOG1859|consen  256 LYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCA  294 (1096)
T ss_pred             hhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccC
Confidence            999999999887421 12245677889999999998764

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.89  E-value=1.2e-08  Score=97.80  Aligned_cols=125  Identities=26%  Similarity=0.306  Sum_probs=82.6

Q ss_pred             EEEEEEECCCcEEEEEEeecccc-------------c-------------hhhhHHHHHHHHhcCCCC--cceeEEeeee
Q 040845          542 SVYKARIRDGMEVAVKVFNLQCG-------------R-------------AFKSFDVECAMMKSIRHR--NLVKVISSCS  593 (824)
Q Consensus       542 ~V~~~~~~~~~~vavK~~~~~~~-------------~-------------~~~~~~~E~~~l~~l~h~--niv~l~~~~~  593 (824)
                      .||.|...+|..+|||..+....             .             ......+|++.|.++..-  ++.+++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            38999988899999998754210             0             113466799999999765  466666542 


Q ss_pred             cCCeeEEEEeccC--CCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHH-hhcCCCCCeEecCCCCCCeeeCCCCcEEEee
Q 040845          594 NEEFKALVLEYMP--HGSLEKYLHSSNYSLDIFQRLNIMIDVASALEY-LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSD  670 (824)
Q Consensus       594 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~-LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D  670 (824)
                         ..++||||++  |..+..+....   ++......++.+++..+.. +|   ..|++|||+++.||+++++ .+.++|
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~iID  149 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVYIID  149 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEEE--
T ss_pred             ---CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEEEEe
Confidence               2369999998  54554433221   1123455677888885555 58   8999999999999999887 999999


Q ss_pred             ccccccc
Q 040845          671 FGIAKLL  677 (824)
Q Consensus       671 fg~a~~~  677 (824)
                      ||.|...
T Consensus       150 f~qav~~  156 (188)
T PF01163_consen  150 FGQAVDS  156 (188)
T ss_dssp             GTTEEET
T ss_pred             cCcceec
Confidence            9998754

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.87  E-value=1.9e-09  Score=83.34  Aligned_cols=61  Identities=39%  Similarity=0.568  Sum_probs=41.7

Q ss_pred             CCccEEEccCCeeeeecCccccCCCCCceEeccCccccccCCccccCCCCCCEEEccCCcC
Q 040845           94 PNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNL  154 (824)
Q Consensus        94 ~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i  154 (824)
                      |+|++|++++|+|+...+..|..+++|++|++++|.++.+.+++|.++++|++|++++|+|
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            4566777777777655556666677777777777777766666777777777777776654

...

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.87  E-value=1.6e-09  Score=83.74  Aligned_cols=61  Identities=38%  Similarity=0.464  Sum_probs=46.9

Q ss_pred             CCCcEEEccCCcccccccccccCCCCCCEEeCCCCcCCcccChhhhCcCCCceeeccCCcc
Q 040845           21 SNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSL   81 (824)
Q Consensus        21 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l   81 (824)
                      ++|++|+|++|+|+...+..|.++++|++|++++|+++...|.+|.++++|++|++++|+|
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            4678888888888866667778888888888888888776677777777777777777764

...

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.87  E-value=2.7e-08  Score=101.49  Aligned_cols=140  Identities=15%  Similarity=0.113  Sum_probs=101.8

Q ss_pred             ceeeeccceEEEEEEECCCcEEEEEEeeccccc-hh----------hhHHHHHHHHhcCCCCcc--eeEEeeeec-----
Q 040845          533 NLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGR-AF----------KSFDVECAMMKSIRHRNL--VKVISSCSN-----  594 (824)
Q Consensus       533 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~----------~~~~~E~~~l~~l~h~ni--v~l~~~~~~-----  594 (824)
                      +.+-+.....|+++.+. |+.|.||........ ..          ..+.+|+..+.++...+|  +.++++...     
T Consensus        28 e~v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            44555555567787775 889999976433211 11          147789999988854443  344555532     


Q ss_pred             CCeeEEEEeccCCC-CHHHHhhhC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC-------CCc
Q 040845          595 EEFKALVLEYMPHG-SLEKYLHSS-NYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD-------NMV  665 (824)
Q Consensus       595 ~~~~~lv~e~~~~g-~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~-------~~~  665 (824)
                      ....++|||++++. +|.+++... ....+...+..++.+++..++-||   ..||+|+|+++.|||++.       ++.
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~  183 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDLK  183 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCce
Confidence            23567999999875 799988532 224556677889999999999999   999999999999999975       568


Q ss_pred             EEEeecccccc
Q 040845          666 AHLSDFGIAKL  676 (824)
Q Consensus       666 ~kl~Dfg~a~~  676 (824)
                      +.++||+.+..
T Consensus       184 ~~LIDl~r~~~  194 (268)
T PRK15123        184 LSVIDLHRAQI  194 (268)
T ss_pred             EEEEECCcccc
Confidence            99999998853

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.83  E-value=1.1e-10  Score=126.30  Aligned_cols=200  Identities=28%  Similarity=0.312  Sum_probs=145.3

Q ss_pred             cCCCCCCEEEcccccCcccC-CccccccCCccEEEccCccccccCCccccCC-CCCcEEEcCCCCCCCCC-------Ccc
Q 040845          242 GKLQKLQDVDLEYNQLEGSI-PDSICLSVELYELELGGNKLSGSIPACFSNM-TFLKVLSLGSNELTSIP-------LNF  312 (824)
Q Consensus       242 ~~l~~L~~L~L~~n~l~~~~-~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l-~~L~~L~L~~N~l~~lp-------~~~  312 (824)
                      .-+++++.|.+-+-.=.+.. |-.+..+.+|+.|.+.++.|...  ..+..+ ..|++|. .+|.++.+.       ..+
T Consensus        81 d~lqkt~~lkl~~~pa~~pt~pi~ifpF~sLr~LElrg~~L~~~--~GL~~lr~qLe~LI-C~~Sl~Al~~v~ascggd~  157 (1096)
T KOG1859|consen   81 DFLQKTKVLKLLPSPARDPTEPISIFPFRSLRVLELRGCDLSTA--KGLQELRHQLEKLI-CHNSLDALRHVFASCGGDI  157 (1096)
T ss_pred             HHHhhheeeeecccCCCCCCCCceeccccceeeEEecCcchhhh--hhhHHHHHhhhhhh-hhccHHHHHHHHHHhcccc
Confidence            34556666666554443333 66777889999999999998741  112222 2455553 445444331       112


Q ss_pred             c---ccccccccccccccccCcCCccccccccchhhhcccccccccCCCccCCCCCCCeEEccCccccccCC-ccccccc
Q 040845          313 W---SLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIP-DSFGDLI  388 (824)
Q Consensus       313 ~---~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~  388 (824)
                      .   ....|...+.++|.+. ....++.-++.|+.|+|++|+++..  +.+..|+.|++|||++|.++ .+| -...++.
T Consensus       158 ~ns~~Wn~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~  233 (1096)
T KOG1859|consen  158 SNSPVWNKLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK  233 (1096)
T ss_pred             ccchhhhhHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhc-cccccchhhhh
Confidence            2   2457888999999998 6778888999999999999999976  47899999999999999999 454 3444554


Q ss_pred             cccEEEccCcccCCCCcccccCCcccceeeccCCcccCC--CCCCCCccccccccccCCccccCC
Q 040845          389 SLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGE--IPRGGSFGNFSAESFKGNELLCGS  451 (824)
Q Consensus       389 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~--~p~~~~~~~~~~~~~~~n~~~c~~  451 (824)
                       |+.|.++||.++ .+ ..+.++.+|+.||+++|-|++-  ......+..+..+.+.|||.-|..
T Consensus       234 -L~~L~lrnN~l~-tL-~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p  295 (1096)
T KOG1859|consen  234 -LQLLNLRNNALT-TL-RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAP  295 (1096)
T ss_pred             -heeeeecccHHH-hh-hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCH
Confidence             999999999998 33 3577899999999999999863  333345677788899999977753

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.77  E-value=4e-08  Score=96.32  Aligned_cols=135  Identities=22%  Similarity=0.200  Sum_probs=99.0

Q ss_pred             CCCCceeeeccceEEEEEEECCCcEEEEEEeeccc----------------------cchhhhHHHHHHHHhcCCCC--c
Q 040845          529 FSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQC----------------------GRAFKSFDVECAMMKSIRHR--N  584 (824)
Q Consensus       529 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----------------------~~~~~~~~~E~~~l~~l~h~--n  584 (824)
                      ..++..||-|--+.||.|..+.|.++|||.=+...                      .......++|.++|.+|.-.  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            45678999999999999999899999999532110                      01124567899999999654  5


Q ss_pred             ceeEEeeeecCCeeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC
Q 040845          585 LVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM  664 (824)
Q Consensus       585 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~  664 (824)
                      +.+.+++    +...+||||++|-.|...-      ++......++..|++-+.-.-   ..||||+|+++-||+++++|
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV~~dg  239 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILVTEDG  239 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEEecCC
Confidence            6666654    3346999999986665442      123344455555665555555   67899999999999999999


Q ss_pred             cEEEeecccccc
Q 040845          665 VAHLSDFGIAKL  676 (824)
Q Consensus       665 ~~kl~Dfg~a~~  676 (824)
                      .+.++||-.+..
T Consensus       240 ~~~vIDwPQ~v~  251 (304)
T COG0478         240 DIVVIDWPQAVP  251 (304)
T ss_pred             CEEEEeCccccc
Confidence            999999987764

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.76  E-value=3.6e-07  Score=96.67  Aligned_cols=167  Identities=19%  Similarity=0.198  Sum_probs=126.6

Q ss_pred             cceEEEEEE-ECCCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeee----cCCeeEEEEeccCC-CCHHH
Q 040845          539 GFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCS----NEEFKALVLEYMPH-GSLEK  612 (824)
Q Consensus       539 ~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~~lv~e~~~~-g~L~~  612 (824)
                      -..+.|++. ..||..|++|+++............-+++++++.|.|+|++..++.    .+...++||+|.++ ++|.+
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            446789996 4579999999995443333333345678999999999999999886    35577899999976 46666


Q ss_pred             HhhhC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccC
Q 040845          613 YLHSS--------------NYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT  678 (824)
Q Consensus       613 ~l~~~--------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~  678 (824)
                      .-...              +...++...|.++.|++.||.++|   +.|..-+-+.+.+|+++.+.+++|+.-|....+.
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence            53211              134677899999999999999999   8999999999999999999899998877776554


Q ss_pred             CCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCC
Q 040845          679 GEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKK  727 (824)
Q Consensus       679 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~  727 (824)
                      .++.                |.+.   --.+-|.=.+|.+++.+.||..
T Consensus       445 ~d~~----------------~~le---~~Qq~D~~~lG~ll~aLAt~~~  474 (655)
T KOG3741|consen  445 EDPT----------------EPLE---SQQQNDLRDLGLLLLALATGTE  474 (655)
T ss_pred             CCCC----------------cchh---HHhhhhHHHHHHHHHHHhhccc
Confidence            3220                1111   1236799999999999999975

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.71  E-value=6.5e-10  Score=95.93  Aligned_cols=134  Identities=24%  Similarity=0.254  Sum_probs=84.6

Q ss_pred             CcEEEcCCCCCCCCCCc---ccccccccccccccccccCcCCccccccccchhhhcccccccccCCCccCCCCCCCeEEc
Q 040845          295 LKVLSLGSNELTSIPLN---FWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFL  371 (824)
Q Consensus       295 L~~L~L~~N~l~~lp~~---~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L  371 (824)
                      +..++|+.++|..++..   +.....|+..+|++|.+....+..-..++.++.|+|++|.|+ .+|.++..++.|+.|++
T Consensus        29 ~h~ldLssc~lm~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl  107 (177)
T KOG4579|consen   29 LHFLDLSSCQLMYIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNL  107 (177)
T ss_pred             hhhcccccchhhHHHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhccc
Confidence            33444455544444333   223344444555555555333333344557777888888887 45666888888888888


Q ss_pred             cCccccccCCccccccccccEEEccCcccCCCCcccccCCcccceeeccCCcccCCCCCC
Q 040845          372 EYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIPRG  431 (824)
Q Consensus       372 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~  431 (824)
                      +.|.+. ..|..+..+.+|-.||..+|.+. .+|..+-.-.......+.+++|.+..+..
T Consensus       108 ~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~k  165 (177)
T KOG4579|consen  108 RFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKKK  165 (177)
T ss_pred             ccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCccc
Confidence            888887 67777777888888888888876 66655443344455556777887777764

>KOG2982 consensus Uncharacterized conserved protein [Function unknown]

Probab=98.66  E-value=4.5e-09  Score=102.62  Aligned_cols=61  Identities=31%  Similarity=0.405  Sum_probs=26.5

Q ss_pred             CCCCEEeCCCCcCCc--ccChhhhCcCCCceeeccCCccccccCccccCCCCCccEEEccCCee
Q 040845           45 HNLGFLDLSQNKLLG--TIPAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNF  106 (824)
Q Consensus        45 ~~L~~L~Ls~n~l~~--~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~i  106 (824)
                      +.++.|||.+|+|+.  ++..-+.+++.|++|+|+.|++...+.... ..+.+|+.|-|.|..+
T Consensus        71 ~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp-~p~~nl~~lVLNgT~L  133 (418)
T KOG2982|consen   71 TDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLP-LPLKNLRVLVLNGTGL  133 (418)
T ss_pred             hhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCc-ccccceEEEEEcCCCC
Confidence            445555555555542  222333444555555555554444333322 1233444444444433

>PRK09902 hypothetical protein; Provisional

Probab=98.65  E-value=3.9e-07  Score=87.67  Aligned_cols=154  Identities=17%  Similarity=0.133  Sum_probs=109.7

Q ss_pred             HHHHHHhhccCCCCceeeeccceEEEEEEECCCcEEEEEEeeccc------cchhhhHHHHHHHHhcCCCCc--ceeEEe
Q 040845          519 YLELFQATDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQC------GRAFKSFDVECAMMKSIRHRN--LVKVIS  590 (824)
Q Consensus       519 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~n--iv~l~~  590 (824)
                      |+.+.....++-..-=-|+||.+.|++.... |..+-+|+-....      ......|.+|+..+..+...+  +.+++.
T Consensus        10 f~~~w~~~~~wve~pN~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf   88 (216)
T PRK09902         10 FNHWWATEGDWVEEPNYRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVF   88 (216)
T ss_pred             HHHHHhCCCceecCCCcCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccce
Confidence            3344444444433334577999999998876 5578888754221      223568999999999985333  444442


Q ss_pred             eeec----CCeeEEEEeccCC-CCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC
Q 040845          591 SCSN----EEFKALVLEYMPH-GSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM  664 (824)
Q Consensus       591 ~~~~----~~~~~lv~e~~~~-g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~  664 (824)
                      +...    ....+||+|-+++ .+|.+++.... ...+......+..+++..++-||   +.|+.|+|+.+.||+++.++
T Consensus        89 ~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g  165 (216)
T PRK09902         89 GEAVKIEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEG  165 (216)
T ss_pred             eeeeccCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCC
Confidence            2111    2345799998853 48999886543 34577778899999999999999   99999999999999998666


Q ss_pred             c--EEEeecccccc
Q 040845          665 V--AHLSDFGIAKL  676 (824)
Q Consensus       665 ~--~kl~Dfg~a~~  676 (824)
                      .  ++++||.-++.
T Consensus       166 ~~~v~lIDlEk~r~  179 (216)
T PRK09902        166 KAEAGFLDLEKSRR  179 (216)
T ss_pred             CeeEEEEEhhccch
Confidence            6  99999987653

>KOG2982 consensus Uncharacterized conserved protein [Function unknown]

Probab=98.63  E-value=6.4e-09  Score=101.56  Aligned_cols=87  Identities=25%  Similarity=0.318  Sum_probs=47.7

Q ss_pred             CCCCCEEEecCCccCC--ccchhhcCCCCCCEEEcccccCcccCCccccccCCccEEEccCccccc-cCCccccCCCCCc
Q 040845          220 LTDLTTIVLGGNKLNG--SIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSG-SIPACFSNMTFLK  296 (824)
Q Consensus       220 l~~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~-~~~~~~~~l~~L~  296 (824)
                      ++.++++||.+|.|+.  .+...+.++|.|++|+|++|++...+...-....+|+.|.|.+..+.- .....+..+|.++
T Consensus        70 ~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vt  149 (418)
T KOG2982|consen   70 VTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVT  149 (418)
T ss_pred             hhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhhcchhhh
Confidence            4556666666666652  122234466677777777776663222111345567777777666652 1223445566667


Q ss_pred             EEEcCCCCCC
Q 040845          297 VLSLGSNELT  306 (824)
Q Consensus       297 ~L~L~~N~l~  306 (824)
                      .|.++.|.++
T Consensus       150 elHmS~N~~r  159 (418)
T KOG2982|consen  150 ELHMSDNSLR  159 (418)
T ss_pred             hhhhccchhh
Confidence            7777666544

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.60  E-value=2.1e-07  Score=102.87  Aligned_cols=141  Identities=22%  Similarity=0.235  Sum_probs=95.4

Q ss_pred             ceeeeccceEEEEEEECCCcEEEEEEeeccccch------------------------------h----------hhHHH
Q 040845          533 NLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRA------------------------------F----------KSFDV  572 (824)
Q Consensus       533 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~------------------------------~----------~~~~~  572 (824)
                      ..|+.++-|.||+|++++|+.||||+.++.-.+.                              .          -++.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            6899999999999999999999999976431100                              0          12345


Q ss_pred             HHHHHhcCC----CCcceeEEeee-ecCCeeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHH-HHhhcCCCC
Q 040845          573 ECAMMKSIR----HRNLVKVISSC-SNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASAL-EYLHFGYSA  646 (824)
Q Consensus       573 E~~~l~~l~----h~niv~l~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l-~~LH~~~~~  646 (824)
                      |+.-+.+++    ..--+.+-.++ +-.....++|||++|-.+.+...-.....+...   ++..++++. ..+-   ..
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~---ia~~~~~~f~~q~~---~d  284 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKE---LAELLVRAFLRQLL---RD  284 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHH---HHHHHHHHHHHHHH---hc
Confidence            665555553    22223333333 334566899999999988888433223455333   333333321 1222   46


Q ss_pred             CeEecCCCCCCeeeCCCCcEEEeecccccccCC
Q 040845          647 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG  679 (824)
Q Consensus       647 ~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  679 (824)
                      |++|+|.+|.||+++.+|.+.+.|||+...+.+
T Consensus       285 gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         285 GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            899999999999999999999999999987654

>KOG2120 consensus SCF ubiquitin ligase, Skp2 component [Posttranslational modification, protein turnover, chaperones]

Probab=98.57  E-value=9.7e-10  Score=107.18  Aligned_cols=179  Identities=22%  Similarity=0.202  Sum_probs=126.1

Q ss_pred             CccEEEccCCeeee-ecCccccCCCCCceEeccCccccccCCccccCCCCCCEEEccCCc-CCCCcCcccccccCCCCCC
Q 040845           95 NLEVLYLWGNNFSG-TIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNN-LTSSTLDLSFLSSLSNCKS  172 (824)
Q Consensus        95 ~L~~L~L~~n~i~~-~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~-i~~~~~~~~~~~~l~~l~~  172 (824)
                      .|++||||...|+. .+-..+..+++|+.|.|.++++++-+...+++-.+|+.|+|+.+. +++....    --+.+++.
T Consensus       186 Rlq~lDLS~s~it~stl~~iLs~C~kLk~lSlEg~~LdD~I~~~iAkN~~L~~lnlsm~sG~t~n~~~----ll~~scs~  261 (419)
T KOG2120|consen  186 RLQHLDLSNSVITVSTLHGILSQCSKLKNLSLEGLRLDDPIVNTIAKNSNLVRLNLSMCSGFTENALQ----LLLSSCSR  261 (419)
T ss_pred             hhHHhhcchhheeHHHHHHHHHHHHhhhhccccccccCcHHHHHHhccccceeeccccccccchhHHH----HHHHhhhh
Confidence            59999999999873 244567778999999999999998888889999999999999764 4443322    13678999


Q ss_pred             CcEEECcCCCCCccCCccccccccccccEEEeecCcce---ecCCccCCCCCCCCEEEecCCc-cCCccchhhcCCCCCC
Q 040845          173 LTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVS---GGIPEEITNLTDLTTIVLGGNK-LNGSIPITLGKLQKLQ  248 (824)
Q Consensus       173 L~~L~Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~---~~~~~~l~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~  248 (824)
                      |.+|+|++|.+....-...+.....+|+.|+|+|+.=.   ..+..-...+++|..|||++|. ++......|..++.|+
T Consensus       262 L~~LNlsWc~l~~~~Vtv~V~hise~l~~LNlsG~rrnl~~sh~~tL~~rcp~l~~LDLSD~v~l~~~~~~~~~kf~~L~  341 (419)
T KOG2120|consen  262 LDELNLSWCFLFTEKVTVAVAHISETLTQLNLSGYRRNLQKSHLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFKFNYLQ  341 (419)
T ss_pred             HhhcCchHhhccchhhhHHHhhhchhhhhhhhhhhHhhhhhhHHHHHHHhCCceeeeccccccccCchHHHHHHhcchhe
Confidence            99999999998766555566677788888888887421   1112223467888888888763 4444445667778888


Q ss_pred             EEEcccccCcccCCccc---cccCCccEEEccCc
Q 040845          249 DVDLEYNQLEGSIPDSI---CLSVELYELELGGN  279 (824)
Q Consensus       249 ~L~L~~n~l~~~~~~~~---~~~~~L~~L~l~~n  279 (824)
                      +|.|+.|..  ++|..+   ...++|.+|++.++
T Consensus       342 ~lSlsRCY~--i~p~~~~~l~s~psl~yLdv~g~  373 (419)
T KOG2120|consen  342 HLSLSRCYD--IIPETLLELNSKPSLVYLDVFGC  373 (419)
T ss_pred             eeehhhhcC--CChHHeeeeccCcceEEEEeccc
Confidence            888887764  344432   33445555555543

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	824
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-37
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-36
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		5e-34
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		1e-33
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		2e-33
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		3e-33
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		3e-25
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		4e-25
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		6e-25
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		8e-25
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-24
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		5e-24
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-22
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		1e-22
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		8e-22
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		4e-21
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		5e-21
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		6e-21
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		7e-21
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		7e-21
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		8e-21
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		8e-21
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		8e-21
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		8e-21
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		8e-21
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		8e-21
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		8e-21
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		9e-21
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		9e-21
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-20
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-20
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-20
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-20
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-20
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-20
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-20
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-20
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		3e-20
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		3e-20
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		3e-20
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		3e-20
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		4e-20
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		4e-20
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		5e-20
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		5e-20
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		5e-20
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		5e-20
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		5e-20
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		5e-20
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		5e-20
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		5e-20
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-20
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		6e-20
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		6e-20
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		6e-20
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		7e-20
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		7e-20
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		7e-20
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		8e-20
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		8e-20
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		8e-20
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		8e-20
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		9e-20
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		9e-20
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-19
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-19
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-19
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-19
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-19
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-19
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-19
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-19
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-19
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-19
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-19
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-19
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		3e-19
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-19
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-19
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		3e-19
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		3e-19
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		4e-19
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		4e-19
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		5e-19
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		5e-19
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		5e-19
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		5e-19
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		5e-19
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		5e-19
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		5e-19
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		6e-19
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		6e-19
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		6e-19
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		6e-19
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		6e-19
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		7e-19
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		7e-19
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		7e-19
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		8e-19
4h58_A	275	Braf In Complex With Compound 3 Length = 275		8e-19
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		8e-19
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		8e-19
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		8e-19
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		9e-19
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		9e-19
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-18
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-18
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-18
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-18
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-18
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-18
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-18
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-18
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-18
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		1e-18
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-18
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-18
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-18
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-18
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		1e-18
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-18
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-18
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-18
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-18
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-18
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-18
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-18
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-18
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-18
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-18
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-18
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-18
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-18
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-18
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-18
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		3e-18
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		3e-18
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-18
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-18
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		3e-18
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-18
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		3e-18
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		3e-18
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		3e-18
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		3e-18
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-18
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		3e-18
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-18
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		4e-18
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		4e-18
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		4e-18
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		5e-18
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		5e-18
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		5e-18
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		5e-18
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		5e-18
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		6e-18
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		6e-18
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		6e-18
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		6e-18
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		6e-18
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		7e-18
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-18
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-17
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-17
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-17
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-17
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-17
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-17
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-17
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-17
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-17
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-17
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-17
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-17
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-17
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-17
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-17
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-17
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-17
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-17
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-17
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-17
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-17
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-17
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		3e-17
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		3e-17
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		4e-17
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		4e-17
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-17
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		5e-17
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		6e-17
3b2t_A	311	Structure Of Phosphotransferase Length = 311		6e-17
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		6e-17
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-16
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-16
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-16
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-16
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-16
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-16
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-16
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-16
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-16
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-16
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		4e-16
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-16
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		6e-16
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		8e-16
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-15
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-15
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-15
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-15
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-15
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-15
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-15
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-15
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-15
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-15
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-15
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-15
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-15
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-15
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-15
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		3e-15
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		3e-15
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		3e-15
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		3e-15
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		3e-15
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		3e-15
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		4e-15
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		4e-15
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		4e-15
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		4e-15
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		4e-15
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		4e-15
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		4e-15
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		4e-15
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		4e-15
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		5e-15
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		5e-15
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		6e-15
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		7e-15
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		7e-15
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		7e-15
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		7e-15
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		8e-15
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		9e-15
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		9e-15
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		9e-15
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		9e-15
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		9e-15
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		9e-15
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-14
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-14
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-14
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-14
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-14
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-14
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-14
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-14
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-14
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-14
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-14
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-14
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-14
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-14
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-14
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-14
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-14
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-14
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-14
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-14
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-14
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-14
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-14
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-14
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-14
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-14
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-14
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-14
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		3e-14
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		3e-14
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		3e-14
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		3e-14
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		3e-14
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		3e-14
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		5e-14
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		5e-14
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		6e-14
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		6e-14
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		7e-14
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		7e-14
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		7e-14
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		8e-14
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		8e-14
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		9e-14
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		9e-14
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-13
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-13
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-13
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-13
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-13
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-13
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-13
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		1e-13
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-13
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-13
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-13
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-13
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-13
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-13
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-13
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-13
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-13
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-13
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-13
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-13
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-13
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-13
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-13
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-13
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-13
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-13
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-13
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-13
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-13
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-13
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-13
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-13
3a7f_A	303	Human Mst3 Kinase Length = 303		3e-13
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-13
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-13
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-13
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		4e-13
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-13
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		4e-13
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		4e-13
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		4e-13
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		4e-13
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-13
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		5e-13
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		5e-13
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		5e-13
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		5e-13
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		5e-13
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		5e-13
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		5e-13
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		5e-13
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		5e-13
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-13
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-13
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		5e-13
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		5e-13
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		5e-13
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-13
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		5e-13
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		5e-13
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		5e-13
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-13
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-13
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		6e-13
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-13
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		6e-13
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-13
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		6e-13
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-13
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-13
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		7e-13
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		7e-13
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		7e-13
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		9e-13
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-12
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-12
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-12
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-12
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-12
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-12
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		1e-12
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		1e-12
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-12
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-12
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-12
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-12
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		1e-12
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-12
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-12
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		1e-12
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		1e-12
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-12
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-12
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		1e-12
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-12
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-12
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-12
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-12
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-12
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-12
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		2e-12
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-12
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-12
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-12
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-12
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		2e-12
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-12
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-12
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-12
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-12
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-12
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-12
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		3e-12
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		3e-12
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		3e-12
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		3e-12
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		3e-12
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		4e-12
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		4e-12
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		4e-12
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		4e-12
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		5e-12
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-12
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		5e-12
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		5e-12
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-12
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		5e-12
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		5e-12
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		6e-12
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		6e-12
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		6e-12
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		6e-12
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		7e-12
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		7e-12
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		7e-12
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		7e-12
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		7e-12
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		7e-12
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		7e-12
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		7e-12
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		8e-12
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		8e-12
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		8e-12
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		8e-12
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		8e-12
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		8e-12
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		8e-12
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		8e-12
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		8e-12
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		8e-12
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		8e-12
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		8e-12
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		9e-12
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		9e-12
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		9e-12
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		9e-12
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		9e-12
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		9e-12
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		9e-12
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		9e-12
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		9e-12
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-11
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-11
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-11
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-11
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-11
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-11
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-11
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-11
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-11
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-11
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-11
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-11
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-11
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-11
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-11
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-11
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-11
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-11
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-11
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-11
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-11
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-11
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		2e-11
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-11
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-11
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-11
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-11
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-11
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-11
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-11
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-11
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-11
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-11
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-11
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-11
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		3e-11
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-11
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		3e-11
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-11
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		3e-11
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		3e-11
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		3e-11
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-11
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		3e-11
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		3e-11
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		3e-11
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-11
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-11
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		3e-11
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		3e-11
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		4e-11
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-11
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		4e-11
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-11
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		4e-11
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		4e-11
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		4e-11
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		4e-11
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		4e-11
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		5e-11
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		5e-11
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		5e-11
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		6e-11
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		6e-11
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		6e-11
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		6e-11
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-11
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		6e-11
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		7e-11
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		7e-11
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		8e-11
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		8e-11
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		8e-11
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		8e-11
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		8e-11
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		9e-11
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-10
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		1e-10
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-10
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		1e-10
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-10
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-10
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-10
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-10
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		1e-10
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-10
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-10
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-10
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-10
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-10
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-10
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-10
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-10
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-10
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-10
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-10
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-10
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-10
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-10
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-10
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-10
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-10
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-10
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-10
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-10
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-10
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		3e-10
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-10
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		3e-10
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		3e-10
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		3e-10
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		4e-10
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-10
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		4e-10
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		4e-10
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-10
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		4e-10
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		4e-10
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-10
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		4e-10
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		4e-10
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		5e-10
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		5e-10
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		5e-10
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		5e-10
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		5e-10
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		5e-10
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		5e-10
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-10
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		5e-10
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		5e-10
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		5e-10
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		5e-10
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-10
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		5e-10
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		5e-10
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-10
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		5e-10
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		5e-10
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		5e-10
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		6e-10
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		6e-10
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		6e-10
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		7e-10
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		7e-10
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		7e-10
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		7e-10
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		7e-10
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		7e-10
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		8e-10
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		8e-10
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		8e-10
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		8e-10
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		8e-10
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		8e-10
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		8e-10
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		8e-10
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		9e-10
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		9e-10
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-10
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-09
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		1e-09
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-09
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-09
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-09
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-09
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		1e-09
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-09
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-09
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-09
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-09
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-09
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-09
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-09
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-09
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-09
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-09
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-09
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		2e-09
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-09
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-09
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-09
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-09
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-09
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-09
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-09
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-09
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-09
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-09
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		2e-09
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-09
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-09
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-09
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-09
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-09
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-09
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-09
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-09
3soa_A	444	Full-Length Human Camkii Length = 444		2e-09
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-09
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-09
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-09
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-09
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-09
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-09
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-09
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		3e-09
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		3e-09
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-09
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-09
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-09
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-09
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		3e-09
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		3e-09
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-09
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		3e-09
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		3e-09
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		3e-09
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		3e-09
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		3e-09
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		3e-09
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		3e-09
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-09
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		3e-09
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		3e-09
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		3e-09
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		3e-09
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		3e-09
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		3e-09
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		3e-09
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		3e-09
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		3e-09
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		3e-09
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		3e-09
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-09
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-09
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		3e-09
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		3e-09
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-09
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		3e-09
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-09
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		3e-09
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		3e-09
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		3e-09
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		3e-09
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		3e-09
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		3e-09
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		3e-09
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		3e-09
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-09
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		4e-09
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		4e-09
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		4e-09
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		4e-09
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		4e-09
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		4e-09
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		4e-09
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		4e-09
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		4e-09
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		4e-09
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		4e-09
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-09
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		4e-09
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		4e-09
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		5e-09
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		5e-09
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		5e-09
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-09
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		6e-09
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		6e-09
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		6e-09
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		7e-09
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-09
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		7e-09
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		8e-09
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		8e-09
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		8e-09
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		8e-09
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		8e-09
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		8e-09
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		8e-09
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		8e-09
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		9e-09
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		9e-09
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		9e-09
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		9e-09
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		9e-09
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		9e-09
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-08
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-08
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-08
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-08
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-08
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-08
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-08
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-08
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-08
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-08
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		1e-08
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-08
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-08
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		1e-08
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-08
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-08
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-08
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-08
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-08
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-08
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-08
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-08
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-08
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-08
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-08
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-08
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-08
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-08
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-08
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		2e-08
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-08
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-08
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-08
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-08
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-08
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-08
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-08
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-08
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		3e-08
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-08
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		3e-08
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		3e-08
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		3e-08
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		3e-08
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		3e-08
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		3e-08
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		3e-08
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		3e-08
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		3e-08
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		3e-08
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-08
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-08
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-08
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		3e-08
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		3e-08
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		3e-08
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-08
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		3e-08
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-08
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		3e-08
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		3e-08
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		3e-08
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		3e-08
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-08
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		4e-08
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		4e-08
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		4e-08
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		4e-08
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-08
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		4e-08
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		4e-08
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		4e-08
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		5e-08
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		5e-08
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		5e-08
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		5e-08
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		5e-08
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-08
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		6e-08
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		6e-08
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-08
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		6e-08
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		6e-08
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		6e-08
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		6e-08
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		7e-08
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-08
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		8e-08
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		8e-08
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		8e-08
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		9e-08
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		9e-08
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		9e-08
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-07
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-07
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-07
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-07
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-07
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		1e-07
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-07
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-07
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-07
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-07
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-07
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-07
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-07
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-07
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-07
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-07
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-07
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-07
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		3e-07
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		3e-07
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-07
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		3e-07
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		3e-07
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-07
4exu_A	371	Mapk13, Inactive Form Length = 371		4e-07
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		4e-07
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		4e-07
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		4e-07
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		4e-07
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-07
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		5e-07
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		5e-07
2omu_A	462	Crystal Structure Of Inla G194s+s Y369s/hec1 Comple		5e-07
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		5e-07
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		5e-07
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		5e-07
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		5e-07
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		6e-07
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		6e-07
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		6e-07
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		6e-07
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		6e-07
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		6e-07
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		6e-07
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		6e-07
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		6e-07
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		7e-07
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		7e-07
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		7e-07
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		8e-07
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		8e-07
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-07
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		8e-07
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		8e-07
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		9e-07
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		9e-07
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		9e-07
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		9e-07
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		9e-07
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		9e-07
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		9e-07
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-06
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-06
2omt_A	462	Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt		1e-06
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		1e-06
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-06
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-06
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-06
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-06
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		1e-06
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		1e-06
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-06
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-06
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-06
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-06
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-06
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-06
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-06
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-06
2omv_A	461	Crystal Structure Of Inla S192n Y369s/hec1 Complex		1e-06
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-06
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-06
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-06
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-06
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-06
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-06
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-06
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-06
2omz_A	466	Crystal Structure Of Inla Y369a/hec1 Complex Length		2e-06
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-06
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-06
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-06
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-06
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-06
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-06
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-06
2omx_A	462	Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX		2e-06
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		2e-06
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-06
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-06
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-06
1o6s_A	466	Internalin (Listeria Monocytogenes) E-Cadherin (Hum		3e-06
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		3e-06
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		3e-06
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-06
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		3e-06
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		3e-06
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-06
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		3e-06
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		3e-06
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		3e-06
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		3e-06
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-06
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		3e-06
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		3e-06
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		3e-06
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-06
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		3e-06
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		3e-06
2omy_A	461	Crystal Structure Of Inla S192n/hec1 Complex Length		4e-06
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		4e-06
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		4e-06
3v47_A	455	Crystal Structure Of The N-Tetminal Fragment Of Zeb		4e-06
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		4e-06
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		4e-06
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		6e-06
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		6e-06
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		6e-06
2o6q_A	270	Structural Diversity Of The Hagfish Variable Lympho		6e-06
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		7e-06
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		7e-06
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		7e-06
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		8e-06
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		8e-06
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		8e-06
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		9e-06
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		9e-06
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		9e-06
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		1e-05
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		1e-05
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		1e-05
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		1e-05
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		2e-05
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-05
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		2e-05
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-05
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-05
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-05
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		3e-05
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		3e-05
3rfj_A	279	Design Of A Binding Scaffold Based On Variable Lymp		4e-05
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		4e-05
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		5e-05
4hni_A	296	Crystal Structure Of Ck1e In Complex With Pf4800567		5e-05
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		7e-05
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		7e-05
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		7e-05
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		7e-05
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		8e-05
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		1e-04
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		1e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  154 bits (390), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 106/296 (35%), Positives = 153/296 (51%), Gaps = 15/296 (5%)
Query: 515 RRFSYLELFQATDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFK-SFDVE 573
           +RFS  EL  A+D FS  N++GRGGFG VYK R+ DG  VAVK    +  +  +  F  E
Sbjct: 26  KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTE 85
Query: 574 CAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLH---SSNYSLDIFQRLNIM 630
             M+    HRNL+++   C     + LV  YM +GS+   L     S   LD  +R  I 
Sbjct: 86  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 145
Query: 631 IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTL 690
           +  A  L YLH      +IH D+K +N+LLD+   A + DFG+AKL+  +D  +      
Sbjct: 146 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXA-VR 204
Query: 691 ATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTD--ELFN-GEMTLKHWVNDCL 747
            TIG++APEY   G+ S   DV+ +G+ML+E  T ++  D   L N  ++ L  WV   L
Sbjct: 205 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 264
Query: 748 PISTME-VVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL 802
               +E +VD +L          K++ V  +  +AL CT  SP +R    E+V  L
Sbjct: 265 KEKKLEALVDVDLQGN------YKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 314

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  151 bits (381), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 103/295 (34%), Positives = 149/295 (50%), Gaps = 13/295 (4%)
Query: 515 RRFSYLELFQATDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFK-SFDVE 573
           +RFS  EL  A+D F   N++GRGGFG VYK R+ DG  VAVK    +  +  +  F  E
Sbjct: 18  KRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTE 77
Query: 574 CAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLH---SSNYSLDIFQRLNIM 630
             M+    HRNL+++   C     + LV  YM +GS+   L     S   LD  +R  I 
Sbjct: 78  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 137
Query: 631 IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTL 690
           +  A  L YLH      +IH D+K +N+LLD+   A + DFG+AKL+  +D  +      
Sbjct: 138 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXA-VR 196
Query: 691 ATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTD--ELFN-GEMTLKHWVNDCL 747
             IG++APEY   G+ S   DV+ +G+ML+E  T ++  D   L N  ++ L  WV   L
Sbjct: 197 GXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256
Query: 748 PISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL 802
               +E      L   D+    K++ V  +  +AL CT  SP +R    E+V  L
Sbjct: 257 KEKKLEA-----LVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  143 bits (360), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 97/303 (32%), Positives = 160/303 (52%), Gaps = 17/303 (5%)
Query: 516 RFSYLELFQATDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECA 575
           R   ++L +AT+ F    LIG G FG VYK  +RDG +VA+K    +  +  + F+ E  
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIE 87
Query: 576 MMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSN---YSLDIFQRLNIMID 632
            +   RH +LV +I  C       L+ +YM +G+L+++L+ S+    S+   QRL I I 
Sbjct: 88  TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIG 147
Query: 633 VASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLAT 692
            A  L YLH   +  +IH D+K  N+LLD+N V  ++DFGI+K  T  DQ+        T
Sbjct: 148 AARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGT 204
Query: 693 IGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMT-LKHWVNDCLPIST 751
           +GY+ PEY  +G+++   DVYSFG++L E    +    +    EM  L  W  +      
Sbjct: 205 LGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264
Query: 752 ME-VVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL---LKIRD 807
           +E +VD NL  +       + + +    + A++C   S E R +  +++ KL   L++++
Sbjct: 265 LEQIVDPNLADK------IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE 318
Query: 808 SLL 810
           S++
Sbjct: 319 SVI 321

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score =  141 bits (356), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 136/462 (29%), Positives = 206/462 (44%), Gaps = 68/462 (14%)
Query: 31  NRLQGEI-IHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVS-TLKAFAVTNNSLSG-CLSS 87
           N   GE+ +  +  +  L  LDLS N+  G +P ++ N+S +L    +++N+ SG  L +
Sbjct: 325 NNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPN 384
Query: 88  ITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWL 147
           +       L+ LYL  N F+G IP  + N S+L  L L  N  SG IPS+ G+L  L  L
Sbjct: 385 LCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDL 444
Query: 148 TLYXXXXXXXXXXXXXXXXXXXCKSLTHISLSNNPLDGILPR--TYVGNLSHSLKNFYMY 205
            L+                              N L+G +P+   YV  L   + +F   
Sbjct: 445 KLWL-----------------------------NMLEGEIPQELMYVKTLETLILDFN-- 473
Query: 206 NCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSI 265
             +++G IP  ++N T+L  I L  N+L G IP  +G+L+ L  + L  N   G+IP  +
Sbjct: 474 --DLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAEL 531
Query: 266 CLSVELYELELGGNKLSGSIPACF------------SNMTFLKVLSLGSNE--------- 304
                L  L+L  N  +G+IPA              +   ++ + + G  +         
Sbjct: 532 GDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLL 591
Query: 305 ----LTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEI 360
               + S  LN  S ++    N++S  + G       N  +++ +D S N  SG IP EI
Sbjct: 592 EFQGIRSEQLNRLSTRN--PCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEI 649
Query: 361 GSLKNLENLFLEYNRLEGSIPDSFGDLIXXXXXXXXXXXXXGTIPVSLEKLSYLKDLNLS 420
           GS+  L  L L +N + GSIPD  GDL              G IP ++  L+ L +++LS
Sbjct: 650 GSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLS 709
Query: 421 FNKLKGEIPRGGSFGNFSAESFKGNELLCGSPNLQVPPCKAS 462
            N L G IP  G F  F    F  N  LCG P   +P C  S
Sbjct: 710 NNNLSGPIPEMGQFETFPPAKFLNNPGLCGYP---LPRCDPS 748

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score =  141 bits (355), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 136/462 (29%), Positives = 206/462 (44%), Gaps = 68/462 (14%)
Query: 31  NRLQGEI-IHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVS-TLKAFAVTNNSLSG-CLSS 87
           N   GE+ +  +  +  L  LDLS N+  G +P ++ N+S +L    +++N+ SG  L +
Sbjct: 328 NNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPN 387
Query: 88  ITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWL 147
           +       L+ LYL  N F+G IP  + N S+L  L L  N  SG IPS+ G+L  L  L
Sbjct: 388 LCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDL 447
Query: 148 TLYXXXXXXXXXXXXXXXXXXXCKSLTHISLSNNPLDGILPR--TYVGNLSHSLKNFYMY 205
            L+                              N L+G +P+   YV  L   + +F   
Sbjct: 448 KLWL-----------------------------NMLEGEIPQELMYVKTLETLILDFN-- 476
Query: 206 NCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSI 265
             +++G IP  ++N T+L  I L  N+L G IP  +G+L+ L  + L  N   G+IP  +
Sbjct: 477 --DLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAEL 534
Query: 266 CLSVELYELELGGNKLSGSIPACF------------SNMTFLKVLSLGSNE--------- 304
                L  L+L  N  +G+IPA              +   ++ + + G  +         
Sbjct: 535 GDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLL 594
Query: 305 ----LTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEI 360
               + S  LN  S ++    N++S  + G       N  +++ +D S N  SG IP EI
Sbjct: 595 EFQGIRSEQLNRLSTRN--PCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEI 652
Query: 361 GSLKNLENLFLEYNRLEGSIPDSFGDLIXXXXXXXXXXXXXGTIPVSLEKLSYLKDLNLS 420
           GS+  L  L L +N + GSIPD  GDL              G IP ++  L+ L +++LS
Sbjct: 653 GSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLS 712
Query: 421 FNKLKGEIPRGGSFGNFSAESFKGNELLCGSPNLQVPPCKAS 462
            N L G IP  G F  F    F  N  LCG P   +P C  S
Sbjct: 713 NNNLSGPIPEMGQFETFPPAKFLNNPGLCGYP---LPRCDPS 751

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  140 bits (352), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 96/303 (31%), Positives = 159/303 (52%), Gaps = 17/303 (5%)
Query: 516 RFSYLELFQATDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECA 575
           R   ++L +AT+ F    LIG G FG VYK  +RDG +VA+K    +  +  + F+ E  
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIE 87
Query: 576 MMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSN---YSLDIFQRLNIMID 632
            +   RH +LV +I  C       L+ +YM +G+L+++L+ S+    S+   QRL I I 
Sbjct: 88  TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIG 147
Query: 633 VASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLAT 692
            A  L YLH   +  +IH D+K  N+LLD+N V  ++DFGI+K  T   Q+        T
Sbjct: 148 AARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGT 204
Query: 693 IGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMT-LKHWVNDCLPIST 751
           +GY+ PEY  +G+++   DVYSFG++L E    +    +    EM  L  W  +      
Sbjct: 205 LGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264
Query: 752 ME-VVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL---LKIRD 807
           +E +VD NL  +       + + +    + A++C   S E R +  +++ KL   L++++
Sbjct: 265 LEQIVDPNLADK------IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE 318
Query: 808 SLL 810
           S++
Sbjct: 319 SVI 321

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  114 bits (284), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 77/230 (33%), Positives = 120/230 (52%), Gaps = 17/230 (7%)
Query: 514 WRRFSYLELFQATDKFSEN------NLIGRGGFGSVYKARIRDGMEVAVK----VFNLQC 563
           +  FS+ EL   T+ F E       N +G GGFG VYK  + +   VAVK    + ++  
Sbjct: 12  FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITT 70
Query: 564 GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYS--L 621
               + FD E  +M   +H NLV+++   S+ +   LV  YMP+GSL   L   + +  L
Sbjct: 71  EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPL 130
Query: 622 DIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 681
               R  I    A+ + +LH  +    IH D+K +N+LLD+   A +SDFG+A+      
Sbjct: 131 SWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFA 187
Query: 682 QSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDE 731
           Q++  ++ + T  YMAPE  R G+++   D+YSFG++L+E  T     DE
Sbjct: 188 QTVMXSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDE 236

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  113 bits (283), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 77/230 (33%), Positives = 119/230 (51%), Gaps = 17/230 (7%)
Query: 514 WRRFSYLELFQATDKFSEN------NLIGRGGFGSVYKARIRDGMEVAVK----VFNLQC 563
           +  FS+ EL   T+ F E       N +G GGFG VYK  + +   VAVK    + ++  
Sbjct: 12  FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITT 70
Query: 564 GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYS--L 621
               + FD E  +M   +H NLV+++   S+ +   LV  YMP+GSL   L   + +  L
Sbjct: 71  EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPL 130
Query: 622 DIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 681
               R  I    A+ + +LH  +    IH D+K +N+LLD+   A +SDFG+A+      
Sbjct: 131 SWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFA 187
Query: 682 QSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDE 731
           Q++   + + T  YMAPE  R G+++   D+YSFG++L+E  T     DE
Sbjct: 188 QTVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDE 236

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  112 bits (281), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 70/198 (35%), Positives = 107/198 (54%), Gaps = 8/198 (4%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFK--SFDVECAMMKSIRHRNLVKVISSC 592
           IG G FG+V++A    G +VAVK+   Q   A +   F  E A+MK +RH N+V  + + 
Sbjct: 45  IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 593 SNEEFKALVLEYMPHGSLEKYLHSS--NYSLDIFQRLNIMIDVASALEYLHFGYSAPVIH 650
           +     ++V EY+  GSL + LH S     LD  +RL++  DVA  + YLH   + P++H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVH 162
Query: 651 CDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNG 710
            DLK  N+L+D      + DFG+++L       +       T  +MAPE  R+   +   
Sbjct: 163 RDLKSPNLLVDKKYTVKVCDFGLSRLKAS--XFLXSKXAAGTPEWMAPEVLRDEPSNEKS 220
Query: 711 DVYSFGIMLMETFTRKKP 728
           DVYSFG++L E  T ++P
Sbjct: 221 DVYSFGVILWELATLQQP 238

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  112 bits (280), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 77/230 (33%), Positives = 118/230 (51%), Gaps = 17/230 (7%)
Query: 514 WRRFSYLELFQATDKFSEN------NLIGRGGFGSVYKARIRDGMEVAVK----VFNLQC 563
           +  FS+ EL   T+ F E       N +G GGFG VYK  + +   VAVK    + ++  
Sbjct: 6   FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITT 64
Query: 564 GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYS--L 621
               + FD E  +M   +H NLV+++   S+ +   LV  YMP+GSL   L   + +  L
Sbjct: 65  EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPL 124
Query: 622 DIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 681
               R  I    A+ + +LH  +    IH D+K +N+LLD+   A +SDFG+A+      
Sbjct: 125 SWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFA 181
Query: 682 QSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDE 731
           Q +   + + T  YMAPE  R G+++   D+YSFG++L+E  T     DE
Sbjct: 182 QXVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDE 230

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 69/198 (34%), Positives = 108/198 (54%), Gaps = 8/198 (4%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFK--SFDVECAMMKSIRHRNLVKVISSC 592
           IG G FG+V++A    G +VAVK+   Q   A +   F  E A+MK +RH N+V  + + 
Sbjct: 45  IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 593 SNEEFKALVLEYMPHGSLEKYLHSS--NYSLDIFQRLNIMIDVASALEYLHFGYSAPVIH 650
           +     ++V EY+  GSL + LH S     LD  +RL++  DVA  + YLH   + P++H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVH 162
Query: 651 CDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNG 710
            +LK  N+L+D      + DFG+++L       ++      T  +MAPE  R+   +   
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRLKAS--TFLSSKSAAGTPEWMAPEVLRDEPSNEKS 220
Query: 711 DVYSFGIMLMETFTRKKP 728
           DVYSFG++L E  T ++P
Sbjct: 221 DVYSFGVILWELATLQQP 238

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score =  110 bits (274), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 82/286 (28%), Positives = 130/286 (45%), Gaps = 45/286 (15%)
Query: 535 IGRGGFGSVYKAR------IRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKV 588
           +G G FG V+ A        +D M VAVK        A K F  E  ++ +++H ++VK 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 589 ISSCSNEEFKALVLEYMPHGSLEKYLHS---------------SNYSLDIFQRLNIMIDV 633
              C + +   +V EYM HG L K+L +               +   L + Q L+I   +
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 634 ASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATI 693
           AS + YL    S   +H DL   N L+  N++  + DFG+++ +   D       T+  I
Sbjct: 143 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199
Query: 694 GYMAPEYGREGQVSTNGDVYSFGIMLMETFTR-KKPTDELFNGEMTLKHWVNDCLPISTM 752
            +M PE     + +T  DV+SFG++L E FT  K+P  +L N E      V +C      
Sbjct: 200 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE------VIEC------ 247
Query: 753 EVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEI 798
            +    +L +  +       C   V+++ L C    P+QR+N KEI
Sbjct: 248 -ITQGRVLERPRV-------CPKEVYDVMLGCWQREPQQRLNIKEI 285

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  105 bits (262), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 74/230 (32%), Positives = 115/230 (50%), Gaps = 17/230 (7%)
Query: 514 WRRFSYLELFQATDKFSEN------NLIGRGGFGSVYKARIRDGMEVAVK----VFNLQC 563
           +  FS+ EL   T+ F E       N  G GGFG VYK  + +   VAVK    + ++  
Sbjct: 3   FHSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITT 61
Query: 564 GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYS--L 621
               + FD E  +    +H NLV+++   S+ +   LV  Y P+GSL   L   + +  L
Sbjct: 62  EELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPL 121
Query: 622 DIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 681
               R  I    A+ + +LH  +    IH D+K +N+LLD+   A +SDFG+A+      
Sbjct: 122 SWHXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFA 178
Query: 682 QSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDE 731
           Q +  ++ + T  Y APE  R G+++   D+YSFG++L+E  T     DE
Sbjct: 179 QXVXXSRIVGTTAYXAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDE 227

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 85/282 (30%), Positives = 136/282 (48%), Gaps = 16/282 (5%)
Query: 189 RTYVGNLSHS-LKNFYMYNCNVSG-------GIPEEITNLTDLTTIVLGG-NKLNGSIPI 239
           RT++G L  +  + + + N ++SG        IP  + NL  L  + +GG N L G IP 
Sbjct: 36  RTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPP 95
Query: 240 TLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLS 299
            + KL +L  + + +  + G+IPD +     L  L+   N LSG++P   S++  L  ++
Sbjct: 96  AIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGIT 155
Query: 300 LGSNELT-SIPLNFWSLKDIL-DLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIP 357
              N ++ +IP ++ S   +   + +S N  +G +P    NL  L  +D S N   G   
Sbjct: 156 FDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDAS 214
Query: 358 MEIGSLKNLENLFLEYNRLEGSIPDSFGDLIXXXXXXXXXXXXXGTIPVSLEKLSYLKDL 417
           +  GS KN + + L  N L   +    G                GT+P  L +L +L  L
Sbjct: 215 VLFGSDKNTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSL 273
Query: 418 NLSFNKLKGEIPRGGSFGNFSAESFKGNELLCGSPNLQVPPC 459
           N+SFN L GEIP+GG+   F   ++  N+ LCGSP   +P C
Sbjct: 274 NVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP---LPAC 312

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score =  102 bits (255), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 141/292 (48%), Gaps = 36/292 (12%)
Query: 530 SENNLIGRGGFGSVYKARIRDG---MEVAVKVFNLQCGRAFKS---FDVECAMMKSIRHR 583
           +   +IG G FG VYK  ++      EV V +  L+ G   K    F  E  +M    H 
Sbjct: 47  TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 106
Query: 584 NLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL-HF 642
           N++++    S  +   ++ EYM +G+L+K+L   +    + Q + ++  +A+ ++YL + 
Sbjct: 107 NIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM 166
Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE-DQSMTQTQTLATIGYMAPEYG 701
            Y    +H DL   N+L++ N+V  +SDFG++++L  + + + T +     I + APE  
Sbjct: 167 NY----VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 222
Query: 702 REGQVSTNGDVYSFGIMLMETFTR-KKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLL 760
              + ++  DV+SFGI++ E  T  ++P  EL N E+     +ND   + T         
Sbjct: 223 SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA--INDGFRLPT--------- 271
Query: 761 SQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVA---KLLKIRDSL 809
                       C S ++ L ++C  +   +R    +IV+   KL++  DSL
Sbjct: 272 ---------PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSL 314

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score =  100 bits (248), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 88/288 (30%), Positives = 127/288 (44%), Gaps = 37/288 (12%)
Query: 532 NNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISS 591
             ++GRG FG V KA+ R   +VA+K    +  R  K+F VE   +  + H N+VK+  +
Sbjct: 14  EEVVGRGAFGVVCKAKWR-AKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGA 70
Query: 592 CSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIM---IDVASALEYLHFGYSAPV 648
           C N     LV+EY   GSL   LH +   L  +   + M   +  +  + YLH      +
Sbjct: 71  CLNP--VCLVMEYAEGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 127
Query: 649 IHCDLKPSNVLL-DDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVS 707
           IH DLKP N+LL     V  + DFG     T  D     T    +  +MAPE       S
Sbjct: 128 IHRDLKPPNLLLVAGGTVLKICDFG-----TACDIQTHMTNNKGSAAWMAPEVFEGSNYS 182
Query: 708 TNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHF 767
              DV+S+GI+L E  TR+KP DE+      +   V++     T   +  NL        
Sbjct: 183 EKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN----GTRPPLIKNLPKP----- 233
Query: 768 VAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLRNVGG 815
                    + +L   C  + P QR + +EIV    KI   L+R   G
Sbjct: 234 ---------IESLMTRCWSKDPSQRPSMEEIV----KIMTHLMRYFPG 268

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score =  100 bits (248), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 88/288 (30%), Positives = 127/288 (44%), Gaps = 37/288 (12%)
Query: 532 NNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISS 591
             ++GRG FG V KA+ R   +VA+K    +  R  K+F VE   +  + H N+VK+  +
Sbjct: 13  EEVVGRGAFGVVCKAKWR-AKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGA 69
Query: 592 CSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIM---IDVASALEYLHFGYSAPV 648
           C N     LV+EY   GSL   LH +   L  +   + M   +  +  + YLH      +
Sbjct: 70  CLNP--VCLVMEYAEGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 126
Query: 649 IHCDLKPSNVLL-DDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVS 707
           IH DLKP N+LL     V  + DFG     T  D     T    +  +MAPE       S
Sbjct: 127 IHRDLKPPNLLLVAGGTVLKICDFG-----TACDIQTHMTNNKGSAAWMAPEVFEGSNYS 181
Query: 708 TNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHF 767
              DV+S+GI+L E  TR+KP DE+      +   V++     T   +  NL        
Sbjct: 182 EKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN----GTRPPLIKNLPKP----- 232
Query: 768 VAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLRNVGG 815
                    + +L   C  + P QR + +EIV    KI   L+R   G
Sbjct: 233 ---------IESLMTRCWSKDPSQRPSMEEIV----KIMTHLMRYFPG 267

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 99.8 bits (247), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 80/306 (26%), Positives = 139/306 (45%), Gaps = 42/306 (13%)
Query: 528 KFSENNL-----IGRGGFGSVYKAR---IRD--GMEVAVKVFNLQCGRAFKSFDVECAMM 577
           +F E +L     +G+G FGSV   R   ++D  G  VAVK          + F+ E  ++
Sbjct: 24  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 83
Query: 578 KSIRHRNLVKVISSCSNEEFK--ALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVAS 635
           KS++H N+VK    C +   +   L++EY+P+GSL  YL      +D  + L     +  
Sbjct: 84  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 143
Query: 636 ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM-TQTQTLATIG 694
            +EYL    +   IH DL   N+L+++     + DFG+ K+L  + +    +    + I 
Sbjct: 144 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 200
Query: 695 YMAPEYGREGQVSTNGDVYSFGIMLMETFT----RKKPTDELF-------NGEMTLKHWV 743
           + APE   E + S   DV+SFG++L E FT     K P  E          G+M + H +
Sbjct: 201 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 260
Query: 744 NDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLL 803
                           L + +      + C   ++ +  EC   +  QR + +++  ++ 
Sbjct: 261 E---------------LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 305
Query: 804 KIRDSL 809
           +IRD++
Sbjct: 306 QIRDNM 311

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 99.4 bits (246), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 80/306 (26%), Positives = 139/306 (45%), Gaps = 42/306 (13%)
Query: 528 KFSENNL-----IGRGGFGSVYKAR---IRD--GMEVAVKVFNLQCGRAFKSFDVECAMM 577
           +F E +L     +G+G FGSV   R   ++D  G  VAVK          + F+ E  ++
Sbjct: 6   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 65
Query: 578 KSIRHRNLVKVISSCSNEEFK--ALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVAS 635
           KS++H N+VK    C +   +   L++EY+P+GSL  YL      +D  + L     +  
Sbjct: 66  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 125
Query: 636 ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT-LATIG 694
            +EYL    +   IH DL   N+L+++     + DFG+ K+L  + +     +   + I 
Sbjct: 126 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 182
Query: 695 YMAPEYGREGQVSTNGDVYSFGIMLMETFT----RKKPTDELF-------NGEMTLKHWV 743
           + APE   E + S   DV+SFG++L E FT     K P  E          G+M + H +
Sbjct: 183 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 242
Query: 744 NDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLL 803
                           L + +      + C   ++ +  EC   +  QR + +++  ++ 
Sbjct: 243 E---------------LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 287
Query: 804 KIRDSL 809
           +IRD++
Sbjct: 288 QIRDNM 293

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 99.4 bits (246), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 80/306 (26%), Positives = 139/306 (45%), Gaps = 42/306 (13%)
Query: 528 KFSENNL-----IGRGGFGSVYKAR---IRD--GMEVAVKVFNLQCGRAFKSFDVECAMM 577
           +F E +L     +G+G FGSV   R   ++D  G  VAVK          + F+ E  ++
Sbjct: 6   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 65
Query: 578 KSIRHRNLVKVISSCSNEEFK--ALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVAS 635
           KS++H N+VK    C +   +   L++EY+P+GSL  YL      +D  + L     +  
Sbjct: 66  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 125
Query: 636 ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT-LATIG 694
            +EYL    +   IH DL   N+L+++     + DFG+ K+L  + +     +   + I 
Sbjct: 126 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 182
Query: 695 YMAPEYGREGQVSTNGDVYSFGIMLMETFT----RKKPTDELF-------NGEMTLKHWV 743
           + APE   E + S   DV+SFG++L E FT     K P  E          G+M + H +
Sbjct: 183 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 242
Query: 744 NDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLL 803
                           L + +      + C   ++ +  EC   +  QR + +++  ++ 
Sbjct: 243 E---------------LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 287
Query: 804 KIRDSL 809
           +IRD++
Sbjct: 288 QIRDNM 293

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 99.4 bits (246), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 80/306 (26%), Positives = 139/306 (45%), Gaps = 42/306 (13%)
Query: 528 KFSENNL-----IGRGGFGSVYKAR---IRD--GMEVAVKVFNLQCGRAFKSFDVECAMM 577
           +F E +L     +G+G FGSV   R   ++D  G  VAVK          + F+ E  ++
Sbjct: 10  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 69
Query: 578 KSIRHRNLVKVISSCSNEEFK--ALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVAS 635
           KS++H N+VK    C +   +   L++EY+P+GSL  YL      +D  + L     +  
Sbjct: 70  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 129
Query: 636 ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT-LATIG 694
            +EYL    +   IH DL   N+L+++     + DFG+ K+L  + +     +   + I 
Sbjct: 130 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 186
Query: 695 YMAPEYGREGQVSTNGDVYSFGIMLMETFT----RKKPTDELF-------NGEMTLKHWV 743
           + APE   E + S   DV+SFG++L E FT     K P  E          G+M + H +
Sbjct: 187 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 246
Query: 744 NDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLL 803
                           L + +      + C   ++ +  EC   +  QR + +++  ++ 
Sbjct: 247 E---------------LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 291
Query: 804 KIRDSL 809
           +IRD++
Sbjct: 292 QIRDNM 297

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 99.4 bits (246), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 80/306 (26%), Positives = 139/306 (45%), Gaps = 42/306 (13%)
Query: 528 KFSENNL-----IGRGGFGSVYKAR---IRD--GMEVAVKVFNLQCGRAFKSFDVECAMM 577
           +F E +L     +G+G FGSV   R   ++D  G  VAVK          + F+ E  ++
Sbjct: 24  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 83
Query: 578 KSIRHRNLVKVISSCSNEEFK--ALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVAS 635
           KS++H N+VK    C +   +   L++EY+P+GSL  YL      +D  + L     +  
Sbjct: 84  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 143
Query: 636 ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM-TQTQTLATIG 694
            +EYL    +   IH DL   N+L+++     + DFG+ K+L  + +    +    + I 
Sbjct: 144 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 200
Query: 695 YMAPEYGREGQVSTNGDVYSFGIMLMETFT----RKKPTDELF-------NGEMTLKHWV 743
           + APE   E + S   DV+SFG++L E FT     K P  E          G+M + H +
Sbjct: 201 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 260
Query: 744 NDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLL 803
                           L + +      + C   ++ +  EC   +  QR + +++  ++ 
Sbjct: 261 E---------------LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 305
Query: 804 KIRDSL 809
           +IRD++
Sbjct: 306 QIRDNM 311

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 99.4 bits (246), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 80/306 (26%), Positives = 139/306 (45%), Gaps = 42/306 (13%)
Query: 528 KFSENNL-----IGRGGFGSVYKAR---IRD--GMEVAVKVFNLQCGRAFKSFDVECAMM 577
           +F E +L     +G+G FGSV   R   ++D  G  VAVK          + F+ E  ++
Sbjct: 5   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 64
Query: 578 KSIRHRNLVKVISSCSNEEFK--ALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVAS 635
           KS++H N+VK    C +   +   L++EY+P+GSL  YL      +D  + L     +  
Sbjct: 65  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 124
Query: 636 ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT-LATIG 694
            +EYL    +   IH DL   N+L+++     + DFG+ K+L  + +     +   + I 
Sbjct: 125 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 181
Query: 695 YMAPEYGREGQVSTNGDVYSFGIMLMETFT----RKKPTDELF-------NGEMTLKHWV 743
           + APE   E + S   DV+SFG++L E FT     K P  E          G+M + H +
Sbjct: 182 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 241
Query: 744 NDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLL 803
                           L + +      + C   ++ +  EC   +  QR + +++  ++ 
Sbjct: 242 E---------------LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 286
Query: 804 KIRDSL 809
           +IRD++
Sbjct: 287 QIRDNM 292

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 99.4 bits (246), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 80/306 (26%), Positives = 139/306 (45%), Gaps = 42/306 (13%)
Query: 528 KFSENNL-----IGRGGFGSVYKAR---IRD--GMEVAVKVFNLQCGRAFKSFDVECAMM 577
           +F E +L     +G+G FGSV   R   ++D  G  VAVK          + F+ E  ++
Sbjct: 9   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 68
Query: 578 KSIRHRNLVKVISSCSNEEFK--ALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVAS 635
           KS++H N+VK    C +   +   L++EY+P+GSL  YL      +D  + L     +  
Sbjct: 69  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 128
Query: 636 ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT-LATIG 694
            +EYL    +   IH DL   N+L+++     + DFG+ K+L  + +     +   + I 
Sbjct: 129 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 185
Query: 695 YMAPEYGREGQVSTNGDVYSFGIMLMETFT----RKKPTDELF-------NGEMTLKHWV 743
           + APE   E + S   DV+SFG++L E FT     K P  E          G+M + H +
Sbjct: 186 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 245
Query: 744 NDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLL 803
                           L + +      + C   ++ +  EC   +  QR + +++  ++ 
Sbjct: 246 E---------------LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 290
Query: 804 KIRDSL 809
           +IRD++
Sbjct: 291 QIRDNM 296

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 99.4 bits (246), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 80/306 (26%), Positives = 138/306 (45%), Gaps = 42/306 (13%)
Query: 528 KFSENNL-----IGRGGFGSVYKAR---IRD--GMEVAVKVFNLQCGRAFKSFDVECAMM 577
           +F E +L     +G+G FGSV   R   ++D  G  VAVK          + F+ E  ++
Sbjct: 4   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 63
Query: 578 KSIRHRNLVKVISSCSNEEFK--ALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVAS 635
           KS++H N+VK    C +   +   L++EY+P+GSL  YL      +D  + L     +  
Sbjct: 64  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 123
Query: 636 ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT-LATIG 694
            +EYL    +   IH DL   N+L+++     + DFG+ K+L  + +     +   + I 
Sbjct: 124 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 180
Query: 695 YMAPEYGREGQVSTNGDVYSFGIMLMETFT----RKKPTDELF-------NGEMTLKHWV 743
           + APE   E + S   DV+SFG++L E FT     K P  E          G+M + H +
Sbjct: 181 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 240
Query: 744 NDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLL 803
                           L + +      + C   ++ +  EC   +  QR + +++  ++ 
Sbjct: 241 E---------------LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 285
Query: 804 KIRDSL 809
           +IRD +
Sbjct: 286 QIRDQM 291

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 99.0 bits (245), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 80/306 (26%), Positives = 138/306 (45%), Gaps = 42/306 (13%)
Query: 528 KFSENNL-----IGRGGFGSVYKAR---IRD--GMEVAVKVFNLQCGRAFKSFDVECAMM 577
           +F E +L     +G+G FGSV   R   ++D  G  VAVK          + F+ E  ++
Sbjct: 37  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 96
Query: 578 KSIRHRNLVKVISSCSNEEFK--ALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVAS 635
           KS++H N+VK    C +   +   L++EY+P+GSL  YL      +D  + L     +  
Sbjct: 97  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 156
Query: 636 ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM-TQTQTLATIG 694
            +EYL    +   IH DL   N+L+++     + DFG+ K+L  + +    +    + I 
Sbjct: 157 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 213
Query: 695 YMAPEYGREGQVSTNGDVYSFGIMLMETFT----RKKPTDELF-------NGEMTLKHWV 743
           + APE   E + S   DV+SFG++L E FT     K P  E          G+M + H +
Sbjct: 214 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 273
Query: 744 NDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLL 803
                           L + +      + C   ++ +  EC   +  QR + +++  ++ 
Sbjct: 274 E---------------LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 318
Query: 804 KIRDSL 809
           +IRD +
Sbjct: 319 QIRDQM 324

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 99.0 bits (245), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 80/306 (26%), Positives = 139/306 (45%), Gaps = 42/306 (13%)
Query: 528 KFSENNL-----IGRGGFGSVYKAR---IRD--GMEVAVKVFNLQCGRAFKSFDVECAMM 577
           +F E +L     +G+G FGSV   R   ++D  G  VAVK          + F+ E  ++
Sbjct: 11  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 70
Query: 578 KSIRHRNLVKVISSCSNEEFK--ALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVAS 635
           KS++H N+VK    C +   +   L++EY+P+GSL  YL      +D  + L     +  
Sbjct: 71  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 130
Query: 636 ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT-LATIG 694
            +EYL    +   IH DL   N+L+++     + DFG+ K+L  + +     +   + I 
Sbjct: 131 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 187
Query: 695 YMAPEYGREGQVSTNGDVYSFGIMLMETFT----RKKPTDELF-------NGEMTLKHWV 743
           + APE   E + S   DV+SFG++L E FT     K P  E          G+M + H +
Sbjct: 188 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 247
Query: 744 NDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLL 803
                           L + +      + C   ++ +  EC   +  QR + +++  ++ 
Sbjct: 248 E---------------LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 292
Query: 804 KIRDSL 809
           +IRD++
Sbjct: 293 QIRDNM 298

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 99.0 bits (245), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 81/307 (26%), Positives = 141/307 (45%), Gaps = 44/307 (14%)
Query: 528 KFSENNL-----IGRGGFGSVYKAR---IRD--GMEVAVKVFNLQCGRAFKSFDVECAMM 577
           +F E +L     +G+G FGSV   R   ++D  G  VAVK          + F+ E  ++
Sbjct: 6   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 65
Query: 578 KSIRHRNLVKVISSCSNEEFK--ALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVAS 635
           KS++H N+VK    C +   +   L++EY+P+GSL  YL      +D  + L     +  
Sbjct: 66  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 125
Query: 636 ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT--LATI 693
            +EYL    +   IH DL   N+L+++     + DFG+ K+L  +D+   + +    + I
Sbjct: 126 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP-QDKEFFKVKEPGESPI 181
Query: 694 GYMAPEYGREGQVSTNGDVYSFGIMLMETFT----RKKPTDELF-------NGEMTLKHW 742
            + APE   E + S   DV+SFG++L E FT     K P  E          G+M + H 
Sbjct: 182 FWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 241
Query: 743 VNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL 802
           +                L + +      + C   ++ +  EC   +  QR + +++  ++
Sbjct: 242 IE---------------LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 286
Query: 803 LKIRDSL 809
            +IRD++
Sbjct: 287 DQIRDNM 293

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 99.0 bits (245), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 80/306 (26%), Positives = 139/306 (45%), Gaps = 42/306 (13%)
Query: 528 KFSENNL-----IGRGGFGSVYKAR---IRD--GMEVAVKVFNLQCGRAFKSFDVECAMM 577
           +F E +L     +G+G FGSV   R   ++D  G  VAVK          + F+ E  ++
Sbjct: 12  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 71
Query: 578 KSIRHRNLVKVISSCSNEEFK--ALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVAS 635
           KS++H N+VK    C +   +   L++EY+P+GSL  YL      +D  + L     +  
Sbjct: 72  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 131
Query: 636 ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT-LATIG 694
            +EYL    +   IH DL   N+L+++     + DFG+ K+L  + +     +   + I 
Sbjct: 132 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 188
Query: 695 YMAPEYGREGQVSTNGDVYSFGIMLMETFT----RKKPTDELF-------NGEMTLKHWV 743
           + APE   E + S   DV+SFG++L E FT     K P  E          G+M + H +
Sbjct: 189 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 248
Query: 744 NDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLL 803
                           L + +      + C   ++ +  EC   +  QR + +++  ++ 
Sbjct: 249 E---------------LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 293
Query: 804 KIRDSL 809
           +IRD++
Sbjct: 294 QIRDNM 299

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 99.0 bits (245), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 80/306 (26%), Positives = 139/306 (45%), Gaps = 42/306 (13%)
Query: 528 KFSENNL-----IGRGGFGSVYKAR---IRD--GMEVAVKVFNLQCGRAFKSFDVECAMM 577
           +F E +L     +G+G FGSV   R   ++D  G  VAVK          + F+ E  ++
Sbjct: 13  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 72
Query: 578 KSIRHRNLVKVISSCSNEEFK--ALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVAS 635
           KS++H N+VK    C +   +   L++EY+P+GSL  YL      +D  + L     +  
Sbjct: 73  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 132
Query: 636 ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM-TQTQTLATIG 694
            +EYL    +   IH DL   N+L+++     + DFG+ K+L  + +    +    + I 
Sbjct: 133 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 189
Query: 695 YMAPEYGREGQVSTNGDVYSFGIMLMETFT----RKKPTDELF-------NGEMTLKHWV 743
           + APE   E + S   DV+SFG++L E FT     K P  E          G+M + H +
Sbjct: 190 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 249
Query: 744 NDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLL 803
                           L + +      + C   ++ +  EC   +  QR + +++  ++ 
Sbjct: 250 E---------------LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 294
Query: 804 KIRDSL 809
           +IRD++
Sbjct: 295 QIRDNM 300

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 99.0 bits (245), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 80/306 (26%), Positives = 140/306 (45%), Gaps = 42/306 (13%)
Query: 528 KFSENNL-----IGRGGFGSVYKAR---IRD--GMEVAVKVFNLQCGRAFKSFDVECAMM 577
           +F E +L     +G+G FGSV   R   ++D  G  VAVK          + F+ E  ++
Sbjct: 9   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 68
Query: 578 KSIRHRNLVKVISSCSNEEFK--ALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVAS 635
           KS++H N+VK    C +   +   L++EY+P+GSL  YL +    +D  + L     +  
Sbjct: 69  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICK 128
Query: 636 ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT-LATIG 694
            +EYL    +   IH DL   N+L+++     + DFG+ K+L  + +     +   + I 
Sbjct: 129 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 185
Query: 695 YMAPEYGREGQVSTNGDVYSFGIMLMETFT----RKKPTDELF-------NGEMTLKHWV 743
           + APE   E + S   DV+SFG++L E FT     K P  E          G+M + H +
Sbjct: 186 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 245
Query: 744 NDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLL 803
                           L + +      + C   ++ +  EC   +  QR + +++  ++ 
Sbjct: 246 E---------------LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 290
Query: 804 KIRDSL 809
           +IRD++
Sbjct: 291 QIRDNM 296

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 106/210 (50%), Gaps = 11/210 (5%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNL--QCGRAFKSFDVECAMMKSIRHRNLVKVISSC 592
           IG G FG+VYK +     +VAVK+  +       F++F  E A+++  RH N++  +   
Sbjct: 44  IGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYM 101
Query: 593 SNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
           + +   A+V ++    SL K+LH       +FQ ++I    A  ++YLH   +  +IH D
Sbjct: 102 TKDNL-AIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRD 157
Query: 653 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR---EGQVSTN 709
           +K +N+ L + +   + DFG+A + +    S    Q   ++ +MAPE  R       S  
Sbjct: 158 MKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQ 217
Query: 710 GDVYSFGIMLMETFTRKKPTDELFNGEMTL 739
            DVYS+GI+L E  T + P   + N +  +
Sbjct: 218 SDVYSYGIVLYELMTGELPYSHINNRDQII 247

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 79/306 (25%), Positives = 140/306 (45%), Gaps = 42/306 (13%)
Query: 528 KFSENNL-----IGRGGFGSVYKAR---IRD--GMEVAVKVFNLQCGRAFKSFDVECAMM 577
           +F E +L     +G+G FGSV   R   ++D  G  VAVK          + F+ E  ++
Sbjct: 9   QFEERHLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 68
Query: 578 KSIRHRNLVKVISSCSNEEFK--ALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVAS 635
           KS++H N+VK    C +   +   L++E++P+GSL +YL      +D  + L     +  
Sbjct: 69  KSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICK 128
Query: 636 ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT-LATIG 694
            +EYL    +   IH DL   N+L+++     + DFG+ K+L  + +     +   + I 
Sbjct: 129 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 185
Query: 695 YMAPEYGREGQVSTNGDVYSFGIMLMETFT----RKKPTDELF-------NGEMTLKHWV 743
           + APE   E + S   DV+SFG++L E FT     K P  E          G+M + H +
Sbjct: 186 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 245
Query: 744 NDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLL 803
                           L + +      + C   ++ +  EC   +  QR + +++  ++ 
Sbjct: 246 E---------------LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 290
Query: 804 KIRDSL 809
           +IRD++
Sbjct: 291 QIRDNM 296

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 124/292 (42%), Gaps = 50/292 (17%)
Query: 535 IGRGGFGSVYKARI------RDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKV 588
           +G G FG V+ A        +D M VAVK        A + F  E  ++  ++H+++V+ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 589 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYS--------------LDIFQRLNIMIDVA 634
              C+      +V EYM HG L ++L S                  L + Q L +   VA
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 635 SALEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA 691
           + + YL   HF      +H DL   N L+   +V  + DFG+++ +   D      +T+ 
Sbjct: 169 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222
Query: 692 TIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTR-KKPTDELFNGEMTLKHWVNDCLPIS 750
            I +M PE     + +T  DV+SFG++L E FT  K+P  +L N E        DC+   
Sbjct: 223 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI------DCI--- 273
Query: 751 TMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL 802
                       +         C   V+ +   C    P+QR + K++ A+L
Sbjct: 274 -----------TQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARL 314

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 82/281 (29%), Positives = 123/281 (43%), Gaps = 38/281 (13%)
Query: 535 IGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKS-FDVECAMMKSIRHRNLVKVISSC 592
           IGRG FG V+  R+R D   VAVK          K+ F  E  ++K   H N+V++I  C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 593 SNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
           + ++   +V+E +  G    +L +    L +   L ++ D A+ +EYL    S   IH D
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRD 238
Query: 653 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDV 712
           L   N L+ +  V  +SDFG+++       + +       + + APE    G+ S+  DV
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRYSSESDV 298
Query: 713 YSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAK-- 770
           +SFGI+L ETF+                      L  S       NL +Q+   FV K  
Sbjct: 299 WSFGILLWETFS----------------------LGASPY----PNLSNQQTREFVEKGG 332
Query: 771 -----EQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIR 806
                E C   VF L  +C    P QR +   I  +L  IR
Sbjct: 333 RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 142/291 (48%), Gaps = 36/291 (12%)
Query: 532 NNLIGRGGFGSVYKARIR--DGMEVAVKVFNLQCG---RAFKSFDVECAMMKSIRHRNLV 586
           + ++G G FG V   R++     E++V +  L+ G   +  + F  E ++M    H N++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 587 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL-HFGYS 645
           ++    +  +   +V EYM +GSL+ +L   +    + Q + ++  +AS ++YL   GY 
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY- 168
Query: 646 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQ-TLATIGYMAPEYGREG 704
              +H DL   N+L++ N+V  +SDFG+A++L  + ++   T+     I + +PE     
Sbjct: 169 ---VHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 705 QVSTNGDVYSFGIMLMETFTR-KKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQE 763
           + ++  DV+S+GI+L E  +  ++P  E+ N ++              ++ VD      E
Sbjct: 226 KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV--------------IKAVD------E 265
Query: 764 DIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLRNVG 814
                    C + ++ L L+C  +    R   ++IV+    I D L+RN G
Sbjct: 266 GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS----ILDKLIRNPG 312

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 121/283 (42%), Gaps = 42/283 (14%)
Query: 535 IGRGGFGSVYKARI------RDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKV 588
           +G G FG V+ A        +D + VAVK        A K F  E  ++ +++H ++VK 
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 589 ISSCSNEEFKALVLEYMPHGSLEKYLHSSN------------YSLDIFQRLNIMIDVASA 636
              C   +   +V EYM HG L K+L +                L   Q L+I   +A+ 
Sbjct: 81  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAG 140
Query: 637 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYM 696
           + YL    S   +H DL   N L+ +N++  + DFG+++ +   D       T+  I +M
Sbjct: 141 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 197
Query: 697 APEYGREGQVSTNGDVYSFGIMLMETFTR-KKPTDELFNGEMTLKHWVNDCLPISTMEVV 755
            PE     + +T  DV+S G++L E FT  K+P  +L N E      V +C       + 
Sbjct: 198 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE------VIEC-------IT 244
Query: 756 DANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEI 798
              +L +          C   V+ L L C    P  R N K I
Sbjct: 245 QGRVLQR-------PRTCPQEVYELMLGCWQREPHMRKNIKGI 280

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 82/281 (29%), Positives = 123/281 (43%), Gaps = 38/281 (13%)
Query: 535 IGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKS-FDVECAMMKSIRHRNLVKVISSC 592
           IGRG FG V+  R+R D   VAVK          K+ F  E  ++K   H N+V++I  C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 593 SNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
           + ++   +V+E +  G    +L +    L +   L ++ D A+ +EYL    S   IH D
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRD 238
Query: 653 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDV 712
           L   N L+ +  V  +SDFG+++       + +       + + APE    G+ S+  DV
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDV 298
Query: 713 YSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAK-- 770
           +SFGI+L ETF+                      L  S       NL +Q+   FV K  
Sbjct: 299 WSFGILLWETFS----------------------LGASPY----PNLSNQQTREFVEKGG 332
Query: 771 -----EQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIR 806
                E C   VF L  +C    P QR +   I  +L  IR
Sbjct: 333 RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Composition-based stats.
 Identities = 71/194 (36%), Positives = 102/194 (52%), Gaps = 17/194 (8%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSN 594
           IG+G FG V     R G +VAVK   ++     ++F  E ++M  +RH NLV+++     
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 595 EEFKA-LVLEYMPHGSLEKYLHSSNYSL---DIFQRLNIMIDVASALEYLHFGYSAPVIH 650
           E+    +V EYM  GSL  YL S   S+   D    L   +DV  A+EYL        +H
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL--LKFSLDVCEAMEYLE---GNNFVH 125
Query: 651 CDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNG 710
            DL   NVL+ ++ VA +SDFG+ K     + S TQ      + + APE  RE + ST  
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKS 180
Query: 711 DVYSFGIMLMETFT 724
           DV+SFGI+L E ++
Sbjct: 181 DVWSFGILLWEIYS 194

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 124/292 (42%), Gaps = 50/292 (17%)
Query: 535 IGRGGFGSVYKARI------RDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKV 588
           +G G FG V+ A        +D M VAVK        A + F  E  ++  ++H+++V+ 
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 589 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYS--------------LDIFQRLNIMIDVA 634
              C+      +V EYM HG L ++L S                  L + Q L +   VA
Sbjct: 80  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 139
Query: 635 SALEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA 691
           + + YL   HF      +H DL   N L+   +V  + DFG+++ +   D      +T+ 
Sbjct: 140 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 193
Query: 692 TIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTR-KKPTDELFNGEMTLKHWVNDCLPIS 750
            I +M PE     + +T  DV+SFG++L E FT  K+P  +L N E        DC+   
Sbjct: 194 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI------DCI--- 244
Query: 751 TMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL 802
                       +         C   V+ +   C    P+QR + K++ A+L
Sbjct: 245 -----------TQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARL 285

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 124/292 (42%), Gaps = 50/292 (17%)
Query: 535 IGRGGFGSVYKARI------RDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKV 588
           +G G FG V+ A        +D M VAVK        A + F  E  ++  ++H+++V+ 
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 589 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYS--------------LDIFQRLNIMIDVA 634
              C+      +V EYM HG L ++L S                  L + Q L +   VA
Sbjct: 86  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 145
Query: 635 SALEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA 691
           + + YL   HF      +H DL   N L+   +V  + DFG+++ +   D      +T+ 
Sbjct: 146 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 199
Query: 692 TIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTR-KKPTDELFNGEMTLKHWVNDCLPIS 750
            I +M PE     + +T  DV+SFG++L E FT  K+P  +L N E        DC+   
Sbjct: 200 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI------DCI--- 250
Query: 751 TMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL 802
                       +         C   V+ +   C    P+QR + K++ A+L
Sbjct: 251 -----------TQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARL 291

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 71/194 (36%), Positives = 101/194 (52%), Gaps = 17/194 (8%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSN 594
           IG+G FG V     R G +VAVK   ++     ++F  E ++M  +RH NLV+++     
Sbjct: 20  IGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 76
Query: 595 EEFK-ALVLEYMPHGSLEKYLHSSNYSL---DIFQRLNIMIDVASALEYLHFGYSAPVIH 650
           E+    +V EYM  GSL  YL S   S+   D    L   +DV  A+EYL        +H
Sbjct: 77  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL--LKFSLDVCEAMEYLE---GNNFVH 131
Query: 651 CDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNG 710
            DL   NVL+ ++ VA +SDFG+ K     + S TQ      + + APE  RE   ST  
Sbjct: 132 RDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREAAFSTKS 186
Query: 711 DVYSFGIMLMETFT 724
           DV+SFGI+L E ++
Sbjct: 187 DVWSFGILLWEIYS 200

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 71/194 (36%), Positives = 102/194 (52%), Gaps = 17/194 (8%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSN 594
           IG+G FG V     R G +VAVK   ++     ++F  E ++M  +RH NLV+++     
Sbjct: 29  IGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 595 EEFK-ALVLEYMPHGSLEKYLHSSNYSL---DIFQRLNIMIDVASALEYLHFGYSAPVIH 650
           E+    +V EYM  GSL  YL S   S+   D    L   +DV  A+EYL        +H
Sbjct: 86  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL--LKFSLDVCEAMEYLE---GNNFVH 140
Query: 651 CDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNG 710
            DL   NVL+ ++ VA +SDFG+ K     + S TQ      + + APE  RE + ST  
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKS 195
Query: 711 DVYSFGIMLMETFT 724
           DV+SFGI+L E ++
Sbjct: 196 DVWSFGILLWEIYS 209

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 80/307 (26%), Positives = 141/307 (45%), Gaps = 44/307 (14%)
Query: 528 KFSENNL-----IGRGGFGSVYKAR---IRD--GMEVAVKVFNLQCGRAFKSFDVECAMM 577
           +F E +L     +G+G FGSV   R   ++D  G  VAVK          + F+ E  ++
Sbjct: 7   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 66
Query: 578 KSIRHRNLVKVISSCSNEEFK--ALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVAS 635
           KS++H N+VK    C +   +   L++EY+P+GSL  YL      +D  + L     +  
Sbjct: 67  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 126
Query: 636 ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT--LATI 693
            +EYL    +   IH +L   N+L+++     + DFG+ K+L  +D+   + +    + I
Sbjct: 127 GMEYLG---TKRYIHRNLATRNILVENENRVKIGDFGLTKVLP-QDKEYYKVKEPGESPI 182
Query: 694 GYMAPEYGREGQVSTNGDVYSFGIMLMETFT----RKKPTDELF-------NGEMTLKHW 742
            + APE   E + S   DV+SFG++L E FT     K P  E          G+M + H 
Sbjct: 183 FWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 242
Query: 743 VNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL 802
           +                L + +      + C   ++ +  EC   +  QR + +++  ++
Sbjct: 243 IE---------------LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 287
Query: 803 LKIRDSL 809
            +IRD++
Sbjct: 288 DQIRDNM 294

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 123/283 (43%), Gaps = 32/283 (11%)
Query: 532 NNLIGRGGFGSVYKARIRDG----MEVAVKVFN--LQCGRAFKSFDVECAMMKSIRHRNL 585
           N +IGRG FG VY   + D     +  AVK  N     G     F  E  +MK   H N+
Sbjct: 34  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 92
Query: 586 VKVISSCSNEEFKALV-LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGY 644
           + ++  C   E   LV L YM HG L  ++ +  ++  +   +   + VA  ++YL    
Sbjct: 93  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 149
Query: 645 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLAT--IGYMAPEYGR 702
           S   +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA E  +
Sbjct: 150 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQ 209
Query: 703 EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ 762
             + +T  DV+SFG++L E  TR  P                   P   +   D  +   
Sbjct: 210 TQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYLL 250
Query: 763 EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKI 805
           +    +  E C   ++ + L+C     E R +  E+V+++  I
Sbjct: 251 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 293

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 78/318 (24%), Positives = 152/318 (47%), Gaps = 37/318 (11%)
Query: 505 DPNMPPVATWRRFSYLELFQATDKFSENNLIGRGGFGSVYKARIR--DGMEVAVKVFNLQ 562
           DP+     T     + +   AT+  S + ++G G FG V   R++     E++V +  L+
Sbjct: 24  DPHTYEDPTQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK 82
Query: 563 CG---RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNY 619
            G   +  + F  E ++M    H N++++    +  +   +V EYM +GSL+ +L   + 
Sbjct: 83  VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA 142
Query: 620 SLDIFQRLNIMIDVASALEYL-HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 678
              + Q + ++  +AS ++YL   GY    +H DL   N+L++ N+V  +SDFG++++L 
Sbjct: 143 QFTVIQLVGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLE 198
Query: 679 GEDQSMTQTQ-TLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTR-KKPTDELFNGE 736
            + ++   T+     I + +PE     + ++  DV+S+GI+L E  +  ++P  E+ N +
Sbjct: 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD 258
Query: 737 MTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAK 796
           +              ++ VD      E         C + ++ L L+C  +    R   +
Sbjct: 259 V--------------IKAVD------EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFE 298
Query: 797 EIVAKLLKIRDSLLRNVG 814
           +IV+    I D L+RN G
Sbjct: 299 QIVS----ILDKLIRNPG 312

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 78/318 (24%), Positives = 152/318 (47%), Gaps = 37/318 (11%)
Query: 505 DPNMPPVATWRRFSYLELFQATDKFSENNLIGRGGFGSVYKARIR--DGMEVAVKVFNLQ 562
           DP+     T     + +   AT+  S + ++G G FG V   R++     E++V +  L+
Sbjct: 24  DPHTYEDPTQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK 82
Query: 563 CG---RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNY 619
            G   +  + F  E ++M    H N++++    +  +   +V EYM +GSL+ +L   + 
Sbjct: 83  VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA 142
Query: 620 SLDIFQRLNIMIDVASALEYL-HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 678
              + Q + ++  +AS ++YL   GY    +H DL   N+L++ N+V  +SDFG++++L 
Sbjct: 143 QFTVIQLVGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLE 198
Query: 679 GEDQSMTQTQ-TLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTR-KKPTDELFNGE 736
            + ++   T+     I + +PE     + ++  DV+S+GI+L E  +  ++P  E+ N +
Sbjct: 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD 258
Query: 737 MTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAK 796
           +              ++ VD      E         C + ++ L L+C  +    R   +
Sbjct: 259 V--------------IKAVD------EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFE 298
Query: 797 EIVAKLLKIRDSLLRNVG 814
           +IV+    I D L+RN G
Sbjct: 299 QIVS----ILDKLIRNPG 312

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 78/318 (24%), Positives = 152/318 (47%), Gaps = 37/318 (11%)
Query: 505 DPNMPPVATWRRFSYLELFQATDKFSENNLIGRGGFGSVYKARIR--DGMEVAVKVFNLQ 562
           DP+     T     + +   AT+  S + ++G G FG V   R++     E++V +  L+
Sbjct: 22  DPHTYEDPTQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK 80
Query: 563 CG---RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNY 619
            G   +  + F  E ++M    H N++++    +  +   +V EYM +GSL+ +L   + 
Sbjct: 81  VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA 140
Query: 620 SLDIFQRLNIMIDVASALEYL-HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 678
              + Q + ++  +AS ++YL   GY    +H DL   N+L++ N+V  +SDFG++++L 
Sbjct: 141 QFTVIQLVGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLE 196
Query: 679 GEDQSMTQTQ-TLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTR-KKPTDELFNGE 736
            + ++   T+     I + +PE     + ++  DV+S+GI+L E  +  ++P  E+ N +
Sbjct: 197 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD 256
Query: 737 MTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAK 796
           +              ++ VD      E         C + ++ L L+C  +    R   +
Sbjct: 257 V--------------IKAVD------EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFE 296
Query: 797 EIVAKLLKIRDSLLRNVG 814
           +IV+    I D L+RN G
Sbjct: 297 QIVS----ILDKLIRNPG 310

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 71/194 (36%), Positives = 102/194 (52%), Gaps = 17/194 (8%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSN 594
           IG+G FG V     R G +VAVK   ++     ++F  E ++M  +RH NLV+++     
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 595 EEFK-ALVLEYMPHGSLEKYLHSSNYSL---DIFQRLNIMIDVASALEYLHFGYSAPVIH 650
           E+    +V EYM  GSL  YL S   S+   D    L   +DV  A+EYL        +H
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL--LKFSLDVCEAMEYLE---GNNFVH 312
Query: 651 CDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNG 710
            DL   NVL+ ++ VA +SDFG+ K     + S TQ      + + APE  RE + ST  
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKS 367
Query: 711 DVYSFGIMLMETFT 724
           DV+SFGI+L E ++
Sbjct: 368 DVWSFGILLWEIYS 381

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 73/294 (24%), Positives = 143/294 (48%), Gaps = 36/294 (12%)
Query: 529 FSENNLIGRGGFGSVYKARIR--DGMEVAVKVFNLQCG---RAFKSFDVECAMMKSIRHR 583
            S + ++G G FG V   R++     E++V +  L+ G   +  + F  E ++M    H 
Sbjct: 35  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 94
Query: 584 NLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL-HF 642
           N++++    +  +   +V EYM +GSL+ +L   +    + Q + ++  +AS ++YL   
Sbjct: 95  NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 154
Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQ-TLATIGYMAPEYG 701
           GY    +H DL   N+L++ N+V  +SDFG++++L  + ++   T+     I + +PE  
Sbjct: 155 GY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 210
Query: 702 REGQVSTNGDVYSFGIMLMETFTR-KKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLL 760
              + ++  DV+S+GI+L E  +  ++P  E+ N ++              ++ VD    
Sbjct: 211 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV--------------IKAVD---- 252
Query: 761 SQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLRNVG 814
             E         C + ++ L L+C  +    R   ++IV+    I D L+RN G
Sbjct: 253 --EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS----ILDKLIRNPG 300

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 73/294 (24%), Positives = 143/294 (48%), Gaps = 36/294 (12%)
Query: 529 FSENNLIGRGGFGSVYKARIR--DGMEVAVKVFNLQCG---RAFKSFDVECAMMKSIRHR 583
            S + ++G G FG V   R++     E++V +  L+ G   +  + F  E ++M    H 
Sbjct: 47  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 584 NLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL-HF 642
           N++++    +  +   +V EYM +GSL+ +L   +    + Q + ++  +AS ++YL   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQ-TLATIGYMAPEYG 701
           GY    +H DL   N+L++ N+V  +SDFG++++L  + ++   T+     I + +PE  
Sbjct: 167 GY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 702 REGQVSTNGDVYSFGIMLMETFTR-KKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLL 760
              + ++  DV+S+GI+L E  +  ++P  E+ N ++              ++ VD    
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV--------------IKAVD---- 264
Query: 761 SQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLRNVG 814
             E         C + ++ L L+C  +    R   ++IV+    I D L+RN G
Sbjct: 265 --EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS----ILDKLIRNPG 312

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 72/291 (24%), Positives = 142/291 (48%), Gaps = 36/291 (12%)
Query: 532 NNLIGRGGFGSVYKARIR--DGMEVAVKVFNLQCG---RAFKSFDVECAMMKSIRHRNLV 586
           + ++G G FG V   R++     E++V +  L+ G   +  + F  E ++M    H N++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 587 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL-HFGYS 645
           ++    +  +   +V EYM +GSL+ +L   +    + Q + ++  +AS ++YL   GY 
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY- 168
Query: 646 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQ-TLATIGYMAPEYGREG 704
              +H DL   N+L++ N+V  +SDFG++++L  + ++   T+     I + +PE     
Sbjct: 169 ---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 705 QVSTNGDVYSFGIMLMETFTR-KKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQE 763
           + ++  DV+S+GI+L E  +  ++P  E+ N ++              ++ VD      E
Sbjct: 226 KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV--------------IKAVD------E 265
Query: 764 DIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLRNVG 814
                    C + ++ L L+C  +    R   ++IV+    I D L+RN G
Sbjct: 266 GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS----ILDKLIRNPG 312

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 96.3 bits (238), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 73/294 (24%), Positives = 143/294 (48%), Gaps = 36/294 (12%)
Query: 529 FSENNLIGRGGFGSVYKARIR--DGMEVAVKVFNLQCG---RAFKSFDVECAMMKSIRHR 583
            S + ++G G FG V   R++     E++V +  L+ G   +  + F  E ++M    H 
Sbjct: 18  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 77
Query: 584 NLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL-HF 642
           N++++    +  +   +V EYM +GSL+ +L   +    + Q + ++  +AS ++YL   
Sbjct: 78  NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 137
Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQ-TLATIGYMAPEYG 701
           GY    +H DL   N+L++ N+V  +SDFG++++L  + ++   T+     I + +PE  
Sbjct: 138 GY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 193
Query: 702 REGQVSTNGDVYSFGIMLMETFTR-KKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLL 760
              + ++  DV+S+GI+L E  +  ++P  E+ N ++              ++ VD    
Sbjct: 194 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV--------------IKAVD---- 235
Query: 761 SQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLRNVG 814
             E         C + ++ L L+C  +    R   ++IV+    I D L+RN G
Sbjct: 236 --EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS----ILDKLIRNPG 283

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 96.3 bits (238), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 123/283 (43%), Gaps = 32/283 (11%)
Query: 532 NNLIGRGGFGSVYKARIRDG----MEVAVKVFN--LQCGRAFKSFDVECAMMKSIRHRNL 585
           N +IGRG FG VY   + D     +  AVK  N     G     F  E  +MK   H N+
Sbjct: 53  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 111
Query: 586 VKVISSCSNEEFKALV-LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGY 644
           + ++  C   E   LV L YM HG L  ++ +  ++  +   +   + VA  ++YL    
Sbjct: 112 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 168
Query: 645 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLAT--IGYMAPEYGR 702
           S   +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA E  +
Sbjct: 169 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 228
Query: 703 EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ 762
             + +T  DV+SFG++L E  TR  P                   P   +   D  +   
Sbjct: 229 TQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYLL 269
Query: 763 EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKI 805
           +    +  E C   ++ + L+C     E R +  E+V+++  I
Sbjct: 270 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 312

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 96.3 bits (238), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 123/283 (43%), Gaps = 32/283 (11%)
Query: 532 NNLIGRGGFGSVYKARIRDG----MEVAVKVFN--LQCGRAFKSFDVECAMMKSIRHRNL 585
           N +IGRG FG VY   + D     +  AVK  N     G     F  E  +MK   H N+
Sbjct: 54  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 112
Query: 586 VKVISSCSNEEFKALV-LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGY 644
           + ++  C   E   LV L YM HG L  ++ +  ++  +   +   + VA  ++YL    
Sbjct: 113 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 169
Query: 645 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLAT--IGYMAPEYGR 702
           S   +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA E  +
Sbjct: 170 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 229
Query: 703 EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ 762
             + +T  DV+SFG++L E  TR  P                   P   +   D  +   
Sbjct: 230 TQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYLL 270
Query: 763 EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKI 805
           +    +  E C   ++ + L+C     E R +  E+V+++  I
Sbjct: 271 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 313

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 96.3 bits (238), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 72/291 (24%), Positives = 141/291 (48%), Gaps = 36/291 (12%)
Query: 532 NNLIGRGGFGSVYKARIR--DGMEVAVKVFNLQCG---RAFKSFDVECAMMKSIRHRNLV 586
           + ++G G FG V   R++     E++V +  L+ G   +  + F  E ++M    H N++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 587 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL-HFGYS 645
           ++    +  +   +V EYM +GSL+ +L   +    + Q + ++  +AS ++YL   GY 
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY- 168
Query: 646 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQ-TLATIGYMAPEYGREG 704
              +H DL   N+L++ N+V  +SDFG+ ++L  + ++   T+     I + +PE     
Sbjct: 169 ---VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 705 QVSTNGDVYSFGIMLMETFTR-KKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQE 763
           + ++  DV+S+GI+L E  +  ++P  E+ N ++              ++ VD      E
Sbjct: 226 KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV--------------IKAVD------E 265
Query: 764 DIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLRNVG 814
                    C + ++ L L+C  +    R   ++IV+    I D L+RN G
Sbjct: 266 GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS----ILDKLIRNPG 312

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 96.3 bits (238), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 123/283 (43%), Gaps = 32/283 (11%)
Query: 532 NNLIGRGGFGSVYKARIRDG----MEVAVKVFN--LQCGRAFKSFDVECAMMKSIRHRNL 585
           N +IGRG FG VY   + D     +  AVK  N     G     F  E  +MK   H N+
Sbjct: 27  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 85
Query: 586 VKVISSCSNEEFKALV-LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGY 644
           + ++  C   E   LV L YM HG L  ++ +  ++  +   +   + VA  ++YL    
Sbjct: 86  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 142
Query: 645 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLAT--IGYMAPEYGR 702
           S   +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA E  +
Sbjct: 143 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 202
Query: 703 EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ 762
             + +T  DV+SFG++L E  TR  P                   P   +   D  +   
Sbjct: 203 TQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYLL 243
Query: 763 EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKI 805
           +    +  E C   ++ + L+C     E R +  E+V+++  I
Sbjct: 244 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 286

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 123/283 (43%), Gaps = 32/283 (11%)
Query: 532 NNLIGRGGFGSVYKARIRDG----MEVAVKVFN--LQCGRAFKSFDVECAMMKSIRHRNL 585
           N +IGRG FG VY   + D     +  AVK  N     G     F  E  +MK   H N+
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 88
Query: 586 VKVISSCSNEEFKALV-LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGY 644
           + ++  C   E   LV L YM HG L  ++ +  ++  +   +   + VA  ++YL    
Sbjct: 89  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 145
Query: 645 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLAT--IGYMAPEYGR 702
           S   +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA E  +
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 205
Query: 703 EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ 762
             + +T  DV+SFG++L E  TR  P                   P   +   D  +   
Sbjct: 206 TQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYLL 246
Query: 763 EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKI 805
           +    +  E C   ++ + L+C     E R +  E+V+++  I
Sbjct: 247 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 289

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 95.9 bits (237), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 123/283 (43%), Gaps = 32/283 (11%)
Query: 532 NNLIGRGGFGSVYKARIRDG----MEVAVKVFN--LQCGRAFKSFDVECAMMKSIRHRNL 585
           N +IGRG FG VY   + D     +  AVK  N     G     F  E  +MK   H N+
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 90
Query: 586 VKVISSCSNEEFKALV-LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGY 644
           + ++  C   E   LV L YM HG L  ++ +  ++  +   +   + VA  ++YL    
Sbjct: 91  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 147
Query: 645 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLAT--IGYMAPEYGR 702
           S   +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA E  +
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 207
Query: 703 EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ 762
             + +T  DV+SFG++L E  TR  P                   P   +   D  +   
Sbjct: 208 TQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYLL 248
Query: 763 EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKI 805
           +    +  E C   ++ + L+C     E R +  E+V+++  I
Sbjct: 249 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 95.9 bits (237), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 123/283 (43%), Gaps = 32/283 (11%)
Query: 532 NNLIGRGGFGSVYKARIRDG----MEVAVKVFN--LQCGRAFKSFDVECAMMKSIRHRNL 585
           N +IGRG FG VY   + D     +  AVK  N     G     F  E  +MK   H N+
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 93
Query: 586 VKVISSCSNEEFKALV-LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGY 644
           + ++  C   E   LV L YM HG L  ++ +  ++  +   +   + VA  ++YL    
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 150
Query: 645 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLAT--IGYMAPEYGR 702
           S   +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA E  +
Sbjct: 151 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 210
Query: 703 EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ 762
             + +T  DV+SFG++L E  TR  P                   P   +   D  +   
Sbjct: 211 TQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYLL 251
Query: 763 EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKI 805
           +    +  E C   ++ + L+C     E R +  E+V+++  I
Sbjct: 252 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 95.9 bits (237), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 123/283 (43%), Gaps = 32/283 (11%)
Query: 532 NNLIGRGGFGSVYKARIRDG----MEVAVKVFN--LQCGRAFKSFDVECAMMKSIRHRNL 585
           N +IGRG FG VY   + D     +  AVK  N     G     F  E  +MK   H N+
Sbjct: 34  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 92
Query: 586 VKVISSCSNEEFKALV-LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGY 644
           + ++  C   E   LV L YM HG L  ++ +  ++  +   +   + VA  ++YL    
Sbjct: 93  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 149
Query: 645 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLAT--IGYMAPEYGR 702
           S   +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA E  +
Sbjct: 150 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 209
Query: 703 EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ 762
             + +T  DV+SFG++L E  TR  P                   P   +   D  +   
Sbjct: 210 TQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYLL 250
Query: 763 EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKI 805
           +    +  E C   ++ + L+C     E R +  E+V+++  I
Sbjct: 251 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 293

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 95.9 bits (237), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 123/283 (43%), Gaps = 32/283 (11%)
Query: 532 NNLIGRGGFGSVYKARIRDG----MEVAVKVFN--LQCGRAFKSFDVECAMMKSIRHRNL 585
           N +IGRG FG VY   + D     +  AVK  N     G     F  E  +MK   H N+
Sbjct: 33  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 91
Query: 586 VKVISSCSNEEFKALV-LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGY 644
           + ++  C   E   LV L YM HG L  ++ +  ++  +   +   + VA  ++YL    
Sbjct: 92  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 148
Query: 645 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLAT--IGYMAPEYGR 702
           S   +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA E  +
Sbjct: 149 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 208
Query: 703 EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ 762
             + +T  DV+SFG++L E  TR  P                   P   +   D  +   
Sbjct: 209 TQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYLL 249
Query: 763 EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKI 805
           +    +  E C   ++ + L+C     E R +  E+V+++  I
Sbjct: 250 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 292

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 95.9 bits (237), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 123/283 (43%), Gaps = 32/283 (11%)
Query: 532 NNLIGRGGFGSVYKARIRDG----MEVAVKVFN--LQCGRAFKSFDVECAMMKSIRHRNL 585
           N +IGRG FG VY   + D     +  AVK  N     G     F  E  +MK   H N+
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 93
Query: 586 VKVISSCSNEEFKALV-LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGY 644
           + ++  C   E   LV L YM HG L  ++ +  ++  +   +   + VA  ++YL    
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 150
Query: 645 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLAT--IGYMAPEYGR 702
           S   +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA E  +
Sbjct: 151 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 210
Query: 703 EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ 762
             + +T  DV+SFG++L E  TR  P                   P   +   D  +   
Sbjct: 211 TQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYLL 251
Query: 763 EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKI 805
           +    +  E C   ++ + L+C     E R +  E+V+++  I
Sbjct: 252 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 95.9 bits (237), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 97/209 (46%), Gaps = 19/209 (9%)
Query: 532 NNLIGRGGFGSVYKARIRDGMEVAVKVF----NLQCGRAFKSFDVECAMMKSIRHRNLVK 587
             +IG GGFG VY+A    G EVAVK      +    +  ++   E  +   ++H N++ 
Sbjct: 12  EEIIGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAP 647
           +   C  E    LV+E+   G L + L       DI   +N  + +A  + YLH     P
Sbjct: 71  LRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDIL--VNWAVQIARGMNYLHDEAIVP 128
Query: 648 VIHCDLKPSNVLLDD--------NMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPE 699
           +IH DLK SN+L+          N +  ++DFG+A+    E    T+        +MAPE
Sbjct: 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR----EWHRTTKMSAAGAYAWMAPE 184
Query: 700 YGREGQVSTNGDVYSFGIMLMETFTRKKP 728
             R    S   DV+S+G++L E  T + P
Sbjct: 185 VIRASMFSKGSDVWSYGVLLWELLTGEVP 213

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 134/289 (46%), Gaps = 36/289 (12%)
Query: 532 NNLIGRGGFGSVYKARIR--DGMEVAVKVFNLQCG---RAFKSFDVECAMMKSIRHRNLV 586
             +IG G  G V   R+R     +V V +  L+ G   R  + F  E ++M    H N++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 587 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL-HFGYS 645
           ++    +      +V EYM +GSL+ +L + +    I Q + ++  V + + YL   GY 
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY- 172
Query: 646 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE-DQSMTQTQTLATIGYMAPEYGREG 704
              +H DL   NVL+D N+V  +SDFG++++L  + D + T T     I + APE     
Sbjct: 173 ---VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFR 229
Query: 705 QVSTNGDVYSFGIMLMETFTR-KKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQE 763
             S+  DV+SFG+++ E     ++P   + N ++           IS++E         E
Sbjct: 230 TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV-----------ISSVE---------E 269
Query: 764 DIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLRN 812
                A   C   +  L L+C  +   QR    +IV+ L    D+L+R+
Sbjct: 270 GYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVL----DALIRS 314

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 134/289 (46%), Gaps = 36/289 (12%)
Query: 532 NNLIGRGGFGSVYKARIR--DGMEVAVKVFNLQCG---RAFKSFDVECAMMKSIRHRNLV 586
             +IG G  G V   R+R     +V V +  L+ G   R  + F  E ++M    H N++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 587 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL-HFGYS 645
           ++    +      +V EYM +GSL+ +L + +    I Q + ++  V + + YL   GY 
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY- 172
Query: 646 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE-DQSMTQTQTLATIGYMAPEYGREG 704
              +H DL   NVL+D N+V  +SDFG++++L  + D + T T     I + APE     
Sbjct: 173 ---VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFR 229
Query: 705 QVSTNGDVYSFGIMLMETFTR-KKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQE 763
             S+  DV+SFG+++ E     ++P   + N ++           IS++E         E
Sbjct: 230 TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV-----------ISSVE---------E 269
Query: 764 DIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLRN 812
                A   C   +  L L+C  +   QR    +IV+ L    D+L+R+
Sbjct: 270 GYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVL----DALIRS 314

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 105/211 (49%), Gaps = 14/211 (6%)
Query: 523 FQATDKF-------SENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDVEC 574
           FQ+ DK+       +  + +G G +G VY    +   + VAVK    +     + F  E 
Sbjct: 21  FQSMDKWEMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLK-EDTMEVEEFLKEA 79
Query: 575 AMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNY-SLDIFQRLNIMIDV 633
           A+MK I+H NLV+++  C+ E    +V EYMP+G+L  YL   N   +     L +   +
Sbjct: 80  AVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQI 139
Query: 634 ASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATI 693
           +SA+EYL        IH DL   N L+ +N V  ++DFG+++L+TG D           I
Sbjct: 140 SSAMEYLE---KKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTG-DTYTAHAGAKFPI 195
Query: 694 GYMAPEYGREGQVSTNGDVYSFGIMLMETFT 724
            + APE       S   DV++FG++L E  T
Sbjct: 196 KWTAPESLAYNTFSIKSDVWAFGVLLWEIAT 226

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/291 (24%), Positives = 142/291 (48%), Gaps = 36/291 (12%)
Query: 532 NNLIGRGGFGSVYKARIR--DGMEVAVKVFNLQCG---RAFKSFDVECAMMKSIRHRNLV 586
           + ++G G FG V   R++     E++V +  L+ G   +  + F  E ++M    H N++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 587 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL-HFGYS 645
           ++    +  +   +V EYM +GSL+ +L   +    + Q + ++  +AS ++YL   G+ 
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGF- 168
Query: 646 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQ-TLATIGYMAPEYGREG 704
              +H DL   N+L++ N+V  +SDFG++++L  + ++   T+     I + +PE     
Sbjct: 169 ---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 705 QVSTNGDVYSFGIMLMETFTR-KKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQE 763
           + ++  DV+S+GI+L E  +  ++P  E+ N ++              ++ VD      E
Sbjct: 226 KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV--------------IKAVD------E 265
Query: 764 DIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLRNVG 814
                    C + ++ L L+C  +    R   ++IV+    I D L+RN G
Sbjct: 266 GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS----ILDKLIRNPG 312

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/296 (26%), Positives = 130/296 (43%), Gaps = 34/296 (11%)
Query: 505 DPNMPPVATWRRFSYLELFQATDKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQC 563
           DP+ P    W         + TD  +  + +G G +G VY+   +   + VAVK    + 
Sbjct: 4   DPSSPNYDKWE-------MERTD-ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-ED 54
Query: 564 GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYS-LD 622
               + F  E A+MK I+H NLV+++  C+ E    +++E+M +G+L  YL   N   ++
Sbjct: 55  TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVN 114
Query: 623 IFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 682
               L +   ++SA+EYL        IH DL   N L+ +N +  ++DFG+++L+TG D 
Sbjct: 115 AVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DT 170
Query: 683 SMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHW 742
                     I + APE     + S   DV++FG++L E  T                  
Sbjct: 171 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS-------------- 216
Query: 743 VNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEI 798
                P   +++     L ++D      E C   V+ L   C   +P  R +  EI
Sbjct: 217 -----PYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 123/283 (43%), Gaps = 32/283 (11%)
Query: 532 NNLIGRGGFGSVYKARIRDG----MEVAVKVFN--LQCGRAFKSFDVECAMMKSIRHRNL 585
           N +IGRG FG VY   + D     +  AVK  N     G     F  E  +MK   H N+
Sbjct: 36  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 94
Query: 586 VKVISSCSNEEFKALV-LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGY 644
           + ++  C   E   LV L YM HG L  ++ +  ++  +   +   + VA  +++L    
Sbjct: 95  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---A 151
Query: 645 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLAT--IGYMAPEYGR 702
           S   +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA E  +
Sbjct: 152 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 211
Query: 703 EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ 762
             + +T  DV+SFG++L E  TR  P                   P   +   D  +   
Sbjct: 212 TQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYLL 252
Query: 763 EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKI 805
           +    +  E C   ++ + L+C     E R +  E+V+++  I
Sbjct: 253 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 295

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Composition-based stats.
 Identities = 66/207 (31%), Positives = 101/207 (48%), Gaps = 6/207 (2%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSN 594
           +G G FG V   + +   +VAVK+   +   +   F  E   M  + H  LVK    CS 
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 595 EEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLK 654
           E    +V EY+ +G L  YL S    L+  Q L +  DV   + +L    S   IH DL 
Sbjct: 75  EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLA 131
Query: 655 PSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYS 714
             N L+D ++   +SDFG+ + +  +DQ ++   T   + + APE     + S+  DV++
Sbjct: 132 ARNCLVDRDLCVKVSDFGMTRYVL-DDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWA 190
Query: 715 FGIMLMETFTR-KKPTDELFNGEMTLK 740
           FGI++ E F+  K P D   N E+ LK
Sbjct: 191 FGILMWEVFSLGKMPYDLYTNSEVVLK 217

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 123/283 (43%), Gaps = 32/283 (11%)
Query: 532 NNLIGRGGFGSVYKARIRDG----MEVAVKVFN--LQCGRAFKSFDVECAMMKSIRHRNL 585
           N +IGRG FG VY   + D     +  AVK  N     G     F  E  +MK   H N+
Sbjct: 36  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 94
Query: 586 VKVISSCSNEEFKALV-LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGY 644
           + ++  C   E   LV L YM HG L  ++ +  ++  +   +   + VA  +++L    
Sbjct: 95  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---A 151
Query: 645 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLAT--IGYMAPEYGR 702
           S   +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA E  +
Sbjct: 152 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQ 211
Query: 703 EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ 762
             + +T  DV+SFG++L E  TR  P                   P   +   D  +   
Sbjct: 212 TQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYLL 252
Query: 763 EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKI 805
           +    +  E C   ++ + L+C     E R +  E+V+++  I
Sbjct: 253 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 295

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 123/283 (43%), Gaps = 32/283 (11%)
Query: 532 NNLIGRGGFGSVYKARIRDG----MEVAVKVFN--LQCGRAFKSFDVECAMMKSIRHRNL 585
           N +IGRG FG VY   + D     +  AVK  N     G     F  E  +MK   H N+
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 93
Query: 586 VKVISSCSNEEFKALV-LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGY 644
           + ++  C   E   LV L YM HG L  ++ +  ++  +   +   + VA  +++L    
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---A 150
Query: 645 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLAT--IGYMAPEYGR 702
           S   +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA E  +
Sbjct: 151 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 210
Query: 703 EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ 762
             + +T  DV+SFG++L E  TR  P                   P   +   D  +   
Sbjct: 211 TQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYLL 251
Query: 763 EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKI 805
           +    +  E C   ++ + L+C     E R +  E+V+++  I
Sbjct: 252 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 123/283 (43%), Gaps = 32/283 (11%)
Query: 532 NNLIGRGGFGSVYKARIRDG----MEVAVKVFN--LQCGRAFKSFDVECAMMKSIRHRNL 585
           N +IGRG FG VY   + D     +  AVK  N     G     F  E  +MK   H N+
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 152
Query: 586 VKVISSCSNEEFKALV-LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGY 644
           + ++  C   E   LV L YM HG L  ++ +  ++  +   +   + VA  +++L    
Sbjct: 153 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---A 209
Query: 645 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLAT--IGYMAPEYGR 702
           S   +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA E  +
Sbjct: 210 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 269
Query: 703 EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ 762
             + +T  DV+SFG++L E  TR  P                   P   +   D  +   
Sbjct: 270 TQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYLL 310
Query: 763 EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKI 805
           +    +  E C   ++ + L+C     E R +  E+V+++  I
Sbjct: 311 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 353

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 123/283 (43%), Gaps = 32/283 (11%)
Query: 532 NNLIGRGGFGSVYKARIRDG----MEVAVKVFN--LQCGRAFKSFDVECAMMKSIRHRNL 585
           N +IGRG FG VY   + D     +  AVK  N     G     F  E  +MK   H N+
Sbjct: 40  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 98
Query: 586 VKVISSCSNEEFKALV-LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGY 644
           + ++  C   E   LV L YM HG L  ++ +  ++  +   +   + VA  +++L    
Sbjct: 99  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---A 155
Query: 645 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLAT--IGYMAPEYGR 702
           S   +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA E  +
Sbjct: 156 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 215
Query: 703 EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ 762
             + +T  DV+SFG++L E  TR  P                   P   +   D  +   
Sbjct: 216 TQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYLL 256
Query: 763 EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKI 805
           +    +  E C   ++ + L+C     E R +  E+V+++  I
Sbjct: 257 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 299

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 77/295 (26%), Positives = 134/295 (45%), Gaps = 41/295 (13%)
Query: 526 TDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRA---FKSFDVECAMMKSIR 581
           +D++    ++G GG   V+ AR +RD  +VAVKV      R    +  F  E     ++ 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 582 HRNLVKVISSCSNE----EFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASAL 637
           H  +V V  +   E        +V+EY+   +L   +H+      +  +  I + +A A 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEV-IADAC 126
Query: 638 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT-LATIGYM 696
           + L+F +   +IH D+KP+N+++       + DFGIA+ +     S+TQT   + T  Y+
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 697 APEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGE----MTLKHWVNDCLPISTM 752
           +PE  R   V    DVYS G +L E  T + P    F G+    +  +H   D +P S  
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVSVAYQHVREDPIPPS-- 240
Query: 753 EVVDANLLSQEDIHFVAKEQCVSFVFN-LALECTVESPEQRIN-AKEIVAKLLKI 805
                           A+ + +S   + + L+   ++PE R   A E+ A L+++
Sbjct: 241 ----------------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 94.4 bits (233), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 77/295 (26%), Positives = 134/295 (45%), Gaps = 41/295 (13%)
Query: 526 TDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRA---FKSFDVECAMMKSIR 581
           +D++    ++G GG   V+ AR +RD  +VAVKV      R    +  F  E     ++ 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 582 HRNLVKVISSCSNE----EFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASAL 637
           H  +V V  +   E        +V+EY+   +L   +H+      +  +  I + +A A 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEV-IADAC 126
Query: 638 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT-LATIGYM 696
           + L+F +   +IH D+KP+N+++       + DFGIA+ +     S+TQT   + T  Y+
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 697 APEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGE----MTLKHWVNDCLPISTM 752
           +PE  R   V    DVYS G +L E  T + P    F G+    +  +H   D +P S  
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPDSVAYQHVREDPIPPS-- 240
Query: 753 EVVDANLLSQEDIHFVAKEQCVSFVFN-LALECTVESPEQRIN-AKEIVAKLLKI 805
                           A+ + +S   + + L+   ++PE R   A E+ A L+++
Sbjct: 241 ----------------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 94.4 bits (233), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 123/283 (43%), Gaps = 32/283 (11%)
Query: 532 NNLIGRGGFGSVYKARIRDG----MEVAVKVFN--LQCGRAFKSFDVECAMMKSIRHRNL 585
           N +IGRG FG VY   + D     +  AVK  N     G     F  E  +MK   H N+
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 93
Query: 586 VKVISSCSNEEFKALV-LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGY 644
           + ++  C   E   LV L YM HG L  ++ +  ++  +   +   + VA  +++L    
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---A 150
Query: 645 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLAT--IGYMAPEYGR 702
           S   +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA E  +
Sbjct: 151 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 210
Query: 703 EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ 762
             + +T  DV+SFG++L E  TR  P                   P   +   D  +   
Sbjct: 211 TQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYLL 251
Query: 763 EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKI 805
           +    +  E C   ++ + L+C     E R +  E+V+++  I
Sbjct: 252 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 123/283 (43%), Gaps = 32/283 (11%)
Query: 532 NNLIGRGGFGSVYKARIRDG----MEVAVKVFN--LQCGRAFKSFDVECAMMKSIRHRNL 585
           N +IGRG FG VY   + D     +  AVK  N     G     F  E  +MK   H N+
Sbjct: 33  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 91
Query: 586 VKVISSCSNEEFKALV-LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGY 644
           + ++  C   E   LV L YM HG L  ++ +  ++  +   +   + VA  +++L    
Sbjct: 92  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---A 148
Query: 645 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLAT--IGYMAPEYGR 702
           S   +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA E  +
Sbjct: 149 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 208
Query: 703 EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ 762
             + +T  DV+SFG++L E  TR  P                   P   +   D  +   
Sbjct: 209 TQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYLL 249
Query: 763 EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKI 805
           +    +  E C   ++ + L+C     E R +  E+V+++  I
Sbjct: 250 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 292

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 136/286 (47%), Gaps = 30/286 (10%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCG--RAFKSFDVECAMMKSIRHRNLVKVISSC 592
           IG G FG+VYK +     +VAVK+ N+     +  ++F  E  +++  RH N++  +   
Sbjct: 20  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 77
Query: 593 SNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
           +  +  A+V ++    SL  +LH+S    ++ + ++I    A  ++YLH   +  +IH D
Sbjct: 78  TKPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRD 133
Query: 653 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR---EGQVSTN 709
           LK +N+ L ++    + DFG+A + +    S    Q   +I +MAPE  R       S  
Sbjct: 134 LKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 193
Query: 710 GDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVA 769
            DVY+FGI+L E  T + P   + N +  +             E+V    LS  D+  V 
Sbjct: 194 SDVYAFGIVLYELMTGQLPYSNINNRDQII-------------EMVGRGSLS-PDLSKV- 238
Query: 770 KEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLRNVGG 815
           +  C   +  L  EC  +  ++R +   I+A++    + L R + G
Sbjct: 239 RSNCPKRMKRLMAECLKKKRDERPSFPRILAEI----EELARELSG 280

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 78/296 (26%), Positives = 129/296 (43%), Gaps = 34/296 (11%)
Query: 505 DPNMPPVATWRRFSYLELFQATDKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQC 563
           DP+ P    W         + TD  +  + +G G +G VY+   +   + VAVK    + 
Sbjct: 4   DPSSPNYDKWE-------MERTD-ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-ED 54
Query: 564 GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSN-YSLD 622
               + F  E A+MK I+H NLV+++  C+ E    ++ E+M +G+L  YL   N   ++
Sbjct: 55  TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVN 114
Query: 623 IFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 682
               L +   ++SA+EYL        IH DL   N L+ +N +  ++DFG+++L+TG D 
Sbjct: 115 AVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DT 170
Query: 683 SMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHW 742
                     I + APE     + S   DV++FG++L E  T                  
Sbjct: 171 XTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS-------------- 216
Query: 743 VNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEI 798
                P   +++     L ++D      E C   V+ L   C   +P  R +  EI
Sbjct: 217 -----PYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 76/293 (25%), Positives = 131/293 (44%), Gaps = 40/293 (13%)
Query: 525 ATDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNL-------QCGRAFKSFDVECAM 576
           A ++      IG+GGFG V+K R ++D   VA+K   L       +    F+ F  E  +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 577 MKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASA 636
           M ++ H N+VK+     N     +V+E++P G L   L    + +    +L +M+D+A  
Sbjct: 77  MSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 637 LEYLHFGYSAPVIHCDLKPSNVL---LDDN--MVAHLSDFGIAKLLTGEDQSMTQTQTLA 691
           +EY+    + P++H DL+  N+    LD+N  + A ++DFG     T +    + +  L 
Sbjct: 135 IEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG-----TSQQSVHSVSGLLG 188
Query: 692 TIGYMAPEY--GREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPI 749
              +MAPE     E   +   D YSF ++L    T + P DE   G++            
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF---------- 238
Query: 750 STMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL 802
                   N++ +E +     E C   + N+   C    P++R +   IV +L
Sbjct: 239 -------INMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 75/261 (28%), Positives = 125/261 (47%), Gaps = 30/261 (11%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGR-AFKSFDVECAMMKSIRHRNLVKVISSCS 593
           +G+G FG V+         VA+K   L+ G  + ++F  E  +MK +RH  LV++ +  S
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 73
Query: 594 NEEFKALVLEYMPHGSLEKYLH-SSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
            E    +V EYM  GSL  +L   +   L + Q +++   +AS + Y+        +H D
Sbjct: 74  EEPI-XIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 129
Query: 653 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGQVSTNGD 711
           L+ +N+L+ +N+V  ++DFG+A+L+  ED   T  Q     I + APE    G+ +   D
Sbjct: 130 LRAANILVGENLVCKVADFGLARLI--EDNEXTARQGAKFPIKWTAPEAALYGRFTIKSD 187
Query: 712 VYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKE 771
           V+SFGI+L E  T+         G +     VN        EV+D     +         
Sbjct: 188 VWSFGILLTELTTK---------GRVPYPGMVN-------REVLDQ---VERGYRMPCPP 228
Query: 772 QCVSFVFNLALECTVESPEQR 792
           +C   + +L  +C  + PE+R
Sbjct: 229 ECPESLHDLMCQCWRKEPEER 249

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 93.6 bits (231), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 78/296 (26%), Positives = 129/296 (43%), Gaps = 34/296 (11%)
Query: 505 DPNMPPVATWRRFSYLELFQATDKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQC 563
           DP+ P    W         + TD  +  + +G G +G VY+   +   + VAVK    + 
Sbjct: 4   DPSSPNYDKWE-------MERTD-ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-ED 54
Query: 564 GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSN-YSLD 622
               + F  E A+MK I+H NLV+++  C+ E    ++ E+M +G+L  YL   N   ++
Sbjct: 55  TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVN 114
Query: 623 IFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 682
               L +   ++SA+EYL        IH DL   N L+ +N +  ++DFG+++L+TG D 
Sbjct: 115 AVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DT 170
Query: 683 SMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHW 742
                     I + APE     + S   DV++FG++L E  T                  
Sbjct: 171 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS-------------- 216
Query: 743 VNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEI 798
                P   +++     L ++D      E C   V+ L   C   +P  R +  EI
Sbjct: 217 -----PYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 77/295 (26%), Positives = 133/295 (45%), Gaps = 41/295 (13%)
Query: 526 TDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRA---FKSFDVECAMMKSIR 581
           +D++    ++G GG   V+ AR +RD  +VAVKV      R    +  F  E     ++ 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 582 HRNLVKVISSCSNE----EFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASAL 637
           H  +V V  +   E        +V+EY+   +L   +H+      +  +  I + +A A 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEV-IADAC 126
Query: 638 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT-LATIGYM 696
           + L+F +   +IH D+KP+N+L+       + DFGIA+ +     S+ QT   + T  Y+
Sbjct: 127 QALNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYL 186
Query: 697 APEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGE----MTLKHWVNDCLPISTM 752
           +PE  R   V    DVYS G +L E  T + P    F G+    +  +H   D +P S  
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVSVAYQHVREDPIPPS-- 240
Query: 753 EVVDANLLSQEDIHFVAKEQCVSFVFN-LALECTVESPEQRIN-AKEIVAKLLKI 805
                           A+ + +S   + + L+   ++PE R   A E+ A L+++
Sbjct: 241 ----------------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 77/318 (24%), Positives = 151/318 (47%), Gaps = 37/318 (11%)
Query: 505 DPNMPPVATWRRFSYLELFQATDKFSENNLIGRGGFGSVYKARIR--DGMEVAVKVFNLQ 562
           DP+     T     + +   AT+  S + ++G G FG V   R++     E++V +  L+
Sbjct: 24  DPHTYEDPTQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK 82
Query: 563 CG---RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNY 619
            G   +  + F  E ++M    H N++++    +  +   +V E M +GSL+ +L   + 
Sbjct: 83  VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDA 142
Query: 620 SLDIFQRLNIMIDVASALEYL-HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 678
              + Q + ++  +AS ++YL   GY    +H DL   N+L++ N+V  +SDFG++++L 
Sbjct: 143 QFTVIQLVGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLE 198
Query: 679 GEDQSMTQTQ-TLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTR-KKPTDELFNGE 736
            + ++   T+     I + +PE     + ++  DV+S+GI+L E  +  ++P  E+ N +
Sbjct: 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD 258
Query: 737 MTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAK 796
           +              ++ VD      E         C + ++ L L+C  +    R   +
Sbjct: 259 V--------------IKAVD------EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFE 298
Query: 797 EIVAKLLKIRDSLLRNVG 814
           +IV+    I D L+RN G
Sbjct: 299 QIVS----ILDKLIRNPG 312

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 77/294 (26%), Positives = 135/294 (45%), Gaps = 42/294 (14%)
Query: 525 ATDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNL-------QCGRAFKSFDVECAM 576
           A ++      IG+GGFG V+K R ++D   VA+K   L       +    F+ F  E  +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 577 MKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASA 636
           M ++ H N+VK+     N     +V+E++P G L   L    + +    +L +M+D+A  
Sbjct: 77  MSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 637 LEYLHFGYSAPVIHCDLKPSNVL---LDDN--MVAHLSDFGIAKLLTGEDQSM-TQTQTL 690
           +EY+    + P++H DL+  N+    LD+N  + A ++DFG+++      QS+ + +  L
Sbjct: 135 IEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ------QSVHSVSGLL 187
Query: 691 ATIGYMAPEY--GREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLP 748
               +MAPE     E   +   D YSF ++L    T + P DE   G++           
Sbjct: 188 GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF--------- 238
Query: 749 ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL 802
                    N++ +E +     E C   + N+   C    P++R +   IV +L
Sbjct: 239 --------INMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 120/266 (45%), Gaps = 26/266 (9%)
Query: 535 IGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCS 593
           +G G +G VY+   +   + VAVK    +     + F  E A+MK I+H NLV+++  C+
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 594 NEEFKALVLEYMPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
            E    +++E+M +G+L  YL   N   ++    L +   ++SA+EYL        IH D
Sbjct: 81  REPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 137
Query: 653 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDV 712
           L   N L+ +N +  ++DFG+++L+TG D           I + APE     + S   DV
Sbjct: 138 LAARNCLVGENHLVKVADFGLSRLMTG-DTXTAHAGAKFPIKWTAPESLAYNKFSIKSDV 196
Query: 713 YSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQ 772
           ++FG++L E  T                       P   +++     L ++D      E 
Sbjct: 197 WAFGVLLWEIATY-------------------GMSPYPGIDLSQVYELLEKDYRMERPEG 237
Query: 773 CVSFVFNLALECTVESPEQRINAKEI 798
           C   V+ L   C   +P  R +  EI
Sbjct: 238 CPEKVYELMRACWQWNPSDRPSFAEI 263

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 78/296 (26%), Positives = 129/296 (43%), Gaps = 34/296 (11%)
Query: 505 DPNMPPVATWRRFSYLELFQATDKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQC 563
           DP+ P    W         + TD  +  + +G G +G VY+   +   + VAVK    + 
Sbjct: 4   DPSSPNYDKWE-------MERTD-ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-ED 54
Query: 564 GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSN-YSLD 622
               + F  E A+MK I+H NLV+++  C+ E    ++ E+M +G+L  YL   N   ++
Sbjct: 55  TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVN 114
Query: 623 IFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 682
               L +   ++SA+EYL        IH DL   N L+ +N +  ++DFG+++L+TG D 
Sbjct: 115 AVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DT 170
Query: 683 SMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHW 742
                     I + APE     + S   DV++FG++L E  T                  
Sbjct: 171 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY----------------- 213
Query: 743 VNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEI 798
                P   +++     L ++D      E C   V+ L   C   +P  R +  EI
Sbjct: 214 --GMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 75/261 (28%), Positives = 125/261 (47%), Gaps = 30/261 (11%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGR-AFKSFDVECAMMKSIRHRNLVKVISSCS 593
           +G+G FG V+         VA+K   L+ G  + ++F  E  +MK +RH  LV++ +  S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 594 NEEFKALVLEYMPHGSLEKYLHSS-NYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
            E    +V+EYM  GSL  +L       L + Q +++   +AS + Y+        +H D
Sbjct: 84  EEPI-YIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 653 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGQVSTNGD 711
           L+ +N+L+ +N+V  ++DFG+A+L+  ED   T  Q     I + APE    G+ +   D
Sbjct: 140 LRAANILVGENLVCKVADFGLARLI--EDNEXTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 712 VYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKE 771
           V+SFGI+L E  T+         G +     VN        EV+D     +         
Sbjct: 198 VWSFGILLTELTTK---------GRVPYPGMVNR-------EVLDQ---VERGYRMPCPP 238
Query: 772 QCVSFVFNLALECTVESPEQR 792
           +C   + +L  +C  + PE+R
Sbjct: 239 ECPESLHDLMCQCWRKDPEER 259

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 93.2 bits (230), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 72/294 (24%), Positives = 142/294 (48%), Gaps = 36/294 (12%)
Query: 529 FSENNLIGRGGFGSVYKARIR--DGMEVAVKVFNLQCG---RAFKSFDVECAMMKSIRHR 583
            S + ++G G FG V   R++     E++V +  L+ G   +  + F  E ++M    H 
Sbjct: 18  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 77
Query: 584 NLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL-HF 642
           N++++    +  +   +V E M +GSL+ +L   +    + Q + ++  +AS ++YL   
Sbjct: 78  NIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 137
Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLAT-IGYMAPEYG 701
           GY    +H DL   N+L++ N+V  +SDFG++++L  + ++   T+     I + +PE  
Sbjct: 138 GY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 193
Query: 702 REGQVSTNGDVYSFGIMLMETFTR-KKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLL 760
              + ++  DV+S+GI+L E  +  ++P  E+ N ++              ++ VD    
Sbjct: 194 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV--------------IKAVD---- 235
Query: 761 SQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLRNVG 814
             E         C + ++ L L+C  +    R   ++IV+    I D L+RN G
Sbjct: 236 --EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS----ILDKLIRNPG 283

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 93.2 bits (230), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 75/261 (28%), Positives = 125/261 (47%), Gaps = 30/261 (11%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGR-AFKSFDVECAMMKSIRHRNLVKVISSCS 593
           +G+G FG V+         VA+K   L+ G  + ++F  E  +MK +RH  LV++ +  S
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 594 NEEFKALVLEYMPHGSLEKYLH-SSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
            E    +V EYM  GSL  +L   +   L + Q +++   +AS + Y+        +H D
Sbjct: 333 EEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 388
Query: 653 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGQVSTNGD 711
           L+ +N+L+ +N+V  ++DFG+A+L+  ED   T  Q     I + APE    G+ +   D
Sbjct: 389 LRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 446
Query: 712 VYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKE 771
           V+SFGI+L E  T+         G +     VN        EV+D     +         
Sbjct: 447 VWSFGILLTELTTK---------GRVPYPGMVN-------REVLDQ---VERGYRMPCPP 487
Query: 772 QCVSFVFNLALECTVESPEQR 792
           +C   + +L  +C  + PE+R
Sbjct: 488 ECPESLHDLMCQCWRKEPEER 508

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 93.2 bits (230), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 125/278 (44%), Gaps = 28/278 (10%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSN 594
           IG G FG V+     +  +VA+K    +   + + F  E  +M  + H  LV++   C  
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 76
Query: 595 EEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLK 654
           +    LV E+M HG L  YL +          L + +DV   + YL     A VIH DL 
Sbjct: 77  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLA 133
Query: 655 PSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYS 714
             N L+ +N V  +SDFG+ + +  +DQ  + T T   + + +PE     + S+  DV+S
Sbjct: 134 ARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 192
Query: 715 FGIMLMETFTRKK-PTDELFNGEMTLKHWVNDCLPIST-MEVVDANLLSQEDIHFVAKEQ 772
           FG+++ E F+  K P +   N E+     V D   IST   +    L S           
Sbjct: 193 FGVLMWEVFSEGKIPYENRSNSEV-----VED---ISTGFRLYKPRLAS----------- 233
Query: 773 CVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLL 810
             + V+ +   C  E PE R     ++ +L +I +S L
Sbjct: 234 --THVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESGL 269

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 75/261 (28%), Positives = 125/261 (47%), Gaps = 30/261 (11%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGR-AFKSFDVECAMMKSIRHRNLVKVISSCS 593
           +G+G FG V+         VA+K   L+ G  + ++F  E  +MK +RH  LV++ +  S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 594 NEEFKALVLEYMPHGSLEKYLHSS-NYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
            E    +V+EYM  GSL  +L       L + Q +++   +AS + Y+        +H D
Sbjct: 84  EEPI-YIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 653 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGQVSTNGD 711
           L+ +N+L+ +N+V  ++DFG+A+L+  ED   T  Q     I + APE    G+ +   D
Sbjct: 140 LRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 712 VYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKE 771
           V+SFGI+L E  T+         G +     VN        EV+D     +         
Sbjct: 198 VWSFGILLTELTTK---------GRVPYPGMVNR-------EVLDQ---VERGYRMPCPP 238
Query: 772 QCVSFVFNLALECTVESPEQR 792
           +C   + +L  +C  + PE+R
Sbjct: 239 ECPESLHDLMCQCWRKDPEER 259

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 75/261 (28%), Positives = 125/261 (47%), Gaps = 30/261 (11%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGR-AFKSFDVECAMMKSIRHRNLVKVISSCS 593
           +G+G FG V+         VA+K   L+ G  + ++F  E  +MK +RH  LV++ +  S
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 76
Query: 594 NEEFKALVLEYMPHGSLEKYLH-SSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
            E    +V EYM  GSL  +L   +   L + Q +++   +AS + Y+        +H D
Sbjct: 77  EEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 132
Query: 653 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGQVSTNGD 711
           L+ +N+L+ +N+V  ++DFG+A+L+  ED   T  Q     I + APE    G+ +   D
Sbjct: 133 LRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 190
Query: 712 VYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKE 771
           V+SFGI+L E  T+         G +     VN        EV+D     +         
Sbjct: 191 VWSFGILLTELTTK---------GRVPYPGMVNR-------EVLDQ---VERGYRMPCPP 231
Query: 772 QCVSFVFNLALECTVESPEQR 792
           +C   + +L  +C  + PE+R
Sbjct: 232 ECPESLHDLMCQCWRKEPEER 252

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 76/261 (29%), Positives = 124/261 (47%), Gaps = 30/261 (11%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGR-AFKSFDVECAMMKSIRHRNLVKVISSCS 593
           +G+G FG V+         VA+K   L+ G  + ++F  E  +MK IRH  LV++ +  S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKIRHEKLVQLYAVVS 83
Query: 594 NEEFKALVLEYMPHGSLEKYLHSS-NYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
            E    +V EYM  GSL  +L       L + Q +++   +AS + Y+        +H D
Sbjct: 84  EEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 653 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGQVSTNGD 711
           L+ +N+L+ +N+V  ++DFG+A+L+  ED   T  Q     I + APE    G+ +   D
Sbjct: 140 LRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 712 VYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKE 771
           V+SFGI+L E  T+         G +     VN        EV+D     +         
Sbjct: 198 VWSFGILLTELTTK---------GRVPYPGMVNR-------EVLDQ---VERGYRMPCPP 238
Query: 772 QCVSFVFNLALECTVESPEQR 792
           +C   + +L  +C  + PE+R
Sbjct: 239 ECPESLHDLMCQCWRKDPEER 259

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 78/296 (26%), Positives = 128/296 (43%), Gaps = 34/296 (11%)
Query: 505 DPNMPPVATWRRFSYLELFQATDKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQC 563
           DP+ P    W         + TD  +  + +G G +G VY+   +   + VAVK    + 
Sbjct: 4   DPSSPNYDKWE-------MERTD-ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-ED 54
Query: 564 GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSN-YSLD 622
               + F  E A+MK I+H NLV+++  C+ E    ++ E+M +G+L  YL   N   + 
Sbjct: 55  TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVS 114
Query: 623 IFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 682
               L +   ++SA+EYL        IH DL   N L+ +N +  ++DFG+++L+TG D 
Sbjct: 115 AVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DT 170
Query: 683 SMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHW 742
                     I + APE     + S   DV++FG++L E  T                  
Sbjct: 171 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT------------------ 212
Query: 743 VNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEI 798
                P   +++     L ++D      E C   V+ L   C   +P  R +  EI
Sbjct: 213 -YGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 107/210 (50%), Gaps = 11/210 (5%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCG--RAFKSFDVECAMMKSIRHRNLVKVISSC 592
           IG G FG+VYK +     +VAVK+ N+     +  ++F  E  +++  RH N++  +   
Sbjct: 21  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 593 SNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
           +  +  A+V ++    SL  +LH      ++ + ++I    A  ++YLH   +  +IH D
Sbjct: 79  TKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 134
Query: 653 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR---EGQVSTN 709
           LK +N+ L +++   + DFG+A + +    S    Q   +I +MAPE  R   +   S  
Sbjct: 135 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 194
Query: 710 GDVYSFGIMLMETFTRKKPTDELFNGEMTL 739
            DVY+FGI+L E  T + P   + N +  +
Sbjct: 195 SDVYAFGIVLYELMTGQLPYSNINNRDQII 224

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 92.8 bits (229), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 125/278 (44%), Gaps = 28/278 (10%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSN 594
           IG G FG V+     +  +VA+K    +   + + F  E  +M  + H  LV++   C  
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 595 EEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLK 654
           +    LV E+M HG L  YL +          L + +DV   + YL     A VIH DL 
Sbjct: 74  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLA 130
Query: 655 PSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYS 714
             N L+ +N V  +SDFG+ + +  +DQ  + T T   + + +PE     + S+  DV+S
Sbjct: 131 ARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 189
Query: 715 FGIMLMETFTRKK-PTDELFNGEMTLKHWVNDCLPIST-MEVVDANLLSQEDIHFVAKEQ 772
           FG+++ E F+  K P +   N E+     V D   IST   +    L S           
Sbjct: 190 FGVLMWEVFSEGKIPYENRSNSEV-----VED---ISTGFRLYKPRLAS----------- 230
Query: 773 CVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLL 810
             + V+ +   C  E PE R     ++ +L +I +S L
Sbjct: 231 --THVYQIMNHCWKERPEDRPAFSRLLRQLAEIAESGL 266

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 92.4 bits (228), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 107/210 (50%), Gaps = 11/210 (5%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCG--RAFKSFDVECAMMKSIRHRNLVKVISSC 592
           IG G FG+VYK +     +VAVK+ N+     +  ++F  E  +++  RH N++  +   
Sbjct: 16  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 593 SNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
           +  +  A+V ++    SL  +LH      ++ + ++I    A  ++YLH   +  +IH D
Sbjct: 74  TKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 129
Query: 653 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR---EGQVSTN 709
           LK +N+ L +++   + DFG+A + +    S    Q   +I +MAPE  R   +   S  
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 189
Query: 710 GDVYSFGIMLMETFTRKKPTDELFNGEMTL 739
            DVY+FGI+L E  T + P   + N +  +
Sbjct: 190 SDVYAFGIVLYELMTGQLPYSNINNRDQII 219

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 92.4 bits (228), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 107/210 (50%), Gaps = 11/210 (5%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCG--RAFKSFDVECAMMKSIRHRNLVKVISSC 592
           IG G FG+VYK +     +VAVK+ N+     +  ++F  E  +++  RH N++  +   
Sbjct: 18  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 75
Query: 593 SNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
           +  +  A+V ++    SL  +LH      ++ + ++I    A  ++YLH   +  +IH D
Sbjct: 76  TKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 131
Query: 653 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR---EGQVSTN 709
           LK +N+ L +++   + DFG+A + +    S    Q   +I +MAPE  R   +   S  
Sbjct: 132 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 191
Query: 710 GDVYSFGIMLMETFTRKKPTDELFNGEMTL 739
            DVY+FGI+L E  T + P   + N +  +
Sbjct: 192 SDVYAFGIVLYELMTGQLPYSNINNRDQII 221

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 92.4 bits (228), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 75/261 (28%), Positives = 125/261 (47%), Gaps = 30/261 (11%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGR-AFKSFDVECAMMKSIRHRNLVKVISSCS 593
           +G+G FG V+         VA+K   L+ G  + ++F  E  +MK +RH  LV++ +  S
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 594 NEEFKALVLEYMPHGSLEKYLH-SSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
            E    +V EYM  GSL  +L   +   L + Q +++   +AS + Y+        +H D
Sbjct: 250 EEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 305
Query: 653 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGQVSTNGD 711
           L+ +N+L+ +N+V  ++DFG+A+L+  ED   T  Q     I + APE    G+ +   D
Sbjct: 306 LRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 712 VYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKE 771
           V+SFGI+L E  T+         G +     VN        EV+D     +         
Sbjct: 364 VWSFGILLTELTTK---------GRVPYPGMVN-------REVLDQ---VERGYRMPCPP 404
Query: 772 QCVSFVFNLALECTVESPEQR 792
           +C   + +L  +C  + PE+R
Sbjct: 405 ECPESLHDLMCQCWRKEPEER 425

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 92.4 bits (228), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 125/278 (44%), Gaps = 28/278 (10%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSN 594
           IG G FG V+     +  +VA+K    +   + + F  E  +M  + H  LV++   C  
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 71
Query: 595 EEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLK 654
           +    LV E+M HG L  YL +          L + +DV   + YL     A VIH DL 
Sbjct: 72  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLA 128
Query: 655 PSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYS 714
             N L+ +N V  +SDFG+ + +  +DQ  + T T   + + +PE     + S+  DV+S
Sbjct: 129 ARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 187
Query: 715 FGIMLMETFTRKK-PTDELFNGEMTLKHWVNDCLPIST-MEVVDANLLSQEDIHFVAKEQ 772
           FG+++ E F+  K P +   N E+     V D   IST   +    L S           
Sbjct: 188 FGVLMWEVFSEGKIPYENRSNSEV-----VED---ISTGFRLYKPRLAS----------- 228
Query: 773 CVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLL 810
             + V+ +   C  E PE R     ++ +L +I +S L
Sbjct: 229 --THVYQIMNHCWKERPEDRPAFSRLLRQLAEIAESGL 264

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 92.4 bits (228), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 75/261 (28%), Positives = 125/261 (47%), Gaps = 30/261 (11%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGR-AFKSFDVECAMMKSIRHRNLVKVISSCS 593
           +G+G FG V+         VA+K   L+ G  + ++F  E  +MK +RH  LV++ +  S
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 594 NEEFKALVLEYMPHGSLEKYLH-SSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
            E    +V EYM  GSL  +L   +   L + Q +++   +AS + Y+        +H D
Sbjct: 250 EEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 305
Query: 653 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGQVSTNGD 711
           L+ +N+L+ +N+V  ++DFG+A+L+  ED   T  Q     I + APE    G+ +   D
Sbjct: 306 LRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 712 VYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKE 771
           V+SFGI+L E  T+         G +     VN        EV+D     +         
Sbjct: 364 VWSFGILLTELTTK---------GRVPYPGMVN-------REVLDQ---VERGYRMPCPP 404
Query: 772 QCVSFVFNLALECTVESPEQR 792
           +C   + +L  +C  + PE+R
Sbjct: 405 ECPESLHDLMCQCWRKEPEER 425

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 92.4 bits (228), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 107/210 (50%), Gaps = 11/210 (5%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCG--RAFKSFDVECAMMKSIRHRNLVKVISSC 592
           IG G FG+VYK +     +VAVK+ N+     +  ++F  E  +++  RH N++  +   
Sbjct: 21  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 593 SNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
           +  +  A+V ++    SL  +LH      ++ + ++I    A  ++YLH   +  +IH D
Sbjct: 79  TKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 134
Query: 653 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR---EGQVSTN 709
           LK +N+ L +++   + DFG+A + +    S    Q   +I +MAPE  R   +   S  
Sbjct: 135 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 194
Query: 710 GDVYSFGIMLMETFTRKKPTDELFNGEMTL 739
            DVY+FGI+L E  T + P   + N +  +
Sbjct: 195 SDVYAFGIVLYELMTGQLPYSNINNRDQII 224

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 135/286 (47%), Gaps = 30/286 (10%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCG--RAFKSFDVECAMMKSIRHRNLVKVISSC 592
           IG G FG+VYK +     +VAVK+ N+     +  ++F  E  +++  RH N++  +   
Sbjct: 32  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 593 SNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
           +  +  A+V ++    SL  +LH+S    ++ + ++I    A  ++YLH   +  +IH D
Sbjct: 90  TKPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRD 145
Query: 653 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR---EGQVSTN 709
           LK +N+ L ++    + DFG+A   +    S    Q   +I +MAPE  R       S  
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205
Query: 710 GDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVA 769
            DVY+FGI+L E  T + P   + N +  +             E+V    LS  D+  V 
Sbjct: 206 SDVYAFGIVLYELMTGQLPYSNINNRDQII-------------EMVGRGSLS-PDLSKV- 250
Query: 770 KEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLRNVGG 815
           +  C   +  L  EC  +  ++R +   I+A++    + L R + G
Sbjct: 251 RSNCPKRMKRLMAECLKKKRDERPSFPRILAEI----EELARELSG 292

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 75/261 (28%), Positives = 125/261 (47%), Gaps = 30/261 (11%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGR-AFKSFDVECAMMKSIRHRNLVKVISSCS 593
           +G+G FG V+         VA+K   L+ G  + ++F  E  +MK +RH  LV++ +  S
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 594 NEEFKALVLEYMPHGSLEKYLH-SSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
            E    +V EYM  GSL  +L   +   L + Q +++   +AS + Y+        +H D
Sbjct: 81  EEPI-YIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYVHRD 136
Query: 653 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGQVSTNGD 711
           L+ +N+L+ +N+V  ++DFG+A+L+  ED   T  Q     I + APE    G+ +   D
Sbjct: 137 LRAANILVGENLVCKVADFGLARLI--EDNEWTARQGAKFPIKWTAPEAALYGRFTIKSD 194
Query: 712 VYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKE 771
           V+SFGI+L E  T+         G +     VN        EV+D     +         
Sbjct: 195 VWSFGILLTELTTK---------GRVPYPGMVN-------REVLDQ---VERGYRMPCPP 235
Query: 772 QCVSFVFNLALECTVESPEQR 792
           +C   + +L  +C  + PE+R
Sbjct: 236 ECPESLHDLMCQCWRKEPEER 256

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 6/205 (2%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSN 594
           IG G FG V+     +  +VA+K    +   + + F  E  +M  + H  LV++   C  
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 595 EEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLK 654
           +    LV E+M HG L  YL +          L + +DV   + YL     A VIH DL 
Sbjct: 74  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EASVIHRDLA 130
Query: 655 PSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYS 714
             N L+ +N V  +SDFG+ + +  +DQ  + T T   + + +PE     + S+  DV+S
Sbjct: 131 ARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 189
Query: 715 FGIMLMETFTRKK-PTDELFNGEMT 738
           FG+++ E F+  K P +   N E+ 
Sbjct: 190 FGVLMWEVFSEGKIPYENRSNSEVV 214

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 125/278 (44%), Gaps = 28/278 (10%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSN 594
           IG G FG V+     +  +VA+K    +   + + F  E  +M  + H  LV++   C  
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 595 EEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLK 654
           +    LV E+M HG L  YL +          L + +DV   + YL     A VIH DL 
Sbjct: 75  QAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLA 131
Query: 655 PSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYS 714
             N L+ +N V  +SDFG+ + +  +DQ  + T T   + + +PE     + S+  DV+S
Sbjct: 132 ARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 190
Query: 715 FGIMLMETFTRKK-PTDELFNGEMTLKHWVNDCLPIST-MEVVDANLLSQEDIHFVAKEQ 772
           FG+++ E F+  K P +   N E+     V D   IST   +    L S           
Sbjct: 191 FGVLMWEVFSEGKIPYENRSNSEV-----VED---ISTGFRLYKPRLAS----------- 231
Query: 773 CVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLL 810
             + V+ +   C  E PE R     ++ +L +I +S L
Sbjct: 232 --THVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESGL 267

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 75/261 (28%), Positives = 124/261 (47%), Gaps = 30/261 (11%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGR-AFKSFDVECAMMKSIRHRNLVKVISSCS 593
           +G+G FG V+         VA+K   L+ G  + ++F  E  +MK +RH  LV++ +  S
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 72
Query: 594 NEEFKALVLEYMPHGSLEKYLHSS-NYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
            E    +V EYM  GSL  +L       L + Q +++   +AS + Y+        +H D
Sbjct: 73  EEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 128
Query: 653 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGQVSTNGD 711
           L+ +N+L+ +N+V  ++DFG+A+L+  ED   T  Q     I + APE    G+ +   D
Sbjct: 129 LRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 186
Query: 712 VYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKE 771
           V+SFGI+L E  T+         G +     VN        EV+D     +         
Sbjct: 187 VWSFGILLTELTTK---------GRVPYPGMVNR-------EVLDQ---VERGYRMPCPP 227
Query: 772 QCVSFVFNLALECTVESPEQR 792
           +C   + +L  +C  + PE+R
Sbjct: 228 ECPESLHDLMCQCWRKDPEER 248

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 75/261 (28%), Positives = 124/261 (47%), Gaps = 30/261 (11%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGR-AFKSFDVECAMMKSIRHRNLVKVISSCS 593
           +G+G FG V+         VA+K   L+ G  + ++F  E  +MK +RH  LV++ +  S
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 74
Query: 594 NEEFKALVLEYMPHGSLEKYLHSS-NYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
            E    +V EYM  GSL  +L       L + Q +++   +AS + Y+        +H D
Sbjct: 75  EEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 130
Query: 653 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGQVSTNGD 711
           L+ +N+L+ +N+V  ++DFG+A+L+  ED   T  Q     I + APE    G+ +   D
Sbjct: 131 LRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 188
Query: 712 VYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKE 771
           V+SFGI+L E  T+         G +     VN        EV+D     +         
Sbjct: 189 VWSFGILLTELTTK---------GRVPYPGMVN-------REVLDQ---VERGYRMPCPP 229
Query: 772 QCVSFVFNLALECTVESPEQR 792
           +C   + +L  +C  + PE+R
Sbjct: 230 ECPESLHDLMCQCWRKDPEER 250

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 124/278 (44%), Gaps = 28/278 (10%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSN 594
           IG G FG V+     +  +VA+K    +   +   F  E  +M  + H  LV++   C  
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIK-EGSMSEDDFIEEAEVMMKLSHPKLVQLYGVCLE 93
Query: 595 EEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLK 654
           +    LV E+M HG L  YL +          L + +DV   + YL     A VIH DL 
Sbjct: 94  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLA 150
Query: 655 PSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYS 714
             N L+ +N V  +SDFG+ + +  +DQ  + T T   + + +PE     + S+  DV+S
Sbjct: 151 ARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 209
Query: 715 FGIMLMETFTRKK-PTDELFNGEMTLKHWVNDCLPIST-MEVVDANLLSQEDIHFVAKEQ 772
           FG+++ E F+  K P +   N E+     V D   IST   +    L S           
Sbjct: 210 FGVLMWEVFSEGKIPYENRSNSEV-----VED---ISTGFRLYKPRLAS----------- 250
Query: 773 CVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLL 810
             + V+ +   C  E PE R     ++ +L +I +S L
Sbjct: 251 --THVYQIMNHCWKERPEDRPAFSRLLRQLAEIAESGL 286

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/237 (28%), Positives = 112/237 (47%), Gaps = 38/237 (16%)
Query: 505 DPNMPPVATWRRFSYLELFQATDKFSENNLIGRGGFGSVYKARIR-DG--MEVAVKVFNL 561
           DP + PV  W    +             ++IG G FG V KARI+ DG  M+ A+K    
Sbjct: 5   DPTIYPVLDWNDIKF------------QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE 52
Query: 562 QCGRA-FKSFDVECAMMKSIRHR-NLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNY 619
              +   + F  E  ++  + H  N++ ++ +C +  +  L +EY PHG+L  +L  S  
Sbjct: 53  YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRV 112
Query: 620 ---------------SLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM 664
                          +L   Q L+   DVA  ++YL        IH DL   N+L+ +N 
Sbjct: 113 LETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENY 169
Query: 665 VAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLME 721
           VA ++DFG+++   G++  + +T     + +MA E       +TN DV+S+G++L E
Sbjct: 170 VAKIADFGLSR---GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWE 223

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 119/266 (44%), Gaps = 26/266 (9%)
Query: 535 IGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCS 593
           +G G +G VY+   +   + VAVK    +     + F  E A+MK I+H NLV+++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 594 NEEFKALVLEYMPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
            E    +++E+M +G+L  YL   N   +     L +   ++SA+EYL        IH D
Sbjct: 80  REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 653 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDV 712
           L   N L+ +N +  ++DFG+++L+TG D           I + APE     + S   DV
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 713 YSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQ 772
           ++FG++L E  T                       P   +++     L ++D      E 
Sbjct: 196 WAFGVLLWEIATYGMS-------------------PYPGIDLSQVYELLEKDYRMERPEG 236
Query: 773 CVSFVFNLALECTVESPEQRINAKEI 798
           C   V+ L   C   +P  R +  EI
Sbjct: 237 CPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 75/261 (28%), Positives = 124/261 (47%), Gaps = 30/261 (11%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGR-AFKSFDVECAMMKSIRHRNLVKVISSCS 593
           +G+G FG V+         VA+K   L+ G  + ++F  E  +MK +RH  LV++ +  S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 594 NEEFKALVLEYMPHGSLEKYLHSS-NYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
            E    +V EYM  GSL  +L       L + Q +++   +AS + Y+        +H D
Sbjct: 84  EEPI-YIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 653 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGQVSTNGD 711
           L+ +N+L+ +N+V  ++DFG+A+L+  ED   T  Q     I + APE    G+ +   D
Sbjct: 140 LRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 712 VYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKE 771
           V+SFGI+L E  T+         G +     VN        EV+D     +         
Sbjct: 198 VWSFGILLTELTTK---------GRVPYPGMVNR-------EVLDQ---VERGYRMPCPP 238
Query: 772 QCVSFVFNLALECTVESPEQR 792
           +C   + +L  +C  + PE+R
Sbjct: 239 ECPESLHDLMCQCWRKDPEER 259

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 107/210 (50%), Gaps = 11/210 (5%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCG--RAFKSFDVECAMMKSIRHRNLVKVISSC 592
           IG G FG+VYK +     +VAVK+ N+     +  ++F  E  +++  RH N++  +   
Sbjct: 16  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 593 SNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
           +  +  A+V ++    SL  +LH      ++ + ++I    A  ++YLH   +  +IH D
Sbjct: 74  TAPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 129
Query: 653 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR---EGQVSTN 709
           LK +N+ L +++   + DFG+A + +    S    Q   +I +MAPE  R   +   S  
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 189
Query: 710 GDVYSFGIMLMETFTRKKPTDELFNGEMTL 739
            DVY+FGI+L E  T + P   + N +  +
Sbjct: 190 SDVYAFGIVLYELMTGQLPYSNINNRDQII 219

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/237 (28%), Positives = 112/237 (47%), Gaps = 38/237 (16%)
Query: 505 DPNMPPVATWRRFSYLELFQATDKFSENNLIGRGGFGSVYKARIR-DG--MEVAVKVFNL 561
           DP + PV  W    +             ++IG G FG V KARI+ DG  M+ A+K    
Sbjct: 15  DPTIYPVLDWNDIKF------------QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE 62
Query: 562 QCGRA-FKSFDVECAMMKSIRHR-NLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNY 619
              +   + F  E  ++  + H  N++ ++ +C +  +  L +EY PHG+L  +L  S  
Sbjct: 63  YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRV 122
Query: 620 ---------------SLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM 664
                          +L   Q L+   DVA  ++YL        IH DL   N+L+ +N 
Sbjct: 123 LETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENY 179
Query: 665 VAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLME 721
           VA ++DFG+++   G++  + +T     + +MA E       +TN DV+S+G++L E
Sbjct: 180 VAKIADFGLSR---GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWE 233

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 71/243 (29%), Positives = 118/243 (48%), Gaps = 26/243 (10%)
Query: 521 ELFQATDKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNL---QCGRAFKSFDVECAM 576
           E ++  DK      +G GG  +VY A      ++VA+K   +   +     K F+ E   
Sbjct: 11  ERYKIVDK------LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHN 64
Query: 577 MKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASA 636
              + H+N+V +I     ++   LV+EY+   +L +Y+ S    L +   +N    +   
Sbjct: 65  SSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDG 123
Query: 637 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQT-QTLATIGY 695
           +++ H      ++H D+KP N+L+D N    + DFGIAK L+  + S+TQT   L T+ Y
Sbjct: 124 IKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS--ETSLTQTNHVLGTVQY 178
Query: 696 MAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGE----MTLKHWVNDCLPIST 751
            +PE  +        D+YS GI+L E    + P    FNGE    + +KH + D +P  T
Sbjct: 179 FSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP----FNGETAVSIAIKH-IQDSVPNVT 233
Query: 752 MEV 754
            +V
Sbjct: 234 TDV 236

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 119/266 (44%), Gaps = 26/266 (9%)
Query: 535 IGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCS 593
           +G G +G VY+   +   + VAVK    +     + F  E A+MK I+H NLV+++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 594 NEEFKALVLEYMPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
            E    +++E+M +G+L  YL   N   +     L +   ++SA+EYL        IH D
Sbjct: 80  REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 653 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDV 712
           L   N L+ +N +  ++DFG+++L+TG D           I + APE     + S   DV
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 713 YSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQ 772
           ++FG++L E  T                       P   +++     L ++D      E 
Sbjct: 196 WAFGVLLWEIAT-------------------YGMSPYPGIDLSQVYELLEKDYRMERPEG 236
Query: 773 CVSFVFNLALECTVESPEQRINAKEI 798
           C   V+ L   C   +P  R +  EI
Sbjct: 237 CPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 107/210 (50%), Gaps = 11/210 (5%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCG--RAFKSFDVECAMMKSIRHRNLVKVISSC 592
           IG G FG+VYK +     +VAVK+ N+     +  ++F  E  +++  RH N++  +   
Sbjct: 43  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 100
Query: 593 SNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
           +  +  A+V ++    SL  +LH      ++ + ++I    A  ++YLH   +  +IH D
Sbjct: 101 TKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 156
Query: 653 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR---EGQVSTN 709
           LK +N+ L +++   + DFG+A + +    S    Q   +I +MAPE  R   +   S  
Sbjct: 157 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 216
Query: 710 GDVYSFGIMLMETFTRKKPTDELFNGEMTL 739
            DVY+FGI+L E  T + P   + N +  +
Sbjct: 217 SDVYAFGIVLYELMTGQLPYSNINNRDQII 246

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 75/261 (28%), Positives = 125/261 (47%), Gaps = 30/261 (11%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGR-AFKSFDVECAMMKSIRHRNLVKVISSCS 593
           +G+G FG V+         VA+K   L+ G  + ++F  E  +MK +RH  LV++ +  S
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 594 NEEFKALVLEYMPHGSLEKYLH-SSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
            E    +V EYM  GSL  +L   +   L + Q +++   +AS + Y+        +H D
Sbjct: 81  EEPI-YIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYVHRD 136
Query: 653 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGQVSTNGD 711
           L+ +N+L+ +N+V  ++DFG+A+L+  ED   T  Q     I + APE    G+ +   D
Sbjct: 137 LRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 194
Query: 712 VYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKE 771
           V+SFGI+L E  T+         G +     VN        EV+D     +         
Sbjct: 195 VWSFGILLTELTTK---------GRVPYPGMVN-------REVLDQ---VERGYRMPCPP 235
Query: 772 QCVSFVFNLALECTVESPEQR 792
           +C   + +L  +C  + PE+R
Sbjct: 236 ECPESLHDLMCQCWRKEPEER 256

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 75/261 (28%), Positives = 124/261 (47%), Gaps = 30/261 (11%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGR-AFKSFDVECAMMKSIRHRNLVKVISSCS 593
           +G+G FG V+         VA+K   L+ G  + ++F  E  +MK +RH  LV++ +  S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 594 NEEFKALVLEYMPHGSLEKYLHSS-NYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
            E    +V EYM  GSL  +L       L + Q +++   +AS + Y+        +H D
Sbjct: 84  EEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 653 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGQVSTNGD 711
           L+ +N+L+ +N+V  ++DFG+A+L+  ED   T  Q     I + APE    G+ +   D
Sbjct: 140 LRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 712 VYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKE 771
           V+SFGI+L E  T+         G +     VN        EV+D     +         
Sbjct: 198 VWSFGILLTELTTK---------GRVPYPGMVNR-------EVLDQ---VERGYRMPCPP 238
Query: 772 QCVSFVFNLALECTVESPEQR 792
           +C   + +L  +C  + PE+R
Sbjct: 239 ECPESLHDLMCQCWRKDPEER 259

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 119/266 (44%), Gaps = 26/266 (9%)
Query: 535 IGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCS 593
           +G G +G VY+   +   + VAVK    +     + F  E A+MK I+H NLV+++  C+
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 83
Query: 594 NEEFKALVLEYMPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
            E    ++ E+M +G+L  YL   N   ++    L +   ++SA+EYL        IH D
Sbjct: 84  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 140
Query: 653 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDV 712
           L   N L+ +N +  ++DFG+++L+TG D           I + APE     + S   DV
Sbjct: 141 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 199
Query: 713 YSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQ 772
           ++FG++L E  T                       P   +++     L ++D      E 
Sbjct: 200 WAFGVLLWEIATYGMS-------------------PYPGIDLSQVYELLEKDYRMERPEG 240
Query: 773 CVSFVFNLALECTVESPEQRINAKEI 798
           C   V+ L   C   +P  R +  EI
Sbjct: 241 CPEKVYELMRACWQWNPSDRPSFAEI 266

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 107/210 (50%), Gaps = 11/210 (5%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCG--RAFKSFDVECAMMKSIRHRNLVKVISSC 592
           IG G FG+VYK +     +VAVK+ N+     +  ++F  E  +++  RH N++  +   
Sbjct: 44  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 593 SNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
           +  +  A+V ++    SL  +LH      ++ + ++I    A  ++YLH   +  +IH D
Sbjct: 102 TKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 157
Query: 653 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR---EGQVSTN 709
           LK +N+ L +++   + DFG+A + +    S    Q   +I +MAPE  R   +   S  
Sbjct: 158 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 217
Query: 710 GDVYSFGIMLMETFTRKKPTDELFNGEMTL 739
            DVY+FGI+L E  T + P   + N +  +
Sbjct: 218 SDVYAFGIVLYELMTGQLPYSNINNRDQII 247

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 70/293 (23%), Positives = 140/293 (47%), Gaps = 34/293 (11%)
Query: 529 FSENNLIGRGGFGSVYKARIR--DGMEVAVKVFNLQCG---RAFKSFDVECAMMKSIRHR 583
            S + ++G G FG V   R++     E++V +  L+ G   +  + F  E ++M    H 
Sbjct: 47  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 584 NLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFG 643
           N++++    +  +   +V E M +GSL+ +L   +    + Q + ++  +AS ++YL   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS-- 164
Query: 644 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQ-TLATIGYMAPEYGR 702
                +H DL   N+L++ N+V  +SDFG++++L  + ++   T+     I + +PE   
Sbjct: 165 -DMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 703 EGQVSTNGDVYSFGIMLMETFTR-KKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLS 761
             + ++  DV+S+GI+L E  +  ++P  E+ N ++              ++ VD     
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV--------------IKAVD----- 264
Query: 762 QEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLRNVG 814
            E         C + ++ L L+C  +    R   ++IV+    I D L+RN G
Sbjct: 265 -EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS----ILDKLIRNPG 312

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 75/261 (28%), Positives = 125/261 (47%), Gaps = 30/261 (11%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGR-AFKSFDVECAMMKSIRHRNLVKVISSCS 593
           +G+G FG V+         VA+K   L+ G  + ++F  E  +MK +RH  LV++ +  S
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 594 NEEFKALVLEYMPHGSLEKYLH-SSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
            E    +V EYM  GSL  +L   +   L + Q +++   +AS + Y+        +H D
Sbjct: 250 EEPI-YIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 305
Query: 653 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGQVSTNGD 711
           L+ +N+L+ +N+V  ++DFG+A+L+  ED   T  Q     I + APE    G+ +   D
Sbjct: 306 LRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 712 VYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKE 771
           V+SFGI+L E  T+         G +     VN        EV+D     +         
Sbjct: 364 VWSFGILLTELTTK---------GRVPYPGMVN-------REVLDQ---VERGYRMPCPP 404
Query: 772 QCVSFVFNLALECTVESPEQR 792
           +C   + +L  +C  + PE+R
Sbjct: 405 ECPESLHDLMCQCWRKEPEER 425

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 119/266 (44%), Gaps = 26/266 (9%)
Query: 535 IGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCS 593
           +G G +G VY+   +   + VAVK    +     + F  E A+MK I+H NLV+++  C+
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 92
Query: 594 NEEFKALVLEYMPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
            E    ++ E+M +G+L  YL   N   ++    L +   ++SA+EYL        IH D
Sbjct: 93  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 149
Query: 653 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDV 712
           L   N L+ +N +  ++DFG+++L+TG D           I + APE     + S   DV
Sbjct: 150 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 208
Query: 713 YSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQ 772
           ++FG++L E  T                       P   +++     L ++D      E 
Sbjct: 209 WAFGVLLWEIATYGMS-------------------PYPGIDLSQVYELLEKDYRMERPEG 249
Query: 773 CVSFVFNLALECTVESPEQRINAKEI 798
           C   V+ L   C   +P  R +  EI
Sbjct: 250 CPEKVYELMRACWQWNPSDRPSFAEI 275

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 60/192 (31%), Positives = 99/192 (51%), Gaps = 7/192 (3%)
Query: 535 IGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCS 593
           +G G +G VY+   +   + VAVK    +     + F  E A+MK I+H NLV+++  C+
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 594 NEEFKALVLEYMPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
            E    +++E+M +G+L  YL   N   +     L +   ++SA+EYL        IH D
Sbjct: 78  REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 134
Query: 653 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDV 712
           L   N L+ +N +  ++DFG+++L+TG D           I + APE     + S   DV
Sbjct: 135 LAARNCLVGENHLVKVADFGLSRLMTG-DTXTAHAGAKFPIKWTAPESLAYNKFSIKSDV 193
Query: 713 YSFGIMLMETFT 724
           ++FG++L E  T
Sbjct: 194 WAFGVLLWEIAT 205

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 101/207 (48%), Gaps = 5/207 (2%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSN 594
           +G G FG V   + R   +VA+K+   +   +   F  E  +M ++ H  LV++   C+ 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 595 EEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLK 654
           +    ++ EYM +G L  YL    +     Q L +  DV  A+EYL    S   +H DL 
Sbjct: 91  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 147
Query: 655 PSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYS 714
             N L++D  V  +SDFG+++ +  +D+  +   +   + +  PE     + S+  D+++
Sbjct: 148 ARNCLVNDQGVVKVSDFGLSRYVL-DDEETSSVGSKFPVRWSPPEVLMYSKFSSKSDIWA 206
Query: 715 FGIMLMETFTRKKPTDELFNGEMTLKH 741
           FG+++ E ++  K   E F    T +H
Sbjct: 207 FGVLMWEIYSLGKMPYERFTNSETAEH 233

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 61/192 (31%), Positives = 98/192 (51%), Gaps = 7/192 (3%)
Query: 535 IGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCS 593
           +G G FG VY+   +   + VAVK    +     + F  E A+MK I+H NLV+++  C+
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 594 NEEFKALVLEYMPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
            E    ++ E+M +G+L  YL   N   +     L +   ++SA+EYL        IH D
Sbjct: 78  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 134
Query: 653 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDV 712
           L   N L+ +N +  ++DFG+++L+TG D           I + APE     + S   DV
Sbjct: 135 LAARNCLVGENHLVKVADFGLSRLMTG-DTXTAHAGAKFPIKWTAPESLAYNKFSIKSDV 193
Query: 713 YSFGIMLMETFT 724
           ++FG++L E  T
Sbjct: 194 WAFGVLLWEIAT 205

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/261 (28%), Positives = 124/261 (47%), Gaps = 30/261 (11%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGR-AFKSFDVECAMMKSIRHRNLVKVISSCS 593
           +G+G FG V+         VA+K   L+ G  + ++F  E  +MK +RH  LV++ +  S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 594 NEEFKALVLEYMPHGSLEKYLHSS-NYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
            E    +V+EYM  G L  +L       L + Q +++   +AS + Y+        +H D
Sbjct: 84  EEPI-YIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 653 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGQVSTNGD 711
           L+ +N+L+ +N+V  ++DFG+A+L+  ED   T  Q     I + APE    G+ +   D
Sbjct: 140 LRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 712 VYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKE 771
           V+SFGI+L E  T+         G +     VN        EV+D     +         
Sbjct: 198 VWSFGILLTELTTK---------GRVPYPGMVNR-------EVLDQ---VERGYRMPCPP 238
Query: 772 QCVSFVFNLALECTVESPEQR 792
           +C   + +L  +C  + PE+R
Sbjct: 239 ECPESLHDLMCQCWRKDPEER 259

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 119/266 (44%), Gaps = 26/266 (9%)
Query: 535 IGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCS 593
           +G G +G VY+   +   + VAVK    +     + F  E A+MK I+H NLV+++  C+
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 594 NEEFKALVLEYMPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
            E    ++ E+M +G+L  YL   N   ++    L +   ++SA+EYL        IH D
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 138
Query: 653 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDV 712
           L   N L+ +N +  ++DFG+++L+TG D           I + APE     + S   DV
Sbjct: 139 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 197
Query: 713 YSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQ 772
           ++FG++L E  T                       P   +++     L ++D      E 
Sbjct: 198 WAFGVLLWEIATYGMS-------------------PYPGIDLSQVYELLEKDYRMERPEG 238
Query: 773 CVSFVFNLALECTVESPEQRINAKEI 798
           C   V+ L   C   +P  R +  EI
Sbjct: 239 CPEKVYELMRACWQWNPSDRPSFAEI 264

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 119/266 (44%), Gaps = 26/266 (9%)
Query: 535 IGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCS 593
           +G G +G VY+   +   + VAVK    +     + F  E A+MK I+H NLV+++  C+
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 594 NEEFKALVLEYMPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
            E    ++ E+M +G+L  YL   N   ++    L +   ++SA+EYL        IH D
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 138
Query: 653 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDV 712
           L   N L+ +N +  ++DFG+++L+TG D           I + APE     + S   DV
Sbjct: 139 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 197
Query: 713 YSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQ 772
           ++FG++L E  T                       P   +++     L ++D      E 
Sbjct: 198 WAFGVLLWEIATYGMS-------------------PYPGIDLSQVYELLEKDYRMERPEG 238
Query: 773 CVSFVFNLALECTVESPEQRINAKEI 798
           C   V+ L   C   +P  R +  EI
Sbjct: 239 CPEKVYELMRACWQWNPSDRPSFAEI 264

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 106/210 (50%), Gaps = 11/210 (5%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCG--RAFKSFDVECAMMKSIRHRNLVKVISSC 592
           IG G FG+VYK +     +VAVK+ N+     +  ++F  E  +++  RH N++  +   
Sbjct: 16  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 593 SNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
           +  +  A+V ++    SL  +LH      ++ + ++I    A  ++YLH   +  +IH D
Sbjct: 74  TKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 129
Query: 653 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR---EGQVSTN 709
           LK +N+ L +++   + DFG+A   +    S    Q   +I +MAPE  R   +   S  
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 189
Query: 710 GDVYSFGIMLMETFTRKKPTDELFNGEMTL 739
            DVY+FGI+L E  T + P   + N +  +
Sbjct: 190 SDVYAFGIVLYELMTGQLPYSNINNRDQII 219

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 118/266 (44%), Gaps = 26/266 (9%)
Query: 535 IGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCS 593
           +G G +G VY+   +   + VAVK    +     + F  E A+MK I+H NLV+++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 594 NEEFKALVLEYMPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
            E    ++ E+M +G+L  YL   N   +     L +   ++SA+EYL        IH D
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 653 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDV 712
           L   N L+ +N +  ++DFG+++L+TG D           I + APE     + S   DV
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 713 YSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQ 772
           ++FG++L E  T                       P   +++     L ++D      E 
Sbjct: 196 WAFGVLLWEIAT-------------------YGMSPYPGIDLSQVYELLEKDYRMERPEG 236
Query: 773 CVSFVFNLALECTVESPEQRINAKEI 798
           C   V+ L   C   +P  R +  EI
Sbjct: 237 CPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 74/261 (28%), Positives = 123/261 (47%), Gaps = 30/261 (11%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGR-AFKSFDVECAMMKSIRHRNLVKVISSCS 593
           +G+G FG V+         VA+K   L+ G  + ++F  E  +MK +RH  LV++ +  S
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKT--LKPGNMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 250
Query: 594 NEEFKALVLEYMPHGSLEKYLHSS-NYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
            E    +V EYM  GSL  +L       L + Q +++   +AS + Y+        +H D
Sbjct: 251 EEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 306
Query: 653 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGQVSTNGD 711
           L+ +N+L+ +N+V  ++DFG+ +L+  ED   T  Q     I + APE    G+ +   D
Sbjct: 307 LRAANILVGENLVCKVADFGLGRLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 364
Query: 712 VYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKE 771
           V+SFGI+L E  T+         G +     VN        EV+D     +         
Sbjct: 365 VWSFGILLTELTTK---------GRVPYPGMVN-------REVLDQ---VERGYRMPCPP 405
Query: 772 QCVSFVFNLALECTVESPEQR 792
           +C   + +L  +C  + PE+R
Sbjct: 406 ECPESLHDLMCQCWRKDPEER 426

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/294 (25%), Positives = 134/294 (45%), Gaps = 42/294 (14%)
Query: 525 ATDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNL-------QCGRAFKSFDVECAM 576
           A ++      IG+GGFG V+K R ++D   VA+K   L       +    F+ F  E  +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 577 MKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASA 636
           M ++ H N+VK+     N     +V+E++P G L   L    + +    +L +M+D+A  
Sbjct: 77  MSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 637 LEYLHFGYSAPVIHCDLKPSNVL---LDDN--MVAHLSDFGIAKLLTGEDQSM-TQTQTL 690
           +EY+    + P++H DL+  N+    LD+N  + A ++DF +++      QS+ + +  L
Sbjct: 135 IEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ------QSVHSVSGLL 187
Query: 691 ATIGYMAPEY--GREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLP 748
               +MAPE     E   +   D YSF ++L    T + P DE   G++           
Sbjct: 188 GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF--------- 238
Query: 749 ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL 802
                    N++ +E +     E C   + N+   C    P++R +   IV +L
Sbjct: 239 --------INMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 118/266 (44%), Gaps = 26/266 (9%)
Query: 535 IGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCS 593
           +G G +G VY+   +   + VAVK    +     + F  E A+MK I+H NLV+++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 594 NEEFKALVLEYMPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
            E    ++ E+M +G+L  YL   N   +     L +   ++SA+EYL        IH D
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 653 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDV 712
           L   N L+ +N +  ++DFG+++L+TG D           I + APE     + S   DV
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 713 YSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQ 772
           ++FG++L E  T                       P   +++     L ++D      E 
Sbjct: 196 WAFGVLLWEIATYGMS-------------------PYPGIDLSQVYELLEKDYRMERPEG 236
Query: 773 CVSFVFNLALECTVESPEQRINAKEI 798
           C   V+ L   C   +P  R +  EI
Sbjct: 237 CPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 74/273 (27%), Positives = 130/273 (47%), Gaps = 26/273 (9%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCG--RAFKSFDVECAMMKSIRHRNLVKVISSC 592
           IG G FG+VYK +     +VAVK+ N+     +  ++F  E  +++  RH N++  +   
Sbjct: 32  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 593 SNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
           +  +  A+V ++    SL  +LH+S    ++ + ++I    A  ++YLH   +  +IH D
Sbjct: 90  TAPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRD 145
Query: 653 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR---EGQVSTN 709
           LK +N+ L ++    + DFG+A   +    S    Q   +I +MAPE  R       S  
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205
Query: 710 GDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVA 769
            DVY+FGI+L E  T + P   + N +  +             E+V    LS  D+  V 
Sbjct: 206 SDVYAFGIVLYELMTGQLPYSNINNRDQII-------------EMVGRGSLS-PDLSKV- 250
Query: 770 KEQCVSFVFNLALECTVESPEQRINAKEIVAKL 802
           +  C   +  L  EC  +  ++R +   I+A++
Sbjct: 251 RSNCPKRMKRLMAECLKKKRDERPSFPRILAEI 283

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 119/266 (44%), Gaps = 26/266 (9%)
Query: 535 IGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCS 593
           +G G +G VY+   +   + VAVK    +     + F  E A+MK I+H NLV+++  C+
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 594 NEEFKALVLEYMPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
            E    ++ E+M +G+L  YL   N   ++    L +   ++SA+EYL        IH D
Sbjct: 81  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 137
Query: 653 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDV 712
           L   N L+ +N +  ++DFG+++L+TG D           I + APE     + S   DV
Sbjct: 138 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAPAGAKFPIKWTAPESLAYNKFSIKSDV 196
Query: 713 YSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQ 772
           ++FG++L E  T                       P   +++     L ++D      E 
Sbjct: 197 WAFGVLLWEIATY-------------------GMSPYPGIDLSQVYELLEKDYRMERPEG 237
Query: 773 CVSFVFNLALECTVESPEQRINAKEI 798
           C   V+ L   C   +P  R +  EI
Sbjct: 238 CPEKVYELMRACWQWNPSDRPSFAEI 263

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 119/266 (44%), Gaps = 26/266 (9%)
Query: 535 IGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCS 593
           +G G +G VY+   +   + VAVK    +     + F  E A+MK I+H NLV+++  C+
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 594 NEEFKALVLEYMPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
            E    ++ E+M +G+L  YL   N   ++    L +   ++SA+EYL        IH D
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 138
Query: 653 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDV 712
           L   N L+ +N +  ++DFG+++L+TG D           I + APE     + S   DV
Sbjct: 139 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAPAGAKFPIKWTAPESLAYNKFSIKSDV 197
Query: 713 YSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQ 772
           ++FG++L E  T                       P   +++     L ++D      E 
Sbjct: 198 WAFGVLLWEIATY-------------------GMSPYPGIDLSQVYELLEKDYRMERPEG 238
Query: 773 CVSFVFNLALECTVESPEQRINAKEI 798
           C   V+ L   C   +P  R +  EI
Sbjct: 239 CPEKVYELMRACWQWNPSDRPSFAEI 264

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/295 (25%), Positives = 134/295 (45%), Gaps = 41/295 (13%)
Query: 526 TDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRA---FKSFDVECAMMKSIR 581
           +D++    ++G GG   V+ AR +R   +VAVKV      R    +  F  E     ++ 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 582 HRNLVKVISSCSNE----EFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASAL 637
           H  +V V ++   E        +V+EY+   +L   +H+      +  +  I + +A A 
Sbjct: 71  HPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEV-IADAC 126
Query: 638 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT-LATIGYM 696
           + L+F +   +IH D+KP+N+++       + DFGIA+ +     S+TQT   + T  Y+
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 697 APEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGE----MTLKHWVNDCLPISTM 752
           +PE  R   V    DVYS G +L E  T + P    F G+    +  +H   D +P S  
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVSVAYQHVREDPIPPS-- 240
Query: 753 EVVDANLLSQEDIHFVAKEQCVSFVFN-LALECTVESPEQRIN-AKEIVAKLLKI 805
                           A+ + +S   + + L+   ++PE R   A E+ A L+++
Sbjct: 241 ----------------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Composition-based stats.
 Identities = 72/266 (27%), Positives = 119/266 (44%), Gaps = 26/266 (9%)
Query: 535 IGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCS 593
           +G G +G VY+   +   + VAVK    +     + F  E A+MK I+H NLV+++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 594 NEEFKALVLEYMPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
            E    ++ E+M +G+L  YL   N   ++    L +   ++SA+EYL        IH D
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 653 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDV 712
           L   N L+ +N +  ++DFG+++L+TG D           I + APE     + S   DV
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 713 YSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQ 772
           ++FG++L E  T                       P   +++     L ++D      E 
Sbjct: 196 WAFGVLLWEIATYGMS-------------------PYPGIDLSQVYELLEKDYRMERPEG 236
Query: 773 CVSFVFNLALECTVESPEQRINAKEI 798
           C   V+ L   C   +P  R +  EI
Sbjct: 237 CPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Composition-based stats.
 Identities = 72/266 (27%), Positives = 119/266 (44%), Gaps = 26/266 (9%)
Query: 535 IGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCS 593
           +G G +G VY+   +   + VAVK    +     + F  E A+MK I+H NLV+++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 594 NEEFKALVLEYMPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
            E    ++ E+M +G+L  YL   N   ++    L +   ++SA+EYL        IH D
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 653 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDV 712
           L   N L+ +N +  ++DFG+++L+TG D           I + APE     + S   DV
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 713 YSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQ 772
           ++FG++L E  T                       P   +++     L ++D      E 
Sbjct: 196 WAFGVLLWEIATYGMS-------------------PYPGIDLSQVYELLEKDYRMERPEG 236
Query: 773 CVSFVFNLALECTVESPEQRINAKEI 798
           C   V+ L   C   +P  R +  EI
Sbjct: 237 CPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 75/261 (28%), Positives = 123/261 (47%), Gaps = 30/261 (11%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGR-AFKSFDVECAMMKSIRHRNLVKVISSCS 593
           +G+G FG V+         VA+K   L+ G  + ++F  E  +MK +RH  LV++ +  S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 594 NEEFKALVLEYMPHGSLEKYLHSS-NYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
            E    +V EYM  GSL  +L       L + Q +++   +AS + Y+        +H D
Sbjct: 84  EEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 653 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGQVSTNGD 711
           L  +N+L+ +N+V  ++DFG+A+L+  ED   T  Q     I + APE    G+ +   D
Sbjct: 140 LAAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 712 VYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKE 771
           V+SFGI+L E  T+         G +     VN        EV+D     +         
Sbjct: 198 VWSFGILLTELTTK---------GRVPYPGMVNR-------EVLDQ---VERGYRMPCPP 238
Query: 772 QCVSFVFNLALECTVESPEQR 792
           +C   + +L  +C  + PE+R
Sbjct: 239 ECPESLHDLMCQCWRKDPEER 259

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 101/207 (48%), Gaps = 5/207 (2%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSN 594
           +G G FG V   + R   +VA+K+   +   +   F  E  +M ++ H  LV++   C+ 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 595 EEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLK 654
           +    ++ EYM +G L  YL    +     Q L +  DV  A+EYL    S   +H DL 
Sbjct: 91  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 147
Query: 655 PSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYS 714
             N L++D  V  +SDFG+++ +  +D+  +   +   + +  PE     + S+  D+++
Sbjct: 148 ARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWA 206
Query: 715 FGIMLMETFTRKKPTDELFNGEMTLKH 741
           FG+++ E ++  K   E F    T +H
Sbjct: 207 FGVLMWEIYSLGKMPYERFTNSETAEH 233

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 71/266 (26%), Positives = 119/266 (44%), Gaps = 26/266 (9%)
Query: 535 IGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCS 593
           +G G +G VY+   +   + VAVK    +     + F  E A+MK I+H NLV+++  C+
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 325
Query: 594 NEEFKALVLEYMPHGSLEKYLHSSNYS-LDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
            E    ++ E+M +G+L  YL   N   ++    L +   ++SA+EYL        IH +
Sbjct: 326 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRN 382
Query: 653 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDV 712
           L   N L+ +N +  ++DFG+++L+TG D           I + APE     + S   DV
Sbjct: 383 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 441
Query: 713 YSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQ 772
           ++FG++L E  T                       P   +++     L ++D      E 
Sbjct: 442 WAFGVLLWEIATY-------------------GMSPYPGIDLSQVYELLEKDYRMERPEG 482
Query: 773 CVSFVFNLALECTVESPEQRINAKEI 798
           C   V+ L   C   +P  R +  EI
Sbjct: 483 CPEKVYELMRACWQWNPSDRPSFAEI 508

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 101/207 (48%), Gaps = 5/207 (2%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSN 594
           +G G FG V   + R   +VA+K+   +   +   F  E  +M ++ H  LV++   C+ 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 595 EEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLK 654
           +    ++ EYM +G L  YL    +     Q L +  DV  A+EYL    S   +H DL 
Sbjct: 76  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 132
Query: 655 PSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYS 714
             N L++D  V  +SDFG+++ +  +D+  +   +   + +  PE     + S+  D+++
Sbjct: 133 ARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWA 191
Query: 715 FGIMLMETFTRKKPTDELFNGEMTLKH 741
           FG+++ E ++  K   E F    T +H
Sbjct: 192 FGVLMWEIYSLGKMPYERFTNSETAEH 218

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 106/210 (50%), Gaps = 11/210 (5%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCG--RAFKSFDVECAMMKSIRHRNLVKVISSC 592
           IG G FG+VYK +     +VAVK+ N+     +  ++F  E  +++  RH N++  +   
Sbjct: 36  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 93
Query: 593 SNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
           +  +  A+V ++    SL  +LH      ++ + ++I    A  ++YLH   +  +IH D
Sbjct: 94  TKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 149
Query: 653 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR---EGQVSTN 709
           LK +N+ L +++   + DFG+A   +    S    Q   +I +MAPE  R   +   S  
Sbjct: 150 LKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 209
Query: 710 GDVYSFGIMLMETFTRKKPTDELFNGEMTL 739
            DVY+FGI+L E  T + P   + N +  +
Sbjct: 210 SDVYAFGIVLYELMTGQLPYSNINNRDQII 239

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 106/210 (50%), Gaps = 11/210 (5%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCG--RAFKSFDVECAMMKSIRHRNLVKVISSC 592
           IG G FG+VYK +     +VAVK+ N+     +  ++F  E  +++  RH N++  +   
Sbjct: 44  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 593 SNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
           +  +  A+V ++    SL  +LH      ++ + ++I    A  ++YLH   +  +IH D
Sbjct: 102 TKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 157
Query: 653 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR---EGQVSTN 709
           LK +N+ L +++   + DFG+A   +    S    Q   +I +MAPE  R   +   S  
Sbjct: 158 LKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 217
Query: 710 GDVYSFGIMLMETFTRKKPTDELFNGEMTL 739
            DVY+FGI+L E  T + P   + N +  +
Sbjct: 218 SDVYAFGIVLYELMTGQLPYSNINNRDQII 247

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 101/207 (48%), Gaps = 5/207 (2%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSN 594
           +G G FG V   + R   +VA+K+   +   +   F  E  +M ++ H  LV++   C+ 
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 74
Query: 595 EEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLK 654
           +    ++ EYM +G L  YL    +     Q L +  DV  A+EYL    S   +H DL 
Sbjct: 75  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 131
Query: 655 PSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYS 714
             N L++D  V  +SDFG+++ +  +D+  +   +   + +  PE     + S+  D+++
Sbjct: 132 ARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWA 190
Query: 715 FGIMLMETFTRKKPTDELFNGEMTLKH 741
           FG+++ E ++  K   E F    T +H
Sbjct: 191 FGVLMWEIYSLGKMPYERFTNSETAEH 217

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 74/261 (28%), Positives = 123/261 (47%), Gaps = 30/261 (11%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGR-AFKSFDVECAMMKSIRHRNLVKVISSCS 593
           +G+G FG V+         VA+K   L+ G  + ++F  E  +MK +RH  LV++ +  S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 594 NEEFKALVLEYMPHGSLEKYLHSS-NYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
            E    +V EYM  G L  +L       L + Q +++   +AS + Y+        +H D
Sbjct: 84  EEPI-YIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 653 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGQVSTNGD 711
           L+ +N+L+ +N+V  ++DFG+A+L+  ED   T  Q     I + APE    G+ +   D
Sbjct: 140 LRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 712 VYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKE 771
           V+SFGI+L E  T+         G +     VN        EV+D     +         
Sbjct: 198 VWSFGILLTELTTK---------GRVPYPGMVNR-------EVLDQ---VERGYRMPCPP 238
Query: 772 QCVSFVFNLALECTVESPEQR 792
           +C   + +L  +C  + PE+R
Sbjct: 239 ECPESLHDLMCQCWRKDPEER 259

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 76/295 (25%), Positives = 133/295 (45%), Gaps = 41/295 (13%)
Query: 526 TDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRA---FKSFDVECAMMKSIR 581
           +D++    ++G GG   V+ AR +R   +VAVKV      R    +  F  E     ++ 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 582 HRNLVKVISSCSNE----EFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASAL 637
           H  +V V  +   E        +V+EY+   +L   +H+      +  +  I + +A A 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEV-IADAC 126
Query: 638 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT-LATIGYM 696
           + L+F +   +IH D+KP+N+++       + DFGIA+ +     S+TQT   + T  Y+
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 697 APEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGE----MTLKHWVNDCLPISTM 752
           +PE  R   V    DVYS G +L E  T + P    F G+    +  +H   D +P S  
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVSVAYQHVREDPIPPS-- 240
Query: 753 EVVDANLLSQEDIHFVAKEQCVSFVFN-LALECTVESPEQRIN-AKEIVAKLLKI 805
                           A+ + +S   + + L+   ++PE R   A E+ A L+++
Sbjct: 241 ----------------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 101/207 (48%), Gaps = 5/207 (2%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSN 594
           +G G FG V   + R   +VA+K+   +   +   F  E  +M ++ H  LV++   C+ 
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 81
Query: 595 EEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLK 654
           +    ++ EYM +G L  YL    +     Q L +  DV  A+EYL    S   +H DL 
Sbjct: 82  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 138
Query: 655 PSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYS 714
             N L++D  V  +SDFG+++ +  +D+  +   +   + +  PE     + S+  D+++
Sbjct: 139 ARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWA 197
Query: 715 FGIMLMETFTRKKPTDELFNGEMTLKH 741
           FG+++ E ++  K   E F    T +H
Sbjct: 198 FGVLMWEIYSLGKMPYERFTNSETAEH 224

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 71/288 (24%), Positives = 140/288 (48%), Gaps = 34/288 (11%)
Query: 532 NNLIGRGGFGSVYKARIR--DGMEVAVKVFNLQCG---RAFKSFDVECAMMKSIRHRNLV 586
             +IG G FG V   R++     +VAV +  L+ G   +  + F  E ++M    H N+V
Sbjct: 48  ERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVV 107
Query: 587 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL-HFGYS 645
            +    +  +   +V+E+M +G+L+ +L   +    + Q + ++  +A+ + YL   GY 
Sbjct: 108 HLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYLADMGY- 166
Query: 646 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM-TQTQTLATIGYMAPEYGREG 704
              +H DL   N+L++ N+V  +SDFG+++++  + +++ T T     + + APE  +  
Sbjct: 167 ---VHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQYR 223
Query: 705 QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQED 764
           + ++  DV+S+GI++ E  +          GE    +W      +S  +V+ A    +E 
Sbjct: 224 KFTSASDVWSYGIVMWEVMS---------YGERP--YW-----DMSNQDVIKA---IEEG 264
Query: 765 IHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLRN 812
               A   C + +  L L+C  +   +R   ++IV     I D ++RN
Sbjct: 265 YRLPAPMDCPAGLHQLMLDCWQKERAERPKFEQIVG----ILDKMIRN 308

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 112/237 (47%), Gaps = 38/237 (16%)
Query: 505 DPNMPPVATWRRFSYLELFQATDKFSENNLIGRGGFGSVYKARIR-DG--MEVAVKVFNL 561
           DP + PV  W    +             ++IG G FG V KARI+ DG  M+ A+K    
Sbjct: 12  DPTIYPVLDWNDIKF------------QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE 59
Query: 562 QCGRA-FKSFDVECAMMKSIRHR-NLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNY 619
              +   + F  E  ++  + H  N++ ++ +C +  +  L +EY PHG+L  +L  S  
Sbjct: 60  YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRV 119
Query: 620 ---------------SLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM 664
                          +L   Q L+   DVA  ++YL        IH +L   N+L+ +N 
Sbjct: 120 LETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRNLAARNILVGENY 176
Query: 665 VAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLME 721
           VA ++DFG+++   G++  + +T     + +MA E       +TN DV+S+G++L E
Sbjct: 177 VAKIADFGLSR---GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWE 230

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 101/207 (48%), Gaps = 5/207 (2%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSN 594
           +G G FG V   + R   +VA+K+   +   +   F  E  +M ++ H  LV++   C+ 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 70
Query: 595 EEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLK 654
           +    ++ EYM +G L  YL    +     Q L +  DV  A+EYL    S   +H DL 
Sbjct: 71  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 127
Query: 655 PSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYS 714
             N L++D  V  +SDFG+++ +  +D+  +   +   + +  PE     + S+  D+++
Sbjct: 128 ARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWA 186
Query: 715 FGIMLMETFTRKKPTDELFNGEMTLKH 741
           FG+++ E ++  K   E F    T +H
Sbjct: 187 FGVLMWEIYSLGKMPYERFTNSETAEH 213

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 101/207 (48%), Gaps = 5/207 (2%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSN 594
           +G G FG V   + R   +VA+K+   +   +   F  E  +M ++ H  LV++   C+ 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 595 EEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLK 654
           +    ++ EYM +G L  YL    +     Q L +  DV  A+EYL    S   +H DL 
Sbjct: 76  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 132
Query: 655 PSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYS 714
             N L++D  V  +SDFG+++ +  +D+  +   +   + +  PE     + S+  D+++
Sbjct: 133 ARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSRGSKFPVRWSPPEVLMYSKFSSKSDIWA 191
Query: 715 FGIMLMETFTRKKPTDELFNGEMTLKH 741
           FG+++ E ++  K   E F    T +H
Sbjct: 192 FGVLMWEIYSLGKMPYERFTNSETAEH 218

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 71/266 (26%), Positives = 118/266 (44%), Gaps = 26/266 (9%)
Query: 535 IGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCS 593
           +G G +G VY+   +   + VAVK    +     + F  E A+MK I+H NLV+++  C+
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 594 NEEFKALVLEYMPHGSLEKYLHSSNYS-LDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
            E    ++ E+M +G+L  YL   N   +     L +   ++SA+EYL        IH +
Sbjct: 287 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRN 343
Query: 653 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDV 712
           L   N L+ +N +  ++DFG+++L+TG D           I + APE     + S   DV
Sbjct: 344 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 402
Query: 713 YSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQ 772
           ++FG++L E  T                       P   +++     L ++D      E 
Sbjct: 403 WAFGVLLWEIATY-------------------GMSPYPGIDLSQVYELLEKDYRMERPEG 443
Query: 773 CVSFVFNLALECTVESPEQRINAKEI 798
           C   V+ L   C   +P  R +  EI
Sbjct: 444 CPEKVYELMRACWQWNPSDRPSFAEI 469

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 76/295 (25%), Positives = 133/295 (45%), Gaps = 41/295 (13%)
Query: 526 TDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRA---FKSFDVECAMMKSIR 581
           +D++    ++G GG   V+ AR +R   +VAVKV      R    +  F  E     ++ 
Sbjct: 28  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 87
Query: 582 HRNLVKVISSCSNE----EFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASAL 637
           H  +V V  +   E        +V+EY+   +L   +H+      +  +  I + +A A 
Sbjct: 88  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEV-IADAC 143
Query: 638 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT-LATIGYM 696
           + L+F +   +IH D+KP+N+++       + DFGIA+ +     S+TQT   + T  Y+
Sbjct: 144 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 203
Query: 697 APEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGE----MTLKHWVNDCLPISTM 752
           +PE  R   V    DVYS G +L E  T + P    F G+    +  +H   D +P S  
Sbjct: 204 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVSVAYQHVREDPIPPS-- 257
Query: 753 EVVDANLLSQEDIHFVAKEQCVSFVFN-LALECTVESPEQRIN-AKEIVAKLLKI 805
                           A+ + +S   + + L+   ++PE R   A E+ A L+++
Sbjct: 258 ----------------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 296

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 80/306 (26%), Positives = 139/306 (45%), Gaps = 33/306 (10%)
Query: 510 PVATWRRFSYLELFQATDKFSENNLIGRGGFGSVYKA-RIRDG----MEVAVKVFNLQCG 564
           P  T    + L + + T+      ++G G FG+VYK   + +G    + VA+K+ N   G
Sbjct: 22  PSGTAPNQAQLRILKETE-LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG 80
Query: 565 -RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDI 623
            +A   F  E  +M S+ H +LV+++  C +   + LV + MPHG L +Y+H    ++  
Sbjct: 81  PKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGS 139
Query: 624 FQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS 683
              LN  + +A  + YL       ++H DL   NVL+       ++DFG+A+LL G+++ 
Sbjct: 140 QLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE 196
Query: 684 MTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHW 742
                    I +MA E     + +   DV+S+G+ + E  T   KP D            
Sbjct: 197 YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG----------- 245
Query: 743 VNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL 802
                 I T E+ D   L ++         C   V+ + ++C +   + R   KE+ A+ 
Sbjct: 246 ------IPTREIPD---LLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEF 296
Query: 803 LKI-RD 807
            ++ RD
Sbjct: 297 SRMARD 302

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 60/192 (31%), Positives = 98/192 (51%), Gaps = 7/192 (3%)
Query: 535 IGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCS 593
           +G G +G VY+   +   + VAVK    +     + F  E A+MK I+H NLV+++  C+
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 594 NEEFKALVLEYMPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
            E    ++ E+M +G+L  YL   N   +     L +   ++SA+EYL        IH D
Sbjct: 78  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 134
Query: 653 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDV 712
           L   N L+ +N +  ++DFG+++L+TG D           I + APE     + S   DV
Sbjct: 135 LAARNCLVGENHLVKVADFGLSRLMTG-DTFTAHAGAKFPIKWTAPESLAYNKFSIKSDV 193
Query: 713 YSFGIMLMETFT 724
           ++FG++L E  T
Sbjct: 194 WAFGVLLWEIAT 205

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 119/261 (45%), Gaps = 30/261 (11%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSN 594
           +G G FG V+        +VAVK    Q   +  +F  E  +MK ++H+ LV++ +  + 
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 88
Query: 595 EEFKALVLEYMPHGSLEKYLHS-SNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 653
           E    ++ EYM +GSL  +L + S   L I + L++   +A  + ++        IH DL
Sbjct: 89  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 144
Query: 654 KPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGQVSTNGDV 712
           + +N+L+ D +   ++DFG+A+L+  ED   T  +     I + APE    G  +   DV
Sbjct: 145 RAANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 202
Query: 713 YSFGIMLMETFTRKK-PTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKE 771
           +SFGI+L E  T  + P   + N E                  V  NL  +     V  +
Sbjct: 203 WSFGILLTEIVTHGRIPYPGMTNPE------------------VIQNL--ERGYRMVRPD 242
Query: 772 QCVSFVFNLALECTVESPEQR 792
            C   ++ L   C  E PE R
Sbjct: 243 NCPEELYQLMRLCWKERPEDR 263

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 119/261 (45%), Gaps = 30/261 (11%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSN 594
           +G G FG V+        +VAVK    Q   +  +F  E  +MK ++H+ LV++ +  + 
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 87
Query: 595 EEFKALVLEYMPHGSLEKYLHS-SNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 653
           E    ++ EYM +GSL  +L + S   L I + L++   +A  + ++        IH DL
Sbjct: 88  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 143
Query: 654 KPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGQVSTNGDV 712
           + +N+L+ D +   ++DFG+A+L+  ED   T  +     I + APE    G  +   DV
Sbjct: 144 RAANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 201
Query: 713 YSFGIMLMETFTRKK-PTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKE 771
           +SFGI+L E  T  + P   + N E                  V  NL  +     V  +
Sbjct: 202 WSFGILLTEIVTHGRIPYPGMTNPE------------------VIQNL--ERGYRMVRPD 241
Query: 772 QCVSFVFNLALECTVESPEQR 792
            C   ++ L   C  E PE R
Sbjct: 242 NCPEELYQLMRLCWKERPEDR 262

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 119/261 (45%), Gaps = 30/261 (11%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSN 594
           +G G FG V+        +VAVK    Q   +  +F  E  +MK ++H+ LV++ +  + 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 595 EEFKALVLEYMPHGSLEKYLHS-SNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 653
           E    ++ EYM +GSL  +L + S   L I + L++   +A  + ++        IH DL
Sbjct: 80  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 135
Query: 654 KPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGQVSTNGDV 712
           + +N+L+ D +   ++DFG+A+L+  ED   T  +     I + APE    G  +   DV
Sbjct: 136 RAANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 713 YSFGIMLMETFTRKK-PTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKE 771
           +SFGI+L E  T  + P   + N E                  V  NL  +     V  +
Sbjct: 194 WSFGILLTEIVTHGRIPYPGMTNPE------------------VIQNL--ERGYRMVRPD 233
Query: 772 QCVSFVFNLALECTVESPEQR 792
            C   ++ L   C  E PE R
Sbjct: 234 NCPEELYQLMRLCWKERPEDR 254

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 119/261 (45%), Gaps = 30/261 (11%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSN 594
           +G G FG V+        +VAVK    Q   +  +F  E  +MK ++H+ LV++ +  + 
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 84
Query: 595 EEFKALVLEYMPHGSLEKYLHS-SNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 653
           E    ++ EYM +GSL  +L + S   L I + L++   +A  + ++        IH DL
Sbjct: 85  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 140
Query: 654 KPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGQVSTNGDV 712
           + +N+L+ D +   ++DFG+A+L+  ED   T  +     I + APE    G  +   DV
Sbjct: 141 RAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 198
Query: 713 YSFGIMLMETFTRKK-PTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKE 771
           +SFGI+L E  T  + P   + N E                  V  NL  +     V  +
Sbjct: 199 WSFGILLTEIVTHGRIPYPGMTNPE------------------VIQNL--ERGYRMVRPD 238
Query: 772 QCVSFVFNLALECTVESPEQR 792
            C   ++ L   C  E PE R
Sbjct: 239 NCPEELYQLMRLCWKERPEDR 259

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 119/261 (45%), Gaps = 30/261 (11%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSN 594
           +G G FG V+        +VAVK    Q   +  +F  E  +MK ++H+ LV++ +  + 
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 85
Query: 595 EEFKALVLEYMPHGSLEKYLHS-SNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 653
           E    ++ EYM +GSL  +L + S   L I + L++   +A  + ++        IH DL
Sbjct: 86  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 141
Query: 654 KPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGQVSTNGDV 712
           + +N+L+ D +   ++DFG+A+L+  ED   T  +     I + APE    G  +   DV
Sbjct: 142 RAANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 199
Query: 713 YSFGIMLMETFTRKK-PTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKE 771
           +SFGI+L E  T  + P   + N E                  V  NL  +     V  +
Sbjct: 200 WSFGILLTEIVTHGRIPYPGMTNPE------------------VIQNL--ERGYRMVRPD 239
Query: 772 QCVSFVFNLALECTVESPEQR 792
            C   ++ L   C  E PE R
Sbjct: 240 NCPEELYQLMRLCWKERPEDR 260

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 119/261 (45%), Gaps = 30/261 (11%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSN 594
           +G G FG V+        +VAVK    Q   +  +F  E  +MK ++H+ LV++ +  + 
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 85
Query: 595 EEFKALVLEYMPHGSLEKYLHS-SNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 653
           E    ++ EYM +GSL  +L + S   L I + L++   +A  + ++        IH DL
Sbjct: 86  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 141
Query: 654 KPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGQVSTNGDV 712
           + +N+L+ D +   ++DFG+A+L+  ED   T  +     I + APE    G  +   DV
Sbjct: 142 RAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 199
Query: 713 YSFGIMLMETFTRKK-PTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKE 771
           +SFGI+L E  T  + P   + N E                  V  NL  +     V  +
Sbjct: 200 WSFGILLTEIVTHGRIPYPGMTNPE------------------VIQNL--ERGYRMVRPD 239
Query: 772 QCVSFVFNLALECTVESPEQR 792
            C   ++ L   C  E PE R
Sbjct: 240 NCPEELYQLMRLCWKERPEDR 260

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 119/261 (45%), Gaps = 30/261 (11%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSN 594
           +G G FG V+        +VAVK    Q   +  +F  E  +MK ++H+ LV++ +  + 
Sbjct: 31  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 89
Query: 595 EEFKALVLEYMPHGSLEKYLHS-SNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 653
           E    ++ EYM +GSL  +L + S   L I + L++   +A  + ++        IH DL
Sbjct: 90  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 145
Query: 654 KPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGQVSTNGDV 712
           + +N+L+ D +   ++DFG+A+L+  ED   T  +     I + APE    G  +   DV
Sbjct: 146 RAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 203
Query: 713 YSFGIMLMETFTRKK-PTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKE 771
           +SFGI+L E  T  + P   + N E                  V  NL  +     V  +
Sbjct: 204 WSFGILLTEIVTHGRIPYPGMTNPE------------------VIQNL--ERGYRMVRPD 243
Query: 772 QCVSFVFNLALECTVESPEQR 792
            C   ++ L   C  E PE R
Sbjct: 244 NCPEELYQLMRLCWKERPEDR 264

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 119/261 (45%), Gaps = 30/261 (11%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSN 594
           +G G FG V+        +VAVK    Q   +  +F  E  +MK ++H+ LV++ +  + 
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 74
Query: 595 EEFKALVLEYMPHGSLEKYLHS-SNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 653
           E    ++ EYM +GSL  +L + S   L I + L++   +A  + ++        IH DL
Sbjct: 75  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 130
Query: 654 KPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGQVSTNGDV 712
           + +N+L+ D +   ++DFG+A+L+  ED   T  +     I + APE    G  +   DV
Sbjct: 131 RAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 188
Query: 713 YSFGIMLMETFTRKK-PTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKE 771
           +SFGI+L E  T  + P   + N E                  V  NL  +     V  +
Sbjct: 189 WSFGILLTEIVTHGRIPYPGMTNPE------------------VIQNL--ERGYRMVRPD 228
Query: 772 QCVSFVFNLALECTVESPEQR 792
            C   ++ L   C  E PE R
Sbjct: 229 NCPEELYQLMRLCWKERPEDR 249

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 79/310 (25%), Positives = 131/310 (42%), Gaps = 59/310 (19%)
Query: 527 DKFSENNLIGRGGFGSVY--------KARIRDGMEVAVKVFNLQCG-RAFKSFDVECAMM 577
           DK +    +G G FG V         K + ++ + VAVK+       +       E  MM
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 578 KSI-RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSN-----YSLDI-------- 623
           K I +H+N++ ++ +C+ +    +++EY   G+L +YL +       YS DI        
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 624 -FQRL-NIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 681
            F+ L +    +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 682 QSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKK------PTDELFNG 735
                T     + +MAPE   +   +   DV+SFG+++ E FT         P +ELF  
Sbjct: 212 XXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK- 270
Query: 736 EMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINA 795
                                   L +E         C + ++ +  +C    P QR   
Sbjct: 271 ------------------------LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTF 306
Query: 796 KEIVAKLLKI 805
           K++V  L +I
Sbjct: 307 KQLVEDLDRI 316

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/288 (23%), Positives = 135/288 (46%), Gaps = 36/288 (12%)
Query: 534 LIGRGGFGSVYKARIR--DGMEVAVKVFNLQCG---RAFKSFDVECAMMKSIRHRNLVKV 588
           +IG G FG V + R++     E  V +  L+ G   R  + F  E ++M    H N++++
Sbjct: 23  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRL 82
Query: 589 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPV 648
               +N     ++ E+M +G+L+ +L  ++    + Q + ++  +AS + YL        
Sbjct: 83  EGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLA---EMSY 139
Query: 649 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA---TIGYMAPEYGREGQ 705
           +H DL   N+L++ N+V  +SDFG+++ L       T+T +L     I + APE     +
Sbjct: 140 VHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFRK 199
Query: 706 VSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQED 764
            ++  D +S+GI++ E  +  ++P            +W      +S  +V++A    ++D
Sbjct: 200 FTSASDAWSYGIVMWEVMSFGERP------------YW-----DMSNQDVINA---IEQD 239
Query: 765 IHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLRN 812
                   C + +  L L+C  +    R    ++V+ L    D ++RN
Sbjct: 240 YRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSAL----DKMIRN 283

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/289 (24%), Positives = 137/289 (47%), Gaps = 36/289 (12%)
Query: 532 NNLIGRGGFGSVYKARIR--DGMEVAVKVFNLQCG---RAFKSFDVECAMMKSIRHRNLV 586
             +IG G FG V   R++     E+ V +  L+ G   +  + F  E ++M    H N++
Sbjct: 27  ERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 86
Query: 587 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL-HFGYS 645
            +    +  +   +V EYM +GSL+ +L  ++    + Q + ++  +++ ++YL   GY 
Sbjct: 87  HLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLSDMGY- 145
Query: 646 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQ-TLATIGYMAPEYGREG 704
              +H DL   N+L++ N+V  +SDFG++++L  + ++   T+     I + APE     
Sbjct: 146 ---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFR 202
Query: 705 QVSTNGDVYSFGIMLMETFTR-KKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQE 763
           + ++  DV+S+GI++ E  +  ++P  E+ N                  +V+ A    +E
Sbjct: 203 KFTSASDVWSYGIVMWEVVSYGERPYWEMTN-----------------QDVIKA---VEE 242
Query: 764 DIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLRN 812
                +   C + ++ L L+C  +    R    EIV  L    D L+RN
Sbjct: 243 GYRLPSPMDCPAALYQLMLDCWQKERNSRPKFDEIVNML----DKLIRN 287

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 72/261 (27%), Positives = 119/261 (45%), Gaps = 30/261 (11%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSN 594
           +G G FG V+        +VAVK    Q   +  +F  E  +MK ++H+ LV++ +  + 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 595 EEFKALVLEYMPHGSLEKYLHS-SNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 653
           E    ++ EYM +GSL  +L + S   L I + L++   +A  + ++        IH DL
Sbjct: 80  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 135
Query: 654 KPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGQVSTNGDV 712
           + +N+L+ D +   ++DFG+A+L+  ED   T  +     I + APE    G  +   DV
Sbjct: 136 RAANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 713 YSFGIMLMETFTRKK-PTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKE 771
           +SFGI+L E  T  + P   + N E+           I  +E              V  +
Sbjct: 194 WSFGILLTEIVTHGRIPYPGMTNPEV-----------IQNLE---------RGYRMVRPD 233
Query: 772 QCVSFVFNLALECTVESPEQR 792
            C   ++ L   C  E PE R
Sbjct: 234 NCPEELYQLMRLCWKERPEDR 254

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 72/261 (27%), Positives = 119/261 (45%), Gaps = 30/261 (11%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSN 594
           +G G FG V+        +VAVK    Q   +  +F  E  +MK ++H+ LV++ +  + 
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 80
Query: 595 EEFKALVLEYMPHGSLEKYLHS-SNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 653
           E    ++ EYM +GSL  +L + S   L I + L++   +A  + ++        IH DL
Sbjct: 81  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 136
Query: 654 KPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGQVSTNGDV 712
           + +N+L+ D +   ++DFG+A+L+  ED   T  +     I + APE    G  +   DV
Sbjct: 137 RAANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 194
Query: 713 YSFGIMLMETFTRKK-PTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKE 771
           +SFGI+L E  T  + P   + N E+           I  +E              V  +
Sbjct: 195 WSFGILLTEIVTHGRIPYPGMTNPEV-----------IQNLE---------RGYRMVRPD 234
Query: 772 QCVSFVFNLALECTVESPEQR 792
            C   ++ L   C  E PE R
Sbjct: 235 NCPEELYQLMRLCWKERPEDR 255

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 76/283 (26%), Positives = 131/283 (46%), Gaps = 32/283 (11%)
Query: 533 NLIGRGGFGSVYKA-RIRDG----MEVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLV 586
            ++G G FG+VYK   + +G    + VA+K+ N   G +A   F  E  +M S+ H +LV
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 80
Query: 587 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSA 646
           +++  C +   + LV + MPHG L +Y+H    ++     LN  + +A  + YL      
Sbjct: 81  RLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ER 136
Query: 647 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQV 706
            ++H DL   NVL+       ++DFG+A+LL G+++          I +MA E     + 
Sbjct: 137 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 196
Query: 707 STNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDI 765
           +   DV+S+G+ + E  T   KP D                  I T E+ D   L ++  
Sbjct: 197 THQSDVWSYGVTIWELMTFGGKPYDG-----------------IPTREIPD---LLEKGE 236
Query: 766 HFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKI-RD 807
                  C   V+ + ++C +   + R   KE+ A+  ++ RD
Sbjct: 237 RLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 279

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 72/261 (27%), Positives = 119/261 (45%), Gaps = 30/261 (11%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSN 594
           +G G FG V+        +VAVK    Q   +  +F  E  +MK ++H+ LV++ +  + 
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 81
Query: 595 EEFKALVLEYMPHGSLEKYLHS-SNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 653
           E    ++ EYM +GSL  +L + S   L I + L++   +A  + ++        IH DL
Sbjct: 82  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 137
Query: 654 KPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGQVSTNGDV 712
           + +N+L+ D +   ++DFG+A+L+  ED   T  +     I + APE    G  +   DV
Sbjct: 138 RAANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 195
Query: 713 YSFGIMLMETFTRKK-PTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKE 771
           +SFGI+L E  T  + P   + N E+           I  +E              V  +
Sbjct: 196 WSFGILLTEIVTHGRIPYPGMTNPEV-----------IQNLE---------RGYRMVRPD 235
Query: 772 QCVSFVFNLALECTVESPEQR 792
            C   ++ L   C  E PE R
Sbjct: 236 NCPEELYQLMRLCWKERPEDR 256

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 72/261 (27%), Positives = 119/261 (45%), Gaps = 30/261 (11%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSN 594
           +G G FG V+        +VAVK    Q   +  +F  E  +MK ++H+ LV++ +  + 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 595 EEFKALVLEYMPHGSLEKYLHS-SNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 653
           E    ++ EYM +GSL  +L + S   L I + L++   +A  + ++        IH DL
Sbjct: 80  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 135
Query: 654 KPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGQVSTNGDV 712
           + +N+L+ D +   ++DFG+A+L+  ED   T  +     I + APE    G  +   DV
Sbjct: 136 RAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 713 YSFGIMLMETFTRKK-PTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKE 771
           +SFGI+L E  T  + P   + N E+           I  +E              V  +
Sbjct: 194 WSFGILLTEIVTHGRIPYPGMTNPEV-----------IQNLE---------RGYRMVRPD 233
Query: 772 QCVSFVFNLALECTVESPEQR 792
            C   ++ L   C  E PE R
Sbjct: 234 NCPEELYQLMRLCWKERPEDR 254

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 79/310 (25%), Positives = 131/310 (42%), Gaps = 59/310 (19%)
Query: 527 DKFSENNLIGRGGFGSVY--------KARIRDGMEVAVKVFNLQCG-RAFKSFDVECAMM 577
           DK +    +G G FG V         K + ++ + VAVK+       +       E  MM
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 578 KSI-RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSN-----YSLDI-------- 623
           K I +H+N++ ++ +C+ +    +++EY   G+L +YL +       YS DI        
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 624 -FQRL-NIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 681
            F+ L +    +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMRIADFGLARDINNID 211
Query: 682 QSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKK------PTDELFNG 735
                T     + +MAPE   +   +   DV+SFG+++ E FT         P +ELF  
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK- 270
Query: 736 EMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINA 795
                                   L +E         C + ++ +  +C    P QR   
Sbjct: 271 ------------------------LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTF 306
Query: 796 KEIVAKLLKI 805
           K++V  L +I
Sbjct: 307 KQLVEDLDRI 316

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 79/310 (25%), Positives = 131/310 (42%), Gaps = 59/310 (19%)
Query: 527 DKFSENNLIGRGGFGSVY--------KARIRDGMEVAVKVFNLQCG-RAFKSFDVECAMM 577
           DK +    +G G FG V         K + ++ + VAVK+       +       E  MM
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 578 KSI-RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSN-----YSLDI-------- 623
           K I +H+N++ ++ +C+ +    +++EY   G+L +YL +       YS DI        
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 624 -FQRL-NIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 681
            F+ L +    +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 682 QSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKK------PTDELFNG 735
                T     + +MAPE   +   +   DV+SFG+++ E FT         P +ELF  
Sbjct: 212 YYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK- 270
Query: 736 EMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINA 795
                                   L +E         C + ++ +  +C    P QR   
Sbjct: 271 ------------------------LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTF 306
Query: 796 KEIVAKLLKI 805
           K++V  L +I
Sbjct: 307 KQLVEDLDRI 316

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/260 (27%), Positives = 119/260 (45%), Gaps = 28/260 (10%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSN 594
           +G G FG V+ A      +VAVK        + ++F  E  +MK+++H  LVK+ +  + 
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 254
Query: 595 EEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASAL-EYLHFGYSAPVIHCDL 653
           E    ++ E+M  GSL  +L S   S    Q L  +ID ++ + E + F      IH DL
Sbjct: 255 EPI-YIITEFMAKGSLLDFLKSDEGSK---QPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 310
Query: 654 KPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGQVSTNGDV 712
           + +N+L+  ++V  ++DFG+A+++  ED   T  +     I + APE    G  +   DV
Sbjct: 311 RAANILVSASLVCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 368
Query: 713 YSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQ 772
           +SFGI+LME  T  +                   +P   M   +     +        E 
Sbjct: 369 WSFGILLMEIVTYGR-------------------IPYPGMSNPEVIRALERGYRMPRPEN 409
Query: 773 CVSFVFNLALECTVESPEQR 792
           C   ++N+ + C    PE+R
Sbjct: 410 CPEELYNIMMRCWKNRPEER 429

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Composition-based stats.
 Identities = 71/260 (27%), Positives = 119/260 (45%), Gaps = 28/260 (10%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSN 594
           +G G FG V+ A      +VAVK        + ++F  E  +MK+++H  LVK+ +  + 
Sbjct: 23  LGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 81
Query: 595 EEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASAL-EYLHFGYSAPVIHCDL 653
           E    ++ E+M  GSL  +L S   S    Q L  +ID ++ + E + F      IH DL
Sbjct: 82  EPI-YIITEFMAKGSLLDFLKSDEGSK---QPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 137
Query: 654 KPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGQVSTNGDV 712
           + +N+L+  ++V  ++DFG+A+++  ED   T  +     I + APE    G  +   DV
Sbjct: 138 RAANILVSASLVCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 195
Query: 713 YSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQ 772
           +SFGI+LME  T  +                   +P   M   +     +        E 
Sbjct: 196 WSFGILLMEIVTYGR-------------------IPYPGMSNPEVIRALERGYRMPRPEN 236
Query: 773 CVSFVFNLALECTVESPEQR 792
           C   ++N+ + C    PE+R
Sbjct: 237 CPEELYNIMMRCWKNRPEER 256

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 79/310 (25%), Positives = 131/310 (42%), Gaps = 59/310 (19%)
Query: 527 DKFSENNLIGRGGFGSVY--------KARIRDGMEVAVKVFNLQCG-RAFKSFDVECAMM 577
           DK +    +G G FG V         K + ++ + VAVK+       +       E  MM
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 578 KSI-RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSN-----YSLDI-------- 623
           K I +H+N++ ++ +C+ +    +++EY   G+L +YL +       YS DI        
Sbjct: 95  KMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 624 -FQRL-NIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 681
            F+ L +    +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 682 QSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKK------PTDELFNG 735
                T     + +MAPE   +   +   DV+SFG+++ E FT         P +ELF  
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK- 270
Query: 736 EMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINA 795
                                   L +E         C + ++ +  +C    P QR   
Sbjct: 271 ------------------------LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTF 306
Query: 796 KEIVAKLLKI 805
           K++V  L +I
Sbjct: 307 KQLVEDLDRI 316

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 79/310 (25%), Positives = 131/310 (42%), Gaps = 59/310 (19%)
Query: 527 DKFSENNLIGRGGFGSVY--------KARIRDGMEVAVKVFNLQCG-RAFKSFDVECAMM 577
           DK +    +G G FG V         K + ++ + VAVK+       +       E  MM
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 578 KSI-RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSN-----YSLDI-------- 623
           K I +H+N++ ++ +C+ +    +++EY   G+L +YL +       YS DI        
Sbjct: 95  KMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 624 -FQRL-NIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 681
            F+ L +    +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 682 QSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKK------PTDELFNG 735
                T     + +MAPE   +   +   DV+SFG+++ E FT         P +ELF  
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK- 270
Query: 736 EMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINA 795
                                   L +E         C + ++ +  +C    P QR   
Sbjct: 271 ------------------------LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTF 306
Query: 796 KEIVAKLLKI 805
           K++V  L +I
Sbjct: 307 KQLVEDLDRI 316

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 103/196 (52%), Gaps = 11/196 (5%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGR-AFKSFDVECAMMKSIRHRNLVKVISSCS 593
           +G G FG V+        +VA+K   L+ G  + +SF  E  +MK ++H  LV++ +  S
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKT--LKPGTMSPESFLEEAQIMKKLKHDKLVQLYAVVS 74
Query: 594 NEEFKALVLEYMPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
            E    +V EYM  GSL  +L      +L +   +++   VA+ + Y+        IH D
Sbjct: 75  EEPI-YIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRD 130
Query: 653 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGQVSTNGD 711
           L+ +N+L+ + ++  ++DFG+A+L+  ED   T  Q     I + APE    G+ +   D
Sbjct: 131 LRSANILVGNGLICKIADFGLARLI--EDNEXTARQGAKFPIKWTAPEAALYGRFTIKSD 188
Query: 712 VYSFGIMLMETFTRKK 727
           V+SFGI+L E  T+ +
Sbjct: 189 VWSFGILLTELVTKGR 204

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 132/283 (46%), Gaps = 41/283 (14%)
Query: 528 KFSENNLIGRGGFGSVYKARIR--DG--MEVAVKVF--NLQCGRAFKSFDVECAMMKSIR 581
           +F+   ++G+G FGSV +A+++  DG  ++VAVK+   ++      + F  E A MK   
Sbjct: 24  QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFD 83
Query: 582 HRNLVKVISSCSNEEFKA------LVLEYMPHGSLEKYLHSSN-----YSLDIFQRLNIM 630
           H ++ K++        K       ++L +M HG L  +L +S      ++L +   +  M
Sbjct: 84  HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFM 143
Query: 631 IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTL 690
           +D+A  +EYL    S   IH DL   N +L ++M   ++DFG+++ +   D       + 
Sbjct: 144 VDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASK 200
Query: 691 ATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTR-KKPTDELFNGEMTLKHWVNDCLPI 749
             + ++A E   +   + + DV++FG+ + E  TR + P   + N E+            
Sbjct: 201 LPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI------------ 248
Query: 750 STMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQR 792
               ++  N L Q         +C+  V++L  +C    P+QR
Sbjct: 249 -YNYLIGGNRLKQ-------PPECMEEVYDLMYQCWSADPKQR 283

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 68/290 (23%), Positives = 134/290 (46%), Gaps = 36/290 (12%)
Query: 532 NNLIGRGGFGSVYKARIR--DGMEVAVKVFNLQCG---RAFKSFDVECAMMKSIRHRNLV 586
             +IG G FG V + R++     E  V +  L+ G   R  + F  E ++M    H N++
Sbjct: 19  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 78
Query: 587 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSA 646
           ++    +N     ++ E+M +G+L+ +L  ++    + Q + ++  +AS + YL      
Sbjct: 79  RLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLA---EM 135
Query: 647 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA---TIGYMAPEYGRE 703
             +H DL   N+L++ N+V  +SDFG+++ L       T T +L     I + APE    
Sbjct: 136 SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAF 195
Query: 704 GQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ 762
            + ++  D +S+GI++ E  +  ++P            +W      +S  +V++A    +
Sbjct: 196 RKFTSASDAWSYGIVMWEVMSFGERP------------YW-----DMSNQDVINA---IE 235
Query: 763 EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLRN 812
           +D        C + +  L L+C  +    R    ++V+ L    D ++RN
Sbjct: 236 QDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSAL----DKMIRN 281

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 72/261 (27%), Positives = 119/261 (45%), Gaps = 30/261 (11%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSN 594
           +G G FG V+        +VAVK    Q   +  +F  E  +MK ++H+ LV++ +  + 
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 75
Query: 595 EEFKALVLEYMPHGSLEKYLHS-SNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 653
           E    ++ EYM +GSL  +L + S   L I + L++   +A  + ++        IH +L
Sbjct: 76  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRNL 131
Query: 654 KPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGQVSTNGDV 712
           + +N+L+ D +   ++DFG+A+L+  ED   T  +     I + APE    G  +   DV
Sbjct: 132 RAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 189
Query: 713 YSFGIMLMETFTRKK-PTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKE 771
           +SFGI+L E  T  + P   + N E                  V  NL  +     V  +
Sbjct: 190 WSFGILLTEIVTHGRIPYPGMTNPE------------------VIQNL--ERGYRMVRPD 229
Query: 772 QCVSFVFNLALECTVESPEQR 792
            C   ++ L   C  E PE R
Sbjct: 230 NCPEELYQLMRLCWKERPEDR 250

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 79/310 (25%), Positives = 130/310 (41%), Gaps = 59/310 (19%)
Query: 527 DKFSENNLIGRGGFGSVY--------KARIRDGMEVAVKVFNLQCGRA-FKSFDVECAMM 577
           DK +    +G G FG V         K + ++ + VAVK+               E  MM
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMM 94
Query: 578 KSI-RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSN-----YSLDI-------- 623
           K I +H+N++ ++ +C+ +    +++EY   G+L +YL +       YS DI        
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 624 -FQRL-NIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 681
            F+ L +    +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 682 QSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKK------PTDELFNG 735
                T     + +MAPE   +   +   DV+SFG+++ E FT         P +ELF  
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK- 270
Query: 736 EMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINA 795
                                   L +E         C + ++ +  +C    P QR   
Sbjct: 271 ------------------------LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTF 306
Query: 796 KEIVAKLLKI 805
           K++V  L +I
Sbjct: 307 KQLVEDLDRI 316

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 79/310 (25%), Positives = 131/310 (42%), Gaps = 59/310 (19%)
Query: 527 DKFSENNLIGRGGFGSVY--------KARIRDGMEVAVKVFNLQCG-RAFKSFDVECAMM 577
           DK +    +G G FG V         K + ++ + VAVK+       +       E  MM
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 578 KSI-RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSN-----YSLDI-------- 623
           K I +H+N++ ++ +C+ +    +++EY   G+L +YL +       YS DI        
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 624 -FQRL-NIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 681
            F+ L +    +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D
Sbjct: 201 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 257
Query: 682 QSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKK------PTDELFNG 735
                T     + +MAPE   +   +   DV+SFG+++ E FT         P +ELF  
Sbjct: 258 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK- 316
Query: 736 EMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINA 795
                                   L +E         C + ++ +  +C    P QR   
Sbjct: 317 ------------------------LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTF 352
Query: 796 KEIVAKLLKI 805
           K++V  L +I
Sbjct: 353 KQLVEDLDRI 362

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 79/310 (25%), Positives = 131/310 (42%), Gaps = 59/310 (19%)
Query: 527 DKFSENNLIGRGGFGSVY--------KARIRDGMEVAVKVFNLQCG-RAFKSFDVECAMM 577
           DK +    +G G FG V         K + ++ + VAVK+       +       E  MM
Sbjct: 27  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 86
Query: 578 KSI-RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSN-----YSLDI-------- 623
           K I +H+N++ ++ +C+ +    +++EY   G+L +YL +       YS DI        
Sbjct: 87  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 146
Query: 624 -FQRL-NIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 681
            F+ L +    +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D
Sbjct: 147 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 203
Query: 682 QSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKK------PTDELFNG 735
                T     + +MAPE   +   +   DV+SFG+++ E FT         P +ELF  
Sbjct: 204 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK- 262
Query: 736 EMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINA 795
                                   L +E         C + ++ +  +C    P QR   
Sbjct: 263 ------------------------LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTF 298
Query: 796 KEIVAKLLKI 805
           K++V  L +I
Sbjct: 299 KQLVEDLDRI 308

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 79/310 (25%), Positives = 131/310 (42%), Gaps = 59/310 (19%)
Query: 527 DKFSENNLIGRGGFGSVY--------KARIRDGMEVAVKVFNLQCG-RAFKSFDVECAMM 577
           DK +    +G G FG V         K + ++ + VAVK+       +       E  MM
Sbjct: 22  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 81
Query: 578 KSI-RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSN-----YSLDI-------- 623
           K I +H+N++ ++ +C+ +    +++EY   G+L +YL +       YS DI        
Sbjct: 82  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 141
Query: 624 -FQRL-NIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 681
            F+ L +    +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D
Sbjct: 142 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLTARNVLVTENNVMKIADFGLARDINNID 198
Query: 682 QSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKK------PTDELFNG 735
                T     + +MAPE   +   +   DV+SFG+++ E FT         P +ELF  
Sbjct: 199 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK- 257
Query: 736 EMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINA 795
                                   L +E         C + ++ +  +C    P QR   
Sbjct: 258 ------------------------LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTF 293
Query: 796 KEIVAKLLKI 805
           K++V  L +I
Sbjct: 294 KQLVEDLDRI 303

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 79/310 (25%), Positives = 131/310 (42%), Gaps = 59/310 (19%)
Query: 527 DKFSENNLIGRGGFGSVY--------KARIRDGMEVAVKVFNLQCG-RAFKSFDVECAMM 577
           DK +    +G G FG V         K + ++ + VAVK+       +       E  MM
Sbjct: 24  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 83
Query: 578 KSI-RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSN-----YSLDI-------- 623
           K I +H+N++ ++ +C+ +    +++EY   G+L +YL +       YS DI        
Sbjct: 84  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 143
Query: 624 -FQRL-NIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 681
            F+ L +    +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D
Sbjct: 144 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 200
Query: 682 QSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKK------PTDELFNG 735
                T     + +MAPE   +   +   DV+SFG+++ E FT         P +ELF  
Sbjct: 201 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK- 259
Query: 736 EMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINA 795
                                   L +E         C + ++ +  +C    P QR   
Sbjct: 260 ------------------------LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTF 295
Query: 796 KEIVAKLLKI 805
           K++V  L +I
Sbjct: 296 KQLVEDLDRI 305

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 98/199 (49%), Gaps = 14/199 (7%)
Query: 535 IGRGGFGSVY-----KARIRDGMEVAVKVFNLQCGRAFKS-FDVECAMMKSIRHRNLVKV 588
           +G G FG V            G  VAVK     CG   +S +  E  +++++ H +++K 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 589 ISSCSNEEFKAL--VLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSA 646
              C ++  K+L  V+EY+P GSL  YL    +S+ + Q L     +   + YLH   S 
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYL--PRHSIGLAQLLLFAQQICEGMAYLH---SQ 136
Query: 647 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-TGEDQSMTQTQTLATIGYMAPEYGREGQ 705
             IH +L   NVLLD++ +  + DFG+AK +  G +    +    + + + APE  +E +
Sbjct: 137 HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK 196
Query: 706 VSTNGDVYSFGIMLMETFT 724
                DV+SFG+ L E  T
Sbjct: 197 FYYASDVWSFGVTLYELLT 215

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/261 (27%), Positives = 118/261 (45%), Gaps = 30/261 (11%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSN 594
           +G G  G V+        +VAVK    Q   +  +F  E  +MK ++H+ LV++ +  + 
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 595 EEFKALVLEYMPHGSLEKYLHS-SNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 653
           E    ++ EYM +GSL  +L + S   L I + L++   +A  + ++        IH DL
Sbjct: 80  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 135
Query: 654 KPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGQVSTNGDV 712
           + +N+L+ D +   ++DFG+A+L+  ED   T  +     I + APE    G  +   DV
Sbjct: 136 RAANILVSDTLSCKIADFGLARLI--EDAEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 713 YSFGIMLMETFTRKK-PTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKE 771
           +SFGI+L E  T  + P   + N E                  V  NL  +     V  +
Sbjct: 194 WSFGILLTEIVTHGRIPYPGMTNPE------------------VIQNL--ERGYRMVRPD 233
Query: 772 QCVSFVFNLALECTVESPEQR 792
            C   ++ L   C  E PE R
Sbjct: 234 NCPEELYQLMRLCWKERPEDR 254

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 103/196 (52%), Gaps = 10/196 (5%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGR-AFKSFDVECAMMKSIRHRNLVKVISSCS 593
           +G G FG V+     +  +VAVK   L+ G  + ++F  E  +MK+++H  LV++ +  +
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVK--TLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 78
Query: 594 NEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRL-NIMIDVASALEYLHFGYSAPVIHCD 652
            EE   ++ EYM  GSL  +L S      +  +L +    +A  + Y+        IH D
Sbjct: 79  REEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRD 135
Query: 653 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGQVSTNGD 711
           L+ +NVL+ ++++  ++DFG+A+++  ED   T  +     I + APE    G  +   D
Sbjct: 136 LRAANVLVSESLMCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGCFTIKSD 193
Query: 712 VYSFGIMLMETFTRKK 727
           V+SFGI+L E  T  K
Sbjct: 194 VWSFGILLYEIVTYGK 209

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/310 (25%), Positives = 130/310 (41%), Gaps = 59/310 (19%)
Query: 527 DKFSENNLIGRGGFGSVY--------KARIRDGMEVAVKVFNLQCG-RAFKSFDVECAMM 577
           DK +    +G G FG V         K + ++ + VAVK+       +       E  MM
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 578 KSI-RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSN-----YSLDI-------- 623
           K I +H+N++ ++ +C+ +    +++ Y   G+L +YL +       YS DI        
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 624 -FQRL-NIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 681
            F+ L +    +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 682 QSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKK------PTDELFNG 735
                T     + +MAPE   +   +   DV+SFG+++ E FT         P +ELF  
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK- 270
Query: 736 EMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINA 795
                                   L +E         C + ++ +  +C    P QR   
Sbjct: 271 ------------------------LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTF 306
Query: 796 KEIVAKLLKI 805
           K++V  L +I
Sbjct: 307 KQLVEDLDRI 316

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/310 (25%), Positives = 130/310 (41%), Gaps = 59/310 (19%)
Query: 527 DKFSENNLIGRGGFGSVY--------KARIRDGMEVAVKVFNLQCG-RAFKSFDVECAMM 577
           DK +    +G G FG V         K + ++ + VAVK+       +       E  MM
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 578 KSI-RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSN-----YSLDI-------- 623
           K I +H+N++ ++ +C+ +    +++EY   G+L +YL +        S DI        
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQM 154
Query: 624 -FQRL-NIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 681
            F+ L +    +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 682 QSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKK------PTDELFNG 735
                T     + +MAPE   +   +   DV+SFG+++ E FT         P +ELF  
Sbjct: 212 XXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK- 270
Query: 736 EMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINA 795
                                   L +E         C + ++ +  +C    P QR   
Sbjct: 271 ------------------------LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTF 306
Query: 796 KEIVAKLLKI 805
           K++V  L +I
Sbjct: 307 KQLVEDLDRI 316

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/288 (23%), Positives = 132/288 (45%), Gaps = 34/288 (11%)
Query: 533 NLIGRGGFGSVYKARIR--DGMEVAVKVFNLQCG---RAFKSFDVECAMMKSIRHRNLVK 587
            +IG G FG V    ++     E+ V +  L+ G   +  + F  E ++M    H N++ 
Sbjct: 39  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 98
Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAP 647
           +    +      ++ E+M +GSL+ +L  ++    + Q + ++  +A+ ++YL       
Sbjct: 99  LEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DMN 155
Query: 648 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA---TIGYMAPEYGREG 704
            +H DL   N+L++ N+V  +SDFG+++ L  +    T T  L     I + APE  +  
Sbjct: 156 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR 215
Query: 705 QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQED 764
           + ++  DV+S+GI++ E  +          GE    +W      ++  +V++A    ++D
Sbjct: 216 KFTSASDVWSYGIVMWEVMSY---------GERP--YW-----DMTNQDVINA---IEQD 256
Query: 765 IHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLRN 812
                   C S +  L L+C  +    R    +IV  L    D ++RN
Sbjct: 257 YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL----DKMIRN 300

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/310 (25%), Positives = 130/310 (41%), Gaps = 59/310 (19%)
Query: 527 DKFSENNLIGRGGFGSVY--------KARIRDGMEVAVKVFNLQCG-RAFKSFDVECAMM 577
           DK +    +G G FG V         K + ++ + VAVK+       +       E  MM
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 578 KSI-RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSN-----YSLDI-------- 623
           K I +H+N++ ++ +C+ +    +++ Y   G+L +YL +       YS DI        
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 624 -FQRL-NIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 681
            F+ L +    +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 682 QSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKK------PTDELFNG 735
                T     + +MAPE   +   +   DV+SFG+++ E FT         P +ELF  
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK- 270
Query: 736 EMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINA 795
                                   L +E         C + ++ +  +C    P QR   
Sbjct: 271 ------------------------LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTF 306
Query: 796 KEIVAKLLKI 805
           K++V  L +I
Sbjct: 307 KQLVEDLDRI 316

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 98/199 (49%), Gaps = 14/199 (7%)
Query: 535 IGRGGFGSVY-----KARIRDGMEVAVKVFNLQCGRAFKS-FDVECAMMKSIRHRNLVKV 588
           +G G FG V            G  VAVK     CG   +S +  E  +++++ H +++K 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 589 ISSCSNEEFKAL--VLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSA 646
              C ++  K+L  V+EY+P GSL  YL    +S+ + Q L     +   + YLH   + 
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYL--PRHSIGLAQLLLFAQQICEGMAYLH---AQ 136
Query: 647 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-TGEDQSMTQTQTLATIGYMAPEYGREGQ 705
             IH +L   NVLLD++ +  + DFG+AK +  G +    +    + + + APE  +E +
Sbjct: 137 HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK 196
Query: 706 VSTNGDVYSFGIMLMETFT 724
                DV+SFG+ L E  T
Sbjct: 197 FYYASDVWSFGVTLYELLT 215

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/281 (24%), Positives = 123/281 (43%), Gaps = 38/281 (13%)
Query: 535 IGRGGFGSVYKARIRDGME------VAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVK 587
           +G+G FG VY+   RD ++      VAVK  N     R    F  E ++MK     ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLD---------IFQRLNIMIDVASALE 638
           ++   S  +   +V+E M HG L+ YL S     +         + + + +  ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 639 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 698
           YL+   +   +H DL   N ++  +    + DFG+ + +   D      + L  + +MAP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201
Query: 699 EYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDAN 758
           E  ++G  +T+ D++SFG++L E  +  +   +  + E  LK             V+D  
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF------------VMDGG 249
Query: 759 LLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIV 799
            L Q D        C   V +L   C   +P+ R    EIV
Sbjct: 250 YLDQPD-------NCPERVTDLMRMCWQFNPKMRPTFLEIV 283

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 125/282 (44%), Gaps = 40/282 (14%)
Query: 535 IGRGGFGSVYKARIRDGME------VAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVK 587
           +G+G FG VY+   RD ++      VAVK  N     R    F  E ++MK     ++V+
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLD---------IFQRLNIMIDVASALE 638
           ++   S  +   +V+E M HG L+ YL S     +         + + + +  ++A  + 
Sbjct: 82  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 141
Query: 639 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 698
           YL+   +   +H DL   N ++  +    + DFG+ + +   D      + L  + +MAP
Sbjct: 142 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 198
Query: 699 EYGREGQVSTNGDVYSFGIMLME-TFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDA 757
           E  ++G  +T+ D++SFG++L E T   ++P   L N E  LK             V+D 
Sbjct: 199 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-EQVLKF------------VMDG 245
Query: 758 NLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIV 799
             L Q D        C   V +L   C   +P+ R    EIV
Sbjct: 246 GYLDQPD-------NCPERVTDLMRMCWQFNPKMRPTFLEIV 280

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 70/281 (24%), Positives = 122/281 (43%), Gaps = 38/281 (13%)
Query: 535 IGRGGFGSVYKARIRDGME------VAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVK 587
           +G+G FG VY+   RD ++      VAVK  N     R    F  E ++MK     ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLD---------IFQRLNIMIDVASALE 638
           ++   S  +   +V+E M HG L+ YL S     +         + + + +  ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 639 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 698
           YL+   +   +H DL   N ++  +    + DFG+ + +   D      + L  + +MAP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201
Query: 699 EYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDAN 758
           E  ++G  +T+ D++SFG++L E  +  +   +  + E  LK             V+D  
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF------------VMDGG 249
Query: 759 LLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIV 799
            L Q D        C   V +L   C   +P  R    EIV
Sbjct: 250 YLDQPD-------NCPERVTDLMRMCWQFNPNMRPTFLEIV 283

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 70/281 (24%), Positives = 123/281 (43%), Gaps = 38/281 (13%)
Query: 535 IGRGGFGSVYKARIRDGME------VAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVK 587
           +G+G FG VY+   RD ++      VAVK  N     R    F  E ++MK     ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLD---------IFQRLNIMIDVASALE 638
           ++   S  +   +V+E M HG L+ YL S     +         + + + +  ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 639 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 698
           YL+   +   +H DL   N ++  +    + DFG+ + +   D      + L  + +MAP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201
Query: 699 EYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDAN 758
           E  ++G  +T+ D++SFG++L E  +  +   +  + E  LK             V+D  
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF------------VMDGG 249
Query: 759 LLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIV 799
            L Q D        C   V +L   C   +P+ R    EIV
Sbjct: 250 YLDQPD-------NCPERVTDLMRMCWQFNPKMRPTFLEIV 283

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 73/311 (23%), Positives = 141/311 (45%), Gaps = 41/311 (13%)
Query: 517 FSYLELFQATDKFSEN---------NLIGRGGFGSVYKARIR--DGMEVAVKVFNLQCG- 564
           F++ +  QA  +F++           +IG G FG V   R++     E+ V +  L+ G 
Sbjct: 10  FTFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGY 69
Query: 565 --RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLD 622
             +  + F  E ++M    H N++ +    +  +   ++ EYM +GSL+ +L  ++    
Sbjct: 70  TDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFT 129
Query: 623 IFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 682
           + Q + ++  + S ++YL        +H DL   N+L++ N+V  +SDFG++++L  + +
Sbjct: 130 VIQLVGMLRGIGSGMKYLS---DMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPE 186
Query: 683 SMTQTQ-TLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKH 741
           +   T+     I + APE     + ++  DV+S+GI++ E  +          GE    +
Sbjct: 187 AAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS---------YGERP--Y 235
Query: 742 WVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK 801
           W      +S  +V+ A    +E         C   +  L L+C  +    R    +IV  
Sbjct: 236 W-----DMSNQDVIKA---IEEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNM 287
Query: 802 LLKIRDSLLRN 812
           L    D L+RN
Sbjct: 288 L----DKLIRN 294

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 125/282 (44%), Gaps = 40/282 (14%)
Query: 535 IGRGGFGSVYKARIRDGME------VAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVK 587
           +G+G FG VY+   RD ++      VAVK  N     R    F  E ++MK     ++V+
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLD---------IFQRLNIMIDVASALE 638
           ++   S  +   +V+E M HG L+ YL S     +         + + + +  ++A  + 
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 639 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 698
           YL+   +   +H DL   N ++  +    + DFG+ + +   D      + L  + +MAP
Sbjct: 144 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 200
Query: 699 EYGREGQVSTNGDVYSFGIMLME-TFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDA 757
           E  ++G  +T+ D++SFG++L E T   ++P   L N E  LK             V+D 
Sbjct: 201 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-EQVLKF------------VMDG 247
Query: 758 NLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIV 799
             L Q D        C   V +L   C   +P+ R    EIV
Sbjct: 248 GYLDQPD-------NCPERVTDLMRMCWQFNPKMRPTFLEIV 282

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/305 (22%), Positives = 136/305 (44%), Gaps = 38/305 (12%)
Query: 525 ATDKFSENNLIGRGGFGSVY----KARIRDGME--VAVKVFNLQCG-RAFKSFDVECAMM 577
           A +K + +  +G+G FG VY    K  ++D  E  VA+K  N     R    F  E ++M
Sbjct: 17  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 76
Query: 578 KSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLD---------IFQRLN 628
           K     ++V+++   S  +   +++E M  G L+ YL S    ++         + + + 
Sbjct: 77  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 136
Query: 629 IMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQ 688
           +  ++A  + YL+   +   +H DL   N ++ ++    + DFG+ + +   D      +
Sbjct: 137 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGK 193
Query: 689 TLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLP 748
            L  + +M+PE  ++G  +T  DV+SFG++L E  T  +   +  + E  L+        
Sbjct: 194 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------- 246
Query: 749 ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDS 808
                V++  LL + D        C   +F L   C   +P+ R +  EI++ + +  + 
Sbjct: 247 -----VMEGGLLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 294
Query: 809 LLRNV 813
             R V
Sbjct: 295 GFREV 299

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/288 (23%), Positives = 131/288 (45%), Gaps = 34/288 (11%)
Query: 533 NLIGRGGFGSVYKARIR--DGMEVAVKVFNLQCG---RAFKSFDVECAMMKSIRHRNLVK 587
            +IG G FG V    ++     E+ V +  L+ G   +  + F  E ++M    H N++ 
Sbjct: 13  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 72
Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAP 647
           +    +      ++ E+M +GSL+ +L  ++    + Q + ++  +A+ ++YL       
Sbjct: 73  LEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DMN 129
Query: 648 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA---TIGYMAPEYGREG 704
            +H  L   N+L++ N+V  +SDFG+++ L  +    T T  L     I + APE  +  
Sbjct: 130 YVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR 189
Query: 705 QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQED 764
           + ++  DV+S+GI++ E  +          GE    +W      ++  +V++A    ++D
Sbjct: 190 KFTSASDVWSYGIVMWEVMSY---------GERP--YW-----DMTNQDVINA---IEQD 230
Query: 765 IHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLRN 812
                   C S +  L L+C  +    R    +IV  L    D ++RN
Sbjct: 231 YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL----DKMIRN 274

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 96/199 (48%), Gaps = 14/199 (7%)
Query: 535 IGRGGFGSVY-----KARIRDGMEVAVKVFNLQCGRAFKS-FDVECAMMKSIRHRNLVKV 588
           +G G FG V            G  VAVK     CG   +S +  E  +++++ H ++VK 
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 589 ISSCSNEEFKA--LVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSA 646
              C ++  K+  LV+EY+P GSL  YL    + + + Q L     +   + YLH   + 
Sbjct: 76  KGCCEDQGEKSVQLVMEYVPLGSLRDYL--PRHCVGLAQLLLFAQQICEGMAYLH---AQ 130
Query: 647 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-TGEDQSMTQTQTLATIGYMAPEYGREGQ 705
             IH  L   NVLLD++ +  + DFG+AK +  G +    +    + + + APE  +E +
Sbjct: 131 HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECK 190
Query: 706 VSTNGDVYSFGIMLMETFT 724
                DV+SFG+ L E  T
Sbjct: 191 FYYASDVWSFGVTLYELLT 209

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 96/199 (48%), Gaps = 14/199 (7%)
Query: 535 IGRGGFGSVY-----KARIRDGMEVAVKVFNLQCGRAFKS-FDVECAMMKSIRHRNLVKV 588
           +G G FG V            G  VAVK     CG   +S +  E  +++++ H ++VK 
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 589 ISSCSNEEFKA--LVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSA 646
              C ++  K+  LV+EY+P GSL  YL    + + + Q L     +   + YLH   + 
Sbjct: 77  KGCCEDQGEKSVQLVMEYVPLGSLRDYL--PRHCVGLAQLLLFAQQICEGMAYLH---AQ 131
Query: 647 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-TGEDQSMTQTQTLATIGYMAPEYGREGQ 705
             IH  L   NVLLD++ +  + DFG+AK +  G +    +    + + + APE  +E +
Sbjct: 132 HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECK 191
Query: 706 VSTNGDVYSFGIMLMETFT 724
                DV+SFG+ L E  T
Sbjct: 192 FYYASDVWSFGVTLYELLT 210

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 103/196 (52%), Gaps = 10/196 (5%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGR-AFKSFDVECAMMKSIRHRNLVKVISSCS 593
           +G G FG V+     +  +VAVK   L+ G  + ++F  E  +MK+++H  LV++ +  +
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVK--TLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 77
Query: 594 NEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRL-NIMIDVASALEYLHFGYSAPVIHCD 652
            EE   ++ E+M  GSL  +L S      +  +L +    +A  + Y+        IH D
Sbjct: 78  KEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRD 134
Query: 653 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREGQVSTNGD 711
           L+ +NVL+ ++++  ++DFG+A+++  ED   T  +     I + APE    G  +   +
Sbjct: 135 LRAANVLVSESLMCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGCFTIKSN 192
Query: 712 VYSFGIMLMETFTRKK 727
           V+SFGI+L E  T  K
Sbjct: 193 VWSFGILLYEIVTYGK 208

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 110/219 (50%), Gaps = 11/219 (5%)
Query: 520 LELFQATDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDVECAMMK 578
           LE     D+  +  ++G+G +G VY  R + + + +A+K    +  R  +    E A+ K
Sbjct: 1   LEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHK 60
Query: 579 SIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSL-DIFQRLNIMI-DVASA 636
            ++H+N+V+ + S S   F  + +E +P GSL   L S    L D  Q +      +   
Sbjct: 61  HLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEG 120
Query: 637 LEYLHFGYSAPVIHCDLKPSNVLLDD-NMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGY 695
           L+YLH      ++H D+K  NVL++  + V  +SDFG +K L G +   T+T T  T+ Y
Sbjct: 121 LKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-PCTETFT-GTLQY 175
Query: 696 MAPEYGREGQ--VSTNGDVYSFGIMLMETFTRKKPTDEL 732
           MAPE   +G        D++S G  ++E  T K P  EL
Sbjct: 176 MAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYEL 214

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/287 (24%), Positives = 131/287 (45%), Gaps = 32/287 (11%)
Query: 532 NNLIGRGGFGSVYKARIR--DGMEVAVKVFNLQCG---RAFKSFDVECAMMKSIRHRNLV 586
             +IG G FG V   R++     E+ V +  L+ G   +  + F  E ++M    H N++
Sbjct: 13  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 72
Query: 587 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSA 646
            +    +  +   ++ EYM +GSL+ +L  ++    + Q + ++  + S ++YL      
Sbjct: 73  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLS---DM 129
Query: 647 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQ-TLATIGYMAPEYGREGQ 705
             +H DL   N+L++ N+V  +SDFG++++L  + ++   T+     I + APE     +
Sbjct: 130 SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 189
Query: 706 VSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDI 765
            ++  DV+S+GI++ E  +          GE    +W      +S  +V+ A    +E  
Sbjct: 190 FTSASDVWSYGIVMWEVMS---------YGERP--YW-----DMSNQDVIKA---IEEGY 230
Query: 766 HFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLRN 812
                  C   +  L L+C  +    R    +IV  L    D L+RN
Sbjct: 231 RLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNML----DKLIRN 273

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/287 (24%), Positives = 131/287 (45%), Gaps = 32/287 (11%)
Query: 532 NNLIGRGGFGSVYKARIR--DGMEVAVKVFNLQCG---RAFKSFDVECAMMKSIRHRNLV 586
             +IG G FG V   R++     E+ V +  L+ G   +  + F  E ++M    H N++
Sbjct: 19  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 78
Query: 587 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSA 646
            +    +  +   ++ EYM +GSL+ +L  ++    + Q + ++  + S ++YL      
Sbjct: 79  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLS---DM 135
Query: 647 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQ-TLATIGYMAPEYGREGQ 705
             +H DL   N+L++ N+V  +SDFG++++L  + ++   T+     I + APE     +
Sbjct: 136 SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 195
Query: 706 VSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDI 765
            ++  DV+S+GI++ E  +          GE    +W      +S  +V+ A    +E  
Sbjct: 196 FTSASDVWSYGIVMWEVMS---------YGERP--YW-----DMSNQDVIKA---IEEGY 236
Query: 766 HFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLRN 812
                  C   +  L L+C  +    R    +IV  L    D L+RN
Sbjct: 237 RLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNML----DKLIRN 279

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/305 (22%), Positives = 136/305 (44%), Gaps = 38/305 (12%)
Query: 525 ATDKFSENNLIGRGGFGSVY----KARIRDGME--VAVKVFNLQCG-RAFKSFDVECAMM 577
           A +K + +  +G+G FG VY    K  ++D  E  VA+K  N     R    F  E ++M
Sbjct: 10  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 69
Query: 578 KSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLD---------IFQRLN 628
           K     ++V+++   S  +   +++E M  G L+ YL S    ++         + + + 
Sbjct: 70  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 129
Query: 629 IMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQ 688
           +  ++A  + YL+   +   +H DL   N ++ ++    + DFG+ + +   D      +
Sbjct: 130 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 186
Query: 689 TLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLP 748
            L  + +M+PE  ++G  +T  DV+SFG++L E  T  +   +  + E  L+        
Sbjct: 187 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------- 239
Query: 749 ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDS 808
                V++  LL + D        C   +F L   C   +P+ R +  EI++ + +  + 
Sbjct: 240 -----VMEGGLLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 287
Query: 809 LLRNV 813
             R V
Sbjct: 288 GFREV 292

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/318 (23%), Positives = 140/318 (44%), Gaps = 46/318 (14%)
Query: 507 NMPPVATWRRFSYLELFQATDKFSENNLIGRGGFGSVYKARI------RDGMEVAVKVFN 560
            MP +   ++    E+  +  +F E   +G   FG VYK  +           VA+K   
Sbjct: 8   EMPLINQHKQAKLKEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK 65
Query: 561 LQC-GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYL----- 614
            +  G   + F  E  +   ++H N+V ++   + ++  +++  Y  HG L ++L     
Sbjct: 66  DKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSP 125
Query: 615 HSSNYSLDIFQRL----------NIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM 664
           HS   S D  + +          +++  +A+ +EYL    S  V+H DL   NVL+ D +
Sbjct: 126 HSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKL 182
Query: 665 VAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 724
              +SD G+ + +   D       +L  I +MAPE    G+ S + D++S+G++L E F+
Sbjct: 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242
Query: 725 RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALEC 784
                           + +      S  +VV+  ++    +     + C ++V+ L +EC
Sbjct: 243 ----------------YGLQPYCGYSNQDVVE--MIRNRQV-LPCPDDCPAWVYALMIEC 283
Query: 785 TVESPEQRINAKEIVAKL 802
             E P +R   K+I ++L
Sbjct: 284 WNEFPSRRPRFKDIHSRL 301

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/230 (32%), Positives = 107/230 (46%), Gaps = 37/230 (16%)
Query: 534 LIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCS 593
           LIGRG +G+VYK  + D   VAVKVF+    + F + +     +  + H N+ + I    
Sbjct: 20  LIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFIN-EKNIYRVPLMEHDNIARFI--VG 75
Query: 594 NEEFKA-------LVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF---- 642
           +E   A       LV+EY P+GSL KYL  S ++ D      +   V   L YLH     
Sbjct: 76  DERVTADGRMEYLLVMEYYPNGSLXKYL--SLHTSDWVSSCRLAHSVTRGLAYLHTELPR 133
Query: 643 --GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE------DQSMTQTQTLATIG 694
              Y   + H DL   NVL+ ++    +SDFG++  LTG       ++       + TI 
Sbjct: 134 GDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIR 193
Query: 695 YMAPEYGREGQVSTNG--------DVYSFGIMLMETFTRKKPTDELFNGE 736
           YMAPE   EG V+           D+Y+ G++  E F R     +LF GE
Sbjct: 194 YMAPEV-LEGAVNLRDXESALKQVDMYALGLIYWEIFMR---CTDLFPGE 239

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/305 (22%), Positives = 136/305 (44%), Gaps = 38/305 (12%)
Query: 525 ATDKFSENNLIGRGGFGSVY----KARIRDGME--VAVKVFNLQCG-RAFKSFDVECAMM 577
           A +K + +  +G+G FG VY    K  ++D  E  VA+K  N     R    F  E ++M
Sbjct: 45  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 104
Query: 578 KSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLD---------IFQRLN 628
           K     ++V+++   S  +   +++E M  G L+ YL S    ++         + + + 
Sbjct: 105 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 164
Query: 629 IMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQ 688
           +  ++A  + YL+   +   +H DL   N ++ ++    + DFG+ + +   D      +
Sbjct: 165 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 221
Query: 689 TLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLP 748
            L  + +M+PE  ++G  +T  DV+SFG++L E  T  +   +  + E  L+        
Sbjct: 222 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------- 274
Query: 749 ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDS 808
                V++  LL + D        C   +F L   C   +P+ R +  EI++ + +  + 
Sbjct: 275 -----VMEGGLLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 322
Query: 809 LLRNV 813
             R V
Sbjct: 323 GFREV 327

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/305 (22%), Positives = 136/305 (44%), Gaps = 38/305 (12%)
Query: 525 ATDKFSENNLIGRGGFGSVY----KARIRDGME--VAVKVFNLQCG-RAFKSFDVECAMM 577
           A +K + +  +G+G FG VY    K  ++D  E  VA+K  N     R    F  E ++M
Sbjct: 17  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 76
Query: 578 KSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLD---------IFQRLN 628
           K     ++V+++   S  +   +++E M  G L+ YL S    ++         + + + 
Sbjct: 77  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 136
Query: 629 IMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQ 688
           +  ++A  + YL+   +   +H DL   N ++ ++    + DFG+ + +   D      +
Sbjct: 137 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 193
Query: 689 TLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLP 748
            L  + +M+PE  ++G  +T  DV+SFG++L E  T  +   +  + E  L+        
Sbjct: 194 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------- 246
Query: 749 ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDS 808
                V++  LL + D        C   +F L   C   +P+ R +  EI++ + +  + 
Sbjct: 247 -----VMEGGLLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 294
Query: 809 LLRNV 813
             R V
Sbjct: 295 GFREV 299

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/259 (26%), Positives = 114/259 (44%), Gaps = 36/259 (13%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSN 594
           +G G FG V+ A      +VAVK        + ++F  E  +MK+++H  LVK+ +  + 
Sbjct: 190 LGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 248
Query: 595 EEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASAL-EYLHFGYSAPVIHCDL 653
           E    ++ E+M  GSL  +L S   S    Q L  +ID ++ + E + F      IH DL
Sbjct: 249 EPI-YIITEFMAKGSLLDFLKSDEGSK---QPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 304
Query: 654 KPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVY 713
           + +N+L+  ++V  ++DFG+A++                I + APE    G  +   DV+
Sbjct: 305 RAANILVSASLVCKIADFGLARV-----------GAKFPIKWTAPEAINFGSFTIKSDVW 353
Query: 714 SFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQC 773
           SFGI+LME  T  +                   +P   M   +     +        E C
Sbjct: 354 SFGILLMEIVTYGR-------------------IPYPGMSNPEVIRALERGYRMPRPENC 394
Query: 774 VSFVFNLALECTVESPEQR 792
              ++N+ + C    PE+R
Sbjct: 395 PEELYNIMMRCWKNRPEER 413

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/305 (22%), Positives = 136/305 (44%), Gaps = 38/305 (12%)
Query: 525 ATDKFSENNLIGRGGFGSVY----KARIRDGME--VAVKVFNLQCG-RAFKSFDVECAMM 577
           A +K + +  +G+G FG VY    K  ++D  E  VA+K  N     R    F  E ++M
Sbjct: 16  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 75
Query: 578 KSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLD---------IFQRLN 628
           K     ++V+++   S  +   +++E M  G L+ YL S    ++         + + + 
Sbjct: 76  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 135
Query: 629 IMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQ 688
           +  ++A  + YL+   +   +H DL   N ++ ++    + DFG+ + +   D      +
Sbjct: 136 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 192
Query: 689 TLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLP 748
            L  + +M+PE  ++G  +T  DV+SFG++L E  T  +   +  + E  L+        
Sbjct: 193 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------- 245
Query: 749 ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDS 808
                V++  LL + D        C   +F L   C   +P+ R +  EI++ + +  + 
Sbjct: 246 -----VMEGGLLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 293
Query: 809 LLRNV 813
             R V
Sbjct: 294 GFREV 298

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/305 (22%), Positives = 136/305 (44%), Gaps = 38/305 (12%)
Query: 525 ATDKFSENNLIGRGGFGSVY----KARIRDGME--VAVKVFNLQCG-RAFKSFDVECAMM 577
           A +K + +  +G+G FG VY    K  ++D  E  VA+K  N     R    F  E ++M
Sbjct: 23  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 82
Query: 578 KSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLD---------IFQRLN 628
           K     ++V+++   S  +   +++E M  G L+ YL S    ++         + + + 
Sbjct: 83  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 142
Query: 629 IMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQ 688
           +  ++A  + YL+   +   +H DL   N ++ ++    + DFG+ + +   D      +
Sbjct: 143 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 199
Query: 689 TLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLP 748
            L  + +M+PE  ++G  +T  DV+SFG++L E  T  +   +  + E  L+        
Sbjct: 200 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------- 252
Query: 749 ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDS 808
                V++  LL + D        C   +F L   C   +P+ R +  EI++ + +  + 
Sbjct: 253 -----VMEGGLLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300
Query: 809 LLRNV 813
             R V
Sbjct: 301 GFREV 305

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/305 (22%), Positives = 136/305 (44%), Gaps = 38/305 (12%)
Query: 525 ATDKFSENNLIGRGGFGSVY----KARIRDGME--VAVKVFNLQCG-RAFKSFDVECAMM 577
           A +K + +  +G+G FG VY    K  ++D  E  VA+K  N     R    F  E ++M
Sbjct: 23  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 82
Query: 578 KSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSL---------DIFQRLN 628
           K     ++V+++   S  +   +++E M  G L+ YL S   ++          + + + 
Sbjct: 83  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 142
Query: 629 IMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQ 688
           +  ++A  + YL+   +   +H DL   N ++ ++    + DFG+ + +   D      +
Sbjct: 143 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 199
Query: 689 TLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLP 748
            L  + +M+PE  ++G  +T  DV+SFG++L E  T  +   +  + E  L+        
Sbjct: 200 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------- 252
Query: 749 ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDS 808
                V++  LL + D        C   +F L   C   +P+ R +  EI++ + +  + 
Sbjct: 253 -----VMEGGLLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300
Query: 809 LLRNV 813
             R V
Sbjct: 301 GFREV 305

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/305 (22%), Positives = 136/305 (44%), Gaps = 38/305 (12%)
Query: 525 ATDKFSENNLIGRGGFGSVY----KARIRDGME--VAVKVFNLQCG-RAFKSFDVECAMM 577
           A +K + +  +G+G FG VY    K  ++D  E  VA+K  N     R    F  E ++M
Sbjct: 14  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 73
Query: 578 KSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLD---------IFQRLN 628
           K     ++V+++   S  +   +++E M  G L+ YL S    ++         + + + 
Sbjct: 74  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 133
Query: 629 IMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQ 688
           +  ++A  + YL+   +   +H DL   N ++ ++    + DFG+ + +   D      +
Sbjct: 134 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 190
Query: 689 TLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLP 748
            L  + +M+PE  ++G  +T  DV+SFG++L E  T  +   +  + E  L+        
Sbjct: 191 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------- 243
Query: 749 ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDS 808
                V++  LL + D        C   +F L   C   +P+ R +  EI++ + +  + 
Sbjct: 244 -----VMEGGLLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 291
Query: 809 LLRNV 813
             R V
Sbjct: 292 GFREV 296

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 110/219 (50%), Gaps = 11/219 (5%)
Query: 520 LELFQATDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDVECAMMK 578
           LE     D+  +  ++G+G +G VY  R + + + +A+K    +  R  +    E A+ K
Sbjct: 15  LEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHK 74
Query: 579 SIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSL-DIFQRLNIMI-DVASA 636
            ++H+N+V+ + S S   F  + +E +P GSL   L S    L D  Q +      +   
Sbjct: 75  HLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEG 134
Query: 637 LEYLHFGYSAPVIHCDLKPSNVLLDD-NMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGY 695
           L+YLH      ++H D+K  NVL++  + V  +SDFG +K L G +   T+T T  T+ Y
Sbjct: 135 LKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-PCTETFT-GTLQY 189
Query: 696 MAPEYGREGQ--VSTNGDVYSFGIMLMETFTRKKPTDEL 732
           MAPE   +G        D++S G  ++E  T K P  EL
Sbjct: 190 MAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYEL 228

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 69/290 (23%), Positives = 129/290 (44%), Gaps = 44/290 (15%)
Query: 535 IGRGGFGSVYKARI------RDGMEVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLVK 587
           +G   FG VYK  +           VA+K    +  G   + F  E  +   ++H N+V 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYL-----HSSNYSLDIFQRL----------NIMID 632
           ++   + ++  +++  Y  HG L ++L     HS   S D  + +          +++  
Sbjct: 77  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 633 VASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLAT 692
           +A+ +EYL    S  V+H DL   NVL+ D +   +SD G+ + +   D       +L  
Sbjct: 137 IAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 193
Query: 693 IGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTM 752
           I +MAPE    G+ S + D++S+G++L E F+                + +      S  
Sbjct: 194 IRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS----------------YGLQPYCGYSNQ 237
Query: 753 EVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL 802
           +VV+  ++    +     + C ++V+ L +EC  E P +R   K+I ++L
Sbjct: 238 DVVE--MIRNRQV-LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRL 284

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/305 (22%), Positives = 136/305 (44%), Gaps = 38/305 (12%)
Query: 525 ATDKFSENNLIGRGGFGSVY----KARIRDGME--VAVKVFNLQCG-RAFKSFDVECAMM 577
           A +K + +  +G+G FG VY    K  ++D  E  VA+K  N     R    F  E ++M
Sbjct: 16  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 75
Query: 578 KSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLD---------IFQRLN 628
           K     ++V+++   S  +   +++E M  G L+ YL S    ++         + + + 
Sbjct: 76  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 135
Query: 629 IMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQ 688
           +  ++A  + YL+   +   +H DL   N ++ ++    + DFG+ + +   D      +
Sbjct: 136 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 192
Query: 689 TLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLP 748
            L  + +M+PE  ++G  +T  DV+SFG++L E  T  +   +  + E  L+        
Sbjct: 193 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------- 245
Query: 749 ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDS 808
                V++  LL + D        C   +F L   C   +P+ R +  EI++ + +  + 
Sbjct: 246 -----VMEGGLLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 293
Query: 809 LLRNV 813
             R V
Sbjct: 294 GFREV 298

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 106/209 (50%), Gaps = 11/209 (5%)
Query: 522 LFQATDKFSENNLIGRGGFGSVYKA-RIRDG----MEVAVKVFNLQCGR-AFKSFDVECA 575
           +F+ T+   +  ++G G FG+V+K   I +G    + V +KV   + GR +F++      
Sbjct: 27  IFKETE-LRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHML 85
Query: 576 MMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVAS 635
            + S+ H ++V+++  C     + LV +Y+P GSL  ++     +L     LN  + +A 
Sbjct: 86  AIGSLDHAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAK 144
Query: 636 ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGY 695
            + YL       ++H +L   NVLL       ++DFG+A LL  +D+ +  ++    I +
Sbjct: 145 GMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKW 201
Query: 696 MAPEYGREGQVSTNGDVYSFGIMLMETFT 724
           MA E    G+ +   DV+S+G+ + E  T
Sbjct: 202 MALESIHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 106/209 (50%), Gaps = 11/209 (5%)
Query: 522 LFQATDKFSENNLIGRGGFGSVYKA-RIRDG----MEVAVKVFNLQCGR-AFKSFDVECA 575
           +F+ T+   +  ++G G FG+V+K   I +G    + V +KV   + GR +F++      
Sbjct: 9   IFKETE-LRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHML 67
Query: 576 MMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVAS 635
            + S+ H ++V+++  C     + LV +Y+P GSL  ++     +L     LN  + +A 
Sbjct: 68  AIGSLDHAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAK 126
Query: 636 ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGY 695
            + YL       ++H +L   NVLL       ++DFG+A LL  +D+ +  ++    I +
Sbjct: 127 GMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKW 183
Query: 696 MAPEYGREGQVSTNGDVYSFGIMLMETFT 724
           MA E    G+ +   DV+S+G+ + E  T
Sbjct: 184 MALESIHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/281 (24%), Positives = 122/281 (43%), Gaps = 38/281 (13%)
Query: 535 IGRGGFGSVYKARIRDGME------VAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVK 587
           +G+G FG VY+   RD ++      VAVK  N     R    F  E ++MK     ++V+
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLD---------IFQRLNIMIDVASALE 638
           ++   S  +   +V+E M HG L+ YL S     +         + + + +  ++A  + 
Sbjct: 86  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 145
Query: 639 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 698
           YL+   +   +H +L   N ++  +    + DFG+ + +   D      + L  + +MAP
Sbjct: 146 YLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 202
Query: 699 EYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDAN 758
           E  ++G  +T+ D++SFG++L E  +  +   +  + E  LK             V+D  
Sbjct: 203 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF------------VMDGG 250
Query: 759 LLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIV 799
            L Q D        C   V +L   C   +P  R    EIV
Sbjct: 251 YLDQPD-------NCPERVTDLMRMCWQFNPNMRPTFLEIV 284

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 70/305 (22%), Positives = 136/305 (44%), Gaps = 38/305 (12%)
Query: 525 ATDKFSENNLIGRGGFGSVY----KARIRDGME--VAVKVFNLQCG-RAFKSFDVECAMM 577
           A +K + +  +G+G FG VY    K  ++D  E  VA+K  N     R    F  E ++M
Sbjct: 13  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 72
Query: 578 KSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSL---------DIFQRLN 628
           K     ++V+++   S  +   +++E M  G L+ YL S   ++          + + + 
Sbjct: 73  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 132
Query: 629 IMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQ 688
           +  ++A  + YL+   +   +H DL   N ++ ++    + DFG+ + +   D      +
Sbjct: 133 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 189
Query: 689 TLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLP 748
            L  + +M+PE  ++G  +T  DV+SFG++L E  T  +   +  + E  L+        
Sbjct: 190 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------- 242
Query: 749 ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDS 808
                V++  LL + D        C   +F L   C   +P+ R +  EI++ + +  + 
Sbjct: 243 -----VMEGGLLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 290
Query: 809 LLRNV 813
             R V
Sbjct: 291 GFREV 295

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/281 (24%), Positives = 122/281 (43%), Gaps = 38/281 (13%)
Query: 535 IGRGGFGSVYKARIRDGME------VAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVK 587
           +G+G FG VY+   RD ++      VAVK  N     R    F  E ++MK     ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLD---------IFQRLNIMIDVASALE 638
           ++   S  +   +V+E M HG L+ YL S     +         + + + +  ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 639 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 698
           YL+   +   +H +L   N ++  +    + DFG+ + +   D      + L  + +MAP
Sbjct: 145 YLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201
Query: 699 EYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDAN 758
           E  ++G  +T+ D++SFG++L E  +  +   +  + E  LK             V+D  
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF------------VMDGG 249
Query: 759 LLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIV 799
            L Q D        C   V +L   C   +P  R    EIV
Sbjct: 250 YLDQPD-------NCPERVTDLMRMCWQFNPNMRPTFLEIV 283

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 119/277 (42%), Gaps = 26/277 (9%)
Query: 524 QATDKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDVECAMMKSIRH 582
           Q  + F     +G G +GSVYKA  ++ G  VA+K   ++     +    E ++M+    
Sbjct: 26  QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDS 83
Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
            ++VK   S        +V+EY   GS+   +   N +L   +   I+      LEYLHF
Sbjct: 84  PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF 143
Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
                 IH D+K  N+LL+    A L+DFG+A  LT  D    +   + T  +MAPE  +
Sbjct: 144 MRK---IHRDIKAGNILLNTEGHAKLADFGVAGQLT--DXMAKRNXVIGTPFWMAPEVIQ 198
Query: 703 EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ 762
           E   +   D++S GI  +E    K P                D  P+  + ++  N    
Sbjct: 199 EIGYNCVADIWSLGITAIEMAEGKPP--------------YADIHPMRAIFMIPTNPPPT 244
Query: 763 EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIV 799
               F   E       +   +C V+SPEQR  A +++
Sbjct: 245 ----FRKPELWSDNFTDFVKQCLVKSPEQRATATQLL 277

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 95/199 (47%), Gaps = 14/199 (7%)
Query: 535 IGRGGFGSVY-----KARIRDGMEVAVKVFNLQCGRAFKS-FDVECAMMKSIRHRNLVKV 588
           +G G FG V            G  VAVK      G   +S +  E  +++++ H +++K 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 589 ISSCSNEEFKAL--VLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSA 646
              C +    +L  V+EY+P GSL  YL    +S+ + Q L     +   + YLH   + 
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRDYL--PRHSIGLAQLLLFAQQICEGMAYLH---AQ 153
Query: 647 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-TGEDQSMTQTQTLATIGYMAPEYGREGQ 705
             IH DL   NVLLD++ +  + DFG+AK +  G +    +    + + + APE  +E +
Sbjct: 154 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEYK 213
Query: 706 VSTNGDVYSFGIMLMETFT 724
                DV+SFG+ L E  T
Sbjct: 214 FYYASDVWSFGVTLYELLT 232

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 101/221 (45%), Gaps = 23/221 (10%)
Query: 521 ELFQATDKFSENNLIGRGGFGSVYKARIRDGMEVAVK----VFNLQCGRAFKSFDVECAM 576
            +F+ +D      ++G+G FG   K   R+  EV V      F+ +  R F     E  +
Sbjct: 5   RIFRPSD-LIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLK---EVKV 60
Query: 577 MKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASA 636
           M+ + H N++K I     ++    + EY+  G+L   + S +      QR++   D+AS 
Sbjct: 61  MRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASG 120
Query: 637 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED---------QSMTQT 687
           + YLH   S  +IH DL   N L+ +N    ++DFG+A+L+  E          +   + 
Sbjct: 121 MAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRK 177
Query: 688 QTLATIG---YMAPEYGREGQVSTNGDVYSFGIMLMETFTR 725
           +    +G   +MAPE           DV+SFGI+L E   R
Sbjct: 178 KRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGR 218

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 106/232 (45%), Gaps = 38/232 (16%)
Query: 528 KFSENNL-----IGRGGFGSVYKARIRDGME------VAVKVFNLQCGRAFKS-FDVECA 575
           ++  NN+     IG G FG V++AR    +       VAVK+   +     ++ F  E A
Sbjct: 43  EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 102
Query: 576 MMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHS-----------SNYS---- 620
           +M    + N+VK++  C+  +   L+ EYM +G L ++L S           S+ S    
Sbjct: 103 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 162
Query: 621 --------LDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFG 672
                   L   ++L I   VA+ + YL        +H DL   N L+ +NMV  ++DFG
Sbjct: 163 VSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFG 219
Query: 673 IAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 724
           +++ +   D           I +M PE     + +T  DV+++G++L E F+
Sbjct: 220 LSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 69/281 (24%), Positives = 122/281 (43%), Gaps = 38/281 (13%)
Query: 535 IGRGGFGSVYKARIRDGME------VAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVK 587
           +G+G FG VY+   RD ++      VAVK  N     R    F  E ++MK     ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLD---------IFQRLNIMIDVASALE 638
           ++   S  +   +V+E M HG L+ YL S     +         + + + +  ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 639 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 698
           YL+   +   +H DL   N ++  +    + DFG+ + +          + L  + +MAP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWMAP 201
Query: 699 EYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDAN 758
           E  ++G  +T+ D++SFG++L E  +  +   +  + E  LK             V+D  
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF------------VMDGG 249
Query: 759 LLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIV 799
            L Q D        C   V +L   C   +P+ R    EIV
Sbjct: 250 YLDQPD-------NCPERVTDLMRMCWQFNPKMRPTFLEIV 283

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 69/305 (22%), Positives = 135/305 (44%), Gaps = 38/305 (12%)
Query: 525 ATDKFSENNLIGRGGFGSVY----KARIRDGME--VAVKVFNLQCG-RAFKSFDVECAMM 577
           A +K + +  +G+G FG VY    K  ++D  E  VA+K  N     R    F  E ++M
Sbjct: 8   AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 67
Query: 578 KSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLD---------IFQRLN 628
           K     ++V+++   S  +   +++E M  G L+ YL S    ++         + + + 
Sbjct: 68  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 127
Query: 629 IMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQ 688
           +  ++A  + YL+   +   +H DL   N ++ ++    + DFG+ + +   D      +
Sbjct: 128 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGK 184
Query: 689 TLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLP 748
            L  + +M+PE  ++G  +T  DV+SFG++L E  T  +   +  + E  L+        
Sbjct: 185 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------- 237
Query: 749 ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDS 808
                V++  LL + D        C   +  L   C   +P+ R +  EI++ + +  + 
Sbjct: 238 -----VMEGGLLDKPD-------NCPDMLLELMRMCWQYNPKMRPSFLEIISSIKEEMEP 285
Query: 809 LLRNV 813
             R V
Sbjct: 286 GFREV 290

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 95/199 (47%), Gaps = 12/199 (6%)
Query: 535 IGRGGFGSVYKARI-----RDGMEVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVKV 588
           +G G FG V   R        G +VAVK    + G         E  +++++ H N+VK 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 589 ISSCSNEEFKA--LVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSA 646
              C+ +      L++E++P GSL++YL  +   +++ Q+L   + +   ++YL    S 
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SR 145
Query: 647 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-TGEDQSMTQTQTLATIGYMAPEYGREGQ 705
             +H DL   NVL++      + DFG+ K + T ++    +    + + + APE   + +
Sbjct: 146 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSK 205
Query: 706 VSTNGDVYSFGIMLMETFT 724
                DV+SFG+ L E  T
Sbjct: 206 FYIASDVWSFGVTLHELLT 224

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 79.7 bits (195), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 75/310 (24%), Positives = 124/310 (40%), Gaps = 59/310 (19%)
Query: 527 DKFSENNLIGRGGFGSVY--------KARIRDGMEVAVKVFNLQCG-RAFKSFDVECAMM 577
           D+      +G G FG V         K +     +VAVK+       +       E  MM
Sbjct: 69  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128
Query: 578 KSI-RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYL---------------HSSNYSL 621
           K I +H+N++ ++ +C+ +    +++EY   G+L +YL               H+    L
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 622 DIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 681
                ++    VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ +   D
Sbjct: 189 SSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 245
Query: 682 QSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKK------PTDELFNG 735
                T     + +MAPE   +   +   DV+SFG++L E FT         P +ELF  
Sbjct: 246 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK- 304
Query: 736 EMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINA 795
                                   L +E         C + ++ +  +C    P QR   
Sbjct: 305 ------------------------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTF 340
Query: 796 KEIVAKLLKI 805
           K++V  L +I
Sbjct: 341 KQLVEDLDRI 350

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 79.7 bits (195), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 95/209 (45%), Gaps = 16/209 (7%)
Query: 529 FSENNL-----IGRGGFGSVYKARI-----RDGMEVAVKVFNLQCGRAFKSFDVECAMMK 578
           F E +L     +G+G FGSV   R        G  VAVK          + F  E  ++K
Sbjct: 4   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 63
Query: 579 SIRHRNLVKV--ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASA 636
           ++    +VK   +S         LV+EY+P G L  +L      LD  + L     +   
Sbjct: 64  ALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 123
Query: 637 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT-GEDQSMTQTQTLATIGY 695
           +EYL    S   +H DL   N+L++      ++DFG+AKLL   +D  + +    + I +
Sbjct: 124 MEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFW 180
Query: 696 MAPEYGREGQVSTNGDVYSFGIMLMETFT 724
            APE   +   S   DV+SFG++L E FT
Sbjct: 181 YAPESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 79.7 bits (195), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 95/199 (47%), Gaps = 12/199 (6%)
Query: 535 IGRGGFGSVYKARI-----RDGMEVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVKV 588
           +G G FG V   R        G +VAVK    + G         E  +++++ H N+VK 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 589 ISSCSNEEFKA--LVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSA 646
              C+ +      L++E++P GSL++YL  +   +++ Q+L   + +   ++YL    S 
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SR 133
Query: 647 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-TGEDQSMTQTQTLATIGYMAPEYGREGQ 705
             +H DL   NVL++      + DFG+ K + T ++    +    + + + APE   + +
Sbjct: 134 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSK 193
Query: 706 VSTNGDVYSFGIMLMETFT 724
                DV+SFG+ L E  T
Sbjct: 194 FYIASDVWSFGVTLHELLT 212

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 75/310 (24%), Positives = 124/310 (40%), Gaps = 59/310 (19%)
Query: 527 DKFSENNLIGRGGFGSVY--------KARIRDGMEVAVKVFNLQCG-RAFKSFDVECAMM 577
           D+      +G G FG V         K +     +VAVK+       +       E  MM
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 578 KSI-RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYL---------------HSSNYSL 621
           K I +H+N++ ++ +C+ +    +++EY   G+L +YL               H+    L
Sbjct: 88  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQL 147
Query: 622 DIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 681
                ++    VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ +   D
Sbjct: 148 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 204
Query: 682 QSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKK------PTDELFNG 735
                T     + +MAPE   +   +   DV+SFG++L E FT         P +ELF  
Sbjct: 205 XXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK- 263
Query: 736 EMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINA 795
                                   L +E         C + ++ +  +C    P QR   
Sbjct: 264 ------------------------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTF 299
Query: 796 KEIVAKLLKI 805
           K++V  L +I
Sbjct: 300 KQLVEDLDRI 309

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 12/201 (5%)
Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDV-----ECAMMKSI 580
           + F    ++G G F +V  AR +    E A+K+  L+     K   V     E  +M  +
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 89
Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
            H   VK+  +  ++E     L Y  +G L KY+     S D         ++ SALEYL
Sbjct: 90  DHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIG-SFDETCTRFYTAEIVSALEYL 148
Query: 641 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
           H      +IH DLKP N+LL+++M   ++DFG AK+L+ E +       + T  Y++PE 
Sbjct: 149 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 205
Query: 701 GREGQVSTNGDVYSFGIMLME 721
             E   S + D+++ G ++ +
Sbjct: 206 LTEKSASKSSDLWALGCIIYQ 226

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 79.3 bits (194), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 100/219 (45%), Gaps = 18/219 (8%)
Query: 521 ELFQATDK--FSENNL-----IGRGGFGSVYKARI-----RDGMEVAVKVFNLQCGRAFK 568
           +L+   D   F E +L     +G+G FGSV   R        G  VAVK          +
Sbjct: 10  QLYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQR 69
Query: 569 SFDVECAMMKSIRHRNLVKV--ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQR 626
            F  E  ++K++    +VK   +S     +   LV+EY+P G L  +L      LD  + 
Sbjct: 70  DFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRL 129
Query: 627 LNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT-GEDQSMT 685
           L     +   +EYL    S   +H DL   N+L++      ++DFG+AKLL   +D  + 
Sbjct: 130 LLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVV 186
Query: 686 QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 724
           +    + I + APE   +   S   DV+SFG++L E FT
Sbjct: 187 REPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 96/209 (45%), Gaps = 16/209 (7%)
Query: 529 FSENNL-----IGRGGFGSVYKARI-----RDGMEVAVKVFNLQCGRAFKSFDVECAMMK 578
           F E +L     +G+G FGSV   R        G  VAVK          + F  E  ++K
Sbjct: 7   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 66
Query: 579 SIRHRNLVKV--ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASA 636
           ++    +VK   +S     +   LV+EY+P G L  +L      LD  + L     +   
Sbjct: 67  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 126
Query: 637 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT-GEDQSMTQTQTLATIGY 695
           +EYL    S   +H DL   N+L++      ++DFG+AKLL   +D  + +    + I +
Sbjct: 127 MEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFW 183
Query: 696 MAPEYGREGQVSTNGDVYSFGIMLMETFT 724
            APE   +   S   DV+SFG++L E FT
Sbjct: 184 YAPESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 66/290 (22%), Positives = 123/290 (42%), Gaps = 36/290 (12%)
Query: 532 NNLIGRGGFGSVYKA--------RIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHR 583
           + +IG+G FG VY          RI+  ++   ++  +Q   AF     E  +M+ + H 
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLR---EGLLMRGLNHP 82
Query: 584 NLVKVIS-SCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
           N++ +I      E    ++L YM HG L +++ S   +  +   ++  + VA  +EYL  
Sbjct: 83  NVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL-- 140
Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLAT--IGYMAPEY 700
                 +H DL   N +LD++    ++DFG+A+ +   +    Q    A   + + A E 
Sbjct: 141 -AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALES 199
Query: 701 GREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLL 760
            +  + +T  DV+SFG++L E  TR  P                   P   ++  D    
Sbjct: 200 LQTYRFTTKSDVWSFGVLLWELLTRGAP-------------------PYRHIDPFDLTHF 240
Query: 761 SQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLL 810
             +       E C   ++ +  +C    P  R   + +V ++ +I  +LL
Sbjct: 241 LAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL 290

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 103/222 (46%), Gaps = 27/222 (12%)
Query: 524 QATDKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAF-----KSFDVECAMM 577
           Q    +     +G GGFG V +   +D G +VA+K    QC +       + + +E  +M
Sbjct: 11  QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIK----QCRQELSPKNRERWCLEIQIM 66
Query: 578 KSIRHRNLVKV------ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQR--LNI 629
           K + H N+V        +   +  +   L +EY   G L KYL+       + +     +
Sbjct: 67  KKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTL 126
Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLTGEDQSMTQ 686
           + D++SAL YLH      +IH DLKP N++L      ++  + D G AK L   DQ    
Sbjct: 127 LSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL---DQGELC 180
Query: 687 TQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKP 728
           T+ + T+ Y+APE   + + +   D +SFG +  E  T  +P
Sbjct: 181 TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 222

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 96/209 (45%), Gaps = 16/209 (7%)
Query: 529 FSENNL-----IGRGGFGSVYKARI-----RDGMEVAVKVFNLQCGRAFKSFDVECAMMK 578
           F E +L     +G+G FGSV   R        G  VAVK          + F  E  ++K
Sbjct: 8   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 67
Query: 579 SIRHRNLVKV--ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASA 636
           ++    +VK   +S     +   LV+EY+P G L  +L      LD  + L     +   
Sbjct: 68  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 127
Query: 637 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT-GEDQSMTQTQTLATIGY 695
           +EYL    S   +H DL   N+L++      ++DFG+AKLL   +D  + +    + I +
Sbjct: 128 MEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFW 184
Query: 696 MAPEYGREGQVSTNGDVYSFGIMLMETFT 724
            APE   +   S   DV+SFG++L E FT
Sbjct: 185 YAPESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 103/222 (46%), Gaps = 27/222 (12%)
Query: 524 QATDKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAF-----KSFDVECAMM 577
           Q    +     +G GGFG V +   +D G +VA+K    QC +       + + +E  +M
Sbjct: 12  QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIK----QCRQELSPKNRERWCLEIQIM 67
Query: 578 KSIRHRNLVKV------ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQR--LNI 629
           K + H N+V        +   +  +   L +EY   G L KYL+       + +     +
Sbjct: 68  KKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTL 127
Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLTGEDQSMTQ 686
           + D++SAL YLH      +IH DLKP N++L      ++  + D G AK L   DQ    
Sbjct: 128 LSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL---DQGELC 181
Query: 687 TQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKP 728
           T+ + T+ Y+APE   + + +   D +SFG +  E  T  +P
Sbjct: 182 TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 223

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 106/236 (44%), Gaps = 16/236 (6%)
Query: 500 KGPPNDPNMPPVATWRRFSYLELFQATDKFSENNLIGRGGFGSVYKAR-IRDGMEVA--- 555
           +GPP     P  A      Y  L      F     IGRG F  VY+A  + DG+ VA   
Sbjct: 9   QGPPVPQFQPQKALRPDMGYNTLAN----FRIEKKIGRGQFSEVYRAACLLDGVPVALKK 64
Query: 556 VKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYL- 614
           V++F+L   +A      E  ++K + H N++K  +S   +    +VLE    G L + + 
Sbjct: 65  VQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIK 124
Query: 615 HSSNYSLDIFQR--LNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFG 672
           H       I +R      + + SALE++H   S  V+H D+KP+NV +    V  L D G
Sbjct: 125 HFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLG 181
Query: 673 IAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKP 728
           + +  +   ++      + T  YM+PE   E   +   D++S G +L E    + P
Sbjct: 182 LGRFFSS--KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 235

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 117/264 (44%), Gaps = 28/264 (10%)
Query: 528 KFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLV 586
           K++    IG+G  G+VY A  +  G EVA++  NLQ     +    E  +M+  ++ N+V
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80
Query: 587 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSA 646
             + S    +   +V+EY+  GSL   +  +   +D  Q   +  +   ALE+LH   S 
Sbjct: 81  NYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SN 135
Query: 647 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQV 706
            VIH D+K  N+LL  +    L+DFG    +T E     +++ + T  +MAPE       
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSEMVGTPYWMAPEVVTRKAY 193
Query: 707 STNGDVYSFGIMLMETFTRKKP-----------------TDELFNGE---MTLKHWVNDC 746
               D++S GIM +E    + P                 T EL N E      + ++N C
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253
Query: 747 LPISTMEVVDANLLSQEDIHFVAK 770
           L +   +   A  L Q     +AK
Sbjct: 254 LDMDVEKRGSAKELLQHQFLKIAK 277

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 75/310 (24%), Positives = 124/310 (40%), Gaps = 59/310 (19%)
Query: 527 DKFSENNLIGRGGFGSVY--------KARIRDGMEVAVKVFNLQCG-RAFKSFDVECAMM 577
           D+      +G G FG V         K +     +VAVK+       +       E  MM
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 578 KSI-RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYL---------------HSSNYSL 621
           K I +H+N++ ++ +C+ +    +++EY   G+L +YL               H+    L
Sbjct: 88  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQL 147
Query: 622 DIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 681
                ++    VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ +   D
Sbjct: 148 SSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 204
Query: 682 QSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKK------PTDELFNG 735
                T     + +MAPE   +   +   DV+SFG++L E FT         P +ELF  
Sbjct: 205 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK- 263
Query: 736 EMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINA 795
                                   L +E         C + ++ +  +C    P QR   
Sbjct: 264 ------------------------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTF 299
Query: 796 KEIVAKLLKI 805
           K++V  L +I
Sbjct: 300 KQLVEDLDRI 309

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 100/212 (47%), Gaps = 24/212 (11%)
Query: 523 FQATDKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVF-NLQCGRAFKSFDV-ECAMMKS 579
           FQ+ +K+    L+G G +G V K R +D G  VA+K F      +  K   + E  ++K 
Sbjct: 21  FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQ 80
Query: 580 IRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKY-LHSSNYSLDIFQRLNIMIDVASALE 638
           +RH NLV ++  C  ++   LV E++ H  L+   L  +     + Q+    I     + 
Sbjct: 81  LRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQI-----IN 135
Query: 639 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 698
            + F +S  +IH D+KP N+L+  + V  L DFG A+ L    +       +AT  Y AP
Sbjct: 136 GIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYDDEVATRWYRAP 193
Query: 699 E-------YGREGQVSTNGDVYSFGIMLMETF 723
           E       YG+        DV++ G ++ E F
Sbjct: 194 ELLVGDVKYGK------AVDVWAIGCLVTEMF 219

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 96/201 (47%), Gaps = 12/201 (5%)
Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDV-----ECAMMKSI 580
           + F    ++G G F +V  AR +    E A+K+  L+     K   V     E  +M  +
Sbjct: 10  EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 67
Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
            H   VK+  +  ++E     L Y  +G L KY+     S D         ++ SALEYL
Sbjct: 68  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYL 126
Query: 641 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
           H      +IH DLKP N+LL+++M   ++DFG AK+L+ E +       + T  Y++PE 
Sbjct: 127 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 183
Query: 701 GREGQVSTNGDVYSFGIMLME 721
             E     + D+++ G ++ +
Sbjct: 184 LTEKSACKSSDLWALGCIIYQ 204

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 96/201 (47%), Gaps = 12/201 (5%)
Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDV-----ECAMMKSI 580
           + F    ++G G F +V  AR +    E A+K+  L+     K   V     E  +M  +
Sbjct: 7   EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 64
Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
            H   VK+  +  ++E     L Y  +G L KY+     S D         ++ SALEYL
Sbjct: 65  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYL 123
Query: 641 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
           H      +IH DLKP N+LL+++M   ++DFG AK+L+ E +       + T  Y++PE 
Sbjct: 124 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 180
Query: 701 GREGQVSTNGDVYSFGIMLME 721
             E     + D+++ G ++ +
Sbjct: 181 LTEKSACKSSDLWALGCIIYQ 201

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/310 (24%), Positives = 124/310 (40%), Gaps = 59/310 (19%)
Query: 527 DKFSENNLIGRGGFGSVY--------KARIRDGMEVAVKVFNLQCG-RAFKSFDVECAMM 577
           D+      +G G FG V         K +     +VAVK+       +       E  MM
Sbjct: 20  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 79
Query: 578 KSI-RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYL---------------HSSNYSL 621
           K I +H+N++ ++ +C+ +    +++EY   G+L +YL               H+    L
Sbjct: 80  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 139
Query: 622 DIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 681
                ++    VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ +   D
Sbjct: 140 SSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 196
Query: 682 QSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKK------PTDELFNG 735
                T     + +MAPE   +   +   DV+SFG++L E FT         P +ELF  
Sbjct: 197 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK- 255
Query: 736 EMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINA 795
                                   L +E         C + ++ +  +C    P QR   
Sbjct: 256 ------------------------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTF 291
Query: 796 KEIVAKLLKI 805
           K++V  L +I
Sbjct: 292 KQLVEDLDRI 301

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 96/201 (47%), Gaps = 12/201 (5%)
Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDV-----ECAMMKSI 580
           + F    ++G G F +V  AR +    E A+K+  L+     K   V     E  +M  +
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 65
Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
            H   VK+  +  ++E     L Y  +G L KY+     S D         ++ SALEYL
Sbjct: 66  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYL 124
Query: 641 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
           H      +IH DLKP N+LL+++M   ++DFG AK+L+ E +       + T  Y++PE 
Sbjct: 125 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 181
Query: 701 GREGQVSTNGDVYSFGIMLME 721
             E     + D+++ G ++ +
Sbjct: 182 LTEKSACKSSDLWALGCIIYQ 202

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/310 (24%), Positives = 124/310 (40%), Gaps = 59/310 (19%)
Query: 527 DKFSENNLIGRGGFGSVY--------KARIRDGMEVAVKVFNLQCG-RAFKSFDVECAMM 577
           D+      +G G FG V         K +     +VAVK+       +       E  MM
Sbjct: 17  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 76
Query: 578 KSI-RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYL---------------HSSNYSL 621
           K I +H+N++ ++ +C+ +    +++EY   G+L +YL               H+    L
Sbjct: 77  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 136
Query: 622 DIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 681
                ++    VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ +   D
Sbjct: 137 SSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 193
Query: 682 QSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKK------PTDELFNG 735
                T     + +MAPE   +   +   DV+SFG++L E FT         P +ELF  
Sbjct: 194 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK- 252
Query: 736 EMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINA 795
                                   L +E         C + ++ +  +C    P QR   
Sbjct: 253 ------------------------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTF 288
Query: 796 KEIVAKLLKI 805
           K++V  L +I
Sbjct: 289 KQLVEDLDRI 298

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/310 (24%), Positives = 124/310 (40%), Gaps = 59/310 (19%)
Query: 527 DKFSENNLIGRGGFGSVY--------KARIRDGMEVAVKVFNLQCG-RAFKSFDVECAMM 577
           D+      +G G FG V         K +     +VAVK+       +       E  MM
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 578 KSI-RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYL---------------HSSNYSL 621
           K I +H+N++ ++ +C+ +    +++EY   G+L +YL               H+    L
Sbjct: 88  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 147
Query: 622 DIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 681
                ++    VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ +   D
Sbjct: 148 SSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 204
Query: 682 QSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKK------PTDELFNG 735
                T     + +MAPE   +   +   DV+SFG++L E FT         P +ELF  
Sbjct: 205 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK- 263
Query: 736 EMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINA 795
                                   L +E         C + ++ +  +C    P QR   
Sbjct: 264 ------------------------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTF 299
Query: 796 KEIVAKLLKI 805
           K++V  L +I
Sbjct: 300 KQLVEDLDRI 309

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/310 (24%), Positives = 124/310 (40%), Gaps = 59/310 (19%)
Query: 527 DKFSENNLIGRGGFGSVY--------KARIRDGMEVAVKVFNLQCG-RAFKSFDVECAMM 577
           D+      +G G FG V         K +     +VAVK+       +       E  MM
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 578 KSI-RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYL---------------HSSNYSL 621
           K I +H+N++ ++ +C+ +    +++EY   G+L +YL               H+    L
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQL 132
Query: 622 DIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 681
                ++    VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ +   D
Sbjct: 133 SSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 682 QSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT------RKKPTDELFNG 735
                T     + +MAPE   +   +   DV+SFG++L E FT         P +ELF  
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK- 248
Query: 736 EMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINA 795
                                   L +E         C + ++ +  +C    P QR   
Sbjct: 249 ------------------------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTF 284
Query: 796 KEIVAKLLKI 805
           K++V  L +I
Sbjct: 285 KQLVEDLDRI 294

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 96/201 (47%), Gaps = 12/201 (5%)
Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDV-----ECAMMKSI 580
           + F    ++G G F +V  AR +    E A+K+  L+     K   V     E  +M  +
Sbjct: 9   EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 66
Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
            H   VK+  +  ++E     L Y  +G L KY+     S D         ++ SALEYL
Sbjct: 67  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYL 125
Query: 641 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
           H      +IH DLKP N+LL+++M   ++DFG AK+L+ E +       + T  Y++PE 
Sbjct: 126 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 182
Query: 701 GREGQVSTNGDVYSFGIMLME 721
             E     + D+++ G ++ +
Sbjct: 183 LTEKSACKSSDLWALGCIIYQ 203

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 96/201 (47%), Gaps = 12/201 (5%)
Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDV-----ECAMMKSI 580
           + F    ++G G F +V  AR +    E A+K+  L+     K   V     E  +M  +
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 86
Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
            H   VK+  +  ++E     L Y  +G L KY+     S D         ++ SALEYL
Sbjct: 87  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYL 145
Query: 641 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
           H      +IH DLKP N+LL+++M   ++DFG AK+L+ E +       + T  Y++PE 
Sbjct: 146 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 202
Query: 701 GREGQVSTNGDVYSFGIMLME 721
             E     + D+++ G ++ +
Sbjct: 203 LTEKSACKSSDLWALGCIIYQ 223

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/310 (24%), Positives = 124/310 (40%), Gaps = 59/310 (19%)
Query: 527 DKFSENNLIGRGGFGSVY--------KARIRDGMEVAVKVFNLQCG-RAFKSFDVECAMM 577
           D+      +G G FG V         K +     +VAVK+       +       E  MM
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 578 KSI-RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYL---------------HSSNYSL 621
           K I +H+N++ ++ +C+ +    +++EY   G+L +YL               H+    L
Sbjct: 88  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQL 147
Query: 622 DIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 681
                ++    VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ +   D
Sbjct: 148 SSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 204
Query: 682 QSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKK------PTDELFNG 735
                T     + +MAPE   +   +   DV+SFG++L E FT         P +ELF  
Sbjct: 205 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK- 263
Query: 736 EMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINA 795
                                   L +E         C + ++ +  +C    P QR   
Sbjct: 264 ------------------------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTF 299
Query: 796 KEIVAKLLKI 805
           K++V  L +I
Sbjct: 300 KQLVEDLDRI 309

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 96/201 (47%), Gaps = 12/201 (5%)
Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDV-----ECAMMKSI 580
           + F    ++G G F +V  AR +    E A+K+  L+     K   V     E  +M  +
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 86
Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
            H   VK+  +  ++E     L Y  +G L KY+     S D         ++ SALEYL
Sbjct: 87  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYL 145
Query: 641 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
           H      +IH DLKP N+LL+++M   ++DFG AK+L+ E +       + T  Y++PE 
Sbjct: 146 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 202
Query: 701 GREGQVSTNGDVYSFGIMLME 721
             E     + D+++ G ++ +
Sbjct: 203 LTEKSACKSSDLWALGCIIYQ 223

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 96/201 (47%), Gaps = 12/201 (5%)
Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDV-----ECAMMKSI 580
           + F    ++G G F +V  AR +    E A+K+  L+     K   V     E  +M  +
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 71
Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
            H   VK+  +  ++E     L Y  +G L KY+     S D         ++ SALEYL
Sbjct: 72  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYL 130
Query: 641 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
           H      +IH DLKP N+LL+++M   ++DFG AK+L+ E +       + T  Y++PE 
Sbjct: 131 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 187
Query: 701 GREGQVSTNGDVYSFGIMLME 721
             E     + D+++ G ++ +
Sbjct: 188 LTEKSACKSSDLWALGCIIYQ 208

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/310 (24%), Positives = 124/310 (40%), Gaps = 59/310 (19%)
Query: 527 DKFSENNLIGRGGFGSVY--------KARIRDGMEVAVKVFNLQCG-RAFKSFDVECAMM 577
           D+      +G G FG V         K +     +VAVK+       +       E  MM
Sbjct: 21  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 80
Query: 578 KSI-RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYL---------------HSSNYSL 621
           K I +H+N++ ++ +C+ +    +++EY   G+L +YL               H+    L
Sbjct: 81  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 140
Query: 622 DIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 681
                ++    VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ +   D
Sbjct: 141 SSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 197
Query: 682 QSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKK------PTDELFNG 735
                T     + +MAPE   +   +   DV+SFG++L E FT         P +ELF  
Sbjct: 198 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK- 256
Query: 736 EMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINA 795
                                   L +E         C + ++ +  +C    P QR   
Sbjct: 257 ------------------------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTF 292
Query: 796 KEIVAKLLKI 805
           K++V  L +I
Sbjct: 293 KQLVEDLDRI 302

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 96/201 (47%), Gaps = 12/201 (5%)
Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDV-----ECAMMKSI 580
           + F    ++G G F +V  AR +    E A+K+  L+     K   V     E  +M  +
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 87
Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
            H   VK+  +  ++E     L Y  +G L KY+     S D         ++ SALEYL
Sbjct: 88  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYL 146
Query: 641 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
           H      +IH DLKP N+LL+++M   ++DFG AK+L+ E +       + T  Y++PE 
Sbjct: 147 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 203
Query: 701 GREGQVSTNGDVYSFGIMLME 721
             E     + D+++ G ++ +
Sbjct: 204 LTEKSACKSSDLWALGCIIYQ 224

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 99/209 (47%), Gaps = 19/209 (9%)
Query: 533 NLIGRGGFGSVYKARIR--DG--MEVAVKVFNLQ--CGRAFKSFDVECAMMKSIRHRNLV 586
            ++G G FGSV +  ++  DG  ++VAVK   L     R  + F  E A MK   H N++
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 587 KVISSCSNEEFKAL-----VLEYMPHGSLEKYLHSSNYS-----LDIFQRLNIMIDVASA 636
           +++  C     + +     +L +M +G L  YL  S        + +   L  M+D+A  
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 637 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYM 696
           +EYL    +   +H DL   N +L D+M   ++DFG++K +   D           + ++
Sbjct: 160 MEYLS---NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 216
Query: 697 APEYGREGQVSTNGDVYSFGIMLMETFTR 725
           A E   +   ++  DV++FG+ + E  TR
Sbjct: 217 AIESLADRVYTSKSDVWAFGVTMWEIATR 245

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 96/201 (47%), Gaps = 12/201 (5%)
Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDV-----ECAMMKSI 580
           + F    ++G G F +V  AR +    E A+K+  L+     K   V     E  +M  +
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 89
Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
            H   VK+  +  ++E     L Y  +G L KY+     S D         ++ SALEYL
Sbjct: 90  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYL 148
Query: 641 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
           H      +IH DLKP N+LL+++M   ++DFG AK+L+ E +       + T  Y++PE 
Sbjct: 149 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 205
Query: 701 GREGQVSTNGDVYSFGIMLME 721
             E     + D+++ G ++ +
Sbjct: 206 LTEKSACKSSDLWALGCIIYQ 226

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 96/201 (47%), Gaps = 12/201 (5%)
Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDV-----ECAMMKSI 580
           + F    ++G G F +V  AR +    E A+K+  L+     K   V     E  +M  +
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 92
Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
            H   VK+  +  ++E     L Y  +G L KY+     S D         ++ SALEYL
Sbjct: 93  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYL 151
Query: 641 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
           H      +IH DLKP N+LL+++M   ++DFG AK+L+ E +       + T  Y++PE 
Sbjct: 152 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 208
Query: 701 GREGQVSTNGDVYSFGIMLME 721
             E     + D+++ G ++ +
Sbjct: 209 LTEKSACKSSDLWALGCIIYQ 229

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 116/264 (43%), Gaps = 28/264 (10%)
Query: 528 KFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLV 586
           K++    IG+G  G+VY A  +  G EVA++  NLQ     +    E  +M+  ++ N+V
Sbjct: 22  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 81
Query: 587 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSA 646
             + S    +   +V+EY+  GSL   +  +   +D  Q   +  +   ALE+LH   S 
Sbjct: 82  NYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SN 136
Query: 647 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQV 706
            VIH D+K  N+LL  +    L+DFG    +T E     ++  + T  +MAPE       
Sbjct: 137 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSXMVGTPYWMAPEVVTRKAY 194
Query: 707 STNGDVYSFGIMLMETFTRKKP-----------------TDELFNGE---MTLKHWVNDC 746
               D++S GIM +E    + P                 T EL N E      + ++N C
Sbjct: 195 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 254
Query: 747 LPISTMEVVDANLLSQEDIHFVAK 770
           L +   +   A  L Q     +AK
Sbjct: 255 LEMDVEKRGSAKELIQHQFLKIAK 278

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 96/201 (47%), Gaps = 12/201 (5%)
Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDV-----ECAMMKSI 580
           + F    ++G G F +V  AR +    E A+K+  L+     K   V     E  +M  +
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 87
Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
            H   VK+  +  ++E     L Y  +G L KY+     S D         ++ SALEYL
Sbjct: 88  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYL 146
Query: 641 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
           H      +IH DLKP N+LL+++M   ++DFG AK+L+ E +       + T  Y++PE 
Sbjct: 147 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 203
Query: 701 GREGQVSTNGDVYSFGIMLME 721
             E     + D+++ G ++ +
Sbjct: 204 LTEKSACKSSDLWALGCIIYQ 224

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 96/201 (47%), Gaps = 12/201 (5%)
Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDV-----ECAMMKSI 580
           + F    ++G G F +V  AR +    E A+K+  L+     K   V     E  +M  +
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 89
Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
            H   VK+  +  ++E     L Y  +G L KY+     S D         ++ SALEYL
Sbjct: 90  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYL 148
Query: 641 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
           H      +IH DLKP N+LL+++M   ++DFG AK+L+ E +       + T  Y++PE 
Sbjct: 149 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 205
Query: 701 GREGQVSTNGDVYSFGIMLME 721
             E     + D+++ G ++ +
Sbjct: 206 LTEKSAXKSSDLWALGCIIYQ 226

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 96/201 (47%), Gaps = 12/201 (5%)
Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDV-----ECAMMKSI 580
           + F    ++G G F +V  AR +    E A+K+  L+     K   V     E  +M  +
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 87
Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
            H   VK+  +  ++E     L Y  +G L KY+     S D         ++ SALEYL
Sbjct: 88  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYL 146
Query: 641 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
           H      +IH DLKP N+LL+++M   ++DFG AK+L+ E +       + T  Y++PE 
Sbjct: 147 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPEL 203
Query: 701 GREGQVSTNGDVYSFGIMLME 721
             E     + D+++ G ++ +
Sbjct: 204 LTEKSACKSSDLWALGCIIYQ 224

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 96/201 (47%), Gaps = 12/201 (5%)
Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDV-----ECAMMKSI 580
           + F    ++G G F +V  AR +    E A+K+  L+     K   V     E  +M  +
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 89
Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
            H   VK+  +  ++E     L Y  +G L KY+     S D         ++ SALEYL
Sbjct: 90  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYL 148
Query: 641 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
           H      +IH DLKP N+LL+++M   ++DFG AK+L+ E +       + T  Y++PE 
Sbjct: 149 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 205
Query: 701 GREGQVSTNGDVYSFGIMLME 721
             E     + D+++ G ++ +
Sbjct: 206 LTEKSACKSSDLWALGCIIYQ 226

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 96/201 (47%), Gaps = 12/201 (5%)
Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDV-----ECAMMKSI 580
           + F    ++G G F +V  AR +    E A+K+  L+     K   V     E  +M  +
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 90
Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
            H   VK+  +  ++E     L Y  +G L KY+     S D         ++ SALEYL
Sbjct: 91  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYL 149
Query: 641 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
           H      +IH DLKP N+LL+++M   ++DFG AK+L+ E +       + T  Y++PE 
Sbjct: 150 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 206
Query: 701 GREGQVSTNGDVYSFGIMLME 721
             E     + D+++ G ++ +
Sbjct: 207 LTEKSACKSSDLWALGCIIYQ 227

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 96/201 (47%), Gaps = 12/201 (5%)
Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDV-----ECAMMKSI 580
           + F    ++G G F +V  AR +    E A+K+  L+     K   V     E  +M  +
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 90
Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
            H   VK+  +  ++E     L Y  +G L KY+     S D         ++ SALEYL
Sbjct: 91  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYL 149
Query: 641 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
           H      +IH DLKP N+LL+++M   ++DFG AK+L+ E +       + T  Y++PE 
Sbjct: 150 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 206
Query: 701 GREGQVSTNGDVYSFGIMLME 721
             E     + D+++ G ++ +
Sbjct: 207 LTEKSACKSSDLWALGCIIYQ 227

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 96/201 (47%), Gaps = 12/201 (5%)
Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDV-----ECAMMKSI 580
           + F    ++G G F +V  AR +    E A+K+  L+     K   V     E  +M  +
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 89
Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
            H   VK+  +  ++E     L Y  +G L KY+     S D         ++ SALEYL
Sbjct: 90  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYL 148
Query: 641 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
           H      +IH DLKP N+LL+++M   ++DFG AK+L+ E +       + T  Y++PE 
Sbjct: 149 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 205
Query: 701 GREGQVSTNGDVYSFGIMLME 721
             E     + D+++ G ++ +
Sbjct: 206 LTEKSACKSSDLWALGCIIYQ 226

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 116/264 (43%), Gaps = 28/264 (10%)
Query: 528 KFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLV 586
           K++    IG+G  G+VY A  +  G EVA++  NLQ     +    E  +M+  ++ N+V
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80
Query: 587 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSA 646
             + S    +   +V+EY+  GSL   +  +   +D  Q   +  +   ALE+LH   S 
Sbjct: 81  NYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SN 135
Query: 647 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQV 706
            VIH D+K  N+LL  +    L+DFG    +T E     ++  + T  +MAPE       
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSXMVGTPYWMAPEVVTRKAY 193
Query: 707 STNGDVYSFGIMLMETFTRKKP-----------------TDELFNGE---MTLKHWVNDC 746
               D++S GIM +E    + P                 T EL N E      + ++N C
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253
Query: 747 LPISTMEVVDANLLSQEDIHFVAK 770
           L +   +   A  L Q     +AK
Sbjct: 254 LEMDVEKRGSAKELLQHQFLKIAK 277

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 96/201 (47%), Gaps = 12/201 (5%)
Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDV-----ECAMMKSI 580
           + F    ++G G F +V  AR +    E A+K+  L+     K   V     E  +M  +
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 89
Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
            H   VK+  +  ++E     L Y  +G L KY+     S D         ++ SALEYL
Sbjct: 90  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYL 148
Query: 641 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
           H      +IH DLKP N+LL+++M   ++DFG AK+L+ E +       + T  Y++PE 
Sbjct: 149 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 205
Query: 701 GREGQVSTNGDVYSFGIMLME 721
             E     + D+++ G ++ +
Sbjct: 206 LTEKSACKSSDLWALGCIIYQ 226

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 76/264 (28%), Positives = 117/264 (44%), Gaps = 28/264 (10%)
Query: 528 KFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLV 586
           K++    IG+G  G+VY A  +  G EVA++  NLQ     +    E  +M+  ++ N+V
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80
Query: 587 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSA 646
             + S    +   +V+EY+  GSL   +  +   +D  Q   +  +   ALE+LH   S 
Sbjct: 81  NYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SN 135
Query: 647 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQV 706
            VIH D+K  N+LL  +    L+DFG    +T E QS   T  + T  +MAPE       
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-QSKRST-MVGTPYWMAPEVVTRKAY 193
Query: 707 STNGDVYSFGIMLMETFTRKKP-----------------TDELFNGE---MTLKHWVNDC 746
               D++S GIM +E    + P                 T EL N E      + ++N C
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253
Query: 747 LPISTMEVVDANLLSQEDIHFVAK 770
           L +   +   A  L Q     +AK
Sbjct: 254 LDMDVEKRGSAKELLQHQFLKIAK 277

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/305 (22%), Positives = 134/305 (43%), Gaps = 38/305 (12%)
Query: 525 ATDKFSENNLIGRGGFGSVY----KARIRDGME--VAVKVFNLQCG-RAFKSFDVECAMM 577
           A +K + +  +G+G FG VY    K  ++D  E  VA+K  N     R    F  E ++M
Sbjct: 10  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 69
Query: 578 KSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLD---------IFQRLN 628
           K     ++V+++   S  +   +++E M  G L+ YL S    ++         + + + 
Sbjct: 70  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 129
Query: 629 IMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQ 688
           +  ++A  + YL+   +   +H DL   N  + ++    + DFG+ + +   D      +
Sbjct: 130 MAGEIADGMAYLN---ANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGK 186
Query: 689 TLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLP 748
            L  + +M+PE  ++G  +T  DV+SFG++L E  T  +   +  + E  L+        
Sbjct: 187 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------- 239
Query: 749 ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDS 808
                V++  LL + D        C   +  L   C   +P+ R +  EI++ + +  + 
Sbjct: 240 -----VMEGGLLDKPD-------NCPDMLLELMRMCWQYNPKMRPSFLEIISSIKEEMEP 287
Query: 809 LLRNV 813
             R V
Sbjct: 288 GFREV 292

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 71/224 (31%), Positives = 111/224 (49%), Gaps = 21/224 (9%)
Query: 518 SYLELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC-GRAFKSFDV-EC 574
            ++E FQ  +K      IG G +G VYKAR +  G  VA+K   L        S  + E 
Sbjct: 7   EFMENFQKVEK------IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI 60
Query: 575 AMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVA 634
           +++K + H N+VK++     E    LV E++ H  L+K++ +S  +L       I   + 
Sbjct: 61  SLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS--ALTGIPLPLIKSYLF 117
Query: 635 SALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIG 694
             L+ L F +S  V+H DLKP N+L++      L+DFG+A+      +  T T  + T+ 
Sbjct: 118 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLW 175
Query: 695 YMAPE--YGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGE 736
           Y APE   G +   ST  D++S G +  E  TR+     LF G+
Sbjct: 176 YRAPEILLGXK-YYSTAVDIWSLGCIFAEMVTRRA----LFPGD 214

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 70/223 (31%), Positives = 110/223 (49%), Gaps = 19/223 (8%)
Query: 518 SYLELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC-GRAFKSFDV-EC 574
            ++E FQ  +K      IG G +G VYKAR +  G  VA+K   L        S  + E 
Sbjct: 7   EFMENFQKVEK------IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI 60
Query: 575 AMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVA 634
           +++K + H N+VK++     E    LV E++ H  L+K++ +S  +L       I   + 
Sbjct: 61  SLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS--ALTGIPLPLIKSYLF 117
Query: 635 SALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIG 694
             L+ L F +S  V+H DLKP N+L++      L+DFG+A+      +  T T  + T+ 
Sbjct: 118 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLW 175
Query: 695 YMAPEYGREGQ-VSTNGDVYSFGIMLMETFTRKKPTDELFNGE 736
           Y APE     +  ST  D++S G +  E  TR+     LF G+
Sbjct: 176 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGD 214

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 95/201 (47%), Gaps = 12/201 (5%)
Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDV-----ECAMMKSI 580
           + F    ++G G F +V  AR +    E A+K+  L+     K   V     E  +M  +
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 94
Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
            H   VK+     ++E     L Y  +G L KY+     S D         ++ SALEYL
Sbjct: 95  DHPFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYL 153
Query: 641 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
           H      +IH DLKP N+LL+++M   ++DFG AK+L+ E +       + T  Y++PE 
Sbjct: 154 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 210
Query: 701 GREGQVSTNGDVYSFGIMLME 721
             E     + D+++ G ++ +
Sbjct: 211 LTEKSACKSSDLWALGCIIYQ 231

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 71/277 (25%), Positives = 118/277 (42%), Gaps = 31/277 (11%)
Query: 532 NNLIGRGGFGSVYKARIR----DGMEVAVKVFNLQCGRAFKS-FDVECAMMKSIRHRNLV 586
           N ++G G FG VY+        + + VAVK     C    K  F  E  +MK++ H ++V
Sbjct: 29  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 88
Query: 587 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSA 646
           K+I     EE   +++E  P+G L  YL  +  SL +   +   + +  A+ YL    S 
Sbjct: 89  KLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SI 144
Query: 647 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQV 706
             +H D+   N+L+       L DFG+++ +  ED        L  I +M+PE     + 
Sbjct: 145 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP-IKWMSPESINFRRF 203
Query: 707 STNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDI 765
           +T  DV+ F + + E  +  K+P   L N ++           I  +E    + L + D+
Sbjct: 204 TTASDVWMFAVCMWEILSFGKQPFFWLENKDV-----------IGVLE--KGDRLPKPDL 250
Query: 766 HFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL 802
                  C   ++ L   C    P  R    E+V  L
Sbjct: 251 -------CPPVLYTLMTRCWDYDPSDRPRFTELVCSL 280

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 95/201 (47%), Gaps = 12/201 (5%)
Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDV-----ECAMMKSI 580
           + F    ++G G F +   AR +    E A+K+  L+     K   V     E  +M  +
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 87
Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
            H   VK+  +  ++E     L Y  +G L KY+     S D         ++ SALEYL
Sbjct: 88  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYL 146
Query: 641 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
           H      +IH DLKP N+LL+++M   ++DFG AK+L+ E +       + T  Y++PE 
Sbjct: 147 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 203
Query: 701 GREGQVSTNGDVYSFGIMLME 721
             E     + D+++ G ++ +
Sbjct: 204 LTEKSACKSSDLWALGCIIYQ 224

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 71/224 (31%), Positives = 100/224 (44%), Gaps = 23/224 (10%)
Query: 521 ELFQATDK---FSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNL---QCGRAFKSFDVE 573
           ELF   D    FS+   IG G FG+VY AR +R+   VA+K  +    Q    ++    E
Sbjct: 45  ELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKE 104
Query: 574 CAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDV 633
              ++ +RH N ++       E    LV+EY   GS    L      L   Q + I    
Sbjct: 105 VRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPL---QEVEIAAVT 160
Query: 634 ASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATI 693
             AL+ L + +S  +IH D+K  N+LL +  +  L DFG A ++            + T 
Sbjct: 161 HGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------PANXFVGTP 214
Query: 694 GYMAPEY---GREGQVSTNGDVYSFGIMLMETFTRKKPTDELFN 734
            +MAPE      EGQ     DV+S GI  +E   RK P   LFN
Sbjct: 215 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP---LFN 255

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 71/277 (25%), Positives = 118/277 (42%), Gaps = 31/277 (11%)
Query: 532 NNLIGRGGFGSVYKARIR----DGMEVAVKVFNLQCGRAFKS-FDVECAMMKSIRHRNLV 586
           N ++G G FG VY+        + + VAVK     C    K  F  E  +MK++ H ++V
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 587 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSA 646
           K+I     EE   +++E  P+G L  YL  +  SL +   +   + +  A+ YL    S 
Sbjct: 77  KLIGIIE-EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SI 132
Query: 647 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQV 706
             +H D+   N+L+       L DFG+++ +  ED        L  I +M+PE     + 
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP-IKWMSPESINFRRF 191
Query: 707 STNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDI 765
           +T  DV+ F + + E  +  K+P   L N ++           I  +E    + L + D+
Sbjct: 192 TTASDVWMFAVCMWEILSFGKQPFFWLENKDV-----------IGVLE--KGDRLPKPDL 238
Query: 766 HFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL 802
                  C   ++ L   C    P  R    E+V  L
Sbjct: 239 -------CPPVLYTLMTRCWDYDPSDRPRFTELVCSL 268

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 71/277 (25%), Positives = 118/277 (42%), Gaps = 31/277 (11%)
Query: 532 NNLIGRGGFGSVYKARIR----DGMEVAVKVFNLQCGRAFKS-FDVECAMMKSIRHRNLV 586
           N ++G G FG VY+        + + VAVK     C    K  F  E  +MK++ H ++V
Sbjct: 13  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 72
Query: 587 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSA 646
           K+I     EE   +++E  P+G L  YL  +  SL +   +   + +  A+ YL    S 
Sbjct: 73  KLIGIIE-EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SI 128
Query: 647 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQV 706
             +H D+   N+L+       L DFG+++ +  ED        L  I +M+PE     + 
Sbjct: 129 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP-IKWMSPESINFRRF 187
Query: 707 STNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDI 765
           +T  DV+ F + + E  +  K+P   L N ++           I  +E    + L + D+
Sbjct: 188 TTASDVWMFAVCMWEILSFGKQPFFWLENKDV-----------IGVLE--KGDRLPKPDL 234
Query: 766 HFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL 802
                  C   ++ L   C    P  R    E+V  L
Sbjct: 235 -------CPPVLYTLMTRCWDYDPSDRPRFTELVCSL 264

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 71/222 (31%), Positives = 110/222 (49%), Gaps = 21/222 (9%)
Query: 520 LELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC-GRAFKSFDV-ECAM 576
           +E FQ  +K      IG G +G VYKAR +  G  VA+K   L        S  + E ++
Sbjct: 2   MENFQKVEK------IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL 55
Query: 577 MKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASA 636
           +K + H N+VK++     E    LV E++ H  L+K++ +S  +L       I   +   
Sbjct: 56  LKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS--ALTGIPLPLIKSYLFQL 112
Query: 637 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYM 696
           L+ L F +S  V+H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y 
Sbjct: 113 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYR 170
Query: 697 APE--YGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGE 736
           APE   G +   ST  D++S G +  E  TR+     LF G+
Sbjct: 171 APEILLGXK-YYSTAVDIWSLGCIFAEMVTRR----ALFPGD 207

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVF-NLQCGRAFKSFDV-ECAMMKSIRHR 583
           +K+ +   IG G +G V+K R RD G  VA+K F   +     K   + E  M+K ++H 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 584 NLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQR---LNIMIDVA-SALEY 639
           NLV ++     +    LV EY  H  L        + LD +QR    +++  +    L+ 
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYCDHTVL--------HELDRYQRGVPEHLVKSITWQTLQA 114
Query: 640 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPE 699
           ++F +    IH D+KP N+L+  + V  L DFG A+LLTG   S      +AT  Y +PE
Sbjct: 115 VNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGP--SDYYDDEVATRWYRSPE 172
Query: 700 -YGREGQVSTNGDVYSFGIMLMETFT 724
               + Q     DV++ G +  E  +
Sbjct: 173 LLVGDTQYGPPVDVWAIGCVFAELLS 198

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 71/224 (31%), Positives = 100/224 (44%), Gaps = 23/224 (10%)
Query: 521 ELFQATDK---FSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNL---QCGRAFKSFDVE 573
           ELF   D    FS+   IG G FG+VY AR +R+   VA+K  +    Q    ++    E
Sbjct: 6   ELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKE 65
Query: 574 CAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDV 633
              ++ +RH N ++       E    LV+EY   GS    L      L   Q + I    
Sbjct: 66  VRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPL---QEVEIAAVT 121
Query: 634 ASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATI 693
             AL+ L + +S  +IH D+K  N+LL +  +  L DFG A ++            + T 
Sbjct: 122 HGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------PANXFVGTP 175
Query: 694 GYMAPEY---GREGQVSTNGDVYSFGIMLMETFTRKKPTDELFN 734
            +MAPE      EGQ     DV+S GI  +E   RK P   LFN
Sbjct: 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP---LFN 216

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 12/215 (5%)
Query: 523 FQATDK---FSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFNLQCGRAFKSF-DVECAMM 577
           FQ+ D    F++   IG+G FG V+K    R    VA+K+ +L+           E  ++
Sbjct: 20  FQSMDPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVL 79
Query: 578 KSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASAL 637
                  + K   S   +    +++EY+  GS    L      LD  Q   I+ ++   L
Sbjct: 80  SQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG--PLDETQIATILREILKGL 137
Query: 638 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMA 697
           +YLH   S   IH D+K +NVLL ++    L+DFG+A  LT  D  + +   + T  +MA
Sbjct: 138 DYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWMA 192
Query: 698 PEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEL 732
           PE  ++    +  D++S GI  +E    + P  EL
Sbjct: 193 PEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 227

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/264 (28%), Positives = 117/264 (44%), Gaps = 28/264 (10%)
Query: 528 KFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLV 586
           K++    IG+G  G+VY A  +  G EVA++  NLQ     +    E  +M+  ++ N+V
Sbjct: 22  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 81
Query: 587 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSA 646
             + S    +   +V+EY+  GSL   +  +   +D  Q   +  +   ALE+LH   S 
Sbjct: 82  NYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SN 136
Query: 647 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQV 706
            VIH ++K  N+LL  +    L+DFG    +T E QS   T  + T  +MAPE       
Sbjct: 137 QVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPE-QSKRST-MVGTPYWMAPEVVTRKAY 194
Query: 707 STNGDVYSFGIMLMETFTRKKP-----------------TDELFNGE---MTLKHWVNDC 746
               D++S GIM +E    + P                 T EL N E      + ++N C
Sbjct: 195 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 254
Query: 747 LPISTMEVVDANLLSQEDIHFVAK 770
           L +   +   A  L Q     +AK
Sbjct: 255 LEMDVEKRGSAKELIQHQFLKIAK 278

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/221 (31%), Positives = 109/221 (49%), Gaps = 19/221 (8%)
Query: 520 LELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC-GRAFKSFDV-ECAM 576
           +E FQ  +K      IG G +G VYKAR +  G  VA+K   L        S  + E ++
Sbjct: 2   MENFQKVEK------IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL 55
Query: 577 MKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASA 636
           +K + H N+VK++     E    LV E++ H  L+K++ +S  +L       I   +   
Sbjct: 56  LKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS--ALTGIPLPLIKSYLFQL 112
Query: 637 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYM 696
           L+ L F +S  V+H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y 
Sbjct: 113 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYR 170
Query: 697 APEYGREGQ-VSTNGDVYSFGIMLMETFTRKKPTDELFNGE 736
           APE     +  ST  D++S G +  E  TR+     LF G+
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR----ALFPGD 207

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/221 (31%), Positives = 109/221 (49%), Gaps = 19/221 (8%)
Query: 520 LELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC-GRAFKSFDV-ECAM 576
           +E FQ  +K      IG G +G VYKAR +  G  VA+K   L        S  + E ++
Sbjct: 2   MENFQKVEK------IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL 55
Query: 577 MKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASA 636
           +K + H N+VK++     E    LV E++ H  L+K++ +S  +L       I   +   
Sbjct: 56  LKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS--ALTGIPLPLIKSYLFQL 112
Query: 637 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYM 696
           L+ L F +S  V+H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y 
Sbjct: 113 LQGLSFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYR 170
Query: 697 APEYGREGQ-VSTNGDVYSFGIMLMETFTRKKPTDELFNGE 736
           APE     +  ST  D++S G +  E  TR+     LF G+
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR----ALFPGD 207

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 25/209 (11%)
Query: 535 IGRGGFGSVYKARIR------DGMEVAVKVFNLQCGRAFK-SFDVECAMMKSIRHRNLVK 587
           +G G FG VY+ ++         ++VAVK     C    +  F +E  ++  + H+N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLH------SSNYSLDIFQRLNIMIDVASALEYL- 640
            I        + ++LE M  G L+ +L       S   SL +   L++  D+A   +YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 641 --HFGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGY 695
             HF      IH D+   N LL       VA + DFG+A+ +            +  + +
Sbjct: 173 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 226
Query: 696 MAPEYGREGQVSTNGDVYSFGIMLMETFT 724
           M PE   EG  ++  D +SFG++L E F+
Sbjct: 227 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/221 (31%), Positives = 109/221 (49%), Gaps = 19/221 (8%)
Query: 520 LELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC-GRAFKSFDV-ECAM 576
           +E FQ  +K      IG G +G VYKAR +  G  VA+K   L        S  + E ++
Sbjct: 2   MENFQKVEK------IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL 55
Query: 577 MKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASA 636
           +K + H N+VK++     E    LV E++ H  L+K++ +S  +L       I   +   
Sbjct: 56  LKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS--ALTGIPLPLIKSYLFQL 112
Query: 637 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYM 696
           L+ L F +S  V+H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y 
Sbjct: 113 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYR 170
Query: 697 APEYGREGQ-VSTNGDVYSFGIMLMETFTRKKPTDELFNGE 736
           APE     +  ST  D++S G +  E  TR+     LF G+
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR----ALFPGD 207

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/221 (31%), Positives = 109/221 (49%), Gaps = 19/221 (8%)
Query: 520 LELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC-GRAFKSFDV-ECAM 576
           +E FQ  +K      IG G +G VYKAR +  G  VA+K   L        S  + E ++
Sbjct: 1   MENFQKVEK------IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL 54
Query: 577 MKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASA 636
           +K + H N+VK++     E    LV E++ H  L+K++ +S  +L       I   +   
Sbjct: 55  LKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS--ALTGIPLPLIKSYLFQL 111
Query: 637 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYM 696
           L+ L F +S  V+H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y 
Sbjct: 112 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYR 169
Query: 697 APEYGREGQ-VSTNGDVYSFGIMLMETFTRKKPTDELFNGE 736
           APE     +  ST  D++S G +  E  TR+     LF G+
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR----ALFPGD 206

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 106/214 (49%), Gaps = 13/214 (6%)
Query: 527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC-GRAFKSFDV-ECAMMKSIRHR 583
           + F +   IG G +G VYKAR +  G  VA+K   L        S  + E +++K + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 584 NLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFG 643
           N+VK++     E    LV E++ H  L+K++ +S  +L       I   +   L+ L F 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 644 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE 703
           +S  V+H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y APE    
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLG 176
Query: 704 GQ-VSTNGDVYSFGIMLMETFTRKKPTDELFNGE 736
            +  ST  D++S G +  E  TR+     LF G+
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRR----ALFPGD 206

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 25/209 (11%)
Query: 535 IGRGGFGSVYKARIR------DGMEVAVKVFNLQCGRAFK-SFDVECAMMKSIRHRNLVK 587
           +G G FG VY+ ++         ++VAVK     C    +  F +E  ++  + H+N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLH------SSNYSLDIFQRLNIMIDVASALEYL- 640
            I        + ++LE M  G L+ +L       S   SL +   L++  D+A   +YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 641 --HFGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGY 695
             HF      IH D+   N LL       VA + DFG+A+ +            +  + +
Sbjct: 159 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 212
Query: 696 MAPEYGREGQVSTNGDVYSFGIMLMETFT 724
           M PE   EG  ++  D +SFG++L E F+
Sbjct: 213 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/221 (31%), Positives = 109/221 (49%), Gaps = 19/221 (8%)
Query: 520 LELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC-GRAFKSFDV-ECAM 576
           +E FQ  +K      IG G +G VYKAR +  G  VA+K   L        S  + E ++
Sbjct: 3   MENFQKVEK------IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL 56
Query: 577 MKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASA 636
           +K + H N+VK++     E    LV E++ H  L+K++ +S  +L       I   +   
Sbjct: 57  LKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS--ALTGIPLPLIKSYLFQL 113
Query: 637 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYM 696
           L+ L F +S  V+H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y 
Sbjct: 114 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYR 171
Query: 697 APEYGREGQ-VSTNGDVYSFGIMLMETFTRKKPTDELFNGE 736
           APE     +  ST  D++S G +  E  TR+     LF G+
Sbjct: 172 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR----ALFPGD 208

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 96/211 (45%), Gaps = 9/211 (4%)
Query: 524 QATDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQC---GRAFKSFDVECAMMKS 579
           +  + F   NL+G+G F  VY+A  I  G+EVA+K+ + +        +    E  +   
Sbjct: 8   EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQ 67
Query: 580 IRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEY 639
           ++H +++++ +   +  +  LVLE   +G + +YL +        +  + M  + + + Y
Sbjct: 68  LKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLY 127
Query: 640 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPE 699
           LH   S  ++H DL  SN+LL  NM   ++DFG+A  L    +         T  Y++PE
Sbjct: 128 LH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK--HYTLCGTPNYISPE 182
Query: 700 YGREGQVSTNGDVYSFGIMLMETFTRKKPTD 730
                      DV+S G M       + P D
Sbjct: 183 IATRSAHGLESDVWSLGCMFYTLLIGRPPFD 213

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/221 (31%), Positives = 109/221 (49%), Gaps = 19/221 (8%)
Query: 520 LELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC-GRAFKSFDV-ECAM 576
           +E FQ  +K      IG G +G VYKAR +  G  VA+K   L        S  + E ++
Sbjct: 6   MENFQKVEK------IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL 59
Query: 577 MKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASA 636
           +K + H N+VK++     E    LV E++ H  L+K++ +S  +L       I   +   
Sbjct: 60  LKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS--ALTGIPLPLIKSYLFQL 116
Query: 637 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYM 696
           L+ L F +S  V+H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y 
Sbjct: 117 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYR 174
Query: 697 APEYGREGQ-VSTNGDVYSFGIMLMETFTRKKPTDELFNGE 736
           APE     +  ST  D++S G +  E  TR+     LF G+
Sbjct: 175 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGD 211

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 140/297 (47%), Gaps = 34/297 (11%)
Query: 522 LFQATDKFSENNLIGRGGFGSVYKAR-IRDGME-VAVKVFNLQCGRAFKSFDV--ECAMM 577
           L +A  ++     IG G +G V+KAR +++G   VA+K   +Q G          E A++
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 578 K---SIRHRNLVKVISSCS----NEEFK-ALVLEYMPHGSLEKYLHS-SNYSLDIFQRLN 628
           +   +  H N+V++   C+    + E K  LV E++    L  YL       +      +
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKD 124
Query: 629 IMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQ 688
           +M  +   L++LH   S  V+H DLKP N+L+  +    L+DFG+A++ + +   M  T 
Sbjct: 125 MMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTS 178
Query: 689 TLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHW--VNDC 746
            + T+ Y APE   +   +T  D++S G +  E F R+KP   LF G   +     + D 
Sbjct: 179 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF-RRKP---LFRGSSDVDQLGKILDV 234
Query: 747 LPISTMEVVDANL-LSQEDIHFVAKEQCVSFVF-------NLALECTVESPEQRINA 795
           + +   E    ++ L ++  H  + +    FV        +L L+C   +P +RI+A
Sbjct: 235 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA 291

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 9/203 (4%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQC-GRAFKSFDV-ECAMMKSIRHRN 584
           +K+ +   +G G +G VYKA+   G  VA+K   L        S  + E +++K + H N
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 585 LVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGY 644
           +V +I    +E    LV E+M    L+K L  +   L   Q   I I +   L  +   +
Sbjct: 81  IVSLIDVIHSERCLTLVFEFM-EKDLKKVLDENKTGL---QDSQIKIYLYQLLRGVAHCH 136
Query: 645 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY-GRE 703
              ++H DLKP N+L++ +    L+DFG+A+      +S   T  + T+ Y AP+     
Sbjct: 137 QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVVTLWYRAPDVLMGS 194
Query: 704 GQVSTNGDVYSFGIMLMETFTRK 726
            + ST+ D++S G +  E  T K
Sbjct: 195 KKYSTSVDIWSIGCIFAEMITGK 217

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 25/209 (11%)
Query: 535 IGRGGFGSVYKARIR------DGMEVAVKVFNLQCGRAFK-SFDVECAMMKSIRHRNLVK 587
           +G G FG VY+ ++         ++VAVK     C    +  F +E  ++    H+N+V+
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLH------SSNYSLDIFQRLNIMIDVASALEYL- 640
            I        + ++LE M  G L+ +L       S   SL +   L++  D+A   +YL 
Sbjct: 90  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 149
Query: 641 --HFGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGY 695
             HF      IH D+   N LL       VA + DFG+A+ +            +  + +
Sbjct: 150 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 203
Query: 696 MAPEYGREGQVSTNGDVYSFGIMLMETFT 724
           M PE   EG  ++  D +SFG++L E F+
Sbjct: 204 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 72/233 (30%), Positives = 115/233 (49%), Gaps = 28/233 (12%)
Query: 507 NMPPVATWRR---FSYLELFQATDKFSENNLIGRGGFGSVYKARIRDGMEV-AVKVFNLQ 562
           +MPPV        F + E+ +A         IG+G FG V   +  D  ++ A+K  N Q
Sbjct: 1   SMPPVFDENEDVNFDHFEILRA---------IGKGSFGKVCIVQKNDTKKMYAMKYMNKQ 51
Query: 563 -CGRAFKSFDV--ECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNY 619
            C    +  +V  E  +M+ + H  LV +  S  +EE   +V++ +  G L  +L  + +
Sbjct: 52  KCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVH 111
Query: 620 SLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG 679
             +   +L I  ++  AL+YL    +  +IH D+KP N+LLD++   H++DF IA +L  
Sbjct: 112 FKEETVKLFI-CELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167
Query: 680 EDQSMTQTQTLA-TIGYMAPEY--GREGQ-VSTNGDVYSFGIMLMETFTRKKP 728
           E    TQ  T+A T  YMAPE    R+G   S   D +S G+   E    ++P
Sbjct: 168 E----TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 25/209 (11%)
Query: 535 IGRGGFGSVYKARIR------DGMEVAVKVFNLQCGRAFK-SFDVECAMMKSIRHRNLVK 587
           +G G FG VY+ ++         ++VAVK     C    +  F +E  ++    H+N+V+
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLH------SSNYSLDIFQRLNIMIDVASALEYL- 640
            I        + ++LE M  G L+ +L       S   SL +   L++  D+A   +YL 
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 164
Query: 641 --HFGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGY 695
             HF      IH D+   N LL       VA + DFG+A+ +            +  + +
Sbjct: 165 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 218
Query: 696 MAPEYGREGQVSTNGDVYSFGIMLMETFT 724
           M PE   EG  ++  D +SFG++L E F+
Sbjct: 219 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 25/209 (11%)
Query: 535 IGRGGFGSVYKARIR------DGMEVAVKVFNLQCGRAFK-SFDVECAMMKSIRHRNLVK 587
           +G G FG VY+ ++         ++VAVK     C    +  F +E  ++    H+N+V+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLH------SSNYSLDIFQRLNIMIDVASALEYL- 640
            I        + ++LE M  G L+ +L       S   SL +   L++  D+A   +YL 
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 641 --HFGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGY 695
             HF      IH D+   N LL       VA + DFG+A+ +            +  + +
Sbjct: 158 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 211
Query: 696 MAPEYGREGQVSTNGDVYSFGIMLMETFT 724
           M PE   EG  ++  D +SFG++L E F+
Sbjct: 212 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 25/209 (11%)
Query: 535 IGRGGFGSVYKARIR------DGMEVAVKVFNLQCGRAFK-SFDVECAMMKSIRHRNLVK 587
           +G G FG VY+ ++         ++VAVK     C    +  F +E  ++    H+N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLH------SSNYSLDIFQRLNIMIDVASALEYL- 640
            I        + ++LE M  G L+ +L       S   SL +   L++  D+A   +YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 641 --HFGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGY 695
             HF      IH D+   N LL       VA + DFG+A+ +            +  + +
Sbjct: 159 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 212
Query: 696 MAPEYGREGQVSTNGDVYSFGIMLMETFT 724
           M PE   EG  ++  D +SFG++L E F+
Sbjct: 213 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 100/220 (45%), Gaps = 23/220 (10%)
Query: 528 KFSENNL-----IGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDVECAMMKSIR 581
           +F  NNL     +G G FG V +A     G E AV    ++  ++    D + A+M  ++
Sbjct: 42  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 582 -------HRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVA 634
                  H N+V ++ +C++     ++ EY  +G L  +L   +  L+      I    A
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTA 161
Query: 635 SALEYLHFG----------YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM 684
           S  + LHF            S   IH D+   NVLL +  VA + DFG+A+ +  +   +
Sbjct: 162 STRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 221
Query: 685 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 724
            +      + +MAPE   +   +   DV+S+GI+L E F+
Sbjct: 222 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 9/203 (4%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQC-GRAFKSFDV-ECAMMKSIRHRN 584
           +K+ +   +G G +G VYKA+   G  VA+K   L        S  + E +++K + H N
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 585 LVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGY 644
           +V +I    +E    LV E+M    L+K L  +   L   Q   I I +   L  +   +
Sbjct: 81  IVSLIDVIHSERCLTLVFEFM-EKDLKKVLDENKTGL---QDSQIKIYLYQLLRGVAHCH 136
Query: 645 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY-GRE 703
              ++H DLKP N+L++ +    L+DFG+A+      +S   T  + T+ Y AP+     
Sbjct: 137 QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVVTLWYRAPDVLMGS 194
Query: 704 GQVSTNGDVYSFGIMLMETFTRK 726
            + ST+ D++S G +  E  T K
Sbjct: 195 KKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 25/209 (11%)
Query: 535 IGRGGFGSVYKARIR------DGMEVAVKVFNLQCGRAFK-SFDVECAMMKSIRHRNLVK 587
           +G G FG VY+ ++         ++VAVK     C    +  F +E  ++    H+N+V+
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLH------SSNYSLDIFQRLNIMIDVASALEYL- 640
            I        + ++LE M  G L+ +L       S   SL +   L++  D+A   +YL 
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 174
Query: 641 --HFGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGY 695
             HF      IH D+   N LL       VA + DFG+A+ +            +  + +
Sbjct: 175 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 228
Query: 696 MAPEYGREGQVSTNGDVYSFGIMLMETFT 724
           M PE   EG  ++  D +SFG++L E F+
Sbjct: 229 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 57/210 (27%), Positives = 105/210 (50%), Gaps = 21/210 (10%)
Query: 541 GSVYKARIRDGMEVAVKVFNLQ--CGRAFKSFDVECAMMKSIRHRNLVKVISSCSN--EE 596
           G ++K R + G ++ VKV  ++    R  + F+ EC  ++   H N++ V+ +C +    
Sbjct: 24  GELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82
Query: 597 FKALVLEYMPHGSLEKYLHS-SNYSLDIFQRLNIMIDVASALEYLHFGYSAPVI--HCDL 653
              L+  +MP+GSL   LH  +N+ +D  Q +   +D+A  + +LH     P+I  H  L
Sbjct: 83  HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH--TLEPLIPRHA-L 139
Query: 654 KPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTN---G 710
              +V++D++M A +S       +     S      +    ++APE  ++    TN    
Sbjct: 140 NSRSVMIDEDMTARIS-------MADVKFSFQSPGRMYAPAWVAPEALQKKPEDTNRRSA 192
Query: 711 DVYSFGIMLMETFTRKKPTDELFNGEMTLK 740
           D++SF ++L E  TR+ P  +L N E+ +K
Sbjct: 193 DMWSFAVLLWELVTREVPFADLSNMEIGMK 222

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 140/297 (47%), Gaps = 34/297 (11%)
Query: 522 LFQATDKFSENNLIGRGGFGSVYKAR-IRDGME-VAVKVFNLQCGRAFKSFDV--ECAMM 577
           L +A  ++     IG G +G V+KAR +++G   VA+K   +Q G          E A++
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 578 K---SIRHRNLVKVISSCS----NEEFK-ALVLEYMPHGSLEKYLHS-SNYSLDIFQRLN 628
           +   +  H N+V++   C+    + E K  LV E++    L  YL       +      +
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKD 124
Query: 629 IMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQ 688
           +M  +   L++LH   S  V+H DLKP N+L+  +    L+DFG+A++ + +   M  T 
Sbjct: 125 MMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTS 178
Query: 689 TLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHW--VNDC 746
            + T+ Y APE   +   +T  D++S G +  E F R+KP   LF G   +     + D 
Sbjct: 179 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF-RRKP---LFRGSSDVDQLGKILDV 234
Query: 747 LPISTMEVVDANL-LSQEDIHFVAKEQCVSFVF-------NLALECTVESPEQRINA 795
           + +   E    ++ L ++  H  + +    FV        +L L+C   +P +RI+A
Sbjct: 235 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA 291

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 109/214 (50%), Gaps = 25/214 (11%)
Query: 536 GRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISS---C 592
            RG FG V+KA++ +   VAVK+F LQ  ++++S + E      ++H NL++ I++    
Sbjct: 24  ARGRFGCVWKAQLMNDF-VAVKIFPLQDKQSWQS-EREIFSTPGMKHENLLQFIAAEKRG 81
Query: 593 SNEEFK-ALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF--------G 643
           SN E +  L+  +   GSL  YL  +  + +  +  ++   ++  L YLH         G
Sbjct: 82  SNLEVELWLITAFHDKGSLTDYLKGNIITWN--ELCHVAETMSRGLSYLHEDVPWCRGEG 139
Query: 644 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIA-KLLTGEDQSMTQTQTLATIGYMAPEYGR 702
           +   + H D K  NVLL  ++ A L+DFG+A +   G+    T  Q + T  YMAPE   
Sbjct: 140 HKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQ-VGTRRYMAPEV-L 197
Query: 703 EGQVSTNG------DVYSFGIMLMETFTRKKPTD 730
           EG ++         D+Y+ G++L E  +R K  D
Sbjct: 198 EGAINFQRDAFLRIDMYAMGLVLWELVSRCKAAD 231

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 72/294 (24%), Positives = 117/294 (39%), Gaps = 58/294 (19%)
Query: 535 IGRGGFGSVYKARIR------DGMEVAVKVFNLQCGRAFK-SFDVECAMMKSIRHRNLVK 587
           +G G FG VY+ ++         ++VAVK     C    +  F +E  ++    H+N+V+
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLH------SSNYSLDIFQRLNIMIDVASALEYL- 640
            I        + ++LE M  G L+ +L       S   SL +   L++  D+A   +YL 
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 641 --HFGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGY 695
             HF      IH D+   N LL       VA + DFG+A+ +            +  + +
Sbjct: 199 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKW 252
Query: 696 MAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVV 755
           M PE   EG  ++  D +SFG++L E F+          G M      N           
Sbjct: 253 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSL---------GYMPYPSKSN----------- 292
Query: 756 DANLLSQEDIHFVAK-------EQCVSFVFNLALECTVESPEQRINAKEIVAKL 802
                 QE + FV         + C   V+ +  +C    PE R N   I+ ++
Sbjct: 293 ------QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 340

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 108/214 (50%), Gaps = 15/214 (7%)
Query: 520 LELFQATDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFD-------V 572
           L++     ++ + + +G G F +VYKAR ++  ++ V +  ++ G   ++ D        
Sbjct: 3   LDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQI-VAIKKIKLGHRSEAKDGINRTALR 61
Query: 573 ECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMID 632
           E  +++ + H N++ ++ +  ++   +LV ++M    LE  +  ++  L        M+ 
Sbjct: 62  EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLM 120
Query: 633 VASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLAT 692
               LEYLH  +   ++H DLKP+N+LLD+N V  L+DFG+AK     +++      + T
Sbjct: 121 TLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--XHQVVT 175
Query: 693 IGYMAPEYGREGQVSTNG-DVYSFGIMLMETFTR 725
             Y APE     ++   G D+++ G +L E   R
Sbjct: 176 RWYRAPELLFGARMYGVGVDMWAVGCILAELLLR 209

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 25/209 (11%)
Query: 535 IGRGGFGSVYKARIR------DGMEVAVKVFNLQCGRAFK-SFDVECAMMKSIRHRNLVK 587
           +G G FG VY+ ++         ++VAVK     C    +  F +E  ++    H+N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLH------SSNYSLDIFQRLNIMIDVASALEYL- 640
            I        + ++LE M  G L+ +L       S   SL +   L++  D+A   +YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 641 --HFGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGY 695
             HF      IH D+   N LL       VA + DFG+A+ +            +  + +
Sbjct: 159 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKW 212
Query: 696 MAPEYGREGQVSTNGDVYSFGIMLMETFT 724
           M PE   EG  ++  D +SFG++L E F+
Sbjct: 213 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 140/297 (47%), Gaps = 34/297 (11%)
Query: 522 LFQATDKFSENNLIGRGGFGSVYKAR-IRDGME-VAVKVFNLQCGRAFKSFDV--ECAMM 577
           L +A  ++     IG G +G V+KAR +++G   VA+K   +Q G          E A++
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 578 K---SIRHRNLVKVISSCS----NEEFK-ALVLEYMPHGSLEKYLHS-SNYSLDIFQRLN 628
           +   +  H N+V++   C+    + E K  LV E++    L  YL       +      +
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKD 124
Query: 629 IMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQ 688
           +M  +   L++LH   S  V+H DLKP N+L+  +    L+DFG+A++ + +   M  T 
Sbjct: 125 MMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTS 178
Query: 689 TLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHW--VNDC 746
            + T+ Y APE   +   +T  D++S G +  E F R+KP   LF G   +     + D 
Sbjct: 179 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF-RRKP---LFRGSSDVDQLGKILDV 234
Query: 747 LPISTMEVVDANL-LSQEDIHFVAKEQCVSFVF-------NLALECTVESPEQRINA 795
           + +   E    ++ L ++  H  + +    FV        +L L+C   +P +RI+A
Sbjct: 235 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA 291

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 9/206 (4%)
Query: 529 FSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFNLQCGRAFKSF-DVECAMMKSIRHRNLV 586
           F++   IG+G FG V+K    R    VA+K+ +L+           E  ++       + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 587 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSA 646
           K   S   +    +++EY+  GS    L      LD  Q   I+ ++   L+YLH   S 
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPG--PLDETQIATILREILKGLDYLH---SE 123
Query: 647 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQV 706
             IH D+K +NVLL ++    L+DFG+A  LT  D  + +   + T  +MAPE  ++   
Sbjct: 124 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNXFVGTPFWMAPEVIKQSAY 181
Query: 707 STNGDVYSFGIMLMETFTRKKPTDEL 732
            +  D++S GI  +E    + P  EL
Sbjct: 182 DSKADIWSLGITAIELARGEPPHSEL 207

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 9/206 (4%)
Query: 529 FSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFNLQCGRAFKSF-DVECAMMKSIRHRNLV 586
           F++   IG+G FG V+K    R    VA+K+ +L+           E  ++       + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 587 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSA 646
           K   S   +    +++EY+  GS    L      LD  Q   I+ ++   L+YLH   S 
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPG--PLDETQIATILREILKGLDYLH---SE 123
Query: 647 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQV 706
             IH D+K +NVLL ++    L+DFG+A  LT  D  + +   + T  +MAPE  ++   
Sbjct: 124 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVIKQSAY 181
Query: 707 STNGDVYSFGIMLMETFTRKKPTDEL 732
            +  D++S GI  +E    + P  EL
Sbjct: 182 DSKADIWSLGITAIELARGEPPHSEL 207

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 25/209 (11%)
Query: 535 IGRGGFGSVYKARIR------DGMEVAVKVFNLQCGRAFK-SFDVECAMMKSIRHRNLVK 587
           +G G FG VY+ ++         ++VAVK     C    +  F +E  ++    H+N+V+
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLH------SSNYSLDIFQRLNIMIDVASALEYL- 640
            I        + ++LE M  G L+ +L       S   SL +   L++  D+A   +YL 
Sbjct: 116 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 175
Query: 641 --HFGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGY 695
             HF      IH D+   N LL       VA + DFG+A+ +            +  + +
Sbjct: 176 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKW 229
Query: 696 MAPEYGREGQVSTNGDVYSFGIMLMETFT 724
           M PE   EG  ++  D +SFG++L E F+
Sbjct: 230 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 25/209 (11%)
Query: 535 IGRGGFGSVYKARIR------DGMEVAVKVFNLQCGRAFK-SFDVECAMMKSIRHRNLVK 587
           +G G FG VY+ ++         ++VAVK     C    +  F +E  ++    H+N+V+
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLH------SSNYSLDIFQRLNIMIDVASALEYL- 640
            I        + ++LE M  G L+ +L       S   SL +   L++  D+A   +YL 
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 184
Query: 641 --HFGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGY 695
             HF      IH D+   N LL       VA + DFG+A+ +            +  + +
Sbjct: 185 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 238
Query: 696 MAPEYGREGQVSTNGDVYSFGIMLMETFT 724
           M PE   EG  ++  D +SFG++L E F+
Sbjct: 239 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 9/206 (4%)
Query: 529 FSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFNLQCGRAFKSF-DVECAMMKSIRHRNLV 586
           F++   IG+G FG V+K    R    VA+K+ +L+           E  ++       + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 587 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSA 646
           K   S   +    +++EY+  GS    L      LD  Q   I+ ++   L+YLH   S 
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPG--PLDETQIATILREILKGLDYLH---SE 138
Query: 647 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQV 706
             IH D+K +NVLL ++    L+DFG+A  LT  D  + +   + T  +MAPE  ++   
Sbjct: 139 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNXFVGTPFWMAPEVIKQSAY 196
Query: 707 STNGDVYSFGIMLMETFTRKKPTDEL 732
            +  D++S GI  +E    + P  EL
Sbjct: 197 DSKADIWSLGITAIELARGEPPHSEL 222

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 25/209 (11%)
Query: 535 IGRGGFGSVYKARIR------DGMEVAVKVFNLQCGRAFK-SFDVECAMMKSIRHRNLVK 587
           +G G FG VY+ ++         ++VAVK     C    +  F +E  ++    H+N+V+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLH------SSNYSLDIFQRLNIMIDVASALEYL- 640
            I        + +++E M  G L+ +L       S   SL +   L++  D+A   +YL 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 641 --HFGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGY 695
             HF      IH D+   N LL       VA + DFG+A+ +            +  + +
Sbjct: 158 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 211
Query: 696 MAPEYGREGQVSTNGDVYSFGIMLMETFT 724
           M PE   EG  ++  D +SFG++L E F+
Sbjct: 212 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 109/222 (49%), Gaps = 19/222 (8%)
Query: 519 YLELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC-GRAFKSFDV-ECA 575
           ++E FQ  +K      IG G +G VYKAR +  G  VA+K   L        S  + E +
Sbjct: 2   HMENFQKVEK------IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREIS 55
Query: 576 MMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVAS 635
           ++K + H N+VK++     E    LV E++ H  L+K++ +S  +L       I   +  
Sbjct: 56  LLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS--ALTGIPLPLIKSYLFQ 112
Query: 636 ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGY 695
            L+ L F +S  V+H DLKP N+L++      L+DFG+A+      +  T    + T+ Y
Sbjct: 113 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWY 170
Query: 696 MAPEYGREGQ-VSTNGDVYSFGIMLMETFTRKKPTDELFNGE 736
            APE     +  ST  D++S G +  E  TR+     LF G+
Sbjct: 171 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGD 208

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 25/209 (11%)
Query: 535 IGRGGFGSVYKARIR------DGMEVAVKVFNLQCGRAFK-SFDVECAMMKSIRHRNLVK 587
           +G G FG VY+ ++         ++VAVK     C    +  F +E  ++    H+N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLH------SSNYSLDIFQRLNIMIDVASALEYL- 640
            I        + +++E M  G L+ +L       S   SL +   L++  D+A   +YL 
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 641 --HFGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGY 695
             HF      IH D+   N LL       VA + DFG+A+ +            +  + +
Sbjct: 173 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 226
Query: 696 MAPEYGREGQVSTNGDVYSFGIMLMETFT 724
           M PE   EG  ++  D +SFG++L E F+
Sbjct: 227 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 103/268 (38%), Gaps = 34/268 (12%)
Query: 535 IGRGGFGSV----YKARIRDGMEVAVKVFN---LQCGRAFKSFDVECAMMKSIRHRNLVK 587
           +G G FG V    + A     + VAVK      L    A   F  E   M S+ HRNL++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYL--HSSNYSLDIFQRLNIMIDVASALEYLHFGYS 645
           +         K +V E  P GSL   L  H  ++ L    R    + VA  + YL    S
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLE---S 129
Query: 646 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-TGEDQSMTQTQTLATIGYMAPEYGREG 704
              IH DL   N+LL    +  + DFG+ + L   +D  + Q        + APE  +  
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTR 189
Query: 705 QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQED 764
             S   D + FG+ L E FT  +      NG   L                  + + +E 
Sbjct: 190 TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL------------------HKIDKEG 231
Query: 765 IHFVAKEQCVSFVFNLALECTVESPEQR 792
                 E C   ++N+ ++C    PE R
Sbjct: 232 ERLPRPEDCPQDIYNVMVQCWAHKPEDR 259

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 108/221 (48%), Gaps = 19/221 (8%)
Query: 520 LELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC-GRAFKSFDV-ECAM 576
           +E FQ  +K      IG G +G VYKAR +  G  VA+K   L        S  + E ++
Sbjct: 5   MENFQKVEK------IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL 58
Query: 577 MKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASA 636
           +K + H N+VK++     E    LV E++ H  L+K++ +S  +L       I   +   
Sbjct: 59  LKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS--ALTGIPLPLIKSYLFQL 115
Query: 637 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYM 696
           L+ L F +S  V+H DLKP N+L++      L+DFG+A+      +  T    + T+ Y 
Sbjct: 116 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYR 173
Query: 697 APEYGREGQ-VSTNGDVYSFGIMLMETFTRKKPTDELFNGE 736
           APE     +  ST  D++S G +  E  TR+     LF G+
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR----ALFPGD 210

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 108/221 (48%), Gaps = 19/221 (8%)
Query: 520 LELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC-GRAFKSFDV-ECAM 576
           +E FQ  +K      IG G +G VYKAR +  G  VA+K   L        S  + E ++
Sbjct: 4   MENFQKVEK------IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL 57
Query: 577 MKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASA 636
           +K + H N+VK++     E    LV E++ H  L+K++ +S  +L       I   +   
Sbjct: 58  LKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS--ALTGIPLPLIKSYLFQL 114
Query: 637 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYM 696
           L+ L F +S  V+H DLKP N+L++      L+DFG+A+      +  T    + T+ Y 
Sbjct: 115 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYR 172
Query: 697 APEYGREGQ-VSTNGDVYSFGIMLMETFTRKKPTDELFNGE 736
           APE     +  ST  D++S G +  E  TR+     LF G+
Sbjct: 173 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR----ALFPGD 209

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 103/268 (38%), Gaps = 34/268 (12%)
Query: 535 IGRGGFGSV----YKARIRDGMEVAVKVFN---LQCGRAFKSFDVECAMMKSIRHRNLVK 587
           +G G FG V    + A     + VAVK      L    A   F  E   M S+ HRNL++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYL--HSSNYSLDIFQRLNIMIDVASALEYLHFGYS 645
           +         K +V E  P GSL   L  H  ++ L    R    + VA  + YL    S
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLE---S 139
Query: 646 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-TGEDQSMTQTQTLATIGYMAPEYGREG 704
              IH DL   N+LL    +  + DFG+ + L   +D  + Q        + APE  +  
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTR 199
Query: 705 QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQED 764
             S   D + FG+ L E FT  +      NG   L                  + + +E 
Sbjct: 200 TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL------------------HKIDKEG 241
Query: 765 IHFVAKEQCVSFVFNLALECTVESPEQR 792
                 E C   ++N+ ++C    PE R
Sbjct: 242 ERLPRPEDCPQDIYNVMVQCWAHKPEDR 269

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 108/205 (52%), Gaps = 23/205 (11%)
Query: 529 FSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKV 588
           +++  +IG G FG VY+A++ D  E+ V +  +  G+AFK+ +++  +M+ + H N+V++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGEL-VAIKKVLQGKAFKNRELQ--IMRKLDHCNIVRL 78
Query: 589 I------SSCSNEEFKALVLEYMPHG--SLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
                      +E +  LVL+Y+P     + ++   +  +L +      M  +  +L Y+
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 641 H-FGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 698
           H FG    + H D+KP N+LLD D  V  L DFG AK L   + +++    + +  Y AP
Sbjct: 139 HSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRAP 191
Query: 699 E--YGREGQVSTNGDVYSFGIMLME 721
           E  +G     S+  DV+S G +L E
Sbjct: 192 ELIFGATDYTSSI-DVWSAGCVLAE 215

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 108/205 (52%), Gaps = 23/205 (11%)
Query: 529 FSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKV 588
           +++  +IG G FG VY+A++ D  E+ V +  +  G+AFK+ +++  +M+ + H N+V++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGEL-VAIKKVLQGKAFKNRELQ--IMRKLDHCNIVRL 78
Query: 589 I------SSCSNEEFKALVLEYMPHG--SLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
                      +E +  LVL+Y+P     + ++   +  +L +      M  +  +L Y+
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 641 H-FGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 698
           H FG    + H D+KP N+LLD D  V  L DFG AK L   + +++    + +  Y AP
Sbjct: 139 HSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRAP 191
Query: 699 E--YGREGQVSTNGDVYSFGIMLME 721
           E  +G     S+  DV+S G +L E
Sbjct: 192 ELIFGATDYTSSI-DVWSAGCVLAE 215

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 108/205 (52%), Gaps = 23/205 (11%)
Query: 529 FSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKV 588
           +++  +IG G FG VY+A++ D  E+ V +  +  G+AFK+ +++  +M+ + H N+V++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGEL-VAIKKVLQGKAFKNRELQ--IMRKLDHCNIVRL 78
Query: 589 I------SSCSNEEFKALVLEYMPHG--SLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
                      +E +  LVL+Y+P     + ++   +  +L +      M  +  +L Y+
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 641 H-FGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 698
           H FG    + H D+KP N+LLD D  V  L DFG AK L   + +++    + +  Y AP
Sbjct: 139 HSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRAP 191
Query: 699 E--YGREGQVSTNGDVYSFGIMLME 721
           E  +G     S+  DV+S G +L E
Sbjct: 192 ELIFGATDYTSSI-DVWSAGCVLAE 215

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 108/221 (48%), Gaps = 19/221 (8%)
Query: 520 LELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC-GRAFKSFDV-ECAM 576
           +E FQ  +K      IG G +G VYKAR +  G  VA+K   L        S  + E ++
Sbjct: 2   MENFQKVEK------IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL 55
Query: 577 MKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASA 636
           +K + H N+VK++     E    LV E++ H  L+K++ +S  +L       I   +   
Sbjct: 56  LKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS--ALTGIPLPLIKSYLFQL 112
Query: 637 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYM 696
           L+ L F +S  V+H DLKP N+L++      L+DFG+A+      +  T    + T+ Y 
Sbjct: 113 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYR 170
Query: 697 APEYGREGQ-VSTNGDVYSFGIMLMETFTRKKPTDELFNGE 736
           APE     +  ST  D++S G +  E  TR+     LF G+
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGD 207

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 108/221 (48%), Gaps = 19/221 (8%)
Query: 520 LELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC-GRAFKSFDV-ECAM 576
           +E FQ  +K      IG G +G VYKAR +  G  VA+K   L        S  + E ++
Sbjct: 3   MENFQKVEK------IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL 56
Query: 577 MKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASA 636
           +K + H N+VK++     E    LV E++ H  L+K++ +S  +L       I   +   
Sbjct: 57  LKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS--ALTGIPLPLIKSYLFQL 113
Query: 637 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYM 696
           L+ L F +S  V+H DLKP N+L++      L+DFG+A+      +  T    + T+ Y 
Sbjct: 114 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYR 171
Query: 697 APEYGREGQ-VSTNGDVYSFGIMLMETFTRKKPTDELFNGE 736
           APE     +  ST  D++S G +  E  TR+     LF G+
Sbjct: 172 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR----ALFPGD 208

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 108/221 (48%), Gaps = 19/221 (8%)
Query: 520 LELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC-GRAFKSFDV-ECAM 576
           +E FQ  +K      IG G +G VYKAR +  G  VA+K   L        S  + E ++
Sbjct: 1   MENFQKVEK------IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL 54
Query: 577 MKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASA 636
           +K + H N+VK++     E    LV E++ H  L+K++ +S  +L       I   +   
Sbjct: 55  LKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS--ALTGIPLPLIKSYLFQL 111
Query: 637 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYM 696
           L+ L F +S  V+H DLKP N+L++      L+DFG+A+      +  T    + T+ Y 
Sbjct: 112 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYR 169
Query: 697 APEYGREGQ-VSTNGDVYSFGIMLMETFTRKKPTDELFNGE 736
           APE     +  ST  D++S G +  E  TR+     LF G+
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGD 206

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 96/206 (46%), Gaps = 9/206 (4%)
Query: 529 FSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFNLQCGRAFKSF-DVECAMMKSIRHRNLV 586
           F++   IG+G FG V+K    R    VA+K+ +L+           E  ++       + 
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 84
Query: 587 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSA 646
           K   S        +++EY+  GS    L +  +  D FQ   ++ ++   L+YLH   S 
Sbjct: 85  KYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPF--DEFQIATMLKEILKGLDYLH---SE 139
Query: 647 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQV 706
             IH D+K +NVLL +     L+DFG+A  LT  D  + +   + T  +MAPE  ++   
Sbjct: 140 KKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVIQQSAY 197
Query: 707 STNGDVYSFGIMLMETFTRKKPTDEL 732
            +  D++S GI  +E    + P  ++
Sbjct: 198 DSKADIWSLGITAIELAKGEPPNSDM 223

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 103/268 (38%), Gaps = 34/268 (12%)
Query: 535 IGRGGFGSV----YKARIRDGMEVAVKVFN---LQCGRAFKSFDVECAMMKSIRHRNLVK 587
           +G G FG V    + A     + VAVK      L    A   F  E   M S+ HRNL++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYL--HSSNYSLDIFQRLNIMIDVASALEYLHFGYS 645
           +         K +V E  P GSL   L  H  ++ L    R    + VA  + YL    S
Sbjct: 80  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLE---S 133
Query: 646 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-TGEDQSMTQTQTLATIGYMAPEYGREG 704
              IH DL   N+LL    +  + DFG+ + L   +D  + Q        + APE  +  
Sbjct: 134 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 193
Query: 705 QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQED 764
             S   D + FG+ L E FT  +      NG   L                  + + +E 
Sbjct: 194 TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL------------------HKIDKEG 235
Query: 765 IHFVAKEQCVSFVFNLALECTVESPEQR 792
                 E C   ++N+ ++C    PE R
Sbjct: 236 ERLPRPEDCPQDIYNVMVQCWAHKPEDR 263

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 108/221 (48%), Gaps = 19/221 (8%)
Query: 520 LELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC-GRAFKSFDV-ECAM 576
           +E FQ  +K      IG G +G VYKAR +  G  VA+K   L        S  + E ++
Sbjct: 2   MENFQKVEK------IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL 55
Query: 577 MKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASA 636
           +K + H N+VK++     E    LV E++ H  L+K++ +S  +L       I   +   
Sbjct: 56  LKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS--ALTGIPLPLIKSYLFQL 112
Query: 637 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYM 696
           L+ L F +S  V+H DLKP N+L++      L+DFG+A+      +  T    + T+ Y 
Sbjct: 113 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYR 170
Query: 697 APEYGREGQ-VSTNGDVYSFGIMLMETFTRKKPTDELFNGE 736
           APE     +  ST  D++S G +  E  TR+     LF G+
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR----ALFPGD 207

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 108/221 (48%), Gaps = 19/221 (8%)
Query: 520 LELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC-GRAFKSFDV-ECAM 576
           +E FQ  +K      IG G +G VYKAR +  G  VA+K   L        S  + E ++
Sbjct: 5   MENFQKVEK------IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL 58
Query: 577 MKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASA 636
           +K + H N+VK++     E    LV E++ H  L+K++ +S  +L       I   +   
Sbjct: 59  LKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS--ALTGIPLPLIKSYLFQL 115
Query: 637 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYM 696
           L+ L F +S  V+H DLKP N+L++      L+DFG+A+      +  T    + T+ Y 
Sbjct: 116 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYR 173
Query: 697 APEYGREGQ-VSTNGDVYSFGIMLMETFTRKKPTDELFNGE 736
           APE     +  ST  D++S G +  E  TR+     LF G+
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR----ALFPGD 210

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 103/268 (38%), Gaps = 34/268 (12%)
Query: 535 IGRGGFGSV----YKARIRDGMEVAVKVFN---LQCGRAFKSFDVECAMMKSIRHRNLVK 587
           +G G FG V    + A     + VAVK      L    A   F  E   M S+ HRNL++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYL--HSSNYSLDIFQRLNIMIDVASALEYLHFGYS 645
           +         K +V E  P GSL   L  H  ++ L    R  +   VA  + YL    S
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ--VAEGMGYLE---S 129
Query: 646 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-TGEDQSMTQTQTLATIGYMAPEYGREG 704
              IH DL   N+LL    +  + DFG+ + L   +D  + Q        + APE  +  
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 189
Query: 705 QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQED 764
             S   D + FG+ L E FT  +      NG   L                  + + +E 
Sbjct: 190 TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL------------------HKIDKEG 231
Query: 765 IHFVAKEQCVSFVFNLALECTVESPEQR 792
                 E C   ++N+ ++C    PE R
Sbjct: 232 ERLPRPEDCPQDIYNVMVQCWAHKPEDR 259

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 108/221 (48%), Gaps = 19/221 (8%)
Query: 520 LELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC-GRAFKSFDV-ECAM 576
           +E FQ  +K      IG G +G VYKAR +  G  VA+K   L        S  + E ++
Sbjct: 6   MENFQKVEK------IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL 59
Query: 577 MKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASA 636
           +K + H N+VK++     E    LV E++ H  L+K++ +S  +L       I   +   
Sbjct: 60  LKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS--ALTGIPLPLIKSYLFQL 116
Query: 637 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYM 696
           L+ L F +S  V+H DLKP N+L++      L+DFG+A+      +  T    + T+ Y 
Sbjct: 117 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYR 174
Query: 697 APEYGREGQ-VSTNGDVYSFGIMLMETFTRKKPTDELFNGE 736
           APE     +  ST  D++S G +  E  TR+     LF G+
Sbjct: 175 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR----ALFPGD 211

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 101/214 (47%), Gaps = 19/214 (8%)
Query: 525 ATDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDV--ECAMMK--- 578
           AT ++     IG G +G+VYKAR    G  VA+K   +  G          E A+++   
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 579 SIRHRNLVKVISSCS----NEEFKA-LVLEYMPHGSLEKYL-HSSNYSLDIFQRLNIMID 632
           +  H N+V+++  C+    + E K  LV E++    L  YL  +    L      ++M  
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 633 VASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLAT 692
               L++LH      ++H DLKP N+L+       L+DFG+A++ + +   M     + T
Sbjct: 121 FLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ---MALAPVVVT 174
Query: 693 IGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRK 726
           + Y APE   +   +T  D++S G +  E F RK
Sbjct: 175 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 108/221 (48%), Gaps = 19/221 (8%)
Query: 520 LELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC-GRAFKSFDV-ECAM 576
           +E FQ  +K      IG G +G VYKAR +  G  VA+K   L        S  + E ++
Sbjct: 4   MENFQKVEK------IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL 57
Query: 577 MKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASA 636
           +K + H N+VK++     E    LV E++ H  L+K++ +S  +L       I   +   
Sbjct: 58  LKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS--ALTGIPLPLIKSYLFQL 114
Query: 637 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYM 696
           L+ L F +S  V+H DLKP N+L++      L+DFG+A+      +  T    + T+ Y 
Sbjct: 115 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYR 172
Query: 697 APEYGREGQ-VSTNGDVYSFGIMLMETFTRKKPTDELFNGE 736
           APE     +  ST  D++S G +  E  TR+     LF G+
Sbjct: 173 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGD 209

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 108/221 (48%), Gaps = 19/221 (8%)
Query: 520 LELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC-GRAFKSFDV-ECAM 576
           +E FQ  +K      IG G +G VYKAR +  G  VA+K   L        S  + E ++
Sbjct: 1   MENFQKVEK------IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL 54
Query: 577 MKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASA 636
           +K + H N+VK++     E    LV E++ H  L+K++ +S  +L       I   +   
Sbjct: 55  LKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS--ALTGIPLPLIKSYLFQL 111
Query: 637 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYM 696
           L+ L F +S  V+H DLKP N+L++      L+DFG+A+      +  T    + T+ Y 
Sbjct: 112 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYR 169
Query: 697 APEYGREGQ-VSTNGDVYSFGIMLMETFTRKKPTDELFNGE 736
           APE     +  ST  D++S G +  E  TR+     LF G+
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR----ALFPGD 206

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 108/221 (48%), Gaps = 19/221 (8%)
Query: 520 LELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC-GRAFKSFDV-ECAM 576
           +E FQ  +K      IG G +G VYKAR +  G  VA+K   L        S  + E ++
Sbjct: 2   MENFQKVEK------IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL 55
Query: 577 MKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASA 636
           +K + H N+VK++     E    LV E++ H  L+K++ +S  +L       I   +   
Sbjct: 56  LKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS--ALTGIPLPLIKSYLFQL 112
Query: 637 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYM 696
           L+ L F +S  V+H DLKP N+L++      L+DFG+A+      +  T    + T+ Y 
Sbjct: 113 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYR 170
Query: 697 APEYGREGQ-VSTNGDVYSFGIMLMETFTRKKPTDELFNGE 736
           APE     +  ST  D++S G +  E  TR+     LF G+
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR----ALFPGD 207

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 105/226 (46%), Gaps = 12/226 (5%)
Query: 520 LELFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVF-----NLQCGRAFKSFDVE 573
           L + + T+ F +  ++G G FG+VYK   I +G +V + V           +A K    E
Sbjct: 11  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 69
Query: 574 CAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDV 633
             +M S+ + ++ +++  C     + L+++ MP G L  Y+     ++     LN  + +
Sbjct: 70  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 128
Query: 634 ASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATI 693
           A  + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I
Sbjct: 129 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 185
Query: 694 GYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMT 738
            +MA E       +   DV+S+G+ + E  T   KP D +   E++
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 231

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 108/221 (48%), Gaps = 19/221 (8%)
Query: 520 LELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC-GRAFKSFDV-ECAM 576
           +E FQ  +K      IG G +G VYKAR +  G  VA+    L        S  + E ++
Sbjct: 2   MENFQKVEK------IGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISL 55
Query: 577 MKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASA 636
           +K + H N+VK++     E    LV E++ H  L+K++ +S  +L       I   +   
Sbjct: 56  LKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS--ALTGIPLPLIKSYLFQL 112
Query: 637 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYM 696
           L+ L F +S  V+H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y 
Sbjct: 113 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYR 170
Query: 697 APEYGREGQ-VSTNGDVYSFGIMLMETFTRKKPTDELFNGE 736
           APE     +  ST  D++S G +  E  TR+     LF G+
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGD 207

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 108/221 (48%), Gaps = 19/221 (8%)
Query: 520 LELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC-GRAFKSFDV-ECAM 576
           +E FQ  +K      IG G +G VYKAR +  G  VA+    L        S  + E ++
Sbjct: 1   MENFQKVEK------IGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISL 54
Query: 577 MKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASA 636
           +K + H N+VK++     E    LV E++ H  L+K++ +S  +L       I   +   
Sbjct: 55  LKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS--ALTGIPLPLIKSYLFQL 111
Query: 637 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYM 696
           L+ L F +S  V+H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y 
Sbjct: 112 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYR 169
Query: 697 APEYGREGQ-VSTNGDVYSFGIMLMETFTRKKPTDELFNGE 736
           APE     +  ST  D++S G +  E  TR+     LF G+
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGD 206

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 103/268 (38%), Gaps = 34/268 (12%)
Query: 535 IGRGGFGSV----YKARIRDGMEVAVKVFN---LQCGRAFKSFDVECAMMKSIRHRNLVK 587
           +G G FG V    + A     + VAVK      L    A   F  E   M S+ HRNL++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYL--HSSNYSLDIFQRLNIMIDVASALEYLHFGYS 645
           +         K +V E  P GSL   L  H  ++ L    R    + VA  + YL    S
Sbjct: 80  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLE---S 133
Query: 646 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-TGEDQSMTQTQTLATIGYMAPEYGREG 704
              IH DL   N+LL    +  + DFG+ + L   +D  + Q        + APE  +  
Sbjct: 134 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 193
Query: 705 QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQED 764
             S   D + FG+ L E FT  +      NG   L                  + + +E 
Sbjct: 194 TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL------------------HKIDKEG 235
Query: 765 IHFVAKEQCVSFVFNLALECTVESPEQR 792
                 E C   ++N+ ++C    PE R
Sbjct: 236 ERLPRPEDCPQDIYNVMVQCWAHKPEDR 263

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 105/226 (46%), Gaps = 12/226 (5%)
Query: 520 LELFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVF-----NLQCGRAFKSFDVE 573
           L + + T+ F +  ++G G FG+VYK   I +G +V + V           +A K    E
Sbjct: 13  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 71
Query: 574 CAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDV 633
             +M S+ + ++ +++  C     + L+++ MP G L  Y+     ++     LN  + +
Sbjct: 72  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 130
Query: 634 ASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATI 693
           A  + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I
Sbjct: 131 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 187
Query: 694 GYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMT 738
            +MA E       +   DV+S+G+ + E  T   KP D +   E++
Sbjct: 188 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 233

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 105/226 (46%), Gaps = 12/226 (5%)
Query: 520 LELFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVF-----NLQCGRAFKSFDVE 573
           L + + T+ F +  ++G G FG+VYK   I +G +V + V           +A K    E
Sbjct: 10  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 68
Query: 574 CAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDV 633
             +M S+ + ++ +++  C     + L+++ MP G L  Y+     ++     LN  + +
Sbjct: 69  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQI 127
Query: 634 ASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATI 693
           A  + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I
Sbjct: 128 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 184
Query: 694 GYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMT 738
            +MA E       +   DV+S+G+ + E  T   KP D +   E++
Sbjct: 185 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 230

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 108/221 (48%), Gaps = 19/221 (8%)
Query: 520 LELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC-GRAFKSFDV-ECAM 576
           +E FQ  +K      IG G +G VYKAR +  G  VA+K   L        S  + E ++
Sbjct: 4   MENFQKVEK------IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL 57
Query: 577 MKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASA 636
           +K + H N+VK++     E    LV E++ H  L+K++ +S  +L       I   +   
Sbjct: 58  LKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS--ALTGIPLPLIKSYLFQL 114
Query: 637 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYM 696
           L+ L F +S  V+H DLKP N+L++      L+DFG+A+      +  T    + T+ Y 
Sbjct: 115 LQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYR 172
Query: 697 APEYGREGQ-VSTNGDVYSFGIMLMETFTRKKPTDELFNGE 736
           APE     +  ST  D++S G +  E  TR+     LF G+
Sbjct: 173 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGD 209

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 105/226 (46%), Gaps = 12/226 (5%)
Query: 520 LELFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVF-----NLQCGRAFKSFDVE 573
           L + + T+ F +  ++G G FG+VYK   I +G +V + V           +A K    E
Sbjct: 12  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 70
Query: 574 CAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDV 633
             +M S+ + ++ +++  C     + L+++ MP G L  Y+     ++     LN  + +
Sbjct: 71  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 129
Query: 634 ASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATI 693
           A  + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I
Sbjct: 130 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 186
Query: 694 GYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMT 738
            +MA E       +   DV+S+G+ + E  T   KP D +   E++
Sbjct: 187 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 232

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 105/226 (46%), Gaps = 12/226 (5%)
Query: 520 LELFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVF-----NLQCGRAFKSFDVE 573
           L + + T+ F +  ++G G FG+VYK   I +G +V + V           +A K    E
Sbjct: 9   LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 67
Query: 574 CAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDV 633
             +M S+ + ++ +++  C     + L+++ MP G L  Y+     ++     LN  + +
Sbjct: 68  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 126
Query: 634 ASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATI 693
           A  + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I
Sbjct: 127 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 694 GYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMT 738
            +MA E       +   DV+S+G+ + E  T   KP D +   E++
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 108/221 (48%), Gaps = 19/221 (8%)
Query: 520 LELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC-GRAFKSFDV-ECAM 576
           +E FQ  +K      IG G +G VYKAR +  G  VA+K   L        S  + E ++
Sbjct: 2   MENFQKVEK------IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL 55
Query: 577 MKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASA 636
           +K + H N+VK++     E    LV E++ H  L+K++ +S  +L       I   +   
Sbjct: 56  LKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS--ALTGIPLPLIKSYLFQL 112
Query: 637 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYM 696
           L+ L F +S  V+H DLKP N+L++      L+DFG+A+      +  T    + T+ Y 
Sbjct: 113 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYR 170
Query: 697 APEYGREGQ-VSTNGDVYSFGIMLMETFTRKKPTDELFNGE 736
           APE     +  ST  D++S G +  E  TR+     LF G+
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGD 207

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 105/226 (46%), Gaps = 12/226 (5%)
Query: 520 LELFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVF-----NLQCGRAFKSFDVE 573
           L + + T+ F +  ++G G FG+VYK   I +G +V + V           +A K    E
Sbjct: 10  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 68
Query: 574 CAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDV 633
             +M S+ + ++ +++  C     + L+++ MP G L  Y+     ++     LN  + +
Sbjct: 69  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 127
Query: 634 ASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATI 693
           A  + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I
Sbjct: 128 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 184
Query: 694 GYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMT 738
            +MA E       +   DV+S+G+ + E  T   KP D +   E++
Sbjct: 185 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 230

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 103/268 (38%), Gaps = 34/268 (12%)
Query: 535 IGRGGFGSV----YKARIRDGMEVAVKVFN---LQCGRAFKSFDVECAMMKSIRHRNLVK 587
           +G G FG V    + A     + VAVK      L    A   F  E   M S+ HRNL++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYL--HSSNYSLDIFQRLNIMIDVASALEYLHFGYS 645
           +         K +V E  P GSL   L  H  ++ L    R    + VA  + YL    S
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLE---S 139
Query: 646 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-TGEDQSMTQTQTLATIGYMAPEYGREG 704
              IH DL   N+LL    +  + DFG+ + L   +D  + Q        + APE  +  
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 199
Query: 705 QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQED 764
             S   D + FG+ L E FT  +      NG   L                  + + +E 
Sbjct: 200 TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL------------------HKIDKEG 241
Query: 765 IHFVAKEQCVSFVFNLALECTVESPEQR 792
                 E C   ++N+ ++C    PE R
Sbjct: 242 ERLPRPEDCPQDIYNVMVQCWAHKPEDR 269

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 101/214 (47%), Gaps = 19/214 (8%)
Query: 525 ATDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDV--ECAMMK--- 578
           AT ++     IG G +G+VYKAR    G  VA+K   +  G          E A+++   
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 579 SIRHRNLVKVISSCS----NEEFKA-LVLEYMPHGSLEKYL-HSSNYSLDIFQRLNIMID 632
           +  H N+V+++  C+    + E K  LV E++    L  YL  +    L      ++M  
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 633 VASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLAT 692
               L++LH      ++H DLKP N+L+       L+DFG+A++ + +   M     + T
Sbjct: 121 FLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ---MALDPVVVT 174
Query: 693 IGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRK 726
           + Y APE   +   +T  D++S G +  E F RK
Sbjct: 175 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 108/221 (48%), Gaps = 19/221 (8%)
Query: 520 LELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC-GRAFKSFDV-ECAM 576
           +E FQ  +K      IG G +G VYKAR +  G  VA+K   L        S  + E ++
Sbjct: 3   MENFQKVEK------IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL 56
Query: 577 MKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASA 636
           +K + H N+VK++     E    LV E++ H  L+K++ +S  +L       I   +   
Sbjct: 57  LKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS--ALTGIPLPLIKSYLFQL 113
Query: 637 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYM 696
           L+ L F +S  V+H DLKP N+L++      L+DFG+A+      +  T    + T+ Y 
Sbjct: 114 LQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYR 171
Query: 697 APEYGREGQ-VSTNGDVYSFGIMLMETFTRKKPTDELFNGE 736
           APE     +  ST  D++S G +  E  TR+     LF G+
Sbjct: 172 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGD 208

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 107/228 (46%), Gaps = 12/228 (5%)
Query: 518 SYLELFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFNLQ-----CGRAFKSFD 571
           + L + + T+ F +  ++G G FG+VYK   I +G +V + V  ++       +A K   
Sbjct: 41  ALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEIL 99
Query: 572 VECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMI 631
            E  +M S+ + ++ +++  C     + L+ + MP G L  Y+     ++     LN  +
Sbjct: 100 DEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCV 158
Query: 632 DVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA 691
            +A  + YL       ++H DL   NVL+       ++DFG+AKLL  E++         
Sbjct: 159 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 215
Query: 692 TIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMT 738
            I +MA E       +   DV+S+G+ + E  T   KP D +   E++
Sbjct: 216 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 263

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 71/319 (22%), Positives = 129/319 (40%), Gaps = 69/319 (21%)
Query: 528 KFSENNLI-----GRGGFGSVYKA-----RIRDG-MEVAVKVFNLQCGRA-FKSFDVECA 575
           +F   NL+     G G FG V KA     + R G   VAVK+       +  +    E  
Sbjct: 19  EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFN 78
Query: 576 MMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYL--------------------- 614
           ++K + H +++K+  +CS +    L++EY  +GSL  +L                     
Sbjct: 79  VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 615 --HSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFG 672
             H    +L +   ++    ++  ++YL       ++H DL   N+L+ +     +SDFG
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFG 195
Query: 673 IAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKK----- 727
           +++ +  ED  + ++Q    + +MA E   +   +T  DV+SFG++L E  T        
Sbjct: 196 LSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 255
Query: 728 -PTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTV 786
            P + LFN                         L +        + C   ++ L L+C  
Sbjct: 256 IPPERLFN-------------------------LLKTGHRMERPDNCSEEMYRLMLQCWK 290
Query: 787 ESPEQRINAKEIVAKLLKI 805
           + P++R    +I   L K+
Sbjct: 291 QEPDKRPVFADISKDLEKM 309

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 71/319 (22%), Positives = 129/319 (40%), Gaps = 69/319 (21%)
Query: 528 KFSENNLI-----GRGGFGSVYKA-----RIRDG-MEVAVKVFNLQCGRA-FKSFDVECA 575
           +F   NL+     G G FG V KA     + R G   VAVK+       +  +    E  
Sbjct: 19  EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFN 78
Query: 576 MMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYL--------------------- 614
           ++K + H +++K+  +CS +    L++EY  +GSL  +L                     
Sbjct: 79  VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 615 --HSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFG 672
             H    +L +   ++    ++  ++YL       ++H DL   N+L+ +     +SDFG
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYLA---EMSLVHRDLAARNILVAEGRKMKISDFG 195
Query: 673 IAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKK----- 727
           +++ +  ED  + ++Q    + +MA E   +   +T  DV+SFG++L E  T        
Sbjct: 196 LSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 255
Query: 728 -PTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTV 786
            P + LFN                         L +        + C   ++ L L+C  
Sbjct: 256 IPPERLFN-------------------------LLKTGHRMERPDNCSEEMYRLMLQCWK 290
Query: 787 ESPEQRINAKEIVAKLLKI 805
           + P++R    +I   L K+
Sbjct: 291 QEPDKRPVFADISKDLEKM 309

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 103/213 (48%), Gaps = 31/213 (14%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGRA-FKSFDVECAMMKSIRHRNLVKVISSCS 593
           IG+G FG V++ + R G EVAVK+F+ +  R+ F+  ++   +M  +RH N++  I++ +
Sbjct: 50  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM--LRHENILGFIAADN 106
Query: 594 NEEFKA----LVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF----GYS 645
            +        LV +Y  HGSL  YL  + Y++ +   + + +  AS L +LH        
Sbjct: 107 KDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQG 164
Query: 646 APVI-HCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA------TIGYMAP 698
            P I H DLK  N+L+  N    ++D G+A        S T T  +A      T  YMAP
Sbjct: 165 KPAIAHRDLKSKNILVKKNGTCCIADLGLAV----RHDSATDTIDIAPNHRVGTKRYMAP 220
Query: 699 EY------GREGQVSTNGDVYSFGIMLMETFTR 725
           E        +  +     D+Y+ G++  E   R
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWEIARR 253

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 108/221 (48%), Gaps = 19/221 (8%)
Query: 520 LELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC-GRAFKSFDV-ECAM 576
           +E FQ  +K      IG G +G VYKAR +  G  VA+K   L        S  + E ++
Sbjct: 1   MENFQKVEK------IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL 54
Query: 577 MKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASA 636
           +K + H N+VK++     E    LV E++ H  L+ ++ +S  +L       I   +   
Sbjct: 55  LKELNHPNIVKLLDVIHTENKLYLVFEHV-HQDLKTFMDAS--ALTGIPLPLIKSYLFQL 111
Query: 637 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYM 696
           L+ L F +S  V+H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y 
Sbjct: 112 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYR 169
Query: 697 APEYGREGQ-VSTNGDVYSFGIMLMETFTRKKPTDELFNGE 736
           APE     +  ST  D++S G +  E  TR+     LF G+
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGD 206

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 101/214 (47%), Gaps = 19/214 (8%)
Query: 525 ATDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDV--ECAMMK--- 578
           AT ++     IG G +G+VYKAR    G  VA+K   +  G          E A+++   
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 579 SIRHRNLVKVISSCS----NEEFKA-LVLEYMPHGSLEKYL-HSSNYSLDIFQRLNIMID 632
           +  H N+V+++  C+    + E K  LV E++    L  YL  +    L      ++M  
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 633 VASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLAT 692
               L++LH      ++H DLKP N+L+       L+DFG+A++ + +   M     + T
Sbjct: 121 FLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ---MALFPVVVT 174
Query: 693 IGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRK 726
           + Y APE   +   +T  D++S G +  E F RK
Sbjct: 175 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 103/213 (48%), Gaps = 31/213 (14%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGRA-FKSFDVECAMMKSIRHRNLVKVISSCS 593
           IG+G FG V++ + R G EVAVK+F+ +  R+ F+  ++   +M  +RH N++  I++ +
Sbjct: 37  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM--LRHENILGFIAADN 93
Query: 594 NEEFKA----LVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF----GYS 645
            +        LV +Y  HGSL  YL  + Y++ +   + + +  AS L +LH        
Sbjct: 94  KDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQG 151
Query: 646 APVI-HCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA------TIGYMAP 698
            P I H DLK  N+L+  N    ++D G+A        S T T  +A      T  YMAP
Sbjct: 152 KPAIAHRDLKSKNILVKKNGTCCIADLGLAV----RHDSATDTIDIAPNHRVGTKRYMAP 207
Query: 699 EY------GREGQVSTNGDVYSFGIMLMETFTR 725
           E        +  +     D+Y+ G++  E   R
Sbjct: 208 EVLDDSINMKHFESFKRADIYAMGLVFWEIARR 240

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 109/213 (51%), Gaps = 24/213 (11%)
Query: 536 GRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISS---- 591
            RG FG V+KA++ +   VAVK+F +Q  +++++ + E   +  ++H N+++ I +    
Sbjct: 33  ARGRFGCVWKAQLLNEY-VAVKIFPIQDKQSWQN-EYEVYSLPGMKHENILQFIGAEKRG 90
Query: 592 CSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF-------GY 644
            S +    L+  +   GSL  +L ++  S +  +  +I   +A  L YLH        G+
Sbjct: 91  TSVDVDLWLITAFHEKGSLSDFLKANVVSWN--ELCHIAETMARGLAYLHEDIPGLKDGH 148
Query: 645 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIA-KLLTGEDQSMTQTQTLATIGYMAPEYGRE 703
              + H D+K  NVLL +N+ A ++DFG+A K   G+    T  Q + T  YMAPE   E
Sbjct: 149 KPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQ-VGTRRYMAPEV-LE 206
Query: 704 GQVSTNG------DVYSFGIMLMETFTRKKPTD 730
           G ++         D+Y+ G++L E  +R    D
Sbjct: 207 GAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 99/220 (45%), Gaps = 23/220 (10%)
Query: 528 KFSENNL-----IGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDVECAMMKSIR 581
           +F  NNL     +G G FG V +A     G E AV    ++  ++    D + A+M  ++
Sbjct: 42  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 582 -------HRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVA 634
                  H N+V ++ +C++     ++ EY  +G L  +L   +  L+      I     
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTL 161
Query: 635 SALEYLHFG----------YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM 684
           S  + LHF            S   IH D+   NVLL +  VA + DFG+A+ +  +   +
Sbjct: 162 STRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 221
Query: 685 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 724
            +      + +MAPE   +   +   DV+S+GI+L E F+
Sbjct: 222 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/319 (22%), Positives = 129/319 (40%), Gaps = 69/319 (21%)
Query: 528 KFSENNLI-----GRGGFGSVYKA-----RIRDG-MEVAVKVFNLQCGRA-FKSFDVECA 575
           +F   NL+     G G FG V KA     + R G   VAVK+       +  +    E  
Sbjct: 19  EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFN 78
Query: 576 MMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYL--------------------- 614
           ++K + H +++K+  +CS +    L++EY  +GSL  +L                     
Sbjct: 79  VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 615 --HSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFG 672
             H    +L +   ++    ++  ++YL       ++H DL   N+L+ +     +SDFG
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFG 195
Query: 673 IAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKK----- 727
           +++ +  ED  + ++Q    + +MA E   +   +T  DV+SFG++L E  T        
Sbjct: 196 LSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 255
Query: 728 -PTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTV 786
            P + LFN                         L +        + C   ++ L L+C  
Sbjct: 256 IPPERLFN-------------------------LLKTGHRMERPDNCSEEMYRLMLQCWK 290
Query: 787 ESPEQRINAKEIVAKLLKI 805
           + P++R    +I   L K+
Sbjct: 291 QEPDKRPVFADISKDLEKM 309

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 103/213 (48%), Gaps = 31/213 (14%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGRA-FKSFDVECAMMKSIRHRNLVKVISSCS 593
           IG+G FG V++ + R G EVAVK+F+ +  R+ F+  ++   +M  +RH N++  I++ +
Sbjct: 14  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM--LRHENILGFIAADN 70
Query: 594 NEEFKA----LVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF----GYS 645
            +        LV +Y  HGSL  YL  + Y++ +   + + +  AS L +LH        
Sbjct: 71  KDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQG 128
Query: 646 APVI-HCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA------TIGYMAP 698
            P I H DLK  N+L+  N    ++D G+A        S T T  +A      T  YMAP
Sbjct: 129 KPAIAHRDLKSKNILVKKNGTCCIADLGLAV----RHDSATDTIDIAPNHRVGTKRYMAP 184
Query: 699 EY------GREGQVSTNGDVYSFGIMLMETFTR 725
           E        +  +     D+Y+ G++  E   R
Sbjct: 185 EVLDDSINMKHFESFKRADIYAMGLVFWEIARR 217

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 103/213 (48%), Gaps = 31/213 (14%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGRA-FKSFDVECAMMKSIRHRNLVKVISSCS 593
           IG+G FG V++ + R G EVAVK+F+ +  R+ F+  ++   +M  +RH N++  I++ +
Sbjct: 11  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM--LRHENILGFIAADN 67
Query: 594 NEEFKA----LVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF----GYS 645
            +        LV +Y  HGSL  YL  + Y++ +   + + +  AS L +LH        
Sbjct: 68  KDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQG 125
Query: 646 APVI-HCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA------TIGYMAP 698
            P I H DLK  N+L+  N    ++D G+A        S T T  +A      T  YMAP
Sbjct: 126 KPAIAHRDLKSKNILVKKNGTCCIADLGLAV----RHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 699 EY------GREGQVSTNGDVYSFGIMLMETFTR 725
           E        +  +     D+Y+ G++  E   R
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARR 214

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 105/228 (46%), Gaps = 12/228 (5%)
Query: 518 SYLELFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVF-----NLQCGRAFKSFD 571
           + L + + T+ F +  ++G G FG+VYK   I +G +V + V           +A K   
Sbjct: 7   ALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL 65
Query: 572 VECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMI 631
            E  +M S+ + ++ +++  C     + L+ + MP G L  Y+     ++     LN  +
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCV 124
Query: 632 DVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA 691
            +A  + YL       ++H DL   NVL+       ++DFG+AKLL  E++         
Sbjct: 125 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181
Query: 692 TIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMT 738
            I +MA E       +   DV+S+G+ + E  T   KP D +   E++
Sbjct: 182 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 103/213 (48%), Gaps = 31/213 (14%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGRA-FKSFDVECAMMKSIRHRNLVKVISSCS 593
           IG+G FG V++ + R G EVAVK+F+ +  R+ F+  ++   +M  +RH N++  I++ +
Sbjct: 12  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM--LRHENILGFIAADN 68
Query: 594 NEEFKA----LVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF----GYS 645
            +        LV +Y  HGSL  YL  + Y++ +   + + +  AS L +LH        
Sbjct: 69  KDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQG 126
Query: 646 APVI-HCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA------TIGYMAP 698
            P I H DLK  N+L+  N    ++D G+A        S T T  +A      T  YMAP
Sbjct: 127 KPAIAHRDLKSKNILVKKNGTCCIADLGLAV----RHDSATDTIDIAPNHRVGTKRYMAP 182
Query: 699 EY------GREGQVSTNGDVYSFGIMLMETFTR 725
           E        +  +     D+Y+ G++  E   R
Sbjct: 183 EVLDDSINMKHFESFKRADIYAMGLVFWEIARR 215

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 94/211 (44%), Gaps = 28/211 (13%)
Query: 529 FSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVK 587
           F E  LIG GGFG V+KA+ R DG    +K       +A    + E   +  + H N+V 
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKA----EREVKALAKLDHVNIVH 68
Query: 588 VI----------------SSCSNEEFKALVLEYMPHGSLEKYLHSSN-YSLDIFQRLNIM 630
                             SS S  +   + +E+   G+LE+++       LD    L + 
Sbjct: 69  YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128
Query: 631 IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTL 690
             +   ++Y+H   S  +I+ DLKPSN+ L D     + DFG+   L  + +   + ++ 
Sbjct: 129 EQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK---RXRSK 182
Query: 691 ATIGYMAPEYGREGQVSTNGDVYSFGIMLME 721
            T+ YM+PE           D+Y+ G++L E
Sbjct: 183 GTLRYMSPEQISSQDYGKEVDLYALGLILAE 213

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 104/226 (46%), Gaps = 12/226 (5%)
Query: 520 LELFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVF-----NLQCGRAFKSFDVE 573
           L + + T+ F +  ++G G FG+VYK   I +G +V + V           +A K    E
Sbjct: 9   LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 67
Query: 574 CAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDV 633
             +M S+ + ++ +++  C     + L+ + MP G L  Y+     ++     LN  + +
Sbjct: 68  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 126
Query: 634 ASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATI 693
           A  + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I
Sbjct: 127 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 694 GYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMT 738
            +MA E       +   DV+S+G+ + E  T   KP D +   E++
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 103/213 (48%), Gaps = 31/213 (14%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGRA-FKSFDVECAMMKSIRHRNLVKVISSCS 593
           IG+G FG V++ + R G EVAVK+F+ +  R+ F+  ++   +M  +RH N++  I++ +
Sbjct: 17  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM--LRHENILGFIAADN 73
Query: 594 NEEFKA----LVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF----GYS 645
            +        LV +Y  HGSL  YL  + Y++ +   + + +  AS L +LH        
Sbjct: 74  KDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQG 131
Query: 646 APVI-HCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA------TIGYMAP 698
            P I H DLK  N+L+  N    ++D G+A        S T T  +A      T  YMAP
Sbjct: 132 KPAIAHRDLKSKNILVKKNGTCCIADLGLAV----RHDSATDTIDIAPNHRVGTKRYMAP 187
Query: 699 EY------GREGQVSTNGDVYSFGIMLMETFTR 725
           E        +  +     D+Y+ G++  E   R
Sbjct: 188 EVLDDSINMKHFESFKRADIYAMGLVFWEIARR 220

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 104/226 (46%), Gaps = 12/226 (5%)
Query: 520 LELFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVF-----NLQCGRAFKSFDVE 573
           L + + T+ F +  ++G G FG+VYK   I +G +V + V           +A K    E
Sbjct: 12  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 70
Query: 574 CAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDV 633
             +M S+ + ++ +++  C     + L+ + MP G L  Y+     ++     LN  + +
Sbjct: 71  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 129
Query: 634 ASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATI 693
           A  + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I
Sbjct: 130 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 186
Query: 694 GYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMT 738
            +MA E       +   DV+S+G+ + E  T   KP D +   E++
Sbjct: 187 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 232

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 110/233 (47%), Gaps = 35/233 (15%)
Query: 523 FQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDV--------- 572
           F   D++     IG G +G V  AR R  G +VA+K       +   +FDV         
Sbjct: 51  FDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIK-------KIPNAFDVVTNAKRTLR 103
Query: 573 ECAMMKSIRHRNLVKVIS----SCSNEEFKAL--VLEYMPHGSLEKYLHSSNYSLDIFQR 626
           E  ++K  +H N++ +      +    EFK++  VL+ M    L + +HSS   L +   
Sbjct: 104 ELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLM-ESDLHQIIHSSQ-PLTLEHV 161
Query: 627 LNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL--TGEDQSM 684
              +  +   L+Y+H   SA VIH DLKPSN+L+++N    + DFG+A+ L  +  +   
Sbjct: 162 RYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQY 218
Query: 685 TQTQTLATIGYMAPEYGREGQVSTNG-DVYSFGIMLMETFTRKKPTDELFNGE 736
             T+ +AT  Y APE        T   D++S G +  E   R+    +LF G+
Sbjct: 219 FMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARR----QLFPGK 267

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 104/226 (46%), Gaps = 12/226 (5%)
Query: 520 LELFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVF-----NLQCGRAFKSFDVE 573
           L + + T+ F +  ++G G FG+VYK   I +G +V + V           +A K    E
Sbjct: 11  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 69
Query: 574 CAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDV 633
             +M S+ + ++ +++  C     + L+ + MP G L  Y+     ++     LN  + +
Sbjct: 70  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 128
Query: 634 ASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATI 693
           A  + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I
Sbjct: 129 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 185
Query: 694 GYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMT 738
            +MA E       +   DV+S+G+ + E  T   KP D +   E++
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 231

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 104/226 (46%), Gaps = 12/226 (5%)
Query: 520 LELFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVF-----NLQCGRAFKSFDVE 573
           L + + T+ F +  ++G G FG+VYK   I +G +V + V           +A K    E
Sbjct: 16  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 74
Query: 574 CAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDV 633
             +M S+ + ++ +++  C     + L+ + MP G L  Y+     ++     LN  + +
Sbjct: 75  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 133
Query: 634 ASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATI 693
           A  + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I
Sbjct: 134 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 190
Query: 694 GYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMT 738
            +MA E       +   DV+S+G+ + E  T   KP D +   E++
Sbjct: 191 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 236

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 104/226 (46%), Gaps = 12/226 (5%)
Query: 520 LELFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVF-----NLQCGRAFKSFDVE 573
           L + + T+ F +  ++G G FG+VYK   I +G +V + V           +A K    E
Sbjct: 9   LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 67
Query: 574 CAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDV 633
             +M S+ + ++ +++  C     + L+ + MP G L  Y+     ++     LN  + +
Sbjct: 68  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQI 126
Query: 634 ASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATI 693
           A  + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I
Sbjct: 127 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 694 GYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMT 738
            +MA E       +   DV+S+G+ + E  T   KP D +   E++
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 104/226 (46%), Gaps = 12/226 (5%)
Query: 520 LELFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVF-----NLQCGRAFKSFDVE 573
           L + + T+ F +  ++G G FG+VYK   I +G +V + V           +A K    E
Sbjct: 12  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 70
Query: 574 CAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDV 633
             +M S+ + ++ +++  C     + L+ + MP G L  Y+     ++     LN  + +
Sbjct: 71  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 129
Query: 634 ASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATI 693
           A  + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I
Sbjct: 130 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 186
Query: 694 GYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMT 738
            +MA E       +   DV+S+G+ + E  T   KP D +   E++
Sbjct: 187 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 232

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 103/217 (47%), Gaps = 22/217 (10%)
Query: 525 ATDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFK-----SFDVECAMMK 578
           AT ++     IG G +G+VYKAR    G  VA+K   +  G         S   E A+++
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 579 ---SIRHRNLVKVISSCS----NEEFKA-LVLEYMPHGSLEKYL-HSSNYSLDIFQRLNI 629
              +  H N+V+++  C+    + E K  LV E++    L  YL  +    L      ++
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDL 125
Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
           M      L++LH      ++H DLKP N+L+       L+DFG+A++ + +   M  T  
Sbjct: 126 MRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ---MALTPV 179
Query: 690 LATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRK 726
           + T+ Y APE   +   +T  D++S G +  E F RK
Sbjct: 180 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 102/213 (47%), Gaps = 31/213 (14%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSI--RHRNLVKVISSC 592
           +G+G +G V++   + G  VAVK+F+    R  KS+  E  +  ++  RH N++  I+S 
Sbjct: 45  VGKGRYGEVWRGSWQ-GENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIASD 100
Query: 593 SNEEFKA----LVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLH---FGYS 645
                 +    L+  Y   GSL  YL  +  +LD    L I++ +AS L +LH   FG  
Sbjct: 101 MTSRHSSTQLWLITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIFGTQ 158
Query: 646 A-PVI-HCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT-----LATIGYMAP 698
             P I H DLK  N+L+  N    ++D G+A +     QS  Q        + T  YMAP
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVM---HSQSTNQLDVGNNPRVGTKRYMAP 215
Query: 699 EYGREG-QVS-----TNGDVYSFGIMLMETFTR 725
           E   E  QV         D+++FG++L E   R
Sbjct: 216 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 248

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 105/229 (45%), Gaps = 12/229 (5%)
Query: 517 FSYLELFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVF-----NLQCGRAFKSF 570
            + L + + T+ F +  ++G G FG+VYK   I +G +V + V           +A K  
Sbjct: 3   MALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI 61
Query: 571 DVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIM 630
             E  +M S+ + ++ +++  C     + L+ + MP G L  Y+     ++     LN  
Sbjct: 62  LDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC 120
Query: 631 IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTL 690
           + +A  + YL       ++H DL   NVL+       ++DFG+AKLL  E++        
Sbjct: 121 VQIAEGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 177
Query: 691 ATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMT 738
             I +MA E       +   DV+S+G+ + E  T   KP D +   E++
Sbjct: 178 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 226

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 104/226 (46%), Gaps = 12/226 (5%)
Query: 520 LELFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVF-----NLQCGRAFKSFDVE 573
           L + + T+ F +  ++G G FG+VYK   I +G +V + V           +A K    E
Sbjct: 15  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 73
Query: 574 CAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDV 633
             +M S+ + ++ +++  C     + L+ + MP G L  Y+     ++     LN  + +
Sbjct: 74  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 132
Query: 634 ASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATI 693
           A  + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I
Sbjct: 133 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 189
Query: 694 GYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMT 738
            +MA E       +   DV+S+G+ + E  T   KP D +   E++
Sbjct: 190 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 235

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 110/233 (47%), Gaps = 35/233 (15%)
Query: 523 FQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDV--------- 572
           F   D++     IG G +G V  AR R  G +VA+K       +   +FDV         
Sbjct: 50  FDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIK-------KIPNAFDVVTNAKRTLR 102
Query: 573 ECAMMKSIRHRNLVKVIS----SCSNEEFKAL--VLEYMPHGSLEKYLHSSNYSLDIFQR 626
           E  ++K  +H N++ +      +    EFK++  VL+ M    L + +HSS   L +   
Sbjct: 103 ELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLM-ESDLHQIIHSSQ-PLTLEHV 160
Query: 627 LNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL--TGEDQSM 684
              +  +   L+Y+H   SA VIH DLKPSN+L+++N    + DFG+A+ L  +  +   
Sbjct: 161 RYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQY 217
Query: 685 TQTQTLATIGYMAPEYGREGQVSTNG-DVYSFGIMLMETFTRKKPTDELFNGE 736
             T+ +AT  Y APE        T   D++S G +  E   R+    +LF G+
Sbjct: 218 FMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARR----QLFPGK 266

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 104/226 (46%), Gaps = 12/226 (5%)
Query: 520 LELFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVF-----NLQCGRAFKSFDVE 573
           L + + T+ F +  ++G G FG+VYK   I +G +V + V           +A K    E
Sbjct: 12  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 70
Query: 574 CAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDV 633
             +M S+ + ++ +++  C     + L+ + MP G L  Y+     ++     LN  + +
Sbjct: 71  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 129
Query: 634 ASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATI 693
           A  + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I
Sbjct: 130 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 186
Query: 694 GYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMT 738
            +MA E       +   DV+S+G+ + E  T   KP D +   E++
Sbjct: 187 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 232

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 104/226 (46%), Gaps = 12/226 (5%)
Query: 520 LELFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVF-----NLQCGRAFKSFDVE 573
           L + + T+ F +  ++G G FG+VYK   I +G +V + V           +A K    E
Sbjct: 3   LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 61
Query: 574 CAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDV 633
             +M S+ + ++ +++  C     + L+ + MP G L  Y+     ++     LN  + +
Sbjct: 62  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 120
Query: 634 ASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATI 693
           A  + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I
Sbjct: 121 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177
Query: 694 GYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMT 738
            +MA E       +   DV+S+G+ + E  T   KP D +   E++
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 223

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 102/213 (47%), Gaps = 31/213 (14%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSI--RHRNLVKVISSC 592
           +G+G +G V++   + G  VAVK+F+    R  KS+  E  +  ++  RH N++  I+S 
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 593 SNEEFKA----LVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLH---FGYS 645
                 +    L+  Y   GSL  YL  +  +LD    L I++ +AS L +LH   FG  
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 646 A-PVI-HCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT-----LATIGYMAP 698
             P I H DLK  N+L+  N    ++D G+A +     QS  Q        + T  YMAP
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVM---HSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 699 EYGREG-QVS-----TNGDVYSFGIMLMETFTR 725
           E   E  QV         D+++FG++L E   R
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 104/226 (46%), Gaps = 12/226 (5%)
Query: 520 LELFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVF-----NLQCGRAFKSFDVE 573
           L + + T+ F +  ++G G FG+VYK   I +G +V + V           +A K    E
Sbjct: 34  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 92
Query: 574 CAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDV 633
             +M S+ + ++ +++  C     + L+ + MP G L  Y+     ++     LN  + +
Sbjct: 93  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 151
Query: 634 ASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATI 693
           A  + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I
Sbjct: 152 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 208
Query: 694 GYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMT 738
            +MA E       +   DV+S+G+ + E  T   KP D +   E++
Sbjct: 209 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 254

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 104/226 (46%), Gaps = 12/226 (5%)
Query: 520 LELFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVF-----NLQCGRAFKSFDVE 573
           L + + T+ F +  ++G G FG+VYK   I +G +V + V           +A K    E
Sbjct: 19  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 77
Query: 574 CAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDV 633
             +M S+ + ++ +++  C     + L+ + MP G L  Y+     ++     LN  + +
Sbjct: 78  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 136
Query: 634 ASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATI 693
           A  + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I
Sbjct: 137 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 193
Query: 694 GYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMT 738
            +MA E       +   DV+S+G+ + E  T   KP D +   E++
Sbjct: 194 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 239

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 104/226 (46%), Gaps = 12/226 (5%)
Query: 520 LELFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVF-----NLQCGRAFKSFDVE 573
           L + + T+ F +  ++G G FG+VYK   I +G +V + V           +A K    E
Sbjct: 13  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 71
Query: 574 CAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDV 633
             +M S+ + ++ +++  C     + L+++ MP G L  Y+     ++     LN  + +
Sbjct: 72  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 130
Query: 634 ASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATI 693
           A  + YL       ++H DL   NVL+       ++DFG AKLL  E++          I
Sbjct: 131 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 187
Query: 694 GYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMT 738
            +MA E       +   DV+S+G+ + E  T   KP D +   E++
Sbjct: 188 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 233

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 104/226 (46%), Gaps = 12/226 (5%)
Query: 520 LELFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVF-----NLQCGRAFKSFDVE 573
           L + + T+ F +  ++G G FG+VYK   I +G +V + V           +A K    E
Sbjct: 11  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 69
Query: 574 CAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDV 633
             +M S+ + ++ +++  C     + L+++ MP G L  Y+     ++     LN  + +
Sbjct: 70  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 128
Query: 634 ASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATI 693
           A  + YL       ++H DL   NVL+       ++DFG AKLL  E++          I
Sbjct: 129 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 185
Query: 694 GYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMT 738
            +MA E       +   DV+S+G+ + E  T   KP D +   E++
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 231

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 102/213 (47%), Gaps = 31/213 (14%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSI--RHRNLVKVISSC 592
           +G+G +G V++   + G  VAVK+F+    R  KS+  E  +  ++  RH N++  I+S 
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 593 SNEEFKA----LVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLH---FGYS 645
                 +    L+  Y   GSL  YL  +  +LD    L I++ +AS L +LH   FG  
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 646 A-PVI-HCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT-----LATIGYMAP 698
             P I H DLK  N+L+  N    ++D G+A +     QS  Q        + T  YMAP
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVM---HSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 699 EYGREG-QVS-----TNGDVYSFGIMLMETFTR 725
           E   E  QV         D+++FG++L E   R
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 104/226 (46%), Gaps = 12/226 (5%)
Query: 520 LELFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVF-----NLQCGRAFKSFDVE 573
           L + + T+ F +  ++G G FG+VYK   I +G +V + V           +A K    E
Sbjct: 11  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 69
Query: 574 CAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDV 633
             +M S+ + ++ +++  C     + L+++ MP G L  Y+     ++     LN  + +
Sbjct: 70  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 128
Query: 634 ASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATI 693
           A  + YL       ++H DL   NVL+       ++DFG AKLL  E++          I
Sbjct: 129 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 185
Query: 694 GYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMT 738
            +MA E       +   DV+S+G+ + E  T   KP D +   E++
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 231

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 95/224 (42%), Gaps = 41/224 (18%)
Query: 529 FSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVK 587
           F E  LIG GGFG V+KA+ R DG    ++       +A    + E   +  + H N+V 
Sbjct: 14  FKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKA----EREVKALAKLDHVNIVH 69
Query: 588 VI-----------------------------SSCSNEEFKALVLEYMPHGSLEKYLHSSN 618
                                          SS S  +   + +E+   G+LE+++    
Sbjct: 70  YNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR 129
Query: 619 -YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 677
              LD    L +   +   ++Y+H   S  +IH DLKPSN+ L D     + DFG+   L
Sbjct: 130 GEKLDKVLALELFEQITKGVDYIH---SKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSL 186
Query: 678 TGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLME 721
             + +   +T++  T+ YM+PE           D+Y+ G++L E
Sbjct: 187 KNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAE 227

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/221 (30%), Positives = 107/221 (48%), Gaps = 19/221 (8%)
Query: 520 LELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC-GRAFKSFDV-ECAM 576
           +E FQ  +K      IG G +G VYKAR +  G  VA+K   L        S  + E ++
Sbjct: 5   MENFQKVEK------IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL 58
Query: 577 MKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASA 636
           +K + H N+VK++     E    LV E++ H  L+ ++ +S  +L       I   +   
Sbjct: 59  LKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKTFMDAS--ALTGIPLPLIKSYLFQL 115
Query: 637 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYM 696
           L+ L F +S  V+H DLKP N+L++      L+DFG+A+      +  T    + T+ Y 
Sbjct: 116 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYR 173
Query: 697 APEYGREGQ-VSTNGDVYSFGIMLMETFTRKKPTDELFNGE 736
           APE     +  ST  D++S G +  E  TR+     LF G+
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGD 210

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/221 (30%), Positives = 107/221 (48%), Gaps = 19/221 (8%)
Query: 520 LELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC-GRAFKSFDV-ECAM 576
           +E FQ  +K      IG G +G VYKAR +  G  VA+K   L        S  + E ++
Sbjct: 2   MENFQKVEK------IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL 55
Query: 577 MKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASA 636
           +K + H N+VK++     E    LV E++ H  L+ ++ +S  +L       I   +   
Sbjct: 56  LKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKDFMDAS--ALTGIPLPLIKSYLFQL 112
Query: 637 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYM 696
           L+ L F +S  V+H DLKP N+L++      L+DFG+A+      +  T    + T+ Y 
Sbjct: 113 LQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYR 170
Query: 697 APEYGREGQ-VSTNGDVYSFGIMLMETFTRKKPTDELFNGE 736
           APE     +  ST  D++S G +  E  TR+     LF G+
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGD 207

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 97/208 (46%), Gaps = 12/208 (5%)
Query: 525 ATDKFSENNLIGRGGFGSVYKARIRDGMEV-AVKV-FNLQCGRAFKSFDV--ECAMMKSI 580
           A + F     +G+G FG+VY AR +    + A+KV F  Q  +A     +  E  +   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYC 124
Query: 641 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
           H   S  VIH D+KP N+LL       ++DFG     +    S  +T+   T+ Y+ PE 
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTELCGTLDYLPPEM 177
Query: 701 GREGQVSTNGDVYSFGIMLMETFTRKKP 728
                     D++S G++  E    K P
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 71/294 (24%), Positives = 117/294 (39%), Gaps = 58/294 (19%)
Query: 535 IGRGGFGSVYKARIR------DGMEVAVKVF-NLQCGRAFKSFDVECAMMKSIRHRNLVK 587
           +G G FG VY+ ++         ++VAVK    +   +    F +E  ++    H+N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLH------SSNYSLDIFQRLNIMIDVASALEYL- 640
            I        + ++LE M  G L+ +L       S   SL +   L++  D+A   +YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 641 --HFGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGY 695
             HF      IH D+   N LL       VA + DFG+A+ +            +  + +
Sbjct: 173 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 226
Query: 696 MAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVV 755
           M PE   EG  ++  D +SFG++L E F+          G M      N           
Sbjct: 227 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSL---------GYMPYPSKSN----------- 266
Query: 756 DANLLSQEDIHFVAK-------EQCVSFVFNLALECTVESPEQRINAKEIVAKL 802
                 QE + FV         + C   V+ +  +C    PE R N   I+ ++
Sbjct: 267 ------QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 314

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 19/208 (9%)
Query: 535 IGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCS 593
           +G G FG VYKA+ ++ G   A KV   +     + + VE  ++ +  H  +VK++ +  
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 594 NEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 653
           ++    +++E+ P G+++  +   +  L   Q   I +     LE L+F +S  +IH DL
Sbjct: 79  HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ---IQVVCRQMLEALNFLHSKRIIHRDL 135
Query: 654 KPSNVLLDDNMVAHLSDFGIA----KLLTGEDQSMTQTQTLATIGYMAPEY-----GREG 704
           K  NVL+       L+DFG++    K L   D        + T  +MAPE       ++ 
Sbjct: 136 KAGNVLMTLEGDIRLADFGVSAKNLKTLQKRD------SFIGTPYWMAPEVVMCETMKDT 189
Query: 705 QVSTNGDVYSFGIMLMETFTRKKPTDEL 732
                 D++S GI L+E    + P  EL
Sbjct: 190 PYDYKADIWSLGITLIEMAQIEPPHHEL 217

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 12/208 (5%)
Query: 525 ATDKFSENNLIGRGGFGSVYKARIRDGMEV-AVKV-FNLQCGRAFKSFDV--ECAMMKSI 580
           A + F     +G+G FG+VY AR +    + A+KV F  Q  +A     +  E  +   +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
           RH N++++     +     L+LEY P G + K L   +   D  +    + ++A+AL Y 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLS-KFDEQRTATYITELANALSYC 129
Query: 641 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
           H   S  VIH D+KP N+LL       ++DFG     +    S  +T    T+ Y+ PE 
Sbjct: 130 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEM 182
Query: 701 GREGQVSTNGDVYSFGIMLMETFTRKKP 728
                     D++S G++  E    K P
Sbjct: 183 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Composition-based stats.
 Identities = 75/286 (26%), Positives = 108/286 (37%), Gaps = 41/286 (14%)
Query: 535 IGRGGFGSV----YKARIRDGMEVAVKVFN---LQCGRAFKSFDVECAMMKSIRHRNLVK 587
           +G G FG V    + A     + VAVK      L    A   F  E   M S+ HRNL++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYL--HSSNYSLDIFQRLNIMIDVASALEYLHFGYS 645
           +         K +V E  P GSL   L  H  ++ L    R    + VA  + YL    S
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRY--AVQVAEGMGYLE---S 129
Query: 646 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-TGEDQSMTQTQTLATIGYMAPEYGREG 704
              IH DL   N+LL    +  + DFG+ + L   +D  + Q        + APE  +  
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 189
Query: 705 QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQED 764
             S   D + FG+ L E FT  +      NG   L                    + +E 
Sbjct: 190 TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK------------------IDKEG 231
Query: 765 IHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLL 810
                 E C   ++N+ ++C    PE R          + +RD LL
Sbjct: 232 ERLPRPEDCPQDIYNVMVQCWAHKPEDR-------PTFVALRDFLL 270

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 98/222 (44%), Gaps = 33/222 (14%)
Query: 533 NLIGRGGFGSVYKA------RIRDGMEVAVKVFNLQCGRAFK-SFDVECAMMKSI-RHRN 584
            ++G G FG V  A      +    ++VAVK+   +   + + +   E  MM  +  H N
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 585 LVKVISSCSNEEFKALVLEYMPHGSLEKYLHSS-------------NYSLDIFQRLNIMI 631
           +V ++ +C+      L+ EY  +G L  YL S                 L+  + LN++ 
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 632 ---------DVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 682
                     VA  +E+L F      +H DL   NVL+    V  + DFG+A+ +  +  
Sbjct: 171 FEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 227
Query: 683 SMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 724
            + +      + +MAPE   EG  +   DV+S+GI+L E F+
Sbjct: 228 YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 104/226 (46%), Gaps = 12/226 (5%)
Query: 520 LELFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVF-----NLQCGRAFKSFDVE 573
           L + + T+ F +  ++  G FG+VYK   I +G +V + V           +A K    E
Sbjct: 16  LRILKETE-FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 74
Query: 574 CAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDV 633
             +M S+ + ++ +++  C     + L+++ MP G L  Y+     ++     LN  + +
Sbjct: 75  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 133
Query: 634 ASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATI 693
           A  + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I
Sbjct: 134 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 190
Query: 694 GYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMT 738
            +MA E       +   DV+S+G+ + E  T   KP D +   E++
Sbjct: 191 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 236

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 104/222 (46%), Gaps = 40/222 (18%)
Query: 521 ELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGR--------AFKSFD 571
           E +Q   K+   ++IGRG    V +   R  G E AVK+  +   R          ++  
Sbjct: 91  EFYQ---KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATR 147
Query: 572 VECAMMKSIR-HRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIM 630
            E  +++ +  H +++ +I S  +  F  LV + M  G L  YL +   +L   +  +IM
Sbjct: 148 RETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL-TEKVALSEKETRSIM 206
Query: 631 IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIA-KLLTGEDQSMTQTQT 689
             +  A+ +LH   +  ++H DLKP N+LLDDNM   LSDFG +  L  GE       + 
Sbjct: 207 RSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE----KLREL 259
Query: 690 LATIGYMAPE------------YGREGQVSTNGDVYSFGIML 719
             T GY+APE            YG+E       D+++ G++L
Sbjct: 260 CGTPGYLAPEILKCSMDETHPGYGKE------VDLWACGVIL 295

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 19/208 (9%)
Query: 535 IGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCS 593
           +G G FG VYKA+ ++ G   A KV   +     + + VE  ++ +  H  +VK++ +  
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 594 NEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 653
           ++    +++E+ P G+++  +   +  L   Q   I +     LE L+F +S  +IH DL
Sbjct: 87  HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ---IQVVCRQMLEALNFLHSKRIIHRDL 143
Query: 654 KPSNVLLDDNMVAHLSDFGIA----KLLTGEDQSMTQTQTLATIGYMAPEY-----GREG 704
           K  NVL+       L+DFG++    K L   D        + T  +MAPE       ++ 
Sbjct: 144 KAGNVLMTLEGDIRLADFGVSAKNLKTLQKRD------SFIGTPYWMAPEVVMCETMKDT 197
Query: 705 QVSTNGDVYSFGIMLMETFTRKKPTDEL 732
                 D++S GI L+E    + P  EL
Sbjct: 198 PYDYKADIWSLGITLIEMAQIEPPHHEL 225

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 70/230 (30%), Positives = 117/230 (50%), Gaps = 34/230 (14%)
Query: 529 FSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKV 588
           ++   +IG G FG V++A++ +  EVA+K   LQ  R FK  + E  +M+ ++H N+V +
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEVAIKKV-LQDKR-FK--NRELQIMRIVKHPNVVDL 97
Query: 589 IS------SCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNI------MIDVASA 636
            +         +E F  LVLEY+P    E    +S +   + Q + +      M  +  +
Sbjct: 98  KAFFYSNGDKKDEVFLNLVLEYVP----ETVYRASRHYAKLKQTMPMLLIKLYMYQLLRS 153
Query: 637 LEYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGY 695
           L Y+H   S  + H D+KP N+LLD  + V  L DFG AK+L   + +++    + +  Y
Sbjct: 154 LAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVS---XICSRYY 207
Query: 696 MAPE--YGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWV 743
            APE  +G     +TN D++S G ++ E   + +P   LF GE  +   V
Sbjct: 208 RAPELIFG-ATNYTTNIDIWSTGCVMAE-LMQGQP---LFPGESGIDQLV 252

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 103/226 (45%), Gaps = 12/226 (5%)
Query: 520 LELFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVF-----NLQCGRAFKSFDVE 573
           L + + T+ F +  ++G G FG+VYK   I +G +V + V           +A K    E
Sbjct: 16  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 74
Query: 574 CAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDV 633
             +M S+ + ++ +++  C     + L+ + MP G L  Y+     ++     LN  + +
Sbjct: 75  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 133
Query: 634 ASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATI 693
           A  + YL       ++H DL   NVL+       ++DFG AKLL  E++          I
Sbjct: 134 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 190
Query: 694 GYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMT 738
            +MA E       +   DV+S+G+ + E  T   KP D +   E++
Sbjct: 191 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 236

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 100/224 (44%), Gaps = 32/224 (14%)
Query: 525 ATDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRH- 582
           A+D F E  ++G+G FG V KAR   D    A+K           +   E  ++ S+ H 
Sbjct: 5   ASD-FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQ 62
Query: 583 ------------RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIM 630
                       RN VK +++   +    + +EY  +G+L   +HS N +    +   + 
Sbjct: 63  YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 631 IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK-------LLTGEDQS 683
             +  AL Y+H   S  +IH DLKP N+ +D++    + DFG+AK       +L  + Q+
Sbjct: 123 RQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 684 M-----TQTQTLATIGYMAPEY-GREGQVSTNGDVYSFGIMLME 721
           +       T  + T  Y+A E     G  +   D+YS GI+  E
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE 223

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 103/226 (45%), Gaps = 12/226 (5%)
Query: 520 LELFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVF-----NLQCGRAFKSFDVE 573
           L + + T+ F +  ++G G FG+VYK   I +G +V + V           +A K    E
Sbjct: 11  LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 69
Query: 574 CAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDV 633
             +M S+ + ++ +++  C     + L+ + MP G L  Y+     ++     LN  + +
Sbjct: 70  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 128
Query: 634 ASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATI 693
           A  + YL       ++H DL   NVL+       ++DFG AKLL  E++          I
Sbjct: 129 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 185
Query: 694 GYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMT 738
            +MA E       +   DV+S+G+ + E  T   KP D +   E++
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 231

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 103/226 (45%), Gaps = 12/226 (5%)
Query: 520 LELFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVF-----NLQCGRAFKSFDVE 573
           L + + T+ F +  ++G G FG+VYK   I +G +V + V           +A K    E
Sbjct: 9   LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 67
Query: 574 CAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDV 633
             +M S+ + ++ +++  C     + L+ + MP G L  Y+     ++     LN  + +
Sbjct: 68  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 126
Query: 634 ASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATI 693
           A  + YL       ++H DL   NVL+       ++DFG AKLL  E++          I
Sbjct: 127 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 183
Query: 694 GYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMT 738
            +MA E       +   DV+S+G+ + E  T   KP D +   E++
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 12/208 (5%)
Query: 525 ATDKFSENNLIGRGGFGSVYKARIRDGMEV-AVKV-FNLQCGRAFKSFDV--ECAMMKSI 580
           A + F     +G+G FG+VY AR +    + A+KV F  Q  +A     +  E  +   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYC 124
Query: 641 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
           H   S  VIH D+KP N+LL       ++DFG     +    S  +T    T+ Y+ PE 
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPPEM 177
Query: 701 GREGQVSTNGDVYSFGIMLMETFTRKKP 728
                     D++S G++  E    K P
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 101/219 (46%), Gaps = 25/219 (11%)
Query: 528 KFSENNL-----IGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDVECAMMKSIR 581
           +F  NNL     +G G FG V +A     G E AV    ++  ++    D + A+M  ++
Sbjct: 34  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 93
Query: 582 -------HRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYS---------LDIFQ 625
                  H N+V ++ +C++     ++ EY  +G L  +L     +         L++  
Sbjct: 94  IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRD 153
Query: 626 RLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMT 685
            L+    VA  + +L    S   IH D+   NVLL +  VA + DFG+A+ +  +   + 
Sbjct: 154 LLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 210
Query: 686 QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 724
           +      + +MAPE   +   +   DV+S+GI+L E F+
Sbjct: 211 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 12/208 (5%)
Query: 525 ATDKFSENNLIGRGGFGSVYKARIRDGMEV-AVKV-FNLQCGRAFKSFDV--ECAMMKSI 580
           A + F     +G+G FG+VY AR +    + A+KV F  Q  +A     +  E  +   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYC 124
Query: 641 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
           H   S  VIH D+KP N+LL       ++DFG     +    S  +T    T+ Y+ PE 
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPPEM 177
Query: 701 GREGQVSTNGDVYSFGIMLMETFTRKKP 728
                     D++S G++  E    K P
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 12/208 (5%)
Query: 525 ATDKFSENNLIGRGGFGSVYKARIRDGMEV-AVKV-FNLQCGRAFKSFDV--ECAMMKSI 580
           A + F     +G+G FG+VY AR +    + A+KV F  Q  +A     +  E  +   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYC 124
Query: 641 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
           H   S  VIH D+KP N+LL       ++DFG     +    S  +T    T+ Y+ PE 
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEM 177
Query: 701 GREGQVSTNGDVYSFGIMLMETFTRKKP 728
                     D++S G++  E    K P
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 12/208 (5%)
Query: 525 ATDKFSENNLIGRGGFGSVYKARIRDGMEV-AVKV-FNLQCGRAFKSFDV--ECAMMKSI 580
           A + F     +G+G FG+VY AR +    + A+KV F  Q  +A     +  E  +   +
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYC 128
Query: 641 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
           H   S  VIH D+KP N+LL       ++DFG     +    S  +T    T+ Y+ PE 
Sbjct: 129 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEM 181
Query: 701 GREGQVSTNGDVYSFGIMLMETFTRKKP 728
                     D++S G++  E    K P
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 209

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 12/208 (5%)
Query: 525 ATDKFSENNLIGRGGFGSVYKARIRDGMEV-AVKV-FNLQCGRAFKSFDV--ECAMMKSI 580
           A + F     +G+G FG+VY AR +    + A+KV F  Q  +A     +  E  +   +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYC 125
Query: 641 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
           H   S  VIH D+KP N+LL       ++DFG     +    S  +T    T+ Y+ PE 
Sbjct: 126 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPPEM 178
Query: 701 GREGQVSTNGDVYSFGIMLMETFTRKKP 728
                     D++S G++  E    K P
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 12/208 (5%)
Query: 525 ATDKFSENNLIGRGGFGSVYKARIRDGMEV-AVKV-FNLQCGRAFKSFDV--ECAMMKSI 580
           A + F     +G+G FG+VY AR +    + A+KV F  Q  +A     +  E  +   +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYC 129
Query: 641 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
           H   S  VIH D+KP N+LL       ++DFG     +    S  +T    T+ Y+ PE 
Sbjct: 130 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPPEM 182
Query: 701 GREGQVSTNGDVYSFGIMLMETFTRKKP 728
                     D++S G++  E    K P
Sbjct: 183 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 12/208 (5%)
Query: 525 ATDKFSENNLIGRGGFGSVYKARIRDGMEV-AVKV-FNLQCGRAFKSFDV--ECAMMKSI 580
           A + F     +G+G FG+VY AR +    + A+KV F  Q  +A     +  E  +   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYC 127
Query: 641 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
           H   S  VIH D+KP N+LL       ++DFG     +    S  +T    T+ Y+ PE 
Sbjct: 128 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEM 180
Query: 701 GREGQVSTNGDVYSFGIMLMETFTRKKP 728
                     D++S G++  E    K P
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 12/208 (5%)
Query: 525 ATDKFSENNLIGRGGFGSVYKARIRDGMEV-AVKV-FNLQCGRAFKSFDV--ECAMMKSI 580
           A + F     +G+G FG+VY AR +    + A+KV F  Q  +A     +  E  +   +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYC 150
Query: 641 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
           H   S  VIH D+KP N+LL       ++DFG     +    S  +T    T+ Y+ PE 
Sbjct: 151 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEM 203
Query: 701 GREGQVSTNGDVYSFGIMLMETFTRKKP 728
                     D++S G++  E    K P
Sbjct: 204 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 231

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 105/205 (51%), Gaps = 23/205 (11%)
Query: 529 FSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKV 588
           +++  +IG G FG VY+A++ D  E+      LQ  R FK+ +++  +M+ + H N+V++
Sbjct: 23  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-FKNRELQ--IMRKLDHCNIVRL 79
Query: 589 I------SSCSNEEFKALVLEYMPHG--SLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
                      +E +  LVL+Y+P     + ++   +  +L +      M  +  +L Y+
Sbjct: 80  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 139
Query: 641 H-FGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 698
           H FG    + H D+KP N+LLD D  V  L DFG AK L   + +++    + +  Y AP
Sbjct: 140 HSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRAP 192
Query: 699 E--YGREGQVSTNGDVYSFGIMLME 721
           E  +G     S+  DV+S G +L E
Sbjct: 193 ELIFGATDYTSSI-DVWSAGCVLAE 216

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 105/205 (51%), Gaps = 23/205 (11%)
Query: 529 FSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKV 588
           +++  +IG G FG VY+A++ D  E+      LQ  R FK+ +++  +M+ + H N+V++
Sbjct: 30  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-FKNRELQ--IMRKLDHCNIVRL 86
Query: 589 I------SSCSNEEFKALVLEYMPHG--SLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
                      +E +  LVL+Y+P     + ++   +  +L +      M  +  +L Y+
Sbjct: 87  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 146
Query: 641 H-FGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 698
           H FG    + H D+KP N+LLD D  V  L DFG AK L   + +++    + +  Y AP
Sbjct: 147 HSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRAP 199
Query: 699 E--YGREGQVSTNGDVYSFGIMLME 721
           E  +G     S+  DV+S G +L E
Sbjct: 200 ELIFGATDYTSSI-DVWSAGCVLAE 223

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 94/211 (44%), Gaps = 22/211 (10%)
Query: 533 NLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGR--AFKSFDVECAMMKSIRHRNLVKVIS 590
            LIG+G FG VY  R     EVA+++ +++       K+F  E    +  RH N+V  + 
Sbjct: 39  ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 591 SCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIH 650
           +C +    A++       +L   +  +   LD+ +   I  ++   + YLH   +  ++H
Sbjct: 97  ACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILH 153
Query: 651 CDLKPSNVLLDDNMVAHLSDFGI----AKLLTGEDQSMTQTQTLATIGYMAPEYGREGQ- 705
            DLK  NV  D+  V  ++DFG+      L  G  +   + Q    + ++APE  R+   
Sbjct: 154 KDLKSKNVFYDNGKVV-ITDFGLFSISGVLQAGRREDKLRIQN-GWLCHLAPEIIRQLSP 211
Query: 706 --------VSTNGDVYSFGIMLMETFTRKKP 728
                    S + DV++ G +  E   R+ P
Sbjct: 212 DTEEDKLPFSKHSDVFALGTIWYELHAREWP 242

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 12/208 (5%)
Query: 525 ATDKFSENNLIGRGGFGSVYKARIRDGMEV-AVKV-FNLQCGRAFKSFDV--ECAMMKSI 580
           A + F     +G+G FG+VY AR +    + A+KV F  Q  +A     +  E  +   +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYC 129
Query: 641 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
           H   S  VIH D+KP N+LL       ++DFG     +    S  +T    T+ Y+ PE 
Sbjct: 130 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEX 182
Query: 701 GREGQVSTNGDVYSFGIMLMETFTRKKP 728
                     D++S G++  E    K P
Sbjct: 183 IEGRXHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 105/205 (51%), Gaps = 23/205 (11%)
Query: 529 FSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKV 588
           +++  +IG G FG VY+A++ D  E+      LQ  R FK+ +++  +M+ + H N+V++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-FKNRELQ--IMRKLDHCNIVRL 78
Query: 589 I------SSCSNEEFKALVLEYMPHG--SLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
                      +E +  LVL+Y+P     + ++   +  +L +      M  +  +L Y+
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 641 H-FGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 698
           H FG    + H D+KP N+LLD D  V  L DFG AK L   + +++    + +  Y AP
Sbjct: 139 HSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRAP 191
Query: 699 E--YGREGQVSTNGDVYSFGIMLME 721
           E  +G     S+  DV+S G +L E
Sbjct: 192 ELIFGATDYTSSI-DVWSAGCVLAE 215

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 95/200 (47%), Gaps = 12/200 (6%)
Query: 526 TDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFNLQ--CGRAFKSFDVECAMMKSIRH 582
           TD++     IG+G F  V +  ++  G E A K+ N +    R  +  + E  + + ++H
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
            N+V++  S S E F  LV + +  G L + + +  Y    +   +    +   LE +  
Sbjct: 63  SNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREY----YSEADASHCIQQILEAVLH 118
Query: 643 GYSAPVIHCDLKPSNVLLDDN---MVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPE 699
            +   V+H DLKP N+LL          L+DFG+A  + G+ Q+        T GY++PE
Sbjct: 119 CHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAW--FGFAGTPGYLSPE 176
Query: 700 YGREGQVSTNGDVYSFGIML 719
             R+       D+++ G++L
Sbjct: 177 VLRKEAYGKPVDIWACGVIL 196

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 108/206 (52%), Gaps = 25/206 (12%)
Query: 529 FSENNLIGRGGFGSVYKARIRDGME-VAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVK 587
           +++  +IG G FG VY+A++ D  E VA+K   LQ  R FK+ +++  +M+ + H N+V+
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FKNRELQ--IMRKLDHCNIVR 111
Query: 588 VI------SSCSNEEFKALVLEYMPHG--SLEKYLHSSNYSLDIFQRLNIMIDVASALEY 639
           +           +E +  LVL+Y+P     + ++   +  +L +      M  +  +L Y
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 171
Query: 640 LH-FGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMA 697
           +H FG    + H D+KP N+LLD D  V  L DFG AK L   + +++    + +  Y A
Sbjct: 172 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRA 224
Query: 698 PE--YGREGQVSTNGDVYSFGIMLME 721
           PE  +G     S+  DV+S G +L E
Sbjct: 225 PELIFGATDYTSSI-DVWSAGCVLAE 249

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 105/205 (51%), Gaps = 23/205 (11%)
Query: 529 FSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKV 588
           +++  +IG G FG VY+A++ D  E+      LQ  R FK+ +++  +M+ + H N+V++
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-FKNRELQ--IMRKLDHCNIVRL 90
Query: 589 I------SSCSNEEFKALVLEYMPHG--SLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
                      +E +  LVL+Y+P     + ++   +  +L +      M  +  +L Y+
Sbjct: 91  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 150
Query: 641 H-FGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 698
           H FG    + H D+KP N+LLD D  V  L DFG AK L   + +++    + +  Y AP
Sbjct: 151 HSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRAP 203
Query: 699 E--YGREGQVSTNGDVYSFGIMLME 721
           E  +G     S+  DV+S G +L E
Sbjct: 204 ELIFGATDYTSSI-DVWSAGCVLAE 227

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 68/221 (30%), Positives = 107/221 (48%), Gaps = 19/221 (8%)
Query: 520 LELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC-GRAFKSFDV-ECAM 576
           +E FQ  +K      IG G +G VYKAR +  G  VA+K   L        S  + E ++
Sbjct: 5   MENFQKVEK------IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL 58
Query: 577 MKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASA 636
           +K + H N+VK++     E    LV E++    L+K++ +S  +L       I   +   
Sbjct: 59  LKELNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKKFMDAS--ALTGIPLPLIKSYLFQL 115
Query: 637 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYM 696
           L+ L F +S  V+H DLKP N+L++      L+DFG+A+      +  T    + T+ Y 
Sbjct: 116 LQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYR 173
Query: 697 APEYGREGQ-VSTNGDVYSFGIMLMETFTRKKPTDELFNGE 736
           APE     +  ST  D++S G +  E  TR+     LF G+
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGD 210

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 108/206 (52%), Gaps = 25/206 (12%)
Query: 529 FSENNLIGRGGFGSVYKARIRDGME-VAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVK 587
           +++  +IG G FG VY+A++ D  E VA+K   LQ  R FK+ +++  +M+ + H N+V+
Sbjct: 41  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FKNRELQ--IMRKLDHCNIVR 96
Query: 588 VI------SSCSNEEFKALVLEYMPHG--SLEKYLHSSNYSLDIFQRLNIMIDVASALEY 639
           +           +E +  LVL+Y+P     + ++   +  +L +      M  +  +L Y
Sbjct: 97  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 156
Query: 640 LH-FGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMA 697
           +H FG    + H D+KP N+LLD D  V  L DFG AK L   + +++    + +  Y A
Sbjct: 157 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRA 209
Query: 698 PE--YGREGQVSTNGDVYSFGIMLME 721
           PE  +G     S+  DV+S G +L E
Sbjct: 210 PELIFGATDYTSSI-DVWSAGCVLAE 234

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Composition-based stats.
 Identities = 57/198 (28%), Positives = 93/198 (46%), Gaps = 12/198 (6%)
Query: 535 IGRGGFGSVYKARIRDGMEV-AVKV-FNLQCGRAFKSFDV--ECAMMKSIRHRNLVKVIS 590
           +G+G FG+VY AR R    + A+KV F  Q  +A     +  E  +   +RH N++++  
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 591 SCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIH 650
              +     L+LEY P G++ + L   +   D  +    + ++A+AL Y H   S  VIH
Sbjct: 80  YFHDATRVYLILEYAPLGTVYRELQKLS-RFDEQRTATYITELANALSYCH---SKRVIH 135
Query: 651 CDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNG 710
            D+KP N+LL  N    ++DFG     +    S  +T    T+ Y+ PE           
Sbjct: 136 RDIKPENLLLGSNGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKV 191
Query: 711 DVYSFGIMLMETFTRKKP 728
           D++S G++  E      P
Sbjct: 192 DLWSLGVLCYEFLVGMPP 209

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 105/205 (51%), Gaps = 23/205 (11%)
Query: 529 FSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKV 588
           +++  +IG G FG VY+A++ D  E+      LQ  R FK+ +++  +M+ + H N+V++
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-FKNRELQ--IMRKLDHCNIVRL 82
Query: 589 I------SSCSNEEFKALVLEYMPHG--SLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
                      +E +  LVL+Y+P     + ++   +  +L +      M  +  +L Y+
Sbjct: 83  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 142
Query: 641 H-FGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 698
           H FG    + H D+KP N+LLD D  V  L DFG AK L   + +++    + +  Y AP
Sbjct: 143 HSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRAP 195
Query: 699 E--YGREGQVSTNGDVYSFGIMLME 721
           E  +G     S+  DV+S G +L E
Sbjct: 196 ELIFGATDYTSSI-DVWSAGCVLAE 219

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 105/205 (51%), Gaps = 23/205 (11%)
Query: 529 FSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKV 588
           +++  +IG G FG VY+A++ D  E+      LQ  R FK+ +++  +M+ + H N+V++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-FKNRELQ--IMRKLDHCNIVRL 78
Query: 589 I------SSCSNEEFKALVLEYMPHG--SLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
                      +E +  LVL+Y+P     + ++   +  +L +      M  +  +L Y+
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 641 H-FGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 698
           H FG    + H D+KP N+LLD D  V  L DFG AK L   + +++    + +  Y AP
Sbjct: 139 HSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRAP 191
Query: 699 E--YGREGQVSTNGDVYSFGIMLME 721
           E  +G     S+  DV+S G +L E
Sbjct: 192 ELIFGATDYTSSI-DVWSAGCVLAE 215

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 12/208 (5%)
Query: 525 ATDKFSENNLIGRGGFGSVYKARIRDGMEV-AVKV-FNLQCGRAFKSFDV--ECAMMKSI 580
           A + F     +G+G FG+VY AR +    + A+KV F  Q  +A     +  E  +   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYC 127
Query: 641 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
           H   S  VIH D+KP N+LL       ++DFG     +    S  +T    T+ Y+ PE 
Sbjct: 128 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEM 180
Query: 701 GREGQVSTNGDVYSFGIMLMETFTRKKP 728
                     D++S G++  E    K P
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 108/206 (52%), Gaps = 25/206 (12%)
Query: 529 FSENNLIGRGGFGSVYKARIRDGME-VAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVK 587
           +++  +IG G FG VY+A++ D  E VA+K   LQ  R FK+ +++  +M+ + H N+V+
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FKNRELQ--IMRKLDHCNIVR 89
Query: 588 VI------SSCSNEEFKALVLEYMPHG--SLEKYLHSSNYSLDIFQRLNIMIDVASALEY 639
           +           +E +  LVL+Y+P     + ++   +  +L +      M  +  +L Y
Sbjct: 90  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 149
Query: 640 LH-FGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMA 697
           +H FG    + H D+KP N+LLD D  V  L DFG AK L   + +++    + +  Y A
Sbjct: 150 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRA 202
Query: 698 PE--YGREGQVSTNGDVYSFGIMLME 721
           PE  +G     S+  DV+S G +L E
Sbjct: 203 PELIFGATDYTSSI-DVWSAGCVLAE 227

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 103/226 (45%), Gaps = 12/226 (5%)
Query: 520 LELFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVF-----NLQCGRAFKSFDVE 573
           L + + T+ F +  ++  G FG+VYK   I +G +V + V           +A K    E
Sbjct: 9   LRILKETE-FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 67
Query: 574 CAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDV 633
             +M S+ + ++ +++  C     + L+ + MP G L  Y+     ++     LN  + +
Sbjct: 68  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 126
Query: 634 ASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATI 693
           A  + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I
Sbjct: 127 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 694 GYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMT 738
            +MA E       +   DV+S+G+ + E  T   KP D +   E++
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 101/219 (46%), Gaps = 25/219 (11%)
Query: 528 KFSENNL-----IGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDVECAMMKSIR 581
           +F  NNL     +G G FG V +A     G E AV    ++  ++    D + A+M  ++
Sbjct: 42  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 582 -------HRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYS---------LDIFQ 625
                  H N+V ++ +C++     ++ EY  +G L  +L     +         L++  
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRD 161
Query: 626 RLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMT 685
            L+    VA  + +L    S   IH D+   NVLL +  VA + DFG+A+ +  +   + 
Sbjct: 162 LLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 218
Query: 686 QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 724
           +      + +MAPE   +   +   DV+S+GI+L E F+
Sbjct: 219 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 68/221 (30%), Positives = 107/221 (48%), Gaps = 19/221 (8%)
Query: 520 LELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC-GRAFKSFDV-ECAM 576
           +E FQ  +K      IG G +G VYKAR +  G  VA+K   L        S  + E ++
Sbjct: 3   MENFQKVEK------IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL 56
Query: 577 MKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASA 636
           +K + H N+VK++     E    LV E++    L+K++ +S  +L       I   +   
Sbjct: 57  LKELNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKKFMDAS--ALTGIPLPLIKSYLFQL 113
Query: 637 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYM 696
           L+ L F +S  V+H DLKP N+L++      L+DFG+A+      +  T    + T+ Y 
Sbjct: 114 LQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYR 171
Query: 697 APEYGREGQ-VSTNGDVYSFGIMLMETFTRKKPTDELFNGE 736
           APE     +  ST  D++S G +  E  TR+     LF G+
Sbjct: 172 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGD 208

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 94/204 (46%), Gaps = 11/204 (5%)
Query: 535 IGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCS 593
           +G G FG VYKA+ ++  +  A KV + +     + + VE  ++ S  H N+VK++ +  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 594 NEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 653
            E    +++E+   G+++  +      L   Q   +      AL YLH      +IH DL
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDL 161
Query: 654 KPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY-----GREGQVST 708
           K  N+L   +    L+DFG++   T   Q   +   + T  +MAPE       ++     
Sbjct: 162 KAGNILFTLDGDIKLADFGVSAKNTRXIQR--RDSFIGTPYWMAPEVVMCETSKDRPYDY 219
Query: 709 NGDVYSFGIMLMETFTRKKPTDEL 732
             DV+S GI L+E    + P  EL
Sbjct: 220 KADVWSLGITLIEMAEIEPPHHEL 243

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 103/226 (45%), Gaps = 12/226 (5%)
Query: 520 LELFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVF-----NLQCGRAFKSFDVE 573
           L + + T+ F +  ++  G FG+VYK   I +G +V + V           +A K    E
Sbjct: 16  LRILKETE-FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 74
Query: 574 CAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDV 633
             +M S+ + ++ +++  C     + L+ + MP G L  Y+     ++     LN  + +
Sbjct: 75  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 133
Query: 634 ASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATI 693
           A  + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I
Sbjct: 134 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 190
Query: 694 GYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMT 738
            +MA E       +   DV+S+G+ + E  T   KP D +   E++
Sbjct: 191 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 236

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 12/208 (5%)
Query: 525 ATDKFSENNLIGRGGFGSVYKARIRDGMEV-AVKV-FNLQCGRAFKSFDV--ECAMMKSI 580
           A + F     +G+G FG+VY AR +    + A+KV F  Q  +A     +  E  +   +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYC 129
Query: 641 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
           H   S  VIH D+KP N+LL       ++DFG     +    S  +T    T+ Y+ PE 
Sbjct: 130 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEM 182
Query: 701 GREGQVSTNGDVYSFGIMLMETFTRKKP 728
                     D++S G++  E    K P
Sbjct: 183 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 96/200 (48%), Gaps = 12/200 (6%)
Query: 526 TDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFNLQ--CGRAFKSFDVECAMMKSIRH 582
           TD++     +G+G F  V +  +I  G E A K+ N +    R  +  + E  + + ++H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
            N+V++  S S E F  LV + +  G L + + +  Y    +   +    +   LE ++ 
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREY----YSEADASHCIQQILESVNH 118
Query: 643 GYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPE 699
            +   ++H DLKP N+LL          L+DFG+A  + G+ Q+        T GY++PE
Sbjct: 119 CHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFA--GTPGYLSPE 176
Query: 700 YGREGQVSTNGDVYSFGIML 719
             R+       D+++ G++L
Sbjct: 177 VLRKDPYGKPVDMWACGVIL 196

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 94/204 (46%), Gaps = 11/204 (5%)
Query: 535 IGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCS 593
           +G G FG VYKA+ ++  +  A KV + +     + + VE  ++ S  H N+VK++ +  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 594 NEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 653
            E    +++E+   G+++  +      L   Q   +      AL YLH      +IH DL
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDL 161
Query: 654 KPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY-----GREGQVST 708
           K  N+L   +    L+DFG++   T   Q   +   + T  +MAPE       ++     
Sbjct: 162 KAGNILFTLDGDIKLADFGVSAKNTRXIQR--RDXFIGTPYWMAPEVVMCETSKDRPYDY 219
Query: 709 NGDVYSFGIMLMETFTRKKPTDEL 732
             DV+S GI L+E    + P  EL
Sbjct: 220 KADVWSLGITLIEMAEIEPPHHEL 243

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 94/204 (46%), Gaps = 11/204 (5%)
Query: 535 IGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCS 593
           +G G FG VYKA+ ++  +  A KV + +     + + VE  ++ S  H N+VK++ +  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 594 NEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 653
            E    +++E+   G+++  +      L   Q   +      AL YLH      +IH DL
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDL 161
Query: 654 KPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY-----GREGQVST 708
           K  N+L   +    L+DFG++   T   Q   +   + T  +MAPE       ++     
Sbjct: 162 KAGNILFTLDGDIKLADFGVSAKNTRTIQR--RDSFIGTPYWMAPEVVMCETSKDRPYDY 219
Query: 709 NGDVYSFGIMLMETFTRKKPTDEL 732
             DV+S GI L+E    + P  EL
Sbjct: 220 KADVWSLGITLIEMAEIEPPHHEL 243

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 12/208 (5%)
Query: 525 ATDKFSENNLIGRGGFGSVYKARIRDGMEV-AVKV-FNLQCGRAFKSFDV--ECAMMKSI 580
           A + F     +G+G FG+VY AR +    + A+KV F  Q  +A     +  E  +   +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYC 125
Query: 641 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
           H   S  VIH D+KP N+LL       ++DFG     +    S  +T    T+ Y+ PE 
Sbjct: 126 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSCHAPSSRRTTLSGTLDYLPPEM 178
Query: 701 GREGQVSTNGDVYSFGIMLMETFTRKKP 728
                     D++S G++  E    K P
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 95/201 (47%), Gaps = 13/201 (6%)
Query: 535 IGRGGFGSVYKAR-IRDGMEVAVKVFN---LQCGRAFKSFDVECAMMKSIRHRNLVKVIS 590
           IG+G F  V  AR I  G EVAVK+ +   L      K F  E  +MK + H N+VK+  
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLFE 73
Query: 591 SCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIH 650
               E+   LV+EY   G +  YL +  +  +   R      + SA++Y H  +   ++H
Sbjct: 74  VIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFR-QIVSAVQYCHQKF---IVH 129
Query: 651 CDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPE-YGREGQVSTN 709
            DLK  N+LLD +M   ++DFG +   T  ++  T      +  Y APE +  +      
Sbjct: 130 RDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPELFQGKKYDGPE 186
Query: 710 GDVYSFGIMLMETFTRKKPTD 730
            DV+S G++L    +   P D
Sbjct: 187 VDVWSLGVILYTLVSGSLPFD 207

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 96/200 (48%), Gaps = 12/200 (6%)
Query: 526 TDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFNLQ--CGRAFKSFDVECAMMKSIRH 582
           TD++     +G+G F  V +  +I  G E A K+ N +    R  +  + E  + + ++H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
            N+V++  S S E F  LV + +  G L + + +  Y    +   +    +   LE ++ 
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREY----YSEADASHCIQQILESVNH 118
Query: 643 GYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPE 699
            +   ++H DLKP N+LL          L+DFG+A  + G+ Q+        T GY++PE
Sbjct: 119 CHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFA--GTPGYLSPE 176
Query: 700 YGREGQVSTNGDVYSFGIML 719
             R+       D+++ G++L
Sbjct: 177 VLRKDPYGKPVDMWACGVIL 196

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 12/208 (5%)
Query: 525 ATDKFSENNLIGRGGFGSVYKARIRDGMEV-AVKV-FNLQCGRA--FKSFDVECAMMKSI 580
           A + F     +G+G FG+VY AR +    + A+KV F  Q  +A        E  +   +
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 83  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYC 141
Query: 641 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
           H   S  VIH D+KP N+LL       ++DFG     +    S  +T    T+ Y+ PE 
Sbjct: 142 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEM 194
Query: 701 GREGQVSTNGDVYSFGIMLMETFTRKKP 728
                     D++S G++  E    K P
Sbjct: 195 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 222

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 12/208 (5%)
Query: 525 ATDKFSENNLIGRGGFGSVYKARIRDGMEV-AVKV-FNLQCGRAFKSFDV--ECAMMKSI 580
           A + F     +G+G FG+VY AR +    + A+KV F  Q  +A     +  E  +   +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
           RH N++++     +     L+LEY P G + K L   +   D  +    + ++A+AL Y 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLS-KFDEQRTATYITELANALSYC 129
Query: 641 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
           H   S  VIH D+KP N+LL       ++DFG     +    S  +     T+ Y+ PE 
Sbjct: 130 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLXGTLDYLPPEM 182
Query: 701 GREGQVSTNGDVYSFGIMLMETFTRKKP 728
                     D++S G++  E    K P
Sbjct: 183 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/221 (30%), Positives = 107/221 (48%), Gaps = 19/221 (8%)
Query: 520 LELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC-GRAFKSFDV-ECAM 576
           +E FQ  +K      IG G +G VYKAR +  G  VA+K   L        S  + E ++
Sbjct: 5   MENFQKVEK------IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL 58
Query: 577 MKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASA 636
           +K + H N+VK++     E    LV E++    L+K++ +S  +L       I   +   
Sbjct: 59  LKELNHPNIVKLLDVIHTENKLYLVFEHVDQ-DLKKFMDAS--ALTGIPLPLIKSYLFQL 115
Query: 637 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYM 696
           L+ L F +S  V+H DLKP N+L++      L+DFG+A+      +  T    + T+ Y 
Sbjct: 116 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYR 173
Query: 697 APEYGREGQ-VSTNGDVYSFGIMLMETFTRKKPTDELFNGE 736
           APE     +  ST  D++S G +  E  TR+     LF G+
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGD 210

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 108/206 (52%), Gaps = 25/206 (12%)
Query: 529 FSENNLIGRGGFGSVYKARIRDGME-VAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVK 587
           +++  +IG G FG VY+A++ D  E VA+K   LQ  R FK+ +++  +M+ + H N+V+
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FKNRELQ--IMRKLDHCNIVR 82
Query: 588 VI------SSCSNEEFKALVLEYMPHG--SLEKYLHSSNYSLDIFQRLNIMIDVASALEY 639
           +           +E +  LVL+Y+P     + ++   +  +L +      M  +  +L Y
Sbjct: 83  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 142
Query: 640 LH-FGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMA 697
           +H FG    + H D+KP N+LLD D  V  L DFG AK L   + +++    + +  Y A
Sbjct: 143 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRA 195
Query: 698 PE--YGREGQVSTNGDVYSFGIMLME 721
           PE  +G     S+  DV+S G +L E
Sbjct: 196 PELIFGATDYTSSI-DVWSAGCVLAE 220

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 108/206 (52%), Gaps = 25/206 (12%)
Query: 529 FSENNLIGRGGFGSVYKARIRDGME-VAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVK 587
           +++  +IG G FG VY+A++ D  E VA+K   LQ  R FK+ +++  +M+ + H N+V+
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FKNRELQ--IMRKLDHCNIVR 105
Query: 588 V------ISSCSNEEFKALVLEYMPHG--SLEKYLHSSNYSLDIFQRLNIMIDVASALEY 639
           +           +E +  LVL+Y+P     + ++   +  +L +      M  +  +L Y
Sbjct: 106 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 165
Query: 640 LH-FGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMA 697
           +H FG    + H D+KP N+LLD D  V  L DFG AK L   + +++    + +  Y A
Sbjct: 166 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRA 218
Query: 698 PE--YGREGQVSTNGDVYSFGIMLME 721
           PE  +G     S+  DV+S G +L E
Sbjct: 219 PELIFGATDYTSSI-DVWSAGCVLAE 243

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 105/205 (51%), Gaps = 23/205 (11%)
Query: 529 FSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKV 588
           +++  +IG G FG VY+A++ D  E+      LQ  R FK+ +++  +M+ + H N+V++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-FKNRELQ--IMRKLDHCNIVRL 78
Query: 589 I------SSCSNEEFKALVLEYMPHG--SLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
                      +E +  LVL+Y+P     + ++   +  +L +      M  +  +L Y+
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 641 H-FGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 698
           H FG    + H D+KP N+LLD D  V  L DFG AK L   + +++    + +  Y AP
Sbjct: 139 HSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRAP 191
Query: 699 E--YGREGQVSTNGDVYSFGIMLME 721
           E  +G     S+  DV+S G +L E
Sbjct: 192 ELIFGATDYTSSI-DVWSAGCVLAE 215

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 105/205 (51%), Gaps = 23/205 (11%)
Query: 529 FSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKV 588
           +++  +IG G FG VY+A++ D  E+      LQ  R FK+ +++  +M+ + H N+V++
Sbjct: 35  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-FKNRELQ--IMRKLDHCNIVRL 91
Query: 589 I------SSCSNEEFKALVLEYMPHG--SLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
                      +E +  LVL+Y+P     + ++   +  +L +      M  +  +L Y+
Sbjct: 92  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 151
Query: 641 H-FGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 698
           H FG    + H D+KP N+LLD D  V  L DFG AK L   + +++    + +  Y AP
Sbjct: 152 HSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRAP 204
Query: 699 E--YGREGQVSTNGDVYSFGIMLME 721
           E  +G     S+  DV+S G +L E
Sbjct: 205 ELIFGATDYTSSI-DVWSAGCVLAE 228

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 12/208 (5%)
Query: 525 ATDKFSENNLIGRGGFGSVYKARIRDGMEV-AVKV-FNLQCGRAFKSFDV--ECAMMKSI 580
           A + F     +G+G FG+VY AR ++   + A+KV F  Q  +A     +  E  +   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYC 124
Query: 641 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
           H   S  VIH D+KP N+LL       ++DFG     +    S  +     T+ Y+ PE 
Sbjct: 125 H---SKKVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGTLDYLPPEM 177
Query: 701 GREGQVSTNGDVYSFGIMLMETFTRKKP 728
                     D++S G++  E    K P
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 108/206 (52%), Gaps = 25/206 (12%)
Query: 529 FSENNLIGRGGFGSVYKARIRDGME-VAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVK 587
           +++  +IG G FG VY+A++ D  E VA+K   LQ  R FK+ +++  +M+ + H N+V+
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FKNRELQ--IMRKLDHCNIVR 115
Query: 588 VI------SSCSNEEFKALVLEYMPHG--SLEKYLHSSNYSLDIFQRLNIMIDVASALEY 639
           +           +E +  LVL+Y+P     + ++   +  +L +      M  +  +L Y
Sbjct: 116 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 175
Query: 640 LH-FGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMA 697
           +H FG    + H D+KP N+LLD D  V  L DFG AK L   + +++    + +  Y A
Sbjct: 176 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRA 228
Query: 698 PE--YGREGQVSTNGDVYSFGIMLME 721
           PE  +G     S+  DV+S G +L E
Sbjct: 229 PELIFGATDYTSSI-DVWSAGCVLAE 253

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 85/169 (50%), Gaps = 7/169 (4%)
Query: 572 VECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMI 631
            E  +M+ + +  +V++I  C  E +  LV+E    G L KYL  + +  D    + ++ 
Sbjct: 61  AEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVH 118
Query: 632 DVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG-EDQSMTQTQTL 690
            V+  ++YL     +  +H DL   NVLL     A +SDFG++K L   E+    QT   
Sbjct: 119 QVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGK 175
Query: 691 ATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTR-KKPTDELFNGEMT 738
             + + APE     + S+  DV+SFG+++ E F+  +KP   +   E+T
Sbjct: 176 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 224

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 108/206 (52%), Gaps = 25/206 (12%)
Query: 529 FSENNLIGRGGFGSVYKARIRDGME-VAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVK 587
           +++  +IG G FG VY+A++ D  E VA+K   LQ  R FK+ +++  +M+ + H N+V+
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FKNRELQ--IMRKLDHCNIVR 113
Query: 588 VI------SSCSNEEFKALVLEYMPHG--SLEKYLHSSNYSLDIFQRLNIMIDVASALEY 639
           +           +E +  LVL+Y+P     + ++   +  +L +      M  +  +L Y
Sbjct: 114 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 173
Query: 640 LH-FGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMA 697
           +H FG    + H D+KP N+LLD D  V  L DFG AK L   + +++    + +  Y A
Sbjct: 174 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRA 226
Query: 698 PE--YGREGQVSTNGDVYSFGIMLME 721
           PE  +G     S+  DV+S G +L E
Sbjct: 227 PELIFGATDYTSSI-DVWSAGCVLAE 251

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 108/206 (52%), Gaps = 25/206 (12%)
Query: 529 FSENNLIGRGGFGSVYKARIRDGME-VAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVK 587
           +++  +IG G FG VY+A++ D  E VA+K   LQ  R FK+ +++  +M+ + H N+V+
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FKNRELQ--IMRKLDHCNIVR 111
Query: 588 VI------SSCSNEEFKALVLEYMPHG--SLEKYLHSSNYSLDIFQRLNIMIDVASALEY 639
           +           +E +  LVL+Y+P     + ++   +  +L +      M  +  +L Y
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 171
Query: 640 LH-FGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMA 697
           +H FG    + H D+KP N+LLD D  V  L DFG AK L   + +++    + +  Y A
Sbjct: 172 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRA 224
Query: 698 PE--YGREGQVSTNGDVYSFGIMLME 721
           PE  +G     S+  DV+S G +L E
Sbjct: 225 PELIFGATDYTSSI-DVWSAGCVLAE 249

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 20/208 (9%)
Query: 533 NLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDV------ECAMMKSIRHRNL 585
           + +G G FG V   +    G +VAVK+ N Q     +S DV      E   +K  RH ++
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQ---KIRSLDVVGKIRREIQNLKLFRHPHI 78
Query: 586 VKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYS 645
           +K+    S      +V+EY+  G L  Y+   N  LD  +   +   + S ++Y H    
Sbjct: 79  IKLYQVISTPSDIFMVMEYVSGGELFDYI-CKNGRLDEKESRRLFQQILSGVDYCH---R 134
Query: 646 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY--GRE 703
             V+H DLKP NVLLD +M A ++DFG++ +++  D    +  +  +  Y APE   GR 
Sbjct: 135 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS--DGEFLRX-SCGSPNYAAPEVISGR- 190
Query: 704 GQVSTNGDVYSFGIMLMETFTRKKPTDE 731
                  D++S G++L        P D+
Sbjct: 191 LYAGPEVDIWSSGVILYALLCGTLPFDD 218

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 12/208 (5%)
Query: 525 ATDKFSENNLIGRGGFGSVYKARIRDGMEV-AVKV-FNLQCGRAFKSFDV--ECAMMKSI 580
           A + F     +G+G FG+VY AR +    + A+KV F  Q  +A     +  E  +   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYC 124
Query: 641 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
           H   S  VIH D+KP N+LL       ++DFG     +    S  +T    T+ Y+ PE 
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTXLCGTLDYLPPEM 177
Query: 701 GREGQVSTNGDVYSFGIMLMETFTRKKP 728
                     D++S G++  E    K P
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 108/206 (52%), Gaps = 25/206 (12%)
Query: 529 FSENNLIGRGGFGSVYKARIRDGME-VAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVK 587
           +++  +IG G FG VY+A++ D  E VA+K   LQ  R FK+ +++  +M+ + H N+V+
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FKNRELQ--IMRKLDHCNIVR 156
Query: 588 VI------SSCSNEEFKALVLEYMPHG--SLEKYLHSSNYSLDIFQRLNIMIDVASALEY 639
           +           +E +  LVL+Y+P     + ++   +  +L +      M  +  +L Y
Sbjct: 157 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 216
Query: 640 LH-FGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMA 697
           +H FG    + H D+KP N+LLD D  V  L DFG AK L   + +++    + +  Y A
Sbjct: 217 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRA 269
Query: 698 PE--YGREGQVSTNGDVYSFGIMLME 721
           PE  +G     S+  DV+S G +L E
Sbjct: 270 PELIFGATDYTSSI-DVWSAGCVLAE 294

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 12/208 (5%)
Query: 525 ATDKFSENNLIGRGGFGSVYKARIRDGMEV-AVKV-FNLQCGRAFKSFDV--ECAMMKSI 580
           A + F     +G+G FG+VY AR +    + A+KV F  Q  +A     +  E  +   +
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYC 123
Query: 641 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
           H   S  VIH D+KP N+LL       ++DFG     +    S  +T    T+ Y+ PE 
Sbjct: 124 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEM 176
Query: 701 GREGQVSTNGDVYSFGIMLMETFTRKKP 728
                     D++S G++  E    K P
Sbjct: 177 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 204

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 107/205 (52%), Gaps = 23/205 (11%)
Query: 529 FSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKV 588
           +++  +IG G FG VY+A++ D  E+      LQ  R FK+ +++  +M+ + H N+V++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-FKNRELQ--IMRKLDHCNIVRL 78
Query: 589 ----ISSCSNEE--FKALVLEYMPHG--SLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
                SS   ++  +  LVL+Y+P     + ++   +  +L +      M  +  +L Y+
Sbjct: 79  RYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 641 H-FGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 698
           H FG    + H D+KP N+LLD D  V  L DFG AK L   + +++    + +  Y AP
Sbjct: 139 HSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRAP 191
Query: 699 E--YGREGQVSTNGDVYSFGIMLME 721
           E  +G     S+  DV+S G +L E
Sbjct: 192 ELIFGATDYTSSI-DVWSAGCVLAE 215

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 77/299 (25%), Positives = 134/299 (44%), Gaps = 36/299 (12%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVF-NLQCGRAFKSFDVECAMMKSIRHRNLVKVISS-- 591
           IG+G +G V+  + R G +VAVKVF   +    F+  ++   ++  +RH N++  I++  
Sbjct: 45  IGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRETEIYQTVL--MRHENILGFIAADI 101
Query: 592 --CSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF----GYS 645
               +     L+ +Y  +GSL  YL S+  +LD    L +     S L +LH        
Sbjct: 102 KGTGSWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQG 159
Query: 646 APVI-HCDLKPSNVLLDDNMVAHLSDFGIA-KLLTGEDQ-SMTQTQTLATIGYMAPEYGR 702
            P I H DLK  N+L+  N    ++D G+A K ++  ++  +     + T  YM PE   
Sbjct: 160 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLD 219
Query: 703 EG------QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWV--NDCLPI----- 749
           E       Q     D+YSFG++L E   R        +G +  ++ +  +D +P      
Sbjct: 220 ESLNRNHFQSYIMADMYSFGLILWEVARR------CVSGGIVEEYQLPYHDLVPSDPSYE 273
Query: 750 STMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDS 808
              E+V    L     +  + ++C+  +  L  EC   +P  R+ A  +   L K+ +S
Sbjct: 274 DMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 85/169 (50%), Gaps = 7/169 (4%)
Query: 572 VECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMI 631
            E  +M+ + +  +V++I  C  E +  LV+E    G L KYL  + +  D    + ++ 
Sbjct: 61  AEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVH 118
Query: 632 DVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG-EDQSMTQTQTL 690
            V+  ++YL     +  +H DL   NVLL     A +SDFG++K L   E+    QT   
Sbjct: 119 QVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 175
Query: 691 ATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTR-KKPTDELFNGEMT 738
             + + APE     + S+  DV+SFG+++ E F+  +KP   +   E+T
Sbjct: 176 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 224

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 20/209 (9%)
Query: 532 NNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDV------ECAMMKSIRHRN 584
            + +G G FG V     +  G +VAVK+ N Q     +S DV      E   +K  RH +
Sbjct: 16  GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQ---KIRSLDVVGKIKREIQNLKLFRHPH 72
Query: 585 LVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGY 644
           ++K+    S      +V+EY+  G L  Y+   +  ++  +   +   + SA++Y H   
Sbjct: 73  IIKLYQVISTPTDFFMVMEYVSGGELFDYI-CKHGRVEEMEARRLFQQILSAVDYCH--- 128
Query: 645 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY--GR 702
              V+H DLKP NVLLD +M A ++DFG++ +++  D    +T +  +  Y APE   GR
Sbjct: 129 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS--DGEFLRT-SCGSPNYAAPEVISGR 185
Query: 703 EGQVSTNGDVYSFGIMLMETFTRKKPTDE 731
                   D++S G++L        P D+
Sbjct: 186 L-YAGPEVDIWSCGVILYALLCGTLPFDD 213

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 85/169 (50%), Gaps = 7/169 (4%)
Query: 572 VECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMI 631
            E  +M+ + +  +V++I  C  E +  LV+E    G L KYL  + +  D    + ++ 
Sbjct: 75  AEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVH 132
Query: 632 DVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG-EDQSMTQTQTL 690
            V+  ++YL     +  +H DL   NVLL     A +SDFG++K L   E+    QT   
Sbjct: 133 QVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 189
Query: 691 ATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTR-KKPTDELFNGEMT 738
             + + APE     + S+  DV+SFG+++ E F+  +KP   +   E+T
Sbjct: 190 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 238

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 17/207 (8%)
Query: 523 FQAT--DKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRA-FKSFDVECAMMK 578
           FQ T  D F     +G G FG V+    R  G+E  +K  N    +   +  + E  ++K
Sbjct: 16  FQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLK 75
Query: 579 SIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNY---SLDIFQRLNIMIDVAS 635
           S+ H N++K+     +     +V+E    G L + + S+     +L       +M  + +
Sbjct: 76  SLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMN 135
Query: 636 ALEYLHFGYSAPVIHCDLKPSNVLLDD---NMVAHLSDFGIAKLLTGEDQSMTQTQTLAT 692
           AL Y H   S  V+H DLKP N+L  D   +    + DFG+A+L   ++ S   T    T
Sbjct: 136 ALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS---TNAAGT 189
Query: 693 IGYMAPEYGREGQVSTNGDVYSFGIML 719
             YMAPE  +   V+   D++S G+++
Sbjct: 190 ALYMAPEVFKR-DVTFKCDIWSAGVVM 215

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 85/169 (50%), Gaps = 7/169 (4%)
Query: 572 VECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMI 631
            E  +M+ + +  +V++I  C  E +  LV+E    G L KYL  + +  D    + ++ 
Sbjct: 67  AEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVH 124
Query: 632 DVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG-EDQSMTQTQTL 690
            V+  ++YL     +  +H DL   NVLL     A +SDFG++K L   E+    QT   
Sbjct: 125 QVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 181
Query: 691 ATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTR-KKPTDELFNGEMT 738
             + + APE     + S+  DV+SFG+++ E F+  +KP   +   E+T
Sbjct: 182 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 230

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 85/169 (50%), Gaps = 7/169 (4%)
Query: 572 VECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMI 631
            E  +M+ + +  +V++I  C  E +  LV+E    G L KYL  + +  D    + ++ 
Sbjct: 419 AEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVH 476
Query: 632 DVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG-EDQSMTQTQTL 690
            V+  ++YL     +  +H DL   NVLL     A +SDFG++K L   E+    QT   
Sbjct: 477 QVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 533
Query: 691 ATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTR-KKPTDELFNGEMT 738
             + + APE     + S+  DV+SFG+++ E F+  +KP   +   E+T
Sbjct: 534 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 582

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 85/169 (50%), Gaps = 7/169 (4%)
Query: 572 VECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMI 631
            E  +M+ + +  +V++I  C  E +  LV+E    G L KYL  + +  D    + ++ 
Sbjct: 420 AEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVH 477
Query: 632 DVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG-EDQSMTQTQTL 690
            V+  ++YL     +  +H DL   NVLL     A +SDFG++K L   E+    QT   
Sbjct: 478 QVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 534
Query: 691 ATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTR-KKPTDELFNGEMT 738
             + + APE     + S+  DV+SFG+++ E F+  +KP   +   E+T
Sbjct: 535 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 583

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 95/208 (45%), Gaps = 12/208 (5%)
Query: 525 ATDKFSENNLIGRGGFGSVYKARIRDGMEV-AVKV-FNLQCGRAFKSFDV--ECAMMKSI 580
           A + F     +G+G FG+VY AR +    + A+KV F  Q  +A     +  E  +   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYC 127
Query: 641 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
           H   S  VIH D+KP N+LL       ++DFG     +    S  +     T+ Y+ PE 
Sbjct: 128 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRDDLCGTLDYLPPEM 180
Query: 701 GREGQVSTNGDVYSFGIMLMETFTRKKP 728
                     D++S G++  E    K P
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 85/169 (50%), Gaps = 7/169 (4%)
Query: 572 VECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMI 631
            E  +M+ + +  +V++I  C  E +  LV+E    G L KYL  + +  D    + ++ 
Sbjct: 77  AEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVH 134
Query: 632 DVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG-EDQSMTQTQTL 690
            V+  ++YL     +  +H DL   NVLL     A +SDFG++K L   E+    QT   
Sbjct: 135 QVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 191
Query: 691 ATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTR-KKPTDELFNGEMT 738
             + + APE     + S+  DV+SFG+++ E F+  +KP   +   E+T
Sbjct: 192 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 240

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 85/169 (50%), Gaps = 7/169 (4%)
Query: 572 VECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMI 631
            E  +M+ + +  +V++I  C  E +  LV+E    G L KYL  + +  D    + ++ 
Sbjct: 77  AEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVH 134
Query: 632 DVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG-EDQSMTQTQTL 690
            V+  ++YL     +  +H DL   NVLL     A +SDFG++K L   E+    QT   
Sbjct: 135 QVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 191
Query: 691 ATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTR-KKPTDELFNGEMT 738
             + + APE     + S+  DV+SFG+++ E F+  +KP   +   E+T
Sbjct: 192 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 240

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 12/208 (5%)
Query: 525 ATDKFSENNLIGRGGFGSVYKARIRD-GMEVAVKV-FNLQCGRAFKSFDV--ECAMMKSI 580
           A + F     +G+G FG+VY AR +     +A+KV F  Q  +A     +  E  +   +
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYC 121
Query: 641 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
           H   S  VIH D+KP N+LL       ++DFG     +    S  +T    T+ Y+ PE 
Sbjct: 122 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEM 174
Query: 701 GREGQVSTNGDVYSFGIMLMETFTRKKP 728
                     D++S G++  E    K P
Sbjct: 175 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 202

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 12/208 (5%)
Query: 525 ATDKFSENNLIGRGGFGSVYKARIRDGMEV-AVKV-FNLQCGRAFKSFDV--ECAMMKSI 580
           A + F     +G+G FG+VY AR +    + A+KV F  Q  +A     +  E  +   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYC 127
Query: 641 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
           H   S  VIH D+KP N+LL       +++FG     +    S  +T    T+ Y+ PE 
Sbjct: 128 H---SKRVIHRDIKPENLLLGSAGELKIANFG----WSVHAPSSRRTTLCGTLDYLPPEM 180
Query: 701 GREGQVSTNGDVYSFGIMLMETFTRKKP 728
                     D++S G++  E    K P
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/278 (24%), Positives = 117/278 (42%), Gaps = 33/278 (11%)
Query: 535 IGRGGFGSV----YKARIRDGMEVAVKVF-NLQCGRAFKSFDVECAMMKSIRHRNLVKVI 589
           IG G FG V    Y +     M VA+K   N       + F  E   M+   H ++VK+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 590 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVI 649
              + E    +++E    G L  +L    YSLD+   +     +++AL YL    S   +
Sbjct: 78  GVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 133
Query: 650 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQ-TQTLATIGYMAPEYGREGQVST 708
           H D+   NVL+  N    L DFG+++ +  ED +  + ++    I +MAPE     + ++
Sbjct: 134 HRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAPESINFRRFTS 191
Query: 709 NGDVYSFGIMLMETFTRK-KPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHF 767
             DV+ FG+ + E      KP   + N ++  +    + LP+                  
Sbjct: 192 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP---------------- 235
Query: 768 VAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKI 805
                C   +++L  +C    P +R    E+ A+L  I
Sbjct: 236 ----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 269

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 100/208 (48%), Gaps = 17/208 (8%)
Query: 522 LFQATDKFSEN----NLIGRGGFGSVYKARIRD-GMEVAVKVFNLQ--CGRAFKSFDVEC 574
           +  A+ KFS+N      +G+G F  V +   +  G+E A K+ N +    R F+  + E 
Sbjct: 20  MMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREA 79
Query: 575 AMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVA 634
            + + ++H N+V++  S   E F  LV + +  G L + +     + + +   +    + 
Sbjct: 80  RICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI----VAREFYSEADASHCIQ 135
Query: 635 SALEYLHFGYSAPVIHCDLKPSNVLLDDN---MVAHLSDFGIAKLLTGEDQSMTQTQTLA 691
             LE + + +S  ++H +LKP N+LL          L+DFG+A  +   + S        
Sbjct: 136 QILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV---NDSEAWHGFAG 192
Query: 692 TIGYMAPEYGREGQVSTNGDVYSFGIML 719
           T GY++PE  ++   S   D+++ G++L
Sbjct: 193 TPGYLSPEVLKKDPYSKPVDIWACGVIL 220

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 91/198 (45%), Gaps = 13/198 (6%)
Query: 535 IGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDV---ECAMMKSIRHRNLVKVIS 590
           +G G FG V+  R R +G   A+KV   +     K  +    E  M+  + H  ++++  
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73
Query: 591 SCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIH 650
           +  + +   ++++Y+  G L   L  S    +   +     +V  ALEYLH   S  +I+
Sbjct: 74  TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKF-YAAEVCLALEYLH---SKDIIY 129
Query: 651 CDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNG 710
            DLKP N+LLD N    ++DFG AK +      +       T  Y+APE       + + 
Sbjct: 130 RDLKPENILLDKNGHIKITDFGFAKYVPDVTYXLC-----GTPDYIAPEVVSTKPYNKSI 184
Query: 711 DVYSFGIMLMETFTRKKP 728
           D +SFGI++ E      P
Sbjct: 185 DWWSFGILIYEMLAGYTP 202

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 95/208 (45%), Gaps = 12/208 (5%)
Query: 525 ATDKFSENNLIGRGGFGSVYKARIRDGMEV-AVKV-FNLQCGRAFKSFDV--ECAMMKSI 580
           A + F     +G+G FG+VY AR +    + A+KV F  Q  +A     +  E  +   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYC 127
Query: 641 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
           H   S  VIH D+KP N+LL       ++DFG     +    S  +     T+ Y+ PE 
Sbjct: 128 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGTLDYLPPEM 180
Query: 701 GREGQVSTNGDVYSFGIMLMETFTRKKP 728
                     D++S G++  E    K P
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 98/213 (46%), Gaps = 19/213 (8%)
Query: 523 FQATDKFSENNLIGRGGFG-SVYKARIRDGMEVAVKVFNLQ--CGRAFKSFDVECAMMKS 579
           FQ+ +K+     IG G FG ++      DG +  +K  N+     +  +    E A++ +
Sbjct: 20  FQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLAN 79
Query: 580 IRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQR---LNIMIDVASA 636
           ++H N+V+   S        +V++Y   G L K +++    L  FQ    L+  + +  A
Sbjct: 80  MKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVL--FQEDQILDWFVQICLA 137
Query: 637 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIG-- 694
           L+++H      ++H D+K  N+ L  +    L DFGIA++L       T     A IG  
Sbjct: 138 LKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS-----TVELARACIGTP 189
Query: 695 -YMAPEYGREGQVSTNGDVYSFGIMLMETFTRK 726
            Y++PE       +   D+++ G +L E  T K
Sbjct: 190 YYLSPEICENKPYNNKSDIWALGCVLYELCTLK 222

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 95/208 (45%), Gaps = 12/208 (5%)
Query: 525 ATDKFSENNLIGRGGFGSVYKARIRDGMEV-AVKV-FNLQCGRAFKSFDV--ECAMMKSI 580
           A + F     +G+G FG+VY AR +    + A+KV F  Q  +A     +  E  +   +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYC 126
Query: 641 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
           H   S  VIH D+KP N+LL       ++DFG     +    S  +     T+ Y+ PE 
Sbjct: 127 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLPPEM 179
Query: 701 GREGQVSTNGDVYSFGIMLMETFTRKKP 728
                     D++S G++  E    K P
Sbjct: 180 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 207

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 95/208 (45%), Gaps = 12/208 (5%)
Query: 525 ATDKFSENNLIGRGGFGSVYKARIRDGMEV-AVKV-FNLQCGRAFKSFDV--ECAMMKSI 580
           A + F     +G+G FG+VY AR +    + A+KV F  Q  +A     +  E  +   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYC 127
Query: 641 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
           H   S  VIH D+KP N+LL       ++DFG     +    S  +     T+ Y+ PE 
Sbjct: 128 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLPPEM 180
Query: 701 GREGQVSTNGDVYSFGIMLMETFTRKKP 728
                     D++S G++  E    K P
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 104/212 (49%), Gaps = 13/212 (6%)
Query: 528 KFSENNLIGRGGFGSVYKARIRDGME-VAVKVFNLQCGR--AFKSFDVECAMMKSIRHRN 584
           K+ +   IG G +G+V+KA+ R+  E VA+K   L         S   E  ++K ++H+N
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 585 LVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGY 644
           +V++     +++   LV E+     L+KY  S N  LD     + +  +   L + H   
Sbjct: 63  IVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH--- 118
Query: 645 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG 704
           S  V+H DLKP N+L++ N    L+DFG+A+      +    +  + T+ Y  P+     
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCY--SAEVVTLWYRPPDVLFGA 176
Query: 705 QV-STNGDVYSFGIMLMETFTRKKPTDELFNG 735
           ++ ST+ D++S G +  E     +P   LF G
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAARP---LFPG 205

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 101/210 (48%), Gaps = 12/210 (5%)
Query: 535 IGRGGFGSV----YKARIRDGMEVAVKVFNLQCGRA-FKSFDVECAMMKSIRHRNLVKVI 589
           +G G FGSV    Y+ R +  ++VA+KV      +A  +    E  +M  + +  +V++I
Sbjct: 18  LGCGNFGSVRQGVYRMR-KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 590 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVI 649
             C  E    LV+E    G L K+L      + +     ++  V+  ++YL        +
Sbjct: 77  GVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFV 132
Query: 650 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMT-QTQTLATIGYMAPEYGREGQVST 708
           H DL   NVLL +   A +SDFG++K L  +D   T ++     + + APE     + S+
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 192
Query: 709 NGDVYSFGIMLMETFTR-KKPTDELFNGEM 737
             DV+S+G+ + E  +  +KP  ++   E+
Sbjct: 193 RSDVWSYGVTMWEALSYGQKPYKKMKGPEV 222

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Composition-based stats.
 Identities = 50/168 (29%), Positives = 85/168 (50%), Gaps = 7/168 (4%)
Query: 573 ECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMID 632
           E  +M+ + +  +V++I  C  E +  LV+E    G L KYL  + +  D    + ++  
Sbjct: 56  EANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQ 113
Query: 633 VASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG-EDQSMTQTQTLA 691
           V+  ++YL     +  +H DL   NVLL     A +SDFG++K L   E+    QT    
Sbjct: 114 VSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 170
Query: 692 TIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTR-KKPTDELFNGEMT 738
            + + APE     + S+  DV+SFG+++ E F+  +KP   +   E+T
Sbjct: 171 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 218

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Composition-based stats.
 Identities = 50/168 (29%), Positives = 85/168 (50%), Gaps = 7/168 (4%)
Query: 573 ECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMID 632
           E  +M+ + +  +V++I  C  E +  LV+E    G L KYL  + +  D    + ++  
Sbjct: 58  EANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQ 115
Query: 633 VASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG-EDQSMTQTQTLA 691
           V+  ++YL     +  +H DL   NVLL     A +SDFG++K L   E+    QT    
Sbjct: 116 VSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 172
Query: 692 TIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTR-KKPTDELFNGEMT 738
            + + APE     + S+  DV+SFG+++ E F+  +KP   +   E+T
Sbjct: 173 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 220

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 100/225 (44%), Gaps = 31/225 (13%)
Query: 528 KFSENNL-----IGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDVECAMMKSIR 581
           +F  NNL     +G G FG V +A     G E AV    ++  ++    D + A+M  ++
Sbjct: 42  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 582 -------HRNLVKVISSCSNEEFKALVLEYMPHGSLEKYL---------------HSSNY 619
                  H N+V ++ +C++     ++ EY  +G L  +L               H+   
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEE 161
Query: 620 SLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG 679
            L     L+    VA  + +L    S   IH D+   NVLL +  VA + DFG+A+ +  
Sbjct: 162 QLSSRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN 218
Query: 680 EDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 724
           +   + +      + +MAPE   +   +   DV+S+GI+L E F+
Sbjct: 219 DSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 106/221 (47%), Gaps = 19/221 (8%)
Query: 520 LELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC-GRAFKSFDV-ECAM 576
           +E FQ  +K      IG G +G VYKAR +  G  VA+K   L        S  + E ++
Sbjct: 5   MENFQKVEK------IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL 58
Query: 577 MKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASA 636
           +K + H N+VK++     E    LV E++    L+ ++ +S  +L       I   +   
Sbjct: 59  LKELNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDAS--ALTGIPLPLIKSYLFQL 115
Query: 637 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYM 696
           L+ L F +S  V+H DLKP N+L++      L+DFG+A+      +  T    + T+ Y 
Sbjct: 116 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYR 173
Query: 697 APEYGREGQ-VSTNGDVYSFGIMLMETFTRKKPTDELFNGE 736
           APE     +  ST  D++S G +  E  TR+     LF G+
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGD 210

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 95/208 (45%), Gaps = 12/208 (5%)
Query: 525 ATDKFSENNLIGRGGFGSVYKARIRDGMEV-AVKV-FNLQCGRAFKSFDV--ECAMMKSI 580
           A + F     +G+G FG+VY AR +    + A+KV F  Q  +A     +  E  +   +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYC 150
Query: 641 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
           H   S  VIH D+KP N+LL       ++DFG     +    S  +     T+ Y+ PE 
Sbjct: 151 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRDDLCGTLDYLPPEM 203
Query: 701 GREGQVSTNGDVYSFGIMLMETFTRKKP 728
                     D++S G++  E    K P
Sbjct: 204 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 231

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 12/208 (5%)
Query: 525 ATDKFSENNLIGRGGFGSVYKARIRDGMEV-AVKV-FNLQCGRAFKSFDV--ECAMMKSI 580
           A + F     +G+G FG+VY AR +    + A+KV F  Q  +A     +  E  +   +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYC 126
Query: 641 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
           H   S  VIH D+KP N+LL       +++FG     +    S  +T    T+ Y+ PE 
Sbjct: 127 H---SKRVIHRDIKPENLLLGSAGELKIANFG----WSVHAPSSRRTTLCGTLDYLPPEM 179
Query: 701 GREGQVSTNGDVYSFGIMLMETFTRKKP 728
                     D++S G++  E    K P
Sbjct: 180 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 207

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/235 (28%), Positives = 104/235 (44%), Gaps = 24/235 (10%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDVECAMMK------S 579
           D F    ++G+G FG V  AR+++ G   AVKV  L+     +  DVEC M +      +
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKV--LKKDVILQDDDVECTMTEKRILSLA 80
Query: 580 IRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEY 639
             H  L ++       +    V+E++  G L  ++  S    +   R     ++ SAL +
Sbjct: 81  RNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-YAAEIISALMF 139
Query: 640 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPE 699
           LH      +I+ DLK  NVLLD      L+DFG+ K   G    +T      T  Y+APE
Sbjct: 140 LH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFCGTPDYIAPE 194
Query: 700 YGREGQVSTNGDVYSFGIMLMETFTRKKP-----TDELF----NGEMTLKHWVND 745
             +E       D ++ G++L E      P      D+LF    N E+    W+++
Sbjct: 195 ILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHE 249

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 94/201 (46%), Gaps = 13/201 (6%)
Query: 535 IGRGGFGSVYKAR-IRDGMEVAVKVFN---LQCGRAFKSFDVECAMMKSIRHRNLVKVIS 590
           IG+G F  V  AR I  G EVAVK+ +   L      K F  E  +MK + H N+VK+  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLFE 80
Query: 591 SCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIH 650
               E+   LV+EY   G +  YL +     +   R      + SA++Y H  +   ++H
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF---IVH 136
Query: 651 CDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPE-YGREGQVSTN 709
            DLK  N+LLD +M   ++DFG +   T  ++  T      +  Y APE +  +      
Sbjct: 137 RDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPELFQGKKYDGPE 193
Query: 710 GDVYSFGIMLMETFTRKKPTD 730
            DV+S G++L    +   P D
Sbjct: 194 VDVWSLGVILYTLVSGSLPFD 214

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 94/201 (46%), Gaps = 13/201 (6%)
Query: 535 IGRGGFGSVYKAR-IRDGMEVAVKVFN---LQCGRAFKSFDVECAMMKSIRHRNLVKVIS 590
           IG+G F  V  AR I  G EVAVK+ +   L      K F  E  +MK + H N+VK+  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLFE 80
Query: 591 SCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIH 650
               E+   LV+EY   G +  YL +     +   R      + SA++Y H  +   ++H
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF---IVH 136
Query: 651 CDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPE-YGREGQVSTN 709
            DLK  N+LLD +M   ++DFG +   T  ++  T      +  Y APE +  +      
Sbjct: 137 RDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPELFQGKKYDGPE 193
Query: 710 GDVYSFGIMLMETFTRKKPTD 730
            DV+S G++L    +   P D
Sbjct: 194 VDVWSLGVILYTLVSGSLPFD 214

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 95/208 (45%), Gaps = 12/208 (5%)
Query: 525 ATDKFSENNLIGRGGFGSVYKARIRDGMEV-AVKV-FNLQCGRAFKSFDV--ECAMMKSI 580
           A + F     +G+G FG+VY AR +    + A+KV F  Q  +A     +  E  +   +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYC 125
Query: 641 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
           H   S  VIH D+KP N+LL       ++DFG     +    S  +     T+ Y+ PE 
Sbjct: 126 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRDTLCGTLDYLPPEM 178
Query: 701 GREGQVSTNGDVYSFGIMLMETFTRKKP 728
                     D++S G++  E    K P
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 86/308 (27%), Positives = 136/308 (44%), Gaps = 54/308 (17%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSI--RHRNLVKVISSC 592
           +G+G +G V++  +  G  VAVK+F+    R  +S+  E  +  ++  RH N++  I+S 
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFS---SRDEQSWFRETEIYNTVLLRHDNILGFIASD 71
Query: 593 SNEEFKA----LVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLH---FGYS 645
                 +    L+  Y  HGSL  +L     +L+    L + +  A  L +LH   FG  
Sbjct: 72  MTSRNSSTQLWLITHYHEHGSLYDFLQRQ--TLEPHLALRLAVSAACGLAHLHVEIFGTQ 129
Query: 646 A-PVI-HCDLKPSNVLLDDNMVAHLSDFGIAKLLT-GEDQ-SMTQTQTLATIGYMAPEYG 701
             P I H D K  NVL+  N+   ++D G+A + + G D   +     + T  YMAPE  
Sbjct: 130 GKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPEVL 189
Query: 702 REGQVSTN-------GDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEV 754
            E Q+ T+        D+++FG++L E   R      + NG       V D  P    +V
Sbjct: 190 DE-QIRTDCFESYKWTDIWAFGLVLWEIARRT-----IVNGI------VEDYRP-PFYDV 236
Query: 755 VDANLLSQEDIHFV--------------AKEQCVSFVFNLALECTVESPEQRINAKEIVA 800
           V  N  S ED+  V              A +  +S +  +  EC   +P  R+ A  I  
Sbjct: 237 V-PNDPSFEDMKKVVCVDQQTPTIPNRLAADPVLSGLAQMMRECWYPNPSARLTALRIKK 295
Query: 801 KLLKIRDS 808
            L KI +S
Sbjct: 296 TLQKISNS 303

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 93/200 (46%), Gaps = 11/200 (5%)
Query: 535 IGRGGFGSVYKAR-IRDGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISS 591
           IG+G F  V  AR +  G EVAVK+ +       + +    E  +MK + H N+VK+   
Sbjct: 23  IGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 592 CSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHC 651
              E+   LV+EY   G +  YL +     +   R      + SA++Y H  Y   ++H 
Sbjct: 83  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKY---IVHR 138
Query: 652 DLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPE-YGREGQVSTNG 710
           DLK  N+LLD +M   ++DFG +   T  ++  T      +  Y APE +  +       
Sbjct: 139 DLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDT---FCGSPPYAAPELFQGKKYDGPEV 195
Query: 711 DVYSFGIMLMETFTRKKPTD 730
           DV+S G++L    +   P D
Sbjct: 196 DVWSLGVILYTLVSGSLPFD 215

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 99/224 (44%), Gaps = 32/224 (14%)
Query: 525 ATDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRH- 582
           A+D F E  ++G+G FG V KAR   D    A+K           +   E  ++ S+ H 
Sbjct: 5   ASD-FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQ 62
Query: 583 ------------RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIM 630
                       RN VK +++   +    + +EY  + +L   +HS N +    +   + 
Sbjct: 63  YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLF 122
Query: 631 IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK-------LLTGEDQS 683
             +  AL Y+H   S  +IH DLKP N+ +D++    + DFG+AK       +L  + Q+
Sbjct: 123 RQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 684 M-----TQTQTLATIGYMAPEY-GREGQVSTNGDVYSFGIMLME 721
           +       T  + T  Y+A E     G  +   D+YS GI+  E
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE 223

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 99/202 (49%), Gaps = 13/202 (6%)
Query: 535 IGRGGFGSVYKA-RIRDGMEVAVKVFN---LQCGRAFKSFDVECAMMKSIRHRNLVKVIS 590
           +G G FG V  A     G +VA+K+ N   L         + E + ++ +RH +++K+  
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 75
Query: 591 SCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIH 650
              +++   +V+EY  +   +  +     S    +R      + SA+EY H      ++H
Sbjct: 76  VIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRF--FQQIISAVEYCH---RHKIVH 130
Query: 651 CDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY-GREGQVSTN 709
            DLKP N+LLD+++   ++DFG++ ++T  D +  +T +  +  Y APE    +      
Sbjct: 131 RDLKPENLLLDEHLNVKIADFGLSNIMT--DGNFLKT-SCGSPNYAAPEVISGKLYAGPE 187
Query: 710 GDVYSFGIMLMETFTRKKPTDE 731
            DV+S G++L     R+ P D+
Sbjct: 188 VDVWSCGVILYVMLCRRLPFDD 209

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 106/221 (47%), Gaps = 19/221 (8%)
Query: 520 LELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC-GRAFKSFDV-ECAM 576
           +E FQ  +K      IG G +G VYKAR +  G  VA+K   L        S  + E ++
Sbjct: 4   MENFQKVEK------IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL 57
Query: 577 MKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASA 636
           +K + H N+VK++     E    LV E++    L+ ++ +S  +L       I   +   
Sbjct: 58  LKELNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDAS--ALTGIPLPLIKSYLFQL 114
Query: 637 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYM 696
           L+ L F +S  V+H DLKP N+L++      L+DFG+A+      +  T    + T+ Y 
Sbjct: 115 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYR 172
Query: 697 APEYGREGQ-VSTNGDVYSFGIMLMETFTRKKPTDELFNGE 736
           APE     +  ST  D++S G +  E  TR+     LF G+
Sbjct: 173 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGD 209

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 99/202 (49%), Gaps = 13/202 (6%)
Query: 535 IGRGGFGSVYKA-RIRDGMEVAVKVFN---LQCGRAFKSFDVECAMMKSIRHRNLVKVIS 590
           +G G FG V  A     G +VA+K+ N   L         + E + ++ +RH +++K+  
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 80
Query: 591 SCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIH 650
              +++   +V+EY  +   +  +     S    +R      + SA+EY H      ++H
Sbjct: 81  VIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRF--FQQIISAVEYCH---RHKIVH 135
Query: 651 CDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY-GREGQVSTN 709
            DLKP N+LLD+++   ++DFG++ ++T  D +  +T +  +  Y APE    +      
Sbjct: 136 RDLKPENLLLDEHLNVKIADFGLSNIMT--DGNFLKT-SCGSPNYAAPEVISGKLYAGPE 192
Query: 710 GDVYSFGIMLMETFTRKKPTDE 731
            DV+S G++L     R+ P D+
Sbjct: 193 VDVWSCGVILYVMLCRRLPFDD 214

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Composition-based stats.
 Identities = 56/198 (28%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 535 IGRGGFGSVYKARIRDGMEV-AVKV-FNLQCGRAFKSFDV--ECAMMKSIRHRNLVKVIS 590
           +G+G FG+VY AR R    + A+KV F  Q  +A     +  E  +   +RH N++++  
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 591 SCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIH 650
              +     L+LEY P G++ + L   +   D  +    + ++A+AL Y H   S  VIH
Sbjct: 80  YFHDATRVYLILEYAPLGTVYRELQKLS-RFDEQRTATYITELANALSYCH---SKRVIH 135
Query: 651 CDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNG 710
            D+KP N+LL  N    ++DFG     +    S  +     T+ Y+ PE           
Sbjct: 136 RDIKPENLLLGSNGELKIADFG----WSVHAPSSRRDTLCGTLDYLPPEMIEGRMHDEKV 191
Query: 711 DVYSFGIMLMETFTRKKP 728
           D++S G++  E      P
Sbjct: 192 DLWSLGVLCYEFLVGMPP 209

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 99/202 (49%), Gaps = 13/202 (6%)
Query: 535 IGRGGFGSVYKA-RIRDGMEVAVKVFN---LQCGRAFKSFDVECAMMKSIRHRNLVKVIS 590
           +G G FG V  A     G +VA+K+ N   L         + E + ++ +RH +++K+  
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 71
Query: 591 SCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIH 650
              +++   +V+EY  +   +  +     S    +R      + SA+EY H      ++H
Sbjct: 72  VIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRF--FQQIISAVEYCH---RHKIVH 126
Query: 651 CDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY-GREGQVSTN 709
            DLKP N+LLD+++   ++DFG++ ++T  D +  +T +  +  Y APE    +      
Sbjct: 127 RDLKPENLLLDEHLNVKIADFGLSNIMT--DGNFLKT-SCGSPNYAAPEVISGKLYAGPE 183
Query: 710 GDVYSFGIMLMETFTRKKPTDE 731
            DV+S G++L     R+ P D+
Sbjct: 184 VDVWSCGVILYVMLCRRLPFDD 205

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 99/202 (49%), Gaps = 13/202 (6%)
Query: 535 IGRGGFGSVYKA-RIRDGMEVAVKVFN---LQCGRAFKSFDVECAMMKSIRHRNLVKVIS 590
           +G G FG V  A     G +VA+K+ N   L         + E + ++ +RH +++K+  
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 81
Query: 591 SCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIH 650
              +++   +V+EY  +   +  +     S    +R      + SA+EY H      ++H
Sbjct: 82  VIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRF--FQQIISAVEYCH---RHKIVH 136
Query: 651 CDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY-GREGQVSTN 709
            DLKP N+LLD+++   ++DFG++ ++T  D +  +T +  +  Y APE    +      
Sbjct: 137 RDLKPENLLLDEHLNVKIADFGLSNIMT--DGNFLKT-SCGSPNYAAPEVISGKLYAGPE 193
Query: 710 GDVYSFGIMLMETFTRKKPTDE 731
            DV+S G++L     R+ P D+
Sbjct: 194 VDVWSCGVILYVMLCRRLPFDD 215

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 90/193 (46%), Gaps = 12/193 (6%)
Query: 535 IGRGGFGSV----YKARIRDGMEVAVKVF-NLQCGRAFKSFDVECAMMKSIRHRNLVKVI 589
           IG G FG V    Y +     M VA+K   N       + F  E   M+   H ++VK+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 590 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVI 649
              + E    +++E    G L  +L    +SLD+   +     +++AL YL    S   +
Sbjct: 78  GVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFV 133
Query: 650 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQ-TQTLATIGYMAPEYGREGQVST 708
           H D+   NVL+  N    L DFG+++ +  ED +  + ++    I +MAPE     + ++
Sbjct: 134 HRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTXXKASKGKLPIKWMAPESINFRRFTS 191
Query: 709 NGDVYSFGIMLME 721
             DV+ FG+ + E
Sbjct: 192 ASDVWMFGVCMWE 204

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 68/278 (24%), Positives = 117/278 (42%), Gaps = 33/278 (11%)
Query: 535 IGRGGFGSV----YKARIRDGMEVAVKVF-NLQCGRAFKSFDVECAMMKSIRHRNLVKVI 589
           IG G FG V    Y +     + VA+K   N       + F  E   M+   H ++VK+I
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 590 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVI 649
              + E    +++E    G L  +L    YSLD+   +     +++AL YL    S   +
Sbjct: 106 GVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 161
Query: 650 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQ-TQTLATIGYMAPEYGREGQVST 708
           H D+   NVL+  N    L DFG+++ +  ED +  + ++    I +MAPE     + ++
Sbjct: 162 HRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAPESINFRRFTS 219
Query: 709 NGDVYSFGIMLMETFTRK-KPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHF 767
             DV+ FG+ + E      KP   + N ++  +    + LP+                  
Sbjct: 220 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP---------------- 263
Query: 768 VAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKI 805
                C   +++L  +C    P +R    E+ A+L  I
Sbjct: 264 ----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 297

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 93/206 (45%), Gaps = 9/206 (4%)
Query: 529 FSENNLIGRGGFGSVYKARIRDGMEV-AVKVFNLQCGRAFKSF-DVECAMMKSIRHRNLV 586
           F++ + IG+G FG VYK       EV A+K+ +L+           E  ++       + 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 587 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSA 646
           +   S        +++EY+  GS    L      L+      I+ ++   L+YLH   S 
Sbjct: 81  RYFGSYLKSTKLWIIMEYLGGGSALDLLKPG--PLEETYIATILREILKGLDYLH---SE 135
Query: 647 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQV 706
             IH D+K +NVLL +     L+DFG+A  LT  D  + +   + T  +MAPE  ++   
Sbjct: 136 RKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNXFVGTPFWMAPEVIKQSAY 193
Query: 707 STNGDVYSFGIMLMETFTRKKPTDEL 732
               D++S GI  +E    + P  +L
Sbjct: 194 DFKADIWSLGITAIELAKGEPPNSDL 219

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Composition-based stats.
 Identities = 57/208 (27%), Positives = 95/208 (45%), Gaps = 12/208 (5%)
Query: 525 ATDKFSENNLIGRGGFGSVYKARIRDGMEV-AVKV-FNLQCGRAFKSFDV--ECAMMKSI 580
           A + F     +G+G FG+VY AR +    + A+KV F  Q  +A     +  E  +   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYC 124
Query: 641 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
           H   S  VIH D+KP N+LL       ++DFG     +    S  +     T+ Y+ PE 
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGTLDYLPPEM 177
Query: 701 GREGQVSTNGDVYSFGIMLMETFTRKKP 728
                     D++S G++  E    K P
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 100/212 (47%), Gaps = 18/212 (8%)
Query: 525 ATDKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDV-ECAMMKSIRH 582
           ++ +F +   +G G + +VYK   +  G+ VA+K   L       S  + E ++MK ++H
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNY-------SLDIFQRLNIMIDVAS 635
            N+V++      E    LV E+M    L+KY+ S           L++ +     +    
Sbjct: 63  ENIVRLYDVIHTENKLTLVFEFM-DNDLKKYMDSRTVGNTPRGLELNLVKYFQWQL---- 117
Query: 636 ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGY 695
            L+ L F +   ++H DLKP N+L++      L DFG+A+       +   +  + T+ Y
Sbjct: 118 -LQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF--SSEVVTLWY 174
Query: 696 MAPEYGREGQV-STNGDVYSFGIMLMETFTRK 726
            AP+     +  ST+ D++S G +L E  T K
Sbjct: 175 RAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Composition-based stats.
 Identities = 57/208 (27%), Positives = 95/208 (45%), Gaps = 12/208 (5%)
Query: 525 ATDKFSENNLIGRGGFGSVYKARIRDGMEV-AVKV-FNLQCGRAFKSFDV--ECAMMKSI 580
           A + F     +G+G FG+VY AR +    + A+KV F  Q  +A     +  E  +   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
           RH N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYC 124
Query: 641 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
           H   S  VIH D+KP N+LL       ++DFG     +    S  +     T+ Y+ PE 
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLPPEM 177
Query: 701 GREGQVSTNGDVYSFGIMLMETFTRKKP 728
                     D++S G++  E    K P
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 68/278 (24%), Positives = 117/278 (42%), Gaps = 33/278 (11%)
Query: 535 IGRGGFGSV----YKARIRDGMEVAVKVF-NLQCGRAFKSFDVECAMMKSIRHRNLVKVI 589
           IG G FG V    Y +     + VA+K   N       + F  E   M+   H ++VK+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 590 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVI 649
              + E    +++E    G L  +L    YSLD+   +     +++AL YL    S   +
Sbjct: 78  GVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 133
Query: 650 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQ-TQTLATIGYMAPEYGREGQVST 708
           H D+   NVL+  N    L DFG+++ +  ED +  + ++    I +MAPE     + ++
Sbjct: 134 HRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAPESINFRRFTS 191
Query: 709 NGDVYSFGIMLMETFTRK-KPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHF 767
             DV+ FG+ + E      KP   + N ++  +    + LP+                  
Sbjct: 192 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP---------------- 235
Query: 768 VAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKI 805
                C   +++L  +C    P +R    E+ A+L  I
Sbjct: 236 ----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 269

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 20/209 (9%)
Query: 532 NNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDV------ECAMMKSIRHRN 584
            + +G G FG V     +  G +VAVK+ N Q     +S DV      E   +K  RH +
Sbjct: 16  GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQ---KIRSLDVVGKIKREIQNLKLFRHPH 72
Query: 585 LVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGY 644
           ++K+    S      +V+EY+  G L  Y+   +  ++  +   +   + SA++Y H   
Sbjct: 73  IIKLYQVISTPTDFFMVMEYVSGGELFDYI-CKHGRVEEMEARRLFQQILSAVDYCH--- 128
Query: 645 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY--GR 702
              V+H DLKP NVLLD +M A ++DFG++ +++  D    +  +  +  Y APE   GR
Sbjct: 129 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS--DGEFLR-DSCGSPNYAAPEVISGR 185
Query: 703 EGQVSTNGDVYSFGIMLMETFTRKKPTDE 731
                   D++S G++L        P D+
Sbjct: 186 L-YAGPEVDIWSCGVILYALLCGTLPFDD 213

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 94/201 (46%), Gaps = 13/201 (6%)
Query: 535 IGRGGFGSVYKAR-IRDGMEVAVKVFN---LQCGRAFKSFDVECAMMKSIRHRNLVKVIS 590
           IG+G F  V  AR I  G EVAV++ +   L      K F  E  +MK + H N+VK+  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLFE 80
Query: 591 SCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIH 650
               E+   LV+EY   G +  YL +     +   R      + SA++Y H  +   ++H
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF---IVH 136
Query: 651 CDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPE-YGREGQVSTN 709
            DLK  N+LLD +M   ++DFG +   T  ++  T      +  Y APE +  +      
Sbjct: 137 RDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPELFQGKKYDGPE 193
Query: 710 GDVYSFGIMLMETFTRKKPTD 730
            DV+S G++L    +   P D
Sbjct: 194 VDVWSLGVILYTLVSGSLPFD 214

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 96/195 (49%), Gaps = 8/195 (4%)
Query: 535 IGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCS 593
           IG G  G V  AR +  G +VAVK+ +L+  +  +    E  +M+  +H N+V++  S  
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 594 NEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 653
             E   +++E++  G+L   +  S   L+  Q   +   V  AL YLH   +  VIH D+
Sbjct: 113 VGEELWVLMEFLQGGALTDIV--SQVRLNEEQIATVCEAVLQALAYLH---AQGVIHRDI 167
Query: 654 KPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVY 713
           K  ++LL  +    LSDFG    ++ +     +   + T  +MAPE       +T  D++
Sbjct: 168 KSDSILLTLDGRVKLSDFGFCAQISKD--VPKRKXLVGTPYWMAPEVISRSLYATEVDIW 225
Query: 714 SFGIMLMETFTRKKP 728
           S GIM++E    + P
Sbjct: 226 SLGIMVIEMVDGEPP 240

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 68/278 (24%), Positives = 117/278 (42%), Gaps = 33/278 (11%)
Query: 535 IGRGGFGSV----YKARIRDGMEVAVKVF-NLQCGRAFKSFDVECAMMKSIRHRNLVKVI 589
           IG G FG V    Y +     + VA+K   N       + F  E   M+   H ++VK+I
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 590 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVI 649
              + E    +++E    G L  +L    YSLD+   +     +++AL YL    S   +
Sbjct: 83  GVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 138
Query: 650 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQ-TQTLATIGYMAPEYGREGQVST 708
           H D+   NVL+  N    L DFG+++ +  ED +  + ++    I +MAPE     + ++
Sbjct: 139 HRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAPESINFRRFTS 196
Query: 709 NGDVYSFGIMLMETFTRK-KPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHF 767
             DV+ FG+ + E      KP   + N ++  +    + LP+                  
Sbjct: 197 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP---------------- 240
Query: 768 VAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKI 805
                C   +++L  +C    P +R    E+ A+L  I
Sbjct: 241 ----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 68/278 (24%), Positives = 117/278 (42%), Gaps = 33/278 (11%)
Query: 535 IGRGGFGSV----YKARIRDGMEVAVKVF-NLQCGRAFKSFDVECAMMKSIRHRNLVKVI 589
           IG G FG V    Y +     + VA+K   N       + F  E   M+   H ++VK+I
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 590 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVI 649
              + E    +++E    G L  +L    YSLD+   +     +++AL YL    S   +
Sbjct: 81  GVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 136
Query: 650 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQ-TQTLATIGYMAPEYGREGQVST 708
           H D+   NVL+  N    L DFG+++ +  ED +  + ++    I +MAPE     + ++
Sbjct: 137 HRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAPESINFRRFTS 194
Query: 709 NGDVYSFGIMLMETFTRK-KPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHF 767
             DV+ FG+ + E      KP   + N ++  +    + LP+                  
Sbjct: 195 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP---------------- 238
Query: 768 VAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKI 805
                C   +++L  +C    P +R    E+ A+L  I
Sbjct: 239 ----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 272

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 94/201 (46%), Gaps = 13/201 (6%)
Query: 535 IGRGGFGSVYKAR-IRDGMEVAVKVFN---LQCGRAFKSFDVECAMMKSIRHRNLVKVIS 590
           IG+G F  V  AR I  G EVAV++ +   L      K F  E  +MK + H N+VK+  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLFE 80
Query: 591 SCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIH 650
               E+   LV+EY   G +  YL +     +   R      + SA++Y H  +   ++H
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF---IVH 136
Query: 651 CDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPE-YGREGQVSTN 709
            DLK  N+LLD +M   ++DFG +   T  ++     +   +  Y APE +  +      
Sbjct: 137 RDLKAENLLLDADMNIKIADFGFSNEFTFGNKL---DEFCGSPPYAAPELFQGKKYDGPE 193
Query: 710 GDVYSFGIMLMETFTRKKPTD 730
            DV+S G++L    +   P D
Sbjct: 194 VDVWSLGVILYTLVSGSLPFD 214

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 90/193 (46%), Gaps = 12/193 (6%)
Query: 535 IGRGGFGSV----YKARIRDGMEVAVKVF-NLQCGRAFKSFDVECAMMKSIRHRNLVKVI 589
           IG G FG V    Y +     + VA+K   N       + F  E   M+   H ++VK+I
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 590 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVI 649
              + E    +++E    G L  +L    YSLD+   +     +++AL YL    S   +
Sbjct: 75  GVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 130
Query: 650 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQ-TQTLATIGYMAPEYGREGQVST 708
           H D+   NVL+  N    L DFG+++ +  ED +  + ++    I +MAPE     + ++
Sbjct: 131 HRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAPESINFRRFTS 188
Query: 709 NGDVYSFGIMLME 721
             DV+ FG+ + E
Sbjct: 189 ASDVWMFGVCMWE 201

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 90/193 (46%), Gaps = 12/193 (6%)
Query: 535 IGRGGFGSV----YKARIRDGMEVAVKVF-NLQCGRAFKSFDVECAMMKSIRHRNLVKVI 589
           IG G FG V    Y +     + VA+K   N       + F  E   M+   H ++VK+I
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 590 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVI 649
              + E    +++E    G L  +L    YSLD+   +     +++AL YL    S   +
Sbjct: 80  GVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 135
Query: 650 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQ-TQTLATIGYMAPEYGREGQVST 708
           H D+   NVL+  N    L DFG+++ +  ED +  + ++    I +MAPE     + ++
Sbjct: 136 HRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAPESINFRRFTS 193
Query: 709 NGDVYSFGIMLME 721
             DV+ FG+ + E
Sbjct: 194 ASDVWMFGVCMWE 206

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 122/268 (45%), Gaps = 28/268 (10%)
Query: 535 IGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCS 593
           IG G  G V  A  +  G +VAVK  +L+  +  +    E  +M+   H N+V + SS  
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYL 112
Query: 594 NEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 653
             +   +V+E++  G+L   +  ++  ++  Q   + + V  AL YLH   +  VIH D+
Sbjct: 113 VGDELWVVMEFLEGGALTDIV--THTRMNEEQIATVCLSVLRALSYLH---NQGVIHRDI 167
Query: 654 KPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVY 713
           K  ++LL  +    LSDFG    ++ E     +   + T  +MAPE        T  D++
Sbjct: 168 KSDSILLTSDGRIKLSDFGFCAQVSKE--VPKRKXLVGTPYWMAPEVISRLPYGTEVDIW 225
Query: 714 SFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ-EDIHFVAKEQ 772
           S GIM++E    + P    FN             P+  M  +  +L  + +D+H V+   
Sbjct: 226 SLGIMVIEMIDGEPP---YFNEP-----------PLQAMRRIRDSLPPRVKDLHKVSS-- 269
Query: 773 CVSFVFNLALECTVESPEQRINAKEIVA 800
            +    +L L   V  P QR  A+E++ 
Sbjct: 270 VLRGFLDLML---VREPSQRATAQELLG 294

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 93/200 (46%), Gaps = 12/200 (6%)
Query: 526 TDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFNLQ--CGRAFKSFDVECAMMKSIRH 582
           TD +     +G+G F  V +  +     E A K+ N +    R  +  + E  + + ++H
Sbjct: 30  TDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKH 89
Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
            N+V++  S S E F  LV + +  G L + + +  Y    +   +    +   LE ++ 
Sbjct: 90  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREY----YSEADASHCIHQILESVNH 145
Query: 643 GYSAPVIHCDLKPSNVLLDDN---MVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPE 699
            +   ++H DLKP N+LL          L+DFG+A  + GE Q+        T GY++PE
Sbjct: 146 IHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAW--FGFAGTPGYLSPE 203
Query: 700 YGREGQVSTNGDVYSFGIML 719
             R+       D+++ G++L
Sbjct: 204 VLRKDPYGKPVDIWACGVIL 223

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 101/212 (47%), Gaps = 18/212 (8%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRDGMEV----AVKVFNLQCGRAFKSFDVECAMMKSIRH 582
           D F +  ++GRGGFG V+  +++   ++     +    L+  + ++   VE  ++  +  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMI---DVASALEY 639
           R +V +  +   +    LV+  M  G +  ++++ +     FQ    +     + S LE+
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 640 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAP 698
           LH      +I+ DLKP NVLLDD+    +SD G+A  L       T+T+  A T G+MAP
Sbjct: 305 LH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA---GQTKTKGYAGTPGFMAP 358
Query: 699 E--YGREGQVSTNGDVYSFGIMLMETFTRKKP 728
           E   G E   S   D ++ G+ L E    + P
Sbjct: 359 ELLLGEEYDFSV--DYFALGVTLYEMIAARGP 388

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 101/212 (47%), Gaps = 18/212 (8%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRDGMEV----AVKVFNLQCGRAFKSFDVECAMMKSIRH 582
           D F +  ++GRGGFG V+  +++   ++     +    L+  + ++   VE  ++  +  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMI---DVASALEY 639
           R +V +  +   +    LV+  M  G +  ++++ +     FQ    +     + S LE+
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 640 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAP 698
           LH      +I+ DLKP NVLLDD+    +SD G+A  L       T+T+  A T G+MAP
Sbjct: 305 LH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA---GQTKTKGYAGTPGFMAP 358
Query: 699 E--YGREGQVSTNGDVYSFGIMLMETFTRKKP 728
           E   G E   S   D ++ G+ L E    + P
Sbjct: 359 ELLLGEEYDFSV--DYFALGVTLYEMIAARGP 388

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 101/212 (47%), Gaps = 18/212 (8%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRDGMEV----AVKVFNLQCGRAFKSFDVECAMMKSIRH 582
           D F +  ++GRGGFG V+  +++   ++     +    L+  + ++   VE  ++  +  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMI---DVASALEY 639
           R +V +  +   +    LV+  M  G +  ++++ +     FQ    +     + S LE+
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 640 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAP 698
           LH      +I+ DLKP NVLLDD+    +SD G+A  L       T+T+  A T G+MAP
Sbjct: 305 LH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA---GQTKTKGYAGTPGFMAP 358
Query: 699 E--YGREGQVSTNGDVYSFGIMLMETFTRKKP 728
           E   G E   S   D ++ G+ L E    + P
Sbjct: 359 ELLLGEEYDFSV--DYFALGVTLYEMIAARGP 388

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 11/205 (5%)
Query: 533 NLIGRGGFGSVYKA-RIRDG----MEVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLV 586
            ++G G FG+VYK   I DG    + VA+KV       +A K    E  +M  +    + 
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVS 82
Query: 587 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSA 646
           +++  C     + LV + MP+G L  ++  +   L     LN  + +A  + YL      
Sbjct: 83  RLLGICLTSTVQ-LVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLE---DV 138
Query: 647 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQV 706
            ++H DL   NVL+       ++DFG+A+LL  ++           I +MA E     + 
Sbjct: 139 RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRRRF 198
Query: 707 STNGDVYSFGIMLMETFT-RKKPTD 730
           +   DV+S+G+ + E  T   KP D
Sbjct: 199 THQSDVWSYGVTVWELMTFGAKPYD 223

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 97/220 (44%), Gaps = 25/220 (11%)
Query: 527 DKFSENNLIGRGGFGSVYKA------RIRDGMEVAVKVFNLQCGRA-FKSFDVECAMMKS 579
           D+      +GRG FG V +A      +      VAVK+       +  ++   E  ++  
Sbjct: 29  DRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIH 88
Query: 580 IRHR-NLVKVISSCSNEEFKALVL-EYMPHGSLEKYLHSSNYSLDIFQRLNIMID----- 632
           I H  N+V ++ +C+      +V+ E+   G+L  YL S       ++  ++  D     
Sbjct: 89  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLE 148
Query: 633 --------VASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM 684
                   VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+ +  +   +
Sbjct: 149 HLIXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXV 205
Query: 685 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 724
            +      + +MAPE   +   +   DV+SFG++L E F+
Sbjct: 206 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 90/193 (46%), Gaps = 12/193 (6%)
Query: 535 IGRGGFGSV----YKARIRDGMEVAVKVF-NLQCGRAFKSFDVECAMMKSIRHRNLVKVI 589
           IG G FG V    Y +     M VA+K   N       + F  E   M+   H ++VK+I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 590 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVI 649
              + E    +++E    G L  +L    +SLD+   +     +++AL YL    S   +
Sbjct: 458 GVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFV 513
Query: 650 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQ-TQTLATIGYMAPEYGREGQVST 708
           H D+   NVL+  N    L DFG+++ +  ED +  + ++    I +MAPE     + ++
Sbjct: 514 HRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAPESINFRRFTS 571
Query: 709 NGDVYSFGIMLME 721
             DV+ FG+ + E
Sbjct: 572 ASDVWMFGVCMWE 584

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 101/212 (47%), Gaps = 18/212 (8%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRDGMEV----AVKVFNLQCGRAFKSFDVECAMMKSIRH 582
           D F +  ++GRGGFG V+  +++   ++     +    L+  + ++   VE  ++  +  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMI---DVASALEY 639
           R +V +  +   +    LV+  M  G +  ++++ +     FQ    +     + S LE+
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 640 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAP 698
           LH      +I+ DLKP NVLLDD+    +SD G+A  L       T+T+  A T G+MAP
Sbjct: 305 LH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA---GQTKTKGYAGTPGFMAP 358
Query: 699 E--YGREGQVSTNGDVYSFGIMLMETFTRKKP 728
           E   G E   S   D ++ G+ L E    + P
Sbjct: 359 ELLLGEEYDFSV--DYFALGVTLYEMIAARGP 388

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 92/201 (45%), Gaps = 13/201 (6%)
Query: 535 IGRGGFGSVYKAR-IRDGMEVAVKVFN---LQCGRAFKSFDVECAMMKSIRHRNLVKVIS 590
           IG+G F  V  AR I  G EVAVK+ +   L      K F  E  +MK + H N+VK+  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLFE 80
Query: 591 SCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIH 650
               E+   LV+EY   G +  YL +     +   R      + SA++Y H  +   ++H
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF---IVH 136
Query: 651 CDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPE-YGREGQVSTN 709
            DLK  N+LLD +M   ++DFG +   T  ++            Y APE +  +      
Sbjct: 137 RDLKAENLLLDADMNIKIADFGFSNEFTFGNKL---DAFCGAPPYAAPELFQGKKYDGPE 193
Query: 710 GDVYSFGIMLMETFTRKKPTD 730
            DV+S G++L    +   P D
Sbjct: 194 VDVWSLGVILYTLVSGSLPFD 214

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 101/210 (48%), Gaps = 12/210 (5%)
Query: 535 IGRGGFGSV----YKARIRDGMEVAVKVFNLQCGRA-FKSFDVECAMMKSIRHRNLVKVI 589
           +G G FGSV    Y+ R +  ++VA+KV      +A  +    E  +M  + +  +V++I
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQ-IDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 590 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVI 649
             C  E    LV+E    G L K+L      + +     ++  V+  ++YL        +
Sbjct: 403 GVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFV 458
Query: 650 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMT-QTQTLATIGYMAPEYGREGQVST 708
           H +L   NVLL +   A +SDFG++K L  +D   T ++     + + APE     + S+
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 518
Query: 709 NGDVYSFGIMLMETFTR-KKPTDELFNGEM 737
             DV+S+G+ + E  +  +KP  ++   E+
Sbjct: 519 RSDVWSYGVTMWEALSYGQKPYKKMKGPEV 548

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 110/233 (47%), Gaps = 38/233 (16%)
Query: 529 FSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKV 588
           FS + +IGRGGFG VY  R  D      K++ ++C    K   ++     ++  R ++ +
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKAD----TGKMYAMKCLDK-KRIKMKQGETLALNERIMLSL 245
Query: 589 ISS-------CSNEEFK-----ALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVAS- 635
           +S+       C +  F      + +L+ M  G L  + H S +   +F   ++    A  
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL--HYHLSQHG--VFSEADMRFYAAEI 301
Query: 636 --ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATI 693
              LE++H  +   V++ DLKP+N+LLD++    +SD G+A   + +        ++ T 
Sbjct: 302 ILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTH 354
Query: 694 GYMAPEYGREG-QVSTNGDVYSFGIMLME------TFTRKKPTDELFNGEMTL 739
           GYMAPE  ++G    ++ D +S G ML +       F + K  D+     MTL
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 407

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 110/233 (47%), Gaps = 38/233 (16%)
Query: 529 FSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKV 588
           FS + +IGRGGFG VY  R  D      K++ ++C    K   ++     ++  R ++ +
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKAD----TGKMYAMKCLDK-KRIKMKQGETLALNERIMLSL 245
Query: 589 ISS-------CSNEEFK-----ALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVAS- 635
           +S+       C +  F      + +L+ M  G L  + H S +   +F   ++    A  
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL--HYHLSQHG--VFSEADMRFYAAEI 301
Query: 636 --ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATI 693
              LE++H  +   V++ DLKP+N+LLD++    +SD G+A   + +        ++ T 
Sbjct: 302 ILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTH 354
Query: 694 GYMAPEYGREG-QVSTNGDVYSFGIMLME------TFTRKKPTDELFNGEMTL 739
           GYMAPE  ++G    ++ D +S G ML +       F + K  D+     MTL
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 407

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 97/202 (48%), Gaps = 17/202 (8%)
Query: 528 KFSEN----NLIGRGGFGSVYKARIRD-GMEVAVKVFNLQ--CGRAFKSFDVECAMMKSI 580
           KFS+N      +G+G F  V +   +  G+E A K+ N +    R F+  + E  + + +
Sbjct: 3   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 62
Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
           +H N+V++  S   E F  LV + +  G L + + +  +    +   +    +   LE +
Sbjct: 63  QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF----YSEADASHCIQQILESI 118
Query: 641 HFGYSAPVIHCDLKPSNVLLDDN---MVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMA 697
            + +S  ++H +LKP N+LL          L+DFG+A  +   + S        T GY++
Sbjct: 119 AYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV---NDSEAWHGFAGTPGYLS 175
Query: 698 PEYGREGQVSTNGDVYSFGIML 719
           PE  ++   S   D+++ G++L
Sbjct: 176 PEVLKKDPYSKPVDIWACGVIL 197

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 101/232 (43%), Gaps = 38/232 (16%)
Query: 528 KFSENNL-----IGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDVECAMMKSIR 581
           +F  NNL     +G G FG V +A     G E AV    ++  ++    D + A+M  ++
Sbjct: 27  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 86
Query: 582 -------HRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYS-------------- 620
                  H N+V ++ +C++     ++ EY  +G L  +L     +              
Sbjct: 87  IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEG 146
Query: 621 --------LDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFG 672
                   L++   L+    VA  + +L    S   IH D+   NVLL +  VA + DFG
Sbjct: 147 LDKEDGRPLELRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFG 203
Query: 673 IAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 724
           +A+ +  +   + +      + +MAPE   +   +   DV+S+GI+L E F+
Sbjct: 204 LARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 255

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 110/233 (47%), Gaps = 38/233 (16%)
Query: 529 FSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKV 588
           FS + +IGRGGFG VY  R  D      K++ ++C    K   ++     ++  R ++ +
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKAD----TGKMYAMKCLDK-KRIKMKQGETLALNERIMLSL 245
Query: 589 ISS-------CSNEEFK-----ALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVAS- 635
           +S+       C +  F      + +L+ M  G L  + H S +   +F   ++    A  
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL--HYHLSQHG--VFSEADMRFYAAEI 301
Query: 636 --ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATI 693
              LE++H  +   V++ DLKP+N+LLD++    +SD G+A   + +        ++ T 
Sbjct: 302 ILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTH 354
Query: 694 GYMAPEYGREG-QVSTNGDVYSFGIMLME------TFTRKKPTDELFNGEMTL 739
           GYMAPE  ++G    ++ D +S G ML +       F + K  D+     MTL
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 407

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 104/212 (49%), Gaps = 13/212 (6%)
Query: 528 KFSENNLIGRGGFGSVYKARIRDGME-VAVKVFNLQCGR--AFKSFDVECAMMKSIRHRN 584
           K+ +   IG G +G+V+KA+ R+  E VA+K   L         S   E  ++K ++H+N
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 585 LVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGY 644
           +V++     +++   LV E+     L+KY  S N  LD     + +  +   L + H   
Sbjct: 63  IVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH--- 118
Query: 645 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG 704
           S  V+H DLKP N+L++ N    L++FG+A+      +    +  + T+ Y  P+     
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVVTLWYRPPDVLFGA 176
Query: 705 QV-STNGDVYSFGIMLMETFTRKKPTDELFNG 735
           ++ ST+ D++S G +  E     +P   LF G
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRP---LFPG 205

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 110/233 (47%), Gaps = 38/233 (16%)
Query: 529 FSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKV 588
           FS + +IGRGGFG VY  R  D      K++ ++C    K   ++     ++  R ++ +
Sbjct: 190 FSVHRIIGRGGFGEVYGCRKAD----TGKMYAMKCLDK-KRIKMKQGETLALNERIMLSL 244
Query: 589 ISS-------CSNEEFK-----ALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVAS- 635
           +S+       C +  F      + +L+ M  G L  + H S +   +F   ++    A  
Sbjct: 245 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL--HYHLSQHG--VFSEADMRFYAAEI 300
Query: 636 --ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATI 693
              LE++H  +   V++ DLKP+N+LLD++    +SD G+A   + +        ++ T 
Sbjct: 301 ILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTH 353
Query: 694 GYMAPEYGREG-QVSTNGDVYSFGIMLME------TFTRKKPTDELFNGEMTL 739
           GYMAPE  ++G    ++ D +S G ML +       F + K  D+     MTL
Sbjct: 354 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 406

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 97/202 (48%), Gaps = 17/202 (8%)
Query: 528 KFSEN----NLIGRGGFGSVYKARIRD-GMEVAVKVFNLQ--CGRAFKSFDVECAMMKSI 580
           KFS+N      +G+G F  V +   +  G+E A K+ N +    R F+  + E  + + +
Sbjct: 2   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 61
Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
           +H N+V++  S   E F  LV + +  G L + + +  +    +   +    +   LE +
Sbjct: 62  QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF----YSEADASHCIQQILESI 117
Query: 641 HFGYSAPVIHCDLKPSNVLLDDN---MVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMA 697
            + +S  ++H +LKP N+LL          L+DFG+A  +   + S        T GY++
Sbjct: 118 AYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV---NDSEAWHGFAGTPGYLS 174
Query: 698 PEYGREGQVSTNGDVYSFGIML 719
           PE  ++   S   D+++ G++L
Sbjct: 175 PEVLKKDPYSKPVDIWACGVIL 196

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 94/214 (43%), Gaps = 12/214 (5%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRDG-MEVAVKV-FNLQCGR--AFKSFDVECAMMKSIRH 582
           D F     +G+G FG+VY AR +     VA+KV F  Q  +         E  +   + H
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
            N++++ +   +     L+LEY P G L K L  S  + D  +   IM ++A AL Y H 
Sbjct: 83  PNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSC-TFDEQRTATIMEELADALMYCH- 140
Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
                VIH D+KP N+LL       ++DFG     +    S+ +     T+ Y+ PE   
Sbjct: 141 --GKKVIHRDIKPENLLLGLKGELKIADFG----WSVHAPSLRRKTMCGTLDYLPPEMIE 194
Query: 703 EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGE 736
               +   D++  G++  E      P +   + E
Sbjct: 195 GRMHNEKVDLWCIGVLCYELLVGNPPFESASHNE 228

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 96/203 (47%), Gaps = 14/203 (6%)
Query: 523 FQATDKFSENNLIGRGGFGSVYK-ARIRDGMEVAVKVFNLQ--CGRAFKSFDVECAMMKS 579
           FQ+  +  E   +G+G F  V +  ++  G E A K+ N +    R  +  + E  + + 
Sbjct: 20  FQSMYQLFEE--LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRL 77
Query: 580 IRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEY 639
           ++H N+V++  S S E    L+ + +  G L + + +  Y    +   +    +   LE 
Sbjct: 78  LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREY----YSEADASHCIQQILEA 133
Query: 640 LHFGYSAPVIHCDLKPSNVLLDDNM---VAHLSDFGIAKLLTGEDQSMTQTQTLATIGYM 696
           +   +   V+H DLKP N+LL   +      L+DFG+A  + GE Q+        T GY+
Sbjct: 134 VLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA--GTPGYL 191
Query: 697 APEYGREGQVSTNGDVYSFGIML 719
           +PE  R+       D+++ G++L
Sbjct: 192 SPEVLRKDPYGKPVDLWACGVIL 214

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/192 (24%), Positives = 91/192 (47%), Gaps = 9/192 (4%)
Query: 530 SENNLIGRGGFGSVYK-ARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKV 588
           S+  ++G G FG V+K      G+++A K+   +  +  +    E ++M  + H NL+++
Sbjct: 92  SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQL 151
Query: 589 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPV 648
             +  ++    LV+EY+  G L   +   +Y+L     +  M  +   + ++H  Y   +
Sbjct: 152 YDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY---I 208
Query: 649 IHCDLKPSNVLL--DDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQV 706
           +H DLKP N+L    D     + DFG+A+     ++         T  ++APE      V
Sbjct: 209 LHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV---NFGTPEFLAPEVVNYDFV 265
Query: 707 STNGDVYSFGIM 718
           S   D++S G++
Sbjct: 266 SFPTDMWSVGVI 277

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 89/208 (42%), Gaps = 12/208 (5%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRDGMEV-AVKVF---NLQCGRAFKSFDVECAMMKSIRH 582
           D F     +G+G FG+VY AR +    + A+KV     L+          E  +   +RH
Sbjct: 15  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 74
Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
            N++++ +   + +   L+LE+ P G L K L       D  +    M ++A AL Y H 
Sbjct: 75  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCH- 132
Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
                VIH D+KP N+L+       ++DFG     +    S+ +     T+ Y+ PE   
Sbjct: 133 --ERKVIHRDIKPENLLMGYKGELKIADFG----WSVHAPSLRRRXMCGTLDYLPPEMIE 186
Query: 703 EGQVSTNGDVYSFGIMLMETFTRKKPTD 730
                   D++  G++  E      P D
Sbjct: 187 GKTHDEKVDLWCAGVLCYEFLVGMPPFD 214

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 106/221 (47%), Gaps = 22/221 (9%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRDGMEV-AVKVFNLQCGRAFKSFDVECAMMK------S 579
           + F  + ++G+G FG V+ A  +   +  A+K   L+        DVEC M++      +
Sbjct: 18  EDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLA 75
Query: 580 IRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEY 639
             H  L  +  +   +E    V+EY+  G L  ++ S  +  D+ +      ++   L++
Sbjct: 76  WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQF 134
Query: 640 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL-LTGEDQSMTQTQTLATIGYMAP 698
           LH   S  +++ DLK  N+LLD +    ++DFG+ K  + G+ ++    +   T  Y+AP
Sbjct: 135 LH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT---NEFCGTPDYIAP 188
Query: 699 EYGREGQVSTNGDVYSFGIMLMETFTRKKP-----TDELFN 734
           E     + + + D +SFG++L E    + P      +ELF+
Sbjct: 189 EILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH 229

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 89/194 (45%), Gaps = 13/194 (6%)
Query: 534 LIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAM------MKSIRHRNLVK 587
           +IG+G FG V  AR +   EV   V  LQ     K  + +  M      +K+++H  LV 
Sbjct: 45  VIGKGSFGKVLLARHK-AEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 103
Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAP 647
           +  S    +    VL+Y+  G L  +L      L+   R     ++ASAL YLH   S  
Sbjct: 104 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLH---SLN 159
Query: 648 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVS 707
           +++ DLKP N+LLD      L+DFG+ K     + + T +    T  Y+APE   +    
Sbjct: 160 IVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNSTTSTFCGTPEYLAPEVLHKQPYD 217
Query: 708 TNGDVYSFGIMLME 721
              D +  G +L E
Sbjct: 218 RTVDWWCLGAVLYE 231

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 51/204 (25%), Positives = 98/204 (48%), Gaps = 17/204 (8%)
Query: 526 TDKFSEN----NLIGRGGFGSVYKARIRD-GMEVAVKVFNLQ--CGRAFKSFDVECAMMK 578
           + KFS+N      +G+G F  V +   +  G+E A K+ N +    R F+  + E  + +
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 579 SIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALE 638
            ++H N+V++  S   E F  LV + +  G L + + +  +    +   +    +   LE
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF----YSEADASHCIQQILE 116
Query: 639 YLHFGYSAPVIHCDLKPSNVLLDDN---MVAHLSDFGIAKLLTGEDQSMTQTQTLATIGY 695
            + + +S  ++H +LKP N+LL          L+DFG+A  +   + S        T GY
Sbjct: 117 SIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV---NDSEAWHGFAGTPGY 173
Query: 696 MAPEYGREGQVSTNGDVYSFGIML 719
           ++PE  ++   S   D+++ G++L
Sbjct: 174 LSPEVLKKDPYSKPVDIWACGVIL 197

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 102/225 (45%), Gaps = 30/225 (13%)
Query: 522 LFQATDKFSENNLIGRGGFGSVYKARIRDGME-VAVK--------VFNLQCGRAFKSFDV 572
           ++  +  F   +L+G G +G V  A  +   E VA+K        +F L+  R  K    
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIK---- 61
Query: 573 ECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMID 632
              ++K  +H N++ + +    + F+     Y+    ++  LH    S  +    +I   
Sbjct: 62  ---ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRV-ISTQMLSDDHIQYF 117
Query: 633 VASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL----------TGEDQ 682
           +   L  +   + + VIH DLKPSN+L++ N    + DFG+A+++          TG+  
Sbjct: 118 IYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 683 SMTQTQTLATIGYMAPEYG-REGQVSTNGDVYSFGIMLMETFTRK 726
            M  T+ +AT  Y APE      + S   DV+S G +L E F R+
Sbjct: 178 GM--TEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 98/218 (44%), Gaps = 23/218 (10%)
Query: 527 DKFSENNLIGRGGFGSVYKA------RIRDGMEVAVKVFNLQCGRA-FKSFDVECAMMKS 579
           D+ +    +GRG FG V +A      +      VAVK+       +  ++   E  ++  
Sbjct: 27  DRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 580 IRHR-NLVKVISSCSNEEFKALVL-EYMPHGSLEKYLHSSNYSL----DIFQR------- 626
           I H  N+V ++ +C+      +V+ E+   G+L  YL S         D+++        
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHL 146
Query: 627 LNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQ 686
           +     VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+ +  +   + +
Sbjct: 147 IXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRK 203
Query: 687 TQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 724
                 + +MAPE   +   +   DV+SFG++L E F+
Sbjct: 204 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 98/218 (44%), Gaps = 23/218 (10%)
Query: 527 DKFSENNLIGRGGFGSVYKA------RIRDGMEVAVKVFNLQCGRA-FKSFDVECAMMKS 579
           D+ +    +GRG FG V +A      +      VAVK+       +  ++   E  ++  
Sbjct: 27  DRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 580 IRHR-NLVKVISSCSNEEFKALVL-EYMPHGSLEKYLHSSNYSL----DIFQRLNIM--- 630
           I H  N+V ++ +C+      +V+ E+   G+L  YL S         D+++    +   
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHL 146
Query: 631 ----IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQ 686
                 VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+ +  +   + +
Sbjct: 147 ICYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 203
Query: 687 TQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 724
                 + +MAPE   +   +   DV+SFG++L E F+
Sbjct: 204 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 100/199 (50%), Gaps = 30/199 (15%)
Query: 533 NLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGR---AFK--SFDVECAMMKSIRHRNLVK 587
            ++G G F  V+  + R    +  K+F L+C +   AF+  S + E A++K I+H N+V 
Sbjct: 15  EVLGSGAFSEVFLVKQR----LTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVT 70
Query: 588 VISSCSNEEFKALVLEYMPHGS-----LEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
           +     +     LV++ +  G      LE+ +++   +  + Q+      V SA++YLH 
Sbjct: 71  LEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQ------VLSAVKYLH- 123
Query: 643 GYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPE 699
                ++H DLKP N+L    ++N    ++DFG++K+    +Q+   +    T GY+APE
Sbjct: 124 --ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM----EQNGIMSTACGTPGYVAPE 177
Query: 700 YGREGQVSTNGDVYSFGIM 718
              +   S   D +S G++
Sbjct: 178 VLAQKPYSKAVDCWSIGVI 196

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 107/218 (49%), Gaps = 21/218 (9%)
Query: 521 ELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKV---FNLQ--CGRAFKSFDVEC 574
           ++F    +++  + IG G +G V  A    + + VA+K    F  Q  C R  +    E 
Sbjct: 19  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EI 74
Query: 575 AMMKSIRHRNLV---KVISSCSNEEFKAL-VLEYMPHGSLEKYLHSSNYSLDIFQRLNIM 630
            ++ + RH N++    +I + + E+ K + +++ +    L K L + + S D       +
Sbjct: 75  KILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFL 132
Query: 631 IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE-DQSMTQTQT 689
             +   L+Y+H   SA V+H DLKPSN+LL+      + DFG+A++   + D +   T+ 
Sbjct: 133 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 189
Query: 690 LATIGYMAPEYGREGQVSTNG-DVYSFGIMLMETFTRK 726
           +AT  Y APE     +  T   D++S G +L E  + +
Sbjct: 190 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 105/218 (48%), Gaps = 21/218 (9%)
Query: 521 ELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKV---FNLQ--CGRAFKSFDVEC 574
           ++F    +++  + IG G +G V  A    + + VA+K    F  Q  C R  +    E 
Sbjct: 37  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EI 92
Query: 575 AMMKSIRHRNLV---KVISSCSNEEFKALVL-EYMPHGSLEKYLHSSNYSLDIFQRLNIM 630
            ++   RH N++    +I + + E+ K + L  ++    L K L + + S D       +
Sbjct: 93  KILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSND--HICYFL 150
Query: 631 IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE-DQSMTQTQT 689
             +   L+Y+H   SA V+H DLKPSN+LL+      + DFG+A++   + D +   T+ 
Sbjct: 151 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEY 207
Query: 690 LATIGYMAPEYGREGQVSTNG-DVYSFGIMLMETFTRK 726
           +AT  Y APE     +  T   D++S G +L E  + +
Sbjct: 208 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 96/224 (42%), Gaps = 32/224 (14%)
Query: 525 ATDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRH- 582
           A+D F E  ++G+G FG V KAR   D    A+K           +   E  ++ S+ H 
Sbjct: 5   ASD-FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVXLLASLNHQ 62
Query: 583 ------------RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIM 630
                       RN VK  ++   +    +  EY  + +L   +HS N +    +   + 
Sbjct: 63  YVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLF 122
Query: 631 IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK-------LLTGEDQS 683
             +  AL Y+H   S  +IH +LKP N+ +D++    + DFG+AK       +L  + Q+
Sbjct: 123 RQILEALSYIH---SQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 684 M-----TQTQTLATIGYMAPEY-GREGQVSTNGDVYSFGIMLME 721
           +       T  + T  Y+A E     G  +   D YS GI+  E
Sbjct: 180 LPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFE 223

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 102/218 (46%), Gaps = 15/218 (6%)
Query: 535 IGRGGFGSVYKA-RIRDGMEVAVKVFNLQCGRA---FKSFDVECAMMKSIRHRNLVKVIS 590
           +G G FG V  A   +   +VA+K  + Q  +        + E + +K +RH +++K+  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 591 SCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIH 650
             +      +V+EY      +  +     + D  +R      +  A+EY H      ++H
Sbjct: 77  VITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRF--FQQIICAIEYCH---RHKIVH 131
Query: 651 CDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY-GREGQVSTN 709
            DLKP N+LLDDN+   ++DFG++ ++T  D +  +T +  +  Y APE    +      
Sbjct: 132 RDLKPENLLLDDNLNVKIADFGLSNIMT--DGNFLKT-SCGSPNYAAPEVINGKLYAGPE 188
Query: 710 GDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCL 747
            DV+S GI+L      + P D+ F   +  K  VN C+
Sbjct: 189 VDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK--VNSCV 224

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 102/225 (45%), Gaps = 30/225 (13%)
Query: 522 LFQATDKFSENNLIGRGGFGSVYKARIRDGME-VAVK--------VFNLQCGRAFKSFDV 572
           ++  +  F   +L+G G +G V  A  +   E VA+K        +F L+  R  K    
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIK---- 61
Query: 573 ECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMID 632
              ++K  +H N++ + +    + F+     Y+    ++  LH    S  +    +I   
Sbjct: 62  ---ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRV-ISTQMLSDDHIQYF 117
Query: 633 VASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL----------TGEDQ 682
           +   L  +   + + VIH DLKPSN+L++ N    + DFG+A+++          TG+  
Sbjct: 118 IYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 683 SMTQTQTLATIGYMAPEYG-REGQVSTNGDVYSFGIMLMETFTRK 726
            M  T+ +AT  Y APE      + S   DV+S G +L E F R+
Sbjct: 178 GM--TEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 98/221 (44%), Gaps = 26/221 (11%)
Query: 527 DKFSENNLIGRGGFGSVYKA------RIRDGMEVAVKVFNLQCGRA-FKSFDVECAMMKS 579
           D+ +    +GRG FG V +A      +      VAVK+       +  ++   E  ++  
Sbjct: 28  DRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 87
Query: 580 IRHR-NLVKVISSCSNEEFKALVL-EYMPHGSLEKYLHSSNYSL-------DIFQRLNIM 630
           I H  N+V ++ +C+      +V+ E+   G+L  YL S            D+++    +
Sbjct: 88  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTL 147
Query: 631 -------IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS 683
                    VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+ +  +   
Sbjct: 148 EHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDX 204
Query: 684 MTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 724
           + +      + +MAPE   +   +   DV+SFG++L E F+
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 89/208 (42%), Gaps = 12/208 (5%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRDGMEV-AVKVF---NLQCGRAFKSFDVECAMMKSIRH 582
           D F     +G+G FG+VY AR +    + A+KV     L+          E  +   +RH
Sbjct: 14  DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
            N++++ +   + +   L+LE+ P G L K L       D  +    M ++A AL Y H 
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCH- 131
Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
                VIH D+KP N+L+       ++DFG     +    S+ +     T+ Y+ PE   
Sbjct: 132 --ERKVIHRDIKPENLLMGYKGELKIADFG----WSVHAPSLRRRXMCGTLDYLPPEMIE 185
Query: 703 EGQVSTNGDVYSFGIMLMETFTRKKPTD 730
                   D++  G++  E      P D
Sbjct: 186 GKTHDEKVDLWCAGVLCYEFLVGMPPFD 213

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 94/198 (47%), Gaps = 9/198 (4%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQC-GRAFKSFDV-ECAMMKSIRHRN 584
           +K+     IG G +G VYKA+   G   A+K   L+       S  + E +++K ++H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 585 LVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGY 644
           +VK+      ++   LV E++    L+K L      L+     + ++ + + + Y H   
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH--- 117
Query: 645 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY-GRE 703
              V+H DLKP N+L++      ++DFG+A+      +    T  + T+ Y AP+     
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY--THEIVTLWYRAPDVLMGS 175
Query: 704 GQVSTNGDVYSFGIMLME 721
            + ST  D++S G +  E
Sbjct: 176 KKYSTTIDIWSVGCIFAE 193

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 78/287 (27%), Positives = 124/287 (43%), Gaps = 29/287 (10%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRDGME-VAVKVFNLQ-CGRAFKSFDVECAMMKSIRHRN 584
           D +    +IG G    V  A      E VA+K  NL+ C  +      E   M    H N
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 585 LVKVISSCSNEEFKALVLEYMPHGSL--------EKYLHSSNYSLDIFQRLNIMIDVASA 636
           +V   +S   ++   LV++ +  GS+         K  H S   LD      I+ +V   
Sbjct: 70  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGV-LDESTIATILREVLEG 128
Query: 637 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-TGEDQSMTQTQT--LATI 693
           LEYLH       IH D+K  N+LL ++    ++DFG++  L TG D +  + +   + T 
Sbjct: 129 LEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 185
Query: 694 GYMAPEYGREGQ-VSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTM 752
            +MAPE   + +      D++SFGI  +E  T   P  +    ++ +    ND   + T 
Sbjct: 186 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLET- 244
Query: 753 EVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIV 799
            V D  +L         K+   SF   ++L C  + PE+R  A E++
Sbjct: 245 GVQDKEML---------KKYGKSFRKMISL-CLQKDPEKRPTAAELL 281

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 106/218 (48%), Gaps = 21/218 (9%)
Query: 521 ELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKV---FNLQ--CGRAFKSFDVEC 574
           ++F    +++  + IG G +G V  A    + + VA+K    F  Q  C R  +    E 
Sbjct: 21  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EI 76
Query: 575 AMMKSIRHRNLV---KVISSCSNEEFKAL-VLEYMPHGSLEKYLHSSNYSLDIFQRLNIM 630
            ++   RH N++    +I + + E+ K + +++ +    L K L + + S D       +
Sbjct: 77  KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFL 134
Query: 631 IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE-DQSMTQTQT 689
             +   L+Y+H   SA V+H DLKPSN+LL+      + DFG+A++   + D +   T+ 
Sbjct: 135 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEY 191
Query: 690 LATIGYMAPEYGREGQVSTNG-DVYSFGIMLMETFTRK 726
           +AT  Y APE     +  T   D++S G +L E  + +
Sbjct: 192 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 89/193 (46%), Gaps = 12/193 (6%)
Query: 535 IGRGGFGSV----YKARIRDGMEVAVKVF-NLQCGRAFKSFDVECAMMKSIRHRNLVKVI 589
           IG G FG V    Y +     M VA+K   N       + F  E   M+   H ++VK+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 590 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVI 649
              + E    +++E    G L  +L    +SLD+   +     +++AL YL    S   +
Sbjct: 78  GVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFV 133
Query: 650 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQ-TQTLATIGYMAPEYGREGQVST 708
           H D+   NVL+       L DFG+++ +  ED +  + ++    I +MAPE     + ++
Sbjct: 134 HRDIAARNVLVSATDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAPESINFRRFTS 191
Query: 709 NGDVYSFGIMLME 721
             DV+ FG+ + E
Sbjct: 192 ASDVWMFGVCMWE 204

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 20/206 (9%)
Query: 534 LIGRGGFGSVYKARIRDGMEV-AVKVFNL-----QCGRAFKSFDVECAMMKSIRHRNLVK 587
           +IGRG FG V   R +   +V A+K+ +      +   AF  F  E  +M       +V+
Sbjct: 82  VIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAF--FWEERDIMAFANSPWVVQ 139
Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAP 647
           +  +  ++++  +V+EYMP G L   +  SNY +          +V  AL+ +H   S  
Sbjct: 140 LFCAFQDDKYLYMVMEYMPGGDLVNLM--SNYDVPEKWAKFYTAEVVLALDAIH---SMG 194
Query: 648 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT-LATIGYMAPE----YGR 702
           +IH D+KP N+LLD +    L+DFG    +  ++  M    T + T  Y++PE     G 
Sbjct: 195 LIHRDVKPDNMLLDKHGHLKLADFGTC--MKMDETGMVHCDTAVGTPDYISPEVLKSQGG 252
Query: 703 EGQVSTNGDVYSFGIMLMETFTRKKP 728
           +G      D +S G+ L E      P
Sbjct: 253 DGYYGRECDWWSVGVFLFEMLVGDTP 278

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 70/281 (24%), Positives = 128/281 (45%), Gaps = 39/281 (13%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCG--RAFKSFDVECAMMKSIRHRN--LVKVIS 590
           IG GG   V++         A+K  NL+    +   S+  E A +  ++  +  ++++  
Sbjct: 20  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 79
Query: 591 SCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIH 650
               +++  +V+E   +  L  +L     S+D ++R +      + LE +H  +   ++H
Sbjct: 80  YEITDQYIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYW---KNMLEAVHTIHQHGIVH 134
Query: 651 CDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVS-TN 709
            DLKP+N L+ D M+  L DFGIA  +  +  S+ +   + T+ YM PE  ++   S  N
Sbjct: 135 SDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSREN 193
Query: 710 G----------DVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANL 759
           G          DV+S G +L      K P  ++ N +++  H + D  P   +E  D   
Sbjct: 194 GKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-QISKLHAIID--PNHEIEFPD--- 247
Query: 760 LSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVA 800
           + ++D+  V K  C          C    P+QRI+  E++A
Sbjct: 248 IPEKDLQDVLK--C----------CLKRDPKQRISIPELLA 276

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 107/218 (49%), Gaps = 21/218 (9%)
Query: 521 ELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKV---FNLQ--CGRAFKSFDVEC 574
           ++F    +++  + IG G +G V  A    + + VA+K    F  Q  C R  +    E 
Sbjct: 19  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EI 74
Query: 575 AMMKSIRHRNLV---KVISSCSNEEFKAL-VLEYMPHGSLEKYLHSSNYSLDIFQRLNIM 630
            ++ + RH N++    +I + + E+ K + +++ +    L K L + + S D       +
Sbjct: 75  KILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFL 132
Query: 631 IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE-DQSMTQTQT 689
             +   L+Y+H   SA V+H DLKPSN+LL+      + DFG+A++   + D +   T+ 
Sbjct: 133 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEY 189
Query: 690 LATIGYMAPEYGREGQVSTNG-DVYSFGIMLMETFTRK 726
           +AT  Y APE     +  T   D++S G +L E  + +
Sbjct: 190 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 106/218 (48%), Gaps = 21/218 (9%)
Query: 521 ELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKV---FNLQ--CGRAFKSFDVEC 574
           ++F    +++  + IG G +G V  A    + + VA+K    F  Q  C R  +    E 
Sbjct: 17  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EI 72
Query: 575 AMMKSIRHRNLV---KVISSCSNEEFKAL-VLEYMPHGSLEKYLHSSNYSLDIFQRLNIM 630
            ++   RH N++    +I + + E+ K + +++ +    L K L + + S D       +
Sbjct: 73  KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFL 130
Query: 631 IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE-DQSMTQTQT 689
             +   L+Y+H   SA V+H DLKPSN+LL+      + DFG+A++   + D +   T+ 
Sbjct: 131 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEY 187
Query: 690 LATIGYMAPEYGREGQVSTNG-DVYSFGIMLMETFTRK 726
           +AT  Y APE     +  T   D++S G +L E  + +
Sbjct: 188 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 106/218 (48%), Gaps = 21/218 (9%)
Query: 521 ELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKV---FNLQ--CGRAFKSFDVEC 574
           ++F    +++  + IG G +G V  A    + + VA+K    F  Q  C R  +    E 
Sbjct: 17  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EI 72
Query: 575 AMMKSIRHRNLV---KVISSCSNEEFKAL-VLEYMPHGSLEKYLHSSNYSLDIFQRLNIM 630
            ++   RH N++    +I + + E+ K + +++ +    L K L + + S D       +
Sbjct: 73  KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFL 130
Query: 631 IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE-DQSMTQTQT 689
             +   L+Y+H   SA V+H DLKPSN+LL+      + DFG+A++   + D +   T+ 
Sbjct: 131 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEY 187
Query: 690 LATIGYMAPEYGREGQVSTNG-DVYSFGIMLMETFTRK 726
           +AT  Y APE     +  T   D++S G +L E  + +
Sbjct: 188 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 106/218 (48%), Gaps = 21/218 (9%)
Query: 521 ELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKV---FNLQ--CGRAFKSFDVEC 574
           ++F    +++  + IG G +G V  A    + + VA+K    F  Q  C R  +    E 
Sbjct: 17  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EI 72
Query: 575 AMMKSIRHRNLV---KVISSCSNEEFKAL-VLEYMPHGSLEKYLHSSNYSLDIFQRLNIM 630
            ++   RH N++    +I + + E+ K + +++ +    L K L + + S D       +
Sbjct: 73  KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFL 130
Query: 631 IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE-DQSMTQTQT 689
             +   L+Y+H   SA V+H DLKPSN+LL+      + DFG+A++   + D +   T+ 
Sbjct: 131 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEY 187
Query: 690 LATIGYMAPEYGREGQVSTNG-DVYSFGIMLMETFTRK 726
           +AT  Y APE     +  T   D++S G +L E  + +
Sbjct: 188 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 106/218 (48%), Gaps = 21/218 (9%)
Query: 521 ELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKV---FNLQ--CGRAFKSFDVEC 574
           ++F    +++  + IG G +G V  A    + + VA+K    F  Q  C R  +    E 
Sbjct: 22  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EI 77
Query: 575 AMMKSIRHRNLV---KVISSCSNEEFKAL-VLEYMPHGSLEKYLHSSNYSLDIFQRLNIM 630
            ++   RH N++    +I + + E+ K + +++ +    L K L + + S D       +
Sbjct: 78  KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFL 135
Query: 631 IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE-DQSMTQTQT 689
             +   L+Y+H   SA V+H DLKPSN+LL+      + DFG+A++   + D +   T+ 
Sbjct: 136 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 192
Query: 690 LATIGYMAPEYGREGQVSTNG-DVYSFGIMLMETFTRK 726
           +AT  Y APE     +  T   D++S G +L E  + +
Sbjct: 193 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 106/218 (48%), Gaps = 21/218 (9%)
Query: 521 ELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKV---FNLQ--CGRAFKSFDVEC 574
           ++F    +++  + IG G +G V  A    + + VA+K    F  Q  C R  +    E 
Sbjct: 23  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EI 78
Query: 575 AMMKSIRHRNLV---KVISSCSNEEFKAL-VLEYMPHGSLEKYLHSSNYSLDIFQRLNIM 630
            ++   RH N++    +I + + E+ K + +++ +    L K L + + S D       +
Sbjct: 79  KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFL 136
Query: 631 IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE-DQSMTQTQT 689
             +   L+Y+H   SA V+H DLKPSN+LL+      + DFG+A++   + D +   T+ 
Sbjct: 137 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 193
Query: 690 LATIGYMAPEYGREGQVSTNG-DVYSFGIMLMETFTRK 726
           +AT  Y APE     +  T   D++S G +L E  + +
Sbjct: 194 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 106/218 (48%), Gaps = 21/218 (9%)
Query: 521 ELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKV---FNLQ--CGRAFKSFDVEC 574
           ++F    +++  + IG G +G V  A    + + VA+K    F  Q  C R  +    E 
Sbjct: 14  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EI 69
Query: 575 AMMKSIRHRNLV---KVISSCSNEEFKAL-VLEYMPHGSLEKYLHSSNYSLDIFQRLNIM 630
            ++   RH N++    +I + + E+ K + +++ +    L K L + + S D       +
Sbjct: 70  KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFL 127
Query: 631 IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE-DQSMTQTQT 689
             +   L+Y+H   SA V+H DLKPSN+LL+      + DFG+A++   + D +   T+ 
Sbjct: 128 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 184
Query: 690 LATIGYMAPEYGREGQVSTNG-DVYSFGIMLMETFTRK 726
           +AT  Y APE     +  T   D++S G +L E  + +
Sbjct: 185 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 106/218 (48%), Gaps = 21/218 (9%)
Query: 521 ELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKV---FNLQ--CGRAFKSFDVEC 574
           ++F    +++  + IG G +G V  A    + + VA+K    F  Q  C R  +    E 
Sbjct: 21  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EI 76
Query: 575 AMMKSIRHRNLV---KVISSCSNEEFKAL-VLEYMPHGSLEKYLHSSNYSLDIFQRLNIM 630
            ++   RH N++    +I + + E+ K + +++ +    L K L + + S D       +
Sbjct: 77  KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFL 134
Query: 631 IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE-DQSMTQTQT 689
             +   L+Y+H   SA V+H DLKPSN+LL+      + DFG+A++   + D +   T+ 
Sbjct: 135 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 191
Query: 690 LATIGYMAPEYGREGQVSTNG-DVYSFGIMLMETFTRK 726
           +AT  Y APE     +  T   D++S G +L E  + +
Sbjct: 192 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 106/218 (48%), Gaps = 21/218 (9%)
Query: 521 ELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKV---FNLQ--CGRAFKSFDVEC 574
           ++F    +++  + IG G +G V  A    + + VA+K    F  Q  C R  +    E 
Sbjct: 15  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EI 70
Query: 575 AMMKSIRHRNLV---KVISSCSNEEFKAL-VLEYMPHGSLEKYLHSSNYSLDIFQRLNIM 630
            ++   RH N++    +I + + E+ K + +++ +    L K L + + S D       +
Sbjct: 71  KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFL 128
Query: 631 IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE-DQSMTQTQT 689
             +   L+Y+H   SA V+H DLKPSN+LL+      + DFG+A++   + D +   T+ 
Sbjct: 129 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 185
Query: 690 LATIGYMAPEYGREGQVSTNG-DVYSFGIMLMETFTRK 726
           +AT  Y APE     +  T   D++S G +L E  + +
Sbjct: 186 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 94/198 (47%), Gaps = 9/198 (4%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQC-GRAFKSFDV-ECAMMKSIRHRN 584
           +K+     IG G +G VYKA+   G   A+K   L+       S  + E +++K ++H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 585 LVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGY 644
           +VK+      ++   LV E++    L+K L      L+     + ++ + + + Y H   
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH--- 117
Query: 645 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY-GRE 703
              V+H DLKP N+L++      ++DFG+A+      +    T  + T+ Y AP+     
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY--THEVVTLWYRAPDVLMGS 175
Query: 704 GQVSTNGDVYSFGIMLME 721
            + ST  D++S G +  E
Sbjct: 176 KKYSTTIDIWSVGCIFAE 193

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 106/218 (48%), Gaps = 21/218 (9%)
Query: 521 ELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKV---FNLQ--CGRAFKSFDVEC 574
           ++F    +++  + IG G +G V  A    + + VA+K    F  Q  C R  +    E 
Sbjct: 19  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EI 74
Query: 575 AMMKSIRHRNLV---KVISSCSNEEFKAL-VLEYMPHGSLEKYLHSSNYSLDIFQRLNIM 630
            ++   RH N++    +I + + E+ K + +++ +    L K L + + S D       +
Sbjct: 75  KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFL 132
Query: 631 IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE-DQSMTQTQT 689
             +   L+Y+H   SA V+H DLKPSN+LL+      + DFG+A++   + D +   T+ 
Sbjct: 133 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 189
Query: 690 LATIGYMAPEYGREGQVSTNG-DVYSFGIMLMETFTRK 726
           +AT  Y APE     +  T   D++S G +L E  + +
Sbjct: 190 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 97/222 (43%), Gaps = 27/222 (12%)
Query: 527 DKFSENNLIGRGGFGSVYKA------RIRDGMEVAVKVFNLQCGRA-FKSFDVECAMMKS 579
           D+      +GRG FG V +A      +      VAVK+       +  ++   E  ++  
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 580 IRHR-NLVKVISSCSNEEFKALVL-EYMPHGSLEKYLHSSNYSL--------DIFQRLNI 629
           I H  N+V ++ +C+      +V+ E+   G+L  YL S             D+++    
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 630 M-------IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 682
           +         VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+ +  +  
Sbjct: 147 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPD 203
Query: 683 SMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 724
            + +      + +MAPE   +   +   DV+SFG++L E F+
Sbjct: 204 XVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 106/218 (48%), Gaps = 21/218 (9%)
Query: 521 ELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKV---FNLQ--CGRAFKSFDVEC 574
           ++F    +++  + IG G +G V  A    + + VA+K    F  Q  C R  +    E 
Sbjct: 17  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EI 72
Query: 575 AMMKSIRHRNLV---KVISSCSNEEFKAL-VLEYMPHGSLEKYLHSSNYSLDIFQRLNIM 630
            ++   RH N++    +I + + E+ K + +++ +    L K L + + S D       +
Sbjct: 73  KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFL 130
Query: 631 IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE-DQSMTQTQT 689
             +   L+Y+H   SA V+H DLKPSN+LL+      + DFG+A++   + D +   T+ 
Sbjct: 131 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 187
Query: 690 LATIGYMAPEYGREGQVSTNG-DVYSFGIMLMETFTRK 726
           +AT  Y APE     +  T   D++S G +L E  + +
Sbjct: 188 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 106/218 (48%), Gaps = 21/218 (9%)
Query: 521 ELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKV---FNLQ--CGRAFKSFDVEC 574
           ++F    +++  + IG G +G V  A    + + VA+K    F  Q  C R  +    E 
Sbjct: 15  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EI 70
Query: 575 AMMKSIRHRNLV---KVISSCSNEEFKAL-VLEYMPHGSLEKYLHSSNYSLDIFQRLNIM 630
            ++   RH N++    +I + + E+ K + +++ +    L K L + + S D       +
Sbjct: 71  KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFL 128
Query: 631 IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE-DQSMTQTQT 689
             +   L+Y+H   SA V+H DLKPSN+LL+      + DFG+A++   + D +   T+ 
Sbjct: 129 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 185
Query: 690 LATIGYMAPEYGREGQVSTNG-DVYSFGIMLMETFTRK 726
           +AT  Y APE     +  T   D++S G +L E  + +
Sbjct: 186 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 91/200 (45%), Gaps = 11/200 (5%)
Query: 535 IGRGGFGSVYKAR-IRDGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISS 591
           IG+G F  V  AR I  G EVA+K+ +       + +    E  +MK + H N+VK+   
Sbjct: 20  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 79
Query: 592 CSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHC 651
              E+   L++EY   G +  YL +     +   R      + SA++Y H      ++H 
Sbjct: 80  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR-QIVSAVQYCH---QKRIVHR 135
Query: 652 DLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPE-YGREGQVSTNG 710
           DLK  N+LLD +M   ++DFG +   T   +  T      +  Y APE +  +       
Sbjct: 136 DLKAENLLLDADMNIKIADFGFSNEFTVGGKLDT---FCGSPPYAAPELFQGKKYDGPEV 192
Query: 711 DVYSFGIMLMETFTRKKPTD 730
           DV+S G++L    +   P D
Sbjct: 193 DVWSLGVILYTLVSGSLPFD 212

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 97/222 (43%), Gaps = 27/222 (12%)
Query: 527 DKFSENNLIGRGGFGSVYKA------RIRDGMEVAVKVFNLQCGRA-FKSFDVECAMMKS 579
           D+      +GRG FG V +A      +      VAVK+       +  ++   E  ++  
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 77
Query: 580 IRHR-NLVKVISSCSNEEFKALVL-EYMPHGSLEKYLHSSNYSL--------DIFQRLNI 629
           I H  N+V ++ +C+      +V+ E+   G+L  YL S             D+++    
Sbjct: 78  IGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 137
Query: 630 M-------IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 682
           +         VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+ +  +  
Sbjct: 138 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPD 194
Query: 683 SMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 724
            + +      + +MAPE   +   +   DV+SFG++L E F+
Sbjct: 195 XVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 106/218 (48%), Gaps = 21/218 (9%)
Query: 521 ELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKV---FNLQ--CGRAFKSFDVEC 574
           ++F    +++  + IG G +G V  A    + + VA+K    F  Q  C R  +    E 
Sbjct: 25  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EI 80
Query: 575 AMMKSIRHRNLV---KVISSCSNEEFKAL-VLEYMPHGSLEKYLHSSNYSLDIFQRLNIM 630
            ++   RH N++    +I + + E+ K + +++ +    L K L + + S D       +
Sbjct: 81  KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFL 138
Query: 631 IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE-DQSMTQTQT 689
             +   L+Y+H   SA V+H DLKPSN+LL+      + DFG+A++   + D +   T+ 
Sbjct: 139 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 195
Query: 690 LATIGYMAPEYGREGQVSTNG-DVYSFGIMLMETFTRK 726
           +AT  Y APE     +  T   D++S G +L E  + +
Sbjct: 196 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 106/218 (48%), Gaps = 21/218 (9%)
Query: 521 ELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKV---FNLQ--CGRAFKSFDVEC 574
           ++F    +++  + IG G +G V  A    + + VA+K    F  Q  C R  +    E 
Sbjct: 17  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EI 72
Query: 575 AMMKSIRHRNLV---KVISSCSNEEFKAL-VLEYMPHGSLEKYLHSSNYSLDIFQRLNIM 630
            ++   RH N++    +I + + E+ K + +++ +    L K L + + S D       +
Sbjct: 73  KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFL 130
Query: 631 IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE-DQSMTQTQT 689
             +   L+Y+H   SA V+H DLKPSN+LL+      + DFG+A++   + D +   T+ 
Sbjct: 131 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 187
Query: 690 LATIGYMAPEYGREGQVSTNG-DVYSFGIMLMETFTRK 726
           +AT  Y APE     +  T   D++S G +L E  + +
Sbjct: 188 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 97/222 (43%), Gaps = 27/222 (12%)
Query: 527 DKFSENNLIGRGGFGSVYKA------RIRDGMEVAVKVFNLQCGRA-FKSFDVECAMMKS 579
           D+      +GRG FG V +A      +      VAVK+       +  ++   E  ++  
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 77
Query: 580 IRHR-NLVKVISSCSNEEFKALVL-EYMPHGSLEKYLHSSNYSL--------DIFQRLNI 629
           I H  N+V ++ +C+      +V+ E+   G+L  YL S             D+++    
Sbjct: 78  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 137
Query: 630 M-------IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 682
           +         VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+ +  +  
Sbjct: 138 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPD 194
Query: 683 SMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 724
            + +      + +MAPE   +   +   DV+SFG++L E F+
Sbjct: 195 XVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 94/198 (47%), Gaps = 9/198 (4%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQC-GRAFKSFDV-ECAMMKSIRHRN 584
           +K+     IG G +G VYKA+   G   A+K   L+       S  + E +++K ++H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 585 LVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGY 644
           +VK+      ++   LV E++    L+K L      L+     + ++ + + + Y H   
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH--- 117
Query: 645 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY-GRE 703
              V+H DLKP N+L++      ++DFG+A+      +    T  + T+ Y AP+     
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY--THEVVTLWYRAPDVLMGS 175
Query: 704 GQVSTNGDVYSFGIMLME 721
            + ST  D++S G +  E
Sbjct: 176 KKYSTTIDIWSVGCIFAE 193

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 70/281 (24%), Positives = 128/281 (45%), Gaps = 39/281 (13%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCG--RAFKSFDVECAMMKSIRHRN--LVKVIS 590
           IG GG   V++         A+K  NL+    +   S+  E A +  ++  +  ++++  
Sbjct: 16  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 75
Query: 591 SCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIH 650
               +++  +V+E   +  L  +L     S+D ++R +      + LE +H  +   ++H
Sbjct: 76  YEITDQYIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYW---KNMLEAVHTIHQHGIVH 130
Query: 651 CDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVS-TN 709
            DLKP+N L+ D M+  L DFGIA  +  +  S+ +   + T+ YM PE  ++   S  N
Sbjct: 131 SDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSREN 189
Query: 710 G----------DVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANL 759
           G          DV+S G +L      K P  ++ N +++  H + D  P   +E  D   
Sbjct: 190 GKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-QISKLHAIID--PNHEIEFPD--- 243
Query: 760 LSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVA 800
           + ++D+  V K  C          C    P+QRI+  E++A
Sbjct: 244 IPEKDLQDVLK--C----------CLKRDPKQRISIPELLA 272

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 106/218 (48%), Gaps = 21/218 (9%)
Query: 521 ELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKV---FNLQ--CGRAFKSFDVEC 574
           ++F    +++  + IG G +G V  A    + + VA+K    F  Q  C R  +    E 
Sbjct: 37  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EI 92
Query: 575 AMMKSIRHRNLV---KVISSCSNEEFKAL-VLEYMPHGSLEKYLHSSNYSLDIFQRLNIM 630
            ++   RH N++    +I + + E+ K + +++ +    L K L + + S D       +
Sbjct: 93  KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFL 150
Query: 631 IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE-DQSMTQTQT 689
             +   L+Y+H   SA V+H DLKPSN+LL+      + DFG+A++   + D +   T+ 
Sbjct: 151 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 207
Query: 690 LATIGYMAPEYGREGQVSTNG-DVYSFGIMLMETFTRK 726
           +AT  Y APE     +  T   D++S G +L E  + +
Sbjct: 208 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Composition-based stats.
 Identities = 55/210 (26%), Positives = 97/210 (46%), Gaps = 21/210 (10%)
Query: 541 GSVYKARIRDGMEVAVKVFNLQ--CGRAFKSFDVECAMMKSIRHRNLVKVISSCSN--EE 596
           G ++K R + G ++ VKV  ++    R  + F+ EC  ++   H N++ V+ +C +    
Sbjct: 24  GELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82
Query: 597 FKALVLEYMPHGSLEKYLHS-SNYSLDIFQRLNIMIDVASALEYLHFGYSAPVI--HCDL 653
              L+  + P+GSL   LH  +N+ +D  Q +   +D A    +LH     P+I  H  L
Sbjct: 83  HPTLITHWXPYGSLYNVLHEGTNFVVDQSQAVKFALDXARGXAFLH--TLEPLIPRHA-L 139
Query: 654 KPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTN---G 710
              +V +D++  A +S   +         S           ++APE  ++    TN    
Sbjct: 140 NSRSVXIDEDXTARISXADVKF-------SFQSPGRXYAPAWVAPEALQKKPEDTNRRSA 192
Query: 711 DVYSFGIMLMETFTRKKPTDELFNGEMTLK 740
           D +SF ++L E  TR+ P  +L N E+  K
Sbjct: 193 DXWSFAVLLWELVTREVPFADLSNXEIGXK 222

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 70/281 (24%), Positives = 128/281 (45%), Gaps = 39/281 (13%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCG--RAFKSFDVECAMMKSIRHRN--LVKVIS 590
           IG GG   V++         A+K  NL+    +   S+  E A +  ++  +  ++++  
Sbjct: 36  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95
Query: 591 SCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIH 650
               +++  +V+E   +  L  +L     S+D ++R +      + LE +H  +   ++H
Sbjct: 96  YEITDQYIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYW---KNMLEAVHTIHQHGIVH 150
Query: 651 CDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVS-TN 709
            DLKP+N L+ D M+  L DFGIA  +  +  S+ +   + T+ YM PE  ++   S  N
Sbjct: 151 SDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSREN 209
Query: 710 G----------DVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANL 759
           G          DV+S G +L      K P  ++ N +++  H + D  P   +E  D   
Sbjct: 210 GKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-QISKLHAIID--PNHEIEFPD--- 263
Query: 760 LSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVA 800
           + ++D+  V K  C          C    P+QRI+  E++A
Sbjct: 264 IPEKDLQDVLK--C----------CLKRDPKQRISIPELLA 292

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 78/287 (27%), Positives = 124/287 (43%), Gaps = 29/287 (10%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRDGME-VAVKVFNLQ-CGRAFKSFDVECAMMKSIRHRN 584
           D +    +IG G    V  A      E VA+K  NL+ C  +      E   M    H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 585 LVKVISSCSNEEFKALVLEYMPHGSL--------EKYLHSSNYSLDIFQRLNIMIDVASA 636
           +V   +S   ++   LV++ +  GS+         K  H S   LD      I+ +V   
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGV-LDESTIATILREVLEG 133
Query: 637 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-TGEDQSMTQTQT--LATI 693
           LEYLH       IH D+K  N+LL ++    ++DFG++  L TG D +  + +   + T 
Sbjct: 134 LEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190
Query: 694 GYMAPEYGREGQ-VSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTM 752
            +MAPE   + +      D++SFGI  +E  T   P  +    ++ +    ND   + T 
Sbjct: 191 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLET- 249
Query: 753 EVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIV 799
            V D  +L         K+   SF   ++L C  + PE+R  A E++
Sbjct: 250 GVQDKEML---------KKYGKSFRKMISL-CLQKDPEKRPTAAELL 286

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 89/193 (46%), Gaps = 12/193 (6%)
Query: 535 IGRGGFGSV----YKARIRDGMEVAVKVF-NLQCGRAFKSFDVECAMMKSIRHRNLVKVI 589
           IG G FG V    Y +     M VA+K   N       + F  E   M+   H ++VK+I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 590 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVI 649
              + E    +++E    G L  +L    +SLD+   +     +++AL YL    S   +
Sbjct: 458 GVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFV 513
Query: 650 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQ-TQTLATIGYMAPEYGREGQVST 708
           H D+   NVL+       L DFG+++ +  ED +  + ++    I +MAPE     + ++
Sbjct: 514 HRDIAARNVLVSATDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAPESINFRRFTS 571
Query: 709 NGDVYSFGIMLME 721
             DV+ FG+ + E
Sbjct: 572 ASDVWMFGVCMWE 584

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 97/222 (43%), Gaps = 27/222 (12%)
Query: 527 DKFSENNLIGRGGFGSVYKA------RIRDGMEVAVKVFNLQCGRA-FKSFDVECAMMKS 579
           D+      +GRG FG V +A      +      VAVK+       +  ++   E  ++  
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 580 IRHR-NLVKVISSCSNEEFKALVL-EYMPHGSLEKYLHSSNYSL--------DIFQRLNI 629
           I H  N+V ++ +C+      +V+ E+   G+L  YL S             D+++    
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 630 M-------IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 682
           +         VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+ +  +  
Sbjct: 147 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 203
Query: 683 SMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 724
            + +      + +MAPE   +   +   DV+SFG++L E F+
Sbjct: 204 XVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 70/281 (24%), Positives = 128/281 (45%), Gaps = 39/281 (13%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCG--RAFKSFDVECAMMKSIRHRN--LVKVIS 590
           IG GG   V++         A+K  NL+    +   S+  E A +  ++  +  ++++  
Sbjct: 17  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 76
Query: 591 SCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIH 650
               +++  +V+E   +  L  +L     S+D ++R +      + LE +H  +   ++H
Sbjct: 77  YEITDQYIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYW---KNMLEAVHTIHQHGIVH 131
Query: 651 CDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVS-TN 709
            DLKP+N L+ D M+  L DFGIA  +  +  S+ +   + T+ YM PE  ++   S  N
Sbjct: 132 SDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSREN 190
Query: 710 G----------DVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANL 759
           G          DV+S G +L      K P  ++ N +++  H + D  P   +E  D   
Sbjct: 191 GKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-QISKLHAIID--PNHEIEFPD--- 244
Query: 760 LSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVA 800
           + ++D+  V K  C          C    P+QRI+  E++A
Sbjct: 245 IPEKDLQDVLK--C----------CLKRDPKQRISIPELLA 273

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 18/205 (8%)
Query: 534 LIGRGGFGSVYKARIRDGMEV-AVKVFNL-----QCGRAFKSFDVECAMMKSIRHRNLVK 587
           +IGRG FG V   R +   +V A+K+ +      +   AF  F  E  +M       +V+
Sbjct: 81  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF--FWEERDIMAFANSPWVVQ 138
Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAP 647
           +  +  ++ +  +V+EYMP G L   +  SNY +          +V  AL+ +H   S  
Sbjct: 139 LFYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARFYTAEVVLALDAIH---SMG 193
Query: 648 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPE----YGRE 703
            IH D+KP N+LLD +    L+DFG    +  E      T  + T  Y++PE     G +
Sbjct: 194 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISPEVLKSQGGD 252
Query: 704 GQVSTNGDVYSFGIMLMETFTRKKP 728
           G      D +S G+ L E      P
Sbjct: 253 GYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 107/232 (46%), Gaps = 28/232 (12%)
Query: 532 NNLIGRGGFGSVYKARIRD-GMEVAVKVFN-LQCGRAFKSFDVECAMMKSIRHRNLVKV- 588
           ++++G+G   +V++ R +  G   A+KVFN +   R       E  ++K + H+N+VK+ 
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 589 -ISSCSNEEFKALVLEYMPHGSLEKYLH--SSNYSLDIFQRLNIMIDVASALEYLHFGYS 645
            I   +    K L++E+ P GSL   L   S+ Y L   + L ++ DV   + +L     
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---E 130
Query: 646 APVIHCDLKPSNVLL----DDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYG 701
             ++H ++KP N++     D   V  L+DFG A+ L  ++Q ++      T  Y+ P   
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS---LYGTEEYLHP--- 184
Query: 702 REGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTME 753
                    D+Y   ++  +   +   T +L++  +T  H     LP    E
Sbjct: 185 ---------DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 105/221 (47%), Gaps = 22/221 (9%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRDGMEV-AVKVFNLQCGRAFKSFDVECAMMK------S 579
           + F  + ++G+G FG V+ A  +   +  A+K   L+        DVEC M++      +
Sbjct: 17  EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLA 74
Query: 580 IRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEY 639
             H  L  +  +   +E    V+EY+  G L  ++ S  +  D+ +      ++   L++
Sbjct: 75  WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQF 133
Query: 640 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL-LTGEDQSMTQTQTLATIGYMAP 698
           LH   S  +++ DLK  N+LLD +    ++DFG+ K  + G+ ++        T  Y+AP
Sbjct: 134 LH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT---NXFCGTPDYIAP 187
Query: 699 EYGREGQVSTNGDVYSFGIMLMETFTRKKP-----TDELFN 734
           E     + + + D +SFG++L E    + P      +ELF+
Sbjct: 188 EILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH 228

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 105/219 (47%), Gaps = 23/219 (10%)
Query: 521 ELFQATDKFSENNLIGRGGFGSVYKA-----RIRDGMEVAVKVFNLQ--CGRAFKSFDVE 573
           ++F    +++  + IG G +G V  A     ++R  +   +  F  Q  C R  +    E
Sbjct: 21  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIR-KISPFEHQTYCQRTLR----E 75
Query: 574 CAMMKSIRHRNLV---KVISSCSNEEFKAL-VLEYMPHGSLEKYLHSSNYSLDIFQRLNI 629
             ++   RH N++    +I + + E+ K + +++ +    L K L + + S D       
Sbjct: 76  IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYF 133
Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE-DQSMTQTQ 688
           +  +   L+Y+H   SA V+H DLKPSN+LL+      + DFG+A++   + D +   T+
Sbjct: 134 LYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 190
Query: 689 TLATIGYMAPEYGREGQVSTNG-DVYSFGIMLMETFTRK 726
            +AT  Y APE     +  T   D++S G +L E  + +
Sbjct: 191 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 88/199 (44%), Gaps = 13/199 (6%)
Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDV---ECAMMKSIRH 582
           D+F     IG G FG V   + +  G   A+K+ + Q     K  +    E  +++++  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
             LVK+  S  +     +V+EYMP G +  +L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 703 EGQVSTNGDVYSFGIMLME 721
               +   D ++ G+++ E
Sbjct: 212 SKGYNKAVDWWALGVLIYE 230

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 88/199 (44%), Gaps = 13/199 (6%)
Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDV---ECAMMKSIRH 582
           D+F     IG G FG V   + +  G   A+K+ + Q     K  +    E  +++++  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
             LVK+  S  +     +V+EYMP G +  +L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 703 EGQVSTNGDVYSFGIMLME 721
               +   D ++ G+++ E
Sbjct: 212 SKGYNKAVDWWALGVLIYE 230

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 18/205 (8%)
Query: 534 LIGRGGFGSVYKARIRDGMEV-AVKVFNL-----QCGRAFKSFDVECAMMKSIRHRNLVK 587
           +IGRG FG V   R +   +V A+K+ +      +   AF  F  E  +M       +V+
Sbjct: 76  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF--FWEERDIMAFANSPWVVQ 133
Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAP 647
           +  +  ++ +  +V+EYMP G L   +  SNY +          +V  AL+ +H   S  
Sbjct: 134 LFYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARFYTAEVVLALDAIH---SMG 188
Query: 648 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPE----YGRE 703
            IH D+KP N+LLD +    L+DFG    +  E      T  + T  Y++PE     G +
Sbjct: 189 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISPEVLKSQGGD 247
Query: 704 GQVSTNGDVYSFGIMLMETFTRKKP 728
           G      D +S G+ L E      P
Sbjct: 248 GYYGRECDWWSVGVFLYEMLVGDTP 272

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 91/203 (44%), Gaps = 17/203 (8%)
Query: 535 IGRGGFGSVYKAR-IRDGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISS 591
           IG+G F  V  AR I  G EVA+K+ +       + +    E  +MK + H N+VK+   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 592 CSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHC 651
              E+   L++EY   G +  YL +     +   R      + SA++Y H      ++H 
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR-QIVSAVQYCH---QKRIVHR 138
Query: 652 DLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIG---YMAPE-YGREGQVS 707
           DLK  N+LLD +M   ++DFG +   T         +  A  G   Y APE +  +    
Sbjct: 139 DLKAENLLLDADMNIKIADFGFSNEFT------VGGKLDAFCGAPPYAAPELFQGKKYDG 192
Query: 708 TNGDVYSFGIMLMETFTRKKPTD 730
              DV+S G++L    +   P D
Sbjct: 193 PEVDVWSLGVILYTLVSGSLPFD 215

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 105/218 (48%), Gaps = 21/218 (9%)
Query: 521 ELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKV---FNLQ--CGRAFKSFDVEC 574
           ++F    +++  + IG G +G V  A    + + VA+K    F  Q  C R  +    E 
Sbjct: 21  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EI 76
Query: 575 AMMKSIRHRNLV---KVISSCSNEEFKAL-VLEYMPHGSLEKYLHSSNYSLDIFQRLNIM 630
            ++   RH N++    +I + + E+ K + +++ +    L K L   + S D       +
Sbjct: 77  KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSND--HICYFL 134
Query: 631 IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE-DQSMTQTQT 689
             +   L+Y+H   SA V+H DLKPSN+LL+      + DFG+A++   + D +   T+ 
Sbjct: 135 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 191
Query: 690 LATIGYMAPEYGREGQVSTNG-DVYSFGIMLMETFTRK 726
           +AT  Y APE     +  T   D++S G +L E  + +
Sbjct: 192 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 51/219 (23%), Positives = 101/219 (46%), Gaps = 12/219 (5%)
Query: 516 RFSYLELFQAT-DKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDV-- 572
           ++ +LE    T + F +  ++G+GGFG V   ++R   ++       +     +  +   
Sbjct: 172 QWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA 231
Query: 573 --ECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYL-HSSNYSLDIFQRLNI 629
             E  +++ +  R +V +  +   ++   LVL  M  G L+ ++ H         + +  
Sbjct: 232 LNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFY 291
Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
             ++   LE LH      +++ DLKP N+LLDD+    +SD G+A  +    +  T    
Sbjct: 292 AAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVP---EGQTIKGR 345
Query: 690 LATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKP 728
           + T+GYMAPE  +  + + + D ++ G +L E    + P
Sbjct: 346 VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 97/222 (43%), Gaps = 27/222 (12%)
Query: 527 DKFSENNLIGRGGFGSVYKA------RIRDGMEVAVKVFNLQCGRA-FKSFDVECAMMKS 579
           D+      +GRG FG V +A      +      VAVK+       +  ++   E  ++  
Sbjct: 64  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 123
Query: 580 IRHR-NLVKVISSCSNEEFKALVL-EYMPHGSLEKYLHSSNYSL--------DIFQRLNI 629
           I H  N+V ++ +C+      +V+ E+   G+L  YL S             D+++    
Sbjct: 124 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 183
Query: 630 M-------IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 682
           +         VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+ +  +  
Sbjct: 184 LEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 240
Query: 683 SMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 724
            + +      + +MAPE   +   +   DV+SFG++L E F+
Sbjct: 241 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 51/219 (23%), Positives = 101/219 (46%), Gaps = 12/219 (5%)
Query: 516 RFSYLELFQAT-DKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDV-- 572
           ++ +LE    T + F +  ++G+GGFG V   ++R   ++       +     +  +   
Sbjct: 172 QWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA 231
Query: 573 --ECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYL-HSSNYSLDIFQRLNI 629
             E  +++ +  R +V +  +   ++   LVL  M  G L+ ++ H         + +  
Sbjct: 232 LNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFY 291
Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
             ++   LE LH      +++ DLKP N+LLDD+    +SD G+A  +    +  T    
Sbjct: 292 AAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVP---EGQTIKGR 345
Query: 690 LATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKP 728
           + T+GYMAPE  +  + + + D ++ G +L E    + P
Sbjct: 346 VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 18/205 (8%)
Query: 534 LIGRGGFGSVYKARIRDGMEV-AVKVFNL-----QCGRAFKSFDVECAMMKSIRHRNLVK 587
           +IGRG FG V   R +   +V A+K+ +      +   AF  F  E  +M       +V+
Sbjct: 81  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF--FWEERDIMAFANSPWVVQ 138
Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAP 647
           +  +  ++ +  +V+EYMP G L   +  SNY +          +V  AL+ +H   S  
Sbjct: 139 LFYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARFYTAEVVLALDAIH---SMG 193
Query: 648 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPE----YGRE 703
            IH D+KP N+LLD +    L+DFG    +  E      T  + T  Y++PE     G +
Sbjct: 194 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISPEVLKSQGGD 252
Query: 704 GQVSTNGDVYSFGIMLMETFTRKKP 728
           G      D +S G+ L E      P
Sbjct: 253 GYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 97/222 (43%), Gaps = 27/222 (12%)
Query: 527 DKFSENNLIGRGGFGSVYKA------RIRDGMEVAVKVFNLQCGRA-FKSFDVECAMMKS 579
           D+      +GRG FG V +A      +      VAVK+       +  ++   E  ++  
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 580 IRHR-NLVKVISSCSNEEFKALVL-EYMPHGSLEKYLHSSNYSL--------DIFQRLNI 629
           I H  N+V ++ +C+      +V+ E+   G+L  YL S             D+++    
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 630 M-------IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 682
           +         VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+ +  +  
Sbjct: 147 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 203
Query: 683 SMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 724
            + +      + +MAPE   +   +   DV+SFG++L E F+
Sbjct: 204 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 18/208 (8%)
Query: 533 NLIGRGGFGSVYKARIRDG--------MEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRN 584
            ++G G +G V+  R   G        M+V  K   +Q  +  +    E  +++ IR   
Sbjct: 60  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119
Query: 585 LVKVISSCSNEEFK-ALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMI-DVASALEYLHF 642
            +  +      E K  L+L+Y+  G L  + H S         + I + ++  ALE+LH 
Sbjct: 120 FLVTLHYAFQTETKLHLILDYINGGEL--FTHLSQRERFTEHEVQIYVGEIVLALEHLH- 176
Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
                +I+ D+K  N+LLD N    L+DFG++K     D++        TI YMAP+  R
Sbjct: 177 --KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA-DETERAYDFCGTIEYMAPDIVR 233
Query: 703 EGQVSTNG--DVYSFGIMLMETFTRKKP 728
            G    +   D +S G+++ E  T   P
Sbjct: 234 GGDSGHDKAVDWWSLGVLMYELLTGASP 261

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 106/232 (45%), Gaps = 28/232 (12%)
Query: 532 NNLIGRGGFGSVYKARIRD-GMEVAVKVFN-LQCGRAFKSFDVECAMMKSIRHRNLVKV- 588
           ++++G+G   +V++ R +  G   A+KVFN +   R       E  ++K + H+N+VK+ 
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 589 -ISSCSNEEFKALVLEYMPHGSLEKYLH--SSNYSLDIFQRLNIMIDVASALEYLHFGYS 645
            I   +    K L++E+ P GSL   L   S+ Y L   + L ++ DV   + +L     
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---E 130
Query: 646 APVIHCDLKPSNVLL----DDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYG 701
             ++H ++KP N++     D   V  L+DFG A+ L  ++Q +       T  Y+ P   
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVX---LYGTEEYLHP--- 184
Query: 702 REGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTME 753
                    D+Y   ++  +   +   T +L++  +T  H     LP    E
Sbjct: 185 ---------DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 97/222 (43%), Gaps = 27/222 (12%)
Query: 527 DKFSENNLIGRGGFGSVYKA------RIRDGMEVAVKVFNLQCGRA-FKSFDVECAMMKS 579
           D+      +GRG FG V +A      +      VAVK+       +  ++   E  ++  
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 77
Query: 580 IRHR-NLVKVISSCSNEEFKALVL-EYMPHGSLEKYLHSSNYSL--------DIFQRLNI 629
           I H  N+V ++ +C+      +V+ E+   G+L  YL S             D+++    
Sbjct: 78  IGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 137
Query: 630 M-------IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 682
           +         VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+ +  +  
Sbjct: 138 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 194
Query: 683 SMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 724
            + +      + +MAPE   +   +   DV+SFG++L E F+
Sbjct: 195 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 97/222 (43%), Gaps = 27/222 (12%)
Query: 527 DKFSENNLIGRGGFGSVYKA------RIRDGMEVAVKVFNLQCGRA-FKSFDVECAMMKS 579
           D+      +GRG FG V +A      +      VAVK+       +  ++   E  ++  
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 77
Query: 580 IRHR-NLVKVISSCSNEEFKALVL-EYMPHGSLEKYLHSSNYSL--------DIFQRLNI 629
           I H  N+V ++ +C+      +V+ E+   G+L  YL S             D+++    
Sbjct: 78  IGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 137
Query: 630 M-------IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 682
           +         VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+ +  +  
Sbjct: 138 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 194
Query: 683 SMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 724
            + +      + +MAPE   +   +   DV+SFG++L E F+
Sbjct: 195 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 97/222 (43%), Gaps = 27/222 (12%)
Query: 527 DKFSENNLIGRGGFGSVYKA------RIRDGMEVAVKVFNLQCGRA-FKSFDVECAMMKS 579
           D+      +GRG FG V +A      +      VAVK+       +  ++   E  ++  
Sbjct: 29  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 88
Query: 580 IRHR-NLVKVISSCSNEEFKALVL-EYMPHGSLEKYLHSSNYSL--------DIFQRLNI 629
           I H  N+V ++ +C+      +V+ E+   G+L  YL S             D+++    
Sbjct: 89  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLT 148
Query: 630 M-------IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 682
           +         VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+ +  +  
Sbjct: 149 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 205
Query: 683 SMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 724
            + +      + +MAPE   +   +   DV+SFG++L E F+
Sbjct: 206 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 247

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 99/217 (45%), Gaps = 23/217 (10%)
Query: 523 FQATDKFSENNLIGRGGFGSVYKA--RIRDGMEVAVKV---FNLQ--CGRAFKSFDVECA 575
           F    ++++   IG G +G V  A   +R    VA+K    F  Q  C R  +    E  
Sbjct: 39  FDVGPRYTQLQYIGEGAYGMVSSAYDHVRK-TRVAIKKISPFEHQTYCQRTLR----EIQ 93
Query: 576 MMKSIRHRNLVKVISSCSNEEFKAL----VLEYMPHGSLEKYLHSSNYSLDIFQRLNIMI 631
           ++   RH N++ +         +A+    +++ +    L K L S   S D       + 
Sbjct: 94  ILLRFRHENVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHI--CYFLY 151
Query: 632 DVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE-DQSMTQTQTL 690
            +   L+Y+H   SA V+H DLKPSN+L++      + DFG+A++   E D +   T+ +
Sbjct: 152 QILRGLKYIH---SANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXV 208
Query: 691 ATIGYMAPEYGREGQVSTNG-DVYSFGIMLMETFTRK 726
           AT  Y APE     +  T   D++S G +L E  + +
Sbjct: 209 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 91/200 (45%), Gaps = 15/200 (7%)
Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDV---ECAMMKSIRH 582
           D+F     +G G FG V   + +  G   A+K+ + Q     K  +    E  +++++  
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 86
Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
             LVK+  S  +     +V+EY+P G +  +L       +   R      +    EYLH 
Sbjct: 87  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 144
Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTL-ATIGYMAPEYG 701
             S  +I+ DLKP N+L+D      ++DFG AK + G      +T TL  T  Y+APE  
Sbjct: 145 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWTLCGTPEYLAPEII 196
Query: 702 REGQVSTNGDVYSFGIMLME 721
                +   D ++ G+++ E
Sbjct: 197 LSKGYNKAVDWWALGVLIYE 216

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 97/211 (45%), Gaps = 38/211 (18%)
Query: 533 NLIGRGGFGSVYKARIRDGMEV----AVKVFN---LQCGRAFKSFDVECAMMKSIRHRNL 585
            ++G+G FG V+  +   G +     A+KV     L+     ++  +E  ++  + H  +
Sbjct: 31  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILVEVNHPFI 89
Query: 586 VKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLN------------IMIDV 633
           VK+  +   E    L+L+++  G             D+F RL+             + ++
Sbjct: 90  VKLHYAFQTEGKLYLILDFLRGG-------------DLFTRLSKEVMFTEEDVKFYLAEL 136
Query: 634 ASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATI 693
           A AL++LH   S  +I+ DLKP N+LLD+     L+DFG++K     D          T+
Sbjct: 137 ALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTV 191
Query: 694 GYMAPEYGREGQVSTNGDVYSFGIMLMETFT 724
            YMAPE       + + D +SFG+++ E  T
Sbjct: 192 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLT 222

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 97/211 (45%), Gaps = 38/211 (18%)
Query: 533 NLIGRGGFGSVYKARIRDGMEV----AVKVFN---LQCGRAFKSFDVECAMMKSIRHRNL 585
            ++G+G FG V+  +   G +     A+KV     L+     ++  +E  ++  + H  +
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILVEVNHPFI 88
Query: 586 VKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLN------------IMIDV 633
           VK+  +   E    L+L+++  G             D+F RL+             + ++
Sbjct: 89  VKLHYAFQTEGKLYLILDFLRGG-------------DLFTRLSKEVMFTEEDVKFYLAEL 135
Query: 634 ASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATI 693
           A AL++LH   S  +I+ DLKP N+LLD+     L+DFG++K     D          T+
Sbjct: 136 ALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTV 190
Query: 694 GYMAPEYGREGQVSTNGDVYSFGIMLMETFT 724
            YMAPE       + + D +SFG+++ E  T
Sbjct: 191 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLT 221

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 97/202 (48%), Gaps = 20/202 (9%)
Query: 533 NLIGRGGFGSVYKARIRDGMEV----AVKVFN---LQCGRAFKSFDVECAMMKSIRHRNL 585
            ++G+G FG V+  +   G +     A+KV     L+     ++  +E  ++  + H  +
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILVEVNHPFI 88
Query: 586 VKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNI---MIDVASALEYLHF 642
           VK+  +   E    L+L+++  G L   L        +F   ++   + ++A AL++LH 
Sbjct: 89  VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV----MFTEEDVKFYLAELALALDHLH- 143
Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
             S  +I+ DLKP N+LLD+     L+DFG++K     D          T+ YMAPE   
Sbjct: 144 --SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVN 199
Query: 703 EGQVSTNGDVYSFGIMLMETFT 724
               + + D +SFG+++ E  T
Sbjct: 200 RRGHTQSADWWSFGVLMFEMLT 221

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 78/172 (45%), Gaps = 25/172 (14%)
Query: 633 VASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLAT 692
           VA  +E+L    S   IH DL   N+LL +N V  + DFG+A+ +      + +  T   
Sbjct: 208 VARGMEFLS---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLP 264
Query: 693 IGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTM 752
           + +MAPE   +   ST  DV+S+G++L E F+          G            P   +
Sbjct: 265 LKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS--------LGGS-----------PYPGV 305
Query: 753 EVVDANLLS--QEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL 802
           + +D +  S  +E +   A E     ++ + L+C    P++R    E+V KL
Sbjct: 306 Q-MDEDFCSRLREGMRMRAPEYSTPEIYQIMLDCWHRDPKERPRFAELVEKL 356

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 70/267 (26%), Positives = 122/267 (45%), Gaps = 28/267 (10%)
Query: 535 IGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCS 593
           IG G  G V  A +R  G  VAVK  +L+  +  +    E  +M+  +H N+V++ +S  
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 594 NEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 653
             +   +V+E++  G+L   +  ++  ++  Q   + + V  AL  LH   +  VIH D+
Sbjct: 88  VGDELWVVMEFLEGGALTDIV--THTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 142
Query: 654 KPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVY 713
           K  ++LL  +    LSDFG    ++ E     +   + T  +MAPE           D++
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAPELISRLPYGPEVDIW 200
Query: 714 SFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ-EDIHFVAKEQ 772
           S GIM++E    + P    FN             P+  M+++  NL  + +++H V+   
Sbjct: 201 SLGIMVIEMVDGEPP---YFNEP-----------PLKAMKMIRDNLPPRLKNLHKVSP-S 245
Query: 773 CVSFVFNLALECTVESPEQRINAKEIV 799
              F+  L     V  P QR  A E++
Sbjct: 246 LKGFLDRL----LVRDPAQRATAAELL 268

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 89/199 (44%), Gaps = 13/199 (6%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDV---ECAMMKSIRH 582
           D+F     +G G FG V   + ++ G   A+K+ + Q     K  +    E  +++++  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
             LVK+  S  +     +V+EY+P G +  +L       +   R      +    EYLH 
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 151
Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+APE   
Sbjct: 152 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 204
Query: 703 EGQVSTNGDVYSFGIMLME 721
               +   D ++ G+++ E
Sbjct: 205 SKGYNKAVDWWALGVLIYE 223

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 101/225 (44%), Gaps = 30/225 (13%)
Query: 522 LFQATDKFSENNLIGRGGFGSVYKARIRDGME-VAVK--------VFNLQCGRAFKSFDV 572
           ++  +  F   +L+G G +G V  A  +   E VA+K        +F L+  R  K    
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIK---- 61
Query: 573 ECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMID 632
              ++K  +H N++ + +    + F+     Y+    ++  LH    S  +    +I   
Sbjct: 62  ---ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRV-ISTQMLSDDHIQYF 117
Query: 633 VASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL----------TGEDQ 682
           +   L  +   + + VIH DLKPSN+L++ N    + DFG+A+++          TG+  
Sbjct: 118 IYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 683 SMTQTQTLATIGYMAPEYG-REGQVSTNGDVYSFGIMLMETFTRK 726
            M   + +AT  Y APE      + S   DV+S G +L E F R+
Sbjct: 178 GM--VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 105/222 (47%), Gaps = 39/222 (17%)
Query: 522 LFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFN------LQCGRAFKSFDVEC 574
           +++  +++   + IG G +GSV  A   + G+ VAVK  +      +   R ++    E 
Sbjct: 22  IWEVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----EL 77
Query: 575 AMMKSIRHRNLVKVIS----SCSNEEFKALVL-EYMPHGSLEKYLHSSNYSLDIFQRLNI 629
            ++K ++H N++ ++     + S EEF  + L  ++    L   +     + D  Q L  
Sbjct: 78  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL-- 135
Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
           +  +   L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+     D  MT    
Sbjct: 136 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLAR---HTDDEMT---- 185
Query: 690 LATIGYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 724
               GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 186 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 223

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 70/267 (26%), Positives = 122/267 (45%), Gaps = 28/267 (10%)
Query: 535 IGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCS 593
           IG G  G V  A +R  G  VAVK  +L+  +  +    E  +M+  +H N+V++ +S  
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 91
Query: 594 NEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 653
             +   +V+E++  G+L   +  ++  ++  Q   + + V  AL  LH   +  VIH D+
Sbjct: 92  VGDELWVVMEFLEGGALTDIV--THTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 146
Query: 654 KPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVY 713
           K  ++LL  +    LSDFG    ++ E     +   + T  +MAPE           D++
Sbjct: 147 KSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAPELISRLPYGPEVDIW 204
Query: 714 SFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ-EDIHFVAKEQ 772
           S GIM++E    + P    FN             P+  M+++  NL  + +++H V+   
Sbjct: 205 SLGIMVIEMVDGEPP---YFNEP-----------PLKAMKMIRDNLPPRLKNLHKVSP-S 249
Query: 773 CVSFVFNLALECTVESPEQRINAKEIV 799
              F+  L     V  P QR  A E++
Sbjct: 250 LKGFLDRL----LVRDPAQRATAAELL 272

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 21/218 (9%)
Query: 521 ELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKV---FNLQ--CGRAFKSFDVEC 574
           ++F    +++  + IG G +G V  A    + + VA+K    F  Q  C R  +    E 
Sbjct: 21  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EI 76
Query: 575 AMMKSIRHRNLV---KVISSCSNEEFKAL-VLEYMPHGSLEKYLHSSNYSLDIFQRLNIM 630
            ++   RH N++    +I + + E+ K + +++ +    L K L + + S D       +
Sbjct: 77  KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFL 134
Query: 631 IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE-DQSMTQTQT 689
             +   L+Y+H   SA V+H DLKPSN+LL+      + DFG+A++   + D +    + 
Sbjct: 135 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEX 191
Query: 690 LATIGYMAPEYGREGQVSTNG-DVYSFGIMLMETFTRK 726
           +AT  Y APE     +  T   D++S G +L E  + +
Sbjct: 192 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 97/212 (45%), Gaps = 18/212 (8%)
Query: 533 NLIGRGGFGSVYKARIRDG--------MEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRN 584
            ++G+GG+G V++ R   G        M+V  K   ++  +       E  +++ ++H  
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 585 LVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGY 644
           +V +I +        L+LEY+  G L   L      ++       + +++ AL +LH   
Sbjct: 83  IVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACF-YLAEISMALGHLH--- 138
Query: 645 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG 704
              +I+ DLKP N++L+      L+DFG+ K  +  D ++T T    TI YMAPE     
Sbjct: 139 QKGIIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHT-FCGTIEYMAPEILMRS 196
Query: 705 QVSTNGDVYSFGIMLMETFTRKKPTDELFNGE 736
             +   D +S G ++ +  T   P    F GE
Sbjct: 197 GHNRAVDWWSLGALMYDMLTGAPP----FTGE 224

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 70/281 (24%), Positives = 129/281 (45%), Gaps = 39/281 (13%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCG--RAFKSFDVECAMMKSIRHRN--LVKVIS 590
           IG GG   V++         A+K  NL+    +   S+  E A +  ++  +  ++++  
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 591 SCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIH 650
               +++  +V+E   +  L  +L     S+D ++R +   ++   LE +H  +   ++H
Sbjct: 124 YEITDQYIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNM---LEAVHTIHQHGIVH 178
Query: 651 CDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVS-TN 709
            DLKP+N L+ D M+  L DFGIA  +  +  S+ +   + T+ YM PE  ++   S  N
Sbjct: 179 SDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSREN 237
Query: 710 G----------DVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANL 759
           G          DV+S G +L      K P  ++ N +++  H + D  P   +E  D   
Sbjct: 238 GKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-QISKLHAIID--PNHEIEFPD--- 291
Query: 760 LSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVA 800
           + ++D+  V K  C          C    P+QRI+  E++A
Sbjct: 292 IPEKDLQDVLK--C----------CLKRDPKQRISIPELLA 320

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 21/218 (9%)
Query: 521 ELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKV---FNLQ--CGRAFKSFDVEC 574
           ++F    +++  + IG G +G V  A    + + VA+K    F  Q  C R  +    E 
Sbjct: 22  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EI 77
Query: 575 AMMKSIRHRNLV---KVISSCSNEEFKAL-VLEYMPHGSLEKYLHSSNYSLDIFQRLNIM 630
            ++   RH N++    +I + + E+ K + +++ +    L K L + + S D       +
Sbjct: 78  KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFL 135
Query: 631 IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE-DQSMTQTQT 689
             +   L+Y+H   SA V+H DLKPSN+LL+      + DFG+A++   + D +    + 
Sbjct: 136 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEX 192
Query: 690 LATIGYMAPEYGREGQVSTNG-DVYSFGIMLMETFTRK 726
           +AT  Y APE     +  T   D++S G +L E  + +
Sbjct: 193 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 82/318 (25%), Positives = 142/318 (44%), Gaps = 42/318 (13%)
Query: 497 KREKGPPNDPNMP--PVATWRRFSYLELFQAT----------DKFSENNL-IGRGGFGSV 543
           ++E G P  P  P  P    +R S+ E F+A             + +N + IG G  G V
Sbjct: 32  RQENGMPEKPPGPRSPQREPQRVSH-EQFRAALQLVVDPGDPRSYLDNFIKIGEGSTGIV 90
Query: 544 YKARIRD-GMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVL 602
             A +R  G  VAVK  +L+  +  +    E  +M+  +H N+V++ +S    +   +V+
Sbjct: 91  CIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 150
Query: 603 EYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD 662
           E++  G+L   +  ++  ++  Q   + + V  AL  LH   +  VIH D+K  ++LL  
Sbjct: 151 EFLEGGALTDIV--THTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTH 205
Query: 663 NMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMET 722
           +    LSDFG    ++ E     +   + T  +MAPE           D++S GIM++E 
Sbjct: 206 DGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEM 263
Query: 723 FTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ-EDIHFVAKEQCVSFVFNLA 781
              + P    FN             P+  M+++  NL  + +++H V+      F+  L 
Sbjct: 264 VDGEPP---YFNEP-----------PLKAMKMIRDNLPPRLKNLHKVSPS-LKGFLDRL- 307
Query: 782 LECTVESPEQRINAKEIV 799
               V  P QR  A E++
Sbjct: 308 ---LVRDPAQRATAAELL 322

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 91/200 (45%), Gaps = 15/200 (7%)
Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDV---ECAMMKSIRH 582
           D+F     +G G FG V   + +  G   A+K+ + Q     K  +    E  +++++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
             LVK+  S  +     +V+EY+P G +  +L       +   R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTL-ATIGYMAPEYG 701
             S  +I+ DLKP N+L+D      ++DFG AK + G      +T TL  T  Y+APE  
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWTLCGTPEYLAPEII 211
Query: 702 REGQVSTNGDVYSFGIMLME 721
                +   D ++ G+++ E
Sbjct: 212 LSKGYNKAVDWWALGVLIYE 231

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 70/281 (24%), Positives = 128/281 (45%), Gaps = 39/281 (13%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCG--RAFKSFDVECAMMKSIRHRN--LVKVIS 590
           IG GG   V++         A+K  NL+    +   S+  E A +  ++  +  ++++  
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 591 SCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIH 650
               +++  +V+E   +  L  +L     S+D ++R +      + LE +H  +   ++H
Sbjct: 124 YEITDQYIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYW---KNMLEAVHTIHQHGIVH 178
Query: 651 CDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVS-TN 709
            DLKP+N L+ D M+  L DFGIA  +  +  S+ +   + T+ YM PE  ++   S  N
Sbjct: 179 SDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSREN 237
Query: 710 G----------DVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANL 759
           G          DV+S G +L      K P  ++ N +++  H + D  P   +E  D   
Sbjct: 238 GKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-QISKLHAIID--PNHEIEFPD--- 291
Query: 760 LSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVA 800
           + ++D+  V K  C          C    P+QRI+  E++A
Sbjct: 292 IPEKDLQDVLK--C----------CLKRDPKQRISIPELLA 320

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 105/222 (47%), Gaps = 39/222 (17%)
Query: 522 LFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFN------LQCGRAFKSFDVEC 574
           +++  +++   + +G G +GSV  A   + G+ VAVK  +      +   R ++    E 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----EL 72
Query: 575 AMMKSIRHRNLVKVIS----SCSNEEFKALVL-EYMPHGSLEKYLHSSNYSLDIFQRLNI 629
            ++K ++H N++ ++     + S EEF  + L  ++    L   +     + D  Q L  
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFL-- 130
Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
           +  +   L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+     D  MT    
Sbjct: 131 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLAR---HTDDEMT---- 180
Query: 690 LATIGYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 724
               GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 181 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 70/267 (26%), Positives = 122/267 (45%), Gaps = 28/267 (10%)
Query: 535 IGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCS 593
           IG G  G V  A +R  G  VAVK  +L+  +  +    E  +M+  +H N+V++ +S  
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 96
Query: 594 NEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 653
             +   +V+E++  G+L   +  ++  ++  Q   + + V  AL  LH   +  VIH D+
Sbjct: 97  VGDELWVVMEFLEGGALTDIV--THTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 151
Query: 654 KPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVY 713
           K  ++LL  +    LSDFG    ++ E     +   + T  +MAPE           D++
Sbjct: 152 KSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAPELISRLPYGPEVDIW 209
Query: 714 SFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ-EDIHFVAKEQ 772
           S GIM++E    + P    FN             P+  M+++  NL  + +++H V+   
Sbjct: 210 SLGIMVIEMVDGEPP---YFNEP-----------PLKAMKMIRDNLPPRLKNLHKVSPS- 254
Query: 773 CVSFVFNLALECTVESPEQRINAKEIV 799
              F+  L     V  P QR  A E++
Sbjct: 255 LKGFLDRL----LVRDPAQRATAAELL 277

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 100/242 (41%), Gaps = 31/242 (12%)
Query: 535 IGRGGFGSVYKARIRDGME-VAVKVFNLQ----CGRAFKSFDVECAMMKSIRHRNLVKVI 589
           +G G +G V  A  R   E VAVK+ +++    C    K    E  + K + H N+VK  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKFY 70
Query: 590 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRL--NIMIDVASALEYLH------ 641
                   + L LEY   G L             F R+  +I +    A  + H      
Sbjct: 71  GHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 642 -FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
            + +   + H D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+APE 
Sbjct: 118 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 177
Query: 701 GREGQVSTNG-DVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANL 759
            +  +      DV+S GI+L      + P D+  +       W      ++  + +D+  
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSXQEYSDWKEKKTYLNPWKKIDSAP 237
Query: 760 LS 761
           L+
Sbjct: 238 LA 239

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 70/267 (26%), Positives = 122/267 (45%), Gaps = 28/267 (10%)
Query: 535 IGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCS 593
           IG G  G V  A +R  G  VAVK  +L+  +  +    E  +M+  +H N+V++ +S  
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 98
Query: 594 NEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 653
             +   +V+E++  G+L   +  ++  ++  Q   + + V  AL  LH   +  VIH D+
Sbjct: 99  VGDELWVVMEFLEGGALTDIV--THTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 153
Query: 654 KPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVY 713
           K  ++LL  +    LSDFG    ++ E     +   + T  +MAPE           D++
Sbjct: 154 KSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAPELISRLPYGPEVDIW 211
Query: 714 SFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ-EDIHFVAKEQ 772
           S GIM++E    + P    FN             P+  M+++  NL  + +++H V+   
Sbjct: 212 SLGIMVIEMVDGEPP---YFNEP-----------PLKAMKMIRDNLPPRLKNLHKVSPS- 256
Query: 773 CVSFVFNLALECTVESPEQRINAKEIV 799
              F+  L     V  P QR  A E++
Sbjct: 257 LKGFLDRL----LVRDPAQRATAAELL 279

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 69/281 (24%), Positives = 127/281 (45%), Gaps = 39/281 (13%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCG--RAFKSFDVECAMMKSIRHRN--LVKVIS 590
           IG GG   V++         A+K  NL+    +   S+  E A +  ++  +  ++++  
Sbjct: 36  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95
Query: 591 SCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIH 650
               +++  +V+E   +  L  +L     S+D ++R +      + LE +H  +   ++H
Sbjct: 96  YEITDQYIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYW---KNMLEAVHTIHQHGIVH 150
Query: 651 CDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVS-TN 709
            DLKP+N L+ D M+  L DFGIA  +  +   + +   + T+ YM PE  ++   S  N
Sbjct: 151 SDLKPANFLIVDGMLK-LIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKDMSSSREN 209
Query: 710 G----------DVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANL 759
           G          DV+S G +L      K P  ++ N +++  H + D  P   +E  D   
Sbjct: 210 GKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-QISKLHAIID--PNHEIEFPD--- 263
Query: 760 LSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVA 800
           + ++D+  V K  C          C    P+QRI+  E++A
Sbjct: 264 IPEKDLQDVLK--C----------CLKRDPKQRISIPELLA 292

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 105/222 (47%), Gaps = 39/222 (17%)
Query: 522 LFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFN------LQCGRAFKSFDVEC 574
           +++  +++   + +G G +GSV  A   + G+ VAVK  +      +   R ++    E 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----EL 72
Query: 575 AMMKSIRHRNLVKVIS----SCSNEEFKALVL-EYMPHGSLEKYLHSSNYSLDIFQRLNI 629
            ++K ++H N++ ++     + S EEF  + L  ++    L   +     + D  Q L  
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL-- 130
Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
           +  +   L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+     D  MT    
Sbjct: 131 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT---- 180
Query: 690 LATIGYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 724
               GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 181 ----GYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLT 218

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 89/178 (50%), Gaps = 14/178 (7%)
Query: 529 FSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMK-SIRHRNLVK 587
           F   +++G G  G++    + D  +VAVK    +C   F   D E  +++ S  H N+++
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIR 82
Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAP 647
              +  + +F+ + +E     +L++Y+   +++    + + ++    S L +LH   S  
Sbjct: 83  YFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLN 138
Query: 648 VIHCDLKPSNVLLD-----DNMVAHLSDFGIAKLLTGEDQSMTQTQTL-ATIGYMAPE 699
           ++H DLKP N+L+        + A +SDFG+ K L     S ++   +  T G++APE
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 105/222 (47%), Gaps = 39/222 (17%)
Query: 522 LFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFN------LQCGRAFKSFDVEC 574
           +++  +++   + +G G +GSV  A   + G+ VAVK  +      +   R ++    E 
Sbjct: 22  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----EL 77
Query: 575 AMMKSIRHRNLVKVIS----SCSNEEFKALVL-EYMPHGSLEKYLHSSNYSLDIFQRLNI 629
            ++K ++H N++ ++     + S EEF  + L  ++    L   +     + D  Q L  
Sbjct: 78  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL-- 135
Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
           +  +   L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+     D  MT    
Sbjct: 136 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLAR---HTDDEMT---- 185
Query: 690 LATIGYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 724
               GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 186 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 223

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 105/222 (47%), Gaps = 39/222 (17%)
Query: 522 LFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFN------LQCGRAFKSFDVEC 574
           +++  +++   + +G G +GSV  A   + G+ VAVK  +      +   R ++    E 
Sbjct: 14  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----EL 69
Query: 575 AMMKSIRHRNLVKVIS----SCSNEEFKALVL-EYMPHGSLEKYLHSSNYSLDIFQRLNI 629
            ++K ++H N++ ++     + S EEF  + L  ++    L   +     + D  Q L  
Sbjct: 70  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL-- 127
Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
           +  +   L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+     D  MT    
Sbjct: 128 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT---- 177
Query: 690 LATIGYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 724
               GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 178 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 215

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 89/199 (44%), Gaps = 13/199 (6%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDV---ECAMMKSIRH 582
           D+F     +G G FG V   + ++ G   A+K+ + Q     K  +    E  +++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
             LVK+  S  +     +V+EY+P G +  +L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 703 EGQVSTNGDVYSFGIMLME 721
               +   D ++ G+++ E
Sbjct: 212 SKGYNKAVDWWALGVLIYE 230

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 105/222 (47%), Gaps = 39/222 (17%)
Query: 522 LFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFN------LQCGRAFKSFDVEC 574
           +++  +++   + +G G +GSV  A   + G+ VAVK  +      +   R ++    E 
Sbjct: 14  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----EL 69
Query: 575 AMMKSIRHRNLVKVIS----SCSNEEFKALVL-EYMPHGSLEKYLHSSNYSLDIFQRLNI 629
            ++K ++H N++ ++     + S EEF  + L  ++    L   +     + D  Q L  
Sbjct: 70  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL-- 127
Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
           +  +   L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+     D  MT    
Sbjct: 128 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT---- 177
Query: 690 LATIGYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 724
               GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 178 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 215

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 103/216 (47%), Gaps = 27/216 (12%)
Query: 522 LFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFN------LQCGRAFKSFDVEC 574
           +++  +++   + +G G +GSV  A   + G+ VAVK  +      +   R ++    E 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----EL 72
Query: 575 AMMKSIRHRNLVKVIS----SCSNEEFKALVL-EYMPHGSLEKYLHSSNYSLDIFQRLNI 629
            ++K ++H N++ ++     + S EEF  + L  ++    L   +     + D  Q L  
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL-- 130
Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
           +  +   L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+    E      T  
Sbjct: 131 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGX 182
Query: 690 LATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFT 724
           +AT  Y APE        +   D++S G ++ E  T
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 105/222 (47%), Gaps = 39/222 (17%)
Query: 522 LFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFN------LQCGRAFKSFDVEC 574
           +++  +++   + +G G +GSV  A   + G+ VAVK  +      +   R ++    E 
Sbjct: 15  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----EL 70
Query: 575 AMMKSIRHRNLVKVIS----SCSNEEFKALVL-EYMPHGSLEKYLHSSNYSLDIFQRLNI 629
            ++K ++H N++ ++     + S EEF  + L  ++    L   +     + D  Q L  
Sbjct: 71  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL-- 128
Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
           +  +   L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+     D  MT    
Sbjct: 129 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT---- 178
Query: 690 LATIGYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 724
               GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 179 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 216

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 89/199 (44%), Gaps = 13/199 (6%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDV---ECAMMKSIRH 582
           D+F     +G G FG V   + ++ G   A+K+ + Q     K  +    E  +++++  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
             LVK+  S  +     +V+EY+P G +  +L       +   R      +    EYLH 
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 151
Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+APE   
Sbjct: 152 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 204
Query: 703 EGQVSTNGDVYSFGIMLME 721
               +   D ++ G+++ E
Sbjct: 205 SKGYNKAVDWWALGVLIYE 223

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 89/199 (44%), Gaps = 13/199 (6%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDV---ECAMMKSIRH 582
           D+F     +G G FG V   + ++ G   A+K+ + Q     K  +    E  +++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
             LVK+  S  +     +V+EY+P G +  +L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 703 EGQVSTNGDVYSFGIMLME 721
               +   D ++ G+++ E
Sbjct: 212 SKGYNKAVDWWALGVLIYE 230

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 94/200 (47%), Gaps = 12/200 (6%)
Query: 526 TDKFSENNLIGRGGFGSVYK-ARIRDGMEVAVKVFNLQ--CGRAFKSFDVECAMMKSIRH 582
           T+++     +G+G F  V +  ++  G E A  + N +    R  +  + E  + + ++H
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
            N+V++  S S E    L+ + +  G L + + +  Y    +   +    +   LE +  
Sbjct: 70  PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREY----YSEADASHCIQQILEAVLH 125
Query: 643 GYSAPVIHCDLKPSNVLLDDNM---VAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPE 699
            +   V+H +LKP N+LL   +      L+DFG+A  + GE Q+        T GY++PE
Sbjct: 126 CHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA--GTPGYLSPE 183
Query: 700 YGREGQVSTNGDVYSFGIML 719
             R+       D+++ G++L
Sbjct: 184 VLRKDPYGKPVDLWACGVIL 203

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 105/222 (47%), Gaps = 39/222 (17%)
Query: 522 LFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFN------LQCGRAFKSFDVEC 574
           +++  +++   + +G G +GSV  A   + G+ VAVK  +      +   R ++    E 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----EL 72
Query: 575 AMMKSIRHRNLVKVIS----SCSNEEFKALVL-EYMPHGSLEKYLHSSNYSLDIFQRLNI 629
            ++K ++H N++ ++     + S EEF  + L  ++    L   +     + D  Q L  
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFL-- 130
Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
           +  +   L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+     D  MT    
Sbjct: 131 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT---- 180
Query: 690 LATIGYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 724
               GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 181 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 105/222 (47%), Gaps = 39/222 (17%)
Query: 522 LFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFN------LQCGRAFKSFDVEC 574
           +++  +++   + +G G +GSV  A   + G+ VAVK  +      +   R ++    E 
Sbjct: 28  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----EL 83
Query: 575 AMMKSIRHRNLVKVIS----SCSNEEFKALVL-EYMPHGSLEKYLHSSNYSLDIFQRLNI 629
            ++K ++H N++ ++     + S EEF  + L  ++    L   +     + D  Q L  
Sbjct: 84  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL-- 141
Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
           +  +   L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+     D  MT    
Sbjct: 142 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLAR---HTDDEMT---- 191
Query: 690 LATIGYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 724
               GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 192 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 229

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 105/222 (47%), Gaps = 39/222 (17%)
Query: 522 LFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFN------LQCGRAFKSFDVEC 574
           +++  +++   + +G G +GSV  A   + G+ VAVK  +      +   R ++    E 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----EL 72
Query: 575 AMMKSIRHRNLVKVIS----SCSNEEFKALVL-EYMPHGSLEKYLHSSNYSLDIFQRLNI 629
            ++K ++H N++ ++     + S EEF  + L  ++    L   +     + D  Q L  
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL-- 130
Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
           +  +   L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+     D  MT    
Sbjct: 131 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT---- 180
Query: 690 LATIGYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 724
               GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 181 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 78/152 (51%), Gaps = 12/152 (7%)
Query: 573 ECAMMKSIRHRNLVKVISSCS--NEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIM 630
           E A++K + H N+VK++      NE+   +V E +  G + +       S D  Q     
Sbjct: 86  EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSED--QARFYF 143
Query: 631 IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTL 690
            D+   +EYLH+     +IH D+KPSN+L+ ++    ++DFG++    G D  +  + T+
Sbjct: 144 QDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALL--SNTV 198
Query: 691 ATIGYMAPEYGREGQVSTNG---DVYSFGIML 719
            T  +MAPE   E +   +G   DV++ G+ L
Sbjct: 199 GTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 99/216 (45%), Gaps = 40/216 (18%)
Query: 533 NLIGRGGFGSVY----KARIRDGMEVAVKVFN---LQCGRAFKSFDVECAMMKSIRHRNL 585
            ++G+G FG V+      R   G   A+KV     L+     ++  +E  ++  + H  +
Sbjct: 34  KVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRT-KMERDILADVNHPFV 92
Query: 586 VKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLN------------IMIDV 633
           VK+  +   E    L+L+++  G             D+F RL+             + ++
Sbjct: 93  VKLHYAFQTEGKLYLILDFLRGG-------------DLFTRLSKEVMFTEEDVKFYLAEL 139
Query: 634 ASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATI 693
           A  L++LH   S  +I+ DLKP N+LLD+     L+DFG++K     D          T+
Sbjct: 140 ALGLDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--EAIDHEKKAYSFCGTV 194
Query: 694 GYMAPE-YGREGQVSTNGDVYSFGIMLMETFTRKKP 728
            YMAPE   R+G  S + D +S+G+++ E  T   P
Sbjct: 195 EYMAPEVVNRQGH-SHSADWWSYGVLMFEMLTGSLP 229

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 105/222 (47%), Gaps = 39/222 (17%)
Query: 522 LFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFN------LQCGRAFKSFDVEC 574
           +++  +++   + +G G +GSV  A   + G+ VAVK  +      +   R ++    E 
Sbjct: 13  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----EL 68
Query: 575 AMMKSIRHRNLVKVIS----SCSNEEFKALVL-EYMPHGSLEKYLHSSNYSLDIFQRLNI 629
            ++K ++H N++ ++     + S EEF  + L  ++    L   +     + D  Q L  
Sbjct: 69  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL-- 126
Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
           +  +   L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+     D  MT    
Sbjct: 127 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT---- 176
Query: 690 LATIGYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 724
               GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 177 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 89/199 (44%), Gaps = 13/199 (6%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDV---ECAMMKSIRH 582
           D+F     +G G FG V   + ++ G   A+K+ + Q     K  +    E  +++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
             LVK+  S  +     +V+EY+P G +  +L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 703 EGQVSTNGDVYSFGIMLME 721
               +   D ++ G+++ E
Sbjct: 212 SKGYNKAVDWWALGVLIYE 230

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 105/214 (49%), Gaps = 13/214 (6%)
Query: 521 ELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDV-ECAMMK 578
           ++F    +++  + IG G +G V  A    + + VA+K  +    + +    + E  ++ 
Sbjct: 21  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILL 80
Query: 579 SIRHRNLV---KVISSCSNEEFKAL-VLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVA 634
             RH N++    +I + + E+ K + +++ +    L K L + + S D       +  + 
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLYQIL 138
Query: 635 SALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE-DQSMTQTQTLATI 693
             L+Y+H   SA V+H DLKPSN+LL+      + DFG+A++   + D +   T+ +AT 
Sbjct: 139 RGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 694 GYMAPEYGREGQVSTNG-DVYSFGIMLMETFTRK 726
            Y APE     +  T   D++S G +L E  + +
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 105/222 (47%), Gaps = 39/222 (17%)
Query: 522 LFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFN------LQCGRAFKSFDVEC 574
           +++  +++   + +G G +GSV  A   + G+ VAVK  +      +   R ++    E 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----EL 72
Query: 575 AMMKSIRHRNLVKVIS----SCSNEEFKALVL-EYMPHGSLEKYLHSSNYSLDIFQRLNI 629
            ++K ++H N++ ++     + S EEF  + L  ++    L   +     + D  Q L  
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL-- 130
Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
           +  +   L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+     D  MT    
Sbjct: 131 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT---- 180
Query: 690 LATIGYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 724
               GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 181 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 88/199 (44%), Gaps = 13/199 (6%)
Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDV---ECAMMKSIRH 582
           D+F     +G G FG V   + +  G   A+K+ + Q     K  +    E  +++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
             LVK+  S  +     +V+EY+P G +  +L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 703 EGQVSTNGDVYSFGIMLME 721
               +   D ++ G+++ E
Sbjct: 212 SKGYNKAVDWWALGVLIYE 230

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 88/199 (44%), Gaps = 13/199 (6%)
Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDV---ECAMMKSIRH 582
           D+F     +G G FG V   + +  G   A+K+ + Q     K  +    E  +++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
             LVK+  S  +     +V+EY+P G +  +L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 703 EGQVSTNGDVYSFGIMLME 721
               +   D ++ G+++ E
Sbjct: 212 SKGYNKAVDWWALGVLIYE 230

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 105/222 (47%), Gaps = 39/222 (17%)
Query: 522 LFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFN------LQCGRAFKSFDVEC 574
           +++  +++   + +G G +GSV  A   + G+ VAVK  +      +   R ++    E 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----EL 72
Query: 575 AMMKSIRHRNLVKVIS----SCSNEEFKALVL-EYMPHGSLEKYLHSSNYSLDIFQRLNI 629
            ++K ++H N++ ++     + S EEF  + L  ++    L   + S   + D  Q L  
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFL-- 130
Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
           +  +   L+Y+H   SA +IH DLKPSN+ ++++    + DFG+ +     D  MT    
Sbjct: 131 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLCR---HTDDEMT---- 180
Query: 690 LATIGYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 724
               GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 181 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 70/267 (26%), Positives = 122/267 (45%), Gaps = 28/267 (10%)
Query: 535 IGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCS 593
           IG G  G V  A +R  G  VAVK  +L+  +  +    E  +M+  +H N+V++ +S  
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 218
Query: 594 NEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 653
             +   +V+E++  G+L   +  ++  ++  Q   + + V  AL  LH   +  VIH D+
Sbjct: 219 VGDELWVVMEFLEGGALTDIV--THTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 273
Query: 654 KPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVY 713
           K  ++LL  +    LSDFG    ++ E     +   + T  +MAPE           D++
Sbjct: 274 KSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAPELISRLPYGPEVDIW 331
Query: 714 SFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ-EDIHFVAKEQ 772
           S GIM++E    + P    FN             P+  M+++  NL  + +++H V+   
Sbjct: 332 SLGIMVIEMVDGEPP---YFNEP-----------PLKAMKMIRDNLPPRLKNLHKVSP-S 376
Query: 773 CVSFVFNLALECTVESPEQRINAKEIV 799
              F+  L     V  P QR  A E++
Sbjct: 377 LKGFLDRL----LVRDPAQRATAAELL 399

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 105/222 (47%), Gaps = 39/222 (17%)
Query: 522 LFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFN------LQCGRAFKSFDVEC 574
           +++  +++   + +G G +GSV  A   + G+ VAVK  +      +   R ++    E 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----EL 72
Query: 575 AMMKSIRHRNLVKVIS----SCSNEEFKALVL-EYMPHGSLEKYLHSSNYSLDIFQRLNI 629
            ++K ++H N++ ++     + S EEF  + L  ++    L   +     + D  Q L  
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL-- 130
Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
           +  +   L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+     D  MT    
Sbjct: 131 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT---- 180
Query: 690 LATIGYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 724
               GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 181 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 105/222 (47%), Gaps = 39/222 (17%)
Query: 522 LFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFN------LQCGRAFKSFDVEC 574
           +++  +++   + +G G +GSV  A   + G+ VAVK  +      +   R ++    E 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----EL 72
Query: 575 AMMKSIRHRNLVKVIS----SCSNEEFKALVL-EYMPHGSLEKYLHSSNYSLDIFQRLNI 629
            ++K ++H N++ ++     + S EEF  + L  ++    L   +     + D  Q L  
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL-- 130
Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
           +  +   L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+     D  MT    
Sbjct: 131 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT---- 180
Query: 690 LATIGYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 724
               GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 181 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 88/199 (44%), Gaps = 13/199 (6%)
Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDV---ECAMMKSIRH 582
           D+F     +G G FG V   + +  G   A+K+ + Q     K  +    E  +++++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
             LVK+  S  +     +V+EY+P G +  +L       +   R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 159
Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+APE   
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 212
Query: 703 EGQVSTNGDVYSFGIMLME 721
               +   D ++ G+++ E
Sbjct: 213 SKGYNKAVDWWALGVLIYE 231

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 105/222 (47%), Gaps = 39/222 (17%)
Query: 522 LFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFN------LQCGRAFKSFDVEC 574
           +++  +++   + +G G +GSV  A   + G+ VAVK  +      +   R ++    E 
Sbjct: 22  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----EL 77
Query: 575 AMMKSIRHRNLVKVIS----SCSNEEFKALVL-EYMPHGSLEKYLHSSNYSLDIFQRLNI 629
            ++K ++H N++ ++     + S EEF  + L  ++    L   +     + D  Q L  
Sbjct: 78  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL-- 135
Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
           +  +   L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+     D  MT    
Sbjct: 136 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT---- 185
Query: 690 LATIGYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 724
               GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 186 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 223

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 105/222 (47%), Gaps = 39/222 (17%)
Query: 522 LFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFN------LQCGRAFKSFDVEC 574
           +++  +++   + +G G +GSV  A   + G+ VAVK  +      +   R ++    E 
Sbjct: 19  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----EL 74
Query: 575 AMMKSIRHRNLVKVIS----SCSNEEFKALVL-EYMPHGSLEKYLHSSNYSLDIFQRLNI 629
            ++K ++H N++ ++     + S EEF  + L  ++    L   +     + D  Q L  
Sbjct: 75  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL-- 132
Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
           +  +   L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+     D  MT    
Sbjct: 133 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT---- 182
Query: 690 LATIGYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 724
               GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 183 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 220

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 105/222 (47%), Gaps = 39/222 (17%)
Query: 522 LFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFN------LQCGRAFKSFDVEC 574
           +++  +++   + +G G +GSV  A   + G+ VAVK  +      +   R ++    E 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----EL 72
Query: 575 AMMKSIRHRNLVKVIS----SCSNEEFKALVL-EYMPHGSLEKYLHSSNYSLDIFQRLNI 629
            ++K ++H N++ ++     + S EEF  + L  ++    L   +     + D  Q L  
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL-- 130
Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
           +  +   L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+     D  MT    
Sbjct: 131 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT---- 180
Query: 690 LATIGYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 724
               GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 181 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 105/222 (47%), Gaps = 39/222 (17%)
Query: 522 LFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFN------LQCGRAFKSFDVEC 574
           +++  +++   + +G G +GSV  A   + G+ VAVK  +      +   R ++    E 
Sbjct: 22  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----EL 77
Query: 575 AMMKSIRHRNLVKVIS----SCSNEEFKALVL-EYMPHGSLEKYLHSSNYSLDIFQRLNI 629
            ++K ++H N++ ++     + S EEF  + L  ++    L   +     + D  Q L  
Sbjct: 78  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL-- 135
Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
           +  +   L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+     D  MT    
Sbjct: 136 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT---- 185
Query: 690 LATIGYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 724
               GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 186 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 223

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 105/222 (47%), Gaps = 39/222 (17%)
Query: 522 LFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFN------LQCGRAFKSFDVEC 574
           +++  +++   + +G G +GSV  A   + G+ VAVK  +      +   R ++    E 
Sbjct: 19  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----EL 74
Query: 575 AMMKSIRHRNLVKVIS----SCSNEEFKALVL-EYMPHGSLEKYLHSSNYSLDIFQRLNI 629
            ++K ++H N++ ++     + S EEF  + L  ++    L   +     + D  Q L  
Sbjct: 75  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL-- 132
Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
           +  +   L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+     D  MT    
Sbjct: 133 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLAR---HTDDEMT---- 182
Query: 690 LATIGYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 724
               GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 183 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 220

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 107/222 (48%), Gaps = 39/222 (17%)
Query: 522 LFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFN------LQCGRAFKSFDVEC 574
           +++  +++   + +G G +GSV  +  ++ G+++AVK  +      +   R ++    E 
Sbjct: 46  IWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYR----EL 101
Query: 575 AMMKSIRHRNLVKVIS----SCSNEEFKALVL-EYMPHGSLEKYLHSSNYSLDIFQRLNI 629
            ++K ++H N++ ++     + S EEF  + L  ++    L   +     + D  Q L  
Sbjct: 102 RLLKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL-- 159
Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
           +  +   L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+     D  MT    
Sbjct: 160 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT---- 209
Query: 690 LATIGYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 724
               GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 210 ----GYVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLT 247

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 105/222 (47%), Gaps = 39/222 (17%)
Query: 522 LFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFN------LQCGRAFKSFDVEC 574
           +++  +++   + +G G +GSV  A   + G+ VAVK  +      +   R ++    E 
Sbjct: 16  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----EL 71
Query: 575 AMMKSIRHRNLVKVIS----SCSNEEFKALVL-EYMPHGSLEKYLHSSNYSLDIFQRLNI 629
            ++K ++H N++ ++     + S EEF  + L  ++    L   +     + D  Q L  
Sbjct: 72  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL-- 129
Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
           +  +   L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+     D  MT    
Sbjct: 130 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT---- 179
Query: 690 LATIGYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 724
               GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 180 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 217

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 89/199 (44%), Gaps = 13/199 (6%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDV---ECAMMKSIRH 582
           D+F     +G G FG V   + ++ G   A+K+ + Q     K  +    E  +++++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
             LVK+  S  +     +V+EY+P G +  +L       +   R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+APE   
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 212
Query: 703 EGQVSTNGDVYSFGIMLME 721
               +   D ++ G+++ E
Sbjct: 213 SKGYNKAVDWWALGVLIYE 231

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 88/199 (44%), Gaps = 13/199 (6%)
Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDV---ECAMMKSIRH 582
           D+F     IG G FG V   + +  G   A+K+ + Q     K  +    E  +++++  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
             LVK+  S  +     +V+EY+P G +  +L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 703 EGQVSTNGDVYSFGIMLME 721
               +   D ++ G+++ E
Sbjct: 212 SKGYNKAVDWWALGVLIYE 230

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 105/222 (47%), Gaps = 39/222 (17%)
Query: 522 LFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFN------LQCGRAFKSFDVEC 574
           +++  +++   + +G G +GSV  A   + G+ VAVK  +      +   R ++    E 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----EL 72
Query: 575 AMMKSIRHRNLVKVIS----SCSNEEFKALVL-EYMPHGSLEKYLHSSNYSLDIFQRLNI 629
            ++K ++H N++ ++     + S EEF  + L  ++    L   +     + D  Q L  
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL-- 130
Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
           +  +   L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+     D  MT    
Sbjct: 131 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT---- 180
Query: 690 LATIGYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 724
               GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 181 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 89/199 (44%), Gaps = 13/199 (6%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDV---ECAMMKSIRH 582
           D+F     +G G FG V   + ++ G   A+K+ + Q     K  +    E  +++++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
             LVK+  S  +     +V+EY+P G +  +L       +   R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+APE   
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 212
Query: 703 EGQVSTNGDVYSFGIMLME 721
               +   D ++ G+++ E
Sbjct: 213 SKGYNKAVDWWALGVLIYE 231

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 105/222 (47%), Gaps = 39/222 (17%)
Query: 522 LFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFN------LQCGRAFKSFDVEC 574
           +++  +++   + +G G +GSV  A   + G+ VAVK  +      +   R ++    E 
Sbjct: 19  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----EL 74
Query: 575 AMMKSIRHRNLVKVIS----SCSNEEFKALVL-EYMPHGSLEKYLHSSNYSLDIFQRLNI 629
            ++K ++H N++ ++     + S EEF  + L  ++    L   +     + D  Q L  
Sbjct: 75  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL-- 132
Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
           +  +   L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+     D  MT    
Sbjct: 133 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT---- 182
Query: 690 LATIGYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 724
               GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 183 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 220

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 105/222 (47%), Gaps = 39/222 (17%)
Query: 522 LFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFN------LQCGRAFKSFDVEC 574
           +++  +++   + +G G +GSV  A   + G+ VAVK  +      +   R ++    E 
Sbjct: 24  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----EL 79
Query: 575 AMMKSIRHRNLVKVIS----SCSNEEFKALVL-EYMPHGSLEKYLHSSNYSLDIFQRLNI 629
            ++K ++H N++ ++     + S EEF  + L  ++    L   +     + D  Q L  
Sbjct: 80  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL-- 137
Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
           +  +   L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+     D  MT    
Sbjct: 138 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT---- 187
Query: 690 LATIGYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 724
               GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 188 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 93/200 (46%), Gaps = 22/200 (11%)
Query: 529 FSENNLIGRGGFGSVYKA-----RIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHR 583
           ++  N IGRG +G V  A     RIR   +   K F     R    F  E  +MKS+ H 
Sbjct: 28  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDR----FKQEIEIMKSLDHP 83
Query: 584 NLVKVISSCSNEEFKALVLEYMPHGSL-EKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
           N++++  +  +     LV+E    G L E+ +H   +      R  IM DV SA+ Y H 
Sbjct: 84  NIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR--IMKDVLSAVAYCH- 140
Query: 643 GYSAPVIHCDLKPSNVL-LDDNMVAHLS--DFGIAKLLTGEDQSMTQTQTLATIGYMAPE 699
                V H DLKP N L L D+  + L   DFG+A     +   M +T+ + T  Y++P+
Sbjct: 141 --KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF--KPGKMMRTK-VGTPYYVSPQ 195
Query: 700 YGREGQVSTNGDVYSFGIML 719
              EG      D +S G+M+
Sbjct: 196 V-LEGLYGPECDEWSAGVMM 214

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 105/222 (47%), Gaps = 39/222 (17%)
Query: 522 LFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFN------LQCGRAFKSFDVEC 574
           +++  +++   + +G G +GSV  A   + G+ VAVK  +      +   R ++    E 
Sbjct: 19  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----EL 74
Query: 575 AMMKSIRHRNLVKVIS----SCSNEEFKALVL-EYMPHGSLEKYLHSSNYSLDIFQRLNI 629
            ++K ++H N++ ++     + S EEF  + L  ++    L   +     + D  Q L  
Sbjct: 75  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL-- 132
Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
           +  +   L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+     D  MT    
Sbjct: 133 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT---- 182
Query: 690 LATIGYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 724
               GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 183 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 220

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 105/222 (47%), Gaps = 39/222 (17%)
Query: 522 LFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFN------LQCGRAFKSFDVEC 574
           +++  +++   + +G G +GSV  A   + G+ VAVK  +      +   R ++    E 
Sbjct: 28  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----EL 83
Query: 575 AMMKSIRHRNLVKVIS----SCSNEEFKALVL-EYMPHGSLEKYLHSSNYSLDIFQRLNI 629
            ++K ++H N++ ++     + S EEF  + L  ++    L   +     + D  Q L  
Sbjct: 84  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL-- 141
Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
           +  +   L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+     D  MT    
Sbjct: 142 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT---- 191
Query: 690 LATIGYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 724
               GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 192 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 229

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 105/222 (47%), Gaps = 39/222 (17%)
Query: 522 LFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFN------LQCGRAFKSFDVEC 574
           +++  +++   + +G G +GSV  A   + G+ VAVK  +      +   R ++    E 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----EL 72
Query: 575 AMMKSIRHRNLVKVIS----SCSNEEFKALVL-EYMPHGSLEKYLHSSNYSLDIFQRLNI 629
            ++K ++H N++ ++     + S EEF  + L  ++    L   +     + D  Q L  
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL-- 130
Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
           +  +   L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+     D  MT    
Sbjct: 131 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT---- 180
Query: 690 LATIGYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 724
               GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 181 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 93/200 (46%), Gaps = 22/200 (11%)
Query: 529 FSENNLIGRGGFGSVYKA-----RIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHR 583
           ++  N IGRG +G V  A     RIR   +   K F     R    F  E  +MKS+ H 
Sbjct: 11  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDR----FKQEIEIMKSLDHP 66
Query: 584 NLVKVISSCSNEEFKALVLEYMPHGSL-EKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
           N++++  +  +     LV+E    G L E+ +H   +      R  IM DV SA+ Y H 
Sbjct: 67  NIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR--IMKDVLSAVAYCH- 123
Query: 643 GYSAPVIHCDLKPSNVL-LDDNMVAHLS--DFGIAKLLTGEDQSMTQTQTLATIGYMAPE 699
                V H DLKP N L L D+  + L   DFG+A     +   M +T+ + T  Y++P+
Sbjct: 124 --KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF--KPGKMMRTK-VGTPYYVSPQ 178
Query: 700 YGREGQVSTNGDVYSFGIML 719
              EG      D +S G+M+
Sbjct: 179 V-LEGLYGPECDEWSAGVMM 197

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 100/242 (41%), Gaps = 31/242 (12%)
Query: 535 IGRGGFGSVYKARIRDGME-VAVKVFNLQ----CGRAFKSFDVECAMMKSIRHRNLVKVI 589
           +G G +G V  A  R   E VAVK+ +++    C    K    E  + K + H N+VK  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKFY 70
Query: 590 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRL--NIMIDVASALEYLH------ 641
                   + L LEY   G L             F R+  +I +    A  + H      
Sbjct: 71  GHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 642 -FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
            + +   + H D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+APE 
Sbjct: 118 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 701 GREGQVSTNG-DVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANL 759
            +  +      DV+S GI+L      + P D+  +       W      ++  + +D+  
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 237
Query: 760 LS 761
           L+
Sbjct: 238 LA 239

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 103/216 (47%), Gaps = 27/216 (12%)
Query: 522 LFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFN------LQCGRAFKSFDVEC 574
           +++  +++   + +G G +GSV  A   + G+ VAVK  +      +   R ++    E 
Sbjct: 24  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----EL 79
Query: 575 AMMKSIRHRNLVKVIS----SCSNEEFKALVL-EYMPHGSLEKYLHSSNYSLDIFQRLNI 629
            ++K ++H N++ ++     + S EEF  + L  ++    L   +     + D  Q L  
Sbjct: 80  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL-- 137
Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
           +  +   L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+    E      T  
Sbjct: 138 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGY 189
Query: 690 LATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFT 724
           +AT  Y APE        +   D++S G ++ E  T
Sbjct: 190 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 89/199 (44%), Gaps = 13/199 (6%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDV---ECAMMKSIRH 582
           D+F     +G G FG V   + ++ G   A+K+ + Q     K  +    E  +++++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
             LVK+  S  +     +V+EY+P G +  +L       +   R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+APE   
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 212
Query: 703 EGQVSTNGDVYSFGIMLME 721
               +   D ++ G+++ E
Sbjct: 213 SKGYNKAVDWWALGVLIYE 231

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 89/199 (44%), Gaps = 13/199 (6%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDV---ECAMMKSIRH 582
           D+F     +G G FG V   + ++ G   A+K+ + Q     K  +    E  +++++  
Sbjct: 62  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
             LVK+  S  +     +V+EY+P G +  +L       +   R      +    EYLH 
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 179
Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+APE   
Sbjct: 180 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 232
Query: 703 EGQVSTNGDVYSFGIMLME 721
               +   D ++ G+++ E
Sbjct: 233 SKGYNKAVDWWALGVLIYE 251

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 105/222 (47%), Gaps = 39/222 (17%)
Query: 522 LFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFN------LQCGRAFKSFDVEC 574
           +++  +++   + +G G +GSV  A   + G+ VAVK  +      +   R ++    E 
Sbjct: 40  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----EL 95
Query: 575 AMMKSIRHRNLVKVIS----SCSNEEFKALVL-EYMPHGSLEKYLHSSNYSLDIFQRLNI 629
            ++K ++H N++ ++     + S EEF  + L  ++    L   +     + D  Q L  
Sbjct: 96  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL-- 153
Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
           +  +   L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+     D  MT    
Sbjct: 154 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT---- 203
Query: 690 LATIGYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 724
               GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 204 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 241

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 103/216 (47%), Gaps = 27/216 (12%)
Query: 522 LFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFN------LQCGRAFKSFDVEC 574
           +++  +++   + +G G +GSV  A   + G+ VAVK  +      +   R ++    E 
Sbjct: 24  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----EL 79
Query: 575 AMMKSIRHRNLVKVIS----SCSNEEFKALVL-EYMPHGSLEKYLHSSNYSLDIFQRLNI 629
            ++K ++H N++ ++     + S EEF  + L  ++    L   +     + D  Q L  
Sbjct: 80  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL-- 137
Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
           +  +   L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+    E      T  
Sbjct: 138 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGY 189
Query: 690 LATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFT 724
           +AT  Y APE        +   D++S G ++ E  T
Sbjct: 190 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 105/222 (47%), Gaps = 39/222 (17%)
Query: 522 LFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFN------LQCGRAFKSFDVEC 574
           +++  +++   + +G G +GSV  A   + G+ VAVK  +      +   R ++    E 
Sbjct: 23  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----EL 78
Query: 575 AMMKSIRHRNLVKVIS----SCSNEEFKALVL-EYMPHGSLEKYLHSSNYSLDIFQRLNI 629
            ++K ++H N++ ++     + S EEF  + L  ++    L   +     + D  Q L  
Sbjct: 79  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL-- 136
Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
           +  +   L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+     D  MT    
Sbjct: 137 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLAR---HTDDEMT---- 186
Query: 690 LATIGYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 724
               GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 187 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 224

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 103/216 (47%), Gaps = 27/216 (12%)
Query: 522 LFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFN------LQCGRAFKSFDVEC 574
           +++  +++   + +G G +GSV  A   + G+ VAVK  +      +   R ++    E 
Sbjct: 24  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----EL 79
Query: 575 AMMKSIRHRNLVKVIS----SCSNEEFKALVL-EYMPHGSLEKYLHSSNYSLDIFQRLNI 629
            ++K ++H N++ ++     + S EEF  + L  ++    L   +     + D  Q L  
Sbjct: 80  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL-- 137
Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
           +  +   L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+    E      T  
Sbjct: 138 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGY 189
Query: 690 LATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFT 724
           +AT  Y APE        +   D++S G ++ E  T
Sbjct: 190 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 105/222 (47%), Gaps = 39/222 (17%)
Query: 522 LFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFN------LQCGRAFKSFDVEC 574
           +++  +++   + +G G +GSV  A   + G+ VAVK  +      +   R ++    E 
Sbjct: 23  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----EL 78
Query: 575 AMMKSIRHRNLVKVIS----SCSNEEFKALVL-EYMPHGSLEKYLHSSNYSLDIFQRLNI 629
            ++K ++H N++ ++     + S EEF  + L  ++    L   +     + D  Q L  
Sbjct: 79  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL-- 136
Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
           +  +   L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+     D  MT    
Sbjct: 137 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT---- 186
Query: 690 LATIGYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 724
               GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 187 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 224

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 105/222 (47%), Gaps = 39/222 (17%)
Query: 522 LFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFN------LQCGRAFKSFDVEC 574
           +++  +++   + +G G +GSV  A   + G+ VAVK  +      +   R ++    E 
Sbjct: 29  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYR----EL 84
Query: 575 AMMKSIRHRNLVKVIS----SCSNEEFKALVL-EYMPHGSLEKYLHSSNYSLDIFQRLNI 629
            ++K ++H N++ ++     + S EEF  + L  ++    L   +     + D  Q L  
Sbjct: 85  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL-- 142
Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
           +  +   L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+     D  MT    
Sbjct: 143 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT---- 192
Query: 690 LATIGYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 724
               GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 193 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 230

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 105/222 (47%), Gaps = 39/222 (17%)
Query: 522 LFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFN------LQCGRAFKSFDVEC 574
           +++  +++   + +G G +GSV  A   + G+ VAVK  +      +   R ++    E 
Sbjct: 36  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----EL 91
Query: 575 AMMKSIRHRNLVKVIS----SCSNEEFKALVL-EYMPHGSLEKYLHSSNYSLDIFQRLNI 629
            ++K ++H N++ ++     + S EEF  + L  ++    L   +     + D  Q L  
Sbjct: 92  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL-- 149
Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
           +  +   L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+     D  MT    
Sbjct: 150 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT---- 199
Query: 690 LATIGYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 724
               GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 200 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 237

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 105/222 (47%), Gaps = 39/222 (17%)
Query: 522 LFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFN------LQCGRAFKSFDVEC 574
           +++  +++   + +G G +GSV  A   + G+ VAVK  +      +   R ++    E 
Sbjct: 29  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----EL 84
Query: 575 AMMKSIRHRNLVKVIS----SCSNEEFKALVL-EYMPHGSLEKYLHSSNYSLDIFQRLNI 629
            ++K ++H N++ ++     + S EEF  + L  ++    L   +     + D  Q L  
Sbjct: 85  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL-- 142
Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
           +  +   L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+     D  MT    
Sbjct: 143 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT---- 192
Query: 690 LATIGYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 724
               GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 193 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 230

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 105/222 (47%), Gaps = 39/222 (17%)
Query: 522 LFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFN------LQCGRAFKSFDVEC 574
           +++  +++   + +G G +GSV  A   + G+ VAVK  +      +   R ++    E 
Sbjct: 29  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----EL 84
Query: 575 AMMKSIRHRNLVKVIS----SCSNEEFKALVL-EYMPHGSLEKYLHSSNYSLDIFQRLNI 629
            ++K ++H N++ ++     + S EEF  + L  ++    L   +     + D  Q L  
Sbjct: 85  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL-- 142
Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
           +  +   L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+     D  MT    
Sbjct: 143 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT---- 192
Query: 690 LATIGYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 724
               GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 193 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 230

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 100/242 (41%), Gaps = 31/242 (12%)
Query: 535 IGRGGFGSVYKARIRDGME-VAVKVFNLQ----CGRAFKSFDVECAMMKSIRHRNLVKVI 589
           +G G +G V  A  R   E VAVK+ +++    C    K    E  + K + H N+VK  
Sbjct: 13  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKFY 69
Query: 590 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRL--NIMIDVASALEYLH------ 641
                   + L LEY   G L             F R+  +I +    A  + H      
Sbjct: 70  GHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGV 116
Query: 642 -FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
            + +   + H D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+APE 
Sbjct: 117 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176
Query: 701 GREGQVSTNG-DVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANL 759
            +  +      DV+S GI+L      + P D+  +       W      ++  + +D+  
Sbjct: 177 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 236
Query: 760 LS 761
           L+
Sbjct: 237 LA 238

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 100/242 (41%), Gaps = 31/242 (12%)
Query: 535 IGRGGFGSVYKARIRDGME-VAVKVFNLQ----CGRAFKSFDVECAMMKSIRHRNLVKVI 589
           +G G +G V  A  R   E VAVK+ +++    C    K    E  + K + H N+VK  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKFY 71
Query: 590 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRL--NIMIDVASALEYLH------ 641
                   + L LEY   G L             F R+  +I +    A  + H      
Sbjct: 72  GHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 642 -FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
            + +   + H D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+APE 
Sbjct: 119 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 701 GREGQVSTNG-DVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANL 759
            +  +      DV+S GI+L      + P D+  +       W      ++  + +D+  
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 238
Query: 760 LS 761
           L+
Sbjct: 239 LA 240

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 105/222 (47%), Gaps = 39/222 (17%)
Query: 522 LFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFN------LQCGRAFKSFDVEC 574
           +++  +++   + +G G +GSV  A   + G+ VAVK  +      +   R ++    E 
Sbjct: 37  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----EL 92
Query: 575 AMMKSIRHRNLVKVIS----SCSNEEFKALVL-EYMPHGSLEKYLHSSNYSLDIFQRLNI 629
            ++K ++H N++ ++     + S EEF  + L  ++    L   +     + D  Q L  
Sbjct: 93  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL-- 150
Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
           +  +   L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+     D  MT    
Sbjct: 151 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT---- 200
Query: 690 LATIGYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 724
               GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 201 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 238

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 100/242 (41%), Gaps = 31/242 (12%)
Query: 535 IGRGGFGSVYKARIRDGME-VAVKVFNLQ----CGRAFKSFDVECAMMKSIRHRNLVKVI 589
           +G G +G V  A  R   E VAVK+ +++    C    K    E  + K + H N+VK  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKFY 71
Query: 590 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRL--NIMIDVASALEYLH------ 641
                   + L LEY   G L             F R+  +I +    A  + H      
Sbjct: 72  GHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 642 -FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
            + +   + H D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+APE 
Sbjct: 119 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 701 GREGQVSTNG-DVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANL 759
            +  +      DV+S GI+L      + P D+  +       W      ++  + +D+  
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 238
Query: 760 LS 761
           L+
Sbjct: 239 LA 240

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 70/259 (27%), Positives = 108/259 (41%), Gaps = 39/259 (15%)
Query: 535 IGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCS 593
           +GRG FG V++   +  G + AVK   L+  RA +   + CA + S R   +V +  +  
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAEEL--MACAGLTSPR---IVPLYGAVR 155
Query: 594 NEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 653
              +  + +E +  GSL + +      L   + L  +      LEYLH   S  ++H D+
Sbjct: 156 EGPWVNIFMELLEGGSLGQLVKEQG-CLPEDRALYYLGQALEGLEYLH---SRRILHGDV 211
Query: 654 KPSNVLL-DDNMVAHLSDFGIA----------KLLTGEDQSMTQTQTLATIGYMAPEYGR 702
           K  NVLL  D   A L DFG A           LLTG+    T+T       +MAPE   
Sbjct: 212 KADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTET-------HMAPEVVL 264
Query: 703 EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLK---------HWVNDCLPISTME 753
                   DV+S   M++       P  + F G + LK              C P++   
Sbjct: 265 GRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPVREIPPSCAPLTAQA 324
Query: 754 VVDANLLSQEDIHFVAKEQ 772
           + +   L +E IH V+  +
Sbjct: 325 IQEG--LRKEPIHRVSAAE 341

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 100/242 (41%), Gaps = 31/242 (12%)
Query: 535 IGRGGFGSVYKARIRDGME-VAVKVFNLQ----CGRAFKSFDVECAMMKSIRHRNLVKVI 589
           +G G +G V  A  R   E VAVK+ +++    C    K    E  + K + H N+VK  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKFY 70
Query: 590 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRL--NIMIDVASALEYLH------ 641
                   + L LEY   G L             F R+  +I +    A  + H      
Sbjct: 71  GHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 642 -FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
            + +   + H D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+APE 
Sbjct: 118 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 701 GREGQVSTNG-DVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANL 759
            +  +      DV+S GI+L      + P D+  +       W      ++  + +D+  
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 237
Query: 760 LS 761
           L+
Sbjct: 238 LA 239

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 100/242 (41%), Gaps = 31/242 (12%)
Query: 535 IGRGGFGSVYKARIRDGME-VAVKVFNLQ----CGRAFKSFDVECAMMKSIRHRNLVKVI 589
           +G G +G V  A  R   E VAVK+ +++    C    K    E  + K + H N+VK  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKFY 71
Query: 590 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRL--NIMIDVASALEYLH------ 641
                   + L LEY   G L             F R+  +I +    A  + H      
Sbjct: 72  GHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 642 -FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
            + +   + H D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+APE 
Sbjct: 119 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 701 GREGQVSTNG-DVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANL 759
            +  +      DV+S GI+L      + P D+  +       W      ++  + +D+  
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 238
Query: 760 LS 761
           L+
Sbjct: 239 LA 240

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 100/242 (41%), Gaps = 31/242 (12%)
Query: 535 IGRGGFGSVYKARIRDGME-VAVKVFNLQ----CGRAFKSFDVECAMMKSIRHRNLVKVI 589
           +G G +G V  A  R   E VAVK+ +++    C    K    E  + K + H N+VK  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKFY 71
Query: 590 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRL--NIMIDVASALEYLH------ 641
                   + L LEY   G L             F R+  +I +    A  + H      
Sbjct: 72  GHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 642 -FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
            + +   + H D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+APE 
Sbjct: 119 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 701 GREGQVSTNG-DVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANL 759
            +  +      DV+S GI+L      + P D+  +       W      ++  + +D+  
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 238
Query: 760 LS 761
           L+
Sbjct: 239 LA 240

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 100/242 (41%), Gaps = 31/242 (12%)
Query: 535 IGRGGFGSVYKARIRDGME-VAVKVFNLQ----CGRAFKSFDVECAMMKSIRHRNLVKVI 589
           +G G +G V  A  R   E VAVK+ +++    C    K    E  + K + H N+VK  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKFY 71
Query: 590 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRL--NIMIDVASALEYLH------ 641
                   + L LEY   G L             F R+  +I +    A  + H      
Sbjct: 72  GHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 642 -FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
            + +   + H D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+APE 
Sbjct: 119 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 701 GREGQVSTNG-DVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANL 759
            +  +      DV+S GI+L      + P D+  +       W      ++  + +D+  
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 238
Query: 760 LS 761
           L+
Sbjct: 239 LA 240

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 100/242 (41%), Gaps = 31/242 (12%)
Query: 535 IGRGGFGSVYKARIRDGME-VAVKVFNLQ----CGRAFKSFDVECAMMKSIRHRNLVKVI 589
           +G G +G V  A  R   E VAVK+ +++    C    K    E  + K + H N+VK  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKFY 70
Query: 590 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRL--NIMIDVASALEYLH------ 641
                   + L LEY   G L             F R+  +I +    A  + H      
Sbjct: 71  GHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 642 -FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
            + +   + H D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+APE 
Sbjct: 118 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 177
Query: 701 GREGQVSTNG-DVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANL 759
            +  +      DV+S GI+L      + P D+  +       W      ++  + +D+  
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 237
Query: 760 LS 761
           L+
Sbjct: 238 LA 239

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 100/242 (41%), Gaps = 31/242 (12%)
Query: 535 IGRGGFGSVYKARIRDGME-VAVKVFNLQ----CGRAFKSFDVECAMMKSIRHRNLVKVI 589
           +G G +G V  A  R   E VAVK+ +++    C    K    E  + K + H N+VK  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EIXINKMLNHENVVKFY 71
Query: 590 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRL--NIMIDVASALEYLH------ 641
                   + L LEY   G L             F R+  +I +    A  + H      
Sbjct: 72  GHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 642 -FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
            + +   + H D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+APE 
Sbjct: 119 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 178
Query: 701 GREGQVSTNG-DVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANL 759
            +  +      DV+S GI+L      + P D+  +       W      ++  + +D+  
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 238
Query: 760 LS 761
           L+
Sbjct: 239 LA 240

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 105/222 (47%), Gaps = 39/222 (17%)
Query: 522 LFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFN------LQCGRAFKSFDVEC 574
           +++  +++   + +G G +GSV  A   + G+ VAVK  +      +   R ++    E 
Sbjct: 23  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----EL 78
Query: 575 AMMKSIRHRNLVKVIS----SCSNEEFKALVL-EYMPHGSLEKYLHSSNYSLDIFQRLNI 629
            ++K ++H N++ ++     + S EEF  + L  ++    L   +     + D  Q L  
Sbjct: 79  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL-- 136
Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
           +  +   L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+     D  MT    
Sbjct: 137 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT---- 186
Query: 690 LATIGYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 724
               GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 187 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 224

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 100/242 (41%), Gaps = 31/242 (12%)
Query: 535 IGRGGFGSVYKARIRDGME-VAVKVFNLQ----CGRAFKSFDVECAMMKSIRHRNLVKVI 589
           +G G +G V  A  R   E VAVK+ +++    C    K    E  + K + H N+VK  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EIXINKMLNHENVVKFY 70
Query: 590 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRL--NIMIDVASALEYLH------ 641
                   + L LEY   G L             F R+  +I +    A  + H      
Sbjct: 71  GHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 642 -FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
            + +   + H D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+APE 
Sbjct: 118 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 177
Query: 701 GREGQVSTNG-DVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANL 759
            +  +      DV+S GI+L      + P D+  +       W      ++  + +D+  
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 237
Query: 760 LS 761
           L+
Sbjct: 238 LA 239

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 88/199 (44%), Gaps = 13/199 (6%)
Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDV---ECAMMKSIRH 582
           D+F     +G G FG V   + +  G   A+K+ + Q     K  +    E  +++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
             LVK+  S  +     +V+EY+P G +  +L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 703 EGQVSTNGDVYSFGIMLME 721
               +   D ++ G+++ E
Sbjct: 212 SKGYNKAVDWWALGVLIYE 230

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 100/242 (41%), Gaps = 31/242 (12%)
Query: 535 IGRGGFGSVYKARIRDGME-VAVKVFNLQ----CGRAFKSFDVECAMMKSIRHRNLVKVI 589
           +G G +G V  A  R   E VAVK+ +++    C    K    E  + K + H N+VK  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EIXINKMLNHENVVKFY 70
Query: 590 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRL--NIMIDVASALEYLH------ 641
                   + L LEY   G L             F R+  +I +    A  + H      
Sbjct: 71  GHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 642 -FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
            + +   + H D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+APE 
Sbjct: 118 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 701 GREGQVSTNG-DVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANL 759
            +  +      DV+S GI+L      + P D+  +       W      ++  + +D+  
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 237
Query: 760 LS 761
           L+
Sbjct: 238 LA 239

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 88/199 (44%), Gaps = 13/199 (6%)
Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDV---ECAMMKSIRH 582
           D+F     +G G FG V   + +  G   A+K+ + Q     K  +    E  +++++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
             LVK+  S  +     +V+EY+P G +  +L       +   R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+APE   
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 212
Query: 703 EGQVSTNGDVYSFGIMLME 721
               +   D ++ G+++ E
Sbjct: 213 SKGYNKAVDWWALGVLIYE 231

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 88/199 (44%), Gaps = 13/199 (6%)
Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDV---ECAMMKSIRH 582
           D+F     +G G FG V   + +  G   A+K+ + Q     K  +    E  +++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
             LVK+  S  +     +V+EY+P G +  +L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 703 EGQVSTNGDVYSFGIMLME 721
               +   D ++ G+++ E
Sbjct: 212 SKGYNKAVDWWALGVLIYE 230

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 88/199 (44%), Gaps = 13/199 (6%)
Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDV---ECAMMKSIRH 582
           D+F     +G G FG V   + +  G   A+K+ + Q     K  +    E  +++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
             LVK+  S  +     +V+EY+P G +  +L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 703 EGQVSTNGDVYSFGIMLME 721
               +   D ++ G+++ E
Sbjct: 212 SKGYNKAVDWWALGVLIYE 230

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 105/222 (47%), Gaps = 39/222 (17%)
Query: 522 LFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFN------LQCGRAFKSFDVEC 574
           +++  +++   + +G G +GSV  A   + G  VAVK  +      +   R ++    E 
Sbjct: 13  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR----EL 68
Query: 575 AMMKSIRHRNLVKVIS----SCSNEEFKALVL-EYMPHGSLEKYLHSSNYSLDIFQRLNI 629
            ++K ++H N++ ++     + S EEF  + L  ++    L   +  +  + D  Q L  
Sbjct: 69  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFL-- 126
Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
           +  +   L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+     D  MT    
Sbjct: 127 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT---- 176
Query: 690 LATIGYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 724
               GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 177 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 87/197 (44%), Gaps = 12/197 (6%)
Query: 535 IGRGGFGSVYKARIR-DGMEVAVKVFNL-QCGRAFKSFDV-ECAMMKSIRHRNLVKVISS 591
           IG G +G   K R + DG  +  K  +      A K   V E  +++ ++H N+V+    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 592 CSNEEFKAL--VLEYMPHGSLEKYLHSSNYS---LDIFQRLNIMIDVASALEYLHFGYSA 646
             +     L  V+EY   G L   +         LD    L +M  +  AL+  H     
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 647 --PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG 704
              V+H DLKP+NV LD      L DFG+A++L   D S  +T  + T  YM+PE     
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN-HDTSFAKT-FVGTPYYMSPEQMNRM 191
Query: 705 QVSTNGDVYSFGIMLME 721
             +   D++S G +L E
Sbjct: 192 SYNEKSDIWSLGCLLYE 208

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 70/259 (27%), Positives = 108/259 (41%), Gaps = 39/259 (15%)
Query: 535 IGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCS 593
           +GRG FG V++   +  G + AVK   L+  RA +   + CA + S R   +V +  +  
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAEEL--MACAGLTSPR---IVPLYGAVR 136
Query: 594 NEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 653
              +  + +E +  GSL + +      L   + L  +      LEYLH   S  ++H D+
Sbjct: 137 EGPWVNIFMELLEGGSLGQLVKEQG-CLPEDRALYYLGQALEGLEYLH---SRRILHGDV 192
Query: 654 KPSNVLL-DDNMVAHLSDFGIA----------KLLTGEDQSMTQTQTLATIGYMAPEYGR 702
           K  NVLL  D   A L DFG A           LLTG+    T+T       +MAPE   
Sbjct: 193 KADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTET-------HMAPEVVL 245
Query: 703 EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLK---------HWVNDCLPISTME 753
                   DV+S   M++       P  + F G + LK              C P++   
Sbjct: 246 GRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPVREIPPSCAPLTAQA 305
Query: 754 VVDANLLSQEDIHFVAKEQ 772
           + +   L +E IH V+  +
Sbjct: 306 IQEG--LRKEPIHRVSAAE 322

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 89/201 (44%), Gaps = 13/201 (6%)
Query: 535 IGRGGFGSVYKAR-IRDGMEVAVKVFN---LQCGRAFKSFDVECAMMKSIRHRNLVKVIS 590
           IG+G F  V  AR I  G EVAVK+ +   L      K F  E  + K + H N+VK+  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIXKVLNHPNIVKLFE 80
Query: 591 SCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIH 650
               E+   LV EY   G +  YL +     +   R      + SA++Y H  +   ++H
Sbjct: 81  VIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFR-QIVSAVQYCHQKF---IVH 136
Query: 651 CDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPE-YGREGQVSTN 709
            DLK  N+LLD +    ++DFG +   T  ++            Y APE +  +      
Sbjct: 137 RDLKAENLLLDADXNIKIADFGFSNEFTFGNKL---DAFCGAPPYAAPELFQGKKYDGPE 193
Query: 710 GDVYSFGIMLMETFTRKKPTD 730
            DV+S G++L    +   P D
Sbjct: 194 VDVWSLGVILYTLVSGSLPFD 214

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 104/222 (46%), Gaps = 39/222 (17%)
Query: 522 LFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFN------LQCGRAFKSFDVEC 574
           +++  +++   + +G G +GSV  A   + G  VAVK  +      +   R ++    E 
Sbjct: 13  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR----EL 68
Query: 575 AMMKSIRHRNLVKVIS----SCSNEEFKALVL-EYMPHGSLEKYLHSSNYSLDIFQRLNI 629
            ++K ++H N++ ++     + S EEF  + L  ++    L   +     + D  Q L  
Sbjct: 69  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL-- 126
Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
           +  +   L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+     D  MT    
Sbjct: 127 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT---- 176
Query: 690 LATIGYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 724
               GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 177 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 69/281 (24%), Positives = 128/281 (45%), Gaps = 39/281 (13%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCG--RAFKSFDVECAMMKSIRHRN--LVKVIS 590
           IG GG   V++         A+K  NL+    +   S+  E A +  ++  +  ++++  
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 591 SCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIH 650
               +++  +V+E   +  L  +L     S+D ++R +   ++   LE +H  +   ++H
Sbjct: 124 YEITDQYIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNM---LEAVHTIHQHGIVH 178
Query: 651 CDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVS-TN 709
            DLKP+N L+ D M+  L DFGIA  +  +  S+ +   +  + YM PE  ++   S  N
Sbjct: 179 SDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSREN 237
Query: 710 G----------DVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANL 759
           G          DV+S G +L      K P  ++ N +++  H + D  P   +E  D   
Sbjct: 238 GKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-QISKLHAIID--PNHEIEFPD--- 291
Query: 760 LSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVA 800
           + ++D+  V K  C          C    P+QRI+  E++A
Sbjct: 292 IPEKDLQDVLK--C----------CLKRDPKQRISIPELLA 320

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 96/212 (45%), Gaps = 18/212 (8%)
Query: 533 NLIGRGGFGSVYKARIRDG--------MEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRN 584
            ++G+GG+G V++ R   G        M+V  K   ++  +       E  +++ ++H  
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 585 LVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGY 644
           +V +I +        L+LEY+  G L   L      ++       + +++ AL +LH   
Sbjct: 83  IVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACF-YLAEISMALGHLH--- 138
Query: 645 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG 704
              +I+ DLKP N++L+      L+DFG+ K  +  D ++T      TI YMAPE     
Sbjct: 139 QKGIIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHX-FCGTIEYMAPEILMRS 196
Query: 705 QVSTNGDVYSFGIMLMETFTRKKPTDELFNGE 736
             +   D +S G ++ +  T   P    F GE
Sbjct: 197 GHNRAVDWWSLGALMYDMLTGAPP----FTGE 224

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 68/287 (23%), Positives = 132/287 (45%), Gaps = 33/287 (11%)
Query: 527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDV-ECAMMKSIRHRN 584
           D F + + +G G  G V+K   +  G+ +A K+ +L+   A ++  + E  ++       
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 68
Query: 585 LVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRL--NIMIDVASALEYLHF 642
           +V    +  ++   ++ +E+M  GSL++ L  +     I +++   + I V   L YL  
Sbjct: 69  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLRE 125
Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
            +   ++H D+KPSN+L++      L DFG++  L  E       + + T  YM+PE  +
Sbjct: 126 KHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDE----MANEFVGTRSYMSPERLQ 179
Query: 703 EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ 762
               S   D++S G+ L+E    + P   +   E+ L + VN+  P      + + + S 
Sbjct: 180 GTHYSVQSDIWSMGLSLVEMAVGRYPRPPMAIFEL-LDYIVNEPPP-----KLPSAVFSL 233
Query: 763 EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEI-VAKLLKIRDS 808
           E   FV K             C +++P +R + K++ V   +K  D+
Sbjct: 234 EFQDFVNK-------------CLIKNPAERADLKQLMVHAFIKRSDA 267

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 105/222 (47%), Gaps = 39/222 (17%)
Query: 522 LFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFN------LQCGRAFKSFDVEC 574
           +++  +++   + +G G +GSV  A   + G+ VAVK  +      +   R ++    E 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----EL 72
Query: 575 AMMKSIRHRNLVKVIS----SCSNEEFKALVL-EYMPHGSLEKYLHSSNYSLDIFQRLNI 629
            ++K ++H N++ ++     + S EEF  + L  ++    L   +     + D  Q L  
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL-- 130
Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
           +  +   L+Y+H   SA +IH DLKPSN+ ++++    + D+G+A+     D  MT    
Sbjct: 131 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDYGLAR---HTDDEMT---- 180
Query: 690 LATIGYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 724
               GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 181 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 87/199 (43%), Gaps = 13/199 (6%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDV---ECAMMKSIRH 582
           D+F     +G G FG V   + ++ G   A+K+ + Q     K  +    E  + +++  
Sbjct: 42  DQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNF 101
Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
             LVK+  S  +     +VLEY P G +  +L       +   R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+APE   
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 212
Query: 703 EGQVSTNGDVYSFGIMLME 721
               +   D ++ G+++ E
Sbjct: 213 SKGYNKAVDWWALGVLIYE 231

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Composition-based stats.
 Identities = 56/212 (26%), Positives = 90/212 (42%), Gaps = 31/212 (14%)
Query: 535 IGRGGFGSVYKARIRDGME-VAVKVFNLQ----CGRAFKSFDVECAMMKSIRHRNLVKVI 589
           +G G +G V  A  R   E VAVK+ +++    C    K    E  + K + H N+VK  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKFY 70
Query: 590 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRL--NIMIDVASALEYLH------ 641
                   + L LEY   G L             F R+  +I +    A  + H      
Sbjct: 71  GHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 642 -FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
            + +   + H D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+APE 
Sbjct: 118 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 177
Query: 701 GREGQVSTNG-DVYSFGIMLMETFTRKKPTDE 731
            +  +      DV+S GI+L      + P D+
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 104/222 (46%), Gaps = 39/222 (17%)
Query: 522 LFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFN------LQCGRAFKSFDVEC 574
           +++  +++   + +G G +GSV  A   + G  VAVK  +      +   R ++    E 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR----EL 72
Query: 575 AMMKSIRHRNLVKVIS----SCSNEEFKALVL-EYMPHGSLEKYLHSSNYSLDIFQRLNI 629
            ++K ++H N++ ++     + S EEF  + L  ++    L   +     + D  Q L  
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL-- 130
Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
           +  +   L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+     D  MT    
Sbjct: 131 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT---- 180
Query: 690 LATIGYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 724
               GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 181 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Composition-based stats.
 Identities = 56/212 (26%), Positives = 90/212 (42%), Gaps = 31/212 (14%)
Query: 535 IGRGGFGSVYKARIRDGME-VAVKVFNLQ----CGRAFKSFDVECAMMKSIRHRNLVKVI 589
           +G G +G V  A  R   E VAVK+ +++    C    K    E  + K + H N+VK  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKFY 70
Query: 590 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRL--NIMIDVASALEYLH------ 641
                   + L LEY   G L             F R+  +I +    A  + H      
Sbjct: 71  GHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 642 -FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
            + +   + H D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+APE 
Sbjct: 118 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 701 GREGQVSTNG-DVYSFGIMLMETFTRKKPTDE 731
            +  +      DV+S GI+L      + P D+
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Composition-based stats.
 Identities = 56/212 (26%), Positives = 90/212 (42%), Gaps = 31/212 (14%)
Query: 535 IGRGGFGSVYKARIRDGME-VAVKVFNLQ----CGRAFKSFDVECAMMKSIRHRNLVKVI 589
           +G G +G V  A  R   E VAVK+ +++    C    K    E  + K + H N+VK  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKFY 70
Query: 590 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRL--NIMIDVASALEYLH------ 641
                   + L LEY   G L             F R+  +I +    A  + H      
Sbjct: 71  GHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 642 -FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
            + +   + H D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+APE 
Sbjct: 118 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 701 GREGQVSTNG-DVYSFGIMLMETFTRKKPTDE 731
            +  +      DV+S GI+L      + P D+
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Composition-based stats.
 Identities = 56/212 (26%), Positives = 90/212 (42%), Gaps = 31/212 (14%)
Query: 535 IGRGGFGSVYKARIRDGME-VAVKVFNLQ----CGRAFKSFDVECAMMKSIRHRNLVKVI 589
           +G G +G V  A  R   E VAVK+ +++    C    K    E  + K + H N+VK  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKFY 70
Query: 590 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRL--NIMIDVASALEYLH------ 641
                   + L LEY   G L             F R+  +I +    A  + H      
Sbjct: 71  GHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 642 -FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
            + +   + H D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+APE 
Sbjct: 118 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 701 GREGQVSTNG-DVYSFGIMLMETFTRKKPTDE 731
            +  +      DV+S GI+L      + P D+
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Composition-based stats.
 Identities = 56/212 (26%), Positives = 90/212 (42%), Gaps = 31/212 (14%)
Query: 535 IGRGGFGSVYKARIRDGME-VAVKVFNLQ----CGRAFKSFDVECAMMKSIRHRNLVKVI 589
           +G G +G V  A  R   E VAVK+ +++    C    K    E  + K + H N+VK  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKFY 70
Query: 590 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRL--NIMIDVASALEYLH------ 641
                   + L LEY   G L             F R+  +I +    A  + H      
Sbjct: 71  GHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 642 -FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
            + +   + H D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+APE 
Sbjct: 118 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 701 GREGQVSTNG-DVYSFGIMLMETFTRKKPTDE 731
            +  +      DV+S GI+L      + P D+
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Composition-based stats.
 Identities = 56/212 (26%), Positives = 90/212 (42%), Gaps = 31/212 (14%)
Query: 535 IGRGGFGSVYKARIRDGME-VAVKVFNLQ----CGRAFKSFDVECAMMKSIRHRNLVKVI 589
           +G G +G V  A  R   E VAVK+ +++    C    K    E  + K + H N+VK  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKFY 71
Query: 590 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRL--NIMIDVASALEYLH------ 641
                   + L LEY   G L             F R+  +I +    A  + H      
Sbjct: 72  GHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 642 -FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
            + +   + H D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+APE 
Sbjct: 119 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 701 GREGQVSTNG-DVYSFGIMLMETFTRKKPTDE 731
            +  +      DV+S GI+L      + P D+
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 88/199 (44%), Gaps = 13/199 (6%)
Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDV---ECAMMKSIRH 582
           D+F     +G G FG V   + +  G   A+K+ + Q     K  +    E  +++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
             LVK+  S  +     +V+EY P G +  +L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
             S  +I+ DLKP N+++D      ++DFG+AK + G    +       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 703 EGQVSTNGDVYSFGIMLME 721
               +   D ++ G+++ E
Sbjct: 212 SKGYNKAVDWWALGVLIYE 230

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 97/206 (47%), Gaps = 18/206 (8%)
Query: 523 FQAT--DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDV--ECAMM 577
           FQ T  ++++   ++G+G FG V K + R    E AVKV N    +   +  +  E  ++
Sbjct: 16  FQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELL 75
Query: 578 KSIRHRNLVKVISSCSNEEFKALVLEYMPHGSL-EKYLHSSNYSLDIFQRLNIMIDVASA 636
           K + H N++K+     +     +V E    G L ++ +    +S     R  I+  V S 
Sbjct: 76  KKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR--IIKQVFSG 133
Query: 637 LEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATI 693
           + Y+H      ++H DLKP N+LL   + +    + DFG++   T   Q+      + T 
Sbjct: 134 ITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLS---TCFQQNTKMKDRIGTA 187
Query: 694 GYMAPEYGREGQVSTNGDVYSFGIML 719
            Y+APE  R G      DV+S G++L
Sbjct: 188 YYIAPEVLR-GTYDEKCDVWSAGVIL 212

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 87/199 (43%), Gaps = 13/199 (6%)
Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDV---ECAMMKSIRH 582
           D+F     +G G FG V   + +  G   A+K+ + Q     K  +    E  +++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
             LVK+  S  +     +V+EY P G +  +L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
             S  +I+ DLKP N+++D      ++DFG AK + G    +       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 703 EGQVSTNGDVYSFGIMLME 721
               +   D ++ G+++ E
Sbjct: 212 SKGYNKAVDWWALGVLIYE 230

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 97/206 (47%), Gaps = 18/206 (8%)
Query: 523 FQAT--DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDV--ECAMM 577
           FQ T  ++++   ++G+G FG V K + R    E AVKV N    +   +  +  E  ++
Sbjct: 16  FQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELL 75
Query: 578 KSIRHRNLVKVISSCSNEEFKALVLEYMPHGSL-EKYLHSSNYSLDIFQRLNIMIDVASA 636
           K + H N++K+     +     +V E    G L ++ +    +S     R  I+  V S 
Sbjct: 76  KKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR--IIKQVFSG 133
Query: 637 LEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATI 693
           + Y+H      ++H DLKP N+LL   + +    + DFG++   T   Q+      + T 
Sbjct: 134 ITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLS---TCFQQNTKMKDRIGTA 187
Query: 694 GYMAPEYGREGQVSTNGDVYSFGIML 719
            Y+APE  R G      DV+S G++L
Sbjct: 188 YYIAPEVLR-GTYDEKCDVWSAGVIL 212

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 104/222 (46%), Gaps = 39/222 (17%)
Query: 522 LFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFN------LQCGRAFKSFDVEC 574
           +++  +++   + +G G +GSV  A   + G  VAVK  +      +   R ++    E 
Sbjct: 36  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR----EL 91
Query: 575 AMMKSIRHRNLVKVIS----SCSNEEFKALVL-EYMPHGSLEKYLHSSNYSLDIFQRLNI 629
            ++K ++H N++ ++     + S EEF  + L  ++    L   +     + D  Q L  
Sbjct: 92  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL-- 149
Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
           +  +   L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+     D  MT    
Sbjct: 150 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT---- 199
Query: 690 LATIGYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 724
               GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 200 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 237

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 104/222 (46%), Gaps = 39/222 (17%)
Query: 522 LFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFN------LQCGRAFKSFDVEC 574
           +++  +++   + +G G +GSV  A   + G  VAVK  +      +   R ++    E 
Sbjct: 37  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR----EL 92
Query: 575 AMMKSIRHRNLVKVIS----SCSNEEFKALVL-EYMPHGSLEKYLHSSNYSLDIFQRLNI 629
            ++K ++H N++ ++     + S EEF  + L  ++    L   +     + D  Q L  
Sbjct: 93  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL-- 150
Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
           +  +   L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+     D  MT    
Sbjct: 151 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT---- 200
Query: 690 LATIGYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 724
               GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 201 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 238

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 105/218 (48%), Gaps = 30/218 (13%)
Query: 528 KFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDV----ECAMMKSIRH 582
           K+ +   IG+G FG V+KAR R  G +VA+K   ++  +  + F +    E  +++ ++H
Sbjct: 19  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKILQLLKH 76
Query: 583 RNLVKVISSCSNE-----EFKA---LVLEYMPH---GSLEKYLHSSNYSLDIFQRLNIMI 631
            N+V +I  C  +       KA   LV ++  H   G L   L    ++L   +R+  M+
Sbjct: 77  ENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVL--VKFTLSEIKRVMQML 134
Query: 632 DVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL--LTGEDQSMTQTQT 689
                L  L++ +   ++H D+K +NVL+  + V  L+DFG+A+   L    Q       
Sbjct: 135 -----LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNR 189
Query: 690 LATIGYMAPE--YGREGQVSTNGDVYSFGIMLMETFTR 725
           + T+ Y  PE   G E       D++  G ++ E +TR
Sbjct: 190 VVTLWYRPPELLLG-ERDYGPPIDLWGAGCIMAEMWTR 226

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 102/213 (47%), Gaps = 43/213 (20%)
Query: 535 IGRGGFGSV---YKARIRDGMEVAVKVFN------LQCGRAFKSFDVECAMMKSIRHRNL 585
           +G G +GSV   Y AR+R   +VAVK  +      +   R ++    E  ++K ++H N+
Sbjct: 36  VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYR----ELRLLKHLKHENV 89
Query: 586 VKVIS----SCSNEEFKALVLEYMPHGS-LEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
           + ++     + S E+F  + L     G+ L   + S   S +  Q L  +  +   L+Y+
Sbjct: 90  IGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFL--VYQLLRGLKYI 147
Query: 641 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
           H   SA +IH DLKPSNV ++++    + DFG+A+     D+ MT        GY+A  +
Sbjct: 148 H---SAGIIHRDLKPSNVAVNEDSELRILDFGLAR---QADEEMT--------GYVATRW 193
Query: 701 GREGQVSTNG-------DVYSFGIMLMETFTRK 726
            R  ++  N        D++S G ++ E    K
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 72/256 (28%), Positives = 111/256 (43%), Gaps = 35/256 (13%)
Query: 535 IGRGGFGSVYKAR-IRDGMEVAVK-----VFNLQCGRAFKSFDVECAMMKSIRHRNLVKV 588
           +GRG +G V K R +  G  +AVK     V + +  R     D+    M+++     V  
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDIS---MRTVDCPFTVTF 115
Query: 589 ISSCSNEEFKALVLEYMPHGSLEKYLHS-----SNYSLDIFQRLNIMIDVASALEYLHFG 643
             +   E    + +E M   SL+K+             DI  +  I + +  ALE+LH  
Sbjct: 116 YGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGK--IAVSIVKALEHLHSK 172
Query: 644 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY--- 700
            S  VIH D+KPSNVL++      + DFGI+  L     S+ +T       YMAPE    
Sbjct: 173 LS--VIHRDVKPSNVLINALGQVKMCDFGISGYLV---DSVAKTIDAGCKPYMAPERINP 227
Query: 701 --GREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDAN 758
              ++G  S   D++S GI ++E    + P D        LK  V +  P      + A+
Sbjct: 228 ELNQKG-YSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSP-----QLPAD 281
Query: 759 LLSQEDIHFVAKEQCV 774
             S E + F +  QC+
Sbjct: 282 KFSAEFVDFTS--QCL 295

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 103/222 (46%), Gaps = 39/222 (17%)
Query: 522 LFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFN------LQCGRAFKSFDVEC 574
           +++  +++   + +G G +GSV  A   + G+ VAVK  +      +   R ++    E 
Sbjct: 40  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----EL 95
Query: 575 AMMKSIRHRNLVKVIS----SCSNEEFKALVL-EYMPHGSLEKYLHSSNYSLDIFQRLNI 629
            ++K ++H N++ ++     + S EEF  + L  ++    L   +     + D  Q L  
Sbjct: 96  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL-- 153
Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
           +  +   L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+    E         
Sbjct: 154 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--------- 201
Query: 690 LATIGYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 724
               GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 202 --MXGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 241

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 104/222 (46%), Gaps = 39/222 (17%)
Query: 522 LFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFN------LQCGRAFKSFDVEC 574
           +++  +++   + +G G +GSV  A   + G  VAVK  +      +   R ++    E 
Sbjct: 23  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR----EL 78
Query: 575 AMMKSIRHRNLVKVIS----SCSNEEFKALVL-EYMPHGSLEKYLHSSNYSLDIFQRLNI 629
            ++K ++H N++ ++     + S EEF  + L  ++    L   +     + D  Q L  
Sbjct: 79  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL-- 136
Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
           +  +   L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+     D  MT    
Sbjct: 137 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT---- 186
Query: 690 LATIGYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 724
               GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 187 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 224

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 96/206 (46%), Gaps = 18/206 (8%)
Query: 523 FQAT--DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDV--ECAMM 577
           FQ T  ++++   ++G+G FG V K + R    E AVKV N    +   +  +  E  ++
Sbjct: 16  FQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELL 75
Query: 578 KSIRHRNLVKVISSCSNEEFKALVLEYMPHGSL-EKYLHSSNYSLDIFQRLNIMIDVASA 636
           K + H N++K+     +     +V E    G L ++ +    +S     R  I+  V S 
Sbjct: 76  KKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR--IIKQVFSG 133
Query: 637 LEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATI 693
           + Y+H      ++H DLKP N+LL   + +    + DFG++       Q+      + T 
Sbjct: 134 ITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ---QNTKMKDRIGTA 187
Query: 694 GYMAPEYGREGQVSTNGDVYSFGIML 719
            Y+APE  R G      DV+S G++L
Sbjct: 188 YYIAPEVLR-GTYDEKCDVWSAGVIL 212

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 88/199 (44%), Gaps = 13/199 (6%)
Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDV---ECAMMKSIRH 582
           D+F     +G G FG V   + +  G   A+K+ + Q     K  +    E  +++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
             LVK+  S  +     +V+EY P G +  +L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
             S  +I+ DLKP N+++D      ++DFG+AK + G    +       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 703 EGQVSTNGDVYSFGIMLME 721
               +   D ++ G+++ E
Sbjct: 212 SKGYNKAVDWWALGVLIYE 230

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 87/199 (43%), Gaps = 13/199 (6%)
Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDV---ECAMMKSIRH 582
           D+F     +G G FG V   + +  G   A+K+ + Q     K  +    E  +++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
             LVK+  S  +     +V+EY P G +  +L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
             S  +I+ DLKP N+++D      ++DFG AK + G    +       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 703 EGQVSTNGDVYSFGIMLME 721
               +   D ++ G+++ E
Sbjct: 212 SKGYNKAVDWWALGVLIYE 230

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 88/199 (44%), Gaps = 13/199 (6%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDV---ECAMMKSIRH 582
           D+F     +G G FG V   + ++ G   A+K+ + Q     K  +    E  +++++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
             LVK+  S  +     +V+EY P G +  +L       +   R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
             S  +I+ DLKP N+++D      ++DFG AK + G    +       T  Y+APE   
Sbjct: 160 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 212
Query: 703 EGQVSTNGDVYSFGIMLME 721
               +   D ++ G+++ E
Sbjct: 213 SKGYNKAVDWWALGVLIYE 231

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 89/199 (44%), Gaps = 13/199 (6%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDV---ECAMMKSIRH 582
           D+F     +G G FG V   + ++ G   A+K+ + Q     K  +    E  +++++  
Sbjct: 28  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 87
Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
             LVK+  S  +     +V+EY+  G +  +L       +   R      +    EYLH 
Sbjct: 88  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 145
Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
             S  +I+ DLKP N+L+D+     ++DFG AK + G    +       T  Y+APE   
Sbjct: 146 --SLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 198
Query: 703 EGQVSTNGDVYSFGIMLME 721
               +   D ++ G+++ E
Sbjct: 199 SKGYNKAVDWWALGVLIYE 217

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 93/226 (41%), Gaps = 24/226 (10%)
Query: 508 MPPVATWRRFSYLELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRA 566
           M P  T   F YL             L+G+G FG V   R +  G   A+K+   +   A
Sbjct: 3   MDPKVTMNDFDYL------------KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA 50
Query: 567 FKSFD---VECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDI 623
                    E  ++++ RH  L  +  +    +    V+EY   G L  + H S   +  
Sbjct: 51  KDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFT 108
Query: 624 FQRLNIM-IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 682
            +R      ++ SALEYLH   S  V++ D+K  N++LD +    ++DFG+ K   G   
Sbjct: 109 EERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISD 163
Query: 683 SMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKP 728
             T      T  Y+APE   +       D +  G+++ E    + P
Sbjct: 164 GATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 94/223 (42%), Gaps = 37/223 (16%)
Query: 529 FSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGR-AFKSFDVECAMMKSIRHRNLV 586
           F     +GRGGFG V++A+ + D    A+K   L     A +    E   +  + H  +V
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 587 KVISSCSNEEFKALVLEYMPHGSLEKYLHSS-------------NYSLDIFQR-----LN 628
           +      N   +    E +   S + YL+               N    I +R     L+
Sbjct: 67  RYF----NAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLH 122
Query: 629 IMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMT--- 685
           I + +A A+E+LH   S  ++H DLKPSN+    + V  + DFG+   +  +++  T   
Sbjct: 123 IFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179
Query: 686 -------QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLME 721
                   T  + T  YM+PE       S   D++S G++L E
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE 222

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 103/222 (46%), Gaps = 39/222 (17%)
Query: 522 LFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFN------LQCGRAFKSFDVEC 574
           +++  +++     +G G +GSV  A   + G  VAVK  +      +   R ++    E 
Sbjct: 27  IWEVPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR----EL 82
Query: 575 AMMKSIRHRNLVKVIS----SCSNEEFKALVL-EYMPHGSLEKYLHSSNYSLDIFQRLNI 629
            ++K ++H N++ ++     + S EEF  + L  ++    L   +     + D  Q L  
Sbjct: 83  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL-- 140
Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
           +  +   L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+     D  MT    
Sbjct: 141 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT---- 190
Query: 690 LATIGYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 724
               GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 191 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 228

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 87/197 (44%), Gaps = 12/197 (6%)
Query: 535 IGRGGFGSVYKARIR-DGMEVAVKVFNL-QCGRAFKSFDV-ECAMMKSIRHRNLVKVISS 591
           IG G +G   K R + DG  +  K  +      A K   V E  +++ ++H N+V+    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 592 CSNEEFKAL--VLEYMPHGSLEKYLHSSNYS---LDIFQRLNIMIDVASALEYLHFGYSA 646
             +     L  V+EY   G L   +         LD    L +M  +  AL+  H     
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 647 --PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG 704
              V+H DLKP+NV LD      L DFG+A++L   D+   + + + T  YM+PE     
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN-HDEDFAK-EFVGTPYYMSPEQMNRM 191
Query: 705 QVSTNGDVYSFGIMLME 721
             +   D++S G +L E
Sbjct: 192 SYNEKSDIWSLGCLLYE 208

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 88/199 (44%), Gaps = 13/199 (6%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDV---ECAMMKSIRH 582
           D+F     +G G FG V   + ++ G   A+K+ + Q     K  +    E  +++++  
Sbjct: 36  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 95
Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
             LVK+  S  +     +V+EY+  G +  +L       +   R      +    EYLH 
Sbjct: 96  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 153
Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+APE   
Sbjct: 154 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 206
Query: 703 EGQVSTNGDVYSFGIMLME 721
               +   D ++ G+++ E
Sbjct: 207 SKGYNKAVDWWALGVLIYE 225

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 87/199 (43%), Gaps = 13/199 (6%)
Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDV---ECAMMKSIRH 582
           D+F     +G G FG V   + +  G   A+K+ + Q     K  +    E  +++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
             LVK+  S  +     +V+EY P G +  +L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
             S  +I+ DLKP N+++D      ++DFG AK + G    +       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 703 EGQVSTNGDVYSFGIMLME 721
               +   D ++ G+++ E
Sbjct: 212 SKGYNKAVDWWALGVLIYE 230

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 91/200 (45%), Gaps = 15/200 (7%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDV---ECAMMKSIRH 582
           D+F     +G G FG V   + ++ G   A+K+ + Q     K  +    E  +++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
             LVK+  S  +     +V+EY+  G +  +L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAPEYG 701
             S  +I+ DLKP N+L+D      ++DFG AK + G      +T  LA T  Y+APE  
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWXLAGTPEYLAPEII 210
Query: 702 REGQVSTNGDVYSFGIMLME 721
                +   D ++ G+++ E
Sbjct: 211 LSKGYNKAVDWWALGVLIYE 230

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 105/253 (41%), Gaps = 39/253 (15%)
Query: 535 IGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCS 593
           +GRG FG V++ + +  G + AVK   L+  R  +   V CA + S R   +V +  +  
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEEL--VACAGLSSPR---IVPLYGAVR 120
Query: 594 NEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 653
              +  + +E +  GSL + +      +        +  +  ALE L + ++  ++H D+
Sbjct: 121 EGPWVNIFMELLEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHTRRILHGDV 176
Query: 654 KPSNVLL-DDNMVAHLSDFGIA----------KLLTGEDQSMTQTQTLATIGYMAPEYGR 702
           K  NVLL  D   A L DFG A           LLTG+    T+T       +MAPE   
Sbjct: 177 KADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTET-------HMAPEVVM 229
Query: 703 EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLK---------HWVNDCLPISTME 753
                   D++S   M++       P  + F G + LK              C P++   
Sbjct: 230 GKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQA 289
Query: 754 VVDANLLSQEDIH 766
           + +   L +E +H
Sbjct: 290 IQEG--LRKEPVH 300

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 88/199 (44%), Gaps = 13/199 (6%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDV---ECAMMKSIRH 582
           D+F     +G G FG V   + ++ G   A+K+ + Q     K  +    E  +++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
             LVK+  S  +     +V+EY+  G +  +L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 703 EGQVSTNGDVYSFGIMLME 721
               +   D ++ G+++ E
Sbjct: 212 SKGYNKAVDWWALGVLIYE 230

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 99/242 (40%), Gaps = 31/242 (12%)
Query: 535 IGRGGFGSVYKARIRDGME-VAVKVFNLQ----CGRAFKSFDVECAMMKSIRHRNLVKVI 589
           +G G  G V  A  R   E VAVK+ +++    C    K    E  + K + H N+VK  
Sbjct: 14  LGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKFY 70
Query: 590 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRL--NIMIDVASALEYLH------ 641
                   + L LEY   G L             F R+  +I +    A  + H      
Sbjct: 71  GHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 642 -FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
            + +   + H D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+APE 
Sbjct: 118 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 701 GREGQVSTNG-DVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANL 759
            +  +      DV+S GI+L      + P D+  +       W      ++  + +D+  
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 237
Query: 760 LS 761
           L+
Sbjct: 238 LA 239

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 103/227 (45%), Gaps = 48/227 (21%)
Query: 524 QATDKFSEN----NLIGRGGFGSVYKARIRDGM--EVAVKVFNLQCGRAFKSFDVEC--- 574
            +T  F EN     ++GRG   SV +  I      E AVK+ ++  G +F + +V+    
Sbjct: 10  HSTHGFYENYEPKEILGRG-VSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELRE 68
Query: 575 AMMKSIR-------HRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRL 627
           A +K +        H N++++  +     F  LV + M  G L  YL +   +L   +  
Sbjct: 69  ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETR 127
Query: 628 NIM---IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM 684
            IM   ++V  AL  L+      ++H DLKP N+LLDD+M   L+DFG +  L   D   
Sbjct: 128 KIMRALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPGE 178
Query: 685 TQTQTLATIGYMAPE------------YGREGQVSTNGDVYSFGIML 719
              +   T  Y+APE            YG+E       D++S G+++
Sbjct: 179 KLREVCGTPSYLAPEIIECSMNDNHPGYGKE------VDMWSTGVIM 219

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 96/202 (47%), Gaps = 25/202 (12%)
Query: 535 IGRGGFGSVYKARIRDGM-EVAVKVF-------------NLQCGRAFKSFDVECAMMKSI 580
           +G G +G V   + ++G  E A+KV              N    +  +    E +++KS+
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
            H N++K+     ++++  LV E+   G L + +  + +  D     NIM  + S + YL
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI-INRHKFDECDAANIMKQILSGICYL 162
Query: 641 HFGYSAPVIHCDLKPSNVLLDDN---MVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMA 697
           H      ++H D+KP N+LL++    +   + DFG++   +   +       L T  Y+A
Sbjct: 163 H---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS---KDYKLRDRLGTAYYIA 216
Query: 698 PEYGREGQVSTNGDVYSFGIML 719
           PE  ++ + +   DV+S G+++
Sbjct: 217 PEVLKK-KYNEKCDVWSCGVIM 237

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 88/199 (44%), Gaps = 13/199 (6%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDV---ECAMMKSIRH 582
           D+F     +G G FG V   + ++ G   A+K+ + Q     K  +    E  +++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
             LVK+  S  +     +V+EY+  G +  +L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 703 EGQVSTNGDVYSFGIMLME 721
               +   D ++ G+++ E
Sbjct: 212 SKGYNKAVDWWALGVLIYE 230

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 88/199 (44%), Gaps = 13/199 (6%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDV---ECAMMKSIRH 582
           D+F     +G G FG V   + ++ G   A+K+ + Q     K  +    E  +++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
             LVK+  S  +     +V+EY+  G +  +L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 703 EGQVSTNGDVYSFGIMLME 721
               +   D ++ G+++ E
Sbjct: 212 SKGYNKAVDWWALGVLIYE 230

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 86/197 (43%), Gaps = 12/197 (6%)
Query: 535 IGRGGFGSVYKARIR-DGMEVAVKVFNL-QCGRAFKSFDV-ECAMMKSIRHRNLVKVISS 591
           IG G +G   K R + DG  +  K  +      A K   V E  +++ ++H N+V+    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 592 CSNEEFKAL--VLEYMPHGSLEKYLHSSNYS---LDIFQRLNIMIDVASALEYLHFGYSA 646
             +     L  V+EY   G L   +         LD    L +M  +  AL+  H     
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 647 --PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG 704
              V+H DLKP+NV LD      L DFG+A++L   D S  +   + T  YM+PE     
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN-HDTSFAKA-FVGTPYYMSPEQMNRM 191
Query: 705 QVSTNGDVYSFGIMLME 721
             +   D++S G +L E
Sbjct: 192 SYNEKSDIWSLGCLLYE 208

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 88/199 (44%), Gaps = 13/199 (6%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDV---ECAMMKSIRH 582
           D+F     +G G FG V   + ++ G   A+K+ + Q     K  +    E  +++++  
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
             LVK+  S  +     +V+EY+  G +  +L       +   R      +    EYLH 
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 179
Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+APE   
Sbjct: 180 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 232
Query: 703 EGQVSTNGDVYSFGIMLME 721
               +   D ++ G+++ E
Sbjct: 233 SKGYNKAVDWWALGVLIYE 251

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 99/205 (48%), Gaps = 11/205 (5%)
Query: 527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDV-ECAMMKSIRHRN 584
           D F   + +G G  G V K + R  G+ +A K+ +L+   A ++  + E  ++       
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 75
Query: 585 LVKVISSCSNEEFKALVLEYMPHGSLEKYL-HSSNYSLDIFQRLNIMIDVASALEYLHFG 643
           +V    +  ++   ++ +E+M  GSL++ L  +     +I  +++I   V   L YL   
Sbjct: 76  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA--VLRGLAYLREK 133
Query: 644 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE 703
           +   ++H D+KPSN+L++      L DFG++  L     SM  +  + T  YMAPE  + 
Sbjct: 134 HQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMAPERLQG 187
Query: 704 GQVSTNGDVYSFGIMLMETFTRKKP 728
              S   D++S G+ L+E    + P
Sbjct: 188 THYSVQSDIWSMGLSLVELAVGRYP 212

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 103/218 (47%), Gaps = 30/218 (13%)
Query: 528 KFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDV----ECAMMKSIRH 582
           K+ +   IG+G FG V+KAR R  G +VA+K   ++  +  + F +    E  +++ ++H
Sbjct: 19  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKILQLLKH 76
Query: 583 RNLVKVISSCSNEEFKA--------LVLEYMPH---GSLEKYLHSSNYSLDIFQRLNIMI 631
            N+V +I  C  +            LV ++  H   G L   L    ++L   +R+  M+
Sbjct: 77  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL--VKFTLSEIKRVMQML 134
Query: 632 DVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL--LTGEDQSMTQTQT 689
                L  L++ +   ++H D+K +NVL+  + V  L+DFG+A+   L    Q       
Sbjct: 135 -----LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNR 189
Query: 690 LATIGYMAPE--YGREGQVSTNGDVYSFGIMLMETFTR 725
           + T+ Y  PE   G E       D++  G ++ E +TR
Sbjct: 190 VVTLWYRPPELLLG-ERDYGPPIDLWGAGCIMAEMWTR 226

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 91/209 (43%), Gaps = 10/209 (4%)
Query: 524 QATDKFSENNLIGRGGFGSVYKARIRDGMEV-AVKVFN---LQCGRAFKSFDVECAMMKS 579
           +   ++     +G+GGF   Y+    D  EV A KV     L      +    E A+ KS
Sbjct: 23  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 82
Query: 580 IRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEY 639
           + + ++V       +++F  +VLE     SL + LH    ++   +    M      ++Y
Sbjct: 83  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQGVQY 141
Query: 640 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPE 699
           LH   +  VIH DLK  N+ L+D+M   + DFG+A  +  E     +     T  Y+APE
Sbjct: 142 LH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKI--EFDGERKKDLCGTPNYIAPE 196
Query: 700 YGREGQVSTNGDVYSFGIMLMETFTRKKP 728
              +   S   D++S G +L      K P
Sbjct: 197 VLCKKGHSFEVDIWSLGCILYTLLVGKPP 225

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 88/199 (44%), Gaps = 13/199 (6%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDV---ECAMMKSIRH 582
           D+F     +G G FG V   + ++ G   A+K+ + Q     K  +    E  +++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
             LVK+  S  +     +V+EY+  G +  +L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARF-YAAQIVLTFEYLH- 158
Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 703 EGQVSTNGDVYSFGIMLME 721
               +   D ++ G+++ E
Sbjct: 212 SKGYNKAVDWWALGVLIYE 230

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 101/217 (46%), Gaps = 16/217 (7%)
Query: 508 MPPVATWRRFSYLELFQATDKFSENNLIGRGGFGSVYKARIRDGME-VAVKVFNLQCGRA 566
           MP      R+   E  +  D +   +++G G F  V  A  +   + VA+K    +    
Sbjct: 1   MPGAVEGPRWKQAEDIR--DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG 58
Query: 567 FK-SFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSL-EKYLHSSNYSLDIF 624
            + S + E A++  I+H N+V +     +     L+++ +  G L ++ +    Y+    
Sbjct: 59  KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDA 118
Query: 625 QRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVL---LDDNMVAHLSDFGIAKLLTGED 681
            RL  +  V  A++YLH      ++H DLKP N+L   LD++    +SDFG++K+   ED
Sbjct: 119 SRL--IFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---ED 170
Query: 682 QSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIM 718
                +    T GY+APE   +   S   D +S G++
Sbjct: 171 PGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 207

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 95/198 (47%), Gaps = 14/198 (7%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRDGME-VAVKVFNLQCGRAFK-SFDVECAMMKSIRHRN 584
           D +   +++G G F  V  A  +   + VA+K    +     + S + E A++  I+H N
Sbjct: 18  DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPN 77
Query: 585 LVKVISSCSNEEFKALVLEYMPHGSL-EKYLHSSNYSLDIFQRLNIMIDVASALEYLHFG 643
           +V +     +     L+++ +  G L ++ +    Y+     RL  +  V  A++YLH  
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRL--IFQVLDAVKYLH-- 133
Query: 644 YSAPVIHCDLKPSNVL---LDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
               ++H DLKP N+L   LD++    +SDFG++K+   ED     +    T GY+APE 
Sbjct: 134 -DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEV 189
Query: 701 GREGQVSTNGDVYSFGIM 718
             +   S   D +S G++
Sbjct: 190 LAQKPYSKAVDCWSIGVI 207

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 105/253 (41%), Gaps = 39/253 (15%)
Query: 535 IGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCS 593
           +GRG FG V++ + +  G + AVK   L+  R  +   V CA + S R   +V +  +  
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEEL--VACAGLSSPR---IVPLYGAVR 136
Query: 594 NEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 653
              +  + +E +  GSL + +      +        +  +  ALE L + ++  ++H D+
Sbjct: 137 EGPWVNIFMELLEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHTRRILHGDV 192
Query: 654 KPSNVLL-DDNMVAHLSDFGIA----------KLLTGEDQSMTQTQTLATIGYMAPEYGR 702
           K  NVLL  D   A L DFG A           LLTG+    T+T       +MAPE   
Sbjct: 193 KADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTET-------HMAPEVVM 245
Query: 703 EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLK---------HWVNDCLPISTME 753
                   D++S   M++       P  + F G + LK              C P++   
Sbjct: 246 GKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQA 305
Query: 754 VVDANLLSQEDIH 766
           + +   L +E +H
Sbjct: 306 IQEG--LRKEPVH 316

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 103/218 (47%), Gaps = 30/218 (13%)
Query: 528 KFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDV----ECAMMKSIRH 582
           K+ +   IG+G FG V+KAR R  G +VA+K   ++  +  + F +    E  +++ ++H
Sbjct: 19  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKILQLLKH 76
Query: 583 RNLVKVISSCSNEEFKA--------LVLEYMPH---GSLEKYLHSSNYSLDIFQRLNIMI 631
            N+V +I  C  +            LV ++  H   G L   L    ++L   +R+  M+
Sbjct: 77  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL--VKFTLSEIKRVMQML 134
Query: 632 DVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL--LTGEDQSMTQTQT 689
                L  L++ +   ++H D+K +NVL+  + V  L+DFG+A+   L    Q       
Sbjct: 135 -----LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNR 189
Query: 690 LATIGYMAPE--YGREGQVSTNGDVYSFGIMLMETFTR 725
           + T+ Y  PE   G E       D++  G ++ E +TR
Sbjct: 190 VVTLWYRPPELLLG-ERDYGPPIDLWGAGCIMAEMWTR 226

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 90/200 (45%), Gaps = 15/200 (7%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDV---ECAMMKSIRH 582
           D+F     +G G FG V   + ++ G   A+K+ + Q     K  +    E  +++++  
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
             LVK+  S  +     +V+EY+  G +  +L       +   R      +    EYLH 
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 179
Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTL-ATIGYMAPEYG 701
             S  +I+ DLKP N+L+D      ++DFG AK + G       T TL  T  Y+APE  
Sbjct: 180 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------ATWTLCGTPEYLAPEII 231
Query: 702 REGQVSTNGDVYSFGIMLME 721
                +   D ++ G+++ E
Sbjct: 232 LSKGYNKAVDWWALGVLIYE 251

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 103/218 (47%), Gaps = 30/218 (13%)
Query: 528 KFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDV----ECAMMKSIRH 582
           K+ +   IG+G FG V+KAR R  G +VA+K   ++  +  + F +    E  +++ ++H
Sbjct: 18  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKILQLLKH 75
Query: 583 RNLVKVISSCSNEEFKA--------LVLEYMPH---GSLEKYLHSSNYSLDIFQRLNIMI 631
            N+V +I  C  +            LV ++  H   G L   L    ++L   +R+  M+
Sbjct: 76  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL--VKFTLSEIKRVMQML 133
Query: 632 DVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL--LTGEDQSMTQTQT 689
                L  L++ +   ++H D+K +NVL+  + V  L+DFG+A+   L    Q       
Sbjct: 134 -----LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNR 188
Query: 690 LATIGYMAPE--YGREGQVSTNGDVYSFGIMLMETFTR 725
           + T+ Y  PE   G E       D++  G ++ E +TR
Sbjct: 189 VVTLWYRPPELLLG-ERDYGPPIDLWGAGCIMAEMWTR 225

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 100/220 (45%), Gaps = 44/220 (20%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRDGM--EVAVKVFNLQCGRAFKSFDVEC---AMMKSIR 581
           + +    ++GRG   SV +  I      E AVK+ ++  G +F + +V+    A +K + 
Sbjct: 4   ENYEPKEILGRG-VSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 62
Query: 582 -------HRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIM---I 631
                  H N++++  +     F  LV + M  G L  YL +   +L   +   IM   +
Sbjct: 63  ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETRKIMRALL 121
Query: 632 DVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA 691
           +V  AL  L+      ++H DLKP N+LLDD+M   L+DFG +  L   D      +   
Sbjct: 122 EVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPGEKLREVCG 172
Query: 692 TIGYMAPE------------YGREGQVSTNGDVYSFGIML 719
           T  Y+APE            YG+E       D++S G+++
Sbjct: 173 TPSYLAPEIIECSMNDNHPGYGKE------VDMWSTGVIM 206

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 88/199 (44%), Gaps = 13/199 (6%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDV---ECAMMKSIRH 582
           D+F     +G G FG V   + ++ G   A+K+ + Q     K  +    E  +++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
             LVK+  S  +     +V+EY+  G +  +L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLX-----GTPEYLAPEIIL 211
Query: 703 EGQVSTNGDVYSFGIMLME 721
               +   D ++ G+++ E
Sbjct: 212 SKGYNKAVDWWALGVLIYE 230

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 104/222 (46%), Gaps = 39/222 (17%)
Query: 522 LFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFN------LQCGRAFKSFDVEC 574
           +++  +++   + +G G +GSV  A   + G+ VAVK  +      +   R ++    E 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----EL 72
Query: 575 AMMKSIRHRNLVKVIS----SCSNEEFKALVL-EYMPHGSLEKYLHSSNYSLDIFQRLNI 629
            ++K ++H N++ ++     + S EEF  + L  ++    L   +     + D  Q L  
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL-- 130
Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
           +  +   L+Y+H   SA +IH DLKPSN+ ++++    +  FG+A+     D  MT    
Sbjct: 131 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILGFGLAR---HTDDEMT---- 180
Query: 690 LATIGYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 724
               GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 181 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 95/198 (47%), Gaps = 14/198 (7%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRDGME-VAVKVFNLQCGRAFK-SFDVECAMMKSIRHRN 584
           D +   +++G G F  V  A  +   + VA+K    +     + S + E A++  I+H N
Sbjct: 18  DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPN 77
Query: 585 LVKVISSCSNEEFKALVLEYMPHGSL-EKYLHSSNYSLDIFQRLNIMIDVASALEYLHFG 643
           +V +     +     L+++ +  G L ++ +    Y+     RL  +  V  A++YLH  
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRL--IFQVLDAVKYLH-- 133
Query: 644 YSAPVIHCDLKPSNVL---LDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
               ++H DLKP N+L   LD++    +SDFG++K+   ED     +    T GY+APE 
Sbjct: 134 -DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEV 189
Query: 701 GREGQVSTNGDVYSFGIM 718
             +   S   D +S G++
Sbjct: 190 LAQKPYSKAVDCWSIGVI 207

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 105/253 (41%), Gaps = 39/253 (15%)
Query: 535 IGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCS 593
           +GRG FG V++ + +  G + AVK   L+  R  +   V CA + S R   +V +  +  
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEEL--VACAGLSSPR---IVPLYGAVR 134
Query: 594 NEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 653
              +  + +E +  GSL + +      +        +  +  ALE L + ++  ++H D+
Sbjct: 135 EGPWVNIFMELLEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHTRRILHGDV 190
Query: 654 KPSNVLL-DDNMVAHLSDFGIA----------KLLTGEDQSMTQTQTLATIGYMAPEYGR 702
           K  NVLL  D   A L DFG A           LLTG+    T+T       +MAPE   
Sbjct: 191 KADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTET-------HMAPEVVM 243
Query: 703 EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLK---------HWVNDCLPISTME 753
                   D++S   M++       P  + F G + LK              C P++   
Sbjct: 244 GKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQA 303
Query: 754 VVDANLLSQEDIH 766
           + +   L +E +H
Sbjct: 304 IQEG--LRKEPVH 314

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 95/198 (47%), Gaps = 14/198 (7%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRDGME-VAVKVFNLQCGRAFK-SFDVECAMMKSIRHRN 584
           D +   +++G G F  V  A  +   + VA+K    +     + S + E A++  I+H N
Sbjct: 18  DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPN 77
Query: 585 LVKVISSCSNEEFKALVLEYMPHGSL-EKYLHSSNYSLDIFQRLNIMIDVASALEYLHFG 643
           +V +     +     L+++ +  G L ++ +    Y+     RL  +  V  A++YLH  
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRL--IFQVLDAVKYLH-- 133
Query: 644 YSAPVIHCDLKPSNVL---LDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
               ++H DLKP N+L   LD++    +SDFG++K+   ED     +    T GY+APE 
Sbjct: 134 -DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEV 189
Query: 701 GREGQVSTNGDVYSFGIM 718
             +   S   D +S G++
Sbjct: 190 LAQKPYSKAVDCWSIGVI 207

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 104/222 (46%), Gaps = 39/222 (17%)
Query: 522 LFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFN------LQCGRAFKSFDVEC 574
           +++  +++   + +G G +GSV  A   + G+ VAVK  +      +   R ++    E 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----EL 72
Query: 575 AMMKSIRHRNLVKVIS----SCSNEEFKALVL-EYMPHGSLEKYLHSSNYSLDIFQRLNI 629
            ++K ++H N++ ++     + S EEF  + L  ++    L   +     + D  Q L  
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL-- 130
Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
           +  +   L+Y+H   SA +IH DLKPSN+ ++++    + D G+A+     D  MT    
Sbjct: 131 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDAGLAR---HTDDEMT---- 180
Query: 690 LATIGYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 724
               GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 181 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 96/231 (41%), Gaps = 29/231 (12%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKS----FDVECAMMKSIRHRNLVKVI- 589
           IGRG F +VYK  +     V V    LQ  +  KS    F  E   +K ++H N+V+   
Sbjct: 34  IGRGSFKTVYKG-LDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYD 92
Query: 590 ---SSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMI------DVASALEYL 640
              S+   ++   LV E    G+L+ YL         F+   I +       +   L++L
Sbjct: 93  SWESTVKGKKCIVLVTELXTSGTLKTYLKR-------FKVXKIKVLRSWCRQILKGLQFL 145
Query: 641 HFGYSAPVIHCDLKPSNVLLDD-NMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPE 699
           H   + P+IH DLK  N+ +        + D G+A L     ++      + T  + APE
Sbjct: 146 H-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEFXAPE 200
Query: 700 YGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPIS 750
              E +   + DVY+FG   +E  T + P  E  N     +   +   P S
Sbjct: 201 XYEE-KYDESVDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVKPAS 250

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 88/199 (44%), Gaps = 13/199 (6%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDV---ECAMMKSIRH 582
           D+F     +G G FG V   + ++ G   A+K+ + Q     K  +    E  +++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
             LVK+  S  +     +V+EY+  G +  +L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 703 EGQVSTNGDVYSFGIMLME 721
               +   D ++ G+++ E
Sbjct: 212 SKGYNKAVDWWALGVLIYE 230

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 88/199 (44%), Gaps = 13/199 (6%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDV---ECAMMKSIRH 582
           D+F     +G G FG V   + ++ G   A+K+ + Q     K  +    E  +++++  
Sbjct: 42  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
             LVK+  S  +     +V+EY+  G +  +L       +   R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+APE   
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 212
Query: 703 EGQVSTNGDVYSFGIMLME 721
               +   D ++ G+++ E
Sbjct: 213 SKGYNKAVDWWALGVLIYE 231

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 86/199 (43%), Gaps = 13/199 (6%)
Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDV---ECAMMKSIRH 582
           D+F     +G G FG V   + +  G   A+K+ + Q     K  +    E  +++++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
             L K+  S  +     +V+EY P G +  +L       +   R      +    EYLH 
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 159
Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
             S  +I+ DLKP N+++D      ++DFG AK + G    +       T  Y+APE   
Sbjct: 160 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 212
Query: 703 EGQVSTNGDVYSFGIMLME 721
               +   D ++ G+++ E
Sbjct: 213 SKGYNKAVDWWALGVLIYE 231

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 88/199 (44%), Gaps = 13/199 (6%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDV---ECAMMKSIRH 582
           D+F     +G G FG V   + ++ G   A+K+ + Q     K  +    E  +++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
             LVK+  S  +     +V+EY+  G +  +L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 703 EGQVSTNGDVYSFGIMLME 721
               +   D ++ G+++ E
Sbjct: 212 SKGYNKAVDWWALGVLIYE 230

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 88/205 (42%), Gaps = 12/205 (5%)
Query: 529 FSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFD---VECAMMKSIRHRN 584
           F    L+G+G FG V   R +  G   A+K+   +   A         E  ++++ RH  
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 585 LVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIM-IDVASALEYLHFG 643
           L  +  +    +    V+EY   G L  + H S   +   +R      ++ SALEYLH  
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYLH-- 122
Query: 644 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE 703
            S  V++ D+K  N++LD +    ++DFG+ K   G     T      T  Y+APE   +
Sbjct: 123 -SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLED 179
Query: 704 GQVSTNGDVYSFGIMLMETFTRKKP 728
                  D +  G+++ E    + P
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 88/205 (42%), Gaps = 12/205 (5%)
Query: 529 FSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFD---VECAMMKSIRHRN 584
           F    L+G+G FG V   R +  G   A+K+   +   A         E  ++++ RH  
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 585 LVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIM-IDVASALEYLHFG 643
           L  +  +    +    V+EY   G L  + H S   +   +R      ++ SALEYLH  
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYLH-- 122
Query: 644 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE 703
            S  V++ D+K  N++LD +    ++DFG+ K   G     T      T  Y+APE   +
Sbjct: 123 -SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLED 179
Query: 704 GQVSTNGDVYSFGIMLMETFTRKKP 728
                  D +  G+++ E    + P
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 88/199 (44%), Gaps = 13/199 (6%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDV---ECAMMKSIRH 582
           D+F     +G G FG V   + ++ G   A+K+ + Q     K  +    E  +++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
             LVK+  S  +     +V+EY+  G +  +L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 703 EGQVSTNGDVYSFGIMLME 721
               +   D ++ G+++ E
Sbjct: 212 SKGYNKAVDWWALGVLIYE 230

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 88/205 (42%), Gaps = 12/205 (5%)
Query: 529 FSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFD---VECAMMKSIRHRN 584
           F    L+G+G FG V   R +  G   A+K+   +   A         E  ++++ RH  
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 585 LVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIM-IDVASALEYLHFG 643
           L  +  +    +    V+EY   G L  + H S   +   +R      ++ SALEYLH  
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYLH-- 122
Query: 644 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE 703
            S  V++ D+K  N++LD +    ++DFG+ K   G     T      T  Y+APE   +
Sbjct: 123 -SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAPEVLED 179
Query: 704 GQVSTNGDVYSFGIMLMETFTRKKP 728
                  D +  G+++ E    + P
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 91/209 (43%), Gaps = 10/209 (4%)
Query: 524 QATDKFSENNLIGRGGFGSVYKARIRDGMEV-AVKVFN---LQCGRAFKSFDVECAMMKS 579
           +   ++     +G+GGF   Y+    D  EV A KV     L      +    E A+ KS
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 580 IRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEY 639
           + + ++V       +++F  +VLE     SL + LH    ++   +    M      ++Y
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQGVQY 157
Query: 640 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPE 699
           LH   +  VIH DLK  N+ L+D+M   + DFG+A  +  E     +     T  Y+APE
Sbjct: 158 LH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKI--EFDGERKKDLCGTPNYIAPE 212
Query: 700 YGREGQVSTNGDVYSFGIMLMETFTRKKP 728
              +   S   D++S G +L      K P
Sbjct: 213 VLCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 104/222 (46%), Gaps = 39/222 (17%)
Query: 522 LFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFN------LQCGRAFKSFDVEC 574
           +++  +++   + +G G +GSV  A   + G+ VAVK  +      +   R ++    E 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----EL 72
Query: 575 AMMKSIRHRNLVKVIS----SCSNEEFKALVL-EYMPHGSLEKYLHSSNYSLDIFQRLNI 629
            ++K ++H N++ ++     + S EEF  + L  ++    L   +     + D  Q L  
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL-- 130
Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
           +  +   L+Y+H   SA +IH DLKPSN+ ++++    + D G+A+     D  MT    
Sbjct: 131 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDRGLAR---HTDDEMT---- 180
Query: 690 LATIGYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 724
               GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 181 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 88/199 (44%), Gaps = 13/199 (6%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDV---ECAMMKSIRH 582
           D+F     +G G FG V   + ++ G   A+K+ + Q     K  +    E  +++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
             LVK+  S  +     +V+EY+  G +  +L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 703 EGQVSTNGDVYSFGIMLME 721
               +   D ++ G+++ E
Sbjct: 212 SKGYNKAVDWWALGVLIYE 230

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 12/210 (5%)
Query: 524 QATDKFSENNLIGRGGFGSVYKARIRDGMEV-AVKVFN---LQCGRAFKSFDVECAMMKS 579
           +   ++     +G+GGF   Y+    D  EV A KV     L      +    E A+ KS
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 580 IRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEY 639
           + + ++V       +++F  +VLE     SL + LH    ++   +    M      ++Y
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQGVQY 157
Query: 640 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTL-ATIGYMAP 698
           LH   +  VIH DLK  N+ L+D+M   + DFG+A  +  + +   + +TL  T  Y+AP
Sbjct: 158 LH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGE---RKKTLCGTPNYIAP 211
Query: 699 EYGREGQVSTNGDVYSFGIMLMETFTRKKP 728
           E   +   S   D++S G +L      K P
Sbjct: 212 EVLCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 88/199 (44%), Gaps = 13/199 (6%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDV---ECAMMKSIRH 582
           D+F     +G G FG V   + ++ G   A+K+ + Q     K  +    E  +++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
             LVK+  S  +     +V+EY+  G +  +L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 703 EGQVSTNGDVYSFGIMLME 721
               +   D ++ G+++ E
Sbjct: 212 SKGYNKAVDWWALGVLIYE 230

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 88/205 (42%), Gaps = 12/205 (5%)
Query: 529 FSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFD---VECAMMKSIRHRN 584
           F    L+G+G FG V   R +  G   A+K+   +   A         E  ++++ RH  
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 585 LVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIM-IDVASALEYLHFG 643
           L  +  +    +    V+EY   G L  + H S   +   +R      ++ SALEYLH  
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYLH-- 122
Query: 644 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE 703
            S  V++ D+K  N++LD +    ++DFG+ K   G     T      T  Y+APE   +
Sbjct: 123 -SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAPEVLED 179
Query: 704 GQVSTNGDVYSFGIMLMETFTRKKP 728
                  D +  G+++ E    + P
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 92/194 (47%), Gaps = 11/194 (5%)
Query: 535 IGRGGFGSVYK--ARIRDGMEVAVKVFNLQCGRAFKSFDV-ECAMMKSIRHRNLVKVISS 591
           +G G + +VYK  +++ D + VA+K   L+         + E +++K ++H N+V +   
Sbjct: 10  LGEGTYATVYKGKSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 592 CSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHC 651
              E+   LV EY+    L++YL       +I    N+ + +   L  L + +   V+H 
Sbjct: 69  IHTEKSLTLVFEYLD-KDLKQYLDDCG---NIINMHNVKLFLFQLLRGLAYCHRQKVLHR 124
Query: 652 DLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPE-YGREGQVSTNG 710
           DLKP N+L+++     L+DFG+A+       + T    + T+ Y  P+        ST  
Sbjct: 125 DLKPQNLLINERGELKLADFGLAR--AKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQI 182
Query: 711 DVYSFGIMLMETFT 724
           D++  G +  E  T
Sbjct: 183 DMWGVGCIFYEMAT 196

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 88/205 (42%), Gaps = 12/205 (5%)
Query: 529 FSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFD---VECAMMKSIRHRN 584
           F    L+G+G FG V   R +  G   A+K+   +   A         E  ++++ RH  
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 585 LVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIM-IDVASALEYLHFG 643
           L  +  +    +    V+EY   G L  + H S   +   +R      ++ SALEYLH  
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYLH-- 122
Query: 644 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE 703
            S  V++ D+K  N++LD +    ++DFG+ K   G     T      T  Y+APE   +
Sbjct: 123 -SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAPEVLED 179
Query: 704 GQVSTNGDVYSFGIMLMETFTRKKP 728
                  D +  G+++ E    + P
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 101/216 (46%), Gaps = 27/216 (12%)
Query: 522 LFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFN------LQCGRAFKSFDVEC 574
           +++  +++   + +G G +GSV  A   + G  VAVK  +      +   R ++    E 
Sbjct: 37  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR----EL 92
Query: 575 AMMKSIRHRNLVKVIS----SCSNEEFKALVL-EYMPHGSLEKYLHSSNYSLDIFQRLNI 629
            ++K ++H N++ ++     + S EEF  + L  ++    L   +     + D  Q L  
Sbjct: 93  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL-- 150
Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
           +  +   L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+    E         
Sbjct: 151 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MXGX 202
Query: 690 LATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFT 724
           +AT  Y APE        +   D++S G ++ E  T
Sbjct: 203 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 238

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 68/295 (23%), Positives = 135/295 (45%), Gaps = 39/295 (13%)
Query: 527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDV-ECAMMKSIRHRN 584
           D F + + +G G  G V+K   +  G+ +A K+ +L+   A ++  + E  ++       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 585 LVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRL--NIMIDVASALEYLHF 642
           +V    +  ++   ++ +E+M  GSL++ L  +     I +++   + I V   L YL  
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLRE 122
Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
            +   ++H D+KPSN+L++      L DFG++  L     SM  +  + T  YM+PE  +
Sbjct: 123 KHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSPERLQ 176
Query: 703 EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ 762
               S   D++S G+ L+E    + P       E       +   P++  E++D      
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE-------DSRPPMAIFELLD------ 223
Query: 763 EDIHFVAKE---QCVSFVFNLALE-----CTVESPEQRINAKEI-VAKLLKIRDS 808
               ++  E   +  S VF+L  +     C +++P +R + K++ V   +K  D+
Sbjct: 224 ----YIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA 274

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 91/209 (43%), Gaps = 10/209 (4%)
Query: 524 QATDKFSENNLIGRGGFGSVYKARIRDGMEV-AVKVFN---LQCGRAFKSFDVECAMMKS 579
           +   ++     +G+GGF   Y+    D  EV A KV     L      +    E A+ KS
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 580 IRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEY 639
           + + ++V       +++F  +VLE     SL + LH    ++   +    M      ++Y
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQGVQY 157
Query: 640 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPE 699
           LH   +  VIH DLK  N+ L+D+M   + DFG+A  +  E     +     T  Y+APE
Sbjct: 158 LH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKI--EFDGERKKXLCGTPNYIAPE 212
Query: 700 YGREGQVSTNGDVYSFGIMLMETFTRKKP 728
              +   S   D++S G +L      K P
Sbjct: 213 VLCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 101/216 (46%), Gaps = 27/216 (12%)
Query: 522 LFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFN------LQCGRAFKSFDVEC 574
           +++  +++   + +G G +GSV  A   + G  VAVK  +      +   R ++    E 
Sbjct: 13  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR----EL 68
Query: 575 AMMKSIRHRNLVKVIS----SCSNEEFKALVL-EYMPHGSLEKYLHSSNYSLDIFQRLNI 629
            ++K ++H N++ ++     + S EEF  + L  ++    L   +     + D  Q L  
Sbjct: 69  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL-- 126
Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
           +  +   L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+    E         
Sbjct: 127 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MAGF 178
Query: 690 LATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFT 724
           +AT  Y APE        +   D++S G ++ E  T
Sbjct: 179 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 102/227 (44%), Gaps = 48/227 (21%)
Query: 524 QATDKFSEN----NLIGRGGFGSVYKARIRDGM--EVAVKVFNLQCGRAFKSFDVEC--- 574
            +T  F EN     ++GRG   SV +  I      E AVK+ ++  G +F + +V+    
Sbjct: 10  HSTHGFYENYEPKEILGRG-VSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELRE 68
Query: 575 AMMKSIR-------HRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRL 627
           A +K +        H N++++  +     F  LV + M  G L  YL +   +L   +  
Sbjct: 69  ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETR 127
Query: 628 NIM---IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM 684
            IM   ++V  AL  L+      ++H DLKP N+LLDD+M   L+DFG +  L   D   
Sbjct: 128 KIMRALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPGE 178
Query: 685 TQTQTLATIGYMAPE------------YGREGQVSTNGDVYSFGIML 719
                  T  Y+APE            YG+E       D++S G+++
Sbjct: 179 KLRSVCGTPSYLAPEIIECSMNDNHPGYGKE------VDMWSTGVIM 219

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 107/230 (46%), Gaps = 32/230 (13%)
Query: 525 ATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFNLQC------GRAFKSFDVECAMM 577
           + D++     +G G +G VYKA        VA+K   L+       G A +    E +++
Sbjct: 32  SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR----EVSLL 87
Query: 578 KSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASAL 637
           K ++HRN++++ S   +     L+ EY     L+KY+   + + D+  R+ I   +   +
Sbjct: 88  KELQHRNIIELKSVIHHNHRLHLIFEYA-ENDLKKYM---DKNPDVSMRV-IKSFLYQLI 142
Query: 638 EYLHFGYSAPVIHCDLKPSNVLL-----DDNMVAHLSDFGIAKLLTGEDQSMTQTQTLAT 692
             ++F +S   +H DLKP N+LL      +  V  + DFG+A+      +    T  + T
Sbjct: 143 NGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF--THEIIT 200
Query: 693 IGYMAPE--YGREGQVSTNGDVYS----FGIMLMET--FTRKKPTDELFN 734
           + Y  PE   G     ST+ D++S    +  MLM+T  F      D+LF 
Sbjct: 201 LWYRPPEILLGSR-HYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFK 249

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 55/212 (25%), Positives = 89/212 (41%), Gaps = 31/212 (14%)
Query: 535 IGRGGFGSVYKARIRDGME-VAVKVFNLQ----CGRAFKSFDVECAMMKSIRHRNLVKVI 589
           +G G +G V  A  R   E VAVK+ +++    C    K    E  +   + H N+VK  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINAMLNHENVVKFY 71
Query: 590 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRL--NIMIDVASALEYLH------ 641
                   + L LEY   G L             F R+  +I +    A  + H      
Sbjct: 72  GHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 642 -FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
            + +   + H D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+APE 
Sbjct: 119 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 701 GREGQVSTNG-DVYSFGIMLMETFTRKKPTDE 731
            +  +      DV+S GI+L      + P D+
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 88/205 (42%), Gaps = 12/205 (5%)
Query: 529 FSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFD---VECAMMKSIRHRN 584
           F    L+G+G FG V   R +  G   A+K+   +   A         E  ++++ RH  
Sbjct: 10  FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 69
Query: 585 LVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIM-IDVASALEYLHFG 643
           L  +  +    +    V+EY   G L  + H S   +   +R      ++ SALEYLH  
Sbjct: 70  LTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYLH-- 125
Query: 644 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE 703
            S  V++ D+K  N++LD +    ++DFG+ K   G     T      T  Y+APE   +
Sbjct: 126 -SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLED 182
Query: 704 GQVSTNGDVYSFGIMLMETFTRKKP 728
                  D +  G+++ E    + P
Sbjct: 183 NDYGRAVDWWGLGVVMYEMMCGRLP 207

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 101/213 (47%), Gaps = 43/213 (20%)
Query: 535 IGRGGFGSV---YKARIRDGMEVAVKVFN------LQCGRAFKSFDVECAMMKSIRHRNL 585
           +G G +GSV   Y AR+R   +VAVK  +      +   R ++    E  ++K ++H N+
Sbjct: 28  VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYR----ELRLLKHLKHENV 81
Query: 586 VKVIS----SCSNEEFKALVLEYMPHGS-LEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
           + ++     + S E+F  + L     G+ L   +     S +  Q L  +  +   L+Y+
Sbjct: 82  IGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFL--VYQLLRGLKYI 139
Query: 641 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
           H   SA +IH DLKPSNV ++++    + DFG+A+     D+ MT        GY+A  +
Sbjct: 140 H---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR---QADEEMT--------GYVATRW 185
Query: 701 GREGQVSTNG-------DVYSFGIMLMETFTRK 726
            R  ++  N        D++S G ++ E    K
Sbjct: 186 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 104/222 (46%), Gaps = 39/222 (17%)
Query: 522 LFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFN------LQCGRAFKSFDVEC 574
           +++  +++   + +G G +GSV  A   + G+ VAVK  +      +   R ++    E 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----EL 72
Query: 575 AMMKSIRHRNLVKVIS----SCSNEEFKALVL-EYMPHGSLEKYLHSSNYSLDIFQRLNI 629
            ++K ++H N++ ++     + S EEF  + L  ++    L   +     + D  Q L  
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL-- 130
Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
           +  +   L+Y+H   SA +IH DLKPSN+ ++++    + D G+A+     D  MT    
Sbjct: 131 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDGGLAR---HTDDEMT---- 180
Query: 690 LATIGYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 724
               GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 181 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 101/216 (46%), Gaps = 27/216 (12%)
Query: 522 LFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFN------LQCGRAFKSFDVEC 574
           +++  +++   + +G G +GSV  A   + G  VAVK  +      +   R ++    E 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR----EL 72
Query: 575 AMMKSIRHRNLVKVIS----SCSNEEFKALVL-EYMPHGSLEKYLHSSNYSLDIFQRLNI 629
            ++K ++H N++ ++     + S EEF  + L  ++    L   +     + D  Q L  
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL-- 130
Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
           +  +   L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+    E         
Sbjct: 131 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MAGF 182
Query: 690 LATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFT 724
           +AT  Y APE        +   D++S G ++ E  T
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 101/213 (47%), Gaps = 43/213 (20%)
Query: 535 IGRGGFGSV---YKARIRDGMEVAVKVFN------LQCGRAFKSFDVECAMMKSIRHRNL 585
           +G G +GSV   Y AR+R   +VAVK  +      +   R ++    E  ++K ++H N+
Sbjct: 36  VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYR----ELRLLKHLKHENV 89
Query: 586 VKVIS----SCSNEEFKALVLEYMPHGS-LEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
           + ++     + S E+F  + L     G+ L   +     S +  Q L  +  +   L+Y+
Sbjct: 90  IGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFL--VYQLLRGLKYI 147
Query: 641 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
           H   SA +IH DLKPSNV ++++    + DFG+A+     D+ MT        GY+A  +
Sbjct: 148 H---SAGIIHRDLKPSNVAVNEDSELRILDFGLAR---QADEEMT--------GYVATRW 193
Query: 701 GREGQVSTNG-------DVYSFGIMLMETFTRK 726
            R  ++  N        D++S G ++ E    K
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 105/222 (47%), Gaps = 34/222 (15%)
Query: 525 ATDKFS---------ENNLIGRGGFGSVYKA-RIRDGMEVAVKVFNLQCG----RAFKSF 570
           +TD FS         + +++G G    V     +    E AVK+   Q G    R F+  
Sbjct: 2   STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREV 61
Query: 571 DVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIM 630
           ++   + +   HRN++++I     E+   LV E M  GS+  ++H   +  +  +   ++
Sbjct: 62  EM---LYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRH-FNELEASVVV 117
Query: 631 IDVASALEYLHFGYSAPVIHCDLKPSNVLLDD-NMVA--HLSDFGIAK--LLTGEDQSMT 685
            DVASAL++LH   +  + H DLKP N+L +  N V+   + DFG+     L G+   ++
Sbjct: 118 QDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPIS 174
Query: 686 QTQTLATIG---YMAPE----YGREGQV-STNGDVYSFGIML 719
             + L   G   YMAPE    +  E  +     D++S G++L
Sbjct: 175 TPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 86/199 (43%), Gaps = 13/199 (6%)
Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDV---ECAMMKSIRH 582
           D+F     +G G FG V   + +  G   A+K+ + Q     K  +    E  +++++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
             L K+  S  +     +V+EY P G +  +L       +   R      +    EYLH 
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
             S  +I+ DLKP N+++D      ++DFG AK + G    +       T  Y+APE   
Sbjct: 160 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 212
Query: 703 EGQVSTNGDVYSFGIMLME 721
               +   D ++ G+++ E
Sbjct: 213 SKGYNKAVDWWALGVLIYE 231

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 101/216 (46%), Gaps = 27/216 (12%)
Query: 522 LFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFN------LQCGRAFKSFDVEC 574
           +++  +++   + +G G +GSV  A   + G  VAVK  +      +   R ++    E 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR----EL 72
Query: 575 AMMKSIRHRNLVKVIS----SCSNEEFKALVL-EYMPHGSLEKYLHSSNYSLDIFQRLNI 629
            ++K ++H N++ ++     + S EEF  + L  ++    L   +     + D  Q L  
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL-- 130
Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
           +  +   L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+    E         
Sbjct: 131 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MAGF 182
Query: 690 LATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFT 724
           +AT  Y APE        +   D++S G ++ E  T
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 86/199 (43%), Gaps = 13/199 (6%)
Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDV---ECAMMKSIRH 582
           D+F     +G G FG V   + +  G   A+K+ + Q     K  +    E  +++++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
             L K+  S  +     +V+EY P G +  +L       +   R      +    EYLH 
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
             S  +I+ DLKP N+++D      ++DFG AK + G    +       T  Y+APE   
Sbjct: 160 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 212
Query: 703 EGQVSTNGDVYSFGIMLME 721
               +   D ++ G+++ E
Sbjct: 213 SKGYNKAVDWWALGVLIYE 231

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 107/244 (43%), Gaps = 28/244 (11%)
Query: 521 ELFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVF--NLQCGRAFKSFDVECAMM 577
           E F+A  ++    L+G+GGFG+V+   R+ D ++VA+KV   N   G +  S  V C + 
Sbjct: 27  EAFEA--EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLE 84
Query: 578 KSI--------RHRNLVKVISSCSNEEFKALVLEY-MPHGSLEKYLHSSNYSLDIFQRLN 628
            ++         H  +++++     +E   LVLE  +P   L  Y+ +    L       
Sbjct: 85  VALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYI-TEKGPLGEGPSRC 143
Query: 629 IMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTGEDQSMTQT 687
               V +A+++ H   S  V+H D+K  N+L+D     A L DFG   LL  E      T
Sbjct: 144 FFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE----PYT 196
Query: 688 QTLATIGYMAPEY-GREGQVSTNGDVYSFGIMLMETFTRKKPTD---ELFNGEMTLK-HW 742
               T  Y  PE+  R    +    V+S GI+L +      P +   E+   E+    H 
Sbjct: 197 DFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHV 256
Query: 743 VNDC 746
             DC
Sbjct: 257 SPDC 260

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 87/199 (43%), Gaps = 13/199 (6%)
Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDV---ECAMMKSIRH 582
           D+F     +G G FG V   + +  G   A+K+ + Q     K  +    E  +++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
             LVK+  S  +     +V+EY+  G +  +L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 703 EGQVSTNGDVYSFGIMLME 721
               +   D ++ G+++ E
Sbjct: 212 SKGYNKAVDWWALGVLIYE 230

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 100/206 (48%), Gaps = 13/206 (6%)
Query: 527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDV-ECAMMKSIRHRN 584
           D F + + +G G  G V+K   +  G+ +A K+ +L+   A ++  + E  ++       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 585 LVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRL--NIMIDVASALEYLHF 642
           +V    +  ++   ++ +E+M  GSL++ L  +     I +++   + I V   L YL  
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLRE 122
Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
            +   ++H D+KPSN+L++      L DFG++  L     SM  +  + T  YM+PE  +
Sbjct: 123 KHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSPERLQ 176
Query: 703 EGQVSTNGDVYSFGIMLMETFTRKKP 728
               S   D++S G+ L+E    + P
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 100/206 (48%), Gaps = 13/206 (6%)
Query: 527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDV-ECAMMKSIRHRN 584
           D F + + +G G  G V+K   +  G+ +A K+ +L+   A ++  + E  ++       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 585 LVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRL--NIMIDVASALEYLHF 642
           +V    +  ++   ++ +E+M  GSL++ L  +     I +++   + I V   L YL  
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLRE 122
Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
            +   ++H D+KPSN+L++      L DFG++  L     SM  +  + T  YM+PE  +
Sbjct: 123 KHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSPERLQ 176
Query: 703 EGQVSTNGDVYSFGIMLMETFTRKKP 728
               S   D++S G+ L+E    + P
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 100/206 (48%), Gaps = 13/206 (6%)
Query: 527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDV-ECAMMKSIRHRN 584
           D F + + +G G  G V+K   +  G+ +A K+ +L+   A ++  + E  ++       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 585 LVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRL--NIMIDVASALEYLHF 642
           +V    +  ++   ++ +E+M  GSL++ L  +     I +++   + I V   L YL  
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLRE 122
Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
            +   ++H D+KPSN+L++      L DFG++  L     SM  +  + T  YM+PE  +
Sbjct: 123 KHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSPERLQ 176
Query: 703 EGQVSTNGDVYSFGIMLMETFTRKKP 728
               S   D++S G+ L+E    + P
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 100/206 (48%), Gaps = 13/206 (6%)
Query: 527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDV-ECAMMKSIRHRN 584
           D F + + +G G  G V+K   +  G+ +A K+ +L+   A ++  + E  ++       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 585 LVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRL--NIMIDVASALEYLHF 642
           +V    +  ++   ++ +E+M  GSL++ L  +     I +++   + I V   L YL  
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLRE 122
Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
            +   ++H D+KPSN+L++      L DFG++  L     SM  +  + T  YM+PE  +
Sbjct: 123 KHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSPERLQ 176
Query: 703 EGQVSTNGDVYSFGIMLMETFTRKKP 728
               S   D++S G+ L+E    + P
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 94/201 (46%), Gaps = 15/201 (7%)
Query: 526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFN---LQCGRAFKSFDVECAMMKSIR 581
           +D++    ++G+G FG V   + +  G E AVKV +   ++     +S   E  ++K + 
Sbjct: 31  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 90
Query: 582 HRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLH 641
           H N++K+     ++ +  LV E    G L   + S     ++     I+  V S + Y+H
Sbjct: 91  HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITYMH 149
Query: 642 FGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 698
                 ++H DLKP N+LL+    +    + DFG++   T  + S      + T  Y+AP
Sbjct: 150 ---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS---THFEASKKMKDKIGTAYYIAP 203
Query: 699 EYGREGQVSTNGDVYSFGIML 719
           E    G      DV+S G++L
Sbjct: 204 EV-LHGTYDEKCDVWSTGVIL 223

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 100/206 (48%), Gaps = 13/206 (6%)
Query: 527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDV-ECAMMKSIRHRN 584
           D F + + +G G  G V+K   +  G+ +A K+ +L+   A ++  + E  ++       
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 127
Query: 585 LVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRL--NIMIDVASALEYLHF 642
           +V    +  ++   ++ +E+M  GSL++ L  +     I +++   + I V   L YL  
Sbjct: 128 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLRE 184
Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
            +   ++H D+KPSN+L++      L DFG++  L     SM  +  + T  YM+PE  +
Sbjct: 185 KHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSPERLQ 238
Query: 703 EGQVSTNGDVYSFGIMLMETFTRKKP 728
               S   D++S G+ L+E    + P
Sbjct: 239 GTHYSVQSDIWSMGLSLVEMAVGRYP 264

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 88/199 (44%), Gaps = 13/199 (6%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDV---ECAMMKSIRH 582
           D+F     +G G FG V   + ++ G   A+K+ + Q     K  +    E  +++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
             LVK+  S  +     +V+EY+  G +  +L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 703 EGQVSTNGDVYSFGIMLME 721
               +   D ++ G+++ +
Sbjct: 212 SKGYNKAVDWWALGVLIYQ 230

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 88/199 (44%), Gaps = 13/199 (6%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDV---ECAMMKSIRH 582
           D+F     +G G FG V   + ++ G   A+K+ + Q     K  +    E  +++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
             LVK+  S  +     +V+EY+  G +  +L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
             S  +I+ DLKP N+++D      ++DFG AK + G    +       T  Y+APE   
Sbjct: 159 --SLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIII 211
Query: 703 EGQVSTNGDVYSFGIMLME 721
               +   D ++ G+++ E
Sbjct: 212 SKGYNKAVDWWALGVLIYE 230

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 103/222 (46%), Gaps = 39/222 (17%)
Query: 522 LFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFN------LQCGRAFKSFDVEC 574
           +++  +++   + +G G +GSV  A   + G  VAVK  +      +   R ++    E 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR----EL 72
Query: 575 AMMKSIRHRNLVKVIS----SCSNEEFKALVL-EYMPHGSLEKYLHSSNYSLDIFQRLNI 629
            ++K ++H N++ ++     + S EEF  + L  ++    L   +     + D  Q L  
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL-- 130
Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
           +  +   L+Y+H   SA +IH DLKPSN+ ++++    + DF +A+     D  MT    
Sbjct: 131 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFYLAR---HTDDEMT---- 180
Query: 690 LATIGYMAPEYGREGQVSTNG-------DVYSFGIMLMETFT 724
               GY+A  + R  ++  N        D++S G ++ E  T
Sbjct: 181 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 100/206 (48%), Gaps = 13/206 (6%)
Query: 527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDV-ECAMMKSIRHRN 584
           D F + + +G G  G V+K   +  G+ +A K+ +L+   A ++  + E  ++       
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 585 LVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRL--NIMIDVASALEYLHF 642
           +V    +  ++   ++ +E+M  GSL++ L  +     I +++   + I V   L YL  
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLRE 149
Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
            +   ++H D+KPSN+L++      L DFG++  L     SM  +  + T  YM+PE  +
Sbjct: 150 KHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSPERLQ 203
Query: 703 EGQVSTNGDVYSFGIMLMETFTRKKP 728
               S   D++S G+ L+E    + P
Sbjct: 204 GTHYSVQSDIWSMGLSLVEMAVGRYP 229

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 88/203 (43%), Gaps = 18/203 (8%)
Query: 527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC------GRAFKSFDVECAMMKS 579
           D +     +G G F  V K R +  G E A K    +       G + +  + E  +++ 
Sbjct: 12  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 71
Query: 580 IRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEY 639
           IRH N++ +     N+    L+LE +  G L  +L +   SL   +    +  +   + Y
Sbjct: 72  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFL-AEKESLTEDEATQFLKQILDGVHY 130
Query: 640 LHFGYSAPVIHCDLKPSNVLLDDNMVAH----LSDFGIAKLLTGEDQSMTQTQTLATIGY 695
           LH   S  + H DLKP N++L D  V +    L DFGIA  +   ++         T  +
Sbjct: 131 LH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFGTPEF 184
Query: 696 MAPEYGREGQVSTNGDVYSFGIM 718
           +APE      +    D++S G++
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVI 207

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 98/229 (42%), Gaps = 28/229 (12%)
Query: 500 KGPPNDPNMPPVATWRRFSYLELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKV 558
           + P  DP+ P             FQ +  F   + +G G +G V+K R + DG   AVK 
Sbjct: 42  QSPGYDPSRPE----------SFFQQS--FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKR 89
Query: 559 ----FNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHG-SLEKY 613
               F     RA K  +V  +  K  +H   V++  +   EE   L L+    G SL+++
Sbjct: 90  SMSPFRGPKDRARKLAEV-GSHEKVGQHPCCVRLEQAW--EEGGILYLQTELCGPSLQQH 146
Query: 614 LHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGI 673
             +   SL   Q    + D   AL +LH   S  ++H D+KP+N+ L       L DFG+
Sbjct: 147 CEAWGASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGL 203
Query: 674 AKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMET 722
              L        Q        YMAPE   +G   T  DV+S G+ ++E 
Sbjct: 204 LVELGTAGAGEVQE---GDPRYMAPEL-LQGSYGTAADVFSLGLTILEV 248

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 129/281 (45%), Gaps = 36/281 (12%)
Query: 527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDV-ECAMMKSIRHRN 584
           D F + + +G G  G V+K   +  G+ +A K+ +L+   A ++  + E  ++       
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 84
Query: 585 LVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRL--NIMIDVASALEYLHF 642
           +V    +  ++   ++ +E+M  GSL++ L  +     I +++   + I V   L YL  
Sbjct: 85  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLRE 141
Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
            +   ++H D+KPSN+L++      L DFG++  L     SM  +  + T  YM+PE  +
Sbjct: 142 KHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSPERLQ 195
Query: 703 EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMT----LKHWVNDCLPISTMEVVDAN 758
               S   D++S G+ L+E    + P     +G M     L + VN+  P      + + 
Sbjct: 196 GTHYSVQSDIWSMGLSLVEMAVGRYPIGS-GSGSMAIFELLDYIVNEPPP-----KLPSG 249
Query: 759 LLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIV 799
           + S E   FV K             C +++P +R + K+++
Sbjct: 250 VFSLEFQDFVNK-------------CLIKNPAERADLKQLM 277

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 93/203 (45%), Gaps = 22/203 (10%)
Query: 534 LIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSI-RHRNLVKVISS 591
           L+G G +G VYK R ++ G   A+KV ++  G   +    E  M+K    HRN+     +
Sbjct: 31  LVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TGDEEEEIKQEINMLKKYSHHRNIATYYGA 89
Query: 592 CSN------EEFKALVLEYMPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGY 644
                    ++   LV+E+   GS+   + ++   +L       I  ++   L +LH   
Sbjct: 90  FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH--- 146
Query: 645 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT-LATIGYMAPEY--- 700
              VIH D+K  NVLL +N    L DFG++  L   D+++ +  T + T  +MAPE    
Sbjct: 147 QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFIGTPYWMAPEVIAC 203
Query: 701 --GREGQVSTNGDVYSFGIMLME 721
               +       D++S GI  +E
Sbjct: 204 DENPDATYDFKSDLWSLGITAIE 226

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 90/203 (44%), Gaps = 18/203 (8%)
Query: 527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVK------VFNLQCGRAFKSFDVECAMMKS 579
           D +     +G G F  V K R +  G E A K      + + + G + +  + E  +++ 
Sbjct: 26  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILRE 85
Query: 580 IRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEY 639
           IRH N++ +     N+    L+LE +  G L  +L +   SL   +    +  +   + Y
Sbjct: 86  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFL-AEKESLTEDEATQFLKQILDGVHY 144
Query: 640 LHFGYSAPVIHCDLKPSNVLLDDNMVAH----LSDFGIAKLLTGEDQSMTQTQTLATIGY 695
           LH   S  + H DLKP N++L D  V +    L DFGIA  +   ++         T  +
Sbjct: 145 LH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFGTPEF 198
Query: 696 MAPEYGREGQVSTNGDVYSFGIM 718
           +APE      +    D++S G++
Sbjct: 199 VAPEIVNYEPLGLEADMWSIGVI 221

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 93/207 (44%), Gaps = 21/207 (10%)
Query: 535 IGRGGFGSVYKARIR-DGMEVAVK-----VFNLQCGRAFKSFDVECAMMKSIRHRNLVKV 588
           IGRG +GSV K   +  G  +AVK     V   +  +     DV   +M+S     +V+ 
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDV---VMRSSDCPYIVQF 86
Query: 589 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLD--IFQRLNIMIDVASALEYLHFGYSA 646
             +   E    + +E M   S +K+       LD  I + +   I +A+     H   + 
Sbjct: 87  YGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL 145
Query: 647 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY-----G 701
            +IH D+KPSN+LLD +    L DFGI+  L     S+ +T+      YMAPE       
Sbjct: 146 KIIHRDIKPSNILLDRSGNIKLCDFGISGQLV---DSIAKTRDAGCRPYMAPERIDPSAS 202
Query: 702 REGQVSTNGDVYSFGIMLMETFTRKKP 728
           R+G      DV+S GI L E  T + P
Sbjct: 203 RQG-YDVRSDVWSLGITLYELATGRFP 228

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 88/203 (43%), Gaps = 18/203 (8%)
Query: 527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC------GRAFKSFDVECAMMKS 579
           D +     +G G F  V K R +  G E A K    +       G + +  + E  +++ 
Sbjct: 5   DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 580 IRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEY 639
           IRH N++ +     N+    L+LE +  G L  +L +   SL   +    +  +   + Y
Sbjct: 65  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFL-AEKESLTEDEATQFLKQILDGVHY 123
Query: 640 LHFGYSAPVIHCDLKPSNVLLDDNMVAH----LSDFGIAKLLTGEDQSMTQTQTLATIGY 695
           LH   S  + H DLKP N++L D  V +    L DFGIA  +   ++         T  +
Sbjct: 124 LH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFGTPEF 177
Query: 696 MAPEYGREGQVSTNGDVYSFGIM 718
           +APE      +    D++S G++
Sbjct: 178 VAPEIVNYEPLGLEADMWSIGVI 200

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 93/213 (43%), Gaps = 18/213 (8%)
Query: 523 FQATDKFSENNLIGRGGFGSVYKARIRDG--MEVAVKVFNLQCGRAFKSFDVECAMMKSI 580
            Q TD +     IG G + SV K  I     ME AVK+ +       +  ++   +++  
Sbjct: 18  IQFTDGYEVKEDIGVGSY-SVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEI---LLRYG 73
Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSL-EKYLHSSNYSLDIFQRLNIMIDVASALEY 639
           +H N++ +     + ++  +V E M  G L +K L    +S    +   ++  +   +EY
Sbjct: 74  QHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSER--EASAVLFTITKTVEY 131
Query: 640 LHFGYSAPVIHCDLKPSNVLLDDNM----VAHLSDFGIAKLLTGEDQSMTQTQTLATIGY 695
           LH   +  V+H DLKPSN+L  D         + DFG AK L  E+  +       T  +
Sbjct: 132 LH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL--MTPCYTANF 186
Query: 696 MAPEYGREGQVSTNGDVYSFGIMLMETFTRKKP 728
           +APE           D++S G++L    T   P
Sbjct: 187 VAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 89/195 (45%), Gaps = 18/195 (9%)
Query: 535 IGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFK------SFDVECAMMKSIRHRNLVK 587
           +G G F  V K R +  G+E A K    +  RA +        + E ++++ + H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAP 647
           +     N     L+LE +  G L  +L +   SL   +  + +  +   + YLH   +  
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDGVNYLH---TKK 135
Query: 648 VIHCDLKPSNV-LLDDNM-VAHLS--DFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE 703
           + H DLKP N+ LLD N+ + H+   DFG+A  +   +  +       T  ++APE    
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGTPEFVAPEIVNY 192
Query: 704 GQVSTNGDVYSFGIM 718
             +    D++S G++
Sbjct: 193 EPLGLEADMWSIGVI 207

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 89/195 (45%), Gaps = 18/195 (9%)
Query: 535 IGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFK------SFDVECAMMKSIRHRNLVK 587
           +G G F  V K R +  G+E A K    +  RA +        + E ++++ + H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAP 647
           +     N     L+LE +  G L  +L +   SL   +  + +  +   + YLH   +  
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDGVNYLH---TKK 135
Query: 648 VIHCDLKPSNV-LLDDNM-VAHLS--DFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE 703
           + H DLKP N+ LLD N+ + H+   DFG+A  +   +  +       T  ++APE    
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGTPEFVAPEIVNY 192
Query: 704 GQVSTNGDVYSFGIM 718
             +    D++S G++
Sbjct: 193 EPLGLEADMWSIGVI 207

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 89/195 (45%), Gaps = 18/195 (9%)
Query: 535 IGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFK------SFDVECAMMKSIRHRNLVK 587
           +G G F  V K R +  G+E A K    +  RA +        + E ++++ + H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAP 647
           +     N     L+LE +  G L  +L +   SL   +  + +  +   + YLH   +  
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDGVNYLH---TKK 135
Query: 648 VIHCDLKPSNV-LLDDNM-VAHLS--DFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE 703
           + H DLKP N+ LLD N+ + H+   DFG+A  +   +  +       T  ++APE    
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGTPEFVAPEIVNY 192
Query: 704 GQVSTNGDVYSFGIM 718
             +    D++S G++
Sbjct: 193 EPLGLEADMWSIGVI 207

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 103/222 (46%), Gaps = 34/222 (15%)
Query: 525 ATDKFS---------ENNLIGRGGFGSVYKA-RIRDGMEVAVKVFNLQCG----RAFKSF 570
           +TD FS         + +++G G    V     +    E AVK+   Q G    R F+  
Sbjct: 2   STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREV 61
Query: 571 DVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIM 630
           ++   + +   HRN++++I     E+   LV E M  GS+  ++H   +  +  +   ++
Sbjct: 62  EM---LYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRH-FNELEASVVV 117
Query: 631 IDVASALEYLHFGYSAPVIHCDLKPSNVLLDD-NMVAHLS----DFGIAKLLTGEDQSMT 685
            DVASAL++LH   +  + H DLKP N+L +  N V+ +     D G    L G+   ++
Sbjct: 118 QDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIS 174
Query: 686 QTQTLATIG---YMAPE----YGREGQV-STNGDVYSFGIML 719
             + L   G   YMAPE    +  E  +     D++S G++L
Sbjct: 175 TPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 89/195 (45%), Gaps = 18/195 (9%)
Query: 535 IGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFK------SFDVECAMMKSIRHRNLVK 587
           +G G F  V K R +  G+E A K    +  RA +        + E ++++ + H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAP 647
           +     N     L+LE +  G L  +L +   SL   +  + +  +   + YLH   +  
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDGVNYLH---TKK 135
Query: 648 VIHCDLKPSNV-LLDDNM-VAHLS--DFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE 703
           + H DLKP N+ LLD N+ + H+   DFG+A  +   +  +       T  ++APE    
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGTPEFVAPEIVNY 192
Query: 704 GQVSTNGDVYSFGIM 718
             +    D++S G++
Sbjct: 193 EPLGLEADMWSIGVI 207

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 89/195 (45%), Gaps = 18/195 (9%)
Query: 535 IGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFK------SFDVECAMMKSIRHRNLVK 587
           +G G F  V K R +  G+E A K    +  RA +        + E ++++ + H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAP 647
           +     N     L+LE +  G L  +L +   SL   +  + +  +   + YLH   +  
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDGVNYLH---TKK 135
Query: 648 VIHCDLKPSNV-LLDDNM-VAHLS--DFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE 703
           + H DLKP N+ LLD N+ + H+   DFG+A  +   +  +       T  ++APE    
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGTPEFVAPEIVNY 192
Query: 704 GQVSTNGDVYSFGIM 718
             +    D++S G++
Sbjct: 193 EPLGLEADMWSIGVI 207

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 95/202 (47%), Gaps = 17/202 (8%)
Query: 526 TDKFSENNLIGRGGFGSVY--KARIRDGMEVAVKVFN---LQCGRAFKSFDVECAMMKSI 580
           +D++    ++G+G FG V   K +I  G E AVKV +   ++     +S   E  ++K +
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
            H N++K+     ++ +  LV E    G L   + S     ++     I+  V S + Y+
Sbjct: 84  DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITYM 142
Query: 641 HFGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMA 697
           H      ++H DLKP N+LL+    +    + DFG++   T  + S      + T  Y+A
Sbjct: 143 H---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS---THFEASKKMKDKIGTAYYIA 196
Query: 698 PEYGREGQVSTNGDVYSFGIML 719
           PE    G      DV+S G++L
Sbjct: 197 PEV-LHGTYDEKCDVWSTGVIL 217

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/240 (23%), Positives = 105/240 (43%), Gaps = 33/240 (13%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRD-GMEVAVKV-----FNLQCGRAFKSFDVECAMMKSI 580
           D +    +IG+G F  V +   R+ G + AVK+     F    G + +    E ++   +
Sbjct: 24  DVYELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASA---- 636
           +H ++V+++ + S++    +V E+M    L           +I +R +     + A    
Sbjct: 84  KHPHIVELLETYSSDGMLYMVFEFMDGADL---------CFEIVKRADAGFVYSEAVASH 134
Query: 637 -----LEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTGEDQSMTQTQ 688
                LE L + +   +IH D+KP NVLL   +++    L DFG+A  L   +  +    
Sbjct: 135 YMRQILEALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLG--ESGLVAGG 192
Query: 689 TLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKP----TDELFNGEMTLKHWVN 744
            + T  +MAPE  +        DV+  G++L    +   P     + LF G +  K+ +N
Sbjct: 193 RVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMN 252

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/188 (22%), Positives = 85/188 (45%), Gaps = 11/188 (5%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDV--ECAMMKSIRHRNLVKVISSC 592
           +G G FG V++   +    V V  F +        + V  E ++M  + H  L+ +  + 
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKF-INTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 117
Query: 593 SNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
            ++    L+LE++  G L   + + +Y +   + +N M      L+++H      ++H D
Sbjct: 118 EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLD 174
Query: 653 LKPSNVLLDDNMVAHLS--DFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNG 710
           +KP N++ +    + +   DFG+A  L  ++       T AT  + APE      V    
Sbjct: 175 IKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV---TTATAEFAAPEIVDREPVGFYT 231
Query: 711 DVYSFGIM 718
           D+++ G++
Sbjct: 232 DMWAIGVL 239

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 87/199 (43%), Gaps = 13/199 (6%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDV---ECAMMKSIRH 582
           D+F     +G G FG V   + ++ G   A+K+ + Q     K  +    E  +++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
             LVK+  S  +     +V+EY+  G +  +L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP    
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPAIIL 211
Query: 703 EGQVSTNGDVYSFGIMLME 721
               +   D ++ G+++ E
Sbjct: 212 SKGYNKAVDWWALGVLIYE 230

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 95/202 (47%), Gaps = 17/202 (8%)
Query: 526 TDKFSENNLIGRGGFGSVY--KARIRDGMEVAVKVFN---LQCGRAFKSFDVECAMMKSI 580
           +D++    ++G+G FG V   K +I  G E AVKV +   ++     +S   E  ++K +
Sbjct: 48  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 106
Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
            H N++K+     ++ +  LV E    G L   + S     ++     I+  V S + Y+
Sbjct: 107 DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITYM 165
Query: 641 HFGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMA 697
           H      ++H DLKP N+LL+    +    + DFG++   T  + S      + T  Y+A
Sbjct: 166 H---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS---THFEASKKMKDKIGTAYYIA 219
Query: 698 PEYGREGQVSTNGDVYSFGIML 719
           PE    G      DV+S G++L
Sbjct: 220 PEV-LHGTYDEKCDVWSTGVIL 240

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 95/202 (47%), Gaps = 17/202 (8%)
Query: 526 TDKFSENNLIGRGGFGSVY--KARIRDGMEVAVKVFN---LQCGRAFKSFDVECAMMKSI 580
           +D++    ++G+G FG V   K +I  G E AVKV +   ++     +S   E  ++K +
Sbjct: 49  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 107
Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
            H N++K+     ++ +  LV E    G L   + S     ++     I+  V S + Y+
Sbjct: 108 DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITYM 166
Query: 641 HFGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMA 697
           H      ++H DLKP N+LL+    +    + DFG++   T  + S      + T  Y+A
Sbjct: 167 H---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS---THFEASKKMKDKIGTAYYIA 220
Query: 698 PEYGREGQVSTNGDVYSFGIML 719
           PE    G      DV+S G++L
Sbjct: 221 PEV-LHGTYDEKCDVWSTGVIL 241

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 91/200 (45%), Gaps = 12/200 (6%)
Query: 534 LIGRGGFGSVYKARIRDGMEV-AVKVFN---LQCGRAFKSFDVECAMMKSIRHRNLVKVI 589
            +G+GGF   ++    D  EV A K+     L      +   +E ++ +S+ H+++V   
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 83
Query: 590 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVI 649
               + +F  +VLE     SL + LH    +L   +    +  +    +YLH      VI
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VI 139
Query: 650 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTL-ATIGYMAPEYGREGQVST 708
           H DLK  N+ L++++   + DFG+A   T  +    + +TL  T  Y+APE   +   S 
Sbjct: 140 HRDLKLGNLFLNEDLEVKIGDFGLA---TKVEYDGERKKTLCGTPNYIAPEVLSKKGHSF 196
Query: 709 NGDVYSFGIMLMETFTRKKP 728
             DV+S G ++      K P
Sbjct: 197 EVDVWSIGCIMYTLLVGKPP 216

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 70/256 (27%), Positives = 110/256 (42%), Gaps = 35/256 (13%)
Query: 535 IGRGGFGSVYKAR-IRDGMEVAVK-----VFNLQCGRAFKSFDVECAMMKSIRHRNLVKV 588
           +GRG +G V K R +  G  +AVK     V + +  R     D+    M+++     V  
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDIS---MRTVDCPFTVTF 71
Query: 589 ISSCSNEEFKALVLEYMPHGSLEKYLHS-----SNYSLDIFQRLNIMIDVASALEYLHFG 643
             +   E    + +E M   SL+K+             DI  +  I + +  ALE+LH  
Sbjct: 72  YGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGK--IAVSIVKALEHLHSK 128
Query: 644 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY--- 700
            S  VIH D+KPSNVL++      + DFGI+  L  +   + +        YMAPE    
Sbjct: 129 LS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDD---VAKDIDAGCKPYMAPERINP 183
Query: 701 --GREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDAN 758
              ++G  S   D++S GI ++E    + P D        LK  V +  P      + A+
Sbjct: 184 ELNQKG-YSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSP-----QLPAD 237
Query: 759 LLSQEDIHFVAKEQCV 774
             S E + F +  QC+
Sbjct: 238 KFSAEFVDFTS--QCL 251

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 89/195 (45%), Gaps = 18/195 (9%)
Query: 535 IGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFK------SFDVECAMMKSIRHRNLVK 587
           +G G F  V K R +  G+E A K    +  RA +        + E ++++ + H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAP 647
           +     N     L+LE +  G L  +L +   SL   +  + +  +   + YLH   +  
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDGVNYLH---TKK 135
Query: 648 VIHCDLKPSNV-LLDDNM-VAHLS--DFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE 703
           + H DLKP N+ LLD N+ + H+   DFG+A  +   +  +       T  ++APE    
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGTPEFVAPEIVNY 192
Query: 704 GQVSTNGDVYSFGIM 718
             +    D++S G++
Sbjct: 193 EPLGLEADMWSIGVI 207

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 91/200 (45%), Gaps = 12/200 (6%)
Query: 534 LIGRGGFGSVYKARIRDGMEV-AVKVFN---LQCGRAFKSFDVECAMMKSIRHRNLVKVI 589
            +G+GGF   ++    D  EV A K+     L      +   +E ++ +S+ H+++V   
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 83
Query: 590 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVI 649
               + +F  +VLE     SL + LH    +L   +    +  +    +YLH      VI
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VI 139
Query: 650 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTL-ATIGYMAPEYGREGQVST 708
           H DLK  N+ L++++   + DFG+A   T  +    + +TL  T  Y+APE   +   S 
Sbjct: 140 HRDLKLGNLFLNEDLEVKIGDFGLA---TKVEYDGERKKTLCGTPNYIAPEVLSKKGHSF 196
Query: 709 NGDVYSFGIMLMETFTRKKP 728
             DV+S G ++      K P
Sbjct: 197 EVDVWSIGCIMYTLLVGKPP 216

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 94/214 (43%), Gaps = 32/214 (14%)
Query: 520 LELFQATDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKS 579
           L +   +D++     IG G FG     R +   E+    +  +  +   +   E    +S
Sbjct: 12  LPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIINHRS 71
Query: 580 IRHRNLVKVISSCSNEEFKALVLEYMPHGSL-EKYLHSSNYSLD----IFQRLNIMIDVA 634
           +RH N+V+           A+V+EY   G L E+  ++  +S D     FQ+L       
Sbjct: 72  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL------I 125
Query: 635 SALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLS--DFGIAKLLTGEDQSMTQTQTLAT 692
           S + Y H   +  V H DLK  N LLD +    L   DFG +K       S+  +Q  +T
Sbjct: 126 SGVSYCH---AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVLHSQPKST 176
Query: 693 IG---YMAPEY----GREGQVSTNGDVYSFGIML 719
           +G   Y+APE       +G+V+   DV+S G+ L
Sbjct: 177 VGTPAYIAPEVLLKKEYDGKVA---DVWSCGVTL 207

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 32/214 (14%)
Query: 520 LELFQATDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKS 579
           L +   +D++     IG G FG     R +   E+    +  +  +  ++   E    +S
Sbjct: 11  LPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRS 70
Query: 580 IRHRNLVKVISSCSNEEFKALVLEYMPHGSL-EKYLHSSNYSLD----IFQRLNIMIDVA 634
           +RH N+V+           A+V+EY   G L E+  ++  +S D     FQ+L       
Sbjct: 71  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL------I 124
Query: 635 SALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLS--DFGIAKLLTGEDQSMTQTQTLAT 692
           S + Y H   +  V H DLK  N LLD +    L   DFG +K       S+  +Q  +T
Sbjct: 125 SGVSYCH---AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVLHSQPKST 175
Query: 693 IG---YMAPEY----GREGQVSTNGDVYSFGIML 719
           +G   Y+APE       +G+V+   DV+S G+ L
Sbjct: 176 VGTPAYIAPEVLLKKEYDGKVA---DVWSCGVTL 206

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 91/200 (45%), Gaps = 12/200 (6%)
Query: 534 LIGRGGFGSVYKARIRDGMEV-AVKVFN---LQCGRAFKSFDVECAMMKSIRHRNLVKVI 589
            +G+GGF   ++    D  EV A K+     L      +   +E ++ +S+ H+++V   
Sbjct: 28  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 87
Query: 590 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVI 649
               + +F  +VLE     SL + LH    +L   +    +  +    +YLH      VI
Sbjct: 88  GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VI 143
Query: 650 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTL-ATIGYMAPEYGREGQVST 708
           H DLK  N+ L++++   + DFG+A   T  +    + +TL  T  Y+APE   +   S 
Sbjct: 144 HRDLKLGNLFLNEDLEVKIGDFGLA---TKVEYDGERKKTLCGTPNYIAPEVLSKKGHSF 200
Query: 709 NGDVYSFGIMLMETFTRKKP 728
             DV+S G ++      K P
Sbjct: 201 EVDVWSIGCIMYTLLVGKPP 220

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 92/202 (45%), Gaps = 23/202 (11%)
Query: 526 TDKFSENNLIGRGGFGSVYKARIRDGME-VAVKVFNLQCGRAFKSFDVECAMMKSIRHRN 584
           +D F   + +GRG    VY+ + +   +  A+KV      +  K    E  ++  + H N
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPN 109
Query: 585 LVKVISSCSNEEFKALVLEYMPHGSL-----EKYLHSSNYSLDIFQRLNIMIDVASALEY 639
           ++K+          +LVLE +  G L     EK  +S   + D  ++      +  A+ Y
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQ------ILEAVAY 163
Query: 640 LHFGYSAPVIHCDLKPSNVLLDD---NMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYM 696
           LH      ++H DLKP N+L      +    ++DFG++K++  E Q + +T    T GY 
Sbjct: 164 LH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV--EHQVLMKT-VCGTPGYC 217
Query: 697 APEYGREGQVSTNGDVYSFGIM 718
           APE  R        D++S GI+
Sbjct: 218 APEILRGCAYGPEVDMWSVGII 239

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 87/199 (43%), Gaps = 13/199 (6%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDV---ECAMMKSIRH 582
           D+F     +G G FG V   + ++ G   A+K+ + Q     K  +    E  +++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
             LVK+  S  +     +V+EY+  G +  +L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
             S  +I+ DLKP N+L+D      ++DFG AK + G    +  T        +APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEA-----LAPEIIL 211
Query: 703 EGQVSTNGDVYSFGIMLME 721
               +   D ++ G+++ E
Sbjct: 212 SKGYNKAVDWWALGVLIYE 230

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 93/202 (46%), Gaps = 17/202 (8%)
Query: 526 TDKFSENNLIGRGGFGSVY--KARIRDGMEVAVKVFN---LQCGRAFKSFDVECAMMKSI 580
           +D++    ++G+G FG V   K +I  G E AVKV +   ++     +S   E  ++K +
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
            H N+ K+     ++ +  LV E    G L   + S     ++     I+  V S + Y 
Sbjct: 84  DHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITYX 142
Query: 641 HFGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMA 697
           H      ++H DLKP N+LL+    +    + DFG++   T  + S      + T  Y+A
Sbjct: 143 H---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS---THFEASKKXKDKIGTAYYIA 196
Query: 698 PEYGREGQVSTNGDVYSFGIML 719
           PE    G      DV+S G++L
Sbjct: 197 PEV-LHGTYDEKCDVWSTGVIL 217

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 102/216 (47%), Gaps = 34/216 (15%)
Query: 535 IGRGGFGSVYKA-RIRDGMEVAVKVFN------LQCGRAFKSFDVECAMMKSIRHRNLVK 587
           +G G +GSV  A   R G +VA+K  +      +   RA++    E  ++K ++H N++ 
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR----ELLLLKHMQHENVIG 105
Query: 588 VI------SSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLH 641
           ++      SS  N     LV+ +M    L+K +    +S +  Q L  +  +   L+Y+H
Sbjct: 106 LLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIM-GMEFSEEKIQYL--VYQMLKGLKYIH 161
Query: 642 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYG 701
              SA V+H DLKP N+ ++++    + DFG+A+    E      T  + T  Y APE  
Sbjct: 162 ---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVI 213
Query: 702 REG-QVSTNGDVYSFGIMLMETFTRKKPTDELFNGE 736
                 +   D++S G ++ E  T K     LF G+
Sbjct: 214 LSWMHYNQTVDIWSVGCIMAEMLTGKT----LFKGK 245

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 100/212 (47%), Gaps = 27/212 (12%)
Query: 523 FQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFN------LQCGRAFKSFDVECA 575
           F    ++ +   IG G  G V  A     G+ VAVK  +          RA++    E  
Sbjct: 20  FTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYR----ELV 75
Query: 576 MMKSIRHRNLVKVISSCSN----EEFKA--LVLEYMPHGSLEKYLHSSNYSLDIFQRLNI 629
           ++K + H+N++ +++  +     EEF+   LV+E M   +L + +H     LD  +   +
Sbjct: 76  LLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIH---MELDHERMSYL 131
Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
           +  +   +++LH   SA +IH DLKPSN+++  +    + DFG+A+       +   T  
Sbjct: 132 LYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT---NFMMTPY 185
Query: 690 LATIGYMAPEYGREGQVSTNGDVYSFGIMLME 721
           + T  Y APE       + N D++S G ++ E
Sbjct: 186 VVTRYYRAPEVILGMGYAANVDIWSVGCIMGE 217

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 102/216 (47%), Gaps = 34/216 (15%)
Query: 535 IGRGGFGSVYKA-RIRDGMEVAVKVFN------LQCGRAFKSFDVECAMMKSIRHRNLVK 587
           +G G +GSV  A   R G +VA+K  +      +   RA++    E  ++K ++H N++ 
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR----ELLLLKHMQHENVIG 87
Query: 588 VI------SSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLH 641
           ++      SS  N     LV+ +M    L+K +    +S +  Q L  +  +   L+Y+H
Sbjct: 88  LLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIM-GLKFSEEKIQYL--VYQMLKGLKYIH 143
Query: 642 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYG 701
              SA V+H DLKP N+ ++++    + DFG+A+    E      T  + T  Y APE  
Sbjct: 144 ---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVI 195
Query: 702 REG-QVSTNGDVYSFGIMLMETFTRKKPTDELFNGE 736
                 +   D++S G ++ E  T K     LF G+
Sbjct: 196 LSWMHYNQTVDIWSVGCIMAEMLTGKT----LFKGK 227

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 87/187 (46%), Gaps = 24/187 (12%)
Query: 562 QCGRAFKSFDVECAMMKSIRHRNLVKVISSCSN----EEFKA--LVLEYMPHGSLEKYLH 615
              RA++    E  +MK + H+N++ +++  +     EEF+   LV+E M   +L + + 
Sbjct: 59  HAKRAYR----ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQ 113
Query: 616 SSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 675
                LD  +   ++  +   +++LH   SA +IH DLKPSN+++  +    + DFG+A+
Sbjct: 114 ME---LDHERMSYLLYQMLXGIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLAR 167
Query: 676 LLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNG 735
                  S   T  + T  Y APE         N D++S G ++ E    K     LF G
Sbjct: 168 ---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPG 220
Query: 736 EMTLKHW 742
              +  W
Sbjct: 221 RDYIDQW 227

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 87/187 (46%), Gaps = 24/187 (12%)
Query: 562 QCGRAFKSFDVECAMMKSIRHRNLVKVISSCSN----EEFKA--LVLEYMPHGSLEKYLH 615
              RA++    E  +MK + H+N++ +++  +     EEF+   LV+E M   +L + + 
Sbjct: 66  HAKRAYR----ELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQ 120
Query: 616 SSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 675
                LD  +   ++  +   +++LH   SA +IH DLKPSN+++  +    + DFG+A+
Sbjct: 121 ME---LDHERMSYLLYQMLXGIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLAR 174
Query: 676 LLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNG 735
                  S   T  + T  Y APE         N D++S G ++ E    K     LF G
Sbjct: 175 ---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPG 227
Query: 736 EMTLKHW 742
              +  W
Sbjct: 228 RDYIDQW 234

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 92/204 (45%), Gaps = 30/204 (14%)
Query: 529 FSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQC--GRAFK----SFDVECAMMKSIRH 582
           F     +G G F  V  A  +       K+F ++C   +A K    S + E A+++ I+H
Sbjct: 24  FEFKETLGTGAFSEVVLAEEK----ATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKH 79
Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSL-----EKYLHSSNYSLDIFQRLNIMIDVASAL 637
            N+V +     +     LV++ +  G L     EK  ++   +  + ++      V  A+
Sbjct: 80  ENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQ------VLDAV 133
Query: 638 EYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIG 694
            YLH      ++H DLKP N+L    D+     +SDFG++K+   E +    +    T G
Sbjct: 134 YYLH---RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKM---EGKGDVMSTACGTPG 187
Query: 695 YMAPEYGREGQVSTNGDVYSFGIM 718
           Y+APE   +   S   D +S G++
Sbjct: 188 YVAPEVLAQKPYSKAVDCWSIGVI 211

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/229 (23%), Positives = 91/229 (39%), Gaps = 40/229 (17%)
Query: 527 DKFSENNLIGRGGFGSVYKA------RIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSI 580
           ++ S    +G G FG V +A      +    M VAVK+         +      A+M  +
Sbjct: 46  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTERE-----ALMSEL 100
Query: 581 R-------HRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMI-- 631
           +       H N+V ++ +C+      ++ EY  +G L  +L     S  I  + +  I  
Sbjct: 101 KVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSF-ICSKTSPAIME 159
Query: 632 ----------------DVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 675
                            VA  + +L    S   IH DL   N+LL    +  + DFG+A+
Sbjct: 160 DDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLAR 216
Query: 676 LLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 724
            +  +   + +      + +MAPE       +   DV+S+GI L E F+
Sbjct: 217 HIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/229 (23%), Positives = 91/229 (39%), Gaps = 40/229 (17%)
Query: 527 DKFSENNLIGRGGFGSVYKA------RIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSI 580
           ++ S    +G G FG V +A      +    M VAVK+         +      A+M  +
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTERE-----ALMSEL 77
Query: 581 R-------HRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMI-- 631
           +       H N+V ++ +C+      ++ EY  +G L  +L     S  I  + +  I  
Sbjct: 78  KVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSF-ICSKTSPAIME 136
Query: 632 ----------------DVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 675
                            VA  + +L    S   IH DL   N+LL    +  + DFG+A+
Sbjct: 137 DDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLAR 193
Query: 676 LLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 724
            +  +   + +      + +MAPE       +   DV+S+GI L E F+
Sbjct: 194 DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 97/356 (27%), Positives = 152/356 (42%), Gaps = 61/356 (17%)
Query: 24  KVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLSG 83
           +V  L  +RL  + I  + +L+NL  ++ S N+L    P  + N++ L    + NN ++ 
Sbjct: 42  QVTTLQADRLGIKSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA- 98
Query: 84  CLSSITDVG-LPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLR 142
               IT +  L NL  L L+ N  +   P  + N + L++L L  N+ S    S    L 
Sbjct: 99  ---DITPLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDI--SALSGLT 151
Query: 143 NLEWLTLYXXXXXXXXXXXXXXXXXXXCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNF 202
           +L+ L+                       +L  + +S+N +  I   + +  L++ L++ 
Sbjct: 152 SLQQLSF-------SSNQVTDLKPLANLTTLERLDISSNKVSDI---SVLAKLTN-LESL 200
Query: 203 YMYNCNVSGGIPEEITNLTDLTTIVLGGNKLN--GSIPITLGKLQKLQDVDLEYNQLEGS 260
              N  +S   P  I  LT+L  + L GN+L   G    TL  L  L D+DL  NQ+   
Sbjct: 201 IATNNQISDITPLGI--LTNLDELSLNGNQLKDIG----TLASLTNLTDLDLANNQISNL 254
Query: 261 IPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILD 320
            P S     +L EL+LG N++S   P              G   LT++ LN   L+DI  
Sbjct: 255 APLSGL--TKLTELKLGANQISNISPLA------------GLTALTNLELNENQLEDI-- 298
Query: 321 LNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRL 376
                     P    I NLK L  +    NN S I P  + SL  L+ LF   N++
Sbjct: 299 ---------SP----ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFSNNKV 339

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/229 (23%), Positives = 91/229 (39%), Gaps = 40/229 (17%)
Query: 527 DKFSENNLIGRGGFGSVYKA------RIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSI 580
           ++ S    +G G FG V +A      +    M VAVK+         +      A+M  +
Sbjct: 39  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTERE-----ALMSEL 93
Query: 581 R-------HRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMI-- 631
           +       H N+V ++ +C+      ++ EY  +G L  +L     S  I  + +  I  
Sbjct: 94  KVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSF-ICSKTSPAIME 152
Query: 632 ----------------DVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 675
                            VA  + +L    S   IH DL   N+LL    +  + DFG+A+
Sbjct: 153 DDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLAR 209
Query: 676 LLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 724
            +  +   + +      + +MAPE       +   DV+S+GI L E F+
Sbjct: 210 DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 258

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 92/211 (43%), Gaps = 26/211 (12%)
Query: 520 LELFQATDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKS 579
           L +   +D++     IG G FG     R +   E+    +  +  +  ++   E    +S
Sbjct: 12  LPIMHDSDRYELVKDIGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREIINHRS 71
Query: 580 IRHRNLVKVISSCSNEEFKALVLEYMPHGSL-EKYLHSSNYSLD----IFQRLNIMIDVA 634
           +RH N+V+           A+V+EY   G L E+  ++  +S D     FQ+L       
Sbjct: 72  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL------I 125
Query: 635 SALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHL--SDFGIAKLLTGEDQSMTQTQTLAT 692
           S + Y H   +  V H DLK  N LLD +    L  +DFG +K      Q  +    + T
Sbjct: 126 SGVSYAH---AMQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKS---AVGT 179
Query: 693 IGYMAPEY----GREGQVSTNGDVYSFGIML 719
             Y+APE       +G+V+   DV+S G+ L
Sbjct: 180 PAYIAPEVLLKKEYDGKVA---DVWSCGVTL 207

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 87/187 (46%), Gaps = 24/187 (12%)
Query: 562 QCGRAFKSFDVECAMMKSIRHRNLVKVISSCSN----EEFKA--LVLEYMPHGSLEKYLH 615
              RA++    E  +MK + H+N++ +++  +     EEF+   LV+E M   +L + + 
Sbjct: 66  HAKRAYR----ELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQ 120
Query: 616 SSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 675
                LD  +   ++  +   +++LH   SA +IH DLKPSN+++  +    + DFG+A+
Sbjct: 121 ME---LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLAR 174
Query: 676 LLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNG 735
                  S   T  + T  Y APE         N D++S G ++ E    K     LF G
Sbjct: 175 ---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPG 227
Query: 736 EMTLKHW 742
              +  W
Sbjct: 228 RDYIDQW 234

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/249 (22%), Positives = 109/249 (43%), Gaps = 19/249 (7%)
Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSN 594
           +GRG FG V++       +  +  F    G        E +++   RHRN++ +  S  +
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES 72
Query: 595 EEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLK 654
            E   ++ E++    + + +++S + L+  + ++ +  V  AL++LH   S  + H D++
Sbjct: 73  MEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIR 129
Query: 655 PSNVLLDDNMVAHLS--DFGIAKLLT-GEDQSMTQTQTLATIGYMAPEYGREGQVSTNGD 711
           P N++      + +   +FG A+ L  G++  +  T       Y APE  +   VST  D
Sbjct: 130 PENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAP----EYYAPEVHQHDVVSTATD 185
Query: 712 VYSFGIMLMETF---------TRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ 762
           ++S G ++             T ++  + + N E T        + I  M+ VD  L+ +
Sbjct: 186 MWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKE 245
Query: 763 EDIHFVAKE 771
                 A E
Sbjct: 246 RKSRMTASE 254

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 96/227 (42%), Gaps = 50/227 (22%)
Query: 535 IGRGGFGSVYKA-RIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIR----------HR 583
           +G+G +G V+K+   R G  VAVK       + F +F       ++ R          H 
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVK-------KIFDAFQNSTDAQRTFREIMILTELSGHE 69
Query: 584 NLVKVIS--SCSNEEFKALVLEYMPHGSLEKYLHSSNYS--LDIFQRLNIMIDVASALEY 639
           N+V +++     N+    LV +YM     E  LH+   +  L+   +  ++  +   ++Y
Sbjct: 70  NIVNLLNVLRADNDRDVYLVFDYM-----ETDLHAVIRANILEPVHKQYVVYQLIKVIKY 124
Query: 640 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG-------------------E 680
           LH   S  ++H D+KPSN+LL+      ++DFG+++                       +
Sbjct: 125 LH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFD 181
Query: 681 DQSMTQTQTLATIGYMAPEYGREGQVSTNG-DVYSFGIMLMETFTRK 726
           D     T  +AT  Y APE        T G D++S G +L E    K
Sbjct: 182 DDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 87/187 (46%), Gaps = 24/187 (12%)
Query: 562 QCGRAFKSFDVECAMMKSIRHRNLVKVISSCSN----EEFKA--LVLEYMPHGSLEKYLH 615
              RA++    E  +MK + H+N++ +++  +     EEF+   LV+E M   +L + + 
Sbjct: 66  HAKRAYR----ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQ 120
Query: 616 SSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 675
                LD  +   ++  +   +++LH   SA +IH DLKPSN+++  +    + DFG+A+
Sbjct: 121 ME---LDHERMSYLLYQMLXGIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLAR 174
Query: 676 LLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNG 735
                  S   T  + T  Y APE         N D++S G ++ E    K     LF G
Sbjct: 175 ---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPG 227
Query: 736 EMTLKHW 742
              +  W
Sbjct: 228 RDYIDQW 234

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/229 (23%), Positives = 91/229 (39%), Gaps = 40/229 (17%)
Query: 527 DKFSENNLIGRGGFGSVYKA------RIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSI 580
           ++ S    +G G FG V +A      +    M VAVK+         +      A+M  +
Sbjct: 46  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTERE-----ALMSEL 100
Query: 581 R-------HRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMI-- 631
           +       H N+V ++ +C+      ++ EY  +G L  +L     S  I  + +  I  
Sbjct: 101 KVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSF-ICSKTSPAIME 159
Query: 632 ----------------DVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 675
                            VA  + +L    S   IH DL   N+LL    +  + DFG+A+
Sbjct: 160 DDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLAR 216
Query: 676 LLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 724
            +  +   + +      + +MAPE       +   DV+S+GI L E F+
Sbjct: 217 DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 48/92 (52%), Gaps = 3/92 (3%)
Query: 633 VASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLAT 692
           VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+ +  +   + +      
Sbjct: 202 VAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 693 IGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 724
           + +MAPE   +   +   DV+SFG++L E F+
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 52/105 (49%), Gaps = 13/105 (12%)
Query: 627 LNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM-- 684
           L+I I +A A+E+LH   S  ++H DLKPSN+    + V  + DFG+   +  +++    
Sbjct: 167 LHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 685 --------TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLME 721
                   T    + T  YM+PE       S   D++S G++L E
Sbjct: 224 LTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFE 268

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/229 (23%), Positives = 91/229 (39%), Gaps = 40/229 (17%)
Query: 527 DKFSENNLIGRGGFGSVYKA------RIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSI 580
           ++ S    +G G FG V +A      +    M VAVK+         +      A+M  +
Sbjct: 41  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTERE-----ALMSEL 95
Query: 581 R-------HRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMI-- 631
           +       H N+V ++ +C+      ++ EY  +G L  +L     S  I  + +  I  
Sbjct: 96  KVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSF-ICSKTSPAIME 154
Query: 632 ----------------DVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 675
                            VA  + +L    S   IH DL   N+LL    +  + DFG+A+
Sbjct: 155 DDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLAR 211
Query: 676 LLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 724
            +  +   + +      + +MAPE       +   DV+S+GI L E F+
Sbjct: 212 DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 260

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 88/199 (44%), Gaps = 10/199 (5%)
Query: 534 LIGRGGFGSVYKARIRDGMEV-AVKVFN---LQCGRAFKSFDVECAMMKSIRHRNLVKVI 589
            +G+GGF   ++    D  EV A K+     L      +   +E ++ +S+ H+++V   
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 590 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVI 649
               + +F  +VLE     SL + LH    +L   +    +  +    +YLH      VI
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VI 163
Query: 650 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTN 709
           H DLK  N+ L++++   + DFG+A  +  E     +     T  Y+APE   +   S  
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKVLCGTPNYIAPEVLSKKGHSFE 221
Query: 710 GDVYSFGIMLMETFTRKKP 728
            DV+S G ++      K P
Sbjct: 222 VDVWSIGCIMYTLLVGKPP 240

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 48/92 (52%), Gaps = 3/92 (3%)
Query: 633 VASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLAT 692
           VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+ +  +   + +      
Sbjct: 200 VAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 256
Query: 693 IGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 724
           + +MAPE   +   +   DV+SFG++L E F+
Sbjct: 257 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 288

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 100/212 (47%), Gaps = 27/212 (12%)
Query: 523 FQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFN------LQCGRAFKSFDVECA 575
           F    ++ +   IG G  G V  A     G+ VAVK  +          RA++    E  
Sbjct: 18  FTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYR----ELV 73
Query: 576 MMKSIRHRNLVKVISSCSN----EEFKA--LVLEYMPHGSLEKYLHSSNYSLDIFQRLNI 629
           ++K + H+N++ +++  +     EEF+   LV+E M   +L + +H     LD  +   +
Sbjct: 74  LLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIH---MELDHERMSYL 129
Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
           +  +   +++LH   SA +IH DLKPSN+++  +    + DFG+A+  +    +   T  
Sbjct: 130 LYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAST---NFMMTPY 183
Query: 690 LATIGYMAPEYGREGQVSTNGDVYSFGIMLME 721
           + T  Y APE         N D++S G ++ E
Sbjct: 184 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 215

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 88/199 (44%), Gaps = 10/199 (5%)
Query: 534 LIGRGGFGSVYKARIRDGMEV-AVKVFN---LQCGRAFKSFDVECAMMKSIRHRNLVKVI 589
            +G+GGF   ++    D  EV A K+     L      +   +E ++ +S+ H+++V   
Sbjct: 46  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 105
Query: 590 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVI 649
               + +F  +VLE     SL + LH    +L   +    +  +    +YLH      VI
Sbjct: 106 GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VI 161
Query: 650 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTN 709
           H DLK  N+ L++++   + DFG+A  +  E     +     T  Y+APE   +   S  
Sbjct: 162 HRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKVLCGTPNYIAPEVLSKKGHSFE 219
Query: 710 GDVYSFGIMLMETFTRKKP 728
            DV+S G ++      K P
Sbjct: 220 VDVWSIGCIMYTLLVGKPP 238

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 30/80 (37%), Positives = 43/80 (53%), Gaps = 3/80 (3%)
Query: 650 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQ-TQTLATIGYMAPEYGREGQVST 708
           H D+KP N+L+  +  A+L DFGIA   T  D+ +TQ   T+ T+ Y APE   E   + 
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATT--DEKLTQLGNTVGTLYYXAPERFSESHATY 214
Query: 709 NGDVYSFGIMLMETFTRKKP 728
             D+Y+   +L E  T   P
Sbjct: 215 RADIYALTCVLYECLTGSPP 234

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 92/210 (43%), Gaps = 22/210 (10%)
Query: 519 YLELFQATDKFSENNLIGRGGFGS----VYKARIRDGMEVAVKVFNLQCGRAFKSFDVEC 574
           Y +    +D +     IG G +      V+KA     ME AVKV +       +  ++  
Sbjct: 19  YFQSMVFSDGYVVKETIGVGSYSECKRCVHKAT---NMEYAVKVIDKSKRDPSEEIEI-- 73
Query: 575 AMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSL-EKYLHSSNYSLDIFQRLNIMIDV 633
            +++  +H N++ +     + +   LV E M  G L +K L    +S    +   ++  +
Sbjct: 74  -LLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSER--EASFVLHTI 130
Query: 634 ASALEYLHFGYSAPVIHCDLKPSNVLLDDNM----VAHLSDFGIAKLLTGEDQSMTQTQT 689
              +EYLH   S  V+H DLKPSN+L  D         + DFG AK L  E+  +     
Sbjct: 131 GKTVEYLH---SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLL--MTP 185
Query: 690 LATIGYMAPEYGREGQVSTNGDVYSFGIML 719
             T  ++APE  +        D++S GI+L
Sbjct: 186 CYTANFVAPEVLKRQGYDEGCDIWSLGILL 215

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 48/92 (52%), Gaps = 3/92 (3%)
Query: 633 VASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLAT 692
           VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+ +  +   + +      
Sbjct: 207 VAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 263
Query: 693 IGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 724
           + +MAPE   +   +   DV+SFG++L E F+
Sbjct: 264 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 295

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 96/213 (45%), Gaps = 30/213 (14%)
Query: 520 LELFQATDKFSENNLIGRGGFGSVYKARIRDGME-VAVKVFNLQCGRAF-KSFDVECAMM 577
           + +   +D++     IG G FG     R +   E VAVK   ++ G A  ++   E    
Sbjct: 13  MPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKY--IERGAAIDENVQREIINH 70
Query: 578 KSIRHRNLVKVISSCSNEEFKALVLEYMPHGSL-EKYLHSSNYSLD----IFQRLNIMID 632
           +S+RH N+V+           A+++EY   G L E+  ++  +S D     FQ+L     
Sbjct: 71  RSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQL----- 125
Query: 633 VASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLS--DFGIAKLLTGEDQSMTQTQTL 690
             S + Y H   S  + H DLK  N LLD +    L   DFG +K       S+  +Q  
Sbjct: 126 -LSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVLHSQPK 175
Query: 691 ATIG---YMAPEY-GREGQVSTNGDVYSFGIML 719
           +T+G   Y+APE   R+       DV+S G+ L
Sbjct: 176 STVGTPAYIAPEVLLRQEYDGKIADVWSCGVTL 208

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 48/92 (52%), Gaps = 3/92 (3%)
Query: 633 VASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLAT 692
           VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+ +  +   + +      
Sbjct: 209 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 265
Query: 693 IGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 724
           + +MAPE   +   +   DV+SFG++L E F+
Sbjct: 266 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 297

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 89/203 (43%), Gaps = 18/203 (8%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQC------GRAFKSFDVECAMMKS 579
           D +     +G G F  V K R +  G++ A K    +       G + +  + E +++K 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 580 IRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEY 639
           I+H N++ +     N+    L+LE +  G L  +L +   SL   +    +  + + + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYY 129
Query: 640 LHFGYSAPVIHCDLKPSNVLLDDNMVA----HLSDFGIAKLLTGEDQSMTQTQTLATIGY 695
           LH   S  + H DLKP N++L D  V      + DFG+A  +   D          T  +
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEF 183
Query: 696 MAPEYGREGQVSTNGDVYSFGIM 718
           +APE      +    D++S G++
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVI 206

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 89/203 (43%), Gaps = 18/203 (8%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQC------GRAFKSFDVECAMMKS 579
           D +     +G G F  V K R +  G++ A K    +       G + +  + E +++K 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 580 IRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEY 639
           I+H N++ +     N+    L+LE +  G L  +L +   SL   +    +  + + + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYY 129
Query: 640 LHFGYSAPVIHCDLKPSNVLLDDNMVA----HLSDFGIAKLLTGEDQSMTQTQTLATIGY 695
           LH   S  + H DLKP N++L D  V      + DFG+A  +   D          T  +
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEF 183
Query: 696 MAPEYGREGQVSTNGDVYSFGIM 718
           +APE      +    D++S G++
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVI 206

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 89/203 (43%), Gaps = 18/203 (8%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQC------GRAFKSFDVECAMMKS 579
           D +     +G G F  V K R +  G++ A K    +       G + +  + E +++K 
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 580 IRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEY 639
           I+H N++ +     N+    L+LE +  G L  +L +   SL   +    +  + + + Y
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYY 128
Query: 640 LHFGYSAPVIHCDLKPSNVLLDDNMVA----HLSDFGIAKLLTGEDQSMTQTQTLATIGY 695
           LH   S  + H DLKP N++L D  V      + DFG+A  +   D          T  +
Sbjct: 129 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEF 182
Query: 696 MAPEYGREGQVSTNGDVYSFGIM 718
           +APE      +    D++S G++
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVI 205

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 89/203 (43%), Gaps = 18/203 (8%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQC------GRAFKSFDVECAMMKS 579
           D +     +G G F  V K R +  G++ A K    +       G + +  + E +++K 
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 580 IRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEY 639
           I+H N++ +     N+    L+LE +  G L  +L +   SL   +    +  + + + Y
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYY 128
Query: 640 LHFGYSAPVIHCDLKPSNVLLDDNMVA----HLSDFGIAKLLTGEDQSMTQTQTLATIGY 695
           LH   S  + H DLKP N++L D  V      + DFG+A  +   D          T  +
Sbjct: 129 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEF 182
Query: 696 MAPEYGREGQVSTNGDVYSFGIM 718
           +APE      +    D++S G++
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVI 205

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 89/203 (43%), Gaps = 18/203 (8%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQC------GRAFKSFDVECAMMKS 579
           D +     +G G F  V K R +  G++ A K    +       G + +  + E +++K 
Sbjct: 11  DYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 580 IRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEY 639
           I+H N++ +     N+    L+LE +  G L  +L +   SL   +    +  + + + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYY 129
Query: 640 LHFGYSAPVIHCDLKPSNVLLDDNMVA----HLSDFGIAKLLTGEDQSMTQTQTLATIGY 695
           LH   S  + H DLKP N++L D  V      + DFG+A  +   D          T  +
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEF 183
Query: 696 MAPEYGREGQVSTNGDVYSFGIM 718
           +APE      +    D++S G++
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVI 206

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 85/190 (44%), Gaps = 30/190 (15%)
Query: 562 QCGRAFKSFDVECAMMKSIRHRNLVKVISSCSN----EEFK--ALVLEYMPHG---SLEK 612
              RA++    E  +MK + H+N++ +++  +     EEF+   LV+E M       ++ 
Sbjct: 66  HAKRAYR----ELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM 121
Query: 613 YLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFG 672
            L     S  ++Q L         +++LH   SA +IH DLKPSN+++  +    + DFG
Sbjct: 122 ELDHERMSYLLYQML-------CGIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFG 171
Query: 673 IAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEL 732
           +A+       S   T  + T  Y APE         N D++S G ++ E    K     L
Sbjct: 172 LAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI----L 224
Query: 733 FNGEMTLKHW 742
           F G   +  W
Sbjct: 225 FPGRDYIDQW 234

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 90/203 (44%), Gaps = 22/203 (10%)
Query: 526 TDKFSENNLIGRGGFGS----VYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIR 581
           +D +     IG G +      V+KA     ME AVKV +       +  ++   +++  +
Sbjct: 26  SDGYVVKETIGVGSYSECKRCVHKA---TNMEYAVKVIDKSKRDPSEEIEI---LLRYGQ 79
Query: 582 HRNLVKVISSCSNEEFKALVLEYMPHGSL-EKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
           H N++ +     + +   LV E M  G L +K L    +S    +   ++  +   +EYL
Sbjct: 80  HPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSER--EASFVLHTIGKTVEYL 137
Query: 641 HFGYSAPVIHCDLKPSNVLLDDNM----VAHLSDFGIAKLLTGEDQSMTQTQTLATIGYM 696
           H   S  V+H DLKPSN+L  D         + DFG AK L  E+  +       T  ++
Sbjct: 138 H---SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLL--MTPCYTANFV 192
Query: 697 APEYGREGQVSTNGDVYSFGIML 719
           APE  +        D++S GI+L
Sbjct: 193 APEVLKRQGYDEGCDIWSLGILL 215

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 89/203 (43%), Gaps = 18/203 (8%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQC------GRAFKSFDVECAMMKS 579
           D +     +G G F  V K R +  G++ A K    +       G + +  + E +++K 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 580 IRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEY 639
           I+H N++ +     N+    L+LE +  G L  +L +   SL   +    +  + + + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYY 129
Query: 640 LHFGYSAPVIHCDLKPSNVLLDDNMVA----HLSDFGIAKLLTGEDQSMTQTQTLATIGY 695
           LH   S  + H DLKP N++L D  V      + DFG+A  +   D          T  +
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEF 183
Query: 696 MAPEYGREGQVSTNGDVYSFGIM 718
           +APE      +    D++S G++
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVI 206

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 89/203 (43%), Gaps = 18/203 (8%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQC------GRAFKSFDVECAMMKS 579
           D +     +G G F  V K R +  G++ A K    +       G + +  + E +++K 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 580 IRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEY 639
           I+H N++ +     N+    L+LE +  G L  +L +   SL   +    +  + + + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYY 129
Query: 640 LHFGYSAPVIHCDLKPSNVLLDDNMVA----HLSDFGIAKLLTGEDQSMTQTQTLATIGY 695
           LH   S  + H DLKP N++L D  V      + DFG+A  +   D          T  +
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEF 183
Query: 696 MAPEYGREGQVSTNGDVYSFGIM 718
           +APE      +    D++S G++
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVI 206

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 89/203 (43%), Gaps = 18/203 (8%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQC------GRAFKSFDVECAMMKS 579
           D +     +G G F  V K R +  G++ A K    +       G + +  + E +++K 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 580 IRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEY 639
           I+H N++ +     N+    L+LE +  G L  +L +   SL   +    +  + + + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYY 129
Query: 640 LHFGYSAPVIHCDLKPSNVLLDDNMVA----HLSDFGIAKLLTGEDQSMTQTQTLATIGY 695
           LH   S  + H DLKP N++L D  V      + DFG+A  +   D          T  +
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPAF 183
Query: 696 MAPEYGREGQVSTNGDVYSFGIM 718
           +APE      +    D++S G++
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVI 206

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 88/199 (44%), Gaps = 10/199 (5%)
Query: 534 LIGRGGFGSVYKARIRDGMEV-AVKVFN---LQCGRAFKSFDVECAMMKSIRHRNLVKVI 589
            +G+GGF   ++    D  EV A K+     L      +   +E ++ +S+ H+++V   
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 590 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVI 649
               + +F  +VLE     SL + LH    +L   +    +  +    +YLH      VI
Sbjct: 82  GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VI 137
Query: 650 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTN 709
           H DLK  N+ L++++   + DFG+A  +  E     +     T  Y+APE   +   S  
Sbjct: 138 HRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKVLCGTPNYIAPEVLSKKGHSFE 195
Query: 710 GDVYSFGIMLMETFTRKKP 728
            DV+S G ++      K P
Sbjct: 196 VDVWSIGCIMYTLLVGKPP 214

>pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 97/356 (27%), Positives = 152/356 (42%), Gaps = 61/356 (17%)
Query: 24  KVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLSG 83
           +V  L  +RL  + I  + +L+NL  ++ S N+L    P  + N++ L    + NN ++ 
Sbjct: 42  QVTTLQADRLGIKSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA- 98
Query: 84  CLSSITDVG-LPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLR 142
               IT +  L NL  L L+ N  +   P  + N + L++L L  N+ S    S    L 
Sbjct: 99  ---DITPLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDI--SALSGLT 151
Query: 143 NLEWLTLYXXXXXXXXXXXXXXXXXXXCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNF 202
           +L+ L+                       +L  + +S+N +  I   + +  L++ L++ 
Sbjct: 152 SLQQLSF-------SSNQVTDLKPLANLTTLERLDISSNKVSDI---SVLAKLTN-LESL 200
Query: 203 YMYNCNVSGGIPEEITNLTDLTTIVLGGNKLN--GSIPITLGKLQKLQDVDLEYNQLEGS 260
              N  +S   P  I  LT+L  + L GN+L   G    TL  L  L D+DL  NQ+   
Sbjct: 201 IATNNQISDITPLGI--LTNLDELSLNGNQLKDIG----TLASLTNLTDLDLANNQISNL 254
Query: 261 IPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILD 320
            P S     +L EL+LG N++S   P              G   LT++ LN   L+DI  
Sbjct: 255 APLSGL--TKLTELKLGANQISNISPLA------------GLTALTNLELNENQLEDI-- 298
Query: 321 LNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRL 376
                     P    I NLK L  +    NN S I P  + SL  L+ LF   N++
Sbjct: 299 ---------SP----ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKV 339

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 26/207 (12%)
Query: 532 NNLIGRGGFGSVYKARIRD--------GMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHR 583
           N  +G+G F  ++K   R+          EV +KV +       +SF    +MM  + H+
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 584 NLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFG 643
           +LV     C   +   LV E++  GSL+ YL  +   ++I  +L +   +A+A   +HF 
Sbjct: 73  HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAA---MHFL 129
Query: 644 YSAPVIHCDLKPSNVLL---DDNMVAH-----LSDFGIAKLLTGEDQSMTQTQTLATIGY 695
               +IH ++   N+LL   +D    +     LSD GI+  +  +D  + Q +    I +
Sbjct: 130 EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD--ILQER----IPW 183
Query: 696 MAPE-YGREGQVSTNGDVYSFGIMLME 721
           + PE       ++   D +SFG  L E
Sbjct: 184 VPPECIENPKNLNLATDKWSFGTTLWE 210

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 86/203 (42%), Gaps = 11/203 (5%)
Query: 533 NLIGRGGFGSVYKARIRDGMEV-AVKVFNLQCGRAFKSFDV----ECAMMKSIRHRNLVK 587
            +IGRG +  V   R++    + A+KV   +     +  D     +    ++  H  LV 
Sbjct: 15  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74
Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAP 647
           + S    E     V+EY+  G L  ++       +   R     +++ AL YLH      
Sbjct: 75  LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLH---ERG 130
Query: 648 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVS 707
           +I+ DLK  NVLLD      L+D+G+ K   G     T +    T  Y+APE  R     
Sbjct: 131 IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIAPEILRGEDYG 188
Query: 708 TNGDVYSFGIMLMETFTRKKPTD 730
            + D ++ G+++ E    + P D
Sbjct: 189 FSVDWWALGVLMFEMMAGRSPFD 211

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 97/218 (44%), Gaps = 39/218 (17%)
Query: 535 IGRGGFGSVYKA-RIRDGMEVAVKVF------NLQCGRAFKSFDVECAMMKSIRHRNLVK 587
           +G G +G+V  A   R G +VA+K         L   RA++    E  ++K +RH N++ 
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR----ELRLLKHMRHENVIG 88
Query: 588 VISSCSNEEFKA------LVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLH 641
           ++   + +E         LV+ +M    L K +       D  Q L     V   L+ L 
Sbjct: 89  LLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFL-----VYQMLKGLR 142
Query: 642 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPE-- 699
           + ++A +IH DLKP N+ ++++    + DFG+A+    E         + T  Y APE  
Sbjct: 143 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MXGXVVTRWYRAPEVI 197
Query: 700 --YGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNG 735
             + R  Q     D++S G ++ E  T K     LF G
Sbjct: 198 LNWMRYTQTV---DIWSVGCIMAEMITGKT----LFKG 228

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 91/226 (40%), Gaps = 23/226 (10%)
Query: 508 MPPVATWRRFSYLELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRA 566
           M P  T   F YL             L+G+G FG V   + +  G   A+K+   +   A
Sbjct: 3   MDPRVTMNEFEYL------------KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVA 50
Query: 567 FKSFD---VECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDI 623
                    E  ++++ RH  L  +  S    +    V+EY   G L  + H S   +  
Sbjct: 51  KDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFS 108
Query: 624 FQRLNIM-IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 682
             R      ++ SAL+YLH      V++ DLK  N++LD +    ++DFG+ K   G   
Sbjct: 109 EDRARFYGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKD 164
Query: 683 SMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKP 728
             T      T  Y+APE   +       D +  G+++ E    + P
Sbjct: 165 GATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 210

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 86/203 (42%), Gaps = 11/203 (5%)
Query: 533 NLIGRGGFGSVYKARIRDGMEV-AVKVFNLQCGRAFKSFDV----ECAMMKSIRHRNLVK 587
            +IGRG +  V   R++    + A+KV   +     +  D     +    ++  H  LV 
Sbjct: 11  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 70
Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAP 647
           + S    E     V+EY+  G L  ++       +   R     +++ AL YLH      
Sbjct: 71  LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLH---ERG 126
Query: 648 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVS 707
           +I+ DLK  NVLLD      L+D+G+ K   G     T +    T  Y+APE  R     
Sbjct: 127 IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIAPEILRGEDYG 184
Query: 708 TNGDVYSFGIMLMETFTRKKPTD 730
            + D ++ G+++ E    + P D
Sbjct: 185 FSVDWWALGVLMFEMMAGRSPFD 207

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 89/203 (43%), Gaps = 18/203 (8%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQC------GRAFKSFDVECAMMKS 579
           D +     +G G F  V K R +  G++ A K    +       G + +  + E +++K 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 580 IRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEY 639
           I+H N++ +     N+    L+LE +  G L  +L +   SL   +    +  + + + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYY 129
Query: 640 LHFGYSAPVIHCDLKPSNVLLDDNMVA----HLSDFGIAKLLTGEDQSMTQTQTLATIGY 695
           LH   S  + H DLKP N++L D  V      + DFG+A  +   D          T  +
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEF 183
Query: 696 MAPEYGREGQVSTNGDVYSFGIM 718
           +APE      +    D++S G++
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVI 206

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 89/203 (43%), Gaps = 18/203 (8%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQC------GRAFKSFDVECAMMKS 579
           D +     +G G F  V K R +  G++ A K    +       G + +  + E +++K 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 580 IRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEY 639
           I+H N++ +     N+    L+LE +  G L  +L +   SL   +    +  + + + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYY 129
Query: 640 LHFGYSAPVIHCDLKPSNVLLDDNMVA----HLSDFGIAKLLTGEDQSMTQTQTLATIGY 695
           LH   S  + H DLKP N++L D  V      + DFG+A  +   D          T  +
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEF 183
Query: 696 MAPEYGREGQVSTNGDVYSFGIM 718
           +APE      +    D++S G++
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVI 206

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 67/251 (26%), Positives = 94/251 (37%), Gaps = 58/251 (23%)
Query: 522 LFQATDKFSENNLIGRGGFGSVYKARIRDGMEV-AVKVFNLQCGRAFKSFDVE-----CA 575
           L +   K+     IG+G +G V  A       + A+K+ N    R     DVE       
Sbjct: 21  LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVR 80
Query: 576 MMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYL--------------------- 614
           +MK + H N+ ++     +E++  LV+E    G L   L                     
Sbjct: 81  LMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQIC 140
Query: 615 --------------HSSNYSLDIFQR----LNIMIDVASALEYLHFGYSAPVIHCDLKPS 656
                         H    SLD  QR     NIM  + SAL YLH   +  + H D+KP 
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPE 197
Query: 657 NVLLDDN--MVAHLSDFGIA----KLLTGEDQSMTQTQTLATIGYMAPEYGREGQVS--T 708
           N L   N      L DFG++    KL  GE   MT      T  ++APE       S   
Sbjct: 198 NFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA--GTPYFVAPEVLNTTNESYGP 255
Query: 709 NGDVYSFGIML 719
             D +S G++L
Sbjct: 256 KCDAWSAGVLL 266

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 93/217 (42%), Gaps = 22/217 (10%)
Query: 534 LIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKS-----IRHRNLVKV 588
           ++G+G FG V  A  R G E    +  L+     +  DVEC M++      +     +  
Sbjct: 26  VLGKGSFGKVMLAD-RKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQ 84
Query: 589 ISSC-SNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAP 647
           + SC    +    V+EY+  G L  ++      +  F+    +   A     L F +   
Sbjct: 85  LHSCFQTVDRLYFVMEYVNGGDLMYHIQQ----VGKFKEPQAVFYAAEISIGLFFLHKRG 140
Query: 648 VIHCDLKPSNVLLDDNMVAHLSDFGIAK--LLTGEDQSMTQTQTLATIGYMAPEYGREGQ 705
           +I+ DLK  NV+LD      ++DFG+ K  ++ G    +T  +   T  Y+APE      
Sbjct: 141 IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDG----VTTREFCGTPDYIAPEIIAYQP 196
Query: 706 VSTNGDVYSFGIMLMETFTRKKP-----TDELFNGEM 737
              + D +++G++L E    + P      DELF   M
Sbjct: 197 YGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIM 233

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 85/187 (45%), Gaps = 30/187 (16%)
Query: 565 RAFKSFDVECAMMKSIRHRNLVKVISSCSN----EEFKA--LVLEYMPHG---SLEKYLH 615
           RA++    E  +MK + H+N++ +++  +     EEF+   LV+E M       ++  L 
Sbjct: 63  RAYR----ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD 118
Query: 616 SSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 675
               S  ++Q L         +++LH   SA +IH DLKPSN+++  +    + DFG+A+
Sbjct: 119 HERMSYLLYQML-------CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 168
Query: 676 LLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNG 735
                  S   T  + T  Y APE         N D++S G ++ E    K     LF G
Sbjct: 169 ---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPG 221
Query: 736 EMTLKHW 742
              +  W
Sbjct: 222 RDYIDQW 228

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 85/187 (45%), Gaps = 30/187 (16%)
Query: 565 RAFKSFDVECAMMKSIRHRNLVKVISSCSN----EEFKA--LVLEYMPHG---SLEKYLH 615
           RA++    E  +MK + H+N++ +++  +     EEF+   LV+E M       ++  L 
Sbjct: 62  RAYR----ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD 117
Query: 616 SSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 675
               S  ++Q L         +++LH   SA +IH DLKPSN+++  +    + DFG+A+
Sbjct: 118 HERMSYLLYQML-------CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167
Query: 676 LLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNG 735
                  S   T  + T  Y APE         N D++S G ++ E    K     LF G
Sbjct: 168 ---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPG 220
Query: 736 EMTLKHW 742
              +  W
Sbjct: 221 RDYIDQW 227

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 85/187 (45%), Gaps = 30/187 (16%)
Query: 565 RAFKSFDVECAMMKSIRHRNLVKVISSCSN----EEFKA--LVLEYMPHG---SLEKYLH 615
           RA++    E  +MK + H+N++ +++  +     EEF+   LV+E M       ++  L 
Sbjct: 63  RAYR----ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD 118
Query: 616 SSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 675
               S  ++Q L         +++LH   SA +IH DLKPSN+++  +    + DFG+A+
Sbjct: 119 HERMSYLLYQML-------CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 168
Query: 676 LLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNG 735
                  S   T  + T  Y APE         N D++S G ++ E    K     LF G
Sbjct: 169 ---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPG 221
Query: 736 EMTLKHW 742
              +  W
Sbjct: 222 RDYIDQW 228

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 86/203 (42%), Gaps = 11/203 (5%)
Query: 533 NLIGRGGFGSVYKARIRDGMEV-AVKVFNLQCGRAFKSFDV----ECAMMKSIRHRNLVK 587
            +IGRG +  V   R++    + A+KV   +     +  D     +    ++  H  LV 
Sbjct: 26  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 85
Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAP 647
           + S    E     V+EY+  G L  ++       +   R     +++ AL YLH      
Sbjct: 86  LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLH---ERG 141
Query: 648 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVS 707
           +I+ DLK  NVLLD      L+D+G+ K   G     T +    T  Y+APE  R     
Sbjct: 142 IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIAPEILRGEDYG 199
Query: 708 TNGDVYSFGIMLMETFTRKKPTD 730
            + D ++ G+++ E    + P D
Sbjct: 200 FSVDWWALGVLMFEMMAGRSPFD 222

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 85/187 (45%), Gaps = 30/187 (16%)
Query: 565 RAFKSFDVECAMMKSIRHRNLVKVISSCSN----EEFKA--LVLEYMPHG---SLEKYLH 615
           RA++    E  +MK + H+N++ +++  +     EEF+   LV+E M       ++  L 
Sbjct: 69  RAYR----ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD 124
Query: 616 SSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 675
               S  ++Q L         +++LH   SA +IH DLKPSN+++  +    + DFG+A+
Sbjct: 125 HERMSYLLYQML-------CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174
Query: 676 LLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNG 735
                  S   T  + T  Y APE         N D++S G ++ E    K     LF G
Sbjct: 175 ---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPG 227
Query: 736 EMTLKHW 742
              +  W
Sbjct: 228 RDYIDQW 234

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 70/157 (44%), Gaps = 9/157 (5%)
Query: 573 ECAMMKSIRHRNLVKVISSCSNEEFKAL--VLEYMPHGSLEKYLHSSNYSLDIFQRLNIM 630
           E  +++ +RH+N+++++    NEE + +  V+EY   G  E           + Q     
Sbjct: 56  EIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYF 115
Query: 631 IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTL 690
             +   LEYLH   S  ++H D+KP N+LL       +S  G+A+ L       T   + 
Sbjct: 116 CQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ 172
Query: 691 ATIGYMAPEYGREGQVSTNG---DVYSFGIMLMETFT 724
            +  +  PE    G  + +G   D++S G+ L    T
Sbjct: 173 GSPAFQPPEIA-NGLDTFSGFKVDIWSAGVTLYNITT 208

>pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 96/354 (27%), Positives = 150/354 (42%), Gaps = 58/354 (16%)
Query: 24  KVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLSG 83
           +V  L  +RL  + I  + +L+NL  ++ S N+L    P  + N++ L    + NN ++ 
Sbjct: 42  QVTTLQADRLGIKSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA- 98
Query: 84  CLSSITDVG-LPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLR 142
               IT +  L NL  L L+ N  +   P  + N + L++L L  N+ S    S    L 
Sbjct: 99  ---DITPLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDI--SALSGLT 151
Query: 143 NLEWLTLYXXXXXXXXXXXXXXXXXXXCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNF 202
           +L+ L                        +L  + +S+N +  I   + +  L++ L++ 
Sbjct: 152 SLQQLNF--------GNQVTDLKPLANLTTLERLDISSNKVSDI---SVLAKLTN-LESL 199
Query: 203 YMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIP 262
              N  +S   P  I  LT+L  + L GN+L      TL  L  L D+DL  NQ+    P
Sbjct: 200 IATNNQISDITPLGI--LTNLDELSLNGNQLKDIG--TLASLTNLTDLDLANNQISNLAP 255
Query: 263 DSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLN 322
            S     +L EL+LG N++S   P              G   LT++ LN   L+DI    
Sbjct: 256 LSGL--TKLTELKLGANQISNISPLA------------GLTALTNLELNENQLEDI---- 297
Query: 323 LSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRL 376
                   P    I NLK L  +    NN S I P  + SL  L+ LF   N++
Sbjct: 298 -------SP----ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFSNNKV 338

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 101/238 (42%), Gaps = 41/238 (17%)
Query: 523 FQATDKFSENNLIGRGGFGSV---YKARIRDGMEVAVKVFN------LQCGRAFKSFDVE 573
           F    ++     IG G  G V   Y A +     VA+K  +          RA++    E
Sbjct: 20  FTVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR----E 73
Query: 574 CAMMKSIRHRNLVKVISSCSN----EEFKA--LVLEYMPHG---SLEKYLHSSNYSLDIF 624
             +MK + H+N++ +++  +     EEF+   LV+E M       ++  L     S  ++
Sbjct: 74  LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLY 133
Query: 625 QRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM 684
           Q L         +++LH   SA +IH DLKPSN+++  +    + DFG+A+       S 
Sbjct: 134 QML-------CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSF 180
Query: 685 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHW 742
             T  + T  Y APE         N D++S G ++ E    K     LF G   +  W
Sbjct: 181 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 234

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 85/187 (45%), Gaps = 30/187 (16%)
Query: 565 RAFKSFDVECAMMKSIRHRNLVKVISSCSN----EEFKA--LVLEYMPHG---SLEKYLH 615
           RA++    E  +MK + H+N++ +++  +     EEF+   LV+E M       ++  L 
Sbjct: 70  RAYR----ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD 125
Query: 616 SSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 675
               S  ++Q L         +++LH   SA +IH DLKPSN+++  +    + DFG+A+
Sbjct: 126 HERMSYLLYQML-------CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 175
Query: 676 LLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNG 735
                  S   T  + T  Y APE         N D++S G ++ E    K     LF G
Sbjct: 176 ---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPG 228
Query: 736 EMTLKHW 742
              +  W
Sbjct: 229 RDYIDQW 235

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 85/187 (45%), Gaps = 30/187 (16%)
Query: 565 RAFKSFDVECAMMKSIRHRNLVKVISSCSN----EEFKA--LVLEYMPHG---SLEKYLH 615
           RA++    E  +MK + H+N++ +++  +     EEF+   LV+E M       ++  L 
Sbjct: 68  RAYR----ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD 123
Query: 616 SSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 675
               S  ++Q L         +++LH   SA +IH DLKPSN+++  +    + DFG+A+
Sbjct: 124 HERMSYLLYQML-------CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 173
Query: 676 LLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNG 735
                  S   T  + T  Y APE         N D++S G ++ E    K     LF G
Sbjct: 174 ---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPG 226
Query: 736 EMTLKHW 742
              +  W
Sbjct: 227 RDYIDQW 233

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 85/187 (45%), Gaps = 30/187 (16%)
Query: 565 RAFKSFDVECAMMKSIRHRNLVKVISSCSN----EEFKA--LVLEYMPHG---SLEKYLH 615
           RA++    E  +MK + H+N++ +++  +     EEF+   LV+E M       ++  L 
Sbjct: 70  RAYR----ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD 125
Query: 616 SSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 675
               S  ++Q L         +++LH   SA +IH DLKPSN+++  +    + DFG+A+
Sbjct: 126 HERMSYLLYQML-------CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 175
Query: 676 LLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNG 735
                  S   T  + T  Y APE         N D++S G ++ E    K     LF G
Sbjct: 176 ---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPG 228
Query: 736 EMTLKHW 742
              +  W
Sbjct: 229 RDYIDQW 235

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 89/203 (43%), Gaps = 18/203 (8%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQC------GRAFKSFDVECAMMKS 579
           D +     +G G F  V K R +  G++ A K    +       G + +  + E +++K 
Sbjct: 11  DYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 580 IRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEY 639
           I+H N++ +     N+    L+LE +  G L  +L +   SL   +    +  + + + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYY 129
Query: 640 LHFGYSAPVIHCDLKPSNVLLDDNMVA----HLSDFGIAKLLTGEDQSMTQTQTLATIGY 695
           LH   S  + H DLKP N++L D  V      + DFG+A  +   D          T  +
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEF 183
Query: 696 MAPEYGREGQVSTNGDVYSFGIM 718
           +APE      +    D++S G++
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVI 206

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 94/209 (44%), Gaps = 28/209 (13%)
Query: 535 IGRGGFGSVYKARIRD-GMEVAVKVFNL-----QCGRAFKSFDVECAMMKSIRHRNLVKV 588
           +G G  G V+K R R  G  +AVK         +  R     DV   ++KS     +V+ 
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDV---VLKSHDCPYIVQC 89
Query: 589 ISS--CSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRL--NIMIDVASALEYLHFGY 644
             +   + + F A+ L       L+K +        I +R+   + + +  AL YL   +
Sbjct: 90  FGTFITNTDVFIAMELMGTCAEKLKKRMQGP-----IPERILGKMTVAIVKALYYLKEKH 144
Query: 645 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY---- 700
              VIH D+KPSN+LLD+     L DFGI+  L  +D++  ++   A   YMAPE     
Sbjct: 145 G--VIHRDVKPSNILLDERGQIKLCDFGISGRLV-DDKAKDRSAGCAA--YMAPERIDPP 199
Query: 701 -GREGQVSTNGDVYSFGIMLMETFTRKKP 728
              +       DV+S GI L+E  T + P
Sbjct: 200 DPTKPDYDIRADVWSLGISLVELATGQFP 228

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 85/187 (45%), Gaps = 30/187 (16%)
Query: 565 RAFKSFDVECAMMKSIRHRNLVKVISSCSN----EEFKA--LVLEYMPHG---SLEKYLH 615
           RA++    E  +MK + H+N++ +++  +     EEF+   LV+E M       ++  L 
Sbjct: 107 RAYR----ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD 162
Query: 616 SSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 675
               S  ++Q L         +++LH   SA +IH DLKPSN+++  +    + DFG+A+
Sbjct: 163 HERMSYLLYQML-------CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 212
Query: 676 LLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNG 735
                  S   T  + T  Y APE         N D++S G ++ E    K     LF G
Sbjct: 213 TAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPG 265
Query: 736 EMTLKHW 742
              +  W
Sbjct: 266 RDYIDQW 272

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 89/203 (43%), Gaps = 18/203 (8%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQC------GRAFKSFDVECAMMKS 579
           D +     +G G F  V K R +  G++ A K    +       G + +  + E +++K 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 580 IRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEY 639
           I+H N++ +     N+    L+LE +  G L  +L +   SL   +    +  + + + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYY 129
Query: 640 LHFGYSAPVIHCDLKPSNVLLDDNMVA----HLSDFGIAKLLTGEDQSMTQTQTLATIGY 695
           LH   S  + H DLKP N++L D  V      + DFG+A  +   D          T  +
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEF 183
Query: 696 MAPEYGREGQVSTNGDVYSFGIM 718
           +APE      +    D++S G++
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVI 206

>pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 96/354 (27%), Positives = 151/354 (42%), Gaps = 58/354 (16%)
Query: 24  KVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLSG 83
           +V  L  +RL  + I  + +L+NL  ++ S N+L    P  + N++ L    + NN ++ 
Sbjct: 46  QVTTLQADRLGIKSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA- 102
Query: 84  CLSSITDVG-LPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLR 142
               IT +  L NL  L L+ N  +   P  + N + L++L L  N+ S    S    L 
Sbjct: 103 ---DITPLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDI--SALSGLT 155
Query: 143 NLEWLTLYXXXXXXXXXXXXXXXXXXXCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNF 202
           +L+ L+                       +L  + +S+N +  I   + +  L++ L++ 
Sbjct: 156 SLQQLSF--------GNQVTDLKPLANLTTLERLDISSNKVSDI---SVLAKLTN-LESL 203
Query: 203 YMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIP 262
              N  +S   P  I  LT+L  + L GN+L      TL  L  L D+DL  NQ+    P
Sbjct: 204 IATNNQISDITPLGI--LTNLDELSLNGNQLKDIG--TLASLTNLTDLDLANNQISNLAP 259
Query: 263 DSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLN 322
            S     +L EL+LG N++S   P              G   LT++ LN   L+DI    
Sbjct: 260 LSGL--TKLTELKLGANQISNISPLA------------GLTALTNLELNENQLEDI---- 301
Query: 323 LSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRL 376
                   P    I NLK L  +    NN S I P  + SL  L+ LF   N++
Sbjct: 302 -------SP----ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKV 342

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 92/207 (44%), Gaps = 20/207 (9%)
Query: 523 FQA-TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDV---ECAMM 577
           FQ  +D++     +G G +G V   + +  G E A+K+          +      E A++
Sbjct: 16  FQGLSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVL 75
Query: 578 KSIRHRNLVKVISSCSNEEFKALVLEYMPHGSL--EKYLHSSNYSLDIFQRLNIMIDVAS 635
           K + H N++K+     ++    LV+E    G L  E  L      +D      IM  V S
Sbjct: 76  KQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDA---AVIMKQVLS 132
Query: 636 ALEYLHFGYSAPVIHCDLKPSNVLLDD---NMVAHLSDFGIAKLLTGEDQSMTQTQTLAT 692
              YLH      ++H DLKP N+LL+    + +  + DFG++      +      + L T
Sbjct: 133 GTTYLH---KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHF---EVGGKMKERLGT 186
Query: 693 IGYMAPEYGREGQVSTNGDVYSFGIML 719
             Y+APE  R+ +     DV+S G++L
Sbjct: 187 AYYIAPEVLRK-KYDEKCDVWSCGVIL 212

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 91/213 (42%), Gaps = 18/213 (8%)
Query: 523 FQATDKFSENNLIGRGGFGSVYKARIRDGM--EVAVKVFNLQCGRAFKSFDVECAMMKSI 580
            Q TD +     IG G + SV K  I      E AVK+ +       +  ++   +++  
Sbjct: 18  IQFTDGYEVKEDIGVGSY-SVCKRCIHKATNXEFAVKIIDKSKRDPTEEIEI---LLRYG 73
Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSL-EKYLHSSNYSLDIFQRLNIMIDVASALEY 639
           +H N++ +     + ++  +V E    G L +K L    +S    +   ++  +   +EY
Sbjct: 74  QHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSER--EASAVLFTITKTVEY 131
Query: 640 LHFGYSAPVIHCDLKPSNVLLDDNM----VAHLSDFGIAKLLTGEDQSMTQTQTLATIGY 695
           LH   +  V+H DLKPSN+L  D         + DFG AK L  E+  +       T  +
Sbjct: 132 LH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL--XTPCYTANF 186
Query: 696 MAPEYGREGQVSTNGDVYSFGIMLMETFTRKKP 728
           +APE           D++S G++L    T   P
Sbjct: 187 VAPEVLERQGYDAACDIWSLGVLLYTXLTGYTP 219

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 89/203 (43%), Gaps = 18/203 (8%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQC------GRAFKSFDVECAMMKS 579
           D +     +G G F  V K R +  G++ A K    +       G + +  + E +++K 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 580 IRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEY 639
           I+H N++ +     N+    L+LE +  G L  +L +   SL   +    +  + + + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYY 129
Query: 640 LHFGYSAPVIHCDLKPSNVLLDDNMVA----HLSDFGIAKLLTGEDQSMTQTQTLATIGY 695
           LH   S  + H DLKP N++L D  V      + DFG+A  +   D          T  +
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEF 183
Query: 696 MAPEYGREGQVSTNGDVYSFGIM 718
           +APE      +    D++S G++
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVI 206

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 92/220 (41%), Gaps = 25/220 (11%)
Query: 535 IGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCS 593
           +G GGF  V     + DG   A+K       +  +    E  M +   H N++++++ C 
Sbjct: 37  LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCL 96
Query: 594 NEEFKA----LVLEYMPHGSL----EKYLHSSNYSLDIFQRLNIMIDVASALEYLHF-GY 644
            E        L+L +   G+L    E+     N+ L   Q L +++ +   LE +H  GY
Sbjct: 97  RERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNF-LTEDQILWLLLGICRGLEAIHAKGY 155
Query: 645 SAPVIHCDLKPSNVLLDDNMVAHLSDFG----IAKLLTGEDQSMTQTQTLA---TIGYMA 697
           +    H DLKP+N+LL D     L D G        + G  Q++T     A   TI Y A
Sbjct: 156 A----HRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRA 211
Query: 698 PE---YGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFN 734
           PE         +    DV+S G +L      + P D +F 
Sbjct: 212 PELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQ 251

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 82/166 (49%), Gaps = 20/166 (12%)
Query: 562 QCGRAFKSFDVECAMMKSIRHRNLVKVIS----SCSNEEFKA--LVLEYMPHGSLEKYLH 615
              RA++    E  +MK + H+N++ +++      S EEF+   +V+E M   +L + + 
Sbjct: 66  HAKRAYR----ELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQ 120
Query: 616 SSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 675
                LD  +   ++  +   +++LH   SA +IH DLKPSN+++  +    + DFG+A+
Sbjct: 121 ---MELDHERMSYLLYQMLVGIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLAR 174
Query: 676 LLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLME 721
                  S   T  + T  Y APE         N D++S G+++ E
Sbjct: 175 ---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGE 217

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 85/187 (45%), Gaps = 30/187 (16%)
Query: 565 RAFKSFDVECAMMKSIRHRNLVKVISSCSN----EEFKA--LVLEYMPHG---SLEKYLH 615
           RA++    E  +MK + H+N++ +++  +     EEF+   LV+E M       ++  L 
Sbjct: 107 RAYR----ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD 162
Query: 616 SSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 675
               S  ++Q L         +++LH   SA +IH DLKPSN+++  +    + DFG+A+
Sbjct: 163 HERMSYLLYQML-------CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 212
Query: 676 LLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNG 735
                  S   T  + T  Y APE         N D++S G ++ E    K     LF G
Sbjct: 213 ---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPG 265
Query: 736 EMTLKHW 742
              +  W
Sbjct: 266 RDYIDQW 272

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/195 (23%), Positives = 78/195 (40%), Gaps = 9/195 (4%)
Query: 527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNL 585
           D +  +  +G G FG V++   R  G   A K          ++   E   M  +RH  L
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216
Query: 586 VKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYS 645
           V +  +  ++    ++ E+M  G L + +   +  +   + +  M  V   L ++H    
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---E 273
Query: 646 APVIHCDLKPSNVLLDDNMVAHLS--DFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE 703
              +H DLKP N++        L   DFG+   L   D   +   T  T  + APE    
Sbjct: 274 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFAAPEVAEG 330
Query: 704 GQVSTNGDVYSFGIM 718
             V    D++S G++
Sbjct: 331 KPVGYYTDMWSVGVL 345

>pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 97/356 (27%), Positives = 151/356 (42%), Gaps = 61/356 (17%)
Query: 24  KVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLSG 83
           +V  L  +RL  + I  + +L+NL  ++ S N+L    P  + N++ L    + NN ++ 
Sbjct: 42  QVTTLQADRLGIKSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA- 98
Query: 84  CLSSITDVG-LPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLR 142
               IT +  L NL  L L+ N  +   P  + N + L++L L  N+ S    S    L 
Sbjct: 99  ---DITPLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDI--SALSGLT 151
Query: 143 NLEWLTLYXXXXXXXXXXXXXXXXXXXCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNF 202
           +L+ L                        +L  + +S+N +  I   + +  L++ L++ 
Sbjct: 152 SLQQLNF-------SSNQVTDLKPLANLTTLERLDISSNKVSDI---SVLAKLTN-LESL 200
Query: 203 YMYNCNVSGGIPEEITNLTDLTTIVLGGNKLN--GSIPITLGKLQKLQDVDLEYNQLEGS 260
              N  +S   P  I  LT+L  + L GN+L   G    TL  L  L D+DL  NQ+   
Sbjct: 201 IATNNQISDITPLGI--LTNLDELSLNGNQLKDIG----TLASLTNLTDLDLANNQISNL 254
Query: 261 IPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILD 320
            P S     +L EL+LG N++S   P              G   LT++ LN   L+DI  
Sbjct: 255 APLSGL--TKLTELKLGANQISNISPLA------------GLTALTNLELNENQLEDI-- 298
Query: 321 LNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRL 376
                     P    I NLK L  +    NN S I P  + SL  L+ LF   N++
Sbjct: 299 ---------SP----ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKV 339

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 94/214 (43%), Gaps = 32/214 (14%)
Query: 520 LELFQATDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKS 579
           L +   +D++     IG G FG     R +   E+    +  +  +  ++   E    +S
Sbjct: 12  LPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRS 71
Query: 580 IRHRNLVKVISSCSNEEFKALVLEYMPHGSL-EKYLHSSNYSLD----IFQRLNIMIDVA 634
           +RH N+V+           A+V+EY   G L E+  ++  +S D     FQ+L       
Sbjct: 72  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL------I 125
Query: 635 SALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLS--DFGIAKLLTGEDQSMTQTQTLAT 692
           S + Y H   +  V H DLK  N LLD +    L    FG +K       S+  +Q  +T
Sbjct: 126 SGVSYCH---AMQVCHRDLKLENTLLDGSPAPRLKICAFGYSK------SSVLHSQPKST 176
Query: 693 IG---YMAPEY----GREGQVSTNGDVYSFGIML 719
           +G   Y+APE       +G+V+   DV+S G+ L
Sbjct: 177 VGTPAYIAPEVLLKKEYDGKVA---DVWSCGVTL 207

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 85/197 (43%), Gaps = 39/197 (19%)
Query: 524 QATDKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQ-----C---GRAFKSFDVEC 574
           + + K+S  + +G G FG V+ A  ++   EV VK    +     C           +E 
Sbjct: 21  EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEI 80
Query: 575 AMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQ------RLN 628
           A++  + H N++KV+    N+ F  LV+E   HGS           LD+F       RL+
Sbjct: 81  AILSRVEHANIIKVLDIFENQGFFQLVME--KHGS----------GLDLFAFIDRHPRLD 128
Query: 629 ------IMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 682
                 I   + SA+ YL       +IH D+K  N+++ ++    L DFG A  L   ++
Sbjct: 129 EPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL---ER 182
Query: 683 SMTQTQTLATIGYMAPE 699
                    TI Y APE
Sbjct: 183 GKLFYTFCGTIEYCAPE 199

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 91/215 (42%), Gaps = 18/215 (8%)
Query: 534 LIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSI------RHRNLVK 587
           ++G+G FG V  +  R G +    V  L+     +  DVEC M++        +   L +
Sbjct: 27  VLGKGSFGKVMLSE-RKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 85
Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAP 647
           + S     +    V+EY+  G L  ++      +  F+  + +   A     L F  S  
Sbjct: 86  LHSCFQTMDRLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSKG 141
Query: 648 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVS 707
           +I+ DLK  NV+LD      ++DFG+ K    +   +T      T  Y+APE        
Sbjct: 142 IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD--GVTTKXFCGTPDYIAPEIIAYQPYG 199
Query: 708 TNGDVYSFGIMLMETFTRKKP-----TDELFNGEM 737
            + D ++FG++L E    + P      DELF   M
Sbjct: 200 KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 234

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 82/166 (49%), Gaps = 20/166 (12%)
Query: 562 QCGRAFKSFDVECAMMKSIRHRNLVKVIS----SCSNEEFKA--LVLEYMPHGSLEKYLH 615
              RA++    E  +MK + H+N++ +++      S EEF+   +V+E M   +L + + 
Sbjct: 66  HAKRAYR----ELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQ 120
Query: 616 SSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 675
                LD  +   ++  +   +++LH   SA +IH DLKPSN+++  +    + DFG+A+
Sbjct: 121 ---MELDHERMSYLLYQMLVGIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLAR 174
Query: 676 LLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLME 721
                  S   T  + T  Y APE         N D++S G+++ E
Sbjct: 175 ---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGE 217

>pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 96/354 (27%), Positives = 151/354 (42%), Gaps = 58/354 (16%)
Query: 24  KVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLSG 83
           +V  L  +RL  + I  + +L+NL  ++ S N+L    P  + N++ L    + NN ++ 
Sbjct: 47  QVTTLQADRLGIKSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA- 103
Query: 84  CLSSITDVG-LPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLR 142
               IT +  L NL  L L+ N  +   P  + N + L++L L  N+ S    S    L 
Sbjct: 104 ---DITPLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDI--SALSGLT 156
Query: 143 NLEWLTLYXXXXXXXXXXXXXXXXXXXCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNF 202
           +L+ L+                       +L  + +S+N +  I   + +  L++ L++ 
Sbjct: 157 SLQQLSF--------GNQVTDLKPLANLTTLERLDISSNKVSDI---SVLAKLTN-LESL 204
Query: 203 YMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIP 262
              N  +S   P  I  LT+L  + L GN+L      TL  L  L D+DL  NQ+    P
Sbjct: 205 IATNNQISDITPLGI--LTNLDELSLNGNQLKDIG--TLASLTNLTDLDLANNQISNLAP 260
Query: 263 DSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLN 322
            S     +L EL+LG N++S   P              G   LT++ LN   L+DI    
Sbjct: 261 LSGL--TKLTELKLGANQISNISPLA------------GLTALTNLELNENQLEDI---- 302
Query: 323 LSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRL 376
                   P    I NLK L  +    NN S I P  + SL  L+ LF   N++
Sbjct: 303 -------SP----ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKV 343

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 26/207 (12%)
Query: 532 NNLIGRGGFGSVYKARIRD--------GMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHR 583
           N  +G+G F  ++K   R+          EV +KV +       +SF    +MM  + H+
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 584 NLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFG 643
           +LV     C   +   LV E++  GSL+ YL  +   ++I  +L +   +A A   +HF 
Sbjct: 73  HLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAWA---MHFL 129
Query: 644 YSAPVIHCDLKPSNVLL---DDNMVAH-----LSDFGIAKLLTGEDQSMTQTQTLATIGY 695
               +IH ++   N+LL   +D    +     LSD GI+  +  +D  + Q +    I +
Sbjct: 130 EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD--ILQER----IPW 183
Query: 696 MAPE-YGREGQVSTNGDVYSFGIMLME 721
           + PE       ++   D +SFG  L E
Sbjct: 184 VPPECIENPKNLNLATDKWSFGTTLWE 210

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/195 (23%), Positives = 78/195 (40%), Gaps = 9/195 (4%)
Query: 527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNL 585
           D +  +  +G G FG V++   R  G   A K          ++   E   M  +RH  L
Sbjct: 51  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 110
Query: 586 VKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYS 645
           V +  +  ++    ++ E+M  G L + +   +  +   + +  M  V   L ++H    
Sbjct: 111 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---E 167
Query: 646 APVIHCDLKPSNVLLDDNMVAHLS--DFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE 703
              +H DLKP N++        L   DFG+   L   D   +   T  T  + APE    
Sbjct: 168 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFAAPEVAEG 224
Query: 704 GQVSTNGDVYSFGIM 718
             V    D++S G++
Sbjct: 225 KPVGYYTDMWSVGVL 239

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 86/203 (42%), Gaps = 11/203 (5%)
Query: 533 NLIGRGGFGSVYKARIRDGMEV-AVKVFNLQCGRAFKSFDV----ECAMMKSIRHRNLVK 587
            +IGRG +  V   R++    + A++V   +     +  D     +    ++  H  LV 
Sbjct: 58  RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 117
Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAP 647
           + S    E     V+EY+  G L  ++       +   R     +++ AL YLH      
Sbjct: 118 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLH---ERG 173
Query: 648 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVS 707
           +I+ DLK  NVLLD      L+D+G+ K   G     T +    T  Y+APE  R     
Sbjct: 174 IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGEDYG 231
Query: 708 TNGDVYSFGIMLMETFTRKKPTD 730
            + D ++ G+++ E    + P D
Sbjct: 232 FSVDWWALGVLMFEMMAGRSPFD 254

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 88/207 (42%), Gaps = 11/207 (5%)
Query: 527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFD---VECAMMKSIRH 582
           ++F    L+G+G FG V   + +  G   A+K+   +   A         E  ++++ RH
Sbjct: 151 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 210
Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIM-IDVASALEYLH 641
             L  +  S    +    V+EY   G L  + H S   +    R      ++ SAL+YLH
Sbjct: 211 PFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALDYLH 268
Query: 642 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYG 701
                 V++ DLK  N++LD +    ++DFG+ K   G     T      T  Y+APE  
Sbjct: 269 --SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVL 324
Query: 702 REGQVSTNGDVYSFGIMLMETFTRKKP 728
            +       D +  G+++ E    + P
Sbjct: 325 EDNDYGRAVDWWGLGVVMYEMMCGRLP 351

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 73/150 (48%), Gaps = 9/150 (6%)
Query: 582 HRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLH 641
           H N+VK+     ++    LV+E +  G L + +    +  +  +   IM  + SA+ ++H
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSET-EASYIMRKLVSAVSHMH 123
Query: 642 FGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 698
                 V+H DLKP N+L    +DN+   + DFG A+L   ++Q +       T+ Y AP
Sbjct: 124 ---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL--KTPCFTLHYAAP 178
Query: 699 EYGREGQVSTNGDVYSFGIMLMETFTRKKP 728
           E   +     + D++S G++L    + + P
Sbjct: 179 ELLNQNGYDESCDLWSLGVILYTMLSGQVP 208

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 88/207 (42%), Gaps = 11/207 (5%)
Query: 527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFD---VECAMMKSIRH 582
           ++F    L+G+G FG V   + +  G   A+K+   +   A         E  ++++ RH
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIM-IDVASALEYLH 641
             L  +  S    +    V+EY   G L  + H S   +    R      ++ SAL+YLH
Sbjct: 208 PFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALDYLH 265
Query: 642 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYG 701
                 V++ DLK  N++LD +    ++DFG+ K   G     T      T  Y+APE  
Sbjct: 266 --SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVL 321
Query: 702 REGQVSTNGDVYSFGIMLMETFTRKKP 728
            +       D +  G+++ E    + P
Sbjct: 322 EDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 97/206 (47%), Gaps = 22/206 (10%)
Query: 521 ELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDV--ECAMM 577
           E++Q   K      +G G +G V   R +   +E A+K+          +  +  E A++
Sbjct: 37  EMYQRVKK------LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVL 90
Query: 578 KSIRHRNLVKVISSCSNEEFKALVLEYMPHGSL-EKYLHSSNYSLDIFQRLNIMIDVASA 636
           K + H N++K+     ++    LV+E    G L ++ +H   ++        I+  V S 
Sbjct: 91  KLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNE--VDAAVIIKQVLSG 148
Query: 637 LEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATI 693
           + YLH      ++H DLKP N+LL   + + +  + DFG++ +   + +     + L T 
Sbjct: 149 VTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK---MKERLGTA 202
Query: 694 GYMAPEYGREGQVSTNGDVYSFGIML 719
            Y+APE  R+ +     DV+S G++L
Sbjct: 203 YYIAPEVLRK-KYDEKCDVWSIGVIL 227

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 41/217 (18%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRDG-MEVAVKVFN---LQCGRAFKS-----FDVECAMM 577
           D++  +  +G G  G V  A  R    +VA+K+ +      G A ++      + E  ++
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 578 KSIRHRNLVKVISSCSNEEFKALVLEYMPHGSL------EKYLHSSNYSLDIFQRLNIMI 631
           K + H  ++K+ +    E++  +VLE M  G L       K L  +   L  +Q L    
Sbjct: 70  KKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML---- 124
Query: 632 DVASALEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTGEDQSMTQTQ 688
               A++YLH      +IH DLKP NVLL   +++ +  ++DFG +K+L GE   M   +
Sbjct: 125 ---LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLM---R 174
Query: 689 TL-ATIGYMAPEYGREGQVSTNG-----DVYSFGIML 719
           TL  T  Y+APE      V T G     D +S G++L
Sbjct: 175 TLCGTPTYLAPEVL--VSVGTAGYNRAVDCWSLGVIL 209

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 102/229 (44%), Gaps = 35/229 (15%)
Query: 566 AFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKY-----LHSSNYS 620
            +  F  E  ++  I++   +      +N +   ++ EYM + S+ K+     +   NY+
Sbjct: 86  KYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYT 145
Query: 621 LDI-FQRLNIMID-VASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 678
             I  Q +  +I  V ++  Y+H      + H D+KPSN+L+D N    LSDFG ++ + 
Sbjct: 146 CFIPIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV 203
Query: 679 GEDQSMTQTQTLATIGYMAPEYGREGQVSTNG---DVYSFGIMLMETFTRKKPTD----- 730
             D+ +  ++   T  +M PE+    + S NG   D++S GI L   F    P       
Sbjct: 204 --DKKIKGSR--GTYEFMPPEFF-SNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL 258
Query: 731 -ELFNGEMT--------LKHWVNDCLPISTME-VVDANLLSQEDIHFVA 769
            ELFN   T          H++    P++  +     N LS EDI F+ 
Sbjct: 259 VELFNNIRTKNIEYPLDRNHFL---YPLTNKKSTCSNNFLSNEDIDFLK 304

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 88/207 (42%), Gaps = 11/207 (5%)
Query: 527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFD---VECAMMKSIRH 582
           ++F    L+G+G FG V   + +  G   A+K+   +   A         E  ++++ RH
Sbjct: 8   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 67
Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIM-IDVASALEYLH 641
             L  +  S    +    V+EY   G L  + H S   +    R      ++ SAL+YLH
Sbjct: 68  PFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALDYLH 125
Query: 642 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYG 701
                 V++ DLK  N++LD +    ++DFG+ K   G     T      T  Y+APE  
Sbjct: 126 --SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEYLAPEVL 181
Query: 702 REGQVSTNGDVYSFGIMLMETFTRKKP 728
            +       D +  G+++ E    + P
Sbjct: 182 EDNDYGRAVDWWGLGVVMYEMMCGRLP 208

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 41/217 (18%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRDG-MEVAVKVFN---LQCGRAFKS-----FDVECAMM 577
           D++  +  +G G  G V  A  R    +VA+K+ +      G A ++      + E  ++
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 578 KSIRHRNLVKVISSCSNEEFKALVLEYMPHGSL------EKYLHSSNYSLDIFQRLNIMI 631
           K + H  ++K+ +    E++  +VLE M  G L       K L  +   L  +Q L    
Sbjct: 70  KKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML---- 124
Query: 632 DVASALEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTGEDQSMTQTQ 688
               A++YLH      +IH DLKP NVLL   +++ +  ++DFG +K+L GE   M   +
Sbjct: 125 ---LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLM---R 174
Query: 689 TL-ATIGYMAPEYGREGQVSTNG-----DVYSFGIML 719
           TL  T  Y+APE      V T G     D +S G++L
Sbjct: 175 TLCGTPTYLAPEVL--VSVGTAGYNRAVDCWSLGVIL 209

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 90/211 (42%), Gaps = 26/211 (12%)
Query: 520 LELFQATDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKS 579
           L +   +D++     IG G FG     R +   E+    +  +  +  ++   E    +S
Sbjct: 12  LPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRS 71
Query: 580 IRHRNLVKVISSCSNEEFKALVLEYMPHGSL-EKYLHSSNYSLD----IFQRLNIMIDVA 634
           +RH N+V+           A+V+EY   G L E+  ++  +S D     FQ+L       
Sbjct: 72  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL------I 125
Query: 635 SALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLS--DFGIAKLLTGEDQSMTQTQTLAT 692
           S + Y H   +  V H DLK  N LLD +    L    FG +K      Q      T+ T
Sbjct: 126 SGVSYCH---AMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQP---KDTVGT 179
Query: 693 IGYMAPEY----GREGQVSTNGDVYSFGIML 719
             Y+APE       +G+V+   DV+S G+ L
Sbjct: 180 PAYIAPEVLLKKEYDGKVA---DVWSCGVTL 207

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 41/217 (18%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRDG-MEVAVKVFN---LQCGRAFKS-----FDVECAMM 577
           D++  +  +G G  G V  A  R    +VA+K+ +      G A ++      + E  ++
Sbjct: 9   DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 68
Query: 578 KSIRHRNLVKVISSCSNEEFKALVLEYMPHGSL------EKYLHSSNYSLDIFQRLNIMI 631
           K + H  ++K+ +    E++  +VLE M  G L       K L  +   L  +Q L    
Sbjct: 69  KKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML---- 123
Query: 632 DVASALEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTGEDQSMTQTQ 688
               A++YLH      +IH DLKP NVLL   +++ +  ++DFG +K+L GE   M   +
Sbjct: 124 ---LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLM---R 173
Query: 689 TL-ATIGYMAPEYGREGQVSTNG-----DVYSFGIML 719
           TL  T  Y+APE      V T G     D +S G++L
Sbjct: 174 TLCGTPTYLAPEVL--VSVGTAGYNRAVDCWSLGVIL 208

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 85/187 (45%), Gaps = 30/187 (16%)
Query: 565 RAFKSFDVECAMMKSIRHRNLVKVIS----SCSNEEFKA--LVLEYMPHG---SLEKYLH 615
           RA++    E  +MK + H+N++ +++      S EEF+   +V+E M       ++  L 
Sbjct: 63  RAYR----ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELD 118
Query: 616 SSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 675
               S  ++Q L         +++LH   SA +IH DLKPSN+++  +    + DFG+A+
Sbjct: 119 HERMSYLLYQML-------CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 168
Query: 676 LLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNG 735
                  S   T  + T  Y APE         N D++S G ++ E    K     LF G
Sbjct: 169 ---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKI----LFPG 221
Query: 736 EMTLKHW 742
              +  W
Sbjct: 222 RDYIDQW 228

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 41/217 (18%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRDG-MEVAVKVFN---LQCGRAFKS-----FDVECAMM 577
           D++  +  +G G  G V  A  R    +VA+K+ +      G A ++      + E  ++
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 578 KSIRHRNLVKVISSCSNEEFKALVLEYMPHGSL------EKYLHSSNYSLDIFQRLNIMI 631
           K + H  ++K+ +    E++  +VLE M  G L       K L  +   L  +Q L    
Sbjct: 70  KKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML---- 124
Query: 632 DVASALEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTGEDQSMTQTQ 688
               A++YLH      +IH DLKP NVLL   +++ +  ++DFG +K+L GE   M   +
Sbjct: 125 ---LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLM---R 174
Query: 689 TL-ATIGYMAPEYGREGQVSTNG-----DVYSFGIML 719
           TL  T  Y+APE      V T G     D +S G++L
Sbjct: 175 TLCGTPTYLAPEVL--VSVGTAGYNRAVDCWSLGVIL 209

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 85/187 (45%), Gaps = 30/187 (16%)
Query: 565 RAFKSFDVECAMMKSIRHRNLVKVIS----SCSNEEFKA--LVLEYMPHG---SLEKYLH 615
           RA++    E  +MK + H+N++ +++      S EEF+   +V+E M       ++  L 
Sbjct: 74  RAYR----ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELD 129
Query: 616 SSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 675
               S  ++Q L         +++LH   SA +IH DLKPSN+++  +    + DFG+A+
Sbjct: 130 HERMSYLLYQML-------CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 179
Query: 676 LLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNG 735
                  S   T  + T  Y APE         N D++S G ++ E    K     LF G
Sbjct: 180 ---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKI----LFPG 232
Query: 736 EMTLKHW 742
              +  W
Sbjct: 233 RDYIDQW 239

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 41/217 (18%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRDG-MEVAVKVFN---LQCGRAFKS-----FDVECAMM 577
           D++  +  +G G  G V  A  R    +VA+K+ +      G A ++      + E  ++
Sbjct: 16  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 75
Query: 578 KSIRHRNLVKVISSCSNEEFKALVLEYMPHGSL------EKYLHSSNYSLDIFQRLNIMI 631
           K + H  ++K+ +    E++  +VLE M  G L       K L  +   L  +Q L    
Sbjct: 76  KKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML---- 130
Query: 632 DVASALEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTGEDQSMTQTQ 688
               A++YLH      +IH DLKP NVLL   +++ +  ++DFG +K+L GE   M   +
Sbjct: 131 ---LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLM---R 180
Query: 689 TL-ATIGYMAPEYGREGQVSTNG-----DVYSFGIML 719
           TL  T  Y+APE      V T G     D +S G++L
Sbjct: 181 TLCGTPTYLAPEVLV--SVGTAGYNRAVDCWSLGVIL 215

>pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 96/354 (27%), Positives = 150/354 (42%), Gaps = 58/354 (16%)
Query: 24  KVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLSG 83
           +V  L  +RL  + I  + +L+NL  ++ S N+L    P  + N++ L    + NN ++ 
Sbjct: 42  QVTTLQADRLGIKSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA- 98
Query: 84  CLSSITDVG-LPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLR 142
               IT +  L NL  L L+ N  +   P  + N + L++L L  N+ S    S    L 
Sbjct: 99  ---DITPLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDI--SALSGLT 151
Query: 143 NLEWLTLYXXXXXXXXXXXXXXXXXXXCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNF 202
           +L+ L                        +L  + +S+N +  I   + +  L++ L++ 
Sbjct: 152 SLQQLNF--------GNQVTDLKPLANLTTLERLDISSNKVSDI---SVLAKLTN-LESL 199
Query: 203 YMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIP 262
              N  +S   P  I  LT+L  + L GN+L      TL  L  L D+DL  NQ+    P
Sbjct: 200 IATNNQISDITPLGI--LTNLDELSLNGNQLKDIG--TLASLTNLTDLDLANNQISNLAP 255
Query: 263 DSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLN 322
            S     +L EL+LG N++S   P              G   LT++ LN   L+DI    
Sbjct: 256 LSGL--TKLTELKLGANQISNISPLA------------GLTALTNLELNENQLEDI---- 297
Query: 323 LSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRL 376
                   P    I NLK L  +    NN S I P  + SL  L+ LF   N++
Sbjct: 298 -------SP----ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKV 338

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 88/207 (42%), Gaps = 11/207 (5%)
Query: 527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFD---VECAMMKSIRH 582
           ++F    L+G+G FG V   + +  G   A+K+   +   A         E  ++++ RH
Sbjct: 9   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 68
Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIM-IDVASALEYLH 641
             L  +  S    +    V+EY   G L  + H S   +    R      ++ SAL+YLH
Sbjct: 69  PFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALDYLH 126
Query: 642 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYG 701
                 V++ DLK  N++LD +    ++DFG+ K   G     T      T  Y+APE  
Sbjct: 127 --SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEYLAPEVL 182
Query: 702 REGQVSTNGDVYSFGIMLMETFTRKKP 728
            +       D +  G+++ E    + P
Sbjct: 183 EDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 91/215 (42%), Gaps = 18/215 (8%)
Query: 534 LIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSI------RHRNLVK 587
           ++G+G FG V  +  R G +    V  L+     +  DVEC M++        +   L +
Sbjct: 348 VLGKGSFGKVMLSE-RKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 406
Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAP 647
           + S     +    V+EY+  G L  ++      +  F+  + +   A     L F  S  
Sbjct: 407 LHSCFQTMDRLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSKG 462
Query: 648 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVS 707
           +I+ DLK  NV+LD      ++DFG+ K    +   +T      T  Y+APE        
Sbjct: 463 IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD--GVTTKXFCGTPDYIAPEIIAYQPYG 520
Query: 708 TNGDVYSFGIMLMETFTRKKP-----TDELFNGEM 737
            + D ++FG++L E    + P      DELF   M
Sbjct: 521 KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 555

>pdb|3V47|A Chain A, Crystal Structure Of The N-Tetminal Fragment Of Zebrafish Tlr5 In Complex With Salmonella Flagellin Length = 455

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/113 (33%), Positives = 56/113 (49%), Gaps = 2/113 (1%)
Query: 275 ELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLN-FWSLKDILDLNLSSNCFSGPLP 333
           +L  +K+   + + FS+ T L+ L+L  NE+  I  N FW L  +L LNLS N       
Sbjct: 281 DLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDS 340
Query: 334 LEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGD 386
               NL  L  +D S N+   +       L NL+ L L+ N+L+ S+PD   D
Sbjct: 341 RMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLK-SVPDGIFD 392

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 99/199 (49%), Gaps = 37/199 (18%)
Query: 496 QKREKGPPNDP--NMP-PVATWRRFSYLELFQATDKFSENNLIGRGGFGSVYKARIRDGM 552
           Q+R++   + P  +MP P + W         Q  D++   +LIG G +G V +A   D +
Sbjct: 28  QQRKQHHSSKPTASMPRPHSDW---------QIPDRYEIRHLIGTGSYGHVCEAY--DKL 76
Query: 553 E---VAVK----VFN--LQCGRAFKSFDVECAMMKSIRHRNLVKVIS---SCSNEEFKAL 600
           E   VA+K    VF   + C R  +    E A++  + H ++VKV+        E+F  L
Sbjct: 77  EKRVVAIKKILRVFEDLIDCKRILR----EIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132
Query: 601 --VLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNV 658
             VLE +     +K   +  Y  ++  +  ++ ++   ++Y+H   SA ++H DLKP+N 
Sbjct: 133 YVVLE-IADSDFKKLFRTPVYLTELHIK-TLLYNLLVGVKYVH---SAGILHRDLKPANC 187
Query: 659 LLDDNMVAHLSDFGIAKLL 677
           L++ +    + DFG+A+ +
Sbjct: 188 LVNQDCSVKVCDFGLARTV 206

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 19/203 (9%)
Query: 526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDV---ECAMMKSIR 581
           +D++     +G G +G V   + +  G E A+K+          +      E A++K + 
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 62
Query: 582 HRNLVKVISSCSNEEFKALVLEYMPHGSL--EKYLHSSNYSLDIFQRLNIMIDVASALEY 639
           H N++K+     ++    LV+E    G L  E  L      +D      IM  V S   Y
Sbjct: 63  HPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDA---AVIMKQVLSGTTY 119
Query: 640 LHFGYSAPVIHCDLKPSNVLLDD---NMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYM 696
           LH      ++H DLKP N+LL+    + +  + DFG++      +      + L T  Y+
Sbjct: 120 LH---KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHF---EVGGKMKERLGTAYYI 173
Query: 697 APEYGREGQVSTNGDVYSFGIML 719
           APE  R+ +     DV+S G++L
Sbjct: 174 APEVLRK-KYDEKCDVWSCGVIL 195

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 89/215 (41%), Gaps = 33/215 (15%)
Query: 533 NLIGRGGFGSVYKARIRDGMEV-AVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISS 591
            +IGRG FG V   ++++   + A+K+ N       K  +  C      R    V V   
Sbjct: 80  KVIGRGAFGEVAVVKMKNTERIYAMKILNKW--EMLKRAETAC-----FREERDVLVNGD 132
Query: 592 CS----------NEEFKALVLEYMPHGSLEKYLHSSNYSL-DIFQRLNI--MIDVASALE 638
           C           +E    LV++Y   G L   L      L +   R  I  M+    ++ 
Sbjct: 133 CQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIH 192
Query: 639 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 698
            LH+      +H D+KP NVLLD N    L+DFG + L   +D ++  +  + T  Y++P
Sbjct: 193 QLHY------VHRDIKPDNVLLDVNGHIRLADFG-SCLKMNDDGTVQSSVAVGTPDYISP 245
Query: 699 EYGRE-----GQVSTNGDVYSFGIMLMETFTRKKP 728
           E  +      G+     D +S G+ + E    + P
Sbjct: 246 EILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 280

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 89/215 (41%), Gaps = 33/215 (15%)
Query: 533 NLIGRGGFGSVYKARIRDGMEV-AVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISS 591
            +IGRG FG V   ++++   + A+K+ N       K  +  C      R    V V   
Sbjct: 96  KVIGRGAFGEVAVVKMKNTERIYAMKILNKW--EMLKRAETAC-----FREERDVLVNGD 148
Query: 592 CS----------NEEFKALVLEYMPHGSLEKYLHSSNYSL-DIFQRLNI--MIDVASALE 638
           C           +E    LV++Y   G L   L      L +   R  I  M+    ++ 
Sbjct: 149 CQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIH 208
Query: 639 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 698
            LH+      +H D+KP NVLLD N    L+DFG + L   +D ++  +  + T  Y++P
Sbjct: 209 QLHY------VHRDIKPDNVLLDVNGHIRLADFG-SCLKMNDDGTVQSSVAVGTPDYISP 261
Query: 699 EYGRE-----GQVSTNGDVYSFGIMLMETFTRKKP 728
           E  +      G+     D +S G+ + E    + P
Sbjct: 262 EILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 296

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 103/218 (47%), Gaps = 41/218 (18%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRDGME-VAVKVFN---LQCGRAFKS-----FDVECAMM 577
           D++  +  +G G  G V  A  R   + VA+++ +      G A ++      + E  ++
Sbjct: 149 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 208
Query: 578 KSIRHRNLVKVISSCSNEEFKALVLEYMPHGSL------EKYLHSSNYSLDIFQRLNIMI 631
           K + H  ++K+ +    E++  +VLE M  G L       K L  +   L  +Q L    
Sbjct: 209 KKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML---- 263
Query: 632 DVASALEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTGEDQSMTQTQ 688
               A++YLH      +IH DLKP NVLL   +++ +  ++DFG +K+L GE   M   +
Sbjct: 264 ---LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLM---R 313
Query: 689 TL-ATIGYMAPEYGREGQVSTNG-----DVYSFGIMLM 720
           TL  T  Y+APE      V T G     D +S G++L 
Sbjct: 314 TLCGTPTYLAPEVL--VSVGTAGYNRAVDCWSLGVILF 349

>pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 80/176 (45%), Gaps = 8/176 (4%)
Query: 260 SIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLN-FWSLKDI 318
           +IP +I    +  +L+L  NKLS      F  +T L++L L  N+L ++P   F  LK++
Sbjct: 30  AIPSNI--PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNL 87
Query: 319 LDLNLSSNCFSGPLPLEI-RNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLE 377
             L ++ N     LP+ +   L  L E+    N    + P    SL  L  L L YN L+
Sbjct: 88  ETLWVTDNKLQA-LPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ 146
Query: 378 GSIPDSFGDLIXXXXXXXXXXXXXGTIPV-SLEKLSYLKDLNLSFNKLKGEIPRGG 432
            S+P    D +               +P  + +KL+ LK L L  N+LK  +P G 
Sbjct: 147 -SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVPEGA 200

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 87/187 (46%), Gaps = 30/187 (16%)
Query: 565 RAFKSFDVECAMMKSIRHRNLVKVIS----SCSNEEFKA--LVLEYMPHG---SLEKYLH 615
           RA++    E  +MK + H+N++ +++      S EEF+   +V+E M       ++  L 
Sbjct: 69  RAYR----ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELD 124
Query: 616 SSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 675
               S  ++Q L         +++LH   SA +IH DLKPSN+++  +    + DFG+A+
Sbjct: 125 HERMSYLLYQML-------CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174
Query: 676 LLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNG 735
             T     M + + + T  Y APE         N D++S G ++ E    K     LF G
Sbjct: 175 --TAGTSFMMEPEVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVCHKI----LFPG 227
Query: 736 EMTLKHW 742
              +  W
Sbjct: 228 RDYIDQW 234

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 103/218 (47%), Gaps = 41/218 (18%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRDGME-VAVKVFN---LQCGRAFKS-----FDVECAMM 577
           D++  +  +G G  G V  A  R   + VA+++ +      G A ++      + E  ++
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 578 KSIRHRNLVKVISSCSNEEFKALVLEYMPHGSL------EKYLHSSNYSLDIFQRLNIMI 631
           K + H  ++K+ +    E++  +VLE M  G L       K L  +   L  +Q L    
Sbjct: 195 KKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML---- 249
Query: 632 DVASALEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTGEDQSMTQTQ 688
               A++YLH      +IH DLKP NVLL   +++ +  ++DFG +K+L GE   M   +
Sbjct: 250 ---LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLM---R 299
Query: 689 TL-ATIGYMAPEYGREGQVSTNG-----DVYSFGIMLM 720
           TL  T  Y+APE      V T G     D +S G++L 
Sbjct: 300 TLCGTPTYLAPEVL--VSVGTAGYNRAVDCWSLGVILF 335

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 81/166 (48%), Gaps = 20/166 (12%)
Query: 562 QCGRAFKSFDVECAMMKSIRHRNLVKVIS----SCSNEEFKA--LVLEYMPHGSLEKYLH 615
              RA++    E  +MK + H+N++ +++      S EEF+   +V+E M   +L + + 
Sbjct: 66  HAKRAYR----ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQ 120
Query: 616 SSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 675
                LD  +   ++  +   +++LH   SA +IH DLKPSN+++  +    + DFG+A+
Sbjct: 121 ---MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLAR 174
Query: 676 LLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLME 721
                  S   T  + T  Y APE         N D++S G ++ E
Sbjct: 175 ---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 81/166 (48%), Gaps = 20/166 (12%)
Query: 562 QCGRAFKSFDVECAMMKSIRHRNLVKVIS----SCSNEEFKA--LVLEYMPHGSLEKYLH 615
              RA++    E  +MK + H+N++ +++      S EEF+   +V+E M   +L + + 
Sbjct: 66  HAKRAYR----ELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQ 120
Query: 616 SSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 675
                LD  +   ++  +   +++LH   SA +IH DLKPSN+++  +    + DFG+A+
Sbjct: 121 ---MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLAR 174
Query: 676 LLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLME 721
                  S   T  + T  Y APE         N D++S G ++ E
Sbjct: 175 ---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 88/203 (43%), Gaps = 18/203 (8%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQC------GRAFKSFDVECAMMKS 579
           D +     +G G F  V K R +  G++ A K    +       G + +  + E +++K 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 580 IRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEY 639
           I+H N++ +     N+    L+ E +  G L  +L +   SL   +    +  + + + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILIGELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYY 129
Query: 640 LHFGYSAPVIHCDLKPSNVLLDDNMVA----HLSDFGIAKLLTGEDQSMTQTQTLATIGY 695
           LH   S  + H DLKP N++L D  V      + DFG+A  +   D          T  +
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEF 183
Query: 696 MAPEYGREGQVSTNGDVYSFGIM 718
           +APE      +    D++S G++
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVI 206

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 81/166 (48%), Gaps = 20/166 (12%)
Query: 562 QCGRAFKSFDVECAMMKSIRHRNLVKVIS----SCSNEEFKA--LVLEYMPHGSLEKYLH 615
              RA++    E  +MK + H+N++ +++      S EEF+   +V+E M   +L + + 
Sbjct: 66  HAKRAYR----ELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQ 120
Query: 616 SSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 675
                LD  +   ++  +   +++LH   SA +IH DLKPSN+++  +    + DFG+A+
Sbjct: 121 ---MELDHERMSYLLYQMLVGIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLAR 174
Query: 676 LLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLME 721
                  S   T  + T  Y APE         N D++S G ++ E
Sbjct: 175 ---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 81/166 (48%), Gaps = 20/166 (12%)
Query: 562 QCGRAFKSFDVECAMMKSIRHRNLVKVIS----SCSNEEFKA--LVLEYMPHGSLEKYLH 615
              RA++    E  +MK + H+N++ +++      S EEF+   +V+E M   +L + + 
Sbjct: 66  HAKRAYR----ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQ 120
Query: 616 SSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 675
                LD  +   ++  +   +++LH   SA +IH DLKPSN+++  +    + DFG+A+
Sbjct: 121 ---MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174
Query: 676 LLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLME 721
                  S   T  + T  Y APE         N D++S G ++ E
Sbjct: 175 ---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 97/209 (46%), Gaps = 21/209 (10%)
Query: 533 NLIGRGGFGSVYKARIRDGMEV-AVKVFNL--QCGRAFKS-FDVECAMMKSIRHRNLVKV 588
            +IGRG FG V   ++++  +V A+K+ N      RA  + F  E  ++ +   + +  +
Sbjct: 80  KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL 139
Query: 589 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSL-DIFQRLNI--MIDVASALEYLHFGYS 645
             +  ++    LV++Y   G L   L      L +   R  +  M+    ++  LH+   
Sbjct: 140 HYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHY--- 196
Query: 646 APVIHCDLKPSNVLLDDNMVAHLSDFGIA-KLLTGEDQSMTQTQTLATIGYMAPEY---- 700
              +H D+KP N+L+D N    L+DFG   KL+  ED ++  +  + T  Y++PE     
Sbjct: 197 ---VHRDIKPDNILMDMNGHIRLADFGSCLKLM--EDGTVQSSVAVGTPDYISPEILQAM 251
Query: 701 -GREGQVSTNGDVYSFGIMLMETFTRKKP 728
            G +G+     D +S G+ + E    + P
Sbjct: 252 EGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 94/206 (45%), Gaps = 25/206 (12%)
Query: 532 NNLIGRGGFGSVYKA-RIRDGMEVAVKVFNLQCG----RAFKSFDVECAMMKSIRHRNLV 586
           + L+G G +  V  A  +++G E AVK+   Q G    R F+  +    + +   ++N++
Sbjct: 18  SELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVET---LYQCQGNKNIL 74
Query: 587 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSA 646
           ++I    ++    LV E +  GS+  ++    +  +  +   ++ DVA+AL++LH   + 
Sbjct: 75  ELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKH-FNEREASRVVRDVAAALDFLH---TK 130
Query: 647 PVIHCDLKPSNVLLDD-NMVAHLS----DFGIAKLLTGEDQSMTQTQTLATIG---YMAP 698
            + H DLKP N+L +    V+ +     D G    L      +T  +     G   YMAP
Sbjct: 131 GIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAP 190
Query: 699 EY-----GREGQVSTNGDVYSFGIML 719
           E       +        D++S G++L
Sbjct: 191 EVVEVFTDQATFYDKRCDLWSLGVVL 216

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 93/236 (39%), Gaps = 36/236 (15%)
Query: 521 ELFQATDKFSENNLIGRGGFGSVYKARIRDGMEVAVK-VFN--------------LQCGR 565
           EL      ++    I  G +G+V      +G+ VA+K VFN                C R
Sbjct: 16  ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75
Query: 566 AFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKA-----LVLEYMPHGSLEKYLHSSNYS 620
             +    E  ++    H N++ +     + E  A     LV E M    L + +H     
Sbjct: 76  VLR----EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIV 130
Query: 621 LDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE 680
           +        M  +   L  LH    A V+H DL P N+LL DN    + DF +A+  T +
Sbjct: 131 ISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTAD 187
Query: 681 DQSMTQTQTLATIGYMAPEYGREGQVSTN-GDVYSFGIMLMETFTRKKPTDELFNG 735
                +T  +    Y APE   + +  T   D++S G ++ E F RK     LF G
Sbjct: 188 ---ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKA----LFRG 236

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 93/236 (39%), Gaps = 36/236 (15%)
Query: 521 ELFQATDKFSENNLIGRGGFGSVYKARIRDGMEVAVK-VFN--------------LQCGR 565
           EL      ++    I  G +G+V      +G+ VA+K VFN                C R
Sbjct: 16  ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75
Query: 566 AFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKA-----LVLEYMPHGSLEKYLHSSNYS 620
             +    E  ++    H N++ +     + E  A     LV E M    L + +H     
Sbjct: 76  VLR----EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIV 130
Query: 621 LDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE 680
           +        M  +   L  LH    A V+H DL P N+LL DN    + DF +A+  T +
Sbjct: 131 ISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTAD 187
Query: 681 DQSMTQTQTLATIGYMAPEYGREGQVSTN-GDVYSFGIMLMETFTRKKPTDELFNG 735
                +T  +    Y APE   + +  T   D++S G ++ E F RK     LF G
Sbjct: 188 ---ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKA----LFRG 236

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 79/166 (47%), Gaps = 26/166 (15%)
Query: 565 RAFKSFDVECAMMKSIRHRNLVKVIS----SCSNEEFKA--LVLEYMPHG---SLEKYLH 615
           RA++    E  +MK + H+N++ +++      S EEF+   +V+E M       ++  L 
Sbjct: 69  RAYR----ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELD 124
Query: 616 SSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 675
               S  ++Q L         +++LH   SA +IH DLKPSN+++  +    + DFG+A+
Sbjct: 125 HERMSYLLYQML-------CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174
Query: 676 LLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLME 721
                  S   T  + T  Y APE         N D++S G ++ E
Sbjct: 175 ---TAGTSFMMTPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 87/187 (46%), Gaps = 30/187 (16%)
Query: 565 RAFKSFDVECAMMKSIRHRNLVKVIS----SCSNEEFKA--LVLEYMPHG---SLEKYLH 615
           RA++    E  +MK + H+N++ +++      S EEF+   +V+E M       ++  L 
Sbjct: 69  RAYR----ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELD 124
Query: 616 SSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 675
               S  ++Q L         +++LH   SA +IH DLKPSN+++  +    + DFG+A+
Sbjct: 125 HERMSYLLYQML-------CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174
Query: 676 LLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNG 735
             T     M + + + T  Y APE         N D++S G ++ E    K     LF G
Sbjct: 175 --TAGTSFMMEPEVV-TRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKI----LFPG 227
Query: 736 EMTLKHW 742
              +  W
Sbjct: 228 RDYIDQW 234

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/240 (22%), Positives = 104/240 (43%), Gaps = 33/240 (13%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRD-GMEVAVKV-----FNLQCGRAFKSFDVECAMMKSI 580
           D +    +IG+G F  V +   R+ G + AVK+     F    G + +    E ++   +
Sbjct: 26  DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 85
Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASA---- 636
           +H ++V+++ + S++    +V E+M           ++   +I +R +     + A    
Sbjct: 86  KHPHIVELLETYSSDGMLYMVFEFM---------DGADLCFEIVKRADAGFVYSEAVASH 136
Query: 637 -----LEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTGEDQSMTQTQ 688
                LE L + +   +IH D+KP  VLL   +++    L  FG+A  L   +  +    
Sbjct: 137 YMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG--ESGLVAGG 194
Query: 689 TLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKP----TDELFNGEMTLKHWVN 744
            + T  +MAPE  +        DV+  G++L    +   P     + LF G +  K+ +N
Sbjct: 195 RVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMN 254

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/240 (22%), Positives = 104/240 (43%), Gaps = 33/240 (13%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRD-GMEVAVKV-----FNLQCGRAFKSFDVECAMMKSI 580
           D +    +IG+G F  V +   R+ G + AVK+     F    G + +    E ++   +
Sbjct: 24  DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASA---- 636
           +H ++V+++ + S++    +V E+M           ++   +I +R +     + A    
Sbjct: 84  KHPHIVELLETYSSDGMLYMVFEFM---------DGADLCFEIVKRADAGFVYSEAVASH 134
Query: 637 -----LEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTGEDQSMTQTQ 688
                LE L + +   +IH D+KP  VLL   +++    L  FG+A  L   +  +    
Sbjct: 135 YMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG--ESGLVAGG 192
Query: 689 TLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKP----TDELFNGEMTLKHWVN 744
            + T  +MAPE  +        DV+  G++L    +   P     + LF G +  K+ +N
Sbjct: 193 RVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMN 252

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 80/179 (44%), Gaps = 12/179 (6%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFN----LQCGRAFKSFDVECAMMKSIR 581
           D F    +IGRG F  V   +++  G   A+K+ N    L+ G     F  E  ++ +  
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEV-SCFREERDVLVNGD 119
Query: 582 HRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLH 641
            R + ++  +  +E +  LV+EY   G L   L      +        + ++  A++ +H
Sbjct: 120 RRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH 179
Query: 642 -FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPE 699
             GY    +H D+KP N+LLD      L+DFG    L   D ++     + T  Y++PE
Sbjct: 180 RLGY----VHRDIKPDNILLDRCGHIRLADFGSCLKLRA-DGTVRSLVAVGTPDYLSPE 233

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 84/187 (44%), Gaps = 30/187 (16%)
Query: 565 RAFKSFDVECAMMKSIRHRNLVKVIS----SCSNEEFKA--LVLEYMPHG---SLEKYLH 615
           RA++    E  +MK + H+N++ +++      S EEF+   +V+E M       ++  L 
Sbjct: 70  RAYR----ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELD 125
Query: 616 SSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 675
               S  ++Q L         +++LH   SA +IH DLKPSN+++  +    + DFG+A+
Sbjct: 126 HERMSYLLYQML-------CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 175
Query: 676 LLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNG 735
                  S   T  + T  Y APE         N D++S G ++ E          LF G
Sbjct: 176 ---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIK----GGVLFPG 228
Query: 736 EMTLKHW 742
              +  W
Sbjct: 229 TDHIDQW 235

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 84/187 (44%), Gaps = 30/187 (16%)
Query: 565 RAFKSFDVECAMMKSIRHRNLVKVIS----SCSNEEFKA--LVLEYMPHG---SLEKYLH 615
           RA++    E  +MK + H+N++ +++      S EEF+   +V+E M       ++  L 
Sbjct: 69  RAYR----ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELD 124
Query: 616 SSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 675
               S  ++Q L         +++LH   SA +IH DLKPSN+++  +    + DFG+A+
Sbjct: 125 HERMSYLLYQML-------CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174
Query: 676 LLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNG 735
                  S   T  + T  Y APE         N D++S G ++ E          LF G
Sbjct: 175 ---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIK----GGVLFPG 227
Query: 736 EMTLKHW 742
              +  W
Sbjct: 228 TDHIDQW 234

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 79/169 (46%), Gaps = 26/169 (15%)
Query: 562 QCGRAFKSFDVECAMMKSIRHRNLVKVIS----SCSNEEFKA--LVLEYMPHG---SLEK 612
              RA++    E  +MK + H+N++ +++      S EEF+   +V+E M       ++ 
Sbjct: 66  HAKRAYR----ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM 121
Query: 613 YLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFG 672
            L     S  ++Q L         +++LH   SA +IH DLKPSN+++  +    + DFG
Sbjct: 122 ELDHERMSYLLYQML-------CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFG 171
Query: 673 IAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLME 721
           +A+       S   T  + T  Y APE         N D++S G ++ E
Sbjct: 172 LAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 102/237 (43%), Gaps = 28/237 (11%)
Query: 523 FQATDKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDVECAMMKSIR 581
           F    ++ +   +G GG G V+ A   D    VA+K   L   ++ K    E  +++ + 
Sbjct: 7   FDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLD 66
Query: 582 HRNLVKV--------------ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRL 627
           H N+VKV              + S +      +V EYM    L   L      L+   RL
Sbjct: 67  HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQGPL-LEEHARL 124
Query: 628 NIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTGEDQSMTQ 686
             M  +   L+Y+H   SA V+H DLKP+N+ ++ +++V  + DFG+A+++         
Sbjct: 125 -FMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGH 180
Query: 687 -TQTLATIGYMAPEYGREGQVSTNG-DVYSFGIMLMETFTRKKPTDELFNGEMTLKH 741
            ++ L T  Y +P         T   D+++ G +  E  T K     LF G   L+ 
Sbjct: 181 LSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKT----LFAGAHELEQ 233

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 67/152 (44%), Gaps = 18/152 (11%)
Query: 628 NIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQT 687
            I + +  ALE+LH   S  VIH D+KPSNVL++        DFGI+  L  +   + + 
Sbjct: 140 KIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKXCDFGISGYLVDD---VAKD 194
Query: 688 QTLATIGYMAPEY-----GREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHW 742
                  Y APE       ++G  S   D++S GI  +E    + P D        LK  
Sbjct: 195 IDAGCKPYXAPERINPELNQKG-YSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQV 253
Query: 743 VNDCLPISTMEVVDANLLSQEDIHFVAKEQCV 774
           V +  P      + A+  S E + F +  QC+
Sbjct: 254 VEEPSP-----QLPADKFSAEFVDFTS--QCL 278

>pdb|3RFJ|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 279

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 76/170 (44%), Gaps = 12/170 (7%)
Query: 17  IDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFN-VSTLKAFA 75
           I  + N++ L L  N+L    I  +  L NL +L L+ N+L  ++P  +F+ ++ LK   
Sbjct: 59  IQYLPNVRYLALGGNKLHD--ISALKELTNLTYLILTGNQL-QSLPNGVFDKLTNLKELV 115
Query: 76  VTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNA-SKLSKLALEMNSFSGFI 134
           +  N L      + D  L NL  LYL+ N    ++P  +F+  + L++L L+ N      
Sbjct: 116 LVENQLQSLPDGVFD-KLTNLTYLYLYHNQLQ-SLPKGVFDKLTNLTRLDLDNNQLQSLP 173
Query: 135 PSTFGNLRNLEWLTLYXXXXXXXXXXXXXXXXXXXCKSLTHISLSNNPLD 184
              F  L  L+ L+L                      SLTHI L NNP D
Sbjct: 174 EGVFDKLTQLKQLSL-----NDNQLKSVPDGVFDRLTSLTHIWLLNNPWD 218

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 100/210 (47%), Gaps = 23/210 (10%)
Query: 527 DKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDVECAM-MKSIRHRN 584
           D+F    + G+G FG+V   + +  GM VA+K   +Q  R F++ +++    +  + H N
Sbjct: 23  DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV-IQDPR-FRNRELQIMQDLAVLHHPN 80
Query: 585 LVKVIS-------SCSNEEFKALVLEYMP---HGSLEKYLHSSNYSLDIFQRLNIMIDVA 634
           +V++ S           + +  +V+EY+P   H     Y         I  ++  +  + 
Sbjct: 81  IVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKV-FLFQLI 139
Query: 635 SALEYLHFGYSAPVIHCDLKPSNVLLDD-NMVAHLSDFGIAKLLTGEDQSMTQTQTLATI 693
            ++  LH   S  V H D+KP NVL+++ +    L DFG AK L+  + ++     + + 
Sbjct: 140 RSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVA---YICSR 195
Query: 694 GYMAPE--YGREGQVSTNGDVYSFGIMLME 721
            Y APE  +G +   +T  D++S G +  E
Sbjct: 196 YYRAPELIFGNQ-HYTTAVDIWSVGCIFAE 224

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 55/235 (23%), Positives = 110/235 (46%), Gaps = 26/235 (11%)
Query: 510 PVATWRRFSYLELFQATDKFSENNLIGRGGFGSVYKA-RIRDGMEVAVKVFNLQCGRAFK 568
           P   W   S++  +   D +     +GRG +  V++A  I +  +V VK+         K
Sbjct: 20  PREYWDYASHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKNKIK 79
Query: 569 SFDVECAMMKSIRH-RNLVKVISSCSN--EEFKALVLEYMPHGSLEK-YLHSSNYSLDIF 624
               E  +++++R   N++ +     +      ALV E++ +   ++ Y   ++Y +  +
Sbjct: 80  R---EIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFY 136
Query: 625 QRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLT-GEDQ 682
                M ++  AL+Y H   S  ++H D+KP NV++D ++    L D+G+A+    G++ 
Sbjct: 137 -----MYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY 188
Query: 683 SMTQTQTLATIGYMAPEYGREGQVSTNG-DVYSFGIMLMETFTRKKPTDELFNGE 736
           ++     +A+  +  PE   + Q+     D++S G ML     RK+P    F+G 
Sbjct: 189 NV----RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP---FFHGH 236

>pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 32/215 (14%)
Query: 524 QATDKFSENNLIGRGGFGSVY-KARIRDGMEVAVKVFNLQCGRA-FKSFDVECAMMKSIR 581
           +  +K+     IG G FG +Y  A I  G EVA+K   L+C +       +E    K ++
Sbjct: 6   RVGNKYRLGRKIGSGSFGDIYLGANIASGEEVAIK---LECVKTKHPQLHIESKFYKMMQ 62
Query: 582 HRNLVKVISSCSNE-EFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
               +  I  C  E ++  +V+E +   SLE   +  +    +   L +   + S +EY+
Sbjct: 63  GGVGIPSIKWCGAEGDYNVMVMELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 121
Query: 641 HFGYSAPVIHCDLKPSNVLL----DDNMVAHLSDFGIAKLLTG----------EDQSMTQ 686
           H   S   IH D+KP N L+      N+V ++ DFG+AK              E++++T 
Sbjct: 122 H---SKNFIHRDVKPDNFLMGLGKKGNLV-YIIDFGLAKKYRDARTHQHIPYRENKNLTG 177
Query: 687 TQTLATIG-YMAPEYGREGQVSTNGDVYSFGIMLM 720
           T   A+I  ++  E  R        D+ S G +LM
Sbjct: 178 TARYASINTHLGIEQSRR------DDLESLGYVLM 206

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 49/95 (51%), Gaps = 9/95 (9%)
Query: 628 NIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD---NMVAHLSDFGIAKLLTGEDQSM 684
            IM  +  A++YLH   S  + H D+KP N+L      N +  L+DFG AK  T  +   
Sbjct: 119 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN--- 172
Query: 685 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIML 719
           + T+   T  Y+APE     +   + D++S G+++
Sbjct: 173 SLTEPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 207

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 83/187 (44%), Gaps = 30/187 (16%)
Query: 565 RAFKSFDVECAMMKSIRHRNLVKVIS----SCSNEEFKA--LVLEYMPHG---SLEKYLH 615
           RA++    E  +MK + H+N++ +++      S EEF+   +V+E M       ++  L 
Sbjct: 71  RAYR----ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELD 126
Query: 616 SSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 675
               S  ++Q L         +++LH   SA +IH DLKPSN+++  +    + DFG+A+
Sbjct: 127 HERMSYLLYQML-------CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 176
Query: 676 LLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNG 735
                  S      + T  Y APE         N D++S G ++ E          LF G
Sbjct: 177 TAG---TSFMMVPFVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIK----GGVLFPG 229
Query: 736 EMTLKHW 742
              +  W
Sbjct: 230 TDHIDQW 236

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 36/124 (29%), Positives = 63/124 (50%), Gaps = 11/124 (8%)
Query: 600 LVLEYMPHGSL-EKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNV 658
           +++E M  G L  +     + +    +   IM D+ +A+++LH   S  + H D+KP N+
Sbjct: 84  IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENL 140
Query: 659 LL---DDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSF 715
           L    + + V  L+DFG AK  T   Q+  QT    T  Y+APE     +   + D++S 
Sbjct: 141 LYTSKEKDAVLKLTDFGFAKETT---QNALQTPCY-TPYYVAPEVLGPEKYDKSCDMWSL 196
Query: 716 GIML 719
           G+++
Sbjct: 197 GVIM 200

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 36/124 (29%), Positives = 63/124 (50%), Gaps = 11/124 (8%)
Query: 600 LVLEYMPHGSL-EKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNV 658
           +++E M  G L  +     + +    +   IM D+ +A+++LH   S  + H D+KP N+
Sbjct: 103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENL 159
Query: 659 LL---DDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSF 715
           L    + + V  L+DFG AK  T   Q+  QT    T  Y+APE     +   + D++S 
Sbjct: 160 LYTSKEKDAVLKLTDFGFAKETT---QNALQTPCY-TPYYVAPEVLGPEKYDKSCDMWSL 215
Query: 716 GIML 719
           G+++
Sbjct: 216 GVIM 219

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 70/158 (44%), Gaps = 12/158 (7%)
Query: 532 NNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIR-HRNLVKVI 589
             ++  GGF  VY+A+ +  G E A+K          ++   E   MK +  H N+V+  
Sbjct: 33  RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92
Query: 590 SSCS--NEEFKA-----LVLEYMPHGSLEKYLH--SSNYSLDIFQRLNIMIDVASALEYL 640
           S+ S   EE        L+L  +  G L ++L    S   L     L I      A++++
Sbjct: 93  SAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHM 152
Query: 641 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 678
           H     P+IH DLK  N+LL +     L DFG A  ++
Sbjct: 153 HR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTIS 189

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 48/95 (50%), Gaps = 9/95 (9%)
Query: 628 NIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD---NMVAHLSDFGIAKLLTGEDQSM 684
            IM  +  A++YLH   S  + H D+KP N+L      N +  L+DFG AK  T  +   
Sbjct: 126 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN--- 179
Query: 685 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIML 719
           + T    T  Y+APE     +   + D++S G+++
Sbjct: 180 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 214

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 48/95 (50%), Gaps = 9/95 (9%)
Query: 628 NIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD---NMVAHLSDFGIAKLLTGEDQSM 684
            IM  +  A++YLH   S  + H D+KP N+L      N +  L+DFG AK  T  +   
Sbjct: 127 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN--- 180
Query: 685 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIML 719
           + T    T  Y+APE     +   + D++S G+++
Sbjct: 181 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 215
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	824
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-136
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-110
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-106
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-106
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-100
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	6e-74
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-91
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	9e-62
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-59
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	6e-86
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-81
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	7e-81
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-78
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-75
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-71
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-49
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-35
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-12
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-06
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	6e-76
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-75
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-74
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-71
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-12
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	7e-74
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-70
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-68
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	9e-33
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-14
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-14
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-69
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	9e-69
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	6e-66
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-64
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-59
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	8e-47
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-37
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-34
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	8e-26
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-64
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	8e-64
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	5e-61
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-53
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	6e-50
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-46
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-32
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	8e-30
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	8e-23
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	3e-61
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-60
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-59
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-59
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-59
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	7e-59
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-58
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	9e-53
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	5e-47
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	4e-36
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-31
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-24
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-58
1o6v_A	466	Internalin A; bacterial infection, extracellular r	6e-57
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-53
1o6v_A	466	Internalin A; bacterial infection, extracellular r	6e-39
1o6v_A	466	Internalin A; bacterial infection, extracellular r	5e-35
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-56
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-56
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	4e-56
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	8e-56
3q4u_A	301	Activin receptor type-1; structural genomics conso	9e-56
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-54
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	7e-54
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-52
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-48
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	7e-47
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-51
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	7e-51
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-48
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	7e-44
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	5e-36
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	6e-25
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-22
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-19
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-46
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-42
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	9e-42
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-35
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	7e-18
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	4e-46
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-41
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-41
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-40
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-28
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	6e-18
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-16
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-44
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-42
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-30
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-30
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-43
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-36
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-36
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-17
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-14
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-13
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	4e-43
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	7e-43
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-40
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	5e-39
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	6e-16
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-42
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-42
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-41
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	4e-41
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-25
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	4e-12
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	5e-41
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-40
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-40
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-40
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-38
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-31
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-14
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-12
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-40
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-40
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-40
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	5e-40
3pls_A	298	Macrophage-stimulating protein receptor; protein k	8e-40
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-39
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-39
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-39
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-39
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-39
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-39
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	3e-39
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	5e-39
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	8e-39
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-38
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-38
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-38
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	3e-38
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	3e-38
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	4e-38
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	5e-38
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	5e-38
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	6e-38
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-37
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-37
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-37
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-37
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	6e-35
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-17
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	3e-15
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-13
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-12
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-37
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-37
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-37
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	3e-37
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	3e-37
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	3e-37
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	5e-37
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	5e-35
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-33
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	8e-24
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-05
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	4e-37
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	5e-37
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	6e-37
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-36
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-36
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-36
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-36
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	4e-28
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-22
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-14
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	3e-13
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-36
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	4e-30
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-28
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-36
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	4e-36
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	8e-36
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	7e-35
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	3e-22
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-35
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-35
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-30
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-35
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-35
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-35
4aoj_A	329	High affinity nerve growth factor receptor; transf	4e-35
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	4e-35
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	5e-35
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	7e-27
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-23
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-19
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	7e-18
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	6e-11
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-34
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-34
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-34
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-29
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-29
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-28
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-26
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-26
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-13
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-07
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-34
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-34
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-34
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-34
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-34
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	5e-34
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	5e-34
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	8e-34
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-33
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-33
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-33
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-33
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	7e-33
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	8e-33
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-32
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-31
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-20
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-13
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	8e-32
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-31
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-31
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-31
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-31
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-30
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-30
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-30
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-30
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-30
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-30
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	3e-30
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-30
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	3e-29
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-28
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-27
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	6e-13
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	6e-29
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	7e-29
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-28
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-28
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-28
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-28
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	4e-26
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-25
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	4e-22
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-05
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-28
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	3e-28
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	6e-25
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	3e-23
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	2e-17
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	4e-08
3aln_A	327	Dual specificity mitogen-activated protein kinase;	8e-28
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	9e-28
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-27
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	3e-27
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	5e-27
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	6e-27
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	7e-27
3an0_A	340	Dual specificity mitogen-activated protein kinase;	7e-27
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	7e-27
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	9e-27
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	1e-26
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	7e-25
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	1e-22
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-22
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-26
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-26
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	3e-26
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	3e-26
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	8e-26
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	9e-26
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	6e-25
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	7e-25
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-20
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-25
2dyl_A	318	Dual specificity mitogen-activated protein kinase	4e-25
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	5e-25
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-24
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	6e-24
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-20
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	7e-10
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	7e-25
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	9e-25
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	9e-25
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-23
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	4e-20
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-24
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-24
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-24
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	3e-24
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	6e-24
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	6e-24
3o0g_A	292	Cell division protein kinase 5; kinase activator c	7e-24
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	7e-24
3uqc_A	286	Probable conserved transmembrane protein; structur	8e-24
3niz_A	311	Rhodanese family protein; structural genomics, str	9e-24
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-23
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-23
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	3e-21
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	3e-21
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-19
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	1e-23
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	7e-23
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	8e-22
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-23
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-23
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	4e-23
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	4e-23
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	4e-23
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	4e-23
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	5e-23
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	5e-23
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	7e-23
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	7e-23
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	9e-23
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-22
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-22
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-22
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	3e-22
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	3e-22
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	4e-22
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	4e-22
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	4e-22
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	5e-22
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	5e-22
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	6e-22
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	6e-22
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-21
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-21
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-21
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-21
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	8e-21
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	7e-18
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-21
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	5e-07
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	4e-21
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	6e-21
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	7e-21
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-19
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	5e-19
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	5e-13
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	3e-12
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	7e-21
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	8e-21
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	8e-21
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	9e-21
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-20
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	8e-19
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	6e-17
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	6e-15
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-12
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-20
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-20
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-20
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-20
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-20
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-20
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-20
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-20
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	3e-20
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	3e-20
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	4e-20
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	6e-19
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	7e-19
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-17
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-11
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	4e-20
3rp9_A	458	Mitogen-activated protein kinase; structural genom	5e-20
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	5e-20
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	5e-20
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	6e-20
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	7e-20
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	7e-20
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	8e-20
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	9e-20
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-19
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	1e-19
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	9e-19
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-15
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	5e-15
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-19
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-19
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	1e-18
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	1e-16
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	1e-12
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-19
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	3e-19
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	3e-19
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	1e-18
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-18
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	3e-18
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	7e-16
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	6e-13
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	4e-19
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	5e-19
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	5e-19
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	6e-19
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-18
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-18
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-18
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-18
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-18
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-18
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	4e-18
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	1e-17
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	3e-16
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	7e-13
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	3e-12
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-17
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-17
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	3e-17
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	4e-17
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	4e-17
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	5e-17
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	9e-17
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-16
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-16
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-16
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-16
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	1e-16
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	5e-13
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	8e-13
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	3e-04
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-16
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	3e-16
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	1e-15
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	6e-15
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	2e-13
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	2e-13
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	3e-12
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	7e-12
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	1e-06
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	4e-16
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	6e-16
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	6e-16
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	9e-15
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	3e-12
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	2e-09
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	4e-08
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-15
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-15
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	4e-09
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-15
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-15
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-15
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	1e-12
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	8e-12
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-09
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-15
3m19_A	251	Variable lymphocyte receptor A diversity region; a	5e-13
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-10
3m19_A	251	Variable lymphocyte receptor A diversity region; a	3e-10
3m19_A	251	Variable lymphocyte receptor A diversity region; a	3e-08
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	3e-15
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	2e-04
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	5e-15
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	9e-15
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-13
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	6e-10
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	3e-07
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-14
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-14
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	6e-14
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-09
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-07
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-14
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	7e-14
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-13
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	3e-13
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-13
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	9e-13
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-12
3e6j_A	229	Variable lymphocyte receptor diversity region; var	1e-11
3e6j_A	229	Variable lymphocyte receptor diversity region; var	2e-11
3e6j_A	229	Variable lymphocyte receptor diversity region; var	2e-10
3e6j_A	229	Variable lymphocyte receptor diversity region; var	1e-09
3e6j_A	229	Variable lymphocyte receptor diversity region; var	6e-09
3e6j_A	229	Variable lymphocyte receptor diversity region; var	3e-06
3e6j_A	229	Variable lymphocyte receptor diversity region; var	2e-05
3e6j_A	229	Variable lymphocyte receptor diversity region; var	1e-04
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-11
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	8e-09
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	5e-08
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	9e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	3e-06
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-05
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-04
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-04
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	8e-04
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	2e-11
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	7e-11
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	5e-09
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	5e-08
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	2e-07
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	3e-11
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	8e-09
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	2e-08
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	1e-07
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	3e-11
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	3e-11
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	5e-11
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	1e-10
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	3e-07
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	5e-06
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	7e-11
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	6e-10
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	7e-11
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-10
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	3e-10
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	5e-09
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	6e-09
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	3e-08
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	3e-07
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	1e-05
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	5e-04
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	4e-10
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	6e-10
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	4e-07
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	5e-06
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	2e-05
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	2e-05
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	2e-05
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	8e-05
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	1e-09
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	6e-09
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	1e-07
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	3e-04
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	9e-09
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-08
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	7e-08
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	7e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-04
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	9e-04
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-08
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-08
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	5e-05
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-08
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	4e-08
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-05
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-05
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	3e-05
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	1e-04
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	5e-08
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	4e-06
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	6e-06
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	2e-07
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	3e-07
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	5e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	5e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-06
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	6e-07
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	3e-06
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	2e-05
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	5e-05
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	8e-07
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-06
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	3e-06
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	5e-06
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	1e-05
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	4e-06
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	5e-06
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	1e-05
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	7e-05
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	8e-05
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	3e-04

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  422 bits (1088), Expect = e-136
 Identities = 144/470 (30%), Positives = 214/470 (45%), Gaps = 17/470 (3%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQGEI-IHEIGHLHNLGFLDLSQNKLLGTIPAA 64
            N      P    + S L+ L L +N   GE+ +  +  +  L  LDLS N+  G +P +
Sbjct: 303 GNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPES 362

Query: 65  IFNVST-LKAFAVTNNSLSGCL-SSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSK 122
           + N+S  L    +++N+ SG +  ++       L+ LYL  N F+G IP  + N S+L  
Sbjct: 363 LTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVS 422

Query: 123 LALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNP 182
           L L  N  SG IPS+ G+L  L  L L+ N L            L   K+L  + L  N 
Sbjct: 423 LHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGE-----IPQELMYVKTLETLILDFND 477

Query: 183 LDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLG 242
           L G +P   + N + +L    + N  ++G IP+ I  L +L  + L  N  +G+IP  LG
Sbjct: 478 LTGEIPSG-LSNCT-NLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELG 535

Query: 243 KLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGS 302
             + L  +DL  N   G+IP ++         ++  N ++G       N    K      
Sbjct: 536 DCRSLIWLDLNTNLFNGTIPAAMFKQ----SGKIAANFIAGKRYVYIKNDGMKKECHGAG 591

Query: 303 NELT---SIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPME 359
           N L            L      N++S  + G       N  +++ +D S N  SG IP E
Sbjct: 592 NLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKE 651

Query: 360 IGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNL 419
           IGS+  L  L L +N + GSIPD  GDL  L  L+LS N L G IP ++  L+ L +++L
Sbjct: 652 IGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDL 711

Query: 420 SFNKLKGEIPRGGSFGNFSAESFKGNELLCGSPNLQVPPCKASIHRTSRK 469
           S N L G IP  G F  F    F  N  LCG P  +  P  A  +   ++
Sbjct: 712 SNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPSNADGYAHHQR 761

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  353 bits (907), Expect = e-110
 Identities = 130/439 (29%), Positives = 206/439 (46%), Gaps = 19/439 (4%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAI 65
           +N  ++  P  + + S L+ L +  N+L G+    I     L  L++S N+ +G IP   
Sbjct: 209 SNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPP-- 265

Query: 66  FNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLAL 125
             + +L+  ++  N  +G +          L  L L GN+F G +P F  + S L  LAL
Sbjct: 266 LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLAL 325

Query: 126 EMNSFSGFIP-STFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCK-SLTHISLSNNPL 183
             N+FSG +P  T   +R L+ L L  N  +          SL+N   SL  + LS+N  
Sbjct: 326 SSNNFSGELPMDTLLKMRGLKVLDLSFNEFSG-----ELPESLTNLSASLLTLDLSSNNF 380

Query: 184 DGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGK 243
            G +      N  ++L+  Y+ N   +G IP  ++N ++L ++ L  N L+G+IP +LG 
Sbjct: 381 SGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGS 440

Query: 244 LQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSN 303
           L KL+D+ L  N LEG IP  +     L  L L  N L+G IP+  SN T L  +SL +N
Sbjct: 441 LSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNN 500

Query: 304 ELT-SIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGS 362
            LT  IP     L+++  L LS+N FSG +P E+ + ++LI +D + N F+G IP  +  
Sbjct: 501 RLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFK 560

Query: 363 LKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYN--NLSGTIPVSLEKLSYLKDLNLS 420
                   +  N + G       +    K  + + N     G     L +LS     N++
Sbjct: 561 QSGK----IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNIT 616

Query: 421 FNKLKGEIPRGGSFGNFSA 439
                G      +F N  +
Sbjct: 617 SRVYGGHTSP--TFDNNGS 633

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  343 bits (882), Expect = e-106
 Identities = 137/443 (30%), Positives = 196/443 (44%), Gaps = 26/443 (5%)

Query: 7   NFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAA-- 64
           N   S     + +++ L+ L+L N+ + G +        +L  LDLS+N L G +     
Sbjct: 63  NVGFSAVSSSLLSLTGLESLFLSNSHINGSV-SGFKCSASLTSLDLSRNSLSGPVTTLTS 121

Query: 65  IFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIF---NASKLS 121
           + + S LK   V++N+L         + L +LEVL L  N+ SG             +L 
Sbjct: 122 LGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELK 181

Query: 122 KLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNN 181
            LA+  N  SG +        NLE+L +  NN ++       +  L +C +L H+ +S N
Sbjct: 182 HLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTG------IPFLGDCSALQHLDISGN 233

Query: 182 PLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITL 241
            L G   R  +   +  LK   + +    G IP     L  L  + L  NK  G IP  L
Sbjct: 234 KLSGDFSRA-ISTCT-ELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFL 289

Query: 242 -GKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPA-CFSNMTFLKVLS 299
            G    L  +DL  N   G++P        L  L L  N  SG +P      M  LKVL 
Sbjct: 290 SGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLD 349

Query: 300 LGSNELT-SIPLNFWSLKDILD-LNLSSNCFSGPLPLEIRN--LKALIEIDFSMNNFSGI 355
           L  NE +  +P +  +L   L  L+LSSN FSGP+   +       L E+    N F+G 
Sbjct: 350 LSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGK 409

Query: 356 IPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLK 415
           IP  + +   L +L L +N L G+IP S G L  L+ L L  N L G IP  L  +  L+
Sbjct: 410 IPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLE 469

Query: 416 DLNLSFNKLKGEIPRGGSFGNFS 438
            L L FN L GEIP      N +
Sbjct: 470 TLILDFNDLTGEIPS--GLSNCT 490

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  343 bits (882), Expect = e-106
 Identities = 120/442 (27%), Positives = 188/442 (42%), Gaps = 47/442 (10%)

Query: 6   NNFLTSTTPKEID-NISNLKVLYLYNNRLQGEI---IHEIGHLHNLGFLDLSQNKLLGTI 61
           +N L           +++L+VL L  N + G              L  L +S NK+ G +
Sbjct: 135 SNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDV 194

Query: 62  PAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLS 121
              +                             NLE L +  NNFS  IP F+ + S L 
Sbjct: 195 D--VSR-------------------------CVNLEFLDVSSNNFSTGIP-FLGDCSALQ 226

Query: 122 KLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNN 181
            L +  N  SG           L+ L +  N           +      KSL ++SL+ N
Sbjct: 227 HLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGP------IPP-LPLKSLQYLSLAEN 279

Query: 182 PLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPI-T 240
              G +P    G    +L    +   +  G +P    + + L ++ L  N  +G +P+ T
Sbjct: 280 KFTGEIPDFLSGACD-TLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDT 338

Query: 241 LGKLQKLQDVDLEYNQLEGSIPDSIC-LSVELYELELGGNKLSGSIPA--CFSNMTFLKV 297
           L K++ L+ +DL +N+  G +P+S+  LS  L  L+L  N  SG I    C +    L+ 
Sbjct: 339 LLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQE 398

Query: 298 LSLGSNELT-SIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGII 356
           L L +N  T  IP    +  +++ L+LS N  SG +P  + +L  L ++   +N   G I
Sbjct: 399 LYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEI 458

Query: 357 PMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKD 416
           P E+  +K LE L L++N L G IP    +  +L  ++LS N L+G IP  + +L  L  
Sbjct: 459 PQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAI 518

Query: 417 LNLSFNKLKGEIPRGGSFGNFS 438
           L LS N   G IP     G+  
Sbjct: 519 LKLSNNSFSGNIPA--ELGDCR 538

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  326 bits (839), Expect = e-100
 Identities = 124/433 (28%), Positives = 204/433 (47%), Gaps = 29/433 (6%)

Query: 21  SNLKVLYLYNNRLQ---GEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVT 77
             +  + L +  L      +   +  L  L  L LS + + G++       ++L +  ++
Sbjct: 50  DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLS 108

Query: 78  NNSLSGCLSSITDVG-LPNLEVLYLWGNNFSGTIP-HFIFNASKLSKLALEMNSFSGFIP 135
            NSLSG ++++T +G    L+ L +  N              + L  L L  NS SG   
Sbjct: 109 RNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANV 168

Query: 136 STF---GNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYV 192
             +        L+ L +  N ++           +S C +L  + +S+N     +P  ++
Sbjct: 169 VGWVLSDGCGELKHLAISGNKISGDV-------DVSRCVNLEFLDVSSNNFSTGIP--FL 219

Query: 193 GNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDL 252
           G+ S +L++  +    +SG     I+  T+L  + +  N+  G IP     L+ LQ + L
Sbjct: 220 GDCS-ALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIP--PLPLKSLQYLSL 276

Query: 253 EYNQLEGSIPDSICLS-VELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELT-SIPL 310
             N+  G IPD +  +   L  L+L GN   G++P  F + + L+ L+L SN  +  +P+
Sbjct: 277 AENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPM 336

Query: 311 N-FWSLKDILDLNLSSNCFSGPLPLEIRNLKA-LIEIDFSMNNFSGIIPMEIG--SLKNL 366
           +    ++ +  L+LS N FSG LP  + NL A L+ +D S NNFSG I   +       L
Sbjct: 337 DTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTL 396

Query: 367 ENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKG 426
           + L+L+ N   G IP +  +   L SL+LS+N LSGTIP SL  LS L+DL L  N L+G
Sbjct: 397 QELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEG 456

Query: 427 EIPRGGSFGNFSA 439
           EIP+         
Sbjct: 457 EIPQ--ELMYVKT 467

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  255 bits (655), Expect = 6e-74
 Identities = 99/342 (28%), Positives = 156/342 (45%), Gaps = 40/342 (11%)

Query: 104 NNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSF 163
           N     +   + + + L  L L  +  +G +   F    +L  L L  N+L+     ++ 
Sbjct: 63  NVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLSRNSLSGP---VTT 118

Query: 164 LSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEIT---NL 220
           L+SL +C  L  +++S+N LD     +    L+ SL+   +   ++SG            
Sbjct: 119 LTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLN-SLEVLDLSANSISGANVVGWVLSDGC 177

Query: 221 TDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNK 280
            +L  + + GNK++G + +   +   L+ +D+  N     IP  +     L  L++ GNK
Sbjct: 178 GELKHLAISGNKISGDVDV--SRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNK 234

Query: 281 LSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLK 340
           LSG      S  T LK+L                       N+SSN F GP+P     LK
Sbjct: 235 LSGDFSRAISTCTELKLL-----------------------NISSNQFVGPIPPL--PLK 269

Query: 341 ALIEIDFSMNNFSGIIPMEI-GSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNN 399
           +L  +  + N F+G IP  + G+   L  L L  N   G++P  FG    L+SL LS NN
Sbjct: 270 SLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNN 329

Query: 400 LSGTIPV-SLEKLSYLKDLNLSFNKLKGEIPRGGSFGNFSAE 440
            SG +P+ +L K+  LK L+LSFN+  GE+P   S  N SA 
Sbjct: 330 FSGELPMDTLLKMRGLKVLDLSFNEFSGELPE--SLTNLSAS 369

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  289 bits (742), Expect = 2e-91
 Identities = 92/308 (29%), Positives = 143/308 (46%), Gaps = 16/308 (5%)

Query: 161 LSFLSSLSNCKSL----THISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSG--GIP 214
           L     L N  +L          N    G+L  T        + N  +   N+     IP
Sbjct: 12  LQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDT-DTQTYR-VNNLDLSGLNLPKPYPIP 69

Query: 215 EEITNLTDLTTIVLGG-NKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYE 273
             + NL  L  + +GG N L G IP  + KL +L  + + +  + G+IPD +     L  
Sbjct: 70  SSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129

Query: 274 LELGGNKLSGSIPACFSNMTFLKVLSLGSNELT-SIPLNFWSLKDIL-DLNLSSNCFSGP 331
           L+   N LSG++P   S++  L  ++   N ++ +IP ++ S   +   + +S N  +G 
Sbjct: 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGK 189

Query: 332 LPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLK 391
           +P    NL  L  +D S N   G   +  GS KN + + L  N L   +    G   +L 
Sbjct: 190 IPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLN 247

Query: 392 SLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIPRGGSFGNFSAESFKGNELLCGS 451
            L+L  N + GT+P  L +L +L  LN+SFN L GEIP+GG+   F   ++  N+ LCGS
Sbjct: 248 GLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGS 307

Query: 452 PNLQVPPC 459
           P   +P C
Sbjct: 308 P---LPAC 312

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  210 bits (536), Expect = 9e-62
 Identities = 71/290 (24%), Positives = 119/290 (41%), Gaps = 16/290 (5%)

Query: 50  LDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLSGCLSSITDVG-LPNLEVLYLWG-NNFS 107
            D      LG +         +    ++  +L       + +  LP L  LY+ G NN  
Sbjct: 31  TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLV 90

Query: 108 GTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSL 167
           G IP  I   ++L  L +   + SG IP     ++ L  L    N L+      +   S+
Sbjct: 91  GPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSG-----TLPPSI 145

Query: 168 SNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIV 227
           S+  +L  I+   N + G +P +  G+ S    +  +    ++G IP    NL +L  + 
Sbjct: 146 SSLPNLVGITFDGNRISGAIPDS-YGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVD 203

Query: 228 LGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPA 287
           L  N L G   +  G  +  Q + L  N L   +   + LS  L  L+L  N++ G++P 
Sbjct: 204 LSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQ 262

Query: 288 CFSNMTFLKVLSLGSNELT-SIPLNFWSLKDILDLNLSSN---CFSGPLP 333
             + + FL  L++  N L   IP    +L+       ++N   C   PLP
Sbjct: 263 GLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLC-GSPLP 310

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  204 bits (521), Expect = 1e-59
 Identities = 74/310 (23%), Positives = 114/310 (36%), Gaps = 40/310 (12%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQGE--IIHEIGHLHNLGFLDLS-QNKLLGTIP 62
           N                +  L L    L     I   + +L  L FL +   N L+G IP
Sbjct: 35  NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIP 94

Query: 63  AAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSK 122
            AI                           L  L  LY+   N SG IP F+     L  
Sbjct: 95  PAIAK-------------------------LTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129

Query: 123 LALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSL-THISLSNN 181
           L    N+ SG +P +  +L NL  +T   N ++      +   S  +   L T +++S N
Sbjct: 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISG-----AIPDSYGSFSKLFTSMTISRN 184

Query: 182 PLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITL 241
            L G +P T   NL  +L    +    + G       +  +   I L  N L   +   +
Sbjct: 185 RLTGKIPPT-FANL--NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KV 240

Query: 242 GKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLG 301
           G  + L  +DL  N++ G++P  +     L+ L +  N L G IP    N+    V +  
Sbjct: 241 GLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYA 299

Query: 302 SNE-LTSIPL 310
           +N+ L   PL
Sbjct: 300 NNKCLCGSPL 309

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  275 bits (705), Expect = 6e-86
 Identities = 97/304 (31%), Positives = 158/304 (51%), Gaps = 17/304 (5%)

Query: 515 RRFSYLELFQATDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVEC 574
            R   ++L +AT+ F    LIG G FG VYK  +RDG +VA+K    +  +  + F+ E 
Sbjct: 27  YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEI 86

Query: 575 AMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSN---YSLDIFQRLNIMI 631
             +   RH +LV +I  C       L+ +YM +G+L+++L+ S+    S+   QRL I I
Sbjct: 87  ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146

Query: 632 DVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA 691
             A  L YLH      +IH D+K  N+LLD+N V  ++DFGI+K  T  DQ+   T    
Sbjct: 147 GAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKG 203

Query: 692 TIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDE-LFNGEMTLKHWVNDCLPIS 750
           T+GY+ PEY  +G+++   DVYSFG++L E    +    + L    + L  W  +     
Sbjct: 204 TLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG 263

Query: 751 T-MEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL---LKIR 806
              ++VD NL  +     + K        + A++C   S E R +  +++ KL   L+++
Sbjct: 264 QLEQIVDPNLADKIRPESLRK------FGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317

Query: 807 DSLL 810
           +S++
Sbjct: 318 ESVI 321

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  264 bits (676), Expect = 1e-81
 Identities = 104/300 (34%), Positives = 153/300 (51%), Gaps = 21/300 (7%)

Query: 514 WRRFSYLELFQATDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKS-FDV 572
            +RFS  EL  A+D FS  N++GRGGFG VYK R+ DG  VAVK    +  +  +  F  
Sbjct: 17  LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76

Query: 573 ECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLH---SSNYSLDIFQRLNI 629
           E  M+    HRNL+++   C     + LV  YM +GS+   L     S   LD  +R  I
Sbjct: 77  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136

Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
            +  A  L YLH      +IH D+K +N+LLD+   A + DFG+AKL+  +D  +T T  
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT-TAV 195

Query: 690 LATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTD---ELFNGEMTLKHWVNDC 746
             TIG++APEY   G+ S   DV+ +G+ML+E  T ++  D      + ++ L  WV   
Sbjct: 196 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV--- 252

Query: 747 LPI----STMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL 802
             +        +VD +L      ++  +E  V  +  +AL CT  SP +R    E+V  L
Sbjct: 253 KGLLKEKKLEALVDVDLQG----NYKDEE--VEQLIQVALLCTQSSPMERPKMSEVVRML 306

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  271 bits (696), Expect = 7e-81
 Identities = 67/460 (14%), Positives = 142/460 (30%), Gaps = 53/460 (11%)

Query: 3   SIINNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIP 62
            I ++    +  K          +   +N +   +   +  L  L    +  +  +    
Sbjct: 165 CINSDPQQKSIKKSSRITLKDTQIGQLSNNI-TFVSKAVMRLTKLRQFYMGNSPFVAENI 223

Query: 63  AAIFNVSTLKAFAVTNNSLSGCL-SSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLS 121
              +                           L +L  + ++       +P F+    ++ 
Sbjct: 224 CEAWENENS-----EYAQQYKTEDLKWD--NLKDLTDVEVYNCPNLTKLPTFLKALPEMQ 276

Query: 122 KLALEMNSF--------SGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSL 173
            + +  N               +       ++ + +  NNL +  ++    +SL   K L
Sbjct: 277 LINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVE----TSLQKMKKL 332

Query: 174 THISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKL 233
             +    N L+G LP    G+    L +  +    ++            +  +    NKL
Sbjct: 333 GMLECLYNQLEGKLP--AFGSEI-KLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKL 389

Query: 234 NGSIPITL--GKLQKLQDVDLEYNQLEG-------SIPDSICLSVELYELELGGNKLSGS 284
              IP       +  +  +D  YN++          +  +    + +  + L  N++S  
Sbjct: 390 K-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKF 448

Query: 285 IPACFSNMTFLKVLSLGSNELTSIPLN--------FWSLKDILDLNLSSNCFSG-PLPLE 335
               FS  + L  ++L  N LT IP N        F +   +  ++L  N  +       
Sbjct: 449 PKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFR 508

Query: 336 IRNLKALIEIDFSMNNFSGIIPMEIGSLKNLE------NLFLEYNRLEGSIPDSFGDLIS 389
              L  L+ ID S N+FS   P +  +   L+          + NR     P+      S
Sbjct: 509 ATTLPYLVGIDLSYNSFSKF-PTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPS 567

Query: 390 LKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIP 429
           L  L +  N++   +   +     +  L++  N       
Sbjct: 568 LTQLQIGSNDIR-KVNEKI--TPNISVLDIKDNPNISIDL 604

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  264 bits (677), Expect = 3e-78
 Identities = 73/462 (15%), Positives = 149/462 (32%), Gaps = 67/462 (14%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQG----EIIHEIGHLHNLGFLDLSQNKLLGTI 61
               +   P  I  ++ L+VL L ++  +          I    +       +     T 
Sbjct: 90  GFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTF 149

Query: 62  PAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLS 121
                                            +L    +  +    +I        K +
Sbjct: 150 VDYDPREDFS-----------------------DLIKDCINSDPQQKSIKKSSRITLKDT 186

Query: 122 KLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNN 181
           ++    N+ +  +      L  L    + ++   +           + C++  + +    
Sbjct: 187 QIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAE----------NICEAWENENSEYA 235

Query: 182 PLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKL-------- 233
                    +  NL   L +  +YNC     +P  +  L ++  I +  N+         
Sbjct: 236 QQYKTEDLKW-DNLK-DLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKD 293

Query: 234 NGSIPITLGKLQKLQDVDLEYNQL-EGSIPDSICLSVELYELELGGNKLSGSIPACFSNM 292
           +          +K+Q + + YN L    +  S+    +L  LE   N+L G +PA F + 
Sbjct: 294 DWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA-FGSE 352

Query: 293 TFLKVLSLGSNELTSIPLNFWS-LKDILDLNLSSNCFSG-PLPLEIRNLKALIEIDFSMN 350
             L  L+L  N++T IP NF    + + +L+ + N     P   + +++  +  IDFS N
Sbjct: 353 IKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYN 412

Query: 351 NFSGI-------IPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSG- 402
               +       +        N+ ++ L  N++     + F     L S+NL  N L+  
Sbjct: 413 EIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEI 472

Query: 403 ------TIPVSLEKLSYLKDLNLSFNKLKGEIPRGGSFGNFS 438
                     + +    L  ++L FNKL   +          
Sbjct: 473 PKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLP 513

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  256 bits (656), Expect = 3e-75
 Identities = 67/439 (15%), Positives = 136/439 (30%), Gaps = 63/439 (14%)

Query: 3   SIINNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLL---- 58
           +        T   + DN+ +L  + +YN     ++   +  L  +  ++++ N+ +    
Sbjct: 231 NSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQ 290

Query: 59  ----GTIPAAIFNVSTLKAFAVTNNSLSGCLSSITDVG-LPNLEVLYLWGNNFSGTIPHF 113
                   A       ++   +  N+L       T +  +  L +L    N   G +P F
Sbjct: 291 LKDDWQALADAPVGEKIQIIYIGYNNLKT-FPVETSLQKMKKLGMLECLYNQLEGKLPAF 349

Query: 114 IFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSL 173
             +  KL+ L L  N  +    +  G    +E L+   N L      +  +    +   +
Sbjct: 350 -GSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKY----IPNIFDAKSVSVM 404

Query: 174 THISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKL 233
           + I  S N +  +                          +        ++++I L  N++
Sbjct: 405 SAIDFSYNEIGSVDG-------------------KNFDPLDPTPFKGINVSSINLSNNQI 445

Query: 234 NGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMT 293
           +            L  ++L  N L   IP +                        F N  
Sbjct: 446 SKFPKELFSTGSPLSSINLMGNMLTE-IPKNSL----------------KDENENFKNTY 488

Query: 294 FLKVLSLGSNELTSIP--LNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEI------ 345
            L  + L  N+LT +       +L  ++ ++LS N FS   P +  N   L         
Sbjct: 489 LLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQR 547

Query: 346 DFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIP 405
           D   N      P  I    +L  L +  N +   + +      ++  L++  N       
Sbjct: 548 DAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKI--TPNISVLDIKDNPNISIDL 604

Query: 406 VSLEKLSYLKDLNLSFNKL 424
             +          L ++K 
Sbjct: 605 SYVCPYIEAGMYMLFYDKT 623

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  245 bits (628), Expect = 3e-71
 Identities = 67/430 (15%), Positives = 128/430 (29%), Gaps = 53/430 (12%)

Query: 16  EIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFA 75
            +++   +  L L      G +   IG L  L  L L  +                    
Sbjct: 76  SLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPK-------- 127

Query: 76  VTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNA--SKLSKLALEMNSFSGF 133
                +S  +S          E       ++  T   +      S L K  +  +     
Sbjct: 128 ----GISANMS---------DEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKS 174

Query: 134 IPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVG 193
           I  +         +    NN+T          ++     L    + N+P           
Sbjct: 175 IKKSSRITLKDTQIGQLSNNITF------VSKAVMRLTKLRQFYMGNSPFVAENICE--- 225

Query: 194 NLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLE 253
               + +N              +  NL DLT + +        +P  L  L ++Q +++ 
Sbjct: 226 ----AWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVA 281

Query: 254 YNQL--------EGSIPDSICLSVELYELELGGNKL-SGSIPACFSNMTFLKVLSLGSNE 304
            N+         +        +  ++  + +G N L +  +      M  L +L    N+
Sbjct: 282 CNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQ 341

Query: 305 LTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGI-IPMEIGSL 363
           L      F S   +  LNL+ N  +          + +  + F+ N    I    +  S+
Sbjct: 342 LEGKLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSV 401

Query: 364 KNLENLFLEYNRLEG-------SIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKD 416
             +  +   YN +          +  +    I++ S+NLS N +S          S L  
Sbjct: 402 SVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSS 461

Query: 417 LNLSFNKLKG 426
           +NL  N L  
Sbjct: 462 INLMGNMLTE 471

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  183 bits (466), Expect = 3e-49
 Identities = 49/373 (13%), Positives = 121/373 (32%), Gaps = 27/373 (7%)

Query: 70  TLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLS---KLALE 126
           T+K  A+T++++     S T   + +   L    +  +G         ++         E
Sbjct: 6   TVKDNALTDDAIVPIKLSRTAEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKE 65

Query: 127 MNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGI 186
           ++ +      +  +   +  L+L     +          ++     L  ++L ++     
Sbjct: 66  LDMWGAQPGVSLNSNGRVTGLSLEGFGASG-----RVPDAIGQLTELEVLALGSHGEKVN 120

Query: 187 LPRTYVGNLSH--SLKNFYMYNCNVSGGIPEEIT--NLTDLTTIVLGGNKLNGSIPITLG 242
                   +S   S +       +      +     + +DL    +  +    SI  +  
Sbjct: 121 ERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSR 180

Query: 243 KLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGS 302
              K   +    N +   +  ++    +L +  +G +                +      
Sbjct: 181 ITLKDTQIGQLSNNIT-FVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQ-- 237

Query: 303 NELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGI------- 355
               +  L + +LKD+ D+ + +      LP  ++ L  +  I+ + N            
Sbjct: 238 --YKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDW 295

Query: 356 -IPMEIGSLKNLENLFLEYNRL-EGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSY 413
               +    + ++ +++ YN L    +  S   +  L  L   YN L G +P +      
Sbjct: 296 QALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIK 354

Query: 414 LKDLNLSFNKLKG 426
           L  LNL++N++  
Sbjct: 355 LASLNLAYNQITE 367

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  141 bits (358), Expect = 3e-35
 Identities = 32/250 (12%), Positives = 78/250 (31%), Gaps = 13/250 (5%)

Query: 196 SHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYN 255
             +  NF              + +   +T + L G   +G +P  +G+L +L+ + L  +
Sbjct: 56  PGANWNFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSH 115

Query: 256 QLEG----SIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSL---GSNELTSI 308
             +       P  I  ++   + +        +         F  ++        +  SI
Sbjct: 116 GEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSI 175

Query: 309 PLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLEN 368
             +         +   SN  +  +   +  L  L +     + F      E    +N E 
Sbjct: 176 KKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSE- 233

Query: 369 LFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEI 428
               Y +   +    + +L  L  + +        +P  L+ L  ++ +N++ N+     
Sbjct: 234 ----YAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGE 289

Query: 429 PRGGSFGNFS 438
                +   +
Sbjct: 290 QLKDDWQALA 299

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 70.1 bits (172), Expect = 2e-12
 Identities = 15/115 (13%), Positives = 31/115 (26%), Gaps = 7/115 (6%)

Query: 348 SMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSG----T 403
            ++ +     + + S   +  L LE     G +PD+ G L  L+ L L  +         
Sbjct: 65  ELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLF 124

Query: 404 IPVSLEKLSYLKDLNLSFNKLKGEIPRGGSFGNFS---AESFKGNELLCGSPNLQ 455
            P  +      +         +          +FS    +    +          
Sbjct: 125 GPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSS 179

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 50.8 bits (122), Expect = 2e-06
 Identities = 19/94 (20%), Positives = 34/94 (36%)

Query: 336 IRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNL 395
           I++  AL EI  ++N  +              N   E +        S      +  L+L
Sbjct: 29  IKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSNGRVTGLSL 88

Query: 396 SYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIP 429
                SG +P ++ +L+ L+ L L  +  K    
Sbjct: 89  EGFGASGRVPDAIGQLTELEVLALGSHGEKVNER 122

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  259 bits (664), Expect = 6e-76
 Identities = 100/481 (20%), Positives = 178/481 (37%), Gaps = 40/481 (8%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIG---HLHNLGFLDLSQNKLLGTIP 62
           +N +   +P     I  L  L+L N +L   +  ++       ++  L LS ++L  T  
Sbjct: 180 SNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSN 239

Query: 63  AAIFN--VSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKL 120
                   + L    ++ N+L+  + + +   LP LE  +L  NN      H +     +
Sbjct: 240 TTFLGLKWTNLTMLDLSYNNLNV-VGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNV 298

Query: 121 SKLAL---------EMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCK 171
             L L          + S       +F  L+ LE L + DN++     +       +   
Sbjct: 299 RYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSN-----MFTGLI 353

Query: 172 SLTHISLSNNPL--DGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLG 229
           +L ++SLSN+      +   T+V      L    +    +S    +  + L  L  + LG
Sbjct: 354 NLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLG 413

Query: 230 GNKLNGSIPI-TLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSG--SIP 286
            N++   +       L+ + ++ L YN+      +S  L   L  L L    L    S P
Sbjct: 414 LNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSP 473

Query: 287 ACFSNMTFLKVLSLGSNELTSIPLN-FWSLKDILDLNLSSN--------CFSGPLPLEIR 337
           + F  +  L +L L +N + +I  +    L+ +  L+L  N           G     ++
Sbjct: 474 SPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLK 533

Query: 338 NLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSY 397
            L  L  ++   N F  I       L  L+ + L  N L       F + +SLKSLNL  
Sbjct: 534 GLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQK 593

Query: 398 NNLSGTIPVSLEK-LSYLKDLNLSFNKLKGEIPRGGSFGNFSAESFK-----GNELLCGS 451
           N ++             L +L++ FN           F N+  E+        +  LC +
Sbjct: 594 NLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNT 653

Query: 452 P 452
           P
Sbjct: 654 P 654

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  256 bits (657), Expect = 5e-75
 Identities = 99/466 (21%), Positives = 162/466 (34%), Gaps = 38/466 (8%)

Query: 3   SIINNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIP 62
            +++N +            NL  L L +N L    +     L NL  L LS NK+     
Sbjct: 103 HLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKS 162

Query: 63  AAI--FNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIF---NA 117
             +  F  S+LK   +++N +    S      +  L  L+L       ++   +      
Sbjct: 163 EELDIFANSSLKKLELSSNQIKE-FSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELAN 221

Query: 118 SKLSKLALEMNSFSGFIPSTFGNLR--NLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTH 175
           + +  L+L  +  S    +TF  L+  NL  L L  NNL     D     S +    L +
Sbjct: 222 TSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGND-----SFAWLPQLEY 276

Query: 176 ISLSNNPLDGILPRTYVG-------NLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVL 228
             L  N +  +   +  G       NL  S     +   ++          L  L  + +
Sbjct: 277 FFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNM 336

Query: 229 GGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLS----VELYELELGGNKLSGS 284
             N + G        L  L+ + L  +        +          L+ L L  NK+S  
Sbjct: 337 EDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKI 396

Query: 285 IPACFSNMTFLKVLSLGSNELTSI--PLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKAL 342
               FS +  L+VL LG NE+        +  L++I ++ LS N +          + +L
Sbjct: 397 ESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSL 456

Query: 343 IEIDFSMNNFSGI--IPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNL 400
             +         +   P     L+NL  L L  N +     D    L  L+ L+L +NNL
Sbjct: 457 QRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNL 516

Query: 401 S--------GTIPVSLEKLSYLKDLNLSFNKLKGEIPRGGSFGNFS 438
           +        G     L+ LS+L  LNL  N           F +  
Sbjct: 517 ARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPV--EVFKDLF 560

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  254 bits (650), Expect = 5e-74
 Identities = 95/439 (21%), Positives = 160/439 (36%), Gaps = 30/439 (6%)

Query: 21  SNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNS 80
           +N+ VL L +N+L+            L  LD+  N +    P     +  LK   + +N 
Sbjct: 25  TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNE 84

Query: 81  LSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGN 140
           LS  LS  T     NL  L+L  N+      +       L  L L  N  S     T   
Sbjct: 85  LSQ-LSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQ 143

Query: 141 LRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLK 200
           L NL+ L L +N + +   +      +    SL  + LS+N +    P      +   L 
Sbjct: 144 LENLQELLLSNNKIQALKSE---ELDIFANSSLKKLELSSNQIKEFSPGC-FHAIGR-LF 198

Query: 201 NFYMYNCNVSGGIPEEIT---NLTDLTTIVLGGNKLNGSIPITLGKLQ--KLQDVDLEYN 255
             ++ N  +   + E++      T +  + L  ++L+ +   T   L+   L  +DL YN
Sbjct: 199 GLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYN 258

Query: 256 QLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSN---------ELT 306
            L     DS     +L    L  N +          +  ++ L+L  +          L 
Sbjct: 259 NLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLP 318

Query: 307 SIPLN-FWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKN 365
            I    F  LK +  LN+  N   G        L  L  +  S N+F+ +  +   +  +
Sbjct: 319 KIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLS-NSFTSLRTLTNETFVS 377

Query: 366 LEN-----LFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVS-LEKLSYLKDLNL 419
           L +     L L  N++     D+F  L  L+ L+L  N +   +       L  + ++ L
Sbjct: 378 LAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYL 437

Query: 420 SFNKLKGEIPRGGSFGNFS 438
           S+NK         SF    
Sbjct: 438 SYNKYLQLTR--NSFALVP 454

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  247 bits (633), Expect = 1e-71
 Identities = 92/436 (21%), Positives = 166/436 (38%), Gaps = 29/436 (6%)

Query: 22  NLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSL 81
           + +V    + +L  ++  ++    N+  L+L+ N+L     A     S L +  V  N++
Sbjct: 5   SHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61

Query: 82  SGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNL 141
           S  L       LP L+VL L  N  S          + L++L L  NS      + F   
Sbjct: 62  SK-LEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQ 120

Query: 142 RNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKN 201
           +NL  L L  N L+S+ L      +    ++L  + LSNN +  +         + SLK 
Sbjct: 121 KNLITLDLSHNGLSSTKLG-----TQVQLENLQELLLSNNKIQALKSEELDIFANSSLKK 175

Query: 202 FYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLG---KLQKLQDVDLEYNQLE 258
             + +  +    P     +  L  + L   +L  S+   L        ++++ L  +QL 
Sbjct: 176 LELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLS 235

Query: 259 GSIPDSI--CLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSI-PLNFWSL 315
            +   +        L  L+L  N L+      F+ +  L+   L  N +  +   +   L
Sbjct: 236 TTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGL 295

Query: 316 KDILDLNLSSNCFSGPL---------PLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNL 366
            ++  LNL  +     +             + LK L  ++   N+  GI       L NL
Sbjct: 296 FNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINL 355

Query: 367 ENLFLEYNRLEGS--IPDSFGDLI--SLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFN 422
           + L L  +         ++F  L    L  LNL+ N +S     +   L +L+ L+L  N
Sbjct: 356 KYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLN 415

Query: 423 KLKGEIPRGGSFGNFS 438
           ++  E+  G  +    
Sbjct: 416 EIGQELT-GQEWRGLE 430

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 70.8 bits (174), Expect = 1e-12
 Identities = 21/110 (19%), Positives = 38/110 (34%)

Query: 3   SIINNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIP 62
            +  +         +  +S+L +L L +N      +     L  L  +DL  N L     
Sbjct: 518 RLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPA 577

Query: 63  AAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPH 112
           +   N  +LK+  +  N ++     +      NL  L +  N F  T   
Sbjct: 578 SVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES 627

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  242 bits (620), Expect = 7e-74
 Identities = 88/308 (28%), Positives = 141/308 (45%), Gaps = 27/308 (8%)

Query: 515 RRFSYLELFQATDKFSE------NNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRA-- 566
             FS+ EL   T+ F E       N +G GGFG VYK  + +   VAVK           
Sbjct: 13  HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTE 71

Query: 567 --FKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYS--LD 622
              + FD E  +M   +H NLV+++   S+ +   LV  YMP+GSL   L   + +  L 
Sbjct: 72  ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLS 131

Query: 623 IFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 682
              R  I    A+ + +LH       IH D+K +N+LLD+   A +SDFG+A+      Q
Sbjct: 132 WHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188

Query: 683 SMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHW 742
           ++  ++ + T  YMAPE  R G+++   D+YSFG++L+E  T     DE       L   
Sbjct: 189 TVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEH-REPQLLLDI 246

Query: 743 VNDCL--PISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVA 800
             +      +  + +D  +    D    + E       ++A +C  E   +R + K++  
Sbjct: 247 KEEIEDEEKTIEDYIDKKM---NDADSTSVEAMY----SVASQCLHEKKNKRPDIKKVQQ 299

Query: 801 KLLKIRDS 808
            L ++  S
Sbjct: 300 LLQEMTAS 307

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  249 bits (636), Expect = 1e-70
 Identities = 76/462 (16%), Positives = 145/462 (31%), Gaps = 47/462 (10%)

Query: 7   NFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIF 66
           +        ++DN   +  L L     +G +   IG L  L  L    +    +      
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGD 368

Query: 67  NVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFS-----GTIPHFIFNASKLS 121
              T        + +      +       L +  L  +  +       I      + K +
Sbjct: 369 EELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDT 428

Query: 122 KLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNN 181
           ++    N  +  I      L  L+ +   ++  T            +        +    
Sbjct: 429 QIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFT----------YDNIAVDWEDANSDYA 477

Query: 182 PLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNG------ 235
                   +   NL   L +  +YNC     +P+ + +L +L ++ +  N+         
Sbjct: 478 KQYENEELS-WSNLK-DLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKA 535

Query: 236 ---SIPITLGKLQKLQDVDLEYNQLEGSIPDSICLS--VELYELELGGNKLSGSIPACFS 290
               +        K+Q   + YN LE   P S  L   V+L  L+   NK+   + A F 
Sbjct: 536 DWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLEA-FG 592

Query: 291 NMTFLKVLSLGSNELTSIPLNFWS-LKDILDLNLSSNCFSG-PLPLEIRNLKALIEIDFS 348
               L  L L  N++  IP +F +    +  L  S N     P     +++  +  +DFS
Sbjct: 593 TNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFS 652

Query: 349 MNNFSGIIP-----MEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLS-- 401
            N            M+     N   + L YN ++    + F     + ++ LS N ++  
Sbjct: 653 YNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSI 712

Query: 402 -----GTIPVSLEKLSYLKDLNLSFNKLKGEIPRGGSFGNFS 438
                     + +    L  ++L FNKL   +          
Sbjct: 713 PENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLP 753

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  242 bits (619), Expect = 2e-68
 Identities = 82/490 (16%), Positives = 155/490 (31%), Gaps = 62/490 (12%)

Query: 7   NFLTSTTPKEIDNISNLKVLYL--YNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAA 64
           N      P + D+  +LK   +    NR+   I   I  L  L  +  + +       A 
Sbjct: 409 NRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAV 467

Query: 65  IFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLA 124
            +  +                 S +   L +L  + L+       +P F+++  +L  L 
Sbjct: 468 DWEDANSD----YAKQYENEELSWS--NLKDLTDVELYNCPNMTQLPDFLYDLPELQSLN 521

Query: 125 LEMNSFSGF---------IPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTH 175
           +  N              +         ++   +  NNL          +SL     L  
Sbjct: 522 IACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEE----FPASASLQKMVKLGL 577

Query: 176 ISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEI-TNLTDLTTIVLGGNKLN 234
           +   +N +  +      G     L +  +    +   IPE+       +  +    NKL 
Sbjct: 578 LDCVHNKVRHLEA---FGTNV-KLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK 632

Query: 235 GSIP--ITLGKLQKLQDVDLEYNQLEGSIPDSICLSVE------LYELELGGNKLSGSIP 286
             IP       +  +  VD  YN++  S   +I  S++         + L  N++     
Sbjct: 633 -YIPNIFNAKSVYVMGSVDFSYNKIG-SEGRNISCSMDDYKGINASTVTLSYNEIQKFPT 690

Query: 287 ACFSNMTFLKVLSLGSNELTSIPLN--------FWSLKDILDLNLSSNCFSG-PLPLEIR 337
             F+  + +  + L +N +TSIP N        + +   +  ++L  N  +         
Sbjct: 691 ELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRAT 750

Query: 338 NLKALIEIDFSMNNFSGIIPMEIGSLKNLE------NLFLEYNRLEGSIPDSFGDLISLK 391
            L  L  +D S N FS   P +  +   L+          E NR+    P       SL 
Sbjct: 751 TLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLI 809

Query: 392 SLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIPRGGSFGNFSAESFK----GNEL 447
            L +  N++   +   L     L  L+++ N     I          A  +       + 
Sbjct: 810 QLQIGSNDIR-KVDEKL--TPQLYILDIADNPNI-SIDVTSVCPYIEAGMYVLLYDKTQD 865

Query: 448 LCGSPNLQVP 457
           + G   L + 
Sbjct: 866 IRGCDALGIE 875

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  135 bits (341), Expect = 9e-33
 Identities = 38/254 (14%), Positives = 84/254 (33%), Gaps = 13/254 (5%)

Query: 201 NFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGS 260
           NF             ++ N   +T + L G    G +P  +G+L +L+ +    +    S
Sbjct: 303 NFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVS 362

Query: 261 IPDSICLSVELYELELGGNKLSGSIPACFSNM-------TFLKVLSLGSNELTSIPLNFW 313
                   +     E   +++       F +          L+     + E+  I  +  
Sbjct: 363 GRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSR 422

Query: 314 SLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEY 373
                  +   +N  +  +   I+ L  L  I F+ + F+           + E+   +Y
Sbjct: 423 ISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAV-----DWEDANSDY 476

Query: 374 NRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIPRGGS 433
            +   +   S+ +L  L  + L        +P  L  L  L+ LN++ N+          
Sbjct: 477 AKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKAD 536

Query: 434 FGNFSAESFKGNEL 447
           +   + +   G ++
Sbjct: 537 WTRLADDEDTGPKI 550

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 77.2 bits (190), Expect = 1e-14
 Identities = 26/208 (12%), Positives = 51/208 (24%), Gaps = 56/208 (26%)

Query: 3   SIINNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEI--GHLHNLGFLDLSQNKLLGT 60
           + I             N   L  + L  N+L   +  +     L  L  +D+S N    +
Sbjct: 710 TSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNC-FSS 767

Query: 61  IPAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKL 120
            P    N                            L+   +                   
Sbjct: 768 FPTQPLN-------------------------SSQLKAFGIRHQ---------------- 786

Query: 121 SKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSN 180
                E N      P+      +L  L +  N++    +D            L  + +++
Sbjct: 787 --RDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK--VDEKLTP------QLYILDIAD 836

Query: 181 NPLDGILPRTYVGNLSHSLKNFYMYNCN 208
           NP   I   +    +   +    +Y+  
Sbjct: 837 NPNISIDVTSVCPYIEAGMYVL-LYDKT 863

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 76.5 bits (188), Expect = 2e-14
 Identities = 29/264 (10%), Positives = 72/264 (27%), Gaps = 38/264 (14%)

Query: 196 SHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYN 255
           ++ +  +  Y+ +       E  ++   +   +  NKL               +V ++  
Sbjct: 215 TYQVVAYTTYSQSGIKRSELETQSVRGES-FTVIDNKLTKD-----------ANVPIQLK 262

Query: 256 QLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSL 315
           +    I D   L                            + L   +    S  +N    
Sbjct: 263 ETAEYIKDYKAL------------------------KAIWEALDGKNWRYYSGTINNTIH 298

Query: 316 KDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNR 375
               + N   + +     +++ N   +  +  +     G +P  IG L  L+ L    + 
Sbjct: 299 SLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHS 358

Query: 376 LEGSIPDSFGDLISLKSLNLSYNNLSGTI-PVSLEKLSYLKDLNLSFNKLKGEIPRGGSF 434
              S      + ++        + +      + L+    L   +L  + +    P     
Sbjct: 359 ETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAIN-RNPEMKPI 417

Query: 435 GNFSAESFKGNELLCGSPNLQVPP 458
              S  S K  ++   +  +    
Sbjct: 418 KKDSRISLKDTQIGNLTNRITFIS 441

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  231 bits (591), Expect = 1e-69
 Identities = 67/307 (21%), Positives = 124/307 (40%), Gaps = 22/307 (7%)

Query: 517 FSYLELFQATDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAM 576
                L+  +       +  RG FG V+KA++     VAVK+F +Q  ++++  + E   
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQ-NEYEVYS 71

Query: 577 MKSIRHRNLVKVISSCSNEEFKA----LVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMID 632
           +  ++H N+++ I +            L+  +   GSL  +L      +   +  +I   
Sbjct: 72  LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK--ANVVSWNELCHIAET 129

Query: 633 VASALEYLH-------FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMT 685
           +A  L YLH        G+   + H D+K  NVLL +N+ A ++DFG+A        +  
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGD 189

Query: 686 QTQTLATIGYMAPEYGREG-----QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMT-L 739
               + T  YMAPE                D+Y+ G++L E  +R    D   +  M   
Sbjct: 190 THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF 249

Query: 740 KHWVNDCLPISTM-EVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEI 798
           +  +     +  M EVV           +  K   ++ +     EC     E R++A  +
Sbjct: 250 EEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCV 309

Query: 799 VAKLLKI 805
             ++ ++
Sbjct: 310 GERITQM 316

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  238 bits (608), Expect = 9e-69
 Identities = 91/439 (20%), Positives = 162/439 (36%), Gaps = 27/439 (6%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHE-IGHLHNLGFLDLSQNKLLGTIPAA 64
              L S     I ++  LK L + +N +Q   + E   +L NL  LDLS NK+       
Sbjct: 109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD 168

Query: 65  IFNVSTLKAFAVTNNSLSGCLSSITD--VGLPNLEVLYLWGNNFSGTIPHFIFNA-SKLS 121
           +  +  +    ++ +     ++ I         L  L L  N  S  +        + L 
Sbjct: 169 LRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLE 228

Query: 122 KLALEMNSFSG------FIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTH 175
              L +  F        F  S    L NL         L     D+      +   +++ 
Sbjct: 229 VHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDII--DLFNCLTNVSS 286

Query: 176 ISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNG 235
            SL +  ++ +   +Y    +   ++  + NC        ++ +L  LT          G
Sbjct: 287 FSLVSVTIERVKDFSY----NFGWQHLELVNCKFGQFPTLKLKSLKRLTF-----TSNKG 337

Query: 236 SIPITLGKLQKLQDVDLEYNQL--EGSIPDSICLSVELYELELGGNKLSGSIPACFSNMT 293
               +   L  L+ +DL  N L  +G    S   +  L  L+L  N +   + + F  + 
Sbjct: 338 GNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLE 396

Query: 294 FLKVLSLGSNELTSIPLN--FWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNN 351
            L+ L    + L  +     F SL++++ L++S              L +L  +  + N+
Sbjct: 397 QLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNS 456

Query: 352 FSG-IIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEK 410
           F    +P     L+NL  L L   +LE   P +F  L SL+ LN+S+NN         + 
Sbjct: 457 FQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKC 516

Query: 411 LSYLKDLNLSFNKLKGEIP 429
           L+ L+ L+ S N +     
Sbjct: 517 LNSLQVLDYSLNHIMTSKK 535

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  230 bits (588), Expect = 6e-66
 Identities = 83/447 (18%), Positives = 144/447 (32%), Gaps = 27/447 (6%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAI 65
            N L         +   L+VL L    +Q         L +L  L L+ N +      A 
Sbjct: 37  FNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAF 96

Query: 66  FNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNF-SGTIPHFIFNASKLSKLA 124
             +S+L+       +L+  L +     L  L+ L +  N   S  +P +  N + L  L 
Sbjct: 97  SGLSSLQKLVAVETNLAS-LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLD 155

Query: 125 LEMNSFSGFIPSTFGNLRNLE----WLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSN 180
           L  N       +    L  +      L L  N +    +       +     L  ++L N
Sbjct: 156 LSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF--IQPGAFKEI----RLHKLTLRN 209

Query: 181 NPLDGILPRTYVGNLSHS-----LKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNG 235
           N     + +T +  L+       +   +    N+       +  L +LT        L+ 
Sbjct: 210 NFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDY 269

Query: 236 S---IPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNM 292
               I      L  +    L    +E     S         LEL   K          ++
Sbjct: 270 YLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFG--WQHLELVNCKFGQFPTLKLKSL 327

Query: 293 TFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNF 352
             L   S       S  ++  SL+  LDL+ +   F G          +L  +D S N  
Sbjct: 328 KRLTFTSNKGGNAFSE-VDLPSLE-FLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGV 385

Query: 353 SGIIPMEIGSLKNLENLFLEYNRLEGSIPDS-FGDLISLKSLNLSYNNLSGTIPVSLEKL 411
             +       L+ LE+L  +++ L+     S F  L +L  L++S+ +           L
Sbjct: 386 ITMSS-NFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGL 444

Query: 412 SYLKDLNLSFNKLKGEIPRGGSFGNFS 438
           S L+ L ++ N  +        F    
Sbjct: 445 SSLEVLKMAGNSFQENFLP-DIFTELR 470

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  226 bits (578), Expect = 1e-64
 Identities = 91/462 (19%), Positives = 162/462 (35%), Gaps = 47/462 (10%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGF----LDLSQNKLLGTI 61
           N   +   P+   N++NL+ L L +N++Q     ++  LH +      LDLS N +   I
Sbjct: 134 NLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-I 192

Query: 62  PAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGT--IPHFIFNA-S 118
               F    L    + NN  S  +      GL  LEV  L    F     +  F  +A  
Sbjct: 193 QPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALE 252

Query: 119 KLSKLALEMNSFS------GFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKS 172
            L  L +E    +        I   F  L N+   +L    +         +   S    
Sbjct: 253 GLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-------VKDFSYNFG 305

Query: 173 LTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNC-------------------NVSGGI 213
             H+ L N                 +  +    N                    +  G  
Sbjct: 306 WQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCC 365

Query: 214 PEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVE-LY 272
            +     T L  + L  N +   +      L++L+ +D +++ L+     S+ LS+  L 
Sbjct: 366 SQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLI 424

Query: 273 ELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTS--IPLNFWSLKDILDLNLSSNCFSG 330
            L++       +    F+ ++ L+VL +  N      +P  F  L+++  L+LS      
Sbjct: 425 YLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ 484

Query: 331 PLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLI-S 389
             P    +L +L  ++ S NNF  +       L +L+ L    N +  S          S
Sbjct: 485 LSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSS 544

Query: 390 LKSLNLSYNNLSGTIPVS--LEKLSYLKDLNLSFNKLKGEIP 429
           L  LNL+ N+ + T      L+ +   + L +   +++   P
Sbjct: 545 LAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATP 586

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  211 bits (540), Expect = 2e-59
 Identities = 85/432 (19%), Positives = 144/432 (33%), Gaps = 52/432 (12%)

Query: 21  SNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNS 80
            + K L L  N L+    +       L  LDLS+ ++      A  +             
Sbjct: 28  FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQS------------- 74

Query: 81  LSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGN 140
                       L +L  L L GN             S L KL     + +       G+
Sbjct: 75  ------------LSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGH 122

Query: 141 LRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVG--NLSHS 198
           L+ L+ L +  N + S  L   F    SN  +L H+ LS+N +  I          +   
Sbjct: 123 LKTLKELNVAHNLIQSFKLPEYF----SNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLL 178

Query: 199 LKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIP-ITLGKLQKLQDVDLEYNQL 257
             +  +    ++   P     +  L  + L  N  + ++    +  L  L+   L   + 
Sbjct: 179 NLSLDLSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEF 237

Query: 258 EGSI---PDSICLSVELYELELGGNKLS------GSIPACFSNMTFLKVLSLGSNELTSI 308
                           L  L +   +L+        I   F+ +T +   SL S  +  +
Sbjct: 238 RNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERV 297

Query: 309 PLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLEN 368
             +F        L L +  F     L++++LK L     +  +  G        L +LE 
Sbjct: 298 K-DFSYNFGWQHLELVNCKFGQFPTLKLKSLKRL-----TFTSNKGGNAFSEVDLPSLEF 351

Query: 369 LFLEYNRL--EGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKG 426
           L L  N L  +G    S     SLK L+LS+N +  T+  +   L  L+ L+   + LK 
Sbjct: 352 LDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQ 410

Query: 427 EIPRGGSFGNFS 438
                  F +  
Sbjct: 411 MSEF-SVFLSLR 421

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  175 bits (447), Expect = 8e-47
 Identities = 74/379 (19%), Positives = 123/379 (32%), Gaps = 47/379 (12%)

Query: 85  LSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNL 144
              I D    + + L L  N       +  F+  +L  L L            + +L +L
Sbjct: 19  FYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78

Query: 145 EWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYM 204
             L L  N + S  L      + S   SL  +      L  +     +G+L  +LK   +
Sbjct: 79  STLILTGNPIQSLALG-----AFSGLSSLQKLVAVETNLASLENFP-IGHLK-TLKELNV 131

Query: 205 -YNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDV----DLEYNQLEG 259
            +N   S  +PE  +NLT+L  + L  NK+       L  L ++  +    DL  N +  
Sbjct: 132 AHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF 191

Query: 260 SIPDSICLSVELYELELGGNKLSGSIPA-CFSNMTFLKVLSLGSNELTS-------IPLN 311
            I       + L++L L  N  S ++   C   +  L+V  L   E  +           
Sbjct: 192 -IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 250

Query: 312 FWSLK--DILDLNLSS-NCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLEN 368
              L    I +  L+  + +   +      L  +            +           ++
Sbjct: 251 LEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQH 308

Query: 369 LFLEYNRLEGSIPDSFGDLIS-------------------LKSLNLSYNNLS--GTIPVS 407
           L L   +           L                     L+ L+LS N LS  G    S
Sbjct: 309 LELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQS 368

Query: 408 LEKLSYLKDLNLSFNKLKG 426
               + LK L+LSFN +  
Sbjct: 369 DFGTTSLKYLDLSFNGVIT 387

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  147 bits (373), Expect = 3e-37
 Identities = 49/259 (18%), Positives = 84/259 (32%), Gaps = 15/259 (5%)

Query: 194 NLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLE 253
           NL  S KN  +    +         +  +L  + L   ++          L  L  + L 
Sbjct: 25  NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILT 84

Query: 254 YNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPL--N 311
            N ++     +      L +L      L+        ++  LK L++  N + S  L   
Sbjct: 85  GNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEY 144

Query: 312 FWSLKDILDLNLSSNCFSGPLPLEIRNLKAL----IEIDFSMNNFSGIIPMEIGSLKNLE 367
           F +L ++  L+LSSN        ++R L  +    + +D S+N  + I P        L 
Sbjct: 145 FSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQP-GAFKEIRLH 203

Query: 368 NLFLEYNRLEGSIP-DSFGDLISLKSLNLSYN------NLSGTIPVSLEKLSYLKDLNLS 420
            L L  N    ++       L  L+   L         NL      +LE L  L      
Sbjct: 204 KLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFR 263

Query: 421 FNKLKGEIPRG-GSFGNFS 438
              L   +      F   +
Sbjct: 264 LAYLDYYLDDIIDLFNCLT 282

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  138 bits (349), Expect = 3e-34
 Identities = 52/331 (15%), Positives = 97/331 (29%), Gaps = 64/331 (19%)

Query: 1   MPSIINNFLTSTTPKEIDNISNLKVLYLYNNRLQ--GEIIHEIGHLHNLGFLDLSQNKLL 58
           +  +              ++ +L+ L L  N L   G          +L +LDLS N ++
Sbjct: 327 LKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI 386

Query: 59  GTIPAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIF-NA 117
            T+ +                             L  LE L    +N        +F + 
Sbjct: 387 -TMSSNFLG-------------------------LEQLEHLDFQHSNLKQMSEFSVFLSL 420

Query: 118 SKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHIS 177
             L  L +            F  L +LE L +  N+   + L        +  ++LT + 
Sbjct: 421 RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL----PDIFTELRNLTFLD 476

Query: 178 LSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSI 237
           LS   L+ +                           P    +L+ L  + +  N      
Sbjct: 477 LSQCQLEQL--------------------------SPTAFNSLSSLQVLNMSHNNFFSLD 510

Query: 238 PITLGKLQKLQDVDLEYNQLEGSIPDSIC-LSVELYELELGGNKLSGSIPAC--FSNMTF 294
                 L  LQ +D   N +  S    +      L  L L  N  + +         +  
Sbjct: 511 TFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKD 570

Query: 295 LKVLSLGSNELT-SIPLNFWSLKDILDLNLS 324
            + L +    +  + P +   +  +L LN++
Sbjct: 571 QRQLLVEVERMECATPSDKQGMP-VLSLNIT 600

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  112 bits (282), Expect = 8e-26
 Identities = 34/151 (22%), Positives = 54/151 (35%), Gaps = 4/151 (2%)

Query: 288 CFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDF 347
           C   +  +    +  N    IP N        +L+LS N           +   L  +D 
Sbjct: 3   CVEVVPNITYQCMELN-FYKIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDL 59

Query: 348 SMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVS 407
           S      I      SL +L  L L  N ++     +F  L SL+ L     NL+      
Sbjct: 60  SRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFP 119

Query: 408 LEKLSYLKDLNLSFNKLKGEIPRGGSFGNFS 438
           +  L  LK+LN++ N ++        F N +
Sbjct: 120 IGHLKTLKELNVAHNLIQS-FKLPEYFSNLT 149

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  226 bits (579), Expect = 1e-64
 Identities = 84/442 (19%), Positives = 148/442 (33%), Gaps = 20/442 (4%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAI 65
            N L       +     LK L+     +       + +   L  L L  N +        
Sbjct: 90  ANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKG 149

Query: 66  FNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLW-GNNFSGTIPHFIFNASKLSKLA 124
           F    LK     NN++   LS      L     L L    N    I    F+++    L 
Sbjct: 150 FPTEKLKVLDFQNNAIHY-LSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLN 208

Query: 125 LEMNSFSGFIPS--TFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNP 182
                    I        +++L   T  D +     +  +    L    S+  I+L  + 
Sbjct: 209 FGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDED--ISPAVFEGLCEM-SVESINLQKHY 265

Query: 183 LDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLG 242
              I   T     S  L+   +   ++S  +P  +  L+ L  +VL  NK      I+  
Sbjct: 266 FFNISSNT-FHCFS-GLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISAS 322

Query: 243 KLQKLQDVDLEYNQLEGSIPDSICLSVE-LYELELGGNKL--SGSIPACFSNMTFLKVLS 299
               L  + ++ N     +      ++E L EL+L  + +  S        N++ L+ L+
Sbjct: 323 NFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLN 382

Query: 300 LGSNELTSIPLN-FWSLKDILDLNLSSNCFSGPLPLEI-RNLKALIEIDFSMNNFSGIIP 357
           L  NE  S+    F     +  L+L+             +NL  L  ++ S +       
Sbjct: 383 LSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSE 442

Query: 358 MEIGSLKNLENLFLEYNRLEGSI---PDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYL 414
                L  L++L L+ N          +S   L  L+ L LS+ +LS     +   L  +
Sbjct: 443 QLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMM 502

Query: 415 KDLNLSFNKLKGEIPRGGSFGN 436
             ++LS N+L        +  +
Sbjct: 503 NHVDLSHNRLTSSSI--EALSH 522

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  224 bits (572), Expect = 8e-64
 Identities = 85/425 (20%), Positives = 144/425 (33%), Gaps = 39/425 (9%)

Query: 21  SNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNS 80
           ++ + L    N L          L NL FLDL++ ++         +   L    +T N 
Sbjct: 33  NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANP 92

Query: 81  LSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGN 140
           L   ++     G   L+ L+      S      + N   L  L L  N  S         
Sbjct: 93  LIF-MAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFP 151

Query: 141 LRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLK 200
              L+ L   +N +    L    +SSL    +L+ ++L+ N +                 
Sbjct: 152 TEKLKVLDFQNNAIHY--LSKEDMSSLQQATNLS-LNLNGNDI----------------- 191

Query: 201 NFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLG--KLQKLQDVDLEYNQLE 258
                      GI     +     ++  GG +    I   L    +Q L     E    E
Sbjct: 192 ----------AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDE 241

Query: 259 GSIPDSI--CLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLK 316
              P        + +  + L  +         F   + L+ L L +  L+ +P     L 
Sbjct: 242 DISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLS 301

Query: 317 DILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPME-IGSLKNLENLFLEYNR 375
            +  L LS+N F     +   N  +L  +    N     +    + +L+NL  L L ++ 
Sbjct: 302 TLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDD 361

Query: 376 LEGS--IPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIPRGGS 433
           +E S        +L  L+SLNLSYN        + ++   L+ L+L+F +LK        
Sbjct: 362 IETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKV-KDAQSP 420

Query: 434 FGNFS 438
           F N  
Sbjct: 421 FQNLH 425

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  216 bits (552), Expect = 5e-61
 Identities = 86/447 (19%), Positives = 157/447 (35%), Gaps = 27/447 (6%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAI 65
              ++S     + N   L+ LYL +N +    + +      L  LD   N +       +
Sbjct: 114 QTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDM 173

Query: 66  FNVSTLKAFAV--TNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNAS--KLS 121
            ++      ++    N ++G      D      + L   G      I   + N++   L 
Sbjct: 174 SSLQQATNLSLNLNGNDIAGIEPGAFD--SAVFQSLNFGGTQNLLVIFKGLKNSTIQSLW 231

Query: 122 KLALEMNSFSGFIPSTFGNLR--NLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLS 179
               E        P+ F  L   ++E + L  +   + + +     +      L  + L+
Sbjct: 232 LGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSN-----TFHCFSGLQELDLT 286

Query: 180 NNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSI-P 238
              L  +     +  LS +LK   +             +N   LT + + GN     +  
Sbjct: 287 ATHLSELPS--GLVGLS-TLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGT 343

Query: 239 ITLGKLQKLQDVDLEYNQLEGSIPDSICLS--VELYELELGGNKLSGSIPACFSNMTFLK 296
             L  L+ L+++DL ++ +E S   ++ L     L  L L  N+        F     L+
Sbjct: 344 GCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLE 403

Query: 297 VLSLGSNELTSIPLN--FWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSG 354
           +L L    L        F +L  +  LNLS +            L AL  ++   N+F  
Sbjct: 404 LLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPK 463

Query: 355 IIPMEIGS---LKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKL 411
               +  S   L  LE L L +  L      +F  L  +  ++LS+N L+ +   +L  L
Sbjct: 464 GNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHL 523

Query: 412 SYLKDLNLSFNKLKGEIPRGGSFGNFS 438
             +  LNL+ N +   +P        S
Sbjct: 524 KGIY-LNLASNHISIILP--SLLPILS 547

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  194 bits (496), Expect = 2e-53
 Identities = 85/410 (20%), Positives = 150/410 (36%), Gaps = 21/410 (5%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQ-GEIIHEIGHLHNLGFLDLSQNKLLGTIPAA 64
           NN +   + +++ ++     L L  N      I            L+    + L  I   
Sbjct: 162 NNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKG 221

Query: 65  IFN--VSTLKAFAVTNNSLSGCLSSITDVGLP--NLEVLYLWGNNFSGTIPHFIFNASKL 120
           + N  + +L      +      +S     GL   ++E + L  + F     +     S L
Sbjct: 222 LKNSTIQSLWLGTFEDMDDED-ISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGL 280

Query: 121 SKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSN 180
            +L L     S  +PS    L  L+ L L  N   +         S SN  SLTH+S+  
Sbjct: 281 QELDLTATHLSE-LPSGLVGLSTLKKLVLSANKFENLCQ-----ISASNFPSLTHLSIKG 334

Query: 181 NPLDGILPRTYVGNLSHSLKNFYMYNCN--VSGGIPEEITNLTDLTTIVLGGNKLNGSIP 238
           N     L    + NL  +L+   + + +   S     ++ NL+ L ++ L  N+      
Sbjct: 335 NTKRLELGTGCLENLE-NLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKT 393

Query: 239 ITLGKLQKLQDVDLEYNQLEGSIPDSICLSVE-LYELELGGNKLSGSIPACFSNMTFLKV 297
               +  +L+ +DL + +L+     S   ++  L  L L  + L  S    F  +  L+ 
Sbjct: 394 EAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQH 453

Query: 298 LSLGSNELTSIPL----NFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFS 353
           L+L  N      +    +  +L  +  L LS    S        +LK +  +D S N  +
Sbjct: 454 LNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLT 513

Query: 354 GIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGT 403
                 +  LK +  L L  N +   +P     L   +++NL  N L  T
Sbjct: 514 SSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQRTINLRQNPLDCT 562

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  185 bits (471), Expect = 6e-50
 Identities = 68/360 (18%), Positives = 118/360 (32%), Gaps = 17/360 (4%)

Query: 85  LSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNL 144
           L+ I      + E L    N               L+ L L           TF +   L
Sbjct: 24  LNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRL 83

Query: 145 EWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYM 204
           + L L  N L           +LS  K+L H+      +  I     + N   +L++ Y+
Sbjct: 84  DTLVLTANPLIFMAET-----ALSGPKALKHLFFIQTGISSI-DFIPLHNQK-TLESLYL 136

Query: 205 YNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQ--DVDLEYNQLEGSIP 262
            + ++S     +      L  +    N ++      +  LQ+     ++L  N +   I 
Sbjct: 137 GSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA-GIE 195

Query: 263 DSICLSVELYELELGGNKLSGSIPACFSNMTF--LKVLSLGSNELTSIP---LNFWSLKD 317
                S     L  GG +    I     N T   L + +    +   I            
Sbjct: 196 PGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMS 255

Query: 318 ILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLE 377
           +  +NL  + F             L E+D +  + S  +P  +  L  L+ L L  N+ E
Sbjct: 256 VESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSE-LPSGLVGLSTLKKLVLSANKFE 314

Query: 378 GSIPDSFGDLISLKSLNLSYNNLSGTI-PVSLEKLSYLKDLNLSFNKLKGEIPRGGSFGN 436
                S  +  SL  L++  N     +    LE L  L++L+LS + ++          N
Sbjct: 315 NLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRN 374

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  174 bits (444), Expect = 2e-46
 Identities = 81/405 (20%), Positives = 136/405 (33%), Gaps = 20/405 (4%)

Query: 6   NNFLTSTTPKEIDN--ISNLKVLYLYNNRLQGEIIHEIGHLHNLG--FLDLSQNKLLGTI 61
                    K + N  I +L +    +   +         L  +    ++L ++      
Sbjct: 211 GTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNIS 270

Query: 62  PAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLS 121
                  S L+   +T   LS   S +   GL  L+ L L  N F         N   L+
Sbjct: 271 SNTFHCFSGLQELDLTATHLSELPSGLV--GLSTLKKLVLSANKFENLCQISASNFPSLT 328

Query: 122 KLALEMNSFSGFIPS-TFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSN 180
            L+++ N+    + +    NL NL  L L  +++ +S         L N   L  ++LS 
Sbjct: 329 HLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNL---QLRNLSHLQSLNLSY 385

Query: 181 NPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEI-TNLTDLTTIVLGGNKLNGSIPI 239
           N    +    +       L+   +    +     +    NL  L  + L  + L+ S   
Sbjct: 386 NEPLSLKTEAFKE--CPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQ 443

Query: 240 TLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELE---LGGNKLSGSIPACFSNMTFLK 296
               L  LQ ++L+ N               L  LE   L    LS      F+++  + 
Sbjct: 444 LFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMN 503

Query: 297 VLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGII 356
            + L  N LTS  +   S    + LNL+SN  S  LP  +  L     I+   N      
Sbjct: 504 HVDLSHNRLTSSSIEALSHLKGIYLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTC 563

Query: 357 PMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLS 401
                 +  LE       +LE +      +   L+ + LS   LS
Sbjct: 564 SN----IYFLEWYKENMQKLEDTEDTLCENPPLLRGVRLSDVTLS 604

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  133 bits (337), Expect = 1e-32
 Identities = 47/270 (17%), Positives = 87/270 (32%), Gaps = 13/270 (4%)

Query: 175 HISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLN 234
             +  N  L+ I P    G L +S +        +        + L +LT + L   ++ 
Sbjct: 16  TYNCENLGLNEI-P----GTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIY 70

Query: 235 GSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTF 294
                T     +L  + L  N L      ++     L  L      +S        N   
Sbjct: 71  WIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKT 130

Query: 295 LKVLSLGSNELTSIPLN-FWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMN-NF 352
           L+ L LGSN ++SI L   +  + +  L+  +N        ++ +L+    +  ++N N 
Sbjct: 131 LESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGND 190

Query: 353 SGIIPMEIGSLKNLENLFLEYNRLEGSIPD--SFGDLISLKSLNLSYNNLSGTIPVSLEK 410
              I          ++L     +    I        + SL        +     P   E 
Sbjct: 191 IAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEG 250

Query: 411 LS--YLKDLNLSFNKLKGEIPRGGSFGNFS 438
           L    ++ +NL  +          +F  FS
Sbjct: 251 LCEMSVESINLQKHYFFNISS--NTFHCFS 278

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  124 bits (314), Expect = 8e-30
 Identities = 47/207 (22%), Positives = 72/207 (34%), Gaps = 6/207 (2%)

Query: 250 VDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIP 309
            + E   L   IP +  L      LE   N L       FS +  L  L L   ++  I 
Sbjct: 17  YNCENLGLN-EIPGT--LPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIH 73

Query: 310 LN-FWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLEN 368
            + F S   +  L L++N         +   KAL  + F     S I  + + + K LE+
Sbjct: 74  EDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLES 133

Query: 369 LFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLK--DLNLSFNKLKG 426
           L+L  N +             LK L+   N +       +  L       LNL+ N + G
Sbjct: 134 LYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG 193

Query: 427 EIPRGGSFGNFSAESFKGNELLCGSPN 453
             P       F + +F G + L     
Sbjct: 194 IEPGAFDSAVFQSLNFGGTQNLLVIFK 220

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  102 bits (257), Expect = 8e-23
 Identities = 26/143 (18%), Positives = 37/143 (25%), Gaps = 4/143 (2%)

Query: 296 KVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGI 355
           K  +  +  L  IP           L  S N            L  L  +D +      I
Sbjct: 15  KTYNCENLGLNEIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWI 72

Query: 356 IPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLK 415
                 S   L+ L L  N L      +     +LK L      +S    + L     L+
Sbjct: 73  HEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLE 132

Query: 416 DLNLSFNKLKGEIPRGGSFGNFS 438
            L L  N +              
Sbjct: 133 SLYLGSNHISSIKL--PKGFPTE 153

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  208 bits (532), Expect = 3e-61
 Identities = 79/288 (27%), Positives = 128/288 (44%), Gaps = 27/288 (9%)

Query: 527 DKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRN 584
              +    IG G FG+V++A    G +VAVK+   Q         F  E A+MK +RH N
Sbjct: 37  CDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPN 95

Query: 585 LVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSN--YSLDIFQRLNIMIDVASALEYLHF 642
           +V  + + +     ++V EY+  GSL + LH S     LD  +RL++  DVA  + YLH 
Sbjct: 96  IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH- 154

Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
             + P++H +LK  N+L+D      + DFG+++L      S        T  +MAPE  R
Sbjct: 155 NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSS--KSAAGTPEWMAPEVLR 212

Query: 703 EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ 762
           +   +   DVYSFG++L E  T ++P    +               ++  +VV A  +  
Sbjct: 213 DEPSNEKSDVYSFGVILWELATLQQP----WGN-------------LNPAQVVAA--VGF 253

Query: 763 EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLL 810
           +             V  +   C    P +R +   I+  L  +  S +
Sbjct: 254 KCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  206 bits (525), Expect = 1e-60
 Identities = 71/297 (23%), Positives = 127/297 (42%), Gaps = 46/297 (15%)

Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRA-------FKSFDVECAMMK 578
           ++      IG+GGFG V+K R ++D   VA+K   L            F+ F  E  +M 
Sbjct: 19  NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78

Query: 579 SIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALE 638
           ++ H N+VK+     N     +V+E++P G L   L    + +    +L +M+D+A  +E
Sbjct: 79  NLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIE 136

Query: 639 YLHFGYSAPVIHCDLKPSNVLLD-----DNMVAHLSDFGIAKLLTGEDQSMTQTQTLATI 693
           Y+    + P++H DL+  N+ L        + A ++DFG+++         + +  L   
Sbjct: 137 YMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNF 190

Query: 694 GYMAPE--YGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDC---LP 748
            +MAPE     E   +   D YSF ++L    T + P DE   G++   + + +      
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPT 250

Query: 749 ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKI 805
           I                     E C   + N+   C    P++R +   IV +L ++
Sbjct: 251 IP--------------------EDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  202 bits (516), Expect = 2e-59
 Identities = 66/281 (23%), Positives = 120/281 (42%), Gaps = 36/281 (12%)

Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSC 592
           +     G ++K R + G ++ VKV  ++    R  + F+ EC  ++   H N++ V+ +C
Sbjct: 18  LNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76

Query: 593 SNEEFK--ALVLEYMPHGSLEKYLHS-SNYSLDIFQRLNIMIDVASALEYLHFGYSAPVI 649
            +       L+  +MP+GSL   LH  +N+ +D  Q +   +D+A  + +LH      + 
Sbjct: 77  QSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLEPLIP 135

Query: 650 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTN 709
              L   +V++D++M A +S   +         S      +    ++APE  ++    TN
Sbjct: 136 RHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAWVAPEALQKKPEDTN 188

Query: 710 G---DVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIH 766
               D++SF ++L E  TR+ P    F               +S ME+     ++ E + 
Sbjct: 189 RRSADMWSFAVLLWELVTREVP----FAD-------------LSNMEIGMK--VALEGLR 229

Query: 767 FVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRD 807
                     V  L   C  E P +R     IV  L K++D
Sbjct: 230 PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  202 bits (517), Expect = 2e-59
 Identities = 71/273 (26%), Positives = 127/273 (46%), Gaps = 26/273 (9%)

Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSC 592
           IG G FG+VYK +     +VAVK+ N+     +  ++F  E  +++  RH N++  +   
Sbjct: 32  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89

Query: 593 SNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
           +  +  A+V ++    SL  +LH+S    ++ + ++I    A  ++YLH   +  +IH D
Sbjct: 90  TAPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRD 145

Query: 653 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPE---YGREGQVSTN 709
           LK +N+ L ++    + DFG+A   +    S    Q   +I +MAPE          S  
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205

Query: 710 GDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVA 769
            DVY+FGI+L E  T + P   + N +  +             E+V    LS +      
Sbjct: 206 SDVYAFGIVLYELMTGQLPYSNINNRDQII-------------EMVGRGSLSPDLS--KV 250

Query: 770 KEQCVSFVFNLALECTVESPEQRINAKEIVAKL 802
           +  C   +  L  EC  +  ++R +   I+A++
Sbjct: 251 RSNCPKRMKRLMAECLKKKRDERPSFPRILAEI 283

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  203 bits (518), Expect = 2e-59
 Identities = 78/288 (27%), Positives = 120/288 (41%), Gaps = 35/288 (12%)

Query: 527 DKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLV 586
            +     ++GRG FG V KA+ R   +VA+K    +     K+F VE   +  + H N+V
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIV 64

Query: 587 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSN--YSLDIFQRLNIMIDVASALEYLHFGY 644
           K+  +C N     LV+EY   GSL   LH +           ++  +  +  + YLH   
Sbjct: 65  KLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122

Query: 645 SAPVIHCDLKPSNVLLDDNM-VAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE 703
              +IH DLKP N+LL     V  + DFG A      D     T    +  +MAPE    
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEG 177

Query: 704 GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCL--PISTMEVVDANLLS 761
              S   DV+S+GI+L E  TR+KP DE+      +   V++    P+            
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLI----------- 226

Query: 762 QEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSL 809
                    +     + +L   C  + P QR + +EIV  +  +    
Sbjct: 227 ---------KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  210 bits (537), Expect = 7e-59
 Identities = 84/437 (19%), Positives = 144/437 (32%), Gaps = 34/437 (7%)

Query: 6   NNFLTS-TTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGF----LDLSQNKLLGT 60
           +NF+ S   P    N++NL  + L  N +Q   ++++  L         LD+S N +   
Sbjct: 137 HNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPI-DF 195

Query: 61  IPAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKL 120
           I    F    L    +  N  S  +       L  L V  L    F       IF  S +
Sbjct: 196 IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIM 255

Query: 121 SKLA--------LEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKS 172
             L         L   +        F  L N+  ++L   ++         L  +     
Sbjct: 256 EGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY-------LEDVPKHFK 308

Query: 173 LTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNK 232
              +S+    L          +L   LK+  +     S  I  +   L  L+ + L  N 
Sbjct: 309 WQSLSIIRCQLKQFPT----LDLPF-LKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNA 361

Query: 233 LNGSIPITL--GKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPA-CF 289
           L+ S   +        L+ +DL +N     +  +     EL  L+   + L        F
Sbjct: 362 LSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAF 420

Query: 290 SNMTFLKVLSLGSNELTSIPLN-FWSLKDILDLNLSSNCFSGPLPLEI-RNLKALIEIDF 347
            ++  L  L +            F  L  +  L ++ N F       +  N   L  +D 
Sbjct: 421 LSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDL 480

Query: 348 SMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVS 407
           S      I      +L  L+ L + +N L       +  L SL +L+ S+N +  +  + 
Sbjct: 481 SKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGIL 540

Query: 408 LEKLSYLKDLNLSFNKL 424
                 L   NL+ N +
Sbjct: 541 QHFPKSLAFFNLTNNSV 557

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  209 bits (535), Expect = 1e-58
 Identities = 86/444 (19%), Positives = 145/444 (32%), Gaps = 22/444 (4%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAI 65
              + +   K    + +L  L L  N +Q         L +L  L   + KL       I
Sbjct: 65  RCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPI 124

Query: 66  FNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLS---- 121
             + TLK   V +N +  C        L NL  + L  N       + +    +      
Sbjct: 125 GQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNL 184

Query: 122 KLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSF--LSSLSNCKSLTHISLS 179
            L + +N         F  +  L  LTL  N  +S+ +      L+ L   + +      
Sbjct: 185 SLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKD 243

Query: 180 NNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPI 239
              L+   P    G    ++  F +   N       +   L +++ + L G  +     +
Sbjct: 244 ERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDV 303

Query: 240 TLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLS 299
              K  K Q + +   QL+   P        L  L L  NK S S       +  L  L 
Sbjct: 304 P--KHFKWQSLSIIRCQLK-QFPTLDLPF--LKSLTLTMNKGSISFK--KVALPSLSYLD 356

Query: 300 LGSNELTSIP---LNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGII 356
           L  N L+       +      +  L+LS N     +      L+ L  +DF  +    + 
Sbjct: 357 LSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVT 415

Query: 357 PME-IGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVS-LEKLSYL 414
                 SL+ L  L + Y   +      F  L SL +L ++ N+       +     + L
Sbjct: 416 EFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNL 475

Query: 415 KDLNLSFNKLKGEIPRGGSFGNFS 438
             L+LS  +L+      G F    
Sbjct: 476 TFLDLSKCQLEQISW--GVFDTLH 497

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  193 bits (492), Expect = 9e-53
 Identities = 83/429 (19%), Positives = 138/429 (32%), Gaps = 51/429 (11%)

Query: 21  SNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNS 80
           S+ K + L  N L+    +   +   L +LDLS+ ++      A                
Sbjct: 32  SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAW--------------- 76

Query: 81  LSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGN 140
                      GL +L  L L GN      P      + L  L       +       G 
Sbjct: 77  ----------HGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQ 126

Query: 141 LRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRT--YVGNLSHS 198
           L  L+ L +  N + S  L   F    SN  +L H+ LS N +  I      ++      
Sbjct: 127 LITLKKLNVAHNFIHSCKLPAYF----SNLTNLVHVDLSYNYIQTITVNDLQFLRENPQV 182

Query: 199 LKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIP-ITLGKLQKLQDVDLEYNQL 257
             +  M    +   I ++      L  + L GN  + +I    L  L  L    L   + 
Sbjct: 183 NLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEF 241

Query: 258 EGSIPDSIC--------LSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIP 309
           +      I           V + E  L            F  +  +  +SL    +  + 
Sbjct: 242 KDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLE 301

Query: 310 LNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENL 369
            +         L++              +L  L  +  +MN  S        +L +L  L
Sbjct: 302 -DVPKHFKWQSLSIIRCQLKQ---FPTLDLPFLKSLTLTMNKGSISFK--KVALPSLSYL 355

Query: 370 FLEYNRLEGSIPDSFGDL--ISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGE 427
            L  N L  S   S+ DL   SL+ L+LS+N     +  +   L  L+ L+   + LK  
Sbjct: 356 DLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKR- 413

Query: 428 IPRGGSFGN 436
           +    +F +
Sbjct: 414 VTEFSAFLS 422

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  176 bits (449), Expect = 5e-47
 Identities = 75/406 (18%), Positives = 126/406 (31%), Gaps = 47/406 (11%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGH-LHNLGFLDLSQNKLLGTIPAA 64
            N +     +    I  L  L L  N     I+      L  L    L   +        
Sbjct: 190 LNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLE 248

Query: 65  IFNVSTLKAFA-VTNNSLSGCLSSITDV------GLPNLEVLYLWGNNFSGTIPHFIFNA 117
           IF  S ++    VT +      ++           L N+  + L G +    +     + 
Sbjct: 249 IFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIK-YLEDVPKH- 306

Query: 118 SKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHIS 177
            K   L++       F      +L  L+ LTL  N         S         SL+++ 
Sbjct: 307 FKWQSLSIIRCQLKQF---PTLDLPFLKSLTLTMNKG-------SISFKKVALPSLSYLD 356

Query: 178 LSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSI 237
           LS N L      +Y    ++SL++  +        +      L +L  +    + L    
Sbjct: 357 LSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVT 415

Query: 238 PI-TLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPAC-FSNMTFL 295
                  L+KL  +D+ Y   +            L  L++ GN    +  +  F+N T L
Sbjct: 416 EFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNL 475

Query: 296 KVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGI 355
             L L   +L  I                              L  L  ++ S NN   +
Sbjct: 476 TFLDLSKCQLEQIS-----------------------WGVFDTLHRLQLLNMSHNNLLFL 512

Query: 356 IPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLS 401
                  L +L  L   +NR+E S         SL   NL+ N+++
Sbjct: 513 DSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  144 bits (364), Expect = 4e-36
 Identities = 53/321 (16%), Positives = 107/321 (33%), Gaps = 18/321 (5%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAI 65
                S    +   ++N+  + L    +  + + ++        L + + +L       +
Sbjct: 270 YTNDFSDDIVKFHCLANVSAMSLAGVSI--KYLEDVPKHFKWQSLSIIRCQLKQFPTLDL 327

Query: 66  FNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPH--FIFNASKLSKL 123
             + +L    +T N  S        V LP+L  L L  N  S +          + L  L
Sbjct: 328 PFLKSLT---LTMNKGSISFKK---VALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHL 381

Query: 124 ALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPL 183
            L  N     + + F  L  L+ L    + L      ++  S+  + + L ++ +S    
Sbjct: 382 DLSFNGAII-MSANFMGLEELQHLDFQHSTLKR----VTEFSAFLSLEKLLYLDISYTNT 436

Query: 184 DGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEI-TNLTDLTTIVLGGNKLNGSIPITLG 242
                  ++G    SL    M   +        +  N T+LT + L   +L         
Sbjct: 437 KIDFDGIFLGL--TSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFD 494

Query: 243 KLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGS 302
            L +LQ +++ +N L             L  L+   N++  S          L   +L +
Sbjct: 495 TLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTN 554

Query: 303 NELTSIPLNFWSLKDILDLNL 323
           N +  I  +   L+ + +   
Sbjct: 555 NSVACICEHQKFLQWVKEQKQ 575

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  129 bits (326), Expect = 3e-31
 Identities = 46/290 (15%), Positives = 90/290 (31%), Gaps = 20/290 (6%)

Query: 162 SFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLT 221
           S    +    ++T     +  L  +       ++  S KN  +    +        +N +
Sbjct: 3   SLNPCIEVVPNIT-YQCMDQKLSKVPD-----DIPSSTKNIDLSFNPLKILKSYSFSNFS 56

Query: 222 DLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKL 281
           +L  + L   ++          L  L ++ L  N ++   P S      L  L     KL
Sbjct: 57  ELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKL 116

Query: 282 SGSIPACFSNMTFLKVLSLGSNELTSIPLN--FWSLKDILDLNLSSNCFSGPLPLEIRNL 339
           +         +  LK L++  N + S  L   F +L +++ ++LS N        +++ L
Sbjct: 117 ASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFL 176

Query: 340 KAL----IEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIP-DSFGDLISLKSLN 394
           +      + +D S+N    I   +      L  L L  N    +I      +L  L    
Sbjct: 177 RENPQVNLSLDMSLNPIDFIQD-QAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHR 235

Query: 395 LSYNNLSGTIPVS------LEKLSYLKDLNLSFNKLKGEIPRGGSFGNFS 438
           L          +       +E L  +                   F   +
Sbjct: 236 LILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLA 285

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  107 bits (269), Expect = 3e-24
 Identities = 37/157 (23%), Positives = 60/157 (38%), Gaps = 6/157 (3%)

Query: 283 GSIPACFSNMTFLKVLSLGSNELTSIPLN-FWSLKDILDLNLSSNCFSGPLPLEIRNLKA 341
           GS+  C   +  +        +L+ +P +   S K+   ++LS N           N   
Sbjct: 2   GSLNPCIEVVPNI-TYQCMDQKLSKVPDDIPSSTKN---IDLSFNPLKILKSYSFSNFSE 57

Query: 342 LIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLS 401
           L  +D S      I       L +L NL L  N ++   P SF  L SL++L      L+
Sbjct: 58  LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117

Query: 402 GTIPVSLEKLSYLKDLNLSFNKLKGEIPRGGSFGNFS 438
                 + +L  LK LN++ N +         F N +
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHS-CKLPAYFSNLT 153

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  202 bits (515), Expect = 1e-58
 Identities = 78/325 (24%), Positives = 123/325 (37%), Gaps = 33/325 (10%)

Query: 517 FSYLELFQATDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAM 576
            +  E     D      LIGRG +G+VYK  +     VAVKVF+    + F +       
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVFSFANRQNFINE-KNIYR 60

Query: 577 MKSIRHRNLVKVISSC-----SNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMI 631
           +  + H N+ + I               LV+EY P+GSL KYL    ++ D      +  
Sbjct: 61  VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS--LHTSDWVSSCRLAH 118

Query: 632 DVASALEYLH------FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMT 685
            V   L YLH        Y   + H DL   NVL+ ++    +SDFG++  LTG      
Sbjct: 119 SVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRP 178

Query: 686 QTQTLA------TIGYMAPEYGRE-------GQVSTNGDVYSFGIMLMETFTRKK---PT 729
             +  A      TI YMAPE                  D+Y+ G++  E F R     P 
Sbjct: 179 GEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238

Query: 730 DELFNGEMTLKHWVNDCLPISTME--VVDANLLSQEDIHFVAKEQCVSFVFNLALECTVE 787
           + +   +M  +  V +      M+  V       +    +      V  +     +C  +
Sbjct: 239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQ 298

Query: 788 SPEQRINAKEIVAKLLKIRDSLLRN 812
             E R+ A+    ++ ++     RN
Sbjct: 299 DAEARLTAQXAEERMAELMMIWERN 323

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  201 bits (514), Expect = 6e-57
 Identities = 95/424 (22%), Positives = 172/424 (40%), Gaps = 42/424 (9%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAI 65
           +  +          ++      L    +   +      L  +  L   +  +       +
Sbjct: 11  DTPINQIFT--DTALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGI--KSIDGV 64

Query: 66  FNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLAL 125
             ++ L     +NN L+  ++ +    L  L  + +  N  +   P  + N + L+ L L
Sbjct: 65  EYLNNLTQINFSNNQLTD-ITPLK--NLTKLVDILMNNNQIADITP--LANLTNLTGLTL 119

Query: 126 EMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDG 185
             N  +   P    NL NL  L L  N ++        +S+LS   SL  +S  N   D 
Sbjct: 120 FNNQITDIDP--LKNLTNLNRLELSSNTISD-------ISALSGLTSLQQLSFGNQVTD- 169

Query: 186 ILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQ 245
           + P   + NL+ +L+   + +  VS      +  LT+L +++   N+++   P  LG L 
Sbjct: 170 LKP---LANLT-TLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILT 221

Query: 246 KLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNEL 305
            L ++ L  NQL+     ++     L +L+L  N++S   P   S +T L  L LG+N++
Sbjct: 222 NLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQI 277

Query: 306 TSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKN 365
           ++I      L  + +L L+ N      P+   NLK L  +    NN S I P  + SL  
Sbjct: 278 SNIS-PLAGLTALTNLELNENQLEDISPIS--NLKNLTYLTLYFNNISDISP--VSSLTK 332

Query: 366 LENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLK 425
           L+ LF   N++      S  +L ++  L+  +N +S   P  L  L+ +  L L+     
Sbjct: 333 LQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWT 388

Query: 426 GEIP 429
               
Sbjct: 389 NAPV 392

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  192 bits (490), Expect = 1e-53
 Identities = 88/414 (21%), Positives = 167/414 (40%), Gaps = 38/414 (9%)

Query: 12  TTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTL 71
            +   ++ ++NL  +   NN+L    I  + +L  L  + ++ N++    P  + N++ L
Sbjct: 59  KSIDGVEYLNNLTQINFSNNQLTD--ITPLKNLTKLVDILMNNNQIADITP--LANLTNL 114

Query: 72  KAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFS 131
               + NN ++  +  +    L NL  L L  N  S      +   + L +L+   N  +
Sbjct: 115 TGLTLFNNQITD-IDPLK--NLTNLNRLELSSNTISDISA--LSGLTSLQQLSFG-NQVT 168

Query: 132 GFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTY 191
              P    NL  LE L +  N ++        +S L+   +L  +  +NN +  I P   
Sbjct: 169 DLKP--LANLTTLERLDISSNKVSD-------ISVLAKLTNLESLIATNNQISDITP--- 216

Query: 192 VGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVD 251
           +G L+ +L    +    +       + +LT+LT + L  N+++   P  L  L KL ++ 
Sbjct: 217 LGILT-NLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELK 271

Query: 252 LEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLN 311
           L  NQ+    P  +     L  LEL  N+L    P   SN+  L  L+L  N ++ I   
Sbjct: 272 LGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDIS-P 326

Query: 312 FWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFL 371
             SL  +  L   +N  S    L   NL  +  +    N  S + P  + +L  +  L L
Sbjct: 327 VSSLTKLQRLFFYNNKVSDVSSLA--NLTNINWLSAGHNQISDLTP--LANLTRITQLGL 382

Query: 372 EYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLK 425
                  + P ++   +S+ +   +        P ++       + ++++N   
Sbjct: 383 NDQAWT-NAPVNYKANVSIPNTVKNVTGAL-IAPATISDGGSYTEPDITWNLPS 434

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  150 bits (380), Expect = 6e-39
 Identities = 88/375 (23%), Positives = 151/375 (40%), Gaps = 57/375 (15%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAI 65
           NN +T   P  + N++NL  L L +N +    I  +  L +L  L    N++    P  +
Sbjct: 121 NNQITDIDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFG-NQVTDLKP--L 173

Query: 66  FNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLAL 125
            N++TL+   +++N +S  +S +    L NLE L    N  S   P  +   + L +L+L
Sbjct: 174 ANLTTLERLDISSNKVSD-ISVLA--KLTNLESLIATNNQISDITP--LGILTNLDELSL 228

Query: 126 EMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDG 185
             N        T  +L NL  L L +N +++       L+ LS    LT + L  N +  
Sbjct: 229 NGNQLKD--IGTLASLTNLTDLDLANNQISN-------LAPLSGLTKLTELKLGANQISN 279

Query: 186 ILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQ 245
           I P   +  L+ +L N  +    +       I+NL +LT + L  N ++   P  +  L 
Sbjct: 280 ISP---LAGLT-ALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDISP--VSSLT 331

Query: 246 KLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNEL 305
           KLQ +    N++      S+     +  L  G N++S   P   +N+T +  L L     
Sbjct: 332 KLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAW 387

Query: 306 TSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMN--------------- 350
           T+ P+N+ +   I +   +        P  I +  +  E D + N               
Sbjct: 388 TNAPVNYKANVSIPNTVKNVTGALIA-PATISDGGSYTEPDITWNLPSYTNEVSYTFSQP 446

Query: 351 --------NFSGIIP 357
                    FSG + 
Sbjct: 447 VTIGKGTTTFSGTVT 461

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  138 bits (350), Expect = 5e-35
 Identities = 68/282 (24%), Positives = 110/282 (39%), Gaps = 23/282 (8%)

Query: 148 TLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNC 207
            L    +T  T  ++ + + +         L    +   +      +L   +        
Sbjct: 2   PLGSATITQDTP-INQIFTDTALAEKMKTVLGKTNVTDTVS---QTDLD-QVTTLQADRL 56

Query: 208 NVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICL 267
            +     + +  L +LT I    N+L    P  L  L KL D+ +  NQ+    P  +  
Sbjct: 57  GIK--SIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LAN 110

Query: 268 SVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNC 327
              L  L L  N+++   P    N+T L  L L SN ++ I      L  +  L+   N 
Sbjct: 111 LTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDIS-ALSGLTSLQQLSF-GNQ 166

Query: 328 FSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDL 387
            +   PL   NL  L  +D S N  S I    +  L NLE+L    N++    P   G L
Sbjct: 167 VTDLKPLA--NLTTLERLDISSNKVSDISV--LAKLTNLESLIATNNQISDITP--LGIL 220

Query: 388 ISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIP 429
            +L  L+L+ N L      +L  L+ L DL+L+ N++    P
Sbjct: 221 TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP 260

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  193 bits (493), Expect = 2e-56
 Identities = 72/283 (25%), Positives = 113/283 (39%), Gaps = 38/283 (13%)

Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQC----GRAFKSFDVECAMMKSIRHRNLVKVIS 590
           IG GGFG VY+A    G EVAVK           +  ++   E  +   ++H N++ +  
Sbjct: 15  IGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73

Query: 591 SCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIH 650
            C  E    LV+E+   G L + L      +     +N  + +A  + YLH     P+IH
Sbjct: 74  VCLKEPNLCLVMEFARGGPLNRVLSGKR--IPPDILVNWAVQIARGMNYLHDEAIVPIIH 131

Query: 651 CDLKPSNVLLD--------DNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
            DLK SN+L+          N +  ++DFG+A+        M+         +MAPE  R
Sbjct: 132 RDLKSSNILILQKVENGDLSNKILKITDFGLAREWH-RTTKMSAA---GAYAWMAPEVIR 187

Query: 703 EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ 762
               S   DV+S+G++L E  T + P    F G             I  + V     ++ 
Sbjct: 188 ASMFSKGSDVWSYGVLLWELLTGEVP----FRG-------------IDGLAVAYG--VAM 228

Query: 763 EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKI 805
             +       C      L  +C    P  R +   I+ +L  I
Sbjct: 229 NKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  195 bits (498), Expect = 4e-56
 Identities = 68/295 (23%), Positives = 115/295 (38%), Gaps = 22/295 (7%)

Query: 533 NLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSC 592
             IG+G +G V+  + R G +VAVKVF      ++   + E      +RH N++  I++ 
Sbjct: 43  KQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWF-RETEIYQTVLMRHENILGFIAAD 100

Query: 593 SNEEFK----ALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLH-----FG 643
                      L+ +Y  +GSL  YL   + +LD    L +     S L +LH       
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLYDYLK--STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQ 158

Query: 644 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA--TIGYMAPE-- 699
               + H DLK  N+L+  N    ++D G+A     +   +         T  YM PE  
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVL 218

Query: 700 ----YGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVV 755
                    Q     D+YSFG++L E   R      +   ++     V        M  +
Sbjct: 219 DESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREI 278

Query: 756 DANLLSQEDI-HFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSL 809
                 +    +  + ++C+  +  L  EC   +P  R+ A  +   L K+ +S 
Sbjct: 279 VCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  194 bits (494), Expect = 8e-56
 Identities = 61/325 (18%), Positives = 125/325 (38%), Gaps = 45/325 (13%)

Query: 501 GPPNDPNMPPVATWRRFSYLELFQATD---KFSE---NNLIGRGGFGSVYKARIRDGMEV 554
           GP  + ++    ++ R +        +    F +     LIG+G FG VY  R     EV
Sbjct: 1   GPEMNLSLLSARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EV 58

Query: 555 AVKVFNLQ--CGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEK 612
           A+++ +++       K+F  E    +  RH N+V  + +C +    A++       +L  
Sbjct: 59  AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYS 118

Query: 613 YLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFG 672
            +  +   LD+ +   I  ++   + YLH   +  ++H DLK  NV  D+  V  ++DFG
Sbjct: 119 VVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYDNGKV-VITDFG 174

Query: 673 IAKLLTGEDQSMTQTQTLA---TIGYMAPEYGREGQVSTNG---------DVYSFGIMLM 720
           +  +         + +       + ++APE  R+    T           DV++ G +  
Sbjct: 175 LFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWY 234

Query: 721 ETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNL 780
           E   R+ P    F                + +  +   +        +++      + ++
Sbjct: 235 ELHAREWP----FKT-QP---------AEAIIWQMGTGMKPN-----LSQIGMGKEISDI 275

Query: 781 ALECTVESPEQRINAKEIVAKLLKI 805
            L C     E+R    +++  L K+
Sbjct: 276 LLFCWAFEQEERPTFTKLMDMLEKL 300

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  193 bits (492), Expect = 9e-56
 Identities = 67/295 (22%), Positives = 117/295 (39%), Gaps = 30/295 (10%)

Query: 533 NLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSC 592
             +G+G +G V++   + G  VAVK+F+ +  +++   + E      +RH N++  I+S 
Sbjct: 14  ECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWF-RETELYNTVMLRHENILGFIASD 71

Query: 593 SNEEFKA----LVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLH-----FG 643
                 +    L+  Y   GSL  YL     +LD    L I++ +AS L +LH       
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYLQ--LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129

Query: 644 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA--TIGYMAPE-- 699
               + H DLK  N+L+  N    ++D G+A + +     +         T  YMAPE  
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 189

Query: 700 ----YGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTME-- 753
                          D+++FG++L E   R      + + +      V +      M   
Sbjct: 190 DETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKV 249

Query: 754 VVDANL---LSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKI 805
           V        +          +  ++ +  L  EC  ++P  R+ A  I   L KI
Sbjct: 250 VCVDQQRPNIPNR----WFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  190 bits (485), Expect = 1e-54
 Identities = 68/302 (22%), Positives = 118/302 (39%), Gaps = 38/302 (12%)

Query: 535 IGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCS 593
           +G+G FG   K   R+ G  + +K          ++F  E  +M+ + H N++K I    
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77

Query: 594 NEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 653
            ++    + EY+  G+L   + S +      QR++   D+AS + YLH   S  +IH DL
Sbjct: 78  KDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDL 134

Query: 654 KPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA------------TIGYMAPEYG 701
              N L+ +N    ++DFG+A+L+  E       ++L                +MAPE  
Sbjct: 135 NSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMI 194

Query: 702 REGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLS 761
                    DV+SFGI+L E   R     +                       +D  L  
Sbjct: 195 NGRSYDEKVDVFSFGIVLCEIIGRVNADPDY------------------LPRTMDFGLNV 236

Query: 762 QEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLRNVGGRCIRQS 821
           +  +       C    F + + C    PE+R +  ++   L    ++L  ++ G      
Sbjct: 237 RGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWL----ETLRMHLAGHLPLGP 292

Query: 822 NL 823
            L
Sbjct: 293 QL 294

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  185 bits (472), Expect = 2e-52
 Identities = 85/423 (20%), Positives = 159/423 (37%), Gaps = 82/423 (19%)

Query: 3   SIINNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIP 62
           + +   +    P    +++      L    +   +      L ++  L ++  K+     
Sbjct: 6   ATLPAPINQIFP--DADLAEGIRAVLQKASVTDVV--TQEELESITKLVVAGEKV----- 56

Query: 63  AAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSK 122
                 ++++                    L NLE L L GN  +   P  + N  KL+ 
Sbjct: 57  ------ASIQGIE----------------YLTNLEYLNLNGNQITDISP--LSNLVKLTN 92

Query: 123 LALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNP 182
           L +  N  +    S   NL NL  L L ++N++        +S L+N   +  ++L  N 
Sbjct: 93  LYIGTNKIT--DISALQNLTNLRELYLNEDNISD-------ISPLANLTKMYSLNLGANH 143

Query: 183 LDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLG 242
                                             ++N+T L  + +  +K+    PI   
Sbjct: 144 N---------------------------LSDLSPLSNMTGLNYLTVTESKVKDVTPI--A 174

Query: 243 KLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGS 302
            L  L  + L YNQ+E   P  +     L+      N+++   P   +NMT L  L +G+
Sbjct: 175 NLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGN 230

Query: 303 NELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGS 362
           N++T +     +L  +  L + +N  S    ++  +L  L  ++   N  S I    + +
Sbjct: 231 NKITDLS-PLANLSQLTWLEIGTNQISDINAVK--DLTKLKMLNVGSNQISDISV--LNN 285

Query: 363 LKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFN 422
           L  L +LFL  N+L     +  G L +L +L LS N+++   P  L  LS +   + +  
Sbjct: 286 LSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQ 343

Query: 423 KLK 425
            +K
Sbjct: 344 VIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  174 bits (443), Expect = 2e-48
 Identities = 77/342 (22%), Positives = 135/342 (39%), Gaps = 29/342 (8%)

Query: 88  ITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWL 147
             D  L       L   + +  +         ++KL +     +         L NLE+L
Sbjct: 16  FPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVASIQG--IEYLTNLEYL 71

Query: 148 TLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNC 207
            L  N +T        +S LSN   LT++ +  N +  I     + NL+ +L+  Y+   
Sbjct: 72  NLNGNQITD-------ISPLSNLVKLTNLYIGTNKITDISA---LQNLT-NLRELYLNED 120

Query: 208 NVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICL 267
           N+S      + NLT + ++ LG N    S    L  +  L  + +  ++++   P  I  
Sbjct: 121 NISD--ISPLANLTKMYSLNLGANHN-LSDLSPLSNMTGLNYLTVTESKVKDVTP--IAN 175

Query: 268 SVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNC 327
             +LY L L  N++    P   +++T L   +   N++T I     ++  +  L + +N 
Sbjct: 176 LTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDIT-PVANMTRLNSLKIGNNK 232

Query: 328 FSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDL 387
            +   PL   NL  L  ++   N  S I    +  L  L+ L +  N++         +L
Sbjct: 233 ITDLSPLA--NLSQLTWLEIGTNQISDINA--VKDLTKLKMLNVGSNQISD--ISVLNNL 286

Query: 388 ISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIP 429
             L SL L+ N L       +  L+ L  L LS N +    P
Sbjct: 287 SQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  169 bits (431), Expect = 7e-47
 Identities = 71/335 (21%), Positives = 129/335 (38%), Gaps = 31/335 (9%)

Query: 96  LEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLT 155
              L       +   P    + ++  +  L+  S +     T   L ++  L +    + 
Sbjct: 2   AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVA 57

Query: 156 SSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPE 215
           S       +  +    +L +++L+ N +  I P   + NL   L N Y+    ++     
Sbjct: 58  S-------IQGIEYLTNLEYLNLNGNQITDISP---LSNLV-KLTNLYIGTNKIT--DIS 104

Query: 216 EITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELE 275
            + NLT+L  + L  + ++   P  L  L K+  ++L  N    S    +     L  L 
Sbjct: 105 ALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLT 161

Query: 276 LGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLE 335
           +  +K+    P   +N+T L  LSL  N++  I     SL  +       N  +   P+ 
Sbjct: 162 VTESKVKDVTP--IANLTDLYSLSLNYNQIEDIS-PLASLTSLHYFTAYVNQITDITPVA 218

Query: 336 IRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNL 395
             N+  L  +    N  + + P  + +L  L  L +  N++     ++  DL  LK LN+
Sbjct: 219 --NMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNV 272

Query: 396 SYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIPR 430
             N +S      L  LS L  L L+ N+L  E   
Sbjct: 273 GSNQISDISV--LNNLSQLNSLFLNNNQLGNEDME 305

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  182 bits (464), Expect = 2e-51
 Identities = 66/295 (22%), Positives = 120/295 (40%), Gaps = 24/295 (8%)

Query: 533 NLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSC 592
             IG+G FG V++ + R G EVAVK+F+ +  R++   + E      +RH N++  I++ 
Sbjct: 48  ESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAAD 105

Query: 593 SNEEFKA----LVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLH-----FG 643
           + +        LV +Y  HGSL  YL+   Y++ +   + + +  AS L +LH       
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQ 163

Query: 644 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA--TIGYMAPE-- 699
               + H DLK  N+L+  N    ++D G+A        ++         T  YMAPE  
Sbjct: 164 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 223

Query: 700 ----YGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTME-- 753
                 +  +     D+Y+ G++  E   R        + ++     V     +  M   
Sbjct: 224 DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKV 283

Query: 754 VVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDS 808
           V +  L       +    + +  +  +  EC   +   R+ A  I   L ++   
Sbjct: 284 VCEQKLRPNIPNRW-QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  186 bits (475), Expect = 7e-51
 Identities = 96/463 (20%), Positives = 169/463 (36%), Gaps = 35/463 (7%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAI 65
              + +       ++S+L  L L  N +Q   +     L +L  L   +  L       I
Sbjct: 61  RCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPI 120

Query: 66  FNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLS---- 121
            ++ TLK   V +N +           L NLE L L  N         +    ++     
Sbjct: 121 GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNL 180

Query: 122 KLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSF--LSSLSNCKSLTHISLS 179
            L L +N  +   P  F  +  L  LTL +N  + + +      L+ L   + +     +
Sbjct: 181 SLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRN 239

Query: 180 NNPLDGILPRTYVGNLSHSLKNFYMYNCNVSG-GIPEEITNLTDLTTIVLGGNKL----- 233
              L+        G  + +++ F +   +     I +    LT++++  L    +     
Sbjct: 240 EGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD 299

Query: 234 --------------NGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGN 279
                                  KL+ L+ +    N+  G+    + L   L  L+L  N
Sbjct: 300 FSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKG-GNAFSEVDLP-SLEFLDLSRN 357

Query: 280 KLS--GSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEI- 336
            LS  G         T LK L L  N + ++  NF  L+ +  L+   +         + 
Sbjct: 358 GLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVF 417

Query: 337 RNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSI-PDSFGDLISLKSLNL 395
            +L+ LI +D S  +           L +LE L +  N  + +  PD F +L +L  L+L
Sbjct: 418 LSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL 477

Query: 396 SYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIPRGGSFGNFS 438
           S   L    P +   LS L+ LN++ N+LK  +P  G F   +
Sbjct: 478 SQCQLEQLSPTAFNSLSSLQVLNMASNQLK-SVPD-GIFDRLT 518

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  179 bits (457), Expect = 2e-48
 Identities = 91/435 (20%), Positives = 162/435 (37%), Gaps = 29/435 (6%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQ-GEIIHEIGHLHNLGFLDLSQNKLLGTIPAA 64
              L S     I ++  LK L + +N +Q  ++     +L NL  LDLS NK+       
Sbjct: 109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD 168

Query: 65  IFNVSTLKAFAVTNNSLSGC-LSSITDVGL--PNLEVLYLWGNNFSGTIPHFIFNA-SKL 120
           +  +  +    ++ + LS   ++ I         L  L L  N  S  +        + L
Sbjct: 169 LRVLHQMPLLNLSLD-LSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGL 227

Query: 121 SKLALEMNSFSG------FIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLT 174
               L +  F        F  S    L NL         L     D+      +   +++
Sbjct: 228 EVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDII--DLFNCLTNVS 285

Query: 175 HISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLN 234
             SL +  ++ +   +Y    +   ++  + NC      P     L  L  +    NK  
Sbjct: 286 SFSLVSVTIERVKDFSY----NFGWQHLELVNCKFGQ-FPTL--KLKSLKRLTFTSNKGG 338

Query: 235 GSIPITLGKLQKLQDVDLEYNQLE--GSIPDSICLSVELYELELGGNKLSGSIPACFSNM 292
            +   +   L  L+ +DL  N L   G    S   +  L  L+L  N +  ++ + F  +
Sbjct: 339 NAF--SEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGL 395

Query: 293 TFLKVLSLGSNELTSIPLN--FWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMN 350
             L+ L    + L  +     F SL++++ L++S              L +L  +  + N
Sbjct: 396 EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGN 455

Query: 351 NFSGIIPMEI-GSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLE 409
           +F      +I   L+NL  L L   +LE   P +F  L SL+ LN++ N L        +
Sbjct: 456 SFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFD 515

Query: 410 KLSYLKDLNLSFNKL 424
           +L+ L+ + L  N  
Sbjct: 516 RLTSLQKIWLHTNPW 530

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  166 bits (423), Expect = 7e-44
 Identities = 87/432 (20%), Positives = 144/432 (33%), Gaps = 56/432 (12%)

Query: 21  SNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNS 80
            + K L L  N L+    +       L  LDLS+ ++  TI    +              
Sbjct: 28  FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQ------------- 73

Query: 81  LSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGN 140
                       L +L  L L GN             S L KL     + +       G+
Sbjct: 74  -----------SLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGH 122

Query: 141 LRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRT--YVGNLSHS 198
           L+ L+ L +  N + S  L   F    SN  +L H+ LS+N +  I       +  +   
Sbjct: 123 LKTLKELNVAHNLIQSFKLPEYF----SNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLL 178

Query: 199 LKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPIT-LGKLQKLQDVDLEY--- 254
             +  +    ++  I         L  + L  N  + ++  T +  L  L+   L     
Sbjct: 179 NLSLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEF 237

Query: 255 ---NQLEGSIPDSICLSVELYELELGGNKLSGS---IPACFSNMTFLKVLSLGSNELTSI 308
                LE     ++     L   E     L      I   F+ +T +   SL S  +  +
Sbjct: 238 RNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERV 297

Query: 309 P--LNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNL 366
                 +  + +  +N     F          LK+L  + F+ N            L +L
Sbjct: 298 KDFSYNFGWQHLELVNCKFGQFPT------LKLKSLKRLTFTSNKGGNAFS--EVDLPSL 349

Query: 367 ENLFLEYNRLE--GSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKL 424
           E L L  N L   G    S     SLK L+LS+N +  T+  +   L  L+ L+   + L
Sbjct: 350 EFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNL 408

Query: 425 KGEIPRGGSFGN 436
           K ++     F +
Sbjct: 409 K-QMSEFSVFLS 419

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  143 bits (362), Expect = 5e-36
 Identities = 78/412 (18%), Positives = 146/412 (35%), Gaps = 43/412 (10%)

Query: 6   NNFLTS-TTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGF----LDLSQNKLLGT 60
           +N + S   P+   N++NL+ L L +N++Q     ++  LH +      LDLS N +   
Sbjct: 133 HNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM-NF 191

Query: 61  IPAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSG-----TIPHFIF 115
           I    F    L    + NN  S  +      GL  LEV  L    F              
Sbjct: 192 IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSAL 251

Query: 116 -NASKLSKLALEMNSFSGF---IPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLS--- 168
                L+     +     +   I   F  L N+   +L    +     D S+        
Sbjct: 252 EGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSYNFGWQHLE 310

Query: 169 ------------NCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVS--GGIP 214
                         KSL  ++ ++N            +L  SL+   +    +S  G   
Sbjct: 311 LVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEV---DLP-SLEFLDLSRNGLSFKGCCS 366

Query: 215 EEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLS--VELY 272
           +     T L  + L  N +  ++      L++L+ +D +++ L+  + +         L 
Sbjct: 367 QSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLI 424

Query: 273 ELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLN--FWSLKDILDLNLSSNCFSG 330
            L++       +    F+ ++ L+VL +  N      L   F  L+++  L+LS      
Sbjct: 425 YLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ 484

Query: 331 PLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPD 382
             P    +L +L  ++ + N    +       L +L+ ++L  N  + S P 
Sbjct: 485 LSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  109 bits (273), Expect = 6e-25
 Identities = 47/245 (19%), Positives = 81/245 (33%), Gaps = 14/245 (5%)

Query: 194 NLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLE 253
           NL  S KN  +    +         +  +L  + L   ++          L  L  + L 
Sbjct: 25  NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILT 84

Query: 254 YNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLN-- 311
            N ++     +      L +L      L+        ++  LK L++  N + S  L   
Sbjct: 85  GNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEY 144

Query: 312 FWSLKDILDLNLSSNCFSGPLPLEIRNLKAL----IEIDFSMNNFSGIIPMEIGSLKNLE 367
           F +L ++  L+LSSN        ++R L  +    + +D S+N  +  I         L 
Sbjct: 145 FSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLH 203

Query: 368 NLFLEYNRLEGSIPD-SFGDLISLKSLNL------SYNNLSGTIPVSLEKLSYLKDLNLS 420
            L L  N    ++       L  L+   L      +  NL      +LE L  L      
Sbjct: 204 KLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFR 263

Query: 421 FNKLK 425
              L 
Sbjct: 264 LAYLD 268

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  102 bits (255), Expect = 1e-22
 Identities = 48/264 (18%), Positives = 93/264 (35%), Gaps = 18/264 (6%)

Query: 3   SIINNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIP 62
           S+++  +        +     + L L N +           L +L  L  + NK      
Sbjct: 288 SLVSVTIERVKDFSYN--FGWQHLELVNCKFGQ---FPTLKLKSLKRLTFTSNKGGNAF- 341

Query: 63  AAIFNVSTLKAFAVTNNSLSGC-LSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLS 121
            +  ++ +L+   ++ N LS     S +D G  +L+ L L  N    T+        +L 
Sbjct: 342 -SEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLE 399

Query: 122 KLALEMNSFSGFIP-STFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSN 180
            L  + ++       S F +LRNL +L +   +           + LS+   L  + ++ 
Sbjct: 400 HLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRV--AFNGIFNGLSS---LEVLKMAG 454

Query: 181 NPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEI-TNLTDLTTIVLGGNKLNGSIPI 239
           N             L  +L    +  C +   +      +L+ L  + +  N+L      
Sbjct: 455 NSFQENFLPDIFTELR-NLTFLDLSQCQLEQ-LSPTAFNSLSSLQVLNMASNQLKSVPDG 512

Query: 240 TLGKLQKLQDVDLEYNQLEGSIPD 263
              +L  LQ + L  N  + S P 
Sbjct: 513 IFDRLTSLQKIWLHTNPWDCSCPR 536

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 90.9 bits (226), Expect = 4e-19
 Identities = 35/152 (23%), Positives = 55/152 (36%), Gaps = 6/152 (3%)

Query: 288 CFSNMTFLKVLSLGSNELTSIPLN-FWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEID 346
           C   +  +            IP N  +S K+   L+LS N           +   L  +D
Sbjct: 3   CVEVVPNITY-QCMELNFYKIPDNLPFSTKN---LDLSFNPLRHLGSYSFFSFPELQVLD 58

Query: 347 FSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPV 406
            S      I      SL +L  L L  N ++     +F  L SL+ L     NL+     
Sbjct: 59  LSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENF 118

Query: 407 SLEKLSYLKDLNLSFNKLKGEIPRGGSFGNFS 438
            +  L  LK+LN++ N ++        F N +
Sbjct: 119 PIGHLKTLKELNVAHNLIQ-SFKLPEYFSNLT 149

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  167 bits (426), Expect = 2e-46
 Identities = 55/334 (16%), Positives = 111/334 (33%), Gaps = 31/334 (9%)

Query: 93  LPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDN 152
               E LY  G+         +    +                    N  N +  T    
Sbjct: 11  SSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNNPQIETRTGR 66

Query: 153 NLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGG 212
            L ++   L   +          + L + PL    P      LSH L++  +    +   
Sbjct: 67  ALKATADLLEDATQ----PGRVALELRSVPLP-QFPDQ-AFRLSH-LQHMTIDAAGLME- 118

Query: 213 IPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELY 272
           +P+ +     L T+ L  N L  ++P ++  L +L+++ +        +P+ +       
Sbjct: 119 LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLA------ 171

Query: 273 ELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPL 332
                    S         +  L+ L L    + S+P +  +L+++  L + ++  S  L
Sbjct: 172 ---------STDASGEHQGLVNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLSA-L 221

Query: 333 PLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFL-EYNRLEGSIPDSFGDLISLK 391
              I +L  L E+D          P   G    L+ L L + + L  ++P     L  L+
Sbjct: 222 GPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLE 280

Query: 392 SLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLK 425
            L+L        +P  + +L     + +  +   
Sbjct: 281 KLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  157 bits (398), Expect = 1e-42
 Identities = 64/346 (18%), Positives = 114/346 (32%), Gaps = 32/346 (9%)

Query: 19  NISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTN 78
           + S  + LY   +         +         D ++            N +  +    T 
Sbjct: 10  HSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNNPQIETRTG 65

Query: 79  NSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTF 138
            +L      + D   P    L L         P   F  S L  + ++       +P T 
Sbjct: 66  RALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLME-LPDTM 123

Query: 139 GNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHS 198
                LE LTL  N L +        +S+++   L  +S+   P    LP   + +    
Sbjct: 124 QQFAGLETLTLARNPLRA------LPASIASLNRLRELSIRACPELTELPEP-LASTD-- 174

Query: 199 LKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLE 258
                            E   L +L ++ L    +  S+P ++  LQ L+ + +  + L 
Sbjct: 175 --------------ASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS 219

Query: 259 GSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSL-GSNELTSIPLNFWSLKD 317
            ++  +I    +L EL+L G     + P  F     LK L L   + L ++PL+   L  
Sbjct: 220 -ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQ 278

Query: 318 ILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSL 363
           +  L+L        LP  I  L A   I    +  + +      + 
Sbjct: 279 LEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVAR 324

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  154 bits (392), Expect = 9e-42
 Identities = 59/375 (15%), Positives = 111/375 (29%), Gaps = 61/375 (16%)

Query: 39  HEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEV 98
           H   H      L    +  L      +            N   +   S+       N ++
Sbjct: 6   HHHHHSSGRENLYFQGSTALRPYHDVLSQWQRH-----YNADRNRWHSAWRQANSNNPQI 60

Query: 99  LYLWGNNFSGTIPHFIFNAS--KLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTS 156
               G          + +A+      L L         P     L +L+ +T+    L  
Sbjct: 61  ETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM- 117

Query: 157 STLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEE 216
                    ++     L  ++L+ NPL   LP + + +L+  L+   +  C     +PE 
Sbjct: 118 -----ELPDTMQQFAGLETLTLARNPLR-ALPAS-IASLN-RLRELSIRACPELTELPEP 169

Query: 217 ITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELEL 276
           + +                        L  LQ + LE+  +  S+P SI           
Sbjct: 170 LAST---------------DASGEHQGLVNLQSLRLEWTGIR-SLPASIA---------- 203

Query: 277 GGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEI 336
                         N+  LK L + ++ L+++      L  + +L+L         P   
Sbjct: 204 --------------NLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRNYPPIF 249

Query: 337 RNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLS 396
                L  +     +    +P++I  L  LE L L        +P     L +   + + 
Sbjct: 250 GGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVP 309

Query: 397 YN---NLSGTIPVSL 408
            +    L    PV+ 
Sbjct: 310 PHLQAQLDQHRPVAR 324

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  136 bits (346), Expect = 1e-35
 Identities = 46/305 (15%), Positives = 104/305 (34%), Gaps = 18/305 (5%)

Query: 14  PKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVS--TL 71
               D +S  +  Y  +            + +N   ++    + L      + + +    
Sbjct: 26  RPYHDVLSQWQRHYNADRNRW-HSAWRQANSNNP-QIETRTGRALKATADLLEDATQPGR 83

Query: 72  KAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFS 131
            A  + +  L           L +L+ + +        +P  +   + L  L L  N   
Sbjct: 84  VALELRSVPLPQFPDQAFR--LSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR 140

Query: 132 GFIPSTFGNLRNLEWLTLYDNN----LTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGIL 187
             +P++  +L  L  L++        L                 +L  + L    +   L
Sbjct: 141 A-LPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRS-L 198

Query: 188 PRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKL 247
           P + + NL  +LK+  + N  +S  +   I +L  L  + L G     + P   G    L
Sbjct: 199 PAS-IANLQ-NLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPL 255

Query: 248 QDVDL-EYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELT 306
           + + L + + L  ++P  I    +L +L+L G      +P+  + +    ++ +  +   
Sbjct: 256 KRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314

Query: 307 SIPLN 311
            +  +
Sbjct: 315 QLDQH 319

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 84.6 bits (210), Expect = 7e-18
 Identities = 36/185 (19%), Positives = 59/185 (31%), Gaps = 34/185 (18%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAI 65
               ++    E   + NL+ L L    ++  +   I +L NL  L +  + L   +  AI
Sbjct: 168 EPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAI 225

Query: 66  FNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLAL 125
            +                         LP LE L L G       P      + L +L L
Sbjct: 226 HH-------------------------LPKLEELDLRGCTALRNYPPIFGGRAPLKRLIL 260

Query: 126 EMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFL-SSLSNCKSLTHISLSNNPLD 184
           +  S    +P     L  LE L L          +LS L S ++   +   I +  +   
Sbjct: 261 KDCSNLLTLPLDIHRLTQLEKLDLRGCV------NLSRLPSLIAQLPANCIILVPPHLQA 314

Query: 185 GILPR 189
            +   
Sbjct: 315 QLDQH 319

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  176 bits (449), Expect = 4e-46
 Identities = 96/489 (19%), Positives = 167/489 (34%), Gaps = 43/489 (8%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKL-LGTIPAA 64
                +   +   N+ NL++L L ++++          L +L  L L    L    +   
Sbjct: 58  QYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDG 117

Query: 65  IF-NVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFN---ASKL 120
            F N+  L    ++ N +       +   L +L+ +    N     +            L
Sbjct: 118 YFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIF-LVCEHELEPLQGKTL 176

Query: 121 SKLALEMNSFSGFIPSTFGNLRN------LEWLTLYDNNLTSSTLDLSF-------LSSL 167
           S  +L  NS    +   +G   N      LE L +  N  T                 SL
Sbjct: 177 SFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSL 236

Query: 168 SNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIV 227
                +       + +      T+ G    S+++  + +  V          L DL  + 
Sbjct: 237 ILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLN 296

Query: 228 LGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPA 287
           L  NK+N         L  LQ ++L YN L      +     ++  ++L  N ++     
Sbjct: 297 LAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQ 356

Query: 288 CFSNMTFLKVLSLGSNELTSIP---------LNFWSLKDILD-------LNLSSNCFSGP 331
            F  +  L+ L L  N LT+I          L+   L  +         ++LS N     
Sbjct: 357 TFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENL 416

Query: 332 LPLEI-RNLKALIEIDFSMNNFSGIIPMEI-GSLKNLENLFLEYNRLEGSI-----PDSF 384
             L     +  L  +  + N FS     +      +LE LFL  N L+ +       D F
Sbjct: 417 DILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVF 476

Query: 385 GDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIPRGGSFGNFSAESFKG 444
             L  L+ L L++N L+   P     L+ L+ L+L+ N+L   +       N        
Sbjct: 477 EGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHNDLPANLEILDISR 535

Query: 445 NELLCGSPN 453
           N+LL  +P+
Sbjct: 536 NQLLAPNPD 544

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  162 bits (412), Expect = 1e-41
 Identities = 87/457 (19%), Positives = 150/457 (32%), Gaps = 65/457 (14%)

Query: 18  DNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVT 77
             ++  + L L  N ++         L  L  L+L       TI    F           
Sbjct: 21  QVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFR---------- 70

Query: 78  NNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIF-NASKLSKLALEMNSFSGFI-- 134
                          LPNL +L L  +     +    F     L +L L     S  +  
Sbjct: 71  --------------NLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLK 115

Query: 135 PSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGN 194
              F NL+ L  L L  N + S  L  SF        SL  I  S+N +  +        
Sbjct: 116 DGYFRNLKALTRLDLSKNQIRSLYLHPSF----GKLNSLKSIDFSSNQIFLVCEHELEPL 171

Query: 195 LSHSLKNFYMYNCNVSGGIPEEITNL------TDLTTIVLGGNKLNGSIPITLGKLQKLQ 248
              +L  F +   ++   +  +            L  + + GN     I           
Sbjct: 172 QGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDIT---------- 221

Query: 249 DVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNM--TFLKVLSLGSNELT 306
                 N +  S   S+ L+  +     G + +       F+ +  + ++ L L    + 
Sbjct: 222 --GNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVF 279

Query: 307 SIPLN-FWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKN 365
           S+    F +LKD+  LNL+ N  +         L  L  ++ S N    +       L  
Sbjct: 280 SLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPK 339

Query: 366 LENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLK 425
           +  + L+ N +      +F  L  L++L+L  N L+     ++  +  + D+ LS NKL 
Sbjct: 340 VAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLV 394

Query: 426 GEIPRGGSFGNF------SAESFKGNELLCGSPNLQV 456
             +P+     N         E+      L   P+LQ+
Sbjct: 395 -TLPKINLTANLIHLSENRLENLDILYFLLRVPHLQI 430

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  161 bits (410), Expect = 3e-41
 Identities = 80/442 (18%), Positives = 151/442 (34%), Gaps = 36/442 (8%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEI-GHLHNLGFLDLSQNKLLGTIPAA 64
            N++ + T      +  L++L L +      I  E   +L NL  LDL  +K+   +   
Sbjct: 33  FNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIY-FLHPD 91

Query: 65  IF-NVSTLKAFAVTNNSLS-GCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIF-NASKLS 121
            F  +  L    +    LS   L       L  L  L L  N       H  F   + L 
Sbjct: 92  AFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLK 151

Query: 122 KLALEMNSFSGFIPSTFGNLR--NLEWLTLYDNNLTS-STLDLSFLSSLSNCKSLTHISL 178
            +    N            L+   L + +L  N+L S  ++D     +      L  + +
Sbjct: 152 SIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDV 211

Query: 179 SNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIP 238
           S N     +   +   +S S                  +     +     G + +     
Sbjct: 212 SGNGWTVDITGNFSNAISKSQ--------------AFSLILAHHIMGAGFGFHNIKDPDQ 257

Query: 239 ITLGKLQK--LQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLK 296
            T   L +  ++ +DL +  +            +L  L L  NK++      F  +  L+
Sbjct: 258 NTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQ 317

Query: 297 VLSLGSNELTSIPLN-FWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGI 355
           VL+L  N L  +  + F+ L  +  ++L  N  +       + L+ L  +D   N  +  
Sbjct: 318 VLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-- 375

Query: 356 IPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSG-TIPVSLEKLSYL 414
               I  + ++ ++FL  N+L      +     +   ++LS N L    I   L ++ +L
Sbjct: 376 ---TIHFIPSIPDIFLSGNKLVTLPKINL----TANLIHLSENRLENLDILYFLLRVPHL 428

Query: 415 KDLNLSFNKLKGEIPRGGSFGN 436
           + L L+ N+         +   
Sbjct: 429 QILILNQNRFS-SCSGDQTPSE 449

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  159 bits (403), Expect = 2e-40
 Identities = 90/530 (16%), Positives = 172/530 (32%), Gaps = 67/530 (12%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLH--NLGFLDLSQNKLLGTIPA 63
           N   +         +++LK +   +N++     HE+  L    L F  L+ N L   +  
Sbjct: 133 NQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSV 192

Query: 64  AIFNVS------TLKAFAVTNNSLS-----------GCLSSITDVGLPNLEVLYLWGNNF 106
                        L+   V+ N  +               + + +   ++       +N 
Sbjct: 193 DWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNI 252

Query: 107 SGTIPHFIF---NASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSF 163
                   F     S +  L L            F  L++L+ L L  N +  + +    
Sbjct: 253 K-DPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKI--NKIADEA 309

Query: 164 LSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDL 223
              L N   L  ++LS N L  +    + G     +    +   +++    +    L  L
Sbjct: 310 FYGLDN---LQVLNLSYNLLGELYSSNFYGL--PKVAYIDLQKNHIAIIQDQTFKFLEKL 364

Query: 224 TTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSG 283
            T+ L  N L      T+  +  + D+ L  N+L      ++  ++    + L  N+L  
Sbjct: 365 QTLDLRDNALT-----TIHFIPSIPDIFLSGNKLVTLPKINLTANL----IHLSENRLEN 415

Query: 284 -SIPACFSNMTFLKVLSLGSNELTSIPLN--FWSLKDILDLNLSSNCFSGPLPLEI---- 336
             I      +  L++L L  N  +S   +        +  L L  N        E+    
Sbjct: 416 LDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDV 475

Query: 337 -RNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNL 395
              L  L  +  + N  + + P     L  L  L L  NRL     +      +L+ L++
Sbjct: 476 FEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDL--PANLEILDI 533

Query: 396 SYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIPRGGSFGNFSAESFKG-----NELLCG 450
           S N L      + +    L  L+++ NK   E     +F N+   +         ++ C 
Sbjct: 534 SRNQLLA---PNPDVFVSLSVLDITHNKFICECEL-STFINWLNHTNVTIAGPPADIYCV 589

Query: 451 SP---------NLQVPPCKASIHRTSRKNALILGIVLPFSTIFMTAIILF 491
            P         +L    C       S K +L +   +  +   MT + + 
Sbjct: 590 YPDSFSGVSLFSLSTEGCDEEEVLKSLKFSLFIVCTVTLTLFLMTILTVT 639

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  121 bits (306), Expect = 2e-28
 Identities = 61/329 (18%), Positives = 113/329 (34%), Gaps = 36/329 (10%)

Query: 138 FGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSH 197
              L   E L L  N + + T      SS    + L  + L +      + +    NL +
Sbjct: 20  PQVLNTTERLLLSFNYIRTVT-----ASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPN 74

Query: 198 SLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSI--PITLGKLQKLQDVDLEYN 255
            L+   + +  +    P+    L  L  + L    L+ ++        L+ L  +DL  N
Sbjct: 75  -LRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKN 133

Query: 256 QLEGSIPDSICLS--VELYELELGGNKLSGSIPACFSNMTF--LKVLSLGSNELTSIP-- 309
           Q+  S+           L  ++   N++          +    L   SL +N L S    
Sbjct: 134 QIR-SLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSV 192

Query: 310 -----LNFWSLKDILDLNLSSNCFSGPLP------------LEIRNLKALIEIDFSMNNF 352
                +N +    +  L++S N ++  +               +     ++   F  +N 
Sbjct: 193 DWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNI 252

Query: 353 SGIIPMEIGSLK--NLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEK 410
                     L   ++ +L L +  +       F  L  LK LNL+YN ++     +   
Sbjct: 253 KDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYG 312

Query: 411 LSYLKDLNLSFNKLKGEIPRGGSFGNFSA 439
           L  L+ LNLS+N L  E+    +F     
Sbjct: 313 LDNLQVLNLSYNLLG-ELY-SSNFYGLPK 339

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 87.9 bits (218), Expect = 6e-18
 Identities = 57/314 (18%), Positives = 106/314 (33%), Gaps = 35/314 (11%)

Query: 3   SIINNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIP 62
            +  N +     +    +  L+ L L +N      +  I  + ++  + LS NKL+ T+P
Sbjct: 344 DLQKNHIAIIQDQTFKFLEKLQTLDLRDNA-----LTTIHFIPSIPDIFLSGNKLV-TLP 397

Query: 63  AAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNA-SKLS 121
                 + +    ++ N L         + +P+L++L L  N FS        +    L 
Sbjct: 398 KINLTANLIH---LSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLE 454

Query: 122 KLALEMNSF-----SGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHI 176
           +L L  N       +      F  L +L+ L L  N L S    +      S+  +L  +
Sbjct: 455 QLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGV-----FSHLTALRGL 509

Query: 177 SLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGS 236
           SL++N L  +       +L  +L+   +    +    P+   +   L+ + +  NK    
Sbjct: 510 SLNSNRLTVLSH----NDLPANLEILDISRNQLLAPNPDVFVS---LSVLDITHNKFICE 562

Query: 237 IPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLK 296
                  L    +     N      P  I     +Y     G  L             LK
Sbjct: 563 CE-----LSTFINWLNHTNVTIAGPPADIY---CVYPDSFSGVSLFSLSTEGCDEEEVLK 614

Query: 297 VLSLGSNELTSIPL 310
            L      + ++ L
Sbjct: 615 SLKFSLFIVCTVTL 628

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 82.9 bits (205), Expect = 2e-16
 Identities = 35/146 (23%), Positives = 54/146 (36%), Gaps = 7/146 (4%)

Query: 296 KVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGI 355
           ++       LT +P     L     L LS N            L+ L  ++         
Sbjct: 7   RIAFYRFCNLTQVPQV---LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLT 63

Query: 356 IPMEI-GSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTI--PVSLEKLS 412
           I  E   +L NL  L L  +++    PD+F  L  L  L L +  LS  +        L 
Sbjct: 64  IDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLK 123

Query: 413 YLKDLNLSFNKLKGEIPRGGSFGNFS 438
            L  L+LS N+++  +    SFG  +
Sbjct: 124 ALTRLDLSKNQIR-SLYLHPSFGKLN 148

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  165 bits (420), Expect = 3e-44
 Identities = 91/422 (21%), Positives = 158/422 (37%), Gaps = 64/422 (15%)

Query: 13  TPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLK 72
            P+ + N + L+    +++ L  E+  E  ++ +      + ++     P        + 
Sbjct: 4   NPRNVSN-TFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61

Query: 73  AFAVTNN--------SLSGC-LSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKL 123
              + +          L+   LSS+ +   P+LE L    N+ +  +P    +   L   
Sbjct: 62  VSRLRDCLDRQAHELELNNLGLSSLPE-LPPHLESLVASCNSLT-ELPELPQSLKSLLVD 119

Query: 124 ALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPL 183
              + + S   P        LE+L + +N L         L  L N   L  I + NN L
Sbjct: 120 NNNLKALSDLPP-------LLEYLGVSNNQLEK-------LPELQNSSFLKIIDVDNNSL 165

Query: 184 DGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGK 243
                   + +L  SL+     N  +   +P E+ NL  LT I    N L   +P     
Sbjct: 166 ------KKLPDLPPSLEFIAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLK-KLPDLPLS 216

Query: 244 LQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSN 303
           L+ +       N L       +     L  +    N L  ++P    +   L+ L++  N
Sbjct: 217 LESI---VAGNNIL--EELPELQNLPFLTTIYADNNLLK-TLPDLPPS---LEALNVRDN 267

Query: 304 ELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSL 363
            LT +P    SL     L++S N FSG L     NL  L   + S N    +        
Sbjct: 268 YLTDLPELPQSLT---FLDVSENIFSG-LSELPPNLYYL---NASSNEIRSL----CDLP 316

Query: 364 KNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNK 423
            +LE L +  N+L   +P        L+ L  S+N+L+  +P   +    LK L++ +N 
Sbjct: 317 PSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVPELPQN---LKQLHVEYNP 368

Query: 424 LK 425
           L+
Sbjct: 369 LR 370

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  159 bits (405), Expect = 3e-42
 Identities = 86/450 (19%), Positives = 150/450 (33%), Gaps = 76/450 (16%)

Query: 2   PSIINNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTI 61
           P        + +            L L N  L   +     HL +L     S N L   +
Sbjct: 52  PGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SLPELPPHLESL---VASCNSL-TEL 106

Query: 62  PAAIFNVSTLKAFAVTNNSLSG-------------CLSSITDVG-LPNLEVLYLWGNNFS 107
           P    ++ +L        +LS               L  + ++     L+++ +  N+  
Sbjct: 107 PELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLK 166

Query: 108 GTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTS--------STL 159
             +P    +   L  +A   N     +P    NL  L  +   +N+L           ++
Sbjct: 167 -KLPDLPPS---LEFIAAGNNQLE-ELPE-LQNLPFLTAIYADNNSLKKLPDLPLSLESI 220

Query: 160 DLSF-----LSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIP 214
                    L  L N   LT I   NN L        + +L  SL+   + +  ++  +P
Sbjct: 221 VAGNNILEELPELQNLPFLTTIYADNNLL------KTLPDLPPSLEALNVRDNYLTD-LP 273

Query: 215 EEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYEL 274
           E   +LT L    +  N  +  +      L  L   +   N++  S+ D       L EL
Sbjct: 274 ELPQSLTFLD---VSENIFS-GLSELPPNLYYL---NASSNEIR-SLCDLP---PSLEEL 322

Query: 275 ELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPL 334
            +  NKL   +PA       L+ L    N L  +P    +LK    L++  N      P 
Sbjct: 323 NVSNNKLI-ELPALPPR---LERLIASFNHLAEVPELPQNLKQ---LHVEYNPLRE-FPD 374

Query: 335 EIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLN 394
              +++ L      MN+    +P       NL+ L +E N L    PD      S++ L 
Sbjct: 375 IPESVEDL-----RMNSHLAEVPELPQ---NLKQLHVETNPLR-EFPDIPE---SVEDLR 422

Query: 395 LSYNNLSGTIPVSLEKLSYLKDLNLSFNKL 424
           ++   +      + E    L+D     +  
Sbjct: 423 MNSERVVDPYEFAHETTDKLEDDVFEHHHH 452

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  124 bits (313), Expect = 2e-30
 Identities = 61/308 (19%), Positives = 99/308 (32%), Gaps = 43/308 (13%)

Query: 133 FIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILP---- 188
           FI     +   L+    + +NLT             N KS T    + +  +   P    
Sbjct: 2   FINPRNVSNTFLQEPLRHSSNLT------EMPVEAENVKSKTEYYNAWSEWERNAPPGNG 55

Query: 189 -------RTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITL 241
                        L        + N  +S  +PE   +L  L       N L   +P   
Sbjct: 56  EQREMAVSRLRDCLDRQAHELELNNLGLS-SLPELPPHLESLV---ASCNSLT-ELPELP 110

Query: 242 GKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLG 301
             L+ L   +     L    P        L  L +  N+L   +P    N +FLK++ + 
Sbjct: 111 QSLKSLLVDNNNLKALSDLPP-------LLEYLGVSNNQLE-KLPE-LQNSSFLKIIDVD 161

Query: 302 SNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIG 361
           +N L  +P    SL+    +   +N     LP E++NL  L  I    N+   +      
Sbjct: 162 NNSLKKLPDLPPSLE---FIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKKLPD---- 212

Query: 362 SLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSF 421
              +LE++    N L         +L  L ++    N L  T+P     L  L   +   
Sbjct: 213 LPLSLESIVAGNNIL--EELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEALNVRDNYL 269

Query: 422 NKLKGEIP 429
             L     
Sbjct: 270 TDLPELPQ 277

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  124 bits (313), Expect = 2e-30
 Identities = 71/348 (20%), Positives = 125/348 (35%), Gaps = 56/348 (16%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAI 65
           NN L        D   +L+ +   NN+L  E + E+ +L  L  +    N L   +P   
Sbjct: 162 NNSLKKL----PDLPPSLEFIAAGNNQL--EELPELQNLPFLTAIYADNNSLK-KLPDLP 214

Query: 66  FNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLAL 125
            ++ ++      NN L   L  +    LP L  +Y   N    T+P        L  L +
Sbjct: 215 LSLESIV---AGNNILE-ELPELQ--NLPFLTTIYADNNLLK-TLPDLP---PSLEALNV 264

Query: 126 EMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDG 185
             N  +  +P    +L  L+      + L+                +L +++ S+N +  
Sbjct: 265 RDNYLTD-LPELPQSLTFLDVSENIFSGLSEL------------PPNLYYLNASSNEI-- 309

Query: 186 ILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQ 245
                 + +L  SL+   + N  +   +P     L  L       N L   +P     L+
Sbjct: 310 ----RSLCDLPPSLEELNVSNNKLIE-LPALPPRLERLI---ASFNHLA-EVPELPQNLK 360

Query: 246 KLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNEL 305
           +L    +EYN L    PD       + +L +  + L+  +P    N   LK L + +N L
Sbjct: 361 QL---HVEYNPLR-EFPDIPE---SVEDLRMN-SHLA-EVPELPQN---LKQLHVETNPL 408

Query: 306 TSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFS 353
              P    S++D   L ++S     P          L +  F  ++  
Sbjct: 409 REFPDIPESVED---LRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  164 bits (417), Expect = 3e-43
 Identities = 84/439 (19%), Positives = 157/439 (35%), Gaps = 32/439 (7%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQG-EIIHEIGHLHNLGFLDLSQNKLLGTIPAA 64
           +N L+S +      +S+LK L L  N  Q   +     +L NL  L +   +    I   
Sbjct: 83  DNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRI 142

Query: 65  IF-NVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNA-SKLSK 122
            F  +++L    +   SL     S +   + ++  L L   + S  +     +  S +  
Sbjct: 143 DFAGLTSLNELEIKALSLRN-YQSQSLKSIRDIHHLTL-HLSESAFLLEIFADILSSVRY 200

Query: 123 LALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSF---LSSLSNCKSLTHISLS 179
           L L   + + F  S          +        S   D SF   L  L     L+ +   
Sbjct: 201 LELRDTNLARFQFSPLPVDEVSSPMKK-LAFRGSVLTDESFNELLKLLRYILELSEVEFD 259

Query: 180 NNPLDGI--LPRTYVGNLSH-------SLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGG 230
           +  L+G+     +    +S        +++  ++    +   +    + L  +  I +  
Sbjct: 260 DCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVEN 319

Query: 231 NKLNGSIPITLGKLQKLQDVDLEYNQL-EGSIPDSICLS--VELYELELGGNKLS--GSI 285
           +K+          L+ L+ +DL  N + E  + +S C      L  L L  N L      
Sbjct: 320 SKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKT 379

Query: 286 PACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEI 345
                 +  L  L +  N    +P +    + +  LNLSS      +   I   + L  +
Sbjct: 380 GEILLTLKNLTSLDISRNTFHPMPDSCQWPEKMRFLNLSSTGIRV-VKTCI--PQTLEVL 436

Query: 346 DFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIP 405
           D S NN           L  L+ L++  N+L+ ++PD+      L  + +S N L     
Sbjct: 437 DVSNNNLDSFSL----FLPRLQELYISRNKLK-TLPDASL-FPVLLVMKISRNQLKSVPD 490

Query: 406 VSLEKLSYLKDLNLSFNKL 424
              ++L+ L+ + L  N  
Sbjct: 491 GIFDRLTSLQKIWLHTNPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  144 bits (365), Expect = 2e-36
 Identities = 56/352 (15%), Positives = 121/352 (34%), Gaps = 14/352 (3%)

Query: 85  LSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNL 144
            +SI       ++ L L  N  +      +   + L  L L+ +  +      F +L +L
Sbjct: 17  FTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSL 76

Query: 145 EWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYM 204
           E L L DN+L+S +             SL +++L  NP   +   +   NL+ +L+   +
Sbjct: 77  EHLDLSDNHLSSLSSSW-----FGPLSSLKYLNLMGNPYQTLGVTSLFPNLT-NLQTLRI 130

Query: 205 YNCNVSGGIPEE-ITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPD 263
            N      I       LT L  + +    L      +L  ++ +  + L  ++    +  
Sbjct: 131 GNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEI 190

Query: 264 SICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIP-LNFWSLKDILDLN 322
              +   +  LEL    L+    +          +   +   + +   +F  L  +L   
Sbjct: 191 FADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYI 250

Query: 323 LSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPD 382
           L  +       +E  +       DF+ +    +  +       +  L +    L   +  
Sbjct: 251 LELS------EVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLST 304

Query: 383 SFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIPRGGSF 434
            +  L  +K + +  + +        + L  L+ L+LS N +  E  +  + 
Sbjct: 305 VYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSAC 356

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  144 bits (364), Expect = 2e-36
 Identities = 69/404 (17%), Positives = 135/404 (33%), Gaps = 35/404 (8%)

Query: 47  LGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNF 106
            G  D        +IP+ +   + +K+  ++ N ++  +         NL+VL L  +  
Sbjct: 7   SGVCDGRSRSF-TSIPSGLT--AAMKSLDLSFNKITY-IGHGDLRACANLQVLILKSSRI 62

Query: 107 SGTIPHFIF-NASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLS 165
           + TI    F +   L  L L  N  S    S FG L +L++L L  N   +  +   F  
Sbjct: 63  N-TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLF-- 119

Query: 166 SLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTT 225
              N  +L  + + N      + R     L+  L    +   ++     + + ++ D+  
Sbjct: 120 --PNLTNLQTLRIGNVETFSEIRRIDFAGLTS-LNELEIKALSLRNYQSQSLKSIRDIHH 176

Query: 226 IVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSG-- 283
           + L  ++    + I    L  ++ ++L    L       + +      ++    + S   
Sbjct: 177 LTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLT 236

Query: 284 --------SIPACFSNMTFLKVLSLGSNELTSIPLN---------FWSLKDILDLNLSSN 326
                    +      ++ ++      N L     +               I  L++   
Sbjct: 237 DESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQF 296

Query: 327 CFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDS--- 383
                L      L+ +  I    +    +       LK+LE L L  N +      +   
Sbjct: 297 YLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSAC 356

Query: 384 FGDLISLKSLNLSYNNLS--GTIPVSLEKLSYLKDLNLSFNKLK 425
            G   SL++L LS N+L         L  L  L  L++S N   
Sbjct: 357 KGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH 400

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 85.9 bits (213), Expect = 1e-17
 Identities = 48/237 (20%), Positives = 81/237 (34%), Gaps = 23/237 (9%)

Query: 3   SIINNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTI- 61
            I   +L          +  +K + + N+++         HL +L FLDLS+N ++    
Sbjct: 292 HIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYL 351

Query: 62  --PAAIFNVSTLKAFAVTNNSLSGCLSSITDV--GLPNLEVLYLWGNNFSGTIPHFIFNA 117
              A      +L+   ++ N L   +    ++   L NL  L +  N F   +P      
Sbjct: 352 KNSACKGAWPSLQTLVLSQNHLR-SMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWP 409

Query: 118 SKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHIS 177
            K+  L L                + LE L + +NNL S +L L           L  + 
Sbjct: 410 EKMRFLNLSSTGIRVV---KTCIPQTLEVLDVSNNNLDSFSLFLP---------RLQELY 457

Query: 178 LSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLN 234
           +S N L  +       +L   L    +    +          LT L  I L  N  +
Sbjct: 458 ISRNKLKTLPD----ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 510

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 77.1 bits (190), Expect = 1e-14
 Identities = 32/181 (17%), Positives = 62/181 (34%), Gaps = 24/181 (13%)

Query: 6   NNFLTS---TTPKEIDNISNLKVLYLYNNRLQ--GEIIHEIGHLHNLGFLDLSQNKLLGT 60
            N +               +L+ L L  N L+   +    +  L NL  LD+S+N     
Sbjct: 343 ENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTF-HP 401

Query: 61  IPAAIFNVSTLKAFAVTNNSLS----GCLSSIT------------DVGLPNLEVLYLWGN 104
           +P +      ++   +++  +         ++              + LP L+ LY+  N
Sbjct: 402 MPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLDSFSLFLPRLQELYISRN 461

Query: 105 NFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFL 164
               T+P        L  + +  N         F  L +L+ + L+ N    S   + +L
Sbjct: 462 KLK-TLPDASL-FPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYL 519

Query: 165 S 165
           S
Sbjct: 520 S 520

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 72.1 bits (177), Expect = 3e-13
 Identities = 38/142 (26%), Positives = 55/142 (38%), Gaps = 27/142 (19%)

Query: 295 LKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSG 354
             V    S   TSIP                      L   +++L      D S N  + 
Sbjct: 7   SGVCDGRSRSFTSIPSG--------------------LTAAMKSL------DLSFNKITY 40

Query: 355 IIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYL 414
           I   ++ +  NL+ L L+ +R+     D+F  L SL+ L+LS N+LS         LS L
Sbjct: 41  IGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSL 100

Query: 415 KDLNLSFNKLKGEIPRGGSFGN 436
           K LNL  N  +  +     F N
Sbjct: 101 KYLNLMGNPYQ-TLGVTSLFPN 121

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  159 bits (405), Expect = 4e-43
 Identities = 79/284 (27%), Positives = 119/284 (41%), Gaps = 44/284 (15%)

Query: 535 IGRGGFGSVYKARIR-DGMEVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVKVISSC 592
           IGRG FG V+  R+R D   VAVK             F  E  ++K   H N+V++I  C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181

Query: 593 SNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
           + ++   +V+E +  G    +L +    L +   L ++ D A+ +EYL    S   IH D
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRD 238

Query: 653 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDV 712
           L   N L+ +  V  +SDFG+++       + +       + + APE    G+ S+  DV
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDV 298

Query: 713 YSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLP---ISTMEVVDANLLSQEDIHFVA 769
           +SFGI+L ETF+          G            P   +S  +             FV 
Sbjct: 299 WSFGILLWETFS---------LGAS----------PYPNLSNQQT----------REFVE 329

Query: 770 K-------EQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIR 806
           K       E C   VF L  +C    P QR +   I  +L  IR
Sbjct: 330 KGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  159 bits (405), Expect = 7e-43
 Identities = 83/456 (18%), Positives = 155/456 (33%), Gaps = 80/456 (17%)

Query: 11  STTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVST 70
                 +        +++           E   L+N   +    +  +  +PAA+ +   
Sbjct: 11  KCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNST-MRKLPAALLD--- 66

Query: 71  LKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIF-NASKLSKLALEMNS 129
                                    +E+L L        I  + F  A  + KL +  N+
Sbjct: 67  ---------------------SFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNA 104

Query: 130 FSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPR 189
                P  F N+  L  L L  N+L+S  L      +      LT +S+SNN L+ I   
Sbjct: 105 IRYLPPHVFQNVPLLTVLVLERNDLSS--LPRGIFHNTPK---LTTLSMSNNNLERIEDD 159

Query: 190 TYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQD 249
           T+      SL+N  + +  ++  +   ++ +  L    +  N L+     TL     +++
Sbjct: 160 TFQAT--TSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLLS-----TLAIPIAVEE 209

Query: 250 VDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIP 309
           +D  +N +   +   + +   L  L+L  N L+        N   L  + L  NEL  I 
Sbjct: 210 LDASHNSIN-VVRGPVNVE--LTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIM 264

Query: 310 LN-FWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLEN 368
            + F  ++ +  L +S+N                             + +    +  L+ 
Sbjct: 265 YHPFVKMQRLERLYISNNRLV-------------------------ALNLYGQPIPTLKV 299

Query: 369 LFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEI 428
           L L +N L   +  +      L++L L +N++  T+ +S      LK+L LS N      
Sbjct: 300 LDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLST--HHTLKNLTLSHNDWD-CN 354

Query: 429 PRGGSFGNFSAESFKGNELLCGSPNLQVPP--CKAS 462
                F N +  +    +  C           CK S
Sbjct: 355 SLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKES 390

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  153 bits (388), Expect = 1e-40
 Identities = 65/393 (16%), Positives = 129/393 (32%), Gaps = 50/393 (12%)

Query: 58  LGTIPAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIF-N 116
              I + +          +   +         D+ L N +++    +     +P  +  +
Sbjct: 10  YKCIDSNLQYDCVFYDVHIDMQTQDV-YFGFEDITLNNQKIVTFKNSTMR-KLPAALLDS 67

Query: 117 ASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHI 176
             ++  L L            F     ++ L +  N +    L      ++     LT +
Sbjct: 68  FRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRY--LPPHVFQNVPL---LTVL 122

Query: 177 SLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGS 236
            L  N L  +                                N   LTT+ +  N L   
Sbjct: 123 VLERNDLSSLPRGI--------------------------FHNTPKLTTLSMSNNNLERI 156

Query: 237 IPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLK 296
              T      LQ++ L  N+L   +  S+  S  L+   +  N LS       +    ++
Sbjct: 157 EDDTFQATTSLQNLQLSSNRLT-HVDLSLIPS--LFHANVSYNLLST-----LAIPIAVE 208

Query: 297 VLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGII 356
            L    N +  +        ++  L L  N  +      + N   L+E+D S N    I+
Sbjct: 209 ELDASHNSINVVRGPV--NVELTILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELEKIM 264

Query: 357 PMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKD 416
                 ++ LE L++  NRL  ++      + +LK L+LS+N+L   +  +  +   L++
Sbjct: 265 YHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLEN 322

Query: 417 LNLSFNKLKGEIPRGGSFGNFSAESFKGNELLC 449
           L L  N +   +    +       +   N+  C
Sbjct: 323 LYLDHNSIV-TLKL-STHHTLKNLTLSHNDWDC 353

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  148 bits (376), Expect = 5e-39
 Identities = 77/416 (18%), Positives = 148/416 (35%), Gaps = 55/416 (13%)

Query: 3   SIINNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIP 62
            I           E   ++N K++   N+ ++      +     +  L+L+  ++   I 
Sbjct: 27  HIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQI-EEID 85

Query: 63  AAIF-NVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIF-NASKL 120
              F    T++   +  N++   L       +P L VL L  N+ S ++P  IF N  KL
Sbjct: 86  TYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKL 143

Query: 121 SKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSN 180
           + L++  N+       TF    +L+ L L  N LT   +DLS +       SL H ++S 
Sbjct: 144 TTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH--VDLSLI------PSLFHANVSY 195

Query: 181 NPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPIT 240
           N L                                 +     +  +    N +N    + 
Sbjct: 196 NLL-------------------------------STLAIPIAVEELDASHNSINV---VR 221

Query: 241 LGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSL 300
                +L  + L++N L       +     L E++L  N+L   +   F  M  L+ L +
Sbjct: 222 GPVNVELTILKLQHNNLT-DTAWLLNYP-GLVEVDLSYNELEKIMYHPFVKMQRLERLYI 279

Query: 301 GSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEI 360
            +N L ++ L    +  +  L+LS N     +         L  +    N+   +   ++
Sbjct: 280 SNNRLVALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIVTL---KL 335

Query: 361 GSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKD 416
            +   L+NL L +N  + +   +     ++    +   +    I   LE     K+
Sbjct: 336 STHHTLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDADQHCKIDYQLEHGLCCKE 389

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 79.7 bits (197), Expect = 6e-16
 Identities = 24/128 (18%), Positives = 45/128 (35%), Gaps = 1/128 (0%)

Query: 304 ELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSL 363
           E   I  N        D+++           E   L     + F  +    +    + S 
Sbjct: 9   EYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSF 68

Query: 364 KNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNK 423
           + +E L L   ++E     +F    +++ L + +N +    P   + +  L  L L  N 
Sbjct: 69  RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERND 128

Query: 424 LKGEIPRG 431
           L   +PRG
Sbjct: 129 LS-SLPRG 135

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  155 bits (394), Expect = 2e-42
 Identities = 75/289 (25%), Positives = 127/289 (43%), Gaps = 36/289 (12%)

Query: 534 LIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGR--AFKS-FDVECAMMKSIRHRNLVKVI 589
            +G GG  +VY A      ++VA+K   +           F+ E      + H+N+V +I
Sbjct: 18  KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77

Query: 590 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVI 649
                ++   LV+EY+   +L +Y+ S +  L +   +N    +   +++ H      ++
Sbjct: 78  DVDEEDDCYYLVMEYIEGPTLSEYIES-HGPLSVDTAINFTNQILDGIKHAH---DMRIV 133

Query: 650 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT-LATIGYMAPEYGREGQVST 708
           H D+KP N+L+D N    + DFGIAK L+  + S+TQT   L T+ Y +PE  +      
Sbjct: 134 HRDIKPQNILIDSNKTLKIFDFGIAKALS--ETSLTQTNHVLGTVQYFSPEQAKGEATDE 191

Query: 709 NGDVYSFGIMLMETFTRKKPTDELFNGE----MTLKHWVNDCLPISTMEVVDANLLSQED 764
             D+YS GI+L E    + P    FNGE    + +KH + D +P  T +V     + Q  
Sbjct: 192 CTDIYSIGIVLYEMLVGEPP----FNGETAVSIAIKH-IQDSVPNVTTDVRKD--IPQS- 243

Query: 765 IHFVAKEQCVSFVFNLALECTVESPEQR-INAKEIVAKLLKIRDSLLRN 812
                       + N+ L  T +    R    +E+   L  +      N
Sbjct: 244 ------------LSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRAN 280

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  160 bits (407), Expect = 2e-42
 Identities = 72/425 (16%), Positives = 135/425 (31%), Gaps = 30/425 (7%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAI 65
           ++ L         +  N+K L L  N L      ++     L  L+LS N L       +
Sbjct: 19  DSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL--YETLDL 76

Query: 66  FNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLAL 125
            ++STL+   + NN     +  +     P++E L+   NN S  +            + L
Sbjct: 77  ESLSTLRTLDLNNNY----VQELL--VGPSIETLHAANNNIS-RVSCSRG--QGKKNIYL 127

Query: 126 EMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDG 185
             N  +       G    +++L L  N + +    ++F    ++  +L H++L  N +  
Sbjct: 128 ANNKITMLRDLDEGCRSRVQYLDLKLNEIDT----VNFAELAASSDTLEHLNLQYNFIYD 183

Query: 186 ILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQ 245
           +  +         LK   + +  ++  +  E  +   +T I L  NKL   I   L   Q
Sbjct: 184 VKGQVVF----AKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQ 237

Query: 246 KLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNEL 305
            L+  DL  N            S       +    +           T   +   G+   
Sbjct: 238 NLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCC 296

Query: 306 TSIP------LNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPME 359
             +P      L     K+   L+   +     L  E  N     EID     +  +I   
Sbjct: 297 EDLPAPFADRLIALKRKEHALLSGQGSETER-LECERENQARQREIDALKEQYRTVIDQV 355

Query: 360 IGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNL 419
               +    L  +   L+  + +       L             +  + E+ S L+ L  
Sbjct: 356 TLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQ-IELQHATEEQSPLQLLRA 414

Query: 420 SFNKL 424
              + 
Sbjct: 415 IVKRY 419

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  157 bits (398), Expect = 3e-41
 Identities = 61/412 (14%), Positives = 128/412 (31%), Gaps = 29/412 (7%)

Query: 19  NISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTN 78
           N +  K+  + ++ L+  +        N+  LDLS N L     A +   + L+   +++
Sbjct: 8   NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67

Query: 79  NSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTF 138
           N L      +    L  L  L L  N         +     +  L    N+ S    S  
Sbjct: 68  NVLYE-TLDLE--SLSTLRTLDLNNNYVQE-----LLVGPSIETLHAANNNISRVSCSRG 119

Query: 139 GNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHS 198
              +  + + L +N +T    DL           + ++ L  N +D +       +   +
Sbjct: 120 ---QGKKNIYLANNKITMLR-DLDE----GCRSRVQYLDLKLNEIDTVNFAELAASS-DT 170

Query: 199 LKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLE 258
           L++  +    +   +  ++     L T+ L  NKL   +         +  + L  N+L 
Sbjct: 171 LEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227

Query: 259 GSIPDSICLSVELYELELGGNKLS-GSIPACFSNMTFLKVLSLGSNELTSIP-LNFWSLK 316
             I  ++  S  L   +L GN    G++   FS     +V ++    +  +   N     
Sbjct: 228 -LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKN--QRVQTVAKQTVKKLTGQNEEECT 284

Query: 317 DILDLNLSSNCFSGPLPLEIRNLKALIEIDFSM----NNFSGIIPMEIGSLKNLENLFLE 372
                +  + C           L AL   + ++     + +  +  E  +      +   
Sbjct: 285 VPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDAL 344

Query: 373 YNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKL 424
             +    I        +  +L      L   +       + L          
Sbjct: 345 KEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQ 396

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  156 bits (397), Expect = 4e-41
 Identities = 54/365 (14%), Positives = 122/365 (33%), Gaps = 31/365 (8%)

Query: 87  SITDV--GLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNL 144
           +I ++       ++  +  ++    +     +A  + +L L  N  S    +       L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 145 EWLTLYDNNLTS----------STLDLSF--LSSLSNCKSLTHISLSNNPLDGILPRTYV 192
           E L L  N L             TLDL+   +  L    S+  +  +NN +  +      
Sbjct: 61  ELLNLSSNVLYETLDLESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSRGQ 120

Query: 193 GNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNG-SIPITLGKLQKLQDVD 251
                  KN Y+ N  ++     +    + +  + L  N+++  +          L+ ++
Sbjct: 121 -----GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175

Query: 252 LEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLN 311
           L+YN +   +   +  + +L  L+L  NKL+  +   F +   +  +SL +N+L  I   
Sbjct: 176 LQYNFIY-DVKGQVVFA-KLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVLIEKA 232

Query: 312 FWSLKDILDLNLSSNCFS-GPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLF 370
               +++   +L  N F  G L       + +  +         +               
Sbjct: 233 LRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVA--KQTVKKLTGQNEEECTVPTLGH 290

Query: 371 LEYNRLEGSIPDSFGDLISLKSLNLSYNNLSG----TIPVSLEKLSYLKDLNLSFNKLKG 426
                 E         LI+LK    +  +  G     +    E  +  ++++    + + 
Sbjct: 291 YGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYR- 349

Query: 427 EIPRG 431
            +   
Sbjct: 350 TVIDQ 354

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  110 bits (276), Expect = 1e-25
 Identities = 49/414 (11%), Positives = 108/414 (26%), Gaps = 45/414 (10%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAI 65
           NN++      E+    +++ L+  NN +   +            + L+ NK+        
Sbjct: 89  NNYVQ-----ELLVGPSIETLHAANNNIS-RV--SCSRGQGKKNIYLANNKITMLRDLDE 140

Query: 66  FNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLAL 125
              S ++   +  N +     +        LE L L  N     +   +   +KL  L L
Sbjct: 141 GCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVVF-AKLKTLDL 198

Query: 126 EMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDG 185
             N  + F+   F +   + W++L +N L           +L   ++L H  L  N    
Sbjct: 199 SSNKLA-FMGPEFQSAAGVTWISLRNNKLVL------IEKALRFSQNLEHFDLRGNGFHC 251

Query: 186 ILPRTYVGNLS------------------------HSLKNFYMYNCNVSGGIPEEITNLT 221
              R +                                        ++     + +  L 
Sbjct: 252 GTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALK 311

Query: 222 --DLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGN 279
             +   +   G++    +        + +++D    Q    I            LE    
Sbjct: 312 RKEHALLSGQGSETE-RLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKK 370

Query: 280 KLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPL-PLEIRN 338
            L   +         L      +     +         +  L      +       +   
Sbjct: 371 ALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQ 430

Query: 339 LKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKS 392
             A+ + D   +  + +        K      L       ++ +      +L S
Sbjct: 431 NNAIRDWDMYQHKETQLAEENARLKKLNGEADLALASANATLQELVVREQNLAS 484

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 68.3 bits (167), Expect = 4e-12
 Identities = 26/98 (26%), Positives = 41/98 (41%), Gaps = 3/98 (3%)

Query: 336 IRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNL 395
            +N         + ++    +     S  N++ L L  N L             L+ LNL
Sbjct: 6   KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65

Query: 396 SYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIPRGGS 433
           S N L  T+   LE LS L+ L+L+ N ++ E+  G S
Sbjct: 66  SSNVLYETLD--LESLSTLRTLDLNNNYVQ-ELLVGPS 100

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  150 bits (382), Expect = 5e-41
 Identities = 70/287 (24%), Positives = 117/287 (40%), Gaps = 46/287 (16%)

Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSN 594
           IG G FG V+     +  +VA+K    +   + + F  E  +M  + H  LV++   C  
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74

Query: 595 EEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL---HFGYSAPVIHC 651
           +    LV E+M HG L  YL +          L + +DV   + YL           IH 
Sbjct: 75  QAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV------IHR 128

Query: 652 DLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGD 711
           DL   N L+ +N V  +SDFG+ + +  +DQ  + T T   + + +PE     + S+  D
Sbjct: 129 DLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 187

Query: 712 VYSFGIMLMETFTR-KKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAK 770
           V+SFG+++ E F+  K P +   N                            E +  ++ 
Sbjct: 188 VWSFGVLMWEVFSEGKIPYENRSN---------------------------SEVVEDIST 220

Query: 771 -------EQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLL 810
                      + V+ +   C  E PE R     ++ +L +I +S L
Sbjct: 221 GFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESGL 267

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  150 bits (382), Expect = 1e-40
 Identities = 73/290 (25%), Positives = 127/290 (43%), Gaps = 29/290 (10%)

Query: 535 IGRGGFGSVYKARIR-----DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVI 589
           +G+G FGSV   R        G  VAVK          + F+ E  ++KS++H N+VK  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77

Query: 590 SSCSNEEFKA--LVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAP 647
             C +   +   L++EY+P+GSL  YL      +D  + L     +   +EYL    +  
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 134

Query: 648 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-TGEDQSMTQTQTLATIGYMAPEYGREGQV 706
            IH DL   N+L+++     + DFG+ K+L   ++    +    + I + APE   E + 
Sbjct: 135 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKF 194

Query: 707 STNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIH 766
           S   DV+SFG++L E FT  + +       M +            M V          I 
Sbjct: 195 SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG----NDKQGQMIV-------FHLIE 243

Query: 767 FVAK-------EQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSL 809
            +         + C   ++ +  EC   +  QR + +++  ++ +IRD++
Sbjct: 244 LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  151 bits (383), Expect = 1e-40
 Identities = 78/336 (23%), Positives = 137/336 (40%), Gaps = 41/336 (12%)

Query: 496 QKREKGPPNDPNMPPVATWRRFSYLELFQATDK--FSENNL-----IGRGGFGSVYKARI 548
              +   P   N+              F+  D   F E +L     +G+G FGSV   R 
Sbjct: 8   HHHDYDIPTTENLYFQGA-----MGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRY 62

Query: 549 -----RDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKA--LV 601
                  G  VAVK          + F+ E  ++KS++H N+VK    C +   +   L+
Sbjct: 63  DPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLI 122

Query: 602 LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD 661
           +EY+P+GSL  YL      +D  + L     +   +EYL    +   IH DL   N+L++
Sbjct: 123 MEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVE 179

Query: 662 DNMVAHLSDFGIAKLL-TGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLM 720
           +     + DFG+ K+L   ++    +    + I + APE   E + S   DV+SFG++L 
Sbjct: 180 NENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 239

Query: 721 ETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAK-------EQC 773
           E FT  + +       M +                   ++    I  +         + C
Sbjct: 240 ELFTYIEKSKSPPAEFMRMIG----NDK-------QGQMIVFHLIELLKNNGRLPRPDGC 288

Query: 774 VSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSL 809
              ++ +  EC   +  QR + +++  ++ +IRD +
Sbjct: 289 PDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  157 bits (398), Expect = 1e-40
 Identities = 78/393 (19%), Positives = 147/393 (37%), Gaps = 53/393 (13%)

Query: 11  STTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVST 70
                 +        +++           E   L+N   +    +  +  +PAA+ +   
Sbjct: 17  KCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNST-MRKLPAALLD--- 72

Query: 71  LKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIF-NASKLSKLALEMNS 129
                                    +E+L L        I  + F  A  + KL +  N+
Sbjct: 73  ---------------------SFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNA 110

Query: 130 FSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPR 189
                P  F N+  L  L L  N+L+S  L      +      LT +S+SNN L+ I   
Sbjct: 111 IRYLPPHVFQNVPLLTVLVLERNDLSS--LPRGIFHNTPK---LTTLSMSNNNLERIEDD 165

Query: 190 TYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQD 249
           T+      SL+N  + +  ++  +   ++ +  L    +  N L+     TL     +++
Sbjct: 166 TFQAT--TSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLLS-----TLAIPIAVEE 215

Query: 250 VDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIP 309
           +D  +N +   +   + +   L  L+L  N L+        N   L  + L  NEL  I 
Sbjct: 216 LDASHNSIN-VVRGPVNVE--LTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIM 270

Query: 310 LN-FWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLEN 368
            + F  ++ +  L +S+N     L L  + +  L  +D S N+    +         LEN
Sbjct: 271 YHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLEN 328

Query: 369 LFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLS 401
           L+L++N +  ++        +LK+L LS+N+  
Sbjct: 329 LYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWD 358

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  151 bits (382), Expect = 2e-38
 Identities = 65/393 (16%), Positives = 130/393 (33%), Gaps = 50/393 (12%)

Query: 58  LGTIPAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIF-N 116
              I + +          +   +         D+ L N +++    +     +P  +  +
Sbjct: 16  YKCIDSNLQYDCVFYDVHIDMQTQDV-YFGFEDITLNNQKIVTFKNSTMR-KLPAALLDS 73

Query: 117 ASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHI 176
             ++  L L            F     ++ L +  N +    L      ++     LT +
Sbjct: 74  FRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRY--LPPHVFQNVPL---LTVL 128

Query: 177 SLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGS 236
            L  N L  +    +                           N   LTT+ +  N L   
Sbjct: 129 VLERNDLSSLPRGIF--------------------------HNTPKLTTLSMSNNNLERI 162

Query: 237 IPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLK 296
              T      LQ++ L  N+L   +  S+  S  L+   +  N LS       +    ++
Sbjct: 163 EDDTFQATTSLQNLQLSSNRLT-HVDLSLIPS--LFHANVSYNLLST-----LAIPIAVE 214

Query: 297 VLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGII 356
            L    N +  +        ++  L L  N  +      + N   L+E+D S N    I+
Sbjct: 215 ELDASHNSINVVRGPV--NVELTILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELEKIM 270

Query: 357 PMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKD 416
                 ++ LE L++  NRL  ++      + +LK L+LS+N+L   +  +  +   L++
Sbjct: 271 YHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLEN 328

Query: 417 LNLSFNKLKGEIPRGGSFGNFSAESFKGNELLC 449
           L L  N +   +    +       +   N+  C
Sbjct: 329 LYLDHNSIV-TLK-LSTHHTLKNLTLSHNDWDC 359

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  129 bits (325), Expect = 3e-31
 Identities = 62/301 (20%), Positives = 110/301 (36%), Gaps = 20/301 (6%)

Query: 128 NSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGIL 187
           N           +         YD ++   T D+ F        +   ++  N+ +  + 
Sbjct: 8   NVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKL- 66

Query: 188 PRTYVGNLSHSLKNFYMYNCNVSGGIPEEI-TNLTDLTTIVLGGNKLNGSIPITLGKLQK 246
           P   + +    ++   + +  +   I          +  + +G N +    P     +  
Sbjct: 67  PAALLDSFR-QVELLNLNDLQIEE-IDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPL 124

Query: 247 LQDVDLEYNQLEGSIPDSICLS-VELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNEL 305
           L  + LE N L  S+P  I  +  +L  L +  N L       F   T L+ L L SN L
Sbjct: 125 LTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRL 183

Query: 306 TSIPLN-FWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLK 364
           T + L+   SL      N+S N  S      +    A+ E+D S N+ + +         
Sbjct: 184 THVDLSLIPSLFH---ANVSYNLLS-----TLAIPIAVEELDASHNSINVV---RGPVNV 232

Query: 365 NLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKL 424
            L  L L++N L  +      +   L  ++LSYN L   +     K+  L+ L +S N+L
Sbjct: 233 ELTILKLQHNNL--TDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRL 290

Query: 425 K 425
            
Sbjct: 291 V 291

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 76.5 bits (188), Expect = 1e-14
 Identities = 24/128 (18%), Positives = 45/128 (35%), Gaps = 1/128 (0%)

Query: 304 ELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSL 363
           E   I  N        D+++           E   L     + F  +    +    + S 
Sbjct: 15  EYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSF 74

Query: 364 KNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNK 423
           + +E L L   ++E     +F    +++ L + +N +    P   + +  L  L L  N 
Sbjct: 75  RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERND 134

Query: 424 LKGEIPRG 431
           L   +PRG
Sbjct: 135 LS-SLPRG 141

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 69.6 bits (170), Expect = 2e-12
 Identities = 59/391 (15%), Positives = 125/391 (31%), Gaps = 37/391 (9%)

Query: 21  SNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIF-NVSTLKAFAVTNN 79
             L +L L +N L       + +   L  +DLS N+L   I    F  +  L+   ++NN
Sbjct: 232 VELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNEL-EKIMYHPFVKMQRLERLYISNN 288

Query: 80  SLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFG 139
            L     ++    +P L+VL L  N+    +        +L  L L+ NS    +     
Sbjct: 289 RLVA--LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LS 342

Query: 140 NLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHS- 198
               L+ LTL  N+   ++L   F       +++   ++ +      +       L    
Sbjct: 343 THHTLKNLTLSHNDWDCNSLRALF-------RNVARPAVDDADQHCKIDYQLEHGLCCKE 395

Query: 199 -------LKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVD 251
                      Y+   +V   +       +   TI    +  +         LQ  + ++
Sbjct: 396 SDKPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLE 455

Query: 252 LEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLN 311
            E N+L   +     L+ E  + E     L   I       T L+   L  + L     N
Sbjct: 456 AEVNELRAEVQQ---LTNEQIQQEQLLQGLHAEID------TNLRRYRLPKDGLARSSDN 506

Query: 312 FWSLKDIL-DLNLSSNCFSGPLPLEIRN-LKALIEIDFSMNNFSGIIPMEIGS-LKNLEN 368
              +   L +        +     E     K   +++         +  +     +  + 
Sbjct: 507 LNKVFTHLKERQAFKLRETQARRTEADAKQKETEDLEQENIALEKQLDNKRAKQAELRQE 566

Query: 369 LFLEYNRLEGSIPDSFGDLISLKSLNLSYNN 399
             L+  +++        +  + +  +  +++
Sbjct: 567 TSLKRQKVKQLEAKKNRNPDTRRVSHHHHHH 597

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  152 bits (386), Expect = 1e-40
 Identities = 84/379 (22%), Positives = 148/379 (39%), Gaps = 63/379 (16%)

Query: 464 HRTSRKNALILGIVLPFST--IFMTAIILFIIKYQKREKGPPNDPNMPPVATWRRFSYL- 520
           H   R+ ++  GI++P  +  +     I  +     ++ G  N             S L 
Sbjct: 13  HHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALN 72

Query: 521 -ELFQATDKFSE---------NNLIGRGGFGSVYKARIRDG----MEVAVKVFNLQCG-R 565
            EL QA               N +IGRG FG VY   + D     +  AVK  N      
Sbjct: 73  PELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG 132

Query: 566 AFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKAL-VLEYMPHGSLEKYLHSSNYSLDIF 624
               F  E  +MK   H N++ ++  C   E   L VL YM HG L  ++ +  ++  + 
Sbjct: 133 EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK 192

Query: 625 QRLNIMIDVASALEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 681
             +   + VA  +++L    F      +H DL   N +LD+     ++DFG+A+ +  ++
Sbjct: 193 DLIGFGLQVAKGMKFLASKKF------VHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246

Query: 682 QSMTQTQTLAT--IGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTL 739
                 +T A   + +MA E  +  + +T  DV+SFG++L E  TR         G    
Sbjct: 247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR---------GAP-- 295

Query: 740 KHWVNDCLPISTMEVVDANLLSQEDIHFVAK-------EQCVSFVFNLALECTVESPEQR 792
                   P   +          +   ++ +       E C   ++ + L+C     E R
Sbjct: 296 --------PYPDVNT-------FDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMR 340

Query: 793 INAKEIVAKLLKIRDSLLR 811
            +  E+V+++  I  + + 
Sbjct: 341 PSFSELVSRISAIFSTFIG 359

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  149 bits (379), Expect = 2e-40
 Identities = 69/295 (23%), Positives = 121/295 (41%), Gaps = 50/295 (16%)

Query: 533 NLIGRGGFGSVYKARIRDG----MEVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVK 587
            +IGRG FG VY   + D     +  AVK  N          F  E  +MK   H N++ 
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90

Query: 588 VISSCSNEEFKAL-VLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL---HFG 643
           ++  C   E   L VL YM HG L  ++ +  ++  +   +   + VA  ++YL    F 
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKF- 149

Query: 644 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED--QSMTQTQTLATIGYMAPEYG 701
                +H DL   N +LD+     ++DFG+A+ +  ++      +T     + +MA E  
Sbjct: 150 -----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 204

Query: 702 REGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLS 761
           +  + +T  DV+SFG++L E  TR         G            P   +         
Sbjct: 205 QTQKFTTKSDVWSFGVLLWELMTR---------GAP----------PYPDVNT------- 238

Query: 762 QEDIHFVAK-------EQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSL 809
            +   ++ +       E C   ++ + L+C     E R +  E+V+++  I  + 
Sbjct: 239 FDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  149 bits (379), Expect = 3e-40
 Identities = 76/290 (26%), Positives = 130/290 (44%), Gaps = 39/290 (13%)

Query: 534 LIGRGGFGSVYKAR-IRDGMEVAVKV--FNLQCGRAFKS-FDVECAMMKSIRHRNLVKVI 589
           ++G GG   V+ AR +RD  +VAVKV   +L    +F   F  E     ++ H  +V V 
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78

Query: 590 SSCSNEEFKA----LVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYS 645
            +   E        +V+EY+   +L   +H+    +   + + ++ D   AL + H    
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSH---Q 134

Query: 646 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT-LATIGYMAPEYGREG 704
             +IH D+KP+N+++       + DFGIA+ +     S+TQT   + T  Y++PE  R  
Sbjct: 135 NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD 194

Query: 705 QVSTNGDVYSFGIMLMETFTRKKPTDELFNGE----MTLKHWVNDCLPISTMEVVDANLL 760
            V    DVYS G +L E  T + P    F G+    +  +H V +  PI      +   L
Sbjct: 195 SVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVSVAYQH-VRE-DPIPPSARHEG--L 246

Query: 761 SQEDIHFVAKEQCVSFVFNLALECTVESPEQR-INAKEIVAKLLKIRDSL 809
           S +             +  + L+   ++PE R   A E+ A L+++ +  
Sbjct: 247 SAD-------------LDAVVLKALAKNPENRYQTAAEMRADLVRVHNGE 283

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  148 bits (377), Expect = 5e-40
 Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 18/216 (8%)

Query: 534 LIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGR--AFKS-FDVECAMMKSIRHRNLVKVI 589
           L+GRGG G VY+A        VA+K+ +        F++    E      ++  ++V + 
Sbjct: 41  LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100

Query: 590 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVI 649
                +    + +  +    L   L      L   + + I+  + SAL+  H   +A   
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAMLRR-QGPLAPPRAVAIVRQIGSALDAAH---AAGAT 156

Query: 650 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT-LATIGYMAPEYGREGQVST 708
           H D+KP N+L+  +  A+L DFGIA   T  D+ +TQ    + T+ YMAPE   E   + 
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATT--DEKLTQLGNTVGTLYYMAPERFSESHATY 214

Query: 709 NGDVYSFGIMLMETFTRKKPTDELFNGE---MTLKH 741
             D+Y+   +L E  T   P    + G+   +   H
Sbjct: 215 RADIYALTCVLYECLTGSPP----YQGDQLSVMGAH 246

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  148 bits (375), Expect = 8e-40
 Identities = 66/299 (22%), Positives = 126/299 (42%), Gaps = 50/299 (16%)

Query: 531 ENNLIGRGGFGSVYKARIRDG----MEVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNL 585
            + +IG+G FG VY     D     ++ A+K  +     +  ++F  E  +M+ + H N+
Sbjct: 25  SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84

Query: 586 VKVISSCSNEE-FKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL---H 641
           + +I      E    ++L YM HG L +++ S   +  +   ++  + VA  +EYL    
Sbjct: 85  LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK 144

Query: 642 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED--QSMTQTQTLATIGYMAPE 699
           F      +H DL   N +LD++    ++DFG+A+ +   +             + + A E
Sbjct: 145 F------VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALE 198

Query: 700 YGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANL 759
             +  + +T  DV+SFG++L E  TR         G            P   ++      
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLTR---------GAP----------PYRHIDP----- 234

Query: 760 LSQEDIHFVAK-------EQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLR 811
              +  HF+A+       E C   ++ +  +C    P  R   + +V ++ +I  +LL 
Sbjct: 235 --FDLTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  148 bits (376), Expect = 1e-39
 Identities = 65/289 (22%), Positives = 115/289 (39%), Gaps = 43/289 (14%)

Query: 535 IGRGGFGSVYKARIRDGME-----VAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVKV 588
           +G G FG+VYK       E     VA+K        +A K    E  +M S+ + ++ ++
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82

Query: 589 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL---HFGYS 645
           +  C     + L+ + MP G L  Y+     ++     LN  + +A  + YL        
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL--- 138

Query: 646 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQ 705
              +H DL   NVL+       ++DFG+AKLL  E++          I +MA E      
Sbjct: 139 ---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195

Query: 706 VSTNGDVYSFGIMLMETFTR-KKPTDELFNGEMTLKHWVNDCLPISTMEVVDANL-LSQE 763
            +   DV+S+G+ + E  T   KP D +   E+                +++    L Q 
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI--------------SSILEKGERLPQP 241

Query: 764 DIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLRN 812
            I       C   V+ +  +C +   + R   +E++ +       + R+
Sbjct: 242 PI-------CTIDVYMIMRKCWMIDADSRPKFRELIIEF----SKMARD 279

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  147 bits (374), Expect = 1e-39
 Identities = 63/293 (21%), Positives = 120/293 (40%), Gaps = 35/293 (11%)

Query: 535 IGRGGFGSVYKAR-----IRDGMEVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVKV 588
           +G G FG V   R        G +VAVK    + G         E  +++++ H N+VK 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88

Query: 589 ISSCSNEEFKA--LVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSA 646
              C+ +      L++E++P GSL++YL  +   +++ Q+L   + +   ++YL    S 
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SR 145

Query: 647 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-TGEDQSMTQTQTLATIGYMAPEYGREGQ 705
             +H DL   NVL++      + DFG+ K + T ++    +    + + + APE   + +
Sbjct: 146 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSK 205

Query: 706 VSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDI 765
                DV+SFG+ L E  T            + +            M V          +
Sbjct: 206 FYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIG-----PTHGQMTVTRL-------V 253

Query: 766 HFVAK-------EQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLR 811
           + + +         C   V+ L  +C    P  R + + ++       ++LL+
Sbjct: 254 NTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGF----EALLK 302

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  147 bits (372), Expect = 2e-39
 Identities = 68/291 (23%), Positives = 106/291 (36%), Gaps = 42/291 (14%)

Query: 535 IGRGGFGSVYKARIR----DGMEVAVKVFN---LQCGRAFKSFDVECAMMKSIRHRNLVK 587
           +G G FG V +          + VAVK      L    A   F  E   M S+ HRNL++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85

Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL---HFGY 644
           +         K +V E  P GSL   L        +       + VA  + YL    F  
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRF-- 142

Query: 645 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQ-TLATIGYMAPEYGRE 703
               IH DL   N+LL    +  + DFG+ + L   D      +       + APE  + 
Sbjct: 143 ----IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 198

Query: 704 GQVSTNGDVYSFGIMLMETFTR-KKPTDELFNGEMTLKHWVNDCLPISTMEVVDAN--LL 760
              S   D + FG+ L E FT  ++P   L   +               +  +D     L
Sbjct: 199 RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ--------------ILHKIDKEGERL 244

Query: 761 SQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLR 811
            + +        C   ++N+ ++C    PE R     +   LL+ + + +R
Sbjct: 245 PRPED-------CPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDMR 288

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  146 bits (371), Expect = 2e-39
 Identities = 71/284 (25%), Positives = 120/284 (42%), Gaps = 46/284 (16%)

Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSN 594
           +G G FG V   + +   +VAVK+   +   +   F  E   M  + H  LVK    CS 
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74

Query: 595 EEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL---HFGYSAPVIHC 651
           E    +V EY+ +G L  YL S    L+  Q L +  DV   + +L    F      IH 
Sbjct: 75  EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQF------IHR 128

Query: 652 DLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGD 711
           DL   N L+D ++   +SDFG+ + +  +DQ ++   T   + + APE     + S+  D
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRYVL-DDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSD 187

Query: 712 VYSFGIMLMETFTR-KKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAK 770
           V++FGI++ E F+  K P D   N                            E +  V++
Sbjct: 188 VWAFGILMWEVFSLGKMPYDLYTN---------------------------SEVVLKVSQ 220

Query: 771 -------EQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRD 807
                        ++ +   C  E PE+R   +++++ +  +R+
Sbjct: 221 GHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  148 bits (375), Expect = 2e-39
 Identities = 64/295 (21%), Positives = 119/295 (40%), Gaps = 55/295 (18%)

Query: 535 IGRGGFGSVYKARIRDGME-----VAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVKV 588
           +G G FG+V+K       E     V +KV   + G ++F++       + S+ H ++V++
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80

Query: 589 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL---HFGYS 645
           +  C     + LV +Y+P GSL  ++     +L     LN  + +A  + YL        
Sbjct: 81  LGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGM--- 136

Query: 646 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQ 705
              +H +L   NVLL       ++DFG+A LL  +D+ +  ++    I +MA E    G+
Sbjct: 137 ---VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGK 193

Query: 706 VSTNGDVYSFGIMLMETFTR-KKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQED 764
            +   DV+S+G+ + E  T   +P   L   E+                           
Sbjct: 194 YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV--------------------------- 226

Query: 765 IHFVAK-------EQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLRN 812
              + K       + C   V+ + ++C +     R   KE+  +       + R+
Sbjct: 227 PDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEF----TRMARD 277

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  146 bits (371), Expect = 2e-39
 Identities = 63/284 (22%), Positives = 121/284 (42%), Gaps = 44/284 (15%)

Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSN 594
           +G G FG V   + R   +VA+K+   +   +   F  E  +M ++ H  LV++   C+ 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90

Query: 595 EEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL---HFGYSAPVIHC 651
           +    ++ EYM +G L  YL    +     Q L +  DV  A+EYL    F      +H 
Sbjct: 91  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF------LHR 144

Query: 652 DLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGD 711
           DL   N L++D  V  +SDFG+++ +  +D+  +   +   + +  PE     + S+  D
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSD 203

Query: 712 VYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAK- 770
           +++FG+++ E ++          G+M  + + N                  E    +A+ 
Sbjct: 204 IWAFGVLMWEIYSL---------GKMPYERFTN-----------------SETAEHIAQG 237

Query: 771 ------EQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDS 808
                       V+ +   C  E  ++R   K +++ +L + D 
Sbjct: 238 LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  147 bits (372), Expect = 3e-39
 Identities = 67/304 (22%), Positives = 121/304 (39%), Gaps = 64/304 (21%)

Query: 535 IGRGGFGSVYKARIRDG----MEVAVKVFNLQCG--RAFKSFDVECAMMKSIRHRNLVKV 588
           +G G FGSV +  ++      ++VAVK   L     R  + F  E A MK   H N++++
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101

Query: 589 ISSCSNEEFKA-----LVLEYMPHGSLEKYL-----HSSNYSLDIFQRLNIMIDVASALE 638
           +  C     +      ++L +M +G L  YL      +    + +   L  M+D+A  +E
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161

Query: 639 YL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGY 695
           YL   +F      +H DL   N +L D+M   ++DFG++K +   D           + +
Sbjct: 162 YLSNRNF------LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 215

Query: 696 MAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLP---ISTM 752
           +A E   +   ++  DV++FG+ + E  TR         G            P   +   
Sbjct: 216 IAIESLADRVYTSKSDVWAFGVTMWEIATR---------GMT----------PYPGVQNH 256

Query: 753 EVVDANLLSQEDIHFVAK-------EQCVSFVFNLALECTVESPEQRINAKEIVAKLLKI 805
           E+            ++         E C+  ++ +   C    P  R     +  +L K+
Sbjct: 257 EM----------YDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306

Query: 806 RDSL 809
            +SL
Sbjct: 307 LESL 310

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  149 bits (379), Expect = 5e-39
 Identities = 76/325 (23%), Positives = 136/325 (41%), Gaps = 49/325 (15%)

Query: 495 YQKREKGP------PNDPNMPPVATWRRFSYLELFQATDKFSENNLIGRGGFGSVYKARI 548
           Y K   G           + P      + ++ E+ +  +       +G+G FG V+    
Sbjct: 149 YSKHADGLCHRLTTVCPTSKPQTQGLAKDAW-EIPR--ESLRLEVKLGQGCFGEVWMGTW 205

Query: 549 RDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHG 608
                VA+K        + ++F  E  +MK +RH  LV++ +  S E    +V EYM  G
Sbjct: 206 NGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKG 263

Query: 609 SLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH 667
           SL  +L       L + Q +++   +AS + Y+        +H DL+ +N+L+ +N+V  
Sbjct: 264 SLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCK 320

Query: 668 LSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKK 727
           ++DFG+A+L+   + +  Q      I + APE    G+ +   DV+SFGI+L E  T+  
Sbjct: 321 VADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDVWSFGILLTELTTK-- 377

Query: 728 PTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAK-------EQCVSFVFNL 780
                  G +     VN                 +E +  V +        +C   + +L
Sbjct: 378 -------GRVPYPGMVN-----------------REVLDQVERGYRMPCPPECPESLHDL 413

Query: 781 ALECTVESPEQRINAKEIVAKLLKI 805
             +C  + PE+R   + + A L   
Sbjct: 414 MCQCWRKEPEERPTFEYLQAFLEDY 438

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  145 bits (369), Expect = 8e-39
 Identities = 74/314 (23%), Positives = 120/314 (38%), Gaps = 39/314 (12%)

Query: 518 SYLELFQATDK--FSENNL-----IGRGGFGSVYKARIR-----DGMEVAVKVFNLQCGR 565
            + +L+   D   F E +L     +G+G FGSV   R        G  VAVK        
Sbjct: 7   HHAQLYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPD 66

Query: 566 AFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKA--LVLEYMPHGSLEKYLHSSNYSLDI 623
             + F  E  ++K++    +VK          ++  LV+EY+P G L  +L      LD 
Sbjct: 67  QQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDA 126

Query: 624 FQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-TGEDQ 682
            + L     +   +EYL    S   +H DL   N+L++      ++DFG+AKLL   +D 
Sbjct: 127 SRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY 183

Query: 683 SMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTR-KKPTDELFNGEMTLKH 741
            + +    + I + APE   +   S   DV+SFG++L E FT   K              
Sbjct: 184 YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS------------- 230

Query: 742 WVNDCLPISTMEVVDANLLSQEDIHFVAK-------EQCVSFVFNLALECTVESPEQRIN 794
                  +  M            +  + +         C + V  L   C   SP+ R +
Sbjct: 231 CSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPS 290

Query: 795 AKEIVAKLLKIRDS 808
              +  +L  +   
Sbjct: 291 FSALGPQLDMLWSG 304

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  150 bits (381), Expect = 1e-38
 Identities = 74/328 (22%), Positives = 137/328 (41%), Gaps = 50/328 (15%)

Query: 493 IKYQKREKGP-------PNDPNMPPVATWRRFSYLELFQATDKFSENNLIGRGGFGSVYK 545
           + Y  +               + P      + ++ E+ + + +      +G+G FG V+ 
Sbjct: 229 VAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAW-EIPRESLRLEV--KLGQGCFGEVWM 285

Query: 546 ARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYM 605
                   VA+K        + ++F  E  +MK +RH  LV++ +  S E    +V EYM
Sbjct: 286 GTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYM 343

Query: 606 PHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM 664
             GSL  +L       L + Q +++   +AS + Y+        +H DL+ +N+L+ +N+
Sbjct: 344 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENL 400

Query: 665 VAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 724
           V  ++DFG+A+L+   + +  Q      I + APE    G+ +   DV+SFGI+L E  T
Sbjct: 401 VCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDVWSFGILLTELTT 459

Query: 725 RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAK-------EQCVSFV 777
           +         G +     VN                 +E +  V +        +C   +
Sbjct: 460 K---------GRVPYPGMVN-----------------REVLDQVERGYRMPCPPECPESL 493

Query: 778 FNLALECTVESPEQRINAKEIVAKLLKI 805
            +L  +C  + PE+R   + + A L   
Sbjct: 494 HDLMCQCWRKEPEERPTFEYLQAFLEDY 521

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  152 bits (386), Expect = 1e-38
 Identities = 55/293 (18%), Positives = 103/293 (35%), Gaps = 52/293 (17%)

Query: 534 LIGRGGFGSVYKAR--IRDGMEVAVKVFNLQCGRAFKS-FDVECAMMKSIRHRNLVKVI- 589
            I  GG G +Y A     +G  V +K          ++    E   +  + H ++V++  
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146

Query: 590 ----SSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYS 645
               +    +    +V+EY+   SL++        L + + +  ++++  AL YLH   S
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALSYLH---S 200

Query: 646 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT-LATIGYMAPEYGREG 704
             +++ DLKP N++L +  +  L D G           +        T G+ APE  R  
Sbjct: 201 IGLVYNDLKPENIMLTEEQLK-LIDLGAVS-------RINSFGYLYGTPGFQAPEIVR-T 251

Query: 705 QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQED 764
             +   D+Y+ G  L              NG   +     D   + T +           
Sbjct: 252 GPTVATDIYTVGRTLAALTLDLPT----RNGR-YVDGLPEDDPVLKTYDSYGR------- 299

Query: 765 IHFVAKEQCVSFVFNLALECTVESPEQR-INAKEIVAKLLKIRDSLLRNVGGR 816
              + +                  P QR   A+E+ A+L  +   ++    G 
Sbjct: 300 --LLRR-------------AIDPDPRQRFTTAEEMSAQLTGVLREVVAQDTGV 337

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  143 bits (363), Expect = 2e-38
 Identities = 67/294 (22%), Positives = 121/294 (41%), Gaps = 42/294 (14%)

Query: 535 IGRGGFGSVYKARIRDG---MEVAVKVFNLQCGRAFKS---FDVECAMMKSIRHRNLVKV 588
           +G G FGSV +   R     ++VA+KV  L+ G           E  +M  + +  +V++
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKV--LKQGTEKADTEEMMREAQIMHQLDNPYIVRL 75

Query: 589 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL---HFGYS 645
           I  C  E    LV+E    G L K+L      + +     ++  V+  ++YL   +F   
Sbjct: 76  IGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF--- 131

Query: 646 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS-MTQTQTLATIGYMAPEYGREG 704
              +H DL   NVLL +   A +SDFG++K L  +D     ++     + + APE     
Sbjct: 132 ---VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 188

Query: 705 QVSTNGDVYSFGIMLMETFTR-KKPTDELFNGEMTLKHWVNDCLPISTMEVVDAN-LLSQ 762
           + S+  DV+S+G+ + E  +  +KP  ++   E               M  ++    +  
Sbjct: 189 KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--------------VMAFIEQGKRMEC 234

Query: 763 EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLRNVGGR 816
                    +C   ++ L  +C +   E R +   +  ++     SL   V G 
Sbjct: 235 -------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGH 281

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  148 bits (376), Expect = 3e-38
 Identities = 70/276 (25%), Positives = 120/276 (43%), Gaps = 28/276 (10%)

Query: 533 NLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISS 591
           + +G G +G VY+   +   + VAVK    +     + F  E A+MK I+H NLV+++  
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284

Query: 592 CSNEEFKALVLEYMPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIH 650
           C+ E    ++ E+M +G+L  YL   N   +     L +   ++SA+EYL        IH
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 341

Query: 651 CDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNG 710
            +L   N L+ +N +  ++DFG+++L+T  D           I + APE     + S   
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 400

Query: 711 DVYSFGIMLMETFTR-KKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVA 769
           DV++FG++L E  T    P   +   +                E+++      +D     
Sbjct: 401 DVWAFGVLLWEIATYGMSPYPGIDLSQ--------------VYELLE------KDYRMER 440

Query: 770 KEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKI 805
            E C   V+ L   C   +P  R +  EI      +
Sbjct: 441 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  145 bits (368), Expect = 3e-38
 Identities = 72/308 (23%), Positives = 137/308 (44%), Gaps = 52/308 (16%)

Query: 535 IGRGGFGSVYKARI----RDGMEVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVKVI 589
           +G G FG V   R+    +  + VA+K   +    +  + F  E ++M    H N++++ 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112

Query: 590 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL---HFGYSA 646
              +  +   +V EYM +GSL+ +L   +    + Q + ++  +AS ++YL    +    
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY---- 168

Query: 647 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT-GEDQSMTQTQTLATIGYMAPEYGREGQ 705
             +H DL   N+L++ N+V  +SDFG+ ++L    + + T       I + +PE     +
Sbjct: 169 --VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226

Query: 706 VSTNGDVYSFGIMLMETFTR-KKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQED 764
            ++  DV+S+GI+L E  +  ++P  E+ N                           Q+ 
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERPYWEMSN---------------------------QDV 259

Query: 765 IHFVAK-------EQCVSFVFNLALECTVESPEQRINAKEIVAKLLK-IRD-SLLRNVGG 815
           I  V +         C + ++ L L+C  +    R   ++IV+ L K IR+   L+ +  
Sbjct: 260 IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITS 319

Query: 816 RCIRQSNL 823
              R SNL
Sbjct: 320 AAARPSNL 327

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  144 bits (364), Expect = 4e-38
 Identities = 70/296 (23%), Positives = 132/296 (44%), Gaps = 47/296 (15%)

Query: 535 IGRGGFGSVYKARIRDG----MEVAVKVFNLQCG--RAFKSFDVECAMMKSIRHRNLVKV 588
           +G+G FGSV +A+++      ++VAVK+           + F  E A MK   H ++ K+
Sbjct: 31  LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90

Query: 589 ISSCSNEEFKA------LVLEYMPHGSLEKYLHSS-----NYSLDIFQRLNIMIDVASAL 637
           +        K       ++L +M HG L  +L +S      ++L +   +  M+D+A  +
Sbjct: 91  VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150

Query: 638 EYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIG 694
           EYL   +F      IH DL   N +L ++M   ++DFG+++ +   D       +   + 
Sbjct: 151 EYLSSRNF------IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK 204

Query: 695 YMAPEYGREGQVSTNGDVYSFGIMLMETFTR-KKPTDELFNGEMTLKHWVNDCLPISTME 753
           ++A E   +   + + DV++FG+ + E  TR + P   + N E+   +            
Sbjct: 205 WLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI-YNY------------ 251

Query: 754 VVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSL 809
           ++  N L Q         +C+  V++L  +C    P+QR +   +  +L  I   L
Sbjct: 252 LIGGNRLKQ-------PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  143 bits (364), Expect = 5e-38
 Identities = 74/294 (25%), Positives = 124/294 (42%), Gaps = 52/294 (17%)

Query: 535 IGRGGFGSVYKARIRDG----MEVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVKVI 589
           IG G  G V   R+R      + VA+K        R  + F  E ++M    H N++++ 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116

Query: 590 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL---HFGYSA 646
              +      +V EYM +GSL+ +L + +    I Q + ++  V + + YL    +    
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY---- 172

Query: 647 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG-EDQSMTQTQTLATIGYMAPEYGREGQ 705
             +H DL   NVL+D N+V  +SDFG++++L    D + T T     I + APE      
Sbjct: 173 --VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRT 230

Query: 706 VSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDI 765
            S+  DV+SFG+++ E             GE    +  N                 ++ I
Sbjct: 231 FSSASDVWSFGVVMWEVLAY---------GERPYWNMTN-----------------RDVI 264

Query: 766 HFVAK-------EQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLRN 812
             V +         C   +  L L+C  +   QR    +IV+ L    D+L+R+
Sbjct: 265 SSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVL----DALIRS 314

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  143 bits (363), Expect = 5e-38
 Identities = 67/290 (23%), Positives = 118/290 (40%), Gaps = 33/290 (11%)

Query: 535 IGRGGFGSVYKARIRD-----GMEVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVKV 588
           +G G FG V            G  VAVK      G +    +  E  +++++ H +++K 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98

Query: 589 ISSCSNEEFKA--LVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSA 646
              C +    +  LV+EY+P GSL  YL     S+ + Q L     +   + YLH   + 
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLH---AQ 153

Query: 647 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-TGEDQSMTQTQTLATIGYMAPEYGREGQ 705
             IH DL   NVLLD++ +  + DFG+AK +  G +    +    + + + APE  +E +
Sbjct: 154 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK 213

Query: 706 VSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDI 765
                DV+SFG+ L E  T    +       + L       +    M V+          
Sbjct: 214 FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIG-----IAQGQMTVLRL-------T 261

Query: 766 HFVAK-------EQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDS 808
             + +       ++C + V++L   C       R   + ++  L  + + 
Sbjct: 262 ELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK 311

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  142 bits (360), Expect = 6e-38
 Identities = 68/284 (23%), Positives = 109/284 (38%), Gaps = 43/284 (15%)

Query: 532 NNLIGRGGFGSVYKAR-IRDGMEVAVKVFNL--QCGRAFKSFDVECAMMKSIRHRNLVKV 588
           +  IGRG F +VYK       +EVA              + F  E  M+K ++H N+V+ 
Sbjct: 31  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90

Query: 589 ISSCSNEEFKA----LVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGY 644
             S  +         LV E M  G+L+ YL      + I    +    +   L++LH   
Sbjct: 91  YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH-TR 148

Query: 645 SAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIG---YMAPEY 700
           + P+IH DLK  N+ +        + D G+A L          +   A IG   +MAPE 
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL-------KRASFAKAVIGTPEFMAPEM 201

Query: 701 GREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLL 760
             E     + DVY+FG+ ++E  T + P  E  N     +   +   P S        + 
Sbjct: 202 YEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS-----FDKVA 255

Query: 761 SQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLK 804
             E    +               C  ++ ++R + K+    LL 
Sbjct: 256 IPEVKEIIEG-------------CIRQNKDERYSIKD----LLN 282

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  146 bits (369), Expect = 1e-37
 Identities = 68/281 (24%), Positives = 124/281 (44%), Gaps = 40/281 (14%)

Query: 533 NLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSC 592
             +G G FG V+ A      +VAVK        + ++F  E  +MK+++H  LVK+ +  
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252

Query: 593 SNEEFKALVLEYMPHGSLEKYLHSSNYS-LDIFQRLNIMIDVASALEYLHFGYSAPVIHC 651
           + E    ++ E+M  GSL  +L S   S   + + ++    +A  + ++        IH 
Sbjct: 253 TKEPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHR 308

Query: 652 DLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGD 711
           DL+ +N+L+  ++V  ++DFG+A+++  +++   +      I + APE    G  +   D
Sbjct: 309 DLRAANILVSASLVCKIADFGLARVIE-DNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 367

Query: 712 VYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAK- 770
           V+SFGI+LME  T          G +          P   M        + E I  + + 
Sbjct: 368 VWSFGILLMEIVTY---------GRI----------PYPGMS-------NPEVIRALERG 401

Query: 771 ------EQCVSFVFNLALECTVESPEQRINAKEIVAKLLKI 805
                 E C   ++N+ + C    PE+R   + I + L   
Sbjct: 402 YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 442

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  145 bits (369), Expect = 1e-37
 Identities = 84/288 (29%), Positives = 124/288 (43%), Gaps = 52/288 (18%)

Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSN 594
           IG+G FG V     R G +VAVK   ++     ++F  E ++M  +RH NLV+++     
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 257

Query: 595 EEFKA-LVLEYMPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
           E+    +V EYM  GSL  YL S     L     L   +DV  A+EYL        +H D
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRD 314

Query: 653 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDV 712
           L   NVL+ ++ VA +SDFG+ K     + S TQ      + + APE  RE + ST  DV
Sbjct: 315 LAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSDV 369

Query: 713 YSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLP---ISTMEVVDANLLSQEDIHFVA 769
           +SFGI+L E ++          G +          P   I   +V          +  V 
Sbjct: 370 WSFGILLWEIYSF---------GRV----------PYPRIPLKDV----------VPRVE 400

Query: 770 K-------EQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLL 810
           K       + C   V+++   C       R    ++  +L  IR   L
Sbjct: 401 KGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHEL 448

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  141 bits (357), Expect = 1e-37
 Identities = 72/281 (25%), Positives = 118/281 (41%), Gaps = 42/281 (14%)

Query: 535 IGRGGFGSVYKARIRDG-MEVAVKVFNLQCGRAFKS-FDVECAMMKSIRHRNLVKVISSC 592
           +G G +G VY+   +   + VAVK   L+        F  E A+MK I+H NLV+++  C
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78

Query: 593 SNEEFKALVLEYMPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHC 651
           + E    ++ E+M +G+L  YL   N   +     L +   ++SA+EYL        IH 
Sbjct: 79  TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHR 135

Query: 652 DLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGD 711
           DL   N L+ +N +  ++DFG+++L+T  D           I + APE     + S   D
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194

Query: 712 VYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAK- 770
           V++FG++L E  T          G            P   +++        +    + K 
Sbjct: 195 VWAFGVLLWEIATY---------GMS----------PYPGIDL-------SQVYELLEKD 228

Query: 771 ------EQCVSFVFNLALECTVESPEQRINAKEIVAKLLKI 805
                 E C   V+ L   C   +P  R +  EI      +
Sbjct: 229 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  145 bits (368), Expect = 2e-37
 Identities = 89/429 (20%), Positives = 150/429 (34%), Gaps = 74/429 (17%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEI-GHLHNLGFLDLSQNKLLGTIPAA 64
            N +          + +L+ L +        I +     L +L  L L  N+ L  +   
Sbjct: 39  LNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-QLETG 97

Query: 65  IF-NVSTLKAFAVTNNSL-SGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIF-NASKLS 121
            F  ++ L+   +T  +L    LS      L +LE+L L  NN     P   F N  +  
Sbjct: 98  AFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFH 157

Query: 122 KLALEMNSFSGFIPSTFGNL--RNLEWLTLYDNNLTS---STLDLSFLSSLSNCKSLTHI 176
            L L  N           N   ++   L L    L       L      +     S+T +
Sbjct: 158 VLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTL 217

Query: 177 SLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGS 236
            LS N     + + +   ++ +     + + + + G     TN  D       G + +  
Sbjct: 218 DLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEAS-- 275

Query: 237 IPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLK 296
                     ++  DL  +++  ++  S+                       FS+ T L+
Sbjct: 276 ---------GVKTCDLSKSKIF-ALLKSV-----------------------FSHFTDLE 302

Query: 297 VLSLGSNELTSIPLN-FWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGI 355
            L+L  NE+  I  N FW L  +L LNLS N            L ++    F        
Sbjct: 303 QLTLAQNEINKIDDNAFWGLTHLLKLNLSQN-----------FLGSIDSRMFE------- 344

Query: 356 IPMEIGSLKNLENLFLEYNRLEGSIP-DSFGDLISLKSLNLSYNNLSGTIPVS-LEKLSY 413
                 +L  LE L L YN +  ++   SF  L +LK L L  N L  ++P    ++L+ 
Sbjct: 345 ------NLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTS 396

Query: 414 LKDLNLSFN 422
           L+ + L  N
Sbjct: 397 LQKIWLHTN 405

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  137 bits (348), Expect = 6e-35
 Identities = 81/420 (19%), Positives = 137/420 (32%), Gaps = 69/420 (16%)

Query: 21  SNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNS 80
           +++  + L  N +          L +L FL + Q      I    F              
Sbjct: 30  AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFR------------- 76

Query: 81  LSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNA-SKLSKLALEMNSF-SGFIPS-T 137
                      GL +L +L L  N F   +    FN  + L  L L   +     +    
Sbjct: 77  -----------GLSSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNF 124

Query: 138 FGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSH 197
           F  L +LE L L DNN+        F     N +    + L+ N +  I     +     
Sbjct: 125 FKPLTSLEMLVLRDNNIKKIQPASFF----LNMRRFHVLDLTFNKVKSICEEDLLNFQGK 180

Query: 198 SLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQL 257
                                 L+ +T   +    L         K   +  +DL  N  
Sbjct: 181 HFTLL----------------RLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGF 224

Query: 258 EGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIP-LNFWSLK 316
           + S+      ++   +++           +   + ++    S G           F  L+
Sbjct: 225 KESMAKRFFDAIAGTKIQ-----------SLILSNSYNMGSSFGHTNFKDPDNFTFKGLE 273

Query: 317 --DILDLNLSSNCFSGPLPLEI-RNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEY 373
              +   +LS +     L   +  +   L ++  + N  + I       L +L  L L  
Sbjct: 274 ASGVKTCDLSKSKIFA-LLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQ 332

Query: 374 NRLEGSIPD-SFGDLISLKSLNLSYNNLSGTIPV-SLEKLSYLKDLNLSFNKLKGEIPRG 431
           N L GSI    F +L  L+ L+LSYN++   +   S   L  LK+L L  N+LK  +P G
Sbjct: 333 NFL-GSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK-SVPDG 389

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 84.8 bits (210), Expect = 2e-17
 Identities = 43/240 (17%), Positives = 85/240 (35%), Gaps = 24/240 (10%)

Query: 214 PEEITNLTDLTTIVLGGNKLNGSIPI-TLGKLQKLQDVDLEYNQLEGSIPDSICLS-VEL 271
               + L DL  + +        I   T   L  L  + L+YNQ    +          L
Sbjct: 47  ETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-QLETGAFNGLANL 105

Query: 272 YELELGGNKL-SGSIPA-CFSNMTFLKVLSLGSNELTSIPLN--FWSLKDILDLNLSSNC 327
             L L    L    +    F  +T L++L L  N +  I     F +++    L+L+ N 
Sbjct: 106 EVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFN- 164

Query: 328 FSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDL 387
                  +++++     ++F   +F+ +       L ++    +    L      +    
Sbjct: 165 -------KVKSICEEDLLNFQGKHFTLL------RLSSITLQDMNEYWLGWEKCGNPFKN 211

Query: 388 ISLKSLNLSYNNLSGTIP---VSLEKLSYLKDLNLSFNKLKGEIPRGGSFGNFSAESFKG 444
            S+ +L+LS N    ++          + ++ L LS +   G      +F +    +FKG
Sbjct: 212 TSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKG 271

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 77.9 bits (192), Expect = 3e-15
 Identities = 44/196 (22%), Positives = 68/196 (34%), Gaps = 25/196 (12%)

Query: 6   NNFLTSTTPKEIDN-ISNLKVLYLYNNRLQGEIIH----EIGHLHNLGF----------L 50
            N    +  K   + I+  K+  L  +                  N  F           
Sbjct: 221 GNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTC 280

Query: 51  DLSQNKLLGTIPAAIF-NVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGT 109
           DLS++K+   +  ++F + + L+   +  N ++  +      GL +L  L L  N    +
Sbjct: 281 DLSKSKI-FALLKSVFSHFTDLEQLTLAQNEINK-IDDNAFWGLTHLLKLNLSQNFLG-S 337

Query: 110 IPHFIFNA-SKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLS 168
           I   +F    KL  L L  N        +F  L NL+ L L  N L S  +       L 
Sbjct: 338 IDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKS--VPDGIFDRL- 394

Query: 169 NCKSLTHISLSNNPLD 184
              SL  I L  NP D
Sbjct: 395 --TSLQKIWLHTNPWD 408

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 72.1 bits (177), Expect = 2e-13
 Identities = 38/194 (19%), Positives = 63/194 (32%), Gaps = 33/194 (17%)

Query: 236 SIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPA-CFSNMTF 294
            +P  +  +      DL  N +      S     +L  L++        I    F  ++ 
Sbjct: 27  ELPAHVNYV------DLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSS 80

Query: 295 LKVLSLGSNELTSIPLN-FWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFS 353
           L +L L  N+   +    F  L ++  L L+                 L     S N F 
Sbjct: 81  LIILKLDYNQFLQLETGAFNGLANLEVLTLTQC--------------NLDGAVLSGNFFK 126

Query: 354 GIIPMEIGSLKNLENLFLEYNRLEGSIPDS-FGDLISLKSLNLSYNNLSGTIPVSLEKL- 411
                    L +LE L L  N ++   P S F ++     L+L++N +       L    
Sbjct: 127 P--------LTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQ 178

Query: 412 -SYLKDLNLSFNKL 424
             +   L LS   L
Sbjct: 179 GKHFTLLRLSSITL 192

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 69.8 bits (171), Expect = 1e-12
 Identities = 36/162 (22%), Positives = 60/162 (37%), Gaps = 27/162 (16%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAI 65
            + + +       + ++L+ L L  N +     +    L +L  L+LSQN L G+I + +
Sbjct: 284 KSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFL-GSIDSRM 342

Query: 66  FNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIF-NASKLSKLA 124
           F                          L  LEVL L  N+    +    F     L +LA
Sbjct: 343 FE------------------------NLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELA 377

Query: 125 LEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSS 166
           L+ N         F  L +L+ + L+ N    S   + +LS 
Sbjct: 378 LDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSR 419

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  142 bits (360), Expect = 2e-37
 Identities = 67/289 (23%), Positives = 128/289 (44%), Gaps = 51/289 (17%)

Query: 535 IGRGGFGSVYKARIRDG-----MEVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVKV 588
           IG G FG VYK  ++       + VA+K        +    F  E  +M    H N++++
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111

Query: 589 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL---HFGYS 645
               S  +   ++ EYM +G+L+K+L   +    + Q + ++  +A+ ++YL   ++   
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNY--- 168

Query: 646 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQ-TLATIGYMAPEYGREG 704
              +H DL   N+L++ N+V  +SDFG++++L  + ++   T      I + APE     
Sbjct: 169 ---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR 225

Query: 705 QVSTNGDVYSFGIMLMETFTR-KKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQE 763
           + ++  DV+SFGI++ E  T  ++P  EL N                            E
Sbjct: 226 KFTSASDVWSFGIVMWEVMTYGERPYWELSN---------------------------HE 258

Query: 764 DIHFVAK-------EQCVSFVFNLALECTVESPEQRINAKEIVAKLLKI 805
            +  +           C S ++ L ++C  +   +R    +IV+ L K+
Sbjct: 259 VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  142 bits (359), Expect = 2e-37
 Identities = 70/300 (23%), Positives = 118/300 (39%), Gaps = 58/300 (19%)

Query: 535 IGRGGFGSVYKARIRDG------MEVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVK 587
           +G G FG VY+ ++         ++VAVK     C  +    F +E  ++    H+N+V+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97

Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLHSS------NYSLDIFQRLNIMIDVASALEYL- 640
            I        + +++E M  G L+ +L  +        SL +   L++  D+A   +YL 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157

Query: 641 --HFGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGY 695
             HF      IH D+   N LL       VA + DFG+A+ +            +  + +
Sbjct: 158 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 211

Query: 696 MAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVV 755
           M PE   EG  ++  D +SFG++L E F+          G M          P  +    
Sbjct: 212 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSL---------GYM----------PYPSKSN- 251

Query: 756 DANLLSQEDIHFVAK-------EQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDS 808
                 QE + FV         + C   V+ +  +C    PE R N   I+ ++      
Sbjct: 252 ------QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  141 bits (358), Expect = 3e-37
 Identities = 56/212 (26%), Positives = 91/212 (42%), Gaps = 17/212 (8%)

Query: 535 IGRGGFGSVYKARIRDGME-----VAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVKV 588
           +G G FG+VYK       E     VA+K        +A K    E  +M S+ + ++ ++
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82

Query: 589 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL---HFGYS 645
           +  C     + L+ + MP G L  Y+     ++     LN  + +A  + YL        
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL--- 138

Query: 646 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQ 705
              +H DL   NVL+       ++DFG+AKLL  E++          I +MA E      
Sbjct: 139 ---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195

Query: 706 VSTNGDVYSFGIMLMETFTR-KKPTDELFNGE 736
            +   DV+S+G+ + E  T   KP D +   E
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  141 bits (357), Expect = 3e-37
 Identities = 63/302 (20%), Positives = 123/302 (40%), Gaps = 52/302 (17%)

Query: 535 IGRGGFGSVYKARIRDG------MEVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLVK 587
           +G+G FG VY+   +          VA+K  N     R    F  E ++MK     ++V+
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92

Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLHSS---------NYSLDIFQRLNIMIDVASALE 638
           ++   S  +   +++E M  G L+ YL S               + + + +  ++A  + 
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152

Query: 639 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 698
           YL+   +   +H DL   N ++ ++    + DFG+ + +   D      + L  + +M+P
Sbjct: 153 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 209

Query: 699 EYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDAN 758
           E  ++G  +T  DV+SFG++L E  T           E           P   +      
Sbjct: 210 ESLKDGVFTTYSDVWSFGVVLWEIATL---------AEQ----------PYQGLSN---- 246

Query: 759 LLSQEDIHFVAK-------EQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLR 811
              ++ + FV +       + C   +F L   C   +P+ R +  EI++ + +  +   R
Sbjct: 247 ---EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR 303

Query: 812 NV 813
            V
Sbjct: 304 EV 305

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  140 bits (354), Expect = 3e-37
 Identities = 68/279 (24%), Positives = 120/279 (43%), Gaps = 40/279 (14%)

Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSN 594
           +G G FG V+        +VAVK    Q   +  +F  E  +MK ++H+ LV++ +  + 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79

Query: 595 EEFKALVLEYMPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 653
           E    ++ EYM +GSL  +L + +   L I + L++   +A  + ++        IH DL
Sbjct: 80  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 135

Query: 654 KPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVY 713
           + +N+L+ D +   ++DFG+A+L+  +++   +      I + APE    G  +   DV+
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 194

Query: 714 SFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAK--- 770
           SFGI+L E  T          G +          P   M          E I  + +   
Sbjct: 195 SFGILLTEIVTH---------GRI----------PYPGMTN-------PEVIQNLERGYR 228

Query: 771 ----EQCVSFVFNLALECTVESPEQRINAKEIVAKLLKI 805
               + C   ++ L   C  E PE R     + + L   
Sbjct: 229 MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  141 bits (357), Expect = 3e-37
 Identities = 52/316 (16%), Positives = 99/316 (31%), Gaps = 47/316 (14%)

Query: 134 IPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVG 193
           I     N    +   + D++L  +   L       +  ++  + LS NPL  I       
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASL-----RQSAWNVKELDLSGNPLSQI------- 49

Query: 194 NLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLE 253
                                 ++   T L  + L  N L       L  L  L+ +DL 
Sbjct: 50  -------------------SAADLAPFTKLELLNLSSNVLY-ETL-DLESLSTLRTLDLN 88

Query: 254 YNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIP-LNF 312
            N ++      + +   +  L    N +S  +    S     K + L +N++T +  L+ 
Sbjct: 89  NNYVQ-----ELLVGPSIETLHAANNNIS-RVSC--SRGQGKKNIYLANNKITMLRDLDE 140

Query: 313 WSLKDILDLNLSSNCFSG-PLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFL 371
                +  L+L  N            +   L  ++   N     +  ++     L+ L L
Sbjct: 141 GCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDL 198

Query: 372 EYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIPRG 431
             N+L   +   F     +  ++L  N L   I  +L     L+  +L  N       R 
Sbjct: 199 SSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRD 256

Query: 432 GSFGNFSAESFKGNEL 447
               N   ++     +
Sbjct: 257 FFSKNQRVQTVAKQTV 272

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  140 bits (356), Expect = 5e-37
 Identities = 55/338 (16%), Positives = 114/338 (33%), Gaps = 26/338 (7%)

Query: 87  SITDV--GLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNL 144
           +I ++       ++  +  ++    +     +A  + +L L  N  S    +       L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 145 EWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYM 204
           E L L  N L            L +  +L  + L+NN +  +L          S++  + 
Sbjct: 61  ELLNLSSNVLYE-------TLDLESLSTLRTLDLNNNYVQELLV-------GPSIETLHA 106

Query: 205 YNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEG-SIPD 263
            N N+S  +            I L  NK+     +  G   ++Q +DL+ N+++  +  +
Sbjct: 107 ANNNIS-RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAE 163

Query: 264 SICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNL 323
               S  L  L L  N +   +         LK L L SN+L  +   F S   +  ++L
Sbjct: 164 LAASSDTLEHLNLQYNFIY-DVKG-QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISL 221

Query: 324 SSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPME-IGSLKNLENLFLEYNRLEGSIPD 382
            +N     +   +R  + L   D   N F      +     + ++ +  +  +      +
Sbjct: 222 RNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNE 280

Query: 383 SFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLS 420
               + +L                  ++L  L   +  
Sbjct: 281 EECTVPTLGHYG--AYCCEDLPAPFADRLIALGHHHHH 316

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  135 bits (341), Expect = 5e-35
 Identities = 60/381 (15%), Positives = 119/381 (31%), Gaps = 75/381 (19%)

Query: 19  NISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTN 78
           N +  K+  + ++ L+  +        N+  LDLS N  L  I AA              
Sbjct: 8   NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNP-LSQISAADLA----------- 55

Query: 79  NSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTF 138
                            LE+L L  N                                  
Sbjct: 56  -------------PFTKLELLNLSSNVLYE--------------------------TLDL 76

Query: 139 GNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHS 198
            +L  L  L L +N +            L    S+  +  +NN +  +       +    
Sbjct: 77  ESLSTLRTLDLNNNYVQ----------ELLVGPSIETLHAANNNISRVSC-----SRGQG 121

Query: 199 LKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNG-SIPITLGKLQKLQDVDLEYNQL 257
            KN Y+ N  ++     +    + +  + L  N+++  +          L+ ++L+YN +
Sbjct: 122 KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI 181

Query: 258 EGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKD 317
              +   +  + +L  L+L  NKL+  +   F +   +  +SL +N+L  I       ++
Sbjct: 182 Y-DVKGQVVFA-KLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVLIEKALRFSQN 238

Query: 318 ILDLNLSSNCFS-GPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRL 376
           +   +L  N F  G L       + +  +          +  +      +  L       
Sbjct: 239 LEHFDLRGNGFHCGTLRDFFSKNQRVQTVA---KQTVKKLTGQNEEECTVPTLGHYGAYC 295

Query: 377 EGSIPDSFG-DLISLKSLNLS 396
              +P  F   LI+L   +  
Sbjct: 296 CEDLPAPFADRLIALGHHHHH 316

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  130 bits (330), Expect = 1e-33
 Identities = 57/338 (16%), Positives = 112/338 (33%), Gaps = 48/338 (14%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAI 65
           ++ L         +  N+K L L  N L      ++     L  L+LS N L       +
Sbjct: 19  DSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL--YETLDL 76

Query: 66  FNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLAL 125
            ++STL+   + NN     +  +     P++E L+   NN S  +            + L
Sbjct: 77  ESLSTLRTLDLNNNY----VQELL--VGPSIETLHAANNNIS-RVSCSRG--QGKKNIYL 127

Query: 126 EMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDG 185
             N  +       G    +++L L  N + +    ++F    ++  +L H++L  N +  
Sbjct: 128 ANNKITMLRDLDEGCRSRVQYLDLKLNEIDT----VNFAELAASSDTLEHLNLQYNFIYD 183

Query: 186 ILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQ 245
           +                            +       L T+ L  NKL   +        
Sbjct: 184 V----------------------------KGQVVFAKLKTLDLSSNKLA-FMGPEFQSAA 214

Query: 246 KLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLS-GSIPACFSNMTFLKVLSLGSN- 303
            +  + L  N+L   I  ++  S  L   +L GN    G++   FS    ++ ++  +  
Sbjct: 215 GVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK 273

Query: 304 ELTSIPLNFWSLKDILDL-NLSSNCFSGPLPLEIRNLK 340
           +LT       ++  +             P    +  L 
Sbjct: 274 KLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALG 311

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  101 bits (255), Expect = 8e-24
 Identities = 30/178 (16%), Positives = 64/178 (35%), Gaps = 12/178 (6%)

Query: 260 SIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLN-FWSLKDI 318
           +I +           ++  + L  ++ +   +   +K L L  N L+ I          +
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 319 LDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEG 378
             LNLSSN     L   + +L  L  +D + N        E+    ++E L    N +  
Sbjct: 61  ELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS- 112

Query: 379 SIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIPRGGSFGN 436
            +          K++ L+ N ++    +     S ++ L+L  N++   +       +
Sbjct: 113 RVS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVNFAELAAS 167

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 46.5 bits (111), Expect = 2e-05
 Identities = 11/60 (18%), Positives = 25/60 (41%), Gaps = 2/60 (3%)

Query: 379 SIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIPRGGSFGNFS 438
           +I +   +    K   ++ ++L   +    +    +K+L+LS N L  +I        F+
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QISA-ADLAPFT 58

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  139 bits (353), Expect = 4e-37
 Identities = 62/290 (21%), Positives = 109/290 (37%), Gaps = 51/290 (17%)

Query: 535 IGRGGFGSVYKARIRDG----MEVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLVKVI 589
           IG G FG V++          + VA+K           + F  E   M+   H ++VK+I
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82

Query: 590 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL---HFGYSA 646
              +      +++E    G L  +L    YSLD+   +     +++AL YL    F    
Sbjct: 83  GVITENPVW-IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF---- 137

Query: 647 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQV 706
             +H D+   NVL+  N    L DFG+++ +  +      ++    I +MAPE     + 
Sbjct: 138 --VHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFRRF 194

Query: 707 STNGDVYSFGIMLMETFTR-KKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDI 765
           ++  DV+ FG+ + E      KP   + N                            + I
Sbjct: 195 TSASDVWMFGVCMWEILMHGVKPFQGVKN---------------------------NDVI 227

Query: 766 HFVAK-------EQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDS 808
             +           C   +++L  +C    P +R    E+ A+L  I + 
Sbjct: 228 GRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  139 bits (353), Expect = 5e-37
 Identities = 82/288 (28%), Positives = 123/288 (42%), Gaps = 52/288 (18%)

Query: 533 NLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSC 592
             IG+G FG V     R G +VAVK   ++     ++F  E ++M  +RH NLV+++   
Sbjct: 27  QTIGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 83

Query: 593 SNEEFKA-LVLEYMPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIH 650
             E+    +V EYM  GSL  YL S     L     L   +DV  A+EYL        +H
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 140

Query: 651 CDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNG 710
            DL   NVL+ ++ VA +SDFG+ K     + S TQ      + + APE  RE + ST  
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKS 195

Query: 711 DVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLP---ISTMEVVDANLLSQEDIHF 767
           DV+SFGI+L E ++          G +          P   I   +V          +  
Sbjct: 196 DVWSFGILLWEIYSF---------GRV----------PYPRIPLKDV----------VPR 226

Query: 768 VAK-------EQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDS 808
           V K       + C   V+ +   C       R +  ++  +L  I+  
Sbjct: 227 VEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  139 bits (352), Expect = 6e-37
 Identities = 65/287 (22%), Positives = 112/287 (39%), Gaps = 51/287 (17%)

Query: 535 IGRGGFGSVYKARIRDG----MEVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLVKVI 589
           +G G FG VY+    +     + VAVK     C     + F  E  +MK++ H ++VK+I
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79

Query: 590 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL---HFGYSA 646
                E    +++E  P+G L  YL  +  SL +   +   + +  A+ YL   +     
Sbjct: 80  GIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINC---- 134

Query: 647 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQV 706
             +H D+   N+L+       L DFG+++ +  ED       T   I +M+PE     + 
Sbjct: 135 --VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKAS-VTRLPIKWMSPESINFRRF 191

Query: 707 STNGDVYSFGIMLMETFTR-KKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDI 765
           +T  DV+ F + + E  +  K+P   L N                           ++ I
Sbjct: 192 TTASDVWMFAVCMWEILSFGKQPFFWLEN---------------------------KDVI 224

Query: 766 HFVAK-------EQCVSFVFNLALECTVESPEQRINAKEIVAKLLKI 805
             + K       + C   ++ L   C    P  R    E+V  L  +
Sbjct: 225 GVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  138 bits (351), Expect = 1e-36
 Identities = 66/289 (22%), Positives = 117/289 (40%), Gaps = 46/289 (15%)

Query: 535 IGRGGFGSVYKARIRDG---MEVAVKVFNLQCG----RAFKSFDVECAMMKSIRHRNLVK 587
           +G G FG+V K   +       VAVK+  L+              E  +M+ + +  +V+
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKI--LKNEANDPALKDELLAEANVMQQLDNPYIVR 82

Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL---HFGY 644
           +I  C  E +  LV+E    G L KYL  +   +     + ++  V+  ++YL   +F  
Sbjct: 83  MIGICEAESWM-LVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEESNF-- 138

Query: 645 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLAT--IGYMAPEYGR 702
               +H DL   NVLL     A +SDFG++K L   D++  + QT     + + APE   
Sbjct: 139 ----VHRDLAARNVLLVTQHYAKISDFGLSKAL-RADENYYKAQTHGKWPVKWYAPECIN 193

Query: 703 EGQVSTNGDVYSFGIMLMETFTR-KKPTDELFNGEMTLKHWVNDCLPISTMEVVDANL-L 760
             + S+  DV+SFG+++ E F+  +KP   +   E                 +++    +
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--------------VTAMLEKGERM 239

Query: 761 SQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSL 809
                       C   +++L   C     E R     +  +L      +
Sbjct: 240 GC-------PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  140 bits (356), Expect = 1e-36
 Identities = 71/300 (23%), Positives = 118/300 (39%), Gaps = 58/300 (19%)

Query: 535 IGRGGFGSVYKARIRDG------MEVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVK 587
           +G G FG VY+ ++         ++VAVK     C  +    F +E  ++    H+N+V+
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138

Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLHSS------NYSLDIFQRLNIMIDVASALEYL- 640
            I        + ++LE M  G L+ +L  +        SL +   L++  D+A   +YL 
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198

Query: 641 --HFGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGY 695
             HF      IH D+   N LL       VA + DFG+A+ +            +  + +
Sbjct: 199 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKW 252

Query: 696 MAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVV 755
           M PE   EG  ++  D +SFG++L E F+          G M          P  +    
Sbjct: 253 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSL---------GYM----------PYPSKSN- 292

Query: 756 DANLLSQEDIHFVAK-------EQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDS 808
                 QE + FV         + C   V+ +  +C    PE R N   I+ ++      
Sbjct: 293 ------QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  138 bits (351), Expect = 1e-36
 Identities = 81/308 (26%), Positives = 127/308 (41%), Gaps = 69/308 (22%)

Query: 535 IGRGGFGSVYKARIRDG------MEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKV 588
           +G G FG V+ A   +       M VAVK        A K F  E  ++ +++H ++VK 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82

Query: 589 ISSCSNEEFKALVLEYMPHGSLEKYL---------------HSSNYSLDIFQRLNIMIDV 633
              C + +   +V EYM HG L K+L                 +   L + Q L+I   +
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142

Query: 634 ASALEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTL 690
           AS + YL   HF      +H DL   N L+  N++  + DFG+++ +   D       T+
Sbjct: 143 ASGMVYLASQHF------VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196

Query: 691 ATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLP-- 748
             I +M PE     + +T  DV+SFG++L E FT          G+           P  
Sbjct: 197 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTY---------GKQ----------PWF 237

Query: 749 -ISTMEVVDANLLSQEDIHFVAK-------EQCVSFVFNLALECTVESPEQRINAKEIVA 800
            +S  EV          I  + +         C   V+++ L C    P+QR+N KEI  
Sbjct: 238 QLSNTEV----------IECITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYK 287

Query: 801 KLLKIRDS 808
            L  +  +
Sbjct: 288 ILHALGKA 295

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  144 bits (365), Expect = 2e-36
 Identities = 80/450 (17%), Positives = 163/450 (36%), Gaps = 30/450 (6%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAI 65
            N ++     +I  +S L+VL L +NR++    H      +L +LD+S N+ L  I    
Sbjct: 61  QNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNR-LQNISCCP 119

Query: 66  FNVSTLKAFAVTNNSLSGCLSSITDVG----LPNLEVLYLWGNNFSGTIPHFIFNASKLS 121
              ++L+   ++ N        +        L  L  L L    F   +         LS
Sbjct: 120 M--ASLRHLDLSFND----FDVLPVCKEFGNLTKLTFLGLSAAKFR-QLDLLPVAHLHLS 172

Query: 122 KLALEMNSFSG-FIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSN 180
            + L++ S+      +    + N   L L  +  +  ++ ++   +      L++I L++
Sbjct: 173 CILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLND 232

Query: 181 NPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNL---TDLTTIVLGGNKLNGSI 237
                ++          +L N  + +   +     ++        +  + +    +   I
Sbjct: 233 ENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERI 292

Query: 238 P-----ITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNM 292
                  +   L+ L    ++      S      +  E+    L  +        C  + 
Sbjct: 293 DREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSP 352

Query: 293 TFLKVLSLGSNELTSIPL-NFWSLKDILDLNLSSNCFS--GPLPLEIRNLKALIEIDFSM 349
           +    L+   N  T        +LK +  L L  N       + L  +N+ +L  +D S+
Sbjct: 353 SSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSL 412

Query: 350 NNF-SGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSL 408
           N+  S          +++  L L  N L GS+         +K L+L  N +  +IP  +
Sbjct: 413 NSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPP--KVKVLDLHNNRIM-SIPKDV 469

Query: 409 EKLSYLKDLNLSFNKLKGEIPRGGSFGNFS 438
             L  L++LN++ N+LK  +P  G F   +
Sbjct: 470 THLQALQELNVASNQLK-SVPD-GVFDRLT 497

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  118 bits (298), Expect = 4e-28
 Identities = 75/410 (18%), Positives = 143/410 (34%), Gaps = 26/410 (6%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIH-EIGHLHNLGFLDLSQNKLLGTIPAA 64
           +N L + +      +++L+ L L  N      +  E G+L  L FL LS  K    +   
Sbjct: 109 HNRLQNISC---CPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFR-QLDLL 164

Query: 65  IFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGN-NFSGTIPHFIFNAS----K 119
                 L    +   S          + +PN  VL+L  + N   ++   +   +    +
Sbjct: 165 PVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQ 224

Query: 120 LSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLS 179
           LS + L   +    +       R    L +   ++ ++      L      + + ++++ 
Sbjct: 225 LSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIY 284

Query: 180 NNPLDGILPRTYVGNLSHSLKNFYMYNC--NVSGGIPEEI-TNLTDLTTIVLGGNKLNGS 236
           N  +   + R        +LK+  + +    V     E + +   ++   +L  +     
Sbjct: 285 NLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFI 344

Query: 237 IPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLK 296
             +          ++   N    S+         L  L L  N L  +          + 
Sbjct: 345 HMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMS 403

Query: 297 VLSLGSNELTSIP-----LNFWSLKDILDLNLSSNCFSGPLPLEI-RNLKALIEIDFSMN 350
            L      L S+            + IL LNLSSN  +G +   +   +K L   D   N
Sbjct: 404 SLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKVKVL---DLHNN 460

Query: 351 NFSGIIPMEIGSLKNLENLFLEYNRLEGSIPD-SFGDLISLKSLNLSYNN 399
                IP ++  L+ L+ L +  N+L+ S+PD  F  L SL+ + L  N 
Sbjct: 461 RIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNP 508

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  101 bits (252), Expect = 2e-22
 Identities = 65/409 (15%), Positives = 119/409 (29%), Gaps = 49/409 (11%)

Query: 21  SNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNS 80
              K L L  N +    + +I  L  L  L LS N++  ++   +F              
Sbjct: 52  PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRI-RSLDFHVFL------------- 97

Query: 81  LSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGF-IPSTFG 139
                         +LE L +  N     I       + L  L L  N F    +   FG
Sbjct: 98  -----------FNQDLEYLDVSHNRLQ-NIS--CCPMASLRHLDLSFNDFDVLPVCKEFG 143

Query: 140 NLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSL 199
           NL  L +L L         LDL  ++ L    S   + L +  + G    +     +  L
Sbjct: 144 NLTKLTFLGLSAAKFRQ--LDLLPVAHLH--LSCILLDLVSYHIKGGETESLQIPNTTVL 199

Query: 200 KNFYMYNCNVSGGIPEEITNLTDL--TTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQL 257
              +  N   S  +   +  L  L  + I L        +       +    +++    +
Sbjct: 200 HLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHI 259

Query: 258 EGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKD 317
           E +   S+ L    +   +    +         N+T          +      +  +LK 
Sbjct: 260 ETTWKCSVKLFQFFWPRPVEYLNIY--------NLTIT-----ERIDREEFTYSETALKS 306

Query: 318 ILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLE 377
           ++  ++ +  F             +     S+++   I  +   S  +   L    N   
Sbjct: 307 LMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFT 366

Query: 378 GSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKG 426
            S+      L  L++L L  N L             +  L      L  
Sbjct: 367 DSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNS 414

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 76.1 bits (187), Expect = 2e-14
 Identities = 37/182 (20%), Positives = 59/182 (32%), Gaps = 12/182 (6%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAI 65
            +           + S+   L    N     +      L  L  L L +N L        
Sbjct: 338 ISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGL-KNFFKVA 396

Query: 66  FNVSTLKAFAVTNNSLSGCLSSITDV---GLPNLEVLYLWGNNFSGTIPHFIFNASKLSK 122
                + +    + SL+   S   D       ++ VL L  N  +G++   +    K+  
Sbjct: 397 LMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKVKV 454

Query: 123 LALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNP 182
           L L  N     IP    +L+ L+ L +  N L S               SL +I L +NP
Sbjct: 455 LDLHNNRIMS-IPKDVTHLQALQELNVASNQLKSVPD-----GVFDRLTSLQYIWLHDNP 508

Query: 183 LD 184
            D
Sbjct: 509 WD 510

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 72.2 bits (177), Expect = 3e-13
 Identities = 34/163 (20%), Positives = 67/163 (41%), Gaps = 7/163 (4%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQ--GEIIHEIGHLHNLGFLDLSQNKLLGTIPA 63
            N  T +  +    +  L+ L L  N L+   ++     ++ +L  LD+S N L      
Sbjct: 362 QNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYD 421

Query: 64  AIFN-VSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSK 122
                  ++    +++N L+    S+     P ++VL L  N    +IP  + +   L +
Sbjct: 422 RTCAWAESILVLNLSSNMLT---GSVFRCLPPKVKVLDLHNNRIM-SIPKDVTHLQALQE 477

Query: 123 LALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLS 165
           L +  N         F  L +L+++ L+DN    +   + +LS
Sbjct: 478 LNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPGIRYLS 520

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  142 bits (361), Expect = 2e-36
 Identities = 59/419 (14%), Positives = 129/419 (30%), Gaps = 72/419 (17%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAI 65
              + +T     + ++ L  L  +N+ +    +  I  L  L  L  + N  + T+   +
Sbjct: 27  AFEMQATDTISEEQLATLTSLDCHNSSITD--MTGIEKLTGLTKLICTSNN-ITTLD--L 81

Query: 66  FNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLAL 125
              + L   A  +N     L+++    L  L  L    N  +  +   +     L+ L  
Sbjct: 82  SQNTNLTYLACDSNK----LTNLDVTPLTKLTYLNCDTNKLT-KLD--VSQNPLLTYLNC 134

Query: 126 EMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDG 185
             N+ +        +   L  L  + N   +          ++    LT +  S N +  
Sbjct: 135 ARNTLTEI---DVSHNTQLTELDCHLNKKIT-------KLDVTPQTQLTTLDCSFNKITE 184

Query: 186 ILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQ 245
           +                             +++    L  +    N +     + L +  
Sbjct: 185 L-----------------------------DVSQNKLLNRLNCDTNNITK---LDLNQNI 212

Query: 246 KLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNEL 305
           +L  +D   N+L   I  +     +L   +   N L+  +    S ++ L  L     +L
Sbjct: 213 QLTFLDCSSNKLT-EIDVTPL--TQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDL 266

Query: 306 TSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKN 365
             I L       ++              L++ +   L  +D      + +   ++     
Sbjct: 267 LEIDLT--HNTQLIYFQAEGC--RKIKELDVTHNTQLYLLDCQAAGITEL---DLSQNPK 319

Query: 366 LENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKL 424
           L  L+L    L   +         LKSL+    ++      S+ K+  L +   +  + 
Sbjct: 320 LVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQT 373

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  123 bits (311), Expect = 4e-30
 Identities = 59/338 (17%), Positives = 112/338 (33%), Gaps = 39/338 (11%)

Query: 88  ITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWL 147
                  N             T        + L+ L    +S +    +    L  L  L
Sbjct: 12  NDWFPDDNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDM--TGIEKLTGLTKL 69

Query: 148 TLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNC 207
               NN+T+  LDLS         +LT+++  +N L  +     V  L+  L        
Sbjct: 70  ICTSNNITT--LDLS------QNTNLTYLACDSNKLTNL----DVTPLT-KLTYLNCDTN 116

Query: 208 NVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICL 267
            ++     +++    LT +    N L     I +    +L ++D   N+    +  +   
Sbjct: 117 KLT---KLDVSQNPLLTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKITKLDVTPQT 170

Query: 268 SVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNC 327
              L  L+   NK++  +    S    L  L+  +N +T + LN      +  L+ SSN 
Sbjct: 171 Q--LTTLDCSFNKIT-ELD--VSQNKLLNRLNCDTNNITKLDLN--QNIQLTFLDCSSNK 223

Query: 328 FSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDL 387
            +    +++  L  L   D S+N  + +   ++ +L  L  L      L   I  +    
Sbjct: 224 LTE---IDVTPLTQLTYFDCSVNPLTEL---DVSTLSKLTTLHCIQTDLL-EIDLTH--N 274

Query: 388 ISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLK 425
             L             + V+    + L  L+     + 
Sbjct: 275 TQLIYFQAEGCRKIKELDVT--HNTQLYLLDCQAAGIT 310

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  118 bits (298), Expect = 2e-28
 Identities = 70/419 (16%), Positives = 136/419 (32%), Gaps = 59/419 (14%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAI 65
           N+ +T  T   I+ ++ L  L   +N +      ++    NL +L    NKL   +   +
Sbjct: 51  NSSITDMTG--IEKLTGLTKLICTSNNITT---LDLSQNTNLTYLACDSNKL-TNLD--V 102

Query: 66  FNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKL-A 124
             ++ L       N L+     +     P L  L    N  +        + S  ++L  
Sbjct: 103 TPLTKLTYLNCDTNKLT----KLDVSQNPLLTYLNCARNTLT------EIDVSHNTQLTE 152

Query: 125 LEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSL---------------SN 169
           L+ +               L  L    N +T   LD+S    L               + 
Sbjct: 153 LDCHLNKKITKLDVTPQTQLTTLDCSFNKITE--LDVSQNKLLNRLNCDTNNITKLDLNQ 210

Query: 170 CKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLG 229
              LT +  S+N L  I     V  L+  L  F      ++  +   ++ L+ LTT+   
Sbjct: 211 NIQLTFLDCSSNKLTEID----VTPLT-QLTYFDCSVNPLTE-LD--VSTLSKLTTLHCI 262

Query: 230 GNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACF 289
              L     I L    +L     E  +    +   +  + +LY L+     ++  +    
Sbjct: 263 QTDLLE---IDLTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGIT-ELD--L 314

Query: 290 SNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSM 349
           S    L  L L + ELT + ++      +  L+  +          +  + AL     + 
Sbjct: 315 SQNPKLVYLYLNNTELTELDVS--HNTKLKSLSCVNAHIQD-FS-SVGKIPALNNNFEAE 370

Query: 350 NNFSGIIPMEIGSLKNLENLFLEYNRLEG---SIPDSFGDLISLKSLNLSYNNLSGTIP 405
                +    + +      +  +     G   +I    G +    +  +++ NLS   P
Sbjct: 371 GQTITMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWENLSTDNP 429

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  145 bits (366), Expect = 2e-36
 Identities = 69/338 (20%), Positives = 129/338 (38%), Gaps = 61/338 (18%)

Query: 501 GPPNDPNMPPVATWRRFSYLELFQATDKFSENNLIGRGGFGSVYKARIRDG---MEVAVK 557
            P +DP                 +  +    +  +G G FGSV +   R     ++VA+K
Sbjct: 317 SPFSDPEELKDKKLF-------LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIK 369

Query: 558 VFNLQCGRAFKS---FDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYL 614
           V  L+ G           E  +M  + +  +V++I  C  E    LV+E    G L K+L
Sbjct: 370 V--LKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFL 426

Query: 615 HSSNYSLDIFQRLNIMIDVASALEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDF 671
                 + +     ++  V+  ++YL   +F      +H +L   NVLL +   A +SDF
Sbjct: 427 VGKREEIPVSNVAELLHQVSMGMKYLEEKNF------VHRNLAARNVLLVNRHYAKISDF 480

Query: 672 GIAKLLTGEDQS-MTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTR-KKPT 729
           G++K L  +D     ++     + + APE     + S+  DV+S+G+ + E  +  +KP 
Sbjct: 481 GLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY 540

Query: 730 DELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAK-------EQCVSFVFNLAL 782
            ++                              E + F+ +        +C   ++ L  
Sbjct: 541 KKMKG---------------------------PEVMAFIEQGKRMECPPECPPELYALMS 573

Query: 783 ECTVESPEQRINAKEIVAKLLKIRDSLLRNVGGRCIRQ 820
           +C +   E R +   +  ++     SL   V G    +
Sbjct: 574 DCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGGSALE 611

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  137 bits (348), Expect = 4e-36
 Identities = 59/281 (20%), Positives = 115/281 (40%), Gaps = 39/281 (13%)

Query: 533 NLIGRGGFGSVYKARIRDGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNL--VKV 588
             IG GG   V++         A+K  NL+    +   S+  E A +  ++  +   +++
Sbjct: 34  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93

Query: 589 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPV 648
                 +++  +V+E   +  L  +L     S+D ++R +   ++  A+  +H      +
Sbjct: 94  YDYEITDQYIYMVMECG-NIDLNSWLK-KKKSIDPWERKSYWKNMLEAVHTIH---QHGI 148

Query: 649 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPE--------- 699
           +H DLKP+N L+ D M+  L DFGIA  +  +  S+ +   + T+ YM PE         
Sbjct: 149 VHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 207

Query: 700 --YGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDA 757
                + ++S   DV+S G +L      K P  ++ N    L   ++    I        
Sbjct: 208 ENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE-----FP 262

Query: 758 NLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEI 798
           ++  ++    +               C    P+QRI+  E+
Sbjct: 263 DIPEKDLQDVLKC-------------CLKRDPKQRISIPEL 290

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  141 bits (356), Expect = 8e-36
 Identities = 72/316 (22%), Positives = 140/316 (44%), Gaps = 21/316 (6%)

Query: 21  SNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIF-NVSTLKAFAVTNN 79
           +  ++L L  NR++     E     +L  L+L++N  +  +    F N+  L+   + +N
Sbjct: 32  TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENI-VSAVEPGAFNNLFNLRTLGLRSN 90

Query: 80  SLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIF-NASKLSKLALEMNSFSGFIPSTF 138
            L   +      GL NL  L +  N     +  ++F +   L  L +  N         F
Sbjct: 91  RLK-LIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLVYISHRAF 148

Query: 139 GNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHS 198
             L +LE LTL   NLTS    +    +LS+   L  + L +  ++ I   ++     + 
Sbjct: 149 SGLNSLEQLTLEKCNLTS----IPT-EALSHLHGLIVLRLRHLNINAIRDYSFKR--LYR 201

Query: 199 LKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIP-ITLGKLQKLQDVDLEYNQL 257
           LK   + +      +        +LT++ +    L  ++P + +  L  L+ ++L YN +
Sbjct: 202 LKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPI 260

Query: 258 EGSIPDSI--CLSVELYELELGGNKLSGSIPAC-FSNMTFLKVLSLGSNELTSIPLN-FW 313
             +I  S+   L   L E++L G +L+  +    F  + +L+VL++  N+LT++  + F 
Sbjct: 261 S-TIEGSMLHELL-RLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLTTLEESVFH 317

Query: 314 SLKDILDLNLSSNCFS 329
           S+ ++  L L SN  +
Sbjct: 318 SVGNLETLILDSNPLA 333

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  138 bits (349), Expect = 7e-35
 Identities = 82/347 (23%), Positives = 130/347 (37%), Gaps = 44/347 (12%)

Query: 85  LSSITDVGLPNLEVLYLWGNNFSGTIPHFIF-NASKLSKLALEMNSFSGFIPSTFGNLRN 143
             ++ +       +L L  N    T+    F +   L +L L  N  S   P  F NL N
Sbjct: 23  FVAVPEGIPTETRLLDLGKNRIK-TLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFN 81

Query: 144 LEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFY 203
           L  L L  N L    + L   + LSN   LT + +S N +  +L   +     ++LK+  
Sbjct: 82  LRTLGLRSNRLKL--IPLGVFTGLSN---LTKLDISENKIVILLDYMFQDL--YNLKSLE 134

Query: 204 MYNCNVSGGIPEEI-TNLTDLTTIVLGGNKLNGSIPI-TLGKLQKLQDVDLEYNQLEGSI 261
           + + ++   I     + L  L  + L    L  SIP   L  L  L  + L +  +  +I
Sbjct: 135 VGDNDLV-YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNIN-AI 191

Query: 262 PDSI--CLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLN-FWSLKDI 318
            D     L   L  LE+       ++         L  LS+    LT++P      L  +
Sbjct: 192 RDYSFKRLY-RLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYL 250

Query: 319 LDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEG 378
             LNLS N         I  ++         +            L  L+ + L   +L  
Sbjct: 251 RFLNLSYN--------PISTIEG--------SMLHE--------LLRLQEIQLVGGQLAV 286

Query: 379 SIPDSFGDLISLKSLNLSYNNLSGTIPVSL-EKLSYLKDLNLSFNKL 424
             P +F  L  L+ LN+S N L+ T+  S+   +  L+ L L  N L
Sbjct: 287 VEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPL 332

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  100 bits (250), Expect = 3e-22
 Identities = 42/233 (18%), Positives = 88/233 (37%), Gaps = 16/233 (6%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHE--IGHLHNLGFLDLSQNKLLGTIPA 63
            N +         ++ NLK L + +N L    I       L++L  L L +  L  +IP 
Sbjct: 113 ENKIVILLDYMFQDLYNLKSLEVGDNDLV--YISHRAFSGLNSLEQLTLEKCNL-TSIPT 169

Query: 64  AIF-NVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSK 122
               ++  L    + + +++  +   +   L  L+VL +    +  T+         L+ 
Sbjct: 170 EALSHLHGLIVLRLRHLNIN-AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTS 228

Query: 123 LALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNP 182
           L++   + +        +L  L +L L  N +++          L     L  I L    
Sbjct: 229 LSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGS-----MLHELLRLQEIQLVGGQ 283

Query: 183 LDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEI-TNLTDLTTIVLGGNKLN 234
           L  + P  + G   + L+   +    ++  + E +  ++ +L T++L  N L 
Sbjct: 284 LAVVEPYAFRGL--NYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPLA 333

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  135 bits (343), Expect = 1e-35
 Identities = 61/301 (20%), Positives = 111/301 (36%), Gaps = 67/301 (22%)

Query: 535 IGRGGFGSVYKARIRD--------GMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLV 586
           +G+G F  ++K   R+          EV +KV +       +SF    +MM  + H++LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75

Query: 587 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL---HFG 643
                C   +   LV E++  GSL+ YL  +   ++I  +L +   +A+A+ +L      
Sbjct: 76  LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTL- 134

Query: 644 YSAPVIHCDLKPSNVLLD--------DNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGY 695
                IH ++   N+LL         +     LSD GI+  +    + + Q      I +
Sbjct: 135 -----IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV--LPKDILQ----ERIPW 183

Query: 696 MAPE---YGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTM 752
           + PE     +   ++   D +SFG  L E  +          G+  L    +        
Sbjct: 184 VPPECIENPK--NLNLATDKWSFGTTLWEICSG---------GDKPLSALDS-------- 224

Query: 753 EVVDANLLSQEDIHFVAKEQ-----CVSFVFNLALECTVESPEQRINAKEIVAKLLKIRD 807
                    Q  + F            + + NL   C    P+ R + + I+  L  +  
Sbjct: 225 ---------QRKLQFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275

Query: 808 S 808
            
Sbjct: 276 P 276

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  142 bits (360), Expect = 1e-35
 Identities = 80/418 (19%), Positives = 147/418 (35%), Gaps = 59/418 (14%)

Query: 44  LHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWG 103
            +    L++ ++  L T+P  +     +    + +N+    L+S+     P L  L + G
Sbjct: 39  NNGNAVLNVGESG-LTTLPDCLPA--HITTLVIPDNN----LTSLPA-LPPELRTLEVSG 90

Query: 104 NNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSF 163
           N  + ++P       +LS  +  +                L  L ++ N LT      S 
Sbjct: 91  NQLT-SLPVLPPGLLELSIFSNPLTHLPALPS-------GLCKLWIFGNQLT------SL 136

Query: 164 LSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDL 223
                  + L+   +S+N L  +        L   L   + YN  ++  +P   + L +L
Sbjct: 137 PVLPPGLQELS---VSDNQLASLPA------LPSELCKLWAYNNQLT-SLPMLPSGLQEL 186

Query: 224 TTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSG 283
           +   +  N+L  S+P    +L KL       N+L  S+P        L EL + GN+L+ 
Sbjct: 187 S---VSDNQLA-SLPTLPSELYKL---WAYNNRLT-SLPALPS---GLKELIVSGNRLT- 234

Query: 284 SIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALI 343
           S+P   S    LK L +  N LTS+P+    L     L++  N  +  LP  + +L +  
Sbjct: 235 SLPVLPSE---LKELMVSGNRLTSLPMLPSGLL---SLSVYRNQLTR-LPESLIHLSSET 287

Query: 344 EIDFSMNNFSGIIPMEIGSLKNLENL---FLEYNRLEGSIPDSFGDLISLKSLNLSYNNL 400
            ++   N  S      +  + +        + ++    S P     L    +  L     
Sbjct: 288 TVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPARE 347

Query: 401 SGTIPV----SLEKLSYLKDLNLSFNKLKGEIPRGGSFGNFSAESFKGNELLCGSPNL 454
               P        +       +L  ++L  E         F A+       L     L
Sbjct: 348 GEPAPADRWHMFGQEDNADAFSLFLDRLS-ETENFIKDAGFKAQISSWLAQLAEDEAL 404

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  127 bits (321), Expect = 1e-30
 Identities = 70/370 (18%), Positives = 122/370 (32%), Gaps = 77/370 (20%)

Query: 18  DNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVT 77
                L+ L +  N+L   +      L  L         L             L      
Sbjct: 78  ALPPELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHL-----------PAL------ 119

Query: 78  NNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPST 137
                             L  L+++GN  + ++P        L +L++  N  +  +P+ 
Sbjct: 120 ---------------PSGLCKLWIFGNQLT-SLPVLPPG---LQELSVSDNQLAS-LPAL 159

Query: 138 FGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSH 197
              L     L  Y+N LT      S     S    L  +S+S+N L   LP      L  
Sbjct: 160 PSELCK---LWAYNNQLT------SLPMLPSG---LQELSVSDNQL-ASLP-----TLPS 201

Query: 198 SLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQL 257
            L   + YN  ++  +P   + L +L    + GN+L  S+P+   +L++L    +  N+L
Sbjct: 202 ELYKLWAYNNRLT-SLPALPSGLKELI---VSGNRLT-SLPVLPSELKEL---MVSGNRL 253

Query: 258 EGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNF----W 313
             S+P        L  L +  N+L+  +P    +++    ++L  N L+   L       
Sbjct: 254 T-SLPMLPS---GLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREIT 308

Query: 314 SLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPME----IGSLKNLENL 369
           S        +  +      P E R L                 P +     G   N +  
Sbjct: 309 SAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPADRWHMFGQEDNADAF 368

Query: 370 FLEYNRLEGS 379
            L  +RL  +
Sbjct: 369 SLFLDRLSET 378

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  139 bits (352), Expect = 1e-35
 Identities = 48/211 (22%), Positives = 98/211 (46%), Gaps = 17/211 (8%)

Query: 528 KFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMK-SIRHRNLV 586
            F   +++G G  G++    + D  +VAVK    +C   F   D E  +++ S  H N++
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVI 81

Query: 587 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSA 646
           +   +  + +F+ + +E     +L++Y+   +++    + + ++    S L +LH   S 
Sbjct: 82  RYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SL 137

Query: 647 PVIHCDLKPSNVLL-----DDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAPEY 700
            ++H DLKP N+L+        + A +SDFG+ K L     S ++   +  T G++APE 
Sbjct: 138 NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEM 197

Query: 701 ---GREGQVSTNGDVYSFGIMLMETFTRKKP 728
                +   +   D++S G +     +    
Sbjct: 198 LSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  137 bits (346), Expect = 1e-35
 Identities = 59/281 (20%), Positives = 115/281 (40%), Gaps = 39/281 (13%)

Query: 533 NLIGRGGFGSVYKARIRDGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNL--VKV 588
             IG GG   V++         A+K  NL+    +   S+  E A +  ++  +   +++
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 589 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPV 648
                 +++  +V+E   +  L  +L     S+D ++R +   ++  A+  +H      +
Sbjct: 75  YDYEITDQYIYMVMEC-GNIDLNSWLK-KKKSIDPWERKSYWKNMLEAVHTIH---QHGI 129

Query: 649 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPE--------- 699
           +H DLKP+N L+ D M+  L DFGIA  +  +  S+ +   + T+ YM PE         
Sbjct: 130 VHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 188

Query: 700 --YGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDA 757
                + ++S   DV+S G +L      K P  ++ N    L   ++    I        
Sbjct: 189 ENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE-----FP 243

Query: 758 NLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEI 798
           ++  ++    +               C    P+QRI+  E+
Sbjct: 244 DIPEKDLQDVLKC-------------CLKRDPKQRISIPEL 271

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  138 bits (348), Expect = 2e-35
 Identities = 58/281 (20%), Positives = 114/281 (40%), Gaps = 39/281 (13%)

Query: 533 NLIGRGGFGSVYKARIRDGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNL--VKV 588
             IG GG   V++         A+K  NL+    +   S+  E A +  ++  +   +++
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121

Query: 589 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPV 648
                 +++  +V+E   +  L  +L     S+D ++R +   ++  A+  +H      +
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLK-KKKSIDPWERKSYWKNMLEAVHTIH---QHGI 176

Query: 649 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPE--------- 699
           +H DLKP+N L+ D M+  L DFGIA  +  +  S+ +   +  + YM PE         
Sbjct: 177 VHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSR 235

Query: 700 --YGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDA 757
                + ++S   DV+S G +L      K P  ++ N    L   ++    I   ++   
Sbjct: 236 ENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP-- 293

Query: 758 NLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEI 798
               ++    +               C    P+QRI+  E+
Sbjct: 294 ---EKDLQDVLKC-------------CLKRDPKQRISIPEL 318

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  135 bits (342), Expect = 4e-35
 Identities = 73/307 (23%), Positives = 123/307 (40%), Gaps = 68/307 (22%)

Query: 535 IGRGGFGSVYKARIRDG------MEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKV 588
           +G G FG V+ A   +       M VAVK        A + F  E  ++  ++H+++V+ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108

Query: 589 ISSCSNEEFKALVLEYMPHGSLEKYL--------------HSSNYSLDIFQRLNIMIDVA 634
              C+      +V EYM HG L ++L                +   L + Q L +   VA
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168

Query: 635 SALEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA 691
           + + YL   HF      +H DL   N L+   +V  + DFG+++ +   D      +T+ 
Sbjct: 169 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222

Query: 692 TIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLP--- 748
            I +M PE     + +T  DV+SFG++L E FT          G+           P   
Sbjct: 223 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTY---------GKQ----------PWYQ 263

Query: 749 ISTMEVVDANLLSQEDIHFVAK-------EQCVSFVFNLALECTVESPEQRINAKEIVAK 801
           +S  E           I  + +         C   V+ +   C    P+QR + K++ A+
Sbjct: 264 LSNTEA----------IDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313

Query: 802 LLKIRDS 808
           L  +  +
Sbjct: 314 LQALAQA 320

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  141 bits (357), Expect = 4e-35
 Identities = 62/290 (21%), Positives = 108/290 (37%), Gaps = 51/290 (17%)

Query: 535 IGRGGFGSVYKARIRDG----MEVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLVKVI 589
           IG G FG V++          M VA+K           + F  E   M+   H ++VK+I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457

Query: 590 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL---HFGYSA 646
              +      +++E    G L  +L    +SLD+   +     +++AL YL    F    
Sbjct: 458 GVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRF---- 512

Query: 647 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQV 706
             +H D+   NVL+  N    L DFG+++ +         ++    I +MAPE     + 
Sbjct: 513 --VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA-SKGKLPIKWMAPESINFRRF 569

Query: 707 STNGDVYSFGIMLMETFTR-KKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDI 765
           ++  DV+ FG+ + E      KP   + N                            + I
Sbjct: 570 TSASDVWMFGVCMWEILMHGVKPFQGVKN---------------------------NDVI 602

Query: 766 HFVAK-------EQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDS 808
             +           C   +++L  +C    P +R    E+ A+L  I + 
Sbjct: 603 GRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  139 bits (352), Expect = 5e-35
 Identities = 77/449 (17%), Positives = 138/449 (30%), Gaps = 50/449 (11%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAI 65
           +N +             L+ L L +N+L     H      NL  LDLS N          
Sbjct: 54  HNRIQYLDISVFKFNQELEYLDLSHNKLVKISCH---PTVNLKHLDLSFNAFDALPICKE 110

Query: 66  FNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLAL 125
           F                          +  L+ L L   +   +    I + +    L +
Sbjct: 111 FG------------------------NMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLV 146

Query: 126 EMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDG 185
              ++          L++    +L+    T+         S+    +L   ++     D 
Sbjct: 147 LGETYGEKED--PEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDN 204

Query: 186 ILPRTY----VGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIV--------LGGNKL 233
                         +  L N  + N   +      I  L   TT+         L G   
Sbjct: 205 KCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLD 264

Query: 234 NGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMT 293
                 +   L+ L    +  +           +   +       +        C S ++
Sbjct: 265 FRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKIS 324

Query: 294 FLKVLSLGSNELTSIPL-NFWSLKDILDLNLSSNCFS--GPLPLEIRNLKALIEIDFSMN 350
               L   +N LT     N   L ++  L L  N       +      +K+L ++D S N
Sbjct: 325 PFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQN 384

Query: 351 NFSGIIPMEI-GSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLE 409
           + S           K+L +L +  N L  +I         +K L+L  N +  +IP  + 
Sbjct: 385 SVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVV 441

Query: 410 KLSYLKDLNLSFNKLKGEIPRGGSFGNFS 438
           KL  L++LN++ N+LK  +P  G F   +
Sbjct: 442 KLEALQELNVASNQLK-SVPD-GIFDRLT 468

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  114 bits (287), Expect = 7e-27
 Identities = 63/355 (17%), Positives = 103/355 (29%), Gaps = 32/355 (9%)

Query: 92  GLP-NLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLY 150
            L     +L +  N  S      I + SKL  L +  N       S F   + LE+L L 
Sbjct: 18  DLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLS 77

Query: 151 DNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVS 210
            N L      +S         +L H+ LS N  D +      GN+S  LK   +   ++ 
Sbjct: 78  HNKLVK----ISC----HPTVNLKHLDLSFNAFDALPICKEFGNMS-QLKFLGLSTTHLE 128

Query: 211 GGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVE 270
                 I +L     +++ G             LQ      L            I     
Sbjct: 129 KSSVLPIAHLNISKVLLVLGETY--GEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSV 186

Query: 271 LYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIP---------------LNFWSL 315
                L  + +   +     +     +  L +N   S                 L     
Sbjct: 187 KTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWH 246

Query: 316 KDILDLNLSSNCFSGPLPLEI-----RNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLF 370
             +   ++S+    G L          +LKAL       + F            N+    
Sbjct: 247 TTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKN 306

Query: 371 LEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLK 425
              +            +     L+ S N L+ T+  +   L+ L+ L L  N+LK
Sbjct: 307 FTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK 361

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  104 bits (260), Expect = 2e-23
 Identities = 74/384 (19%), Positives = 136/384 (35%), Gaps = 40/384 (10%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLG-FLDLSQNKLLGTIPAA 64
           N F      KE  N+S LK L L    L+   +  I HL+     L L +       P  
Sbjct: 100 NAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEG 159

Query: 65  IFNVSTLK-AFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKL--- 120
           + + +T         N     +  ++   + NLE+  +          +F+   +KL   
Sbjct: 160 LQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTN 219

Query: 121 ---SKLALEMNSFSG---FIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLT 174
              S L L     +               + + ++ +  L        F  S ++ K+L+
Sbjct: 220 PKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALS 279

Query: 175 HISLSNNPLDG-------ILPRTYVGNLSHS---------------LKNFYMYNCNVSGG 212
              + ++           I     + N + S                 +    N  ++  
Sbjct: 280 IHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDT 339

Query: 213 IPEEITNLTDLTTIVLGGNKLNGSIPITLG---KLQKLQDVDLEYNQLEGSIPDSICLS- 268
           + E   +LT+L T++L  N+L   +        +++ LQ +D+  N +        C   
Sbjct: 340 VFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWT 398

Query: 269 VELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCF 328
             L  L +  N L+ +I  C      +KVL L SN++ SIP     L+ + +LN++SN  
Sbjct: 399 KSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIKSIPKQVVKLEALQELNVASNQL 456

Query: 329 SGPLPLEIRNLKALIEIDFSMNNF 352
                     L +L +I    N +
Sbjct: 457 KSVPDGIFDRLTSLQKIWLHTNPW 480

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 91.5 bits (227), Expect = 2e-19
 Identities = 55/287 (19%), Positives = 99/287 (34%), Gaps = 18/287 (6%)

Query: 2   PSIINNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHL---HNLGFLDLSQNKLL 58
                     +   ++     L  L L N          I  L     + +  +S  KL 
Sbjct: 201 LEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQ 260

Query: 59  GTIPAAIFNVS-----TLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHF 113
           G +    F+ S      L    V ++      S I +    N+ +     +         
Sbjct: 261 GQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYE-IFSNMNIKNFTVSGTRMVHMLC 319

Query: 114 IFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSL 173
               S    L    N  +  +    G+L  LE L L  N L   +      + + +   L
Sbjct: 320 PSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKS---L 376

Query: 174 THISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKL 233
             + +S N +     +        SL +  M +  ++  I   +     +  + L  NK+
Sbjct: 377 QQLDISQNSVSYDEKKGDCSWTK-SLLSLNMSSNILTDTIFRCLPPR--IKVLDLHSNKI 433

Query: 234 NGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVE-LYELELGGN 279
             SIP  + KL+ LQ++++  NQL+ S+PD I   +  L ++ L  N
Sbjct: 434 K-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTN 478

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 86.8 bits (215), Expect = 7e-18
 Identities = 39/163 (23%), Positives = 70/163 (42%), Gaps = 7/163 (4%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQ--GEIIHEIGHLHNLGFLDLSQNKLLGTIPA 63
           NN LT T  +   +++ L+ L L  N+L+   +I      + +L  LD+SQN +      
Sbjct: 333 NNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKK 392

Query: 64  AIF-NVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSK 122
                  +L +  +++N L+    +I     P ++VL L  N    +IP  +     L +
Sbjct: 393 GDCSWTKSLLSLNMSSNILT---DTIFRCLPPRIKVLDLHSNKIK-SIPKQVVKLEALQE 448

Query: 123 LALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLS 165
           L +  N         F  L +L+ + L+ N    S   + +LS
Sbjct: 449 LNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLS 491

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 64.5 bits (157), Expect = 6e-11
 Identities = 37/164 (22%), Positives = 62/164 (37%), Gaps = 13/164 (7%)

Query: 297 VLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGII 356
           ++    N L  +P +    +    LN+S N  S     +I +L  L  +  S N    + 
Sbjct: 4   LVDRSKNGLIHVPKDL--SQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLD 61

Query: 357 PMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVS--LEKLSYL 414
                  + LE L L +N+L   I       ++LK L+LS+N     +P+      +S L
Sbjct: 62  ISVFKFNQELEYLDLSHNKLV-KIS--CHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQL 117

Query: 415 KDLNLSFNKLKGEIPRGGSFGNFSAESFKGNELLCGSPNLQVPP 458
           K L LS   L+       S    +  +     L+ G    +   
Sbjct: 118 KFLGLSTTHLE-----KSSVLPIAHLNISKVLLVLGETYGEKED 156

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  134 bits (339), Expect = 1e-34
 Identities = 48/201 (23%), Positives = 79/201 (39%), Gaps = 14/201 (6%)

Query: 533 NLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISS 591
             +GRG FG V++ +  + G + AVK   L+  R       E      +    +V +  +
Sbjct: 64  PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGA 118

Query: 592 CSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHC 651
                +  + +E +  GSL + +      L   + L  +      LEYLH   +  ++H 
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLH---TRRILHG 174

Query: 652 DLKPSNVLLDDN-MVAHLSDFGIAKLLTGEDQSMTQTQTLATIG---YMAPEYGREGQVS 707
           D+K  NVLL  +   A L DFG A  L  +    +        G   +MAPE        
Sbjct: 175 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD 234

Query: 708 TNGDVYSFGIMLMETFTRKKP 728
              D++S   M++       P
Sbjct: 235 AKVDIWSSCCMMLHMLNGCHP 255

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  133 bits (336), Expect = 2e-34
 Identities = 64/235 (27%), Positives = 102/235 (43%), Gaps = 16/235 (6%)

Query: 501 GPPNDPNMPPVATWRRFSYLELFQATDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVK-- 557
           GPP     P  A      Y  L      F     IGRG F  VY+A  + DG+ VA+K  
Sbjct: 10  GPPVPQFQPQKALRPDMGYNTL----ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKV 65

Query: 558 -VFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHS 616
            +F+L   +A      E  ++K + H N++K  +S   +    +VLE    G L + +  
Sbjct: 66  QIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKH 125

Query: 617 SNYSLDIF---QRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGI 673
                 +          + + SALE++H   S  V+H D+KP+NV +    V  L D G+
Sbjct: 126 FKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGL 182

Query: 674 AKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKP 728
            +  + +  +   +    T  YM+PE   E   +   D++S G +L E    + P
Sbjct: 183 GRFFSSKT-TAAHSLV-GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 235

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  133 bits (336), Expect = 2e-34
 Identities = 62/300 (20%), Positives = 107/300 (35%), Gaps = 45/300 (15%)

Query: 528 KFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLV 586
            +     +G GGF  V     + DG   A+K       +  +    E  M +   H N++
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89

Query: 587 KVISSCSNEEFKA----LVLEYMPHGSLEKYL---HSSNYSLDIFQRLNIMIDVASALEY 639
           ++++ C  E        L+L +   G+L   +         L   Q L +++ +   LE 
Sbjct: 90  RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149

Query: 640 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA-------T 692
           +H   +    H DLKP+N+LL D     L D G         +   Q  TL        T
Sbjct: 150 IH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206

Query: 693 IGYMAPE------YGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDC 746
           I Y APE      +    + +   DV+S G +L      + P D +F    ++   V + 
Sbjct: 207 ISYRAPELFSVQSHCVIDERT---DVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQ 263

Query: 747 LPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIR 806
           L I       +   S      +                    P QR +   ++++L  ++
Sbjct: 264 LSIP-----QSPRHSSALWQLLNS-------------MMTVDPHQRPHIPLLLSQLEALQ 305

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  134 bits (339), Expect = 2e-34
 Identities = 68/306 (22%), Positives = 118/306 (38%), Gaps = 67/306 (21%)

Query: 535 IGRGGFGSVYKARIRD--------GMEVAVKVFNLQCG-RAFKSFDVECAMMKSI-RHRN 584
           +G G FG V  A             + VAVK+       +       E  MMK I +H+N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148

Query: 585 LVKVISSCSNEEFKALVLEYMPHGSLEKYL---------------HSSNYSLDIFQRLNI 629
           ++ ++ +C+ +    +++EY   G+L +YL                     +     ++ 
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208

Query: 630 MIDVASALEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQ 686
              +A  +EYL           IH DL   NVL+ +N V  ++DFG+A+ +   D     
Sbjct: 209 TYQLARGMEYLASQKC------IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 262

Query: 687 TQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDC 746
           T     + +MAPE   +   +   DV+SFG+++ E FT          G           
Sbjct: 263 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL---------GGS--------- 304

Query: 747 LPISTMEVVDANLLSQEDIHFVAK-------EQCVSFVFNLALECTVESPEQRINAKEIV 799
            P   + V       +E    + +         C + ++ +  +C    P QR   K++V
Sbjct: 305 -PYPGIPV-------EELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLV 356

Query: 800 AKLLKI 805
             L +I
Sbjct: 357 EDLDRI 362

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  132 bits (335), Expect = 2e-34
 Identities = 63/311 (20%), Positives = 119/311 (38%), Gaps = 72/311 (23%)

Query: 535 IGRGGFGSVYKARIRDG------MEVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVK 587
           +G G FG V KA             VAVK+          +    E  ++K + H +++K
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90

Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYL-----------------------HSSNYSLDIF 624
           +  +CS +    L++EY  +GSL  +L                       H    +L + 
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150

Query: 625 QRLNIMIDVASALEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 681
             ++    ++  ++YL           +H DL   N+L+ +     +SDFG+++ +  ED
Sbjct: 151 DLISFAWQISQGMQYLAEMKL------VHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204

Query: 682 QSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKH 741
             + ++Q    + +MA E   +   +T  DV+SFG++L E  T          G      
Sbjct: 205 SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTL---------GGN---- 251

Query: 742 WVNDCLPISTMEVVDANLLSQEDIHFVAK-------EQCVSFVFNLALECTVESPEQRIN 794
                 P   +         +   + +         + C   ++ L L+C  + P++R  
Sbjct: 252 ------PYPGIPP-------ERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPV 298

Query: 795 AKEIVAKLLKI 805
             +I   L K+
Sbjct: 299 FADISKDLEKM 309

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  131 bits (333), Expect = 3e-34
 Identities = 65/305 (21%), Positives = 123/305 (40%), Gaps = 64/305 (20%)

Query: 535 IGRGGFGSVYKARIRDG------MEVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLVK 587
           +G   FG VYK  +           VA+K    +  G   + F  E  +   ++H N+V 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76

Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLHSS---------------NYSLDIFQRLNIMID 632
           ++   + ++  +++  Y  HG L ++L                    +L+    ++++  
Sbjct: 77  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136

Query: 633 VASALEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
           +A+ +EYL   H       +H DL   NVL+ D +   +SD G+ + +   D       +
Sbjct: 137 IAAGMEYLSSHHV------VHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNS 190

Query: 690 LATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPI 749
           L  I +MAPE    G+ S + D++S+G++L E F+          G            P 
Sbjct: 191 LLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSY---------GLQ----------PY 231

Query: 750 STMEVVDANLLSQEDIHFVAK-------EQCVSFVFNLALECTVESPEQRINAKEIVAKL 802
                       Q+ +  +         + C ++V+ L +EC  E P +R   K+I ++L
Sbjct: 232 CGYSN-------QDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRL 284

Query: 803 LKIRD 807
               +
Sbjct: 285 RAWGN 289

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  132 bits (333), Expect = 3e-34
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 13/209 (6%)

Query: 534 LIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSC 592
           ++G+G +G VY  R + + + +A+K    +  R  +    E A+ K ++H+N+V+ + S 
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88

Query: 593 SNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRL--NIMIDVASALEYLHFGYSAPVIH 650
           S   F  + +E +P GSL   L S    L   ++        +   L+YLH      ++H
Sbjct: 89  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVH 145

Query: 651 CDLKPSNVLLD-DNMVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAPE--YGREGQV 706
            D+K  NVL++  + V  +SDFG +K L G       T+T   T+ YMAPE         
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAG---INPCTETFTGTLQYMAPEIIDKGPRGY 202

Query: 707 STNGDVYSFGIMLMETFTRKKPTDELFNG 735
               D++S G  ++E  T K P  EL   
Sbjct: 203 GKAADIWSLGCTIIEMATGKPPFYELGEP 231

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  132 bits (334), Expect = 5e-34
 Identities = 68/306 (22%), Positives = 118/306 (38%), Gaps = 67/306 (21%)

Query: 535 IGRGGFGSVYKARIRD--------GMEVAVKVFNLQCG-RAFKSFDVECAMMKSI-RHRN 584
           +G G FG V  A             + VAVK+       +       E  MMK I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102

Query: 585 LVKVISSCSNEEFKALVLEYMPHGSLEKYL---------------HSSNYSLDIFQRLNI 629
           ++ ++ +C+ +    +++EY   G+L +YL                     +     ++ 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162

Query: 630 MIDVASALEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQ 686
              +A  +EYL           IH DL   NVL+ +N V  ++DFG+A+ +   D     
Sbjct: 163 TYQLARGMEYLASQKC------IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216

Query: 687 TQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDC 746
           T     + +MAPE   +   +   DV+SFG+++ E FT          G           
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL---------GGS--------- 258

Query: 747 LPISTMEVVDANLLSQEDIHFVAK-------EQCVSFVFNLALECTVESPEQRINAKEIV 799
            P   + V       +E    + +         C + ++ +  +C    P QR   K++V
Sbjct: 259 -PYPGIPV-------EELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLV 310

Query: 800 AKLLKI 805
             L +I
Sbjct: 311 EDLDRI 316

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  132 bits (335), Expect = 5e-34
 Identities = 74/314 (23%), Positives = 121/314 (38%), Gaps = 72/314 (22%)

Query: 535 IGRGGFGSVYKARIRDG------MEVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLVK 587
           IG G FG V++AR            VAVK+   +        F  E A+M    + N+VK
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114

Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLHSS-----------------------NYSLDIF 624
           ++  C+  +   L+ EYM +G L ++L S                           L   
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174

Query: 625 QRLNIMIDVASALEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 681
           ++L I   VA+ + YL    F      +H DL   N L+ +NMV  ++DFG+++ +   D
Sbjct: 175 EQLCIARQVAAGMAYLSERKF------VHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228

Query: 682 QSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKH 741
                      I +M PE     + +T  DV+++G++L E F+          G      
Sbjct: 229 YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY---------GLQ---- 275

Query: 742 WVNDCLPISTMEVVDANLLSQEDIHFVAK-------EQCVSFVFNLALECTVESPEQRIN 794
                 P   M         +E I++V         E C   ++NL   C  + P  R +
Sbjct: 276 ------PYYGMAH-------EEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPS 322

Query: 795 AKEIVAKLLKIRDS 808
              I   L ++ + 
Sbjct: 323 FCSIHRILQRMCER 336

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  133 bits (336), Expect = 8e-34
 Identities = 80/384 (20%), Positives = 138/384 (35%), Gaps = 81/384 (21%)

Query: 464 HRTSRKNALILGIVLPFSTIFMTAIILFIIKYQKREKGPPNDPNMPPVATWRRFSYLELF 523
           H       +     L F+ +       +   +      P    N+         S  EL 
Sbjct: 6   HHHHHDYDIPTTENLYFNGM-----GYYHHHHHHDYDIPTT-ENLYFQGMLAGVSEYELP 59

Query: 524 QATDK--FSENNL-----IGRGGFGSVYKARIRD--------GMEVAVKVFNLQC-GRAF 567
           +   +     + L     +G G FG V  A              +VAVK+       +  
Sbjct: 60  ED-PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDL 118

Query: 568 KSFDVECAMMKSI-RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYL------------ 614
                E  MMK I +H+N++ ++ +C+ +    +++EY   G+L +YL            
Sbjct: 119 SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSY 178

Query: 615 ---HSSNYSLDIFQRLNIMIDVASALEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHL 668
              H+    L     ++    VA  +EYL           IH DL   NVL+ ++ V  +
Sbjct: 179 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKC------IHRDLAARNVLVTEDNVMKI 232

Query: 669 SDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKP 728
           +DFG+A+ +   D     T     + +MAPE   +   +   DV+SFG++L E FT    
Sbjct: 233 ADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL--- 289

Query: 729 TDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAK-------EQCVSFVFNLA 781
                 G            P   + V       +E    + +         C + ++ + 
Sbjct: 290 ------GGS----------PYPGVPV-------EELFKLLKEGHRMDKPSNCTNELYMMM 326

Query: 782 LECTVESPEQRINAKEIVAKLLKI 805
            +C    P QR   K++V  L +I
Sbjct: 327 RDCWHAVPSQRPTFKQLVEDLDRI 350

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  129 bits (327), Expect = 1e-33
 Identities = 55/220 (25%), Positives = 86/220 (39%), Gaps = 16/220 (7%)

Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHR 583
           + +     IG G +G   K R   DG  +  K  +         +    E  +++ ++H 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65

Query: 584 NLVKVISSCSNEEFKAL--VLEYMPHGSLEKYLHSSNYSLDIF---QRLNIMIDVASALE 638
           N+V+      +     L  V+EY   G L   +               L +M  +  AL+
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125

Query: 639 YLH--FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYM 696
             H        V+H DLKP+NV LD      L DFG+A++L   D S  +T  + T  YM
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN-HDTSFAKTF-VGTPYYM 183

Query: 697 APEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGE 736
           +PE       +   D++S G +L E      P    F   
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPP----FTAF 219

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  129 bits (327), Expect = 1e-33
 Identities = 55/226 (24%), Positives = 89/226 (39%), Gaps = 28/226 (12%)

Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNL 585
             F E  LIG GGFG V+KA+   DG    +K       +A +    E   +  + H N+
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDHVNI 66

Query: 586 VKVISSCSNEEFKA----------------LVLEYMPHGSLEKYLHSSNYS-LDIFQRLN 628
           V         ++                  + +E+   G+LE+++       LD    L 
Sbjct: 67  VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126

Query: 629 IMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQ 688
           +   +   ++Y+H   S  +I+ DLKPSN+ L D     + DFG+   L  + +      
Sbjct: 127 LFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKG 183

Query: 689 TLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFN 734
           TL    YM+PE           D+Y+ G++L E         E   
Sbjct: 184 TLR---YMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK 226

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  130 bits (328), Expect = 2e-33
 Identities = 63/303 (20%), Positives = 111/303 (36%), Gaps = 60/303 (19%)

Query: 535 IGRGGFGSVYKARIRD------GMEVAVKVFNLQCG-RAFKSFDVECAMMKSI-RHRNLV 586
           +G G FG V +A           M VAVK+          ++   E  ++  +  H N+V
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90

Query: 587 KVISSCSNEEFKALVLEYMPHGSLEKYL-----------------HSSNYSLDIFQRLNI 629
            ++ +C+      ++ EY  +G L  +L                      +LD+   L+ 
Sbjct: 91  NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150

Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
              VA  + +L    S   IH DL   N+LL    +  + DFG+A+ +  +   + +   
Sbjct: 151 SYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207

Query: 690 LATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPI 749
              + +MAPE       +   DV+S+GI L E F+          G            P 
Sbjct: 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSL---------GSS----------PY 248

Query: 750 STMEVVDANLLSQEDIHFVAK-------EQCVSFVFNLALECTVESPEQRINAKEIVAKL 802
             M V        +    + +       E   + ++++   C    P +R   K+IV  +
Sbjct: 249 PGMPV------DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302

Query: 803 LKI 805
            K 
Sbjct: 303 EKQ 305

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  130 bits (329), Expect = 3e-33
 Identities = 48/206 (23%), Positives = 91/206 (44%), Gaps = 9/206 (4%)

Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHR 583
           +K+     IG G FG     +   DG +  +K  N+     +  +    E A++ +++H 
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83

Query: 584 NLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYS-LDIFQRLNIMIDVASALEYLHF 642
           N+V+   S        +V++Y   G L K +++         Q L+  + +  AL+++H 
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH- 142

Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
                ++H D+K  N+ L  +    L DFGIA++L      + +     T  Y++PE   
Sbjct: 143 --DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN-STVELARACI-GTPYYLSPEICE 198

Query: 703 EGQVSTNGDVYSFGIMLMETFTRKKP 728
               +   D+++ G +L E  T K  
Sbjct: 199 NKPYNNKSDIWALGCVLYELCTLKHA 224

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  128 bits (324), Expect = 7e-33
 Identities = 63/302 (20%), Positives = 113/302 (37%), Gaps = 59/302 (19%)

Query: 535 IGRGGFGSVYKARIRD------GMEVAVKVFNLQC-GRAFKSFDVECAMMKSI-RHRNLV 586
           +GRG FG V +A             VAVK+          ++   E  ++  I  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94

Query: 587 KVISSCSNEEFKA-LVLEYMPHGSLEKYL---------------HSSNYSLDIFQRLNIM 630
            ++ +C+       +++E+   G+L  YL                     L +   +   
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154

Query: 631 IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTL 690
             VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+ +  +   + +    
Sbjct: 155 FQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211

Query: 691 ATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPIS 750
             + +MAPE   +   +   DV+SFG++L E F+          G            P  
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL---------GAS----------PYP 252

Query: 751 TMEVVDANLLSQEDIHFVAK-------EQCVSFVFNLALECTVESPEQRINAKEIVAKLL 803
            +++       +E    + +       +     ++   L+C    P QR    E+V  L 
Sbjct: 253 GVKI------DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 306

Query: 804 KI 805
            +
Sbjct: 307 NL 308

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  128 bits (325), Expect = 8e-33
 Identities = 75/312 (24%), Positives = 133/312 (42%), Gaps = 73/312 (23%)

Query: 533 NLIGRGGFGSVYKARIRDG---MEVAVKVFNLQCG---RAFKSFDVECAMMKSI-RHRNL 585
           ++IG G FG V KARI+     M+ A+K   ++        + F  E  ++  +  H N+
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKR--MKEYASKDDHRDFAGELEVLCKLGHHPNI 88

Query: 586 VKVISSCSNEEFKALVLEYMPHGSLEKYL---------------HSSNYSLDIFQRLNIM 630
           + ++ +C +  +  L +EY PHG+L  +L               +S+  +L   Q L+  
Sbjct: 89  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148

Query: 631 IDVASALEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQT 687
            DVA  ++YL    F      IH DL   N+L+ +N VA ++DFG+++   G++  + +T
Sbjct: 149 ADVARGMDYLSQKQF------IHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKT 199

Query: 688 QTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCL 747
                + +MA E       +TN DV+S+G++L E  +          G            
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSL---------GGT---------- 240

Query: 748 PISTMEVVDANLLSQEDIHFVAK-------EQCVSFVFNLALECTVESPEQRINAKEIVA 800
           P   M          E    + +         C   V++L  +C  E P +R +  +I+ 
Sbjct: 241 PYCGMTC-------AELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 293

Query: 801 KLLKIRDSLLRN 812
            L    + +L  
Sbjct: 294 SL----NRMLEE 301

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  127 bits (320), Expect = 3e-32
 Identities = 59/343 (17%), Positives = 122/343 (35%), Gaps = 58/343 (16%)

Query: 95  NLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNL 154
           +L V+          +P  +      + L L+ N  +      F NL+NL  L L +N +
Sbjct: 32  HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88

Query: 155 TSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIP 214
           +   +     + L     L  + LS N L  +        +  +L+   ++   ++  + 
Sbjct: 89  SK--ISPGAFAPLVK---LERLYLSKNQLKELPE-----KMPKTLQELRVHENEITK-VR 137

Query: 215 EEI-TNLTDLTTIVLGGNKLNGSI--PITLGKLQKLQDVDLEYNQLEGSIPDSICLSVEL 271
           + +   L  +  + LG N L  S         ++KL  + +    +  +IP  +  S  L
Sbjct: 138 KSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPPS--L 194

Query: 272 YELELGGNKLSGSIPA-CFSNMTFLKVLSLGSNELTSIPLN-FWSLKDILDLNLSSNCFS 329
            EL L GNK++  + A     +  L  L L  N ++++      +   + +L+L++N   
Sbjct: 195 TELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNN--- 250

Query: 330 GPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDS------ 383
                    L                +P  +   K ++ ++L  N +  +I  +      
Sbjct: 251 --------KLVK--------------VPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPG 287

Query: 384 -FGDLISLKSLNLSYNNLSGTI--PVSLEKLSYLKDLNLSFNK 423
                 S   ++L  N +      P +   +     + L   K
Sbjct: 288 YNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  124 bits (313), Expect = 3e-31
 Identities = 70/395 (17%), Positives = 123/395 (31%), Gaps = 107/395 (27%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAI 65
           +  L    PK++    +  +L L NN++      +  +L NL  L L  NK+   I    
Sbjct: 40  DLGLEKV-PKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI-SKISPGA 95

Query: 66  FNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLAL 125
           F                          L  LE LYL  N     +P  +     L +L +
Sbjct: 96  FA------------------------PLVKLERLYLSKNQLK-ELPEKMP--KTLQELRV 128

Query: 126 EMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDG 185
             N  +    S F  L  +  + L  N L SS ++     +    K L++I +++  +  
Sbjct: 129 HENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENG---AFQGMKKLSYIRIADTNITT 185

Query: 186 ILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQ 245
           I                                    LT + L GNK+      +L  L 
Sbjct: 186 IPQGL-----------------------------PPSLTELHLDGNKITKVDAASLKGLN 216

Query: 246 KLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNEL 305
            L  + L +N +  ++ +                          +N   L+ L L +N+L
Sbjct: 217 NLAKLGLSFNSIS-AVDNGS-----------------------LANTPHLRELHLNNNKL 252

Query: 306 TSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKN 365
             +P      K I  + L +N         I  + +        N+F    P       +
Sbjct: 253 VKVPGGLADHKYIQVVYLHNN--------NISAIGS--------NDFCP--PGYNTKKAS 294

Query: 366 LENLFLEYNRLEGSI--PDSFGDLISLKSLNLSYN 398
              + L  N ++     P +F  +    ++ L   
Sbjct: 295 YSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 92.4 bits (230), Expect = 2e-20
 Identities = 40/235 (17%), Positives = 85/235 (36%), Gaps = 36/235 (15%)

Query: 3   SIINNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHE--IGHLHNLGFLDLSQNKLLGT 60
            +  N +T       + ++ + V+ L  N L+   I       +  L ++ ++    + T
Sbjct: 127 RVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTN-ITT 185

Query: 61  IPAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIF-NASK 119
           IP  +    +L    +  N ++  + + +  GL NL  L L  N+ S  + +    N   
Sbjct: 186 IPQGLP--PSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSIS-AVDNGSLANTPH 241

Query: 120 LSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTS-STLDLSFLSSLSNCKSLTHISL 178
           L +L L  N     +P    + + ++ + L++NN+++  + D       +   S + +SL
Sbjct: 242 LRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSL 300

Query: 179 SNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEI-TNLTDLTTIVLGGNK 232
            +NP+                             I       +     + LG  K
Sbjct: 301 FSNPVQ-------------------------YWEIQPSTFRCVYVRAAVQLGNYK 330

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 70.8 bits (174), Expect = 3e-13
 Identities = 34/144 (23%), Positives = 59/144 (40%), Gaps = 7/144 (4%)

Query: 294 FLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFS 353
            L+V+      L  +P +     D   L+L +N  +     + +NLK L  +    N  S
Sbjct: 32  HLRVVQCSDLGLEKVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS 89

Query: 354 GIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPV-SLEKLS 412
            I P     L  LE L+L  N+L+  +P+      +L+ L +  N ++  +       L+
Sbjct: 90  KISPGAFAPLVKLERLYLSKNQLK-ELPE--KMPKTLQELRVHENEIT-KVRKSVFNGLN 145

Query: 413 YLKDLNLSFNKLKGEIPRGGSFGN 436
            +  + L  N LK      G+F  
Sbjct: 146 QMIVVELGTNPLKSSGIENGAFQG 169

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  125 bits (315), Expect = 8e-32
 Identities = 60/313 (19%), Positives = 106/313 (33%), Gaps = 76/313 (24%)

Query: 526 TDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRN 584
              F E  ++G+G FG V KAR   D    A+K           +   E  ++ S+ H+ 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQY 63

Query: 585 LVKVISSCSNEEFKA-------------LVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMI 631
           +V+  ++                     + +EY  +G+L   +HS N +    +   +  
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123

Query: 632 DVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA 691
            +  AL Y+H   S  +IH DLKP N+ +D++    + DFG+AK +      +       
Sbjct: 124 QILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180

Query: 692 T---------IG---YMAPE-------YGREGQVSTNGDVYSFGIMLME-------TFTR 725
                     IG   Y+A E       Y  +       D+YS GI+  E          R
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEK------IDMYSLGIIFFEMIYPFSTGMER 234

Query: 726 KKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECT 785
                +L +  +      +D                + +   +                 
Sbjct: 235 VNILKKLRSVSIEFPPDFDDN-------------KMKVEKKIIRL-------------LI 268

Query: 786 VESPEQRINAKEI 798
              P +R  A+ +
Sbjct: 269 DHDPNKRPGARTL 281

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  125 bits (317), Expect = 1e-31
 Identities = 59/305 (19%), Positives = 114/305 (37%), Gaps = 64/305 (20%)

Query: 533 NLIGRGGFGSVYKARIRD------GMEVAVKVFNLQC-GRAFKSFDVECAMMKSI-RHRN 584
             +G G FG V +A           ++VAVK+          ++   E  +M  + +H N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111

Query: 585 LVKVISSCSNEEFKALVLEYMPHGSLEKYL-------------HSSNYSLDIFQRLNIMI 631
           +V ++ +C++     ++ EY  +G L  +L               +N +      L+   
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171

Query: 632 DVASALEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQ 688
            VA  + +L   +       IH D+   NVLL +  VA + DFG+A+ +  +   + +  
Sbjct: 172 QVAQGMAFLASKNC------IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 225

Query: 689 TLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTR-KKPTDELFNGEMTLKHWVNDCL 747
               + +MAPE   +   +   DV+S+GI+L E F+    P    + G +          
Sbjct: 226 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP----YPGILV--------- 272

Query: 748 PISTMEVVDANLLSQEDIHFVAK-------EQCVSFVFNLALECTVESPEQRINAKEIVA 800
                        + +    V               ++++   C    P  R   ++I +
Sbjct: 273 -------------NSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS 319

Query: 801 KLLKI 805
            L + 
Sbjct: 320 FLQEQ 324

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  125 bits (315), Expect = 1e-31
 Identities = 63/282 (22%), Positives = 98/282 (34%), Gaps = 42/282 (14%)

Query: 527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECA------MMKS 579
             F   + +G G +G V+K R + DG   AVK             D            K 
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMS---PFRGPKDRARKLAEVGSHEKV 113

Query: 580 IRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEY 639
            +H   V++  +        L  E     SL+++  +   SL   Q    + D   AL +
Sbjct: 114 GQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAH 172

Query: 640 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAP 698
           LH   S  ++H D+KP+N+ L       L DFG+   L     +    +       YMAP
Sbjct: 173 LH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG----TAGAGEVQEGDPRYMAP 225

Query: 699 EYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDAN 758
           E   +G   T  DV+S G+ ++E     +       GE   +       P  T       
Sbjct: 226 EL-LQGSYGTAADVFSLGLTILEVACNMELP---HGGEGWQQLRQGYLPPEFT------A 275

Query: 759 LLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVA 800
            LS E    +                    P+ R  A+ ++A
Sbjct: 276 GLSSELRSVLVM-------------MLEPDPKLRATAEALLA 304

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  123 bits (311), Expect = 3e-31
 Identities = 48/221 (21%), Positives = 91/221 (41%), Gaps = 29/221 (13%)

Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNL-QCGRAFKSFDVECAMMKSIRHRN 584
             F     +GRGGFG V++A+   D    A+K   L     A +    E   +  + H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 585 LVKVISSCSNEEFKA------------LVLEYMPHGSLEKYLHSSNYS--LDIFQRLNIM 630
           +V+  ++   +                + ++     +L+ +++        +    L+I 
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124

Query: 631 IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTL 690
           + +A A+E+LH   S  ++H DLKPSN+    + V  + DFG+   +  +++  T    +
Sbjct: 125 LQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181

Query: 691 ATIG----------YMAPEYGREGQVSTNGDVYSFGIMLME 721
                         YM+PE       S   D++S G++L E
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE 222

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  124 bits (314), Expect = 3e-31
 Identities = 61/308 (19%), Positives = 103/308 (33%), Gaps = 65/308 (21%)

Query: 535 IGRGGFGSVYKARIRDG------MEVAVKVFNLQCG-RAFKSFDVECAMMKSI-RHRNLV 586
           +G G FG V  A           ++VAVK+   +      ++   E  MM  +  H N+V
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112

Query: 587 KVISSCSNEEFKALVLEYMPHGSLEKYL----------------------HSSNYSLDIF 624
            ++ +C+      L+ EY  +G L  YL                            L   
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172

Query: 625 QRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM 684
             L     VA  +E+L        +H DL   NVL+    V  + DFG+A+ +  +   +
Sbjct: 173 DLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 229

Query: 685 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVN 744
            +      + +MAPE   EG  +   DV+S+GI+L E F+          G         
Sbjct: 230 VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL---------GVN------- 273

Query: 745 DCLPISTMEVVDANLLSQEDIHFVAK-------EQCVSFVFNLALECTVESPEQRINAKE 797
              P   + V             +               ++ +   C      +R +   
Sbjct: 274 ---PYPGIPV------DANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPN 324

Query: 798 IVAKLLKI 805
           + + L   
Sbjct: 325 LTSFLGCQ 332

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  124 bits (313), Expect = 1e-30
 Identities = 37/261 (14%), Positives = 75/261 (28%), Gaps = 52/261 (19%)

Query: 534 LIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCG---------------------------- 564
           ++G+    +  +A     G    V V                                  
Sbjct: 85  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144

Query: 565 RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYM-PHGSLEKYLH------SS 617
           +    F     ++K  + + +++V     +    +    Y     +L+ +        S+
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204

Query: 618 NYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 677
           + SL    RL + + V   L  LH      ++H  L+P +++LD      L+ F      
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261

Query: 678 TGEDQSMTQTQTLATIGYMAPEYGREGQVSTNG-----DVYSFGIMLMETFTRKKPTDEL 732
            G        +  A     A      GQ          D ++ G+ +   +    P    
Sbjct: 262 -GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP---- 316

Query: 733 FNGE--MTLKHWV-NDCLPIS 750
              +  +    W+   C  I 
Sbjct: 317 NTDDAALGGSEWIFRSCKNIP 337

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  124 bits (314), Expect = 1e-30
 Identities = 59/303 (19%), Positives = 110/303 (36%), Gaps = 55/303 (18%)

Query: 527 DKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECA-MMKSIRHRNL 585
           +      ++G G  G+V       G  VAVK   +          +E   + +S  H N+
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNV 71

Query: 586 VKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRL------NIMIDVASALEY 639
           ++   S + + F  + LE     +L+  + S N S +  +        +++  +AS + +
Sbjct: 72  IRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130

Query: 640 LHFGYSAPVIHCDLKPSNVLLD-------------DNMVAHLSDFGIAKLLTGEDQSMTQ 686
           LH   S  +IH DLKP N+L+              +N+   +SDFG+ K L     S   
Sbjct: 131 LH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187

Query: 687 TQTLA--TIGYMAPEYGREGQVSTNG-------DVYSFGIMLMETFTRKKP--TDELFNG 735
                  T G+ APE   E              D++S G +     ++ K    D+    
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247

Query: 736 EMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINA 795
              ++   +    +  M+ +    L  E    +++                  P +R  A
Sbjct: 248 SNIIRGIFS----LDEMKCLHDRSLIAEATDLISQ-------------MIDHDPLKRPTA 290

Query: 796 KEI 798
            ++
Sbjct: 291 MKV 293

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  121 bits (306), Expect = 1e-30
 Identities = 59/198 (29%), Positives = 95/198 (47%), Gaps = 10/198 (5%)

Query: 526 TDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRN 584
             K++    IG+G  G+VY A  +  G EVA++  NLQ     +    E  +M+  ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 585 LVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGY 644
           +V  + S    +   +V+EY+  GSL   +  +   +D  Q   +  +   ALE+LH   
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH--- 133

Query: 645 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGRE 703
           S  VIH D+K  N+LL  +    L+DFG    +T      ++  T+  T  +MAPE    
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT---PEQSKRSTMVGTPYWMAPEVVTR 190

Query: 704 GQVSTNGDVYSFGIMLME 721
                  D++S GIM +E
Sbjct: 191 KAYGPKVDIWSLGIMAIE 208

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  121 bits (306), Expect = 1e-30
 Identities = 65/298 (21%), Positives = 117/298 (39%), Gaps = 59/298 (19%)

Query: 526 TDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRN 584
            + +     +G G FG VYKA+    G   A KV   +     + + VE  ++ +  H  
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77

Query: 585 LVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGY 644
           +VK++ +  ++    +++E+ P G+++  +   +  L   Q   +   +  AL +LH   
Sbjct: 78  IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH--- 134

Query: 645 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIG---YMAPEYG 701
           S  +IH DLK  NVL+       L+DFG++       +++ +  +   IG   +MAPE  
Sbjct: 135 SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL---KTLQKRDSF--IGTPYWMAPEVV 189

Query: 702 REGQVSTNG-----DVYSFGIMLMETFTRKKPTDE------LF----NGEMTLKHWVNDC 746
               +         D++S GI L+E    + P  E      L     +   TL       
Sbjct: 190 MCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLL------ 243

Query: 747 LPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLK 804
                      +  S E   F+                  ++PE R +A +    LL+
Sbjct: 244 ---------TPSKWSVEFRDFLKI-------------ALDKNPETRPSAAQ----LLE 275

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  122 bits (307), Expect = 1e-30
 Identities = 79/293 (26%), Positives = 119/293 (40%), Gaps = 56/293 (19%)

Query: 526 TDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRN 584
            + F     +G G +GSVYKA     G  VA+K   ++     +    E ++M+     +
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPH 85

Query: 585 LVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGY 644
           +VK   S        +V+EY   GS+   +   N +L   +   I+      LEYLH   
Sbjct: 86  VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH--- 142

Query: 645 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIG---YMAPEYG 701
               IH D+K  N+LL+    A L+DFG+A  LT    +M +  T+  IG   +MAPE  
Sbjct: 143 FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLT---DTMAKRNTV--IGTPFWMAPEVI 197

Query: 702 REGQVSTNGDVYSFGIMLMETFTRKKPTDE------LF----NGEMTLKHWVNDCLPIST 751
           +E   +   D++S GI  +E    K P  +      +F    N   T +           
Sbjct: 198 QEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFR----------- 246

Query: 752 MEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLK 804
                  L S     FV +             C V+SPEQR  A +    LL+
Sbjct: 247 ----KPELWSDNFTDFVKQ-------------CLVKSPEQRATATQ----LLQ 278

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  121 bits (304), Expect = 3e-30
 Identities = 52/212 (24%), Positives = 98/212 (46%), Gaps = 26/212 (12%)

Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFN-LQCGRAFKSFDVECAMMKSIRHRN 584
             +  ++++G+G   +V++ R  + G   A+KVFN +   R       E  ++K + H+N
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 585 LVK---VISSCSNEEFKALVLEYMPHGSLEKYL--HSSNYSLDIFQRLNIMIDVASALEY 639
           +VK   +    +      L++E+ P GSL   L   S+ Y L   + L ++ DV   + +
Sbjct: 69  IVKLFAIEEETTTRHK-VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127

Query: 640 LHFGYSAPVIHCDLKPSNVLL----DDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGY 695
           L       ++H ++KP N++     D   V  L+DFG A+ L  ++Q ++      T  Y
Sbjct: 128 LR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL---YGTEEY 181

Query: 696 MAPE-YGREGQVSTNG-------DVYSFGIML 719
           + P+ Y R      +        D++S G+  
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTF 213

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  120 bits (304), Expect = 3e-30
 Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 14/200 (7%)

Query: 526 TDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRN 584
                    IG G  G V  AR    G +VAVK+ +L+  +  +    E  +M+  +H N
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103

Query: 585 LVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGY 644
           +V++  S    E   +++E++  G+L   +      L+  Q   +   V  AL YLH   
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV--RLNEEQIATVCEAVLQALAYLH--- 158

Query: 645 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIG---YMAPEYG 701
           +  VIH D+K  ++LL  +    LSDFG    ++   + + + ++L  +G   +MAPE  
Sbjct: 159 AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQIS---KDVPKRKSL--VGTPYWMAPEVI 213

Query: 702 REGQVSTNGDVYSFGIMLME 721
                +T  D++S GIM++E
Sbjct: 214 SRSLYATEVDIWSLGIMVIE 233

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  122 bits (306), Expect = 3e-30
 Identities = 36/330 (10%), Positives = 78/330 (23%), Gaps = 59/330 (17%)

Query: 508 MPPVATWRRFSYLELFQATDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFN---LQC 563
            P  A     S   L Q   K      +  G    V+  R +    + A+KVF       
Sbjct: 45  WPQNAETTVDS--LLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENS 102

Query: 564 GRAFKSFDVECAMMKSIRHRNLV---------------------KVISSCSNEEFKA--- 599
               +           +   +                               ++  A   
Sbjct: 103 RSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVAN 162

Query: 600 --LVLEYM-----PHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
             L++           S   +++       I     +   +      L    S  ++H  
Sbjct: 163 YLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHGH 219

Query: 653 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY--GREGQVSTNG 710
             P N+ +  +    L D      + G     +       + Y   E+        +   
Sbjct: 220 FTPDNLFIMPDGRLMLGDVSALWKV-GTRGPASSV----PVTYAPREFLNASTATFTHAL 274

Query: 711 DVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAK 770
           + +  G+ +   +    P    F         +       + +     +   + + F + 
Sbjct: 275 NAWQLGLSIYRVWCLFLP----F--------GLVTPGIKGSWKRPSLRVPGTDSLAFGSC 322

Query: 771 EQCVSFVFNLALECTVESPEQRINAKEIVA 800
                FV  L          +R+   E + 
Sbjct: 323 TPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  118 bits (297), Expect = 3e-29
 Identities = 61/310 (19%), Positives = 111/310 (35%), Gaps = 38/310 (12%)

Query: 94  PNLEVLYLWGNNFSGTIPHFIF-NASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDN 152
           P+  +L L  N+ S  +    F     L  L L  N  S      F  LR L+ L +  N
Sbjct: 54  PDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKN 112

Query: 153 NLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYM-YNCNVSG 211
           +L     +L          SL  + + +N +  +    + G    ++    M  N   + 
Sbjct: 113 HLVEIPPNLP--------SSLVELRIHDNRIRKVPKGVFSGL--RNMNCIEMGGNPLENS 162

Query: 212 GIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLS-VE 270
           G      +   L  + +   KL   IP  L   + L ++ L++N+++ +I     L   +
Sbjct: 163 GFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQ-AIELEDLLRYSK 218

Query: 271 LYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSG 330
           LY L LG N++        S +  L+ L L +N+L+ +P     LK +  + L +N    
Sbjct: 219 LYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSRVPAGLPDLKLLQVVYLHTN---- 274

Query: 331 PLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSI--PDSFGDLI 388
                I  +          N+F  +             + L  N +      P +F  + 
Sbjct: 275 ----NITKVGV--------NDFCPVGFGV--KRAYYNGISLFNNPVPYWEVQPATFRCVT 320

Query: 389 SLKSLNLSYN 398
              ++     
Sbjct: 321 DRLAIQFGNY 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  116 bits (293), Expect = 1e-28
 Identities = 71/348 (20%), Positives = 121/348 (34%), Gaps = 78/348 (22%)

Query: 95  NLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNL 154
           +L V+          +P  I      + L L+ N  S      F  L++L  L L +N +
Sbjct: 34  HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90

Query: 155 TSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIP 214
           +          + S  + L  + +S N L  I P     NL  SL    +++  +   +P
Sbjct: 91  SKIHEK-----AFSPLRKLQKLYISKNHLVEIPP-----NLPSSLVELRIHDNRIRK-VP 139

Query: 215 EEI-TNLTDLTTIVLGGNKL-NGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELY 272
           + + + L ++  I +GGN L N           KL  + +   +L   IP  +  +  L 
Sbjct: 140 KGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDLPET--LN 196

Query: 273 ELELGGNKLSGSIPA-CFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGP 331
           EL L  NK+  +I        + L  L LG N++  I                +   S  
Sbjct: 197 ELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIE---------------NGSLSF- 239

Query: 332 LPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLK 391
                                          L  L  L L+ N+L   +P    DL  L+
Sbjct: 240 -------------------------------LPTLRELHLDNNKLS-RVPAGLPDLKLLQ 267

Query: 392 SLNLSYNNLSGTIPVS-------LEKLSYLKDLNLSFNKLK-GEIPRG 431
            + L  NN++  + V+         K +Y   ++L  N +   E+   
Sbjct: 268 VVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPA 314

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  113 bits (284), Expect = 2e-27
 Identities = 64/310 (20%), Positives = 108/310 (34%), Gaps = 54/310 (17%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHE--IGHLHNLGFLDLSQNKLLGTIPA 63
           NN ++     +   + +L  L L NN++    IHE     L  L  L +S+N  L  IP 
Sbjct: 63  NNDISELRKDDFKGLQHLYALVLVNNKIS--KIHEKAFSPLRKLQKLYISKNH-LVEIPP 119

Query: 64  AIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNF-SGTIPHFIFNASKLSK 122
            +   S+L    + +N +   +      GL N+  + + GN   +       F+  KL+ 
Sbjct: 120 NLP--SSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNY 176

Query: 123 LALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNP 182
           L +     +G IP        L  L L  N + +  L+      L     L  + L +N 
Sbjct: 177 LRISEAKLTG-IPK--DLPETLNELHLDHNKIQAIELE-----DLLRYSKLYRLGLGHNQ 228

Query: 183 LDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLG 242
           +  I   +                          ++ L  L  + L  NKL+  +P  L 
Sbjct: 229 IRMIENGS--------------------------LSFLPTLRELHLDNNKLS-RVPAGLP 261

Query: 243 KLQKLQDVDLEYNQLEGSIPDSI-------CLSVELYELELGGNKLSGSI--PACFSNMT 293
            L+ LQ V L  N +   +  +                + L  N +      PA F  +T
Sbjct: 262 DLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVT 320

Query: 294 FLKVLSLGSN 303
               +  G+ 
Sbjct: 321 DRLAIQFGNY 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 70.0 bits (172), Expect = 6e-13
 Identities = 30/143 (20%), Positives = 51/143 (35%), Gaps = 5/143 (3%)

Query: 294 FLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFS 353
            L+V+      L ++P       D   L+L +N  S     + + L+ L  +    N  S
Sbjct: 34  HLRVVQCSDLGLKAVPKEI--SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS 91

Query: 354 GIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSY 413
            I       L+ L+ L++  N L   IP       SL  L +  N +          L  
Sbjct: 92  KIHEKAFSPLRKLQKLYISKNHLV-EIPP--NLPSSLVELRIHDNRIRKVPKGVFSGLRN 148

Query: 414 LKDLNLSFNKLKGEIPRGGSFGN 436
           +  + +  N L+      G+F  
Sbjct: 149 MNCIEMGGNPLENSGFEPGAFDG 171

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  119 bits (299), Expect = 6e-29
 Identities = 52/212 (24%), Positives = 98/212 (46%), Gaps = 26/212 (12%)

Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFN-LQCGRAFKSFDVECAMMKSIRHRN 584
             +  ++++G+G   +V++ R  + G   A+KVFN +   R       E  ++K + H+N
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 585 LVK---VISSCSNEEFKALVLEYMPHGSLEKYL--HSSNYSLDIFQRLNIMIDVASALEY 639
           +VK   +    +      L++E+ P GSL   L   S+ Y L   + L ++ DV   + +
Sbjct: 69  IVKLFAIEEETTTRHK-VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127

Query: 640 LHFGYSAPVIHCDLKPSNVLL----DDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGY 695
           L       ++H ++KP N++     D   V  L+DFG A+ L  ++Q ++      T  Y
Sbjct: 128 LR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL---YGTEEY 181

Query: 696 MAPE-YGREGQVSTNG-------DVYSFGIML 719
           + P+ Y R      +        D++S G+  
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTF 213

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  116 bits (293), Expect = 7e-29
 Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 15/208 (7%)

Query: 526 TDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNL-QCGRAFKSFDVECAMMKSIRHR 583
            + F++   IG+G FG V+K    R    VA+K+ +L +     +    E  ++      
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80

Query: 584 NLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFG 643
            + K   S   +    +++EY+  GS    L      LD  Q   I+ ++   L+YLH  
Sbjct: 81  YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG--PLDETQIATILREILKGLDYLH-- 136

Query: 644 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIG---YMAPEY 700
            S   IH D+K +NVLL ++    L+DFG+A  LT    +  +  T   +G   +MAPE 
Sbjct: 137 -SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT---DTQIKRNTF--VGTPFWMAPEV 190

Query: 701 GREGQVSTNGDVYSFGIMLMETFTRKKP 728
            ++    +  D++S GI  +E    + P
Sbjct: 191 IKQSAYDSKADIWSLGITAIELARGEPP 218

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  117 bits (295), Expect = 1e-28
 Identities = 39/237 (16%), Positives = 75/237 (31%), Gaps = 26/237 (10%)

Query: 526 TDKFSENNLIGRGGFGSVYKARIRD------GMEVAVKVFNLQCGRAFKSFDVECAMMKS 579
           +     ++L+G G F  VY+A   D        +  +KV        F         +K 
Sbjct: 64  SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123

Query: 580 IRHRNLVKVISSCSNEEFKALVLEYMPHGSL----EKYLHSSNYSLDIFQRLNIMIDVAS 635
                 +K  S+   +    LV E   +G+L      Y ++    +     ++  + +  
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183

Query: 636 ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH-----------LSDFGIAKLLTGEDQSM 684
            +E +H      +IH D+KP N +L +  +             L D G +  +    +  
Sbjct: 184 MIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240

Query: 685 TQTQTLATIGYMAPEYGREGQVSTNG-DVYSFGIMLMETFTRKKPTDELFNGEMTLK 740
             T    T G+   E     +      D +     +           +   GE   +
Sbjct: 241 IFTAKCETSGFQCVEM-LSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPE 296

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  121 bits (304), Expect = 1e-28
 Identities = 59/237 (24%), Positives = 95/237 (40%), Gaps = 31/237 (13%)

Query: 524 QATDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQ-CGRAFKSFDVECAMMKSIR 581
           Q    +     +G GGFG V +      G +VA+K    +   +  + + +E  +MK + 
Sbjct: 11  QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN 70

Query: 582 HRNLVKVI------SSCSNEEFKALVLEYMPHGSLEKYL--HSSNYSLDIFQRLNIMIDV 633
           H N+V            +  +   L +EY   G L KYL    +   L       ++ D+
Sbjct: 71  HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDI 130

Query: 634 ASALEYLHFGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLTGEDQSMTQTQTL 690
           +SAL YLH      +IH DLKP N++L      ++  + D G AK L  +   +     +
Sbjct: 131 SSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEF-V 184

Query: 691 ATIGYMAPE------YGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKH 741
            T+ Y+APE      Y          D +SFG +  E  T  +P    +        
Sbjct: 185 GTLQYLAPELLEQKKYTVT------VDYWSFGTLAFECITGFRPFLPNWQPVQWHGK 235

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  116 bits (292), Expect = 2e-28
 Identities = 68/301 (22%), Positives = 113/301 (37%), Gaps = 52/301 (17%)

Query: 534 LIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIR-HRNLVKVISS 591
           ++  GGF  VY+A+ +  G E A+K          ++   E   MK +  H N+V+  S+
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94

Query: 592 CS-------NEEFKALVLEYMPHGSLEKYL--HSSNYSLDIFQRLNIMIDVASALEYLHF 642
            S         + + L+L  +  G L ++L    S   L     L I      A++++H 
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH- 153

Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA----------T 692
               P+IH DLK  N+LL +     L DFG A  ++         Q  A          T
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213

Query: 693 IGYMAPE----YGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLP 748
             Y  PE    Y     +    D+++ G +L     R+ P    F     L+        
Sbjct: 214 PMYRTPEIIDLYSNFP-IGEKQDIWALGCILYLLCFRQHP----FEDGAKLR-------- 260

Query: 749 ISTMEVVDANLLSQEDIHFVAKEQCVSFVF-NLALECTVESPEQRINAKEIVAKLLKIRD 807
                +V+                    VF +L       +PE+R++  E+V +L +I  
Sbjct: 261 -----IVNGKYSIPPHDTQ-------YTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308

Query: 808 S 808
           +
Sbjct: 309 A 309

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  116 bits (292), Expect = 2e-28
 Identities = 59/352 (16%), Positives = 119/352 (33%), Gaps = 63/352 (17%)

Query: 64  AIFNVSTLKAFAVTNNSL----SGCLSSITDVGL--------PNLEVLYLWGNNFSGTIP 111
            +  + +L     +N +        +   +   L          ++ L L  N  +  I 
Sbjct: 10  VLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRIT-YIS 68

Query: 112 HFIF-NASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNC 170
           +        L  L L  N  +     +F +L +LE L L  N L++  L  S+   LS+ 
Sbjct: 69  NSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSN--LSSSWFKPLSS- 125

Query: 171 KSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEI-TNLTDLTTIVLG 229
             LT ++L  NP   +   +   +L+  L+   + N +    I  +    LT L  + + 
Sbjct: 126 --LTFLNLLGNPYKTLGETSLFSHLT-KLQILRVGNMDTFTKIQRKDFAGLTFLEELEID 182

Query: 230 GNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACF 289
            + L    P +L  +Q +  + L   Q    + +                          
Sbjct: 183 ASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIF-----------------------V 218

Query: 290 SNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSM 349
              + ++ L L   +L +   +           LS+   +      +        +  + 
Sbjct: 219 DVTSSVECLELRDTDLDTFHFS----------ELSTGETNS-----LIKKFTFRNVKITD 263

Query: 350 NNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDS-FGDLISLKSLNLSYNNL 400
            +   ++ + +  +  L  L    N+L+ S+PD  F  L SL+ + L  N  
Sbjct: 264 ESLFQVMKL-LNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPW 313

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  109 bits (275), Expect = 4e-26
 Identities = 61/368 (16%), Positives = 111/368 (30%), Gaps = 61/368 (16%)

Query: 62  PAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLS 121
           P  ++ V  L      +   S   +S   +      +      + + +IP  +     + 
Sbjct: 2   PHTLWMVWVLGVIISLSKEESSNQAS---LSCDRNGICKGSSGSLN-SIPSGLT--EAVK 55

Query: 122 KLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNN 181
            L L  N  +    S      NL+ L L  N + +  ++    SSL +   L H+ LS N
Sbjct: 56  SLDLSNNRITYISNSDLQRCVNLQALVLTSNGINT--IEEDSFSSLGS---LEHLDLSYN 110

Query: 182 PLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIP--I 239
            L  +    +                            L+ LT + L GN    ++    
Sbjct: 111 YLSNLSSSWF--------------------------KPLSSLTFLNLLGNPYK-TLGETS 143

Query: 240 TLGKLQKLQDVDLEYNQLEGSIPDSICLS-VELYELELGGNKLSGSIPACFSNMTFLKVL 298
               L KLQ + +        I          L ELE+  + L    P    ++  +  L
Sbjct: 144 LFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHL 203

Query: 299 SLGSNELTSIPLN-FWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIP 357
            L   +   +          +  L L          L+  +   L   +   N+      
Sbjct: 204 ILHMKQHILLLEIFVDVTSSVECLELRDT------DLDTFHFSELSTGET--NSLIK--- 252

Query: 358 MEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVS-LEKLSYLKD 416
                     N+ +    L   +      +  L  L  S N L  ++P    ++L+ L+ 
Sbjct: 253 -----KFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQK 305

Query: 417 LNLSFNKL 424
           + L  N  
Sbjct: 306 IWLHTNPW 313

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  108 bits (271), Expect = 1e-25
 Identities = 57/326 (17%), Positives = 105/326 (32%), Gaps = 80/326 (24%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHE--IGHLHNLGFLDLSQNKLLGTIPA 63
           NN +T  +  ++    NL+ L L +N +    I E     L +L  LDLS N  L  + +
Sbjct: 61  NNRITYISNSDLQRCVNLQALVLTSNGIN--TIEEDSFSSLGSLEHLDLSYNY-LSNLSS 117

Query: 64  AIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNA-SKLSK 122
           + F                          L +L  L L GN +       +F+  +KL  
Sbjct: 118 SWFK------------------------PLSSLTFLNLLGNPYKTLGETSLFSHLTKLQI 153

Query: 123 LALEMNSFSGFIPS-TFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNN 181
           L +        I    F  L  LE L +  ++L S         SL + ++++H+ L   
Sbjct: 154 LRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPK-----SLKSIQNVSHLILHMK 208

Query: 182 PLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITL 241
               +L                                 + +  + L    L+       
Sbjct: 209 QHILLLEIFV--------------------------DVTSSVECLELRDTDLDT------ 236

Query: 242 GKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLG 301
                       +++L     +S+        +++    L   +    + ++ L  L   
Sbjct: 237 ----------FHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFS 285

Query: 302 SNELTSIPLN-FWSLKDILDLNLSSN 326
            N+L S+P   F  L  +  + L +N
Sbjct: 286 RNQLKSVPDGIFDRLTSLQKIWLHTN 311

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 97.9 bits (244), Expect = 4e-22
 Identities = 46/240 (19%), Positives = 88/240 (36%), Gaps = 21/240 (8%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHE--IGHLHNLGFLDLSQNKLLGTIPA 63
           +N + +       ++ +L+ L L  N L    +       L +L FL+L  N        
Sbjct: 85  SNGINTIEEDSFSSLGSLEHLDLSYNYLS--NLSSSWFKPLSSLTFLNLLGNPYKTLGET 142

Query: 64  AIF-NVSTLKAFAVTNNSLSGCLSSITD---VGLPNLEVLYLWGNNFSGTIPHFIF-NAS 118
           ++F +++ L+   V N       + I      GL  LE L +  ++   +       +  
Sbjct: 143 SLFSHLTKLQILRVGNMDT---FTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQ 198

Query: 119 KLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTS---STLDLSFLSSLSNCKSLTH 175
            +S L L M      +        ++E L L D +L +   S L     +SL    +  +
Sbjct: 199 NVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRN 258

Query: 176 ISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEI-TNLTDLTTIVLGGNKLN 234
           + +++  L  ++       +S  L         +   +P+ I   LT L  I L  N  +
Sbjct: 259 VKITDESLFQVMKLLN--QIS-GLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNPWD 314

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 46.7 bits (111), Expect = 2e-05
 Identities = 18/68 (26%), Positives = 33/68 (48%), Gaps = 3/68 (4%)

Query: 365 NLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPV-SLEKLSYLKDLNLSFNK 423
            +++L L  NR+           ++L++L L+ N ++ TI   S   L  L+ L+LS+N 
Sbjct: 53  AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNY 111

Query: 424 LKGEIPRG 431
           L   +   
Sbjct: 112 LS-NLSSS 118

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  115 bits (289), Expect = 2e-28
 Identities = 68/299 (22%), Positives = 112/299 (37%), Gaps = 47/299 (15%)

Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNL-QCGRAFKSFDVECAMMKSIRHRN 584
           D +    +IG G    V  A       +VA+K  NL +C  +      E   M    H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74

Query: 585 LVKVISSCSNEEFKALVLEYMPHGSL-EKYLHSSNYSLDIFQRLN------IMIDVASAL 637
           +V   +S   ++   LV++ +  GS+ +   H           L+      I+ +V   L
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134

Query: 638 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIG--- 694
           EYLH       IH D+K  N+LL ++    ++DFG++  L               +G   
Sbjct: 135 EYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191

Query: 695 YMAPEYGREGQV-STNGDVYSFGIMLMET------FTRKKPTDELFNGEMTLKHWVND-- 745
           +MAPE   + +      D++SFGI  +E       + +  P   L    +TL+   ND  
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM---LTLQ---NDPP 245

Query: 746 CLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLK 804
            L     +        +     ++              C  + PE+R  A E    LL+
Sbjct: 246 SLETGVQDKEMLKKYGKSFRKMISL-------------CLQKDPEKRPTAAE----LLR 287

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  119 bits (300), Expect = 3e-28
 Identities = 68/318 (21%), Positives = 114/318 (35%), Gaps = 55/318 (17%)

Query: 109 TIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLS 168
           +I   I N   LS+ +   N+ SG     F      E   L   N          +S L 
Sbjct: 2   SIMLPINNNFSLSQNSFY-NTISGTYADYFSAWDKWEKQALPGENRNE------AVSLLK 54

Query: 169 NC--KSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTI 226
            C     + + L+   L   LP     NL   +    +    +   +PE   +L  L   
Sbjct: 55  ECLINQFSELQLNRLNLS-SLPD----NLPPQITVLEITQNALIS-LPELPASLEYLD-- 106

Query: 227 VLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIP 286
               N+L+ ++P     L+ L   D++ NQL   +P+   L   L  +    N+L+  +P
Sbjct: 107 -ACDNRLS-TLPELPASLKHL---DVDNNQLT-MLPELPAL---LEYINADNNQLT-MLP 156

Query: 287 ACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEID 346
              ++   L+VLS+ +N+LT +P    SL+    L++S+N     LP             
Sbjct: 157 ELPTS---LEVLSVRNNQLTFLPELPESLEA---LDVSTNLLES-LPAVPVRNHHS---- 205

Query: 347 FSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPV 406
                            +         NR+   IP++   L    ++ L  N LS  I  
Sbjct: 206 ----------------EETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRE 248

Query: 407 SLEKLSYLKDLNLSFNKL 424
           SL + +   D +      
Sbjct: 249 SLSQQTAQPDYHGPRIYF 266

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  109 bits (273), Expect = 6e-25
 Identities = 58/327 (17%), Positives = 105/327 (32%), Gaps = 60/327 (18%)

Query: 37  IIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNL 96
           I+  I +  +L   +   N + GT           +  A+   + +  +S + +  +   
Sbjct: 3   IMLPINNNFSLS-QNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQF 61

Query: 97  EVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTS 156
             L L   N S ++P  +    +++ L +  N+    +P    +L  L+     DN L++
Sbjct: 62  SELQLNRLNLS-SLPDNLP--PQITVLEITQNALI-SLPELPASLEYLD---ACDNRLST 114

Query: 157 STLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEE 216
                      ++ K L    + NN L  +                           PE 
Sbjct: 115 ------LPELPASLKHL---DVDNNQLTML---------------------------PEL 138

Query: 217 ITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELEL 276
              L  +       N+L   +P     L+ L    +  NQL   +P+       L  L++
Sbjct: 139 PALLEYIN---ADNNQLT-MLPELPTSLEVL---SVRNNQLT-FLPELP---ESLEALDV 187

Query: 277 GGNKLSGSIPACFSNMTFLK----VLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPL 332
             N L  S+PA        +          N +T IP N  SL     + L  N  S  +
Sbjct: 188 STNLLE-SLPAVPVRNHHSEETEIFFRCRENRITHIPENILSLDPTCTIILEDNPLSSRI 246

Query: 333 PLEIRNLKALIEIDFSMNNFSGIIPME 359
              +    A  +       FS     +
Sbjct: 247 RESLSQQTAQPDYHGPRIYFSMSDGQQ 273

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  104 bits (260), Expect = 3e-23
 Identities = 69/437 (15%), Positives = 127/437 (29%), Gaps = 73/437 (16%)

Query: 11  STTPKEI----DNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIF 66
           S T  +     D      +     N     +  +   ++    L L++   L ++P  + 
Sbjct: 23  SGTYADYFSAWDKWEKQALPGENRNEAVSLL--KECLINQFSELQLNRLN-LSSLPDNLP 79

Query: 67  NVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALE 126
               +    +T N+L             +LE L    N  S T+P    +   L  L ++
Sbjct: 80  --PQITVLEITQNALISLPELPA-----SLEYLDACDNRLS-TLPELPAS---LKHLDVD 128

Query: 127 MNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGI 186
            N  +  +P     L  +      +N LT        L  L    SL  +S+ NN L   
Sbjct: 129 NNQLT-MLPELPALLEYIN---ADNNQLTM-------LPEL--PTSLEVLSVRNNQL--- 172

Query: 187 LPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQK 246
                                     +PE   +L  L    +  N L  S+P    +   
Sbjct: 173 ------------------------TFLPELPESLEALD---VSTNLLE-SLPAVPVRNHH 204

Query: 247 LQDV----DLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGS 302
            ++         N++   IP++I        + L  N LS S      +    +    G 
Sbjct: 205 SEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLS-SRIRESLSQQTAQPDYHGP 262

Query: 303 NELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGS 362
               S+     +       +  +  F      ++  +    E +   N FS  +   +  
Sbjct: 263 RIYFSMSDGQQNTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFSAFL-DRLSD 321

Query: 363 LKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFN 422
             +  N      ++   +      L +   L      ++     S E    L   NL   
Sbjct: 322 TVSARNTSGFREQVAAWLE----KLSASAELRQQSFAVAADATESCEDRVALTWNNLRKT 377

Query: 423 KLKGEIPRGGSFGNFSA 439
            L  +   G    +  A
Sbjct: 378 LLVHQASEGLFDNDTGA 394

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 85.8 bits (212), Expect = 2e-17
 Identities = 45/193 (23%), Positives = 78/193 (40%), Gaps = 24/193 (12%)

Query: 236 SIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGG---NKLSGSIPACFSNM 292
           SI + +     L   +  YN + G+  D      +  +  L G   N+    +  C   +
Sbjct: 2   SIMLPINNNFSLS-QNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--I 58

Query: 293 TFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNF 352
                L L    L+S+P N      I  L ++ N     LP    +L+ L   D   N  
Sbjct: 59  NQFSELQLNRLNLSSLPDNL--PPQITVLEITQNALI-SLPELPASLEYL---DACDNRL 112

Query: 353 SGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLS 412
           S  +P    SLK+L+   ++ N+L   +P+       L+ +N   N L+  +P   E  +
Sbjct: 113 S-TLPELPASLKHLD---VDNNQLT-MLPELPA---LLEYINADNNQLT-MLP---ELPT 160

Query: 413 YLKDLNLSFNKLK 425
            L+ L++  N+L 
Sbjct: 161 SLEVLSVRNNQLT 173

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 55.7 bits (134), Expect = 4e-08
 Identities = 30/179 (16%), Positives = 53/179 (29%), Gaps = 18/179 (10%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAI 65
           NN LT          ++L+VL + NN+L   +      L     LD+S N  L ++PA  
Sbjct: 149 NNQLTMLPEL----PTSLEVLSVRNNQLT-FLPELPESLEA---LDVSTNL-LESLPAVP 199

Query: 66  FNVSTLKAFAVT----NNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLS 121
                 +   +      N ++    +I    L     + L  N  S  I   +   +   
Sbjct: 200 VRNHHSEETEIFFRCRENRITHIPENILS--LDPTCTIILEDNPLSSRIRESLSQQTAQP 257

Query: 122 KLALEMNSFSGFIPSTFGNLRNLEWL---TLYDNNLTSSTLDLSFLSSLSNCKSLTHIS 177
                   FS          R L         +N  +  +          +  + +   
Sbjct: 258 DYHGPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFSAFL 316

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  113 bits (286), Expect = 8e-28
 Identities = 73/283 (25%), Positives = 106/283 (37%), Gaps = 40/283 (14%)

Query: 535 IGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRA-FKSFDVECA-MMKSIRHRNLVKVISS 591
           IGRG +GSV K      G  +AVK           K   ++   +M+S     +V+   +
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89

Query: 592 CSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLN------IMIDVASALEYLHFGYS 645
              E    + +E M   S +K+       LD    +       I +    AL +L     
Sbjct: 90  LFREGDCWICMELMS-TSFDKFYKYVYSVLD--DVIPEEILGKITLATVKALNHLKENLK 146

Query: 646 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPE----YG 701
             +IH D+KPSN+LLD +    L DFGI+  L     S+ +T+      YMAPE      
Sbjct: 147 --IIHRDIKPSNILLDRSGNIKLCDFGISGQLV---DSIAKTRDAGCRPYMAPERIDPSA 201

Query: 702 REGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLS 761
                    DV+S GI L E  T + P  +  +    L   V    P   +   +    S
Sbjct: 202 SRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPP--QLSNSEEREFS 259

Query: 762 QEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLK 804
              I+FV               C  +   +R   KE    LLK
Sbjct: 260 PSFINFVNL-------------CLTKDESKRPKYKE----LLK 285

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  112 bits (283), Expect = 9e-28
 Identities = 54/197 (27%), Positives = 94/197 (47%), Gaps = 23/197 (11%)

Query: 534 LIGRGGFGSVYKAR-IRDGMEVAVKVFN---LQCGRAFKSFDVECAMMKSIRHRNLVKVI 589
           L+G+G F  VY+A  I  G+EVA+K+ +   +      +    E  +   ++H +++++ 
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77

Query: 590 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVI 649
           +   +  +  LVLE   +G + +YL +        +  + M  + + + YLH   S  ++
Sbjct: 78  NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGIL 134

Query: 650 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTL-ATIGYMAPE------YGR 702
           H DL  SN+LL  NM   ++DFG+A  L    +      TL  T  Y++PE      +G 
Sbjct: 135 HRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH---YTLCGTPNYISPEIATRSAHGL 191

Query: 703 EGQVSTNGDVYSFGIML 719
           E       DV+S G M 
Sbjct: 192 E------SDVWSLGCMF 202

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  112 bits (283), Expect = 2e-27
 Identities = 61/235 (25%), Positives = 100/235 (42%), Gaps = 29/235 (12%)

Query: 507 NMPPVATWRRFSYLELFQATD---KFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQ 562
           +M   +  R    ++L    D    F    L+G G +G VYK R ++ G   A+KV ++ 
Sbjct: 1   SMASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT 60

Query: 563 CGRAFKSFDVECAMMKSI-RHRNLVKVISSCSNEEFKA------LVLEYMPHGSLEKYLH 615
            G   +    E  M+K    HRN+     +   +          LV+E+   GS+   + 
Sbjct: 61  -GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK 119

Query: 616 SS-NYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIA 674
           ++   +L       I  ++   L +LH      VIH D+K  NVLL +N    L DFG++
Sbjct: 120 NTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVS 176

Query: 675 KLLTGEDQSMTQTQTLATIG---YMAPEYGREGQVSTNG-----DVYSFGIMLME 721
             L    +++ +  T   IG   +MAPE     +          D++S GI  +E
Sbjct: 177 AQLD---RTVGRRNTF--IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 226

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  111 bits (280), Expect = 3e-27
 Identities = 55/300 (18%), Positives = 105/300 (35%), Gaps = 59/300 (19%)

Query: 526 TDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDV---ECAMMKSIR 581
           T +F E   IG G FGSV+K     DG   A+K        +    +      A     +
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 582 HRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIF---QRLNIMIDVASALE 638
           H ++V+  S+ + ++   +  EY   GSL   +  +   +  F   +  ++++ V   L 
Sbjct: 70  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129

Query: 639 YLHFGYSAPVIHCDLKPSNVLLDDN-------------------MVAHLSDFGIAKLLTG 679
           Y+H   S  ++H D+KPSN+ +                      ++  + D G    +  
Sbjct: 130 YIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI-- 184

Query: 680 EDQSMTQTQTLATIGYMAPEYGREGQVSTN-GDVYSFGIMLMETFTRKKPTDELFNGEMT 738
              S  Q +      ++A E  +E        D+++  + ++     +       NG+  
Sbjct: 185 ---SSPQVEE-GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL---PRNGDQW 237

Query: 739 LKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEI 798
            +        I  +       LSQE    +                    PE+R +A  +
Sbjct: 238 HEIRQGRLPRIPQV-------LSQEFTELLKV-------------MIHPDPERRPSAMAL 277

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  112 bits (282), Expect = 5e-27
 Identities = 63/242 (26%), Positives = 97/242 (40%), Gaps = 32/242 (13%)

Query: 499 EKGPPNDPNMPPVATWRRFSYLELFQATDKFSENN---------LIGRGGFGSVYKAR-I 548
            +       M P+    R   L+     + F +++          IG G FG+VY AR +
Sbjct: 17  TENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDV 76

Query: 549 RDGMEVAVKVFNLQCGRA---FKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYM 605
           R+   VA+K  +    ++   ++    E   ++ +RH N ++       E    LV+EY 
Sbjct: 77  RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC 136

Query: 606 PHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMV 665
             GS    L      L   +   +       L YLH   S  +IH D+K  N+LL +  +
Sbjct: 137 L-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGL 192

Query: 666 AHLSDFGIAKLLTGEDQSMTQTQTLATIG---YMAPE---YGREGQVSTNGDVYSFGIML 719
             L DFG A         M    +   +G   +MAPE      EGQ     DV+S GI  
Sbjct: 193 VKLGDFGSA-------SIMAPANSF--VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC 243

Query: 720 ME 721
           +E
Sbjct: 244 IE 245

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  110 bits (277), Expect = 6e-27
 Identities = 51/212 (24%), Positives = 90/212 (42%), Gaps = 38/212 (17%)

Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFN---LQCGRAFKSFDVECAMMKSIRH 582
           + F     +G+G FG+VY AR  +    +A+KV     L+          E  +   +RH
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68

Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLN------IMIDVASA 636
            N++++     +     L+LEY P G++ + L           + +       + ++A+A
Sbjct: 69  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL-------SKFDEQRTATYITELANA 121

Query: 637 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTL-ATIGY 695
           L Y H   S  VIH D+KP N+LL       ++DFG +           +   L  T+ Y
Sbjct: 122 LSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-----RRTDLCGTLDY 173

Query: 696 MAPE------YGREGQVSTNGDVYSFGIMLME 721
           + PE      +  +       D++S G++  E
Sbjct: 174 LPPEMIEGRMHDEK------VDLWSLGVLCYE 199

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  112 bits (281), Expect = 7e-27
 Identities = 38/265 (14%), Positives = 84/265 (31%), Gaps = 59/265 (22%)

Query: 534 LIGRGGFGSVYKAR-IRDGMEVAVKVFNL----------------QCGRAFK-------- 568
           ++G+    +  +A     G    V V                      R  +        
Sbjct: 80  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 569 ----SFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYM-PHGSLEKYLH------SS 617
                F     ++K  + + +++V     +    +    Y     +L+ +        S+
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 618 NYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 677
           + SL    RL + + V   L  LH      ++H  L+P +++LD      L+ F      
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV-- 254

Query: 678 TGEDQSMTQTQTLATIGYMAPEY-----------GREGQVSTNGDVYSFGIMLMETFTRK 726
              D +   +    + G+  PE             R   ++ + D ++ G+++   +   
Sbjct: 255 --RDGARVVSSV--SRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310

Query: 727 KPTDELFNGEMTLKHWV-NDCLPIS 750
            P  +  +  +    W+   C  I 
Sbjct: 311 LPITK--DAALGGSEWIFRSCKNIP 333

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  112 bits (281), Expect = 7e-27
 Identities = 51/204 (25%), Positives = 93/204 (45%), Gaps = 9/204 (4%)

Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRA-FKSFDVECAMMKSIRHRN 584
           D F + + +G G  G V+K      G+ +A K+ +L+   A       E  ++       
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92

Query: 585 LVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGY 644
           +V    +  ++   ++ +E+M  GSL++ L  +   +       + I V   L YL   +
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKH 151

Query: 645 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG 704
              ++H D+KPSN+L++      L DFG++  L     SM  +  + T  YM+PE  +  
Sbjct: 152 K--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSPERLQGT 205

Query: 705 QVSTNGDVYSFGIMLMETFTRKKP 728
             S   D++S G+ L+E    + P
Sbjct: 206 HYSVQSDIWSMGLSLVEMAVGRYP 229

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  110 bits (277), Expect = 9e-27
 Identities = 55/265 (20%), Positives = 98/265 (36%), Gaps = 15/265 (5%)

Query: 168 SNCK-SLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTI 226
           S C  S T I  ++  L  + P      +  S     + +  +          LT LT +
Sbjct: 3   SRCSCSGTEIRCNSKGLTSV-PT----GIPSSATRLELESNKLQSLPHGVFDKLTQLTKL 57

Query: 227 VLGGNKLN--GSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGS 284
            L  N L+  G    +      L+ +DL +N +  ++  +     +L  L+   + L   
Sbjct: 58  SLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-Q 115

Query: 285 IPAC--FSNMTFLKVLSLGSNELTSIPLN-FWSLKDILDLNLSSNCFSGPLPLEI-RNLK 340
           +     F ++  L  L +            F  L  +  L ++ N F      +I   L+
Sbjct: 116 MSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELR 175

Query: 341 ALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNL 400
            L  +D S      + P    SL +L+ L + +N         +  L SL+ L+ S N++
Sbjct: 176 NLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHI 235

Query: 401 SGTIPVSLEKL-SYLKDLNLSFNKL 424
             +    L+   S L  LNL+ N  
Sbjct: 236 MTSKKQELQHFPSSLAFLNLTQNDF 260

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  110 bits (276), Expect = 1e-26
 Identities = 54/312 (17%), Positives = 93/312 (29%), Gaps = 63/312 (20%)

Query: 95  NLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNL 154
           +   +       + ++P  I   S  ++L LE N         F  L  L  L+L  N L
Sbjct: 8   SGTEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGL 64

Query: 155 TSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIP 214
           +            ++   L ++ LS N +                             + 
Sbjct: 65  SFKGCCSQSDFGTTS---LKYLDLSFNGV---------------------------ITMS 94

Query: 215 EEITNLTDLTTIVLGGNKLNGSIPI-TLGKLQKLQDVDLEYNQLEGSIPDSICLS-VELY 272
                L  L  +    + L           L+ L  +D+ +        + I      L 
Sbjct: 95  SNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLE 153

Query: 273 ELELGGNKLSGSIPA-CFSNMTFLKVLSLGSNELTSIPLN-FWSLKDILDLNLSSNCFSG 330
            L++ GN    +     F+ +  L  L L   +L  +    F SL  +  LN+S N    
Sbjct: 154 VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHN---- 209

Query: 331 PLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLI-S 389
                  N  +L         +          L +L+ L    N +  S          S
Sbjct: 210 -------NFFSL-----DTFPYKC--------LNSLQVLDYSLNHIMTSKKQELQHFPSS 249

Query: 390 LKSLNLSYNNLS 401
           L  LNL+ N+ +
Sbjct: 250 LAFLNLTQNDFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  105 bits (263), Expect = 7e-25
 Identities = 56/312 (17%), Positives = 89/312 (28%), Gaps = 87/312 (27%)

Query: 21  SNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKL-LGTIPAAIFNVSTLKAFAVTNN 79
           S+   L L +N+LQ         L  L  L LS N L      +                
Sbjct: 28  SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDF------------ 75

Query: 80  SLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFG 139
                       G  +L+ L L  N                             + S F 
Sbjct: 76  ------------GTTSLKYLDLSFNGVIT-------------------------MSSNFL 98

Query: 140 NLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSL 199
            L  LE L    +NL      +S  S   + ++L ++ +S+          +        
Sbjct: 99  GLEQLEHLDFQHSNLKQ----MSEFSVFLSLRNLIYLDISHTHTRVAFNGIF-------- 146

Query: 200 KNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSI-PITLGKLQKLQDVDLEYNQLE 258
                               L+ L  + + GN    +  P    +L+ L  +DL   QLE
Sbjct: 147 ------------------NGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 188

Query: 259 GSIPDSI--CLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLN-FWSL 315
             +  +    LS  L  L +  N         +  +  L+VL    N + +         
Sbjct: 189 -QLSPTAFNSLS-SLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHF 246

Query: 316 KDIL-DLNLSSN 326
              L  LNL+ N
Sbjct: 247 PSSLAFLNLTQN 258

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 98.5 bits (246), Expect = 1e-22
 Identities = 51/282 (18%), Positives = 85/282 (30%), Gaps = 62/282 (21%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQGEII--HEIGHLHNLGFLDLSQNKLLGTIPA 63
           +N L S      D ++ L  L L +N L  +           +L +LDLS N ++ T+ +
Sbjct: 37  SNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSS 95

Query: 64  AIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIF-NASKLSK 122
                                       GL  LE L    +N        +F +   L  
Sbjct: 96  NFL-------------------------GLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIY 130

Query: 123 LALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNP 182
           L +            F  L +LE L +  N+   + L   F    +  ++LT + LS   
Sbjct: 131 LDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIF----TELRNLTFLDLSQCQ 186

Query: 183 LDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLG 242
           L+ + P  +                           +L+ L  + +  N           
Sbjct: 187 LEQLSPTAF--------------------------NSLSSLQVLNMSHNNFFSLDTFPYK 220

Query: 243 KLQKLQDVDLEYNQLEGSIPDSI--CLSVELYELELGGNKLS 282
            L  LQ +D   N +  +            L  L L  N  +
Sbjct: 221 CLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 97.8 bits (244), Expect = 2e-22
 Identities = 50/222 (22%), Positives = 80/222 (36%), Gaps = 29/222 (13%)

Query: 213 IPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLS--VE 270
           +P  I   +  T + L  NKL         KL +L  + L  N L      S        
Sbjct: 22  VPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTS 79

Query: 271 LYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSG 330
           L  L+L  N +  ++ + F  +  L+ L    + L  +                 + F  
Sbjct: 80  LKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMS--------------EFSVF-- 122

Query: 331 PLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSI-PDSFGDLIS 389
                  +L+ LI +D S  +           L +LE L +  N  + +  PD F +L +
Sbjct: 123 ------LSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRN 176

Query: 390 LKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIPRG 431
           L  L+LS   L    P +   LS L+ LN+S N     +   
Sbjct: 177 LTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF-SLDTF 217

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  111 bits (280), Expect = 1e-26
 Identities = 42/209 (20%), Positives = 82/209 (39%), Gaps = 16/209 (7%)

Query: 526 TDKFSENNLIGRG--GFGSVYKAR-IRDGMEVAVKVFNL--QCGRAFKSFDVECAMMKSI 580
              +    +IG+G     +V  AR    G  V V+  NL             E  + K  
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83

Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSS-NYSLDIFQRLNIMIDVASALEY 639
            H N+V   ++   +    +V  +M +GS +  + +     ++      I+  V  AL+Y
Sbjct: 84  NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDY 143

Query: 640 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL--TGEDQSMTQTQTLATIG--- 694
           +H       +H  +K S++L+  +   +LS       +   G+ Q +       ++    
Sbjct: 144 IH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLP 200

Query: 695 YMAPEYGREGQVSTNG--DVYSFGIMLME 721
           +++PE  ++     +   D+YS GI   E
Sbjct: 201 WLSPEVLQQNLQGYDAKSDIYSVGITACE 229

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  108 bits (273), Expect = 2e-26
 Identities = 69/283 (24%), Positives = 113/283 (39%), Gaps = 44/283 (15%)

Query: 535 IGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRA-FKSFDVECAM-MKSIRHRNLVKVISS 591
           +GRG +G V K R +  G  +AVK           K   ++  + M+++     V    +
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74

Query: 592 CSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLN------IMIDVASALEYLHFGYS 645
              E    + +E M   SL+K+       +D  Q +       I + +  ALE+LH   S
Sbjct: 75  LFREGDVWICMELMD-TSLDKFYK---QVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS 130

Query: 646 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPE----YG 701
             VIH D+KPSNVL++      + DFGI+  L      + +        YMAPE      
Sbjct: 131 --VIHRDVKPSNVLINALGQVKMCDFGISGYLV---DDVAKDIDAGCKPYMAPERINPEL 185

Query: 702 REGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLS 761
            +   S   D++S GI ++E    + P D        LK  V +  P        A+  S
Sbjct: 186 NQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQL-----PADKFS 240

Query: 762 QEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLK 804
            E + F ++             C  ++ ++R    E    L++
Sbjct: 241 AEFVDFTSQ-------------CLKKNSKERPTYPE----LMQ 266

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  108 bits (273), Expect = 3e-26
 Identities = 43/206 (20%), Positives = 81/206 (39%), Gaps = 42/206 (20%)

Query: 534 LIGRGGFGSVYKAR-IRDGMEVAVKVFN---LQCGRAFKSFDVECAMMKSIRHRNLVKVI 589
            +G+GGF   ++          A K+     L      +   +E ++ +S+ H+++V   
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81

Query: 590 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLN------IMIDVASALEYLHFG 643
               + +F  +VLE     SL +            + L        +  +    +YLH  
Sbjct: 82  GFFEDNDFVFVVLELCRRRSLLELHKRR-------KALTEPEARYYLRQIVLGCQYLH-- 132

Query: 644 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATI-G---YMAPE 699
               VIH DLK  N+ L++++   + DFG+A  +          +    + G   Y+APE
Sbjct: 133 -RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV------EYDGERKKVLCGTPNYIAPE 185

Query: 700 ------YGREGQVSTNGDVYSFGIML 719
                 +    +V    DV+S G ++
Sbjct: 186 VLSKKGHS--FEV----DVWSIGCIM 205

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  109 bits (275), Expect = 3e-26
 Identities = 43/206 (20%), Positives = 81/206 (39%), Gaps = 42/206 (20%)

Query: 534 LIGRGGFGSVYKAR-IRDGMEVAVKVFN---LQCGRAFKSFDVECAMMKSIRHRNLVKVI 589
            +G+GGF   ++          A K+     L      +   +E ++ +S+ H+++V   
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107

Query: 590 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLN------IMIDVASALEYLHFG 643
               + +F  +VLE     SL +            + L        +  +    +YLH  
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRR-------KALTEPEARYYLRQIVLGCQYLH-- 158

Query: 644 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATI-G---YMAPE 699
               VIH DLK  N+ L++++   + DFG+A  +          +    + G   Y+APE
Sbjct: 159 -RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV------EYDGERKKVLCGTPNYIAPE 211

Query: 700 ------YGREGQVSTNGDVYSFGIML 719
                 +    +V    DV+S G ++
Sbjct: 212 VLSKKGHS--FEV----DVWSIGCIM 231

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  108 bits (272), Expect = 8e-26
 Identities = 59/303 (19%), Positives = 105/303 (34%), Gaps = 60/303 (19%)

Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFN---LQCGRAFKSFDV--------------ECAMM 577
           + +G F  +     +D    A+K +    L+  R F   +               E  ++
Sbjct: 39  LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97

Query: 578 KSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHS-------SNYSLDIFQRLNIM 630
             I++   +      +N +   ++ EYM + S+ K+              + I     I+
Sbjct: 98  TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157

Query: 631 IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTL 690
             V ++  Y+H      + H D+KPSN+L+D N    LSDFG ++ +  +       +  
Sbjct: 158 KSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK-----IKGS 210

Query: 691 A-TIGYMAPE--YGREGQVSTNGDVYSFGIMLMETFTRKKP------TDELF----NGEM 737
             T  +M PE             D++S GI L   F    P        ELF       +
Sbjct: 211 RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNI 270

Query: 738 TL--KHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINA 795
                         +       N LS EDI F+                  ++P +RI +
Sbjct: 271 EYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKL-------------FLRKNPAERITS 317

Query: 796 KEI 798
           ++ 
Sbjct: 318 EDA 320

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  110 bits (276), Expect = 9e-26
 Identities = 70/332 (21%), Positives = 118/332 (35%), Gaps = 88/332 (26%)

Query: 94  PNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNN 153
                +       S  +P  I   S    L L  N+       TF +L +LE L L  N+
Sbjct: 54  NQFSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110

Query: 154 LTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGI 213
           +    +++   + L++   L  + L +N L  I                           
Sbjct: 111 I--RQIEVGAFNGLAS---LNTLELFDNWLTVIPSGA----------------------- 142

Query: 214 PEEITNLTDLTTIVLGGNKLNGSIPI-TLGKLQKLQDVDL-EYNQLEGSIPDSICLSVEL 271
                 L+ L  + L  N +  SIP     ++  L  +DL E  +LE  I +        
Sbjct: 143 ---FEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLE-YISEGA------ 191

Query: 272 YELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGP 331
                            F  +  LK L+LG   +  +P N   L  + +L +S N     
Sbjct: 192 -----------------FEGLFNLKYLNLGMCNIKDMP-NLTPLVGLEELEMSGN----- 228

Query: 332 LPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLK 391
                  ++          +F G        L +L+ L++  +++     ++F  L SL 
Sbjct: 229 ---HFPEIRP--------GSFHG--------LSSLKKLWVMNSQVSLIERNAFDGLASLV 269

Query: 392 SLNLSYNNLSGTIPVS-LEKLSYLKDLNLSFN 422
            LNL++NNLS ++P      L YL +L+L  N
Sbjct: 270 ELNLAHNNLS-SLPHDLFTPLRYLVELHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  107 bits (270), Expect = 6e-25
 Identities = 58/244 (23%), Positives = 94/244 (38%), Gaps = 15/244 (6%)

Query: 213 IPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSI--CLSVE 270
           +P+ I   ++   + L  N +      T   L  L+ + L  N +   I       L+  
Sbjct: 69  VPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLA-S 124

Query: 271 LYELELGGNKLSGSIPA-CFSNMTFLKVLSLGSNELTSIPLN-FWSLKDILDLNLSSNCF 328
           L  LEL  N L+  IP+  F  ++ L+ L L +N + SIP   F  +  ++ L+L     
Sbjct: 125 LNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKK 183

Query: 329 SGPLPLEI-RNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDL 387
              +       L  L  ++  M N   +    +  L  LE L +  N      P SF  L
Sbjct: 184 LEYISEGAFEGLFNLKYLNLGMCNIKDM--PNLTPLVGLEELEMSGNHFPEIRPGSFHGL 241

Query: 388 ISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIPRG--GSFGNFSAESFKGN 445
            SLK L +  + +S     + + L+ L +LNL+ N L   +P                 N
Sbjct: 242 SSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHN 300

Query: 446 ELLC 449
              C
Sbjct: 301 PWNC 304

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  107 bits (269), Expect = 7e-25
 Identities = 65/248 (26%), Positives = 102/248 (41%), Gaps = 19/248 (7%)

Query: 14  PKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIF-NVSTLK 72
           P+ I   SN + L L  N +Q        HLH+L  L L +N  +  I    F  +++L 
Sbjct: 70  PQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS-IRQIEVGAFNGLASLN 126

Query: 73  AFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNA-SKLSKLAL-EMNSF 130
              + +N L+  + S     L  L  L+L  N    +IP + FN    L +L L E+   
Sbjct: 127 TLELFDNWLTV-IPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKL 184

Query: 131 SGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRT 190
                  F  L NL++L L   N+         + +L+    L  + +S N    I P +
Sbjct: 185 EYISEGAFEGLFNLKYLNLGMCNIKD-------MPNLTPLVGLEELEMSGNHFPEIRPGS 237

Query: 191 YVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPI-TLGKLQKLQD 249
           + G    SLK  ++ N  VS         L  L  + L  N L+ S+P      L+ L +
Sbjct: 238 FHG--LSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVE 294

Query: 250 VDLEYNQL 257
           + L +N  
Sbjct: 295 LHLHHNPW 302

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 94.8 bits (236), Expect = 1e-20
 Identities = 48/183 (26%), Positives = 77/183 (42%), Gaps = 15/183 (8%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEI-GHLHNLGFLDLSQNKLLGTIPAA 64
           +N+LT       + +S L+ L+L NN ++  I       + +L  LDL + K L  I   
Sbjct: 132 DNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEG 190

Query: 65  IF-NVSTLKAFAVTNNSLSGCLSSI-TDVGLPNLEVLYLWGNNFSGTIPHFIF-NASKLS 121
            F  +  LK   +   ++      +     L  LE L + GN+F   I    F   S L 
Sbjct: 191 AFEGLFNLKYLNLGMCNIK----DMPNLTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLK 245

Query: 122 KLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNN 181
           KL +  +  S    + F  L +L  L L  NNL+  +L     + L   + L  + L +N
Sbjct: 246 KLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS--SLPHDLFTPL---RYLVELHLHHN 300

Query: 182 PLD 184
           P +
Sbjct: 301 PWN 303

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  107 bits (270), Expect = 2e-25
 Identities = 50/216 (23%), Positives = 91/216 (42%), Gaps = 37/216 (17%)

Query: 526 TDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFN---LQCGRAFKSFDV--ECAMMKS 579
            D +    +IG+G F  V +      G + AVK+ +           + D+  E ++   
Sbjct: 23  EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82

Query: 580 IRHRNLVKVISSCSNEEFKALVLEYMPHGSL-----EKYLHSSNYSLDIFQRL--NIMID 632
           ++H ++V+++ + S++    +V E+M    L     ++      YS    + +  + M  
Sbjct: 83  LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYS----EAVASHYMRQ 138

Query: 633 VASALEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
           +  AL Y H      +IH D+KP  VLL   +++    L  FG+A  L            
Sbjct: 139 ILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVA--GGR 193

Query: 690 LATIGYMAPE------YGREGQVSTNGDVYSFGIML 719
           + T  +MAPE      YG+        DV+  G++L
Sbjct: 194 VGTPHFMAPEVVKREPYGKP------VDVWGCGVIL 223

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  106 bits (266), Expect = 4e-25
 Identities = 51/203 (25%), Positives = 81/203 (39%), Gaps = 14/203 (6%)

Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRA-FKSFDVECA-MMKSIRHR 583
           +       +G G  G V+K R  + G  +AVK       +   K   ++   ++KS    
Sbjct: 25  NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84

Query: 584 NLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFG 643
            +V+   +        + +E M     EK        +       + + +  AL YL   
Sbjct: 85  YIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK 143

Query: 644 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPE---- 699
           +   VIH D+KPSN+LLD+     L DFGI+  L        + ++     YMAPE    
Sbjct: 144 HG--VIHRDVKPSNILLDERGQIKLCDFGISGRLV---DDKAKDRSAGCAAYMAPERIDP 198

Query: 700 -YGREGQVSTNGDVYSFGIMLME 721
               +       DV+S GI L+E
Sbjct: 199 PDPTKPDYDIRADVWSLGISLVE 221

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  107 bits (270), Expect = 5e-25
 Identities = 55/242 (22%), Positives = 95/242 (39%), Gaps = 11/242 (4%)

Query: 213 IPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELY 272
           +P+ I   T+   + L  N++      +   L+ L+ + L  N +      +      L 
Sbjct: 58  VPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLN 115

Query: 273 ELELGGNKLSGSIPA-CFSNMTFLKVLSLGSNELTSIPLN-FWSLKDILDLNLSSNCFSG 330
            LEL  N+L+ +IP   F  ++ LK L L +N + SIP   F  +  +  L+L       
Sbjct: 116 TLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLS 174

Query: 331 PLPLEI-RNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLIS 389
            +       L  L  ++ +M N   I    +  L  L+ L L  N L    P SF  L+ 
Sbjct: 175 YISEGAFEGLSNLRYLNLAMCNLREIP--NLTPLIKLDELDLSGNHLSAIRPGSFQGLMH 232

Query: 390 LKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIPRG--GSFGNFSAESFKGNEL 447
           L+ L +  + +      + + L  L ++NL+ N L   +P        +        N  
Sbjct: 233 LQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHNPW 291

Query: 448 LC 449
            C
Sbjct: 292 NC 293

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  107 bits (268), Expect = 1e-24
 Identities = 67/332 (20%), Positives = 123/332 (37%), Gaps = 88/332 (26%)

Query: 94  PNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNN 153
                +     N    +P  I   +    L L  N       ++F +LR+LE L L  N+
Sbjct: 43  NQFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNH 99

Query: 154 LTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGI 213
           +   T+++   + L+N   L  + L +N L  I                           
Sbjct: 100 I--RTIEIGAFNGLAN---LNTLELFDNRLTTIPNGA----------------------- 131

Query: 214 PEEITNLTDLTTIVLGGNKLNGSIPI-TLGKLQKLQDVDL-EYNQLEGSIPDSICLSVEL 271
                 L+ L  + L  N +  SIP     ++  L+ +DL E  +L   I +        
Sbjct: 132 ---FVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLS-YISEGA------ 180

Query: 272 YELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGP 331
                            F  ++ L+ L+L    L  IP N   L  + +L+LS N     
Sbjct: 181 -----------------FEGLSNLRYLNLAMCNLREIP-NLTPLIKLDELDLSGN----- 217

Query: 332 LPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLK 391
               +  ++          +F G        L +L+ L++  ++++    ++F +L SL 
Sbjct: 218 ---HLSAIRP--------GSFQG--------LMHLQKLWMIQSQIQVIERNAFDNLQSLV 258

Query: 392 SLNLSYNNLSGTIPVS-LEKLSYLKDLNLSFN 422
            +NL++NNL+  +P      L +L+ ++L  N
Sbjct: 259 EINLAHNNLT-LLPHDLFTPLHHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  104 bits (262), Expect = 6e-24
 Identities = 71/317 (22%), Positives = 114/317 (35%), Gaps = 90/317 (28%)

Query: 14  PKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKA 73
           P  I   +N ++L L+ N++Q   ++   HL +L  L LS+N +  TI    FN      
Sbjct: 59  PDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI-RTIEIGAFN------ 109

Query: 74  FAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIF-NASKLSKLALEMNSFSG 132
                             GL NL  L L+ N  + TIP+  F   SKL +L L  N    
Sbjct: 110 ------------------GLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIES 150

Query: 133 FIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLS--SLSNCKSLTHISLSNNPLDGILPRT 190
                F  + +L  L L +         LS++S  +     +L +++L+   L  I    
Sbjct: 151 IPSYAFNRIPSLRRLDLGELKR------LSYISEGAFEGLSNLRYLNLAMCNLREI---- 200

Query: 191 YVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDV 250
                                     +T L  L  + L GN L+   P +   L  LQ +
Sbjct: 201 ------------------------PNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKL 236

Query: 251 DLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPL 310
            +  +Q++  I                           F N+  L  ++L  N LT +P 
Sbjct: 237 WMIQSQIQ-VIE-----------------------RNAFDNLQSLVEINLAHNNLTLLPH 272

Query: 311 N-FWSLKDILDLNLSSN 326
           + F  L  +  ++L  N
Sbjct: 273 DLFTPLHHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 94.4 bits (235), Expect = 2e-20
 Identities = 51/184 (27%), Positives = 75/184 (40%), Gaps = 17/184 (9%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHE--IGHLHNLGFLDLSQNKLLGTIPA 63
           +N LT+        +S LK L+L NN ++   I       + +L  LDL + K L  I  
Sbjct: 121 DNRLTTIPNGAFVYLSKLKELWLRNNPIE--SIPSYAFNRIPSLRRLDLGELKRLSYISE 178

Query: 64  AIF-NVSTLKAFAVTNNSLSGCLSSI-TDVGLPNLEVLYLWGNNFSGTIPHFIF-NASKL 120
             F  +S L+   +   +L      I     L  L+ L L GN+ S  I    F     L
Sbjct: 179 GAFEGLSNLRYLNLAMCNLR----EIPNLTPLIKLDELDLSGNHLS-AIRPGSFQGLMHL 233

Query: 121 SKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSN 180
            KL +  +       + F NL++L  + L  NNLT   L     + L     L  I L +
Sbjct: 234 QKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT--LLPHDLFTPLH---HLERIHLHH 288

Query: 181 NPLD 184
           NP +
Sbjct: 289 NPWN 292

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 60.9 bits (148), Expect = 7e-10
 Identities = 29/144 (20%), Positives = 45/144 (31%), Gaps = 30/144 (20%)

Query: 288 CFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDF 347
           C +       +      L  +P                      +    R L      + 
Sbjct: 41  CSNQ---FSKVICVRKNLREVPDG--------------------ISTNTRLL------NL 71

Query: 348 SMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVS 407
             N    I       L++LE L L  N +      +F  L +L +L L  N L+     +
Sbjct: 72  HENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGA 131

Query: 408 LEKLSYLKDLNLSFNKLKGEIPRG 431
              LS LK+L L  N ++  IP  
Sbjct: 132 FVYLSKLKELWLRNNPIE-SIPSY 154

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  107 bits (270), Expect = 7e-25
 Identities = 52/210 (24%), Positives = 94/210 (44%), Gaps = 32/210 (15%)

Query: 526 TDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDV--ECAMMKSIRH 582
           T+++     +G+G F  V +   +  G E A  + N +   A     +  E  + + ++H
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69

Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSL-EKYLHSSNYSLDIFQR--LNIMIDVASALEY 639
            N+V++  S S E    L+ + +  G L E  +    YS    +    + +  +  A+ +
Sbjct: 70  PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYS----EADASHCIQQILEAVLH 125

Query: 640 LHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGY 695
            H      V+H +LKP N+LL          L+DFG+A  + GE Q+       A T GY
Sbjct: 126 CH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF---GFAGTPGY 179

Query: 696 MAPE------YGREGQVSTNGDVYSFGIML 719
           ++PE      YG+        D+++ G++L
Sbjct: 180 LSPEVLRKDPYGKP------VDLWACGVIL 203

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  104 bits (261), Expect = 9e-25
 Identities = 52/212 (24%), Positives = 91/212 (42%), Gaps = 38/212 (17%)

Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFN---LQCGRAFKSFDVECAMMKSIRH 582
           D F     +G+G FG+VY AR  ++   +A+KV     L+          E  +   +RH
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73

Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLN------IMIDVASA 636
            N++++ +   + +   L+LE+ P G L K L           R +       M ++A A
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKH-------GRFDEQRSATFMEELADA 126

Query: 637 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTL-ATIGY 695
           L Y H      VIH D+KP N+L+       ++DFG +           + +T+  T+ Y
Sbjct: 127 LHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-----RRRTMCGTLDY 178

Query: 696 MAPE------YGREGQVSTNGDVYSFGIMLME 721
           + PE      +  +       D++  G++  E
Sbjct: 179 LPPEMIEGKTHDEK------VDLWCAGVLCYE 204

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score =  104 bits (262), Expect = 9e-25
 Identities = 54/292 (18%), Positives = 112/292 (38%), Gaps = 26/292 (8%)

Query: 116 NASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTH 175
             +   K+A   ++ +     T  +L  +  L+ +   +T+       +  +    +L  
Sbjct: 17  ALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTT-------IEGVQYLNNLIG 67

Query: 176 ISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNG 235
           + L +N +  + P   + NL+  +    +    +       I  L  + T+ L   ++  
Sbjct: 68  LELKDNQITDLAP---LKNLTK-ITELELSGNPLK--NVSAIAGLQSIKTLDLTSTQITD 121

Query: 236 SIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFL 295
             P  L  L  LQ + L+ NQ+  +I     L+  L  L +G  ++S  +    +N++ L
Sbjct: 122 VTP--LAGLSNLQVLYLDLNQIT-NISPLAGLT-NLQYLSIGNAQVS-DLTP-LANLSKL 175

Query: 296 KVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGI 355
             L    N+++ I     SL ++++++L +N  S   PL   N   L  +  +    +  
Sbjct: 176 TTLKADDNKISDIS-PLASLPNLIEVHLKNNQISDVSPLA--NTSNLFIVTLTNQTITNQ 232

Query: 356 IPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVS 407
                 +L     +           P +  D  +  S NL++N  S    VS
Sbjct: 233 PVFYNNNLVVPNVVKGPSGAP--IAPATISDNGTYASPNLTWNLTSFINNVS 282

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score =  100 bits (252), Expect = 2e-23
 Identities = 48/261 (18%), Positives = 98/261 (37%), Gaps = 19/261 (7%)

Query: 164 LSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDL 223
           +       +   I+   + +   +      +L   +     +   V+    E +  L +L
Sbjct: 12  IFPDPALANAIKIAAGKSNVTDTVT---QADLDG-ITTLSAFGTGVTT--IEGVQYLNNL 65

Query: 224 TTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSG 283
             + L  N++    P  L  L K+ +++L  N L      +I     +  L+L   +++ 
Sbjct: 66  IGLELKDNQITDLAP--LKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITD 121

Query: 284 SIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALI 343
             P   + ++ L+VL L  N++T+I      L ++  L++ +   S   PL   NL  L 
Sbjct: 122 VTP--LAGLSNLQVLYLDLNQITNIS-PLAGLTNLQYLSIGNAQVSDLTPLA--NLSKLT 176

Query: 344 EIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGT 403
            +    N  S I P  + SL NL  + L+ N++    P    +  +L  + L+   ++  
Sbjct: 177 TLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQ 232

Query: 404 IPVSLEKLSYLKDLNLSFNKL 424
                  L     +       
Sbjct: 233 PVFYNNNLVVPNVVKGPSGAP 253

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 91.3 bits (227), Expect = 4e-20
 Identities = 56/319 (17%), Positives = 106/319 (33%), Gaps = 50/319 (15%)

Query: 12  TTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTL 71
           T      ++  +  L  +   +    I  + +L+NL  L+L  N++           + L
Sbjct: 32  TDTVTQADLDGITTLSAFGTGV--TTIEGVQYLNNLIGLELKDNQI-----------TDL 78

Query: 72  KAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFS 131
                                L  +  L L GN         I     +  L L     +
Sbjct: 79  APLK----------------NLTKITELELSGNPLKNVSA--IAGLQSIKTLDLTSTQIT 120

Query: 132 GFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTY 191
              P     L NL+ L L  N +T+       +S L+   +L ++S+ N  +  + P   
Sbjct: 121 DVTP--LAGLSNLQVLYLDLNQITN-------ISPLAGLTNLQYLSIGNAQVSDLTP--- 168

Query: 192 VGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVD 251
           + NLS  L      +  +S      + +L +L  + L  N+++   P  L     L  V 
Sbjct: 169 LANLS-KLTTLKADDNKISD--ISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVT 223

Query: 252 LEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLN 311
           L    +  +       +  +    + G   +   PA  S+       +L  N  + I   
Sbjct: 224 LTNQTI--TNQPVFYNNNLVVPNVVKGPSGAPIAPATISDNGTYASPNLTWNLTSFINNV 281

Query: 312 FWSLKDILDLNLSSNCFSG 330
            ++    +    ++  FSG
Sbjct: 282 SYTFNQSVTFKNTTVPFSG 300

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  104 bits (261), Expect = 1e-24
 Identities = 56/223 (25%), Positives = 93/223 (41%), Gaps = 49/223 (21%)

Query: 534 LIGRGGFGSVYKAR-IRDGMEVAVKVFN--------------------LQCGRAFKSFDV 572
            IG+G +G V  A    D    A+KV +                       G   +    
Sbjct: 20  EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79

Query: 573 ------ECAMMKSIRHRNLVK---VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLD- 622
                 E A++K + H N+VK   V+   + +    +V E +  G + +       S D 
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL-YMVFELVNQGPVMEVPTLKPLSEDQ 138

Query: 623 ---IFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG 679
               FQ      D+   +EYLH      +IH D+KPSN+L+ ++    ++DFG++    G
Sbjct: 139 ARFYFQ------DLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG 189

Query: 680 EDQSMTQTQTLATIGYMAPEYGREGQVSTNG---DVYSFGIML 719
            D ++    T+ T  +MAPE   E +   +G   DV++ G+ L
Sbjct: 190 SD-ALLSN-TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  103 bits (260), Expect = 2e-24
 Identities = 53/229 (23%), Positives = 92/229 (40%), Gaps = 60/229 (26%)

Query: 526 TDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDV---------ECA 575
            + +    ++GRG    V +        E AVK+ ++  G +F + +V         E  
Sbjct: 16  YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75

Query: 576 MMKSI-RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRL------- 627
           +++ +  H N++++  +     F  LV + M  G L             F  L       
Sbjct: 76  ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL-------------FDYLTEKVTLS 122

Query: 628 -----NIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 682
                 IM  +   +  LH      ++H DLKP N+LLDD+M   L+DFG +  L    +
Sbjct: 123 EKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL-DPGE 178

Query: 683 SMTQTQTLATIGYMAPE------------YGREGQVSTNGDVYSFGIML 719
            +   +   T  Y+APE            YG+E       D++S G+++
Sbjct: 179 KL--REVCGTPSYLAPEIIECSMNDNHPGYGKE------VDMWSTGVIM 219

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  103 bits (260), Expect = 2e-24
 Identities = 52/217 (23%), Positives = 90/217 (41%), Gaps = 50/217 (23%)

Query: 526 TDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRN 584
              F    ++G G F  V+  +    G   A+K           S + E A++K I+H N
Sbjct: 8   RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67

Query: 585 LVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRL------------NIMID 632
           +V +     +     LV++ +  G L             F R+             ++  
Sbjct: 68  IVTLEDIYESTTHYYLVMQLVSGGEL-------------FDRILERGVYTEKDASLVIQQ 114

Query: 633 VASALEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
           V SA++YLH      ++H DLKP N+L    ++N    ++DFG++K+   ++  M+   T
Sbjct: 115 VLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME--QNGIMS---T 166

Query: 690 LA-TIGYMAPE------YGREGQVSTNGDVYSFGIML 719
              T GY+APE      Y +        D +S G++ 
Sbjct: 167 ACGTPGYVAPEVLAQKPYSKA------VDCWSIGVIT 197

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  102 bits (256), Expect = 3e-24
 Identities = 50/206 (24%), Positives = 91/206 (44%), Gaps = 26/206 (12%)

Query: 526 TDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFN--LQCGRAFKSFDVECAMMKSIRH 582
            ++++   ++G+G FG V K +      E AVKV N      +   +   E  ++K + H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSL-EKYLHSSNYSLDIFQRLNIMIDVASALEYLH 641
            N++K+     +     +V E    G L ++ +    +S        I+  V S + Y+H
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEH--DAARIIKQVFSGITYMH 138

Query: 642 FGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 698
                 ++H DLKP N+LL   + +    + DFG++     ++  M     + T  Y+AP
Sbjct: 139 ---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF-QQNTKM--KDRIGTAYYIAP 192

Query: 699 E-----YGREGQVSTNGDVYSFGIML 719
           E     Y  +       DV+S G++L
Sbjct: 193 EVLRGTYDEK------CDVWSAGVIL 212

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  103 bits (258), Expect = 6e-24
 Identities = 47/218 (21%), Positives = 83/218 (38%), Gaps = 52/218 (23%)

Query: 526 TDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRN 584
           TD +     IG G +    +       ME AVK+ +          +    +++  +H N
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDK---SKRDPTEEIEILLRYGQHPN 77

Query: 585 LVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRL------------NIMID 632
           ++ +     + ++  +V E M  G L               ++             ++  
Sbjct: 78  IITLKDVYDDGKYVYVVTELMKGGEL-------------LDKILRQKFFSEREASAVLFT 124

Query: 633 VASALEYLHFGYSAPVIHCDLKPSNVLL----DDNMVAHLSDFGIAKLLTGEDQSMTQTQ 688
           +   +EYLH   +  V+H DLKPSN+L      +     + DFG AK L  E+  +    
Sbjct: 125 ITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLM--- 178

Query: 689 TLA-TIGYMAPE------YGREGQVSTNGDVYSFGIML 719
           T   T  ++APE      Y          D++S G++L
Sbjct: 179 TPCYTANFVAPEVLERQGYDAA--C----DIWSLGVLL 210

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  103 bits (259), Expect = 6e-24
 Identities = 65/263 (24%), Positives = 105/263 (39%), Gaps = 65/263 (24%)

Query: 496 QKREKGPPNDPNMPPVATWRRFSYLELFQATDKFSEN----NLIGRGGFGSVYKARIRD- 550
           +K     P         +      L  + A  +F +     ++IGRG    V +   R  
Sbjct: 59  KKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRAT 118

Query: 551 GMEVAVKVFNL--------QCGRAFKSFDVECAMMKSIR-HRNLVKVISSCSNEEFKALV 601
           G E AVK+  +        Q     ++   E  +++ +  H +++ +I S  +  F  LV
Sbjct: 119 GHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLV 178

Query: 602 LEYMPHGSLEKYLHSSNYSLDIFQRL------------NIMIDVASALEYLHFGYSAPVI 649
            + M  G L             F  L            +IM  +  A+ +LH   +  ++
Sbjct: 179 FDLMRKGEL-------------FDYLTEKVALSEKETRSIMRSLLEAVSFLH---ANNIV 222

Query: 650 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAPE--------- 699
           H DLKP N+LLDDNM   LSDFG +  L    + +     L  T GY+APE         
Sbjct: 223 HRDLKPENILLDDNMQIRLSDFGFSCHL-EPGEKLR---ELCGTPGYLAPEILKCSMDET 278

Query: 700 ---YGREGQVSTNGDVYSFGIML 719
              YG+E       D+++ G++L
Sbjct: 279 HPGYGKE------VDLWACGVIL 295

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  101 bits (255), Expect = 7e-24
 Identities = 57/217 (26%), Positives = 102/217 (47%), Gaps = 19/217 (8%)

Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDV----ECAMMKSIR 581
            K+ +   IG G +G+V+KA+       VA+K   L      +        E  ++K ++
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD--EGVPSSALREICLLKELK 59

Query: 582 HRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLH 641
           H+N+V++     +++   LV E+     L+KY  S N  LD     + +  +   L + H
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118

Query: 642 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPE-- 699
              S  V+H DLKP N+L++ N    L++FG+A+      +    +  + T+ Y  P+  
Sbjct: 119 ---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVVTLWYRPPDVL 173

Query: 700 YGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGE 736
           +G +   ST+ D++S G +  E     +P   LF G 
Sbjct: 174 FGAK-LYSTSIDMWSAGCIFAELANAGRP---LFPGN 206

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  103 bits (259), Expect = 7e-24
 Identities = 46/230 (20%), Positives = 95/230 (41%), Gaps = 13/230 (5%)

Query: 497 KREKGPPNDPNMPPVATWRRFSYLELFQATDKFSEN----NLIGRGGFGSVYKARIRD-G 551
           K +    ND +      W+++    +        +       +G G FG V++   +  G
Sbjct: 17  KYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATG 76

Query: 552 MEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLE 611
                K  N        +   E ++M  + H  L+ +  +  ++    L+LE++  G L 
Sbjct: 77  RVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELF 136

Query: 612 KYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHL--S 669
             + + +Y +   + +N M      L+++H      ++H D+KP N++ +    + +   
Sbjct: 137 DRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKII 193

Query: 670 DFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIML 719
           DFG+A  L   D+ +    T AT  + APE      V    D+++ G++ 
Sbjct: 194 DFGLATKL-NPDEIV--KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLG 240

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  101 bits (253), Expect = 8e-24
 Identities = 31/202 (15%), Positives = 56/202 (27%), Gaps = 39/202 (19%)

Query: 534 LIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRA--FKS-FDVECAMMKSIRHRNLVKVI 589
             G       ++A       +VA+   + Q                 +  I    + +V+
Sbjct: 38  FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97

Query: 590 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVI 649
                     +V E++  GSL++   +S         +  M  +A+A +  H    A V 
Sbjct: 98  DVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAH---RAGVA 151

Query: 650 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTN 709
                PS V +  +        G                 LA    M     ++      
Sbjct: 152 LSIDHPSRVRVSID--------GDVV--------------LAYPATMPDANPQD------ 183

Query: 710 GDVYSFGIMLMETFTRKKPTDE 731
            D+   G  L      + P  E
Sbjct: 184 -DIRGIGASLYALLVNRWPLPE 204

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  101 bits (255), Expect = 9e-24
 Identities = 61/216 (28%), Positives = 102/216 (47%), Gaps = 19/216 (8%)

Query: 527 DKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDV----ECAMMKSIRH 582
           +K+ +   +G G +G VYKA+   G  VA+K   L      +        E +++K + H
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAED--EGIPSTAIREISLLKELHH 78

Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
            N+V +I    +E    LV E+M    L+K L  +   L   Q    +  +   + + H 
Sbjct: 79  PNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH- 136

Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPE--Y 700
                ++H DLKP N+L++ +    L+DFG+A+      +S   T  + T+ Y AP+   
Sbjct: 137 --QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVVTLWYRAPDVLM 192

Query: 701 GREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGE 736
           G + + ST+ D++S G +  E  T  KP   LF G 
Sbjct: 193 GSK-KYSTSVDIWSIGCIFAEMITG-KP---LFPGV 223

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  100 bits (252), Expect = 1e-23
 Identities = 50/207 (24%), Positives = 93/207 (44%), Gaps = 27/207 (13%)

Query: 526 TDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQ--CGRAFKSFDVECAMMKSIRH 582
           +D +     +G+G F  V +      G+E A K+ N +    R F+  + E  + + ++H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64

Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSL-EKYLHSSNYSLDIFQRLNIMIDVASALEYLH 641
            N+V++  S   E F  LV + +  G L E  +    YS       + +  +  ++ Y H
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEA--DASHCIQQILESIAYCH 122

Query: 642 FGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 698
              S  ++H +LKP N+LL          L+DFG+A  +  + ++        T GY++P
Sbjct: 123 ---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV-NDSEAW--HGFAGTPGYLSP 176

Query: 699 E------YGREGQVSTNGDVYSFGIML 719
           E      Y +        D+++ G++L
Sbjct: 177 EVLKKDPYSKP------VDIWACGVIL 197

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score =  100 bits (252), Expect = 1e-23
 Identities = 55/194 (28%), Positives = 86/194 (44%), Gaps = 11/194 (5%)

Query: 247 LQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELT 306
             +V+ +   L  ++P  +    +   L L  N L     A     T L  L+L   ELT
Sbjct: 12  HLEVNCDKRNL-TALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT 68

Query: 307 SIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNL 366
            + +   +L  +  L+LS N     LPL  + L AL  +D S N  + +    +  L  L
Sbjct: 69  KLQV-DGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGEL 126

Query: 367 ENLFLEYNRLEGSIPDS-FGDLISLKSLNLSYNNLSGTIPVSL-EKLSYLKDLNLSFNKL 424
           + L+L+ N L+ ++P         L+ L+L+ NNL+  +P  L   L  L  L L  N L
Sbjct: 127 QELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSL 184

Query: 425 KGEIPRGGSFGNFS 438
              IP+ G FG+  
Sbjct: 185 YT-IPK-GFFGSHL 196

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 94.0 bits (234), Expect = 3e-21
 Identities = 51/238 (21%), Positives = 85/238 (35%), Gaps = 43/238 (18%)

Query: 92  GLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYD 151
            + +   +     N +  +P  +      + L L  N    F  +T      L  L L  
Sbjct: 8   KVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64

Query: 152 NNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSG 211
             LT        L        L  + LS+N L                            
Sbjct: 65  AELTK-------LQVDGTLPVLGTLDLSHNQLQ--------------------------- 90

Query: 212 GIPEEITNLTDLTTIVLGGNKLNGSIPI-TLGKLQKLQDVDLEYNQLEGSIPDSICLS-V 269
            +P     L  LT + +  N+L  S+P+  L  L +LQ++ L+ N+L+ ++P  +     
Sbjct: 91  SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTP 148

Query: 270 ELYELELGGNKLSGSIPA-CFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSN 326
           +L +L L  N L+  +PA   + +  L  L L  N L +IP  F+    +    L  N
Sbjct: 149 KLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 94.0 bits (234), Expect = 3e-21
 Identities = 49/183 (26%), Positives = 70/183 (38%), Gaps = 18/183 (9%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAI 65
            N L + +   +   + L  L L    L    +   G L  LG LDLS N+L  ++P   
Sbjct: 40  ENLLYTFSLATLMPYTRLTQLNLDRAELT--KLQVDGTLPVLGTLDLSHNQL-QSLPLLG 96

Query: 66  FNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNA-SKLSKLA 124
             +  L    V+ N L+  L      GL  L+ LYL GN    T+P  +     KL KL+
Sbjct: 97  QTLPALTVLDVSFNRLTS-LPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLS 154

Query: 125 LEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTS---STLDLSFLSSLSNCKSLTHISLSNN 181
           L  N+ +         L NL+ L L +N+L +                   L    L  N
Sbjct: 155 LANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGS---------HLLPFAFLHGN 205

Query: 182 PLD 184
           P  
Sbjct: 206 PWL 208

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 89.0 bits (221), Expect = 2e-19
 Identities = 50/192 (26%), Positives = 79/192 (41%), Gaps = 13/192 (6%)

Query: 209 VSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLS 268
           +   +P       D T + L  N L      TL    +L  ++L+  +L   +     L 
Sbjct: 25  LPPDLP------KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVDGTL- 76

Query: 269 VELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLN-FWSLKDILDLNLSSNC 327
             L  L+L  N+L  S+P     +  L VL +  N LTS+PL     L ++ +L L  N 
Sbjct: 77  PVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNE 135

Query: 328 FSGPLPLEI-RNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGD 386
               LP  +      L ++  + NN + +    +  L+NL+ L L+ N L  +IP  F  
Sbjct: 136 LKT-LPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFG 193

Query: 387 LISLKSLNLSYN 398
              L    L  N
Sbjct: 194 SHLLPFAFLHGN 205

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  100 bits (252), Expect = 1e-23
 Identities = 57/215 (26%), Positives = 83/215 (38%), Gaps = 10/215 (4%)

Query: 213 IPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLS-VEL 271
           +P  I        I L GN+++     +    + L  + L  N L   I  +       L
Sbjct: 26  VPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALL 82

Query: 272 YELELGGNKLSGSIPA-CFSNMTFLKVLSLGSNELTSIPLN-FWSLKDILDLNLSSNCFS 329
            +L+L  N    S+    F  +  L  L L    L  +    F  L  +  L L  N   
Sbjct: 83  EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142

Query: 330 GPLPLEI-RNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLI 388
             LP +  R+L  L  +    N  S +       L +L+ L L  NR+    P +F DL 
Sbjct: 143 A-LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLG 201

Query: 389 SLKSLNLSYNNLSGTIPVS-LEKLSYLKDLNLSFN 422
            L +L L  NNLS  +P   L  L  L+ L L+ N
Sbjct: 202 RLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 98.5 bits (246), Expect = 7e-23
 Identities = 50/223 (22%), Positives = 90/223 (40%), Gaps = 17/223 (7%)

Query: 109 TIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLS 168
            +P  I   +   ++ L  N  S    ++F   RNL  L L+ N L    +D +  + L+
Sbjct: 25  AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLAR--IDAAAFTGLA 80

Query: 169 NCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEI-TNLTDLTTIV 227
               L  + LS+N     +       L   L   ++  C +   +   +   L  L  + 
Sbjct: 81  L---LEQLDLSDNAQLRSVDPATFHGLG-RLHTLHLDRCGLQ-ELGPGLFRGLAALQYLY 135

Query: 228 LGGNKLNGSIPI-TLGKLQKLQDVDLEYNQLEGSIPDSICLS-VELYELELGGNKLSGSI 285
           L  N L  ++P  T   L  L  + L  N++  S+P+        L  L L  N+++  +
Sbjct: 136 LQDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVA-HV 192

Query: 286 PA-CFSNMTFLKVLSLGSNELTSIPLN-FWSLKDILDLNLSSN 326
               F ++  L  L L +N L+++P      L+ +  L L+ N
Sbjct: 193 HPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 95.4 bits (238), Expect = 8e-22
 Identities = 46/185 (24%), Positives = 79/185 (42%), Gaps = 17/185 (9%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEI-GHLHNLGFLDLSQNKLLGTIPAA 64
           +N L          ++ L+ L L +N     +       L  L  L L +  L   +   
Sbjct: 65  SNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGL-QELGPG 123

Query: 65  IF-NVSTLKAFAVTNNSLSGCLSSITD---VGLPNLEVLYLWGNNFSGTIPHFIF-NASK 119
           +F  ++ L+   + +N+L     ++ D     L NL  L+L GN  S ++P   F     
Sbjct: 124 LFRGLAALQYLYLQDNALQ----ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHS 178

Query: 120 LSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLS 179
           L +L L  N  +   P  F +L  L  L L+ NNL++  L    L+ L   ++L ++ L+
Sbjct: 179 LDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSA--LPTEALAPL---RALQYLRLN 233

Query: 180 NNPLD 184
           +NP  
Sbjct: 234 DNPWV 238

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  102 bits (256), Expect = 1e-23
 Identities = 55/244 (22%), Positives = 103/244 (42%), Gaps = 55/244 (22%)

Query: 506 PNMPPVATWRRFSYLELF--QATDKFSEN----NLIGRGGFGSVYKARIRD-GMEVAVKV 558
           P+M  +   ++      F   A+ KFS+N      +G+G F  V +   +  G+E A K+
Sbjct: 2   PHMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKI 61

Query: 559 FN--LQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHS 616
            N      R F+  + E  + + ++H N+V++  S   E F  LV + +  G L      
Sbjct: 62  INTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL------ 115

Query: 617 SNYSLDIFQRL------------NIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL---D 661
                  F+ +            + +  +  ++ Y H   S  ++H +LKP N+LL    
Sbjct: 116 -------FEDIVAREFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKA 165

Query: 662 DNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPE------YGREGQVSTNGDVYSF 715
                 L+DFG+A  +  + ++        T GY++PE      Y +        D+++ 
Sbjct: 166 KGAAVKLADFGLAIEV-NDSEAW--HGFAGTPGYLSPEVLKKDPYSKP------VDIWAC 216

Query: 716 GIML 719
           G++L
Sbjct: 217 GVIL 220

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  102 bits (256), Expect = 2e-23
 Identities = 56/245 (22%), Positives = 86/245 (35%), Gaps = 40/245 (16%)

Query: 521 ELFQATDKFSENNLIGRGGFGSVYKARIRDGMEVAVK-VFNLQCGRAFKS-FDV------ 572
           EL      ++    I  G +G+V      +G+ VA+K VFN        +          
Sbjct: 16  ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75

Query: 573 ---ECAMMKSIRHRNLVK---VISSCSNEEFKA--LVLEYMPHGSLEKYLHSSNYSLDIF 624
              E  ++    H N++    +             LV E M    L + +H     +   
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQ 134

Query: 625 QRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM 684
                M  +   L  LH    A V+H DL P N+LL DN    + DF +A+     D + 
Sbjct: 135 HIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAR-EDTADANK 190

Query: 685 TQTQTLATIGYMAPE-------YGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEM 737
             T  +    Y APE       +      +   D++S G ++ E F RK     LF G  
Sbjct: 191 --THYVTHRWYRAPELVMQFKGF------TKLVDMWSAGCVMAEMFNRK----ALFRGST 238

Query: 738 TLKHW 742
                
Sbjct: 239 FYNQL 243

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  100 bits (250), Expect = 4e-23
 Identities = 57/231 (24%), Positives = 88/231 (38%), Gaps = 52/231 (22%)

Query: 525 ATDKFSEN---------NLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDVEC 574
           +TD FS           +++G G    V     +    E AVK+   Q G        E 
Sbjct: 2   STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREV 61

Query: 575 AMMKSIR-HRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRL------ 627
            M+   + HRN++++I     E+   LV E M  GS+                +      
Sbjct: 62  EMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI-------------LSHIHKRRHF 108

Query: 628 ------NIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLT 678
                  ++ DVASAL++LH   +  + H DLKP N+L    +      + DF +   + 
Sbjct: 109 NELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165

Query: 679 -GEDQSMTQTQTLATI----GYMAPEYGREGQVSTNG-----DVYSFGIML 719
              D S   T  L T      YMAPE         +      D++S G++L
Sbjct: 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 99.2 bits (248), Expect = 4e-23
 Identities = 56/204 (27%), Positives = 83/204 (40%), Gaps = 24/204 (11%)

Query: 526 TDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRN 584
              ++  N IGRG +G V  A      +  A K            F  E  +MKS+ H N
Sbjct: 8   NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67

Query: 585 LVKVISSCSNEEFKALVLEYMPHGSL-EKYLHSSNYSLDIFQRLNIMIDVASALEYLHFG 643
           ++++  +  +     LV+E    G L E+ +H   +         IM DV SA+ Y H  
Sbjct: 68  IIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRES--DAARIMKDVLSAVAYCH-- 123

Query: 644 YSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPE- 699
               V H DLKP N L      +    L DFG+A       + M     + T  Y++P+ 
Sbjct: 124 -KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF-KPGKMM--RTKVGTPYYVSPQV 179

Query: 700 ----YGREGQVSTNGDVYSFGIML 719
               YG E       D +S G+M+
Sbjct: 180 LEGLYGPE------CDEWSAGVMM 197

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 99.5 bits (249), Expect = 4e-23
 Identities = 56/216 (25%), Positives = 99/216 (45%), Gaps = 19/216 (8%)

Query: 527 DKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDV----ECAMMKSIRH 582
           +K+     IG G +G VYKA+   G   A+K   L+     +        E +++K ++H
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKED--EGIPSTTIREISILKELKH 59

Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
            N+VK+      ++   LV E++    L+K L      L+     + ++ + + + Y H 
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH- 117

Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPE--Y 700
                V+H DLKP N+L++      ++DFG+A+      +    T  + T+ Y AP+   
Sbjct: 118 --DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY--THEIVTLWYRAPDVLM 173

Query: 701 GREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGE 736
           G + + ST  D++S G +  E      P   LF G 
Sbjct: 174 GSK-KYSTTIDIWSVGCIFAEMVNG-TP---LFPGV 204

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  100 bits (250), Expect = 4e-23
 Identities = 52/208 (25%), Positives = 84/208 (40%), Gaps = 50/208 (24%)

Query: 535 IGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIR-HRNLVKVISSC 592
           +G G F    K    +     AVK+ +    R   +   E   +K    H N+VK+    
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVF 75

Query: 593 SNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRL------------NIMIDVASALEYL 640
            ++    LV+E +  G L             F+R+             IM  + SA+ ++
Sbjct: 76  HDQLHTFLVMELLNGGEL-------------FERIKKKKHFSETEASYIMRKLVSAVSHM 122

Query: 641 HFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMA 697
           H      V+H DLKP N+L    +DN+   + DFG A+L   ++Q +       T+ Y A
Sbjct: 123 H---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL--KTPCFTLHYAA 177

Query: 698 PE------YGREGQVSTNGDVYSFGIML 719
           PE      Y          D++S G++L
Sbjct: 178 PELLNQNGYDES------CDLWSLGVIL 199

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  102 bits (256), Expect = 5e-23
 Identities = 52/207 (25%), Positives = 93/207 (44%), Gaps = 27/207 (13%)

Query: 526 TDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFN---LQCGRAFKSFDVECAMMKSIR 581
           +D++    ++G+G FG V   +    G E AVKV +   ++     +S   E  ++K + 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84

Query: 582 HRNLVKVISSCSNEEFKALVLEYMPHGSL-EKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
           H N++K+     ++ +  LV E    G L ++ +    +S        I+  V S + Y+
Sbjct: 85  HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV--DAARIIRQVLSGITYM 142

Query: 641 HFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMA 697
           H      ++H DLKP N+LL     +    + DFG++       + M     + T  Y+A
Sbjct: 143 H---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE-ASKKM--KDKIGTAYYIA 196

Query: 698 PE-----YGREGQVSTNGDVYSFGIML 719
           PE     Y  +       DV+S G++L
Sbjct: 197 PEVLHGTYDEK------CDVWSTGVIL 217

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  102 bits (256), Expect = 5e-23
 Identities = 53/240 (22%), Positives = 97/240 (40%), Gaps = 30/240 (12%)

Query: 496 QKREKGPPNDPNMPPVATWRRFSYLELFQATDKFSEN----NLIGRGGFGSVYKAR-IRD 550
                      N+      +    + +       SE       +G G +G V   R    
Sbjct: 2   HHHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVT 61

Query: 551 GMEVAVKVFNLQCGRAFKSFDV--ECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHG 608
            +E A+K+          +  +  E A++K + H N++K+     ++    LV+E    G
Sbjct: 62  HVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGG 121

Query: 609 SL-EKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL---DDNM 664
            L ++ +H   ++        I+  V S + YLH      ++H DLKP N+LL   + + 
Sbjct: 122 ELFDEIIHRMKFNEV--DAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDA 176

Query: 665 VAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPE-----YGREGQVSTNGDVYSFGIML 719
           +  + DFG++ +     + M   + L T  Y+APE     Y  +       DV+S G++L
Sbjct: 177 LIKIVDFGLSAVF-ENQKKM--KERLGTAYYIAPEVLRKKYDEK------CDVWSIGVIL 227

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 99.2 bits (248), Expect = 7e-23
 Identities = 62/220 (28%), Positives = 95/220 (43%), Gaps = 26/220 (11%)

Query: 527 DKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNL-QCGRAFKSFDV-ECAMMKSIRHR 583
           +K+ +   IG G +G V+K R RD G  VA+K F   +     K   + E  M+K ++H 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62

Query: 584 NLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFG 643
           NLV ++     +    LV EY  H ++   L      +      +I      A+ + H  
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH-- 119

Query: 644 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPE---- 699
                IH D+KP N+L+  + V  L DFG A+LLTG          +AT  Y +PE    
Sbjct: 120 -KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY--DDEVATRWYRSPELLVG 176

Query: 700 ---YGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGE 736
              Y          DV++ G +  E  +   P   L+ G+
Sbjct: 177 DTQY------GPPVDVWAIGCVFAELLSG-VP---LWPGK 206

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  102 bits (256), Expect = 7e-23
 Identities = 48/233 (20%), Positives = 90/233 (38%), Gaps = 13/233 (5%)

Query: 494 KYQKREKGPPNDPNMPPVATWRRFSYLELFQATDKFSE----NNLIGRGGFGSVYKARIR 549
           K  + +    ++ +      W+++    +    D   +    +  +G G FG V++   R
Sbjct: 120 KIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTER 179

Query: 550 D-GMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHG 608
             G   A K          ++   E   M  +RH  LV +  +  ++    ++ E+M  G
Sbjct: 180 ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGG 239

Query: 609 SLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHL 668
            L + +   +  +   + +  M  V   L ++H       +H DLKP N++        L
Sbjct: 240 ELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNEL 296

Query: 669 --SDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIML 719
              DFG+   L    QS+    T  T  + APE      V    D++S G++ 
Sbjct: 297 KLIDFGLTAHLD-PKQSV--KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 99.2 bits (248), Expect = 9e-23
 Identities = 67/241 (27%), Positives = 110/241 (45%), Gaps = 19/241 (7%)

Query: 501 GPPNDPNMPPVATWRRFSYLELFQATDKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVF 559
           G  +  +   V       Y   FQ+ +K+    L+G G +G V K R +D G  VA+K F
Sbjct: 2   GHHHHHHSSGVDLGTENLY---FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKF 58

Query: 560 NL-QCGRAFKSFDV-ECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSS 617
                 +  K   + E  ++K +RH NLV ++  C  ++   LV E++ H ++   L   
Sbjct: 59  LESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELF 117

Query: 618 NYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 677
              LD       +  + + + + H   S  +IH D+KP N+L+  + V  L DFG A+ L
Sbjct: 118 PNGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTL 174

Query: 678 TGEDQSMTQTQTLATIGYMAPE--YGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNG 735
               +       +AT  Y APE   G + +     DV++ G ++ E F   +P   LF G
Sbjct: 175 AAPGEVY--DDEVATRWYRAPELLVG-DVKYGKAVDVWAIGCLVTEMFMG-EP---LFPG 227

Query: 736 E 736
           +
Sbjct: 228 D 228

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  101 bits (254), Expect = 1e-22
 Identities = 50/206 (24%), Positives = 91/206 (44%), Gaps = 26/206 (12%)

Query: 526 TDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQ--CGRAFKSFDVECAMMKSIRH 582
            ++++   ++G+G FG V K +      E AVKV N      +   +   E  ++K + H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSL-EKYLHSSNYSLDIFQRLNIMIDVASALEYLH 641
            N++K+     +     +V E    G L ++ +    +S        I+  V S + Y+H
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEH--DAARIIKQVFSGITYMH 138

Query: 642 FGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 698
                 ++H DLKP N+LL   + +    + DFG++     ++  M     + T  Y+AP
Sbjct: 139 ---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF-QQNTKM--KDRIGTAYYIAP 192

Query: 699 E-----YGREGQVSTNGDVYSFGIML 719
           E     Y  +       DV+S G++L
Sbjct: 193 EVLRGTYDEK------CDVWSAGVIL 212

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 98.1 bits (245), Expect = 2e-22
 Identities = 59/228 (25%), Positives = 98/228 (42%), Gaps = 61/228 (26%)

Query: 526 TDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFN---LQCGRAFKSFDV-----ECAM 576
            D++  +  +G G  G V  A   +   +VA+K+ +      G A ++        E  +
Sbjct: 9   RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68

Query: 577 MKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRL--------- 627
           +K + H  ++K+ +    E++  +VLE M  G L             F ++         
Sbjct: 69  LKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGEL-------------FDKVVGNKRLKEA 114

Query: 628 ---NIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTGED 681
                   +  A++YLH      +IH DLKP NVLL   +++ +  ++DFG +K+L GE 
Sbjct: 115 TCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GET 170

Query: 682 QSMTQTQTLA-TIGYMAPE---------YGREGQVSTNGDVYSFGIML 719
             M    TL  T  Y+APE         Y R   V    D +S G++L
Sbjct: 171 SLMR---TLCGTPTYLAPEVLVSVGTAGYNRA--V----DCWSLGVIL 209

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 99.3 bits (248), Expect = 2e-22
 Identities = 66/262 (25%), Positives = 112/262 (42%), Gaps = 50/262 (19%)

Query: 501 GPPNDPNMPPVATWRRFSYLE------LFQATDKFSENNLIGRGGFGSVYKARIRDGMEV 554
            P N   + P+    +   +         Q    ++   +IG G FG V++A++ +  EV
Sbjct: 8   APLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEV 67

Query: 555 AVK-VFNLQC--GRAFKSFDVECAMMKSIRHRNLVK----VISSCSNEEFKA--LVLEYM 605
           A+K V   +    R       E  +M+ ++H N+V       S+   ++     LVLEY+
Sbjct: 68  AIKKVLQDKRFKNR-------ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV 120

Query: 606 PHGSLEKYLHS---SNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD- 661
           P  ++ +          ++ +      M  +  +L Y+H   S  + H D+KP N+LLD 
Sbjct: 121 PE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDP 176

Query: 662 DNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPE-------YGREGQVSTNGDVYS 714
            + V  L DFG AK+L    +       + +  Y APE       Y      +TN D++S
Sbjct: 177 PSGVLKLIDFGSAKILI-AGEPN--VSYICSRYYRAPELIFGATNY------TTNIDIWS 227

Query: 715 FGIMLMETFTRKKPTDELFNGE 736
            G ++ E     +P   LF GE
Sbjct: 228 TGCVMAELMQG-QP---LFPGE 245

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 98.5 bits (246), Expect = 3e-22
 Identities = 71/301 (23%), Positives = 127/301 (42%), Gaps = 53/301 (17%)

Query: 502 PPNDPNMPPVATWRRFSYLELFQATDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVK--- 557
             +       A        ++F    +++  + IG G +G V  A    + + VA+K   
Sbjct: 2   HHHHHMAAAAAAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS 61

Query: 558 VFN--LQCGRAFKSFDVECAMMKSIRHRNLVK---VISSCSNEEFKA--LVLEYMPHGSL 610
            F     C R  +    E  ++   RH N++    +I + + E+ K   +V + M    L
Sbjct: 62  PFEHQTYCQRTLR----EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDL 116

Query: 611 EKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSD 670
            K L + + S D       +  +   L+Y+H   SA V+H DLKPSN+LL+      + D
Sbjct: 117 YKLLKTQHLSNDHIC--YFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICD 171

Query: 671 FGIAKLLTGEDQSMTQ-TQTLATIGYMAPE-------YGREGQVSTNGDVYSFGIMLMET 722
           FG+A++   +       T+ +AT  Y APE       Y      + + D++S G +L E 
Sbjct: 172 FGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY------TKSIDIWSVGCILAEM 225

Query: 723 FTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLL---SQEDIHFVAKEQCVSFVFN 779
            + +     +F G+  L     D L           +L   SQED++ +   +  +++ +
Sbjct: 226 LSNR----PIFPGKHYL-----DQLNHIL------GILGSPSQEDLNCIINLKARNYLLS 270

Query: 780 L 780
           L
Sbjct: 271 L 271

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 98.2 bits (245), Expect = 3e-22
 Identities = 57/256 (22%), Positives = 94/256 (36%), Gaps = 65/256 (25%)

Query: 496 QKREKGPPNDPNMPPVATWRRFSYLELFQATDKFSEN----NLIGRGGFGSVYKARIRD- 550
              +       +  P        Y       D  S+     + +GRG    VY+ + +  
Sbjct: 18  LYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGT 77

Query: 551 GMEVAVKVFNLQCGRAFKSFDV-----ECAMMKSIRHRNLVKVISSCSNEEFKALVLEYM 605
               A+KV         K+ D      E  ++  + H N++K+          +LVLE +
Sbjct: 78  QKPYALKVLK-------KTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELV 130

Query: 606 PHGSLEKYLHSSNYSLDIFQRL------------NIMIDVASALEYLHFGYSAPVIHCDL 653
             G L             F R+            + +  +  A+ YLH      ++H DL
Sbjct: 131 TGGEL-------------FDRIVEKGYYSERDAADAVKQILEAVAYLH---ENGIVHRDL 174

Query: 654 KPSNVLL---DDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAPE------YGRE 703
           KP N+L      +    ++DFG++K++      M    T+  T GY APE      YG E
Sbjct: 175 KPENLLYATPAPDAPLKIADFGLSKIV-EHQVLMK---TVCGTPGYCAPEILRGCAYGPE 230

Query: 704 GQVSTNGDVYSFGIML 719
             V    D++S GI+ 
Sbjct: 231 --V----DMWSVGIIT 240

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 96.1 bits (240), Expect = 4e-22
 Identities = 53/209 (25%), Positives = 85/209 (40%), Gaps = 29/209 (13%)

Query: 526 TDKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFN-LQCGRAFKSFDVECAMMKSIRHR 583
            D F     +G G FG V+    R  G+E  +K  N  +     +  + E  ++KS+ H 
Sbjct: 21  DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80

Query: 584 NLVKVISSCSNEEFKALVLEYMPHGSL-----EKYLHSSNYSLDIFQRLNIMIDVASALE 638
           N++K+     +     +V+E    G L              S        +M  + +AL 
Sbjct: 81  NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEG--YVAELMKQMMNALA 138

Query: 639 YLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGY 695
           Y H   S  V+H DLKP N+L      +    + DFG+A+L    D+    T    T  Y
Sbjct: 139 YFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF-KSDEHS--TNAAGTALY 192

Query: 696 MAPE-----YGREGQVSTNGDVYSFGIML 719
           MAPE        +       D++S G+++
Sbjct: 193 MAPEVFKRDVTFK------CDIWSAGVVM 215

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 98.2 bits (245), Expect = 4e-22
 Identities = 62/237 (26%), Positives = 97/237 (40%), Gaps = 37/237 (15%)

Query: 522 LFQATDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVK----VFNLQ--CGRAFKSFDVEC 574
            F    ++     IG G  G V  A        VA+K     F  Q    RA++    E 
Sbjct: 20  TFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR----EL 75

Query: 575 AMMKSIRHRNLVKV----ISSCSNEEFKA--LVLEYMP---HGSLEKYLHSSNYSLDIFQ 625
            +MK + H+N++ +        S EEF+   +V+E M       ++  L     S  ++Q
Sbjct: 76  VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQ 135

Query: 626 RLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMT 685
            L         +++LH   SA +IH DLKPSN+++  +    + DFG+A+       S  
Sbjct: 136 MLC-------GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFM 182

Query: 686 QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHW 742
            T  + T  Y APE         N D++S G ++ E          LF G   +  W
Sbjct: 183 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV----LFPGTDHIDQW 235

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 99.8 bits (249), Expect = 4e-22
 Identities = 51/252 (20%), Positives = 100/252 (39%), Gaps = 43/252 (17%)

Query: 495 YQKREKGPPNDPNMPPVATWRRFSYLELFQA--TDKFSENNLIGRGGFGSVYKAR-IRDG 551
           +         +             Y+   +    + + +   +G G +G V   +     
Sbjct: 2   HHHHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGH 61

Query: 552 MEVAVKV-------------FNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFK 598
            E A+KV              N    +  +    E +++KS+ H N++K+     ++++ 
Sbjct: 62  SEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYF 121

Query: 599 ALVLEYMPHGSL-EKYLHSSNYSLDIFQR--LNIMIDVASALEYLHFGYSAPVIHCDLKP 655
            LV E+   G L E+ ++   +     +    NIM  + S + YLH      ++H D+KP
Sbjct: 122 YLVTEFYEGGELFEQIINRHKFD----ECDAANIMKQILSGICYLH---KHNIVHRDIKP 174

Query: 656 SNVLL---DDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPE-----YGREGQVS 707
            N+LL   +  +   + DFG++     +D  +     L T  Y+APE     Y  +    
Sbjct: 175 ENILLENKNSLLNIKIVDFGLSSFF-SKDYKL--RDRLGTAYYIAPEVLKKKYNEK---- 227

Query: 708 TNGDVYSFGIML 719
              DV+S G+++
Sbjct: 228 --CDVWSCGVIM 237

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 97.6 bits (244), Expect = 5e-22
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 19/218 (8%)

Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFK-SFDV----ECAMMKSI 580
            ++ + + +G G F +VYKAR       VA+K   L      K   +     E  +++ +
Sbjct: 10  KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69

Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
            H N++ ++ +  ++   +LV ++M    LE  +  ++  L        M+     LEYL
Sbjct: 70  SHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYL 128

Query: 641 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPE- 699
           H      ++H DLKP+N+LLD+N V  L+DFG+AK     +++   T  + T  Y APE 
Sbjct: 129 H---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--THQVVTRWYRAPEL 183

Query: 700 -YGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGE 736
            +G         D+++ G +L E   R  P      G+
Sbjct: 184 LFGAR-MYGVGVDMWAVGCILAELLLR-VP---FLPGD 216

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 98.6 bits (246), Expect = 5e-22
 Identities = 59/228 (25%), Positives = 98/228 (42%), Gaps = 61/228 (26%)

Query: 526 TDKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFN---LQCGRAFKSFDV-----ECAM 576
            D++  +  +G G  G V  A  R    +VA+++ +      G A ++        E  +
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193

Query: 577 MKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRL--------- 627
           +K + H  ++K+ +    E++  +VLE M  G L             F ++         
Sbjct: 194 LKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGEL-------------FDKVVGNKRLKEA 239

Query: 628 ---NIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTGED 681
                   +  A++YLH      +IH DLKP NVLL   +++ +  ++DFG +K+L GE 
Sbjct: 240 TCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GET 295

Query: 682 QSMTQTQTLA-TIGYMAPE---------YGREGQVSTNGDVYSFGIML 719
             M    TL  T  Y+APE         Y R   V    D +S G++L
Sbjct: 296 SLMR---TLCGTPTYLAPEVLVSVGTAGYNRA--V----DCWSLGVIL 334

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 99.9 bits (249), Expect = 6e-22
 Identities = 61/226 (26%), Positives = 99/226 (43%), Gaps = 27/226 (11%)

Query: 527 DKFSENNLIGRGGFGSVYKARIRDGMEV-AVKVFNLQCGRAFKSFDVECAM-----MKSI 580
           D F +  ++GRGGFG V+  +++   ++ A K   L   R  K    + AM     +  +
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKK--LNKKRLKKRKGYQGAMVEKKILAKV 242

Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIF--QRLNIMI-DVASAL 637
             R +V +  +   +    LV+  M  G +  ++++ +     F   R       + S L
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302

Query: 638 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYM 696
           E+LH      +I+ DLKP NVLLDD+    +SD G+A  L       T+T+  A T G+M
Sbjct: 303 EHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ---TKTKGYAGTPGFM 356

Query: 697 APEYGREGQVSTNGDVYSFGIMLMETFT---------RKKPTDELF 733
           APE     +   + D ++ G+ L E             K    EL 
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK 402

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 97.2 bits (242), Expect = 6e-22
 Identities = 56/251 (22%), Positives = 86/251 (34%), Gaps = 66/251 (26%)

Query: 526 TDKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDV-----ECAMMKS 579
             K+     IG+G +G V  A         A+K+ N    R     DV     E  +MK 
Sbjct: 25  QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84

Query: 580 IRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRL------------ 627
           + H N+ ++     +E++  LV+E    G L   L+           +            
Sbjct: 85  LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144

Query: 628 ---------------------------NIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL 660
                                      NIM  + SAL YLH   +  + H D+KP N L 
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLF 201

Query: 661 DDNMVAHL--SDFGIAKLLTGEDQSMTQ--TQTLATIGYMAPE--------YGREGQVST 708
             N    +   DFG++K     +       T    T  ++APE        YG +     
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK----- 256

Query: 709 NGDVYSFGIML 719
             D +S G++L
Sbjct: 257 -CDAWSAGVLL 266

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 97.1 bits (242), Expect = 1e-21
 Identities = 51/229 (22%), Positives = 99/229 (43%), Gaps = 11/229 (4%)

Query: 496 QKREKGPPNDPNMPPVATWRRFSYLELFQATDKFS--ENNLIGRGGFGSVYKARIRD-GM 552
            KR      D   PP     R    +       ++  +  ++G G FG V+K      G+
Sbjct: 56  SKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGL 115

Query: 553 EVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEK 612
           ++A K+   +  +  +    E ++M  + H NL+++  +  ++    LV+EY+  G L  
Sbjct: 116 KLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFD 175

Query: 613 YLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHL--SD 670
            +   +Y+L     +  M  +   + ++H  Y   ++H DLKP N+L  +     +   D
Sbjct: 176 RIIDESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIID 232

Query: 671 FGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIML 719
           FG+A+      + +       T  ++APE      VS   D++S G++ 
Sbjct: 233 FGLARRY-KPREKL--KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 95.7 bits (239), Expect = 1e-21
 Identities = 52/214 (24%), Positives = 97/214 (45%), Gaps = 15/214 (7%)

Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDV-ECAMMKSIRHRN 584
           + + + + +G G + +VYK +       VA+K   L+         + E +++K ++H N
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61

Query: 585 LVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGY 644
           +V +      E+   LV EY+    L++YL      +++      +  +   L Y H   
Sbjct: 62  IVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH--- 117

Query: 645 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPE--YGR 702
              V+H DLKP N+L+++     L+DFG+A+  +   ++      + T+ Y  P+   G 
Sbjct: 118 RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY--DNEVVTLWYRPPDILLGS 175

Query: 703 EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGE 736
               ST  D++  G +  E  T  +P   LF G 
Sbjct: 176 T-DYSTQIDMWGVGCIFYEMATG-RP---LFPGS 204

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 95.4 bits (238), Expect = 1e-21
 Identities = 45/200 (22%), Positives = 79/200 (39%), Gaps = 22/200 (11%)

Query: 534 LIGRGGFGSVYKAR-IRDGMEVAVKVFN----LQCGRAFKSFDVECAMMKSIRHRNLVK- 587
           L+G G +G V +          AVK+       +      +   E  +++ +RH+N+++ 
Sbjct: 12  LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71

Query: 588 --VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYS 645
             V+ +   ++   +V+EY   G  E           + Q       +   LEYLH   S
Sbjct: 72  VDVLYNEEKQKM-YMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---S 127

Query: 646 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATI----GYMAPE-- 699
             ++H D+KP N+LL       +S  G+A+ L           T  T      +  PE  
Sbjct: 128 QGIVHKDIKPGNLLLTTGGTLKISALGVAEAL----HPFAADDTCRTSQGSPAFQPPEIA 183

Query: 700 YGREGQVSTNGDVYSFGIML 719
            G +       D++S G+ L
Sbjct: 184 NGLDTFSGFKVDIWSAGVTL 203

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 98.6 bits (245), Expect = 2e-21
 Identities = 55/285 (19%), Positives = 104/285 (36%), Gaps = 28/285 (9%)

Query: 140 NLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSH-- 197
                    L   ++T          + +   S+  I  +N+ +        V  + +  
Sbjct: 19  AFAETIKDNLKKKSVTD-------AVTQNELNSIDQIIANNSDI------KSVQGIQYLP 65

Query: 198 SLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQL 257
           ++   ++    ++  I + +TNL +L  + L  NK+   +  +L  L+KL+ + LE+N +
Sbjct: 66  NVTKLFLNGNKLT-DI-KPLTNLKNLGWLFLDENKIK-DLS-SLKDLKKLKSLSLEHNGI 121

Query: 258 EGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKD 317
              I + +    +L  L LG NK++  I    S +T L  LSL  N+++ I      L  
Sbjct: 122 S-DI-NGLVHLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQISDIV-PLAGLTK 176

Query: 318 ILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLE 377
           + +L LS N  S    L    LK L  ++               +L     +      L 
Sbjct: 177 LQNLYLSKNHISDLRALA--GLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV 234

Query: 378 GSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFN 422
              P+   D    +  N+ ++    T  VS      +        
Sbjct: 235 --TPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKAR 277

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 96.3 bits (239), Expect = 8e-21
 Identities = 50/281 (17%), Positives = 87/281 (30%), Gaps = 48/281 (17%)

Query: 144 LEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFY 203
           +         +         +            +L    +   +       L+  +    
Sbjct: 1   MGETITVSTPIKQ-------IFPDDAFAETIKDNLKKKSVTDAVT---QNELNS-IDQII 49

Query: 204 MYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPD 263
             N ++     + I  L ++T + L GNKL   I   L  L+ L  + L+ N+++     
Sbjct: 50  ANNSDIK--SVQGIQYLPNVTKLFLNGNKLT-DIK-PLTNLKNLGWLFLDENKIK----- 100

Query: 264 SICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNL 323
                            LS        ++  LK LSL  N ++ I      L  +  L L
Sbjct: 101 ----------------DLSS-----LKDLKKLKSLSLEHNGISDIN-GLVHLPQLESLYL 138

Query: 324 SSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDS 383
            +N  +    L    L  L  +    N  S I+P  +  L  L+NL+L  N +  S   +
Sbjct: 139 GNNKITDITVLS--RLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHI--SDLRA 192

Query: 384 FGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKL 424
              L +L  L L               L     +  +   L
Sbjct: 193 LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 233

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 87.1 bits (215), Expect = 7e-18
 Identities = 47/237 (19%), Positives = 91/237 (38%), Gaps = 24/237 (10%)

Query: 3   SIINNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIP 62
           ++    +T       + ++++  +   N+ +  + +  I +L N+  L L+ NKL    P
Sbjct: 27  NLKKKSVTDAVT--QNELNSIDQIIANNSDI--KSVQGIQYLPNVTKLFLNGNKLTDIKP 82

Query: 63  AAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSK 122
             + N+  L    +  N +   LSS+ D  L  L+ L L  N  S  I   + +  +L  
Sbjct: 83  --LTNLKNLGWLFLDENKIK-DLSSLKD--LKKLKSLSLEHNGIS-DING-LVHLPQLES 135

Query: 123 LALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNP 182
           L L  N  +    +    L  L+ L+L DN ++        +  L+    L ++ LS N 
Sbjct: 136 LYLGNNKITDI--TVLSRLTKLDTLSLEDNQISD-------IVPLAGLTKLQNLYLSKNH 186

Query: 183 LDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPI 239
           +  +     +  L  +L    +++           +NL    T+      L     I
Sbjct: 187 ISDLRA---LAGLK-NLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEII 239

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 94.9 bits (236), Expect = 3e-21
 Identities = 39/178 (21%), Positives = 74/178 (41%), Gaps = 15/178 (8%)

Query: 569 SFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNY--SLDIFQR 626
           +  V+   M     +N V  +   S + +  + ++     +L+ +++        +    
Sbjct: 107 APSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVC 166

Query: 627 LNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQ 686
           L+I I +A A+E+LH   S  ++H DLKPSN+    + V  + DFG+   +  +++  T 
Sbjct: 167 LHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223

Query: 687 TQTLA----------TIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFN 734
              +           T  YM+PE       S   D++S G++L E         E   
Sbjct: 224 LTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVR 281

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 51.4 bits (123), Expect = 5e-07
 Identities = 19/96 (19%), Positives = 34/96 (35%), Gaps = 2/96 (2%)

Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNL-QCGRAFKSFDVECAMMKSIRHRN 584
             F     +GRGGFG V++A+   D    A+K   L     A +    E   +  + H  
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65

Query: 585 LVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYS 620
           +V+  ++      +    E       ++       S
Sbjct: 66  IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSS 101

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 95.1 bits (237), Expect = 4e-21
 Identities = 65/273 (23%), Positives = 121/273 (44%), Gaps = 41/273 (15%)

Query: 522 LFQATDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVK----VFN--LQCGRAFKSFDVEC 574
           +++  +++   + +G G +GSV  A   + G+ VAVK     F   +   R ++    E 
Sbjct: 24  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----EL 79

Query: 575 AMMKSIRHRNLVKV----ISSCSNEEFKA--LVLEYMPHGSLEKYLHSSNYSLDIFQRLN 628
            ++K ++H N++ +      + S EEF    LV   M    L   +     + D  Q   
Sbjct: 80  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQ--F 136

Query: 629 IMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQ 688
           ++  +   L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+        M  T 
Sbjct: 137 LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTADEM--TG 188

Query: 689 TLATIGYMAPE-YGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCL 747
            +AT  Y APE        +   D++S G ++ E  T +     LF G       ++   
Sbjct: 189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR----TLFPG----TDHIDQLK 240

Query: 748 PISTMEVVDANLLSQEDIHFVAKEQCVSFVFNL 780
            I  + +V       E +  ++ E   +++ +L
Sbjct: 241 LI--LRLVGT--PGAELLKKISSESARNYIQSL 269

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 95.2 bits (237), Expect = 6e-21
 Identities = 63/235 (26%), Positives = 105/235 (44%), Gaps = 45/235 (19%)

Query: 523 FQATDKFSENNLIGRGGFGSVYKARIRD-GMEVAVK-VFNLQ--CGRAFKSFDVECAMMK 578
                 +++  +IG G FG VY+A++ D G  VA+K V   +    R       E  +M+
Sbjct: 50  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMR 102

Query: 579 SIRHRNLVKVI------SSCSNEEFKALVLEYMPHGSLEKYLHS---SNYSLDIFQRLNI 629
            + H N+V++           +E +  LVL+Y+P  ++ +       +  +L +      
Sbjct: 103 KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLY 161

Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTGEDQSMTQTQ 688
           M  +  +L Y+H   S  + H D+KP N+LLD D  V  L DFG AK L    +      
Sbjct: 162 MYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-RGEPN--VS 215

Query: 689 TLATIGYMAPE-------YGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGE 736
            + +  Y APE       Y      +++ DV+S G +L E     +P   +F G+
Sbjct: 216 YICSRYYRAPELIFGATDY------TSSIDVWSAGCVLAELLLG-QP---IFPGD 260

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 92.3 bits (230), Expect = 7e-21
 Identities = 55/218 (25%), Positives = 86/218 (39%), Gaps = 13/218 (5%)

Query: 213 IPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLS-VEL 271
           IP+ +        + L  N L      +     +LQ +DL   +++ +I D    S   L
Sbjct: 22  IPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHL 78

Query: 272 YELELGGNKLSGSIPA-CFSNMTFLKVLSLGSNELTSIPLN-FWSLKDILDLNLSSNCF- 328
             L L GN +  S+    FS ++ L+ L      L S+       LK + +LN++ N   
Sbjct: 79  STLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ 137

Query: 329 SGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLE----NLFLEYNRLEGSIPDSF 384
           S  LP    NL  L  +D S N    I   ++  L  +     +L L  N +   I    
Sbjct: 138 SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGA 196

Query: 385 GDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFN 422
              I LK L L  N L        ++L+ L+ + L  N
Sbjct: 197 FKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 88.5 bits (220), Expect = 2e-19
 Identities = 59/285 (20%), Positives = 94/285 (32%), Gaps = 80/285 (28%)

Query: 21  SNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNS 80
            + K L L  N L+    +       L  LDLS+ ++  TI    +              
Sbjct: 28  FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEI-QTIEDGAYQ------------- 73

Query: 81  LSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNA-SKLSKLALEMNSFSGFIPSTFG 139
                       L +L  L L GN    ++    F+  S L KL     + +       G
Sbjct: 74  -----------SLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIG 121

Query: 140 NLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSL 199
           +L+ L+ L +  N + S  L   F S+L+N   L H+ LS+N +  I             
Sbjct: 122 HLKTLKELNVAHNLIQSFKLPEYF-SNLTN---LEHLDLSSNKIQSIYCTD--------- 168

Query: 200 KNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEG 259
                            +  L  +  + L                     +DL  N +  
Sbjct: 169 -----------------LRVLHQMPLLNL--------------------SLDLSLNPMN- 190

Query: 260 SIPDSICLSVELYELELGGNKLSGSIPA-CFSNMTFLKVLSLGSN 303
            I       + L EL L  N+L  S+P   F  +T L+ + L +N
Sbjct: 191 FIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 86.9 bits (216), Expect = 5e-19
 Identities = 43/205 (20%), Positives = 65/205 (31%), Gaps = 30/205 (14%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHE--IGHLHNLGFLDLSQNKLLGTIPA 63
            N L         +   L+VL L    +Q   I +     L +L  L L+ N  + ++  
Sbjct: 37  FNPLRHLGSYSFFSFPELQVLDLSRCEIQ--TIEDGAYQSLSHLSTLILTGNP-IQSLAL 93

Query: 64  AIF-NVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIF-NASKLS 121
             F  +S+L+       +L+  L +     L  L+ L +  N          F N + L 
Sbjct: 94  GAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLE 152

Query: 122 KLALEMNSFSGFIPSTFGNLRNLEW----LTLYDNNLTS-----------STLDLSF--L 164
            L L  N       +    L  +      L L  N +               L L    L
Sbjct: 153 HLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELALDTNQL 212

Query: 165 SSLS-----NCKSLTHISLSNNPLD 184
            S+         SL  I L  NP D
Sbjct: 213 KSVPDGIFDRLTSLQKIWLHTNPWD 237

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 69.2 bits (170), Expect = 5e-13
 Identities = 36/165 (21%), Positives = 64/165 (38%), Gaps = 7/165 (4%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAI 65
            N + S        +S+L+ L      L       IGHL  L  L+++ N +        
Sbjct: 85  GNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEY 144

Query: 66  F-NVSTLKAFAVTNNSLSGCLSSITDVGLPNLEV----LYLWGNNFSGTIPHFIFNASKL 120
           F N++ L+   +++N +     +     L  + +    L L  N  +  I    F   +L
Sbjct: 145 FSNLTNLEHLDLSSNKIQSIYCTDLR-VLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRL 202

Query: 121 SKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLS 165
            +LAL+ N         F  L +L+ + L+ N    S   + +LS
Sbjct: 203 KELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLS 247

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 66.9 bits (164), Expect = 3e-12
 Identities = 35/178 (19%), Positives = 56/178 (31%), Gaps = 52/178 (29%)

Query: 260 SIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDIL 319
            IPD++        L+L  N L       F +   L+VL L   E+ +I           
Sbjct: 21  KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIE---------- 68

Query: 320 DLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGS 379
                   +                                  L +L  L L  N ++ S
Sbjct: 69  -----DGAYQS--------------------------------LSHLSTLILTGNPIQ-S 90

Query: 380 IP-DSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIPRGGSFGN 436
           +   +F  L SL+ L     NL+      +  L  LK+LN++ N ++        F N
Sbjct: 91  LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFSN 147

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 93.1 bits (232), Expect = 8e-21
 Identities = 52/212 (24%), Positives = 87/212 (41%), Gaps = 48/212 (22%)

Query: 534 LIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSF-----DVECAM-----MKSIRH 582
           ++G G F +V  AR      E A+K+         K        V         M  + H
Sbjct: 37  ILGEGSFSTVVLARELATSREYAIKILE-------KRHIIKENKVPYVTRERDVMSRLDH 89

Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNI------MIDVASA 636
              VK+  +  ++E     L Y  +G L KY+             +         ++ SA
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-------GSFDETCTRFYTAEIVSA 142

Query: 637 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTL-ATIGY 695
           LEYLH      +IH DLKP N+LL+++M   ++DFG AK+L+ E +      +   T  Y
Sbjct: 143 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR-ANSFVGTAQY 198

Query: 696 MAPE------YGREGQVSTNGDVYSFGIMLME 721
           ++PE        +        D+++ G ++ +
Sbjct: 199 VSPELLTEKSACKS------SDLWALGCIIYQ 224

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 96.4 bits (240), Expect = 8e-21
 Identities = 57/242 (23%), Positives = 102/242 (42%), Gaps = 31/242 (12%)

Query: 517 FSYLELFQAT-DKFSENNLIGRGGFGSVYKARIRDGMEV-AVKVFNLQCGRAFKSFDVEC 574
           + +LE    T + F +  ++G+GGFG V   ++R   ++ A K   L+  R  K      
Sbjct: 173 WKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKK--LEKKRIKKRKGEAM 230

Query: 575 AM-----MKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNI 629
           A+     ++ +  R +V +  +   ++   LVL  M  G L    H  +     F     
Sbjct: 231 ALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDL--KFHIYHMGQAGFPEARA 288

Query: 630 MI---DVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQ 686
           +    ++   LE LH      +++ DLKP N+LLDD+    +SD G+A  +         
Sbjct: 289 VFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ----T 341

Query: 687 TQTLA-TIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT---------RKKPTDELFNGE 736
            +    T+GYMAPE  +  + + + D ++ G +L E            +K   +E+    
Sbjct: 342 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV 401

Query: 737 MT 738
             
Sbjct: 402 KE 403

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 95.3 bits (237), Expect = 9e-21
 Identities = 63/237 (26%), Positives = 99/237 (41%), Gaps = 37/237 (15%)

Query: 522 LFQATDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVK----VFN--LQCGRAFKSFDVEC 574
            F    ++     IG G  G V  A        VA+K     F       RA++    E 
Sbjct: 57  TFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR----EL 112

Query: 575 AMMKSIRHRNLVKVI----SSCSNEEFKA--LVLEYMP---HGSLEKYLHSSNYSLDIFQ 625
            +MK + H+N++ ++       + EEF+   LV+E M       ++  L     S  ++Q
Sbjct: 113 VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQ 172

Query: 626 RLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMT 685
            L         +++LH   SA +IH DLKPSN+++  +    + DFG+A+   G    M 
Sbjct: 173 MLC-------GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMM- 220

Query: 686 QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHW 742
            T  + T  Y APE         N D++S G ++ E    K     LF G   +  W
Sbjct: 221 -TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK----ILFPGRDYIDQW 272

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 93.0 bits (231), Expect = 1e-20
 Identities = 56/314 (17%), Positives = 92/314 (29%), Gaps = 40/314 (12%)

Query: 79  NSLSGCLSSIT---DVGLPNLEVLYLWGNNFSGTIPHF-IFNASKLSKLALEMNSFSGFI 134
           +S   CL +       G  +LE L    +  +       I  +  L +L +        I
Sbjct: 25  SSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRI 84

Query: 135 PST---FGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTY 191
                    +  L+ LTL +  +T +       ++  +   L   ++S    D  L    
Sbjct: 85  LFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQ 144

Query: 192 VGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPIT----LGKLQKL 247
              L   LK   +   +      E++     L+T+ L  N   G   +       K   L
Sbjct: 145 -QWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTL 203

Query: 248 QDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTS 307
           Q + L    +                        SG   A  +    L+ L L  N L  
Sbjct: 204 QVLALRNAGM---------------------ETPSGVCSALAAARVQLQGLDLSHNSLRD 242

Query: 308 IP--LNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKN 365
                +      +  LNLS       +P  +     L  +D S N            L  
Sbjct: 243 AAGAPSCDWPSQLNSLNLSFTGLKQ-VPKGL--PAKLSVLDLSYNRLDRNPS--PDELPQ 297

Query: 366 LENLFLEYNRLEGS 379
           + NL L+ N    S
Sbjct: 298 VGNLSLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 87.3 bits (216), Expect = 8e-19
 Identities = 51/323 (15%), Positives = 88/323 (27%), Gaps = 63/323 (19%)

Query: 19  NISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPA---AIFNVSTLKAFA 75
             S   +L   +         +I    +L  L +   ++   I      +  +S L+   
Sbjct: 42  GRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELT 101

Query: 76  VTNNSLSG-CLSSITDVGLPNLEVLYLWGNNFSGTIPH----FIFNASKLSKLALEMNSF 130
           + N  ++G     + +   P+L +L L   +++           +    L  L++     
Sbjct: 102 LENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHS 161

Query: 131 SGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRT 190
             F          L  L L DN        L          +L  ++L N  +       
Sbjct: 162 LNFSCEQVRVFPALSTLDLSDNPELGER-GLISALCPLKFPTLQVLALRNAGM------- 213

Query: 191 YVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDV 250
                                                      +G          +LQ +
Sbjct: 214 ----------------------------------------ETPSGVCSALAAARVQLQGL 233

Query: 251 DLEYNQLEGSIPDSICLSVE-LYELELGGNKLSGSIPAC-FSNMTFLKVLSLGSNELTSI 308
           DL +N L  +     C     L  L L    L   +P    +    L VL L  N L   
Sbjct: 234 DLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLPAK---LSVLDLSYNRLDRN 289

Query: 309 PLNFWSLKDILDLNLSSNCFSGP 331
           P     L  + +L+L  N F   
Sbjct: 290 PS-PDELPQVGNLSLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 81.5 bits (201), Expect = 6e-17
 Identities = 42/176 (23%), Positives = 69/176 (39%), Gaps = 16/176 (9%)

Query: 271 LYELELGGNKLSGSIPACFSNMTF--LKVLSLGSNELTSIP-----LNFWSLKDILDLNL 323
           L EL L   +++G+ P      T   L +L+L +    +       L  W    +  L++
Sbjct: 97  LQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSI 156

Query: 324 SSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEI----GSLKNLENLFLEYNRLE-- 377
           +          ++R   AL  +D S N   G   +           L+ L L    +E  
Sbjct: 157 AQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETP 216

Query: 378 -GSIPDSFGDLISLKSLNLSYNNLSGTIPVSL-EKLSYLKDLNLSFNKLKGEIPRG 431
            G         + L+ L+LS+N+L         +  S L  LNLSF  LK ++P+G
Sbjct: 217 SGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKG 271

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 75.7 bits (186), Expect = 6e-15
 Identities = 39/192 (20%), Positives = 58/192 (30%), Gaps = 24/192 (12%)

Query: 5   INNFLTSTTPKEIDNISN-----LKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLG 59
           + N   +T    +  +       LKVL +           ++     L  LDLS N  LG
Sbjct: 128 LRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELG 187

Query: 60  TIP----AAIFNVSTLKAFAVTNN---SLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPH 112
                         TL+  A+ N    + SG  S++       L+ L L  N+       
Sbjct: 188 ERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAA-ARVQLQGLDLSHNSLRDAAGA 246

Query: 113 FIF-NASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCK 171
                 S+L+ L L                  L  L L  N L           S     
Sbjct: 247 PSCDWPSQLNSLNLSFTGLKQVPKGLP---AKLSVLDLSYNRLDR-------NPSPDELP 296

Query: 172 SLTHISLSNNPL 183
            + ++SL  NP 
Sbjct: 297 QVGNLSLKGNPF 308

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 68.0 bits (166), Expect = 2e-12
 Identities = 41/243 (16%), Positives = 77/243 (31%), Gaps = 26/243 (10%)

Query: 207 CNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSIC 266
           CN S   P+  +    L    +       S+   L ++    D+    + ++        
Sbjct: 15  CNFSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIK-------- 66

Query: 267 LSVELYELELGGNKLSGSIPACFS---NMTFLKVLSLGSNELT---SIPLNFWSLKDILD 320
            S+ L  L +   ++   I         ++ L+ L+L + E+T     PL   +  D+  
Sbjct: 67  -SLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNI 125

Query: 321 LNLSSNCFSGPLP----LEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRL 376
           LNL +  ++        L+      L  +  +  +       ++     L  L L  N  
Sbjct: 126 LNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPE 185

Query: 377 EGSIP----DSFGDLISLKSLNLSYNN---LSGTIPVSLEKLSYLKDLNLSFNKLKGEIP 429
            G              +L+ L L        SG           L+ L+LS N L+    
Sbjct: 186 LGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAG 245

Query: 430 RGG 432
              
Sbjct: 246 APS 248

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 93.5 bits (233), Expect = 1e-20
 Identities = 59/238 (24%), Positives = 99/238 (41%), Gaps = 40/238 (16%)

Query: 522 LFQATDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVK----VFN--LQCGRAFKSFDVEC 574
            ++    +     +G G +GSV  A   R G +VA+K     F   +   RA++    E 
Sbjct: 19  AWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR----EL 74

Query: 575 AMMKSIRHRNLVK----VISSCSNEEFKA--LVLEYMP---HGSLEKYLHSSNYSLDIFQ 625
            ++K ++H N++        + S   F    LV+ +M       +            ++Q
Sbjct: 75  LLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQ 134

Query: 626 RLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMT 685
            L         L+Y+H   SA V+H DLKP N+ ++++    + DFG+A+     D  M 
Sbjct: 135 MLK-------GLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR---HADAEM- 180

Query: 686 QTQTLATIGYMAPE-YGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHW 742
            T  + T  Y APE        +   D++S G ++ E  T K     LF G+  L   
Sbjct: 181 -TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK----TLFKGKDYLDQL 233

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 92.7 bits (231), Expect = 1e-20
 Identities = 42/199 (21%), Positives = 87/199 (43%), Gaps = 14/199 (7%)

Query: 526 TDKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDV--ECAMMKSIRH 582
            +K+     +GRG FG V++            K       +      V  E +++   RH
Sbjct: 4   YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK---VKGTDQVLVKKEISILNIARH 60

Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
           RN++ +  S  + E   ++ E++    + + +++S + L+  + ++ +  V  AL++LH 
Sbjct: 61  RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120

Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHL--SDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY 700
                + H D++P N++      + +   +FG A+ L     +           Y APE 
Sbjct: 121 HN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK-PGDNF--RLLFTAPEYYAPEV 174

Query: 701 GREGQVSTNGDVYSFGIML 719
            +   VST  D++S G ++
Sbjct: 175 HQHDVVSTATDMWSLGTLV 193

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 92.3 bits (230), Expect = 2e-20
 Identities = 44/207 (21%), Positives = 81/207 (39%), Gaps = 22/207 (10%)

Query: 526 TDKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNL-QCGRAFKSFDV-----ECAMMK 578
            D +     +G G F  V K R +  G+E A K     Q   + +         E ++++
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70

Query: 579 SIRHRNLVKVISSCSNEEFKALVLEYMPHGSL-EKYLHSSNYS-LDIFQRLNIMIDVASA 636
            + H N++ +     N     L+LE +  G L +      + S  +     + +  +   
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEA---TSFIKQILDG 127

Query: 637 LEYLHFGYSAPVIHCDLKPSNVLL----DDNMVAHLSDFGIAKLLTGEDQSMTQTQTLAT 692
           + YLH   +  + H DLKP N++L           L DFG+A  +  +           T
Sbjct: 128 VNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-EDGVEF--KNIFGT 181

Query: 693 IGYMAPEYGREGQVSTNGDVYSFGIML 719
             ++APE      +    D++S G++ 
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVIT 208

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 91.5 bits (228), Expect = 2e-20
 Identities = 51/207 (24%), Positives = 83/207 (40%), Gaps = 22/207 (10%)

Query: 526 TDKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFN---LQCGRAFKSFDV---ECAMMK 578
            D +     +G G F  V K R +  G E A K      L   R   S +    E  +++
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63

Query: 579 SIRHRNLVKVISSCSNEEFKALVLEYMPHGSL-EKYLHSSNYS-LDIFQRLNIMIDVASA 636
            IRH N++ +     N+    L+LE +  G L +      + +  +       +  +   
Sbjct: 64  EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEA---TQFLKQILDG 120

Query: 637 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH----LSDFGIAKLLTGEDQSMTQTQTLAT 692
           + YLH   S  + H DLKP N++L D  V +    L DFGIA  +              T
Sbjct: 121 VHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI-EAGNEF--KNIFGT 174

Query: 693 IGYMAPEYGREGQVSTNGDVYSFGIML 719
             ++APE      +    D++S G++ 
Sbjct: 175 PEFVAPEIVNYEPLGLEADMWSIGVIT 201

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 92.7 bits (231), Expect = 2e-20
 Identities = 55/227 (24%), Positives = 104/227 (45%), Gaps = 28/227 (12%)

Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDV----ECAMMKSIR 581
            K+ +   IG+G FG V+KAR  + G +VA+K   ++     + F +    E  +++ ++
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLME--NEKEGFPITALREIKILQLLK 74

Query: 582 HRNLVK---VISSCSNEEFKA-----LVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDV 633
           H N+V    +  + ++   +      LV ++  H  L   L +      + +   +M  +
Sbjct: 75  HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQML 133

Query: 634 ASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQ--TQTLA 691
            + L Y+H      ++H D+K +NVL+  + V  L+DFG+A+  +    S     T  + 
Sbjct: 134 LNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 190

Query: 692 TIGYMAPE--YGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGE 736
           T+ Y  PE   G E       D++  G ++ E +TR  P   +  G 
Sbjct: 191 TLWYRPPELLLG-ERDYGPPIDLWGAGCIMAEMWTR-SP---IMQGN 232

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 92.8 bits (231), Expect = 2e-20
 Identities = 44/207 (21%), Positives = 82/207 (39%), Gaps = 22/207 (10%)

Query: 526 TDKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFN------LQCGRAFKSFDVECAMMK 578
            D +     +G G F  V K R +  G+E A K          + G   +  + E ++++
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70

Query: 579 SIRHRNLVKVISSCSNEEFKALVLEYMPHGSL-EKYLHSSNYS-LDIFQRLNIMIDVASA 636
            + H N++ +     N     L+LE +  G L +      + S  +     + +  +   
Sbjct: 71  QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEA---TSFIKQILDG 127

Query: 637 LEYLHFGYSAPVIHCDLKPSNVLL----DDNMVAHLSDFGIAKLLTGEDQSMTQTQTLAT 692
           + YLH   +  + H DLKP N++L           L DFG+A  +  +           T
Sbjct: 128 VNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-EDGVEF--KNIFGT 181

Query: 693 IGYMAPEYGREGQVSTNGDVYSFGIML 719
             ++APE      +    D++S G++ 
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVIT 208

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 91.9 bits (229), Expect = 3e-20
 Identities = 43/207 (20%), Positives = 82/207 (39%), Gaps = 22/207 (10%)

Query: 526 TDKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFN-LQCGRAFKSFDV-----ECAMMK 578
            D +     +G G F  V K R +  G++ A K     +   + +         E +++K
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69

Query: 579 SIRHRNLVKVISSCSNEEFKALVLEYMPHGSL-EKYLHSSNYS-LDIFQRLNIMIDVASA 636
            I+H N++ +     N+    L+LE +  G L +      + +  +       +  + + 
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEA---TEFLKQILNG 126

Query: 637 LEYLHFGYSAPVIHCDLKPSNVLL----DDNMVAHLSDFGIAKLLTGEDQSMTQTQTLAT 692
           + YLH   S  + H DLKP N++L           + DFG+A  +              T
Sbjct: 127 VYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-DFGNEF--KNIFGT 180

Query: 693 IGYMAPEYGREGQVSTNGDVYSFGIML 719
             ++APE      +    D++S G++ 
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVIT 207

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 90.7 bits (226), Expect = 3e-20
 Identities = 60/251 (23%), Positives = 99/251 (39%), Gaps = 42/251 (16%)

Query: 534 LIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDV------ECAMMKSIRHRNLV 586
            +G G +G V  A        VAVK+ +++     ++ D       E  + K + H N+V
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-----RAVDCPENIKKEICINKMLNHENVV 68

Query: 587 K---VISSCSNEEFKALVLEYMPHGSLEKYLHSS-----NYSLDIFQRLNIMIDVASALE 638
           K         N ++  L LEY   G L   +          +   F +L       + + 
Sbjct: 69  KFYGHRRE-GNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------MAGVV 119

Query: 639 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 698
           YLH      + H D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+AP
Sbjct: 120 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

Query: 699 E--YGRE--GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVND---CLPIST 751
           E    RE   +     DV+S GI+L      + P D+  +       W        P   
Sbjct: 177 ELLKRREFHAEPV---DVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK 233

Query: 752 MEVVDANLLSQ 762
           ++     LL +
Sbjct: 234 IDSAPLALLHK 244

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 92.3 bits (230), Expect = 3e-20
 Identities = 63/246 (25%), Positives = 102/246 (41%), Gaps = 46/246 (18%)

Query: 523 FQATDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVK---VFN--LQCGRAFKSFDVECAM 576
           +  +  F   +L+G G +G V  A     G  VA+K    F+  L   R  +    E  +
Sbjct: 7   YNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR----EIKI 62

Query: 577 MKSIRHRNLVK---VISSCSNEEFKA--LVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMI 631
           +K  +H N++    +    S E F    ++ E M    L + + +   S D  Q    + 
Sbjct: 63  LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVISTQMLSDDHIQ--YFIY 119

Query: 632 DVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQ----- 686
               A++ LH    + VIH DLKPSN+L++ N    + DFG+A+++       ++     
Sbjct: 120 QTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176

Query: 687 ---TQTLATIGYMAPE-------YGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGE 736
               + +AT  Y APE       Y      S   DV+S G +L E F R+     +F G 
Sbjct: 177 SGMVEFVATRWYRAPEVMLTSAKY------SRAMDVWSCGCILAELFLRRP----IFPGR 226

Query: 737 MTLKHW 742
                 
Sbjct: 227 DYRHQL 232

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 92.4 bits (230), Expect = 3e-20
 Identities = 55/236 (23%), Positives = 94/236 (39%), Gaps = 41/236 (17%)

Query: 523 FQATDKFSENNLIGRGGFGSVYKARIRD-GMEVAVK-VFN--LQCGRAFKSFDVECAMMK 578
            +  D+F    + G+G FG+V   + +  GM VA+K V        R  +        + 
Sbjct: 19  RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ----IMQDLA 74

Query: 579 SIRHRNLVK---VISSCSNEEFK----ALVLEYMP---HGSLEKYLHSSNYSLDIFQRLN 628
            + H N+V+      +    + +     +V+EY+P   H     Y         I  ++ 
Sbjct: 75  VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKV- 133

Query: 629 IMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTGEDQSMTQT 687
            +  +  ++  LH   S  V H D+KP NVL++  +    L DFG AK L    +     
Sbjct: 134 FLFQLIRSIGCLH-LPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL-SPSEPN--V 189

Query: 688 QTLATIGYMAPE-------YGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGE 736
             + +  Y APE       Y      +T  D++S G +  E     +P   +F G+
Sbjct: 190 AYICSRYYRAPELIFGNQHY------TTAVDIWSVGCIFAEMMLG-EP---IFRGD 235

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 88.1 bits (219), Expect = 4e-20
 Identities = 34/195 (17%), Positives = 70/195 (35%), Gaps = 14/195 (7%)

Query: 114 IFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSL 173
               S        +   S     T   + +L ++TL + N+T        L+ +    ++
Sbjct: 16  NIPDSTFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTD-------LTGIEYAHNI 68

Query: 174 THISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKL 233
             ++++N       P   +  LS +L+   +   +V+      ++ LT LT + +  +  
Sbjct: 69  KDLTINNIHATNYNP---ISGLS-NLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAH 124

Query: 234 NGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMT 293
           + SI   +  L K+  +DL YN     I   +    EL  L +  + +         +  
Sbjct: 125 DDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFP 181

Query: 294 FLKVLSLGSNELTSI 308
            L  L   S  +   
Sbjct: 182 KLNQLYAFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 85.0 bits (211), Expect = 6e-19
 Identities = 37/178 (20%), Positives = 70/178 (39%), Gaps = 9/178 (5%)

Query: 248 QDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTS 307
           +   L+ +Q   +IPDS            G    S +     + M  L  ++L +  +T 
Sbjct: 4   EQTGLKASQDNVNIPDS-----TFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTD 58

Query: 308 IPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLE 367
           +        +I DL +++   +   P+    L  L  +     + +      +  L +L 
Sbjct: 59  LT-GIEYAHNIKDLTINNIHATNYNPIS--GLSNLERLRIMGKDVTSDKIPNLSGLTSLT 115

Query: 368 NLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLK 425
            L + ++  + SI      L  + S++LSYN     I   L+ L  LK LN+ F+ + 
Sbjct: 116 LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVH 172

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 84.6 bits (210), Expect = 7e-19
 Identities = 35/215 (16%), Positives = 71/215 (33%), Gaps = 32/215 (14%)

Query: 215 EEITNLTD--LTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELY 272
           ++  N+ D      + G    + +  IT  ++  L  + L    +               
Sbjct: 12  QDNVNIPDSTFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVT-------------- 57

Query: 273 ELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPL 332
                   L+G           +K L++ +   T+       L ++  L +     +   
Sbjct: 58  -------DLTG-----IEYAHNIKDLTINNIHATNYN-PISGLSNLERLRIMGKDVTSDK 104

Query: 333 PLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKS 392
              +  L +L  +D S +     I  +I +L  + ++ L YN     I      L  LKS
Sbjct: 105 IPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKS 163

Query: 393 LNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGE 427
           LN+ ++ +       +E    L  L      + G+
Sbjct: 164 LNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 80.0 bits (198), Expect = 3e-17
 Identities = 28/202 (13%), Positives = 65/202 (32%), Gaps = 39/202 (19%)

Query: 10  TSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVS 69
           +ST       +++L  + L N  +    +  I + HN+  L ++             N +
Sbjct: 33  SSTANITEAQMNSLTYITLANINVTD--LTGIEYAHNIKDLTINNIH--------ATNYN 82

Query: 70  TLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNS 129
            +                    GL NLE L + G + +      +   + L+ L +  ++
Sbjct: 83  PIS-------------------GLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSA 123

Query: 130 FSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPR 189
               I +    L  +  + L  N   +       +  L     L  +++  + +      
Sbjct: 124 HDDSILTKINTLPKVNSIDLSYNGAITD------IMPLKTLPELKSLNIQFDGVHDYRG- 176

Query: 190 TYVGNLSHSLKNFYMYNCNVSG 211
             + +    L   Y ++  + G
Sbjct: 177 --IEDFP-KLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 63.1 bits (154), Expect = 2e-11
 Identities = 22/128 (17%), Positives = 51/128 (39%), Gaps = 9/128 (7%)

Query: 302 SNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIG 361
           S +  +IP +  + K  L+  L  +  +    +    + +L  I  +  N + +  +E  
Sbjct: 11  SQDNVNIPDS--TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTDLTGIE-- 63

Query: 362 SLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSF 421
              N+++L +         P     L +L+ L +   +++     +L  L+ L  L++S 
Sbjct: 64  YAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISH 121

Query: 422 NKLKGEIP 429
           +     I 
Sbjct: 122 SAHDDSIL 129

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 92.4 bits (230), Expect = 4e-20
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 38/214 (17%)

Query: 534 LIGRGGFGSVYKARIRDGMEV-AVKVFNLQCGRAFKSFDVECA-----MMKSIRHRNLVK 587
            IG+G FG V   +  D  ++ A+K  N Q  +  +  +V        +M+ + H  LV 
Sbjct: 22  AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQ--KCVERNEVRNVFKELQIMQGLEHPFLVN 79

Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMID---------VASALE 638
           +  S  +EE   +V++ +  G L  +L          Q+     +         +  AL+
Sbjct: 80  LWYSFQDEEDMFMVVDLLLGGDLRYHL----------QQNVHFKEETVKLFICELVMALD 129

Query: 639 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMA 697
           YL    +  +IH D+KP N+LLD++   H++DF IA +L  E    TQ  T+A T  YMA
Sbjct: 130 YLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE----TQITTMAGTKPYMA 182

Query: 698 PE-YGREGQVSTNGDV--YSFGIMLMETFTRKKP 728
           PE +        +  V  +S G+   E    ++P
Sbjct: 183 PEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 93.0 bits (231), Expect = 5e-20
 Identities = 70/347 (20%), Positives = 126/347 (36%), Gaps = 80/347 (23%)

Query: 498 REKGPPNDPNMPPVATWRRFSYLELFQATDKFSENNLIGRGGFGSVYKAR-IRDGMEVAV 556
           +++G     +     T         +Q  D++   +LIG G +G V +A    +   VA+
Sbjct: 24  QQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAI 83

Query: 557 K----VFN--LQCGRAFKSFDVECAMMKSIRHRNLVK---VISSCSNEEFKA--LVLEYM 605
           K    VF   + C R  +    E A++  + H ++VK   ++     E+F    +VLE  
Sbjct: 84  KKILRVFEDLIDCKRILR----EIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA 139

Query: 606 PHGSLEKYLHSSNY-SLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM 664
                +K   +  Y +    +   ++ ++   ++Y+H   SA ++H DLKP+N L++ + 
Sbjct: 140 DS-DFKKLFRTPVYLTELHIKT--LLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDC 193

Query: 665 VAHLSDFGIAKLLTGEDQSMTQ-------------------------TQTLATIGYMAPE 699
              + DFG+A+ +   +   +Q                         T  + T  Y APE
Sbjct: 194 SVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPE 253

Query: 700 -------YGREGQVSTNGDVYSFGIMLMETFTRKKPTDE-------LFNGEMTLKHWVND 745
                  Y      +   DV+S G +  E     K           LF G        + 
Sbjct: 254 LILLQENY------TEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQ 307

Query: 746 CLPISTMEVVDA---------NLL---SQEDIHFVAKEQCVSFVFNL 780
                                N+L   S+EDI  + KE    ++   
Sbjct: 308 KAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIF 354

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 91.3 bits (227), Expect = 5e-20
 Identities = 61/250 (24%), Positives = 98/250 (39%), Gaps = 47/250 (18%)

Query: 535 IGRGGFGSVYKAR-IRDGMEVAVKVFN--------LQCGRAFKSFDVECAMMKSIRHRNL 585
           +G G FG V+ A       EV VK                      +E A++  + H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 586 VKVISSCSNEEFKALVLE-YMPHGSLEKYLHSSNYSLD------IFQRLNIMIDVASALE 638
           +KV+    N+ F  LV+E +     L  ++   +  LD      IF++L       SA+ 
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSGLDLFAFI-DRHPRLDEPLASYIFRQL------VSAVG 144

Query: 639 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 698
           YL       +IH D+K  N+++ ++    L DFG A  L  E   +  T    TI Y AP
Sbjct: 145 YLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL--ERGKLFYT-FCGTIEYCAP 198

Query: 699 E------Y-GREGQVSTNGDVYSFGIMLMETFTRKKPTDEL---FNGEMTLKHWV-NDCL 747
           E      Y G E       +++S G+ L      + P  EL       +   + V  + +
Sbjct: 199 EVLMGNPYRGPE------LEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSKELM 252

Query: 748 P-ISTMEVVD 756
             +S +    
Sbjct: 253 SLVSGLLQPV 262

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 90.8 bits (226), Expect = 5e-20
 Identities = 58/248 (23%), Positives = 99/248 (39%), Gaps = 48/248 (19%)

Query: 523 FQATDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVK--VFN--LQCGRAFKSFDVECAMM 577
           F    ++ +   +G GG G V+ A        VA+K  V         A +    E  ++
Sbjct: 7   FDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR----EIKII 62

Query: 578 KSIRHRNLVKVI------------SSCSNEEFKA--LVLEYMPHGSLEKYLHSSNYSLDI 623
           + + H N+VKV                S  E  +  +V EYM    L   L       + 
Sbjct: 63  RRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQGPLLEEH 121

Query: 624 FQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTGEDQ 682
            +    M  +   L+Y+H   SA V+H DLKP+N+ ++ +++V  + DFG+A+++     
Sbjct: 122 AR--LFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYS 176

Query: 683 SMTQ-TQTLATIGYMAPE-------YGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFN 734
                ++ L T  Y +P        Y      +   D+++ G +  E  T K     LF 
Sbjct: 177 HKGHLSEGLVTKWYRSPRLLLSPNNY------TKAIDMWAAGCIFAEMLTGK----TLFA 226

Query: 735 GEMTLKHW 742
           G   L+  
Sbjct: 227 GAHELEQM 234

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 91.6 bits (228), Expect = 6e-20
 Identities = 60/234 (25%), Positives = 105/234 (44%), Gaps = 33/234 (14%)

Query: 523 FQATDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVK----VFN--LQCGRAFKSFDVECA 575
           ++    + +   +G G +G+V  A   R G +VA+K     F   L   RA++    E  
Sbjct: 21  WEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR----ELR 76

Query: 576 MMKSIRHRNLVKVI----SSCSNEEFKA--LVLEYMPHGSLEKYLHSSNYSLDIFQRLNI 629
           ++K +RH N++ ++       + ++F    LV+ +M    L K +       D  Q   +
Sbjct: 77  LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDRIQF--L 133

Query: 630 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT 689
           +  +   L Y+H   +A +IH DLKP N+ ++++    + DFG+A+     D  M  T  
Sbjct: 134 VYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR---QADSEM--TGY 185

Query: 690 LATIGYMAPEY-GREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHW 742
           + T  Y APE      + +   D++S G ++ E  T K     LF G   L   
Sbjct: 186 VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK----TLFKGSDHLDQL 235

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 93.8 bits (233), Expect = 7e-20
 Identities = 54/209 (25%), Positives = 94/209 (44%), Gaps = 28/209 (13%)

Query: 527 DKFSENNLIGRGGFGSVYKARIRDGMEV-AVKVFNLQCGRAFKSFDVECAM--------M 577
           + FS + +IGRGGFG VY  R  D  ++ A+K   L   R         A+        +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKC--LDKKRIKMKQGETLALNERIMLSLV 246

Query: 578 KSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIF--QRLNIMI-DVA 634
            +     +V +  +    +  + +L+ M  G L  +L        +F    +     ++ 
Sbjct: 247 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEADMRFYAAEII 302

Query: 635 SALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA-TI 693
             LE++H   +  V++ DLKP+N+LLD++    +SD G+A   + +     +      T 
Sbjct: 303 LGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-----KPHASVGTH 354

Query: 694 GYMAPEYGREGQVSTNG-DVYSFGIMLME 721
           GYMAPE  ++G    +  D +S G ML +
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFK 383

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 90.3 bits (225), Expect = 7e-20
 Identities = 60/222 (27%), Positives = 101/222 (45%), Gaps = 20/222 (9%)

Query: 524 QATDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDV-ECAMMKSIR 581
            ++ +F +   +G G + +VYK      G+ VA+K   L       S  + E ++MK ++
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK 61

Query: 582 HRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYS-----LDIFQRLNIMIDVASA 636
           H N+V++      E    LV E+M +  L+KY+ S         L++         +   
Sbjct: 62  HENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQG 120

Query: 637 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYM 696
           L + H      ++H DLKP N+L++      L DFG+A+       +   +  + T+ Y 
Sbjct: 121 LAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF--SSEVVTLWYR 175

Query: 697 APE--YGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGE 736
           AP+   G     ST+ D++S G +L E  T  KP   LF G 
Sbjct: 176 APDVLMGSR-TYSTSIDIWSCGCILAEMITG-KP---LFPGT 212

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 90.5 bits (225), Expect = 8e-20
 Identities = 60/251 (23%), Positives = 99/251 (39%), Gaps = 42/251 (16%)

Query: 534 LIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDV------ECAMMKSIRHRNLV 586
            +G G +G V  A        VAVK+ +++     ++ D       E  + K + H N+V
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-----RAVDCPENIKKEICINKMLNHENVV 68

Query: 587 K---VISSCSNEEFKALVLEYMPHGSLEKYLHSS-----NYSLDIFQRLNIMIDVASALE 638
           K         N ++  L LEY   G L   +          +   F +L       + + 
Sbjct: 69  KFYGHRRE-GNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------MAGVV 119

Query: 639 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 698
           YLH      + H D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+AP
Sbjct: 120 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

Query: 699 E--YGRE--GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVND---CLPIST 751
           E    RE   +     DV+S GI+L      + P D+  +       W        P   
Sbjct: 177 ELLKRREFHAEPV---DVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK 233

Query: 752 MEVVDANLLSQ 762
           ++     LL +
Sbjct: 234 IDSAPLALLHK 244

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 90.4 bits (225), Expect = 9e-20
 Identities = 55/252 (21%), Positives = 105/252 (41%), Gaps = 32/252 (12%)

Query: 497 KREKGPPNDPNMPPVATWRRFSYLELFQATDKFSENNLIGRGGFGSVYKAR-IRDGMEVA 555
              +     P    V+     + ++ ++   K      +G G +G VYKA        VA
Sbjct: 10  GTLEAQTQGPGSMSVSAAPSATSIDRYRRITK------LGEGTYGEVYKAIDTVTNETVA 63

Query: 556 VKVFNLQCGRAFKSFDV----ECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLE 611
           +K   L      +        E +++K ++HRN++++ S   +     L+ EY  +  L+
Sbjct: 64  IKRIRL--EHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLK 120

Query: 612 KYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH---- 667
           KY+  +   + +    + +  + + + + H   S   +H DLKP N+LL  +  +     
Sbjct: 121 KYMDKNP-DVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVL 176

Query: 668 -LSDFGIAKLLTGEDQSMTQTQTLATIGYMAPE--YGREGQVSTNGDVYSFGIMLMETFT 724
            + DFG+A+      +    T  + T+ Y  PE   G     ST+ D++S   +  E   
Sbjct: 177 KIGDFGLARAFGIPIRQF--THEIITLWYRPPEILLGSR-HYSTSVDIWSIACIWAEMLM 233

Query: 725 RKKPTDELFNGE 736
           +  P   LF G+
Sbjct: 234 K-TP---LFPGD 241

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 91.4 bits (227), Expect = 1e-19
 Identities = 52/241 (21%), Positives = 96/241 (39%), Gaps = 52/241 (21%)

Query: 527 DKFS-ENNLIGRGGFGSVYKARIRD---GMEVAVKVFNLQCGRAFKSFDV----ECAMMK 578
           D F  E   +GRG +G VYKA+ +D     + A+K              +    E A+++
Sbjct: 20  DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIE------GTGISMSACREIALLR 73

Query: 579 SIRHRNLVK---VISSCSNEEFKALVLEYMPHGSLEKYLHS--------SNYSLDIFQRL 627
            ++H N++    V  S ++ +   L+ +Y  H  L   +              L      
Sbjct: 74  ELKHPNVISLQKVFLSHADRKV-WLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVK 131

Query: 628 NIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH----LSDFGIAKLLTGEDQS 683
           +++  +   + YLH   +  V+H DLKP+N+L+           ++D G A+L     + 
Sbjct: 132 SLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP 188

Query: 684 MTQ-TQTLATIGYMAPE-------YGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNG 735
           +      + T  Y APE       Y      +   D+++ G +  E  T  +P   +F+ 
Sbjct: 189 LADLDPVVVTFWYRAPELLLGARHY------TKAIDIWAIGCIFAELLTS-EP---IFHC 238

Query: 736 E 736
            
Sbjct: 239 R 239

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 89.3 bits (222), Expect = 1e-19
 Identities = 55/286 (19%), Positives = 105/286 (36%), Gaps = 48/286 (16%)

Query: 140 NLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSL 199
                    L   ++T          + +   S+  I  +N+ +  +             
Sbjct: 22  AFAETIKDNLKKKSVTD-------AVTQNELNSIDQIIANNSDIKSV------------- 61

Query: 200 KNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEG 259
                          + I  L ++T + L GNKL    P  L  L+ L  + L+ N+++ 
Sbjct: 62  ---------------QGIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVK- 103

Query: 260 SIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDIL 319
            +  S+    +L  L L  N +S  I     ++  L+ L LG+N++T I      L  + 
Sbjct: 104 DL-SSLKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKITDIT-VLSRLTKLD 159

Query: 320 DLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGS 379
            L+L  N  S  +PL    L  L  +  S N+ S +    +  LKNL+ L L        
Sbjct: 160 TLSLEDNQISDIVPLA--GLTKLQNLYLSKNHISDLRA--LAGLKNLDVLELFSQECLNK 215

Query: 380 IPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLK 425
             +   +L+   ++  +  +L    P  +      +  N+ ++  +
Sbjct: 216 PINHQSNLVVPNTVKNTDGSL--VTPEIISDDGDYEKPNVKWHLPE 259

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 86.6 bits (215), Expect = 9e-19
 Identities = 60/309 (19%), Positives = 115/309 (37%), Gaps = 53/309 (17%)

Query: 118 SKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHIS 177
           ++  K  L+  S +     T   L +++ +   ++++ S       +  +    ++T + 
Sbjct: 24  AETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIKS-------VQGIQYLPNVTKLF 74

Query: 178 LSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSI 237
           L+ N L  I                            + + NL +L  + L  NK+   +
Sbjct: 75  LNGNKLTDI----------------------------KPLANLKNLGWLFLDENKVK-DL 105

Query: 238 PITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKV 297
             +L  L+KL+ + LE+N +   I   + L  +L  L LG NK++  I    S +T L  
Sbjct: 106 S-SLKDLKKLKSLSLEHNGIS-DINGLVHLP-QLESLYLGNNKIT-DITV-LSRLTKLDT 160

Query: 298 LSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIP 357
           LSL  N+++ I      L  + +L LS N  S    L    LK L  ++           
Sbjct: 161 LSLEDNQISDIV-PLAGLTKLQNLYLSKNHISDLRALA--GLKNLDVLELFSQECLNKPI 217

Query: 358 MEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDL 417
               +L     +      L    P+   D    +  N+ ++      P    ++S++   
Sbjct: 218 NHQSNLVVPNTVKNTDGSL--VTPEIISDDGDYEKPNVKWHL-----PEFTNEVSFIFYQ 270

Query: 418 NLSFNKLKG 426
            ++  K K 
Sbjct: 271 PVTIGKAKA 279

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 77.0 bits (190), Expect = 2e-15
 Identities = 46/231 (19%), Positives = 90/231 (38%), Gaps = 24/231 (10%)

Query: 3   SIINNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIP 62
           ++    +T       + ++++  +   N+ +  + +  I +L N+  L L+ NKL    P
Sbjct: 30  NLKKKSVTDAVT--QNELNSIDQIIANNSDI--KSVQGIQYLPNVTKLFLNGNKLTDIKP 85

Query: 63  AAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSK 122
             + N+  L    +  N +   LSS+ D  L  L+ L L  N  S  I   + +  +L  
Sbjct: 86  --LANLKNLGWLFLDENKVK-DLSSLKD--LKKLKSLSLEHNGIS-DING-LVHLPQLES 138

Query: 123 LALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNP 182
           L L  N  +    +    L  L+ L+L DN ++        +  L+    L ++ LS N 
Sbjct: 139 LYLGNNKITDI--TVLSRLTKLDTLSLEDNQISD-------IVPLAGLTKLQNLYLSKNH 189

Query: 183 LDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKL 233
           +  +     +  L  +L    +++           +NL    T+      L
Sbjct: 190 ISDLRA---LAGLK-NLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 75.5 bits (186), Expect = 5e-15
 Identities = 63/341 (18%), Positives = 113/341 (33%), Gaps = 97/341 (28%)

Query: 17  IDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAV 76
            D  +      L    +          L+++  +  + + +            +++    
Sbjct: 20  DDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDI-----------KSVQGIQ- 65

Query: 77  TNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPS 136
                           LPN+  L+L GN              KL+ +             
Sbjct: 66  ---------------YLPNVTKLFLNGN--------------KLTDI------------K 84

Query: 137 TFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLS 196
              NL+NL WL L +N +         LSSL + K L  +SL +N +  I          
Sbjct: 85  PLANLKNLGWLFLDENKVKD-------LSSLKDLKKLKSLSLEHNGISDI---------- 127

Query: 197 HSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQ 256
                               + +L  L ++ LG NK+  +    L +L KL  + LE NQ
Sbjct: 128 ------------------NGLVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQ 167

Query: 257 LEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLK 316
           +   I     L+ +L  L L  N +S  + A  + +  L VL L S E  + P+N  S  
Sbjct: 168 IS-DIVPLAGLT-KLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNL 223

Query: 317 DILD-LNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGII 356
            + + +  +      P  +          + + +  F+  +
Sbjct: 224 VVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEV 264

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 89.9 bits (223), Expect = 2e-19
 Identities = 49/287 (17%), Positives = 91/287 (31%), Gaps = 45/287 (15%)

Query: 95  NLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNL 154
           +  V     +  +  IP  +       +L   +          F    +LE + +  N++
Sbjct: 10  SNRVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 66

Query: 155 TSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIP 214
               ++    S+L     L  I +               NL +               I 
Sbjct: 67  L-EVIEADVFSNLPK---LHEIRIEKAN-----------NLLY---------------IN 96

Query: 215 EEI-TNLTDLTTIVLGGNKLNGSIP-ITLGKLQKLQDVDLEYNQLEGSIPDSI--CLSVE 270
            E   NL +L  +++    +   +P +      +   +D++ N    +I  +    LS E
Sbjct: 97  PEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFE 155

Query: 271 LYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLN-FWSLKDILDLNLSSNCFS 329
              L L  N +     + F+     ++    +N L  +P + F      + L++S     
Sbjct: 156 SVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH 215

Query: 330 GPLPLEI-RNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNR 375
             LP     NLK L     S  N   +  +E   L  L    L Y  
Sbjct: 216 -SLPSYGLENLKKLRA--RSTYNLKKLPTLE--KLVALMEASLTYPS 257

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 89.5 bits (222), Expect = 2e-19
 Identities = 46/281 (16%), Positives = 89/281 (31%), Gaps = 40/281 (14%)

Query: 50  LDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGT 109
               ++K+   IP+ +               L   +      G  +LE + +  N+    
Sbjct: 14  FLCQESKVT-EIPSDLP--RNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEV 69

Query: 110 IPHFIF-NASKLSKLALE-MNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSL 167
           I   +F N  KL ++ +E  N+     P  F NL NL++L + +  +     D+  + SL
Sbjct: 70  IEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHL-PDVHKIHSL 128

Query: 168 SNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIV 227
                   + + +N     + R     LS      ++    +   I     N T L  + 
Sbjct: 129 Q----KVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE-IHNSAFNGTQLDELN 183

Query: 228 L-GGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIP 286
           L   N L                +D+   ++  S+P                        
Sbjct: 184 LSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYG--------------------- 221

Query: 287 ACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNC 327
               N+  L+  S     L  +P     L  +++ +L+   
Sbjct: 222 --LENLKKLRARST--YNLKKLP-TLEKLVALMEASLTYPS 257

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 87.2 bits (216), Expect = 1e-18
 Identities = 35/217 (16%), Positives = 72/217 (33%), Gaps = 9/217 (4%)

Query: 213 IPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLS-VEL 271
           IP ++    +   +     KL             L+ +++  N +   I   +  +  +L
Sbjct: 24  IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL 81

Query: 272 YELEL-GGNKLSGSIPA-CFSNMTFLKVLSLGSNELTSIP-LNFWSLKDILDLNLSSNCF 328
           +E+ +   N L   I    F N+  L+ L + +  +  +P ++       + L++  N  
Sbjct: 82  HEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNIN 140

Query: 329 SGPLPLE-IRNLKA-LIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGD 386
              +       L    + +  + N    I        +  E    + N LE    D F  
Sbjct: 141 IHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHG 200

Query: 387 LISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNK 423
                 L++S   +       LE L  L+  +    K
Sbjct: 201 ASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 237

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 81.0 bits (200), Expect = 1e-16
 Identities = 38/226 (16%), Positives = 70/226 (30%), Gaps = 13/226 (5%)

Query: 3   SIINNFLTSTTPKEIDNISNLKVLYLYNNRLQGEI-IHEIGHLHNLGFLDLSQNKLLGTI 61
             +   L            +L+ + +  N +   I      +L  L  + + +   L  I
Sbjct: 36  RFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYI 95

Query: 62  PAAIF-NVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFN--AS 118
               F N+  L+   ++N  +   L  +  +      +L +  N    TI    F   + 
Sbjct: 96  NPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSF 154

Query: 119 KLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISL 178
           +   L L  N       S F   +  E     +NNL     D               + +
Sbjct: 155 ESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPND-----VFHGASGPVILDI 209

Query: 179 SNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLT 224
           S   +   LP   + NL   L+    YN        E++  L + +
Sbjct: 210 SRTRIH-SLPSYGLENLKK-LRARSTYN-LKKLPTLEKLVALMEAS 252

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 69.1 bits (169), Expect = 1e-12
 Identities = 39/195 (20%), Positives = 64/195 (32%), Gaps = 46/195 (23%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEI--GHLHNLGFLDLSQNKLLGTIPA 63
            N L    P+   N+ NL+ L + N  ++   + ++   H      LD+  N  + TI  
Sbjct: 89  ANNLLYINPEAFQNLPNLQYLLISNTGIK--HLPDVHKIHSLQKVLLDIQDNINIHTIER 146

Query: 64  AIFNVSTLKAFAVTNNSLSGCLSSITDVGLP-NLEVLYLWGNNFSGTIPHFIFNASKLSK 122
             F                        VGL     +L+L  N     I +  FN ++L +
Sbjct: 147 NSF------------------------VGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDE 181

Query: 123 LAL-EMNSFSGFIPSTFGNLRNLEWLTLYDNNLTS---------------STLDLSFLSS 166
           L L + N+        F        L +    + S               ST +L  L +
Sbjct: 182 LNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLKKLPT 241

Query: 167 LSNCKSLTHISLSNN 181
           L    +L   SL+  
Sbjct: 242 LEKLVALMEASLTYP 256

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 89.3 bits (222), Expect = 2e-19
 Identities = 45/214 (21%), Positives = 84/214 (39%), Gaps = 58/214 (27%)

Query: 534 LIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDVE---CAMMKSIRHRNLVKVI 589
           ++G G  G V +    R G + A+K+          S           ++    ++V ++
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLLY-------DSPKARQEVDHHWQASGGPHIVCIL 88

Query: 590 ----SSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLD-IFQRLN----------IMIDVA 634
               +    +    +++E M  G L             I +R +          IM D+ 
Sbjct: 89  DVYENMHHGKRCLLIIMECMEGGEL----------FSRIQERGDQAFTEREAAEIMRDIG 138

Query: 635 SALEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA 691
           +A+++LH   S  + H D+KP N+L    + + V  L+DFG AK       ++       
Sbjct: 139 TAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET--TQNAL--QTPCY 191

Query: 692 TIGYMAPE------YGREGQVSTNGDVYSFGIML 719
           T  Y+APE      Y +        D++S G+++
Sbjct: 192 TPYYVAPEVLGPEKYDKS------CDMWSLGVIM 219

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 89.8 bits (223), Expect = 3e-19
 Identities = 51/253 (20%), Positives = 93/253 (36%), Gaps = 58/253 (22%)

Query: 496 QKREKGPPNDPNMPPVATWRRFSYLELFQATDKFSENN-LIGRGGFGSVYKAR-IRDGME 553
               + PP  P   P    +    ++     D +   + ++G G  G V +    R   +
Sbjct: 30  HPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEK 89

Query: 554 VAVKVFNLQCGRAFKSFDV--ECAMMKSI-RHRNLVKVI----SSCSNEEFKALVLEYMP 606
            A+K+                E  +     +  ++V+++    +  +  +   +V+E + 
Sbjct: 90  FALKMLQ-------DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 142

Query: 607 HGSLEKYLHSSNYSLD-IFQRLN----------IMIDVASALEYLHFGYSAPVIHCDLKP 655
            G L             I  R +          IM  +  A++YLH   S  + H D+KP
Sbjct: 143 GGEL----------FSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKP 189

Query: 656 SNVLL---DDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPE------YGREGQV 706
            N+L      N +  L+DFG AK  T  +   T      T  Y+APE      Y +    
Sbjct: 190 ENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT---PCYTPYYVAPEVLGPEKYDKS--- 243

Query: 707 STNGDVYSFGIML 719
               D++S G+++
Sbjct: 244 ---CDMWSLGVIM 253

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 87.3 bits (217), Expect = 3e-19
 Identities = 63/190 (33%), Positives = 90/190 (47%), Gaps = 11/190 (5%)

Query: 246 KLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNEL 305
               VD    +L  +IP +I    +  +L+L  NKLS      F  +T L++L L  N+L
Sbjct: 17  NKNSVDCSSKKLT-AIPSNI--PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKL 73

Query: 306 TSIPLN-FWSLKDILDLNLSSNCFSGPLPLEI-RNLKALIEIDFSMNNFSGIIPMEIGSL 363
            ++P   F  LK++  L ++ N     LP+ +   L  L E+    N    + P    SL
Sbjct: 74  QTLPAGIFKELKNLETLWVTDNKLQA-LPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSL 132

Query: 364 KNLENLFLEYNRLEGSIPD-SFGDLISLKSLNLSYNNLSGTIPVSL-EKLSYLKDLNLSF 421
             L  L L YN L+ S+P   F  L SLK L L  N L   +P    +KL+ LK L L  
Sbjct: 133 TKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDN 190

Query: 422 NKLKGEIPRG 431
           N+LK  +P G
Sbjct: 191 NQLK-RVPEG 199

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 85.8 bits (213), Expect = 1e-18
 Identities = 48/182 (26%), Positives = 75/182 (41%), Gaps = 12/182 (6%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEI-GHLHNLGFLDLSQNKLLGTIPAA 64
           +N L+S   K    ++ L++LYL +N+LQ  +   I   L NL  L ++ NKL   +P  
Sbjct: 46  SNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKL-QALPIG 103

Query: 65  IF-NVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNA-SKLSK 122
           +F  +  L    +  N L      + D  L  L  L L  N    ++P  +F+  + L +
Sbjct: 104 VFDQLVNLAELRLDRNQLKSLPPRVFD-SLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKE 161

Query: 123 LALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNP 182
           L L  N         F  L  L+ L L +N L              + + L  + L  NP
Sbjct: 162 LRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGA-----FDSLEKLKMLQLQENP 216

Query: 183 LD 184
            D
Sbjct: 217 WD 218

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 85.4 bits (212), Expect = 2e-18
 Identities = 59/215 (27%), Positives = 88/215 (40%), Gaps = 37/215 (17%)

Query: 212 GIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLS-VE 270
            IP       D   + L  NKL+        +L KL+ + L  N+L+ ++P  I      
Sbjct: 34  NIP------ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKN 86

Query: 271 LYELELGGNKLSGSIPAC-FSNMTFLKVLSLGSNELTSIPLN-FWSLKDILDLNLSSNCF 328
           L  L +  NKL  ++P   F  +  L  L L  N+L S+P   F SL  +  L+L  N  
Sbjct: 87  LETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYN-- 143

Query: 329 SGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDS-FGDL 387
                 E+++L            F          L +L+ L L  N+L+  +P+  F  L
Sbjct: 144 ------ELQSLPK--------GVFDK--------LTSLKELRLYNNQLK-RVPEGAFDKL 180

Query: 388 ISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFN 422
             LK+L L  N L      + + L  LK L L  N
Sbjct: 181 TELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 84.6 bits (210), Expect = 3e-18
 Identities = 58/210 (27%), Positives = 84/210 (40%), Gaps = 40/210 (19%)

Query: 122 KLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNN 181
           KL L+ N  S      F  L  L  L L DN L +  L       L N   L  + +++N
Sbjct: 41  KLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT--LPAGIFKELKN---LETLWVTDN 95

Query: 182 PLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEI-TNLTDLTTIVLGGNKLNGSIPIT 240
            L                             +P  +   L +L  + L  N+L  S+P  
Sbjct: 96  KLQ---------------------------ALPIGVFDQLVNLAELRLDRNQLK-SLPPR 127

Query: 241 L-GKLQKLQDVDLEYNQLEGSIPDSICLS-VELYELELGGNKLSGSIPA-CFSNMTFLKV 297
           +   L KL  + L YN+L+ S+P  +      L EL L  N+L   +P   F  +T LK 
Sbjct: 128 VFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKT 185

Query: 298 LSLGSNELTSIPLN-FWSLKDILDLNLSSN 326
           L L +N+L  +P   F SL+ +  L L  N
Sbjct: 186 LKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 77.7 bits (192), Expect = 7e-16
 Identities = 57/213 (26%), Positives = 83/213 (38%), Gaps = 36/213 (16%)

Query: 21  SNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNS 80
           ++ K L L +N+L          L  L  L L+ NKL  T+PA IF              
Sbjct: 37  ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKL-QTLPAGIFK------------- 82

Query: 81  LSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNA-SKLSKLALEMNSFSGFIPSTFG 139
                       L NLE L++  N     +P  +F+    L++L L+ N      P  F 
Sbjct: 83  -----------ELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFD 130

Query: 140 NLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSL 199
           +L  L +L+L  N L S  L       L++   L  + L NN L  + P      L+  L
Sbjct: 131 SLTKLTYLSLGYNELQS--LPKGVFDKLTS---LKELRLYNNQLKRV-PEGAFDKLT-EL 183

Query: 200 KNFYMYNCNVSGGIPEEI-TNLTDLTTIVLGGN 231
           K   + N N    +PE    +L  L  + L  N
Sbjct: 184 KTLKLDN-NQLKRVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 68.9 bits (169), Expect = 6e-13
 Identities = 38/163 (23%), Positives = 74/163 (45%), Gaps = 7/163 (4%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEI-GHLHNLGFLDLSQNKLLGTIPAA 64
           +N L +        + NL+ L++ +N+LQ  +   +   L NL  L L +N+L  ++P  
Sbjct: 70  DNKLQTLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQL-KSLPPR 127

Query: 65  IF-NVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIF-NASKLSK 122
           +F +++ L   ++  N L      + D  L +L+ L L+ N     +P   F   ++L  
Sbjct: 128 VFDSLTKLTYLSLGYNELQSLPKGVFD-KLTSLKELRLYNNQLK-RVPEGAFDKLTELKT 185

Query: 123 LALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLS 165
           L L+ N         F +L  L+ L L +N    +   + +++
Sbjct: 186 LKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCNGIIYMA 228

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 88.2 bits (219), Expect = 4e-19
 Identities = 52/205 (25%), Positives = 81/205 (39%), Gaps = 34/205 (16%)

Query: 534 LIGRGGFGSVYKAR-IRDGMEVAVKVFN----LQCGRAFKSFDV--ECAMMKSIRHR--N 584
           L+G GGFGSVY    + D + VA+K          G       V  E  ++K +      
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109

Query: 585 LVKVISSCSNEEFKALVLEY-MPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFG 643
           +++++      +   L+LE   P   L  ++ +   +L      +    V  A+ + H  
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCH-- 166

Query: 644 YSAPVIHCDLKPSNVLLDDN-MVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAPEY- 700
            +  V+H D+K  N+L+D N     L DFG   LL       T       T  Y  PE+ 
Sbjct: 167 -NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD-----TVYTDFDGTRVYSPPEWI 220

Query: 701 ------GREGQVSTNGDVYSFGIML 719
                 GR         V+S GI+L
Sbjct: 221 RYHRYHGRS------AAVWSLGILL 239

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 87.3 bits (217), Expect = 5e-19
 Identities = 59/203 (29%), Positives = 93/203 (45%), Gaps = 36/203 (17%)

Query: 534 LIGRGGFGSVYKAR-IRDGMEVAVKVFN---LQCGRAFKSFDVECAMMKSIRHRNLVK-- 587
            +G G FG V        G +VAVK+ N   ++          E   +K  RH +++K  
Sbjct: 18  TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77

Query: 588 -VISSCSNEEFKALVLEYMPHGSLEKYL-----HSSNYSLDIFQRLNIMIDVASALEYLH 641
            VIS+   + F  +V+EY+  G L  Y+          +  +FQ++       SA++Y H
Sbjct: 78  QVIST-PTDFF--MVMEYVSGGELFDYICKHGRVEEMEARRLFQQI------LSAVDYCH 128

Query: 642 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATI----GYMA 697
                 V+H DLKP NVLLD +M A ++DFG++ +       M+  + L T      Y A
Sbjct: 129 ---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNM-------MSDGEFLRTSCGSPNYAA 178

Query: 698 PE-YGREGQVSTNGDVYSFGIML 719
           PE            D++S G++L
Sbjct: 179 PEVISGRLYAGPEVDIWSCGVIL 201

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 88.1 bits (219), Expect = 5e-19
 Identities = 43/209 (20%), Positives = 77/209 (36%), Gaps = 46/209 (22%)

Query: 535 IGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDV-----ECAMMKSIRHR-NLVK 587
           +GRG F  V +   +  G E A K       R            E A+++  +    ++ 
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKK---RRRGQDCRAEILHEIAVLELAKSCPRVIN 93

Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRL--------------NIMIDV 633
           +     N     L+LEY   G +             F                  ++  +
Sbjct: 94  LHEVYENTSEIILILEYAAGGEI-------------FSLCLPELAEMVSENDVIRLIKQI 140

Query: 634 ASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH---LSDFGIAKLLTGEDQSMTQTQTL 690
              + YLH      ++H DLKP N+LL          + DFG+++ + G    +   + +
Sbjct: 141 LEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI-GHACEL--REIM 194

Query: 691 ATIGYMAPEYGREGQVSTNGDVYSFGIML 719
            T  Y+APE      ++T  D+++ GI+ 
Sbjct: 195 GTPEYLAPEILNYDPITTATDMWNIGIIA 223

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 88.1 bits (219), Expect = 6e-19
 Identities = 55/201 (27%), Positives = 87/201 (43%), Gaps = 35/201 (17%)

Query: 535 IGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDV-----ECAMMKSIRHRNLVKV 588
           IG+G F  V  AR I  G EVA+K+ +           +     E  +MK + H N+VK+
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIID---KTQLNPTSLQKLFREVRIMKILNHPNIVKL 79

Query: 589 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNY-----SLDIFQRLNIMIDVASALEYLHFG 643
                 E+   L++EY   G +  YL +        +   F+++       SA++Y H  
Sbjct: 80  FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQI------VSAVQYCH-- 131

Query: 644 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATI----GYMAPE 699
               ++H DLK  N+LLD +M   ++DFG +          T    L        Y APE
Sbjct: 132 -QKRIVHRDLKAENLLLDADMNIKIADFGFS-------NEFTVGGKLDAFCGAPPYAAPE 183

Query: 700 -YGREGQVSTNGDVYSFGIML 719
            +  +       DV+S G++L
Sbjct: 184 LFQGKKYDGPEVDVWSLGVIL 204

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 88.3 bits (219), Expect = 1e-18
 Identities = 59/319 (18%), Positives = 118/319 (36%), Gaps = 70/319 (21%)

Query: 517 FSYLELFQATDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVK----VFN--LQCGRAFKS 569
           F  ++     D +   +LIGRG +G VY A        VA+K    +F   + C R  + 
Sbjct: 16  FQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR- 74

Query: 570 FDVECAMMKSIRHRNLVK---VISSCSNEEFKA--LVLEYMPHGSLEKYLHSSNYSLDIF 624
              E  ++  ++   +++   +I      +F    +VLE      L+K   +  +  +  
Sbjct: 75  ---EITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEH 130

Query: 625 QRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM 684
            +  I+ ++     ++H    + +IH DLKP+N LL+ +    + DFG+A+ +  E  + 
Sbjct: 131 IKT-ILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTN 186

Query: 685 TQ--------------------TQTLATIGYMAPE-------YGREGQVSTNGDVYSFGI 717
                                 T  + T  Y APE       Y      + + D++S G 
Sbjct: 187 IVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENY------TKSIDIWSTGC 240

Query: 718 MLMETFTRKKPTDE-------LFNGEMTLK-HWVNDCLPISTMEVVD-----ANLL---S 761
           +  E     +           LF G          +   +      D      N++   +
Sbjct: 241 IFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPT 300

Query: 762 QEDIHFVAKEQCVSFVFNL 780
           ++D+  + K + + ++   
Sbjct: 301 EDDLKNINKPEVIKYIKLF 319

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 88.3 bits (219), Expect = 2e-18
 Identities = 45/205 (21%), Positives = 86/205 (41%), Gaps = 29/205 (14%)

Query: 534 LIGRGGFGSVYKARIRDGMEV-AVKVFNLQCGRAFKSFDVECAM-----MKSIRHRNLVK 587
           +IGRG FG V   ++++  +V A+K+  L      K  +  C       + +   + +  
Sbjct: 81  VIGRGAFGEVAVVKLKNADKVFAMKI--LNKWEMLKRAETACFREERDVLVNGDSKWITT 138

Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQ----RLNIMIDVASALEYLHFG 643
           +  +  ++    LV++Y   G L      S +  D       R  +  ++  A++ +H  
Sbjct: 139 LHYAFQDDNNLYLVMDYYVGGDL--LTLLSKFE-DRLPEEMARFYLA-EMVIAIDSVH-- 192

Query: 644 YSAPVIHCDLKPSNVLLDDNMVAH--LSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYG 701
                +H D+KP N+L+D N   H  L+DFG    L  +    +    + T  Y++PE  
Sbjct: 193 -QLHYVHRDIKPDNILMDMN--GHIRLADFGSCLKLMEDGTVQSSV-AVGTPDYISPEIL 248

Query: 702 REGQVSTNG-----DVYSFGIMLME 721
           +  +          D +S G+ + E
Sbjct: 249 QAMEGGKGRYGPECDWWSLGVCMYE 273

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 86.2 bits (214), Expect = 2e-18
 Identities = 59/240 (24%), Positives = 92/240 (38%), Gaps = 43/240 (17%)

Query: 501 GPPNDPNMPPVATWRRFSYLELFQATDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVF 559
            PP  P  PP    R            ++    L+G+GGFG+V+    + D ++VA+KV 
Sbjct: 12  APPGTPTPPPGGKDRE-------AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVI 64

Query: 560 N----LQCGRAFKSFDV--ECAMMKSIR----HRNLVKVISSCSNEEFKALVLEY-MPHG 608
                L       S     E A++  +     H  +++++     +E   LVLE  +P  
Sbjct: 65  PRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQ 124

Query: 609 SLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD-DNMVAH 667
            L  Y+ +    L           V +A+++ H   S  V+H D+K  N+L+D     A 
Sbjct: 125 DLFDYI-TEKGPLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAK 180

Query: 668 LSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAPEY-------GREGQVSTNGDVYSFGIML 719
           L DFG   LL               T  Y  PE+                  V+S GI+L
Sbjct: 181 LIDFGSGALLHD-----EPYTDFDGTRVYSPPEWISRHQYHALP------ATVWSLGILL 229

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 86.1 bits (214), Expect = 2e-18
 Identities = 67/235 (28%), Positives = 107/235 (45%), Gaps = 38/235 (16%)

Query: 523 FQATDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGR-AFKSFDV----ECAM 576
             AT ++     IG G +G+VYKAR    G  VA+K   +  G        +    E A+
Sbjct: 5   SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64

Query: 577 MKSIR---HRNLVK----VISSCSNEEFKA-LVLEYMPHGSLEKYLHSSN-YSLDIFQRL 627
           ++ +    H N+V+      +S ++ E K  LV E++    L  YL  +    L      
Sbjct: 65  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIK 123

Query: 628 NIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQT 687
           ++M      L++LH   +  ++H DLKP N+L+       L+DFG+A++ + +   M  T
Sbjct: 124 DLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ---MALT 177

Query: 688 QTLATIGYMAPE------YGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGE 736
             + T+ Y APE      Y      +T  D++S G +  E F R KP   LF G 
Sbjct: 178 PVVVTLWYRAPEVLLQSTY------ATPVDMWSVGCIFAEMFRR-KP---LFCGN 222

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 87.0 bits (216), Expect = 2e-18
 Identities = 56/204 (27%), Positives = 82/204 (40%), Gaps = 40/204 (19%)

Query: 534 LIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDV------ECAMMKSIRHRNLV 586
            IG G FG     R       VAVK          +   +      E    +S+RH N+V
Sbjct: 27  DIGSGNFGVARLMRDKLTKELVAVKYIE-------RGAAIDENVQREIINHRSLRHPNIV 79

Query: 587 KVISSCSNEEFKALVLEYMPHGSLEKYL-----HSSNYSLDIFQRLNIMIDVASALEYLH 641
           +           A+++EY   G L + +      S + +   FQ+L       S + Y H
Sbjct: 80  RFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQL------LSGVSYCH 133

Query: 642 FGYSAPVIHCDLKPSNVLLDDNMVAHL--SDFGIAKLLTGEDQSMTQTQTLATIGYMAPE 699
              S  + H DLK  N LLD +    L   DFG +K      Q  +   T A   Y+APE
Sbjct: 134 ---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA---YIAPE 187

Query: 700 --YGRE--GQVSTNGDVYSFGIML 719
               +E  G+++   DV+S G+ L
Sbjct: 188 VLLRQEYDGKIA---DVWSCGVTL 208

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 87.1 bits (216), Expect = 3e-18
 Identities = 55/219 (25%), Positives = 87/219 (39%), Gaps = 46/219 (21%)

Query: 527 DKFSENNLIGRGGFGSVYKARIRDGMEV-AVKVFNLQCGRAFKSFDVECAM-----MKSI 580
           + +    +IGRG FG V   R +   +V A+K+ +       K  D          M   
Sbjct: 69  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKF--EMIKRSDSAFFWEERDIMAFA 126

Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVA------ 634
               +V++  +  ++ +  +V+EYMP G L   +             ++    A      
Sbjct: 127 NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM----------SNYDVPEKWARFYTAE 176

Query: 635 --SALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLAT 692
              AL+ +H   S   IH D+KP N+LLD +    L+DFG    +  E      T  + T
Sbjct: 177 VVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGT 232

Query: 693 IGYMAPE----------YGREGQVSTNGDVYSFGIMLME 721
             Y++PE          YGRE       D +S G+ L E
Sbjct: 233 PDYISPEVLKSQGGDGYYGRE--C----DWWSVGVFLYE 265

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 87.2 bits (216), Expect = 4e-18
 Identities = 63/206 (30%), Positives = 97/206 (47%), Gaps = 42/206 (20%)

Query: 534 LIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDV------ECAMMKSIRHRNLV 586
            +G G FG V   +    G +VAVK+ N Q     +S DV      E   +K  RH +++
Sbjct: 23  TLGVGTFGKVKVGKHELTGHKVAVKILNRQ---KIRSLDVVGKIRREIQNLKLFRHPHII 79

Query: 587 K---VISSCSNEEFKALVLEYMPHGSLEKYL-----HSSNYSLDIFQRLNIMIDVASALE 638
           K   VIS+  ++ F  +V+EY+  G L  Y+          S  +FQ++       S ++
Sbjct: 80  KLYQVIST-PSDIF--MVMEYVSGGELFDYICKNGRLDEKESRRLFQQI------LSGVD 130

Query: 639 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATI----G 694
           Y H      V+H DLKP NVLLD +M A ++DFG++ +       M+  + L T      
Sbjct: 131 YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNM-------MSDGEFLRTSCGSPN 180

Query: 695 YMAPE-YGREGQVSTNGDVYSFGIML 719
           Y APE            D++S G++L
Sbjct: 181 YAAPEVISGRLYAGPEVDIWSSGVIL 206

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 84.5 bits (209), Expect = 1e-17
 Identities = 54/192 (28%), Positives = 78/192 (40%), Gaps = 39/192 (20%)

Query: 248 QDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPA--CFSNMTFLKVLSLGSNEL 305
             +     QL  ++P S+        L+L  N LS  + A    + +T L  L L  N L
Sbjct: 21  NILSCSKQQLP-NVPQSL--PSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHL 76

Query: 306 TSIPLN-FWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLK 364
             I    F  + ++  L+LSSN           +L  L E  FS              L+
Sbjct: 77  NFISSEAFVPVPNLRYLDLSSN-----------HLHTLDEFLFS-------------DLQ 112

Query: 365 NLENLFLEYNRLEGSIP-DSFGDLISLKSLNLSYNNLSGTIP----VSLEKLSYLKDLNL 419
            LE L L  N +   +  ++F D+  L+ L LS N +S   P        KL  L  L+L
Sbjct: 113 ALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDL 170

Query: 420 SFNKLKGEIPRG 431
           S NKLK ++P  
Sbjct: 171 SSNKLK-KLPLT 181

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 80.3 bits (198), Expect = 3e-16
 Identities = 49/186 (26%), Positives = 70/186 (37%), Gaps = 38/186 (20%)

Query: 6   NNFLTSTTPKEI-DNISNLKVLYLYNNRLQGEIIHE--IGHLHNLGFLDLSQNKLLGTIP 62
           +N L+    +     ++NL  L L +N L    I       + NL +LDLS N  L T+ 
Sbjct: 48  HNNLSRLRAEWTPTRLTNLHSLLLSHNHLN--FISSEAFVPVPNLRYLDLSSNH-LHTLD 104

Query: 63  AAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIF-NASKLS 121
             +F+                         L  LEVL L+ N+    +    F + ++L 
Sbjct: 105 EFLFS------------------------DLQALEVLLLYNNHIV-VVDRNAFEDMAQLQ 139

Query: 122 KLALEMNSFSGFIPSTFGN---LRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISL 178
           KL L  N  S F      +   L  L  L L  N L    L L+ L  L        + L
Sbjct: 140 KLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK--LPLTDLQKLPAWVKNG-LYL 196

Query: 179 SNNPLD 184
            NNPL+
Sbjct: 197 HNNPLE 202

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 69.9 bits (171), Expect = 7e-13
 Identities = 39/194 (20%), Positives = 62/194 (31%), Gaps = 37/194 (19%)

Query: 212 GIPEEITNLTDLTTIVLGGNKLNGSIP--ITLGKLQKLQDVDLEYNQLEGSIPDSI--CL 267
            +P     L       L  N L   +    T  +L  L  + L +N L   I       +
Sbjct: 36  SLPSYTALL------DLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPV 87

Query: 268 SVELYELELGGNKLSGSIPA-CFSNMTFLKVLSLGSNELTSIPLN-FWSLKDILDLNLSS 325
              L  L+L  N L  ++    FS++  L+VL L +N +  +  N F  +  +  L LS 
Sbjct: 88  -PNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQ 145

Query: 326 NCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFG 385
           N            +                   +   L  L  L L  N+L+        
Sbjct: 146 N-----------QISRFPVELIK----------DGNKLPKLMLLDLSSNKLKKLPLTDLQ 184

Query: 386 DLISLKSLNLSYNN 399
            L +     L  +N
Sbjct: 185 KLPAWVKNGLYLHN 198

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 67.9 bits (166), Expect = 3e-12
 Identities = 37/185 (20%), Positives = 65/185 (35%), Gaps = 12/185 (6%)

Query: 54  QNKLLGTIPAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHF 113
             + L  +P ++   S      +++N+LS   +  T   L NL  L L  N+ +  I   
Sbjct: 26  SKQQLPNVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSE 82

Query: 114 IF-NASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKS 172
            F     L  L L  N         F +L+ LE L LY+N++    +D +    ++    
Sbjct: 83  AFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVV--VDRNAFEDMAQ--- 137

Query: 173 LTHISLSNNPLDGILPRTYVGNLS-HSLKNFYMYNCNVSGGIPEEITNLTDLT--TIVLG 229
           L  + LS N +                L    + +  +      ++  L       + L 
Sbjct: 138 LQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLH 197

Query: 230 GNKLN 234
            N L 
Sbjct: 198 NNPLE 202

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 84.8 bits (210), Expect = 1e-17
 Identities = 45/207 (21%), Positives = 83/207 (40%), Gaps = 31/207 (14%)

Query: 534 LIGRGGFGSVYKARIRDGMEV-AVKVFNLQCGRAFKSFDVECAM-----MKSIRHRNLVK 587
           +IGRG F  V   +++   +V A+K+  +      K  +V C       + +   R + +
Sbjct: 68  VIGRGAFSEVAVVKMKQTGQVYAMKI--MNKWDMLKRGEVSCFREERDVLVNGDRRWITQ 125

Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQ----RLNIMIDVASALEYLHFG 643
           +  +  +E +  LV+EY   G L      S +  +       R  +  ++  A++ +H  
Sbjct: 126 LHFAFQDENYLYLVMEYYVGGDL--LTLLSKFG-ERIPAEMARFYLA-EIVMAIDSVH-- 179

Query: 644 YSAPVIHCDLKPSNVLLDDNMVAH--LSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYG 701
                +H D+KP N+LLD     H  L+DFG    L  +    +    + T  Y++PE  
Sbjct: 180 -RLGYVHRDIKPDNILLDRC--GHIRLADFGSCLKLRADGTVRSLV-AVGTPDYLSPEIL 235

Query: 702 REGQVSTNGDVY-------SFGIMLME 721
           +          Y       + G+   E
Sbjct: 236 QAVGGGPGTGSYGPECDWWALGVFAYE 262

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 83.1 bits (206), Expect = 3e-17
 Identities = 54/207 (26%), Positives = 91/207 (43%), Gaps = 45/207 (21%)

Query: 534 LIGRGGFGSVYKAR-IRDGMEVAVKVFN---LQCGRAFKSFDVECAMMKSIRHRNLVK-- 587
            +G G FG V  A   +   +VA+K  +   L+        + E + +K +RH +++K  
Sbjct: 16  TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75

Query: 588 -VISSCSNEEFKALVLEY---------MPHGSLEKYLHSSNYSLDIFQRLNIMIDVASAL 637
            VI++   +    +V+EY         +    +     + +     FQ++        A+
Sbjct: 76  DVITT-PTDIV--MVIEYAGGELFDYIVEKKRM-----TEDEGRRFFQQI------ICAI 121

Query: 638 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATI---- 693
           EY H      ++H DLKP N+LLDDN+   ++DFG++ +       MT    L T     
Sbjct: 122 EYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNI-------MTDGNFLKTSCGSP 171

Query: 694 GYMAPE-YGREGQVSTNGDVYSFGIML 719
            Y APE    +       DV+S GI+L
Sbjct: 172 NYAAPEVINGKLYAGPEVDVWSCGIVL 198

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 84.0 bits (208), Expect = 3e-17
 Identities = 62/297 (20%), Positives = 116/297 (39%), Gaps = 70/297 (23%)

Query: 523 FQATDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVK-VFN-----LQCGRAFKSFDVECA 575
                K+     +G+G +G V+K+   R G  VAVK +F+         R F+    E  
Sbjct: 5   RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR----EIM 60

Query: 576 MMKSIR-HRNLVKVISSCSNEEFKA--LVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMID 632
           ++  +  H N+V +++    +  +   LV +YM    L   + ++       Q   ++  
Sbjct: 61  ILTELSGHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRANILEPVHKQ--YVVYQ 117

Query: 633 VASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQ------ 686
           +   ++YLH   S  ++H D+KPSN+LL+      ++DFG+++      +          
Sbjct: 118 LIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSIN 174

Query: 687 -------------TQTLATIGYMAPE-------YGREGQVSTNGDVYSFGIMLMETFTRK 726
                        T  +AT  Y APE       Y      +   D++S G +L E     
Sbjct: 175 ENTENFDDDQPILTDYVATRWYRAPEILLGSTKY------TKGIDMWSLGCILGEILCG- 227

Query: 727 KPTDELFNGEMTLKHWVNDCLPISTMEVVDANLL---SQEDIHFVAKEQCVSFVFNL 780
           KP   +F G  T+              ++   ++   S ED+  +      + + +L
Sbjct: 228 KP---IFPGSSTMNQL---------ERIIG--VIDFPSNEDVESIQSPFAKTMIESL 270

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 82.6 bits (205), Expect = 4e-17
 Identities = 66/230 (28%), Positives = 110/230 (47%), Gaps = 32/230 (13%)

Query: 524 QATDKFSENNLIGRGGFGSVYKAR-IRDGME-VAVKVFNLQCGRAFKSFDV----ECAMM 577
           +A  ++     IG G +G V+KAR +++G   VA+K   +Q G   +   +    E A++
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE--EGMPLSTIREVAVL 65

Query: 578 KSIR---HRNLVK----VISSCSNEEFKA-LVLEYMPHGSLEKYLHS-SNYSLDIFQRLN 628
           + +    H N+V+       S ++ E K  LV E++    L  YL       +      +
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKD 124

Query: 629 IMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQ 688
           +M  +   L++LH   S  V+H DLKP N+L+  +    L+DFG+A++ + +   M  T 
Sbjct: 125 MMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTS 178

Query: 689 TLATIGYMAPE--YGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGE 736
            + T+ Y APE         +T  D++S G +  E F R KP   LF G 
Sbjct: 179 VVVTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEMFRR-KP---LFRGS 222

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 82.3 bits (204), Expect = 4e-17
 Identities = 53/238 (22%), Positives = 103/238 (43%), Gaps = 40/238 (16%)

Query: 514 WRRFSYLELFQATDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNL-QCGRAFKSFD 571
           W   S++  +   D +     +GRG +  V++A  I +  +V VK+    +  +  +   
Sbjct: 23  WDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR--- 79

Query: 572 VECAMMKSIR-HRNLVK----VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQR 626
            E  +++++R   N++     V    S     ALV E++ +   ++   +   +    + 
Sbjct: 80  -EIKILENLRGGPNIITLADIVKDPVSRTP--ALVFEHVNNTDFKQLYQT--LTDYDIRF 134

Query: 627 LNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTGEDQSMT 685
              M ++  AL+Y H   S  ++H D+KP NV++D ++    L D+G+A+      Q   
Sbjct: 135 Y--MYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEY- 187

Query: 686 QTQTLATIGYMAPE-------YGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGE 736
               +A+  +  PE       Y        + D++S G ML     RK+P    F+G 
Sbjct: 188 -NVRVASRYFKGPELLVDYQMY------DYSLDMWSLGCMLASMIFRKEP---FFHGH 235

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 81.0 bits (201), Expect = 9e-17
 Identities = 58/212 (27%), Positives = 92/212 (43%), Gaps = 53/212 (25%)

Query: 534 LIGRGGFGSVYKARIRDGMEV-AVKVFNLQCGRAFKSFDVECAM-----MKSIRHRNLVK 587
            +G G FG V+  R R      A+KV  L+     +   VE        +  + H  +++
Sbjct: 13  TLGTGSFGRVHLIRSRHNGRYYAMKV--LKKEIVVRLKQVEHTNDERLMLSIVTHPFIIR 70

Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLHSSN---------YSLDIFQRLNIMIDVASALE 638
           +  +  + +   ++++Y+  G L   L  S          Y+ ++            ALE
Sbjct: 71  MWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV----------CLALE 120

Query: 639 YLHFGYSAPVIHCDLKPSNVLLDDNMVAH--LSDFGIAKLLTGEDQSMTQTQTL-ATIGY 695
           YLH   S  +I+ DLKP N+LLD N   H  ++DFG AK +         T TL  T  Y
Sbjct: 121 YLH---SKDIIYRDLKPENILLDKN--GHIKITDFGFAKYVP------DVTYTLCGTPDY 169

Query: 696 MAPE------YGREGQVSTNGDVYSFGIMLME 721
           +APE      Y +   +    D +SFGI++ E
Sbjct: 170 IAPEVVSTKPYNKS--I----DWWSFGILIYE 195

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 82.1 bits (203), Expect = 1e-16
 Identities = 54/261 (20%), Positives = 98/261 (37%), Gaps = 71/261 (27%)

Query: 526 TDKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRN 584
           + K+S    +G G FG V +    + G   A+K          +    E  +MK + H N
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR----ELDIMKVLDHVN 61

Query: 585 LVKVI--------------------------------------SSCSNEEFKALVLEYMP 606
           ++K++                                       + S  ++  +++EY+P
Sbjct: 62  IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121

Query: 607 ---HGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD-D 662
              H  L+ ++ S          +  +  +  A+ ++H   S  + H D+KP N+L++  
Sbjct: 122 DTLHKVLKSFIRSGRSIPMNLISI-YIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSK 177

Query: 663 NMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPE-------YGREGQVSTNGDVYSF 715
           +    L DFG AK L    +       + +  Y APE       Y      + + D++S 
Sbjct: 178 DNTLKLCDFGSAKKLI-PSEPS--VAYICSRFYRAPELMLGATEY------TPSIDLWSI 228

Query: 716 GIMLMETFTRKKPTDELFNGE 736
           G +  E     KP   LF+GE
Sbjct: 229 GCVFGELILG-KP---LFSGE 245

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 83.5 bits (206), Expect = 1e-16
 Identities = 60/229 (26%), Positives = 96/229 (41%), Gaps = 52/229 (22%)

Query: 534 LIGRGGFGSVYKARIRDGMEV-AVKVFNLQCGRAFKSFDVECAMM------KSIRHRNLV 586
           ++G+G FG V  +  +   E+ AVK+  L+     +  DVEC M+         +   L 
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKI--LKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 405

Query: 587 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSN---------YSLDIFQRLNIMIDVASAL 637
           ++ S     +    V+EY+  G L  ++             Y+ +I          A  L
Sbjct: 406 QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEI----------AIGL 455

Query: 638 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYM 696
            +L    S  +I+ DLK  NV+LD      ++DFG+ K    +      T+T   T  Y+
Sbjct: 456 FFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV---TTKTFCGTPDYI 509

Query: 697 APE------YGREGQVSTNGDVYSFGIMLMETFTRKKP-----TDELFN 734
           APE      YG+   V    D ++FG++L E    + P      DELF 
Sbjct: 510 APEIIAYQPYGKS--V----DWWAFGVLLYEMLAGQAPFEGEDEDELFQ 552

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 81.2 bits (201), Expect = 1e-16
 Identities = 53/214 (24%), Positives = 91/214 (42%), Gaps = 43/214 (20%)

Query: 527 DKFSENNLIGRGGFGSVYKARIRDGMEV-AVKVFNLQCGRAFKSFDVEC-----AMMKSI 580
           D+F     +G G FG V   + ++     A+K+  L   +  K   +E       +++++
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKI--LDKQKVVKLKQIEHTLNEKRILQAV 98

Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMI------DVA 634
               LVK+  S  +     +V+EY+  G +  +L           R +          + 
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI-------GRFSEPHARFYAAQIV 151

Query: 635 SALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTL-ATI 693
              EYLH   S  +I+ DLKP N+L+D      ++DFG AK + G      +T TL  T 
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWTLCGTP 202

Query: 694 GYMAPE------YGREGQVSTNGDVYSFGIMLME 721
             +APE      Y +   V    D ++ G+++ E
Sbjct: 203 EALAPEIILSKGYNK--AV----DWWALGVLIYE 230

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 82.1 bits (203), Expect = 1e-16
 Identities = 55/228 (24%), Positives = 93/228 (40%), Gaps = 50/228 (21%)

Query: 534 LIGRGGFGSVYKARIRDGMEV-AVKVFNLQCGRAFKSFDVECAM-----MKSIRHRNLVK 587
           L+G+G FG V   + +      A+K+  L+        +V   +     +++ RH  L  
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKI--LKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 212

Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLHSSN---------YSLDIFQRLNIMIDVASALE 638
           +  S    +    V+EY   G L  +L             Y  +I           SAL+
Sbjct: 213 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEI----------VSALD 262

Query: 639 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTL-ATIGYMA 697
           YLH   +  V++ DLK  N++LD +    ++DFG+ K    +  +    +T   T  Y+A
Sbjct: 263 YLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---MKTFCGTPEYLA 317

Query: 698 PE------YGREGQVSTNGDVYSFGIMLMETFTRKKP-----TDELFN 734
           PE      YGR   V    D +  G+++ E    + P      ++LF 
Sbjct: 318 PEVLEDNDYGRA--V----DWWGLGVVMYEMMCGRLPFYNQDHEKLFE 359

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 79.3 bits (196), Expect = 1e-16
 Identities = 46/289 (15%), Positives = 97/289 (33%), Gaps = 56/289 (19%)

Query: 140 NLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSL 199
            L N     L   ++T        L S      + + +  N+ +  +             
Sbjct: 17  GLANAVKQNLGKQSVTD-------LVSQKELSGVQNFNGDNSNIQSL------------- 56

Query: 200 KNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEG 259
                            +   T+L  + L  N+++  +   L  L KL+++ +  N+L+ 
Sbjct: 57  ---------------AGMQFFTNLKELHLSHNQIS-DLS-PLKDLTKLEELSVNRNRLK- 98

Query: 260 SIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDIL 319
           ++         L  L L  N+L     +   ++  L++LS+ +N+L SI      L  + 
Sbjct: 99  NLNGIPSAC--LSRLFLDNNELR-DTDS-LIHLKNLEILSIRNNKLKSIV-MLGFLSKLE 153

Query: 320 DLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGS 379
            L+L  N  +    L    LK +  ID +       +   +     L       +  +G 
Sbjct: 154 VLDLHGNEITNTGGLT--RLKKVNWIDLTGQK---CVNEPVKYQPELYITNTVKD-PDGR 207

Query: 380 I--PDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKG 426
              P    +  S     + +       PV  +++SY     ++  + + 
Sbjct: 208 WISPYYISNGGSYVDGCVLWEL-----PVYTDEVSYKFSEYINVGETEA 251

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 69.3 bits (170), Expect = 5e-13
 Identities = 33/211 (15%), Positives = 69/211 (32%), Gaps = 25/211 (11%)

Query: 17  IDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAV 76
              ++N     L    +    +     L  +   +   + +     A +   + LK   +
Sbjct: 15  DPGLANAVKQNLGKQSV--TDLVSQKELSGVQNFNGDNSNI--QSLAGMQFFTNLKELHL 70

Query: 77  TNNSLSGCLSSITDV-GLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIP 135
           ++N     +S ++ +  L  LE L +  N            ++ LS+L L+ N       
Sbjct: 71  SHN----QISDLSPLKDLTKLEELSVNRNRLKNLNG---IPSACLSRLFLDNNELRDT-- 121

Query: 136 STFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNL 195
            +  +L+NLE L++ +N L S       +  L     L  + L  N +        +  L
Sbjct: 122 DSLIHLKNLEILSIRNNKLKS-------IVMLGFLSKLEVLDLHGNEITNTGG---LTRL 171

Query: 196 SHSLKNFYMYNCNVSGGIPEEITNLTDLTTI 226
              +    +          +    L    T+
Sbjct: 172 K-KVNWIDLTGQKCVNEPVKYQPELYITNTV 201

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 68.5 bits (168), Expect = 8e-13
 Identities = 33/178 (18%), Positives = 66/178 (37%), Gaps = 21/178 (11%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAI 65
              +T         +S ++     N+ +  + +  +    NL  L LS N++  +  + +
Sbjct: 28  KQSVTDLVS--QKELSGVQNFNGDNSNI--QSLAGMQFFTNLKELHLSHNQI--SDLSPL 81

Query: 66  FNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLAL 125
            +++ L+  +V  N     L ++  +    L  L+L  N    T    + +   L  L++
Sbjct: 82  KDLTKLEELSVNRNR----LKNLNGIPSACLSRLFLDNNELRDTDS--LIHLKNLEILSI 135

Query: 126 EMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPL 183
             N          G L  LE L L+ N +T+          L+  K +  I L+    
Sbjct: 136 RNNKLKSI--VMLGFLSKLEVLDLHGNEITN-------TGGLTRLKKVNWIDLTGQKC 184

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 42.3 bits (100), Expect = 3e-04
 Identities = 33/169 (19%), Positives = 50/169 (29%), Gaps = 40/169 (23%)

Query: 15  KEIDNIS--NLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLK 72
           K ++ I    L  L+L NN L+      + HL NL  L +  NK        + ++  L 
Sbjct: 98  KNLNGIPSACLSRLFLDNNELRD--TDSLIHLKNLEILSIRNNK--------LKSIVMLG 147

Query: 73  AFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSG 132
                               L  LEVL L GN  + T    +    K++ + L       
Sbjct: 148 -------------------FLSKLEVLDLHGNEITNTGG--LTRLKKVNWIDLTGQKCVN 186

Query: 133 FIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNN 181
                   L     +   D    S          +SN  S     +   
Sbjct: 187 EPVKYQPELYITNTVKDPDGRWIS-------PYYISNGGSYVDGCVLWE 228

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 80.3 bits (199), Expect = 2e-16
 Identities = 56/228 (24%), Positives = 91/228 (39%), Gaps = 51/228 (22%)

Query: 534 LIGRGGFGSVYKARIRDGMEV-AVKVFNLQCGRAFKSFDVECAMM-----KSIRHRNLVK 587
           L+G+G FG V   R +      A+K+  L+        +V   +      ++ RH  L  
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKI--LRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69

Query: 588 VISSCSNEEFKALVLEYMPHGSLEKYLHSSN---------YSLDIFQRLNIMIDVASALE 638
           +  +    +    V+EY   G L  +L             Y  +I           SALE
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEI----------VSALE 119

Query: 639 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTL-ATIGYMA 697
           YLH   S  V++ D+K  N++LD +    ++DFG+ K    +  +    +T   T  Y+A
Sbjct: 120 YLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKTFCGTPEYLA 173

Query: 698 PE------YGREGQVSTNGDVYSFGIMLMETFTRKKP-----TDELFN 734
           PE      YGR   V    D +  G+++ E    + P      + LF 
Sbjct: 174 PEVLEDNDYGRA--V----DWWGLGVVMYEMMCGRLPFYNQDHERLFE 215

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 77.7 bits (192), Expect = 3e-16
 Identities = 33/247 (13%), Positives = 69/247 (27%), Gaps = 55/247 (22%)

Query: 21  SNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNS 80
            + + L L    L+    H   +L N+  + +S +  L  + +  F              
Sbjct: 31  PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFY------------- 77

Query: 81  LSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGN 140
                       L  +  + +        I                        P     
Sbjct: 78  -----------NLSKVTHIEIRNTRNLTYID-----------------------PDALKE 103

Query: 141 LRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLK 200
           L  L++L +++  L         L+ + +      + +++NP    +P      L +   
Sbjct: 104 LPLLKFLGIFNTGLKM----FPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETL 159

Query: 201 NFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITL--GKLQKLQDVDLEYNQLE 258
              +YN   +  +     N T L  + L  NK    I      G       +D+    + 
Sbjct: 160 TLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT 218

Query: 259 GSIPDSI 265
            ++P   
Sbjct: 219 -ALPSKG 224

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 76.2 bits (188), Expect = 1e-15
 Identities = 40/248 (16%), Positives = 83/248 (33%), Gaps = 43/248 (17%)

Query: 85  LSSITDVGLPNLEVLYLWGNNFSGTIPHFIF-NASKLSKLALEMNSFSGFIPS-TFGNLR 142
           +  I  +  P+ + L L   +   TIP   F N   +S++ + ++     + S +F NL 
Sbjct: 23  IQRIPSL-PPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLS 80

Query: 143 NLEWLTLYDNNLTSSTLDLSFLSS--LSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLK 200
            +  + + +        +L+++    L     L  + + N  L      T          
Sbjct: 81  KVTHIEIRNTR------NLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTK--------- 125

Query: 201 NFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITL--GKLQKLQDVDLEYNQLE 258
                           + +      + +  N    SIP+    G   +   + L  N   
Sbjct: 126 ----------------VYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT 169

Query: 259 GSIPDSICLSVELYELELGGNKLSGSIPA-CFSNM-TFLKVLSLGSNELTSIPLN-FWSL 315
            S+        +L  + L  NK    I    F  + +   +L +    +T++P      L
Sbjct: 170 -SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSKGLEHL 228

Query: 316 KDILDLNL 323
           K+++  N 
Sbjct: 229 KELIARNT 236

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 74.3 bits (183), Expect = 6e-15
 Identities = 36/210 (17%), Positives = 76/210 (36%), Gaps = 13/210 (6%)

Query: 220 LTDLTTIVLGGNKLNGSIPI-TLGKLQKLQDVDLEYNQLEGSIPDSICLS-VELYELELG 277
                T+ L    L  +IP      L  +  + +  +     +      +  ++  +E+ 
Sbjct: 30  PPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIR 88

Query: 278 GNKLSGSIPA-CFSNMTFLKVLSLGSNELTSIP--LNFWSLKDILDLNLSSNCFSGPLPL 334
             +    I       +  LK L + +  L   P     +S      L ++ N +   +P+
Sbjct: 89  NTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPV 148

Query: 335 EI-RNL-KALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIP-DSFGDLIS-L 390
              + L    + +    N F+  +     +   L+ ++L  N+    I  D+FG + S  
Sbjct: 149 NAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGP 207

Query: 391 KSLNLSYNNLSGTIPV-SLEKLSYLKDLNL 419
             L++S  +++  +P   LE L  L   N 
Sbjct: 208 SLLDVSQTSVT-ALPSKGLEHLKELIARNT 236

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 69.6 bits (171), Expect = 2e-13
 Identities = 35/178 (19%), Positives = 65/178 (36%), Gaps = 20/178 (11%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEI-----GHLHNLGFLDLSQNKLLGT 60
           +  L         N+S +  + + N R     +  I       L  L FL +     L  
Sbjct: 65  DVTLQQLESHSFYNLSKVTHIEIRNTRN----LTYIDPDALKELPLLKFLGIFNTG-LKM 119

Query: 61  IPA--AIFNVSTLKAFAVTNNSLSGCLSSITDVGLPN-LEVLYLWGNNFSGTIPHFIFNA 117
            P    +++        +T+N     +      GL N    L L+ N F+ ++  + FN 
Sbjct: 120 FPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNG 178

Query: 118 SKLSKLALEMNSFSGFIPS-TFGNLRN-LEWLTLYDNNLTS---STLD-LSFLSSLSN 169
           +KL  + L  N +   I    FG + +    L +   ++T+     L+ L  L + + 
Sbjct: 179 TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSKGLEHLKELIARNT 236

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 69.6 bits (171), Expect = 2e-13
 Identities = 44/264 (16%), Positives = 86/264 (32%), Gaps = 66/264 (25%)

Query: 141 LRNLEWLTLYDNNLTSSTLDLSFLSS--LSNCKSLTHISLS-NNPLDGILPRTYVGNLSH 197
             + + L L + +L +       + S   SN  +++ I +S +  L  +   +       
Sbjct: 30  PPSTQTLKLIETHLRT-------IPSHAFSNLPNISRIYVSIDVTLQQLESHS------- 75

Query: 198 SLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPI-TLGKLQKLQDVDLEYNQ 256
               FY               NL+ +T I +   +    I    L +L  L+ + +    
Sbjct: 76  ----FY---------------NLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTG 116

Query: 257 LEGSIPDSICLS--VELYELELGGNKLSGSIPA-CFSNMT-FLKVLSLGSNELTSIPLNF 312
           L+   PD   +      + LE+  N    SIP   F  +      L L +N  TS+    
Sbjct: 117 LK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYA 175

Query: 313 WSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLE 372
           ++   +  + L+ N          + L  +       + F G+             L + 
Sbjct: 176 FNGTKLDAVYLNKN----------KYLTVI-----DKDAFGGV-------YSGPSLLDVS 213

Query: 373 YNRLEGSIP-DSFGDLISLKSLNL 395
              +  ++P      L  L + N 
Sbjct: 214 QTSVT-ALPSKGLEHLKELIARNT 236

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 66.6 bits (163), Expect = 3e-12
 Identities = 28/186 (15%), Positives = 60/186 (32%), Gaps = 16/186 (8%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIG-----HLHNLGFLDLSQNKLLGT 60
              L +       N+ N+  +Y+  +      + ++      +L  +  +++   + L  
Sbjct: 40  ETHLRTIPSHAFSNLPNISRIYVSIDVT----LQQLESHSFYNLSKVTHIEIRNTRNLTY 95

Query: 61  IPAAIF-NVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFN--A 117
           I       +  LK   + N  L                +L +  N +  +IP   F    
Sbjct: 96  IDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLC 155

Query: 118 SKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHIS 177
           ++   L L  N F+      F N   L+ + L  N   +     +F    S     + + 
Sbjct: 156 NETLTLKLYNNGFTSVQGYAF-NGTKLDAVYLNKNKYLTVIDKDAFGGVYSG---PSLLD 211

Query: 178 LSNNPL 183
           +S   +
Sbjct: 212 VSQTSV 217

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 65.0 bits (159), Expect = 7e-12
 Identities = 33/192 (17%), Positives = 71/192 (36%), Gaps = 13/192 (6%)

Query: 247 LQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPA-CFSNMTFLKVLSLGSN-E 304
            +D  +    ++  IP    L      L+L    L  +IP+  FSN+  +  + +  +  
Sbjct: 13  EEDFRVTCKDIQ-RIPS---LPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVT 67

Query: 305 LTSIPLN-FWSLKDILDLNLSSNCFSGPLPLEI-RNLKALIEIDFSMNNFSGIIPME-IG 361
           L  +  + F++L  +  + + +      +  +  + L  L  +            +  + 
Sbjct: 68  LQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVY 127

Query: 362 SLKNLENLFLEYNRLEGSIP-DSFGDLIS-LKSLNLSYNNLSGTIPVSLEKLSYLKDLNL 419
           S      L +  N    SIP ++F  L +   +L L  N  + ++       + L  + L
Sbjct: 128 STDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYL 186

Query: 420 SFNKLKGEIPRG 431
           + NK    I + 
Sbjct: 187 NKNKYLTVIDKD 198

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 49.6 bits (119), Expect = 1e-06
 Identities = 15/97 (15%), Positives = 32/97 (32%), Gaps = 3/97 (3%)

Query: 342 LIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIP-DSFGDLISLKSLNLSYNNL 400
              +     +   I      +L N+  +++  +     +   SF +L  +  + +     
Sbjct: 33  TQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRN 92

Query: 401 SGTIPVS-LEKLSYLKDLNLSFNKLKGEIPRGGSFGN 436
              I    L++L  LK L +    LK   P      +
Sbjct: 93  LTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYS 128

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 79.6 bits (197), Expect = 4e-16
 Identities = 59/225 (26%), Positives = 99/225 (44%), Gaps = 44/225 (19%)

Query: 534 LIGRGGFGSVYKARIRDGMEV-AVKVFNLQCGRAFKSFDVECAMM------KSIRHRNLV 586
           ++G+G FG V+ A  +   +  A+K   L+        DVEC M+       +  H  L 
Sbjct: 24  MLGKGSFGKVFLAEFKKTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 81

Query: 587 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSN---------YSLDIFQRLNIMIDVASAL 637
            +  +   +E    V+EY+  G L  ++ S +         Y+ +I             L
Sbjct: 82  HMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEI----------ILGL 131

Query: 638 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAH--LSDFGIAKLLTGEDQSMTQTQTL-ATIG 694
           ++LH   S  +++ DLK  N+LLD +   H  ++DFG+ K     D     T T   T  
Sbjct: 132 QFLH---SKGIVYRDLKLDNILLDKD--GHIKIADFGMCKENMLGDAK---TNTFCGTPD 183

Query: 695 YMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKP-----TDELFN 734
           Y+APE     + + + D +SFG++L E    + P      +ELF+
Sbjct: 184 YIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH 228

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 79.2 bits (196), Expect = 6e-16
 Identities = 68/231 (29%), Positives = 97/231 (41%), Gaps = 56/231 (24%)

Query: 534 LIGRGGFGSVYKARIRDGMEV-AVKVFNLQCGRAFKSFDVECAMM------KSIRHRNLV 586
           +IG+G FG V  AR +      AVKV  LQ     K  + +  M       K+++H  LV
Sbjct: 45  VIGKGSFGKVLLARHKAEEVFYAVKV--LQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102

Query: 587 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSN---------YSLDIFQRLNIMIDVASAL 637
            +  S    +    VL+Y+  G L  +L             Y+ +I          ASAL
Sbjct: 103 GLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEI----------ASAL 152

Query: 638 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAH--LSDFGIAKLLTGEDQSMTQTQTL-ATIG 694
            YLH   S  +++ DLKP N+LLD     H  L+DFG+ K     + +   T T   T  
Sbjct: 153 GYLH---SLNIVYRDLKPENILLDSQ--GHIVLTDFGLCKENIEHNST---TSTFCGTPE 204

Query: 695 YMAPE------YGREGQVSTNGDVYSFGIMLMETFTRKKP-----TDELFN 734
           Y+APE      Y R   V    D +  G +L E      P     T E+++
Sbjct: 205 YLAPEVLHKQPYDRT--V----DWWCLGAVLYEMLYGLPPFYSRNTAEMYD 249

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 77.7 bits (192), Expect = 6e-16
 Identities = 61/214 (28%), Positives = 91/214 (42%), Gaps = 36/214 (16%)

Query: 221 TDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNK 280
            +     L    +      T  +L  +  +    + ++ S+   I     +  L LGGNK
Sbjct: 19  AETIKANLKKKSVT-DAV-TQNELNSIDQIIANNSDIK-SVQ-GIQYLPNVRYLALGGNK 74

Query: 281 LSGSIPACFSNMTFLKVLSLGSNELTSIPLN-FWSLKDILDLNLSSNCFSGPLPLEIRNL 339
           L   I A    +T L  L L  N+L S+P   F  L ++ +L L  N     LP      
Sbjct: 75  LH-DISA-LKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQS-LP------ 125

Query: 340 KALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDS-FGDLISLKSLNLSYN 398
                         G+       L NL  L L +N+L+ S+P   F  L +L  L+LSYN
Sbjct: 126 -------------DGVF----DKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYN 167

Query: 399 NLSGTIPVSL-EKLSYLKDLNLSFNKLKGEIPRG 431
            L  ++P  + +KL+ LKDL L  N+LK  +P G
Sbjct: 168 QLQ-SLPEGVFDKLTQLKDLRLYQNQLKS-VPDG 199

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 74.3 bits (183), Expect = 9e-15
 Identities = 52/187 (27%), Positives = 80/187 (42%), Gaps = 26/187 (13%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIG---HLHNLGFLDLSQNKLLGTIP 62
           N+ + S     I  + N++ L L  N+L      +I     L NL +L L+ N+L  ++P
Sbjct: 50  NSDIKSVQG--IQYLPNVRYLALGGNKLH-----DISALKELTNLTYLILTGNQL-QSLP 101

Query: 63  AAIFN-VSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNA-SKL 120
             +F+ ++ LK   +  N L      + D  L NL  L L  N    ++P  +F+  + L
Sbjct: 102 NGVFDKLTNLKELVLVENQLQSLPDGVFD-KLTNLTYLNLAHNQLQ-SLPKGVFDKLTNL 159

Query: 121 SKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTS---STLDLSFLSSLSNCKSLTHIS 177
           ++L L  N         F  L  L+ L LY N L S      D           SL +I 
Sbjct: 160 TELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFD--------RLTSLQYIW 211

Query: 178 LSNNPLD 184
           L +NP D
Sbjct: 212 LHDNPWD 218

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 66.6 bits (163), Expect = 3e-12
 Identities = 57/249 (22%), Positives = 96/249 (38%), Gaps = 52/249 (20%)

Query: 82  SGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNL 141
               +              L   + +          + + ++    +            L
Sbjct: 15  DDAFAETIK--------ANLKKKSVT-DAVTQN-ELNSIDQIIANNSDIKSVQG--IQYL 62

Query: 142 RNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKN 201
            N+ +L L  N L      +S L  L+N   LT++ L+ N L                  
Sbjct: 63  PNVRYLALGGNKLHD----ISALKELTN---LTYLILTGNQLQ----------------- 98

Query: 202 FYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITL-GKLQKLQDVDLEYNQLEGS 260
                 ++  G+ +++TNL +L    L  N+L  S+P  +  KL  L  ++L +NQL+ S
Sbjct: 99  ------SLPNGVFDKLTNLKELV---LVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQ-S 147

Query: 261 IPDSICLS-VELYELELGGNKLSGSIPA-CFSNMTFLKVLSLGSNELTSIPLN-FWSLKD 317
           +P  +      L EL+L  N+L  S+P   F  +T LK L L  N+L S+P   F  L  
Sbjct: 148 LPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTS 206

Query: 318 ILDLNLSSN 326
           +  + L  N
Sbjct: 207 LQYIWLHDN 215

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 58.5 bits (142), Expect = 2e-09
 Identities = 36/180 (20%), Positives = 69/180 (38%), Gaps = 36/180 (20%)

Query: 248 QDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTS 307
           + + +     +   PD      E  +  L    ++       + +  +  +   ++++ S
Sbjct: 1   ETITVSTPIKQ-IFPDDA--FAETIKANLKKKSVT-DAVT-QNELNSIDQIIANNSDIKS 55

Query: 308 IPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLE 367
           +      L ++  L L  N            L  +  +                 L NL 
Sbjct: 56  VQ-GIQYLPNVRYLALGGN-----------KLHDISALK---------------ELTNLT 88

Query: 368 NLFLEYNRLEGSIPDS-FGDLISLKSLNLSYNNLSGTIPVSL-EKLSYLKDLNLSFNKLK 425
            L L  N+L+ S+P+  F  L +LK L L  N L  ++P  + +KL+ L  LNL+ N+L+
Sbjct: 89  YLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQ 146

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 54.6 bits (132), Expect = 4e-08
 Identities = 55/217 (25%), Positives = 89/217 (41%), Gaps = 45/217 (20%)

Query: 50  LDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGT 109
            +L +  +          ++++      N+ +   +  I    LPN+  L L GN     
Sbjct: 24  ANLKKKSV-TDAVTQN-ELNSIDQIIANNSDIKS-VQGIQY--LPNVRYLALGGNKLH-D 77

Query: 110 IPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSN 169
           I       + L+ L L  N         F  L NL+ L L +N L S  L       L+N
Sbjct: 78  ISAL-KELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQS--LPDGVFDKLTN 134

Query: 170 CKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLG 229
              LT+++L++N L  +                         G+ +++TNLT+L    L 
Sbjct: 135 ---LTYLNLAHNQLQSLPK-----------------------GVFDKLTNLTELD---LS 165

Query: 230 GNKLNGSIPITLG---KLQKLQDVDLEYNQLEGSIPD 263
            N+L  S+P   G   KL +L+D+ L  NQL+ S+PD
Sbjct: 166 YNQLQ-SLPE--GVFDKLTQLKDLRLYQNQLK-SVPD 198

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 78.4 bits (194), Expect = 1e-15
 Identities = 63/229 (27%), Positives = 96/229 (41%), Gaps = 52/229 (22%)

Query: 534 LIGRGGFGSVYKARIRDGMEV-AVKVFNLQCGRAFKSFDVECAMM------KSIRHRNLV 586
           ++G+G FG V  AR+++  ++ AVKV  L+     +  DVEC M        +  H  L 
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKV--LKKDVILQDDDVECTMTEKRILSLARNHPFLT 87

Query: 587 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSN---------YSLDIFQRLNIMIDVASAL 637
           ++       +    V+E++  G L  ++  S          Y+ +I           SAL
Sbjct: 88  QLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEI----------ISAL 137

Query: 638 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTL-ATIGYM 696
            +LH      +I+ DLK  NVLLD      L+DFG+ K       +   T T   T  Y+
Sbjct: 138 MFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT---TATFCGTPDYI 191

Query: 697 APE------YGREGQVSTNGDVYSFGIMLMETFTRKKP-----TDELFN 734
           APE      YG    V    D ++ G++L E      P      D+LF 
Sbjct: 192 APEILQEMLYGPA--V----DWWAMGVLLYEMLCGHAPFEAENEDDLFE 234

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 78.4 bits (193), Expect = 1e-15
 Identities = 38/162 (23%), Positives = 68/162 (41%), Gaps = 5/162 (3%)

Query: 563 CGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLD 622
             R  K +     +    R  ++    SS S+   +   L  +      + L+     L 
Sbjct: 134 RFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKD--FLT 191

Query: 623 IFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 682
           +   +     VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+ +  +  
Sbjct: 192 LEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248

Query: 683 SMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 724
            + +      + +MAPE   +   +   DV+SFG++L E F+
Sbjct: 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 58.4 bits (141), Expect = 4e-09
 Identities = 24/93 (25%), Positives = 40/93 (43%), Gaps = 9/93 (9%)

Query: 535 IGRGGFGSVYKARI------RDGMEVAVKVFNLQ-CGRAFKSFDVECAMMKSI-RHRNLV 586
           +GRG FG V +A             VAVK+          ++   E  ++  I  H N+V
Sbjct: 30  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89

Query: 587 KVISSCSNEEFKALV-LEYMPHGSLEKYLHSSN 618
            ++ +C+      +V +E+   G+L  YL S  
Sbjct: 90  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR 122

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 78.0 bits (193), Expect = 1e-15
 Identities = 60/229 (26%), Positives = 96/229 (41%), Gaps = 52/229 (22%)

Query: 534 LIGRGGFGSVYKARIRDGMEV-AVKVFNLQCGRAFKSFDVECAMM------KSIRHRNLV 586
           ++G+G FG V  +  +   E+ AVK+  L+     +  DVEC M+         +   L 
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKI--LKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 84

Query: 587 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSN---------YSLDIFQRLNIMIDVASAL 637
           ++ S     +    V+EY+  G L  ++             Y+ +I          A  L
Sbjct: 85  QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEI----------AIGL 134

Query: 638 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTL-ATIGYM 696
            +L    S  +I+ DLK  NV+LD      ++DFG+ K    +      T+T   T  Y+
Sbjct: 135 FFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV---TTKTFCGTPDYI 188

Query: 697 APE------YGREGQVSTNGDVYSFGIMLMETFTRKKP-----TDELFN 734
           APE      YG+   V    D ++FG++L E    + P      DELF 
Sbjct: 189 APEIIAYQPYGKS--V----DWWAFGVLLYEMLAGQAPFEGEDEDELFQ 231

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 76.9 bits (190), Expect = 2e-15
 Identities = 40/200 (20%), Positives = 78/200 (39%), Gaps = 53/200 (26%)

Query: 506 PNMPPVATWRRFSYLELFQATDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCG 564
           P++      ++ + ++ ++ T +     ++G G  G V +    R   + A+K+      
Sbjct: 2   PHVKSGLQIKKNAIIDDYKVTSQ-----VLGLGINGKVLQIFNKRTQEKFALKMLQ---- 52

Query: 565 RAFKSFDV--ECAMMKSI-RHRNLVKVI----SSCSNEEFKALVLEYMPHGSLEKYLHSS 617
                     E  +     +  ++V+++    +  +  +   +V+E +  G L       
Sbjct: 53  ---DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGEL------- 102

Query: 618 NYSLDIFQRL--------------NIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL--- 660
                 F R+               IM  +  A++YLH   S  + H D+KP N+L    
Sbjct: 103 ------FSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSK 153

Query: 661 DDNMVAHLSDFGIAKLLTGE 680
             N +  L+DFG AK  TGE
Sbjct: 154 RPNAILKLTDFGFAKETTGE 173

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 75.1 bits (185), Expect = 2e-15
 Identities = 35/166 (21%), Positives = 55/166 (33%), Gaps = 33/166 (19%)

Query: 21  SNLKVLYLYNNRLQG-EIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNN 79
                L L NN     E       L  L  ++ S NK+   I    F             
Sbjct: 32  QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKI-TDIEEGAFE------------ 78

Query: 80  SLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIF-NASKLSKLALEMNSFSGFIPSTF 138
                       G   +  + L  N     + H +F     L  L L  N  +     +F
Sbjct: 79  ------------GASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSF 125

Query: 139 GNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLD 184
             L ++  L+LYDN +T+  +      +L    SL+ ++L  NP +
Sbjct: 126 IGLSSVRLLSLYDNQITT--VAPGAFDTL---HSLSTLNLLANPFN 166

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 67.0 bits (164), Expect = 1e-12
 Identities = 42/178 (23%), Positives = 73/178 (41%), Gaps = 35/178 (19%)

Query: 250 VDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIP--ACFSNMTFLKVLSLGSNELTS 307
           VD    +L   IP+ I       EL L  N+ +  +     F  +  L+ ++  +N++T 
Sbjct: 16  VDCSNQKLN-KIPEHIPQYTA--ELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKITD 71

Query: 308 IPLN-FWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNL 366
           I    F     + ++ L+SN            L+ +    F               L++L
Sbjct: 72  IEEGAFEGASGVNEILLTSN-----------RLENVQHKMFK-------------GLESL 107

Query: 367 ENLFLEYNRLEGSIP-DSFGDLISLKSLNLSYNNLSGTIPV-SLEKLSYLKDLNLSFN 422
           + L L  NR+   +  DSF  L S++ L+L  N ++ T+   + + L  L  LNL  N
Sbjct: 108 KTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 64.7 bits (158), Expect = 8e-12
 Identities = 35/132 (26%), Positives = 59/132 (44%), Gaps = 6/132 (4%)

Query: 302 SNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEI-RNLKALIEIDFSMNNFSGIIPMEI 360
           + +L  IP +        +L L++N F+      I + L  L +I+FS N  + I     
Sbjct: 20  NQKLNKIPEHIPQ--YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAF 77

Query: 361 GSLKNLENLFLEYNRLEGSIPDS-FGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNL 419
                +  + L  NRLE ++    F  L SLK+L L  N ++     S   LS ++ L+L
Sbjct: 78  EGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSL 136

Query: 420 SFNKLKGEIPRG 431
             N++   +  G
Sbjct: 137 YDNQIT-TVAPG 147

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 57.7 bits (140), Expect = 2e-09
 Identities = 32/182 (17%), Positives = 61/182 (33%), Gaps = 57/182 (31%)

Query: 147 LTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYN 206
           L L +N  T     L           L  I+ SNN +  I    + G             
Sbjct: 37  LRLNNNEFTV----LEATGIFKKLPQLRKINFSNNKITDIEEGAFEG------------- 79

Query: 207 CNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPI-TLGKLQKLQDVDLEYNQLEGSIPDSI 265
                         + +  I+L  N+L  ++       L+ L+ + L  N++   + +  
Sbjct: 80  -------------ASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDS 124

Query: 266 CLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLN-FWSLKDILDLNLS 324
                                  F  ++ +++LSL  N++T++    F +L  +  LNL 
Sbjct: 125 -----------------------FIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLL 161

Query: 325 SN 326
           +N
Sbjct: 162 AN 163

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 75.9 bits (187), Expect = 2e-15
 Identities = 45/163 (27%), Positives = 68/163 (41%), Gaps = 10/163 (6%)

Query: 24  KVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFN-VSTLKAFAVTNNSLS 82
           + L L +  L          L  L +L+L  N+L  T+ A +F+ ++ L    + NN L+
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQL-QTLSAGVFDDLTELGTLGLANNQLA 96

Query: 83  GCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIF-NASKLSKLALEMNSFSGFIPSTFGNL 141
                + D  L  L+ LYL GN    ++P  +F   +KL +L L  N         F  L
Sbjct: 97  SLPLGVFD-HLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKL 154

Query: 142 RNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLD 184
            NL+ L+L  N L S         +      L  I+L  N  D
Sbjct: 155 TNLQTLSLSTNQLQSVPH-----GAFDRLGKLQTITLFGNQFD 192

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 69.0 bits (169), Expect = 5e-13
 Identities = 51/175 (29%), Positives = 79/175 (45%), Gaps = 32/175 (18%)

Query: 260 SIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLN-FWSLKDI 318
           S+P  I    E  +L+L    L+    A F  +T L  L+L  N+L ++    F  L ++
Sbjct: 28  SVPSGIPADTE--KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTEL 85

Query: 319 LDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEG 378
             L L++N            L +L    F               L  L+ L+L  N+L+ 
Sbjct: 86  GTLGLANN-----------QLASLPLGVFD-------------HLTQLDKLYLGGNQLK- 120

Query: 379 SIPDS-FGDLISLKSLNLSYNNLSGTIPVSL-EKLSYLKDLNLSFNKLKGEIPRG 431
           S+P   F  L  LK L L+ N L  +IP    +KL+ L+ L+LS N+L+  +P G
Sbjct: 121 SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQS-VPHG 173

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 60.9 bits (148), Expect = 2e-10
 Identities = 53/232 (22%), Positives = 77/232 (33%), Gaps = 82/232 (35%)

Query: 97  EVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTS 156
           E L L     +          +KL+ L L+ N         F +L  L  L L +N L S
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLAS 97

Query: 157 STLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEE 216
                                         LP                       G+ + 
Sbjct: 98  ------------------------------LPL----------------------GVFDH 105

Query: 217 ITNLTDLTTIVLGGNKLNGSIPITL-GKLQKLQDVDLEYNQLEGSIPDSICLSVELYELE 275
           +T L  L    LGGN+L  S+P  +  +L KL+++ L  NQL+ SIP             
Sbjct: 106 LTQLDKLY---LGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGA---------- 150

Query: 276 LGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLN-FWSLKDILDLNLSSN 326
                        F  +T L+ LSL +N+L S+P   F  L  +  + L  N
Sbjct: 151 -------------FDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 60.5 bits (147), Expect = 3e-10
 Identities = 53/189 (28%), Positives = 78/189 (41%), Gaps = 35/189 (18%)

Query: 237 IPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPA-CFSNMTFL 295
           IP    KL      DL+   L      +     +L  L L  N+L  ++ A  F ++T L
Sbjct: 33  IPADTEKL------DLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTEL 85

Query: 296 KVLSLGSNELTSIPLN-FWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSG 354
             L L +N+L S+PL  F  L  +  L L  N            LK+L    F       
Sbjct: 86  GTLGLANNQLASLPLGVFDHLTQLDKLYLGGN-----------QLKSLPSGVFD------ 128

Query: 355 IIPMEIGSLKNLENLFLEYNRLEGSIPDS-FGDLISLKSLNLSYNNLSGTIPVSLEKLSY 413
                   L  L+ L L  N+L+ SIP   F  L +L++L+LS N L      + ++L  
Sbjct: 129 -------RLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGK 180

Query: 414 LKDLNLSFN 422
           L+ + L  N
Sbjct: 181 LQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 54.3 bits (131), Expect = 3e-08
 Identities = 48/180 (26%), Positives = 72/180 (40%), Gaps = 14/180 (7%)

Query: 54  QNKLLGTIPAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHF 113
           Q K L ++P+ I    T +   + +  L+  LS  T  GL  L  L L  N    T+   
Sbjct: 22  QGKSLDSVPSGIP-ADT-EKLDLQSTGLAT-LSDATFRGLTKLTWLNLDYNQLQ-TLSAG 77

Query: 114 IFNA-SKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKS 172
           +F+  ++L  L L  N  +      F +L  L+ L L  N L S  L       L+    
Sbjct: 78  VFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKS--LPSGVFDRLTK--- 132

Query: 173 LTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEI-TNLTDLTTIVLGGN 231
           L  + L+ N L   +P      L+ +L+   +   N    +P      L  L TI L GN
Sbjct: 133 LKELRLNTNQLQS-IPAGAFDKLT-NLQTLSLST-NQLQSVPHGAFDRLGKLQTITLFGN 189

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 78.1 bits (193), Expect = 3e-15
 Identities = 80/461 (17%), Positives = 142/461 (30%), Gaps = 75/461 (16%)

Query: 21  SNLKVLYLYNNRLQGEIIHEIGH-LHNLGFLDLSQNKL----LGTIPAAIFNVSTLKAFA 75
            +++ L +    L      E+   L     + L    L       I +A+     L    
Sbjct: 3   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62

Query: 76  VTNNSLSG----CLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNA----SKLSKLALEM 127
           + +N L      C+          ++ L L     +G     + +       L +L L  
Sbjct: 63  LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122

Query: 128 NSFSG-----FIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSS-LSNCKSLTHISLSNN 181
           N                    LE L L   +L+++      L+S L        +++SNN
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAA--SCEPLASVLRAKPDFKELTVSNN 180

Query: 182 PLDGILPRTYVGNLSHS---LKNFYMYNCNVS----GGIPEEITNLTDLTTIVLGGNKLN 234
            ++    R     L  S   L+   + +C V+      +   + +   L  + LG NKL 
Sbjct: 181 DINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLG 240

Query: 235 GS-----IPITLGKLQKLQDVDLEYNQLE----GSIPDSICLSVELYELELGGNKLSGS- 284
                   P  L    +L+ + +    +     G +   +     L EL L GN+L    
Sbjct: 241 DVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEG 300

Query: 285 ----IPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLK 340
                         L+ L + S   T+             + L+ N             +
Sbjct: 301 ARLLCETLLEPGCQLESLWVKSCSFTAA-----CCSHFSSV-LAQN-------------R 341

Query: 341 ALIEIDFSMNNFSGIIPMEIG-----SLKNLENLFLEYNRL--EG--SIPDSFGDLISLK 391
            L+E+  S N        E+          L  L+L    +      S+  +     SL+
Sbjct: 342 FLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLR 401

Query: 392 SLNLSYNNLSGT----IPVSLEKLSY-LKDLNLSFNKLKGE 427
            L+LS N L       +  S+ +    L+ L L       E
Sbjct: 402 ELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEE 442

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 43.8 bits (104), Expect = 2e-04
 Identities = 34/183 (18%), Positives = 66/183 (36%), Gaps = 26/183 (14%)

Query: 267 LSVELYELELGGNKLS-GSIPACFSNMTFLKVLSLGSNELT-----SIPLNFWSLKDILD 320
           +S+++  L++   +LS          +   +V+ L    LT      I         + +
Sbjct: 1   MSLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE 60

Query: 321 LNLSSNCFSGP------LPLEIRNLKALIEIDFSMNNFS----GIIPMEIGSLKNLENLF 370
           LNL SN             L+  + K + ++       +    G++   + +L  L+ L 
Sbjct: 61  LNLRSNELGDVGVHCVLQGLQTPSCK-IQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELH 119

Query: 371 LEYNRLEGSIPDSFGDLI-----SLKSLNLSYNNLSGT----IPVSLEKLSYLKDLNLSF 421
           L  N L  +      + +      L+ L L Y +LS      +   L      K+L +S 
Sbjct: 120 LSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSN 179

Query: 422 NKL 424
           N +
Sbjct: 180 NDI 182

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 76.5 bits (189), Expect = 5e-15
 Identities = 54/211 (25%), Positives = 84/211 (39%), Gaps = 47/211 (22%)

Query: 534 LIGRGGFGSVYKARIRDGMEV-AVKVFNLQCGRAFKSFDVECAMM------KSIRHRNLV 586
           +IGRG +  V   R++    + A+KV  ++        D++          ++  H  LV
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKV--VKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 73

Query: 587 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSN---------YSLDIFQRLNIMIDVASAL 637
            + S    E     V+EY+  G L  ++             YS +I          + AL
Sbjct: 74  GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEI----------SLAL 123

Query: 638 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTL-ATIGYM 696
            YLH      +I+ DLK  NVLLD      L+D+G+ K           T T   T  Y+
Sbjct: 124 NYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGTPNYI 177

Query: 697 APE------YGREGQVSTNGDVYSFGIMLME 721
           APE      YG    V    D ++ G+++ E
Sbjct: 178 APEILRGEDYGFS--V----DWWALGVLMFE 202

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 77.1 bits (189), Expect = 9e-15
 Identities = 46/360 (12%), Positives = 96/360 (26%), Gaps = 52/360 (14%)

Query: 81  LSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGN 140
               L       +     +       S      +   S++  L L ++     +     +
Sbjct: 232 HRWLLGRAEPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPD 291

Query: 141 LRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLK 200
            RN     ++  +L +++L+                S     L    P  +  + +   +
Sbjct: 292 GRN-RPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQ 350

Query: 201 NFYMY-NCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEG 259
            F    +   S  +  E+ +  +L  +         +I + +  L  L            
Sbjct: 351 LFRCELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFST 410

Query: 260 ---------------------SIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVL 298
                                          ++  L L    L+  +      +  +  L
Sbjct: 411 LKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLCH-LEQLLLVTHL 468

Query: 299 SLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPM 358
            L  N L ++P    +L+ +  L  S N         + N+                   
Sbjct: 469 DLSHNRLRALPPALAALRCLEVLQASDN--------ALENVD------------------ 502

Query: 359 EIGSLKNLENLFLEYNRLEG-SIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDL 417
            + +L  L+ L L  NRL+  +          L  LNL  N+L     +       L  +
Sbjct: 503 GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSV 562

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 73.3 bits (179), Expect = 1e-13
 Identities = 35/229 (15%), Positives = 72/229 (31%), Gaps = 9/229 (3%)

Query: 197 HSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQ 256
             L    + +           T        VL  ++            ++L   +L   +
Sbjct: 302 CDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPE-CWCRDSATDEQLFRCELSVEK 360

Query: 257 LEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLK 316
               +   +    EL ELE        +I      +  L          ++  L      
Sbjct: 361 ST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFST--LKAVDPM 417

Query: 317 DILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRL 376
               L+   + F     +       +  +  +  + + +    +  L  + +L L +NRL
Sbjct: 418 RAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVLC--HLEQLLLVTHLDLSHNRL 475

Query: 377 EGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLK 425
             ++P +   L  L+ L  S N L   +   +  L  L++L L  N+L+
Sbjct: 476 R-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQ 521

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 61.7 bits (149), Expect = 6e-10
 Identities = 33/183 (18%), Positives = 57/183 (31%), Gaps = 58/183 (31%)

Query: 1   MPSIINNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGT 60
               + +             ++++VL+L +  L   ++  +  L  +  LDLS N+L   
Sbjct: 421 YLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRL--- 475

Query: 61  IPAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKL 120
                              +L   L++     L  LEVL    N               L
Sbjct: 476 ------------------RALPPALAA-----LRCLEVLQASDN--------------AL 498

Query: 121 SKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSN 180
             +                NL  L+ L L +N L       + +  L +C  L  ++L  
Sbjct: 499 ENV------------DGVANLPRLQELLLCNNRLQ----QSAAIQPLVSCPRLVLLNLQG 542

Query: 181 NPL 183
           N L
Sbjct: 543 NSL 545

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 52.8 bits (126), Expect = 3e-07
 Identities = 20/102 (19%), Positives = 36/102 (35%), Gaps = 27/102 (26%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAI 65
           +N L +  P  +  +  L+VL   +N L  E +  + +L  L  L L  N+        +
Sbjct: 472 HNRLRAL-PPALAALRCLEVLQASDNAL--ENVDGVANLPRLQELLLCNNR--------L 520

Query: 66  FNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFS 107
              + ++                     P L +L L GN+  
Sbjct: 521 QQSAAIQPLV----------------SCPRLVLLNLQGNSLC 546

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 76.2 bits (188), Expect = 1e-14
 Identities = 53/211 (25%), Positives = 84/211 (39%), Gaps = 47/211 (22%)

Query: 534 LIGRGGFGSVYKARIRDGMEV-AVKVFNLQCGRAFKSFDVECAMM------KSIRHRNLV 586
           +IGRG +  V   R++    + A++V  ++        D++          ++  H  LV
Sbjct: 59  VIGRGSYAKVLLVRLKKTDRIYAMRV--VKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 116

Query: 587 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSN---------YSLDIFQRLNIMIDVASAL 637
            + S    E     V+EY+  G L  ++             YS +I          + AL
Sbjct: 117 GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEI----------SLAL 166

Query: 638 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTL-ATIGYM 696
            YLH      +I+ DLK  NVLLD      L+D+G+ K           T T   T  Y+
Sbjct: 167 NYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGTPNYI 220

Query: 697 APE------YGREGQVSTNGDVYSFGIMLME 721
           APE      YG    V    D ++ G+++ E
Sbjct: 221 APEILRGEDYGFS--V----DWWALGVLMFE 245

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 72.8 bits (179), Expect = 1e-14
 Identities = 38/177 (21%), Positives = 70/177 (39%), Gaps = 30/177 (16%)

Query: 248 QDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTS 307
             VD     L   IP ++  ++   E+ L  N +    P  FS    L+ + L +N+++ 
Sbjct: 14  NIVDCRGKGLT-EIPTNLPETIT--EIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISE 70

Query: 308 IPLN-FWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNL 366
           +  + F  L+ +  L L  N            +  L +  F               L +L
Sbjct: 71  LAPDAFQGLRSLNSLVLYGN-----------KITELPKSLFE-------------GLFSL 106

Query: 367 ENLFLEYNRLEGSIP-DSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFN 422
           + L L  N++   +  D+F DL +L  L+L  N L      +   L  ++ ++L+ N
Sbjct: 107 QLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 70.8 bits (174), Expect = 6e-14
 Identities = 35/180 (19%), Positives = 55/180 (30%), Gaps = 56/180 (31%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAI 65
            N +    P        L+ + L NN++                           +    
Sbjct: 41  QNTIKVIPPGAFSPYKKLRRIDLSNNQIS-------------------------ELAPDA 75

Query: 66  FNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIF-NASKLSKLA 124
           F                         GL +L  L L+GN  +  +P  +F     L  L 
Sbjct: 76  FQ------------------------GLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLL 110

Query: 125 LEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLD 184
           L  N  +      F +L NL  L+LYDN L +  +     S L    ++  + L+ NP  
Sbjct: 111 LNANKINCLRVDAFQDLHNLNLLSLYDNKLQT--IAKGTFSPLR---AIQTMHLAQNPFI 165

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 58.1 bits (141), Expect = 1e-09
 Identities = 35/131 (26%), Positives = 47/131 (35%), Gaps = 29/131 (22%)

Query: 302 SNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIG 361
              LT IP N                    LP  I  +          N    I P    
Sbjct: 20  GKGLTEIPTN--------------------LPETITEI------RLEQNTIKVIPPGAFS 53

Query: 362 SLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSL-EKLSYLKDLNLS 420
             K L  + L  N++    PD+F  L SL SL L  N ++  +P SL E L  L+ L L+
Sbjct: 54  PYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLN 112

Query: 421 FNKLKGEIPRG 431
            NK+   +   
Sbjct: 113 ANKIN-CLRVD 122

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 52.3 bits (126), Expect = 1e-07
 Identities = 30/183 (16%), Positives = 55/183 (30%), Gaps = 57/183 (31%)

Query: 122 KLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNN 181
           ++ LE N+     P  F   + L  + L +N ++   L       L +   L  + L  N
Sbjct: 36  EIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS--ELAPDAFQGLRS---LNSLVLYGN 90

Query: 182 PLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPI-T 240
            +  +               F                 L  L  ++L  NK+N  + +  
Sbjct: 91  KITELPKSL-----------FE---------------GLFSLQLLLLNANKIN-CLRVDA 123

Query: 241 LGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSL 300
              L  L  + L  N+L+ +I                           FS +  ++ + L
Sbjct: 124 FQDLHNLNLLSLYDNKLQ-TIAKGT-----------------------FSPLRAIQTMHL 159

Query: 301 GSN 303
             N
Sbjct: 160 AQN 162

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 74.1 bits (183), Expect = 2e-14
 Identities = 55/237 (23%), Positives = 94/237 (39%), Gaps = 65/237 (27%)

Query: 534 LIGRGGFGSVYKAR---IRDGMEV-AVKVFN----LQCGRAFKSFDVECAMM-----KSI 580
           ++G+GG+G V++ R     +  ++ A+KV      ++      + D           + +
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVR-----NAKDTAHTKAERNILEEV 78

Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSN---------YSLDIFQRLNIMI 631
           +H  +V +I +        L+LEY+  G L   L             Y  +I        
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEI-------- 130

Query: 632 DVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH--LSDFGIAKLLTGEDQSMTQTQT 689
             + AL +LH      +I+ DLKP N++L+     H  L+DFG+ K    +      T T
Sbjct: 131 --SMALGHLH---QKGIIYRDLKPENIMLNHQ--GHVKLTDFGLCKESIHDGTV---THT 180

Query: 690 LA-TIGYMAPE------YGREGQVSTNGDVYSFGIMLMETFTRKKP-----TDELFN 734
              TI YMAPE      + R   V    D +S G ++ +  T   P       +  +
Sbjct: 181 FCGTIEYMAPEILMRSGHNRA--V----DWWSLGALMYDMLTGAPPFTGENRKKTID 231

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 72.6 bits (179), Expect = 7e-14
 Identities = 57/237 (24%), Positives = 95/237 (40%), Gaps = 67/237 (28%)

Query: 534 LIGRGGFGSVYKARIRDGMEV----AVKVFNLQCGRAFKSF-----DVECAM----MKSI 580
           ++G+G FG V+  +   G +     A+KV         K+       V   M    +  +
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLK-------KATLKVRDRVRTKMERDILVEV 83

Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSN---------YSLDIFQRLNIMI 631
            H  +VK+  +   E    L+L+++  G L   L             Y  ++        
Sbjct: 84  NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAEL-------- 135

Query: 632 DVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH--LSDFGIAKLLTGEDQSMTQTQT 689
             A AL++LH   S  +I+ DLKP N+LLD+    H  L+DFG++K     ++      +
Sbjct: 136 --ALALDHLH---SLGIIYRDLKPENILLDEE--GHIKLTDFGLSKESIDHEKK---AYS 185

Query: 690 L-ATIGYMAPE------YGREGQVSTNGDVYSFGIMLMETFTRKKP-----TDELFN 734
              T+ YMAPE      + +        D +SFG+++ E  T   P       E   
Sbjct: 186 FCGTVEYMAPEVVNRRGHTQS--A----DWWSFGVLMFEMLTGTLPFQGKDRKETMT 236

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 71.3 bits (175), Expect = 3e-13
 Identities = 43/238 (18%), Positives = 87/238 (36%), Gaps = 42/238 (17%)

Query: 534 LIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIR--------HRN 584
            +G G F +V+ A+ + +   VA+K+         ++ + E  +++ +            
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMG 84

Query: 585 LVKVISSCSNEEFKA-------LVLEYMPHGSLEKYLHSSNY---SLDIFQRLNIMIDVA 634
              ++    +   K        +V E +   +L   +    +    L   ++  I   + 
Sbjct: 85  ANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQ--ISKQLL 141

Query: 635 SALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH------LSDFGIAKLLTGEDQSMTQT- 687
             L+Y+H      +IH D+KP NVL++            ++D G A      D+  T + 
Sbjct: 142 LGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA---CWYDEHYTNSI 196

Query: 688 QTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVND 745
           QT     Y +PE           D++S   ++ E  T       LF  +    +  +D
Sbjct: 197 QTRE---YRSPEVLLGAPWGCGADIWSTACLIFELITGDF----LFEPDEGHSYTKDD 247

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 70.8 bits (174), Expect = 3e-13
 Identities = 56/218 (25%), Positives = 88/218 (40%), Gaps = 54/218 (24%)

Query: 534 LIGRGGFGSVYKARIRDGMEV----AVKVFN----LQCGRAFKSFDVECAMM-----KSI 580
           ++G G +G V+  R   G +     A+KV      +Q     K+   E         + I
Sbjct: 61  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQ-----KAKTTEHTRTERQVLEHI 115

Query: 581 RHRN-LVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVA----- 634
           R    LV +  +   E    L+L+Y+  G L  + H       + QR             
Sbjct: 116 RQSPFLVTLHYAFQTETKLHLILDYINGGEL--FTH-------LSQRERFTEHEVQIYVG 166

Query: 635 ---SALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH--LSDFGIAKLLTGEDQSMTQTQT 689
               ALE+LH      +I+ D+K  N+LLD N   H  L+DFG++K    ++        
Sbjct: 167 EIVLALEHLH---KLGIIYRDIKLENILLDSN--GHVVLTDFGLSKEFVADETERAYD-F 220

Query: 690 LATIGYMAPE------YGREGQVSTNGDVYSFGIMLME 721
             TI YMAP+       G +  V    D +S G+++ E
Sbjct: 221 CGTIEYMAPDIVRGGDSGHDKAV----DWWSLGVLMYE 254

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 70.5 bits (173), Expect = 3e-13
 Identities = 38/150 (25%), Positives = 67/150 (44%), Gaps = 17/150 (11%)

Query: 535 IGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRH-RNLVKVISSC 592
           IG G FG +   + +     VA+K+  ++         +E    K +     + +V    
Sbjct: 17  IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGIPQVYYFG 74

Query: 593 SNEEFKALVLEYMPHG-SLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHC 651
              ++ A+VLE +  G SLE      + +  +   L I I + S +EY+H   S  +I+ 
Sbjct: 75  PCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYR 129

Query: 652 DLKPSNVLL------DDNMVAHLSDFGIAK 675
           D+KP N L+         ++ H+ DF +AK
Sbjct: 130 DVKPENFLIGRPGNKTQQVI-HIIDFALAK 158

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 68.9 bits (169), Expect = 9e-13
 Identities = 29/149 (19%), Positives = 58/149 (38%), Gaps = 15/149 (10%)

Query: 535 IGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRH-RNLVKVISSC 592
           IG G FG +++   + +  +VA+K    +          E    K +     +  V    
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFG 75

Query: 593 SNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
                  LV++ +   SLE  L        +         + + ++ +H      +++ D
Sbjct: 76  QEGLHNVLVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRD 131

Query: 653 LKPSNVLL------DDNMVAHLSDFGIAK 675
           +KP N L+      + NM+ ++ DFG+ K
Sbjct: 132 IKPDNFLIGRPNSKNANMI-YVVDFGMVK 159

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 67.8 bits (166), Expect = 2e-12
 Identities = 37/146 (25%), Positives = 67/146 (45%), Gaps = 11/146 (7%)

Query: 535 IGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRH-RNLVKVISSC 592
           IG G FG +Y    I  G EVA+K+  ++         +E  + K ++    +  +    
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCG 74

Query: 593 SNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
           +  ++  +V+E +   SLE   +  +    +   L +   + S +EY+H   S   IH D
Sbjct: 75  AEGDYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRD 130

Query: 653 LKPSNVLL---DDNMVAHLSDFGIAK 675
           +KP N L+       + ++ DFG+AK
Sbjct: 131 VKPDNFLMGLGKKGNLVYIIDFGLAK 156

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 63.9 bits (156), Expect = 1e-11
 Identities = 43/165 (26%), Positives = 64/165 (38%), Gaps = 33/165 (20%)

Query: 21  SNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNS 80
           +N ++LYL++N++          L NL  L L  N+L G +P  +F+             
Sbjct: 40  TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQL-GALPVGVFD------------- 85

Query: 81  LSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNA-SKLSKLALEMNSFSGFIPSTFG 139
                       L  L VL L  N  +  +P  +F+    L +L +  N  +  +P    
Sbjct: 86  -----------SLTQLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLTE-LPRGIE 132

Query: 140 NLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLD 184
            L +L  L L  N L S     +F        SLTH  L  NP D
Sbjct: 133 RLTHLTHLALDQNQLKS-IPHGAF----DRLSSLTHAYLFGNPWD 172

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 63.6 bits (155), Expect = 2e-11
 Identities = 35/122 (28%), Positives = 55/122 (45%), Gaps = 14/122 (11%)

Query: 209 VSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQL---EGSIPDSI 265
           V  GIP      T+   + L  N++    P     L  L+++ L  NQL      + DS+
Sbjct: 34  VPAGIP------TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSL 87

Query: 266 CLSVELYELELGGNKLSGSIPA-CFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLS 324
               +L  L+LG N+L+  +P+  F  +  LK L +  N+LT +P     L  +  L L 
Sbjct: 88  ---TQLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLTELPRGIERLTHLTHLALD 143

Query: 325 SN 326
            N
Sbjct: 144 QN 145

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 60.9 bits (148), Expect = 2e-10
 Identities = 36/111 (32%), Positives = 56/111 (50%), Gaps = 6/111 (5%)

Query: 219 NLTDLTTIVLGGNKLNGSIPITL-GKLQKLQDVDLEYNQLEGSIPDSICLS-VELYELEL 276
           +L +L  + LG N+L  ++P+ +   L +L  +DL  NQL   +P ++    V L EL +
Sbjct: 62  SLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT-VLPSAVFDRLVHLKELFM 119

Query: 277 GGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLN-FWSLKDILDLNLSSN 326
             NKL+  +P     +T L  L+L  N+L SIP   F  L  +    L  N
Sbjct: 120 CCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 58.2 bits (141), Expect = 1e-09
 Identities = 46/176 (26%), Positives = 70/176 (39%), Gaps = 29/176 (16%)

Query: 248 QDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTS 307
             VD    +   S+P  I  + +   L L  N+++   P  F ++  LK L LGSN+L +
Sbjct: 22  TTVDCRSKRHA-SVPAGIPTNAQ--ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA 78

Query: 308 IPLN-FWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNL 366
           +P+  F SL  +  L+L +N            L  L    F               L +L
Sbjct: 79  LPVGVFDSLTQLTVLDLGTN-----------QLTVLPSAVFD-------------RLVHL 114

Query: 367 ENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFN 422
           + LF+  N+L   +P     L  L  L L  N L      + ++LS L    L  N
Sbjct: 115 KELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 56.2 bits (136), Expect = 6e-09
 Identities = 39/131 (29%), Positives = 58/131 (44%), Gaps = 6/131 (4%)

Query: 302 SNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIG 361
           S    S+P    +   IL L+   N  +   P    +L  L E+    N    +      
Sbjct: 28  SKRHASVPAGIPTNAQILYLH--DNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFD 85

Query: 362 SLKNLENLFLEYNRLEGSIPDS-FGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLS 420
           SL  L  L L  N+L   +P + F  L+ LK L +  N L+  +P  +E+L++L  L L 
Sbjct: 86  SLTQLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALD 143

Query: 421 FNKLKGEIPRG 431
            N+LK  IP G
Sbjct: 144 QNQLKS-IPHG 153

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 48.2 bits (115), Expect = 3e-06
 Identities = 39/143 (27%), Positives = 59/143 (41%), Gaps = 13/143 (9%)

Query: 92  GLP-NLEVLYLWGNNFSGTIPHFIFNA-SKLSKLALEMNSFSGFIPSTFGNLRNLEWLTL 149
           G+P N ++LYL  N  +  +   +F++   L +L L  N         F +L  L  L L
Sbjct: 37  GIPTNAQILYLHDNQIT-KLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDL 95

Query: 150 YDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNV 209
             N LT   L  +    L +   L  + +  N L  + PR  +  L+H L +  +   N 
Sbjct: 96  GTNQLTV--LPSAVFDRLVH---LKELFMCCNKLTEL-PRG-IERLTH-LTHLALDQ-NQ 146

Query: 210 SGGIPEEI-TNLTDLTTIVLGGN 231
              IP      L+ LT   L GN
Sbjct: 147 LKSIPHGAFDRLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 44/136 (32%), Positives = 56/136 (41%), Gaps = 10/136 (7%)

Query: 122 KLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNN 181
            L L  N  +   P  F +L NL+ L L  N L +  L +    SL+    LT + L  N
Sbjct: 44  ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA--LPVGVFDSLTQ---LTVLDLGTN 98

Query: 182 PLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPI-T 240
            L   LP      L H LK  +M   N    +P  I  LT LT + L  N+L  SIP   
Sbjct: 99  QLTV-LPSAVFDRLVH-LKELFMCC-NKLTELPRGIERLTHLTHLALDQNQLK-SIPHGA 154

Query: 241 LGKLQKLQDVDLEYNQ 256
             +L  L    L  N 
Sbjct: 155 FDRLSSLTHAYLFGNP 170

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 43.5 bits (103), Expect = 1e-04
 Identities = 28/102 (27%), Positives = 42/102 (41%), Gaps = 8/102 (7%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIG---HLHNLGFLDLSQNKLLGTIP 62
           +N L +      D+++ L VL L  N+L             L +L  L +  NK L  +P
Sbjct: 73  SNQLGALPVGVFDSLTQLTVLDLGTNQLTV---LPSAVFDRLVHLKELFMCCNK-LTELP 128

Query: 63  AAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGN 104
             I  ++ L   A+  N L        D  L +L   YL+GN
Sbjct: 129 RGIERLTHLTHLALDQNQLKSIPHGAFD-RLSSLTHAYLFGN 169

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 65.5 bits (159), Expect = 2e-11
 Identities = 23/94 (24%), Positives = 31/94 (32%), Gaps = 7/94 (7%)

Query: 92  GLPNLEVLYLWGNNFSGTIPHFIF-NASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLY 150
           G  NL  LY+        +         +L  L +  +      P  F     L  L L 
Sbjct: 29  GAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88

Query: 151 DNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLD 184
            N L   +L    +  L    SL  + LS NPL 
Sbjct: 89  FNALE--SLSWKTVQGL----SLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 57.4 bits (138), Expect = 8e-09
 Identities = 23/93 (24%), Positives = 38/93 (40%), Gaps = 2/93 (2%)

Query: 333 PLEIRNLKALIEIDFSMNNFSGIIPME-IGSLKNLENLFLEYNRLEGSIPDSFGDLISLK 391
              +   + L E+          + +  +  L  L NL +  + L    PD+F     L 
Sbjct: 24  LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLS 83

Query: 392 SLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKL 424
            LNLS+N L  ++     +   L++L LS N L
Sbjct: 84  RLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 54.7 bits (131), Expect = 5e-08
 Identities = 22/97 (22%), Positives = 37/97 (38%), Gaps = 5/97 (5%)

Query: 356 IPMEIGSLKNLENLFLEYNRLEGSIPD-SFGDLISLKSLNLSYNNLSGTIPVSLEKLSYL 414
               +   +NL  L++E  +    +       L  L++L +  + L    P +      L
Sbjct: 23  SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82

Query: 415 KDLNLSFNKLKGEIPRGGSFGNFSAES--FKGNELLC 449
             LNLSFN L+  +    +    S +     GN L C
Sbjct: 83  SRLNLSFNALE-SLSW-KTVQGLSLQELVLSGNPLHC 117

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 50.9 bits (121), Expect = 9e-07
 Identities = 19/105 (18%), Positives = 34/105 (32%), Gaps = 3/105 (2%)

Query: 224 TTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLS-VELYELELGGNKLS 282
           ++ +             L   + L ++ +E  Q    +         EL  L +  + L 
Sbjct: 10  SSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR 69

Query: 283 GSIPA-CFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSN 326
             +    F     L  L+L  N L S+         + +L LS N
Sbjct: 70  -FVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGN 113

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 49.0 bits (116), Expect = 3e-06
 Identities = 19/120 (15%), Positives = 33/120 (27%), Gaps = 27/120 (22%)

Query: 12  TTPKEIDNISNLKVLYLYNNRLQGEIIHE-IGHLHNLGFLDLSQNKLLGTIPAAIFNVST 70
            +   +    NL  LY+ N +    +    +  L  L  L + ++  L  +    F+   
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSG-LRFVAPDAFH--- 77

Query: 71  LKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSF 130
                                  P L  L L  N    ++         L +L L  N  
Sbjct: 78  ---------------------FTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 47.0 bits (111), Expect = 2e-05
 Identities = 13/78 (16%), Positives = 28/78 (35%), Gaps = 5/78 (6%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHE--IGHLHNLGFLDLSQNKLLGTIPA 63
              L     +++  +  L+ L +  + L    +          L  L+LS N L  ++  
Sbjct: 41  QQHLQHLELRDLRGLGELRNLTIVKSGL--RFVAPDAFHFTPRLSRLNLSFNALE-SLSW 97

Query: 64  AIFNVSTLKAFAVTNNSL 81
                 +L+   ++ N L
Sbjct: 98  KTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 44.0 bits (103), Expect = 2e-04
 Identities = 17/101 (16%), Positives = 33/101 (32%), Gaps = 7/101 (6%)

Query: 134 IPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVG 193
                    NL  L + +       L+L  L  L     L ++++  + L  + P  +  
Sbjct: 23  SLHHLPGAENLTELYIENQQH-LQHLELRDLRGLGE---LRNLTIVKSGLRFVAPDAFHF 78

Query: 194 NLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLN 234
                L    +    +   +  +      L  +VL GN L+
Sbjct: 79  T--PRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 43.2 bits (101), Expect = 2e-04
 Identities = 20/114 (17%), Positives = 41/114 (35%), Gaps = 7/114 (6%)

Query: 170 CKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEE-ITNLTDLTTIVL 228
               + +  + +     L   ++    + L   Y+ N      +    +  L +L  + +
Sbjct: 7   PHGSSGLRCTRDGALDSLH--HLPGAEN-LTELYIENQQHLQHLELRDLRGLGELRNLTI 63

Query: 229 GGNKLNGSIPI-TLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKL 281
             + L   +         +L  ++L +N LE S+       + L EL L GN L
Sbjct: 64  VKSGLR-FVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 41.6 bits (97), Expect = 8e-04
 Identities = 7/59 (11%), Positives = 16/59 (27%), Gaps = 2/59 (3%)

Query: 374 NRLEGSIPDSFGDLISLKSLNLSYNNLSGTIP-VSLEKLSYLKDLNLSFNKLKGEIPRG 431
                          +L  L +        +    L  L  L++L +  + L+  +   
Sbjct: 17  RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPD 74

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 63.1 bits (154), Expect = 2e-11
 Identities = 32/118 (27%), Positives = 56/118 (47%), Gaps = 12/118 (10%)

Query: 212 GIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLS-VE 270
           GIP ++T L       L GN+    +P  L   + L  +DL  N++  ++ +    +  +
Sbjct: 28  GIPRDVTEL------YLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQ 79

Query: 271 LYELELGGNKLSGSIPA-CFSNMTFLKVLSLGSNELTSIPLN-FWSLKDILDLNLSSN 326
           L  L L  N+L   IP   F  +  L++LSL  N+++ +P   F  L  +  L + +N
Sbjct: 80  LLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 61.2 bits (149), Expect = 7e-11
 Identities = 29/113 (25%), Positives = 48/113 (42%), Gaps = 21/113 (18%)

Query: 92  GLP-NLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLY 150
           G+P ++  LYL GN F+  +P  + N   L+ + L  N  S     +F N+  L  L L 
Sbjct: 28  GIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILS 86

Query: 151 DNNLTS------------STLDLSF--LSSL-----SNCKSLTHISLSNNPLD 184
            N L                L L    +S +     ++  +L+H+++  NPL 
Sbjct: 87  YNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY 139

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 55.8 bits (135), Expect = 5e-09
 Identities = 35/142 (24%), Positives = 58/142 (40%), Gaps = 31/142 (21%)

Query: 260 SIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLN-FWSLKDI 318
            +P  I   V   EL L GN+ +  +P   SN   L ++ L +N ++++    F ++  +
Sbjct: 24  VLPKGIPRDVT--ELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQL 80

Query: 319 LDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEG 378
           L L LS N            L+ +    F               LK+L  L L  N +  
Sbjct: 81  LTLILSYN-----------RLRCIPPRTFD-------------GLKSLRLLSLHGNDIS- 115

Query: 379 SIPD-SFGDLISLKSLNLSYNN 399
            +P+ +F DL +L  L +   N
Sbjct: 116 VVPEGAFNDLSALSHLAI-GAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 52.7 bits (127), Expect = 5e-08
 Identities = 28/89 (31%), Positives = 45/89 (50%), Gaps = 4/89 (4%)

Query: 344 EIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGT 403
           E+    N F+ ++P E+ + K+L  + L  NR+      SF ++  L +L LSYN L   
Sbjct: 35  ELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR-C 92

Query: 404 IPVSL-EKLSYLKDLNLSFNKLKGEIPRG 431
           IP    + L  L+ L+L  N +   +P G
Sbjct: 93  IPPRTFDGLKSLRLLSLHGNDIS-VVPEG 120

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 51.1 bits (123), Expect = 2e-07
 Identities = 36/124 (29%), Positives = 51/124 (41%), Gaps = 28/124 (22%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAI 65
            N  T   PKE+ N  +L ++ L NNR+         ++  L  L LS N+ L  IP   
Sbjct: 40  GNQFTLV-PKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR-LRCIPPRT 97

Query: 66  FNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIF-NASKLSKLA 124
           F+                        GL +L +L L GN+ S  +P   F + S LS LA
Sbjct: 98  FD------------------------GLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLA 132

Query: 125 LEMN 128
           +  N
Sbjct: 133 IGAN 136

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 65.5 bits (160), Expect = 3e-11
 Identities = 56/398 (14%), Positives = 115/398 (28%), Gaps = 85/398 (21%)

Query: 23  LKVLYLYNNRLQGE----IIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTN 78
           ++   L  + +  E    +   +    ++  + LS N +     AA       +  +   
Sbjct: 6   IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTI--GTEAA-------RWLS--- 53

Query: 79  NSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTF 138
            +++            +LE+                     L + AL             
Sbjct: 54  ENIASK---------KDLEIAEFSDIFTGRVKDEIPEALRLLLQ-ALLKCP--------- 94

Query: 139 GNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPL--DGILPRTYVGNLS 196
                L  + L DN    +  +   +  LS    L H+ L NN L             ++
Sbjct: 95  ----KLHTVRLSDNAFGPTAQE-PLIDFLSKHTPLEHLYLHNNGLGPQA------GAKIA 143

Query: 197 HSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKL--NGSIPI--TLGKLQKLQDVDL 252
            +L+            + ++  N   L +I+ G N+L          T    + L  V +
Sbjct: 144 RALQELA---------VNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKM 194

Query: 253 EYNQL-----EGSIPDSICLSVELYELELGGNKLSG----SIPACFSNMTFLKVLSLGSN 303
             N +     E  + + +    EL  L+L  N  +     ++     +   L+ L L   
Sbjct: 195 VQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDC 254

Query: 304 ELTSI-------PLNFWSLKDILDLNLSSNCFSGPLPLEI-----RNLKALIEIDFSMNN 351
            L++          +      +  L L  N         +       +  L+ ++ + N 
Sbjct: 255 LLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNR 314

Query: 352 FS--GIIPMEIGS-LKNLENLFLEYNRLEGSIPDSFGD 386
           FS    +  EI           L+       + D   +
Sbjct: 315 FSEEDDVVDEIREVFSTRGRGELDELDDMEELTDEEEE 352

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 57.4 bits (139), Expect = 8e-09
 Identities = 65/329 (19%), Positives = 113/329 (34%), Gaps = 63/329 (19%)

Query: 142 RNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPL--DGILPRTYVGNLSHSL 199
            ++E  +L  + +T+     S  + L    S+  I LS N +  +          LS ++
Sbjct: 4   FSIEGKSLKLDAITTEDE-KSVFAVLLEDDSVKEIVLSGNTIGTEAARW------LSENI 56

Query: 200 KNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPIT--LGKLQKLQDVDLEYNQL 257
            +      ++      EI   +D+ T  +          +   L K  KL  V L  N  
Sbjct: 57  AS----KKDL------EIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAF 106

Query: 258 --EG--SIPDSICLSVELYELELGGNKLS-------------GSIPACFSNMTFLKVLSL 300
                  + D +     L  L L  N L               ++     N   L+ +  
Sbjct: 107 GPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIIC 166

Query: 301 GSNELTSIPLNFWS-----LKDILDLNLSSNCF-----SGPLPLEIRNLKALIEIDFSMN 350
           G N L +  +  W+      + +  + +  N          L   +   + L  +D   N
Sbjct: 167 GRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDN 226

Query: 351 NFS--GIIPM--EIGSLKNLENLFLEYNRL--EG--SIPDSFGDL--ISLKSLNLSYNNL 400
            F+  G   +   + S  NL  L L    L   G  ++ D+F  L  I L++L L YN +
Sbjct: 227 TFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEI 286

Query: 401 SGTIPVSL-----EKLSYLKDLNLSFNKL 424
                 +L     EK+  L  L L+ N+ 
Sbjct: 287 ELDAVRTLKTVIDEKMPDLLFLELNGNRF 315

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 56.6 bits (137), Expect = 2e-08
 Identities = 59/347 (17%), Positives = 102/347 (29%), Gaps = 83/347 (23%)

Query: 15  KEIDNISNLKVLYLYNNRLQGEIIHEIG----HLHNLGFLDLSQNKLLGTIPAAIFNVST 70
             +    ++K + L  N +  E    +        +L   + S     G +   I     
Sbjct: 26  AVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFT-GRVKDEIPEALR 84

Query: 71  LKAFAVTNNS------LSGCLSSITDVGL----------PNLEVLYLWGNNFS------- 107
           L   A+          LS    +                  LE LYL  N          
Sbjct: 85  LLLQALLKCPKLHTVRLSDN--AFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKI 142

Query: 108 ------GTIPHFIFNASKLSKLALEMNSFSG----FIPSTFGNLRNLEWLTLYDNNLTSS 157
                   +     NA  L  +    N            TF + R L  + +  N +   
Sbjct: 143 ARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPE 202

Query: 158 TLDLSFLSSLSNCKSLTHISLSNNPL--DGILPRTYVGNLSHSLKNFYMYNCNVSGGIPE 215
            ++   L  L+ C+ L  + L +N     G         L+ +LK               
Sbjct: 203 GIEHLLLEGLAYCQELKVLDLQDNTFTHLGSS------ALAIALK--------------- 241

Query: 216 EITNLTDLTTIVLGGNKL--NGSIPI----TLGKLQKLQDVDLEYNQLEGSIPDSICLSV 269
              +  +L  + L    L   G+  +    +  +   LQ + L+YN++E     ++   +
Sbjct: 242 ---SWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVI 298

Query: 270 E-----LYELELGGNKLS------GSIPACFSNMTFLKVLSLGSNEL 305
           +     L  LEL GN+ S        I   FS     ++  L   E 
Sbjct: 299 DEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGELDELDDMEE 345

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 53.9 bits (130), Expect = 1e-07
 Identities = 40/267 (14%), Positives = 85/267 (31%), Gaps = 53/267 (19%)

Query: 213 IPEEITNLTDLTTIVLGGNKLN--GSIPI--TLGKLQKLQDVDLEYNQLEGSIPDSICLS 268
           +   +     +  IVL GN +    +  +   +   + L+  +       G + D I  +
Sbjct: 24  VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFT-GRVKDEIPEA 82

Query: 269 VE-----------LYELELGGNKLSG----SIPACFSNMTFLKVLSLGSNELT------- 306
           +            L+ + L  N         +    S  T L+ L L +N L        
Sbjct: 83  LRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKI 142

Query: 307 -------SIPLNFWSLKDILDLNLSSNCFSGP----LPLEIRNLKALIEIDFSMNNF--- 352
                  ++     +   +  +    N              ++ + L  +    N     
Sbjct: 143 ARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPE 202

Query: 353 --SGIIPMEIGSLKNLENLFLEYNRL--EG--SIPDSFGDLISLKSLNLSYNNLS--GTI 404
               ++   +   + L+ L L+ N     G  ++  +     +L+ L L+   LS  G  
Sbjct: 203 GIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAA 262

Query: 405 PVS--LEKLS--YLKDLNLSFNKLKGE 427
            V     KL    L+ L L +N+++ +
Sbjct: 263 AVVDAFSKLENIGLQTLRLQYNEIELD 289

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 65.8 bits (160), Expect = 3e-11
 Identities = 36/146 (24%), Positives = 67/146 (45%), Gaps = 11/146 (7%)

Query: 535 IGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLV-KVISSC 592
           IG G FG +Y    I+   EVA+K+ N++          E  + + ++    +  V    
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFG 72

Query: 593 SNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 652
              ++  LV++ +   SLE   +  +  L +   L +   + + +E++H   S   +H D
Sbjct: 73  VEGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRD 128

Query: 653 LKPSNVLLDDNMVAH---LSDFGIAK 675
           +KP N L+     A+   + DFG+AK
Sbjct: 129 IKPDNFLMGLGRRANQVYIIDFGLAK 154

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 64.8 bits (158), Expect = 3e-11
 Identities = 34/171 (19%), Positives = 63/171 (36%), Gaps = 39/171 (22%)

Query: 534 LIGRGGFGSVYKAR------IRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVK 587
            IG+GGFG +Y A       +       VKV     G  F     E    +       ++
Sbjct: 42  PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLF----TELKFYQRAAKPEQIQ 97

Query: 588 VISS-------------------CSNEEFKALVLEYMPHG-SLEKYLHSSNYSLDIFQRL 627
                                   + + ++ ++++    G  L+K   ++         L
Sbjct: 98  KWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKTVL 155

Query: 628 NIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAK 675
            + + +   LEY+H       +H D+K SN+LL   + + V +L D+G+A 
Sbjct: 156 QLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQV-YLVDYGLAY 202

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 61.6 bits (150), Expect = 5e-11
 Identities = 36/132 (27%), Positives = 52/132 (39%), Gaps = 9/132 (6%)

Query: 54  QNKLLGTIPAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHF 113
             + L  IP  I          + +N L    S      LP+L  L L  N  +  I   
Sbjct: 16  TGRGLKEIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPN 72

Query: 114 IF-NASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKS 172
            F  AS + +L L  N         F  L  L+ L LYDN ++      SF     +  S
Sbjct: 73  AFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVM-PGSF----EHLNS 127

Query: 173 LTHISLSNNPLD 184
           LT ++L++NP +
Sbjct: 128 LTSLNLASNPFN 139

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 60.8 bits (148), Expect = 1e-10
 Identities = 36/120 (30%), Positives = 54/120 (45%), Gaps = 14/120 (11%)

Query: 212 GIPEEITNLTDLTTIVLGGNKLNGSIPIT--LGKLQKLQDVDLEYNQLEGSIPDSICLS- 268
            IP   T L      +L  N+L   I      G+L  L  ++L+ NQL   I  +     
Sbjct: 26  DIPLHTTEL------LLNDNELG-RISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGA 77

Query: 269 VELYELELGGNKLSGSIPA-CFSNMTFLKVLSLGSNELTSIPLN-FWSLKDILDLNLSSN 326
             + EL+LG NK+   I    F  +  LK L+L  N+++ +    F  L  +  LNL+SN
Sbjct: 78  SHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 50.4 bits (121), Expect = 3e-07
 Identities = 24/91 (26%), Positives = 38/91 (41%), Gaps = 6/91 (6%)

Query: 344 EIDFSMNNFSGIIPMEI-GSLKNLENLFLEYNRLEGSIPDS-FGDLISLKSLNLSYNNLS 401
           E+  + N    I    + G L +L  L L+ N+L   I  + F     ++ L L  N + 
Sbjct: 33  ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIK 91

Query: 402 GTIPVSL-EKLSYLKDLNLSFNKLKGEIPRG 431
             I   +   L  LK LNL  N++   +  G
Sbjct: 92  -EISNKMFLGLHQLKTLNLYDNQISC-VMPG 120

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 46.9 bits (112), Expect = 5e-06
 Identities = 28/130 (21%), Positives = 45/130 (34%), Gaps = 34/130 (26%)

Query: 6   NNFLTSTTPKEI-DNISNLKVLYLYNNRLQGEIIHEIG---HLHNLGFLDLSQNKLLGTI 61
           +N L   +   +   + +L  L L  N+L G    E        ++  L L +NK +  I
Sbjct: 38  DNELGRISSDGLFGRLPHLVKLELKRNQLTG---IEPNAFEGASHIQELQLGENK-IKEI 93

Query: 62  PAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIF-NASKL 120
              +F                         GL  L+ L L+ N  S  +    F + + L
Sbjct: 94  SNKMFL------------------------GLHQLKTLNLYDNQIS-CVMPGSFEHLNSL 128

Query: 121 SKLALEMNSF 130
           + L L  N F
Sbjct: 129 TSLNLASNPF 138

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 61.6 bits (150), Expect = 7e-11
 Identities = 36/163 (22%), Positives = 63/163 (38%), Gaps = 8/163 (4%)

Query: 265 ICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLS 324
           +    E  EL      +   + A  S +   K L+L +N +  I  +   ++++  L+L 
Sbjct: 21  VATEAEKVELHGMIPPIEK-MDATLSTLKACKHLALSTNNIEKIS-SLSGMENLRILSLG 78

Query: 325 SNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLE--GSIPD 382
            N       L+      L E+  S N  + +  +E   L NL  L++  N++   G I D
Sbjct: 79  RNLIKKIENLD-AVADTLEELWISYNQIASLSGIE--KLVNLRVLYMSNNKITNWGEI-D 134

Query: 383 SFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLK 425
               L  L+ L L+ N L      +     Y  ++      LK
Sbjct: 135 KLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLK 177

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 58.9 bits (143), Expect = 6e-10
 Identities = 33/171 (19%), Positives = 60/171 (35%), Gaps = 37/171 (21%)

Query: 15  KEIDNISNLKVLYLYN--NRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLK 72
           ++    +  + + L+     ++ ++   +  L     L LS N         I  +S+L 
Sbjct: 17  RKSVVATEAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNN--------IEKISSLS 67

Query: 73  AFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSG 132
                              G+ NL +L L  N     I +    A  L +L +  N  + 
Sbjct: 68  -------------------GMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS 107

Query: 133 FIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPL 183
              S    L NL  L + +N +T    +   +  L+    L  + L+ NPL
Sbjct: 108 L--SGIEKLVNLRVLYMSNNKIT----NWGEIDKLAALDKLEDLLLAGNPL 152

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 64.0 bits (156), Expect = 7e-11
 Identities = 49/205 (23%), Positives = 90/205 (43%), Gaps = 28/205 (13%)

Query: 534 LIGRGGFGSVYKAR-IRDGMEVAVKVF-NLQCGRAFKSFDVECAMMKSIRHR------NL 585
           +IG+G FG V KA   +    VA+K+  N +  R  +    E  +++ +R +      N+
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEK--RFHRQAAEEIRILEHLRKQDKDNTMNV 161

Query: 586 VKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNY---SLDIFQRLNIMIDVASALEYLHF 642
           + ++ + +      +  E +   +L + +  + +   SL + ++      +   L+ LH 
Sbjct: 162 IHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRK--FAHSILQCLDALH- 217

Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAH--LSDFGIAKLLTGEDQSMTQT-QTLATIGYMAPE 699
                +IHCDLKP N+LL     +   + DFG +     E Q +    Q+     Y APE
Sbjct: 218 --KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS---CYEHQRVYTYIQSRF---YRAPE 269

Query: 700 YGREGQVSTNGDVYSFGIMLMETFT 724
                +     D++S G +L E  T
Sbjct: 270 VILGARYGMPIDMWSLGCILAELLT 294

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 62.4 bits (152), Expect = 2e-10
 Identities = 35/166 (21%), Positives = 62/166 (37%), Gaps = 31/166 (18%)

Query: 535 IGRGGFGSVYKAR---------IRDGMEVAVKV-------FNLQ--CGRAFKSFDVEC-A 575
             R   G +Y+A               + ++K+       FN Q    RA K   V    
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 576 MMKSIRHRNLVKVISSCSNE-EFKALVLEYMPHG-SLEKYLHSSNY-SLDIFQRLNIMID 632
            + S     +   +    ++ +++ LVL  +  G SL+  L  S    L     L +   
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQVACR 167

Query: 633 VASALEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAK 675
           +  ALE+LH       +H ++   N+ +   D + V  L+ +G A 
Sbjct: 168 LLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQV-TLAGYGFAF 209

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 59.7 bits (145), Expect = 3e-10
 Identities = 44/162 (27%), Positives = 61/162 (37%), Gaps = 32/162 (19%)

Query: 24  KVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLSG 83
             L L  N L+         L +L  L L  NK L ++P  +FN                
Sbjct: 31  TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNK-LQSLPNGVFN---------------- 73

Query: 84  CLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNA-SKLSKLALEMNSFSGFIPSTFGNLR 142
                    L +L  L L  N    ++P+ +F+  ++L +LAL  N         F  L 
Sbjct: 74  --------KLTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLT 124

Query: 143 NLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLD 184
            L+ L LY N L  S  D  F        SL +I L +NP D
Sbjct: 125 QLKDLRLYQNQLK-SVPDGVF----DRLTSLQYIWLHDNPWD 161

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 56.2 bits (136), Expect = 5e-09
 Identities = 38/121 (31%), Positives = 54/121 (44%), Gaps = 11/121 (9%)

Query: 209 VSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLS 268
           V  GIP         T + L  N L         +L  L  + L  N+L+ S+P+ +   
Sbjct: 22  VPTGIP------AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNK 74

Query: 269 -VELYELELGGNKLSGSIPA-CFSNMTFLKVLSLGSNELTSIPLN-FWSLKDILDLNLSS 325
              L  L L  N+L  S+P   F  +T LK L+L +N+L S+P   F  L  + DL L  
Sbjct: 75  LTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQ 133

Query: 326 N 326
           N
Sbjct: 134 N 134

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 55.8 bits (135), Expect = 6e-09
 Identities = 43/112 (38%), Positives = 60/112 (53%), Gaps = 7/112 (6%)

Query: 219 NLTDLTTIVLGGNKLNGSIPITL-GKLQKLQDVDLEYNQLEGSIPDSICLS-VELYELEL 276
            LT LT + LGGNKL  S+P  +  KL  L  ++L  NQL+ S+P+ +     +L EL L
Sbjct: 50  ELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELAL 107

Query: 277 GGNKLSGSIPA-CFSNMTFLKVLSLGSNELTSIPLN-FWSLKDILDLNLSSN 326
             N+L  S+P   F  +T LK L L  N+L S+P   F  L  +  + L  N
Sbjct: 108 NTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 53.9 bits (130), Expect = 3e-08
 Identities = 40/132 (30%), Positives = 60/132 (45%), Gaps = 7/132 (5%)

Query: 302 SNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIG 361
           S   TS+P    +    LDL   +N            L +L ++    N    +      
Sbjct: 16  SQGRTSVPTGIPAQTTYLDLE--TNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFN 73

Query: 362 SLKNLENLFLEYNRLEGSIPDS-FGDLISLKSLNLSYNNLSGTIPVSL-EKLSYLKDLNL 419
            L +L  L L  N+L+ S+P+  F  L  LK L L+ N L  ++P  + +KL+ LKDL L
Sbjct: 74  KLTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRL 131

Query: 420 SFNKLKGEIPRG 431
             N+LK  +P G
Sbjct: 132 YQNQLKS-VPDG 142

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 50.8 bits (122), Expect = 3e-07
 Identities = 50/166 (30%), Positives = 75/166 (45%), Gaps = 36/166 (21%)

Query: 237 IPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPA-CFSNMTFL 295
           IP     L      DLE N L+            L +L LGGNKL  S+P   F+ +T L
Sbjct: 26  IPAQTTYL------DLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSL 78

Query: 296 KVLSLGSNELTSIPLN-FWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSG 354
             L+L +N+L S+P   F  L  + +L L++N            L++L +  F       
Sbjct: 79  TYLNLSTNQLQSLPNGVFDKLTQLKELALNTN-----------QLQSLPDGVFD------ 121

Query: 355 IIPMEIGSLKNLENLFLEYNRLEGSIPD-SFGDLISLKSLNLSYNN 399
                   L  L++L L  N+L+ S+PD  F  L SL+ + L ++N
Sbjct: 122 -------KLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWL-HDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 46.2 bits (110), Expect = 1e-05
 Identities = 35/136 (25%), Positives = 51/136 (37%), Gaps = 9/136 (6%)

Query: 97  EVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTS 156
             L L  N+            + L++L L  N         F  L +L +L L  N L S
Sbjct: 31  TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQS 90

Query: 157 STLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEE 216
             L       L+    L  ++L+ N L   LP      L+  LK+  +Y  N    +P+ 
Sbjct: 91  --LPNGVFDKLTQ---LKELALNTNQLQS-LPDGVFDKLT-QLKDLRLYQ-NQLKSVPDG 142

Query: 217 I-TNLTDLTTIVLGGN 231
           +   LT L  I L  N
Sbjct: 143 VFDRLTSLQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 41.2 bits (97), Expect = 5e-04
 Identities = 28/103 (27%), Positives = 45/103 (43%), Gaps = 9/103 (8%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIG---HLHNLGFLDLSQNKLLGTIP 62
            N L S      + +++L  L L  N+LQ       G    L  L  L L+ N+ L ++P
Sbjct: 61  GNKLQSLPNGVFNKLTSLTYLNLSTNQLQS---LPNGVFDKLTQLKELALNTNQ-LQSLP 116

Query: 63  AAIFNVST-LKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGN 104
             +F+  T LK   +  N L      + D  L +L+ ++L  N
Sbjct: 117 DGVFDKLTQLKDLRLYQNQLKSVPDGVFD-RLTSLQYIWLHDN 158

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 61.1 bits (147), Expect = 4e-10
 Identities = 35/200 (17%), Positives = 59/200 (29%), Gaps = 52/200 (26%)

Query: 523 FQATDKFSENNLIGRGGFGSVYKARIRDGMEVAVKV--------FNLQCGRAFKSFDVEC 574
              T+K      IG G FG V++    D   VA+K+         N    + F+    E 
Sbjct: 16  CLPTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEI 74

Query: 575 AMMKSI---------RHRNLVKVISSC------------------------------SNE 595
            + K +         R    + + S                                  +
Sbjct: 75  IISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKD 134

Query: 596 EFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKP 655
           +   +VLE+   G   + + +   SL      +I+  + ++L            H DL  
Sbjct: 135 DQLFIVLEFEFGGIDLEQMRTKLSSLA--TAKSILHQLTASLAVAEASLR--FEHRDLHW 190

Query: 656 SNVLLDDNMVAHLSDFGIAK 675
            NVLL    +  L      K
Sbjct: 191 GNVLLKKTSLKKLHYTLNGK 210

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 58.0 bits (141), Expect = 6e-10
 Identities = 40/124 (32%), Positives = 58/124 (46%), Gaps = 17/124 (13%)

Query: 209 VSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIP----DS 264
           V  GIP      +  T + L  NKL         KL +L  + L  NQ++ S+P    D 
Sbjct: 22  VPTGIP------SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDK 74

Query: 265 ICLSVELYELELGGNKLSGSIPA-CFSNMTFLKVLSLGSNELTSIPLN-FWSLKDILDLN 322
           +    +L  L L  NKL  S+P   F  +T LK L+L +N+L S+P   F  L  +  + 
Sbjct: 75  L---TKLTILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIW 130

Query: 323 LSSN 326
           L +N
Sbjct: 131 LHTN 134

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 50.0 bits (120), Expect = 4e-07
 Identities = 39/164 (23%), Positives = 55/164 (33%), Gaps = 54/164 (32%)

Query: 21  SNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNS 80
           S+   L L +N+LQ         L  L  L LSQN+ + ++P  +F+             
Sbjct: 28  SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQ-IQSLPDGVFD------------- 73

Query: 81  LSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGN 140
                       L  L +LYL  N    ++P+ +F+                        
Sbjct: 74  -----------KLTKLTILYLHENKLQ-SLPNGVFD-----------------------K 98

Query: 141 LRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLD 184
           L  L+ L L  N L  S  D  F        SL  I L  NP D
Sbjct: 99  LTQLKELALDTNQLK-SVPDGIF----DRLTSLQKIWLHTNPWD 137

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 46.5 bits (111), Expect = 5e-06
 Identities = 43/154 (27%), Positives = 61/154 (39%), Gaps = 31/154 (20%)

Query: 248 QDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTS 307
            ++      L  S+P  I  S     LEL  NKL       F  +T L  LSL  N++ S
Sbjct: 10  TEIRCNSKGLT-SVPTGIPSSAT--RLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQS 66

Query: 308 IPLN-FWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNL 366
           +P   F  L  +  L L  N            L++L    F               L  L
Sbjct: 67  LPDGVFDKLTKLTILYLHEN-----------KLQSLPNGVFD-------------KLTQL 102

Query: 367 ENLFLEYNRLEGSIPD-SFGDLISLKSLNLSYNN 399
           + L L+ N+L+ S+PD  F  L SL+ + L + N
Sbjct: 103 KELALDTNQLK-SVPDGIFDRLTSLQKIWL-HTN 134

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 44.9 bits (107), Expect = 2e-05
 Identities = 27/72 (37%), Positives = 39/72 (54%), Gaps = 5/72 (6%)

Query: 362 SLKNLENLFLEYNRLEGSIPDS-FGDLISLKSLNLSYNNLSGTIPVSL-EKLSYLKDLNL 419
            L  L  L L  N+++ S+PD  F  L  L  L L  N L  ++P  + +KL+ LK+L L
Sbjct: 50  KLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQ-SLPNGVFDKLTQLKELAL 107

Query: 420 SFNKLKGEIPRG 431
             N+LK  +P G
Sbjct: 108 DTNQLKS-VPDG 118

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 44.9 bits (107), Expect = 2e-05
 Identities = 23/66 (34%), Positives = 34/66 (51%), Gaps = 3/66 (4%)

Query: 367 ENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSL-EKLSYLKDLNLSFNKLK 425
             L LE N+L+      F  L  L  L+LS N +  ++P  + +KL+ L  L L  NKL+
Sbjct: 31  TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQ 89

Query: 426 GEIPRG 431
             +P G
Sbjct: 90  -SLPNG 94

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 44.9 bits (107), Expect = 2e-05
 Identities = 30/103 (29%), Positives = 46/103 (44%), Gaps = 9/103 (8%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIG---HLHNLGFLDLSQNKLLGTIP 62
           +N L S      D ++ L  L L  N++Q       G    L  L  L L +NK L ++P
Sbjct: 37  SNKLQSLPHGVFDKLTQLTKLSLSQNQIQS---LPDGVFDKLTKLTILYLHENK-LQSLP 92

Query: 63  AAIF-NVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGN 104
             +F  ++ LK  A+  N L      I D  L +L+ ++L  N
Sbjct: 93  NGVFDKLTQLKELALDTNQLKSVPDGIFD-RLTSLQKIWLHTN 134

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 43.0 bits (102), Expect = 8e-05
 Identities = 32/111 (28%), Positives = 41/111 (36%), Gaps = 9/111 (8%)

Query: 122 KLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNN 181
           +L LE N         F  L  L  L+L  N + S  L       L+    LT + L  N
Sbjct: 32  RLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQS--LPDGVFDKLTK---LTILYLHEN 86

Query: 182 PLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEI-TNLTDLTTIVLGGN 231
            L   LP      L+  LK   +   N    +P+ I   LT L  I L  N
Sbjct: 87  KLQS-LPNGVFDKLT-QLKELALDT-NQLKSVPDGIFDRLTSLQKIWLHTN 134

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 59.7 bits (145), Expect = 1e-09
 Identities = 34/166 (20%), Positives = 66/166 (39%), Gaps = 32/166 (19%)

Query: 534 LIGRGGFGSVYKA-RIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKV---- 588
            IG GGFG +Y A       + A  V  ++          E    + +  ++ +K     
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQEN-GPLFSELKFYQRVAKKDCIKKWIER 102

Query: 589 ---------------ISSCSNEEFKALVLEYMPHG-SLEKYLHSSNYSLDIFQRLNIMID 632
                          ++      ++ +V+E +  G  L+K     N +      L + I 
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKIS-GQNGTFKKSTVLQLGIR 159

Query: 633 VASALEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAK 675
           +   LEY+H       +H D+K +N+LL   + + V +L+D+G++ 
Sbjct: 160 MLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQV-YLADYGLSY 201

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 58.4 bits (141), Expect = 6e-09
 Identities = 61/376 (16%), Positives = 118/376 (31%), Gaps = 49/376 (13%)

Query: 80  SLSGCLSSITDVGL--------PNLEVLYLWG-NNFSGT-IPHFIFNASKLSKLALEMNS 129
                   ++D+ L         +LE L L   + F+   +   + +  K+  L +E +S
Sbjct: 118 HFRRM--IVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESS 175

Query: 130 FSGFIPSTFG----NLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDG 185
           FS            +  +LE L  Y       +      +   NC+SL  + + +  +  
Sbjct: 176 FSEKDGKWLHELAQHNTSLEVLNFYMTEFAKIS-PKDLETIARNCRSLVSVKVGDFEILE 234

Query: 186 ILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKL--NGSIPITLGK 243
           ++        + +L+ F   + N   G+PE+  NL     +   G        +PI    
Sbjct: 235 LVG---FFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPF 291

Query: 244 LQKLQDVDLEYNQLEG-SIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSL-G 301
             +++ +DL Y  LE       I     L  LE         +         LK L +  
Sbjct: 292 AAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIER 351

Query: 302 SNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIG 361
             +   +      +     + L+  C            + L  +   +++ +      IG
Sbjct: 352 GADEQGMEDEEGLVSQRGLIALAQGC------------QELEYMAVYVSDITNESLESIG 399

Query: 362 S-LKNLENLFLEYNRLEGSIPDSFGD---------LISLKSLNLSYNNLSGT---IPVSL 408
           + LKNL +  L     E  I D   D            L+           T   +    
Sbjct: 400 TYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIG 459

Query: 409 EKLSYLKDLNLSFNKL 424
           +    ++ + L +   
Sbjct: 460 QYSPNVRWMLLGYVGE 475

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 54.2 bits (130), Expect = 1e-07
 Identities = 49/428 (11%), Positives = 117/428 (27%), Gaps = 64/428 (14%)

Query: 21  SNLKVLYLYNNRLQGE--IIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVST-LKAFAVT 77
            +L+ L L          ++  + H   +  L + ++         +  ++    +  V 
Sbjct: 138 DDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVL 197

Query: 78  NNSLSGCLSSITDVGL-------PNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSF 130
           N  ++   + I+   L        +L  + +        +  F   A+ L +      + 
Sbjct: 198 NFYMTEF-AKISPKDLETIARNCRSLVSVKVGDFEIL-ELVGFFKAAANLEEFCGGSLNE 255

Query: 131 SGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRT 190
              +P  + NL     L     +                   +  + L    L+     T
Sbjct: 256 DIGMPEKYMNLVFPRKLCRLGLSYMG---PNEMPILFPFAAQIRKLDLLYALLETEDHCT 312

Query: 191 YVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDV 250
            +     +L+     N     G+         L  + +        +    G    +   
Sbjct: 313 LIQKC-PNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEG---LVSQR 368

Query: 251 DLEYNQLEGSIPDSICLS-VELYELELGGNKLS----GSIPACFSNMTFLKVLSL-GSNE 304
            L           ++     EL  + +  + ++     SI     N+   +++ L     
Sbjct: 369 GLI----------ALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREER 418

Query: 305 LTSIPLN------FWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPM 358
           +T +PL+          K +               L    L  + +              
Sbjct: 419 ITDLPLDNGVRSLLIGCKKLRRFAFYLRQGG----LTDLGLSYIGQ-------------- 460

Query: 359 EIGSLKNLENLFLEYNRL-EGSIPDSFGDLISLKSLNLSYNNLS-GTIPVSLEKLSYLKD 416
                 N+  + L Y    +  + +      +L+ L +     S   I  ++ KL  L+ 
Sbjct: 461 ---YSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRY 517

Query: 417 LNLSFNKL 424
           L +   + 
Sbjct: 518 LWVQGYRA 525

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 43.4 bits (102), Expect = 3e-04
 Identities = 44/311 (14%), Positives = 86/311 (27%), Gaps = 56/311 (18%)

Query: 140 NLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPL---DGILPRTYVGNLS 196
           NLR L+ +      ++    DL  L+  +    L  + L        DG+L    +    
Sbjct: 110 NLRQLKSVHFRRMIVSDL--DLDRLAK-ARADDLETLKLDKCSGFTTDGLL---SIVTHC 163

Query: 197 HSLKNFYMYNCNVS-------GGIPEEITNLTDLTTIVLGGNKLNGSIPITLGK-LQKLQ 248
             +K   M   + S         + +  T+L  L   +    K++     T+ +  + L 
Sbjct: 164 RKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLV 223

Query: 249 DVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSI 308
            V +                +EL         L              +      NE   +
Sbjct: 224 SVKVGD-----------FEILELVGFFKAAANLE-------------EFCGGSLNEDIGM 259

Query: 309 PLNFWSLKDILDLNLSSNCFSGP--LPLEIRNLKALIEIDFSMNNFSGIIPME-IGSLKN 365
           P  + +L     L      + GP  +P+       + ++D              I    N
Sbjct: 260 PEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPN 319

Query: 366 LENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLS------------Y 413
           LE L       +  +         LK L +        +      +S             
Sbjct: 320 LEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQE 379

Query: 414 LKDLNLSFNKL 424
           L+ + +  + +
Sbjct: 380 LEYMAVYVSDI 390

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 57.4 bits (139), Expect = 9e-09
 Identities = 52/215 (24%), Positives = 95/215 (44%), Gaps = 30/215 (13%)

Query: 526 TDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSF----DVECAMMKSI 580
            D++  ++LIG+G FG V KA    +   VA+K+      +  K+F     +E  +++ +
Sbjct: 53  MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII-----KNKKAFLNQAQIEVRLLELM 107

Query: 581 RHR------NLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNY---SLDIFQRLNIMI 631
                     +V +           LV E +   +L   L ++N+   SL++ ++     
Sbjct: 108 NKHDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRK--FAQ 164

Query: 632 DVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH--LSDFGIAKLLTGEDQSMTQTQT 689
            + +AL +L       +IHCDLKP N+LL +   +   + DFG +       Q +   Q 
Sbjct: 165 QMCTALLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS---CQLGQRI--YQY 218

Query: 690 LATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT 724
           + +  Y +PE           D++S G +L+E  T
Sbjct: 219 IQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHT 253

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 53.9 bits (130), Expect = 1e-08
 Identities = 29/107 (27%), Positives = 47/107 (43%), Gaps = 3/107 (2%)

Query: 270 ELYELELGGNKLS-GSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCF 328
           ++ EL L  ++ + G +         L+ LS  +  LTSI  N   L  +  L LS N  
Sbjct: 18  DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIA-NLPKLNKLKKLELSDNRV 76

Query: 329 SGPLPLEIRNLKALIEIDFSMNNFSGIIPME-IGSLKNLENLFLEYN 374
           SG L +       L  ++ S N    +  +E +  L+NL++L L   
Sbjct: 77  SGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 51.6 bits (124), Expect = 7e-08
 Identities = 31/166 (18%), Positives = 46/166 (27%), Gaps = 56/166 (33%)

Query: 19  NISNLKVLYLYNNRLQ-GEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVT 77
             S++K L L N+R   G++         L FL      L                    
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGL-------------------- 54

Query: 78  NNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPST 137
             S++          L  L+ L L  N  SG +                           
Sbjct: 55  -TSIANLPK------LNKLKKLELSDNRVSGGLEVL------------------------ 83

Query: 138 FGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPL 183
                NL  L L  N +     DLS +  L   ++L  + L N  +
Sbjct: 84  AEKCPNLTHLNLSGNKIK----DLSTIEPLKKLENLKSLDLFNCEV 125

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 45.8 bits (109), Expect = 7e-06
 Identities = 29/93 (31%), Positives = 39/93 (41%), Gaps = 3/93 (3%)

Query: 334 LEIRNLKALIEIDFSMNNFSGIIPMEIG-SLKNLENLFLEYNRLEGSIPDSFGDLISLKS 392
           L  R    + E+    +  +      +    + LE L      L  SI +    L  LK 
Sbjct: 11  LRNRTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKK 68

Query: 393 LNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLK 425
           L LS N +SG + V  EK   L  LNLS NK+K
Sbjct: 69  LELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 45.4 bits (108), Expect = 1e-05
 Identities = 20/92 (21%), Positives = 35/92 (38%), Gaps = 10/92 (10%)

Query: 17  IDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAV 76
            D    L+ L   N  L    I  +  L+ L  L+LS N++ G +         L    +
Sbjct: 38  TDEFEELEFLSTINVGL--TSIANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNL 95

Query: 77  TNNSLSGCLSSITDV----GLPNLEVLYLWGN 104
           + N     +  ++ +     L NL+ L L+  
Sbjct: 96  SGN----KIKDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 42.0 bits (99), Expect = 1e-04
 Identities = 25/113 (22%), Positives = 52/113 (46%), Gaps = 9/113 (7%)

Query: 219 NLTDLTTIVLGGNKLN-GSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELG 277
             +D+  +VL  ++ N G +     + ++L+ +      L  SI + +    +L +LEL 
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELS 72

Query: 278 GNKLSGSIPACFSNMTFLKVLSLGSNELTSI----PLNFWSLKDILDLNLSSN 326
            N++SG +         L  L+L  N++  +    PL    L+++  L+L + 
Sbjct: 73  DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLK--KLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 39.7 bits (93), Expect = 9e-04
 Identities = 19/69 (27%), Positives = 35/69 (50%), Gaps = 3/69 (4%)

Query: 362 SLKNLENLFLEYNRL-EGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLS 420
           +  +++ L L+ +R  EG +     +   L+ L+     L+ +I   L KL+ LK L LS
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELS 72

Query: 421 FNKLKGEIP 429
            N++ G + 
Sbjct: 73  DNRVSGGLE 81

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 54.0 bits (130), Expect = 2e-08
 Identities = 30/107 (28%), Positives = 45/107 (42%), Gaps = 3/107 (2%)

Query: 270 ELYELELGGNKLS-GSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCF 328
            + EL L   K + G I    +    L+ LSL +  L S+  N   L  +  L LS N  
Sbjct: 25  AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVS-NLPKLPKLKKLELSENRI 83

Query: 329 SGPLPLEIRNLKALIEIDFSMNNFSGIIPME-IGSLKNLENLFLEYN 374
            G L +    L  L  ++ S N    I  +E +  L+ L++L L   
Sbjct: 84  FGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 53.2 bits (128), Expect = 3e-08
 Identities = 26/91 (28%), Positives = 34/91 (37%), Gaps = 6/91 (6%)

Query: 93  LPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDN 152
             NLE L L       ++ +      KL KL L  N   G +      L NL  L L  N
Sbjct: 48  FVNLEFLSLINVGLI-SVSNLPKL-PKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGN 105

Query: 153 NLTSSTLDLSFLSSLSNCKSLTHISLSNNPL 183
            L     D+S L  L   + L  + L N  +
Sbjct: 106 KLK----DISTLEPLKKLECLKSLDLFNCEV 132

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 44.7 bits (106), Expect = 2e-05
 Identities = 21/92 (22%), Positives = 36/92 (39%), Gaps = 10/92 (10%)

Query: 17  IDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAV 76
                NL+ L L N  L    +  +  L  L  L+LS+N++ G +      +  L    +
Sbjct: 45  TAEFVNLEFLSLINVGLI--SVSNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNL 102

Query: 77  TNNSLSGCLSSITDV----GLPNLEVLYLWGN 104
           + N     L  I+ +     L  L+ L L+  
Sbjct: 103 SGN----KLKDISTLEPLKKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 44.7 bits (106), Expect = 2e-05
 Identities = 34/94 (36%), Positives = 42/94 (44%), Gaps = 5/94 (5%)

Query: 334 LEIRNLKALIEIDFSMNNFSGIIPME--IGSLKNLENLFLEYNRLEGSIPDSFGDLISLK 391
           L  R   A+ E+    N  S    +E       NLE L L    L  S+  +   L  LK
Sbjct: 18  LRNRTPAAVRELVLD-NCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLK 74

Query: 392 SLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLK 425
            L LS N + G + +  EKL  L  LNLS NKLK
Sbjct: 75  KLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 43.6 bits (103), Expect = 5e-05
 Identities = 26/111 (23%), Positives = 45/111 (40%), Gaps = 5/111 (4%)

Query: 219 NLTDLTTIVLGGNKLN-GSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELG 277
               +  +VL   K N G I     +   L+ + L    L  S+ +   L  +L +LEL 
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSNLPKLP-KLKKLELS 79

Query: 278 GNKLSGSIPACFSNMTFLKVLSLGSNELTSIP--LNFWSLKDILDLNLSSN 326
            N++ G +      +  L  L+L  N+L  I        L+ +  L+L + 
Sbjct: 80  ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 53.5 bits (129), Expect = 2e-08
 Identities = 25/109 (22%), Positives = 42/109 (38%), Gaps = 13/109 (11%)

Query: 80  SLSGC-LSSITDVG--LPNLEVLYLWGNNFS--GTIPHFIFNASKLSKLALEMNSFSGFI 134
            L G  +  I ++G  L   + +    N        P       +L  L +  N      
Sbjct: 25  DLRGYKIPVIENLGATLDQFDAIDFSDNEIRKLDGFPLL----RRLKTLLVNNNRICRIG 80

Query: 135 PSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPL 183
                 L +L  L L +N+L     +L  L  L++ KSLT++ +  NP+
Sbjct: 81  EGLDQALPDLTELILTNNSLV----ELGDLDPLASLKSLTYLCILRNPV 125

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 52.7 bits (127), Expect = 4e-08
 Identities = 23/107 (21%), Positives = 45/107 (42%), Gaps = 3/107 (2%)

Query: 269 VELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCF 328
           V   EL+L G K+   I    + +     +    NE+  +   F  L+ +  L +++N  
Sbjct: 19  VRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLD-GFPLLRRLKTLLVNNNRI 76

Query: 329 SGPLPLEIRNLKALIEIDFSMNNFSGIIPME-IGSLKNLENLFLEYN 374
                   + L  L E+  + N+   +  ++ + SLK+L  L +  N
Sbjct: 77  CRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 45.0 bits (107), Expect = 2e-05
 Identities = 23/114 (20%), Positives = 39/114 (34%), Gaps = 5/114 (4%)

Query: 215 EEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYEL 274
            + TN      + L G K+   I      L +   +D   N++   +     L   L  L
Sbjct: 13  AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDGFPLL-RRLKTL 69

Query: 275 ELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIP--LNFWSLKDILDLNLSSN 326
            +  N++          +  L  L L +N L  +       SLK +  L +  N
Sbjct: 70  LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 44.6 bits (106), Expect = 2e-05
 Identities = 21/118 (17%), Positives = 35/118 (29%), Gaps = 9/118 (7%)

Query: 93  LPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDN 152
                 L L G      I +      +   +    N         F  LR L+ L + +N
Sbjct: 18  AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNN 74

Query: 153 NLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVS 210
            +      L           LT + L+NN L  +     + +L   L    +    V+
Sbjct: 75  RICRIGEGL-----DQALPDLTELILTNNSLVELGDLDPLASLKS-LTYLCILRNPVT 126

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 44.6 bits (106), Expect = 3e-05
 Identities = 19/91 (20%), Positives = 34/91 (37%), Gaps = 3/91 (3%)

Query: 335 EIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLN 394
           +  N     E+D        I  +   +L   + +    N +   + D F  L  LK+L 
Sbjct: 14  QYTNAVRDRELDLRGYKIPVIENLGA-TLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLL 70

Query: 395 LSYNNLSGTIPVSLEKLSYLKDLNLSFNKLK 425
           ++ N +        + L  L +L L+ N L 
Sbjct: 71  VNNNRICRIGEGLDQALPDLTELILTNNSLV 101

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 42.7 bits (101), Expect = 1e-04
 Identities = 25/150 (16%), Positives = 47/150 (31%), Gaps = 38/150 (25%)

Query: 165 SSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNF---YMYNCNVS--GGIPEEITN 219
           +  +N      + L    +  I       NL  +L  F      +  +    G P     
Sbjct: 13  AQYTNAVRDRELDLRGYKIPVI------ENLGATLDQFDAIDFSDNEIRKLDGFP----L 62

Query: 220 LTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGN 279
           L  L T+++  N++          L  L ++ L  N L            EL +L+    
Sbjct: 63  LRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-----------ELGDLD---- 107

Query: 280 KLSGSIPACFSNMTFLKVLSLGSNELTSIP 309
                     +++  L  L +  N +T+  
Sbjct: 108 --------PLASLKSLTYLCILRNPVTNKK 129

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 55.7 bits (134), Expect = 5e-08
 Identities = 60/416 (14%), Positives = 134/416 (32%), Gaps = 41/416 (9%)

Query: 18  DNISNLKVLYLYN-NRLQGEIIHEIG-HLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFA 75
            +  N KVL L +      + +  I     NL  LDL ++ +       + +       +
Sbjct: 127 KSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDT-YTS 185

Query: 76  VTNNSLSGCLSSITDVGL-------PNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMN 128
           + + ++S   S ++   L       PNL+ L L        +   +  A +L +L     
Sbjct: 186 LVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGY 245

Query: 129 SFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILP 188
           +                             +      +LS CK L  +S   + +   LP
Sbjct: 246 T-----------------------AEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLP 282

Query: 189 RTYVGNLSHSLKNFYMYNCNVSG-GIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKL 247
              V ++   L    +    V    + + +     L  + +     +  + +     + L
Sbjct: 283 --AVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLEVLASTCKDL 340

Query: 248 QDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTS 307
           +++ +  ++     P+       L  + +G  KL  S+      MT   ++++  N    
Sbjct: 341 RELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLE-SVLYFCRQMTNAALITIARNRPNM 399

Query: 308 IPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGS-LKNL 366
                  ++      L+           + + K L  +  S    +  +   IG+  K +
Sbjct: 400 TRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLS-GLLTDKVFEYIGTYAKKM 458

Query: 367 ENLFLEYNRL-EGSIPDSFGDLISLKSLNLSYNNLSG-TIPVSLEKLSYLKDLNLS 420
           E L + +    +  +        SL+ L +         +  +  KL  ++ L +S
Sbjct: 459 EMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMS 514

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 49.5 bits (118), Expect = 4e-06
 Identities = 31/218 (14%), Positives = 68/218 (31%), Gaps = 32/218 (14%)

Query: 17  IDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAV 76
           +     L+ L++ +      +        +L  L +  ++     P        L + ++
Sbjct: 310 LCQCPKLQRLWVLDYIEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSM 369

Query: 77  TNNSL----SGCLSSITDVGL-------PNLEVLYLWGNNFSGT-----------IPHFI 114
               L      C   +T+  L       PN+    L                       +
Sbjct: 370 GCPKLESVLYFC-RQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIV 428

Query: 115 FNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLT 174
            +   L +L+L                + +E L++     +    DL     LS C SL 
Sbjct: 429 EHCKDLRRLSLSGLLTDKVFEYIGTYAKKMEMLSVAFAGDS----DLGMHHVLSGCDSLR 484

Query: 175 HISLSNNPL--DGILPRTYVGNLSHSLKNFYMYNCNVS 210
            + + + P     +L      +   ++++ +M +C+VS
Sbjct: 485 KLEIRDCPFGDKALL---ANASKLETMRSLWMSSCSVS 519

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 48.7 bits (116), Expect = 6e-06
 Identities = 38/251 (15%), Positives = 86/251 (34%), Gaps = 35/251 (13%)

Query: 21  SNLKVLYLYNNRLQGE-IIHEIGHLHNLGFLDLSQN---KLLGTIPAAIFNVSTLKAFAV 76
           S L  L L    +Q   ++  +     L  L +        L  + +   ++  L+ F  
Sbjct: 289 SRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLEVLASTCKDLRELRVFPS 348

Query: 77  TNNSLSGCLSSITDVGL-------PNLEVLYLWGNNFSG-TIPHFIFNASKLSKLALEMN 128
               +     ++T+ GL       P LE +  +    +   +     N   +++      
Sbjct: 349 EPFVMEPN-VALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRF----- 402

Query: 129 SFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILP 188
                       L  +E      + LT   LD+ F + + +CK L  +SLS    D +  
Sbjct: 403 -----------RLCIIE--PKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSGLLTDKVF- 448

Query: 189 RTYVGNLSHSLKNFYMYNCNVSG-GIPEEITNLTDLTTIVLGG-NKLNGSIPITLGKLQK 246
             Y+G  +  ++   +     S  G+   ++    L  + +      + ++     KL+ 
Sbjct: 449 -EYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLET 507

Query: 247 LQDVDLEYNQL 257
           ++ + +    +
Sbjct: 508 MRSLWMSSCSV 518

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 52.7 bits (127), Expect = 2e-07
 Identities = 47/238 (19%), Positives = 84/238 (35%), Gaps = 76/238 (31%)

Query: 534 LIGRGGFGSVYKA--RIRDGMEVAVKVFNLQCGRAFKSF----DVECAMMKSIRHR---- 583
            +G G FG V +     R   +VA+K+      R    +     +E  ++K I+ +    
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKII-----RNVGKYREAARLEINVLKKIKEKDKEN 80

Query: 584 --NLVKVISS-------CSNEEFKALVLEYMPHGSLEKYLHSSNY---SLDIFQRLNIMI 631
               V +          C       +  E +   +  ++L  +N+    L   +   +  
Sbjct: 81  KFLCVLMSDWFNFHGHMC-------IAFELL-GKNTFEFLKENNFQPYPLPHVRH--MAY 130

Query: 632 DVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH-------------------LSDFG 672
            +  AL +LH      + H DLKP N+L  ++                       ++DFG
Sbjct: 131 QLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG 187

Query: 673 IAKLLTGEDQSMTQTQTLATIGYMAPE------YGREGQVSTNGDVYSFGIMLMETFT 724
            A   T + +    T  +AT  Y  PE      +      +   DV+S G +L E + 
Sbjct: 188 SA---TFDHE--HHTTIVATRHYRPPEVILELGW------AQPCDVWSIGCILFEYYR 234

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 52.6 bits (126), Expect = 3e-07
 Identities = 57/278 (20%), Positives = 95/278 (34%), Gaps = 84/278 (30%)

Query: 535 IGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIR-----HRNLVKV 588
           +G G F +V+ +  I+    VA+KV          + D E  ++KS+R       N   V
Sbjct: 45  LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD-EIRLLKSVRNSDPNDPNREMV 103

Query: 589 ISSCSNEEFK---------ALVLEYMPHGSLEKYLHSSNY---SLDIFQRLNIMIDVASA 636
           +     ++FK          +V E + H  L K++  SNY    L   ++  I+  V   
Sbjct: 104 VQLL--DDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKK--IIQQVLQG 158

Query: 637 LEYLHFGYSAPVIHCDLKPSNVLL------------------------------------ 660
           L+YLH      +IH D+KP N+LL                                    
Sbjct: 159 LDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 216

Query: 661 -------------DDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVS 707
                         + +   ++D G A  +        QT+      Y + E       +
Sbjct: 217 AGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYN 271

Query: 708 TNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVND 745
           T  D++S   M  E  T     D LF      ++  ++
Sbjct: 272 TPADIWSTACMAFELATG----DYLFEPHSGEEYTRDE 305

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 51.6 bits (124), Expect = 5e-07
 Identities = 57/245 (23%), Positives = 87/245 (35%), Gaps = 86/245 (35%)

Query: 534 LIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSF----DVECAMMKSIRHR----- 583
            +G G FG V   + I +    AVKV      R  K +     +E  ++K I++      
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVV-----RNIKKYTRSAKIEADILKKIQNDDINNN 96

Query: 584 NLVKVISS-------CSNEEFKALVLEYMPHGSLEKYLHSSNY---SLDIFQRLNIMIDV 633
           N+VK           C       L+ E +   SL + +  +NY    ++  +     I++
Sbjct: 97  NIVKYHGKFMYYDHMC-------LIFEPL-GPSLYEIITRNNYNGFHIEDIKL--YCIEI 146

Query: 634 ASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLS------------------------ 669
             AL YL       + H DLKP N+LLDD                               
Sbjct: 147 LKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKL 203

Query: 670 -DFGIAKLLTGEDQSMT---QTQTLATIGYMAPE------YGREGQVSTNGDVYSFGIML 719
            DFG A   T +         T+      Y APE      +        + D++SFG +L
Sbjct: 204 IDFGCA---TFKSDYHGSIINTRQ-----YRAPEVILNLGW------DVSSDMWSFGCVL 249

Query: 720 METFT 724
            E +T
Sbjct: 250 AELYT 254

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 52.5 bits (125), Expect = 5e-07
 Identities = 81/491 (16%), Positives = 147/491 (29%), Gaps = 152/491 (30%)

Query: 312 FWSLKDILDLNLSSNCFSGPLPLEI-RNLKALIEIDF-SMNNFSGIIPMEIGSLKN-LEN 368
           FW       LNL  NC S    LE+ + L   I+ ++ S ++ S  I + I S++  L  
Sbjct: 185 FW-------LNLK-NCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRR 236

Query: 369 LFLE--YNR-L-------EGSIPDSFGD-----LISLKSLNLSYNNLSG--TIPVSLEKL 411
           L     Y   L            ++F +     L++ +   ++ + LS   T  +SL+  
Sbjct: 237 LLKSKPYENCLLVLLNVQNAKAWNAF-NLSCKILLTTRFKQVT-DFLSAATTTHISLDHH 294

Query: 412 S-----------YLKDLNLSFNKLKGEIPRGGSFGNFSAESFKGNELLCG--SPNLQVPP 458
           S            LK L+     L    PR         E    N       + +++   
Sbjct: 295 SMTLTPDEVKSLLLKYLDCRPQDL----PR---------EVLTTNPRRLSIIAESIRDGL 341

Query: 459 CKASIHRTSRKNALILGI-----VLP---FSTIFMTAIILFIIKYQKREKGPPNDPNMPP 510
                 +    + L   I     VL    +  +F     L +          P   ++P 
Sbjct: 342 ATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDR---LSVF---------PPSAHIPT 389

Query: 511 ---VATWRRFSYLELFQATDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAF 567
                 W      ++    +K  + +L+ +    S     I            +      
Sbjct: 390 ILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTI--SIPS----------IYL---- 433

Query: 568 KSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRL 627
               V+     ++ HR++V        + +  +   +     +  YL    Y        
Sbjct: 434 -ELKVKLENEYAL-HRSIV--------DHYN-IPKTFDSDDLIPPYL--DQYF------- 473

Query: 628 NIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHL-SDFGI--AKLL---TGED 681
                      Y H G+     H  LK         +   +  DF     K+    T  +
Sbjct: 474 -----------YSHIGH-----H--LKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWN 515

Query: 682 QSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKH 741
            S +   TL  + +    Y  +  +  N   Y   +  +  F  K   + L   + T   
Sbjct: 516 ASGSILNTLQQLKF----Y--KPYICDNDPKYERLVNAILDFLPKIEEN-LICSKYT--- 565

Query: 742 WVNDCLPISTM 752
              D L I+ M
Sbjct: 566 ---DLLRIALM 573

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 50.6 bits (120), Expect = 2e-06
 Identities = 107/701 (15%), Positives = 205/701 (29%), Gaps = 247/701 (35%)

Query: 5   INNFLTST-TPKEIDNISNLK-----VLYLYNN-RLQGEIIHE--IGHLH--NLGFL--- 50
           + +   S  + +EID+I   K      L L+     + E + +  +  +   N  FL   
Sbjct: 38  VQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSP 97

Query: 51  ------DLS---------QNKLLGTIPAAI-FNVSTLKAFAVTNNSLSGCLSSITDVGLP 94
                   S         +++L         +NVS L+ +     +L   L    +V   
Sbjct: 98  IKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLE-LRPAKNV--- 153

Query: 95  NLEVLY-LWGNNFSGTIPHFIFNASKLSKLALE-MNSFSGFIPSTFGNLRNLEWLTLYDN 152
              ++  + G   SG          K + +AL+   S+   +         + WL L   
Sbjct: 154 ---LIDGVLG---SG----------K-TWVALDVCLSYK--VQCKMDF--KIFWLNL--K 190

Query: 153 NLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMY----NC- 207
           N  S    L  L  L         S S++  +  L    + ++   L+         NC 
Sbjct: 191 NCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLR---IHSIQAELRRLLKSKPYENCL 247

Query: 208 ----NVSGGIPEEITNLTDL--TTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSI 261
               NV      +  N  +L    ++    K    +            + L+ +      
Sbjct: 248 LVLLNVQN---AKAWNAFNLSCKILLTTRFK---QV-TDFLSAATTTHISLD-HHSMTLT 299

Query: 262 PD------SICLSVELYEL---ELGGNKLSGS-IPACFSNMT-----FLKVLSLGSNELT 306
           PD         L     +L    L  N    S I     +       +  V         
Sbjct: 300 PDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHV--------- 350

Query: 307 SIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDF--SMNNFSGIIPMEIGSLK 364
               N   L  I++ +L  N      P E R +   + + F  S +     IP  +    
Sbjct: 351 ----NCDKLTTIIESSL--NVLE---PAEYRKMFDRLSV-FPPSAH-----IPTIL---- 391

Query: 365 NLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKL 424
            L  ++ +   +  S      + +   SL +       TI         +  + L     
Sbjct: 392 -LSLIWFD---VIKSDVMVVVNKLHKYSL-VEKQPKESTI--------SIPSIYL----- 433

Query: 425 KGEIPRGGSFGNFSAESFKGNELLCGSPNLQVPPCKASIHRTSRKNALILGIVLPFSTIF 484
                                EL     N      + ++HR+                  
Sbjct: 434 ---------------------ELKVKLEN------EYALHRS------------------ 448

Query: 485 MTAIILFIIKYQKREKGPPNDPNMPPVAT-WRRFSY----LELFQATDKFSENNLIGRGG 539
                  +  Y   +    +D   P +   +  +S+    L+  +  ++ +         
Sbjct: 449 ------IVDHYNIPKTFDSDDLIPPYLDQYF--YSHIGHHLKNIEHPERMTL-------- 492

Query: 540 FGSVY------KARIR-DGMEVAVK--VFN-LQCGRAFKSFDVECAMMKSIRHRNLVKVI 589
           F  V+      + +IR D         + N LQ  + +K +         I         
Sbjct: 493 FRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPY---------I--------- 534

Query: 590 SSCSNE-EFKALV---LEYMPHGSLEKYLHSSNYSLDIFQR 626
             C N+ +++ LV   L+++P   +E+ L  S Y+ D+ + 
Sbjct: 535 --CDNDPKYERLVNAILDFLP--KIEENLICSKYT-DLLRI 570

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 51.6 bits (124), Expect = 6e-07
 Identities = 52/331 (15%), Positives = 94/331 (28%), Gaps = 71/331 (21%)

Query: 140 NLRNLEWLTLYDNNLTSSTLDLSFLSSL--SNCKSLTHISLSNNPL--DGILPRTYVGNL 195
              ++  L L  N+L     +   L  +  +   ++T ++LS N L             L
Sbjct: 49  TPASVTSLNLSGNSLGFK--NSDELVQILAAIPANVTSLNLSGNFLSYKS------SDEL 100

Query: 196 SHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKL-----QKLQDV 250
             +L                       +T + LG N  +        +        +  +
Sbjct: 101 VKTLAA-----------------IPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSL 143

Query: 251 DLEYNQLEGSIPDSICLSVE-----LYELELGGNKLSGS-----IPACFSNMTFLKVLSL 300
           +L  N L     D +   +      +  L L GN L+            S    +  L L
Sbjct: 144 NLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDL 203

Query: 301 GSNELTSIPLNFWS--LKD----ILDLNLSSNCFSGP----LPLEIRNLKALIEIDFSMN 350
            +N L        +         ++ LNL  NC  GP    L L   +LK L  +    +
Sbjct: 204 SANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYD 263

Query: 351 NFSGIIPMEIGSL-------KNLENLFLEYNRLEGSIPDSFGDLI-----SLKSLNLSYN 398
               +   +  +L       + +  +      +  S      +LI          +L   
Sbjct: 264 IVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQ 323

Query: 399 NLS-----GTIPVSLEKLSYLKDLNLSFNKL 424
            L       T    L     L++   +   L
Sbjct: 324 CLIFAQKHQTNIEDLNIPDELRESIQTCKPL 354

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 48.9 bits (117), Expect = 3e-06
 Identities = 46/312 (14%), Positives = 96/312 (30%), Gaps = 57/312 (18%)

Query: 152 NNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSH---SLKNFYMYNCN 208
             LT            S    +T + LS N L  I     +   ++   S+ +  +   +
Sbjct: 3   YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNS 62

Query: 209 VSGGIPEEI-----TNLTDLTTIVLGGNKLNGSIPITLGKL-----QKLQDVDLEYNQLE 258
           +     +E+         ++T++ L GN L+      L K        +  +DL +N   
Sbjct: 63  LGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFS 122

Query: 259 GSIPDSICLSVE-----LYELELGGNKLSGS-----IPACFSNMTFLKVLSLGSNELTSI 308
                    +       +  L L GN L        I    +    +  L+L  N L S 
Sbjct: 123 SKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASK 182

Query: 309 PLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSL----- 363
                +  ++     S                ++  +D S N        E+  +     
Sbjct: 183 -----NCAELAKFLASIPA-------------SVTSLDLSANLLGLKSYAELAYIFSSIP 224

Query: 364 KNLENLFLEYNRLEGS----IPDSFGDLISLKSLNLSYNNLSGTIPV-------SLEKLS 412
            ++ +L L  N L G     +      L  L+++ L Y+ +             +   + 
Sbjct: 225 NHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQ 284

Query: 413 YLKDLNLSFNKL 424
            +  ++ +  ++
Sbjct: 285 KIILVDKNGKEI 296

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 46.2 bits (110), Expect = 2e-05
 Identities = 60/356 (16%), Positives = 110/356 (30%), Gaps = 75/356 (21%)

Query: 21  SNLKVLYLYNNRLQGEIIHEIG-----HLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFA 75
             +  L L  N L      E+         ++  L+LS N L       +  +       
Sbjct: 22  HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81

Query: 76  VTNNSLSGCLSSITDVGLP-----------NLEVLYLWGNNFSGTIPHFIFNA-----SK 119
           VT+ +LSG    ++                 + VL L  N+FS         A     + 
Sbjct: 82  VTSLNLSGN--FLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPAS 139

Query: 120 LSKLALEMNSFS-----GFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSL--SNCKS 172
           ++ L L  N          I        N+  L L  NNL S     + L+    S   S
Sbjct: 140 ITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKN--CAELAKFLASIPAS 197

Query: 173 LTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNK 232
           +T + LS N L           L++   +                     + ++ L  N 
Sbjct: 198 VTSLDLSANLLGLKS----YAELAYIFSS-----------------IPNHVVSLNLCLNC 236

Query: 233 LNGS----IPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVE-------LYELELGGNKL 281
           L+G     + +    L+ LQ V L+Y+ ++    +              +  ++  G ++
Sbjct: 237 LHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEI 296

Query: 282 SGSIPACFSNM-----TFLKVLSLGSNELTSIPLNFWSL------KDILDLNLSSN 326
             S     SN+         V SL +  L     +  ++       ++ +   +  
Sbjct: 297 HPSHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCK 352

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 45.5 bits (108), Expect = 5e-05
 Identities = 34/267 (12%), Positives = 85/267 (31%), Gaps = 49/267 (18%)

Query: 21  SNLKVLYLYNNRLQGEIIHEIGHL-----HNLGFLDLSQNKLLGTIPAAIFNVSTLKAFA 75
             + VL L  N    +   E          ++  L+L  N L   I ++   +  L A  
Sbjct: 109 FTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDL--GIKSSDELIQILAAIP 166

Query: 76  VTNNSLSGCLSSITDVGL-----------PNLEVLYLWGNNFSGT-----IPHFIFNASK 119
              NSL+   +++                 ++  L L  N             F    + 
Sbjct: 167 ANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNH 226

Query: 120 LSKLALEMNSFSG----FIPSTFGNLRNLEWLTLYDNNLTSSTLDL--SFLSSLSNCKSL 173
           +  L L +N   G     +     +L++L+ + L  + + + + +   +  ++  N + +
Sbjct: 227 VVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKI 286

Query: 174 THISLSNNPL--DGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGN 231
             +  +   +     +       +S+ ++     +         ++ +L +   I    +
Sbjct: 287 ILVDKNGKEIHPSHSI------PISNLIRE---LSGKA------DVPSLLNQCLIFAQKH 331

Query: 232 KLNGSIPITLGKLQKLQDVDLEYNQLE 258
           + N      L    +L++       L 
Sbjct: 332 QTNIED---LNIPDELRESIQTCKPLL 355

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 51.0 bits (122), Expect = 8e-07
 Identities = 44/237 (18%), Positives = 77/237 (32%), Gaps = 48/237 (20%)

Query: 17  IDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQ-----NKLLGTIPAAIFNVSTL 71
           +   S L+ L L   RL   I++ +    NL  L+LS         L T+ ++   +  L
Sbjct: 114 LSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDEL 173

Query: 72  KAFAVTNNSLSGCLSSITDVGL--------PNLEVLYLWGNNFS---GTIPHFIFNASKL 120
                   +LS C    T+  +          +  L L G   +     +   +     L
Sbjct: 174 --------NLSWC-FDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNL 224

Query: 121 SKLALEMNSF-SGFIPSTFGNLRNLEWLTLYD-NNLTSSTLDLSFLSSLSNCKSLTHISL 178
             L L  +          F  L  L+ L+L    ++   T     L  L    +L  + +
Sbjct: 225 VHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPET-----LLELGEIPTLKTLQV 279

Query: 179 SNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNG 235
                 GI+P   +  L  +L +    NC          ++ T +    +G  K   
Sbjct: 280 F-----GIVPDGTLQLLKEALPHL-QINC----------SHFTTIARPTIGNKKNQE 320

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 49.6 bits (119), Expect = 2e-06
 Identities = 40/226 (17%), Positives = 79/226 (34%), Gaps = 52/226 (23%)

Query: 534 LIGRGGFGSVYKA--RIRDGMEVAVKVFNLQCGRAFKSF----DVECAMMKSIRHR---- 583
            +G G FG V +       G  VAVK+      +    +      E  +++ +       
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIV-----KNVDRYCEAARSEIQVLEHLNTTDPNS 75

Query: 584 --NLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNY---SLDIFQRLNIMIDVASALE 638
               V+++    +     +V E +   S   ++  + +    LD  ++  +   +  ++ 
Sbjct: 76  TFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRK--MAYQICKSVN 132

Query: 639 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS----------MTQTQ 688
           +LH   S  + H DLKP N+L   +      +  I +                      +
Sbjct: 133 FLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDE 189

Query: 689 TLATI----GYMAPE------YGREGQVSTNGDVYSFGIMLMETFT 724
             +T+     Y APE      +      S   DV+S G +L+E + 
Sbjct: 190 HHSTLVSTRHYRAPEVILALGW------SQPCDVWSIGCILIEYYL 229

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 47.2 bits (113), Expect = 3e-06
 Identities = 34/98 (34%), Positives = 48/98 (48%), Gaps = 14/98 (14%)

Query: 92  GLP-NLEVLYLWGNNFSGTIPHFIFNA-SKLSKLALEMNSFSGFIPSTFGNLRNLEWLTL 149
           G+P   +VLYL+ N  +  +   +F+  ++L++L L+ N  +      F  L  L  L+L
Sbjct: 27  GIPTTTQVLYLYDNQIT-KLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSL 85

Query: 150 YDNNLTS---STLDLSFLSSLSNCKSLTHISLSNNPLD 184
            DN L S      D        N KSLTHI L NNP D
Sbjct: 86  NDNQLKSIPRGAFD--------NLKSLTHIWLLNNPWD 115

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 46.8 bits (112), Expect = 5e-06
 Identities = 31/96 (32%), Positives = 45/96 (46%), Gaps = 17/96 (17%)

Query: 237 IPITLGKLQKLQDVDLEYNQLEGSIP----DSICLSVELYELELGGNKLSGSIPA-CFSN 291
           IP T   L       L  NQ+   +     D +    +L  L+L  N+L+  +PA  F  
Sbjct: 28  IPTTTQVL------YLYDNQIT-KLEPGVFDRL---TQLTRLDLDNNQLT-VLPAGVFDK 76

Query: 292 MTFLKVLSLGSNELTSIPLN-FWSLKDILDLNLSSN 326
           +T L  LSL  N+L SIP   F +LK +  + L +N
Sbjct: 77  LTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWLLNN 112

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 45.7 bits (109), Expect = 1e-05
 Identities = 24/68 (35%), Positives = 37/68 (54%), Gaps = 3/68 (4%)

Query: 365 NLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSL-EKLSYLKDLNLSFNK 423
             + L+L  N++    P  F  L  L  L+L  N L+  +P  + +KL+ L  L+L+ N+
Sbjct: 31  TTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQLTQLSLNDNQ 89

Query: 424 LKGEIPRG 431
           LK  IPRG
Sbjct: 90  LKS-IPRG 96

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 46.9 bits (112), Expect = 4e-06
 Identities = 30/96 (31%), Positives = 42/96 (43%), Gaps = 17/96 (17%)

Query: 237 IPITLGKLQKLQDVDLEYNQLEGSIP----DSICLSVELYELELGGNKLSGSIPA-CFSN 291
           IP    +L       L  NQ+   +     D +   V L +L    NKL+ +IP   F  
Sbjct: 31  IPTDKQRL------WLNNNQIT-KLEPGVFDHL---VNLQQLYFNSNKLT-AIPTGVFDK 79

Query: 292 MTFLKVLSLGSNELTSIPLN-FWSLKDILDLNLSSN 326
           +T L  L L  N L SIP   F +LK +  + L +N
Sbjct: 80  LTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYLYNN 115

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 46.5 bits (111), Expect = 5e-06
 Identities = 31/98 (31%), Positives = 42/98 (42%), Gaps = 14/98 (14%)

Query: 92  GLP-NLEVLYLWGNNFSGTIPHFIFNA-SKLSKLALEMNSFSGFIPSTFGNLRNLEWLTL 149
           G+P + + L+L  N  +  +   +F+    L +L    N  +      F  L  L  L L
Sbjct: 30  GIPTDKQRLWLNNNQIT-KLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDL 88

Query: 150 YDNNLTS---STLDLSFLSSLSNCKSLTHISLSNNPLD 184
            DN+L S      D        N KSLTHI L NNP D
Sbjct: 89  NDNHLKSIPRGAFD--------NLKSLTHIYLYNNPWD 118

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 45.7 bits (109), Expect = 1e-05
 Identities = 24/68 (35%), Positives = 39/68 (57%), Gaps = 3/68 (4%)

Query: 365 NLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSL-EKLSYLKDLNLSFNK 423
           + + L+L  N++    P  F  L++L+ L  + N L+  IP  + +KL+ L  L+L+ N 
Sbjct: 34  DKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQLTQLDLNDNH 92

Query: 424 LKGEIPRG 431
           LK  IPRG
Sbjct: 93  LKS-IPRG 99

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 44.9 bits (105), Expect = 7e-05
 Identities = 32/185 (17%), Positives = 57/185 (30%), Gaps = 20/185 (10%)

Query: 18  DNISNLKVLYLYNNRLQGEIIHEIGH------LHNLGFLDLSQNKLLGTIPAAIFNVSTL 71
           +  ++ + L+  +   + + I  I        L  +  L+  + K    +         L
Sbjct: 136 EKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNL 195

Query: 72  KAFAVTNNSLSG-CLSSITDVGLPNLEVLYLW-------GNNFSGTIPHFIFNAS--KLS 121
           K+  + +  L    +  I    LPNLE L L+        +                 L 
Sbjct: 196 KSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLK 255

Query: 122 KLALEMNSFSGFIPSTFGN---LRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISL 178
            L +        +   F     L  LE + +    LT     L  L  +   K L  I++
Sbjct: 256 WLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARL-LLDHVDKIKHLKFINM 314

Query: 179 SNNPL 183
             N L
Sbjct: 315 KYNYL 319

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 44.9 bits (105), Expect = 8e-05
 Identities = 21/124 (16%), Positives = 50/124 (40%), Gaps = 20/124 (16%)

Query: 320 DLNLSSNCFSGPLPLEIR-----NLKALIEIDFSMNNFSGIIPMEI-------GSLKNLE 367
            L + S      +  +I      NL+ L  +   + ++     M +           NL+
Sbjct: 197 SLEIISGGLPDSVVEDILGSDLPNLEKL-VLYVGVEDYGFDGDMNVFRPLFSKDRFPNLK 255

Query: 368 NLFLEYNRLEGSIPDSFGD---LISLKSLNLSYNNLSGT----IPVSLEKLSYLKDLNLS 420
            L +     +  + + F +   L  L+++++S   L+      +   ++K+ +LK +N+ 
Sbjct: 256 WLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMK 315

Query: 421 FNKL 424
           +N L
Sbjct: 316 YNYL 319

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 42.8 bits (101), Expect = 3e-04
 Identities = 26/184 (14%), Positives = 46/184 (25%), Gaps = 48/184 (26%)

Query: 19  NISNLKVLYLYNNRLQGEIIHEIG-HLHNLGFLDLSQNKL-------LGTIPAAIFNVST 70
               L  + L + +L    +  +         L L  N L       L      + +   
Sbjct: 99  GRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRD--LLLHDQCQ 156

Query: 71  LKAFAVTNNSLSGCLSSITDVGL----------PNLEVLYLWGNNFSGTIPHFIFNASKL 120
           +         LS     +T  G+           ++  L L                  L
Sbjct: 157 ITTL-----RLSNN--PLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDE------GLELL 203

Query: 121 SKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSN 180
           +   L+ N               L+ L +  N    +   L+   +     SL  + L  
Sbjct: 204 AA-QLDRNR-------------QLQELNVAYNGAGDTAA-LALARAAREHPSLELLHLYF 248

Query: 181 NPLD 184
           N L 
Sbjct: 249 NELS 252

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	824
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	100.0
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	100.0
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	100.0
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	99.98
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.98
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.96
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.96
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.96
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.96
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.96
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.96
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.96
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.96
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.96
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.96
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.96
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.96
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.96
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.96
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.95
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.95
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.95
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.95
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.95
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.95
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.95
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.95
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.94
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.93
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.93
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.93
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.93
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.92
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.92
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.92
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.91
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.91
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.91
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.91
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.9
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.9
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.9
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.9
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.89
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.89
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.89
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.88
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.88
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.88
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.88
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.88
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.88
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.88
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.87
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.87
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.87
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.84
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.83
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.82
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.81
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.81
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.81
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.81
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.81
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.8
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.8
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.8
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.8
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.78
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.78
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.78
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.77
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.77
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.77
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.76
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.76
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.75
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.75
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.75
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.74
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.74
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.74
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.73
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.73
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.73
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.71
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.71
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.7
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.69
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.66
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.65
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.65
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.65
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.63
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.63
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.61
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.6
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.6
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.58
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.57
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.55
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.53
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.51
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.49
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.47
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.47
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.46
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.44
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.42
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.4
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.3
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.29
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	99.29
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.28
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	99.22
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.14
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.94
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.91
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.91
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.85
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.58
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.56
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.47
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.47
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.43
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.43
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.42
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.39
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.23
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.22
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.96
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.88
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.86
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.83
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.72
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.71
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.58
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.44
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.42
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.39
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.39
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.23
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.15
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.08
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.05
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	97.01
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.96
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.93
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.77
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	96.68
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.33
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.28
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.05
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	94.02
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	86.08
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	81.29

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=1.4e-57  Score=544.06  Aligned_cols=453  Identities=32%  Similarity=0.530  Sum_probs=327.1

Q ss_pred             CcccccccccCCcccccCCCCCcEEEccCCcccccccccccCCCCCCEEeCCCCcCCcccChhhhCcCCCceeeccCCcc
Q 040845            2 PSIINNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSL   81 (824)
Q Consensus         2 ~~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l   81 (824)
                      |+|.+|++++.+|. |+++++|++|+|++|++++.+|..|+++++|++|+|++|++++.+|..  .+++|++|++++|++
T Consensus       205 L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L~~n~l  281 (768)
T 3rgz_A          205 LDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKF  281 (768)
T ss_dssp             EECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECCSSCCEESCCCC--CCTTCCEEECCSSEE
T ss_pred             EECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECCCCcccCccCcc--ccCCCCEEECcCCcc
Confidence            34555555555554 555555555555555555555555555555555555555555444433  455555555555555


Q ss_pred             ccccCccccCCCCCccEEEccCCeeeeecCccccCCCCCceEeccCccccccCCcc-ccCCCCCCEEEccCCcCC-CCcC
Q 040845           82 SGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPST-FGNLRNLEWLTLYDNNLT-SSTL  159 (824)
Q Consensus        82 ~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~-~~~l~~L~~L~L~~n~i~-~~~~  159 (824)
                      ++..+......+++|++|+|++|++++.+|..|..+++|++|+|++|++++.+|.. |.++++|++|++++|+++ .++.
T Consensus       282 ~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~  361 (768)
T 3rgz_A          282 TGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPE  361 (768)
T ss_dssp             EESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCT
T ss_pred             CCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccH
Confidence            53322222222466667777777666666666666677777777777666555544 666666666766666665 2221


Q ss_pred             ccc-------------------ccccCCC--CCCCcEEECcCCCCCccCCccccccccccccEEEeecCcceecCCccCC
Q 040845          160 DLS-------------------FLSSLSN--CKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEIT  218 (824)
Q Consensus       160 ~~~-------------------~~~~l~~--l~~L~~L~Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~  218 (824)
                      .+.                   .+..+..  +++|++|++++|.+.+..|..+..  .++|+.|++++|++++.+|..+.
T Consensus       362 ~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~--l~~L~~L~Ls~N~l~~~~p~~l~  439 (768)
T 3rgz_A          362 SLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSN--CSELVSLHLSFNYLSGTIPSSLG  439 (768)
T ss_dssp             THHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGG--CTTCCEEECCSSEEESCCCGGGG
T ss_pred             HHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhc--CCCCCEEECcCCcccCcccHHHh
Confidence            110                   0111222  455666666666655555554432  34677777777777777777777


Q ss_pred             CCCCCCEEEecCCccCCccchhhcCCCCCCEEEcccccCcccCCccccccCCccEEEccCccccccCCccccCCCCCcEE
Q 040845          219 NLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVL  298 (824)
Q Consensus       219 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L  298 (824)
                      .+++|+.|++++|.+.+..|..|..+++|++|++++|++++..|..+..+++|+.|++++|++++..|..++.+++|++|
T Consensus       440 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  519 (768)
T 3rgz_A          440 SLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAIL  519 (768)
T ss_dssp             GCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEE
T ss_pred             cCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEE
Confidence            77777777777777777777777777788888888888877777778888888888888888887788888888888888


Q ss_pred             EcCCCCCC-CCCCcccccccccccccccccccCcCCccc-----------------------------------------
Q 040845          299 SLGSNELT-SIPLNFWSLKDILDLNLSSNCFSGPLPLEI-----------------------------------------  336 (824)
Q Consensus       299 ~L~~N~l~-~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~-----------------------------------------  336 (824)
                      +|++|+++ .+|..+..+++|+.|++++|++.+.+|..+                                         
T Consensus       520 ~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  599 (768)
T 3rgz_A          520 KLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGI  599 (768)
T ss_dssp             ECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTC
T ss_pred             ECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccc
Confidence            88888887 677778888888888888888876666433                                         


Q ss_pred             -----------------------------cccccchhhhcccccccccCCCccCCCCCCCeEEccCccccccCCcccccc
Q 040845          337 -----------------------------RNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDL  387 (824)
Q Consensus       337 -----------------------------~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  387 (824)
                                                   ..+++|+.|||++|++++.+|..|+.+++|+.|+|++|++++.+|..|+.+
T Consensus       600 ~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L  679 (768)
T 3rgz_A          600 RSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDL  679 (768)
T ss_dssp             CGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGC
T ss_pred             cchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCC
Confidence                                         335678889999999999999999999999999999999999999999999


Q ss_pred             ccccEEEccCcccCCCCcccccCCcccceeeccCCcccCCCCCCCCccccccccccCCccccCCCCCCCCCCCCc
Q 040845          388 ISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIPRGGSFGNFSAESFKGNELLCGSPNLQVPPCKAS  462 (824)
Q Consensus       388 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~~~~~~~c~~~  462 (824)
                      ++|+.|||++|+++|.+|..+..+++|+.|++++|+++|.+|..+++..+...+|.|||.+||.|.   ++|...
T Consensus       680 ~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l---~~C~~~  751 (768)
T 3rgz_A          680 RGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPL---PRCDPS  751 (768)
T ss_dssp             TTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTS---CCCCSC
T ss_pred             CCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCC---cCCCCC
Confidence            999999999999999999999999999999999999999999999999999999999999999884   367644

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=3.4e-54  Score=449.53  Aligned_cols=261  Identities=29%  Similarity=0.456  Sum_probs=218.8

Q ss_pred             ccCCCCceeeeccceEEEEEEEC------CCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEE
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR------DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKAL  600 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  600 (824)
                      ++|.+.+.||+|+||+||+|++.      ++..||||+++.......++|.+|+++|++++|||||+++|+|.+++..++
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            56888899999999999999864      478899999986655667889999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhhCC------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEE
Q 040845          601 VLEYMPHGSLEKYLHSSN------------YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHL  668 (824)
Q Consensus       601 v~e~~~~g~L~~~l~~~~------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl  668 (824)
                      ||||+++|+|.++++..+            ..+++.+++.++.|||+||+|||   +++|+||||||+|||+++++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcEEE
Confidence            999999999999997642            46899999999999999999999   899999999999999999999999


Q ss_pred             eecccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhC
Q 040845          669 SDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCL  747 (824)
Q Consensus       669 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~  747 (824)
                      +|||+|+.....+.........||+.|||||++.++.|+.++|||||||++|||+| |+.||.+....  .....+... 
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~--~~~~~i~~~-  246 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN--EVIECITQG-  246 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHHHHHHHT-
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHcC-
Confidence            99999987654444434445569999999999999999999999999999999999 89999764221  111111110 


Q ss_pred             CCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhc
Q 040845          748 PISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLL  810 (824)
Q Consensus       748 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~  810 (824)
                                       .....|..|+.++.+||.+||+.||++||||+|+++.|+++.++.+
T Consensus       247 -----------------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~p  292 (299)
T 4asz_A          247 -----------------RVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASP  292 (299)
T ss_dssp             -----------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred             -----------------CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCC
Confidence                             0112234577889999999999999999999999999999876543

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=9.8e-54  Score=452.47  Aligned_cols=260  Identities=28%  Similarity=0.461  Sum_probs=210.9

Q ss_pred             ccCCCCceeeeccceEEEEEEEC------CCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEE
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR------DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKAL  600 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  600 (824)
                      ++|.+.+.||+|+||+||+|+++      +++.||||+++.......++|.+|+++|++++|||||+++|+|.+++..++
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            46777889999999999999875      478899999976655667889999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhhCC--------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcE
Q 040845          601 VLEYMPHGSLEKYLHSSN--------------YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVA  666 (824)
Q Consensus       601 v~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~  666 (824)
                      ||||+++|+|.++++...              ..+++.+++.|+.|||+||+|||   +++||||||||+|||+++++.+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCCcE
Confidence            999999999999997643              35899999999999999999999   8999999999999999999999


Q ss_pred             EEeecccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhh
Q 040845          667 HLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVND  745 (824)
Q Consensus       667 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~  745 (824)
                      ||+|||+|+.....+.....+...||+.|||||++.+..++.++|||||||++|||+| |+.||.+....+  ....+..
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~--~~~~i~~  275 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE--AIDCITQ  275 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH--HHHHHHH
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH--HHHHHHc
Confidence            9999999987755444444455679999999999999999999999999999999999 899997632211  1111111


Q ss_pred             hCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhh
Q 040845          746 CLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSL  809 (824)
Q Consensus       746 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~  809 (824)
                                        ..+...|..|++++.+||.+||+.||++||||+||+++|+.+.++.
T Consensus       276 ------------------g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~p  321 (329)
T 4aoj_A          276 ------------------GRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP  321 (329)
T ss_dssp             ------------------TCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSC
T ss_pred             ------------------CCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCC
Confidence                              0112223467788999999999999999999999999999987653

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=3.6e-53  Score=441.37  Aligned_cols=264  Identities=27%  Similarity=0.448  Sum_probs=210.1

Q ss_pred             hccCCCCceeeeccceEEEEEEECCCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEe
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLE  603 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  603 (824)
                      .+++.+.+.||+|+||+||+|+++  ..||||+++...  .+..+.|.+|++++++++|||||+++|++.+ +..++|||
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE  111 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ  111 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence            467888999999999999999876  369999986442  3345789999999999999999999999865 56799999


Q ss_pred             ccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 040845          604 YMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS  683 (824)
Q Consensus       604 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  683 (824)
                      |+++|+|.++++.....+++.++..|+.|||+||+|||   +++||||||||+|||+++++.+||+|||+|+........
T Consensus       112 y~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~  188 (307)
T 3omv_A          112 WCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS  188 (307)
T ss_dssp             CCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence            99999999999877778999999999999999999999   899999999999999999999999999999876543333


Q ss_pred             cccccccccccccCccCcC---CCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhcccccc
Q 040845          684 MTQTQTLATIGYMAPEYGR---EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLL  760 (824)
Q Consensus       684 ~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  760 (824)
                      .......||+.|||||++.   .+.|+.++|||||||++|||+||+.||.+..... .....+......       +.. 
T Consensus       189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~-~~~~~~~~~~~~-------p~~-  259 (307)
T 3omv_A          189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD-QIIFMVGRGYAS-------PDL-  259 (307)
T ss_dssp             -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-HHHHHHHTTCCC-------CCS-
T ss_pred             eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH-HHHHHHhcCCCC-------CCc-
Confidence            3445567999999999885   3468999999999999999999999997632211 111111111100       000 


Q ss_pred             CchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhc
Q 040845          761 SQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLL  810 (824)
Q Consensus       761 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~  810 (824)
                            ...+.+|+..+.+||.+||+.||++||||.||+++|+.++.+++
T Consensus       260 ------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp  303 (307)
T 3omv_A          260 ------SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP  303 (307)
T ss_dssp             ------TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred             ------ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence                  01123567889999999999999999999999999999877664

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=4.7e-52  Score=496.38  Aligned_cols=435  Identities=34%  Similarity=0.514  Sum_probs=364.3

Q ss_pred             CcccccccccCCcccccCCCCCcEEEccCCcccccccccccCCCCCCEEeCCCCcCCcccChhhhCcCCCceeeccCCcc
Q 040845            2 PSIINNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSL   81 (824)
Q Consensus         2 ~~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l   81 (824)
                      |++.+|.+++..|.  ..+++|++|+|++|++++.+|. ++++++|++|+|++|++++.+|.++.++++|++|+|++|++
T Consensus       183 L~Ls~n~l~~~~~~--~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~l  259 (768)
T 3rgz_A          183 LAISGNKISGDVDV--SRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQF  259 (768)
T ss_dssp             EECCSSEEESCCBC--TTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECCSSCC
T ss_pred             EECCCCcccccCCc--ccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECCCCcc
Confidence            45566666665553  7888888889999988877776 99999999999999999988999999999999999999999


Q ss_pred             ccccCccccCCCCCccEEEccCCeeeeecCccccCC-CCCceEeccCccccccCCccccCCCCCCEEEccCCcCC-CCcC
Q 040845           82 SGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNA-SKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLT-SSTL  159 (824)
Q Consensus        82 ~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l-~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~-~~~~  159 (824)
                      ++..+..   .+++|++|+|++|++++.+|..+... ++|++|+|++|++++.+|..|+++++|++|++++|.++ .++.
T Consensus       260 ~~~~~~~---~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~  336 (768)
T 3rgz_A          260 VGPIPPL---PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPM  336 (768)
T ss_dssp             EESCCCC---CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCH
T ss_pred             cCccCcc---ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCH
Confidence            8765554   58999999999999999999988876 99999999999999999999999999999999999987 4442


Q ss_pred             cccccccCCCCCCCcEEECcCCCCCccCCcccccc-------------------------ccccccEEEeecCcceecCC
Q 040845          160 DLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGN-------------------------LSHSLKNFYMYNCNVSGGIP  214 (824)
Q Consensus       160 ~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~-------------------------l~~~L~~L~l~~n~l~~~~~  214 (824)
                           ..+..+++|++|++++|.+.+..|..+...                         ...+|++|++++|++++.+|
T Consensus       337 -----~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p  411 (768)
T 3rgz_A          337 -----DTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIP  411 (768)
T ss_dssp             -----HHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECC
T ss_pred             -----HHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccC
Confidence                 226777888888888888776555443221                         13467778888888877888


Q ss_pred             ccCCCCCCCCEEEecCCccCCccchhhcCCCCCCEEEcccccCcccCCccccccCCccEEEccCccccccCCccccCCCC
Q 040845          215 EEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTF  294 (824)
Q Consensus       215 ~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~  294 (824)
                      ..+.++++|+.|+|++|.+++..|..|..+++|++|++++|++.+..|..+..+++|++|++++|++++..|..+.++++
T Consensus       412 ~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~  491 (768)
T 3rgz_A          412 PTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTN  491 (768)
T ss_dssp             GGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTT
T ss_pred             HHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCC
Confidence            88888888888888888888888888888888888888888888888888888888888888888888888888888888


Q ss_pred             CcEEEcCCCCCC-CCCCcccccccccccccccccccCcCCccccccccchhhhcccccccccCCCc--------------
Q 040845          295 LKVLSLGSNELT-SIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPME--------------  359 (824)
Q Consensus       295 L~~L~L~~N~l~-~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~--------------  359 (824)
                      |++|+|++|+++ .+|..+..+++|+.|++++|++.+.+|..+.++++|+.|++++|++++.+|..              
T Consensus       492 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~  571 (768)
T 3rgz_A          492 LNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIA  571 (768)
T ss_dssp             CCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTC
T ss_pred             CCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccc
Confidence            999999999888 67878888888999999999988888888888999999999988887666543              


Q ss_pred             --------------------------------------------------------cCCCCCCCeEEccCccccccCCcc
Q 040845          360 --------------------------------------------------------IGSLKNLENLFLEYNRLEGSIPDS  383 (824)
Q Consensus       360 --------------------------------------------------------~~~l~~L~~L~L~~N~l~~~~~~~  383 (824)
                                                                              ++.+++|+.|+|++|++++.+|..
T Consensus       572 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~  651 (768)
T 3rgz_A          572 GKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKE  651 (768)
T ss_dssp             SCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGG
T ss_pred             cccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHH
Confidence                                                                    334577888999999999889999


Q ss_pred             ccccccccEEEccCcccCCCCcccccCCcccceeeccCCcccCCCCCC-CCccccccccccCCcc
Q 040845          384 FGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIPRG-GSFGNFSAESFKGNEL  447 (824)
Q Consensus       384 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~~~~~~~~~~~n~~  447 (824)
                      |+.+++|+.|+|++|+++|.+|..+..+++|+.|+|++|+++|.+|.. ..+..+..+.+.+|+.
T Consensus       652 l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l  716 (768)
T 3rgz_A          652 IGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNL  716 (768)
T ss_dssp             GGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEE
T ss_pred             HhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcc
Confidence            999999999999999999999999999999999999999999888863 4466677777888864

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2e-53  Score=445.77  Aligned_cols=256  Identities=25%  Similarity=0.426  Sum_probs=213.7

Q ss_pred             ccCCCCceeeeccceEEEEEEEC------CCcEEEEEEeecccc-chhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeE
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR------DGMEVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKA  599 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  599 (824)
                      .++++.+.||+|+||+||+|++.      +++.||||+++.... ...+.|.+|+.++++++|||||+++|+|.+++..+
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            34566789999999999999873      468899999865433 34578999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHhhhCC---------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC
Q 040845          600 LVLEYMPHGSLEKYLHSSN---------------YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM  664 (824)
Q Consensus       600 lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~  664 (824)
                      +||||+++|+|.+++....               ..+++.++..++.|||+||+|||   +++||||||||+|||+++++
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEECCCC
Confidence            9999999999999996532               35899999999999999999999   99999999999999999999


Q ss_pred             cEEEeecccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhh
Q 040845          665 VAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWV  743 (824)
Q Consensus       665 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~  743 (824)
                      .+||+|||+|+.....+.....+...||+.|||||++.++.|+.++|||||||++|||+| |+.||.+....  .....+
T Consensus       183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~--~~~~~i  260 (308)
T 4gt4_A          183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ--DVVEMI  260 (308)
T ss_dssp             CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH--HHHHHH
T ss_pred             CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH--HHHHHH
Confidence            999999999987755444444455679999999999999999999999999999999999 89998763221  112111


Q ss_pred             hhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 040845          744 NDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKI  805 (824)
Q Consensus       744 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~  805 (824)
                      ...                  ...+.+..|+..+.+||.+||+.||++||||+||+++|+++
T Consensus       261 ~~~------------------~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          261 RNR------------------QVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             HTT------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             HcC------------------CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            110                  11123446788899999999999999999999999999764

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=1.8e-51  Score=480.43  Aligned_cols=446  Identities=21%  Similarity=0.187  Sum_probs=361.9

Q ss_pred             CcccccccccCCcccccCCCCCcEEEccCCcccccccccccCCCCCCEEeCCCCcCCcccChhhhCcCCCceeeccCCcc
Q 040845            2 PSIINNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSL   81 (824)
Q Consensus         2 ~~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l   81 (824)
                      |+|++|+|+++.|..|.++++|++|+|++|++++..|..|+++++|++|+|++|++++..|.+|.++++|++|++++|++
T Consensus        38 L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i  117 (606)
T 3t6q_A           38 LEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGI  117 (606)
T ss_dssp             EECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECTTSCC
T ss_pred             EEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeeccccCc
Confidence            67899999999999999999999999999999988899999999999999999999988899999999999999999999


Q ss_pred             ccccCccccCCCCCccEEEccCCeeeeecCccccCCCCCceEeccCccccccCCccccCCCCCC--EEEccCCcCCCCcC
Q 040845           82 SGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLE--WLTLYDNNLTSSTL  159 (824)
Q Consensus        82 ~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~--~L~L~~n~i~~~~~  159 (824)
                      +++.... ...+++|++|+|++|++++.....+..+++|++|+|++|++++..+..|+++++|+  +|++++|.++..+.
T Consensus       118 ~~l~~~~-~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~~~~~  196 (606)
T 3t6q_A          118 SSIDFIP-LHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEP  196 (606)
T ss_dssp             SCGGGSC-CTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCCEECT
T ss_pred             ccCCcch-hccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccCccCh
Confidence            8864332 24689999999999999875544555689999999999999988888889999888  88888888776543


Q ss_pred             cccc----------------------------------------------------------------------cccCCC
Q 040845          160 DLSF----------------------------------------------------------------------LSSLSN  169 (824)
Q Consensus       160 ~~~~----------------------------------------------------------------------~~~l~~  169 (824)
                      ....                                                                      ...|..
T Consensus       197 ~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~  276 (606)
T 3t6q_A          197 GAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHC  276 (606)
T ss_dssp             TTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTTTTTT
T ss_pred             hHhhhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCHHHhcc
Confidence            2100                                                                      112566


Q ss_pred             CCCCcEEECcCCCCCccCCccccccccccccEEEeecCcceecCCccCCCCCCCCEEEecCCccCCccc-hhhcCCCCCC
Q 040845          170 CKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIP-ITLGKLQKLQ  248 (824)
Q Consensus       170 l~~L~~L~Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~  248 (824)
                      +++|++|++++|.+..+++ .+. . .++|++|++++|.+.+..|..+..+++|++|++++|.+.+..+ ..|..+++|+
T Consensus       277 l~~L~~L~l~~n~l~~lp~-~l~-~-l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~  353 (606)
T 3t6q_A          277 FSGLQELDLTATHLSELPS-GLV-G-LSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLR  353 (606)
T ss_dssp             CTTCSEEECTTSCCSCCCS-SCC-S-CTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCC
T ss_pred             ccCCCEEeccCCccCCCCh-hhc-c-cccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCcCC
Confidence            6777777777777765433 221 1 3467777777777777767777777777777777777764443 3477788888


Q ss_pred             EEEcccccCcccC--CccccccCCccEEEccCccccccCCccccCCCCCcEEEcCCCCCCCCC-C-cccccccccccccc
Q 040845          249 DVDLEYNQLEGSI--PDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIP-L-NFWSLKDILDLNLS  324 (824)
Q Consensus       249 ~L~L~~n~l~~~~--~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp-~-~~~~l~~L~~L~l~  324 (824)
                      +|++++|.+++..  +..+..+++|++|++++|++.+..+..|..+++|+.|++++|+++..+ . .+..+++|+.|+++
T Consensus       354 ~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~  433 (606)
T 3t6q_A          354 ELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLS  433 (606)
T ss_dssp             EEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECT
T ss_pred             EEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECC
Confidence            8888888887655  667788888888888888888888888888888888888888887653 2 37778889999999


Q ss_pred             cccccCcCCccccccccchhhhccccccccc---CCCccCCCCCCCeEEccCccccccCCccccccccccEEEccCcccC
Q 040845          325 SNCFSGPLPLEIRNLKALIEIDFSMNNFSGI---IPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLS  401 (824)
Q Consensus       325 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~---~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  401 (824)
                      +|.+.+..|..+.++++|+.|++++|++++.   .+..+..+++|+.|++++|++++..|..|..+++|+.|+|++|+++
T Consensus       434 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~  513 (606)
T 3t6q_A          434 HSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLT  513 (606)
T ss_dssp             TCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCC
T ss_pred             CCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccC
Confidence            9998888888888899999999999998762   3356888899999999999999888888999999999999999999


Q ss_pred             CCCcccccCCcccceeeccCCcccCCCCCC-CCccccccccccCCccccCCC
Q 040845          402 GTIPVSLEKLSYLKDLNLSFNKLKGEIPRG-GSFGNFSAESFKGNELLCGSP  452 (824)
Q Consensus       402 ~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~~~~~~~~~~~n~~~c~~~  452 (824)
                      +..|..+..++.| .|++++|++++.+|.. ..+.++..+.+.+||+.|+|+
T Consensus       514 ~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~  564 (606)
T 3t6q_A          514 SSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCS  564 (606)
T ss_dssp             GGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGG
T ss_pred             cCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCC
Confidence            8889999999999 9999999999877753 446677888999999999876

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=2e-51  Score=495.94  Aligned_cols=443  Identities=21%  Similarity=0.202  Sum_probs=363.1

Q ss_pred             CcccccccccCCcccccCCCCCcEEEccCCcccccc-cccccCCCCCCEEeCCCCcCCcccChhhhCcCCCceeeccCCc
Q 040845            2 PSIINNFLTSTTPKEIDNISNLKVLYLYNNRLQGEI-IHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNS   80 (824)
Q Consensus         2 ~~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~   80 (824)
                      |+|++|.|+++.|..|.++++|++|+|++|.+.+.+ |..|+++++|++|+|++|.+++..|.+|.++++|++|+|++|+
T Consensus        29 LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~  108 (844)
T 3j0a_A           29 LLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCG  108 (844)
T ss_dssp             EEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCC
T ss_pred             EECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCC
Confidence            678999999999999999999999999999655455 7889999999999999999998889999999999999999999


Q ss_pred             ccc-ccCccccCCCCCccEEEccCCeeeeecC-ccccCCCCCceEeccCccccccCCccccCC--CCCCEEEccCCcCCC
Q 040845           81 LSG-CLSSITDVGLPNLEVLYLWGNNFSGTIP-HFIFNASKLSKLALEMNSFSGFIPSTFGNL--RNLEWLTLYDNNLTS  156 (824)
Q Consensus        81 l~~-~~~~~~~~~l~~L~~L~L~~n~i~~~~~-~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l--~~L~~L~L~~n~i~~  156 (824)
                      +++ .+....+..+++|++|+|++|.+++..+ ..|+++++|++|+|++|.+++..+..|..+  ++|+.|+++.|.++.
T Consensus       109 l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n~l~~  188 (844)
T 3j0a_A          109 LSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYS  188 (844)
T ss_dssp             CSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEECCSBSCC
T ss_pred             CCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECCCCcccc
Confidence            987 3444334579999999999999987654 579999999999999999998888888887  889999999998876


Q ss_pred             CcCcccccccCCCCC------CCcEEECcCCCCCccCCcccccc------------------------------------
Q 040845          157 STLDLSFLSSLSNCK------SLTHISLSNNPLDGILPRTYVGN------------------------------------  194 (824)
Q Consensus       157 ~~~~~~~~~~l~~l~------~L~~L~Ls~n~l~~~~~~~~~~~------------------------------------  194 (824)
                      ...     ..+..++      +|++|++++|.+.+..+..+...                                    
T Consensus       189 ~~~-----~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l  263 (844)
T 3j0a_A          189 RVS-----VDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGL  263 (844)
T ss_dssp             CCC-----CCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTT
T ss_pred             ccc-----cchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhcc
Confidence            432     1233333      48888888887765544433321                                    


Q ss_pred             ccccccEEEeecCcceecCCccCCCCCCCCEEEecCCccCCccchhhcCCCCCCEEEcccccCcccCCccccccCCccEE
Q 040845          195 LSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYEL  274 (824)
Q Consensus       195 l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L  274 (824)
                      .+.+|+.|++++|.+.+..+..|..+++|+.|+|++|++++..+.+|.++++|++|+|++|++++..+..|..+++|+.|
T Consensus       264 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  343 (844)
T 3j0a_A          264 ARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYI  343 (844)
T ss_dssp             TTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEE
T ss_pred             ccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEE
Confidence            13578888888888888888888888888888888888887778888888888888888888887778888888888888


Q ss_pred             EccCccccccCCccccCCCCCcEEEcCCCCCCCCCC-------------------c----------------------cc
Q 040845          275 ELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPL-------------------N----------------------FW  313 (824)
Q Consensus       275 ~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~-------------------~----------------------~~  313 (824)
                      ++++|++....+..|.++++|++|+|++|.++.++.                   .                      +.
T Consensus       344 ~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~L~~L~l~~N~l~~l~~~~~~l~~L~ls~N~l~~l~~~~~~~  423 (844)
T 3j0a_A          344 DLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLL  423 (844)
T ss_dssp             ECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCSSCCSCSEEEEESCCCCCCCCCCTTCCEEECCSCCCCSSTTHHHHT
T ss_pred             ECCCCCCCccChhhhcCCCCCCEEECCCCCCCcccCCCCcchhccCCCCcccccccccccceeecccCccccCchhhhhh
Confidence            888888887777788888888888888887776542                   0                      22


Q ss_pred             ccccccccccccccccCcCCc-cccccccchhhhccccccc-----ccCCCccCCCCCCCeEEccCccccccCCcccccc
Q 040845          314 SLKDILDLNLSSNCFSGPLPL-EIRNLKALIEIDFSMNNFS-----GIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDL  387 (824)
Q Consensus       314 ~l~~L~~L~l~~N~l~~~~~~-~~~~l~~L~~L~l~~N~l~-----~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  387 (824)
                      .+++|+.|+|++|++++..+. .+..+++|+.|++++|.++     +..+..|..+++|+.|+|++|+|++..|..|.++
T Consensus       424 ~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l  503 (844)
T 3j0a_A          424 RVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHL  503 (844)
T ss_dssp             TCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSC
T ss_pred             cCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccch
Confidence            567777888888887754332 3556788888888888886     3445668889999999999999998888889999


Q ss_pred             ccccEEEccCcccCCCCcccccCCcccceeeccCCcccCCCCCCCCccccccccccCCccccCCCC
Q 040845          388 ISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIPRGGSFGNFSAESFKGNELLCGSPN  453 (824)
Q Consensus       388 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~~  453 (824)
                      ++|+.|+|++|+|++..|..+.  ++|+.|+|++|++++.+|.  .+.++..+.+.+||+.|+|+.
T Consensus       504 ~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~--~~~~L~~l~l~~Np~~C~c~~  565 (844)
T 3j0a_A          504 TALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPD--VFVSLSVLDITHNKFICECEL  565 (844)
T ss_dssp             CSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSC--CCSSCCEEEEEEECCCCSSSC
T ss_pred             hhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChh--HhCCcCEEEecCCCccccccc
Confidence            9999999999999976666665  7999999999999998886  466888899999999998863

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.3e-51  Score=434.77  Aligned_cols=250  Identities=25%  Similarity=0.328  Sum_probs=211.7

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEecc
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYM  605 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  605 (824)
                      ..|++.+.||+|+||+||+|+++ +|+.||||++........+.+.+|+++|+.++|||||++++++.+++..|+||||+
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            46889999999999999999875 59999999998776666778899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccc
Q 040845          606 PHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMT  685 (824)
Q Consensus       606 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  685 (824)
                      ++|+|.+++...  .+++.++..++.||+.||+|||   +++|+||||||+|||++.+|.+||+|||+|+.+.....  .
T Consensus       154 ~gg~L~~~l~~~--~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~--~  226 (346)
T 4fih_A          154 EGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--R  226 (346)
T ss_dssp             TTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--C
T ss_pred             CCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC--c
Confidence            999999999764  5899999999999999999999   99999999999999999999999999999987643322  2


Q ss_pred             cccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhh
Q 040845          686 QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDI  765 (824)
Q Consensus       686 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  765 (824)
                      ....+||+.|||||++.+..|+.++||||+||++|||++|+.||.+...  ......+....+.                
T Consensus       227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--~~~~~~i~~~~~~----------------  288 (346)
T 4fih_A          227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMKMIRDNLPP----------------  288 (346)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHHSSCC----------------
T ss_pred             ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHHHHHHHcCCCC----------------
Confidence            3456799999999999999999999999999999999999999976321  1111111111110                


Q ss_pred             hhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          766 HFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       766 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      ....+..+++++.+|+.+||+.||++|||++|+++|
T Consensus       289 ~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H  324 (346)
T 4fih_A          289 RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  324 (346)
T ss_dssp             CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            011123456779999999999999999999999876

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=4.3e-51  Score=429.63  Aligned_cols=257  Identities=23%  Similarity=0.289  Sum_probs=210.8

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEec
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      .+.|+..++||+|+||+||+|+++ +|+.||||+++....     ..+|+.+++.++|||||++++++.+++..|+||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  131 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL  131 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            356788889999999999999875 589999999975422     24699999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC-cEEEeecccccccCCCCCc
Q 040845          605 MPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM-VAHLSDFGIAKLLTGEDQS  683 (824)
Q Consensus       605 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~Dfg~a~~~~~~~~~  683 (824)
                      +++|+|.+++...+ .+++.++..++.||+.||+|||   +++||||||||+|||++.+| .+||+|||+|+.+......
T Consensus       132 ~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~  207 (336)
T 4g3f_A          132 LEGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG  207 (336)
T ss_dssp             CTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred             cCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence            99999999998765 7999999999999999999999   99999999999999999987 6999999999877543221


Q ss_pred             ---cccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhcccccc
Q 040845          684 ---MTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLL  760 (824)
Q Consensus       684 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  760 (824)
                         ......+||+.|||||++.+..|+.++||||+||++|||+||+.||.+....+. .........             
T Consensus       208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~i~~~~~-------------  273 (336)
T 4g3f_A          208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL-CLKIASEPP-------------  273 (336)
T ss_dssp             ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC-HHHHHHSCC-------------
T ss_pred             cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH-HHHHHcCCC-------------
Confidence               122335799999999999999999999999999999999999999976443322 111111100             


Q ss_pred             CchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhh
Q 040845          761 SQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSL  809 (824)
Q Consensus       761 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~  809 (824)
                          .....+..+++.+.+++.+||+.||++|||+.|+++++....+..
T Consensus       274 ----~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~  318 (336)
T 4g3f_A          274 ----PIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV  318 (336)
T ss_dssp             ----GGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             ----CchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhh
Confidence                000122356778999999999999999999999999998887643

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=4.5e-51  Score=429.48  Aligned_cols=278  Identities=23%  Similarity=0.326  Sum_probs=204.9

Q ss_pred             ccCCCCceeeeccceEEEEEEECCCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCC----eeEEEE
Q 040845          527 DKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEE----FKALVL  602 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~  602 (824)
                      .+|.+.+.||+|+||+||+|+++ |+.||||+++.... ....++.|+..+.+++|||||++++++.+++    ..++||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            45778899999999999999985 89999999865422 1222345666677899999999999997653    579999


Q ss_pred             eccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCC-----CCCeEecCCCCCCeeeCCCCcEEEeeccccccc
Q 040845          603 EYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGY-----SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  677 (824)
Q Consensus       603 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-----~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~  677 (824)
                      ||+++|+|.++++..  .+++.++.+++.|+++||+|||+.+     ..+|+||||||+|||++.++.+||+|||+|+..
T Consensus        81 Ey~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~  158 (303)
T 3hmm_A           81 DYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  158 (303)
T ss_dssp             ECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred             cCCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence            999999999999865  5899999999999999999999321     239999999999999999999999999999876


Q ss_pred             CCCCCcc--ccccccccccccCccCcCCC------CCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCC
Q 040845          678 TGEDQSM--TQTQTLATIGYMAPEYGREG------QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPI  749 (824)
Q Consensus       678 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~------~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  749 (824)
                      .......  ......||++|||||++.+.      .++.++|||||||++|||+||++||......+.....+.......
T Consensus       159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~  238 (303)
T 3hmm_A          159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV  238 (303)
T ss_dssp             ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred             cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH
Confidence            5443321  22345799999999998654      467899999999999999999988765433322222111100000


Q ss_pred             c-chhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 040845          750 S-TMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDS  808 (824)
Q Consensus       750 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~  808 (824)
                      . ....+.................++..+.+||.+||+.||++||||.||++.|+++.++
T Consensus       239 ~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~  298 (303)
T 3hmm_A          239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             HHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence            0 0000100011111111122335677899999999999999999999999999998754

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=9.2e-52  Score=429.21  Aligned_cols=251  Identities=25%  Similarity=0.370  Sum_probs=212.1

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecc---ccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQ---CGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALV  601 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  601 (824)
                      .++|++.+.||+|+||+||+|+.+ +|+.||||++...   .....+.+.+|++++++++|||||++++++.+++..|+|
T Consensus        31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv  110 (311)
T 4aw0_A           31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG  110 (311)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            367999999999999999999865 5899999999754   234456789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 040845          602 LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED  681 (824)
Q Consensus       602 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  681 (824)
                      |||+++|+|.+++.+.+ .+++.++..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+.+....
T Consensus       111 mEy~~gG~L~~~i~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~  186 (311)
T 4aw0_A          111 LSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES  186 (311)
T ss_dssp             ECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred             EecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence            99999999999998765 7999999999999999999999   9999999999999999999999999999999876544


Q ss_pred             CccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccC
Q 040845          682 QSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLS  761 (824)
Q Consensus       682 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  761 (824)
                      ........+||+.|||||++.+..|+.++||||+||++|||+||+.||.+.... ..........+              
T Consensus       187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~-~~~~~i~~~~~--------------  251 (311)
T 4aw0_A          187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG-LIFAKIIKLEY--------------  251 (311)
T ss_dssp             TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHTCC--------------
T ss_pred             CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHcCCC--------------
Confidence            444445568999999999999999999999999999999999999999763211 11111111110              


Q ss_pred             chhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          762 QEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       762 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                            ..+..+++++.+|+.+||+.||++|||++|+..+
T Consensus       252 ------~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~  285 (311)
T 4aw0_A          252 ------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY  285 (311)
T ss_dssp             ------CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred             ------CCCcccCHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence                  0112345678999999999999999999997544

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=1.6e-49  Score=464.15  Aligned_cols=419  Identities=22%  Similarity=0.209  Sum_probs=371.9

Q ss_pred             CcccccccccCCcccccCCCCCcEEEccCCcccccccccccCCCCCCEEeCCCCcCCcccChhhhCcCCCceeeccCCcc
Q 040845            2 PSIINNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSL   81 (824)
Q Consensus         2 ~~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l   81 (824)
                      |+|++|+|+++.|.+|+++++|++|+|++|++++..|..|+++++|++|+|++|++++..+..+.++++|++|++++|++
T Consensus        62 L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l  141 (606)
T 3t6q_A           62 LDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHI  141 (606)
T ss_dssp             EECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCC
T ss_pred             EECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcc
Confidence            67899999999999999999999999999999988899999999999999999999977788899999999999999999


Q ss_pred             ccccCccccCCCCCccEEEccCCeeeeecCccccCCCCCc--eEeccCcccccc--------------------------
Q 040845           82 SGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLS--KLALEMNSFSGF--------------------------  133 (824)
Q Consensus        82 ~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~--~L~L~~N~i~~~--------------------------  133 (824)
                      ++++..... ++++|++|+|++|++++..+..+..+++|+  +|++++|.+++.                          
T Consensus       142 ~~~~~~~~~-~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~~~L~~L~l~~~~~~~~~~~  220 (606)
T 3t6q_A          142 SSIKLPKGF-PTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFK  220 (606)
T ss_dssp             CCCCCCTTC-CCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCCEECTTTTTTCEEEEEECTTCSCHHHHHH
T ss_pred             cccCccccc-CCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccCccChhHhhhccccccccCCchhHHHHhh
Confidence            986433332 488999999999999877777777777777  666666665543                          


Q ss_pred             -------------------------------------------------CCccccCCCCCCEEEccCCcCCCCcCccccc
Q 040845          134 -------------------------------------------------IPSTFGNLRNLEWLTLYDNNLTSSTLDLSFL  164 (824)
Q Consensus       134 -------------------------------------------------~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~  164 (824)
                                                                       .+..|.++++|++|++++|.++.++      
T Consensus       221 ~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~lp------  294 (606)
T 3t6q_A          221 GLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELP------  294 (606)
T ss_dssp             HTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCSCCC------
T ss_pred             hccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccCCCC------
Confidence                                                             3444777889999999999998765      


Q ss_pred             ccCCCCCCCcEEECcCCCCCccCCccccccccccccEEEeecCcceecCCc-cCCCCCCCCEEEecCCccCCcc--chhh
Q 040845          165 SSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPE-EITNLTDLTTIVLGGNKLNGSI--PITL  241 (824)
Q Consensus       165 ~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~-~l~~l~~L~~L~L~~n~l~~~~--~~~~  241 (824)
                      ..+..+++|++|++++|.+.++.+..+..  .++|++|++++|.+.+.++. .+..+++|++|++++|.+.+..  +..+
T Consensus       295 ~~l~~l~~L~~L~l~~n~l~~~~~~~~~~--l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~  372 (606)
T 3t6q_A          295 SGLVGLSTLKKLVLSANKFENLCQISASN--FPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQL  372 (606)
T ss_dssp             SSCCSCTTCCEEECTTCCCSBGGGGCGGG--CTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTT
T ss_pred             hhhcccccCCEEECccCCcCcCchhhhhc--cCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhc
Confidence            45788999999999999999887766544  46899999999999876665 4999999999999999999766  7789


Q ss_pred             cCCCCCCEEEcccccCcccCCccccccCCccEEEccCccccccCCc-cccCCCCCcEEEcCCCCCCCCC-Cccccccccc
Q 040845          242 GKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPA-CFSNMTFLKVLSLGSNELTSIP-LNFWSLKDIL  319 (824)
Q Consensus       242 ~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~~l~~L~~L~L~~N~l~~lp-~~~~~l~~L~  319 (824)
                      ..+++|++|++++|++.+..|..+..+++|+.|++++|++.+..+. .+.++++|++|++++|.++.++ ..+..+++|+
T Consensus       373 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~  452 (606)
T 3t6q_A          373 RNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQ  452 (606)
T ss_dssp             TTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCC
T ss_pred             ccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCC
Confidence            9999999999999999999999999999999999999999977654 4899999999999999999774 4578899999


Q ss_pred             ccccccccccCc---CCccccccccchhhhcccccccccCCCccCCCCCCCeEEccCccccccCCccccccccccEEEcc
Q 040845          320 DLNLSSNCFSGP---LPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLS  396 (824)
Q Consensus       320 ~L~l~~N~l~~~---~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  396 (824)
                      .|++++|++.+.   .+..+..+++|+.|++++|++++..|..|..+++|+.|+|++|++++..|..|..+++| .|+++
T Consensus       453 ~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~  531 (606)
T 3t6q_A          453 HLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLA  531 (606)
T ss_dssp             EEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECC
T ss_pred             EEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECc
Confidence            999999999862   34678999999999999999999999999999999999999999999999999999999 99999


Q ss_pred             CcccCCCCcccccCCcccceeeccCCcccCCCCC
Q 040845          397 YNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIPR  430 (824)
Q Consensus       397 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~  430 (824)
                      +|++++..|..+..+++|+.|++++|+|+|.++.
T Consensus       532 ~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~  565 (606)
T 3t6q_A          532 SNHISIILPSLLPILSQQRTINLRQNPLDCTCSN  565 (606)
T ss_dssp             SSCCCCCCGGGHHHHHTSSEEECTTCCEECSGGG
T ss_pred             CCcccccCHhhcccCCCCCEEeCCCCCccccCCc
Confidence            9999988899999999999999999999998874

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=4.9e-50  Score=468.41  Aligned_cols=440  Identities=20%  Similarity=0.170  Sum_probs=364.9

Q ss_pred             CcccccccccCCcccccCCCCCcEEEccCCcccccccccccCCCCCCEEeCCCCcCCcccChhhhCcCCCceeeccCCcc
Q 040845            2 PSIINNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSL   81 (824)
Q Consensus         2 ~~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l   81 (824)
                      |+|++|+|+++.|..|.++++|++|+|++|++++..|..|+++++|++|+|++|.+++..|.+|.++++|++|+|++|++
T Consensus        37 L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l  116 (606)
T 3vq2_A           37 IDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKL  116 (606)
T ss_dssp             EECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCC
T ss_pred             EECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCcc
Confidence            67899999999999999999999999999999988888999999999999999999988899999999999999999999


Q ss_pred             ccccCccccCCCCCccEEEccCCeeee-ecCccccCCCCCceEeccCccccccCCccccCCCCCC----EEEccCCcCCC
Q 040845           82 SGCLSSITDVGLPNLEVLYLWGNNFSG-TIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLE----WLTLYDNNLTS  156 (824)
Q Consensus        82 ~~~~~~~~~~~l~~L~~L~L~~n~i~~-~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~----~L~L~~n~i~~  156 (824)
                      ++.+... ...+++|++|+|++|.+++ .+|..+.++++|++|+|++|++++..+..|+.+++|+    +|++++|.++.
T Consensus       117 ~~~~~~~-~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~  195 (606)
T 3vq2_A          117 ASLESFP-IGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDF  195 (606)
T ss_dssp             CCSSSSC-CTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTCCCCE
T ss_pred             ccccccc-cCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCCCcce
Confidence            8877443 3469999999999999986 4689999999999999999999988888787766554    68888887775


Q ss_pred             CcCccc--------------------------------------------------------------------------
Q 040845          157 STLDLS--------------------------------------------------------------------------  162 (824)
Q Consensus       157 ~~~~~~--------------------------------------------------------------------------  162 (824)
                      ++....                                                                          
T Consensus       196 ~~~~~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~  275 (606)
T 3vq2_A          196 IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFS  275 (606)
T ss_dssp             ECTTTTTTCEEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCCTTCC
T ss_pred             eCcccccCceeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheecccccccc
Confidence            543210                                                                          


Q ss_pred             -ccccCCCCCCCcEEECcCCCCCccCCccccccccccccEEEeecCcceecCCccCCCCCCCCEEEecCCccCCccchhh
Q 040845          163 -FLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITL  241 (824)
Q Consensus       163 -~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~  241 (824)
                       ....+..+++|++|++++|.+..++  .+ .. ..+|++|++++|.+ +.+| .+ .+++|+.|++++|...+  +..+
T Consensus       276 ~~~~~~~~l~~L~~L~l~~~~~~~l~--~l-~~-~~~L~~L~l~~n~l-~~lp-~~-~l~~L~~L~l~~n~~~~--~~~~  346 (606)
T 3vq2_A          276 DDIVKFHCLANVSAMSLAGVSIKYLE--DV-PK-HFKWQSLSIIRCQL-KQFP-TL-DLPFLKSLTLTMNKGSI--SFKK  346 (606)
T ss_dssp             GGGGSCGGGTTCSEEEEESCCCCCCC--CC-CT-TCCCSEEEEESCCC-SSCC-CC-CCSSCCEEEEESCSSCE--ECCC
T ss_pred             ccccccccCCCCCEEEecCccchhhh--hc-cc-cccCCEEEcccccC-cccc-cC-CCCccceeeccCCcCcc--chhh
Confidence             0001233444555555555544432  11 11 24677777777777 4566 44 77788888888875443  3367


Q ss_pred             cCCCCCCEEEcccccCccc--CCccccccCCccEEEccCccccccCCccccCCCCCcEEEcCCCCCCCCCC--ccccccc
Q 040845          242 GKLQKLQDVDLEYNQLEGS--IPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPL--NFWSLKD  317 (824)
Q Consensus       242 ~~l~~L~~L~L~~n~l~~~--~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~--~~~~l~~  317 (824)
                      ..+++|++|++++|++++.  .+..+..+++|++|++++|.+.+ .|..+..+++|+.|++++|+++.++.  .+..+++
T Consensus       347 ~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~  425 (606)
T 3vq2_A          347 VALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEK  425 (606)
T ss_dssp             CCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTT
T ss_pred             ccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhcccc
Confidence            7889999999999999865  37888999999999999999985 55889999999999999999998764  5788999


Q ss_pred             ccccccccccccCcCCccccccccchhhhcccccccc-cCCCccCCCCCCCeEEccCccccccCCccccccccccEEEcc
Q 040845          318 ILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSG-IIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLS  396 (824)
Q Consensus       318 L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  396 (824)
                      |+.|++++|.+.+..|..+.++++|+.|++++|++++ .+|..|+.+++|+.|+|++|++++..|..|..+++|+.|+|+
T Consensus       426 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls  505 (606)
T 3vq2_A          426 LLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMS  505 (606)
T ss_dssp             CCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECC
T ss_pred             CCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECC
Confidence            9999999999998899999999999999999999997 478899999999999999999998889999999999999999


Q ss_pred             CcccCCCCcccccCCcccceeeccCCcccCCCCCCCCcc-ccccccccCCccccCCC
Q 040845          397 YNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIPRGGSFG-NFSAESFKGNELLCGSP  452 (824)
Q Consensus       397 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~-~~~~~~~~~n~~~c~~~  452 (824)
                      +|++++..|..+..+++|+.|++++|+++..++....+. ++..+.+.+||+.|+|+
T Consensus       506 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~p~~~~~l~~~L~~l~l~~N~~~c~c~  562 (606)
T 3vq2_A          506 HNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACICE  562 (606)
T ss_dssp             SSCCSCEEGGGTTTCTTCCEEECTTSCCCCEESCGGGSCTTCCEEECCSCCCCCSST
T ss_pred             CCcCCCcCHHHccCCCcCCEEECCCCcCcccCHhHhhhcccCcEEEccCCCcccCCc
Confidence            999998889999999999999999999996555444454 47888999999999987

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=2e-51  Score=438.17  Aligned_cols=269  Identities=24%  Similarity=0.376  Sum_probs=221.1

Q ss_pred             HHHHHhhccCCCCceeeeccceEEEEEEECC------CcEEEEEEeecccc-chhhhHHHHHHHHhcCCC-CcceeEEee
Q 040845          520 LELFQATDKFSENNLIGRGGFGSVYKARIRD------GMEVAVKVFNLQCG-RAFKSFDVECAMMKSIRH-RNLVKVISS  591 (824)
Q Consensus       520 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h-~niv~l~~~  591 (824)
                      .+++...++|++.+.||+|+||+||+|++..      ++.||||+++.... ...+.+.+|+++|++++| ||||+++|+
T Consensus        57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~  136 (353)
T 4ase_A           57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA  136 (353)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence            4444556889999999999999999998642      36899999975533 345678999999999975 899999999


Q ss_pred             eecC-CeeEEEEeccCCCCHHHHhhhCC---------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCC
Q 040845          592 CSNE-EFKALVLEYMPHGSLEKYLHSSN---------------YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKP  655 (824)
Q Consensus       592 ~~~~-~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~  655 (824)
                      |.++ ...++|||||++|+|.++++...               ..+++.++..++.|||+||+|||   +++||||||||
T Consensus       137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRDLK~  213 (353)
T 4ase_A          137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAA  213 (353)
T ss_dssp             ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSG
T ss_pred             EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCccCc
Confidence            9764 56899999999999999997532               35899999999999999999999   99999999999


Q ss_pred             CCeeeCCCCcEEEeecccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCccccc
Q 040845          656 SNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFN  734 (824)
Q Consensus       656 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~  734 (824)
                      +|||+++++.+||+|||+|+.+.............||+.|||||++.+..|+.++|||||||++|||+| |+.||.+...
T Consensus       214 ~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~  293 (353)
T 4ase_A          214 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI  293 (353)
T ss_dssp             GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             cceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999997765554444556679999999999999999999999999999999998 8999976432


Q ss_pred             CcchhhhhhhhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhc
Q 040845          735 GEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLL  810 (824)
Q Consensus       735 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~  810 (824)
                      .+. +...+...                  .+...|..+++++.++|.+||+.||++||||+|++++|+++.++-.
T Consensus       294 ~~~-~~~~i~~g------------------~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~~  350 (353)
T 4ase_A          294 DEE-FCRRLKEG------------------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA  350 (353)
T ss_dssp             SHH-HHHHHHHT------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred             HHH-HHHHHHcC------------------CCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHhh
Confidence            221 11111111                  1112234567789999999999999999999999999999877543

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=3.3e-51  Score=432.36  Aligned_cols=251  Identities=22%  Similarity=0.342  Sum_probs=204.0

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVL  602 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  602 (824)
                      .++|++.+.||+|+||+||+|++. +|+.||||++....  ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm  102 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM  102 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence            478999999999999999999865 59999999997543  234567899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 040845          603 EYMPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED  681 (824)
Q Consensus       603 e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  681 (824)
                      ||+++|+|.+++...+ ..+++.+++.++.||+.||+|||   +++|+||||||+|||++++|.+||+|||+|+.+... 
T Consensus       103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-  178 (350)
T 4b9d_A          103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST-  178 (350)
T ss_dssp             ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH-
T ss_pred             eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeecCC-
Confidence            9999999999997544 45789999999999999999999   999999999999999999999999999999865321 


Q ss_pred             CccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccC
Q 040845          682 QSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLS  761 (824)
Q Consensus       682 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  761 (824)
                       .......+||+.|||||++.+..|+.++||||+||++|||+||+.||.+....+ .+........+             
T Consensus       179 -~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~-~~~~i~~~~~~-------------  243 (350)
T 4b9d_A          179 -VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN-LVLKIISGSFP-------------  243 (350)
T ss_dssp             -HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHTCCC-------------
T ss_pred             -cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-HHHHHHcCCCC-------------
Confidence             112334579999999999999999999999999999999999999997632111 11111111111             


Q ss_pred             chhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          762 QEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       762 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                            ..+..++.++.+|+.+||+.||++|||++|++++
T Consensus       244 ------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  277 (350)
T 4b9d_A          244 ------PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK  277 (350)
T ss_dssp             ------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                  0112356678999999999999999999999875

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=1.8e-49  Score=470.02  Aligned_cols=445  Identities=23%  Similarity=0.249  Sum_probs=287.7

Q ss_pred             cccccccccCCcccccCCCCCcEEEccCCcccccccccccCCCCCCEEeCCCCcCCcccChhhhCcCCCceeeccCCccc
Q 040845            3 SIINNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLS   82 (824)
Q Consensus         3 ~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~   82 (824)
                      +|++|.|+++.|..|+++++|++|+|++|++++..+..|+++++|++|+|++|++++..|.+|.++++|++|+|++|+++
T Consensus        55 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~  134 (680)
T 1ziw_A           55 DVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLS  134 (680)
T ss_dssp             ECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCS
T ss_pred             ECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCccc
Confidence            44455555555555555555555555555555333334555555555555555555444444555555555555555544


Q ss_pred             cccCccccCCCCC--------------------------ccEEEccCCeeeeecCccccCC-------------------
Q 040845           83 GCLSSITDVGLPN--------------------------LEVLYLWGNNFSGTIPHFIFNA-------------------  117 (824)
Q Consensus        83 ~~~~~~~~~~l~~--------------------------L~~L~L~~n~i~~~~~~~l~~l-------------------  117 (824)
                      +.+.... ..+++                          |++|++++|++++..|..+..+                   
T Consensus       135 ~~~~~~~-~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~  213 (680)
T 1ziw_A          135 STKLGTQ-VQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTE  213 (680)
T ss_dssp             CCCCCSS-SCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHH
T ss_pred             ccCchhh-cccccCCEEEccCCcccccCHHHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHH
Confidence            4332211 12344                          4444444444433333322211                   


Q ss_pred             --------CCCceEeccCccccccCCccccCCCC--CCEEEccCCcCCCCcCcccccccCCCCCCCcEEECcCCCCCccC
Q 040845          118 --------SKLSKLALEMNSFSGFIPSTFGNLRN--LEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGIL  187 (824)
Q Consensus       118 --------~~L~~L~L~~N~i~~~~~~~~~~l~~--L~~L~L~~n~i~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~  187 (824)
                              ++|+.|++++|.+++..|..|.+++.  |++|++++|.++.++.     ..+..+++|++|++++|.+.++.
T Consensus       214 ~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~-----~~~~~l~~L~~L~L~~n~l~~~~  288 (680)
T 1ziw_A          214 KLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGN-----DSFAWLPQLEYFFLEYNNIQHLF  288 (680)
T ss_dssp             HHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEECT-----TTTTTCTTCCEEECCSCCBSEEC
T ss_pred             HHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCccCc-----ccccCcccccEeeCCCCccCccC
Confidence                    12223333333333333333333322  5555555555444322     23455555555555555555443


Q ss_pred             Cccccc-------------------------------cccccccEEEeecCcceecCCccCCCCCCCCEEEecC------
Q 040845          188 PRTYVG-------------------------------NLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGG------  230 (824)
Q Consensus       188 ~~~~~~-------------------------------~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~------  230 (824)
                      +..|.+                               .-.++|++|++++|++.+..+..|.++++|++|++++      
T Consensus       289 ~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~  368 (680)
T 1ziw_A          289 SHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLR  368 (680)
T ss_dssp             TTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCC
T ss_pred             hhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhh
Confidence            332211                               0124677777777777766666666666666555544      


Q ss_pred             ----------------------CccCCccchhhcCCCCCCEEEcccccCcccCC-ccccccCCccEEEccCccccccCCc
Q 040845          231 ----------------------NKLNGSIPITLGKLQKLQDVDLEYNQLEGSIP-DSICLSVELYELELGGNKLSGSIPA  287 (824)
Q Consensus       231 ----------------------n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~~~~L~~L~l~~n~l~~~~~~  287 (824)
                                            |++++..|.+|..+++|++|+|++|++.+.+| ..+..+++|++|++++|++.+..+.
T Consensus       369 ~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~  448 (680)
T 1ziw_A          369 TLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRN  448 (680)
T ss_dssp             EECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTT
T ss_pred             hcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChh
Confidence                                  44555556677777888888888888775544 5677778888888888888777777


Q ss_pred             cccCCCCCcEEEcCCCCCC---CCCCcccccccccccccccccccCcCCccccccccchhhhcccccccccCC-------
Q 040845          288 CFSNMTFLKVLSLGSNELT---SIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIP-------  357 (824)
Q Consensus       288 ~~~~l~~L~~L~L~~N~l~---~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~-------  357 (824)
                      .|..+++|+.|++++|.++   .+|..+..+++|+.|++++|.+++..+..|.++++|+.|++++|++++..+       
T Consensus       449 ~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~  528 (680)
T 1ziw_A          449 SFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGP  528 (680)
T ss_dssp             TTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSC
T ss_pred             hhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCc
Confidence            8888888888888888775   457778889999999999999998888889999999999999999986532       


Q ss_pred             -CccCCCCCCCeEEccCccccccCCccccccccccEEEccCcccCCCCcccccCCcccceeeccCCcccCCCCCCC--Cc
Q 040845          358 -MEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIPRGG--SF  434 (824)
Q Consensus       358 -~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~--~~  434 (824)
                       ..|.++++|+.|+|++|+++...+..|.++++|+.|+|++|++++..+..+..+++|+.|++++|++++.+|...  .+
T Consensus       529 ~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~  608 (680)
T 1ziw_A          529 IYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAF  608 (680)
T ss_dssp             CCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHH
T ss_pred             chhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccc
Confidence             237889999999999999996555679999999999999999997667778899999999999999998777532  46


Q ss_pred             cccccccccCCccccCCCC
Q 040845          435 GNFSAESFKGNELLCGSPN  453 (824)
Q Consensus       435 ~~~~~~~~~~n~~~c~~~~  453 (824)
                      .++..+.+.+||+.|+|+.
T Consensus       609 ~~L~~l~l~~N~~~c~c~~  627 (680)
T 1ziw_A          609 RNLTELDMRFNPFDCTCES  627 (680)
T ss_dssp             TTCSEEECTTCCCCBCCCC
T ss_pred             cccCEEEccCCCcccCCcc
Confidence            7788899999999999873

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=3.4e-50  Score=415.88  Aligned_cols=245  Identities=25%  Similarity=0.377  Sum_probs=197.7

Q ss_pred             CCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeec----CCeeEEEE
Q 040845          530 SENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSN----EEFKALVL  602 (824)
Q Consensus       530 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~  602 (824)
                      ++.+.||+|+||+||+|.+. ++..||||++....  ....+.+.+|++++++++|||||++++++.+    +...|+||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            56678999999999999875 58999999987542  2345678999999999999999999999864    35689999


Q ss_pred             eccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC--eEecCCCCCCeeeC-CCCcEEEeecccccccCC
Q 040845          603 EYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAP--VIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTG  679 (824)
Q Consensus       603 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlk~~Nill~-~~~~~kl~Dfg~a~~~~~  679 (824)
                      ||+++|+|.+++.+.. .+++..+..++.||+.||+|||   +++  |+||||||+|||++ .++.+||+|||+|+....
T Consensus       109 Ey~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~  184 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence            9999999999998765 7899999999999999999999   777  99999999999998 479999999999985432


Q ss_pred             CCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccc
Q 040845          680 EDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANL  759 (824)
Q Consensus       680 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  759 (824)
                      .    .....+||+.|||||++.+ .|+.++|||||||++|||+||+.||.+...... +...+.....           
T Consensus       185 ~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~-~~~~i~~~~~-----------  247 (290)
T 3fpq_A          185 S----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-IYRRVTSGVK-----------  247 (290)
T ss_dssp             T----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-HHHHHTTTCC-----------
T ss_pred             C----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH-HHHHHHcCCC-----------
Confidence            1    2234679999999998865 699999999999999999999999965322111 1111111000           


Q ss_pred             cCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          760 LSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       760 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                            ....+..+++++.+|+.+||+.||++|||++|+++|
T Consensus       248 ------~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H  283 (290)
T 3fpq_A          248 ------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             ------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ------CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                  001122345678999999999999999999999875

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.2e-50  Score=435.90  Aligned_cols=250  Identities=25%  Similarity=0.328  Sum_probs=211.6

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEecc
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYM  605 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  605 (824)
                      +.|++.+.||+|+||+||+|+++ +|+.||||++........+.+.+|+.+|+.++|||||++++++.+++..|+|||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            56999999999999999999875 59999999998766666778999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccc
Q 040845          606 PHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMT  685 (824)
Q Consensus       606 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  685 (824)
                      +||+|.+++...  .+++.++..++.||+.||+|||   +++||||||||+|||++.+|.+||+|||+|+.+.....  .
T Consensus       231 ~gG~L~~~i~~~--~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~--~  303 (423)
T 4fie_A          231 EGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--R  303 (423)
T ss_dssp             TTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC--C
T ss_pred             CCCcHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc--c
Confidence            999999999765  5899999999999999999999   99999999999999999999999999999987643322  2


Q ss_pred             cccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhh
Q 040845          686 QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDI  765 (824)
Q Consensus       686 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  765 (824)
                      ....+||+.|||||++.+..|+.++||||+||++|||++|+.||.+...  ......+....+.                
T Consensus       304 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--~~~~~~i~~~~~~----------------  365 (423)
T 4fie_A          304 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMKMIRDNLPP----------------  365 (423)
T ss_dssp             BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHHSCCC----------------
T ss_pred             ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHHHHHHHcCCCC----------------
Confidence            3456799999999999999999999999999999999999999975321  1111111111110                


Q ss_pred             hhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          766 HFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       766 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      ....+..++.++.+|+.+||..||++|||++|+++|
T Consensus       366 ~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H  401 (423)
T 4fie_A          366 RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  401 (423)
T ss_dssp             CCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            001112346678999999999999999999999876

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=4e-50  Score=411.51  Aligned_cols=247  Identities=23%  Similarity=0.382  Sum_probs=192.9

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALV  601 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  601 (824)
                      .++|++.+.||+|+||+||+|+.. +|+.||||+++...   ....+.+.+|++++++++|||||++++++.+++..|+|
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV   91 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            368999999999999999999864 59999999986542   23356789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 040845          602 LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED  681 (824)
Q Consensus       602 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  681 (824)
                      |||+ +|+|.+++...+ .+++.++..++.||+.||+|||   +++|+||||||+|||+++++.+||+|||+|+......
T Consensus        92 mEy~-~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~  166 (275)
T 3hyh_A           92 IEYA-GNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN  166 (275)
T ss_dssp             EECC-CEEHHHHHHHSC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred             EeCC-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence            9999 679999998765 7999999999999999999999   9999999999999999999999999999998654322


Q ss_pred             CccccccccccccccCccCcCCCCC-CccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhcccccc
Q 040845          682 QSMTQTQTLATIGYMAPEYGREGQV-STNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLL  760 (824)
Q Consensus       682 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  760 (824)
                         ......||+.|||||++.+..+ +.++||||+||++|||+||+.||.+.... ...........             
T Consensus       167 ---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~-~~~~~i~~~~~-------------  229 (275)
T 3hyh_A          167 ---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP-VLFKNISNGVY-------------  229 (275)
T ss_dssp             -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHTCC-------------
T ss_pred             ---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHcCCC-------------
Confidence               2234579999999999988776 68999999999999999999999752111 01111111100             


Q ss_pred             CchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          761 SQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       761 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                             ..+..+++++.+++.+||+.||++|||++|+++|
T Consensus       230 -------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  263 (275)
T 3hyh_A          230 -------TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD  263 (275)
T ss_dssp             -------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred             -------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence                   0112345678999999999999999999999885

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=2e-50  Score=419.56  Aligned_cols=248  Identities=25%  Similarity=0.314  Sum_probs=198.7

Q ss_pred             ccCCCCceeeeccceEEEEEEEC----CCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEE
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR----DGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKAL  600 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  600 (824)
                      ++|++.+.||+|+||+||+|+..    +++.||||+++...  ......+.+|++++++++|||||++++++.+++..|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            57999999999999999999763    47899999986542  2334568889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 040845          601 VLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE  680 (824)
Q Consensus       601 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  680 (824)
                      ||||++||+|.+++.+.+ .+++.++..++.||+.||+|||   +++|+||||||+|||++.+|.+||+|||+|+.....
T Consensus       104 vmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  179 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH  179 (304)
T ss_dssp             EECCCTTCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred             EEEcCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence            999999999999998765 7999999999999999999999   999999999999999999999999999999865432


Q ss_pred             CCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhcccccc
Q 040845          681 DQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLL  760 (824)
Q Consensus       681 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  760 (824)
                      .  .......||+.|||||++.+..|+.++||||+||++|||+||+.||.+....+ ..........             
T Consensus       180 ~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~-~~~~i~~~~~-------------  243 (304)
T 3ubd_A          180 E--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE-TMTMILKAKL-------------  243 (304)
T ss_dssp             ---CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCC-------------
T ss_pred             C--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH-HHHHHHcCCC-------------
Confidence            2  22334679999999999999999999999999999999999999997632111 1111111100             


Q ss_pred             CchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 040845          761 SQEDIHFVAKEQCVSFVFNLALECTVESPEQRINA-----KEIVAK  801 (824)
Q Consensus       761 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~-----~evl~~  801 (824)
                             ..+..+++++.+|+.+||+.||++|||+     +|+++|
T Consensus       244 -------~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H  282 (304)
T 3ubd_A          244 -------GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH  282 (304)
T ss_dssp             -------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred             -------CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence                   1122356778999999999999999985     566653

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.9e-48  Score=449.20  Aligned_cols=435  Identities=21%  Similarity=0.196  Sum_probs=358.6

Q ss_pred             CcccccccccCCcccccCCCCCcEEEccCCcccccccccccCCCCCCEEeCCCCcCCcccChhhhCcCCCceeeccCCcc
Q 040845            2 PSIINNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSL   81 (824)
Q Consensus         2 ~~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l   81 (824)
                      |+|++|+|+++.+.+|.++++|++|+|++|++++..+..|+++++|++|+|++|++++..|.+|.++++|++|++++|++
T Consensus        33 L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l  112 (570)
T 2z63_A           33 LDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNL  112 (570)
T ss_dssp             EECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCC
T ss_pred             EEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCcccccccccccccc
Confidence            57888999999888999999999999999999887788899999999999999999877778899999999999999998


Q ss_pred             ccccCccccCCCCCccEEEccCCeeee-ecCccccCCCCCceEeccCccccccCCccccCCCCC----CEEEccCCcCCC
Q 040845           82 SGCLSSITDVGLPNLEVLYLWGNNFSG-TIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNL----EWLTLYDNNLTS  156 (824)
Q Consensus        82 ~~~~~~~~~~~l~~L~~L~L~~n~i~~-~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L----~~L~L~~n~i~~  156 (824)
                      ++++... ..++++|++|+|++|.+++ .+|..+.++++|++|++++|++++..+..|+.+++|    +.|++++|.++.
T Consensus       113 ~~l~~~~-~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n~l~~  191 (570)
T 2z63_A          113 ASLENFP-IGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF  191 (570)
T ss_dssp             CCSTTCS-CTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCE
T ss_pred             ccCCCcc-ccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCCCcee
Confidence            8776532 3468899999999999886 368889999999999999999988888888888888    889999998887


Q ss_pred             CcCcccccccCCCCCCCcEEECcCCCCC----------------------------------------------------
Q 040845          157 STLDLSFLSSLSNCKSLTHISLSNNPLD----------------------------------------------------  184 (824)
Q Consensus       157 ~~~~~~~~~~l~~l~~L~~L~Ls~n~l~----------------------------------------------------  184 (824)
                      ++..     .+..+ +|++|++++|...                                                    
T Consensus       192 ~~~~-----~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~  265 (570)
T 2z63_A          192 IQPG-----AFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA  265 (570)
T ss_dssp             ECTT-----TTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEE
T ss_pred             cCHH-----HhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhh
Confidence            6542     24433 6888888776321                                                    


Q ss_pred             ------ccCCccccccccccccEEEeecCcceecCCccCCCCCCCCEEEecCCccCCccchhhcCCCCCCEEEcccccCc
Q 040845          185 ------GILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLE  258 (824)
Q Consensus       185 ------~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~  258 (824)
                            +..+..+..  .++|++|++++|.+. .+|..+..+ +|+.|++++|.+. .+|.  ..+++|++|++++|.+.
T Consensus       266 ~~~~~~~~~~~~~~~--l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~-~l~~--~~l~~L~~L~l~~n~~~  338 (570)
T 2z63_A          266 YLDYYLDDIIDLFNC--LTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFG-QFPT--LKLKSLKRLTFTSNKGG  338 (570)
T ss_dssp             ETTEEESCSTTTTGG--GTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCS-SCCB--CBCSSCCEEEEESCBSC
T ss_pred             cchhhhhhchhhhcC--cCcccEEEecCccch-hhhhhhccC-CccEEeeccCccc-ccCc--ccccccCEEeCcCCccc
Confidence                  111111111  346777788777776 466677777 7888888888777 3443  46777888888888877


Q ss_pred             ccCCccccccCCccEEEccCccccccC--CccccCCCCCcEEEcCCCCCCCCCCcccccccccccccccccccCcCC-cc
Q 040845          259 GSIPDSICLSVELYELELGGNKLSGSI--PACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLP-LE  335 (824)
Q Consensus       259 ~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~-~~  335 (824)
                      +..+.  ..+++|+.|++++|++++..  +..+.++++|++|++++|.++.+|..+..+++|+.|++++|.+.+..+ ..
T Consensus       339 ~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~  416 (570)
T 2z63_A          339 NAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSV  416 (570)
T ss_dssp             CBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEEEETCTTCCEEECTTSEEESCTTSCT
T ss_pred             ccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCccccccccccccCCCCEEEccCCccccccchhh
Confidence            55444  67889999999999998654  677889999999999999999998888889999999999999987665 57


Q ss_pred             ccccccchhhhcccccccccCCCccCCCCCCCeEEccCcccc-ccCCccccccccccEEEccCcccCCCCcccccCCccc
Q 040845          336 IRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLE-GSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYL  414 (824)
Q Consensus       336 ~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L  414 (824)
                      +.++++|+.|++++|.+.+..|..|..+++|+.|++++|.++ +.+|..+..+++|+.|++++|++++..|..+..+++|
T Consensus       417 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L  496 (570)
T 2z63_A          417 FLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSL  496 (570)
T ss_dssp             TTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTC
T ss_pred             hhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCC
Confidence            889999999999999999889999999999999999999997 5688999999999999999999998889999999999


Q ss_pred             ceeeccCCcccCCCCCC-CCccccccccccCCccccCCC
Q 040845          415 KDLNLSFNKLKGEIPRG-GSFGNFSAESFKGNELLCGSP  452 (824)
Q Consensus       415 ~~L~l~~N~l~~~~p~~-~~~~~~~~~~~~~n~~~c~~~  452 (824)
                      +.|++++|++++.+|.. ..+.++..+.+.+|++.|+|+
T Consensus       497 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  535 (570)
T 2z63_A          497 QVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  535 (570)
T ss_dssp             CEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred             CEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCc
Confidence            99999999999887753 557788888999999999887

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=4.1e-47  Score=443.66  Aligned_cols=413  Identities=19%  Similarity=0.137  Sum_probs=356.9

Q ss_pred             CcccccccccCCcccccCCCCCcEEEccCCcccccccccccCCCCCCEEeCCCCcCCcccChhhhCcCCCceeeccCCcc
Q 040845            2 PSIINNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSL   81 (824)
Q Consensus         2 ~~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l   81 (824)
                      |+|++|+|+++.|.+|.++++|++|+|++|++++..|..|+++++|++|+|++|++++..+..+.++++|++|++++|++
T Consensus        61 L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l  140 (606)
T 3vq2_A           61 LDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFI  140 (606)
T ss_dssp             EECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCC
T ss_pred             EeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcc
Confidence            67899999999999999999999999999999988899999999999999999999977778899999999999999999


Q ss_pred             ccccCccccCCCCCccEEEccCCeeeeecCccccCCCCCc----eEeccCccccccCCcccc------------------
Q 040845           82 SGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLS----KLALEMNSFSGFIPSTFG------------------  139 (824)
Q Consensus        82 ~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~----~L~L~~N~i~~~~~~~~~------------------  139 (824)
                      ++.........+++|++|+|++|++++..+..+..+++|+    +|++++|.++++.+..+.                  
T Consensus       141 ~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~n~~~~~~  220 (606)
T 3vq2_A          141 HSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNI  220 (606)
T ss_dssp             CCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSCHHH
T ss_pred             cceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCCCcceeCcccccCceeeeeeccCCccchhH
Confidence            8633222234699999999999999988888777666554    677777777655544443                  


Q ss_pred             --------------------------------------------------------------CCCCCCEEEccCCcCCCC
Q 040845          140 --------------------------------------------------------------NLRNLEWLTLYDNNLTSS  157 (824)
Q Consensus       140 --------------------------------------------------------------~l~~L~~L~L~~n~i~~~  157 (824)
                                                                                    .+++|++|++++|.+..+
T Consensus       221 ~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~l~~L~~L~l~~~~~~~l  300 (606)
T 3vq2_A          221 MKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYL  300 (606)
T ss_dssp             HHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGSCGGGTTCSEEEEESCCCCCC
T ss_pred             HHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheeccccccccccccccccCCCCCEEEecCccchhh
Confidence                                                                          334555555555555443


Q ss_pred             cCcccccccCCCCCCCcEEECcCCCCCccCCccccccccccccEEEeecCcceecCCccCCCCCCCCEEEecCCccCCcc
Q 040845          158 TLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSI  237 (824)
Q Consensus       158 ~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~  237 (824)
                      +       .+..+++|++|++++|.+..++  .+   -.++|++|++++|...+..  .+..+++|+.|++++|.+++..
T Consensus       301 ~-------~l~~~~~L~~L~l~~n~l~~lp--~~---~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~  366 (606)
T 3vq2_A          301 E-------DVPKHFKWQSLSIIRCQLKQFP--TL---DLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSG  366 (606)
T ss_dssp             C-------CCCTTCCCSEEEEESCCCSSCC--CC---CCSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEE
T ss_pred             h-------hccccccCCEEEcccccCcccc--cC---CCCccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCc
Confidence            3       4788899999999999996554  23   2568999999999766544  6779999999999999998663


Q ss_pred             --chhhcCCCCCCEEEcccccCcccCCccccccCCccEEEccCccccccCC-ccccCCCCCcEEEcCCCCCCCC-CCccc
Q 040845          238 --PITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIP-ACFSNMTFLKVLSLGSNELTSI-PLNFW  313 (824)
Q Consensus       238 --~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~~l-p~~~~  313 (824)
                        +..+..+++|++|++++|.+++ .|..+..+++|+.|++++|++.+..+ ..+.++++|++|++++|.++.. |..+.
T Consensus       367 ~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~  445 (606)
T 3vq2_A          367 CCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFL  445 (606)
T ss_dssp             ECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTT
T ss_pred             chhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhc
Confidence              7889999999999999999985 66889999999999999999998877 7899999999999999999975 56688


Q ss_pred             ccccccccccccccccC-cCCccccccccchhhhcccccccccCCCccCCCCCCCeEEccCccccccCCccccccccccE
Q 040845          314 SLKDILDLNLSSNCFSG-PLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKS  392 (824)
Q Consensus       314 ~l~~L~~L~l~~N~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  392 (824)
                      .+++|+.|++++|.+++ ..|..+..+++|+.|++++|++++..|..|..+++|+.|+|++|++++..|..|..+++|+.
T Consensus       446 ~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  525 (606)
T 3vq2_A          446 GLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLST  525 (606)
T ss_dssp             TCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCE
T ss_pred             CCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCE
Confidence            99999999999999997 47999999999999999999999999999999999999999999999888999999999999


Q ss_pred             EEccCcccCCCCcccccCCc-ccceeeccCCcccCCCCC
Q 040845          393 LNLSYNNLSGTIPVSLEKLS-YLKDLNLSFNKLKGEIPR  430 (824)
Q Consensus       393 L~L~~N~l~~~~p~~~~~l~-~L~~L~l~~N~l~~~~p~  430 (824)
                      |+|++|+|+ .+|..+..++ +|+.|++++|+|.|.++.
T Consensus       526 L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~~  563 (606)
T 3vq2_A          526 LDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICEH  563 (606)
T ss_dssp             EECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSSTT
T ss_pred             EECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCcc
Confidence            999999999 8888899997 599999999999998875

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=4.3e-48  Score=451.42  Aligned_cols=385  Identities=19%  Similarity=0.262  Sum_probs=308.5

Q ss_pred             CCcCCcccChhhhCcCCCceeeccCCcccc------------------ccCccccCCCCCccEEEccCCeeeeecCcccc
Q 040845           54 QNKLLGTIPAAIFNVSTLKAFAVTNNSLSG------------------CLSSITDVGLPNLEVLYLWGNNFSGTIPHFIF  115 (824)
Q Consensus        54 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~------------------~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~  115 (824)
                      +|++++ +|.+++++++|++|+|++|++++                  +|..+.+..+++|++|+|++|++.+.+|..++
T Consensus       192 ~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~  270 (636)
T 4eco_A          192 SNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLK  270 (636)
T ss_dssp             SCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTT
T ss_pred             cCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHh
Confidence            456666 88889999999999999999988                  77766533588999999999998888899999


Q ss_pred             CCCCCceEeccCcc-ccc-cCCccccCC------CCCCEEEccCCcCCCCcCcccccccCCCCCCCcEEECcCCCCCccC
Q 040845          116 NASKLSKLALEMNS-FSG-FIPSTFGNL------RNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGIL  187 (824)
Q Consensus       116 ~l~~L~~L~L~~N~-i~~-~~~~~~~~l------~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~  187 (824)
                      ++++|++|+|++|+ +++ .+|..++++      ++|++|++++|+++.++..    ..+.++++|++|++++|.+.+..
T Consensus       271 ~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~~ip~~----~~l~~l~~L~~L~L~~N~l~g~i  346 (636)
T 4eco_A          271 ALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVE----TSLQKMKKLGMLECLYNQLEGKL  346 (636)
T ss_dssp             TCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCSSCCCH----HHHTTCTTCCEEECCSCCCEEEC
T ss_pred             cCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCCccCch----hhhccCCCCCEEeCcCCcCccch
Confidence            99999999999998 887 778888776      8999999999998865420    14788899999999999998655


Q ss_pred             CccccccccccccEEEeecCcceecCCccCCCCCC-CCEEEecCCccCCccchhhcCCC--CCCEEEcccccCcccCCcc
Q 040845          188 PRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTD-LTTIVLGGNKLNGSIPITLGKLQ--KLQDVDLEYNQLEGSIPDS  264 (824)
Q Consensus       188 ~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~-L~~L~L~~n~l~~~~~~~~~~l~--~L~~L~L~~n~l~~~~~~~  264 (824)
                      | .+..  .++|++|++++|+++ .+|..+..+++ |++|++++|.++ .+|..+..++  +|++|++++|++++..|..
T Consensus       347 p-~~~~--l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~  421 (636)
T 4eco_A          347 P-AFGS--EIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKN  421 (636)
T ss_dssp             C-CCEE--EEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCS
T ss_pred             h-hhCC--CCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhh
Confidence            5 4422  457999999999988 77888888988 999999999998 6777777655  8999999999998888888


Q ss_pred             cc-------ccCCccEEEccCccccccCCccccCCCCCcEEEcCCCCCCCCCCcccccc--------ccccccccccccc
Q 040845          265 IC-------LSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLK--------DILDLNLSSNCFS  329 (824)
Q Consensus       265 ~~-------~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~--------~L~~L~l~~N~l~  329 (824)
                      +.       .+++|+.|++++|+++...+..+..+++|+.|+|++|+++.+|.......        +|+.|+|++|+++
T Consensus       422 l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~  501 (636)
T 4eco_A          422 FDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT  501 (636)
T ss_dssp             SCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCSSSSEETTEECTTGGGCCEEECCSSCCC
T ss_pred             hcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCCCcCHHHhccccccccccCCccEEECcCCcCC
Confidence            87       77889999999999986666667778999999999999998887755432        8999999999998


Q ss_pred             CcCCcccc--ccccchhhhcccccccccCCCccCCCCCCCeEEc------cCccccccCCccccccccccEEEccCcccC
Q 040845          330 GPLPLEIR--NLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFL------EYNRLEGSIPDSFGDLISLKSLNLSYNNLS  401 (824)
Q Consensus       330 ~~~~~~~~--~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L------~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  401 (824)
                       .+|..+.  .+++|+.|+|++|++++ +|..+..+++|+.|+|      ++|++.+.+|..+..+++|+.|+|++|++ 
T Consensus       502 -~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-  578 (636)
T 4eco_A          502 -KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-  578 (636)
T ss_dssp             -BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-
T ss_pred             -ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcC-
Confidence             6777776  88999999999999987 7888888999999999      55777888888899999999999999999 


Q ss_pred             CCCcccccCCcccceeeccCCcccCCCCCCCC---ccccccccccCCccccCCCC
Q 040845          402 GTIPVSLEKLSYLKDLNLSFNKLKGEIPRGGS---FGNFSAESFKGNELLCGSPN  453 (824)
Q Consensus       402 ~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~---~~~~~~~~~~~n~~~c~~~~  453 (824)
                      +.+|..+.  ++|+.|++++|++.+..+....   ......+.+..+...|+|+.
T Consensus       579 ~~ip~~~~--~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~C~~  631 (636)
T 4eco_A          579 RKVNEKIT--PNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQDIRGCDA  631 (636)
T ss_dssp             CBCCSCCC--TTCCEEECCSCTTCEEECTTTHHHHHTTCCEEECCTTSEEESCGG
T ss_pred             CccCHhHh--CcCCEEECcCCCCccccHHhcchhhhcccceeecCCccccCCCcc
Confidence            48888766  7899999999988754432110   12222334455556667664

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=9.9e-47  Score=446.48  Aligned_cols=442  Identities=21%  Similarity=0.192  Sum_probs=308.0

Q ss_pred             CcccccccccCCcccccCCCCCcEEEccCCcccccccccccCCCCCCEEeCCCCcCCcccChhhhCcCCCceeeccCCcc
Q 040845            2 PSIINNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSL   81 (824)
Q Consensus         2 ~~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l   81 (824)
                      |+|++|.|+++.+..|.++++|++|+|++|++++..|..|+++++|++|+|++|++++..+.+|.++++|++|+|++|++
T Consensus        30 L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l  109 (680)
T 1ziw_A           30 LNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSI  109 (680)
T ss_dssp             EECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCC
T ss_pred             EECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCCcc
Confidence            45666666666666666666666666666666666666666666666666666666644444566666666666666666


Q ss_pred             ccccCccccCCCCCccEEEccCCeeeeecCccccCCCCCceEeccCccccccCCcccc--CCCCCCEEEccCCcCCCCcC
Q 040845           82 SGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFG--NLRNLEWLTLYDNNLTSSTL  159 (824)
Q Consensus        82 ~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~--~l~~L~~L~L~~n~i~~~~~  159 (824)
                      ++++.... .++++|++|+|++|.+++..+..+..+++|++|+|++|.+++..+..+.  .+++|++|++++|.++..+.
T Consensus       110 ~~~~~~~~-~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~  188 (680)
T 1ziw_A          110 QKIKNNPF-VKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSP  188 (680)
T ss_dssp             CCCCSCTT-TTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCCCCBCT
T ss_pred             CccChhHc-cccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCcccccCh
Confidence            65553322 2466666677766666666666666666666666666666655555443  34666666766666665443


Q ss_pred             cccccccCC------------------------CCCCCcEEECcCCCCCccCCccccccccccccEEEeecCcceecCCc
Q 040845          160 DLSFLSSLS------------------------NCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPE  215 (824)
Q Consensus       160 ~~~~~~~l~------------------------~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~  215 (824)
                      ..  +..+.                        ..++|++|++++|.+.+..+..|...-..+|++|++++|++++..+.
T Consensus       189 ~~--~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~  266 (680)
T 1ziw_A          189 GC--FHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGND  266 (680)
T ss_dssp             TG--GGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEECTT
T ss_pred             hh--hhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCccCcc
Confidence            21  01111                        12556667777777766666655442224578888888887777777


Q ss_pred             cCCCCCCCCEEEecCCccCCccchhhcCCCCCCEEEcccccCcc-----cCC----ccccccCCccEEEccCccccccCC
Q 040845          216 EITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEG-----SIP----DSICLSVELYELELGGNKLSGSIP  286 (824)
Q Consensus       216 ~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-----~~~----~~~~~~~~L~~L~l~~n~l~~~~~  286 (824)
                      .|..+++|++|++++|.+.+..|..|.++++|++|++++|...+     .+|    ..|..+++|++|++++|++.+..+
T Consensus       267 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~  346 (680)
T 1ziw_A          267 SFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKS  346 (680)
T ss_dssp             TTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCCT
T ss_pred             cccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCCCh
Confidence            77778888888888888777777777777888888877765442     122    256677888888888888888778


Q ss_pred             ccccCCCCCcEEEcCCCCC--CCCCCc-ccc--cccccccccccccccCcCCccccccccchhhhcccccccccCC-Ccc
Q 040845          287 ACFSNMTFLKVLSLGSNEL--TSIPLN-FWS--LKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIP-MEI  360 (824)
Q Consensus       287 ~~~~~l~~L~~L~L~~N~l--~~lp~~-~~~--l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~-~~~  360 (824)
                      ..|.++++|++|++++|.+  ..++.. |..  .++|+.|++++|++++..|..|..+++|+.|++++|++++.+| ..|
T Consensus       347 ~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  426 (680)
T 1ziw_A          347 NMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEW  426 (680)
T ss_dssp             TTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGG
T ss_pred             hHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccc
Confidence            8888888888888888864  344433 222  2578888888888888788888888888888888888876554 678


Q ss_pred             CCCCCCCeEEccCccccccCCccccccccccEEEccCcccC--CCCcccccCCcccceeeccCCcccCCCCC-CCCcccc
Q 040845          361 GSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLS--GTIPVSLEKLSYLKDLNLSFNKLKGEIPR-GGSFGNF  437 (824)
Q Consensus       361 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~~~~  437 (824)
                      .++++|+.|++++|++++..+..|..+++|+.|++++|.++  +.+|..+..+++|+.|++++|++++.+|. ...+.++
T Consensus       427 ~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L  506 (680)
T 1ziw_A          427 RGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKL  506 (680)
T ss_dssp             TTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred             cCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhcccccc
Confidence            88888888888888888777788888888888888888876  46788888888888888888888876665 3445667


Q ss_pred             ccccccCCc
Q 040845          438 SAESFKGNE  446 (824)
Q Consensus       438 ~~~~~~~n~  446 (824)
                      ..+.+.+|.
T Consensus       507 ~~L~Ls~N~  515 (680)
T 1ziw_A          507 EILDLQHNN  515 (680)
T ss_dssp             CEEECCSSC
T ss_pred             CEEeCCCCC
Confidence            777777775

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=5.1e-48  Score=403.84  Aligned_cols=250  Identities=24%  Similarity=0.372  Sum_probs=189.7

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc-chhhhHHHHHHHHhcCCCCcceeEEeeeecCC--------
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVKVISSCSNEE--------  596 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--------  596 (824)
                      ++|++.+.||+|+||+||+|+++ +|+.||||+++.... ...+.+.+|+++|++++|||||++++++.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            46899999999999999999875 589999999976543 34567889999999999999999999986543        


Q ss_pred             ----eeEEEEeccCCCCHHHHhhhCC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEee
Q 040845          597 ----FKALVLEYMPHGSLEKYLHSSN--YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSD  670 (824)
Q Consensus       597 ----~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D  670 (824)
                          ..|+||||+++|+|.+++....  ...++..++.++.||++||+|||   +++|+||||||+|||++.++.+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEEcc
Confidence                3689999999999999998654  23456778899999999999999   99999999999999999999999999


Q ss_pred             cccccccCCCCCc----------cccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhh
Q 040845          671 FGIAKLLTGEDQS----------MTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLK  740 (824)
Q Consensus       671 fg~a~~~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~  740 (824)
                      ||+|+.+......          ...+..+||+.|||||++.+..|+.++||||+||++|||++   ||....+....+.
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~  238 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLT  238 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHH
Confidence            9999876543221          12234579999999999999999999999999999999996   7654211100001


Q ss_pred             hhhhhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          741 HWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       741 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      .....               ..    ........+.+.+++.+||+.||++|||+.|++++
T Consensus       239 ~~~~~---------------~~----p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  280 (299)
T 4g31_A          239 DVRNL---------------KF----PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN  280 (299)
T ss_dssp             HHHTT---------------CC----CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHhcC---------------CC----CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            00000               00    01122344567889999999999999999999874

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=2.7e-47  Score=439.74  Aligned_cols=435  Identities=21%  Similarity=0.206  Sum_probs=338.0

Q ss_pred             CcccccccccCCcccccCCCCCcEEEccCCcccccccccccCCCCCCEEeCCCCcCCcccChhhhCcCCCceeeccCCcc
Q 040845            2 PSIINNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSL   81 (824)
Q Consensus         2 ~~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l   81 (824)
                      |+|++|+|+++.|..|.++++|++|+|++|++++..|..|+++++|++|||++|++++..|.+|.++++|++|+|++|++
T Consensus        31 L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l  110 (549)
T 2z81_A           31 LDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPY  110 (549)
T ss_dssp             EECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCC
T ss_pred             EECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcc
Confidence            67889999999999999999999999999999988888899999999999999999977777799999999999999999


Q ss_pred             ccccCccccCCCCCccEEEccCCe-eeeecCccccCCCCCceEeccCccccccCCccccCCCCCCEEEccCCcCCCCcCc
Q 040845           82 SGCLSSITDVGLPNLEVLYLWGNN-FSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLD  160 (824)
Q Consensus        82 ~~~~~~~~~~~l~~L~~L~L~~n~-i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~  160 (824)
                      ++.........+++|++|++++|. +....+..+..+++|++|++++|++++..|..++++++|++|+++.|.+..++..
T Consensus       111 ~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~  190 (549)
T 2z81_A          111 QTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEI  190 (549)
T ss_dssp             SSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBSTTHHHH
T ss_pred             cccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCcccccchh
Confidence            865332233468999999999998 5544456889999999999999999988899999999999999998888765432


Q ss_pred             ccccccCCCCCCCcEEECcCCCCCccCCcc-ccccccccccEEEeecCcceecCC----ccCCCCCCCCEEEecCCccCC
Q 040845          161 LSFLSSLSNCKSLTHISLSNNPLDGILPRT-YVGNLSHSLKNFYMYNCNVSGGIP----EEITNLTDLTTIVLGGNKLNG  235 (824)
Q Consensus       161 ~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~-~~~~l~~~L~~L~l~~n~l~~~~~----~~l~~l~~L~~L~L~~n~l~~  235 (824)
                           .+..+++|++|++++|++.+..... .......+|+.|++++|.+++..+    ..+..+++|+.|++++|.+.+
T Consensus       191 -----~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~  265 (549)
T 2z81_A          191 -----FADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNG  265 (549)
T ss_dssp             -----HHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEEC
T ss_pred             -----hHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHHHHHhhhhccccccccccccccc
Confidence                 1346788999999999988752110 111223456666666666654322    122334444444444444332


Q ss_pred             c-----------------------------------cchhhcCCCCCCEEEcccccCcccCCccc-cccCCccEEEccCc
Q 040845          236 S-----------------------------------IPITLGKLQKLQDVDLEYNQLEGSIPDSI-CLSVELYELELGGN  279 (824)
Q Consensus       236 ~-----------------------------------~~~~~~~l~~L~~L~L~~n~l~~~~~~~~-~~~~~L~~L~l~~n  279 (824)
                      .                                   .+..+...++|+.|++++|++. .+|..+ ..+++|+.|++++|
T Consensus       266 ~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N  344 (549)
T 2z81_A          266 LGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSEN  344 (549)
T ss_dssp             CSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSS
T ss_pred             cccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCccc-cCCHHHHhcCccccEEEccCC
Confidence            1                                   1122334567889999999987 556555 57899999999999


Q ss_pred             cccccCC---ccccCCCCCcEEEcCCCCCCCCCC---cccccccccccccccccccCcCCccccccccchhhhccccccc
Q 040845          280 KLSGSIP---ACFSNMTFLKVLSLGSNELTSIPL---NFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFS  353 (824)
Q Consensus       280 ~l~~~~~---~~~~~l~~L~~L~L~~N~l~~lp~---~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~  353 (824)
                      ++.+..|   ..++.+++|++|++++|+++.++.   .+..+++|+.|++++|+++ .+|..+..+++|+.|++++|+++
T Consensus       345 ~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~  423 (549)
T 2z81_A          345 LMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR  423 (549)
T ss_dssp             CCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCS
T ss_pred             ccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCcc
Confidence            9987653   457888999999999999998863   3778999999999999998 67888889999999999999998


Q ss_pred             ccCCCccCCCCCCCeEEccCccccccCCccccccccccEEEccCcccCCCCcccccCCcccceeeccCCcccCCCCC-CC
Q 040845          354 GIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIPR-GG  432 (824)
Q Consensus       354 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~  432 (824)
                      + +|..+.  ++|+.|+|++|+|++.    +..+++|+.|+|++|+|+ .+|. ...+++|+.|+|++|++++.+|. ..
T Consensus       424 ~-l~~~~~--~~L~~L~Ls~N~l~~~----~~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~  494 (549)
T 2z81_A          424 V-VKTCIP--QTLEVLDVSNNNLDSF----SLFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFD  494 (549)
T ss_dssp             C-CCTTSC--TTCSEEECCSSCCSCC----CCCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGG
T ss_pred             c-ccchhc--CCceEEECCCCChhhh----cccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHh
Confidence            4 444332  6899999999999864    257889999999999998 7776 46789999999999999988876 35


Q ss_pred             CccccccccccCCccccCCC
Q 040845          433 SFGNFSAESFKGNELLCGSP  452 (824)
Q Consensus       433 ~~~~~~~~~~~~n~~~c~~~  452 (824)
                      .+.++..+.+.+|++.|+|+
T Consensus       495 ~l~~L~~L~l~~N~~~~~~~  514 (549)
T 2z81_A          495 RLTSLQKIWLHTNPWDCSCP  514 (549)
T ss_dssp             GCTTCCEEECCSSCBCCCHH
T ss_pred             cCcccCEEEecCCCccCCCc
Confidence            67788888999999988875

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=3.5e-47  Score=450.04  Aligned_cols=437  Identities=19%  Similarity=0.223  Sum_probs=349.9

Q ss_pred             CcccccccccCCcccccCCCCCcEEEc-cCCcccccccccc---------------------------------------
Q 040845            2 PSIINNFLTSTTPKEIDNISNLKVLYL-YNNRLQGEIIHEI---------------------------------------   41 (824)
Q Consensus         2 ~~l~~n~i~~~~p~~~~~l~~L~~L~L-~~n~l~~~~~~~~---------------------------------------   41 (824)
                      |+|.+|+|++.+|+.|++|++|++|+| ++|.+.+..+-.-                                       
T Consensus       328 L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~  407 (876)
T 4ecn_A          328 LSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDA  407 (876)
T ss_dssp             EECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHH
T ss_pred             EECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHH
Confidence            567788888888888888888888888 7777766522110                                       


Q ss_pred             ------------cCCCCCCEEeCCC--CcCCcccChhhhCcCCCceeeccCCcccc------------------ccCccc
Q 040845           42 ------------GHLHNLGFLDLSQ--NKLLGTIPAAIFNVSTLKAFAVTNNSLSG------------------CLSSIT   89 (824)
Q Consensus        42 ------------~~l~~L~~L~Ls~--n~l~~~~~~~~~~l~~L~~L~L~~n~l~~------------------~~~~~~   89 (824)
                                  .....++.+.++.  |++++ +|..|.++++|++|+|++|++++                  +|..+.
T Consensus       408 l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~  486 (876)
T 4ecn_A          408 INRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELS  486 (876)
T ss_dssp             HHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCC
T ss_pred             hhhCccccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhh
Confidence                        1112333444433  77776 89999999999999999999998                  777765


Q ss_pred             cCCCCCccEEEccCCeeeeecCccccCCCCCceEeccCcc-ccc-cCCccccCC-------CCCCEEEccCCcCCCCcCc
Q 040845           90 DVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNS-FSG-FIPSTFGNL-------RNLEWLTLYDNNLTSSTLD  160 (824)
Q Consensus        90 ~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~L~~N~-i~~-~~~~~~~~l-------~~L~~L~L~~n~i~~~~~~  160 (824)
                      +..+++|++|+|++|++.+.+|..|.++++|+.|+|++|+ +++ .+|..++++       ++|++|+|++|.++.++. 
T Consensus       487 f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~~ip~-  565 (876)
T 4ecn_A          487 WSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPA-  565 (876)
T ss_dssp             GGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCCBCCC-
T ss_pred             hccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCCccCC-
Confidence            4469999999999999999999999999999999999998 887 677766555       499999999999986542 


Q ss_pred             ccccccCCCCCCCcEEECcCCCCCccCCccccccccccccEEEeecCcceecCCccCCCCCC-CCEEEecCCccCCccch
Q 040845          161 LSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTD-LTTIVLGGNKLNGSIPI  239 (824)
Q Consensus       161 ~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~-L~~L~L~~n~l~~~~~~  239 (824)
                         ...+.++++|++|+|++|.+..++  .| +. .++|+.|++++|+++ .+|..+..+++ |+.|+|++|.++ .+|.
T Consensus       566 ---~~~l~~L~~L~~L~Ls~N~l~~lp--~~-~~-L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~  636 (876)
T 4ecn_A          566 ---SASLQKMVKLGLLDCVHNKVRHLE--AF-GT-NVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPN  636 (876)
T ss_dssp             ---HHHHTTCTTCCEEECTTSCCCBCC--CC-CT-TSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCS
T ss_pred             ---hhhhhcCCCCCEEECCCCCcccch--hh-cC-CCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCch
Confidence               014789999999999999998544  33 22 468999999999999 88888999999 999999999999 6788


Q ss_pred             hhcCCCC--CCEEEcccccCcccCCccc---c--ccCCccEEEccCccccccCCccccCCCCCcEEEcCCCCCCCCCCcc
Q 040845          240 TLGKLQK--LQDVDLEYNQLEGSIPDSI---C--LSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNF  312 (824)
Q Consensus       240 ~~~~l~~--L~~L~L~~n~l~~~~~~~~---~--~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~  312 (824)
                      .+..++.  |+.|+|++|++.+.+|...   .  .+++|+.|++++|+++...+..+..+++|+.|+|++|+|+.+|..+
T Consensus       637 ~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~~ip~~~  716 (876)
T 4ecn_A          637 IFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENS  716 (876)
T ss_dssp             CCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCSCCCTTS
T ss_pred             hhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCCccChHH
Confidence            8877654  9999999999987665432   2  3458999999999999555555568999999999999999999876


Q ss_pred             ccc--------ccccccccccccccCcCCcccc--ccccchhhhcccccccccCCCccCCCCCCCeEEccC------ccc
Q 040845          313 WSL--------KDILDLNLSSNCFSGPLPLEIR--NLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEY------NRL  376 (824)
Q Consensus       313 ~~l--------~~L~~L~l~~N~l~~~~~~~~~--~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~------N~l  376 (824)
                      +..        ++|+.|+|++|+++ .+|..+.  .+++|+.|+|++|++++ +|..+..+++|+.|+|++      |++
T Consensus       717 ~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l  794 (876)
T 4ecn_A          717 LKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRI  794 (876)
T ss_dssp             SSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBC
T ss_pred             hccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccc
Confidence            543        39999999999999 6788887  99999999999999997 688899999999999976      788


Q ss_pred             cccCCccccccccccEEEccCcccCCCCcccccCCcccceeeccCCcccCCCCCCCC-ccccccccccCCcc--ccCCCC
Q 040845          377 EGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIPRGGS-FGNFSAESFKGNEL--LCGSPN  453 (824)
Q Consensus       377 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-~~~~~~~~~~~n~~--~c~~~~  453 (824)
                      .+.+|..|..+++|+.|+|++|+| +.+|..+.  ++|+.|+|++|++....+.... ........+..|+.  .++|+.
T Consensus       795 ~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~~~~~~~~~~~~~~L~~n~~~~I~gC~~  871 (876)
T 4ecn_A          795 LRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDIRGCDA  871 (876)
T ss_dssp             CCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEECGGGHHHHHTTCCEEECCTTSEEESCGG
T ss_pred             cccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCccChHHccccccchheeecCCCccccCCCCC
Confidence            889999999999999999999999 58998876  6999999999998765443111 11123344455544  457764


Q ss_pred             C
Q 040845          454 L  454 (824)
Q Consensus       454 ~  454 (824)
                      .
T Consensus       872 L  872 (876)
T 4ecn_A          872 L  872 (876)
T ss_dssp             G
T ss_pred             c
Confidence            3

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=7.2e-46  Score=447.51  Aligned_cols=421  Identities=20%  Similarity=0.184  Sum_probs=348.7

Q ss_pred             Ccccccccc-cCCcccccCCCCCcEEEccCCcccccccccccCCCCCCEEeCCCCcCCcccChh--hhCcCCCceeeccC
Q 040845            2 PSIINNFLT-STTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAA--IFNVSTLKAFAVTN   78 (824)
Q Consensus         2 ~~l~~n~i~-~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~--~~~l~~L~~L~L~~   78 (824)
                      |+|++|.+. .+.|.+|.++++|++|+|++|+|++..|..|+++++|++|+|++|.+++..|..  |.++++|++|+|++
T Consensus        53 LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~  132 (844)
T 3j0a_A           53 LELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSK  132 (844)
T ss_dssp             EEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEES
T ss_pred             EeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCC
Confidence            577888544 455899999999999999999999988999999999999999999999766665  99999999999999


Q ss_pred             CccccccCccccCCCCCccEEEccCCeeeeecCccccCC--CCCceEeccCccccccCCccccCCCC------CCEEEcc
Q 040845           79 NSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNA--SKLSKLALEMNSFSGFIPSTFGNLRN------LEWLTLY  150 (824)
Q Consensus        79 n~l~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l--~~L~~L~L~~N~i~~~~~~~~~~l~~------L~~L~L~  150 (824)
                      |.+++......+..+++|++|+|++|.+++..+..+..+  ++|+.|+|++|.+.+..+..++.+++      |++|+++
T Consensus       133 N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls  212 (844)
T 3j0a_A          133 NQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVS  212 (844)
T ss_dssp             CCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCS
T ss_pred             CcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecC
Confidence            999987654444579999999999999998888888887  89999999999999888877777665      8999999


Q ss_pred             CCcCCCCcCccccc--------------------------------ccCCC--CCCCcEEECcCCCCCccCCcccccccc
Q 040845          151 DNNLTSSTLDLSFL--------------------------------SSLSN--CKSLTHISLSNNPLDGILPRTYVGNLS  196 (824)
Q Consensus       151 ~n~i~~~~~~~~~~--------------------------------~~l~~--l~~L~~L~Ls~n~l~~~~~~~~~~~l~  196 (824)
                      +|.++...... +.                                ..+..  .++|++|++++|.+.++.+..|..  .
T Consensus       213 ~n~l~~~~~~~-~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~--l  289 (844)
T 3j0a_A          213 GNGWTVDITGN-FSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFET--L  289 (844)
T ss_dssp             SCCSSTTTTSG-GGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSS--C
T ss_pred             CCcCchhHHHH-HHhhcCcccccceecccccccccccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhc--C
Confidence            98765322110 00                                11222  267888888888888777666543  4


Q ss_pred             ccccEEEeecCcceecCCccCCCCCCCCEEEecCCccCCccchhhcCCCCCCEEEcccccCcccCCccccccCCccEEEc
Q 040845          197 HSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELEL  276 (824)
Q Consensus       197 ~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l  276 (824)
                      ++|+.|++++|++++..+..|..+++|+.|+|++|.+++..+..|..+++|++|++++|+++...+..|..+++|+.|++
T Consensus       290 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L  369 (844)
T 3j0a_A          290 KDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDL  369 (844)
T ss_dssp             CCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEE
T ss_pred             CCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEEC
Confidence            57888888888888888888888888888888888888777888888888888888888888777777888888888888


Q ss_pred             cCccccccC------------------Cc----------------------cccCCCCCcEEEcCCCCCCCCCCc--ccc
Q 040845          277 GGNKLSGSI------------------PA----------------------CFSNMTFLKVLSLGSNELTSIPLN--FWS  314 (824)
Q Consensus       277 ~~n~l~~~~------------------~~----------------------~~~~l~~L~~L~L~~N~l~~lp~~--~~~  314 (824)
                      ++|.+++..                  |.                      .+.++++|+.|+|++|+++.++..  +..
T Consensus       370 s~N~l~~i~~~~~L~~L~l~~N~l~~l~~~~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~  449 (844)
T 3j0a_A          370 RDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSE  449 (844)
T ss_dssp             ETCCSCCCSSCCSCSEEEEESCCCCCCCCCCTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCS
T ss_pred             CCCCCCcccCCCCcchhccCCCCcccccccccccceeecccCccccCchhhhhhcCCccceeeCCCCccccccccccccc
Confidence            888776421                  10                      133788999999999999987654  566


Q ss_pred             ccccccccccccccc-----CcCCccccccccchhhhcccccccccCCCccCCCCCCCeEEccCccccccCCcccccccc
Q 040845          315 LKDILDLNLSSNCFS-----GPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLIS  389 (824)
Q Consensus       315 l~~L~~L~l~~N~l~-----~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  389 (824)
                      +++|+.|++++|.++     +..+..|.++++|+.|+|++|++++.+|..|..+++|+.|+|++|+|++..+..+.  ++
T Consensus       450 ~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~  527 (844)
T 3j0a_A          450 NPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--AN  527 (844)
T ss_dssp             CTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SC
T ss_pred             CCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--cc
Confidence            899999999999997     34556789999999999999999999999999999999999999999977666665  89


Q ss_pred             ccEEEccCcccCCCCcccccCCcccceeeccCCcccCCCCC
Q 040845          390 LKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIPR  430 (824)
Q Consensus       390 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~  430 (824)
                      |+.|+|++|+|++..|..+.   +|+.|++++|++.|.++.
T Consensus       528 L~~L~Ls~N~l~~~~~~~~~---~L~~l~l~~Np~~C~c~~  565 (844)
T 3j0a_A          528 LEILDISRNQLLAPNPDVFV---SLSVLDITHNKFICECEL  565 (844)
T ss_dssp             CCEEEEEEECCCCCCSCCCS---SCCEEEEEEECCCCSSSC
T ss_pred             ccEEECCCCcCCCCChhHhC---CcCEEEecCCCccccccc
Confidence            99999999999988887764   788999999999998874

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.2e-46  Score=434.47  Aligned_cols=437  Identities=21%  Similarity=0.235  Sum_probs=374.3

Q ss_pred             CcccccccccCCcccccCCCCCcEEEccCCcccccccccccCCCCCCEEeCCCCcCCcccChhhhCcCCCceeeccCCcc
Q 040845            2 PSIINNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSL   81 (824)
Q Consensus         2 ~~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l   81 (824)
                      |+|++|+|+++.|..|.++++|++|+|++|++++..+..|+++++|++|++++|++++..+.++.++++|++|++++|.+
T Consensus        57 L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l  136 (570)
T 2z63_A           57 LDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLI  136 (570)
T ss_dssp             EECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCC
T ss_pred             EECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccccccccccCCCccccccccccEEecCCCcc
Confidence            67899999999999999999999999999999988889999999999999999999966666799999999999999999


Q ss_pred             ccc--cCccccCCCCCccEEEccCCeeeeecCccccCCCCC----ceEeccCccccccCCccccCCCCCCEEEccCCcCC
Q 040845           82 SGC--LSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKL----SKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLT  155 (824)
Q Consensus        82 ~~~--~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L----~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~  155 (824)
                      +++  +..+  .++++|++|++++|++++..+..+..+++|    +.|++++|.+++..+..|..+ +|++|++++|...
T Consensus       137 ~~~~lp~~~--~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~-~L~~L~l~~n~~~  213 (570)
T 2z63_A          137 QSFKLPEYF--SNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDS  213 (570)
T ss_dssp             CCCCCCGGG--GGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSC
T ss_pred             ceecChhhh--cccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCCCceecCHHHhccC-cceeEeccccccc
Confidence            874  4433  359999999999999998888889999998    899999999999988888876 8999999887322


Q ss_pred             CC-------------------------------c----------------------CcccccccCCCCCCCcEEECcCCC
Q 040845          156 SS-------------------------------T----------------------LDLSFLSSLSNCKSLTHISLSNNP  182 (824)
Q Consensus       156 ~~-------------------------------~----------------------~~~~~~~~l~~l~~L~~L~Ls~n~  182 (824)
                      ..                               +                      .....+..+..+++|++|++++|.
T Consensus       214 ~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~  293 (570)
T 2z63_A          214 LNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVT  293 (570)
T ss_dssp             TTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCE
T ss_pred             ccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEEecCcc
Confidence            10                               0                      000112446778999999999999


Q ss_pred             CCccCCccccccccccccEEEeecCcceecCCccCCCCCCCCEEEecCCccCCccchhhcCCCCCCEEEcccccCcccC-
Q 040845          183 LDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSI-  261 (824)
Q Consensus       183 l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~-  261 (824)
                      +..++.. + ..+  +|++|++++|.+. .+|.  ..+++|+.|++++|.+.+..+.  ..+++|++|++++|++++.. 
T Consensus       294 l~~l~~~-~-~~~--~L~~L~l~~n~~~-~l~~--~~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~  364 (570)
T 2z63_A          294 IERVKDF-S-YNF--GWQHLELVNCKFG-QFPT--LKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGC  364 (570)
T ss_dssp             ECSCCBC-C-SCC--CCSEEEEESCBCS-SCCB--CBCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEE
T ss_pred             chhhhhh-h-ccC--CccEEeeccCccc-ccCc--ccccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCcccc
Confidence            9875443 3 222  8999999999998 5554  5789999999999999866554  78999999999999998654 


Q ss_pred             -CccccccCCccEEEccCccccccCCccccCCCCCcEEEcCCCCCCCCCC--cccccccccccccccccccCcCCccccc
Q 040845          262 -PDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPL--NFWSLKDILDLNLSSNCFSGPLPLEIRN  338 (824)
Q Consensus       262 -~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~--~~~~l~~L~~L~l~~N~l~~~~~~~~~~  338 (824)
                       +..+..+++|+.|++++|++.+..+. +..+++|++|++++|.++.++.  .+..+++|+.|++++|.+.+..|..+.+
T Consensus       365 ~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~  443 (570)
T 2z63_A          365 CSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNG  443 (570)
T ss_dssp             EEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTT
T ss_pred             ccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhc
Confidence             67888999999999999999976665 9999999999999999998754  5788999999999999999989999999


Q ss_pred             cccchhhhccccccc-ccCCCccCCCCCCCeEEccCccccccCCccccccccccEEEccCcccCCCCcccccCCccccee
Q 040845          339 LKALIEIDFSMNNFS-GIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDL  417 (824)
Q Consensus       339 l~~L~~L~l~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  417 (824)
                      +++|+.|++++|+++ +.+|..+..+++|+.|++++|++++..|..|..+++|+.|++++|++++..|..+..+++|+.|
T Consensus       444 l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L  523 (570)
T 2z63_A          444 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKI  523 (570)
T ss_dssp             CTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEE
T ss_pred             CCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEE
Confidence            999999999999998 5788999999999999999999998889999999999999999999998888889999999999


Q ss_pred             eccCCcccCCCCCCCCc-ccc--ccccccCCccccCCC
Q 040845          418 NLSFNKLKGEIPRGGSF-GNF--SAESFKGNELLCGSP  452 (824)
Q Consensus       418 ~l~~N~l~~~~p~~~~~-~~~--~~~~~~~n~~~c~~~  452 (824)
                      ++++|+++|.+|....+ ..+  ....+.+.+ .|..|
T Consensus       524 ~l~~N~~~~~~~~~~~~~~wl~~~~~~~~~~~-~C~~~  560 (570)
T 2z63_A          524 WLHTNPWDCSCPRIDYLSRWLNKNSQKEQGSA-KCSGS  560 (570)
T ss_dssp             ECCSSCBCCCTTTTHHHHHHHHHTGGGEESCC-BBTTT
T ss_pred             EecCCcccCCCcchHHHHHHHHhccccCCCch-hhCCC
Confidence            99999999999875433 111  112344444 66655

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=4.1e-46  Score=426.67  Aligned_cols=431  Identities=20%  Similarity=0.185  Sum_probs=339.2

Q ss_pred             CcccccccccCCcccccCCCCCcEEEccCCcccccccccccCCCCCCEEeCCCCcCCcccChhhhCcCCCceeeccCCcc
Q 040845            2 PSIINNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSL   81 (824)
Q Consensus         2 ~~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l   81 (824)
                      +++++|+|++ +|..+.  ++|++|+|++|++++..|..|+++++|++|+|++|++++..|.+|.++++|++|+|++|++
T Consensus         5 l~ls~n~l~~-ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l   81 (520)
T 2z7x_B            5 VDRSKNGLIH-VPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKL   81 (520)
T ss_dssp             EECTTSCCSS-CCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCC
T ss_pred             EecCCCCccc-cccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCce
Confidence            6789999996 555555  8999999999999988888999999999999999999988899999999999999999999


Q ss_pred             ccccCccccCCCCCccEEEccCCeeee-ecCccccCCCCCceEeccCccccccCCccccCCCCC--CEEEccCCcC--CC
Q 040845           82 SGCLSSITDVGLPNLEVLYLWGNNFSG-TIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNL--EWLTLYDNNL--TS  156 (824)
Q Consensus        82 ~~~~~~~~~~~l~~L~~L~L~~n~i~~-~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L--~~L~L~~n~i--~~  156 (824)
                      +.++..    .+++|++|+|++|++++ .+|..|+.+++|++|+|++|++++   ..|..+++|  ++|++++|.+  ..
T Consensus        82 ~~lp~~----~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~  154 (520)
T 2z7x_B           82 VKISCH----PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEK  154 (520)
T ss_dssp             CEEECC----CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSS
T ss_pred             eecCcc----ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccccc
Confidence            987776    58999999999999997 468999999999999999999986   467788888  9999999998  33


Q ss_pred             CcCc-ccc--------------------cccCCCCCCCcEEECcCCC-------CCccCCccccccccccccEEEeecCc
Q 040845          157 STLD-LSF--------------------LSSLSNCKSLTHISLSNNP-------LDGILPRTYVGNLSHSLKNFYMYNCN  208 (824)
Q Consensus       157 ~~~~-~~~--------------------~~~l~~l~~L~~L~Ls~n~-------l~~~~~~~~~~~l~~~L~~L~l~~n~  208 (824)
                      .... +..                    ...+.++++|+.|++++|.       +.+..+ .+ +. ..+|+.|++.+|.
T Consensus       155 ~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l-~~-l~~L~~L~l~~~~  231 (520)
T 2z7x_B          155 EDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KL-QT-NPKLSNLTLNNIE  231 (520)
T ss_dssp             CCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GG-GG-CTTCCEEEEEEEE
T ss_pred             cccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hh-cc-ccchhhccccccc
Confidence            2211 000                    0123345555566665554       222222 11 11 2356666666666


Q ss_pred             ceecCCccCC---CCCCCCEEEecCCccCCccchhh-----cCCCCCCEEEcccccCcccCC-cccccc---CCccEEEc
Q 040845          209 VSGGIPEEIT---NLTDLTTIVLGGNKLNGSIPITL-----GKLQKLQDVDLEYNQLEGSIP-DSICLS---VELYELEL  276 (824)
Q Consensus       209 l~~~~~~~l~---~l~~L~~L~L~~n~l~~~~~~~~-----~~l~~L~~L~L~~n~l~~~~~-~~~~~~---~~L~~L~l  276 (824)
                      +++..+..+.   .+++|+.|++++|++++.+|..+     ..+++|+.+++++|.+  .+| ..+..+   .+|+.|++
T Consensus       232 l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l  309 (520)
T 2z7x_B          232 TTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTV  309 (520)
T ss_dssp             EEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEE
T ss_pred             cCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEc
Confidence            6543222111   13477777777777776677766     7777777777777777  334 444444   56888888


Q ss_pred             cCccccccCCccccCCCCCcEEEcCCCCCCC-CCCcccccccccccccccccccC--cCCccccccccchhhhccccccc
Q 040845          277 GGNKLSGSIPACFSNMTFLKVLSLGSNELTS-IPLNFWSLKDILDLNLSSNCFSG--PLPLEIRNLKALIEIDFSMNNFS  353 (824)
Q Consensus       277 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~-lp~~~~~l~~L~~L~l~~N~l~~--~~~~~~~~l~~L~~L~l~~N~l~  353 (824)
                      ++|.+....  .+..+++|++|++++|+++. +|..+..+++|+.|++++|++++  ..|..+.++++|+.|++++|+++
T Consensus       310 ~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~  387 (520)
T 2z7x_B          310 SGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVS  387 (520)
T ss_dssp             ESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCB
T ss_pred             CCCcccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCC
Confidence            888876432  23688999999999999997 67888999999999999999986  45677999999999999999999


Q ss_pred             ccCC-CccCCCCCCCeEEccCccccccCCccccccccccEEEccCcccCCCCcccccCCcccceeeccCCcccCCCCC-C
Q 040845          354 GIIP-MEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIPR-G  431 (824)
Q Consensus       354 ~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~  431 (824)
                      +.+| ..+..+++|+.|++++|++++..|..+.  ++|+.|+|++|+|+ .+|..+..+++|+.|++++|+++..++. .
T Consensus       388 ~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~  464 (520)
T 2z7x_B          388 YDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIF  464 (520)
T ss_dssp             CCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTT
T ss_pred             cccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHh
Confidence            8444 4588999999999999999887776664  79999999999999 8898888999999999999999965444 4


Q ss_pred             CCccccccccccCCccccCCC
Q 040845          432 GSFGNFSAESFKGNELLCGSP  452 (824)
Q Consensus       432 ~~~~~~~~~~~~~n~~~c~~~  452 (824)
                      ..+.++..+.+.+|++.|+|+
T Consensus       465 ~~l~~L~~L~l~~N~~~c~c~  485 (520)
T 2z7x_B          465 DRLTSLQKIWLHTNPWDCSCP  485 (520)
T ss_dssp             TTCTTCCEEECCSSCBCCCHH
T ss_pred             ccCCcccEEECcCCCCcccCC
Confidence            557778889999999999875

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=3.4e-46  Score=435.47  Aligned_cols=383  Identities=17%  Similarity=0.226  Sum_probs=338.5

Q ss_pred             CcccccccccCCcccccCCCCCcEEEccCC--------------------------------------------------
Q 040845            2 PSIINNFLTSTTPKEIDNISNLKVLYLYNN--------------------------------------------------   31 (824)
Q Consensus         2 ~~l~~n~i~~~~p~~~~~l~~L~~L~L~~n--------------------------------------------------   31 (824)
                      |+|++|++++.+|++|+++++|++|+|++|                                                  
T Consensus        86 L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l  165 (636)
T 4eco_A           86 LSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDC  165 (636)
T ss_dssp             EECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHH
T ss_pred             EEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHH
Confidence            678999999999999999999999999998                                                  


Q ss_pred             ----------------------------cccccccccccCCCCCCEEeCCCCcCCcc-----------------cChhhh
Q 040845           32 ----------------------------RLQGEIIHEIGHLHNLGFLDLSQNKLLGT-----------------IPAAIF   66 (824)
Q Consensus        32 ----------------------------~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~-----------------~~~~~~   66 (824)
                                                  ++++ +|..|+++++|++|+|++|.+++.                 +|..+.
T Consensus       166 ~~~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~  244 (636)
T 4eco_A          166 INSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLK  244 (636)
T ss_dssp             HHHCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCC
T ss_pred             hhcCccccccccccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhh
Confidence                                        4455 788999999999999999999975                 999999


Q ss_pred             --CcCCCceeeccCCccccccCccccCCCCCccEEEccCCe-eee-ecCccccCC------CCCceEeccCccccccCCc
Q 040845           67 --NVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNN-FSG-TIPHFIFNA------SKLSKLALEMNSFSGFIPS  136 (824)
Q Consensus        67 --~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~-i~~-~~~~~l~~l------~~L~~L~L~~N~i~~~~~~  136 (824)
                        ++++|++|+|++|++.+..+... ..+++|++|+|++|+ +++ .+|..++.+      ++|++|+|++|+++ .+|.
T Consensus       245 ~~~l~~L~~L~L~~n~l~~~~p~~l-~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~  322 (636)
T 4eco_A          245 WDNLKDLTDVEVYNCPNLTKLPTFL-KALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPV  322 (636)
T ss_dssp             GGGCTTCCEEEEECCTTCSSCCTTT-TTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCC
T ss_pred             hcccCCCCEEEecCCcCCccChHHH-hcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCc
Confidence              99999999999999887554332 369999999999998 998 789888886      99999999999999 7788


Q ss_pred             --cccCCCCCCEEEccCCcCC-CCcCcccccccCCCCCCCcEEECcCCCCCccCCccccccccccccEEEeecCcceecC
Q 040845          137 --TFGNLRNLEWLTLYDNNLT-SSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGI  213 (824)
Q Consensus       137 --~~~~l~~L~~L~L~~n~i~-~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~  213 (824)
                        .|+++++|++|++++|+++ .++       .+..+++|++|++++|.+..++. .+ ..++.+|++|++++|.++ .+
T Consensus       323 ~~~l~~l~~L~~L~L~~N~l~g~ip-------~~~~l~~L~~L~L~~N~l~~lp~-~l-~~l~~~L~~L~Ls~N~l~-~l  392 (636)
T 4eco_A          323 ETSLQKMKKLGMLECLYNQLEGKLP-------AFGSEIKLASLNLAYNQITEIPA-NF-CGFTEQVENLSFAHNKLK-YI  392 (636)
T ss_dssp             HHHHTTCTTCCEEECCSCCCEEECC-------CCEEEEEESEEECCSSEEEECCT-TS-EEECTTCCEEECCSSCCS-SC
T ss_pred             hhhhccCCCCCEEeCcCCcCccchh-------hhCCCCCCCEEECCCCccccccH-hh-hhhcccCcEEEccCCcCc-cc
Confidence              9999999999999999998 543       47888999999999999985543 33 344444999999999999 78


Q ss_pred             CccCCCCC--CCCEEEecCCccCCccchhhc-------CCCCCCEEEcccccCcccCCccccccCCccEEEccCcccccc
Q 040845          214 PEEITNLT--DLTTIVLGGNKLNGSIPITLG-------KLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGS  284 (824)
Q Consensus       214 ~~~l~~l~--~L~~L~L~~n~l~~~~~~~~~-------~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~  284 (824)
                      |..+..++  +|+.|++++|.+.+..|..|.       .+++|++|+|++|+++...+..+..+++|+.|++++|+++..
T Consensus       393 p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i  472 (636)
T 4eco_A          393 PNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEI  472 (636)
T ss_dssp             CSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBC
T ss_pred             chhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCCCc
Confidence            88888765  999999999999999998888       888999999999999955555566799999999999999955


Q ss_pred             CCccccCCC-------CCcEEEcCCCCCCCCCCccc--ccccccccccccccccCcCCccccccccchhhhc------cc
Q 040845          285 IPACFSNMT-------FLKVLSLGSNELTSIPLNFW--SLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDF------SM  349 (824)
Q Consensus       285 ~~~~~~~l~-------~L~~L~L~~N~l~~lp~~~~--~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l------~~  349 (824)
                      .+..+....       +|+.|+|++|+++.+|..+.  .+++|+.|+|++|++++ +|..+.++++|+.|+|      ++
T Consensus       473 ~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~  551 (636)
T 4eco_A          473 PKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQG  551 (636)
T ss_dssp             CSSSSEETTEECTTGGGCCEEECCSSCCCBCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTC
T ss_pred             CHHHhccccccccccCCccEEECcCCcCCccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCccccc
Confidence            555554443       99999999999999999987  89999999999999997 8999999999999999      56


Q ss_pred             ccccccCCCccCCCCCCCeEEccCccccccCCccccccccccEEEccCcccC
Q 040845          350 NNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLS  401 (824)
Q Consensus       350 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  401 (824)
                      |++.+.+|..++.+++|+.|+|++|+++ .+|..+.  ++|+.|+|++|+++
T Consensus       552 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~  600 (636)
T 4eco_A          552 NRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKIT--PNISVLDIKDNPNI  600 (636)
T ss_dssp             CBCCCCCCTTGGGCSSCCEEECCSSCCC-BCCSCCC--TTCCEEECCSCTTC
T ss_pred             CcccccChHHHhcCCCCCEEECCCCcCC-ccCHhHh--CcCCEEECcCCCCc
Confidence            8888899999999999999999999995 7887766  79999999999887

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=8.9e-46  Score=397.69  Aligned_cols=269  Identities=21%  Similarity=0.284  Sum_probs=201.4

Q ss_pred             HhhccCCCCceeeeccceEEEEEEEC----CCcEEEEEEeeccccchhhhHHHHHHHHhcC-CCCcceeEEeeeecCCee
Q 040845          524 QATDKFSENNLIGRGGFGSVYKARIR----DGMEVAVKVFNLQCGRAFKSFDVECAMMKSI-RHRNLVKVISSCSNEEFK  598 (824)
Q Consensus       524 ~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  598 (824)
                      ...++|++.+.||+|+||+||+|+.+    +++.||||++...  .....+.+|+++++.+ +||||+++++++.+.++.
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~   95 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV   95 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence            45678999999999999999999753    4688999998654  2345678899999998 699999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCC-CcEEEeeccccccc
Q 040845          599 ALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDN-MVAHLSDFGIAKLL  677 (824)
Q Consensus       599 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~Dfg~a~~~  677 (824)
                      |+||||+++|+|.+++.    .+++.++..++.|++.||+|||   +++|+||||||+|||++.+ +.+||+|||+|+..
T Consensus        96 ~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~  168 (361)
T 4f9c_A           96 VIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGT  168 (361)
T ss_dssp             EEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence            99999999999999984    4889999999999999999999   9999999999999999876 89999999999865


Q ss_pred             CCCCCc--------------------------cccccccccccccCccCcCCC-CCCccchHHHHHHHHHHHHhCCCCCc
Q 040845          678 TGEDQS--------------------------MTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTD  730 (824)
Q Consensus       678 ~~~~~~--------------------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~p~~  730 (824)
                      ......                          ...+..+||++|+|||++.+. .|+.++||||+||++|||+||+.||.
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~  248 (361)
T 4f9c_A          169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY  248 (361)
T ss_dssp             TTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred             CCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence            432211                          112335799999999988765 58999999999999999999999996


Q ss_pred             ccccCcchhhhhhhhhC---------------------CCcc-hhhcc---------ccccC---chhhhhhhHHHHHHH
Q 040845          731 ELFNGEMTLKHWVNDCL---------------------PIST-MEVVD---------ANLLS---QEDIHFVAKEQCVSF  776 (824)
Q Consensus       731 ~~~~~~~~~~~~~~~~~---------------------~~~~-~~~~~---------~~~~~---~~~~~~~~~~~~~~~  776 (824)
                      ........+..+.....                     +... .....         +....   ............+++
T Consensus       249 ~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~  328 (361)
T 4f9c_A          249 KASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDE  328 (361)
T ss_dssp             CCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHH
T ss_pred             CCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHH
Confidence            53222111111111000                     0000 00000         00000   000000111235677


Q ss_pred             HHHHHHHccccCCCCCCCHHHHHHH
Q 040845          777 VFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       777 l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      +.+|+.+|++.||++||||+|+++|
T Consensus       329 a~DLl~~lL~~dP~~R~ta~eaL~H  353 (361)
T 4f9c_A          329 AYDLLDKLLDLNPASRITAEEALLH  353 (361)
T ss_dssp             HHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             HHHHHHHHCcCChhHCcCHHHHhcC
Confidence            8999999999999999999999875

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.9e-46  Score=402.65  Aligned_cols=270  Identities=26%  Similarity=0.301  Sum_probs=203.7

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc--chhhhHHHHHHHHhcCCCCcceeEEeeeec------CC
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG--RAFKSFDVECAMMKSIRHRNLVKVISSCSN------EE  596 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~  596 (824)
                      .++|++.+.||+|+||+||+|+++ +|+.||||+++....  ...+.+.+|+++|+.++|||||++++++..      .+
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            367999999999999999999875 699999999965432  234567889999999999999999998753      46


Q ss_pred             eeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccc
Q 040845          597 FKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  676 (824)
Q Consensus       597 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~  676 (824)
                      ..|+||||++ |+|.+++...+ .+++.++..++.||+.||+|||   +++||||||||+|||++.++.+||+|||+|+.
T Consensus       133 ~~~ivmE~~~-g~L~~~i~~~~-~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~  207 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIHSSQ-PLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARG  207 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHTSSS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred             EEEEEEeCCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecceeee
Confidence            7899999996 68999998765 7999999999999999999999   99999999999999999999999999999987


Q ss_pred             cCCCCC--ccccccccccccccCccCcCCC-CCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcc--
Q 040845          677 LTGEDQ--SMTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPIST--  751 (824)
Q Consensus       677 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--  751 (824)
                      +.....  .......+||+.|||||++.+. .++.++||||+||++|||++|++||.+.... ..+..+.........  
T Consensus       208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~-~~l~~I~~~~g~p~~~~  286 (398)
T 4b99_A          208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYV-HQLQLIMMVLGTPSPAV  286 (398)
T ss_dssp             C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH-HHHHHHHHHHCCCCGGG
T ss_pred             cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHH-HHHHHHHHhcCCCChHH
Confidence            643321  2233456899999999998765 5699999999999999999999999763211 111111111111100  


Q ss_pred             hhhccc--------cccCchhhh-hhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          752 MEVVDA--------NLLSQEDIH-FVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       752 ~~~~~~--------~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      ......        ......... .......+.++.+|+.+||..||++||||+|+++|
T Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  345 (398)
T 4b99_A          287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH  345 (398)
T ss_dssp             TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            000000        000000000 00112346678999999999999999999999875

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=3.6e-45  Score=422.08  Aligned_cols=416  Identities=19%  Similarity=0.212  Sum_probs=343.7

Q ss_pred             CcccccccccCCcccccCCCCCcEEEccCCcccccccccccCCCCCCEEeCCCCcCCc-ccChhhhCcCCCceeeccCCc
Q 040845            2 PSIINNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLG-TIPAAIFNVSTLKAFAVTNNS   80 (824)
Q Consensus         2 ~~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~L~~n~   80 (824)
                      |+|++|+|+++.|.+|.++++|++|+|++|++++..+..|+++++|++|+|++|.+++ ..|..+.++++|++|++++|+
T Consensus        55 L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~  134 (549)
T 2z81_A           55 LILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVE  134 (549)
T ss_dssp             EECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESS
T ss_pred             EECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCc
Confidence            6789999999999999999999999999999998888789999999999999999986 357789999999999999998


Q ss_pred             -cccccCccccCCCCCccEEEccCCeeeeecCccccCCCCCceEeccCccccccCCccccCCCCCCEEEccCCcCCCCcC
Q 040845           81 -LSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTL  159 (824)
Q Consensus        81 -l~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~  159 (824)
                       +..++.. .+.++++|++|++++|++++..|..+..+++|++|++++|.+.......+..+++|++|++++|+++..+.
T Consensus       135 ~~~~~~~~-~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~  213 (549)
T 2z81_A          135 TFSEIRRI-DFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQF  213 (549)
T ss_dssp             SCCEECTT-TTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCC
T ss_pred             cccccCHh-hhhcccccCeeeccCCcccccChhhhhccccCceEecccCcccccchhhHhhcccccEEEccCCccccccc
Confidence             5555433 33479999999999999999999999999999999999999885444445679999999999999987642


Q ss_pred             cccccccCCCCCCCcEEECcCCCCCccCCccccc--cccccccEEEeecCcceecCC---------cc------------
Q 040845          160 DLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVG--NLSHSLKNFYMYNCNVSGGIP---------EE------------  216 (824)
Q Consensus       160 ~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~--~l~~~L~~L~l~~n~l~~~~~---------~~------------  216 (824)
                      ..  ......+++|++|++++|.+.+..+..+..  ....+|+.+++.+|.+.+...         ..            
T Consensus       214 ~~--~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~  291 (549)
T 2z81_A          214 SP--LPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRL  291 (549)
T ss_dssp             CC--CSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESC
T ss_pred             cc--cchhhhhhcccceeccccccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhccccccccccc
Confidence            11  122345778888888888776543332211  112467777777776654210         00            


Q ss_pred             --------------CCCCCCCCEEEecCCccCCccchhh-cCCCCCCEEEcccccCcccCCc---cccccCCccEEEccC
Q 040845          217 --------------ITNLTDLTTIVLGGNKLNGSIPITL-GKLQKLQDVDLEYNQLEGSIPD---SICLSVELYELELGG  278 (824)
Q Consensus       217 --------------l~~l~~L~~L~L~~n~l~~~~~~~~-~~l~~L~~L~L~~n~l~~~~~~---~~~~~~~L~~L~l~~  278 (824)
                                    +..+.+|+.|++++|.+. .+|..+ ..+++|++|+|++|++++..|.   .+..+++|+.|++++
T Consensus       292 ~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~  370 (549)
T 2z81_A          292 HIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQ  370 (549)
T ss_dssp             BCSCGGGSCCCCHHHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTT
T ss_pred             ccchhhhcccchhhhhhcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccC
Confidence                          122367999999999998 455554 6899999999999999976643   477889999999999


Q ss_pred             ccccccCC--ccccCCCCCcEEEcCCCCCCCCCCcccccccccccccccccccCcCCccccccccchhhhcccccccccC
Q 040845          279 NKLSGSIP--ACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGII  356 (824)
Q Consensus       279 n~l~~~~~--~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~  356 (824)
                      |++++..+  ..+..+++|++|++++|+++.+|..+..+++|+.|++++|.++. +|..+  .++|+.|++++|++++.+
T Consensus       371 N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~~~~L~~L~Ls~N~l~~-l~~~~--~~~L~~L~Ls~N~l~~~~  447 (549)
T 2z81_A          371 NHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQWPEKMRFLNLSSTGIRV-VKTCI--PQTLEVLDVSNNNLDSFS  447 (549)
T ss_dssp             SCCCCHHHHHHHGGGCTTCCEEECTTCCCCCCCSCCCCCTTCCEEECTTSCCSC-CCTTS--CTTCSEEECCSSCCSCCC
T ss_pred             CcccccccchhhhhcCCCCCEEECCCCCCccCChhhcccccccEEECCCCCccc-ccchh--cCCceEEECCCCChhhhc
Confidence            99986543  56889999999999999999999999999999999999999984 44443  268999999999999653


Q ss_pred             CCccCCCCCCCeEEccCccccccCCccccccccccEEEccCcccCCCCcccccCCcccceeeccCCcccCCCCC
Q 040845          357 PMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIPR  430 (824)
Q Consensus       357 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~  430 (824)
                          ..+++|++|+|++|+|+ .+|. ...+++|+.|+|++|++++..|..+..+++|+.|++++|+++|.+|.
T Consensus       448 ----~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~  515 (549)
T 2z81_A          448 ----LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR  515 (549)
T ss_dssp             ----CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHHH
T ss_pred             ----ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCcc
Confidence                57899999999999999 5776 57899999999999999988888899999999999999999999884

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.5e-45  Score=420.20  Aligned_cols=413  Identities=20%  Similarity=0.230  Sum_probs=346.9

Q ss_pred             CcccccccccCCcccccCCCCCcEEEccCCcccccccccccCCCCCCEEeCCCCcCCcccChhhhCcCCCceeeccCCcc
Q 040845            2 PSIINNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSL   81 (824)
Q Consensus         2 ~~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l   81 (824)
                      |+|++|+|+++.|..|.++++|++|+|++|+|++..|..|+++++|++|||++|+++ .+|..  .+++|++|+|++|++
T Consensus        26 L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L~~N~l  102 (520)
T 2z7x_B           26 LNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDLSFNAF  102 (520)
T ss_dssp             EECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEECCSSCC
T ss_pred             EECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEeccCCcc
Confidence            689999999999999999999999999999999888999999999999999999999 56666  899999999999999


Q ss_pred             ccccCccccCCCCCccEEEccCCeeeeecCccccCCCCC--ceEeccCccc--cccCCccccC-----------------
Q 040845           82 SGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKL--SKLALEMNSF--SGFIPSTFGN-----------------  140 (824)
Q Consensus        82 ~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L--~~L~L~~N~i--~~~~~~~~~~-----------------  140 (824)
                      ++++....+..+++|++|+|++|++++   ..+..+++|  ++|+|++|.+  .+..|..|..                 
T Consensus       103 ~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~  179 (520)
T 2z7x_B          103 DALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFH  179 (520)
T ss_dssp             SSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSSSCCC
T ss_pred             ccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccccccccccccccccceEEEEeccCcchh
Confidence            875432233469999999999999985   467778888  9999999999  6666666655                 


Q ss_pred             ---------CCCCCEEEccCCc----CCCCcCcccccccCCCCCCCcEEECcCCCCCccCCcccccc-ccccccEEEeec
Q 040845          141 ---------LRNLEWLTLYDNN----LTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGN-LSHSLKNFYMYN  206 (824)
Q Consensus       141 ---------l~~L~~L~L~~n~----i~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~-l~~~L~~L~l~~  206 (824)
                               +++|+.|++++|.    +.....   ..+.+..+++|++|++++|.+.+.....+... ...+|++|++++
T Consensus       180 ~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~---~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~  256 (520)
T 2z7x_B          180 FILDVSVKTVANLELSNIKCVLEDNKCSYFLS---ILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISN  256 (520)
T ss_dssp             CCCCCCCTTCSEEEECCEEECCSTTTTHHHHH---HHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEE
T ss_pred             hhhhhhhhcccceeeccccccccccccceeec---chhhhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeec
Confidence                     5677777777775    111110   12357889999999999998875432222111 124899999999


Q ss_pred             CcceecCCccC-----CCCCCCCEEEecCCccCCccchhhcCC---CCCCEEEcccccCcccCCccccccCCccEEEccC
Q 040845          207 CNVSGGIPEEI-----TNLTDLTTIVLGGNKLNGSIPITLGKL---QKLQDVDLEYNQLEGSIPDSICLSVELYELELGG  278 (824)
Q Consensus       207 n~l~~~~~~~l-----~~l~~L~~L~L~~n~l~~~~~~~~~~l---~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~  278 (824)
                      |++++.+|..+     ..+++|+.+++++|.+ ......+..+   .+|+.|++++|.+....  .+..+++|++|++++
T Consensus       257 n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~-~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~  333 (520)
T 2z7x_B          257 VKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF-GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSN  333 (520)
T ss_dssp             EEEESCCCCCCCCCCSCCCCEEEEEEEEECCC-CSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCS
T ss_pred             ccccCccccchhhcccccCceeEeccccccce-ecchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeEC
Confidence            99999999998     9999999999999999 2332555544   78999999999987432  126789999999999


Q ss_pred             ccccccCCccccCCCCCcEEEcCCCCCCCC---CCcccccccccccccccccccCcCCc-cccccccchhhhcccccccc
Q 040845          279 NKLSGSIPACFSNMTFLKVLSLGSNELTSI---PLNFWSLKDILDLNLSSNCFSGPLPL-EIRNLKALIEIDFSMNNFSG  354 (824)
Q Consensus       279 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l---p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~l~~L~~L~l~~N~l~~  354 (824)
                      |++++..|..++++++|++|++++|+++.+   |..+..+++|+.|++++|.+++.+|. .+..+++|+.|++++|++++
T Consensus       334 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~  413 (520)
T 2z7x_B          334 NLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTD  413 (520)
T ss_dssp             SCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCG
T ss_pred             CccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCc
Confidence            999998999999999999999999999965   45688899999999999999984554 58899999999999999988


Q ss_pred             cCCCccCCCCCCCeEEccCccccccCCccccccccccEEEccCcccCCCCccc-ccCCcccceeeccCCcccCCCCC
Q 040845          355 IIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVS-LEKLSYLKDLNLSFNKLKGEIPR  430 (824)
Q Consensus       355 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~l~~N~l~~~~p~  430 (824)
                      ..|..+.  ++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|+ .+|.. +..+++|+.|++++|+++|.++.
T Consensus       414 ~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c~~  486 (520)
T 2z7x_B          414 TIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCPR  486 (520)
T ss_dssp             GGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred             chhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCC-ccCHHHhccCCcccEEECcCCCCcccCCc
Confidence            8777665  79999999999999 78888889999999999999999 66665 89999999999999999998763

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=4.5e-44  Score=423.54  Aligned_cols=417  Identities=17%  Similarity=0.204  Sum_probs=348.4

Q ss_pred             CCCcEEEccCCcccccccccccCCCCCCEEeC-CCCcCCcccChhh----------------------------------
Q 040845           21 SNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDL-SQNKLLGTIPAAI----------------------------------   65 (824)
Q Consensus        21 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L-s~n~l~~~~~~~~----------------------------------   65 (824)
                      ..++.|+|++|.+.|.+|.+|++|++|++||| ++|.+++..|-..                                  
T Consensus       323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~  402 (876)
T 4ecn_A          323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD  402 (876)
T ss_dssp             SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred             CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence            57999999999999999999999999999999 9998765522110                                  


Q ss_pred             -----------------hCcCCCceeeccC--CccccccCccccCCCCCccEEEccCCeeee-----------------e
Q 040845           66 -----------------FNVSTLKAFAVTN--NSLSGCLSSITDVGLPNLEVLYLWGNNFSG-----------------T  109 (824)
Q Consensus        66 -----------------~~l~~L~~L~L~~--n~l~~~~~~~~~~~l~~L~~L~L~~n~i~~-----------------~  109 (824)
                                       .....++.+.+..  |+++++|..+.  .+++|++|+|++|++++                 .
T Consensus       403 l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~IP~~l~--~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~  480 (876)
T 4ecn_A          403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQ--RLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQY  480 (876)
T ss_dssp             HHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEEECGGGG--GCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHH
T ss_pred             HHHHHhhhCccccccccccccchhhceeccccCcccchhHHHh--cCCCCCEEECcCCcCCCCccccccccccccccccc
Confidence                             1122344455544  88888776654  59999999999999998                 3


Q ss_pred             cCcccc--CCCCCceEeccCccccccCCccccCCCCCCEEEccCCc-CCC--CcCcccccc-cCCCCCCCcEEECcCCCC
Q 040845          110 IPHFIF--NASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNN-LTS--STLDLSFLS-SLSNCKSLTHISLSNNPL  183 (824)
Q Consensus       110 ~~~~l~--~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~-i~~--~~~~~~~~~-~l~~l~~L~~L~Ls~n~l  183 (824)
                      +|..++  ++++|++|+|++|++.+.+|..|+++++|++|+|++|+ ++.  +|..+.-+. .+..+++|++|+|++|.+
T Consensus       481 iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L  560 (876)
T 4ecn_A          481 ENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNL  560 (876)
T ss_dssp             TTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCC
T ss_pred             CChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcC
Confidence            888887  99999999999999999999999999999999999998 774  443322222 566778999999999999


Q ss_pred             CccCCc-cccccccccccEEEeecCcceecCCccCCCCCCCCEEEecCCccCCccchhhcCCCC-CCEEEcccccCcccC
Q 040845          184 DGILPR-TYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQK-LQDVDLEYNQLEGSI  261 (824)
Q Consensus       184 ~~~~~~-~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~-L~~L~L~~n~l~~~~  261 (824)
                      ..++.. .+ +. .++|+.|++++|+++ .+| .|..+++|+.|+|++|++. .+|..+..+++ |++|+|++|+++ .+
T Consensus       561 ~~ip~~~~l-~~-L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~l  634 (876)
T 4ecn_A          561 EEFPASASL-QK-MVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YI  634 (876)
T ss_dssp             CBCCCHHHH-TT-CTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SC
T ss_pred             CccCChhhh-hc-CCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cC
Confidence            955441 33 33 458999999999999 777 9999999999999999999 78888999999 999999999999 77


Q ss_pred             CccccccCC--ccEEEccCccccccCCccc---c--CCCCCcEEEcCCCCCCCCCCccc-ccccccccccccccccCcCC
Q 040845          262 PDSICLSVE--LYELELGGNKLSGSIPACF---S--NMTFLKVLSLGSNELTSIPLNFW-SLKDILDLNLSSNCFSGPLP  333 (824)
Q Consensus       262 ~~~~~~~~~--L~~L~l~~n~l~~~~~~~~---~--~l~~L~~L~L~~N~l~~lp~~~~-~l~~L~~L~l~~N~l~~~~~  333 (824)
                      |..+..+..  |+.|++++|++.+.+|...   .  .+++|+.|+|++|.++.+|..+. .+++|+.|+|++|+++...+
T Consensus       635 p~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~~ip~  714 (876)
T 4ecn_A          635 PNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPE  714 (876)
T ss_dssp             CSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCSCCCT
T ss_pred             chhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCCccCh
Confidence            888877654  9999999999997765432   2  34589999999999999998865 78999999999999994333


Q ss_pred             cccc-------ccccchhhhcccccccccCCCccC--CCCCCCeEEccCccccccCCccccccccccEEEccC------c
Q 040845          334 LEIR-------NLKALIEIDFSMNNFSGIIPMEIG--SLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSY------N  398 (824)
Q Consensus       334 ~~~~-------~l~~L~~L~l~~N~l~~~~~~~~~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~------N  398 (824)
                      ..+.       ++++|+.|+|++|+++ .+|..+.  .+++|+.|+|++|+|++ +|..+..+++|+.|+|++      |
T Consensus       715 ~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N  792 (876)
T 4ecn_A          715 NSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGN  792 (876)
T ss_dssp             TSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCC
T ss_pred             HHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccc
Confidence            3333       3349999999999999 6788887  99999999999999996 798999999999999976      8


Q ss_pred             ccCCCCcccccCCcccceeeccCCcccCCCCCCCCccccccccccCCcccc
Q 040845          399 NLSGTIPVSLEKLSYLKDLNLSFNKLKGEIPRGGSFGNFSAESFKGNELLC  449 (824)
Q Consensus       399 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c  449 (824)
                      ++.+.+|..+..+++|+.|+|++|++ +.+|.. ..+++..+.+.+|+...
T Consensus       793 ~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~-l~~~L~~LdLs~N~l~~  841 (876)
T 4ecn_A          793 RILRQWPTGITTCPSLIQLQIGSNDI-RKVDEK-LTPQLYILDIADNPNIS  841 (876)
T ss_dssp             BCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSC-CCSSSCEEECCSCTTCE
T ss_pred             cccccChHHHhcCCCCCEEECCCCCC-CccCHh-hcCCCCEEECCCCCCCc
Confidence            88899999999999999999999999 777775 33678888889997543

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.2e-44  Score=412.69  Aligned_cols=253  Identities=20%  Similarity=0.282  Sum_probs=211.5

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEec
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      .++|++.+.||+|+||+||+|+.+ +|+.||+|++........+.+.+|+++|+.++|||||++++++.++...|+||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            468999999999999999999875 5999999999766555567889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCC--CcEEEeecccccccCCCCC
Q 040845          605 MPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDN--MVAHLSDFGIAKLLTGEDQ  682 (824)
Q Consensus       605 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~--~~~kl~Dfg~a~~~~~~~~  682 (824)
                      ++||+|.+++......+++.++..++.||+.||+|||   +++|+||||||+|||++.+  +.+||+|||+|+.+.... 
T Consensus       236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~-  311 (573)
T 3uto_A          236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ-  311 (573)
T ss_dssp             CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS-
T ss_pred             cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC-
Confidence            9999999999766667999999999999999999999   9999999999999999854  899999999999875332 


Q ss_pred             ccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCc
Q 040845          683 SMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ  762 (824)
Q Consensus       683 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  762 (824)
                        .....+||+.|||||++.+..|+.++||||+||++|||++|+.||.+....+ .+.........              
T Consensus       312 --~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~-~~~~i~~~~~~--------------  374 (573)
T 3uto_A          312 --SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE-TLRNVKSCDWN--------------  374 (573)
T ss_dssp             --EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHHHHTTCCC--------------
T ss_pred             --ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-HHHHHHhCCCC--------------
Confidence              2334579999999999999999999999999999999999999997632211 11111111000              


Q ss_pred             hhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          763 EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       763 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                        ........++..+.+|+.+||+.||++|||+.|+++|
T Consensus       375 --~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H  411 (573)
T 3uto_A          375 --MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  411 (573)
T ss_dssp             --CCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             --CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence              0001112346678999999999999999999999875

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.3e-44  Score=407.77  Aligned_cols=250  Identities=22%  Similarity=0.298  Sum_probs=202.4

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhH---HHHHHHHhcCCCCcceeEEeeeecCCee
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSF---DVECAMMKSIRHRNLVKVISSCSNEEFK  598 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~---~~E~~~l~~l~h~niv~l~~~~~~~~~~  598 (824)
                      .++|++.+.||+|+||+||+|+.+ +|+.||||++.+..   ......+   ..++.+++.++|||||+++++|.+++..
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            468999999999999999999875 59999999997542   1222223   3446777888999999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccC
Q 040845          599 ALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT  678 (824)
Q Consensus       599 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~  678 (824)
                      |+||||++||+|.+++.+.+ .+++.++..++.||+.||+|||   +++||||||||+|||++.+|.+||+|||+|+.+.
T Consensus       268 ylVmEy~~GGdL~~~l~~~~-~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~  343 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS  343 (689)
T ss_dssp             EEEECCCCSCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             EEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence            99999999999999998765 7899999999999999999999   9999999999999999999999999999998764


Q ss_pred             CCCCccccccccccccccCccCcCC-CCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccc
Q 040845          679 GEDQSMTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDA  757 (824)
Q Consensus       679 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  757 (824)
                      ...    ....+||+.|||||++.. ..|+.++|+||+||++|||++|++||.+....+.  ........        ..
T Consensus       344 ~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~--~~i~~~i~--------~~  409 (689)
T 3v5w_A          344 KKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTL--------TM  409 (689)
T ss_dssp             SCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH--HHHHHHHH--------HC
T ss_pred             CCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHhhc--------CC
Confidence            332    223579999999999965 5799999999999999999999999976332211  11111000        00


Q ss_pred             cccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 040845          758 NLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRIN-----AKEIVAK  801 (824)
Q Consensus       758 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt-----~~evl~~  801 (824)
                              ....+..+++++.+|+.+||+.||++|++     ++|+++|
T Consensus       410 --------~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H  450 (689)
T 3v5w_A          410 --------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  450 (689)
T ss_dssp             --------CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred             --------CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence                    00112235667899999999999999998     7888765

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=6.7e-43  Score=403.38  Aligned_cols=411  Identities=19%  Similarity=0.182  Sum_probs=286.1

Q ss_pred             CcccccccccCCcccccCCCCCcEEEccCCcccccccccccCCCCCCEEeCCCCcCCcccChhhhCcCCCceeeccCCcc
Q 040845            2 PSIINNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSL   81 (824)
Q Consensus         2 ~~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l   81 (824)
                      +++++|+|+++ |..+.  ++|++|+|++|+|++..+.+|+++++|++|+|++|++++..|++|.++++|++|+|++|++
T Consensus        36 l~ls~~~L~~i-p~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  112 (562)
T 3a79_B           36 VDYSNRNLTHV-PKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRL  112 (562)
T ss_dssp             EECTTSCCCSC-CTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCC
T ss_pred             EEcCCCCCccC-CCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcC
Confidence            57889999984 44443  8999999999999988888999999999999999999988899999999999999999999


Q ss_pred             ccccCccccCCCCCccEEEccCCeeeee-cCccccCCCCCceEeccCccccccCCccccCCCCC--CEEEccCCcC--CC
Q 040845           82 SGCLSSITDVGLPNLEVLYLWGNNFSGT-IPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNL--EWLTLYDNNL--TS  156 (824)
Q Consensus        82 ~~~~~~~~~~~l~~L~~L~L~~n~i~~~-~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L--~~L~L~~n~i--~~  156 (824)
                      +.++..    .+++|++|+|++|++++. .|..|.++++|++|+|++|+++..   .+.++++|  ++|++++|.+  +.
T Consensus       113 ~~lp~~----~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~~  185 (562)
T 3a79_B          113 QNISCC----PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIKG  185 (562)
T ss_dssp             CEECSC----CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCCCS
T ss_pred             CccCcc----ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeecccccccc
Confidence            988776    589999999999999864 468999999999999999999864   45556666  9999999998  44


Q ss_pred             CcCcc-cc--------------------cccCCCCCCCcEEECcCCCCC----------------------------ccC
Q 040845          157 STLDL-SF--------------------LSSLSNCKSLTHISLSNNPLD----------------------------GIL  187 (824)
Q Consensus       157 ~~~~~-~~--------------------~~~l~~l~~L~~L~Ls~n~l~----------------------------~~~  187 (824)
                      ..... ..                    ...+..+++|+.|++++|...                            +..
T Consensus       186 ~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~  265 (562)
T 3a79_B          186 GETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKC  265 (562)
T ss_dssp             SSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHH
T ss_pred             cCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHH
Confidence            32211 00                    001234556666666666310                            000


Q ss_pred             Cccc-cccccccccEEEeecCcceecCCccC-----CCCCCCCEEEecCCccCCccchhhcC---CCCCCEEEcccccCc
Q 040845          188 PRTY-VGNLSHSLKNFYMYNCNVSGGIPEEI-----TNLTDLTTIVLGGNKLNGSIPITLGK---LQKLQDVDLEYNQLE  258 (824)
Q Consensus       188 ~~~~-~~~l~~~L~~L~l~~n~l~~~~~~~l-----~~l~~L~~L~L~~n~l~~~~~~~~~~---l~~L~~L~L~~n~l~  258 (824)
                      .... ......+|++|++++|.+++.+|..+     .+++.|+.++++.|.+. .....+..   ..+|++|++++|.+.
T Consensus       266 ~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~-~p~~~~~~~~~~~~L~~L~l~~n~~~  344 (562)
T 3a79_B          266 SVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFL-FSKEALYSVFAEMNIKMLSISDTPFI  344 (562)
T ss_dssp             HHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCS-SCHHHHHHHHHTCCCSEEEEESSCCC
T ss_pred             HHHHHHhhhcccccEEEEeccEeeccccchhhhcccccchheehhhcccceee-cChhhhhhhhccCcceEEEccCCCcc
Confidence            0000 00001256777777777766666665     55555555555555551 21122222   256777777777765


Q ss_pred             ccCCccccccCCccEEEccCccccccCCccccCCCCCcEEEcCCCCCCCCC---CcccccccccccccccccccC-cCCc
Q 040845          259 GSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIP---LNFWSLKDILDLNLSSNCFSG-PLPL  334 (824)
Q Consensus       259 ~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp---~~~~~l~~L~~L~l~~N~l~~-~~~~  334 (824)
                      ...  ....+++|++|++++|++++..|..++++++|++|++++|+++.++   ..+..+++|+.|++++|.+++ ..+.
T Consensus       345 ~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~  422 (562)
T 3a79_B          345 HMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDR  422 (562)
T ss_dssp             CCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSC
T ss_pred             ccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChh
Confidence            221  1245677777777777777767777777777777777777777654   346667777777777777776 3333


Q ss_pred             cccccccchhhhcccccccccCCCccCCCCCCCeEEccCccccccCCccccccccccEEEccCcccCCCCccc-ccCCcc
Q 040845          335 EIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVS-LEKLSY  413 (824)
Q Consensus       335 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~  413 (824)
                      .+..+++|+.|++++|++++..|..+.  ++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|+ .+|.. +..+++
T Consensus       423 ~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~  498 (562)
T 3a79_B          423 TCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTS  498 (562)
T ss_dssp             CCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCC-CCCTTSTTTCTT
T ss_pred             hhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCC-CCCHHHHhcCCC
Confidence            466777777777777777665555443  57777777777777 45655567777777777777777 45544 677777


Q ss_pred             cceeeccCCcccCCCC
Q 040845          414 LKDLNLSFNKLKGEIP  429 (824)
Q Consensus       414 L~~L~l~~N~l~~~~p  429 (824)
                      |+.|++++|+|+|.+|
T Consensus       499 L~~L~l~~N~~~c~c~  514 (562)
T 3a79_B          499 LQYIWLHDNPWDCTCP  514 (562)
T ss_dssp             CCCEECCSCCBCCCHH
T ss_pred             CCEEEecCCCcCCCcc
Confidence            7777777777777665

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=8.7e-43  Score=409.82  Aligned_cols=434  Identities=21%  Similarity=0.220  Sum_probs=305.1

Q ss_pred             CcccccccccCCcccccCCCCCcEEEccCCcccccccccccCCCCCCEEeCCCCcCCcccChhhhCcCCCceeeccCCcc
Q 040845            2 PSIINNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSL   81 (824)
Q Consensus         2 ~~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l   81 (824)
                      |+|++|+|+++.|.+|.++++|++|+|++|+|++..+++|+++++|++|+|++|+|++..+.+|.++++|++|+|++|++
T Consensus        57 LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l  136 (635)
T 4g8a_A           57 LDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNL  136 (635)
T ss_dssp             EECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCC
T ss_pred             EEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcC
Confidence            56667777777766777777777777777777765566677777777777777777655555666777777777777777


Q ss_pred             ccccCccccCCCCCccEEEccCCeeeee-cCccccCCCCCceEeccCccccccCCccccCCCCCC----EEEccCCcCCC
Q 040845           82 SGCLSSITDVGLPNLEVLYLWGNNFSGT-IPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLE----WLTLYDNNLTS  156 (824)
Q Consensus        82 ~~~~~~~~~~~l~~L~~L~L~~n~i~~~-~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~----~L~L~~n~i~~  156 (824)
                      ++++.... .++++|++|+|++|.+++. .|..+..+++|++|+|++|++++..+..|..+.+++    .++++.|.++.
T Consensus       137 ~~l~~~~~-~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~  215 (635)
T 4g8a_A          137 ASLENFPI-GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF  215 (635)
T ss_dssp             CCSTTCCC-TTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCE
T ss_pred             CCCChhhh-hcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccc
Confidence            66554322 3566777777777776543 456666677777777777777666666655544332    45566555544


Q ss_pred             CcCcccccccCCCCCCCcEEECcCC-------------------------------------------------------
Q 040845          157 STLDLSFLSSLSNCKSLTHISLSNN-------------------------------------------------------  181 (824)
Q Consensus       157 ~~~~~~~~~~l~~l~~L~~L~Ls~n-------------------------------------------------------  181 (824)
                      ++..      ......+..|++++|                                                       
T Consensus       216 i~~~------~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~  289 (635)
T 4g8a_A          216 IQPG------AFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA  289 (635)
T ss_dssp             ECTT------TTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEE
T ss_pred             cCcc------cccchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhh
Confidence            3221      111112222222222                                                       


Q ss_pred             ---------------------------CCCccCCccccccccccccEEEeecCcceecCCccCCCCCCCCEEEecCCccC
Q 040845          182 ---------------------------PLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLN  234 (824)
Q Consensus       182 ---------------------------~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~  234 (824)
                                                 .+..+.+..    ...+++.|++.+|.+.+..+   ..+..|+.+++.+|.+.
T Consensus       290 ~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~----~~~~L~~L~l~~~~~~~~~~---~~l~~L~~l~l~~n~~~  362 (635)
T 4g8a_A          290 YLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVKDFS----YNFGWQHLELVNCKFGQFPT---LKLKSLKRLTFTSNKGG  362 (635)
T ss_dssp             CCCSCEEECTTTTGGGTTCSEEEEESCEEEECGGGG----SCCCCSEEEEESCEESSCCC---CBCTTCCEEEEESCCSC
T ss_pred             hhcccccchhhhhhhhcccccccccccccccccccc----cchhhhhhhcccccccCcCc---ccchhhhhcccccccCC
Confidence                                       211111100    11234555555555443322   12345555555555554


Q ss_pred             CccchhhcCCCCCCEEEcccccCcc--cCCccccccCCccEEEccCccccccCCccccCCCCCcEEEcCCCCCCCCCC--
Q 040845          235 GSIPITLGKLQKLQDVDLEYNQLEG--SIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPL--  310 (824)
Q Consensus       235 ~~~~~~~~~l~~L~~L~L~~n~l~~--~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~--  310 (824)
                      .  +..+..+++|+.|++++|.+..  ..+..+..+.+|+.+++..|.+.. .+..+..+++|+.+++.+|.....+.  
T Consensus       363 ~--~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~-~~~~~~~l~~L~~l~l~~~~~~~~~~~~  439 (635)
T 4g8a_A          363 N--AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFS  439 (635)
T ss_dssp             C--BCCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEE-ECSCCTTCTTCCEEECTTSEEESTTSSC
T ss_pred             C--Ccccccccccccchhhccccccccccccchhhhhhhhhhhcccccccc-ccccccccccccchhhhhcccccccccc
Confidence            2  2234467889999999998863  345566778889999999988874 45568889999999999988776543  


Q ss_pred             cccccccccccccccccccCcCCccccccccchhhhcccccc-cccCCCccCCCCCCCeEEccCccccccCCcccccccc
Q 040845          311 NFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNF-SGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLIS  389 (824)
Q Consensus       311 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l-~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  389 (824)
                      .+..+++++.++++.|.+.+..+..+..++.|+.|++++|.+ .+..|..|..+++|+.|+|++|+|++..|..|.++++
T Consensus       440 ~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~  519 (635)
T 4g8a_A          440 VFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSS  519 (635)
T ss_dssp             TTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTT
T ss_pred             ccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCC
Confidence            367899999999999999988999999999999999999985 4567889999999999999999999888999999999


Q ss_pred             ccEEEccCcccCCCCcccccCCcccceeeccCCcccCCCCCCC-Cc-cccccccccCCccccCCC
Q 040845          390 LKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIPRGG-SF-GNFSAESFKGNELLCGSP  452 (824)
Q Consensus       390 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~-~~-~~~~~~~~~~n~~~c~~~  452 (824)
                      |++|+|++|+|++..|..+..+++|+.|+|++|++++.+|... .+ .++..+.+.+||+.|+|.
T Consensus       520 L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~  584 (635)
T 4g8a_A          520 LQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE  584 (635)
T ss_dssp             CCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred             CCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCC
Confidence            9999999999998888899999999999999999999888642 33 567888999999999986

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.3e-43  Score=379.20  Aligned_cols=281  Identities=33%  Similarity=0.528  Sum_probs=230.5

Q ss_pred             cHHHHHHhhccCCCCceeeeccceEEEEEEECCCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCe
Q 040845          518 SYLELFQATDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEF  597 (824)
Q Consensus       518 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  597 (824)
                      ++.++..++++|++.+.||+|+||.||+|++++++.||||++........+.+.+|+.+++.++||||+++++++.+.+.
T Consensus        30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  109 (321)
T 2qkw_B           30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNE  109 (321)
T ss_dssp             CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTC
T ss_pred             cHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCe
Confidence            33445567789999999999999999999988899999999877666667889999999999999999999999999999


Q ss_pred             eEEEEeccCCCCHHHHhhhCC---CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccc
Q 040845          598 KALVLEYMPHGSLEKYLHSSN---YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIA  674 (824)
Q Consensus       598 ~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a  674 (824)
                      .++||||+++|+|.+++....   ..+++.+++.++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||++
T Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~  186 (321)
T 2qkw_B          110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGIS  186 (321)
T ss_dssp             CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECCCTTC
T ss_pred             EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEeecccc
Confidence            999999999999999997654   35899999999999999999999   899999999999999999999999999999


Q ss_pred             cccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCc-chhhhhhhhhCC-Ccch
Q 040845          675 KLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGE-MTLKHWVNDCLP-ISTM  752 (824)
Q Consensus       675 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~-~~~~  752 (824)
                      ................||+.|+|||.+.+..++.++||||||+++|||++|+.||......+ .....|...... ....
T Consensus       187 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (321)
T 2qkw_B          187 KKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE  266 (321)
T ss_dssp             EECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCC
T ss_pred             cccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHH
Confidence            87544333333344568999999999988899999999999999999999999997644332 223333222111 1112


Q ss_pred             hhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 040845          753 EVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRD  807 (824)
Q Consensus       753 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~  807 (824)
                      ..+++...      ...+..++..+.+++.+||+.||++|||+.|++++|+.+.+
T Consensus       267 ~~~~~~~~------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~  315 (321)
T 2qkw_B          267 QIVDPNLA------DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR  315 (321)
T ss_dssp             SSSSSSCT------TCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HhcChhhc------cccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence            22222211      11234678889999999999999999999999999998865

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=4.5e-43  Score=374.89  Aligned_cols=276  Identities=23%  Similarity=0.325  Sum_probs=213.9

Q ss_pred             hccCCCCceeeeccceEEEEEEECCCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCC----eeEEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEE----FKALV  601 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv  601 (824)
                      .++|++.+.||+|+||+||+|++. ++.||||++.... ........|+.++++++||||+++++++.+..    ..++|
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv  100 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI  100 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence            468999999999999999999987 8999999986543 33445566999999999999999999997743    46999


Q ss_pred             EeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC----------CeEecCCCCCCeeeCCCCcEEEeec
Q 040845          602 LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSA----------PVIHCDLKPSNVLLDDNMVAHLSDF  671 (824)
Q Consensus       602 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~----------~ivH~Dlk~~Nill~~~~~~kl~Df  671 (824)
                      |||+++|+|.+++...  .+++.+++.++.|+++|++|||   +.          +|+||||||+||+++.++.+||+||
T Consensus       101 ~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF  175 (322)
T 3soc_A          101 TAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF  175 (322)
T ss_dssp             EECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred             EecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence            9999999999999765  4899999999999999999999   88          9999999999999999999999999


Q ss_pred             ccccccCCCCCccccccccccccccCccCcCC-----CCCCccchHHHHHHHHHHHHhCCCCCcccccCcc-hhhhhhhh
Q 040845          672 GIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE-----GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEM-TLKHWVND  745 (824)
Q Consensus       672 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~  745 (824)
                      |+|+.+.............||+.|+|||++.+     ..++.++|||||||++|||+||+.||........ ........
T Consensus       176 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  255 (322)
T 3soc_A          176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ  255 (322)
T ss_dssp             TTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCS
T ss_pred             CcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhcc
Confidence            99987755444334445679999999999876     3566789999999999999999999976432211 11111000


Q ss_pred             hCCCc-chhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 040845          746 CLPIS-TMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDS  808 (824)
Q Consensus       746 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~  808 (824)
                      ..... ..+...................++..+.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~  319 (322)
T 3soc_A          256 HPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL  319 (322)
T ss_dssp             SCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            00000 0011111111111112223345677899999999999999999999999999998764

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=6.2e-43  Score=372.08  Aligned_cols=265  Identities=25%  Similarity=0.383  Sum_probs=219.4

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEec
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      .++|.+.+.||+|+||+||+|++. +++.||+|.+........+.+.+|++++++++||||+++++++.+++..++||||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            467899999999999999999875 5899999998665556677899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 040845          605 MPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM  684 (824)
Q Consensus       605 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  684 (824)
                      +++|+|.+++......+++.++..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||++..........
T Consensus        89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  165 (310)
T 3s95_A           89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP  165 (310)
T ss_dssp             CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred             cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence            9999999999987678999999999999999999999   9999999999999999999999999999998764332211


Q ss_pred             ------------ccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcch
Q 040845          685 ------------TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTM  752 (824)
Q Consensus       685 ------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  752 (824)
                                  ......||+.|+|||.+.+..++.++||||||+++|||++|..|+...............        
T Consensus       166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~--------  237 (310)
T 3s95_A          166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVR--------  237 (310)
T ss_dssp             --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHH--------
T ss_pred             cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhh--------
Confidence                        111456899999999999999999999999999999999999998764332211110000        


Q ss_pred             hhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhcc
Q 040845          753 EVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLR  811 (824)
Q Consensus       753 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~  811 (824)
                                .......+..++..+.+++.+||+.||++|||+.|+++.|++++..+..
T Consensus       238 ----------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~  286 (310)
T 3s95_A          238 ----------GFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG  286 (310)
T ss_dssp             ----------HHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred             ----------ccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccC
Confidence                      0001111234566789999999999999999999999999999876543

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.1e-42  Score=373.10  Aligned_cols=282  Identities=37%  Similarity=0.554  Sum_probs=232.2

Q ss_pred             ccccccHHHHHHhhccCCCCceeeeccceEEEEEEECCCcEEEEEEeecccc-chhhhHHHHHHHHhcCCCCcceeEEee
Q 040845          513 TWRRFSYLELFQATDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVKVISS  591 (824)
Q Consensus       513 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~  591 (824)
                      ....+++.++....++|++.+.||+|+||.||+|+.++|+.||||++..... .....+.+|+++++.++||||++++++
T Consensus        16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   95 (326)
T 3uim_A           16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF   95 (326)
T ss_dssp             CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred             ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence            3567889999999999999999999999999999988899999999875432 233468899999999999999999999


Q ss_pred             eecCCeeEEEEeccCCCCHHHHhhhCC---CCCCHHHHHHHHHHHHHHHHHhhcCCCC---CeEecCCCCCCeeeCCCCc
Q 040845          592 CSNEEFKALVLEYMPHGSLEKYLHSSN---YSLDIFQRLNIMIDVASALEYLHFGYSA---PVIHCDLKPSNVLLDDNMV  665 (824)
Q Consensus       592 ~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~---~ivH~Dlk~~Nill~~~~~  665 (824)
                      +.++...++||||+++|+|.+++....   ..+++..+..++.|++.||+|||   +.   +|+||||||+||+++.++.
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~ivH~Dlkp~Nil~~~~~~  172 (326)
T 3uim_A           96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLH---DHCDPKIIHRDVKAANILLDEEFE  172 (326)
T ss_dssp             ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHH---HSSSSCEECCCCSGGGEEECTTCC
T ss_pred             EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCeEeCCCchhhEEECCCCC
Confidence            999999999999999999999998654   34899999999999999999999   66   9999999999999999999


Q ss_pred             EEEeecccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCccc---ccCcchhhhh
Q 040845          666 AHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEL---FNGEMTLKHW  742 (824)
Q Consensus       666 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~---~~~~~~~~~~  742 (824)
                      +||+|||++........ .......||+.|+|||.+.+..++.++||||+|+++|||++|+.||+..   .........|
T Consensus       173 ~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  251 (326)
T 3uim_A          173 AVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW  251 (326)
T ss_dssp             EEECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHH
T ss_pred             EEeccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHH
Confidence            99999999987643322 2233455899999999998888999999999999999999999999642   2233445556


Q ss_pred             hhhhCCCc-chhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 040845          743 VNDCLPIS-TMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLK  804 (824)
Q Consensus       743 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~  804 (824)
                      +....... .....+....      ...+..++..+.+++.+||+.||++|||+.|++++|+.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          252 VKGLLKEKKLEALVDVDLQ------GNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             HTTTTSSCCSTTSSCTTCT------TSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             HHHHhhchhhhhhcChhhc------cccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence            55444333 2222222221      12234567889999999999999999999999999986

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=3.7e-42  Score=387.09  Aligned_cols=371  Identities=22%  Similarity=0.218  Sum_probs=226.7

Q ss_pred             CCCCEEeCCCCcCCcccChhhhCcCCCceeeccCCccccccCccccCCCCCccEEEccCCeeeeecCccccCCCCCceEe
Q 040845           45 HNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLA  124 (824)
Q Consensus        45 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~  124 (824)
                      ++|++|||++|.+++..|..|.++++|++|+|++|.+.+......+.++++|++|+|++|++++..|..|..+++|++|+
T Consensus        30 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~  109 (455)
T 3v47_A           30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLT  109 (455)
T ss_dssp             TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEE
T ss_pred             CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEe
Confidence            34444444444444444444444444444444444443222111122344444444444444444444444444555555


Q ss_pred             ccCccccccCCcc--ccCCCCCCEEEccCCcCCCCcCcccccccCCCCCCCcEEECcCCCCCccCCccccccccccccEE
Q 040845          125 LEMNSFSGFIPST--FGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNF  202 (824)
Q Consensus       125 L~~N~i~~~~~~~--~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~~L~~L  202 (824)
                      |++|++++..+..  |.++++|++|+|++|+++.....    ..+.++++|++|++++|.+.+..+..+...-..+++.|
T Consensus       110 L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~----~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L  185 (455)
T 3v47_A          110 LTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPA----SFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLL  185 (455)
T ss_dssp             CTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCC----GGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEE
T ss_pred             CCCCCCCccccCcccccCcccCCEEECCCCccCccCcc----cccCCCCcccEEeCCCCcccccChhhhhcccccccccc
Confidence            5555444322222  44445555555555544443211    01344445555555555444444433322212334444


Q ss_pred             EeecCcceecCCc--------cCCCCCCCCEEEecCCccCCccchhhcCC---CCCCEEEcccccCcccCCccccccCCc
Q 040845          203 YMYNCNVSGGIPE--------EITNLTDLTTIVLGGNKLNGSIPITLGKL---QKLQDVDLEYNQLEGSIPDSICLSVEL  271 (824)
Q Consensus       203 ~l~~n~l~~~~~~--------~l~~l~~L~~L~L~~n~l~~~~~~~~~~l---~~L~~L~L~~n~l~~~~~~~~~~~~~L  271 (824)
                      ++++|.+.+..+.        .+..+++|++|++++|++++..|..+...   ++|+.|++++|.+.+...         
T Consensus       186 ~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~---------  256 (455)
T 3v47_A          186 RLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSF---------  256 (455)
T ss_dssp             ECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCT---------
T ss_pred             ccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeecccccccccc---------
Confidence            4444444432222        23456778888888888877777666543   778888888776653211         


Q ss_pred             cEEEccCccccccCCccccC--CCCCcEEEcCCCCCCCC-CCcccccccccccccccccccCcCCccccccccchhhhcc
Q 040845          272 YELELGGNKLSGSIPACFSN--MTFLKVLSLGSNELTSI-PLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFS  348 (824)
Q Consensus       272 ~~L~l~~n~l~~~~~~~~~~--l~~L~~L~L~~N~l~~l-p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~  348 (824)
                           ..+.+.+..+..+..  .++|++|++++|.++.+ |..+..+++|+.|++++|.+++..|..|.++++|+.|+|+
T Consensus       257 -----~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls  331 (455)
T 3v47_A          257 -----GHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLS  331 (455)
T ss_dssp             -----TCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECC
T ss_pred             -----chhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECC
Confidence                 112222222223332  25677888888877765 4446677788888888888887778888889999999999


Q ss_pred             cccccccCCCccCCCCCCCeEEccCccccccCCccccccccccEEEccCcccCCCCcccccCCcccceeeccCCcccCCC
Q 040845          349 MNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEI  428 (824)
Q Consensus       349 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~  428 (824)
                      +|++++..|..|..+++|+.|+|++|++++..|..|..+++|+.|+|++|++++..+..+..+++|+.|++++|+++|.+
T Consensus       332 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~  411 (455)
T 3v47_A          332 QNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC  411 (455)
T ss_dssp             SSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCT
T ss_pred             CCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCC
Confidence            99998888888999999999999999999888889999999999999999999766677889999999999999999999


Q ss_pred             CCCCC
Q 040845          429 PRGGS  433 (824)
Q Consensus       429 p~~~~  433 (824)
                      |....
T Consensus       412 ~~~~~  416 (455)
T 3v47_A          412 PRIDY  416 (455)
T ss_dssp             TTTHH
T ss_pred             CcchH
Confidence            86443

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.3e-42  Score=377.91  Aligned_cols=261  Identities=27%  Similarity=0.447  Sum_probs=215.9

Q ss_pred             hccCCCCceeeeccceEEEEEEEC--------CCcEEEEEEeecccc-chhhhHHHHHHHHhcC-CCCcceeEEeeeecC
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR--------DGMEVAVKVFNLQCG-RAFKSFDVECAMMKSI-RHRNLVKVISSCSNE  595 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  595 (824)
                      .++|++.+.||+|+||.||+|++.        ++..||||+++.... ...+.+.+|+++++.+ +||||+++++++.++
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            468899999999999999999852        356799999875532 3456788999999999 899999999999999


Q ss_pred             CeeEEEEeccCCCCHHHHhhhCC---------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee
Q 040845          596 EFKALVLEYMPHGSLEKYLHSSN---------------YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL  660 (824)
Q Consensus       596 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill  660 (824)
                      +..++||||+++|+|.+++....               ..+++.+++.++.||+.||+|||   +.+|+||||||+||++
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEEE
Confidence            99999999999999999998653               24789999999999999999999   9999999999999999


Q ss_pred             CCCCcEEEeecccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchh
Q 040845          661 DDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTL  739 (824)
Q Consensus       661 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~  739 (824)
                      +.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+  .
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~--~  314 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--L  314 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--H
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH--H
Confidence            9999999999999987654443333444567889999999998899999999999999999999 999987632211  1


Q ss_pred             hhhhhhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhh
Q 040845          740 KHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSL  809 (824)
Q Consensus       740 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~  809 (824)
                      ...+....                  ....+..++..+.+++.+||+.||++|||+.|++++|+++.+..
T Consensus       315 ~~~~~~~~------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~  366 (370)
T 2psq_A          315 FKLLKEGH------------------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT  366 (370)
T ss_dssp             HHHHHTTC------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHhcCC------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence            11111100                  01112345677999999999999999999999999999987654

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.7e-42  Score=365.66  Aligned_cols=251  Identities=27%  Similarity=0.361  Sum_probs=210.7

Q ss_pred             hccCCCCceeeeccceEEEEEEE-CCCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEec
Q 040845          526 TDKFSENNLIGRGGFGSVYKARI-RDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      .++|++.+.||+|+||+||+|.. .+++.||||++........+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            46799999999999999999985 46899999999877666677889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 040845          605 MPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM  684 (824)
Q Consensus       605 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  684 (824)
                      +++|+|.+++...  .+++.++..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||++........  
T Consensus        99 ~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  171 (297)
T 3fxz_A           99 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--  171 (297)
T ss_dssp             CTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--
T ss_pred             CCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc--
Confidence            9999999999875  4889999999999999999999   89999999999999999999999999999987643322  


Q ss_pred             ccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchh
Q 040845          685 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQED  764 (824)
Q Consensus       685 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  764 (824)
                      ......||+.|+|||.+.+..++.++||||+||++|||++|+.||........ .........+                
T Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~----------------  234 (297)
T 3fxz_A          172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIATNGTP----------------  234 (297)
T ss_dssp             CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHHCSC----------------
T ss_pred             ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhCCCC----------------
Confidence            23345699999999999999999999999999999999999999975321111 1111110000                


Q ss_pred             hhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          765 IHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       765 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                       ....+..++..+.+++.+||+.||++|||++|++++
T Consensus       235 -~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  270 (297)
T 3fxz_A          235 -ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  270 (297)
T ss_dssp             -CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             -CCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence             011123456778999999999999999999999875

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=6.2e-42  Score=395.31  Aligned_cols=412  Identities=18%  Similarity=0.181  Sum_probs=321.0

Q ss_pred             CCCCCcEEEccCCcccccccccccCCCCCCEEeCCCCcCCcccChhhhCcCCCceeeccCCccccccCccccCCCCCccE
Q 040845           19 NISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEV   98 (824)
Q Consensus        19 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~   98 (824)
                      .....+++++++|+++ .+|..+.  ++|++|+|++|++++..|.+|.++++|++|+|++|+++++++... .++++|++
T Consensus        29 ~~~~~~~l~ls~~~L~-~ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~  104 (562)
T 3a79_B           29 SNELESMVDYSNRNLT-HVPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVF-LFNQDLEY  104 (562)
T ss_dssp             ----CCEEECTTSCCC-SCCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTT-TTCTTCCE
T ss_pred             ccCCCcEEEcCCCCCc-cCCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHh-CCCCCCCE
Confidence            3445589999999999 4776664  899999999999998878899999999999999999998865533 46999999


Q ss_pred             EEccCCeeeeecCccccCCCCCceEeccCcccccc-CCccccCCCCCCEEEccCCcCCCCcCcccccccCCCCCCC--cE
Q 040845           99 LYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGF-IPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSL--TH  175 (824)
Q Consensus        99 L~L~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~-~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~~L--~~  175 (824)
                      |+|++|+|+ .+|..  .+++|++|+|++|++++. .|..|+++++|++|++++|+++...        +..+++|  ++
T Consensus       105 L~Ls~N~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~~--------~~~l~~L~L~~  173 (562)
T 3a79_B          105 LDVSHNRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLD--------LLPVAHLHLSC  173 (562)
T ss_dssp             EECTTSCCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTTT--------TGGGTTSCEEE
T ss_pred             EECCCCcCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccCc--------hhhhhhceeeE
Confidence            999999999 45555  899999999999999975 3689999999999999999998632        3444555  99


Q ss_pred             EECcCCCC--CccCCccccccccccccEEEeecCcceecCCc-cCCCCCCCCEEEecCC---------------------
Q 040845          176 ISLSNNPL--DGILPRTYVGNLSHSLKNFYMYNCNVSGGIPE-EITNLTDLTTIVLGGN---------------------  231 (824)
Q Consensus       176 L~Ls~n~l--~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~-~l~~l~~L~~L~L~~n---------------------  231 (824)
                      |++++|.+  .+..+..+.. +......+++++|.+.+.++. .+..+++|+.|++++|                     
T Consensus       174 L~L~~n~l~~~~~~~~~l~~-l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~  252 (562)
T 3a79_B          174 ILLDLVSYHIKGGETESLQI-PNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLL  252 (562)
T ss_dssp             EEEEESSCCCCSSSCCEEEE-CCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCE
T ss_pred             EEeecccccccccCcccccc-cCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcce
Confidence            99999999  7777666543 111222445555555543332 2334455555555554                     


Q ss_pred             -------ccCCc----cchhhcCCCCCCEEEcccccCcccCCccc-----ccc--------------------------C
Q 040845          232 -------KLNGS----IPITLGKLQKLQDVDLEYNQLEGSIPDSI-----CLS--------------------------V  269 (824)
Q Consensus       232 -------~l~~~----~~~~~~~l~~L~~L~L~~n~l~~~~~~~~-----~~~--------------------------~  269 (824)
                             .+.+.    .+.. ...++|++|++++|.+++.+|..+     ..+                          .
T Consensus       253 ~L~L~~~~l~~~~~~~~~~~-~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~  331 (562)
T 3a79_B          253 NVTLQHIETTWKCSVKLFQF-FWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEM  331 (562)
T ss_dssp             EEEEEEEEECHHHHHHHHHH-HTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTC
T ss_pred             EEEecCCcCcHHHHHHHHHh-hhcccccEEEEeccEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccC
Confidence                   33321    1111 123589999999999987777665     222                          3


Q ss_pred             CccEEEccCccccccCCccccCCCCCcEEEcCCCCCCC-CCCcccccccccccccccccccCc--CCccccccccchhhh
Q 040845          270 ELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTS-IPLNFWSLKDILDLNLSSNCFSGP--LPLEIRNLKALIEID  346 (824)
Q Consensus       270 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~-lp~~~~~l~~L~~L~l~~N~l~~~--~~~~~~~l~~L~~L~  346 (824)
                      +|+.|++++|.+....  ....+++|++|++++|.++. +|..+..+++|+.|++++|++++.  .|..+.++++|+.|+
T Consensus       332 ~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~  409 (562)
T 3a79_B          332 NIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLD  409 (562)
T ss_dssp             CCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEE
T ss_pred             cceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEE
Confidence            4677777777765321  12688999999999999997 677889999999999999999963  356789999999999


Q ss_pred             cccccccc-cCCCccCCCCCCCeEEccCccccccCCccccccccccEEEccCcccCCCCcccccCCcccceeeccCCccc
Q 040845          347 FSMNNFSG-IIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLK  425 (824)
Q Consensus       347 l~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~  425 (824)
                      +++|++++ ..+..+..+++|+.|++++|++++..|..+.  ++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+++
T Consensus       410 l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~  486 (562)
T 3a79_B          410 VSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK  486 (562)
T ss_dssp             CTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCC
T ss_pred             CCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCC
Confidence            99999998 4445688999999999999999877766554  79999999999998 88888889999999999999999


Q ss_pred             CCCCC-CCCccccccccccCCccccCCC
Q 040845          426 GEIPR-GGSFGNFSAESFKGNELLCGSP  452 (824)
Q Consensus       426 ~~~p~-~~~~~~~~~~~~~~n~~~c~~~  452 (824)
                      ..++. ...+..+..+.+.+||+.|+|+
T Consensus       487 ~l~~~~~~~l~~L~~L~l~~N~~~c~c~  514 (562)
T 3a79_B          487 SVPDGVFDRLTSLQYIWLHDNPWDCTCP  514 (562)
T ss_dssp             CCCTTSTTTCTTCCCEECCSCCBCCCHH
T ss_pred             CCCHHHHhcCCCCCEEEecCCCcCCCcc
Confidence            65554 4567788889999999999875

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.4e-42  Score=368.33  Aligned_cols=262  Identities=29%  Similarity=0.419  Sum_probs=204.9

Q ss_pred             hhccCCCCceeeeccceEEEEEEECCCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEE
Q 040845          525 ATDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVL  602 (824)
Q Consensus       525 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  602 (824)
                      ...+|++.+.||+|+||+||+|++. |+.||||++....  ....+.+.+|++++++++||||+++++++.+....++||
T Consensus        35 ~~~~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  113 (309)
T 3p86_A           35 PWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT  113 (309)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred             ChhHceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence            3568999999999999999999885 8999999986543  233467889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhhCC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCC--eEecCCCCCCeeeCCCCcEEEeecccccccC
Q 040845          603 EYMPHGSLEKYLHSSN--YSLDIFQRLNIMIDVASALEYLHFGYSAP--VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT  678 (824)
Q Consensus       603 e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~  678 (824)
                      ||+++|+|.+++....  ..+++..++.++.|++.||+|||   +.+  |+||||||+||+++.++.+||+|||+++...
T Consensus       114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~  190 (309)
T 3p86_A          114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA  190 (309)
T ss_dssp             ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred             ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence            9999999999998654  23899999999999999999999   888  9999999999999999999999999997543


Q ss_pred             CCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhcccc
Q 040845          679 GEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDAN  758 (824)
Q Consensus       679 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  758 (824)
                      ..  ........||+.|+|||.+.+..++.++||||+||++|||++|+.||......+  ....+....           
T Consensus       191 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~--~~~~~~~~~-----------  255 (309)
T 3p86_A          191 ST--FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ--VVAAVGFKC-----------  255 (309)
T ss_dssp             -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH--HHHHHHHSC-----------
T ss_pred             cc--ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhcC-----------
Confidence            22  122334568999999999999999999999999999999999999997632211  111110000           


Q ss_pred             ccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhcc
Q 040845          759 LLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLR  811 (824)
Q Consensus       759 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~  811 (824)
                            .....+..++..+.+++.+||+.||++|||++|+++.|+.+.++...
T Consensus       256 ------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p  302 (309)
T 3p86_A          256 ------KRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVP  302 (309)
T ss_dssp             ------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC----
T ss_pred             ------CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCC
Confidence                  00011224566789999999999999999999999999998765544

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=4.1e-43  Score=383.40  Aligned_cols=260  Identities=30%  Similarity=0.452  Sum_probs=214.7

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc-chhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEe
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLE  603 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  603 (824)
                      .++|.+.+.||+|+||.||+|++. +++.||||+++.... ...+.+.+|++++++++||||+++++++.+++..++|||
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  192 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME  192 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence            467889999999999999999986 689999999875432 334678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 040845          604 YMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS  683 (824)
Q Consensus       604 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  683 (824)
                      |+++|+|.+++...+..+++.++..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++........
T Consensus       193 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~  269 (377)
T 3cbl_A          193 LVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA  269 (377)
T ss_dssp             CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence            99999999999876667899999999999999999999   999999999999999999999999999999865332211


Q ss_pred             cccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhccccccCc
Q 040845          684 MTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ  762 (824)
Q Consensus       684 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  762 (824)
                      .......+++.|+|||.+.++.++.++|||||||++|||+| |..||......  ....++...                
T Consensus       270 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~--~~~~~~~~~----------------  331 (377)
T 3cbl_A          270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ--QTREFVEKG----------------  331 (377)
T ss_dssp             CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH--HHHHHHHTT----------------
T ss_pred             ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcC----------------
Confidence            12222345778999999988889999999999999999999 99998763221  111111110                


Q ss_pred             hhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 040845          763 EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDS  808 (824)
Q Consensus       763 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~  808 (824)
                        .+...+..++..+.++|.+||+.||++|||++++++.|+++.+.
T Consensus       332 --~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~  375 (377)
T 3cbl_A          332 --GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR  375 (377)
T ss_dssp             --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence              01112234677899999999999999999999999999998754

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=2.2e-42  Score=369.73  Aligned_cols=263  Identities=27%  Similarity=0.442  Sum_probs=213.9

Q ss_pred             hccCCCCceeeeccceEEEEEEEC----CCcEEEEEEeeccc-cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR----DGMEVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKAL  600 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  600 (824)
                      .++|++.+.||+|+||.||+|++.    .+..||||+++... ....+.+.+|+.+++.++||||+++++++.+....++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            367888999999999999999874    35569999997543 3345678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 040845          601 VLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE  680 (824)
Q Consensus       601 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  680 (824)
                      ||||+++|+|.+++......+++.+++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++......
T Consensus       128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  204 (325)
T 3kul_A          128 VTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD  204 (325)
T ss_dssp             EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred             EeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence            99999999999999877668999999999999999999999   999999999999999999999999999999876543


Q ss_pred             CCc-cccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhcccc
Q 040845          681 DQS-MTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDAN  758 (824)
Q Consensus       681 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  758 (824)
                      ... .......+|+.|+|||.+.+..++.++||||||+++|||++ |..||......+  ....+....           
T Consensus       205 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~~~~~~~~-----------  271 (325)
T 3kul_A          205 PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD--VISSVEEGY-----------  271 (325)
T ss_dssp             --CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH--HHHHHHTTC-----------
T ss_pred             ccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH--HHHHHHcCC-----------
Confidence            222 22333456788999999988899999999999999999999 999987632211  111111000           


Q ss_pred             ccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhcc
Q 040845          759 LLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLR  811 (824)
Q Consensus       759 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~  811 (824)
                             ....+..++..+.+++.+||..||++|||+.|+++.|+++.++...
T Consensus       272 -------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~  317 (325)
T 3kul_A          272 -------RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES  317 (325)
T ss_dssp             -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred             -------CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccc
Confidence                   0111234567799999999999999999999999999999875443

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=4.7e-41  Score=357.16  Aligned_cols=281  Identities=31%  Similarity=0.489  Sum_probs=226.9

Q ss_pred             cccccHHHHHHhhccCCCC------ceeeeccceEEEEEEECCCcEEEEEEeeccc----cchhhhHHHHHHHHhcCCCC
Q 040845          514 WRRFSYLELFQATDKFSEN------NLIGRGGFGSVYKARIRDGMEVAVKVFNLQC----GRAFKSFDVECAMMKSIRHR  583 (824)
Q Consensus       514 ~~~~~~~~~~~~~~~~~~~------~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~  583 (824)
                      ...|++.++..++++|...      +.||+|+||.||+|.. +++.||||++....    ....+.+.+|+.+++.++||
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   90 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE   90 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence            4578899999999998877      8999999999999987 48999999986432    23456788999999999999


Q ss_pred             cceeEEeeeecCCeeEEEEeccCCCCHHHHhhhC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC
Q 040845          584 NLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSS--NYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD  661 (824)
Q Consensus       584 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~  661 (824)
                      ||+++++++.+.+..++||||+++++|.+++...  ...+++..+..++.|++.||+|||   +.+|+||||||+||+++
T Consensus        91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nili~  167 (307)
T 2nru_A           91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLD  167 (307)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEC
T ss_pred             CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEEEc
Confidence            9999999999999999999999999999998743  246899999999999999999999   89999999999999999


Q ss_pred             CCCcEEEeecccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhh
Q 040845          662 DNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKH  741 (824)
Q Consensus       662 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~  741 (824)
                      .++.+||+|||++................||+.|+|||.+.+ .++.++||||||+++|||++|..||....... ....
T Consensus       168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~  245 (307)
T 2nru_A          168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ-LLLD  245 (307)
T ss_dssp             TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS-BTTH
T ss_pred             CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH-HHHH
Confidence            999999999999987654333333344568999999998765 58999999999999999999999997643332 1222


Q ss_pred             hhhhhCC--CcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 040845          742 WVNDCLP--ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRD  807 (824)
Q Consensus       742 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~  807 (824)
                      +......  ....+.++.....       .+..++..+.+++.+||+.||++|||+.|++++|+++..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          246 IKEEIEDEEKTIEDYIDKKMND-------ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             HHHHHHTTSCCHHHHSCSSCSC-------CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             HHHHhhhhhhhhhhhccccccc-------cchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            2221111  1111222222111       123567789999999999999999999999999998754

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.8e-42  Score=359.08  Aligned_cols=258  Identities=27%  Similarity=0.423  Sum_probs=214.7

Q ss_pred             hccCCCCceeeeccceEEEEEEECCCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEecc
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYM  605 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  605 (824)
                      .++|++.+.||+|+||.||+|++.+++.||+|++.... ...+.+.+|++++++++||||+++++++.++...++||||+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   87 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence            36789999999999999999999889999999997543 34567899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccc
Q 040845          606 PHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMT  685 (824)
Q Consensus       606 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  685 (824)
                      ++++|.+++......+++..++.++.|+++|++|||   +.+|+||||||+||+++.++.+||+|||++....... ...
T Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~  163 (269)
T 4hcu_A           88 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTS  163 (269)
T ss_dssp             TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHS
T ss_pred             CCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEeccccccccccccc-ccc
Confidence            999999999877767999999999999999999999   9999999999999999999999999999998653221 122


Q ss_pred             cccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchh
Q 040845          686 QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQED  764 (824)
Q Consensus       686 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  764 (824)
                      .....+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||......+  ....+....                 
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~--~~~~~~~~~-----------------  224 (269)
T 4hcu_A          164 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVEDISTGF-----------------  224 (269)
T ss_dssp             TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHHTTC-----------------
T ss_pred             ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH--HHHHHhcCc-----------------
Confidence            233456788999999988899999999999999999999 899987632211  111111000                 


Q ss_pred             hhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 040845          765 IHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDS  808 (824)
Q Consensus       765 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~  808 (824)
                       ....+..++..+.+++.+||+.||++|||++|++++|+++.++
T Consensus       225 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~  267 (269)
T 4hcu_A          225 -RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  267 (269)
T ss_dssp             -CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             -cCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence             0011122456689999999999999999999999999998764

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.6e-42  Score=366.26  Aligned_cols=275  Identities=25%  Similarity=0.441  Sum_probs=212.6

Q ss_pred             hccCCCCceeeeccceEEEEEEE-----CCCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeec--CCee
Q 040845          526 TDKFSENNLIGRGGFGSVYKARI-----RDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSN--EEFK  598 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~  598 (824)
                      .++|++.+.||+|+||+||+|++     .+++.||||++........+.+.+|++++++++||||+++++++..  ....
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            46789999999999999999985     2589999999976655566788999999999999999999999854  4568


Q ss_pred             EEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccC
Q 040845          599 ALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT  678 (824)
Q Consensus       599 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~  678 (824)
                      ++||||+++|+|.+++......+++.+++.++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||++....
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~  165 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP  165 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred             EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence            9999999999999999887667999999999999999999999   9999999999999999999999999999998765


Q ss_pred             CCCCc-cccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcc--hhhc
Q 040845          679 GEDQS-MTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPIST--MEVV  755 (824)
Q Consensus       679 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~  755 (824)
                      ..... .......++..|+|||.+.+..++.++||||||+++|||+||..||......   ...+.........  ....
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  242 (295)
T 3ugc_A          166 QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE---FMRMIGNDKQGQMIVFHLI  242 (295)
T ss_dssp             ----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH---HHHHHCTTCCTHHHHHHHH
T ss_pred             CCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH---HHhhhcCccccchhHHHHH
Confidence            43222 2223345778899999999889999999999999999999999998653211   0000000000000  0000


Q ss_pred             cccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhh
Q 040845          756 DANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSL  809 (824)
Q Consensus       756 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~  809 (824)
                      +. .  ....+...+..++..+.+++.+||+.||++|||++|+++.|+++++.+
T Consensus       243 ~~-~--~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l  293 (295)
T 3ugc_A          243 EL-L--KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM  293 (295)
T ss_dssp             HH-H--HTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             HH-H--hccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence            00 0  001111223456788999999999999999999999999999998765

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.2e-41  Score=363.29  Aligned_cols=261  Identities=25%  Similarity=0.325  Sum_probs=215.7

Q ss_pred             cccHHHHHHhhcc----------CCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCc
Q 040845          516 RFSYLELFQATDK----------FSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRN  584 (824)
Q Consensus       516 ~~~~~~~~~~~~~----------~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n  584 (824)
                      .++++++..+++.          |+..+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++|||
T Consensus        24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n  103 (321)
T 2c30_A           24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN  103 (321)
T ss_dssp             -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred             cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence            4677777777654          677789999999999999876 69999999998766666778899999999999999


Q ss_pred             ceeEEeeeecCCeeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC
Q 040845          585 LVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM  664 (824)
Q Consensus       585 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~  664 (824)
                      |+++++++...+..++||||+++++|.+++...  .+++.++..++.|++.||+|||   +.+|+||||||+||+++.++
T Consensus       104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~  178 (321)
T 2c30_A          104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV--RLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLDG  178 (321)
T ss_dssp             BCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTC
T ss_pred             cceEEEEEEECCEEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCC
Confidence            999999999999999999999999999998754  5899999999999999999999   89999999999999999999


Q ss_pred             cEEEeecccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhh
Q 040845          665 VAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVN  744 (824)
Q Consensus       665 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~  744 (824)
                      .+||+|||++........  ......||+.|+|||++.+..++.++||||||+++|||++|+.||.....  ......+.
T Consensus       179 ~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~--~~~~~~~~  254 (321)
T 2c30_A          179 RVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP--VQAMKRLR  254 (321)
T ss_dssp             CEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHH
T ss_pred             cEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHh
Confidence            999999999987643221  22345699999999999999999999999999999999999999975321  11111111


Q ss_pred             hhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          745 DCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       745 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      ...+        +.        ......++..+.+++.+||+.||++|||+.|++++
T Consensus       255 ~~~~--------~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          255 DSPP--------PK--------LKNSHKVSPVLRDFLERMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             HSSC--------CC--------CTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             cCCC--------CC--------cCccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1100        00        01112345678999999999999999999999886

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=3e-42  Score=368.03  Aligned_cols=248  Identities=25%  Similarity=0.326  Sum_probs=207.0

Q ss_pred             hccCCCCceeeeccceEEEEEEE-CCCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARI-RDGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVL  602 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  602 (824)
                      .++|++.+.||+|+||.||+|++ .+|+.||||++....  ....+.+.+|+++++.++||||+++++++..++..++||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            56899999999999999999987 569999999997553  234567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 040845          603 EYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ  682 (824)
Q Consensus       603 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  682 (824)
                      ||+++|+|.+++...+ .+++.++..++.|+++|++|||   +.+|+||||||+||+++.++.+||+|||++....... 
T Consensus        94 e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-  168 (328)
T 3fe3_A           94 EYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-  168 (328)
T ss_dssp             CCCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC-
T ss_pred             ECCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC-
Confidence            9999999999997765 6899999999999999999999   9999999999999999999999999999998764332 


Q ss_pred             ccccccccccccccCccCcCCCCCC-ccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccC
Q 040845          683 SMTQTQTLATIGYMAPEYGREGQVS-TNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLS  761 (824)
Q Consensus       683 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  761 (824)
                        ......||+.|+|||++.+..++ .++||||+||++|||++|+.||.+....+. .........              
T Consensus       169 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~i~~~~~--------------  231 (328)
T 3fe3_A          169 --KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKEL-RERVLRGKY--------------  231 (328)
T ss_dssp             --GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHCCC--------------
T ss_pred             --ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHH-HHHHHhCCC--------------
Confidence              23445799999999999887764 899999999999999999999976321110 011100000              


Q ss_pred             chhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          762 QEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       762 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                            ..+..++..+.+++.+||..||++|||++|++++
T Consensus       232 ------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          232 ------RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             ------CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             ------CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                  0112345678899999999999999999999876

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=3.5e-42  Score=358.20  Aligned_cols=257  Identities=26%  Similarity=0.425  Sum_probs=213.9

Q ss_pred             hccCCCCceeeeccceEEEEEEECCCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEecc
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYM  605 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  605 (824)
                      .++|++.+.||+|+||.||+|+++++..||||+++... ...+.+.+|++++++++||||+++++++.++...++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI   85 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence            46799999999999999999999988899999997543 34567899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccc
Q 040845          606 PHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMT  685 (824)
Q Consensus       606 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  685 (824)
                      ++++|.+++......+++.+++.++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||.+....... ...
T Consensus        86 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~  161 (268)
T 3sxs_A           86 SNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ-YVS  161 (268)
T ss_dssp             TTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC-EEE
T ss_pred             CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchhh-hhc
Confidence            999999999877667999999999999999999999   9999999999999999999999999999998764332 222


Q ss_pred             cccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchh
Q 040845          686 QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQED  764 (824)
Q Consensus       686 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  764 (824)
                      .....+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||......+. ....... .                 
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-~~~~~~~-~-----------------  222 (268)
T 3sxs_A          162 SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV-VLKVSQG-H-----------------  222 (268)
T ss_dssp             CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-HHHHHTT-C-----------------
T ss_pred             ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHH-HHHHHcC-C-----------------
Confidence            334456788999999988889999999999999999999 9999875322111 1111000 0                 


Q ss_pred             hhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 040845          765 IHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRD  807 (824)
Q Consensus       765 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~  807 (824)
                       ....+..++..+.+++.+||+.||++|||+.|++++|+++++
T Consensus       223 -~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (268)
T 3sxs_A          223 -RLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE  264 (268)
T ss_dssp             -CCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred             -CCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence             000112235568999999999999999999999999988753

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=4.3e-42  Score=373.81  Aligned_cols=271  Identities=24%  Similarity=0.378  Sum_probs=218.7

Q ss_pred             ccHHHHHHhhccCCCCceeeeccceEEEEEEEC------CCcEEEEEEeecccc-chhhhHHHHHHHHhcC-CCCcceeE
Q 040845          517 FSYLELFQATDKFSENNLIGRGGFGSVYKARIR------DGMEVAVKVFNLQCG-RAFKSFDVECAMMKSI-RHRNLVKV  588 (824)
Q Consensus       517 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l  588 (824)
                      +....+....++|++.+.||+|+||.||+|++.      +++.||||+++.... ...+.+.+|+++++++ +||||+++
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~   91 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   91 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence            344555566789999999999999999999742      368999999975432 3346789999999999 78999999


Q ss_pred             EeeeecCC-eeEEEEeccCCCCHHHHhhhCCC------------------------------------------------
Q 040845          589 ISSCSNEE-FKALVLEYMPHGSLEKYLHSSNY------------------------------------------------  619 (824)
Q Consensus       589 ~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------  619 (824)
                      ++++.+.+ ..++||||+++|+|.+++.....                                                
T Consensus        92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (359)
T 3vhe_A           92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK  171 (359)
T ss_dssp             EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred             eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence            99987754 48999999999999999976532                                                


Q ss_pred             -----------------CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 040845          620 -----------------SLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ  682 (824)
Q Consensus       620 -----------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  682 (824)
                                       .+++.+++.++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||++........
T Consensus       172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  248 (359)
T 3vhe_A          172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD  248 (359)
T ss_dssp             ------------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred             ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence                             1889999999999999999999   89999999999999999999999999999987654444


Q ss_pred             ccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhccccccC
Q 040845          683 SMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLS  761 (824)
Q Consensus       683 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  761 (824)
                      ........+|+.|+|||++.+..++.++|||||||++|||+| |+.||......+...... .....             
T Consensus       249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~~~~~-------------  314 (359)
T 3vhe_A          249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL-KEGTR-------------  314 (359)
T ss_dssp             CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHH-HHTCC-------------
T ss_pred             chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHH-HcCCC-------------
Confidence            444455678999999999998899999999999999999998 999987643222211111 11000             


Q ss_pred             chhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhh
Q 040845          762 QEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSL  809 (824)
Q Consensus       762 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~  809 (824)
                           ...+..++..+.+++.+||+.||++|||+.|++++|+++.++.
T Consensus       315 -----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  357 (359)
T 3vhe_A          315 -----MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  357 (359)
T ss_dssp             -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             -----CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence                 0011234567899999999999999999999999999998654

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=6.3e-42  Score=372.74  Aligned_cols=260  Identities=25%  Similarity=0.477  Sum_probs=202.8

Q ss_pred             hccCCCCceeeeccceEEEEEEEC----CCcEEEEEEeeccc-cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR----DGMEVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKAL  600 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  600 (824)
                      ..+|++.+.||+|+||.||+|++.    ++..||||+++... ....+.+.+|+.++++++||||+++++++.+....++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            357999999999999999999865    47789999987543 2345678999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 040845          601 VLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE  680 (824)
Q Consensus       601 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  680 (824)
                      ||||+++|+|.+++......+++.+++.++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus       124 v~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  200 (373)
T 2qol_A          124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD  200 (373)
T ss_dssp             EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence            99999999999999887778999999999999999999999   899999999999999999999999999999876533


Q ss_pred             CCc-cccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhcccc
Q 040845          681 DQS-MTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDAN  758 (824)
Q Consensus       681 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  758 (824)
                      ... .......+++.|+|||++.+..++.++||||||+++||+++ |+.||......+  ....+..            .
T Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~--~~~~i~~------------~  266 (373)
T 2qol_A          201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD--VIKAVDE------------G  266 (373)
T ss_dssp             -------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH--HHHHHHT------------T
T ss_pred             CccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHc------------C
Confidence            221 12223345788999999998899999999999999999998 999986532211  1111110            0


Q ss_pred             ccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 040845          759 LLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDS  808 (824)
Q Consensus       759 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~  808 (824)
                            .+...+..++..+.+++.+||+.||++||++.|+++.|+++.+.
T Consensus       267 ------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  310 (373)
T 2qol_A          267 ------YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN  310 (373)
T ss_dssp             ------EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             ------CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence                  01111224567799999999999999999999999999998764

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=3.7e-41  Score=363.90  Aligned_cols=252  Identities=22%  Similarity=0.328  Sum_probs=208.2

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccc------hhhhHHHHHHHHhcCCCCcceeEEeeeecCCee
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGR------AFKSFDVECAMMKSIRHRNLVKVISSCSNEEFK  598 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  598 (824)
                      .++|++.+.||+|+||.||+|+.+ +|+.||+|+++.....      ..+.+.+|+.+++.++||||+++++++.+....
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            467999999999999999999876 5899999999765322      346789999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC----cEEEeecccc
Q 040845          599 ALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM----VAHLSDFGIA  674 (824)
Q Consensus       599 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~----~~kl~Dfg~a  674 (824)
                      ++||||+++|+|.+++.... .+++.++..++.||+.||+|||   +.+|+||||||+||+++.++    .+||+|||++
T Consensus        91 ~lv~e~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a  166 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTCS-CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred             EEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence            99999999999999997654 7899999999999999999999   89999999999999998777    7999999999


Q ss_pred             cccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhh
Q 040845          675 KLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEV  754 (824)
Q Consensus       675 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  754 (824)
                      .......   ......||+.|+|||++.+..++.++||||+||++|+|++|..||.+....+ ....+......      
T Consensus       167 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~-~~~~i~~~~~~------  236 (361)
T 2yab_A          167 HEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-TLANITAVSYD------  236 (361)
T ss_dssp             EECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHHHHTTCCC------
T ss_pred             eEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhcCCC------
Confidence            8764332   2234569999999999998899999999999999999999999997632111 11111111000      


Q ss_pred             ccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          755 VDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       755 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                                .....+..++..+.+++.+||..||++|||+.|++++
T Consensus       237 ----------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  273 (361)
T 2yab_A          237 ----------FDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (361)
T ss_dssp             ----------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ----------CCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                      0111223456778999999999999999999999864

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-41  Score=361.57  Aligned_cols=253  Identities=21%  Similarity=0.309  Sum_probs=210.4

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEec
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      .++|++.+.||+|+||.||+|+.. +++.||+|.+... ....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            468999999999999999999876 5889999998644 34456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC--CCcEEEeecccccccCCCCC
Q 040845          605 MPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD--NMVAHLSDFGIAKLLTGEDQ  682 (824)
Q Consensus       605 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~--~~~~kl~Dfg~a~~~~~~~~  682 (824)
                      +++|+|.+++......+++.+++.++.|++.|++|||   +.+|+||||||+||+++.  ++.+||+|||++..+.... 
T Consensus        83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~-  158 (321)
T 1tki_A           83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-  158 (321)
T ss_dssp             CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC-
Confidence            9999999999877667999999999999999999999   999999999999999987  7899999999998764332 


Q ss_pred             ccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCc
Q 040845          683 SMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ  762 (824)
Q Consensus       683 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  762 (824)
                        ......||+.|+|||++.+..++.++||||+||++|||++|..||......+ ....+......              
T Consensus       159 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~--------------  221 (321)
T 1tki_A          159 --NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-IIENIMNAEYT--------------  221 (321)
T ss_dssp             --EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHTCCC--------------
T ss_pred             --ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH-HHHHHHcCCCC--------------
Confidence              2234568999999999998889999999999999999999999997632211 11111111110              


Q ss_pred             hhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 040845          763 EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL  802 (824)
Q Consensus       763 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L  802 (824)
                        ........++.++.+++.+||..||++|||+.|++++=
T Consensus       222 --~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp  259 (321)
T 1tki_A          222 --FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHP  259 (321)
T ss_dssp             --CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred             --CChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence              01111234567799999999999999999999999864

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=4.3e-41  Score=357.45  Aligned_cols=270  Identities=23%  Similarity=0.297  Sum_probs=208.3

Q ss_pred             hhccCCCCceeeeccceEEEEEEECCCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEE
Q 040845          525 ATDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVL  602 (824)
Q Consensus       525 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  602 (824)
                      ..++|++.+.||+|+||+||+|+..+|+.||+|++....  ....+.+.+|++++++++||||+++++++.++...++||
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   98 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF   98 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence            357899999999999999999999889999999986543  223467889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 040845          603 EYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ  682 (824)
Q Consensus       603 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  682 (824)
                      ||++ ++|.+++......+++.++..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++....... 
T Consensus        99 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-  173 (311)
T 3niz_A           99 EFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV-  173 (311)
T ss_dssp             ECCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC-
T ss_pred             cCCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecCCCc-
Confidence            9997 4899888877767999999999999999999999   9999999999999999999999999999998764322 


Q ss_pred             ccccccccccccccCccCcCC-CCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCc---chhhccc-
Q 040845          683 SMTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPIS---TMEVVDA-  757 (824)
Q Consensus       683 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~-  757 (824)
                       .......+|+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+ .............   .....+. 
T Consensus       174 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~  251 (311)
T 3niz_A          174 -RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD-QLPKIFSILGTPNPREWPQVQELP  251 (311)
T ss_dssp             -C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT-HHHHHHHHHCCCCTTTSGGGTTSH
T ss_pred             -ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHHCCCChHHhhhhhccc
Confidence             22334568999999998876 568999999999999999999999997643332 2222221111110   0000000 


Q ss_pred             -----ccc-CchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          758 -----NLL-SQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       758 -----~~~-~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                           ... ............++.++.+++.+||+.||++|||++|++++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  301 (311)
T 3niz_A          252 LWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH  301 (311)
T ss_dssp             HHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             hhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence                 000 00000111122456778999999999999999999999874

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.2e-41  Score=362.37  Aligned_cols=249  Identities=22%  Similarity=0.300  Sum_probs=207.3

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecc---ccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQ---CGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALV  601 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  601 (824)
                      .++|++.+.||+|+||.||+|+.+ +|+.||+|+++..   .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            468999999999999999999875 5899999999754   233456788899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 040845          602 LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED  681 (824)
Q Consensus       602 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  681 (824)
                      |||+++|+|.+++...+ .+++.++..++.||+.||+|||   +.+|+||||||+||+++.+|.+||+|||+++......
T Consensus        84 ~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  159 (337)
T 1o6l_A           84 MEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             EECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred             EeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence            99999999999998655 6899999999999999999999   9999999999999999999999999999998543222


Q ss_pred             CccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccC
Q 040845          682 QSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLS  761 (824)
Q Consensus       682 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  761 (824)
                        .......||+.|+|||++.+..++.++||||+||++|||++|+.||......+ ..........              
T Consensus       160 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-~~~~i~~~~~--------------  222 (337)
T 1o6l_A          160 --ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-LFELILMEEI--------------  222 (337)
T ss_dssp             --CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCC--------------
T ss_pred             --CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH-HHHHHHcCCC--------------
Confidence              12334569999999999999999999999999999999999999997532111 0111111000              


Q ss_pred             chhhhhhhHHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 040845          762 QEDIHFVAKEQCVSFVFNLALECTVESPEQRI-----NAKEIVAK  801 (824)
Q Consensus       762 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~evl~~  801 (824)
                            ..+..++..+.+++.+||+.||++||     +++|+++|
T Consensus       223 ------~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          223 ------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             ------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             ------CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence                  01123466789999999999999999     89999876

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.4e-41  Score=363.02  Aligned_cols=254  Identities=24%  Similarity=0.354  Sum_probs=208.7

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc-chhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEe
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLE  603 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  603 (824)
                      .++|++.+.||+|+||+||+|+.. +++.||||++..... ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            468999999999999999999876 689999999865432 334678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 040845          604 YMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS  683 (824)
Q Consensus       604 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  683 (824)
                      |+++|+|.+++.... .+++.++..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++..+......
T Consensus        86 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  161 (323)
T 3tki_A           86 YCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  161 (323)
T ss_dssp             CCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             cCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence            999999999997654 6899999999999999999999   999999999999999999999999999999876543333


Q ss_pred             cccccccccccccCccCcCCCCC-CccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCc
Q 040845          684 MTQTQTLATIGYMAPEYGREGQV-STNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ  762 (824)
Q Consensus       684 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  762 (824)
                      .......||+.|+|||++.+..+ +.++||||+||++|||++|+.||............|......              
T Consensus       162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--------------  227 (323)
T 3tki_A          162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY--------------  227 (323)
T ss_dssp             CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTT--------------
T ss_pred             cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccccc--------------
Confidence            33345679999999999887765 789999999999999999999997644333333333221110              


Q ss_pred             hhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          763 EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       763 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                          ......++..+.+++.+||..||++|||+.|++++
T Consensus       228 ----~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          228 ----LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             ----STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ----CCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence                00112345678899999999999999999999875

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.3e-41  Score=356.99  Aligned_cols=258  Identities=25%  Similarity=0.443  Sum_probs=211.5

Q ss_pred             hccCCCCceeeeccceEEEEEEECCCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEecc
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYM  605 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  605 (824)
                      .++|++.+.||+|+||.||+|+++++..||||+++... ...+.+.+|++++++++||||+++++++.+....++||||+
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  101 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM  101 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence            56899999999999999999999988899999997543 33567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccc
Q 040845          606 PHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMT  685 (824)
Q Consensus       606 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  685 (824)
                      ++++|.+++......+++.+++.++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||++....... ...
T Consensus       102 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~  177 (283)
T 3gen_A          102 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTS  177 (283)
T ss_dssp             TTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH-HHS
T ss_pred             CCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEccccccccccccc-ccc
Confidence            999999999875567999999999999999999999   9999999999999999999999999999998654221 122


Q ss_pred             cccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchh
Q 040845          686 QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQED  764 (824)
Q Consensus       686 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  764 (824)
                      .....+|+.|+|||.+.+..++.++||||+|+++|||+| |+.||......+ ........ .                 
T Consensus       178 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~-~~~~~~~~-~-----------------  238 (283)
T 3gen_A          178 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-TAEHIAQG-L-----------------  238 (283)
T ss_dssp             TTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-HHHHHHTT-C-----------------
T ss_pred             ccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH-HHHHHhcc-c-----------------
Confidence            233456788999999998889999999999999999998 999987632211 11111110 0                 


Q ss_pred             hhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 040845          765 IHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDS  808 (824)
Q Consensus       765 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~  808 (824)
                       ....+..++..+.+++.+||+.||++|||++|++++|+++.+.
T Consensus       239 -~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~  281 (283)
T 3gen_A          239 -RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE  281 (283)
T ss_dssp             -CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -CCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence             0001122356688999999999999999999999999998753

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=6.1e-41  Score=377.20  Aligned_cols=378  Identities=23%  Similarity=0.248  Sum_probs=305.5

Q ss_pred             ccccccccCCcccccCCCCCcEEEccCCcccccccccccCCCCCCEEeCCCCcCCcc-cChhhhCcCCCceeeccCCccc
Q 040845            4 IINNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGT-IPAAIFNVSTLKAFAVTNNSLS   82 (824)
Q Consensus         4 l~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~-~~~~~~~l~~L~~L~L~~n~l~   82 (824)
                      ..++.++.++.  +.  ++|++|+|++|+|++..|..|+++++|++|+|++|.+.+. .+.+|.++++|++|+|++|+++
T Consensus        17 c~~~~l~~lp~--l~--~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~   92 (455)
T 3v47_A           17 CINRGLHQVPE--LP--AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL   92 (455)
T ss_dssp             CCSSCCSSCCC--CC--TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTC
T ss_pred             cCCCCcccCCC--CC--CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccC
Confidence            34566666554  32  7899999999999988899999999999999999999744 4678999999999999999998


Q ss_pred             cccCccccCCCCCccEEEccCCeeeeecCcc--ccCCCCCceEeccCccccccCCcc-ccCCCCCCEEEccCCcCCCCcC
Q 040845           83 GCLSSITDVGLPNLEVLYLWGNNFSGTIPHF--IFNASKLSKLALEMNSFSGFIPST-FGNLRNLEWLTLYDNNLTSSTL  159 (824)
Q Consensus        83 ~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~--l~~l~~L~~L~L~~N~i~~~~~~~-~~~l~~L~~L~L~~n~i~~~~~  159 (824)
                      +.++... .++++|++|+|++|++++..+..  +..+++|++|+|++|++++..|.. |.++++|++|++++|+++....
T Consensus        93 ~~~~~~~-~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~  171 (455)
T 3v47_A           93 QLETGAF-NGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICE  171 (455)
T ss_dssp             EECTTTT-TTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCT
T ss_pred             ccChhhc-cCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccCh
Confidence            8754433 36899999999999998755444  889999999999999999887776 8999999999999999987754


Q ss_pred             cccccccCCCC--CCCcEEECcCCCCCccCCcccccc------ccccccEEEeecCcceecCCccCCCC---CCCCEEEe
Q 040845          160 DLSFLSSLSNC--KSLTHISLSNNPLDGILPRTYVGN------LSHSLKNFYMYNCNVSGGIPEEITNL---TDLTTIVL  228 (824)
Q Consensus       160 ~~~~~~~l~~l--~~L~~L~Ls~n~l~~~~~~~~~~~------l~~~L~~L~l~~n~l~~~~~~~l~~l---~~L~~L~L  228 (824)
                      .     .+..+  ++|+.|++++|.+.+..+..+...      -..+|++|++++|++++..|..+..+   ++|+.|++
T Consensus       172 ~-----~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l  246 (455)
T 3v47_A          172 E-----DLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLIL  246 (455)
T ss_dssp             T-----TSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEEC
T ss_pred             h-----hhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEee
Confidence            3     24443  799999999999988766543210      12579999999999998877766543   89999999


Q ss_pred             cCCccCCccchhhcCCCCCCEEEcccccCcccCCccccc--cCCccEEEccCccccccCCccccCCCCCcEEEcCCCCCC
Q 040845          229 GGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICL--SVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELT  306 (824)
Q Consensus       229 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~--~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~  306 (824)
                      ++|.+.+...              ..+.+....+..+..  .++|+.|++++|++.+..+..|+.+++|++|+|++|+++
T Consensus       247 ~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~  312 (455)
T 3v47_A          247 SNSYNMGSSF--------------GHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEIN  312 (455)
T ss_dssp             TTCTTTSCCT--------------TCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCC
T ss_pred             cccccccccc--------------chhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCccc
Confidence            9998764311              122222222222222  357888888888888788888888888888888888888


Q ss_pred             CCC-CcccccccccccccccccccCcCCccccccccchhhhcccccccccCCCccCCCCCCCeEEccCccccccCCcccc
Q 040845          307 SIP-LNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFG  385 (824)
Q Consensus       307 ~lp-~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  385 (824)
                      .++ ..+..+++|+.|++++|.+++..|..|.++++|+.|+|++|++++..|..|..+++|++|+|++|+|++..+..|.
T Consensus       313 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  392 (455)
T 3v47_A          313 KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFD  392 (455)
T ss_dssp             EECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTT
T ss_pred             ccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhc
Confidence            774 4577788888888888888877888899999999999999999988899999999999999999999987777889


Q ss_pred             ccccccEEEccCcccCCCCc
Q 040845          386 DLISLKSLNLSYNNLSGTIP  405 (824)
Q Consensus       386 ~l~~L~~L~L~~N~l~~~~p  405 (824)
                      .+++|+.|++++|++++..|
T Consensus       393 ~l~~L~~L~l~~N~l~~~~~  412 (455)
T 3v47_A          393 RLTSLQKIWLHTNPWDCSCP  412 (455)
T ss_dssp             TCTTCCEEECCSSCBCCCTT
T ss_pred             cCCcccEEEccCCCcccCCC
Confidence            99999999999999997776

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.3e-41  Score=370.42  Aligned_cols=264  Identities=27%  Similarity=0.422  Sum_probs=217.3

Q ss_pred             hccCCCCceeeeccceEEEEEEEC--------CCcEEEEEEeecccc-chhhhHHHHHHHHhcC-CCCcceeEEeeeecC
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR--------DGMEVAVKVFNLQCG-RAFKSFDVECAMMKSI-RHRNLVKVISSCSNE  595 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  595 (824)
                      .++|.+.+.||+|+||.||+|++.        ++..||||+++.... ...+.+.+|+++++++ +||||+++++++.++
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            468899999999999999999852        246799999875532 3446788999999999 899999999999999


Q ss_pred             CeeEEEEeccCCCCHHHHhhhCC---------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee
Q 040845          596 EFKALVLEYMPHGSLEKYLHSSN---------------YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL  660 (824)
Q Consensus       596 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill  660 (824)
                      +..++||||+++|+|.+++....               ..+++.+++.++.|++.||+|||   +.+|+||||||+||++
T Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll  224 (382)
T 3tt0_A          148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV  224 (382)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEE
T ss_pred             CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceEEE
Confidence            99999999999999999998654               35899999999999999999999   8999999999999999


Q ss_pred             CCCCcEEEeecccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchh
Q 040845          661 DDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTL  739 (824)
Q Consensus       661 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~  739 (824)
                      +.++.+||+|||+|+...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||......  ..
T Consensus       225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~--~~  302 (382)
T 3tt0_A          225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--EL  302 (382)
T ss_dssp             CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HH
T ss_pred             cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HH
Confidence            9999999999999987654443334445567889999999999999999999999999999999 99998753211  11


Q ss_pred             hhhhhhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhccc
Q 040845          740 KHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLRN  812 (824)
Q Consensus       740 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~~  812 (824)
                      ...+....                  ....+..++..+.+++.+||+.||++|||++|++++|+++......+
T Consensus       303 ~~~~~~~~------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~  357 (382)
T 3tt0_A          303 FKLLKEGH------------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ  357 (382)
T ss_dssp             HHHHHTTC------------------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSC
T ss_pred             HHHHHcCC------------------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcC
Confidence            11111110                  00111235667999999999999999999999999999998755443

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1e-41  Score=368.52  Aligned_cols=267  Identities=27%  Similarity=0.419  Sum_probs=214.5

Q ss_pred             HHhhccCCCCceeeeccceEEEEEEEC------CCcEEEEEEeecccc-chhhhHHHHHHHHhcCCCCcceeEEeeeecC
Q 040845          523 FQATDKFSENNLIGRGGFGSVYKARIR------DGMEVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVKVISSCSNE  595 (824)
Q Consensus       523 ~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  595 (824)
                      ....++|++.+.||+|+||.||+|++.      +++.||||+++.... ...+.+.+|+.++++++||||+++++++.+.
T Consensus        43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~  122 (343)
T 1luf_A           43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG  122 (343)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence            334688999999999999999999874      348899999875532 3456789999999999999999999999999


Q ss_pred             CeeEEEEeccCCCCHHHHhhhCC-----------------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecC
Q 040845          596 EFKALVLEYMPHGSLEKYLHSSN-----------------------YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCD  652 (824)
Q Consensus       596 ~~~~lv~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~D  652 (824)
                      +..++||||+++|+|.+++....                       ..+++.+++.++.|+++||+|||   +.+|+|||
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~D  199 (343)
T 1luf_A          123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRD  199 (343)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSC
T ss_pred             CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCC
Confidence            99999999999999999997642                       46899999999999999999999   99999999


Q ss_pred             CCCCCeeeCCCCcEEEeecccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcc
Q 040845          653 LKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDE  731 (824)
Q Consensus       653 lk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~  731 (824)
                      |||+||+++.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||++ |..||..
T Consensus       200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  279 (343)
T 1luf_A          200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG  279 (343)
T ss_dssp             CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence            999999999999999999999987644333333344568899999999988889999999999999999999 9999875


Q ss_pred             cccCcchhhhhhhhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhcc
Q 040845          732 LFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLR  811 (824)
Q Consensus       732 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~  811 (824)
                      ....  .....+...           ..       ...+..++..+.+++.+||+.||++|||+.|++++|+++.+.+..
T Consensus       280 ~~~~--~~~~~~~~~-----------~~-------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~~  339 (343)
T 1luf_A          280 MAHE--EVIYYVRDG-----------NI-------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAEG  339 (343)
T ss_dssp             SCHH--HHHHHHHTT-----------CC-------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC----
T ss_pred             CChH--HHHHHHhCC-----------Cc-------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhhh
Confidence            3221  111111100           00       001224567799999999999999999999999999998765544


Q ss_pred             c
Q 040845          812 N  812 (824)
Q Consensus       812 ~  812 (824)
                      .
T Consensus       340 ~  340 (343)
T 1luf_A          340 T  340 (343)
T ss_dssp             -
T ss_pred             h
Confidence            3

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.8e-41  Score=363.32  Aligned_cols=259  Identities=24%  Similarity=0.414  Sum_probs=206.4

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCc----EEEEEEeeccc-cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGM----EVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKA  599 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  599 (824)
                      .++|++.+.||+|+||+||+|++. +++    +||+|.+.... ....+.+.+|+.++++++||||+++++++.+.. .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~   92 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence            367899999999999999999864 344    35788775432 344577899999999999999999999998765 67


Q ss_pred             EEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCC
Q 040845          600 LVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG  679 (824)
Q Consensus       600 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  679 (824)
                      +|+||+++|+|.+++......+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+|+....
T Consensus        93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  169 (327)
T 3poz_A           93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             EEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence            999999999999999887778999999999999999999999   89999999999999999999999999999988755


Q ss_pred             CCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhcccc
Q 040845          680 EDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDAN  758 (824)
Q Consensus       680 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  758 (824)
                      ...........+|+.|+|||.+.+..++.++|||||||++|||+| |+.||......+  ....+....           
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~~~~~~-----------  236 (327)
T 3poz_A          170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSILEKGE-----------  236 (327)
T ss_dssp             TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHHHTTC-----------
T ss_pred             CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH--HHHHHHcCC-----------
Confidence            544444445567889999999999999999999999999999999 999997633221  112111110           


Q ss_pred             ccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 040845          759 LLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDS  808 (824)
Q Consensus       759 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~  808 (824)
                             ....+..++..+.+++.+||+.||++|||+.|++++|+++.+.
T Consensus       237 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~  279 (327)
T 3poz_A          237 -------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             -------CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred             -------CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence                   0111223566789999999999999999999999999998754

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=4.3e-41  Score=354.56  Aligned_cols=261  Identities=24%  Similarity=0.431  Sum_probs=208.3

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc---chhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG---RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALV  601 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  601 (824)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++.....   ...+.+.+|+.++++++||||+++++++.+++..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            467999999999999999999865 589999999865432   3346788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 040845          602 LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED  681 (824)
Q Consensus       602 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  681 (824)
                      |||+++++|.+++...+ .+++.+++.++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||++.......
T Consensus        90 ~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  165 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS  165 (294)
T ss_dssp             EECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred             EeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence            99999999999998765 7899999999999999999999   9999999999999999999999999999998654322


Q ss_pred             CccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccC
Q 040845          682 QSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLS  761 (824)
Q Consensus       682 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  761 (824)
                       ........||+.|+|||.+.+..++.++||||+|+++|||++|+.||............ .....              
T Consensus       166 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~-~~~~~--------------  229 (294)
T 4eqm_A          166 -LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKH-IQDSV--------------  229 (294)
T ss_dssp             ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHH-HSSCC--------------
T ss_pred             -ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-hhccC--------------
Confidence             12233456899999999999989999999999999999999999999763221111111 00000              


Q ss_pred             chhhhhhhHHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHHHH
Q 040845          762 QEDIHFVAKEQCVSFVFNLALECTVESPEQRI-NAKEIVAKLLKIRD  807 (824)
Q Consensus       762 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-t~~evl~~L~~~~~  807 (824)
                       .......+..++..+.+++.+||..||++|| +++++.+.|+++..
T Consensus       230 -~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~  275 (294)
T 4eqm_A          230 -PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH  275 (294)
T ss_dssp             -CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred             -CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence             0001111234567799999999999999999 99999999887643

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.2e-40  Score=352.92  Aligned_cols=265  Identities=26%  Similarity=0.392  Sum_probs=205.6

Q ss_pred             hccCCCCceeeeccceEEEEEEECCCcEEEEEEeeccccchhhhHHHHHHHHhc--CCCCcceeEEeeeec----CCeeE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKS--IRHRNLVKVISSCSN----EEFKA  599 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~----~~~~~  599 (824)
                      .++|++.+.||+|+||+||+|++ +++.||||++...   ....+..|.+++..  ++||||+++++++..    ....+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~   82 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW   82 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence            47899999999999999999998 4899999998643   33455566666666  799999999998644    35688


Q ss_pred             EEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCC-----CCCeEecCCCCCCeeeCCCCcEEEeecccc
Q 040845          600 LVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGY-----SAPVIHCDLKPSNVLLDDNMVAHLSDFGIA  674 (824)
Q Consensus       600 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-----~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a  674 (824)
                      +||||+++|+|.++++..  .+++..++.++.|++.|++|||+..     +.+|+||||||+||+++.++.+||+|||+|
T Consensus        83 lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  160 (301)
T 3q4u_A           83 LITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA  160 (301)
T ss_dssp             EEECCCTTCBHHHHHTTC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EehhhccCCCHHHHHhhc--ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCe
Confidence            999999999999999654  6899999999999999999999322     579999999999999999999999999999


Q ss_pred             cccCCCCCcc--ccccccccccccCccCcCCC------CCCccchHHHHHHHHHHHHhC----------CCCCcccccCc
Q 040845          675 KLLTGEDQSM--TQTQTLATIGYMAPEYGREG------QVSTNGDVYSFGIMLMETFTR----------KKPTDELFNGE  736 (824)
Q Consensus       675 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~------~~~~~~DvwslG~~l~el~tg----------~~p~~~~~~~~  736 (824)
                      ..........  ......||+.|+|||.+.+.      .++.++|||||||++|||+||          +.||.......
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~  240 (301)
T 3q4u_A          161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND  240 (301)
T ss_dssp             EEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             eecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCC
Confidence            8664433221  12334699999999998876      455799999999999999999          77776644433


Q ss_pred             chhhhhhhhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 040845          737 MTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKI  805 (824)
Q Consensus       737 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~  805 (824)
                      .....+........         .............++..+.+++.+||+.||++|||+.|+++.|+++
T Consensus       241 ~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          241 PSFEDMRKVVCVDQ---------QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             CCHHHHHHHHTTSC---------CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cchhhhhHHHhccC---------CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            33332222111100         0000011112335678899999999999999999999999999876

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-40  Score=357.11  Aligned_cols=269  Identities=27%  Similarity=0.402  Sum_probs=207.0

Q ss_pred             HHhhccCCCCceeeeccceEEEEEEECCCcEEEEEEeeccccchhhhHHHHHHHHhcC--CCCcceeEEeeeecC----C
Q 040845          523 FQATDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSI--RHRNLVKVISSCSNE----E  596 (824)
Q Consensus       523 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~----~  596 (824)
                      ....++|++.+.||+|+||.||+|++. ++.||||++...   ....+..|.+++...  +||||+++++++...    .
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~  108 (337)
T 3mdy_A           33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT  108 (337)
T ss_dssp             TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred             cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence            444578999999999999999999987 899999998643   233445555665554  899999999999876    7


Q ss_pred             eeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC--------CeEecCCCCCCeeeCCCCcEEE
Q 040845          597 FKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSA--------PVIHCDLKPSNVLLDDNMVAHL  668 (824)
Q Consensus       597 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~--------~ivH~Dlk~~Nill~~~~~~kl  668 (824)
                      ..++||||+++|+|.+++...  .+++.+++.++.|++.|++|||   +.        +|+||||||+||+++.++.+||
T Consensus       109 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl  183 (337)
T 3mdy_A          109 QLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI  183 (337)
T ss_dssp             EEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred             ceEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence            889999999999999999765  5899999999999999999999   77        9999999999999999999999


Q ss_pred             eecccccccCCCCCcc--ccccccccccccCccCcCCCCCCcc------chHHHHHHHHHHHHhCC----------CCCc
Q 040845          669 SDFGIAKLLTGEDQSM--TQTQTLATIGYMAPEYGREGQVSTN------GDVYSFGIMLMETFTRK----------KPTD  730 (824)
Q Consensus       669 ~Dfg~a~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~------~DvwslG~~l~el~tg~----------~p~~  730 (824)
                      +|||++..+.......  ......||+.|+|||++.+..++.+      +|||||||++|||+||.          .||.
T Consensus       184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~  263 (337)
T 3mdy_A          184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH  263 (337)
T ss_dssp             CCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             EeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence            9999998764333221  1224569999999999987766655      99999999999999994          4444


Q ss_pred             ccccCcchhhhhhhhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhh
Q 040845          731 ELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSL  809 (824)
Q Consensus       731 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~  809 (824)
                      ...........+...         ..................++..+.+++.+||+.||++|||+.|++++|+++.++.
T Consensus       264 ~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  333 (337)
T 3mdy_A          264 DLVPSDPSYEDMREI---------VCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ  333 (337)
T ss_dssp             TTSCSSCCHHHHHHH---------HTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             hhcCCCCchhhhHHH---------HhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence            432222222111111         1111111111122233478889999999999999999999999999999998764

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=3.5e-41  Score=359.25  Aligned_cols=264  Identities=23%  Similarity=0.380  Sum_probs=217.6

Q ss_pred             hccCCCCceeeeccceEEEEEEE------CCCcEEEEEEeecccc-chhhhHHHHHHHHhcC-CCCcceeEEeeeecCCe
Q 040845          526 TDKFSENNLIGRGGFGSVYKARI------RDGMEVAVKVFNLQCG-RAFKSFDVECAMMKSI-RHRNLVKVISSCSNEEF  597 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  597 (824)
                      .++|++.+.||+|+||.||+|++      .+++.||||+++.... ...+.+.+|+.+++++ +||||+++++++.+++.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  101 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence            46899999999999999999985      2468999999975533 3457788999999999 99999999999999999


Q ss_pred             eEEEEeccCCCCHHHHhhhCCC-----------------CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee
Q 040845          598 KALVLEYMPHGSLEKYLHSSNY-----------------SLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL  660 (824)
Q Consensus       598 ~~lv~e~~~~g~L~~~l~~~~~-----------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill  660 (824)
                      .++||||+++|+|.+++.....                 .+++.+++.++.|+++||+|||   +.+|+||||||+||++
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~  178 (313)
T 1t46_A          102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILL  178 (313)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred             cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEE
Confidence            9999999999999999986542                 4899999999999999999999   8999999999999999


Q ss_pred             CCCCcEEEeecccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchh
Q 040845          661 DDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTL  739 (824)
Q Consensus       661 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~  739 (824)
                      +.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||+| |+.||........ .
T Consensus       179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-~  257 (313)
T 1t46_A          179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-F  257 (313)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH-H
T ss_pred             cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH-H
Confidence            9999999999999987755444333344567889999999988899999999999999999999 9999876432211 1


Q ss_pred             hhhhhhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhcc
Q 040845          740 KHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLR  811 (824)
Q Consensus       740 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~  811 (824)
                      ...+.....                  ...+..++..+.+++.+||+.||++|||+.|++++|+++.++...
T Consensus       258 ~~~~~~~~~------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~  311 (313)
T 1t46_A          258 YKMIKEGFR------------------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTN  311 (313)
T ss_dssp             HHHHHHTCC------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTCC
T ss_pred             HHHhccCCC------------------CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhhc
Confidence            111111110                  001123456789999999999999999999999999998876543

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-41  Score=365.33  Aligned_cols=266  Identities=23%  Similarity=0.351  Sum_probs=213.1

Q ss_pred             hhccCCCCceeeeccceEEEEEEE------CCCcEEEEEEeeccc-cchhhhHHHHHHHHhcC-CCCcceeEEeeeecCC
Q 040845          525 ATDKFSENNLIGRGGFGSVYKARI------RDGMEVAVKVFNLQC-GRAFKSFDVECAMMKSI-RHRNLVKVISSCSNEE  596 (824)
Q Consensus       525 ~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  596 (824)
                      ..++|++.+.||+|+||.||+|++      .++..||||++.... ....+.+.+|+.+++++ +||||+++++++...+
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  122 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  122 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence            357899999999999999999986      235689999987542 33457789999999999 8999999999999999


Q ss_pred             eeEEEEeccCCCCHHHHhhhCCC----------------------CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCC
Q 040845          597 FKALVLEYMPHGSLEKYLHSSNY----------------------SLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLK  654 (824)
Q Consensus       597 ~~~lv~e~~~~g~L~~~l~~~~~----------------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk  654 (824)
                      ..++||||+++|+|.+++.....                      .+++.+++.++.|++.||+|||   +.+|+|||||
T Consensus       123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dik  199 (344)
T 1rjb_A          123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLA  199 (344)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCS
T ss_pred             ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCC
Confidence            99999999999999999986542                      3789999999999999999999   9999999999


Q ss_pred             CCCeeeCCCCcEEEeecccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccc
Q 040845          655 PSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELF  733 (824)
Q Consensus       655 ~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~  733 (824)
                      |+||+++.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||+| |..||....
T Consensus       200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  279 (344)
T 1rjb_A          200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  279 (344)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence            9999999999999999999987654444334445567889999999988899999999999999999998 999987643


Q ss_pred             cCcchhhhhhhhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhccc
Q 040845          734 NGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLRN  812 (824)
Q Consensus       734 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~~  812 (824)
                      ... .....+.....                  ...+..++..+.+++.+||..||++|||+.|++++|+.+.+...+.
T Consensus       280 ~~~-~~~~~~~~~~~------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~  339 (344)
T 1rjb_A          280 VDA-NFYKLIQNGFK------------------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEEA  339 (344)
T ss_dssp             CSH-HHHHHHHTTCC------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC------
T ss_pred             cHH-HHHHHHhcCCC------------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHHH
Confidence            221 11121111110                  0111234667899999999999999999999999999987765543

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=5.8e-42  Score=378.32  Aligned_cols=262  Identities=19%  Similarity=0.240  Sum_probs=210.5

Q ss_pred             HHHHHhhccCCCCceeeeccceEEEEEEECC-CcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeeeecC
Q 040845          520 LELFQATDKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSCSNE  595 (824)
Q Consensus       520 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  595 (824)
                      .++....++|++.+.||+|+||+||+|+.+. ++.||||+++...   ....+.+.+|+.+++.++||||+++++++.++
T Consensus        67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~  146 (437)
T 4aw2_A           67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDD  146 (437)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred             hcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC
Confidence            3444556899999999999999999998764 7899999997532   23345588999999999999999999999999


Q ss_pred             CeeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccc
Q 040845          596 EFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK  675 (824)
Q Consensus       596 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~  675 (824)
                      +..++||||+++|+|.+++......+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+|+
T Consensus       147 ~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~DFGla~  223 (437)
T 4aw2_A          147 NNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCL  223 (437)
T ss_dssp             SEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             CEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcchhhhh
Confidence            9999999999999999999876667999999999999999999999   9999999999999999999999999999998


Q ss_pred             ccCCCCCccccccccccccccCccCcC-----CCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCc
Q 040845          676 LLTGEDQSMTQTQTLATIGYMAPEYGR-----EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPIS  750 (824)
Q Consensus       676 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  750 (824)
                      ....... .......||+.|+|||++.     .+.++.++||||+||++|||++|+.||......+ ...........  
T Consensus       224 ~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~-~~~~i~~~~~~--  299 (437)
T 4aw2_A          224 KLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE-TYGKIMNHKER--  299 (437)
T ss_dssp             ECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHTHHHH--
T ss_pred             hcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH-HHHhhhhcccc--
Confidence            7643322 2233457999999999986     5578999999999999999999999997632111 11111110000  


Q ss_pred             chhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 040845          751 TMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQ--RINAKEIVAK  801 (824)
Q Consensus       751 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rpt~~evl~~  801 (824)
                         ...+.          ....++..+.+++.+|+..+|++  ||+++|+++|
T Consensus       300 ---~~~p~----------~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          300 ---FQFPT----------QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             ---CCCCS----------SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred             ---ccCCc----------ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence               00000          00124567899999999998888  9999999875

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=5.7e-41  Score=374.83  Aligned_cols=252  Identities=31%  Similarity=0.455  Sum_probs=210.1

Q ss_pred             hccCCCCceeeeccceEEEEEEECCCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCC-eeEEEEec
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEE-FKALVLEY  604 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~  604 (824)
                      .++|++.+.||+|+||.||+|.+. |+.||||+++..  ...+.+.+|+.++++++||||+++++++.+.. ..++||||
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~  268 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY  268 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSC--TTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCc--hHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence            467889999999999999999987 889999998754  35678999999999999999999999987655 78999999


Q ss_pred             cCCCCHHHHhhhCCC-CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 040845          605 MPHGSLEKYLHSSNY-SLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS  683 (824)
Q Consensus       605 ~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  683 (824)
                      +++|+|.+++...+. .+++..++.++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++.....   
T Consensus       269 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---  342 (450)
T 1k9a_A          269 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---  342 (450)
T ss_dssp             CTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc---
Confidence            999999999987653 4689999999999999999999   999999999999999999999999999999854321   


Q ss_pred             cccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhccccccCc
Q 040845          684 MTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ  762 (824)
Q Consensus       684 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  762 (824)
                        .....+++.|+|||.+.+..++.++|||||||++|||+| |+.||......+.  ...+..                 
T Consensus       343 --~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~--~~~i~~-----------------  401 (450)
T 1k9a_A          343 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV--VPRVEK-----------------  401 (450)
T ss_dssp             ------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH--HHHHHT-----------------
T ss_pred             --ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH--HHHHHc-----------------
Confidence              122357889999999999999999999999999999999 9999876432211  111110                 


Q ss_pred             hhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 040845          763 EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDS  808 (824)
Q Consensus       763 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~  808 (824)
                       ..+...+..|+..+.++|.+||+.||++|||+.|+++.|+++...
T Consensus       402 -~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~  446 (450)
T 1k9a_A          402 -GYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH  446 (450)
T ss_dssp             -TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             -CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence             011122345678899999999999999999999999999998764

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=3.5e-41  Score=360.32  Aligned_cols=248  Identities=25%  Similarity=0.387  Sum_probs=205.0

Q ss_pred             hccCCCCceeeeccceEEEEEEE-CCCcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARI-RDGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALV  601 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  601 (824)
                      .++|.+.+.||+|+||.||+|++ .+++.||||++....   ......+.+|+.+++.++||||+++++++..+...++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            46899999999999999999986 468999999987542   23345788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 040845          602 LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED  681 (824)
Q Consensus       602 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  681 (824)
                      |||+ +|+|.+++.... .+++.++..++.|++.|++|||   +.+|+||||||+||++++++.+||+|||++.......
T Consensus        88 ~E~~-~g~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~  162 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN  162 (336)
T ss_dssp             ECCC-CEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred             EECC-CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence            9999 789999987655 6899999999999999999999   8999999999999999999999999999998654322


Q ss_pred             CccccccccccccccCccCcCCCCC-CccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhcccccc
Q 040845          682 QSMTQTQTLATIGYMAPEYGREGQV-STNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLL  760 (824)
Q Consensus       682 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  760 (824)
                         ......||+.|+|||.+.+..+ +.++||||+||++|||++|+.||.........              ..+...  
T Consensus       163 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~--------------~~i~~~--  223 (336)
T 3h4j_B          163 ---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF--------------KKVNSC--  223 (336)
T ss_dssp             ---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB--------------CCCCSS--
T ss_pred             ---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH--------------HHHHcC--
Confidence               2234569999999999988776 78999999999999999999999763221110              000000  


Q ss_pred             CchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 040845          761 SQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL  802 (824)
Q Consensus       761 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L  802 (824)
                           ....+..++..+.+++.+||+.||.+|||++|++++=
T Consensus       224 -----~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp  260 (336)
T 3h4j_B          224 -----VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDP  260 (336)
T ss_dssp             -----CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCH
T ss_pred             -----CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhCh
Confidence                 0011223456789999999999999999999998863

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=1.9e-40  Score=369.96  Aligned_cols=384  Identities=25%  Similarity=0.329  Sum_probs=258.3

Q ss_pred             CcccccccccCCcccccCCCCCcEEEccCCcccccccccccCCCCC-------------CEEeCCCCcCCcccChhhhCc
Q 040845            2 PSIINNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNL-------------GFLDLSQNKLLGTIPAAIFNV   68 (824)
Q Consensus         2 ~~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L-------------~~L~Ls~n~l~~~~~~~~~~l   68 (824)
                      +++++|+| +.+|++|+++++|++|+|++|++.+.+|..++++++|             ++|++++|.+++ +|..   .
T Consensus        16 L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-lp~~---~   90 (454)
T 1jl5_A           16 PLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS-LPEL---P   90 (454)
T ss_dssp             -------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-CCSC---C
T ss_pred             hhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc-CCCC---c
Confidence            57788888 7788889999999999999999988888888888764             889999999884 4442   4


Q ss_pred             CCCceeeccCCccccccCccccCCCCCccEEEccCCeeeeecCccccCCCCCceEeccCccccccCCccccCCCCCCEEE
Q 040845           69 STLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLT  148 (824)
Q Consensus        69 ~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~  148 (824)
                      ++|++|++++|++++++..     +++|++|++++|++++ ++..   .++|++|++++|++++ +| .|+++++|++|+
T Consensus        91 ~~L~~L~l~~n~l~~lp~~-----~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~  159 (454)
T 1jl5_A           91 PHLESLVASCNSLTELPEL-----PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIID  159 (454)
T ss_dssp             TTCSEEECCSSCCSSCCCC-----CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEE
T ss_pred             CCCCEEEccCCcCCccccc-----cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEE
Confidence            7889999999988886542     4789999999998874 3322   2689999999999886 55 588899999999


Q ss_pred             ccCCcCCCCcCcccccccCCCCCCCcEEECcCCCCCccCCccccccccccccEEEeecCcceecCCccCCCCCCCCEEEe
Q 040845          149 LYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVL  228 (824)
Q Consensus       149 L~~n~i~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L  228 (824)
                      +++|+++.++..         .++|++|++++|.+.+++  .+ +. .++|++|++++|++++ +|..   .++|++|++
T Consensus       160 l~~N~l~~lp~~---------~~~L~~L~L~~n~l~~l~--~~-~~-l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l  222 (454)
T 1jl5_A          160 VDNNSLKKLPDL---------PPSLEFIAAGNNQLEELP--EL-QN-LPFLTAIYADNNSLKK-LPDL---PLSLESIVA  222 (454)
T ss_dssp             CCSSCCSCCCCC---------CTTCCEEECCSSCCSSCC--CC-TT-CTTCCEEECCSSCCSS-CCCC---CTTCCEEEC
T ss_pred             CCCCcCcccCCC---------cccccEEECcCCcCCcCc--cc-cC-CCCCCEEECCCCcCCc-CCCC---cCcccEEEC
Confidence            999988876521         258899999999988864  23 22 4578999999998875 3432   258889999


Q ss_pred             cCCccCCccchhhcCCCCCCEEEcccccCcccCCccccccCCccEEEccCccccccCCccccCCCCCcEEEcCCCCCCCC
Q 040845          229 GGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSI  308 (824)
Q Consensus       229 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l  308 (824)
                      ++|.++ .+| .|..+++|++|++++|++++ +|..   +++|+.|++++|++++ +|..   .++|+.|++++|+++.+
T Consensus       223 ~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~l  292 (454)
T 1jl5_A          223 GNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSGL  292 (454)
T ss_dssp             CSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSEE
T ss_pred             cCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCcc
Confidence            999888 556 48888999999999998885 4432   4788999999998885 3433   37888999999998877


Q ss_pred             CCcccccccccccccccccccCcCCcccccc-ccchhhhcccccccccCCCccCCCCCCCeEEccCccccccCCcccccc
Q 040845          309 PLNFWSLKDILDLNLSSNCFSGPLPLEIRNL-KALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDL  387 (824)
Q Consensus       309 p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l-~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  387 (824)
                      |..   .++|+.|++++|++++. +    .+ ++|+.|++++|++++ +|..   +++|+.|++++|+++ .+|.   .+
T Consensus       293 ~~~---~~~L~~L~l~~N~l~~i-~----~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~-~lp~---~l  356 (454)
T 1jl5_A          293 SEL---PPNLYYLNASSNEIRSL-C----DLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLA-EVPE---LP  356 (454)
T ss_dssp             SCC---CTTCCEEECCSSCCSEE-C----CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-CCCC---CC
T ss_pred             cCc---CCcCCEEECcCCcCCcc-c----CCcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCccc-cccc---hh
Confidence            632   26788899999988752 2    23 588899999999986 4543   578999999999998 4665   46


Q ss_pred             ccccEEEccCcccCC--CCcccccCC-------------cccceeeccCCcccC--CCCCCCCccccccccccCCcccc
Q 040845          388 ISLKSLNLSYNNLSG--TIPVSLEKL-------------SYLKDLNLSFNKLKG--EIPRGGSFGNFSAESFKGNELLC  449 (824)
Q Consensus       388 ~~L~~L~L~~N~l~~--~~p~~~~~l-------------~~L~~L~l~~N~l~~--~~p~~~~~~~~~~~~~~~n~~~c  449 (824)
                      ++|+.|++++|++++  .+|..+..+             ++|+.|++++|++++  .+|.     .+..+.+.+|...|
T Consensus       357 ~~L~~L~L~~N~l~~l~~ip~~l~~L~~n~~~~~i~~~~~~L~~L~ls~N~l~~~~~iP~-----sl~~L~~~~~~~~~  430 (454)
T 1jl5_A          357 QNLKQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLREFPDIPE-----SVEDLRMNSERVVD  430 (454)
T ss_dssp             TTCCEEECCSSCCSSCCCCCTTCCEEECCC-------------------------------------------------
T ss_pred             hhccEEECCCCCCCcCCCChHHHHhhhhcccccccccccCcCCEEECCCCcCCccccchh-----hHhheeCcCcccCC
Confidence            889999999999997  788888877             789999999999987  5553     23344455554433

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=5.6e-40  Score=385.87  Aligned_cols=419  Identities=20%  Similarity=0.169  Sum_probs=347.2

Q ss_pred             CcccccccccCCcccccCCCCCcEEEccCCcccccccccccCCCCCCEEeCCCCcCCcccChhhhCcCCCceeeccCCcc
Q 040845            2 PSIINNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSL   81 (824)
Q Consensus         2 ~~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l   81 (824)
                      |+|++|+|+++.|.+|.++++|++|+|++|+|++..+..|+++++|++|+|++|++++..+.+|.++++|++|+|++|++
T Consensus        81 L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l  160 (635)
T 4g8a_A           81 LDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLI  160 (635)
T ss_dssp             EECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCC
T ss_pred             EECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCcc
Confidence            68999999999999999999999999999999988788899999999999999999977777899999999999999999


Q ss_pred             ccccCccccCCCCCccEEEccCCeeeeecCccccCCCCCc----eEeccCccccccCCccccCCCCCCEEEccCCcCCC-
Q 040845           82 SGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLS----KLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTS-  156 (824)
Q Consensus        82 ~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~----~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~-  156 (824)
                      ++.........+++|++|+|++|+|++..+..+..+.+++    .++++.|.++.+.+..+.. ..++.|++.+|.... 
T Consensus       161 ~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~~-~~~~~l~l~~n~~~~~  239 (635)
T 4g8a_A          161 QSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE-IRLHKLTLRNNFDSLN  239 (635)
T ss_dssp             CCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTT-CEEEEEEEESCCSSHH
T ss_pred             ccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCcccccc-hhhhhhhhhccccccc
Confidence            8765444445699999999999999988888877665544    6778888887655443332 233344443332110 


Q ss_pred             ------------------------------CcC----------------------------c----------------cc
Q 040845          157 ------------------------------STL----------------------------D----------------LS  162 (824)
Q Consensus       157 ------------------------------~~~----------------------------~----------------~~  162 (824)
                                                    ...                            .                ..
T Consensus       240 ~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~  319 (635)
T 4g8a_A          240 VMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIE  319 (635)
T ss_dssp             HHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEE
T ss_pred             ccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhcccccccccccccc
Confidence                                          000                            0                00


Q ss_pred             ccccCCCCCCCcEEECcCCCCCccCCccccccccccccEEEeecCcceecCCccCCCCCCCCEEEecCCccCC--ccchh
Q 040845          163 FLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNG--SIPIT  240 (824)
Q Consensus       163 ~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~--~~~~~  240 (824)
                      ....+....+|+.|++++|.+..+....     ...|+.+++.+|.+...  .....+++|+.|++++|.+..  ..+..
T Consensus       320 ~~~~~~~~~~L~~L~l~~~~~~~~~~~~-----l~~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~~~~~  392 (635)
T 4g8a_A          320 RVKDFSYNFGWQHLELVNCKFGQFPTLK-----LKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQS  392 (635)
T ss_dssp             ECGGGGSCCCCSEEEEESCEESSCCCCB-----CTTCCEEEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEEEECCHH
T ss_pred             cccccccchhhhhhhcccccccCcCccc-----chhhhhcccccccCCCC--cccccccccccchhhccccccccccccc
Confidence            0123455678999999999988775543     35799999999987644  345578999999999999863  35667


Q ss_pred             hcCCCCCCEEEcccccCcccCCccccccCCccEEEccCccccccC-CccccCCCCCcEEEcCCCCCCCCCCc-ccccccc
Q 040845          241 LGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSI-PACFSNMTFLKVLSLGSNELTSIPLN-FWSLKDI  318 (824)
Q Consensus       241 ~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~-~~~~~~l~~L~~L~L~~N~l~~lp~~-~~~l~~L  318 (824)
                      +..+.+|+.|+++.|.+. ..+..+..+++|+.+++..|...... ...|..+++++.++++.|.++.++.. +..++.|
T Consensus       393 ~~~~~~L~~L~~~~~~~~-~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L  471 (635)
T 4g8a_A          393 DFGTISLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSL  471 (635)
T ss_dssp             HHSCSCCCEEECCSCSEE-EECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTC
T ss_pred             hhhhhhhhhhhccccccc-cccccccccccccchhhhhccccccccccccccccccccccccccccccccccccccchhh
Confidence            788999999999999988 45667888999999999998877554 45788999999999999999977554 6779999


Q ss_pred             cccccccccc-cCcCCccccccccchhhhcccccccccCCCccCCCCCCCeEEccCccccccCCccccccccccEEEccC
Q 040845          319 LDLNLSSNCF-SGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSY  397 (824)
Q Consensus       319 ~~L~l~~N~l-~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  397 (824)
                      +.|++++|.+ .+..|..|..+++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++
T Consensus       472 ~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~  551 (635)
T 4g8a_A          472 EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSL  551 (635)
T ss_dssp             CEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTT
T ss_pred             hhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCC
Confidence            9999999985 446788999999999999999999999999999999999999999999988888999999999999999


Q ss_pred             cccCCCCcccccCC-cccceeeccCCcccCCCC
Q 040845          398 NNLSGTIPVSLEKL-SYLKDLNLSFNKLKGEIP  429 (824)
Q Consensus       398 N~l~~~~p~~~~~l-~~L~~L~l~~N~l~~~~p  429 (824)
                      |+|++..|..+..+ ++|+.|+|++|+|+|.+.
T Consensus       552 N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~  584 (635)
T 4g8a_A          552 NHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE  584 (635)
T ss_dssp             SCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred             CcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCC
Confidence            99999999999988 689999999999999876

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=6.7e-42  Score=372.12  Aligned_cols=260  Identities=25%  Similarity=0.415  Sum_probs=211.9

Q ss_pred             hccCCCCceeeeccceEEEEEEEC------CCcEEEEEEeeccc-cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCee
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR------DGMEVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFK  598 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  598 (824)
                      .++|++.+.||+|+||+||+|++.      +++.||||+++... ......+.+|+.++++++||||+++++++.+....
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            367889999999999999999853      36789999986442 33445688899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhhCC------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC---cEEEe
Q 040845          599 ALVLEYMPHGSLEKYLHSSN------YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM---VAHLS  669 (824)
Q Consensus       599 ~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~---~~kl~  669 (824)
                      ++||||+++|+|.+++...+      ..+++.+++.++.|+++||+|||   +.+|+||||||+||+++.++   .+||+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEEC
Confidence            99999999999999997643      35899999999999999999999   99999999999999999555   59999


Q ss_pred             ecccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCC
Q 040845          670 DFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLP  748 (824)
Q Consensus       670 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  748 (824)
                      |||+|+...............+|+.|+|||.+.+..++.++|||||||++|||++ |..||......  .....+.... 
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~--~~~~~i~~~~-  303 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--EVLEFVTSGG-  303 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHHHHHHTTC-
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCC-
Confidence            9999986543333333344568999999999988899999999999999999998 99998763211  1111111100 


Q ss_pred             CcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 040845          749 ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDS  808 (824)
Q Consensus       749 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~  808 (824)
                                       ....+..++..+.+++.+||+.||++|||+.|++++|+.+.+.
T Consensus       304 -----------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~  346 (367)
T 3l9p_A          304 -----------------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  346 (367)
T ss_dssp             -----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             -----------------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence                             0011224566789999999999999999999999999998763

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.2e-40  Score=356.47  Aligned_cols=252  Identities=21%  Similarity=0.329  Sum_probs=207.6

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccc------hhhhHHHHHHHHhcCCCCcceeEEeeeecCCee
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGR------AFKSFDVECAMMKSIRHRNLVKVISSCSNEEFK  598 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  598 (824)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|++......      ..+.+.+|+.+++.++||||+++++++.+....
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            457999999999999999999875 5899999998754321      356789999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC----cEEEeecccc
Q 040845          599 ALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM----VAHLSDFGIA  674 (824)
Q Consensus       599 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~----~~kl~Dfg~a  674 (824)
                      ++||||+++|+|.+++.... .+++.++..++.|++.||+|||   +.+|+||||||+||+++.++    .+||+|||++
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a  165 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  165 (326)
T ss_dssp             EEEEECCCSCBHHHHHTTSS-CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEEEcCCCCCHHHHHHhcC-CcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence            99999999999999997654 7899999999999999999999   99999999999999999887    8999999999


Q ss_pred             cccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhh
Q 040845          675 KLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEV  754 (824)
Q Consensus       675 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  754 (824)
                      .......   ......||+.|+|||++.+..++.++||||+||++|||++|+.||......+ ...........      
T Consensus       166 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~~~~~~~~------  235 (326)
T 2y0a_A          166 HKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-TLANVSAVNYE------  235 (326)
T ss_dssp             EECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHHHHHTCCC------
T ss_pred             eECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-HHHHHHhcCCC------
Confidence            8764322   1233568999999999998899999999999999999999999996532111 11111110000      


Q ss_pred             ccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          755 VDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       755 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                                ........++..+.+++.+||..||++|||+.|++++
T Consensus       236 ----------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  272 (326)
T 2y0a_A          236 ----------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  272 (326)
T ss_dssp             ----------CCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             ----------cCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                      0011123456778999999999999999999999975

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.4e-40  Score=350.60  Aligned_cols=269  Identities=24%  Similarity=0.289  Sum_probs=206.3

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc--chhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEe
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG--RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLE  603 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  603 (824)
                      ++|++.+.||+|+||+||+|+.. +++.||||++.....  ...+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            57899999999999999999875 589999999975532  334678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 040845          604 YMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS  683 (824)
Q Consensus       604 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  683 (824)
                      |+++ ++.+++......+++.++..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||++.......  
T Consensus        82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--  155 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV--  155 (292)
T ss_dssp             CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC--
T ss_pred             cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc--
Confidence            9975 777777665568999999999999999999999   8999999999999999999999999999998764322  


Q ss_pred             cccccccccccccCccCcCCCC-CCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcch---hhcc---
Q 040845          684 MTQTQTLATIGYMAPEYGREGQ-VSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTM---EVVD---  756 (824)
Q Consensus       684 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~---  756 (824)
                      .......+|+.|+|||.+.+.. ++.++||||+||++|||++|+.||.......................   ....   
T Consensus       156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  235 (292)
T 3o0g_A          156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD  235 (292)
T ss_dssp             SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred             ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccc
Confidence            2233456899999999987765 79999999999999999999988654322222222222211111000   0000   


Q ss_pred             cc---ccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          757 AN---LLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       757 ~~---~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      ..   ..............++..+.+++.+||+.||++|||++|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  283 (292)
T 3o0g_A          236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            00   0000000001112356778999999999999999999999875

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=5e-41  Score=358.23  Aligned_cols=260  Identities=24%  Similarity=0.402  Sum_probs=214.8

Q ss_pred             hccCCCCceeeeccceEEEEEEE------CCCcEEEEEEeeccc-cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCee
Q 040845          526 TDKFSENNLIGRGGFGSVYKARI------RDGMEVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFK  598 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  598 (824)
                      .++|.+.+.||+|+||.||+|+.      .+++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  101 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL  101 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence            56889999999999999999986      235889999987543 23456788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhhCC-----------------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCC
Q 040845          599 ALVLEYMPHGSLEKYLHSSN-----------------------YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKP  655 (824)
Q Consensus       599 ~lv~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~  655 (824)
                      ++||||+++++|.+++....                       ..+++.+++.++.|+++||+|||   +.+|+||||||
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dikp  178 (314)
T 2ivs_A          102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAA  178 (314)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCCSG
T ss_pred             EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcccccch
Confidence            99999999999999998653                       23889999999999999999999   89999999999


Q ss_pred             CCeeeCCCCcEEEeecccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCccccc
Q 040845          656 SNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFN  734 (824)
Q Consensus       656 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~  734 (824)
                      +||+++.++.+||+|||++................+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||.....
T Consensus       179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  258 (314)
T 2ivs_A          179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP  258 (314)
T ss_dssp             GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999987654443333444567889999999988889999999999999999999 9999876332


Q ss_pred             CcchhhhhhhhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 040845          735 GEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDS  808 (824)
Q Consensus       735 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~  808 (824)
                      ..  ....+.....                  ...+..++..+.+++.+||+.||++|||+.|++++|+++.+.
T Consensus       259 ~~--~~~~~~~~~~------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  312 (314)
T 2ivs_A          259 ER--LFNLLKTGHR------------------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK  312 (314)
T ss_dssp             GG--HHHHHHTTCC------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             HH--HHHHhhcCCc------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence            11  1111111000                  011124567799999999999999999999999999998654

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=9.5e-41  Score=351.11  Aligned_cols=268  Identities=23%  Similarity=0.286  Sum_probs=204.2

Q ss_pred             ccCCCCceeeeccceEEEEEEECCCcEEEEEEeecccc--chhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEec
Q 040845          527 DKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCG--RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      ++|++.+.||+|+||+||+|+..+|+.||+|++.....  ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            57899999999999999999988899999999865432  2346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 040845          605 MPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM  684 (824)
Q Consensus       605 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  684 (824)
                      +++ +|.+++......+++.++..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||++.......  .
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~  155 (288)
T 1ob3_A           82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV--R  155 (288)
T ss_dssp             CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCccc--c
Confidence            975 999999877668999999999999999999999   8999999999999999999999999999998654222  1


Q ss_pred             ccccccccccccCccCcCCC-CCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCc---ch-----hhc
Q 040845          685 TQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPIS---TM-----EVV  755 (824)
Q Consensus       685 ~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~-----~~~  755 (824)
                      ......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||......+ .............   ..     ...
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T 1ob3_A          156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-QLMRIFRILGTPNSKNWPNVTELPKY  234 (288)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHHCCCChhhchhhhccccc
Confidence            22345689999999988764 58999999999999999999999997643221 1111111111000   00     000


Q ss_pred             cccccCchh-hhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          756 DANLLSQED-IHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       756 ~~~~~~~~~-~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      ++....... ........++..+.+++.+||+.||++|||++|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  281 (288)
T 1ob3_A          235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (288)
T ss_dssp             CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            000000000 0000112356778999999999999999999999874

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=3.3e-40  Score=349.13  Aligned_cols=266  Identities=14%  Similarity=0.137  Sum_probs=217.0

Q ss_pred             hccCCCCceeeeccceEEEEEEE-CCCcEEEEEEeeccccchhhhHHHHHHHHhcC-CCCcceeEEeeeecCCeeEEEEe
Q 040845          526 TDKFSENNLIGRGGFGSVYKARI-RDGMEVAVKVFNLQCGRAFKSFDVECAMMKSI-RHRNLVKVISSCSNEEFKALVLE  603 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  603 (824)
                      .++|++.+.||+|+||.||+|+. .+++.||||++...  ...+.+.+|+.+++.+ +|+|++++++++.+....++|||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccC--CccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            46799999999999999999986 46899999998643  3446788999999999 79999999999999999999999


Q ss_pred             ccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCc-----EEEeecccccccC
Q 040845          604 YMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMV-----AHLSDFGIAKLLT  678 (824)
Q Consensus       604 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~-----~kl~Dfg~a~~~~  678 (824)
                      |+ +++|.+++...+..+++.+++.++.|+++|++|||   +.+|+||||||+||+++.++.     +||+|||++....
T Consensus        87 ~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~  162 (298)
T 1csn_A           87 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  162 (298)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             ec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence            99 99999999887767999999999999999999999   999999999999999987776     9999999998765


Q ss_pred             CCCCc-----cccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcch--hhhhhhhhCCCcc
Q 040845          679 GEDQS-----MTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMT--LKHWVNDCLPIST  751 (824)
Q Consensus       679 ~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~  751 (824)
                      .....     .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.........  .........+   
T Consensus       163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~---  239 (298)
T 1csn_A          163 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS---  239 (298)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH---
T ss_pred             cccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC---
Confidence            43321     1234456999999999999999999999999999999999999999764322110  0100000000   


Q ss_pred             hhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhccc
Q 040845          752 MEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLRN  812 (824)
Q Consensus       752 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~~  812 (824)
                                  .........++..+.+++.+||+.||++|||++++++.|+++.++...+
T Consensus       240 ------------~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~  288 (298)
T 1csn_A          240 ------------TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT  288 (298)
T ss_dssp             ------------SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred             ------------ccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCC
Confidence                        0000111245778999999999999999999999999999998765543

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1e-40  Score=369.95  Aligned_cols=254  Identities=21%  Similarity=0.297  Sum_probs=206.6

Q ss_pred             hhccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEE
Q 040845          525 ATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALV  601 (824)
Q Consensus       525 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  601 (824)
                      ..++|++.+.||+|+||+||+|... +|+.||+|++....  ....+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            4578999999999999999999864 68999999987543  23356788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC---CCCcEEEeecccccccC
Q 040845          602 LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLT  678 (824)
Q Consensus       602 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~---~~~~~kl~Dfg~a~~~~  678 (824)
                      |||+++|+|.+++.... .+++.++..++.|++.|++|||   +.+|+||||||+||+++   .++.+||+|||+|....
T Consensus        89 ~E~~~gg~L~~~i~~~~-~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~  164 (444)
T 3soa_A           89 FDLVTGGELFEDIVARE-YYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE  164 (444)
T ss_dssp             ECCCBCCBHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred             EEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence            99999999999998765 6899999999999999999999   99999999999999998   56889999999998764


Q ss_pred             CCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhcccc
Q 040845          679 GEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDAN  758 (824)
Q Consensus       679 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  758 (824)
                      ....  ......||+.|+|||++.+..++.++||||+||++|+|++|..||......+ ....+.......         
T Consensus       165 ~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~-~~~~i~~~~~~~---------  232 (444)
T 3soa_A          165 GEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR-LYQQIKAGAYDF---------  232 (444)
T ss_dssp             TTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHTCCCC---------
T ss_pred             CCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH-HHHHHHhCCCCC---------
Confidence            3322  2234579999999999999899999999999999999999999996532111 111111111100         


Q ss_pred             ccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          759 LLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       759 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                             .......+++.+.+++.+||+.||++|||+.|++++
T Consensus       233 -------~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          233 -------PSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             -------CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             -------CccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence                   000112346678999999999999999999999885

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=7.8e-41  Score=361.60  Aligned_cols=253  Identities=21%  Similarity=0.313  Sum_probs=205.8

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc-----cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC-----GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKA  599 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  599 (824)
                      .++|++.+.||+|+||+||+|..+ +|+.||||++....     ....+.+.+|+.+++.++||||+++++++.+++..+
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            357999999999999999999875 58999999986432     123567899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHhhhC---CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCc---EEEeeccc
Q 040845          600 LVLEYMPHGSLEKYLHSS---NYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMV---AHLSDFGI  673 (824)
Q Consensus       600 lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~---~kl~Dfg~  673 (824)
                      +||||+++++|.+++...   ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            999999999999887543   245899999999999999999999   999999999999999986654   99999999


Q ss_pred             ccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchh
Q 040845          674 AKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTME  753 (824)
Q Consensus       674 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  753 (824)
                      +.......  .......||+.|+|||++.+..++.++||||+||++|||++|+.||....  +............     
T Consensus       180 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~i~~~~~~-----  250 (351)
T 3c0i_A          180 AIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGIIKGKYK-----  250 (351)
T ss_dssp             CEECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH--HHHHHHHHHTCCC-----
T ss_pred             eeEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH--HHHHHHHHcCCCC-----
Confidence            98764322  22334569999999999999899999999999999999999999997621  1111111111100     


Q ss_pred             hccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          754 VVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       754 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                                 ........++..+.+++.+||+.||++|||+.|++++
T Consensus       251 -----------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  287 (351)
T 3c0i_A          251 -----------MNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNH  287 (351)
T ss_dssp             -----------CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             -----------CCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                       0011122456778999999999999999999999875

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=4.5e-41  Score=352.35  Aligned_cols=259  Identities=24%  Similarity=0.394  Sum_probs=201.5

Q ss_pred             hccCCCCceeeeccceEEEEEEECC----CcEEEEEEeeccc-cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIRD----GMEVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKAL  600 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  600 (824)
                      .++|++.+.||+|+||.||+|.+..    +..||+|+..... ....+.+.+|+.++++++||||+++++++. ++..++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l   92 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   92 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence            4689999999999999999998643    4579999986543 234567889999999999999999999985 456789


Q ss_pred             EEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 040845          601 VLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE  680 (824)
Q Consensus       601 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  680 (824)
                      ||||+++++|.+++......+++.+++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++......
T Consensus        93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  169 (281)
T 1mp8_A           93 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  169 (281)
T ss_dssp             EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred             EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECccccccccCcc
Confidence            99999999999999877767999999999999999999999   899999999999999999999999999999876433


Q ss_pred             CCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhccccc
Q 040845          681 DQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANL  759 (824)
Q Consensus       681 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  759 (824)
                      .. .......+|+.|+|||.+.+..++.++||||+|+++|||++ |..||......+  ....+....            
T Consensus       170 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~--~~~~i~~~~------------  234 (281)
T 1mp8_A          170 TY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIGRIENGE------------  234 (281)
T ss_dssp             ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHHHTTC------------
T ss_pred             cc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH--HHHHHHcCC------------
Confidence            22 22233456789999999988889999999999999999997 899987643221  111111000            


Q ss_pred             cCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhh
Q 040845          760 LSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSL  809 (824)
Q Consensus       760 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~  809 (824)
                            ....+..++..+.+++.+||+.||++|||+.|++++|+++.++.
T Consensus       235 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  278 (281)
T 1mp8_A          235 ------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  278 (281)
T ss_dssp             ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence                  00112345677999999999999999999999999999997654

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.4e-40  Score=353.60  Aligned_cols=273  Identities=21%  Similarity=0.304  Sum_probs=211.6

Q ss_pred             hccCCCCceeeeccceEEEEEEECC-CcEEEEEEeeccc-cchhhhHHHHHHHHhcCCCCcceeEEeeeecCC--eeEEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEE--FKALV  601 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv  601 (824)
                      .++|.+.+.||+|+||+||+|++.. ++.||||++.... ....+.+.+|++++++++||||+++++++....  ..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence            3679999999999999999998764 8999999987543 234567789999999999999999999987655  77999


Q ss_pred             EeccCCCCHHHHhhhCC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee----CCCCcEEEeeccccc
Q 040845          602 LEYMPHGSLEKYLHSSN--YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL----DDNMVAHLSDFGIAK  675 (824)
Q Consensus       602 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill----~~~~~~kl~Dfg~a~  675 (824)
                      |||+++++|.+++....  ..+++.+++.++.|++.||+|||   +.+|+||||||+||++    +.++.+||+|||+++
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            99999999999998654  34899999999999999999999   9999999999999999    788889999999998


Q ss_pred             ccCCCCCccccccccccccccCccCcC--------CCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchh---hhhhh
Q 040845          676 LLTGEDQSMTQTQTLATIGYMAPEYGR--------EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTL---KHWVN  744 (824)
Q Consensus       676 ~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~---~~~~~  744 (824)
                      .......   .....||+.|+|||++.        +..++.++|||||||++|||++|+.||..........   .....
T Consensus       165 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  241 (319)
T 4euu_A          165 ELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (319)
T ss_dssp             ECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred             ecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence            7644332   23356899999999875        5678999999999999999999999997543322211   11111


Q ss_pred             hhCCCcchhhccc-----cccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 040845          745 DCLPISTMEVVDA-----NLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLK  804 (824)
Q Consensus       745 ~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~  804 (824)
                      ...+.........     .+.............++..+.+++.+||+.||++|||++|++++..+
T Consensus       242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d  306 (319)
T 4euu_A          242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD  306 (319)
T ss_dssp             HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred             CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHH
Confidence            1111110000000     00000011112234677889999999999999999999999999876

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5.5e-41  Score=348.99  Aligned_cols=258  Identities=27%  Similarity=0.419  Sum_probs=214.0

Q ss_pred             hccCCCCceeeeccceEEEEEEECCCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEecc
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYM  605 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  605 (824)
                      .++|++.+.||+|+||.||+|.+.+++.||+|++.... ...+.+.+|+++++.++||||+++++++.+++..++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM   85 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred             hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence            46788999999999999999999889999999997543 33467899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccc
Q 040845          606 PHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMT  685 (824)
Q Consensus       606 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  685 (824)
                      ++++|.+++......+++.++..++.|++.|++|||   +.+++||||||+||+++.++.+||+|||++...... ....
T Consensus        86 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~-~~~~  161 (267)
T 3t9t_A           86 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-QYTS  161 (267)
T ss_dssp             TTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH-HHHS
T ss_pred             CCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEcccccccccccc-cccc
Confidence            999999999887667899999999999999999999   999999999999999999999999999999865322 1112


Q ss_pred             cccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchh
Q 040845          686 QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQED  764 (824)
Q Consensus       686 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  764 (824)
                      .....++..|+|||.+.+..++.++||||+|+++|||++ |+.||......+  ....+.....                
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~i~~~~~----------------  223 (267)
T 3t9t_A          162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVEDISTGFR----------------  223 (267)
T ss_dssp             TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHHTTCC----------------
T ss_pred             cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH--HHHHHhcCCc----------------
Confidence            233457788999999988889999999999999999999 899987532111  1111111000                


Q ss_pred             hhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 040845          765 IHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDS  808 (824)
Q Consensus       765 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~  808 (824)
                        ...+..++..+.+++.+||+.||++|||+.|++++|+++.++
T Consensus       224 --~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (267)
T 3t9t_A          224 --LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  265 (267)
T ss_dssp             --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             --CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence              001123456789999999999999999999999999998763

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.7e-41  Score=379.89  Aligned_cols=258  Identities=25%  Similarity=0.437  Sum_probs=212.9

Q ss_pred             hccCCCCceeeeccceEEEEEEECCCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEecc
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYM  605 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  605 (824)
                      .++|++.+.||+|+||.||+|+++++..||||+++.. ....+.+.+|+.+++.++||||+++++++. .+..++||||+
T Consensus       187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~  264 (454)
T 1qcf_A          187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFM  264 (454)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred             hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCC-CccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeec
Confidence            5678899999999999999999988999999999754 345678999999999999999999999986 56789999999


Q ss_pred             CCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 040845          606 PHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM  684 (824)
Q Consensus       606 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  684 (824)
                      ++|+|.+++.... ..+++.+++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++...... ..
T Consensus       265 ~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~-~~  340 (454)
T 1qcf_A          265 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-YT  340 (454)
T ss_dssp             TTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH-HH
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc-ee
Confidence            9999999997543 36788999999999999999999   8999999999999999999999999999998764221 11


Q ss_pred             ccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhccccccCch
Q 040845          685 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQE  763 (824)
Q Consensus       685 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  763 (824)
                      ......+|..|+|||.+..+.++.++|||||||++|||+| |+.||......+  ....+...                 
T Consensus       341 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~--~~~~i~~~-----------------  401 (454)
T 1qcf_A          341 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE--VIRALERG-----------------  401 (454)
T ss_dssp             TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHHHHHHT-----------------
T ss_pred             ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcC-----------------
Confidence            2233446788999999988899999999999999999999 999987632211  11111110                 


Q ss_pred             hhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhh
Q 040845          764 DIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSL  809 (824)
Q Consensus       764 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~  809 (824)
                       .+...+..++..+.++|.+||+.||++|||+.++++.|+++..+.
T Consensus       402 -~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~  446 (454)
T 1qcf_A          402 -YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT  446 (454)
T ss_dssp             -CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred             -CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence             111123456778999999999999999999999999998875443

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=9.1e-41  Score=364.09  Aligned_cols=253  Identities=19%  Similarity=0.288  Sum_probs=209.2

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEec
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      .++|++.+.||+|+||.||+|... +|+.||+|++..........+.+|+.+++.++||||+++++++.+....++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            467999999999999999999875 5899999999765444566788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC--CCcEEEeecccccccCCCCC
Q 040845          605 MPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD--NMVAHLSDFGIAKLLTGEDQ  682 (824)
Q Consensus       605 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~--~~~~kl~Dfg~a~~~~~~~~  682 (824)
                      +++|+|.+++......+++.+++.++.|++.||+|||   +.+|+||||||+||+++.  ++.+||+|||++....... 
T Consensus       130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~-  205 (387)
T 1kob_A          130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE-  205 (387)
T ss_dssp             CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred             CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceecCCCc-
Confidence            9999999999877667999999999999999999999   999999999999999974  5789999999998764332 


Q ss_pred             ccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCc
Q 040845          683 SMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ  762 (824)
Q Consensus       683 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  762 (824)
                        ......||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+.......      +      
T Consensus       206 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-~~~~~i~~~~~~~------~------  270 (387)
T 1kob_A          206 --IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-ETLQNVKRCDWEF------D------  270 (387)
T ss_dssp             --CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHHHHHHCCCCC------C------
T ss_pred             --ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCCCC------C------
Confidence              223346899999999999989999999999999999999999999763211 1111111110000      0      


Q ss_pred             hhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          763 EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       763 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                          ......++..+.+++.+||+.||++|||+.|++++
T Consensus       271 ----~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          271 ----EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             ----SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             ----ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence                00112346678999999999999999999999985

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=5.3e-41  Score=359.47  Aligned_cols=260  Identities=25%  Similarity=0.475  Sum_probs=196.6

Q ss_pred             hccCCCCceeeeccceEEEEEEECC-C---cEEEEEEeecc--ccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCee-
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIRD-G---MEVAVKVFNLQ--CGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFK-  598 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~~-~---~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-  598 (824)
                      .++|++.+.||+|+||.||+|++.. +   ..||||+++..  .....+.+.+|++++++++||||+++++++...... 
T Consensus        22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  101 (323)
T 3qup_A           22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG  101 (323)
T ss_dssp             ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred             hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence            4689999999999999999998654 3   27999998754  334567889999999999999999999999876655 


Q ss_pred             -----EEEEeccCCCCHHHHhhhCC-----CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEE
Q 040845          599 -----ALVLEYMPHGSLEKYLHSSN-----YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHL  668 (824)
Q Consensus       599 -----~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl  668 (824)
                           ++||||+++|+|.+++....     ..+++.+++.++.|+++||+|||   +.+|+||||||+||+++.++.+||
T Consensus       102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~~kl  178 (323)
T 3qup_A          102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCV  178 (323)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEE
T ss_pred             CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCCEEE
Confidence                 89999999999999986432     25899999999999999999999   899999999999999999999999


Q ss_pred             eecccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhC
Q 040845          669 SDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCL  747 (824)
Q Consensus       669 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~  747 (824)
                      +|||++................+++.|+|||.+.+..++.++||||+||++|||++ |+.||......+. ........ 
T Consensus       179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~-~~~~~~~~-  256 (323)
T 3qup_A          179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI-YNYLIGGN-  256 (323)
T ss_dssp             CCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-HHHHHTTC-
T ss_pred             eeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH-HHHHhcCC-
Confidence            99999987654443333444557889999999998899999999999999999999 8999876332211 11111100 


Q ss_pred             CCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 040845          748 PISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDS  808 (824)
Q Consensus       748 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~  808 (824)
                                        ....+..++..+.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus       257 ------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~  299 (323)
T 3qup_A          257 ------------------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH  299 (323)
T ss_dssp             ------------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             ------------------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence                              0011123556789999999999999999999999999998763

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=6.4e-41  Score=365.01  Aligned_cols=255  Identities=21%  Similarity=0.296  Sum_probs=203.4

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcC-CCCcceeEEeeeecCCeeEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSI-RHRNLVKVISSCSNEEFKAL  600 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  600 (824)
                      .++|++.+.||+|+||+||+|+.+ +++.||||+++...   ....+.+..|..+++++ +||||+++++++.+.+..++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            468999999999999999999876 48899999997652   23345678899999887 89999999999999999999


Q ss_pred             EEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 040845          601 VLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE  680 (824)
Q Consensus       601 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  680 (824)
                      ||||+++|+|.+++...+ .+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+|+.....
T Consensus       131 V~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~  206 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  206 (396)
T ss_dssp             EEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEEcCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence            999999999999998765 6899999999999999999999   999999999999999999999999999999853222


Q ss_pred             CCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcch---hhhhhhhhCCCcchhhccc
Q 040845          681 DQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMT---LKHWVNDCLPISTMEVVDA  757 (824)
Q Consensus       681 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  757 (824)
                      .  .......||+.|+|||++.+..++.++||||+||++|||++|+.||......+..   ...+....       ....
T Consensus       207 ~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~-------i~~~  277 (396)
T 4dc2_A          207 G--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV-------ILEK  277 (396)
T ss_dssp             T--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHH-------HHHC
T ss_pred             C--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHH-------Hhcc
Confidence            1  2234457999999999999999999999999999999999999999653221110   00000000       0000


Q ss_pred             cccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCH------HHHHHH
Q 040845          758 NLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINA------KEIVAK  801 (824)
Q Consensus       758 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~------~evl~~  801 (824)
                              ....+..++..+.+++.+||+.||++||++      +|+++|
T Consensus       278 --------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H  319 (396)
T 4dc2_A          278 --------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  319 (396)
T ss_dssp             --------CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred             --------ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence                    001122356678999999999999999996      565553

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.2e-41  Score=364.79  Aligned_cols=249  Identities=24%  Similarity=0.321  Sum_probs=201.5

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcC-CCCcceeEEeeeecCCeeEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSI-RHRNLVKVISSCSNEEFKAL  600 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  600 (824)
                      .++|++.+.||+|+||.||+|+.+ +|+.||||+++...   ....+.+..|..+++.+ +||||+++++++.+.+..++
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            478999999999999999999875 58999999997542   23456678899999988 69999999999999999999


Q ss_pred             EEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 040845          601 VLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE  680 (824)
Q Consensus       601 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  680 (824)
                      ||||+++|+|.+++...+ .+++.+++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+|+.....
T Consensus       102 v~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~  177 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQKSR-RFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN  177 (353)
T ss_dssp             EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred             EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence            999999999999998765 6899999999999999999999   999999999999999999999999999999853322


Q ss_pred             CCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhcccccc
Q 040845          681 DQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLL  760 (824)
Q Consensus       681 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  760 (824)
                        ........||+.|+|||++.+..++.++||||+||++|||++|+.||......+ ..........             
T Consensus       178 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-~~~~i~~~~~-------------  241 (353)
T 3txo_A          178 --GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD-LFEAILNDEV-------------  241 (353)
T ss_dssp             ----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCC-------------
T ss_pred             --CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH-HHHHHHcCCC-------------
Confidence              222334569999999999988889999999999999999999999997632211 1111111100             


Q ss_pred             CchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCH------HHHHHH
Q 040845          761 SQEDIHFVAKEQCVSFVFNLALECTVESPEQRINA------KEIVAK  801 (824)
Q Consensus       761 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~------~evl~~  801 (824)
                             ..+..++..+.+++.+||+.||++||++      +|+++|
T Consensus       242 -------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h  281 (353)
T 3txo_A          242 -------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH  281 (353)
T ss_dssp             -------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred             -------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence                   0111245668899999999999999998      777664

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.3e-40  Score=360.73  Aligned_cols=253  Identities=21%  Similarity=0.342  Sum_probs=207.0

Q ss_pred             hhccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEE
Q 040845          525 ATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALV  601 (824)
Q Consensus       525 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  601 (824)
                      ..++|++.+.||+|+||.||+|..+ +|+.||+|++....  ....+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  106 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV  106 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            3568999999999999999999875 58999999997543  23456788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCC---CcEEEeecccccccC
Q 040845          602 LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDN---MVAHLSDFGIAKLLT  678 (824)
Q Consensus       602 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~---~~~kl~Dfg~a~~~~  678 (824)
                      |||+++|+|.+++.... .+++.++..++.||+.||+|||   +.+|+||||||+||+++.+   +.+||+|||++....
T Consensus       107 ~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~  182 (362)
T 2bdw_A          107 FDLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  182 (362)
T ss_dssp             ECCCCSCBHHHHHTTCS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred             EecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence            99999999999997654 6899999999999999999999   8999999999999999865   459999999998764


Q ss_pred             CCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhcccc
Q 040845          679 GEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDAN  758 (824)
Q Consensus       679 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  758 (824)
                      ...   ......||+.|+|||++.+..++.++||||+||++|||++|+.||......+ ............         
T Consensus       183 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~-~~~~i~~~~~~~---------  249 (362)
T 2bdw_A          183 DSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-LYAQIKAGAYDY---------  249 (362)
T ss_dssp             TCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCCCC---------
T ss_pred             CCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhCCCCC---------
Confidence            332   2234569999999999999899999999999999999999999987532111 111111110000         


Q ss_pred             ccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          759 LLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       759 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                             .......++..+.+++.+||..||++|||+.|++++
T Consensus       250 -------~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          250 -------PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             -------CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             -------CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                   000112356678999999999999999999999876

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=2.1e-41  Score=362.58  Aligned_cols=259  Identities=24%  Similarity=0.392  Sum_probs=207.7

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCcE----EEEEEeeccc-cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEE
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGME----VAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKAL  600 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  600 (824)
                      ++|++.+.||+|+||+||+|++. +++.    ||+|.+.... ......+.+|+.+++.++||||+++++++. +...++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            57889999999999999999865 3443    7888775432 334566788999999999999999999986 456889


Q ss_pred             EEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 040845          601 VLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE  680 (824)
Q Consensus       601 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  680 (824)
                      ||||+++|+|.+++......+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  168 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD  168 (325)
T ss_dssp             EEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred             EEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence            99999999999999876567889999999999999999999   899999999999999999999999999999987655


Q ss_pred             CCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhccccc
Q 040845          681 DQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANL  759 (824)
Q Consensus       681 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  759 (824)
                      ..........+|..|+|||.+.++.++.++||||+|+++|||+| |+.||......+  ....+....            
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~~~------------  234 (325)
T 3kex_A          169 DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE--VPDLLEKGE------------  234 (325)
T ss_dssp             TTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH--HHHHHHTTC------------
T ss_pred             cccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH--HHHHHHcCC------------
Confidence            44444455678889999999998899999999999999999999 999997633221  111111100            


Q ss_pred             cCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhh
Q 040845          760 LSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSL  809 (824)
Q Consensus       760 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~  809 (824)
                            ....+..++..+.+++.+||..||++|||+.|++++|+++....
T Consensus       235 ------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~  278 (325)
T 3kex_A          235 ------RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP  278 (325)
T ss_dssp             ------BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred             ------CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence                  00111123445788999999999999999999999999886533

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=5.8e-41  Score=355.63  Aligned_cols=269  Identities=23%  Similarity=0.417  Sum_probs=210.6

Q ss_pred             ccCCCCceeeeccceEEEEEEE-----CCCcEEEEEEeeccc-cchhhhHHHHHHHHhcCCCCcceeEEeeeecC--Cee
Q 040845          527 DKFSENNLIGRGGFGSVYKARI-----RDGMEVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLVKVISSCSNE--EFK  598 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  598 (824)
                      ..|++.+.||+|+||.||+|++     .+++.||||++.... ....+.+.+|+++++.++||||+++++++.++  ...
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            4688899999999999999984     358999999987543 33457789999999999999999999999876  678


Q ss_pred             EEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccC
Q 040845          599 ALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT  678 (824)
Q Consensus       599 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~  678 (824)
                      ++||||+++|+|.+++......+++.+++.++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||++....
T Consensus       101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  177 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE  177 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECccccccccc
Confidence            9999999999999999776667999999999999999999999   9999999999999999999999999999998775


Q ss_pred             CCCCc-cccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCc---chhh
Q 040845          679 GEDQS-MTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPIS---TMEV  754 (824)
Q Consensus       679 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~  754 (824)
                      ..... .......+|..|+|||.+.+..++.++||||+|+++|||++|+.|+......      +.....+..   ....
T Consensus       178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~  251 (302)
T 4e5w_A          178 TDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMAL------FLKMIGPTHGQMTVTR  251 (302)
T ss_dssp             TTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH------HHHHHCSCCGGGHHHH
T ss_pred             CCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhH------HhhccCCcccccCHHH
Confidence            44322 2233456888899999998888999999999999999999999986542110      000000000   0000


Q ss_pred             ccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 040845          755 VDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIR  806 (824)
Q Consensus       755 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~  806 (824)
                      .....  ........+..++..+.+++.+||+.||++|||+.|+++.|+++.
T Consensus       252 ~~~~~--~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          252 LVNTL--KEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HHHHH--HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHH--hccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            00000  000111122356778999999999999999999999999999874

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1e-40  Score=351.00  Aligned_cols=259  Identities=27%  Similarity=0.443  Sum_probs=197.5

Q ss_pred             hccCCCCceeeeccceEEEEEEECCCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEe
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLE  603 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  603 (824)
                      .++|++.+.||+|+||.||+|++.  ..||||+++...  ....+.+.+|+.+++.++||||+++++++ .....++|||
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e   99 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ   99 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence            468999999999999999999865  369999986543  23456788999999999999999999965 4556789999


Q ss_pred             ccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 040845          604 YMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS  683 (824)
Q Consensus       604 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  683 (824)
                      |+++++|.+++......+++.+++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++.........
T Consensus       100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  176 (289)
T 3og7_A          100 WCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS  176 (289)
T ss_dssp             CCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC-----------
T ss_pred             ecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceecccccccccc
Confidence            99999999999877778999999999999999999999   899999999999999999999999999999865433333


Q ss_pred             cccccccccccccCccCcC---CCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhh-hCCCcchhhccccc
Q 040845          684 MTQTQTLATIGYMAPEYGR---EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVND-CLPISTMEVVDANL  759 (824)
Q Consensus       684 ~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  759 (824)
                      .......||+.|+|||.+.   +..++.++||||+|+++|||++|+.||......+. ....+.. .......       
T Consensus       177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~-------  248 (289)
T 3og7_A          177 HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-IIEMVGRGSLSPDLS-------  248 (289)
T ss_dssp             -------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH-HHHHHHHTSCCCCTT-------
T ss_pred             ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH-HHHHhcccccCcchh-------
Confidence            3334456899999999886   56788999999999999999999999976432221 1111111 1110000       


Q ss_pred             cCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 040845          760 LSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIR  806 (824)
Q Consensus       760 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~  806 (824)
                              .....++..+.+++.+||+.||++|||+.|+++.|+++.
T Consensus       249 --------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          249 --------KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             --------SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             --------hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence                    011245677999999999999999999999999998864

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-40  Score=353.98  Aligned_cols=246  Identities=25%  Similarity=0.323  Sum_probs=206.0

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALV  601 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  601 (824)
                      .++|++.+.||+|+||.||+|+.+ +|+.||+|+++...   ....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            467999999999999999999875 58999999997542   23456778899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 040845          602 LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED  681 (824)
Q Consensus       602 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  681 (824)
                      |||+++|+|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.+|.+||+|||+++..... 
T Consensus        85 ~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-  159 (318)
T 1fot_A           85 MDYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-  159 (318)
T ss_dssp             ECCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred             EeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCCc-
Confidence            99999999999998765 6899999999999999999999   999999999999999999999999999999865422 


Q ss_pred             CccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccC
Q 040845          682 QSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLS  761 (824)
Q Consensus       682 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  761 (824)
                          .....||+.|+|||++.+..++.++||||+||++|||++|+.||...... ...........              
T Consensus       160 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~--------------  220 (318)
T 1fot_A          160 ----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM-KTYEKILNAEL--------------  220 (318)
T ss_dssp             ----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHHCCC--------------
T ss_pred             ----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCC--------------
Confidence                22346899999999999999999999999999999999999999753211 11111111100              


Q ss_pred             chhhhhhhHHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 040845          762 QEDIHFVAKEQCVSFVFNLALECTVESPEQRI-----NAKEIVAK  801 (824)
Q Consensus       762 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~evl~~  801 (824)
                            ..+..++..+.+++.+|+..||++||     +++|+++|
T Consensus       221 ------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h  259 (318)
T 1fot_A          221 ------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  259 (318)
T ss_dssp             ------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             ------CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence                  01123456789999999999999999     88998865

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.9e-40  Score=348.91  Aligned_cols=253  Identities=27%  Similarity=0.451  Sum_probs=206.0

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccc-------hhhhHHHHHHHHhcCCCCcceeEEeeeecCCe
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGR-------AFKSFDVECAMMKSIRHRNLVKVISSCSNEEF  597 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  597 (824)
                      .++|++.+.||+|+||+||+|++. +++.||||++......       ..+.+.+|+.++++++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            367899999999999999999874 6899999998654321       1267889999999999999999999997665 


Q ss_pred             eEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC--eEecCCCCCCeeeCCCCc-----EEEee
Q 040845          598 KALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAP--VIHCDLKPSNVLLDDNMV-----AHLSD  670 (824)
Q Consensus       598 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlk~~Nill~~~~~-----~kl~D  670 (824)
                       ++||||+++|+|.+++......+++..++.++.|++.|++|||   +.+  |+||||||+||+++.++.     +||+|
T Consensus        97 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             -eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence             6999999999999999877778999999999999999999999   888  999999999999988776     99999


Q ss_pred             cccccccCCCCCccccccccccccccCccCcC--CCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCC
Q 040845          671 FGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR--EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLP  748 (824)
Q Consensus       671 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  748 (824)
                      ||+++....     ......||+.|+|||.+.  ...++.++||||+||++|||++|+.||...................
T Consensus       173 fg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  247 (287)
T 4f0f_A          173 FGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL  247 (287)
T ss_dssp             CTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCC
T ss_pred             CCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCC
Confidence            999975322     233456899999999983  4567899999999999999999999997644333222221111000


Q ss_pred             CcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 040845          749 ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKI  805 (824)
Q Consensus       749 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~  805 (824)
                                       ....+..++..+.+++.+||+.||++|||+.|+++.|+++
T Consensus       248 -----------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          248 -----------------RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             -----------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             -----------------CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence                             0011234567799999999999999999999999999763

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.2e-40  Score=358.80  Aligned_cols=281  Identities=26%  Similarity=0.346  Sum_probs=204.2

Q ss_pred             hccCCCCceeeeccceEEEEEEECCCcEEEEEEeeccccchhhhHHHHHHH--HhcCCCCcceeEEeeee-----cCCee
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAM--MKSIRHRNLVKVISSCS-----NEEFK  598 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~-----~~~~~  598 (824)
                      .++|++.+.||+|+||.||+|+.. ++.||||++....   ...+..|.++  +..++||||+++++++.     .....
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEEC-CeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            468999999999999999999874 8999999987542   2334444444  55689999999998543     23467


Q ss_pred             EEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC---------CeEecCCCCCCeeeCCCCcEEEe
Q 040845          599 ALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSA---------PVIHCDLKPSNVLLDDNMVAHLS  669 (824)
Q Consensus       599 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~---------~ivH~Dlk~~Nill~~~~~~kl~  669 (824)
                      ++||||+++|+|.+++....  .++..+..++.|+++||+|||   +.         +|+||||||+||+++.++.+||+
T Consensus        88 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~  162 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS  162 (336)
T ss_dssp             EEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred             EEEEecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCcEEEe
Confidence            89999999999999997664  588999999999999999999   77         99999999999999999999999


Q ss_pred             ecccccccCCCCC------ccccccccccccccCccCcCC-------CCCCccchHHHHHHHHHHHHhCCCCCcccccCc
Q 040845          670 DFGIAKLLTGEDQ------SMTQTQTLATIGYMAPEYGRE-------GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGE  736 (824)
Q Consensus       670 Dfg~a~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~  736 (824)
                      |||++..+.....      ........||+.|+|||++.+       ..++.++|||||||++|||++|+.||.......
T Consensus       163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~  242 (336)
T 3g2f_A          163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP  242 (336)
T ss_dssp             CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred             eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence            9999987653321      112234569999999999876       456789999999999999999988765432211


Q ss_pred             chhhhhhhhhCCCcchhh----c-cccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhcc
Q 040845          737 MTLKHWVNDCLPISTMEV----V-DANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLR  811 (824)
Q Consensus       737 ~~~~~~~~~~~~~~~~~~----~-~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~  811 (824)
                      .....+..........+.    . .................++..+.+++.+||+.||++|||++|+++.|+++...+.+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~  322 (336)
T 3g2f_A          243 EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWER  322 (336)
T ss_dssp             CCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC
T ss_pred             HHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHh
Confidence            111111110110000000    0 00000000011111234677899999999999999999999999999999999988


Q ss_pred             ccCC
Q 040845          812 NVGG  815 (824)
Q Consensus       812 ~~~~  815 (824)
                      +-+.
T Consensus       323 ~~~~  326 (336)
T 3g2f_A          323 NKSV  326 (336)
T ss_dssp             ----
T ss_pred             cccC
Confidence            7544

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1e-40  Score=363.13  Aligned_cols=272  Identities=16%  Similarity=0.196  Sum_probs=210.6

Q ss_pred             hccCCCCceeeeccceEEEEEEECC------CcEEEEEEeeccccch-----------hhhHHHHHHHHhcCCCCcceeE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIRD------GMEVAVKVFNLQCGRA-----------FKSFDVECAMMKSIRHRNLVKV  588 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~l  588 (824)
                      .++|++.+.||+|+||.||+|.+.+      ++.||||++.......           ...+..|+..++.++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            4689999999999999999998764      4789999987543211           1223446667788899999999


Q ss_pred             EeeeecC----CeeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC--C
Q 040845          589 ISSCSNE----EFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD--D  662 (824)
Q Consensus       589 ~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~--~  662 (824)
                      ++++...    ...++||||+ +++|.+++......+++.+++.++.|++.||+|||   +.+|+||||||+||+++  .
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill~~~~  189 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKN  189 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEESSC
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEEecCC
Confidence            9998764    5589999999 99999999887668999999999999999999999   89999999999999999  8


Q ss_pred             CCcEEEeecccccccCCCCCcc-----ccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcc
Q 040845          663 NMVAHLSDFGIAKLLTGEDQSM-----TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEM  737 (824)
Q Consensus       663 ~~~~kl~Dfg~a~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~  737 (824)
                      ++.+||+|||+|+.+.......     ......||+.|+|||++.+..++.++|||||||++|||+||+.||........
T Consensus       190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~  269 (364)
T 3op5_A          190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK  269 (364)
T ss_dssp             TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred             CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHH
Confidence            8999999999998764332211     11334599999999999999999999999999999999999999986432221


Q ss_pred             hhhhhhhhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhcc
Q 040845          738 TLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLR  811 (824)
Q Consensus       738 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~  811 (824)
                       ...+..........+..+..+         ....++..+.+++..||..||++||++.++++.|+++.+....
T Consensus       270 -~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~  333 (364)
T 3op5_A          270 -YVRDSKIRYRENIASLMDKCF---------PAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGS  333 (364)
T ss_dssp             -HHHHHHHHHHHCHHHHHHHHS---------CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             -HHHHHHHHhhhhHHHHHHHhc---------ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence             111111111111111111111         0124577899999999999999999999999999998876544

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2.9e-40  Score=354.63  Aligned_cols=264  Identities=20%  Similarity=0.213  Sum_probs=213.3

Q ss_pred             hccCCCCceeeeccceEEEEEEE-CCCcEEEEEEeeccccchhhhHHHHHHHHhcC-CCCcceeEEeeeecCCeeEEEEe
Q 040845          526 TDKFSENNLIGRGGFGSVYKARI-RDGMEVAVKVFNLQCGRAFKSFDVECAMMKSI-RHRNLVKVISSCSNEEFKALVLE  603 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  603 (824)
                      .++|++.+.||+|+||.||+|+. .+|+.||||++...  ...+.+.+|+.+++.+ +||||+++++++...+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMK--SRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETT--CSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccc--cchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            36799999999999999999986 46899999998754  2345688999999999 99999999999999999999999


Q ss_pred             ccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCc-----EEEeecccccccC
Q 040845          604 YMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMV-----AHLSDFGIAKLLT  678 (824)
Q Consensus       604 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~-----~kl~Dfg~a~~~~  678 (824)
                      |+ +++|.+++......+++.+++.++.|++.||+|||   +.+|+||||||+||+++.++.     +||+|||+|..+.
T Consensus        86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~  161 (330)
T 2izr_A           86 LL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI  161 (330)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred             eC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence            99 89999999876668999999999999999999999   899999999999999998887     9999999998764


Q ss_pred             CCCCcc-----ccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchh
Q 040845          679 GEDQSM-----TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTME  753 (824)
Q Consensus       679 ~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  753 (824)
                      ......     ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.  .......       
T Consensus       162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~--~~~~~~i-------  232 (330)
T 2izr_A          162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTL--KERYQKI-------  232 (330)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSH--HHHHHHH-------
T ss_pred             cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccH--HHHHHHH-------
Confidence            433211     12356799999999999999999999999999999999999999986432211  1110000       


Q ss_pred             hccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhh
Q 040845          754 VVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSL  809 (824)
Q Consensus       754 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~  809 (824)
                       ........   .......++ .+.+++..||..||++||++.++++.|+++.+..
T Consensus       233 -~~~~~~~~---~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~  283 (330)
T 2izr_A          233 -GDTKRATP---IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK  283 (330)
T ss_dssp             -HHHHHHSC---HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             -HhhhccCC---HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence             00000000   000011244 8999999999999999999999999999887654

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=5.8e-41  Score=367.50  Aligned_cols=258  Identities=23%  Similarity=0.280  Sum_probs=208.3

Q ss_pred             HHHHhhccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeeeecCC
Q 040845          521 ELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEE  596 (824)
Q Consensus       521 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  596 (824)
                      ++....++|++.+.||+|+||+||+|+.+ +++.||+|+++...   ....+.+.+|+.+++.++||||+++++++.++.
T Consensus        63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~  142 (410)
T 3v8s_A           63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR  142 (410)
T ss_dssp             HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence            34445688999999999999999999876 48899999987532   233456889999999999999999999999999


Q ss_pred             eeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccc
Q 040845          597 FKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  676 (824)
Q Consensus       597 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~  676 (824)
                      ..|+||||+++|+|.+++...  .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+|+.
T Consensus       143 ~~~lV~E~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG~a~~  217 (410)
T 3v8s_A          143 YLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK  217 (410)
T ss_dssp             EEEEEECCCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEeccceeEe
Confidence            999999999999999999764  5889999999999999999999   99999999999999999999999999999987


Q ss_pred             cCCCCCccccccccccccccCccCcCCCC----CCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcch
Q 040845          677 LTGEDQSMTQTQTLATIGYMAPEYGREGQ----VSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTM  752 (824)
Q Consensus       677 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  752 (824)
                      ..... ........||+.|+|||++.+..    ++.++||||+||++|||++|+.||...... .....+.....     
T Consensus       218 ~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-~~~~~i~~~~~-----  290 (410)
T 3v8s_A          218 MNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-GTYSKIMNHKN-----  290 (410)
T ss_dssp             CCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHTHHH-----
T ss_pred             eccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh-hHHHHHHhccc-----
Confidence            64322 12233457999999999887654    789999999999999999999999753211 11111111000     


Q ss_pred             hhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 040845          753 EVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQ--RINAKEIVAK  801 (824)
Q Consensus       753 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rpt~~evl~~  801 (824)
                                 ....+....++..+.+++.+||+.+|.+  ||+++|+++|
T Consensus       291 -----------~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          291 -----------SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             -----------HCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             -----------cccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence                       0000111134567899999999999998  9999999886

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=7.2e-41  Score=348.91  Aligned_cols=251  Identities=27%  Similarity=0.429  Sum_probs=195.9

Q ss_pred             hccCCCCceeeeccceEEEEEEECCCcEEEEEEeecccc----chhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCG----RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALV  601 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  601 (824)
                      .++|++.+.||+|+||.||+|.+. ++.||||+++....    ...+.+.+|+++++.++||||+++++++.+++..++|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            367889999999999999999986 89999999865432    2346788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC---eEecCCCCCCeeeCC--------CCcEEEee
Q 040845          602 LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAP---VIHCDLKPSNVLLDD--------NMVAHLSD  670 (824)
Q Consensus       602 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~---ivH~Dlk~~Nill~~--------~~~~kl~D  670 (824)
                      |||+++++|.+++...  .+++..++.++.|+++|++|||   +.+   |+||||||+||+++.        ++.+||+|
T Consensus        85 ~e~~~~~~L~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D  159 (271)
T 3dtc_A           85 MEFARGGPLNRVLSGK--RIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD  159 (271)
T ss_dssp             EECCTTEEHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred             EEcCCCCCHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence            9999999999999643  6899999999999999999999   777   999999999999986        77899999


Q ss_pred             cccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCc
Q 040845          671 FGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPIS  750 (824)
Q Consensus       671 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  750 (824)
                      ||.+.......    .....||+.|+|||.+.+..++.++||||+|+++|||++|+.||......... ........   
T Consensus       160 fg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~---  231 (271)
T 3dtc_A          160 FGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVA-YGVAMNKL---  231 (271)
T ss_dssp             CCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHH-HHHHTSCC---
T ss_pred             CCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HhhhcCCC---
Confidence            99998654322    22346899999999998888999999999999999999999999763221111 00000000   


Q ss_pred             chhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 040845          751 TMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKI  805 (824)
Q Consensus       751 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~  805 (824)
                                     ....+..++..+.+++.+||+.||++|||+.|++++|+++
T Consensus       232 ---------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          232 ---------------ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             ---------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             ---------------CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence                           0011224566799999999999999999999999999764

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.1e-40  Score=358.42  Aligned_cols=262  Identities=26%  Similarity=0.441  Sum_probs=214.3

Q ss_pred             hccCCCCceeeeccceEEEEEEEC--------CCcEEEEEEeecccc-chhhhHHHHHHHHhcC-CCCcceeEEeeeecC
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR--------DGMEVAVKVFNLQCG-RAFKSFDVECAMMKSI-RHRNLVKVISSCSNE  595 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  595 (824)
                      .++|++.+.||+|+||.||+|++.        ++..||||+++.... ...+.+.+|+++++++ +||||+++++++.+.
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            478999999999999999999863        467899999875432 3456788999999999 899999999999999


Q ss_pred             CeeEEEEeccCCCCHHHHhhhCC---------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee
Q 040845          596 EFKALVLEYMPHGSLEKYLHSSN---------------YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL  660 (824)
Q Consensus       596 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill  660 (824)
                      +..++||||+++|+|.+++....               ..+++.+++.++.|++.||+|||   +.+|+||||||+||++
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll  190 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV  190 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEE
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceEEE
Confidence            99999999999999999998654               24889999999999999999999   8999999999999999


Q ss_pred             CCCCcEEEeecccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchh
Q 040845          661 DDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTL  739 (824)
Q Consensus       661 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~  739 (824)
                      +.++.+||+|||++................+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||......  ..
T Consensus       191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~  268 (334)
T 2pvf_A          191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--EL  268 (334)
T ss_dssp             CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HH
T ss_pred             cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH--HH
Confidence            9999999999999987654433333344557889999999988889999999999999999999 99998753211  11


Q ss_pred             hhhhhhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhc
Q 040845          740 KHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLL  810 (824)
Q Consensus       740 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~  810 (824)
                      ...+.....                  ...+..++..+.+++.+||..||++|||+.|++++|+++.....
T Consensus       269 ~~~~~~~~~------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~  321 (334)
T 2pvf_A          269 FKLLKEGHR------------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT  321 (334)
T ss_dssp             HHHHHHTCC------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             HHHHhcCCC------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence            111111000                  01112456678999999999999999999999999999987543

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=2.2e-39  Score=364.87  Aligned_cols=349  Identities=27%  Similarity=0.422  Sum_probs=272.3

Q ss_pred             cCCCCCcEEEccCCcccccccccccCCCCCCEEeCCCCcCCcccChhhhCcCCCceeeccCCccccccCccccCCCCCcc
Q 040845           18 DNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLE   97 (824)
Q Consensus        18 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~   97 (824)
                      ..+++|+.|++++|.++. +| .+..+++|++|||++|.+++. +. +.++++|++|++++|++++.+.   ...+++|+
T Consensus        43 ~~l~~l~~L~l~~~~i~~-l~-~~~~l~~L~~L~Ls~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~~~~---~~~l~~L~  115 (466)
T 1o6v_A           43 TDLDQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDI-TP-LKNLTKLVDILMNNNQIADITP---LANLTNLT  115 (466)
T ss_dssp             HHHHTCCEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCCCGG---GTTCTTCC
T ss_pred             hHhccccEEecCCCCCcc-Cc-chhhhcCCCEEECCCCccCCc-hh-hhccccCCEEECCCCccccChh---hcCCCCCC
Confidence            456789999999999984 55 488899999999999999854 33 8899999999999999988776   34689999


Q ss_pred             EEEccCCeeeeecCccccCCCCCceEeccCccccccCCccccCCCCCCEEEccCCcCCCCcCcccccccCCCCCCCcEEE
Q 040845           98 VLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHIS  177 (824)
Q Consensus        98 ~L~L~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~~L~~L~  177 (824)
                      +|+|++|.+++..+  +..+++|++|++++|.+++. + .+.++++|++|+++ |.+...       ..+.++++|++|+
T Consensus       116 ~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~l~-~~~~~~-------~~~~~l~~L~~L~  183 (466)
T 1o6v_A          116 GLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDI-S-ALSGLTSLQQLSFG-NQVTDL-------KPLANLTTLERLD  183 (466)
T ss_dssp             EEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCC-G-GGTTCTTCSEEEEE-ESCCCC-------GGGTTCTTCCEEE
T ss_pred             EEECCCCCCCCChH--HcCCCCCCEEECCCCccCCC-h-hhccCCcccEeecC-CcccCc-------hhhccCCCCCEEE
Confidence            99999999985533  88899999999999998854 3 58889999999996 444443       2377888999999


Q ss_pred             CcCCCCCccCCccccccccccccEEEeecCcceecCCccCCCCCCCCEEEecCCccCCccchhhcCCCCCCEEEcccccC
Q 040845          178 LSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQL  257 (824)
Q Consensus       178 Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l  257 (824)
                      +++|.+.++.                            .+..+++|+.|++++|.+.+..+  +..+++|++|++++|++
T Consensus       184 l~~n~l~~~~----------------------------~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l  233 (466)
T 1o6v_A          184 ISSNKVSDIS----------------------------VLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQL  233 (466)
T ss_dssp             CCSSCCCCCG----------------------------GGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCC
T ss_pred             CcCCcCCCCh----------------------------hhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCc
Confidence            9998876541                            24456777777777777775544  66677777777777777


Q ss_pred             cccCCccccccCCccEEEccCccccccCCccccCCCCCcEEEcCCCCCCCCCCcccccccccccccccccccCcCCcccc
Q 040845          258 EGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIR  337 (824)
Q Consensus       258 ~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~  337 (824)
                      ++.  ..+..+++|+.|++++|.+.+..+  +..+++|+.|++++|.++.++. +..+++|+.|++++|++++..+  +.
T Consensus       234 ~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~L~~n~l~~~~~--~~  306 (466)
T 1o6v_A          234 KDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP-LAGLTALTNLELNENQLEDISP--IS  306 (466)
T ss_dssp             CCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCSCCGG--GG
T ss_pred             ccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc-ccCCCccCeEEcCCCcccCchh--hc
Confidence            643  356677777777777777775544  7777788888888888877765 6677888888888888875443  77


Q ss_pred             ccccchhhhcccccccccCCCccCCCCCCCeEEccCccccccCCccccccccccEEEccCcccCCCCcccccCCccccee
Q 040845          338 NLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDL  417 (824)
Q Consensus       338 ~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  417 (824)
                      .+++|+.|++++|++++..|  +..+++|+.|++++|++++.  ..+..+++|+.|++++|++++..|  +..+++|+.|
T Consensus       307 ~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L  380 (466)
T 1o6v_A          307 NLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQL  380 (466)
T ss_dssp             GCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEE
T ss_pred             CCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEE
Confidence            88888888888888887655  77888899999999988854  468888899999999999987666  7888899999


Q ss_pred             eccCCcccCCC
Q 040845          418 NLSFNKLKGEI  428 (824)
Q Consensus       418 ~l~~N~l~~~~  428 (824)
                      ++++|++++.+
T Consensus       381 ~l~~n~~~~~p  391 (466)
T 1o6v_A          381 GLNDQAWTNAP  391 (466)
T ss_dssp             ECCCEEEECCC
T ss_pred             eccCCcccCCc
Confidence            99999988753

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=5.4e-41  Score=375.24  Aligned_cols=262  Identities=27%  Similarity=0.423  Sum_probs=209.5

Q ss_pred             hccCCCCceeeeccceEEEEEEECCCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEecc
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYM  605 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  605 (824)
                      .++|++.+.||+|+||.||+|+++++..||||+++... ...+.+.+|++++++++||||+++++++.+ +..++||||+
T Consensus       183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~  260 (452)
T 1fmk_A          183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM  260 (452)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence            46788999999999999999999888899999987543 345778999999999999999999999876 6789999999


Q ss_pred             CCCCHHHHhhhC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 040845          606 PHGSLEKYLHSS-NYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM  684 (824)
Q Consensus       606 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  684 (824)
                      ++|+|.+++... ...+++.++..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++...... ..
T Consensus       261 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~~  336 (452)
T 1fmk_A          261 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YT  336 (452)
T ss_dssp             TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred             cCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecCCCc-ee
Confidence            999999999753 246899999999999999999999   9999999999999999999999999999998764322 22


Q ss_pred             ccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhccccccCch
Q 040845          685 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQE  763 (824)
Q Consensus       685 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  763 (824)
                      ......++..|+|||.+.++.++.++||||||+++|||++ |+.||......+  ....+...                 
T Consensus       337 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~~~~i~~~-----------------  397 (452)
T 1fmk_A          337 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQVERG-----------------  397 (452)
T ss_dssp             ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHHTT-----------------
T ss_pred             cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcC-----------------
Confidence            2233457889999999988899999999999999999999 899987532211  11111100                 


Q ss_pred             hhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhcccc
Q 040845          764 DIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLRNV  813 (824)
Q Consensus       764 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~~~  813 (824)
                       .+...+..++..+.++|.+||+.||++|||++++++.|+++..+...++
T Consensus       398 -~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~~  446 (452)
T 1fmk_A          398 -YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQY  446 (452)
T ss_dssp             -CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCC
T ss_pred             -CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCccc
Confidence             0111223567789999999999999999999999999988765544433

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.2e-40  Score=355.74  Aligned_cols=271  Identities=24%  Similarity=0.375  Sum_probs=218.6

Q ss_pred             cHHHHHHhhccCCCCceeeeccceEEEEEEE------CCCcEEEEEEeecccc-chhhhHHHHHHHHhcC-CCCcceeEE
Q 040845          518 SYLELFQATDKFSENNLIGRGGFGSVYKARI------RDGMEVAVKVFNLQCG-RAFKSFDVECAMMKSI-RHRNLVKVI  589 (824)
Q Consensus       518 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~  589 (824)
                      ....+....++|++.+.||+|+||.||+|++      .+++.||||+++.... ...+.+.+|+.+++++ +||||++++
T Consensus        18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~   97 (316)
T 2xir_A           18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   97 (316)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence            3444455568999999999999999999974      2468999999875432 2346788999999999 799999999


Q ss_pred             eeeecCC-eeEEEEeccCCCCHHHHhhhCCCC---------------CCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCC
Q 040845          590 SSCSNEE-FKALVLEYMPHGSLEKYLHSSNYS---------------LDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL  653 (824)
Q Consensus       590 ~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~---------------~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dl  653 (824)
                      +++..++ ..++||||+++|+|.+++......               +++.+++.++.|+++|++|||   +.+|+||||
T Consensus        98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~di  174 (316)
T 2xir_A           98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDL  174 (316)
T ss_dssp             EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCSCC
T ss_pred             EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCcccccC
Confidence            9987654 589999999999999999875422               789999999999999999999   899999999


Q ss_pred             CCCCeeeCCCCcEEEeecccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCccc
Q 040845          654 KPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDEL  732 (824)
Q Consensus       654 k~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~  732 (824)
                      ||+||+++.++.+||+|||++................+|+.|+|||.+.+..++.++||||+|+++|||+| |..||...
T Consensus       175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~  254 (316)
T 2xir_A          175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  254 (316)
T ss_dssp             SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence            99999999999999999999987654444444445568899999999988899999999999999999998 99998764


Q ss_pred             ccCcchhhhhhhhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhc
Q 040845          733 FNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLL  810 (824)
Q Consensus       733 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~  810 (824)
                      ...+......... ..                  ...+..++..+.+++.+||+.||++|||+.|++++|+++.++..
T Consensus       255 ~~~~~~~~~~~~~-~~------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  313 (316)
T 2xir_A          255 KIDEEFCRRLKEG-TR------------------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA  313 (316)
T ss_dssp             CCSHHHHHHHHHT-CC------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             chhHHHHHHhccC-cc------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence            3222111111110 00                  00112245678999999999999999999999999999987543

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.3e-40  Score=356.38  Aligned_cols=260  Identities=24%  Similarity=0.408  Sum_probs=204.2

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcE----EEEEEeecc-ccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGME----VAVKVFNLQ-CGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKA  599 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  599 (824)
                      .++|++.+.||+|+||.||+|++. +++.    ||+|.+... .....+.+.+|+.+++.++||||+++++++.... .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            367999999999999999999864 3444    577766433 2345677899999999999999999999998765 78


Q ss_pred             EEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCC
Q 040845          600 LVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG  679 (824)
Q Consensus       600 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  679 (824)
                      +|+||+++|+|.+++......+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus        93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~  169 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence            999999999999999887778999999999999999999999   99999999999999999999999999999987654


Q ss_pred             CCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhcccc
Q 040845          680 EDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDAN  758 (824)
Q Consensus       680 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  758 (824)
                      ...........+|+.|+|||.+.+..++.++||||+||++|||++ |+.||......+  ....+....           
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~~~~~~~~-----------  236 (327)
T 3lzb_A          170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSILEKGE-----------  236 (327)
T ss_dssp             ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHHHTTC-----------
T ss_pred             ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HHHHHHcCC-----------
Confidence            444444444567889999999999999999999999999999999 999997643221  111111110           


Q ss_pred             ccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhh
Q 040845          759 LLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSL  809 (824)
Q Consensus       759 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~  809 (824)
                             ....+..++..+.+++.+||..||++|||+.|+++.|+++.+..
T Consensus       237 -------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  280 (327)
T 3lzb_A          237 -------RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP  280 (327)
T ss_dssp             -------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred             -------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence                   01112235667899999999999999999999999999987543

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=5.1e-41  Score=360.40  Aligned_cols=250  Identities=23%  Similarity=0.333  Sum_probs=204.4

Q ss_pred             HhhccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcC-CCCcceeEEeeeecCCee
Q 040845          524 QATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSI-RHRNLVKVISSCSNEEFK  598 (824)
Q Consensus       524 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  598 (824)
                      ...++|++.+.||+|+||.||+|+.+ +|+.||||+++...   ....+.+..|..+++.+ +||||+++++++.+.+..
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~   93 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL   93 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence            34678999999999999999999876 58999999997542   33456677899999877 899999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccC
Q 040845          599 ALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT  678 (824)
Q Consensus       599 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~  678 (824)
                      ++||||+++|+|.+++.... .+++.++..++.|++.||+|||   +.+|+||||||+||+++.+|.+||+|||+|+...
T Consensus        94 ~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  169 (345)
T 1xjd_A           94 FFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM  169 (345)
T ss_dssp             EEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence            99999999999999998755 6899999999999999999999   8999999999999999999999999999998543


Q ss_pred             CCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhcccc
Q 040845          679 GEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDAN  758 (824)
Q Consensus       679 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  758 (824)
                      ...  .......||+.|+|||++.+..++.++||||+||++|||++|+.||......  .....+....+          
T Consensus       170 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~i~~~~~----------  235 (345)
T 1xjd_A          170 LGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE--ELFHSIRMDNP----------  235 (345)
T ss_dssp             CTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCCC----------
T ss_pred             cCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHHhCCC----------
Confidence            222  1233456999999999999999999999999999999999999999753211  11111110000          


Q ss_pred             ccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 040845          759 LLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAK-EIVA  800 (824)
Q Consensus       759 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~-evl~  800 (824)
                               ..+..++..+.+++.+||..||++||++. |+++
T Consensus       236 ---------~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~  269 (345)
T 1xjd_A          236 ---------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  269 (345)
T ss_dssp             ---------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             ---------CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence                     00122456789999999999999999997 6654

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=6.3e-41  Score=359.38  Aligned_cols=277  Identities=25%  Similarity=0.337  Sum_probs=214.5

Q ss_pred             hccCCCCceeeeccceEEEEEEE-----CCCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeee--cCCee
Q 040845          526 TDKFSENNLIGRGGFGSVYKARI-----RDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCS--NEEFK  598 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~  598 (824)
                      .++|++.+.||+|+||.||+|++     .+++.||||++........+.+.+|++++++++||||+++++++.  +....
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  101 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL  101 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence            36789999999999999999984     358899999997665556677899999999999999999999886  45678


Q ss_pred             EEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccC
Q 040845          599 ALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT  678 (824)
Q Consensus       599 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~  678 (824)
                      ++||||+++++|.+++......+++.+++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++....
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  178 (327)
T 3lxl_A          102 RLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLP  178 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred             EEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccceecc
Confidence            9999999999999999876557899999999999999999999   9999999999999999999999999999998765


Q ss_pred             CCCCc-cccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccc
Q 040845          679 GEDQS-MTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDA  757 (824)
Q Consensus       679 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  757 (824)
                      ..... .......+|..|+|||.+.+..++.++||||+|+++|||++|+.||............+..  .........+.
T Consensus       179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~  256 (327)
T 3lxl_A          179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCER--DVPALSRLLEL  256 (327)
T ss_dssp             TTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC------CCHHHHHHHH
T ss_pred             cCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhccccc--ccccHHHHHHH
Confidence            43322 2233455888899999998888999999999999999999999998653211000000000  00000000000


Q ss_pred             cccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhc
Q 040845          758 NLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLL  810 (824)
Q Consensus       758 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~  810 (824)
                      .   ........+..++..+.+++.+||+.||++|||+.|++++|+.+..+..
T Consensus       257 ~---~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~  306 (327)
T 3lxl_A          257 L---EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR  306 (327)
T ss_dssp             H---HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred             h---hcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence            0   0001111233567789999999999999999999999999999865443

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.2e-41  Score=363.46  Aligned_cols=263  Identities=25%  Similarity=0.445  Sum_probs=201.9

Q ss_pred             ccCCCCceeeeccceEEEEEEEC--CC--cEEEEEEeeccc-cchhhhHHHHHHHHhcCCCCcceeEEeeeec-CCeeEE
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR--DG--MEVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLVKVISSCSN-EEFKAL  600 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~--~~--~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~l  600 (824)
                      ..|++.+.||+|+||.||+|++.  ++  ..||||.++... ....+.+.+|+.++++++||||+++++++.+ ++..++
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l  168 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  168 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence            34677789999999999999864  22  468999886443 3456778999999999999999999998754 567899


Q ss_pred             EEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 040845          601 VLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE  680 (824)
Q Consensus       601 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  680 (824)
                      ||||+++|+|.+++......+++.+++.++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus       169 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~  245 (373)
T 3c1x_A          169 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  245 (373)
T ss_dssp             EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeecccccccccc
Confidence            99999999999999877777899999999999999999999   999999999999999999999999999999866433


Q ss_pred             CCc--cccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhccc
Q 040845          681 DQS--MTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDA  757 (824)
Q Consensus       681 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  757 (824)
                      ...  .......+|+.|+|||.+.+..++.++|||||||++|||+| |.+||......+  ....+....          
T Consensus       246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~--~~~~~~~~~----------  313 (373)
T 3c1x_A          246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--ITVYLLQGR----------  313 (373)
T ss_dssp             ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC--HHHHHHTTC----------
T ss_pred             ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH--HHHHHHcCC----------
Confidence            221  12234457889999999998899999999999999999999 566665532221  111111100          


Q ss_pred             cccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhccc
Q 040845          758 NLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLRN  812 (824)
Q Consensus       758 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~~  812 (824)
                              ....+..++..+.+++.+||..||++|||+.|++++|+++..++..+
T Consensus       314 --------~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~  360 (373)
T 3c1x_A          314 --------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE  360 (373)
T ss_dssp             --------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred             --------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcccc
Confidence                    01112345677999999999999999999999999999998876644

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=4e-40  Score=362.04  Aligned_cols=272  Identities=19%  Similarity=0.265  Sum_probs=207.0

Q ss_pred             hccCCCCceeeec--cceEEEEEEEC-CCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEE
Q 040845          526 TDKFSENNLIGRG--GFGSVYKARIR-DGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKAL  600 (824)
Q Consensus       526 ~~~~~~~~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  600 (824)
                      .++|++.+.||+|  +||.||+|+.. +|+.||||++....  ....+.+.+|+.+++.++||||+++++++.+++..++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            4679999999999  99999999876 69999999997653  2335678889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCC
Q 040845          601 VLEYMPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG  679 (824)
Q Consensus       601 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  679 (824)
                      ||||+++|+|.+++.... ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||.+.....
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~  180 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS  180 (389)
T ss_dssp             EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred             EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence            999999999999997652 46899999999999999999999   99999999999999999999999999999875532


Q ss_pred             CCCc-----cccccccccccccCccCcCC--CCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcc-
Q 040845          680 EDQS-----MTQTQTLATIGYMAPEYGRE--GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPIST-  751 (824)
Q Consensus       680 ~~~~-----~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-  751 (824)
                      ....     .......||+.|+|||++.+  ..++.++||||+||++|||++|+.||.+....+.....+ ....+... 
T Consensus       181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~  259 (389)
T 3gni_B          181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL-NGTVPCLLD  259 (389)
T ss_dssp             TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------
T ss_pred             ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh-cCCCCcccc
Confidence            2111     11223468999999999887  578999999999999999999999997643322211111 10000000 


Q ss_pred             -----hhh-----------------c---cccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          752 -----MEV-----------------V---DANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       752 -----~~~-----------------~---~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                           .+.                 .   ..............+..++..+.+|+.+||+.||++|||++|++++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence                 000                 0   0000000000111233567789999999999999999999999976

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2.9e-40  Score=358.64  Aligned_cols=250  Identities=25%  Similarity=0.325  Sum_probs=204.3

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALV  601 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  601 (824)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            367999999999999999999865 48899999987542   33456788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 040845          602 LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED  681 (824)
Q Consensus       602 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  681 (824)
                      |||+++|+|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.+|.+||+|||+|.......
T Consensus        94 ~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  169 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQNV-HFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET  169 (384)
T ss_dssp             ECCCTTEEHHHHHHTTC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred             EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeeccCCC
Confidence            99999999999998755 6899999999999999999999   9999999999999999999999999999998764322


Q ss_pred             CccccccccccccccCccCcCC---CCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhcccc
Q 040845          682 QSMTQTQTLATIGYMAPEYGRE---GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDAN  758 (824)
Q Consensus       682 ~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  758 (824)
                         ......||+.|+|||++..   ..++.++||||+||++|||++|+.||.......  .........         ..
T Consensus       170 ---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~--~~~~~~~~~---------~~  235 (384)
T 4fr4_A          170 ---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS--SKEIVHTFE---------TT  235 (384)
T ss_dssp             ---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC--HHHHHHHHH---------HC
T ss_pred             ---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc--HHHHHHHHh---------hc
Confidence               2344569999999999864   458999999999999999999999997532211  111111000         00


Q ss_pred             ccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 040845          759 LLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRIN-AKEIVA  800 (824)
Q Consensus       759 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt-~~evl~  800 (824)
                      .       ...+..++..+.+++.+||+.||++||+ ++++.+
T Consensus       236 ~-------~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          236 V-------VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             C-------CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             c-------cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence            0       0011234667899999999999999998 666654

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.3e-40  Score=349.19  Aligned_cols=257  Identities=29%  Similarity=0.410  Sum_probs=202.0

Q ss_pred             hccCCCCceeeeccceEEEEEEECCCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEecc
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYM  605 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  605 (824)
                      .++|++.+.||+|+||.||+|++. ++.||||++..  ....+.+.+|++++++++||||+++++++.+  ..++||||+
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~   81 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYA   81 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSS--TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECC
T ss_pred             HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecC--hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcC
Confidence            357889999999999999999986 88999999864  3455778999999999999999999999874  478999999


Q ss_pred             CCCCHHHHhhhCC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCc-EEEeecccccccCCCCC
Q 040845          606 PHGSLEKYLHSSN--YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMV-AHLSDFGIAKLLTGEDQ  682 (824)
Q Consensus       606 ~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~-~kl~Dfg~a~~~~~~~~  682 (824)
                      ++|+|.+++....  ..+++..++.++.|+++|++|||+....+|+||||||+||+++.++. +||+|||++......  
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--  159 (307)
T 2eva_A           82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--  159 (307)
T ss_dssp             TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred             CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--
Confidence            9999999998654  24788999999999999999999211189999999999999998886 799999999765322  


Q ss_pred             ccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCc
Q 040845          683 SMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ  762 (824)
Q Consensus       683 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  762 (824)
                         .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...................              
T Consensus       160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--------------  222 (307)
T 2eva_A          160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTR--------------  222 (307)
T ss_dssp             --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCC--------------
T ss_pred             ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCC--------------
Confidence               123458999999999999899999999999999999999999997633222111111110000              


Q ss_pred             hhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhc
Q 040845          763 EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLL  810 (824)
Q Consensus       763 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~  810 (824)
                          ...+..++..+.+++.+||+.||++|||+.|++++|+.+.+.+.
T Consensus       223 ----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  266 (307)
T 2eva_A          223 ----PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFP  266 (307)
T ss_dssp             ----CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCC
T ss_pred             ----CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhcc
Confidence                00112345678999999999999999999999999999876553

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=2.4e-40  Score=353.11  Aligned_cols=272  Identities=24%  Similarity=0.395  Sum_probs=213.1

Q ss_pred             CCCCceeeeccceEEEEEEEC-----CCcEEEEEEeecccc-chhhhHHHHHHHHhcCCCCcceeEEeeeec--CCeeEE
Q 040845          529 FSENNLIGRGGFGSVYKARIR-----DGMEVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVKVISSCSN--EEFKAL  600 (824)
Q Consensus       529 ~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l  600 (824)
                      |++.+.||+|+||+||+|.++     +++.||||+++.... ...+.+.+|++++++++||||+++++++.+  ....++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            388999999999999998753     588999999976532 345678999999999999999999999977  467899


Q ss_pred             EEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 040845          601 VLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE  680 (824)
Q Consensus       601 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  680 (824)
                      ||||+++|+|.+++....  +++.+++.++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||++......
T Consensus       113 v~e~~~~~~L~~~l~~~~--~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  187 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG  187 (318)
T ss_dssp             EECCCTTCBHHHHGGGSC--CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred             EEecccCCcHHHHHhhCC--CCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence            999999999999997654  899999999999999999999   999999999999999999999999999999877543


Q ss_pred             CCc-cccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCC-cchhhcccc
Q 040845          681 DQS-MTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPI-STMEVVDAN  758 (824)
Q Consensus       681 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  758 (824)
                      ... .......+|..|+|||.+.+..++.++||||+|+++|||++|+.||............+....... ...+.....
T Consensus       188 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (318)
T 3lxp_A          188 HEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG  267 (318)
T ss_dssp             CSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTT
T ss_pred             ccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcc
Confidence            322 223345578889999999988899999999999999999999999875322111110000000000 000011100


Q ss_pred             ccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhcc
Q 040845          759 LLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLR  811 (824)
Q Consensus       759 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~  811 (824)
                            .....+..++..+.+++.+||+.||++|||+.|+++.|+++.+++..
T Consensus       268 ------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~  314 (318)
T 3lxp_A          268 ------ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG  314 (318)
T ss_dssp             ------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC
T ss_pred             ------cCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhcc
Confidence                  11112335677899999999999999999999999999999887754

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.8e-40  Score=357.38  Aligned_cols=246  Identities=22%  Similarity=0.251  Sum_probs=206.3

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALV  601 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  601 (824)
                      .++|++.+.||+|+||.||+|+.+ +|+.||||++....   ....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            367899999999999999999875 58999999987542   23456788899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 040845          602 LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED  681 (824)
Q Consensus       602 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  681 (824)
                      |||+++|+|.+++...+ .+++.++..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++..... 
T Consensus       120 ~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-  194 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-  194 (350)
T ss_dssp             EECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred             EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceeccCC-
Confidence            99999999999998765 6899999999999999999999   999999999999999999999999999999876432 


Q ss_pred             CccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccC
Q 040845          682 QSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLS  761 (824)
Q Consensus       682 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  761 (824)
                          .....||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+.....              
T Consensus       195 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-~~~~~i~~~~~--------------  255 (350)
T 1rdq_E          195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKIVSGKV--------------  255 (350)
T ss_dssp             ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHCCC--------------
T ss_pred             ----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH-HHHHHHHcCCC--------------
Confidence                12346899999999999999999999999999999999999999753211 11111111100              


Q ss_pred             chhhhhhhHHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 040845          762 QEDIHFVAKEQCVSFVFNLALECTVESPEQRIN-----AKEIVAK  801 (824)
Q Consensus       762 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt-----~~evl~~  801 (824)
                            ..+..++..+.+++.+||+.||++||+     ++|+++|
T Consensus       256 ------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h  294 (350)
T 1rdq_E          256 ------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             ------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             ------CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence                  011234667899999999999999998     8888765

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.8e-40  Score=347.43  Aligned_cols=265  Identities=23%  Similarity=0.387  Sum_probs=215.6

Q ss_pred             hccCCCCc-eeeeccceEEEEEEEC---CCcEEEEEEeeccc-cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEE
Q 040845          526 TDKFSENN-LIGRGGFGSVYKARIR---DGMEVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKAL  600 (824)
Q Consensus       526 ~~~~~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  600 (824)
                      .++|.+.+ .||+|+||.||+|.+.   ++..||||+++... ....+.+.+|+++++.++||||+++++++ ..+..++
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l   86 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML   86 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence            35566666 9999999999999864   57889999997643 23456788999999999999999999999 4556899


Q ss_pred             EEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 040845          601 VLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE  680 (824)
Q Consensus       601 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  680 (824)
                      ||||+++++|.+++......+++.+++.++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||++......
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~  163 (287)
T 1u59_A           87 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  163 (287)
T ss_dssp             EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence            99999999999999876667999999999999999999999   999999999999999999999999999999876533


Q ss_pred             CCc-cccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhcccc
Q 040845          681 DQS-MTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDAN  758 (824)
Q Consensus       681 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  758 (824)
                      ... .......+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||......  .....+....           
T Consensus       164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~i~~~~-----------  230 (287)
T 1u59_A          164 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMAFIEQGK-----------  230 (287)
T ss_dssp             SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HHHHHHHTTC-----------
T ss_pred             cceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--HHHHHHhcCC-----------
Confidence            322 12233456889999999988889999999999999999999 99998763221  1111111100           


Q ss_pred             ccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhccccC
Q 040845          759 LLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLRNVG  814 (824)
Q Consensus       759 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~~~~  814 (824)
                             ....+..++..+.+++.+||..||++||++.|++++|+++..+......
T Consensus       231 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~  279 (287)
T 1u59_A          231 -------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE  279 (287)
T ss_dssp             -------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCS
T ss_pred             -------cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCccc
Confidence                   0011224567899999999999999999999999999999887766543

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.2e-40  Score=356.25  Aligned_cols=255  Identities=22%  Similarity=0.294  Sum_probs=204.2

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcC-CCCcceeEEeeeecCCeeEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSI-RHRNLVKVISSCSNEEFKAL  600 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  600 (824)
                      .++|++.+.||+|+||.||+|+.+ +++.||||+++...   ....+.+.+|..+++++ +||||+++++++.+....++
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            367899999999999999999876 58999999997653   22345678899999988 89999999999999999999


Q ss_pred             EEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 040845          601 VLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE  680 (824)
Q Consensus       601 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  680 (824)
                      ||||+++|+|.+++...+ .+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+|+.....
T Consensus        88 v~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~  163 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  163 (345)
T ss_dssp             EECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred             EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence            999999999999998755 6899999999999999999999   999999999999999999999999999999854322


Q ss_pred             CCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcc---hhhhhhhhhCCCcchhhccc
Q 040845          681 DQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEM---TLKHWVNDCLPISTMEVVDA  757 (824)
Q Consensus       681 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  757 (824)
                      .  .......||+.|+|||++.+..++.++||||+||++|||++|+.||......+.   ........       .+...
T Consensus       164 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-------~i~~~  234 (345)
T 3a8x_A          164 G--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ-------VILEK  234 (345)
T ss_dssp             T--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHH-------HHHHC
T ss_pred             C--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHH-------HHHcC
Confidence            2  123345799999999999999999999999999999999999999975321110   00000000       00000


Q ss_pred             cccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCH------HHHHHH
Q 040845          758 NLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINA------KEIVAK  801 (824)
Q Consensus       758 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~------~evl~~  801 (824)
                      .        ...+..++..+.+++.+||+.||++||++      .|+++|
T Consensus       235 ~--------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h  276 (345)
T 3a8x_A          235 Q--------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  276 (345)
T ss_dssp             C--------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred             C--------CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence            0        00122356678999999999999999996      566654

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2e-40  Score=360.70  Aligned_cols=248  Identities=21%  Similarity=0.322  Sum_probs=200.4

Q ss_pred             CCceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEeccCCCC
Q 040845          531 ENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGS  609 (824)
Q Consensus       531 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  609 (824)
                      ..+.||+|+||.||+|+.. +|+.||+|+++.......+.+.+|++++++++||||+++++++.+.+..++||||+++++
T Consensus        93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~  172 (373)
T 2x4f_A           93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE  172 (373)
T ss_dssp             EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred             cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence            3568999999999999864 589999999986655566789999999999999999999999999999999999999999


Q ss_pred             HHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee--CCCCcEEEeecccccccCCCCCccccc
Q 040845          610 LEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL--DDNMVAHLSDFGIAKLLTGEDQSMTQT  687 (824)
Q Consensus       610 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill--~~~~~~kl~Dfg~a~~~~~~~~~~~~~  687 (824)
                      |.+++......+++.+++.++.|++.||+|||   +.+|+||||||+||++  +.++.+||+|||++..+.....   ..
T Consensus       173 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---~~  246 (373)
T 2x4f_A          173 LFDRIIDESYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---LK  246 (373)
T ss_dssp             EHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---CC
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---cc
Confidence            99999876667899999999999999999999   9999999999999999  6778999999999987643322   22


Q ss_pred             cccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhhhh
Q 040845          688 QTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHF  767 (824)
Q Consensus       688 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  767 (824)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+........                .
T Consensus       247 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~i~~~~~~~~----------------~  309 (373)
T 2x4f_A          247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA-ETLNNILACRWDLE----------------D  309 (373)
T ss_dssp             CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHHTCCCSC----------------S
T ss_pred             cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccCCCC----------------h
Confidence            346899999999999889999999999999999999999999763221 11122221111100                0


Q ss_pred             hhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          768 VAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       768 ~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      .....++..+.+++.+||+.||++|||+.|++++
T Consensus       310 ~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h  343 (373)
T 2x4f_A          310 EEFQDISEEAKEFISKLLIKEKSWRISASEALKH  343 (373)
T ss_dssp             GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0112346678999999999999999999999984

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=3.3e-40  Score=343.89  Aligned_cols=252  Identities=25%  Similarity=0.405  Sum_probs=206.3

Q ss_pred             hccCCCCceeeeccceEEEEEEECCCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeecC--CeeEEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSNE--EFKALV  601 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv  601 (824)
                      .++|++.+.||+|+||.||+|+++ ++.||||++....  ....+.+.+|+.++++++||||+++++++.+.  ...++|
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI   87 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence            467899999999999999999986 8999999987553  23456788999999999999999999999877  788999


Q ss_pred             EeccCCCCHHHHhhhCCC-CCCHHHHHHHHHHHHHHHHHhhcCCCCC--eEecCCCCCCeeeCCCCcEEEeecccccccC
Q 040845          602 LEYMPHGSLEKYLHSSNY-SLDIFQRLNIMIDVASALEYLHFGYSAP--VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT  678 (824)
Q Consensus       602 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~  678 (824)
                      |||+++|+|.+++..... .+++.+++.++.|++.|++|||   +.+  |+||||||+||+++.++.++++|||++....
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~  164 (271)
T 3kmu_A           88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ  164 (271)
T ss_dssp             EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred             ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence            999999999999987653 5899999999999999999999   888  9999999999999999999999999876432


Q ss_pred             CCCCccccccccccccccCccCcCCCCCCc---cchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhc
Q 040845          679 GEDQSMTQTQTLATIGYMAPEYGREGQVST---NGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVV  755 (824)
Q Consensus       679 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~---~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  755 (824)
                      .       ....+|+.|+|||.+.+..++.   ++||||+|+++|||++|+.||......+... .......        
T Consensus       165 ~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-~~~~~~~--------  228 (271)
T 3kmu_A          165 S-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGM-KVALEGL--------  228 (271)
T ss_dssp             C-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHH-HHHHSCC--------
T ss_pred             c-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHH-HHHhcCC--------
Confidence            1       2345889999999987665444   7999999999999999999997632221111 1110000        


Q ss_pred             cccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 040845          756 DANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRD  807 (824)
Q Consensus       756 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~  807 (824)
                                ....+..++..+.+++.+||+.||++|||++|+++.|+++.+
T Consensus       229 ----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          229 ----------RPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             ----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             ----------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence                      001112356679999999999999999999999999998743

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=3.3e-40  Score=354.86  Aligned_cols=251  Identities=24%  Similarity=0.366  Sum_probs=199.6

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc-cchhhhHHHHHHHHhcCCCCcceeEEeeeecCC-------
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEE-------  596 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------  596 (824)
                      .++|++.+.||+|+||.||+|+++ +|+.||||+++... ....+.+.+|++++++++||||+++++++.+..       
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            467999999999999999999876 69999999997543 334577899999999999999999999985543       


Q ss_pred             --------------------------------------------------eeEEEEeccCCCCHHHHhhhCC--CCCCHH
Q 040845          597 --------------------------------------------------FKALVLEYMPHGSLEKYLHSSN--YSLDIF  624 (824)
Q Consensus       597 --------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~--~~~~~~  624 (824)
                                                                        ..++||||+++++|.+++....  ...++.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                              3789999999999999998754  345667


Q ss_pred             HHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc----------ccccccccccc
Q 040845          625 QRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS----------MTQTQTLATIG  694 (824)
Q Consensus       625 ~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~----------~~~~~~~~~~~  694 (824)
                      .++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++........          .......||+.
T Consensus       165 ~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            78999999999999999   999999999999999999999999999999877543221          12234569999


Q ss_pred             ccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhhhhhhHHHHH
Q 040845          695 YMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCV  774 (824)
Q Consensus       695 y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  774 (824)
                      |+|||.+.+..++.++||||+||++|||++|..|+.....    .......              .    ........++
T Consensus       242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~----~~~~~~~--------------~----~~~~~~~~~~  299 (332)
T 3qd2_B          242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVR----IITDVRN--------------L----KFPLLFTQKY  299 (332)
T ss_dssp             GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHH----HHHHHHT--------------T----CCCHHHHHHC
T ss_pred             ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHH----HHHHhhc--------------c----CCCcccccCC
Confidence            9999999988999999999999999999998776432110    0000000              0    0001123445


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          775 SFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       775 ~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      +.+.+++.+||+.||++|||+.|++++
T Consensus       300 ~~~~~li~~~l~~~p~~Rps~~~~l~~  326 (332)
T 3qd2_B          300 PQEHMMVQDMLSPSPTERPEATDIIEN  326 (332)
T ss_dssp             HHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred             hhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence            677899999999999999999999874

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-40  Score=365.09  Aligned_cols=261  Identities=23%  Similarity=0.292  Sum_probs=208.9

Q ss_pred             HHHHHhhccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeeeecC
Q 040845          520 LELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSCSNE  595 (824)
Q Consensus       520 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  595 (824)
                      .+.....++|++.+.||+|+||.||+|+.+ +|+.||||+++...   ....+.+.+|..++..++||||+++++++.++
T Consensus        54 ~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~  133 (412)
T 2vd5_A           54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDE  133 (412)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred             hhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence            344445688999999999999999999875 69999999997532   23445688999999999999999999999999


Q ss_pred             CeeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccc
Q 040845          596 EFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK  675 (824)
Q Consensus       596 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~  675 (824)
                      +..|+||||+++|+|.+++...+..+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+|+
T Consensus       134 ~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~DFGla~  210 (412)
T 2vd5_A          134 NYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCL  210 (412)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             CEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEeechhhe
Confidence            9999999999999999999876657999999999999999999999   9999999999999999999999999999998


Q ss_pred             ccCCCCCccccccccccccccCccCcC-------CCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCC
Q 040845          676 LLTGEDQSMTQTQTLATIGYMAPEYGR-------EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLP  748 (824)
Q Consensus       676 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  748 (824)
                      ....... .......||+.|+|||++.       ...++.++||||+||++|||++|+.||......+ ....+..... 
T Consensus       211 ~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-~~~~i~~~~~-  287 (412)
T 2vd5_A          211 KLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE-TYGKIVHYKE-  287 (412)
T ss_dssp             ECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHTHHH-
T ss_pred             eccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH-HHHHHHhccc-
Confidence            7643322 2223457999999999886       4568999999999999999999999997632111 1111111000 


Q ss_pred             CcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCC---CCHHHHHHH
Q 040845          749 ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQR---INAKEIVAK  801 (824)
Q Consensus       749 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R---pt~~evl~~  801 (824)
                                ....+    ..+..++.++.+++.+||. +|++|   |+++|+++|
T Consensus       288 ----------~~~~p----~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H  328 (412)
T 2vd5_A          288 ----------HLSLP----LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH  328 (412)
T ss_dssp             ----------HCCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred             ----------CcCCC----ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence                      00000    0112356779999999999 99998   589998775

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=8e-41  Score=377.79  Aligned_cols=256  Identities=27%  Similarity=0.437  Sum_probs=213.7

Q ss_pred             hccCCCCceeeeccceEEEEEEECC-CcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEec
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      ..+|++.+.||+|+||.||+|+++. +..||||+++.. ....+.+.+|+.++++++||||+++++++.+....++||||
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~  297 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF  297 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCc-ccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence            4678889999999999999999875 889999998754 33467899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 040845          605 MPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS  683 (824)
Q Consensus       605 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  683 (824)
                      +++|+|.+++.... ..+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++...... .
T Consensus       298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~  373 (495)
T 1opk_A          298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT-Y  373 (495)
T ss_dssp             CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC-E
T ss_pred             cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceeccCCc-e
Confidence            99999999998643 56899999999999999999999   9999999999999999999999999999998764322 2


Q ss_pred             cccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhccccccCc
Q 040845          684 MTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ  762 (824)
Q Consensus       684 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  762 (824)
                      .......++..|+|||.+....++.++|||||||++|||+| |..||......+  ....+...                
T Consensus       374 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~--~~~~~~~~----------------  435 (495)
T 1opk_A          374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYELLEKD----------------  435 (495)
T ss_dssp             ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--HHHHHHTT----------------
T ss_pred             eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcC----------------
Confidence            22334456789999999988899999999999999999999 888987632211  11111110                


Q ss_pred             hhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 040845          763 EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIR  806 (824)
Q Consensus       763 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~  806 (824)
                        .+...+..++..+.++|.+||+.||++|||+.|+++.|+++.
T Consensus       436 --~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~  477 (495)
T 1opk_A          436 --YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  477 (495)
T ss_dssp             --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             --CCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence              111123356778999999999999999999999999998764

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=6.3e-40  Score=346.90  Aligned_cols=263  Identities=26%  Similarity=0.446  Sum_probs=208.0

Q ss_pred             hccCCCCceeeeccceEEEEEEECC----CcEEEEEEeecccc-chhhhHHHHHHHHhcCCCCcceeEEeee-ecCCeeE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIRD----GMEVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVKVISSC-SNEEFKA  599 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~  599 (824)
                      ..+|++.+.||+|+||.||+|++.+    +..||+|.+..... ...+.+.+|+.++++++||||+++++++ ..+...+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            3568888999999999999998643    23689998865432 3456788999999999999999999986 4566889


Q ss_pred             EEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCC
Q 040845          600 LVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG  679 (824)
Q Consensus       600 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  679 (824)
                      +||||+++|+|.+++......+++.+++.++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||++.....
T Consensus       104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~  180 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  180 (298)
T ss_dssp             EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred             EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence            999999999999999876667899999999999999999999   99999999999999999999999999999987643


Q ss_pred             CCC--ccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCC-CCcccccCcchhhhhhhhhCCCcchhhcc
Q 040845          680 EDQ--SMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKK-PTDELFNGEMTLKHWVNDCLPISTMEVVD  756 (824)
Q Consensus       680 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  756 (824)
                      ...  ........+|+.|+|||.+.+..++.++||||+|+++|||++|+. ||......+ .........          
T Consensus       181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~-~~~~~~~~~----------  249 (298)
T 3f66_A          181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-ITVYLLQGR----------  249 (298)
T ss_dssp             GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT-HHHHHHTTC----------
T ss_pred             cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH-HHHHHhcCC----------
Confidence            321  122334567889999999988899999999999999999999554 544322111 111111110          


Q ss_pred             ccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhcc
Q 040845          757 ANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLR  811 (824)
Q Consensus       757 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~  811 (824)
                               ....+..++..+.+++.+||+.||++|||+.|+++.|+++.+++..
T Consensus       250 ---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~  295 (298)
T 3f66_A          250 ---------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG  295 (298)
T ss_dssp             ---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred             ---------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence                     0011123456789999999999999999999999999999876654

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=5e-40  Score=350.41  Aligned_cols=269  Identities=25%  Similarity=0.345  Sum_probs=192.6

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc-chhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEe
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLE  603 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  603 (824)
                      .++|++.+.||+|+||.||+|..+ +|+.||||+++.... ...+.+.+|++++++++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            468999999999999999999865 589999999875532 334678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhhCC-----CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccC
Q 040845          604 YMPHGSLEKYLHSSN-----YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT  678 (824)
Q Consensus       604 ~~~~g~L~~~l~~~~-----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~  678 (824)
                      |++ |+|.+++....     ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++....
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            997 59999986532     35889999999999999999999   9999999999999999999999999999998764


Q ss_pred             CCCCccccccccccccccCccCcCCC-CCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCC--Ccch-hh
Q 040845          679 GEDQSMTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLP--ISTM-EV  754 (824)
Q Consensus       679 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~--~~~~-~~  754 (824)
                      ....  ......+|+.|+|||++.+. .++.++||||+||++|||++|+.||......+ ...........  .... ..
T Consensus       160 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~  236 (317)
T 2pmi_A          160 IPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE-QLKLIFDIMGTPNESLWPSV  236 (317)
T ss_dssp             SCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCSCCTTTCGGG
T ss_pred             CCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCChhHhhhh
Confidence            3221  22345689999999998764 68999999999999999999999997632211 11111111110  0000 00


Q ss_pred             -----ccccccCc------hhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          755 -----VDANLLSQ------EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       755 -----~~~~~~~~------~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                           ..+.....      .......+..++..+.+++.+||+.||++|||++|++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h  294 (317)
T 2pmi_A          237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH  294 (317)
T ss_dssp             GGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence                 00000000      000111112456779999999999999999999999875

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.7e-40  Score=344.89  Aligned_cols=250  Identities=23%  Similarity=0.401  Sum_probs=187.0

Q ss_pred             hccCCCCceeeeccceEEEEEEE-CCCcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARI-RDGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALV  601 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  601 (824)
                      .++|++.+.||+|+||.||+|+. .+|+.||||++....   ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            46799999999999999999986 468999999986542   22346788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 040845          602 LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED  681 (824)
Q Consensus       602 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  681 (824)
                      |||+++++|.+++......+++.+++.++.|+++|++|||   +.+|+||||||+||+++.++.+||+|||.+.......
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~  166 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH  166 (278)
T ss_dssp             EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred             EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence            9999999999999877667999999999999999999999   8999999999999999999999999999998764222


Q ss_pred             CccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccC
Q 040845          682 QSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLS  761 (824)
Q Consensus       682 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  761 (824)
                      .  ......+|+.|+|||.+.+..++.++||||+|+++|||++|+.||......+. ....    .        ...   
T Consensus       167 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~----~--------~~~---  228 (278)
T 3cok_A          167 E--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-LNKV----V--------LAD---  228 (278)
T ss_dssp             ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------C----C--------SSC---
T ss_pred             C--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-HHHH----h--------hcc---
Confidence            1  12234689999999999988899999999999999999999999875322110 0000    0        000   


Q ss_pred             chhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          762 QEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       762 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                           ...+..++..+.+++.+||+.||++|||+.|++++
T Consensus       229 -----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  263 (278)
T 3cok_A          229 -----YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH  263 (278)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             -----cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence                 00112345678999999999999999999999874

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.7e-40  Score=351.22  Aligned_cols=250  Identities=26%  Similarity=0.351  Sum_probs=197.4

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc--------------------------chhhhHHHHHHHHh
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG--------------------------RAFKSFDVECAMMK  578 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~  578 (824)
                      .++|++.+.||+|+||.||+|+.. +++.||||++.....                          ...+.+.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            468999999999999999999865 589999999865421                          12356889999999


Q ss_pred             cCCCCcceeEEeeeec--CCeeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCC
Q 040845          579 SIRHRNLVKVISSCSN--EEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPS  656 (824)
Q Consensus       579 ~l~h~niv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~  656 (824)
                      +++||||+++++++.+  ....++||||+++++|.+++..  ..+++.++..++.|+++||+|||   +.+|+||||||+
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~  166 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--KPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPS  166 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGG
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHH
Confidence            9999999999999986  5688999999999999887643  36899999999999999999999   899999999999


Q ss_pred             CeeeCCCCcEEEeecccccccCCCCCccccccccccccccCccCcCCCC---CCccchHHHHHHHHHHHHhCCCCCcccc
Q 040845          657 NVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQ---VSTNGDVYSFGIMLMETFTRKKPTDELF  733 (824)
Q Consensus       657 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~DvwslG~~l~el~tg~~p~~~~~  733 (824)
                      ||+++.++.+||+|||++........  ......||+.|+|||.+.+..   ++.++||||+||++|||++|+.||....
T Consensus       167 Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  244 (298)
T 2zv2_A          167 NLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER  244 (298)
T ss_dssp             GEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             HEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence            99999999999999999987643322  223456999999999987655   4788999999999999999999997532


Q ss_pred             cCcchhhhhhhhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          734 NGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       734 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      .  ......+....            ..     ......++..+.+++.+||+.||++|||+.|++++
T Consensus       245 ~--~~~~~~~~~~~------------~~-----~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h  293 (298)
T 2zv2_A          245 I--MCLHSKIKSQA------------LE-----FPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH  293 (298)
T ss_dssp             H--HHHHHHHHHCC------------CC-----CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred             H--HHHHHHHhccc------------CC-----CCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence            1  11111111000            00     00012345678999999999999999999999865

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=2.2e-40  Score=356.71  Aligned_cols=249  Identities=20%  Similarity=0.260  Sum_probs=205.3

Q ss_pred             hccCCCCceeeeccceEEEEEEECC-CcEEEEEEeeccc---cchhhhHHHHHHHHhcC-CCCcceeEEeeeecCCeeEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQC---GRAFKSFDVECAMMKSI-RHRNLVKVISSCSNEEFKAL  600 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  600 (824)
                      .++|++.+.||+|+||.||+|+.+. |+.||||+++...   ....+.+..|..++..+ +||+|+++++++.+.+..|+
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   98 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   98 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence            5789999999999999999998764 7899999997542   23456778899999988 79999999999999999999


Q ss_pred             EEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 040845          601 VLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE  680 (824)
Q Consensus       601 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  680 (824)
                      ||||+++|+|.+++...+ .+++.+++.++.|++.||+|||   +.+|+||||||+||+++.+|.+||+|||+|+.....
T Consensus        99 v~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  174 (353)
T 2i0e_A           99 VMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD  174 (353)
T ss_dssp             EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence            999999999999998755 6899999999999999999999   999999999999999999999999999999854322


Q ss_pred             CCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhcccccc
Q 040845          681 DQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLL  760 (824)
Q Consensus       681 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  760 (824)
                      .  .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+.....             
T Consensus       175 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-~~~~~i~~~~~-------------  238 (353)
T 2i0e_A          175 G--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-ELFQSIMEHNV-------------  238 (353)
T ss_dssp             T--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHCCC-------------
T ss_pred             C--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH-HHHHHHHhCCC-------------
Confidence            1  1233456999999999999999999999999999999999999999753211 11111111000             


Q ss_pred             CchhhhhhhHHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 040845          761 SQEDIHFVAKEQCVSFVFNLALECTVESPEQRIN-----AKEIVAK  801 (824)
Q Consensus       761 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt-----~~evl~~  801 (824)
                             ..+..++..+.+++.+||..||++||+     ++|+++|
T Consensus       239 -------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h  277 (353)
T 2i0e_A          239 -------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  277 (353)
T ss_dssp             -------CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred             -------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence                   011234567899999999999999995     5777765

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.5e-40  Score=350.03  Aligned_cols=253  Identities=24%  Similarity=0.366  Sum_probs=206.3

Q ss_pred             hccCCCCceeeeccceEEEEEEECC-C-------cEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCe
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIRD-G-------MEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEF  597 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  597 (824)
                      .++|.+.+.||+|+||.||+|+... +       ..||+|++........+.+.+|+.+++.++||||+++++++.+++.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            4678999999999999999997653 3       5799999977666667889999999999999999999999999999


Q ss_pred             eEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCc--------EEEe
Q 040845          598 KALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMV--------AHLS  669 (824)
Q Consensus       598 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~--------~kl~  669 (824)
                      .++||||+++|+|.+++......+++..++.++.|+++||+|||   +.+|+||||||+||+++.++.        +||+
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~  163 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLS  163 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred             CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccceeeec
Confidence            99999999999999999887656899999999999999999999   999999999999999998887        9999


Q ss_pred             ecccccccCCCCCccccccccccccccCccCcCC-CCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCC
Q 040845          670 DFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLP  748 (824)
Q Consensus       670 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  748 (824)
                      |||.+.....      .....+++.|+|||.+.+ ..++.++||||+|+++|||++|+.|+........... .......
T Consensus       164 Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~-~~~~~~~  236 (289)
T 4fvq_A          164 DPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQ-FYEDRHQ  236 (289)
T ss_dssp             CCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH-HHHTTCC
T ss_pred             cCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHH-HhhccCC
Confidence            9999875421      123457889999999887 6789999999999999999997665543222111111 1111000


Q ss_pred             CcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 040845          749 ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDS  808 (824)
Q Consensus       749 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~  808 (824)
                                          .+..++..+.+++.+||+.||++|||+.|++++|+++..+
T Consensus       237 --------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p  276 (289)
T 4fvq_A          237 --------------------LPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP  276 (289)
T ss_dssp             --------------------CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred             --------------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence                                0011234578899999999999999999999999988653

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.3e-40  Score=355.94  Aligned_cols=253  Identities=23%  Similarity=0.383  Sum_probs=199.0

Q ss_pred             hccCCCCceeeeccceEEEEEEECCCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCC--CcceeEEeeeecCCeeEEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRH--RNLVKVISSCSNEEFKALV  601 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv  601 (824)
                      .++|++.+.||+|+||.||+|...+++.||||++....  ....+.+.+|+.+++.++|  +||+++++++.++...++|
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            35799999999999999999998889999999987543  2334678899999999986  9999999999999999999


Q ss_pred             EeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 040845          602 LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED  681 (824)
Q Consensus       602 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  681 (824)
                      ||+ .+++|.+++.... .+++.++..++.|++.||+|||   +.+|+||||||+||+++ ++.+||+|||++.......
T Consensus        88 ~e~-~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~  161 (343)
T 3dbq_A           88 MEC-GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  161 (343)
T ss_dssp             ECC-CSEEHHHHHHHSC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred             EeC-CCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence            995 5789999998765 7899999999999999999999   89999999999999997 6789999999998765444


Q ss_pred             CccccccccccccccCccCcCC-----------CCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCc
Q 040845          682 QSMTQTQTLATIGYMAPEYGRE-----------GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPIS  750 (824)
Q Consensus       682 ~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  750 (824)
                      .........||+.|+|||++.+           ..++.++|||||||++|||++|+.||.............+...... 
T Consensus       162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-  240 (343)
T 3dbq_A          162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI-  240 (343)
T ss_dssp             --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCC-
T ss_pred             ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCccc-
Confidence            3333445679999999998754           6789999999999999999999999976332211111111110000 


Q ss_pred             chhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 040845          751 TMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL  802 (824)
Q Consensus       751 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L  802 (824)
                                       ..+..++..+.+++.+||+.||++|||+.|++++-
T Consensus       241 -----------------~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp  275 (343)
T 3dbq_A          241 -----------------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  275 (343)
T ss_dssp             -----------------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             -----------------CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence                             00112245688999999999999999999999874

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=2.3e-40  Score=354.33  Aligned_cols=249  Identities=23%  Similarity=0.312  Sum_probs=196.2

Q ss_pred             hccCCCCceeeeccceEEEEEEE----CCCcEEEEEEeeccc----cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCe
Q 040845          526 TDKFSENNLIGRGGFGSVYKARI----RDGMEVAVKVFNLQC----GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEF  597 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  597 (824)
                      .++|++.+.||+|+||.||+|+.    .+|+.||+|+++...    ......+.+|+.+++.++||||+++++++...+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            46899999999999999999986    468999999987542    2334567889999999999999999999999999


Q ss_pred             eEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccccc
Q 040845          598 KALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  677 (824)
Q Consensus       598 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~  677 (824)
                      .++||||+++++|.+++...+ .+++.++..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++..
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~  171 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLEREG-IFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES  171 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred             EEEEEeCCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence            999999999999999998655 6889999999999999999999   899999999999999999999999999999754


Q ss_pred             CCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccc
Q 040845          678 TGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDA  757 (824)
Q Consensus       678 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  757 (824)
                      ....  .......||+.|+|||++.+..++.++||||+||++|||++|+.||......+ ..........          
T Consensus       172 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~----------  238 (327)
T 3a62_A          172 IHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK-TIDKILKCKL----------  238 (327)
T ss_dssp             ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHTCC----------
T ss_pred             ccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhCCC----------
Confidence            3221  12234568999999999998899999999999999999999999997632111 1111111100          


Q ss_pred             cccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 040845          758 NLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRI-----NAKEIVAK  801 (824)
Q Consensus       758 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~evl~~  801 (824)
                                ..+..++..+.+++.+||..||++||     ++.|+++|
T Consensus       239 ----------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h  277 (327)
T 3a62_A          239 ----------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH  277 (327)
T ss_dssp             ----------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred             ----------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence                      01123456789999999999999999     78888775

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=3.9e-40  Score=355.65  Aligned_cols=252  Identities=21%  Similarity=0.294  Sum_probs=192.4

Q ss_pred             hhccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEe
Q 040845          525 ATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLE  603 (824)
Q Consensus       525 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  603 (824)
                      ..++|++.+.||+|+||.||+|+.. +++.||||+++...  ..+.+.+|++++++++||||+++++++.+....++|||
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  128 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE  128 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence            3567999999999999999999876 47899999987542  34668889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC---CCcEEEeecccccccCCC
Q 040845          604 YMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD---NMVAHLSDFGIAKLLTGE  680 (824)
Q Consensus       604 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~Dfg~a~~~~~~  680 (824)
                      |+++|+|.+++.... .+++.+++.++.|++.||+|||   +.+|+||||||+||+++.   ++.+||+|||+++.....
T Consensus       129 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~  204 (349)
T 2w4o_A          129 LVTGGELFDRIVEKG-YYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ  204 (349)
T ss_dssp             CCCSCBHHHHHTTCS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred             eCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence            999999999997655 6899999999999999999999   899999999999999975   899999999999865422


Q ss_pred             CCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhcccccc
Q 040845          681 DQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLL  760 (824)
Q Consensus       681 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  760 (824)
                      .   ......||+.|+|||++.+..++.++|||||||++|||++|+.||............+.......     .     
T Consensus       205 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~-----~-----  271 (349)
T 2w4o_A          205 V---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYF-----I-----  271 (349)
T ss_dssp             -----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCC-----C-----
T ss_pred             c---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCcc-----C-----
Confidence            1   22345689999999999998999999999999999999999999976332221222221111100     0     


Q ss_pred             CchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          761 SQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       761 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                            ......++..+.+++.+||..||++|||+.|++++
T Consensus       272 ------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  306 (349)
T 2w4o_A          272 ------SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH  306 (349)
T ss_dssp             ------TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ------CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                  00112345678999999999999999999999874

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=3.6e-40  Score=351.33  Aligned_cols=263  Identities=25%  Similarity=0.430  Sum_probs=200.9

Q ss_pred             hhccCCCCceeeeccceEEEEEEEC----CCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeecCC--
Q 040845          525 ATDKFSENNLIGRGGFGSVYKARIR----DGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEE--  596 (824)
Q Consensus       525 ~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--  596 (824)
                      ..++|.+.+.||+|+||.||+|++.    ++..||||+++...  ....+.+.+|+.++++++||||+++++++.+..  
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  111 (313)
T 3brb_A           32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ  111 (313)
T ss_dssp             CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred             CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence            3577899999999999999999754    24589999987543  234567889999999999999999999997654  


Q ss_pred             ---eeEEEEeccCCCCHHHHhhh-----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEE
Q 040845          597 ---FKALVLEYMPHGSLEKYLHS-----SNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHL  668 (824)
Q Consensus       597 ---~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl  668 (824)
                         ..++||||+++|+|.+++..     ....+++.+++.++.|+++||+|||   +.+|+||||||+||+++.++.+||
T Consensus       112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kl  188 (313)
T 3brb_A          112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTVCV  188 (313)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTSCEEE
T ss_pred             CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEE
Confidence               45899999999999999853     2356899999999999999999999   999999999999999999999999


Q ss_pred             eecccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhC
Q 040845          669 SDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCL  747 (824)
Q Consensus       669 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~  747 (824)
                      +|||++................+++.|+|||.+.+..++.++||||||+++|||++ |..||......+  ....+....
T Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~~~~~~~  266 (313)
T 3brb_A          189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE--MYDYLLHGH  266 (313)
T ss_dssp             CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--HHHHHHTTC
T ss_pred             eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH--HHHHHHcCC
Confidence            99999987654433333344557889999999998899999999999999999999 888886532221  111111000


Q ss_pred             CCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhc
Q 040845          748 PISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLL  810 (824)
Q Consensus       748 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~  810 (824)
                                        ....+..++..+.+++.+||..||++|||+.+++++|+++.+++.
T Consensus       267 ------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp  311 (313)
T 3brb_A          267 ------------------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP  311 (313)
T ss_dssp             ------------------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred             ------------------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence                              001122456679999999999999999999999999999987654

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=3.1e-40  Score=352.83  Aligned_cols=249  Identities=20%  Similarity=0.273  Sum_probs=182.6

Q ss_pred             CceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcCC-CCcceeEEeeeecCCeeEEEEeccCCCC
Q 040845          532 NNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIR-HRNLVKVISSCSNEEFKALVLEYMPHGS  609 (824)
Q Consensus       532 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~  609 (824)
                      .+.||+|+||.||+|..+ +++.||||++...   ....+.+|+.+++.++ ||||+++++++.++...++||||+++|+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            478999999999999875 5899999998643   3466788999999997 9999999999999999999999999999


Q ss_pred             HHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC---cEEEeecccccccCCCCCcccc
Q 040845          610 LEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM---VAHLSDFGIAKLLTGEDQSMTQ  686 (824)
Q Consensus       610 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~---~~kl~Dfg~a~~~~~~~~~~~~  686 (824)
                      |.+++.... .+++.++..++.|++.||+|||   +.+|+||||||+||+++.++   .+||+|||++.......  ...
T Consensus        93 L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~~~  166 (325)
T 3kn6_A           93 LFERIKKKK-HFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--QPL  166 (325)
T ss_dssp             HHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------
T ss_pred             HHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC--Ccc
Confidence            999998765 7899999999999999999999   99999999999999997665   89999999998654322  222


Q ss_pred             ccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCc--chhhhhhhhhCCCcchhhccccccCchh
Q 040845          687 TQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGE--MTLKHWVNDCLPISTMEVVDANLLSQED  764 (824)
Q Consensus       687 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~  764 (824)
                      ....+|+.|+|||++.+..++.++||||+||++|||++|+.||.......  ...........            .....
T Consensus       167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~------------~~~~~  234 (325)
T 3kn6_A          167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIK------------KGDFS  234 (325)
T ss_dssp             -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHT------------TTCCC
T ss_pred             cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHH------------cCCCC
Confidence            34568999999999999999999999999999999999999997633211  01111111110            00001


Q ss_pred             hhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          765 IHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       765 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      ........++..+.+++.+||..||++|||++|++++
T Consensus       235 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  271 (325)
T 3kn6_A          235 FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN  271 (325)
T ss_dssp             CCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred             CCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence            1111223467789999999999999999999998754

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=9.7e-40  Score=341.51  Aligned_cols=251  Identities=23%  Similarity=0.285  Sum_probs=207.8

Q ss_pred             hccCCCCceeeeccceEEEEEEECC-CcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEec
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      .++|++.+.||+|+||.||+|.... +..||+|++........+.+.+|+++++.++||||+++++++.+....++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL   87 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence            4679999999999999999998764 779999999876666678899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee---CCCCcEEEeecccccccCCCC
Q 040845          605 MPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTGED  681 (824)
Q Consensus       605 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill---~~~~~~kl~Dfg~a~~~~~~~  681 (824)
                      +++++|.+++.... .+++.++..++.|++.|++|||   +.+|+||||||+||++   +.++.+||+|||++.......
T Consensus        88 ~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~  163 (277)
T 3f3z_A           88 CTGGELFERVVHKR-VFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK  163 (277)
T ss_dssp             CCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred             cCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence            99999999987755 6899999999999999999999   9999999999999999   788999999999998764332


Q ss_pred             CccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccC
Q 040845          682 QSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLS  761 (824)
Q Consensus       682 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  761 (824)
                         ......+|+.|+|||.+.+ .++.++||||+|+++|||++|+.||......+ ....+......             
T Consensus       164 ---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~-------------  225 (277)
T 3f3z_A          164 ---MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSE-VMLKIREGTFT-------------  225 (277)
T ss_dssp             ---CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCCC-------------
T ss_pred             ---chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhCCCC-------------
Confidence               2234568999999998865 48999999999999999999999997632211 11111111000             


Q ss_pred             chhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          762 QEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       762 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                         ........++..+.+++.+||+.||++|||+.|++++
T Consensus       226 ---~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  262 (277)
T 3f3z_A          226 ---FPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH  262 (277)
T ss_dssp             ---CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             ---CCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               0001112456778999999999999999999999875

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.3e-40  Score=354.71  Aligned_cols=272  Identities=26%  Similarity=0.440  Sum_probs=215.9

Q ss_pred             hccCCCCceeeeccceEEEEEEE-----CCCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCC--ee
Q 040845          526 TDKFSENNLIGRGGFGSVYKARI-----RDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEE--FK  598 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~  598 (824)
                      .++|++.+.||+|+||.||+|++     .+++.||||++........+.+.+|++++++++||||+++++++...+  ..
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            35688999999999999999984     358999999997765666778999999999999999999999986643  78


Q ss_pred             EEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccC
Q 040845          599 ALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT  678 (824)
Q Consensus       599 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~  678 (824)
                      ++||||+++++|.+++......+++.+++.++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||++....
T Consensus       120 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~  196 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP  196 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence            9999999999999999887667999999999999999999999   8999999999999999999999999999998765


Q ss_pred             CCCCcc-ccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCc-----ch
Q 040845          679 GEDQSM-TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPIS-----TM  752 (824)
Q Consensus       679 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-----~~  752 (824)
                      ...... ......++..|+|||.+.+..++.++||||+|+++|||+||..||......   ............     ..
T Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  273 (326)
T 2w1i_A          197 QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE---FMRMIGNDKQGQMIVFHLI  273 (326)
T ss_dssp             SSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH---HHHHHCTTCCTHHHHHHHH
T ss_pred             ccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH---HHHhhccccchhhhHHHHH
Confidence            433221 123345778899999998888999999999999999999999987642110   000000000000     00


Q ss_pred             hhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhh
Q 040845          753 EVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSL  809 (824)
Q Consensus       753 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~  809 (824)
                      +.+...      .....+..++..+.+++.+||..||++|||+.|+++.|+++++++
T Consensus       274 ~~~~~~------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l  324 (326)
T 2w1i_A          274 ELLKNN------GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM  324 (326)
T ss_dssp             HHHHTT------CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHhhcC------CCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence            000000      011123356778999999999999999999999999999998765

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2.6e-40  Score=358.57  Aligned_cols=253  Identities=23%  Similarity=0.287  Sum_probs=196.2

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEec
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      .++|++.+.||+|+||+||+|+.. +++.||||++.... ...+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            468999999999999999999876 68999999987542 3346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCc--EEEeecccccccCCCCC
Q 040845          605 MPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMV--AHLSDFGIAKLLTGEDQ  682 (824)
Q Consensus       605 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~--~kl~Dfg~a~~~~~~~~  682 (824)
                      +++|+|.+++...+ .+++.+++.++.|++.||+|||   +.+|+||||||+||+++.++.  +||+|||+++.....  
T Consensus        98 ~~~~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~--  171 (361)
T 3uc3_A           98 ASGGELYERICNAG-RFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--  171 (361)
T ss_dssp             CCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred             CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc--
Confidence            99999999997655 6899999999999999999999   999999999999999987765  999999999743222  


Q ss_pred             ccccccccccccccCccCcCCCCCCcc-chHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccC
Q 040845          683 SMTQTQTLATIGYMAPEYGREGQVSTN-GDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLS  761 (824)
Q Consensus       683 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  761 (824)
                       .......||+.|+|||++.+..++.+ +||||+||++|||++|+.||........ ............        .  
T Consensus       172 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-~~~~~~~~~~~~--------~--  239 (361)
T 3uc3_A          172 -SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD-YRKTIQRILSVK--------Y--  239 (361)
T ss_dssp             ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC-HHHHHHHHHTTC--------C--
T ss_pred             -CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH-HHHHHHHHhcCC--------C--
Confidence             12234569999999999988777655 8999999999999999999976433221 111111111100        0  


Q ss_pred             chhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          762 QEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       762 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                          .......++..+.+++.+||+.||++|||+.|+++|
T Consensus       240 ----~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          240 ----SIPDDIRISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             ----CCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             ----CCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence                000111245678899999999999999999999987

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=3.8e-40  Score=344.99  Aligned_cols=248  Identities=25%  Similarity=0.366  Sum_probs=203.2

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALV  601 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  601 (824)
                      .++|++.+.||+|+||.||+|... ++..||||++....   ......+.+|+.+++.++||||+++++++.+....++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            578999999999999999999865 47799999986542   22346688999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 040845          602 LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED  681 (824)
Q Consensus       602 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  681 (824)
                      |||+++++|.+++.... .+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||++...... 
T Consensus        88 ~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~-  162 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-  162 (279)
T ss_dssp             ECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred             EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCCcc-
Confidence            99999999999998765 6899999999999999999999   999999999999999999999999999998654322 


Q ss_pred             CccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccC
Q 040845          682 QSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLS  761 (824)
Q Consensus       682 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  761 (824)
                         ......+++.|+|||.+.+..++.++||||+|+++|||++|+.||......+ ........                
T Consensus       163 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~----------------  222 (279)
T 3fdn_A          163 ---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-TYKRISRV----------------  222 (279)
T ss_dssp             --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHT----------------
T ss_pred             ---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH-HHHHHHhC----------------
Confidence               2234568999999999999899999999999999999999999987532111 00110000                


Q ss_pred             chhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 040845          762 QEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL  802 (824)
Q Consensus       762 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L  802 (824)
                          ....+..++..+.+++.+||+.||++|||+.|++++-
T Consensus       223 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~  259 (279)
T 3fdn_A          223 ----EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHP  259 (279)
T ss_dssp             ----CCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred             ----CCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence                0001123456688999999999999999999999874

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.3e-40  Score=357.99  Aligned_cols=265  Identities=23%  Similarity=0.377  Sum_probs=215.6

Q ss_pred             hhccCCCCceeeeccceEEEEEEECC------CcEEEEEEeecccc-chhhhHHHHHHHHhcC-CCCcceeEEeeeecCC
Q 040845          525 ATDKFSENNLIGRGGFGSVYKARIRD------GMEVAVKVFNLQCG-RAFKSFDVECAMMKSI-RHRNLVKVISSCSNEE  596 (824)
Q Consensus       525 ~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  596 (824)
                      ..++|++.+.||+|+||.||+|.+..      +..||+|.+..... ...+.+.+|+.+++.+ +||||+++++++.+.+
T Consensus        44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  123 (333)
T 2i1m_A           44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG  123 (333)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence            35789999999999999999998653      24799999875432 3456788999999999 8999999999999999


Q ss_pred             eeEEEEeccCCCCHHHHhhhC-------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCC
Q 040845          597 FKALVLEYMPHGSLEKYLHSS-------------NYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDN  663 (824)
Q Consensus       597 ~~~lv~e~~~~g~L~~~l~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~  663 (824)
                      ..++||||+++|+|.+++...             ...+++..++.++.|++.||+|||   +.+|+||||||+||+++.+
T Consensus       124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~  200 (333)
T 2i1m_A          124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNG  200 (333)
T ss_dssp             SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCEEEGG
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEEECCC
Confidence            999999999999999998753             235789999999999999999999   8999999999999999999


Q ss_pred             CcEEEeecccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhh
Q 040845          664 MVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHW  742 (824)
Q Consensus       664 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~  742 (824)
                      +.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||+| |..||....... .....
T Consensus       201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-~~~~~  279 (333)
T 2i1m_A          201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS-KFYKL  279 (333)
T ss_dssp             GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH-HHHHH
T ss_pred             CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH-HHHHH
Confidence            9999999999987654443333344567889999999988899999999999999999999 888987643221 11111


Q ss_pred             hhhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhcc
Q 040845          743 VNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLR  811 (824)
Q Consensus       743 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~  811 (824)
                      +.....                  ...+..++..+.+++.+||+.||++|||+.|++++|+++.....+
T Consensus       280 ~~~~~~------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~  330 (333)
T 2i1m_A          280 VKDGYQ------------------MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDRR  330 (333)
T ss_dssp             HHHTCC------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred             HhcCCC------------------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhhhc
Confidence            111110                  001123456789999999999999999999999999998776544

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=3.7e-40  Score=345.40  Aligned_cols=258  Identities=25%  Similarity=0.416  Sum_probs=207.6

Q ss_pred             hccCCCCceeeeccceEEEEEEECC----CcEEEEEEeeccc-cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIRD----GMEVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKAL  600 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  600 (824)
                      .++|.+.+.||+|+||.||+|++.+    +..||||.+.... ....+.+.+|+.+++.++||||+++++++.++ ..++
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~   89 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWI   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEE
Confidence            4688999999999999999998643    3469999987553 23457788999999999999999999998754 5689


Q ss_pred             EEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 040845          601 VLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE  680 (824)
Q Consensus       601 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  680 (824)
                      ||||+++++|.+++......+++..+..++.|+++|++|||   +.+|+||||||+||+++.++.+||+|||++......
T Consensus        90 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  166 (281)
T 3cc6_A           90 IMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE  166 (281)
T ss_dssp             EEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC---
T ss_pred             EEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCcccccc
Confidence            99999999999999877667999999999999999999999   999999999999999999999999999999876433


Q ss_pred             CCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhccccc
Q 040845          681 DQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANL  759 (824)
Q Consensus       681 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  759 (824)
                      .. .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+  ....+.....           
T Consensus       167 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~--~~~~~~~~~~-----------  232 (281)
T 3cc6_A          167 DY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD--VIGVLEKGDR-----------  232 (281)
T ss_dssp             -------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG--HHHHHHHTCC-----------
T ss_pred             cc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH--HHHHHhcCCC-----------
Confidence            22 22233457889999999988889999999999999999998 999987532221  1111111000           


Q ss_pred             cCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 040845          760 LSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDS  808 (824)
Q Consensus       760 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~  808 (824)
                             ...+..++..+.+++.+||..||++|||+.|++++|+++.+.
T Consensus       233 -------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~  274 (281)
T 3cc6_A          233 -------LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM  274 (281)
T ss_dssp             -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -------CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence                   011123456789999999999999999999999999998764

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1e-39  Score=341.23  Aligned_cols=255  Identities=24%  Similarity=0.344  Sum_probs=210.7

Q ss_pred             hhccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc-cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEE
Q 040845          525 ATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVL  602 (824)
Q Consensus       525 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  602 (824)
                      ..++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence            3468999999999999999999875 68999999987543 334577889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 040845          603 EYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ  682 (824)
Q Consensus       603 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  682 (824)
                      ||+++++|.+++.... .+++.++..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||.+........
T Consensus        85 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  160 (276)
T 2yex_A           85 EYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  160 (276)
T ss_dssp             ECCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             EecCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence            9999999999987654 6899999999999999999999   89999999999999999999999999999987643332


Q ss_pred             ccccccccccccccCccCcCCCCC-CccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccC
Q 040845          683 SMTQTQTLATIGYMAPEYGREGQV-STNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLS  761 (824)
Q Consensus       683 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  761 (824)
                      ........|++.|+|||.+.+..+ +.++||||+|+++|||++|+.||............|......             
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------------  227 (276)
T 2yex_A          161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY-------------  227 (276)
T ss_dssp             ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTT-------------
T ss_pred             hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccc-------------
Confidence            223344568999999999987665 789999999999999999999997644333333333221100             


Q ss_pred             chhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          762 QEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       762 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                           ......++..+.+++.+||+.||++|||+.|++++
T Consensus       228 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (276)
T 2yex_A          228 -----LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (276)
T ss_dssp             -----STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             -----cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence                 00112345678899999999999999999999875

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=4.5e-41  Score=359.93  Aligned_cols=266  Identities=24%  Similarity=0.425  Sum_probs=214.6

Q ss_pred             HHHHhhccCCCCceeeeccceEEEEEEEC------CCcEEEEEEeecccc-chhhhHHHHHHHHhcCCCCcceeEEeeee
Q 040845          521 ELFQATDKFSENNLIGRGGFGSVYKARIR------DGMEVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVKVISSCS  593 (824)
Q Consensus       521 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~  593 (824)
                      ++....++|++.+.||+|+||.||+|++.      +++.||||.+..... .....+.+|+.+++.++||||+++++++.
T Consensus        19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   98 (322)
T 1p4o_A           19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS   98 (322)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred             hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence            33445688999999999999999999764      367899999875432 33456889999999999999999999999


Q ss_pred             cCCeeEEEEeccCCCCHHHHhhhCC---------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC
Q 040845          594 NEEFKALVLEYMPHGSLEKYLHSSN---------YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM  664 (824)
Q Consensus       594 ~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~  664 (824)
                      +.+..++||||+++|+|.+++...+         ..+++.+++.++.|++.||+|||   +.+|+||||||+||+++.++
T Consensus        99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli~~~~  175 (322)
T 1p4o_A           99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDF  175 (322)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTC
T ss_pred             cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEEcCCC
Confidence            9999999999999999999987532         35689999999999999999999   89999999999999999999


Q ss_pred             cEEEeecccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhh
Q 040845          665 VAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWV  743 (824)
Q Consensus       665 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~  743 (824)
                      .+||+|||++................+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||......  .....+
T Consensus       176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~  253 (322)
T 1p4o_A          176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE--QVLRFV  253 (322)
T ss_dssp             CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH--HHHHHH
T ss_pred             eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH--HHHHHH
Confidence            999999999986644333333344457889999999988889999999999999999999 88888653211  111111


Q ss_pred             hhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhh
Q 040845          744 NDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSL  809 (824)
Q Consensus       744 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~  809 (824)
                      ...           ..       ...+..++..+.+++.+||+.||++|||+.|++++|+++.+..
T Consensus       254 ~~~-----------~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~  301 (322)
T 1p4o_A          254 MEG-----------GL-------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG  301 (322)
T ss_dssp             HTT-----------CC-------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred             HcC-----------Cc-------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccC
Confidence            100           00       0011245667899999999999999999999999998875433

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=4.5e-39  Score=347.56  Aligned_cols=277  Identities=23%  Similarity=0.372  Sum_probs=216.0

Q ss_pred             cHHHHHHhhccCCCCceeeeccceEEEEEEECCCcEEEEEEeeccccchhhhHHHHHHHHhc--CCCCcceeEEeeeecC
Q 040845          518 SYLELFQATDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKS--IRHRNLVKVISSCSNE  595 (824)
Q Consensus       518 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~  595 (824)
                      ++..-....++|++.+.||+|+||.||+|++. |+.||||++...   ....+.+|+++++.  ++||||+++++++...
T Consensus        33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~  108 (342)
T 1b6c_B           33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKD  108 (342)
T ss_dssp             CHHHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred             ceeecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence            33444556689999999999999999999985 899999998643   34567788888887  7899999999999877


Q ss_pred             C----eeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCC-----CCCeEecCCCCCCeeeCCCCcE
Q 040845          596 E----FKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGY-----SAPVIHCDLKPSNVLLDDNMVA  666 (824)
Q Consensus       596 ~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-----~~~ivH~Dlk~~Nill~~~~~~  666 (824)
                      .    ..++||||+++|+|.+++...  .+++.+++.++.|++.|++|||...     +.+|+||||||+||+++.++.+
T Consensus       109 ~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~  186 (342)
T 1b6c_B          109 NGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC  186 (342)
T ss_dssp             CSSCCCEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCE
T ss_pred             CCccceeEEEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCE
Confidence            5    789999999999999999764  5899999999999999999999321     4789999999999999999999


Q ss_pred             EEeecccccccCCCCCcc--ccccccccccccCccCcCCC------CCCccchHHHHHHHHHHHHhC----------CCC
Q 040845          667 HLSDFGIAKLLTGEDQSM--TQTQTLATIGYMAPEYGREG------QVSTNGDVYSFGIMLMETFTR----------KKP  728 (824)
Q Consensus       667 kl~Dfg~a~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~------~~~~~~DvwslG~~l~el~tg----------~~p  728 (824)
                      ||+|||++..........  ......||+.|+|||.+.+.      .++.++|||||||++|||+||          ..|
T Consensus       187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p  266 (342)
T 1b6c_B          187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP  266 (342)
T ss_dssp             EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred             EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence            999999998765433221  22345689999999998765      234789999999999999999          667


Q ss_pred             CcccccCcchhhhhhhhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 040845          729 TDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDS  808 (824)
Q Consensus       729 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~  808 (824)
                      |......+.....+........         .............++..+.+++.+||+.||++|||+.|++++|+++.++
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~  337 (342)
T 1b6c_B          267 YYDLVPSDPSVEEMRKVVCEQK---------LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  337 (342)
T ss_dssp             TTTTSCSSCCHHHHHHHHTTSC---------CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             ccccCcCcccHHHHHHHHHHHH---------hCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence            7654433333333322211110         0000011112236778899999999999999999999999999999765


Q ss_pred             h
Q 040845          809 L  809 (824)
Q Consensus       809 ~  809 (824)
                      .
T Consensus       338 ~  338 (342)
T 1b6c_B          338 E  338 (342)
T ss_dssp             T
T ss_pred             h
Confidence            3

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.9e-39  Score=365.52  Aligned_cols=347  Identities=21%  Similarity=0.176  Sum_probs=218.0

Q ss_pred             ceeeccCCccccccCccccCCCCCccEEEccCCeeeeecCccccCCCCCceEeccCccccccCCccccCCCCCCEEEccC
Q 040845           72 KAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYD  151 (824)
Q Consensus        72 ~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~  151 (824)
                      +.++.++++++.+|..+    .+++++|+|++|+|++..+..|..+++|++|+|++|.+++..|.+|.++++|++|+|++
T Consensus        14 ~~v~c~~~~l~~ip~~~----~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~   89 (477)
T 2id5_A           14 RAVLCHRKRFVAVPEGI----PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRS   89 (477)
T ss_dssp             TEEECCSCCCSSCCSCC----CTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CEEEeCCCCcCcCCCCC----CCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCC
Confidence            45666666666666543    25778888888888877777888888888888888888877788888888888888888


Q ss_pred             CcCCCCcCcccccccCCCCCCCcEEECcCCCCCccCCccccccccccccEEEeecCcceecCCccCCCCCCCCEEEecCC
Q 040845          152 NNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGN  231 (824)
Q Consensus       152 n~i~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n  231 (824)
                      |+++.++..     .|.++++|++|+|++|.+.++.+..|..  ..+|++|++++|.+.+..+..|.++++|+.|+|++|
T Consensus        90 n~l~~~~~~-----~~~~l~~L~~L~Ls~n~i~~~~~~~~~~--l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n  162 (477)
T 2id5_A           90 NRLKLIPLG-----VFTGLSNLTKLDISENKIVILLDYMFQD--LYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKC  162 (477)
T ss_dssp             SCCCSCCTT-----SSTTCTTCCEEECTTSCCCEECTTTTTT--CTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESC
T ss_pred             CcCCccCcc-----cccCCCCCCEEECCCCccccCChhHccc--cccCCEEECCCCccceeChhhccCCCCCCEEECCCC
Confidence            888776542     3677788888888888776554443322  223444444444444444445555555555555555


Q ss_pred             ccCCccchhhcCCCCCCEEEcccccCcccCCccccccCCccEEEccCccccccCCccccCCCCCcEEEcCCCCCCCCCCc
Q 040845          232 KLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLN  311 (824)
Q Consensus       232 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~  311 (824)
                      ++++..+..|..+++|+.|+|++|.+.+..+..|..+++|+.|++++|...+.                       +|..
T Consensus       163 ~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~-----------------------~~~~  219 (477)
T 2id5_A          163 NLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDT-----------------------MTPN  219 (477)
T ss_dssp             CCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCE-----------------------ECTT
T ss_pred             cCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccc-----------------------cCcc
Confidence            55544444455555555555555555544444444444444444444443333                       3433


Q ss_pred             ccccccccccccccccccCcCCccccccccchhhhcccccccccCCCccCCCCCCCeEEccCccccccCCcccccccccc
Q 040845          312 FWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLK  391 (824)
Q Consensus       312 ~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  391 (824)
                      .....+|+.|++++|.++...+..|.++++|+.|+|++|++++..+..|..+++|+.|+|++|++++..|..|..+++|+
T Consensus       220 ~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~  299 (477)
T 2id5_A          220 CLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLR  299 (477)
T ss_dssp             TTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCC
T ss_pred             cccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCC
Confidence            33344555555555555543334566666777777777777766666677777777777777777766677777777777


Q ss_pred             EEEccCcccCCCCcccccCCcccceeeccCCcccCCCCCCCCccccccccccCCccccCCC
Q 040845          392 SLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIPRGGSFGNFSAESFKGNELLCGSP  452 (824)
Q Consensus       392 ~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~  452 (824)
                      .|+|++|+|++..+..|..+++|+.|++++|+|+|.++....+.......+.++...|.+|
T Consensus       300 ~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~~~~~~~~~~~~~~~~~~~C~~p  360 (477)
T 2id5_A          300 VLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCRLLWVFRRRWRLNFNRQQPTCATP  360 (477)
T ss_dssp             EEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGGGHHHHTTTTSSCCTTCCCBEEES
T ss_pred             EEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccchHhHHhhhhccccCccCceeCCc
Confidence            7777777777655666677777777777777777765432222223334556666677655

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.8e-40  Score=346.67  Aligned_cols=262  Identities=24%  Similarity=0.415  Sum_probs=209.7

Q ss_pred             cCCCCceeeeccceEEEEEEECC----CcEEEEEEeecccc-chhhhHHHHHHHHhcCCCCcceeEEeeeecCCee-EEE
Q 040845          528 KFSENNLIGRGGFGSVYKARIRD----GMEVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFK-ALV  601 (824)
Q Consensus       528 ~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~lv  601 (824)
                      .|...+.||+|+||+||+|++.+    +..||+|.+..... ...+.+.+|+.+++.++||||+++++++.+.+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            45667899999999999998532    23799999865432 3456788999999999999999999999766554 899


Q ss_pred             EeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 040845          602 LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED  681 (824)
Q Consensus       602 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  681 (824)
                      |||+.+|+|.+++......+++.+++.++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||++.......
T Consensus       102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  178 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE  178 (298)
T ss_dssp             ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred             EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence            9999999999999886678899999999999999999999   8999999999999999999999999999998654322


Q ss_pred             C--ccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccc
Q 040845          682 Q--SMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANL  759 (824)
Q Consensus       682 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  759 (824)
                      .  ........+|+.|+|||.+.+..++.++||||+|+++|||++|+.|+....... .....+.....           
T Consensus       179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~-~~~~~~~~~~~-----------  246 (298)
T 3pls_A          179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF-DLTHFLAQGRR-----------  246 (298)
T ss_dssp             GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG-GHHHHHHTTCC-----------
T ss_pred             ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH-HHHHHhhcCCC-----------
Confidence            1  122234557889999999999999999999999999999999766654322221 11111111110           


Q ss_pred             cCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhcc
Q 040845          760 LSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLR  811 (824)
Q Consensus       760 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~  811 (824)
                             ...+..++..+.+++.+||+.||++|||+.|+++.|+++.+++..
T Consensus       247 -------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~  291 (298)
T 3pls_A          247 -------LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG  291 (298)
T ss_dssp             -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred             -------CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence                   011223456789999999999999999999999999999887654

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=4e-40  Score=344.83  Aligned_cols=260  Identities=25%  Similarity=0.428  Sum_probs=211.8

Q ss_pred             hccCCCCceeeeccceEEEEEEECCCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEecc
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYM  605 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  605 (824)
                      .++|++.+.||+|+||.||+|...++..||||++.... ...+.+.+|+++++.++||||+++++++.+ +..++||||+
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~   89 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecC
Confidence            46889999999999999999999888899999987543 345778999999999999999999999874 4578999999


Q ss_pred             CCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 040845          606 PHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM  684 (824)
Q Consensus       606 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  684 (824)
                      ++++|.+++.... ..+++.++..++.|++.|++|||   +.+|+||||||+||++++++.+||+|||.+........ .
T Consensus        90 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~  165 (279)
T 1qpc_A           90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-T  165 (279)
T ss_dssp             TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-E
T ss_pred             CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCccc-c
Confidence            9999999997543 36899999999999999999999   99999999999999999999999999999987653322 2


Q ss_pred             ccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhccccccCch
Q 040845          685 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQE  763 (824)
Q Consensus       685 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  763 (824)
                      ......++..|+|||.+.++.++.++||||+|+++|||++ |+.||......+  ....+....                
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~~~~~~~----------------  227 (279)
T 1qpc_A          166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE--VIQNLERGY----------------  227 (279)
T ss_dssp             CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHHTTC----------------
T ss_pred             cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH--HHHHHhccc----------------
Confidence            2233456789999999988889999999999999999999 899986532211  111111000                


Q ss_pred             hhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhcc
Q 040845          764 DIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLR  811 (824)
Q Consensus       764 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~  811 (824)
                        ....+..++..+.+++.+||..||++|||+.++++.|+++..+...
T Consensus       228 --~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~  273 (279)
T 1qpc_A          228 --RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEG  273 (279)
T ss_dssp             --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred             --CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccC
Confidence              0011124566799999999999999999999999999998776443

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=6.7e-40  Score=348.43  Aligned_cols=245  Identities=22%  Similarity=0.242  Sum_probs=195.6

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc--chhhhHHHHHHHHhcC-CCCcceeEEeeeecCCeeEEEE
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG--RAFKSFDVECAMMKSI-RHRNLVKVISSCSNEEFKALVL  602 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  602 (824)
                      ++|++.+.||+|+||+||+|+.. +|+.||||++.....  ........|+..+.++ +||||+++++++.+.+..++||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            57999999999999999999876 699999999864422  2233344455555554 8999999999999999999999


Q ss_pred             eccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 040845          603 EYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ  682 (824)
Q Consensus       603 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  682 (824)
                      ||+ +++|.+++...+..+++.+++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++....... 
T Consensus       137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~-  211 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG-  211 (311)
T ss_dssp             ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred             ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC-
Confidence            999 67999998877778999999999999999999999   8999999999999999999999999999998754322 


Q ss_pred             ccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCc
Q 040845          683 SMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ  762 (824)
Q Consensus       683 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  762 (824)
                        ......||++|+|||++.+ .++.++|||||||++|||++|..|+...    .....+....                
T Consensus       212 --~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~----~~~~~~~~~~----------------  268 (311)
T 3p1a_A          212 --AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG----EGWQQLRQGY----------------  268 (311)
T ss_dssp             -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH----HHHHHHTTTC----------------
T ss_pred             --CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc----cHHHHHhccC----------------
Confidence              2234458999999998875 7899999999999999999997765431    1111111100                


Q ss_pred             hhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          763 EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       763 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                        .....+..++..+.+++.+||+.||++|||++|++++
T Consensus       269 --~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  305 (311)
T 3p1a_A          269 --LPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL  305 (311)
T ss_dssp             --CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             --CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence              0011223456789999999999999999999999874

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.2e-40  Score=354.45  Aligned_cols=260  Identities=25%  Similarity=0.406  Sum_probs=198.6

Q ss_pred             hccCCCCceeeeccceEEEEEEE-CCCcEEEEEEeecccc---chhhhHHHHHHHHhcCCCCcceeEEeeeecCCe----
Q 040845          526 TDKFSENNLIGRGGFGSVYKARI-RDGMEVAVKVFNLQCG---RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEF----  597 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----  597 (824)
                      .++|++.+.||+|+||.||+|++ .+++.||||+++....   .....+.+|+.++++++||||+++++++.....    
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            46899999999999999999986 4689999999976432   234578899999999999999999999876543    


Q ss_pred             eEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccccc
Q 040845          598 KALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  677 (824)
Q Consensus       598 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~  677 (824)
                      .++||||+++++|.+++...+ .+++.+++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++..+
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  166 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAI  166 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred             cEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence            489999999999999998765 6899999999999999999999   899999999999999999999999999999876


Q ss_pred             CCCCCc-cccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhcc
Q 040845          678 TGEDQS-MTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVD  756 (824)
Q Consensus       678 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  756 (824)
                      ...... .......||+.|+|||.+.+..++.++||||+|+++|||++|+.||......+.. ......           
T Consensus       167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~-~~~~~~-----------  234 (311)
T 3ork_A          167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA-YQHVRE-----------  234 (311)
T ss_dssp             ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHC-----------
T ss_pred             cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHhcC-----------
Confidence            543222 2223456899999999999889999999999999999999999999763221111 111110           


Q ss_pred             ccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHH-HHHHHHH
Q 040845          757 ANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIV-AKLLKIR  806 (824)
Q Consensus       757 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl-~~L~~~~  806 (824)
                           ...........++..+.+++.+||+.||++||++.+++ +.+.+..
T Consensus       235 -----~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  280 (311)
T 3ork_A          235 -----DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  280 (311)
T ss_dssp             -----CCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             -----CCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence                 00001111224567799999999999999999665554 5555544

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.5e-39  Score=347.64  Aligned_cols=252  Identities=22%  Similarity=0.336  Sum_probs=207.5

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccc------hhhhHHHHHHHHhcCCCCcceeEEeeeecCCee
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGR------AFKSFDVECAMMKSIRHRNLVKVISSCSNEEFK  598 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  598 (824)
                      .++|++.+.||+|+||.||+|+.. +|+.||||++......      ..+.+.+|+.+++.++||||+++++++.+....
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            467999999999999999999876 5899999998754321      356789999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC----cEEEeecccc
Q 040845          599 ALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM----VAHLSDFGIA  674 (824)
Q Consensus       599 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~----~~kl~Dfg~a  674 (824)
                      ++||||+++++|.+++.... .+++..++.++.|++.||+|||   +.+|+||||||+||+++.++    .+||+|||++
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~  166 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTCS-CEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred             EEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence            99999999999999997654 7899999999999999999999   89999999999999999888    7999999999


Q ss_pred             cccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhh
Q 040845          675 KLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEV  754 (824)
Q Consensus       675 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  754 (824)
                      .......   ......||+.|+|||.+.+..++.++||||+|+++|||++|+.||......+ ....+.....       
T Consensus       167 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~-------  235 (321)
T 2a2a_A          167 HEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-TLANITSVSY-------  235 (321)
T ss_dssp             EECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHHHHTTCC-------
T ss_pred             eecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhccc-------
Confidence            8764332   2234568999999999998899999999999999999999999996532111 1111111000       


Q ss_pred             ccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          755 VDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       755 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                               .........++..+.+++.+||..||++|||+.|++++
T Consensus       236 ---------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h  273 (321)
T 2a2a_A          236 ---------DFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (321)
T ss_dssp             ---------CCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred             ---------ccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                     00011123456678999999999999999999999875

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.9e-40  Score=352.31  Aligned_cols=260  Identities=27%  Similarity=0.477  Sum_probs=205.4

Q ss_pred             ccCCCCceeeeccceEEEEEEECC-----CcEEEEEEeecccc-chhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEE
Q 040845          527 DKFSENNLIGRGGFGSVYKARIRD-----GMEVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKAL  600 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  600 (824)
                      .+|.+.+.||+|+||.||+|.+..     +..||||+++.... .....+.+|+.+++.++||||+++++++.+.+..++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            567778999999999999998653     24699999875432 334578899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 040845          601 VLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE  680 (824)
Q Consensus       601 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  680 (824)
                      ||||+++|+|.+++......+++.+++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++......
T Consensus       124 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~  200 (333)
T 1mqb_A          124 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  200 (333)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchhhccc
Confidence            99999999999999877668999999999999999999999   899999999999999999999999999999876433


Q ss_pred             CCc-cccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhcccc
Q 040845          681 DQS-MTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDAN  758 (824)
Q Consensus       681 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  758 (824)
                      ... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+  ....+....           
T Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~--~~~~~~~~~-----------  267 (333)
T 1mqb_A          201 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE--VMKAINDGF-----------  267 (333)
T ss_dssp             ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHHTTC-----------
T ss_pred             cccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH--HHHHHHCCC-----------
Confidence            221 12223446788999999988899999999999999999999 999986532211  111111000           


Q ss_pred             ccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhh
Q 040845          759 LLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSL  809 (824)
Q Consensus       759 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~  809 (824)
                             +...+..++..+.+++.+||+.||++||++.|++++|+++.+..
T Consensus       268 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~  311 (333)
T 1mqb_A          268 -------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP  311 (333)
T ss_dssp             -------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             -------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence                   00112245667899999999999999999999999999987643

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=6.5e-40  Score=348.31  Aligned_cols=263  Identities=22%  Similarity=0.272  Sum_probs=202.4

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc---chhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG---RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALV  601 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  601 (824)
                      .++|++.+.||+|+||.||+|+.. +++.||||++.....   ...+.+.+|+.++++++||||+++++++..++..++|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            578999999999999999999875 589999999865422   2346788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 040845          602 LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED  681 (824)
Q Consensus       602 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  681 (824)
                      |||+++++|.+++.... .+++.+++.++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||++.......
T Consensus       113 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  188 (309)
T 2h34_A          113 MRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEK  188 (309)
T ss_dssp             EECCCCEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred             EEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence            99999999999998755 6899999999999999999999   8999999999999999999999999999998654322


Q ss_pred             CccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccC
Q 040845          682 QSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLS  761 (824)
Q Consensus       682 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  761 (824)
                      . .......+++.|+|||.+.+..++.++||||||+++|||++|+.||......  .....+....+.            
T Consensus       189 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~------------  253 (309)
T 2h34_A          189 L-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--VMGAHINQAIPR------------  253 (309)
T ss_dssp             ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--HHHHHHHSCCCC------------
T ss_pred             c-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--HHHHHhccCCCC------------
Confidence            1 2223456899999999999989999999999999999999999999763211  111111110000            


Q ss_pred             chhhhhhhHHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHHHHhhcc
Q 040845          762 QEDIHFVAKEQCVSFVFNLALECTVESPEQRI-NAKEIVAKLLKIRDSLLR  811 (824)
Q Consensus       762 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-t~~evl~~L~~~~~~~~~  811 (824)
                          ....+..++..+.+++.+||+.||++|| +++++++.|+++.+....
T Consensus       254 ----~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~  300 (309)
T 2h34_A          254 ----PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQ  300 (309)
T ss_dssp             ----GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC----
T ss_pred             ----ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcc
Confidence                0011224566789999999999999999 999999999887654433

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.6e-40  Score=352.65  Aligned_cols=268  Identities=21%  Similarity=0.278  Sum_probs=200.0

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccc-hhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEec
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGR-AFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      ++|.+.+.||+|+||+||+|+.. +++.||||++...... ....+.+|+.+++.++||||+++++++.+++..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            57899999999999999999876 6899999998654322 223455799999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 040845          605 MPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM  684 (824)
Q Consensus       605 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  684 (824)
                      ++ |+|.+++...+..+++.++..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++.......  .
T Consensus        82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~--~  155 (324)
T 3mtl_A           82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT--K  155 (324)
T ss_dssp             CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred             cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCCc--c
Confidence            97 5999999887777999999999999999999999   9999999999999999999999999999998653222  2


Q ss_pred             ccccccccccccCccCcCC-CCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCc---chhhcccc--
Q 040845          685 TQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPIS---TMEVVDAN--  758 (824)
Q Consensus       685 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~--  758 (824)
                      ......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||......+ .............   ........  
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~  234 (324)
T 3mtl_A          156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE-QLHFIFRILGTPTEETWPGILSNEEF  234 (324)
T ss_dssp             -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTTSTTGGGCHHH
T ss_pred             ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChHhchhhhcchhh
Confidence            2334568999999998876 568999999999999999999999997632221 1111111111000   00000000  


Q ss_pred             ----cc-CchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          759 ----LL-SQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       759 ----~~-~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                          .. ............++..+.+++.+||+.||++|||++|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  282 (324)
T 3mtl_A          235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH  282 (324)
T ss_dssp             HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence                00 00000111223456778999999999999999999999874

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=8.7e-40  Score=347.85  Aligned_cols=265  Identities=23%  Similarity=0.352  Sum_probs=203.1

Q ss_pred             hccCCCCceeeeccceEEEEEEE-CCCcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARI-RDGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALV  601 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  601 (824)
                      .++|++.+.||+|+||.||+|.. .+|+.||||++....   ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            46899999999999999999986 468999999987532   23456788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhh---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccC
Q 040845          602 LEYMPHGSLEKYLHS---SNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT  678 (824)
Q Consensus       602 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~  678 (824)
                      |||+++++|.+++..   ....+++..++.++.|++.|++|||   +.+++||||||+||+++.++.+||+|||++....
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            999999999999864   3356899999999999999999999   9999999999999999999999999999998654


Q ss_pred             CCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhcccc
Q 040845          679 GEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDAN  758 (824)
Q Consensus       679 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  758 (824)
                      ....  ......+++.|+|||.+.+..++.++||||||+++|||++|+.||.............+....           
T Consensus       188 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----------  254 (310)
T 2wqm_A          188 SKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD-----------  254 (310)
T ss_dssp             -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTC-----------
T ss_pred             CCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhccc-----------
Confidence            3221  223346899999999999989999999999999999999999998753222111111111100           


Q ss_pred             ccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhccc
Q 040845          759 LLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLRN  812 (824)
Q Consensus       759 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~~  812 (824)
                       ...     .....++..+.+++.+||..||++|||+.|+++.|+++.......
T Consensus       255 -~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~  302 (310)
T 2wqm_A          255 -YPP-----LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASS  302 (310)
T ss_dssp             -SCC-----CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred             -CCC-----CcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhh
Confidence             000     001234567899999999999999999999999999998876544

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=2.1e-39  Score=352.98  Aligned_cols=253  Identities=16%  Similarity=0.150  Sum_probs=207.9

Q ss_pred             hccCCCCceeeeccceEEEEEE------ECCCcEEEEEEeeccccchhhhHHHHHHHHhcCC---CCcceeEEeeeecCC
Q 040845          526 TDKFSENNLIGRGGFGSVYKAR------IRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIR---HRNLVKVISSCSNEE  596 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~  596 (824)
                      .++|.+.+.||+|+||+||+|.      ..+++.||||+++..   ....+..|+++++.++   |+||+++++++...+
T Consensus        64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~  140 (365)
T 3e7e_A           64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN  140 (365)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred             CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence            4679999999999999999994      345889999998643   3456778888888887   999999999999999


Q ss_pred             eeEEEEeccCCCCHHHHhhh----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC----------
Q 040845          597 FKALVLEYMPHGSLEKYLHS----SNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD----------  662 (824)
Q Consensus       597 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~----------  662 (824)
                      ..++||||+++|+|.+++..    ....+++.+++.++.|++.||+|||   +.+|+||||||+|||++.          
T Consensus       141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~~~~~  217 (365)
T 3e7e_A          141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDD  217 (365)
T ss_dssp             CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC-----
T ss_pred             CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCcccccc
Confidence            99999999999999999975    3357999999999999999999999   999999999999999998          


Q ss_pred             -CCcEEEeecccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhh
Q 040845          663 -NMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKH  741 (824)
Q Consensus       663 -~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~  741 (824)
                       ++.+||+|||+|+.+.............||++|+|||++.+..++.++|||||||++|||+||+.||.....+......
T Consensus       218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~  297 (365)
T 3e7e_A          218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEG  297 (365)
T ss_dssp             -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEEECS
T ss_pred             ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCceeech
Confidence             8999999999998664333334445567999999999999999999999999999999999999998654332111000


Q ss_pred             hhhhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCC-CCHHHHHHHHHHHHHhh
Q 040845          742 WVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQR-INAKEIVAKLLKIRDSL  809 (824)
Q Consensus       742 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R-pt~~evl~~L~~~~~~~  809 (824)
                                      . ...    .    .....+.+++..|++.+|.+| |+++++.+.|+++.++.
T Consensus       298 ----------------~-~~~----~----~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~  341 (365)
T 3e7e_A          298 ----------------L-FRR----L----PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH  341 (365)
T ss_dssp             ----------------C-CTT----C----SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             ----------------h-ccc----c----CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence                            0 000    0    113456789999999999998 58888999998887653

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=5.7e-40  Score=350.52  Aligned_cols=261  Identities=22%  Similarity=0.284  Sum_probs=208.2

Q ss_pred             hccCCCCceeeeccceEEEEEEE-CCCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeee----cCCeeEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARI-RDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCS----NEEFKAL  600 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~~l  600 (824)
                      .++|++.+.||+|+||.||+|+. .+++.||||++........+.+.+|+++++.++||||+++++++.    .....++
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  107 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL  107 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence            46799999999999999999987 568999999987665566778899999999999999999999986    3457889


Q ss_pred             EEeccCCCCHHHHhhh---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccccc
Q 040845          601 VLEYMPHGSLEKYLHS---SNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  677 (824)
Q Consensus       601 v~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~  677 (824)
                      ||||+++|+|.+++..   ....+++.+++.++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||.+...
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~  184 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA  184 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred             EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence            9999999999999876   3457899999999999999999999   899999999999999999999999999998765


Q ss_pred             CCCCCc-------cccccccccccccCccCcCCCC---CCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhC
Q 040845          678 TGEDQS-------MTQTQTLATIGYMAPEYGREGQ---VSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCL  747 (824)
Q Consensus       678 ~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~---~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  747 (824)
                      ......       .......||+.|+|||.+.+..   ++.++||||||+++|||++|+.||..................
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~  264 (317)
T 2buj_A          185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQL  264 (317)
T ss_dssp             CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC-
T ss_pred             ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccC
Confidence            321111       0112345799999999987553   689999999999999999999999754322222221111100


Q ss_pred             CCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 040845          748 PISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRD  807 (824)
Q Consensus       748 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~  807 (824)
                                        .......++..+.+++.+||+.||++|||+.|++++|+++..
T Consensus       265 ------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~  306 (317)
T 2buj_A          265 ------------------SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP  306 (317)
T ss_dssp             -------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred             ------------------CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence                              001112345679999999999999999999999999988753

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=4.3e-40  Score=346.37  Aligned_cols=258  Identities=27%  Similarity=0.439  Sum_probs=214.9

Q ss_pred             hhccCCCCceeeeccceEEEEEEECC-CcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEe
Q 040845          525 ATDKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLE  603 (824)
Q Consensus       525 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  603 (824)
                      ..++|++.+.||+|+||.||+|.+.. +..||+|++... ....+.+.+|++++++++||||+++++++.++...++|||
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   89 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   89 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence            45789999999999999999998764 889999998754 3456778999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 040845          604 YMPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ  682 (824)
Q Consensus       604 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  682 (824)
                      |+++++|.+++.... ..+++..++.++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||.+....... 
T Consensus        90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  165 (288)
T 3kfa_A           90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-  165 (288)
T ss_dssp             CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS-
T ss_pred             cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceeccCCc-
Confidence            999999999998644 46899999999999999999999   8999999999999999999999999999998764332 


Q ss_pred             ccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhccccccC
Q 040845          683 SMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLS  761 (824)
Q Consensus       683 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  761 (824)
                      ........+|+.|+|||.+.+..++.++||||+|+++|+|++ |..||.......  ....+....              
T Consensus       166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~--~~~~~~~~~--------------  229 (288)
T 3kfa_A          166 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYELLEKDY--------------  229 (288)
T ss_dssp             SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--HHHHHHTTC--------------
T ss_pred             cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHhccC--------------
Confidence            223344557889999999988899999999999999999999 888987532211  111111100              


Q ss_pred             chhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 040845          762 QEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRD  807 (824)
Q Consensus       762 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~  807 (824)
                          ....+..++..+.+++.+||..||++|||+.|+++.|+++.+
T Consensus       230 ----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~  271 (288)
T 3kfa_A          230 ----RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  271 (288)
T ss_dssp             ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence                011122456779999999999999999999999999999865

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=8.3e-40  Score=353.73  Aligned_cols=260  Identities=23%  Similarity=0.315  Sum_probs=203.4

Q ss_pred             HHHhhccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecc-----ccchhhhHHHHHHHHhcCCCCcceeEEeeeecC
Q 040845          522 LFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQ-----CGRAFKSFDVECAMMKSIRHRNLVKVISSCSNE  595 (824)
Q Consensus       522 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  595 (824)
                      +....++|++.+.||+|+||.||+|... +++.||+|++...     .....+.+.+|+.++++++||||+++++++.+.
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  100 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE  100 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence            3456788999999999999999999864 5889999998654     234557889999999999999999999999999


Q ss_pred             CeeEEEEeccCCCCHHHHhhhC---------------------------------------CCCCCHHHHHHHHHHHHHH
Q 040845          596 EFKALVLEYMPHGSLEKYLHSS---------------------------------------NYSLDIFQRLNIMIDVASA  636 (824)
Q Consensus       596 ~~~~lv~e~~~~g~L~~~l~~~---------------------------------------~~~~~~~~~~~i~~~i~~~  636 (824)
                      +..++||||+++|+|.+++...                                       ...+++..++.++.|++.|
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~  180 (345)
T 3hko_A          101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA  180 (345)
T ss_dssp             SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence            9999999999999999998521                                       1123567788999999999


Q ss_pred             HHHhhcCCCCCeEecCCCCCCeeeCCCC--cEEEeecccccccCCCCC--ccccccccccccccCccCcCC--CCCCccc
Q 040845          637 LEYLHFGYSAPVIHCDLKPSNVLLDDNM--VAHLSDFGIAKLLTGEDQ--SMTQTQTLATIGYMAPEYGRE--GQVSTNG  710 (824)
Q Consensus       637 l~~LH~~~~~~ivH~Dlk~~Nill~~~~--~~kl~Dfg~a~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~--~~~~~~~  710 (824)
                      |+|||   +.+|+||||||+||+++.++  .+||+|||++..+.....  ........||+.|+|||.+.+  ..++.++
T Consensus       181 l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~  257 (345)
T 3hko_A          181 LHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC  257 (345)
T ss_dssp             HHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred             HHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence            99999   89999999999999998776  899999999987643222  122345569999999998865  6789999


Q ss_pred             hHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCC
Q 040845          711 DVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPE  790 (824)
Q Consensus       711 DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~  790 (824)
                      |||||||++|||++|+.||......+ ...........                ........++..+.+++.+||+.||+
T Consensus       258 DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~----------------~~~~~~~~~~~~~~~li~~~l~~~p~  320 (345)
T 3hko_A          258 DAWSAGVLLHLLLMGAVPFPGVNDAD-TISQVLNKKLC----------------FENPNYNVLSPLARDLLSNLLNRNVD  320 (345)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCCC----------------TTSGGGGGSCHHHHHHHHHHSCSCTT
T ss_pred             HHHHHHHHHHHHHHCCCCCCCCChHH-HHHHHHhcccc----------------cCCcccccCCHHHHHHHHHHcCCChh
Confidence            99999999999999999997632221 11111111000                00011123466789999999999999


Q ss_pred             CCCCHHHHHHH
Q 040845          791 QRINAKEIVAK  801 (824)
Q Consensus       791 ~Rpt~~evl~~  801 (824)
                      +|||+.|++++
T Consensus       321 ~Rps~~~~l~h  331 (345)
T 3hko_A          321 ERFDAMRALQH  331 (345)
T ss_dssp             TSCCHHHHHHS
T ss_pred             HCCCHHHHhcC
Confidence            99999999875

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=5.5e-40  Score=366.22  Aligned_cols=248  Identities=25%  Similarity=0.369  Sum_probs=206.3

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALV  601 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  601 (824)
                      .++|.+.+.||+|+||.||+|++. +|+.||||++....   ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            367899999999999999999876 69999999997542   23356788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 040845          602 LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED  681 (824)
Q Consensus       602 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  681 (824)
                      |||+++|+|.+++...+ .+++.++..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||++.......
T Consensus        95 ~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~  170 (476)
T 2y94_A           95 MEYVSGGELFDYICKNG-RLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  170 (476)
T ss_dssp             EECCSSEEHHHHTTSSS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred             EeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence            99999999999997654 6899999999999999999999   9999999999999999999999999999998764332


Q ss_pred             CccccccccccccccCccCcCCCCC-CccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhcccccc
Q 040845          682 QSMTQTQTLATIGYMAPEYGREGQV-STNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLL  760 (824)
Q Consensus       682 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  760 (824)
                         ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||....... ..........             
T Consensus       171 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~-~~~~i~~~~~-------------  233 (476)
T 2y94_A          171 ---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT-LFKKICDGIF-------------  233 (476)
T ss_dssp             ---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH-HHHHHHTTCC-------------
T ss_pred             ---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH-HHHHHhcCCc-------------
Confidence               2233569999999999988765 789999999999999999999997632111 1111111000             


Q ss_pred             CchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          761 SQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       761 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                             ..+..++..+.+++.+||+.||++|||+.|++++
T Consensus       234 -------~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h  267 (476)
T 2y94_A          234 -------YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH  267 (476)
T ss_dssp             -------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             -------CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence                   0112245668999999999999999999999985

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=8.8e-40  Score=358.07  Aligned_cols=252  Identities=23%  Similarity=0.381  Sum_probs=199.0

Q ss_pred             ccCCCCceeeeccceEEEEEEECCCcEEEEEEeeccc--cchhhhHHHHHHHHhcCC--CCcceeEEeeeecCCeeEEEE
Q 040845          527 DKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIR--HRNLVKVISSCSNEEFKALVL  602 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~  602 (824)
                      .+|++.+.||+|+||.||+|...+++.||||++....  ....+.+.+|+.++++++  ||||+++++++..++..++||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            4599999999999999999998889999999987543  234567889999999996  599999999999999999999


Q ss_pred             eccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 040845          603 EYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ  682 (824)
Q Consensus       603 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  682 (824)
                      | +.+++|.+++.... .+++.++..++.||+.||+|||   +.+|+||||||+||+++ ++.+||+|||+++.+.....
T Consensus       136 E-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~  209 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT  209 (390)
T ss_dssp             E-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred             e-cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence            9 55889999998765 7889999999999999999999   99999999999999995 58999999999987654433


Q ss_pred             ccccccccccccccCccCcCC-----------CCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcc
Q 040845          683 SMTQTQTLATIGYMAPEYGRE-----------GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPIST  751 (824)
Q Consensus       683 ~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  751 (824)
                      ........||+.|+|||++.+           ..++.++|||||||++|||++|+.||.........+..........  
T Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~--  287 (390)
T 2zmd_A          210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI--  287 (390)
T ss_dssp             ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCC--
T ss_pred             cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccC--
Confidence            333345679999999998764           4689999999999999999999999975332211111111110000  


Q ss_pred             hhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 040845          752 MEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL  802 (824)
Q Consensus       752 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L  802 (824)
                                      ..+..++..+.+++.+||..||++|||+.|++++-
T Consensus       288 ----------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp  322 (390)
T 2zmd_A          288 ----------------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  322 (390)
T ss_dssp             ----------------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             ----------------CCCccchHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence                            00111245688999999999999999999998763

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=2.3e-39  Score=342.24  Aligned_cols=266  Identities=19%  Similarity=0.235  Sum_probs=209.6

Q ss_pred             hhccCCCCceeeeccceEEEEEEE-CCCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeee-ecCCeeEEEE
Q 040845          525 ATDKFSENNLIGRGGFGSVYKARI-RDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSC-SNEEFKALVL  602 (824)
Q Consensus       525 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~  602 (824)
                      ..++|++.+.||+|+||.||+|+. .+++.||||++...  ...+.+.+|+.+++.++|++++..++.+ .+.+..++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccc--ccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            457899999999999999999986 56899999987543  2345688899999999988877666655 6678889999


Q ss_pred             eccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee---CCCCcEEEeecccccccCC
Q 040845          603 EYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTG  679 (824)
Q Consensus       603 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill---~~~~~~kl~Dfg~a~~~~~  679 (824)
                      ||+ +++|.+++......+++.+++.++.|++.||+|||   +.+|+||||||+||++   +.++.+||+|||++.....
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~  160 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  160 (296)
T ss_dssp             ECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             Ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence            999 89999999876668999999999999999999999   9999999999999999   7899999999999987654


Q ss_pred             CCCc-----cccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcc--hhhhhhhhhCCCcch
Q 040845          680 EDQS-----MTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEM--TLKHWVNDCLPISTM  752 (824)
Q Consensus       680 ~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~  752 (824)
                      ....     .......||+.|+|||.+.+..++.++||||+||++|||++|+.||........  ..........+    
T Consensus       161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~----  236 (296)
T 4hgt_A          161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS----  236 (296)
T ss_dssp             TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH----
T ss_pred             cccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccccc----
Confidence            3321     122345689999999999999999999999999999999999999976432211  11111000000    


Q ss_pred             hhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhcc
Q 040845          753 EVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLR  811 (824)
Q Consensus       753 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~  811 (824)
                              .   ........++..+.+++.+||+.||++|||++|+++.|+++.++...
T Consensus       237 --------~---~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~  284 (296)
T 4hgt_A          237 --------T---PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF  284 (296)
T ss_dssp             --------S---CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred             --------c---hhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCC
Confidence                    0   00001123467899999999999999999999999999999876543

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.9e-40  Score=378.26  Aligned_cols=261  Identities=23%  Similarity=0.388  Sum_probs=208.7

Q ss_pred             CCCCc-eeeeccceEEEEEEEC---CCcEEEEEEeeccc-cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEe
Q 040845          529 FSENN-LIGRGGFGSVYKARIR---DGMEVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLE  603 (824)
Q Consensus       529 ~~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  603 (824)
                      +.+.+ .||+|+||.||+|.++   ++..||||+++... ....+.+.+|++++++++||||+++++++.. +..++|||
T Consensus       337 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E  415 (613)
T 2ozo_A          337 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVME  415 (613)
T ss_dssp             EEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEE
T ss_pred             eeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEE
Confidence            33334 7999999999999764   46789999997643 3356789999999999999999999999976 56899999


Q ss_pred             ccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 040845          604 YMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS  683 (824)
Q Consensus       604 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  683 (824)
                      |+++|+|.+++......+++.++..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++........
T Consensus       416 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~  492 (613)
T 2ozo_A          416 MAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY  492 (613)
T ss_dssp             CCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----
T ss_pred             eCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCce
Confidence            99999999999877767999999999999999999999   999999999999999999999999999999876433222


Q ss_pred             -cccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhccccccC
Q 040845          684 -MTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLS  761 (824)
Q Consensus       684 -~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  761 (824)
                       .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+  ....+...               
T Consensus       493 ~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--~~~~i~~~---------------  555 (613)
T 2ozo_A          493 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VMAFIEQG---------------  555 (613)
T ss_dssp             ---------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH--HHHHHHTT---------------
T ss_pred             eeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HHHHHHcC---------------
Confidence             12223346789999999998899999999999999999998 999997643221  11111110               


Q ss_pred             chhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhcccc
Q 040845          762 QEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLRNV  813 (824)
Q Consensus       762 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~~~  813 (824)
                         .+...+..++..+.++|.+||..||++||++.++++.|+.+..+.....
T Consensus       556 ---~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~  604 (613)
T 2ozo_A          556 ---KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV  604 (613)
T ss_dssp             ---CCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCSC
T ss_pred             ---CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcccc
Confidence               0111233567889999999999999999999999999999887765543

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=4.8e-40  Score=352.76  Aligned_cols=243  Identities=25%  Similarity=0.348  Sum_probs=204.4

Q ss_pred             hhccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc--------chhhhHHHHHHHHhcCCCCcceeEEeeeecC
Q 040845          525 ATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG--------RAFKSFDVECAMMKSIRHRNLVKVISSCSNE  595 (824)
Q Consensus       525 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  595 (824)
                      ..++|++.+.||+|+||.||+|+.. +++.||||++.....        ...+.+.+|+.++++++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            4578999999999999999999864 589999999875431        1344677899999999999999999999999


Q ss_pred             CeeEEEEeccCCC-CHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccc
Q 040845          596 EFKALVLEYMPHG-SLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIA  674 (824)
Q Consensus       596 ~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a  674 (824)
                      +..++||||+.+| +|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~~~-~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a  177 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDRHP-RLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSA  177 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHTCC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CEEEEEEEeCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEeecccc
Confidence            9999999999777 9999998765 6899999999999999999999   899999999999999999999999999999


Q ss_pred             cccCCCCCccccccccccccccCccCcCCCCC-CccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchh
Q 040845          675 KLLTGEDQSMTQTQTLATIGYMAPEYGREGQV-STNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTME  753 (824)
Q Consensus       675 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  753 (824)
                      ........   .....||+.|+|||++.+..+ +.++||||+||++|||++|+.||......       ...        
T Consensus       178 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------~~~--------  239 (335)
T 3dls_A          178 AYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-------VEA--------  239 (335)
T ss_dssp             EECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-------TTT--------
T ss_pred             eECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-------Hhh--------
Confidence            87643322   233568999999999988776 88999999999999999999999752110       000        


Q ss_pred             hccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          754 VVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       754 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                          ..        ..+..++..+.+++.+||+.||++|||+.|++++
T Consensus       240 ----~~--------~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          240 ----AI--------HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             ----CC--------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             ----cc--------CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                00        0011245668999999999999999999999987

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=9.4e-40  Score=359.27  Aligned_cols=277  Identities=20%  Similarity=0.301  Sum_probs=213.4

Q ss_pred             hccCCCCceeeeccceEEEEEEECC-CcEEEEEEeeccc-cchhhhHHHHHHHHhcCCCCcceeEEeeeecCC--eeEEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEE--FKALV  601 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv  601 (824)
                      .++|.+.+.||+|+||.||+|++.. |+.||||++.... ....+.+.+|++++++++||||+++++++.+..  ..++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            3679999999999999999998764 8999999997543 234567789999999999999999999997755  77999


Q ss_pred             EeccCCCCHHHHhhhCC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee----CCCCcEEEeeccccc
Q 040845          602 LEYMPHGSLEKYLHSSN--YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL----DDNMVAHLSDFGIAK  675 (824)
Q Consensus       602 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill----~~~~~~kl~Dfg~a~  675 (824)
                      |||+++|+|.+++....  ..+++.+++.++.|++.||+|||   +.+|+||||||+||++    +.++.+||+|||+++
T Consensus        88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            99999999999997644  34899999999999999999999   9999999999999999    778889999999998


Q ss_pred             ccCCCCCccccccccccccccCccCcCC--------CCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhh---hhhh
Q 040845          676 LLTGEDQSMTQTQTLATIGYMAPEYGRE--------GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLK---HWVN  744 (824)
Q Consensus       676 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~---~~~~  744 (824)
                      ......   ......||+.|+|||++.+        ..++.++|||||||++|||++|+.||...........   ....
T Consensus       165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~  241 (396)
T 4eut_A          165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (396)
T ss_dssp             ECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred             EccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence            764322   2234568999999998764        5678899999999999999999999976433222211   1111


Q ss_pred             hhCCCcchhhccc-----cccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 040845          745 DCLPISTMEVVDA-----NLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDS  808 (824)
Q Consensus       745 ~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~  808 (824)
                      ...+.........     .+.............++..+.+++.+||+.||++||++.|+++.++++.+.
T Consensus       242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence            1111110000000     000000111112246778899999999999999999999999999887653

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.6e-39  Score=341.22  Aligned_cols=252  Identities=21%  Similarity=0.344  Sum_probs=206.3

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVL  602 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  602 (824)
                      .++|++.+.||+|+||.||+|... +|+.||+|++....  ....+.+.+|+.++++++||||+++++++.++...++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            478999999999999999999875 58999999987553  234567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCc---EEEeecccccccCC
Q 040845          603 EYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMV---AHLSDFGIAKLLTG  679 (824)
Q Consensus       603 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~---~kl~Dfg~a~~~~~  679 (824)
                      ||+++++|.+++.... .+++.++..++.|++.|++|||   +.+|+||||||+||+++.++.   +||+|||.+.....
T Consensus        85 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  160 (284)
T 3kk8_A           85 DLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND  160 (284)
T ss_dssp             CCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred             ecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence            9999999999987665 6899999999999999999999   999999999999999986655   99999999986643


Q ss_pred             CCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccc
Q 040845          680 EDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANL  759 (824)
Q Consensus       680 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  759 (824)
                      ..   ......||+.|+|||.+.+..++.++||||+|+++|+|++|+.||......+ ............          
T Consensus       161 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~----------  226 (284)
T 3kk8_A          161 SE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-LYAQIKAGAYDY----------  226 (284)
T ss_dssp             SC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCCCC----------
T ss_pred             Cc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH-HHHHHHhccccC----------
Confidence            22   2234568999999999999999999999999999999999999996532111 111111111000          


Q ss_pred             cCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          760 LSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       760 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                            .......++..+.+++.+||+.||++|||+.|++++
T Consensus       227 ------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          227 ------PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  262 (284)
T ss_dssp             ------CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             ------CchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence                  000112345678999999999999999999999986

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7e-40  Score=359.80  Aligned_cols=270  Identities=22%  Similarity=0.310  Sum_probs=195.6

Q ss_pred             HhhccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecc--ccchhhhHHHHHHHHhcCC-CCcceeEEeeeecC--Ce
Q 040845          524 QATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQ--CGRAFKSFDVECAMMKSIR-HRNLVKVISSCSNE--EF  597 (824)
Q Consensus       524 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~  597 (824)
                      ...++|++.+.||+|+||.||+|.+. +|+.||||++...  .......+.+|+.+++.+. ||||+++++++..+  ..
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            34678999999999999999999864 5899999998543  2234566778999999997 99999999999754  37


Q ss_pred             eEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccccc
Q 040845          598 KALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  677 (824)
Q Consensus       598 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~  677 (824)
                      .|+||||++ ++|.+++...  .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+|+.+
T Consensus        86 ~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  159 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSF  159 (388)
T ss_dssp             EEEEEECCS-EEHHHHHHHT--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred             EEEEecccC-cCHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence            899999997 5999999764  5889999999999999999999   999999999999999999999999999999876


Q ss_pred             CCCCC-------------------ccccccccccccccCccCcCC-CCCCccchHHHHHHHHHHHHhCCCCCcccccCcc
Q 040845          678 TGEDQ-------------------SMTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEM  737 (824)
Q Consensus       678 ~~~~~-------------------~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~  737 (824)
                      .....                   ....+...||++|+|||++.+ ..++.++||||+||++|||++|++||.+.... .
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~  238 (388)
T 3oz6_A          160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM-N  238 (388)
T ss_dssp             SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-H
T ss_pred             cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH-H
Confidence            43111                   112234579999999998876 67899999999999999999999999763211 1


Q ss_pred             hhhhhhhhhCCCcchhhcc---cc------------------ccCch-------hhhhhhHHHHHHHHHHHHHHccccCC
Q 040845          738 TLKHWVNDCLPISTMEVVD---AN------------------LLSQE-------DIHFVAKEQCVSFVFNLALECTVESP  789 (824)
Q Consensus       738 ~~~~~~~~~~~~~~~~~~~---~~------------------~~~~~-------~~~~~~~~~~~~~l~~l~~~cl~~dP  789 (824)
                      .+..+.... .....+...   ..                  .....       ......+..++..+.+|+.+||+.||
T Consensus       239 ~~~~i~~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP  317 (388)
T 3oz6_A          239 QLERIIGVI-DFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNP  317 (388)
T ss_dssp             HHHHHHHHH-CCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSG
T ss_pred             HHHHHHHhc-CCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCc
Confidence            111111111 100000000   00                  00000       00000111456789999999999999


Q ss_pred             CCCCCHHHHHHH
Q 040845          790 EQRINAKEIVAK  801 (824)
Q Consensus       790 ~~Rpt~~evl~~  801 (824)
                      ++|||++|+++|
T Consensus       318 ~~R~t~~e~l~H  329 (388)
T 3oz6_A          318 NKRISANDALKH  329 (388)
T ss_dssp             GGSCCHHHHTTS
T ss_pred             ccCCCHHHHhCC
Confidence            999999999987

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.1e-39  Score=347.20  Aligned_cols=269  Identities=24%  Similarity=0.300  Sum_probs=201.1

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc--chhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG--RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVL  602 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  602 (824)
                      .++|++.+.||+|+||+||+|+.. +|+.||||++.....  ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF   81 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence            367999999999999999999875 489999999865432  23466788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 040845          603 EYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ  682 (824)
Q Consensus       603 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  682 (824)
                      ||+++++|.+++.... .+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||.+........
T Consensus        82 e~~~~~~l~~~~~~~~-~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  157 (311)
T 4agu_A           82 EYCDHTVLHELDRYQR-GVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD  157 (311)
T ss_dssp             ECCSEEHHHHHHHTSS-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             EeCCCchHHHHHhhhc-CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc
Confidence            9999999998887654 6899999999999999999999   99999999999999999999999999999987643222


Q ss_pred             ccccccccccccccCccCcCC-CCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCc--chhhc----
Q 040845          683 SMTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPIS--TMEVV----  755 (824)
Q Consensus       683 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~----  755 (824)
                        ......+|+.|+|||.+.+ ..++.++||||+|+++|||++|+.||......+. ............  .....    
T Consensus       158 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  234 (311)
T 4agu_A          158 --YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQ-LYLIRKTLGDLIPRHQQVFSTNQ  234 (311)
T ss_dssp             ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCSCCHHHHHHHHTCG
T ss_pred             --ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhccccccccccccccc
Confidence              2234568999999998875 5689999999999999999999999976432211 111111000000  00000    


Q ss_pred             --cccccC---chhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          756 --DANLLS---QEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       756 --~~~~~~---~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                        ......   ...........++..+.+++.+||+.||++|||++|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence              000000   0000001112456779999999999999999999999875

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=4.3e-39  Score=340.15  Aligned_cols=265  Identities=19%  Similarity=0.236  Sum_probs=212.7

Q ss_pred             hccCCCCceeeeccceEEEEEEE-CCCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeee-ecCCeeEEEEe
Q 040845          526 TDKFSENNLIGRGGFGSVYKARI-RDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSC-SNEEFKALVLE  603 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e  603 (824)
                      .++|++.+.||+|+||.||+|+. .+|+.||||++....  ..+.+.+|+.+++.++|++++..+.++ .+....++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            46899999999999999999986 569999999986543  345688999999999988866666655 66778899999


Q ss_pred             ccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee---CCCCcEEEeecccccccCCC
Q 040845          604 YMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTGE  680 (824)
Q Consensus       604 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill---~~~~~~kl~Dfg~a~~~~~~  680 (824)
                      |+ +++|.+++......+++.+++.++.|++.|++|||   +.+|+||||||+||++   +.++.+||+|||++......
T Consensus        86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  161 (296)
T 3uzp_A           86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             ec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence            99 89999999866668999999999999999999999   9999999999999999   48899999999999876543


Q ss_pred             CCc-----cccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCc--chhhhhhhhhCCCcchh
Q 040845          681 DQS-----MTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGE--MTLKHWVNDCLPISTME  753 (824)
Q Consensus       681 ~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~  753 (824)
                      ...     .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......  ............     
T Consensus       162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-----  236 (296)
T 3uzp_A          162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS-----  236 (296)
T ss_dssp             TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH-----
T ss_pred             ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccC-----
Confidence            321     11234569999999999999999999999999999999999999998643221  111111110000     


Q ss_pred             hccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhcc
Q 040845          754 VVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLR  811 (824)
Q Consensus       754 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~  811 (824)
                             .   ........++..+.+++.+||+.||++|||+.|+++.|+++......
T Consensus       237 -------~---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~  284 (296)
T 3uzp_A          237 -------T---PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF  284 (296)
T ss_dssp             -------S---CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             -------C---chHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence                   0   00011134567899999999999999999999999999999876544

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=3.1e-40  Score=369.20  Aligned_cols=249  Identities=23%  Similarity=0.291  Sum_probs=197.0

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecc---ccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQ---CGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALV  601 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  601 (824)
                      .++|++.+.||+|+||.||+|+.. +|+.||||++...   .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            467999999999999999999865 5899999999754   233445677899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 040845          602 LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYS-APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE  680 (824)
Q Consensus       602 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  680 (824)
                      |||+++|+|.+++.... .+++..+..++.|++.||+|||   + .+|+||||||+||+++.++.+||+|||+|+.....
T Consensus       227 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  302 (446)
T 4ejn_A          227 MEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD  302 (446)
T ss_dssp             ECCCSSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred             EeeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence            99999999999997765 7899999999999999999999   7 89999999999999999999999999999854322


Q ss_pred             CCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhcccccc
Q 040845          681 DQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLL  760 (824)
Q Consensus       681 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  760 (824)
                      .  .......||+.|+|||++.+..++.++||||+||++|||++|+.||....... ..........             
T Consensus       303 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-~~~~i~~~~~-------------  366 (446)
T 4ejn_A          303 G--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-LFELILMEEI-------------  366 (446)
T ss_dssp             ------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCC-------------
T ss_pred             C--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH-HHHHHHhCCC-------------
Confidence            2  22334679999999999999999999999999999999999999997532111 1111111000             


Q ss_pred             CchhhhhhhHHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 040845          761 SQEDIHFVAKEQCVSFVFNLALECTVESPEQRI-----NAKEIVAK  801 (824)
Q Consensus       761 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~evl~~  801 (824)
                             ..+..++..+.+++.+||+.||++||     +++|+++|
T Consensus       367 -------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h  405 (446)
T 4ejn_A          367 -------RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH  405 (446)
T ss_dssp             -------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             -------CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence                   01123456789999999999999999     99999875

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=7.5e-40  Score=349.42  Aligned_cols=266  Identities=22%  Similarity=0.289  Sum_probs=201.1

Q ss_pred             hccCCCC-ceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcC-CCCcceeEEeeeecCCeeEEEE
Q 040845          526 TDKFSEN-NLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSI-RHRNLVKVISSCSNEEFKALVL  602 (824)
Q Consensus       526 ~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  602 (824)
                      .+.|++. +.||+|+||.||+|+.. +++.||||++........+.+.+|++++.++ +||||+++++++.+++..++||
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   90 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF   90 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            3567774 78999999999999854 6899999999766555667889999999985 7999999999999999999999


Q ss_pred             eccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCc---EEEeecccccccCC
Q 040845          603 EYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMV---AHLSDFGIAKLLTG  679 (824)
Q Consensus       603 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~---~kl~Dfg~a~~~~~  679 (824)
                      ||+++|+|.+++.... .+++.++..++.|++.||+|||   +.+|+||||||+||+++.++.   +||+|||++.....
T Consensus        91 e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  166 (316)
T 2ac3_A           91 EKMRGGSILSHIHKRR-HFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL  166 (316)
T ss_dssp             ECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred             EcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence            9999999999998765 6899999999999999999999   899999999999999998776   99999999976542


Q ss_pred             CCCc-----cccccccccccccCccCcCC-----CCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCC
Q 040845          680 EDQS-----MTQTQTLATIGYMAPEYGRE-----GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPI  749 (824)
Q Consensus       680 ~~~~-----~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  749 (824)
                      ....     .......||+.|+|||++..     ..++.++||||+||++|||++|+.||......+..   |.......
T Consensus       167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~~  243 (316)
T 2ac3_A          167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCG---WDRGEACP  243 (316)
T ss_dssp             ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSC---C----CCH
T ss_pred             CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccc---ccccccch
Confidence            2211     11223458999999998864     45889999999999999999999999764332211   10000000


Q ss_pred             c----chhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          750 S----TMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       750 ~----~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      .    ..+.+.......   .......++..+.+++.+||..||++|||+.|++++
T Consensus       244 ~~~~~~~~~i~~~~~~~---~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  296 (316)
T 2ac3_A          244 ACQNMLFESIQEGKYEF---PDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH  296 (316)
T ss_dssp             HHHHHHHHHHHHCCCCC---CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hHHHHHHHHHhccCccc---CchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            0    000000000000   001112456779999999999999999999999875

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.5e-39  Score=353.79  Aligned_cols=277  Identities=24%  Similarity=0.272  Sum_probs=210.0

Q ss_pred             cccccHHHHHHhhccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcCC-----CCccee
Q 040845          514 WRRFSYLELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIR-----HRNLVK  587 (824)
Q Consensus       514 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~  587 (824)
                      ...+++.+.....++|++.+.||+|+||+||+|+.. +++.||||+++.. ....+.+..|+.+++.++     ||||++
T Consensus        22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~  100 (360)
T 3llt_A           22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVK  100 (360)
T ss_dssp             GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred             ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence            334455555555789999999999999999999874 5899999998642 334566778999999997     999999


Q ss_pred             EEeeeecCCeeEEEEeccCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC----
Q 040845          588 VISSCSNEEFKALVLEYMPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD----  662 (824)
Q Consensus       588 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~----  662 (824)
                      +++++...+..++||||+ +++|.+++.... ..+++.++..++.|++.||+|||   +.+|+||||||+||+++.    
T Consensus       101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~  176 (360)
T 3llt_A          101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFE  176 (360)
T ss_dssp             EEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTTCC
T ss_pred             ccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEcccccc
Confidence            999999999999999999 889999998755 45899999999999999999999   999999999999999975    


Q ss_pred             ---------------------CCcEEEeecccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHH
Q 040845          663 ---------------------NMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLME  721 (824)
Q Consensus       663 ---------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~e  721 (824)
                                           ++.+||+|||+|.......     ....||+.|+|||++.+..++.++||||+||++||
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e  251 (360)
T 3llt_A          177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE  251 (360)
T ss_dssp             EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred             ccccchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHH
Confidence                                 7899999999998643322     23468999999999999999999999999999999


Q ss_pred             HHhCCCCCcccccCcchhhhhhhhhCCCcc-----------hhhcccccc----Cchhh-----------hhhhHHHHHH
Q 040845          722 TFTRKKPTDELFNGEMTLKHWVNDCLPIST-----------MEVVDANLL----SQEDI-----------HFVAKEQCVS  775 (824)
Q Consensus       722 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~----~~~~~-----------~~~~~~~~~~  775 (824)
                      |++|+.||......+ ..........+...           ....+....    .....           ....+.....
T Consensus       252 ll~g~~pf~~~~~~~-~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  330 (360)
T 3llt_A          252 LYTGSLLFRTHEHME-HLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHE  330 (360)
T ss_dssp             HHHSSCSCCCSSHHH-HHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCH
T ss_pred             HHHCCCCCCCCcHHH-HHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHH
Confidence            999999997632211 11111111111000           000000000    00000           0000112236


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          776 FVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       776 ~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      .+.+++.+||+.||++|||++|++++
T Consensus       331 ~l~~li~~~L~~dP~~Rpta~elL~h  356 (360)
T 3llt_A          331 LFCDFLYSILQIDPTLRPSPAELLKH  356 (360)
T ss_dssp             HHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            78899999999999999999999864

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2.5e-39  Score=343.92  Aligned_cols=269  Identities=25%  Similarity=0.325  Sum_probs=202.9

Q ss_pred             hhccCCCCceeeeccceEEEEEEE-CCCcEEEEEEeecccc-----chhhhHHHHHHHHhcCC---CCcceeEEeeeecC
Q 040845          525 ATDKFSENNLIGRGGFGSVYKARI-RDGMEVAVKVFNLQCG-----RAFKSFDVECAMMKSIR---HRNLVKVISSCSNE  595 (824)
Q Consensus       525 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~  595 (824)
                      ..++|++.+.||+|+||+||+|+. .+++.||||++.....     .....+.+|+++++.++   ||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            357899999999999999999986 4589999999875431     22346677888877775   99999999999765


Q ss_pred             C-----eeEEEEeccCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEe
Q 040845          596 E-----FKALVLEYMPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLS  669 (824)
Q Consensus       596 ~-----~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  669 (824)
                      .     ..++||||++ ++|.+++.... ..+++.+++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~  162 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLA  162 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEEEC
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEEe
Confidence            4     5789999996 59999998765 34899999999999999999999   9999999999999999999999999


Q ss_pred             ecccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCC
Q 040845          670 DFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPI  749 (824)
Q Consensus       670 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  749 (824)
                      |||++.......   ......||+.|+|||.+.+..++.++||||+||++|||++|+.||......+ ............
T Consensus       163 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~  238 (308)
T 3g33_A          163 DFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QLGKIFDLIGLP  238 (308)
T ss_dssp             SCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH-HHHHHHHHHCCC
T ss_pred             eCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCC
Confidence            999998654222   2344568999999999988899999999999999999999999997633221 112221111100


Q ss_pred             cchhhc-----cccccCc--hhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          750 STMEVV-----DANLLSQ--EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       750 ~~~~~~-----~~~~~~~--~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      ......     .......  ..........++..+.+++.+||+.||++|||+.|++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  297 (308)
T 3g33_A          239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH  297 (308)
T ss_dssp             CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence            000000     0000000  000011122456788999999999999999999999875

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=2.3e-39  Score=360.02  Aligned_cols=201  Identities=24%  Similarity=0.356  Sum_probs=168.7

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeecC-----Ce
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSNE-----EF  597 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  597 (824)
                      .++|++.+.||+|+||.||+|++. +++.||||++....  ....+.+.+|+++++.++||||+++++++...     ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            578999999999999999999865 48899999986532  23456788999999999999999999998765     57


Q ss_pred             eEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccccc
Q 040845          598 KALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  677 (824)
Q Consensus       598 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~  677 (824)
                      .|+||||++ ++|.+++.... .+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+|+..
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGla~~~  179 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTPI-FLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTI  179 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSSC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEecCC-cCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence            899999996 59999997654 6899999999999999999999   999999999999999999999999999999876


Q ss_pred             CCCCCc--------------------cccccccccccccCccCc-CCCCCCccchHHHHHHHHHHHHhCCCCCcc
Q 040845          678 TGEDQS--------------------MTQTQTLATIGYMAPEYG-REGQVSTNGDVYSFGIMLMETFTRKKPTDE  731 (824)
Q Consensus       678 ~~~~~~--------------------~~~~~~~~~~~y~aPE~~-~~~~~~~~~DvwslG~~l~el~tg~~p~~~  731 (824)
                      ......                    ...+..+||++|+|||++ ....++.++||||+||++|||++|..||..
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~  254 (432)
T 3n9x_A          180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIN  254 (432)
T ss_dssp             -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCS
T ss_pred             cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccc
Confidence            433221                    123556799999999985 566799999999999999999997666543

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=6.8e-40  Score=342.81  Aligned_cols=252  Identities=30%  Similarity=0.443  Sum_probs=201.3

Q ss_pred             hccCCCCceeeeccceEEEEEEECCCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecC-CeeEEEEec
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNE-EFKALVLEY  604 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~  604 (824)
                      .++|++.+.||+|+||.||+|++. |+.||||+++..  ...+.+.+|+.++++++||||+++++++.+. +..++||||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            468999999999999999999886 899999998643  3457789999999999999999999997554 578999999


Q ss_pred             cCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 040845          605 MPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS  683 (824)
Q Consensus       605 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  683 (824)
                      +++++|.+++.... ..+++..++.++.|+++|++|||   +.+|+||||||+||+++.++.+||+|||++.......  
T Consensus        97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--  171 (278)
T 1byg_A           97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  171 (278)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeeccccccccccc--
Confidence            99999999997654 23788999999999999999999   9999999999999999999999999999987543221  


Q ss_pred             cccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhccccccCc
Q 040845          684 MTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ  762 (824)
Q Consensus       684 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  762 (824)
                         ....+++.|+|||.+.+..++.++||||+|+++|||++ |+.||......+  ....+....               
T Consensus       172 ---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--~~~~~~~~~---------------  231 (278)
T 1byg_A          172 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRVEKGY---------------  231 (278)
T ss_dssp             -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--HHHHHTTTC---------------
T ss_pred             ---cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHhcCC---------------
Confidence               22347889999999988889999999999999999998 999987532211  111110000               


Q ss_pred             hhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 040845          763 EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDS  808 (824)
Q Consensus       763 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~  808 (824)
                         ....+..++..+.+++.+||+.||++|||+.|+++.|++++..
T Consensus       232 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~  274 (278)
T 1byg_A          232 ---KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  274 (278)
T ss_dssp             ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence               0011224567799999999999999999999999999998764

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=7.8e-39  Score=356.84  Aligned_cols=358  Identities=24%  Similarity=0.291  Sum_probs=278.1

Q ss_pred             CcccccCCCCCcEEEccCCcccccccccccCCCCCCEEeCCCCcCCcccChhhhCcCCC-------------ceeeccCC
Q 040845           13 TPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTL-------------KAFAVTNN   79 (824)
Q Consensus        13 ~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L-------------~~L~L~~n   79 (824)
                      .|+.+ ..++|++|++++|.+ +.+|.+|+++++|++|++++|.+.+.+|.+++++.+|             ++|++++|
T Consensus         4 ~p~~~-~~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~   81 (454)
T 1jl5_A            4 NPRNV-SNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNL   81 (454)
T ss_dssp             --------------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTS
T ss_pred             ccccc-ccccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCC
Confidence            35555 468999999999999 5899999999999999999999999999999998875             99999999


Q ss_pred             ccccccCccccCCCCCccEEEccCCeeeeecCccccCCCCCceEeccCccccccCCccccCCCCCCEEEccCCcCCCCcC
Q 040845           80 SLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTL  159 (824)
Q Consensus        80 ~l~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~  159 (824)
                      .+++++..     .++|++|++++|.+++ +|..   +++|++|++++|++++. +..   .++|++|++++|+++.++ 
T Consensus        82 ~l~~lp~~-----~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~l-~~~---~~~L~~L~L~~n~l~~lp-  147 (454)
T 1jl5_A           82 GLSSLPEL-----PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKAL-SDL---PPLLEYLGVSNNQLEKLP-  147 (454)
T ss_dssp             CCSCCCSC-----CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSCC-CSC---CTTCCEEECCSSCCSSCC-
T ss_pred             ccccCCCC-----cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCcc-cCC---CCCCCEEECcCCCCCCCc-
Confidence            99987762     4799999999999996 6654   48999999999999953 221   279999999999998754 


Q ss_pred             cccccccCCCCCCCcEEECcCCCCCccCCccccccccccccEEEeecCcceecCCccCCCCCCCCEEEecCCccCCccch
Q 040845          160 DLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPI  239 (824)
Q Consensus       160 ~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~  239 (824)
                            .+.++++|++|++++|++.+++..      +.+|++|++++|++++ +| .++++++|+.|++++|.+++ +|.
T Consensus       148 ------~~~~l~~L~~L~l~~N~l~~lp~~------~~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~  212 (454)
T 1jl5_A          148 ------ELQNSSFLKIIDVDNNSLKKLPDL------PPSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPD  212 (454)
T ss_dssp             ------CCTTCTTCCEEECCSSCCSCCCCC------CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCC
T ss_pred             ------ccCCCCCCCEEECCCCcCcccCCC------cccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCC
Confidence                  388999999999999999975432      3589999999999997 55 69999999999999999986 443


Q ss_pred             hhcCCCCCCEEEcccccCcccCCccccccCCccEEEccCccccccCCccccCCCCCcEEEcCCCCCCCCCCccccccccc
Q 040845          240 TLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDIL  319 (824)
Q Consensus       240 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~  319 (824)
                      .   .++|++|++++|+++ .+|. +..+++|+.|++++|++++ +|..   +++|+.|++++|+++.+|..   +++|+
T Consensus       213 ~---~~~L~~L~l~~n~l~-~lp~-~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~l~~~---~~~L~  280 (454)
T 1jl5_A          213 L---PLSLESIVAGNNILE-ELPE-LQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTDLPEL---PQSLT  280 (454)
T ss_dssp             C---CTTCCEEECCSSCCS-SCCC-CTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSCCCCC---CTTCC
T ss_pred             C---cCcccEEECcCCcCC-cccc-cCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccccCcc---cCcCC
Confidence            2   269999999999999 5664 8999999999999999996 3432   47899999999999999864   38899


Q ss_pred             ccccccccccCcCCccccccccchhhhcccccccccCCCccCCC-CCCCeEEccCccccccCCccccccccccEEEccCc
Q 040845          320 DLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSL-KNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYN  398 (824)
Q Consensus       320 ~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l-~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  398 (824)
                      .|++++|++++. |..   .++|+.|++++|++++. +    .+ ++|+.|++++|++++ +|..   +++|+.|++++|
T Consensus       281 ~L~ls~N~l~~l-~~~---~~~L~~L~l~~N~l~~i-~----~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N  347 (454)
T 1jl5_A          281 FLDVSENIFSGL-SEL---PPNLYYLNASSNEIRSL-C----DLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFN  347 (454)
T ss_dssp             EEECCSSCCSEE-SCC---CTTCCEEECCSSCCSEE-C----CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSS
T ss_pred             EEECcCCccCcc-cCc---CCcCCEEECcCCcCCcc-c----CCcCcCCEEECCCCcccc-cccc---CCcCCEEECCCC
Confidence            999999999863 221   26899999999999863 2    23 589999999999996 6654   589999999999


Q ss_pred             ccCCCCcccccCCcccceeeccCCcccC--CCCC
Q 040845          399 NLSGTIPVSLEKLSYLKDLNLSFNKLKG--EIPR  430 (824)
Q Consensus       399 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~--~~p~  430 (824)
                      +++ .+|.   .+++|+.|++++|++++  .+|.
T Consensus       348 ~l~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~  377 (454)
T 1jl5_A          348 HLA-EVPE---LPQNLKQLHVEYNPLREFPDIPE  377 (454)
T ss_dssp             CCS-CCCC---CCTTCCEEECCSSCCSSCCCCCT
T ss_pred             ccc-cccc---hhhhccEEECCCCCCCcCCCChH
Confidence            999 6776   47899999999999999  5564

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=2.4e-40  Score=377.32  Aligned_cols=262  Identities=27%  Similarity=0.425  Sum_probs=213.5

Q ss_pred             hhccCCCCceeeeccceEEEEEEECCCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEec
Q 040845          525 ATDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       525 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      ..++|++.+.||+|+||.||+|+++++..||||+++... ...+.+.+|+++|++++|+||+++++++.+ +..++||||
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~  342 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  342 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence            356788999999999999999999888899999997543 345779999999999999999999999876 678999999


Q ss_pred             cCCCCHHHHhhhC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 040845          605 MPHGSLEKYLHSS-NYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS  683 (824)
Q Consensus       605 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  683 (824)
                      +++|+|.+++... ...+++.+++.++.||++||+|||   +++|+||||||+|||++.++.+||+|||+++...... .
T Consensus       343 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~  418 (535)
T 2h8h_A          343 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-Y  418 (535)
T ss_dssp             CTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH-H
T ss_pred             hcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc-e
Confidence            9999999999753 246899999999999999999999   9999999999999999999999999999998654211 1


Q ss_pred             cccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhccccccCc
Q 040845          684 MTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ  762 (824)
Q Consensus       684 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  762 (824)
                      .......++..|+|||.+..+.++.++|||||||++|||++ |+.||......+  ....+...                
T Consensus       419 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~--~~~~i~~~----------------  480 (535)
T 2h8h_A          419 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQVERG----------------  480 (535)
T ss_dssp             HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH--HHHHHHTT----------------
T ss_pred             ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcC----------------
Confidence            12223456789999999988899999999999999999999 899987532211  11111100                


Q ss_pred             hhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhccc
Q 040845          763 EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLRN  812 (824)
Q Consensus       763 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~~  812 (824)
                        .+...+..++..+.++|.+||+.||++|||+.++++.|+++..+...+
T Consensus       481 --~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~  528 (535)
T 2h8h_A          481 --YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ  528 (535)
T ss_dssp             --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSCS
T ss_pred             --CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCcc
Confidence              011122356778999999999999999999999999998876544433

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=4.8e-40  Score=355.04  Aligned_cols=266  Identities=18%  Similarity=0.211  Sum_probs=203.1

Q ss_pred             hccCCCCceeeeccceEEEEEEEC----CCcEEEEEEeeccccc-----------hhhhHHHHHHHHhcCCCCcceeEEe
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR----DGMEVAVKVFNLQCGR-----------AFKSFDVECAMMKSIRHRNLVKVIS  590 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~~  590 (824)
                      .++|++.+.||+|+||.||+|.+.    ++..||||+.......           ....+.+|+..++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            367999999999999999999875    5788999998754321           1234667889999999999999999


Q ss_pred             eeec----CCeeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC--
Q 040845          591 SCSN----EEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM--  664 (824)
Q Consensus       591 ~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~--  664 (824)
                      ++..    ....++||||+ +++|.+++...+ .+++.+++.++.|++.||+|||   +.+|+||||||+||+++.++  
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~  190 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPD  190 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESSSTT
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccCCCC
Confidence            9877    77899999999 999999998766 7899999999999999999999   89999999999999998877  


Q ss_pred             cEEEeecccccccCCCCCc-----cccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchh
Q 040845          665 VAHLSDFGIAKLLTGEDQS-----MTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTL  739 (824)
Q Consensus       665 ~~kl~Dfg~a~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~  739 (824)
                      .+||+|||+|+.+......     .......||+.|+|||++.+..++.++|||||||++|||++|+.||..........
T Consensus       191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~  270 (345)
T 2v62_A          191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV  270 (345)
T ss_dssp             SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH
T ss_pred             cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHH
Confidence            9999999999876432211     11234569999999999998889999999999999999999999996533322222


Q ss_pred             hhhhhhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 040845          740 KHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIR  806 (824)
Q Consensus       740 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~  806 (824)
                      ........+. .         ............++..+.+++.+||..||++|||++++++.|+++.
T Consensus       271 ~~~~~~~~~~-~---------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  327 (345)
T 2v62_A          271 QTAKTNLLDE-L---------PQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG  327 (345)
T ss_dssp             HHHHHHHHHT-T---------THHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred             HHHHHhhccc-c---------cHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence            2111110000 0         0000000001145678999999999999999999999999998753

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=5.2e-40  Score=356.27  Aligned_cols=249  Identities=27%  Similarity=0.307  Sum_probs=195.1

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc---chhhhHHHHHHH-HhcCCCCcceeEEeeeecCCeeEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG---RAFKSFDVECAM-MKSIRHRNLVKVISSCSNEEFKAL  600 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~l  600 (824)
                      .++|++.+.||+|+||.||+|+.+ +++.||||+++....   .....+..|..+ ++.++||||+++++++.+.+..|+
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            467999999999999999999876 488999999976532   233455667666 577899999999999999999999


Q ss_pred             EEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 040845          601 VLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE  680 (824)
Q Consensus       601 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  680 (824)
                      ||||+++|+|.+++...+ .+++..+..++.||+.||+|||   +.+|+||||||+||+++.+|.+||+|||+++.....
T Consensus       117 v~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~  192 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH  192 (373)
T ss_dssp             EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred             EEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence            999999999999998755 6889999999999999999999   999999999999999999999999999999864322


Q ss_pred             CCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhcccccc
Q 040845          681 DQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLL  760 (824)
Q Consensus       681 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  760 (824)
                      .  .......||+.|+|||++.+..++.++||||+||++|||++|+.||......+ ....+...            .. 
T Consensus       193 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-~~~~i~~~------------~~-  256 (373)
T 2r5t_A          193 N--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE-MYDNILNK------------PL-  256 (373)
T ss_dssp             C--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH-HHHHHHHS------------CC-
T ss_pred             C--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHhc------------cc-
Confidence            2  12334569999999999999999999999999999999999999997532111 11111110            00 


Q ss_pred             CchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          761 SQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       761 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                             ..+..++..+.+++.+||+.||++||++.+.++.
T Consensus       257 -------~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~  290 (373)
T 2r5t_A          257 -------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFME  290 (373)
T ss_dssp             -------CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHH
T ss_pred             -------CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHH
Confidence                   0012345678999999999999999998644333

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=6.8e-40  Score=353.13  Aligned_cols=247  Identities=28%  Similarity=0.400  Sum_probs=202.1

Q ss_pred             ccCCCCceeeeccceEEEEEEE-CCCcEEEEEEeecccc---chhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEE
Q 040845          527 DKFSENNLIGRGGFGSVYKARI-RDGMEVAVKVFNLQCG---RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVL  602 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  602 (824)
                      +.|+..+.||+|+||.||+|+. .+|+.||||++.....   ...+.+.+|++++++++||||+++++++.+++..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            4588899999999999999986 4689999999875432   23467889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 040845          603 EYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ  682 (824)
Q Consensus       603 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  682 (824)
                      ||++ |++.+++......+++.++..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||++......  
T Consensus       134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~--  207 (348)
T 1u5q_A          134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--  207 (348)
T ss_dssp             ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred             ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC--
Confidence            9996 6888888766668999999999999999999999   899999999999999999999999999999865321  


Q ss_pred             ccccccccccccccCccCcC---CCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccc
Q 040845          683 SMTQTQTLATIGYMAPEYGR---EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANL  759 (824)
Q Consensus       683 ~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  759 (824)
                          ....||+.|+|||++.   .+.++.++|||||||++|||++|+.||....... ..........+         ..
T Consensus       208 ----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-~~~~~~~~~~~---------~~  273 (348)
T 1u5q_A          208 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNESP---------AL  273 (348)
T ss_dssp             ----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHSCCC---------CC
T ss_pred             ----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhcCCC---------CC
Confidence                2346899999999873   5678999999999999999999999986532111 11111111000         00


Q ss_pred             cCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 040845          760 LSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL  802 (824)
Q Consensus       760 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L  802 (824)
                               .+..++..+.+++.+||+.||++|||++|++++-
T Consensus       274 ---------~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~  307 (348)
T 1u5q_A          274 ---------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  307 (348)
T ss_dssp             ---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred             ---------CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence                     0123456688999999999999999999998764

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=4.2e-39  Score=337.83  Aligned_cols=252  Identities=23%  Similarity=0.335  Sum_probs=204.6

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc------chhhhHHHHHHHHhcCCCCcceeEEeeeecCCee
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG------RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFK  598 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  598 (824)
                      .++|++.+.||+|+||.||+|+.. +++.||+|+++....      ...+.+.+|+.++++++||||+++++++.+....
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            357899999999999999999876 589999999875421      1356789999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC----cEEEeecccc
Q 040845          599 ALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM----VAHLSDFGIA  674 (824)
Q Consensus       599 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~----~~kl~Dfg~a  674 (824)
                      ++||||+++++|.+++.... .+++.++..++.|++.|++|||   +.+|+||||||+||+++.++    .+||+|||.+
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~  159 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAEKE-SLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA  159 (283)
T ss_dssp             EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence            99999999999999997654 6899999999999999999999   99999999999999998877    8999999999


Q ss_pred             cccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhh
Q 040845          675 KLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEV  754 (824)
Q Consensus       675 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  754 (824)
                      .......   ......+++.|+|||.+.+..++.++||||+|+++|||++|+.||......+ ....+....        
T Consensus       160 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~--------  227 (283)
T 3bhy_A          160 HKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE-TLTNISAVN--------  227 (283)
T ss_dssp             EECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHTTC--------
T ss_pred             eeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH-HHHHhHhcc--------
Confidence            8764322   2233468999999999998899999999999999999999999987632111 111111000        


Q ss_pred             ccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          755 VDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       755 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                              ..........++..+.+++.+||..||++|||+.|++++
T Consensus       228 --------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  266 (283)
T 3bhy_A          228 --------YDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH  266 (283)
T ss_dssp             --------CCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred             --------cCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence                    000111223456678999999999999999999999985

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.5e-39  Score=342.58  Aligned_cols=261  Identities=24%  Similarity=0.371  Sum_probs=209.4

Q ss_pred             hccCCCCc-eeeeccceEEEEEEEC---CCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeE
Q 040845          526 TDKFSENN-LIGRGGFGSVYKARIR---DGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKA  599 (824)
Q Consensus       526 ~~~~~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  599 (824)
                      ..+|.+.+ .||+|+||.||+|.+.   +++.||||+++...  ....+.+.+|+.+++.++||||+++++++ +.+..+
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~   93 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM   93 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence            46788877 9999999999999642   36889999987543  22356788999999999999999999999 566788


Q ss_pred             EEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCC
Q 040845          600 LVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG  679 (824)
Q Consensus       600 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  679 (824)
                      +||||+++++|.+++.... .+++.+++.++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||++.....
T Consensus        94 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  169 (291)
T 1xbb_A           94 LVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA  169 (291)
T ss_dssp             EEEECCTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred             EEEEeCCCCCHHHHHHhCc-CCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence            9999999999999998765 6899999999999999999999   89999999999999999999999999999987654


Q ss_pred             CCCcc-ccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhccc
Q 040845          680 EDQSM-TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDA  757 (824)
Q Consensus       680 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  757 (824)
                      ..... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......  .....+.....         
T Consensus       170 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~~~~---------  238 (291)
T 1xbb_A          170 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTAMLEKGER---------  238 (291)
T ss_dssp             TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTTCC---------
T ss_pred             CCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHHcCCC---------
Confidence            33221 2223446788999999988889999999999999999999 99998763221  11111111000         


Q ss_pred             cccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhcc
Q 040845          758 NLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLR  811 (824)
Q Consensus       758 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~  811 (824)
                               ...+..++..+.+++.+||+.||++|||+.|+++.|+++..+...
T Consensus       239 ---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~  283 (291)
T 1xbb_A          239 ---------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN  283 (291)
T ss_dssp             ---------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHH
T ss_pred             ---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhh
Confidence                     011224567799999999999999999999999999999876544

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=3.4e-39  Score=360.76  Aligned_cols=266  Identities=22%  Similarity=0.254  Sum_probs=197.1

Q ss_pred             hhccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecc--ccchhhhHHHHHHHHhcCCCCcceeEEeeeecC------
Q 040845          525 ATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQ--CGRAFKSFDVECAMMKSIRHRNLVKVISSCSNE------  595 (824)
Q Consensus       525 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  595 (824)
                      ..++|++.+.||+|+||+||+|... +|+.||||++...  .....+.+.+|+.+++.++||||+++++++...      
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  139 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF  139 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence            3578999999999999999999865 5899999999754  223456788999999999999999999998654      


Q ss_pred             CeeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccc
Q 040845          596 EFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK  675 (824)
Q Consensus       596 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~  675 (824)
                      ...|+||||+++ ++.+.+..   .+++.++..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+|+
T Consensus       140 ~~~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~  212 (464)
T 3ttj_A          140 QDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (464)
T ss_dssp             CEEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred             CeEEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEeee
Confidence            457999999976 57666643   4889999999999999999999   8999999999999999999999999999998


Q ss_pred             ccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCc--ch-
Q 040845          676 LLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPIS--TM-  752 (824)
Q Consensus       676 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~-  752 (824)
                      .....   .......||++|+|||++.+..++.++||||+||++|||++|+.||.+....+ .+...+.......  .. 
T Consensus       213 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~-~~~~i~~~lg~p~~~~~~  288 (464)
T 3ttj_A          213 TAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVIEQLGTPCPEFMK  288 (464)
T ss_dssp             ----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCSCCHHHHT
T ss_pred             ecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHHHH
Confidence            65432   22344679999999999999999999999999999999999999997632111 1111111100000  00 


Q ss_pred             -------hhcc----------ccccCch--hhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          753 -------EVVD----------ANLLSQE--DIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       753 -------~~~~----------~~~~~~~--~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                             ...+          +......  ..........+..+.+|+.+||+.||++|||++|+++|
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                   0000          0000000  00001122346779999999999999999999999986

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.4e-39  Score=348.94  Aligned_cols=259  Identities=28%  Similarity=0.468  Sum_probs=207.2

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCcE--EEEEEeeccc-cchhhhHHHHHHHHhcC-CCCcceeEEeeeecCCeeEEE
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGME--VAVKVFNLQC-GRAFKSFDVECAMMKSI-RHRNLVKVISSCSNEEFKALV  601 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~--vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  601 (824)
                      ++|++.+.||+|+||.||+|+.. ++..  ||||.+.... ....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            67899999999999999999864 4664  4999886432 34456788999999999 899999999999999999999


Q ss_pred             EeccCCCCHHHHhhhCC---------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcE
Q 040845          602 LEYMPHGSLEKYLHSSN---------------YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVA  666 (824)
Q Consensus       602 ~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~  666 (824)
                      |||+++|+|.+++....               ..+++.+++.++.|+++||+|||   +.+|+||||||+||+++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCCeE
Confidence            99999999999997653               46899999999999999999999   9999999999999999999999


Q ss_pred             EEeecccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhh
Q 040845          667 HLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVND  745 (824)
Q Consensus       667 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~  745 (824)
                      ||+|||++.....   ........+++.|+|||.+.+..++.++||||+|+++|||++ |+.||......+  ....+..
T Consensus       182 kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~--~~~~~~~  256 (327)
T 1fvr_A          182 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--LYEKLPQ  256 (327)
T ss_dssp             EECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHGGG
T ss_pred             EEcccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH--HHHHhhc
Confidence            9999999974321   112233457889999999988889999999999999999998 999987632111  1111100


Q ss_pred             hCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhcc
Q 040845          746 CLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLR  811 (824)
Q Consensus       746 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~  811 (824)
                      ..                  ....+..++..+.+++.+||..||++|||+.|++++|+++.+....
T Consensus       257 ~~------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~  304 (327)
T 1fvr_A          257 GY------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT  304 (327)
T ss_dssp             TC------------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred             CC------------------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcC
Confidence            00                  0011223566789999999999999999999999999999875443

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=2.8e-39  Score=342.90  Aligned_cols=251  Identities=21%  Similarity=0.305  Sum_probs=204.0

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEec
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      .++|.+.+.||+|+||.||+|+.. +|+.||+|++........+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL   87 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence            467999999999999999999875 6899999999765444556788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee---CCCCcEEEeecccccccCCCC
Q 040845          605 MPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTGED  681 (824)
Q Consensus       605 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill---~~~~~~kl~Dfg~a~~~~~~~  681 (824)
                      +++++|.+++...+ .+++.++..++.|++.|++|||   +.+|+||||||+||++   +.++.+||+|||++...... 
T Consensus        88 ~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-  162 (304)
T 2jam_A           88 VSGGELFDRILERG-VYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-  162 (304)
T ss_dssp             CCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-
T ss_pred             CCCccHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-
Confidence            99999999987655 6899999999999999999999   8999999999999999   78899999999998754321 


Q ss_pred             CccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccC
Q 040845          682 QSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLS  761 (824)
Q Consensus       682 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  761 (824)
                         ......||+.|+|||.+.+..++.++||||+|+++|||++|+.||......+ ....+.......            
T Consensus       163 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~------------  226 (304)
T 2jam_A          163 ---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK-LFEKIKEGYYEF------------  226 (304)
T ss_dssp             ---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHCCCCC------------
T ss_pred             ---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHcCCCCC------------
Confidence               2233468999999999999999999999999999999999999987532111 111111110000            


Q ss_pred             chhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          762 QEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       762 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                          .......++..+.+++.+||..||++|||+.|++++
T Consensus       227 ----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (304)
T 2jam_A          227 ----ESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH  262 (304)
T ss_dssp             ----CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             ----CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                001112346678999999999999999999999875

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=6.1e-40  Score=352.40  Aligned_cols=254  Identities=22%  Similarity=0.290  Sum_probs=201.8

Q ss_pred             hhccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcC-CCCcceeEEeeeecCCeeEEEE
Q 040845          525 ATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSI-RHRNLVKVISSCSNEEFKALVL  602 (824)
Q Consensus       525 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  602 (824)
                      ..++|++.+.||+|+||.||+|..+ +|+.||||++....    ....+|++++.++ +||||+++++++.+....++||
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK----RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT----CCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc----CChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            3578999999999999999999875 58999999997543    2345688888888 7999999999999999999999


Q ss_pred             eccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCC----CcEEEeecccccccC
Q 040845          603 EYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDN----MVAHLSDFGIAKLLT  678 (824)
Q Consensus       603 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~----~~~kl~Dfg~a~~~~  678 (824)
                      ||+++|+|.+++...+ .+++.++..++.|++.|++|||   +.+|+||||||+||++.++    +.+||+|||++....
T Consensus        96 E~~~gg~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~  171 (342)
T 2qr7_A           96 ELMKGGELLDKILRQK-FFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR  171 (342)
T ss_dssp             CCCCSCBHHHHHHTCT-TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred             eCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence            9999999999997765 6899999999999999999999   9999999999999998533    359999999998764


Q ss_pred             CCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhcccc
Q 040845          679 GEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDAN  758 (824)
Q Consensus       679 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  758 (824)
                      ....  ......||+.|+|||++.+..++.++||||+||++|||++|+.||......  ....+.......         
T Consensus       172 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~~~~i~~~---------  238 (342)
T 2qr7_A          172 AENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD--TPEEILARIGSG---------  238 (342)
T ss_dssp             CTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS--CHHHHHHHHHHC---------
T ss_pred             CCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC--CHHHHHHHHccC---------
Confidence            3322  223456899999999998878999999999999999999999999753211  111111110000         


Q ss_pred             ccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 040845          759 LLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL  802 (824)
Q Consensus       759 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L  802 (824)
                      ....   ....+..++..+.+++.+||..||++|||+.|++++=
T Consensus       239 ~~~~---~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp  279 (342)
T 2qr7_A          239 KFSL---SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHP  279 (342)
T ss_dssp             CCCC---CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSH
T ss_pred             Cccc---CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCC
Confidence            0000   0001123566789999999999999999999998863

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.7e-39  Score=351.96  Aligned_cols=266  Identities=14%  Similarity=0.134  Sum_probs=210.3

Q ss_pred             ccCCCCceeeeccceEEEEEEECC---------CcEEEEEEeeccccchhhhHHHHHHHHhcCCCCccee----------
Q 040845          527 DKFSENNLIGRGGFGSVYKARIRD---------GMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVK----------  587 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------  587 (824)
                      ++|++.+.||+|+||.||+|+...         ++.||||++...     +.+.+|++++++++||||++          
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  116 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL  116 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence            689999999999999999998763         789999998643     56889999999999999988          


Q ss_pred             -----EEeeeec-CCeeEEEEeccCCCCHHHHhhhC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee
Q 040845          588 -----VISSCSN-EEFKALVLEYMPHGSLEKYLHSS-NYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL  660 (824)
Q Consensus       588 -----l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill  660 (824)
                           +++++.. +...++||||+ +++|.+++... ...+++.+++.++.|++.||+|||   +.+|+||||||+||++
T Consensus       117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIl~  192 (352)
T 2jii_A          117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIFV  192 (352)
T ss_dssp             CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGGGEEE
T ss_pred             cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEE
Confidence                 5666655 77889999999 99999999875 247999999999999999999999   8999999999999999


Q ss_pred             CCCC--cEEEeecccccccCCCCCc-----cccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccc
Q 040845          661 DDNM--VAHLSDFGIAKLLTGEDQS-----MTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELF  733 (824)
Q Consensus       661 ~~~~--~~kl~Dfg~a~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~  733 (824)
                      +.++  .+||+|||+++.+......     .......||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus       193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  272 (352)
T 2jii_A          193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL  272 (352)
T ss_dssp             ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence            9998  9999999999876433221     11233479999999999999899999999999999999999999998754


Q ss_pred             cCcchhhhhhhhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhcc
Q 040845          734 NGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLR  811 (824)
Q Consensus       734 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~  811 (824)
                      ................ .....+.         ......++..+.+++.+||..||++|||++|+++.|+++.+....
T Consensus       273 ~~~~~~~~~~~~~~~~-~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~  340 (352)
T 2jii_A          273 PNTEDIMKQKQKFVDK-PGPFVGP---------CGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRV  340 (352)
T ss_dssp             TCHHHHHHHHHHHHHS-CCCEECT---------TSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             cCHHHHHHHHHhccCC-hhhhhhh---------ccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCC
Confidence            3322222222111000 0000000         000112356789999999999999999999999999999876653

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=3.6e-38  Score=354.90  Aligned_cols=343  Identities=26%  Similarity=0.365  Sum_probs=273.4

Q ss_pred             CcccccccccCCcccccCCCCCcEEEccCCcccccccccccCCCCCCEEeCCCCcCCcccChhhhCcCCCceeeccCCcc
Q 040845            2 PSIINNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSL   81 (824)
Q Consensus         2 ~~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l   81 (824)
                      |++.+|.++++ | .+..+++|++|+|++|.+++..+  ++++++|++|++++|.+++..+  +.++++|++|++++|++
T Consensus        51 L~l~~~~i~~l-~-~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l  124 (466)
T 1o6v_A           51 LQADRLGIKSI-D-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQI  124 (466)
T ss_dssp             EECCSSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred             EecCCCCCccC-c-chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEECCCCCC
Confidence            56788888875 3 38999999999999999996544  9999999999999999995544  99999999999999999


Q ss_pred             ccccCccccCCCCCccEEEccCCeeeeecCccccCCCCCceEeccCccccccCCccccCCCCCCEEEccCCcCCCCcCcc
Q 040845           82 SGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDL  161 (824)
Q Consensus        82 ~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~  161 (824)
                      ++.+.   ...+++|++|++++|.+++. + .+..+++|++|+++ |.+.+..  .+.++++|++|++++|.++.++   
T Consensus       125 ~~~~~---~~~l~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~l~-~~~~~~~--~~~~l~~L~~L~l~~n~l~~~~---  193 (466)
T 1o6v_A          125 TDIDP---LKNLTNLNRLELSSNTISDI-S-ALSGLTSLQQLSFG-NQVTDLK--PLANLTTLERLDISSNKVSDIS---  193 (466)
T ss_dssp             CCCGG---GTTCTTCSEEEEEEEEECCC-G-GGTTCTTCSEEEEE-ESCCCCG--GGTTCTTCCEEECCSSCCCCCG---
T ss_pred             CCChH---HcCCCCCCEEECCCCccCCC-h-hhccCCcccEeecC-CcccCch--hhccCCCCCEEECcCCcCCCCh---
Confidence            98765   34699999999999999853 3 58999999999997 5565443  4999999999999999998763   


Q ss_pred             cccccCCCCCCCcEEECcCCCCCccCCccccccccccccEEEeecCcceecCCccCCCCCCCCEEEecCCccCCccchhh
Q 040845          162 SFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITL  241 (824)
Q Consensus       162 ~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~  241 (824)
                          .+..+++|++|++++|.+.+..+                            ++.+++|+.|++++|.+++.  ..+
T Consensus       194 ----~l~~l~~L~~L~l~~n~l~~~~~----------------------------~~~l~~L~~L~l~~n~l~~~--~~l  239 (466)
T 1o6v_A          194 ----VLAKLTNLESLIATNNQISDITP----------------------------LGILTNLDELSLNGNQLKDI--GTL  239 (466)
T ss_dssp             ----GGGGCTTCSEEECCSSCCCCCGG----------------------------GGGCTTCCEEECCSSCCCCC--GGG
T ss_pred             ----hhccCCCCCEEEecCCccccccc----------------------------ccccCCCCEEECCCCCcccc--hhh
Confidence                37889999999999999876543                            23356666667776666643  346


Q ss_pred             cCCCCCCEEEcccccCcccCCccccccCCccEEEccCccccccCCccccCCCCCcEEEcCCCCCCCCCCccccccccccc
Q 040845          242 GKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDL  321 (824)
Q Consensus       242 ~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L  321 (824)
                      ..+++|++|++++|.+++..+  +..+++|+.|++++|++++..+  +..+++|+.|++++|+++.++. +..+++|+.|
T Consensus       240 ~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L  314 (466)
T 1o6v_A          240 ASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP-ISNLKNLTYL  314 (466)
T ss_dssp             GGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG-GGGCTTCSEE
T ss_pred             hcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh-hcCCCCCCEE
Confidence            667777777777777764433  6667777777777777775443  6777778888888888777765 6677888888


Q ss_pred             ccccccccCcCCccccccccchhhhcccccccccCCCccCCCCCCCeEEccCccccccCCccccccccccEEEccCcccC
Q 040845          322 NLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLS  401 (824)
Q Consensus       322 ~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  401 (824)
                      ++++|++++..|  +..+++|+.|++++|++++.  ..+..+++|+.|++++|++++..|  +..+++|+.|++++|+++
T Consensus       315 ~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~  388 (466)
T 1o6v_A          315 TLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWT  388 (466)
T ss_dssp             ECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEE
T ss_pred             ECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCccc
Confidence            888888876554  67888899999999998865  468889999999999999987666  888999999999999998


Q ss_pred             CCCccc
Q 040845          402 GTIPVS  407 (824)
Q Consensus       402 ~~~p~~  407 (824)
                      + .|..
T Consensus       389 ~-~p~~  393 (466)
T 1o6v_A          389 N-APVN  393 (466)
T ss_dssp             C-CCBC
T ss_pred             C-Cchh
Confidence            4 4544

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.9e-39  Score=366.05  Aligned_cols=251  Identities=23%  Similarity=0.362  Sum_probs=207.8

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALV  601 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  601 (824)
                      .++|++.+.||+|+||.||+|+.+ +|+.||||++....   ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            467899999999999999999875 69999999997542   23446678899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 040845          602 LEYMPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE  680 (824)
Q Consensus       602 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  680 (824)
                      |||+++|+|.+++...+ ..+++..++.++.||+.||+|||   +.+|+||||||+||+++.+|.+||+|||+|......
T Consensus       263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~  339 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  339 (576)
T ss_dssp             ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence            99999999999997654 35899999999999999999999   899999999999999999999999999999876433


Q ss_pred             CCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcc--hhhhhhhhhCCCcchhhcccc
Q 040845          681 DQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEM--TLKHWVNDCLPISTMEVVDAN  758 (824)
Q Consensus       681 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  758 (824)
                      .   ......||+.|+|||++.+..++.++||||+||++|||++|+.||........  .+...+... +.         
T Consensus       340 ~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~-~~---------  406 (576)
T 2acx_A          340 Q---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV-PE---------  406 (576)
T ss_dssp             C---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC-CC---------
T ss_pred             c---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc-cc---------
Confidence            2   22335799999999999998999999999999999999999999976432111  111111100 00         


Q ss_pred             ccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 040845          759 LLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRI-----NAKEIVAK  801 (824)
Q Consensus       759 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~evl~~  801 (824)
                               ..+..++..+.+++.+||+.||++||     +++|+++|
T Consensus       407 ---------~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H  445 (576)
T 2acx_A          407 ---------EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH  445 (576)
T ss_dssp             ---------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred             ---------cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence                     00123456789999999999999999     78998876

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=7e-40  Score=351.26  Aligned_cols=259  Identities=25%  Similarity=0.417  Sum_probs=206.6

Q ss_pred             hccCCCCceeeeccceEEEEEEEC------CCcEEEEEEeeccc-cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCee
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR------DGMEVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFK  598 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  598 (824)
                      .++|++.+.||+|+||.||+|++.      +++.||||++.... ......+.+|+.++++++||||+++++++.+....
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            478999999999999999999842      47789999986442 23456788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhhCC------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC---CCcEEEe
Q 040845          599 ALVLEYMPHGSLEKYLHSSN------YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD---NMVAHLS  669 (824)
Q Consensus       599 ~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~  669 (824)
                      ++||||+++++|.+++....      ..+++.+++.++.|++.||+|||   +.+|+||||||+||+++.   +..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEEEC
Confidence            99999999999999998654      35889999999999999999999   999999999999999984   4569999


Q ss_pred             ecccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCC
Q 040845          670 DFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLP  748 (824)
Q Consensus       670 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  748 (824)
                      |||++................+|+.|+|||.+.+..++.++||||||+++|||+| |..||......  .....+.....
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~~~~~~~  263 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--EVLEFVTSGGR  263 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHHHHHHTTCC
T ss_pred             ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH--HHHHHHhcCCC
Confidence            9999986644333333344567899999999988899999999999999999998 88898653211  11111111000


Q ss_pred             CcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 040845          749 ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRD  807 (824)
Q Consensus       749 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~  807 (824)
                                        ...+..++..+.+++.+||+.||++|||+.|++++|+.+.+
T Consensus       264 ------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  304 (327)
T 2yfx_A          264 ------------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  304 (327)
T ss_dssp             ------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence                              00112356678999999999999999999999999999875

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2.3e-39  Score=347.23  Aligned_cols=271  Identities=22%  Similarity=0.294  Sum_probs=198.4

Q ss_pred             HHhhccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc--chhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeE
Q 040845          523 FQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG--RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKA  599 (824)
Q Consensus       523 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  599 (824)
                      ....++|++.+.||+|+||+||+|+.. +++.||||+++....  ...+.+.+|+.++++++||||+++++++.+++..+
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (329)
T 3gbz_A           30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH  109 (329)
T ss_dssp             --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred             ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence            344678999999999999999999865 689999999865432  23456778999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee-----CCCCcEEEeecccc
Q 040845          600 LVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL-----DDNMVAHLSDFGIA  674 (824)
Q Consensus       600 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill-----~~~~~~kl~Dfg~a  674 (824)
                      +||||++ |+|.+++.... .+++.++..++.|++.||+|||   +.+|+||||||+||++     +.++.+||+|||++
T Consensus       110 lv~e~~~-~~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a  184 (329)
T 3gbz_A          110 LIFEYAE-NDLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA  184 (329)
T ss_dssp             EEEECCS-EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred             EEEecCC-CCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence            9999997 59999998765 6899999999999999999999   8999999999999999     45556999999999


Q ss_pred             cccCCCCCccccccccccccccCccCcCCC-CCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhC-CCc-c
Q 040845          675 KLLTGEDQSMTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCL-PIS-T  751 (824)
Q Consensus       675 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~-~  751 (824)
                      .......  .......+|+.|+|||++.+. .++.++||||+||++|||++|+.||......+ .......... +.. .
T Consensus       185 ~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~  261 (329)
T 3gbz_A          185 RAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID-QLFKIFEVLGLPDDTT  261 (329)
T ss_dssp             HHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCTTT
T ss_pred             cccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH-HHHHHHHHhCCCchhh
Confidence            8764222  223345689999999998775 48999999999999999999999997632211 1111111110 000 0


Q ss_pred             h-hhc-----cc--cccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          752 M-EVV-----DA--NLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       752 ~-~~~-----~~--~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      . ...     ..  ............+..++..+.+++.+||+.||++|||++|++++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  319 (329)
T 3gbz_A          262 WPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH  319 (329)
T ss_dssp             STTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             hhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence            0 000     00  00011111222233456789999999999999999999999874

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=3.5e-39  Score=356.86  Aligned_cols=254  Identities=22%  Similarity=0.287  Sum_probs=195.6

Q ss_pred             HhhccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc--------cchhhhHHHHHHHHhcCCCCcceeEEeeeec
Q 040845          524 QATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC--------GRAFKSFDVECAMMKSIRHRNLVKVISSCSN  594 (824)
Q Consensus       524 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  594 (824)
                      ...++|.+.+.||+|+||.||+|... +++.||||++....        ......+.+|+.++++++||||+++++++..
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  211 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA  211 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            34678999999999999999999865 58999999987542        1223457899999999999999999999864


Q ss_pred             CCeeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCC---CcEEEeec
Q 040845          595 EEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDN---MVAHLSDF  671 (824)
Q Consensus       595 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~---~~~kl~Df  671 (824)
                       +..++||||+++|+|.+++.... .+++.++..++.|++.||+|||   +.+|+||||||+||+++.+   +.+||+||
T Consensus       212 -~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl~DF  286 (419)
T 3i6u_A          212 -EDYYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDF  286 (419)
T ss_dssp             -SEEEEEEECCTTCBGGGGTSSSC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred             -CceEEEEEcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEEEeec
Confidence             45789999999999999987655 7899999999999999999999   8999999999999999754   45999999


Q ss_pred             ccccccCCCCCccccccccccccccCccCcCC---CCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCC
Q 040845          672 GIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE---GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLP  748 (824)
Q Consensus       672 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  748 (824)
                      |+|+......   ......||+.|+|||++.+   ..++.++||||+||++|||++|+.||............+......
T Consensus       287 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~  363 (419)
T 3i6u_A          287 GHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN  363 (419)
T ss_dssp             STTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCC
T ss_pred             ccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCC
Confidence            9998754221   2234568999999999853   567889999999999999999999997633222111111111000


Q ss_pred             CcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          749 ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       749 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                                      ........++..+.+++.+||+.||++|||++|++++
T Consensus       364 ----------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  400 (419)
T 3i6u_A          364 ----------------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  400 (419)
T ss_dssp             ----------------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             ----------------CCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence                            0011122456779999999999999999999999875

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=3e-39  Score=362.82  Aligned_cols=195  Identities=25%  Similarity=0.371  Sum_probs=155.3

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeec-----CCe
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSN-----EEF  597 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~  597 (824)
                      .++|++.+.||+|+||+||+|+.. +++.||||++....  ....+.+.+|+++++.++||||+++++++..     ...
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            478999999999999999999865 58999999986532  2345678899999999999999999999843     357


Q ss_pred             eEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccccc
Q 040845          598 KALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  677 (824)
Q Consensus       598 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~  677 (824)
                      .|+||||+ +++|.+++.... .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+..
T Consensus       132 ~~lv~e~~-~~~L~~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  206 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFRTPV-YLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTV  206 (458)
T ss_dssp             EEEEECCC-SEEHHHHHHSSC-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred             EEEEEecc-ccchhhhcccCC-CCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccchhc
Confidence            89999998 569999997654 7899999999999999999999   999999999999999999999999999999876


Q ss_pred             CCCCCc-------------------------cccccccccccccCccCc-CCCCCCccchHHHHHHHHHHHHhC
Q 040845          678 TGEDQS-------------------------MTQTQTLATIGYMAPEYG-REGQVSTNGDVYSFGIMLMETFTR  725 (824)
Q Consensus       678 ~~~~~~-------------------------~~~~~~~~~~~y~aPE~~-~~~~~~~~~DvwslG~~l~el~tg  725 (824)
                      ......                         ...+..+||++|+|||++ ....++.++||||+||++|||++|
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            432211                         123445789999999975 566799999999999999999994

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-39  Score=349.99  Aligned_cols=272  Identities=23%  Similarity=0.295  Sum_probs=201.7

Q ss_pred             HHhhccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc-----chhhhHHHHHHHHhcCCCCcceeEEeeeecCC
Q 040845          523 FQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG-----RAFKSFDVECAMMKSIRHRNLVKVISSCSNEE  596 (824)
Q Consensus       523 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  596 (824)
                      ....++|++.+.||+|+||.||+|+.. +|+.||||++.....     ...+.+.+|+++++.++||||+++++++.+..
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (346)
T 1ua2_A            6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS   85 (346)
T ss_dssp             -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence            345678999999999999999999875 589999999865321     12356789999999999999999999999999


Q ss_pred             eeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccc
Q 040845          597 FKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  676 (824)
Q Consensus       597 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~  676 (824)
                      ..++||||+++ +|.+++......+++.++..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||++..
T Consensus        86 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (346)
T 1ua2_A           86 NISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKS  161 (346)
T ss_dssp             CCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred             ceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence            99999999975 899999877667889999999999999999999   99999999999999999999999999999987


Q ss_pred             cCCCCCccccccccccccccCccCcCCC-CCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcc---h
Q 040845          677 LTGEDQSMTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPIST---M  752 (824)
Q Consensus       677 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~  752 (824)
                      +....  .......+|+.|+|||.+.+. .++.++||||+||++|||++|.+||......+ .+............   .
T Consensus       162 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~  238 (346)
T 1ua2_A          162 FGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD-QLTRIFETLGTPTEEQWP  238 (346)
T ss_dssp             TTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCTTTSS
T ss_pred             ccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHcCCCChhhhh
Confidence            64322  223345689999999988654 58999999999999999999999987632211 11222211111000   0


Q ss_pred             hh---ccccccCc-hh-hhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          753 EV---VDANLLSQ-ED-IHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       753 ~~---~~~~~~~~-~~-~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      +.   .+...... +. ........++..+.+++.+||+.||++|||+.|++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          239 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            00   00000000 00 0001113456789999999999999999999999886

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2e-39  Score=342.27  Aligned_cols=250  Identities=20%  Similarity=0.295  Sum_probs=207.1

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALV  601 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  601 (824)
                      .++|.+.+.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            467999999999999999999876 48899999987542   23456788899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 040845          602 LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED  681 (824)
Q Consensus       602 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  681 (824)
                      |||+++++|.+++.... .+++.++..++.|+++|++|||   +.+|+||||||+||+++.++.+||+|||.+.......
T Consensus        94 ~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  169 (294)
T 2rku_A           94 LELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  169 (294)
T ss_dssp             EECCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence            99999999999987654 6899999999999999999999   8999999999999999999999999999998764322


Q ss_pred             CccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccC
Q 040845          682 QSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLS  761 (824)
Q Consensus       682 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  761 (824)
                      .  ......+|+.|+|||.+.+..++.++||||+|+++|||++|+.||......+. ...+....               
T Consensus       170 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~---------------  231 (294)
T 2rku_A          170 E--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET-YLRIKKNE---------------  231 (294)
T ss_dssp             C--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHTTC---------------
T ss_pred             c--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHhhcc---------------
Confidence            2  22345689999999999988899999999999999999999999976322111 11110000               


Q ss_pred             chhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 040845          762 QEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL  802 (824)
Q Consensus       762 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L  802 (824)
                           ...+..++..+.+++.+||+.||++|||++|++++-
T Consensus       232 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~  267 (294)
T 2rku_A          232 -----YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDE  267 (294)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred             -----CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence                 001123455688999999999999999999999863

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=6.3e-39  Score=348.42  Aligned_cols=258  Identities=25%  Similarity=0.378  Sum_probs=208.3

Q ss_pred             HHHHHhhccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc--------chhhhHHHHHHHHhcC-CCCcceeEE
Q 040845          520 LELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG--------RAFKSFDVECAMMKSI-RHRNLVKVI  589 (824)
Q Consensus       520 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~niv~l~  589 (824)
                      .......++|++.+.||+|+||.||+|+.. +|+.||||++.....        ...+.+.+|+.+++++ +||||++++
T Consensus        87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~  166 (365)
T 2y7j_A           87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI  166 (365)
T ss_dssp             HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred             hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence            344555678999999999999999999875 699999999875432        1245678899999999 799999999


Q ss_pred             eeeecCCeeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEe
Q 040845          590 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLS  669 (824)
Q Consensus       590 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  669 (824)
                      +++......++||||+++++|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+
T Consensus       167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ikl~  242 (365)
T 2y7j_A          167 DSYESSSFMFLVFDLMRKGELFDYLTEKV-ALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLS  242 (365)
T ss_dssp             EEEEBSSEEEEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEEC
T ss_pred             EEEeeCCEEEEEEEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEE
Confidence            99999999999999999999999997654 6899999999999999999999   8999999999999999999999999


Q ss_pred             ecccccccCCCCCccccccccccccccCccCcCC------CCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhh
Q 040845          670 DFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE------GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWV  743 (824)
Q Consensus       670 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~  743 (824)
                      |||++..+.....   .....||+.|+|||++.+      ..++.++|||||||++|||++|+.||.....  ......+
T Consensus       243 DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~--~~~~~~i  317 (365)
T 2y7j_A          243 DFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ--ILMLRMI  317 (365)
T ss_dssp             CCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHH
T ss_pred             ecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH--HHHHHHH
Confidence            9999987653322   234568999999998753      3588999999999999999999999975321  1111111


Q ss_pred             hhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          744 NDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       744 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      ....            ..   ........++..+.+++.+||..||++|||+.|++++
T Consensus       318 ~~~~------------~~---~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  360 (365)
T 2y7j_A          318 MEGQ------------YQ---FSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH  360 (365)
T ss_dssp             HHTC------------CC---CCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HhCC------------CC---CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            1000            00   0011122446678999999999999999999999874

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=2.5e-39  Score=339.60  Aligned_cols=251  Identities=25%  Similarity=0.359  Sum_probs=198.8

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc-cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEe
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLE  603 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  603 (824)
                      .++|.+.+.||+|+||.||+|+.. ++..||+|++.... ....+.+.+|++++++++||||+++++++.+....++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  100 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME  100 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence            367899999999999999999865 58999999987654 2345778999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhhC---CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee---CCCCcEEEeeccccccc
Q 040845          604 YMPHGSLEKYLHSS---NYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLL  677 (824)
Q Consensus       604 ~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill---~~~~~~kl~Dfg~a~~~  677 (824)
                      |+++|+|.+++...   ...+++..++.++.|+++||+|||   +.+|+||||||+||++   +.++.+||+|||++...
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A          101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            99999999998643   357899999999999999999999   9999999999999999   45688999999999865


Q ss_pred             CCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccc
Q 040845          678 TGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDA  757 (824)
Q Consensus       678 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  757 (824)
                      ....   ......+|+.|+|||.+. +.++.++||||+|+++|||++|+.||......+  .........+.        
T Consensus       178 ~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~--~~~~~~~~~~~--------  243 (285)
T 3is5_A          178 KSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE--VQQKATYKEPN--------  243 (285)
T ss_dssp             ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHCCCC--------
T ss_pred             CCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH--HHhhhccCCcc--------
Confidence            4322   223456899999999875 568999999999999999999999997632211  11111100000        


Q ss_pred             cccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          758 NLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       758 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                        ...      ....+++.+.+++.+||+.||++|||+.|++++
T Consensus       244 --~~~------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  279 (285)
T 3is5_A          244 --YAV------ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH  279 (285)
T ss_dssp             --CCC--------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             --ccc------ccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              000      001134568899999999999999999999864

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=5.2e-39  Score=363.34  Aligned_cols=251  Identities=23%  Similarity=0.330  Sum_probs=205.0

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVL  602 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  602 (824)
                      .++|++.+.||+|+||+||+|+.. +++.||||++....  ......+.+|++++++++||||+++++++.+....++||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  100 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence            468999999999999999999875 68999999986542  334567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC---CCCcEEEeecccccccCC
Q 040845          603 EYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLTG  679 (824)
Q Consensus       603 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~---~~~~~kl~Dfg~a~~~~~  679 (824)
                      ||+++|+|.+++.... .+++.++..++.|++.||+|||   +.+|+||||||+||+++   .++.+||+|||++..+..
T Consensus       101 e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  176 (486)
T 3mwu_A          101 ELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ  176 (486)
T ss_dssp             CCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred             EcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence            9999999999987655 6899999999999999999999   99999999999999995   566899999999986643


Q ss_pred             CCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccc
Q 040845          680 EDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANL  759 (824)
Q Consensus       680 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  759 (824)
                      ..   ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||......+ ....+......           
T Consensus       177 ~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~-----------  240 (486)
T 3mwu_A          177 NT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-ILKRVETGKYA-----------  240 (486)
T ss_dssp             C-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCCC-----------
T ss_pred             CC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCC-----------
Confidence            22   2234569999999999875 58999999999999999999999997632211 11111111100           


Q ss_pred             cCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          760 LSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       760 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                           ........++..+.+++.+||+.||++|||+.|++++
T Consensus       241 -----~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          241 -----FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             -----SCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             -----CCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                 0111223456778999999999999999999999986

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=3.2e-39  Score=338.81  Aligned_cols=247  Identities=25%  Similarity=0.349  Sum_probs=205.7

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALV  601 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  601 (824)
                      .++|++.+.||+|+||.||+|+.. +++.||||++....   ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            367999999999999999999876 57899999986542   22346788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 040845          602 LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED  681 (824)
Q Consensus       602 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  681 (824)
                      |||+++++|.+++...+ .+++.++..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||++...... 
T Consensus        93 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~-  167 (284)
T 2vgo_A           93 LEFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-  167 (284)
T ss_dssp             ECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-
T ss_pred             EEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCccc-
Confidence            99999999999998765 6899999999999999999999   999999999999999999999999999998765322 


Q ss_pred             CccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccC
Q 040845          682 QSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLS  761 (824)
Q Consensus       682 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  761 (824)
                         ......|++.|+|||.+.+..++.++||||+|+++|||++|+.||......+ ........          +     
T Consensus       168 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~----------~-----  228 (284)
T 2vgo_A          168 ---RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE-THRRIVNV----------D-----  228 (284)
T ss_dssp             ---CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHTT----------C-----
T ss_pred             ---ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH-HHHHHhcc----------c-----
Confidence               1233568999999999999899999999999999999999999997532111 01111100          0     


Q ss_pred             chhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          762 QEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       762 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                           ...+..++..+.+++.+||..||++|||+.|++++
T Consensus       229 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  263 (284)
T 2vgo_A          229 -----LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH  263 (284)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred             -----cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence                 00112345678899999999999999999999986

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=6e-39  Score=349.31  Aligned_cols=278  Identities=21%  Similarity=0.248  Sum_probs=206.1

Q ss_pred             cccHHHHHHhhccCCCCceeeeccceEEEEEEECCCcEEEEEEeeccccc-----------hhhhHHHHHHHHhcCCCCc
Q 040845          516 RFSYLELFQATDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGR-----------AFKSFDVECAMMKSIRHRN  584 (824)
Q Consensus       516 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~n  584 (824)
                      +....++....++|++.+.||+|+||.||+|...+|+.||||++......           ..+.+.+|++++++++|||
T Consensus        11 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~   90 (362)
T 3pg1_A           11 RDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPN   90 (362)
T ss_dssp             HHHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTT
T ss_pred             HHHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcC
Confidence            34466788889999999999999999999999888999999998644221           1367889999999999999


Q ss_pred             ceeEEeeeec-----CCeeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCee
Q 040845          585 LVKVISSCSN-----EEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVL  659 (824)
Q Consensus       585 iv~l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nil  659 (824)
                      |+++++++..     ....++||||++ |+|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+
T Consensus        91 iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl  166 (362)
T 3pg1_A           91 ILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNIL  166 (362)
T ss_dssp             BCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEE
T ss_pred             ccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHEE
Confidence            9999999843     346899999997 6899998877668999999999999999999999   899999999999999


Q ss_pred             eCCCCcEEEeecccccccCCCCCccccccccccccccCccCcCC-CCCCccchHHHHHHHHHHHHhCCCCCcccccCcch
Q 040845          660 LDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMT  738 (824)
Q Consensus       660 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~  738 (824)
                      ++.++.+||+|||++.......   ......+|+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+ .
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~  242 (362)
T 3pg1_A          167 LADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN-Q  242 (362)
T ss_dssp             ECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-H
T ss_pred             EcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH-H
Confidence            9999999999999997543222   2334568999999998876 678999999999999999999999997632211 1


Q ss_pred             hhhhhhhhCCCcch-----------hhccccccCc-hhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          739 LKHWVNDCLPISTM-----------EVVDANLLSQ-EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       739 ~~~~~~~~~~~~~~-----------~~~~~~~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      ..............           +......... ..........++..+.+++.+||+.||++|||+.|++++
T Consensus       243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  317 (362)
T 3pg1_A          243 LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH  317 (362)
T ss_dssp             HHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence            11111111110000           0000000000 000111223456779999999999999999999999875

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.1e-38  Score=335.79  Aligned_cols=248  Identities=25%  Similarity=0.371  Sum_probs=199.0

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeec----CCeeE
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSN----EEFKA  599 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~  599 (824)
                      ..|.+.+.||+|+||.||+|... ++..||+|.+....  ....+.+.+|+.+++.++||||+++++++..    ....+
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  105 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence            34777889999999999999865 58899999987543  3345678899999999999999999998864    45689


Q ss_pred             EEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC--eEecCCCCCCeeeC-CCCcEEEeecccccc
Q 040845          600 LVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAP--VIHCDLKPSNVLLD-DNMVAHLSDFGIAKL  676 (824)
Q Consensus       600 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlk~~Nill~-~~~~~kl~Dfg~a~~  676 (824)
                      +||||+++++|.+++.... .+++..++.++.|++.|++|||   +.+  |+||||||+||+++ .++.+||+|||++..
T Consensus       106 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~  181 (290)
T 1t4h_A          106 LVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             EEEEecCCCCHHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence            9999999999999998754 6899999999999999999999   888  99999999999998 889999999999975


Q ss_pred             cCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhcc
Q 040845          677 LTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVD  756 (824)
Q Consensus       677 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  756 (824)
                      ....    ......||+.|+|||.+. +.++.++||||+|+++|+|++|+.||..................+        
T Consensus       182 ~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--------  248 (290)
T 1t4h_A          182 KRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP--------  248 (290)
T ss_dssp             CCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC--------
T ss_pred             cccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCc--------
Confidence            4322    223456899999999876 458999999999999999999999997532221111111110000        


Q ss_pred             ccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          757 ANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       757 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                                ...+..+++.+.+++.+||+.||++|||++|++++
T Consensus       249 ----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  283 (290)
T 1t4h_A          249 ----------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             ----------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ----------cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence                      01112234568999999999999999999999875

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=5e-39  Score=346.42  Aligned_cols=258  Identities=24%  Similarity=0.308  Sum_probs=191.6

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcCC-CCcceeEEeeee--------cC
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIR-HRNLVKVISSCS--------NE  595 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~--------~~  595 (824)
                      ..+|++.+.||+|+||.||+|++. +++.||||++........+.+.+|+.+++++. ||||+++++++.        ..
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            357999999999999999999875 58999999987665556678899999999996 999999999983        34


Q ss_pred             CeeEEEEeccCCCCHHHHhhh--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC--eEecCCCCCCeeeCCCCcEEEeec
Q 040845          596 EFKALVLEYMPHGSLEKYLHS--SNYSLDIFQRLNIMIDVASALEYLHFGYSAP--VIHCDLKPSNVLLDDNMVAHLSDF  671 (824)
Q Consensus       596 ~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlk~~Nill~~~~~~kl~Df  671 (824)
                      ...++||||++ |+|.+++..  ....+++.+++.++.|++.||+|||   +.+  |+||||||+||+++.++.+||+||
T Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~kl~Df  182 (337)
T 3ll6_A          107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIKLCDF  182 (337)
T ss_dssp             EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred             ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEEEecC
Confidence            56789999995 699998865  3346999999999999999999999   888  999999999999999999999999


Q ss_pred             ccccccCCCCCcc----------ccccccccccccCccCc---CCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcch
Q 040845          672 GIAKLLTGEDQSM----------TQTQTLATIGYMAPEYG---REGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMT  738 (824)
Q Consensus       672 g~a~~~~~~~~~~----------~~~~~~~~~~y~aPE~~---~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~  738 (824)
                      |++..........          ......+|+.|+|||.+   .+..++.++|||||||++|||++|+.||.......  
T Consensus       183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--  260 (337)
T 3ll6_A          183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR--  260 (337)
T ss_dssp             TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred             ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH--
Confidence            9998765432211          11134589999999988   56678999999999999999999999986532111  


Q ss_pred             hhhhhhhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhc
Q 040845          739 LKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLL  810 (824)
Q Consensus       739 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~  810 (824)
                         ........                  ..+..++..+.+++.+||+.||++|||+.|++++|+.+.....
T Consensus       261 ---~~~~~~~~------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~  311 (337)
T 3ll6_A          261 ---IVNGKYSI------------------PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN  311 (337)
T ss_dssp             --------CCC------------------CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred             ---hhcCcccC------------------CcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence               11100000                  0011223347789999999999999999999999999976543

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=3.1e-39  Score=374.05  Aligned_cols=252  Identities=25%  Similarity=0.386  Sum_probs=202.5

Q ss_pred             ceeeeccceEEEEEEEC---CCcEEEEEEeecccc--chhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEeccCC
Q 040845          533 NLIGRGGFGSVYKARIR---DGMEVAVKVFNLQCG--RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPH  607 (824)
Q Consensus       533 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  607 (824)
                      +.||+|+||.||+|.+.   .++.||||+++....  ...+.+.+|++++++++||||+++++++.. +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            47999999999999653   467899999976432  335789999999999999999999999965 457899999999


Q ss_pred             CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc-ccc
Q 040845          608 GSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS-MTQ  686 (824)
Q Consensus       608 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~  686 (824)
                      |+|.+++.... .+++.+++.++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+|+.+...... ...
T Consensus       454 g~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  529 (635)
T 4fl3_A          454 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  529 (635)
T ss_dssp             EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred             CCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence            99999997655 7899999999999999999999   999999999999999999999999999999876543322 223


Q ss_pred             ccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhh
Q 040845          687 TQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDI  765 (824)
Q Consensus       687 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  765 (824)
                      ....+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+  ....+....                  
T Consensus       530 ~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--~~~~i~~~~------------------  589 (635)
T 4fl3_A          530 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VTAMLEKGE------------------  589 (635)
T ss_dssp             -----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHHTTC------------------
T ss_pred             cCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCC------------------
Confidence            34457889999999998899999999999999999998 999997632211  111111100                  


Q ss_pred             hhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhh
Q 040845          766 HFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSL  809 (824)
Q Consensus       766 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~  809 (824)
                      ....+..++.++.++|.+||+.||++|||+.++++.|+++..++
T Consensus       590 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l  633 (635)
T 4fl3_A          590 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV  633 (635)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence            11112346778999999999999999999999999999987654

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.3e-38  Score=349.80  Aligned_cols=251  Identities=21%  Similarity=0.271  Sum_probs=193.5

Q ss_pred             hccCCCC-ceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHh-cCCCCcceeEEeeeec----CCee
Q 040845          526 TDKFSEN-NLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMK-SIRHRNLVKVISSCSN----EEFK  598 (824)
Q Consensus       526 ~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~----~~~~  598 (824)
                      .++|.+. +.||+|+||+||+|... +|+.||||++..     ...+.+|++++. ..+||||+++++++..    ....
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~  134 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL  134 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence            3567665 68999999999999875 589999999863     245677888874 4589999999999865    5678


Q ss_pred             EEEEeccCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC---CCcEEEeecccc
Q 040845          599 ALVLEYMPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD---NMVAHLSDFGIA  674 (824)
Q Consensus       599 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~Dfg~a  674 (824)
                      ++||||+++|+|.+++.... ..+++.++..++.||+.||+|||   +.+|+||||||+||+++.   ++.+||+|||++
T Consensus       135 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a  211 (400)
T 1nxk_A          135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA  211 (400)
T ss_dssp             EEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEecccc
Confidence            99999999999999998654 46899999999999999999999   899999999999999997   789999999999


Q ss_pred             cccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcch--hhhhhhhhCCCcch
Q 040845          675 KLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMT--LKHWVNDCLPISTM  752 (824)
Q Consensus       675 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~~  752 (824)
                      +......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||.........  ....+....     
T Consensus       212 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~-----  283 (400)
T 1nxk_A          212 KETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ-----  283 (400)
T ss_dssp             EECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTC-----
T ss_pred             cccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCc-----
Confidence            8654222   223456899999999999999999999999999999999999999764322110  111110000     


Q ss_pred             hhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 040845          753 EVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL  802 (824)
Q Consensus       753 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L  802 (824)
                             ....   ......++.++.+++.+||+.||++|||+.|++++-
T Consensus       284 -------~~~~---~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp  323 (400)
T 1nxk_A          284 -------YEFP---NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP  323 (400)
T ss_dssp             -------CCCC---TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred             -------ccCC---CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence                   0000   001123567789999999999999999999999864

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2.3e-39  Score=348.22  Aligned_cols=249  Identities=20%  Similarity=0.293  Sum_probs=206.7

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALV  601 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  601 (824)
                      ..+|.+.+.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            468999999999999999999876 47899999987542   23456788899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 040845          602 LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED  681 (824)
Q Consensus       602 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  681 (824)
                      |||+++++|.+++.... .+++.+++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++.......
T Consensus       120 ~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  195 (335)
T 2owb_A          120 LELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  195 (335)
T ss_dssp             ECCCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EecCCCCCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence            99999999999987654 7899999999999999999999   8999999999999999999999999999998764322


Q ss_pred             CccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccC
Q 040845          682 QSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLS  761 (824)
Q Consensus       682 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  761 (824)
                      .  ......||..|+|||.+.+..++.++||||||+++|||++|+.||......+. ...+.....              
T Consensus       196 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~--------------  258 (335)
T 2owb_A          196 E--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET-YLRIKKNEY--------------  258 (335)
T ss_dssp             C--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHHTCC--------------
T ss_pred             c--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH-HHHHhcCCC--------------
Confidence            2  22345689999999999888899999999999999999999999975321110 111111000              


Q ss_pred             chhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          762 QEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       762 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                            ..+..++..+.+++.+||+.||++|||+.|++++
T Consensus       259 ------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          259 ------SIPKHINPVAASLIQKMLQTDPTARPTINELLND  292 (335)
T ss_dssp             ------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             ------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                  0112345568899999999999999999999986

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=2.2e-39  Score=340.24  Aligned_cols=252  Identities=26%  Similarity=0.416  Sum_probs=206.0

Q ss_pred             hhccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeec---------
Q 040845          525 ATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSN---------  594 (824)
Q Consensus       525 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---------  594 (824)
                      ...+|++.+.||+|+||.||+|++. +++.||+|++....    +.+.+|++++++++||||+++++++..         
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            3467999999999999999999876 69999999987542    457789999999999999999998854         


Q ss_pred             -------CCeeEEEEeccCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcE
Q 040845          595 -------EEFKALVLEYMPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVA  666 (824)
Q Consensus       595 -------~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~  666 (824)
                             ....++||||+++++|.+++.... ..+++..++.++.|++.|++|||   +.+|+||||||+||+++.++.+
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~  161 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQV  161 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEE
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCCCCE
Confidence                   445789999999999999997543 57899999999999999999999   8999999999999999999999


Q ss_pred             EEeecccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhh
Q 040845          667 HLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDC  746 (824)
Q Consensus       667 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~  746 (824)
                      ||+|||++........   .....+++.|+|||.+.+..++.++||||||+++|||++|..|+....       .+....
T Consensus       162 kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-------~~~~~~  231 (284)
T 2a19_B          162 KIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS-------KFFTDL  231 (284)
T ss_dssp             EECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH-------HHHHHH
T ss_pred             EECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH-------HHHHHh
Confidence            9999999987653322   233468999999999988889999999999999999999998865311       111100


Q ss_pred             CCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhcc
Q 040845          747 LPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLR  811 (824)
Q Consensus       747 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~  811 (824)
                      ..        . .         .+..++..+.+++.+||..||++|||+.|++++|+.+.++...
T Consensus       232 ~~--------~-~---------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~  278 (284)
T 2a19_B          232 RD--------G-I---------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEK  278 (284)
T ss_dssp             HT--------T-C---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC----
T ss_pred             hc--------c-c---------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCc
Confidence            00        0 0         0112345688999999999999999999999999998765444

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.2e-39  Score=345.48  Aligned_cols=253  Identities=23%  Similarity=0.346  Sum_probs=202.5

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEec
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      .++|++.+.||+|+||.||+|++. +++.||+|++........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   97 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF   97 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence            467999999999999999999876 4899999998766566678889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 040845          605 MPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM  684 (824)
Q Consensus       605 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  684 (824)
                      +++++|.+++......+++.++..++.|++.|++|||   +.+++||||||+||+++.++.+||+|||++......  ..
T Consensus        98 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~  172 (302)
T 2j7t_A           98 CPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT--LQ  172 (302)
T ss_dssp             CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH--HH
T ss_pred             CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc--cc
Confidence            9999999999876667999999999999999999999   899999999999999999999999999987643211  11


Q ss_pred             ccccccccccccCccCc-----CCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccc
Q 040845          685 TQTQTLATIGYMAPEYG-----REGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANL  759 (824)
Q Consensus       685 ~~~~~~~~~~y~aPE~~-----~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  759 (824)
                      ......||+.|+|||.+     .+..++.++||||+|+++|||++|+.||....... ..........+           
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~-----------  240 (302)
T 2j7t_A          173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-VLLKIAKSDPP-----------  240 (302)
T ss_dssp             C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHSCCC-----------
T ss_pred             ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH-HHHHHhccCCc-----------
Confidence            12234689999999987     46678999999999999999999999987632211 11111111000           


Q ss_pred             cCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          760 LSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       760 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                            ....+..++..+.+++.+||..||++|||+.|++++
T Consensus       241 ------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  276 (302)
T 2j7t_A          241 ------TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH  276 (302)
T ss_dssp             ------CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred             ------ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence                  011123456678999999999999999999999874

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=4.2e-39  Score=364.33  Aligned_cols=252  Identities=23%  Similarity=0.351  Sum_probs=207.5

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALV  601 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  601 (824)
                      .++|++.+.||+|+||.||+|+.. +|+.||||++....   ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            467999999999999999999876 68999999986542   33467789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee---CCCCcEEEeecccccccC
Q 040845          602 LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLT  678 (824)
Q Consensus       602 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill---~~~~~~kl~Dfg~a~~~~  678 (824)
                      |||+++|+|.+++.... .+++.++..++.|++.||+|||   +.+|+||||||+||++   +.++.+||+|||+|..+.
T Consensus       105 ~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  180 (484)
T 3nyv_A          105 GEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE  180 (484)
T ss_dssp             ECCCCSCBHHHHHHTCS-CCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred             EecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence            99999999999997655 6899999999999999999999   8999999999999999   567899999999998764


Q ss_pred             CCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhcccc
Q 040845          679 GEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDAN  758 (824)
Q Consensus       679 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  758 (824)
                      ...   ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||......+ ....+......          
T Consensus       181 ~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~----------  245 (484)
T 3nyv_A          181 ASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD-ILKKVEKGKYT----------  245 (484)
T ss_dssp             CCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCCC----------
T ss_pred             ccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHcCCCC----------
Confidence            332   2334569999999998865 68999999999999999999999997632211 11111111000          


Q ss_pred             ccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 040845          759 LLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL  802 (824)
Q Consensus       759 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L  802 (824)
                            ........++..+.+++.+||+.||++|||+.|+++|=
T Consensus       246 ------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~  283 (484)
T 3nyv_A          246 ------FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHE  283 (484)
T ss_dssp             ------CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSH
T ss_pred             ------CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhCh
Confidence                  01112234567789999999999999999999999863

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=9.4e-39  Score=343.15  Aligned_cols=263  Identities=20%  Similarity=0.287  Sum_probs=202.6

Q ss_pred             hccCCCCceeeeccceEEEEEEE-CCCcEEEEEEeeccccchhhhHHHHHHHHhcCC-CCcceeEEeeeec--CCeeEEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARI-RDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIR-HRNLVKVISSCSN--EEFKALV  601 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lv  601 (824)
                      .++|++.+.||+|+||+||+|+. .+++.||||+++.   ...+.+.+|+.++++++ ||||+++++++.+  ....++|
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            36799999999999999999986 4689999999863   33567889999999997 9999999999987  6678999


Q ss_pred             EeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC-cEEEeecccccccCCC
Q 040845          602 LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM-VAHLSDFGIAKLLTGE  680 (824)
Q Consensus       602 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~Dfg~a~~~~~~  680 (824)
                      |||+++++|.+++.    .+++.++..++.|++.||+|||   +.+|+||||||+||+++.++ .+||+|||+|......
T Consensus       112 ~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~  184 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  184 (330)
T ss_dssp             EECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             EeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence            99999999999985    3788999999999999999999   99999999999999999776 8999999999876433


Q ss_pred             CCccccccccccccccCccCcCC-CCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhcc---
Q 040845          681 DQSMTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVD---  756 (824)
Q Consensus       681 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  756 (824)
                      ..   .....++..|+|||.+.+ ..++.++||||+||++|||++|+.||.........+.............+..+   
T Consensus       185 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  261 (330)
T 3nsz_A          185 QE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN  261 (330)
T ss_dssp             CC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred             Cc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhc
Confidence            22   233468999999999876 66899999999999999999999999653322222211111111000000000   


Q ss_pred             ------------ccccC--chhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          757 ------------ANLLS--QEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       757 ------------~~~~~--~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                                  .....  ........+..++..+.+++.+||+.||++|||++|++++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h  320 (330)
T 3nsz_A          262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  320 (330)
T ss_dssp             CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence                        00000  0000011122357789999999999999999999999875

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=4.9e-39  Score=335.98  Aligned_cols=248  Identities=25%  Similarity=0.372  Sum_probs=197.8

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALV  601 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  601 (824)
                      .++|.+.+.||+|+||.||+|+.. +|+.||||++....   ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            367999999999999999999876 68999999987542   23456788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 040845          602 LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED  681 (824)
Q Consensus       602 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  681 (824)
                      |||+++++|.+++.... .+++.++..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||++.......
T Consensus        90 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  165 (276)
T 2h6d_A           90 MEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  165 (276)
T ss_dssp             EECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred             EeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence            99999999999997765 6899999999999999999999   8999999999999999999999999999998654322


Q ss_pred             CccccccccccccccCccCcCCCCC-CccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhcccccc
Q 040845          682 QSMTQTQTLATIGYMAPEYGREGQV-STNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLL  760 (824)
Q Consensus       682 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  760 (824)
                         ......+++.|+|||.+.+..+ +.++||||+|+++|||++|+.||......  .....+....            .
T Consensus       166 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~------------~  228 (276)
T 2h6d_A          166 ---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP--TLFKKIRGGV------------F  228 (276)
T ss_dssp             --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCC------------C
T ss_pred             ---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH--HHHHHhhcCc------------c
Confidence               1233468999999999987765 68999999999999999999998753211  1111111000            0


Q ss_pred             CchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          761 SQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       761 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                             ..+..++..+.+++.+||+.||++|||+.|++++
T Consensus       229 -------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          229 -------YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             -------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             -------cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                   0112345668899999999999999999999986

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=6.5e-39  Score=341.84  Aligned_cols=252  Identities=28%  Similarity=0.375  Sum_probs=203.2

Q ss_pred             hhccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEe
Q 040845          525 ATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLE  603 (824)
Q Consensus       525 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  603 (824)
                      ..++|++.+.||+|+||.||+|... +|+.||||++...  ...+.+.+|+.+++.++||||+++++++......++|||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  104 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME  104 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence            4577999999999999999999876 4899999998754  345678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 040845          604 YMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS  683 (824)
Q Consensus       604 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  683 (824)
                      |+++++|.+++......+++.++..++.|++.|++|||   +.+++|+||||+||+++.++.+||+|||.+.......  
T Consensus       105 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~--  179 (314)
T 3com_A          105 YCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM--  179 (314)
T ss_dssp             CCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB--
T ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc--
Confidence            99999999999865567999999999999999999999   9999999999999999999999999999998764322  


Q ss_pred             cccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCch
Q 040845          684 MTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQE  763 (824)
Q Consensus       684 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  763 (824)
                      .......+++.|+|||.+.+..++.++||||+|+++|||++|+.||.......  .........+               
T Consensus       180 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~---------------  242 (314)
T 3com_A          180 AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR--AIFMIPTNPP---------------  242 (314)
T ss_dssp             SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHHHSCC---------------
T ss_pred             cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHhcCCC---------------
Confidence            12234568999999999999899999999999999999999999987532111  0000000000               


Q ss_pred             hhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          764 DIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       764 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                       .....+..++..+.+++.+||..||++|||+.|++++
T Consensus       243 -~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~  279 (314)
T 3com_A          243 -PTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH  279 (314)
T ss_dssp             -CCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             -cccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence             0001122346678999999999999999999999874

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=7.1e-39  Score=360.97  Aligned_cols=254  Identities=23%  Similarity=0.330  Sum_probs=206.5

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALV  601 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  601 (824)
                      .++|.+.+.||+|+||.||+|+.+ +|+.||||++....   ....+.+..|+.++++++||||+++++++.+....|+|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            367889999999999999999875 59999999997542   23346788899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhhCC---CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccC
Q 040845          602 LEYMPHGSLEKYLHSSN---YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT  678 (824)
Q Consensus       602 ~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~  678 (824)
                      |||+++|+|.+++....   ..+++..++.++.||+.||+|||   +.+|+||||||+||+++.+|.+||+|||+++.+.
T Consensus       264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            99999999999987643   46899999999999999999999   9999999999999999999999999999998764


Q ss_pred             CCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhcccc
Q 040845          679 GEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDAN  758 (824)
Q Consensus       679 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  758 (824)
                      ....  ......||+.|+|||++.+..++.++||||+||++|||++|+.||....... ....+.....        ...
T Consensus       341 ~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~-~~~~~~~~i~--------~~~  409 (543)
T 3c4z_A          341 AGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKELKQRVL--------EQA  409 (543)
T ss_dssp             TTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC-CHHHHHHHHH--------HCC
T ss_pred             CCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch-hHHHHHHHHh--------hcc
Confidence            3322  2233579999999999999999999999999999999999999997642211 1111111100        000


Q ss_pred             ccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 040845          759 LLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINA-----KEIVAK  801 (824)
Q Consensus       759 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~-----~evl~~  801 (824)
                              ...+..++..+.+++.+||+.||++||++     +|+++|
T Consensus       410 --------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H  449 (543)
T 3c4z_A          410 --------VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH  449 (543)
T ss_dssp             --------CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred             --------cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence                    00112346678999999999999999965     666653

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.2e-38  Score=345.19  Aligned_cols=271  Identities=23%  Similarity=0.326  Sum_probs=204.5

Q ss_pred             hccCCCCceeeeccceEEEEEEE-CCCcEEEEEEeecccc--chhhhHHHHHHHHhcCCCCcceeEEeeeec--------
Q 040845          526 TDKFSENNLIGRGGFGSVYKARI-RDGMEVAVKVFNLQCG--RAFKSFDVECAMMKSIRHRNLVKVISSCSN--------  594 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------  594 (824)
                      .++|++.+.||+|+||.||+|+. .+|+.||||++.....  .....+.+|+.+++.++||||+++++++..        
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            46899999999999999999987 4689999999865432  234567889999999999999999999876        


Q ss_pred             CCeeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccc
Q 040845          595 EEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIA  674 (824)
Q Consensus       595 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a  674 (824)
                      .+..++||||+++ ++.+.+......+++.+++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+|
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  171 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA  171 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence            3468999999975 888888776667999999999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCCC--ccccccccccccccCccCcCC-CCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhC--CC
Q 040845          675 KLLTGEDQ--SMTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCL--PI  749 (824)
Q Consensus       675 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~--~~  749 (824)
                      ..+.....  ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+ ..........  +.
T Consensus       172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~  250 (351)
T 3mi9_A          172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH-QLALISQLCGSITP  250 (351)
T ss_dssp             EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCT
T ss_pred             ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCh
Confidence            87643222  222344568999999998876 457999999999999999999999997632211 1111111111  10


Q ss_pred             cc-hhhccccc------cC---chhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          750 ST-MEVVDANL------LS---QEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       750 ~~-~~~~~~~~------~~---~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      .. ........      ..   ............++.+.+++.+||+.||++|||++|++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence            00 00000000      00   0000111111235668999999999999999999999986

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=7.7e-39  Score=338.03  Aligned_cols=251  Identities=27%  Similarity=0.397  Sum_probs=199.6

Q ss_pred             cCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEeccC
Q 040845          528 KFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMP  606 (824)
Q Consensus       528 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  606 (824)
                      +|....+||+|+||.||+|.+. +++.||||.+........+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  102 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP  102 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence            4555569999999999999864 588999999987655667789999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhCC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC-CCcEEEeecccccccCCCCCc
Q 040845          607 HGSLEKYLHSSN--YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD-NMVAHLSDFGIAKLLTGEDQS  683 (824)
Q Consensus       607 ~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~Dfg~a~~~~~~~~~  683 (824)
                      +++|.+++....  ...++..+..++.|++.|++|||   +.+|+||||||+||+++. ++.+||+|||.+.......  
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~--  177 (295)
T 2clq_A          103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN--  177 (295)
T ss_dssp             EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred             CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC--
Confidence            999999998653  35678899999999999999999   899999999999999987 8999999999998764322  


Q ss_pred             cccccccccccccCccCcCCCC--CCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccC
Q 040845          684 MTQTQTLATIGYMAPEYGREGQ--VSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLS  761 (824)
Q Consensus       684 ~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  761 (824)
                      .......|++.|+|||.+.+..  ++.++||||||+++|||++|+.||...............  ..      .      
T Consensus       178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--~~------~------  243 (295)
T 2clq_A          178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGM--FK------V------  243 (295)
T ss_dssp             ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHH--HC------C------
T ss_pred             CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcc--cc------c------
Confidence            1223446899999999987643  789999999999999999999999753221111110000  00      0      


Q ss_pred             chhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          762 QEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       762 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                          ....+..++..+.+++.+||+.||++|||+.|++++
T Consensus       244 ----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  279 (295)
T 2clq_A          244 ----HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD  279 (295)
T ss_dssp             ----CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred             ----cccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                000112346678999999999999999999999764

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=3.4e-39  Score=346.47  Aligned_cols=269  Identities=25%  Similarity=0.340  Sum_probs=203.2

Q ss_pred             hhccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc--chhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEE
Q 040845          525 ATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG--RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALV  601 (824)
Q Consensus       525 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  601 (824)
                      ..++|++.+.||+|+||.||+|+.. +|+.||||++.....  ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  102 (331)
T 4aaa_A           23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV  102 (331)
T ss_dssp             CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence            3578999999999999999999876 489999999865432  2345677899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 040845          602 LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED  681 (824)
Q Consensus       602 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  681 (824)
                      |||+++++|.++..... .+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||++.......
T Consensus       103 ~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  178 (331)
T 4aaa_A          103 FEFVDHTILDDLELFPN-GLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  178 (331)
T ss_dssp             EECCSEEHHHHHHHSTT-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred             EecCCcchHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence            99999988888866544 6899999999999999999999   9999999999999999999999999999998654322


Q ss_pred             CccccccccccccccCccCcCCC-CCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCc----------
Q 040845          682 QSMTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPIS----------  750 (824)
Q Consensus       682 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~----------  750 (824)
                      .  ......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||......+ .............          
T Consensus       179 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  255 (331)
T 4aaa_A          179 E--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID-QLYHIMMCLGNLIPRHQELFNKN  255 (331)
T ss_dssp             -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCSCCHHHHHHHHHC
T ss_pred             c--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCChhhhhHhhhc
Confidence            2  22345689999999998775 68999999999999999999999997633221 1111111100000          


Q ss_pred             --chhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          751 --TMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       751 --~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                        ......+.... ..........++..+.+++.+||+.||++|||++|++++
T Consensus       256 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  307 (331)
T 4aaa_A          256 PVFAGVRLPEIKE-REPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH  307 (331)
T ss_dssp             GGGTTCCCCCCSS-CCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             cccccccCccccc-cchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence              00000000000 001111122467789999999999999999999999875

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.5e-38  Score=361.04  Aligned_cols=252  Identities=21%  Similarity=0.332  Sum_probs=203.6

Q ss_pred             hhccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc-------------chhhhHHHHHHHHhcCCCCcceeEEe
Q 040845          525 ATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG-------------RAFKSFDVECAMMKSIRHRNLVKVIS  590 (824)
Q Consensus       525 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l~~  590 (824)
                      ..++|.+.+.||+|+||+||+|+.+ +++.||||++.....             ...+.+.+|+.++++++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            3578999999999999999999875 488999999865421             23467889999999999999999999


Q ss_pred             eeecCCeeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC---cEE
Q 040845          591 SCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM---VAH  667 (824)
Q Consensus       591 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~---~~k  667 (824)
                      ++.+....++||||+++|+|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++   .+|
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~k  189 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIK  189 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCCSSEE
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCCccEE
Confidence            9999999999999999999999987655 6899999999999999999999   99999999999999998776   699


Q ss_pred             EeecccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhC
Q 040845          668 LSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCL  747 (824)
Q Consensus       668 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  747 (824)
                      |+|||+|..+....   ......||+.|+|||++. +.++.++||||+||++|+|++|..||......+ ..........
T Consensus       190 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~  264 (504)
T 3q5i_A          190 IVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD-IIKKVEKGKY  264 (504)
T ss_dssp             ECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCC
T ss_pred             EEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHcCCC
Confidence            99999998764332   223456999999999886 468999999999999999999999997632211 1111111000


Q ss_pred             CCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          748 PISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       748 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                                      .........++..+.+++.+||+.||++|||++|++++
T Consensus       265 ----------------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h  302 (504)
T 3q5i_A          265 ----------------YFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS  302 (504)
T ss_dssp             ----------------CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ----------------CCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence                            01111223456779999999999999999999999876

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.2e-39  Score=343.63  Aligned_cols=259  Identities=26%  Similarity=0.385  Sum_probs=200.2

Q ss_pred             hccCCCCceeeeccceEEEEEEEC--CCc--EEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCee
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR--DGM--EVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFK  598 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~--~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  598 (824)
                      .++|++.+.||+|+||.||+|++.  +++  .||||+++...   ....+.+.+|++++++++||||+++++++.++. .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            367999999999999999999863  233  68999886542   344577889999999999999999999998765 7


Q ss_pred             EEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccC
Q 040845          599 ALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT  678 (824)
Q Consensus       599 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~  678 (824)
                      ++||||+++++|.+++......+++.++..++.|+++|++|||   +.+|+||||||+||+++.++.+||+|||++....
T Consensus        96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  172 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP  172 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence            8999999999999999876557899999999999999999999   8999999999999999999999999999998765


Q ss_pred             CCCCcc-ccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhcc
Q 040845          679 GEDQSM-TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVD  756 (824)
Q Consensus       679 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  756 (824)
                      ...... ......+|..|+|||.+.+..++.++||||+|+++|||++ |+.||......+ ..........         
T Consensus       173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-~~~~~~~~~~---------  242 (291)
T 1u46_A          173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ-ILHKIDKEGE---------  242 (291)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-HHHHHHTSCC---------
T ss_pred             ccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH-HHHHHHccCC---------
Confidence            433221 2233457888999999988889999999999999999999 999987632211 1111100000         


Q ss_pred             ccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 040845          757 ANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRD  807 (824)
Q Consensus       757 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~  807 (824)
                               ....+..++..+.+++.+||..||++|||+.++++.|+++..
T Consensus       243 ---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          243 ---------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             ---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             ---------CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence                     001112456779999999999999999999999999998764

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=9.7e-39  Score=361.69  Aligned_cols=251  Identities=22%  Similarity=0.337  Sum_probs=200.8

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVL  602 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  602 (824)
                      .++|++.+.||+|+||+||+|+.+ ++..||||++....  ......+.+|+.+++.++||||+++++++.+....++||
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            457999999999999999999876 58999999987543  334567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC---CCcEEEeecccccccCC
Q 040845          603 EYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD---NMVAHLSDFGIAKLLTG  679 (824)
Q Consensus       603 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~Dfg~a~~~~~  679 (824)
                      ||+++|+|.+++.... .+++.++..++.|++.||+|||   +.+|+||||||+||+++.   ++.+||+|||+|..+..
T Consensus       116 e~~~~g~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~  191 (494)
T 3lij_A          116 ECYKGGELFDEIIHRM-KFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN  191 (494)
T ss_dssp             ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred             ecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence            9999999999887654 6899999999999999999999   999999999999999976   45599999999987643


Q ss_pred             CCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccc
Q 040845          680 EDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANL  759 (824)
Q Consensus       680 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  759 (824)
                      ..   ......||+.|+|||++. +.++.++||||+||++|+|++|+.||......+ ....+.......          
T Consensus       192 ~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~----------  256 (494)
T 3lij_A          192 QK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE-ILRKVEKGKYTF----------  256 (494)
T ss_dssp             TB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCCCC----------
T ss_pred             Cc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCCC----------
Confidence            22   223456999999999886 468999999999999999999999997632211 111111111100          


Q ss_pred             cCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          760 LSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       760 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                            .......++..+.+++.+||+.||++|||+.|++++
T Consensus       257 ------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          257 ------DSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             ------CSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             ------CchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence                  001112346678999999999999999999999976

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.3e-39  Score=356.10  Aligned_cols=246  Identities=16%  Similarity=0.213  Sum_probs=191.4

Q ss_pred             hccCCCCceeeeccceEEEEEEE-CCCcEEEEEEeecc---ccchhhhHHHHHH---HHhcCCCCcceeEE-------ee
Q 040845          526 TDKFSENNLIGRGGFGSVYKARI-RDGMEVAVKVFNLQ---CGRAFKSFDVECA---MMKSIRHRNLVKVI-------SS  591 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~---~l~~l~h~niv~l~-------~~  591 (824)
                      .++|++.+.||+|+||.||+|++ .+|+.||||++...   .....+.+.+|+.   ++++++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            46788899999999999999986 46999999999743   2345577889994   55555799999998       55


Q ss_pred             eecCC-----------------eeEEEEeccCCCCHHHHhhhCCC------CCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 040845          592 CSNEE-----------------FKALVLEYMPHGSLEKYLHSSNY------SLDIFQRLNIMIDVASALEYLHFGYSAPV  648 (824)
Q Consensus       592 ~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~------~~~~~~~~~i~~~i~~~l~~LH~~~~~~i  648 (824)
                      +.+++                 ..++||||+ +|+|.+++...+.      .+++..++.++.|++.||+|||   +.+|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCCe
Confidence            55443                 378999999 6799999976431      2335888899999999999999   8999


Q ss_pred             EecCCCCCCeeeCCCCcEEEeecccccccCCCCCccccccccccccccCccCcCCC-----------CCCccchHHHHHH
Q 040845          649 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-----------QVSTNGDVYSFGI  717 (824)
Q Consensus       649 vH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----------~~~~~~DvwslG~  717 (824)
                      +||||||+||+++.++.+||+|||+|+....     ......| +.|+|||++.+.           .++.++|||||||
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~  301 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL  301 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence            9999999999999999999999999985321     2233457 999999999877           8999999999999


Q ss_pred             HHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHH
Q 040845          718 MLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKE  797 (824)
Q Consensus       718 ~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~e  797 (824)
                      ++|||++|+.||........  ...           ...            ....++..+.+++.+||+.||++|||+.|
T Consensus       302 il~elltg~~Pf~~~~~~~~--~~~-----------~~~------------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e  356 (377)
T 3byv_A          302 VIYWIWCADLPITKDAALGG--SEW-----------IFR------------SCKNIPQPVRALLEGFLRYPKEDRLLPLQ  356 (377)
T ss_dssp             HHHHHHHSSCCC------CC--SGG-----------GGS------------SCCCCCHHHHHHHHHHTCSSGGGCCCHHH
T ss_pred             HHHHHHHCCCCCcccccccc--hhh-----------hhh------------hccCCCHHHHHHHHHHcCCCchhCCCHHH
Confidence            99999999999865322110  000           000            00234567899999999999999999999


Q ss_pred             HHHH--HHHHH
Q 040845          798 IVAK--LLKIR  806 (824)
Q Consensus       798 vl~~--L~~~~  806 (824)
                      ++++  ++.+.
T Consensus       357 ~l~hp~f~~~~  367 (377)
T 3byv_A          357 AMETPEYEQLR  367 (377)
T ss_dssp             HHTSHHHHHHH
T ss_pred             HhhChHHHHHH
Confidence            9873  44443

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=5.9e-39  Score=349.02  Aligned_cols=265  Identities=21%  Similarity=0.323  Sum_probs=206.3

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc-cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEe
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLE  603 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  603 (824)
                      .++|++.+.||+|+||.||+|++. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            367999999999999999999876 58999999987653 2345678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-CeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 040845          604 YMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSA-PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ  682 (824)
Q Consensus       604 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  682 (824)
                      |+++++|.+++.... .+++..+..++.|++.|++|||   +. +|+||||||+||+++.++.+||+|||++......  
T Consensus       112 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--  185 (360)
T 3eqc_A          112 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  185 (360)
T ss_dssp             CCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred             CCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc--
Confidence            999999999998765 6899999999999999999999   75 8999999999999999999999999999755321  


Q ss_pred             ccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhC---------------
Q 040845          683 SMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCL---------------  747 (824)
Q Consensus       683 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~---------------  747 (824)
                        ......||+.|+|||++.+..++.++||||+||++|||++|+.||......+..  .......               
T Consensus       186 --~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  261 (360)
T 3eqc_A          186 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE--LMFGCQVEGDAAETPPRPRTPG  261 (360)
T ss_dssp             --C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHH--HHHC------------------
T ss_pred             --cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHhcccccccCCCCCCCcccCC
Confidence              123346899999999999999999999999999999999999999763221110  0000000               


Q ss_pred             ------------CCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 040845          748 ------------PISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL  802 (824)
Q Consensus       748 ------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L  802 (824)
                                  +....+..+......  ........++..+.+++.+||+.||++|||++|+++|=
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  326 (360)
T 3eqc_A          262 RPLNKFGMDSRPPMAIFELLDYIVNEP--PPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA  326 (360)
T ss_dssp             ------------CCCHHHHHHHHHHSC--CCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred             CcccccccCCCCcccchhhhhHHhccC--CCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhCh
Confidence                        000000000000000  00001123566799999999999999999999999863

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=3.5e-38  Score=351.84  Aligned_cols=354  Identities=17%  Similarity=0.137  Sum_probs=250.6

Q ss_pred             ccccCCcccccCCCCCcEEEccCCcccccccccccCCCCCCEEeCCCCcCCcccChhhhCcCCCceeeccCCccccccCc
Q 040845            8 FLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLSGCLSS   87 (824)
Q Consensus         8 ~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~   87 (824)
                      .+....+..++++++|++|+|++|.+++. | .|+.+++|++|+|++|++++. |  +..+++|++|++++|++++++  
T Consensus        29 ~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~~--  101 (457)
T 3bz5_A           29 EMQATDTISEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNLD--  101 (457)
T ss_dssp             TCCTTSEEEHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCCC--
T ss_pred             CcCcccccChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCceee--
Confidence            44556666788899999999999999864 5 688899999999999999854 4  888899999999999988764  


Q ss_pred             cccCCCCCccEEEccCCeeeeecCccccCCCCCceEeccCccccccCCccccCCCCCCEEEccCCc-CCCCcCccccccc
Q 040845           88 ITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNN-LTSSTLDLSFLSS  166 (824)
Q Consensus        88 ~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~-i~~~~~~~~~~~~  166 (824)
                        ...+++|++|+|++|++++. +  +..+++|++|++++|++++.   .++++++|++|++++|. +..+        .
T Consensus       102 --~~~l~~L~~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~--------~  165 (457)
T 3bz5_A          102 --VTPLTKLTYLNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL--------D  165 (457)
T ss_dssp             --CTTCTTCCEEECCSSCCSCC-C--CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC--------C
T ss_pred             --cCCCCcCCEEECCCCcCCee-c--CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCccccc--------c
Confidence              34688999999999998863 3  78888999999999998864   37888899999999884 4333        2


Q ss_pred             CCCCCCCcEEECcCCCCCccCCccccccccccccEEEeecCcceecCCccCCCCCCCCEEEecCCccCCccchhhcCCCC
Q 040845          167 LSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQK  246 (824)
Q Consensus       167 l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~  246 (824)
                      +..+++|++|++++|++++++   + +. .++|+.|++++|++++.   .+..+++|+.|++++|++++ +|  +..+++
T Consensus       166 ~~~l~~L~~L~ls~n~l~~l~---l-~~-l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~  234 (457)
T 3bz5_A          166 VTPQTQLTTLDCSFNKITELD---V-SQ-NKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQ  234 (457)
T ss_dssp             CTTCTTCCEEECCSSCCCCCC---C-TT-CTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTT
T ss_pred             cccCCcCCEEECCCCccceec---c-cc-CCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCC
Confidence            677888999999999888763   1 11 34677777777777754   36677777777777777775 34  667777


Q ss_pred             CCEEEcccccCcccCCccccccCCccEEEccCccccccCCccccCCCCCcEEEcCCCCCC-CCCCccccccccccccccc
Q 040845          247 LQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELT-SIPLNFWSLKDILDLNLSS  325 (824)
Q Consensus       247 L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~l~~  325 (824)
                      |++|++++|++++..+   ..+++|+.|++++|+              |+.|++++|.+. .+|  +..+++|+.|++++
T Consensus       235 L~~L~l~~N~l~~~~~---~~l~~L~~L~l~~n~--------------L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~  295 (457)
T 3bz5_A          235 LTYFDCSVNPLTELDV---STLSKLTTLHCIQTD--------------LLEIDLTHNTQLIYFQ--AEGCRKIKELDVTH  295 (457)
T ss_dssp             CSEEECCSSCCSCCCC---TTCTTCCEEECTTCC--------------CSCCCCTTCTTCCEEE--CTTCTTCCCCCCTT
T ss_pred             CCEEEeeCCcCCCcCH---HHCCCCCEEeccCCC--------------CCEEECCCCccCCccc--ccccccCCEEECCC
Confidence            7777777777775433   334455555544442              233333444321 222  23445566666666


Q ss_pred             ccccCcCCc--------cccccccchhhhcccccccccCCCccCCCCCCCeEEccCccccccCCccccccccccEEEccC
Q 040845          326 NCFSGPLPL--------EIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSY  397 (824)
Q Consensus       326 N~l~~~~~~--------~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  397 (824)
                      |...+.+|.        .+.++++|+.|++++|++++.   .++.+++|+.|++++|+|++        ++.|..|++++
T Consensus       296 n~~l~~l~~~~~~L~~L~l~~~~~L~~L~L~~N~l~~l---~l~~l~~L~~L~l~~N~l~~--------l~~L~~L~l~~  364 (457)
T 3bz5_A          296 NTQLYLLDCQAAGITELDLSQNPKLVYLYLNNTELTEL---DVSHNTKLKSLSCVNAHIQD--------FSSVGKIPALN  364 (457)
T ss_dssp             CTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCCCSCC---CCTTCTTCSEEECCSSCCCB--------CTTGGGSSGGG
T ss_pred             CcccceeccCCCcceEechhhcccCCEEECCCCccccc---ccccCCcCcEEECCCCCCCC--------ccccccccccC
Confidence            654433332        234446777888888888764   27778888888888888875        24566667788


Q ss_pred             cccCCCCcccccCCcccceeeccCCcccCCCCC
Q 040845          398 NNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIPR  430 (824)
Q Consensus       398 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~  430 (824)
                      |.+.|.     ..+..|..+++++|+++|.+|.
T Consensus       365 n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~  392 (457)
T 3bz5_A          365 NNFEAE-----GQTITMPKETLTNNSLTIAVSP  392 (457)
T ss_dssp             TSEEEE-----EEEEECCCBCCBTTBEEEECCT
T ss_pred             CcEEec-----ceeeecCccccccCcEEEEcCh
Confidence            887754     3456778889999999998886

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=3.4e-38  Score=352.40  Aligned_cols=265  Identities=18%  Similarity=0.232  Sum_probs=212.2

Q ss_pred             hccCCCCceeeeccceEEEEEEE-CCCcEEEEEEeeccccchhhhHHHHHHHHhcCCC-CcceeEEeeeecCCeeEEEEe
Q 040845          526 TDKFSENNLIGRGGFGSVYKARI-RDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRH-RNLVKVISSCSNEEFKALVLE  603 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e  603 (824)
                      .++|++.+.||+|+||.||+|++ .+++.||||++....  ....+..|+++++.++| +++..+..++.+.+..++|||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC--SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc--ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            46899999999999999999986 468999999876543  34568899999999987 556666667778889999999


Q ss_pred             ccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee---CCCCcEEEeecccccccCCC
Q 040845          604 YMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTGE  680 (824)
Q Consensus       604 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill---~~~~~~kl~Dfg~a~~~~~~  680 (824)
                      |+ +++|.+++......+++.+++.++.||+.||+|||   +.+|+||||||+|||+   +.++.+||+|||+++.+...
T Consensus        84 ~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (483)
T 3sv0_A           84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT  159 (483)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             CC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence            99 89999999876668999999999999999999999   9999999999999999   68899999999999877543


Q ss_pred             CCc-----cccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhc
Q 040845          681 DQS-----MTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVV  755 (824)
Q Consensus       681 ~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  755 (824)
                      ...     .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......... ..+..         +.
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~-~~~~~---------i~  229 (483)
T 3sv0_A          160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK-QKYEK---------IS  229 (483)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHH-HHHHH---------HH
T ss_pred             ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHH-HHHHH---------Hh
Confidence            322     1223567999999999999999999999999999999999999999874332111 10000         00


Q ss_pred             cccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhh
Q 040845          756 DANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSL  809 (824)
Q Consensus       756 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~  809 (824)
                      ......   ........++.++.+++..||..||++||++.++++.|+++....
T Consensus       230 ~~~~~~---~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~  280 (483)
T 3sv0_A          230 EKKVAT---SIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE  280 (483)
T ss_dssp             HHHHHS---CHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             hccccc---cHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence            000000   001112345778999999999999999999999999999987643

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.3e-38  Score=337.95  Aligned_cols=252  Identities=21%  Similarity=0.305  Sum_probs=200.3

Q ss_pred             hhccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc----cchhhhHHHHHHHHhcCCCCcceeEEeee--ecCCe
Q 040845          525 ATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC----GRAFKSFDVECAMMKSIRHRNLVKVISSC--SNEEF  597 (824)
Q Consensus       525 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~--~~~~~  597 (824)
                      ..++|++.+.||+|+||.||+|... +++.||+|++....    ....+.+.+|+++++.++||||+++++++  .+...
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK   82 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence            3578999999999999999999874 58999999987542    23456789999999999999999999998  44568


Q ss_pred             eEEEEeccCCCCHHHHhhhC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccc
Q 040845          598 KALVLEYMPHGSLEKYLHSS-NYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  676 (824)
Q Consensus       598 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~  676 (824)
                      .++||||++++ +.+++... ...+++.++..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||.+..
T Consensus        83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~  158 (305)
T 2wtk_C           83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEA  158 (305)
T ss_dssp             EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeeccccccc
Confidence            89999999876 77777653 356899999999999999999999   89999999999999999999999999999987


Q ss_pred             cCCCCCccccccccccccccCccCcCCCC--CCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhh
Q 040845          677 LTGEDQSMTQTQTLATIGYMAPEYGREGQ--VSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEV  754 (824)
Q Consensus       677 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  754 (824)
                      ..............||+.|+|||.+.+..  ++.++||||+|+++|||++|+.||......  .....+...        
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~i~~~--------  228 (305)
T 2wtk_C          159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY--KLFENIGKG--------  228 (305)
T ss_dssp             CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHC--------
T ss_pred             cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHHHhcC--------
Confidence            65433333334556899999999887643  478999999999999999999998752111  010000000        


Q ss_pred             ccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          755 VDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       755 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                          .       ...+..++..+.+++.+||..||++|||+.|++++
T Consensus       229 ----~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          229 ----S-------YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             ----C-------CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             ----C-------CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                0       00112356678999999999999999999999986

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.8e-39  Score=348.98  Aligned_cols=255  Identities=24%  Similarity=0.330  Sum_probs=204.4

Q ss_pred             hccCCCCceeeeccceEEEEEEE----CCCcEEEEEEeeccc----cchhhhHHHHHHHHhcC-CCCcceeEEeeeecCC
Q 040845          526 TDKFSENNLIGRGGFGSVYKARI----RDGMEVAVKVFNLQC----GRAFKSFDVECAMMKSI-RHRNLVKVISSCSNEE  596 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  596 (824)
                      .++|++.+.||+|+||.||+|+.    .+++.||||+++...    ....+.+.+|+++++.+ +||||+++++++..+.
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            36899999999999999999987    368999999986432    23345677899999999 6999999999999999


Q ss_pred             eeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccc
Q 040845          597 FKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  676 (824)
Q Consensus       597 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~  676 (824)
                      ..++||||+++|+|.+++.... .+++.++..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  208 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  208 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             eEEEEeecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence            9999999999999999998755 6899999999999999999999   89999999999999999999999999999986


Q ss_pred             cCCCCCccccccccccccccCccCcCCC--CCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhh
Q 040845          677 LTGEDQSMTQTQTLATIGYMAPEYGREG--QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEV  754 (824)
Q Consensus       677 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  754 (824)
                      +..... .......||+.|+|||++.+.  .++.++|||||||++|||++|+.||........ ...+......      
T Consensus       209 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~------  280 (355)
T 1vzo_A          209 FVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-QAEISRRILK------  280 (355)
T ss_dssp             CCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-HHHHHHHHHH------
T ss_pred             cccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch-HHHHHHHHhc------
Confidence            543221 222345699999999998753  478999999999999999999999975322211 1111111000      


Q ss_pred             ccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 040845          755 VDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRI-----NAKEIVAKL  802 (824)
Q Consensus       755 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~evl~~L  802 (824)
                        .        ....+..++..+.+++.+||..||++||     +++|++++.
T Consensus       281 --~--------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          281 --S--------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             --C--------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             --c--------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence              0        0001123456788999999999999999     999999875

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=8.1e-39  Score=339.17  Aligned_cols=251  Identities=25%  Similarity=0.386  Sum_probs=208.1

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc-cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEe
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLE  603 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  603 (824)
                      .+.|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.++...++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            356889999999999999999864 58999999997553 3445788999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 040845          604 YMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS  683 (824)
Q Consensus       604 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  683 (824)
                      |+++++|.+++...  .+++.++..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||++.......  
T Consensus       101 ~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~--  173 (303)
T 3a7i_A          101 YLGGGSALDLLEPG--PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--  173 (303)
T ss_dssp             CCTTEEHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB--
T ss_pred             eCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCccc--
Confidence            99999999999753  5899999999999999999999   8999999999999999999999999999998764322  


Q ss_pred             cccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCch
Q 040845          684 MTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQE  763 (824)
Q Consensus       684 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  763 (824)
                      .......|++.|+|||.+.+..++.++||||||+++|||++|+.||......  .....+....+.              
T Consensus       174 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~--------------  237 (303)
T 3a7i_A          174 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM--KVLFLIPKNNPP--------------  237 (303)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHSCCC--------------
T ss_pred             cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH--HHHHHhhcCCCC--------------
Confidence            2223456899999999999999999999999999999999999998753221  111111110000              


Q ss_pred             hhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 040845          764 DIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLL  803 (824)
Q Consensus       764 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~  803 (824)
                          ..+..++..+.+++.+||..||++|||+.|++++..
T Consensus       238 ----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~  273 (303)
T 3a7i_A          238 ----TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKF  273 (303)
T ss_dssp             ----CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHH
T ss_pred             ----CCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChh
Confidence                001234566899999999999999999999998754

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.2e-38  Score=347.00  Aligned_cols=273  Identities=23%  Similarity=0.308  Sum_probs=202.3

Q ss_pred             HHhhccCCCCceeeeccceEEEEEEE-CCCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeec-------
Q 040845          523 FQATDKFSENNLIGRGGFGSVYKARI-RDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSN-------  594 (824)
Q Consensus       523 ~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------  594 (824)
                      ....++|++.+.||+|+||+||+|+. .+|+.||||++....    ....+|+++++.++||||+++++++..       
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            34567899999999999999999986 468999999986432    223479999999999999999999843       


Q ss_pred             -------------------------------CCeeEEEEeccCCCCHHHHhhh---CCCCCCHHHHHHHHHHHHHHHHHh
Q 040845          595 -------------------------------EEFKALVLEYMPHGSLEKYLHS---SNYSLDIFQRLNIMIDVASALEYL  640 (824)
Q Consensus       595 -------------------------------~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~L  640 (824)
                                                     ....++||||++ |+|.+.+..   ....+++..+..++.|+++||+||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                           334889999997 588777653   335789999999999999999999


Q ss_pred             hcCCCCCeEecCCCCCCeeeC-CCCcEEEeecccccccCCCCCccccccccccccccCccCcCCC-CCCccchHHHHHHH
Q 040845          641 HFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIM  718 (824)
Q Consensus       641 H~~~~~~ivH~Dlk~~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~  718 (824)
                      |   +.+|+||||||+||+++ .++.+||+|||+|+.......   .....+|+.|+|||.+.+. .++.++||||+||+
T Consensus       158 H---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i  231 (383)
T 3eb0_A          158 H---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV  231 (383)
T ss_dssp             H---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred             H---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence            9   99999999999999997 689999999999987643322   2345689999999988765 48999999999999


Q ss_pred             HHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhh--ccc-------cccCchhhhhhhHHHHHHHHHHHHHHccccCC
Q 040845          719 LMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEV--VDA-------NLLSQEDIHFVAKEQCVSFVFNLALECTVESP  789 (824)
Q Consensus       719 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~-------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP  789 (824)
                      +|||++|+.||.+.... ..+..++..........+  .++       ............+..++..+.+++.+||+.||
T Consensus       232 l~ell~g~~pf~~~~~~-~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP  310 (383)
T 3eb0_A          232 FGELILGKPLFSGETSI-DQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP  310 (383)
T ss_dssp             HHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred             HHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence            99999999999763221 112222221111100000  000       00011112222334567789999999999999


Q ss_pred             CCCCCHHHHHHH--HHHHHH
Q 040845          790 EQRINAKEIVAK--LLKIRD  807 (824)
Q Consensus       790 ~~Rpt~~evl~~--L~~~~~  807 (824)
                      ++|||+.|+++|  ++++++
T Consensus       311 ~~R~t~~e~l~hp~f~~~~~  330 (383)
T 3eb0_A          311 DLRINPYEAMAHPFFDHLRN  330 (383)
T ss_dssp             GGSCCHHHHHTSGGGHHHHH
T ss_pred             hhCCCHHHHhcCHHHHHHHh
Confidence            999999999864  444443

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=8.6e-39  Score=346.19  Aligned_cols=265  Identities=18%  Similarity=0.275  Sum_probs=207.0

Q ss_pred             hccCCCCceeeeccceEEEEEEECCCcEEEEEEeeccccch-----------------hhhHHHHHHHHhcCCCCcceeE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRA-----------------FKSFDVECAMMKSIRHRNLVKV  588 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~h~niv~l  588 (824)
                      .++|++.+.||+|+||.||+|+. +|+.||||++.......                 .+.+.+|+.++++++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            46899999999999999999998 79999999987542211                 1788999999999999999999


Q ss_pred             EeeeecCCeeEEEEeccCCCCHHHH------hhhC-CCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEecCCCCCCeee
Q 040845          589 ISSCSNEEFKALVLEYMPHGSLEKY------LHSS-NYSLDIFQRLNIMIDVASALEYLHFGYS-APVIHCDLKPSNVLL  660 (824)
Q Consensus       589 ~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dlk~~Nill  660 (824)
                      ++++.+.+..++||||+++|+|.++      +... ...+++..++.++.|++.|++|||   + .+|+||||||+||++
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~Nil~  185 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPSNILM  185 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGGGEEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChHhEEE
Confidence            9999999999999999999999998      6542 357899999999999999999999   7 999999999999999


Q ss_pred             CCCCcEEEeecccccccCCCCCccccccccccccccCccCcCCC-CCCc-cchHHHHHHHHHHHHhCCCCCcccccCcch
Q 040845          661 DDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-QVST-NGDVYSFGIMLMETFTRKKPTDELFNGEMT  738 (824)
Q Consensus       661 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~-~~DvwslG~~l~el~tg~~p~~~~~~~~~~  738 (824)
                      +.++.+||+|||.+......    ......++..|+|||.+.+. .++. ++||||+|+++|||++|+.||.........
T Consensus       186 ~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~  261 (348)
T 2pml_X          186 DKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL  261 (348)
T ss_dssp             CTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH
T ss_pred             cCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence            99999999999999875432    23445689999999999877 5666 999999999999999999999764332222


Q ss_pred             hhhhhhhhCCCcc--hhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          739 LKHWVNDCLPIST--MEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       739 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      ...+.........  ...... ...  .........++..+.+++.+||+.||++|||+.|++++
T Consensus       262 ~~~i~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h  323 (348)
T 2pml_X          262 FNNIRTKNIEYPLDRNHFLYP-LTN--KKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH  323 (348)
T ss_dssp             HHHHTSCCCCCCCSSSSSTTT-TCC----------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HHHHhccCcCCccchhhhhcc-ccc--cccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            2221111111100  000000 000  00011123456789999999999999999999999874

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.6e-39  Score=347.43  Aligned_cols=264  Identities=24%  Similarity=0.297  Sum_probs=196.4

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeecCC------
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEE------  596 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  596 (824)
                      .++|++.+.||+|+||.||+|... +|+.||||++....  ....+.+.+|+++++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            578999999999999999999874 59999999985432  223467889999999999999999999997653      


Q ss_pred             eeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccc
Q 040845          597 FKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  676 (824)
Q Consensus       597 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~  676 (824)
                      ..++||||+ +++|.+++...  .+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  177 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ  177 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence            459999999 78999999763  5899999999999999999999   99999999999999999999999999999987


Q ss_pred             cCCCCCccccccccccccccCccCcCC-CCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCc--chh
Q 040845          677 LTGEDQSMTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPIS--TME  753 (824)
Q Consensus       677 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~  753 (824)
                      ....     .....+|++|+|||++.+ ..++.++||||+||++|||++|+.||.+....+ .+...........  ...
T Consensus       178 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~l~~i~~~~g~~~~~~~~  251 (367)
T 1cm8_A          178 ADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD-QLKEIMKVTGTPPAEFVQ  251 (367)
T ss_dssp             CCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCHHHHH
T ss_pred             cccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHHHH
Confidence            5322     234568999999998876 678999999999999999999999997632111 1111111111000  000


Q ss_pred             hccc--------cccCchhhh-hhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          754 VVDA--------NLLSQEDIH-FVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       754 ~~~~--------~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      .+..        ......... ......++..+.+++.+||..||++|||++|+++|
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h  308 (367)
T 1cm8_A          252 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  308 (367)
T ss_dssp             TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence            0000        000000000 00112456779999999999999999999999885

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=2.6e-39  Score=353.00  Aligned_cols=255  Identities=12%  Similarity=0.127  Sum_probs=183.8

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc---chhhhHHHHHHHHhcC--CCCcceeEE-------eee
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG---RAFKSFDVECAMMKSI--RHRNLVKVI-------SSC  592 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l--~h~niv~l~-------~~~  592 (824)
                      ..+|.+.+.||+|+||.||+|++. +|+.||||++.....   ...+.+.+|+.+++.+  +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            356889999999999999999875 689999999986532   3345677785544444  699988755       333


Q ss_pred             ecC-----------------CeeEEEEeccCCCCHHHHhhhCCCCCCHHHH------HHHHHHHHHHHHHhhcCCCCCeE
Q 040845          593 SNE-----------------EFKALVLEYMPHGSLEKYLHSSNYSLDIFQR------LNIMIDVASALEYLHFGYSAPVI  649 (824)
Q Consensus       593 ~~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~------~~i~~~i~~~l~~LH~~~~~~iv  649 (824)
                      ..+                 ...++||||++ |+|.+++...+..+++..+      ..++.|+++||+|||   +.+|+
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~iv  216 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLV  216 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHH---HCCCc
Confidence            322                 34799999998 8999999865434455556      778899999999999   99999


Q ss_pred             ecCCCCCCeeeCCCCcEEEeecccccccCCCCCccccccccccccccCccCcCC--CCCCccchHHHHHHHHHHHHhCCC
Q 040845          650 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE--GQVSTNGDVYSFGIMLMETFTRKK  727 (824)
Q Consensus       650 H~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~tg~~  727 (824)
                      ||||||+||+++.++.+||+|||+|+.....     .....+|+.|+|||++.+  ..++.++|||||||++|||++|+.
T Consensus       217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~  291 (371)
T 3q60_A          217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL  291 (371)
T ss_dssp             ETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred             cCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence            9999999999999999999999999865311     113457799999999987  679999999999999999999999


Q ss_pred             CCcccccCcchhhhhhhhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          728 PTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       728 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      ||.........  .|......    .      .............++..+.+++.+||+.||++|||+.|++++
T Consensus       292 Pf~~~~~~~~~--~~~~~~~~----~------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  353 (371)
T 3q60_A          292 PFGLVTPGIKG--SWKRPSLR----V------PGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET  353 (371)
T ss_dssp             STTBCCTTCTT--CCCBCCTT----S------CCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred             CCCCcCccccc--chhhhhhh----h------ccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            99875332111  01000000    0      000001111112456779999999999999999999999763

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.1e-38  Score=335.89  Aligned_cols=251  Identities=25%  Similarity=0.305  Sum_probs=189.6

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc--chhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG--RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVL  602 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  602 (824)
                      .++|++.+.||+|+||+||+|+.. +|+.||||+++....  ...+.+.++...++.++||||+++++++.+++..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            468999999999999999999874 689999999865422  22334455666688899999999999999999999999


Q ss_pred             eccCCCCHHHHhhh---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-CeEecCCCCCCeeeCCCCcEEEeecccccccC
Q 040845          603 EYMPHGSLEKYLHS---SNYSLDIFQRLNIMIDVASALEYLHFGYSA-PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT  678 (824)
Q Consensus       603 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~  678 (824)
                      ||++ |+|.+++..   ....+++..++.++.|++.|++|||   +. +|+||||||+||+++.++.+||+|||++....
T Consensus        86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            9997 588887754   3457999999999999999999999   87 99999999999999999999999999998654


Q ss_pred             CCCCccccccccccccccCccCc----CCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhh
Q 040845          679 GEDQSMTQTQTLATIGYMAPEYG----REGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEV  754 (824)
Q Consensus       679 ~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  754 (824)
                      ...   ......||+.|+|||.+    .+..++.++||||+|+++|||++|+.||..................+.     
T Consensus       162 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-----  233 (290)
T 3fme_A          162 DDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQ-----  233 (290)
T ss_dssp             -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCC-----
T ss_pred             ccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCC-----
Confidence            322   22334689999999985    566789999999999999999999999975332222222222111110     


Q ss_pred             ccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          755 VDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       755 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                             .      ....++..+.+++.+||+.||++|||+.|++++
T Consensus       234 -------~------~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h  267 (290)
T 3fme_A          234 -------L------PADKFSAEFVDFTSQCLKKNSKERPTYPELMQH  267 (290)
T ss_dssp             -------C------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             -------c------ccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence                   0      012345678999999999999999999999884

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=2.3e-38  Score=351.28  Aligned_cols=197  Identities=21%  Similarity=0.306  Sum_probs=171.6

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcC------CCCcceeEEeeeecCCee
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSI------RHRNLVKVISSCSNEEFK  598 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~~  598 (824)
                      ..+|++.+.||+|+||.||+|... +++.||||+++.. ....+.+.+|+.+++.+      .|+||+++++++......
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            457999999999999999999865 4899999998753 23345677888888877      577999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCc--EEEeeccccc
Q 040845          599 ALVLEYMPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMV--AHLSDFGIAK  675 (824)
Q Consensus       599 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~--~kl~Dfg~a~  675 (824)
                      ++||||++ ++|.+++.... ..+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.  +||+|||+|.
T Consensus       175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~  250 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC  250 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred             EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence            99999995 69999988665 45899999999999999999999   899999999999999999887  9999999997


Q ss_pred             ccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCccc
Q 040845          676 LLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEL  732 (824)
Q Consensus       676 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~  732 (824)
                      .....     .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       251 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~  302 (429)
T 3kvw_A          251 YEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE  302 (429)
T ss_dssp             ETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence            64322     22346899999999999999999999999999999999999999764

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=9.2e-39  Score=336.29  Aligned_cols=244  Identities=20%  Similarity=0.290  Sum_probs=199.1

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc--cchhhhHHHHHHHHhcC-CCCcceeEEeeeecCCeeEEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC--GRAFKSFDVECAMMKSI-RHRNLVKVISSCSNEEFKALV  601 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  601 (824)
                      .++|++.+.||+|+||.||+|... +++.||||++....  ......+.+|+..+..+ +||||+++++++.+++..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            468999999999999999999876 69999999987542  33456778899999999 999999999999999999999


Q ss_pred             EeccCCCCHHHHhhhCC---CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCC---------------
Q 040845          602 LEYMPHGSLEKYLHSSN---YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDN---------------  663 (824)
Q Consensus       602 ~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~---------------  663 (824)
                      |||+++++|.+++....   ..+++.+++.++.|++.||+|||   +.+|+||||||+||+++.+               
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~  166 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW  166 (289)
T ss_dssp             EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC-----------------
T ss_pred             EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence            99999999999997642   46899999999999999999999   9999999999999999844               


Q ss_pred             ----CcEEEeecccccccCCCCCccccccccccccccCccCcCCC-CCCccchHHHHHHHHHHHHhCCCCCcccccCcch
Q 040845          664 ----MVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMT  738 (824)
Q Consensus       664 ----~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~  738 (824)
                          ..+||+|||.+.......      ...||+.|+|||.+.+. .++.++||||+||++|||++|.+|+...    ..
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----~~  236 (289)
T 1x8b_A          167 ASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG----DQ  236 (289)
T ss_dssp             ---CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS----HH
T ss_pred             cCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch----hH
Confidence                489999999998764322      23489999999998766 5678999999999999999998875431    11


Q ss_pred             hhhhhhhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          739 LKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       739 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      ...+.....+                   ..+..++..+.+++.+||+.||++|||+.|++++
T Consensus       237 ~~~~~~~~~~-------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  280 (289)
T 1x8b_A          237 WHEIRQGRLP-------------------RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH  280 (289)
T ss_dssp             HHHHHTTCCC-------------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             HHHHHcCCCC-------------------CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence            1111111000                   0112345678999999999999999999999875

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=3.5e-38  Score=337.23  Aligned_cols=253  Identities=23%  Similarity=0.301  Sum_probs=199.1

Q ss_pred             hhccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc--------cchhhhHHHHHHHHhcCCCCcceeEEeeeecC
Q 040845          525 ATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC--------GRAFKSFDVECAMMKSIRHRNLVKVISSCSNE  595 (824)
Q Consensus       525 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  595 (824)
                      ..++|.+.+.||+|+||.||+|... +++.||||++....        ......+.+|+++++.++||||+++++++..+
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            4578999999999999999999875 48999999986432        12234688999999999999999999998766


Q ss_pred             CeeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCc---EEEeecc
Q 040845          596 EFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMV---AHLSDFG  672 (824)
Q Consensus       596 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~---~kl~Dfg  672 (824)
                      . .++||||+++++|.+++.... .+++.+++.++.|++.||+|||   +.+|+||||||+||+++.++.   +||+|||
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg  162 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFG  162 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHSTTC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred             c-eEEEEecCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEccCc
Confidence            5 799999999999999987654 7899999999999999999999   999999999999999987654   9999999


Q ss_pred             cccccCCCCCccccccccccccccCccCcC---CCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCC
Q 040845          673 IAKLLTGEDQSMTQTQTLATIGYMAPEYGR---EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPI  749 (824)
Q Consensus       673 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  749 (824)
                      ++......   .......||+.|+|||++.   ...++.++|||||||++|||++|+.||........ ....+..... 
T Consensus       163 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~-  237 (322)
T 2ycf_A          163 HSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-LKDQITSGKY-  237 (322)
T ss_dssp             TCEECCCC---HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC-HHHHHHHTCC-
T ss_pred             cceecccc---cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH-HHHHHHhCcc-
Confidence            99875322   1223456899999999863   56789999999999999999999999976332221 1111111000 


Q ss_pred             cchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          750 STMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       750 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                                 .   ........++..+.+++.+||..||++|||+.|++++
T Consensus       238 -----------~---~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h  275 (322)
T 2ycf_A          238 -----------N---FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  275 (322)
T ss_dssp             -----------C---CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             -----------c---cCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence                       0   0001122456778999999999999999999999863

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.7e-38  Score=340.22  Aligned_cols=256  Identities=19%  Similarity=0.250  Sum_probs=203.6

Q ss_pred             HHhhccCCCC-ceeeeccceEEEEEEEC-CCcEEEEEEeeccc--cchhhhHHHHHHHHhcCC-CCcceeEEeeeecCCe
Q 040845          523 FQATDKFSEN-NLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIR-HRNLVKVISSCSNEEF  597 (824)
Q Consensus       523 ~~~~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~  597 (824)
                      ....++|.+. +.||+|+||.||+|... +++.||||++....  ......+.+|+.+++.++ ||||+++++++.+...
T Consensus        24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~  103 (327)
T 3lm5_A           24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE  103 (327)
T ss_dssp             HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence            3445677777 89999999999999876 58999999987543  233567889999999995 6999999999999999


Q ss_pred             eEEEEeccCCCCHHHHhhhC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC---CCcEEEeeccc
Q 040845          598 KALVLEYMPHGSLEKYLHSS-NYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD---NMVAHLSDFGI  673 (824)
Q Consensus       598 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~Dfg~  673 (824)
                      .++||||+++|+|.+++... ...+++.+++.++.|++.||+|||   +.+|+||||||+||+++.   ++.+||+|||+
T Consensus       104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~  180 (327)
T 3lm5_A          104 IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGM  180 (327)
T ss_dssp             EEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCCEEECCGGG
T ss_pred             EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCcEEEeeCcc
Confidence            99999999999999998654 357899999999999999999999   999999999999999987   78999999999


Q ss_pred             ccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchh
Q 040845          674 AKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTME  753 (824)
Q Consensus       674 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  753 (824)
                      +.......   ......||+.|+|||++.+..++.++||||+|+++|||++|+.||......+. ..........     
T Consensus       181 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~~~~-----  251 (327)
T 3lm5_A          181 SRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET-YLNISQVNVD-----  251 (327)
T ss_dssp             CEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHTCCC-----
T ss_pred             ccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH-HHHHHhcccc-----
Confidence            98764322   22335689999999999999999999999999999999999999976322111 1111110000     


Q ss_pred             hccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          754 VVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       754 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                                 ........++..+.+++.+||+.||++|||++|++++
T Consensus       252 -----------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          252 -----------YSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             -----------CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             -----------cCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence                       0001112346678999999999999999999999876

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=5.3e-38  Score=342.29  Aligned_cols=266  Identities=21%  Similarity=0.218  Sum_probs=194.5

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeecCC------
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEE------  596 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  596 (824)
                      .++|++.+.||+|+||.||+|... +++.||||++....  ....+.+.+|+.+++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            468999999999999999999865 58999999987542  233466889999999999999999999997654      


Q ss_pred             eeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccc
Q 040845          597 FKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  676 (824)
Q Consensus       597 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~  676 (824)
                      ..++||||+++ +|.+++..   .+++.++..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++..
T Consensus       104 ~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~  176 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART  176 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred             ceEEEEEcCCC-CHHHHHhh---ccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence            78999999964 78888853   5889999999999999999999   89999999999999999999999999999986


Q ss_pred             cCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCc--chhh
Q 040845          677 LTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPIS--TMEV  754 (824)
Q Consensus       677 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~  754 (824)
                      ....   .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+ .....+.......  ....
T Consensus       177 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~  252 (371)
T 2xrw_A          177 AGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID-QWNKVIEQLGTPCPEFMKK  252 (371)
T ss_dssp             ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHC-CCCCCHHHHTT
T ss_pred             cccc---cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHHH
Confidence            5322   12234568999999999999899999999999999999999999997632111 1111111000000  0000


Q ss_pred             c----------cccccC--------c--hhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 040845          755 V----------DANLLS--------Q--EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL  802 (824)
Q Consensus       755 ~----------~~~~~~--------~--~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L  802 (824)
                      .          .+....        .  ...........+..+.+++.+||..||++|||++|++++=
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp  320 (371)
T 2xrw_A          253 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP  320 (371)
T ss_dssp             SCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred             hhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCc
Confidence            0          000000        0  0001112234577899999999999999999999999863

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=3.2e-39  Score=337.99  Aligned_cols=253  Identities=23%  Similarity=0.309  Sum_probs=203.1

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeee--cCCeeEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCS--NEEFKAL  600 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~l  600 (824)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++....  ....+.+.+|+.++++++||||+++++++.  .....++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            468999999999999999999875 58999999987543  234567889999999999999999999874  4678899


Q ss_pred             EEeccCCCCHHHHhhhCC---CCCCHHHHHHHHHHHHHHHHHhhcCCCCC-----eEecCCCCCCeeeCCCCcEEEeecc
Q 040845          601 VLEYMPHGSLEKYLHSSN---YSLDIFQRLNIMIDVASALEYLHFGYSAP-----VIHCDLKPSNVLLDDNMVAHLSDFG  672 (824)
Q Consensus       601 v~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~-----ivH~Dlk~~Nill~~~~~~kl~Dfg  672 (824)
                      ||||+++++|.+++....   ..+++..++.++.|++.|++|||   +.+     |+||||||+||+++.++.+||+|||
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            999999999999997532   35899999999999999999999   777     9999999999999999999999999


Q ss_pred             cccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcch
Q 040845          673 IAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTM  752 (824)
Q Consensus       673 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  752 (824)
                      .+.......  .......+++.|+|||.+.+..++.++||||||+++|||++|+.||......  .....+.....    
T Consensus       162 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~i~~~~~----  233 (279)
T 2w5a_A          162 LARILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK--ELAGKIREGKF----  233 (279)
T ss_dssp             HHHHC---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHTCC----
T ss_pred             hheeecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH--HHHHHHhhccc----
Confidence            998754322  1223346899999999998888999999999999999999999998763211  11111111000    


Q ss_pred             hhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 040845          753 EVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLL  803 (824)
Q Consensus       753 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~  803 (824)
                              .      ..+..++..+.+++.+||+.||++|||+.|+++++.
T Consensus       234 --------~------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~  270 (279)
T 2w5a_A          234 --------R------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL  270 (279)
T ss_dssp             --------C------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred             --------c------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence                    0      011234667899999999999999999999998764

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.5e-37  Score=351.52  Aligned_cols=348  Identities=20%  Similarity=0.223  Sum_probs=231.0

Q ss_pred             cEEEccCCcccccccccccCCCCCCEEeCCCCcCCcccChhhhCcCCCceeeccCCccccccCccccCCCCCccEEEccC
Q 040845           24 KVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWG  103 (824)
Q Consensus        24 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~  103 (824)
                      +.++.++++++ .+|..+.  ++|++|||++|++++..+..|.++++|++|+|++|.++++.+... .++++|++|+|++
T Consensus        14 ~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~-~~l~~L~~L~L~~   89 (477)
T 2id5_A           14 RAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAF-NNLFNLRTLGLRS   89 (477)
T ss_dssp             TEEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTT-TTCTTCCEEECCS
T ss_pred             CEEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhh-hCCccCCEEECCC
Confidence            45666666666 4555443  466777777777766556666666666666666666665533322 2466666666666


Q ss_pred             CeeeeecCccccCCCCCceEeccCccccccCCccccCCCCCCEEEccCCcCCCCcCcccccccCCCCCCCcEEECcCCCC
Q 040845          104 NNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPL  183 (824)
Q Consensus       104 n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l  183 (824)
                      |++++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|.++.+..     ..|..+++|++|+|++|.+
T Consensus        90 n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~-----~~~~~l~~L~~L~l~~n~l  164 (477)
T 2id5_A           90 NRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISH-----RAFSGLNSLEQLTLEKCNL  164 (477)
T ss_dssp             SCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECT-----TSSTTCTTCCEEEEESCCC
T ss_pred             CcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeCh-----hhccCCCCCCEEECCCCcC
Confidence            66665555556666777777777777766666667777777777777776665432     2356666666666666666


Q ss_pred             CccCCccccccccccccEEEeecCcceecCCccCCCCCCCCEEEecCCccCCccchhhcCCCCCCEEEcccccCcccCCc
Q 040845          184 DGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPD  263 (824)
Q Consensus       184 ~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~  263 (824)
                      .++                          .+..+.++++|+.|+|++|.+.+..+..|..+++|++|++++|.+.+..+.
T Consensus       165 ~~~--------------------------~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~  218 (477)
T 2id5_A          165 TSI--------------------------PTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTP  218 (477)
T ss_dssp             SSC--------------------------CHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECT
T ss_pred             ccc--------------------------ChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCc
Confidence            543                          234467789999999999999988888999999999999999988777776


Q ss_pred             cccccCCccEEEccCccccccCCccccCCCCCcEEEcCCCCCCCCCCcccccccccccccccccccCcCCccccccccch
Q 040845          264 SICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALI  343 (824)
Q Consensus       264 ~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~  343 (824)
                      ......+|+.|++++|++++..+..|..+++|+.|+|++|.++.++                       +..|.++++|+
T Consensus       219 ~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~-----------------------~~~~~~l~~L~  275 (477)
T 2id5_A          219 NCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIE-----------------------GSMLHELLRLQ  275 (477)
T ss_dssp             TTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEEC-----------------------TTSCTTCTTCC
T ss_pred             ccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccC-----------------------hhhccccccCC
Confidence            6555567777777777777554456666666766666666665543                       44555666666


Q ss_pred             hhhcccccccccCCCccCCCCCCCeEEccCccccccCCccccccccccEEEccCcccCCCCcccccCCcccceeeccCCc
Q 040845          344 EIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNK  423 (824)
Q Consensus       344 ~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~  423 (824)
                      .|+|++|++++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+++..-+ ...-...+..+.+.++.
T Consensus       276 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~-~~~~~~~~~~~~~~~~~  354 (477)
T 2id5_A          276 EIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCR-LLWVFRRRWRLNFNRQQ  354 (477)
T ss_dssp             EEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGG-GHHHHTTTTSSCCTTCC
T ss_pred             EEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccc-hHhHHhhhhccccCccC
Confidence            66777777766667777777777777777777776556667777777777777777763222 11111223334555566


Q ss_pred             ccCCCCC
Q 040845          424 LKGEIPR  430 (824)
Q Consensus       424 l~~~~p~  430 (824)
                      ..|.-|.
T Consensus       355 ~~C~~p~  361 (477)
T 2id5_A          355 PTCATPE  361 (477)
T ss_dssp             CBEEESG
T ss_pred             ceeCCch
Confidence            6555443

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=7.9e-39  Score=339.38  Aligned_cols=263  Identities=24%  Similarity=0.320  Sum_probs=188.2

Q ss_pred             hhccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc-cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEE
Q 040845          525 ATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVL  602 (824)
Q Consensus       525 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  602 (824)
                      ..++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   92 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM   92 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred             chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence            4578999999999999999999854 58999999886542 334567888999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhh-------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccc
Q 040845          603 EYMPHGSLEKYLHS-------SNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK  675 (824)
Q Consensus       603 e~~~~g~L~~~l~~-------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~  675 (824)
                      ||+++++|.+++..       ....+++..++.++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||.+.
T Consensus        93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~  169 (303)
T 2vwi_A           93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSA  169 (303)
T ss_dssp             ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred             hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence            99999999999874       2346899999999999999999999   8999999999999999999999999999998


Q ss_pred             ccCCCCC---ccccccccccccccCccCcCC-CCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcc
Q 040845          676 LLTGEDQ---SMTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPIST  751 (824)
Q Consensus       676 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  751 (824)
                      .......   ........||+.|+|||.+.+ ..++.++||||+|+++|||++|+.||........... ......+...
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~~  248 (303)
T 2vwi_A          170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML-TLQNDPPSLE  248 (303)
T ss_dssp             HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHH-HHTSSCCCTT
T ss_pred             eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHH-HhccCCCccc
Confidence            6643221   112234568999999998865 4689999999999999999999999976432221111 1111000000


Q ss_pred             hhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          752 MEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       752 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      ....+..          ....++..+.+++.+||+.||++|||+.|++++
T Consensus       249 ~~~~~~~----------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  288 (303)
T 2vwi_A          249 TGVQDKE----------MLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH  288 (303)
T ss_dssp             C-----C----------CCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             cccccch----------hhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            0000000          112345678999999999999999999999875

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2.7e-38  Score=334.33  Aligned_cols=253  Identities=23%  Similarity=0.337  Sum_probs=205.0

Q ss_pred             hhccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc---------chhhhHHHHHHHHhcCC-CCcceeEEeeee
Q 040845          525 ATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG---------RAFKSFDVECAMMKSIR-HRNLVKVISSCS  593 (824)
Q Consensus       525 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~l~~~~~  593 (824)
                      ..++|++.+.||+|+||.||+|+.+ +|+.||||++.....         ...+.+.+|++++++++ ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            4578999999999999999999875 589999999875431         22456788999999996 999999999999


Q ss_pred             cCCeeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccc
Q 040845          594 NEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGI  673 (824)
Q Consensus       594 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~  673 (824)
                      .....++||||+++++|.+++.... .+++.+++.++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||.
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~  170 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGF  170 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             cCCeEEEEEeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEecccc
Confidence            9999999999999999999998654 6899999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCCccccccccccccccCccCcC------CCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhC
Q 040845          674 AKLLTGEDQSMTQTQTLATIGYMAPEYGR------EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCL  747 (824)
Q Consensus       674 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  747 (824)
                      +.......   ......+++.|+|||.+.      ...++.++||||+|+++|||++|+.||....... ..........
T Consensus       171 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~  246 (298)
T 1phk_A          171 SCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-MLRMIMSGNY  246 (298)
T ss_dssp             CEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCC
T ss_pred             hhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH-HHHHHhcCCc
Confidence            98764332   223356899999999874      4568899999999999999999999986532111 1111111100


Q ss_pred             CCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          748 PISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       748 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      ..                .......++..+.+++.+||+.||++|||+.|++++
T Consensus       247 ~~----------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (298)
T 1phk_A          247 QF----------------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  284 (298)
T ss_dssp             CC----------------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             cc----------------CcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence            00                001112456779999999999999999999999863

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.3e-38  Score=371.31  Aligned_cols=250  Identities=20%  Similarity=0.269  Sum_probs=206.0

Q ss_pred             hhccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecc---ccchhhhHHHHHHHHhcC-CCCcceeEEeeeecCCeeE
Q 040845          525 ATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQ---CGRAFKSFDVECAMMKSI-RHRNLVKVISSCSNEEFKA  599 (824)
Q Consensus       525 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  599 (824)
                      ..++|++.+.||+|+||.||+|+.+ +++.||||+++..   .....+.+..|..++..+ +||+|+++++++.+.+..|
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            4578999999999999999999875 4889999999754   234456778899999988 7999999999999999999


Q ss_pred             EEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCC
Q 040845          600 LVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG  679 (824)
Q Consensus       600 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  679 (824)
                      +||||+++|+|.+++...+ .+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+....
T Consensus       419 lV~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~  494 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  494 (674)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred             EEEeCcCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence            9999999999999998765 6899999999999999999999   99999999999999999999999999999986432


Q ss_pred             CCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccc
Q 040845          680 EDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANL  759 (824)
Q Consensus       680 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  759 (824)
                      ..  .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ....+...            . 
T Consensus       495 ~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~-~~~~i~~~------------~-  558 (674)
T 3pfq_A          495 DG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE-LFQSIMEH------------N-  558 (674)
T ss_dssp             TT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHSS------------C-
T ss_pred             CC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH-HHHHHHhC------------C-
Confidence            22  22344579999999999999999999999999999999999999997632111 11111110            0 


Q ss_pred             cCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 040845          760 LSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINA-----KEIVAK  801 (824)
Q Consensus       760 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~-----~evl~~  801 (824)
                             ...+..++.++.+|+.+||+.||++||++     +|+++|
T Consensus       559 -------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h  598 (674)
T 3pfq_A          559 -------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  598 (674)
T ss_dssp             -------CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred             -------CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence                   00112346678999999999999999997     666653

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=3.7e-38  Score=342.90  Aligned_cols=268  Identities=22%  Similarity=0.253  Sum_probs=203.5

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc-chhhhHHHHHHHHhcCCCCcceeEEeeeecC-----Cee
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVKVISSCSNE-----EFK  598 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~  598 (824)
                      .++|++.+.||+|+||.||+|... +++.||||++..... ...+.+.+|++++++++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            468999999999999999999865 588999999875432 3346788999999999999999999998654     468


Q ss_pred             EEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccC
Q 040845          599 ALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT  678 (824)
Q Consensus       599 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~  678 (824)
                      ++||||++ |+|.+++...  .+++.++..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++....
T Consensus       106 ~iv~e~~~-~~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~  179 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKTQ--HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD  179 (364)
T ss_dssp             EEEEECCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEcccC-cCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence            99999996 5999999764  5899999999999999999999   9999999999999999999999999999998764


Q ss_pred             CCCCc-cccccccccccccCccCcCC-CCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhcc
Q 040845          679 GEDQS-MTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVD  756 (824)
Q Consensus       679 ~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  756 (824)
                      ..... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+ .............. +...
T Consensus       180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~-~~~~  257 (364)
T 3qyz_A          180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD-QLNHILGILGSPSQ-EDLN  257 (364)
T ss_dssp             GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG-HHHHHHHHHCSCCH-HHHH
T ss_pred             CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH-HHHHHHHHhCCCCH-HHHH
Confidence            33221 12244579999999997654 458999999999999999999999997643221 11111111111100 0000


Q ss_pred             c------------cccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          757 A------------NLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       757 ~------------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      .            ...............++..+.+++.+||+.||++|||+.|++++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  314 (364)
T 3qyz_A          258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  314 (364)
T ss_dssp             TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0            00000000001112456779999999999999999999999875

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-38  Score=342.06  Aligned_cols=257  Identities=25%  Similarity=0.351  Sum_probs=199.8

Q ss_pred             HHHHHhhccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcC-CCCcceeEEeeeec---
Q 040845          520 LELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSI-RHRNLVKVISSCSN---  594 (824)
Q Consensus       520 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~---  594 (824)
                      .++....++|++.+.||+|+||.||+|++. +|+.||||++... ....+.+.+|+.+++++ +||||+++++++..   
T Consensus        17 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   95 (326)
T 2x7f_A           17 SALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP   95 (326)
T ss_dssp             CCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC-
T ss_pred             hhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecC-cccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccC
Confidence            334445788999999999999999999874 6899999998754 33457788999999999 79999999999976   


Q ss_pred             ---CCeeEEEEeccCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEee
Q 040845          595 ---EEFKALVLEYMPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSD  670 (824)
Q Consensus       595 ---~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D  670 (824)
                         ....++||||+++|+|.+++.... ..+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~kl~D  172 (326)
T 2x7f_A           96 PGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVD  172 (326)
T ss_dssp             -CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECC
T ss_pred             ccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCCEEEee
Confidence               568899999999999999998643 46899999999999999999999   89999999999999999999999999


Q ss_pred             cccccccCCCCCccccccccccccccCccCcC-----CCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhh
Q 040845          671 FGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR-----EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVND  745 (824)
Q Consensus       671 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~  745 (824)
                      ||++.......  .......|++.|+|||.+.     +..++.++|||||||++|||++|+.||........ .......
T Consensus       173 fg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~  249 (326)
T 2x7f_A          173 FGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA-LFLIPRN  249 (326)
T ss_dssp             CTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHS
T ss_pred             CcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH-HHHhhcC
Confidence            99998653221  1223346899999999886     56789999999999999999999999865322111 1111000


Q ss_pred             hCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          746 CLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       746 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      ..+         ..         ....++..+.+++.+||..||++|||+.|++++
T Consensus       250 ~~~---------~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  287 (326)
T 2x7f_A          250 PAP---------RL---------KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH  287 (326)
T ss_dssp             CCC---------CC---------SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             ccc---------cC---------CccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            000         00         011245678999999999999999999999885

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.7e-38  Score=369.25  Aligned_cols=258  Identities=24%  Similarity=0.394  Sum_probs=207.5

Q ss_pred             hccCCCCceeeeccceEEEEEEECC----CcEEEEEEeeccc-cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIRD----GMEVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKAL  600 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  600 (824)
                      .++|++.+.||+|+||.||+|.+..    +..||||.++... ....+.+.+|+.++++++||||+++++++.+ +..++
T Consensus       389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~l  467 (656)
T 2j0j_A          389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI  467 (656)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceEE
Confidence            4678889999999999999998742    4679999886543 2334678899999999999999999999854 56889


Q ss_pred             EEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 040845          601 VLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE  680 (824)
Q Consensus       601 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  680 (824)
                      ||||+++|+|.+++......+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus       468 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~  544 (656)
T 2j0j_A          468 IMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  544 (656)
T ss_dssp             EEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-
T ss_pred             EEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCCeecCCC
Confidence            99999999999999877767999999999999999999999   899999999999999999999999999999876433


Q ss_pred             CCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhccccc
Q 040845          681 DQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANL  759 (824)
Q Consensus       681 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  759 (824)
                      .. .......+|+.|+|||.+.+..++.++|||||||++|||++ |..||.+....+  ....+....            
T Consensus       545 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~~~i~~~~------------  609 (656)
T 2j0j_A          545 TY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIGRIENGE------------  609 (656)
T ss_dssp             ----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHHHTC------------
T ss_pred             cc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHHcCC------------
Confidence            22 22233457789999999988899999999999999999997 889987632211  111111100            


Q ss_pred             cCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 040845          760 LSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDS  808 (824)
Q Consensus       760 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~  808 (824)
                            ....+..++..+.+++.+||..||++|||+.|+++.|+++.+.
T Consensus       610 ------~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~  652 (656)
T 2j0j_A          610 ------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  652 (656)
T ss_dssp             ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ------CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence                  0111234567899999999999999999999999999998754

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=3.8e-38  Score=335.59  Aligned_cols=254  Identities=23%  Similarity=0.378  Sum_probs=198.5

Q ss_pred             hhccCCCCceeeeccceEEEEEEECCCcEEEEEEeeccc--cchhhhHHHHHHHHhcCC--CCcceeEEeeeecCCeeEE
Q 040845          525 ATDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIR--HRNLVKVISSCSNEEFKAL  600 (824)
Q Consensus       525 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~l  600 (824)
                      ..++|++.+.||+|+||.||+|...+++.||||++....  ....+.+.+|++++++++  |+||+++++++.++...++
T Consensus        26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l  105 (313)
T 3cek_A           26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM  105 (313)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred             ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence            357799999999999999999998889999999987543  234567889999999997  5999999999999999999


Q ss_pred             EEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 040845          601 VLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE  680 (824)
Q Consensus       601 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  680 (824)
                      ||| +.+++|.+++.... .+++.+++.++.|+++||+|||   +.+|+||||||+||++++ +.+||+|||++......
T Consensus       106 v~e-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~  179 (313)
T 3cek_A          106 VME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPD  179 (313)
T ss_dssp             EEC-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TEEEECCCSSSCC----
T ss_pred             EEe-cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-CeEEEeeccccccccCc
Confidence            999 55789999998765 7899999999999999999999   899999999999999964 89999999999876544


Q ss_pred             CCccccccccccccccCccCcCC-----------CCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCC
Q 040845          681 DQSMTQTQTLATIGYMAPEYGRE-----------GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPI  749 (824)
Q Consensus       681 ~~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  749 (824)
                      ..........|++.|+|||.+.+           ..++.++||||||+++|||++|+.||............+...... 
T Consensus       180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-  258 (313)
T 3cek_A          180 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE-  258 (313)
T ss_dssp             ----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSC-
T ss_pred             cccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccc-
Confidence            33333344568999999998865           468889999999999999999999997643221111111111000 


Q ss_pred             cchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 040845          750 STMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL  802 (824)
Q Consensus       750 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L  802 (824)
                                       ...+..++..+.+++.+||..||++|||+.|++++-
T Consensus       259 -----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~  294 (313)
T 3cek_A          259 -----------------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  294 (313)
T ss_dssp             -----------------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             -----------------cCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence                             000112245688999999999999999999999864

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=7.9e-38  Score=328.74  Aligned_cols=254  Identities=22%  Similarity=0.317  Sum_probs=205.2

Q ss_pred             HHhhccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeE
Q 040845          523 FQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKA  599 (824)
Q Consensus       523 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  599 (824)
                      ....++|++.+.||+|+||.||+|+.. +++.||||++....  ....+.+.+|++++++++||||+++++++.+....+
T Consensus        18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   97 (287)
T 2wei_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY   97 (287)
T ss_dssp             HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence            344578999999999999999999875 68999999987543  234567889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCC---CcEEEeecccccc
Q 040845          600 LVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDN---MVAHLSDFGIAKL  676 (824)
Q Consensus       600 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~---~~~kl~Dfg~a~~  676 (824)
                      +||||+++++|.+++.... .+++.+++.++.|++.|++|||   +.+|+||||||+||+++.+   +.+||+|||++..
T Consensus        98 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~  173 (287)
T 2wei_A           98 IVGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (287)
T ss_dssp             EEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred             EEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCccee
Confidence            9999999999999987654 6899999999999999999999   8999999999999999754   4799999999986


Q ss_pred             cCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhcc
Q 040845          677 LTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVD  756 (824)
Q Consensus       677 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  756 (824)
                      ......   .....+++.|+|||.+.+ .++.++||||+|+++|+|++|+.||......+ ....+......        
T Consensus       174 ~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~--------  240 (287)
T 2wei_A          174 FQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-ILKRVETGKYA--------  240 (287)
T ss_dssp             BCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCCC--------
T ss_pred             ecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHcCCCC--------
Confidence            543222   223458899999998865 48999999999999999999999987632111 01111110000        


Q ss_pred             ccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          757 ANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       757 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                              ........++..+.+++.+||..||++|||+.|++++
T Consensus       241 --------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  277 (287)
T 2wei_A          241 --------FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (287)
T ss_dssp             --------CCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             --------CCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence                    0011112346678999999999999999999999985

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.8e-38  Score=344.49  Aligned_cols=264  Identities=23%  Similarity=0.295  Sum_probs=185.5

Q ss_pred             hhccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeecC------
Q 040845          525 ATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSNE------  595 (824)
Q Consensus       525 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  595 (824)
                      ..++|++.+.||+|+||.||+|... +|+.||||++....  ....+.+.+|+.+++.++||||+++++++...      
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  106 (367)
T 2fst_X           27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF  106 (367)
T ss_dssp             EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence            3578999999999999999999864 58999999986432  23456778999999999999999999998654      


Q ss_pred             CeeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccc
Q 040845          596 EFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK  675 (824)
Q Consensus       596 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~  675 (824)
                      ...++|+||+ +++|.+++..  ..+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++
T Consensus       107 ~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~a~  180 (367)
T 2fst_X          107 NDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR  180 (367)
T ss_dssp             CCCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred             CeEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence            5679999999 6899998875  36899999999999999999999   9999999999999999999999999999998


Q ss_pred             ccCCCCCccccccccccccccCccCcCC-CCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhh
Q 040845          676 LLTGEDQSMTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEV  754 (824)
Q Consensus       676 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  754 (824)
                      .....     .....+|++|+|||++.+ ..++.++||||+||++|||++|+.||.+.... ..+..+...... ...+.
T Consensus       181 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~l~~i~~~~g~-p~~~~  253 (367)
T 2fst_X          181 HTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGT-PGAEL  253 (367)
T ss_dssp             ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCS-CCHHH
T ss_pred             ccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCC-CCHHH
Confidence            65321     234568999999998876 67899999999999999999999999763211 111111111110 00000


Q ss_pred             ccc-----------cccCchhhhh-hhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          755 VDA-----------NLLSQEDIHF-VAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       755 ~~~-----------~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      ...           .+........ .....+++.+.+|+.+||+.||++|||+.|++++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          254 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             HTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence            000           0000000000 0112346778999999999999999999999886

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=7.4e-38  Score=343.52  Aligned_cols=265  Identities=24%  Similarity=0.327  Sum_probs=196.4

Q ss_pred             hccCCCCceeeeccceEEEEEEECCCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCC------eeE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEE------FKA  599 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~  599 (824)
                      ..+|++.+.||+|+||+||+|+...+..||+|++....    ....+|+++++.++||||+++++++....      ..+
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK----RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCc----chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            35799999999999999999998877779999885432    22346999999999999999999985433      378


Q ss_pred             EEEeccCCCCHHHHhh--hCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC-CCCcEEEeecccccc
Q 040845          600 LVLEYMPHGSLEKYLH--SSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKL  676 (824)
Q Consensus       600 lv~e~~~~g~L~~~l~--~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~-~~~~~kl~Dfg~a~~  676 (824)
                      +||||++++.+.....  .....+++..+..++.|+++||+|||   +.+|+||||||+||+++ .++.+||+|||+|+.
T Consensus       115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~  191 (394)
T 4e7w_A          115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI  191 (394)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence            9999997643333322  22357899999999999999999999   99999999999999999 799999999999987


Q ss_pred             cCCCCCccccccccccccccCccCcCCC-CCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCc--chh
Q 040845          677 LTGEDQSMTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPIS--TME  753 (824)
Q Consensus       677 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~  753 (824)
                      ......   .....+|+.|+|||++.+. .++.++||||+||++|||++|+.||.+.... ..+..++.......  ...
T Consensus       192 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~l~~i~~~~g~p~~~~~~  267 (394)
T 4e7w_A          192 LIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI-DQLVEIIKVLGTPSREQIK  267 (394)
T ss_dssp             CCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHHH
T ss_pred             ccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHHH
Confidence            643322   2345689999999988765 5899999999999999999999999763221 11222221111100  000


Q ss_pred             hccccc-------cCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          754 VVDANL-------LSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       754 ~~~~~~-------~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      ..++..       ..........+..++.++.+++.+||+.||++|||+.|+++|
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          268 TMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             HHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             hhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence            000000       000111111222456789999999999999999999999876

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=6.1e-38  Score=335.29  Aligned_cols=269  Identities=22%  Similarity=0.298  Sum_probs=197.3

Q ss_pred             hccCCCCceeeeccceEEEEEEECC-CcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeee-----------
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCS-----------  593 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-----------  593 (824)
                      .++|++.+.||+|+||.||+|.... ++.||||++........+.+.+|++++++++||||+++++++.           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            4679999999999999999998764 8999999997665566678899999999999999999999873           


Q ss_pred             ---cCCeeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC-CCCcEEEe
Q 040845          594 ---NEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLS  669 (824)
Q Consensus       594 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~-~~~~~kl~  669 (824)
                         +....++||||++ |+|.+++...  .+++..++.++.|++.||+|||   +.+|+||||||+||+++ +++.+||+
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~  163 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLEQG--PLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIG  163 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred             cccccCceeEEeeccC-CCHHHHhhcC--CccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCeEEEc
Confidence               4467899999997 6999999753  5889999999999999999999   99999999999999997 57799999


Q ss_pred             ecccccccCCCCC-ccccccccccccccCccCcCC-CCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhC
Q 040845          670 DFGIAKLLTGEDQ-SMTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCL  747 (824)
Q Consensus       670 Dfg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  747 (824)
                      |||++........ ........++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+ ..........
T Consensus       164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~  242 (320)
T 2i6l_A          164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE-QMQLILESIP  242 (320)
T ss_dssp             CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHSC
T ss_pred             cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcC
Confidence            9999987643211 112233457899999998765 678999999999999999999999997643211 1111111111


Q ss_pred             CCcch---hh-------ccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          748 PISTM---EV-------VDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       748 ~~~~~---~~-------~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      .....   +.       ..................++..+.+++.+||+.||++|||++|++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (320)
T 2i6l_A          243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH  306 (320)
T ss_dssp             CCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             CCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence            00000   00       00000000000011112467789999999999999999999999875

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=4.4e-38  Score=333.58  Aligned_cols=253  Identities=24%  Similarity=0.346  Sum_probs=194.4

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeec----------
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSN----------  594 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----------  594 (824)
                      .++|++.+.||+|+||.||+|+.. +++.||||++... ....+.+.+|+.++++++||||+++++++.+          
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            568999999999999999999875 6899999998643 3445778899999999999999999998754          


Q ss_pred             ---CCeeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeec
Q 040845          595 ---EEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDF  671 (824)
Q Consensus       595 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df  671 (824)
                         ....++||||+++|+|.+++......+++.+++.++.|+++|++|||   +.+|+||||||+||+++.++.+||+||
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~kl~df  160 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDF  160 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCC
T ss_pred             cccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEEEeeC
Confidence               45778999999999999999877667889999999999999999999   899999999999999999999999999


Q ss_pred             ccccccCCCCC------------ccccccccccccccCccCcCCC-CCCccchHHHHHHHHHHHHhCCCCCcccccCcch
Q 040845          672 GIAKLLTGEDQ------------SMTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMT  738 (824)
Q Consensus       672 g~a~~~~~~~~------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~  738 (824)
                      |.+........            ........|++.|+|||.+.+. .++.++||||+||++|||++   ||.........
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~  237 (303)
T 1zy4_A          161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNI  237 (303)
T ss_dssp             CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred             cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHH
Confidence            99986542211            1122345689999999998754 68999999999999999998   54321111111


Q ss_pred             hhhhhhhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          739 LKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       739 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      ...+......      ..          ...+..++..+.+++.+||+.||++|||+.|++++
T Consensus       238 ~~~~~~~~~~------~~----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  284 (303)
T 1zy4_A          238 LKKLRSVSIE------FP----------PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS  284 (303)
T ss_dssp             HHHHHSTTCC------CC----------TTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             HHhccccccc------cC----------ccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence            1111100000      00          00112345668899999999999999999999874

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.6e-37  Score=333.05  Aligned_cols=269  Identities=26%  Similarity=0.352  Sum_probs=203.7

Q ss_pred             hhccCCCCceeeeccceEEEEEEE--CCCcEEEEEEeecccc--chhhhHHHHHHHHhcC---CCCcceeEEeeee----
Q 040845          525 ATDKFSENNLIGRGGFGSVYKARI--RDGMEVAVKVFNLQCG--RAFKSFDVECAMMKSI---RHRNLVKVISSCS----  593 (824)
Q Consensus       525 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~----  593 (824)
                      +.++|++.+.||+|+||.||+|+.  .+|+.||||++.....  .....+.+|+.+++.+   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            457899999999999999999987  3588999999875432  2234667788877766   8999999999987    


Q ss_pred             -cCCeeEEEEeccCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeec
Q 040845          594 -NEEFKALVLEYMPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDF  671 (824)
Q Consensus       594 -~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df  671 (824)
                       .....++||||++ |+|.+++.... ..+++.+++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+||
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl~Df  164 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADF  164 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEEecC
Confidence             5678899999997 69999998654 35899999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcc
Q 040845          672 GIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPIST  751 (824)
Q Consensus       672 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  751 (824)
                      |.+......   .......+|..|+|||.+.+..++.++||||+|+++|||++|+.||......+ ..............
T Consensus       165 g~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~~~  240 (326)
T 1blx_A          165 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVIGLPGE  240 (326)
T ss_dssp             CSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCG
T ss_pred             cccccccCC---CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHHcCCCCc
Confidence            999765321   22334568999999999998899999999999999999999999997632211 11111111100000


Q ss_pred             hhhc------cccccC-chhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          752 MEVV------DANLLS-QEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       752 ~~~~------~~~~~~-~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      ....      ...... ...........++..+.+++.+||..||++|||+.|++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  297 (326)
T 1blx_A          241 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  297 (326)
T ss_dssp             GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            0000      000000 0000001112456778999999999999999999999864

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=7.3e-38  Score=346.40  Aligned_cols=263  Identities=24%  Similarity=0.323  Sum_probs=195.5

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeec------CCeeE
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSN------EEFKA  599 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~~~  599 (824)
                      .+|++.+.||+|+||.||+|++. +|+.||||++....    ....+|+++++.++||||+++++++..      ....+
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            46889999999999999999975 58999999986432    233479999999999999999998843      22467


Q ss_pred             EEEeccCCCCHHHHhh---hCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCC-CcEEEeeccccc
Q 040845          600 LVLEYMPHGSLEKYLH---SSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDN-MVAHLSDFGIAK  675 (824)
Q Consensus       600 lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~Dfg~a~  675 (824)
                      +||||+++ ++.+.+.   .....+++..+..++.||++||+|||   +.+|+||||||+|||++.+ +.+||+|||+|+
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            99999975 6766654   23457899999999999999999999   9999999999999999955 678999999998


Q ss_pred             ccCCCCCccccccccccccccCccCcCCC-CCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcc--h
Q 040845          676 LLTGEDQSMTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPIST--M  752 (824)
Q Consensus       676 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~  752 (824)
                      .+.....   .....+|+.|+|||++.+. .++.++||||+||++|||++|+.||.+... ...+..++........  .
T Consensus       206 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~-~~~l~~i~~~lg~p~~~~~  281 (420)
T 1j1b_A          206 QLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG-VDQLVEIIKVLGTPTREQI  281 (420)
T ss_dssp             ECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCSCCHHHH
T ss_pred             hcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCHHHH
Confidence            7643322   2335689999999988765 789999999999999999999999976321 1122222221111000  0


Q ss_pred             hhccccc-------cCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          753 EVVDANL-------LSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       753 ~~~~~~~-------~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      ....+..       ..........+..++.++.+|+.+||..||++|||+.|+++|
T Consensus       282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h  337 (420)
T 1j1b_A          282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  337 (420)
T ss_dssp             HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence            0000000       000001111122456789999999999999999999999875

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=6.7e-38  Score=345.83  Aligned_cols=266  Identities=22%  Similarity=0.244  Sum_probs=201.1

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcCC--------CCcceeEEeeee---
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIR--------HRNLVKVISSCS---  593 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~---  593 (824)
                      .++|++.+.||+|+||+||+|+.. +++.||||+++.. ....+.+.+|+.+++.++        |+||+++++++.   
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            367999999999999999999864 5889999998643 334567889999999996        788999999987   


Q ss_pred             -cCCeeEEEEeccCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCC-CeEecCCCCCCeeeCCCC------
Q 040845          594 -NEEFKALVLEYMPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSA-PVIHCDLKPSNVLLDDNM------  664 (824)
Q Consensus       594 -~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~Dlk~~Nill~~~~------  664 (824)
                       +....++||||+ ++++.+++.... ..+++..++.++.|++.||+|||   ++ +|+||||||+||+++.++      
T Consensus       115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~~~~~  190 (397)
T 1wak_A          115 VNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQYIRRL  190 (397)
T ss_dssp             TTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHHHHHH
T ss_pred             CCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchhhhhh
Confidence             566889999999 556666665443 57999999999999999999999   87 999999999999999775      


Q ss_pred             -------------------------------------------cEEEeecccccccCCCCCccccccccccccccCccCc
Q 040845          665 -------------------------------------------VAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYG  701 (824)
Q Consensus       665 -------------------------------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~  701 (824)
                                                                 .+||+|||.|......     .....||+.|+|||++
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~  265 (397)
T 1wak_A          191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVL  265 (397)
T ss_dssp             HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHH
T ss_pred             hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChhh
Confidence                                                       7999999999875432     2334689999999999


Q ss_pred             CCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcch-----hhhhhhhhCCCcc---------hhhcccc--c--c-C-
Q 040845          702 REGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMT-----LKHWVNDCLPIST---------MEVVDAN--L--L-S-  761 (824)
Q Consensus       702 ~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~-----~~~~~~~~~~~~~---------~~~~~~~--~--~-~-  761 (824)
                      .+..++.++|||||||++|||++|+.||......+..     .............         .+.....  .  . . 
T Consensus       266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (397)
T 1wak_A          266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL  345 (397)
T ss_dssp             HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred             cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence            9889999999999999999999999999764322111     1111110000000         0000000  0  0 0 


Q ss_pred             -c------hhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          762 -Q------EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       762 -~------~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                       .      .......+..++..+.+|+.+||+.||++|||++|++++
T Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  392 (397)
T 1wak_A          346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH  392 (397)
T ss_dssp             CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred             CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence             0      000011224567789999999999999999999999875

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=7.9e-38  Score=340.92  Aligned_cols=263  Identities=21%  Similarity=0.258  Sum_probs=198.4

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc--chhhhHHHHHHHHhcCCCCcceeEEeeeecCCee----
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG--RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFK----  598 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~----  598 (824)
                      .++|.+.+.||+|+||.||+|... +|+.||||++.....  ...+.+.+|+.+++.++||||+++++++......    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            568999999999999999999865 589999999875422  2356788999999999999999999999876654    


Q ss_pred             --EEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccc
Q 040845          599 --ALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  676 (824)
Q Consensus       599 --~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~  676 (824)
                        ++||||++ ++|.+++..   .+++.++..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus       121 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  193 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMGM---EFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARH  193 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred             eEEEEEcccc-ccHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence              99999996 688888743   4899999999999999999999   89999999999999999999999999999986


Q ss_pred             cCCCCCccccccccccccccCccCcCC-CCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCc--chh
Q 040845          677 LTGEDQSMTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPIS--TME  753 (824)
Q Consensus       677 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~  753 (824)
                      ....     .....+|+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+ .............  ...
T Consensus       194 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~  267 (371)
T 4exu_A          194 ADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVTGVPGTEFVQ  267 (371)
T ss_dssp             -----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCHHHHT
T ss_pred             cccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCcHHHHH
Confidence            5322     234568999999998877 678999999999999999999999997632111 1111111111000  000


Q ss_pred             hcc--------ccccCc-hhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          754 VVD--------ANLLSQ-EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       754 ~~~--------~~~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      ...        ...... ..........++..+.+++.+||+.||++|||++|++++
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          268 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             TCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence            000        000000 000011112457789999999999999999999999876

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=5.6e-39  Score=343.16  Aligned_cols=261  Identities=22%  Similarity=0.334  Sum_probs=201.9

Q ss_pred             hhccCCCCceeeeccceEEEEEEECCCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEE
Q 040845          525 ATDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVL  602 (824)
Q Consensus       525 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  602 (824)
                      ..++|++.+.||+|+||.||+|++..  .||+|+++...  ....+.+.+|+.++++++||||+++++++.++...++||
T Consensus        31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  108 (319)
T 2y4i_B           31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT  108 (319)
T ss_dssp             CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred             CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence            35789999999999999999998763  59999986542  233466788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC-
Q 040845          603 EYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED-  681 (824)
Q Consensus       603 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~-  681 (824)
                      ||+++++|.+++...+..+++.+++.++.|++.|++|||   +.+|+||||||+||+++ ++.+||+|||++....... 
T Consensus       109 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~  184 (319)
T 2y4i_B          109 SLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQA  184 (319)
T ss_dssp             BCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSCCC-------
T ss_pred             ecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCCccccccccc
Confidence            999999999999887767999999999999999999999   89999999999999998 6799999999987543211 


Q ss_pred             --CccccccccccccccCccCcCC---------CCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCc
Q 040845          682 --QSMTQTQTLATIGYMAPEYGRE---------GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPIS  750 (824)
Q Consensus       682 --~~~~~~~~~~~~~y~aPE~~~~---------~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  750 (824)
                        .........|++.|+|||.+..         ..++.++||||||+++|||++|+.||........ .........   
T Consensus       185 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~~~~---  260 (319)
T 2y4i_B          185 GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI-IWQMGTGMK---  260 (319)
T ss_dssp             ---CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHH-HHHHHTTCC---
T ss_pred             cccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHhccCCC---
Confidence              1122233458999999998864         3578899999999999999999999976322111 111100000   


Q ss_pred             chhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhc
Q 040845          751 TMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLL  810 (824)
Q Consensus       751 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~  810 (824)
                            +...         +..++..+.+++.+||..||++|||+.|+++.|+++.+...
T Consensus       261 ------~~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~  305 (319)
T 2y4i_B          261 ------PNLS---------QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNR  305 (319)
T ss_dssp             ------CCCC---------CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-----
T ss_pred             ------CCCC---------cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhc
Confidence                  0000         01234558899999999999999999999999999876543

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.5e-37  Score=335.18  Aligned_cols=265  Identities=20%  Similarity=0.274  Sum_probs=203.7

Q ss_pred             hccCCCCceeeeccceEEEEEEE-C-CCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCc------ceeEEeeeecCCe
Q 040845          526 TDKFSENNLIGRGGFGSVYKARI-R-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRN------LVKVISSCSNEEF  597 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~-~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~  597 (824)
                      .++|++.+.||+|+||.||+|.. . +++.||||+++.. ....+.+.+|+++++.++|++      ++++++++...+.
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            36899999999999999999986 3 5889999998643 334567888999999887654      9999999999999


Q ss_pred             eEEEEeccCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC--------------
Q 040845          598 KALVLEYMPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD--------------  662 (824)
Q Consensus       598 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~--------------  662 (824)
                      .++||||+ +++|.+++.... ..+++.++..++.|++.||+|||   +.+|+||||||+||+++.              
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~  167 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRD  167 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred             EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCccccc
Confidence            99999999 889999997665 46889999999999999999999   999999999999999987              


Q ss_pred             -----CCcEEEeecccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcc
Q 040845          663 -----NMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEM  737 (824)
Q Consensus       663 -----~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~  737 (824)
                           ++.+||+|||++......     .....||+.|+|||++.+..++.++||||+||++|||++|+.||......+ 
T Consensus       168 ~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-  241 (339)
T 1z57_A          168 ERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE-  241 (339)
T ss_dssp             EEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH-
T ss_pred             cccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH-
Confidence                 678999999999864322     223468999999999999899999999999999999999999997632211 


Q ss_pred             hhhhhhhhhCCCc--chhhc---------cccccC-------------chhhhhhhHHHHHHHHHHHHHHccccCCCCCC
Q 040845          738 TLKHWVNDCLPIS--TMEVV---------DANLLS-------------QEDIHFVAKEQCVSFVFNLALECTVESPEQRI  793 (824)
Q Consensus       738 ~~~~~~~~~~~~~--~~~~~---------~~~~~~-------------~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp  793 (824)
                      ....+.....+..  .....         ...+..             ...........++..+.+++.+||+.||++||
T Consensus       242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  321 (339)
T 1z57_A          242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI  321 (339)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence            1111111111000  00000         000000             00000111234678899999999999999999


Q ss_pred             CHHHHHHH
Q 040845          794 NAKEIVAK  801 (824)
Q Consensus       794 t~~evl~~  801 (824)
                      |++|++++
T Consensus       322 t~~ell~h  329 (339)
T 1z57_A          322 TLREALKH  329 (339)
T ss_dssp             CHHHHTTS
T ss_pred             CHHHHhcC
Confidence            99999875

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=6.6e-38  Score=346.01  Aligned_cols=269  Identities=21%  Similarity=0.274  Sum_probs=185.0

Q ss_pred             ccCCC-CceeeeccceEEEEEEEC---CCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeee--cCCeeEE
Q 040845          527 DKFSE-NNLIGRGGFGSVYKARIR---DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCS--NEEFKAL  600 (824)
Q Consensus       527 ~~~~~-~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~l  600 (824)
                      +.|++ .++||+|+||+||+|+++   +++.||||++...  .....+.+|+.+++.++||||+++++++.  .....++
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l   97 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL   97 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence            45666 458999999999999875   4789999998643  33457889999999999999999999994  4778999


Q ss_pred             EEeccCCCCHHHHhhhCC--------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee----CCCCcEEE
Q 040845          601 VLEYMPHGSLEKYLHSSN--------YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL----DDNMVAHL  668 (824)
Q Consensus       601 v~e~~~~g~L~~~l~~~~--------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill----~~~~~~kl  668 (824)
                      ||||++ ++|.+++....        ..+++..++.++.|++.||+|||   +.+|+||||||+||++    +.++.+||
T Consensus        98 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl  173 (405)
T 3rgf_A           98 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKI  173 (405)
T ss_dssp             EEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred             EEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcEEE
Confidence            999996 58888875321        24899999999999999999999   9999999999999999    67899999


Q ss_pred             eecccccccCCCCC-ccccccccccccccCccCcCCC-CCCccchHHHHHHHHHHHHhCCCCCcccccCc--------ch
Q 040845          669 SDFGIAKLLTGEDQ-SMTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDELFNGE--------MT  738 (824)
Q Consensus       669 ~Dfg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~--------~~  738 (824)
                      +|||+|+.+..... ........||+.|+|||++.+. .++.++||||+||++|||++|+.||.......        ..
T Consensus       174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  253 (405)
T 3rgf_A          174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ  253 (405)
T ss_dssp             CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred             EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence            99999987643221 1223446789999999988774 58999999999999999999999997532210        11


Q ss_pred             hhhhhhhhCCCcchhhccccccCc----------hhh------hh--hhHHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 040845          739 LKHWVNDCLPISTMEVVDANLLSQ----------EDI------HF--VAKEQCVSFVFNLALECTVESPEQRINAKEIVA  800 (824)
Q Consensus       739 ~~~~~~~~~~~~~~~~~~~~~~~~----------~~~------~~--~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~  800 (824)
                      +..++............+......          ...      ..  ......+..+.+|+.+||+.||++|||++|+++
T Consensus       254 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~  333 (405)
T 3rgf_A          254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ  333 (405)
T ss_dssp             HHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            111111111000000000000000          000      00  000012456889999999999999999999998


Q ss_pred             H
Q 040845          801 K  801 (824)
Q Consensus       801 ~  801 (824)
                      |
T Consensus       334 h  334 (405)
T 3rgf_A          334 D  334 (405)
T ss_dssp             S
T ss_pred             C
Confidence            6

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=8.2e-38  Score=339.22  Aligned_cols=269  Identities=23%  Similarity=0.265  Sum_probs=201.2

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc-chhhhHHHHHHHHhcCCCCcceeEEeeeecC-----Cee
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVKVISSCSNE-----EFK  598 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~  598 (824)
                      .++|++.+.||+|+||.||+|++. +|+.||||++..... .....+.+|+.++++++||||+++++++..+     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            468999999999999999999875 589999999864332 3345678899999999999999999987654     678


Q ss_pred             EEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccC
Q 040845          599 ALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT  678 (824)
Q Consensus       599 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~  678 (824)
                      ++||||++ ++|.+++...  .+++.++..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++....
T Consensus        90 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  163 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVISTQ--MLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID  163 (353)
T ss_dssp             EEEECCCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEeccC-ccHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence            99999996 5999998764  5899999999999999999999   8999999999999999999999999999998764


Q ss_pred             CCCCcc--------ccccccccccccCccCcCC-CCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhC-C
Q 040845          679 GEDQSM--------TQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCL-P  748 (824)
Q Consensus       679 ~~~~~~--------~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-~  748 (824)
                      ......        ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+ .......... +
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~  242 (353)
T 2b9h_A          164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH-QLLLIFGIIGTP  242 (353)
T ss_dssp             ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCC
T ss_pred             cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCC
Confidence            322111        1223468999999997654 678999999999999999999999997632211 1111111000 0


Q ss_pred             C--cch---------hhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          749 I--STM---------EVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       749 ~--~~~---------~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      .  ...         +...................++..+.+++.+||+.||++|||++|++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (353)
T 2b9h_A          243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH  306 (353)
T ss_dssp             CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             chhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            0  000         0000000000000011123567789999999999999999999999875

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.3e-37  Score=344.58  Aligned_cols=251  Identities=21%  Similarity=0.377  Sum_probs=190.1

Q ss_pred             hccCCCCceeeeccceEEEEEEECCCcEEEEEEeeccccchhhhHHHHHHHHhcC-CCCcceeEEeeeecCCeeEEEEec
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSI-RHRNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      ..+|...+.||+|+||+||.....+++.||||++...   ....+.+|+++++.+ +||||+++++++.+....++||||
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~   99 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPE---CFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL   99 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTT---TEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence            3568888999999999976655567999999998643   234467899999999 799999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC-----CCcEEEeecccccccCC
Q 040845          605 MPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD-----NMVAHLSDFGIAKLLTG  679 (824)
Q Consensus       605 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~-----~~~~kl~Dfg~a~~~~~  679 (824)
                      ++ |+|.+++........+.+++.++.|+++||+|||   +.+|+||||||+||+++.     ...+||+|||+|+....
T Consensus       100 ~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~  175 (432)
T 3p23_A          100 CA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV  175 (432)
T ss_dssp             CS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred             CC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence            96 5999999877655666677899999999999999   899999999999999953     33688999999987653


Q ss_pred             CCCc-cccccccccccccCccCcC---CCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhh
Q 040845          680 EDQS-MTQTQTLATIGYMAPEYGR---EGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEV  754 (824)
Q Consensus       680 ~~~~-~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  754 (824)
                      .... .......||++|+|||++.   ...++.++||||+||++|||++ |..||........   ...   ........
T Consensus       176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~---~~~---~~~~~~~~  249 (432)
T 3p23_A          176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA---NIL---LGACSLDC  249 (432)
T ss_dssp             ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH---HHH---TTCCCCTT
T ss_pred             CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH---HHH---hccCCccc
Confidence            3221 2334467999999999987   4567889999999999999999 8888865322111   000   00000000


Q ss_pred             ccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          755 VDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       755 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                                  .......+..+.+++.+||+.||++|||+.|+++|
T Consensus       250 ------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h  284 (432)
T 3p23_A          250 ------------LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH  284 (432)
T ss_dssp             ------------SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ------------cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence                        00112345568899999999999999999999953

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=5.1e-37  Score=336.07  Aligned_cols=200  Identities=25%  Similarity=0.346  Sum_probs=171.1

Q ss_pred             hhccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcCC-CC-----cceeEEeeeecCCe
Q 040845          525 ATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIR-HR-----NLVKVISSCSNEEF  597 (824)
Q Consensus       525 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~~~  597 (824)
                      ..++|++.+.||+|+||+||+|... +++.||||+++.. ......+..|+.+++.++ |+     +|+++++++...+.
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  130 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH  130 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence            3578999999999999999999865 5889999998743 233566778899988885 55     49999999999999


Q ss_pred             eEEEEeccCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC--CCCcEEEeecccc
Q 040845          598 KALVLEYMPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD--DNMVAHLSDFGIA  674 (824)
Q Consensus       598 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~--~~~~~kl~Dfg~a  674 (824)
                      .++||||++ ++|.+++.... ..+++..+..++.|++.|++|||.. +.+|+||||||+||+++  .++.+||+|||+|
T Consensus       131 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a  208 (382)
T 2vx3_A          131 LCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS  208 (382)
T ss_dssp             EEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             eEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence            999999995 59999998764 4689999999999999999999921 36899999999999994  5788999999999


Q ss_pred             cccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCccc
Q 040845          675 KLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDEL  732 (824)
Q Consensus       675 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~  732 (824)
                      +.....     .....+|+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       209 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~  261 (382)
T 2vx3_A          209 CQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA  261 (382)
T ss_dssp             EETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             eecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            876422     22356899999999999999999999999999999999999999763

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=9.6e-37  Score=340.26  Aligned_cols=358  Identities=17%  Similarity=0.150  Sum_probs=284.4

Q ss_pred             CcEEEccCCcccccccccccCCCCCCEEeCCCCcCCcccChhhhCcCCCceeeccCCccccccCccccCCCCCccEEEcc
Q 040845           23 LKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLW  102 (824)
Q Consensus        23 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~  102 (824)
                      ++......+...+..+..++++++|++|++++|.+++ +| ++..+++|++|+|++|++++++    ...+++|++|+|+
T Consensus        20 l~~~~~~~~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~~~----~~~l~~L~~L~Ls   93 (457)
T 3bz5_A           20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNITTLD----LSQNTNLTYLACD   93 (457)
T ss_dssp             HHHHHHHHTTCCTTSEEEHHHHTTCCEEECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSCCC----CTTCTTCSEEECC
T ss_pred             HHHHHHHhcCcCcccccChhHcCCCCEEEccCCCccc-Ch-hhcccCCCCEEEccCCcCCeEc----cccCCCCCEEECc
Confidence            3334444555555667789999999999999999995 45 7999999999999999999874    3468999999999


Q ss_pred             CCeeeeecCccccCCCCCceEeccCccccccCCccccCCCCCCEEEccCCcCCCCcCcccccccCCCCCCCcEEECcCCC
Q 040845          103 GNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNP  182 (824)
Q Consensus       103 ~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~~L~~L~Ls~n~  182 (824)
                      +|++++. +  ++.+++|++|+|++|++++. +  ++++++|++|++++|+++.++        +..+++|++|++++|.
T Consensus        94 ~N~l~~~-~--~~~l~~L~~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l~--------l~~l~~L~~L~l~~n~  159 (457)
T 3bz5_A           94 SNKLTNL-D--VTPLTKLTYLNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTEID--------VSHNTQLTELDCHLNK  159 (457)
T ss_dssp             SSCCSCC-C--CTTCTTCCEEECCSSCCSCC-C--CTTCTTCCEEECTTSCCSCCC--------CTTCTTCCEEECTTCS
T ss_pred             CCCCcee-e--cCCCCcCCEEECCCCcCCee-c--CCCCCcCCEEECCCCccceec--------cccCCcCCEEECCCCC
Confidence            9999964 3  88999999999999999974 3  899999999999999998853        6789999999999995


Q ss_pred             CCccCCccccccccccccEEEeecCcceecCCccCCCCCCCCEEEecCCccCCccchhhcCCCCCCEEEcccccCcccCC
Q 040845          183 LDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIP  262 (824)
Q Consensus       183 l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~  262 (824)
                      ..+..+  + + -.++|+.|++++|++++. |  +..+++|+.|++++|++++.   .+..+++|++|++++|++++ +|
T Consensus       160 ~~~~~~--~-~-~l~~L~~L~ls~n~l~~l-~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip  228 (457)
T 3bz5_A          160 KITKLD--V-T-PQTQLTTLDCSFNKITEL-D--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID  228 (457)
T ss_dssp             CCCCCC--C-T-TCTTCCEEECCSSCCCCC-C--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC
T ss_pred             cccccc--c-c-cCCcCCEEECCCCcccee-c--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC
Confidence            443322  1 1 245799999999998874 3  78888999999999998864   37888999999999999986 44


Q ss_pred             ccccccCCccEEEccCccccccCCccccCCCCCcEEEcCCCCCCCCCCcccccccccccccccccccCcCCccccccccc
Q 040845          263 DSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKAL  342 (824)
Q Consensus       263 ~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L  342 (824)
                        +..+++|+.|++++|++++..   ++.+++|+.|++++|+             |+.|++++|.+.+.+|  ++.+++|
T Consensus       229 --~~~l~~L~~L~l~~N~l~~~~---~~~l~~L~~L~l~~n~-------------L~~L~l~~n~~~~~~~--~~~l~~L  288 (457)
T 3bz5_A          229 --VTPLTQLTYFDCSVNPLTELD---VSTLSKLTTLHCIQTD-------------LLEIDLTHNTQLIYFQ--AEGCRKI  288 (457)
T ss_dssp             --CTTCTTCSEEECCSSCCSCCC---CTTCTTCCEEECTTCC-------------CSCCCCTTCTTCCEEE--CTTCTTC
T ss_pred             --ccccCCCCEEEeeCCcCCCcC---HHHCCCCCEEeccCCC-------------CCEEECCCCccCCccc--ccccccC
Confidence              778889999999999988654   4567788888888765             4567788998877666  5788999


Q ss_pred             hhhhcccccccccCCC--------ccCCCCCCCeEEccCccccccCCccccccccccEEEccCcccCCCCcccccCCccc
Q 040845          343 IEIDFSMNNFSGIIPM--------EIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYL  414 (824)
Q Consensus       343 ~~L~l~~N~l~~~~~~--------~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L  414 (824)
                      +.|++++|...+.+|.        .+..+++|+.|++++|++++. +  ++.+++|+.|++++|+|++        ++.|
T Consensus       289 ~~L~Ls~n~~l~~l~~~~~~L~~L~l~~~~~L~~L~L~~N~l~~l-~--l~~l~~L~~L~l~~N~l~~--------l~~L  357 (457)
T 3bz5_A          289 KELDVTHNTQLYLLDCQAAGITELDLSQNPKLVYLYLNNTELTEL-D--VSHNTKLKSLSCVNAHIQD--------FSSV  357 (457)
T ss_dssp             CCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCCCSCC-C--CTTCTTCSEEECCSSCCCB--------CTTG
T ss_pred             CEEECCCCcccceeccCCCcceEechhhcccCCEEECCCCccccc-c--cccCCcCcEEECCCCCCCC--------cccc
Confidence            9999999987666553        256677888888888888863 3  8888888888888888874        2466


Q ss_pred             ceeeccCCcccCCCCCCCCccccccccccCCc
Q 040845          415 KDLNLSFNKLKGEIPRGGSFGNFSAESFKGNE  446 (824)
Q Consensus       415 ~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~  446 (824)
                      ..|++++|.++|.    +.+..+....+..|.
T Consensus       358 ~~L~l~~n~l~g~----~~~~~l~~l~l~~N~  385 (457)
T 3bz5_A          358 GKIPALNNNFEAE----GQTITMPKETLTNNS  385 (457)
T ss_dssp             GGSSGGGTSEEEE----EEEEECCCBCCBTTB
T ss_pred             ccccccCCcEEec----ceeeecCccccccCc
Confidence            7778888888876    133444555555554

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=2.1e-37  Score=332.05  Aligned_cols=254  Identities=25%  Similarity=0.300  Sum_probs=179.4

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc-chhhhHHHHHH-HHhcCCCCcceeEEeeeecCCeeEEEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG-RAFKSFDVECA-MMKSIRHRNLVKVISSCSNEEFKALVL  602 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~  602 (824)
                      .++|++.+.||+|+||.||+|... +|+.||||++..... .....+..|+. +++.++||||+++++++.+++..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            468899999999999999999875 689999999975432 23344555555 778889999999999999999999999


Q ss_pred             eccCCCCHHHHhhh----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-CeEecCCCCCCeeeCCCCcEEEeeccccccc
Q 040845          603 EYMPHGSLEKYLHS----SNYSLDIFQRLNIMIDVASALEYLHFGYSA-PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  677 (824)
Q Consensus       603 e~~~~g~L~~~l~~----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~  677 (824)
                      ||+++ +|.+++..    ....+++..+..++.|++.|++|||   +. +|+||||||+||+++.++.+||+|||++...
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            99975 88887763    2357899999999999999999999   77 9999999999999999999999999999865


Q ss_pred             CCCCCccccccccccccccCccCc----CCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchh
Q 040845          678 TGEDQSMTQTQTLATIGYMAPEYG----REGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTME  753 (824)
Q Consensus       678 ~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  753 (824)
                      ....   ......||+.|+|||.+    .+..++.++||||||+++|||++|+.||..................      
T Consensus       177 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~------  247 (327)
T 3aln_A          177 VDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDP------  247 (327)
T ss_dssp             --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCC------
T ss_pred             cccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCC------
Confidence            4322   22234689999999998    4567899999999999999999999999753221111111000000      


Q ss_pred             hccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          754 VVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       754 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                         +..      .......++..+.+++.+||..||++|||+.|++++
T Consensus       248 ---~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  286 (327)
T 3aln_A          248 ---PQL------SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH  286 (327)
T ss_dssp             ---CCC------CCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             ---CCC------CCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence               000      000112345678999999999999999999999875

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=5.8e-37  Score=333.47  Aligned_cols=275  Identities=21%  Similarity=0.254  Sum_probs=192.7

Q ss_pred             HHHHHhhccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCC--
Q 040845          520 LELFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEE--  596 (824)
Q Consensus       520 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--  596 (824)
                      .......++|++.+.||+|+||.||+|+.. +|+.||||++... ......+.+|++.++.++||||+++++++....  
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            445666789999999999999999999875 5899999998643 333456677888899999999999999986533  


Q ss_pred             -----eeEEEEeccCCCCHHHHhhh---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC-CCcEE
Q 040845          597 -----FKALVLEYMPHGSLEKYLHS---SNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD-NMVAH  667 (824)
Q Consensus       597 -----~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~-~~~~k  667 (824)
                           ..++||||+++ ++.+.+..   ....+++..+..++.|++.|++|||.. +.+|+||||||+||+++. ++.+|
T Consensus        95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~ivH~Dlkp~NIll~~~~~~~k  172 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLK  172 (360)
T ss_dssp             CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTST-TTCCBCSCCCGGGEEEETTTTEEE
T ss_pred             cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCC-CCCeecCcCCHHHEEEeCCCCcEE
Confidence                 27899999976 55544432   335788999999999999999999932 679999999999999996 89999


Q ss_pred             EeecccccccCCCCCccccccccccccccCccCcCCC-CCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhh
Q 040845          668 LSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDC  746 (824)
Q Consensus       668 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~  746 (824)
                      |+|||++........   .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...... .....+....
T Consensus       173 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~-~~~~~~~~~~  248 (360)
T 3e3p_A          173 LCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA-GQLHEIVRVL  248 (360)
T ss_dssp             ECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHH
T ss_pred             EeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH-HHHHHHHHHc
Confidence            999999987643322   2344689999999988655 4899999999999999999999999763221 1222222211


Q ss_pred             CCCc--chhhccc----------cccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          747 LPIS--TMEVVDA----------NLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       747 ~~~~--~~~~~~~----------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      ....  .....++          ...............++..+.+++.+||+.||++|||+.|++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  315 (360)
T 3e3p_A          249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH  315 (360)
T ss_dssp             CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            1110  0000110          00000000000111356789999999999999999999999875

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.9e-37  Score=333.04  Aligned_cols=254  Identities=20%  Similarity=0.249  Sum_probs=176.0

Q ss_pred             hhccCCCC-ceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeec----CCee
Q 040845          525 ATDKFSEN-NLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSN----EEFK  598 (824)
Q Consensus       525 ~~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~  598 (824)
                      ..++|.+. ++||+|+||.||+|... +|+.||||++...    .....+....++.++||||+++++++..    ....
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            35688885 46999999999999876 5899999998642    1222333445677799999999999876    4568


Q ss_pred             EEEEeccCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC---CCcEEEeecccc
Q 040845          599 ALVLEYMPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD---NMVAHLSDFGIA  674 (824)
Q Consensus       599 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~Dfg~a  674 (824)
                      ++||||+++|+|.+++.... ..+++.+++.++.|++.||+|||   +.+|+||||||+||+++.   ++.+||+|||++
T Consensus       102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~  178 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA  178 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence            99999999999999998654 46899999999999999999999   899999999999999976   456999999999


Q ss_pred             cccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhh
Q 040845          675 KLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEV  754 (824)
Q Consensus       675 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  754 (824)
                      .......    .....+|+.|+|||++.+..++.++||||+|+++|||++|+.||........... ....         
T Consensus       179 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~~~~---------  244 (336)
T 3fhr_A          179 KETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG-MKRR---------  244 (336)
T ss_dssp             EEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred             eeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh-HHHh---------
Confidence            8654221    2334579999999999888899999999999999999999999976432211000 0000         


Q ss_pred             ccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 040845          755 VDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL  802 (824)
Q Consensus       755 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L  802 (824)
                      .......   ........++..+.+++.+||+.||++|||+.|++++-
T Consensus       245 ~~~~~~~---~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  289 (336)
T 3fhr_A          245 IRLGQYG---FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHP  289 (336)
T ss_dssp             ------C---CCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred             hhccccc---cCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence            0000000   00011124567789999999999999999999999854

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=1.5e-36  Score=333.66  Aligned_cols=334  Identities=19%  Similarity=0.209  Sum_probs=237.4

Q ss_pred             CCccEEEccCCeeeeecCccccCCCCCceEeccCccccccCCccccCCCCCCEEEccCCcCCCCcCcccccccCCCCCCC
Q 040845           94 PNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSL  173 (824)
Q Consensus        94 ~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~~L  173 (824)
                      ++++.|++++|.++...+..+..+++|++|+|++|.+++..+..|.++++|++|+|++|.++.++.     ..+..+++|
T Consensus        45 ~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-----~~~~~l~~L  119 (390)
T 3o6n_A           45 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPP-----HVFQNVPLL  119 (390)
T ss_dssp             CCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCT-----TTTTTCTTC
T ss_pred             CCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCH-----HHhcCCCCC
Confidence            444444444444443333334444455555555555444444444445555555555554444332     124444455


Q ss_pred             cEEECcCCCCCccCCccccccccccccEEEeecCcceecCCccCCCCCCCCEEEecCCccCCccchhhcCCCCCCEEEcc
Q 040845          174 THISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLE  253 (824)
Q Consensus       174 ~~L~Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  253 (824)
                      ++|+|++|.+..+++..|..  .++|++|++++|.+++..+..+..+++|++|++++|++++.   .+..+++|+.|+++
T Consensus       120 ~~L~L~~n~l~~l~~~~~~~--l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~  194 (390)
T 3o6n_A          120 TVLVLERNDLSSLPRGIFHN--TPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVS  194 (390)
T ss_dssp             CEEECCSSCCCCCCTTTTTT--CTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECC
T ss_pred             CEEECCCCccCcCCHHHhcC--CCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeecc
Confidence            55555555544443332211  23455555555555555566788899999999999999854   35678899999999


Q ss_pred             cccCcccCCccccccCCccEEEccCccccccCCccccCCCCCcEEEcCCCCCCCCCCcccccccccccccccccccCcCC
Q 040845          254 YNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLP  333 (824)
Q Consensus       254 ~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~  333 (824)
                      +|.+++     +...++|+.|++++|.+......   ..++|+.|++++|.++.++ .+..+++|+.|++++|.+++..|
T Consensus       195 ~n~l~~-----~~~~~~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~~n~l~~~~-~l~~l~~L~~L~Ls~n~l~~~~~  265 (390)
T 3o6n_A          195 YNLLST-----LAIPIAVEELDASHNSINVVRGP---VNVELTILKLQHNNLTDTA-WLLNYPGLVEVDLSYNELEKIMY  265 (390)
T ss_dssp             SSCCSE-----EECCSSCSEEECCSSCCCEEECC---CCSSCCEEECCSSCCCCCG-GGGGCTTCSEEECCSSCCCEEES
T ss_pred             cccccc-----cCCCCcceEEECCCCeeeecccc---ccccccEEECCCCCCcccH-HHcCCCCccEEECCCCcCCCcCh
Confidence            999874     34456899999999999865433   2478999999999999874 67889999999999999998889


Q ss_pred             ccccccccchhhhcccccccccCCCccCCCCCCCeEEccCccccccCCccccccccccEEEccCcccCCCCcccccCCcc
Q 040845          334 LEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSY  413 (824)
Q Consensus       334 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~  413 (824)
                      ..|.++++|+.|++++|++++ +|..+..+++|+.|+|++|+++ .+|..+..+++|+.|+|++|+++ .+|  +..+++
T Consensus       266 ~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~-~~~--~~~~~~  340 (390)
T 3o6n_A          266 HPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHT  340 (390)
T ss_dssp             GGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCC-CCC--CCTTCC
T ss_pred             hHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCccc-eeC--chhhcc
Confidence            999999999999999999985 5667788999999999999998 57778899999999999999998 444  778899


Q ss_pred             cceeeccCCcccCCCCCCCCccccccccccCCccccCCC
Q 040845          414 LKDLNLSFNKLKGEIPRGGSFGNFSAESFKGNELLCGSP  452 (824)
Q Consensus       414 L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~  452 (824)
                      |+.|++++|+|+|.... ..+..+....+.+++..|.++
T Consensus       341 L~~L~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~c~~~  378 (390)
T 3o6n_A          341 LKNLTLSHNDWDCNSLR-ALFRNVARPAVDDADQHCKID  378 (390)
T ss_dssp             CSEEECCSSCEEHHHHH-HHTTTCCTTTBCCCCSCCCTT
T ss_pred             CCEEEcCCCCccchhHH-HHHHHHHhhcccccCceeccc
Confidence            99999999999985432 234455556677888888765

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.7e-37  Score=344.91  Aligned_cols=251  Identities=22%  Similarity=0.358  Sum_probs=188.3

Q ss_pred             cCCCCceeeeccceEEEEEEECCCcEEEEEEeeccccchhhhHHHHHHHHhcC-CCCcceeEEeeeecCCeeEEEEeccC
Q 040845          528 KFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSI-RHRNLVKVISSCSNEEFKALVLEYMP  606 (824)
Q Consensus       528 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  606 (824)
                      .|...+.||+|+||+||.+...+|+.||||++...   ..+.+.+|+.+++++ +||||+++++++.++...++||||++
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~   92 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN   92 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred             eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence            34556889999999998776667999999998643   345678899999876 89999999999999999999999995


Q ss_pred             CCCHHHHhhhCCCC------CCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCC-------------CcEE
Q 040845          607 HGSLEKYLHSSNYS------LDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDN-------------MVAH  667 (824)
Q Consensus       607 ~g~L~~~l~~~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~-------------~~~k  667 (824)
                       |+|.+++......      .++..++.++.||+.||+|||   +.+|+||||||+||+++.+             +.+|
T Consensus        93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k  168 (434)
T 2rio_A           93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL  168 (434)
T ss_dssp             -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred             -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCceEEE
Confidence             6999999865421      123345789999999999999   8999999999999999654             4899


Q ss_pred             EeecccccccCCCCCcc--ccccccccccccCccCcCC-------CCCCccchHHHHHHHHHHHHh-CCCCCcccccCcc
Q 040845          668 LSDFGIAKLLTGEDQSM--TQTQTLATIGYMAPEYGRE-------GQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEM  737 (824)
Q Consensus       668 l~Dfg~a~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~  737 (824)
                      |+|||+|..........  ......||++|+|||++.+       ..++.++||||+||++|||+| |+.||......+ 
T Consensus       169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-  247 (434)
T 2rio_A          169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE-  247 (434)
T ss_dssp             ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH-
T ss_pred             EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH-
Confidence            99999998765432221  2234569999999998865       568999999999999999999 899987533221 


Q ss_pred             hhhhhhhhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          738 TLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       738 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                        ..+.........             ........++.++.+++.+||+.||++|||+.|++++
T Consensus       248 --~~i~~~~~~~~~-------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  296 (434)
T 2rio_A          248 --SNIIRGIFSLDE-------------MKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH  296 (434)
T ss_dssp             --HHHHHTCCCCCC-------------CTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             --HHHhcCCCCccc-------------ccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence              111111111000             0111123467789999999999999999999999863

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.9e-38  Score=334.03  Aligned_cols=245  Identities=25%  Similarity=0.338  Sum_probs=192.5

Q ss_pred             HHHhhccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc------chhhhHHHHHHHHhcC----CCCcceeEEe
Q 040845          522 LFQATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG------RAFKSFDVECAMMKSI----RHRNLVKVIS  590 (824)
Q Consensus       522 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l----~h~niv~l~~  590 (824)
                      .....++|++.+.||+|+||.||+|+.. +++.||||++.....      .....+.+|+.+++++    +|+||+++++
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~  105 (312)
T 2iwi_A           26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD  105 (312)
T ss_dssp             -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred             hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence            3455678999999999999999999864 589999999865432      1234456799999988    8999999999


Q ss_pred             eeecCCeeEEEEec-cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC-CCCcEEE
Q 040845          591 SCSNEEFKALVLEY-MPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHL  668 (824)
Q Consensus       591 ~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~-~~~~~kl  668 (824)
                      ++...+..++|||| +++++|.+++.... .+++..++.++.|+++||+|||   +.+|+||||||+||+++ .++.+||
T Consensus       106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl  181 (312)
T 2iwi_A          106 WFETQEGFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKL  181 (312)
T ss_dssp             EC-----CEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTTEEEE
T ss_pred             EEecCCeEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCCeEEE
Confidence            99999999999999 78999999998755 6899999999999999999999   89999999999999999 8999999


Q ss_pred             eecccccccCCCCCccccccccccccccCccCcCCCCC-CccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhC
Q 040845          669 SDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQV-STNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCL  747 (824)
Q Consensus       669 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  747 (824)
                      +|||++.......    .....|+..|+|||++.+..+ +.++||||+|+++|||++|+.||....       .......
T Consensus       182 ~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------~~~~~~~  250 (312)
T 2iwi_A          182 IDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-------EILEAEL  250 (312)
T ss_dssp             CCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HHHHTCC
T ss_pred             EEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-------HHhhhcc
Confidence            9999998764322    234458999999998877666 458999999999999999999986521       1111000


Q ss_pred             CCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          748 PISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       748 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                                          ..+..++..+.+++.+||+.||++|||+.|++++
T Consensus       251 --------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  284 (312)
T 2iwi_A          251 --------------------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD  284 (312)
T ss_dssp             --------------------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             --------------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                                0012345678899999999999999999999874

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=2.4e-37  Score=335.20  Aligned_cols=263  Identities=20%  Similarity=0.248  Sum_probs=196.9

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc--chhhhHHHHHHHHhcCCCCcceeEEeeeecCCe-----
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG--RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEF-----  597 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  597 (824)
                      .++|.+.+.||+|+||.||+|... +|+.||||++.....  ...+.+.+|+.+++.++||||+++++++.....     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            467999999999999999999875 589999999865422  234678899999999999999999999977654     


Q ss_pred             -eEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccc
Q 040845          598 -KALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  676 (824)
Q Consensus       598 -~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~  676 (824)
                       .++||||++ ++|.+++..   .+++.++..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++..
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~  175 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARH  175 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred             eEEEEecccc-CCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeecccccC
Confidence             499999996 588887743   5899999999999999999999   89999999999999999999999999999986


Q ss_pred             cCCCCCccccccccccccccCccCcCC-CCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCc--chh
Q 040845          677 LTGEDQSMTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPIS--TME  753 (824)
Q Consensus       677 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~  753 (824)
                      ....     .....+|+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+ .+...........  ...
T Consensus       176 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~  249 (353)
T 3coi_A          176 ADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVTGVPGTEFVQ  249 (353)
T ss_dssp             -------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH-HHHHHHHHHCBCCHHHHT
T ss_pred             CCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHH
Confidence            4321     234568999999998876 678999999999999999999999997632111 1111111100000  000


Q ss_pred             ---------hccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          754 ---------VVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       754 ---------~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                               ............-......++..+.+++.+||..||++|||++|++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  306 (353)
T 3coi_A          250 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  306 (353)
T ss_dssp             TCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence                     000000000000000112456789999999999999999999999875

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=6.7e-37  Score=332.36  Aligned_cols=265  Identities=22%  Similarity=0.272  Sum_probs=200.7

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CC-cEEEEEEeeccccchhhhHHHHHHHHhcCCCCc------ceeEEeeeecCCe
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DG-MEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRN------LVKVISSCSNEEF  597 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~  597 (824)
                      .++|++.+.||+|+||+||+|... ++ +.||||+++.. ....+.+.+|+.+++.++|++      ++.+++++.....
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            468999999999999999999875 34 78999998643 344567888999999998766      8999999999999


Q ss_pred             eEEEEeccCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee----------------
Q 040845          598 KALVLEYMPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL----------------  660 (824)
Q Consensus       598 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill----------------  660 (824)
                      .++||||+ ++++.+++.... ..+++.++..++.|++.||+|||   +.+|+||||||+||++                
T Consensus        97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~  172 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCE  172 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred             EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeccccccccccccccc
Confidence            99999999 667777776544 56899999999999999999999   9999999999999999                


Q ss_pred             ---CCCCcEEEeecccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcc
Q 040845          661 ---DDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEM  737 (824)
Q Consensus       661 ---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~  737 (824)
                         +.++.+||+|||++.......     ....||+.|+|||++.+..++.++||||+||++|||++|+.||......+ 
T Consensus       173 ~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-  246 (355)
T 2eu9_A          173 EKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE-  246 (355)
T ss_dssp             EEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-
T ss_pred             ccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-
Confidence               567899999999998643221     23468999999999999999999999999999999999999997632211 


Q ss_pred             hhhhhhhhhCCCc--chhhc-------cc--cccCc-------------hhhhhhhHHHHHHHHHHHHHHccccCCCCCC
Q 040845          738 TLKHWVNDCLPIS--TMEVV-------DA--NLLSQ-------------EDIHFVAKEQCVSFVFNLALECTVESPEQRI  793 (824)
Q Consensus       738 ~~~~~~~~~~~~~--~~~~~-------~~--~~~~~-------------~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp  793 (824)
                      ..........+..  .....       ..  .+...             ..........++..+.+++.+||+.||++||
T Consensus       247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  326 (355)
T 2eu9_A          247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI  326 (355)
T ss_dssp             HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence            1111111110000  00000       00  00000             0000011123466899999999999999999


Q ss_pred             CHHHHHHH
Q 040845          794 NAKEIVAK  801 (824)
Q Consensus       794 t~~evl~~  801 (824)
                      |+.|++++
T Consensus       327 t~~e~l~h  334 (355)
T 2eu9_A          327 TLAEALLH  334 (355)
T ss_dssp             CHHHHTTS
T ss_pred             CHHHHhcC
Confidence            99999864

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=8.3e-38  Score=333.71  Aligned_cols=243  Identities=23%  Similarity=0.310  Sum_probs=201.0

Q ss_pred             HhhccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccc------hhhhHHHHHHHHhcCC--CCcceeEEeeeec
Q 040845          524 QATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGR------AFKSFDVECAMMKSIR--HRNLVKVISSCSN  594 (824)
Q Consensus       524 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~l~~~~~~  594 (824)
                      ...++|++.+.||+|+||.||+|+.. +++.||||++......      ..+.+.+|+.++++++  |+||+++++++.+
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~  119 (320)
T 3a99_A           40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER  119 (320)
T ss_dssp             CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred             CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence            34578999999999999999999864 5899999999765321      2355678999999996  5999999999999


Q ss_pred             CCeeEEEEeccCC-CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC-CCCcEEEeecc
Q 040845          595 EEFKALVLEYMPH-GSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFG  672 (824)
Q Consensus       595 ~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~-~~~~~kl~Dfg  672 (824)
                      ++..++||||+.+ ++|.+++.... .+++..++.++.|+++||+|||   +.+|+||||||+||+++ +++.+||+|||
T Consensus       120 ~~~~~lv~e~~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg  195 (320)
T 3a99_A          120 PDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFG  195 (320)
T ss_dssp             SSEEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred             CCcEEEEEEcCCCCccHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence            9999999999976 89999998754 6899999999999999999999   99999999999999999 78999999999


Q ss_pred             cccccCCCCCccccccccccccccCccCcCCCCC-CccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcc
Q 040845          673 IAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQV-STNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPIST  751 (824)
Q Consensus       673 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  751 (824)
                      ++.......    .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||....       .......    
T Consensus       196 ~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-------~~~~~~~----  260 (320)
T 3a99_A          196 SGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------EIIRGQV----  260 (320)
T ss_dssp             TCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HHHHCCC----
T ss_pred             ccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-------hhhcccc----
Confidence            998764322    233468999999998877665 688999999999999999999986521       1111000    


Q ss_pred             hhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          752 MEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       752 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                              .        .+..++..+.+++.+||..||++|||++|++++
T Consensus       261 --------~--------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  294 (320)
T 3a99_A          261 --------F--------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  294 (320)
T ss_dssp             --------C--------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             --------c--------ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                    0        011245678899999999999999999999874

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2.9e-37  Score=337.59  Aligned_cols=266  Identities=15%  Similarity=0.235  Sum_probs=200.0

Q ss_pred             hccCCCCceeeeccceEEEEEEE-CCCcEEEEEEeeccccchhhhHHHHHHHHhcCC-----------CCcceeEEeeee
Q 040845          526 TDKFSENNLIGRGGFGSVYKARI-RDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIR-----------HRNLVKVISSCS  593 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~  593 (824)
                      .++|++.+.||+|+||+||+|+. .+++.||||++... ....+.+.+|+.++++++           |+||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            36799999999999999999986 46899999998643 234567788999999886           899999999987


Q ss_pred             cCC----eeEEEEeccCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCC-CeEecCCCCCCeeeC------
Q 040845          594 NEE----FKALVLEYMPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSA-PVIHCDLKPSNVLLD------  661 (824)
Q Consensus       594 ~~~----~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~Dlk~~Nill~------  661 (824)
                      ...    ..++||||+ +++|.+++.... ..+++..+..++.|++.||+|||   +. +|+||||||+||+++      
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~~~~  172 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSPE  172 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETTT
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccCCCc
Confidence            644    789999999 889999998643 45899999999999999999999   87 999999999999994      


Q ss_pred             CCCcEEEeecccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCc-----
Q 040845          662 DNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGE-----  736 (824)
Q Consensus       662 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~-----  736 (824)
                      ..+.+||+|||++......     .....+|+.|+|||++.+..++.++|||||||++|||++|+.||.......     
T Consensus       173 ~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  247 (373)
T 1q8y_A          173 NLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD  247 (373)
T ss_dssp             TEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred             CcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence            4458999999999876432     223468999999999998899999999999999999999999997532111     


Q ss_pred             chhhhhhhhhCCCcch---------hhccc----------cccC---chhhhhhhHHHHHHHHHHHHHHccccCCCCCCC
Q 040845          737 MTLKHWVNDCLPISTM---------EVVDA----------NLLS---QEDIHFVAKEQCVSFVFNLALECTVESPEQRIN  794 (824)
Q Consensus       737 ~~~~~~~~~~~~~~~~---------~~~~~----------~~~~---~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt  794 (824)
                      ................         ..+..          ....   ........+..++..+.+++.+||+.||++|||
T Consensus       248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt  327 (373)
T 1q8y_A          248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD  327 (373)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred             HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence            1111111111100000         00000          0000   000011123467888999999999999999999


Q ss_pred             HHHHHHH
Q 040845          795 AKEIVAK  801 (824)
Q Consensus       795 ~~evl~~  801 (824)
                      ++|++++
T Consensus       328 ~~ell~h  334 (373)
T 1q8y_A          328 AGGLVNH  334 (373)
T ss_dssp             HHHHHTC
T ss_pred             HHHHhhC
Confidence            9999875

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=5.8e-37  Score=327.37  Aligned_cols=252  Identities=23%  Similarity=0.300  Sum_probs=184.3

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccc--hhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGR--AFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVL  602 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  602 (824)
                      .++|++.+.||+|+||.||+|++. +|+.||||++......  ..+.+.++..+++.++||||+++++++.+++..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            467889999999999999999875 6899999999755322  2234455566788889999999999999999999999


Q ss_pred             eccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-CeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 040845          603 EYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSA-PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED  681 (824)
Q Consensus       603 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  681 (824)
                      ||+ ++.+..+.......+++..+..++.|+++|++|||   +. +|+||||||+||+++.++.+||+|||++.......
T Consensus       104 e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  179 (318)
T 2dyl_A          104 ELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK  179 (318)
T ss_dssp             CCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred             ecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence            999 55666666654557899999999999999999999   75 99999999999999999999999999997654322


Q ss_pred             CccccccccccccccCccCcC-----CCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhcc
Q 040845          682 QSMTQTQTLATIGYMAPEYGR-----EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVD  756 (824)
Q Consensus       682 ~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  756 (824)
                         ......+++.|+|||.+.     ...++.++||||||+++|||++|+.||..................+.       
T Consensus       180 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-------  249 (318)
T 2dyl_A          180 ---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPL-------  249 (318)
T ss_dssp             ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCC-------
T ss_pred             ---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCC-------
Confidence               223346899999999984     45688999999999999999999999975322211111111110000       


Q ss_pred             ccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          757 ANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       757 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                                ......++..+.+++.+||..||++|||++|++++
T Consensus       250 ----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (318)
T 2dyl_A          250 ----------LPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH  284 (318)
T ss_dssp             ----------CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             ----------CCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence                      00011245678999999999999999999999875

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=9.5e-36  Score=327.36  Aligned_cols=311  Identities=21%  Similarity=0.216  Sum_probs=220.8

Q ss_pred             CCCCCcEEEccCCcccccccccccCCCCCCEEeCCCCcCCcccChhhhCcCCCceeeccCCccccccCccccCCCCCccE
Q 040845           19 NISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEV   98 (824)
Q Consensus        19 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~   98 (824)
                      .++++++|++++|.++...+..|+.+++|++|+|++|.+++..+.+|..+++|++|+|++|++++.++... .++++|++
T Consensus        43 ~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~-~~l~~L~~  121 (390)
T 3o6n_A           43 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVF-QNVPLLTV  121 (390)
T ss_dssp             GGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTT-TTCTTCCE
T ss_pred             ccCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHh-cCCCCCCE
Confidence            46888889999988886555557888889999999998887777788888888888888888887765533 36888888


Q ss_pred             EEccCCeeeeecCccccCCCCCceEeccCccccccCCccccCCCCCCEEEccCCcCCCCcCcccccccCCCCCCCcEEEC
Q 040845           99 LYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISL  178 (824)
Q Consensus        99 L~L~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~~L~~L~L  178 (824)
                      |+|++|+++...+..|..+++|++|+|++|++++..+..|.++++|++|++++|+++.++        +..+++|++|++
T Consensus       122 L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~--------~~~l~~L~~L~l  193 (390)
T 3o6n_A          122 LVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD--------LSLIPSLFHANV  193 (390)
T ss_dssp             EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCC--------GGGCTTCSEEEC
T ss_pred             EECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCccc--------cccccccceeec
Confidence            888888888555555688888888888888888777888888888888888888887653        455678888888


Q ss_pred             cCCCCCccCCccccccccccccEEEeecCcceecCCccCCCCCCCCEEEecCCccCCccchhhcCCCCCCEEEcccccCc
Q 040845          179 SNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLE  258 (824)
Q Consensus       179 s~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~  258 (824)
                      ++|.+.++.       .+.+                        |+.|++++|.+... |..  ..++|++|++++|.++
T Consensus       194 ~~n~l~~~~-------~~~~------------------------L~~L~l~~n~l~~~-~~~--~~~~L~~L~l~~n~l~  239 (390)
T 3o6n_A          194 SYNLLSTLA-------IPIA------------------------VEELDASHNSINVV-RGP--VNVELTILKLQHNNLT  239 (390)
T ss_dssp             CSSCCSEEE-------CCSS------------------------CSEEECCSSCCCEE-ECC--CCSSCCEEECCSSCCC
T ss_pred             ccccccccC-------CCCc------------------------ceEEECCCCeeeec-ccc--ccccccEEECCCCCCc
Confidence            888776441       1234                        44555555554422 211  1245555555555555


Q ss_pred             ccCCccccccCCccEEEccCccccccCCccccCCCCCcEEEcCCCCCCCCCCcccccccccccccccccccCcCCccccc
Q 040845          259 GSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRN  338 (824)
Q Consensus       259 ~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~  338 (824)
                      +.  ..+..+++|+.|++++|++++..|..|..+++|++|+|++|+++.+|..+..+++|+.|++++|+++ .+|..+..
T Consensus       240 ~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~  316 (390)
T 3o6n_A          240 DT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQ  316 (390)
T ss_dssp             CC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCEEECSSSCCTTCCEEECCSSCCC-CCGGGHHH
T ss_pred             cc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcccCcccCCCCCCCEEECCCCcce-ecCccccc
Confidence            32  3455555666666666666655566666666666666666666666665656666777777777666 45556677


Q ss_pred             cccchhhhcccccccccCCCccCCCCCCCeEEccCccccc
Q 040845          339 LKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEG  378 (824)
Q Consensus       339 l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  378 (824)
                      +++|+.|++++|+++.. +  +..+++|+.|++++|.++.
T Consensus       317 l~~L~~L~L~~N~i~~~-~--~~~~~~L~~L~l~~N~~~~  353 (390)
T 3o6n_A          317 FDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDC  353 (390)
T ss_dssp             HTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEH
T ss_pred             cCcCCEEECCCCcccee-C--chhhccCCEEEcCCCCccc
Confidence            77788888888887754 2  6677889999999998875

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=6.8e-36  Score=346.60  Aligned_cols=335  Identities=19%  Similarity=0.206  Sum_probs=248.0

Q ss_pred             CCCccEEEccCCeeeeecCccccCCCCCceEeccCccccccCCccccCCCCCCEEEccCCcCCCCcCcccccccCCCCCC
Q 040845           93 LPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKS  172 (824)
Q Consensus        93 l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~~  172 (824)
                      +++++.|++++|.++...+..+..+++|++|+|++|.+++..+..|+++++|++|+|++|.++.++.     ..|.++++
T Consensus        50 l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-----~~~~~l~~  124 (597)
T 3oja_B           50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPP-----HVFQNVPL  124 (597)
T ss_dssp             GCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCT-----TTTTTCTT
T ss_pred             CCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCH-----HHHcCCCC
Confidence            3455555555555554444445555555555555555555555555555555555555555555432     12455555


Q ss_pred             CcEEECcCCCCCccCCccccccccccccEEEeecCcceecCCccCCCCCCCCEEEecCCccCCccchhhcCCCCCCEEEc
Q 040845          173 LTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDL  252 (824)
Q Consensus       173 L~~L~Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  252 (824)
                      |++|+|++|.+.++++..|..  .++|++|++++|.+++..|..|..+++|+.|+|++|.+++..   +..+++|+.|++
T Consensus       125 L~~L~L~~n~l~~l~~~~~~~--l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~L~l  199 (597)
T 3oja_B          125 LTVLVLERNDLSSLPRGIFHN--TPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANV  199 (597)
T ss_dssp             CCEEECCSSCCCCCCTTTTTT--CTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC---GGGCTTCSEEEC
T ss_pred             CCEEEeeCCCCCCCCHHHhcc--CCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC---hhhhhhhhhhhc
Confidence            555555555555444433322  235555555556665666677888999999999999998653   566789999999


Q ss_pred             ccccCcccCCccccccCCccEEEccCccccccCCccccCCCCCcEEEcCCCCCCCCCCcccccccccccccccccccCcC
Q 040845          253 EYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPL  332 (824)
Q Consensus       253 ~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~  332 (824)
                      ++|.+++     +....+|+.|++++|.+....+..   .++|+.|+|++|.++.. ..+..+++|+.|+|++|.+++..
T Consensus       200 ~~n~l~~-----l~~~~~L~~L~ls~n~l~~~~~~~---~~~L~~L~L~~n~l~~~-~~l~~l~~L~~L~Ls~N~l~~~~  270 (597)
T 3oja_B          200 SYNLLST-----LAIPIAVEELDASHNSINVVRGPV---NVELTILKLQHNNLTDT-AWLLNYPGLVEVDLSYNELEKIM  270 (597)
T ss_dssp             CSSCCSE-----EECCTTCSEEECCSSCCCEEECSC---CSCCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCEEE
T ss_pred             ccCcccc-----ccCCchhheeeccCCccccccccc---CCCCCEEECCCCCCCCC-hhhccCCCCCEEECCCCccCCCC
Confidence            9999874     345578999999999998655443   36899999999999985 56888999999999999999999


Q ss_pred             CccccccccchhhhcccccccccCCCccCCCCCCCeEEccCccccccCCccccccccccEEEccCcccCCCCcccccCCc
Q 040845          333 PLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLS  412 (824)
Q Consensus       333 ~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~  412 (824)
                      |..|.++++|+.|+|++|.+++ +|..+..+++|+.|+|++|.++ .+|..+..+++|+.|+|++|.+++ +|  +..++
T Consensus       271 ~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~-~~--~~~~~  345 (597)
T 3oja_B          271 YHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVT-LK--LSTHH  345 (597)
T ss_dssp             SGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCC-CC--CCTTC
T ss_pred             HHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCC-cC--hhhcC
Confidence            9999999999999999999996 5677788999999999999999 678889999999999999999984 44  67889


Q ss_pred             ccceeeccCCcccCCCCCCCCccccccccccCCccccCCC
Q 040845          413 YLKDLNLSFNKLKGEIPRGGSFGNFSAESFKGNELLCGSP  452 (824)
Q Consensus       413 ~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~  452 (824)
                      +|+.|++++|+|+|.++. ..+..+....+.+++..|+.+
T Consensus       346 ~L~~L~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~C~~~  384 (597)
T 3oja_B          346 TLKNLTLSHNDWDCNSLR-ALFRNVARPAVDDADQHCKID  384 (597)
T ss_dssp             CCSEEECCSSCEEHHHHH-HHTTTCCTTTBCCCCCCCCTT
T ss_pred             CCCEEEeeCCCCCChhHH-HHHHHHhhhccccccccCCcc
Confidence            999999999999986543 234556666788888888864

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=8.1e-37  Score=347.62  Aligned_cols=272  Identities=24%  Similarity=0.309  Sum_probs=202.5

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc-cchhhhHHHHHHHHhcCCCCcceeEEeeeec------CCe
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLVKVISSCSN------EEF  597 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~  597 (824)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++.... ....+.+.+|++++++++||||+++++++..      .+.
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            378999999999999999999864 58999999986542 3345678899999999999999999999765      677


Q ss_pred             eEEEEeccCCCCHHHHhhhCC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCc---EEEeecc
Q 040845          598 KALVLEYMPHGSLEKYLHSSN--YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMV---AHLSDFG  672 (824)
Q Consensus       598 ~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~---~kl~Dfg  672 (824)
                      .++||||+++|+|.+++....  ..+++..++.++.|++.|++|||   +.+|+||||||+||+++.++.   +||+|||
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence            899999999999999998654  35888899999999999999999   899999999999999997665   9999999


Q ss_pred             cccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcch
Q 040845          673 IAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTM  752 (824)
Q Consensus       673 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  752 (824)
                      .+........   .....||+.|+|||.+.+..++.++||||+|+++|||++|+.||.....    ...|..........
T Consensus       170 ~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~----~~~~~~~i~~~~~~  242 (676)
T 3qa8_A          170 YAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ----PVQWHGKVREKSNE  242 (676)
T ss_dssp             CCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH----HHHSSTTCC-----
T ss_pred             cccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc----hhhhhhhhhcccch
Confidence            9987643322   2345689999999999999999999999999999999999999965321    11221111110000


Q ss_pred             -----hhcccccc--CchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHH-----HHHHHHHHHH
Q 040845          753 -----EVVDANLL--SQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKE-----IVAKLLKIRD  807 (824)
Q Consensus       753 -----~~~~~~~~--~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~e-----vl~~L~~~~~  807 (824)
                           +.......  ............++..+.+++.+||..||++|||+.|     +.+.++++.+
T Consensus       243 ~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~  309 (676)
T 3qa8_A          243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS  309 (676)
T ss_dssp             -CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred             hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence                 00000000  0000001112346788999999999999999999988     4555555543

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=9.3e-36  Score=311.68  Aligned_cols=232  Identities=14%  Similarity=0.063  Sum_probs=186.1

Q ss_pred             ccCCCCceeeeccceEEEEEEECC-CcEEEEEEeecccc---chhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEE
Q 040845          527 DKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCG---RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVL  602 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  602 (824)
                      ++|++.+.||+|+||.||+|++.. ++.||||++.....   ...+.+.+|+.+++.++||||+++++++.+++..|+||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            679999999999999999998764 89999999975532   23467889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 040845          603 EYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ  682 (824)
Q Consensus       603 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  682 (824)
                      ||+++++|.+++...   ....++..++.|++.||+|||   +.+|+||||||+||+++.++.+||+++|          
T Consensus       111 e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~----------  174 (286)
T 3uqc_A          111 EWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPA----------  174 (286)
T ss_dssp             ECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCC----------
T ss_pred             EecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEecc----------
Confidence            999999999999643   356678999999999999999   9999999999999999999999998543          


Q ss_pred             ccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCc
Q 040845          683 SMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ  762 (824)
Q Consensus       683 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  762 (824)
                                  |++       .++.++|||||||++|||+||+.||......+.... .             .......
T Consensus       175 ------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~-~-------------~~~~~~~  221 (286)
T 3uqc_A          175 ------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP-A-------------ERDTAGQ  221 (286)
T ss_dssp             ------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE-C-------------CBCTTSC
T ss_pred             ------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH-H-------------HHHhccC
Confidence                        333       268899999999999999999999976332210000 0             0000000


Q ss_pred             hhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 040845          763 EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDS  808 (824)
Q Consensus       763 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~  808 (824)
                      ..........++..+.+++.+||+.||++| |+.|+++.|+++...
T Consensus       222 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~  266 (286)
T 3uqc_A          222 PIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV  266 (286)
T ss_dssp             BCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred             CCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence            000011123466779999999999999999 999999999998654

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=7.2e-35  Score=315.18  Aligned_cols=307  Identities=27%  Similarity=0.378  Sum_probs=168.2

Q ss_pred             ccCCCCCCEEeCCCCcCCcccChhhhCcCCCceeeccCCccccccCccccCCCCCccEEEccCCeeeeecCccccCCCCC
Q 040845           41 IGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKL  120 (824)
Q Consensus        41 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L  120 (824)
                      +..+++|++|++++|.+. .++ ++..+++|++|++++|++++++.   ...+++|++|+|++|.++. + ..+..+++|
T Consensus        40 ~~~l~~L~~L~l~~~~i~-~~~-~~~~~~~L~~L~l~~n~i~~~~~---~~~l~~L~~L~L~~n~i~~-~-~~~~~l~~L  112 (347)
T 4fmz_A           40 QEELESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNLNGNQITDISP---LSNLVKLTNLYIGTNKITD-I-SALQNLTNL  112 (347)
T ss_dssp             HHHHTTCSEEECCSSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG---GTTCTTCCEEECCSSCCCC-C-GGGTTCTTC
T ss_pred             chhcccccEEEEeCCccc-cch-hhhhcCCccEEEccCCccccchh---hhcCCcCCEEEccCCcccC-c-hHHcCCCcC
Confidence            455666677777776665 233 35556666666666666555443   2245555555555555543 2 234455555


Q ss_pred             ceEeccCccccccCCccccCCCCCCEEEccCCcCCCCcCcccccccCCCCCCCcEEECcCCCCCccCCcccccccccccc
Q 040845          121 SKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLK  200 (824)
Q Consensus       121 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~~L~  200 (824)
                      ++|+|++|.+++..+  +.++++|++|++++|......      ..+..+++|++|++++|.+.+..+            
T Consensus       113 ~~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~------~~~~~l~~L~~L~l~~~~~~~~~~------------  172 (347)
T 4fmz_A          113 RELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDL------SPLSNMTGLNYLTVTESKVKDVTP------------  172 (347)
T ss_dssp             SEEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCC------GGGTTCTTCCEEECCSSCCCCCGG------------
T ss_pred             CEEECcCCcccCchh--hccCCceeEEECCCCCCcccc------cchhhCCCCcEEEecCCCcCCchh------------
Confidence            555555555543221  444555555555554322211      123444444444444444332210            


Q ss_pred             EEEeecCcceecCCccCCCCCCCCEEEecCCccCCccchhhcCCCCCCEEEcccccCcccCCccccccCCccEEEccCcc
Q 040845          201 NFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNK  280 (824)
Q Consensus       201 ~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~  280 (824)
                                      +..+++|++|++++|.+.+..+  +..+++|+.|++++|.+                       
T Consensus       173 ----------------~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l-----------------------  211 (347)
T 4fmz_A          173 ----------------IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQI-----------------------  211 (347)
T ss_dssp             ----------------GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCC-----------------------
T ss_pred             ----------------hccCCCCCEEEccCCccccccc--ccCCCccceeecccCCC-----------------------
Confidence                            2334445555555555443222  44444455555544444                       


Q ss_pred             ccccCCccccCCCCCcEEEcCCCCCCCCCCcccccccccccccccccccCcCCccccccccchhhhcccccccccCCCcc
Q 040845          281 LSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEI  360 (824)
Q Consensus       281 l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~  360 (824)
                       .+..+  +..+++|++|++++|.++.++. +..+++|+.|++++|.+++.  ..+..+++|+.|++++|++++.  ..+
T Consensus       212 -~~~~~--~~~~~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~  283 (347)
T 4fmz_A          212 -TDITP--VANMTRLNSLKIGNNKITDLSP-LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVL  283 (347)
T ss_dssp             -CCCGG--GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGG
T ss_pred             -CCCch--hhcCCcCCEEEccCCccCCCcc-hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhh
Confidence             43322  4445555555555555555544 44455555555555555532  3456666777777777777654  346


Q ss_pred             CCCCCCCeEEccCccccccCCccccccccccEEEccCcccCCCCcccccCCcccceeeccCCccc
Q 040845          361 GSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLK  425 (824)
Q Consensus       361 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~  425 (824)
                      ..+++|+.|++++|.+++..|..|..+++|+.|++++|++++..|  +..+++|+.|++++|+++
T Consensus       284 ~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~  346 (347)
T 4fmz_A          284 NNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK  346 (347)
T ss_dssp             GGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred             cCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence            777788888888888877777777778888888888888875555  677778888888888765

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=4.9e-35  Score=339.40  Aligned_cols=312  Identities=21%  Similarity=0.210  Sum_probs=219.5

Q ss_pred             CCCCCcEEEccCCcccccccccccCCCCCCEEeCCCCcCCcccChhhhCcCCCceeeccCCccccccCccccCCCCCccE
Q 040845           19 NISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEV   98 (824)
Q Consensus        19 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~   98 (824)
                      .+.+++.|++++|.++...+..|+++++|++|+|++|.+++..|.+|..+++|++|+|++|.++++++... .++++|++
T Consensus        49 ~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~-~~l~~L~~  127 (597)
T 3oja_B           49 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVF-QNVPLLTV  127 (597)
T ss_dssp             GGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTT-TTCTTCCE
T ss_pred             cCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHH-cCCCCCCE
Confidence            35677778888887776555567777788888888888776666677777777888887777777665443 35777777


Q ss_pred             EEccCCeeeeecCccccCCCCCceEeccCccccccCCccccCCCCCCEEEccCCcCCCCcCcccccccCCCCCCCcEEEC
Q 040845           99 LYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISL  178 (824)
Q Consensus        99 L~L~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~~L~~L~L  178 (824)
                      |+|++|.+++..+..|..+++|++|+|++|.+++..|..|+++++|++|+|++|.++.++        +..+++|++|++
T Consensus       128 L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~--------~~~l~~L~~L~l  199 (597)
T 3oja_B          128 LVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD--------LSLIPSLFHANV  199 (597)
T ss_dssp             EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC--------GGGCTTCSEEEC
T ss_pred             EEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC--------hhhhhhhhhhhc
Confidence            777777777555555677777777777777777777777777777777777777776643        345677777777


Q ss_pred             cCCCCCccCCccccccccccccEEEeecCcceecCCccCCCCCCCCEEEecCCccCCccchhhcCCCCCCEEEcccccCc
Q 040845          179 SNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLE  258 (824)
Q Consensus       179 s~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~  258 (824)
                      ++|.+.++.                               ..++|+.|++++|.+....+ .+  .++|+.|+|++|.++
T Consensus       200 ~~n~l~~l~-------------------------------~~~~L~~L~ls~n~l~~~~~-~~--~~~L~~L~L~~n~l~  245 (597)
T 3oja_B          200 SYNLLSTLA-------------------------------IPIAVEELDASHNSINVVRG-PV--NVELTILKLQHNNLT  245 (597)
T ss_dssp             CSSCCSEEE-------------------------------CCTTCSEEECCSSCCCEEEC-SC--CSCCCEEECCSSCCC
T ss_pred             ccCcccccc-------------------------------CCchhheeeccCCccccccc-cc--CCCCCEEECCCCCCC
Confidence            777765431                               12345555555555553222 11  245666666666665


Q ss_pred             ccCCccccccCCccEEEccCccccccCCccccCCCCCcEEEcCCCCCCCCCCcccccccccccccccccccCcCCccccc
Q 040845          259 GSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRN  338 (824)
Q Consensus       259 ~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~  338 (824)
                      +  +..+..+++|+.|+|++|.+.+..|..|+.+++|+.|+|++|.++.+|..+..+++|+.|+|++|.++ .+|..+..
T Consensus       246 ~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~  322 (597)
T 3oja_B          246 D--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQ  322 (597)
T ss_dssp             C--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCEEECSSSCCTTCCEEECCSSCCC-CCGGGHHH
T ss_pred             C--ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCCCCcccccCCCCcEEECCCCCCC-ccCccccc
Confidence            3  35566666666677777766666667777777777777777777777766666777777777777777 46667778


Q ss_pred             cccchhhhcccccccccCCCccCCCCCCCeEEccCcccccc
Q 040845          339 LKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGS  379 (824)
Q Consensus       339 l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  379 (824)
                      +++|+.|+|++|.+++..   +..+++|+.|+|++|.+.+.
T Consensus       323 l~~L~~L~L~~N~l~~~~---~~~~~~L~~L~l~~N~~~~~  360 (597)
T 3oja_B          323 FDRLENLYLDHNSIVTLK---LSTHHTLKNLTLSHNDWDCN  360 (597)
T ss_dssp             HTTCSEEECCSSCCCCCC---CCTTCCCSEEECCSSCEEHH
T ss_pred             CCCCCEEECCCCCCCCcC---hhhcCCCCEEEeeCCCCCCh
Confidence            888888888888887542   67788999999999999853

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=9.3e-35  Score=314.28  Aligned_cols=308  Identities=25%  Similarity=0.392  Sum_probs=240.8

Q ss_pred             cccCCCCCcEEEccCCcccccccccccCCCCCCEEeCCCCcCCcccChhhhCcCCCceeeccCCccccccCccccCCCCC
Q 040845           16 EIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPN   95 (824)
Q Consensus        16 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~   95 (824)
                      .+.++++|++|++++|.+.. ++ .++.+++|++|++++|++++. +. +..+++|++|++++|++++++.   ...+++
T Consensus        39 ~~~~l~~L~~L~l~~~~i~~-~~-~~~~~~~L~~L~l~~n~i~~~-~~-~~~l~~L~~L~L~~n~i~~~~~---~~~l~~  111 (347)
T 4fmz_A           39 TQEELESITKLVVAGEKVAS-IQ-GIEYLTNLEYLNLNGNQITDI-SP-LSNLVKLTNLYIGTNKITDISA---LQNLTN  111 (347)
T ss_dssp             CHHHHTTCSEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCCCGG---GTTCTT
T ss_pred             cchhcccccEEEEeCCcccc-ch-hhhhcCCccEEEccCCccccc-hh-hhcCCcCCEEEccCCcccCchH---HcCCCc
Confidence            35789999999999999984 44 499999999999999999854 44 9999999999999999998653   346999


Q ss_pred             ccEEEccCCeeeeecCccccCCCCCceEeccCccccccCCccccCCCCCCEEEccCCcCCCCcCcccccccCCCCCCCcE
Q 040845           96 LEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTH  175 (824)
Q Consensus        96 L~~L~L~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~~L~~  175 (824)
                      |++|++++|.+++..+  +..+++|++|++++|...... ..+.++++|++|++++|.++..+       .+..+++|++
T Consensus       112 L~~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~-~~~~~l~~L~~L~l~~~~~~~~~-------~~~~l~~L~~  181 (347)
T 4fmz_A          112 LRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDL-SPLSNMTGLNYLTVTESKVKDVT-------PIANLTDLYS  181 (347)
T ss_dssp             CSEEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCC-GGGTTCTTCCEEECCSSCCCCCG-------GGGGCTTCSE
T ss_pred             CCEEECcCCcccCchh--hccCCceeEEECCCCCCcccc-cchhhCCCCcEEEecCCCcCCch-------hhccCCCCCE
Confidence            9999999999985433  889999999999999766444 45999999999999999998764       2778999999


Q ss_pred             EECcCCCCCccCCccccccccccccEEEeecCcceecCCccCCCCCCCCEEEecCCccCCccchhhcCCCCCCEEEcccc
Q 040845          176 ISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYN  255 (824)
Q Consensus       176 L~Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n  255 (824)
                      |++++|.+.++.+                            +..+++|+.|++++|.+.+..+  +..+++|++|++++|
T Consensus       182 L~l~~n~l~~~~~----------------------------~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n  231 (347)
T 4fmz_A          182 LSLNYNQIEDISP----------------------------LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNN  231 (347)
T ss_dssp             EECTTSCCCCCGG----------------------------GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSS
T ss_pred             EEccCCccccccc----------------------------ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCC
Confidence            9999999875422                            4567899999999999986554  888999999999999


Q ss_pred             cCcccCCccccccCCccEEEccCccccccCCccccCCCCCcEEEcCCCCCCCCCCcccccccccccccccccccCcCCcc
Q 040845          256 QLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLE  335 (824)
Q Consensus       256 ~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~  335 (824)
                      .+++..+  +..+++|+.|++++|.+++.  ..+..+++|++|++++|.++.++                         .
T Consensus       232 ~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~~-------------------------~  282 (347)
T 4fmz_A          232 KITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDIS-------------------------V  282 (347)
T ss_dssp             CCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCCG-------------------------G
T ss_pred             ccCCCcc--hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCCh-------------------------h
Confidence            9985433  66777777777777777643  34666666777776666665542                         3


Q ss_pred             ccccccchhhhcccccccccCCCccCCCCCCCeEEccCccccccCCccccccccccEEEccCcccC
Q 040845          336 IRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLS  401 (824)
Q Consensus       336 ~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  401 (824)
                      +..+++|+.|++++|++++..+..++.+++|+.|++++|++++..|  +..+++|+.|++++|+|+
T Consensus       283 ~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~  346 (347)
T 4fmz_A          283 LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK  346 (347)
T ss_dssp             GGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred             hcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence            4556666666666666666666667777777777777777775444  677777777777777765

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=5.5e-35  Score=308.84  Aligned_cols=232  Identities=20%  Similarity=0.286  Sum_probs=182.1

Q ss_pred             hccCCCC-ceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHH-hcCCCCcceeEEeeeec----CCee
Q 040845          526 TDKFSEN-NLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMM-KSIRHRNLVKVISSCSN----EEFK  598 (824)
Q Consensus       526 ~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~  598 (824)
                      .++|.+. +.||+|+||.||+|... +++.||||+++.     ...+.+|+.++ +..+||||+++++++..    ....
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   90 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   90 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence            4567776 78999999999999874 589999999863     24567788887 66699999999999876    6788


Q ss_pred             EEEEeccCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC---CCcEEEeecccc
Q 040845          599 ALVLEYMPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD---NMVAHLSDFGIA  674 (824)
Q Consensus       599 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~Dfg~a  674 (824)
                      ++||||+++|+|.+++.... ..+++.+++.++.|++.||+|||   +.+|+||||||+||+++.   ++.+||+|||++
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a  167 (299)
T 3m2w_A           91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA  167 (299)
T ss_dssp             EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence            99999999999999998754 46899999999999999999999   999999999999999998   789999999998


Q ss_pred             cccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhh
Q 040845          675 KLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEV  754 (824)
Q Consensus       675 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  754 (824)
                      ....                        +..++.++||||+||++|||++|+.||...........          ....
T Consensus       168 ~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~----------~~~~  213 (299)
T 3m2w_A          168 KETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG----------MKTR  213 (299)
T ss_dssp             EECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CC----------SCCS
T ss_pred             cccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHH----------HHHH
Confidence            7532                        23467899999999999999999999975322110000          0000


Q ss_pred             ccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 040845          755 VDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL  802 (824)
Q Consensus       755 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L  802 (824)
                      ..   .............++..+.+++.+||+.||++|||+.|++++-
T Consensus       214 ~~---~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp  258 (299)
T 3m2w_A          214 IR---MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP  258 (299)
T ss_dssp             SC---TTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             Hh---hccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence            00   0000011112234677899999999999999999999999863

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.6e-35  Score=348.11  Aligned_cols=241  Identities=23%  Similarity=0.330  Sum_probs=195.2

Q ss_pred             hccCCCCceeeeccceEEEEEEEC--CCcEEEEEEeeccc-cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCe-----
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR--DGMEVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEF-----  597 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  597 (824)
                      .++|++.+.||+|+||.||+|.+.  +|+.||||++.... ....+.+.+|+.++++++||||+++++++...+.     
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            368999999999999999999875  58999999986443 2345678899999999999999999999977654     


Q ss_pred             eEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccccc
Q 040845          598 KALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  677 (824)
Q Consensus       598 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~  677 (824)
                      .|+||||+++++|.+++..   .+++.+++.++.||++||+|||   +.+|+||||||+||+++.+ .+||+|||+++..
T Consensus       159 ~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~  231 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI  231 (681)
T ss_dssp             EEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred             eEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccchhc
Confidence            6999999999999988754   6899999999999999999999   9999999999999999885 8999999999876


Q ss_pred             CCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccc
Q 040845          678 TGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDA  757 (824)
Q Consensus       678 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  757 (824)
                      ...      ....||++|+|||++.++ ++.++|||||||++|||++|..||........          +         
T Consensus       232 ~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~----------~---------  285 (681)
T 2pzi_A          232 NSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL----------P---------  285 (681)
T ss_dssp             TCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC----------C---------
T ss_pred             ccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccccc----------c---------
Confidence            432      334689999999988665 48999999999999999999888765221110          0         


Q ss_pred             cccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHHHH
Q 040845          758 NLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRI-NAKEIVAKLLKIRD  807 (824)
Q Consensus       758 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-t~~evl~~L~~~~~  807 (824)
                              .......++..+.+++.+||..||++|| +++++.+.+..+..
T Consensus       286 --------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~  328 (681)
T 2pzi_A          286 --------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR  328 (681)
T ss_dssp             --------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred             --------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence                    0001112356788999999999999999 56777777777654

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=9.6e-36  Score=328.67  Aligned_cols=241  Identities=17%  Similarity=0.176  Sum_probs=180.9

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcCCC-Cccee-------------
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRH-RNLVK-------------  587 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h-~niv~-------------  587 (824)
                      ...|...+.||+|+||+||+|++. +|+.||||++....   ....+.+.+|+.+++.++| ++...             
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            345778899999999999999854 69999999987432   2336778999999999987 32211             


Q ss_pred             --------EEeeeec-----CCeeEEEEeccCCCCHHHHhh------hCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 040845          588 --------VISSCSN-----EEFKALVLEYMPHGSLEKYLH------SSNYSLDIFQRLNIMIDVASALEYLHFGYSAPV  648 (824)
Q Consensus       588 --------l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i  648 (824)
                              +..++..     ....+++|+++ +++|.+++.      .....+++..++.++.|+++||+|||   +.+|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i  232 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL  232 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCc
Confidence                    1111111     22456777776 679999984      22345778899999999999999999   9999


Q ss_pred             EecCCCCCCeeeCCCCcEEEeecccccccCCCCCccccccccccccccCccCc----------CCCCCCccchHHHHHHH
Q 040845          649 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYG----------REGQVSTNGDVYSFGIM  718 (824)
Q Consensus       649 vH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~----------~~~~~~~~~DvwslG~~  718 (824)
                      +||||||+|||++.++.+||+|||+++.....     .....| +.|+|||++          .+..++.++|||||||+
T Consensus       233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi  306 (413)
T 3dzo_A          233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA  306 (413)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred             ccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence            99999999999999999999999998864322     233456 999999998          56668999999999999


Q ss_pred             HHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 040845          719 LMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEI  798 (824)
Q Consensus       719 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~ev  798 (824)
                      +|||++|+.||......+.                 .+.....        ...++..+.+++.+||+.||++|||+.|+
T Consensus       307 l~elltg~~Pf~~~~~~~~-----------------~~~~~~~--------~~~~~~~~~~li~~~l~~dP~~Rpt~~~~  361 (413)
T 3dzo_A          307 IYWIWCADLPNTDDAALGG-----------------SEWIFRS--------CKNIPQPVRALLEGFLRYPKEDRLLPLQA  361 (413)
T ss_dssp             HHHHHHSSCCCCTTGGGSC-----------------SGGGGSS--------CCCCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHHHHCCCCCCCcchhhh-----------------HHHHHhh--------cccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence            9999999999976322110                 0000000        01235678999999999999999999888


Q ss_pred             HHH
Q 040845          799 VAK  801 (824)
Q Consensus       799 l~~  801 (824)
                      +++
T Consensus       362 l~~  364 (413)
T 3dzo_A          362 MET  364 (413)
T ss_dssp             TTS
T ss_pred             HhC
Confidence            654

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=4.8e-35  Score=310.71  Aligned_cols=255  Identities=32%  Similarity=0.539  Sum_probs=237.9

Q ss_pred             ccccEEEeecCccee--cCCccCCCCCCCCEEEecC-CccCCccchhhcCCCCCCEEEcccccCcccCCccccccCCccE
Q 040845          197 HSLKNFYMYNCNVSG--GIPEEITNLTDLTTIVLGG-NKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYE  273 (824)
Q Consensus       197 ~~L~~L~l~~n~l~~--~~~~~l~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~  273 (824)
                      .+++.|++++|.+.+  .+|..+.++++|++|+|++ |.+.+.+|..|.++++|++|+|++|.+++..|..+..+++|++
T Consensus        50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~  129 (313)
T 1ogq_A           50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT  129 (313)
T ss_dssp             CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred             ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCE
Confidence            357778888888877  7888999999999999995 9999889999999999999999999999899999999999999


Q ss_pred             EEccCccccccCCccccCCCCCcEEEcCCCCCC-CCCCcccccc-cccccccccccccCcCCccccccccchhhhccccc
Q 040845          274 LELGGNKLSGSIPACFSNMTFLKVLSLGSNELT-SIPLNFWSLK-DILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNN  351 (824)
Q Consensus       274 L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~-~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~  351 (824)
                      |++++|.+++..|..|..+++|++|++++|+++ .+|..+..++ +|+.|++++|.+++..|..+..++ |+.|++++|+
T Consensus       130 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~  208 (313)
T 1ogq_A          130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNM  208 (313)
T ss_dssp             EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSE
T ss_pred             EeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCc
Confidence            999999999999999999999999999999999 8898898887 999999999999999999999998 9999999999


Q ss_pred             ccccCCCccCCCCCCCeEEccCccccccCCccccccccccEEEccCcccCCCCcccccCCcccceeeccCCcccCCCCCC
Q 040845          352 FSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIPRG  431 (824)
Q Consensus       352 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~  431 (824)
                      +++..|..|..+++|+.|+|++|.+++.+|. +..+++|+.|+|++|++++.+|..+..+++|+.|++++|++++.+|..
T Consensus       209 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~  287 (313)
T 1ogq_A          209 LEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG  287 (313)
T ss_dssp             EEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS
T ss_pred             ccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC
Confidence            9999999999999999999999999976655 889999999999999999999999999999999999999999999998


Q ss_pred             CCccccccccccCCccccCCCC
Q 040845          432 GSFGNFSAESFKGNELLCGSPN  453 (824)
Q Consensus       432 ~~~~~~~~~~~~~n~~~c~~~~  453 (824)
                      +.+.++..+.+.+|+++||.|.
T Consensus       288 ~~l~~L~~l~l~~N~~lc~~p~  309 (313)
T 1ogq_A          288 GNLQRFDVSAYANNKCLCGSPL  309 (313)
T ss_dssp             TTGGGSCGGGTCSSSEEESTTS
T ss_pred             ccccccChHHhcCCCCccCCCC
Confidence            8899999999999999999874

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=3.5e-35  Score=315.86  Aligned_cols=245  Identities=17%  Similarity=0.200  Sum_probs=185.5

Q ss_pred             hccCCCCceeeeccceEEEEEEECCCcEEEEEEeeccc--------cchhhhHHHHHHHHhcCC---------CCcceeE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQC--------GRAFKSFDVECAMMKSIR---------HRNLVKV  588 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------h~niv~l  588 (824)
                      .++|++.+.||+|+||+||+|++ +|+.||||++....        ....+.+.+|+.+++.++         ||||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            46789999999999999999998 58999999997653        223377889999999886         6666666


Q ss_pred             Eee-----------------eec-------------CCeeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHH
Q 040845          589 ISS-----------------CSN-------------EEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALE  638 (824)
Q Consensus       589 ~~~-----------------~~~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~  638 (824)
                      .++                 +.+             ....++||||+++|++.+.+.+  ..+++.++..++.||+.||+
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~  175 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLA  175 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHH
Confidence            554                 332             6789999999999977666644  35899999999999999999


Q ss_pred             HhhcCCCCCeEecCCCCCCeeeCCCC--------------------cEEEeecccccccCCCCCccccccccccccccCc
Q 040845          639 YLHFGYSAPVIHCDLKPSNVLLDDNM--------------------VAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP  698 (824)
Q Consensus       639 ~LH~~~~~~ivH~Dlk~~Nill~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aP  698 (824)
                      |||+  +.+|+||||||+|||++.++                    .+||+|||+|+....       ....||+.|+||
T Consensus       176 ~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~aP  246 (336)
T 2vuw_A          176 VAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSMDE  246 (336)
T ss_dssp             HHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTTCS
T ss_pred             HHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecccCh
Confidence            9993  37899999999999999887                    999999999987642       134699999999


Q ss_pred             cCcCCCCCCccchHHHHHHH-HHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhhhhhhHHHHHHHH
Q 040845          699 EYGREGQVSTNGDVYSFGIM-LMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFV  777 (824)
Q Consensus       699 E~~~~~~~~~~~DvwslG~~-l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  777 (824)
                      |++.+.. +.++||||+|++ .+++++|..||...        .|.....    ......... ........+..+++++
T Consensus       247 E~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~--------~~~~~~~----~~~~~~~~~-~~~~~~~~~~~~s~~~  312 (336)
T 2vuw_A          247 DLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV--------LWLHYLT----DKMLKQMTF-KTKCNTPAMKQIKRKI  312 (336)
T ss_dssp             GGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH--------HHHHHHH----HHHHHTCCC-SSCCCSHHHHHHHHHH
T ss_pred             hhhcCCC-ccceehhhhhCCCCcccccccCCCcch--------hhhhHHH----Hhhhhhhcc-CcccchhhhhhcCHHH
Confidence            9998666 899999998777 77889999997541        1100000    000000000 0001112344678899


Q ss_pred             HHHHHHccccCCCCCCCHHHHH-HH
Q 040845          778 FNLALECTVESPEQRINAKEIV-AK  801 (824)
Q Consensus       778 ~~l~~~cl~~dP~~Rpt~~evl-~~  801 (824)
                      .+|+.+||+.|     |++|++ +|
T Consensus       313 ~dli~~~L~~d-----sa~e~l~~H  332 (336)
T 2vuw_A          313 QEFHRTMLNFS-----SATDLLCQH  332 (336)
T ss_dssp             HHHHHHGGGSS-----SHHHHHHHC
T ss_pred             HHHHHHHhccC-----CHHHHHhcC
Confidence            99999999977     999988 54

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=100.00  E-value=6.2e-33  Score=297.70  Aligned_cols=287  Identities=23%  Similarity=0.281  Sum_probs=178.4

Q ss_pred             CCceeeccCCccccccCccccCCCCCccEEEccCCeeeeecCccccCCCCCceEeccCccccccCCccccCCCCCCEEEc
Q 040845           70 TLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTL  149 (824)
Q Consensus        70 ~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L  149 (824)
                      +|+.+++++|.++.+|..+    .++|+.|+|++|++++..+..|..+++|++|+|++|++++..|..|+++++|++|++
T Consensus        34 ~l~~l~~~~~~l~~ip~~~----~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  109 (332)
T 2ft3_A           34 HLRVVQCSDLGLKAVPKEI----SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYI  109 (332)
T ss_dssp             ETTEEECCSSCCSSCCSCC----CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEEC
T ss_pred             cCCEEECCCCCccccCCCC----CCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEEC
Confidence            4566666666665555433    256777777777777666666777777777777777777666777777777777777


Q ss_pred             cCCcCCCCcCcccccccCCCCCCCcEEECcCCCCCccCCccccccccccccEEEeecCcceecCCccCCCCCCCCEEEec
Q 040845          150 YDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLG  229 (824)
Q Consensus       150 ~~n~i~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~  229 (824)
                      ++|+++.++..      +.  ++|++|++++|.+..+.+                          ..|.++++|+.|+++
T Consensus       110 ~~n~l~~l~~~------~~--~~L~~L~l~~n~i~~~~~--------------------------~~~~~l~~L~~L~l~  155 (332)
T 2ft3_A          110 SKNHLVEIPPN------LP--SSLVELRIHDNRIRKVPK--------------------------GVFSGLRNMNCIEMG  155 (332)
T ss_dssp             CSSCCCSCCSS------CC--TTCCEEECCSSCCCCCCS--------------------------GGGSSCSSCCEEECC
T ss_pred             CCCcCCccCcc------cc--ccCCEEECCCCccCccCH--------------------------hHhCCCccCCEEECC
Confidence            77777665432      11  566666666666654433                          234445555555555


Q ss_pred             CCccCC--ccchhhcCCCCCCEEEcccccCcccCCccccccCCccEEEccCccccccCCccccCCCCCcEEEcCCCCCCC
Q 040845          230 GNKLNG--SIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTS  307 (824)
Q Consensus       230 ~n~l~~--~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~  307 (824)
                      +|.++.  ..+..|..+ +|++|++++|++++ +|..+.  ++|+.|++++|++++..+..|..+++|++|++++|+++.
T Consensus       156 ~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~  231 (332)
T 2ft3_A          156 GNPLENSGFEPGAFDGL-KLNYLRISEAKLTG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRM  231 (332)
T ss_dssp             SCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCC
T ss_pred             CCccccCCCCcccccCC-ccCEEECcCCCCCc-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCc
Confidence            555532  344455555 56666666666553 333322  456666666666665555566666666666666666666


Q ss_pred             CCC-cccccccccccccccccccCcCCccccccccchhhhcccccccccCCCccCC------CCCCCeEEccCcccc--c
Q 040845          308 IPL-NFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGS------LKNLENLFLEYNRLE--G  378 (824)
Q Consensus       308 lp~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~------l~~L~~L~L~~N~l~--~  378 (824)
                      ++. .+..+++|+.|++++|+++ .+|..+..+++|+.|++++|++++..+..|..      .++|+.|++++|.+.  +
T Consensus       232 ~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~  310 (332)
T 2ft3_A          232 IENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWE  310 (332)
T ss_dssp             CCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGG
T ss_pred             CChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccc
Confidence            554 3555666666666666666 45555666666777777777776665555544      367888888888887  5


Q ss_pred             cCCccccccccccEEEccCcc
Q 040845          379 SIPDSFGDLISLKSLNLSYNN  399 (824)
Q Consensus       379 ~~~~~~~~l~~L~~L~L~~N~  399 (824)
                      ..|..|..+++|+.|++++|+
T Consensus       311 ~~~~~~~~l~~L~~l~l~~n~  331 (332)
T 2ft3_A          311 VQPATFRCVTDRLAIQFGNYK  331 (332)
T ss_dssp             SCGGGGTTBCCSTTEEC----
T ss_pred             cCcccccccchhhhhhccccc
Confidence            677788888888888888875

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=100.00  E-value=2.1e-32  Score=293.41  Aligned_cols=288  Identities=20%  Similarity=0.255  Sum_probs=164.6

Q ss_pred             CCceeeccCCccccccCccccCCCCCccEEEccCCeeeeecCccccCCCCCceEeccCccccccCCccccCCCCCCEEEc
Q 040845           70 TLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTL  149 (824)
Q Consensus        70 ~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L  149 (824)
                      +|+.++++++.++.+|...    .++|++|+|++|++++..+..|.++++|++|+|++|++++..|..|+++++|++|++
T Consensus        32 ~l~~l~~~~~~l~~lp~~~----~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  107 (330)
T 1xku_A           32 HLRVVQCSDLGLEKVPKDL----PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL  107 (330)
T ss_dssp             ETTEEECTTSCCCSCCCSC----CTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred             CCeEEEecCCCccccCccC----CCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEEC
Confidence            4555555555555544432    246666666666666555556666777777777777776666666777777777777


Q ss_pred             cCCcCCCCcCcccccccCCCCCCCcEEECcCCCCCccCCccccccccccccEEEeecCcceecCCccCCCCCCCCEEEec
Q 040845          150 YDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLG  229 (824)
Q Consensus       150 ~~n~i~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~  229 (824)
                      ++|+++.++...        .++|++|++++|.+.++.+.                          .+.++++|+.|+++
T Consensus       108 s~n~l~~l~~~~--------~~~L~~L~l~~n~l~~~~~~--------------------------~~~~l~~L~~L~l~  153 (330)
T 1xku_A          108 SKNQLKELPEKM--------PKTLQELRVHENEITKVRKS--------------------------VFNGLNQMIVVELG  153 (330)
T ss_dssp             CSSCCSBCCSSC--------CTTCCEEECCSSCCCBBCHH--------------------------HHTTCTTCCEEECC
T ss_pred             CCCcCCccChhh--------cccccEEECCCCcccccCHh--------------------------HhcCCccccEEECC
Confidence            777666554321        15666666666666544332                          33444555555555


Q ss_pred             CCccCC--ccchhhcCCCCCCEEEcccccCcccCCccccccCCccEEEccCccccccCCccccCCCCCcEEEcCCCCCCC
Q 040845          230 GNKLNG--SIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTS  307 (824)
Q Consensus       230 ~n~l~~--~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~  307 (824)
                      +|.+..  ..+..|..+++|++|++++|.++. +|..+.  ++|+.|++++|++++..+..|..+++|++|++++|.++.
T Consensus       154 ~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~  230 (330)
T 1xku_A          154 TNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISA  230 (330)
T ss_dssp             SSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS-CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCE
T ss_pred             CCcCCccCcChhhccCCCCcCEEECCCCcccc-CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCce
Confidence            555432  334445555555555555555542 232221  455555555555555555555555555555555555555


Q ss_pred             CCC-cccccccccccccccccccCcCCccccccccchhhhcccccccccCCCccCC------CCCCCeEEccCccccc--
Q 040845          308 IPL-NFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGS------LKNLENLFLEYNRLEG--  378 (824)
Q Consensus       308 lp~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~------l~~L~~L~L~~N~l~~--  378 (824)
                      ++. .+..+++|+.|++++|+++ .+|..+..+++|+.|++++|+|++..+..|..      .+.|+.|++++|.+..  
T Consensus       231 ~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~  309 (330)
T 1xku_A          231 VDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWE  309 (330)
T ss_dssp             ECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGG
T ss_pred             eChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccc
Confidence            443 3444555555555555555 44555555566666666666666555555533      3678888888888763  


Q ss_pred             cCCccccccccccEEEccCcc
Q 040845          379 SIPDSFGDLISLKSLNLSYNN  399 (824)
Q Consensus       379 ~~~~~~~~l~~L~~L~L~~N~  399 (824)
                      ..|..|..+++|+.++|++|+
T Consensus       310 i~~~~f~~~~~l~~l~L~~N~  330 (330)
T 1xku_A          310 IQPSTFRCVYVRAAVQLGNYK  330 (330)
T ss_dssp             SCGGGGTTCCCGGGEEC----
T ss_pred             cCccccccccceeEEEecccC
Confidence            556788888888888888885

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=100.00  E-value=2.9e-37  Score=347.90  Aligned_cols=383  Identities=19%  Similarity=0.151  Sum_probs=235.7

Q ss_pred             CCCcEEEccCCccccccccc-ccCCCCCCEEeCCCCcCCc----ccChhhhCcCCCceeeccCCccccccCccccCCCC-
Q 040845           21 SNLKVLYLYNNRLQGEIIHE-IGHLHNLGFLDLSQNKLLG----TIPAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLP-   94 (824)
Q Consensus        21 ~~L~~L~L~~n~l~~~~~~~-~~~l~~L~~L~Ls~n~l~~----~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~-   94 (824)
                      ++|++|+|++|+++...... +..+++|++|+|++|.++.    .++..+..+++|++|+|++|++++.........++ 
T Consensus         3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~   82 (461)
T 1z7x_W            3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT   82 (461)
T ss_dssp             EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred             ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence            57899999999998655444 7889999999999999884    35677888899999999999987633222222344 


Q ss_pred             ---CccEEEccCCeeee----ecCccccCCCCCceEeccCccccccCCcccc-----CCCCCCEEEccCCcCCCCcCccc
Q 040845           95 ---NLEVLYLWGNNFSG----TIPHFIFNASKLSKLALEMNSFSGFIPSTFG-----NLRNLEWLTLYDNNLTSSTLDLS  162 (824)
Q Consensus        95 ---~L~~L~L~~n~i~~----~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~-----~l~~L~~L~L~~n~i~~~~~~~~  162 (824)
                         +|++|+|++|+++.    .++..+..+++|++|+|++|.+++..+..+.     ..++|++|++++|+++..... .
T Consensus        83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~-~  161 (461)
T 1z7x_W           83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCE-P  161 (461)
T ss_dssp             TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHH-H
T ss_pred             CCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHH-H
Confidence               79999999999884    4578888899999999999998865444333     356899999999988764321 1


Q ss_pred             ccccCCCCCCCcEEECcCCCCCccCCccccccccccccEEEeecCcceecCCccCCCCCCCCEEEecCCccCCc----cc
Q 040845          163 FLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGS----IP  238 (824)
Q Consensus       163 ~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~----~~  238 (824)
                      +...+..+++|++|++++|.+.+.....+...+.                     ...++|++|++++|.+++.    ++
T Consensus       162 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~---------------------~~~~~L~~L~L~~n~l~~~~~~~l~  220 (461)
T 1z7x_W          162 LASVLRAKPDFKELTVSNNDINEAGVRVLCQGLK---------------------DSPCQLEALKLESCGVTSDNCRDLC  220 (461)
T ss_dssp             HHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHH---------------------HSCCCCCEEECTTSCCBTTHHHHHH
T ss_pred             HHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHh---------------------cCCCCceEEEccCCCCcHHHHHHHH
Confidence            2344667789999999999886543333322111                     0123444555555544432    23


Q ss_pred             hhhcCCCCCCEEEcccccCcccCC-----ccccccCCccEEEccCcccccc----CCccccCCCCCcEEEcCCCCCCCCC
Q 040845          239 ITLGKLQKLQDVDLEYNQLEGSIP-----DSICLSVELYELELGGNKLSGS----IPACFSNMTFLKVLSLGSNELTSIP  309 (824)
Q Consensus       239 ~~~~~l~~L~~L~L~~n~l~~~~~-----~~~~~~~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~L~~N~l~~lp  309 (824)
                      ..+..+++|++|++++|.+++...     ..+..+++|++|++++|.++..    ++..+..+++|++|++++|.++..+
T Consensus       221 ~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~  300 (461)
T 1z7x_W          221 GIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEG  300 (461)
T ss_dssp             HHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHH
T ss_pred             HHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHH
Confidence            344444555555555555443221     1111344555555555555432    2333444555555555555554221


Q ss_pred             C-----ccc-ccccccccccccccccCc----CCccccccccchhhhcccccccccCCCccCC-----CCCCCeEEccCc
Q 040845          310 L-----NFW-SLKDILDLNLSSNCFSGP----LPLEIRNLKALIEIDFSMNNFSGIIPMEIGS-----LKNLENLFLEYN  374 (824)
Q Consensus       310 ~-----~~~-~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-----l~~L~~L~L~~N  374 (824)
                      .     .+. ..++|+.|++++|.+++.    ++..+..+++|+.|++++|++++..+..+..     .++|+.|+|++|
T Consensus       301 ~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n  380 (461)
T 1z7x_W          301 ARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADC  380 (461)
T ss_dssp             HHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTS
T ss_pred             HHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCC
Confidence            1     111 123555555566655533    3444556677777777777776544433332     567888888888


Q ss_pred             cccc----cCCccccccccccEEEccCcccCCCCccccc-----CCcccceeeccCCccc
Q 040845          375 RLEG----SIPDSFGDLISLKSLNLSYNNLSGTIPVSLE-----KLSYLKDLNLSFNKLK  425 (824)
Q Consensus       375 ~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~-----~l~~L~~L~l~~N~l~  425 (824)
                      .+++    .+|..+..+++|+.|++++|++++.-...+.     ...+|+.|++.++.+.
T Consensus       381 ~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~~~~~~~  440 (461)
T 1z7x_W          381 DVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS  440 (461)
T ss_dssp             CCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCC
T ss_pred             CCChhhHHHHHHHHHhCCCccEEECCCCCCCHHHHHHHHHHhccCCcchhheeecccccC
Confidence            8875    5667777778888888888887643111111     1234666666666554

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=100.00  E-value=2.1e-32  Score=293.53  Aligned_cols=312  Identities=21%  Similarity=0.227  Sum_probs=199.9

Q ss_pred             ccccccCCcccccCC-----CCCcEEEccCCcccccccccccCCCCCCEEeCCCCcCCcccChhhhCcCCCceeeccCCc
Q 040845            6 NNFLTSTTPKEIDNI-----SNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNS   80 (824)
Q Consensus         6 ~n~i~~~~p~~~~~l-----~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~   80 (824)
                      .+.+++++|.....+     .+++.+++++|.++ .+|..+.  ++|++|+|++|.+++..|.+|.++++|++|+|++|+
T Consensus        13 ~~~l~~lp~~~~~~cp~~c~c~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~   89 (332)
T 2ft3_A           13 IPDLDSLPPTYSAMCPFGCHCHLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNK   89 (332)
T ss_dssp             ------------CCCCSSCEEETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred             CCccccCCCcccCCCCCCCcccCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCc
Confidence            445555555433332     37999999999998 6676664  689999999999997777889999999999999999


Q ss_pred             cccccCccccCCCCCccEEEccCCeeeeecCccccCCCCCceEeccCccccccCCccccCCCCCCEEEccCCcCCCCcCc
Q 040845           81 LSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLD  160 (824)
Q Consensus        81 l~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~  160 (824)
                      ++++++... .++++|++|+|++|+++ .+|..+.  ++|++|++++|+++...+..|.++++|++|++++|.++..+..
T Consensus        90 l~~~~~~~~-~~l~~L~~L~L~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~  165 (332)
T 2ft3_A           90 ISKIHEKAF-SPLRKLQKLYISKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFE  165 (332)
T ss_dssp             CCEECGGGS-TTCTTCCEEECCSSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSC
T ss_pred             cCccCHhHh-hCcCCCCEEECCCCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCC
Confidence            987754332 36899999999999998 4555544  7899999999999977777889999999999999988753322


Q ss_pred             ccccccCCCCCCCcEEECcCCCCCccCCccccccccccccEEEeecCcceecCCccCCCCCCCCEEEecCCccCCccchh
Q 040845          161 LSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPIT  240 (824)
Q Consensus       161 ~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~  240 (824)
                         +..+..+ +|++|++++|.+.+++...     +.+|++|++++|.+++..+..+..+++|+.|+|++|++++..+..
T Consensus       166 ---~~~~~~l-~L~~L~l~~n~l~~l~~~~-----~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~  236 (332)
T 2ft3_A          166 ---PGAFDGL-KLNYLRISEAKLTGIPKDL-----PETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGS  236 (332)
T ss_dssp             ---TTSSCSC-CCSCCBCCSSBCSSCCSSS-----CSSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTG
T ss_pred             ---cccccCC-ccCEEECcCCCCCccCccc-----cCCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhH
Confidence               2346666 8899999999888754322     245666666666665555555556666666666666665555555


Q ss_pred             hcCCCCCCEEEcccccCcccCCccccccCCccEEEccCccccccCCccccCCCCCcEEEcCCCCCCCCCCcccccccccc
Q 040845          241 LGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILD  320 (824)
Q Consensus       241 ~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~  320 (824)
                      |..+++|++|+|++|+++ .+|..+..+++|+.|++++|++++..+..|.....                 ......|+.
T Consensus       237 ~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~-----------------~~~~~~l~~  298 (332)
T 2ft3_A          237 LSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGF-----------------GVKRAYYNG  298 (332)
T ss_dssp             GGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSC-----------------CSSSCCBSE
T ss_pred             hhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHcccccc-----------------ccccccccc
Confidence            555555555655555555 44444555555555555555555444444433200                 000234555


Q ss_pred             ccccccccc--CcCCccccccccchhhhccccc
Q 040845          321 LNLSSNCFS--GPLPLEIRNLKALIEIDFSMNN  351 (824)
Q Consensus       321 L~l~~N~l~--~~~~~~~~~l~~L~~L~l~~N~  351 (824)
                      |++++|++.  +..|..|..+++|+.|++++|+
T Consensus       299 L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~  331 (332)
T 2ft3_A          299 ISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK  331 (332)
T ss_dssp             EECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred             eEeecCcccccccCcccccccchhhhhhccccc
Confidence            555555554  3455666667777777776664

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=100.00  E-value=7e-32  Score=289.35  Aligned_cols=293  Identities=20%  Similarity=0.264  Sum_probs=194.8

Q ss_pred             CCCCCcEEEccCCcccccccccccCCCCCCEEeCCCCcCCcccChhhhCcCCCceeeccCCccccccCccccCCCCCccE
Q 040845           19 NISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEV   98 (824)
Q Consensus        19 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~   98 (824)
                      ...+++.++++++.++ .+|..+.  ++|++|+|++|++++..+..|.++++|++|+|++|+++++.+... ..+++|++
T Consensus        29 c~c~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~-~~l~~L~~  104 (330)
T 1xku_A           29 CQCHLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAF-APLVKLER  104 (330)
T ss_dssp             CEEETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTT-TTCTTCCE
T ss_pred             CcCCCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHh-cCCCCCCE
Confidence            3447899999999998 5676654  689999999999997777789999999999999999987744332 36889999


Q ss_pred             EEccCCeeeeecCccccCCCCCceEeccCccccccCCccccCCCCCCEEEccCCcCCCCcCcccccccCCCCCCCcEEEC
Q 040845           99 LYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISL  178 (824)
Q Consensus        99 L~L~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~~L~~L~L  178 (824)
                      |+|++|+++ .+|..+.  ++|++|++++|++++..+..|.++++|++|++++|.++..+..   ...+..+++|++|++
T Consensus       105 L~Ls~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~---~~~~~~l~~L~~L~l  178 (330)
T 1xku_A          105 LYLSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIE---NGAFQGMKKLSYIRI  178 (330)
T ss_dssp             EECCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBC---TTGGGGCTTCCEEEC
T ss_pred             EECCCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcC---hhhccCCCCcCEEEC
Confidence            999999998 4555543  7899999999999988888899999999999999988753322   245778899999999


Q ss_pred             cCCCCCccCCccccccccccccEEEeecCcceecCCccCCCCCCCCEEEecCCccCCccchhhcCCCCCCEEEcccccCc
Q 040845          179 SNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLE  258 (824)
Q Consensus       179 s~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~  258 (824)
                      ++|.+..++...     +++|++|++++|.+++..+..+..+++|+.|+|++|.+++..+..|..+++|++|+|++|+++
T Consensus       179 ~~n~l~~l~~~~-----~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~  253 (330)
T 1xku_A          179 ADTNITTIPQGL-----PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV  253 (330)
T ss_dssp             CSSCCCSCCSSC-----CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS
T ss_pred             CCCccccCCccc-----cccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc
Confidence            999887653322     234555555555555444455555555555555555555444444445555555555555544


Q ss_pred             ccCCccccccCCccEEEccCccccccCCccccCCCCCcEEEcCCCCCCCCCCccc-------ccccccccccccccccC-
Q 040845          259 GSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFW-------SLKDILDLNLSSNCFSG-  330 (824)
Q Consensus       259 ~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~-------~l~~L~~L~l~~N~l~~-  330 (824)
                       .+|                        ..+..+++|++|++++|+|+.+|...+       ..+.++.|++++|.+.. 
T Consensus       254 -~lp------------------------~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~  308 (330)
T 1xku_A          254 -KVP------------------------GGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYW  308 (330)
T ss_dssp             -SCC------------------------TTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGG
T ss_pred             -cCC------------------------hhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCccccc
Confidence             334                        444455555555555555555443311       12455556666666542 


Q ss_pred             -cCCccccccccchhhhccccc
Q 040845          331 -PLPLEIRNLKALIEIDFSMNN  351 (824)
Q Consensus       331 -~~~~~~~~l~~L~~L~l~~N~  351 (824)
                       ..|..|..+.+++.++|++|+
T Consensus       309 ~i~~~~f~~~~~l~~l~L~~N~  330 (330)
T 1xku_A          309 EIQPSTFRCVYVRAAVQLGNYK  330 (330)
T ss_dssp             GSCGGGGTTCCCGGGEEC----
T ss_pred             ccCccccccccceeEEEecccC
Confidence             455667777777777777764

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=99.98  E-value=1.8e-32  Score=290.82  Aligned_cols=250  Identities=30%  Similarity=0.484  Sum_probs=204.1

Q ss_pred             CCcEEECcCCCCCc--cCCccccccccccccEEEeec-CcceecCCccCCCCCCCCEEEecCCccCCccchhhcCCCCCC
Q 040845          172 SLTHISLSNNPLDG--ILPRTYVGNLSHSLKNFYMYN-CNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQ  248 (824)
Q Consensus       172 ~L~~L~Ls~n~l~~--~~~~~~~~~l~~~L~~L~l~~-n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~  248 (824)
                      ++++|+|++|.+.+  ..|..+..  .++|++|++++ |.+.+.+|..|.++++|++|+|++|.+++..|..|.++++|+
T Consensus        51 ~l~~L~L~~~~l~~~~~~~~~l~~--l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~  128 (313)
T 1ogq_A           51 RVNNLDLSGLNLPKPYPIPSSLAN--LPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLV  128 (313)
T ss_dssp             CEEEEEEECCCCSSCEECCGGGGG--CTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCC
T ss_pred             eEEEEECCCCCccCCcccChhHhC--CCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCC
Confidence            45555555555554  33333322  23566666663 666666777778888888888888888877888888888888


Q ss_pred             EEEcccccCcccCCccccccCCccEEEccCccccccCCccccCCC-CCcEEEcCCCCCC-CCCCcccccccccccccccc
Q 040845          249 DVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMT-FLKVLSLGSNELT-SIPLNFWSLKDILDLNLSSN  326 (824)
Q Consensus       249 ~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~l~~N  326 (824)
                      +|+|++|.+++..|..+..+++|++|++++|++++..|..+..++ +|++|++++|+++ .+|..+..++ |+.|++++|
T Consensus       129 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N  207 (313)
T 1ogq_A          129 TLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRN  207 (313)
T ss_dssp             EEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSS
T ss_pred             EEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCC
Confidence            888888888877888888888888888888888878888888887 8888888888888 5677777776 889999999


Q ss_pred             cccCcCCccccccccchhhhcccccccccCCCccCCCCCCCeEEccCccccccCCccccccccccEEEccCcccCCCCcc
Q 040845          327 CFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPV  406 (824)
Q Consensus       327 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~  406 (824)
                      .+++..|..|..+++|+.|++++|++++.+|. +..+++|++|+|++|++++.+|..|..+++|+.|+|++|++++.+|.
T Consensus       208 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~  286 (313)
T 1ogq_A          208 MLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ  286 (313)
T ss_dssp             EEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC
T ss_pred             cccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCC
Confidence            99888899999999999999999999876665 88899999999999999999999999999999999999999999998


Q ss_pred             cccCCcccceeeccCCc-ccC
Q 040845          407 SLEKLSYLKDLNLSFNK-LKG  426 (824)
Q Consensus       407 ~~~~l~~L~~L~l~~N~-l~~  426 (824)
                      . ..+++|+.+++++|+ ++|
T Consensus       287 ~-~~l~~L~~l~l~~N~~lc~  306 (313)
T 1ogq_A          287 G-GNLQRFDVSAYANNKCLCG  306 (313)
T ss_dssp             S-TTGGGSCGGGTCSSSEEES
T ss_pred             C-ccccccChHHhcCCCCccC
Confidence            7 889999999999999 544

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.98  E-value=9.8e-36  Score=335.34  Aligned_cols=358  Identities=20%  Similarity=0.209  Sum_probs=262.3

Q ss_pred             CCCCEEeCCCCcCCcccChh-hhCcCCCceeeccCCccccc-----cCccccCCCCCccEEEccCCeeeeecCccc-cCC
Q 040845           45 HNLGFLDLSQNKLLGTIPAA-IFNVSTLKAFAVTNNSLSGC-----LSSITDVGLPNLEVLYLWGNNFSGTIPHFI-FNA  117 (824)
Q Consensus        45 ~~L~~L~Ls~n~l~~~~~~~-~~~l~~L~~L~L~~n~l~~~-----~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l-~~l  117 (824)
                      ++|++|||++|+++...... +..+++|++|+|++|+++..     +..+  ..+++|++|+|++|.+++..+..+ ..+
T Consensus         3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l--~~~~~L~~L~Ls~n~l~~~~~~~l~~~l   80 (461)
T 1z7x_W            3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSAL--RVNPALAELNLRSNELGDVGVHCVLQGL   80 (461)
T ss_dssp             EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHH--HTCTTCCEEECTTCCCHHHHHHHHHHTT
T ss_pred             ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHH--HhCCCcCEEeCCCCcCChHHHHHHHHHH
Confidence            46788888888887543333 67788888888888887632     2221  236777888888877765433332 224


Q ss_pred             C----CCceEeccCccccc----cCCccccCCCCCCEEEccCCcCCCCcCccccccc-CCCCCCCcEEECcCCCCCccCC
Q 040845          118 S----KLSKLALEMNSFSG----FIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSS-LSNCKSLTHISLSNNPLDGILP  188 (824)
Q Consensus       118 ~----~L~~L~L~~N~i~~----~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~  188 (824)
                      +    +|++|+|++|+++.    .++..|.++++|++|++++|.++...... +... ....++|++|++++|.+.+...
T Consensus        81 ~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~-l~~~l~~~~~~L~~L~L~~n~l~~~~~  159 (461)
T 1z7x_W           81 QTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQL-LCEGLLDPQCRLEKLQLEYCSLSAASC  159 (461)
T ss_dssp             CSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHH-HHHHHTSTTCCCCEEECTTSCCBGGGH
T ss_pred             hhCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHH-HHHHHhcCCCcceEEECCCCCCCHHHH
Confidence            4    57777777777774    33666777777777777777765432211 1111 2234567777777776654322


Q ss_pred             ccccccccccccEEEeecCcceecCCccCCCCCCCCEEEecCCccCCccchhhc-----CCCCCCEEEcccccCccc---
Q 040845          189 RTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLG-----KLQKLQDVDLEYNQLEGS---  260 (824)
Q Consensus       189 ~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~-----~l~~L~~L~L~~n~l~~~---  260 (824)
                      .                      .++..+..+++|++|++++|.+.+..+..+.     ..++|++|+|++|.+++.   
T Consensus       160 ~----------------------~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~  217 (461)
T 1z7x_W          160 E----------------------PLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCR  217 (461)
T ss_dssp             H----------------------HHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHH
T ss_pred             H----------------------HHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHH
Confidence            1                      2234566688999999999999865555554     367999999999999864   


Q ss_pred             -CCccccccCCccEEEccCccccccC-----CccccCCCCCcEEEcCCCCCCC-----CCCccccccccccccccccccc
Q 040845          261 -IPDSICLSVELYELELGGNKLSGSI-----PACFSNMTFLKVLSLGSNELTS-----IPLNFWSLKDILDLNLSSNCFS  329 (824)
Q Consensus       261 -~~~~~~~~~~L~~L~l~~n~l~~~~-----~~~~~~l~~L~~L~L~~N~l~~-----lp~~~~~l~~L~~L~l~~N~l~  329 (824)
                       ++..+..+++|++|++++|++++..     +..+..+++|++|++++|.++.     ++..+..+++|++|++++|.++
T Consensus       218 ~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~  297 (461)
T 1z7x_W          218 DLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELG  297 (461)
T ss_dssp             HHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCH
T ss_pred             HHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCc
Confidence             4677788899999999999988543     3334468999999999999997     6767777999999999999997


Q ss_pred             CcCCcccccc-----ccchhhhccccccccc----CCCccCCCCCCCeEEccCccccccCCccccc-----cccccEEEc
Q 040845          330 GPLPLEIRNL-----KALIEIDFSMNNFSGI----IPMEIGSLKNLENLFLEYNRLEGSIPDSFGD-----LISLKSLNL  395 (824)
Q Consensus       330 ~~~~~~~~~l-----~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-----l~~L~~L~L  395 (824)
                      +..+..+...     ++|+.|++++|.+++.    ++..+..+++|++|+|++|.+++..+..+..     .++|+.|+|
T Consensus       298 ~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L  377 (461)
T 1z7x_W          298 DEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWL  377 (461)
T ss_dssp             HHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEEC
T ss_pred             hHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEEC
Confidence            6544444433     6999999999999865    4556778899999999999998765555543     679999999


Q ss_pred             cCcccCC----CCcccccCCcccceeeccCCcccCC
Q 040845          396 SYNNLSG----TIPVSLEKLSYLKDLNLSFNKLKGE  427 (824)
Q Consensus       396 ~~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~  427 (824)
                      ++|.+++    .+|..+..+++|+.|++++|++++.
T Consensus       378 ~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~  413 (461)
T 1z7x_W          378 ADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDA  413 (461)
T ss_dssp             TTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHH
T ss_pred             CCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCHH
Confidence            9999986    7888999999999999999999853

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.96  E-value=9.4e-30  Score=269.70  Aligned_cols=254  Identities=19%  Similarity=0.189  Sum_probs=206.4

Q ss_pred             cccEEEeecCcceecCCccCCCCCCCCEEEecCCccCCc--cchhhcCCCCCCEEEcccccCcccCCccccccCCccEEE
Q 040845          198 SLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGS--IPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELE  275 (824)
Q Consensus       198 ~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~--~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~  275 (824)
                      ++++|++++|+++...+..|.++++|++|+|++|.++..  .+..+..+++|++|+|++|.+. .+|..+..+++|++|+
T Consensus        29 ~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~  107 (306)
T 2z66_A           29 SATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLD  107 (306)
T ss_dssp             TCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEEE
T ss_pred             CCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCCCccc-cChhhcCCCCCCCEEE
Confidence            455555555555534444578889999999999998743  3677788999999999999998 4667788899999999


Q ss_pred             ccCccccccCC-ccccCCCCCcEEEcCCCCCCCCC-CcccccccccccccccccccC-cCCccccccccchhhhcccccc
Q 040845          276 LGGNKLSGSIP-ACFSNMTFLKVLSLGSNELTSIP-LNFWSLKDILDLNLSSNCFSG-PLPLEIRNLKALIEIDFSMNNF  352 (824)
Q Consensus       276 l~~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~~lp-~~~~~l~~L~~L~l~~N~l~~-~~~~~~~~l~~L~~L~l~~N~l  352 (824)
                      +++|++++..+ ..+..+++|++|++++|.++.++ ..+..+++|+.|++++|.+.+ ..|..+..+++|+.|++++|++
T Consensus       108 l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l  187 (306)
T 2z66_A          108 FQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL  187 (306)
T ss_dssp             CTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCC
T ss_pred             CCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCc
Confidence            99999987665 67889999999999999998664 447788999999999999986 5788899999999999999999


Q ss_pred             cccCCCccCCCCCCCeEEccCccccccCCccccccccccEEEccCcccCCCCcccccCCc-ccceeeccCCcccCCCCCC
Q 040845          353 SGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLS-YLKDLNLSFNKLKGEIPRG  431 (824)
Q Consensus       353 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~l~~N~l~~~~p~~  431 (824)
                      ++..|..|..+++|+.|+|++|++++..+..+..+++|+.|+|++|++++..|..+..++ +|+.|++++|+++|.++..
T Consensus       188 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~  267 (306)
T 2z66_A          188 EQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQ  267 (306)
T ss_dssp             CEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGH
T ss_pred             CCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccChH
Confidence            988889999999999999999999977777899999999999999999988999999885 8999999999999876532


Q ss_pred             C---CccccccccccCCccccCCC
Q 040845          432 G---SFGNFSAESFKGNELLCGSP  452 (824)
Q Consensus       432 ~---~~~~~~~~~~~~n~~~c~~~  452 (824)
                      .   .+..........+...|..|
T Consensus       268 ~~~~~l~~~~~~~~~~~~~~C~~p  291 (306)
T 2z66_A          268 SFLQWIKDQRQLLVEVERMECATP  291 (306)
T ss_dssp             HHHHHHHHTGGGBSCGGGCBEEES
T ss_pred             HHHHHHHhhhhhhccccccccCCc
Confidence            1   12223334445666777665

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.96  E-value=1e-29  Score=269.42  Aligned_cols=277  Identities=21%  Similarity=0.257  Sum_probs=158.5

Q ss_pred             cEEEccCCeeeeecCccccCCCCCceEeccCccccccCCccccCCCCCCEEEccCCcCCCCcCcccccccCCCCCCCcEE
Q 040845           97 EVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHI  176 (824)
Q Consensus        97 ~~L~L~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~~L~~L  176 (824)
                      +.++++++.++ .+|..+  .++|++|+|++|+++.+.+..|.++++|++|+|++|.++.....   ...+..+++|++|
T Consensus        10 ~~l~c~~~~l~-~ip~~~--~~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~---~~~~~~~~~L~~L   83 (306)
T 2z66_A           10 TEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCC---SQSDFGTTSLKYL   83 (306)
T ss_dssp             TEEECCSSCCS-SCCSCC--CTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEE---EHHHHSCSCCCEE
T ss_pred             CEEEcCCCCcc-cCCCCC--CCCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCc---ccccccccccCEE
Confidence            35566666665 333332  24556666666655544444455555555555555555432110   0112233444444


Q ss_pred             ECcCCCCCccCCccccccccccccEEEeecCcceecCCccCCCCCCCCEEEecCCccCCccc-hhhcCCCCCCEEEcccc
Q 040845          177 SLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIP-ITLGKLQKLQDVDLEYN  255 (824)
Q Consensus       177 ~Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n  255 (824)
                      ++++|.+..                           +|..+..+++|++|++++|++++..+ ..|..+++|++|++++|
T Consensus        84 ~Ls~n~i~~---------------------------l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n  136 (306)
T 2z66_A           84 DLSFNGVIT---------------------------MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT  136 (306)
T ss_dssp             ECCSCSEEE---------------------------EEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTS
T ss_pred             ECCCCcccc---------------------------ChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCC
Confidence            444443321                           12223344555555555555543332 34444455555555555


Q ss_pred             cCcccCCccccccCCccEEEccCccccccCCccccCCCCCcEEEcCCCCCCC--CCCcccccccccccccccccccCcCC
Q 040845          256 QLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTS--IPLNFWSLKDILDLNLSSNCFSGPLP  333 (824)
Q Consensus       256 ~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~--lp~~~~~l~~L~~L~l~~N~l~~~~~  333 (824)
                      .+                        .+..+..|.++++|++|++++|.++.  +|..+..+++|+.|++++|.+++..|
T Consensus       137 ~l------------------------~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~  192 (306)
T 2z66_A          137 HT------------------------RVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSP  192 (306)
T ss_dssp             CC------------------------EECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECT
T ss_pred             cC------------------------CccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCH
Confidence            44                        44444445555555555555555543  44445555555555556666665556


Q ss_pred             ccccccccchhhhcccccccccCCCccCCCCCCCeEEccCccccccCCccccccc-cccEEEccCcccCCCCc--ccccC
Q 040845          334 LEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLI-SLKSLNLSYNNLSGTIP--VSLEK  410 (824)
Q Consensus       334 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~p--~~~~~  410 (824)
                      ..+..+++|+.|++++|++++..+..+..+++|+.|+|++|++++..|..+..++ +|+.|+|++|++++.-+  .....
T Consensus       193 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~  272 (306)
T 2z66_A          193 TAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQW  272 (306)
T ss_dssp             TTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHHHHH
T ss_pred             HHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccChHHHHHH
Confidence            6777777788888888888776666788888888888888888887888888874 88888888888875422  12233


Q ss_pred             CcccceeeccCCcccCCCCC
Q 040845          411 LSYLKDLNLSFNKLKGEIPR  430 (824)
Q Consensus       411 l~~L~~L~l~~N~l~~~~p~  430 (824)
                      +...+.+.+..+.+.|..|.
T Consensus       273 l~~~~~~~~~~~~~~C~~p~  292 (306)
T 2z66_A          273 IKDQRQLLVEVERMECATPS  292 (306)
T ss_dssp             HHHTGGGBSCGGGCBEEESG
T ss_pred             HHhhhhhhccccccccCCch
Confidence            44555666677788877665

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.96  E-value=2.1e-29  Score=272.63  Aligned_cols=294  Identities=17%  Similarity=0.199  Sum_probs=204.9

Q ss_pred             CCCCCEEeCCCCcCCcccChhhhCcCCCceeeccCCccccccCccccCCCCCccEEEccCCeeeeecCccccCCCCCceE
Q 040845           44 LHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKL  123 (824)
Q Consensus        44 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L  123 (824)
                      ++.....|+++|.++ .+|..+.  ++|++|++++|++++++.... .++++|++|+|++|++++..+..|..+++|++|
T Consensus        30 C~~~~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~-~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  105 (353)
T 2z80_A           30 CDRNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDL-QRCVNLQALVLTSNGINTIEEDSFSSLGSLEHL  105 (353)
T ss_dssp             ECTTSEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTT-TTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred             CCCCeEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHh-ccCCCCCEEECCCCccCccCHhhcCCCCCCCEE
Confidence            344445566666665 4454443  356666666666665544222 246677777777777776666667777777777


Q ss_pred             eccCccccccCCccccCCCCCCEEEccCCcCCCCcCcccccccCCCCCCCcEEECcCC-CCCccCCccccccccccccEE
Q 040845          124 ALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNN-PLDGILPRTYVGNLSHSLKNF  202 (824)
Q Consensus       124 ~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~~L~~L~Ls~n-~l~~~~~~~~~~~l~~~L~~L  202 (824)
                      +|++|++++..+..|+++++|++|++++|+++.++..    ..+..+++|++|++++| .+..+.+..|..  .++|++|
T Consensus       106 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~----~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~--l~~L~~L  179 (353)
T 2z80_A          106 DLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGET----SLFSHLTKLQILRVGNMDTFTKIQRKDFAG--LTFLEEL  179 (353)
T ss_dssp             ECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSS----CSCTTCTTCCEEEEEESSSCCEECTTTTTT--CCEEEEE
T ss_pred             ECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCch----hhhccCCCCcEEECCCCccccccCHHHccC--CCCCCEE
Confidence            7777777755555577777777777777777765431    23667777777777777 365555554433  3567888


Q ss_pred             EeecCcceecCCccCCCCCCCCEEEecCCccCCccchhhcCCCCCCEEEcccccCcccCCcccc---ccCCccEEEccCc
Q 040845          203 YMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSIC---LSVELYELELGGN  279 (824)
Q Consensus       203 ~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~---~~~~L~~L~l~~n  279 (824)
                      ++++|++++..|..+..+++|++|++++|.+....+..+..+++|++|++++|.+++..+..+.   ....++.++++++
T Consensus       180 ~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~  259 (353)
T 2z80_A          180 EIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNV  259 (353)
T ss_dssp             EEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESC
T ss_pred             ECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccc
Confidence            8888888878888899999999999999999755545566789999999999999876555443   3566888888888


Q ss_pred             cccc----cCCccccCCCCCcEEEcCCCCCCCCCCcc-cccccccccccccccccCcCCccccccccchhhhcccccccc
Q 040845          280 KLSG----SIPACFSNMTFLKVLSLGSNELTSIPLNF-WSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSG  354 (824)
Q Consensus       280 ~l~~----~~~~~~~~l~~L~~L~L~~N~l~~lp~~~-~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~  354 (824)
                      .+.+    .+|..+..+++|+.|++++|+++.+|..+ ..+++|++|++++|++.+       .++.++.|....+...+
T Consensus       260 ~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~-------~~~~l~~l~~~~~~~~~  332 (353)
T 2z80_A          260 KITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDC-------SCPRIDYLSRWLNKNSQ  332 (353)
T ss_dssp             BCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCC-------CHHHHHHHHHHHHHTTT
T ss_pred             cccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccC-------cCCCcHHHHHHHHhccc
Confidence            8774    35667888999999999999999998874 678999999999998874       33455555555554443

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.96  E-value=6.4e-29  Score=278.25  Aligned_cols=232  Identities=25%  Similarity=0.276  Sum_probs=174.2

Q ss_pred             cccccEEEeecCcceecCCccCCCCCCCCEEEecCCccCCccchhhcCCCCCCEEEcccccCcccCCccccccCCccEEE
Q 040845          196 SHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELE  275 (824)
Q Consensus       196 ~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~  275 (824)
                      +.+++.|+|++|++++..+..|.++++|+.|+|++|.++++.+..|.++++|++|+|++|+++...+..|..+++|++|+
T Consensus        74 ~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  153 (452)
T 3zyi_A           74 PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELW  153 (452)
T ss_dssp             CTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEE
T ss_pred             CCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEE
Confidence            34555555555555556666677777777777777777766667777777777777777777766666677777777777


Q ss_pred             ccCccccccCCccccCCCCCcEEEcCC-CCCCCCCCc-ccccccccccccccccccCcCCccccccccchhhhccccccc
Q 040845          276 LGGNKLSGSIPACFSNMTFLKVLSLGS-NELTSIPLN-FWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFS  353 (824)
Q Consensus       276 l~~n~l~~~~~~~~~~l~~L~~L~L~~-N~l~~lp~~-~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~  353 (824)
                      |++|+++...+..|.++++|+.|++++ |.+..++.. |..+++|+.|++++|.+++. | .+..+++|+.|+|++|+++
T Consensus       154 L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~Ls~N~l~  231 (452)
T 3zyi_A          154 LRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-P-NLTPLVGLEELEMSGNHFP  231 (452)
T ss_dssp             CCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-C-CCTTCTTCCEEECTTSCCS
T ss_pred             CCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-c-cccccccccEEECcCCcCc
Confidence            777777766667777777777777777 566666654 66677777777777777743 3 4677788888888888888


Q ss_pred             ccCCCccCCCCCCCeEEccCccccccCCccccccccccEEEccCcccCCCCcccccCCcccceeeccCCcccCCCC
Q 040845          354 GIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIP  429 (824)
Q Consensus       354 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p  429 (824)
                      +..|..|..+++|+.|+|++|++++..+..|.++++|+.|+|++|+|++..+..+..+++|+.|+|++|+|.|.+.
T Consensus       232 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~  307 (452)
T 3zyi_A          232 EIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDCD  307 (452)
T ss_dssp             EECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECSTT
T ss_pred             ccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCCCC
Confidence            7778888888888888888888887777788888888888888888886666677788888888888888877654

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.96  E-value=8e-29  Score=276.42  Aligned_cols=231  Identities=23%  Similarity=0.258  Sum_probs=183.2

Q ss_pred             ccccEEEeecCcceecCCccCCCCCCCCEEEecCCccCCccchhhcCCCCCCEEEcccccCcccCCccccccCCccEEEc
Q 040845          197 HSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELEL  276 (824)
Q Consensus       197 ~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l  276 (824)
                      .+++.|+|++|++++..+..|.++++|++|+|++|.++++.+..|.++++|++|+|++|+|+...+..|..+++|++|+|
T Consensus        64 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  143 (440)
T 3zyj_A           64 TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWL  143 (440)
T ss_dssp             TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEEC
T ss_pred             CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeC
Confidence            45555555555555566667777888888888888888777778888888888888888888666667888888888888


Q ss_pred             cCccccccCCccccCCCCCcEEEcCC-CCCCCCCCc-ccccccccccccccccccCcCCccccccccchhhhcccccccc
Q 040845          277 GGNKLSGSIPACFSNMTFLKVLSLGS-NELTSIPLN-FWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSG  354 (824)
Q Consensus       277 ~~n~l~~~~~~~~~~l~~L~~L~L~~-N~l~~lp~~-~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~  354 (824)
                      ++|+++...+..|.++++|++|++++ |.+..++.. |..+++|+.|++++|.++. +| .+..+++|+.|+|++|++++
T Consensus       144 ~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~  221 (440)
T 3zyj_A          144 RNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IP-NLTPLIKLDELDLSGNHLSA  221 (440)
T ss_dssp             CSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSS-CC-CCTTCSSCCEEECTTSCCCE
T ss_pred             CCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcc-cc-ccCCCcccCEEECCCCccCc
Confidence            88888877777888888888888887 566666653 6678888888888888873 34 47788888888888888888


Q ss_pred             cCCCccCCCCCCCeEEccCccccccCCccccccccccEEEccCcccCCCCcccccCCcccceeeccCCcccCCCC
Q 040845          355 IIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIP  429 (824)
Q Consensus       355 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p  429 (824)
                      ..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|++..+..+..+++|+.|+|++|+|.|.+.
T Consensus       222 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~  296 (440)
T 3zyj_A          222 IRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCNCD  296 (440)
T ss_dssp             ECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECSST
T ss_pred             cChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccCCCC
Confidence            888888888888888888888888778888888888888888888887777777888888888888888887654

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.96  E-value=1.7e-29  Score=273.49  Aligned_cols=279  Identities=19%  Similarity=0.235  Sum_probs=203.4

Q ss_pred             CCCCceEeccCccccccCCccccCCCCCCEEEccCCcCCCCcCcccccccCCCCCCCcEEECcCCCCCccCCcccccccc
Q 040845          117 ASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLS  196 (824)
Q Consensus       117 l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~  196 (824)
                      ++.....++++|.++ .+|..+.  ++|++|++++|.++.++.     ..+.++++|++|++++|.+.++          
T Consensus        30 C~~~~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~-----~~~~~l~~L~~L~L~~n~l~~~----------   91 (353)
T 2z80_A           30 CDRNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISN-----SDLQRCVNLQALVLTSNGINTI----------   91 (353)
T ss_dssp             ECTTSEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECT-----TTTTTCTTCCEEECTTSCCCEE----------
T ss_pred             CCCCeEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCH-----HHhccCCCCCEEECCCCccCcc----------
Confidence            344555777777777 3454443  477777777777776543     2366777777777777766544          


Q ss_pred             ccccEEEeecCcceecCCccCCCCCCCCEEEecCCccCCccchhhcCCCCCCEEEcccccCcccCC-ccccccCCccEEE
Q 040845          197 HSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIP-DSICLSVELYELE  275 (824)
Q Consensus       197 ~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~~~~L~~L~  275 (824)
                                      .+..|.++++|++|+|++|++++..+..|.++++|++|+|++|+++...+ ..+..+++|++|+
T Consensus        92 ----------------~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~  155 (353)
T 2z80_A           92 ----------------EEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILR  155 (353)
T ss_dssp             ----------------CTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEE
T ss_pred             ----------------CHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEE
Confidence                            34556677788888888888876666667778888888888888874443 4677778888888


Q ss_pred             ccCc-cccccCCccccCCCCCcEEEcCCCCCCCC-CCcccccccccccccccccccCcCCccccccccchhhhccccccc
Q 040845          276 LGGN-KLSGSIPACFSNMTFLKVLSLGSNELTSI-PLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFS  353 (824)
Q Consensus       276 l~~n-~l~~~~~~~~~~l~~L~~L~L~~N~l~~l-p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~  353 (824)
                      +++| .+....+..|.++++|++|++++|.++.+ |..+..+++|++|++++|.+....+..+..+++|+.|++++|+++
T Consensus       156 l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~  235 (353)
T 2z80_A          156 VGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLD  235 (353)
T ss_dssp             EEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCT
T ss_pred             CCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccc
Confidence            8887 46666677778888888888888888766 556777788888888888876444444556788888888888888


Q ss_pred             ccCCCccC---CCCCCCeEEccCccccc----cCCccccccccccEEEccCcccCCCCccc-ccCCcccceeeccCCccc
Q 040845          354 GIIPMEIG---SLKNLENLFLEYNRLEG----SIPDSFGDLISLKSLNLSYNNLSGTIPVS-LEKLSYLKDLNLSFNKLK  425 (824)
Q Consensus       354 ~~~~~~~~---~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~l~~N~l~  425 (824)
                      +..+..+.   ....++.++|++|.+++    .+|..+..+++|+.|+|++|+++ .+|.. +..+++|+.|++++|+++
T Consensus       236 ~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~L~~N~~~  314 (353)
T 2z80_A          236 TFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWD  314 (353)
T ss_dssp             TCCCC------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBC
T ss_pred             cccccccccccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCC-ccCHHHHhcCCCCCEEEeeCCCcc
Confidence            66554433   35677888888887775    36778889999999999999998 66665 589999999999999999


Q ss_pred             CCCCC
Q 040845          426 GEIPR  430 (824)
Q Consensus       426 ~~~p~  430 (824)
                      |.+|.
T Consensus       315 ~~~~~  319 (353)
T 2z80_A          315 CSCPR  319 (353)
T ss_dssp             CCHHH
T ss_pred             CcCCC
Confidence            98874

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.96  E-value=6.6e-32  Score=314.22  Aligned_cols=410  Identities=14%  Similarity=0.084  Sum_probs=275.8

Q ss_pred             ccCCcccccCCCCCcEEEccCCccc---cccccccc------------CCCCCCEEeCCCCcCCcccChhhhCc--CCCc
Q 040845           10 TSTTPKEIDNISNLKVLYLYNNRLQ---GEIIHEIG------------HLHNLGFLDLSQNKLLGTIPAAIFNV--STLK   72 (824)
Q Consensus        10 ~~~~p~~~~~l~~L~~L~L~~n~l~---~~~~~~~~------------~l~~L~~L~Ls~n~l~~~~~~~~~~l--~~L~   72 (824)
                      ...++..+..+++|++|+|+++...   +.+|..++            .+++|++|+|++|.+++..+..+...  .+|+
T Consensus        62 ~~~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~  141 (592)
T 3ogk_B           62 TATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLE  141 (592)
T ss_dssp             GSCHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHHGGGCC
T ss_pred             ccChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHHHHhccccCc
Confidence            3445556678889999999886431   22333333            78899999999998887666666663  4499


Q ss_pred             eeeccCCc-cccccCccccCCCCCccEEEccCCeeeee----cCccccCCCCCceEeccCccccc----cCCccccCCCC
Q 040845           73 AFAVTNNS-LSGCLSSITDVGLPNLEVLYLWGNNFSGT----IPHFIFNASKLSKLALEMNSFSG----FIPSTFGNLRN  143 (824)
Q Consensus        73 ~L~L~~n~-l~~~~~~~~~~~l~~L~~L~L~~n~i~~~----~~~~l~~l~~L~~L~L~~N~i~~----~~~~~~~~l~~  143 (824)
                      +|+|++|. ++..........+++|++|+|++|.+++.    ++..+..+++|++|+|++|.+++    ..+..+.++++
T Consensus       142 ~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~  221 (592)
T 3ogk_B          142 TLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRS  221 (592)
T ss_dssp             EEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTT
T ss_pred             EEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCC
Confidence            99999886 22111000112478999999999988765    34456678899999999998873    33444567899


Q ss_pred             CCEEEccCCcCCCCcCcccccccCCCCCCCcEEECcCCCCCcc-CCccccccccccccEEEeecCcceecCCccCCCCCC
Q 040845          144 LEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGI-LPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTD  222 (824)
Q Consensus       144 L~~L~L~~n~i~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~-~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~  222 (824)
                      |++|++++|.+..++      ..+..+++|++|+++.+..... .+....-..+.+|+.|.+.++.. ..+|..+..+++
T Consensus       222 L~~L~L~~~~~~~l~------~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~-~~l~~~~~~~~~  294 (592)
T 3ogk_B          222 LVSVKVGDFEILELV------GFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGP-NEMPILFPFAAQ  294 (592)
T ss_dssp             CCEEECSSCBGGGGH------HHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCT-TTGGGGGGGGGG
T ss_pred             CcEEeccCccHHHHH------HHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccch-hHHHHHHhhcCC
Confidence            999999998887644      3466778888888875332211 00000111245788888877533 355666777888


Q ss_pred             CCEEEecCCccCCccc-hhhcCCCCCCEEEcccccCcc-cCCccccccCCccEEEccC-----------ccccccC-Ccc
Q 040845          223 LTTIVLGGNKLNGSIP-ITLGKLQKLQDVDLEYNQLEG-SIPDSICLSVELYELELGG-----------NKLSGSI-PAC  288 (824)
Q Consensus       223 L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~~~~L~~L~l~~-----------n~l~~~~-~~~  288 (824)
                      |++|+|++|.+++... ..+..+++|++|+++ +.+.+ ..+..+..+++|++|++++           |.+++.. ...
T Consensus       295 L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l  373 (592)
T 3ogk_B          295 IRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIAL  373 (592)
T ss_dssp             CCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHH
T ss_pred             CcEEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHH
Confidence            8888888888764433 346788888888888 44443 2333445678888888883           5555332 222


Q ss_pred             ccCCCCCcEEEcCCCCCCCC-CCcccc-cccccccccc----cccccCc-----CCccccccccchhhhccccc--cccc
Q 040845          289 FSNMTFLKVLSLGSNELTSI-PLNFWS-LKDILDLNLS----SNCFSGP-----LPLEIRNLKALIEIDFSMNN--FSGI  355 (824)
Q Consensus       289 ~~~l~~L~~L~L~~N~l~~l-p~~~~~-l~~L~~L~l~----~N~l~~~-----~~~~~~~l~~L~~L~l~~N~--l~~~  355 (824)
                      +..+++|++|+++.|.++.. +..+.. +++|+.|+++    .|.+++.     ++..+.++++|+.|++++|.  +++.
T Consensus       374 ~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~  453 (592)
T 3ogk_B          374 AQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDL  453 (592)
T ss_dssp             HHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHH
T ss_pred             HhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHH
Confidence            44578888888888887743 222333 6788888885    6677653     23336678888889887543  5554


Q ss_pred             CCCccC-CCCCCCeEEccCccccc-cCCccccccccccEEEccCcccCCC-CcccccCCcccceeeccCCcccCC
Q 040845          356 IPMEIG-SLKNLENLFLEYNRLEG-SIPDSFGDLISLKSLNLSYNNLSGT-IPVSLEKLSYLKDLNLSFNKLKGE  427 (824)
Q Consensus       356 ~~~~~~-~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~l~~N~l~~~  427 (824)
                      .+..+. .+++|++|+|++|++++ .++..+.++++|++|+|++|.+++. ++..+..+++|+.|++++|+++..
T Consensus       454 ~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~  528 (592)
T 3ogk_B          454 GLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMT  528 (592)
T ss_dssp             HHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTT
T ss_pred             HHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHH
Confidence            444443 47889999999998875 3445567788899999999988644 445556788899999999987754

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.96  E-value=7.4e-28  Score=269.61  Aligned_cols=245  Identities=22%  Similarity=0.242  Sum_probs=143.5

Q ss_pred             CEEeCCCCcCCcccChhhhCcCCCceeeccCCccccccCccccCCCCCccEEEccCCeeeeecCccccCCCCCceEeccC
Q 040845           48 GFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEM  127 (824)
Q Consensus        48 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~L~~  127 (824)
                      ..++.+++.++ .+|..+.  ++|++|+|++|++++++.... .++++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus        57 ~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~-~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~  132 (452)
T 3zyi_A           57 SKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTF-RHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFD  132 (452)
T ss_dssp             CEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTT-TTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             cEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHc-CCCCCCCEEECCCCccCCcChhhccCcccCCEEECCC
Confidence            44555555554 3443332  355555555555554433222 2455566666666666555555666666666666666


Q ss_pred             ccccccCCccccCCCCCCEEEccCCcCCCCcCcccccccCCCCCCCcEEECcCCC-CCccCCccccccccccccEEEeec
Q 040845          128 NSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNP-LDGILPRTYVGNLSHSLKNFYMYN  206 (824)
Q Consensus       128 N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~~L~~L~Ls~n~-l~~~~~~~~~~~l~~~L~~L~l~~  206 (824)
                      |+++...+..|.++++|++|+|++|+++.++.     ..|.++++|++|++++|. +..+                    
T Consensus       133 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-----~~~~~l~~L~~L~l~~~~~l~~i--------------------  187 (452)
T 3zyi_A          133 NWLTVIPSGAFEYLSKLRELWLRNNPIESIPS-----YAFNRVPSLMRLDLGELKKLEYI--------------------  187 (452)
T ss_dssp             SCCSBCCTTTSSSCTTCCEEECCSCCCCEECT-----TTTTTCTTCCEEECCCCTTCCEE--------------------
T ss_pred             CcCCccChhhhcccCCCCEEECCCCCcceeCH-----hHHhcCCcccEEeCCCCCCcccc--------------------
Confidence            66665555556666666666666666655442     235566666666666532 2211                    


Q ss_pred             CcceecCCccCCCCCCCCEEEecCCccCCccchhhcCCCCCCEEEcccccCcccCCccccccCCccEEEccCccccccCC
Q 040845          207 CNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIP  286 (824)
Q Consensus       207 n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~  286 (824)
                            .+..|.++++|+.|+|++|++++. | .+..+++|++|+|++|++++..|..|..+++|+.|++++|++++..+
T Consensus       188 ------~~~~~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~  259 (452)
T 3zyi_A          188 ------SEGAFEGLFNLKYLNLGMCNIKDM-P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIER  259 (452)
T ss_dssp             ------CTTTTTTCTTCCEEECTTSCCSSC-C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECT
T ss_pred             ------ChhhccCCCCCCEEECCCCccccc-c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECH
Confidence                  122345556666666666666532 2 35566666666666666666666666666666666666666666666


Q ss_pred             ccccCCCCCcEEEcCCCCCCCCCCc-cccccccccccccccccc
Q 040845          287 ACFSNMTFLKVLSLGSNELTSIPLN-FWSLKDILDLNLSSNCFS  329 (824)
Q Consensus       287 ~~~~~l~~L~~L~L~~N~l~~lp~~-~~~l~~L~~L~l~~N~l~  329 (824)
                      ..|.++++|+.|+|++|+|+.+|.. +..+++|+.|+|++|.+.
T Consensus       260 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~  303 (452)
T 3zyi_A          260 NAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWN  303 (452)
T ss_dssp             TTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEE
T ss_pred             HHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcC
Confidence            6677777777777777777766654 445677777777777765

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.96  E-value=1.2e-28  Score=258.32  Aligned_cols=233  Identities=21%  Similarity=0.240  Sum_probs=161.7

Q ss_pred             ccccEEEeecCcceecCCccCCCCCCCCEEEecCCccCCccchhhcCCCCCCEEEccccc-CcccCCccccccCCccEEE
Q 040845          197 HSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQ-LEGSIPDSICLSVELYELE  275 (824)
Q Consensus       197 ~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~~~~L~~L~  275 (824)
                      .++++|++++|.+++..+..|..+++|++|+|++|.+++..+..|..+++|++|++++|. ++...+..+..+++|++|+
T Consensus        32 ~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~  111 (285)
T 1ozn_A           32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH  111 (285)
T ss_dssp             TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred             CCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEE
Confidence            345555555555555555667778888888888888887777788888888888888886 7766677777778888888


Q ss_pred             ccCccccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccccccccccccccccccCcCCccccccccchhhhcccccccc
Q 040845          276 LGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLN-FWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSG  354 (824)
Q Consensus       276 l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~-~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~  354 (824)
                      +++|++++..+..|.++++|++|++++|+++.++.. +..+++|+.|++++|.+++..+..|.++++|+.|++++|++++
T Consensus       112 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~  191 (285)
T 1ozn_A          112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH  191 (285)
T ss_dssp             CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE
T ss_pred             CCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccc
Confidence            888888777777777888888888888887777654 5566777777777777765555556667777777777777776


Q ss_pred             cCCCccCCCCCCCeEEccCccccccCCccccccccccEEEccCcccCCCCcccccCCcccceeeccCCcccCCCCC
Q 040845          355 IIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIPR  430 (824)
Q Consensus       355 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~  430 (824)
                      ..|..|..+++|+.|++++|++++..+..+..+++|+.|++++|++....+. ..-...++.+..+.|.+.|..|.
T Consensus       192 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~-~~~~~~l~~~~~~~~~~~c~~p~  266 (285)
T 1ozn_A          192 VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQ  266 (285)
T ss_dssp             ECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG-HHHHHHHHHCCSEECCCBEEESG
T ss_pred             cCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCc-HHHHHHHHhcccccCccccCCch
Confidence            6666777777777777777777755555566777777777777776633221 12223455556666666666654

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.96  E-value=7.3e-28  Score=268.65  Aligned_cols=246  Identities=22%  Similarity=0.232  Sum_probs=154.6

Q ss_pred             CCEEeCCCCcCCcccChhhhCcCCCceeeccCCccccccCccccCCCCCccEEEccCCeeeeecCccccCCCCCceEecc
Q 040845           47 LGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALE  126 (824)
Q Consensus        47 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~L~  126 (824)
                      ...++.+++.++ .+|..+.  ++++.|+|++|+++.++.... .++++|++|+|++|+|++..+..|.++++|++|+|+
T Consensus        45 ~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~-~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~  120 (440)
T 3zyj_A           45 FSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSF-KHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELF  120 (440)
T ss_dssp             SCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTT-SSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECC
T ss_pred             CCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHh-hCCCCCCEEECCCCcCCccChhhccCCccCCEEECC
Confidence            445555555555 4444442  455555555555555443322 245666666666666665555666666666666666


Q ss_pred             CccccccCCccccCCCCCCEEEccCCcCCCCcCcccccccCCCCCCCcEEECcCCC-CCccCCccccccccccccEEEee
Q 040845          127 MNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNP-LDGILPRTYVGNLSHSLKNFYMY  205 (824)
Q Consensus       127 ~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~~L~~L~Ls~n~-l~~~~~~~~~~~l~~~L~~L~l~  205 (824)
                      +|+++.+.+..|.++++|++|+|++|.|+.++.     ..|..+++|++|+|++|. +..                    
T Consensus       121 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~-----~~~~~l~~L~~L~l~~~~~l~~--------------------  175 (440)
T 3zyj_A          121 DNRLTTIPNGAFVYLSKLKELWLRNNPIESIPS-----YAFNRIPSLRRLDLGELKRLSY--------------------  175 (440)
T ss_dssp             SSCCSSCCTTTSCSCSSCCEEECCSCCCCEECT-----TTTTTCTTCCEEECCCCTTCCE--------------------
T ss_pred             CCcCCeeCHhHhhccccCceeeCCCCcccccCH-----HHhhhCcccCEeCCCCCCCcce--------------------
Confidence            666665555566666666666666666665543     235666666766666633 221                    


Q ss_pred             cCcceecCCccCCCCCCCCEEEecCCccCCccchhhcCCCCCCEEEcccccCcccCCccccccCCccEEEccCccccccC
Q 040845          206 NCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSI  285 (824)
Q Consensus       206 ~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~  285 (824)
                            ..+..|.++++|+.|+|++|+++. +| .+..+++|++|+|++|++++..|..|..+++|+.|++++|++++..
T Consensus       176 ------i~~~~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~  247 (440)
T 3zyj_A          176 ------ISEGAFEGLSNLRYLNLAMCNLRE-IP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIE  247 (440)
T ss_dssp             ------ECTTTTTTCSSCCEEECTTSCCSS-CC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEEC
T ss_pred             ------eCcchhhcccccCeecCCCCcCcc-cc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEC
Confidence                  122345556666666666666663 33 3566667777777777777666667777777777777777777777


Q ss_pred             CccccCCCCCcEEEcCCCCCCCCCCc-cccccccccccccccccc
Q 040845          286 PACFSNMTFLKVLSLGSNELTSIPLN-FWSLKDILDLNLSSNCFS  329 (824)
Q Consensus       286 ~~~~~~l~~L~~L~L~~N~l~~lp~~-~~~l~~L~~L~l~~N~l~  329 (824)
                      +..|.++++|+.|+|++|+|+.+|.. +..+++|+.|+|++|.+.
T Consensus       248 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~  292 (440)
T 3zyj_A          248 RNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN  292 (440)
T ss_dssp             TTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEE
T ss_pred             hhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCcc
Confidence            77777777777777777777777655 455777777777877776

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.96  E-value=3.6e-28  Score=254.64  Aligned_cols=254  Identities=21%  Similarity=0.199  Sum_probs=134.3

Q ss_pred             ceeeccCCccccccCccccCCCCCccEEEccCCeeeeecCccccCCCCCceEeccCccccccCCccccCCCCCCEEEccC
Q 040845           72 KAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYD  151 (824)
Q Consensus        72 ~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~  151 (824)
                      ++++++++.++.+|...    .++|++|+|++|++++..+..|..+++|++|+|++|.+++..+..|.++++|++|++++
T Consensus        14 ~~~~c~~~~l~~ip~~~----~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~   89 (285)
T 1ozn_A           14 VTTSCPQQGLQAVPVGI----PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD   89 (285)
T ss_dssp             CEEECCSSCCSSCCTTC----CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             eEEEcCcCCcccCCcCC----CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCC
Confidence            34444444444444322    24566666666666655555566666666666666666655566666666666666666


Q ss_pred             Cc-CCCCcCcccccccCCCCCCCcEEECcCCCCCccCCccccccccccccEEEeecCcceecCCccCCCCCCCCEEEecC
Q 040845          152 NN-LTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGG  230 (824)
Q Consensus       152 n~-i~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~  230 (824)
                      |. ++.++.     ..+..+++|++|++++|.+.++.+                          ..+.++++|++|++++
T Consensus        90 n~~l~~~~~-----~~~~~l~~L~~L~l~~n~l~~~~~--------------------------~~~~~l~~L~~L~l~~  138 (285)
T 1ozn_A           90 NAQLRSVDP-----ATFHGLGRLHTLHLDRCGLQELGP--------------------------GLFRGLAALQYLYLQD  138 (285)
T ss_dssp             CTTCCCCCT-----TTTTTCTTCCEEECTTSCCCCCCT--------------------------TTTTTCTTCCEEECCS
T ss_pred             CCCccccCH-----HHhcCCcCCCEEECCCCcCCEECH--------------------------hHhhCCcCCCEEECCC
Confidence            65 554432     235556666666666665554322                          2334445555555555


Q ss_pred             CccCCccchhhcCCCCCCEEEcccccCcccCCccccccCCccEEEccCccccccCCccccCCCCCcEEEcCCCCCCCCCC
Q 040845          231 NKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPL  310 (824)
Q Consensus       231 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~  310 (824)
                      |++++..+..|..+++|++|+|++|++++..+..+..+++|+.|++++|++++..|..|..+++|+.|++++|.++.+|.
T Consensus       139 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~  218 (285)
T 1ozn_A          139 NALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPT  218 (285)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCH
T ss_pred             CcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCH
Confidence            55554444445555555555555555554444445555555555555555555555555555555555555555555553


Q ss_pred             c-ccccccccccccccccccCcCCccccccccchhhhcccccccccCCCccC
Q 040845          311 N-FWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIG  361 (824)
Q Consensus       311 ~-~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~  361 (824)
                      . +..+++|+.|++++|++....+. ..-...++.+..+.+.+....|..+.
T Consensus       219 ~~~~~l~~L~~L~l~~N~~~c~~~~-~~~~~~l~~~~~~~~~~~c~~p~~l~  269 (285)
T 1ozn_A          219 EALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQRLA  269 (285)
T ss_dssp             HHHTTCTTCCEEECCSSCEECSGGG-HHHHHHHHHCCSEECCCBEEESGGGT
T ss_pred             HHcccCcccCEEeccCCCccCCCCc-HHHHHHHHhcccccCccccCCchHhC
Confidence            3 44555555555555555532211 11223455555566666555555543

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.96  E-value=1.4e-28  Score=262.36  Aligned_cols=223  Identities=19%  Similarity=0.229  Sum_probs=174.4

Q ss_pred             ccEEEeecCcceecCCccCCCCCCCCEEEecCCccCCccchhhcCCCCCCEEEcccccCcccCCccccccCCccEEEccC
Q 040845          199 LKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGG  278 (824)
Q Consensus       199 L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~  278 (824)
                      ++.|++++|.++ .+|..+.++++|++|+|++|.++ .+|..|..+++|++|+|++|+++ .+|..+..+++|++|++++
T Consensus        83 l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~  159 (328)
T 4fcg_A           83 RVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRA  159 (328)
T ss_dssp             CCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEE
T ss_pred             eeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCC
Confidence            344444444443 34444555666666666666666 55666666666666666666666 5566666666666666666


Q ss_pred             ccccccCCcccc---------CCCCCcEEEcCCCCCCCCCCcccccccccccccccccccCcCCccccccccchhhhccc
Q 040845          279 NKLSGSIPACFS---------NMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSM  349 (824)
Q Consensus       279 n~l~~~~~~~~~---------~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~  349 (824)
                      |.+.+..|..+.         ++++|++|+|++|+++.+|..+..+++|+.|++++|.+++ +|..+..+++|+.|++++
T Consensus       160 n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~  238 (328)
T 4fcg_A          160 CPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRG  238 (328)
T ss_dssp             ETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCCCCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTT
T ss_pred             CCCccccChhHhhccchhhhccCCCCCEEECcCCCcCcchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcC
Confidence            665555555544         4889999999999999999888889999999999999984 666789999999999999


Q ss_pred             ccccccCCCccCCCCCCCeEEccCccccccCCccccccccccEEEccCcccCCCCcccccCCcccceeeccCCccc
Q 040845          350 NNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLK  425 (824)
Q Consensus       350 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~  425 (824)
                      |++.+.+|..|+.+++|+.|+|++|.+.+.+|..+..+++|+.|+|++|++.+.+|..+..+++|+.+++..|.+.
T Consensus       239 n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~  314 (328)
T 4fcg_A          239 CTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA  314 (328)
T ss_dssp             CTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred             CcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence            9999899999999999999999999988899999999999999999999999999999999999999999877665

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.96  E-value=8.1e-28  Score=275.80  Aligned_cols=268  Identities=24%  Similarity=0.303  Sum_probs=162.3

Q ss_pred             CCcEEEccCCcccccccccccCCCCCCEEeCCCCcCCcccChhhhCcCCCceeeccCCccccccCccccCCCCCccEEEc
Q 040845           22 NLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYL  101 (824)
Q Consensus        22 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L  101 (824)
                      +++.|++++|.++ .+|..+.  ++|++|+|++|.|+ .+|.   .+++|++|+|++|++++++.     .+++|++|+|
T Consensus        41 ~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~~lp~-----~l~~L~~L~L  108 (622)
T 3g06_A           41 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLTSLPV-----LPPGLLELSI  108 (622)
T ss_dssp             CCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCSCCCC-----CCTTCCEEEE
T ss_pred             CCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCCcCCC-----CCCCCCEEEC
Confidence            4667777777776 5555554  56777777777766 3444   45666666666666665544     3566666666


Q ss_pred             cCCeeeeecCccccCCCCCceEeccCccccccCCccccCCCCCCEEEccCCcCCCCcCcccccccCCCCCCCcEEECcCC
Q 040845          102 WGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNN  181 (824)
Q Consensus       102 ~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~~L~~L~Ls~n  181 (824)
                      ++|++++ +|.   .+++|+.|+|++|+++. +|..   +++|++|+|++|.++.++.         .+++|+.|++++|
T Consensus       109 s~N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~l~~---------~~~~L~~L~L~~N  171 (622)
T 3g06_A          109 FSNPLTH-LPA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLASLPA---------LPSELCKLWAYNN  171 (622)
T ss_dssp             CSCCCCC-CCC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSCCCC---------CCTTCCEEECCSS
T ss_pred             cCCcCCC-CCC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCCcCC---------ccCCCCEEECCCC
Confidence            6666663 233   34566666666666663 2322   3566666666666655431         1245555555555


Q ss_pred             CCCccCCccccccccccccEEEeecCcceecCCccCCCCCCCCEEEecCCccCCccchhhcCCCCCCEEEcccccCcccC
Q 040845          182 PLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSI  261 (824)
Q Consensus       182 ~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~  261 (824)
                      .+.+++                              ..+++|+.|++++|.+++ +|.   .+++|+.|++++|.++ .+
T Consensus       172 ~l~~l~------------------------------~~~~~L~~L~Ls~N~l~~-l~~---~~~~L~~L~L~~N~l~-~l  216 (622)
T 3g06_A          172 QLTSLP------------------------------MLPSGLQELSVSDNQLAS-LPT---LPSELYKLWAYNNRLT-SL  216 (622)
T ss_dssp             CCSCCC------------------------------CCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCS-SC
T ss_pred             CCCCCc------------------------------ccCCCCcEEECCCCCCCC-CCC---ccchhhEEECcCCccc-cc
Confidence            555432                              234556666666666653 222   2356666666666666 23


Q ss_pred             CccccccCCccEEEccCccccccCCccccCCCCCcEEEcCCCCCCCCCCcccccccccccccccccccCcCCcccccccc
Q 040845          262 PDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKA  341 (824)
Q Consensus       262 ~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~  341 (824)
                      |..   +++|+.|++++|+|++ +|   ..+++|+.|+|++|.|+.+|.   .+++|+.|+|++|+++ .+|..+.++++
T Consensus       217 ~~~---~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~  285 (622)
T 3g06_A          217 PAL---PSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLTSLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSS  285 (622)
T ss_dssp             CCC---CTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSCCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCT
T ss_pred             CCC---CCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCCcCCc---ccccCcEEeCCCCCCC-cCCHHHhhccc
Confidence            322   3566777777776664 33   345667777777777777776   4567777777777777 55667777777


Q ss_pred             chhhhcccccccccCCCccCCCC
Q 040845          342 LIEIDFSMNNFSGIIPMEIGSLK  364 (824)
Q Consensus       342 L~~L~l~~N~l~~~~~~~~~~l~  364 (824)
                      |+.|+|++|++++..|..+..++
T Consensus       286 L~~L~L~~N~l~~~~~~~l~~L~  308 (622)
T 3g06_A          286 ETTVNLEGNPLSERTLQALREIT  308 (622)
T ss_dssp             TCEEECCSCCCCHHHHHHHHHHH
T ss_pred             cCEEEecCCCCCCcCHHHHHhcc
Confidence            77777777777776666555444

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.96  E-value=7.1e-28  Score=276.26  Aligned_cols=269  Identities=25%  Similarity=0.360  Sum_probs=211.7

Q ss_pred             CCCCEEeCCCCcCCcccChhhhCcCCCceeeccCCccccccCccccCCCCCccEEEccCCeeeeecCccccCCCCCceEe
Q 040845           45 HNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLA  124 (824)
Q Consensus        45 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~  124 (824)
                      .++++|++++|.++ .+|..+.  ++|++|+|++|+++.++.     .+++|++|+|++|+|++ +|.   .+++|++|+
T Consensus        40 ~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~~lp~-----~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~  107 (622)
T 3g06_A           40 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTSLPA-----LPPELRTLEVSGNQLTS-LPV---LPPGLLELS  107 (622)
T ss_dssp             HCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCSCCCC-----CCTTCCEEEECSCCCSC-CCC---CCTTCCEEE
T ss_pred             CCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCCCCCC-----cCCCCCEEEcCCCcCCc-CCC---CCCCCCEEE
Confidence            36888888888888 6676664  788888888888887665     36788888888888873 444   567788888


Q ss_pred             ccCccccccCCccccCCCCCCEEEccCCcCCCCcCcccccccCCCCCCCcEEECcCCCCCccCCccccccccccccEEEe
Q 040845          125 LEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYM  204 (824)
Q Consensus       125 L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~~L~~L~l  204 (824)
                      |++|+++++ |.   .+++|+.|++++|+|+.++.         .+++|++|+|++|.+.++                  
T Consensus       108 Ls~N~l~~l-~~---~l~~L~~L~L~~N~l~~lp~---------~l~~L~~L~Ls~N~l~~l------------------  156 (622)
T 3g06_A          108 IFSNPLTHL-PA---LPSGLCKLWIFGNQLTSLPV---------LPPGLQELSVSDNQLASL------------------  156 (622)
T ss_dssp             ECSCCCCCC-CC---CCTTCCEEECCSSCCSCCCC---------CCTTCCEEECCSSCCSCC------------------
T ss_pred             CcCCcCCCC-CC---CCCCcCEEECCCCCCCcCCC---------CCCCCCEEECcCCcCCCc------------------
Confidence            888887754 33   56777888888887776542         136777777777776543                  


Q ss_pred             ecCcceecCCccCCCCCCCCEEEecCCccCCccchhhcCCCCCCEEEcccccCcccCCccccccCCccEEEccCcccccc
Q 040845          205 YNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGS  284 (824)
Q Consensus       205 ~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~  284 (824)
                               |.   .+++|+.|++++|.+++ +|   ..+++|+.|++++|.|++ +|..   +++|+.|++++|.++. 
T Consensus       157 ---------~~---~~~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~~-  215 (622)
T 3g06_A          157 ---------PA---LPSELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS-  215 (622)
T ss_dssp             ---------CC---CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSS-
T ss_pred             ---------CC---ccCCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCcccc-
Confidence                     11   23678999999999985 45   457999999999999995 4443   4789999999999995 


Q ss_pred             CCccccCCCCCcEEEcCCCCCCCCCCcccccccccccccccccccCcCCccccccccchhhhcccccccccCCCccCCCC
Q 040845          285 IPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLK  364 (824)
Q Consensus       285 ~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~  364 (824)
                      +|.   .+++|+.|+|++|.|+.+|   ..+++|+.|++++|.++. +|.   .+++|+.|+|++|+|+ .+|..|..++
T Consensus       216 l~~---~~~~L~~L~Ls~N~L~~lp---~~l~~L~~L~Ls~N~L~~-lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~  284 (622)
T 3g06_A          216 LPA---LPSGLKELIVSGNRLTSLP---VLPSELKELMVSGNRLTS-LPM---LPSGLLSLSVYRNQLT-RLPESLIHLS  284 (622)
T ss_dssp             CCC---CCTTCCEEECCSSCCSCCC---CCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCC-SCCGGGGGSC
T ss_pred             cCC---CCCCCCEEEccCCccCcCC---CCCCcCcEEECCCCCCCc-CCc---ccccCcEEeCCCCCCC-cCCHHHhhcc
Confidence            443   3488999999999999999   446899999999999994 554   6789999999999999 6688899999


Q ss_pred             CCCeEEccCccccccCCccccccc
Q 040845          365 NLENLFLEYNRLEGSIPDSFGDLI  388 (824)
Q Consensus       365 ~L~~L~L~~N~l~~~~~~~~~~l~  388 (824)
                      +|+.|+|++|.+++..|..+..++
T Consensus       285 ~L~~L~L~~N~l~~~~~~~l~~L~  308 (622)
T 3g06_A          285 SETTVNLEGNPLSERTLQALREIT  308 (622)
T ss_dssp             TTCEEECCSCCCCHHHHHHHHHHH
T ss_pred             ccCEEEecCCCCCCcCHHHHHhcc
Confidence            999999999999988888777665

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.95  E-value=1.8e-29  Score=268.50  Aligned_cols=266  Identities=19%  Similarity=0.185  Sum_probs=161.7

Q ss_pred             CEEeCCCCcCCcccChhhhCcCCCceeeccCCccccccCccccCCCCCccEEEccCCeeeeecCccccCCCCCceEeccC
Q 040845           48 GFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEM  127 (824)
Q Consensus        48 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~L~~  127 (824)
                      +.++++.+.+.......+..+++|++|+|++|++++.+.... ..+++|++|+|++|++++..+  +..+++|++|+|++
T Consensus        13 ~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~-~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~   89 (317)
T 3o53_A           13 KIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADL-APFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNN   89 (317)
T ss_dssp             EEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHH-TTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCS
T ss_pred             eEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHh-hCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcC
Confidence            345666666654444444445556666666665555432211 235555555555555554332  45555555555555


Q ss_pred             ccccccCCccccCCCCCCEEEccCCcCCCCcCcccccccCCCCCCCcEEECcCCCCCccCCccccccccccccEEEeecC
Q 040845          128 NSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNC  207 (824)
Q Consensus       128 N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n  207 (824)
                      |++++..     ..++|++|++++|+++.++.        ..+++|++|++++|                          
T Consensus        90 n~l~~l~-----~~~~L~~L~l~~n~l~~~~~--------~~~~~L~~L~l~~N--------------------------  130 (317)
T 3o53_A           90 NYVQELL-----VGPSIETLHAANNNISRVSC--------SRGQGKKNIYLANN--------------------------  130 (317)
T ss_dssp             SEEEEEE-----ECTTCCEEECCSSCCSEEEE--------CCCSSCEEEECCSS--------------------------
T ss_pred             Ccccccc-----CCCCcCEEECCCCccCCcCc--------cccCCCCEEECCCC--------------------------
Confidence            5555321     22455555555555544321        11334444444444                          


Q ss_pred             cceecCCccCCCCCCCCEEEecCCccCCccchhhc-CCCCCCEEEcccccCcccCCccccccCCccEEEccCccccccCC
Q 040845          208 NVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLG-KLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIP  286 (824)
Q Consensus       208 ~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~  286 (824)
                      ++++..+..+..+++|++|+|++|.+++..+..+. .+++|++|+|++|.+++. + ....+++|+.|++++|++++..+
T Consensus       131 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~l~~  208 (317)
T 3o53_A          131 KITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAFMGP  208 (317)
T ss_dssp             CCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCEECG
T ss_pred             CCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-c-cccccccCCEEECCCCcCCcchh
Confidence            44444445566677788888888888766666653 677888888888887754 2 22347778888888888875444


Q ss_pred             ccccCCCCCcEEEcCCCCCCCCCCccccccccccccccccccc-CcCCccccccccchhhhcccc-cccccCCC
Q 040845          287 ACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFS-GPLPLEIRNLKALIEIDFSMN-NFSGIIPM  358 (824)
Q Consensus       287 ~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~-~~~~~~~~~l~~L~~L~l~~N-~l~~~~~~  358 (824)
                       .+..+++|+.|+|++|+++.+|..+..+++|+.|++++|++. +..+..+..+++|+.|++++| .+++..|.
T Consensus       209 -~~~~l~~L~~L~L~~N~l~~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~  281 (317)
T 3o53_A          209 -EFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEE  281 (317)
T ss_dssp             -GGGGGTTCSEEECTTSCCCEECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSC
T ss_pred             -hhcccCcccEEECcCCcccchhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchh
Confidence             477778888888888888888777777788888888888877 566677777788888888743 45554443

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.95  E-value=1.7e-29  Score=284.38  Aligned_cols=217  Identities=21%  Similarity=0.227  Sum_probs=133.3

Q ss_pred             CCCCCcEEECcCCCCCccCCccccccccccccEEEeecCcceecCCccCCCCCCCCEEEecCCccCCccchhhcCCCCCC
Q 040845          169 NCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQ  248 (824)
Q Consensus       169 ~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~  248 (824)
                      .+++|++|+|++|.+.++.+                          ..|..+++|+.|+|++|.+++..|  |..+++|+
T Consensus        32 ~~~~L~~L~Ls~n~l~~~~~--------------------------~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~   83 (487)
T 3oja_A           32 SAWNVKELDLSGNPLSQISA--------------------------ADLAPFTKLELLNLSSNVLYETLD--LESLSTLR   83 (487)
T ss_dssp             TGGGCCEEECCSSCCCCCCG--------------------------GGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCC
T ss_pred             cCCCccEEEeeCCcCCCCCH--------------------------HHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCC
Confidence            34467777777777665544                          445556666666666666654443  56666666


Q ss_pred             EEEcccccCcccCCccccccCCccEEEccCccccccCCccccCCCCCcEEEcCCCCCCCC-CCccccccccccccccccc
Q 040845          249 DVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSI-PLNFWSLKDILDLNLSSNC  327 (824)
Q Consensus       249 ~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l-p~~~~~l~~L~~L~l~~N~  327 (824)
                      +|+|++|.|++..     ..++|+.|++++|.+++..+.   .+++|+.|+|++|.++.+ |..+..+++|+.|+|++|.
T Consensus        84 ~L~Ls~N~l~~l~-----~~~~L~~L~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~  155 (487)
T 3oja_A           84 TLDLNNNYVQELL-----VGPSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNE  155 (487)
T ss_dssp             EEECCSSEEEEEE-----ECTTCCEEECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSC
T ss_pred             EEEecCCcCCCCC-----CCCCcCEEECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCC
Confidence            6666666665322     225666666666666654443   235566666666666655 3345556666666666666


Q ss_pred             ccCcCCcccc-ccccchhhhcccccccccCCCccCCCCCCCeEEccCccccccCCccccccccccEEEccCcccCCCCcc
Q 040845          328 FSGPLPLEIR-NLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPV  406 (824)
Q Consensus       328 l~~~~~~~~~-~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~  406 (824)
                      +++..|..+. .+++|+.|+|++|.|++..+  +..+++|+.|+|++|.|++ +|..|..+++|+.|+|++|.|+ .+|.
T Consensus       156 l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~-~lp~  231 (487)
T 3oja_A          156 IDTVNFAELAASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEK  231 (487)
T ss_dssp             CCEEEGGGGGGGTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCC-EECT
T ss_pred             CCCcChHHHhhhCCcccEEecCCCccccccc--cccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCc-ccch
Confidence            6665555554 56667777777777665422  3346677777777777764 3334666677777777777776 4566


Q ss_pred             cccCCcccceeeccCCccc
Q 040845          407 SLEKLSYLKDLNLSFNKLK  425 (824)
Q Consensus       407 ~~~~l~~L~~L~l~~N~l~  425 (824)
                      .+..+++|+.|++++|++.
T Consensus       232 ~l~~l~~L~~L~l~~N~l~  250 (487)
T 3oja_A          232 ALRFSQNLEHFDLRGNGFH  250 (487)
T ss_dssp             TCCCCTTCCEEECTTCCBC
T ss_pred             hhccCCCCCEEEcCCCCCc
Confidence            6666677777777777766

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.95  E-value=6.3e-28  Score=257.38  Aligned_cols=182  Identities=19%  Similarity=0.243  Sum_probs=143.9

Q ss_pred             CCCCCCCEEEecCCccCCccchhhcCCCCCCEEEcccccCcccCCccc---------cccCCccEEEccCccccccCCcc
Q 040845          218 TNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSI---------CLSVELYELELGGNKLSGSIPAC  288 (824)
Q Consensus       218 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~---------~~~~~L~~L~l~~n~l~~~~~~~  288 (824)
                      +++++|++|+|++|.++ .+|..|..+++|++|+|++|.+.+.+|..+         ..+++|+.|++++|+++ .+|..
T Consensus       124 ~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~  201 (328)
T 4fcg_A          124 QQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPAS  201 (328)
T ss_dssp             GGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGG
T ss_pred             hccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHh
Confidence            33444444444444444 334444444555555555544444444443         34788888888888888 66777


Q ss_pred             ccCCCCCcEEEcCCCCCCCCCCcccccccccccccccccccCcCCccccccccchhhhcccccccccCCCccCCCCCCCe
Q 040845          289 FSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLEN  368 (824)
Q Consensus       289 ~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~  368 (824)
                      ++++++|++|+|++|.++.+|..+..+++|+.|++++|.+.+.+|..+.++++|+.|++++|++.+.+|..++.+++|+.
T Consensus       202 l~~l~~L~~L~L~~N~l~~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~  281 (328)
T 4fcg_A          202 IANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEK  281 (328)
T ss_dssp             GGGCTTCCEEEEESSCCCCCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCE
T ss_pred             hcCCCCCCEEEccCCCCCcCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCE
Confidence            88888999999999999988888888999999999999998899999999999999999999999999999999999999


Q ss_pred             EEccCccccccCCccccccccccEEEccCcccC
Q 040845          369 LFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLS  401 (824)
Q Consensus       369 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  401 (824)
                      |+|++|.+.+.+|..++.+++|+.+++..|.+.
T Consensus       282 L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~  314 (328)
T 4fcg_A          282 LDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA  314 (328)
T ss_dssp             EECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred             EeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence            999999999999999999999999999988776

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.95  E-value=6.5e-30  Score=297.41  Aligned_cols=397  Identities=13%  Similarity=0.046  Sum_probs=296.8

Q ss_pred             CCCCCcEEEccCCcccccccccccCC--CCCCEEeCCCCc-CCc-ccChhhhCcCCCceeeccCCccccccCcc---ccC
Q 040845           19 NISNLKVLYLYNNRLQGEIIHEIGHL--HNLGFLDLSQNK-LLG-TIPAAIFNVSTLKAFAVTNNSLSGCLSSI---TDV   91 (824)
Q Consensus        19 ~l~~L~~L~L~~n~l~~~~~~~~~~l--~~L~~L~Ls~n~-l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~---~~~   91 (824)
                      .+++|++|+|++|.+++..+..++.+  .+|++|+|++|. ++. .++.....+++|++|+|++|.+++.....   ...
T Consensus       110 ~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~  189 (592)
T 3ogk_B          110 NLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQ  189 (592)
T ss_dssp             HCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHH
T ss_pred             hCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHh
Confidence            78999999999999998777777764  459999999997 321 13333457899999999999986543211   112


Q ss_pred             CCCCccEEEccCCeee----eecCccccCCCCCceEeccCccccccCCccccCCCCCCEEEccCCcCCCCcCcccccccC
Q 040845           92 GLPNLEVLYLWGNNFS----GTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSL  167 (824)
Q Consensus        92 ~l~~L~~L~L~~n~i~----~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l  167 (824)
                      .+++|++|+|++|.++    +.++..+.++++|++|+|++|.+.+ ++..+.++++|++|+++........  ......+
T Consensus       190 ~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~--~~~~~~l  266 (592)
T 3ogk_B          190 HNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGM--PEKYMNL  266 (592)
T ss_dssp             HCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTC--TTSSSCC
T ss_pred             cCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccch--HHHHHHh
Confidence            5899999999999997    3455667789999999999999996 5688999999999999864332111  1123568


Q ss_pred             CCCCCCcEEECcCCCCCccCCccccccccccccEEEeecCcceecCC-ccCCCCCCCCEEEecCCccCC-ccchhhcCCC
Q 040845          168 SNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIP-EEITNLTDLTTIVLGGNKLNG-SIPITLGKLQ  245 (824)
Q Consensus       168 ~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~-~~l~~l~~L~~L~L~~n~l~~-~~~~~~~~l~  245 (824)
                      ..+++|+.|+++++....++ .. .. ..++|++|++++|.+++... ..+..+++|+.|+++ +.+.. ..+..+..++
T Consensus       267 ~~~~~L~~L~l~~~~~~~l~-~~-~~-~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~~~  342 (592)
T 3ogk_B          267 VFPRKLCRLGLSYMGPNEMP-IL-FP-FAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCK  342 (592)
T ss_dssp             CCCTTCCEEEETTCCTTTGG-GG-GG-GGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHHHHHHCT
T ss_pred             hccccccccCccccchhHHH-HH-Hh-hcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCHHHHHHHHHhCC
Confidence            88999999999987544332 22 22 24589999999999765443 446889999999999 44443 3444557789


Q ss_pred             CCCEEEcc-----------cccCcccCCc-cccccCCccEEEccCccccccCCccccC-CCCCcEEEcC----CCCCCCC
Q 040845          246 KLQDVDLE-----------YNQLEGSIPD-SICLSVELYELELGGNKLSGSIPACFSN-MTFLKVLSLG----SNELTSI  308 (824)
Q Consensus       246 ~L~~L~L~-----------~n~l~~~~~~-~~~~~~~L~~L~l~~n~l~~~~~~~~~~-l~~L~~L~L~----~N~l~~l  308 (824)
                      +|++|+++           .|.+++.... .+..+++|++|+++.|.+++..+..+.. +++|+.|+++    .|.++..
T Consensus       343 ~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~  422 (592)
T 3ogk_B          343 QLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDL  422 (592)
T ss_dssp             TCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSC
T ss_pred             CCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCc
Confidence            99999999           4677644322 2456899999999999998766666665 8999999996    7889886


Q ss_pred             CCc------cccccccccccccccc--ccCcCCcccc-ccccchhhhccccccccc-CCCccCCCCCCCeEEccCccccc
Q 040845          309 PLN------FWSLKDILDLNLSSNC--FSGPLPLEIR-NLKALIEIDFSMNNFSGI-IPMEIGSLKNLENLFLEYNRLEG  378 (824)
Q Consensus       309 p~~------~~~l~~L~~L~l~~N~--l~~~~~~~~~-~l~~L~~L~l~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~  378 (824)
                      |..      +.++++|+.|++++|.  +++..+..+. .+++|+.|++++|++++. ++..+..+++|+.|+|++|.+++
T Consensus       423 p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~  502 (592)
T 3ogk_B          423 PLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSE  502 (592)
T ss_dssp             CCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBH
T ss_pred             hHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcH
Confidence            543      5568999999997543  5544444443 488999999999999863 34456789999999999999875


Q ss_pred             c-CCccccccccccEEEccCcccCCCCcccc-cCCcccceeeccCC
Q 040845          379 S-IPDSFGDLISLKSLNLSYNNLSGTIPVSL-EKLSYLKDLNLSFN  422 (824)
Q Consensus       379 ~-~~~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~l~~N  422 (824)
                      . ++..+..+++|+.|+|++|+++..-...+ ..++.+....+..+
T Consensus       503 ~~~~~~~~~l~~L~~L~ls~n~it~~~~~~l~~~~p~l~~~~~~~~  548 (592)
T 3ogk_B          503 RAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELIPSR  548 (592)
T ss_dssp             HHHHHHHHHCSSCCEEEEESCBCCTTCTTGGGGCCTTEEEEEECCC
T ss_pred             HHHHHHHHhcCccCeeECcCCcCCHHHHHHHHHhCCCcEEEEecCc
Confidence            4 34445678999999999999986533333 45677766666554

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.95  E-value=1e-29  Score=270.35  Aligned_cols=266  Identities=20%  Similarity=0.213  Sum_probs=139.7

Q ss_pred             EEccCCeeeeecCccccCCCCCceEeccCccccccCCccccCCCCCCEEEccCCcCCCCcCcccccccCCCCCCCcEEEC
Q 040845           99 LYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISL  178 (824)
Q Consensus        99 L~L~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~~L~~L~L  178 (824)
                      ++++.+.+...+...+..+++|++|+|++|++++..|..|.++++|++|+|++|.++..+       .+..+++|++|++
T Consensus        15 ~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~-------~~~~l~~L~~L~L   87 (317)
T 3o53_A           15 EKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETL-------DLESLSTLRTLDL   87 (317)
T ss_dssp             ESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEE-------EETTCTTCCEEEC
T ss_pred             eeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcch-------hhhhcCCCCEEEC
Confidence            334444443333333333444555555555555444444555555555555555444321       1344455555555


Q ss_pred             cCCCCCccCCccccccccccccEEEeecCcceecCCccCCCCCCCCEEEecCCccCCccchhhcCCCCCCEEEcccccCc
Q 040845          179 SNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLE  258 (824)
Q Consensus       179 s~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~  258 (824)
                      ++|.+.++.+       .++|++|++++|++++..+.   .+++|++|++++|++++..+..|..+++|++|+|++|.++
T Consensus        88 s~n~l~~l~~-------~~~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  157 (317)
T 3o53_A           88 NNNYVQELLV-------GPSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID  157 (317)
T ss_dssp             CSSEEEEEEE-------CTTCCEEECCSSCCSEEEEC---CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCC
T ss_pred             cCCccccccC-------CCCcCEEECCCCccCCcCcc---ccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCC
Confidence            5554432210       01222222222222222111   1345556666666665554555555555555555555555


Q ss_pred             ccCCccccccCCccEEEccCccccccCCccccCCCCCcEEEcCCCCCCCCCCcccccccccccccccccccCcCCccccc
Q 040845          259 GSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRN  338 (824)
Q Consensus       259 ~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~  338 (824)
                      +..+..+.                       ..+++|++|+|++|.++.+|... .+++|+.|++++|++++ +|..+..
T Consensus       158 ~~~~~~~~-----------------------~~l~~L~~L~L~~N~l~~~~~~~-~l~~L~~L~Ls~N~l~~-l~~~~~~  212 (317)
T 3o53_A          158 TVNFAELA-----------------------ASSDTLEHLNLQYNFIYDVKGQV-VFAKLKTLDLSSNKLAF-MGPEFQS  212 (317)
T ss_dssp             EEEGGGGG-----------------------GGTTTCCEEECTTSCCCEEECCC-CCTTCCEEECCSSCCCE-ECGGGGG
T ss_pred             cccHHHHh-----------------------hccCcCCEEECCCCcCccccccc-ccccCCEEECCCCcCCc-chhhhcc
Confidence            44433332                       23445555555555555443222 24555555555555553 3334666


Q ss_pred             cccchhhhcccccccccCCCccCCCCCCCeEEccCcccc-ccCCccccccccccEEEccC-cccCCCCccc
Q 040845          339 LKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLE-GSIPDSFGDLISLKSLNLSY-NNLSGTIPVS  407 (824)
Q Consensus       339 l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~  407 (824)
                      +++|+.|++++|++++ +|..+..+++|+.|++++|.++ +.+|..+..+++|+.|++++ +.+++..|..
T Consensus       213 l~~L~~L~L~~N~l~~-l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~~  282 (317)
T 3o53_A          213 AAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEE  282 (317)
T ss_dssp             GTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSCC
T ss_pred             cCcccEEECcCCcccc-hhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchhc
Confidence            7777777777777773 5666777888888888888887 66777788888888888884 4566555544

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.95  E-value=2.8e-29  Score=286.18  Aligned_cols=185  Identities=20%  Similarity=0.122  Sum_probs=131.4

Q ss_pred             eeeccceEEEEEE-ECCCcEEEEEEeeccc----------cchhhhHHHHHHHHhcC-CCCcceeEEeeeecCCeeEEEE
Q 040845          535 IGRGGFGSVYKAR-IRDGMEVAVKVFNLQC----------GRAFKSFDVECAMMKSI-RHRNLVKVISSCSNEEFKALVL  602 (824)
Q Consensus       535 lg~G~~g~V~~~~-~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  602 (824)
                      .+.|+.|.+..++ ..-|+.||||++....          ....+.+.+|+++|+++ .|+||++++++++++...||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            4556666655553 3348899999997542          12345688999999999 6999999999999999999999


Q ss_pred             eccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 040845          603 EYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ  682 (824)
Q Consensus       603 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  682 (824)
                      ||++|++|.+++.+.+ .++..   +|+.||++||+|+|   ++|||||||||+|||++++|.+||+|||+|+...... 
T Consensus       322 Eyv~G~~L~d~i~~~~-~l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~-  393 (569)
T 4azs_A          322 EKLPGRLLSDMLAAGE-EIDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC-  393 (569)
T ss_dssp             ECCCSEEHHHHHHTTC-CCCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC----
T ss_pred             ecCCCCcHHHHHHhCC-CCCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC-
Confidence            9999999999998765 56653   58899999999999   9999999999999999999999999999998764332 


Q ss_pred             ccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCC
Q 040845          683 SMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPT  729 (824)
Q Consensus       683 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~  729 (824)
                       ......+||++|||||++.+ .+..++|+||+|++++++.++..++
T Consensus       394 -~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~  438 (569)
T 4azs_A          394 -SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW  438 (569)
T ss_dssp             -CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred             -ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence             22344679999999999865 5677899999999998887765543

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.95  E-value=9.7e-29  Score=262.23  Aligned_cols=202  Identities=22%  Similarity=0.211  Sum_probs=102.7

Q ss_pred             CCCCCceEeccCccccccCCccc--cCCCCCCEEEccCCcCCCCcCcccccccCCCC-----CCCcEEECcCCCCCccCC
Q 040845          116 NASKLSKLALEMNSFSGFIPSTF--GNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNC-----KSLTHISLSNNPLDGILP  188 (824)
Q Consensus       116 ~l~~L~~L~L~~N~i~~~~~~~~--~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l-----~~L~~L~Ls~n~l~~~~~  188 (824)
                      .+++|++|+|++|++++..|..+  .++++|++|+|++|+++..+..      +..+     ++|++|+|++|++.    
T Consensus        93 ~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~------~~~l~~~~~~~L~~L~L~~N~l~----  162 (312)
T 1wwl_A           93 GISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAW------LAELQQWLKPGLKVLSIAQAHSL----  162 (312)
T ss_dssp             TTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSSSSH------HHHHHTTCCTTCCEEEEESCSCC----
T ss_pred             CcCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcchhHH------HHHHHHhhcCCCcEEEeeCCCCc----
Confidence            45555555555555555555544  5555666666666555544211      1111     33333333333332    


Q ss_pred             ccccccccccccEEEeecCcceecCCccCCCCCCCCEEEecCCccCCc--cchhh--cCCCCCCEEEcccccCcc---cC
Q 040845          189 RTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGS--IPITL--GKLQKLQDVDLEYNQLEG---SI  261 (824)
Q Consensus       189 ~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~--~~~~~--~~l~~L~~L~L~~n~l~~---~~  261 (824)
                                            +..+..|+.+++|++|+|++|++.+.  .+..+  ..+++|++|+|++|++++   ..
T Consensus       163 ----------------------~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  220 (312)
T 1wwl_A          163 ----------------------NFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVC  220 (312)
T ss_dssp             ----------------------CCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHH
T ss_pred             ----------------------cchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHH
Confidence                                  22334445555555555555555432  12222  555666666666666552   11


Q ss_pred             CccccccCCccEEEccCccccccCC-ccccCCCCCcEEEcCCCCCCCCCCcccccccccccccccccccCcCCccccccc
Q 040845          262 PDSICLSVELYELELGGNKLSGSIP-ACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLK  340 (824)
Q Consensus       262 ~~~~~~~~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~  340 (824)
                      ...+..+++|+.|++++|++++..| ..+..+++|++|+|++|+|+.+|..+.  ++|+.|++++|++++. |. +..++
T Consensus       221 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~  296 (312)
T 1wwl_A          221 SALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELP  296 (312)
T ss_dssp             HHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCSSCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSC
T ss_pred             HHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccChhhhhcc--CCceEEECCCCCCCCC-hh-HhhCC
Confidence            1223344566666666666655443 345556777777777777777665544  5555555555555533 32 44444


Q ss_pred             cchhhhccccccc
Q 040845          341 ALIEIDFSMNNFS  353 (824)
Q Consensus       341 ~L~~L~l~~N~l~  353 (824)
                      +|+.|++++|+++
T Consensus       297 ~L~~L~L~~N~l~  309 (312)
T 1wwl_A          297 QVGNLSLKGNPFL  309 (312)
T ss_dssp             EEEEEECTTCTTT
T ss_pred             CCCEEeccCCCCC
Confidence            4444444444444

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.95  E-value=5.4e-29  Score=264.18  Aligned_cols=202  Identities=18%  Similarity=0.186  Sum_probs=140.2

Q ss_pred             CCCCCCEEEecCCccCCccchhh--cCCCCCCEEEcccccCcccCCcccccc-----CCccEEEccCccccccCCccccC
Q 040845          219 NLTDLTTIVLGGNKLNGSIPITL--GKLQKLQDVDLEYNQLEGSIPDSICLS-----VELYELELGGNKLSGSIPACFSN  291 (824)
Q Consensus       219 ~l~~L~~L~L~~n~l~~~~~~~~--~~l~~L~~L~L~~n~l~~~~~~~~~~~-----~~L~~L~l~~n~l~~~~~~~~~~  291 (824)
                      ++++|++|+|++|++++..|..+  ..+++|++|+|++|++++. |..+..+     ++|++|++++|++.+..+..|++
T Consensus        93 ~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~  171 (312)
T 1wwl_A           93 GISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRV  171 (312)
T ss_dssp             TTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCC
T ss_pred             CcCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhcc
Confidence            45666666666666665555544  5666666666666666644 5555554     66666666666666666666666


Q ss_pred             CCCCcEEEcCCCCCCC---CCCcc--cccccccccccccccccC---cCCccccccccchhhhcccccccccCC-CccCC
Q 040845          292 MTFLKVLSLGSNELTS---IPLNF--WSLKDILDLNLSSNCFSG---PLPLEIRNLKALIEIDFSMNNFSGIIP-MEIGS  362 (824)
Q Consensus       292 l~~L~~L~L~~N~l~~---lp~~~--~~l~~L~~L~l~~N~l~~---~~~~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~  362 (824)
                      +++|++|++++|++..   +|..+  ..+++|++|++++|.+++   .....+.++++|+.|++++|++++..| ..+..
T Consensus       172 l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~  251 (312)
T 1wwl_A          172 FPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDW  251 (312)
T ss_dssp             CSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCC
T ss_pred             CCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhh
Confidence            6666666666666543   12222  556666777777776662   122334567888888888888887664 45667


Q ss_pred             CCCCCeEEccCccccccCCccccccccccEEEccCcccCCCCcccccCCcccceeeccCCcccC
Q 040845          363 LKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKG  426 (824)
Q Consensus       363 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~  426 (824)
                      +++|+.|+|++|+|+ .+|..+.  ++|+.|+|++|+|++. |. +..+++|+.|++++|++++
T Consensus       252 l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~  310 (312)
T 1wwl_A          252 PSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD  310 (312)
T ss_dssp             CTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred             cCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence            889999999999998 6777666  8899999999999854 66 8899999999999999875

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.94  E-value=5e-27  Score=264.15  Aligned_cols=235  Identities=20%  Similarity=0.190  Sum_probs=139.6

Q ss_pred             CCccEEEccCCeeeeecCccccCCCCCceEeccCccccccCCccccCCCCCCEEEccCCcCCCCcCcccccccCCCCCCC
Q 040845           94 PNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSL  173 (824)
Q Consensus        94 ~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~~L  173 (824)
                      ++|++|+|++|.+++..|..|..+++|++|+|++|.+++..|  |.++++|++|+|++|.|+.++          ..++|
T Consensus        34 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~----------~~~~L  101 (487)
T 3oja_A           34 WNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL----------VGPSI  101 (487)
T ss_dssp             GGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEE----------ECTTC
T ss_pred             CCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCC----------CCCCc
Confidence            355555555555555555555556666666666666554433  555666666666666555432          12556


Q ss_pred             cEEECcCCCCCccCCccccccccccccEEEeecCcceecCCccCCCCCCCCEEEecCCccCCccchhhc-CCCCCCEEEc
Q 040845          174 THISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLG-KLQKLQDVDL  252 (824)
Q Consensus       174 ~~L~Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L  252 (824)
                      ++|++++|.+.++.+..     .++|+.|++++|.+++..|..++.+++|+.|+|++|.+++..|..|. .+++|++|+|
T Consensus       102 ~~L~L~~N~l~~~~~~~-----l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~L  176 (487)
T 3oja_A          102 ETLHAANNNISRVSCSR-----GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL  176 (487)
T ss_dssp             CEEECCSSCCCCEEECC-----CSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEEC
T ss_pred             CEEECcCCcCCCCCccc-----cCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEec
Confidence            66666666665543322     12455555555555555555566667777777777777766666665 5677777777


Q ss_pred             ccccCcccCCccccccCCccEEEccCccccccCCccccCCCCCcEEEcCCCCCCCCCCccccccccccccccccccc-Cc
Q 040845          253 EYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFS-GP  331 (824)
Q Consensus       253 ~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~-~~  331 (824)
                      ++|.|++..  ....+++|+.|+|++|++++.++. +..+++|+.|+|++|.|+.+|..+..+++|+.|++++|.+. +.
T Consensus       177 s~N~l~~~~--~~~~l~~L~~L~Ls~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~lp~~l~~l~~L~~L~l~~N~l~c~~  253 (487)
T 3oja_A          177 QYNFIYDVK--GQVVFAKLKTLDLSSNKLAFMGPE-FQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCGT  253 (487)
T ss_dssp             TTSCCCEEE--CCCCCTTCCEEECCSSCCCEECGG-GGGGTTCSEEECTTSCCCEECTTCCCCTTCCEEECTTCCBCHHH
T ss_pred             CCCcccccc--ccccCCCCCEEECCCCCCCCCCHh-HcCCCCccEEEecCCcCcccchhhccCCCCCEEEcCCCCCcCcc
Confidence            777776442  223466667777777766654433 66666777777777777766666666666666666666665 34


Q ss_pred             CCccccccccchhhhcc
Q 040845          332 LPLEIRNLKALIEIDFS  348 (824)
Q Consensus       332 ~~~~~~~l~~L~~L~l~  348 (824)
                      +|..+..++.|+.|+++
T Consensus       254 ~~~~~~~l~~L~~l~~~  270 (487)
T 3oja_A          254 LRDFFSKNQRVQTVAKQ  270 (487)
T ss_dssp             HHHHHTTCHHHHHHHHH
T ss_pred             hHHHHHhCCCCcEEecc
Confidence            45555556666666554

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.93  E-value=7.7e-26  Score=235.66  Aligned_cols=227  Identities=22%  Similarity=0.217  Sum_probs=135.9

Q ss_pred             EEECcCCCCCccCCccccccccccccEEEeecCcceecCCccCCCCCCCCEEEecCCccCCccchhhcCCCCCCEEEccc
Q 040845          175 HISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEY  254 (824)
Q Consensus       175 ~L~Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~  254 (824)
                      .++.++..+..++.     .++.++++|++++|++++..+..|.++++|++|++++|.+++..+..|.++++|++|+|++
T Consensus        11 ~~~c~~~~l~~ip~-----~l~~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~   85 (276)
T 2z62_A           11 TYQCMELNFYKIPD-----NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTG   85 (276)
T ss_dssp             EEECTTSCCSSCCS-----SSCTTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTT
T ss_pred             eEEecCCCccccCC-----CCCCCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCC
Confidence            45555555554432     1234455555555555544444555555555555555555544444455555555555555


Q ss_pred             ccCcccCCccccccCCccEEEccCccccccCCccccCCCCCcEEEcCCCCCCCCCC-cccccccccccccccccccCc-C
Q 040845          255 NQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPL-NFWSLKDILDLNLSSNCFSGP-L  332 (824)
Q Consensus       255 n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~-~~~~l~~L~~L~l~~N~l~~~-~  332 (824)
                      |.+++                        ..+..|.++++|++|++++|.++.++. .+..+++|++|++++|.+++. +
T Consensus        86 n~l~~------------------------~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l  141 (276)
T 2z62_A           86 NPIQS------------------------LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKL  141 (276)
T ss_dssp             CCCCE------------------------ECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCC
T ss_pred             CccCc------------------------cChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecC
Confidence            55544                        444444555555555555555554443 244455555555555555432 3


Q ss_pred             CccccccccchhhhcccccccccCCCccCCCCCCC----eEEccCccccccCCccccccccccEEEccCcccCCCCcccc
Q 040845          333 PLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLE----NLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSL  408 (824)
Q Consensus       333 ~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~----~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~  408 (824)
                      |..+.++++|+.|++++|++++..+..+..+++|+    .|++++|.+++..+..+. ..+|+.|+|++|++++..+..+
T Consensus       142 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~-~~~L~~L~L~~n~l~~~~~~~~  220 (276)
T 2z62_A          142 PEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK-EIRLKELALDTNQLKSVPDGIF  220 (276)
T ss_dssp             CGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSC-SCCEEEEECCSSCCSCCCTTTT
T ss_pred             chhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCccccC-CCcccEEECCCCceeecCHhHh
Confidence            55666666666777777776666556666656565    788888888865554444 4588899999999886666667


Q ss_pred             cCCcccceeeccCCcccCCCCCC
Q 040845          409 EKLSYLKDLNLSFNKLKGEIPRG  431 (824)
Q Consensus       409 ~~l~~L~~L~l~~N~l~~~~p~~  431 (824)
                      ..+++|+.|++++|+|+|.+|..
T Consensus       221 ~~l~~L~~L~l~~N~~~c~c~~l  243 (276)
T 2z62_A          221 DRLTSLQKIWLHTNPWDCSCPRI  243 (276)
T ss_dssp             TTCCSCCEEECCSSCBCCCTTTT
T ss_pred             cccccccEEEccCCcccccCCch
Confidence            88889999999999998888754

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.93  E-value=1.9e-28  Score=285.17  Aligned_cols=397  Identities=15%  Similarity=0.096  Sum_probs=198.2

Q ss_pred             cccCCCCCcEEEccCCcccccc---c------------ccccCCCCCCEEeCCCCcCCcccChhhh-CcCCCceeeccCC
Q 040845           16 EIDNISNLKVLYLYNNRLQGEI---I------------HEIGHLHNLGFLDLSQNKLLGTIPAAIF-NVSTLKAFAVTNN   79 (824)
Q Consensus        16 ~~~~l~~L~~L~L~~n~l~~~~---~------------~~~~~l~~L~~L~Ls~n~l~~~~~~~~~-~l~~L~~L~L~~n   79 (824)
                      .+..+++|++|+|++|......   |            ..+..+++|++|+|++|.+++..+..+. .+++|++|+|++|
T Consensus        61 ~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~  140 (594)
T 2p1m_B           61 VIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSC  140 (594)
T ss_dssp             HHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESC
T ss_pred             HHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCc
Confidence            4567788888888887532111   1            1134677888888888888766666665 6788888888888


Q ss_pred             -ccccccCccccCCCCCccEEEccCCeeeeecCcccc----CCCCCceEeccCcc--cccc-CCccccCCCCCCEEEccC
Q 040845           80 -SLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIF----NASKLSKLALEMNS--FSGF-IPSTFGNLRNLEWLTLYD  151 (824)
Q Consensus        80 -~l~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~----~l~~L~~L~L~~N~--i~~~-~~~~~~~l~~L~~L~L~~  151 (824)
                       .++..........+++|++|+|++|.+++..+..+.    .+++|++|+|++|.  ++.. ....+.++++|++|++++
T Consensus       141 ~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~  220 (594)
T 2p1m_B          141 EGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNR  220 (594)
T ss_dssp             EEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCT
T ss_pred             CCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCC
Confidence             444311111112478888888888888765444443    56688888888886  2211 111224468888888888


Q ss_pred             C-cCCCCcCcccccccCCCCCCCcEEECcCCCC-------CccCCccccccccccccEE-EeecCcceecCCccCCCCCC
Q 040845          152 N-NLTSSTLDLSFLSSLSNCKSLTHISLSNNPL-------DGILPRTYVGNLSHSLKNF-YMYNCNVSGGIPEEITNLTD  222 (824)
Q Consensus       152 n-~i~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l-------~~~~~~~~~~~l~~~L~~L-~l~~n~l~~~~~~~l~~l~~  222 (824)
                      | .++.      +...+..+++|++|+++.+..       .++.+ .+ .. .++|+.| .+.+... +.++..+..+++
T Consensus       221 ~~~~~~------l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~-~l-~~-~~~L~~Ls~~~~~~~-~~l~~~~~~~~~  290 (594)
T 2p1m_B          221 AVPLEK------LATLLQRAPQLEELGTGGYTAEVRPDVYSGLSV-AL-SG-CKELRCLSGFWDAVP-AYLPAVYSVCSR  290 (594)
T ss_dssp             TSCHHH------HHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHH-HH-HT-CTTCCEEECCBTCCG-GGGGGGHHHHTT
T ss_pred             CCcHHH------HHHHHhcCCcceEcccccccCccchhhHHHHHH-HH-hc-CCCcccccCCcccch-hhHHHHHHhhCC
Confidence            7 2222      123355667777777655431       11110 11 00 1234444 1111111 122222234455


Q ss_pred             CCEEEecCCccCCccc-hhhcCCCCCCEEEcccccCcccC-CccccccCCccEEEccC---------ccccccCCcccc-
Q 040845          223 LTTIVLGGNKLNGSIP-ITLGKLQKLQDVDLEYNQLEGSI-PDSICLSVELYELELGG---------NKLSGSIPACFS-  290 (824)
Q Consensus       223 L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~-~~~~~~~~~L~~L~l~~---------n~l~~~~~~~~~-  290 (824)
                      |++|+|++|.+++... ..+..+++|++|++++| ++... +.....+++|+.|++.+         +.+++.....+. 
T Consensus       291 L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~  369 (594)
T 2p1m_B          291 LTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSM  369 (594)
T ss_dssp             CCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHH
T ss_pred             CCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHH
Confidence            5555555555442211 12334555555555555 32111 11112345555555522         233221111111 


Q ss_pred             CCCCCcEEEcCCCCCCCCCC-ccc-ccccccccccc--c----ccccCcC-----CccccccccchhhhcccccccccCC
Q 040845          291 NMTFLKVLSLGSNELTSIPL-NFW-SLKDILDLNLS--S----NCFSGPL-----PLEIRNLKALIEIDFSMNNFSGIIP  357 (824)
Q Consensus       291 ~l~~L~~L~L~~N~l~~lp~-~~~-~l~~L~~L~l~--~----N~l~~~~-----~~~~~~l~~L~~L~l~~N~l~~~~~  357 (824)
                      ++++|+.|.++.|.++.... .+. .+++|+.|+++  +    |.++...     +..+..+++|+.|++++ .+++..+
T Consensus       370 ~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~  448 (594)
T 2p1m_B          370 GCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVF  448 (594)
T ss_dssp             HCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHH
T ss_pred             hchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHH
Confidence            24555555555555543211 111 24555555555  2    3333111     11134455555666654 4443333


Q ss_pred             CccCC-CCCCCeEEccCccccccCCccc-cccccccEEEccCcccCCCCcc-cccCCcccceeeccCCcc
Q 040845          358 MEIGS-LKNLENLFLEYNRLEGSIPDSF-GDLISLKSLNLSYNNLSGTIPV-SLEKLSYLKDLNLSFNKL  424 (824)
Q Consensus       358 ~~~~~-l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~l~~N~l  424 (824)
                      ..++. +++|+.|+|++|.+++..+..+ ..+++|+.|+|++|++++..+. ....+++|+.|++++|++
T Consensus       449 ~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~  518 (594)
T 2p1m_B          449 EYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSV  518 (594)
T ss_dssp             HHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCC
T ss_pred             HHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCC
Confidence            33333 5556666666665554333333 4455666666666665432222 233455666666666655

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.93  E-value=2.3e-25  Score=232.01  Aligned_cols=226  Identities=24%  Similarity=0.262  Sum_probs=176.6

Q ss_pred             CEEEccCCcCCCCcCcccccccCCCCCCCcEEECcCCCCCccCCccccccccccccEEEeecCcceecCCccCCCCCCCC
Q 040845          145 EWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLT  224 (824)
Q Consensus       145 ~~L~L~~n~i~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~  224 (824)
                      ...+..+..++.+|..      +  .++|++|++++|.+.++.+..|..  .++|++|++++|++++..+..|.++++|+
T Consensus        10 ~~~~c~~~~l~~ip~~------l--~~~l~~L~ls~n~l~~~~~~~~~~--l~~L~~L~l~~n~l~~~~~~~~~~l~~L~   79 (276)
T 2z62_A           10 ITYQCMELNFYKIPDN------L--PFSTKNLDLSFNPLRHLGSYSFFS--FPELQVLDLSRCEIQTIEDGAYQSLSHLS   79 (276)
T ss_dssp             TEEECTTSCCSSCCSS------S--CTTCCEEECTTCCCCEECTTTTTT--CTTCSEEECTTCCCCEECTTTTTTCTTCC
T ss_pred             ceEEecCCCccccCCC------C--CCCccEEECCCCcccccCHhHhcc--ccCCcEEECCCCcCCccCHHHccCCcCCC
Confidence            4567777788777643      2  258999999999999988766644  46899999999999998888999999999


Q ss_pred             EEEecCCccCCccchhhcCCCCCCEEEcccccCcccCCccccccCCccEEEccCcccccc-CCccccCCCCCcEEEcCCC
Q 040845          225 TIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGS-IPACFSNMTFLKVLSLGSN  303 (824)
Q Consensus       225 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~-~~~~~~~l~~L~~L~L~~N  303 (824)
                      +|+|++|.+++..+..|.++++|++|++++|.+.+..+..+..+++|++|++++|++++. .|..|.++++|++|++++|
T Consensus        80 ~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N  159 (276)
T 2z62_A           80 TLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN  159 (276)
T ss_dssp             EEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSS
T ss_pred             EEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCC
Confidence            999999999988888999999999999999999876665677777777777777777653 3666666666666666666


Q ss_pred             CCCCCCCcccccccccccccccccccCcCCccccccccch----hhhcccccccccCCCccCCCCCCCeEEccCcccccc
Q 040845          304 ELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALI----EIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGS  379 (824)
Q Consensus       304 ~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~----~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  379 (824)
                      +++.++                       +..+..+++|+    .|++++|++++..+..+.. .+|+.|+|++|++++.
T Consensus       160 ~l~~~~-----------------------~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~-~~L~~L~L~~n~l~~~  215 (276)
T 2z62_A          160 KIQSIY-----------------------CTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE-IRLKELALDTNQLKSV  215 (276)
T ss_dssp             CCCEEC-----------------------GGGGHHHHTCTTCCEEEECCSSCCCEECTTSSCS-CCEEEEECCSSCCSCC
T ss_pred             CCCcCC-----------------------HHHhhhhhhccccceeeecCCCcccccCccccCC-CcccEEECCCCceeec
Confidence            666554                       33444444444    6788888888666655554 4899999999999976


Q ss_pred             CCccccccccccEEEccCcccCCCC
Q 040845          380 IPDSFGDLISLKSLNLSYNNLSGTI  404 (824)
Q Consensus       380 ~~~~~~~l~~L~~L~L~~N~l~~~~  404 (824)
                      .+..|..+++|+.|+|++|++++..
T Consensus       216 ~~~~~~~l~~L~~L~l~~N~~~c~c  240 (276)
T 2z62_A          216 PDGIFDRLTSLQKIWLHTNPWDCSC  240 (276)
T ss_dssp             CTTTTTTCCSCCEEECCSSCBCCCT
T ss_pred             CHhHhcccccccEEEccCCcccccC
Confidence            6677888999999999999998543

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.93  E-value=2e-25  Score=233.47  Aligned_cols=206  Identities=22%  Similarity=0.191  Sum_probs=176.5

Q ss_pred             CCCCCCCCEEEecCCccCCccchhhcCCCCCCEEEcccccCcccCCccccccCCccEEEccCccccccCCccccCCCCCc
Q 040845          217 ITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLK  296 (824)
Q Consensus       217 l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~  296 (824)
                      +.++++++++++++|.++. +|..+.  ++++.|+|++|.+++..+..|..+++|+.|++++|.+++..+.  +.+++|+
T Consensus         6 ~~~l~~l~~l~~~~~~l~~-ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~   80 (290)
T 1p9a_G            6 VSKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLG   80 (290)
T ss_dssp             EECSTTCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCC
T ss_pred             ccccCCccEEECCCCCCCc-CCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCC
Confidence            4567788888888888884 444443  6788888888888877778888888888888888888865443  7888999


Q ss_pred             EEEcCCCCCCCCCCcccccccccccccccccccCcCCccccccccchhhhcccccccccCCCccCCCCCCCeEEccCccc
Q 040845          297 VLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRL  376 (824)
Q Consensus       297 ~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  376 (824)
                      +|++++|+++.+|..+..+++|+.|++++|++++..+..|.++++|+.|+|++|++++..+..|..+++|+.|+|++|+|
T Consensus        81 ~L~Ls~N~l~~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  160 (290)
T 1p9a_G           81 TLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNL  160 (290)
T ss_dssp             EEECCSSCCSSCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCC
T ss_pred             EEECCCCcCCcCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcC
Confidence            99999999999998888899999999999999987778899999999999999999988888889999999999999999


Q ss_pred             cccCCccccccccccEEEccCcccCCCCcccccCCcccceeeccCCcccCCC
Q 040845          377 EGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEI  428 (824)
Q Consensus       377 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~  428 (824)
                      ++..+..|..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|.|.+
T Consensus       161 ~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~c  211 (290)
T 1p9a_G          161 TELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNC  211 (290)
T ss_dssp             SCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred             CccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCcC
Confidence            9766677888999999999999998 88888888889999999999998765

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.92  E-value=8.3e-25  Score=226.84  Aligned_cols=206  Identities=24%  Similarity=0.302  Sum_probs=150.0

Q ss_pred             CCCEEEecCCccCCccchhhcCCCCCCEEEcccccCcccCCccccccCCccEEEccCccccccCCccccCCCCCcEEEcC
Q 040845          222 DLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLG  301 (824)
Q Consensus       222 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~  301 (824)
                      +.+.+++++++++ .+|..+.  ++|++|+|++|++++..+..|..+++|++|++++|+++...+..|.++++|++|+++
T Consensus        17 ~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~   93 (270)
T 2o6q_A           17 NKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVT   93 (270)
T ss_dssp             TTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECC
T ss_pred             CCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECC
Confidence            3556666666666 3343332  456666666666665555566666666666666666665555666677777777777


Q ss_pred             CCCCCCCCCc-ccccccccccccccccccCcCCccccccccchhhhcccccccccCCCccCCCCCCCeEEccCccccccC
Q 040845          302 SNELTSIPLN-FWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSI  380 (824)
Q Consensus       302 ~N~l~~lp~~-~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  380 (824)
                      +|+++.+|.. +..+++|+.|++++|.+++..+..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|++++..
T Consensus        94 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~  173 (270)
T 2o6q_A           94 DNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVP  173 (270)
T ss_dssp             SSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred             CCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeC
Confidence            7777776654 455777777777777777666777788888888888888888776667888888888888888888766


Q ss_pred             CccccccccccEEEccCcccCCCCcccccCCcccceeeccCCcccCCCCC
Q 040845          381 PDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIPR  430 (824)
Q Consensus       381 ~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~  430 (824)
                      +..|..+++|+.|+|++|++++..+..+..+++|+.|++++|+|.|.++.
T Consensus       174 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~  223 (270)
T 2o6q_A          174 EGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCNG  223 (270)
T ss_dssp             TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSSS
T ss_pred             hhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCcc
Confidence            66788888888888888888866666688888888888888888877653

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.92  E-value=6.4e-25  Score=229.57  Aligned_cols=208  Identities=26%  Similarity=0.261  Sum_probs=187.2

Q ss_pred             hhcCCCCCCEEEcccccCcccCCccccccCCccEEEccCccccccCCccccCCCCCcEEEcCCCCCCCCCCccccccccc
Q 040845          240 TLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDIL  319 (824)
Q Consensus       240 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~  319 (824)
                      .+.++++++++++++|.++ .+|..+.  ++++.|++++|++++..+..|.++++|++|+|++|.|+.++.. ..+++|+
T Consensus         5 ~~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-~~l~~L~   80 (290)
T 1p9a_G            5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD-GTLPVLG   80 (290)
T ss_dssp             EEECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC-SCCTTCC
T ss_pred             cccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC-CCCCcCC
Confidence            3667899999999999999 5565543  6899999999999988899999999999999999999998765 7799999


Q ss_pred             ccccccccccCcCCccccccccchhhhcccccccccCCCccCCCCCCCeEEccCccccccCCccccccccccEEEccCcc
Q 040845          320 DLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNN  399 (824)
Q Consensus       320 ~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  399 (824)
                      .|++++|.++ .+|..+..+++|+.|++++|+|++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+
T Consensus        81 ~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  159 (290)
T 1p9a_G           81 TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN  159 (290)
T ss_dssp             EEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred             EEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCc
Confidence            9999999998 678889999999999999999998888999999999999999999998778889999999999999999


Q ss_pred             cCCCCcccccCCcccceeeccCCcccCCCCCCCCccccccccccCCccccCCC
Q 040845          400 LSGTIPVSLEKLSYLKDLNLSFNKLKGEIPRGGSFGNFSAESFKGNELLCGSP  452 (824)
Q Consensus       400 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~  452 (824)
                      |++..+..+..+++|+.|+|++|+++..++.......+..+.+.+||+.|+|.
T Consensus       160 l~~l~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~~~~L~~l~L~~Np~~C~c~  212 (290)
T 1p9a_G          160 LTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNCE  212 (290)
T ss_dssp             CSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCSGG
T ss_pred             CCccCHHHhcCcCCCCEEECCCCcCCccChhhcccccCCeEEeCCCCccCcCc
Confidence            99666667789999999999999999766665666778888999999999874

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.92  E-value=8e-26  Score=256.31  Aligned_cols=186  Identities=17%  Similarity=0.192  Sum_probs=145.7

Q ss_pred             CCCceeeeccceEEEEEEECCCcEEEEEEeecccc--------chhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEE
Q 040845          530 SENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCG--------RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALV  601 (824)
Q Consensus       530 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  601 (824)
                      ...+.||+|+||.||+|++. ++.+|+|.......        ...+.+.+|++++++++||||+++..++...+..++|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            44678999999999999655 78899998643221        1134578999999999999999666666677778999


Q ss_pred             EeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 040845          602 LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED  681 (824)
Q Consensus       602 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  681 (824)
                      |||+++++|.+++..         +..++.|+++|++|||   +.+|+||||||+||+++.  .+||+|||+|+......
T Consensus       418 mE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~  483 (540)
T 3en9_A          418 MSYINGKLAKDVIED---------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE  483 (540)
T ss_dssp             EECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred             EECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence            999999999999875         5589999999999999   999999999999999998  99999999999764322


Q ss_pred             Ccc-----ccccccccccccCccCcCC--CCCCccchHHHHHHHHHHHHhCCCCCc
Q 040845          682 QSM-----TQTQTLATIGYMAPEYGRE--GQVSTNGDVYSFGIMLMETFTRKKPTD  730 (824)
Q Consensus       682 ~~~-----~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~tg~~p~~  730 (824)
                      ...     ......||+.|||||++..  ..|+..+|+|+.++-..+-+.++.+|.
T Consensus       484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             ccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            111     1234579999999999876  567888999999999998888877663

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.91  E-value=6.3e-25  Score=227.92  Aligned_cols=165  Identities=24%  Similarity=0.251  Sum_probs=80.3

Q ss_pred             CCCCCCEEEecCCccCCccchhhcCCCCCCEEEcccccCcccCCccccccCCccEEEccCccccccCCccccCCCCCcEE
Q 040845          219 NLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVL  298 (824)
Q Consensus       219 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L  298 (824)
                      .+++|++|+|++|.+++..+..|..+++|++|+|++|++++..+..+..+++|++|++++|++++..+..|..+++|+.|
T Consensus        83 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  162 (272)
T 3rfs_A           83 ELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTEL  162 (272)
T ss_dssp             TCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred             CCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEE
Confidence            34444444444444444333344444444444444444443333333333333333333333333333333334444444


Q ss_pred             EcCCCCCCCCCCcccccccccccccccccccCcCCccccccccchhhhcccccccccCCCccCCCCCCCeEEccCccccc
Q 040845          299 SLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEG  378 (824)
Q Consensus       299 ~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  378 (824)
                      ++++|+++                       +..+..+.++++|+.|++++|++++..+..|..+++|+.|++++|.+.+
T Consensus       163 ~l~~n~l~-----------------------~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~  219 (272)
T 3rfs_A          163 DLSYNQLQ-----------------------SLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC  219 (272)
T ss_dssp             ECCSSCCC-----------------------CCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred             ECCCCCcC-----------------------ccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccc
Confidence            44333333                       3333344555555555555566555555556666666666666666553


Q ss_pred             cCCccccccccccEEEccCcccCCCCcccccCCcc
Q 040845          379 SIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSY  413 (824)
Q Consensus       379 ~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~  413 (824)
                      .       +++|+.|++..|.++|.+|..++.++.
T Consensus       220 ~-------~~~l~~l~~~~n~~~g~ip~~~~~~~~  247 (272)
T 3rfs_A          220 T-------CPGIRYLSEWINKHSGVVRNSAGSVAP  247 (272)
T ss_dssp             C-------TTTTHHHHHHHHHTGGGBBCTTSCBCG
T ss_pred             c-------CcHHHHHHHHHHhCCCcccCcccccCC
Confidence            2       345666666666666666666655543

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.91  E-value=9.7e-24  Score=218.77  Aligned_cols=203  Identities=26%  Similarity=0.275  Sum_probs=126.1

Q ss_pred             CCcEEECcCCCCCccCCccccccccccccEEEeecCcceecCCccCCCCCCCCEEEecCCccCCccchhhcCCCCCCEEE
Q 040845          172 SLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVD  251 (824)
Q Consensus       172 ~L~~L~Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  251 (824)
                      +.++++++++.++.++..     ++.++++|++++|++++..+..|.++++|++|+|++|.++...+..|..+++|++|+
T Consensus        17 ~~~~l~~~~~~l~~ip~~-----~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~   91 (270)
T 2o6q_A           17 NKNSVDCSSKKLTAIPSN-----IPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLW   91 (270)
T ss_dssp             TTTEEECTTSCCSSCCSC-----CCTTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEE
T ss_pred             CCCEEEccCCCCCccCCC-----CCCCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEE
Confidence            345555555555543221     123444444444444444445566666677777777666655555566666666666


Q ss_pred             cccccCcccCCccccccCCccEEEccCccccccCCccccCCCCCcEEEcCCCCCCCCCCcccccccccccccccccccCc
Q 040845          252 LEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGP  331 (824)
Q Consensus       252 L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~  331 (824)
                      |++|++++..+..+..+++|++|++++|++++..+..|..+++|++|+|++|.++.+                       
T Consensus        92 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~-----------------------  148 (270)
T 2o6q_A           92 VTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSL-----------------------  148 (270)
T ss_dssp             CCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCC-----------------------
T ss_pred             CCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCcc-----------------------
Confidence            666666654444555555555555555555555555555555555555555555444                       


Q ss_pred             CCccccccccchhhhcccccccccCCCccCCCCCCCeEEccCccccccCCccccccccccEEEccCcccCC
Q 040845          332 LPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSG  402 (824)
Q Consensus       332 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  402 (824)
                      .+..|..+++|+.|++++|++++..+..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|++..
T Consensus       149 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c  219 (270)
T 2o6q_A          149 PKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDC  219 (270)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred             CHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeC
Confidence            44446666777777777777776666677788888888888888886666667888888888888888763

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.91  E-value=1.5e-24  Score=225.09  Aligned_cols=180  Identities=27%  Similarity=0.277  Sum_probs=126.6

Q ss_pred             CCCCCCEEEcccccCcccCCccccccCCccEEEccCccccccCCccccCCCCCcEEEcCCCCCCCCCCc-cccccccccc
Q 040845          243 KLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLN-FWSLKDILDL  321 (824)
Q Consensus       243 ~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~-~~~l~~L~~L  321 (824)
                      .+++|++|++++|.+++.  ..+..+++|++|++++|++++..+..|.++++|++|++++|+++.+|.. +..+++|+.|
T Consensus        61 ~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  138 (272)
T 3rfs_A           61 YLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYL  138 (272)
T ss_dssp             GCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEE
T ss_pred             cCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEE
Confidence            334444444444443321  2333444444444444444444444455555555555555555555443 3445556666


Q ss_pred             ccccccccCcCCccccccccchhhhcccccccccCCCccCCCCCCCeEEccCccccccCCccccccccccEEEccCcccC
Q 040845          322 NLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLS  401 (824)
Q Consensus       322 ~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  401 (824)
                      ++++|.+++..+..+.++++|+.|++++|++++..+..|+.+++|+.|++++|++++..+..|..+++|+.|++++|++.
T Consensus       139 ~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~  218 (272)
T 3rfs_A          139 NLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWD  218 (272)
T ss_dssp             ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred             ECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcc
Confidence            66666666555667788999999999999999888888999999999999999999888888999999999999999998


Q ss_pred             CCCcccccCCcccceeeccCCcccCCCCCC
Q 040845          402 GTIPVSLEKLSYLKDLNLSFNKLKGEIPRG  431 (824)
Q Consensus       402 ~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~  431 (824)
                      +.       ++.|+.+++..|.++|.+|..
T Consensus       219 ~~-------~~~l~~l~~~~n~~~g~ip~~  241 (272)
T 3rfs_A          219 CT-------CPGIRYLSEWINKHSGVVRNS  241 (272)
T ss_dssp             CC-------TTTTHHHHHHHHHTGGGBBCT
T ss_pred             cc-------CcHHHHHHHHHHhCCCcccCc
Confidence            54       457899999999999999873

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.91  E-value=1.7e-27  Score=277.14  Aligned_cols=403  Identities=14%  Similarity=0.090  Sum_probs=285.4

Q ss_pred             ccCCCCCcEEEccCCccccccccccc-CCCCCCEEeCCCC-cCCcc-cChhhhCcCCCceeeccCCccccccCcc---cc
Q 040845           17 IDNISNLKVLYLYNNRLQGEIIHEIG-HLHNLGFLDLSQN-KLLGT-IPAAIFNVSTLKAFAVTNNSLSGCLSSI---TD   90 (824)
Q Consensus        17 ~~~l~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~Ls~n-~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~---~~   90 (824)
                      +..+++|++|+|++|.+++..+..+. .+++|++|+|++| .++.. ++..+.++++|++|+|++|.+++.....   ..
T Consensus       101 ~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~  180 (594)
T 2p1m_B          101 SSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFP  180 (594)
T ss_dssp             HHHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSC
T ss_pred             HHhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHh
Confidence            45789999999999999987777776 7999999999999 56532 4455568999999999999977533211   11


Q ss_pred             CCCCCccEEEccCCe--eee-ecCccccCCCCCceEeccCc-cccccCCccccCCCCCCEEEccCCcCCCCcCc-ccccc
Q 040845           91 VGLPNLEVLYLWGNN--FSG-TIPHFIFNASKLSKLALEMN-SFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLD-LSFLS  165 (824)
Q Consensus        91 ~~l~~L~~L~L~~n~--i~~-~~~~~l~~l~~L~~L~L~~N-~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~-~~~~~  165 (824)
                      ..+++|++|++++|.  ++. .++..+..+++|++|+|++| .+++ ++..+.++++|++|+++.+...-.... ..+..
T Consensus       181 ~~~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~  259 (594)
T 2p1m_B          181 DTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPDVYSGLSV  259 (594)
T ss_dssp             TTCCCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHH
T ss_pred             hcCCcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCccchhhHHHHHH
Confidence            257899999999997  321 12233455799999999999 5554 677888999999999776542100000 01123


Q ss_pred             cCCCCCCCcEE-ECcCCCCCccCCccccccccccccEEEeecCcceecC-CccCCCCCCCCEEEecCCccCCc-cchhhc
Q 040845          166 SLSNCKSLTHI-SLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGI-PEEITNLTDLTTIVLGGNKLNGS-IPITLG  242 (824)
Q Consensus       166 ~l~~l~~L~~L-~Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~-~~~l~~l~~L~~L~L~~n~l~~~-~~~~~~  242 (824)
                      .+.++++|+.| .+.+.....+ +.. .. ..++|++|++++|.+++.. ...+..+++|+.|++++| +... .+....
T Consensus       260 ~l~~~~~L~~Ls~~~~~~~~~l-~~~-~~-~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~  335 (594)
T 2p1m_B          260 ALSGCKELRCLSGFWDAVPAYL-PAV-YS-VCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLAS  335 (594)
T ss_dssp             HHHTCTTCCEEECCBTCCGGGG-GGG-HH-HHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHH
T ss_pred             HHhcCCCcccccCCcccchhhH-HHH-HH-hhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHH
Confidence            56788999998 4443322211 111 11 2468999999999976543 233568899999999998 5422 223334


Q ss_pred             CCCCCCEEEcc---------cccCcccCCcccc-ccCCccEEEccCccccccCCcccc-CCCCCcEEEcC--C----CCC
Q 040845          243 KLQKLQDVDLE---------YNQLEGSIPDSIC-LSVELYELELGGNKLSGSIPACFS-NMTFLKVLSLG--S----NEL  305 (824)
Q Consensus       243 ~l~~L~~L~L~---------~n~l~~~~~~~~~-~~~~L~~L~l~~n~l~~~~~~~~~-~l~~L~~L~L~--~----N~l  305 (824)
                      .+++|++|+++         .+.+++.....+. .+++|+.|.++.|.+++.....+. .+++|+.|+++  +    |.+
T Consensus       336 ~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l  415 (594)
T 2p1m_B          336 TCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYL  415 (594)
T ss_dssp             HCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTT
T ss_pred             hCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccc
Confidence            68999999994         3556544333333 478999999999998866555554 58999999999  4    677


Q ss_pred             CCCCCc------ccccccccccccccccccCcCCccccc-cccchhhhcccccccccCCCcc-CCCCCCCeEEccCcccc
Q 040845          306 TSIPLN------FWSLKDILDLNLSSNCFSGPLPLEIRN-LKALIEIDFSMNNFSGIIPMEI-GSLKNLENLFLEYNRLE  377 (824)
Q Consensus       306 ~~lp~~------~~~l~~L~~L~l~~N~l~~~~~~~~~~-l~~L~~L~l~~N~l~~~~~~~~-~~l~~L~~L~L~~N~l~  377 (824)
                      +..|..      +..+++|+.|++++ .+++..+..+.. +++|+.|+|++|.+++..+..+ ..+++|+.|+|++|.++
T Consensus       416 ~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~  494 (594)
T 2p1m_B          416 TLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFG  494 (594)
T ss_dssp             TCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCC
T ss_pred             cCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCc
Confidence            766542      45678999999987 666555555554 8899999999999976555555 66899999999999997


Q ss_pred             ccCCc-cccccccccEEEccCcccCCCCcccc-cCCcccceeeccCCccc
Q 040845          378 GSIPD-SFGDLISLKSLNLSYNNLSGTIPVSL-EKLSYLKDLNLSFNKLK  425 (824)
Q Consensus       378 ~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~l~~N~l~  425 (824)
                      +.... ....+++|+.|++++|+++..-...+ ..++.|+...+..+.-.
T Consensus       495 ~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~~lp~l~i~~~~~~~~~  544 (594)
T 2p1m_B          495 DKALLANASKLETMRSLWMSSCSVSFGACKLLGQKMPKLNVEVIDERGAP  544 (594)
T ss_dssp             HHHHHHTGGGGGGSSEEEEESSCCBHHHHHHHHHHCTTEEEEEECSSSCG
T ss_pred             HHHHHHHHHhCCCCCEEeeeCCCCCHHHHHHHHHhCCCCEEEEecCCCcc
Confidence            54433 44568999999999999864333334 56788877777766443

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.90  E-value=8.9e-24  Score=214.87  Aligned_cols=197  Identities=17%  Similarity=0.235  Sum_probs=106.9

Q ss_pred             ccccEEEeecCcceecCCccCCCCCCCCEEEecCCc-cCCccchhhcCCCCCCEEEccc-ccCcccCCccccccCCccEE
Q 040845          197 HSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNK-LNGSIPITLGKLQKLQDVDLEY-NQLEGSIPDSICLSVELYEL  274 (824)
Q Consensus       197 ~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~~~~L~~L  274 (824)
                      .++++|++++|++++..+..|.++++|++|++++|+ ++.+.+.+|.++++|++|++++ |+++                
T Consensus        31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~----------------   94 (239)
T 2xwt_C           31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLT----------------   94 (239)
T ss_dssp             TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCC----------------
T ss_pred             CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCee----------------
Confidence            345555555555554444455555555555555554 4444444455555555555554 4554                


Q ss_pred             EccCccccccCCccccCCCCCcEEEcCCCCCCCCCCccccccccc---ccccccc-cccCcCCccccccccch-hhhccc
Q 040845          275 ELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDIL---DLNLSSN-CFSGPLPLEIRNLKALI-EIDFSM  349 (824)
Q Consensus       275 ~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~---~L~l~~N-~l~~~~~~~~~~l~~L~-~L~l~~  349 (824)
                              +..+..|.++++|++|++++|+++.+|. +..+++|+   .|++++| .+++..+..|.++++|+ .|++++
T Consensus        95 --------~i~~~~f~~l~~L~~L~l~~n~l~~lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~  165 (239)
T 2xwt_C           95 --------YIDPDALKELPLLKFLGIFNTGLKMFPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYN  165 (239)
T ss_dssp             --------EECTTSEECCTTCCEEEEEEECCCSCCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCS
T ss_pred             --------EcCHHHhCCCCCCCEEeCCCCCCccccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCC
Confidence                    4444445555555555555555555543 44444444   5555555 55544445566666666 666666


Q ss_pred             ccccccCCCccCCCCCCCeEEccCcc-ccccCCcccccc-ccccEEEccCcccCCCCcccccCCcccceeeccCC
Q 040845          350 NNFSGIIPMEIGSLKNLENLFLEYNR-LEGSIPDSFGDL-ISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFN  422 (824)
Q Consensus       350 N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l-~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N  422 (824)
                      |+++.+.+..|.. ++|+.|++++|+ +++..+..|..+ ++|+.|++++|+++ .+|..  .+++|+.|+++++
T Consensus       166 n~l~~i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~-~l~~~--~~~~L~~L~l~~~  236 (239)
T 2xwt_C          166 NGFTSVQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSK--GLEHLKELIARNT  236 (239)
T ss_dssp             CCCCEECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCC-CCCCT--TCTTCSEEECTTC
T ss_pred             CCCcccCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccc-cCChh--HhccCceeeccCc
Confidence            6666443334444 666666776663 665555566666 66777777777666 34433  4556666666554

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.90  E-value=9.1e-26  Score=247.29  Aligned_cols=189  Identities=21%  Similarity=0.246  Sum_probs=116.2

Q ss_pred             cCCCCCCCCEEEecCCccCC----ccchhhcCCCCCCEEEcccccCcccCCccccc----c---------CCccEEEccC
Q 040845          216 EITNLTDLTTIVLGGNKLNG----SIPITLGKLQKLQDVDLEYNQLEGSIPDSICL----S---------VELYELELGG  278 (824)
Q Consensus       216 ~l~~l~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~----~---------~~L~~L~l~~  278 (824)
                      .+..+++|++|+|++|.+++    .++..+..+++|++|+|++|.++...+..+..    +         ++|++|++++
T Consensus        89 ~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~  168 (386)
T 2ca6_A           89 ALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGR  168 (386)
T ss_dssp             HHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCS
T ss_pred             HHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCC
Confidence            34566777777777777765    35666777777777777777776443333332    2         6777777777


Q ss_pred             cccc-ccCC---ccccCCCCCcEEEcCCCCCCC------CCCccccccccccccccccccc----CcCCccccccccchh
Q 040845          279 NKLS-GSIP---ACFSNMTFLKVLSLGSNELTS------IPLNFWSLKDILDLNLSSNCFS----GPLPLEIRNLKALIE  344 (824)
Q Consensus       279 n~l~-~~~~---~~~~~l~~L~~L~L~~N~l~~------lp~~~~~l~~L~~L~l~~N~l~----~~~~~~~~~l~~L~~  344 (824)
                      |+++ ...+   ..+..+++|++|+|++|+++.      +|..+..+++|+.|+|++|.++    ..+|..+..+++|+.
T Consensus       169 n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~  248 (386)
T 2ca6_A          169 NRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRE  248 (386)
T ss_dssp             SCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCE
T ss_pred             CCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCE
Confidence            7765 2222   345566777777777777762      2334555666666666666664    344555666666666


Q ss_pred             hhccccccccc----CCCcc--CCCCCCCeEEccCccccc----cCCccc-cccccccEEEccCcccCCCC
Q 040845          345 IDFSMNNFSGI----IPMEI--GSLKNLENLFLEYNRLEG----SIPDSF-GDLISLKSLNLSYNNLSGTI  404 (824)
Q Consensus       345 L~l~~N~l~~~----~~~~~--~~l~~L~~L~L~~N~l~~----~~~~~~-~~l~~L~~L~L~~N~l~~~~  404 (824)
                      |+|++|.+++.    ++..+  +.+++|+.|+|++|.+++    .+|..+ ..+++|+.|+|++|++++..
T Consensus       249 L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~  319 (386)
T 2ca6_A          249 LGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEED  319 (386)
T ss_dssp             EECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTS
T ss_pred             EECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcch
Confidence            66666666543    33444  336667777777777665    255555 44667777777777776554

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.90  E-value=4.2e-24  Score=226.35  Aligned_cols=230  Identities=16%  Similarity=0.129  Sum_probs=131.8

Q ss_pred             CCCcEEECcCCCCCccCCccccc-cccccccEEEeecCcceecCCccC--CCCCCCCEEEecCCccCCccchhhcCCCCC
Q 040845          171 KSLTHISLSNNPLDGILPRTYVG-NLSHSLKNFYMYNCNVSGGIPEEI--TNLTDLTTIVLGGNKLNGSIPITLGKLQKL  247 (824)
Q Consensus       171 ~~L~~L~Ls~n~l~~~~~~~~~~-~l~~~L~~L~l~~n~l~~~~~~~l--~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L  247 (824)
                      ..++.|.+.++.+....-..+.. ....+|++|++++|.+.+..|..+  ..+++|++|+|++|.+++..+..       
T Consensus        64 ~~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~-------  136 (310)
T 4glp_A           64 LRVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWL-------  136 (310)
T ss_dssp             CCCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSH-------
T ss_pred             cceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhh-------
Confidence            45677777777664321111100 001235555555555555555544  45555555555555554322200       


Q ss_pred             CEEEcccccCcccCCccccccCCccEEEccCccccccCCccccCCCCCcEEEcCCCCCCC---CCC--cccccccccccc
Q 040845          248 QDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTS---IPL--NFWSLKDILDLN  322 (824)
Q Consensus       248 ~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~---lp~--~~~~l~~L~~L~  322 (824)
                                   ....+..+++|++|++++|++.+..+..|+.+++|++|+|++|++..   ++.  .+..+++|++|+
T Consensus       137 -------------~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~  203 (310)
T 4glp_A          137 -------------AELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLA  203 (310)
T ss_dssp             -------------HHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCB
T ss_pred             -------------HHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEE
Confidence                         00122234455555555555544444555555555555555555432   211  123455566666


Q ss_pred             cccccccCcCCc----cccccccchhhhcccccccccCCCccCCC---CCCCeEEccCccccccCCccccccccccEEEc
Q 040845          323 LSSNCFSGPLPL----EIRNLKALIEIDFSMNNFSGIIPMEIGSL---KNLENLFLEYNRLEGSIPDSFGDLISLKSLNL  395 (824)
Q Consensus       323 l~~N~l~~~~~~----~~~~l~~L~~L~l~~N~l~~~~~~~~~~l---~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  395 (824)
                      |++|.++. ++.    .+.++++|++|+|++|++++..|..+..+   ++|++|+|++|+|+ .+|..+.  ++|+.|+|
T Consensus       204 Ls~N~l~~-l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~L  279 (310)
T 4glp_A          204 LRNTGMET-PTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDL  279 (310)
T ss_dssp             CCSSCCCC-HHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEEC
T ss_pred             CCCCCCCc-hHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEEC
Confidence            66666642 222    24566778888888888877667666665   68888888888888 5666654  68888888


Q ss_pred             cCcccCCCCcccccCCcccceeeccCCcccC
Q 040845          396 SYNNLSGTIPVSLEKLSYLKDLNLSFNKLKG  426 (824)
Q Consensus       396 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~  426 (824)
                      ++|+|++ +|. +..+++|+.|++++|+|+.
T Consensus       280 s~N~l~~-~~~-~~~l~~L~~L~L~~N~l~~  308 (310)
T 4glp_A          280 SSNRLNR-APQ-PDELPEVDNLTLDGNPFLV  308 (310)
T ss_dssp             CSCCCCS-CCC-TTSCCCCSCEECSSTTTSC
T ss_pred             CCCcCCC-Cch-hhhCCCccEEECcCCCCCC
Confidence            8888884 344 5777888888888888864

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.90  E-value=6e-25  Score=238.24  Aligned_cols=260  Identities=19%  Similarity=0.138  Sum_probs=170.7

Q ss_pred             CcccccccccCCcccccCCCCCcEEEccCCccccccc----ccccCCC-CCCEEeCCCCcCCcccChhhhCc-----CCC
Q 040845            2 PSIINNFLTSTTPKEIDNISNLKVLYLYNNRLQGEII----HEIGHLH-NLGFLDLSQNKLLGTIPAAIFNV-----STL   71 (824)
Q Consensus         2 ~~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~----~~~~~l~-~L~~L~Ls~n~l~~~~~~~~~~l-----~~L   71 (824)
                      ..|.+|++++.+|+.+...++|++|+|++|++++..+    ..|.+++ +|++|+|++|.+++..+..+..+     ++|
T Consensus         3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L   82 (362)
T 3goz_A            3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV   82 (362)
T ss_dssp             EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTC
T ss_pred             cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCc
Confidence            3578899999999888888889999999999997766    7788888 89999999999987777777775     889


Q ss_pred             ceeeccCCccccccCccc---cCCC-CCccEEEccCCeeeeecCcccc----C-CCCCceEeccCccccccCCc----cc
Q 040845           72 KAFAVTNNSLSGCLSSIT---DVGL-PNLEVLYLWGNNFSGTIPHFIF----N-ASKLSKLALEMNSFSGFIPS----TF  138 (824)
Q Consensus        72 ~~L~L~~n~l~~~~~~~~---~~~l-~~L~~L~L~~n~i~~~~~~~l~----~-l~~L~~L~L~~N~i~~~~~~----~~  138 (824)
                      ++|+|++|++++......   ...+ ++|++|+|++|++++..+..+.    . .++|++|+|++|++++..+.    .+
T Consensus        83 ~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l  162 (362)
T 3goz_A           83 TSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQIL  162 (362)
T ss_dssp             CEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHH
T ss_pred             cEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHH
Confidence            999999998876543311   1123 6888888888888765554433    3 36888888888888854433    33


Q ss_pred             cCCC-CCCEEEccCCcCCCCcCcccccccCCCC-CCCcEEECcCCCCCccCCccccccccccccEEEeecCcceecCCcc
Q 040845          139 GNLR-NLEWLTLYDNNLTSSTLDLSFLSSLSNC-KSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEE  216 (824)
Q Consensus       139 ~~l~-~L~~L~L~~n~i~~~~~~~~~~~~l~~l-~~L~~L~Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~  216 (824)
                      ..++ +|++|+|++|+++..... .+...+..+ ++|++|+|++|.+.+.....+                      +..
T Consensus       163 ~~~~~~L~~L~Ls~n~l~~~~~~-~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l----------------------~~~  219 (362)
T 3goz_A          163 AAIPANVNSLNLRGNNLASKNCA-ELAKFLASIPASVTSLDLSANLLGLKSYAEL----------------------AYI  219 (362)
T ss_dssp             HTSCTTCCEEECTTSCGGGSCHH-HHHHHHHTSCTTCCEEECTTSCGGGSCHHHH----------------------HHH
T ss_pred             hcCCccccEeeecCCCCchhhHH-HHHHHHHhCCCCCCEEECCCCCCChhHHHHH----------------------HHH
Confidence            4554 888888888888765432 122334455 488888888888765432222                      122


Q ss_pred             CCC-CCCCCEEEecCCccCCccc----hhhcCCCCCCEEEcccccCcccC-------CccccccCCccEEEccCcccccc
Q 040845          217 ITN-LTDLTTIVLGGNKLNGSIP----ITLGKLQKLQDVDLEYNQLEGSI-------PDSICLSVELYELELGGNKLSGS  284 (824)
Q Consensus       217 l~~-l~~L~~L~L~~n~l~~~~~----~~~~~l~~L~~L~L~~n~l~~~~-------~~~~~~~~~L~~L~l~~n~l~~~  284 (824)
                      +.. .++|++|+|++|.+++..+    ..+..+++|++|+|++|.+.+..       +..+..+++|+.|++++|.+...
T Consensus       220 l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~  299 (362)
T 3goz_A          220 FSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPS  299 (362)
T ss_dssp             HHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGG
T ss_pred             HhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCc
Confidence            222 2356666666666554333    22344556666666666533222       22344555666666666666544

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.89  E-value=7.4e-25  Score=237.55  Aligned_cols=59  Identities=22%  Similarity=0.154  Sum_probs=40.0

Q ss_pred             EEccCCcccccccccccCCCCCCEEeCCCCcCCcccC----hhhhCcC-CCceeeccCCccccc
Q 040845           26 LYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIP----AAIFNVS-TLKAFAVTNNSLSGC   84 (824)
Q Consensus        26 L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~----~~~~~l~-~L~~L~L~~n~l~~~   84 (824)
                      +.|++|++++.+|..+...++|++|||++|.+++..+    .++..++ +|++|+|++|++++.
T Consensus         3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~   66 (362)
T 3goz_A            3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFK   66 (362)
T ss_dssp             EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGS
T ss_pred             cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHH
Confidence            5677778877777666666668888888888775555    5565665 666666666666543

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.89  E-value=2.1e-23  Score=220.96  Aligned_cols=233  Identities=16%  Similarity=0.146  Sum_probs=159.6

Q ss_pred             CCCCEEEccCCcCCCCcCcccccccCCCCCCCcEEECcCCCCCccCCccccccccccccEEEeecCcceecCC----ccC
Q 040845          142 RNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIP----EEI  217 (824)
Q Consensus       142 ~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~----~~l  217 (824)
                      ..++.|.+.++.++.....  ....+..+++|++|++++|.+.+..+..+...-..+|++|++++|.+++..+    ..+
T Consensus        64 ~~l~~l~l~~~~~~~~~~~--~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~  141 (310)
T 4glp_A           64 LRVRRLTVGAAQVPAQLLV--GALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQ  141 (310)
T ss_dssp             CCCCEEEECSCCCBHHHHH--HHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHT
T ss_pred             cceeEEEEeCCcCCHHHHH--HHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHh
Confidence            4688899998877542211  0111234567999999999999888877642235689999999999987554    344


Q ss_pred             CCCCCCCEEEecCCccCCccchhhcCCCCCCEEEcccccCcccCCccccccCCccEEEccCccccccCCccccCCCCCcE
Q 040845          218 TNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKV  297 (824)
Q Consensus       218 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~  297 (824)
                      ..+++|++|+|++|++.+..+..|..+++|++|+|++|++.+...                    -..+..+..+++|++
T Consensus       142 ~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--------------------~~~~~~~~~l~~L~~  201 (310)
T 4glp_A          142 WLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERG--------------------LMAALCPHKFPAIQN  201 (310)
T ss_dssp             TBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHH--------------------HHTTSCTTSSCCCCS
T ss_pred             hhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchh--------------------hhHHHhhhcCCCCCE
Confidence            567788888888888877777777777777777777777653100                    001222345566666


Q ss_pred             EEcCCCCCCCCCCc----ccccccccccccccccccCcCCcccccc---ccchhhhcccccccccCCCccCCCCCCCeEE
Q 040845          298 LSLGSNELTSIPLN----FWSLKDILDLNLSSNCFSGPLPLEIRNL---KALIEIDFSMNNFSGIIPMEIGSLKNLENLF  370 (824)
Q Consensus       298 L~L~~N~l~~lp~~----~~~l~~L~~L~l~~N~l~~~~~~~~~~l---~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~  370 (824)
                      |+|++|+++.++..    +..+++|++|+|++|++++..|..+..+   ++|+.|+|++|+|+ .+|..+.  ++|+.|+
T Consensus       202 L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~  278 (310)
T 4glp_A          202 LALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLD  278 (310)
T ss_dssp             CBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEE
T ss_pred             EECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEE
Confidence            66666666655432    2345666677777777766556666555   57888888888887 4565554  7888888


Q ss_pred             ccCccccccCCccccccccccEEEccCcccC
Q 040845          371 LEYNRLEGSIPDSFGDLISLKSLNLSYNNLS  401 (824)
Q Consensus       371 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  401 (824)
                      |++|+|++. |. +..+++|+.|+|++|+|+
T Consensus       279 Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~  307 (310)
T 4glp_A          279 LSSNRLNRA-PQ-PDELPEVDNLTLDGNPFL  307 (310)
T ss_dssp             CCSCCCCSC-CC-TTSCCCCSCEECSSTTTS
T ss_pred             CCCCcCCCC-ch-hhhCCCccEEECcCCCCC
Confidence            888888853 43 677888888888888886

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.89  E-value=7.1e-23  Score=208.17  Aligned_cols=197  Identities=18%  Similarity=0.161  Sum_probs=150.4

Q ss_pred             CCCcEEECcCCCCCccCCccccccccccccEEEeecCc-ceecCCccCCCCCCCCEEEecC-CccCCccchhhcCCCCCC
Q 040845          171 KSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCN-VSGGIPEEITNLTDLTTIVLGG-NKLNGSIPITLGKLQKLQ  248 (824)
Q Consensus       171 ~~L~~L~Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n~-l~~~~~~~l~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~  248 (824)
                      ++|++|++++|.+.++++..|..  .++|++|++++|+ ++...+..|.++++|++|++++ |+++...+..|.++++|+
T Consensus        31 ~~l~~L~l~~n~l~~i~~~~~~~--l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~  108 (239)
T 2xwt_C           31 PSTQTLKLIETHLRTIPSHAFSN--LPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLK  108 (239)
T ss_dssp             TTCCEEEEESCCCSEECTTTTTT--CTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCC
T ss_pred             CcccEEEEeCCcceEECHHHccC--CCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCC
Confidence            48999999999999998877644  5689999999997 8888888999999999999999 999987778999999999


Q ss_pred             EEEcccccCcccCCccccccCCcc---EEEccCc-cccccCCccccCCCCCc-EEEcCCCCCCCCCCccccccccccccc
Q 040845          249 DVDLEYNQLEGSIPDSICLSVELY---ELELGGN-KLSGSIPACFSNMTFLK-VLSLGSNELTSIPLNFWSLKDILDLNL  323 (824)
Q Consensus       249 ~L~L~~n~l~~~~~~~~~~~~~L~---~L~l~~n-~l~~~~~~~~~~l~~L~-~L~L~~N~l~~lp~~~~~l~~L~~L~l  323 (824)
                      +|++++|++++ +|. +..+++|+   .|++++| ++++..+..|.++++|+ .|++++|+++.+|...+..++|     
T Consensus       109 ~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~~~L-----  181 (239)
T 2xwt_C          109 FLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNGTKL-----  181 (239)
T ss_dssp             EEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTTCEE-----
T ss_pred             EEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCCCCC-----
Confidence            99999999985 555 77777777   8888888 88877777888888888 8888888888777543333444     


Q ss_pred             ccccccCcCCccccccccchhhhccccc-ccccCCCccCCC-CCCCeEEccCccccccCCccccccccccEEEccCc
Q 040845          324 SSNCFSGPLPLEIRNLKALIEIDFSMNN-FSGIIPMEIGSL-KNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYN  398 (824)
Q Consensus       324 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~-l~~~~~~~~~~l-~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  398 (824)
                                         +.|++++|+ +++..+..|..+ ++|+.|++++|++++ +|..  .+++|+.|+++++
T Consensus       182 -------------------~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~-l~~~--~~~~L~~L~l~~~  236 (239)
T 2xwt_C          182 -------------------DAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTA-LPSK--GLEHLKELIARNT  236 (239)
T ss_dssp             -------------------EEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCC-CCCT--TCTTCSEEECTTC
T ss_pred             -------------------CEEEcCCCCCcccCCHHHhhccccCCcEEECCCCcccc-CChh--HhccCceeeccCc
Confidence                               445555552 544444555555 666666666666663 3322  4456666666654

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.88  E-value=1.8e-22  Score=213.17  Aligned_cols=194  Identities=22%  Similarity=0.327  Sum_probs=102.7

Q ss_pred             ccCCCCCCEEeCCCCcCCcccChhhhCcCCCceeeccCCccccccCccccCCCCCccEEEccCCeeeeecCccccCCCCC
Q 040845           41 IGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKL  120 (824)
Q Consensus        41 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L  120 (824)
                      ++.+++|++|++++|.+. .++ ++..+++|++|+|++|++++++.   ...+++|++|+|++|++++.  ..+..+++|
T Consensus        37 ~~~l~~L~~L~l~~~~i~-~l~-~~~~l~~L~~L~L~~n~i~~~~~---~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L  109 (308)
T 1h6u_A           37 QADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAP---LKNLTKITELELSGNPLKNV--SAIAGLQSI  109 (308)
T ss_dssp             HHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG---GTTCCSCCEEECCSCCCSCC--GGGTTCTTC
T ss_pred             HHHcCCcCEEEeeCCCcc-Cch-hhhccCCCCEEEccCCcCCCChh---HccCCCCCEEEccCCcCCCc--hhhcCCCCC
Confidence            334555555555555554 222 35555555555555555554443   22355555555555555532  245556666


Q ss_pred             ceEeccCccccccCCccccCCCCCCEEEccCCcCCCCcCcccccccCCCCCCCcEEECcCCCCCccCCcccccccccccc
Q 040845          121 SKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLK  200 (824)
Q Consensus       121 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~~L~  200 (824)
                      ++|+|++|++++. + .+.++++|++|++++|.++.++       .+..+++|++|++++|.+.++.+            
T Consensus       110 ~~L~l~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~~~~-------~l~~l~~L~~L~l~~n~l~~~~~------------  168 (308)
T 1h6u_A          110 KTLDLTSTQITDV-T-PLAGLSNLQVLYLDLNQITNIS-------PLAGLTNLQYLSIGNAQVSDLTP------------  168 (308)
T ss_dssp             CEEECTTSCCCCC-G-GGTTCTTCCEEECCSSCCCCCG-------GGGGCTTCCEEECCSSCCCCCGG------------
T ss_pred             CEEECCCCCCCCc-h-hhcCCCCCCEEECCCCccCcCc-------cccCCCCccEEEccCCcCCCChh------------
Confidence            6666666666543 2 2566666666666666665543       14555666666666665553311            


Q ss_pred             EEEeecCcceecCCccCCCCCCCCEEEecCCccCCccchhhcCCCCCCEEEcccccCcccCCccccccCCccEEEccCcc
Q 040845          201 NFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNK  280 (824)
Q Consensus       201 ~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~  280 (824)
                                      +..+++|+.|++++|.+++..+  +..+++|++|+|++|++++..  .+..+++|+.|++++|.
T Consensus       169 ----------------l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~L~l~~N~  228 (308)
T 1h6u_A          169 ----------------LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTNQT  228 (308)
T ss_dssp             ----------------GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEEEE
T ss_pred             ----------------hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCccc--cccCCCCCCEEEccCCe
Confidence                            3344555555555555553322  455555555555555555332  24555555666666665


Q ss_pred             cc
Q 040845          281 LS  282 (824)
Q Consensus       281 l~  282 (824)
                      ++
T Consensus       229 i~  230 (308)
T 1h6u_A          229 IT  230 (308)
T ss_dssp             EE
T ss_pred             ee
Confidence            55

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.88  E-value=1.7e-22  Score=217.71  Aligned_cols=167  Identities=17%  Similarity=0.170  Sum_probs=85.7

Q ss_pred             ecCCccCCccchhhcCCCCCCEEEcccccCcccCCccccccCCccEEEccC-ccccccCCccccCCC-CCcEEEcCCCCC
Q 040845          228 LGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGG-NKLSGSIPACFSNMT-FLKVLSLGSNEL  305 (824)
Q Consensus       228 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~-n~l~~~~~~~~~~l~-~L~~L~L~~N~l  305 (824)
                      +++|+++.+.|++|..+++|++|++++|+++...+..+....++..|++.+ |++....+..|..+. .++.|+|++|+|
T Consensus        87 ~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i  166 (350)
T 4ay9_X           87 EKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGI  166 (350)
T ss_dssp             EEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCC
T ss_pred             ccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccc
Confidence            334444444444455555555555555555444444444444555555533 345544555555553 466667777777


Q ss_pred             CCCCCccccccccccccccc-ccccCcCCccccccccchhhhcccccccccCCCccCCCCCCCeEEccCccccccCCccc
Q 040845          306 TSIPLNFWSLKDILDLNLSS-NCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSF  384 (824)
Q Consensus       306 ~~lp~~~~~l~~L~~L~l~~-N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~  384 (824)
                      +.+|...+...+|+.|++++ |.++.+.+..|.++++|+.|+|++|+|+...+..|.++++|+.+++  +.++ .+| .+
T Consensus       167 ~~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~~L~~l~~--~~l~-~lP-~l  242 (350)
T 4ay9_X          167 QEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK-KLP-TL  242 (350)
T ss_dssp             CEECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCCEEECTTC--TTCC-CCC-CT
T ss_pred             cCCChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhccchHhhhccC--CCcC-cCC-Cc
Confidence            66666655555666666653 4454433445566666666666666666444333333333322222  2333 344 25


Q ss_pred             cccccccEEEccCc
Q 040845          385 GDLISLKSLNLSYN  398 (824)
Q Consensus       385 ~~l~~L~~L~L~~N  398 (824)
                      ..+++|+.++++++
T Consensus       243 ~~l~~L~~l~l~~~  256 (350)
T 4ay9_X          243 EKLVALMEASLTYP  256 (350)
T ss_dssp             TTCCSCCEEECSCH
T ss_pred             hhCcChhhCcCCCC
Confidence            55566666666544

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.88  E-value=1e-24  Score=238.92  Aligned_cols=194  Identities=18%  Similarity=0.253  Sum_probs=104.2

Q ss_pred             CCCccEEEccCCeeee----ecCccccCCCCCceEeccCccccccCCccccC----C---------CCCCEEEccCCcCC
Q 040845           93 LPNLEVLYLWGNNFSG----TIPHFIFNASKLSKLALEMNSFSGFIPSTFGN----L---------RNLEWLTLYDNNLT  155 (824)
Q Consensus        93 l~~L~~L~L~~n~i~~----~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~----l---------~~L~~L~L~~n~i~  155 (824)
                      +++|++|+|++|.++.    .++..+..+++|++|+|++|.++...+..+..    +         ++|++|+|++|+++
T Consensus        93 ~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~  172 (386)
T 2ca6_A           93 CPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLE  172 (386)
T ss_dssp             CTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCT
T ss_pred             CCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCC
Confidence            4566666666666654    34555666666666666666665433333332    2         66777777776665


Q ss_pred             CCcCcccccccCCCCCCCcEEECcCCCCCccCCccccccccccccEEEeecCcceecCCccCCCCCCCCEEEecCCccC-
Q 040845          156 SSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLN-  234 (824)
Q Consensus       156 ~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~-  234 (824)
                      ..... .+...+..+++|++|+|++|.+.......                     ..+..+..+++|+.|+|++|.++ 
T Consensus       173 ~~~~~-~l~~~l~~~~~L~~L~L~~n~l~~~g~~~---------------------l~~~~l~~~~~L~~L~Ls~n~l~~  230 (386)
T 2ca6_A          173 NGSMK-EWAKTFQSHRLLHTVKMVQNGIRPEGIEH---------------------LLLEGLAYCQELKVLDLQDNTFTH  230 (386)
T ss_dssp             GGGHH-HHHHHHHHCTTCCEEECCSSCCCHHHHHH---------------------HHHTTGGGCTTCCEEECCSSCCHH
T ss_pred             cHHHH-HHHHHHHhCCCcCEEECcCCCCCHhHHHH---------------------HHHHHhhcCCCccEEECcCCCCCc
Confidence            32211 01123445566666666666654210000                     11224555666777777777664 


Q ss_pred             ---CccchhhcCCCCCCEEEcccccCccc----CCcccc--ccCCccEEEccCccccc----cCCccc-cCCCCCcEEEc
Q 040845          235 ---GSIPITLGKLQKLQDVDLEYNQLEGS----IPDSIC--LSVELYELELGGNKLSG----SIPACF-SNMTFLKVLSL  300 (824)
Q Consensus       235 ---~~~~~~~~~l~~L~~L~L~~n~l~~~----~~~~~~--~~~~L~~L~l~~n~l~~----~~~~~~-~~l~~L~~L~L  300 (824)
                         ..+|..+..+++|++|+|++|.+++.    ++..+.  .+++|+.|+|++|.+++    .+|..+ .++++|++|++
T Consensus       231 ~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l  310 (386)
T 2ca6_A          231 LGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLEL  310 (386)
T ss_dssp             HHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEEC
T ss_pred             HHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEc
Confidence               34555666666777777777766643    233332  25555555555555554    234333 44555666666


Q ss_pred             CCCCCCCC
Q 040845          301 GSNELTSI  308 (824)
Q Consensus       301 ~~N~l~~l  308 (824)
                      ++|.++..
T Consensus       311 ~~N~l~~~  318 (386)
T 2ca6_A          311 NGNRFSEE  318 (386)
T ss_dssp             TTSBSCTT
T ss_pred             cCCcCCcc
Confidence            55555543

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.88  E-value=1.1e-23  Score=226.31  Aligned_cols=224  Identities=19%  Similarity=0.184  Sum_probs=151.9

Q ss_pred             CCCEEeCCCCcCCcccChhhhCc--CCCceeeccCCccccccCccccCCCCCccEEEccCCeeeee-cCccccCCCCCce
Q 040845           46 NLGFLDLSQNKLLGTIPAAIFNV--STLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGT-IPHFIFNASKLSK  122 (824)
Q Consensus        46 ~L~~L~Ls~n~l~~~~~~~~~~l--~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~i~~~-~~~~l~~l~~L~~  122 (824)
                      .++.||+++|.+.   +..+..+  ++++.|++++|.+.+.+....  .+++|++|+|++|.+++. ++..+..+++|++
T Consensus        48 ~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~~~--~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~  122 (336)
T 2ast_B           48 LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHF--SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQN  122 (336)
T ss_dssp             TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCSCC--CCBCCCEEECTTCEECHHHHHHHHTTBCCCSE
T ss_pred             hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchhhc--cCCCCCEEEccCCCcCHHHHHHHHhhCCCCCE
Confidence            4778888888776   4556666  778888888888777666543  478888888888888755 6777788888888


Q ss_pred             EeccCccccccCCccccCCCCCCEEEccCC-cCCCCcCcccccccCCCCCCCcEEECcCC-CCCccCCcccccccccccc
Q 040845          123 LALEMNSFSGFIPSTFGNLRNLEWLTLYDN-NLTSSTLDLSFLSSLSNCKSLTHISLSNN-PLDGILPRTYVGNLSHSLK  200 (824)
Q Consensus       123 L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n-~i~~~~~~~~~~~~l~~l~~L~~L~Ls~n-~l~~~~~~~~~~~l~~~L~  200 (824)
                      |+|++|.+++..+..++++++|++|+|++| .++...    +...+..+++|++|++++| .+++..             
T Consensus       123 L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~----l~~~~~~~~~L~~L~l~~~~~l~~~~-------------  185 (336)
T 2ast_B          123 LSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFA----LQTLLSSCSRLDELNLSWCFDFTEKH-------------  185 (336)
T ss_dssp             EECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHH----HHHHHHHCTTCCEEECCCCTTCCHHH-------------
T ss_pred             EeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHH----HHHHHhcCCCCCEEcCCCCCCcChHH-------------
Confidence            888888888777777888888888888888 455321    1123556777777777777 665321             


Q ss_pred             EEEeecCcceecCCccCCCCC-CCCEEEecCC--ccC-CccchhhcCCCCCCEEEccccc-CcccCCccccccCCccEEE
Q 040845          201 NFYMYNCNVSGGIPEEITNLT-DLTTIVLGGN--KLN-GSIPITLGKLQKLQDVDLEYNQ-LEGSIPDSICLSVELYELE  275 (824)
Q Consensus       201 ~L~l~~n~l~~~~~~~l~~l~-~L~~L~L~~n--~l~-~~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~~~~L~~L~  275 (824)
                                  ++..+..++ +|++|++++|  .++ +.++..+..+++|++|++++|. +++..+..+..+++|+.|+
T Consensus       186 ------------~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~  253 (336)
T 2ast_B          186 ------------VQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLS  253 (336)
T ss_dssp             ------------HHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEE
T ss_pred             ------------HHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEee
Confidence                        122334456 7777777777  343 3445566677777777777777 6656666667777777777


Q ss_pred             ccCcc-ccccCCccccCCCCCcEEEcCCC
Q 040845          276 LGGNK-LSGSIPACFSNMTFLKVLSLGSN  303 (824)
Q Consensus       276 l~~n~-l~~~~~~~~~~l~~L~~L~L~~N  303 (824)
                      +++|. +.......+.++++|+.|++++|
T Consensus       254 l~~~~~~~~~~~~~l~~~~~L~~L~l~~~  282 (336)
T 2ast_B          254 LSRCYDIIPETLLELGEIPTLKTLQVFGI  282 (336)
T ss_dssp             CTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred             CCCCCCCCHHHHHHHhcCCCCCEEeccCc
Confidence            77774 22222224666777777777766

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.88  E-value=2.3e-22  Score=205.94  Aligned_cols=175  Identities=25%  Similarity=0.307  Sum_probs=78.5

Q ss_pred             CEEEecCCccCCccchhhcCCCCCCEEEcccccCcccCCccccccCCccEEEccCccccccCCccccCCCCCcEEEcCCC
Q 040845          224 TTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSN  303 (824)
Q Consensus       224 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N  303 (824)
                      ++++++++.++ .+|..+.  ++|+.|+|++|.+++..+..|..+++|++|+|++|++++..+..|.++++|++|+|++|
T Consensus        17 ~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n   93 (251)
T 3m19_A           17 KEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANN   93 (251)
T ss_dssp             TEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTS
T ss_pred             eEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCC
Confidence            34444444444 2232222  34444444444444444444444444444444444444444444455555555555555


Q ss_pred             CCCCCCCc-ccccccccccccccccccCcCCccccccccchhhhcccccccccCCCccCCCCCCCeEEccCccccccCCc
Q 040845          304 ELTSIPLN-FWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPD  382 (824)
Q Consensus       304 ~l~~lp~~-~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  382 (824)
                      +++.+|.. |..+++|++|+|++|.+++..+..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|++++..+.
T Consensus        94 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  173 (251)
T 3m19_A           94 QLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHG  173 (251)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTT
T ss_pred             cccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHH
Confidence            54444322 22333333333333333333333334444444444444444444444444444555555555555444344


Q ss_pred             cccccccccEEEccCcccC
Q 040845          383 SFGDLISLKSLNLSYNNLS  401 (824)
Q Consensus       383 ~~~~l~~L~~L~L~~N~l~  401 (824)
                      .|..+++|+.|+|++|+++
T Consensus       174 ~~~~l~~L~~L~l~~N~~~  192 (251)
T 3m19_A          174 AFDRLGKLQTITLFGNQFD  192 (251)
T ss_dssp             TTTTCTTCCEEECCSCCBC
T ss_pred             HHhCCCCCCEEEeeCCcee
Confidence            4444445555555555444

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.88  E-value=2.8e-22  Score=205.31  Aligned_cols=183  Identities=23%  Similarity=0.293  Sum_probs=167.3

Q ss_pred             CCCCEEEcccccCcccCCccccccCCccEEEccCccccccCCccccCCCCCcEEEcCCCCCCCCCCc-cccccccccccc
Q 040845          245 QKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLN-FWSLKDILDLNL  323 (824)
Q Consensus       245 ~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~-~~~l~~L~~L~l  323 (824)
                      .+.++++++++.++ .+|..+.  ++++.|++++|++++..+..|.++++|++|+|++|.++.++.. +..+++|+.|+|
T Consensus        14 ~~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L   90 (251)
T 3m19_A           14 EGKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGL   90 (251)
T ss_dssp             GGGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEEC
Confidence            46789999999998 5666554  6899999999999999999999999999999999999998765 788999999999


Q ss_pred             ccccccCcCCccccccccchhhhcccccccccCCCccCCCCCCCeEEccCccccccCCccccccccccEEEccCcccCCC
Q 040845          324 SSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGT  403 (824)
Q Consensus       324 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  403 (824)
                      ++|.+++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++++.
T Consensus        91 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  170 (251)
T 3m19_A           91 ANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSV  170 (251)
T ss_dssp             TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred             CCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCcc
Confidence            99999988888899999999999999999988888899999999999999999977777899999999999999999977


Q ss_pred             CcccccCCcccceeeccCCcccCCCCC
Q 040845          404 IPVSLEKLSYLKDLNLSFNKLKGEIPR  430 (824)
Q Consensus       404 ~p~~~~~l~~L~~L~l~~N~l~~~~p~  430 (824)
                      .+..+..+++|+.|++++|+|+|....
T Consensus       171 ~~~~~~~l~~L~~L~l~~N~~~c~~~~  197 (251)
T 3m19_A          171 PHGAFDRLGKLQTITLFGNQFDCSRCE  197 (251)
T ss_dssp             CTTTTTTCTTCCEEECCSCCBCTTSTT
T ss_pred             CHHHHhCCCCCCEEEeeCCceeCCccc
Confidence            788899999999999999999987544

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.88  E-value=1.1e-22  Score=214.96  Aligned_cols=191  Identities=24%  Similarity=0.331  Sum_probs=92.7

Q ss_pred             CCCCEEEecCCccCCccchhhcCCCCCCEEEcccccCcccCCccccccCCccEEEccCccccccCCccccCCCCCcEEEc
Q 040845          221 TDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSL  300 (824)
Q Consensus       221 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L  300 (824)
                      ++|++|++++|.+.. ++ .+..+++|++|+|++|.+++..+  +..+++|++|++++|++++.  ..+..+++|++|++
T Consensus        41 ~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~L~l  114 (308)
T 1h6u_A           41 DGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIKTLDL  114 (308)
T ss_dssp             HTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCEEEC
T ss_pred             CCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc--hhhcCCCCCCEEEC
Confidence            344444444444432 12 23444444444444444442222  44444444444444444422  13444445555555


Q ss_pred             CCCCCCCCCCcccccccccccccccccccCcCCccccccccchhhhcccccccccCCCccCCCCCCCeEEccCccccccC
Q 040845          301 GSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSI  380 (824)
Q Consensus       301 ~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  380 (824)
                      ++|+++.++. +..+++|+.|++++|.+++..+  +..+++|+.|++++|++++..+  +..+++|+.|++++|++++..
T Consensus       115 ~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~  189 (308)
T 1h6u_A          115 TSTQITDVTP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISDIS  189 (308)
T ss_dssp             TTSCCCCCGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCG
T ss_pred             CCCCCCCchh-hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCccCcCh
Confidence            5555544442 4444555555555555543222  4555555555555555554322  555566666666666665322


Q ss_pred             CccccccccccEEEccCcccCCCCcccccCCcccceeeccCCcccC
Q 040845          381 PDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKG  426 (824)
Q Consensus       381 ~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~  426 (824)
                      +  +..+++|+.|+|++|++++..  .+..+++|+.|++++|++++
T Consensus       190 ~--l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~L~l~~N~i~~  231 (308)
T 1h6u_A          190 P--LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTNQTITN  231 (308)
T ss_dssp             G--GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEEEEEEC
T ss_pred             h--hcCCCCCCEEEccCCccCccc--cccCCCCCCEEEccCCeeec
Confidence            2  555566666666666665322  25555666666666666654

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.87  E-value=8.9e-24  Score=226.97  Aligned_cols=228  Identities=20%  Similarity=0.203  Sum_probs=166.5

Q ss_pred             cccEEEeecCcceecCCccCCCCCCCCEEEecCCccCCc-cchhhcCCCCCCEEEcccccCcccCCccccccCCccEEEc
Q 040845          198 SLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGS-IPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELEL  276 (824)
Q Consensus       198 ~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l  276 (824)
                      .++.|++.+|.+.+..+. +..+++|++|+|++|.+++. .+..+..+++|++|+|++|.+++..+..+..+++|++|++
T Consensus        71 ~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L  149 (336)
T 2ast_B           71 GVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNL  149 (336)
T ss_dssp             TCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEEC
T ss_pred             cceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEEC
Confidence            445555555555444333 44577788888888877654 6667777788888888888777767777777788888888


Q ss_pred             cCc-ccccc-CCccccCCCCCcEEEcCCC-CCCC--CCCcccccc-ccccccccccc--cc-CcCCccccccccchhhhc
Q 040845          277 GGN-KLSGS-IPACFSNMTFLKVLSLGSN-ELTS--IPLNFWSLK-DILDLNLSSNC--FS-GPLPLEIRNLKALIEIDF  347 (824)
Q Consensus       277 ~~n-~l~~~-~~~~~~~l~~L~~L~L~~N-~l~~--lp~~~~~l~-~L~~L~l~~N~--l~-~~~~~~~~~l~~L~~L~l  347 (824)
                      ++| .+++. .+..+.++++|++|++++| .++.  ++..+..++ +|++|++++|.  ++ +.++..+..+++|+.|++
T Consensus       150 ~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l  229 (336)
T 2ast_B          150 SGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDL  229 (336)
T ss_dssp             TTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEEC
T ss_pred             CCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeC
Confidence            887 56642 4555777788888888888 7774  455566677 88888888884  43 345667788899999999


Q ss_pred             cccc-ccccCCCccCCCCCCCeEEccCcc-ccccCCccccccccccEEEccCcccCCCCcccccCC-cccceeeccCCcc
Q 040845          348 SMNN-FSGIIPMEIGSLKNLENLFLEYNR-LEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKL-SYLKDLNLSFNKL  424 (824)
Q Consensus       348 ~~N~-l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~L~l~~N~l  424 (824)
                      ++|. +++..+..+..+++|+.|++++|. +.......+..+++|+.|++++| ++.   ..+..+ ..+..|++++|++
T Consensus       230 ~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i~~---~~~~~l~~~l~~L~l~~n~l  305 (336)
T 2ast_B          230 SDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPD---GTLQLLKEALPHLQINCSHF  305 (336)
T ss_dssp             TTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCT---TCHHHHHHHSTTSEESCCCS
T ss_pred             CCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-cCH---HHHHHHHhhCcceEEecccC
Confidence            9999 777777788999999999999995 43322336888999999999999 442   234444 3477888999999


Q ss_pred             cCCCCC
Q 040845          425 KGEIPR  430 (824)
Q Consensus       425 ~~~~p~  430 (824)
                      ++..|.
T Consensus       306 ~~~~~~  311 (336)
T 2ast_B          306 TTIARP  311 (336)
T ss_dssp             CCTTCS
T ss_pred             ccccCC
Confidence            998876

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.87  E-value=8.5e-23  Score=211.97  Aligned_cols=152  Identities=16%  Similarity=0.121  Sum_probs=121.3

Q ss_pred             HHHHHhhccCCCCceeeeccceEEEEEEECCCcEEEEEEeecccc------------------chhhhHHHHHHHHhcCC
Q 040845          520 LELFQATDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCG------------------RAFKSFDVECAMMKSIR  581 (824)
Q Consensus       520 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~  581 (824)
                      ..+......|.+.+.||+|+||.||+|.+.+|+.||||+++....                  .....+.+|++++++++
T Consensus        83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~  162 (282)
T 1zar_A           83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ  162 (282)
T ss_dssp             HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence            334445566778899999999999999987799999999864321                  12456889999999999


Q ss_pred             CCcceeEEeeeecCCeeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC
Q 040845          582 HRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD  661 (824)
Q Consensus       582 h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~  661 (824)
                        | +++.+++.. +..++||||+++++|.+ +..       .+...++.|++.|++|||   +.+|+||||||+||+++
T Consensus       163 --~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl~  227 (282)
T 1zar_A          163 --G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVS  227 (282)
T ss_dssp             --T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE
T ss_pred             --C-CCcCeEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEEE
Confidence              4 666665543 45689999999999988 422       134579999999999999   99999999999999999


Q ss_pred             CCCcEEEeecccccccCCCCCccccccccccccccCccCcC
Q 040845          662 DNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR  702 (824)
Q Consensus       662 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~  702 (824)
                       ++.+||+|||+|+.               +..++|||++.
T Consensus       228 -~~~vkl~DFG~a~~---------------~~~~~a~e~l~  252 (282)
T 1zar_A          228 -EEGIWIIDFPQSVE---------------VGEEGWREILE  252 (282)
T ss_dssp             -TTEEEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred             -CCcEEEEECCCCeE---------------CCCCCHHHHHH
Confidence             99999999999873               33467888764

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.87  E-value=1e-21  Score=211.64  Aligned_cols=238  Identities=17%  Similarity=0.109  Sum_probs=159.3

Q ss_pred             EEECcCCCCCccCCccccccccccccEEEeecCcceecCCccCCCCCCCCEEEecCCccCCccc-hhhcCCCCCCE-EEc
Q 040845          175 HISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIP-ITLGKLQKLQD-VDL  252 (824)
Q Consensus       175 ~L~Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~-L~L  252 (824)
                      +++.++++++.++.     .++.++++|+|++|+|+...+.+|.++++|++|+|++|++.+.+| .+|.+++++.+ +.+
T Consensus        13 ~v~C~~~~Lt~iP~-----~l~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~   87 (350)
T 4ay9_X           13 VFLCQESKVTEIPS-----DLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE   87 (350)
T ss_dssp             EEEEESTTCCSCCT-----TCCTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEE
T ss_pred             EEEecCCCCCccCc-----CcCCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcc
Confidence            44555555554432     124456666666666665556678888999999999998865444 57888888775 566


Q ss_pred             ccccCcccCCccccccCCccEEEccCccccccCCccccCCCCCcEEEcCC-CCCCCCCCc-cccc-cccccccccccccc
Q 040845          253 EYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGS-NELTSIPLN-FWSL-KDILDLNLSSNCFS  329 (824)
Q Consensus       253 ~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~-N~l~~lp~~-~~~l-~~L~~L~l~~N~l~  329 (824)
                      +.|+++...|+.|..+++|++|++++|++....+..+....++..|++.+ |.++.+|.. |..+ ..++.|+|++|.|+
T Consensus        88 ~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~  167 (350)
T 4ay9_X           88 KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ  167 (350)
T ss_dssp             EETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred             cCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccccc
Confidence            77888877788888888888888888888877777777777788888854 677777654 4444 35777778888777


Q ss_pred             CcCCccccccccchhhhccc-ccccccCCCccCCCCCCCeEEccCccccccCCccccccccccEEEccCcccCCCCcccc
Q 040845          330 GPLPLEIRNLKALIEIDFSM-NNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSL  408 (824)
Q Consensus       330 ~~~~~~~~~l~~L~~L~l~~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~  408 (824)
                      .+.+..| ...+|+.|++++ |.++.+.++.|..+++|+.|+|++|+|+...+..|   .+|+.|.+.++.-.+.+| .+
T Consensus       168 ~i~~~~f-~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~---~~L~~L~~l~~~~l~~lP-~l  242 (350)
T 4ay9_X          168 EIHNSAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGL---ENLKKLRARSTYNLKKLP-TL  242 (350)
T ss_dssp             EECTTSS-TTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSC---TTCCEEECTTCTTCCCCC-CT
T ss_pred             CCChhhc-cccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhh---ccchHhhhccCCCcCcCC-Cc
Confidence            4444333 445677777764 56665555567777777777777777774333333   344555544433233666 36


Q ss_pred             cCCcccceeeccCC
Q 040845          409 EKLSYLKDLNLSFN  422 (824)
Q Consensus       409 ~~l~~L~~L~l~~N  422 (824)
                      ..+++|+.++++++
T Consensus       243 ~~l~~L~~l~l~~~  256 (350)
T 4ay9_X          243 EKLVALMEASLTYP  256 (350)
T ss_dssp             TTCCSCCEEECSCH
T ss_pred             hhCcChhhCcCCCC
Confidence            67777777777644

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.84  E-value=3.2e-20  Score=184.18  Aligned_cols=161  Identities=26%  Similarity=0.271  Sum_probs=119.3

Q ss_pred             cccEEEeecCcceecCCccCCCCCCCCEEEecCCccCCccchhhcCCCCCCEEEcccccCcccCCccccccCCccEEEcc
Q 040845          198 SLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELG  277 (824)
Q Consensus       198 ~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~  277 (824)
                      ++++|++++|++++..+..|..+++|++|++++|++++..+..|..+++|++|+|++|++++..+..+..+++|++|+++
T Consensus        29 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~  108 (208)
T 2o6s_A           29 QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALN  108 (208)
T ss_dssp             TCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcC
Confidence            44444444444444445556778888888888888887666677888888888888888886666667788888888888


Q ss_pred             CccccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccccccccccccccccccCcCCccccccccchhhhcccccccccC
Q 040845          278 GNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLN-FWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGII  356 (824)
Q Consensus       278 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~-~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~  356 (824)
                      +|++++..+..|..+++|++|++++|+++.+|.. +..+++|+.|++++|.+.+       .+++|+.|+++.|++++.+
T Consensus       109 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~i  181 (208)
T 2o6s_A          109 TNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVV  181 (208)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTTB
T ss_pred             CCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec-------CCCCHHHHHHHHHhCCcee
Confidence            8888877777778888888888888888877765 5667788888888887653       4557777778888887777


Q ss_pred             CCccCCCCC
Q 040845          357 PMEIGSLKN  365 (824)
Q Consensus       357 ~~~~~~l~~  365 (824)
                      |..++.++.
T Consensus       182 p~~~~~l~~  190 (208)
T 2o6s_A          182 RNSAGSVAP  190 (208)
T ss_dssp             BCTTSSBCT
T ss_pred             eccCccccC
Confidence            777766554

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.83  E-value=9e-21  Score=214.60  Aligned_cols=169  Identities=24%  Similarity=0.307  Sum_probs=97.7

Q ss_pred             CCCCEEEecCCccCCccchhhcCCCCCCEEEcccccCcccCCccccccCCccEEEccCccccccCCccccCCCCCcEEEc
Q 040845          221 TDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSL  300 (824)
Q Consensus       221 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L  300 (824)
                      ++|+.|+|++|+|+ .+|   ..+++|++|+|++|+|++ +|. +..  +|+.|++++|+|++ +|.   .+++|+.|+|
T Consensus        80 ~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~L  147 (571)
T 3cvr_A           80 PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINA  147 (571)
T ss_dssp             TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEEC
T ss_pred             CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeC
Confidence            34555555555555 233   234555555555555553 333 332  55555555555554 222   3555666666


Q ss_pred             CCCCCCCCCCcccccccccccccccccccCcCCccccccccchhhhcccccccccCCCccCCCCCC-------CeEEccC
Q 040845          301 GSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNL-------ENLFLEY  373 (824)
Q Consensus       301 ~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L-------~~L~L~~  373 (824)
                      ++|.|+.+|.   .+++|+.|+|++|++++ +|. |.  ++|+.|+|++|+|+ .+|. |..  +|       +.|+|++
T Consensus       148 s~N~l~~lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~  216 (571)
T 3cvr_A          148 DNNQLTMLPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRE  216 (571)
T ss_dssp             CSSCCSCCCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCS
T ss_pred             CCCccCcCCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCC
Confidence            6666665554   34555556666666554 333 43  56666666666666 3344 443  55       8888888


Q ss_pred             ccccccCCccccccccccEEEccCcccCCCCcccccCCcc
Q 040845          374 NRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSY  413 (824)
Q Consensus       374 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~  413 (824)
                      |+|+ .+|..+..+++|+.|+|++|+|++.+|..+..++.
T Consensus       217 N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~  255 (571)
T 3cvr_A          217 NRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTA  255 (571)
T ss_dssp             SCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHHH
T ss_pred             Ccce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhhc
Confidence            8887 56777777888888888888888777777766543

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.82  E-value=2.6e-20  Score=210.79  Aligned_cols=183  Identities=25%  Similarity=0.291  Sum_probs=158.3

Q ss_pred             CCCCEEEecCCccCCccchhhcCCCCCCEEEcccccCcccCCccccccCCccEEEccCccccccCCccccCCCCCcEEEc
Q 040845          221 TDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSL  300 (824)
Q Consensus       221 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L  300 (824)
                      .+|+.|+|++|.+++ +|..+  .++|++|+|++|+|+ .+|   ..+++|+.|++++|+|++ +|. +.+  +|++|+|
T Consensus        59 ~~L~~L~Ls~n~L~~-lp~~l--~~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~L  127 (571)
T 3cvr_A           59 NQFSELQLNRLNLSS-LPDNL--PPQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDV  127 (571)
T ss_dssp             TTCSEEECCSSCCSC-CCSCC--CTTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEEC
T ss_pred             CCccEEEeCCCCCCc-cCHhH--cCCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEEC
Confidence            389999999999986 56544  388999999999999 566   457899999999999997 555 665  9999999


Q ss_pred             CCCCCCCCCCcccccccccccccccccccCcCCccccccccchhhhcccccccccCCCccCCCCCCCeEEccCccccccC
Q 040845          301 GSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSI  380 (824)
Q Consensus       301 ~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  380 (824)
                      ++|+|+.+|.   .+++|+.|+|++|.+++ +|.   .+++|+.|+|++|+|++ +|. |.  ++|+.|+|++|+|+ .+
T Consensus       128 s~N~l~~lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~l  195 (571)
T 3cvr_A          128 DNNQLTMLPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SL  195 (571)
T ss_dssp             CSSCCSCCCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SC
T ss_pred             CCCcCCCCCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-ch
Confidence            9999999998   68999999999999996 554   57899999999999997 566 66  99999999999999 67


Q ss_pred             Cccccccccc-------cEEEccCcccCCCCcccccCCcccceeeccCCcccCCCCC
Q 040845          381 PDSFGDLISL-------KSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIPR  430 (824)
Q Consensus       381 ~~~~~~l~~L-------~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~  430 (824)
                      |. |..  +|       +.|+|++|+|+ .+|..+..+++|+.|+|++|++++.+|.
T Consensus       196 p~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~  248 (571)
T 3cvr_A          196 PA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRE  248 (571)
T ss_dssp             CC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHH
T ss_pred             hh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHH
Confidence            76 665  77       99999999999 7899888899999999999999987764

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.81  E-value=1.4e-20  Score=188.04  Aligned_cols=154  Identities=25%  Similarity=0.306  Sum_probs=105.1

Q ss_pred             EEEccCccccccCCccccCCCCCcEEEcCCCCCCCCCC--cccccccccccccccccccCcCCccccccccchhhhcccc
Q 040845          273 ELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPL--NFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMN  350 (824)
Q Consensus       273 ~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~--~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N  350 (824)
                      .+++++|.++. +|..+.  +.+++|+|++|+|+.++.  .|..+++|+.|+|++|.+++..+..|.++++|+.|+|++|
T Consensus        15 ~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N   91 (220)
T 2v70_A           15 TVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN   91 (220)
T ss_dssp             EEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             EeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence            44455554442 232221  234555555555555522  2445566666666666666555666777777777777777


Q ss_pred             cccccCCCccCCCCCCCeEEccCccccccCCccccccccccEEEccCcccCCCCcccccCCcccceeeccCCcccCCCC
Q 040845          351 NFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIP  429 (824)
Q Consensus       351 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p  429 (824)
                      ++++..+..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..|..+..+++|+.|+|++|+|+|.++
T Consensus        92 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~  170 (220)
T 2v70_A           92 RLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY  170 (220)
T ss_dssp             CCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred             ccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence            7777777777788888888888888887777778888888888888888887777788888888888888888887765

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.81  E-value=3.2e-19  Score=176.94  Aligned_cols=190  Identities=23%  Similarity=0.223  Sum_probs=149.4

Q ss_pred             ceEeccCccccccCCccccCCCCCCEEEccCCcCCCCcCcccccccCCCCCCCcEEECcCCCCCccCCcccccccccccc
Q 040845          121 SKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLK  200 (824)
Q Consensus       121 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~~L~  200 (824)
                      +.++++++.++. +|..+  .++|++|++++|.++.++..     .+..+++|++|++++|++.++              
T Consensus        10 ~~v~c~~~~l~~-~p~~~--~~~l~~L~l~~n~l~~~~~~-----~~~~l~~L~~L~l~~n~l~~~--------------   67 (208)
T 2o6s_A           10 TTVECYSQGRTS-VPTGI--PAQTTYLDLETNSLKSLPNG-----VFDELTSLTQLYLGGNKLQSL--------------   67 (208)
T ss_dssp             TEEECCSSCCSS-CCSCC--CTTCSEEECCSSCCCCCCTT-----TTTTCTTCSEEECCSSCCCCC--------------
T ss_pred             CEEEecCCCccC-CCCCC--CCCCcEEEcCCCccCcCChh-----hhcccccCcEEECCCCccCcc--------------
Confidence            467777777774 34333  35788888888888766532     366777777777777777644              


Q ss_pred             EEEeecCcceecCCccCCCCCCCCEEEecCCccCCccchhhcCCCCCCEEEcccccCcccCCccccccCCccEEEccCcc
Q 040845          201 NFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNK  280 (824)
Q Consensus       201 ~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~  280 (824)
                                  .+..|..+++|++|+|++|++++..+..|..+++|++|+|++|++++..+..+..+++|+.|++++|+
T Consensus        68 ------------~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~  135 (208)
T 2o6s_A           68 ------------PNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQ  135 (208)
T ss_dssp             ------------CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             ------------ChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCc
Confidence                        33456778899999999999987777778899999999999999997777778899999999999999


Q ss_pred             ccccCCccccCCCCCcEEEcCCCCCCCCCCcccccccccccccccccccCcCCccccccccchhhhcccccccc
Q 040845          281 LSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSG  354 (824)
Q Consensus       281 l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~  354 (824)
                      +++..+..|..+++|++|++++|.+.      ..+++|+.|+++.|.+++.+|..++.++.    ++..+...+
T Consensus       136 l~~~~~~~~~~l~~L~~L~l~~N~~~------~~~~~l~~L~~~~n~~~g~ip~~~~~l~~----~~~~C~~~~  199 (208)
T 2o6s_A          136 LKSVPDGVFDRLTSLQYIWLHDNPWD------CTCPGIRYLSEWINKHSGVVRNSAGSVAP----DSAKCSGSG  199 (208)
T ss_dssp             CSCCCTTTTTTCTTCCEEECCSCCBC------CCTTTTHHHHHHHHHCTTTBBCTTSSBCT----TCSBBTTTC
T ss_pred             cceeCHHHhccCCCccEEEecCCCee------cCCCCHHHHHHHHHhCCceeeccCccccC----CccccccCC
Confidence            99888888999999999999999765      34678999999999999999998887765    444444443

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.81  E-value=2.7e-20  Score=185.97  Aligned_cols=136  Identities=23%  Similarity=0.283  Sum_probs=86.6

Q ss_pred             CCcEEEcCCCCCCCCCC-cccccccccccccccccccCcCCccccccccchhhhcccccccccCCCccCCCCCCCeEEcc
Q 040845          294 FLKVLSLGSNELTSIPL-NFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLE  372 (824)
Q Consensus       294 ~L~~L~L~~N~l~~lp~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~  372 (824)
                      +|+.|++++|+|+.++. .|..+++|+.|+|++|.+++..|..|.++++|+.|+|++|+|+...+..|..+++|+.|+|+
T Consensus        33 ~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~  112 (220)
T 2v9t_B           33 TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLN  112 (220)
T ss_dssp             TCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECC
Confidence            44445555555544443 24444555555555555555556666666666677777777765555556677777777777


Q ss_pred             CccccccCCccccccccccEEEccCcccCCCCcccccCCcccceeeccCCcccCCCC
Q 040845          373 YNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIP  429 (824)
Q Consensus       373 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p  429 (824)
                      +|+|++..|..|..+++|+.|+|++|+|++..+..+..+++|+.|+|++|+|.|.+.
T Consensus       113 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~  169 (220)
T 2v9t_B          113 ANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDCH  169 (220)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred             CCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCCc
Confidence            777776666677777777777777777776556667777777777777777776543

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.81  E-value=5e-20  Score=192.65  Aligned_cols=170  Identities=23%  Similarity=0.323  Sum_probs=84.9

Q ss_pred             CCCCCCEEEecCCccCCccchhhcCCCCCCEEEcccccCcccCCccccccCCccEEEccCccccccCCccccCCCCCcEE
Q 040845          219 NLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVL  298 (824)
Q Consensus       219 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L  298 (824)
                      .+++|+.|++++|.+... + .+..+++|++|+|++|++++..+  +..+++|+.|++++|++++.  ..+..+++|++|
T Consensus        44 ~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L  117 (291)
T 1h6t_A           44 ELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDL--SSLKDLKKLKSL  117 (291)
T ss_dssp             HHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCG--GGGTTCTTCCEE
T ss_pred             hcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCCC--hhhccCCCCCEE
Confidence            455666666666666533 2 35556666666666666654332  55555566666666655532  125555555555


Q ss_pred             EcCCCCCCCCCCcccccccccccccccccccCcCCccccccccchhhhcccccccccCCCccCCCCCCCeEEccCccccc
Q 040845          299 SLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEG  378 (824)
Q Consensus       299 ~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  378 (824)
                      ++++|+++.++ .+..+++|+.|++++|.+++.  ..+..+++|+.|++++|++++..+  +..+++|+.|++++|.+++
T Consensus       118 ~L~~n~i~~~~-~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~  192 (291)
T 1h6t_A          118 SLEHNGISDIN-GLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD  192 (291)
T ss_dssp             ECTTSCCCCCG-GGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB
T ss_pred             ECCCCcCCCCh-hhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCC
Confidence            55555555542 344445555555555555432  334444444444444444443322  4444444444444444442


Q ss_pred             cCCccccccccccEEEccCcccC
Q 040845          379 SIPDSFGDLISLKSLNLSYNNLS  401 (824)
Q Consensus       379 ~~~~~~~~l~~L~~L~L~~N~l~  401 (824)
                       ++ .+..+++|+.|++++|+++
T Consensus       193 -l~-~l~~l~~L~~L~l~~n~i~  213 (291)
T 1h6t_A          193 -LR-ALAGLKNLDVLELFSQECL  213 (291)
T ss_dssp             -CG-GGTTCTTCSEEEEEEEEEE
T ss_pred             -Ch-hhccCCCCCEEECcCCccc
Confidence             22 2444444444444444444

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.81  E-value=1e-19  Score=208.35  Aligned_cols=192  Identities=22%  Similarity=0.296  Sum_probs=119.6

Q ss_pred             CCCCcEEEccCCcccccccccccCCCCCCEEeCCCCcCCcccChhhhCcCCCceeeccCCccccccCccccCCCCCccEE
Q 040845           20 ISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVL   99 (824)
Q Consensus        20 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L   99 (824)
                      +..+..+.|+.+.+....  .+..|++|+.|++++|.+.. ++ .+..+++|+.|+|++|++++++.   ...+++|+.|
T Consensus        20 l~~l~~l~l~~~~i~~~~--~~~~L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~---l~~l~~L~~L   92 (605)
T 1m9s_A           20 FAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP---LTNLKNLGWL   92 (605)
T ss_dssp             HHHHHHHHTTCSCTTSEE--CHHHHTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG---GGGCTTCCEE
T ss_pred             HHHHHHHhccCCCccccc--chhcCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh---hccCCCCCEE
Confidence            334555566666666432  25566677777777777663 33 46667777777777777766554   2346777777


Q ss_pred             EccCCeeeeecCccccCCCCCceEeccCccccccCCccccCCCCCCEEEccCCcCCCCcCcccccccCCCCCCCcEEECc
Q 040845          100 YLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLS  179 (824)
Q Consensus       100 ~L~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~~L~~L~Ls  179 (824)
                      +|++|++++ ++ .+..+++|+.|+|++|++++.  ..+..+++|+.|+|++|+|+.+       ..+..+++|++|+|+
T Consensus        93 ~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l-------~~l~~l~~L~~L~Ls  161 (605)
T 1m9s_A           93 FLDENKIKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI-------TVLSRLTKLDTLSLE  161 (605)
T ss_dssp             ECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC-------GGGGSCTTCSEEECC
T ss_pred             ECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc-------hhhcccCCCCEEECc
Confidence            777777763 23 566777777777777777743  3577777777777777777664       236677777777777


Q ss_pred             CCCCCccCCccccccccccccEEEeecCcceecCCccCCCCCCCCEEEecCCccCCccchhhcCCCCCCEEEcccccCcc
Q 040845          180 NNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEG  259 (824)
Q Consensus       180 ~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~  259 (824)
                      +|.+.++.+                            +..+++|+.|+|++|.|++.  ..+..+++|+.|+|++|++.+
T Consensus       162 ~N~l~~~~~----------------------------l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~  211 (605)
T 1m9s_A          162 DNQISDIVP----------------------------LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLN  211 (605)
T ss_dssp             SSCCCCCGG----------------------------GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEEC
T ss_pred             CCcCCCchh----------------------------hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcC
Confidence            777765422                            33455556666666655532  235556666666666666553

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.80  E-value=7.5e-20  Score=197.84  Aligned_cols=179  Identities=22%  Similarity=0.198  Sum_probs=109.2

Q ss_pred             CEEEecCCccCCccchhhcCCCCCCEEEcccccCcccCCcccc-ccCCccEEEccCccccccCCccccCCCCCcEEEcCC
Q 040845          224 TTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSIC-LSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGS  302 (824)
Q Consensus       224 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~-~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~  302 (824)
                      +.++++++.++. +|..+.  +.++.|+|++|+|++..+..+. .+++|+.|+|++|+|++..+..|.++++|++|+|++
T Consensus        21 ~~l~c~~~~l~~-iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~   97 (361)
T 2xot_A           21 NILSCSKQQLPN-VPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS   97 (361)
T ss_dssp             TEEECCSSCCSS-CCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CEEEeCCCCcCc-cCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence            456666666663 343332  3455666666666554444444 455555555555555544444555555555555555


Q ss_pred             CCCCCCCCcccccccccccccccccccCcCCccccccccchhhhcccccccccCCCccCCCCCCCeEEccCccccccCCc
Q 040845          303 NELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPD  382 (824)
Q Consensus       303 N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  382 (824)
                      |+                       ++...+..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..+.
T Consensus        98 N~-----------------------l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~  154 (361)
T 2xot_A           98 NH-----------------------LHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVE  154 (361)
T ss_dssp             SC-----------------------CCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGG
T ss_pred             Cc-----------------------CCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHH
Confidence            44                       4444445566667777777777777766677777777777777777777754444


Q ss_pred             cc---cccccccEEEccCcccCCCCcccccCCcc--cceeeccCCcccCCC
Q 040845          383 SF---GDLISLKSLNLSYNNLSGTIPVSLEKLSY--LKDLNLSFNKLKGEI  428 (824)
Q Consensus       383 ~~---~~l~~L~~L~L~~N~l~~~~p~~~~~l~~--L~~L~l~~N~l~~~~  428 (824)
                      .|   ..+++|+.|+|++|+|++..+..+..++.  ++.|+|++|+|.|.+
T Consensus       155 ~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C~C  205 (361)
T 2xot_A          155 LIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLECDC  205 (361)
T ss_dssp             GTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEECCH
T ss_pred             HhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCccCCc
Confidence            44   45777888888888887555566666766  377777777777654

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.80  E-value=1.4e-19  Score=207.22  Aligned_cols=191  Identities=24%  Similarity=0.345  Sum_probs=108.2

Q ss_pred             CCCCEEeCCCCcCCcccChhhhCcCCCceeeccCCccccccCccccCCCCCccEEEccCCeeeeecCccccCCCCCceEe
Q 040845           45 HNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLA  124 (824)
Q Consensus        45 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~  124 (824)
                      .++..++++.+.+....+  +..+++|+.|++++|.++.++. +  ..+++|+.|+|++|+|++..+  +..+++|+.|+
T Consensus        21 ~~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~l~~-l--~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~   93 (605)
T 1m9s_A           21 AETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG-I--QYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLF   93 (605)
T ss_dssp             HHHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCCCTT-G--GGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEE
T ss_pred             HHHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCCChH-H--ccCCCCCEEEeeCCCCCCChh--hccCCCCCEEE
Confidence            345556666666664333  4556667777777776665542 2  236666666666666664433  55666666666


Q ss_pred             ccCccccccCCccccCCCCCCEEEccCCcCCCCcCcccccccCCCCCCCcEEECcCCCCCccCCccccccccccccEEEe
Q 040845          125 LEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYM  204 (824)
Q Consensus       125 L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~~L~~L~l  204 (824)
                      |++|.+++.  ..|..+++|++|+|++|+|+.++       .+..+++|+.|+|++|.+.++                  
T Consensus        94 Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l~-------~l~~l~~L~~L~Ls~N~l~~l------------------  146 (605)
T 1m9s_A           94 LDENKIKDL--SSLKDLKKLKSLSLEHNGISDIN-------GLVHLPQLESLYLGNNKITDI------------------  146 (605)
T ss_dssp             CCSSCCCCC--TTSTTCTTCCEEECTTSCCCCCG-------GGGGCTTCSEEECCSSCCCCC------------------
T ss_pred             CcCCCCCCC--hhhccCCCCCEEEecCCCCCCCc-------cccCCCccCEEECCCCccCCc------------------
Confidence            666666532  24556666666666666655432       244555555555555555432                  


Q ss_pred             ecCcceecCCccCCCCCCCCEEEecCCccCCccchhhcCCCCCCEEEcccccCcccCCccccccCCccEEEccCccccc
Q 040845          205 YNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSG  283 (824)
Q Consensus       205 ~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~  283 (824)
                                ..+..+++|+.|+|++|.+.+..|  +..+++|+.|+|++|+|++.  ..+..+++|+.|+|++|.+.+
T Consensus       147 ----------~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~  211 (605)
T 1m9s_A          147 ----------TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLN  211 (605)
T ss_dssp             ----------GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEEC
T ss_pred             ----------hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcC
Confidence                      234455666666666666665444  56666666666666666532  234555555555555555543

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.80  E-value=1.4e-19  Score=189.27  Aligned_cols=187  Identities=24%  Similarity=0.318  Sum_probs=137.9

Q ss_pred             EEecCCccCCccchhhcCCCCCCEEEcccccCcccCCccccccCCccEEEccCccccccCCccccCCCCCcEEEcCCCCC
Q 040845          226 IVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNEL  305 (824)
Q Consensus       226 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l  305 (824)
                      +.++.+.+.+..  .+..+++|++|++++|.+... + .+..+++|+.|++++|++++..+  +.++++|++|++++|.+
T Consensus        29 ~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l  102 (291)
T 1h6t_A           29 DNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKV  102 (291)
T ss_dssp             HHTTCSCTTSEE--CHHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred             HHhcCCCccccc--chhhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcC
Confidence            344555555332  244677788888888888743 3 47777888888888888876544  77888888888888888


Q ss_pred             CCCCCcccccccccccccccccccCcCCccccccccchhhhcccccccccCCCccCCCCCCCeEEccCccccccCCcccc
Q 040845          306 TSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFG  385 (824)
Q Consensus       306 ~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  385 (824)
                      +.+|. +..+++|+.|++++|.+++.  ..+..+++|+.|++++|++++.  ..+..+++|+.|++++|++++..+  +.
T Consensus       103 ~~~~~-l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~  175 (291)
T 1h6t_A          103 KDLSS-LKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LA  175 (291)
T ss_dssp             CCGGG-GTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GT
T ss_pred             CCChh-hccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hc
Confidence            87664 77788888888888888753  4677788888888888888765  567778888888888888875443  77


Q ss_pred             ccccccEEEccCcccCCCCcccccCCcccceeeccCCcccCC
Q 040845          386 DLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGE  427 (824)
Q Consensus       386 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~  427 (824)
                      .+++|+.|++++|.++ .+|. +..+++|+.|++++|+++..
T Consensus       176 ~l~~L~~L~L~~N~i~-~l~~-l~~l~~L~~L~l~~n~i~~~  215 (291)
T 1h6t_A          176 GLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNK  215 (291)
T ss_dssp             TCTTCCEEECCSSCCC-BCGG-GTTCTTCSEEEEEEEEEECC
T ss_pred             CCCccCEEECCCCcCC-CChh-hccCCCCCEEECcCCcccCC
Confidence            8888888888888887 4553 77788888888888887753

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.80  E-value=1.8e-19  Score=179.97  Aligned_cols=155  Identities=25%  Similarity=0.285  Sum_probs=142.5

Q ss_pred             cEEEcCCCCCCCCCCcccccccccccccccccccCcCCccccccccchhhhcccccccccCCCccCCCCCCCeEEccCcc
Q 040845          296 KVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNR  375 (824)
Q Consensus       296 ~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~  375 (824)
                      +.+++++|.++.+|..+.  ++|+.|++++|.+++..+..|..+++|+.|+|++|+|++..|..|.++++|+.|+|++|+
T Consensus        14 ~~v~c~~~~l~~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~   91 (220)
T 2v9t_B           14 NIVDCRGKGLTEIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK   91 (220)
T ss_dssp             TEEECTTSCCSSCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSC
T ss_pred             CEEEcCCCCcCcCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCc
Confidence            678999999999998765  789999999999998888899999999999999999999989999999999999999999


Q ss_pred             ccccCCccccccccccEEEccCcccCCCCcccccCCcccceeeccCCcccCCCCC-CCCccccccccccCCccccCCC
Q 040845          376 LEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIPR-GGSFGNFSAESFKGNELLCGSP  452 (824)
Q Consensus       376 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~~~~~~~~~~~n~~~c~~~  452 (824)
                      |+...+..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|++++.++. ...+.++..+.+.+|++.|+|.
T Consensus        92 l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~  169 (220)
T 2v9t_B           92 ITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDCH  169 (220)
T ss_dssp             CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred             CCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCCc
Confidence            9976667789999999999999999988899999999999999999999988775 4457788889999999999875

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.78  E-value=4.7e-19  Score=191.58  Aligned_cols=173  Identities=23%  Similarity=0.189  Sum_probs=115.3

Q ss_pred             EEECcCCCCCccCCccccccccccccEEEeecCcceecCCccCC-CCCCCCEEEecCCccCCccchhhcCCCCCCEEEcc
Q 040845          175 HISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEIT-NLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLE  253 (824)
Q Consensus       175 ~L~Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~-~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  253 (824)
                      .+++++|.+..++..     ++..++.|+|++|++++..+..+. ++++|+.|+|++|+|+++.+..|.++++|++|+|+
T Consensus        22 ~l~c~~~~l~~iP~~-----~~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls   96 (361)
T 2xot_A           22 ILSCSKQQLPNVPQS-----LPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLS   96 (361)
T ss_dssp             EEECCSSCCSSCCSS-----CCTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred             EEEeCCCCcCccCcc-----CCCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECC
Confidence            444555444443221     233455555555555555556666 78888888888888887777778888888888888


Q ss_pred             cccCcccCCccccccCCccEEEccCccccccCCccccCCCCCcEEEcCCCCCCCCCCcc----ccccccccccccccccc
Q 040845          254 YNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNF----WSLKDILDLNLSSNCFS  329 (824)
Q Consensus       254 ~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~----~~l~~L~~L~l~~N~l~  329 (824)
                      +|+|+...+..|..+++|+.|+|++|+|....+..|.++++|+.|+|++|+|+.+|..+    ..+++|+.|+|++|+|+
T Consensus        97 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~  176 (361)
T 2xot_A           97 SNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLK  176 (361)
T ss_dssp             SSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCC
T ss_pred             CCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCC
Confidence            88888777777888888888888888888777888888888888888888888877654    23555666666666555


Q ss_pred             CcCCccccccccc--hhhhcccccc
Q 040845          330 GPLPLEIRNLKAL--IEIDFSMNNF  352 (824)
Q Consensus       330 ~~~~~~~~~l~~L--~~L~l~~N~l  352 (824)
                      ...+..+..++.+  +.|+|++|.+
T Consensus       177 ~l~~~~~~~l~~~~l~~l~l~~N~~  201 (361)
T 2xot_A          177 KLPLTDLQKLPAWVKNGLYLHNNPL  201 (361)
T ss_dssp             CCCHHHHHHSCHHHHTTEECCSSCE
T ss_pred             ccCHHHhhhccHhhcceEEecCCCc
Confidence            4433444444432  3344444443

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.78  E-value=3.9e-19  Score=177.60  Aligned_cols=156  Identities=21%  Similarity=0.215  Sum_probs=101.5

Q ss_pred             CEEEecCCccCCccchhhcCCCCCCEEEcccccCcccCC-ccccccCCccEEEccCccccccCCccccCCCCCcEEEcCC
Q 040845          224 TTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIP-DSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGS  302 (824)
Q Consensus       224 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~  302 (824)
                      +.+++++|.++. +|..+.  +.+++|+|++|+|++..+ ..|..+++|+.|+|++|+|++..+..|.++++|++|+|  
T Consensus        14 ~~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~L--   88 (220)
T 2v70_A           14 TTVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILL--   88 (220)
T ss_dssp             TEEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC--
T ss_pred             CEeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEEC--
Confidence            466777777663 343332  344566666666664433 23445555555555555555444445555555555555  


Q ss_pred             CCCCCCCCcccccccccccccccccccCcCCccccccccchhhhcccccccccCCCccCCCCCCCeEEccCccccccCCc
Q 040845          303 NELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPD  382 (824)
Q Consensus       303 N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  382 (824)
                                           ++|.+++..+..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..|.
T Consensus        89 ---------------------s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  147 (220)
T 2v70_A           89 ---------------------TSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPG  147 (220)
T ss_dssp             ---------------------CSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTT
T ss_pred             ---------------------CCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHH
Confidence                                 55555545555677777788888888888877778888888888888888888877788


Q ss_pred             cccccccccEEEccCcccCCCCc
Q 040845          383 SFGDLISLKSLNLSYNNLSGTIP  405 (824)
Q Consensus       383 ~~~~l~~L~~L~L~~N~l~~~~p  405 (824)
                      .|..+++|+.|+|++|++....+
T Consensus       148 ~~~~l~~L~~L~L~~N~l~c~c~  170 (220)
T 2v70_A          148 AFDTLHSLSTLNLLANPFNCNCY  170 (220)
T ss_dssp             TTTTCTTCCEEECCSCCEECSGG
T ss_pred             HhcCCCCCCEEEecCcCCcCCCc
Confidence            88888888888888888875433

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.78  E-value=1.1e-18  Score=175.54  Aligned_cols=155  Identities=27%  Similarity=0.343  Sum_probs=101.1

Q ss_pred             CEEEcccccCcccCCccccccCCccEEEccCccccccCCccccCCCCCcEEEcCCCCCCCCCCccccccccccccccccc
Q 040845          248 QDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNC  327 (824)
Q Consensus       248 ~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~  327 (824)
                      +.++.+++.++ .+|..+.  ++|+.|+|++|++++..+..|.++++|++|+|++|+|+.+|                  
T Consensus        22 ~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~------------------   80 (229)
T 3e6j_A           22 TTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALP------------------   80 (229)
T ss_dssp             TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC------------------
T ss_pred             CEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcC------------------
Confidence            44566666555 3333322  45555555555555555555555555555555555554443                  


Q ss_pred             ccCcCCccccccccchhhhcccccccccCCCccCCCCCCCeEEccCccccccCCccccccccccEEEccCcccCCCCccc
Q 040845          328 FSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVS  407 (824)
Q Consensus       328 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~  407 (824)
                           +..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++..+..
T Consensus        81 -----~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~  154 (229)
T 3e6j_A           81 -----VGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGA  154 (229)
T ss_dssp             -----TTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTT
T ss_pred             -----hhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHH
Confidence                 444566666777777777777666666777777888888888777 56777777778888888888887555566


Q ss_pred             ccCCcccceeeccCCcccCCCC
Q 040845          408 LEKLSYLKDLNLSFNKLKGEIP  429 (824)
Q Consensus       408 ~~~l~~L~~L~l~~N~l~~~~p  429 (824)
                      +..+++|+.|++++|+++|.++
T Consensus       155 ~~~l~~L~~L~l~~N~~~c~c~  176 (229)
T 3e6j_A          155 FDRLSSLTHAYLFGNPWDCECR  176 (229)
T ss_dssp             TTTCTTCCEEECTTSCBCTTBG
T ss_pred             HhCCCCCCEEEeeCCCccCCcc
Confidence            7777788888888888877765

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.77  E-value=1.1e-18  Score=175.43  Aligned_cols=155  Identities=24%  Similarity=0.244  Sum_probs=139.9

Q ss_pred             CcEEEcCCCCCCCCCCcccccccccccccccccccCcCCccccccccchhhhcccccccccCCCccCCCCCCCeEEccCc
Q 040845          295 LKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYN  374 (824)
Q Consensus       295 L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N  374 (824)
                      .+.++.++++++.+|..+.  ++|+.|+|++|.+++..|..|.++++|+.|+|++|+|+...+..|..+++|+.|+|++|
T Consensus        21 ~~~v~c~~~~l~~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N   98 (229)
T 3e6j_A           21 GTTVDCRSKRHASVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTN   98 (229)
T ss_dssp             TTEEECTTSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CCEeEccCCCcCccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCC
Confidence            5678899999999987664  88999999999999888999999999999999999999877788999999999999999


Q ss_pred             cccccCCccccccccccEEEccCcccCCCCcccccCCcccceeeccCCcccCCCCC-CCCccccccccccCCccccCCC
Q 040845          375 RLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIPR-GGSFGNFSAESFKGNELLCGSP  452 (824)
Q Consensus       375 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~~~~~~~~~~~n~~~c~~~  452 (824)
                      +|++..+..|..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|++++.++. ...+.++..+.+.+|++.|.|+
T Consensus        99 ~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~  176 (229)
T 3e6j_A           99 QLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR  176 (229)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred             cCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence            999877778899999999999999999 8899999999999999999999977764 3456788889999999999875

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.77  E-value=5.1e-21  Score=217.98  Aligned_cols=140  Identities=19%  Similarity=0.156  Sum_probs=71.8

Q ss_pred             cCCCCCcEEEccCCcccccccccccCCCCCCEEeCCCCc-------------CCcccChhhhCcCCCceee-ccCCcccc
Q 040845           18 DNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNK-------------LLGTIPAAIFNVSTLKAFA-VTNNSLSG   83 (824)
Q Consensus        18 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~-------------l~~~~~~~~~~l~~L~~L~-L~~n~l~~   83 (824)
                      ...++|+.|+|++|+++ .+|..++++++|+.|++++|.             +.+..|..+..+++|+.|+ ++.|.+. 
T Consensus       346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~-  423 (567)
T 1dce_A          346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD-  423 (567)
T ss_dssp             STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH-
T ss_pred             ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc-
Confidence            45566666666666666 556666666666666665554             3344555555666666665 4444332 


Q ss_pred             ccCccccCCCCCccEEEccCCeeeeecCccccCCCCCceEeccCccccccCCccccCCCCCCEEEccCCcCCCCcCcccc
Q 040845           84 CLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSF  163 (824)
Q Consensus        84 ~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~  163 (824)
                                 +|+.+.+++|.++...+      ..|+.|+|++|+|++ +|. |+++++|++|+|++|.|+.+|     
T Consensus       424 -----------~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~~lp-----  479 (567)
T 1dce_A          424 -----------DLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLRALP-----  479 (567)
T ss_dssp             -----------HHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCCCCC-----
T ss_pred             -----------hhhhhhhhcccccccCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCcccccccc-----
Confidence                       33334444444442211      125555555555553 233 555555555555555554332     


Q ss_pred             cccCCCCCCCcEEECcCCCCC
Q 040845          164 LSSLSNCKSLTHISLSNNPLD  184 (824)
Q Consensus       164 ~~~l~~l~~L~~L~Ls~n~l~  184 (824)
                       ..+..+++|++|+|++|.|+
T Consensus       480 -~~~~~l~~L~~L~Ls~N~l~  499 (567)
T 1dce_A          480 -PALAALRCLEVLQASDNALE  499 (567)
T ss_dssp             -GGGGGCTTCCEEECCSSCCC
T ss_pred             -hhhhcCCCCCEEECCCCCCC
Confidence             22344444444444444443

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.77  E-value=3e-19  Score=174.28  Aligned_cols=128  Identities=28%  Similarity=0.348  Sum_probs=62.4

Q ss_pred             cEEEccCccccccCCccccCCCCCcEEEcCCCCCCCCCCc--ccccccccccccccccccCcCCccccccccchhhhccc
Q 040845          272 YELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLN--FWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSM  349 (824)
Q Consensus       272 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~--~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~  349 (824)
                      +.+++++|+++ .+|..+..  +|++|++++|.|+.++..  +..+++|+.|+|++|.+++..|..|.++++|+.|+|++
T Consensus        11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~   87 (192)
T 1w8a_A           11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence            45555555554 23332221  455555555555555432  44455555555555555544444455555555555555


Q ss_pred             ccccccCCCccCCCCCCCeEEccCccccccCCccccccccccEEEccCcccCC
Q 040845          350 NNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSG  402 (824)
Q Consensus       350 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  402 (824)
                      |+|++..+..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|++++
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c  140 (192)
T 1w8a_A           88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC  140 (192)
T ss_dssp             CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCC
T ss_pred             CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccC
Confidence            55544444444445555555555555544444444444555555555554443

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.76  E-value=7e-19  Score=180.89  Aligned_cols=168  Identities=22%  Similarity=0.292  Sum_probs=87.2

Q ss_pred             cCCCceeeccCCccccccCccccCCCCCccEEEccCCeeeeecCccccCCCCCceEeccCccccccCCccccCCCCCCEE
Q 040845           68 VSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWL  147 (824)
Q Consensus        68 l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L  147 (824)
                      +.++..+++++|.+++++. .  ..+++|++|++++|+++ .++ .+..+++|++|+|++|++++..+  |.++++|++|
T Consensus        18 l~~l~~l~l~~~~i~~~~~-~--~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L   90 (263)
T 1xeu_A           18 LANAVKQNLGKQSVTDLVS-Q--KELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL   90 (263)
T ss_dssp             HHHHHHHHHTCSCTTSEEC-H--HHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred             HHHHHHHHhcCCCcccccc-h--hhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence            3445555555555554431 1  12455555555555555 223 45555566666666666554332  5556666666


Q ss_pred             EccCCcCCCCcCcccccccCCCCCCCcEEECcCCCCCccCCccccccccccccEEEeecCcceecCCccCCCCCCCCEEE
Q 040845          148 TLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIV  227 (824)
Q Consensus       148 ~L~~n~i~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~  227 (824)
                      +|++|+++.++.       +.. ++|++|+|++|.+.++                            ..+..+++|+.|+
T Consensus        91 ~L~~N~l~~l~~-------~~~-~~L~~L~L~~N~l~~~----------------------------~~l~~l~~L~~L~  134 (263)
T 1xeu_A           91 SVNRNRLKNLNG-------IPS-ACLSRLFLDNNELRDT----------------------------DSLIHLKNLEILS  134 (263)
T ss_dssp             ECCSSCCSCCTT-------CCC-SSCCEEECCSSCCSBS----------------------------GGGTTCTTCCEEE
T ss_pred             ECCCCccCCcCc-------ccc-CcccEEEccCCccCCC----------------------------hhhcCcccccEEE
Confidence            666666555431       112 5555555555554432                            1244556666666


Q ss_pred             ecCCccCCccchhhcCCCCCCEEEcccccCcccCCccccccCCccEEEccCcccc
Q 040845          228 LGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLS  282 (824)
Q Consensus       228 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~  282 (824)
                      |++|++++. + .+..+++|++|+|++|++++.  ..+..+++|+.|++++|++.
T Consensus       135 Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~  185 (263)
T 1xeu_A          135 IRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCV  185 (263)
T ss_dssp             CTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEE
T ss_pred             CCCCcCCCC-h-HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCccc
Confidence            666666543 2 455566666666666666543  34444555555555555554

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.76  E-value=7.3e-19  Score=187.62  Aligned_cols=263  Identities=14%  Similarity=0.116  Sum_probs=131.2

Q ss_pred             cCCCceeeccCCccc--cccCccccCCCCCccEEEccCCeeeeecCccccC--------CCCCceEeccCccccccCCcc
Q 040845           68 VSTLKAFAVTNNSLS--GCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFN--------ASKLSKLALEMNSFSGFIPST  137 (824)
Q Consensus        68 l~~L~~L~L~~n~l~--~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~--------l~~L~~L~L~~N~i~~~~~~~  137 (824)
                      +++|++|||++|++.  .....    .++.++.+.+..|.|   .+..|.+        +++|++|+|.+ .++.+.+.+
T Consensus        48 l~~L~~LdLs~n~i~~~~~~~~----~~~~~~~~~~~~~~I---~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~a  119 (329)
T 3sb4_A           48 FPSLKVLDISNAEIKMYSGKAG----TYPNGKFYIYMANFV---PAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAA  119 (329)
T ss_dssp             CTTCCEEEEEEEEECCEEESSS----SSGGGCCEEECTTEE---CTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTT
T ss_pred             hccCeEEecCcceeEEecCccc----ccccccccccccccc---CHHHhcccccccccccCCCcEEECCc-cccchhHHH
Confidence            445555555555554  11111    122344445555532   2345555        77777777777 677677777


Q ss_pred             ccCCCCCCEEEccCCcCCCCcCcccccccCCCCCCCcEEECcCCCCCccCCccccccccccccEEEeecCcceecCCccC
Q 040845          138 FGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEI  217 (824)
Q Consensus       138 ~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l  217 (824)
                      |.++++|++|++++|.+..++.     .+|..+.++..+.+..+....                      .........|
T Consensus       120 F~~~~~L~~l~l~~n~i~~i~~-----~aF~~~~~l~~l~~~~~~~~~----------------------~~~~i~~~~f  172 (329)
T 3sb4_A          120 FKGCDNLKICQIRKKTAPNLLP-----EALADSVTAIFIPLGSSDAYR----------------------FKNRWEHFAF  172 (329)
T ss_dssp             TTTCTTCCEEEBCCSSCCEECT-----TSSCTTTCEEEECTTCTHHHH----------------------TSTTTTTSCE
T ss_pred             hhcCcccceEEcCCCCccccch-----hhhcCCCceEEecCcchhhhh----------------------cccccccccc
Confidence            7777777777777777766554     235666666666554422100                      0000111233


Q ss_pred             CCCCCCC-EEEecCCccCCccchhh----cCCCCCCEEEcccccCcccCCccc-cccCCccEEEccCccccccCCccccC
Q 040845          218 TNLTDLT-TIVLGGNKLNGSIPITL----GKLQKLQDVDLEYNQLEGSIPDSI-CLSVELYELELGGNKLSGSIPACFSN  291 (824)
Q Consensus       218 ~~l~~L~-~L~L~~n~l~~~~~~~~----~~l~~L~~L~L~~n~l~~~~~~~~-~~~~~L~~L~l~~n~l~~~~~~~~~~  291 (824)
                      .++..|+ .+.+....   .++..+    ....+++.+.+.++-.. .....+ ..+++|+.|+|++|+++.+.+.+|.+
T Consensus       173 ~~~~~L~~~i~~~~~~---~l~~~~~~~~~~~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~  248 (329)
T 3sb4_A          173 IEGEPLETTIQVGAMG---KLEDEIMKAGLQPRDINFLTIEGKLDN-ADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQ  248 (329)
T ss_dssp             EESCCCEEEEEECTTC---CHHHHHHHTTCCGGGCSEEEEEECCCH-HHHHHHHHHCTTCCEEECTTBCCCEECTTTTTT
T ss_pred             ccccccceeEEecCCC---cHHHHHhhcccCccccceEEEeeeecH-HHHHHHHHhcCCCeEEECCCCCcceecHhhhhC
Confidence            3444444 33333321   112211    12344555555443221 111111 12455555555555555555555656


Q ss_pred             CCCCcEEEcCCCCCCCCCCcccccccccccccccccccCcCCccccccccch-hhhcccccccccCCCccCCCCCCCeEE
Q 040845          292 MTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALI-EIDFSMNNFSGIIPMEIGSLKNLENLF  370 (824)
Q Consensus       292 l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~-~L~l~~N~l~~~~~~~~~~l~~L~~L~  370 (824)
                      +++|+.|+|.+| ++.|+                       +.+|.++++|+ .+++.+ .++.+.+.+|.+|++|+.|+
T Consensus       249 ~~~L~~l~l~~n-i~~I~-----------------------~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~  303 (329)
T 3sb4_A          249 KKYLLKIKLPHN-LKTIG-----------------------QRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVL  303 (329)
T ss_dssp             CTTCCEEECCTT-CCEEC-----------------------TTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEE
T ss_pred             CCCCCEEECCcc-cceeh-----------------------HHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEE
Confidence            655666655554 44443                       44455555555 555555 44445555566666666666


Q ss_pred             ccCccccccCCccccccccccEEE
Q 040845          371 LEYNRLEGSIPDSFGDLISLKSLN  394 (824)
Q Consensus       371 L~~N~l~~~~~~~~~~l~~L~~L~  394 (824)
                      +++|.++...+.+|.++++|+.++
T Consensus       304 l~~n~i~~I~~~aF~~~~~L~~ly  327 (329)
T 3sb4_A          304 ATGDKITTLGDELFGNGVPSKLIY  327 (329)
T ss_dssp             ECSSCCCEECTTTTCTTCCCCEEE
T ss_pred             eCCCccCccchhhhcCCcchhhhc
Confidence            666666554455566666666554

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.75  E-value=5.8e-19  Score=207.53  Aligned_cols=196  Identities=18%  Similarity=0.135  Sum_probs=120.0

Q ss_pred             CCCCEEEccCCcCCCCcCcccccccCCCCCCCcEEECcCCCCCccCCccccccccccccEEEeecCcceecCCccCCCCC
Q 040845          142 RNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLT  221 (824)
Q Consensus       142 ~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~  221 (824)
                      +.++.|+|.+|.+...+.           ..|+.++|+.|.|.+                +++..|.+. ..+..+..++
T Consensus       173 ~~~~~l~L~~n~~~~~~~-----------~~l~~l~Ls~~~i~~----------------~~~~~n~~~-~~~~~~~~l~  224 (727)
T 4b8c_D          173 PLTPKIELFANGKDEANQ-----------ALLQHKKLSQYSIDE----------------DDDIENRMV-MPKDSKYDDQ  224 (727)
T ss_dssp             -----------------------------------------------------------------------------CCC
T ss_pred             CccceEEeeCCCCCcchh-----------hHhhcCccCcccccC----------------cccccccee-cChhhhccCC
Confidence            445666666666654321           234555555555432                233344444 5577788899


Q ss_pred             CCCEEEecCCccCCccchhhcCCCCCCEEEcccccCcccCCccccccCCccEEEccCccccccCCccccCCCCCcEEEcC
Q 040845          222 DLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLG  301 (824)
Q Consensus       222 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~  301 (824)
                      +|+.|+|++|.+. .+|..+..+++|++|+|++|.|+ .+|..|+.+++|+.|+|++|+|+ .+|..|+++++|++|+|+
T Consensus       225 ~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~  301 (727)
T 4b8c_D          225 LWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFF  301 (727)
T ss_dssp             CCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECC
T ss_pred             CCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECC
Confidence            9999999999998 56666668999999999999999 78888999999999999999999 668889999999999999


Q ss_pred             CCCCCCCCCcccccccccccccccccccCcCCcccccccc-chhhhcccccccccCCCccCCCCCCCeEEccCc
Q 040845          302 SNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKA-LIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYN  374 (824)
Q Consensus       302 ~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~-L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N  374 (824)
                      +|.|+.+|..|..+++|+.|+|++|.+++.+|..+..+.. +..|+|++|.+++.+|.      .|+.|++++|
T Consensus       302 ~N~l~~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~------~l~~l~l~~n  369 (727)
T 4b8c_D          302 DNMVTTLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH------ERRFIEINTD  369 (727)
T ss_dssp             SSCCCCCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC------C---------
T ss_pred             CCCCCccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcc------ccceeEeecc
Confidence            9999999999999999999999999999888887766543 34578999999877765      4556677776

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.75  E-value=4.1e-19  Score=182.60  Aligned_cols=168  Identities=21%  Similarity=0.256  Sum_probs=108.6

Q ss_pred             CCCCCEEEecCCccCCccchhhcCCCCCCEEEcccccCcccCCccccccCCccEEEccCccccccCCccccCCCCCcEEE
Q 040845          220 LTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLS  299 (824)
Q Consensus       220 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~  299 (824)
                      +.++..+++++|.+++..  .+..+++|++|++++|.++. ++ .+..+++|+.|++++|++++..+  +.++++|++|+
T Consensus        18 l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~   91 (263)
T 1xeu_A           18 LANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELS   91 (263)
T ss_dssp             HHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEE
T ss_pred             HHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEE
Confidence            455666677777776433  46677777888888777773 33 56777777777777777775544  77777888888


Q ss_pred             cCCCCCCCCCCcccccccccccccccccccCcCCccccccccchhhhcccccccccCCCccCCCCCCCeEEccCcccccc
Q 040845          300 LGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGS  379 (824)
Q Consensus       300 L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  379 (824)
                      +++|+++.+|....  ++|+.|++++|.+++.  ..+..+++|+.|++++|++++. + .+..+++|+.|+|++|++++.
T Consensus        92 L~~N~l~~l~~~~~--~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~  165 (263)
T 1xeu_A           92 VNRNRLKNLNGIPS--ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT  165 (263)
T ss_dssp             CCSSCCSCCTTCCC--SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC
T ss_pred             CCCCccCCcCcccc--CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcch
Confidence            88887777764332  6666666666666642  2455666666666666666543 2 455666666666666666643


Q ss_pred             CCccccccccccEEEccCcccC
Q 040845          380 IPDSFGDLISLKSLNLSYNNLS  401 (824)
Q Consensus       380 ~~~~~~~l~~L~~L~L~~N~l~  401 (824)
                        ..+..+++|+.|++++|+++
T Consensus       166 --~~l~~l~~L~~L~l~~N~~~  185 (263)
T 1xeu_A          166 --GGLTRLKKVNWIDLTGQKCV  185 (263)
T ss_dssp             --TTSTTCCCCCEEEEEEEEEE
T ss_pred             --HHhccCCCCCEEeCCCCccc
Confidence              44566666666666666665

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.75  E-value=1.4e-18  Score=170.55  Aligned_cols=150  Identities=18%  Similarity=0.247  Sum_probs=88.2

Q ss_pred             CCccEEEccCccccccCCccccCCCCCcEEEcCCCCCCCCCCcccccccccccccccccccCcCCccccccccchhhhcc
Q 040845          269 VELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFS  348 (824)
Q Consensus       269 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~  348 (824)
                      ++|+.|++++|.++ .++ .+..+++|++|++++|.++.++ .+..+++|++|++++|.+++..+..+..+++|+.|+++
T Consensus        44 ~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~~~-~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls  120 (197)
T 4ezg_A           44 NSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATNYN-PISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDIS  120 (197)
T ss_dssp             HTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSCCG-GGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECC
T ss_pred             CCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCcch-hhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEec
Confidence            33444444444443 122 2444445555555555444433 34445555555555555555555666666777777777


Q ss_pred             cccccccCCCccCCCCCCCeEEccCcc-ccccCCccccccccccEEEccCcccCCCCcccccCCcccceeeccCCccc
Q 040845          349 MNNFSGIIPMEIGSLKNLENLFLEYNR-LEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLK  425 (824)
Q Consensus       349 ~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~  425 (824)
                      +|++++..+..++.+++|++|++++|. ++ .+| .+..+++|+.|++++|++++ ++ .+..+++|+.|++++|++.
T Consensus       121 ~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N~i~  194 (197)
T 4ezg_A          121 HSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQTIG  194 (197)
T ss_dssp             SSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC---
T ss_pred             CCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCcccC
Confidence            777766566667777777777777776 55 344 57777777777777777763 44 5667777777777777764

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.74  E-value=7.3e-19  Score=180.16  Aligned_cols=138  Identities=21%  Similarity=0.270  Sum_probs=107.2

Q ss_pred             cCCCCceeeeccceEEEEEEE-CCCcE--EEEEEeeccccc------------------------hhhhHHHHHHHHhcC
Q 040845          528 KFSENNLIGRGGFGSVYKARI-RDGME--VAVKVFNLQCGR------------------------AFKSFDVECAMMKSI  580 (824)
Q Consensus       528 ~~~~~~~lg~G~~g~V~~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l  580 (824)
                      -|++.+.||+|+||.||+|.+ .+|+.  ||||+++.....                        ....+.+|+.+++++
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            367789999999999999987 67989  999987543111                        113578899999999


Q ss_pred             CCCcc--eeEEeeeecCCeeEEEEeccCC-C----CHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCC
Q 040845          581 RHRNL--VKVISSCSNEEFKALVLEYMPH-G----SLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL  653 (824)
Q Consensus       581 ~h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dl  653 (824)
                      +|+++  +.+++.    ...++||||+.+ |    +|.++...    .++.++..++.|++.|++|||.  +.+|+||||
T Consensus       128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~--~~givHrDl  197 (258)
T 1zth_A          128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQ--EAELVHADL  197 (258)
T ss_dssp             HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHH--TSCEECSSC
T ss_pred             HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHH--HCCEEeCCC
Confidence            88764  344432    356899999942 3    77776543    2244577899999999999994  579999999


Q ss_pred             CCCCeeeCCCCcEEEeeccccccc
Q 040845          654 KPSNVLLDDNMVAHLSDFGIAKLL  677 (824)
Q Consensus       654 k~~Nill~~~~~~kl~Dfg~a~~~  677 (824)
                      ||+|||++.  .++|+|||+|...
T Consensus       198 kp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          198 SEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             STTSEEESS--SEEECCCTTCEET
T ss_pred             CHHHEEEcC--cEEEEECcccccC
Confidence            999999998  9999999999754

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.74  E-value=3.2e-20  Score=211.38  Aligned_cols=180  Identities=22%  Similarity=0.207  Sum_probs=101.1

Q ss_pred             CCCCCCCEEEecCCccCCccchhhcCCCCCCEEEccccc-------------CcccCCccccccCCccEEE-ccCccccc
Q 040845          218 TNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQ-------------LEGSIPDSICLSVELYELE-LGGNKLSG  283 (824)
Q Consensus       218 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~-------------l~~~~~~~~~~~~~L~~L~-l~~n~l~~  283 (824)
                      ..+++|+.|+|++|+++ .+|..++.+++|+.|++++|.             +.+..|..+..+++|+.|+ ++.|.+..
T Consensus       346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~~  424 (567)
T 1dce_A          346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDD  424 (567)
T ss_dssp             STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHHH
T ss_pred             ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccch
Confidence            55677777888888876 667777777888888776664             3445556666666666666 44443321


Q ss_pred             cCCc-----cccC--CCCCcEEEcCCCCCCCCCCcccccccccccccccccccCcCCccccccccchhhhcccccccccC
Q 040845          284 SIPA-----CFSN--MTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGII  356 (824)
Q Consensus       284 ~~~~-----~~~~--l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~  356 (824)
                      ....     .+..  ...|+.|+|++|.|+.+|. +..+++|+.|+|++|.++ .+|..|+++++|+.|+|++|+|++ +
T Consensus       425 L~~l~l~~n~i~~l~~~~L~~L~Ls~n~l~~lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-l  501 (567)
T 1dce_A          425 LRSKFLLENSVLKMEYADVRVLHLAHKDLTVLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-V  501 (567)
T ss_dssp             HHHHHHHHHHHHHHHHTTCSEEECTTSCCSSCCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-C
T ss_pred             hhhhhhhcccccccCccCceEEEecCCCCCCCcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-C
Confidence            0000     0000  0135555555555555554 555555555555555555 445555555555555555555554 3


Q ss_pred             CCccCCCCCCCeEEccCccccccC-CccccccccccEEEccCcccCC
Q 040845          357 PMEIGSLKNLENLFLEYNRLEGSI-PDSFGDLISLKSLNLSYNNLSG  402 (824)
Q Consensus       357 ~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~  402 (824)
                      | .++.+++|+.|+|++|+|++.. |..|+.+++|+.|+|++|+|++
T Consensus       502 p-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~  547 (567)
T 1dce_A          502 D-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ  547 (567)
T ss_dssp             G-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred             c-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCC
Confidence            3 4555555555555555555443 5555555555555555555553

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.74  E-value=3.6e-18  Score=167.57  Aligned_cols=131  Identities=16%  Similarity=0.250  Sum_probs=63.4

Q ss_pred             cCCCCCCEEeCCCCcCCcccChhhhCcCCCceeeccCCccccccCccccCCCCCccEEEccCCeeeeecCccccCCCCCc
Q 040845           42 GHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLS  121 (824)
Q Consensus        42 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~  121 (824)
                      +.+++|++|++++|.++ .+| .+..+++|++|++++|.++..+ .  ...+++|++|++++|++++..+..+..+++|+
T Consensus        41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~~~-~--l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~  115 (197)
T 4ezg_A           41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATNYN-P--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLT  115 (197)
T ss_dssp             HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSCCG-G--GTTCTTCCEEEEECTTCBGGGSCCCTTCTTCC
T ss_pred             hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCcch-h--hhcCCCCCEEEeECCccCcccChhhcCCCCCC
Confidence            44555555555555555 333 3555555555555555443332 1  12345555555555555544444455555555


Q ss_pred             eEeccCccccccCCccccCCCCCCEEEccCCc-CCCCcCcccccccCCCCCCCcEEECcCCCCC
Q 040845          122 KLALEMNSFSGFIPSTFGNLRNLEWLTLYDNN-LTSSTLDLSFLSSLSNCKSLTHISLSNNPLD  184 (824)
Q Consensus       122 ~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~-i~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~  184 (824)
                      +|+|++|++++..+..|+++++|++|++++|+ ++.++       .+..+++|++|++++|.+.
T Consensus       116 ~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~-------~l~~l~~L~~L~l~~n~i~  172 (197)
T 4ezg_A          116 LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-------PLKTLPELKSLNIQFDGVH  172 (197)
T ss_dssp             EEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG-------GGGGCSSCCEEECTTBCCC
T ss_pred             EEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccH-------hhcCCCCCCEEECCCCCCc
Confidence            55555555554444445555555555555554 43332       1344444444444444443

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.73  E-value=4.1e-19  Score=208.82  Aligned_cols=163  Identities=24%  Similarity=0.196  Sum_probs=89.6

Q ss_pred             EEecCCccCCccchhhcCCCCCCEEEcccccCcccCCccccccCCccEEEccCccccccCCccccCCCCCcEEEcCCCCC
Q 040845          226 IVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNEL  305 (824)
Q Consensus       226 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l  305 (824)
                      +++..|.+. ..+..|..+++|+.|+|++|.+. .+|..+..+++|++|+|++|+|+ .+|..|+++++|++|+|++|.|
T Consensus       206 ~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l  282 (727)
T 4b8c_D          206 DDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRL  282 (727)
T ss_dssp             -----------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCC
T ss_pred             cccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcC
Confidence            344455555 55667777777777777777777 55555556777777777777776 5566667777777777777777


Q ss_pred             CCCCCcccccccccccccccccccCcCCccccccccchhhhcccccccccCCCccCCCCC-CCeEEccCccccccCCccc
Q 040845          306 TSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKN-LENLFLEYNRLEGSIPDSF  384 (824)
Q Consensus       306 ~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~-L~~L~L~~N~l~~~~~~~~  384 (824)
                      +.+|..+..+++|+.|+|++|.|+ .+|..|+++++|+.|+|++|.|++.+|..+..+.. +..|+|++|.+++.+|.  
T Consensus       283 ~~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~--  359 (727)
T 4b8c_D          283 TSLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH--  359 (727)
T ss_dssp             SSCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC--
T ss_pred             CccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcc--
Confidence            777666666666666666666665 45555666666666666666666665555544321 12355666666655553  


Q ss_pred             cccccccEEEccCc
Q 040845          385 GDLISLKSLNLSYN  398 (824)
Q Consensus       385 ~~l~~L~~L~L~~N  398 (824)
                          .|+.|++++|
T Consensus       360 ----~l~~l~l~~n  369 (727)
T 4b8c_D          360 ----ERRFIEINTD  369 (727)
T ss_dssp             ----C---------
T ss_pred             ----ccceeEeecc
Confidence                2344455554

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.73  E-value=9.7e-18  Score=163.57  Aligned_cols=155  Identities=25%  Similarity=0.314  Sum_probs=126.9

Q ss_pred             cEEEcCCCCCCCCCCcccccccccccccccccccCcCCc-cccccccchhhhcccccccccCCCccCCCCCCCeEEccCc
Q 040845          296 KVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPL-EIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYN  374 (824)
Q Consensus       296 ~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N  374 (824)
                      +.+++++|.++++|..+..  +|+.|++++|.+++..+. .|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|
T Consensus        11 ~~l~~s~~~l~~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N   88 (192)
T 1w8a_A           11 TTVDCTGRGLKEIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN   88 (192)
T ss_dssp             TEEECTTSCCSSCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred             CEEEcCCCCcCcCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCC
Confidence            6889999999999887654  889999999999876654 4888999999999999999888889999999999999999


Q ss_pred             cccccCCccccccccccEEEccCcccCCCCcccccCCcccceeeccCCcccCCCCCCCCccccccccccCCccccCCC
Q 040845          375 RLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIPRGGSFGNFSAESFKGNELLCGSP  452 (824)
Q Consensus       375 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~  452 (824)
                      +|++..+..|..+++|+.|+|++|+|++..|..+..+++|+.|+|++|+|+|.++.......+....+.++...|+.|
T Consensus        89 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~P  166 (192)
T 1w8a_A           89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP  166 (192)
T ss_dssp             CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSS
T ss_pred             cCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCCC
Confidence            999877888889999999999999999888888999999999999999999887642222223333455666677766

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.73  E-value=7.6e-18  Score=179.71  Aligned_cols=287  Identities=11%  Similarity=0.078  Sum_probs=196.9

Q ss_pred             CCCCCcEEEccCCcccccccccccC-CCCCCEEeCCCCcCC--cccChhhhCcCCCceeeccCCccccccCccccCC---
Q 040845           19 NISNLKVLYLYNNRLQGEIIHEIGH-LHNLGFLDLSQNKLL--GTIPAAIFNVSTLKAFAVTNNSLSGCLSSITDVG---   92 (824)
Q Consensus        19 ~l~~L~~L~L~~n~l~~~~~~~~~~-l~~L~~L~Ls~n~l~--~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~---   92 (824)
                      .+.++++|.++++ +.......+.. +++|++|||++|+|.  ...+..+   +.++.+.+..|.|.   .. .+.+   
T Consensus        23 ~~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~~~---~~~~~~~~~~~~I~---~~-aF~~~~~   94 (329)
T 3sb4_A           23 EANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAGTY---PNGKFYIYMANFVP---AY-AFSNVVN   94 (329)
T ss_dssp             HHHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSSSS---GGGCCEEECTTEEC---TT-TTEEEET
T ss_pred             hhCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCccccc---cccccccccccccC---HH-Hhccccc
Confidence            3678999999876 33222334444 889999999999998  3222222   23556666666432   22 2345   


Q ss_pred             -----CCCccEEEccCCeeeeecCccccCCCCCceEeccCccccccCCccccCCCCCCEEEccCCcC----CCCcCcccc
Q 040845           93 -----LPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNL----TSSTLDLSF  163 (824)
Q Consensus        93 -----l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i----~~~~~~~~~  163 (824)
                           +++|+.|+|.+ .++.+.+.+|.++++|+.|++.+|.+..+.+.+|.++.++..+.+..+..    ..+..    
T Consensus        95 ~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~----  169 (329)
T 3sb4_A           95 GVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEH----  169 (329)
T ss_dssp             TEEEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTT----
T ss_pred             ccccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccc----
Confidence                 89999999999 88878888899999999999999999888899999988888887766322    11111    


Q ss_pred             cccCCCCCCCc-EEECcCCCCCccCCcccc-ccccccccEEEeecCcceecCCccCCCCCCCCEEEecCCccCCccchhh
Q 040845          164 LSSLSNCKSLT-HISLSNNPLDGILPRTYV-GNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITL  241 (824)
Q Consensus       164 ~~~l~~l~~L~-~L~Ls~n~l~~~~~~~~~-~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~  241 (824)
                       .+|.++.+|+ .+.+....-  +....+. ...+.++..+.+.++-...........+++|+.|+|++|+++.+.+.+|
T Consensus       170 -~~f~~~~~L~~~i~~~~~~~--l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF  246 (329)
T 3sb4_A          170 -FAFIEGEPLETTIQVGAMGK--LEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTF  246 (329)
T ss_dssp             -SCEEESCCCEEEEEECTTCC--HHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTT
T ss_pred             -cccccccccceeEEecCCCc--HHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhh
Confidence             2355566666 455543221  1111110 0123456666666542211111111237888888888888887777788


Q ss_pred             cCCCCCCEEEcccccCcccCCccccccCCcc-EEEccCccccccCCccccCCCCCcEEEcCCCCCCCCCCc-cccccccc
Q 040845          242 GKLQKLQDVDLEYNQLEGSIPDSICLSVELY-ELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLN-FWSLKDIL  319 (824)
Q Consensus       242 ~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~-~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~-~~~l~~L~  319 (824)
                      .++++|++|+|.+| ++.+.+.+|..+.+|+ .+++.+ .++.+.+.+|.++++|+.|++++|.++.++.. |.++++|+
T Consensus       247 ~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~  324 (329)
T 3sb4_A          247 AQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSK  324 (329)
T ss_dssp             TTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCC
T ss_pred             hCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchh
Confidence            88888888888887 7767777888888888 888888 77777788888888899999888888888764 77788888


Q ss_pred             cccc
Q 040845          320 DLNL  323 (824)
Q Consensus       320 ~L~l  323 (824)
                      .++.
T Consensus       325 ~ly~  328 (329)
T 3sb4_A          325 LIYK  328 (329)
T ss_dssp             EEEC
T ss_pred             hhcc
Confidence            7753

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.71  E-value=4.5e-16  Score=169.38  Aligned_cols=266  Identities=13%  Similarity=0.147  Sum_probs=159.3

Q ss_pred             CCCCCcEEEccCCcccccccccccCCCCCCEEeCCCCcCCcccChhhhCcCCCceeeccCCccccccCccccCCCCCccE
Q 040845           19 NISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEV   98 (824)
Q Consensus        19 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~   98 (824)
                      ....++.+.+.+ .++......|.+. +|+.+++..| ++.+...+|.++ +|+.+.+.+ .++.+.... +.++++|+.
T Consensus       111 ~~~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~a-F~~c~~L~~  184 (401)
T 4fdw_A          111 ILKGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDI-FYYCYNLKK  184 (401)
T ss_dssp             ECSSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSST-TTTCTTCCE
T ss_pred             ecCCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHH-hhCcccCCe
Confidence            345666666654 3444555666664 5777777665 554555666663 577777764 555544443 346777777


Q ss_pred             EEccCCeeeeecCccccCCCCCceEeccCccccccCCccccCCCCCCEEEccCCcCCCCcCcccccccCCCCCCCcEEEC
Q 040845           99 LYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISL  178 (824)
Q Consensus        99 L~L~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~~L~~L~L  178 (824)
                      ++|++|+++......|. ..+|+.+.|..+ ++.+...+|.++++|+.+++..| ++.++.     .+|.+ .+|+.+.+
T Consensus       185 l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~-----~aF~~-~~L~~i~l  255 (401)
T 4fdw_A          185 ADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQ-----EAFRE-SGITTVKL  255 (401)
T ss_dssp             EECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECT-----TTTTT-CCCSEEEE
T ss_pred             eecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCccc-----ccccc-CCccEEEe
Confidence            77777777755555554 477777777643 66666777777777777777654 444433     23444 56666666


Q ss_pred             cCCCCCccCCccccccccccccEEEeecCcceecCCccCCCCCCCCEEEecCCccC-----CccchhhcCCCCCCEEEcc
Q 040845          179 SNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLN-----GSIPITLGKLQKLQDVDLE  253 (824)
Q Consensus       179 s~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~-----~~~~~~~~~l~~L~~L~L~  253 (824)
                      . +.+..+                          ...+|.+|++|+.+++.+|.+.     .+.+.+|.++++|+.++|.
T Consensus       256 p-~~i~~I--------------------------~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~  308 (401)
T 4fdw_A          256 P-NGVTNI--------------------------ASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP  308 (401)
T ss_dssp             E-TTCCEE--------------------------CTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC
T ss_pred             C-CCccEE--------------------------ChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC
Confidence            3 223322                          2344555666666666655543     3445566666666666666


Q ss_pred             cccCcccCCccccccCCccEEEccCccccccCCccccCCCCCcEEEcCCCCCCCCCCc-cccc-cccccccccccccc
Q 040845          254 YNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLN-FWSL-KDILDLNLSSNCFS  329 (824)
Q Consensus       254 ~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~-~~~l-~~L~~L~l~~N~l~  329 (824)
                       +.++.....+|..+.+|+.+.|..| ++.+...+|.++ +|+.+++.+|.+..++.. |.++ .++..|++..+.+.
T Consensus       309 -~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~  383 (401)
T 4fdw_A          309 -ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE  383 (401)
T ss_dssp             -TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred             -CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence             3355555566666666666666444 555666677777 777777777777666544 4444 35666666666543

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.71  E-value=8.1e-18  Score=164.06  Aligned_cols=131  Identities=31%  Similarity=0.407  Sum_probs=101.9

Q ss_pred             cEEEcCCCCCCCCCCcccccccccccccccccccCcCCccccccccchhhhcccccccccCCCccCCCCCCCeEEccCcc
Q 040845          296 KVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNR  375 (824)
Q Consensus       296 ~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~  375 (824)
                      +.+++++|.++.+|..+.  ++|+.|++++|.++ .+|..|.++++|+.|+|++|+|++..+..|.++++|+.|+|++|+
T Consensus        13 ~~l~~~~~~l~~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~   89 (193)
T 2wfh_A           13 TVVRCSNKGLKVLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR   89 (193)
T ss_dssp             TEEECTTSCCSSCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             CEEEcCCCCCCcCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence            466777777777776543  46777777777776 456777788888888888888887777788888888888888888


Q ss_pred             ccccCCccccccccccEEEccCcccCCCCcccccCCcccceeeccCCcccCCCC
Q 040845          376 LEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIP  429 (824)
Q Consensus       376 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p  429 (824)
                      |++..|..|..+++|+.|+|++|+|++..+..+..+++|+.|++++|+|.|.+.
T Consensus        90 l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~  143 (193)
T 2wfh_A           90 LRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCN  143 (193)
T ss_dssp             CCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred             cCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCc
Confidence            887777788888888888888888885555568888888888888888887654

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.70  E-value=7.6e-16  Score=168.53  Aligned_cols=336  Identities=13%  Similarity=0.082  Sum_probs=173.9

Q ss_pred             ccccCCcccccCCCCCcEEEccCCcccccccccccCCCCCCEEeCCCCcCCcccChhhhCcCCCceeeccCCccccccCc
Q 040845            8 FLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLSGCLSS   87 (824)
Q Consensus         8 ~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~   87 (824)
                      .++++-..+|.++.+|+.+.|.. .++.....+|.++++|+.+++.++ ++.+...+|.++.+|+.+.+..+ +..+...
T Consensus        58 ~VtsIg~~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~  134 (394)
T 4fs7_A           58 DVVSIGYAAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVE  134 (394)
T ss_dssp             EEEEECTTTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTT
T ss_pred             eEeEhHHHHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecce
Confidence            45666667777777777777764 366555667777777777777654 55455567777777777666543 3322222


Q ss_pred             cccCCCCCccEEEccCCeeeeecCccccCCCCCceEeccCccccccCCccccCCCCCCEEEccCCcCCCCcCcccccccC
Q 040845           88 ITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSL  167 (824)
Q Consensus        88 ~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l  167 (824)
                      .. .+...++.......  .......|.++++|+.+.+..+. ..+...+|.++++|+.+.+..| ++.+..     .++
T Consensus       135 aF-~~~~~~~~~~~~~~--~~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I~~-----~~F  204 (394)
T 4fs7_A          135 AF-KGCDFKEITIPEGV--TVIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKIIRD-----YCF  204 (394)
T ss_dssp             TT-TTCCCSEEECCTTC--CEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEECT-----TTT
T ss_pred             ee-ecccccccccCccc--cccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEeCc-----hhh
Confidence            21 23332222222222  12334556666666666665443 2255556666666666666544 333322     235


Q ss_pred             CCCCCCcEEECcCCCCCccCCccccccccccccEEEeecCcceecCCccCCCCCCCCEEEecCCccCCccchhhcCCCCC
Q 040845          168 SNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKL  247 (824)
Q Consensus       168 ~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L  247 (824)
                      .++..|+.+.+..+... +                           .......++|+.+.+..+ ++.+...+|.++..|
T Consensus       205 ~~~~~L~~i~~~~~~~~-i---------------------------~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l  255 (394)
T 4fs7_A          205 AECILLENMEFPNSLYY-L---------------------------GDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDL  255 (394)
T ss_dssp             TTCTTCCBCCCCTTCCE-E---------------------------CTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSC
T ss_pred             ccccccceeecCCCceE-e---------------------------ehhhcccCCCceEEECCC-ceecccccccccccc
Confidence            55555555555433221 1                           111222344555554432 222333445555555


Q ss_pred             CEEEcccccCcccCCccccccCCccEEEccCccccccCCccccCCCCCcEEEcCCCCCCCCCCccccccccccccccccc
Q 040845          248 QDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNC  327 (824)
Q Consensus       248 ~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~  327 (824)
                      +.+.+..+... .....|.....++.+....+.+   ...+|..+.+|+.+.+.++ ++.                    
T Consensus       256 ~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i---~~~~F~~~~~L~~i~l~~~-i~~--------------------  310 (394)
T 4fs7_A          256 ESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIV---PEKTFYGCSSLTEVKLLDS-VKF--------------------  310 (394)
T ss_dssp             CEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEE---CTTTTTTCTTCCEEEECTT-CCE--------------------
T ss_pred             eeEEcCCCcce-eeccccccccccceeccCceee---ccccccccccccccccccc-cce--------------------
Confidence            55555444332 3334444444444444443332   2234444555555554322 333                    


Q ss_pred             ccCcCCccccccccchhhhcccccccccCCCccCCCCCCCeEEccCccccccCCccccccccccEEEccCcccCCCCccc
Q 040845          328 FSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVS  407 (824)
Q Consensus       328 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~  407 (824)
                         +...+|.++.+|+.++|.++ ++.+...+|.++.+|+.+++..| ++.....+|.+|.+|+.+++..+ ++ .+...
T Consensus       311 ---I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~  383 (394)
T 4fs7_A          311 ---IGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-QYRYD  383 (394)
T ss_dssp             ---ECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGGGG
T ss_pred             ---echhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-Ehhhe
Confidence               33445555566666655433 44455566666666666666655 54445566666777777766544 33 34455


Q ss_pred             ccCCccccee
Q 040845          408 LEKLSYLKDL  417 (824)
Q Consensus       408 ~~~l~~L~~L  417 (824)
                      |.++++|+.+
T Consensus       384 F~~c~~L~~I  393 (394)
T 4fs7_A          384 FEDTTKFKWI  393 (394)
T ss_dssp             BCTTCEEEEE
T ss_pred             ecCCCCCcEE
Confidence            6666666654

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.69  E-value=8.8e-16  Score=167.12  Aligned_cols=265  Identities=10%  Similarity=0.090  Sum_probs=154.1

Q ss_pred             CCCccEEEccCCeeeeecCccccCCCCCceEeccCccccccCCccccCCCCCCEEEccCCcCCCCcCcccccccCCCCCC
Q 040845           93 LPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKS  172 (824)
Q Consensus        93 l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~~  172 (824)
                      +..++.+.+.++ ++.+...+|.+. +|+.+.|..| ++.+...+|.+ .+|+.+.+.. .++.++.     .+|.++++
T Consensus       112 ~~~l~~i~ip~~-i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~-~~L~~i~lp~-~l~~I~~-----~aF~~c~~  181 (401)
T 4fdw_A          112 LKGYNEIILPNS-VKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFN-STVQEIVFPS-TLEQLKE-----DIFYYCYN  181 (401)
T ss_dssp             CSSCSEEECCTT-CCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTT-CCCCEEECCT-TCCEECS-----STTTTCTT
T ss_pred             cCCccEEEECCc-cCEehHhhcccC-CccEEEeCCC-ccEECHHhcCC-CCceEEEeCC-CccEehH-----HHhhCccc
Confidence            345666666543 444555566653 5777777655 55566667766 3577777764 4554443     34667777


Q ss_pred             CcEEECcCCCCCccCCccccccccccccEEEeecCcceecCCccCCCCCCCCEEEecCCccCCccchhhcCCCCCCEEEc
Q 040845          173 LTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDL  252 (824)
Q Consensus       173 L~~L~Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  252 (824)
                      |+.++++.|.+..+....|..   .+|+.+.+.++ +..+...+|.++++|+.+++..| ++.+...+|.+ .       
T Consensus       182 L~~l~l~~n~l~~I~~~aF~~---~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~-------  248 (401)
T 4fdw_A          182 LKKADLSKTKITKLPASTFVY---AGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-S-------  248 (401)
T ss_dssp             CCEEECTTSCCSEECTTTTTT---CCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-C-------
T ss_pred             CCeeecCCCcceEechhhEee---cccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-C-------
Confidence            777777777766665555531   34455554422 44344444455555555555442 33333344444 3       


Q ss_pred             ccccCcccCCccccccCCccEEEccCccccccCCccccCCCCCcEEEcCCCCCC-----CCCC-cccccccccccccccc
Q 040845          253 EYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELT-----SIPL-NFWSLKDILDLNLSSN  326 (824)
Q Consensus       253 ~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-----~lp~-~~~~l~~L~~L~l~~N  326 (824)
                                       +|+.+.+ .+.++.+...+|.++++|+.+++.+|.+.     .++. .|.++++|+.+++. +
T Consensus       249 -----------------~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~  309 (401)
T 4fdw_A          249 -----------------GITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-E  309 (401)
T ss_dssp             -----------------CCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-T
T ss_pred             -----------------CccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-C
Confidence                             4555555 23344344555555555555555555443     3333 25555666666666 3


Q ss_pred             cccCcCCccccccccchhhhcccccccccCCCccCCCCCCCeEEccCccccccCCccccccc-cccEEEccCcccC
Q 040845          327 CFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLI-SLKSLNLSYNNLS  401 (824)
Q Consensus       327 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~  401 (824)
                      .++.+...+|.+|++|+.++|..| ++.+.+.+|.++ +|+.|++++|.+....+..|.+++ +++.|.+..|.+.
T Consensus       310 ~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~  383 (401)
T 4fdw_A          310 SIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE  383 (401)
T ss_dssp             TCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred             ceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence            355455667777777777777544 665667778888 888888888877766667777774 6778888777653

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.66  E-value=2e-16  Score=152.28  Aligned_cols=134  Identities=25%  Similarity=0.274  Sum_probs=105.8

Q ss_pred             CcEEEcCCCCCCCCCCcccccccccccccccccccCcCCccccccccchhhhcccccccccCCCccCCCCCCCeEEccCc
Q 040845          295 LKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYN  374 (824)
Q Consensus       295 L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N  374 (824)
                      .+.+++++|+++.+|..+.  ++|+.|++++|.+++..+..|.++++|+.|++++|++++..+..|..+++|+.|+|++|
T Consensus         9 ~~~l~~~~~~l~~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   86 (177)
T 2o6r_A            9 GTEIRCNSKGLTSVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN   86 (177)
T ss_dssp             TTEEECCSSCCSSCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CCEEEecCCCCccCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCC
Confidence            4567777777777775543  56777777777777666667788888888888888888777777888889999999999


Q ss_pred             cccccCCccccccccccEEEccCcccCCCCcccccCCcccceeeccCCcccCCCCC
Q 040845          375 RLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIPR  430 (824)
Q Consensus       375 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~  430 (824)
                      +|++..+..|..+++|+.|++++|++++..+..+..+++|+.|++++|+++|.+|.
T Consensus        87 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~  142 (177)
T 2o6r_A           87 KLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR  142 (177)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred             CccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCcc
Confidence            98876666788888999999999998865555678888899999999998887764

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.65  E-value=7.7e-17  Score=170.71  Aligned_cols=138  Identities=14%  Similarity=0.149  Sum_probs=100.0

Q ss_pred             cCCCCceeeeccceEEEEEEECCCcEEEEEEeeccccc--------------hhh--------hHHHHHHHHhcCCCCcc
Q 040845          528 KFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGR--------------AFK--------SFDVECAMMKSIRHRNL  585 (824)
Q Consensus       528 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------------~~~--------~~~~E~~~l~~l~h~ni  585 (824)
                      -|++.+.||+|++|.||+|...+|+.||||+++.....              ...        ...+|...|.++.+.++
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            38999999999999999999888999999987532100              001        12345666666644433


Q ss_pred             eeEEeeeecCCeeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC-
Q 040845          586 VKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM-  664 (824)
Q Consensus       586 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~-  664 (824)
                      ....-+...  ..++||||++|++|.++...       .....++.|++.++.|||   ..+||||||||.|||+++++ 
T Consensus       176 ~vp~p~~~~--~~~LVME~i~G~~L~~l~~~-------~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl~~dgd  243 (397)
T 4gyi_A          176 PVPEPIAQS--RHTIVMSLVDALPMRQVSSV-------PDPASLYADLIALILRLA---KHGLIHGDFNEFNILIREEKD  243 (397)
T ss_dssp             SCCCEEEEE--TTEEEEECCSCEEGGGCCCC-------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEEEEEC
T ss_pred             CCCeeeecc--CceEEEEecCCccHhhhccc-------HHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeCCCC
Confidence            211111111  23699999999888665421       134568899999999999   89999999999999998776 


Q ss_pred             ---------cEEEeeccccccc
Q 040845          665 ---------VAHLSDFGIAKLL  677 (824)
Q Consensus       665 ---------~~kl~Dfg~a~~~  677 (824)
                               .+.|+||+.+...
T Consensus       244 ~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          244 AEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             SSCTTSEEEEEEECCCTTCEET
T ss_pred             cccccccccceEEEEeCCcccC
Confidence                     3899999988754

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.65  E-value=4.2e-15  Score=162.58  Aligned_cols=318  Identities=14%  Similarity=0.082  Sum_probs=201.6

Q ss_pred             CCcccChhhhCcCCCceeeccCCccccccCccccCCCCCccEEEccCCeeeeecCccccCCCCCceEeccCccccccCCc
Q 040845           57 LLGTIPAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPS  136 (824)
Q Consensus        57 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~  136 (824)
                      ++.+...+|.++.+|+.+.+.. .++.+... .+.++++|+.++|..+ ++.+....|.++++|+.+.+..+ +..+...
T Consensus        59 VtsIg~~AF~~c~~L~~i~lp~-~i~~I~~~-aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~  134 (394)
T 4fs7_A           59 VVSIGYAAFQGCRKVTEIKIPS-TVREIGEF-AFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVE  134 (394)
T ss_dssp             EEEECTTTTTTCTTEEEEECCT-TCCEECTT-TTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTT
T ss_pred             EeEhHHHHhhCCCCceEEEeCC-CccCcchh-HhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecce
Confidence            3334445566666666666643 24433332 2235566666666543 44344556666666666665543 3335555


Q ss_pred             cccCCCCCCEEEccCCcCCCCcCcccccccCCCCCCCcEEECcCCCCCccCCccccccccccccEEEeecCcceecCCcc
Q 040845          137 TFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEE  216 (824)
Q Consensus       137 ~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~  216 (824)
                      +|.+...++.......  ..+..     .+|.++++|+.+.+.++. ..                          .....
T Consensus       135 aF~~~~~~~~~~~~~~--~~i~~-----~aF~~c~~L~~i~l~~~~-~~--------------------------I~~~~  180 (394)
T 4fs7_A          135 AFKGCDFKEITIPEGV--TVIGD-----EAFATCESLEYVSLPDSM-ET--------------------------LHNGL  180 (394)
T ss_dssp             TTTTCCCSEEECCTTC--CEECT-----TTTTTCTTCCEEECCTTC-CE--------------------------ECTTT
T ss_pred             eeecccccccccCccc--cccch-----hhhcccCCCcEEecCCcc-ce--------------------------ecccc
Confidence            6666544333322221  11111     346666777777665432 11                          22345


Q ss_pred             CCCCCCCCEEEecCCccCCccchhhcCCCCCCEEEcccccCcccCCccccccCCccEEEccCccccccCCccccCCCCCc
Q 040845          217 ITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLK  296 (824)
Q Consensus       217 l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~  296 (824)
                      |.++++|+.+.+..+ ++.+...+|.++..|+.+.+..+...  +.+.+....+|+.+.+..+ +......+|.++.+|+
T Consensus       181 F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~--i~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~  256 (394)
T 4fs7_A          181 FSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNSLYY--LGDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLE  256 (394)
T ss_dssp             TTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCE--ECTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCC
T ss_pred             ccCCCCceEEEcCCC-ceEeCchhhccccccceeecCCCceE--eehhhcccCCCceEEECCC-ceecccccccccccce
Confidence            666777777777655 44455567777777777776665443  2233334456777777644 3335566777888888


Q ss_pred             EEEcCCCCCCCCCCcccccccccccccccccccCcCCccccccccchhhhcccccccccCCCccCCCCCCCeEEccCccc
Q 040845          297 VLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRL  376 (824)
Q Consensus       297 ~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  376 (824)
                      .+.+..+..+--...|.....++.+....+.+.   ...|..+.+|+.+.+.++ ++.+...+|.++.+|+.++|..+ +
T Consensus       257 ~~~~~~~~~~i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v  331 (394)
T 4fs7_A          257 SISIQNNKLRIGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-V  331 (394)
T ss_dssp             EEEECCTTCEECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-C
T ss_pred             eEEcCCCcceeeccccccccccceeccCceeec---cccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-c
Confidence            888877654433444666777777777665543   457888999999999765 66677889999999999999755 7


Q ss_pred             cccCCccccccccccEEEccCcccCCCCcccccCCcccceeeccCC
Q 040845          377 EGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFN  422 (824)
Q Consensus       377 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N  422 (824)
                      +.....+|.+|.+|+.+++..| ++..-..+|.++++|+.+++..+
T Consensus       332 ~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~  376 (394)
T 4fs7_A          332 EEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR  376 (394)
T ss_dssp             CEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG
T ss_pred             cEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC
Confidence            6566789999999999999887 77566778999999999999754

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.65  E-value=1.4e-16  Score=151.98  Aligned_cols=111  Identities=24%  Similarity=0.198  Sum_probs=44.3

Q ss_pred             cCCCCCcEEEcCCCCCCCCCCcccccccccccccccccccCcCCccccccccchhhhcccccccccCC-CccCCCCCCCe
Q 040845          290 SNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIP-MEIGSLKNLEN  368 (824)
Q Consensus       290 ~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~  368 (824)
                      ..+++|++|++++|.++.+ ..+..+++|+.|++++|.+++.+|..+.++++|+.|++++|++++..+ ..+..+++|+.
T Consensus        46 ~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~  124 (168)
T 2ell_A           46 AEFVNLEFLSLINVGLISV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKS  124 (168)
T ss_dssp             GGGGGCCEEEEESSCCCCC-SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCSSGGGGGGSSCSCCCE
T ss_pred             HhCCCCCEEeCcCCCCCCh-hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCcchhHHHHhcCCCCCE
Confidence            3333333333333333333 223333333333333333332233333334444444444444443211 33444444444


Q ss_pred             EEccCccccccCC---ccccccccccEEEccCcccC
Q 040845          369 LFLEYNRLEGSIP---DSFGDLISLKSLNLSYNNLS  401 (824)
Q Consensus       369 L~L~~N~l~~~~~---~~~~~l~~L~~L~L~~N~l~  401 (824)
                      |++++|.+++..+   ..+..+++|+.|++++|.+.
T Consensus       125 L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~  160 (168)
T 2ell_A          125 LDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ  160 (168)
T ss_dssp             EECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred             EEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence            4444444443222   24444444444444444443

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.63  E-value=2.6e-16  Score=149.95  Aligned_cols=134  Identities=20%  Similarity=0.133  Sum_probs=119.9

Q ss_pred             CCCCcEEEcCCCCCC--CCCCcccccccccccccccccccCcCCccccccccchhhhcccccccccCCCccCCCCCCCeE
Q 040845          292 MTFLKVLSLGSNELT--SIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENL  369 (824)
Q Consensus       292 l~~L~~L~L~~N~l~--~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L  369 (824)
                      .++|++|++++|.++  .+|..+..+++|+.|++++|.+++.  ..+..+++|+.|++++|++++.+|..+..+++|+.|
T Consensus        23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  100 (168)
T 2ell_A           23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL  100 (168)
T ss_dssp             TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred             cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence            478999999999999  8998889999999999999999965  789999999999999999998788888889999999


Q ss_pred             EccCccccccC-CccccccccccEEEccCcccCCCCc---ccccCCcccceeeccCCcccCC
Q 040845          370 FLEYNRLEGSI-PDSFGDLISLKSLNLSYNNLSGTIP---VSLEKLSYLKDLNLSFNKLKGE  427 (824)
Q Consensus       370 ~L~~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~l~~N~l~~~  427 (824)
                      +|++|.+++.. +..+..+++|+.|++++|++++..+   ..+..+++|+.|++++|.+...
T Consensus       101 ~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~  162 (168)
T 2ell_A          101 NLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQEA  162 (168)
T ss_dssp             ECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCBC
T ss_pred             eccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhhc
Confidence            99999999642 2789999999999999999995544   4889999999999999998743

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.63  E-value=7.9e-16  Score=149.89  Aligned_cols=128  Identities=24%  Similarity=0.274  Sum_probs=107.9

Q ss_pred             cEEEccCccccccCCccccCCCCCcEEEcCCCCCCCCCCcccccccccccccccccccCcCCccccccccchhhhccccc
Q 040845          272 YELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNN  351 (824)
Q Consensus       272 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~  351 (824)
                      +.+++++|+++. +|..+.  ++|++|++++|.|+.+|..|..+++|+.|+|++|.+++..+..|.++++|+.|+|++|+
T Consensus        13 ~~l~~~~~~l~~-ip~~~~--~~l~~L~L~~n~i~~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~   89 (193)
T 2wfh_A           13 TVVRCSNKGLKV-LPKGIP--RDVTELYLDGNQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR   89 (193)
T ss_dssp             TEEECTTSCCSS-CCSCCC--TTCCEEECCSSCCCSCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             CEEEcCCCCCCc-CCCCCC--CCCCEEECCCCcCchhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence            466777777763 343332  57888888888888888778888888888888888888778889999999999999999


Q ss_pred             ccccCCCccCCCCCCCeEEccCccccccCCccccccccccEEEccCcccCC
Q 040845          352 FSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSG  402 (824)
Q Consensus       352 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  402 (824)
                      |++..+..|..+++|+.|+|++|+|+...+..|..+++|+.|+|++|++..
T Consensus        90 l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C  140 (193)
T 2wfh_A           90 LRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC  140 (193)
T ss_dssp             CCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred             cCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence            998888899999999999999999997666789999999999999999973

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.61  E-value=5.3e-16  Score=144.59  Aligned_cols=128  Identities=26%  Similarity=0.308  Sum_probs=76.4

Q ss_pred             CCCCcEEEccCCccc-ccccccccCCCCCCEEeCCCCcCCcccChhhhCcCCCceeeccCCccccccCccccCCCCCccE
Q 040845           20 ISNLKVLYLYNNRLQ-GEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEV   98 (824)
Q Consensus        20 l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~   98 (824)
                      .++|++|++++|+++ +.+|..++.+++|++|++++|.+++.  ..+..+++|++|++++|++++..+... ..+++|++
T Consensus        16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~-~~l~~L~~   92 (149)
T 2je0_A           16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLA-EKCPNLTH   92 (149)
T ss_dssp             GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHH-HHCTTCCE
T ss_pred             CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHh-hhCCCCCE
Confidence            466777777777777 56676777777777777777777744  556666666666666666665222111 12556666


Q ss_pred             EEccCCeeeee-cCccccCCCCCceEeccCccccccCC---ccccCCCCCCEEEcc
Q 040845           99 LYLWGNNFSGT-IPHFIFNASKLSKLALEMNSFSGFIP---STFGNLRNLEWLTLY  150 (824)
Q Consensus        99 L~L~~n~i~~~-~~~~l~~l~~L~~L~L~~N~i~~~~~---~~~~~l~~L~~L~L~  150 (824)
                      |++++|++++. .+..+..+++|++|++++|.+++..+   ..+..+++|++|+++
T Consensus        93 L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~  148 (149)
T 2je0_A           93 LNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY  148 (149)
T ss_dssp             EECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred             EECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence            66666665542 22455555555555555555554433   345555555555554

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.60  E-value=4.6e-16  Score=144.98  Aligned_cols=126  Identities=25%  Similarity=0.247  Sum_probs=54.8

Q ss_pred             CccEEEccCcccc-ccCCccccCCCCCcEEEcCCCCCCCCCCcccccccccccccccccccCcCCccccccccchhhhcc
Q 040845          270 ELYELELGGNKLS-GSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFS  348 (824)
Q Consensus       270 ~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~  348 (824)
                      +|+.|++++|.++ +.+|..+..+++|++|++++|.++.+ ..+..+++|+.|++++|.+++.+|..+..+++|+.|+++
T Consensus        18 ~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls   96 (149)
T 2je0_A           18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLS   96 (149)
T ss_dssp             GCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC-TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECT
T ss_pred             cCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc-hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECC
Confidence            3444444444444 33444445555555555555555544 233334444444444444443333333334444444444


Q ss_pred             ccccccc-CCCccCCCCCCCeEEccCccccccCC---ccccccccccEEEcc
Q 040845          349 MNNFSGI-IPMEIGSLKNLENLFLEYNRLEGSIP---DSFGDLISLKSLNLS  396 (824)
Q Consensus       349 ~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~L~  396 (824)
                      +|++++. .+..++.+++|+.|++++|.+++..+   ..+..+++|+.|+++
T Consensus        97 ~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~  148 (149)
T 2je0_A           97 GNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY  148 (149)
T ss_dssp             TSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred             CCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence            4444432 12334444444444444444443222   234444444444443

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.60  E-value=7.9e-16  Score=147.78  Aligned_cols=145  Identities=17%  Similarity=0.214  Sum_probs=86.9

Q ss_pred             CCcccccccccCCcccccCCCCCcEEEccCCcccccccccccCCC-CCCEEeCCCCcCCcccChhhhCcCCCceeeccCC
Q 040845            1 MPSIINNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLH-NLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNN   79 (824)
Q Consensus         1 ~~~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n   79 (824)
                      |+.+..+.|...  ..+..+++|++|+|++|+++. ++. +..+. +|++|+|++|.+++.  ..+..+++|++|+|++|
T Consensus         1 m~~lt~~~i~~~--~~~~~~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N   74 (176)
T 1a9n_A            1 MVKLTAELIEQA--AQYTNAVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNN   74 (176)
T ss_dssp             -CCCCHHHHHTS--CEEECTTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSS
T ss_pred             CccccHHHHHHH--HhcCCcCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCC
Confidence            566666666653  236777888888888888883 443 54444 888888888888743  45666666666666666


Q ss_pred             ccccccCccccCCCCCccEEEccCCeeeeecCc--cccCCCCCceEeccCccccccCCc----cccCCCCCCEEEccCCc
Q 040845           80 SLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPH--FIFNASKLSKLALEMNSFSGFIPS----TFGNLRNLEWLTLYDNN  153 (824)
Q Consensus        80 ~l~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~--~l~~l~~L~~L~L~~N~i~~~~~~----~~~~l~~L~~L~L~~n~  153 (824)
                      ++++++.... ..+++|++|+|++|+|+ .+|.  .+..+++|+.|++++|.++.. |.    .+..+++|++|++++|.
T Consensus        75 ~l~~~~~~~~-~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~~-~~~~~~~~~~l~~L~~Ld~~~n~  151 (176)
T 1a9n_A           75 RICRIGEGLD-QALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTNK-KHYRLYVIYKVPQVRVLDFQKVK  151 (176)
T ss_dssp             CCCEECSCHH-HHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGGS-TTHHHHHHHHCTTCSEETTEECC
T ss_pred             cccccCcchh-hcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCCc-HhHHHHHHHHCCccceeCCCcCC
Confidence            6665554331 13566666666666664 3333  455555566666666655532 33    25555555555555554


Q ss_pred             C
Q 040845          154 L  154 (824)
Q Consensus       154 i  154 (824)
                      +
T Consensus       152 ~  152 (176)
T 1a9n_A          152 L  152 (176)
T ss_dssp             H
T ss_pred             H
Confidence            4

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.58  E-value=1.2e-14  Score=139.58  Aligned_cols=131  Identities=22%  Similarity=0.216  Sum_probs=69.1

Q ss_pred             CcEEEccCCcccccccccccCCCCCCEEeCCCCcCCcccChhhhCcCCCceeeccCCccccccCccccCCCCCccEEEcc
Q 040845           23 LKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLW  102 (824)
Q Consensus        23 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~  102 (824)
                      .+.+++++|+++ .+|..+  .++|++|++++|++++..+..|..+++|++|++++|+++++                  
T Consensus         9 ~~~l~~~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~------------------   67 (177)
T 2o6r_A            9 GTEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSL------------------   67 (177)
T ss_dssp             TTEEECCSSCCS-SCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCC------------------
T ss_pred             CCEEEecCCCCc-cCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEe------------------
Confidence            355666666666 334333  24666666666666644444455555555555555555443                  


Q ss_pred             CCeeeeecCccccCCCCCceEeccCccccccCCccccCCCCCCEEEccCCcCCCCcCcccccccCCCCCCCcEEECcCCC
Q 040845          103 GNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNP  182 (824)
Q Consensus       103 ~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~~L~~L~Ls~n~  182 (824)
                             .+..|..+++|++|+|++|++++..+..|.++++|++|++++|+++.++..     .+..+++|++|+|++|+
T Consensus        68 -------~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~-----~~~~l~~L~~L~l~~N~  135 (177)
T 2o6r_A           68 -------PDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDG-----IFDRLTSLQKIWLHTNP  135 (177)
T ss_dssp             -------CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTT-----TTTTCTTCCEEECCSSC
T ss_pred             -------ChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHH-----HhcCCcccCEEEecCCC
Confidence                   333444555555555555555544444455555555555555555544321     24455555666666665


Q ss_pred             CCcc
Q 040845          183 LDGI  186 (824)
Q Consensus       183 l~~~  186 (824)
                      +.+.
T Consensus       136 ~~~~  139 (177)
T 2o6r_A          136 WDCS  139 (177)
T ss_dssp             BCCC
T ss_pred             eecc
Confidence            5543

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.57  E-value=1e-15  Score=147.05  Aligned_cols=132  Identities=20%  Similarity=0.166  Sum_probs=89.4

Q ss_pred             ccCCCCCcEEEcCCCCCCCCCCcccccc-cccccccccccccCcCCccccccccchhhhcccccccccCCCccCCCCCCC
Q 040845          289 FSNMTFLKVLSLGSNELTSIPLNFWSLK-DILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLE  367 (824)
Q Consensus       289 ~~~l~~L~~L~L~~N~l~~lp~~~~~l~-~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~  367 (824)
                      +.++++|+.|++++|.++.+|. +..+. +|+.|++++|.+++.  ..+..+++|+.|++++|+|++..+..|..+++|+
T Consensus        15 ~~~~~~L~~L~l~~n~l~~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~   91 (176)
T 1a9n_A           15 YTNAVRDRELDLRGYKIPVIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT   91 (176)
T ss_dssp             EECTTSCEEEECTTSCCCSCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred             cCCcCCceEEEeeCCCCchhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCC
Confidence            4455566666666666666643 33333 666666666666643  4666777777777777777765545557777788


Q ss_pred             eEEccCccccccCCc--cccccccccEEEccCcccCCCCccc----ccCCcccceeeccCCccc
Q 040845          368 NLFLEYNRLEGSIPD--SFGDLISLKSLNLSYNNLSGTIPVS----LEKLSYLKDLNLSFNKLK  425 (824)
Q Consensus       368 ~L~L~~N~l~~~~~~--~~~~l~~L~~L~L~~N~l~~~~p~~----~~~l~~L~~L~l~~N~l~  425 (824)
                      .|+|++|+|+ .+|.  .+..+++|+.|++++|+++ .+|..    +..+++|+.|++++|...
T Consensus        92 ~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~  153 (176)
T 1a9n_A           92 ELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK  153 (176)
T ss_dssp             EEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred             EEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence            8888888776 4554  6777778888888888877 55654    777778888888777654

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.55  E-value=5.5e-17  Score=159.23  Aligned_cols=134  Identities=25%  Similarity=0.286  Sum_probs=66.2

Q ss_pred             hcCCCCCCEEEcccccCcccCCc------cccccCCccEEEccCccccccCCccccCCCCCcEEEcCCCCCCCCCCcccc
Q 040845          241 LGKLQKLQDVDLEYNQLEGSIPD------SICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWS  314 (824)
Q Consensus       241 ~~~l~~L~~L~L~~n~l~~~~~~------~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~  314 (824)
                      +.....++.++++.+.+.+..|.      .+..+++|++|++++|++++ +| .+..+++|++|++++|.++.+|..+..
T Consensus        14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~~l~~~~~~   91 (198)
T 1ds9_A           14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIKKIENLDAV   91 (198)
T ss_dssp             HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEECSCSSHHHH
T ss_pred             HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcccccchhhc
Confidence            44455566666666666554443      45555555555555555553 23 455555555555555555555544444


Q ss_pred             cccccccccccccccCcCCccccccccchhhhcccccccccCC-CccCCCCCCCeEEccCccccc
Q 040845          315 LKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIP-MEIGSLKNLENLFLEYNRLEG  378 (824)
Q Consensus       315 l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~  378 (824)
                      +++|+.|++++|++++ +| .+..+++|+.|++++|++++..+ ..+..+++|+.|++++|.+++
T Consensus        92 ~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~  154 (198)
T 1ds9_A           92 ADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYN  154 (198)
T ss_dssp             HHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHH
T ss_pred             CCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCcccc
Confidence            4555555555555543 22 34444444444444444443211 234444444444444444443

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.53  E-value=5.1e-17  Score=159.49  Aligned_cols=155  Identities=23%  Similarity=0.258  Sum_probs=123.5

Q ss_pred             ccccCCccEEEccCccccccCCc------cccCCCCCcEEEcCCCCCCCCCCcccccccccccccccccccCcCCccccc
Q 040845          265 ICLSVELYELELGGNKLSGSIPA------CFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRN  338 (824)
Q Consensus       265 ~~~~~~L~~L~l~~n~l~~~~~~------~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~  338 (824)
                      +.....++.++++.+.+.+..|.      .+..+++|++|++++|.++.+| .+..+++|+.|++++|.++ .+|..+..
T Consensus        14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~   91 (198)
T 1ds9_A           14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEKIS-SLSGMENLRILSLGRNLIK-KIENLDAV   91 (198)
T ss_dssp             HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESCCC-CHHHHTTCCEEEEEEEEEC-SCSSHHHH
T ss_pred             HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcccc-ccccCCCCCEEECCCCCcc-cccchhhc
Confidence            45566778888888888877766      7888899999999999999988 7888889999999999988 56777777


Q ss_pred             cccchhhhcccccccccCCCccCCCCCCCeEEccCccccccCC-ccccccccccEEEccCcccCCCCccc----------
Q 040845          339 LKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIP-DSFGDLISLKSLNLSYNNLSGTIPVS----------  407 (824)
Q Consensus       339 l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~----------  407 (824)
                      +++|+.|++++|++++. | .+..+++|+.|++++|++++..+ ..+..+++|+.|++++|++++..|..          
T Consensus        92 ~~~L~~L~L~~N~l~~l-~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~  169 (198)
T 1ds9_A           92 ADTLEELWISYNQIASL-S-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEV  169 (198)
T ss_dssp             HHHCSEEEEEEEECCCH-H-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHH
T ss_pred             CCcCCEEECcCCcCCcC-C-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHH
Confidence            88889999999988863 4 57888889999999998885322 46788888899999998887665542          


Q ss_pred             ccCCcccceeeccCCccc
Q 040845          408 LEKLSYLKDLNLSFNKLK  425 (824)
Q Consensus       408 ~~~l~~L~~L~l~~N~l~  425 (824)
                      +..+++|+.|+  +|+++
T Consensus       170 ~~~l~~L~~Ld--~~~i~  185 (198)
T 1ds9_A          170 VKRLPNLKKLD--GMPVD  185 (198)
T ss_dssp             HHHCSSCSEEC--CGGGT
T ss_pred             HHhCCCcEEEC--CcccC
Confidence            67788888776  66665

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.51  E-value=1.6e-12  Score=141.98  Aligned_cols=336  Identities=12%  Similarity=0.091  Sum_probs=201.4

Q ss_pred             ccccCCcccccCCC-CCcEEEccCCcccccccccccCCCCCCEEeCCCCc---CCcccChhhhCcCCCceeeccCCcccc
Q 040845            8 FLTSTTPKEIDNIS-NLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNK---LLGTIPAAIFNVSTLKAFAVTNNSLSG   83 (824)
Q Consensus         8 ~i~~~~p~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~---l~~~~~~~~~~l~~L~~L~L~~n~l~~   83 (824)
                      .++++-..+|.+.+ .|+.+.+..+ ++.....+|.++++|+.+.++.|.   ++.+...+|.++.+|+.+.+..+ ++.
T Consensus        50 ~Vt~Ig~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~  127 (394)
T 4gt6_A           50 PVSKIGDRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTE  127 (394)
T ss_dssp             EEEEECTTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSE
T ss_pred             eeeEcCHhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cce
Confidence            35667777888875 5999999754 666677889999999999998774   66566778989999998888765 444


Q ss_pred             ccCccccCCCCCccEEEccCCeeeeecCccccCCCCCceEeccCccccccCCccccCCCCCCEEEccCCcCCCCcCcccc
Q 040845           84 CLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSF  163 (824)
Q Consensus        84 ~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~  163 (824)
                      +.... +.++.+|+.+.+..+- +......|..+.+|+.+.+..+ ++.+...+|.+ .+|+.+.+..+-. .+..    
T Consensus       128 I~~~a-F~~c~~L~~i~lp~~~-~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~-~i~~----  198 (394)
T 4gt6_A          128 IDSEA-FHHCEELDTVTIPEGV-TSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVT-RIGT----  198 (394)
T ss_dssp             ECTTT-TTTCTTCCEEECCTTC-CEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCC-EECT----
T ss_pred             ehhhh-hhhhccccccccccee-eeecccceecccccccccccce-eeEeccccccc-cceeEEEECCccc-cccc----
Confidence            44433 3468899999997554 4466778888999999998765 55466777765 6788888865432 2221    


Q ss_pred             cccCCCCCCCcEEECcCCCCCccCCccccccccccccEEEeecCcceecCCccCCCCCCCCEEEecCCccCCccchhhcC
Q 040845          164 LSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGK  243 (824)
Q Consensus       164 ~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~  243 (824)
                       .++..+.+|+......+.........+........             ....+.....+..+.+.. .++.+...+|.+
T Consensus       199 -~af~~c~~l~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~ip~-~v~~i~~~aF~~  263 (394)
T 4gt6_A          199 -NAFSECFALSTITSDSESYPAIDNVLYEKSANGDY-------------ALIRYPSQREDPAFKIPN-GVARIETHAFDS  263 (394)
T ss_dssp             -TTTTTCTTCCEEEECCSSSCBSSSCEEEECTTSCE-------------EEEECCTTCCCSEEECCT-TEEEECTTTTTT
T ss_pred             -chhhhccccceecccccccccccceeecccccccc-------------cccccccccccceEEcCC-cceEcccceeee
Confidence             45788888888887776655443322211100000             000111223333333322 222234445555


Q ss_pred             CCCCCEEEcccccCcccCCccccccCCccEEEccCccccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccccccccccc
Q 040845          244 LQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLN-FWSLKDILDLN  322 (824)
Q Consensus       244 l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~-~~~l~~L~~L~  322 (824)
                      +.+|+.+.+..+... ....+|..+.+|+.+.+. +.+..+...+|.++++|+.+.|..+ ++.|+.. |.++.+|+.+.
T Consensus       264 c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~  340 (394)
T 4gt6_A          264 CAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIA  340 (394)
T ss_dssp             CSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEE
T ss_pred             cccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEE
Confidence            666666665544332 444555555666666664 3344455566666666666666543 5555433 55566666666


Q ss_pred             cccccccCcCCccccccccchhhhcccccccccCCCccCCCCCCCeEEccCccc
Q 040845          323 LSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRL  376 (824)
Q Consensus       323 l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  376 (824)
                      +..+ ++.+...+|.+|++|+.+++.+|....   ..+..+.+|+.+.+..|.+
T Consensus       341 ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~~  390 (394)
T 4gt6_A          341 IPSS-VTKIPESAFSNCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPGSI  390 (394)
T ss_dssp             ECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---HTCBCCCCC----------
T ss_pred             ECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCCCE
Confidence            6543 444556677777777777777765431   3466667777777766654

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.49  E-value=4e-14  Score=134.71  Aligned_cols=109  Identities=22%  Similarity=0.207  Sum_probs=58.8

Q ss_pred             CcEEEcCCCCCCCCCCcccccccccccccccccccCcCCccccccccchhhhcccccccccCCCccCCCCCCCeEEccCc
Q 040845          295 LKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYN  374 (824)
Q Consensus       295 L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N  374 (824)
                      .+.+++++|.++.+|..+.  ++|+.|+|++|.++                        +..|..|..+++|++|+|++|
T Consensus        11 ~~~l~~s~n~l~~ip~~~~--~~l~~L~L~~N~i~------------------------~~~~~~~~~l~~L~~L~Ls~N   64 (170)
T 3g39_A           11 GTTVDCSGKSLASVPTGIP--TTTQVLYLYDNQIT------------------------KLEPGVFDRLTQLTRLDLDNN   64 (170)
T ss_dssp             TTEEECTTSCCSSCCSCCC--TTCSEEECCSSCCC------------------------CCCTTTTTTCTTCSEEECCSS
T ss_pred             CCEEEeCCCCcCccCccCC--CCCcEEEcCCCcCC------------------------ccChhhhcCcccCCEEECCCC
Confidence            4677777777777775442  44555555555554                        444444555555555555555


Q ss_pred             cccccCCccccccccccEEEccCcccCCCCcccccCCcccceeeccCCcccCCCC
Q 040845          375 RLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIP  429 (824)
Q Consensus       375 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p  429 (824)
                      +|++..+..|..+++|+.|+|++|+|++..+..+..+++|+.|+|++|+|+|.++
T Consensus        65 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~  119 (170)
T 3g39_A           65 QLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWLLNNPWDCACS  119 (170)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred             CcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence            5554444444555555555555555554334445555555555555555555444

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.47  E-value=7.4e-14  Score=132.88  Aligned_cols=105  Identities=25%  Similarity=0.289  Sum_probs=73.0

Q ss_pred             CccEEEccCccccccCCccccCCCCCcEEEcCCCCCCCCCC-cccccccccccccccccccCcCCccccccccchhhhcc
Q 040845          270 ELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPL-NFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFS  348 (824)
Q Consensus       270 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~  348 (824)
                      +.+.+++++|+++. +|..+  .++|++|+|++|+|+.++. .|..++                        +|+.|+|+
T Consensus        10 ~~~~l~~s~n~l~~-ip~~~--~~~l~~L~L~~N~i~~~~~~~~~~l~------------------------~L~~L~Ls   62 (170)
T 3g39_A           10 SGTTVDCSGKSLAS-VPTGI--PTTTQVLYLYDNQITKLEPGVFDRLT------------------------QLTRLDLD   62 (170)
T ss_dssp             ETTEEECTTSCCSS-CCSCC--CTTCSEEECCSSCCCCCCTTTTTTCT------------------------TCSEEECC
T ss_pred             CCCEEEeCCCCcCc-cCccC--CCCCcEEEcCCCcCCccChhhhcCcc------------------------cCCEEECC
Confidence            35789999999995 55544  3789999999999999853 344444                        45555555


Q ss_pred             cccccccCCCccCCCCCCCeEEccCccccccCCccccccccccEEEccCcccC
Q 040845          349 MNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLS  401 (824)
Q Consensus       349 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  401 (824)
                      +|+|++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+++
T Consensus        63 ~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~  115 (170)
T 3g39_A           63 NNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWLLNNPWD  115 (170)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred             CCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEeCCCCCC
Confidence            55555555555666677777777777777555556777777777777777776

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.47  E-value=6.5e-14  Score=133.74  Aligned_cols=104  Identities=24%  Similarity=0.253  Sum_probs=58.1

Q ss_pred             cEEEcCCCCCCCCCCcccccccccccccccccccCcCCccccccccchhhhcccccccccCCCccCCCCCCCeEEccCcc
Q 040845          296 KVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNR  375 (824)
Q Consensus       296 ~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~  375 (824)
                      +.+++++|+++++|..+.  ++|+.|+|++|.+++..|..|.++++|+.|+|++|+|+++.+..|..+++|+.|+|++|+
T Consensus        15 ~~l~~~~n~l~~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~   92 (174)
T 2r9u_A           15 TLVNCQNIRLASVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNH   92 (174)
T ss_dssp             SEEECCSSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             cEEEeCCCCCCccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCc
Confidence            567777777777776543  555555555555555445555555555555555555554444444555555555555555


Q ss_pred             ccccCCccccccccccEEEccCcccC
Q 040845          376 LEGSIPDSFGDLISLKSLNLSYNNLS  401 (824)
Q Consensus       376 l~~~~~~~~~~l~~L~~L~L~~N~l~  401 (824)
                      |++..+..|..+++|+.|+|++|++.
T Consensus        93 l~~l~~~~~~~l~~L~~L~L~~N~~~  118 (174)
T 2r9u_A           93 LKSIPRGAFDNLKSLTHIYLYNNPWD  118 (174)
T ss_dssp             CCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred             cceeCHHHhccccCCCEEEeCCCCcc
Confidence            55433334555555555555555554

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.46  E-value=9.7e-14  Score=132.50  Aligned_cols=110  Identities=21%  Similarity=0.247  Sum_probs=97.8

Q ss_pred             ccccccccccccCcCCccccccccchhhhcccccccccCCCccCCCCCCCeEEccCccccccCCccccccccccEEEccC
Q 040845          318 ILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSY  397 (824)
Q Consensus       318 L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  397 (824)
                      -+.+++++|.++ .+|..+.  ++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++
T Consensus        14 ~~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~   90 (174)
T 2r9u_A           14 QTLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND   90 (174)
T ss_dssp             SSEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CcEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence            367899999997 5666654  8899999999999998899999999999999999999976667789999999999999


Q ss_pred             cccCCCCcccccCCcccceeeccCCcccCCCCC
Q 040845          398 NNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIPR  430 (824)
Q Consensus       398 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~  430 (824)
                      |+|++..+..+..+++|+.|+|++|+|.+.++.
T Consensus        91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~~  123 (174)
T 2r9u_A           91 NHLKSIPRGAFDNLKSLTHIYLYNNPWDCECRD  123 (174)
T ss_dssp             SCCCCCCTTTTTTCTTCSEEECCSSCBCTTBGG
T ss_pred             CccceeCHHHhccccCCCEEEeCCCCccccccc
Confidence            999966666699999999999999999988764

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.44  E-value=6.6e-12  Score=137.16  Aligned_cols=302  Identities=14%  Similarity=0.152  Sum_probs=156.7

Q ss_pred             CCCCccEEEccCCe---eeeecCccccCCCCCceEeccCccccccCCccccCCCCCCEEEccCCcCCCCcCcccccccCC
Q 040845           92 GLPNLEVLYLWGNN---FSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLS  168 (824)
Q Consensus        92 ~l~~L~~L~L~~n~---i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~  168 (824)
                      ++.+|+.+.+..|.   ++.+...+|..+.+|+.+.+..+ ++.+...+|.++.+|+.+.+..+ ++.++.     .+|.
T Consensus        85 ~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~~c~~L~~i~lp~~-~~~I~~-----~~F~  157 (394)
T 4gt6_A           85 NCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAFHHCEELDTVTIPEG-VTSVAD-----GMFS  157 (394)
T ss_dssp             TCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTTTTCTTCCEEECCTT-CCEECT-----TTTT
T ss_pred             CCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhhhhhcccccccccce-eeeecc-----ccee
Confidence            34444444444332   33344555666666666666544 44455666777777777777543 333322     2466


Q ss_pred             CCCCCcEEECcCCCCCccCCccccccccccccEEEeecCcceecCCccCCCCCCCCEEEecCCccCCccchhhcCCCCCC
Q 040845          169 NCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQ  248 (824)
Q Consensus       169 ~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~  248 (824)
                      .+.+|+.+.+..+ +..+...+|.+   ..|+.+.+..+- ......+|.++.+++......+.........+.......
T Consensus       158 ~c~~L~~i~~~~~-~~~I~~~aF~~---~~l~~i~ip~~~-~~i~~~af~~c~~l~~~~~~~~~~~~~~~~~~~~~~~~~  232 (394)
T 4gt6_A          158 YCYSLHTVTLPDS-VTAIEERAFTG---TALTQIHIPAKV-TRIGTNAFSECFALSTITSDSESYPAIDNVLYEKSANGD  232 (394)
T ss_dssp             TCTTCCEEECCTT-CCEECTTTTTT---CCCSEEEECTTC-CEECTTTTTTCTTCCEEEECCSSSCBSSSCEEEECTTSC
T ss_pred             cccccccccccce-eeEeccccccc---cceeEEEECCcc-cccccchhhhccccceecccccccccccceeeccccccc
Confidence            6777777777543 44454444432   235555554332 224445666677777666655544321111111111100


Q ss_pred             EEEcccccCcccCCccccccCCccEEEccCccccccCCccccCCCCCcEEEcCCCCCCCCCC-ccccccccccccccccc
Q 040845          249 DVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPL-NFWSLKDILDLNLSSNC  327 (824)
Q Consensus       249 ~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~-~~~~l~~L~~L~l~~N~  327 (824)
                      .-..           .+.....+..+.+. +.+......+|.++.+|+.+.+.++.. .++. .|..++.|+.+.+. +.
T Consensus       233 ~~~~-----------~~~~~~~~~~~~ip-~~v~~i~~~aF~~c~~L~~i~lp~~~~-~I~~~aF~~c~~L~~i~l~-~~  298 (394)
T 4gt6_A          233 YALI-----------RYPSQREDPAFKIP-NGVARIETHAFDSCAYLASVKMPDSVV-SIGTGAFMNCPALQDIEFS-SR  298 (394)
T ss_dssp             EEEE-----------ECCTTCCCSEEECC-TTEEEECTTTTTTCSSCCEEECCTTCC-EECTTTTTTCTTCCEEECC-TT
T ss_pred             cccc-----------ccccccccceEEcC-CcceEcccceeeecccccEEecccccc-eecCcccccccccccccCC-Cc
Confidence            0000           01111223333332 223334556677777777777654433 3332 35556666666664 33


Q ss_pred             ccCcCCccccccccchhhhcccccccccCCCccCCCCCCCeEEccCccccccCCccccccccccEEEccCcccCCCCccc
Q 040845          328 FSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVS  407 (824)
Q Consensus       328 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~  407 (824)
                      ++.+....|.++.+|+.++|.++ ++.+...+|.+|.+|+.+.+..+ ++.....+|.+|.+|+.+++.+|...   -..
T Consensus       299 i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~---~~~  373 (394)
T 4gt6_A          299 ITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQ---WNA  373 (394)
T ss_dssp             CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHH---HHT
T ss_pred             ccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceee---hhh
Confidence            44455667777777777777654 55566677777778888877544 55455667777888888887776543   134


Q ss_pred             ccCCcccceeeccCCcc
Q 040845          408 LEKLSYLKDLNLSFNKL  424 (824)
Q Consensus       408 ~~~l~~L~~L~l~~N~l  424 (824)
                      +..+.+|+.+.+..|.+
T Consensus       374 ~~~~~~L~~i~i~~~~~  390 (394)
T 4gt6_A          374 ISTDSGLQNLPVAPGSI  390 (394)
T ss_dssp             CBCCCCC----------
T ss_pred             hhccCCCCEEEeCCCCE
Confidence            55666777776665544

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.42  E-value=2.8e-15  Score=161.49  Aligned_cols=165  Identities=16%  Similarity=0.108  Sum_probs=84.4

Q ss_pred             CCCcEEEccCCcccccccccccCC-----CCCCEEeCCCCcCCcccChhhh-CcCCCceeeccCCccccccCcccc----
Q 040845           21 SNLKVLYLYNNRLQGEIIHEIGHL-----HNLGFLDLSQNKLLGTIPAAIF-NVSTLKAFAVTNNSLSGCLSSITD----   90 (824)
Q Consensus        21 ~~L~~L~L~~n~l~~~~~~~~~~l-----~~L~~L~Ls~n~l~~~~~~~~~-~l~~L~~L~L~~n~l~~~~~~~~~----   90 (824)
                      ++|++|+|++|.|+......|..+     ++|++|||++|.++......+. .+++|++|+|++|+++........    
T Consensus        72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~  151 (372)
T 3un9_A           72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL  151 (372)
T ss_dssp             TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred             hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence            456666666666664433333322     5666666666666533222222 345666666666666532211110    


Q ss_pred             CCCCCccEEEccCCeeeee----cCccccCCCCCceEeccCccccccC----CccccCCCCCCEEEccCCcCCCCcCccc
Q 040845           91 VGLPNLEVLYLWGNNFSGT----IPHFIFNASKLSKLALEMNSFSGFI----PSTFGNLRNLEWLTLYDNNLTSSTLDLS  162 (824)
Q Consensus        91 ~~l~~L~~L~L~~n~i~~~----~~~~l~~l~~L~~L~L~~N~i~~~~----~~~~~~l~~L~~L~L~~n~i~~~~~~~~  162 (824)
                      ...++|++|+|++|.|+..    ++..+..+++|++|+|++|.|++..    ...+...++|++|+|++|.|+..... .
T Consensus       152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~-~  230 (372)
T 3un9_A          152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAAL-A  230 (372)
T ss_dssp             STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHH-H
T ss_pred             hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHH-H
Confidence            1235566666666666432    2333455566666666666665422    33445555666666666666543221 1


Q ss_pred             ccccCCCCCCCcEEECcCCCCCcc
Q 040845          163 FLSSLSNCKSLTHISLSNNPLDGI  186 (824)
Q Consensus       163 ~~~~l~~l~~L~~L~Ls~n~l~~~  186 (824)
                      +...+..+++|++|+|++|.|.+.
T Consensus       231 l~~~L~~~~~L~~L~Ls~N~i~~~  254 (372)
T 3un9_A          231 LARAAREHPSLELLHLYFNELSSE  254 (372)
T ss_dssp             HHHHHHHCSSCCEEECTTSSCCHH
T ss_pred             HHHHHHhCCCCCEEeccCCCCCHH
Confidence            223344455666666666665543

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.40  E-value=3.8e-15  Score=160.55  Aligned_cols=126  Identities=18%  Similarity=0.216  Sum_probs=60.3

Q ss_pred             CCCceEeccCccccccCCccc-----cCCCCCCEEEccCCcCCCCcCcccccccCCCCCCCcEEECcCCCCCccCCcccc
Q 040845          118 SKLSKLALEMNSFSGFIPSTF-----GNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYV  192 (824)
Q Consensus       118 ~~L~~L~L~~N~i~~~~~~~~-----~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~  192 (824)
                      ++|++|+|++|.+++.....+     ...++|++|+|++|.|+..... .+...+..+++|++|+|++|.|.+.....  
T Consensus       126 ~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~-~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~--  202 (372)
T 3un9_A          126 LRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVA-VLMEGLAGNTSVTHLSLLHTGLGDEGLEL--  202 (372)
T ss_dssp             HTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHH-HHHHHHHTCSSCCEEECTTSSCHHHHHHH--
T ss_pred             HhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHH-HHHHHHhcCCCcCEEeCCCCCCCcHHHHH--
Confidence            345555555555543322222     1235566666666655442211 12233445566666666666654321111  


Q ss_pred             ccccccccEEEeecCcceecCCccCCCCCCCCEEEecCCccCCc----cchhhcCCCCCCEEEcccccCcccCCcccc
Q 040845          193 GNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGS----IPITLGKLQKLQDVDLEYNQLEGSIPDSIC  266 (824)
Q Consensus       193 ~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~  266 (824)
                                          ++..+..+++|++|+|++|.|+..    +...+...++|++|+|++|.|+......++
T Consensus       203 --------------------L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~  260 (372)
T 3un9_A          203 --------------------LAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLR  260 (372)
T ss_dssp             --------------------HHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHHH
T ss_pred             --------------------HHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHHH
Confidence                                112333445566666666666532    223344456666666666666644444443

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.30  E-value=2.3e-12  Score=138.41  Aligned_cols=103  Identities=20%  Similarity=0.199  Sum_probs=67.4

Q ss_pred             EEEcCCC-CCCCCCCccccccccccccccc-ccccCcCCccccccccchhhhcccccccccCCCccCCCCCCCeEEccCc
Q 040845          297 VLSLGSN-ELTSIPLNFWSLKDILDLNLSS-NCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYN  374 (824)
Q Consensus       297 ~L~L~~N-~l~~lp~~~~~l~~L~~L~l~~-N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N  374 (824)
                      .++++++ +|+.+|. +..+++|+.|+|++ |.|++..+..|.++++|+.|+|++|+|++..|..|.++++|+.|+|++|
T Consensus        12 ~v~~~~~n~l~~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N   90 (347)
T 2ifg_A           12 GLRCTRDGALDSLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN   90 (347)
T ss_dssp             CEECCSSCCCTTTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred             EEEcCCCCCCCccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCC
Confidence            4566665 6666666 65566666666664 6666555566666777777777777777666666777777777777777


Q ss_pred             cccccCCccccccccccEEEccCcccC
Q 040845          375 RLEGSIPDSFGDLISLKSLNLSYNNLS  401 (824)
Q Consensus       375 ~l~~~~~~~~~~l~~L~~L~L~~N~l~  401 (824)
                      +|++..+..|..++ |+.|+|++|.+.
T Consensus        91 ~l~~~~~~~~~~~~-L~~l~l~~N~~~  116 (347)
T 2ifg_A           91 ALESLSWKTVQGLS-LQELVLSGNPLH  116 (347)
T ss_dssp             CCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred             ccceeCHHHcccCC-ceEEEeeCCCcc
Confidence            77654445555544 777777777765

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.29  E-value=9.3e-12  Score=127.85  Aligned_cols=146  Identities=16%  Similarity=0.093  Sum_probs=115.8

Q ss_pred             HHhhccCCCCceeeeccceEEEEEEECCCcEEEEEEeeccccchhhhHHHHHHHHhcCC-CCcceeEEeeeecCCeeEEE
Q 040845          523 FQATDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIR-HRNLVKVISSCSNEEFKALV  601 (824)
Q Consensus       523 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv  601 (824)
                      ......|.+....+.|+.+.||++... ++.+++|+...........+.+|+.+++.+. +..+.++++++.+.+..|+|
T Consensus        10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv   88 (263)
T 3tm0_A           10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL   88 (263)
T ss_dssp             HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred             HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence            445567888888898999999999865 7899999986533233457899999999985 67788999999888899999


Q ss_pred             EeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcC--------------------------------------
Q 040845          602 LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFG--------------------------------------  643 (824)
Q Consensus       602 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~--------------------------------------  643 (824)
                      |||++|.++.+.+..      ......++.+++++++.||..                                      
T Consensus        89 ~e~i~G~~l~~~~~~------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (263)
T 3tm0_A           89 MSEADGVLCSEEYED------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT  162 (263)
T ss_dssp             EECCSSEEHHHHCCT------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred             EEecCCeehhhccCC------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence            999999999876421      112346889999999999941                                      


Q ss_pred             ------------------CCCCeEecCCCCCCeeeCCCCcEEEeeccccc
Q 040845          644 ------------------YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK  675 (824)
Q Consensus       644 ------------------~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~  675 (824)
                                        ....++|+|++|.||+++++..+.|+||+.+.
T Consensus       163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                              01458999999999999876666799999775

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=99.29  E-value=3.6e-10  Score=122.71  Aligned_cols=129  Identities=12%  Similarity=0.102  Sum_probs=55.9

Q ss_pred             ccCCCCCCCCEEEecCCccCCccchhhcCCCCCCEEEcccccCcccCCccccccCCccEEEccCccccccCCccccCCCC
Q 040845          215 EEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTF  294 (824)
Q Consensus       215 ~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~  294 (824)
                      ..+..+.+|+.+.+..+ +..+...+|.++..|+.+.+..+ ++......|..+.+|+.+.+..+ +......+|.++++
T Consensus       211 ~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~  287 (379)
T 4h09_A          211 YGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSN  287 (379)
T ss_dssp             TTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTT
T ss_pred             cccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccc
Confidence            33444455555554433 22233444555555555555443 33333444444445555554332 33334444555555


Q ss_pred             CcEEEcCCCCCCCCCCc-ccccccccccccccccccCcCCccccccccchhhhc
Q 040845          295 LKVLSLGSNELTSIPLN-FWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDF  347 (824)
Q Consensus       295 L~~L~L~~N~l~~lp~~-~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l  347 (824)
                      |+.+.+.++.++.|+.. |.++.+|+.+.|..+ ++.+...+|.++.+|+.+.+
T Consensus       288 L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~i  340 (379)
T 4h09_A          288 LTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISY  340 (379)
T ss_dssp             CCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCC
T ss_pred             cccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEE
Confidence            55555544444444332 333444444444322 22233333444444444444

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.28  E-value=2.1e-12  Score=138.65  Aligned_cols=132  Identities=22%  Similarity=0.237  Sum_probs=106.5

Q ss_pred             cccccccc-cccCcCCccccccccchhhhccc-ccccccCCCccCCCCCCCeEEccCccccccCCccccccccccEEEcc
Q 040845          319 LDLNLSSN-CFSGPLPLEIRNLKALIEIDFSM-NNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLS  396 (824)
Q Consensus       319 ~~L~l~~N-~l~~~~~~~~~~l~~L~~L~l~~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  396 (824)
                      ..++++++ .++. +|. +..+++|+.|+|++ |+|++..+..|.++++|+.|+|++|+|++..|..|.++++|+.|+|+
T Consensus        11 ~~v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~   88 (347)
T 2ifg_A           11 SGLRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS   88 (347)
T ss_dssp             SCEECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred             CEEEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence            35688888 8984 677 99999999999996 99998888999999999999999999999889999999999999999


Q ss_pred             CcccCCCCcccccCCcccceeeccCCcccCCCCCCC--CccccccccccCCccccCCCC
Q 040845          397 YNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIPRGG--SFGNFSAESFKGNELLCGSPN  453 (824)
Q Consensus       397 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~--~~~~~~~~~~~~n~~~c~~~~  453 (824)
                      +|+|++..+..+..++ |+.|+|.+|+|.|.+.-..  .+.......+..+...|..|.
T Consensus        89 ~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~l~~~~~~~~~~~~~l~~~~~~C~~~~  146 (347)
T 2ifg_A           89 FNALESLSWKTVQGLS-LQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQG  146 (347)
T ss_dssp             SSCCSCCCSTTTCSCC-CCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSS
T ss_pred             CCccceeCHHHcccCC-ceEEEeeCCCccCCCccHHHHHHHHhCcccccccCCCCCCCh
Confidence            9999966666666665 9999999999998765211  111112233455667777654

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=99.22  E-value=5.1e-10  Score=121.53  Aligned_cols=313  Identities=10%  Similarity=0.036  Sum_probs=148.0

Q ss_pred             cCCCCCCEEeCCCCcCCcccChhhhCcCCCceeeccCCccccccCccccCCCCCccEEEccCCeeeeecCccccCCCCCc
Q 040845           42 GHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLS  121 (824)
Q Consensus        42 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~  121 (824)
                      ....+|+.+.+.. .++.+...+|.++.+|+.++|..+ ++.+....+ .++ +|+.+.+..+ ++......|.. .+|+
T Consensus        43 ~~~~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF-~~c-~l~~i~~~~~-l~~I~~~aF~~-~~L~  116 (379)
T 4h09_A           43 KDRDRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAF-ADT-KLQSYTGMER-VKKFGDYVFQG-TDLD  116 (379)
T ss_dssp             GGGGGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTT-TTC-CCCEEEECTT-CCEECTTTTTT-CCCS
T ss_pred             ccccCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhh-cCC-CCceEECCce-eeEeccceecc-CCcc
Confidence            3344555555543 233344445555555555555432 333333222 222 3444444332 33233333333 3566


Q ss_pred             eEeccCccccccCCccccCCCCCCEEEccCCcCCCCcCcccccccCCCCCCCcEEECcCCCCCccCCccccccccccccE
Q 040845          122 KLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKN  201 (824)
Q Consensus       122 ~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~~L~~  201 (824)
                      .+.+..+ +..+...+|.+. +|+.+.+..+ ++.+..     .++..+.+++.+.+..+.........+..        
T Consensus       117 ~i~lp~~-~~~i~~~~F~~~-~l~~~~~~~~-v~~i~~-----~~f~~~~~l~~~~~~~~~~~~~~~~~~~~--------  180 (379)
T 4h09_A          117 DFEFPGA-TTEIGNYIFYNS-SVKRIVIPKS-VTTIKD-----GIGYKAENLEKIEVSSNNKNYVAENYVLY--------  180 (379)
T ss_dssp             EEECCTT-CCEECTTTTTTC-CCCEEEECTT-CCEECS-----CTTTTCTTCCEEEECTTCSSEEEETTEEE--------
T ss_pred             cccCCCc-cccccccccccc-eeeeeeccce-eecccc-----chhcccccccccccccccceeecccceec--------
Confidence            6666544 222444455443 4555444332 222221     23555666666665554432211110000        


Q ss_pred             EEeecCcceecCCccCCCCCCCCEEEecCCccCCccchhhcCCCCCCEEEcccccCcccCCccccccCCccEEEccCccc
Q 040845          202 FYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKL  281 (824)
Q Consensus       202 L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l  281 (824)
                         ..+   ......+.....+..+.+....-. ....++....+|+.+.+..+ +.......+..+..|+.+.+..+ +
T Consensus       181 ---~~~---~~~~~~~~~~~~~~~~~~~~~~~~-i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v  251 (379)
T 4h09_A          181 ---NKN---KTILESYPAAKTGTEFTIPSTVKT-VTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-V  251 (379)
T ss_dssp             ---ETT---SSEEEECCTTCCCSEEECCTTCCE-ECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-C
T ss_pred             ---ccc---cceeccccccccccccccccceeE-Eeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-c
Confidence               000   011123444555555555443322 34455666667777666544 33244455555666666666554 4


Q ss_pred             cccCCccccCCCCCcEEEcCCCCCCCCCCcccccccccccccccccccCcCCccccccccchhhhcccccccccCCCccC
Q 040845          282 SGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIG  361 (824)
Q Consensus       282 ~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~  361 (824)
                      +.+...+|.++.+|+.+.+.. .++.+                       ....|.++.+|+.+.+.++.++.+...+|.
T Consensus       252 ~~I~~~aF~~~~~l~~i~l~~-~i~~i-----------------------~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~  307 (379)
T 4h09_A          252 TSIGSFLLQNCTALKTLNFYA-KVKTV-----------------------PYLLCSGCSNLTKVVMDNSAIETLEPRVFM  307 (379)
T ss_dssp             CEECTTTTTTCTTCCEEEECC-CCSEE-----------------------CTTTTTTCTTCCEEEECCTTCCEECTTTTT
T ss_pred             cEeCccccceeehhccccccc-cceec-----------------------cccccccccccccccccccccceehhhhhc
Confidence            444555566666666665532 23333                       334455555666666655555555555666


Q ss_pred             CCCCCCeEEccCccccccCCccccccccccEEEccCcccCCCCcccccCC
Q 040845          362 SLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKL  411 (824)
Q Consensus       362 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l  411 (824)
                      ++.+|+.+.|..+ ++.+...+|.+|.+|+.+.+..+ ++..-..+|.++
T Consensus       308 ~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF~~c  355 (379)
T 4h09_A          308 DCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-ITLIESGAFEGS  355 (379)
T ss_dssp             TCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTS
T ss_pred             CCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cCEEchhHhhCC
Confidence            6666666666443 44344456666666666666543 442333444444

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.14  E-value=6.1e-11  Score=121.62  Aligned_cols=136  Identities=16%  Similarity=0.105  Sum_probs=101.2

Q ss_pred             cCCCCceeeeccceEEEEEEECCCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCc--ceeEEeeeecCCeeEEEEecc
Q 040845          528 KFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRN--LVKVISSCSNEEFKALVLEYM  605 (824)
Q Consensus       528 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~  605 (824)
                      .|.+..+.+.|..+.||++...+|+.+++|+....   ....+..|+.+++.+++.+  +.+++++...++..++||||+
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i   97 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV   97 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred             CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence            44443333455669999998777888999987543   3456888999999986544  566888888878889999999


Q ss_pred             CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCC-----------------------------------------
Q 040845          606 PHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGY-----------------------------------------  644 (824)
Q Consensus       606 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-----------------------------------------  644 (824)
                      +|.++.  ..    ..+   ...++.++++.++.||...                                         
T Consensus        98 ~G~~l~--~~----~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (264)
T 1nd4_A           98 PGQDLL--SS----HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA  168 (264)
T ss_dssp             SSEETT--TS----CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred             CCcccC--cC----cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHH
Confidence            998884  21    112   2357788888899998321                                         


Q ss_pred             --------------CCCeEecCCCCCCeeeCCCCcEEEeeccccc
Q 040845          645 --------------SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK  675 (824)
Q Consensus       645 --------------~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~  675 (824)
                                    ...++|+|++|.||++++++.+.|+|||.+.
T Consensus       169 ~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          169 ELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                          1129999999999999877667799999875

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.94  E-value=1.7e-09  Score=116.42  Aligned_cols=141  Identities=13%  Similarity=0.173  Sum_probs=106.1

Q ss_pred             CceeeeccceEEEEEEECCCcEEEEEEee--ccc-cchhhhHHHHHHHHhcCC--CCcceeEEeeeecC---CeeEEEEe
Q 040845          532 NNLIGRGGFGSVYKARIRDGMEVAVKVFN--LQC-GRAFKSFDVECAMMKSIR--HRNLVKVISSCSNE---EFKALVLE  603 (824)
Q Consensus       532 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~e  603 (824)
                      .+.++.|.++.||+++.. +..+++|+..  ... ......+.+|+.+++.+.  +..+.++++++.+.   +..++|||
T Consensus        43 ~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme  121 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME  121 (359)
T ss_dssp             EEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred             EEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence            467899999999999876 4678888765  321 123457888999999997  45578899888766   45889999


Q ss_pred             ccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCC---------------------------------------
Q 040845          604 YMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGY---------------------------------------  644 (824)
Q Consensus       604 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~---------------------------------------  644 (824)
                      |++|..+.+..   ...++..++..++.++++.|+.||...                                       
T Consensus       122 ~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  198 (359)
T 3dxp_A          122 FVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMD  198 (359)
T ss_dssp             CCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHH
T ss_pred             ecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHH
Confidence            99987774321   124678888899999999999999410                                       


Q ss_pred             ----------------CCCeEecCCCCCCeeeCCCCc--EEEeecccccc
Q 040845          645 ----------------SAPVIHCDLKPSNVLLDDNMV--AHLSDFGIAKL  676 (824)
Q Consensus       645 ----------------~~~ivH~Dlk~~Nill~~~~~--~kl~Dfg~a~~  676 (824)
                                      ...++|+|+++.||+++.++.  +.++||+.+..
T Consensus       199 ~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          199 SLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                            257999999999999997753  68999998864

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.91  E-value=3.3e-10  Score=120.69  Aligned_cols=160  Identities=17%  Similarity=0.281  Sum_probs=80.0

Q ss_pred             CCCccEEEccCCeeeeecCccccCCCCCceEeccCccccccCCcccc--CCCCCCEEEccC--CcC-CCCcCcccccccC
Q 040845           93 LPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFG--NLRNLEWLTLYD--NNL-TSSTLDLSFLSSL  167 (824)
Q Consensus        93 l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~--~l~~L~~L~L~~--n~i-~~~~~~~~~~~~l  167 (824)
                      +|+|+.|+|++|.-. .++. + .+++|++|+|..|.++......++  .+++|+.|+|+.  |.. ...... .....+
T Consensus       171 ~P~L~~L~L~g~~~l-~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~-~l~~~l  246 (362)
T 2ra8_A          171 MPLLNNLKIKGTNNL-SIGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMN-VFRPLF  246 (362)
T ss_dssp             CTTCCEEEEECCBTC-BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGG-GTGGGS
T ss_pred             CCCCcEEEEeCCCCc-eecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHH-HHHHHH
Confidence            456666666655211 1222 2 256666666666665543333333  567777777643  111 110000 000112


Q ss_pred             --CCCCCCcEEECcCCCCCccCCccccccccccccEEEeecCcceecCCccCCCCCCCCEEEecCCccCCccch----hh
Q 040845          168 --SNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPI----TL  241 (824)
Q Consensus       168 --~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~----~~  241 (824)
                        ..+++|++|+|++|.+.+..+..+..                       ...+++|++|+|+.|.+.+....    .+
T Consensus       247 ~~~~~p~Lr~L~L~~~~i~~~~~~~la~-----------------------a~~~~~L~~LdLs~n~L~d~G~~~L~~~L  303 (362)
T 2ra8_A          247 SKDRFPNLKWLGIVDAEEQNVVVEMFLE-----------------------SDILPQLETMDISAGVLTDEGARLLLDHV  303 (362)
T ss_dssp             CTTTCTTCCEEEEESCTTHHHHHHHHHH-----------------------CSSGGGCSEEECCSSCCBHHHHHHHHTTH
T ss_pred             hcCCCCCcCEEeCCCCCCchHHHHHHHh-----------------------CccCCCCCEEECCCCCCChHHHHHHHhhc
Confidence              34678888888888775432111110                       01246677777777776643222    23


Q ss_pred             cCCCCCCEEEcccccCcccCCccccccCCccEEEccCcc
Q 040845          242 GKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNK  280 (824)
Q Consensus       242 ~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~  280 (824)
                      ..+++|+.|+|++|.|+......+...- ...+++++++
T Consensus       304 ~~l~~L~~L~L~~n~i~d~~~~~l~~al-g~~~~~~~~~  341 (362)
T 2ra8_A          304 DKIKHLKFINMKYNYLSDEMKKELQKSL-PMKIDVSDSQ  341 (362)
T ss_dssp             HHHTTCSEEECCSBBCCHHHHHHHHHHC-CSEEECCSBC
T ss_pred             ccCCcceEEECCCCcCCHHHHHHHHHHc-CCEEEecCCc
Confidence            3457777777777776644333333211 3456776665

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.91  E-value=1.3e-10  Score=123.86  Aligned_cols=182  Identities=16%  Similarity=0.183  Sum_probs=97.6

Q ss_pred             CCCCCCCEEEecCCccC---------CccchhhcCCCCCCEEEccccc-CcccCCccccccCCccEEEccCccccccCCc
Q 040845          218 TNLTDLTTIVLGGNKLN---------GSIPITLGKLQKLQDVDLEYNQ-LEGSIPDSICLSVELYELELGGNKLSGSIPA  287 (824)
Q Consensus       218 ~~l~~L~~L~L~~n~l~---------~~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~  287 (824)
                      ..+++|+.|.+.++...         +.+...+..+++|+.|+|++|. +.  .+. + .+++|+.|+|..|.+......
T Consensus       136 ~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l~--l~~-~-~~~~L~~L~L~~~~l~~~~l~  211 (362)
T 2ra8_A          136 EKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLS--IGK-K-PRPNLKSLEIISGGLPDSVVE  211 (362)
T ss_dssp             HHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTCB--CCS-C-BCTTCSEEEEECSBCCHHHHH
T ss_pred             hhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCce--ecc-c-cCCCCcEEEEecCCCChHHHH
Confidence            34556666666543221         1233445566667777766652 21  122 2 255666666666655432222


Q ss_pred             ccc--CCCCCcEEEcCCC--CCCCCCCcccccccccccccccccccCcCCccc--cccccchhhhcccccccccCCCcc-
Q 040845          288 CFS--NMTFLKVLSLGSN--ELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEI--RNLKALIEIDFSMNNFSGIIPMEI-  360 (824)
Q Consensus       288 ~~~--~l~~L~~L~L~~N--~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~--~~l~~L~~L~l~~N~l~~~~~~~~-  360 (824)
                      .+.  .+++|+.|+|+.+  ....-                 ..+.. +...+  ..+++|+.|+|++|.+.+..+..+ 
T Consensus       212 ~l~~~~lp~L~~L~L~~~~~~~~~~-----------------~~~~~-l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la  273 (362)
T 2ra8_A          212 DILGSDLPNLEKLVLYVGVEDYGFD-----------------GDMNV-FRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFL  273 (362)
T ss_dssp             HHHHSBCTTCCEEEEECBCGGGTCC-----------------SCGGG-TGGGSCTTTCTTCCEEEEESCTTHHHHHHHHH
T ss_pred             HHHHccCCCCcEEEEeccccccccc-----------------hhHHH-HHHHHhcCCCCCcCEEeCCCCCCchHHHHHHH
Confidence            222  4566666665321  10000                 00000 00111  246777888887777764322222 


Q ss_pred             --CCCCCCCeEEccCcccccc----CCccccccccccEEEccCcccCCCCcccccC-CcccceeeccCCc
Q 040845          361 --GSLKNLENLFLEYNRLEGS----IPDSFGDLISLKSLNLSYNNLSGTIPVSLEK-LSYLKDLNLSFNK  423 (824)
Q Consensus       361 --~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~L~l~~N~  423 (824)
                        ..+++|+.|+|+.|.|++.    ++..+..+++|+.|+|++|.|+...-..+.. +  ...+++++|+
T Consensus       274 ~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~al--g~~~~~~~~~  341 (362)
T 2ra8_A          274 ESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSL--PMKIDVSDSQ  341 (362)
T ss_dssp             HCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHHHC--CSEEECCSBC
T ss_pred             hCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHHHc--CCEEEecCCc
Confidence              2578899999999998863    3444456789999999999887433333332 2  2467888876

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.85  E-value=1.2e-09  Score=114.56  Aligned_cols=188  Identities=18%  Similarity=0.173  Sum_probs=122.7

Q ss_pred             CceeeeccceEEEEEEECCCcEEEEEEeeccccchhhhHHHHHHHHhcCC-CCc--ceeEEeeeecCC---eeEEEEecc
Q 040845          532 NNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIR-HRN--LVKVISSCSNEE---FKALVLEYM  605 (824)
Q Consensus       532 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~e~~  605 (824)
                      .+.++.|.+..||++.    ..+++|.....  .....+.+|+++++.+. +..  +.+++.......   ..|+|||++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            4568999999999873    56889986432  34567889999998884 332  445555543333   457999999


Q ss_pred             CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcC------------------------------------------
Q 040845          606 PHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFG------------------------------------------  643 (824)
Q Consensus       606 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~------------------------------------------  643 (824)
                      +|.++.+....   .++..++..++.++++.++.||..                                          
T Consensus        99 ~G~~l~~~~~~---~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  175 (304)
T 3sg8_A           99 KGVPLTPLLLN---NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD  175 (304)
T ss_dssp             CCEECCHHHHH---TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred             CCeECCccccc---cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence            99888654332   467777888888999888888841                                          


Q ss_pred             -------------CCCCeEecCCCCCCeeeCC--CCcEEEeecccccccCCCCCcccccc------------cccccccc
Q 040845          644 -------------YSAPVIHCDLKPSNVLLDD--NMVAHLSDFGIAKLLTGEDQSMTQTQ------------TLATIGYM  696 (824)
Q Consensus       644 -------------~~~~ivH~Dlk~~Nill~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~------------~~~~~~y~  696 (824)
                                   ....++|+|++|.||++++  +..+.++||+.+..-.....-.....            .....+..
T Consensus       176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~  255 (304)
T 3sg8_A          176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHK  255 (304)
T ss_dssp             HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCS
T ss_pred             HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCC
Confidence                         0135799999999999998  55678999998865321100000000            00000111


Q ss_pred             C-ccCcCCCCCCccchHHHHHHHHHHHHhCCCCCc
Q 040845          697 A-PEYGREGQVSTNGDVYSFGIMLMETFTRKKPTD  730 (824)
Q Consensus       697 a-PE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~  730 (824)
                      . |+...  ......+.|++|.++|++.+|..+|.
T Consensus       256 ~~~~~~~--r~~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          256 DIPTVLE--KYRMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             CHHHHHH--HHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             CcHHHHH--HHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence            1 11111  11223589999999999999998753

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.56  E-value=1.1e-08  Score=98.18  Aligned_cols=62  Identities=13%  Similarity=0.120  Sum_probs=36.8

Q ss_pred             CCccEEEccCCeeeee----cCccccCCCCCceEec--cCccccccC----CccccCCCCCCEEEccCCcCC
Q 040845           94 PNLEVLYLWGNNFSGT----IPHFIFNASKLSKLAL--EMNSFSGFI----PSTFGNLRNLEWLTLYDNNLT  155 (824)
Q Consensus        94 ~~L~~L~L~~n~i~~~----~~~~l~~l~~L~~L~L--~~N~i~~~~----~~~~~~l~~L~~L~L~~n~i~  155 (824)
                      ++|++|+|++|.|+..    +...+...++|++|+|  ++|.|+...    ...+...++|++|+|++|.+.
T Consensus        93 ~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A           93 NTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             SSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             CCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence            4555666666655432    3445556667777777  667766432    233444567777777777664

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.47  E-value=1.9e-08  Score=96.53  Aligned_cols=124  Identities=13%  Similarity=0.127  Sum_probs=58.8

Q ss_pred             ccccCCCCCceEeccCc-ccccc----CCccccCCCCCCEEEccCCcCCCCcCcccccccCCCCCCCcEEECcCCCCCcc
Q 040845          112 HFIFNASKLSKLALEMN-SFSGF----IPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGI  186 (824)
Q Consensus       112 ~~l~~l~~L~~L~L~~N-~i~~~----~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~  186 (824)
                      ..+...++|++|+|++| .|+..    +...+...++|++|+|++|.|+..... .+...+...++|++|+|++|.|.+.
T Consensus        30 ~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~-~l~~~L~~n~~L~~L~L~~N~i~~~  108 (185)
T 1io0_A           30 RIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAF-ALAEMLKVNNTLKSLNVESNFISGS  108 (185)
T ss_dssp             HHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHH-HHHHHHHHCSSCCEEECCSSCCCHH
T ss_pred             HHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHH-HHHHHHHhCCCcCEEECcCCcCCHH
Confidence            34555566666666666 65532    123344445566666666655442211 1122333445555555555555432


Q ss_pred             CCccccccccccccEEEeecCcceecCCccCCCCCCCCEEEe--cCCccCCc----cchhhcCCCCCCEEEcccccCc
Q 040845          187 LPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVL--GGNKLNGS----IPITLGKLQKLQDVDLEYNQLE  258 (824)
Q Consensus       187 ~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L--~~n~l~~~----~~~~~~~l~~L~~L~L~~n~l~  258 (824)
                      ....                      +...+...++|++|+|  ++|.|...    +...+...++|++|+|++|.+.
T Consensus       109 g~~~----------------------l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A          109 GILA----------------------LVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             HHHH----------------------HHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             HHHH----------------------HHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence            1111                      1223344455666666  55655532    1223334455555555555554

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.47  E-value=1.7e-08  Score=101.75  Aligned_cols=80  Identities=25%  Similarity=0.254  Sum_probs=41.4

Q ss_pred             CcCCCceeeccCCccccccCc-cccCCCCCccEEEccCCeeeeecCccccCCC--CCceEeccCccccccCC-------c
Q 040845           67 NVSTLKAFAVTNNSLSGCLSS-ITDVGLPNLEVLYLWGNNFSGTIPHFIFNAS--KLSKLALEMNSFSGFIP-------S  136 (824)
Q Consensus        67 ~l~~L~~L~L~~n~l~~~~~~-~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~--~L~~L~L~~N~i~~~~~-------~  136 (824)
                      ++++|++|+|++|+|+++..- .....+++|+.|+|++|+|++.  ..+..+.  +|++|+|++|.+.+..|       .
T Consensus       168 ~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~  245 (267)
T 3rw6_A          168 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISA  245 (267)
T ss_dssp             HCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHH
T ss_pred             hCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHHH
Confidence            345555555555555543210 0011355566666666655533  2233333  67777777777665443       2


Q ss_pred             cccCCCCCCEEE
Q 040845          137 TFGNLRNLEWLT  148 (824)
Q Consensus       137 ~~~~l~~L~~L~  148 (824)
                      .+..+++|+.||
T Consensus       246 il~~~P~L~~LD  257 (267)
T 3rw6_A          246 IRERFPKLLRLD  257 (267)
T ss_dssp             HHHHCTTCCEES
T ss_pred             HHHHCcccCeEC
Confidence            356677777775

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.43  E-value=2.3e-08  Score=100.80  Aligned_cols=80  Identities=24%  Similarity=0.299  Sum_probs=42.6

Q ss_pred             cccccchhhhccccccccc--CCCccCCCCCCCeEEccCccccccCCccccccc--cccEEEccCcccCCCCcc------
Q 040845          337 RNLKALIEIDFSMNNFSGI--IPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLI--SLKSLNLSYNNLSGTIPV------  406 (824)
Q Consensus       337 ~~l~~L~~L~l~~N~l~~~--~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~--~L~~L~L~~N~l~~~~p~------  406 (824)
                      .++++|+.|+|++|+|++.  +|..+..+++|+.|+|++|+|++.  ..+..+.  +|+.|+|++|++.+.+|.      
T Consensus       167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~  244 (267)
T 3rw6_A          167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYIS  244 (267)
T ss_dssp             HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHH
T ss_pred             hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHH
Confidence            3455566666666666552  234445566666666666666543  2233333  566666666666544441      


Q ss_pred             -cccCCcccceee
Q 040845          407 -SLEKLSYLKDLN  418 (824)
Q Consensus       407 -~~~~l~~L~~L~  418 (824)
                       .+..+|+|+.||
T Consensus       245 ~il~~~P~L~~LD  257 (267)
T 3rw6_A          245 AIRERFPKLLRLD  257 (267)
T ss_dssp             HHHHHCTTCCEES
T ss_pred             HHHHHCcccCeEC
Confidence             244555555554

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.42  E-value=1.1e-06  Score=90.29  Aligned_cols=134  Identities=17%  Similarity=0.106  Sum_probs=99.4

Q ss_pred             eeeeccce-EEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcCC-CCcceeEEeeeecCCeeEEEEeccCCCCH
Q 040845          534 LIGRGGFG-SVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIR-HRNLVKVISSCSNEEFKALVLEYMPHGSL  610 (824)
Q Consensus       534 ~lg~G~~g-~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~L  610 (824)
                      .+..|..| .||+.... ++..+++|+-..   .....+.+|+..|+.+. +--+.++++++.+++..++|||+++|.++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence            45667766 68998755 467899998653   34556788999999884 33477889999989999999999999888


Q ss_pred             HHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcC-----------------------------------------------
Q 040845          611 EKYLHSSNYSLDIFQRLNIMIDVASALEYLHFG-----------------------------------------------  643 (824)
Q Consensus       611 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-----------------------------------------------  643 (824)
                      .+......     .....++.+++..++.||..                                               
T Consensus       108 ~~~~~~~~-----~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  182 (272)
T 4gkh_A          108 FQVLEEYP-----DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKE  182 (272)
T ss_dssp             HHHHHHCG-----GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHH
T ss_pred             cccccCCH-----HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHH
Confidence            77654321     22345667777777777731                                               


Q ss_pred             --------CCCCeEecCCCCCCeeeCCCCcEEEeeccccc
Q 040845          644 --------YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK  675 (824)
Q Consensus       644 --------~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~  675 (824)
                              ....++|+|+.+.||++++++.+-|+||+.+.
T Consensus       183 l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          183 MHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                    01237899999999999988777899999875

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.39  E-value=1.4e-06  Score=90.93  Aligned_cols=136  Identities=14%  Similarity=0.114  Sum_probs=96.1

Q ss_pred             CceeeeccceEEEEEEECCCcEEEEEEeeccccchhhhHHHHHHHHhcCCCC---cceeEEeeee-cCCeeEEEEeccCC
Q 040845          532 NNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHR---NLVKVISSCS-NEEFKALVLEYMPH  607 (824)
Q Consensus       532 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~~  607 (824)
                      .+.++.|....||+.    |..+++|+..  .......+..|+++++.+++.   .+.+++.+.. ..+..++||||++|
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            356888999999998    5678888743  223456788999999999753   3566777664 45667899999999


Q ss_pred             CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcC--------------------------------------------
Q 040845          608 GSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFG--------------------------------------------  643 (824)
Q Consensus       608 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~--------------------------------------------  643 (824)
                      .++.+....   .++..+...++.++++.++.||..                                            
T Consensus        98 ~~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~  174 (306)
T 3tdw_A           98 QILGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL  174 (306)
T ss_dssp             EECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred             eECchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence            888763221   234455555666666666666521                                            


Q ss_pred             -------------CCCCeEecCCCCCCeeeCC---CCc-EEEeecccccc
Q 040845          644 -------------YSAPVIHCDLKPSNVLLDD---NMV-AHLSDFGIAKL  676 (824)
Q Consensus       644 -------------~~~~ivH~Dlk~~Nill~~---~~~-~kl~Dfg~a~~  676 (824)
                                   ....++|+|+++.||+++.   ++. +.|+||+.+..
T Consensus       175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                         1335699999999999987   455 48999997753

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.23  E-value=1.6e-06  Score=92.85  Aligned_cols=79  Identities=8%  Similarity=-0.024  Sum_probs=56.6

Q ss_pred             cee-eeccceEEEEEEEC-------CCcEEEEEEeeccc---cchhhhHHHHHHHHhcCC-C--CcceeEEeeeecC---
Q 040845          533 NLI-GRGGFGSVYKARIR-------DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIR-H--RNLVKVISSCSNE---  595 (824)
Q Consensus       533 ~~l-g~G~~g~V~~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~---  595 (824)
                      +.| +.|....+|+....       +++.+++|......   ......+..|+.+++.+. +  -.+.++++++.+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            567 78889999998754       26789999865332   112356788999999884 3  3567788887655   


Q ss_pred             CeeEEEEeccCCCCHH
Q 040845          596 EFKALVLEYMPHGSLE  611 (824)
Q Consensus       596 ~~~~lv~e~~~~g~L~  611 (824)
                      +..++||||++|.++.
T Consensus       106 g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             SSCEEEEECCCCBCCC
T ss_pred             CCceEEEEecCCCChh
Confidence            3568999999887654

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.96  E-value=3.2e-05  Score=84.04  Aligned_cols=75  Identities=16%  Similarity=0.166  Sum_probs=50.0

Q ss_pred             CceeeeccceEEEEEEEC-CCcEEEEEEeecccc-------chhhhHHHHHHHHhcCCC--C-cceeEEeeeecCCeeEE
Q 040845          532 NNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG-------RAFKSFDVECAMMKSIRH--R-NLVKVISSCSNEEFKAL  600 (824)
Q Consensus       532 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~-niv~l~~~~~~~~~~~l  600 (824)
                      .+.+|.|.++.||+++.. +++.|+||.......       ...+.+..|+++++.+..  + .+.+++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            457899999999999754 468899998653211       123556789999988742  3 34456544  3445679


Q ss_pred             EEeccCCC
Q 040845          601 VLEYMPHG  608 (824)
Q Consensus       601 v~e~~~~g  608 (824)
                      ||||+++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999763

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.88  E-value=5.3e-06  Score=77.28  Aligned_cols=59  Identities=3%  Similarity=0.057  Sum_probs=33.5

Q ss_pred             CCCcEEEccCCcccccccccccCCCCCCEEeCCCCc-CCcccChhhhCc----CCCceeeccCC
Q 040845           21 SNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNK-LLGTIPAAIFNV----STLKAFAVTNN   79 (824)
Q Consensus        21 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~-l~~~~~~~~~~l----~~L~~L~L~~n   79 (824)
                      ..|++|||++|.|+......++++++|++|+|++|. |++..-..+..+    ++|++|+|++|
T Consensus        61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C  124 (176)
T 3e4g_A           61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISC  124 (176)
T ss_dssp             CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESC
T ss_pred             ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCC
Confidence            346777777777666555566666777777777764 553322333332    24555555554

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.86  E-value=4.5e-05  Score=80.97  Aligned_cols=138  Identities=17%  Similarity=0.187  Sum_probs=79.7

Q ss_pred             ceeeeccceEEEEEEECCCcEEEEEEeeccccchhhhHHHHHHHHhcCCC--CcceeEEee------eecCCeeEEEEec
Q 040845          533 NLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRH--RNLVKVISS------CSNEEFKALVLEY  604 (824)
Q Consensus       533 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~------~~~~~~~~lv~e~  604 (824)
                      +.|+.|..+.||++...+| .+++|+....    ...+..|+.+++.+..  -.+.+++..      ....+..++||||
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            3466677899999987644 5899988642    2334456666665531  123444431      2345677899999


Q ss_pred             cCCCCHH--------------HHhhhC--CC--C---------CCHHHH-------------------------------
Q 040845          605 MPHGSLE--------------KYLHSS--NY--S---------LDIFQR-------------------------------  626 (824)
Q Consensus       605 ~~~g~L~--------------~~l~~~--~~--~---------~~~~~~-------------------------------  626 (824)
                      ++|.++.              ..+|..  ..  .         ..|...                               
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            9886432              111211  00  0         122211                               


Q ss_pred             HHHHHHHHHHHHHhhc----------CCCCCeEecCCCCCCeeeCCCCcEEEeeccccc
Q 040845          627 LNIMIDVASALEYLHF----------GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK  675 (824)
Q Consensus       627 ~~i~~~i~~~l~~LH~----------~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~  675 (824)
                      ..+...+..++++|+.          .....++|+|+++.||+++.++.+.++||+.+.
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            0111223345556642          025789999999999999888899999999774

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.83  E-value=5.7e-06  Score=77.05  Aligned_cols=34  Identities=9%  Similarity=-0.002  Sum_probs=16.7

Q ss_pred             cccEEEeecCcceecCCccCCCCCCCCEEEecCC
Q 040845          198 SLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGN  231 (824)
Q Consensus       198 ~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n  231 (824)
                      .|++|++++|.|+..--..+..+++|+.|+|++|
T Consensus        62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C   95 (176)
T 3e4g_A           62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKC   95 (176)
T ss_dssp             CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESC
T ss_pred             eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCC
Confidence            3555555555544433344444555555555554

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.72  E-value=0.00023  Score=73.29  Aligned_cols=77  Identities=14%  Similarity=0.135  Sum_probs=57.3

Q ss_pred             CCCCceeeeccceEEEEEEECCCcEEEEEEeeccccchhhhHHHHHHHHhcCCCC---cceeEEeeeecCCeeEEEEecc
Q 040845          529 FSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHR---NLVKVISSCSNEEFKALVLEYM  605 (824)
Q Consensus       529 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~~~~~lv~e~~  605 (824)
                      ......+|.|..+.||+.+..||+.|++|+...........+..|+..|+.+.-.   -+.+++++.    ..++||||+
T Consensus        17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l   92 (288)
T 3f7w_A           17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWV   92 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECC
T ss_pred             eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEee
Confidence            3445779999999999999999999999987654444456788999999988422   345555542    236899999


Q ss_pred             CCCC
Q 040845          606 PHGS  609 (824)
Q Consensus       606 ~~g~  609 (824)
                      +++.
T Consensus        93 ~~~~   96 (288)
T 3f7w_A           93 DERP   96 (288)
T ss_dssp             CCCC
T ss_pred             cccC
Confidence            8764

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.71  E-value=0.00015  Score=75.20  Aligned_cols=136  Identities=14%  Similarity=0.108  Sum_probs=92.2

Q ss_pred             CceeeeccceEEEEEEECCCcEEEEEEeeccccchhhhHHHHHHHHhcCC---CCcceeEEeeeecCCeeEEEEeccCCC
Q 040845          532 NNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIR---HRNLVKVISSCSNEEFKALVLEYMPHG  608 (824)
Q Consensus       532 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~g  608 (824)
                      .+.|+.|....+|+.... +..+++|+....   ....+..|+..|+.+.   ...+.+++++....+..++||||+++.
T Consensus        41 ~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~  116 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLINDE-VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS  116 (312)
T ss_dssp             EEEECCSSSSEEEEEESS-SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred             eEEeCCccceeeeEEEEC-CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence            357899999999999864 778999987532   3567888999998884   356888999888888899999999987


Q ss_pred             CHH--------H---HhhhCCC---------------------CCCHHHHH---HHHH----------------HHHHH-
Q 040845          609 SLE--------K---YLHSSNY---------------------SLDIFQRL---NIMI----------------DVASA-  636 (824)
Q Consensus       609 ~L~--------~---~l~~~~~---------------------~~~~~~~~---~i~~----------------~i~~~-  636 (824)
                      .+.        +   .+|....                     .-+|.+..   ++..                .++.. 
T Consensus       117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l  196 (312)
T 3jr1_A          117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV  196 (312)
T ss_dssp             CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred             CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence            541        1   1232211                     12343321   1111                11111 


Q ss_pred             HHHhh-cCCCCCeEecCCCCCCeeeCCCCcEEEeecc
Q 040845          637 LEYLH-FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFG  672 (824)
Q Consensus       637 l~~LH-~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  672 (824)
                      ...|. ......++|+|+.+.|++++.++ +.+.||+
T Consensus       197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            22342 12357899999999999999887 8899974

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.58  E-value=1.1e-05  Score=76.51  Aligned_cols=121  Identities=12%  Similarity=0.183  Sum_probs=57.5

Q ss_pred             cCCCCCceEeccCc-ccccc----CCccccCCCCCCEEEccCCcCCCCcCcccccccCCCCCCCcEEECcCCCCCccCCc
Q 040845          115 FNASKLSKLALEMN-SFSGF----IPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPR  189 (824)
Q Consensus       115 ~~l~~L~~L~L~~N-~i~~~----~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~  189 (824)
                      .+-+.|++|+|++| +|...    +.+++..-+.|+.|+|++|.|...... .+...+...+.|++|+|++|.|......
T Consensus        38 ~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~-alA~aL~~N~tL~~L~L~~N~Ig~~Ga~  116 (197)
T 1pgv_A           38 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEAR-GLIELIETSPSLRVLNVESNFLTPELLA  116 (197)
T ss_dssp             TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHT-THHHHHHHCSSCCEEECCSSBCCHHHHH
T ss_pred             hcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHH-HHHHHHhcCCccCeEecCCCcCCHHHHH
Confidence            33445555555553 44421    123333445555555555555543221 1233444555666666666665533222


Q ss_pred             cccccccccccEEEeecCcceecCCccCCCCCCCCEEEecCC---ccCCc----cchhhcCCCCCCEEEcccccCc
Q 040845          190 TYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGN---KLNGS----IPITLGKLQKLQDVDLEYNQLE  258 (824)
Q Consensus       190 ~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n---~l~~~----~~~~~~~l~~L~~L~L~~n~l~  258 (824)
                      .                      +.+.+..-+.|++|+|++|   .+...    +..++...+.|+.|+++.|.+.
T Consensus       117 a----------------------la~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~g  170 (197)
T 1pgv_A          117 R----------------------LLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME  170 (197)
T ss_dssp             H----------------------HHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred             H----------------------HHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCcc
Confidence            1                      1233444455666666544   22211    2334555566666666665543

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.44  E-value=2.3e-05  Score=74.48  Aligned_cols=46  Identities=15%  Similarity=0.320  Sum_probs=23.4

Q ss_pred             cCCCCCCEEEccCC-cCCCCcCcccccccCCCCCCCcEEECcCCCCCc
Q 040845          139 GNLRNLEWLTLYDN-NLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDG  185 (824)
Q Consensus       139 ~~l~~L~~L~L~~n-~i~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~  185 (824)
                      .+-+.|++|+|++| +|...... .+..++...+.|++|+|++|.|.+
T Consensus        38 ~~n~~L~~L~L~~nn~igd~ga~-~la~aL~~N~~L~~L~L~~n~igd   84 (197)
T 1pgv_A           38 EDDTDLKEVNINNMKRVSKERIR-SLIEAACNSKHIEKFSLANTAISD   84 (197)
T ss_dssp             TTCSSCCEEECTTCCSSCHHHHH-HHHHHHTTCSCCCEEECTTSCCBH
T ss_pred             hcCCCccEEECCCCCCCCHHHHH-HHHHHHhhCCCcCEEEccCCCCCh
Confidence            33456666666654 55432211 123445555566666666665543

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.42  E-value=0.00045  Score=75.39  Aligned_cols=78  Identities=12%  Similarity=0.127  Sum_probs=48.5

Q ss_pred             CCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcccccccc--ccccccCccCcCCC---CCCccchHHHHHHHH
Q 040845          645 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTL--ATIGYMAPEYGREG---QVSTNGDVYSFGIML  719 (824)
Q Consensus       645 ~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~--~~~~y~aPE~~~~~---~~~~~~DvwslG~~l  719 (824)
                      ...++|+|+++.||+++.++ ++++||+.+..-.   .........  -...|.+|+.....   ......++.+.+..+
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~---p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGP---MGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT  306 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEEC---HHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCc---hHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence            68899999999999998876 9999999886421   110000000  12345666554311   122335566788888


Q ss_pred             HHHHhCC
Q 040845          720 METFTRK  726 (824)
Q Consensus       720 ~el~tg~  726 (824)
                      |+.+++.
T Consensus       307 ~~~y~~~  313 (420)
T 2pyw_A          307 WNLFNKR  313 (420)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            8877653

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.39  E-value=0.00044  Score=71.69  Aligned_cols=71  Identities=10%  Similarity=0.090  Sum_probs=46.2

Q ss_pred             CceeeeccceEEEEEEECCCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcc-eeEEeeeecCCeeEEEEecc-CCCC
Q 040845          532 NNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNL-VKVISSCSNEEFKALVLEYM-PHGS  609 (824)
Q Consensus       532 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~g~  609 (824)
                      .+.|+.|....+|++     +.+++|+..... ........|+.+++.+...++ .+++++.  .+.-++++||+ ++.+
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~-~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~   94 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGT-EEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT   94 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCc-cceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence            678999999999999     568889875432 222334668888887743233 4666543  33346899999 6544


Q ss_pred             H
Q 040845          610 L  610 (824)
Q Consensus       610 L  610 (824)
                      +
T Consensus        95 l   95 (301)
T 3dxq_A           95 M   95 (301)
T ss_dssp             C
T ss_pred             C
Confidence            4

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.39  E-value=0.00058  Score=71.56  Aligned_cols=159  Identities=16%  Similarity=0.180  Sum_probs=90.9

Q ss_pred             cccccHHHHHHhhccCCCC-----ceeeeccceEEEEEEECCCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCc--ce
Q 040845          514 WRRFSYLELFQATDKFSEN-----NLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRN--LV  586 (824)
Q Consensus       514 ~~~~~~~~~~~~~~~~~~~-----~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv  586 (824)
                      +..++.+++.....+|...     +.|+.|....+|+....+| .+++|.....  ...+.+..|+.+++.+....  +.
T Consensus         4 ~~~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP   80 (322)
T 2ppq_A            4 YTDITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCP   80 (322)
T ss_dssp             -CCCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCC
T ss_pred             cccCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCC
Confidence            3445667777777777663     3466788899999987655 6889987642  22345667888887774222  33


Q ss_pred             eEEee------eecCCeeEEEEeccCCCCHHH--------------HhhhC--C--CC----C---CHHHHHH-------
Q 040845          587 KVISS------CSNEEFKALVLEYMPHGSLEK--------------YLHSS--N--YS----L---DIFQRLN-------  628 (824)
Q Consensus       587 ~l~~~------~~~~~~~~lv~e~~~~g~L~~--------------~l~~~--~--~~----~---~~~~~~~-------  628 (824)
                      +++..      ....+..+++++|++|..+..              .+|..  .  ..    .   .|.....       
T Consensus        81 ~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~  160 (322)
T 2ppq_A           81 LPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERAD  160 (322)
T ss_dssp             CBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGG
T ss_pred             cccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHH
Confidence            33322      122356789999998764311              01211  1  00    0   1221100       


Q ss_pred             -----HHHHHHHHHHHhhc----CCCCCeEecCCCCCCeeeCCCCcEEEeeccccc
Q 040845          629 -----IMIDVASALEYLHF----GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK  675 (824)
Q Consensus       629 -----i~~~i~~~l~~LH~----~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~  675 (824)
                           +...+...+++++.    ....+++|+|+++.||++++++.+.++||+.+.
T Consensus       161 ~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          161 EVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             GTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence                 00113344444441    224679999999999999887666899999775

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.23  E-value=0.00095  Score=70.29  Aligned_cols=139  Identities=12%  Similarity=0.082  Sum_probs=74.7

Q ss_pred             ceeeeccceE-EEEEEECCCcEEEEEEeeccccchhhhHHHHHHHHhcCCC--CcceeEEeeeecCCeeEEEEeccCCCC
Q 040845          533 NLIGRGGFGS-VYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRH--RNLVKVISSCSNEEFKALVLEYMPHGS  609 (824)
Q Consensus       533 ~~lg~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~  609 (824)
                      +.|+.|+... +|+....+|+.+++|......   .+.+..|+.+++.+..  -.+.+++.+..+.+  +++||++++.+
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~   98 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL   98 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence            3465565554 677765446778887654321   1445667777777742  23556776643333  68999997766


Q ss_pred             HHHHhhhCC-------------------------CCCCHHHHH-------H-H------------HHHHHHHHHHhh---
Q 040845          610 LEKYLHSSN-------------------------YSLDIFQRL-------N-I------------MIDVASALEYLH---  641 (824)
Q Consensus       610 L~~~l~~~~-------------------------~~~~~~~~~-------~-i------------~~~i~~~l~~LH---  641 (824)
                      +.+++....                         ..++.....       . +            ...+...++.+.   
T Consensus        99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~  178 (333)
T 3csv_A           99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ  178 (333)
T ss_dssp             HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence            654432110                         011111100       0 0            001111222221   


Q ss_pred             cCCCCCeEecCCCCCCeeeCCC----CcEEEeecccccc
Q 040845          642 FGYSAPVIHCDLKPSNVLLDDN----MVAHLSDFGIAKL  676 (824)
Q Consensus       642 ~~~~~~ivH~Dlk~~Nill~~~----~~~kl~Dfg~a~~  676 (824)
                      ......++|||+.+.||+++.+    +.+.++||+.+..
T Consensus       179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            1125689999999999999874    6899999998864

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.15  E-value=0.0039  Score=65.34  Aligned_cols=158  Identities=13%  Similarity=0.141  Sum_probs=91.0

Q ss_pred             cccccHHHHHHhhccCCC-----CceeeeccceEEEEEEECCCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCc--ce
Q 040845          514 WRRFSYLELFQATDKFSE-----NNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRN--LV  586 (824)
Q Consensus       514 ~~~~~~~~~~~~~~~~~~-----~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv  586 (824)
                      +...+.+.+......|.+     ...++ |....||++...+|+.+++|...... ...+.+..|..+++.+....  ++
T Consensus         8 ~~~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp   85 (328)
T 1zyl_A            8 FQTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVA   85 (328)
T ss_dssp             CCCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBC
T ss_pred             CCCCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeec
Confidence            334555555555555543     23566 88889999987778789999986331 23456777888888774222  44


Q ss_pred             eEEee-----eecCCeeEEEEeccCCCCHH-----H------H---hhh----CC----CCCCHHHH-------------
Q 040845          587 KVISS-----CSNEEFKALVLEYMPHGSLE-----K------Y---LHS----SN----YSLDIFQR-------------  626 (824)
Q Consensus       587 ~l~~~-----~~~~~~~~lv~e~~~~g~L~-----~------~---l~~----~~----~~~~~~~~-------------  626 (824)
                      +++..     ....+..+++|+|++|.++.     .      .   +|.    ..    ...++...             
T Consensus        86 ~~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  165 (328)
T 1zyl_A           86 APVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATL  165 (328)
T ss_dssp             CCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSS
T ss_pred             ceeecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCc
Confidence            44443     12244567899999875321     1      1   111    00    11122111             


Q ss_pred             ---------HHHHHHHHHHHHHhhc-CCCCCeEecCCCCCCeeeCCCCcEEEeeccccc
Q 040845          627 ---------LNIMIDVASALEYLHF-GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK  675 (824)
Q Consensus       627 ---------~~i~~~i~~~l~~LH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~  675 (824)
                               ...+..++..+.-.-. .....++|+|+++.||+++ + .+.++||+.+.
T Consensus       166 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~  222 (328)
T 1zyl_A          166 IPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR  222 (328)
T ss_dssp             SCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence                     0111112222222211 1256789999999999999 4 89999998775

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.08  E-value=0.0018  Score=70.81  Aligned_cols=73  Identities=12%  Similarity=0.158  Sum_probs=48.8

Q ss_pred             ceeeeccceEEEEEEECC-CcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcc-eeEEeeeecCCeeEEEEeccCCCCH
Q 040845          533 NLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNL-VKVISSCSNEEFKALVLEYMPHGSL  610 (824)
Q Consensus       533 ~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g~L  610 (824)
                      +.|+.|-...+|++...+ +..|++|+..... ...-+...|..+++.+...++ .++++++.  .  ..||||++|.++
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l  188 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL  188 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-C-CSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence            568888899999998764 4789999875332 222223679999998864444 57777763  2  369999987443

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.05  E-value=0.0012  Score=72.05  Aligned_cols=71  Identities=17%  Similarity=0.232  Sum_probs=49.5

Q ss_pred             ceeeeccceEEEEEEECC--------CcEEEEEEeeccccchhhhHHHHHHHHhcCCCCc-ceeEEeeeecCCeeEEEEe
Q 040845          533 NLIGRGGFGSVYKARIRD--------GMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRN-LVKVISSCSNEEFKALVLE  603 (824)
Q Consensus       533 ~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e  603 (824)
                      +.|+.|....||++...+        ++.|++|+....  ...+.+..|..+++.+...+ ..++++.+.+    .+|+|
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e  152 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  152 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence            568888899999998753        578999987432  11245567999988885333 3677776543    38999


Q ss_pred             ccCCCC
Q 040845          604 YMPHGS  609 (824)
Q Consensus       604 ~~~~g~  609 (824)
                      |++|.+
T Consensus       153 ~l~G~~  158 (429)
T 1nw1_A          153 YIPSRP  158 (429)
T ss_dssp             CCCEEE
T ss_pred             EeCCcc
Confidence            997643

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=97.01  E-value=0.00081  Score=59.59  Aligned_cols=58  Identities=26%  Similarity=0.312  Sum_probs=33.1

Q ss_pred             eEEccCcccc-ccCCccccccccccEEEccCcccCCCCcccccCCcccceeeccCCcccCC
Q 040845          368 NLFLEYNRLE-GSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGE  427 (824)
Q Consensus       368 ~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~  427 (824)
                      .++.++++|+ ..+|..+.  ++|+.|+|++|+|+...+..|..+++|+.|+|++|+|.+.
T Consensus        12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~Cd   70 (130)
T 3rfe_A           12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRCD   70 (130)
T ss_dssp             EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBCS
T ss_pred             EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeecc
Confidence            5666666665 12443322  3566666666666644445556666666666666666543

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.96  E-value=0.0047  Score=58.79  Aligned_cols=104  Identities=14%  Similarity=0.096  Sum_probs=70.5

Q ss_pred             CHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcccccc
Q 040845          609 SLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQ  688 (824)
Q Consensus       609 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  688 (824)
                      +|.+.+...+.+++++++|.++.|.+.++.-.-.  .+.-..+=+.|..|++..+|.|...+ +.+.             
T Consensus        34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~--~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------   97 (229)
T 2yle_A           34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAAR--RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------------   97 (229)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred             cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhh--cccCCceecCCcceEEecCCceeccc-cccc-------------
Confidence            7999999988899999999999999999877620  11111333456889999999987763 1110             


Q ss_pred             ccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCc
Q 040845          689 TLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTD  730 (824)
Q Consensus       689 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~  730 (824)
                       .....+.|||... ...+.+.=|||+|+++|..+--..|-+
T Consensus        98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~  137 (229)
T 2yle_A           98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKEN  137 (229)
T ss_dssp             ----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCcc
Confidence             0122466888763 345788899999999999998666543

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.93  E-value=0.0022  Score=68.19  Aligned_cols=138  Identities=14%  Similarity=0.190  Sum_probs=83.3

Q ss_pred             ceeeeccceEEEEEEEC--------CCcEEEEEEeeccccchhhhHHHHHHHHhcCC-CCcceeEEeeeecCCeeEEEEe
Q 040845          533 NLIGRGGFGSVYKARIR--------DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIR-HRNLVKVISSCSNEEFKALVLE  603 (824)
Q Consensus       533 ~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  603 (824)
                      +.+..|-...+|++...        +++.|++|+.... ........+|..+++.+. +.-..++++++.+    .+|||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e  130 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ  130 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence            56777888999999864        2578999986332 223456678999998884 3334677776654    29999


Q ss_pred             ccCCCCHHH-----------H------hhhCC----CCCC--HHHHHHHHHHHHH-------------------HHHH--
Q 040845          604 YMPHGSLEK-----------Y------LHSSN----YSLD--IFQRLNIMIDVAS-------------------ALEY--  639 (824)
Q Consensus       604 ~~~~g~L~~-----------~------l~~~~----~~~~--~~~~~~i~~~i~~-------------------~l~~--  639 (824)
                      |++|.++..           .      +|...    ....  +.++.++..++..                   .+..  
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            998765421           0      12111    1122  3444445444322                   1222  


Q ss_pred             --hh-cCCCCCeEecCCCCCCeeeCCC----CcEEEeeccccc
Q 040845          640 --LH-FGYSAPVIHCDLKPSNVLLDDN----MVAHLSDFGIAK  675 (824)
Q Consensus       640 --LH-~~~~~~ivH~Dlk~~Nill~~~----~~~kl~Dfg~a~  675 (824)
                        |. ......++|+|+.+.||+++.+    +.+.++||..|.
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence              22 1224578999999999999876    789999999875

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.77  E-value=0.0017  Score=69.51  Aligned_cols=72  Identities=8%  Similarity=0.187  Sum_probs=45.1

Q ss_pred             ceeeeccceEEEEEEECC---------CcEEEEEEeeccccchhhhHHHHHHHHhcCCCCc-ceeEEeeeecCCeeEEEE
Q 040845          533 NLIGRGGFGSVYKARIRD---------GMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRN-LVKVISSCSNEEFKALVL  602 (824)
Q Consensus       533 ~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~  602 (824)
                      ..++.|....+|++...+         ++.+++|+..... ........|..+++.+...+ +.++++...    -++||
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~v~  113 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTFN----GGRIE  113 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEecC----CcEEE
Confidence            467788889999998754         2688999875432 22223467888888885333 446665542    36899


Q ss_pred             eccCCCC
Q 040845          603 EYMPHGS  609 (824)
Q Consensus       603 e~~~~g~  609 (824)
                      ||++|.+
T Consensus       114 e~i~G~~  120 (369)
T 3c5i_A          114 EWLYGDP  120 (369)
T ss_dssp             ECCCSEE
T ss_pred             EEecCCc
Confidence            9998754

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=96.68  E-value=0.002  Score=57.07  Aligned_cols=37  Identities=22%  Similarity=0.244  Sum_probs=20.0

Q ss_pred             CCceEeccCccccccCCccccCCCCCCEEEccCCcCC
Q 040845          119 KLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLT  155 (824)
Q Consensus       119 ~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~  155 (824)
                      +|++|+|++|+|+.+.++.|..+++|++|+|++|.+.
T Consensus        32 ~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           32 DTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             TCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             CCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence            3455555555555444455555555555666655543

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.33  E-value=0.021  Score=59.95  Aligned_cols=66  Identities=9%  Similarity=0.141  Sum_probs=43.0

Q ss_pred             ccceEEEEEEECCCcEEEEEEeeccccchhhhHHHHHHHHhcCC---CCcceeEEee------eecCCeeEEEEeccCCC
Q 040845          538 GGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIR---HRNLVKVISS------CSNEEFKALVLEYMPHG  608 (824)
Q Consensus       538 G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~------~~~~~~~~lv~e~~~~g  608 (824)
                      |....||+....+| .+++|+......      ..|+.+++.+.   -+.+++++..      ....+..++||+|++|.
T Consensus        34 g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G~  106 (339)
T 3i1a_A           34 DTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHAP  106 (339)
T ss_dssp             CSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCCC
T ss_pred             ccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCCC
Confidence            33679999987767 899998764321      34666666663   2224555543      23356778999999886


Q ss_pred             CH
Q 040845          609 SL  610 (824)
Q Consensus       609 ~L  610 (824)
                      .+
T Consensus       107 ~~  108 (339)
T 3i1a_A          107 NG  108 (339)
T ss_dssp             BT
T ss_pred             cC
Confidence            54

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.05  E-value=0.0094  Score=64.30  Aligned_cols=72  Identities=11%  Similarity=0.172  Sum_probs=49.2

Q ss_pred             ceeeeccceEEEEEEECC--------CcEEEEEEeeccccchhhhHHHHHHHHhcCC-CCcceeEEeeeecCCeeEEEEe
Q 040845          533 NLIGRGGFGSVYKARIRD--------GMEVAVKVFNLQCGRAFKSFDVECAMMKSIR-HRNLVKVISSCSNEEFKALVLE  603 (824)
Q Consensus       533 ~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  603 (824)
                      +.+..|-...+|+....+        ++.|++|+.... ....-+..+|..+++.+. +.-..++++.+.    -+.|||
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~-t~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e  150 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKH-VGKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEE  150 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCC-C-CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCC-cchhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence            467778889999998763        578999986433 222334567888888884 333456665442    268999


Q ss_pred             ccCCCC
Q 040845          604 YMPHGS  609 (824)
Q Consensus       604 ~~~~g~  609 (824)
                      |++|.+
T Consensus       151 fI~G~~  156 (424)
T 3mes_A          151 FIDGEP  156 (424)
T ss_dssp             CCCSEE
T ss_pred             EeCCcc
Confidence            998865

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=94.02  E-value=0.12  Score=55.51  Aligned_cols=29  Identities=28%  Similarity=0.384  Sum_probs=24.8

Q ss_pred             CeEecCCCCCCeee------CCCCcEEEeeccccc
Q 040845          647 PVIHCDLKPSNVLL------DDNMVAHLSDFGIAK  675 (824)
Q Consensus       647 ~ivH~Dlk~~Nill------~~~~~~kl~Dfg~a~  675 (824)
                      .++|+|+.+.||++      +++..+.++||.+|.
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~  279 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS  279 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence            45799999999999      456789999999876

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=86.08  E-value=1.8  Score=41.12  Aligned_cols=129  Identities=11%  Similarity=0.214  Sum_probs=86.3

Q ss_pred             HHHHHhcCCCCcceeEEeeeecCCeeEEEEeccCCC-CHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 040845          573 ECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHG-SLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHC  651 (824)
Q Consensus       573 E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~  651 (824)
                      |+.++.. .||+++.. .+-.+++...+.++.-+.+ ++.. +.    ..+..++++++.+|+....+++     .-+|-
T Consensus        36 el~LL~~-~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik----~~~~~eKlr~l~ni~~l~~~~~-----~r~tf  103 (215)
T 4ann_A           36 LMYLLEQ-HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK----SFTKNEKLRYLLNIKNLEEVNR-----TRYTF  103 (215)
T ss_dssp             GGGGGGS-CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG----GSCHHHHHHHHHHGGGGGGGGG-----SSEEC
T ss_pred             HHHHHhc-cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH----hcCHHHHHHHHHHHHHHHHHhc-----CceEE
Confidence            3444432 68888866 4556666666666654322 2222 22    5678899999999999886665     34788


Q ss_pred             CCCCCCeeeCCCCcEEEeecccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcc
Q 040845          652 DLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDE  731 (824)
Q Consensus       652 Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~  731 (824)
                      -++|+|++++.++.+++.-.|+-..+                   +|.     ..++..=.-.+=+++..+++++..|+.
T Consensus       104 ~L~P~NL~f~~~~~p~i~~RGik~~l-------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~  159 (215)
T 4ann_A          104 VLAPDELFFTRDGLPIAKTRGLQNVV-------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFDA  159 (215)
T ss_dssp             CCSGGGEEECTTSCEEESCCEETTTB-------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred             EEecceEEEcCCCCEEEEEccCccCC-------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence            99999999999999999877764332                   222     112222334567788889999999887


Q ss_pred             cccCcc
Q 040845          732 LFNGEM  737 (824)
Q Consensus       732 ~~~~~~  737 (824)
                      ...+..
T Consensus       160 l~~G~l  165 (215)
T 4ann_A          160 LVEGNL  165 (215)
T ss_dssp             HHHSCG
T ss_pred             HHcChH
Confidence            655544

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=81.29  E-value=1.1  Score=30.07  Aligned_cols=10  Identities=20%  Similarity=0.228  Sum_probs=4.7

Q ss_pred             eEeeehhhHH
Q 040845          472 LILGIVLPFS  481 (824)
Q Consensus       472 ~~~~~~~~~~  481 (824)
                      .++++++++.
T Consensus        13 ~Ia~~vVGvl   22 (44)
T 2jwa_A           13 SIISAVVGIL   22 (44)
T ss_dssp             HHHHHHHHHH
T ss_pred             chHHHHHHHH
Confidence            3455555533

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	824
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-68
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	5e-61
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-60
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-59
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-59
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-59
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	5e-58
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-57
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-56
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-55
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-55
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	5e-55
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	8e-55
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	5e-54
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	7e-54
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-53
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-53
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-53
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	4e-53
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	5e-53
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	6e-53
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	8e-53
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	5e-52
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	6e-52
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	6e-52
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	9e-52
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-50
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-50
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-50
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-50
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	5e-50
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-49
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	6e-49
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-47
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-45
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	3e-44
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	6e-44
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	5e-43
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	8e-42
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	3e-41
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	3e-41
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	4e-41
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	5e-41
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	5e-41
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	8e-41
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	3e-40
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-39
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-39
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-39
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	7e-39
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-37
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	8e-37
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	6e-36
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-35
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	3e-35
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	7e-34
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-33
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	5e-33
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-32
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-31
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	8e-30
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-28
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-26
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	5e-21
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-16
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	6e-26
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-21
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	9e-21
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	4e-20
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-17
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-08
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	7e-07
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	7e-22
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	8e-22
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-16
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	3e-14
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	4e-10
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-04
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	1e-19
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	3e-17
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	5e-15
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	5e-13
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	4e-10
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	1e-05
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	3e-11
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	5e-10
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	3e-09
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	5e-10
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	9e-07
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	9e-07
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	3e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	4e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-08
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	4e-08
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	3e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.001
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.003
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.004
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	8e-08
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	5e-07
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	1e-05
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	0.001
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	0.002
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	8e-08
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	2e-06
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	8e-06
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	3e-04
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	3e-07
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	2e-06
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	1e-05
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	1e-06
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	2e-04
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	4e-04
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	5e-06
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	1e-05
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	0.004
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	7e-06
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	4e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	7e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	6e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	6e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	8e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.002
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.002
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.003
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.003
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.004
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	1e-05
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	4e-05
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	5e-05
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	1e-04
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	3e-04
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	2e-04
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	5e-04
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	0.003
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	0.003
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	0.004
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	0.002

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  225 bits (574), Expect = 3e-68
 Identities = 70/288 (24%), Positives = 127/288 (44%), Gaps = 26/288 (9%)

Query: 527 DKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRN 584
            + +    IG G FG+VYK +     +VAVK+ N+     +  ++F  E  +++  RH N
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65

Query: 585 LVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGY 644
           ++  +   +     A+V ++    SL  +LH      ++ + ++I    A  ++YLH   
Sbjct: 66  ILLFMGYST-APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA-- 122

Query: 645 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY---G 701
              +IH DLK +N+ L +++   + DFG+A + +    S    Q   +I +MAPE     
Sbjct: 123 -KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181

Query: 702 REGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLS 761
            +   S   DVY+FGI+L E  T + P   + N +  +       L     +V       
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV------- 234

Query: 762 QEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSL 809
                   +  C   +  L  EC  +  ++R    +I+A +  +  SL
Sbjct: 235 --------RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (522), Expect = 5e-61
 Identities = 65/277 (23%), Positives = 118/277 (42%), Gaps = 26/277 (9%)

Query: 527 DKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLV 586
           +       +G G FG V+        +VAVK    Q   +  +F  E  +MK ++H+ LV
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 71

Query: 587 KVISSCSNEEFKALVLEYMPHGSLEKYLHS-SNYSLDIFQRLNIMIDVASALEYLHFGYS 645
           ++ +  + E    ++ EYM +GSL  +L + S   L I + L++   +A  + ++     
Sbjct: 72  RLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---E 127

Query: 646 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQ 705
              IH DL+ +N+L+ D +   ++DFG+A+L+  +++   +      I + APE    G 
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAINYGT 186

Query: 706 VSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDI 765
            +   DV+SFGI+L E  T  +           +++                        
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM----------------- 229

Query: 766 HFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL 802
             V  + C   ++ L   C  E PE R     + + L
Sbjct: 230 --VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  204 bits (520), Expect = 2e-60
 Identities = 68/313 (21%), Positives = 133/313 (42%), Gaps = 43/313 (13%)

Query: 517 FSYLELFQATDKFSEN---------NLIGRGGFGSVYKARIR----DGMEVAVKVFNLQ- 562
           F++ +  +A  +F++           +IG G FG V    ++      + VA+K      
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 563 CGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLD 622
             +  + F  E ++M    H N++ +    +      ++ E+M +GSL+ +L  ++    
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126

Query: 623 IFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 682
           + Q + ++  +A+ ++YL        +H DL   N+L++ N+V  +SDFG+++ L  +  
Sbjct: 127 VIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183

Query: 683 SMTQTQTL---ATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTL 739
             T T  L     I + APE  +  + ++  DV+S+GI++ E  +  +            
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER----------- 232

Query: 740 KHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIV 799
                   P   M   D     ++D        C S +  L L+C  +    R    +IV
Sbjct: 233 --------PYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIV 284

Query: 800 AKLLKIRDSLLRN 812
             L    D ++RN
Sbjct: 285 NTL----DKMIRN 293

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (512), Expect = 1e-59
 Identities = 68/282 (24%), Positives = 116/282 (41%), Gaps = 24/282 (8%)

Query: 527 DKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLV 586
            + +    IG G FG V+     +  +VA+K        + + F  E  +M  + H  LV
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLV 63

Query: 587 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSA 646
           ++   C  +    LV E+M HG L  YL +          L + +DV   + YL     A
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EA 120

Query: 647 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQV 706
            VIH DL   N L+ +N V  +SDFG+ + +  +  + +   T   + + +PE     + 
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG-TKFPVKWASPEVFSFSRY 179

Query: 707 STNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIH 766
           S+  DV+SFG+++ E F+  K   E  +    ++             +    L S     
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG------FRLYKPRLASTH--- 230

Query: 767 FVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDS 808
                     V+ +   C  E PE R     ++ +L +I +S
Sbjct: 231 ----------VYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (513), Expect = 1e-59
 Identities = 67/301 (22%), Positives = 120/301 (39%), Gaps = 29/301 (9%)

Query: 521 ELFQATDKFS-ENNLIGRGGFGSVYKARIR---DGMEVAVKVFNLQCGRAF-KSFDVECA 575
           +LF   D     +  +G G FGSV +   R     ++VA+KV      +A  +    E  
Sbjct: 2   KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61

Query: 576 MMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVAS 635
           +M  + +  +V++I  C  E    LV+E    G L K+L      + +     ++  V+ 
Sbjct: 62  IMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSM 120

Query: 636 ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIG 694
            ++YL        +H DL   NVLL +   A +SDFG++K L  +D   T        + 
Sbjct: 121 GMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 177

Query: 695 YMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEV 754
           + APE     + S+  DV+S+G+ + E  +  +                    P   M+ 
Sbjct: 178 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK-------------------PYKKMKG 218

Query: 755 VDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLRNVG 814
            +     ++        +C   ++ L  +C +   E R +   +  ++     SL   V 
Sbjct: 219 PEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 278

Query: 815 G 815
           G
Sbjct: 279 G 279

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (510), Expect = 2e-59
 Identities = 63/279 (22%), Positives = 123/279 (44%), Gaps = 24/279 (8%)

Query: 527 DKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLV 586
              +    +G G FG V   + R   +VA+K+   +   +   F  E  +M ++ H  LV
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLV 62

Query: 587 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSA 646
           ++   C+ +    ++ EYM +G L  YL    +     Q L +  DV  A+EYL      
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---K 119

Query: 647 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQV 706
             +H DL   N L++D  V  +SDFG+++ +  +D+  +   +   + +  PE     + 
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKF 178

Query: 707 STNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIH 766
           S+  D+++FG+++ E ++  K   E F    T +H          + +   +L S++   
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG------LRLYRPHLASEK--- 229

Query: 767 FVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKI 805
                     V+ +   C  E  ++R   K +++ +L +
Sbjct: 230 ----------VYTIMYSCWHEKADERPTFKILLSNILDV 258

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (504), Expect = 5e-58
 Identities = 67/292 (22%), Positives = 122/292 (41%), Gaps = 22/292 (7%)

Query: 535 IGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSN 594
           IG+G FG V++ + R G EVAVK+F+ +  R++   + E      +RH N++  I++ + 
Sbjct: 11  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAADNK 68

Query: 595 EEFKA----LVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLH-----FGYS 645
           +        LV +Y  HGSL  YL+   Y++ +   + + +  AS L +LH         
Sbjct: 69  DNGTWTQLWLVSDYHEHGSLFDYLN--RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 126

Query: 646 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMT--QTQTLATIGYMAPEY--- 700
             + H DLK  N+L+  N    ++D G+A        ++       + T  YMAPE    
Sbjct: 127 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 186

Query: 701 ---GREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTM-EVVD 756
               +  +     D+Y+ G++  E   R        + ++     V     +  M +VV 
Sbjct: 187 SINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVC 246

Query: 757 ANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDS 808
              L     +     + +  +  +  EC   +   R+ A  I   L ++   
Sbjct: 247 EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (495), Expect = 3e-57
 Identities = 80/282 (28%), Positives = 121/282 (42%), Gaps = 32/282 (11%)

Query: 527 DKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLV 586
            +      IG+G FG V     R G +VAVK          ++F  E ++M  +RH NLV
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63

Query: 587 KVISSCSNEEFK-ALVLEYMPHGSLEKYLHSSNYS-LDIFQRLNIMIDVASALEYLHFGY 644
           +++     E+    +V EYM  GSL  YL S   S L     L   +DV  A+EYL    
Sbjct: 64  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--- 120

Query: 645 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG 704
               +H DL   NVL+ ++ VA +SDFG+ K       S TQ      + + APE  RE 
Sbjct: 121 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA-----SSTQDTGKLPVKWTAPEALREK 175

Query: 705 QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQED 764
           + ST  DV+SFGI+L E ++  +                    P   + + D     ++ 
Sbjct: 176 KFSTKSDVWSFGILLWEIYSFGRV-------------------PYPRIPLKDVVPRVEKG 216

Query: 765 IHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIR 806
               A + C   V+ +   C       R +  ++  +L  I+
Sbjct: 217 YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (490), Expect = 2e-56
 Identities = 65/277 (23%), Positives = 118/277 (42%), Gaps = 26/277 (9%)

Query: 527 DKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLV 586
           +       +G+G FG V+         VA+K        + ++F  E  +MK +RH  LV
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 75

Query: 587 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIF-QRLNIMIDVASALEYLHFGYS 645
           ++ +  S E    +V EYM  GSL  +L           Q +++   +AS + Y+     
Sbjct: 76  QLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER--- 131

Query: 646 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQ 705
              +H DL+ +N+L+ +N+V  ++DFG+A+L+  +++   +      I + APE    G+
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGR 190

Query: 706 VSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDI 765
            +   DV+SFGI+L E  T+ +           L                      +   
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-------------------ERGY 231

Query: 766 HFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL 802
                 +C   + +L  +C  + PE+R   + + A L
Sbjct: 232 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 268

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (485), Expect = 1e-55
 Identities = 63/289 (21%), Positives = 128/289 (44%), Gaps = 29/289 (10%)

Query: 527 DKFSENNLIGRGGFGSVYKARIRDG-----MEVAVKVFNLQCG-RAFKSFDVECAMMKSI 580
              +   +IG G FG VYK  ++       + VA+K        +    F  E  +M   
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 581 RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYL 640
            H N++++    S  +   ++ EYM +G+L+K+L   +    + Q + ++  +A+ ++YL
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126

Query: 641 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-TGEDQSMTQTQTLATIGYMAPE 699
               +   +H DL   N+L++ N+V  +SDFG++++L    + + T +     I + APE
Sbjct: 127 A---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 183

Query: 700 YGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANL 759
                + ++  DV+SFGI++ E  T  +      +    +K   +     + M+   A  
Sbjct: 184 AISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSA-- 241

Query: 760 LSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDS 808
                            ++ L ++C  +   +R    +IV+ L K+  +
Sbjct: 242 -----------------IYQLMMQCWQQERARRPKFADIVSILDKLIRA 273

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  190 bits (483), Expect = 3e-55
 Identities = 75/303 (24%), Positives = 124/303 (40%), Gaps = 34/303 (11%)

Query: 505 DPNMPPVATWRRFSYLELFQATDKFSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQC 563
           DP+ P    W      E+       +  + +G G +G VY+   +   + VAVK      
Sbjct: 3   DPSSPNYDKW------EM--ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED- 53

Query: 564 GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSN-YSLD 622
               + F  E A+MK I+H NLV+++  C+ E    ++ E+M +G+L  YL   N   + 
Sbjct: 54  TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVS 113

Query: 623 IFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 682
               L +   ++SA+EYL        IH DL   N L+ +N +  ++DFG+++L+TG D 
Sbjct: 114 AVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DT 169

Query: 683 SMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHW 742
                     I + APE     + S   DV++FG++L E  T         +     +  
Sbjct: 170 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 229

Query: 743 VNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL 802
                              ++D      E C   V+ L   C   +P  R +  EI    
Sbjct: 230 -------------------EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270

Query: 803 LKI 805
             +
Sbjct: 271 ETM 273

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 5e-55
 Identities = 59/304 (19%), Positives = 117/304 (38%), Gaps = 34/304 (11%)

Query: 520 LELFQATDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKS-FDVECAMM 577
           +EL    D F + + +G G  G V+K      G+ +A K+ +L+   A ++    E  ++
Sbjct: 1   MEL--KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL 58

Query: 578 KSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASAL 637
                  +V    +  ++   ++ +E+M  GSL++ L  +   +       + I V   L
Sbjct: 59  HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGL 117

Query: 638 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMA 697
            YL       ++H D+KPSN+L++      L DFG++  L     SM  +    T  YM+
Sbjct: 118 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFV-GTRSYMS 171

Query: 698 PEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDA 757
           PE  +    S   D++S G+ L+E    + P       E+ L          +       
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231

Query: 758 NLLSQEDIHFVAKEQCVSF-----------------------VFNLALECTVESPEQRIN 794
                   + +     ++                          +   +C +++P +R +
Sbjct: 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD 291

Query: 795 AKEI 798
            K++
Sbjct: 292 LKQL 295

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (478), Expect = 8e-55
 Identities = 60/275 (21%), Positives = 107/275 (38%), Gaps = 25/275 (9%)

Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNL-QCGRAFKSFDVECAMMKSIRHRN 584
           + +     +G G +G V  A        VAVK+ ++ +     ++   E  + K + H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 585 LVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGY 644
           +VK          + L LEY   G L   +   +  +           + + + YLH   
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLH--- 120

Query: 645 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG 704
              + H D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+APE  +  
Sbjct: 121 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180

Query: 705 QVSTNG-DVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQE 763
           +      DV+S GI+L      + P D+  +       W      ++  + +D+  L   
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL--- 237

Query: 764 DIHFVAKEQCVSFVFNLALECTVESPEQRINAKEI 798
                           L  +  VE+P  RI   +I
Sbjct: 238 ---------------ALLHKILVENPSARITIPDI 257

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 5e-54
 Identities = 63/279 (22%), Positives = 111/279 (39%), Gaps = 32/279 (11%)

Query: 531 ENNLIGRGGFGSVYKARIRD---GMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNL 585
           E+  +G G FG+V K   +       VAVK+   +            E  +M+ + +  +
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70

Query: 586 VKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYS 645
           V++I  C  E +  LV+E    G L KYL   N  +     + ++  V+  ++YL     
Sbjct: 71  VRMIGICEAESW-MLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEE--- 125

Query: 646 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYMAPEYGREG 704
           +  +H DL   NVLL     A +SDFG++K L  ++            + + APE     
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185

Query: 705 QVSTNGDVYSFGIMLMETFTRKK-PTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQE 763
           + S+  DV+SFG+++ E F+  + P   +   E+T      + +                
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP------------- 232

Query: 764 DIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL 802
                    C   +++L   C     E R     +  +L
Sbjct: 233 -------AGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (475), Expect = 7e-54
 Identities = 68/288 (23%), Positives = 122/288 (42%), Gaps = 30/288 (10%)

Query: 532 NNLIGRGGFGSVYKARIRD----GMEVAVKVFNLQCGRAF-KSFDVECAMMKSIRHRNLV 586
           N +IGRG FG VY   + D     +  AVK  N          F  E  +MK   H N++
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91

Query: 587 KVISSCSNEEFKA-LVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYS 645
            ++  C   E    +VL YM HG L  ++ +  ++  +   +   + VA  +++L     
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS--- 148

Query: 646 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED--QSMTQTQTLATIGYMAPEYGRE 703
              +H DL   N +LD+     ++DFG+A+ +  ++      +T     + +MA E  + 
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 208

Query: 704 GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQE 763
            + +T  DV+SFG++L E  TR  P                   P   +   D  +   +
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYLLQ 249

Query: 764 DIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLR 811
               +  E C   ++ + L+C     E R +  E+V+++  I  + + 
Sbjct: 250 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (475), Expect = 1e-53
 Identities = 65/341 (19%), Positives = 116/341 (34%), Gaps = 53/341 (15%)

Query: 493 IKYQKREKGPPNDPNMPPVATWRRFSYLELFQ-ATDKFSENNLIGRGGFGSVYKARIRD- 550
            + Q  +    +D     V   R + Y   ++   +      ++G G FG V  A     
Sbjct: 3   SQLQMVQVTGSSDNEYFYVDF-REYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGI 61

Query: 551 -----GMEVAVKVFNLQCGRAF-KSFDVECAMMKSI-RHRNLVKVISSCSNEEFKALVLE 603
                 ++VAVK+   +   +  ++   E  MM  +  H N+V ++ +C+      L+ E
Sbjct: 62  SKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFE 121

Query: 604 YMPHGSLEKYLHSSN----------------------YSLDIFQRLNIMIDVASALEYLH 641
           Y  +G L  YL S                          L     L     VA  +E+L 
Sbjct: 122 YCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE 181

Query: 642 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYG 701
                  +H DL   NVL+    V  + DFG+A+ +  +   + +      + +MAPE  
Sbjct: 182 ---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESL 238

Query: 702 REGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLS 761
            EG  +   DV+S+GI+L E F+           +      +                  
Sbjct: 239 FEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLI------------------ 280

Query: 762 QEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL 802
           Q              ++ +   C      +R +   + + L
Sbjct: 281 QNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (472), Expect = 1e-53
 Identities = 62/279 (22%), Positives = 110/279 (39%), Gaps = 29/279 (10%)

Query: 526 TDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRN 584
            D +     +G G FG VYKA+     +  A KV + +     + + VE  ++ S  H N
Sbjct: 11  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70

Query: 585 LVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGY 644
           +VK++ +   E    +++E+   G+++  +      L   Q   +      AL YLH   
Sbjct: 71  IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH--- 127

Query: 645 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY---- 700
              +IH DLK  N+L   +    L+DFG++   T   Q         T  +MAPE     
Sbjct: 128 DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI--GTPYWMAPEVVMCE 185

Query: 701 -GREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANL 759
             ++       DV+S GI L+E    + P  EL    + LK   ++   ++      +N 
Sbjct: 186 TSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNF 245

Query: 760 LSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEI 798
                              +   +C  ++ + R    ++
Sbjct: 246 K------------------DFLKKCLEKNVDARWTTSQL 266

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  186 bits (472), Expect = 1e-53
 Identities = 74/320 (23%), Positives = 124/320 (38%), Gaps = 54/320 (16%)

Query: 516 RFSYLELFQATDKFSENNLIGRGGFGSVYKARIR------DGMEVAVKVFNLQCGRAF-K 568
           +   LE     +       IG G FG V++AR            VAVK+   +       
Sbjct: 4   KLLSLEY--PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA 61

Query: 569 SFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYS-------- 620
            F  E A+M    + N+VK++  C+  +   L+ EYM +G L ++L S +          
Sbjct: 62  DFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHS 121

Query: 621 ---------------LDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMV 665
                          L   ++L I   VA+ + YL        +H DL   N L+ +NMV
Sbjct: 122 DLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMV 178

Query: 666 AHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTR 725
             ++DFG+++ +   D           I +M PE     + +T  DV+++G++L E F+ 
Sbjct: 179 VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 238

Query: 726 KKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECT 785
                     E  + +            V D N+L+         E C   ++NL   C 
Sbjct: 239 GLQPYYGMAHEEVIYY------------VRDGNILACP-------ENCPLELYNLMRLCW 279

Query: 786 VESPEQRINAKEIVAKLLKI 805
            + P  R +   I   L ++
Sbjct: 280 SKLPADRPSFCSIHRILQRM 299

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  184 bits (469), Expect = 4e-53
 Identities = 67/281 (23%), Positives = 108/281 (38%), Gaps = 36/281 (12%)

Query: 526 TDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNL---QCGRAFKSFDVECAMMKSIR 581
              FS+   IG G FG+VY AR +R+   VA+K  +    Q    ++    E   ++ +R
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 582 HRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLH 641
           H N ++       E    LV+EY    + +         L   +   +       L YLH
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLH 132

Query: 642 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEY- 700
              S  +IH D+K  N+LL +  +  L DFG A ++            + T  +MAPE  
Sbjct: 133 ---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------PANSFVGTPYWMAPEVI 183

Query: 701 --GREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDAN 758
               EGQ     DV+S GI  +E   RK P   +           N+   + +       
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW---- 239

Query: 759 LLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIV 799
             S+   +FV               C  + P+ R  ++ ++
Sbjct: 240 --SEYFRNFVDS-------------CLQKIPQDRPTSEVLL 265

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (465), Expect = 5e-53
 Identities = 61/283 (21%), Positives = 97/283 (34%), Gaps = 32/283 (11%)

Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHR 583
           + +     IG G +G   K R   DG  +  K  +         +    E  +++ ++H 
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63

Query: 584 NLVKVISSCSNEEFKAL--VLEYMPHGSLEKYLHS---SNYSLDIFQRLNIMIDVASALE 638
           N+V+      +     L  V+EY   G L   +         LD    L +M  +  AL+
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 639 YLH--FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYM 696
             H        V+H DLKP+NV LD      L DFG+A++L  +           T  YM
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVG--TPYYM 181

Query: 697 APEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVD 756
           +PE       +   D++S G +L E      P       E+  K        I       
Sbjct: 182 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIP------ 235

Query: 757 ANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIV 799
               S E    + +                     R + +EI+
Sbjct: 236 -YRYSDELNEIITR-------------MLNLKDYHRPSVEEIL 264

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 6e-53
 Identities = 62/304 (20%), Positives = 113/304 (37%), Gaps = 46/304 (15%)

Query: 527 DKFSENNLIGRGGFGSVYKARIR------DGMEVAVKVFNLQCGRAF-KSFDVECAMMKS 579
           ++ S    +G G FG V +A           M VAVK+          ++   E  ++  
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 580 I-RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYS-----------------L 621
           +  H N+V ++ +C+      ++ EY  +G L  +L     S                 L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 622 DIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 681
           D+   L+    VA  + +L    S   IH DL   N+LL    +  + DFG+A+ +  + 
Sbjct: 143 DLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 682 QSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKH 741
             + +      + +MAPE       +   DV+S+GI L E F+           +     
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259

Query: 742 WVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK 801
            +                  +E    ++ E   + ++++   C    P +R   K+IV  
Sbjct: 260 MI------------------KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301

Query: 802 LLKI 805
           + K 
Sbjct: 302 IEKQ 305

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (464), Expect = 8e-53
 Identities = 64/276 (23%), Positives = 112/276 (40%), Gaps = 33/276 (11%)

Query: 532 NNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQ--CGRAFKSFDVECAMMKSIRHRNLVKV 588
           +  IGRG F +VYK    +  +EVA      +       + F  E  M+K ++H N+V+ 
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 589 ISSC----SNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGY 644
             S       ++   LV E M  G+L+ YL      + I    +    +   L++LH   
Sbjct: 74  YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHT-R 131

Query: 645 SAPVIHCDLKPSNVLLDD-NMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE 703
           + P+IH DLK  N+ +        + D G+A L             + T  +MAPE   E
Sbjct: 132 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEM-YE 186

Query: 704 GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQE 763
            +   + DVY+FG+ ++E  T + P  E  N     +   +   P S  +V    +    
Sbjct: 187 EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVK--- 243

Query: 764 DIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIV 799
                           +   C  ++ ++R + K+++
Sbjct: 244 ---------------EIIEGCIRQNKDERYSIKDLL 264

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 5e-52
 Identities = 69/288 (23%), Positives = 100/288 (34%), Gaps = 30/288 (10%)

Query: 527 DKFSENNLIGRGGFGSVYKARIR----DGMEVAVKVFN---LQCGRAFKSFDVECAMMKS 579
                   +G G FG V +          + VAVK      L    A   F  E   M S
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 580 IRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEY 639
           + HRNL+++         K +V E  P GSL   L        +       + VA  + Y
Sbjct: 68  LDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126

Query: 640 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT-GEDQSMTQTQTLATIGYMAP 698
           L    S   IH DL   N+LL    +  + DFG+ + L   +D  + Q        + AP
Sbjct: 127 LE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183

Query: 699 EYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDAN 758
           E  +    S   D + FG+ L E FT  +      NG   L                   
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK-------------- 229

Query: 759 LLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIR 806
               E       E C   ++N+ ++C    PE R     +   LL+ +
Sbjct: 230 ----EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (457), Expect = 6e-52
 Identities = 61/277 (22%), Positives = 113/277 (40%), Gaps = 33/277 (11%)

Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFN---LQCGRAFKSFDVECAMMKSIRH 582
           + F     +G+G FG+VY AR  +    +A+KV     L+          E  +   +RH
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
            N++++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y H 
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCH- 123

Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
             S  VIH D+KP N+LL       ++DFG +       ++        T+ Y+ PE   
Sbjct: 124 --SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCG----TLDYLPPEMIE 177

Query: 703 EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ 762
                   D++S G++  E    K P    F      + +      IS +E    + +++
Sbjct: 178 GRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKR----ISRVEFTFPDFVTE 229

Query: 763 EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIV 799
                +++                 +P QR   +E++
Sbjct: 230 GARDLISR-------------LLKHNPSQRPMLREVL 253

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (461), Expect = 6e-52
 Identities = 61/292 (20%), Positives = 119/292 (40%), Gaps = 30/292 (10%)

Query: 520 LELFQATDKFSENNLIGRGGFGSVYKARIRD-----GMEVAVKVFNL-QCGRAFKSFDVE 573
           L + + T+ F +  ++G G FG+VYK           + VA+K        +A K    E
Sbjct: 3   LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 61

Query: 574 CAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDV 633
             +M S+ + ++ +++  C     + L+ + MP G L  Y+     ++     LN  + +
Sbjct: 62  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 120

Query: 634 ASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATI 693
           A  + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I
Sbjct: 121 AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177

Query: 694 GYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTME 753
            +MA E       +   DV+S+G+ + E  T                       P   + 
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK-------------------PYDGIP 218

Query: 754 VVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKI 805
             + + + ++         C   V+ + ++C +   + R   +E++ +  K+
Sbjct: 219 ASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 9e-52
 Identities = 72/274 (26%), Positives = 114/274 (41%), Gaps = 26/274 (9%)

Query: 526 TDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRN 584
             K++    IG+G  G+VY A  +  G EVA++  NLQ     +    E  +M+  ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 585 LVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGY 644
           +V  + S    +   +V+EY+  GSL   +  +       Q   +  +   ALE+LH   
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG--QIAAVCRECLQALEFLH--- 133

Query: 645 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG 704
           S  VIH D+K  N+LL  +    L+DFG    +T E    +      T  +MAPE     
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVG--TPYWMAPEVVTRK 191

Query: 705 QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQED 764
                 D++S GIM +E    + P     N    L     +  P    E+ +   LS   
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIATNGTP----ELQNPEKLSAIF 246

Query: 765 IHFVAKEQCVSFVFNLALECTVESPEQRINAKEI 798
             F+ +             C     E+R +AKE+
Sbjct: 247 RDFLNR-------------CLDMDVEKRGSAKEL 267

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 1e-50
 Identities = 63/287 (21%), Positives = 111/287 (38%), Gaps = 31/287 (10%)

Query: 527 DKFSENNLIGRGGFGSVYKARIRD----GMEVAVKVFNLQCGRAFKS-FDVECAMMKSIR 581
           ++      IG G FG V++          + VA+K        + +  F  E   M+   
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 582 HRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLH 641
           H ++VK+I   + E    +++E    G L  +L    YSLD+   +     +++AL YL 
Sbjct: 67  HPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125

Query: 642 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYG 701
              S   +H D+   NVL+  N    L DFG+++ +            L  I +MAPE  
Sbjct: 126 ---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESI 181

Query: 702 REGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVN-DCLPISTMEVVDANLL 760
              + ++  DV+ FG+ + E         +       +    N + LP+           
Sbjct: 182 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMP---------- 231

Query: 761 SQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRD 807
                       C   +++L  +C    P +R    E+ A+L  I +
Sbjct: 232 ----------PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (451), Expect = 1e-50
 Identities = 70/307 (22%), Positives = 126/307 (41%), Gaps = 45/307 (14%)

Query: 527 DKFSENNLIGRGGFGSVYKARIRDG---MEVAVKVFNLQCGR-AFKSFDVECAMMKSI-R 581
           +     ++IG G FG V KARI+     M+ A+K       +   + F  E  ++  +  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 582 HRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNY---------------SLDIFQR 626
           H N++ ++ +C +  +  L +EY PHG+L  +L  S                 +L   Q 
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 627 LNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQ 686
           L+   DVA  ++YL        IH DL   N+L+ +N VA ++DFG+++   G++  + +
Sbjct: 130 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKK 183

Query: 687 TQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDC 746
           T     + +MA E       +TN DV+S+G++L E  +               +      
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 243

Query: 747 LPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIR 806
                                     C   V++L  +C  E P +R +  +I+  L ++ 
Sbjct: 244 RL-------------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284

Query: 807 DSLLRNV 813
           +     V
Sbjct: 285 EERKTYV 291

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  178 bits (453), Expect = 2e-50
 Identities = 54/275 (19%), Positives = 99/275 (36%), Gaps = 26/275 (9%)

Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNL 585
           D +  +  +G G FG V++      G   A K          ++   E   M  +RH  L
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85

Query: 586 VKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYS 645
           V +  +  ++    ++ E+M  G L + +   +  +   + +  M  V   L ++H    
Sbjct: 86  VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---E 142

Query: 646 APVIHCDLKPSNVLL--DDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE 703
              +H DLKP N++     +    L DFG+   L  +      T T     + APE    
Sbjct: 143 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTA---EFAAPEVAEG 199

Query: 704 GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQE 763
             V    D++S G++     +   P    F GE   +   N       M+    + +S++
Sbjct: 200 KPVGYYTDMWSVGVLSYILLSGLSP----FGGENDDETLRNVKSCDWNMDDSAFSGISED 255

Query: 764 DIHFVAKEQCVSFVFNLALECTVESPEQRINAKEI 798
              F+ K               +  P  R+   + 
Sbjct: 256 GKDFIRK-------------LLLADPNTRMTIHQA 277

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 2e-50
 Identities = 66/303 (21%), Positives = 131/303 (43%), Gaps = 38/303 (12%)

Query: 527 DKFSENNLIGRGGFGSVYKARIR------DGMEVAVKVFNLQCG-RAFKSFDVECAMMKS 579
           +K + +  +G+G FG VY+   +          VA+K  N     R    F  E ++MK 
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 580 IRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYS---------LDIFQRLNIM 630
               ++V+++   S  +   +++E M  G L+ YL S   +           + + + + 
Sbjct: 80  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 631 IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTL 690
            ++A  + YL+   +   +H DL   N ++ ++    + DFG+ + +   D      + L
Sbjct: 140 GEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196

Query: 691 ATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPIS 750
             + +M+PE  ++G  +T  DV+SFG++L E  T  +   +  + E  L+          
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF--------- 247

Query: 751 TMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLL 810
              V++  LL + D        C   +F L   C   +P+ R +  EI++ + +  +   
Sbjct: 248 ---VMEGGLLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGF 297

Query: 811 RNV 813
           R V
Sbjct: 298 REV 300

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 5e-50
 Identities = 64/279 (22%), Positives = 110/279 (39%), Gaps = 29/279 (10%)

Query: 524 QATDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFN---LQCGRAFKSFDVECAMMKS 579
           +  + F    ++G G F +V  AR +    E A+K+     +           E  +M  
Sbjct: 5   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64

Query: 580 IRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEY 639
           + H   VK+  +  ++E     L Y  +G L KY+     S D         ++ SALEY
Sbjct: 65  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEY 123

Query: 640 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPE 699
           LH      +IH DLKP N+LL+++M   ++DFG AK+L+ E +       + T  Y++PE
Sbjct: 124 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 180

Query: 700 YGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANL 759
              E     + D+++ G ++ +      P    F        +      I  +E      
Sbjct: 181 LLTEKSACKSSDLWALGCIIYQLVAGLPP----FRAGNEYLIFQK----IIKLEYDFPEK 232

Query: 760 LSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEI 798
              +    V K               V    +R+  +E+
Sbjct: 233 FFPKARDLVEK-------------LLVLDATKRLGCEEM 258

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  173 bits (440), Expect = 2e-49
 Identities = 74/292 (25%), Positives = 125/292 (42%), Gaps = 31/292 (10%)

Query: 526 TDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGR---AFKSFDVECAMMKSIR 581
           +D++    ++G GG   V+ AR +R   +VAVKV      R    +  F  E     ++ 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 582 HRNLVKVISSCSNEEFKA----LVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASAL 637
           H  +V V  +   E        +V+EY+   +L   +H+    +   + + ++ D   AL
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQAL 124

Query: 638 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLA-TIGYM 696
            + H      +IH D+KP+N+++       + DFGIA+ +     S+TQT  +  T  Y+
Sbjct: 125 NFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 181

Query: 697 APEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVD 756
           +PE  R   V    DVYS G +L E  T + P        +  +H   D +P S      
Sbjct: 182 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA----R 237

Query: 757 ANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRI-NAKEIVAKLLKIRD 807
              LS +    V K                ++PE R   A E+ A L+++ +
Sbjct: 238 HEGLSADLDAVVLK-------------ALAKNPENRYQTAAEMRADLVRVHN 276

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  174 bits (442), Expect = 6e-49
 Identities = 50/275 (18%), Positives = 100/275 (36%), Gaps = 26/275 (9%)

Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNL 585
           D +     +G G FG V++      G     K  N        +   E ++M  + H  L
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88

Query: 586 VKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYS 645
           + +  +  ++    L+LE++  G L   + + +Y +   + +N M      L+++H    
Sbjct: 89  INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---E 145

Query: 646 APVIHCDLKPSNVLLD--DNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE 703
             ++H D+KP N++ +        + DFG+A  L  ++     T   AT  + APE    
Sbjct: 146 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAPEIVDR 202

Query: 704 GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQE 763
             V    D+++ G++     +   P    F GE               +E +        
Sbjct: 203 EPVGFYTDMWAIGVLGYVLLSGLSP----FAGE-------------DDLETLQNVKRCDW 245

Query: 764 DIHFVAKEQCVSFVFNLALECTVESPEQRINAKEI 798
           +    A         +       + P +R+   + 
Sbjct: 246 EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDA 280

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 1e-47
 Identities = 71/304 (23%), Positives = 118/304 (38%), Gaps = 47/304 (15%)

Query: 527 DKFSENNLIGRGGFGSVYKARIR--------DGMEVAVKVFNLQCG-RAFKSFDVECAMM 577
           D+      +G G FG V  A              +VAVK+       +       E  MM
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 578 KSI-RHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLH---------------SSNYSL 621
           K I +H+N++ ++ +C+ +    +++EY   G+L +YL                +    L
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 622 DIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED 681
                ++    VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ +   D
Sbjct: 133 SSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189

Query: 682 QSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKH 741
                T     + +MAPE   +   +   DV+SFG++L E FT           E   K 
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 249

Query: 742 WVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK 801
                               +E         C + ++ +  +C    P QR   K++V  
Sbjct: 250 L-------------------KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290

Query: 802 LLKI 805
           L +I
Sbjct: 291 LDRI 294

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (415), Expect = 2e-45
 Identities = 56/281 (19%), Positives = 115/281 (40%), Gaps = 30/281 (10%)

Query: 521 ELFQATDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDVECAMMKS 579
           EL+   +K+     +GRG FG V++            K   ++ G        E +++  
Sbjct: 2   ELY---EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNI 57

Query: 580 IRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEY 639
            RHRN++ +  S  + E   ++ E++    + + +++S + L+  + ++ +  V  AL++
Sbjct: 58  ARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQF 117

Query: 640 LHFGYSAPVIHCDLKPSNVLLD--DNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMA 697
           LH   S  + H D++P N++     +    + +FG A+ L   D             Y A
Sbjct: 118 LH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT---APEYYA 171

Query: 698 PEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDA 757
           PE  +   VST  D++S G ++    +   P       +  +++ +N           + 
Sbjct: 172 PEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE-TNQQIIENIMNAEYTFDEEAFKE- 229

Query: 758 NLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEI 798
             +S E + FV +               V+  + R+ A E 
Sbjct: 230 --ISIEAMDFVDR-------------LLVKERKSRMTASEA 255

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (403), Expect = 3e-44
 Identities = 63/306 (20%), Positives = 109/306 (35%), Gaps = 45/306 (14%)

Query: 527 DKFSENNLIGRGGFGSVYKARIR------DGMEVAVKVFNLQCGRA-FKSFDVECAMMKS 579
           D+      +GRG FG V +A             VAVK+       +  ++   E  ++  
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 580 IRHRNLVKVISSCSNEEFKAL--VLEYMPHGSLEKYLHSSNYS---------------LD 622
           I H   V  +     +    L  ++E+   G+L  YL S                   L 
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 623 IFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ 682
           +   +     VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+ +  +  
Sbjct: 133 LEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 683 SMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHW 742
            + +      + +MAPE   +   +   DV+SFG++L E F+           +      
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249

Query: 743 VNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL 802
           +                  +E     A +     ++   L+C    P QR    E+V  L
Sbjct: 250 L------------------KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 291

Query: 803 LKIRDS 808
             +  +
Sbjct: 292 GNLLQA 297

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  157 bits (399), Expect = 6e-44
 Identities = 63/289 (21%), Positives = 112/289 (38%), Gaps = 41/289 (14%)

Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDV---------ECAM 576
           + +    ++GRG    V +        E AVK+ ++  G +F + +V         E  +
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 577 MKSIR-HRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVAS 635
           ++ +  H N++++  +     F  LV + M  G L  YL     +L   +   IM  +  
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLE 121

Query: 636 ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGY 695
            +  LH      ++H DLKP N+LLDD+M   L+DFG +  L   D      +   T  Y
Sbjct: 122 VICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPGEKLREVCGTPSY 175

Query: 696 MAPEYGREGQVSTNG------DVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPI 749
           +APE         +       D++S G+++        P        + L+  ++     
Sbjct: 176 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR-KQMLMLRMIMSGNYQF 234

Query: 750 STMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEI 798
            + E  D    S      V++               V  P++R  A+E 
Sbjct: 235 GSPEWDD---YSDTVKDLVSR-------------FLVVQPQKRYTAEEA 267

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  156 bits (395), Expect = 5e-43
 Identities = 53/275 (19%), Positives = 97/275 (35%), Gaps = 23/275 (8%)

Query: 526 TDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAF-KSFDVECAMMKSIRHR 583
            D +   +++G G F  V  A   R    VA+K    +       S + E A++  I+H 
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67

Query: 584 NLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFG 643
           N+V +     +     L+++ +  G L   +    +         ++  V  A++YLH  
Sbjct: 68  NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF-YTERDASRLIFQVLDAVKYLHDL 126

Query: 644 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGRE 703
                           LD++    +SDFG++K+   ED     +    T GY+APE   +
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVLAQ 183

Query: 704 GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQE 763
              S   D +S G++         P    F  E   K +          +    + +S  
Sbjct: 184 KPYSKAVDCWSIGVIAYILLCGYPP----FYDENDAKLFEQILKAEYEFDSPYWDDISDS 239

Query: 764 DIHFVAKEQCVSFVFNLALECTVESPEQRINAKEI 798
              F+                  + PE+R   ++ 
Sbjct: 240 AKDFIRH-------------LMEKDPEKRFTCEQA 261

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (389), Expect = 8e-42
 Identities = 60/296 (20%), Positives = 120/296 (40%), Gaps = 23/296 (7%)

Query: 521 ELFQATDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAF-KSFDVECAMMK 578
           ++F    +++  + IG G +G V  A    + + VA+K  +    + + +    E  ++ 
Sbjct: 2   QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 61

Query: 579 SIRHRNLVKVISSCSNEEFKAL----VLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVA 634
             RH N++ +         + +    ++ ++    L K L + + S D       +  + 
Sbjct: 62  RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSND--HICYFLYQIL 119

Query: 635 SALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT-GEDQSMTQTQTLATI 693
             L+Y+H   SA V+H DLKPSN+LL+      + DFG+A++     D +   T+ +AT 
Sbjct: 120 RGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 176

Query: 694 GYMAPEYGREGQVSTN-GDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTM 752
            Y APE     +  T   D++S G +L E  + +         +           P    
Sbjct: 177 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 236

Query: 753 EVVDANLLSQEDIHFVAKEQCVSF----------VFNLALECTVESPEQRINAKEI 798
                NL ++  +  +  +  V +            +L  +    +P +RI  ++ 
Sbjct: 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 3e-41
 Identities = 51/274 (18%), Positives = 104/274 (37%), Gaps = 32/274 (11%)

Query: 534 LIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSC 592
           ++G G  G V +    R   + A+K+    C +A +  ++     ++ +  ++V+++   
Sbjct: 19  VLGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARREVEL---HWRASQCPHIVRIVDVY 74

Query: 593 ----SNEEFKALVLEYMPHGSLEKYLHS-SNYSLDIFQRLNIMIDVASALEYLHFGYSAP 647
               +  +   +V+E +  G L   +    + +    +   IM  +  A++YLH   S  
Sbjct: 75  ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SIN 131

Query: 648 VIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREG 704
           + H D+KP N+L      N +  L+DFG AK  T  +   T      T  Y+APE     
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEVLGPE 188

Query: 705 QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQED 764
           +   + D++S G+++        P        ++        +        + + +S+E 
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEV 248

Query: 765 IHFVAKEQCVSFVFNLALECTVESPEQRINAKEI 798
              +                    P QR+   E 
Sbjct: 249 KMLIRN-------------LLKTEPTQRMTITEF 269

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (383), Expect = 3e-41
 Identities = 56/278 (20%), Positives = 105/278 (37%), Gaps = 32/278 (11%)

Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDV----ECAMMKSIR 581
           + F  + ++G+G FG V+ A   +     A+K             +     +  +  +  
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 582 HRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLH 641
           H  L  +  +   +E    V+EY+  G L  ++ S  +  D+ +      ++   L++LH
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLH 120

Query: 642 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYG 701
              S  +++ DLK  N+LLD +    ++DFG+ K     D          T  Y+APE  
Sbjct: 121 ---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC--GTPDYIAPEIL 175

Query: 702 REGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLS 761
              + + + D +SFG++L E    + P     + E        D              L 
Sbjct: 176 LGQKYNHSVDWWSFGVLLYEMLIGQSPFHG-QDEEELFHSIRMDNPFYP-------RWLE 227

Query: 762 QEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIV 799
           +E    + K               V  PE+R+  +  +
Sbjct: 228 KEAKDLLVK-------------LFVREPEKRLGVRGDI 252

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  150 bits (380), Expect = 4e-41
 Identities = 54/288 (18%), Positives = 96/288 (33%), Gaps = 27/288 (9%)

Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNL 585
           +++     IG G FG +Y    I  G EVA+K+  ++         +E  + K ++    
Sbjct: 7   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVG 64

Query: 586 VKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYS 645
           +  I  C  E    +++  +   SLE   +  +    +   L +   + S +EY+H   S
Sbjct: 65  IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---S 121

Query: 646 APVIHCDLKPSNVL---LDDNMVAHLSDFGIAKLLTGED-----QSMTQTQTLATIGYMA 697
              IH D+KP N L        + ++ DFG+AK                     T  Y +
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 181

Query: 698 PEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDA 757
                  + S   D+ S G +LM       P   L       K+       +ST   V  
Sbjct: 182 INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC 241

Query: 758 NLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKI 805
                E   ++               C     + + +   +      +
Sbjct: 242 KGYPSEFATYLNF-------------CRSLRFDDKPDYSYLRQLFRNL 276

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  151 bits (381), Expect = 5e-41
 Identities = 60/282 (21%), Positives = 111/282 (39%), Gaps = 34/282 (12%)

Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFN---LQCGRAFKSFDVECAMMKSIRH 582
             F     +G G FG V+  R   +G   A+KV     +   +  +  + E  M+  + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
             ++++  +  + +   ++++Y+  G     L   +             +V  ALEYLH 
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIE-GGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH- 121

Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
             S  +I+ DLKP N+LLD N    ++DFG AK +     ++       T  Y+APE   
Sbjct: 122 --SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCG-----TPDYIAPEVVS 174

Query: 703 EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ 762
               + + D +SFGI++ E      P    F    T+K +      I   E+      ++
Sbjct: 175 TKPYNKSIDWWSFGILIYEMLAGYTP----FYDSNTMKTYEK----ILNAELRFPPFFNE 226

Query: 763 EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLK 804
           +    +++                    QR+   +   + +K
Sbjct: 227 DVKDLLSR-------------LITRDLSQRLGNLQNGTEDVK 255

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  150 bits (378), Expect = 5e-41
 Identities = 61/283 (21%), Positives = 119/283 (42%), Gaps = 17/283 (6%)

Query: 527 DKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRN 584
           +K+     IG G +G VYKA+   G   A+K   L+        +   E +++K ++H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 585 LVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGY 644
           +VK+      ++   LV E++    L+K L      L+     + ++ + + + Y H   
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH--- 117

Query: 645 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPE-YGRE 703
              V+H DLKP N+L++      ++DFG+A+           T  + T+ Y AP+     
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAF--GIPVRKYTHEIVTLWYRAPDVLMGS 175

Query: 704 GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHW-------VNDCLPISTMEVVD 756
            + ST  D++S G +  E          +   +  ++ +         +   ++ +   D
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235

Query: 757 ANLLSQEDIHFVAKEQCVSFVF-NLALECTVESPEQRINAKEI 798
            N    E + + +  + +     +L  +     P QRI AK+ 
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  151 bits (383), Expect = 8e-41
 Identities = 57/286 (19%), Positives = 110/286 (38%), Gaps = 34/286 (11%)

Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNL------QCGRAFKSFDVECAMMKS 579
           + FS + +IGRGGFG VY  R    G   A+K  +       Q      +  +  +++ +
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 580 IRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEY 639
                +V +  +    +  + +L+ M  G L  +L       +         ++   LE+
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-DMRFYAAEIILGLEH 122

Query: 640 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPE 699
           +H   +  V++ DLKP+N+LLD++    +SD G+A   + +    +      T GYMAPE
Sbjct: 123 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG----THGYMAPE 175

Query: 700 YGREGQ-VSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDAN 758
             ++G    ++ D +S G ML +      P  +    +      +   + +   +     
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF--- 232

Query: 759 LLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLK 804
             S E    +                      +R+      A+ +K
Sbjct: 233 --SPELRSLLEG-------------LLQRDVNRRLGCLGRGAQEVK 263

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (373), Expect = 3e-40
 Identities = 70/284 (24%), Positives = 116/284 (40%), Gaps = 17/284 (5%)

Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHR 583
           + F +   IG G +G VYKAR    G  VA+K   L         +   E +++K + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61

Query: 584 NLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFG 643
           N+VK++     E    LV E++     +    S+   + +    + +  +   L + H  
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 119

Query: 644 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPE-YGR 702
            S  V+H DLKP N+L++      L+DFG+A+      ++ T      T+ Y APE    
Sbjct: 120 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLG 176

Query: 703 EGQVSTNGDVYSFGIMLMETFTRKKP------TDELFNGEMTLKHWVNDCLP-ISTMEVV 755
               ST  D++S G +  E  TR+         D+LF    TL        P +++M   
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236

Query: 756 DANLLSQEDIHFVAKEQCVSFVF-NLALECTVESPEQRINAKEI 798
             +        F      +     +L  +     P +RI+AK  
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (368), Expect = 1e-39
 Identities = 65/280 (23%), Positives = 110/280 (39%), Gaps = 20/280 (7%)

Query: 533 NLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQC-----GRAFKSFDVECAMMKSIRHRNLV 586
           + +G G F +VYKAR       VA+K   L           ++   E  +++ + H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 587 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSA 646
            ++ +  ++   +LV ++M        +  ++  L        M+     LEYLH     
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLE-VIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QH 119

Query: 647 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQV 706
            ++H DLKP+N+LLD+N V  L+DFG+AK       +   T  + T  Y APE     ++
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSF--GSPNRAYTHQVVTRWYRAPELLFGARM 177

Query: 707 -STNGDVYSFGIMLMETFTRKKP------TDELFNGEMTLKHWVNDCLPISTMEVVDANL 759
                D+++ G +L E   R          D+L     TL     +  P           
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237

Query: 760 LSQEDIHFVAKEQCVSFVF-NLALECTVESPEQRINAKEI 798
            S   I              +L     + +P  RI A + 
Sbjct: 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (367), Expect = 2e-39
 Identities = 59/283 (20%), Positives = 109/283 (38%), Gaps = 35/283 (12%)

Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNL------QCGRAFKSFDVECAMMKS 579
           D +     +G G F  V K R    G++ A K          + G + +  + E +++K 
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 580 IRHRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEY 639
           I+H N++ +     N+    L+LE +  G L  +  +   SL   +    +  + + + Y
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDF-LAEKESLTEEEATEFLKQILNGVYY 128

Query: 640 LHFGYSAPVIHCDLKPSNVLLDDNMVA----HLSDFGIAKLLTGEDQSMTQTQTLATIGY 695
           LH   S  + H DLKP N++L D  V      + DFG+A  +   D          T  +
Sbjct: 129 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEF 182

Query: 696 MAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVV 755
           +APE      +    D++S G++     +   P    F G+   +   N        E  
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGDTKQETLANVSAVNYEFEDE 238

Query: 756 DANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEI 798
             +  S     F+ +               V+ P++R+  ++ 
Sbjct: 239 YFSNTSALAKDFIRR-------------LLVKDPKKRMTIQDS 268

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (366), Expect = 3e-39
 Identities = 68/293 (23%), Positives = 119/293 (40%), Gaps = 26/293 (8%)

Query: 525 ATDKFSENNLIGRGGFGSVYKARIR--DGMEVAVKVFNLQCG--RAFKSFDVECAMMK-- 578
           A  ++     IG G +G V+KAR     G  VA+K   +Q G      S   E A+++  
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 579 -SIRHRNLVKVISSCSNEEFKA-----LVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMID 632
            +  H N+V++   C+           LV E++               +      ++M  
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124

Query: 633 VASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLAT 692
           +   L++LH   S  V+H DLKP N+L+  +    L+DFG+A++       M  T  + T
Sbjct: 125 LLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVT 178

Query: 693 IGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTM 752
           + Y APE   +   +T  D++S G +  E F RK       + +  L   ++        
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ-LGKILDVIGLPGEE 237

Query: 753 EVVDANLLSQEDIHFVAKEQCVSFVFNLALE-------CTVESPEQRINAKEI 798
           +      L ++  H  + +    FV ++          C   +P +RI+A   
Sbjct: 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (367), Expect = 7e-39
 Identities = 65/289 (22%), Positives = 115/289 (39%), Gaps = 29/289 (10%)

Query: 529 FSENNLIGRGGFGSVYKARIRD-GMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVK 587
           +++  +IG G FG VY+A++ D G  VA+K          +  + E  +M+ + H N+V+
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVR 77

Query: 588 VISSC------SNEEFKALVLEYMPHGSLEKYLH--SSNYSLDIFQRLNIMIDVASALEY 639
           +           +E +  LVL+Y+P        H   +  +L +      M  +  +L Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137

Query: 640 LHFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAP 698
           +H   S  + H D+KP N+LLD D  V  L DFG AK L   + +++    + +  Y AP
Sbjct: 138 IH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---YICSRYYRAP 191

Query: 699 -EYGREGQVSTNGDVYSFGIMLMETFTRKKP------TDELFNGEMTLKHWVNDCLPIST 751
                    +++ DV+S G +L E    +         D+L      L     + +    
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251

Query: 752 MEVVDANL--LSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEI 798
               +     +       V + +       L       +P  R+   E 
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (352), Expect = 1e-37
 Identities = 58/283 (20%), Positives = 97/283 (34%), Gaps = 45/283 (15%)

Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAF------KSFDVECAMMKS 579
            ++    L+G GGFGSVY    + D + VA+K         +          +E  ++K 
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63

Query: 580 IR--HRNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASAL 637
           +      +++++      +   L+LE            +   +L      +    V  A+
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123

Query: 638 EYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYM 696
            + H   +  V+H D+K  N+L+D +     L DFG   LL         T    T  Y 
Sbjct: 124 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYS 176

Query: 697 APEYGREGQVSTNG-DVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVV 755
            PE+ R  +       V+S GI+L +      P    F  +            I   +V 
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP----FEHDE----------EIIRGQVF 222

Query: 756 DANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEI 798
               +S E  H +               C    P  R   +EI
Sbjct: 223 FRQRVSSECQHLIRW-------------CLALRPSDRPTFEEI 252

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (347), Expect = 8e-37
 Identities = 57/285 (20%), Positives = 111/285 (38%), Gaps = 19/285 (6%)

Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCG--RAFKSFDVECAMMKSIRHR 583
            K+ +   IG G +G+V+KA+       VA+K   L         S   E  ++K ++H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 584 NLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFG 643
           N+V++     +++   LV E+      + +   +    D     + +  +   L + H  
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-DPEIVKSFLFQLLKGLGFCHS- 119

Query: 644 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPE-YGR 702
               V+H DLKP N+L++ N    L++FG+A+      +    +  + T+ Y  P+    
Sbjct: 120 --RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVVTLWYRPPDVLFG 175

Query: 703 EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ 762
               ST+ D++S G +  E     +P     + +  LK         +  +      L  
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235

Query: 763 EDIHFVAKEQCVSFVF---------NLALECTVESPEQRINAKEI 798
              + +                   +L       +P QRI+A+E 
Sbjct: 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  135 bits (341), Expect = 6e-36
 Identities = 42/294 (14%), Positives = 91/294 (30%), Gaps = 29/294 (9%)

Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNL 585
             +     IG G FG +++   + +  +VA+K    +          E    K +     
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62

Query: 586 VKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYS 645
           +  +     E    +++  +   SLE  L        +         + + ++ +H    
Sbjct: 63  IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---E 119

Query: 646 APVIHCDLKPSNVLLDDNMVAH-----LSDFGIAKLL----TGEDQSMTQTQTLA-TIGY 695
             +++ D+KP N L+      +     + DFG+ K      T +     + + L+ T  Y
Sbjct: 120 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 179

Query: 696 MAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVV 755
           M+       + S   D+ + G + M       P   L       K+        ST    
Sbjct: 180 MSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE 239

Query: 756 DANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSL 809
                 +E   ++                   + +   +   +     K+ + L
Sbjct: 240 LCAGFPEEFYKYMHY-------------ARNLAFDATPDYDYLQGLFSKVLERL 280

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (340), Expect = 2e-35
 Identities = 60/297 (20%), Positives = 118/297 (39%), Gaps = 29/297 (9%)

Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHR 583
            K+ +   IG+G FG V+KAR  + G +VA+K   ++        +   E  +++ ++H 
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69

Query: 584 NLVKVISSCSNEEFKA--------LVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVAS 635
           N+V +I  C  +            LV ++  H       +       + +   +M  + +
Sbjct: 70  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV-LVKFTLSEIKRVMQMLLN 128

Query: 636 ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQT--LATI 693
            L Y+H      ++H D+K +NVL+  + V  L+DFG+A+  +    S     T  + T+
Sbjct: 129 GLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 185

Query: 694 GYMAPEYGREGQ-VSTNGDVYSFGIMLMETFTRKKPTD-----------ELFNGEMTLKH 741
            Y  PE     +      D++  G ++ E +TR                    G +T + 
Sbjct: 186 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 245

Query: 742 WVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEI 798
           W N        ++       ++    +       +  +L  +  V  P QRI++ + 
Sbjct: 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (339), Expect = 3e-35
 Identities = 62/282 (21%), Positives = 107/282 (37%), Gaps = 31/282 (10%)

Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRA---FKSFDVECAMMKSIRH 582
           + F    L+G+G FG V   R    G   A+K+   +   A         E  ++++ RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
             L  +  +    +    V+EY   G L  +L          +      ++ SALEYLH 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLH- 122

Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
             S  V++ D+K  N++LD +    ++DFG+ K    +  +M       T  Y+APE   
Sbjct: 123 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPEYLAPEVLE 178

Query: 703 EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ 762
           +       D +  G+++ E    + P    F  +   + +      I   E+     LS 
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLP----FYNQDHERLFEL----ILMEEIRFPRTLSP 230

Query: 763 EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLK 804
           E    +A                 + P+QR+      AK + 
Sbjct: 231 EAKSLLAG-------------LLKKDPKQRLGGGPSDAKEVM 259

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  131 bits (329), Expect = 7e-34
 Identities = 49/230 (21%), Positives = 91/230 (39%), Gaps = 20/230 (8%)

Query: 527 DKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFN---LQCGRAFKSFDVECAMMKSIRH 582
           D+F     +G G FG V   +    G   A+K+ +   +   +  +    E  +++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHF 642
             LVK+  S  +     +V+EY+  G +  +L                  +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHARFYAAQIVLTFEYLH- 158

Query: 643 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGR 702
             S  +I+ DLKP N+L+D      ++DFG AK + G   ++       T   +APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCG-----TPEALAPEIIL 211

Query: 703 EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGE---MTLKHWVNDCLPI 749
               +   D ++ G+++ E      P    F  +      +  V+  +  
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP----FFADQPIQIYEKIVSGKVRF 257

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (323), Expect = 2e-33
 Identities = 62/289 (21%), Positives = 108/289 (37%), Gaps = 33/289 (11%)

Query: 527 DKFSENNLIGRGGFGSVYKAR----IRDGMEVAVKVFN----LQCGRAFKSFDVECAMMK 578
           + F    ++G G +G V+  R       G   A+KV      +Q  +  +    E  +++
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 579 SIRHR-NLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASAL 637
            IR    LV +  +   E    L+L+Y+  G L  +L         F    + I V   +
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER----FTEHEVQIYVGEIV 139

Query: 638 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMA 697
             L   +   +I+ D+K  N+LLD N    L+DFG++K    ++          TI YMA
Sbjct: 140 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC-GTIEYMA 198

Query: 698 PEYGREGQVSTNG--DVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVV 755
           P+  R G    +   D +S G+++ E  T   P    F  +            I   E  
Sbjct: 199 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP----FTVDGEKNSQAEISRRILKSEPP 254

Query: 756 DANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLK 804
               +S      + +               ++ P++R+      A  +K
Sbjct: 255 YPQEMSALAKDLIQR-------------LLMKDPKKRLGCGPRDADEIK 290

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (323), Expect = 5e-33
 Identities = 64/306 (20%), Positives = 119/306 (38%), Gaps = 35/306 (11%)

Query: 517 FSYLELFQATDKFSEN----NLIGRGGFGSVYKAR-IRDGMEVAVKVFN--LQCGRAFKS 569
           F   E+ +   +          +G G +G+V  A   R G +VA+K      Q     K 
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63

Query: 570 FDVECAMMKSIRHRNLVKVISSCSNEEFKA------LVLEYMPHGSLEKYLHSSNYSLDI 623
              E  ++K +RH N++ ++   + +E         LV+ +M  G+    L      L  
Sbjct: 64  AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHE-KLGE 120

Query: 624 FQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS 683
            +   ++  +   L Y+H   +A +IH DLKP N+ ++++    + DFG+A+    E   
Sbjct: 121 DRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE--- 174

Query: 684 MTQTQTLATIGYMAPE-YGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHW 742
              T  + T  Y APE      + +   D++S G ++ E  T K       + +   +  
Sbjct: 175 --MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIM 232

Query: 743 VNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSF----------VFNLALECTVESPEQR 792
                P +       +  ++  +  + + +   F            NL  +  V   EQR
Sbjct: 233 KVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQR 292

Query: 793 INAKEI 798
           + A E 
Sbjct: 293 VTAGEA 298

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  127 bits (319), Expect = 1e-32
 Identities = 59/319 (18%), Positives = 121/319 (37%), Gaps = 37/319 (11%)

Query: 504 NDPNMP-PVATWRRFSYLELFQATDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFNL 561
            D N   P   W   S++  +   D +     +GRG +  V++A  I +  +V VK+   
Sbjct: 11  TDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP 70

Query: 562 QCGRAFKSFDVECAMMKSIR-HRNLVKVISSCSNEEFK--ALVLEYMPHGSLEKYLHSSN 618
              +  K    E  +++++R   N++ +     +   +  ALV E++ +   ++      
Sbjct: 71  VKKKKIKR---EIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ--- 124

Query: 619 YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLL 677
            +L  +     M ++  AL+Y H   S  ++H D+KP NV++D ++    L D+G+A+  
Sbjct: 125 -TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 180

Query: 678 TGEDQSMTQTQTLATIGYMAPEYGREGQ-VSTNGDVYSFGIMLMETFTRKKPTDELFNGE 736
                       +A+  +  PE   + Q    + D++S G ML     RK+P     +  
Sbjct: 181 ---HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY 237

Query: 737 MTLKHWVNDCLPISTMEVVDANLLS-----------------QEDIHFVAKEQCVSFVFN 779
             L             + +D   +                  +  +H   +        +
Sbjct: 238 DQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALD 297

Query: 780 LALECTVESPEQRINAKEI 798
              +      + R+ A+E 
Sbjct: 298 FLDKLLRYDHQSRLTAREA 316

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (312), Expect = 1e-31
 Identities = 54/294 (18%), Positives = 115/294 (39%), Gaps = 25/294 (8%)

Query: 522 LFQATDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFN--LQCGRAFKSFDVECAMMK 578
           +++  +++   + +G G +GSV  A   + G+ VAVK  +   Q     K    E  ++K
Sbjct: 13  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 72

Query: 579 SIRHRNLVKVISSCSNE----EFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVA 634
            ++H N++ ++   +      EF  + L     G+    +      L       ++  + 
Sbjct: 73  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQIL 131

Query: 635 SALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIG 694
             L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+    E      T       
Sbjct: 132 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT----RWY 184

Query: 695 YMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEV 754
                       +   D++S G ++ E  T +       + +           P + +  
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 244

Query: 755 VDANLLSQEDIHFVAKEQCVSF----------VFNLALECTVESPEQRINAKEI 798
             ++  ++  I  + +   ++F            +L  +  V   ++RI A + 
Sbjct: 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (299), Expect = 8e-30
 Identities = 59/306 (19%), Positives = 114/306 (37%), Gaps = 40/306 (13%)

Query: 523 FQATDKFSENNLIGRGGFGSVYKAR-IRDGMEVAVKVFN--LQCGRAFKSFDVECAMMKS 579
           F    ++     IG G  G V  A        VA+K  +   Q     K    E  +MK 
Sbjct: 13  FTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKC 72

Query: 580 IRHRNLVKVISSCSNEEFK------ALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDV 633
           + H+N++ +++  + ++         LV+E M     +      ++     +   ++  +
Sbjct: 73  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE----RMSYLLYQM 128

Query: 634 ASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATI 693
              +++LH   SA +IH DLKPSN+++  +    + DFG+A+       S   T  + T 
Sbjct: 129 LCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMMTPYVVTR 182

Query: 694 GYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKP---------------------TDEL 732
            Y APE         N D++S G ++ E    K                        + +
Sbjct: 183 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242

Query: 733 FNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQR 792
              + T++++V +    + +        S         +   S   +L  +  V  P +R
Sbjct: 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 302

Query: 793 INAKEI 798
           I+  + 
Sbjct: 303 ISVDDA 308

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  115 bits (288), Expect = 2e-28
 Identities = 50/309 (16%), Positives = 102/309 (33%), Gaps = 47/309 (15%)

Query: 534 LIGRGGFGSVYKAR-IRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSC 592
            +G G F +V+ A+ + +   VA+K+         ++ + E  +++ +   +  K  S  
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-EAAEDEIKLLQRVNDADNTKEDSMG 78

Query: 593 SNEEFK---------------ALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASAL 637
           +N   K                +V E +    L       +  + +     I   +   L
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138

Query: 638 EYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYM 696
           +Y+H      +IH D+KP NVL++  +   +L    IA L          T ++ T  Y 
Sbjct: 139 DYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196

Query: 697 APEYGREGQVSTNGDVYSFGIMLMETFTRKKP---------------------------T 729
           +PE           D++S   ++ E  T                               +
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPS 256

Query: 730 DELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESP 789
             L NG+ T   + +  L  +  ++    L       +   +     + +         P
Sbjct: 257 YLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 316

Query: 790 EQRINAKEI 798
            +R +A  +
Sbjct: 317 RKRADAGGL 325

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score =  110 bits (274), Expect = 2e-26
 Identities = 77/380 (20%), Positives = 143/380 (37%), Gaps = 30/380 (7%)

Query: 50  LDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLSGCLSSITDVG-LPNLEVLYLWGNNFSG 108
             L +  +  T+     ++  +         +     SI  V  L NL  +    N  + 
Sbjct: 27  TVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK----SIDGVEYLNNLTQINFSNNQLTD 80

Query: 109 TIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLE------WLTLYDNNLTSSTLDLS 162
             P  + N +KL  + +  N  +   P                   +      ++   L 
Sbjct: 81  ITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLE 138

Query: 163 FLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTD 222
             S+  +  S      S   L      T +  L++      +   +        +  LT+
Sbjct: 139 LSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTN 198

Query: 223 LTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLS 282
           L +++   N+++   P+ +     L ++ L  NQL+     ++     L +L+L  N++S
Sbjct: 199 LESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQIS 254

Query: 283 GSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKAL 342
              P   S +T L  L LG+N++++I      L  + +L L+ N      P  I NLK L
Sbjct: 255 NLAP--LSGLTKLTELKLGANQISNIS-PLAGLTALTNLELNENQLEDISP--ISNLKNL 309

Query: 343 IEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSG 402
             +    NN S I P  + SL  L+ LF   N++      S  +L ++  L+  +N +S 
Sbjct: 310 TYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISD 365

Query: 403 TIPVSLEKLSYLKDLNLSFN 422
             P  L  L+ +  L L+  
Sbjct: 366 LTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 93.9 bits (232), Expect = 5e-21
 Identities = 81/375 (21%), Positives = 129/375 (34%), Gaps = 55/375 (14%)

Query: 88  ITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWL 147
            TD  L       L   N + T+     +  +++ L  +              L NL  +
Sbjct: 16  FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQI 71

Query: 148 TLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNC 207
              +N LT        ++ L N   L  I ++NN +  I P   + NL+           
Sbjct: 72  NFSNNQLTD-------ITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITD 124

Query: 208 NVSGGIPEE-------------ITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEY 254
                                 I+ L+ LT++         +    L  L  L+ +D+  
Sbjct: 125 IDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISS 184

Query: 255 NQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWS 314
           N++      +      L  L    N++S   P     +T L  LSL  N+L  I     S
Sbjct: 185 NKVSDISVLAKL--TNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKDIG-TLAS 239

Query: 315 LKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIP----------------- 357
           L ++ DL+L++N  S   PL    L  L E+    N  S I P                 
Sbjct: 240 LTNLTDLDLANNQISNLAPLS--GLTKLTELKLGANQISNISPLAGLTALTNLELNENQL 297

Query: 358 ---MEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYL 414
                I +LKNL  L L +N +    P     L  L+ L  + N +S     SL  L+ +
Sbjct: 298 EDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNI 353

Query: 415 KDLNLSFNKLKGEIP 429
             L+   N++    P
Sbjct: 354 NWLSAGHNQISDLTP 368

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 79.7 bits (195), Expect = 2e-16
 Identities = 49/195 (25%), Positives = 79/195 (40%), Gaps = 36/195 (18%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAI 65
           NN ++  TP  I   +NL  L L  N+L+   I  +  L NL  LDL+ N++    P  +
Sbjct: 206 NNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--L 259

Query: 66  FNVSTLKAFAVTNNSLSG-------------------CLSSITDVGLPNLEVLYLWGNNF 106
             ++ L    +  N +S                             L NL  L L+ NN 
Sbjct: 260 SGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNI 319

Query: 107 SGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSS 166
           S   P  + + +KL +L    N  S    S+  NL N+ WL+   N ++        L+ 
Sbjct: 320 SDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISD-------LTP 368

Query: 167 LSNCKSLTHISLSNN 181
           L+N   +T + L++ 
Sbjct: 369 LANLTRITQLGLNDQ 383

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  106 bits (265), Expect = 6e-26
 Identities = 60/313 (19%), Positives = 101/313 (32%), Gaps = 31/313 (9%)

Query: 85  LSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNL 144
           L  +     P+  +L L  N  +        N   L  L L  N  S   P  F  L  L
Sbjct: 22  LEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81

Query: 145 EWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYM 204
           E L L  N L      +         K+L  + +  N +  +    + G     +     
Sbjct: 82  ERLYLSKNQLKELPEKM--------PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGT 133

Query: 205 YNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDS 264
                SG        +  L+ I +    +     I  G    L ++ L+ N++      S
Sbjct: 134 NPLKSSGIENGAFQGMKKLSYIRIADTNIT---TIPQGLPPSLTELHLDGNKITKVDAAS 190

Query: 265 ICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLS 324
           +     L +L L  N +S       +N   L+ L L +N+L  +P      K I  + L 
Sbjct: 191 LKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLH 250

Query: 325 SNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGS--IPD 382
           +N           N+ A+   DF         P       +   + L  N ++     P 
Sbjct: 251 NN-----------NISAIGSNDFC-------PPGYNTKKASYSGVSLFSNPVQYWEIQPS 292

Query: 383 SFGDLISLKSLNL 395
           +F  +    ++ L
Sbjct: 293 TFRCVYVRAAVQL 305

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 94.3 bits (233), Expect = 1e-21
 Identities = 53/261 (20%), Positives = 99/261 (37%), Gaps = 12/261 (4%)

Query: 171 KSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGG 230
                + L NN +  I    +  NL + L    + N  +S   P     L  L  + L  
Sbjct: 31  PDTALLDLQNNKITEIKDGDF-KNLKN-LHTLILINNKISKISPGAFAPLVKLERLYLSK 88

Query: 231 NKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFS 290
           N+L          LQ+L+  + E  ++  S+ + +   + +  L     K SG     F 
Sbjct: 89  NQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTNPLKSSGIENGAFQ 147

Query: 291 NMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMN 350
            M  L  + +    +T+IP        + +L+L  N  +      ++ L  L ++  S N
Sbjct: 148 GMKKLSYIRIADTNITTIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFN 205

Query: 351 NFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSG------TI 404
           + S +    + +  +L  L L  N+L   +P    D   ++ + L  NN+S         
Sbjct: 206 SISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCP 264

Query: 405 PVSLEKLSYLKDLNLSFNKLK 425
           P    K +    ++L  N ++
Sbjct: 265 PGYNTKKASYSGVSLFSNPVQ 285

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 91.6 bits (226), Expect = 9e-21
 Identities = 55/288 (19%), Positives = 99/288 (34%), Gaps = 21/288 (7%)

Query: 21  SNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNS 80
            +  +L L NN++      +  +L NL  L L  NK+    P A   +  L+   ++ N 
Sbjct: 31  PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90

Query: 81  LSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGN 140
           L   L       L  L V          ++ + +     +  L       SG     F  
Sbjct: 91  LKE-LPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTNPLKSSGIENGAFQG 148

Query: 141 LRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLK 200
           ++ L ++ + D N+T+    L          SLT + L  N +  +   +  G   ++L 
Sbjct: 149 MKKLSYIRIADTNITTIPQGL--------PPSLTELHLDGNKITKVDAASLKGL--NNLA 198

Query: 201 NFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGS 260
              +   ++S      + N   L  + L  NKL   +P  L   + +Q V L  N +   
Sbjct: 199 KLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAI 257

Query: 261 IPDSICLSVE------LYELELGGNKLSGS--IPACFSNMTFLKVLSL 300
             +  C             + L  N +      P+ F  +     + L
Sbjct: 258 GSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 89.7 bits (221), Expect = 4e-20
 Identities = 52/246 (21%), Positives = 92/246 (37%), Gaps = 5/246 (2%)

Query: 213 IPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELY 272
           +P+++    D   + L  NK+          L+ L  + L  N++    P +    V+L 
Sbjct: 25  VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 82

Query: 273 ELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPL 332
            L L  N+L          +  L+V      ++     N  +   +++L  +    SG  
Sbjct: 83  RLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIE 142

Query: 333 PLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKS 392
               + +K L  I  +  N + I     G   +L  L L+ N++      S   L +L  
Sbjct: 143 NGAFQGMKKLSYIRIADTNITTIPQ---GLPPSLTELHLDGNKITKVDAASLKGLNNLAK 199

Query: 393 LNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIPRGGSFGNFSAESFKGNELLCGSP 452
           L LS+N++S     SL    +L++L+L+ NKL                    N +     
Sbjct: 200 LGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGS 259

Query: 453 NLQVPP 458
           N   PP
Sbjct: 260 NDFCPP 265

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 81.6 bits (200), Expect = 2e-17
 Identities = 45/205 (21%), Positives = 76/205 (37%), Gaps = 6/205 (2%)

Query: 222 DLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKL 281
            L  +      L   +P  L        +DL+ N++             L+ L L  NK+
Sbjct: 11  HLRVVQCSDLGLE-KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67

Query: 282 SGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKA 341
           S   P  F+ +  L+ L L  N+L  +P         L ++ +             N   
Sbjct: 68  SKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMI 127

Query: 342 LIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLS 401
           ++E+  +    SGI       +K L  + +    +  +IP       SL  L+L  N ++
Sbjct: 128 VVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKIT 184

Query: 402 GTIPVSLEKLSYLKDLNLSFNKLKG 426
                SL+ L+ L  L LSFN +  
Sbjct: 185 KVDAASLKGLNNLAKLGLSFNSISA 209

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 55.0 bits (131), Expect = 1e-08
 Identities = 27/129 (20%), Positives = 44/129 (34%)

Query: 342 LIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLS 401
              +D   N  + I   +  +LKNL  L L  N++    P +F  L+ L+ L LS N L 
Sbjct: 33  TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 92

Query: 402 GTIPVSLEKLSYLKDLNLSFNKLKGEIPRGGSFGNFSAESFKGNELLCGSPNLQVPPCKA 461
                  + L  L+       K++  +  G +            +             K 
Sbjct: 93  ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKL 152

Query: 462 SIHRTSRKN 470
           S  R +  N
Sbjct: 153 SYIRIADTN 161

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 49.7 bits (117), Expect = 7e-07
 Identities = 26/179 (14%), Positives = 59/179 (32%), Gaps = 14/179 (7%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAI 65
               +         +  L  + + +  +        G   +L  L L  NK+     A++
Sbjct: 135 PLKSSGIENGAFQGMKKLSYIRIADTNIT---TIPQGLPPSLTELHLDGNKITKVDAASL 191

Query: 66  FNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLAL 125
             ++ L    ++ NS+S   +       P+L  L+L  N     +P  + +   +  + L
Sbjct: 192 KGLNNLAKLGLSFNSISAVDNGSLANT-PHLRELHLNNNKLV-KVPGGLADHKYIQVVYL 249

Query: 126 EMNSFSGFIPSTF------GNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISL 178
             N+ S    + F          +   ++L+ N +    +  S    +        + L
Sbjct: 250 HNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCV---YVRAAVQL 305

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 91.8 bits (227), Expect = 7e-22
 Identities = 28/201 (13%), Positives = 63/201 (31%), Gaps = 27/201 (13%)

Query: 533 NLIGRGGFGSVYKARIRDGMEVAVKVFNL----------QCGRAFKSFDVECAMMKSIRH 582
            L+G G   +V+        E  VK   +          +       F V          
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 583 RNLVKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYSL-DIFQRLNIMIDVASALEYLH 641
           R L K+      + +      +  +  L + + +       +     ++  +   +   +
Sbjct: 66  RALQKLQGLAVPKVY-----AWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120

Query: 642 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED-QSMTQTQTLATIGYMAPEY 700
                 ++H DL   NVL+ +  +  + DF  +  +  E  + + +      I Y +  Y
Sbjct: 121 ---HRGIVHGDLSQYNVLVSEEGI-WIIDFPQSVEVGEEGWREILERDVRNIITYFSRTY 176

Query: 701 GREGQVSTNGDVYSFGIMLME 721
             E       D+ S    +++
Sbjct: 177 RTE------KDINSAIDRILQ 191

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 94.8 bits (234), Expect = 8e-22
 Identities = 70/308 (22%), Positives = 124/308 (40%), Gaps = 16/308 (5%)

Query: 161 LSFLSSLSNCKSLTHISLSNNPLDGILPRTYVG------NLSHSLKNFYMYNCNVSGG-- 212
           L     L N  +L+    + +  +     T++G        ++ + N  +   N+     
Sbjct: 12  LQIKKDLGNPTTLSSWLPTTDCCNR----TWLGVLCDTDTQTYRVNNLDLSGLNLPKPYP 67

Query: 213 IPEEITNLTDLTTIVLGGN-KLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVEL 271
           IP  + NL  L  + +GG   L G IP  + KL +L  + + +  + G+IPD +     L
Sbjct: 68  IPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTL 127

Query: 272 YELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGP 331
             L+   N LSG++P   S++  L  ++   N ++    + +     L  +++ +     
Sbjct: 128 VTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLT 187

Query: 332 LPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLK 391
             +        +       N        +                        G   +L 
Sbjct: 188 GKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLN 247

Query: 392 SLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIPRGGSFGNFSAESFKGNELLCGS 451
            L+L  N + GT+P  L +L +L  LN+SFN L GEIP+GG+   F   ++  N+ LCGS
Sbjct: 248 GLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGS 307

Query: 452 PNLQVPPC 459
           P   +P C
Sbjct: 308 P---LPAC 312

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 78.6 bits (192), Expect = 2e-16
 Identities = 59/268 (22%), Positives = 106/268 (39%), Gaps = 9/268 (3%)

Query: 116 NASKLSKLALEMNSFSGF--IPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSL 173
              +++ L L   +      IPS+  NL  L +L +   N     L      +++    L
Sbjct: 48  QTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGIN----NLVGPIPPAIAKLTQL 103

Query: 174 THISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKL 233
            ++ +++  + G +P         +L         +SG +P  I++L +L  I   GN++
Sbjct: 104 HYLYITHTNVSGAIPDFLSQI--KTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRI 161

Query: 234 NGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMT 293
           +G+IP + G   KL                    ++ L  ++L  N L G     F +  
Sbjct: 162 SGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDK 221

Query: 294 FLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFS 353
             + + L  N L          K++  L+L +N   G LP  +  LK L  ++ S NN  
Sbjct: 222 NTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLC 281

Query: 354 GIIPMEIGSLKNLENLFLEYNRLEGSIP 381
           G IP + G+L+  +      N+     P
Sbjct: 282 GEIP-QGGNLQRFDVSAYANNKCLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 72.5 bits (176), Expect = 3e-14
 Identities = 56/267 (20%), Positives = 94/267 (35%), Gaps = 21/267 (7%)

Query: 42  GHLHNLGFLDLSQNKLLG--TIPAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVL 99
              + +  LDLS   L     IP+++ N+  L    +   +            L  L  L
Sbjct: 47  TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106

Query: 100 YLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTL 159
           Y+   N SG IP F+     L  L    N+ SG +P +  +L NL  +T   N ++ +  
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166

Query: 160 DLSFL-SSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEIT 218
           D     S L    +++   L+                          +         +  
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKI 226

Query: 219 N---------------LTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPD 263
           +                 +L  + L  N++ G++P  L +L+ L  +++ +N L G IP 
Sbjct: 227 HLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ 286

Query: 264 SICLSVELYELELGGNK-LSGS-IPAC 288
              L           NK L GS +PAC
Sbjct: 287 GGNLQ-RFDVSAYANNKCLCGSPLPAC 312

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 59.8 bits (143), Expect = 4e-10
 Identities = 33/178 (18%), Positives = 51/178 (28%), Gaps = 8/178 (4%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAI 65
            N L+ T P  I ++ NL  +    NR+ G I    G    L          L       
Sbjct: 134 YNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKI--P 191

Query: 66  FNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLAL 125
              + L    V  +       +    G            N        +  +  L+ L L
Sbjct: 192 PTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDL 251

Query: 126 EMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPL 183
             N   G +P     L+ L  L +  NNL         +    N +     + +NN  
Sbjct: 252 RNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGE------IPQGGNLQRFDVSAYANNKC 303

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 42.8 bits (99), Expect = 1e-04
 Identities = 49/231 (21%), Positives = 77/231 (33%), Gaps = 30/231 (12%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAI 65
            N L    P  I  ++ L  LY+ +  + G I   +  +  L  LD S N L GT+P +I
Sbjct: 86  INNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSI 145

Query: 66  FNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLAL 125
            ++  L       N +SG +             + +  N  +G IP    N +       
Sbjct: 146 SSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLS 205

Query: 126 EM----------------------NSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSF 163
                                    +   F     G  +NL  L L +N +  +      
Sbjct: 206 RNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGT-----L 260

Query: 164 LSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIP 214
              L+  K L  +++S N L G +P+   GNL          N     G P
Sbjct: 261 PQGLTQLKFLHSLNVSFNNLCGEIPQG--GNLQ-RFDVSAYANNKCLCGSP 308

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 87.9 bits (216), Expect = 1e-19
 Identities = 49/257 (19%), Positives = 84/257 (32%), Gaps = 6/257 (2%)

Query: 171 KSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGG 230
            +   I L  N +  +   ++     +    +   N                    +   
Sbjct: 32  AASQRIFLHGNRISHVPAASF-RACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90

Query: 231 NKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFS 290
            +L    P T   L +L  + L+   L+   P        L  L L  N L       F 
Sbjct: 91  AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFR 150

Query: 291 NMTFLKVLSLGSNELTSIPLN-FWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSM 349
           ++  L  L L  N ++S+P   F  L  +  L L  N  +   P   R+L  L+ +    
Sbjct: 151 DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFA 210

Query: 350 NNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLE 409
           NN S +    +  L+ L+ L L  N        +      L+    S + +  ++P  L 
Sbjct: 211 NNLSALPTEALAPLRALQYLRLNDNPWVCDC-RARPLWAWLQKFRGSSSEVPCSLPQRLA 269

Query: 410 KLSYLKDLNLSFNKLKG 426
                    L+ N L+G
Sbjct: 270 GRDL---KRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 81.0 bits (198), Expect = 3e-17
 Identities = 53/270 (19%), Positives = 89/270 (32%), Gaps = 9/270 (3%)

Query: 85  LSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNL 144
           L ++        + ++L GN  S            L+ L L  N  +    + F  L  L
Sbjct: 23  LQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82

Query: 145 EWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYM 204
           E L L DN    S    +F         L  + L    L  + P  + G    +L+  Y+
Sbjct: 83  EQLDLSDNAQLRSVDPATF----HGLGRLHTLHLDRCGLQELGPGLFRGL--AALQYLYL 136

Query: 205 YNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDS 264
            +  +     +   +L +LT + L GN+++         L  L  + L  N++    P +
Sbjct: 137 QDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHA 196

Query: 265 ICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLS 324
                 L  L L  N LS       + +  L+ L L  N              +     S
Sbjct: 197 FRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGS 256

Query: 325 SNCFSGPLPLEIRNLKALIEIDFSMNNFSG 354
           S+     LP  +           + N+  G
Sbjct: 257 SSEVPCSLPQRLAGRDLK---RLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 74.1 bits (180), Expect = 5e-15
 Identities = 56/242 (23%), Positives = 85/242 (35%), Gaps = 4/242 (1%)

Query: 213 IPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELY 272
           +P  I        I L GN+++     +    + L  + L  N L      +      L 
Sbjct: 26  VPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83

Query: 273 ELELGGNKLSGSI-PACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDL-NLSSNCFSG 330
           +L+L  N    S+ PA F  +  L  L L    L  +    +     L    L  N    
Sbjct: 84  QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA 143

Query: 331 PLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISL 390
                 R+L  L  +    N  S +       L +L+ L L  NR+    P +F DL  L
Sbjct: 144 LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRL 203

Query: 391 KSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIPRGGSFGNFSAESFKGNELLCG 450
            +L L  NNLS     +L  L  L+ L L+ N    +      +          +E+ C 
Sbjct: 204 MTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCS 263

Query: 451 SP 452
            P
Sbjct: 264 LP 265

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 68.3 bits (165), Expect = 5e-13
 Identities = 51/262 (19%), Positives = 92/262 (35%), Gaps = 11/262 (4%)

Query: 45  HNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGN 104
                + L  N++     A+      L    + +N L+   ++         ++      
Sbjct: 32  AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91

Query: 105 NFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFL 164
                 P       +L  L L+        P  F  L  L++L L DN L +   D    
Sbjct: 92  QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDD---- 147

Query: 165 SSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLT 224
            +  +  +LTH+ L  N +  +  R + G   HSL    ++   V+   P    +L  L 
Sbjct: 148 -TFRDLGNLTHLFLHGNRISSVPERAFRG--LHSLDRLLLHQNRVAHVHPHAFRDLGRLM 204

Query: 225 TIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGS 284
           T+ L  N L+      L  L+ LQ + L  N        +  L   L +     +++  S
Sbjct: 205 TLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDC-RARPLWAWLQKFRGSSSEVPCS 263

Query: 285 IPACFSNMTFLKVLSLGSNELT 306
           +P   +      +  L +N+L 
Sbjct: 264 LPQRLAG---RDLKRLAANDLQ 282

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 59.4 bits (142), Expect = 4e-10
 Identities = 45/207 (21%), Positives = 67/207 (32%), Gaps = 7/207 (3%)

Query: 1   MPSIINNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGT 60
           +    N  L S  P     +  L  L+L    LQ         L  L +L L  N L   
Sbjct: 85  LDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQAL 144

Query: 61  IPAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKL 120
                 ++  L    +  N +S         GL +L+ L L  N  +   PH   +  +L
Sbjct: 145 PDDTFRDLGNLTHLFLHGNRISSVPERAFR-GLHSLDRLLLHQNRVAHVHPHAFRDLGRL 203

Query: 121 SKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSN 180
             L L  N+ S         LR L++L L DN            +       L     S+
Sbjct: 204 MTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWA------WLQKFRGSS 257

Query: 181 NPLDGILPRTYVGNLSHSLKNFYMYNC 207
           + +   LP+   G     L    +  C
Sbjct: 258 SEVPCSLPQRLAGRDLKRLAANDLQGC 284

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.6 bits (106), Expect = 1e-05
 Identities = 31/170 (18%), Positives = 45/170 (26%), Gaps = 27/170 (15%)

Query: 286 PACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEI 345
            AC          S     L ++P+          + L  N  S       R  + L  +
Sbjct: 4   GACVCYNEPKVTTSCPQQGLQAVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTIL 61

Query: 346 DFSMNNF-------------------------SGIIPMEIGSLKNLENLFLEYNRLEGSI 380
               N                             + P     L  L  L L+   L+   
Sbjct: 62  WLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELG 121

Query: 381 PDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIPR 430
           P  F  L +L+ L L  N L      +   L  L  L L  N++     R
Sbjct: 122 PGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPER 171

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 62.8 bits (151), Expect = 3e-11
 Identities = 47/209 (22%), Positives = 74/209 (35%), Gaps = 6/209 (2%)

Query: 216 EITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELE 275
           E++ +     +      L  ++P  L K      + L  N L      ++     L +L 
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 276 LGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLE 335
           L   +   +       +  L  L L  N+L S+PL   +L  +  L++S N  +      
Sbjct: 62  LDRAE--LTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGA 119

Query: 336 IRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNL 395
           +R L  L E+    N    + P  +     LE L L  N L          L +L +L L
Sbjct: 120 LRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLL 179

Query: 396 SYNNLSGTIPVSLEKLSYLKDLNLSFNKL 424
             N+L  TIP        L    L  N  
Sbjct: 180 QENSLY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 59.0 bits (141), Expect = 5e-10
 Identities = 39/199 (19%), Positives = 60/199 (30%), Gaps = 29/199 (14%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAI 65
              LT+  P ++    +  +L+L  N L    +  +     L  L+L + +L        
Sbjct: 19  KRNLTAL-PPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGT 75

Query: 66  FNVSTLKAFAVTNNSLSGC--------------------LSSITDVGLPNLEVLYLWGNN 105
             V      +                             L      GL  L+ LYL GN 
Sbjct: 76  LPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNE 135

Query: 106 FSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLS 165
                P  +    KL KL+L  N+ +         L NL+ L L +N+L +         
Sbjct: 136 LKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYT------IPK 189

Query: 166 SLSNCKSLTHISLSNNPLD 184
                  L    L  NP  
Sbjct: 190 GFFGSHLLPFAFLHGNPWL 208

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 56.6 bits (135), Expect = 3e-09
 Identities = 39/193 (20%), Positives = 72/193 (37%), Gaps = 12/193 (6%)

Query: 134 IPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVG 193
           +P      ++   L L +N L + +L     ++L     LT ++L    L  +     + 
Sbjct: 25  LPPDLP--KDTTILHLSENLLYTFSL-----ATLMPYTRLTQLNLDRAELTKLQVDGTLP 77

Query: 194 NLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLE 253
            L     +          G       + D++      N+L       L  L +LQ++ L+
Sbjct: 78  VLGTLDLSHNQLQSLPLLGQTLPALTVLDVSF-----NRLTSLPLGALRGLGELQELYLK 132

Query: 254 YNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFW 313
            N+L+   P  +  + +L +L L  N L+       + +  L  L L  N L +IP  F+
Sbjct: 133 GNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFF 192

Query: 314 SLKDILDLNLSSN 326
               +    L  N
Sbjct: 193 GSHLLPFAFLHGN 205

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 55.9 bits (134), Expect = 5e-10
 Identities = 28/124 (22%), Positives = 46/124 (37%), Gaps = 5/124 (4%)

Query: 296 KVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGI 355
           +VL L   +LT +  +   L  +  L+LS N      P  +  L+ L  +  S N    +
Sbjct: 1   RVLHLAHKDLTVLC-HLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENV 58

Query: 356 IPMEIGSLKNLENLFLEYNRLEG-SIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYL 414
             +       L+ L L  NRL+  +          L  LNL  N+L     +       L
Sbjct: 59  DGVANL--PRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116

Query: 415 KDLN 418
             ++
Sbjct: 117 PSVS 120

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 46.6 bits (110), Expect = 9e-07
 Identities = 27/114 (23%), Positives = 45/114 (39%), Gaps = 13/114 (11%)

Query: 147 LTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYN 206
           L L   +LT        L  L     +TH+ LS+N L  + P      L+       +  
Sbjct: 3   LHLAHKDLTV-------LCHLEQLLLVTHLDLSHNRLRALPP-----ALAALRCLEVLQA 50

Query: 207 CNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPI-TLGKLQKLQDVDLEYNQLEG 259
            + +    + + NL  L  ++L  N+L  S  I  L    +L  ++L+ N L  
Sbjct: 51  SDNALENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 46.2 bits (109), Expect = 9e-07
 Identities = 21/118 (17%), Positives = 37/118 (31%), Gaps = 6/118 (5%)

Query: 274 LELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLP 333
           L L    L+  +      +  +  L L  N L ++P    +L+ +  L  S N       
Sbjct: 3   LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDG 60

Query: 334 LEIRNLKALIEIDFSMNNFSGIIPME-IGSLKNLENLFLEYNRLEGSIPDSFGDLISL 390
           +         E+    N       ++ + S   L  L L+ N L          L  +
Sbjct: 61  VANLPRL--QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 45.1 bits (106), Expect = 2e-06
 Identities = 28/108 (25%), Positives = 43/108 (39%), Gaps = 6/108 (5%)

Query: 321 LNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSI 380
           L+L+    +    LE   L  +  +D S N    + P  + +L+ LE   L+ +      
Sbjct: 3   LHLAHKDLTVLCHLE--QLLLVTHLDLSHNRLRALPP-ALAALRCLE--VLQASDNALEN 57

Query: 381 PDSFGDLISLKSLNLSYNNLSGTIPV-SLEKLSYLKDLNLSFNKLKGE 427
            D   +L  L+ L L  N L  +  +  L     L  LNL  N L  E
Sbjct: 58  VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 44.7 bits (105), Expect = 3e-06
 Identities = 24/108 (22%), Positives = 40/108 (37%), Gaps = 4/108 (3%)

Query: 213 IPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELY 272
           +   +  L  +T + L  N+L    P  L  L+ L+ +    N       D +     L 
Sbjct: 12  VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNA--LENVDGVANLPRLQ 68

Query: 273 ELELGGNKL-SGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDIL 319
           EL L  N+L   +      +   L +L+L  N L         L ++L
Sbjct: 69  ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 44.7 bits (105), Expect = 4e-06
 Identities = 28/151 (18%), Positives = 48/151 (31%), Gaps = 30/151 (19%)

Query: 24  KVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLSG 83
           +VL+L +  L   ++  +  L  +  LDLS N+L    P     ++ L+   V   S + 
Sbjct: 1   RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP----ALAALRCLEVLQASDNA 54

Query: 84  CLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRN 143
             +      LP L+ L L  N    +                              +   
Sbjct: 55  LENVDGVANLPRLQELLLCNNRLQQSAA-----------------------IQPLVSCPR 91

Query: 144 LEWLTLYDNNLTS-STLDLSFLSSLSNCKSL 173
           L  L L  N+L     +       L +  S+
Sbjct: 92  LVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 42.4 bits (99), Expect = 2e-05
 Identities = 23/119 (19%), Positives = 40/119 (33%), Gaps = 12/119 (10%)

Query: 85  LSSITDVG-LPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALE-MNSFSGFIPSTFGNLR 142
           L+ +  +  L  +  L L  N      P      + L  L +   +  +        NL 
Sbjct: 10  LTVLCHLEQLLLVTHLDLSHNRLRALPPAL----AALRCLEVLQASDNALENVDGVANLP 65

Query: 143 NLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKN 201
            L+ L L +N L       + +  L +C  L  ++L  N L           L+  L +
Sbjct: 66  RLQELLLCNNRLQQ----SAAIQPLVSCPRLVLLNLQGNSLCQE--EGIQERLAEMLPS 118

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 39.7 bits (92), Expect = 2e-04
 Identities = 23/97 (23%), Positives = 38/97 (39%), Gaps = 3/97 (3%)

Query: 12  TTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTL 71
           T    ++ +  +  L L +NRL+  +   +  L  L  L  S N         + N+  L
Sbjct: 11  TVLCHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNA--LENVDGVANLPRL 67

Query: 72  KAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSG 108
           +   + NN L    +    V  P L +L L GN+   
Sbjct: 68  QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 55.6 bits (132), Expect = 1e-08
 Identities = 56/326 (17%), Positives = 101/326 (30%), Gaps = 19/326 (5%)

Query: 95  NLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLR--NLEWLTLYDN 152
               L L     S ++P    +   L  L    NS +  +P    +L+   ++   L   
Sbjct: 39  QAHELELNNLGLS-SLPELPPH---LESLVASCNSLTE-LPELPQSLKSLLVDNNNLKAL 93

Query: 153 NLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGG 212
           +     L+   +S+    K     + S   +  +   +            ++   N    
Sbjct: 94  SDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLE 153

Query: 213 IPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELY 272
              E+ NL  LT I    N L     + L     +   ++     E      +       
Sbjct: 154 ELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADN 213

Query: 273 ELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWS---LKDILDLNLSSNCFS 329
            L      L  S+ A      +L  L      LT + ++      L ++       N  S
Sbjct: 214 NLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASS 273

Query: 330 GPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLIS 389
             +        +L E++ S N    +          LE L   +N L   +P+      +
Sbjct: 274 NEIRSLCDLPPSLEELNVSNNKLIELPA----LPPRLERLIASFNHLA-EVPELPQ---N 325

Query: 390 LKSLNLSYNNLSGTIPVSLEKLSYLK 415
           LK L++ YN L    P   E +  L+
Sbjct: 326 LKQLHVEYNPLR-EFPDIPESVEDLR 350

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 53.7 bits (127), Expect = 4e-08
 Identities = 50/320 (15%), Positives = 96/320 (30%), Gaps = 17/320 (5%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAI 65
           N  L+S      +   +L+ L    N L  E+      L +L   + +   L    P   
Sbjct: 47  NLGLSSLP----ELPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLE 101

Query: 66  FNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLAL 125
           +   +           +     I DV   +L+ L     +                   L
Sbjct: 102 YLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNL 161

Query: 126 EMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSS---TLDLSFLSSLSNCKSLTHISLSNNP 182
              +      ++   L +L           +      +L  L  L+   +  ++  +   
Sbjct: 162 PFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLKTLPD 221

Query: 183 LDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLG 242
           L   L    V +   +       +           + L++L   +   N  +  I     
Sbjct: 222 LPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCD 281

Query: 243 KLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGS 302
               L+++++  N+L   +P        L  L    N L+  +P    N   LK L +  
Sbjct: 282 LPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVPELPQN---LKQLHVEY 333

Query: 303 NELTSIPLNFWSLKDILDLN 322
           N L   P    S++D L +N
Sbjct: 334 NPLREFPDIPESVED-LRMN 352

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 51.0 bits (120), Expect = 3e-07
 Identities = 23/83 (27%), Positives = 38/83 (45%), Gaps = 9/83 (10%)

Query: 347 FSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPV 406
           + +N  S  I        +LE L +  N+L   +P        L+ L  S+N+L+  +P 
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVP- 320

Query: 407 SLEKLSYLKDLNLSFNKLKGEIP 429
             E    LK L++ +N L+ E P
Sbjct: 321 --ELPQNLKQLHVEYNPLR-EFP 340

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 39.8 bits (91), Expect = 0.001
 Identities = 20/102 (19%), Positives = 34/102 (33%), Gaps = 15/102 (14%)

Query: 1   MPSIINNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGT 60
                 N  ++      D   +L+ L + NN+L  E+      L     L  S N  L  
Sbjct: 264 PNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLER---LIASFNH-LAE 318

Query: 61  IPAAIFNVSTLKAFAVTNNSLSGC-LSSITDVGLPNLEVLYL 101
           +P    N+  L         +    L    D+   ++E L +
Sbjct: 319 VPELPQNLKQL--------HVEYNPLREFPDI-PESVEDLRM 351

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 38.7 bits (88), Expect = 0.003
 Identities = 23/69 (33%), Positives = 32/69 (46%), Gaps = 6/69 (8%)

Query: 266 CLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLK--DILDLNL 323
           CL  + +ELEL    LS S+P    +   L+ L    N LT +P    SLK   + + NL
Sbjct: 35  CLDRQAHELELNNLGLS-SLPELPPH---LESLVASCNSLTELPELPQSLKSLLVDNNNL 90

Query: 324 SSNCFSGPL 332
            +     PL
Sbjct: 91  KALSDLPPL 99

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 37.9 bits (86), Expect = 0.004
 Identities = 18/60 (30%), Positives = 23/60 (38%), Gaps = 5/60 (8%)

Query: 370 FLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIP 429
               N     I        SL+ LN+S N L   +P    +L     L  SFN L  E+P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLER---LIASFNHLA-EVP 320

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 51.6 bits (122), Expect = 8e-08
 Identities = 27/221 (12%), Positives = 73/221 (33%), Gaps = 24/221 (10%)

Query: 116 NASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTH 175
             +   K+A   ++ +  +  T  +L  +  L+ +   +T+       +  +    +L  
Sbjct: 17  ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-------IEGVQYLNNLIG 67

Query: 176 ISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKL-- 233
           + L +N +  + P   +  ++    +        +    + I  L   +T +     L  
Sbjct: 68  LELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAG 127

Query: 234 ----------NGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSG 283
                        I              L     + S    +    +L  L+   NK+S 
Sbjct: 128 LSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD 187

Query: 284 SIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLS 324
             P   +++  L  + L +N+++ +     +  ++  + L+
Sbjct: 188 ISP--LASLPNLIEVHLKNNQISDVS-PLANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 49.3 bits (116), Expect = 5e-07
 Identities = 44/227 (19%), Positives = 80/227 (35%), Gaps = 18/227 (7%)

Query: 194 NLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLE 253
            L++++K       NV+  + +   +L  +TT+   G  +  +I   +  L  L  ++L+
Sbjct: 17  ALANAIKI-AAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELK 71

Query: 254 YNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFW 313
            NQ+    P      +   EL     K   +I    S  T         +   +      
Sbjct: 72  DNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLT-----STQITDVTPLA 126

Query: 314 SLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEY 373
            L ++  L L  N  +   PL             S+ N        + +L  L  L  + 
Sbjct: 127 GLSNLQVLYLDLNQITNISPLAGLT----NLQYLSIGNAQVSDLTPLANLSKLTTLKADD 182

Query: 374 NRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLS 420
           N++    P     L +L  ++L  N +S   P  L   S L  + L+
Sbjct: 183 NKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 45.4 bits (106), Expect = 1e-05
 Identities = 34/205 (16%), Positives = 67/205 (32%), Gaps = 24/205 (11%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKL-------- 57
            + +T T  +   ++  +  L  +   +    I  + +L+NL  L+L  N++        
Sbjct: 28  KSNVTDTVTQA--DLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELKDNQITDLAPLKN 83

Query: 58  -----LGTIPAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPH 112
                   +        +  A   +  +L    + ITDV                  I +
Sbjct: 84  LTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITN 143

Query: 113 FIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKS 172
               A   +   L + +      +   NL  L  L   DN ++        +S L++  +
Sbjct: 144 ISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD-------ISPLASLPN 196

Query: 173 LTHISLSNNPLDGILPRTYVGNLSH 197
           L  + L NN +  + P     NL  
Sbjct: 197 LIEVHLKNNQISDVSPLANTSNLFI 221

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.9 bits (89), Expect = 0.001
 Identities = 39/253 (15%), Positives = 78/253 (30%), Gaps = 41/253 (16%)

Query: 62  PAAIFNVSTLKAFA-VTNNSLSGC--LSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNAS 118
           P AI  +    A A     +        ++T   L  +  L  +G   +           
Sbjct: 6   PTAINVIFPDPALANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVT----------- 54

Query: 119 KLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISL 178
                     +  G        L NL  L L DN +T      +         S   +  
Sbjct: 55  ----------TIEG-----VQYLNNLIGLELKDNQITDLAPLKNLTKITELELSGNPLKN 99

Query: 179 SNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNG--- 235
            +        +T     +       +   +    +  ++  +T+++ +    N       
Sbjct: 100 VSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIG 159

Query: 236 ----SIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSN 291
               S    L  L KL  +  + N++    P  +     L E+ L  N++S   P   +N
Sbjct: 160 NAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LAN 215

Query: 292 MTFLKVLSLGSNE 304
            + L +++L +N+
Sbjct: 216 TSNLFIVTL-TNQ 227

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.1 bits (87), Expect = 0.002
 Identities = 32/212 (15%), Positives = 72/212 (33%), Gaps = 17/212 (8%)

Query: 219 NLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGG 278
            L +   I  G + +     +T   L  +  +      +  +I     L+  L  LEL  
Sbjct: 17  ALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TIEGVQYLN-NLIGLELKD 72

Query: 279 NKL-SGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIR 337
           N++   +     + +T L++       +++I          L     ++         ++
Sbjct: 73  NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132

Query: 338 NLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSY 397
            L   +    +++  +G+  ++  S              + S      +L  L +L    
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLS----------IGNAQVSDLTPLANLSKLTTLKADD 182

Query: 398 NNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIP 429
           N +S   P  L  L  L +++L  N++    P
Sbjct: 183 NKISDISP--LASLPNLIEVHLKNNQISDVSP 212

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.4 bits (124), Expect = 8e-08
 Identities = 38/282 (13%), Positives = 84/282 (29%), Gaps = 31/282 (10%)

Query: 14  PKEIDNISNLKVLYLYNNRL-QGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLK 72
           P     + +  V+     R    + + E      +  +DLS + +  +    I +     
Sbjct: 14  PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILS----- 68

Query: 73  AFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALE--MNSF 130
                                  L+ L L G   S  I + +   S L +L L       
Sbjct: 69  -------------------QCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFS 109

Query: 131 SGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRT 190
              + +   +   L+ L L      +       ++ +S   +  ++S     L      T
Sbjct: 110 EFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLST 169

Query: 191 YVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGG-NKLNGSIPITLGKLQKLQD 249
            V    + +      +  +     +E   L  L  + L     +     + LG++  L+ 
Sbjct: 170 LVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKT 229

Query: 250 VDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSN 291
           + +     +G++     L   L  L++  +  +        N
Sbjct: 230 LQVFGIVPDGTLQL---LKEALPHLQINCSHFTTIARPTIGN 268

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.8 bits (112), Expect = 2e-06
 Identities = 44/254 (17%), Positives = 90/254 (35%), Gaps = 16/254 (6%)

Query: 174 THISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKL 233
             + L+   L    P      LS  +  F      +   + E  +    +  + L  + +
Sbjct: 3   QTLDLTGKNL---HPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVI 58

Query: 234 NG-SIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGG--NKLSGSIPACFS 290
              ++   L +  KLQ++ LE  +L   I +++  +  L  L L G       ++    S
Sbjct: 59  EVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLS 118

Query: 291 NMTFLKVLSLGSNELTSIPLNFWSLKDILD-------LNLSSNCFSGPLPLEIRNLKALI 343
           + + L  L+L      +      ++  + +            N     L   +R    L+
Sbjct: 119 SCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLV 178

Query: 344 EIDFSMN-NFSGIIPMEIGSLKNLENLFLEY-NRLEGSIPDSFGDLISLKSLNLSYNNLS 401
            +D S +         E   L  L++L L     +        G++ +LK+L +      
Sbjct: 179 HLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPD 238

Query: 402 GTIPVSLEKLSYLK 415
           GT+ +  E L +L+
Sbjct: 239 GTLQLLKEALPHLQ 252

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.3 bits (108), Expect = 8e-06
 Identities = 36/285 (12%), Positives = 84/285 (29%), Gaps = 31/285 (10%)

Query: 129 SFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILP 188
           +     P   G L +   +         S +D       S  + + H+ LSN+ ++    
Sbjct: 8   TGKNLHPDVTGRLLSQGVIAF---RCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVSTL 63

Query: 189 RTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTI--VLGGNKLNGSIPITLGKLQK 246
              +   S  L+N  +    +S  I   +   ++L  +           ++   L    +
Sbjct: 64  HGILSQCSK-LQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR 122

Query: 247 LQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELT 306
           L +++L +          +                   +      +T L +     N   
Sbjct: 123 LDELNLSWCFDFTEKHVQVA------------------VAHVSETITQLNLSGYRKNLQK 164

Query: 307 SIPLNFWSLKDILDLNLSSNC--FSGPLPLEIRNLKALIEIDFS-MNNFSGIIPMEIGSL 363
           S           L     S+          E   L  L  +  S   +      +E+G +
Sbjct: 165 SDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEI 224

Query: 364 KNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSL 408
             L+ L +     +G++        +L  L ++ ++ +     ++
Sbjct: 225 PTLKTLQVFGIVPDGTLQLLKE---ALPHLQINCSHFTTIARPTI 266

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.6 bits (96), Expect = 3e-04
 Identities = 33/222 (14%), Positives = 63/222 (28%), Gaps = 17/222 (7%)

Query: 6   NNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAA- 64
           +    ST    +   S L+ L L   RL   I++ +    NL  L+LS            
Sbjct: 56  SVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQT 115

Query: 65  -------IFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNA 117
                  +  ++    F  T   +   ++ +++         Y      S          
Sbjct: 116 LLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCP 175

Query: 118 SKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHIS 177
           + +     +           F  L  L+ L+L         +    L  L    +L  + 
Sbjct: 176 NLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCY----DIIPETLLELGEIPTLKTLQ 231

Query: 178 LSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITN 219
           +     DG L       L  +L +  +   + +      I N
Sbjct: 232 VFGIVPDGTLQL-----LKEALPHLQINCSHFTTIARPTIGN 268

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.7 bits (115), Expect = 3e-07
 Identities = 31/155 (20%), Positives = 58/155 (37%), Gaps = 5/155 (3%)

Query: 275 ELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPL 334
           EL   ++   +    S        +L    L S P +  +    + LN  S+  +  L +
Sbjct: 3   ELKPEQVE-QLKLIMSKRYDGSQQALDLKGLRSDP-DLVAQNIDVVLNRRSSMAAT-LRI 59

Query: 335 EIRNLKALIEIDFSMNNFSGI--IPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKS 392
              N+  L+ ++ S N    +  +   +    NL+ L L  N L+          + L+ 
Sbjct: 60  IEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEE 119

Query: 393 LNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGE 427
           L L  N+LS T       +S +++      +L G 
Sbjct: 120 LWLDGNSLSDTFRDQSTYISAIRERFPKLLRLDGH 154

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.3 bits (109), Expect = 2e-06
 Identities = 24/137 (17%), Positives = 51/137 (37%), Gaps = 5/137 (3%)

Query: 251 DLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPL 310
           +L+  Q+E  +   +    +  +  L    L               VL+  S+   ++ +
Sbjct: 3   ELKPEQVE-QLKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRRSSMAATLRI 59

Query: 311 NFWSLKDILDLNLSSNCFSG--PLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLEN 368
              ++ ++L LNLS+N       +   ++    L  ++ S N       ++      LE 
Sbjct: 60  IEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEE 119

Query: 369 LFLEYNRLEGSIPDSFG 385
           L+L+ N L  +  D   
Sbjct: 120 LWLDGNSLSDTFRDQST 136

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.0 bits (103), Expect = 1e-05
 Identities = 28/155 (18%), Positives = 52/155 (33%), Gaps = 5/155 (3%)

Query: 300 LGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPME 359
           L   ++  + L      D     L           ++      + ++   ++ +  + + 
Sbjct: 4   LKPEQVEQLKLIMSKRYDGSQQALDLKGL--RSDPDLVAQNIDVVLNRR-SSMAATLRII 60

Query: 360 IGSLKNLENLFLEYNRLEG--SIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDL 417
             ++  L +L L  NRL     +        +LK LNLS N L     +   K   L++L
Sbjct: 61  EENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEEL 120

Query: 418 NLSFNKLKGEIPRGGSFGNFSAESFKGNELLCGSP 452
            L  N L        ++ +   E F     L G  
Sbjct: 121 WLDGNSLSDTFRDQSTYISAIRERFPKLLRLDGHE 155

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 47.9 bits (112), Expect = 1e-06
 Identities = 38/158 (24%), Positives = 61/158 (38%), Gaps = 3/158 (1%)

Query: 296 KVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIR-NLKALIEIDFSMNNFSG 354
             +      L  IP +        +L L+ N         +   L  L++++   N  +G
Sbjct: 11  TTVDCTGRGLKEIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTG 68

Query: 355 IIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYL 414
           I P       +++ L L  N+++      F  L  LK+LNL  N +S  +P S E L+ L
Sbjct: 69  IEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSL 128

Query: 415 KDLNLSFNKLKGEIPRGGSFGNFSAESFKGNELLCGSP 452
             LNL+ N                 +S  G    CG+P
Sbjct: 129 TSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP 166

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 41.3 bits (95), Expect = 2e-04
 Identities = 34/181 (18%), Positives = 63/181 (34%), Gaps = 28/181 (15%)

Query: 172 SLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGN 231
             T + L++N L  I      G L H L    +    ++G  P      + +  + LG N
Sbjct: 30  HTTELLLNDNELGRISSDGLFGRLPH-LVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88

Query: 232 KLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSN 291
           K+          L +L+ ++L  NQ+   +P S                        F +
Sbjct: 89  KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGS------------------------FEH 124

Query: 292 MTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNN 351
           +  L  L+L SN         W  + +   +L+        P ++R+++     D   + 
Sbjct: 125 LNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSKVRDVQIK---DLPHSE 181

Query: 352 F 352
           F
Sbjct: 182 F 182

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 39.8 bits (91), Expect = 4e-04
 Identities = 36/174 (20%), Positives = 72/174 (41%), Gaps = 6/174 (3%)

Query: 213 IPEEITNLTDLTTIVLGGNKLNGSIPITL-GKLQKLQDVDLEYNQLEGSIPDSICLSVEL 271
           IP +I      T ++L  N+L       L G+L  L  ++L+ NQL G  P++   +  +
Sbjct: 23  IPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHI 80

Query: 272 YELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGP 331
            EL+LG NK+       F  +  LK L+L  N+++ +    +   + L     ++     
Sbjct: 81  QELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC 140

Query: 332 LPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFG 385
                   + L +   +        P     +++++   L ++  + S  +S G
Sbjct: 141 NCHLAWFAEWLRKKSLNGGAARCGAP---SKVRDVQIKDLPHSEFKCSSENSEG 191

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 45.8 bits (107), Expect = 5e-06
 Identities = 38/203 (18%), Positives = 69/203 (33%), Gaps = 15/203 (7%)

Query: 218 TNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELG 277
               +     L    +     +T  +L  +  +    + ++      I     + +L L 
Sbjct: 21  DAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLN 76

Query: 278 GNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIR 337
           GNKL+         +  LK L     +   +             +LS           + 
Sbjct: 77  GNKLTD-----IKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLV 131

Query: 338 NLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSY 397
           +L  L  +    N  + I  +    L  L+ L LE N++   +P     L  L++L LS 
Sbjct: 132 HLPQLESLYLGNNKITDITVLSR--LTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSK 187

Query: 398 NNLSGTIPVSLEKLSYLKDLNLS 420
           N++S  +  +L  L  L  L L 
Sbjct: 188 NHIS-DLR-ALAGLKNLDVLELF 208

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 44.6 bits (104), Expect = 1e-05
 Identities = 32/210 (15%), Positives = 72/210 (34%), Gaps = 22/210 (10%)

Query: 116 NASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTH 175
             ++  K  L+  S +  +      L +++ +   ++++ S       +  +    ++T 
Sbjct: 22  AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS-------VQGIQYLPNVTK 72

Query: 176 ISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNG 235
           + L+ N L  I            L N              +  +       +   +  + 
Sbjct: 73  LFLNGNKLTDI----------KPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHN 122

Query: 236 SIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFL 295
            I    G +   Q   L     + +    +    +L  L L  N++S  +P   + +T L
Sbjct: 123 GISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKL 180

Query: 296 KVLSLGSNELTSIPLNFWSLKDILDLNLSS 325
           + L L  N ++ +      LK++  L L S
Sbjct: 181 QNLYLSKNHISDLR-ALAGLKNLDVLELFS 209

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 37.3 bits (85), Expect = 0.004
 Identities = 24/202 (11%), Positives = 62/202 (30%), Gaps = 18/202 (8%)

Query: 10  TSTTPKEIDNI------SNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPA 63
           T T P  I  I      +      L    +   +      L+++  +  + + +      
Sbjct: 7   TITVPTPIKQIFSDDAFAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDI--KSVQ 62

Query: 64  AIFNVSTLKAFAVTNNSLSGC--LSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLS 121
            I  +  +    +  N L+    L+++ ++G   L+   +   +    +      + + +
Sbjct: 63  GIQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHN 122

Query: 122 KLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLD------LSFLSSLSNCKSLTH 175
            ++            +     N        + LT           +S +  L+    L +
Sbjct: 123 GISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQN 182

Query: 176 ISLSNNPLDGILPRTYVGNLSH 197
           + LS N +  +     + NL  
Sbjct: 183 LYLSKNHISDLRALAGLKNLDV 204

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 46.8 bits (109), Expect = 7e-06
 Identities = 38/304 (12%), Positives = 84/304 (27%), Gaps = 19/304 (6%)

Query: 134 IPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILP----- 188
           + +      +++ + L  N + +         ++++ K L     S+     +       
Sbjct: 23  VFAVLLEDDSVKEIVLSGNTIGTEAAR-WLSENIASKKDLEIAEFSDIFTGRVKDEIPEA 81

Query: 189 RTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQ 248
              +          +    + +   P     L D  +     +     + +    L    
Sbjct: 82  LRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSK----HTPLEHLYLHNNGLGPQA 137

Query: 249 DVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSI 308
              +     E ++      +  L  +  G N+L       ++        S        +
Sbjct: 138 GAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQ----SHRLLHTVKM 193

Query: 309 PLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLEN 368
             N    + I  L L    +   L +          +  S    +      +  L   + 
Sbjct: 194 VQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDC 253

Query: 369 LFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSL-----EKLSYLKDLNLSFNK 423
           L             S  + I L++L L YN +      +L     EK+  L  L L+ N+
Sbjct: 254 LLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNR 313

Query: 424 LKGE 427
              E
Sbjct: 314 FSEE 317

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 44.1 bits (102), Expect = 4e-05
 Identities = 34/329 (10%), Positives = 83/329 (25%), Gaps = 26/329 (7%)

Query: 22  NLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKL----LGTIPAAIFNVSTLKAFAVT 77
           +LK+  +     +  +   +    ++  + LS N +       +   I +   L+    +
Sbjct: 9   SLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 67

Query: 78  NNSLSGCLSSITD---------VGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMN 128
           +         I +         +  P L  + L  N F  T    + +          + 
Sbjct: 68  DIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLY 127

Query: 129 SFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILP 188
             +  +    G         L  N    +   L  +    N      +            
Sbjct: 128 LHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKT-FQSHR 186

Query: 189 RTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQ 248
             +   +  +          +  G+                 +  + ++ I L     L+
Sbjct: 187 LLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLR 246

Query: 249 DVDLEYNQLEGSIPDSI------CLSVELYELELGGNKLSGSIP-----ACFSNMTFLKV 297
           ++ L    L      ++        ++ L  L L  N++               M  L  
Sbjct: 247 ELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLF 306

Query: 298 LSLGSNELTSIPLNFWSLKDILDLNLSSN 326
           L L  N  +        ++++        
Sbjct: 307 LELNGNRFSEEDDVVDEIREVFSTRGRGE 335

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.9 bits (109), Expect = 7e-06
 Identities = 13/71 (18%), Positives = 27/71 (38%), Gaps = 5/71 (7%)

Query: 365 NLENLFLEYNRL-EGSIPDSFGDLISLKSLNLSYNNLSG----TIPVSLEKLSYLKDLNL 419
           ++++L ++   L +    +    L   + + L    L+      I  +L     L +LNL
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 420 SFNKLKGEIPR 430
             N+L      
Sbjct: 63  RSNELGDVGVH 73

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.1 bits (107), Expect = 1e-05
 Identities = 19/91 (20%), Positives = 34/91 (37%), Gaps = 4/91 (4%)

Query: 133 FIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYV 192
                      L  L L D +++ S+   S  ++L    SL  + LSNN L        V
Sbjct: 360 LCQGLGQPGSVLRVLWLADCDVSDSSCS-SLAATLLANHSLRELDLSNNCLGDAGILQLV 418

Query: 193 GNLSHS---LKNFYMYNCNVSGGIPEEITNL 220
            ++      L+   +Y+   S  + + +  L
Sbjct: 419 ESVRQPGCLLEQLVLYDIYWSEEMEDRLQAL 449

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.1 bits (107), Expect = 1e-05
 Identities = 15/89 (16%), Positives = 28/89 (31%), Gaps = 10/89 (11%)

Query: 342 LIEIDFSMNNFSGIIPMEI-GSLKNLENLFLEYNRLEG----SIPDSFGDLISLKSLNLS 396
           +  +D      S     E+   L+  + + L+   L       I  +     +L  LNL 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 397 YNNLSGTIPVSL-----EKLSYLKDLNLS 420
            N L       +          ++ L+L 
Sbjct: 64  SNELGDVGVHCVLQGLQTPSCKIQKLSLQ 92

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.0 bits (104), Expect = 3e-05
 Identities = 16/93 (17%), Positives = 33/93 (35%), Gaps = 5/93 (5%)

Query: 120 LSKLALEMNSFSGF-IPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISL 178
           +  L ++    S          L+  + + L D  LT +       S+L    +L  ++L
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCK-DISSALRVNPALAELNL 62

Query: 179 SNNPLDGILPRTYVGNLSH---SLKNFYMYNCN 208
            +N L  +     +  L      ++   + NC 
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.0 bits (104), Expect = 3e-05
 Identities = 16/76 (21%), Positives = 26/76 (34%), Gaps = 9/76 (11%)

Query: 364 KNLENLFLEYNRLEG----SIPDSFGDLISLKSLNLSYNNLSGTIPVSL-----EKLSYL 414
             L  L+L    +      S+  +     SL+ L+LS N L     + L     +    L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428

Query: 415 KDLNLSFNKLKGEIPR 430
           + L L       E+  
Sbjct: 429 EQLVLYDIYWSEEMED 444

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.2 bits (102), Expect = 5e-05
 Identities = 13/84 (15%), Positives = 26/84 (30%), Gaps = 9/84 (10%)

Query: 337 RNLKALIEIDFSMNNFSGIIPMEIGS----LKNLENLFLEYNRLEGSIPDSFGDLI---- 388
           +    L  +  +  + S      + +      +L  L L  N L  +      + +    
Sbjct: 366 QPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPG 425

Query: 389 -SLKSLNLSYNNLSGTIPVSLEKL 411
             L+ L L     S  +   L+ L
Sbjct: 426 CLLEQLVLYDIYWSEEMEDRLQAL 449

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.8 bits (101), Expect = 6e-05
 Identities = 13/92 (14%), Positives = 26/92 (28%), Gaps = 5/92 (5%)

Query: 95  NLEVLYLWGNNFSGT-IPHFIFNASKLSKLALEMNSFSG----FIPSTFGNLRNLEWLTL 149
           +++ L +     S       +    +   + L+    +      I S       L  L L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 150 YDNNLTSSTLDLSFLSSLSNCKSLTHISLSNN 181
             N L    +        +    +  +SL N 
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.8 bits (101), Expect = 6e-05
 Identities = 13/91 (14%), Positives = 23/91 (25%), Gaps = 5/91 (5%)

Query: 317 DILDLNLSSNCFS-GPLPLEIRNLKALIEIDFSMNNFSGI----IPMEIGSLKNLENLFL 371
           DI  L++     S       +  L+    +       +      I   +     L  L L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 372 EYNRLEGSIPDSFGDLISLKSLNLSYNNLSG 402
             N L           +   S  +   +L  
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.3 bits (97), Expect = 2e-04
 Identities = 14/92 (15%), Positives = 23/92 (25%), Gaps = 4/92 (4%)

Query: 102 WGNNFSGTIPHFIFNASKLSKLALEMNSFSG----FIPSTFGNLRNLEWLTLYDNNLTSS 157
                           S L  L L     S      + +T     +L  L L +N L  +
Sbjct: 353 EDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDA 412

Query: 158 TLDLSFLSSLSNCKSLTHISLSNNPLDGILPR 189
            +     S       L  + L +      +  
Sbjct: 413 GILQLVESVRQPGCLLEQLVLYDIYWSEEMED 444

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.9 bits (96), Expect = 3e-04
 Identities = 14/89 (15%), Positives = 35/89 (39%), Gaps = 10/89 (11%)

Query: 286 PACFSNMTFLKVLSLGSNELT-----SIPLNFWSLKDILDLNLSSNCFSGPLPLEI---- 336
                  + L+VL L   +++     S+     +   + +L+LS+NC      L++    
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421

Query: 337 -RNLKALIEIDFSMNNFSGIIPMEIGSLK 364
            +    L ++      +S  +   + +L+
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQALE 450

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.3 bits (92), Expect = 8e-04
 Identities = 15/113 (13%), Positives = 26/113 (23%), Gaps = 22/113 (19%)

Query: 22  NLKVLYLYNNRLQGEIIHEI-GHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNS 80
           +++ L +    L      E+   L     + L    L       I +             
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSA------------ 50

Query: 81  LSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGF 133
           L            P L  L L  N       H +    +     ++  S    
Sbjct: 51  LRVN---------PALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.8 bits (88), Expect = 0.002
 Identities = 19/97 (19%), Positives = 35/97 (36%), Gaps = 5/97 (5%)

Query: 222 DLTTIVLGGNKLNGS-IPITLGKLQKLQDVDLEYNQLEG----SIPDSICLSVELYELEL 276
           D+ ++ +   +L+ +     L  LQ+ Q V L+   L       I  ++ ++  L EL L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 277 GGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFW 313
             N+L      C           +    L +  L   
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGA 99

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.8 bits (88), Expect = 0.002
 Identities = 22/112 (19%), Positives = 39/112 (34%), Gaps = 13/112 (11%)

Query: 201 NFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNG----SIPITLGKLQKLQDVDLEYNQ 256
           N  + +  V           + L  + L    ++     S+  TL     L+++DL  N 
Sbjct: 349 NNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNC 408

Query: 257 LEGSIPDSICLSVE-----LYELELGGNKLSGSIP----ACFSNMTFLKVLS 299
           L  +    +  SV      L +L L     S  +     A   +   L+V+S
Sbjct: 409 LGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.8 bits (88), Expect = 0.003
 Identities = 19/100 (19%), Positives = 31/100 (31%), Gaps = 24/100 (24%)

Query: 19  NISNLKVLYLYNNRLQGEIIHEIG----HLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAF 74
             S L+VL+L +  +       +       H+L  LDLS N L       +         
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVE------- 419

Query: 75  AVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFI 114
           +V                   LE L L+   +S  +   +
Sbjct: 420 SVRQPG-------------CLLEQLVLYDIYWSEEMEDRL 446

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.4 bits (87), Expect = 0.003
 Identities = 12/117 (10%), Positives = 31/117 (26%), Gaps = 26/117 (22%)

Query: 143 NLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNF 202
           +++ L +    L+    D  +   L   +    + L +  L     +             
Sbjct: 3   DIQSLDIQCEELS----DARWAELLPLLQQCQVVRLDDCGLTEARCKD------------ 46

Query: 203 YMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEG 259
                     I   +     L  + L  N+L       + +  +     ++   L+ 
Sbjct: 47  ----------ISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.0 bits (86), Expect = 0.004
 Identities = 14/75 (18%), Positives = 27/75 (36%), Gaps = 6/75 (8%)

Query: 268 SVELYELELGGNKLSGS-IPACFSNMTFLKVLSLGSNELT-----SIPLNFWSLKDILDL 321
           S+++  L++   +LS +        +   +V+ L    LT      I         + +L
Sbjct: 1   SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60

Query: 322 NLSSNCFSGPLPLEI 336
           NL SN         +
Sbjct: 61  NLRSNELGDVGVHCV 75

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.3 bits (105), Expect = 1e-05
 Identities = 27/216 (12%), Positives = 57/216 (26%), Gaps = 7/216 (3%)

Query: 213 IPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELY 272
           IP ++    +   +     KL             L+ +++  N +   I   +  ++   
Sbjct: 23  IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL 80

Query: 273 ELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDI-----LDLNLSSNC 327
                    +       +      +  L  +      L             LD+  + N 
Sbjct: 81  HEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINI 140

Query: 328 FSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDL 387
            +      +      + +  + N    I        +  E    + N LE    D F   
Sbjct: 141 HTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGA 200

Query: 388 ISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNK 423
                L++S   +       LE L  L+  +    K
Sbjct: 201 SGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.7 bits (101), Expect = 4e-05
 Identities = 14/89 (15%), Positives = 25/89 (28%), Gaps = 4/89 (4%)

Query: 321 LNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSI 380
           L L+ N             +         NN   +             L +   R+    
Sbjct: 158 LWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLP 217

Query: 381 PDSFGDLISLKSLNLSYNNLSGTIPVSLE 409
                +L  L++ +    NL   +P +LE
Sbjct: 218 SYGLENLKKLRARST--YNLK-KLP-TLE 242

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.4 bits (100), Expect = 5e-05
 Identities = 27/225 (12%), Positives = 60/225 (26%), Gaps = 5/225 (2%)

Query: 85  LSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNL 144
           ++ I      N   L                    L K+ +  N     I +   +    
Sbjct: 20  VTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 79

Query: 145 EWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYM 204
                      ++ L      +  N  +L ++ +SN  +  +     + +L   L +   
Sbjct: 80  LH---EIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQD 136

Query: 205 YNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDS 264
                +      +    +   + L  N +           Q  +    + N LE    D 
Sbjct: 137 NINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDV 196

Query: 265 ICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIP 309
              +     L++   ++         N+  L+  S     L  +P
Sbjct: 197 FHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLKKLP 239

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 42.0 bits (97), Expect = 1e-04
 Identities = 35/179 (19%), Positives = 59/179 (32%), Gaps = 27/179 (15%)

Query: 12  TTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIP--------- 62
           T      ++  +  L      ++   I  + +L+NL  ++ S N+L    P         
Sbjct: 31  TDTVSQTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQLTDITPLKNLTKLVD 88

Query: 63  --------AAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFI 114
                   A I  ++ L          +          L NL  L L  N  S       
Sbjct: 89  ILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSG 148

Query: 115 FNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSL 173
             + +        N  +   P    NL  LE L +  N ++    D+S L+ L+N +SL
Sbjct: 149 LTSLQQLNF--SSNQVTDLKP--LANLTTLERLDISSNKVS----DISVLAKLTNLESL 199

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.4 bits (93), Expect = 3e-04
 Identities = 33/200 (16%), Positives = 74/200 (37%), Gaps = 15/200 (7%)

Query: 218 TNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELG 277
           T L +    VLG   +     ++   L ++  +  +   ++ SI     L+  L ++   
Sbjct: 15  TALAEKMKTVLGKTNVTD--TVSQTDLDQVTTLQADRLGIK-SIDGVEYLN-NLTQINFS 70

Query: 278 GNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIR 337
            N+L+        N+T L  + + +N++  I               ++          + 
Sbjct: 71  NNQLTDIT--PLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 128

Query: 338 NLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSY 397
           NL  L     ++++ S +  +      N  +  +       +      +L +L+ L++S 
Sbjct: 129 NLNRLELSSNTISDISALSGLTSLQQLNFSSNQV-------TDLKPLANLTTLERLDISS 181

Query: 398 NNLSGTIPVSLEKLSYLKDL 417
           N +S      L KL+ L+ L
Sbjct: 182 NKVSD--ISVLAKLTNLESL 199

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.3 bits (93), Expect = 2e-04
 Identities = 23/132 (17%), Positives = 48/132 (36%), Gaps = 6/132 (4%)

Query: 269 VELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCF 328
           V   EL+L G K+   I    + +     +    NE+  +   F  L+ +  L +++N  
Sbjct: 18  VRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLD-GFPLLRRLKTLLVNNNRI 75

Query: 329 SGPLPLEIRNLKALIEIDFSMNNFSGI-IPMEIGSLKNLENLFLE---YNRLEGSIPDSF 384
                   + L  L E+  + N+   +     + SLK+L  L +        +       
Sbjct: 76  CRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVI 135

Query: 385 GDLISLKSLNLS 396
             +  ++ L+  
Sbjct: 136 YKVPQVRVLDFQ 147

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.2 bits (90), Expect = 5e-04
 Identities = 25/136 (18%), Positives = 44/136 (32%), Gaps = 6/136 (4%)

Query: 289 FSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFS 348
           ++N    + L L   ++  I     +L     ++ S N            L+ L  +  +
Sbjct: 14  YTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKLDGFP--LLRRLKTLLVN 71

Query: 349 MNNFSGIIPMEIGSLKNLENLFLEYNRLEG-SIPDSFGDLISLKSLNLS---YNNLSGTI 404
            N    I      +L +L  L L  N L      D    L SL  L +      N     
Sbjct: 72  NNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYR 131

Query: 405 PVSLEKLSYLKDLNLS 420
              + K+  ++ L+  
Sbjct: 132 LYVIYKVPQVRVLDFQ 147

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.2 bits (85), Expect = 0.003
 Identities = 24/138 (17%), Positives = 43/138 (31%), Gaps = 8/138 (5%)

Query: 216 EITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELE 275
           + TN      + L G K+   I      L +   +D   N++       +     L  L 
Sbjct: 13  QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFPLLRR--LKTLL 69

Query: 276 LGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIP--LNFWSLKDILDLNLSS---NCFSG 330
           +  N++          +  L  L L +N L  +       SLK +  L +          
Sbjct: 70  VNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKH 129

Query: 331 PLPLEIRNLKALIEIDFS 348
                I  +  +  +DF 
Sbjct: 130 YRLYVIYKVPQVRVLDFQ 147

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 36.8 bits (84), Expect = 0.003
 Identities = 6/42 (14%), Positives = 16/42 (38%), Gaps = 1/42 (2%)

Query: 383 SFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKL 424
            + + +  + L+L    +   I      L     ++ S N++
Sbjct: 13  QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI 53

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 36.8 bits (84), Expect = 0.004
 Identities = 20/145 (13%), Positives = 45/145 (31%), Gaps = 13/145 (8%)

Query: 110 IPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSN 169
              +  NA +  +L L        I +    L   + +   DN +         L     
Sbjct: 11  AAQYT-NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-------KLDGFPL 61

Query: 170 CKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLG 229
            + L  + ++NN +  I           +       +     G  + + +L  LT + + 
Sbjct: 62  LRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLCIL 120

Query: 230 GNK---LNGSIPITLGKLQKLQDVD 251
            N            + K+ +++ +D
Sbjct: 121 RNPVTNKKHYRLYVIYKVPQVRVLD 145

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.5 bits (85), Expect = 0.002
 Identities = 22/110 (20%), Positives = 34/110 (30%), Gaps = 2/110 (1%)

Query: 45  HNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGN 104
           H    L  +++  L      +     L    + N      L      GL  L  L +  +
Sbjct: 8   HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66

Query: 105 NFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNL 154
                 P       +LS+L L  N+       T     +L+ L L  N L
Sbjct: 67  GLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTV-QGLSLQELVLSGNPL 115

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	824
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.97
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.97
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.96
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.95
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.95
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.94
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.92
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.92
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.91
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.91
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.88
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.88
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.86
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.82
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.79
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.79
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.78
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.78
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.77
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.76
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.76
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.75
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.75
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.74
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.74
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.61
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.58
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.58
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.57
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.56
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.54
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.54
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.53
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.38
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.38
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.33
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.31
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.57
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.56
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.5
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.1
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.86
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.82
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.59
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	97.4
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	97.19
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.12
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.84
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.74

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-51  Score=423.91  Aligned_cols=265  Identities=26%  Similarity=0.427  Sum_probs=211.0

Q ss_pred             hccCCCCceeeeccceEEEEEEECCCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEe
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLE  603 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  603 (824)
                      .++|++.+.||+|+||+||+|+++  ..||||+++...  ....+.+.+|++++++++|||||++++++.+ ...++|||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence            468999999999999999999875  369999986542  3456788999999999999999999998765 45789999


Q ss_pred             ccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 040845          604 YMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS  683 (824)
Q Consensus       604 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  683 (824)
                      |+++|+|.+++...+..+++.++..++.|||+||+|||   +++||||||||+|||++.++.+||+|||+|+........
T Consensus        84 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~  160 (276)
T d1uwha_          84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS  160 (276)
T ss_dssp             CCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence            99999999999877768999999999999999999999   899999999999999999999999999999876544444


Q ss_pred             cccccccccccccCccCcCC---CCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhcccccc
Q 040845          684 MTQTQTLATIGYMAPEYGRE---GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLL  760 (824)
Q Consensus       684 ~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  760 (824)
                      .......||+.|||||++.+   +.++.++|||||||++|||+||+.||.+...... ....+........         
T Consensus       161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~-~~~~~~~~~~~p~---------  230 (276)
T d1uwha_         161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-IIFMVGRGYLSPD---------  230 (276)
T ss_dssp             -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-HHHHHHHTSCCCC---------
T ss_pred             ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH-HHHHHhcCCCCCc---------
Confidence            44455679999999998864   3589999999999999999999999976432211 1111111110000         


Q ss_pred             CchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhcc
Q 040845          761 SQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLR  811 (824)
Q Consensus       761 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~  811 (824)
                           ....+.+++..+.+++.+||+.||++||||+|++++|+.+.+++++
T Consensus       231 -----~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~Pk  276 (276)
T d1uwha_         231 -----LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPK  276 (276)
T ss_dssp             -----GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCC
T ss_pred             -----chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCCC
Confidence                 0111235677899999999999999999999999999999887653

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-51  Score=421.23  Aligned_cols=258  Identities=26%  Similarity=0.400  Sum_probs=206.4

Q ss_pred             ccCCCCceeeeccceEEEEEEECCCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEeccC
Q 040845          527 DKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMP  606 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  606 (824)
                      ++|++.+.||+|+||+||+|++.+++.||||+++.. ....+++.+|++++++++|||||+++|+|.+++..++||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            578889999999999999999988999999998754 3445779999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcccc
Q 040845          607 HGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQ  686 (824)
Q Consensus       607 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  686 (824)
                      +|+|.+++......+++..+..++.|+|+||+|||   +.+|+||||||+||++++++.+||+|||+|+....... ...
T Consensus        84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~~~  159 (263)
T d1sm2a_          84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSS  159 (263)
T ss_dssp             TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred             CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCCc-eee
Confidence            99999999877778999999999999999999999   99999999999999999999999999999987643322 223


Q ss_pred             ccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhhh
Q 040845          687 TQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIH  766 (824)
Q Consensus       687 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  766 (824)
                      ....||+.|+|||++.+..++.++|||||||++|||+|++.|+...... ......+....                  +
T Consensus       160 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~-~~~~~~i~~~~------------------~  220 (263)
T d1sm2a_         160 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-SEVVEDISTGF------------------R  220 (263)
T ss_dssp             -----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH-HHHHHHHHHTC------------------C
T ss_pred             cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH-HHHHHHHHhcC------------------C
Confidence            3456899999999999999999999999999999999965554332111 11111111110                  1


Q ss_pred             hhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 040845          767 FVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDS  808 (824)
Q Consensus       767 ~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~  808 (824)
                      ...+..+++++.+++.+||+.||++||||+|++++|+++.++
T Consensus       221 ~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es  262 (263)
T d1sm2a_         221 LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES  262 (263)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence            112234567799999999999999999999999999998764

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-51  Score=417.60  Aligned_cols=254  Identities=24%  Similarity=0.350  Sum_probs=208.8

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc-cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEe
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLE  603 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  603 (824)
                      .++|++.+.||+|+||+||+|+++ +|+.||||+++... .+..+.+.+|++++++++||||+++++++.+++..|+|||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            367999999999999999999875 58999999987543 2345678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 040845          604 YMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS  683 (824)
Q Consensus       604 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  683 (824)
                      |+++|+|.+++.... .+++.++..++.|+++||+|||   +++|+||||||+|||+++++.+||+|||+|+.+......
T Consensus        84 y~~gg~L~~~l~~~~-~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~  159 (271)
T d1nvra_          84 YCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  159 (271)
T ss_dssp             CCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             ccCCCcHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence            999999999997654 7999999999999999999999   999999999999999999999999999999987544444


Q ss_pred             cccccccccccccCccCcCCCCC-CccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCc
Q 040845          684 MTQTQTLATIGYMAPEYGREGQV-STNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ  762 (824)
Q Consensus       684 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  762 (824)
                      ......+||+.|||||++.+..+ +.++||||+||++|||+||+.||............+.....               
T Consensus       160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~---------------  224 (271)
T d1nvra_         160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT---------------  224 (271)
T ss_dssp             CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCT---------------
T ss_pred             ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC---------------
Confidence            44455679999999999987776 67899999999999999999999764333222222211100               


Q ss_pred             hhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          763 EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       763 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                         .......++.++.+++.+||+.||++|||++|++++
T Consensus       225 ---~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  260 (271)
T d1nvra_         225 ---YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  260 (271)
T ss_dssp             ---TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ---CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence               001112345678899999999999999999998764

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-50  Score=414.35  Aligned_cols=250  Identities=28%  Similarity=0.359  Sum_probs=210.9

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEecc
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYM  605 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  605 (824)
                      ++|++.+.||+|+||+||+|+.. +|+.||||+++.......+.+.+|++++++++|||||++++++.+++..|+||||+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            47999999999999999999864 69999999998766566778999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccc
Q 040845          606 PHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMT  685 (824)
Q Consensus       606 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  685 (824)
                      ++|+|.+++...  .+++.++..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+.+....  ..
T Consensus       100 ~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~--~~  172 (293)
T d1yhwa1         100 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SK  172 (293)
T ss_dssp             TTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--CC
T ss_pred             CCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeecccc--cc
Confidence            999999988764  5899999999999999999999   9999999999999999999999999999998764332  22


Q ss_pred             cccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhh
Q 040845          686 QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDI  765 (824)
Q Consensus       686 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  765 (824)
                      .....||+.|+|||++.+..++.++||||+||++|||+||+.||.+....+ ..........+                 
T Consensus       173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~~~~~~~~-----------------  234 (293)
T d1yhwa1         173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-ALYLIATNGTP-----------------  234 (293)
T ss_dssp             BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHHCSC-----------------
T ss_pred             ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH-HHHHHHhCCCC-----------------
Confidence            344579999999999999999999999999999999999999996532111 11111111000                 


Q ss_pred             hhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          766 HFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       766 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      ....+..++..+.+++.+||+.||++|||++|+++|
T Consensus       235 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H  270 (293)
T d1yhwa1         235 ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (293)
T ss_dssp             CCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred             CCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            111123456779999999999999999999999875

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-50  Score=407.93  Aligned_cols=254  Identities=24%  Similarity=0.430  Sum_probs=215.9

Q ss_pred             hccCCCCceeeeccceEEEEEEECCCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEecc
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYM  605 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  605 (824)
                      .++|++.+.||+|+||+||+|++++++.||||+++.. ....+++.+|++++++++||||++++|+|.++...++||||+
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~   81 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM   81 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred             hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcC-cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence            3689999999999999999999998899999999764 334578999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccc
Q 040845          606 PHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMT  685 (824)
Q Consensus       606 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  685 (824)
                      ++|+|.+++......+++..+.+++.|+++||+|||   +.+|+||||||+||++++++.+||+|||+|+....... ..
T Consensus        82 ~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-~~  157 (258)
T d1k2pa_          82 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TS  157 (258)
T ss_dssp             TTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC-CC
T ss_pred             CCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCCc-ee
Confidence            999999998877778899999999999999999999   89999999999999999999999999999987654332 23


Q ss_pred             cccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchh
Q 040845          686 QTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQED  764 (824)
Q Consensus       686 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  764 (824)
                      .....+|+.|+|||.+.+..++.++|||||||++|||+| |+.||......+  ....+...                  
T Consensus       158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~--~~~~i~~~------------------  217 (258)
T d1k2pa_         158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE--TAEHIAQG------------------  217 (258)
T ss_dssp             CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH--HHHHHHTT------------------
T ss_pred             ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH--HHHHHHhC------------------
Confidence            344668999999999999999999999999999999998 788987643221  11111110                  


Q ss_pred             hhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 040845          765 IHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLK  804 (824)
Q Consensus       765 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~  804 (824)
                      .+...+..++.++.+++.+||+.||++||||+|++++|.+
T Consensus       218 ~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         218 LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             CCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence            1111223456789999999999999999999999999865

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-50  Score=413.15  Aligned_cols=258  Identities=24%  Similarity=0.425  Sum_probs=212.1

Q ss_pred             hccCCCCceeeeccceEEEEEEECCCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEecc
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYM  605 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  605 (824)
                      .++|++.+.||+|+||+||+|++++++.||||+++.. ....+.+.+|++++++++|||||+++|++.+ +..++||||+
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~   89 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence            4678899999999999999999998899999999754 3445779999999999999999999998865 4568999999


Q ss_pred             CCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 040845          606 PHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM  684 (824)
Q Consensus       606 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  684 (824)
                      ++|+|.+++.... ..+++.+++.++.||++||+|||   +++|+||||||+||++++++.+||+|||+|+...... ..
T Consensus        90 ~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~-~~  165 (272)
T d1qpca_          90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YT  165 (272)
T ss_dssp             TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-EE
T ss_pred             CCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccCCc-cc
Confidence            9999999876433 36899999999999999999999   8999999999999999999999999999999775432 22


Q ss_pred             ccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchh
Q 040845          685 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQED  764 (824)
Q Consensus       685 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  764 (824)
                      ......||+.|+|||++.++.++.++|||||||++|||+||+.|+............ +...                  
T Consensus       166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~-i~~~------------------  226 (272)
T d1qpca_         166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN-LERG------------------  226 (272)
T ss_dssp             CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-HHTT------------------
T ss_pred             cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHH-HHhc------------------
Confidence            334456899999999999889999999999999999999977665442221111111 1110                  


Q ss_pred             hhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 040845          765 IHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDS  808 (824)
Q Consensus       765 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~  808 (824)
                      .+...+..++.++.+++.+||+.||++||||+|+++.|+++..+
T Consensus       227 ~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         227 YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence            11112234667899999999999999999999999999987643

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-50  Score=409.45  Aligned_cols=247  Identities=25%  Similarity=0.365  Sum_probs=208.1

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALV  601 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  601 (824)
                      .++|++.+.||+|+||+||+|+.+ +++.||+|++....   ....+.+.+|++++++++|||||++++++.+++..++|
T Consensus         5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv   84 (263)
T d2j4za1           5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   84 (263)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence            367999999999999999999875 58999999986432   33456788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 040845          602 LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED  681 (824)
Q Consensus       602 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  681 (824)
                      |||+++|+|.+++...+ .+++.++..++.||++||+|||   +++|+||||||+|||++.++.+||+|||+|.......
T Consensus        85 mEy~~~g~L~~~l~~~~-~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~  160 (263)
T d2j4za1          85 LEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR  160 (263)
T ss_dssp             EECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC
T ss_pred             EeecCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecCCCc
Confidence            99999999999998765 6899999999999999999999   9999999999999999999999999999998654322


Q ss_pred             CccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccC
Q 040845          682 QSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLS  761 (824)
Q Consensus       682 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  761 (824)
                          .....||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+ ......+..               
T Consensus       161 ----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-~~~~i~~~~---------------  220 (263)
T d2j4za1         161 ----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-TYKRISRVE---------------  220 (263)
T ss_dssp             ----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHTTC---------------
T ss_pred             ----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH-HHHHHHcCC---------------
Confidence                234569999999999999999999999999999999999999997532111 111111100               


Q ss_pred             chhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          762 QEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       762 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                           ...+..+++++.+++.+||+.||++|||++|+++|
T Consensus       221 -----~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h  255 (263)
T d2j4za1         221 -----FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  255 (263)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             -----CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence                 00122356678999999999999999999999874

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.7e-50  Score=417.75  Aligned_cols=259  Identities=23%  Similarity=0.425  Sum_probs=203.5

Q ss_pred             ccCCCCceeeeccceEEEEEEECC-C---cEEEEEEeeccc-cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEE
Q 040845          527 DKFSENNLIGRGGFGSVYKARIRD-G---MEVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALV  601 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  601 (824)
                      ++|++.++||+|+||+||+|+++. +   ..||||.+.... ....+.+.+|+++|++++|||||+++|++.+++..++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            456777899999999999998753 2   368999876543 33456799999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 040845          602 LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED  681 (824)
Q Consensus       602 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  681 (824)
                      |||+++|+|.+++......+++.++..++.|||+||+|||   +++|+||||||+|||++.++.+||+|||+|+.+....
T Consensus       106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~  182 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  182 (299)
T ss_dssp             EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEECCCCcEEECCcccceEccCCC
Confidence            9999999999999887768999999999999999999999   9999999999999999999999999999998765433


Q ss_pred             Ccc---ccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhccc
Q 040845          682 QSM---TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDA  757 (824)
Q Consensus       682 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  757 (824)
                      ...   ......+|+.|+|||.+.++.++.++|||||||++|||+| |+.||.+....  .....+...           
T Consensus       183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~--~~~~~i~~~-----------  249 (299)
T d1jpaa_         183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ--DVINAIEQD-----------  249 (299)
T ss_dssp             -------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTT-----------
T ss_pred             CcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH--HHHHHHHcC-----------
Confidence            221   2223457899999999999999999999999999999998 89998763221  111111110           


Q ss_pred             cccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 040845          758 NLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDS  808 (824)
Q Consensus       758 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~  808 (824)
                             .+...+.+++..+.+++.+||+.||++||||+|+++.|+++.++
T Consensus       250 -------~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~  293 (299)
T d1jpaa_         250 -------YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN  293 (299)
T ss_dssp             -------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             -------CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence                   11122345677899999999999999999999999999998754

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-50  Score=415.26  Aligned_cols=252  Identities=24%  Similarity=0.334  Sum_probs=210.5

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEecc
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYM  605 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  605 (824)
                      +.|++.+.||+|+||+||+|++. +|+.||||+++.......+.+.+|++++++++|||||++++++.+++..++||||+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            46889999999999999999875 58999999998776677788999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCccc
Q 040845          606 PHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMT  685 (824)
Q Consensus       606 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  685 (824)
                      ++|+|.+++......+++.++..++.||++||+|||   +++|+||||||+|||++.++.+||+|||+|+.....  ...
T Consensus        92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--~~~  166 (288)
T d2jfla1          92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQR  166 (288)
T ss_dssp             TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH--HHH
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCCC--ccc
Confidence            999999998776667999999999999999999999   999999999999999999999999999999764321  112


Q ss_pred             cccccccccccCccCcC-----CCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhcccccc
Q 040845          686 QTQTLATIGYMAPEYGR-----EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLL  760 (824)
Q Consensus       686 ~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  760 (824)
                      .....||+.|+|||++.     +..|+.++||||+||++|||+||+.||.+....+ .+........             
T Consensus       167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~-~~~~i~~~~~-------------  232 (288)
T d2jfla1         167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR-VLLKIAKSEP-------------  232 (288)
T ss_dssp             HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-HHHHHHHSCC-------------
T ss_pred             ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH-HHHHHHcCCC-------------
Confidence            23457999999999873     4568999999999999999999999997632221 1111111110             


Q ss_pred             CchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          761 SQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       761 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                          .....+..++.++.+++.+||+.||++|||++|+++|
T Consensus       233 ----~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h  269 (288)
T d2jfla1         233 ----PTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH  269 (288)
T ss_dssp             ----CCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             ----CCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                0111223456789999999999999999999999875

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-49  Score=411.09  Aligned_cols=263  Identities=24%  Similarity=0.398  Sum_probs=216.4

Q ss_pred             ccCCCCce-eeeccceEEEEEEEC---CCcEEEEEEeecccc-chhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEE
Q 040845          527 DKFSENNL-IGRGGFGSVYKARIR---DGMEVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALV  601 (824)
Q Consensus       527 ~~~~~~~~-lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  601 (824)
                      ++|.+.+. ||+|+||+||+|.++   ++..||||+++.... ...+.+.+|++++++++|||||+++|++.+ +..++|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            45666674 999999999999764   356899999975433 345778999999999999999999999875 457899


Q ss_pred             EeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 040845          602 LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED  681 (824)
Q Consensus       602 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  681 (824)
                      |||+++|+|.+++...+..+++.++..++.||++||+|||   +++|+||||||+||+++.++.+||+|||+|+.+....
T Consensus        87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~  163 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD  163 (285)
T ss_dssp             EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred             EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhcccccc
Confidence            9999999999998877678999999999999999999999   9999999999999999999999999999999875443


Q ss_pred             Cc-cccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhccccc
Q 040845          682 QS-MTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANL  759 (824)
Q Consensus       682 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  759 (824)
                      .. .......||+.|+|||++.++.++.++|||||||++|||+| |+.||.+....  .....+...             
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~--~~~~~i~~~-------------  228 (285)
T d1u59a_         164 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMAFIEQG-------------  228 (285)
T ss_dssp             CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HHHHHHHTT-------------
T ss_pred             cccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH--HHHHHHHcC-------------
Confidence            32 22334568999999999998999999999999999999998 89999764321  111111110             


Q ss_pred             cCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhcccc
Q 040845          760 LSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLRNV  813 (824)
Q Consensus       760 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~~~  813 (824)
                           .+...+..++.++.+||.+||+.||++||||.+|++.|+.+..++....
T Consensus       229 -----~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~~~  277 (285)
T d1u59a_         229 -----KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV  277 (285)
T ss_dssp             -----CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTC
T ss_pred             -----CCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhhcc
Confidence                 1112234567889999999999999999999999999999877665544

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.2e-50  Score=417.05  Aligned_cols=257  Identities=26%  Similarity=0.414  Sum_probs=214.4

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEec
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      .++|++.+.||+|+||+||+|+++ +|+.||||+++.. ....+++.+|++++++++|||||+++++|.+++..++||||
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~   94 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   94 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence            467899999999999999999876 4889999998754 34467899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 040845          605 MPHGSLEKYLHSS-NYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS  683 (824)
Q Consensus       605 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  683 (824)
                      +++|+|.+++... ...+++..+..++.||++||+|||   +++|+||||||+|||+++++.+||+|||+|+...... .
T Consensus        95 ~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~-~  170 (287)
T d1opja_          95 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-Y  170 (287)
T ss_dssp             CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS-S
T ss_pred             ccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeecCCCC-c
Confidence            9999999999764 357899999999999999999999   8999999999999999999999999999998765332 2


Q ss_pred             cccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCch
Q 040845          684 MTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQE  763 (824)
Q Consensus       684 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  763 (824)
                      .......|++.|+|||++.++.++.++|||||||++|||++|+.||....... .....+...                 
T Consensus       171 ~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~-~~~~~i~~~-----------------  232 (287)
T d1opja_         171 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-QVYELLEKD-----------------  232 (287)
T ss_dssp             EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-HHHHHHHTT-----------------
T ss_pred             eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH-HHHHHHhcC-----------------
Confidence            33344568999999999999999999999999999999999887765422211 111111111                 


Q ss_pred             hhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 040845          764 DIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIR  806 (824)
Q Consensus       764 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~  806 (824)
                       .+...+..++..+.+|+.+||+.||++||||+|+++.|+.+.
T Consensus       233 -~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~  274 (287)
T d1opja_         233 -YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  274 (287)
T ss_dssp             -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             -CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence             011122356778999999999999999999999999998764

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-49  Score=412.02  Aligned_cols=251  Identities=24%  Similarity=0.348  Sum_probs=206.5

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEE
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVL  602 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  602 (824)
                      ++|++.+.||+|+||+||+|+.+ +|+.||||++....   ....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            67999999999999999999875 68999999987532   334567899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 040845          603 EYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ  682 (824)
Q Consensus       603 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  682 (824)
                      ||+++|+|.+++...+ .+++.++..++.|++.||+|||   +.+|+||||||+||++++++.+||+|||+|+.+.....
T Consensus        88 Ey~~gg~L~~~~~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~  163 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  163 (288)
T ss_dssp             CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             EccCCCCHHHhhhccC-CCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence            9999999999988765 7899999999999999999999   99999999999999999999999999999998754444


Q ss_pred             ccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCc
Q 040845          683 SMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ  762 (824)
Q Consensus       683 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  762 (824)
                      ........||+.|+|||++.+..++.++||||+||++|||++|+.||......+ ..........               
T Consensus       164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-~~~~i~~~~~---------------  227 (288)
T d1uu3a_         164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-IFQKIIKLEY---------------  227 (288)
T ss_dssp             ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHTTCC---------------
T ss_pred             ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH-HHHHHHcCCC---------------
Confidence            444445679999999999999999999999999999999999999997532111 1111111000               


Q ss_pred             hhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 040845          763 EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKL  802 (824)
Q Consensus       763 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L  802 (824)
                           ..+..+++.+.+|+.+||+.||++|||++|++++-
T Consensus       228 -----~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~  262 (288)
T d1uu3a_         228 -----DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYG  262 (288)
T ss_dssp             -----CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHH
T ss_pred             -----CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCH
Confidence                 01123456789999999999999999999986653

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-49  Score=408.24  Aligned_cols=260  Identities=25%  Similarity=0.452  Sum_probs=206.4

Q ss_pred             ccCCCCceeeeccceEEEEEEECCC-----cEEEEEEeecccc-chhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEE
Q 040845          527 DKFSENNLIGRGGFGSVYKARIRDG-----MEVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKAL  600 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~~~-----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  600 (824)
                      +.|+..++||+|+||+||+|.++++     ..||||+++.... .....+.+|++++++++|||||+++|++.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            5688889999999999999987642     4799999865433 334578899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 040845          601 VLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE  680 (824)
Q Consensus       601 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  680 (824)
                      ||||++++++.+++......+++.+++.++.|++.|++|||   +.+|+||||||+|||++.++.+||+|||+|+.+...
T Consensus        87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~  163 (283)
T d1mqba_          87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  163 (283)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence            99999999999998877778999999999999999999999   999999999999999999999999999999876543


Q ss_pred             CC-ccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccc
Q 040845          681 DQ-SMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANL  759 (824)
Q Consensus       681 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  759 (824)
                      .. ........||+.|+|||++.++.++.++|||||||++|||++|+.|+....... .....+...             
T Consensus       164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~-~~~~~i~~~-------------  229 (283)
T d1mqba_         164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-EVMKAINDG-------------  229 (283)
T ss_dssp             ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHHHHHHTT-------------
T ss_pred             CccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH-HHHHHHhcc-------------
Confidence            32 223344568999999999999999999999999999999999777654422211 111111110             


Q ss_pred             cCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 040845          760 LSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDS  808 (824)
Q Consensus       760 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~  808 (824)
                           .+...+..++..+.+|+.+||+.||++||||.||++.|+++.++
T Consensus       230 -----~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~  273 (283)
T d1mqba_         230 -----FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  273 (283)
T ss_dssp             -----CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             -----CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence                 11122234667899999999999999999999999999988764

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-49  Score=415.70  Aligned_cols=257  Identities=23%  Similarity=0.379  Sum_probs=211.0

Q ss_pred             hccCCCCceeeeccceEEEEEEECC------CcEEEEEEeeccc-cchhhhHHHHHHHHhcC-CCCcceeEEeeeecCCe
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIRD------GMEVAVKVFNLQC-GRAFKSFDVECAMMKSI-RHRNLVKVISSCSNEEF  597 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  597 (824)
                      .++|++.+.||+|+||+||+|++..      ...||||++.... ......+.+|+.++.++ +|||||++++++.+++.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~  115 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  115 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence            3678999999999999999998643      2369999886442 34456788999999998 89999999999999999


Q ss_pred             eEEEEeccCCCCHHHHhhhCC----------------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCC
Q 040845          598 KALVLEYMPHGSLEKYLHSSN----------------------YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKP  655 (824)
Q Consensus       598 ~~lv~e~~~~g~L~~~l~~~~----------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~  655 (824)
                      .++||||+++|+|.++++...                      ..+++.+++.++.||++||+|||   +++|+||||||
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDlKp  192 (325)
T d1rjba_         116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAA  192 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSG
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCch
Confidence            999999999999999997643                      24789999999999999999999   99999999999


Q ss_pred             CCeeeCCCCcEEEeecccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCccccc
Q 040845          656 SNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFN  734 (824)
Q Consensus       656 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~  734 (824)
                      +||+++.++.+||+|||+|+...............||+.|||||++.++.++.++|||||||++|||+| |+.||.+...
T Consensus       193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~  272 (325)
T d1rjba_         193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  272 (325)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999987765554444455678999999999999999999999999999999998 8999876332


Q ss_pred             CcchhhhhhhhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 040845          735 GEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLK  804 (824)
Q Consensus       735 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~  804 (824)
                      .+ .+...+....                  +...+..++.++.+||.+||+.||++||||+||+++|..
T Consensus       273 ~~-~~~~~~~~~~------------------~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~  323 (325)
T d1rjba_         273 DA-NFYKLIQNGF------------------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC  323 (325)
T ss_dssp             SH-HHHHHHHTTC------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HH-HHHHHHhcCC------------------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence            21 2222222111                  112234567789999999999999999999999999853

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-49  Score=404.38  Aligned_cols=251  Identities=25%  Similarity=0.378  Sum_probs=203.7

Q ss_pred             ceeeeccceEEEEEEECC---CcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEeccCC
Q 040845          533 NLIGRGGFGSVYKARIRD---GMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYMPH  607 (824)
Q Consensus       533 ~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  607 (824)
                      +.||+|+||+||+|.+++   ++.||||+++...  ....+.+.+|++++++++|||||+++++|..+ ..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence            579999999999998643   5689999986542  23456799999999999999999999999654 57899999999


Q ss_pred             CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc-ccc
Q 040845          608 GSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS-MTQ  686 (824)
Q Consensus       608 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~  686 (824)
                      |+|.+++.... .+++.++..++.||+.||+|||   +.+|+||||||+||+++.++.+|++|||+|+.+...... ...
T Consensus        92 g~L~~~l~~~~-~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~  167 (277)
T d1xbba_          92 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  167 (277)
T ss_dssp             EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred             CcHHHHHhhcc-CCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence            99999998765 7999999999999999999999   899999999999999999999999999999876544332 223


Q ss_pred             ccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchhh
Q 040845          687 TQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDI  765 (824)
Q Consensus       687 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  765 (824)
                      ....||+.|+|||.+.+..++.++|||||||++|||+| |+.||.+....  .....+...                  .
T Consensus       168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~--~~~~~i~~~------------------~  227 (277)
T d1xbba_         168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTAMLEKG------------------E  227 (277)
T ss_dssp             ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTT------------------C
T ss_pred             cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH--HHHHHHHcC------------------C
Confidence            34568999999999999999999999999999999998 89998763221  111111110                  1


Q ss_pred             hhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 040845          766 HFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDS  808 (824)
Q Consensus       766 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~  808 (824)
                      +...+..++.++.+|+.+||+.||++|||++||++.|+....+
T Consensus       228 ~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  270 (277)
T d1xbba_         228 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  270 (277)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence            1122345677899999999999999999999999999887543

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-49  Score=406.47  Aligned_cols=254  Identities=22%  Similarity=0.301  Sum_probs=193.9

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeec--CCeeEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSN--EEFKAL  600 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l  600 (824)
                      .++|++.+.||+|+||+||+|+.+ +|+.||||++....  ....+.+.+|++++++++|||||++++++.+  +...|+
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence            468999999999999999999875 58999999986543  2335678899999999999999999999865  456899


Q ss_pred             EEeccCCCCHHHHhhhC---CCCCCHHHHHHHHHHHHHHHHHhhcCC--CCCeEecCCCCCCeeeCCCCcEEEeeccccc
Q 040845          601 VLEYMPHGSLEKYLHSS---NYSLDIFQRLNIMIDVASALEYLHFGY--SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK  675 (824)
Q Consensus       601 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~--~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~  675 (824)
                      ||||+++|+|.+++...   ...+++.+++.++.|+++||+|||+..  ..+|+||||||+|||++.++.+||+|||+|+
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~  162 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  162 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred             EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence            99999999999998642   357999999999999999999999211  1349999999999999999999999999998


Q ss_pred             ccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhc
Q 040845          676 LLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVV  755 (824)
Q Consensus       676 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  755 (824)
                      .+.....  ......||+.|+|||++.+..++.++|||||||++|||+||+.||.+....+ ....+.....+       
T Consensus       163 ~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~-~~~~i~~~~~~-------  232 (269)
T d2java1         163 ILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-LAGKIREGKFR-------  232 (269)
T ss_dssp             HC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHTCCC-------
T ss_pred             ecccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH-HHHHHHcCCCC-------
Confidence            7643222  2334679999999999999999999999999999999999999997632211 11111110000       


Q ss_pred             cccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          756 DANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       756 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                                  ..+..+++++.+++.+||+.||++|||++|++++
T Consensus       233 ------------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h  266 (269)
T d2java1         233 ------------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN  266 (269)
T ss_dssp             ------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ------------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence                        0112356679999999999999999999999864

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-48  Score=395.83  Aligned_cols=245  Identities=25%  Similarity=0.383  Sum_probs=197.4

Q ss_pred             CCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeec----CCeeEEEE
Q 040845          530 SENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSN----EEFKALVL  602 (824)
Q Consensus       530 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~  602 (824)
                      +..+.||+|+||+||+|++. +++.||+|++....  ....+.+.+|++++++++|||||++++++.+    ....++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            55678999999999999875 58899999987543  2345678899999999999999999999864    45679999


Q ss_pred             eccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC--eEecCCCCCCeeeC-CCCcEEEeecccccccCC
Q 040845          603 EYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAP--VIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTG  679 (824)
Q Consensus       603 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlk~~Nill~-~~~~~kl~Dfg~a~~~~~  679 (824)
                      ||+++|+|.+++.+.. .+++.++..++.||++||+|||   +++  |+||||||+|||++ +++.+||+|||+|+....
T Consensus        92 E~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~  167 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  167 (270)
T ss_dssp             ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCcHHHHHhccc-cccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence            9999999999998765 7899999999999999999999   777  99999999999996 579999999999986432


Q ss_pred             CCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccc
Q 040845          680 EDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANL  759 (824)
Q Consensus       680 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  759 (824)
                      .    ......||+.|+|||++.+ .++.++||||+||++|||++|+.||.+................+           
T Consensus       168 ~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~-----------  231 (270)
T d1t4ha_         168 S----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP-----------  231 (270)
T ss_dssp             T----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC-----------
T ss_pred             C----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCC-----------
Confidence            2    2234579999999998865 59999999999999999999999997532221111111110000           


Q ss_pred             cCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          760 LSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       760 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                             ...+..+++++.+++.+||+.||++|||++|+++|
T Consensus       232 -------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H  266 (270)
T d1t4ha_         232 -------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  266 (270)
T ss_dssp             -------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             -------cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence                   01112345678999999999999999999999874

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-49  Score=414.08  Aligned_cols=266  Identities=21%  Similarity=0.308  Sum_probs=207.1

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc-cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEe
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLE  603 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  603 (824)
                      .++|++.+.||+|+||+||+|++. +|+.||+|+++... ....+.+.+|+.++++++|||||+++++|.+++..++|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            578999999999999999999875 68999999997653 3345678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-CeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 040845          604 YMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSA-PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ  682 (824)
Q Consensus       604 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  682 (824)
                      |+++|+|.+++.+.+ .+++.++..++.|+++||+|||   ++ +|+||||||+|||++.++.+||+|||+|+.+...  
T Consensus        85 y~~gg~L~~~l~~~~-~l~~~~~~~~~~qil~aL~yLH---~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--  158 (322)
T d1s9ja_          85 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  158 (322)
T ss_dssp             CCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred             cCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---HhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC--
Confidence            999999999998765 6899999999999999999999   64 8999999999999999999999999999876422  


Q ss_pred             ccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhC--C------------
Q 040845          683 SMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCL--P------------  748 (824)
Q Consensus       683 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~--~------------  748 (824)
                        .....+||+.|+|||++.+..|+.++||||+||++|||++|+.||......+...........  .            
T Consensus       159 --~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (322)
T d1s9ja_         159 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP  236 (322)
T ss_dssp             --TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred             --ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence              123457999999999999999999999999999999999999999763222111100000000  0            


Q ss_pred             -----------CcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          749 -----------ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       749 -----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                                 ....+..+....... . .......+.++.+++.+||+.||++||||+|+++|
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H  298 (322)
T d1s9ja_         237 LSSYGMDSRPPMAIFELLDYIVNEPP-P-KLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  298 (322)
T ss_dssp             ---------CCCCHHHHHHHHHTSCC-C-CCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccchhHHHHHhhhhccCC-c-cCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence                       000000000000000 0 00001245678999999999999999999999986

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=3.9e-48  Score=411.63  Aligned_cols=253  Identities=20%  Similarity=0.275  Sum_probs=211.1

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEec
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      .++|++.+.||+|+||+||+|+.+ +|+.||||++........+.+.+|+.++++++|||||++++++.+++..++||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            468999999999999999999875 6899999999766555567889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC--CCCcEEEeecccccccCCCCC
Q 040845          605 MPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD--DNMVAHLSDFGIAKLLTGEDQ  682 (824)
Q Consensus       605 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~--~~~~~kl~Dfg~a~~~~~~~~  682 (824)
                      +++|+|.+++......+++.++..++.||+.||+|||   +.+|+||||||+|||++  .++.+||+|||+|+.+.... 
T Consensus       105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~-  180 (350)
T d1koaa2         105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ-  180 (350)
T ss_dssp             CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS-
T ss_pred             CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc-
Confidence            9999999999766667999999999999999999999   99999999999999996  46899999999998764332 


Q ss_pred             ccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCc
Q 040845          683 SMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ  762 (824)
Q Consensus       683 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  762 (824)
                        ......||+.|||||++.+..++.++||||+||++|||++|+.||.+.... ..+..........             
T Consensus       181 --~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-~~~~~i~~~~~~~-------------  244 (350)
T d1koaa2         181 --SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD-ETLRNVKSCDWNM-------------  244 (350)
T ss_dssp             --CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHTCCCS-------------
T ss_pred             --ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCCCC-------------
Confidence              233456899999999999999999999999999999999999999753211 1111111111100             


Q ss_pred             hhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          763 EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       763 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                         .......++..+.+++.+||+.||++|||++|+++|
T Consensus       245 ---~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         245 ---DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             ---CCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             ---CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence               001112356678999999999999999999999886

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.3e-48  Score=406.34  Aligned_cols=253  Identities=20%  Similarity=0.287  Sum_probs=193.5

Q ss_pred             hhccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc-cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEE
Q 040845          525 ATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVL  602 (824)
Q Consensus       525 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  602 (824)
                      ..+.|++.+.||+|+||+||+|+.+ +|+.||||++.... ....+.+.+|+.++++++|||||++++++.+++..|+||
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm   86 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM   86 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            3467999999999999999999875 58999999987543 233456788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC---CCCcEEEeecccccccCC
Q 040845          603 EYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLTG  679 (824)
Q Consensus       603 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~---~~~~~kl~Dfg~a~~~~~  679 (824)
                      ||+++|+|.+++...+ .+++.++..++.||+.||+|||   +++|+||||||+||++.   +++.+||+|||+|+....
T Consensus        87 E~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~  162 (307)
T d1a06a_          87 QLVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP  162 (307)
T ss_dssp             CCCCSCBHHHHHHTCS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred             eccCCCcHHHhhhccc-CCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence            9999999999998755 7999999999999999999999   99999999999999994   578999999999986543


Q ss_pred             CCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccc
Q 040845          680 EDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANL  759 (824)
Q Consensus       680 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  759 (824)
                      ..   ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+ ..........+           
T Consensus       163 ~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-~~~~i~~~~~~-----------  227 (307)
T d1a06a_         163 GS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK-LFEQILKAEYE-----------  227 (307)
T ss_dssp             -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHTTCCC-----------
T ss_pred             CC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH-HHHHHhccCCC-----------
Confidence            22   2234569999999999999999999999999999999999999997632211 11111111000           


Q ss_pred             cCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          760 LSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       760 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                           ........+++++.+++.+||+.||++|||++|+++|
T Consensus       228 -----~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         228 -----FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             -----CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             -----CCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence                 0011122456778999999999999999999999985

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-48  Score=401.92  Aligned_cols=260  Identities=26%  Similarity=0.400  Sum_probs=207.3

Q ss_pred             hccCCCCceeeeccceEEEEEEECCCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEecc
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEYM  605 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  605 (824)
                      .++|++.+.||+|+||+||+|++++++.||||+++.. ....+.+.+|+.++++++|||||++++++.+ +..++||||+
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~   93 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   93 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence            4689999999999999999999988889999998754 3445789999999999999999999999865 4578999999


Q ss_pred             CCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 040845          606 PHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM  684 (824)
Q Consensus       606 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  684 (824)
                      ++|+|.+++.... ..+++.+++.++.||+.|++|||   +.+|+||||||+|||++.++++||+|||+|+...... ..
T Consensus        94 ~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~-~~  169 (285)
T d1fmka3          94 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YT  169 (285)
T ss_dssp             TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred             CCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCCC-ce
Confidence            9999999987543 46899999999999999999999   8999999999999999999999999999998764332 22


Q ss_pred             ccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCchh
Q 040845          685 TQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQED  764 (824)
Q Consensus       685 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  764 (824)
                      ......||+.|+|||++.++.++.++|||||||++|||+||+.|+......... ...+....                 
T Consensus       170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~-~~~i~~~~-----------------  231 (285)
T d1fmka3         170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-LDQVERGY-----------------  231 (285)
T ss_dssp             ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-HHHHHTTC-----------------
T ss_pred             eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHH-HHHHHhcC-----------------
Confidence            334456899999999999999999999999999999999987776543222211 11111110                 


Q ss_pred             hhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhc
Q 040845          765 IHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLL  810 (824)
Q Consensus       765 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~  810 (824)
                       +...+..++.++.+++.+||+.||++||||++|++.|++...+..
T Consensus       232 -~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~  276 (285)
T d1fmka3         232 -RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  276 (285)
T ss_dssp             -CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             -CCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence             111223466789999999999999999999999998887654433

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=7.1e-48  Score=409.97  Aligned_cols=253  Identities=19%  Similarity=0.290  Sum_probs=211.2

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEec
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      .++|++.+.||+|+||+||+|+.. +|+.||||+++.......+.+.+|+.++++++|||||++++++.+++..|+||||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            357999999999999999999864 6999999999766555567788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC--CCCcEEEeecccccccCCCCC
Q 040845          605 MPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD--DNMVAHLSDFGIAKLLTGEDQ  682 (824)
Q Consensus       605 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~--~~~~~kl~Dfg~a~~~~~~~~  682 (824)
                      +++|+|.+++......+++.+++.++.||+.||+|||   +.+|+||||||+|||++  .++.+||+|||+|+.+.... 
T Consensus       108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~-  183 (352)
T d1koba_         108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE-  183 (352)
T ss_dssp             CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred             CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecCCCC-
Confidence            9999999998777667999999999999999999999   99999999999999997  67899999999998775432 


Q ss_pred             ccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCc
Q 040845          683 SMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ  762 (824)
Q Consensus       683 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  762 (824)
                        ......||+.|+|||++.+..++.++||||+||++|||+||+.||.+....+ .+........+.             
T Consensus       184 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-~~~~i~~~~~~~-------------  247 (352)
T d1koba_         184 --IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-TLQNVKRCDWEF-------------  247 (352)
T ss_dssp             --CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHHHHHCCCCC-------------
T ss_pred             --ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCCC-------------
Confidence              2334568999999999999999999999999999999999999997532211 111111111100             


Q ss_pred             hhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          763 EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       763 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                         .......++.++.+|+.+||+.||++|||++|+++|
T Consensus       248 ---~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         248 ---DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             ---CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             ---CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence               000112346678999999999999999999999875

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-47  Score=397.65  Aligned_cols=252  Identities=21%  Similarity=0.325  Sum_probs=208.5

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc------chhhhHHHHHHHHhcCCCCcceeEEeeeecCCee
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG------RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFK  598 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  598 (824)
                      .++|++.+.||+|+||+||+|+++ +|+.||||+++....      ...+.+.+|++++++++|||||++++++.+++..
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            467999999999999999999875 689999999865421      2356789999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC----cEEEeecccc
Q 040845          599 ALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM----VAHLSDFGIA  674 (824)
Q Consensus       599 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~----~~kl~Dfg~a  674 (824)
                      ++||||+++|+|.+++...+ .+++.++..++.|++.||+|||   +.+|+||||||+||+++.++    .+|++|||+|
T Consensus        89 ~iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a  164 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  164 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEEEcCCCccccchhcccc-ccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecchhhh
Confidence            99999999999999998765 7999999999999999999999   99999999999999998776    5999999999


Q ss_pred             cccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhh
Q 040845          675 KLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEV  754 (824)
Q Consensus       675 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  754 (824)
                      ........   .....||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+ ....+....        
T Consensus       165 ~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-~~~~i~~~~--------  232 (293)
T d1jksa_         165 HKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-TLANVSAVN--------  232 (293)
T ss_dssp             EECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHTTC--------
T ss_pred             hhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH-HHHHHHhcC--------
Confidence            87643322   234568999999999999999999999999999999999999997632111 111111100        


Q ss_pred             ccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          755 VDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       755 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                              .......+..++..+.+++.+||+.||++|||++|+++|
T Consensus       233 --------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  271 (293)
T d1jksa_         233 --------YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  271 (293)
T ss_dssp             --------CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             --------CCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                    001111223456778999999999999999999999874

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-47  Score=404.75  Aligned_cols=258  Identities=24%  Similarity=0.414  Sum_probs=208.3

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCc----EEEEEEeecc-ccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEE
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGM----EVAVKVFNLQ-CGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKAL  600 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  600 (824)
                      ++|++.+.||+|+||+||+|++. +|+    +||||+++.. ..+..+.+.+|++++++++|||||+++|+|.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            46999999999999999999865 343    6888887643 234567899999999999999999999999875 4678


Q ss_pred             EEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 040845          601 VLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE  680 (824)
Q Consensus       601 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  680 (824)
                      ++||+.+|+|.+++......+++..++.++.|||+||+|||   +++|+||||||+||+++.++.+||+|||+|+.....
T Consensus        88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~  164 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  164 (317)
T ss_dssp             EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred             EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence            89999999999999888778999999999999999999999   899999999999999999999999999999987655


Q ss_pred             CCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhccccc
Q 040845          681 DQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANL  759 (824)
Q Consensus       681 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  759 (824)
                      ..........||+.|+|||++.++.++.++|||||||++|||+| |.+||++....+  +...+...             
T Consensus       165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~--~~~~i~~~-------------  229 (317)
T d1xkka_         165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSILEKG-------------  229 (317)
T ss_dssp             CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG--HHHHHHHT-------------
T ss_pred             cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH--HHHHHHcC-------------
Confidence            54444455678999999999999999999999999999999999 788876532221  11111110             


Q ss_pred             cCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 040845          760 LSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDS  808 (824)
Q Consensus       760 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~  808 (824)
                           .+...+..++..+.+++.+||+.||++|||+.|++++|..+...
T Consensus       230 -----~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~  273 (317)
T d1xkka_         230 -----ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  273 (317)
T ss_dssp             -----CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             -----CCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence                 11122345677899999999999999999999999999988654

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-48  Score=396.87  Aligned_cols=258  Identities=24%  Similarity=0.399  Sum_probs=202.5

Q ss_pred             hccCCCCceeeeccceEEEEEEECC----CcEEEEEEeecccc-chhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIRD----GMEVAVKVFNLQCG-RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKAL  600 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  600 (824)
                      .++|++.+.||+|+||.||+|++..    +..||||+++.... ...+.+.+|++++++++||||+++++++. ++..++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence            4689999999999999999998653    45689998864432 34567899999999999999999999996 467899


Q ss_pred             EEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCC
Q 040845          601 VLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGE  680 (824)
Q Consensus       601 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  680 (824)
                      ||||+++|++.+++......+++.+++.++.||++||+|||   +++|+||||||+||+++.++.+||+|||+|+.....
T Consensus        85 v~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~  161 (273)
T d1mp8a_          85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  161 (273)
T ss_dssp             EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred             EEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhheeccCC
Confidence            99999999999998877778999999999999999999999   999999999999999999999999999999876433


Q ss_pred             CCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhccccc
Q 040845          681 DQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANL  759 (824)
Q Consensus       681 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  759 (824)
                      .. .......||+.|+|||.+.++.++.++|||||||++|||+| |.+||......+  ....+...             
T Consensus       162 ~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~--~~~~i~~~-------------  225 (273)
T d1mp8a_         162 TY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIGRIENG-------------  225 (273)
T ss_dssp             ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHHHTT-------------
T ss_pred             cc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH--HHHHHHcC-------------
Confidence            22 23344568999999999999999999999999999999998 788887643221  11111110             


Q ss_pred             cCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 040845          760 LSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDS  808 (824)
Q Consensus       760 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~  808 (824)
                           .+...+..++..+.+|+.+||+.||++||||.|++++|+++.++
T Consensus       226 -----~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  269 (273)
T d1mp8a_         226 -----ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  269 (273)
T ss_dssp             -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -----CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence                 01112335677899999999999999999999999999998764

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.3e-47  Score=400.54  Aligned_cols=246  Identities=26%  Similarity=0.365  Sum_probs=201.6

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc---chhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEE
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG---RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVL  602 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  602 (824)
                      +.|+..+.||+|+||+||+|+.. +|+.||||+++....   ...+.+.+|++++++++|||||++++++.+++..++||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            35889999999999999999864 689999999875432   33456889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 040845          603 EYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ  682 (824)
Q Consensus       603 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  682 (824)
                      ||+++|++..++.... .+++.++..++.||++||+|||   +++|+||||||+|||++.++.+||+|||+|.....   
T Consensus        95 E~~~~g~l~~~~~~~~-~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---  167 (309)
T d1u5ra_          95 EYCLGSASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---  167 (309)
T ss_dssp             ECCSEEHHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---
T ss_pred             EecCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccCC---
Confidence            9999999987765544 7999999999999999999999   99999999999999999999999999999986532   


Q ss_pred             ccccccccccccccCccCcCC---CCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccc
Q 040845          683 SMTQTQTLATIGYMAPEYGRE---GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANL  759 (824)
Q Consensus       683 ~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  759 (824)
                         .....||+.|||||++.+   +.|+.++|||||||++|||++|+.||.+....+ .+........+.          
T Consensus       168 ---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~-~~~~i~~~~~~~----------  233 (309)
T d1u5ra_         168 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNESPA----------  233 (309)
T ss_dssp             ---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHSCCCC----------
T ss_pred             ---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhCCCCC----------
Confidence               223469999999998853   468999999999999999999999987532211 111111110000          


Q ss_pred             cCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          760 LSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       760 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                              ..+..+++.+.+++.+||+.||++||||+|+++|
T Consensus       234 --------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H  267 (309)
T d1u5ra_         234 --------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (309)
T ss_dssp             --------CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             --------CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence                    0112346678999999999999999999999863

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-48  Score=392.83  Aligned_cols=252  Identities=30%  Similarity=0.438  Sum_probs=201.7

Q ss_pred             hccCCCCceeeeccceEEEEEEECCCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeec-CCeeEEEEec
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSN-EEFKALVLEY  604 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~  604 (824)
                      .++|++.+.||+|+||.||+|+++ |+.||||+++..  ...+.+.+|++++++++||||++++|++.+ .+..++||||
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey   82 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   82 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence            467888999999999999999996 889999998643  455789999999999999999999999855 4668999999


Q ss_pred             cCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 040845          605 MPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS  683 (824)
Q Consensus       605 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  683 (824)
                      +++|+|.+++.... ..+++..+++++.||+.|++|||   +.+|+||||||+||+++.++.+|++|||+++.....   
T Consensus        83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~---  156 (262)
T d1byga_          83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---  156 (262)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCCC---
Confidence            99999999997543 35899999999999999999999   899999999999999999999999999999865322   


Q ss_pred             cccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhccccccCc
Q 040845          684 MTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ  762 (824)
Q Consensus       684 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  762 (824)
                        .....+|..|+|||++.++.++.++|||||||++|||+| |++||.....  .....++...                
T Consensus       157 --~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~--~~~~~~i~~~----------------  216 (262)
T d1byga_         157 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPRVEKG----------------  216 (262)
T ss_dssp             -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG--GGHHHHHTTT----------------
T ss_pred             --CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH--HHHHHHHHcC----------------
Confidence              223457889999999999999999999999999999998 6777655322  1222222111                


Q ss_pred             hhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 040845          763 EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDS  808 (824)
Q Consensus       763 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~  808 (824)
                        .+...+..+++++.+++.+||..||++||||.|++++|++++..
T Consensus       217 --~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~  260 (262)
T d1byga_         217 --YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  260 (262)
T ss_dssp             --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --CCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence              11112234567799999999999999999999999999998753

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.3e-47  Score=401.60  Aligned_cols=262  Identities=27%  Similarity=0.420  Sum_probs=213.9

Q ss_pred             HHHhhccCCCCceeeeccceEEEEEEEC------CCcEEEEEEeeccccc-hhhhHHHHHHHHhcCCCCcceeEEeeeec
Q 040845          522 LFQATDKFSENNLIGRGGFGSVYKARIR------DGMEVAVKVFNLQCGR-AFKSFDVECAMMKSIRHRNLVKVISSCSN  594 (824)
Q Consensus       522 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~  594 (824)
                      ++...++|++.+.||+|+||+||+|+++      +++.||||+++..... ..+++.+|++++++++||||+++++++.+
T Consensus         8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~   87 (301)
T d1lufa_           8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV   87 (301)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence            3334678999999999999999999864      3578999998754333 35678999999999999999999999999


Q ss_pred             CCeeEEEEeccCCCCHHHHhhhCC-----------------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 040845          595 EEFKALVLEYMPHGSLEKYLHSSN-----------------------YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHC  651 (824)
Q Consensus       595 ~~~~~lv~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~  651 (824)
                      ....++||||+++|+|.+++....                       ..+++.+++.++.|++.||+|||   +.+||||
T Consensus        88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~ivHr  164 (301)
T d1lufa_          88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHR  164 (301)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeEee
Confidence            999999999999999999996532                       24789999999999999999999   9999999


Q ss_pred             CCCCCCeeeCCCCcEEEeecccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCC-CCCc
Q 040845          652 DLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRK-KPTD  730 (824)
Q Consensus       652 Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~-~p~~  730 (824)
                      ||||+|||++.++.+||+|||+|+...........+...+++.|+|||.+.+..++.++|||||||++|||++|. +||.
T Consensus       165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~  244 (301)
T d1lufa_         165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY  244 (301)
T ss_dssp             CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             EEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence            999999999999999999999998765544444445567889999999999999999999999999999999986 4565


Q ss_pred             ccccCcchhhhhhhhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHH
Q 040845          731 ELFNGEMTLKHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIR  806 (824)
Q Consensus       731 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~  806 (824)
                      .....  .....+....                  ....+..++.++.+|+.+||+.||++||||.||++.|+++.
T Consensus       245 ~~~~~--e~~~~v~~~~------------------~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         245 GMAHE--EVIYYVRDGN------------------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             TSCHH--HHHHHHHTTC------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCHH--HHHHHHHcCC------------------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            43221  1111111110                  01122355678999999999999999999999999999874

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-47  Score=400.48  Aligned_cols=249  Identities=22%  Similarity=0.295  Sum_probs=209.3

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALV  601 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  601 (824)
                      .++|++.+.||+|+||.||+|+.+ +|+.||||+++...   ....+.+.+|+.+|++++||||+++++++.+++..|+|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            468999999999999999999874 69999999997542   33456788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 040845          602 LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED  681 (824)
Q Consensus       602 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  681 (824)
                      |||+++|+|.+++...+ .+++..++.++.|++.||+|||   +++|+||||||+|||++++|.+||+|||+|+......
T Consensus        84 ~ey~~gg~L~~~~~~~~-~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~  159 (337)
T d1o6la_          84 MEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             EECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred             eeccCCCchhhhhhccc-CCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence            99999999999998766 7899999999999999999999   9999999999999999999999999999998654322


Q ss_pred             CccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccC
Q 040845          682 QSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLS  761 (824)
Q Consensus       682 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  761 (824)
                        ......+||+.|+|||++.+..|+.++||||+||++|||++|++||.+....+ ....+....               
T Consensus       160 --~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~-~~~~i~~~~---------------  221 (337)
T d1o6la_         160 --ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-LFELILMEE---------------  221 (337)
T ss_dssp             --CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCC---------------
T ss_pred             --cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH-HHHHHhcCC---------------
Confidence              22344679999999999999999999999999999999999999997632211 111111110               


Q ss_pred             chhhhhhhHHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 040845          762 QEDIHFVAKEQCVSFVFNLALECTVESPEQRIN-----AKEIVAK  801 (824)
Q Consensus       762 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt-----~~evl~~  801 (824)
                           ...+..+++++.+|+.+||+.||++||+     ++|+++|
T Consensus       222 -----~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H  261 (337)
T d1o6la_         222 -----IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             -----CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence                 0112235667899999999999999994     8888875

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-47  Score=395.28  Aligned_cols=259  Identities=26%  Similarity=0.453  Sum_probs=211.8

Q ss_pred             CceeeeccceEEEEEEECCC----cEEEEEEeecc-ccchhhhHHHHHHHHhcCCCCcceeEEeeeec-CCeeEEEEecc
Q 040845          532 NNLIGRGGFGSVYKARIRDG----MEVAVKVFNLQ-CGRAFKSFDVECAMMKSIRHRNLVKVISSCSN-EEFKALVLEYM  605 (824)
Q Consensus       532 ~~~lg~G~~g~V~~~~~~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~  605 (824)
                      .++||+|+||+||+|++.++    ..||||+++.. .....+++.+|++++++++||||++++|++.+ +...++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            46899999999999987542    36899998643 33456789999999999999999999999865 56889999999


Q ss_pred             CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc--
Q 040845          606 PHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS--  683 (824)
Q Consensus       606 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~--  683 (824)
                      ++|+|.+++.......++..++.++.|+++|+.|+|   +.+|+||||||+|||+++++.+||+|||+++........  
T Consensus       112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~  188 (311)
T d1r0pa_         112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV  188 (311)
T ss_dssp             TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred             ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence            999999999887778889999999999999999999   999999999999999999999999999999876543322  


Q ss_pred             cccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCch
Q 040845          684 MTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQE  763 (824)
Q Consensus       684 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  763 (824)
                      .......||+.|+|||.+.++.++.++||||||+++|||+||+.||....... ....++....                
T Consensus       189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~-~~~~~i~~g~----------------  251 (311)
T d1r0pa_         189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-DITVYLLQGR----------------  251 (311)
T ss_dssp             TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHHHTTC----------------
T ss_pred             eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH-HHHHHHHcCC----------------
Confidence            23344578999999999999999999999999999999999888876533221 1122211110                


Q ss_pred             hhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhccc
Q 040845          764 DIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLRN  812 (824)
Q Consensus       764 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~~  812 (824)
                        +...+..++..+.++|.+||+.||++||||.||+++|+++++++..+
T Consensus       252 --~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~  298 (311)
T d1r0pa_         252 --RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE  298 (311)
T ss_dssp             --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred             --CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhh
Confidence              11122345677999999999999999999999999999999887765

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-46  Score=394.07  Aligned_cols=278  Identities=23%  Similarity=0.323  Sum_probs=204.9

Q ss_pred             ccCCCCceeeeccceEEEEEEECCCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCC----eeEEEE
Q 040845          527 DKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEE----FKALVL  602 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~  602 (824)
                      ++|.+.+.||+|+||.||+|+++ |+.||||+++... ......+.|+..++.++||||+++++++.+++    ..++||
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~-~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~   80 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccc-hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence            46778889999999999999975 8999999986432 11222334555666789999999999997643    678999


Q ss_pred             eccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcC-----CCCCeEecCCCCCCeeeCCCCcEEEeeccccccc
Q 040845          603 EYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFG-----YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  677 (824)
Q Consensus       603 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~  677 (824)
                      ||+++|+|.+++++.  .+++..++.++.|+|.|++|+|+.     .+++|+||||||+|||++.++.+||+|||+++..
T Consensus        81 Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~  158 (303)
T d1vjya_          81 DYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  158 (303)
T ss_dssp             ECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred             ecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccc
Confidence            999999999999875  589999999999999999999932     1369999999999999999999999999999877


Q ss_pred             CCCCCc--cccccccccccccCccCcCCC------CCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCC
Q 040845          678 TGEDQS--MTQTQTLATIGYMAPEYGREG------QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPI  749 (824)
Q Consensus       678 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~------~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  749 (824)
                      ......  .......||+.|+|||++.+.      .++.++|||||||++|||+||..||....................
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~  238 (303)
T d1vjya_         159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV  238 (303)
T ss_dssp             ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred             cCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchH
Confidence            544332  223456799999999988654      267789999999999999999988765332222111111000000


Q ss_pred             c-chhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 040845          750 S-TMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDS  808 (824)
Q Consensus       750 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~  808 (824)
                      . ..+...................++..+.+++.+||+.||++||||.||+++|+++.++
T Consensus       239 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  298 (303)
T d1vjya_         239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             HHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence            0 0001100011111112223345677899999999999999999999999999998765

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-47  Score=398.32  Aligned_cols=261  Identities=25%  Similarity=0.395  Sum_probs=202.6

Q ss_pred             hccCCCCceeeeccceEEEEEEEC------CCcEEEEEEeeccc-cchhhhHHHHHHHHhcC-CCCcceeEEeeeecC-C
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR------DGMEVAVKVFNLQC-GRAFKSFDVECAMMKSI-RHRNLVKVISSCSNE-E  596 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~  596 (824)
                      .++|++.+.||+|+||.||+|++.      +++.||||+++... ....+.+.+|..++.++ +|+||+.+++++.++ .
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~   91 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   91 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence            478999999999999999999864      24689999986543 23355677788877777 689999999998654 5


Q ss_pred             eeEEEEeccCCCCHHHHhhhCC---------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC
Q 040845          597 FKALVLEYMPHGSLEKYLHSSN---------------YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD  661 (824)
Q Consensus       597 ~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~  661 (824)
                      ..++||||+++|+|.++++...               ..+++.+++.++.||++||+|||   +++|+||||||+|||++
T Consensus        92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~NILl~  168 (299)
T d1ywna1          92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLS  168 (299)
T ss_dssp             CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEC
T ss_pred             eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCccceeEC
Confidence            6899999999999999997532               35889999999999999999999   99999999999999999


Q ss_pred             CCCcEEEeecccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCC-CCcccccCcchhh
Q 040845          662 DNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKK-PTDELFNGEMTLK  740 (824)
Q Consensus       662 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~-p~~~~~~~~~~~~  740 (824)
                      +++.+||+|||+|+...............||+.|+|||++.++.++.++|||||||++|||+||.. ||...... ..+.
T Consensus       169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~-~~~~  247 (299)
T d1ywna1         169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-EEFC  247 (299)
T ss_dssp             GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS-HHHH
T ss_pred             CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH-HHHH
Confidence            999999999999987655554445556679999999999999999999999999999999999754 56543222 1222


Q ss_pred             hhhhhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHh
Q 040845          741 HWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDS  808 (824)
Q Consensus       741 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~  808 (824)
                      ..+....                  +...+..+++++.+++.+||+.||++||||+|++++|+++.++
T Consensus       248 ~~~~~~~------------------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~  297 (299)
T d1ywna1         248 RRLKEGT------------------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  297 (299)
T ss_dssp             HHHHHTC------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHhcCC------------------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            2211111                  1112234567799999999999999999999999999998764

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.3e-46  Score=394.79  Aligned_cols=246  Identities=25%  Similarity=0.327  Sum_probs=207.0

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALV  601 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  601 (824)
                      .++|++.+.||+|+||+||+|+.+ +|+.||||+++...   ....+.+.+|+.++++++|||||++++++.+++..|+|
T Consensus         3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   82 (316)
T d1fota_           3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   82 (316)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence            357999999999999999999875 59999999997542   33456788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 040845          602 LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED  681 (824)
Q Consensus       602 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  681 (824)
                      |||+++|++..++.... .+++..+..++.||+.|++|||   +++|+||||||+|||++.+|.+||+|||+|+......
T Consensus        83 mE~~~gg~l~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~  158 (316)
T d1fota_          83 MDYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT  158 (316)
T ss_dssp             ECCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB
T ss_pred             eeecCCccccccccccc-cccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEecccc
Confidence            99999999999988766 6788999999999999999999   9999999999999999999999999999998764322


Q ss_pred             CccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccC
Q 040845          682 QSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLS  761 (824)
Q Consensus       682 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  761 (824)
                           ....||+.|+|||++.+..++.++||||+||++|||+||+.||.+....+ ..........              
T Consensus       159 -----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~i~~~~~--------------  218 (316)
T d1fota_         159 -----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK-TYEKILNAEL--------------  218 (316)
T ss_dssp             -----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHCCC--------------
T ss_pred             -----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH-HHHHHHcCCC--------------
Confidence                 23569999999999999999999999999999999999999997632111 1111111100              


Q ss_pred             chhhhhhhHHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 040845          762 QEDIHFVAKEQCVSFVFNLALECTVESPEQRI-----NAKEIVAK  801 (824)
Q Consensus       762 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~evl~~  801 (824)
                            ..+..+++++.+++.+||..||++|+     |++|+++|
T Consensus       219 ------~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         219 ------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             ------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             ------CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence                  01123456789999999999999996     89999876

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-47  Score=393.54  Aligned_cols=256  Identities=26%  Similarity=0.391  Sum_probs=200.1

Q ss_pred             ccCCCCceeeeccceEEEEEEECC--C--cEEEEEEeecc---ccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeE
Q 040845          527 DKFSENNLIGRGGFGSVYKARIRD--G--MEVAVKVFNLQ---CGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKA  599 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~~--~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  599 (824)
                      ++|++.+.||+|+||.||+|++..  +  ..||||+++..   ..+..+.+.+|+.++++++||||++++|++.++ ..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chh
Confidence            578999999999999999998642  2  47899988654   234456889999999999999999999999764 678


Q ss_pred             EEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCC
Q 040845          600 LVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG  679 (824)
Q Consensus       600 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  679 (824)
                      +||||+++|++.+++......+++..++.++.|+|.||+|||   +++|+||||||+||+++.++.+||+|||+++....
T Consensus        87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~  163 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  163 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence            999999999999998776667999999999999999999999   89999999999999999999999999999998754


Q ss_pred             CCCc-cccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchhhhhhhhhCCCcchhhccc
Q 040845          680 EDQS-MTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTLKHWVNDCLPISTMEVVDA  757 (824)
Q Consensus       680 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  757 (824)
                      .... .......+|..|+|||.+.+..++.++|||||||++|||+| |+.||.+....  ....++...           
T Consensus       164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~--~~~~~i~~~-----------  230 (273)
T d1u46a_         164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS--QILHKIDKE-----------  230 (273)
T ss_dssp             -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTS-----------
T ss_pred             CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH--HHHHHHHhC-----------
Confidence            4332 23334567889999999999999999999999999999998 89998753221  111111110           


Q ss_pred             cccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHH
Q 040845          758 NLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKI  805 (824)
Q Consensus       758 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~  805 (824)
                            ..+...+..++..+.+++.+||+.||++||||+||++.|++.
T Consensus       231 ------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         231 ------GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             ------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                  011112234567799999999999999999999999988764

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.6e-46  Score=388.79  Aligned_cols=260  Identities=24%  Similarity=0.390  Sum_probs=204.1

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc---chhhhHHHHHHHHhcCCCCcceeEEeeeecCC----e
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG---RAFKSFDVECAMMKSIRHRNLVKVISSCSNEE----F  597 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~  597 (824)
                      .++|++.+.||+|+||+||+|+.. +|+.||||+++....   ...+.+.+|+++++.++||||+++++++..++    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            467999999999999999999864 699999999975432   33457889999999999999999999987643    4


Q ss_pred             eEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccccc
Q 040845          598 KALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  677 (824)
Q Consensus       598 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~  677 (824)
                      .|+||||+++++|.+++...+ .+++.+++.++.||+.|++|||   +.+|+||||||+||+++.++..+++|||.+...
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~-~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~  161 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAI  161 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred             EEEEEECCCCCEehhhhcccC-CCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhhhhh
Confidence            789999999999999987765 7899999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCCC-ccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhcc
Q 040845          678 TGEDQ-SMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVD  756 (824)
Q Consensus       678 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  756 (824)
                      ..... ........||+.|+|||++.+..++.++||||+||++|||+||+.||......+. ....+.....        
T Consensus       162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-~~~~~~~~~~--------  232 (277)
T d1o6ya_         162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV-AYQHVREDPI--------  232 (277)
T ss_dssp             C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHCCCC--------
T ss_pred             ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH-HHHHHhcCCC--------
Confidence            43322 2233456799999999999999999999999999999999999999975322111 1111111000        


Q ss_pred             ccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHHH
Q 040845          757 ANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRI-NAKEIVAKLLKIR  806 (824)
Q Consensus       757 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-t~~evl~~L~~~~  806 (824)
                              ........+++.+.+++.+||+.||++|| |++++.+.|.+++
T Consensus       233 --------~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         233 --------PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             --------CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             --------CCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence                    00011124567799999999999999999 8999999998875

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-46  Score=393.05  Aligned_cols=252  Identities=20%  Similarity=0.302  Sum_probs=208.9

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEec
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      .++|++.+.||+|+||+||+|.++ +|+.||||+++... .....+.+|+++|+.++|||||++++++.+++..|+||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            468999999999999999999875 58899999997653 3345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC--CCcEEEeecccccccCCCCC
Q 040845          605 MPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD--NMVAHLSDFGIAKLLTGEDQ  682 (824)
Q Consensus       605 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~--~~~~kl~Dfg~a~~~~~~~~  682 (824)
                      +++|+|.+++...+..+++.++..++.||++|++|||   +.+|+||||||+||+++.  .+.+||+|||+++...... 
T Consensus        83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~-  158 (321)
T d1tkia_          83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-  158 (321)
T ss_dssp             CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhccccCC-
Confidence            9999999999877767999999999999999999999   999999999999999985  4589999999998764322 


Q ss_pred             ccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCc
Q 040845          683 SMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ  762 (824)
Q Consensus       683 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  762 (824)
                        ......+|+.|+|||...+..++.++||||+||++|||++|+.||......+ ...........              
T Consensus       159 --~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~-~~~~i~~~~~~--------------  221 (321)
T d1tkia_         159 --NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-IIENIMNAEYT--------------  221 (321)
T ss_dssp             --EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHTCCC--------------
T ss_pred             --cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCC--------------
Confidence              2234568999999999999999999999999999999999999997632211 11111111000              


Q ss_pred             hhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          763 EDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       763 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                        ........++.++.+++.+||..||++|||++|+++|
T Consensus       222 --~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  258 (321)
T d1tkia_         222 --FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             --CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             --CChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence              0111122456778999999999999999999999985

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=3.5e-46  Score=383.69  Aligned_cols=251  Identities=24%  Similarity=0.346  Sum_probs=206.2

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc---------chhhhHHHHHHHHhcCC-CCcceeEEeeeecC
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG---------RAFKSFDVECAMMKSIR-HRNLVKVISSCSNE  595 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~  595 (824)
                      ++|++.+.||+|+||+||+|+.. +|+.||||+++....         ...+.+.+|+.++++++ ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            68999999999999999999874 689999999875432         12346788999999997 99999999999999


Q ss_pred             CeeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccccc
Q 040845          596 EFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK  675 (824)
Q Consensus       596 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~  675 (824)
                      +..|+||||+++|+|.+++...+ .+++.++..++.||++||+|||   +++|+||||||+||+++.++.+||+|||+|+
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~  158 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSC  158 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             cceEEEEEcCCCchHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccchhee
Confidence            99999999999999999998765 7899999999999999999999   9999999999999999999999999999998


Q ss_pred             ccCCCCCccccccccccccccCccCcC------CCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCC
Q 040845          676 LLTGEDQSMTQTQTLATIGYMAPEYGR------EGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPI  749 (824)
Q Consensus       676 ~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  749 (824)
                      ......   ......||+.|+|||++.      ...++.++||||+||++|||++|+.||.+....+ ........... 
T Consensus       159 ~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~-~~~~i~~~~~~-  233 (277)
T d1phka_         159 QLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-MLRMIMSGNYQ-  233 (277)
T ss_dssp             ECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCCC-
T ss_pred             EccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH-HHHHHHhCCCC-
Confidence            764322   224457999999999875      3357889999999999999999999997632211 11111111110 


Q ss_pred             cchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          750 STMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       750 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                                     ........+++++.+++.+||+.||++|||++|+++|
T Consensus       234 ---------------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         234 ---------------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             ---------------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             ---------------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence                           0111223567789999999999999999999998765

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-46  Score=392.47  Aligned_cols=261  Identities=23%  Similarity=0.378  Sum_probs=216.5

Q ss_pred             hccCCCCceeeeccceEEEEEEEC------CCcEEEEEEeecccc-chhhhHHHHHHHHhcC-CCCcceeEEeeeecCCe
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR------DGMEVAVKVFNLQCG-RAFKSFDVECAMMKSI-RHRNLVKVISSCSNEEF  597 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  597 (824)
                      .++|++.+.||+|+||.||+|++.      +++.||||+++.... .....+.+|+.+++++ +|||||++++++.+++.
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~  101 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence            468899999999999999999862      367899999976533 3445788999999999 69999999999999999


Q ss_pred             eEEEEeccCCCCHHHHhhhCC-----------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee
Q 040845          598 KALVLEYMPHGSLEKYLHSSN-----------------YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL  660 (824)
Q Consensus       598 ~~lv~e~~~~g~L~~~l~~~~-----------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill  660 (824)
                      .++||||+++|+|.++++...                 ..+++..+..++.||++|++|||   +++|+||||||+||++
T Consensus       102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NIl~  178 (311)
T d1t46a_         102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILL  178 (311)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred             EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccccccccc
Confidence            999999999999999997643                 25889999999999999999999   9999999999999999


Q ss_pred             CCCCcEEEeecccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhh
Q 040845          661 DDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLK  740 (824)
Q Consensus       661 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~  740 (824)
                      +.++.+|++|||.++...........+...||+.|+|||++.++.++.++|||||||++|||+|++.|+.........+.
T Consensus       179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~  258 (311)
T d1t46a_         179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY  258 (311)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred             cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            99999999999999987655555555667899999999999999999999999999999999996555443333322233


Q ss_pred             hhhhhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 040845          741 HWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRD  807 (824)
Q Consensus       741 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~  807 (824)
                      .++....                  +...+..++..+.+|+.+||+.||++||||+|+++.|+++..
T Consensus       259 ~~i~~~~------------------~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~  307 (311)
T d1t46a_         259 KMIKEGF------------------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS  307 (311)
T ss_dssp             HHHHHTC------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHhcCC------------------CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence            3322211                  111123456779999999999999999999999999987654

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-46  Score=391.51  Aligned_cols=259  Identities=27%  Similarity=0.452  Sum_probs=207.4

Q ss_pred             ccCCCCceeeeccceEEEEEEECC-Cc--EEEEEEeecc-ccchhhhHHHHHHHHhcC-CCCcceeEEeeeecCCeeEEE
Q 040845          527 DKFSENNLIGRGGFGSVYKARIRD-GM--EVAVKVFNLQ-CGRAFKSFDVECAMMKSI-RHRNLVKVISSCSNEEFKALV  601 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  601 (824)
                      ++|++.+.||+|+||+||+|++++ |.  .||||+++.. .....+.+.+|+++++++ +|||||++++++.+++..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            678889999999999999998754 44  5778887543 334567899999999999 799999999999999999999


Q ss_pred             EeccCCCCHHHHhhhC---------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcE
Q 040845          602 LEYMPHGSLEKYLHSS---------------NYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVA  666 (824)
Q Consensus       602 ~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~  666 (824)
                      |||+++|+|.++++..               ...+++.+++.++.|||+|+.|+|   +++|+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCce
Confidence            9999999999999754               257899999999999999999999   9999999999999999999999


Q ss_pred             EEeecccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCC-CCcccccCcchhhhhhhh
Q 040845          667 HLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKK-PTDELFNGEMTLKHWVND  745 (824)
Q Consensus       667 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~-p~~~~~~~~~~~~~~~~~  745 (824)
                      ||+|||+|+.....   .......||..|+|||.+.++.++.++|||||||++|||++|.. ||....  ...+...+..
T Consensus       167 kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~--~~~~~~~i~~  241 (309)
T d1fvra_         167 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--CAELYEKLPQ  241 (309)
T ss_dssp             EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHHHGGG
T ss_pred             EEcccccccccccc---ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC--HHHHHHHHHh
Confidence            99999999764322   22233458999999999999999999999999999999999765 554421  1111111111


Q ss_pred             hCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhcc
Q 040845          746 CLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLLR  811 (824)
Q Consensus       746 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~~  811 (824)
                      .                  .+...+..+++++.+|+.+||+.||++||||+||+++|+++.++...
T Consensus       242 ~------------------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~~  289 (309)
T d1fvra_         242 G------------------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT  289 (309)
T ss_dssp             T------------------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred             c------------------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCcC
Confidence            0                  11112234677899999999999999999999999999999875443

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.7e-46  Score=395.95  Aligned_cols=245  Identities=22%  Similarity=0.254  Sum_probs=206.6

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEE
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVL  602 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  602 (824)
                      ++|++.+.||+|+||.||+|+++ +|+.||||++....   ....+.+.+|+.+++.++|||||++++++.+....++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            57999999999999999999875 69999999987532   334567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 040845          603 EYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQ  682 (824)
Q Consensus       603 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  682 (824)
                      ||+.+|+|.+++...+ .+++.++..++.||+.||.|||   +.+||||||||+|||++.+|.+||+|||+|+.+.... 
T Consensus       121 e~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~-  195 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-  195 (350)
T ss_dssp             ECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB-
T ss_pred             ccccccchhhhHhhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeeccccc-
Confidence            9999999999998765 6899999999999999999999   9999999999999999999999999999998764322 


Q ss_pred             ccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccCc
Q 040845          683 SMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLSQ  762 (824)
Q Consensus       683 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  762 (824)
                          ....||+.|||||++.+..++.++||||+||++|||+||+.||.+.... ...........               
T Consensus       196 ----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-~~~~~i~~~~~---------------  255 (350)
T d1rdqe_         196 ----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKIVSGKV---------------  255 (350)
T ss_dssp             ----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHCCC---------------
T ss_pred             ----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH-HHHHHHhcCCC---------------
Confidence                2356999999999999999999999999999999999999999753111 11111111100               


Q ss_pred             hhhhhhhHHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 040845          763 EDIHFVAKEQCVSFVFNLALECTVESPEQRI-----NAKEIVAK  801 (824)
Q Consensus       763 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~evl~~  801 (824)
                           ..+..+++++.+++.+||..||++|+     |++|+++|
T Consensus       256 -----~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H  294 (350)
T d1rdqe_         256 -----RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             -----CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             -----CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence                 01123466789999999999999994     89999874

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-46  Score=392.73  Aligned_cols=262  Identities=23%  Similarity=0.409  Sum_probs=214.7

Q ss_pred             hccCCCCceeeeccceEEEEEEEC------CCcEEEEEEeeccc-cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCee
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR------DGMEVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFK  598 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  598 (824)
                      .++|++.+.||+|+||+||+|.+.      +++.||||+++... ......+.+|++++++++||||+++++++..++..
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~   98 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT   98 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence            478899999999999999999864      25789999987543 23345688999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhhCC---------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEe
Q 040845          599 ALVLEYMPHGSLEKYLHSSN---------YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLS  669 (824)
Q Consensus       599 ~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  669 (824)
                      ++||||+++|+|.+++....         ..+++..+..++.|+|+||+|||   +.+|+||||||+|||+++++++||+
T Consensus        99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~~Kl~  175 (308)
T d1p4oa_          99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIG  175 (308)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred             eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCceEEEe
Confidence            99999999999999986432         35789999999999999999999   8999999999999999999999999


Q ss_pred             ecccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCC-CCCcccccCcchhhhhhhhhCC
Q 040845          670 DFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRK-KPTDELFNGEMTLKHWVNDCLP  748 (824)
Q Consensus       670 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~-~p~~~~~~~~~~~~~~~~~~~~  748 (824)
                      |||+|+...............+|+.|+|||.+.++.++.++||||||+++|||+||+ .||.+...     .++..... 
T Consensus       176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~-----~~~~~~i~-  249 (308)
T d1p4oa_         176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-----EQVLRFVM-  249 (308)
T ss_dssp             CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH-----HHHHHHHH-
T ss_pred             ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHH-
Confidence            999998775554444455567899999999999999999999999999999999986 55544211     11111110 


Q ss_pred             CcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhhc
Q 040845          749 ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSLL  810 (824)
Q Consensus       749 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~~  810 (824)
                             +.       .....+..++..+.++|.+||+.||++|||++||+++|++..+...
T Consensus       250 -------~~-------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~  297 (308)
T d1p4oa_         250 -------EG-------GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGF  297 (308)
T ss_dssp             -------TT-------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTH
T ss_pred             -------hC-------CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence                   10       0111223466789999999999999999999999999988755443

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.3e-45  Score=394.82  Aligned_cols=250  Identities=22%  Similarity=0.305  Sum_probs=201.7

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhH---HHHHHHHhcCCCCcceeEEeeeecCCee
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSF---DVECAMMKSIRHRNLVKVISSCSNEEFK  598 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~---~~E~~~l~~l~h~niv~l~~~~~~~~~~  598 (824)
                      .++|++.+.||+|+||.||+|+.. +|+.||||++....   ......+   ..|+++++.++|||||++++++.+++..
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence            368999999999999999999875 59999999986432   1112223   3457778888999999999999999999


Q ss_pred             EEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccC
Q 040845          599 ALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT  678 (824)
Q Consensus       599 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~  678 (824)
                      |+||||+++|+|.+++.... .+++.++..++.||+.||+|||   +++|+||||||+|||++.+|.+||+|||+|+.+.
T Consensus        83 ~ivmE~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~  158 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS  158 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred             EEEEEecCCCcHHHHHHhcc-cccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence            99999999999999998765 6889999999999999999999   9999999999999999999999999999998764


Q ss_pred             CCCCccccccccccccccCccCcCC-CCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccc
Q 040845          679 GEDQSMTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDA  757 (824)
Q Consensus       679 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  757 (824)
                      ...    .....||+.|+|||++.. ..++.++||||+||++|||+||+.||......+.  ...........       
T Consensus       159 ~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~~~~~~~~~~~-------  225 (364)
T d1omwa3         159 KKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTLTMA-------  225 (364)
T ss_dssp             SSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH--HHHHHHSSSCC-------
T ss_pred             CCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhcccCC-------
Confidence            332    233569999999999865 4689999999999999999999999976332211  11111111000       


Q ss_pred             cccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 040845          758 NLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRIN-----AKEIVAK  801 (824)
Q Consensus       758 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt-----~~evl~~  801 (824)
                               ...+..+++++.+++.+||+.||++|||     |+|+++|
T Consensus       226 ---------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H  265 (364)
T d1omwa3         226 ---------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  265 (364)
T ss_dssp             ---------CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred             ---------CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence                     0011234667899999999999999999     7888875

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-46  Score=392.24  Aligned_cols=247  Identities=23%  Similarity=0.328  Sum_probs=203.1

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc---cchhhhHHHHHHHHh-cCCCCcceeEEeeeecCCeeEEE
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC---GRAFKSFDVECAMMK-SIRHRNLVKVISSCSNEEFKALV  601 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv  601 (824)
                      ++|++.+.||+|+||+||+|+.+ +|+.||||+++...   ....+.+..|..++. .++|||||++++++.+++..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            57999999999999999999875 58999999997542   333455666766654 68999999999999999999999


Q ss_pred             EeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCC
Q 040845          602 LEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGED  681 (824)
Q Consensus       602 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  681 (824)
                      |||+++|+|.+++.... .+++.++..++.||+.||+|||   +++|+||||||+|||+++++.+||+|||+|+......
T Consensus        82 mEy~~~g~L~~~i~~~~-~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~  157 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD  157 (320)
T ss_dssp             EECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EeecCCCcHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhccccc
Confidence            99999999999998765 6899999999999999999999   9999999999999999999999999999998654322


Q ss_pred             CccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhccccccC
Q 040845          682 QSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVVDANLLS  761 (824)
Q Consensus       682 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  761 (824)
                        .......||+.|+|||++.+..++.++||||+||++|||+||+.||.+....  ....-+....              
T Consensus       158 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~--~~~~~i~~~~--------------  219 (320)
T d1xjda_         158 --AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE--ELFHSIRMDN--------------  219 (320)
T ss_dssp             --CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCC--------------
T ss_pred             --ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH--HHHHHHHcCC--------------
Confidence              2334457999999999999999999999999999999999999999753211  1111111000              


Q ss_pred             chhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 040845          762 QEDIHFVAKEQCVSFVFNLALECTVESPEQRINAK-EIVA  800 (824)
Q Consensus       762 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~-evl~  800 (824)
                           ...+..++.++.+|+.+||..||++|||+. |+++
T Consensus       220 -----~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         220 -----PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             -----CCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence                 001123566789999999999999999995 6765

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-46  Score=387.79  Aligned_cols=259  Identities=27%  Similarity=0.436  Sum_probs=209.6

Q ss_pred             hccCCCCceeeeccceEEEEEEECC--------CcEEEEEEeecccc-chhhhHHHHHHHHhcC-CCCcceeEEeeeecC
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIRD--------GMEVAVKVFNLQCG-RAFKSFDVECAMMKSI-RHRNLVKVISSCSNE  595 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  595 (824)
                      .++|++.+.||+|+||.||+|+...        +..||||+++.... .....+.+|+..+.++ +|||||+++++|.++
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            4688999999999999999997532        34799999876543 3356788898888888 899999999999999


Q ss_pred             CeeEEEEeccCCCCHHHHhhhCC---------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeee
Q 040845          596 EFKALVLEYMPHGSLEKYLHSSN---------------YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL  660 (824)
Q Consensus       596 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill  660 (824)
                      +..++||||+++|+|.+++....               ..+++.+++.++.|++.||+|||   +.+||||||||+|||+
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiLl  168 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV  168 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred             CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccceee
Confidence            99999999999999999997543               35899999999999999999999   9999999999999999


Q ss_pred             CCCCcEEEeecccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHh-CCCCCcccccCcchh
Q 040845          661 DDNMVAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFT-RKKPTDELFNGEMTL  739 (824)
Q Consensus       661 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t-g~~p~~~~~~~~~~~  739 (824)
                      +.++.+||+|||+++...............+|+.|+|||.+.++.|+.++|||||||++|||++ |.+||......  ..
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~--~~  246 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--EL  246 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HH
T ss_pred             cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH--HH
Confidence            9999999999999998765555445556678999999999999999999999999999999998 67777653221  11


Q ss_pred             hhhhhhhCCCcchhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 040845          740 KHWVNDCLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRD  807 (824)
Q Consensus       740 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~  807 (824)
                      ...+....                  +...+..++..+.+++.+||+.||++||||.||++.|+++..
T Consensus       247 ~~~i~~~~------------------~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a  296 (299)
T d1fgka_         247 FKLLKEGH------------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  296 (299)
T ss_dssp             HHHHHTTC------------------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHcCC------------------CCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence            12211111                  111123456779999999999999999999999999998864

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-45  Score=387.17  Aligned_cols=252  Identities=21%  Similarity=0.277  Sum_probs=200.3

Q ss_pred             hccCCCCc-eeeeccceEEEEEEE-CCCcEEEEEEeeccccchhhhHHHHHHHHhc-CCCCcceeEEeeeec----CCee
Q 040845          526 TDKFSENN-LIGRGGFGSVYKARI-RDGMEVAVKVFNLQCGRAFKSFDVECAMMKS-IRHRNLVKVISSCSN----EEFK  598 (824)
Q Consensus       526 ~~~~~~~~-~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~----~~~~  598 (824)
                      .++|++.+ .||+|+||+||+|++ .+++.||||+++.     ...+.+|++++.+ .+|||||++++++.+    +...
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            46888764 699999999999986 4689999999863     2457789988655 489999999999865    4678


Q ss_pred             EEEEeccCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC---CCcEEEeecccc
Q 040845          599 ALVLEYMPHGSLEKYLHSSN-YSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD---NMVAHLSDFGIA  674 (824)
Q Consensus       599 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~Dfg~a  674 (824)
                      |+|||||+||+|.+++...+ ..+++.++..++.||+.||+|||   +.+|+||||||+||+++.   .+.+||+|||+|
T Consensus        85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a  161 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA  161 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH---HcCCcccccccccccccccccccccccccccee
Confidence            99999999999999997653 57999999999999999999999   999999999999999985   567999999999


Q ss_pred             cccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhh
Q 040845          675 KLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEV  754 (824)
Q Consensus       675 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  754 (824)
                      +.......   .....||+.|+|||++.+..|+.++||||+||++|||+||+.||.+......  .........      
T Consensus       162 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~--~~~~~~~i~------  230 (335)
T d2ozaa1         162 KETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI--SPGMKTRIR------  230 (335)
T ss_dssp             EECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------CCC------
T ss_pred             eeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH--HHHHHHHHh------
Confidence            87654332   2345699999999999999999999999999999999999999976322111  000000000      


Q ss_pred             ccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          755 VDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       755 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                           .............+++++.+|+.+||+.||++|||+.|+++|
T Consensus       231 -----~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         231 -----MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             -----SCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             -----cCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence                 000001111233567789999999999999999999999885

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-45  Score=380.47  Aligned_cols=269  Identities=25%  Similarity=0.269  Sum_probs=202.7

Q ss_pred             ccCCCCceeeeccceEEEEEEE-CCCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEe
Q 040845          527 DKFSENNLIGRGGFGSVYKARI-RDGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLE  603 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  603 (824)
                      ++|++.+.||+|+||+||+|++ .+|+.||||+++...  ....+.+.+|++++++++|||||++++++.++...|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            6899999999999999999986 469999999986543  2345778899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 040845          604 YMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS  683 (824)
Q Consensus       604 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  683 (824)
                      |++++.+..........+++.++..++.|++.||+|||   +.+||||||||+||+++.++.+||+|||.|+......  
T Consensus        82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~--  156 (298)
T d1gz8a_          82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--  156 (298)
T ss_dssp             CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS--
T ss_pred             ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccCCc--
Confidence            99764444343444567999999999999999999999   9999999999999999999999999999998764322  


Q ss_pred             cccccccccccccCccCcCCCC-CCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCC-Cc-c-hhhccc--
Q 040845          684 MTQTQTLATIGYMAPEYGREGQ-VSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLP-IS-T-MEVVDA--  757 (824)
Q Consensus       684 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~-~-~~~~~~--  757 (824)
                      .......||+.|+|||.+.... ++.++||||+||++|||++|+.||.+....+ .+......... .. . ......  
T Consensus       157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~  235 (298)
T d1gz8a_         157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIFRTLGTPDEVVWPGVTSMPD  235 (298)
T ss_dssp             BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH-HHHHHHHhcCCCchhhccccccccc
Confidence            2334457999999999876655 5889999999999999999999997532211 11111111111 00 0 000000  


Q ss_pred             ---cccC-chhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          758 ---NLLS-QEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       758 ---~~~~-~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                         .... ...........++..+.+++.+||+.||++|||++|+++|
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence               0000 0000011112456778999999999999999999999886

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-45  Score=381.42  Aligned_cols=264  Identities=23%  Similarity=0.283  Sum_probs=196.4

Q ss_pred             CCceeeeccceEEEEEEEC-CCcEEEEEEeecccc-----chhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEec
Q 040845          531 ENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG-----RAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       531 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      ..++||+|+||+||+|+.+ +|+.||||+++....     ...+.+.+|++++++++|||||++++++.+++..++||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            3578999999999999865 589999999864422     1245688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 040845          605 MPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM  684 (824)
Q Consensus       605 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  684 (824)
                      ++++++..+.. ....+++.++..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+|+.......  
T Consensus        82 ~~~~~~~~~~~-~~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~--  155 (299)
T d1ua2a_          82 METDLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--  155 (299)
T ss_dssp             CSEEHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC--
T ss_pred             hcchHHhhhhh-cccCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCCcc--
Confidence            98876665554 3447888999999999999999999   99999999999999999999999999999986643322  


Q ss_pred             ccccccccccccCccCcCCC-CCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhhc------c-
Q 040845          685 TQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEVV------D-  756 (824)
Q Consensus       685 ~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------~-  756 (824)
                      .....+||+.|+|||++... .++.++||||+||++|||+||++||......+ .+................      . 
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~-~l~~i~~~~~~~~~~~~~~~~~~~~~  234 (299)
T d1ua2a_         156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD-QLTRIFETLGTPTEEQWPDMCSLPDY  234 (299)
T ss_dssp             CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred             cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH-HHHHHHHhcCCCChhhccchhccchh
Confidence            22345689999999988654 57999999999999999999999987532211 111111111100000000      0 


Q ss_pred             ccccCchhhh-hhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          757 ANLLSQEDIH-FVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       757 ~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      .......... .......++.+.+|+.+||+.||++||||+|+++|
T Consensus       235 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H  280 (299)
T d1ua2a_         235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  280 (299)
T ss_dssp             CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence            0000000000 00112346679999999999999999999999875

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.5e-44  Score=376.19  Aligned_cols=268  Identities=22%  Similarity=0.269  Sum_probs=202.8

Q ss_pred             ccCCCCceeeeccceEEEEEEECCCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEec
Q 040845          527 DKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      ++|++.+.||+|+||+||+|++++|+.||||+++...  ....+.+.+|+.+|++++||||+++++++.+++..+++|||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            6899999999999999999999999999999986542  23356789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 040845          605 MPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQSM  684 (824)
Q Consensus       605 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  684 (824)
                      +.++.+..+.. ....+++.++..++.||+.||+|||   +.+||||||||+||+++.++.+|++|||.|........  
T Consensus        82 ~~~~~~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~--  155 (286)
T d1ob3a_          82 LDQDLKKLLDV-CEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--  155 (286)
T ss_dssp             CSEEHHHHHHT-STTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             ehhhhHHHHHh-hcCCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccCcc--
Confidence            97765555544 4458999999999999999999999   89999999999999999999999999999987643222  


Q ss_pred             ccccccccccccCccCcCCC-CCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcch---hh-----c
Q 040845          685 TQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTM---EV-----V  755 (824)
Q Consensus       685 ~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~-----~  755 (824)
                      ......+++.|+|||.+.+. .++.++||||+||++|||++|+.||.+....+. +.............   ..     .
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~  234 (286)
T d1ob3a_         156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ-LMRIFRILGTPNSKNWPNVTELPKY  234 (286)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH-HHHHHHhhCCCChhhccchhhhhhc
Confidence            23344689999999988654 569999999999999999999999976432211 11111111110000   00     0


Q ss_pred             ccccc-CchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          756 DANLL-SQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       756 ~~~~~-~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      +.... .............+..+.+++.+||+.||++||||+|+++|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H  281 (286)
T d1ob3a_         235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (286)
T ss_dssp             CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00000 00000111123456678999999999999999999999864

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-45  Score=376.62  Aligned_cols=241  Identities=23%  Similarity=0.301  Sum_probs=198.2

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc------chhhhHHHHHHHHhcCC--CCcceeEEeeeecCC
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG------RAFKSFDVECAMMKSIR--HRNLVKVISSCSNEE  596 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~  596 (824)
                      .++|++.+.||+|+||+||+|+.. +|+.||||+++....      .....+.+|+.++++++  |||||++++++.+++
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            357999999999999999999865 689999999875421      12244678999999996  899999999999999


Q ss_pred             eeEEEEeccCC-CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC-CCcEEEeecccc
Q 040845          597 FKALVLEYMPH-GSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD-NMVAHLSDFGIA  674 (824)
Q Consensus       597 ~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~Dfg~a  674 (824)
                      ..++||||+++ +++.+++.... .+++.++..++.|+++||+|||   +.+|+||||||+||+++. ++.+||+|||+|
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~~~-~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a  158 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSG  158 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             eEEEEEEeccCcchHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECccccc
Confidence            99999999976 57888887654 7899999999999999999999   999999999999999985 579999999999


Q ss_pred             cccCCCCCccccccccccccccCccCcCCCCC-CccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchh
Q 040845          675 KLLTGEDQSMTQTQTLATIGYMAPEYGREGQV-STNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTME  753 (824)
Q Consensus       675 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  753 (824)
                      +.....    ..+...||+.|+|||++.+..+ +.++||||+||++|||+||+.||....       ...+....     
T Consensus       159 ~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-------~i~~~~~~-----  222 (273)
T d1xwsa_         159 ALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------EIIRGQVF-----  222 (273)
T ss_dssp             EECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HHHHCCCC-----
T ss_pred             eecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-------HHhhcccC-----
Confidence            865332    2234569999999999887665 677999999999999999999986521       11111000     


Q ss_pred             hccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          754 VVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       754 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                                     .+..+++++.+++.+||+.||++|||++|++++
T Consensus       223 ---------------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  255 (273)
T d1xwsa_         223 ---------------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  255 (273)
T ss_dssp             ---------------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ---------------CCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence                           011245678999999999999999999999875

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-44  Score=374.94  Aligned_cols=269  Identities=25%  Similarity=0.307  Sum_probs=202.2

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-C-CcEEEEEEeecccc--chhhhHHHHHHHHhcC---CCCcceeEEeeeec----
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-D-GMEVAVKVFNLQCG--RAFKSFDVECAMMKSI---RHRNLVKVISSCSN----  594 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~----  594 (824)
                      .++|++.+.||+|+||+||+|++. + ++.||||+++....  .....+.+|+.+++.+   +||||++++++|..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            468999999999999999999874 4 67799999875432  2344567788887766   79999999999853    


Q ss_pred             -CCeeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeeccc
Q 040845          595 -EEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGI  673 (824)
Q Consensus       595 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~  673 (824)
                       ....+++|||++++.+..........+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||.
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~dfg~  162 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGL  162 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred             cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecchhh
Confidence             35778999999887776666656667999999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchh
Q 040845          674 AKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTME  753 (824)
Q Consensus       674 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  753 (824)
                      +.....   ........||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.... ..+..............
T Consensus       163 ~~~~~~---~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~  238 (305)
T d1blxa_         163 ARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKILDVIGLPGEED  238 (305)
T ss_dssp             CCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCGGG
T ss_pred             hhhhcc---cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH-HHHHHHHHhhCCCchhc
Confidence            875432   22334567999999999999999999999999999999999999999763221 11111111111000000


Q ss_pred             h------ccccc-cCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          754 V------VDANL-LSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       754 ~------~~~~~-~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      .      ..... ..............++.+.+|+.+||+.||++||||+|+++|
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H  293 (305)
T d1blxa_         239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  293 (305)
T ss_dssp             SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            0      00000 000000011122456678999999999999999999999875

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-42  Score=366.20  Aligned_cols=271  Identities=23%  Similarity=0.310  Sum_probs=198.5

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeec--------
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSN--------  594 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------  594 (824)
                      .++|++.+.||+|+||+||+|++. +|+.||||++....  .....++.+|+++|++++||||+++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            478999999999999999999874 69999999986442  3345678899999999999999999999854        


Q ss_pred             CCeeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccc
Q 040845          595 EEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIA  674 (824)
Q Consensus       595 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a  674 (824)
                      +...++||||++++.+..+. .....++..+++.++.|+++|+.|||   +.+|+||||||+||+++.++.+|++|||+|
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~-~~~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg~~  164 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA  164 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHT-CTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             CceEEEEEeccCCCccchhh-hcccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeeccee
Confidence            34678999999876655444 44457899999999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCCCc--cccccccccccccCccCcCCC-CCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhC---C
Q 040845          675 KLLTGEDQS--MTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCL---P  748 (824)
Q Consensus       675 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~---~  748 (824)
                      ..+......  .......||+.|+|||.+.+. .++.++||||+||++|||++|+.||.+....+ ..........   +
T Consensus       165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~  243 (318)
T d3blha1         165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH-QLALISQLCGSITP  243 (318)
T ss_dssp             EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCT
T ss_pred             eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHH-HHHHHHHhcCCCCh
Confidence            876533222  222335699999999988755 68999999999999999999999997532211 1111111111   0


Q ss_pred             Ccchhh--------cc-ccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          749 ISTMEV--------VD-ANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       749 ~~~~~~--------~~-~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      ......        .. ..................+.+.+|+.+||+.||++||||+|+++|
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence            000000        00 000000111111222345678899999999999999999999875

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.3e-42  Score=360.87  Aligned_cols=260  Identities=19%  Similarity=0.233  Sum_probs=204.1

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcce-eEEeeeecCCeeEEEEec
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLV-KVISSCSNEEFKALVLEY  604 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~  604 (824)
                      ++|++.+.||+|+||+||+|++. +|+.||||++....  ..+.+..|+++++.++|++++ .+.+++.+.+..++||||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence            57999999999999999999864 58999999987543  345688999999999877655 555566778889999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeC---CCCcEEEeecccccccCCCC
Q 040845          605 MPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLTGED  681 (824)
Q Consensus       605 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~---~~~~~kl~Dfg~a~~~~~~~  681 (824)
                      + ++++.+.+......+++..+..++.|++.||+|||   +++|+||||||+||+++   .+..+|++|||+|+.+....
T Consensus        85 ~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~  160 (299)
T d1ckia_          85 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR  160 (299)
T ss_dssp             C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred             c-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence            9 56787777766668999999999999999999999   99999999999999986   45579999999999875433


Q ss_pred             Cc-----cccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhh--hhhhhhCCCcchhh
Q 040845          682 QS-----MTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLK--HWVNDCLPISTMEV  754 (824)
Q Consensus       682 ~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~  754 (824)
                      ..     .......||+.|+|||.+.+..++.++|||||||++|||+||+.||...........  .+...         
T Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~---------  231 (299)
T d1ckia_         161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK---------  231 (299)
T ss_dssp             TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHH---------
T ss_pred             cccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcc---------
Confidence            22     123345799999999999999999999999999999999999999976432221111  10000         


Q ss_pred             ccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHH
Q 040845          755 VDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRD  807 (824)
Q Consensus       755 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~  807 (824)
                         ..   ..........+++++.+++.+||+.+|++||+++++.+.|+.+..
T Consensus       232 ---~~---~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~  278 (299)
T d1ckia_         232 ---KM---STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  278 (299)
T ss_dssp             ---HH---HSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred             ---cC---CCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence               00   000011123567889999999999999999999999998888754

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=6.4e-42  Score=356.33  Aligned_cols=264  Identities=14%  Similarity=0.161  Sum_probs=212.1

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcCCC-CcceeEEeeeecCCeeEEEEec
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRH-RNLVKVISSCSNEEFKALVLEY  604 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~  604 (824)
                      ++|++.+.||+|+||+||+|++. +|+.||||++...  ...+.+.+|++.++.++| +|++.+++++.+....++||||
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~   82 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL   82 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccc--cCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence            57999999999999999999865 5899999988643  334567889999999975 8999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCC-----CCcEEEeecccccccCC
Q 040845          605 MPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD-----NMVAHLSDFGIAKLLTG  679 (824)
Q Consensus       605 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~-----~~~~kl~Dfg~a~~~~~  679 (824)
                      + +++|.+++......+++.++..++.|++.|++|||   +.+|+||||||+||+++.     ++.+||+|||+|+.+..
T Consensus        83 ~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~  158 (293)
T d1csna_          83 L-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD  158 (293)
T ss_dssp             C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred             c-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence            9 68999999887778999999999999999999999   999999999999999974     57899999999988754


Q ss_pred             CCCc-----cccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhh
Q 040845          680 EDQS-----MTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEV  754 (824)
Q Consensus       680 ~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  754 (824)
                      ....     .......||+.|||||.+.+..++.++||||+||++|||+||+.||.+....... ..+..         +
T Consensus       159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~-~~~~~---------i  228 (293)
T d1csna_         159 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK-QKYER---------I  228 (293)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH-HHHHH---------H
T ss_pred             CccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHH-HHHHH---------H
Confidence            3221     1233457999999999999999999999999999999999999999764322111 11000         0


Q ss_pred             ccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHHHHhh
Q 040845          755 VDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAKLLKIRDSL  809 (824)
Q Consensus       755 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~L~~~~~~~  809 (824)
                      .......   ........+++++.+++..|++.+|++||+++.+.+.|+++.+..
T Consensus       229 ~~~~~~~---~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~  280 (293)
T d1csna_         229 GEKKQST---PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL  280 (293)
T ss_dssp             HHHHHHS---CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             HhccCCC---ChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence            0000000   000011246778999999999999999999999999988876544

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-42  Score=359.87  Aligned_cols=269  Identities=22%  Similarity=0.267  Sum_probs=207.0

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeecCCeeEEEEe
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEEFKALVLE  603 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  603 (824)
                      ++|++.+.||+|+||+||+|++. +|+.||||+++...  ....+.+.+|+.+++.++||||+++++++.+....++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            58999999999999999999864 68999999997553  2345788999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 040845          604 YMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTGEDQS  683 (824)
Q Consensus       604 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  683 (824)
                      ++.++++..++...+ .+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+|++|||.|........ 
T Consensus        82 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~-  156 (292)
T d1unla_          82 FCDQDLKKYFDSCNG-DLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-  156 (292)
T ss_dssp             CCSEEHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS-
T ss_pred             ecccccccccccccc-ccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccCCCc-
Confidence            999988888776554 7889999999999999999999   99999999999999999999999999999987643332 


Q ss_pred             cccccccccccccCccCcCCCC-CCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCc------chhhcc
Q 040845          684 MTQTQTLATIGYMAPEYGREGQ-VSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPIS------TMEVVD  756 (824)
Q Consensus       684 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~------~~~~~~  756 (824)
                       ......++..|+|||.+.... ++.++||||+||++|||++|+.||..................+..      .....+
T Consensus       157 -~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (292)
T d1unla_         157 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD  235 (292)
T ss_dssp             -CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred             -cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccc
Confidence             223345788999999887665 699999999999999999999997542222221221111111100      000000


Q ss_pred             cc---ccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          757 AN---LLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       757 ~~---~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      ..   ...............++.+.+|+.+||+.||.+||||+|+++|
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H  283 (292)
T d1unla_         236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             ccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00   0000011111223456678999999999999999999999875

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-42  Score=367.03  Aligned_cols=262  Identities=24%  Similarity=0.310  Sum_probs=193.7

Q ss_pred             cCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcceeEEeeeec------CCeeEE
Q 040845          528 KFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNLVKVISSCSN------EEFKAL  600 (824)
Q Consensus       528 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~~~l  600 (824)
                      +|+..++||+|+||+||+|++. +|+.||||++....    ....+|+++|++++||||+++++++..      ..+.++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc----hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            6888899999999999999875 59999999986542    233579999999999999999999843      345789


Q ss_pred             EEeccCCCCHHHHhh--hCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC-cEEEeeccccccc
Q 040845          601 VLEYMPHGSLEKYLH--SSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM-VAHLSDFGIAKLL  677 (824)
Q Consensus       601 v~e~~~~g~L~~~l~--~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~Dfg~a~~~  677 (824)
                      ||||++++.+..+..  .....+++.++..++.||+.||+|||   +++|+||||||+|||++.++ .+||+|||+|+..
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence            999997654333332  23457999999999999999999999   99999999999999999775 8999999999876


Q ss_pred             CCCCCccccccccccccccCccCcCC-CCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCc------
Q 040845          678 TGEDQSMTQTQTLATIGYMAPEYGRE-GQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPIS------  750 (824)
Q Consensus       678 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~------  750 (824)
                      .....   .....||..|+|||.+.+ ..++.++||||+||++|||++|+.||......+ .+..+........      
T Consensus       174 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~-~l~~i~~~~g~~~~~~~~~  249 (350)
T d1q5ka_         174 VRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD-QLVEIIKVLGTPTREQIRE  249 (350)
T ss_dssp             CTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH-HHHHHHHHHCCCCHHHHHH
T ss_pred             cCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH-HHHHHHHHhCCChHHhhhh
Confidence            43322   233568999999998764 568999999999999999999999997532211 1111111110000      


Q ss_pred             ----chhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          751 ----TMEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       751 ----~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                          .....-+.... ...........++++.+|+.+||..||++||||+|+++|
T Consensus       250 ~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  303 (350)
T d1q5ka_         250 MNPNYTEFKFPQIKA-HPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  303 (350)
T ss_dssp             HCC---CCCCCCCCC-CCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hccchhhcccccccc-CchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                00000000000 000011112356678999999999999999999999976

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-42  Score=366.23  Aligned_cols=270  Identities=21%  Similarity=0.228  Sum_probs=198.4

Q ss_pred             hccCCCCceeeeccceEEEEEEE-CCCcEEEEEEeeccc-cchhhhHHHHHHHHhcCCCCcceeEEeeeecCC----eeE
Q 040845          526 TDKFSENNLIGRGGFGSVYKARI-RDGMEVAVKVFNLQC-GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEE----FKA  599 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~  599 (824)
                      .++|++.+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+++|++++||||+++++++..+.    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            46799999999999999999986 479999999996543 234567889999999999999999999986543    234


Q ss_pred             EEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccccCC
Q 040845          600 LVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTG  679 (824)
Q Consensus       600 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~~~~  679 (824)
                      ++++|+.+|+|.+++...  .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+|.....
T Consensus        87 ~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~  161 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP  161 (345)
T ss_dssp             EEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred             EEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence            555666799999999765  5899999999999999999999   99999999999999999999999999999987643


Q ss_pred             CCCc-cccccccccccccCccCcCCC-CCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhh---
Q 040845          680 EDQS-MTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEV---  754 (824)
Q Consensus       680 ~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---  754 (824)
                      .... .......||+.|+|||++... .++.++||||+||++|||++|+.||......+... ..............   
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~  240 (345)
T d1pmea_         162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN-HILGILGSPSQEDLNCI  240 (345)
T ss_dssp             GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-HHHHHHCSCCHHHHHTC
T ss_pred             CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHH-HHhhhccCCChhhhhhh
Confidence            3222 223456799999999988554 57899999999999999999999997643221111 11110000000000   


Q ss_pred             --------ccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          755 --------VDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       755 --------~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                              ...................+..+.+++.+||+.||++||||+|+++|
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                    00000000000000111345678999999999999999999999986

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-42  Score=366.29  Aligned_cols=268  Identities=24%  Similarity=0.280  Sum_probs=197.4

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeecCC------
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSNEE------  596 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  596 (824)
                      .++|++.+.||+|+||+||+|++. +|+.||||+++...  ....+.+.+|+++|+.++|||||+++++|...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            578999999999999999999865 59999999987542  233567889999999999999999999997654      


Q ss_pred             eeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccc
Q 040845          597 FKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  676 (824)
Q Consensus       597 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~  676 (824)
                      ..++||||+ +.+|..+.+..  .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+|++|||.|+.
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~  170 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ  170 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEecc-cccHHHHHHhc--cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhcccccccccccccceec
Confidence            569999999 56888877654  5899999999999999999999   99999999999999999999999999999987


Q ss_pred             cCCCCCccccccccccccccCccCcCCC-CCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCc--chh
Q 040845          677 LTGEDQSMTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPIS--TME  753 (824)
Q Consensus       677 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~  753 (824)
                      ....     .+...||+.|+|||.+.+. .++.++||||+||++|||++|+.||.+.... ..+..+........  ...
T Consensus       171 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~  244 (346)
T d1cm8a_         171 ADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL-DQLKEIMKVTGTPPAEFVQ  244 (346)
T ss_dssp             CCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHHH
T ss_pred             cCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChH-HHHHHHHhccCCCcHHHHh
Confidence            5432     2345699999999988654 5689999999999999999999999763211 11111111111000  000


Q ss_pred             hc--------cccccCchhh-hhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHHH
Q 040845          754 VV--------DANLLSQEDI-HFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK--LLKI  805 (824)
Q Consensus       754 ~~--------~~~~~~~~~~-~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~--L~~~  805 (824)
                      ..        .......... -......+++.+.+|+.+||..||++||||+|+++|  ++.+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~  307 (346)
T d1cm8a_         245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL  307 (346)
T ss_dssp             TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             hhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence            00        0000000000 000112345678899999999999999999999987  5544

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-42  Score=363.79  Aligned_cols=254  Identities=24%  Similarity=0.331  Sum_probs=203.8

Q ss_pred             hccCCCCceeeeccceEEEEEEEC----CCcEEEEEEeeccc----cchhhhHHHHHHHHhcCCC-CcceeEEeeeecCC
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR----DGMEVAVKVFNLQC----GRAFKSFDVECAMMKSIRH-RNLVKVISSCSNEE  596 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~  596 (824)
                      .++|++.+.||+|+||+||+|+..    +|+.||||+++...    ....+.+.+|++++++++| |||+++++++.+..
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~  102 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  102 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence            367999999999999999999752    47899999986432    2345678889999999977 89999999999999


Q ss_pred             eeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccc
Q 040845          597 FKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  676 (824)
Q Consensus       597 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~  676 (824)
                      ..++||||+++|+|.+++...+ ..++..+..++.|++.|++|+|   +.+|+||||||+||+++.++.+||+|||+|+.
T Consensus       103 ~~~~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~  178 (322)
T d1vzoa_         103 KLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  178 (322)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             ceeeeeecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccchhh
Confidence            9999999999999999998776 5778899999999999999999   99999999999999999999999999999987


Q ss_pred             cCCCCCccccccccccccccCccCcCCC--CCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCcchhh
Q 040845          677 LTGEDQSMTQTQTLATIGYMAPEYGREG--QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPISTMEV  754 (824)
Q Consensus       677 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  754 (824)
                      +...... ......|++.|+|||.+.+.  .++.++||||+||++|||++|+.||......+.. .........      
T Consensus       179 ~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~-~~i~~~~~~------  250 (322)
T d1vzoa_         179 FVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ-AEISRRILK------  250 (322)
T ss_dssp             CCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH-HHHHHHHHH------
T ss_pred             hcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHhccc------
Confidence            6433222 23345689999999988654  4688999999999999999999999764332211 111111000      


Q ss_pred             ccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 040845          755 VDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRI-----NAKEIVAK  801 (824)
Q Consensus       755 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----t~~evl~~  801 (824)
                                .....+..++.++.+++.+||.+||++||     |++|+++|
T Consensus       251 ----------~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H  292 (322)
T d1vzoa_         251 ----------SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  292 (322)
T ss_dssp             ----------CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             ----------CCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence                      00011224577899999999999999999     58999874

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=2e-41  Score=359.87  Aligned_cols=262  Identities=19%  Similarity=0.283  Sum_probs=198.5

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcCC-CCcceeEEeeeec--CCeeEEEE
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIR-HRNLVKVISSCSN--EEFKALVL  602 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lv~  602 (824)
                      ++|++.+.||+|+||+||+|+.. +|+.||||+++..   ..+.+.+|+++|+.++ ||||+++++++..  ....++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            67999999999999999999874 6899999998643   3467889999999995 9999999999874  45789999


Q ss_pred             eccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC-cEEEeecccccccCCCC
Q 040845          603 EYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM-VAHLSDFGIAKLLTGED  681 (824)
Q Consensus       603 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~Dfg~a~~~~~~~  681 (824)
                      ||+++++|..+.    ..+++.++..++.||+.||+|||   +++|+||||||+|||++.++ .+||+|||+|+......
T Consensus       112 e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~  184 (328)
T d3bqca1         112 EHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ  184 (328)
T ss_dssp             ECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred             eecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence            999999987764    26899999999999999999999   99999999999999998654 69999999998765332


Q ss_pred             CccccccccccccccCccCcCCC-CCCccchHHHHHHHHHHHHhCCCCCcccccCcchhh------------hhhhhhCC
Q 040845          682 QSMTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLK------------HWVNDCLP  748 (824)
Q Consensus       682 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~------------~~~~~~~~  748 (824)
                      .   .....+|+.|+|||.+.+. .++.++||||+||++|||++|+.||...........            .|......
T Consensus       185 ~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~  261 (328)
T d3bqca1         185 E---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI  261 (328)
T ss_dssp             C---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred             c---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence            2   3345689999999987765 479999999999999999999999865322111111            11110000


Q ss_pred             Ccc---hhhccc--cccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          749 IST---MEVVDA--NLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       749 ~~~---~~~~~~--~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                      ...   ......  ...............+++++.+|+.+||+.||++|||++|+++|
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H  319 (328)
T d3bqca1         262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  319 (328)
T ss_dssp             CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            000   000000  00000001111223456778999999999999999999999864

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-41  Score=361.35  Aligned_cols=262  Identities=22%  Similarity=0.240  Sum_probs=192.1

Q ss_pred             hccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccc--cchhhhHHHHHHHHhcCCCCcceeEEeeeec------CC
Q 040845          526 TDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQC--GRAFKSFDVECAMMKSIRHRNLVKVISSCSN------EE  596 (824)
Q Consensus       526 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~  596 (824)
                      .++|++.+.||+|+||+||+|.+. +|+.||||+++...  ......+.+|+.++++++||||+++++++..      ..
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~   95 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ   95 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence            468999999999999999999876 59999999997543  2334568899999999999999999999853      46


Q ss_pred             eeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccc
Q 040845          597 FKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  676 (824)
Q Consensus       597 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~  676 (824)
                      +.|+||||+.++ +.+.+.   ..+++.+++.++.||+.|++|||   +.||+||||||+||+++.++.+|++|||+++.
T Consensus        96 ~~~iv~Ey~~~~-l~~~~~---~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~  168 (355)
T d2b1pa1          96 DVYLVMELMDAN-LCQVIQ---MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART  168 (355)
T ss_dssp             EEEEEEECCSEE-HHHHHT---SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             eeEEEEeccchH-HHHhhh---cCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhhhhc
Confidence            889999999765 444443   25789999999999999999999   99999999999999999999999999999876


Q ss_pred             cCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhh-------------
Q 040845          677 LTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWV-------------  743 (824)
Q Consensus       677 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~-------------  743 (824)
                      ...   ........+|+.|+|||++.+..++.++||||+||++|||++|+.||.+..... ......             
T Consensus       169 ~~~---~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~-~~~~i~~~~~~~~~~~~~~  244 (355)
T d2b1pa1         169 AGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVIEQLGTPCPEFMKK  244 (355)
T ss_dssp             ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCHHHHTT
T ss_pred             ccc---ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHH-HHHHHHHhccCCCHHHHHH
Confidence            532   223345568999999999999999999999999999999999999986432110 011110             


Q ss_pred             ---------hhhCCCcc---hhhccccccCchhhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          744 ---------NDCLPIST---MEVVDANLLSQEDIHFVAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       744 ---------~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                               ........   ........   ...........+..+.+|+.+|+..||++||||+|+++|
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         245 LQPTVRNYVENRPKYAGLTFPKLFPDSL---FPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             SCHHHHHHHHTSCCCCCCCHHHHSCGGG---SCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhHHHHhhcCcccccccccccccccc---ccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence                     00000000   00000000   011112234567789999999999999999999999876

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-40  Score=357.84  Aligned_cols=266  Identities=22%  Similarity=0.278  Sum_probs=196.6

Q ss_pred             hhccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeecccc--chhhhHHHHHHHHhcCCCCcceeEEeeeec-----CC
Q 040845          525 ATDKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCG--RAFKSFDVECAMMKSIRHRNLVKVISSCSN-----EE  596 (824)
Q Consensus       525 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~  596 (824)
                      ..++|++.+.||+|+||+||+|+.. +|+.||||+++....  ...+.+.+|++++++++|||||++++++..     +.
T Consensus        16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~   95 (348)
T d2gfsa1          16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF   95 (348)
T ss_dssp             EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred             CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence            3578999999999999999999864 699999999875432  334568899999999999999999999853     33


Q ss_pred             eeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeecccccc
Q 040845          597 FKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  676 (824)
Q Consensus       597 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~~  676 (824)
                      ..+++++|+.+|+|.+++...  .+++.++..++.||+.||+|||   +++|+||||||+||+++.++.+|++|||.|..
T Consensus        96 ~~~~i~~~~~gg~L~~~~~~~--~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~  170 (348)
T d2gfsa1          96 NDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARH  170 (348)
T ss_dssp             CCCEEEEECCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred             ceEEEEEeecCCchhhhcccc--cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchhcc
Confidence            446777788899999999654  5899999999999999999999   99999999999999999999999999999975


Q ss_pred             cCCCCCccccccccccccccCccCcCCC-CCCccchHHHHHHHHHHHHhCCCCCcccccCcchhhhhhhhhCCCc-----
Q 040845          677 LTGEDQSMTQTQTLATIGYMAPEYGREG-QVSTNGDVYSFGIMLMETFTRKKPTDELFNGEMTLKHWVNDCLPIS-----  750 (824)
Q Consensus       677 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-----  750 (824)
                      ...     ......|++.|+|||...+. .++.++||||+||++|+|++|+.||.+..... .............     
T Consensus       171 ~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~-~~~~i~~~~~~~~~~~~~  244 (348)
T d2gfsa1         171 TDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILRLVGTPGAELLK  244 (348)
T ss_dssp             CTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCHHHHT
T ss_pred             cCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCChHHhh
Confidence            432     23345689999999986665 46899999999999999999999997532111 1111111111000     


Q ss_pred             -----chhhccccccCchhhhh-hhHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 040845          751 -----TMEVVDANLLSQEDIHF-VAKEQCVSFVFNLALECTVESPEQRINAKEIVAK  801 (824)
Q Consensus       751 -----~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~evl~~  801 (824)
                           ................. .....+++.+.+|+.+||..||++||||+|+++|
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H  301 (348)
T d2gfsa1         245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  301 (348)
T ss_dssp             TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence                 00000000000000000 0112456778999999999999999999999985

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.5e-36  Score=327.46  Aligned_cols=267  Identities=15%  Similarity=0.186  Sum_probs=189.1

Q ss_pred             ccCCCCceeeeccceEEEEEEEC-CCcEEEEEEeeccccchhhhHHHHHHHHhcCC-----------CCcceeEEeeeec
Q 040845          527 DKFSENNLIGRGGFGSVYKARIR-DGMEVAVKVFNLQCGRAFKSFDVECAMMKSIR-----------HRNLVKVISSCSN  594 (824)
Q Consensus       527 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~  594 (824)
                      .+|++.+.||+|+||+||+|+.. +|+.||||+++... ...+.+.+|+.+++.++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            35999999999999999999874 69999999997542 23466788999988875           5789999988754


Q ss_pred             --CCeeEEEEeccCCCCH-HHH-hhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCC------
Q 040845          595 --EEFKALVLEYMPHGSL-EKY-LHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM------  664 (824)
Q Consensus       595 --~~~~~lv~e~~~~g~L-~~~-l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~------  664 (824)
                        ....+++++++..+.. ... .......+++..+..++.||+.|++|||+  ..+|+||||||+|||++.++      
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~  169 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLI  169 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred             ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccc
Confidence              4556666666654432 222 23333578899999999999999999992  38999999999999998655      


Q ss_pred             cEEEeecccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHHHHHHhCCCCCcccccCc-----chh
Q 040845          665 VAHLSDFGIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIMLMETFTRKKPTDELFNGE-----MTL  739 (824)
Q Consensus       665 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~tg~~p~~~~~~~~-----~~~  739 (824)
                      .++++|||.|......     .....||+.|+|||.+....++.++||||+||+++||++|+.||.......     ...
T Consensus       170 ~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~  244 (362)
T d1q8ya_         170 QIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI  244 (362)
T ss_dssp             EEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred             eeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence            4999999999865332     234569999999999999999999999999999999999999987532110     011


Q ss_pred             hhhhhhhCCCc--c-------hhhcccc-------ccCch------hhhhhhHHHHHHHHHHHHHHccccCCCCCCCHHH
Q 040845          740 KHWVNDCLPIS--T-------MEVVDAN-------LLSQE------DIHFVAKEQCVSFVFNLALECTVESPEQRINAKE  797 (824)
Q Consensus       740 ~~~~~~~~~~~--~-------~~~~~~~-------~~~~~------~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rpt~~e  797 (824)
                      ...+.......  .       ....+..       .....      ..........+..+.+|+.+|+..||++||||+|
T Consensus       245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e  324 (362)
T d1q8ya_         245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG  324 (362)
T ss_dssp             HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred             HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence            11111111000  0       0000000       00000      0011122456788999999999999999999999


Q ss_pred             HHHH
Q 040845          798 IVAK  801 (824)
Q Consensus       798 vl~~  801 (824)
                      +++|
T Consensus       325 ~L~H  328 (362)
T d1q8ya_         325 LVNH  328 (362)
T ss_dssp             HHTC
T ss_pred             HhcC
Confidence            9875

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.97  E-value=2.1e-31  Score=280.74  Aligned_cols=257  Identities=32%  Similarity=0.571  Sum_probs=232.2

Q ss_pred             cccEEEeecCccee--cCCccCCCCCCCCEEEecC-CccCCccchhhcCCCCCCEEEcccccCcccCCccccccCCccEE
Q 040845          198 SLKNFYMYNCNVSG--GIPEEITNLTDLTTIVLGG-NKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYEL  274 (824)
Q Consensus       198 ~L~~L~l~~n~l~~--~~~~~l~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L  274 (824)
                      .++.|+|++|.+.+  .+|..++++++|++|+|++ |.+.+.+|..|+++++|++|+|++|++.+..+..+..+.+|+.+
T Consensus        51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l  130 (313)
T d1ogqa_          51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL  130 (313)
T ss_dssp             CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred             EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccc
Confidence            35566666666655  5788999999999999987 88998899999999999999999999999899999999999999


Q ss_pred             EccCccccccCCccccCCCCCcEEEcCCCCCC-CCCCcccccccc-cccccccccccCcCCccccccccchhhhcccccc
Q 040845          275 ELGGNKLSGSIPACFSNMTFLKVLSLGSNELT-SIPLNFWSLKDI-LDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNF  352 (824)
Q Consensus       275 ~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L-~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l  352 (824)
                      ++++|.+.+..|..+.+++.|+.+++++|.++ .+|..+..+..+ +.+++++|++++..|..+.++..+ .+++++|.+
T Consensus       131 ~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~  209 (313)
T d1ogqa_         131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNML  209 (313)
T ss_dssp             ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEE
T ss_pred             ccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-ccccccccc
Confidence            99999999999999999999999999999998 678888887775 789999999999999988887655 699999999


Q ss_pred             cccCCCccCCCCCCCeEEccCccccccCCccccccccccEEEccCcccCCCCcccccCCcccceeeccCCcccCCCCCCC
Q 040845          353 SGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIPRGG  432 (824)
Q Consensus       353 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~  432 (824)
                      .+.+|..+..+++|+.|++++|.+++.+ ..+..+++|+.|+|++|+++|.+|..+.++++|+.|+|++|+|+|.+|..+
T Consensus       210 ~~~~~~~~~~~~~l~~l~~~~~~l~~~~-~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~  288 (313)
T d1ogqa_         210 EGDASVLFGSDKNTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG  288 (313)
T ss_dssp             EECCGGGCCTTSCCSEEECCSSEECCBG-GGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCST
T ss_pred             cccccccccccccccccccccccccccc-cccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcc
Confidence            9999999999999999999999999655 468899999999999999999999999999999999999999999999988


Q ss_pred             CccccccccccCCccccCCCCCCCCCC
Q 040845          433 SFGNFSAESFKGNELLCGSPNLQVPPC  459 (824)
Q Consensus       433 ~~~~~~~~~~~~n~~~c~~~~~~~~~c  459 (824)
                      .+.++..+.+.+|+.+||.|   .|+|
T Consensus       289 ~L~~L~~l~l~~N~~l~g~p---lp~c  312 (313)
T d1ogqa_         289 NLQRFDVSAYANNKCLCGSP---LPAC  312 (313)
T ss_dssp             TGGGSCGGGTCSSSEEESTT---SSCC
T ss_pred             cCCCCCHHHhCCCccccCCC---CCCC
Confidence            89999999999999999988   4566

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.97  E-value=6.5e-30  Score=277.84  Aligned_cols=342  Identities=24%  Similarity=0.329  Sum_probs=213.1

Q ss_pred             CCCCCCEEeCCCCcCCcccChhhhCcCCCceeeccCCccccccCccccCCCCCccEEEccCCeeeeecCccccCCCCCce
Q 040845           43 HLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSK  122 (824)
Q Consensus        43 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~  122 (824)
                      .+.+|++|++++|.|+. + +.+..+++|++|+|++|+|++++.   ..++++|++|++++|++++..  .+..+++|+.
T Consensus        42 ~l~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~l~~---l~~L~~L~~L~L~~n~i~~i~--~l~~l~~L~~  114 (384)
T d2omza2          42 DLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP---LKNLTKLVDILMNNNQIADIT--PLANLTNLTG  114 (384)
T ss_dssp             HHTTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG---GTTCTTCCEEECCSSCCCCCG--GGTTCTTCCE
T ss_pred             HhCCCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCCCCcc---ccCCccccccccccccccccc--cccccccccc
Confidence            44455555555555542 2 234445555555555555554432   123555555555555554322  2455555555


Q ss_pred             EeccCccccccCCccccCCCCCCEEEccCCcCCCCcCcccccccCCCCCCCcEEECcCCCCCccCCccccccccccccEE
Q 040845          123 LALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNF  202 (824)
Q Consensus       123 L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~~L~~L  202 (824)
                      |++++|.+++..  .......+..+....|.+.......     ................+.....       .......
T Consensus       115 L~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~  180 (384)
T d2omza2         115 LTLFNNQITDID--PLKNLTNLNRLELSSNTISDISALS-----GLTSLQQLSFGNQVTDLKPLAN-------LTTLERL  180 (384)
T ss_dssp             EECCSSCCCCCG--GGTTCTTCSEEEEEEEEECCCGGGT-----TCTTCSEEEEEESCCCCGGGTT-------CTTCCEE
T ss_pred             cccccccccccc--ccccccccccccccccccccccccc-----ccccccccccccccchhhhhcc-------ccccccc
Confidence            555555555332  2233445555555555544332110     1111111111111111111100       1112222


Q ss_pred             EeecCcceecCCccCCCCCCCCEEEecCCccCCccchhhcCCCCCCEEEcccccCcccCCccccccCCccEEEccCcccc
Q 040845          203 YMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLS  282 (824)
Q Consensus       203 ~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~  282 (824)
                      ....|..  .....+..+++++.+++++|.+++..|  +...++|++|++++|+++.  .+.+..+++|+.|++++|+++
T Consensus       181 ~~~~~~~--~~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~--~~~l~~l~~L~~L~l~~n~l~  254 (384)
T d2omza2         181 DISSNKV--SDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQIS  254 (384)
T ss_dssp             ECCSSCC--CCCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCC
T ss_pred             ccccccc--ccccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCC--cchhhcccccchhccccCccC
Confidence            2222222  223445667788888888888876544  4566788888888888874  245777888888888888887


Q ss_pred             ccCCccccCCCCCcEEEcCCCCCCCCCCcccccccccccccccccccCcCCccccccccchhhhcccccccccCCCccCC
Q 040845          283 GSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGS  362 (824)
Q Consensus       283 ~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~  362 (824)
                      +..+  ++.+++|++|++++|+++.++. +..++.++.++++.|.+.+  ...+..+++++.|++++|++++..  .+..
T Consensus       255 ~~~~--~~~~~~L~~L~l~~~~l~~~~~-~~~~~~l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~--~l~~  327 (384)
T d2omza2         255 NLAP--LSGLTKLTELKLGANQISNISP-LAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDIS--PVSS  327 (384)
T ss_dssp             CCGG--GTTCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCCG--GGGG
T ss_pred             CCCc--ccccccCCEeeccCcccCCCCc-ccccccccccccccccccc--ccccchhcccCeEECCCCCCCCCc--cccc
Confidence            5443  7778888999998888887763 6677888888888888874  345788888999999999998753  3888


Q ss_pred             CCCCCeEEccCccccccCCccccccccccEEEccCcccCCCCcccccCCcccceeeccCC
Q 040845          363 LKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFN  422 (824)
Q Consensus       363 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N  422 (824)
                      +++|+.|++++|+|++ ++ .+.++++|++|++++|+|++..|  +.++++|+.|+|++|
T Consensus       328 l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N  383 (384)
T d2omza2         328 LTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ  383 (384)
T ss_dssp             CTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred             CCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence            9999999999999984 44 58899999999999999985544  788999999999987

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.96  E-value=1.3e-28  Score=267.34  Aligned_cols=356  Identities=24%  Similarity=0.307  Sum_probs=264.4

Q ss_pred             ccccccccCCcccccCCCCCcEEEccCCcccccccccccCCCCCCEEeCCCCcCCcccChhhhCcCCCceeeccCCcccc
Q 040845            4 IINNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLSG   83 (824)
Q Consensus         4 l~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~   83 (824)
                      +.++++++.++  ..++.+|++|++++|.|+. + ..++.+++|++|||++|+|++. + .+.++++|++|++++|++++
T Consensus        29 l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~l-~-~l~~L~~L~~L~L~~n~i~~  102 (384)
T d2omza2          29 LGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDI-T-PLKNLTKLVDILMNNNQIAD  102 (384)
T ss_dssp             TTCSSTTSEEC--HHHHTTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC
T ss_pred             hCCCCCCCccC--HHHhCCCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCCCC-c-cccCCccccccccccccccc
Confidence            45566766655  3678899999999999985 3 4688999999999999999954 4 49999999999999999987


Q ss_pred             ccCccccCCCCCccEEEccCCeeeeecCccccCCCCCceEeccCccccccCCccccCCCCCCEEEccCCcCCCCcCcccc
Q 040845           84 CLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSF  163 (824)
Q Consensus        84 ~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~  163 (824)
                      +++   ..++++|+.|++++|.+++..+  ......+..+....|.+....+..................+         
T Consensus       103 i~~---l~~l~~L~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~---------  168 (384)
T d2omza2         103 ITP---LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDL---------  168 (384)
T ss_dssp             CGG---GTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCC---------
T ss_pred             ccc---cccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccchh---------
Confidence            654   2469999999999999985433  44567888888888888754433333222222222222211         


Q ss_pred             cccCCCCCCCcEEECcCCCCCccCCccccccccccccEEEeecCcceecCCccCCCCCCCCEEEecCCccCCccchhhcC
Q 040845          164 LSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGK  243 (824)
Q Consensus       164 ~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~  243 (824)
                       ..+...+.........|........    ....+++.+++++|.+++..|  +..+++|++|++++|.++..  ..+..
T Consensus       169 -~~~~~~~~~~~~~~~~~~~~~~~~~----~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~  239 (384)
T d2omza2         169 -KPLANLTTLERLDISSNKVSDISVL----AKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLAS  239 (384)
T ss_dssp             -GGGTTCTTCCEEECCSSCCCCCGGG----GGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGG
T ss_pred             -hhhcccccccccccccccccccccc----ccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc--chhhc
Confidence             1234445555555555554432111    113456777777777665433  34567888888888888742  36778


Q ss_pred             CCCCCEEEcccccCcccCCccccccCCccEEEccCccccccCCccccCCCCCcEEEcCCCCCCCCCCccccccccccccc
Q 040845          244 LQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNL  323 (824)
Q Consensus       244 l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l  323 (824)
                      +++|+.|++++|++++..  .+..+++|+.|++++|++.+..  .+..++.++.+++++|.++.++ .+..+++++.|++
T Consensus       240 l~~L~~L~l~~n~l~~~~--~~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~~~-~~~~~~~l~~L~l  314 (384)
T d2omza2         240 LTNLTDLDLANNQISNLA--PLSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLEDIS-PISNLKNLTYLTL  314 (384)
T ss_dssp             CTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSCCG-GGGGCTTCSEEEC
T ss_pred             ccccchhccccCccCCCC--cccccccCCEeeccCcccCCCC--cccccccccccccccccccccc-ccchhcccCeEEC
Confidence            888999999999887543  3677888999999998887543  3778888999999999988765 4677888999999


Q ss_pred             ccccccCcCCccccccccchhhhcccccccccCCCccCCCCCCCeEEccCccccccCCccccccccccEEEccCcc
Q 040845          324 SSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNN  399 (824)
Q Consensus       324 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  399 (824)
                      ++|++++..  .+..+++|+.|++++|+|++. + .++++++|++|++++|+|++..|  +.++++|+.|+|++|.
T Consensus       315 s~n~l~~l~--~l~~l~~L~~L~L~~n~l~~l-~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~Na  384 (384)
T d2omza2         315 YFNNISDIS--PVSSLTKLQRLFFANNKVSDV-S-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQA  384 (384)
T ss_dssp             CSSCCSCCG--GGGGCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCEE
T ss_pred             CCCCCCCCc--ccccCCCCCEEECCCCCCCCC-h-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCCc
Confidence            999998643  378899999999999999853 3 68999999999999999996544  8999999999999983

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.95  E-value=1.6e-28  Score=258.44  Aligned_cols=252  Identities=29%  Similarity=0.443  Sum_probs=204.4

Q ss_pred             CCcEEECcCCCCCcc--CCccccccccccccEEEeec-CcceecCCccCCCCCCCCEEEecCCccCCccchhhcCCCCCC
Q 040845          172 SLTHISLSNNPLDGI--LPRTYVGNLSHSLKNFYMYN-CNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQ  248 (824)
Q Consensus       172 ~L~~L~Ls~n~l~~~--~~~~~~~~l~~~L~~L~l~~-n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~  248 (824)
                      ++++|+|++|.+.+.  .|..+ +. .++|++|+|++ |+++|.+|..|+++++|++|+|++|++.+..+..+..+.+|+
T Consensus        51 ~v~~L~L~~~~l~g~~~lp~~l-~~-L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~  128 (313)
T d1ogqa_          51 RVNNLDLSGLNLPKPYPIPSSL-AN-LPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLV  128 (313)
T ss_dssp             CEEEEEEECCCCSSCEECCGGG-GG-CTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCC
T ss_pred             EEEEEECCCCCCCCCCCCChHH-hc-Cccccccccccccccccccccccccccccchhhhccccccccccccccchhhhc
Confidence            344455555544432  22222 22 23455666654 566677788888899999999999999888888888899999


Q ss_pred             EEEcccccCcccCCccccccCCccEEEccCccccccCCccccCCCCC-cEEEcCCCCCCCCCCccccccccccccccccc
Q 040845          249 DVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFL-KVLSLGSNELTSIPLNFWSLKDILDLNLSSNC  327 (824)
Q Consensus       249 ~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L-~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~  327 (824)
                      .+++++|.+.+.+|..+..++.++.+++++|.+.+.+|..+..+..+ +.+++++|+++..+...........+++++|.
T Consensus       129 ~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~  208 (313)
T d1ogqa_         129 TLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNM  208 (313)
T ss_dssp             EEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSE
T ss_pred             ccccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            99999999888888889999999999999999988888888888775 88999999988654443333344578999999


Q ss_pred             ccCcCCccccccccchhhhcccccccccCCCccCCCCCCCeEEccCccccccCCccccccccccEEEccCcccCCCCccc
Q 040845          328 FSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVS  407 (824)
Q Consensus       328 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~  407 (824)
                      ..+.+|..+..+++++.+++++|.+.+.+| .++.+++|+.|+|++|++++.+|..|+++++|++|+|++|+|+|.+|. 
T Consensus       209 ~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-  286 (313)
T d1ogqa_         209 LEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-  286 (313)
T ss_dssp             EEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-
T ss_pred             cccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-
Confidence            999999999999999999999999987654 688999999999999999999999999999999999999999999995 


Q ss_pred             ccCCcccceeeccCCc-ccCC
Q 040845          408 LEKLSYLKDLNLSFNK-LKGE  427 (824)
Q Consensus       408 ~~~l~~L~~L~l~~N~-l~~~  427 (824)
                      +.++++|+.+++++|+ ++|.
T Consensus       287 ~~~L~~L~~l~l~~N~~l~g~  307 (313)
T d1ogqa_         287 GGNLQRFDVSAYANNKCLCGS  307 (313)
T ss_dssp             STTGGGSCGGGTCSSSEEEST
T ss_pred             cccCCCCCHHHhCCCccccCC
Confidence            5789999999999998 5654

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.95  E-value=1.7e-26  Score=241.92  Aligned_cols=243  Identities=21%  Similarity=0.228  Sum_probs=139.4

Q ss_pred             CCceeeccCCccccccCccccCCCCCccEEEccCCeeeeecCccccCCCCCceEeccCccccccCCccccCCCCCCEEEc
Q 040845           70 TLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTL  149 (824)
Q Consensus        70 ~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L  149 (824)
                      .+++++.++++++.+|..+.    +++++|+|++|+|+...+..|.++++|++|++++|.+..+.|.+|.++++|++|++
T Consensus        11 ~~~~~~C~~~~L~~lP~~l~----~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l   86 (305)
T d1xkua_          11 HLRVVQCSDLGLEKVPKDLP----PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL   86 (305)
T ss_dssp             ETTEEECTTSCCCSCCCSCC----TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred             cCCEEEecCCCCCccCCCCC----CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecc
Confidence            45566666767776666432    56778888888877555567777888888888888888777777888888888888


Q ss_pred             cCCcCCCCcCcccccccCCCCCCCcEEECcCCCCCccCCccccccccccccEEEeecCcce--ecCCccCCCCCCCCEEE
Q 040845          150 YDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVS--GGIPEEITNLTDLTTIV  227 (824)
Q Consensus       150 ~~n~i~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~--~~~~~~l~~l~~L~~L~  227 (824)
                      ++|+++.++.        .....|+.|++++|.+.++.+..+..  ...+..+....|...  ...+..+..+++|+.++
T Consensus        87 ~~n~l~~l~~--------~~~~~l~~L~~~~n~l~~l~~~~~~~--~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~  156 (305)
T d1xkua_          87 SKNQLKELPE--------KMPKTLQELRVHENEITKVRKSVFNG--LNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIR  156 (305)
T ss_dssp             CSSCCSBCCS--------SCCTTCCEEECCSSCCCBBCHHHHTT--CTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEE
T ss_pred             cCCccCcCcc--------chhhhhhhhhccccchhhhhhhhhhc--cccccccccccccccccCCCccccccccccCccc
Confidence            8888777653        22356777777777777665444322  122333444433221  22233444555555555


Q ss_pred             ecCCccCCccchhhcCCCCCCEEEcccccCcccCCccccccCCccEEEccCccccccCCccccCCCCCcEEEcCCCCCCC
Q 040845          228 LGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTS  307 (824)
Q Consensus       228 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~  307 (824)
                      +++|.+.. +|..  .+++|++|++++|.+....+..+..++.++.|++++|.+.+..+..+.++++|++|+|++|+|+.
T Consensus       157 l~~n~l~~-l~~~--~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~  233 (305)
T d1xkua_         157 IADTNITT-IPQG--LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK  233 (305)
T ss_dssp             CCSSCCCS-CCSS--CCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSS
T ss_pred             cccCCccc-cCcc--cCCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeecccccccc
Confidence            55555542 2222  13455555555555554445555555555555555555554445555555555555555555555


Q ss_pred             CCCccccccccccccccccccc
Q 040845          308 IPLNFWSLKDILDLNLSSNCFS  329 (824)
Q Consensus       308 lp~~~~~l~~L~~L~l~~N~l~  329 (824)
                      +|.++..+++|+.|+|++|+|+
T Consensus       234 lp~~l~~l~~L~~L~Ls~N~i~  255 (305)
T d1xkua_         234 VPGGLADHKYIQVVYLHNNNIS  255 (305)
T ss_dssp             CCTTTTTCSSCCEEECCSSCCC
T ss_pred             cccccccccCCCEEECCCCccC
Confidence            4444444444444444444444

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.94  E-value=7.3e-26  Score=237.02  Aligned_cols=248  Identities=25%  Similarity=0.361  Sum_probs=132.6

Q ss_pred             CcEEEccCCcccccccccccCCCCCCEEeCCCCcCCcccChhhhCcCCCceeeccCCccccccCccccCCCCCccEEEcc
Q 040845           23 LKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLW  102 (824)
Q Consensus        23 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~  102 (824)
                      ++.++-++++++ .+|..+.  +++++|+|++|+|+...+.+|.++++|++|++++|.+..+++... ..+++|++|+++
T Consensus        12 ~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f-~~l~~L~~L~l~   87 (305)
T d1xkua_          12 LRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAF-APLVKLERLYLS   87 (305)
T ss_dssp             TTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTT-TTCTTCCEEECC
T ss_pred             CCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhh-hCCCccCEeccc
Confidence            444555555555 3344442  345555555555553333345555555555555555554433221 245555555555


Q ss_pred             CCeeeeecCccccCCCCCceEeccCccccccCCccccCCCCCCEEEccCCcCCCCcCcccccccCCCCCCCcEEECcCCC
Q 040845          103 GNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNP  182 (824)
Q Consensus       103 ~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~~L~~L~Ls~n~  182 (824)
                      +|+++. +|..+  ...++.|++.+|.+..+.+..+.....+..++...|........   ...+..+++|+.+++++|.
T Consensus        88 ~n~l~~-l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~---~~~~~~l~~L~~l~l~~n~  161 (305)
T d1xkua_          88 KNQLKE-LPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIE---NGAFQGMKKLSYIRIADTN  161 (305)
T ss_dssp             SSCCSB-CCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBC---TTGGGGCTTCCEEECCSSC
T ss_pred             CCccCc-Cccch--hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCC---ccccccccccCccccccCC
Confidence            555552 23222  24556666666666655555555666666666666654333221   1345566667777777666


Q ss_pred             CCccCCccccccccccccEEEeecCcceecCCccCCCCCCCCEEEecCCccCCccchhhcCCCCCCEEEcccccCcccCC
Q 040845          183 LDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIP  262 (824)
Q Consensus       183 l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~  262 (824)
                      +..++..     .                        +++|+.|++++|.+....+..|.+++.+++|++++|.+.+..+
T Consensus       162 l~~l~~~-----~------------------------~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~  212 (305)
T d1xkua_         162 ITTIPQG-----L------------------------PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDN  212 (305)
T ss_dssp             CCSCCSS-----C------------------------CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECT
T ss_pred             ccccCcc-----c------------------------CCccCEEECCCCcCCCCChhHhhcccccccccccccccccccc
Confidence            6543211     1                        2344555555555554445555555555555555555555555


Q ss_pred             ccccccCCccEEEccCccccccCCccccCCCCCcEEEcCCCCCCCCCC
Q 040845          263 DSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPL  310 (824)
Q Consensus       263 ~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~  310 (824)
                      ..+..+++|++|+|++|+|+ .+|..|.++++|++|+|++|+|+.++.
T Consensus       213 ~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~  259 (305)
T d1xkua_         213 GSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGS  259 (305)
T ss_dssp             TTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCT
T ss_pred             ccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCccCh
Confidence            55555556666666666665 335566667777777777777776654

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=2e-25  Score=230.90  Aligned_cols=205  Identities=23%  Similarity=0.253  Sum_probs=106.2

Q ss_pred             ccccEEEeecCcceecCCccCCCCCCCCEEEecCCccCCccchhhcCCCCCCEEEcc-cccCcccCCccccccCCccEEE
Q 040845          197 HSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLE-YNQLEGSIPDSICLSVELYELE  275 (824)
Q Consensus       197 ~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~-~n~l~~~~~~~~~~~~~L~~L~  275 (824)
                      .++++|+|++|+|+...+..|.++++|+.|++++|++..+.+..+..++.+..++.. .|.++...+..|..+++|++|+
T Consensus        32 ~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~  111 (284)
T d1ozna_          32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH  111 (284)
T ss_dssp             TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEe
Confidence            344445555555544444556666666666666666665555666666666666543 4445544455555555555555


Q ss_pred             ccCccccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccccccccccccccccccCcCCccccccccchhhhcccccccc
Q 040845          276 LGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLN-FWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSG  354 (824)
Q Consensus       276 l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~-~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~  354 (824)
                      +++|.+....+..+...++|+.+++++|.|+.+|.. |..+++|+.|++++|.++...+..|.++++|+.+++++|++++
T Consensus       112 l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~  191 (284)
T d1ozna_         112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH  191 (284)
T ss_dssp             CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE
T ss_pred             cCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccc
Confidence            555555544555555555555555555555555432 3334444444444444444444444444444444444444444


Q ss_pred             cCCCccCCCCCCCeEEccCccccccCCccccccccccEEEccCcccC
Q 040845          355 IIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLS  401 (824)
Q Consensus       355 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  401 (824)
                      ..|..|..+++|++|++++|++.+..+..|..+++|+.|+|++|++.
T Consensus       192 i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~  238 (284)
T d1ozna_         192 VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV  238 (284)
T ss_dssp             ECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEE
T ss_pred             cChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCC
Confidence            44444444444444444444444444444444444444444444444

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=7.8e-25  Score=226.34  Aligned_cols=205  Identities=21%  Similarity=0.258  Sum_probs=98.3

Q ss_pred             CccEEEccCCeeeeecCccccCCCCCceEeccCccccccCCccccCCCCCCEEEcc-CCcCCCCcCcccccccCCCCCCC
Q 040845           95 NLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLY-DNNLTSSTLDLSFLSSLSNCKSL  173 (824)
Q Consensus        95 ~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~-~n~i~~~~~~~~~~~~l~~l~~L  173 (824)
                      ++++|+|++|+|+...+..|.++++|++|++++|++..+.+..+.+++.++.+... .|.++.++.     ..++++++|
T Consensus        33 ~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~-----~~~~~l~~L  107 (284)
T d1ozna_          33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDP-----ATFHGLGRL  107 (284)
T ss_dssp             TCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCT-----TTTTTCTTC
T ss_pred             CCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccc-----hhhcccccC
Confidence            45555555555554444555555555555555555555555555555555555443 334444432     235555555


Q ss_pred             cEEECcCCCCCccCCccccccccccccEEEeecCcceecCCccCCCCCCCCEEEecCCccCCccchhhcCCCCCCEEEcc
Q 040845          174 THISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLE  253 (824)
Q Consensus       174 ~~L~Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  253 (824)
                      ++|++++|.+..+.+..+..  ..+|+.+++.+|++++..+..|..+++|+.|++++|+++...+.+|.++++|+.++++
T Consensus       108 ~~L~l~~n~~~~~~~~~~~~--~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~  185 (284)
T d1ozna_         108 HTLHLDRCGLQELGPGLFRG--LAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLH  185 (284)
T ss_dssp             CEEECTTSCCCCCCTTTTTT--CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred             CEEecCCcccccccccccch--hcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhh
Confidence            55555555554332222110  1122222222222222223334444455555555555554444455555555555555


Q ss_pred             cccCcccCCccccccCCccEEEccCccccccCCccccCCCCCcEEEcCCCCCC
Q 040845          254 YNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELT  306 (824)
Q Consensus       254 ~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~  306 (824)
                      +|++++..|..|..+++|++|++++|++.+..+..|+++++|++|++++|.+.
T Consensus       186 ~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~  238 (284)
T d1ozna_         186 QNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV  238 (284)
T ss_dssp             SSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEE
T ss_pred             hccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCC
Confidence            55555444444444455555555555554444444445555555555444443

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=1.8e-24  Score=221.00  Aligned_cols=203  Identities=23%  Similarity=0.182  Sum_probs=156.5

Q ss_pred             CCCCCEEEecCCccCCccchhhcCCCCCCEEEcccccCcccCCccccccCCccEEEccCccccccCCccccCCCCCcEEE
Q 040845          220 LTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLS  299 (824)
Q Consensus       220 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~  299 (824)
                      ...+.+++.++++++ .+|..+.  +++++|+|++|+|++..+..|..+++|++|+|++|+|+...  .++.+++|++|+
T Consensus         9 ~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~--~~~~l~~L~~L~   83 (266)
T d1p9ag_           9 VASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQ--VDGTLPVLGTLD   83 (266)
T ss_dssp             STTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEE--CCSCCTTCCEEE
T ss_pred             cCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhccccccccccccccccccc--cccccccccccc
Confidence            345555666666666 3444332  45667777777776555566666777777777777766432  246677888888


Q ss_pred             cCCCCCCCCCCcccccccccccccccccccCcCCccccccccchhhhcccccccccCCCccCCCCCCCeEEccCcccccc
Q 040845          300 LGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGS  379 (824)
Q Consensus       300 L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  379 (824)
                      |++|+++.++..+..+++|+.|++++|.+....+..+..+.+++.|++++|.++...+..+..+++|+.|++++|+|++.
T Consensus        84 Ls~N~l~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~  163 (266)
T d1p9ag_          84 LSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTEL  163 (266)
T ss_dssp             CCSSCCSSCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCC
T ss_pred             cccccccccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhccccccccccc
Confidence            88888887777777788888888888888777777888888888999999998887778888889999999999999877


Q ss_pred             CCccccccccccEEEccCcccCCCCcccccCCcccceeeccCCcccCCC
Q 040845          380 IPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEI  428 (824)
Q Consensus       380 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~  428 (824)
                      .+..|..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|.|.+
T Consensus       164 ~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC  211 (266)
T d1p9ag_         164 PAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNC  211 (266)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred             CccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCCc
Confidence            7788888999999999999998 88888888888999999888887754

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=4.1e-24  Score=218.29  Aligned_cols=206  Identities=26%  Similarity=0.250  Sum_probs=184.8

Q ss_pred             cCCCCCCEEEcccccCcccCCccccccCCccEEEccCccccccCCccccCCCCCcEEEcCCCCCCCCCCccccccccccc
Q 040845          242 GKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDL  321 (824)
Q Consensus       242 ~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L  321 (824)
                      .+...+.+++.+++.++ .+|..+.  +++++|+|++|+|++..+..|.++++|++|+|++|+|+.+|. +..+++|+.|
T Consensus         7 ~~~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~~-~~~l~~L~~L   82 (266)
T d1p9ag_           7 SKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV-DGTLPVLGTL   82 (266)
T ss_dssp             ECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC-CSCCTTCCEE
T ss_pred             cccCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccccc-cccccccccc
Confidence            45667788899999999 5676653  689999999999998888899999999999999999999874 5679999999


Q ss_pred             ccccccccCcCCccccccccchhhhcccccccccCCCccCCCCCCCeEEccCccccccCCccccccccccEEEccCcccC
Q 040845          322 NLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLS  401 (824)
Q Consensus       322 ~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  401 (824)
                      +|++|+++ ..+..+.++++|+.|++++|.+.+..+..+..+.+++.|++++|.++...+..+..+++|+.|++++|+|+
T Consensus        83 ~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~  161 (266)
T d1p9ag_          83 DLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT  161 (266)
T ss_dssp             ECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCS
T ss_pred             cccccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhccccccccc
Confidence            99999998 45778999999999999999999888899999999999999999999877888899999999999999999


Q ss_pred             CCCcccccCCcccceeeccCCcccCCCCCCCCccccccccccCCccccCCC
Q 040845          402 GTIPVSLEKLSYLKDLNLSFNKLKGEIPRGGSFGNFSAESFKGNELLCGSP  452 (824)
Q Consensus       402 ~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~  452 (824)
                      +..+..+..+++|+.|+|++|+|+..++.......+..+.+.||||.|+|.
T Consensus       162 ~~~~~~~~~l~~L~~L~Ls~N~L~~lp~~~~~~~~L~~L~L~~Np~~CdC~  212 (266)
T d1p9ag_         162 ELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNCE  212 (266)
T ss_dssp             CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCSGG
T ss_pred             ccCccccccccccceeecccCCCcccChhHCCCCCCCEEEecCCCCCCCcc
Confidence            888888999999999999999999554455667788899999999999974

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.88  E-value=4.3e-21  Score=204.72  Aligned_cols=140  Identities=29%  Similarity=0.307  Sum_probs=95.0

Q ss_pred             CCCcEEEccCCcccccccccccCCCCCCEEeCCCCcCCcccChhhhCcCCCceeeccCCccccccCccccCCCCCccEEE
Q 040845           21 SNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLY  100 (824)
Q Consensus        21 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~  100 (824)
                      .++++|+|++|.++ .+|+.   .++|++|+|++|+|+ .+|+.   +.+|+.|++++|+++.++..     .++|++|+
T Consensus        38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~~l~~l-----p~~L~~L~  104 (353)
T d1jl5a_          38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLKALSDL-----PPLLEYLG  104 (353)
T ss_dssp             HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSCCCSC-----CTTCCEEE
T ss_pred             cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccchhhhh-----cccccccc
Confidence            35788888888887 56643   467888888888887 66654   35778888888887765431     24688888


Q ss_pred             ccCCeeeeecCccccCCCCCceEeccCccccccCCccccCCCCCCEEEccCCcCCCCcCcccccccCCCCCCCcEEECcC
Q 040845          101 LWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSN  180 (824)
Q Consensus       101 L~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~~L~~L~Ls~  180 (824)
                      +++|.++ .+|. ++.+++|+.|++++|.+... +   .....+..|.+..+.....       ..+..++.++.|++++
T Consensus       105 L~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~-~---~~~~~l~~l~~~~~~~~~~-------~~l~~l~~l~~L~l~~  171 (353)
T d1jl5a_         105 VSNNQLE-KLPE-LQNSSFLKIIDVDNNSLKKL-P---DLPPSLEFIAAGNNQLEEL-------PELQNLPFLTAIYADN  171 (353)
T ss_dssp             CCSSCCS-SCCC-CTTCTTCCEEECCSSCCSCC-C---CCCTTCCEEECCSSCCSSC-------CCCTTCTTCCEEECCS
T ss_pred             ccccccc-cccc-hhhhccceeecccccccccc-c---cccccccchhhcccccccc-------ccccccccceeccccc
Confidence            8888877 4443 56677888888887777633 2   2245667777766655432       2356677777777777


Q ss_pred             CCCCcc
Q 040845          181 NPLDGI  186 (824)
Q Consensus       181 n~l~~~  186 (824)
                      |.+...
T Consensus       172 n~~~~~  177 (353)
T d1jl5a_         172 NSLKKL  177 (353)
T ss_dssp             SCCSSC
T ss_pred             cccccc
Confidence            776543

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.88  E-value=1.6e-20  Score=200.15  Aligned_cols=299  Identities=26%  Similarity=0.300  Sum_probs=165.7

Q ss_pred             CCCEEeCCCCcCCcccChhhhCcCCCceeeccCCccccccCccccCCCCCccEEEccCCeeeeecCccccCCCCCceEec
Q 040845           46 NLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLAL  125 (824)
Q Consensus        46 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~L  125 (824)
                      +|++|||++|.++ .+|+.   +++|++|+|++|+|+.+|..     +.+|+.|++++|+++ .++..   .++|++|++
T Consensus        39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~~lp~~-----~~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L  105 (353)
T d1jl5a_          39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLTELPEL-----PQSLKSLLVDNNNLK-ALSDL---PPLLEYLGV  105 (353)
T ss_dssp             TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCSSCCCC-----CTTCCEEECCSSCCS-CCCSC---CTTCCEEEC
T ss_pred             CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCcccccc-----hhhhhhhhhhhcccc-hhhhh---ccccccccc
Confidence            5777788887777 56643   45677777777777766542     356777777777665 22221   234666666


Q ss_pred             cCccccccCCccccCCCCCCEEEccCCcCCCCcCcccccccCCCCCCCcEEECcCCCCCccCCccccccccccccEEEee
Q 040845          126 EMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMY  205 (824)
Q Consensus       126 ~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~~L~~L~l~  205 (824)
                      ++|.+.. +| .++.+++|+.|++++|.++..+.         ....+..+.+..+....                    
T Consensus       106 ~~n~l~~-lp-~~~~l~~L~~L~l~~~~~~~~~~---------~~~~l~~l~~~~~~~~~--------------------  154 (353)
T d1jl5a_         106 SNNQLEK-LP-ELQNSSFLKIIDVDNNSLKKLPD---------LPPSLEFIAAGNNQLEE--------------------  154 (353)
T ss_dssp             CSSCCSS-CC-CCTTCTTCCEEECCSSCCSCCCC---------CCTTCCEEECCSSCCSS--------------------
T ss_pred             ccccccc-cc-chhhhccceeecccccccccccc---------ccccccchhhccccccc--------------------
Confidence            6666663 33 24556666666666666554321         12444555554444332                    


Q ss_pred             cCcceecCCccCCCCCCCCEEEecCCccCCccchhhcCCCCCCEEEcccccCcccCCccccccCCccEEEccCccccccC
Q 040845          206 NCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSI  285 (824)
Q Consensus       206 ~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~  285 (824)
                              ...+..++.++.|++++|.+... +.   .....+.+....+.+. ..+ .+..++.|+.+++++|.... .
T Consensus       155 --------~~~l~~l~~l~~L~l~~n~~~~~-~~---~~~~~~~l~~~~~~~~-~~~-~~~~l~~L~~l~l~~n~~~~-~  219 (353)
T d1jl5a_         155 --------LPELQNLPFLTAIYADNNSLKKL-PD---LPLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-L  219 (353)
T ss_dssp             --------CCCCTTCTTCCEEECCSSCCSSC-CC---CCTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-C
T ss_pred             --------cccccccccceeccccccccccc-cc---cccccccccccccccc-ccc-cccccccccccccccccccc-c
Confidence                    23345566666777776666532 11   1223445555555554 222 24456667777777766552 2


Q ss_pred             CccccCCCCCcEEEcCCCCCCCCCCcccccccccccccccccccCcCCcccccc-ccchhhhcccccccccCCCccCCCC
Q 040845          286 PACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNL-KALIEIDFSMNNFSGIIPMEIGSLK  364 (824)
Q Consensus       286 ~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l-~~L~~L~l~~N~l~~~~~~~~~~l~  364 (824)
                      +   ....++..+.+.+|.+...+...   ..+...++..|.+.+.     ..+ ......++..|.+.+.    ...++
T Consensus       220 ~---~~~~~l~~~~~~~~~~~~~~~~~---~~l~~~~~~~~~~~~l-----~~l~~~~~~~~~~~~~~~~~----~~~~~  284 (353)
T d1jl5a_         220 P---DLPPSLEALNVRDNYLTDLPELP---QSLTFLDVSENIFSGL-----SELPPNLYYLNASSNEIRSL----CDLPP  284 (353)
T ss_dssp             C---SCCTTCCEEECCSSCCSCCCCCC---TTCCEEECCSSCCSEE-----SCCCTTCCEEECCSSCCSEE----CCCCT
T ss_pred             c---ccccccccccccccccccccccc---cccccccccccccccc-----ccccchhcccccccCccccc----cccCC
Confidence            2   22345666777777666554332   2333333333333211     111 1223344555555432    23356


Q ss_pred             CCCeEEccCccccccCCccccccccccEEEccCcccCCCCcccccCCcccceeeccCCcccC
Q 040845          365 NLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKG  426 (824)
Q Consensus       365 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~  426 (824)
                      +|++|+|++|+|+ .+|..   +++|+.|+|++|+|+ .+|..   +++|+.|++++|+++.
T Consensus       285 ~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~~  338 (353)
T d1jl5a_         285 SLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLRE  338 (353)
T ss_dssp             TCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCSS
T ss_pred             CCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCCC
Confidence            7777777777777 45543   467777777777777 56643   3467777777777774

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.86  E-value=8.9e-23  Score=196.85  Aligned_cols=169  Identities=17%  Similarity=0.159  Sum_probs=120.3

Q ss_pred             CCCceeeeccceEEEEEEECCCcEEEEEEeecccc------------------chhhhHHHHHHHHhcCCCCcceeEEee
Q 040845          530 SENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCG------------------RAFKSFDVECAMMKSIRHRNLVKVISS  591 (824)
Q Consensus       530 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~l~~~  591 (824)
                      .+.+.||+|+||+||+|+..+|+.||||+++....                  ........|+..+.++.|.+++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            45789999999999999988899999998753211                  012334568899999999999988866


Q ss_pred             eecCCeeEEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecCCCCCCeeeCCCCcEEEeec
Q 040845          592 CSNEEFKALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDF  671 (824)
Q Consensus       592 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df  671 (824)
                      ..    .+++|||++++.+.+        ++...+..++.|++++++|||   +.+|+||||||+|||++++ .++++||
T Consensus        83 ~~----~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~~~liDF  146 (191)
T d1zara2          83 EG----NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-GIWIIDF  146 (191)
T ss_dssp             ET----TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-EEEECCC
T ss_pred             cC----CEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-CEEEEEC
Confidence            42    369999998765433        233446679999999999999   9999999999999999865 4899999


Q ss_pred             ccccccCCCCCccccccccccccccCccCcCCCCCCccchHHHHHHHH
Q 040845          672 GIAKLLTGEDQSMTQTQTLATIGYMAPEYGREGQVSTNGDVYSFGIML  719 (824)
Q Consensus       672 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l  719 (824)
                      |.|.....+........   +... -.+. ....|+.++|+||..--+
T Consensus       147 G~a~~~~~~~~~~~l~r---d~~~-~~~~-f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         147 PQSVEVGEEGWREILER---DVRN-IITY-FSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             TTCEETTSTTHHHHHHH---HHHH-HHHH-HHHHHCCCCCHHHHHHHH
T ss_pred             CCcccCCCCCcHHHHHH---HHHH-HHHH-HcCCCCCcccHHHHHHHH
Confidence            99976532211100000   0000 0011 135678899999976443

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.82  E-value=2.2e-23  Score=231.24  Aligned_cols=385  Identities=18%  Similarity=0.154  Sum_probs=202.6

Q ss_pred             CCCcEEEccCCcccccc-cccccCCCCCCEEeCCCCcCCc----ccChhhhCcCCCceeeccCCccccccC----ccccC
Q 040845           21 SNLKVLYLYNNRLQGEI-IHEIGHLHNLGFLDLSQNKLLG----TIPAAIFNVSTLKAFAVTNNSLSGCLS----SITDV   91 (824)
Q Consensus        21 ~~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~Ls~n~l~~----~~~~~~~~l~~L~~L~L~~n~l~~~~~----~~~~~   91 (824)
                      .+|+.|++++|++++.. ..-+..+++|++|+|++|.++.    .++.++..+++|++|+|++|+|+....    .....
T Consensus         2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~   81 (460)
T d1z7xw1           2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT   81 (460)
T ss_dssp             EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred             CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence            36889999999998643 3346778999999999999873    345667788999999999998863211    11111


Q ss_pred             CCCCccEEEccCCeeeee----cCccccCCCCCceEeccCccccccCCcccc-----CCCCCCEEEccCCcCCCCcCccc
Q 040845           92 GLPNLEVLYLWGNNFSGT----IPHFIFNASKLSKLALEMNSFSGFIPSTFG-----NLRNLEWLTLYDNNLTSSTLDLS  162 (824)
Q Consensus        92 ~l~~L~~L~L~~n~i~~~----~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~-----~l~~L~~L~L~~n~i~~~~~~~~  162 (824)
                      ...+|++|+|++|+++..    ++..+..+++|++|+|++|.++......+.     .......+......+...... .
T Consensus        82 ~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~-~  160 (460)
T d1z7xw1          82 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCE-P  160 (460)
T ss_dssp             TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHH-H
T ss_pred             CCCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhc-c
Confidence            235799999999988743    455677788999999999988753222221     223344555555444322111 1


Q ss_pred             ccccCCCCCCCcEEECcCCCCCccCCcccc---ccccccccEEEeecCcceec----CCccCCCCCCCCEEEecCCccCC
Q 040845          163 FLSSLSNCKSLTHISLSNNPLDGILPRTYV---GNLSHSLKNFYMYNCNVSGG----IPEEITNLTDLTTIVLGGNKLNG  235 (824)
Q Consensus       163 ~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~---~~l~~~L~~L~l~~n~l~~~----~~~~l~~l~~L~~L~L~~n~l~~  235 (824)
                      ....+.....++.++++++.+.......+.   .........+.+.++.+...    ....+...+.++.+++++|.+..
T Consensus       161 ~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~  240 (460)
T d1z7xw1         161 LASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGD  240 (460)
T ss_dssp             HHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhccccc
Confidence            123345667788888887776432111111   11122344555555544311    11122344556666666665532


Q ss_pred             c-----cchhhcCCCCCCEEEcccccCcccC----CccccccCCccEEEccCccccccCCcc-----ccCCCCCcEEEcC
Q 040845          236 S-----IPITLGKLQKLQDVDLEYNQLEGSI----PDSICLSVELYELELGGNKLSGSIPAC-----FSNMTFLKVLSLG  301 (824)
Q Consensus       236 ~-----~~~~~~~l~~L~~L~L~~n~l~~~~----~~~~~~~~~L~~L~l~~n~l~~~~~~~-----~~~l~~L~~L~L~  301 (824)
                      .     ....+.....++.|++++|.+....    ...+...+.++.+++++|.+++.....     ....+.|+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~  320 (460)
T d1z7xw1         241 VGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVK  320 (460)
T ss_dssp             HHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECT
T ss_pred             cccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhcccccccccccccccc
Confidence            1     1222334456666666666654221    122334455666666666554221111     1122345555555


Q ss_pred             CCCCCCCCCcccccccccccccccccccCcCCccccccccchhhhccccccccc----CCCcc-CCCCCCCeEEccCccc
Q 040845          302 SNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGI----IPMEI-GSLKNLENLFLEYNRL  376 (824)
Q Consensus       302 ~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~----~~~~~-~~l~~L~~L~L~~N~l  376 (824)
                      +|.++.....                   .+...+...++|++|+|++|+|++.    ++..+ ...+.|++|+|++|.|
T Consensus       321 ~~~l~~~~~~-------------------~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i  381 (460)
T d1z7xw1         321 SCSFTAACCS-------------------HFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDV  381 (460)
T ss_dssp             TSCCBGGGHH-------------------HHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCC
T ss_pred             ccchhhhhhh-------------------hcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCC
Confidence            5555432111                   0011122333455555555555431    11112 1234566666666666


Q ss_pred             ccc----CCccccccccccEEEccCcccCCCCccc----cc-CCcccceeeccCCccc
Q 040845          377 EGS----IPDSFGDLISLKSLNLSYNNLSGTIPVS----LE-KLSYLKDLNLSFNKLK  425 (824)
Q Consensus       377 ~~~----~~~~~~~l~~L~~L~L~~N~l~~~~p~~----~~-~l~~L~~L~l~~N~l~  425 (824)
                      ++.    +++.+..+++|++|+|++|+|+......    +. ....|+.|++.+|.+.
T Consensus       382 ~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~  439 (460)
T d1z7xw1         382 SDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS  439 (460)
T ss_dssp             CHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCC
T ss_pred             ChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCC
Confidence            531    2233444566666666666665322211    21 2224666666666654

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.79  E-value=2e-19  Score=178.50  Aligned_cols=76  Identities=24%  Similarity=0.393  Sum_probs=33.2

Q ss_pred             CCCCCEEEecCCccCCccchhhcCCCCCCEEEcccccCcccCCccccccCCccEEEccCccccccCCccccCCCCCcEEE
Q 040845          220 LTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLS  299 (824)
Q Consensus       220 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~  299 (824)
                      +++|+.|++++|.+....  .+.++++|++|+|++|++++. + .++.+++|++|++++|++++..+  ++++++|+.|+
T Consensus       150 ~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~i~~--l~~l~~L~~L~  223 (227)
T d1h6ua2         150 LTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVT  223 (227)
T ss_dssp             CTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEE
T ss_pred             ccccccccccccccccch--hhcccccceecccCCCccCCC-h-hhcCCCCCCEEECcCCcCCCCcc--cccCCCCCEEE
Confidence            344455555555444221  244445555555555554421 1 13444444444444444443221  44444455544


Q ss_pred             cC
Q 040845          300 LG  301 (824)
Q Consensus       300 L~  301 (824)
                      ++
T Consensus       224 ls  225 (227)
T d1h6ua2         224 LT  225 (227)
T ss_dssp             EE
T ss_pred             ee
Confidence            43

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.79  E-value=2.3e-19  Score=178.00  Aligned_cols=206  Identities=17%  Similarity=0.275  Sum_probs=131.8

Q ss_pred             CCceeeccCCccccccCccccCCCCCccEEEccCCeeeeecCccccCCCCCceEeccCccccccCCccccCCCCCCEEEc
Q 040845           70 TLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTL  149 (824)
Q Consensus        70 ~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L  149 (824)
                      ++..++++.+++++...   ...+.+|+.|++++|.|+. ++ .+..+++|++|++++|++++..  .+.++++|++|++
T Consensus        20 ~~~~~~l~~~~~~d~~~---~~~l~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~ls~n~i~~~~--~l~~l~~l~~l~~   92 (227)
T d1h6ua2          20 NAIKIAAGKSNVTDTVT---QADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLA--PLKNLTKITELEL   92 (227)
T ss_dssp             HHHHHHTTCSSTTSEEC---HHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCG--GGTTCCSCCEEEC
T ss_pred             HHHHHHhCCCCcCCcCC---HHHcCCcCEEECCCCCCCc-ch-hHhcCCCCcEeecCCceeeccc--ccccccccccccc
Confidence            33445555555554332   1235677777777777763 33 4677777777777777777543  3777888888888


Q ss_pred             cCCcCCCCcCcccccccCCCCCCCcEEECcCCCCCccCCccccccccccccEEEeecCcceecCCccCCCCCCCCEEEec
Q 040845          150 YDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLG  229 (824)
Q Consensus       150 ~~n~i~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~  229 (824)
                      ++|.++.++       ++..+++|+.+++++|...+.                            ..+...+.++.+.++
T Consensus        93 ~~n~~~~i~-------~l~~l~~L~~l~l~~~~~~~~----------------------------~~~~~~~~~~~l~~~  137 (227)
T d1h6ua2          93 SGNPLKNVS-------AIAGLQSIKTLDLTSTQITDV----------------------------TPLAGLSNLQVLYLD  137 (227)
T ss_dssp             CSCCCSCCG-------GGTTCTTCCEEECTTSCCCCC----------------------------GGGTTCTTCCEEECC
T ss_pred             ccccccccc-------ccccccccccccccccccccc----------------------------chhccccchhhhhch
Confidence            888776643       366777888888777766533                            123445677777777


Q ss_pred             CCccCCccchhhcCCCCCCEEEcccccCcccCCccccccCCccEEEccCccccccCCccccCCCCCcEEEcCCCCCCCCC
Q 040845          230 GNKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIP  309 (824)
Q Consensus       230 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp  309 (824)
                      ++.+...  ..+.+.++|++|++++|.+.+.  ..+..+++|+.|++++|++++..  .++++++|++|+|++|+|++++
T Consensus       138 ~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~Ls~n~l~~l~--~l~~l~~L~~L~Ls~N~lt~i~  211 (227)
T d1h6ua2         138 LNQITNI--SPLAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNKISDIS--PLASLPNLIEVHLKNNQISDVS  211 (227)
T ss_dssp             SSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECTTSCCCBCG
T ss_pred             hhhhchh--hhhccccccccccccccccccc--hhhcccccceecccCCCccCCCh--hhcCCCCCCEEECcCCcCCCCc
Confidence            7777643  2366777888888888877632  23566677777777777766432  2666677777777777766665


Q ss_pred             Ccccccccccccccc
Q 040845          310 LNFWSLKDILDLNLS  324 (824)
Q Consensus       310 ~~~~~l~~L~~L~l~  324 (824)
                      . +..+++|+.|+++
T Consensus       212 ~-l~~l~~L~~L~ls  225 (227)
T d1h6ua2         212 P-LANTSNLFIVTLT  225 (227)
T ss_dssp             G-GTTCTTCCEEEEE
T ss_pred             c-cccCCCCCEEEee
Confidence            2 4455555555554

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.78  E-value=5.4e-19  Score=177.43  Aligned_cols=219  Identities=16%  Similarity=0.134  Sum_probs=118.7

Q ss_pred             cEEECcCCCCCccCCccccccccccccEEEeecCcceecCCccCCCCCCCCEEEecCCccCCc-cchhhcCCCCCCEEEc
Q 040845          174 THISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGS-IPITLGKLQKLQDVDL  252 (824)
Q Consensus       174 ~~L~Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L  252 (824)
                      +.++.+++.++.+++.     ++.++++|++++|.|+...+..|.++++|++|++++|.+... .+.+|.+++++++|.+
T Consensus        11 ~~i~c~~~~l~~iP~~-----l~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~   85 (242)
T d1xwdc1          11 RVFLCQESKVTEIPSD-----LPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRI   85 (242)
T ss_dssp             SEEEEESCSCSSCCSC-----SCSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEE
T ss_pred             CEEEEeCCCCCCcCCC-----CCCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccc
Confidence            4666666666654332     233455555555555544444455555555555555544432 2234444455555444


Q ss_pred             ccccCcccCCccccccCCccEEEccCccccccCCccccCCCCCcEEEcCCCCCCCCCCc--ccccccccccccccccccC
Q 040845          253 EYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLN--FWSLKDILDLNLSSNCFSG  330 (824)
Q Consensus       253 ~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~--~~~l~~L~~L~l~~N~l~~  330 (824)
                      ..                       .|.+....+..|.++++|++|++++|+++..+..  +..+..+..+...++.+..
T Consensus        86 ~~-----------------------~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~  142 (242)
T d1xwdc1          86 EK-----------------------ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHT  142 (242)
T ss_dssp             EC-----------------------CTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCE
T ss_pred             cc-----------------------cccccccccccccccccccccccchhhhccccccccccccccccccccccccccc
Confidence            32                       2334444444555555555555555555544321  2223444444445555554


Q ss_pred             cCCccccccc-cchhhhcccccccccCCCccCCCCCCCe-EEccCccccccCCccccccccccEEEccCcccCCCCcccc
Q 040845          331 PLPLEIRNLK-ALIEIDFSMNNFSGIIPMEIGSLKNLEN-LFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSL  408 (824)
Q Consensus       331 ~~~~~~~~l~-~L~~L~l~~N~l~~~~~~~~~~l~~L~~-L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~  408 (824)
                      ..+..|.+++ .++.|++++|+++.+.+..|. .++++. +++++|+|+...+..|.++++|+.|+|++|+|+...+..|
T Consensus       143 i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~-~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~  221 (242)
T d1xwdc1         143 IERNSFVGLSFESVILWLNKNGIQEIHNCAFN-GTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGL  221 (242)
T ss_dssp             ECTTSSTTSBSSCEEEECCSSCCCEECTTTTT-TCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSC
T ss_pred             ccccccccccccceeeeccccccccccccccc-chhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHH
Confidence            4445555543 566777777777755444443 344443 4567777775445567778888888888888874445567


Q ss_pred             cCCcccceeeccC
Q 040845          409 EKLSYLKDLNLSF  421 (824)
Q Consensus       409 ~~l~~L~~L~l~~  421 (824)
                      .++++|+.+++.+
T Consensus       222 ~~l~~L~~l~~~~  234 (242)
T d1xwdc1         222 ENLKKLRARSTYN  234 (242)
T ss_dssp             TTCCEEESSSEES
T ss_pred             cCCcccccCcCCC
Confidence            7777777776643

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.78  E-value=7e-22  Score=219.00  Aligned_cols=358  Identities=20%  Similarity=0.211  Sum_probs=205.1

Q ss_pred             CCCEEeCCCCcCCcc-cChhhhCcCCCceeeccCCccccccCc-c--ccCCCCCccEEEccCCeeeee----cCccccC-
Q 040845           46 NLGFLDLSQNKLLGT-IPAAIFNVSTLKAFAVTNNSLSGCLSS-I--TDVGLPNLEVLYLWGNNFSGT----IPHFIFN-  116 (824)
Q Consensus        46 ~L~~L~Ls~n~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~-~--~~~~l~~L~~L~L~~n~i~~~----~~~~l~~-  116 (824)
                      +|+.||+++|++++. +.+.+..+++|++|+|++|.++..... +  ....+++|++|+|++|.|+..    +...+.. 
T Consensus         3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~   82 (460)
T d1z7xw1           3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP   82 (460)
T ss_dssp             EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred             CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence            578899999998853 234466678888888888877632110 0  012366777777777777522    1122221 


Q ss_pred             CCCCceEeccCcccccc----CCccccCCCCCCEEEccCCcCCCCcCcccccccC-CCCCCCcEEECcCCCCCccCCccc
Q 040845          117 ASKLSKLALEMNSFSGF----IPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLSSL-SNCKSLTHISLSNNPLDGILPRTY  191 (824)
Q Consensus       117 l~~L~~L~L~~N~i~~~----~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l-~~l~~L~~L~Ls~n~l~~~~~~~~  191 (824)
                      ..+|++|+|++|++++.    ++..+..+++|++|++++|.|+..+... +...+ ........+......+....... 
T Consensus        83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~-l~~~l~~~~~~~~~~~~~~~~~~~~~~~~-  160 (460)
T d1z7xw1          83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQL-LCEGLLDPQCRLEKLQLEYCSLSAASCEP-  160 (460)
T ss_dssp             TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHH-HHHHHTSTTCCCCEEECTTSCCBGGGHHH-
T ss_pred             CCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhh-hhhcccccccccccccccccccchhhhcc-
Confidence            24577777777776643    2344556667777777777665432211 11111 11223333333333322111000 


Q ss_pred             cccccccccEEEeecCcceecCCccCCCCCCCCEEEecCCccCCccc----hhh-cCCCCCCEEEcccccCcccC----C
Q 040845          192 VGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGNKLNGSIP----ITL-GKLQKLQDVDLEYNQLEGSI----P  262 (824)
Q Consensus       192 ~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~----~~~-~~l~~L~~L~L~~n~l~~~~----~  262 (824)
                                           ....+.....++.++++++.+.....    ..+ ........+++..+.+....    .
T Consensus       161 ---------------------~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~  219 (460)
T d1z7xw1         161 ---------------------LASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLC  219 (460)
T ss_dssp             ---------------------HHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHH
T ss_pred             ---------------------cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhccc
Confidence                                 01112334566666766665542111    111 12335556666666554211    1


Q ss_pred             ccccccCCccEEEccCccccc-----cCCccccCCCCCcEEEcCCCCCCCCCC-----cccccccccccccccccccCcC
Q 040845          263 DSICLSVELYELELGGNKLSG-----SIPACFSNMTFLKVLSLGSNELTSIPL-----NFWSLKDILDLNLSSNCFSGPL  332 (824)
Q Consensus       263 ~~~~~~~~L~~L~l~~n~l~~-----~~~~~~~~l~~L~~L~L~~N~l~~lp~-----~~~~l~~L~~L~l~~N~l~~~~  332 (824)
                      ..+...+.++.+++++|++..     .....+.....++.+++++|.+...+.     .+...+.++.+++++|.++...
T Consensus       220 ~~l~~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~  299 (460)
T d1z7xw1         220 GIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEG  299 (460)
T ss_dssp             HHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHH
T ss_pred             ccccccccccccchhhccccccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            223345667777777776542     122334445677788888877764322     2344667777788888775322


Q ss_pred             Cccc-----cccccchhhhcccccccccCCCc----cCCCCCCCeEEccCcccccc----CCcccc-ccccccEEEccCc
Q 040845          333 PLEI-----RNLKALIEIDFSMNNFSGIIPME----IGSLKNLENLFLEYNRLEGS----IPDSFG-DLISLKSLNLSYN  398 (824)
Q Consensus       333 ~~~~-----~~l~~L~~L~l~~N~l~~~~~~~----~~~l~~L~~L~L~~N~l~~~----~~~~~~-~l~~L~~L~L~~N  398 (824)
                      ...+     .....|+.+++++|.++......    +...++|++|+|++|+|++.    +++.+. ..+.|+.|+|++|
T Consensus       300 ~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n  379 (460)
T d1z7xw1         300 ARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADC  379 (460)
T ss_dssp             HHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTS
T ss_pred             cchhhccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCC
Confidence            2111     23357888889988887543332    34567899999999999753    233333 4567999999999


Q ss_pred             ccCCC----CcccccCCcccceeeccCCcccC
Q 040845          399 NLSGT----IPVSLEKLSYLKDLNLSFNKLKG  426 (824)
Q Consensus       399 ~l~~~----~p~~~~~l~~L~~L~l~~N~l~~  426 (824)
                      .|+..    ++..+..+++|++|+|++|+++.
T Consensus       380 ~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~  411 (460)
T d1z7xw1         380 DVSDSSCSSLAATLLANHSLRELDLSNNCLGD  411 (460)
T ss_dssp             CCCHHHHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred             CCChHHHHHHHHHHhcCCCCCEEECCCCcCCH
Confidence            99742    45667788999999999999974

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.77  E-value=1.3e-18  Score=174.49  Aligned_cols=219  Identities=15%  Similarity=0.074  Sum_probs=154.8

Q ss_pred             CCEEEccCCcCCCCcCcccccccCCCCCCCcEEECcCCCCCccCCccccccccccccEEEeecCcceecC-CccCCCCCC
Q 040845          144 LEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGI-PEEITNLTD  222 (824)
Q Consensus       144 L~~L~L~~n~i~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~-~~~l~~l~~  222 (824)
                      .+.++.+++.++++|...        .+++++|+|++|+|..+++..|.+  .++|++|++++|.+...+ +..|.++++
T Consensus        10 ~~~i~c~~~~l~~iP~~l--------~~~l~~L~Ls~n~i~~l~~~~f~~--l~~L~~L~ls~n~~~~~i~~~~f~~l~~   79 (242)
T d1xwdc1          10 NRVFLCQESKVTEIPSDL--------PRNAIELRFVLTKLRVIQKGAFSG--FGDLEKIEISQNDVLEVIEADVFSNLPK   79 (242)
T ss_dssp             SSEEEEESCSCSSCCSCS--------CSCCSEEEEESCCCCEECTTTTTT--CTTCCEEEEESCTTCCEECSSSEESCTT
T ss_pred             CCEEEEeCCCCCCcCCCC--------CCCCCEEECcCCcCCccChhHhhc--cchhhhhhhccccccceeeccccccccc
Confidence            378999999999887532        158999999999999988877755  468999999999987654 557889999


Q ss_pred             CCEEEecC-CccCCccchhhcCCCCCCEEEcccccCcccCCc-cccccCCccEEEccCccccccCCccccCCC-CCcEEE
Q 040845          223 LTTIVLGG-NKLNGSIPITLGKLQKLQDVDLEYNQLEGSIPD-SICLSVELYELELGGNKLSGSIPACFSNMT-FLKVLS  299 (824)
Q Consensus       223 L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~  299 (824)
                      ++++.+.. |++....+..|.++++|++|++++|.+....+. .+..+..+..+..+++.+....+..|.+++ .++.|+
T Consensus        80 l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~  159 (242)
T d1xwdc1          80 LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILW  159 (242)
T ss_dssp             CCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEE
T ss_pred             cccccccccccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeee
Confidence            99999765 688877888899999999999999999754332 234556666777777777777777777664 677788


Q ss_pred             cCCCCCCCCCCcccccccccccccccccccCcCCccccccccchhhhcccccccccCCCccCCCCCCCeEEccCcccccc
Q 040845          300 LGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGS  379 (824)
Q Consensus       300 L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  379 (824)
                      +++|+++.++...+...+++.+                       +++++|+++.+.+..|.++++|+.|+|++|+|+..
T Consensus       160 l~~n~l~~i~~~~~~~~~l~~~-----------------------~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l  216 (242)
T d1xwdc1         160 LNKNGIQEIHNCAFNGTQLDEL-----------------------NLSDNNNLEELPNDVFHGASGPVILDISRTRIHSL  216 (242)
T ss_dssp             CCSSCCCEECTTTTTTCCEEEE-----------------------ECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCC
T ss_pred             cccccccccccccccchhhhcc-----------------------ccccccccccccHHHhcCCCCCCEEECCCCcCCcc
Confidence            8777777776554443333322                       23444455544444456666666666666666644


Q ss_pred             CCccccccccccEEEc
Q 040845          380 IPDSFGDLISLKSLNL  395 (824)
Q Consensus       380 ~~~~~~~l~~L~~L~L  395 (824)
                      .+..|.++++|+.+++
T Consensus       217 ~~~~~~~l~~L~~l~~  232 (242)
T d1xwdc1         217 PSYGLENLKKLRARST  232 (242)
T ss_dssp             CSSSCTTCCEEESSSE
T ss_pred             CHHHHcCCcccccCcC
Confidence            4445555555555444

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.76  E-value=6.2e-19  Score=170.73  Aligned_cols=159  Identities=18%  Similarity=0.239  Sum_probs=84.8

Q ss_pred             ccccccCCcccccCCCCCcEEEccCCcccccccccccCCCCCCEEeCCCCcCCcccChhhhCcCCCceeeccCCcccccc
Q 040845            6 NNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLSGCL   85 (824)
Q Consensus         6 ~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~   85 (824)
                      ++.|.++.|+  .++.++..+.++.+.+++.+  ....+.+|++|++++|.++. + +++..+++|++|++++|++++++
T Consensus         5 ~~pi~~if~d--~~l~~~i~~~l~~~~~~~~~--~~~~l~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~~   78 (199)
T d2omxa2           5 DTPINQIFTD--TALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDIT   78 (199)
T ss_dssp             CEEHHHHSCS--HHHHHHHHHHTTCSSTTSEE--CHHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCG
T ss_pred             CCCcCccccC--HHHHHHHHHHhCCCCCCCcc--CHHHhcCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCcc
Confidence            4455555554  23444445566666666432  23456677777777777763 2 24556666666666666665544


Q ss_pred             CccccCCCCCccEEEccCCeeeeecCccccCCCCCceEeccCccccccCCccccCCCCCCEEEccCCcCCCCcCcccccc
Q 040845           86 SSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFLS  165 (824)
Q Consensus        86 ~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~  165 (824)
                      +   ..++++|++|++++|.+... + .+.++++|+.|++++|.+...  ..+.++++|+.|++++|++..++       
T Consensus        79 ~---l~~l~~L~~L~l~~n~~~~~-~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~~-------  144 (199)
T d2omxa2          79 P---LKNLTKLVDILMNNNQIADI-T-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISDIS-------  144 (199)
T ss_dssp             G---GTTCTTCCEEECCSSCCCCC-G-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCCG-------
T ss_pred             c---ccCCcccccccccccccccc-c-ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhcccc-------
Confidence            3   12455666666666655422 2 245555555555555555532  23455555555555555554332       


Q ss_pred             cCCCCCCCcEEECcCCCCC
Q 040845          166 SLSNCKSLTHISLSNNPLD  184 (824)
Q Consensus       166 ~l~~l~~L~~L~Ls~n~l~  184 (824)
                      .+..+++|++|++++|+++
T Consensus       145 ~l~~~~~L~~L~l~~n~l~  163 (199)
T d2omxa2         145 ALSGLTSLQQLNFSSNQVT  163 (199)
T ss_dssp             GGTTCTTCSEEECCSSCCC
T ss_pred             ccccccccccccccccccc
Confidence            2444555555555555444

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.76  E-value=1.1e-18  Score=167.78  Aligned_cols=175  Identities=24%  Similarity=0.283  Sum_probs=117.7

Q ss_pred             EEEccCccccccCCccccCCCCCcEEEcCCCCCCC-CCC-cccccccccccccccccccCcCCccccccccchhhhcccc
Q 040845          273 ELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTS-IPL-NFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMN  350 (824)
Q Consensus       273 ~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~-lp~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N  350 (824)
                      .++.++++++. +|..+.  +++++|+|++|+|+. ++. .|..+++|+.|+|++|.+....+..|..+++|+.|+|++|
T Consensus        12 ~v~Cs~~~L~~-iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N   88 (192)
T d1w8aa_          12 TVDCTGRGLKE-IPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN   88 (192)
T ss_dssp             EEECTTSCCSS-CCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred             EEEEeCCCcCc-cCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccc
Confidence            45555555552 333221  356666666666653 322 2455666666666666666666777777888888888888


Q ss_pred             cccccCCCccCCCCCCCeEEccCccccccCCccccccccccEEEccCcccCCCCcccccCCcccceeeccCCcccCCCCC
Q 040845          351 NFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKLSYLKDLNLSFNKLKGEIPR  430 (824)
Q Consensus       351 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~  430 (824)
                      +|+.+.+..|.++++|++|+|++|+|++..+++|..+++|++|+|++|++.... ....-...++.+.+..|.++|..|.
T Consensus        89 ~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~-~~~~~~~~l~~~~l~~~~~~c~~p~  167 (192)
T d1w8aa_          89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC-HLAWFAEWLRKKSLNGGAARCGAPS  167 (192)
T ss_dssp             CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG-GGHHHHHHHHHHCCSGGGCBBCSST
T ss_pred             cccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccccccccccccc-chHHHhhhhhhhcccCCCeEeCCCh
Confidence            888777778888888888888888888777778888888888888888887332 2222234567777888888877664


Q ss_pred             CCCccccccccccCCccccCCCC
Q 040845          431 GGSFGNFSAESFKGNELLCGSPN  453 (824)
Q Consensus       431 ~~~~~~~~~~~~~~n~~~c~~~~  453 (824)
                        .+.......+..|...|.++.
T Consensus       168 --~l~~~~l~~L~~n~l~C~~~~  188 (192)
T d1w8aa_         168 --KVRDVQIKDLPHSEFKCSSEN  188 (192)
T ss_dssp             --TTTTSBGGGSCTTTCCCCCC-
T ss_pred             --hhcCCEeeecCHhhCcCCCCC
Confidence              344555566777777787654

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.75  E-value=6.4e-18  Score=164.93  Aligned_cols=178  Identities=22%  Similarity=0.275  Sum_probs=102.2

Q ss_pred             cccccccCCcccccCCCCCcEEEccCCcccccccccccCCCCCCEEeCCCCcCCcccChhhhCcCCCceeeccCCccccc
Q 040845            5 INNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLSGC   84 (824)
Q Consensus         5 ~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~   84 (824)
                      .++.+++.++.  .++.+|++|++++|+++.. + .+..+++|++|+|++|++++. + .+..+++|++|++++|+++++
T Consensus        32 ~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~L~~n~i~~l-~-~~~~l~~L~~L~l~~n~i~~l  105 (210)
T d1h6ta2          32 KKKSVTDAVTQ--NELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDI-K-PLANLKNLGWLFLDENKVKDL  105 (210)
T ss_dssp             TCSCTTSEECH--HHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCCG
T ss_pred             CcCccCCccCH--HHhcCccEEECcCCCCCCc-h-hHhhCCCCCEEeCCCccccCc-c-ccccCcccccccccccccccc
Confidence            34444444432  3455666666666666632 2 356666666666666666632 2 355666666666666666654


Q ss_pred             cCccccCCCCCccEEEccCCeeeeecCccccCCCCCceEeccCccccccCCccccCCCCCCEEEccCCcCCCCcCccccc
Q 040845           85 LSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLSFL  164 (824)
Q Consensus        85 ~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~  164 (824)
                      +.   ..++++|+.|++++|.+.. + ..+..+++|+.+++++|.+++  +..+..+++|+++++++|++++++      
T Consensus       106 ~~---l~~l~~L~~L~l~~~~~~~-~-~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~------  172 (210)
T d1h6ta2         106 SS---LKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIV------  172 (210)
T ss_dssp             GG---GTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCG------
T ss_pred             cc---ccccccccccccccccccc-c-ccccccccccccccccccccc--cccccccccccccccccccccccc------
Confidence            42   1245666666666666542 2 245556666666666666653  234555666666666666665432      


Q ss_pred             ccCCCCCCCcEEECcCCCCCccCCccccccccccccEEEeecCcceecCCccCCCCCCCCEEEecC
Q 040845          165 SSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGG  230 (824)
Q Consensus       165 ~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~  230 (824)
                       .++++++|++|+|++|+|+++                            +.+.++++|++|+|++
T Consensus       173 -~l~~l~~L~~L~Ls~N~i~~l----------------------------~~l~~l~~L~~L~Ls~  209 (210)
T d1h6ta2         173 -PLAGLTKLQNLYLSKNHISDL----------------------------RALAGLKNLDVLELFS  209 (210)
T ss_dssp             -GGTTCTTCCEEECCSSCCCBC----------------------------GGGTTCTTCSEEEEEE
T ss_pred             -cccCCCCCCEEECCCCCCCCC----------------------------hhhcCCCCCCEEEccC
Confidence             255566666666666665432                            2466778888888764

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.75  E-value=6.2e-18  Score=163.56  Aligned_cols=164  Identities=23%  Similarity=0.335  Sum_probs=138.8

Q ss_pred             cccccccccCCcccccCCCCCcEEEccCCcccccccccccCCCCCCEEeCCCCcCCcccChhhhCcCCCceeeccCCccc
Q 040845            3 SIINNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLS   82 (824)
Q Consensus         3 ~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~   82 (824)
                      .+.++.+++.++  ...++++++|++++|.|+. + +.++.+++|++|++++|++++..  .+.++++|++|++++|.+.
T Consensus        24 ~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~~--~l~~l~~L~~L~l~~n~~~   97 (199)
T d2omxa2          24 VLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQIA   97 (199)
T ss_dssp             HTTCSSTTSEEC--HHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC
T ss_pred             HhCCCCCCCccC--HHHhcCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCcc--cccCCcccccccccccccc
Confidence            355677777655  3578999999999999994 3 35899999999999999998543  3899999999999999998


Q ss_pred             cccCccccCCCCCccEEEccCCeeeeecCccccCCCCCceEeccCccccccCCccccCCCCCCEEEccCCcCCCCcCccc
Q 040845           83 GCLSSITDVGLPNLEVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDLS  162 (824)
Q Consensus        83 ~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~  162 (824)
                      .++.   ..++++|+.|++++|.+...  ..+..+++|+.|++++|++...  ..+..+++|++|++++|++++++    
T Consensus        98 ~~~~---l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~--~~l~~~~~L~~L~l~~n~l~~l~----  166 (199)
T d2omxa2          98 DITP---LANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISDI--SALSGLTSLQQLNFSSNQVTDLK----  166 (199)
T ss_dssp             CCGG---GTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCCG----
T ss_pred             cccc---cccccccccccccccccccc--cccchhhhhHHhhhhhhhhccc--ccccccccccccccccccccCCc----
Confidence            7664   34689999999999998743  4588899999999999999843  46899999999999999998764    


Q ss_pred             ccccCCCCCCCcEEECcCCCCCcc
Q 040845          163 FLSSLSNCKSLTHISLSNNPLDGI  186 (824)
Q Consensus       163 ~~~~l~~l~~L~~L~Ls~n~l~~~  186 (824)
                         .++++++|++|++++|+++++
T Consensus       167 ---~l~~l~~L~~L~ls~N~i~~i  187 (199)
T d2omxa2         167 ---PLANLTTLERLDISSNKVSDI  187 (199)
T ss_dssp             ---GGTTCTTCCEEECCSSCCCCC
T ss_pred             ---cccCCCCCCEEECCCCCCCCC
Confidence               478999999999999999765

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.74  E-value=2.5e-18  Score=167.85  Aligned_cols=165  Identities=25%  Similarity=0.324  Sum_probs=96.5

Q ss_pred             CCCCCEEEcccccCcccCCccccccCCccEEEccCccccccCCccccCCCCCcEEEcCCCCCCCCCCccccccccccccc
Q 040845          244 LQKLQDVDLEYNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNL  323 (824)
Q Consensus       244 l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l  323 (824)
                      +.+|++|++++|.++..  ..+..+++|++|++++|+|++..  .++.+++|++|++++|+|+.+| .+..+++|+.|++
T Consensus        45 L~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~l~-~l~~l~~L~~L~l  119 (210)
T d1h6ta2          45 LNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKDLS-SLKDLKKLKSLSL  119 (210)
T ss_dssp             HHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCGG-GGTTCTTCCEEEC
T ss_pred             hcCccEEECcCCCCCCc--hhHhhCCCCCEEeCCCccccCcc--ccccCccccccccccccccccc-ccccccccccccc
Confidence            34455555555555422  12444555555555555555322  2445556666666666665555 3555566666666


Q ss_pred             ccccccCcCCccccccccchhhhcccccccccCCCccCCCCCCCeEEccCccccccCCccccccccccEEEccCcccCCC
Q 040845          324 SSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGT  403 (824)
Q Consensus       324 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  403 (824)
                      ++|.+..  ...+..++.++.+++++|.+++.  ..+..+++|+.+++++|++++ ++ .+.++++|+.|+|++|+|+ .
T Consensus       120 ~~~~~~~--~~~l~~l~~l~~l~~~~n~l~~~--~~~~~l~~L~~l~l~~n~l~~-i~-~l~~l~~L~~L~Ls~N~i~-~  192 (210)
T d1h6ta2         120 EHNGISD--INGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISD-IV-PLAGLTKLQNLYLSKNHIS-D  192 (210)
T ss_dssp             TTSCCCC--CGGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC-B
T ss_pred             ccccccc--ccccccccccccccccccccccc--ccccccccccccccccccccc-cc-cccCCCCCCEEECCCCCCC-C
Confidence            6665542  23455666667777777766532  345566777777777777764 32 3667777777777777776 4


Q ss_pred             CcccccCCcccceeeccC
Q 040845          404 IPVSLEKLSYLKDLNLSF  421 (824)
Q Consensus       404 ~p~~~~~l~~L~~L~l~~  421 (824)
                      +| .+.++++|+.|+|++
T Consensus       193 l~-~l~~l~~L~~L~Ls~  209 (210)
T d1h6ta2         193 LR-ALAGLKNLDVLELFS  209 (210)
T ss_dssp             CG-GGTTCTTCSEEEEEE
T ss_pred             Ch-hhcCCCCCCEEEccC
Confidence            54 467777777777653

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.74  E-value=5.2e-18  Score=163.08  Aligned_cols=170  Identities=17%  Similarity=0.211  Sum_probs=106.2

Q ss_pred             EEECcCCCCCccCCccccccccccccEEEeecCcceec-CCccCCCCCCCCEEEecCCccCCccchhhcCCCCCCEEEcc
Q 040845          175 HISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGG-IPEEITNLTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLE  253 (824)
Q Consensus       175 ~L~Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~-~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  253 (824)
                      ++++++++++.++..     +|.++++|+|++|+|++. .+..|.++++|+.|+|++|.+....+..|..+++|++|+|+
T Consensus        12 ~v~Cs~~~L~~iP~~-----lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls   86 (192)
T d1w8aa_          12 TVDCTGRGLKEIPRD-----IPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG   86 (192)
T ss_dssp             EEECTTSCCSSCCSC-----CCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred             EEEEeCCCcCccCCC-----CCCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeec
Confidence            445555555443321     233455555555555432 24456677888888888888887777788888888888888


Q ss_pred             cccCcccCCccccccCCccEEEccCccccccCCccccCCCCCcEEEcCCCCCCCCCCcccccccccccccccccccCcCC
Q 040845          254 YNQLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLP  333 (824)
Q Consensus       254 ~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~  333 (824)
                      +|+|+...+..|..+++|++|+|++|+|+.+.++.|..+++|++|+|++|.+.......+-...++.+.+..|.++...|
T Consensus        87 ~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~~~l~~~~l~~~~~~c~~p  166 (192)
T d1w8aa_          87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP  166 (192)
T ss_dssp             SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSS
T ss_pred             cccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHHHhhhhhhhcccCCCeEeCCC
Confidence            88888777777777888888888888888777777878888888888777776443322222334445555555544334


Q ss_pred             ccccccccchhhhcccccc
Q 040845          334 LEIRNLKALIEIDFSMNNF  352 (824)
Q Consensus       334 ~~~~~l~~L~~L~l~~N~l  352 (824)
                      ..+   ..++.++|+.|.+
T Consensus       167 ~~l---~~~~l~~L~~n~l  182 (192)
T d1w8aa_         167 SKV---RDVQIKDLPHSEF  182 (192)
T ss_dssp             TTT---TTSBGGGSCTTTC
T ss_pred             hhh---cCCEeeecCHhhC
Confidence            322   2333444554444

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.61  E-value=1.1e-16  Score=164.00  Aligned_cols=86  Identities=24%  Similarity=0.230  Sum_probs=56.6

Q ss_pred             CCCccEEEccCCeeeee-cCccccCCCCCceEeccCccccccCCccccCCCCCCEEEccCC-cCCCCcCcccccccCCCC
Q 040845           93 LPNLEVLYLWGNNFSGT-IPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDN-NLTSSTLDLSFLSSLSNC  170 (824)
Q Consensus        93 l~~L~~L~L~~n~i~~~-~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n-~i~~~~~~~~~~~~l~~l  170 (824)
                      ..+|++|+|++|.++.. +...+..+++|++|+|++|.+++..+..++++++|++|+++++ .+++....    .-+..+
T Consensus        45 ~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~----~l~~~~  120 (284)
T d2astb2          45 PFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQ----TLLSSC  120 (284)
T ss_dssp             CBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHH----HHHHHC
T ss_pred             CCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccc----hhhHHH
Confidence            45777777777777533 3445666778888888888777666677777788888888774 44432211    113456


Q ss_pred             CCCcEEECcCCC
Q 040845          171 KSLTHISLSNNP  182 (824)
Q Consensus       171 ~~L~~L~Ls~n~  182 (824)
                      ++|++|+++++.
T Consensus       121 ~~L~~L~ls~c~  132 (284)
T d2astb2         121 SRLDELNLSWCF  132 (284)
T ss_dssp             TTCCEEECCCCT
T ss_pred             Hhcccccccccc
Confidence            788888887753

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.58  E-value=7.7e-17  Score=170.57  Aligned_cols=146  Identities=16%  Similarity=0.202  Sum_probs=72.4

Q ss_pred             CCCCCCEEEccCCcCCCCcCcccccccCCCCCCCcEEECcCCCCCccCCccccccccccccEEEeecCcceecCCccCCC
Q 040845          140 NLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTHISLSNNPLDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITN  219 (824)
Q Consensus       140 ~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~  219 (824)
                      ..+.|+.|++++|+++..... .+...+..++.|++|+|++|.|.......                     .+...+..
T Consensus       156 ~~~~L~~l~l~~n~i~~~~~~-~l~~~l~~~~~L~~L~L~~n~i~~~g~~~---------------------~l~~~l~~  213 (344)
T d2ca6a1         156 NAPPLRSIICGRNRLENGSMK-EWAKTFQSHRLLHTVKMVQNGIRPEGIEH---------------------LLLEGLAY  213 (344)
T ss_dssp             TCCCCCEEECCSSCCTGGGHH-HHHHHHHHCTTCCEEECCSSCCCHHHHHH---------------------HHHTTGGG
T ss_pred             cCcccceeecccccccccccc-cccchhhhhhhhccccccccccccccccc---------------------chhhhhcc
Confidence            345666666666666543221 12233445566666666666654211000                     11223445


Q ss_pred             CCCCCEEEecCCccCCc----cchhhcCCCCCCEEEcccccCcccCCcccc------ccCCccEEEccCccccccC----
Q 040845          220 LTDLTTIVLGGNKLNGS----IPITLGKLQKLQDVDLEYNQLEGSIPDSIC------LSVELYELELGGNKLSGSI----  285 (824)
Q Consensus       220 l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~------~~~~L~~L~l~~n~l~~~~----  285 (824)
                      +++|+.|+|++|.++..    +...+..+++|++|+|++|.|++.....++      ..+.|++|++++|.|+...    
T Consensus       214 ~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l  293 (344)
T d2ca6a1         214 CQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTL  293 (344)
T ss_dssp             CTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHH
T ss_pred             hhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHH
Confidence            56666666666666432    223455666666666666666543222221      1234555666665554221    


Q ss_pred             Ccccc-CCCCCcEEEcCCCCCCC
Q 040845          286 PACFS-NMTFLKVLSLGSNELTS  307 (824)
Q Consensus       286 ~~~~~-~l~~L~~L~L~~N~l~~  307 (824)
                      ...+. +.++|+.|+|++|++..
T Consensus       294 ~~~l~~~~~~L~~L~l~~N~~~~  316 (344)
T d2ca6a1         294 KTVIDEKMPDLLFLELNGNRFSE  316 (344)
T ss_dssp             HHHHHHHCTTCCEEECTTSBSCT
T ss_pred             HHHHHccCCCCCEEECCCCcCCC
Confidence            12221 34556666666666554

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.58  E-value=3e-16  Score=160.64  Aligned_cols=225  Identities=16%  Similarity=0.130  Sum_probs=134.3

Q ss_pred             cEEEccCCcccccccccccCCCCCCEEeCCCCcCCcccChhhhCcCCCceeeccCCccccccCccccCCCCCccEEEccC
Q 040845           24 KVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWG  103 (824)
Q Consensus        24 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~  103 (824)
                      ++|||+++.+.......+-. ..+..+.++...+... ........+|++|++++|.++..........+++|++|+|++
T Consensus         3 ~~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~~~-~~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~   80 (284)
T d2astb2           3 QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQP-LAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEG   80 (284)
T ss_dssp             SEEECTTCBCCHHHHHHHHH-TTCSEEECTTCEECSC-CCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTT
T ss_pred             CEEECCCCCCCchHHHHHHh-ccceEeeccccccccc-hhhhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccc
Confidence            46788887776332222221 2355667766665522 223345567888888888776432222234578888888888


Q ss_pred             CeeeeecCccccCCCCCceEeccCc-cccccC-CccccCCCCCCEEEccCC-cCCCCcCcccccccCC-CCCCCcEEECc
Q 040845          104 NNFSGTIPHFIFNASKLSKLALEMN-SFSGFI-PSTFGNLRNLEWLTLYDN-NLTSSTLDLSFLSSLS-NCKSLTHISLS  179 (824)
Q Consensus       104 n~i~~~~~~~l~~l~~L~~L~L~~N-~i~~~~-~~~~~~l~~L~~L~L~~n-~i~~~~~~~~~~~~l~-~l~~L~~L~Ls  179 (824)
                      |.+++..+..+..+++|++|+|+++ .+++.. ...+.++++|++|+++++ .+++....    ..+. ..++|+.|+++
T Consensus        81 ~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~----~~~~~~~~~L~~L~l~  156 (284)
T d2astb2          81 LRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQ----VAVAHVSETITQLNLS  156 (284)
T ss_dssp             CBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHH----HHHHHSCTTCCEEECC
T ss_pred             cCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccch----hhhcccccccchhhhc
Confidence            8887777777888888999999885 565332 122356788999999885 34332111    1122 24678888887


Q ss_pred             CCC--CCccCCccccccccccccEEEeecCcceecCCccCCCCCCCCEEEecCC-ccCCccchhhcCCCCCCEEEcccc-
Q 040845          180 NNP--LDGILPRTYVGNLSHSLKNFYMYNCNVSGGIPEEITNLTDLTTIVLGGN-KLNGSIPITLGKLQKLQDVDLEYN-  255 (824)
Q Consensus       180 ~n~--l~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~L~~n-  255 (824)
                      ++.  +++..-                         ...+.++++|++|++++| .+++.....+..+++|++|+|++| 
T Consensus       157 ~~~~~i~~~~l-------------------------~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~  211 (284)
T d2astb2         157 GYRKNLQKSDL-------------------------STLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCY  211 (284)
T ss_dssp             SCGGGSCHHHH-------------------------HHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCT
T ss_pred             ccccccccccc-------------------------cccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCC
Confidence            642  221111                         111234566666666664 355455556666677777777664 


Q ss_pred             cCcccCCccccccCCccEEEccCc
Q 040845          256 QLEGSIPDSICLSVELYELELGGN  279 (824)
Q Consensus       256 ~l~~~~~~~~~~~~~L~~L~l~~n  279 (824)
                      .+++.....++.+++|+.|+++++
T Consensus       212 ~i~~~~l~~L~~~~~L~~L~l~~~  235 (284)
T d2astb2         212 DIIPETLLELGEIPTLKTLQVFGI  235 (284)
T ss_dssp             TCCGGGGGGGGGCTTCCEEECTTS
T ss_pred             CCChHHHHHHhcCCCCCEEeeeCC
Confidence            455555555666677777777665

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.57  E-value=8.8e-16  Score=142.07  Aligned_cols=132  Identities=17%  Similarity=0.181  Sum_probs=68.5

Q ss_pred             ccCCCCCcEEEccCCcccccccccccCCCCCCEEeCCCCcCCcccChhhhCcCCCceeeccCCccccccCccccCCCCCc
Q 040845           17 IDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNL   96 (824)
Q Consensus        17 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L   96 (824)
                      |.+..+|++|+|++|+|+ .+++.+..+++|++|||++|+|+. + +.|..                         +++|
T Consensus        14 ~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~-l-~~~~~-------------------------l~~L   65 (162)
T d1a9na_          14 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK-L-DGFPL-------------------------LRRL   65 (162)
T ss_dssp             EECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCE-E-CCCCC-------------------------CSSC
T ss_pred             ccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCc-c-CCccc-------------------------Ccch
Confidence            344455555555555555 234444455555555555555542 2 12333                         5555


Q ss_pred             cEEEccCCeeeeecCccccCCCCCceEeccCccccccCC-ccccCCCCCCEEEccCCcCCCCcCcccccccCCCCCCCcE
Q 040845           97 EVLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIP-STFGNLRNLEWLTLYDNNLTSSTLDLSFLSSLSNCKSLTH  175 (824)
Q Consensus        97 ~~L~L~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~~L~~  175 (824)
                      ++|++++|+++...+..+..+++|++|+|++|+|+.... ..+.++++|++|++++|.++..+.-.  ...++.+++|+.
T Consensus        66 ~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r--~~~i~~lp~L~~  143 (162)
T d1a9na_          66 KTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYR--LYVIYKVPQVRV  143 (162)
T ss_dssp             CEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHH--HHHHHHCTTCSE
T ss_pred             hhhhcccccccCCCccccccccccccceeccccccccccccccccccccchhhcCCCccccccchH--HHHHHHCCCcCe
Confidence            555555555554444444555666666666666553321 34566666666666666665543100  012455666776


Q ss_pred             EEC
Q 040845          176 ISL  178 (824)
Q Consensus       176 L~L  178 (824)
                      ||-
T Consensus       144 LD~  146 (162)
T d1a9na_         144 LDF  146 (162)
T ss_dssp             ETT
T ss_pred             eCC
Confidence            653

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.56  E-value=6e-15  Score=129.49  Aligned_cols=102  Identities=26%  Similarity=0.388  Sum_probs=64.4

Q ss_pred             cEEEccCCcccccccccccCCCCCCEEeCCCCcCCcccChhhhCcCCCceeeccCCccccccCccccCCCCCccEEEccC
Q 040845           24 KVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLEVLYLWG  103 (824)
Q Consensus        24 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~  103 (824)
                      |+|+|++|+|+ .++ .++++++|++||+++|+|+ .+|+.+..+++|++|++++|+|++++.   ...+++|++|++++
T Consensus         1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l~~---~~~l~~L~~L~l~~   74 (124)
T d1dcea3           1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENVDG---VANLPRLQELLLCN   74 (124)
T ss_dssp             SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCGG---GTTCSSCCEEECCS
T ss_pred             CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccccCc---cccccccCeEECCC
Confidence            46777777777 333 3777777777777777776 556667777777777777777765542   12466666666666


Q ss_pred             Ceeeeec-CccccCCCCCceEeccCcccc
Q 040845          104 NNFSGTI-PHFIFNASKLSKLALEMNSFS  131 (824)
Q Consensus       104 n~i~~~~-~~~l~~l~~L~~L~L~~N~i~  131 (824)
                      |+|+... ...+..+++|+.|++++|+++
T Consensus        75 N~i~~~~~~~~l~~~~~L~~L~l~~N~i~  103 (124)
T d1dcea3          75 NRLQQSAAIQPLVSCPRLVLLNLQGNSLC  103 (124)
T ss_dssp             SCCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred             CccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence            6665332 134555566666666666655

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.54  E-value=7.1e-17  Score=170.88  Aligned_cols=44  Identities=11%  Similarity=0.155  Sum_probs=22.7

Q ss_pred             ccccCCCCCceEeccCccccccC----CccccCCCCCCEEEccCCcCC
Q 040845          112 HFIFNASKLSKLALEMNSFSGFI----PSTFGNLRNLEWLTLYDNNLT  155 (824)
Q Consensus       112 ~~l~~l~~L~~L~L~~N~i~~~~----~~~~~~l~~L~~L~L~~n~i~  155 (824)
                      ..+....+|+.|+|++|.|....    ...+...++|+.|+++++...
T Consensus        25 ~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~   72 (344)
T d2ca6a1          25 AVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTG   72 (344)
T ss_dssp             HHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTT
T ss_pred             HHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCccc
Confidence            34455566666666666654321    223444555666665555443

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.54  E-value=1.4e-15  Score=140.71  Aligned_cols=127  Identities=20%  Similarity=0.123  Sum_probs=78.3

Q ss_pred             ccCCCCCcEEEcCCCCCCCCCCcccccccccccccccccccCcCCccccccccchhhhcccccccccCCCccCCCCCCCe
Q 040845          289 FSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGIIPMEIGSLKNLEN  368 (824)
Q Consensus       289 ~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~  368 (824)
                      |.+..++++|+|++|+|+.++..+..+++|+.|+|++|.++..  ..|..+++|+.|++++|+++...+..+..+++|++
T Consensus        14 ~~n~~~lr~L~L~~n~I~~i~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~   91 (162)
T d1a9na_          14 YTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTE   91 (162)
T ss_dssp             EECTTSCEEEECTTSCCCSCCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCE
T ss_pred             ccCcCcCcEEECCCCCCCccCccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCcccccccccccc
Confidence            4455556666666666666654444556666666666666532  23566667777777777776555555566777777


Q ss_pred             EEccCccccccC-CccccccccccEEEccCcccCCCCcc----cccCCcccceee
Q 040845          369 LFLEYNRLEGSI-PDSFGDLISLKSLNLSYNNLSGTIPV----SLEKLSYLKDLN  418 (824)
Q Consensus       369 L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~p~----~~~~l~~L~~L~  418 (824)
                      |++++|+|+... ...+..+++|+.|++++|+++ ..|.    .+..+|+|+.||
T Consensus        92 L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~-~~~~~r~~~i~~lp~L~~LD  145 (162)
T d1a9na_          92 LILTNNSLVELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLD  145 (162)
T ss_dssp             EECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEET
T ss_pred             ceeccccccccccccccccccccchhhcCCCccc-cccchHHHHHHHCCCcCeeC
Confidence            777777776321 135667777777777777776 4442    456667777665

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.53  E-value=8.9e-15  Score=128.36  Aligned_cols=118  Identities=22%  Similarity=0.268  Sum_probs=97.2

Q ss_pred             CCcccccccccCCcccccCCCCCcEEEccCCcccccccccccCCCCCCEEeCCCCcCCcccChhhhCcCCCceeeccCCc
Q 040845            1 MPSIINNFLTSTTPKEIDNISNLKVLYLYNNRLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNS   80 (824)
Q Consensus         1 ~~~l~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~   80 (824)
                      +|+|++|+|+...  .++++++|++|+|++|+|+ .+|..|+.+++|++|++++|+|++ +| ++..+++|++|++++|+
T Consensus         2 ~L~Ls~n~l~~l~--~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~   76 (124)
T d1dcea3           2 VLHLAHKDLTVLC--HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNR   76 (124)
T ss_dssp             EEECTTSCCSSCC--CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSC
T ss_pred             EEEcCCCCCCCCc--ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCCc
Confidence            4789999999764  3899999999999999999 577789999999999999999984 44 59999999999999999


Q ss_pred             cccccCccccCCCCCccEEEccCCeeeee---cCccccCCCCCceE
Q 040845           81 LSGCLSSITDVGLPNLEVLYLWGNNFSGT---IPHFIFNASKLSKL  123 (824)
Q Consensus        81 l~~~~~~~~~~~l~~L~~L~L~~n~i~~~---~~~~l~~l~~L~~L  123 (824)
                      +++++.......+++|+.|++++|.++..   .......+++|+.|
T Consensus        77 i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L  122 (124)
T d1dcea3          77 LQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI  122 (124)
T ss_dssp             CCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred             cCCCCCchhhcCCCCCCEEECCCCcCCcCccHHHHHHHHCcCcceE
Confidence            99877544445699999999999999733   12233445666554

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.38  E-value=4.9e-15  Score=142.04  Aligned_cols=109  Identities=25%  Similarity=0.225  Sum_probs=52.8

Q ss_pred             ccccCCccEEEccCccccccCCccccCCCCCcEEEcCCCCCCCCCCcccccccccccccccccccCcCCccccccccchh
Q 040845          265 ICLSVELYELELGGNKLSGSIPACFSNMTFLKVLSLGSNELTSIPLNFWSLKDILDLNLSSNCFSGPLPLEIRNLKALIE  344 (824)
Q Consensus       265 ~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~  344 (824)
                      +..+++|++|+|++|+|+.. + .+.++++|+.|+|++|.|+++|..+..+++|+.|++++|+++..  ..+..+++|+.
T Consensus        44 l~~L~~L~~L~Ls~n~I~~i-~-~l~~l~~L~~L~Ls~N~i~~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l~~L~~  119 (198)
T d1m9la_          44 LSTLKACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIASL--SGIEKLVNLRV  119 (198)
T ss_dssp             HHHTTTCCEEECSEEEESCC-C-CHHHHTTCCEEECCEEEECSCSSHHHHHHHCCEEECSEEECCCH--HHHHHHHHSSE
T ss_pred             HhcccccceeECcccCCCCc-c-cccCCccccChhhccccccccccccccccccccccccccccccc--ccccccccccc
Confidence            33344444444444444422 1 24455555555555555555553333344555555555555421  22445555555


Q ss_pred             hhcccccccccCC-CccCCCCCCCeEEccCcccc
Q 040845          345 IDFSMNNFSGIIP-MEIGSLKNLENLFLEYNRLE  377 (824)
Q Consensus       345 L~l~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~  377 (824)
                      |++++|+|+.... ..+..+++|+.|+|++|.+.
T Consensus       120 L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~  153 (198)
T d1m9la_         120 LYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY  153 (198)
T ss_dssp             EEESEEECCCHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred             cccccchhccccccccccCCCccceeecCCCccc
Confidence            5555555543211 23455555555665555554

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.38  E-value=4.1e-15  Score=142.61  Aligned_cols=151  Identities=17%  Similarity=0.155  Sum_probs=110.8

Q ss_pred             CCCCcEEEccCC--cccccccccccCCCCCCEEeCCCCcCCcccChhhhCcCCCceeeccCCccccccCccccCCCCCcc
Q 040845           20 ISNLKVLYLYNN--RLQGEIIHEIGHLHNLGFLDLSQNKLLGTIPAAIFNVSTLKAFAVTNNSLSGCLSSITDVGLPNLE   97 (824)
Q Consensus        20 l~~L~~L~L~~n--~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~   97 (824)
                      ...++.+++.++  .++ .++.+|+.+++|++|+|++|+|+. ++ .+.++++|++|+|++|+|+.++....  .+++|+
T Consensus        22 ~~~~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~~i~~~~~--~~~~L~   96 (198)
T d1m9la_          22 ATEAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIKKIENLDA--VADTLE   96 (198)
T ss_dssp             CTTCSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEECSCSSHHH--HHHHCC
T ss_pred             ccccceeeeecccCchh-hhhhHHhcccccceeECcccCCCC-cc-cccCCccccChhhccccccccccccc--cccccc
Confidence            344566677665  354 456778889999999999999884 44 58888999999999998887654332  256799


Q ss_pred             EEEccCCeeeeecCccccCCCCCceEeccCccccccCC-ccccCCCCCCEEEccCCcCCCCcCccccc-----ccCCCCC
Q 040845           98 VLYLWGNNFSGTIPHFIFNASKLSKLALEMNSFSGFIP-STFGNLRNLEWLTLYDNNLTSSTLDLSFL-----SSLSNCK  171 (824)
Q Consensus        98 ~L~L~~n~i~~~~~~~l~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~L~~n~i~~~~~~~~~~-----~~l~~l~  171 (824)
                      .|++++|+|+..  ..+..+++|+.|+|++|+|+.... ..|..+++|++|+|++|.+..........     ..+..++
T Consensus        97 ~L~l~~N~i~~l--~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp  174 (198)
T d1m9la_          97 ELWISYNQIASL--SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLP  174 (198)
T ss_dssp             EEECSEEECCCH--HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCS
T ss_pred             cccccccccccc--ccccccccccccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCC
Confidence            999999998843  347788899999999999885432 56888999999999999886654332110     0156788


Q ss_pred             CCcEEE
Q 040845          172 SLTHIS  177 (824)
Q Consensus       172 ~L~~L~  177 (824)
                      +|+.||
T Consensus       175 ~L~~LD  180 (198)
T d1m9la_         175 NLKKLD  180 (198)
T ss_dssp             SCCEES
T ss_pred             CcCEeC
Confidence            999987

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.33  E-value=2.1e-12  Score=118.03  Aligned_cols=109  Identities=18%  Similarity=0.084  Sum_probs=83.6

Q ss_pred             CCCCCEEEecCCccCCccchhhcCCCCCCEEEcccc-cCcccCCccccccCCccEEEccCccccccCCccccCCCCCcEE
Q 040845          220 LTDLTTIVLGGNKLNGSIPITLGKLQKLQDVDLEYN-QLEGSIPDSICLSVELYELELGGNKLSGSIPACFSNMTFLKVL  298 (824)
Q Consensus       220 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n-~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L  298 (824)
                      +...+.++.+++.+. ..|..+..+++|++|++++| .|+...+..|..+++|+.|+|++|+|+.+.+.+|..+++|++|
T Consensus         7 c~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L   85 (156)
T d2ifga3           7 PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRL   85 (156)
T ss_dssp             CSSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEE
T ss_pred             cCCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccce
Confidence            344556777777776 45666777788888888655 4776666778888888888888888887778888888888888


Q ss_pred             EcCCCCCCCCCCccccccccccccccccccc
Q 040845          299 SLGSNELTSIPLNFWSLKDILDLNLSSNCFS  329 (824)
Q Consensus       299 ~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~  329 (824)
                      +|++|+|+.+|...+...+|+.|+|++|++.
T Consensus        86 ~Ls~N~l~~l~~~~~~~~~l~~L~L~~Np~~  116 (156)
T d2ifga3          86 NLSFNALESLSWKTVQGLSLQELVLSGNPLH  116 (156)
T ss_dssp             ECCSSCCSCCCSTTTCSCCCCEEECCSSCCC
T ss_pred             eccCCCCcccChhhhccccccccccCCCccc
Confidence            8888888888877666667888888888875

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.31  E-value=1.4e-12  Score=119.27  Aligned_cols=95  Identities=24%  Similarity=0.236  Sum_probs=58.8

Q ss_pred             Cccccccccchhhhcccc-cccccCCCccCCCCCCCeEEccCccccccCCccccccccccEEEccCcccCCCCcccccCC
Q 040845          333 PLEIRNLKALIEIDFSMN-NFSGIIPMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSLNLSYNNLSGTIPVSLEKL  411 (824)
Q Consensus       333 ~~~~~~l~~L~~L~l~~N-~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l  411 (824)
                      |..+..+++|++|++++| .|+.+.+..|.++++|+.|+|++|+|+...+.+|..+++|+.|+|++|+|+ .+|......
T Consensus        24 p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~  102 (156)
T d2ifga3          24 LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQG  102 (156)
T ss_dssp             TTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS-CCCSTTTCS
T ss_pred             cccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCc-ccChhhhcc
Confidence            333444555555555544 355555566677777777777777777655666777777777777777776 444443334


Q ss_pred             cccceeeccCCcccCCC
Q 040845          412 SYLKDLNLSFNKLKGEI  428 (824)
Q Consensus       412 ~~L~~L~l~~N~l~~~~  428 (824)
                      .+|+.|+|++|+|.|.+
T Consensus       103 ~~l~~L~L~~Np~~C~C  119 (156)
T d2ifga3         103 LSLQELVLSGNPLHCSC  119 (156)
T ss_dssp             CCCCEEECCSSCCCCCG
T ss_pred             ccccccccCCCcccCCc
Confidence            45777777777776543

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.57  E-value=1.7e-07  Score=93.21  Aligned_cols=149  Identities=17%  Similarity=0.118  Sum_probs=106.2

Q ss_pred             HHHHHhhccCCCCceeeeccceEEEEEEECCCcEEEEEEeeccccchhhhHHHHHHHHhcCC-CCcceeEEeeeecCCee
Q 040845          520 LELFQATDKFSENNLIGRGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIR-HRNLVKVISSCSNEEFK  598 (824)
Q Consensus       520 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~  598 (824)
                      .++....++|+..+..+.++.+.||+.... ++.+++|............+.+|...++.+. +--+.+++++..+++..
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~   85 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence            355666677876665544555789998754 6678889876655555667888999988774 33467888888888899


Q ss_pred             EEEEeccCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhcC-----------------------------------
Q 040845          599 ALVLEYMPHGSLEKYLHSSNYSLDIFQRLNIMIDVASALEYLHFG-----------------------------------  643 (824)
Q Consensus       599 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-----------------------------------  643 (824)
                      ++||++++|.++.+......   .   ...++.++++.++.||..                                   
T Consensus        86 ~lv~~~l~G~~~~~~~~~~~---~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (263)
T d1j7la_          86 NLLMSEADGVLCSEEYEDEQ---S---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE  159 (263)
T ss_dssp             EEEEECCSSEEHHHHTTTCS---C---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred             EEEEEecccccccccccccc---c---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence            99999999988866543211   1   233456666666666631                                   


Q ss_pred             ---------------------CCCCeEecCCCCCCeeeCCCCcEEEeeccccc
Q 040845          644 ---------------------YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK  675 (824)
Q Consensus       644 ---------------------~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~  675 (824)
                                           ....++|+|+.|.||++++++.+-++||+.+.
T Consensus       160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                 02237899999999999987767799999775

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.56  E-value=2.1e-09  Score=98.43  Aligned_cols=85  Identities=21%  Similarity=0.160  Sum_probs=42.9

Q ss_pred             CCCccEEEccCCeeeee--cCccccCCCCCceEeccCccccccCCccccCCCCCCEEEccCCcCCCCcCcc-cc-cccCC
Q 040845           93 LPNLEVLYLWGNNFSGT--IPHFIFNASKLSKLALEMNSFSGFIPSTFGNLRNLEWLTLYDNNLTSSTLDL-SF-LSSLS  168 (824)
Q Consensus        93 l~~L~~L~L~~n~i~~~--~~~~l~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~-~~-~~~l~  168 (824)
                      +++|++|+|++|+|+..  ++..+..+++|+.|+|++|+|+...+-.+.+..+|++|++++|.+.....+. .+ ...+.
T Consensus        64 ~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~  143 (162)
T d1koha1          64 IPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRE  143 (162)
T ss_dssp             CTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHT
T ss_pred             CCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHH
Confidence            44555555555555432  1233455666666666666666443323333445666666666665432211 00 01245


Q ss_pred             CCCCCcEEE
Q 040845          169 NCKSLTHIS  177 (824)
Q Consensus       169 ~l~~L~~L~  177 (824)
                      .+|+|+.||
T Consensus       144 ~~P~L~~LD  152 (162)
T d1koha1         144 RFPKLLRLD  152 (162)
T ss_dssp             TSTTCCEET
T ss_pred             HCCCCCEEC
Confidence            567777665

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.50  E-value=4.1e-09  Score=96.49  Aligned_cols=102  Identities=24%  Similarity=0.159  Sum_probs=63.1

Q ss_pred             ccccccccccccccCcCCccccccccchhhhcccccccccC--CCccCCCCCCCeEEccCccccccCCccccccccccEE
Q 040845          316 KDILDLNLSSNCFSGPLPLEIRNLKALIEIDFSMNNFSGII--PMEIGSLKNLENLFLEYNRLEGSIPDSFGDLISLKSL  393 (824)
Q Consensus       316 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  393 (824)
                      ..+..++...|... .++..+.++++|+.|+|++|+|+...  +..+..+++|+.|+|++|.|+...+-.+....+|+.|
T Consensus        42 ~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L  120 (162)
T d1koha1          42 NIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEEL  120 (162)
T ss_dssp             TCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSC
T ss_pred             cchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhcccccee
Confidence            33444444444433 33444556777888888888887542  3445667888888888888874333233444567888


Q ss_pred             EccCcccCCCCcc-------cccCCcccceee
Q 040845          394 NLSYNNLSGTIPV-------SLEKLSYLKDLN  418 (824)
Q Consensus       394 ~L~~N~l~~~~p~-------~~~~l~~L~~L~  418 (824)
                      ++++|+++.....       .+..+|+|+.||
T Consensus       121 ~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD  152 (162)
T d1koha1         121 WLDGNSLSDTFRDQSTYISAIRERFPKLLRLD  152 (162)
T ss_dssp             CCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred             ecCCCCcCcCcccchhHHHHHHHHCCCCCEEC
Confidence            8888888754432       245677777665

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.10  E-value=3.3e-06  Score=83.11  Aligned_cols=130  Identities=18%  Similarity=0.143  Sum_probs=87.8

Q ss_pred             eeeeccc-eEEEEEEECCCcEEEEEEeeccccchhhhHHHHHHHHhcCCC--CcceeEEeeeecCCeeEEEEeccCCCCH
Q 040845          534 LIGRGGF-GSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRH--RNLVKVISSCSNEEFKALVLEYMPHGSL  610 (824)
Q Consensus       534 ~lg~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~L  610 (824)
                      .+..|.. +.||+...+++..+++|.....   ....+..|+..++.+..  -.+.+++++..+++..++||++++|.++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~---~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCcc---CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            4555664 6799999887888999976533   34567788888887743  3366788888888889999999988654


Q ss_pred             HHHhhhCCCCCCHHHHHHHHHHHHHHHHHhhc------------------------------------------------
Q 040845          611 EKYLHSSNYSLDIFQRLNIMIDVASALEYLHF------------------------------------------------  642 (824)
Q Consensus       611 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~------------------------------------------------  642 (824)
                      .+..      .+.   ...+.++++.++-||.                                                
T Consensus        94 ~~~~------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (255)
T d1nd4a_          94 LSSH------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR  164 (255)
T ss_dssp             TTSC------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred             cccc------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHH
Confidence            3210      111   1112233333333331                                                


Q ss_pred             -------CCCCCeEecCCCCCCeeeCCCCcEEEeeccccc
Q 040845          643 -------GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK  675 (824)
Q Consensus       643 -------~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~  675 (824)
                             .....++|+|+.|.||+++++..+.|+||+.+.
T Consensus       165 l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         165 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence                   112347999999999999987777899999775

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.86  E-value=1.7e-06  Score=78.87  Aligned_cols=15  Identities=13%  Similarity=0.344  Sum_probs=7.0

Q ss_pred             hcCCCCCCEEEcccc
Q 040845          241 LGKLQKLQDVDLEYN  255 (824)
Q Consensus       241 ~~~l~~L~~L~L~~n  255 (824)
                      +...++|+.|+++.+
T Consensus       127 L~~n~sL~~l~l~~~  141 (167)
T d1pgva_         127 IEENESLLRVGISFA  141 (167)
T ss_dssp             HHHCSSCCEEECCCC
T ss_pred             HHhCCCccEeeCcCC
Confidence            333455555555443

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.82  E-value=2.8e-06  Score=77.40  Aligned_cols=65  Identities=18%  Similarity=0.294  Sum_probs=37.6

Q ss_pred             cCCCCCcEEEccCC-ccccc----ccccccCCCCCCEEeCCCCcCCcc----cChhhhCcCCCceeeccCCccc
Q 040845           18 DNISNLKVLYLYNN-RLQGE----IIHEIGHLHNLGFLDLSQNKLLGT----IPAAIFNVSTLKAFAVTNNSLS   82 (824)
Q Consensus        18 ~~l~~L~~L~L~~n-~l~~~----~~~~~~~l~~L~~L~Ls~n~l~~~----~~~~~~~l~~L~~L~L~~n~l~   82 (824)
                      .+.++|++|+|+++ .++..    +...+...+.|++|+|++|.+...    +...+...+.|++|+|++|.++
T Consensus        12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~   85 (167)
T d1pgva_          12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT   85 (167)
T ss_dssp             TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred             hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcc
Confidence            44577777777764 45532    233455667777777777777632    2233444455566666555554

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.59  E-value=0.00013  Score=76.23  Aligned_cols=75  Identities=17%  Similarity=0.214  Sum_probs=49.3

Q ss_pred             ceeeeccceEEEEEEECC-CcEEEEEEeeccc-------cchhhhHHHHHHHHhcCC-C--CcceeEEeeeecCCeeEEE
Q 040845          533 NLIGRGGFGSVYKARIRD-GMEVAVKVFNLQC-------GRAFKSFDVECAMMKSIR-H--RNLVKVISSCSNEEFKALV  601 (824)
Q Consensus       533 ~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~lv  601 (824)
                      +.||.|....||+++..+ ++.|+||......       .....+...|++.++.+. +  ..+.+++.+  +++..++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence            468999999999998654 6789999764321       112345667888888763 3  345566554  34456799


Q ss_pred             EeccCCCC
Q 040845          602 LEYMPHGS  609 (824)
Q Consensus       602 ~e~~~~g~  609 (824)
                      ||++++..
T Consensus       110 mE~L~~~~  117 (392)
T d2pula1         110 MEDLSHLK  117 (392)
T ss_dssp             ECCCTTSE
T ss_pred             EeccCCcc
Confidence            99997653

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.40  E-value=1.2e-05  Score=73.03  Aligned_cols=75  Identities=15%  Similarity=0.105  Sum_probs=46.3

Q ss_pred             ccccCCcccccCCCCCcEEEccC-Cccccc----ccccccCCCCCCEEeCCCCcCCcc----cChhhhCcCCCceeeccC
Q 040845            8 FLTSTTPKEIDNISNLKVLYLYN-NRLQGE----IIHEIGHLHNLGFLDLSQNKLLGT----IPAAIFNVSTLKAFAVTN   78 (824)
Q Consensus         8 ~i~~~~p~~~~~l~~L~~L~L~~-n~l~~~----~~~~~~~l~~L~~L~Ls~n~l~~~----~~~~~~~l~~L~~L~L~~   78 (824)
                      +|.+++.....+.+.|++|+|++ +.|+..    +...+...++|++|+|++|.++..    +...+...++|+.|++++
T Consensus         4 ~i~~~l~~~~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~   83 (166)
T d1io0a_           4 DVEETLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVES   83 (166)
T ss_dssp             CHHHHHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCS
T ss_pred             cHHHHHHHHHhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhcc
Confidence            34445555556778888888887 456533    233345777888888888887643    223444456666666666


Q ss_pred             Cccc
Q 040845           79 NSLS   82 (824)
Q Consensus        79 n~l~   82 (824)
                      |.+.
T Consensus        84 ~~~~   87 (166)
T d1io0a_          84 NFIS   87 (166)
T ss_dssp             SCCC
T ss_pred             cccc
Confidence            6554

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.19  E-value=1.2e-05  Score=73.05  Aligned_cols=16  Identities=25%  Similarity=0.320  Sum_probs=7.9

Q ss_pred             hcCCCCCCEEEccccc
Q 040845          241 LGKLQKLQDVDLEYNQ  256 (824)
Q Consensus       241 ~~~l~~L~~L~L~~n~  256 (824)
                      +...++|+.|+++.+.
T Consensus       128 L~~n~~L~~L~l~~~~  143 (166)
T d1io0a_         128 LEKNTTLLKFGYHFTQ  143 (166)
T ss_dssp             HHHCSSCCEEECCCSS
T ss_pred             HHhCCCcCEEeCcCCC
Confidence            3345555555554443

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.12  E-value=0.00021  Score=72.40  Aligned_cols=133  Identities=13%  Similarity=0.131  Sum_probs=78.9

Q ss_pred             ceEEEEEEECCCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcc--eeEEe-----eeecCCeeEEEEeccCCCCH--
Q 040845          540 FGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNL--VKVIS-----SCSNEEFKALVLEYMPHGSL--  610 (824)
Q Consensus       540 ~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~-----~~~~~~~~~lv~e~~~~g~L--  610 (824)
                      --.||+++.++|+.|++|+.+.. ....+++..|...+..|....+  +..+.     .+......+.++++++|..+  
T Consensus        35 EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~  113 (325)
T d1zyla1          35 ENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA  113 (325)
T ss_dssp             SSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred             cceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence            35899999989999999998654 3345678889988888853322  22221     12345677889999976421  


Q ss_pred             ----------------HHHhhhCC----CCCCH----------------------HHHHHHHHHHHHHHHHh-hcCCCCC
Q 040845          611 ----------------EKYLHSSN----YSLDI----------------------FQRLNIMIDVASALEYL-HFGYSAP  647 (824)
Q Consensus       611 ----------------~~~l~~~~----~~~~~----------------------~~~~~i~~~i~~~l~~L-H~~~~~~  647 (824)
                                      +.......    ...+.                      ......+.++...+.-. ......+
T Consensus       114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~  193 (325)
T d1zyla1         114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL  193 (325)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred             CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence                            11111000    11111                      11122233333333222 2233567


Q ss_pred             eEecCCCCCCeeeCCCCcEEEeeccccc
Q 040845          648 VIHCDLKPSNVLLDDNMVAHLSDFGIAK  675 (824)
Q Consensus       648 ivH~Dlk~~Nill~~~~~~kl~Dfg~a~  675 (824)
                      +||+|+.+.||+++++  ..++||+-|.
T Consensus       194 liHgDlh~~NvL~~~~--~~~IDFdd~~  219 (325)
T d1zyla1         194 RLHGDCHAGNILWRDG--PMFVDLDDAR  219 (325)
T ss_dssp             ECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred             eecCCCCcccEEEeCC--ceEEechhcc
Confidence            8999999999999743  4589999776

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.84  E-value=0.0027  Score=63.70  Aligned_cols=157  Identities=15%  Similarity=0.088  Sum_probs=88.9

Q ss_pred             cccHHHHHHhhccCCCCceee-----eccceEEEEEEECCCcEEEEEEeeccccchhhhHHHHHHHHhcCCCCcc--eeE
Q 040845          516 RFSYLELFQATDKFSENNLIG-----RGGFGSVYKARIRDGMEVAVKVFNLQCGRAFKSFDVECAMMKSIRHRNL--VKV  588 (824)
Q Consensus       516 ~~~~~~~~~~~~~~~~~~~lg-----~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l  588 (824)
                      ..+.+++.....+|.++++..     .|---+.|+.+..+| .+++|++...  ...+.+..|.+++..+...++  ...
T Consensus         2 ~ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~--~~~~~l~~~~~~l~~L~~~g~pvp~p   78 (316)
T d2ppqa1           2 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLP   78 (316)
T ss_dssp             CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred             CCCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCC--CCHHHHHHHHHHHHhhhhcccccccc
Confidence            356778888889998866543     455577899987755 4899987543  234556667777777743322  111


Q ss_pred             Eee------eecCCeeEEEEeccCCCCHH--------------HHhhh----CC----CC------------------CC
Q 040845          589 ISS------CSNEEFKALVLEYMPHGSLE--------------KYLHS----SN----YS------------------LD  622 (824)
Q Consensus       589 ~~~------~~~~~~~~lv~e~~~~g~L~--------------~~l~~----~~----~~------------------~~  622 (824)
                      +..      .......+.++.++.+....              ..++.    ..    ..                  ..
T Consensus        79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (316)
T d2ppqa1          79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV  158 (316)
T ss_dssp             CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred             ceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhc
Confidence            111      12234556677776654211              00110    00    00                  00


Q ss_pred             HHHHHHHHHHHHHHHHHhh-cCCCCCeEecCCCCCCeeeCCCCcEEEeeccccc
Q 040845          623 IFQRLNIMIDVASALEYLH-FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK  675 (824)
Q Consensus       623 ~~~~~~i~~~i~~~l~~LH-~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg~a~  675 (824)
                      .......+......+...+ .....++||+|+.+.||+++.+...-++||+.|.
T Consensus       159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             chhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            0111122222333333333 2346789999999999999988877999999875

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.74  E-value=0.0018  Score=67.37  Aligned_cols=72  Identities=17%  Similarity=0.220  Sum_probs=50.2

Q ss_pred             ceeeeccceEEEEEEECC--------CcEEEEEEeeccccchhhhHHHHHHHHhcCC-CCcceeEEeeeecCCeeEEEEe
Q 040845          533 NLIGRGGFGSVYKARIRD--------GMEVAVKVFNLQCGRAFKSFDVECAMMKSIR-HRNLVKVISSCSNEEFKALVLE  603 (824)
Q Consensus       533 ~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  603 (824)
                      +.|+.|-.-.+|++...+        .+.|.+++.. . ........+|..+++.+. +.-..++++++.+    ++|+|
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e  121 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  121 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence            568888889999998654        3567777764 2 223345667999998884 4445678887753    58999


Q ss_pred             ccCCCCH
Q 040845          604 YMPHGSL  610 (824)
Q Consensus       604 ~~~~g~L  610 (824)
                      |++|.++
T Consensus       122 fi~g~~l  128 (395)
T d1nw1a_         122 YIPSRPL  128 (395)
T ss_dssp             CCCEEEC
T ss_pred             EeccccC
Confidence            9987543